PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zhai, B; Hu, FL; Yan, HJ; Zhao, DL; Jin, X; Fang, TS; Pan, SH; Sun, XY; Xu, LS				Zhai, Bo; Hu, Fengli; Yan, Haijiang; Zhao, Dali; Jin, Xin; Fang, Taishi; Pan, Shangha; Sun, Xueying; Xu, Lishan			Bufalin Reverses Resistance to Sorafenib by Inhibiting Akt Activation in Hepatocellular Carcinoma: The Role of Endoplasmic Reticulum Stress	PLOS ONE			English	Article							AUTOPHAGIC CELL-DEATH; OVARIAN-CANCER CELLS; ARSENIC TRIOXIDE; ACQUIRED-RESISTANCE; INDUCED APOPTOSIS; BREAST-CANCER; UP-REGULATION; CROSS-TALK; PATHWAYS; CONTRIBUTES	Sorafenib is the standard first-line therapeutic treatment for patients with advanced hepatocellular carcinoma (HCC), but its use is hampered by the development of drug resistance. The activation of Akt by sorafenib is thought to be responsible for this resistance. Bufalin is the major active ingredient of the traditional Chinese medicine Chan su, which inhibits Akt activation; therefore, Chan su is currently used in the clinic to treat cancer. The present study aimed to investigate the ability of bufalin to reverse both inherent and acquired resistance to sorafenib. Bufalin synergized with sorafenib to inhibit tumor cell proliferation and induce apoptosis. This effect was at least partially due to the ability of bufalin to inhibit Akt activation by sorafenib. Moreover, the ability of bufalin to inactivate Akt depended on endoplasmic reticulum (ER) stress mediated by inositol-requiring enzyme 1 (IRE1). Silencing IRE1 with siRNA blocked the bufalin-induced Akt inactivation, but silencing eukaryotic initiation factor 2 (eIF2) or C/EBP-homologous protein (CHOP) did not have the same effect. Additionally, silencing Akt did not influence IRE1, CHOP or phosphorylated eIF2 alpha expression. Two sorafenib-resistant HCC cell lines, which were established from human HCC HepG2 and Huh7 cells, were refractory to sorafenib-induced growth inhibition but were sensitive to bufalin. Thus, Bufalin reversed acquired resistance to sorafenib by downregulating phosphorylated Akt in an ER-stress-dependent manner via the IRE1 pathway. These findings warrant further studies to examine the utility of bufalin alone or in combination with sorafenib as a first-or second-line treatment after sorafenib failure for advanced HCC.	[Zhai, Bo; Yan, Haijiang; Jin, Xin; Fang, Taishi; Xu, Lishan] Harbin Med Univ, Affiliated Hosp 4, Dept Gen Surg, Harbin, Heilongjiang, Peoples R China; [Hu, Fengli] Harbin Med Univ, Affiliated Hosp 4, Dept Gastroenterol, Harbin, Heilongjiang, Peoples R China; [Zhao, Dali; Pan, Shangha; Sun, Xueying] Harbin Med Univ, Affiliated Hosp 1, Dept Gen Surg, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Xu, LS (corresponding author), Harbin Med Univ, Affiliated Hosp 4, Dept Gen Surg, Harbin, Heilongjiang, Peoples R China.	xulishan001@126.com		Sun, Xueying/0000-0002-8065-8747	National Natural Scientific Foundation of China [81401975]; Natural Science Foundation of Heilongjiang Province [D201250]; Youth Scientific Fund of Heilongjiang Province [QC2013C103]; Heilongjiang Postdoctoral Fund [LBH-Z14219]; Scientific Research Project of Heilongjiang Medical Science Institute [201502]; Science and Technology Research Project of Heilongjiang Province Education Department [12541329]; Heilongjiang Province Health Bureau, China [2014-399]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Youth Scientific Fund of Heilongjiang Province; Heilongjiang Postdoctoral Fund; Scientific Research Project of Heilongjiang Medical Science Institute; Science and Technology Research Project of Heilongjiang Province Education Department; Heilongjiang Province Health Bureau, China	This work was supported in part by grants from the National Natural Scientific Foundation of China (81401975), Natural Science Foundation of Heilongjiang Province (D201250), The Youth Scientific Fund of Heilongjiang Province (QC2013C103), Heilongjiang Postdoctoral Fund (LBH-Z14219), Scientific Research Project of Heilongjiang Medical Science Institute (201502), Science and Technology Research Project of Heilongjiang Province Education Department (12541329), and Heilongjiang Province Health Bureau (2014-399), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottsford-Miller JN, 2012, J CLIN ONCOL, V30, P4026, DOI 10.1200/JCO.2012.41.9242; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Brozovic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076397; Chen J, 2012, LEUKEMIA RES, V36, P1526, DOI 10.1016/j.leukres.2012.08.018; Chen KF, 2011, J PHARMACOL EXP THER, V337, P155, DOI 10.1124/jpet.110.175786; Chen YY, 2015, ENVIRON TOXICOL, V30, P74, DOI 10.1002/tox.21896; Chow SE, 2014, APOPTOSIS, V19, P527, DOI 10.1007/s10495-013-0945-0; Dai RY, 2009, INT J ONCOL, V34, P1749, DOI 10.3892/ijo_00000306; Dong XF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092864; Fan LL, 2013, J PINEAL RES, V55, P184, DOI 10.1111/jpi.12061; Fan LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062627; Gao Y, 2012, MOL BIOL REP, V39, P1683, DOI 10.1007/s11033-011-0908-x; Gedaly R, 2010, ANTICANCER RES, V30, P4951; Gu W, 2014, ONCOL REP, V31, P216, DOI 10.3892/or.2013.2817; He CJ, 2012, CANCER SCI, V103, P528, DOI 10.1111/j.1349-7006.2011.02177.x; Holz MS, 2013, MOL CANCER THER, V12, P173, DOI 10.1158/1535-7163.MCT-12-0532; Hsui CM, 2013, INT J ONCOL, V43, P338, DOI 10.3892/ijo.2013.1942; Hu FL, 2014, APOPTOSIS, V19, P210, DOI 10.1007/s10495-013-0914-7; Huynh H, 2009, J CELL MOL MED, V13, P2673, DOI 10.1111/j.1582-4934.2009.00692.x; Jiang CC, 2009, NEOPLASIA, V11, P436, DOI 10.1593/neo.09208; Jiang HC, 2010, CANCER SCI, V101, P975, DOI 10.1111/j.1349-7006.2009.01464.x; Kato H, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00093; Lackner MR, 2012, FUTURE ONCOL, V8, P999, DOI [10.2217/fon.12.86, 10.2217/FON.12.86]; Lei Y, 2015, ONCOGENE, V34, P485, DOI 10.1038/onc.2013.566; Liu N, 2013, ONCOL REP, V30, P2677, DOI 10.3892/or.2013.2771; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Ma Y, 2011, CANCER LETT, V301, P75, DOI 10.1016/j.canlet.2010.10.022; McCloy RA, 2013, BRIT J CANCER, V109, P3034, DOI 10.1038/bjc.2013.693; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Meng ZQ, 2009, CANCER-AM CANCER SOC, V115, P5309, DOI 10.1002/cncr.24602; Piguet AC, 2011, MOL CANCER THER, V10, P1007, DOI 10.1158/1535-7163.MCT-10-0666; Qi FH, 2011, CANCER SCI, V102, P951, DOI 10.1111/j.1349-7006.2011.01900.x; Qin L, 2010, AUTOPHAGY, V6, P239, DOI 10.4161/auto.6.2.11062; Qiu DZ, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-185; Rong XF, 2014, INFLAMMATION, V37, P1050, DOI 10.1007/s10753-014-9828-y; Santoro A, 2013, LANCET ONCOL, V14, P55, DOI 10.1016/S1470-2045(12)70490-4; Shen SY, 2014, INT J BIOL SCI, V10, P212, DOI 10.7150/ijbs.8056; Shi YH, 2011, AUTOPHAGY, V7, P1159, DOI 10.4161/auto.7.10.16818; Sun XP, 2014, FEBS J, V281, P115, DOI 10.1111/febs.12577; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tsai SC, 2012, INT J ONCOL, V41, P1431, DOI 10.3892/ijo.2012.1579; van Malenstein H, 2013, CANCER LETT, V329, P74, DOI 10.1016/j.canlet.2012.10.021; Wang JZ, 2011, J HEPATOL, V55, P359, DOI 10.1016/j.jhep.2010.10.043; Wang WA, 2014, BBA-MOL CELL RES, V1843, P2143, DOI 10.1016/j.bbamcr.2014.01.012; Wei Z, 2013, TUMOR BIOL, V34, P181, DOI 10.1007/s13277-012-0527-8; Xiu P, 2013, CANCER SCI, V104, P375, DOI 10.1111/cas.12088; Yi P, 2012, MOL CANCER THER, V11, P2610, DOI 10.1158/1535-7163.MCT-12-0516; Zhai B, 2015, TUMOR BIOL, V36, P2323, DOI 10.1007/s13277-014-2839-3; Zhai B, 2014, MOL CANCER THER, V13, P1589, DOI 10.1158/1535-7163.MCT-13-1043; Zhai B, 2013, WORLD J HEPATOL, V5, P345, DOI 10.4254/wjh.v5.i7.345; Zhang DM, 2012, EUR J PHARMACOL, V692, P19, DOI 10.1016/j.ejphar.2012.06.045; Zhang ZJ, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-57; Zhao DL, 2014, CELL SIGNAL, V26, P1030, DOI 10.1016/j.cellsig.2014.01.026; Zheng YZ, 2014, BREAST CANCER RES TR, V145, P349, DOI 10.1007/s10549-014-2967-x; Zhou LD, 2010, MED ONCOL, V27, P255, DOI 10.1007/s12032-009-9201-4; Zhu AX, 2010, ANN SURG ONCOL, V17, P1247, DOI 10.1245/s10434-010-0975-6	56	36	36	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138485	10.1371/journal.pone.0138485	http://dx.doi.org/10.1371/journal.pone.0138485			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381511	Green Published, gold, Green Submitted			2022-12-27	WOS:000361790200114
J	Bentley, KT; Schindler, DE; Armstrong, JB; Cline, TJ; Brooks, GT				Bentley, Kale T.; Schindler, Daniel E.; Armstrong, Jonathan B.; Cline, Timothy J.; Brooks, Gabriel T.			Inter-Tributary Movements by Resident Salmonids across a Boreal Riverscape	PLOS ONE			English	Article							RAINBOW-TROUT; POPULATION DIVERSITY; SOCKEYE-SALMON; BROWN TROUT; HABITAT USE; BULL TROUT; STREAM; FISH; DYNAMICS; ECOLOGY	Stream-dwelling fishes inhabit river networks where resources are distributed heterogeneously across space and time. Current theory emphasizes that fishes often perform largescale movements among habitat patches for reproduction and seeking refugia, but assumes that fish are relatively sedentary during growth phases of their life cycle. Using stationary passive integrated transponder (PIT)-tag antennas and snorkel surveys, we assessed the individual and population level movement patterns of two species of fish across a network of tributaries within the Wood River basin in southwestern Alaska where summer foraging opportunities vary substantially among streams, seasons, and years. Across two years, Arctic grayling (Thymallus arcticus) and rainbow trout (Oncorhynchus mykiss) exhibited kilometer-scale movements among streams during the summer growing season. Although we monitored movements at a small fraction of all tributaries used by grayling and rainbow trout, approximately 50% of individuals moved among two or more streams separated by at least 7 km within a single summer. Movements were concentrated in June and July, and subsided by early August. The decline in movements coincided with spawning by anadromous sockeye salmon, which offer a high-quality resource pulse of food to resident species. Inter-stream movements may represent prospecting behavior as individuals seek out the most profitable foraging opportunities that are patchily distributed across space and time. Our results highlight that large-scale movements may not only be necessary for individuals to fulfill their life-cycle, but also to exploit heterogeneously spaced trophic resources. Therefore, habitat fragmentation and homogenization may have strong, but currently undescribed, ecological effects on the access to critical food resources in stream-dwelling fish populations.	[Bentley, Kale T.; Schindler, Daniel E.; Armstrong, Jonathan B.; Cline, Timothy J.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Armstrong, Jonathan B.] Univ Wyoming, Dept Zool & Physiol, Wyoming Cooperat Fish & Wildlife Res Unit, Laramie, WY 82071 USA; [Brooks, Gabriel T.] NOAA, Fish Ecol Div, NW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Wyoming; National Oceanic Atmospheric Admin (NOAA) - USA	Bentley, KT (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Box 355020, Seattle, WA 98195 USA.	bentley2@uw.edu			National Science Foundation; National Science Foundation Coupled Natural and Human systems program grant [1114918]; Gordon and Betty Moore Foundation	National Science Foundation(National Science Foundation (NSF)); National Science Foundation Coupled Natural and Human systems program grant; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	Funding was provided by National Science Foundation Graduate Research Fellowship to KTB, National Science Foundation Coupled Natural and Human systems program grant to DES (Diversification, Portfolio Effects, and the Sustainability of Fishing Communities, proposal # 1114918), Gordon and Betty Moore Foundation grant to DES (Title: Improve scientific understanding biocomplexity and how it promotes resilience and productivity in salmon ecosystems).	Albanese B, 2004, CAN J FISH AQUAT SCI, V61, P857, DOI 10.1139/F04-096; Armstrong JB, 2013, ECOSYSTEMS, V16, P1429, DOI 10.1007/s10021-013-9693-9; Armstrong JB, 2013, ECOLOGY, V94, P2066, DOI 10.1890/12-1200.1; Armstrong JB, 2010, CAN J FISH AQUAT SCI, V67, P2052, DOI 10.1139/F10-127; Baker TT, 2009, FISHERY MANUSCRIPT S; Benda L, 2004, BIOSCIENCE, V54, P413, DOI 10.1641/0006-3568(2004)054[0413:TNDHHC]2.0.CO;2; Bentley KT, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00231.1; Bentley KT, 2013, T AM FISH SOC, V142, P747, DOI 10.1080/00028487.2013.769899; Berg OK, 2011, J FISH BIOL, V79, P1156, DOI 10.1111/j.1095-8649.2011.03097.x; Biro PA, 2008, P NATL ACAD SCI USA, V105, P2919, DOI 10.1073/pnas.0708159105; Bond MH, 2007, T AM FISH SOC, V136, P562, DOI 10.1577/T06-084.1; Brink SR, 1995, SUMMER HABITAT ECOLO; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; CUNJAK RA, 1987, J FISH BIOL, V31, P493, DOI 10.1111/j.1095-8649.1987.tb05254.x; Delgado MM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2851; Duffield JW, 2007, EC WILD SALMON ECOSY; Dye JE, 2005, FISHERY MANUSCRIPT S; Eastman DE, 1996, RESPONSE FRESHWATER; Ebersole JL, 2001, ECOL FRESHW FISH, V10, P1, DOI 10.1034/j.1600-0633.2001.100101.x; Eide NE, 2004, J ANIM ECOL, V73, P1056, DOI 10.1111/j.0021-8790.2004.00885.x; Fausch KD, 2002, BIOSCIENCE, V52, P483, DOI 10.1641/0006-3568(2002)052[0483:LTRBTG]2.0.CO;2; Frair JL, 2005, LANDSCAPE ECOL, V20, P273, DOI 10.1007/s10980-005-2075-8; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Fryxell JM, 2005, ECOL LETT, V8, P328, DOI 10.1111/j.1461-0248.2005.00727.x; GOWAN C, 1994, CAN J FISH AQUAT SCI, V51, P2626, DOI 10.1139/f94-262; HEGGENES J, 1988, T AM FISH SOC, V117, P336, DOI 10.1577/1548-8659(1988)117<0336:EOSFFO>2.3.CO;2; Lapointe N.W.R., 2013, ENVIRON REV, V22, P1; Lisi PJ, 2013, GEOMORPHOLOGY, V185, P78, DOI 10.1016/j.geomorph.2012.12.013; Meka JM, 2003, T AM FISH SOC, V132, P717, DOI 10.1577/T01-166; Moore JW, 2008, ECOLOGY, V89, P306, DOI 10.1890/07-1269.1; Moore JW, 2008, J ANIM ECOL, V77, P275, DOI 10.1111/j.1365-2656.2007.01336.x; Morita K, 2002, CONSERV BIOL, V16, P1318, DOI 10.1046/j.1523-1739.2002.01476.x; Muhlfeld CC, 2005, N AM J FISH MANAGE, V25, P797, DOI 10.1577/M04-045.1; Northcote T. G., 1997, North American Journal of Fisheries Management, V17, P1029, DOI 10.1577/1548-8675(1997)017<1029:PISAMI>2.3.CO;2; Porto L. M., 1999, North American Journal of Fisheries Management, V19, P1028, DOI 10.1577/1548-8675(1999)019<1028:LHBDRT>2.0.CO;2; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RAHEL FJ, 1991, T AM FISH SOC, V120, P319, DOI 10.1577/1548-8659(1991)120<0319:FAAHGI>2.3.CO;2; Reynolds HV, 1987, BEARS THEIR BIOL MAN, V7, P59, DOI DOI 10.2307/3872608; Rogers LA, 2008, OIKOS, V117, P1578, DOI 10.1111/j.0030-1299.2008.16758.x; Ruff CP, 2011, ECOLOGY, V92, P2073, DOI 10.1890/10-1762.1; Sawyer H., 2014, RED DESERT HOBACK MU; Sawyer H, 2013, J APPL ECOL, V50, P68, DOI 10.1111/1365-2664.12013; Scheuerell MD, 2007, FRESHWATER BIOL, V52, P1944, DOI 10.1111/j.1365-2427.2007.01823.x; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Schindler DE, 2013, BIOL LETT, V9; Schlosser IJ, 1995, AM FISH S S, V17, P392; SCHLOSSER IJ, 1991, BIOSCIENCE, V41, P704, DOI 10.2307/1311765; Schmetterling DA, 2003, N AM J FISH MANAGE, V23, P721, DOI 10.1577/M01-216; Stanford JA, 2005, INT VER THEOR ANGEW, V29, P123; Tockner K, 2006, SPEC PUBL INT ASS SE, V36, P339; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Wang GM, 2006, ECOLOGY, V87, P95, DOI 10.1890/05-0355; Warren ML, 1998, T AM FISH SOC, V127, P637, DOI 10.1577/1548-8659(1998)127<0637:RCABTS>2.0.CO;2; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; WILLSON MF, 1995, CONSERV BIOL, V9, P489, DOI 10.1046/j.1523-1739.1995.09030489.x	55	12	13	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0136985	10.1371/journal.pone.0136985	http://dx.doi.org/10.1371/journal.pone.0136985			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379237	Green Published, Green Submitted, gold			2022-12-27	WOS:000361769400011
J	Ningappa, M; So, J; Glessner, J; Ashokkumar, C; Ranganathan, S; Min, J; Higgs, BW; Sun, Q; Haberman, K; Schmitt, L; Vilarinho, S; Mistry, PK; Vockley, G; Dhawan, A; Gittes, GK; Hakonarson, H; Jaffe, R; Subramaniam, S; Shin, DH; Sindhi, R				Ningappa, Mylarappa; So, Juhoon; Glessner, Joseph; Ashokkumar, Chethan; Ranganathan, Sarangarajan; Min, Jun; Higgs, Brandon W.; Sun, Qing; Haberman, Kimberly; Schmitt, Lori; Vilarinho, Silvia; Mistry, Pramod K.; Vockley, Gerard; Dhawan, Anil; Gittes, George K.; Hakonarson, Hakon; Jaffe, Ronald; Subramaniam, Shankar; Shin, Donghun; Sindhi, Rakesh			The Role of ARF6 in Biliary Atresia	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INTRAHEPATIC BILE-DUCTS; GROWTH-FACTOR; SUSCEPTIBILITY; ZEBRAFISH; CELLS; ACTIVATION; SYSTEM; SIGNAL; EPITHELIA	Background & Aims Altered extrahepatic bile ducts, gut, and cardiovascular anomalies constitute the variable phenotype of biliary atresia (BA). Methods To identify potential susceptibility loci, Caucasian children, normal (controls) and with BA (cases) at two US centers were compared at >550000 SNP loci. Systems biology analysis was carried out on the data. In order to validate a key gene identified in the analysis, biliary morphogenesis was evaluated in 2-5-day post-fertilization zebrafish embryos after morpholino-antisense oligonucleotide knockdown of the candidate gene ADP ribosylation factor-6 (ARF6, Mo-arf6). Results Among 39 and 24 cases at centers 1 and 2, respectively, and 1907 controls, which clustered together on principal component analysis, the SNPs rs3126184 and rs10140366 in a 3' flanking enhancer region for ARF6 demonstrated higher minor allele frequencies (MAF) in each cohort, and 63 combined cases, compared with controls (0.286 vs. 0.131, P = 5.94x10(-7), OR 2.66; 0.286 vs. 0.13, P = 5.57x10(-7), OR 2.66). Significance was enhanced in 77 total cases, which included 14 additional BA genotyped at rs3126184 only (p = 1.58x10(-2), OR = 2.66). Pathway analysis of the 1000 top-ranked SNPs in CHP cases revealed enrichment of genes for EGF regulators (p<1 x10(-7)), ERK/MAPK and CREB canonical pathways (p<1 x10(-34)), and functional networks for cellular development and proliferation (p<1 x10(-45)), further supporting the role of EGFR-ARF6 signaling in BA. In zebrafish embryos, Mo-arf6 injection resulted in a sparse intrahepatic biliary network, several biliary epithelial cell defects, and poor bile excretion to the gall bladder compared with uninjected embryos. Biliary defects were reproduced with the EGFR-blocker AG1478 alone or with Mo-arf6 at lower doses of each agent and rescued with arf6 mRNA. Conclusions The BA-associated SNPs identify a chromosome 14q21.3 susceptibility locus encompassing the ARF6 gene. arf6 knockdown in zebrafish implicates early biliary dysgenesis as a basis for BA, and also suggests a role for EGFR signaling in BA pathogenesis.	[Ningappa, Mylarappa; Ashokkumar, Chethan; Higgs, Brandon W.; Sun, Qing; Haberman, Kimberly; Sindhi, Rakesh] Univ Pittsburgh, Med Ctr UPMC, Childrens Hosp Pittsburgh, Hillman Ctr Pediat Transplantat, Pittsburgh, PA 15224 USA; [So, Juhoon; Shin, Donghun] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA 15261 USA; [So, Juhoon; Shin, Donghun] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15261 USA; [Glessner, Joseph; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Ranganathan, Sarangarajan] UPMC, Childrens Hosp Pittsburgh, Div Pediat Pathol, Dept Pathol, Pittsburgh, PA 15224 USA; [Schmitt, Lori; Jaffe, Ronald] UPMC, Childrens Hosp Pittsburgh, Histol Core Lab, Pittsburgh, PA 15224 USA; [Vilarinho, Silvia; Mistry, Pramod K.] Yale Univ, Sch Med, Dept Internal Med, Sect Digest Dis, New Haven, CT 06510 USA; [Dhawan, Anil] Kings Coll Hosp London, Paediat Liver GI & Nutr, London WC2R 2L5, England; [Gittes, George K.] UPMC, Childrens Hosp Pittsburgh, Pediat Gen & Thorac Surg, Pittsburgh, PA 15224 USA; [Min, Jun; Subramaniam, Shankar] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92013 USA; [Vockley, Gerard] UPMC, Childrens Hosp Pittsburgh, Dept Pediat & Human Genet, Pittsburgh, PA 15224 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yale University; King's College Hospital NHS Foundation Trust; King's College Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sindhi, R (corresponding author), Univ Pittsburgh, Med Ctr UPMC, Childrens Hosp Pittsburgh, Hillman Ctr Pediat Transplantat, Pittsburgh, PA 15224 USA.	rakesh.sindhi@chp.edu	Vockley, Jerry/B-5210-2016	Vockley, Jerry/0000-0002-8180-6457; Vilarinho, Silvia/0000-0002-2099-4212; Ranganathan, Sarangarajan/0000-0001-6214-9167; Higgs, Brandon/0000-0002-2951-0245; Glessner, Joseph/0000-0001-5131-2811; Dhawan, Anil/0000-0002-4942-0845	Hillman Foundation of Pittsburgh; American Liver Foundation; Team Transplant; Herridge family; Giventer-Braff family; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034989] Funding Source: NIH RePORTER	Hillman Foundation of Pittsburgh; American Liver Foundation; Team Transplant; Herridge family; Giventer-Braff family; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the Hillman Foundation of Pittsburgh, The American Liver Foundation, Team Transplant, the Herridge and Giventer-Braff families. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 1998, DEV GENET, V22, P288, DOI 10.1002/(SICI)1520-6408(1998)22:3<288::AID-DVG10>3.3.CO;2-T; Azar G, 2002, J PEDIATR GASTR NUTR, V34, P212, DOI 10.1097/00005176-200202000-00020; Balistreri WF, 1996, HEPATOLOGY, V23, P1682, DOI 10.1002/hep.510230652; Bu LN, 2002, J PEDIATR SURG, V37, P1183, DOI 10.1053/jpsu.2002.34468; Cabernard C, 2005, DEV CELL, V9, P831, DOI 10.1016/j.devcel.2005.10.008; Carbonetto P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003770; Chang H, 2010, INT J BIOCHEM CELL B, V42, P1462, DOI 10.1016/j.biocel.2010.04.016; Cheng G, 2013, J HEPATOL, V59, P1285, DOI 10.1016/j.jhep.2013.07.021; Chung WS, 2008, DEV CELL, V14, P582, DOI 10.1016/j.devcel.2008.02.012; Yamaguti DCC, 2011, EUR J GASTROEN HEPAT, V23, P759, DOI 10.1097/MEG.0b013e32832e9df0; Cui S, 2013, GASTROENTEROLOGY, V144, P1107, DOI 10.1053/j.gastro.2013.01.022; Delous M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002754; Desmet VJ, 1998, MAYO CLIN PROC, V73, P80; Dong PDS, 2007, NAT GENET, V39, P397, DOI 10.1038/ng1961; Farber SA, 2001, SCIENCE, V292, P1385, DOI 10.1126/science.1060418; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Garcia-Barcelo MM, 2010, HUM MOL GENET, V19, P2917, DOI 10.1093/hmg/ddq196; Gerloff T, 1998, J BIOL CHEM, V273, P10046, DOI 10.1074/jbc.273.16.10046; Grisaru S, 2001, DEV BIOL, V231, P31, DOI 10.1006/dbio.2000.0127; Guttman OR, 2011, LIVER INT, V31, P1485, DOI 10.1111/j.1478-3231.2011.02578.x; Hesselson D, 2009, P NATL ACAD SCI USA, V106, P14896, DOI 10.1073/pnas.0906348106; Holm K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-600; Hu ZZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038777; Iguchi H, 2011, ENDOCR J, V58, P747, DOI 10.1507/endocrj.K11E-104; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karrer FM, 1996, ARCH SURG-CHICAGO, V131, P493; Korzh S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-84; Koster RW, 2004, METHOD CELL BIOL, V76, P207; Ku NO, 1999, AM J PHYSIOL-GASTR L, V277, pG1108, DOI 10.1152/ajpgi.1999.277.6.G1108; Lambaerts K, 2012, J CELL SCI, V125, P1129, DOI 10.1242/jcs.089987; Landing B H, 1974, Prog Pediatr Surg, V6, P113; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Leyva-Vega M, 2010, AM J MED GENET A, V152A, P886, DOI 10.1002/ajmg.a.33332; Lorent K, 2010, DEV DYNAM, V239, P855, DOI 10.1002/dvdy.22220; Mack CL, 2006, HEPATOLOGY, V44, P1231, DOI 10.1002/hep.21366; Matys V, NUCL ACIDS RES, V31, P374; Mazalouskas MD, 2014, J BIOL CHEM, V289, P4219, DOI 10.1074/jbc.M113.518514; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Monteleon CL, 2012, MOL BIOL CELL, V23, P4495, DOI 10.1091/mbc.E12-03-0246; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Nakanuma Y, 2010, HISTOL HISTOPATHOL, V25, P223, DOI 10.14670/HH-25.223; Naydenov NG, 2010, MOL BIOL CELL, V21, P3506, DOI 10.1091/mbc.E10-03-0259; Ninov N, 2012, DEVELOPMENT, V139, P1557, DOI 10.1242/dev.076000; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; OHYA T, 1995, J PEDIATR SURG, V30, P515, DOI 10.1016/0022-3468(95)90120-5; Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002; Perugorria MJ, 2008, HEPATOLOGY, V48, P1251, DOI 10.1002/hep.22437; Petersen C, 1997, J PEDIATR SURG, V32, P1190, DOI 10.1016/S0022-3468(97)90680-1; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rauschenfels S, 2009, EUR J PEDIATR, V168, P469, DOI 10.1007/s00431-008-0774-2; RAWEILY EA, 1990, HISTOPATHOLOGY, V17, P521, DOI 10.1111/j.1365-2559.1990.tb00791.x; RiepenhoffTalty M, 1996, J INFECT DIS, V174, P8, DOI 10.1093/infdis/174.1.8; Russo P, 2011, CLIN GASTROENTEROL H, V9, P357, DOI 10.1016/j.cgh.2011.01.003; Sabe H, 2009, TRAFFIC, V10, P982, DOI 10.1111/j.1600-0854.2009.00917.x; Sarro E, 2008, KIDNEY INT, V73, P77, DOI 10.1038/sj.ki.5002638; Schwarz KB, 2013, HEPATOLOGY, V58, P1724, DOI 10.1002/hep.26512; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shneider BL, 2006, J PEDIATR-US, V148, P467, DOI 10.1016/j.jpeds.2005.12.054; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Suzuki T, 2006, MOL CELL BIOL, V26, P6149, DOI 10.1128/MCB.00298-06; Tarr PI, 1996, PEDIATRICS, V97, P828; Tsai EA, 2014, HUM GENET, V133, P235, DOI 10.1007/s00439-013-1368-2; Tyler KL, 1998, HEPATOLOGY, V27, P1475, DOI 10.1002/hep.510270603; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Weng LJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-99; Zhang Q, 1999, MOL CELL BIOL, V19, P8158	68	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138381	10.1371/journal.pone.0138381	http://dx.doi.org/10.1371/journal.pone.0138381			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379158	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000361769400094
J	Rodriguez-Munoz, R; Cardenas-Aguayo, MD; Aleman, V; Osorio, B; Chavez-Gonzalez, O; Rendon, A; Martinez-Rojas, D; Meraz-Rios, MA				Rodriguez-Munoz, Rafael; del Carmen Cardenas-Aguayo, Maria; Aleman, Victor; Osorio, Beatriz; Chavez-Gonzalez, Oscar; Rendon, Alvaro; Martinez-Rojas, Dalila; Antonio Meraz-Rios, Marco			Novel Nuclear Protein Complexes of Dystrophin 71 Isoforms in Rat Cultured Hippocampal GABAergic and Glutamatergic Neurons	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; BETA-DYSTROGLYCAN; DP71; GENE; LOCALIZATION; EXPRESSION; DUCHENNE; MATRIX; DOMAIN; CELLS	The precise functional role of the dystrophin 71 in neurons is still elusive. Previously, we reported that dystrophin 71d and dystrophin 71f are present in nuclei from cultured neurons. In the present work, we performed a detailed analysis of the intranuclear distribution of dystrophin 71 isoforms (Dp71d and Dp71f), during the temporal course of 7-day postnatal rats hippocampal neurons culture for lh, 2, 4, 10, 15 and 21 days in vitro (DIV). By immunofluorescence assays, we detected the highest level of nuclear expression of both dystrophin Dp71 isoforms at 10 DIV, during the temporal course of primary culture. Dp71d and Dp7lf were detected mainly in bipolar GABAergic (>= 60%) and multipolar Glutamatergic (<= 40%) neurons, respectively. We also characterized the existence of two nuclear dystrophin-associated protein complexes (DAPC): dystrophin 71d or dystrophin 71f bound to 6-dystroglycan, alpha 1-, beta-, alpha 2-dystrobrevins, a-syntrophin, and syntrophin-associated protein nNOS (Dp71d-DAPC or Dp71f-DAPC, respectively), in the hippocampal neurons. Furthermore, both complexes were localized in interchromatin granule cluster structures (nuclear speckles) of neuronal nucleoskeleton preparations. The present study evinces that each Dp71'5 complexes differ slightly in dystrobrevins composition. The results demonstrated that Dp71d-DAPC was mainly localized in bipolar GABAergic and Dp71f-DAPC in multipolar Glutamatergic hippocampal neurons. Taken together, our results show that dystrophin 71d, dystrophin 71f and DAP integrate protein complexes, and both complexes were associated to nuclear speckles structures.	[Rodriguez-Munoz, Rafael; Aleman, Victor; Osorio, Beatriz; Chavez-Gonzalez, Oscar; Martinez-Rojas, Dalila] CINVESTAV IPN, Natl Polytech Inst, Ctr Res & Adv Studies, Dept Physiol, Mexico City, DF, Mexico; [Rodriguez-Munoz, Rafael; Aleman, Victor; Osorio, Beatriz; Chavez-Gonzalez, Oscar; Martinez-Rojas, Dalila] CINVESTAV IPN, Natl Polytech Inst, Ctr Res & Adv Studies, Dept Biophys & Neurosci, Mexico City, DF, Mexico; [del Carmen Cardenas-Aguayo, Maria; Antonio Meraz-Rios, Marco] CINVESTAV IPN, Natl Polytech Inst, Ctr Res & Adv Studies, Mol Biomed, Mexico City, DF, Mexico; [Rendon, Alvaro] Univ Paris 06, UMR Inserm, Inst Vis, Lab Physiopathol Cellulaire & Mol Retine, Paris, France	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Martinez-Rojas, D (corresponding author), CINVESTAV IPN, Natl Polytech Inst, Ctr Res & Adv Studies, Dept Physiol, Mexico City, DF, Mexico.	damartin@fiso.cinvestav.mx; mmeraz@cinvestav.mx	del Carmen Cardenas-Aguayo, Maria/AAH-5073-2020; MERAZ RIOS, MARCO ANTONIO/F-4194-2016	del Carmen Cardenas-Aguayo, Maria/0000-0001-9156-2161; MERAZ RIOS, MARCO ANTONIO/0000-0001-6748-8117; Rodriguez-Munoz, Rafael/0000-0001-9668-052X	Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico City [CB-2013-01 222193]	Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico City(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This Study was funded by The Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico City. Grant Number: CB-2013-01 222193 (www.conacyt.mx). Authors who received the funding: MAMR MDCCA. The Founder CONACYT had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman V, 2001, HISTOCHEM CELL BIOL, V115, P243; Aquilano K, 2007, J NEUROCHEM, V101, P1327, DOI 10.1111/j.1471-4159.2006.04431.x; Aquilano K, 2014, J BIOL CHEM, V289, P365, DOI 10.1074/jbc.M113.506733; Aragon J, 2011, J NEUROCHEM, V119, P697, DOI 10.1111/j.1471-4159.2011.07347.x; Artegiani B, 2010, J BIOL CHEM, V285, P24740, DOI 10.1074/jbc.M109.090654; Austin RC, 2000, NEUROMUSCULAR DISORD, V10, P187, DOI 10.1016/S0960-8966(99)00105-4; Baldelli S, 2011, INT J BIOCHEM CELL B, V43, P163, DOI 10.1016/j.biocel.2010.10.016; Benabdesselam R, 2012, J ENDOCRINOL, V213, P239, DOI 10.1530/JOE-12-0066; Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007; Blake DJ, 1999, J CELL BIOL, V147, P645, DOI 10.1083/jcb.147.3.645; BURRY RW, 1983, BRAIN RES, V261, P261, DOI 10.1016/0006-8993(83)90629-7; Chen YJ, 2003, BIOCHEM J, V375, P329, DOI 10.1042/BJ20030808; Claudepierre T, 1999, INVEST OPHTH VIS SCI, V40, P1520; Claudepierre T, 2000, J CELL SCI, V113, P3409; Daoud F, 2009, HUM MOL GENET, V18, P3779, DOI 10.1093/hmg/ddp320; DIAZBARRIGA F, 1989, TOXICOL IN VITRO, V3, P277, DOI 10.1016/0887-2333(89)90034-9; FABBRIZIO E, 1994, BIOCHEM J, V299, P359, DOI 10.1042/bj2990359; Fornasiero EF, 2010, CELL MOL LIFE SCI, V67, P1383, DOI 10.1007/s00018-009-0227-8; Fort P, 2005, NEUROSCI RES, V53, P25, DOI 10.1016/j.neures.2005.05.007; Fuentes-Mera L, 2006, EXP CELL RES, V312, P3023, DOI 10.1016/j.yexcr.2006.06.002; Gieni RS, 2009, BIOCHEM CELL BIOL, V87, P283, DOI 10.1139/O08-133; Goldman Robert D., 2005, V264, P3, DOI 10.1002/0470093765.ch2; Gonzalez-Ramirez R, 2008, J CELL BIOCHEM, V105, P735, DOI 10.1002/jcb.21870; GORECKI DC, 1995, NEUROREPORT, V6, P893, DOI 10.1097/00001756-199504190-00017; Greenberg DS, 1996, HUM MOL GENET, V5, P1299, DOI 10.1093/hmg/5.9.1299; Gribbon C, 2002, EUR J CELL BIOL, V81, P557, DOI 10.1078/0171-9335-00275; Henry MD, 1999, CURR OPIN CELL BIOL, V11, P602, DOI 10.1016/S0955-0674(99)00024-1; Hervy M, 2006, CURR OPIN CELL BIOL, V18, P524, DOI 10.1016/j.ceb.2006.08.006; Higginson JR, 2005, BIOCHEM SOC T, V33, P1254, DOI 10.1042/BST0331254; Hnia K, 2006, NEUROSCIENCE, V141, P607, DOI 10.1016/j.neuroscience.2006.04.043; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Houben F, 2007, BBA-MOL CELL RES, V1773, P675, DOI 10.1016/j.bbamcr.2006.09.018; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Kumeta Masahiro, 2012, Int J Cell Biol, V2012, P494902, DOI 10.1155/2012/494902; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; LEDERFEIN D, 1992, P NATL ACAD SCI USA, V89, P5346, DOI 10.1073/pnas.89.12.5346; Lin KT, 2004, MOL CELL BIOL, V24, P9176, DOI 10.1128/MCB.24.20.9176-9185.2004; Lin SR, 2007, ADV EXP MED BIOL, V623, P107, DOI 10.1007/978-0-387-77374-2_7; Morales-Lazaro SL, 2010, J NEUROCHEM, V112, P474, DOI 10.1111/j.1471-4159.2009.06467.x; Martinez-Vieyra IA, 2013, BBA-MOL CELL RES, V1833, P698, DOI 10.1016/j.bbamcr.2012.11.019; Mathew G, 2013, SCI REP-UK, V3, DOI 10.1038/srep02792; Meissner M, 2003, EXP CELL RES, V283, P184, DOI 10.1016/S0014-4827(02)00046-0; Miranda R, 2011, NEUROBIOL DIS, V43, P134, DOI 10.1016/j.nbd.2011.02.017; Moizard MP, 2000, EUR J HUM GENET, V8, P552, DOI 10.1038/sj.ejhg.5200488; Moore CJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-3; Muschler J, 2002, CANCER RES, V62, P7102; Nickerson JA, 2001, J CELL SCI, V114, P463; NORTON PA, 1994, J CELL SCI, V107, P1; Oppizzi ML, 2008, TRAFFIC, V9, P2063, DOI 10.1111/j.1600-0854.2008.00822.x; Patturajan M, 1998, MOL CELL BIOL, V18, P2406, DOI 10.1128/MCB.18.4.2406; Peters MF, 1997, J CELL BIOL, V138, P81, DOI 10.1083/jcb.138.1.81; Postnikov Y, 2010, BBA-GENE REGUL MECH, V1799, P62, DOI 10.1016/j.bbagrm.2009.11.016; Reeves R, 2010, BBA-GENE REGUL MECH, V1799, P3, DOI 10.1016/j.bbagrm.2009.09.001; Rivier F, 1999, HISTOCHEM J, V31, P425, DOI 10.1023/A:1003805905456; Rodriguez-Munoz R, 2008, BIOCHEM BIOPH RES CO, V375, P303, DOI 10.1016/j.bbrc.2008.07.135; Royuela M, 2003, J MUSCLE RES CELL M, V24, P387, DOI 10.1023/A:1027309822007; Royuela M, 2003, EUR J HISTOCHEM, V47, P29; SadouletPuccio HM, 1997, P NATL ACAD SCI USA, V94, P12413, DOI 10.1073/pnas.94.23.12413; SEGAL M, 1983, J NEUROPHYSIOL, V50, P1249, DOI 10.1152/jn.1983.50.6.1249; Sgambato A, 2005, J CELL PHYSIOL, V205, P163, DOI 10.1002/jcp.20411; Simon DN, 2011, NAT REV MOL CELL BIO, V12, P695, DOI 10.1038/nrm3207; Spector DL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000646; SPECTOR DL, 1991, EMBO J, V10, P3467, DOI 10.1002/j.1460-2075.1991.tb04911.x; Suarez-Sanchez R, 2014, BBA-MOL CELL RES, V1843, P985, DOI 10.1016/j.bbamcr.2014.01.027; Sudol M, 2001, FEBS LETT, V490, P190, DOI 10.1016/S0014-5793(01)02122-6; Tadayoni R, 2012, MOL NEUROBIOL, V45, P43, DOI 10.1007/s12035-011-8218-9; Tang CW, 2008, J CELL SCI, V121, P1014, DOI 10.1242/jcs.020982; Valtorta F, 2011, SEMIN CELL DEV BIOL, V22, P378, DOI 10.1016/j.semcdb.2011.07.008; Vasquez-Limeta A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090629; Villarreal-Silva M, 2010, NEUROCHEM RES, V35, P366, DOI 10.1007/s11064-009-0064-z; WANSINK DG, 1993, J CELL BIOL, V122, P283, DOI 10.1083/jcb.122.2.283	71	14	14	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137328	10.1371/journal.pone.0137328	http://dx.doi.org/10.1371/journal.pone.0137328			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378780	Green Published, gold, Green Submitted			2022-12-27	WOS:000361769400014
J	Wakabayashi, K; Soga, K; Hoson, T; Kotake, T; Yamazaki, T; Higashibata, A; Ishioka, N; Shimazu, T; Fukui, K; Osada, I; Kasahara, H; Kamada, M				Wakabayashi, Kazuyuki; Soga, Kouichi; Hoson, Takayuki; Kotake, Toshihisa; Yamazaki, Takashi; Higashibata, Akira; Ishioka, Noriaki; Shimazu, Toru; Fukui, Keiji; Osada, Ikuko; Kasahara, Haruo; Kamada, Motoshi			Suppression of Hydroxycinnamate Network Formation in Cell Walls of Rice Shoots Grown under Microgravity Conditions in Space	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; FERULIC ACID; HYPERGRAVITY CONDITIONS; ARABIDOPSIS SEEDLINGS; WHEAT COLEOPTILES; ELONGATION GROWTH; LIGNIN FORMATION; GENE-EXPRESSION; DIFERULIC ACIDS; CROSS-LINKING	Network structures created by hydroxycinnamate cross-links within the cell wall architecture of gramineous plants make the cell wall resistant to the gravitational force of the earth. In this study, the effects of microgravity on the formation of cell wall-bound hydroxycinnamates were examined using etiolated rice shoots simultaneously grown under artificial 1 g and microgravity conditions in the Cell Biology Experiment Facility on the International Space Station. Measurement of the mechanical properties of cell walls showed that shoot cell walls became stiff during the growth period and that microgravity suppressed this stiffening. Amounts of cell wall polysaccharides, cell wall-bound phenolic acids, and lignin in rice shoots increased as the shoot grew. Microgravity did not influence changes in the amounts of cell wall polysaccharides or phenolic acid monomers such as ferulic acid (FA) and p-coumaric acid, but it suppressed increases in diferulic acid (DFA) isomers and lignin. Activities of the enzymes phenylalanine ammonia-lyase (PAL) and cell wall-bound peroxidase (CW-PRX) in shoots also increased as the shoot grew. PAL activity in microgravity-grown shoots was almost comparable to that in artificial 1 g-grown shoots, while CW-PRX activity increased less in microgravity-grown shoots than in artificial 1 g-grown shoots. Furthermore, the increases in expression levels of some class III peroxidase genes were reduced under microgravity conditions. These results suggest that a microgravity environment modifies the expression levels of certain class III peroxidase genes in rice shoots, that the resultant reduction of CW-PRX activity may be involved in suppressing DFA formation and lignin polymerization, and that this suppression may cause a decrease in cross-linkages within the cell wall architecture. The reduction in intra-network structures may contribute to keeping the cell wall loose under microgravity conditions.	[Wakabayashi, Kazuyuki; Soga, Kouichi; Hoson, Takayuki] Osaka City Univ, Grad Sch Sci, Dept Biol Sci, Sumiyoshi Ku, Osaka 558, Japan; [Kotake, Toshihisa] Saitama Univ, Grad Sch Sci & Engn, Div Life Sci, Sakura Ku, Saitama 3388570, Japan; [Yamazaki, Takashi; Higashibata, Akira; Ishioka, Noriaki] Japan Aerosp Explorat Agcy JAXA, Tsukuba, Ibaraki, Japan; [Shimazu, Toru; Fukui, Keiji] Japan Space Forum, Chiyoda Ku, Tokyo, Japan; [Osada, Ikuko; Kasahara, Haruo] Japan Manned Space Syst Corp, Tsuchiura, Ibaraki, Japan; [Kamada, Motoshi] Adv Engn Serv Co Ltd, Tsukuba, Ibaraki, Japan	Osaka Metropolitan University; Saitama University; Japan Aerospace Exploration Agency (JAXA); Advanced Engineering Services Co., Ltd. (A.E.S.)	Wakabayashi, K (corresponding author), Osaka City Univ, Grad Sch Sci, Dept Biol Sci, Sumiyoshi Ku, Osaka 558, Japan.	wakaba@sci.osaka-cu.ac.jp	shimazu, Toru/AAA-5311-2020; KOTAKE, TOSHIHISA/F-1117-2011	shimazu, Toru/0000-0003-0343-8035; KOTAKE, TOSHIHISA/0000-0002-1110-5006	JAXA; Japan Space Forum; Japan Manned Space Systems Corp.; Advanced Engineering Services Co., Ltd.	JAXA; Japan Space Forum; Japan Manned Space Systems Corp.; Advanced Engineering Services Co., Ltd.	The experimental cost for this study was funded by JAXA. Japan Space Forum, Japan Manned Space Systems Corp., and Advanced Engineering Services Co., Ltd. provided support in the form of salaries for authors TS, KF, IO, HK, and MK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Carpita NC, 1996, ANNU REV PLANT PHYS, V47, P445, DOI 10.1146/annurev.arplant.47.1.445; Cosgrove DJ, 2000, PLANT PHYSIOL BIOCH, V38, P109, DOI 10.1016/S0981-9428(00)00164-9; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; FRY SC, 1986, ANNU REV PLANT PHYS, V37, P165, DOI 10.1146/annurev.arplant.37.1.165; Gonzalez LF, 1999, PHYTOCHEMISTRY, V50, P711, DOI 10.1016/S0031-9422(98)00611-6; GRABBER JH, 1995, PHYTOCHEMISTRY, V40, P1077, DOI 10.1016/0031-9422(95)00413-2; Hausmann N, 2014, PLANT BIOLOGY, V16, P120, DOI 10.1111/plb.12051; Hoson T, 1996, J EXP BOT, V47, P513, DOI 10.1093/jxb/47.4.513; Hoson T, 2003, INT REV CYTOL, V229, P209, DOI 10.1016/S0074-7696(03)29005-7; Hoson T, 2002, J PLANT RES, V115, P277, DOI 10.1007/s10265-002-0035-9; Hoson T, 2002, PLANT CELL PHYSIOL, V43, P1067, DOI 10.1093/pcp/pcf126; Hoson T, 1999, J PLANT RES, V112, P477, DOI 10.1007/PL00013903; Hoson T., 2006, J GRAVIT PHYSL, V13, P97; Hoson Takayuki, 2000, P137; Hoson T, 2015, PHYTOCHEMISTRY, V112, P84, DOI 10.1016/j.phytochem.2014.08.022; Hossain MT, 2007, J PLANT PHYSIOL, V164, P385, DOI 10.1016/j.jplph.2006.02.003; Jiang JL, 2012, PLANT PHYSIOL BIOCH, V53, P84, DOI 10.1016/j.plaphy.2012.01.017; KAMISAKA S, 1990, PHYSIOL PLANTARUM, V78, P1; Kawamura Y, 2000, J PLANT PHYSIOL, V156, P689, DOI 10.1016/S0176-1617(00)80233-3; Kwon T, 2015, AM J BOT, V102, P21, DOI 10.3732/ajb.1400458; Levine LH, 2001, PHYTOCHEMISTRY, V57, P835, DOI 10.1016/S0031-9422(01)00148-0; Masuda Y, 1990, BOT MAG TOKYO, V103, P103; Neill S, 2002, CURR OPIN PLANT BIOL, V5, P388, DOI 10.1016/S1369-5266(02)00282-0; Obel N, 2002, PHYTOCHEMISTRY, V60, P603, DOI 10.1016/S0031-9422(02)00148-6; Parr AJ, 1996, J SCI FOOD AGR, V71, P501, DOI 10.1002/(SICI)1097-0010(199608)71:4<501::AID-JSFA608>3.0.CO;2-L; Parvez MM, 1997, PHYSIOL PLANTARUM, V99, P39, DOI 10.1034/j.1399-3054.1997.990106.x; Passardi F, 2004, PHYTOCHEMISTRY, V65, P1879, DOI 10.1016/j.phytochem.2004.06.023; RICHTZENHAIN H, 1949, CHEM BER-RECL, V82, P447, DOI 10.1002/cber.19490820602; SAKURAI N, 1991, BOT MAG TOKYO, V104, P235, DOI 10.1007/BF02489456; Saulnier L, 1999, CARBOHYD RES, V320, P82, DOI 10.1016/S0008-6215(99)00152-4; Saulnier L, 1999, J SCI FOOD AGR, V79, P396, DOI [10.1002/(SICI)1097-0010(19990301)79:3<396::AID-JSFA262>3.0.CO;2-B, 10.1002/(SICI)1097-0010(19990301)79:3&lt;396::AID-JSFA262&gt;3.0.CO;2-B]; SMITH MM, 1983, CARBOHYD RES, V118, P65, DOI 10.1016/0008-6215(83)88036-7; Soga K, 1999, PLANT CELL PHYSIOL, V40, P581, DOI 10.1093/oxfordjournals.pcp.a029580; Tamaoki D, 2006, J PLANT RES, V119, P79, DOI 10.1007/s10265-005-0243-1; Tamaoki D, 2011, J EXP BOT, V62, P5463, DOI 10.1093/jxb/err224; TAN KS, 1992, PLANT CELL PHYSIOL, V33, P103; TAN KS, 1991, PHYSIOL PLANTARUM, V83, P397, DOI 10.1111/j.1399-3054.1991.tb00111.x; Volkmann D, 2006, PROTOPLASMA, V229, P143, DOI 10.1007/s00709-006-0200-4; Wakabayashi K, 1997, PLANT PHYSIOL, V113, P967, DOI 10.1104/pp.113.3.967; Wakabayashi K, 2005, PHYSIOL PLANTARUM, V125, P127, DOI 10.1111/j.1399-3054.2005.00544.x; Wakabayashi K, 2012, J PLANT PHYSIOL, V169, P262, DOI 10.1016/j.jplph.2011.10.002; Wakabayashi K, 2011, J PLANT PHYSIOL, V168, P1997, DOI 10.1016/j.jplph.2011.05.010; Wakabayashi K, 2009, J PLANT PHYSIOL, V166, P947, DOI 10.1016/j.jplph.2008.12.006; Waldron KW, 1996, PHYTOCHEM ANALYSIS, V7, P305, DOI 10.1002/(SICI)1099-1565(199611)7:6&lt;305::AID-PCA320&gt;3.0.CO;2-A; WHETTEN R, 1995, PLANT CELL, V7, P1001, DOI 10.2307/3870053; YAMAMOTO R, 1970, PLANT CELL PHYSIOL, V11, P947, DOI 10.1093/oxfordjournals.pcp.a074586; Yano S, 2012, BIOL SCI SPACE, V26, P12	47	8	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137992	10.1371/journal.pone.0137992	http://dx.doi.org/10.1371/journal.pone.0137992			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378793	Green Submitted, Green Published, gold			2022-12-27	WOS:000361769400042
J	Isanaka, S; Guesdon, B; Labar, AS; Hanson, K; Langendorf, C; Grais, RF				Isanaka, Sheila; Guesdon, Benjamin; Labar, Amy S.; Hanson, Kerstin; Langendorf, Celine; Grais, Rebecca F.			Comparison of Clinical Characteristics and Treatment Outcomes of Children Selected for Treatment of Severe Acute Malnutrition Using Mid Upper Arm Circumference and/or Weight-for-Height Z-Score	PLOS ONE			English	Article							HOME-BASED THERAPY; HOSPITALIZED CHILDREN; COST-EFFECTIVENESS; COMMUNITY; ADMISSION; MUAC	Objectives Debate for a greater role of mid-upper arm circumference (MUAC) measures in nutritional programming continues, but a shift from therapeutic feeding programs admitting children using MUAC and/or weight-for-height Z (WHZ) to a new model admitting children using MUAC only remains complicated by limited information regarding the clinical profile and response to treatment of children selected by MUAC vs. WHZ. To broaden our understanding of how children identified for therapeutic feeding by MUAC and/or WHZ may differ, we aimed to investigate differences between children identified for therapeutic feeding by MUAC and/or WHZ in terms of demographic, anthropometric, clinical, and laboratory and treatment response characteristics. Methods Using secondary data from a randomized trial in rural Niger among children with uncomplicated severe acute malnutrition, we compared children that would be admitted to a therapeutic feeding program that used a single anthropometric criterion of MUAC < 115 mm vs. children that are admitted under current admission criteria (WHZ < -3 and/or MUAC < 115 mm) but would be excluded from a program that used a single MUAC < 115 mm admission criterion. We assessed differences between groups using multivariate regression, employing linear regression for continuous outcomes and log-binomial regression for dichotomous outcomes. Results We found no difference in terms of clinical and laboratory characteristics and discharge outcomes evaluated between children that would be included in a MUAC< 115 mm therapeutic feeding program vs. children that are currently eligible for therapeutic feeding but would be excluded from a MUAC-only program. Conclusions A single anthropometric admission criterion of MUAC < 115 mm did not differentiate well between children in terms of clinical or laboratory measures or program outcomes in this context. If nutritional programming is to use a single MUAC-based criterion for admission to treatment, further research and program experience can help to identify the most appropriate criterion in a broad range of contexts to target children in most urgent need of treatment.	[Isanaka, Sheila; Labar, Amy S.; Langendorf, Celine; Grais, Rebecca F.] Epicentre, Dept Res, Paris, France; [Isanaka, Sheila] Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Isanaka, Sheila] Harvard Univ, TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Guesdon, Benjamin] Act Faim, Paris, France; [Hanson, Kerstin] Med Sans Frontieres, Paris, France	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Doctors Without Borders	Isanaka, S (corresponding author), Epicentre, Dept Res, Paris, France.	sheila.isanaka@epicentre.msf.org	Isanaka, Sheila/AAQ-9056-2020	CELINE, LANGENDORF/0000-0002-0811-7540; Freeman Grais, Rebecca/0000-0002-5037-8218; Guesdon, Benjamin/0000-0002-2876-0533				Ali E, 2013, T ROY SOC TROP MED H, V107, P319, DOI 10.1093/trstmh/trt018; ASHWORTH A, 1969, BRIT J NUTR, V23, P835, DOI 10.1079/BJN19690094; Bachmann MO, 2010, EXPERT REV PHARM OUT, V10, P605, DOI 10.1586/ERP.10.54; Berkley J, 2005, JAMA-J AM MED ASSOC, V294, P591, DOI 10.1001/jama.294.5.591; BERN C, 1995, LANCET, V345, P631, DOI 10.1016/S0140-6736(95)90527-8; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Briend A, 2012, MATERN CHILD NUTR, V8, P130, DOI 10.1111/j.1740-8709.2011.00340.x; Ciliberto MA, 2005, AM J CLIN NUTR, V81, P864, DOI 10.1093/ajcn/81.4.864; Collins S, 2007, ARCH DIS CHILD, V92, P453, DOI 10.1136/adc.2006.098327; Dasgupta R, 2013, INDIAN PEDIATR, V50, P154, DOI 10.1007/s13312-013-0032-1; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Fernandez MAL, 2010, PEDIATRICS, V126, pE195, DOI 10.1542/peds.2009-2175; Goossens S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049320; Grellety E, 2015, PUBLIC HEALTH NUTR, V18, P2575, DOI 10.1017/S1368980015000737; International Federation of Red Cross and Red Crescent Societies, 2010, TACKL MALN NIG; Laillou A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101159; Manary MJ, 2004, ARCH DIS CHILD, V89, P557, DOI 10.1136/adc.2003.034306; McDonald CM, 2013, AM J CLIN NUTR, V97, P896, DOI 10.3945/ajcn.112.047639; Modi P, 2015, J NUTR, V145, P1582, DOI 10.3945/jn.114.209718; Mwangome MK, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-92; Myatt M, 2006, FOOD NUTR BULL, V27, pS7, DOI 10.1177/15648265060273S302; Puett C, 2013, HEALTH POLICY PLANN, V28, P386, DOI 10.1093/heapol/czs070; Roberfroid D, 2013, UTILIZATION MIDUPPER; UNICEF/Coverage Monitoring Network/ACF International, 2012, STAT GLOB SAM MAN CO; United Nations Development Programme, 2014, SUST HUM PROGR RED V; Wilford R, 2012, HEALTH POLICY PLANN, V27, P127, DOI 10.1093/heapol/czr017; World Health Organization, 2013, GUID UPD MAN SEV MAL; World Health Organization, 2008, WHO CHILD GROWTH STA	28	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137606	10.1371/journal.pone.0137606	http://dx.doi.org/10.1371/journal.pone.0137606			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376281	Green Published, Green Submitted, gold			2022-12-27	WOS:000361610200044
J	Li, SH; Zhao, P; Tian, HB; Chen, LH; Cui, LQ				Li, Shao-Hua; Zhao, Peng; Tian, Hong-Bo; Chen, Liang-Hua; Cui, Lian-Qun			Effect of Grape Polyphenols on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							IMPROVE ENDOTHELIAL FUNCTION; RED WINE POLYPHENOLS; SEED EXTRACT; CARDIOVASCULAR-DISEASE; VASCULAR FUNCTION; PLASMA-LIPIDS; DOUBLE-BLIND; VITAMIN-C; RISK; JUICE	Background The effect of grape polyphenols on blood pressure remains unclear, which we aimed to address via a meta-analysis study. Methods We conducted study trial searches in PubMed, Embase, and the Cochrane Library databases. Summary estimates of weighted mean differences and 95% confidence intervals were obtained by using fixed-effects models. Subgroup analyses were performed to identify the source of heterogeneity. The protocol details of our meta-analysis have been submitted to the international database of prospectively registered systematic reviews (registration number CRD42015019196). Results Ten studies were included in the present meta-analysis. Our results showed daily grape polyphenol intake could significantly reduce systolic blood pressure by 1.48 mmHg when compared to control subjects (12 comparisons; -1.48 [-2.79 to -0.16] mmHg; P = 0.03). Subgroup analyses indicated larger reduction was identified in the intake of low-dose of grape polyphenols (< 733 mg/day, median level of the included studies) or patients with metabolic syndrome. Contrarily, diastolic blood pressure was not significantly decreased in the grape polyphenols group as compared to controls. No significant heterogeneity or publication bias was detected in the meta-analysis of either systolic or diastolic blood pressure. Conclusions Daily grape polyphenol intake can significantly reduce the systolic blood pressure in humans, although the reduction is modest when compared with anti-hypertensive medications. Larger, better designed trials, that specifically include hypertensive subjects, are required to verify our results in the future.	[Li, Shao-Hua; Zhao, Peng; Tian, Hong-Bo; Chen, Liang-Hua; Cui, Lian-Qun] Shandong Univ, Dept Cardiol, Shandong Prov Hosp, Jinan 250100, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Li, SH (corresponding author), Shandong Univ, Dept Cardiol, Shandong Prov Hosp, Jinan 250100, Peoples R China.	lishaohua82@gmail.com			National Natural Science Foundation of China [81300216, 81200176]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The present study was supported by the National Natural Science Foundation of China (81300216 to Shao-Hua Li and 81200176 to Peng Zhao, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade ACM, 2009, CLINICS, V64, P435, DOI 10.1590/S1807-59322009000500011; Appel LJ, 2006, HYPERTENSION, V47, P296, DOI 10.1161/01.HYP.0000202568.01167.B6; Barona J, 2012, J NUTR, V142, P1626, DOI 10.3945/jn.112.162743; Castilla P, 2008, AM J CLIN NUTR, V87, P1053, DOI 10.1093/ajcn/87.4.1053; Castilla P, 2006, AM J CLIN NUTR, V84, P252, DOI 10.1093/ajcn/84.1.252; Clifton PM, 2004, J BIOMED BIOTECHNOL, P272, DOI 10.1155/S1110724304403088; DerSimonian R, 1996, STAT MED, V15, P1237, DOI 10.1002/(SICI)1097-0258(19960630)15:12<1237::AID-SIM301>3.0.CO;2-N; Edirisinghe I, 2008, CLIN SCI, V114, P331, DOI 10.1042/CS20070264; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feringa HHH, 2011, J AM DIET ASSOC, V111, P1173, DOI 10.1016/j.jada.2011.05.015; FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q; Halanych JH, 2010, AM J EPIDEMIOL, V171, P532, DOI 10.1093/aje/kwp417; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hodgson JM, 2014, BRIT J NUTR, V112, P1551, DOI 10.1017/S0007114514002542; Hollis JH, 2009, J AM COLL NUTR, V28, P574, DOI 10.1080/07315724.2009.10719789; Queipo-Ortuno MI, 2012, AM J CLIN NUTR, V95, P1323, DOI 10.3945/ajcn.111.027847; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Leikert JF, 2002, CIRCULATION, V106, P1614, DOI 10.1161/01.CIR.0000034445.31543.43; Lekakis J, 2005, EUR J CARDIOV PREV R, V12, P596, DOI 10.1097/00149831-200512000-00013; Li SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069818; Lippi G, 2010, SEMIN THROMB HEMOST, V36, P59, DOI 10.1055/s-0030-1248725; Lopez-Sepulveda R, 2008, HYPERTENSION, V51, P1088, DOI 10.1161/HYPERTENSIONAHA.107.107672; Magyar K, 2012, CLIN HEMORHEOL MICRO, V50, P179, DOI 10.3233/CH-2011-1424; McInnes GT, 2005, J HYPERTENS, V23, pS3, DOI 10.1097/01.hjh.0000165622.34192.fd; Mellen PB, 2010, J AM COLL NUTR, V29, P469, DOI 10.1080/07315724.2010.10719883; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Park YK, 2004, BIOFACTORS, V22, P145, DOI 10.1002/biof.5520220128; Peng N, 2005, AM J PHYSIOL-REG I, V289, pR771, DOI 10.1152/ajpregu.00147.2005; Perez-Jimenez J, 2008, NUTRITION, V24, P646, DOI 10.1016/j.nut.2008.03.012; Puglisi MJ, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-14; Ras RT, 2013, BRIT J NUTR, V110, P2234, DOI 10.1017/S000711451300161X; Sano A, 2007, J NUTR SCI VITAMINOL, V53, P174, DOI 10.3177/jnsv.53.174; Sivaprakasapillai B, 2009, METABOLISM, V58, P1743, DOI 10.1016/j.metabol.2009.05.030; van Golde PHM, 1999, ATHEROSCLEROSIS, V147, P365; van Mierlo LAJ, 2010, J NUTR, V140, P1769, DOI 10.3945/jn.110.125518; Vigna GB, 2003, METABOLISM, V52, P1250, DOI 10.1016/S0026-0495(03)00192-6; Vita JA, 2005, AM J CLIN NUTR, V81, p292S, DOI 10.1093/ajcn/81.1.292S; Ward NC, 2005, J HYPERTENS, V23, P427, DOI 10.1097/00004872-200502000-00026; Xia EQ, 2010, INT J MOL SCI, V11, P622, DOI 10.3390/ijms11020622; Yubero N, 2013, INT J FOOD SCI NUTR, V64, P400, DOI 10.3109/09637486.2012.753040; Zern TL, 2005, J NUTR, V135, P1911, DOI 10.1093/jn/135.8.1911; Zern TL, 2005, J NUTR, V135, P2291, DOI 10.1093/jn/135.10.2291; Zilkens RR, 2005, HYPERTENSION, V45, P874, DOI 10.1161/01.HYP.0000164639.83623.76; Zunino SJ, 2014, BRIT J NUTR, V112, P369, DOI 10.1017/S0007114514000890	45	30	31	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137665	10.1371/journal.pone.0137665	http://dx.doi.org/10.1371/journal.pone.0137665			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375022	Green Published, Green Submitted, gold			2022-12-27	WOS:000361610200047
J	Liu, TR; Xiao, T; Li, XY; Shi, JN				Liu, Tongran; Xiao, Tong; Li, Xiaoyan; Shi, Jiannong			Fluid Intelligence and Automatic Neural Processes in Facial Expression Perception: An Event-Related Potential Study	PLOS ONE			English	Article							VISUAL MISMATCH NEGATIVITY; EMOTIONAL INTELLIGENCE; SOCIOECONOMIC-STATUS; WORKING-MEMORY; MENTAL-ABILITY; FACES; DISCRIMINATION; PERSONALITY; MECHANISMS; PREDICTION	The relationship between human fluid intelligence and social-emotional abilities has been a topic of considerable interest. The current study investigated whether adolescents with different intellectual levels had different automatic neural processing of facial expressions. Two groups of adolescent males were enrolled: a high IQ group and an average IQ group. Age and parental socioeconomic status were matched between the two groups. Participants counted the numbers of the central cross changes while paired facial expressions were presented bilaterally in an oddball paradigm. There were two experimental conditions: a happy condition, in which neutral expressions were standard stimuli (p = 0.8) and happy expressions were deviant stimuli (p = 0.2), and a fearful condition, in which neutral expressions were standard stimuli (p = 0.8) and fearful expressions were deviant stimuli (p = 0.2). Participants were required to concentrate on the primary task of counting the central cross changes and to ignore the expressions to ensure that facial expression processing was automatic. Event-related potentials (ERPs) were obtained during the tasks. The visual mismatch negativity (vMMN) components were analyzed to index the automatic neural processing of facial expressions. For the early vMMN (50-130 ms), the high IQ group showed more negative vMMN amplitudes than the average IQ group in the happy condition. For the late vMMN (320-450 ms), the high IQ group had greater vMMN responses than the average IQ group over frontal and occipito-temporal areas in the fearful condition, and the average IQ group evoked larger vMMN amplitudes than the high IQ group over occipito-temporal areas in the happy condition. The present study elucidated the close relationships between fluid intelligence and pre-attentive change detection on social-emotional information.	[Liu, Tongran; Li, Xiaoyan; Shi, Jiannong] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Xiao, Tong] Northeastern Univ, Coll Informat Sci & Engn, Nat Language Proc Lab, Liaoning 110819, Peoples R China; [Shi, Jiannong] Aalborg Univ, Dept Learning & Philosophy, Aalborg, Denmark	Chinese Academy of Sciences; Institute of Psychology, CAS; Northeastern University - China; Aalborg University	Liu, TR (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	liutr@psych.ac.cn; shijn@psych.ac.cn	Xiao, Tong/AAP-5944-2020		National Natural Science Foundation of China [31370020]; Natural Science Foundation for the Youth of China [31000468]; Scientific Foundation of Institute of Psychology; Chinese Academy of Sciences for Outstanding Doctoral Dissertation; President Award of Chinese Academy of Sciences [Y0CX272B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation for the Youth of China; Scientific Foundation of Institute of Psychology; Chinese Academy of Sciences for Outstanding Doctoral Dissertation; President Award of Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by the National Natural Science Foundation of China (Grant No. 31370020), the Natural Science Foundation for the Youth of China (Grant No. 31000468), the Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences for Outstanding Doctoral Dissertation and President Award of Chinese Academy of Sciences (No. Y0CX272B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Astikainen P, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00557; Astikainen P, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-30; Austin EJ, 2002, PERS INDIV DIFFER, V32, P1391, DOI 10.1016/S0191-8869(01)00129-5; Barrett LF, 2010, PSYCHOL SCI, V21, P595, DOI 10.1177/0956797610363547; Beauchamp CM, 2006, INTELLIGENCE, V34, P571, DOI 10.1016/j.intell.2006.03.007; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Burnett S, 2011, NEUROSCI BIOBEHAV R, V35, P1654, DOI 10.1016/j.neubiorev.2010.10.011; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Campanella S, 2002, J COGNITIVE NEUROSCI, V14, P210, DOI 10.1162/089892902317236858; Campanella S, 2012, PSYCHIAT RES, V197, P145, DOI 10.1016/j.psychres.2011.12.026; Casey BJ, 2010, NEURON, V67, P749, DOI 10.1016/j.neuron.2010.08.033; CATTELL RB, 1963, J EDUC PSYCHOL, V54, P1, DOI 10.1037/h0046743; Chang Y, 2010, NEUROSCI LETT, V472, P33, DOI 10.1016/j.neulet.2010.01.050; Colom R, 2013, NEUROIMAGE, V72, P143, DOI 10.1016/j.neuroimage.2013.01.032; Conway ARA, 2002, INTELLIGENCE, V30, P163, DOI 10.1016/S0160-2896(01)00096-4; Coplan Jeremy D, 2011, Front Evol Neurosci, V3, P8, DOI 10.3389/fnevo.2011.00008; Csukly G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075444; Czigler I, 2007, J PSYCHOPHYSIOL, V21, P224, DOI 10.1027/0269-8803.21.34.224; Czigler I, 2010, ADV CONSC RES, V78, P107; Dahl RE, 2004, ANN NY ACAD SCI, V1021, P294, DOI 10.1196/annals.1308.034; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Deary IJ, 2005, INTELLIGENCE, V33, P455, DOI 10.1016/j.intell.2005.06.003; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; Duncan J, 2003, NAT NEUROSCI, V6, P207, DOI 10.1038/nn0303-207; Fiori M, 2012, INTELLIGENCE, V40, P245, DOI 10.1016/j.intell.2012.02.004; Fujimura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063703; Gardner Howard, 1983, FRAMES MIND THEORY M; Gayle LC, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00334; Gray JR, 2004, NAT REV NEUROSCI, V5, P471, DOI 10.1038/nrn1405; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Green AE, 2013, CEREB CORTEX, V23, P552, DOI 10.1093/cercor/bhs035; Houlihan M, 2012, INTELLIGENCE, V40, P239, DOI 10.1016/j.intell.2012.02.003; Kimura M, 2012, CEREB CORTEX, V22, P1774, DOI 10.1093/cercor/bhr244; Konstantopoulos S, 2001, AM J EDUC, V109, P344, DOI 10.1086/444275; Kreegipuu K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00714; Li XY, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-7; Liu T, 2011, NEUROSCIENCE, V180, P122, DOI 10.1016/j.neuroscience.2011.02.022; Liu T, 2007, NEUROREPORT, V18, P1571, DOI 10.1097/WNR.0b013e3282ef7640; Liu TR, 2015, NEUROSCI LETT, V592, P22, DOI 10.1016/j.neulet.2015.02.062; Liu TR, 2011, NEUROSCI LETT, V490, P101, DOI 10.1016/j.neulet.2010.12.035; Lubinski D, 2000, AM PSYCHOL, V55, P137, DOI 10.1037/0003-066X.55.1.137; Luo WB, 2010, NEUROIMAGE, V49, P1857, DOI 10.1016/j.neuroimage.2009.09.018; Mayer JD, 1999, INTELLIGENCE, V27, P267, DOI 10.1016/S0160-2896(99)00016-1; Mayer JD, 2003, EMOTION, V3, P97, DOI 10.1037/1528-3542.3.1.97; Pourtois G, 2005, HUM BRAIN MAPP, V26, P65, DOI 10.1002/hbm.20130; Raven, 2010, RAVENS PROGRESSIVE M; Rowe G, 2007, P NATL ACAD SCI USA, V104, P383, DOI 10.1073/pnas.0605198104; Scherf KS, 2011, CORTEX, V21, P1663, DOI DOI 10.1016/J.BANDC.2009.10.003; Schweizer K, 2004, INTELLIGENCE, V32, P329, DOI 10.1016/j.intell.2004.06.006; Sculthorpe LD, 2009, INTELLIGENCE, V37, P405, DOI 10.1016/j.intell.2009.03.006; Spearman C., 1927, ABILITIES MAN; Stefanics G, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01074; Stefanics G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00666; Stefanics G, 2012, NEUROIMAGE, V63, P253, DOI 10.1016/j.neuroimage.2012.06.068; Stefanics G, 2012, NEUROIMAGE, V59, P3042, DOI 10.1016/j.neuroimage.2011.10.041; Sternberg RobertJ., 2000, HDB INTELLIGENCE, DOI [10.1017/CBO9780511807947, DOI 10.1017/CBO9780511807947]; Strenze T, 2007, INTELLIGENCE, V35, P401, DOI 10.1016/j.intell.2006.09.004; Susac A, 2004, BRAIN TOPOGR, V16, P265; Terman LM., 1925, MENTAL PHYS TRAITS 1; Todd J, 2010, BRAIN RES, V1310, P113, DOI 10.1016/j.brainres.2009.11.019; Toyomaki A, 2008, PROG NEURO-PSYCHOPH, V32, P95, DOI 10.1016/j.pnpbp.2007.07.020; Troche SJ, 2010, PERS INDIV DIFFER, V49, P228, DOI 10.1016/j.paid.2010.03.040; Turkheimer E, 2003, PSYCHOL SCI, V14, P623, DOI 10.1046/j.0956-7976.2003.psci_1475.x; Wartenburger I, 2010, INTELLIGENCE, V38, P193, DOI 10.1016/j.intell.2009.11.001; Zeidner M, 2005, INTELLIGENCE, V33, P369, DOI 10.1016/j.intell.2005.03.001; Zhao L, 2006, NEUROSCI LETT, V410, P126, DOI 10.1016/j.neulet.2006.09.081	68	6	8	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138199	10.1371/journal.pone.0138199	http://dx.doi.org/10.1371/journal.pone.0138199			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8NH	26375031	Green Published, gold, Green Submitted			2022-12-27	WOS:000361610200086
J	Yao, F; Zhang, C; Du, W; Liu, C; Xu, Y				Yao, Fang; Zhang, Chi; Du, Wei; Liu, Chao; Xu, Ying			Identification of Gene-Expression Signatures and Protein Markers for Breast Cancer Grading and Staging	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; BIOMARKER; SELECTION; TARGET; SUPPRESSION; PROGNOSIS; INVASION; GROWTH; LEVEL; BASAL	The grade of a cancer is a measure of the cancer's malignancy level, and the stage of a cancer refers to the size and the extent that the cancer has spread. Here we present a computational method for prediction of gene signatures and blood/urine protein markers for breast cancer grades and stages based on RNA-seq data, which are retrieved from the TCGA breast cancer dataset and cover 111 pairs of disease and matching adjacent noncancerous tissues with pathologists-assigned stages and grades. By applying a differential expression and an SVM-based classification approach, we found that 324 and 227 genes in cancer have their expression levels consistently up-regulated vs. their matching controls in a grade-and stage-dependent manner, respectively. By using these genes, we predicted a 9-gene panel as a gene signature for distinguishing poorly differentiated from moderately and well differentiated breast cancers, and a 19-gene panel as a gene signature for discriminating between the moderately and well differentiated breast cancers. Similarly, a 30-gene panel and a 21-gene panel are predicted as gene signatures for distinguishing advanced stage (stages III-IV) from early stage (stages I-II) cancer samples and for distinguishing stage II from stage I samples, respectively. We expect these gene panels can be used as gene-expression signatures for cancer grade and stage classification. In addition, of the 324 grade-dependent genes, 188 and 66 encode proteins that are predicted to be blood-secretory and urine-excretory, respectively; and of the 227 stage-dependent genes, 123 and 51 encode proteins predicted to be blood-secretory and urine-excretory, respectively. We anticipate that some combinations of these blood and urine proteins could serve as markers for monitoring breast cancer at specific grades and stages through blood and urine tests.	[Yao, Fang; Du, Wei; Xu, Ying] Jilin Univ, Coll Comp Sci & Technol, Minist Educ, Key Lab Symbol Computat & Knowledge Engn, Changchun 130023, Peoples R China; [Yao, Fang; Zhang, Chi; Du, Wei; Liu, Chao; Xu, Ying] Univ Georgia, Dept Biochem & Mol Biol, Computat Syst Biol Lab, Athens, GA 30602 USA; [Yao, Fang; Zhang, Chi; Du, Wei; Liu, Chao; Xu, Ying] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Liu, Chao] Shandong Univ, Shandong Prov Hosp, Dept Oral & Maxillofacial Surg, Jinan 250100, Peoples R China; [Yao, Fang] Jilin Teachers Inst Engn & Technol, Changchun, Peoples R China	Jilin University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Du, W (corresponding author), Jilin Univ, Coll Comp Sci & Technol, Minist Educ, Key Lab Symbol Computat & Knowledge Engn, Changchun 130023, Peoples R China.	weidu@jlu.edu.cn; xyn@bmb.uga.edu	Zhang, Chi/AAD-3036-2021	Zhang, Chi/0000-0001-9553-0925	Natural Science Foundation of China [81320108025, 61402194, 61572227]; Ph.D. Program Foundation of MOE of China [20120061120106]; China Postdoctoral Science Foundation [2014T70291]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Program Foundation of MOE of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was supported by the Natural Science Foundation of China, 81320108025, http://www.nsfc.gov.cn/ Natural Science Foundation of China, 61402194, http://www.nsfc.gov.cn/, award number: 61572227, recipient: Ying Xu; the Ph.D. Program Foundation of MOE of China, 20120061120106, http://www.cutech.edu.cn/cn/index.htm China Postdoctoral Science Foundation, 2014T70291, http://res.chinapostdoctor.org.cn/BshWeb/index.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Beltran AS, 2014, ONCOGENE, V33, P4767, DOI 10.1038/onc.2013.422; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigbee W, 2003, CANC MED; BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Boelens MC, 2009, J PATHOL, V218, P182, DOI 10.1002/path.2520; Boyle P., 2008, World Cancer Report 2008; Cancer Genome Atlas Research Network, 2013, Nat Genet, V45, P1113, DOI 10.1038/ng.2764; Castro M, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-86; Chakrabarti A, 2015, TRENDS PHARMACOL SCI, V36, P481, DOI 10.1016/j.tips.2015.04.013; Chen Jie Qing, 2011, Hormones & Cancer, V2, P132, DOI 10.1007/s12672-011-0067-5; Chen SC, 2012, J PATHOL, V228, P158, DOI 10.1002/path.3988; Chen X, 2015, ONCOL LETT, V9, P2143, DOI 10.3892/ol.2015.3004; Chen X, 2012, CANCER RES, V72, P2294, DOI 10.1158/0008-5472.CAN-11-2181; Crichton N, 2000, J CLIN NURS, V9, P584; Cui J, 2008, BIOINFORMATICS, V24, P2370, DOI 10.1093/bioinformatics/btn418; Cui JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017819; Dijkstra S, 2014, CLIN BIOCHEM, V47, P889, DOI 10.1016/j.clinbiochem.2013.10.023; Dougherty ER, 2012, BIOESSAYS, V34, P277, DOI 10.1002/bies.201200003; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Elston C W, 2002, Histopathology, V41, P154; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Gast MCW, 2009, BREAST CANCER RES TR, V116, P17, DOI 10.1007/s10549-008-0263-3; Gauthier TD, 2001, ENVIRON FORENSICS, V2, P359, DOI 10.1006/enfo.2001.0061; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hix LM, 2013, J BIOL CHEM, V288, P11676, DOI 10.1074/jbc.M112.441402; Hong CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016875; Hu LD, 2008, ONCOL REP, V19, P1015; Hudler P, 2014, SCI WORLD J, DOI 10.1155/2014/260348; Inza I, 2004, ARTIF INTELL MED, V31, P91, DOI 10.1016/j.artmed.2004.01.007; Ishizaki F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01528; Israelsen WJ, 2013, CELL, V155, P397, DOI 10.1016/j.cell.2013.09.025; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kelemen LE, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2201; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kongkham PN, 2008, CANCER RES, V68, P9945, DOI 10.1158/0008-5472.CAN-08-2169; Leeming DJ, 2006, CANCER EPIDEM BIOMAR, V15, P1392, DOI 10.1158/1055-9965.EPI-05-0909; Li CI, 2003, ARCH INTERN MED, V163, P49, DOI 10.1001/archinte.163.1.49; Liu Y, 2013, INT J MOL MED, V31, P855, DOI 10.3892/ijmm.2013.1279; Majid SM, 2006, ONCOGENE, V25, P756, DOI 10.1038/sj.onc.1209107; Nishimura D, 2001, BIOTECH SOFTW INTERN, P117, DOI [10.1089/152791601750294344, DOI 10.1089/152791601750294344]; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Rodriguez-Pinto D, 2009, CANCER IMMUNOL IMMUN, V58, P221, DOI 10.1007/s00262-008-0543-0; Ross JS, 2003, ONCOLOGIST, V8, P307, DOI 10.1634/theoncologist.8-4-307; Sharma S, 2009, INDIAN J MED PAEDIAT, V30, P1, DOI 10.4103/0971-5851.56328; Shimo A, 2008, CANCER SCI, V99, P62, DOI 10.1111/j.1349-7006.2007.00635.x; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Souza B, 2004, GENE, V4, P599; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vickers Andrew J, 2005, BMC Med Res Methodol, V5, P35, DOI 10.1186/1471-2288-5-35; Wakefield L, 2008, GENE CHROMOSOME CANC, V47, P118, DOI 10.1002/gcc.20512; Wang C, 2014, NAT BIOTECHNOL, V32, P926, DOI 10.1038/nbt.3001; Xu HL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2814; Xu Y, CANC BIOINFORMATICS; Yang ZP, 2006, CLIN CHEM, V52, P1897, DOI 10.1373/clinchem.2005.065862; Zhang C., 2014, QUANT BIOL, V2, P85, DOI [10.1007/s40484-014-0032-8, DOI 10.1007/S40484-014-0032-8]; Zhang C, 2015, J MOL CELL BIOL, V7, P267, DOI 10.1093/jmcb/mjv031; Zhou X, 2007, BIOINFORMATICS, V23, P1106, DOI 10.1093/bioinformatics/btm036	61	29	29	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138213	10.1371/journal.pone.0138213	http://dx.doi.org/10.1371/journal.pone.0138213			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375396	gold, Green Submitted, Green Published			2022-12-27	WOS:000361610200088
J	Eadie, EC				Eadie, Elizabeth Christine			Ontogeny of Foraging Competence in Capuchin Monkeys (Cebus capucinus) for Easy versus Difficult to Acquire Fruits: A Test of the Needing to Learn Hypothesis	PLOS ONE			English	Article							ECOLOGICAL RISK-AVERSION; HUMAN LIFE-HISTORY; NEW-WORLD MONKEYS; SAIMIRI-SCIUREUS; APELLA-APELLA; DRY FOREST; BRAIN SIZE; PRIMATES; FOOD; EVOLUTION	Which factors select for long juvenile periods in some species is not well understood. One potential reason to delay the onset of reproduction is slow food acquisition rates, either due to competition (part of the ecological risk avoidance hypothesis), or due to a decreased foraging efficiency (a version of the needing to learn hypothesis). Capuchins provide a useful genus to test the needing to learn hypothesis because they are known for having long juvenile periods and a difficult-to-acquire diet. Generalized, linear, mixed models with data from 609 fruit forage focal follows on 49, habituated, wild Cebus capucinus were used to test two predictions from the needing-to-learn hypothesis as it applies to fruit foraging skills: 1) capuchin monkeys do not achieve adult foraging return rates for difficult-to-acquire fruits before late in the juvenile period; and 2) variance in return rates for these fruits is at least partially associated with differences in foraging skill. In support of the first prediction, adults, compared with all younger age classes, had significantly higher foraging return rates when foraging for fruits that were ranked as difficult-to-acquire (return rates relative to adults: 0.30-0.41, p-value range 0.008-0.016), indicating that the individuals in the group who have the most foraging experience also achieve the highest return rates. In contrast, and in support of the second prediction, there were no significant differences between age classes for fruits that were ranked as easy to acquire (return rates relative to adults: 0.97-1.42, p-value range 0.086-0.896), indicating that strength and/or skill are likely to affect return rates. In addition, fruits that were difficult to acquire were foraged at nearly identical rates by adult males and significantly smaller (and presumably weaker) adult females (males relative to females: 1.01, p = 0.978), while subadult females had much lower foraging efficiency than the similarly-sized but more experienced adult females (subadults relative to adults: 0.34, p = 0.052), indicating that skill, specifically, is likely to have an effect on return rates. These results are consistent with the needing to learn hypothesis and indicate that long juvenile periods in capuchins may be the result of selection for more time to learn foraging skills for difficult-to-acquire fruits.	Univ Arizona, Sch Anthropol, Tucson, AZ 85721 USA	University of Arizona	Eadie, EC (corresponding author), Univ Arizona, Sch Anthropol, Tucson, AZ 85721 USA.	eeadie@email.arizona.edu			National Science Foundation [DIG-0925843]; Leakey Foundation Grant; Sigma Xi [G200710101136267644]	National Science Foundation(National Science Foundation (NSF)); Leakey Foundation Grant; Sigma Xi	The following sources provided funding to EE for this project: the National Science Foundation (DIG-0925843) (http://www.nsf.gov/funding/pgm_summ.jsp/pims_id=505067&org=NSF), the Leakey Foundation Grant (http://www.leakeyfoundation.org/research-grants), and Sigma Xi Grants-in-Aid-of-Research (G200710101136267644) (https://www.sigmaxi.org/programs/grants-in-aid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 2009, IME4 LINEAR MIXED EF; [Anonymous], 1996, SEE THEY GROW TRACKI; Bird RB, 2002, HUM NATURE-INT BIOS, V13, P239, DOI 10.1007/s12110-002-1009-2; Bock J., 2005, HUNTER GATHERER CHIL, P109; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Charnov Eric L., 1993, Evolutionary Anthropology, V1, P191, DOI 10.1002/evan.1360010604; Crittenden AN, 2013, EVOL HUM BEHAV, V34, P299, DOI 10.1016/j.evolhumbehav.2013.04.004; Deaner Robert O., 2003, P233; Fedigan LM, 2001, INT J PRIMATOL, V22, P689, DOI 10.1023/A:1012092115012; Fragaszy D. M., 2004, COMPLETE CAPUCHIN BI; FRAGASZY DM, 1995, J COMP PSYCHOL, V109, P339, DOI 10.1037/0735-7036.109.4.339; Fragaszy DM, 1997, INT J PRIMATOL, V18, P683, DOI 10.1023/A:1026339712071; GADGIL M, 1970, American Naturalist, V104, P1, DOI 10.1086/282637; Gibson K.R., 1986, P93; Godfrey LR, 2004, AM J PHYS ANTHROPOL, V123, P250, DOI 10.1002/ajpa.10315; Gunst N, 2008, BEHAVIOUR, V145, P195, DOI 10.1163/156853907783244701; Gunst N, 2010, AM J PRIMATOL, V72, P960, DOI 10.1002/ajp.20856; Gunst N, 2010, J COMP PSYCHOL, V124, P194, DOI 10.1037/a0017723; Gurven M, 2006, J HUM EVOL, V51, P454, DOI 10.1016/j.jhevol.2006.05.003; Hartwig W, 2011, ANAT REC, V294, P2207, DOI 10.1002/ar.21515; HARVEY PH, 1985, EVOLUTION, V39, P559, DOI 10.1111/j.1558-5646.1985.tb00395.x; HARVEY PH, 1980, P NATL ACAD SCI-BIOL, V77, P4387, DOI 10.1073/pnas.77.7.4387; JANSON CH, 1992, AM J PHYS ANTHROPOL, V88, P483, DOI 10.1002/ajpa.1330880405; Janson Charles H., 1993, P57; Johnson SE, 2004, HUM NATURE-INT BIOS, V15, P45, DOI 10.1007/s12110-004-1003-y; Jones NB, 2002, HUM NATURE-INT BIOS, V13, P199, DOI 10.1007/s12110-002-1008-3; Kaplan H, 2000, EVOL ANTHROPOL, V9, P156, DOI 10.1002/1520-6505(2000)9:4<156::AID-EVAN5>3.0.CO;2-7; Kaplan H., 2007, GUTS BRAINS INTEGRAT, P47; Lucas PW, 2012, INT J PRIMATOL, V33, P598, DOI 10.1007/s10764-011-9540-9; MacKinnon KC, 2006, DEV PRIMATOL-PROG PR, P349, DOI 10.1007/0-387-25872-8_17; O'Mara MT, 2015, FOLIA PRIMATOL, V86, P96, DOI 10.1159/000368275; Ossi-Lupo K, 2010, ANTHR LEARNING CHILD, P309; Ottoni EB, 2008, CAPUCHIN MONKEY TOOL, DOI [10.1002/evan.20185, DOI 10.1002/EVAN.20185]; Pereira M. E, 2002, JUVENILE PRIMATES LI, pvii; Perry S, 1997, BEHAVIOUR, V134, P477, DOI 10.1163/156853997X00494; Perry Susan, 2012, P141; Rose LM, 1997, INT J PRIMATOL, V18, P727, DOI 10.1023/A:1026343812980; ROSS C, 1991, INT J PRIMATOL, V12, P481, DOI 10.1007/BF02547635; Ross Caroline, 1999, P73, DOI 10.1017/CBO9780511542466.007; Schuppli C, 2012, J HUM EVOL, V63, P843, DOI 10.1016/j.jhevol.2012.08.009; Sirianni G, 2013, AM J PRIMATOL, V75, P387, DOI 10.1002/ajp.22119; Smith RJ, 1997, J HUM EVOL, V32, P523, DOI 10.1006/jhev.1996.0122; Spagnoletti N, 2012, ANIM BEHAV, V83, P1285, DOI 10.1016/j.anbehav.2012.03.002; Stone AI, 2006, ETHOLOGY, V112, P105, DOI 10.1111/j.1439-0310.2005.01121.x; Stone AI, 2007, ETHOLOGY, V113, P782, DOI 10.1111/j.1439-0310.2007.01377.x; Team RDC, 2010, R LANG ENV STAT COMP; Vogel ER, 2005, BEHAV ECOL SOCIOBIOL, V58, P333, DOI 10.1007/s00265-005-0960-4; Walker R, 2006, AM J PHYS ANTHROPOL, V129, P577, DOI 10.1002/ajpa.20306; Wright BW, 2009, AM J PHYS ANTHROPOL, V140, P687, DOI 10.1002/ajpa.21116	50	16	16	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138001	10.1371/journal.pone.0138001	http://dx.doi.org/10.1371/journal.pone.0138001			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372642	Green Published, Green Submitted, gold			2022-12-27	WOS:000361604400044
J	Kim, YC; Chen, CC; Bolton, EC				Kim, Young-Chae; Chen, Congcong; Bolton, Eric C.			Androgen Receptor-Mediated Growth Suppression of HPr-1AR and PC3-Lenti-AR Prostate Epithelial Cells	PLOS ONE			English	Article							CANCER CELLS; CYCLIN D3; DOWN-REGULATION; LNCAP CELLS; POINT MUTATIONS; APOPTOTIC DEATH; FACTOR-I; PROLIFERATION; EXPRESSION; GENE	The androgen receptor (AR) mediates the developmental, physiologic, and pathologic effects of androgens including 5 alpha-dihydrotestosterone (DHT). However, the mechanisms whereby AR regulates growth suppression and differentiation of luminal epithelial cells in the prostate gland and proliferation of malignant versions of these cells are not well understood, though they are central to prostate development, homeostasis, and neoplasia. Here, we identify androgen-responsive genes that restrain cell cycle progression and proliferation of human prostate epithelial cell lines (HPr-1AR and PC3-Lenti-AR), and we investigate the mechanisms through which AR regulates their expression. DHT inhibited proliferation of HPr-1AR and PC3-Lenti-AR, and cell cycle analysis revealed a prolonged G(1) interval. In the cell cycle, the G(1)/S-phase transition is initiated by the activity of cyclin D and cyclin-dependent kinase (CDK) complexes, which relieve growth suppression. In HPr-1AR, cyclin D1/2 and CDK4/6 mRNAs were androgen-repressed, whereas CDK inhibitor, CDKN1A, mRNA was androgen-induced. The regulation of these transcripts was AR-dependent, and involved multiple mechanisms. Similar AR-mediated down-regulation of CDK4/6 mRNAs and up-regulation of CDKN1A mRNA occurred in PC3-Lenti-AR. Further, CDK4/6 overexpression suppressed DHT-inhibited cell cycle progression and proliferation of HPr-1AR and PC3-Lenti-AR, whereas CDKN1A overexpression induced cell cycle arrest. We therefore propose that AR-mediated growth suppression of HPr-1AR involves cyclin D1 mRNA decay, transcriptional repression of cyclin D2 and CDK4/6, and transcriptional activation of CDKN1A, which serve to decrease CDK4/6 activity. AR-mediated inhibition of PC3-Lenti-AR proliferation occurs through a similar mechanism, albeit without down-regulation of cyclin D. Our findings provide insight into AR-mediated regulation of prostate epithelial cell proliferation.	[Kim, Young-Chae; Chen, Congcong; Bolton, Eric C.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign	Bolton, EC (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL USA.	boltonec@life.illinois.edu		Kim, Young-Chae/0000-0002-5130-4413	University of Illinois at Urbana-Champaign	University of Illinois at Urbana-Champaign	This work was supported by University of Illinois at Urbana-Champaign startup funds to ECB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agus DB, 1999, J NATL CANCER I, V91, P1869, DOI 10.1093/jnci/91.21.1869; Bai VU, 2005, J CELL PHYSIOL, V204, P381, DOI 10.1002/jcp.20422; Bartkova J, 1998, ONCOGENE, V17, P1027, DOI 10.1038/sj.onc.1202016; BETTICHER DC, 1995, ONCOGENE, V11, P1005; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; BONKHOFF H, 1993, VIRCHOWS ARCH A, V422, P35, DOI 10.1007/BF01605130; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Burger PE, 2005, P NATL ACAD SCI USA, V102, P7180, DOI 10.1073/pnas.0502761102; Cai CM, 2011, ENDOCR-RELAT CANCER, V18, pR175, DOI 10.1530/ERC-10-0339; CARROLL AG, 1993, PROSTATE, V23, P123, DOI 10.1002/pros.2990230206; Chen Y, 1998, ONCOGENE, V16, P1913, DOI 10.1038/sj.onc.1201719; Choo CK, 1999, PROSTATE, V40, P150, DOI 10.1002/(SICI)1097-0045(19990801)40:3<150::AID-PROS2>3.0.CO;2-7; Claessens F, 2001, J STEROID BIOCHEM, V76, P23, DOI 10.1016/S0960-0760(00)00154-0; D'Antonio JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011475; De Santa F, 2007, MOL CELL BIOL, V27, P7248, DOI 10.1128/MCB.02199-06; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; DELANY AM, 1995, ENDOCRINOLOGY, V136, P4776, DOI 10.1210/en.136.11.4776; DOWDY SF, 1993, CELL, V73, P499, DOI 10.1016/0092-8674(93)90137-F; France KA, 2011, J BIOL CHEM, V286, P22750, DOI 10.1074/jbc.M111.225433; Friedlander TW, 2012, UROL CLIN N AM, V39, P453, DOI 10.1016/j.ucl.2012.07.003; Fujita Y, 2008, BIOCHEM BIOPH RES CO, V377, P114, DOI 10.1016/j.bbrc.2008.09.086; Galindo CL, 2004, J BIOL CHEM, V279, P37597, DOI 10.1074/jbc.M404641200; Georgieva J, 2001, J CLIN PATHOL, V54, P229, DOI 10.1136/jcp.54.3.229; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; HARPER JW, 1993, CELL, V75, P805; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Heisler LE, 1997, MOL CELL ENDOCRINOL, V126, P59, DOI 10.1016/S0303-7207(96)03970-6; Henderson L, 2013, AM J PHYSIOL-CELL PH, V304, pC927, DOI 10.1152/ajpcell.00006.2013; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; HOSOKAWA Y, 1995, CANCER LETT, V93, P165, DOI 10.1016/0304-3835(95)03805-7; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Isaacs JT, 2004, NAT MED, V10, P26, DOI 10.1038/nm0104-26; ISAACS JT, 1994, SEMIN CANCER BIOL, V5, P391; KIESS M, 1995, ONCOGENE, V10, P159; Knudsen KE, 1998, J BIOL CHEM, V273, P20213, DOI 10.1074/jbc.273.32.20213; Kurita T, 2001, CELL DEATH DIFFER, V8, P192, DOI 10.1038/sj.cdd.4400797; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Lamont KR, 2011, MOL ENDOCRINOL, V25, P897, DOI 10.1210/me.2010-0469; Lanzino M, 2010, NUCLEIC ACIDS RES, V38, P5351, DOI 10.1093/nar/gkq278; Le H, 2006, AM J PHYSIOL-ENDOC M, V290, pE952, DOI 10.1152/ajpendo.00451.2005; Lee SO, 2012, J ENDOCRINOL, V213, P173, DOI 10.1530/JOE-11-0474; Ling MT, 2001, J ENDOCRINOL, V170, P287, DOI 10.1677/joe.0.1700287; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P9774, DOI 10.1073/pnas.86.24.9774; Litvinov IV, 2003, J CLIN ENDOCR METAB, V88, P2972, DOI 10.1210/jc.2002-022038; Litvinov IV, 2006, PROSTATE, V66, P1329, DOI 10.1002/pros.20483; Lu FM, 2003, CANCER RES, V63, P7056; Lu S, 1999, MOL ENDOCRINOL, V13, P376, DOI 10.1210/me.13.3.376; Lu S, 1997, CANCER RES, V57, P4511; Lu WQ, 1999, J BIOL CHEM, V274, P12827, DOI 10.1074/jbc.274.18.12827; MARCELLI M, 1995, ENDOCRINOLOGY, V136, P1040, DOI 10.1210/en.136.3.1040; Massie CE, 2007, EMBO REP, V8, P871, DOI 10.1038/sj.embor.7401046; Mirochnik Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031052; Mirosevich J, 1999, J ENDOCRINOL, V162, P341, DOI 10.1677/joe.0.1620341; Nesslinger NJ, 2003, CANCER RES, V63, P2228; Neugebauer KM, 2002, J CELL SCI, V115, P3865, DOI 10.1242/jcs.00073; Ohlson N, 2006, PROSTATE, V66, P1687, DOI 10.1002/pros.20368; Pernicova Z, 2011, NEOPLASIA, V13, P526, DOI 10.1593/neo.11182; Planz B, 1999, PROSTATE, V41, P233; Pozzobon A, 2012, INT J MOL MED, V30, P967, DOI 10.3892/ijmm.2012.1082; Ratliff Timothy L, 2005, J Urol, V174, P1149; Recchia AG, 2009, INT J BIOCHEM CELL B, V41, P603, DOI 10.1016/j.biocel.2008.07.004; REDDY GPV, 1994, J CELL BIOCHEM, V54, P379, DOI 10.1002/jcb.240540404; Rojas P, 2009, MOL CARCINOGEN, V48, P508, DOI 10.1002/mc.20489; RUBIN SJ, 1991, J SURG ONCOL, V46, P31, DOI 10.1002/jso.2930460108; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Solomon DA, 2003, J BIOL CHEM, V278, P30339, DOI 10.1074/jbc.M303969200; Srivastava SK, 2012, CARCINOGENESIS, V33, P1149, DOI 10.1093/carcin/bgs134; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; SWEE MH, 1995, J BIOL CHEM, V270, P14899, DOI 10.1074/jbc.270.25.14899; Taneja SS, 2002, J CELL BIOCHEM, V84, P188, DOI 10.1002/jcb.1278; TILLEY WD, 1995, STEROIDS, V60, P180, DOI 10.1016/0039-128X(94)00031-7; Tzur A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016053; Uzgare AR, 2004, J CELL BIOCHEM, V91, P196, DOI 10.1002/jcb.10764; VELDSCHOLTE J, 1992, J STEROID BIOCHEM, V41, P665, DOI 10.1016/0960-0760(92)90401-4; Wang GL, 2006, MOL CELL BIOL, V26, P2570, DOI 10.1128/MCB.26.7.2570-2582.2006; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Wang XT, 1997, ONCOGENE, V15, P2991, DOI 10.1038/sj.onc.1201450; Whitacre DC, 2002, CELL GROWTH DIFFER, V13, P1; Wiestner A, 2007, BLOOD, V109, P4599, DOI 10.1182/blood-2006-08-039859; Wikstrom P, 1999, PROSTATE, V38, P268; Wu CT, 2007, P NATL ACAD SCI USA, V104, P12679, DOI 10.1073/pnas.0704940104; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Xu YY, 2006, CANCER RES, V66, P7783, DOI 10.1158/0008-5472.CAN-05-4472; YAN GC, 1992, MOL ENDOCRINOL, V6, P2123, DOI 10.1210/me.6.12.2123; YUAN SX, 1993, CANCER RES, V53, P1304; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008; Zhou Y, 2015, J MOL ENDOCRINOL, V54, pR15, DOI 10.1530/JME-14-0203	93	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138286	10.1371/journal.pone.0138286	http://dx.doi.org/10.1371/journal.pone.0138286			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372468	Green Published, Green Submitted, gold			2022-12-27	WOS:000361604400062
J	Lee, TY; Huang, JC; Lee, JY; Jien, SH; Zehetner, F; Kao, SJ				Lee, Tsung-Yu; Huang, Jr-Chuan; Lee, Jun-Yi; Jien, Shih-Hao; Zehetner, Franz; Kao, Shuh-Ji			Magnified Sediment Export of Small Mountainous Rivers in Taiwan: Chain Reactions from Increased Rainfall Intensity under Global Warming	PLOS ONE			English	Article							PARTICULATE ORGANIC-CARBON; FLUVIAL SEDIMENT; TRANSPORT; OCEAN; DISCHARGE; EROSION; TRENDS; PRECIPITATION; TEMPERATURE; FLUXES	Fluvial sediment export from small mountainous rivers in Oceania has global biogeochemical significance affecting the turnover rate and export of terrestrial carbon, which might be speeding up at the recognized conditions of increased rainfall intensity. In this study, the historical runoff and sediment export from 16 major rivers in Taiwan are investigated and separated into an early stage (1970-1989) and a recent stage (1990-2010) to illustrate the changes of both runoff and sediment export. The mean daily sediment export from Taiwan Island in the recent stage significantly increased by >80% with subtle increase in daily runoff, indicating more sediment being delivered to the ocean per unit of runoff in the recent stage. The medians of the runoff depth and sediment yield extremes (99.0-99.9 percentiles) among the 16 rivers increased by 6.5%-37% and 62%-94%, respectively, reflecting the disproportionately magnified response of sediment export to the increased runoff. Taiwan is facing increasing event rainfall intensity which has resulted in chain reactions on magnified runoff and sediment export responses. As the globe is warming, rainfall extremes, which are proved to be temperature-dependent, very likely intensify runoff and trigger more sediment associated hazards. Such impacts might occur globally because significant increases of high-intensity precipitation have been observed not only in Taiwan but over most land areas of the globe.	[Lee, Tsung-Yu] Natl Taiwan Normal Univ, Dept Geog, Taipei, Taiwan; [Huang, Jr-Chuan; Lee, Jun-Yi] Natl Taiwan Univ, Dept Geog, Taipei 10764, Taiwan; [Jien, Shih-Hao] Natl Pingtung Univ Sci & Technol, Dept Soil & Water Conservat, Pingtung, Taiwan; [Zehetner, Franz] Univ Nat Resources & Life Sci, Inst Soil Res, Vienna, Austria; [Kao, Shuh-Ji] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China	National Taiwan Normal University; National Taiwan University; National Pingtung University Science & Technology; University of Natural Resources & Life Sciences, Vienna; Xiamen University	Lee, TY (corresponding author), Natl Taiwan Normal Univ, Dept Geog, Taipei, Taiwan.	tylee@ntnu.edu.tw	Lee, Jun-Yi/AAL-9645-2021	Lee, Jun-Yi/0000-0002-4442-0264; Huang, Jr-Chuan/0000-0001-6589-4963	Ministry of Science and Technology [102-2923-M-002-001-MY3, 103-2119-M-003-006]; Austrian Science Fund (FWF) [I 1396-B16]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by the Ministry of Science and Technology (102-2923-M-002-001-MY3, 103-2119-M-003-006)(http://www.most.gov.tw/) and by the Austrian Science Fund (FWF): I 1396-B16 (http://www.fwf.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carey AE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023159; Carey AE, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015690; Carter L., 2009, UNEP WCMC BIODIVERSI, V31; Chen JC, 2014, NAT HAZARD EARTH SYS, V14, P1719, DOI 10.5194/nhess-14-1719-2014; Chen YC, 2012, EARTH SURF PROCESSES, V38, P372; Chen YC, 2013, EARTH SURF PROC LAND, V38, P372, DOI 10.1002/esp.3284; Chien FC, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015092; Chou C, 2013, NAT GEOSCI, V6, P263, DOI [10.1038/NGEO1744, 10.1038/ngeo1744]; Dadson S, 2005, J GEOPHYS RES-EARTH, V110, DOI 10.1029/2004JF000244; Dadson SJ, 2003, NATURE, V426, P648, DOI 10.1038/nature02150; Dadson SJ, 2004, GEOLOGY, V32, P733, DOI 10.1130/G20639.1; Gabet EJ, 2007, EARTH PLANET SC LETT, V264, P259, DOI 10.1016/j.epsl.2007.09.028; Galy V, 2008, GEOCHIM COSMOCHIM AC, V72, P1767, DOI 10.1016/j.gca.2008.01.027; Goldsmith ST, 2008, GEOLOGY, V36, P483, DOI 10.1130/G24624A.1; Hilton RG, 2008, NAT GEOSCI, V1, P759, DOI 10.1038/ngeo333; Hilton RG, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2012GB004314; Hilton RG, 2011, GEOLOGY, V39, P71, DOI 10.1130/G31352.1; Hilton RG, 2010, GEOCHIM COSMOCHIM AC, V74, P3164, DOI 10.1016/j.gca.2010.03.004; Hovius N, 2000, J GEOL, V108, P73, DOI 10.1086/314387; Hovius N, 2011, EARTH PLANET SC LETT, V304, P347, DOI 10.1016/j.epsl.2011.02.005; Huang JC, 2007, NAT HAZARD EARTH SYS, V7, P781, DOI 10.5194/nhess-7-781-2007; Huang JC, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/034008; Kao SJ, 2008, J GEOL, V116, P431, DOI 10.1086/590921; Kao SJ, 2014, EARTH SURF DYNAM, V2, P127, DOI 10.5194/esurf-2-127-2014; Kao SJ, 2006, CONT SHELF RES, V26, P2520, DOI 10.1016/j.csr.2006.07.030; Kao SJ, 2005, TERR ATMOS OCEAN SCI, V16, P653, DOI 10.3319/TAO.2005.16.3.653(T); Kao SJ, 2005, J GEOL, V113, P217, DOI 10.1086/427670; Kao SJ, 1996, LIMNOL OCEANOGR, V41, P1749, DOI 10.4319/lo.1996.41.8.1749; Kao SJ, 2011, IAHS PUBL, V349; Karl TR, 1998, B AM METEOROL SOC, V79, P231, DOI 10.1175/1520-0477(1998)079<0231:STOPAF>2.0.CO;2; Lin CH, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044685; Lin GW, 2008, EARTH SURF PROC LAND, V33, P1354, DOI 10.1002/esp.1716; Liu SC, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040218; Lyons WB, 2002, GEOLOGY, V30, P443, DOI 10.1130/0091-7613(2002)030<0443:OCFTTO>2.0.CO;2; Manton MJ, 2001, INT J CLIMATOL, V21, P269, DOI 10.1002/joc.610; Milliman J.D., 2013, RIVER DISCHARGE COAS; Milliman JD, 2005, J GEOL, V113, P503, DOI 10.1086/431906; Neil DT, 2002, MAR FRESHWATER RES, V53, P733, DOI 10.1071/MF00151; Rabalais NN, 2007, ECOL APPL, V17, pS129, DOI 10.1890/06-0644.1; Schlunz B, 2000, INT J EARTH SCI, V88, P599, DOI 10.1007/s005310050290; Schmidt JC, 2001, ECOL APPL, V11, P657, DOI 10.1890/1051-0761(2001)011[0657:TCFIGC]2.0.CO;2; Shiu CJ, 2009, J CLIMATE, V22, P5635, DOI 10.1175/2009JCLI2514.1; Steer P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6564; Tank AMGK, 2003, J CLIMATE, V16, P3665, DOI [10.1175/1520-0442(2003)016<3665:TIIODT>2.0.CO;2, 10.1175/1520-0442(2003)016&lt;3665:TIIODT&gt;2.0.CO;2]; Tsai ZX, 2013, EARTH SURF PROC LAND, V38, P661, DOI 10.1002/esp.3309; Tsou CY, 2011, GEOMORPHOLOGY, V127, P166, DOI 10.1016/j.geomorph.2010.12.013; Tu JY, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014023; Tu JY, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034013; Tu JY, 2009, J CLIMATE, V22, P3617, DOI 10.1175/2009JCLI2411.1; von Blanckenburg F, 2005, EARTH PLANET SC LETT, V237, P462, DOI 10.1016/j.epsl.2005.06.030; West AJ, 2011, LIMNOL OCEANOGR, V56, P77, DOI 10.4319/lo.2011.56.1.0077; Wheatcroft RA, 2010, LIMNOL OCEANOGR, V55, P161, DOI 10.4319/lo.2010.55.1.0161	52	38	39	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138283	10.1371/journal.pone.0138283	http://dx.doi.org/10.1371/journal.pone.0138283			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372356	gold, Green Published, Green Submitted			2022-12-27	WOS:000361604400061
J	Ding, QF; Zhao, M; Yu, BL; Bai, C; Huang, ZF				Ding, Qingfeng; Zhao, Mei; Yu, Bolan; Bai, Chuan; Huang, Zhaofeng			Identification of Tetraazacyclic Compounds as Novel Potent Inhibitors Antagonizing ROR gamma t Activity and Suppressing Th17 Cell Differentiation	PLOS ONE			English	Article							NUCLEAR RECEPTORS; DERIVATIVES; PROTEIN; GENE; AUTOIMMUNITY; DIGOXIN; IL-17F; TARGET; LIGAND; BETA	CD4(+) T-helper cells that produce interleukin-17 (Th17 cells) are characterized as pathological T-helper cells in autoimmune diseases. Differentiation of human and mouse Th17 cells requires a key transcription regulator, retinoic acid receptor-related orphan receptor gamma t (ROR gamma t), which is a potential therapeutic target for autoimmune diseases. To develop a therapeutic agent for Th17-mediated autoimmune diseases, we have established a highthroughput screening (HTS) assay for candidate screening, in which the luciferase activity in ROR gamma t-LBD positive and negative Jurkat cells were analyzed to evaluate induction of ROR gamma t activity by compounds. This technique was applied to screen a commercially-available drug-like chemical compound library (Enamine) which contains 20155 compounds. The screening identified 17 compounds that can inhibit ROR gamma t function in the HTS screen system. Of these, three tetraazacyclic compounds can potently inhibit ROR gamma t activity, and suppress Th17 differentiation and IL-17 production. These three candidate compounds could significantly attenuate the expression of the Il17a by 65%-90%, and inhibit IL-17A secretion by 47%, 63%, and 74%, respectively. These compounds also exhibited a potent anti-ROR gamma t activity, with EC50 values of 0.25 mu M, 0.67 mu M and 2.6 mu M, respectively. Our data demonstrated the feasibility of targeting the ROR gamma t to inhibit Th17 cell differentiation and function with these tetraazacyclic compounds, and the potential to improve the structure of these compounds for autoimmune diseases therapeutics.	[Ding, Qingfeng; Zhao, Mei; Bai, Chuan; Huang, Zhaofeng] Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Guangzhou 510080, Guangdong, Peoples R China; [Ding, Qingfeng; Zhao, Mei; Bai, Chuan; Huang, Zhaofeng] Sun Yat Sen Univ, Key Lab Trop Dis Control, Minist Educ China, Guangzhou 510080, Guangdong, Peoples R China; [Yu, Bolan] Guangzhou Med Univ, Key Lab Major Obstet Dis Guangdong Prov, Affiliated Hosp 3, Guangzhou 510150, Guangdong, Peoples R China; [Huang, Zhaofeng] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Ministry of Education, China; Sun Yat Sen University; Guangzhou Medical University; Sun Yat Sen University	Huang, ZF (corresponding author), Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Guangzhou 510080, Guangdong, Peoples R China.	hzhaof@mail.sysu.edu.cn			Natural Science Foundation of China [81370751, 31170831]; Guangdong Recruitment Program of Creative Research Group [2009010058]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Recruitment Program of Creative Research Group	Funds supported by the Natural Science Foundation of China (81370751 and 31170831), and the Guangdong Recruitment Program of Creative Research Group (No. 2009010058).	Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Chen YP, 2009, J PHARMACOL EXP THER, V329, P192, DOI 10.1124/jpet.108.148916; Chuang KA, 2010, BRAZ J MED BIOL RES, V43, P931, DOI 10.1590/S0100-879X2010001000003; Fujita-Sato S, 2011, J BIOL CHEM, V286, P31409, DOI 10.1074/jbc.M111.254003; Griffin P, 2012, J EXPT PHARM, P141, DOI [10.2147/jep.s27078, DOI 10.2147/JEP.S27078]; Huang ZF, 2008, J IMMUNOL, V180, P6586, DOI 10.4049/jimmunol.180.10.6586; Huang ZF, 2007, EXPERT OPIN THER TAR, V11, P737, DOI 10.1517/14728222.11.6.737; Huh JR, 2012, EUR J IMMUNOL, V42, P2232, DOI 10.1002/eji.201242740; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jetten AM, 2001, PROG NUCLEIC ACID RE, V69, P205, DOI 10.1016/S0079-6603(01)69048-2; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Kassi E, 2009, CANCER INVEST, V27, P723, DOI 10.1080/07357900802672712; Kumar N, 2011, ACS CHEM BIOL, V6, P218, DOI 10.1021/cb1002762; Kwon MJ, 2012, J IMMUNOL, V188, P5887, DOI 10.4049/jimmunol.1102941; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Li YS, 2012, RHEUMATOL INT, V32, P2415, DOI 10.1007/s00296-011-1867-1; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Medvedev A, 1997, GENOMICS, V46, P93, DOI 10.1006/geno.1997.4980; Miossec P, 2009, MICROBES INFECT, V11, P625, DOI 10.1016/j.micinf.2009.04.003; Mongrain V, 2008, GENES CELLS, V13, P1197, DOI 10.1111/j.1365-2443.2008.01237.x; Muhlbauer E, 2013, MOL CELL ENDOCRINOL, V365, P129, DOI 10.1016/j.mce.2012.10.001; Pappu R, 2010, J CLIN IMMUNOL, V30, P185, DOI 10.1007/s10875-010-9369-6; Renaud JP, 2000, CELL MOL LIFE SCI, V57, P1748, DOI 10.1007/PL00000656; Solt LA, 2012, ACS CHEM BIOL, V7, P1515, DOI 10.1021/cb3002649; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Wang XH, 2012, IMMUNITY, V36, P23, DOI 10.1016/j.immuni.2011.10.019; Xie HM, 2005, J IMMUNOL, V175, P3800, DOI 10.4049/jimmunol.175.6.3800; Xu T, 2011, J BIOL CHEM, V286, P22707, DOI 10.1074/jbc.C111.250407; Yang T, 2014, ACS MED CHEM LETT, V5, P65, DOI 10.1021/ml4003875; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yin Y, 2015, J BIOL CHEM, V290, P35, DOI 10.1074/jbc.M114.598631; Zhong FD, 2015, ORG BIOMOL CHEM, V13, P1792, DOI 10.1039/c4ob02247e	34	6	6	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137711	10.1371/journal.pone.0137711	http://dx.doi.org/10.1371/journal.pone.0137711			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368822	Green Submitted, gold, Green Published			2022-12-27	WOS:000361601100116
J	Yu, H; Hahn, Y; Yang, I				Yu, Hannah; Hahn, Yoonsoo; Yang, Inchul			Reference Materials for Calibration of Analytical Biases in Quantification of DNA Methylation	PLOS ONE			English	Article							PCR-BIAS; PATTERNS; ASSAY; QUANTITATION; CHALLENGES; GENOME	Most contemporary methods for the quantification of DNA methylation employ bisulfite conversion and PCR amplification. However, many reports have indicated that bisulfite-mediated PCR methodologies can result in inaccurate measurements of DNA methylation owing to amplification biases. To calibrate analytical biases in quantification of gene methylation, especially those that arise during PCR, we utilized reference materials that represent exact bisulfite-converted sequences with 0% and 100% methylation status of specific genes. After determining relative quantities using qPCR, pairs of plasmids were gravimetrically mixed to generate working standards with predefined DNA methylation levels at 10% intervals in terms of mole fractions. The working standards were used as controls to optimize the experimental conditions and also as calibration standards in melting-based and sequencing-based analyses of DNA methylation. Use of the reference materials enabled precise characterization and proper calibration of various biases during PCR and subsequent methylation measurement processes, resulting in accurate measurements.	[Yu, Hannah; Yang, Inchul] Korea Res Inst Stand & Sci, Ctr Bioanal, Div Metrol Qual Life, Taejon 305340, South Korea; [Yu, Hannah; Yang, Inchul] Univ Sci & Technol, Bioanalyt Sci, Taejon 305340, South Korea; [Hahn, Yoonsoo] Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea	Korea Research Institute of Standards & Science (KRISS); Chung Ang University	Yang, I (corresponding author), Korea Res Inst Stand & Sci, Ctr Bioanal, Div Metrol Qual Life, Taejon 305340, South Korea.	icy@kriss.re.kr	Yu, Hannah/AAH-6002-2021	HAHN, YOONSOO/0000-0003-4273-9842	Korea Research Institute of Standards and Science [KRISS-GP2015-0008]	Korea Research Institute of Standards and Science	This work was supported by Korea Research Institute of Standards and Science under the project 'Development of Bio and Clinical Measurement Standards (KRISS-GP2015-0008)'.	Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Chhibber A, 2008, ANAL BIOCHEM, V377, P46, DOI 10.1016/j.ab.2008.02.026; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Fuso A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118318; Hernandez HG, 2013, BIOTECHNIQUES, V55, P181, DOI 10.2144/000114087; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Jeong S, 2007, GENOME RES, V17, P1093, DOI 10.1101/gr.6028507; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Kit AH, 2012, BIOCHIMIE, V94, P2314, DOI 10.1016/j.biochi.2012.07.014; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Langevin SM, 2012, EPIGENETICS-US, V7, P291, DOI 10.4161/epi.7.3.19134; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li M, 2009, NAT BIOTECHNOL, V27, P858, DOI 10.1038/nbt.1559; Moskalev EA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr213; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Shen LL, 2007, BIOTECHNIQUES, V42, P48, DOI 10.2144/000112312; Smith E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-123; Sriraksa R, 2010, CLIN BIOCHEM, V43, P528, DOI 10.1016/j.clinbiochem.2009.11.005; Taylor KH, 2007, CANCER RES, V67, P8511, DOI 10.1158/0008-5472.CAN-07-1016; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Van de Voorde L, 2012, MUTAT RES-REV MUTAT, V751, P304, DOI 10.1016/j.mrrev.2012.06.001; Warnecke PM, 1997, NUCLEIC ACIDS RES, V25, P4422, DOI 10.1093/nar/25.21.4422; White G H, 2004, Clin Biochem Rev, V25, pS1; Wojdacz TK, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm013; Wojdacz TK, 2006, BIOTECHNIQUES, V41, P274, DOI 10.2144/000112240; Wojdacz TK, 2008, NAT PROTOC, V3, P1903, DOI 10.1038/nprot.2008.191; Wojdacz TK, 2009, EPIGENETICS-US, V4, P231, DOI 10.4161/epi.9020; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Yang I, 2009, ANAL BIOCHEM, V384, P288, DOI 10.1016/j.ab.2008.09.036; Zhou LM, 2005, CLIN CHEM, V51, P1770, DOI 10.1373/clinchem.2005.054924	33	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137006	10.1371/journal.pone.0137006	http://dx.doi.org/10.1371/journal.pone.0137006			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368560	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100045
J	Cao, RH; Ye, X; Chen, XG; Zhang, L; Chen, XW; Tian, YH; Hu, PP; Wang, K				Cao, Ruihua; Ye, Xing; Chen, Xingui; Zhang, Long; Chen, Xianwen; Tian, Yanghua; Hu, Panpan; Wang, Kai			Exploring Biological Motion Processing in Parkinson's Disease Using Temporal Dilation	PLOS ONE			English	Article							NEURAL MECHANISMS; CEREBELLAR LESIONS; VISUAL-PERCEPTION; STROKE PATIENTS; FUSIFORM GYRUS; MOTOR DEFICITS; HUMAN-BODY; MOVEMENTS; DOPAMINE; REHABILITATION	Biological motion (BM) perception is the compelling ability of the visual system to perceive complex animated movements effortlessly and promptly. A recent study has shown that BM can automatically lengthen perceived temporal duration independent of global configuration. The present study aimed mainly to investigate this temporal dilation effect of BM signals in Parkinson's disease (PD) patients. We used the temporal dilation effect as an implicit measure of visual processing of BM. In all, 32 PD patients (under off-therapy conditions) and 32 healthy controls (HCs) participated in our study. In each trial, an upright BM sequence and an inverted BM sequence were presented within an interval in the center of the screen. We tested both canonical and scrambled BM sequences; the scrambled ones were generated by disturbing the global configuration of the canonical ones but preserving exactly the same local motion components. Observers were required to make a verbal two-alternative forced choice response to indicate which interval (the first or the second) appeared longer. Statistical analyses were conducted on the points of subjective equality (PSEs). We found that the temporal dilation effect was significantly reduced for PD patients compared with HCs in both canonical and scrambled BM conditions. Moreover, no temporal dilation effects of scrambled BM were shown in both early-and late-stage PD patients, while the temporal dilation effect of canonical BM was relatively preserved in the early stages.	[Cao, Ruihua] Anhui Prov Hosp, Dept Geriatr Med, Hefei, Anhui, Peoples R China; [Ye, Xing; Chen, Xingui; Zhang, Long; Chen, Xianwen; Tian, Yanghua; Hu, Panpan; Wang, Kai] Anhui Med Univ, Affiliated Hosp 1, Dept Neurol, Hefei, Anhui, Peoples R China	Anhui Medical University	Hu, PP (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Neurol, Hefei, Anhui, Peoples R China.	hpppanda9@126.com; wangkai1964@126.com	Wang, Dapeng/HGD-4818-2022; hu, panpan/ABD-5695-2021	Tian, Yanghua/0000-0001-5038-0599	National Natural Science Foundation of China [91232717, 31000503]; National Basic Research Program of China [2011CB707805]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from the Key Project of the National Natural Science Foundation of China (91232717), the National Basic Research Program of China (2011CB707805), the National Natural Science Foundation of China (31000503) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2006, NEUROPSYCHOLOGIA, V44, P161, DOI 10.1016/j.neuropsychologia.2005.05.018; Alegre M, 2010, CLIN NEUROPHYSIOL, V121, P414, DOI 10.1016/j.clinph.2009.11.013; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Beintema JA, 2002, P NATL ACAD SCI USA, V99, P5661, DOI 10.1073/pnas.082483699; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Bhasin A, 2012, NEUROL INDIA, V60, P570, DOI 10.4103/0028-3886.105188; Bodis-Wollner I, 2003, PARKINSONISM RELAT D, V9, pS83, DOI 10.1016/S1353-8020(03)00022-1; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Casile A, 2006, CURR BIOL, V16, P69, DOI 10.1016/j.cub.2005.10.071; Chang DHF, 2008, J VISION, V8, DOI 10.1167/8.5.3; Daniel S E, 1993, J Neural Transm Suppl, V39, P165; Dayan E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030369; de-Wit LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016232; Decety J, 1999, TRENDS COGN SCI, V3, P172, DOI 10.1016/S1364-6613(99)01312-1; Downing PE, 2006, CEREB CORTEX, V16, P1453, DOI 10.1093/cercor/bhj086; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Dubois B, 1997, J NEUROL, V244, P2, DOI 10.1007/pl00007725; Eagleman DM, 2009, PHILOS T R SOC B, V364, P1841, DOI 10.1098/rstb.2009.0026; Ertelt D, 2007, NEUROIMAGE, V36, pT164, DOI 10.1016/j.neuroimage.2007.03.043; Ertelt D, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-42; FOLSTEIN MF, 1983, ARCH GEN PSYCHIAT, V40, P812; Giese MA, 2003, NAT REV NEUROSCI, V4, P179, DOI 10.1038/nrn1057; Grossman ED, 2002, NEURON, V35, P1167, DOI 10.1016/S0896-6273(02)00897-8; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Ivry RB, 2002, ANN NY ACAD SCI, V978, P302, DOI 10.1111/j.1749-6632.2002.tb07576.x; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Kato Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028087; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Koch G, 2004, NEUROLOGY, V63, P2405, DOI 10.1212/01.WNL.0000147336.19972.82; Koch G, 2008, NEUROPSYCHOLOGIA, V46, P1305, DOI 10.1016/j.neuropsychologia.2007.12.005; Lewis MM, 2013, CAN J NEUROL SCI, V40, P299, DOI 10.1017/S0317167100014232; Marceglia S, 2009, NEUROSCIENCE, V161, P1027, DOI 10.1016/j.neuroscience.2009.04.018; Marsili L, 2014, PARKINSONISM RELAT D, V20, P370, DOI 10.1016/j.parkreldis.2014.01.013; Pavlova M, 2000, PERCEPT PSYCHOPHYS, V62, P889, DOI 10.3758/BF03212075; Pavlova M, 2003, BRAIN, V126, P692, DOI 10.1093/brain/awg062; Pavlova MA, 2012, CEREB CORTEX, V22, P981, DOI 10.1093/cercor/bhr156; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; Pinsk MA, 2009, J NEUROPHYSIOL, V101, P2581, DOI 10.1152/jn.91198.2008; Poliakoff E, 2013, J NEUROPSYCHOL, V7, P241, DOI 10.1111/jnp.12005; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Puce A, 2003, PHILOS T R SOC B, V358, P435, DOI 10.1098/rstb.2002.1221; REED CL, 1995, J EXP PSYCHOL HUMAN, V21, P334, DOI 10.1037/0096-1523.21.2.334; SCATTON B, 1982, NEUROLOGY, V32, P1039, DOI 10.1212/WNL.32.9.1039; Schwarzlose RF, 2005, J NEUROSCI, V25, P11055, DOI 10.1523/JNEUROSCI.2621-05.2005; Sokolov AA, 2014, CEREB CORTEX, V24, P626, DOI 10.1093/cercor/bhs346; Spencer RMC, 2005, BRAIN COGNITION, V58, P84, DOI 10.1016/j.bandc.2004.09.010; Spencer RMC, 2003, SCIENCE, V300, P1437, DOI 10.1126/science.1083661; SUMI S, 1984, PERCEPTION, V13, P283, DOI 10.1068/p130283; Thompson JC, 2005, J NEUROSCI, V25, P9059, DOI 10.1523/JNEUROSCI.2129-05.2005; Troje NF, 2006, CURR BIOL, V16, P821, DOI 10.1016/j.cub.2006.03.022; van der Hoorn A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095861; Vanrie J, 2004, BEHAV RES METH INS C, V36, P625, DOI 10.3758/BF03206542; Wang L, 2012, P NATL ACAD SCI USA, V109, pE673, DOI 10.1073/pnas.1115515109; Wang L, 2010, PSYCHOL SCI, V21, P1083, DOI 10.1177/0956797610376072; Wearden JH, 1996, Q J EXP PSYCHOL-B, V49, P24, DOI 10.1080/713932615; Wu T, 2013, BRAIN, V136, P696, DOI 10.1093/brain/aws360	59	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138502	10.1371/journal.pone.0138502	http://dx.doi.org/10.1371/journal.pone.0138502			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381888	Green Submitted, Green Published, gold			2022-12-27	WOS:000361790200117
J	Shojo, H; Tanaka, M; Takahashi, R; Kakuda, T; Adachi, N				Shojo, Hideki; Tanaka, Mayumi; Takahashi, Ryohei; Kakuda, Tsuneo; Adachi, Noboru			A Unique Primer with an Inosine Chain at the 5 '-Terminus Improves the Reliability of SNP Analysis Using the PCR-Amplified Product Length Polymorphism Method	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; MITOCHONDRIAL-DNA ANALYSIS; SEQUENCING DATA; MICROARRAY HYBRIDIZATION; JOMON SKELETONS; DEOXYINOSINE; DISCOVERY; APLP; DEGENERATE; FRAMEWORK	Polymerase chain reaction-amplified product length polymorphism (PCR-APLP) is one of the most convenient and reliable methods for single nucleotide polymorphism (SNP) analysis. This method is based on PCR, but uses allele-specific primers containing SNP sites at the 3'-terminus of each primer. To use this method at least two allele-specific primers and one "counter-primer", which serves as a common forward or reverse primer of the allele-specific primers, are required. The allele-specific primers have SNP sites at the 30-terminus, and another primer should have a few non-complementary flaps at the 5'-terminus to detect SNPs by determining the difference of amplicon length by PCR and subsequent electrophoresis. A major disadvantage of the addition of a non-complementary flap is the non-specific annealing of the primer with non-complementary flaps. However, a design principle for avoiding this undesired annealing has not been fully established, therefore, it is often difficult to design effective APLP primers. Here, we report allele-specific primers with an inosine chain at the 5'-terminus for PCR-APLP analysis. This unique design improves the competitiveness of allele-specific primers and the reliability of SNP analysis when using the PCR-APLP method.	[Shojo, Hideki; Tanaka, Mayumi; Takahashi, Ryohei; Kakuda, Tsuneo; Adachi, Noboru] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Legal Med, Yamanashi 4093898, Japan	University of Yamanashi	Adachi, N (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Legal Med, 1110 Shimokato, Yamanashi 4093898, Japan.	nadachi@yamanashi.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23570280]; Japan Society for the Promotion of Science core-to-core program (Advanced Core Research Centre for the History of Human Ecology in the North)	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science core-to-core program (Advanced Core Research Centre for the History of Human Ecology in the North)	This study was supported by a Grant-in-Aid (No. 23570280) for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and the Japan Society for the Promotion of Science core-to-core program (Advanced Core Research Centre for the History of Human Ecology in the North).	Adachi N, 2004, J ARCHAEOL SCI, V31, P1339, DOI 10.1016/j.jas.2004.02.011; Adachi N, 2014, LEGAL MED-TOKYO, V16, P52, DOI 10.1016/j.legalmed.2013.10.001; Adachi N, 2011, AM J PHYS ANTHROPOL, V146, P346, DOI 10.1002/ajpa.21561; Adachi N, 2009, AM J PHYS ANTHROPOL, V138, P255, DOI 10.1002/ajpa.20923; Afonina I, 2007, BIOTECHNIQUES, V43, P770, DOI 10.2144/000112631; Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Aoshima T, 1998, ELECTROPHORESIS, V19, P659, DOI 10.1002/elps.1150190508; Arif M, 2014, APPL ENVIRON MICROB, V80, P320, DOI 10.1128/AEM.02340-13; Arif M, 2013, MOL BIOTECHNOL, V55, P17, DOI 10.1007/s12033-012-9617-5; Binladen J, 2007, BIOTECHNIQUES, V42, P172, DOI 10.2144/000112316; Burns MA, 1998, SCIENCE, V282, P484, DOI 10.1126/science.282.5388.484; CASEGREEN SC, 1994, NUCLEIC ACIDS RES, V22, P131, DOI 10.1093/nar/22.2.131; Chen N, 2014, GENETICS, V198, P847, DOI 10.1534/genetics.114.169052; Chizhikov V, 2002, J CLIN MICROBIOL, V40, P2398, DOI 10.1128/JCM.40.7.2398-2407.2002; CORFIELD PWR, 1987, NUCLEIC ACIDS RES, V15, P7935, DOI 10.1093/nar/15.19.7935; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ferraro MB, 2014, J COMPUT BIOL, V21, P665, DOI 10.1089/cmb.2014.0037; Garritano S, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-5; Gondro C, 2014, ANIM GENET, V45, P758, DOI 10.1111/age.12198; KNOTH K, 1988, NUCLEIC ACIDS RES, V16, P10932, DOI 10.1093/nar/16.22.10932; Lee S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108818; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; LOAKES D, 1995, NUCLEIC ACIDS RES, V23, P2361, DOI 10.1093/nar/23.13.2361; MARTIN FH, 1985, NUCLEIC ACIDS RES, V13, P8927, DOI 10.1093/nar/13.24.8927; Martino A, 2010, J BIOMOL SCREEN, V15, P623, DOI 10.1177/1087057110365900; MIURA N, 1985, GENE, V38, P271; NICHOLS R, 1994, NATURE, V369, P492, DOI 10.1038/369492a0; PALVA A, 1994, J MICROBIOL METH, V19, P315, DOI 10.1016/0167-7012(94)90034-5; PATIL RV, 1990, NUCLEIC ACIDS RES, V18, P3080, DOI 10.1093/nar/18.10.3080; Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036; SantaLucia John Jr., 2007, V402, P3; SUGGS SV, 1981, P NATL ACAD SCI-BIOL, V78, P6613, DOI 10.1073/pnas.78.11.6613; Sun XJ, 2010, J ORG CHEM, V75, P1848, DOI 10.1021/jo9023683; UESUGI S, 1987, J BIOL CHEM, V262, P6965; Umetsu K, 2005, ELECTROPHORESIS, V26, P91, DOI 10.1002/elps.200406129; Uricaru R, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1187; Wang J, 1998, ANAL CHIM ACTA, V375, P197, DOI 10.1016/S0003-2670(98)00503-0; Watanabe G, 1997, HUM GENET, V99, P34; Watanabe G, 2001, ELECTROPHORESIS, V22, P418; Watanabe G, 1999, INT J LEGAL MED, V112, P134, DOI 10.1007/s004140050216; Watkins NE, 2005, NUCLEIC ACIDS RES, V33, P6258, DOI 10.1093/nar/gki918; Wei T, 2008, J VIROL METHODS, V153, P16, DOI 10.1016/j.jviromet.2008.06.020	45	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0136995	10.1371/journal.pone.0136995	http://dx.doi.org/10.1371/journal.pone.0136995			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381262	Green Published, Green Submitted, gold			2022-12-27	WOS:000361790200012
J	Sugimoto, M; Takagi, T; Suzuki, R; Konno, N; Watanabe, K; Nakamura, J; Kikuchi, H; Waragai, Y; Asama, H; Takasumi, M; Hikichi, T; Watanabe, H; Obara, K; Ohira, H				Sugimoto, Mitsuru; Takagi, Tadayuki; Suzuki, Rei; Konno, Naoki; Watanabe, Ko; Nakamura, Jun; Kikuchi, Hitomi; Waragai, Yuichi; Asama, Hiroyuki; Takasumi, Mika; Hikichi, Takuto; Watanabe, Hiroshi; Obara, Katsutoshi; Ohira, Hiromasa			Efficacy of Steroid Pulse Therapy for Autoimmune Pancreatitis Type 1: A Retrospective Study	PLOS ONE			English	Article							LONG-TERM PROGNOSIS; METHYLPREDNISOLONE; DISEASE; CORTICOSTEROIDS; ASSOCIATION	Autoimmune pancreatitis (AIP) is treatable with steroids, but relapse is frequent. The efficacy of steroid pulse therapy has been shown for various autoimmune diseases, but has not become established therapy. In this study, we reviewed the efficacy of steroid pulse therapy in 24 subjects who were diagnosed with AIP type 1 at our hospital. Patient characteristics, time-course of serum IgG4, and the cumulative relapse-free survival rate were compared between patients who received oral steroid therapy (oral group) and those who were treated with steroid pulse therapy (pulse group). Serum IgG4 was reduced significantly after therapy in both groups and the 5-year cumulative relapse-free survival rates in the two groups did not differ significantly (oral group 46.9%, pulse group 77.8%). However, in a subset of cases with diffuse pancreatic swelling, this rate was significantly lower in the oral group (33.3% vs. 100.0%, p = 0.046). These results suggest that steroid pulse therapy is effective for prevention of relapse in AIP patients with diffuse pancreatic swelling.	[Sugimoto, Mitsuru; Takagi, Tadayuki; Suzuki, Rei; Konno, Naoki; Watanabe, Ko; Nakamura, Jun; Kikuchi, Hitomi; Waragai, Yuichi; Asama, Hiroyuki; Takasumi, Mika; Watanabe, Hiroshi; Ohira, Hiromasa] Fukushima Med Univ, Sch Med, Dept Gastroenterol & Rheumatol, Fukushima, Japan; [Hikichi, Takuto; Obara, Katsutoshi] Fukushima Med Univ Hosp, Dept Endoscopy, Fukushima, Japan	Fukushima Medical University; Fukushima Medical University	Takagi, T (corresponding author), Fukushima Med Univ, Sch Med, Dept Gastroenterol & Rheumatol, Fukushima, Japan.	daccho@fmu.ac.jp	Suzuki, Rei/S-8531-2017	Suzuki, Rei/0000-0002-4049-0484; Sugimoto, Mitsuru/0000-0002-4223-613X				BAETHGE BA, 1992, ANN PHARMACOTHER, V26, P316, DOI 10.1177/106002809202600301; CATHCART ES, 1976, LANCET, V1, P163; Frulloni L, 2009, AM J GASTROENTEROL, V104, P2288, DOI 10.1038/ajg.2009.327; Ghazale A, 2008, GASTROENTEROLOGY, V134, P706, DOI 10.1053/j.gastro.2007.12.009; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Hart PA, 2012, GUT, V0, P1; Haugeberg G, 2004, ANN RHEUM DIS, V63, P940, DOI 10.1136/ard.2003.011734; Hirano K, 2007, GUT, V56, P1719, DOI 10.1136/gut.2006.115246; Kamisawa T, 2011, EXPERT OPIN PHARMACO, V12, P2149, DOI 10.1517/14656566.2011.595710; Kamisawa T, 2010, J GASTROENTEROL, V45, P471, DOI 10.1007/s00535-010-0221-9; Kawa S, 2009, CLIN GASTROENTEROL H, V7, pS18, DOI 10.1016/j.cgh.2009.07.041; Klein-Gitelman MS, 1998, J RHEUMATOL, V25, P1995; KOUNTZ SL, 1969, LANCET, V1, P338; Kubota K, 2011, J GASTROENTEROL, V46, P834, DOI 10.1007/s00535-011-0393-y; Kuruma S, 2013, GUT LIVER, V7, P96, DOI 10.5009/gnl.2013.7.1.96; Maire F, 2011, AM J GASTROENTEROL, V106, P151, DOI 10.1038/ajg.2010.314; Matsubayashi H, 2011, DIGEST LIVER DIS, V43, P731, DOI 10.1016/j.dld.2011.03.006; Matsushita M, 2007, AM J GASTROENTEROL, V102, P220; Melamud B, 2014, ISR MED ASSOC J, V16, P180; Naitoh I, 2010, PANCREAS, V39, pE1, DOI 10.1097/MPA.0b013e3181bd64a1; Shimosegawa T, 2011, PANCREAS, V40, P352, DOI 10.1097/MPA.0b013e3182142fd2; Tabata T, 2011, INTERNAL MED, V50, P69, DOI 10.2169/internalmedicine.50.4321; Takuma K, 2011, EUR J GASTROEN HEPAT, V23, P146, DOI 10.1097/MEG.0b013e3283431e23; Tomiyama T, 2011, J GASTROENTEROL, V46, P696, DOI 10.1007/s00535-010-0361-y; VICHYANOND P, 1989, J ALLERGY CLIN IMMUN, V84, P867, DOI 10.1016/0091-6749(89)90381-3; Wakabayashi T, 2005, PANCREAS, V30, P31; YOSHIDA K, 1995, DIGEST DIS SCI, V40, P1561, DOI 10.1007/BF02285209; Zonana-Nacach A, 2000, ARTHRITIS RHEUM, V43, P1801, DOI 10.1002/1529-0131(200008)43:8<1801::AID-ANR16>3.0.CO;2-O	28	9	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138604	10.1371/journal.pone.0138604	http://dx.doi.org/10.1371/journal.pone.0138604			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381760	gold, Green Submitted, Green Published			2022-12-27	WOS:000361790200136
J	Garcia-Etxebarria, K; Bracho, MA; Galan, JC; Pumarola, T; Castilla, J; de Lejarazu, RO; Rodriguez-Dominguez, M; Quintela, I; Bonet, N; Garcia-Garcera, M; Dominguez, A; Gonzalez-Candelas, F; Calafell, F				Garcia-Etxebarria, Koldo; Alma Bracho, Maria; Carlos Galan, Juan; Pumarola, Tomas; Castilla, Jesus; Ortiz de Lejarazu, Raul; Rodriguez-Dominguez, Mario; Quintela, Ines; Bonet, Nuria; Garcia-Garcera, Marc; Dominguez, Angela; Gonzalez-Candelas, Fernando; Calafell, Francesc		CIBERESP Cases Controls Pandemic I	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VIRUS-INFECTION; POPULATION; POLYMORPHISMS; LINKAGE; TNF	While most patients affected by the influenza A(H1N1) pandemic experienced mild symptoms, a small fraction required hospitalization, often without concomitant factors that could explain such a severe course. We hypothesize that host genetic factors could contribute to aggravate the disease. To test this hypothesis, we compared the allele frequencies of 547,296 genome-wide single nucleotide polymorphisms (SNPs) between 49 severe and 107 mild confirmed influenza A cases, as well as against a general population sample of 549 individuals. When comparing severe vs. mild influenza A cases, only one SNP was close to the conventional p = 5x10(-8). This SNP, rs28454025, sits in an intron of the GSK233 gene, which is involved in a neural development, but seems not to have any connections with immunological or inflammatory functions. Indirectly, a previous association reported with CD55 was replicated. Although sample sizes are low, we show that the statistical power in our design was sufficient to detect highly-penetrant, quasi-Mendelian genetic factors. Hence, and assuming that rs28454025 is likely to be a false positive, no major genetic factor was detected that could explain poor influenza A course.	[Garcia-Etxebarria, Koldo; Bonet, Nuria; Garcia-Garcera, Marc; Calafell, Francesc] Univ Pompeu Fabra, CSIC, Inst Biol Evolut, Barcelona, Spain; [Alma Bracho, Maria; Gonzalez-Candelas, Fernando] Unidad Mixta Invest Genom & Salud CSISP UVEG Inst, Valencia, Spain; [Alma Bracho, Maria; Carlos Galan, Juan; Castilla, Jesus; Dominguez, Angela; Gonzalez-Candelas, Fernando] CIBER Epidemiol & Salud Publ, Madrid, Spain; [Carlos Galan, Juan; Rodriguez-Dominguez, Mario] Hosp Univ Ramon y Cajal, Microbiol Serv, Madrid, Spain; [Carlos Galan, Juan; Rodriguez-Dominguez, Mario] Inst Ramon y Cajal Invest Sanitaria, Madrid, Spain; [Pumarola, Tomas] Univ Autonoma Barcelona, Dept Microbiol, Hosp Univ Vall dHebron, Vall dHebron Inst Recerca, E-08193 Barcelona, Spain; [Castilla, Jesus] Inst Salud Publ Navarra, Pamplona, Spain; [Ortiz de Lejarazu, Raul] Hosp Clin Univ, Dept Microbiol & Immunol, Valladolid, Spain; [Rodriguez-Dominguez, Mario] Red Espanola Invest Patol Infecciosa, Madrid, Spain; [Quintela, Ines] Univ Santiago de Compostela, Grp Med Xenom, Ctr Nacl Genotipado,Inst Salud Carlos 3,CeGen PRB, Plataforma Recursos Biomol & Bioinformat, Santiago De Compostela, Spain; [Dominguez, Angela] Univ Barcelona, Dept Salut Publ, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Universitario Ramon y Cajal; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Public Health Institute of Navarra; Universidade de Santiago de Compostela; University of Barcelona	Calafell, F (corresponding author), Univ Pompeu Fabra, CSIC, Inst Biol Evolut, Barcelona, Spain.	franoeso.calafell@upf.edu	Pumarola, Tomàs/AAB-5532-2019; Calafell, Francesc/C-8595-2014; Garcia-Etxebarria, Koldo/AAQ-4638-2021; Castilla, Jesus/B-9048-2008; Candelas, Fernando Gonzalez/G-5681-2010; Bracho, Maria/K-6018-2014; Suñe, Tomàs Pumarola/F-7583-2017; Rodriguez-Dominguez, Mario/J-4431-2015	Pumarola, Tomàs/0000-0002-5171-7461; Calafell, Francesc/0000-0002-1083-9438; Garcia-Etxebarria, Koldo/0000-0002-6107-9416; Castilla, Jesus/0000-0002-6396-7265; Candelas, Fernando Gonzalez/0000-0002-0879-5798; Bracho, Maria/0000-0002-9204-5526; Suñe, Tomàs Pumarola/0000-0002-5171-7461; Rodriguez-Dominguez, Mario/0000-0002-1783-9318; Quintela, Ines/0000-0002-0239-7975; Garcia-Garcera, Marc/0000-0001-6408-7561	Instituto de Salud Carlos III (Madrid, Spain) [GR09/0032]	Instituto de Salud Carlos III (Madrid, Spain)(Instituto de Salud Carlos III)	Fundign for this work came from Instituto de Salud Carlos III (Madrid, Spain; www.isciii.es) grant GR09/0032. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright FS, 2008, J INFECT DIS, V197, P18, DOI 10.1086/524064; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Antonopoulou A, 2012, INT J INFECT DIS, V16, pE204, DOI 10.1016/j.ijid.2011.11.012; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; Chung SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001323; Esteban-Vasallo MD, 2012, EUR J PUBLIC HEALTH, V22, P792, DOI 10.1093/eurpub/ckr171; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Ferdinands JM, 2011, EMERG INFECT DIS, V17, P2294, DOI 10.3201/eid1712.111002; Gonzalez-Candelas F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033139; Gottfredsson M, 2008, P NATL ACAD SCI USA, V105, P1303, DOI 10.1073/pnas.0707659105; Horby P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033180; Johnson RC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-724; Morales-Garcia G, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-299; O'Donnell CJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S4; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2012, R LANG ENV STAT COMP; Radhakrishnan P, 2011, BIOCHEM BIOPH RES CO, V409, P436, DOI 10.1016/j.bbrc.2011.05.019; Rogers AJ, 2009, AM J RESP CRIT CARE, V179, P1084, DOI 10.1164/rccm.200812-1860OC; Tanaka H, 2006, J BIOL CHEM, V281, P10355, DOI 10.1074/jbc.M511314200; WHO, CDC PROT REALT RTPCR; Zhou J, 2012, J INFECT DIS, V206, P495, DOI 10.1093/infdis/jis378; Zuniga J, 2012, EUR RESPIR J, V39, P604, DOI 10.1183/09031936.00020611	23	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0135983	10.1371/journal.pone.0135983	http://dx.doi.org/10.1371/journal.pone.0135983			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379185	Green Published, gold			2022-12-27	WOS:000361769400003
J	Horniblow, RD; Dowle, M; Iqbal, TH; Latunde-Dada, GO; Palmer, RE; Pikramenou, Z; Tselepis, C				Horniblow, Richard D.; Dowle, Miriam; Iqbal, Tariq H.; Latunde-Dada, Gladys O.; Palmer, Richard E.; Pikramenou, Zoe; Tselepis, Chris			Alginate-Iron Speciation and Its Effect on In Vitro Cellular Iron Metabolism	PLOS ONE			English	Article							OXIDE NANOPARTICLES; ION-BINDING; FERRITIN; ABSORPTION; STABILIZATION; FERRIHYDRITE; IRON(III); WELL	Alginates are a class of biopolymers with known iron binding properties which are routinely used in the fabrication of iron-oxide nanoparticles. In addition, alginates have been implicated in influencing human iron absorption. However, the synthesis of iron oxide nanoparticles employs non-physiological pH conditions and whether nanoparticle formation in vivo is responsible for influencing cellular iron metabolism is unclear. Thus the aims of this study were to determine how alginate and iron interact at gastric-comparable pH conditions and how this influences iron metabolism. Employing a range of spectroscopic techniques under physiological conditions alginate-iron complexation was confirmed and, in conjunction with aberration corrected scanning transmission electron microscopy, nanoparticles were observed. The results infer a nucleation-type model of iron binding whereby alginate is templating the condensation of iron-hydroxide complexes to form iron oxide centred nanoparticles. The interaction of alginate and iron at a cellular level was found to decrease cellular iron acquisition by 37% (p < 0.05) and in combination with confocal microscopy the alginate inhibits cellular iron transport through extracellular iron chelation with the resulting complexes not internalised. These results infer alginate as being useful in the chelation of excess iron, especially in the context of inflammatory bowel disease and colorectal cancer where excess unabsorbed luminal iron is thought to be a driver of disease.	[Horniblow, Richard D.; Iqbal, Tariq H.; Tselepis, Chris] Univ Birmingham, Sch Canc Sci, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [Dowle, Miriam; Palmer, Richard E.] Univ Birmingham, Sch Phys, Coll Engn & Phys Sci, Birmingham B15 2TT, W Midlands, England; [Latunde-Dada, Gladys O.] Kings Coll London, Diabet & Nutr Sci, London SE1 9NH, England; [Pikramenou, Zoe] Univ Birmingham, Sch Chem, Coll Engn & Phys Sci, Birmingham B15 2TT, W Midlands, England	University of Birmingham; University of Birmingham; University of London; King's College London; University of Birmingham	Tselepis, C (corresponding author), Univ Birmingham, Sch Canc Sci, Coll Med & Dent Sci, Vincent Dr, Birmingham B15 2TT, W Midlands, England.	c.tselepis@bham.ac.uk	Pikramenou, Zoe/K-3340-2012; Palmer, Richard E/A-5366-2008	Pikramenou, Zoe/0000-0002-6001-1380; Palmer, Richard E/0000-0001-8728-8083; iqbal, tariq/0000-0002-6681-9882	Biotechnology and Biological Sciences Research Council [BB/J500288/1]; Biotechnology and Biological Sciences Research Council [1134509] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/E005918/1, EP/K006061/1] Funding Source: researchfish; Medical Research Council [MC_PC_13057] Funding Source: researchfish; EPSRC [EP/K006061/1, EP/E005918/1] Funding Source: UKRI; MRC [MC_PC_13057] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Biotechnology and Biological Sciences Research Council BB/J500288/1.	Bedford MR, 2013, J CLIN PHARMACOL, V53, P885, DOI 10.1002/jcph.113; BERNER LA, 1983, J FOOD SCI, V48, P755, DOI 10.1111/j.1365-2621.1983.tb14891.x; Bou-Abdallah F, 2002, BIOCHEMISTRY-US, V41, P11184, DOI 10.1021/bi020215g; Brookes MJ, 2008, ONCOGENE, V27, P966, DOI 10.1038/sj.onc.1210711; EVANS DF, 1988, GUT, V29, P1035, DOI 10.1136/gut.29.8.1035; Fang YP, 2007, J PHYS CHEM B, V111, P2456, DOI 10.1021/jp0689870; George M, 2006, J CONTROL RELEASE, V114, P1, DOI 10.1016/j.jconrel.2006.04.017; Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002; Hampson FC, 2005, INT J PHARMACEUT, V294, P137, DOI 10.1016/j.ijpharm.2005.01.036; HARMUTHHOENE AE, 1980, J NUTR, V110, P1774, DOI 10.1093/jn/110.9.1774; Hoffman AS, 2012, ADV DRUG DELIVER REV, V64, P18, DOI 10.1016/j.addr.2012.09.010; Johnson JA, 1996, CIRC RES, V79, P1086, DOI 10.1161/01.RES.79.6.1086; Jonathan MC, 2013, J AGR FOOD CHEM, V61, P553, DOI 10.1021/jf304338z; Jones F, 2000, BIOMACROMOLECULES, V1, P556, DOI 10.1021/bm0055089; Karlsen V, 2010, THERMOCHIM ACTA, V501, P119, DOI 10.1016/j.tca.2010.01.007; Kim SW, 2008, B KOREAN CHEM SOC, V29, P1969; Kroll E, 1996, CHEM MATER, V8, P1594, DOI 10.1021/cm960095x; Latunde-Dada GO, 2014, J NUTR, V144, P1896, DOI 10.3945/jn.114.201715; Laurent S, 2008, CHEM REV, V108, P2064, DOI 10.1021/cr068445e; Llanes F, 2000, INT J BIOL MACROMOL, V27, P35, DOI 10.1016/S0141-8130(99)00115-4; Ma HL, 2007, INT J PHARMACEUT, V333, P177, DOI 10.1016/j.ijpharm.2006.10.006; Maity D, 2007, J MAGN MAGN MATER, V308, P46, DOI 10.1016/j.jmmm.2006.05.001; Pan Y, 2006, MICRON, V37, P403, DOI 10.1016/j.micron.2005.12.009; Pan YH, 2009, J STRUCT BIOL, V166, P22, DOI 10.1016/j.jsb.2008.12.001; Pereira DIA, 2014, NANOMED-NANOTECHNOL, V10, P1877, DOI 10.1016/j.nano.2014.06.012; Pereira DIA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081250; Powell JJ, 2014, NANOMED-NANOTECHNOL, V10, P1529, DOI 10.1016/j.nano.2013.12.011; Radulescu S, 2012, CELL REP, V2, P270, DOI 10.1016/j.celrep.2012.07.003; SANDBERG AS, 1994, AM J CLIN NUTR, V60, P751, DOI 10.1093/ajcn/60.5.751; Shen F, 2003, BIOTECHNOL BIOENG, V83, P282, DOI 10.1002/bit.10674; Sourty E, 2009, MICROSC MICROANAL, V15, P251, DOI 10.1017/S1431927609090278; Sreeram KJ, 2004, BBA-GEN SUBJECTS, V1670, P121, DOI 10.1016/j.bbagen.2003.11.001; Strand BL, 2003, BIOTECHNOL BIOENG, V82, P386, DOI 10.1002/bit.10577; Thebaudin JY, 1997, TRENDS FOOD SCI TECH, V8, P41, DOI 10.1016/S0924-2244(97)01007-8; TROWELL H, 1976, LANCET, V1, P967; WANG ZY, 1993, BIOPOLYMERS, V33, P703, DOI 10.1002/bip.360330419; Wawer AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112144; Wawer AA, 2012, J AGR FOOD CHEM, V60, P11318, DOI 10.1021/jf3031309; Werner T, 2011, GUT, V60, P325, DOI 10.1136/gut.2010.216929	39	16	16	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138240	10.1371/journal.pone.0138240	http://dx.doi.org/10.1371/journal.pone.0138240			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378798	Green Published, Green Submitted, gold			2022-12-27	WOS:000361769400070
J	Huang, SY; Lin, HH; Yao, M; Tang, JL; Wu, SJ; Hou, HA; Chou, WC; Chou, SC; Hsu, SC; Ko, BS; Lu, HY; Tsay, W; Tien, HF				Huang, Shang-Yi; Lin, Hsiu-Hsia; Yao, Ming; Tang, Jih-Luh; Wu, Shang-Ju; Hou, Hsin-An; Chou, Wen-Chien; Chou, Sheng-Chieh; Hsu, Szu-Chun; Ko, Bor-Sheng; Lu, Hsiao-Yun; Tsay, Woei; Tien, Hwei-Fang			Higher Decorin Levels in Bone Marrow Plasma Are Associated with Superior Treatment Response to Novel Agent-Based Induction in Patients with Newly Diagnosed Myeloma - A Retrospective Study	PLOS ONE			English	Article							MULTIPLE-MYELOMA; EXTRACELLULAR-MATRIX; PROTEOGLYCANS; INHIBITION; DEFICIENCY	The growth of myeloma cells depends on bone marrow (BM) stroma consisting of stromal cells, secreted cytokines and the extracellular matrix (ECM). Decorin, a small leucine-rich proteoglycan in the ECM, is a signaling ligand and native anti-tumor agent. However, the role of decorin in patients with myeloma is not clear. We evaluated the correlation between the decorin levels measured by enzyme-linked immunosorbent assay in BM plasma from 121 patients with newly diagnosed myeloma based on their clinical features and treatment response. The median decorin levels in the patients and the normal control group were 12.31 ng/mL [standard deviation (SD), 7.50 ng/mL; range, 2.45 to 44.46 ng/mL] and 10.31 ng/mL (SD, 2.42 ng/mL; range, 4.85-15.14 ng/mL), respectively (P <0.001). Using 15.15 ng/mL as a cut-off, 46 patients (38%) exhibited higher decorin levels (H-DCN), whereas the other patients exhibited normal to lower decorin levels (NL-DCN). Except for the median age, which was significantly younger in the H-DCN than in the NL-DCN group (60.6 14.0 vs. 65.8 12.2 years, respectively; P = 0.034), there were no differences between the two groups. However, in 79 patients who had received novel agent-based induction, the overall response rate was significantly better in the H-DCN than in the NL-DCN (97 vs. 63%, respectively; P < 0.001), as was the depth of responses (P = 0.008), which were not observed in those who had received chemotherapeutic agents alone. Progression-free survival (PFS) was significantly longer in H-DCN than NL-DCN (not reached vs. 19.5 mo, respectively; P = 0.0003). Multivariate analyses indicated that H-DCN, as a significantly independent factor, was associated with better treatment response (odds ratio, 20.014; 95% Cl, 2.187-183.150; P = 0.008) and longer PFS (hazard ratio, 0.135; 95% Cl, 0.051 0.361; P < 0.001). These findings disclose the potential role of decorin in myeloma and provide a basis for further study on possible synergistic anti-myeloma effects between decorin and the novel agents that target BM stroma.	[Huang, Shang-Yi; Lin, Hsiu-Hsia; Yao, Ming; Tang, Jih-Luh; Wu, Shang-Ju; Hou, Hsin-An; Chou, Sheng-Chieh; Ko, Bor-Sheng; Lu, Hsiao-Yun; Tsay, Woei; Tien, Hwei-Fang] Natl Taiwan Univ, Dept Internal Med, Med Coll & Hosp, Taipei, Taiwan; [Chou, Wen-Chien; Hsu, Szu-Chun] Natl Taiwan Univ, Dept Lab Med, Med Coll & Hosp, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University	Huang, SY (corresponding author), Natl Taiwan Univ, Dept Internal Med, Med Coll & Hosp, Taipei, Taiwan.	syhuang55@ntuh.gov.tw		Huang, Shang-Yi/0000-0001-5688-3410; TIEN, HWEI-FANG/0000-0002-1384-5593; CHOU, WEN-CHIEN/0000-0003-2967-698X; TANG, JIH-LUH/0000-0003-4021-3281; YAO, MING/0000-0003-2932-0019; CHOU, SHENG-CHIEH/0000-0002-4121-019X; KO, BOR-SHENG/0000-0002-7965-7579; HOU, HSIN-AN/0000-0003-2780-4845	National Science Council [NSC97-2314-B-002-036-MY3, NSC101-2314-B-002-086, NSC102-2628-B-002-052-MY3]; National Taiwan University Hospital [NTUH 99-S1031, 100-S1659, 101-S1801, 102-S2161, 103-S2435, 104-S2720]	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	Shang-Yi Huang received funding from National Science Council (NSC97-2314-B-002-036-MY3; NSC101-2314-B-002-086; NSC102-2628-B-002-052-MY3) and National Taiwan University Hospital (NTUH 99-S1031, 100-S1659, 101-S1801, 102-S2161, 103-S2435, 104-S2720). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Anderson KC, 2011, CLIN CANCER RES, V17, P1225, DOI 10.1158/1078-0432.CCR-10-3366; Bi XL, 2008, CARCINOGENESIS, V29, P1435, DOI 10.1093/carcin/bgn141; Bi YM, 2005, J BIOL CHEM, V280, P30481, DOI 10.1074/jbc.M500573200; Bird JM, 2011, BRIT J HAEMATOL, V154, P32, DOI 10.1111/j.1365-2141.2011.08573.x; Bozoky B, 2014, CANCER MED-US, V3, P485, DOI 10.1002/cam4.231; Buraschi Simone, 2010, J Biol Chem, V285, P42075, DOI 10.1074/jbc.M110.172841; Chen SJ, 2013, AM J PATHOL, V183, P247, DOI 10.1016/j.ajpath.2013.04.001; Feugaing DDS, 2013, EUR J CELL BIOL, V92, P1, DOI 10.1016/j.ejcb.2012.08.004; Horvath Z, 2014, MATRIX BIOL, V35, P194, DOI 10.1016/j.matbio.2013.11.004; HOSMER DW, 2000, WILEY PS TX, P1; Huang SY, 2005, ANN ONCOL, V16, P1530, DOI 10.1093/annonc/mdi273; Huang SY, 2004, AM J PATHOL, V164, P747, DOI 10.1016/S0002-9440(10)63162-8; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Iozzo RV, 1999, P NATL ACAD SCI USA, V96, P3092, DOI 10.1073/pnas.96.6.3092; Kristensen IB, 2013, EUR J HAEMATOL, V91, P196, DOI 10.1111/ejh.12125; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Kwan P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123054; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Li X, 2008, BLOOD, V112, P159, DOI 10.1182/blood-2007-11-124164; Li X, 2012, J BONE MINER RES, V27, P1635, DOI 10.1002/jbmr.1620; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Ludwig H, 2013, J CLIN ONCOL, V31, P247, DOI 10.1200/JCO.2011.39.5137; Mahindra A, 2012, NAT REV CLIN ONCOL, V9, P135, DOI 10.1038/nrclinonc.2012.15; Manier S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/157496; Moreth K, 2012, CELL CYCLE, V11, P2084, DOI 10.4161/cc.20316; Munshi NC, 2011, BLOOD, V117, P4696, DOI 10.1182/blood-2010-10-300970; Munz C, 1999, EUR J IMMUNOL, V29, P1032; Nash MA, 1999, CANCER RES, V59, P6192; Neill T, 2012, AM J PATHOL, V181, P380, DOI 10.1016/j.ajpath.2012.04.029; Neill T, 2012, J BIOL CHEM, V287, P5492, DOI 10.1074/jbc.M111.283499; Nemani N, 2015, J BONE MINER RES, V30, P533, DOI 10.1002/jbmr.2371; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Patel CG, 2014, CLIN CANCER RES, V20, P3955, DOI 10.1158/1078-0432.CCR-14-0434; Pennisi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015233; Rajkumar SV, 2011, BLOOD, V117, P4691, DOI 10.1182/blood-2010-10-299487; Shintani K, 2008, ONCOL REP, V19, P1533; Todoerti K, 2010, EXP HEMATOL, V38, P141, DOI 10.1016/j.exphem.2009.11.009	38	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137552	10.1371/journal.pone.0137552	http://dx.doi.org/10.1371/journal.pone.0137552			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379028	gold, Green Published, Green Submitted			2022-12-27	WOS:000361769400016
J	Kim, KR; An, JU; Lee, SH; Oh, DK				Kim, Kyoung-Rok; An, Jung-Ung; Lee, Seon-Hwa; Oh, Deok-Kun			Selective Production of 9R-Hydroxy-10E,12Z,15Z-Octadecatrienoic Acid from alpha-Linolenic Acid in Perilla Seed Oil Hydrolyzate by a Lipoxygenase from Nostoc Sp SAG 25.82	PLOS ONE			English	Article							FATTY-ACIDS; SOYBEAN LIPOXYGENASE-1; HYDROPEROXIDE PRODUCTION; METHYL-ESTER; SYSTEM; HYDROXYLATION; OPTIMIZATION; ENZYMES; LEAVES; CELLS	Hydroxy fatty acids (HFAs) derived from omega-3 polyunsaturated fatty acids have been known as versatile bioactive molecules. However, its practical production from omega-3 or omega-3 rich oil has not been well established. In the present study, the stereo-selective enzymatic production of 9R-hydroxy-1 0E,12Z,15Z-octadecatrienoic acid (9R-HOTE) from a-linolenic acid (ALA) in perilla seed oil (PO) hydrolyzate was achieved using purified recombinant 9R-lipoxygenase (9R-LOX) from Nostoc sp. SAG 25.82. The specific activity of the enzyme followed the order linoleic acid (LA) > ALA > y-linolenic acid (GLA). A total of 75% fatty acids (ALA and LA) were used as a substrate for 9R-LOX from commercial PO by hydrolysis of Candida rugosa lipase. The optimal reaction conditions for the production of 9R-HOTE from ALA using 9R-LOX were pH 8.5, 15 degrees C, 5% (v/v) acetone, 0.2% (w/v) Tween 80, 40 g/L ALA, and 1 g/L enzyme. Under these conditions, 9R-LOX produced 37.6 g/L 9RHOTE from 40 g/L ALA for 1 h, with a conversion yield of 94% and a productivity of 37.6 g/U h; and the enzyme produced 34 g/L 9R-HOTE from 40 g/L ALA in PO hydrolyzate for 1 h, with a conversion yields of 85% and a productivity of 34 g/Uh. The enzyme also converted 9R-hydroxy-1 0E,12Z-octadecadienoic acid (9R-HODE) from 40 g/L LA for 1.0 h, with a conversion yield of 95% and a productivity of 38.4 g/L. This is the highest productivity of HFA from both ALA and ALA-rich vegetable oil using LOX ever reported. Therefore, our result suggests an efficient method for the production of 9R-HFA5 from LA and ALA in vegetable oil using recombinant LOX in biotechnology.	[Kim, Kyoung-Rok; An, Jung-Ung; Lee, Seon-Hwa; Oh, Deok-Kun] Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea	Konkuk University	Oh, DK (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea.	deokkun@konkuk.ac.kr	An, Jungung/GYQ-7327-2022		Ministry for Agriculture, Food and Rural Affairs [112002-3]; Ministry for Health & Welfare, Republic of Korea [2012-009]	Ministry for Agriculture, Food and Rural Affairs; Ministry for Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by grants from the Bio-industry Technology Development Program, Ministry for Agriculture, Food and Rural Affairs (No. 112002-3), and the Korea Healthcare Technology R&D Project, Ministry for Health & Welfare, Republic of Korea (No. 2012-009).	Akakabe Y, 2002, BIOORGAN MED CHEM, V10, P3171, DOI 10.1016/S0968-0896(02)00212-2; An JU, 2015, APPL MICROBIOL BIOT, P1; Axelrod B., 1981, METH ENZYMOL, V441, P451, DOI [10.1016/0076-6879(81)71055-3, DOI 10.1016/0076-6879(81)71055-3]; Berry H, 1998, J BIOL CHEM, V273, P2769, DOI 10.1074/jbc.273.5.2769; Biermann U, 2011, ANGEW CHEM INT EDIT, V50, P3854, DOI 10.1002/anie.201002767; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Brodhun F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064919; Ciftci ON, 2012, EUR J LIPID SCI TECH, V114, P794, DOI 10.1002/ejlt.201100207; Dong M, 2000, BIOSCI BIOTECH BIOCH, V64, P882, DOI 10.1271/bbb.64.882; DROUET P, 1994, TETRAHEDRON LETT, V35, P3923, DOI 10.1016/S0040-4039(00)76703-7; Elshof MBW, 1998, FETT-LIPID, V100, P246; Fauconnier ML, 1996, BIOTECHNOL TECH, V10, P839, DOI 10.1007/BF00154668; Gao BL, 2010, BBA-MOL CELL BIOL L, V1801, P58, DOI 10.1016/j.bbalip.2009.09.004; Gargouri M, 2002, BIOTECHNOL LETT, V24, P915, DOI 10.1023/A:1015588008300; Gargouri M, 1997, ENZYME MICROB TECH, V21, P79, DOI 10.1016/S0141-0229(96)00229-3; Hansen J, 2013, APPL MICROBIOL BIOT, V97, P4737, DOI 10.1007/s00253-013-4887-9; Hou CT, 2009, NEW BIOTECHNOL, V26, P2, DOI 10.1016/j.nbt.2009.05.001; Hou CT, 2000, ADV APPL MICROBIOL, V47, P201, DOI 10.1016/S0065-2164(00)47005-X; IACAZIO G, 1990, J ORG CHEM, V55, P1690, DOI 10.1021/jo00292a056; Ivanov I, 2010, ARCH BIOCHEM BIOPHYS, V503, P161, DOI 10.1016/j.abb.2010.08.016; Jo YS, 2014, J AGR FOOD CHEM, V62, P6736, DOI 10.1021/jf501081z; Joo YC, 2012, BIOTECHNOL ADV, V30, P1524, DOI 10.1016/j.biotechadv.2012.04.004; Kim KR, 2014, J MOL CATAL B-ENZYM, V104, P56, DOI 10.1016/j.molcatb.2014.03.009; Kim KR, 2013, BIOTECHNOL ADV, V31, P1473, DOI 10.1016/j.biotechadv.2013.07.004; Knapp MJ, 2003, BIOCHEMISTRY-US, V42, P11466, DOI 10.1021/bi0300884; KUHN H, 1989, EUR J BIOCHEM, V186, P155, DOI 10.1111/j.1432-1033.1989.tb15190.x; Marques G, 2011, BIORESOURCE TECHNOL, V102, P1338, DOI 10.1016/j.biortech.2010.08.112; MARTINI D, 1994, BIOCATALYSIS, V11, P47, DOI 10.3109/10242429409034376; Marzo V, 1996, EXPERIENTIA, V52, P120; MURAKAMI N, 1992, LIPIDS, V27, P776, DOI 10.1007/BF02535848; NAMAI T, 1993, BIOSCI BIOTECH BIOCH, V57, P611, DOI 10.1271/bbb.57.611; Noordermeer MA, 2002, J AGR FOOD CHEM, V50, P4270, DOI 10.1021/jf0202685; O'Fallon JV, 2007, J ANIM SCI, V85, P1511, DOI 10.2527/jas.2006-491; Obinata H, 2005, J BIOL CHEM, V280, P40676, DOI 10.1074/jbc.M507787200; Okuno M, 1997, J NUTR, V127, P1752, DOI 10.1093/jn/127.9.1752; Pinto MD, 1997, BIOTECHNOL PROGR, V13, P394, DOI 10.1021/bp9700465; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; SHIMURA M, 1983, AGR BIOL CHEM TOKYO, V47, P1983, DOI 10.1080/00021369.1983.10865897; SHIN HS, 1994, J AM OIL CHEM SOC, V71, P619, DOI 10.1007/BF02540589; Su C, 1998, J BIOL CHEM, V273, P13072, DOI 10.1074/jbc.273.21.13072; Villaverde JJ, 2013, CHEM ENG J, V231, P519, DOI 10.1016/j.cej.2013.07.064; Villaverde JJ, 2013, CHEM ENG J, V217, P82, DOI 10.1016/j.cej.2012.11.090; Wang X, 2014, J AGR FOOD CHEM; Zhang C, 2012, APPL MICROBIOL BIOT, V94, P949, DOI 10.1007/s00253-012-3895-5; Zheng YX, 2008, J BIOL CHEM, V283, P5138, DOI 10.1074/jbc.M705780200	45	12	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137785	10.1371/journal.pone.0137785	http://dx.doi.org/10.1371/journal.pone.0137785			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379279	Green Published, gold, Green Submitted			2022-12-27	WOS:000361769400026
J	Oushy, MH; Palacios, R; Holden, AEC; Ramirez, AG; Gallion, KJ; O'Connell, MA				Oushy, Mai H.; Palacios, Rebecca; Holden, Alan E. C.; Ramirez, Amelie G.; Gallion, Kipling J.; O'Connell, Mary A.			To Share or Not to Share? A Survey of Biomedical Researchers in the US Southwest, an Ethnically Diverse Region	PLOS ONE			English	Article							CANCER HUMAN BIOBANK; CLINICAL-TRIAL DATA; COEFFICIENT ALPHA; DISPARITIES; BIORESOURCES; WILLINGNESS; PARTICIPATE; PERCEPTIONS; MINORITIES; LESSONS	Background Cancer health disparities research depends on access to biospecimens from diverse racial/ethnic populations. This multimethodological study, using mixed methods for quantitative and qualitative analysis of survey results, assessed barriers, concerns, and practices for sharing biospecimens/data among researchers working with biospecimens from minority populations in a 5 state region of the United States (Arizona, Colorado, New Mexico, Oklahoma, and Texas). The ultimate goals of this research were to understand data sharing barriers among biomedical researchers; guide strategies to increase participation in biospecimen research; and strengthen collaborative opportunities among researchers. Methods and Population Email invitations to anonymous participants (n = 605 individuals identified by the NIH RePORT database), resulted in 112 responses. The survey assessed demographics, specimen collection data, and attitudes about virtual biorepositories. Respondents were primarily principal investigators at PhD granting institutions (91.1%) conducting basic (62.3%) research; most were non-Hispanic White (63.4%) and men (60.6%). The low response rate limited the statistical power of the analyses, further the number of respondents for each survey question was variable. Results Findings from this study identified barriers to biospecimen research, including lack of access to sufficient biospecimens, and limited availability of diverse tissue samples. Many of these barriers can be attributed to poor annotation of biospecimens, and researchers' unwillingness to share existing collections. Addressing these barriers to accessing biospecimens is essential to combating cancer in general and cancer health disparities in particular. This study confirmed researchers' willingness to participate in a virtual biorepository (n = 50 respondents agreed). However, researchers in this region listed clear specifications for establishing and using such a biorepository: specifications related to standardized procedures, funding, and protections of human subjects and intellectual property. The results help guide strategies to increase data sharing behaviors and to increase participation of researchers with multiethnic biospecimen collections in collaborative research endeavors Conclusions Data sharing by researchers is essential to leveraging knowledge and resources needed for the advancement of research on cancer health disparities. Although U.S. funding entities have guidelines for data and resource sharing, future efforts should address researcher preferences in order to promote collaboration to address cancer health disparities.	[Oushy, Mai H.; O'Connell, Mary A.] New Mexico State Univ, Plant & Environm Sci, Las Cruces, NM 88003 USA; [Palacios, Rebecca] New Mexico State Univ, Publ Hlth Sci, Las Cruces, NM 88003 USA; [Holden, Alan E. C.; Ramirez, Amelie G.; Gallion, Kipling J.] Univ Texas Hlth Sci Ctr San Antonio, Inst Hlth Promot Res, San Antonio, TX 78229 USA	New Mexico State University; New Mexico State University; University of Texas System; University of Texas Health San Antonio	O'Connell, MA (corresponding author), New Mexico State Univ, Plant & Environm Sci, Las Cruces, NM 88003 USA.	moconnel@nmsu.edu		O'Connell, Mary/0000-0003-4430-6733; Palacios, Rebecca/0000-0002-5844-3475	NM Agricultural Experiment Station [NIH NCI 5 U54CA132383, NIH NCI 1 U54CA153511]; NATIONAL CANCER INSTITUTE [U54CA132383, U54CA153511] Funding Source: NIH RePORTER	NM Agricultural Experiment Station; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NM Agricultural Experiment Station, NIH NCI 5 U54CA132383, NIH NCI 1 U54CA153511. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizer AA, 2014, CANCER-AM CANCER SOC, V120, P1532, DOI 10.1002/cncr.28617; BARTLETT MS, 1954, J ROY STAT SOC B, V16, P296; Beskow LM, 2008, CANCER EPIDEM BIOMAR, V17, P1440, DOI 10.1158/1055-9965.EPI-08-0086; Boone SD, 2014, CANCER CAUSE CONTROL, V25, P273, DOI 10.1007/s10552-013-0329-3; Bravo E, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0266-y; Byrne MM, 2014, MED DECIS MAKING, V34, P116, DOI 10.1177/0272989X13497264; Campbell EG, 2002, JAMA-J AM MED ASSOC, V287, P473, DOI 10.1001/jama.287.4.473; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Chien FL, 2014, CANCER-AM CANCER SOC, V120, P2728, DOI 10.1002/cncr.28684; Colledge F, 2015, BIOETHICS, V29, P424, DOI 10.1111/bioe.12134; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Cronbach LJ, 2004, EDUC PSYCHOL MEAS, V64, P391, DOI 10.1177/0013164404266386; Dash C, 2014, J COMMUN GENET, V5, P329, DOI 10.1007/s12687-014-0187-z; De Castro Paola, 2013, Acta Inform Med, V21, P291, DOI 10.5455/aim.2013.21.291-292; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Fecher B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118053; Garrison Nanibaa' A, 2013, AJOB Prim Res, V4, P55; Goldenberg AJ, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0020-1; Groves T, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c564; GUADAGNOLI E, 1988, PSYCHOL BULL, V103, P265, DOI 10.1037/0033-2909.103.2.265; Harman H.H., 1976, MODERN FACTOR ANAL; He S, 2013, MEDINFO; Hewitt RE, 2011, CURR OPIN ONCOL, V23, P112, DOI 10.1097/CCO.0b013e32834161b8; Hrynaszkiewicz I, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-17; Johnson RA., 2007, APPL MULTIVARIATE ST; KAISER HF, 1970, PSYCHOMETRIKA, V35, P401, DOI 10.1007/BF02291817; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Kalinsky K, 2014, CANCER INVEST, V32, P439, DOI 10.3109/07357907.2014.958232; Kang Byunghak, 2013, Genomics & Informatics, V11, P211, DOI 10.5808/GI.2013.11.4.211; Kaur JS, 2012, J CANCER EDUC, V27, pS12, DOI [10.1007/s13187-012-0322-7, DOI 10.1007/S13187-012-0322-7]; Kirwan JR, 1997, J RHEUMATOL, V24, P822; Knerr S, 2011, J LAW MED ETHICS, V39, P502, DOI 10.1111/j.1748-720X.2011.00617.x; Laine C, 2007, ANN INTERN MED, V146, P450, DOI 10.7326/0003-4819-146-6-200703200-00154; Lemke AA, 2010, PUBLIC HEALTH GENOM, V13, P368, DOI 10.1159/000276767; Lemke Amy A, 2011, IRB, V33, P1; Luque JS, 2012, J CANCER EDUC, V27, P91, DOI 10.1007/s13187-011-0275-2; Mabile L, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-7; Massett Holly A., 2011, Journal of the National Cancer Institute Monographs, P8, DOI 10.1093/jncimonographs/lgr007; Mello MM, 2010, NEW ENGL J MED, V363, P204, DOI 10.1056/NEJMp1005203; Moore Helen M, 2009, Cancer Res, V69, P6770, DOI 10.1158/0008-5472.CAN-09-1795; Myles Renate, 2011, Journal of the National Cancer Institute Monographs, P16, DOI 10.1093/jncimonographs/lgr008; National Cancer Institute, 2011, NCI BEST PRACT BIOSP; National Cancer Institute, 2013, GEOGR MAN CANC HLTH; National Institutes of Health (NIH), 2003, FIN NIH STAT SHAR RE; Pacheco CM, 2013, AM J PUBLIC HEALTH, V103, P2152, DOI 10.2105/AJPH.2013.301480; Patel AA, 2007, CANCER INFORM, V3, P255; Pisani E, 2010, B WORLD HEALTH ORGAN, V88, P462, DOI 10.2471/BLT.09.074393; Piwowar HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018657; Piwowar HA, 2010, J INFORMETR, V4, P148, DOI 10.1016/j.joi.2009.11.010; Ramirez AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099365; Rathi V, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7570; Reidpath DD, 2001, BIOETHICS, V15, P125, DOI 10.1111/1467-8519.00220; Riegman PHJ, 2008, MOL ONCOL, V2, P213, DOI 10.1016/j.molonc.2008.07.004; Ross JS, 2012, CIRC-CARDIOVASC QUAL, V5, P238, DOI 10.1161/CIRCOUTCOMES.112.965798; Rubio DM, 2010, ACAD MED, V85, P470, DOI 10.1097/ACM.0b013e3181ccd618; Samur MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106397; Sanderson SC, 2013, J COMMUN GENET, V4, P469, DOI 10.1007/s12687-013-0154-0; Savage CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007078; Schully SD, 2011, PUBLIC HEALTH GENOM, V14, P1, DOI 10.1159/000272897; Schully SD, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv012; Setiawan VW, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju326; Sheikh A, 2006, PLOS MED, V3, P166, DOI 10.1371/journal.pmed.0030049; Sherman A, 2011, AMYOTROPH LATERAL SC, V12, P11, DOI 10.3109/17482968.2010.539233; Simon MA, 2014, J CANCER EDUC, V29, P366, DOI 10.1007/s13187-014-0617-y; Sun YH, 2014, CANCER-AM CANCER SOC, V120, P3040, DOI 10.1002/cncr.28792; Tenopir C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021101; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vaught Jimmie, 2011, Journal of the National Cancer Institute Monographs, P1, DOI 10.1093/jncimonographs/lgr006; Wallis JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067332; Waltz E, 2007, NAT BIOTECHNOL, V25, P1204, DOI 10.1038/nbt1107-1204; Weiler G, 2014, ECANCERMEDICALSCIENC, V8, DOI 10.3332/ecancer.2014.401; Wendler D, 2006, PLOS MED, V3, P201, DOI 10.1371/journal.pmed.0030019	72	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138239	10.1371/journal.pone.0138239	http://dx.doi.org/10.1371/journal.pone.0138239			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0RH	26378445	Green Submitted, Green Published, gold			2022-12-27	WOS:000361769400069
J	Wang, WR; Wang, JW; Qu, M; Li, XJ; Zhang, JY; Zhang, HH; Wu, JX; Yu, B; Wu, H; Kong, W; Yu, XH				Wang, Weiran; Wang, Jiawen; Qu, Meng; Li, Xiaojun; Zhang, Jingyao; Zhang, Haihong; Wu, Jiaxin; Yu, Bin; Wu, Hui; Kong, Wei; Yu, Xianghui			Viral Restriction Activity of Feline BST2 Is Independent of Its N-Glycosylation and Induction of NF-kappa B Activation	PLOS ONE			English	Article							VIRUS ENVELOPE GLYCOPROTEIN; IMMUNODEFICIENCY VIRUS; HIV-1 INFECTION; INHIBITS HIV-1; RETROVIRAL SEQUENCES; APOBEC3 FAMILY; FACTOR SAMHD1; VPU PROTEIN; HOST-CELL; TETHERIN	BST2 (CD317, tetherin, HM1.24) is an interferon-inducible transmembrane protein which can directly inhibit the release of enveloped virus particles from infected cells, and its antiviral activity is reported to be related to the specific topological arrangement of its four structural domains. The N-terminal cytoplasmic tail of feline BST2 (fBST2) is characterized by a shorter N-terminal region compared to those of other known homologs. In this study, we investigated the functional impact of modifying the cytoplasmic tail region of fBST2 and its molecular mechanism. The fBST2 protein with the addition of a peptide at the N-terminus retained anti-release activity against human immunodeficiency virus type-1 and pseudovirus based on feline immunodeficiency virus at a weaker level compared with the wild-type fBST2. However, the fBST2 protein with addition of a peptide internally in the ectodomain proximal to the GPI anchor still retained its anti-viral activity well. Notably, the N-glycosylation state and the cell surface level of the N-terminally modified variants were unlike those of the wild-type protein, while no difference was observed in their intracellular localizations. However, in contrast to human BST2, the wild-type fBST2 did not show the ability to activate NF-kappa B. Consistent with previous reports, our findings showed that adding a peptide in the cytoplasmic tail region of fBST2 may influence its anti-viral activity. The shorter N-terminal cytoplasmic region of fBST2 compared with human BST2 did not apparently affect its antiviral activity, which is independent of its N-glycosylation and ability to activate NF-kappa B.	[Wang, Weiran; Wang, Jiawen; Qu, Meng; Li, Xiaojun; Zhang, Jingyao; Zhang, Haihong; Wu, Jiaxin; Yu, Bin; Wu, Hui; Kong, Wei; Yu, Xianghui] Jilin Univ, Sch Life Sci, Natl Engn Lab AIDS Vaccine, Changchun 130023, Jilin Province, Peoples R China; [Kong, Wei; Yu, Xianghui] Jilin Univ, Sch Life Sci, Key Lab Mol Enzymol & Engn, Minist Educ, Changchun 130023, Jilin Province, Peoples R China; [Wang, Jiawen] Changchun Univ Chinese Med, Ctr New Med Res, Changchun, Jilin Province, Peoples R China	Jilin University; Jilin University; Changchun University of Chinese Medicine	Kong, W (corresponding author), Jilin Univ, Sch Life Sci, Natl Engn Lab AIDS Vaccine, Changchun 130023, Jilin Province, Peoples R China.	weikong@jlu.edu.cn; xianghui@jlu.edu.cn	Wu, Jiaxin/GVT-3486-2022; wang, weiran/HGU-3350-2022		National Natural Science Foundation of China [31270807, 81261120385]; Key Projects in the National Science & Technology Pillar Program in the Twelfth Five-year Plan Period [2013ZX10004608-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science & Technology Pillar Program in the Twelfth Five-year Plan Period	Support was provided by National Natural Science Foundation of China 31270807 XHY; National Natural Science Foundation of China 81261120385 XHY; Key Projects in the National Science & Technology Pillar Program in the Twelfth Five-year Plan Period 2013ZX10004608-003 XHY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2012, J BIOL CHEM, V287, P12550, DOI 10.1074/jbc.M112.340711; Arnaud F, 2010, J VIROL, V84, P4415, DOI 10.1128/JVI.00029-10; Asaoka K, 2005, BIOCHEM BIOPH RES CO, V338, P1950, DOI 10.1016/j.bbrc.2005.10.173; Bieniasz PD, 2004, NAT IMMUNOL, V5, P1109, DOI 10.1038/ni1125; Celestino M, 2012, J VIROL, V86, P6688, DOI 10.1128/JVI.07037-11; Cocka LJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002931; Dietrich I, 2011, J VIROL, V85, P5840, DOI 10.1128/JVI.00071-11; Elder JH, 2010, CURR HIV RES, V8, P73, DOI 10.2174/157016210790416389; Freed EO, 2004, TRENDS MICROBIOL, V12, P170, DOI 10.1016/j.tim.2004.02.001; Fukuma A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018247; Galao RP, 2012, CELL HOST MICROBE, V12, P633, DOI 10.1016/j.chom.2012.10.007; Goff SP, 2004, MOL CELL, V16, P849, DOI 10.1016/j.molcel.2004.12.001; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Goffinet C, 2010, J VIROL, V84, P11374, DOI 10.1128/JVI.01067-10; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Gramberg T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-26; Gupta RK, 2009, P NATL ACAD SCI USA, V106, P20889, DOI 10.1073/pnas.0907075106; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Huthoff H, 2008, TRENDS MICROBIOL, V16, P612, DOI 10.1016/j.tim.2008.08.013; Jia B, 2009, PLOS PATHOG, V5, P15; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Le Tortorec A, 2009, J VIROL, V83, P11966, DOI 10.1128/JVI.01515-09; Lochelt M, 2005, P NATL ACAD SCI USA, V102, P7982, DOI 10.1073/pnas.0501445102; Lv MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111422; Lv MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020890; Masuyama N, 2009, J BIOL CHEM, V284, P15927, DOI 10.1074/jbc.M109.005124; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil SJD, 2007, CELL HOST MICROBE, V2, P193, DOI 10.1016/j.chom.2007.08.001; Pecon-Slattery J, 2008, VET IMMUNOL IMMUNOP, V123, P32, DOI 10.1016/j.vetimm.2008.01.010; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Perkovic M, 2009, J BIOL CHEM, V284, P5819, DOI 10.1074/jbc.M808853200; Poeschla EM, 1998, J VIROL, V72, P6858, DOI 10.1128/JVI.72.8.6858-6866.1998; REEVES RH, 1985, J VIROL, V56, P303, DOI 10.1128/JVI.56.1.303-306.1985; REEVES RH, 1984, J VIROL, V52, P164, DOI 10.1128/JVI.52.1.164-171.1984; Roca AL, 2004, J VIROL, V78, P4370, DOI 10.1128/JVI.78.8.4370-4375.2004; Russell RA, 2005, J VIROL, V79, P8724, DOI 10.1128/JVI.79.14.8724-8731.2005; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shimojima M, 2004, SCIENCE, V303, P1192, DOI 10.1126/science.1092124; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Tanaka Y, 2006, BIOCHEM BIOPH RES CO, V341, P314, DOI 10.1016/j.bbrc.2005.12.192; Tokarev A, 2013, J VIROL, V87, P2046, DOI 10.1128/JVI.02272-12; TOMONAGA K, 1992, J VIROL, V66, P6181, DOI 10.1128/JVI.66.10.6181-6185.1992; Troyer JL, 2008, VET IMMUNOL IMMUNOP, V123, P159, DOI 10.1016/j.vetimm.2008.01.023; Troyer JL, 2004, J VIROL, V78, P3777, DOI 10.1128/JVI.78.7.3777-3791.2004; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; VandeWoude S, 2006, CLIN MICROBIOL REV, V19, P728, DOI 10.1128/CMR.00009-06; Wang JW, 2011, J VIROL, V85, P12482, DOI 10.1128/JVI.05218-11; Willett BJ, 1997, NATURE, V385, P587, DOI 10.1038/385587a0; Willett BJ, 1997, IMMUNOL TODAY, V18, P182, DOI 10.1016/S0167-5699(97)84665-8; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008	59	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138190	10.1371/journal.pone.0138190	http://dx.doi.org/10.1371/journal.pone.0138190			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379128	Green Submitted, Green Published, gold			2022-12-27	WOS:000361769400066
J	Williams, AK; McInnes, AS; Rooker, JR; Quigg, A				Williams, Alicia K.; McInnes, Allison S.; Rooker, Jay R.; Quigg, Antonietta			Changes in Microbial Plankton Assemblages Induced by Mesoscale Oceanographic Features in the Northern Gulf of Mexico	PLOS ONE			English	Article							FLOW-CYTOMETRIC ANALYSIS; MISSISSIPPI RIVER PLUME; LOOP CURRENT; EDDY ACTIVITY; E-FLUX; EDDIES; PHYTOPLANKTON; NUTRIENT; ATLANTIC; PICOPLANKTON	Mesoscale circulation generated by the Loop Current in the Northern Gulf of Mexico (NGOM) delivers growth-limiting nutrients to the microbial plankton of the euphotic zone. Consequences of physicochemically driven community shifts on higher order consumers and subsequent impacts on the biological carbon pump remain poorly understood. This study evaluates microbial plankton < 10 mu m abundance and community structure across both cyclonic and anti-cyclonic circulation features in the NGOM using flow cytometry (SYBR Green I and autofluorescence parameters). Non-parametric multivariate hierarchical cluster analyses indicated that significant spatial variability in community structure exists such that stations that clustered together were defined as having a specific 'microbial signature' (i.e. statistically homogeneous community structure profiles based on relative abundance of microbial groups). Salinity and a combination of sea surface height anomaly and sea surface temperature were determined by distance based linear modeling to be abiotic predictor variables significantly correlated to changes in microbial signatures. Correlations between increased microbial abundance and availability of nitrogen suggest nitrogen-limitation of microbial plankton in this open ocean area. Regions of combined coastal water entrainment and mesoscale convergence corresponded to increased heterotrophic prokaryote abundance relative to autotrophic plankton. The results provide an initial assessment of how mesoscale circulation potentially influences microbial plankton abundance and community structure in the NGOM.	[Williams, Alicia K.; McInnes, Allison S.; Quigg, Antonietta] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; [McInnes, Allison S.] Univ Technol Sydney, Climate Change Cluster, Sydney, NSW 2007, Australia; [Rooker, Jay R.; Quigg, Antonietta] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Rooker, Jay R.] Texas A&M Univ, Dept Wildlife & Fisheries, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; University of Technology Sydney; Texas A&M University System; Texas A&M University System; Texas A&M University College Station	Williams, AK (corresponding author), Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA.	sheparda@tamug.edu			McDaniel Charitable Foundation; Louisiana Department of Wildlife and Fisheries; Texas Institute of Oceanography; University Libraries; Office of the Vice President for Research	McDaniel Charitable Foundation; Louisiana Department of Wildlife and Fisheries; Texas Institute of Oceanography; University Libraries; Office of the Vice President for Research	The McDaniel Charitable Foundation, Louisiana Department of Wildlife and Fisheries, and the Texas Institute of Oceanography provided funding for this project. Additionally, the open access publishing fees for this article have been covered by the Texas A&M University Online Access to Knowledge (OAK) Fund, supported by the University Libraries and the Office of the Vice President for Research.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], ALGAL CULTURING TECH; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Baines SB, 2012, NAT GEOSCI, V5, P886, DOI [10.1038/ngeo1641, 10.1038/NGEO1641]; Beaugrand G, 2005, ICES J MAR SCI, V62, P333, DOI 10.1016/j.icesjms.2005.01.002; Benitez-Nelson CR, 2008, DEEP-SEA RES PT II, V55, P1133, DOI 10.1016/j.dsr2.2008.03.001; Benitez-Nelson CR, 2007, SCIENCE, V316, P1017, DOI 10.1126/science.1136221; Bibby TS, 2011, BIOGEOSCIENCES, V8, P657, DOI 10.5194/bg-8-657-2011; Bibby TS, 2008, DEEP-SEA RES PT II, V55, P1310, DOI 10.1016/j.dsr2.2008.01.014; Biggs DC, 1997, FISH B-NOAA, V95, P369; BIGGS DC, 1994, J GEOPHYS RES-OCEANS, V99, P7371, DOI 10.1029/93JC02153; Bouman HA, 2011, ENV MICROBIOL REP, V3, P473, DOI 10.1111/j.1758-2229.2011.00241.x; BROOKS DA, 1982, J GEOPHYS RES-OCEANS, V87, P4195, DOI 10.1029/JC087iC06p04195; Brown SL, 2008, DEEP-SEA RES PT II, V55, P1321, DOI 10.1016/j.dsr2.2008.02.012; Calil PHR, 2008, DEEP-SEA RES PT II, V55, P1179, DOI 10.1016/j.dsr2.2008.01.008; Campbell L, 2001, METHOD MICROBIOL, V30, P317, DOI 10.1016/S0580-9517(01)30051-X; Cherubin LM, 2006, J PHYS OCEANOGR, V36, P569, DOI 10.1175/JPO2871.1; Chistaki CC C., 2011, LIMNOLOGY OCEANOGRAP, V9, P329; Church MJ, 2009, P NATL ACAD SCI USA, V106, P15519, DOI 10.1073/pnas.0908881106; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Collier JL, 1999, HYDROBIOLOGIA, V401, P33; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Dai A, 2009, J CLIMATE, V22, P2773, DOI 10.1175/2008JCLI2592.1; Dickey TD, 2008, DEEP-SEA RES PT II, V55, P1195, DOI 10.1016/j.dsr2.2008.01.006; Dohan K, 2010, OCEANOGRAPHY, V23, P94, DOI 10.5670/oceanog.2010.08; Dorado S, 2012, MAR ECOL PROG SER, V464, P37, DOI 10.3354/meps09854; DORTCH Q, 1992, CONT SHELF RES, V12, P1293, DOI 10.1016/0278-4343(92)90065-R; DUGDALE RC, 1995, DEEP-SEA RES PT I, V42, P697, DOI 10.1016/0967-0637(95)00015-X; Evans C, 2011, DEEP-SEA RES PT II, V58, P2150, DOI 10.1016/j.dsr2.2011.05.019; Ewart CS, 2008, DEEP-SEA RES PT II, V55, P1334, DOI 10.1016/j.dsr2.2008.02.013; FALKOWSKI PG, 1991, NATURE, V352, P55, DOI 10.1038/352055a0; Falkowski PG, 2007, AQUATIC PHOTOSYNTHES, pxiii; Finkel ZV, 2010, J PLANKTON RES, V32, P119, DOI 10.1093/plankt/fbp098; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; Giovannoni SJ, 2014, ISME J, V8, P1553, DOI 10.1038/ismej.2014.60; Hammes F, 2010, ANAL BIOANAL CHEM, V397, P1083, DOI 10.1007/s00216-010-3646-3; Hansen H.P., 2007, METHODS SEAWATER ANA, P159, DOI [10.1002/9783527613984.ch10, DOI 10.1002/9783527613984, DOI 10.1002/9783527613984.CH10]; Harpole WS, 2011, ECOL LETT, V14, P852, DOI 10.1111/j.1461-0248.2011.01651.x; Howarth RW, 2006, LIMNOL OCEANOGR, V51, P364, DOI 10.4319/lo.2006.51.1_part_2.0364; HURLBURT HE, 1980, J PHYS OCEANOGR, V10, P1611, DOI 10.1175/1520-0485(1980)010<1611:ANSOLC>2.0.CO;2; ICHIYE T, 1959, J GEOPHYS RES, V64, P1109; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Jochem FJ, 2004, MAR BIOL, V145, P1213, DOI 10.1007/s00227-004-1406-7; Kamiya E, 2007, J OCEANOGR, V63, P101, DOI 10.1007/s10872-007-0008-7; Kirchman DL, 2008, MICROBIAL ECOLOGY OF; Koch C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00273; Lamkin J, 1997, FISH B-NOAA, V95, P250; Laws EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1231, DOI 10.1029/1999GB001229; Lebaron P, 2001, APPL ENVIRON MICROB, V67, P1775, DOI 10.1128/AEM.67.4.1775-1782.2001; LI WKW, 1983, SCIENCE, V219, P292, DOI 10.1126/science.219.4582.292; Liu HB, 2004, ESTUARIES, V27, P147, DOI 10.1007/BF02803568; LOHRENZ SE, 1990, CONT SHELF RES, V10, P639, DOI 10.1016/0278-4343(90)90043-L; Marie D, 1997, APPL ENVIRON MICROB, V63, P186, DOI 10.1128/AEM.63.1.186-193.1997; Massana R, 2011, ANNU REV MICROBIOL, V65, P91, DOI 10.1146/annurev-micro-090110-102903; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; McGillicuddy DJ, 1998, NATURE, V394, P263, DOI 10.1038/28367; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/ngeo1765, 10.1038/NGEO1765]; Moran XAG, 2001, DEEP-SEA RES PT I, V48, P405, DOI 10.1016/S0967-0637(00)00042-X; Mourino-Carballido B, 2009, DEEP-SEA RES PT I, V56, P1242, DOI 10.1016/j.dsr.2009.03.001; Nencioli F, 2008, DEEP-SEA RES PT II, V55, P1252, DOI 10.1016/j.dsr2.2008.02.003; Qian YR, 2003, CONT SHELF RES, V23, P1, DOI 10.1016/S0278-4343(02)00173-5; Quigg A, 2011, AQUAT GEOCHEM, V17, P519, DOI 10.1007/s10498-011-9134-3; Ressler PH, 2003, CONT SHELF RES, V23, P41, DOI 10.1016/S0278-4343(02)00149-8; Rivas D, 2008, J PHYS OCEANOGR, V38, P2461, DOI 10.1175/2008JPO3755.1; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Rooker JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076080; Sahl LE, 1997, CONT SHELF RES, V17, P117, DOI 10.1016/S0278-4343(96)00017-9; Sherr EB, 2002, ANTON LEEUW INT J G, V81, P293, DOI 10.1023/A:1020591307260; SHILLER AM, 1993, ESTUARIES, V16, P541, DOI 10.2307/1352601; Sweeney EN, 2003, DEEP-SEA RES PT II, V50, P3017, DOI 10.1016/j.dsr2.2003.07.008; Thingstad TF, 2008, NATURE, V455, P387, DOI 10.1038/nature07235; Waite AM, 2007, DEEP-SEA RES PT II, V54, P789, DOI 10.1016/j.dsr2.2006.12.008; Walker N, 2009, OCEANS-IEEE, P1484; Wang YY, 2010, TRENDS BIOTECHNOL, V28, P416, DOI 10.1016/j.tibtech.2010.04.006; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Zhao Y., 2014, PLOS ONE, V9	77	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138230	10.1371/journal.pone.0138230	http://dx.doi.org/10.1371/journal.pone.0138230			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375709	Green Published, Green Submitted, gold			2022-12-27	WOS:000361610200091
J	Bednarska, M; Bajer, A; Drozdowska, A; Mierzejewska, EJ; Tolkacz, K; Welc-Faleciak, R				Bednarska, Malgorzata; Bajer, Anna; Drozdowska, Anna; Mierzejewska, Ewa J.; Tolkacz, Katarzyna; Welc-Faleciak, Renata			Vertical Transmission of Babesia microti in BALB/c Mice: Preliminary Report	PLOS ONE			English	Article							TRANSPLACENTAL TRANSMISSION; CONGENITAL TRANSMISSION; THEILERIA-EQUI; NEW-YORK; INFECTION; DOGS; RESISTANCE; PREGNANCY; MALARIA; GIBSONI	Babesia spp. (Apicomplexa, Piroplasmida) are obligate parasites of many species of mammals, causing a malaria-like infection- babesiosis. Three routes of Babesia infection have been recognized to date. The main route is by a tick bite, the second is via blood transfusion. The third, vertical route of infection is poorly recognized and understood. Our study focused on vertical transmission of B. microti in a well-established mouse model. We assessed the success of this route of infection in BALB/c mice with acute and chronic infections of B. microti. In experimental groups, females were mated on the 1st day of Babesia infection (Group G0); on the 28th day post infection (dpi) in the post-acute phase of the parasite infection (G28); and on the 90th and 150th dpi (G90 and G150 group, respectively), in the chronic phase of the parasite infection. Pups were obtained from 58% of females mated in the post-acute phase (G28) and from 33% of females in groups G90 and G150. Mice mated in the pre-acute phase of infection (G0) did not deliver pups. Congenital B. microti infections were detected by PCR amplification of Babesia 18S rDNA in almost all pups (96%) from the experimental groups G28, G90 and G150. Parasitaemia in the F1 generation was low and varied between 0.01-0.001%. Vertical transmission of B. microti was demonstrated for the first time in BALB/c mice.	[Bednarska, Malgorzata; Bajer, Anna; Drozdowska, Anna; Mierzejewska, Ewa J.; Tolkacz, Katarzyna; Welc-Faleciak, Renata] Univ Warsaw, Dept Parasitol, Inst Zool, Fac Biol, Warsaw, Poland	University of Warsaw	Bednarska, M (corresponding author), Univ Warsaw, Dept Parasitol, Inst Zool, Fac Biol, 1 Miecznikowa St, Warsaw, Poland.	mabed@biol.uw.edu.pl	Bednarska, Małgorzata/ABF-9465-2020; Tołkacz, Katarzyna/AAJ-5452-2021	Tołkacz, Katarzyna/0000-0002-8578-3870; Welc-Faleciak, Renata/0000-0003-2266-1435; Bajer, Anna/0000-0001-6199-8458; Bednarska, Malgorzata/0000-0002-5278-2417	research grant of the National Science Centre Poland [2014/13/B/NZ7/02348]	research grant of the National Science Centre Poland	This study was financially supported by the research grant of the National Science Centre Poland no. 2014/13/B/NZ7/02348.	Aderinboye O, 2010, PEDIATR INFECT DIS J, V29, P188, DOI 10.1097/INF.0b013e3181c3c971; Bajer A, 2006, J ZOOL, V270, P9, DOI 10.1111/j.1469-7998.2006.00089.x; Bajer A, 2014, MICROB ECOL, V68, P196, DOI 10.1007/s00248-014-0390-9; Bednarska M, 2008, EXP PARASITOL, V120, P21, DOI 10.1016/j.exppara.2008.04.007; Bonnet S, 2007, EMERG INFECT DIS, V13, P1208, DOI 10.3201/eid1308.061560; Carlier Y, 2012, ACTA TROP, V121, P55, DOI 10.1016/j.actatropica.2011.10.018; Chaudhry SA, 2014, CAN FAM PHYSICIAN, V60, P334; Chhabra Sushma, 2012, J Parasit Dis, V36, P31, DOI 10.1007/s12639-011-0072-1; Cornett JK, 2012, INFECT DIS CLIN PRAC, V20, P408; Curno O, 2009, P ROY SOC B-BIOL SCI, V276, P1047, DOI 10.1098/rspb.2008.1612; DACOSTAMACEDO LM, 1990, REV I MED TROP, V32, P351, DOI 10.1590/S0036-46651990000500007; De Vos A.J., 1976, Onderstepoort Journal of Veterinary Research, V43, P75; Duffy P, 2001, IMMUNITY MALARIA PRE, P70; ESERNIOJENSSEN D, 1987, J PEDIATR-US, V110, P570, DOI 10.1016/S0022-3476(87)80552-8; Fukumoto S, 2005, INT J PARASITOL, V35, P1031, DOI 10.1016/j.ijpara.2005.03.018; Homer MJ, 2000, CLIN MICROBIOL REV, V13, P451, DOI 10.1128/CMR.13.3.451-469.2000; Hughes VL, 2001, PARASITOLOGY, V123, P365, DOI 10.1017/S0031182001008599; Hughes VL, 2001, J PARASITOL, V87, P49, DOI 10.1645/0022-3395(2001)087[0049:TDIAAR]2.0.CO;2; Jefferies R, 2007, AUST VET J, V85, P459, DOI 10.1111/j.1751-0813.2007.00220.x; Jin ZF, 2008, PARASITOL INT, V57, P495, DOI 10.1016/j.parint.2008.06.006; Joseph JT, 2012, EMERG INFECT DIS, V18, P1318, DOI 10.3201/eid1808.110988; Klinger Y., 1972, Refuah Veterinarith, V29, P73; Krause PJ, 1998, NEW ENGL J MED, V339, P160, DOI 10.1056/NEJM199807163390304; Leiby DA, 2011, CLIN MICROBIOL REV, V24, P14, DOI 10.1128/CMR.00022-10; Luo YZ, 2011, PARASITOL INT, V60, P119, DOI 10.1016/j.parint.2010.11.001; Mierzejewskal EJ, 2014, ANN AGR ENV MED, V21, P500, DOI 10.5604/12321966.1120590; NEITZ WO, 1956, ANN NY ACAD SCI, V64, P56, DOI 10.1111/j.1749-6632.1956.tb36607.x; New DL, 1997, J PEDIATR-US, V131, P163, DOI 10.1016/S0022-3476(97)70143-4; Osorio Y, 2012, AM J TROP MED HYG, V86, P812, DOI 10.4269/ajtmh.2012.11-0458; Phipps LP, 2004, VET REC, V154, P406, DOI 10.1136/vr.154.13.406; Poovassery J, 2006, INFECT IMMUN, V74, P2839, DOI 10.1128/IAI.74.5.2839-2848.2006; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Sappenfield E, 2013, INFECT DIS OBSTET GY, P752; Sasaki M, 2013, AM J TROP MED HYG, V88, P367, DOI 10.4269/ajtmh.2012.12-0338; SCIMECA PG, 1986, AM J DIS CHILD, V140, P971, DOI 10.1001/archpedi.1986.02140240017009; Sethi S, 2009, EMERG INFECT DIS, V15, P788, DOI 10.3201/eid1505.070808; Shoop WL, 2002, J PARASITOL, V88, P536, DOI 10.1645/0022-3395(2002)088[0536:TTOSSI]2.0.CO;2; Trintis J, 2010, INT J STD AIDS, V21, P606, DOI 10.1258/ijsa.2010.010174; Vannier E, 2004, J INFECT DIS, V189, P1721, DOI 10.1086/382965; VANNIER E, 2009, INTERDISCIP PERSPECT, DOI DOI 10.1155/2009/984568:1-9; Sanchez LV, 2013, PARASITOLOGY, V140, P147, DOI 10.1017/S0031182012001394; Welc-Faleciak R, 2007, ANN AGR ENV MED, V14, P287; White DJ, 1998, ARCH INTERN MED, V158, P2149, DOI 10.1001/archinte.158.19.2149; Yeruham I, 2003, J VET MED B, V50, P60, DOI 10.1046/j.1439-0450.2003.00597.x	44	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137731	10.1371/journal.pone.0137731	http://dx.doi.org/10.1371/journal.pone.0137731			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372043	Green Published, Green Submitted, gold			2022-12-27	WOS:000361604400028
J	Fu, ZD; Cui, JY; Klaassen, CD				Fu, Zidong Donna; Cui, Julia Yue; Klaassen, Curtis D.			The Role of Sirt1 in Bile Acid Regulation during Calorie Restriction in Mice	PLOS ONE			English	Article							NUCLEAR RECEPTOR; STEROL 12-ALPHA-HYDROXYLASE; DIETARY RESTRICTION; X-RECEPTOR; LIFE-SPAN; METABOLISM; CHOLESTEROL; PROTECTS; EXPRESSION; DELETION	Sirtuin 1 (Sirt1) is an NAD(+)-dependent protein deacetylase that is proposed to mediate many health-promoting effects of calorie restriction (CR). We recently reported that short-term CR increased the bile acid (BA) pool size in mice, likely due to increased BA synthesis in liver. Given the important role of Sirt1 in the regulation of glucose, lipid, as well as BA metabolism, we hypothesized that the CR-induced increase in BAs is Sirt1-dependent. To address this, the present study utilized genetically-modified mice that were Sirt1 loss of function (liver knockout, LKO) or Sirt1 gain of function (whole body-transgenic, TG). Three genotypes of mice (Sirt1-LKO, wild-type, and Sirt1-TG) were each randomly divided into ad libitum or 40% CR feeding for one month. BAs were extracted from various compartments of the enterohepatic circulation, followed by BA profiling by UPLC-MS/MS. CR increased the BA pool size and total BAs in serum, gallbladder, and small intestine. The CR-induced increase in BA pool size correlated with the tendency of increase in the expression of the rate-limiting BA-synthetic enzyme Cyp7a1. However, in contrast to the hypothesis, the CR-induced increase in BA pool size and Cyp7a1 expression was still observed with ablated expression of Sirt1 in liver, and completely suppressed with whole-body overexpression of Sirt1. Furthermore, in terms of BA composition, CR increased the ratio of 12 alpha-hydroxylated BAs regardless of Sirt1 genotypes. In conclusion, the CR-induced alterations in BA pool size, BA profiles, and expression of BA-related genes do not appear to be dependent on Sirt1.	[Fu, Zidong Donna] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA; [Fu, Zidong Donna] Harbin Med Univ, Dept Pharmacol, Harbin 150081, Heilongjiang Pr, Peoples R China; [Cui, Julia Yue] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Klaassen, Curtis D.] Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; Harbin Medical University; University of Washington; University of Washington Seattle; University of Kansas; University of Kansas Medical Center	Klaassen, CD (corresponding author), Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66103 USA.	curtisklaassenphd@gmail.com	Fu, Zidong/A-2703-2017		National Institutes of Health [ES-019487, ES-025708]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES025708, R01ES019487] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funded by the National Institutes of Health [Grants ES-019487 and ES-025708].	Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Escola-Gil JC, 2013, TRANSL RES, V161, P110, DOI 10.1016/j.trsl.2012.10.008; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Chen YR, 2010, BIOCHEM CELL BIOL, V88, P715, DOI 10.1139/O10-010; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chiang JYL, 2013, COMPR PHYSIOL, V3, P1191, DOI 10.1002/cphy.c120023; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Fu ZD, 2013, TOXICOL APPL PHARM, V273, P680, DOI 10.1016/j.taap.2013.10.020; Geng YQ, 2011, J CELL BIOCHEM, V112, P3755, DOI 10.1002/jcb.23315; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Haeusler RA, 2012, CELL METAB, V15, P65, DOI 10.1016/j.cmet.2011.11.010; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Hofmann AF, 2014, J LIPID RES; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Kazgan N, 2014, GASTROENTEROLOGY, V146, P1006, DOI 10.1053/j.gastro.2013.12.029; Kemper JK, 2013, VITAM HORM, V91, P385, DOI 10.1016/B978-0-12-407766-9.00016-X; Kim I, 2007, J LIPID RES, V48, P2664, DOI 10.1194/jlr.M700330-JLR200; Kir S, 2012, J BIOL CHEM, V287, P41334, DOI 10.1074/jbc.M112.421834; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lettieri Barbato Daniele, 2012, Int J Cell Biol, V2012, P759583, DOI 10.1155/2012/759583; Li TG, 2012, J LIPIDS, V2012, DOI 10.1155/2012/754067; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Mitchell SJ, 2014, CELL REP, V6, P836, DOI 10.1016/j.celrep.2014.01.031; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Omodei D, 2011, FEBS LETT, V585, P1537, DOI 10.1016/j.febslet.2011.03.015; Pandak WM, 2001, GASTROENTEROLOGY, V120, P1801, DOI 10.1053/gast.2001.24833; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Purushotham A, 2012, MOL CELL BIOL, V32, P1226, DOI 10.1128/MCB.05988-11; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Schwarz M, 2001, J LIPID RES, V42, P1594; Shin DJ, 2008, J BIOL CHEM, V283, P15089, DOI 10.1074/jbc.M710452200; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; TUCHWEBER B, 1987, LIFE SCI, V41, P2091, DOI 10.1016/0024-3205(87)90526-1; Vlahcevic ZR, 2000, GASTROENTEROLOGY, V118, P599, DOI 10.1016/S0016-5085(00)70267-8; Wang DQH, 2003, AM J PHYSIOL-GASTR L, V285, pG494, DOI 10.1152/ajpgi.00156.2003; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Yu W, 2014, MOL MED REP, V9, P1218, DOI 10.3892/mmr.2014.1944; Zhang YC, 2012, LIVER INT, V32, P58, DOI 10.1111/j.1478-3231.2011.02662.x; Zhang YC, 2010, J LIPID RES, V51, P3230, DOI 10.1194/jlr.M007641	57	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138307	10.1371/journal.pone.0138307	http://dx.doi.org/10.1371/journal.pone.0138307			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372644	Green Submitted, Green Published, gold			2022-12-27	WOS:000361604400064
J	Holgate, RGE; Weldon, R; Jones, TD; Baker, MP				Holgate, Robert G. E.; Weldon, Richard; Jones, Timothy D.; Baker, Matthew P.			Characterisation of a Novel Anti-CD52 Antibody with Improved Efficacy and Reduced Immunogenicity	PLOS ONE			English	Article							CD52 ANTIGEN; MODEL	Anti-CD52 therapy has been shown to be effective in the treatment of a number of B cell malignancies, hematopoietic disorders and autoimmune diseases (including rheumatoid arthritis and multiple sclerosis); however the current standard of treatment, the humanized monoclonal antibody alemtuzumab, is associated with the development of anti-drug antibodies in a high proportion of patients. In order to address this problem, we have identified a novel murine anti-CD52 antibody which has been humanized using a process that avoids the inclusion within the variable domains of non-human germline MHC class II binding peptides and known CD4+ T cell epitopes, thus reducing its potential for immunogenicity in the clinic. The resultant humanized antibody, ANT1034, was shown to have superior binding to CD52 expressing cells than alemtuzumab and was more effective at directing both antibody dependent and complement dependent cell cytotoxicity. Furthermore, when in the presence of a cross-linking antibody, ANT1034 was more effective at directly inducing apoptosis than alemtuzumab. ANT1034 also showed superior activity in a SCID mouse/human CD52 tumour xenograft model where a single 1 mg/Kg dose of ANT1034 led to increased mouse survival compared to a 10 mg/Kg dose of alemtuzumab. Finally, ANT1034 was compared to alemtuzumab in in vitro T cell assays in order to evaluate its potential to stimulate proliferation of T cells in peripheral blood mononuclear cells derived from a panel of human donors: whereas alemtuzumab stimulated proliferation in a high proportion of the donor cohort, ANT1034 did not stimulate proliferation in any of the donors. Therefore we have developed a candidate therapeutic humanized antibody, ANT1034, that may have the potential to be more efficacious and less immunogenic than the current standard anti-CD52 therapy.	[Holgate, Robert G. E.; Weldon, Richard; Jones, Timothy D.; Baker, Matthew P.] Antitope Ltd, Cambridge, England		Holgate, RGE (corresponding author), Antitope Ltd, Babraham Res Campus, Cambridge, England.	rob.holgate@antitope.com			Antitope Ltd.	Antitope Ltd.	All work was funded by the authors' employer, Antitope Ltd. The funder provided support in the form of salaries for RGEH, RW, TDJ, and MPB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Alinari L, 2007, ONCOGENE; Almagro JC, 2012, INT IMMUNOL, V24, P1620, DOI DOI 10.1093/INTIMM/DXS032; Baker MP, 2007, CURR OPIN DRUG DISC, V10, P219; BAUM C, 1994, BIOTECHNIQUES, V17, P1058; Brett SJ, 1996, INT IMMUNOL; Bryson CJ, 2010, BIODRUGS, V24, P1, DOI 10.2165/11318560-000000000-00000; Dearden CE, 2006, BEST PRACT RES CLIN; Enblad G, 2004, BLOOD; Faulkner RD, 2004, BLOOD; Garnock-Jones KP., 2014, DRUGS; Ginaldi L, 1998, LEUK RES; Golay J, 2003, HAEMATOLOGICA; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gupta V, 2004, BIOL BLOOD MARROW TR; Hale G, 2001, CYTOTHERAPY, V3, P137, DOI 10.1080/146532401753174098; Hale G, 1995, IMMUNOTECHNOLOGY, V1, P175, DOI 10.1016/1380-2933(95)00017-8; Hale G., 1995, IMMUNOTECHNOLOGY; Hansel TT, 2010, NAT REV DRUG DISCOV, V9, P325, DOI 10.1038/nrd3003; Hu Y, 2009, IMMUNOLOGY; Isaacs JD, 1992, LANCET; Jones JL, 2014, EXP NEUROL; JONES ST, 1991, BIO-TECHNOL, V9, P88, DOI 10.1038/nbt0191-88; Jones Tim D., 2009, V525, P405, DOI 10.1007/978-1-59745-554-1_21; Jordan M, 1998, CYTOTECHNOLOGY; Kabat E. A., 1991, SEQUENCES PROTEINS I; Keating MJ, 2002, BLOOD, V99, P3554, DOI 10.1182/blood.V99.10.3554; Lapalombella R, 2008, CLIN CANCER RES, V14, P569, DOI 10.1158/1078-0432.CCR-07-1006; Lundin J, 1998, J CLIN ONCOL; Masuyama J, 1999, J EXP MED; Matteson EL, 1995, ARTHRITIS RHEUM; Mone AP, 2006, LEUKEMIA; Osterborg A, 1997, EUR J HAEMATOL; Pawson R, 1997, J CLIN ONCOL; Perry LCA, 2008, DRUGS R D; Riechmann L, 1988, NATURE; Rowan WC, 1995, INT IMMUNOL; Shi B, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-30; Somerfield J, 2010, J IMMUNOL; Stanglmaier M, 2004, ANN HEMATOL; Tang Y, 2007, J IMMUNOL, V179, P2815, DOI 10.4049/jimmunol.179.5.2815; Watanabe T, 2006, CLIN IMMUNOL; Weinblatt ME, 1995, ARTHRITIS RHEUM; Xia MQ, 1993, BIOCH J; Zent CS, 2008, LEUK RES	44	22	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138123	10.1371/journal.pone.0138123	http://dx.doi.org/10.1371/journal.pone.0138123			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372145	gold, Green Published, Green Submitted			2022-12-27	WOS:000361604400049
J	McNamara, NP; Gregg, R; Oakley, S; Stott, A; Rahman, MT; Murrell, JC; Wardle, DA; Bardgett, RD; Ostle, NJ				McNamara, Niall P.; Gregg, Ruth; Oakley, Simon; Stott, Andy; Rahman, Md. Tanvir; Murrell, J. Colin; Wardle, David A.; Bardgett, Richard D.; Ostle, Nick J.			Soil Methane Sink Capacity Response to a Long-Term Wildfire Chronosequence in Northern Sweden	PLOS ONE			English	Article							BOREAL FOREST; ISLAND AREA; OXIDATION; FIRE; TEMPERATE; EXCHANGE	Boreal forests occupy nearly one fifth of the terrestrial land surface and are recognised as globally important regulators of carbon (C) cycling and greenhouse gas emissions. Carbon sequestration processes in these forests include assimilation of CO2 into biomass and subsequently into soil organic matter, and soil microbial oxidation of methane (CH4). In this study we explored how ecosystem retrogression, which drives vegetation change, regulates the important process of soil CH4 oxidation in boreal forests. We measured soil CH4 oxidation processes on a group of 30 forested islands in northern Sweden differing greatly in fire history, and collectively representing a retrogressive chronosequence, spanning 5000 years. Across these islands the build-up of soil organic matter was observed to increase with time since fire disturbance, with a significant correlation between greater humus depth and increased net soil CH4 oxidation rates. We suggest that this increase in net CH4 oxidation rates, in the absence of disturbance, results as deeper humus stores accumulate and provide niches for methanotrophs to thrive. By using this gradient we have discovered important regulatory controls on the stability of soil CH4 oxidation processes that could not have not been explored through shorter-term experiments. Our findings indicate that in the absence of human interventions such as fire suppression, and with increased wildfire frequency, the globally important boreal CH4 sink could be diminished.	[McNamara, Niall P.; Gregg, Ruth; Oakley, Simon; Ostle, Nick J.] Lancaster Environm Ctr, Ctr Ecol & Hydrol, Lancaster, England; [Stott, Andy] Lancaster Environm Ctr, Ctr Ecol & Hydrol, NERC Life Sci Stable Isotope Facil, Lancaster, England; [Rahman, Md. Tanvir] Bangladesh Agr Univ, Dept Microbiol & Hyg, Mymensingh, Bangladesh; [Murrell, J. Colin] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Wardle, David A.] Swedish Univ Agr Sci, Dept Forest Ecol & Management, S-90183 Umea, Sweden; [Bardgett, Richard D.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Gregg, Ruth; Bardgett, Richard D.; Ostle, Nick J.] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England	Lancaster University; UK Centre for Ecology & Hydrology (UKCEH); Lancaster University; UK Centre for Ecology & Hydrology (UKCEH); Bangladesh Agricultural University (BAU); University of East Anglia; Swedish University of Agricultural Sciences; University of Manchester; Lancaster University	McNamara, NP (corresponding author), Lancaster Environm Ctr, Ctr Ecol & Hydrol, Lancaster, England.	nmcn@ceh.ac.uk	Murrell, John C/B-1443-2012; Rahman, Md.Tanvir, PhD (UK)/C-3110-2009; Oakley, Simon/K-1857-2013; Wardle, David A./F-6031-2011; McNamara, Niall P/B-4907-2008; STOTT, ANDREW/I-7920-2012; Ostle, Nicholas J/E-4847-2014	Rahman, Md.Tanvir, PhD (UK)/0000-0001-5432-480X; Oakley, Simon/0000-0002-5757-7420; Wardle, David A./0000-0002-0476-7335; McNamara, Niall P/0000-0002-5143-5819; Ostle, Nicholas J/0000-0003-3263-3702	UK Natural Environmental Research Council; Swedish research Council (Vetenskapsradet); Natural Environment Research Council [ceh020008, lsmsf010003, NE/I027037/1, NER/A/S/2002/00876, NE/E016855/1, NE/I027037/2] Funding Source: researchfish; NERC [NE/I027037/2, NE/E016855/1, NE/I027037/1, lsmsf010003, ceh020008] Funding Source: UKRI	UK Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Swedish research Council (Vetenskapsradet)(Swedish Research Council); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was funded by a UK Natural Environmental Research Council (www.nerc.ac.uk) award to NM, NO and RGB. The contribution from DAW was supported by the Swedish research Council (Vetenskapsradet). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSEN APS, 1993, APPL ENVIRON MICROB, V59, P485, DOI 10.1128/AEM.59.2.485-490.1993; Beck PSA, 2011, GLOBAL CHANGE BIOL, V17, P2853, DOI 10.1111/j.1365-2486.2011.02412.x; Bradshaw CJA, 2009, TRENDS ECOL EVOL, V24, P541, DOI 10.1016/j.tree.2009.03.019; Burke RA, 1997, J GEOPHYS RES-ATMOS, V102, P29289, DOI 10.1029/97JD01331; Chan ASK, 2001, J ENVIRON QUAL, V30, P786, DOI 10.2134/jeq2001.303786x; Chuvieco E, 2008, REMOTE SENS ENVIRON, V112, P2381, DOI 10.1016/j.rse.2007.11.007; Gathany MA, 2011, INT J WILDLAND FIRE, V20, P838, DOI 10.1071/WF09135; Girardin MP, 2009, GLOBAL CHANGE BIOL, V15, P2751, DOI 10.1111/j.1365-2486.2009.01869.x; Holland E A, 1999, STANDARD SOIL METHOD; Jaatinen K, 2004, FEMS MICROBIOL ECOL, V50, P195, DOI 10.1016/j.femsec.2004.06.013; Kasischke ES, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002300; Kasischke ES, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000461; Knief C, 2006, ENVIRON MICROBIOL, V8, P321, DOI 10.1111/j.1462-2920.2005.00898.x; Liptay K, 1998, J GEOPHYS RES-ATMOS, V103, P8243, DOI 10.1029/97JD02630; Maxfield PJ, 2008, ENVIRON SCI TECHNOL, V42, P7824, DOI 10.1021/es800544q; McNamara NP, 2008, SOIL USE MANAGE, V24, P1, DOI 10.1111/j.1475-2743.2008.00147.x; Nakano T, 2006, SOIL SCI PLANT NUTR, V52, P77, DOI 10.1111/j.1747-0765.2006.00004.x; Ohlson M, 2009, NAT GEOSCI, V2, P692, DOI 10.1038/NGEO617; Pluchon N, 2014, FUNCT ECOL, V28, P766, DOI 10.1111/1365-2435.12221; Prieme A, 1999, J GEOPHYS RES-ATMOS, V104, P23617, DOI 10.1029/1999JD900427; Reay DS, 2005, SOIL BIOL BIOCHEM, V37, P719, DOI 10.1016/j.soilbio.2004.10.004; Reeburgh WS, 1997, GEOCHIM COSMOCHIM AC, V61, P4761, DOI 10.1016/S0016-7037(97)00277-9; Sjogersten S, 2002, GLOBAL CHANGE BIOL, V8, P885, DOI 10.1046/j.1365-2486.2002.00522.x; Smith KA, 2000, GLOBAL CHANGE BIOL, V6, P791, DOI 10.1046/j.1365-2486.2000.00356.x; Soja AJ, 2007, GLOBAL PLANET CHANGE, V56, P274, DOI 10.1016/j.gloplacha.2006.07.028; Teh YA, 2005, GLOBAL CHANGE BIOL, V11, P1283, DOI 10.1111/j.1365-2486.2005.00983.x; Trotsenko YA, 2008, ADV APPL MICROBIOL, V63, P183, DOI 10.1016/S0065-2164(07)00005-6; TYLER SC, 1994, GEOCHIM COSMOCHIM AC, V58, P1625, DOI 10.1016/0016-7037(94)90564-9; Wardle DA, 2003, SCIENCE, V300, P972, DOI 10.1126/science.1082709; Wardle DA, 1997, SCIENCE, V277, P1296, DOI 10.1126/science.277.5330.1296; Wardle DA, 2005, NATURE, V435, P806, DOI 10.1038/nature03611; Wardle DA, 2012, J ECOL, V100, P16, DOI 10.1111/j.1365-2745.2011.01907.x; Zhang YH, 2003, REMOTE SENS ENVIRON, V87, P1, DOI 10.1016/S0034-4257(03)00141-X	33	10	10	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0129892	10.1371/journal.pone.0129892	http://dx.doi.org/10.1371/journal.pone.0129892			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372346	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000361604400001
J	Moreira-Arce, D; Vergara, PM; Boutin, S				Moreira-Arce, Dario; Vergara, Pablo M.; Boutin, Stan			Diurnal Human Activity and Introduced Species Affect Occurrence of Carnivores in a Human-Dominated Landscape	PLOS ONE			English	Article							FREE-RANGING DOGS; LAND-USE CHANGE; HABITAT USE; SOUTHERN CHILE; ACTIVITY PATTERNS; FOREST LANDSCAPE; PROTECTED AREAS; FELIS-CONCOLOR; SPATIAL SCALE; DARWIN FOX	Diurnal human activity and domestic dogs in agro-forestry mosaics should theoretically modify the diurnal habitat use patterns of native carnivores, with these effects being scale-dependent. We combined intensive camera trapping data with Bayesian occurrence probability models to evaluate both diurnal and nocturnal patterns of space use by carnivores in a mosaic of land-use types in southern Chile. A total of eight carnivores species were recorded, including human-introduced dogs. During the day the most frequently detected species were the culpeo fox and the cougar. Conversely, during the night, the kodkod and chilla fox were the most detected species. The best supported models showed that native carnivores responded differently to landscape attributes and dogs depending on both the time of day as well as the spatial scale of landscape attributes. The positive effect of native forest cover at 250m and 500 m radius buffers was stronger during the night for the Darwin's fox and cougar. Road density at 250m scale negatively affected the diurnal occurrence of Darwin's fox, whereas at 500m scale roads had a stronger negative effect on the diurnal occurrence of Darwin's foxes and cougars. A positive effect of road density on dog occurrence was evidenced during both night and day. Patch size had a positive effect on cougar occurrence during night whereas it affected negatively the occurrence of culpeo foxes and skunks during day. Dog occurrence had a negative effect on Darwin's fox occurrence during day-time and night-time, whereas its negative effect on the occurrence of cougar was evidenced only during day-time. Carnivore occurrences were not influenced by the proximity to a conservation area. Our results provided support for the hypothesis that diurnal changes to carnivore occurrence were associated with human and dog activity. Landscape planning in our study area should be focused in reducing both the levels of diurnal human activity in native forest remnants and the dispersion rates of dogs into these habitats.	[Moreira-Arce, Dario; Boutin, Stan] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Moreira-Arce, Dario; Vergara, Pablo M.] Univ Santiago Chile, Dept Gest Agr, Lab Ecol & Conservac, Santiago, Chile	University of Alberta; Universidad de Santiago de Chile	Moreira-Arce, D (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	moreira.dario@gmail.com	Vergara, Pablo M/F-2519-2010; Moreira-Arce, Dario/ABG-2898-2021; Boutin, Stan/A-2619-2014	Vergara, Pablo M/0000-0002-0024-1678; Moreira-Arce, Dario/0000-0002-1188-496X; Boutin, Stan/0000-0001-6317-038X	Rufford Small Grant Program [10410-1]; Mohammed bin Zayed Conservation Fund [11252508]; Fondo Nacional de Ciencia y Tecnologia [1131133]; NSERC [RGPIN 05874]; Becas-Chile fellowship; Forestal Arauco; Forestal Mininco; University of Alberta; Etica en los Bosques; Environmental Ministry of Chile [NAC-I-008-2012]	Rufford Small Grant Program; Mohammed bin Zayed Conservation Fund; Fondo Nacional de Ciencia y Tecnologia; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Becas-Chile fellowship; Forestal Arauco; Forestal Mininco; University of Alberta(University of Alberta); Etica en los Bosques; Environmental Ministry of Chile	This study was supported by funds derived from an agreement among Forestal Arauco, Forestal Mininco, University of Alberta, Etica en los Bosques and Environmental Ministry of Chile (NAC-I-008-2012). Additional support was provided by Rufford Small Grant Program (10410-1), Mohammed bin Zayed Conservation Fund (11252508), Fondo Nacional de Ciencia y Tecnologia 1131133, and NSERC RGPIN 05874. DMA was funded by a Becas-Chile fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta G, 2008, IUCN RED LIST THREAT; Acosta-Jamett G, 2004, BIODIVERS CONSERV, V13, P1135, DOI 10.1023/B:BIOC.0000018297.93657.7d; Aguayo M, 2009, REV CHIL HIST NAT, V82, P361, DOI 10.4067/S0716-078X2009000300004; Altamirano TA, 2013, REV CHIL HIST NAT, V86, P501, DOI 10.4067/S0716-078X2013000400014; Balme GA, 2010, ANIM CONSERV, V13, P315, DOI 10.1111/j.1469-1795.2009.00342.x; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Beckmann JP, 2003, J ZOOL, V261, P207, DOI 10.1017/S0952836903004126; Besag J, 1995, BIOMETRIKA, V82, P733, DOI 10.2307/2337341; BOISSY A, 1995, Q REV BIOL, V70, P165, DOI 10.1086/418981; Burton AC, 2015, J APPL ECOL, V52, P675, DOI 10.1111/1365-2664.12432; Burton AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038007; Clarke MF, 1997, BIOL CONSERV, V80, P161, DOI 10.1016/S0006-3207(96)00075-4; Davis ML, 2011, ANIM CONSERV, V14, P56, DOI 10.1111/j.1469-1795.2010.00389.x; DeFries R, 2007, ECOL APPL, V17, P1031, DOI 10.1890/05-1111; Dickson BG, 2002, J WILDLIFE MANAGE, V66, P1235, DOI 10.2307/3802956; Donadio E, 2001, MAMMALIA, V65, P49, DOI 10.1515/mamm.2001.65.1.49; Echeverria C, 2006, BIOL CONSERV, V130, P481, DOI 10.1016/j.biocon.2006.01.017; Fahrig L, 2009, ECOL SOC, V14; Forman R., 2014, ECOLOGICAL DESIGN PL, P217; Franklin WL, 1999, BIOL CONSERV, V90, P33, DOI 10.1016/S0006-3207(99)00008-7; Gaillard JM, 2010, PHILOS T R SOC B, V365, P2255, DOI 10.1098/rstb.2010.0085; Gelman A., 2003, BAYESIAN DATA ANAL; George SL, 2006, BIOL CONSERV, V133, P107, DOI 10.1016/j.biocon.2006.05.024; Gittleman GL, 2001, CARNIVORE CONSERVATI; Grilo C, 2009, BIOL CONSERV, V142, P301, DOI 10.1016/j.biocon.2008.10.026; Hels T, 2001, BIOL CONSERV, V99, P331, DOI 10.1016/S0006-3207(00)00215-9; Holland JD, 2004, BIOSCIENCE, V54, P227, DOI 10.1641/0006-3568(2004)054[0227:DTSSOS]2.0.CO;2; JAKSIC FM, 1990, J MAMMAL, V71, P246, DOI 10.2307/1382176; Jim?nez JE., 2004, CANIDS FOXES WOLVES, P50; Klar N, 2009, J WILDLIFE MANAGE, V73, P631, DOI 10.2193/2007-574; Knopff AA, 2014, BIOL CONSERV, V178, P136, DOI 10.1016/j.biocon.2014.07.017; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; Lawson A.B, 2013, BAYESIAN DIS MAPPING, Vsecond; Lode T., 2011, INT J ZOOLOGY, DOI [10.1155/2011/15946, DOI 10.1155/2011/15946]; Lyra-Jorge MC, 2010, EUR J WILDLIFE RES, V56, P359, DOI 10.1007/s10344-009-0324-x; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Marable MK, 2012, BEHAV PROCESS, V91, P119, DOI 10.1016/j.beproc.2012.06.006; MEDEL RG, 1990, BIOL CONSERV, V51, P71, DOI 10.1016/0006-3207(90)90033-L; Munozpedreros A, 1995, REV CHIL HIST NAT, V68, P501; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Ngoprasert D, 2007, ORYX, V41, P343, DOI 10.1017/S0030605307001102; Nichols JD, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P253, DOI 10.1007/978-4-431-99495-4_14; NUDDS T D, 1977, Wildlife Society Bulletin, V5, P113; Ordiz A, 2013, J APPL ECOL, V50, P306, DOI 10.1111/1365-2664.12047; PATTERSON BD, 1989, J MAMMAL, V70, P67, DOI 10.2307/1381670; Ramesh T, 2012, J ZOOL, V287, P269, DOI 10.1111/j.1469-7998.2012.00908.x; Redford K.H., 1992, MAMMALS NEOTROPICS S, V2; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Royle J. A., 2008, HIERARCHICAL MODELIN; Schuette P, 2013, BIOL CONSERV, V158, P301, DOI 10.1016/j.biocon.2012.08.008; Schwartz CC, 2010, J WILDLIFE MANAGE, V74, P1628, DOI 10.2193/2009-571; Sepulveda MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086152; Silva-Rodriguez EA, 2012, BIOL CONSERV, V150, P103, DOI 10.1016/j.biocon.2012.03.008; Silva-Rodriguez EA, 2010, AUSTRAL ECOL, V35, P765, DOI 10.1111/j.1442-9993.2009.02083.x; Simonetti JA, 1997, REV CHIL HIST NAT, V70, P213; Smith-Ramirez C, 2004, BIODIVERS CONSERV, V13, P373, DOI 10.1023/B:BIOC.0000006505.67560.9f; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Takahata C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086181; Thomas DL, 2006, J WILDLIFE MANAGE, V70, P324, DOI 10.2193/0022-541X(2006)70[324:SDATFC]2.0.CO;2; Vanak AT, 2010, J APPL ECOL, V47, P1225, DOI 10.1111/j.1365-2664.2010.01870.x; Vanak AT, 2009, MAMMAL REV, V39, P265, DOI 10.1111/j.1365-2907.2009.00148.x; Lantschner MV, 2012, FOREST ECOL MANAG, V269, P271, DOI 10.1016/j.foreco.2011.12.045; Whittington J, 2004, ECOL SOC, V9; Woodroffe R, 1999, ORYX, V33, P132, DOI 10.1017/S0030605300030398; Zuniga A, THESIS U LOS LAGOS C; Zuniga A, 2009, GAYANA, V73, P200	67	33	33	5	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137854	10.1371/journal.pone.0137854	http://dx.doi.org/10.1371/journal.pone.0137854			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368395	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100156
J	Sun, ZL; He, JJ; Qiu, SH; Lei, CH; Zhou, Y; Xie, ZL; Zhang, L; Wang, YP; Jin, H				Sun, Zilin; He, Jiajia; Qiu, Shanhu; Lei, Chenghao; Zhou, Yi; Xie, Zuolin; Zhang, Lin; Wang, Yanping; Jin, Hui			Using Serum Advanced Glycation End Products-Peptides to Improve the Efficacy of World Health Organization Fasting Plasma Glucose Criterion in Screening for Diabetes in High-Risk Chinese Subjects	PLOS ONE			English	Article							LIFE-STYLE; GLYCOSYLATION; PREVALENCE; HBA(1C); MELLITUS; INTERVENTION; FRUCTOSAMINE; INDIVIDUALS; POPULATION; TOLERANCE	The efficacy of using fasting plasma glucose (FPG) alone as a preferred screening test for diabetes has been questioned. This study was aimed to evaluate whether the use of serum advanced glycation end products-peptides (sAGEP) would help to improve the efficacy of FPG in diabetes screening among high-risk Chinese subjects with FPG <7.0 mmol/L. FPG, 2-h plasma glucose (2h-PG), serum glycated haemoglobin A1c (HbA1c), and sAGEP were measured in 857 Chinese subjects with risk factors for diabetes. The areas under receiver operating characteristic (ROC) curves generated by logistic regression models were assessed and compared to find the best model for diabetes screening in subjects with FPG <7.0 mmol/L. The optimal critical line was determined by maximizing the sum of sensitivity and specificity. Among the enrolled subjects, 730 of them had FPG <7.0 mmol/L, and only 41.7% new diabetes cases were identified using the 1999 World Health Organization FPG criterion (FPG >= 7.0 mmol/L). The area under ROC curves generated by the model on FPG-sAGEP was the largest compared with that on FPG-HbA1c, sAGEP, HbA1c or FPG in subjects with FPG <7.0 mmol/L. By maximizing the sum of sensitivity and specificity, the optimal critical line was determined as 0.69xFPG + 0.14xsAGEP = 7.03, giving a critical sensitivity of 91.2% in detecting 2h-PG >= 11.1 mmol/L, which was significantly higher than that of FPG-HbA1c or HbA1c. The model on FPG-sAGEP improves the efficacy of using FPG alone in detecting diabetes among high-risk Chinese subjects with FPG <7.0 mmol/L, and is worth being promoted for future diabetes screening.	[Sun, Zilin; He, Jiajia; Qiu, Shanhu; Lei, Chenghao; Zhou, Yi; Xie, Zuolin; Wang, Yanping; Jin, Hui] Southeast Univ, Zhongda Hosp, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China; [Sun, Zilin; He, Jiajia; Qiu, Shanhu; Lei, Chenghao; Zhou, Yi; Zhang, Lin; Wang, Yanping] Southeast Univ, Sch Med, Inst Diabet, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Sun, ZL (corresponding author), Southeast Univ, Zhongda Hosp, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China.	sunzilin1963@126.com	Qiu, Shanhu/AAI-1318-2019	Qiu, Shanhu/0000-0003-2597-3856	Key Program of Jiangsu Natural Science Foundation [BK2010087]	Key Program of Jiangsu Natural Science Foundation	This study was supported by the Key Program of Jiangsu Natural Science Foundation (BK2010087, http://www.jstd.gov.cn/kjgz/kjjh/zjjh/jcyj/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Andrews RC, 2011, LANCET, V378, P129, DOI 10.1016/S0140-6736(11)60442-X; Bao YQ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2249; Barr ELM, 2007, CIRCULATION, V116, P151, DOI 10.1161/CIRCULATIONAHA.106.685628; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Drzewoski J, 2001, DIABETIC MED, V18, P29, DOI 10.1046/j.1464-5491.2001.00403.x; Gavin JR, 1999, DIABETES CARE, V22, pS5; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Gradinaru D, 2013, J PROTEOMICS, V92, P313, DOI 10.1016/j.jprot.2013.03.034; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; Hu DS, 2009, DIABETES RES CLIN PR, V84, P288, DOI 10.1016/j.diabres.2009.02.021; Jakus V, 2004, PHYSIOL RES, V53, P131; Janssen PGH, 2007, FAM PRACT, V24, P555, DOI 10.1093/fampra/cmm052; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Ko GTC, 1998, DIABETES CARE, V21, P1221, DOI 10.2337/diacare.21.8.1221; Lachenbruch PA, 1998, STAT MED, V17, P2207, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2207::AID-SIM920>3.0.CO;2-Y; Li R, 2012, DIABETES CARE, V35, P1028, DOI 10.2337/dc11-1212; Liu NF, 2000, ACTA PHARMACOL SIN, V21, P276; Luevano-Contreras C, 2010, NUTRIENTS, V2, P1247, DOI 10.3390/nu2121247; MAKITA Z, 1991, NEW ENGL J MED, V325, P836, DOI 10.1056/NEJM199109193251202; Makita Z, 1996, NEPHROL DIAL TRANSPL, V11, P31; McDonald JH., 2008, HDB BIOL STAT; Munch G, 1997, EUR J CLIN CHEM CLIN, V35, P669; Nathan DM, 2007, DIABETIC MED, V24, P137; Nowotny K, 2015, BIOMOLECULES, V5, P194, DOI 10.3390/biom5010194; Perry RC, 2001, DIABETES CARE, V24, P465, DOI 10.2337/diacare.24.3.465; Qiu SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109767; Qiu SH, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-36; SCHATZKIN A, 1987, AM J EPIDEMIOL, V125, P672, DOI 10.1093/oxfordjournals.aje.a114580; Shimoike T, 2000, METABOLISM, V49, P1030, DOI 10.1053/meta.2000.7738; Sun ZL, 2001, CLIN CHIM ACTA, V313, P69, DOI 10.1016/S0009-8981(01)00651-9; TAHARA Y, 1995, DIABETES CARE, V18, P440, DOI 10.2337/diacare.18.4.440; Takeuchi M, 1999, MOL MED, V5, P393, DOI 10.1007/BF03402128; Tangvarasittichai S, 2015, WORLD J DIABETES, V6, P456, DOI 10.4239/wjd.v6.i3.456; Wang WY, 2002, DIABETES CARE, V25, P1365, DOI 10.2337/diacare.25.8.1365; Wang X, 2015, IN VITRO CELL DEV-AN, V51, P204, DOI 10.1007/s11626-014-9823-5; Wrobel K, 1997, CLIN CHEM, V43, P1563; Xie Zuo-ling, 2012, Zhonghua Yi Xue Za Zhi, V92, P2843; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yanagisawa K, 1998, METABOLISM, V47, P1348, DOI 10.1016/S0026-0495(98)90303-1; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhou XH, 2010, DIABETES CARE, V33, P545, DOI 10.2337/dc09-1410	44	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137756	10.1371/journal.pone.0137756	http://dx.doi.org/10.1371/journal.pone.0137756			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368827	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100130
J	Yu, B; Wang, XD; Ma, L; Li, L; Li, HF				Yu, Bo; Wang, Xunda; Ma, Lin; Li, Liang; Li, Haifeng			The Complex Pre-Execution Stage of Auditory Cognitive Control: ERPs Evidence from Stroop Tasks	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; MISMATCH NEGATIVITY MMN; CONFLICT; INTERFERENCE; PERFORMANCE; FMRI; BRAIN; POTENTIALS; MECHANISMS; TIME	Cognitive control has been extensively studied from Event-Related Potential (ERP) point of view in visual modality using Stroop paradigms. Little work has been done in auditory Stroop paradigms, and inconsistent conclusions have been reported, especially on the conflict detection stage of cognitive control. This study investigated the early ERP components in an auditory Stroop paradigm, during which participants were asked to identify the volume of spoken words and ignore the word meanings. A series of significant ERP components were revealed that distinguished incongruent and congruent trials: two declined negative polarity waves (the N1 and the N2) and three declined positive polarity wave (the P1, the P2 and the P3) over the fronto-central area for the incongruent trials. These early ERP components imply that both a perceptual stage and an identification stage exist in the auditory Stroop effect. A 3-stage cognitive control model was thus proposed for a more detailed description of the human cognitive control mechanism in the auditory Stroop tasks.	[Yu, Bo; Wang, Xunda; Ma, Lin; Li, Haifeng] Harbin Inst Technol, Sch Comp Sci & Technol, Harbin 150001, Peoples R China; [Yu, Bo] Harbin Univ Sci & Technol, Software Coll, Harbin 150001, Peoples R China; [Li, Liang] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China; [Li, Liang] Peking Univ, Beijing Key Lab Behav & Mental Hlth, PKU IDG McGovern Inst Brain Res,Minist Educ, Speech & Hearing Res Ctr,Key Lab Machine Percept, Beijing 100871, Peoples R China	Harbin Institute of Technology; Harbin University of Science & Technology; Peking University; Peking University	Li, HF (corresponding author), Harbin Inst Technol, Sch Comp Sci & Technol, Harbin 150001, Peoples R China.	lihaifeng@hit.edu.cn			National Natural Science Foundation of China [61171186, 61271345]; Key Laboratory Opening Funding of MOE-Microsoft Key Laboratory of Natural Language Processing and Speech [HIT.KLOF.20110xx]; Fundamental Research Funds for the Central Universities [HIT.NSRIF.2012047]; Scientific Research Fund [CJN13J004]; Microsoft Research Asia Joint Lab Program (JLP)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory Opening Funding of MOE-Microsoft Key Laboratory of Natural Language Processing and Speech; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Scientific Research Fund; Microsoft Research Asia Joint Lab Program (JLP)	This work was supported by the National Natural Science Foundation of China [61171186], [61271345]; Key Laboratory Opening Funding of MOE-Microsoft Key Laboratory of Natural Language Processing and Speech [HIT.KLOF.20110xx]; Fundamental Research Funds for the Central Universities [HIT.NSRIF.2012047]; Scientific Research Fund CJN13J004. HFL conceived, designed and performed the original experiments. HFL supervised the research activities and made the final approval of the version to be published. Microsoft Research Asia Joint Lab Program (JLP) provided funding towards this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adleman NE, 2002, NEUROIMAGE, V16, P61, DOI 10.1006/nimg.2001.1046; Amenedo E, 1998, BIOL PSYCHOL, V48, P235, DOI 10.1016/S0301-0511(98)00040-4; Ben-Haim MS, 2014, ATTEN PERCEPT PSYCHO, V76, P81, DOI 10.3758/s13414-013-0545-7; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Buzzell GA, 2013, INT J PSYCHOPHYSIOL, V90, P265, DOI 10.1016/j.ijpsycho.2013.08.008; Cane JE, 2009, J PSYCHOPHARMACOL, V23, P510, DOI 10.1177/0269881108091253; COHEN G, 1975, PERCEPT PSYCHOPHYS, V17, P79, DOI 10.3758/BF03204002; Cox WM, 2006, PSYCHOL BULL, V132, P443, DOI 10.1037/0033-2909.132.3.443; Donohue SE, 2012, COGN AFFECT BEHAV NE, V12, P1, DOI 10.3758/s13415-011-0060-z; Doucet C, 1999, PSYCHOPHYSIOLOGY, V36, P351, DOI 10.1017/S0048577299980563; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Egner T, 2005, NEUROIMAGE, V24, P539, DOI 10.1016/j.neuroimage.2004.09.007; Federmeier KD, 2002, NEUROPSYCHOLOGIA, V40, P730, DOI 10.1016/S0028-3932(01)00193-2; Finnigan S, 2011, PSYCHOPHYSIOLOGY, V48, P601, DOI 10.1111/j.1469-8986.2010.01128.x; Garland EL, 2012, BIOL PSYCHOL, V89, P87, DOI 10.1016/j.biopsycho.2011.09.010; Gootjes L, 2011, INT J PSYCHOPHYSIOL, V79, P356, DOI 10.1016/j.ijpsycho.2010.12.003; HAMERS JF, 1972, J VERB LEARN VERB BE, V11, P303, DOI 10.1016/S0022-5371(72)80091-4; Harrison BJ, 2005, NEUROIMAGE, V24, P181, DOI 10.1016/j.neuroimage.2004.08.033; Henkin Y, 2010, J AM ACAD AUDIOL, V21, P474, DOI 10.3766/jaaa.21.7.6; Herd SA, 2006, J COGNITIVE NEUROSCI, V18, P22, DOI 10.1162/089892906775250012; ISREAL JB, 1980, PSYCHOPHYSIOLOGY, V17, P259, DOI 10.1111/j.1469-8986.1980.tb00146.x; JERGER S, 1988, BRAIN LANG, V35, P86, DOI 10.1016/0093-934X(88)90102-2; Jun C, 2007, PSYCHOL SCI CHINESE, V30, P415; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Klimesch W, 2007, J NEUROPHYSIOL, V97, P1311, DOI 10.1152/jn.00876.2006; Larson MJ, 2009, NEUROPSYCHOLOGIA, V47, P663, DOI 10.1016/j.neuropsychologia.2008.11.013; Lefebvre CD, 2005, CLIN NEUROPHYSIOL, V116, P1665, DOI 10.1016/j.clinph.2005.03.015; Lew H, 1997, J Am Acad Audiol, V8, P104; Liotti M, 2000, NEUROPSYCHOLOGIA, V38, P701, DOI 10.1016/S0028-3932(99)00106-2; Luck S.J., 2005, INTRO EVENT RELATED; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mama Y, 2013, COGNITION EMOTION, V27, P589, DOI 10.1080/02699931.2012.726212; Markela-Lerenc J, 2004, COGNITIVE BRAIN RES, V18, P278, DOI 10.1016/j.cogbrainres.2003.10.013; Martin BA, 2000, J ACOUST SOC AM, V107, P2155, DOI 10.1121/1.428556; May PJC, 2010, PSYCHOPHYSIOLOGY, V47, P66, DOI 10.1111/j.1469-8986.2009.00856.x; MCCLAIN L, 1983, PERCEPT PSYCHOPHYS, V33, P266, DOI 10.3758/BF03202864; Meier ME, 2013, J EXP PSYCHOL LEARN, V39, P748, DOI 10.1037/a0029200; Milham MP, 2003, COGNITIVE BRAIN RES, V17, P212, DOI 10.1016/S0926-6410(03)00108-3; Milham MP, 2002, BRAIN COGNITION, V49, P277, DOI 10.1006/brcg.2001.1501; MORGAN ALR, 1989, BRAIN LANG, V36, P592, DOI 10.1016/0093-934X(89)90088-6; Most SB, 2007, AUDITORY STROOP REVE; Most SB, 2007, J EXP SOC PSYCHOL, V43, P287, DOI 10.1016/j.jesp.2006.02.002; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Peressotti F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049099; Qiu J, 2006, BRAIN RES, V1072, P186, DOI 10.1016/j.brainres.2005.12.029; Rebai M, 1997, INT J NEUROSCI, V91, P85, DOI 10.3109/00207459708986367; Redmann A, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00363; Roberts KL, 2008, J COGNITIVE NEUROSCI, V20, P1063, DOI 10.1162/jocn.2008.20074; Roelofs A, 2002, COGNITIVE BRAIN RES, V15, P85, DOI 10.1016/S0926-6410(02)00218-5; SHOR RE, 1975, J GEN PSYCHOL, V93, P281; SIMSON R, 1977, ELECTROEN CLIN NEURO, V42, P528, DOI 10.1016/0013-4694(77)90216-4; Soutschek A, 2013, PSYCHOL RES-PSYCH FO, V77, P333, DOI 10.1007/s00426-012-0429-9; Soutschek A, 2013, EXP PSYCHOL, V60, P140, DOI 10.1027/1618-3169/a000181; Stafford T, 2007, PHILOS T R SOC B, V362, P1671, DOI 10.1098/rstb.2007.2060; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Swainson R, 2003, J COGNITIVE NEUROSCI, V15, P785, DOI 10.1162/089892903322370717; Thabet MT, 2012, INT J PEDIATR OTORHI, V76, P1712, DOI 10.1016/j.ijporl.2012.08.007; Tome D, 2015, J NEURAL TRANSM, V122, P375, DOI 10.1007/s00702-014-1258-3; West R, 1999, COGNITIVE BRAIN RES, V8, P157, DOI 10.1016/S0926-6410(99)00017-8; West R, 2004, J COGNITIVE NEUROSCI, V16, P103, DOI 10.1162/089892904322755593; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; Winkler I, 2007, J PSYCHOPHYSIOL, V21, P147, DOI 10.1027/0269-8803.21.34.147; Wolach I, 2001, CLIN NEUROPHYSIOL, V112, P186, DOI 10.1016/S1388-2457(00)00501-0; Wuhr P, 2007, J GEN PSYCHOL, V134, P285, DOI 10.3200/GENP.134.3.285-294; Zhao Y, 2014, NEUROSCIENCE, V262, P92, DOI 10.1016/j.neuroscience.2013.12.052	68	9	9	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137649	10.1371/journal.pone.0137649	http://dx.doi.org/10.1371/journal.pone.0137649			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368570	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100101
J	Lin, BR; Lin, YL; Lai, HS; Lee, PH; Chang, KJ; Liang, JT				Lin, Been-Ren; Lin, Yu-Lin; Lai, Hong-Shiee; Lee, Po-Huang; Chang, King-Jen; Liang, Jin-Tung			Overall Survival of Stage III Colon Cancer with Only One Lymph Node Metastasis Is Independently Predicted by Preoperative Carcinoembryonic Antigen Level and Lymph Node Sampling Status	PLOS ONE			English	Article							ADJUVANT CHEMOTHERAPY USE; COLORECTAL-CANCER; AGE; SURGERY; HARVEST	Background This study identified predictors of favorable overall survival (OS) for stage III colon cancer patients who had only one lymph node (LN) metastasis (N1a). Methods Variables, including preoperative carcinoembryonic antigen (CEA) level, LN sampling status, and the choices of postoperative adjuvant chemotherapy, were recorded. Prognostic significance was determined using the log-rank test and multivariate Cox regression analysis. Results The median 42-month follow-up period included 363 eligible patients. Among them, 230 (63.3%) received only 5-flurouracil (5-FU) adjuvant chemotherapy; 76 (20.9%) underwent oxaliplatin-based regimens; and 57 (15.7%) chose surgery alone. The 5-year survival rate of these evaluated patients was 75%, 63%, and 77%, respectively (P = 0.823). Multivariate analysis revealed that normal preoperative CEA level (<= 5 ng/mL) and adequate LN sampling (LN. 12) were significant predictors for higher 5-year OS (P < 0.001; P = 0.007, respectively). However, the use of postoperative adjuvant chemotherapy in these N1a colon cancer patients did not significantly affect their 5-year OS. Conclusions A preoperative CEA level of less than or equal to 5 ng/mL, and curative surgery with an adequate lymphadenectomy determined a favorable OS outcome in stage III colon cancer with only one LN metastasis.	[Lin, Been-Ren; Lai, Hong-Shiee; Lee, Po-Huang; Chang, King-Jen; Liang, Jin-Tung] Natl Taiwan Univ Hosp, Dept Surg, Div Colorectal Surg, Taipei 100, Taiwan; [Lin, Been-Ren; Lin, Yu-Lin; Lai, Hong-Shiee; Lee, Po-Huang; Chang, King-Jen; Liang, Jin-Tung] Coll Med, Taipei, Taiwan; [Lin, Yu-Lin] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Liang, JT (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Div Colorectal Surg, 7 Chung Shan South Rd, Taipei 100, Taiwan.	jintung@ntu.edu.tw		Liang, Jin-Tung/0000-0002-0264-7735; Lai, Hong-Shiee/0000-0002-7958-2183; Chang, King jen/0000-0001-9811-3422; LIN, BEEN-REN/0000-0001-8354-1758; LEE, PO-HUANG/0000-0001-5831-035X	National Research Program for Biopharmaceuticals (NRPB) at Ministry of science and Technology of Taiwan [MOST 103-2325-B-002-033]	National Research Program for Biopharmaceuticals (NRPB) at Ministry of science and Technology of Taiwan	This study was funded by National Research Program for Biopharmaceuticals (NRPB) at the Ministry of science and Technology of Taiwan; MOST 103-2325-B-002-033.	Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; [Anonymous], 2009, ANN CANC REP TAIW CA; Baxter NN, 2009, J SURG ONCOL, V99, P265, DOI 10.1002/jso.21197; Berg M, 2013, MOL MED, V19, P286, DOI 10.2119/molmed.2013.00049; Chandrasinghe PC, 2014, INDIAN J GASTROENTER, V33, P249, DOI 10.1007/s12664-013-0406-2; Cianchi F, 2002, WORLD J SURG, V26, P384, DOI 10.1007/s00268-001-0236-8; Duffy MJ, 2001, CLIN CHEM, V47, P624; Edge SB, 2010, AJCC CANC STAGING MA; Fakih MG, 2006, ONCOLOGY-NY, V20, P579; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Gunderson LL, 2010, J CLIN ONCOL, V28, P264, DOI 10.1200/JCO.2009.24.0952; HALL WH, 1990, JAMA-J AM MED ASSOC, V264, P1444; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jessup JM, 2005, JAMA-J AM MED ASSOC, V294, P2703, DOI 10.1001/jama.294.21.2703; Kahn KL, 2010, JAMA-J AM MED ASSOC, V303, P1037, DOI 10.1001/jama.2010.272; McCleary NJ, 2013, J CLIN ONCOL, V31, P2600, DOI 10.1200/JCO.2013.49.6638; Nedrebo BS, 2013, COLORECTAL DIS, V15, pE301, DOI 10.1111/codi.12245; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Schrag D, 2001, J NATL CANCER I, V93, P850, DOI 10.1093/jnci/93.11.850; Shia J, 2012, J AM COLL SURGEONS, V214, P348, DOI 10.1016/j.jamcollsurg.2011.11.010; Thirunavukarasu P, 2011, JNCI-J NATL CANCER I, V103, P689, DOI 10.1093/jnci/djr078; Wright FC, 2009, J SURG ONCOL, V99, P248, DOI 10.1002/jso.21226	22	7	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137053	10.1371/journal.pone.0137053	http://dx.doi.org/10.1371/journal.pone.0137053			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381396	gold, Green Published, Green Submitted			2022-12-27	WOS:000361790200013
J	Reid, R; Ezekowitz, JA; Brown, PM; McAlister, FA; Rowe, BH; Braam, B				Reid, Ryan; Ezekowitz, Justin A.; Brown, Paul M.; McAlister, Finlay A.; Rowe, Brian H.; Braam, Branko			The Prognostic Importance of Changes in Renal Function during Treatment for Acute Heart Failure Depends on Admission Renal Function	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; DYSFUNCTION; IMPROVEMENT; OUTCOMES; CARE	Background Worsening and improving renal function during acute heart failure have been associated with adverse outcomes but few studies have considered the admission level of renal function upon which these changes are superimposed. Objectives The objective of this study was to evaluate definitions that incorporate both admission renal function and change in renal function. Methods 696 patients with acute heart failure with calculable eGFR were classified by admission renal function (Reduced [R, eGFR< 45 ml/min] or Preserved [P, eGFR >= 45 ml/min]) and change over hospital admission (worsening [WRF]: eGFR >= 20% decline; stable [SRF]; and improving [IRF]: eGFR >= 20% increase). The primary outcome was all-cause mortality. The prevalence of Pres and Red renal function was 47.8% and 52.2%. The frequency of RWRF, R-SRF, and R-IRF was 11.4%, 28.7%, and 12.1%, respectively; the incidence of PWRF, P-SRF, and P-IRF was 5.7%, 35.3%, and 6.8%, respectively. Survival was shorter for patients with R-WRF compared to R-IRF (median survival times 13.9 months (95% CI 7.7-24.9) and 32.5 months (95% CI 18.8-56.1), respectively), resulting in an acceleration factor of 2.3 (p = 0.016). Thus, an increase compared with a decrease in renal function was associated with greater than two times longer survival among patients with Reduced renal function.	[Reid, Ryan; Braam, Branko] Univ Alberta, Dept Med, Div Nephrol, Edmonton, AB, Canada; [Ezekowitz, Justin A.] Univ Alberta, Div Cardiol, Edmonton, AB, Canada; [Ezekowitz, Justin A.; Braam, Branko] Univ Alberta, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada; [Ezekowitz, Justin A.; Brown, Paul M.] Univ Alberta, Canadian VIGOUR Ctr, Edmonton, AB, Canada; [McAlister, Finlay A.] Univ Alberta, Patient Hlth Outcomes Res & Clin Effectiveness Un, Edmonton, AB, Canada; [McAlister, Finlay A.] Univ Alberta, Div Gen Internal Med, Edmonton, AB, Canada; [Rowe, Brian H.] Univ Alberta, Dept Emergency Med, Edmonton, AB, Canada; [Rowe, Brian H.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Braam, Branko] Univ Alberta, Dept Physiol, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta	Ezekowitz, JA (corresponding author), Univ Alberta, Div Cardiol, Edmonton, AB, Canada.	jae2@ualberta.ca	Brown, Paul M/E-2019-2016; Ezekowitz, Justin/C-4579-2013; McAlister, Finlay/C-4151-2013	Ezekowitz, Justin/0000-0002-2724-4086; Brown, Paul/0000-0002-2411-3312; McAlister, Finlay/0000-0001-7435-3341	Alberta Innovates - Health Solutions (AIHS); Canadian Institutes of Health Research (CIHR)	Alberta Innovates - Health Solutions (AIHS); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Alberta Innovates - Health Solutions (AIHS) and the Canadian Institutes of Health Research (CIHR) provided grant support for AHF-EM. The sponsor had no role in the design and conduct of the study; collection, management, analysis, or interpretation of the data; and preparation, review, or approval of the manuscript, which is solely the responsibility of the authors. The authors had complete control and authority over the design, data analysis, interpretation, manuscript preparation, and the decision to submit this manuscript to PLOS One.	Aronson D, 2010, J CARD FAIL, V16, P541, DOI 10.1016/j.cardfail.2010.02.001; Astor BC, 2002, ARCH INTERN MED, V162, P1401, DOI 10.1001/archinte.162.12.1401; Braam B, 2014, NAT REV NEPHROL, V10, P48, DOI 10.1038/nrneph.2013.250; CARLSON KJ, 1985, J CHRON DIS, V38, P733, DOI 10.1016/0021-9681(85)90115-8; Damman K, 2014, EUR HEART J, V35, P455, DOI 10.1093/eurheartj/eht386; Ezekowitz JA, 2011, EUR J HEART FAIL, V13, P142, DOI 10.1093/eurjhf/hfq185; Filippatos G, 2014, EUR HEART J, V35, P416, DOI 10.1093/eurheartj/eht515; Ghilagaber G, 2005, QUAL QUANT, V39, P71, DOI 10.1007/s11135-004-0435-0; Givertz MM, 2014, CIRC-HEART FAIL, V7, P59, DOI 10.1161/CIRCHEARTFAILURE.113.000556; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gottlieb SS, 2002, J CARD FAIL, V8, P136, DOI 10.1054/jcaf.2002.125289; Gronda E, 2015, CARDIOL J, V22, P459, DOI 10.5603/CJ.a2015.0019; Lee DS, 2012, ANN INTERN MED, V156, P767, DOI 10.7326/0003-4819-156-11-201206050-00003; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2007, KIDNEY INT, V71, P31, DOI 10.1038/sj.ki.5002009; Massie BM, 2010, NEW ENGL J MED, V363, P1419, DOI 10.1056/NEJMoa0912613; McAlister FA, 2004, CIRCULATION, V109, P1004, DOI 10.1161/01.CIR.0000116764.53225.A9; McAlister FA, 2004, CIRCULATION; McAlister FA, 2012, CIRC-HEART FAIL, V5, P309, DOI 10.1161/CIRCHEARTFAILURE.111.966242; Metra M, 2008, EUR J HEART FAIL, V10, P188, DOI 10.1016/j.ejheart.2008.01.011; Nunez J, 2017, EUR HEART J-ACUTE CA, V6, P430, DOI 10.1177/2048872614540094; O'Connor CM, 2011, NEW ENGL J MED, V365, P32, DOI 10.1056/NEJMoa1100171; Patel K, 2006, PHARM STAT, V5, P213, DOI 10.1002/pst.213; Rao MV, 2008, AM J KIDNEY DIS, V51, pS30, DOI 10.1053/j.ajkd.2007.12.012; Ronco C, 2010, EUR HEART J, V31, P703, DOI 10.1093/eurheartj/ehp507; Sarnak MJ, 2014, CLIN J AM SOC NEPHRO, V9, P1790, DOI 10.2215/CJN.11601113; Testani JM, 2011, J CARD FAIL, V17, P993, DOI 10.1016/j.cardfail.2011.08.009; Testani JM, 2010, AM J CARDIOL, V106, P1763, DOI 10.1016/j.amjcard.2010.07.050; Thompson S, 2015, J AM SOC NEPHROL, V26, P2504, DOI 10.1681/ASN.2014070714	30	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138579	10.1371/journal.pone.0138579	http://dx.doi.org/10.1371/journal.pone.0138579			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26380982	Green Published, gold, Green Submitted			2022-12-27	WOS:000361790200130
J	Salali, GD; Whitehouse, H; Hochberg, ME				Salali, Gul Deniz; Whitehouse, Harvey; Hochberg, Michael E.			A Life-Cycle Model of Human Social Groups Produces a U-Shaped Distribution in Group Size	PLOS ONE			English	Article							CULTURAL-GROUP SELECTION; POLITICAL COMPLEXITY; EVOLUTION; TRANSITION; EXPANSION; ORIGIN; WORLD; STATE	One of the central puzzles in the study of sociocultural evolution is how and why transitions from small-scale human groups to large-scale, hierarchically more complex ones occurred. Here we develop a spatially explicit agent-based model as a first step towards understanding the ecological dynamics of small and large-scale human groups. By analogy with the interactions between single-celled and multicellular organisms, we build a theory of group lifecycles as an emergent property of single cell demographic and expansion behaviours. We find that once the transition from small-scale to large-scale groups occurs, a few large-scale groups continue expanding while small-scale groups gradually become scarcer, and large-scale groups become larger in size and fewer in number over time. Demographic and expansion behaviours of groups are largely influenced by the distribution and availability of resources. Our results conform to a pattern of human political change in which religions and nation states come to be represented by a few large units and many smaller ones. Future enhancements of the model should include decision-making rules and probabilities of fragmentation for large-scale societies. We suggest that the synthesis of population ecology and social evolution will generate increasingly plausible models of human group dynamics.	[Salali, Gul Deniz; Hochberg, Michael E.] Univ Montpellier, Inst Sci Evolut, F-34095 Montpellier 5, France; [Salali, Gul Deniz] UCL, Dept Anthropol, London WC1H 0BW, England; [Whitehouse, Harvey] Univ Oxford, Inst Cognit & Evolutionary Anthropol, Oxford OX2 6PN, England; [Hochberg, Michael E.] Santa Fe Inst, Santa Fe, NM 87501 USA	Universite de Montpellier; University of London; University College London; University of Oxford; The Santa Fe Institute	Hochberg, ME (corresponding author), Univ Montpellier, Inst Sci Evolut, Pl E Bataillon, F-34095 Montpellier 5, France.	mhochber@univ-montp2.fr		Salali, Gul Deniz/0000-0001-9538-3064; Whitehouse, Harvey/0000-0001-6935-6724	Erasmus Mundus Scholarship from EU; Centre National de la Recherche Scientifique grant [APICS 06313]; Economic and Social Research Council [ES/I005455/1] Funding Source: researchfish; ESRC [ES/I005455/1] Funding Source: UKRI	Erasmus Mundus Scholarship from EU; Centre National de la Recherche Scientifique grant; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was supported by an Erasmus Mundus Scholarship from EU (http://www.evobio.eu/) to GDS and a Centre National de la Recherche Scientifique grant (APICS 06313) (http://www.cnrs.fr/derci/spip.php?article51&lang=fr) to MEH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrutyn S, 2010, SOCIOL PERSPECT, V53, P419, DOI 10.1525/sop.2010.53.3.419; Adams ES, 2003, BEHAV ECOL, V14, P719, DOI 10.1093/beheco/arg061; [Anonymous], 2010, RELIG EMERGENCE CIVI; [Anonymous], 1997, GUNS GERMS STEEL; Atkinson QD, 2011, EVOL HUM BEHAV, V32, P50, DOI 10.1016/j.evolhumbehav.2010.09.002; Bettinger R, 2009, CURR ANTHROPOL, V50, P627, DOI 10.1086/605359; Boyd R, 2011, P NATL ACAD SCI USA, V108, P10918, DOI 10.1073/pnas.1100290108; Carneiro RL, 2000, P NATL ACAD SCI USA, V97, P12926, DOI 10.1073/pnas.240462397; Carneiro RL, 2004, CROSS-CULT RES, V38, P162, DOI 10.1177/1069397103260530; CARNEIRO RL, 1988, AM BEHAV SCI, V31, P497, DOI 10.1177/000276488031004010; CARNEIRO RL, 1970, SCIENCE, V169, P733, DOI 10.1126/science.169.3947.733; CATTON WR, 1987, BIOSCIENCE, V37, P413, DOI 10.2307/1310565; Cederman LE, 2010, INT STUD QUART, V54, P27, DOI 10.1111/j.1468-2478.2009.00576.x; Cioffi-Revilla C, 2005, J MATH SOCIOL, V29, P133, DOI 10.1080/00222500590920860; Currie TE, 2011, PHILOS T R SOC B, V366, P1108, DOI 10.1098/rstb.2010.0318; Currie TE, 2010, NATURE, V467, P801, DOI 10.1038/nature09461; Currie TE, 2009, P NATL ACAD SCI USA, V106, P7339, DOI 10.1073/pnas.0804698106; Dacey MF, 1969, PEACE RES SOC PAP, V14, P147; Diamond J., 2011, COLLAPSE SOC CHOOSE; Flannery K.V., 1972, ANNU REV ECOL SYST, V3, P399, DOI 10.1146/annurev.es.03.110172.002151; Foley RA, 2011, PHILOS T R SOC B, V366, P1080, DOI 10.1098/rstb.2010.0370; Gavrilets S, 2010, CLIODYNAMICS J THEOR, V1, P58; Gurven M, 2007, POPUL DEV REV, V33, P321, DOI 10.1111/j.1728-4457.2007.00171.x; HAMBURGER H, 1975, J CONFLICT RESOLUT, V19, P503, DOI 10.1177/002200277501900307; Henrich J, 2004, J ECON BEHAV ORGAN, V53, P3, DOI 10.1016/S0167-2681(03)00094-5; Johnson DDP, 2015, EVOL HUM BEHAV, V36, P152, DOI 10.1016/j.evolhumbehav.2014.11.001; Johnson G. A., 1982, THEORY EXPLANATION A, P389; Kirch P.V., 1984, EVOLUTION POLYNESIAN; Lanchester, 1916, AIRCRAFT WARFARE DAW; Lewis HM, 2014, NAT COMMUN, P5; Michod RE, 1997, AM NAT, V149, P607, DOI 10.1086/286012; Michod RE, 2007, P NATL ACAD SCI USA, V104, P8613, DOI 10.1073/pnas.0701489104; Ostrom E., 1990, GOVERNING COMMONS EV; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; R Core Team, 2013, R LANG ENV STAT COMP; Richerson PJ., 2001, P BR ACAD, V110, P197; SOLTIS J, 1995, CURR ANTHROPOL, V36, P473, DOI 10.1086/204381; Spencer CS, 2010, P NATL ACAD SCI USA, V107, P7119, DOI 10.1073/pnas.1002470107; STEPONAITIS VP, 1981, AM ANTHROPOL, V83, P320, DOI 10.1525/aa.1981.83.2.02a00030; Taagepera R, 1997, INT STUD QUART, V41, P475, DOI 10.1111/0020-8833.00053; Tainter J.A., 1988, COLLAPSE COMPLEX SOC; Tainter JA, 2006, ANNU REV ANTHROPOL, V35, P59, DOI 10.1146/annurev.anthro.35.081705.123136; Turchin P., 2009, SECULAR CYCLES; Turchin P, 2013, P NATL ACAD SCI USA, V110, P16384, DOI 10.1073/pnas.1308825110; Turchin P, 2009, SOC EVOL HIST, V8, P167; Whitehouse H., 2012, OXFORD HDB RELIG VIO; Whitehouse H., 2000, ARGUMENTS ICONS DIVE; Whitehouse H, 2014, CURR ANTHROPOL, V55, P674, DOI 10.1086/678698; Whitehouse Harvey, 1995, INSIDE CULT RELIG IN; Whitehouse Harvey, 2004, MODES RELIGIOSITY CO; Wilensky U., 1999, CTR CONNECTED LEARNI; WRIGHT HT, 1977, ANNU REV ANTHROPOL, V6, P379, DOI 10.1146/annurev.an.06.100177.002115	52	3	3	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138496	10.1371/journal.pone.0138496	http://dx.doi.org/10.1371/journal.pone.0138496			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0ZE	26381745	Green Published, Green Submitted, gold			2022-12-27	WOS:000361790200116
J	Watt, SA; Dayal, JHS; Wright, S; Riddle, M; Pourreyron, C; McMillan, JR; Kimble, RM; Prisco, M; Gartner, U; Warbrick, E; McLean, WHI; Leigh, IM; McGrath, JA; Salas-Alanis, JC; Tolar, J; South, AP				Watt, Stephen A.; Dayal, Jasbani H. S.; Wright, Sheila; Riddle, Megan; Pourreyron, Celine; McMillan, James R.; Kimble, Roy M.; Prisco, Marco; Gartner, Ulrike; Warbrick, Emma; McLean, W. H. Irwin; Leigh, Irene M.; McGrath, John A.; Salas-Alanis, Julio C.; Tolar, Jakub; South, Andrew P.			Lysyl Hydroxylase 3 Localizes to Epidermal Basement Membrane and Is Reduced in Patients with Recessive Dystrophic Epidermolysis Bullosa	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; ANCHORING FIBRIL-COLLAGEN; VII COLLAGEN; DISEASE SEVERITY; LYSYL-HYDROXYLASE-3 LH3; MMP1 PROMOTER; GENE COL7A1; MUTATIONS; EXPRESSION; PHENOTYPE	Recessive dystrophic epidermolysis bullosa (RDEB) is caused by mutations in COL7A1 resulting in reduced or absent type VII collagen, aberrant anchoring fibril formation and subsequent dermal-epidermal fragility. Here, we identify a significant decrease in PLOD3 expression and its encoded protein, the collagen modifying enzyme lysyl hydroxylase 3 (LH3), in RDEB. We show abundant LH3 localising to the basement membrane in normal skin which is severely depleted in RDEB patient skin. We demonstrate expression is in-part regulated by endogenous type VII collagen and that, in agreement with previous studies, even small reductions in LH3 expression lead to significantly less secreted LH3 protein. Exogenous type VII collagen did not alter LH3 expression in cultured RDEB keratinocytes and we show that RDEB patients receiving bone marrow transplantation who demonstrate significant increase in type VII collagen do not show increased levels of LH3 at the basement membrane. Our data report a direct link between LH3 and endogenous type VII collagen expression concluding that reduction of LH3 at the basement membrane in patients with RDEB will likely have significant implications for disease progression and therapeutic intervention.	[Watt, Stephen A.; Dayal, Jasbani H. S.; Wright, Sheila; Pourreyron, Celine; Leigh, Irene M.; South, Andrew P.] Univ Dundee, Div Canc Res, Dundee, Scotland; [Riddle, Megan; Tolar, Jakub] Univ Minnesota, Stem Cell Inst, Minneapolis, MN USA; [Riddle, Megan; Tolar, Jakub] Univ Minnesota, Pediat Blood & Marrow Transplantat, Minneapolis, MN USA; [McMillan, James R.; Kimble, Roy M.] Univ Queensland, Royal Childrens Hosp, Queensland Childrens Med Res Inst, Ctr Childrens Burns Res, Brisbane, Qld, Australia; [Prisco, Marco; South, Andrew P.] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; [Gartner, Ulrike; Warbrick, Emma; McLean, W. H. Irwin] Univ Dundee, Coll Life Sci, Ctr Dermatol & Genet Med, Div Mol Med, Dundee, Scotland; [Gartner, Ulrike; Warbrick, Emma; McLean, W. H. Irwin] Univ Dundee, Coll Med Dent & Nursing, Dundee, Scotland; [McGrath, John A.] Kings Coll London, St Johns Inst Dermatol, London, England; [Salas-Alanis, Julio C.] Univ Monterrey, Sch Med, Dept Basic Sci, Monterrey, Mexico	University of Dundee; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Royal Children's Hospital Brisbane; University of Queensland; Jefferson University; University of Dundee; University of Dundee; University of London; King's College London; Universidad de Monterrey	South, AP (corresponding author), Univ Dundee, Div Canc Res, Dundee, Scotland.	Andrew.South@Jefferson.edu	Pourreyron, Celine/AAE-7362-2020; McGrath, John/D-6824-2012	Tolar, Jakub/0000-0002-0957-4380; McGrath, John/0000-0002-3708-9964	Dystrophic Epidermolysis Bullosa Research Association; British Skin Foundation; Cancer Research UK; European Research Council; Wellcome Trust; Royal Children's Hospital Foundation; New Staff Start-Up Grant from University of Queensland; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063070] Funding Source: NIH RePORTER; Cancer Research UK [13044] Funding Source: researchfish	Dystrophic Epidermolysis Bullosa Research Association; British Skin Foundation; Cancer Research UK(Cancer Research UK); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Royal Children's Hospital Foundation; New Staff Start-Up Grant from University of Queensland; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Cancer Research UK(Cancer Research UK)	The authors received no specific funding for this work but would like to acknowledge the following organizations who contributed to this study: the Dystrophic Epidermolysis Bullosa Research Association, The British Skin Foundation, Cancer Research UK, The European Research Council, a strategic grant from the Wellcome Trust, the Royal Children's Hospital Foundation and a New Staff Start-Up Grant from The University of Queensland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUER EA, 1978, J EXP MED, V148, P1378, DOI 10.1084/jem.148.5.1378; BENTZ H, 1983, P NATL ACAD SCI-BIOL, V80, P3168, DOI 10.1073/pnas.80.11.3168; BRUCKNERTUDERMAN L, 1988, DERMATOLOGICA, V176, P57, DOI 10.1159/000248673; Chino T, 2008, AM J PATHOL, V173, P803, DOI 10.2353/ajpath.2008.070977; CHRISTIANO AM, 1994, J BIOL CHEM, V269, P20256; Dayal JHS, 2014, J CELL SCI, V127, P740, DOI 10.1242/jcs.128454; Fine JD, 2014, J AM ACAD DERMATOL, V70, P1103, DOI 10.1016/j.jaad.2014.01.903; Fine JD, 2009, J AM ACAD DERMATOL, V60, P203, DOI 10.1016/j.jaad.2008.09.035; Ha-Vinh R, 2004, AM J MED GENET A, V131A, P115, DOI 10.1002/ajmg.a.30231; Heinonen S, 1999, J CELL SCI, V112, P3641; Hiremagalore R, 2015, BRIT J DERMATOL, V172, P384, DOI 10.1111/bjd.13305; Kern JS, 2009, BRIT J DERMATOL, V161, P1089, DOI 10.1111/j.1365-2133.2009.09333.x; Kuttner V, 2014, J INVEST DERMATOL, V134, P2381, DOI 10.1038/jid.2014.185; Kuttner V, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.17; LANGEVELD JPM, 1991, J BIOL CHEM, V266, P2622; LEIGH IM, 1988, J INVEST DERMATOL, V90, P639, DOI 10.1111/1523-1747.ep12560795; Mavilio F, 2006, NAT MED, V12, P1397, DOI 10.1038/nm1504; MCGRATH JA, 1992, BRIT J DERMATOL, V127, P312, DOI 10.1111/j.1365-2133.1992.tb00447.x; McMillan JR, 2003, EXP DERMATOL, V12, P261, DOI 10.1034/j.1600-0625.2003.120305.x; Mellerio JE, 1997, J INVEST DERMATOL, V109, P246, DOI 10.1111/1523-1747.ep12319792; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Myllyla R, 2007, J CELL PHYSIOL, V212, P323, DOI 10.1002/jcp.21036; Nystrom A, 2013, J CLIN INVEST, V123, P3498, DOI 10.1172/JCI68127; Odorisio T, 2014, HUM MOL GENET, V23, P3907, DOI 10.1093/hmg/ddu102; Pourreyron C, 2014, BRIT J DERMATOL, V170, P1256, DOI 10.1111/bjd.12715; Rattenholl A, 2002, J BIOL CHEM, V277, P26372, DOI 10.1074/jbc.M203247200; Rautavuoma K, 2004, P NATL ACAD SCI USA, V101, P14120, DOI 10.1073/pnas.0404966101; Remington J, 2009, MOL THER, V17, P26, DOI 10.1038/mt.2008.234; Risteli M, 2009, J BIOL CHEM, V284, P28204, DOI 10.1074/jbc.M109.038190; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; Ruotsalainen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050045; SAKAI LY, 1986, J CELL BIOL, V103, P1577, DOI 10.1083/jcb.103.4.1577; Salo AM, 2006, J CELL PHYSIOL, V207, P644, DOI 10.1002/jcp.20596; Salo AM, 2008, AM J HUM GENET, V83, P495, DOI 10.1016/j.ajhg.2008.09.004; SHIMIZU H, 1989, ARCH DERMATOL RES, V281, P443, DOI 10.1007/BF00510078; Takaluoma K, 2007, MATRIX BIOL, V26, P396, DOI 10.1016/j.matbio.2007.01.002; Titeux M, 2008, HUM MUTAT, V29, P267, DOI 10.1002/humu.20647; Uitto J, 2010, J INVEST DERMATOL, V130, P1778, DOI 10.1038/jid.2010.90; Vanden Oever Michael J, 2014, F1000Prime Rep, V6, P35, DOI 10.12703/P6-35; Varki R, 2007, J MED GENET, V44, P181, DOI 10.1136/jmg.2006.045302; Villone D, 2008, J BIOL CHEM, V283, P24506, DOI 10.1074/jbc.M802415200; Wagner JE, 2010, NEW ENGL J MED, V363, P629, DOI 10.1056/NEJMoa0910501; Walker LC, 1999, MOL GENET METAB, V67, P74, DOI 10.1006/mgme.1999.2824; Wang CG, 2002, MATRIX BIOL, V21, P559, DOI 10.1016/S0945-053X(02)00071-9; Wang CG, 2012, J CELL PHYSIOL, V227, P668, DOI 10.1002/jcp.22774; Watt SA, 2011, ONCOGENE, V30, P4666, DOI 10.1038/onc.2011.180; Wong T, 2008, J INVEST DERMATOL, V128, P2179, DOI 10.1038/jid.2008.78; Ng YZ, 2012, CANCER RES, V72, P3522, DOI 10.1158/0008-5472.CAN-11-2996	48	17	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137639	10.1371/journal.pone.0137639	http://dx.doi.org/10.1371/journal.pone.0137639			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26380979	Green Published, gold			2022-12-27	WOS:000361790200030
J	Lammers, KM; Chieppa, M; Liu, L; Liu, S; Omatsu, T; Janka-Junttila, M; Casolaro, V; Reinecker, HC; Parent, CA; Fasano, A				Lammers, Karen M.; Chieppa, Marcello; Liu, Lunhua; Liu, Song; Omatsu, Tatsushi; Janka-Junttila, Mirkka; Casolaro, Vincenzo; Reinecker, Hans-Christian; Parent, Carole A.; Fasano, Alessio			Gliadin Induces Neutrophil Migration via Engagement of the Formyl Peptide Receptor, FPR1	PLOS ONE			English	Article							MUCOSAL GRANULOCYTE ACTIVATION; CELIAC-DISEASE; INTESTINAL PERMEABILITY; BARRIER FUNCTION; GUT PERMEABILITY; CONTROLLED-TRIAL; GENE-EXPRESSION; GLUTEN; ZONULIN; CHEMOTAXIS	Background Gliadin, the immunogenic component within gluten and trigger of celiac disease, is known to induce the production of Interleukin-8, a potent neutrophil-activating and chemoattractant chemokine. We sought to study the involvement of neutrophils in the early immunological changes following gliadin exposure. Methods Utilizing immunofluorescence microscopy and flow cytometry, the redistribution of major tight junction protein, Zonula occludens (ZO)-1, and neutrophil recruitment were assessed in duodenal tissues of gliadin-gavaged C57BL/6 wild-type and Lys-GFP reporter mice, respectively. Intravital microscopy with Lys-GFP mice allowed monitoring of neutrophil recruitment in response to luminal gliadin exposure in real time. In vitro chemotaxis assays were used to study murine and human neutrophil chemotaxis to gliadin, synthetic alpha-gliadin peptides and the neutrophil chemoattractant, fMet-Leu-Phe, in the presence or absence of a specific inhibitor of the fMet-Leu-Phe receptor-1 (FPR1), cyclosporine H. An irrelevant protein, zein, served as a control. Results Redistribution of ZO-1 and an influx of CD11b(+)Lys6G(+) cells in the lamina propria of the small intestine were observed upon oral gavage of gliadin. In vivo intravital microscopy revealed a slowing down of GFP(+) cells within the vessels and influx in the mucosal tissue within 2 hours after challenge. In vitro chemotaxis assays showed that gliadin strongly induced neutrophil migration, similar to fMet-Leu-Phe. We identified thirteen synthetic gliadin peptide motifs that induced cell migration. Blocking of FPR1 completely abrogated the fMet-Leu-Phe-, gliadin- and synthetic peptide-induced migration. Conclusions Gliadin possesses neutrophil chemoattractant properties similar to the classical neutrophil chemoattractant, fMet-Leu-Phe, and likewise uses FPR1 in the process.	[Lammers, Karen M.; Fasano, Alessio] Massachusetts Gen Hosp, Dept Pediat, Mucosal Immunol & Biol Res Ctr, Charlestown, MA 02129 USA; [Chieppa, Marcello] NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Liu, Lunhua; Janka-Junttila, Mirkka; Parent, Carole A.] NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Liu, Song; Omatsu, Tatsushi; Reinecker, Hans-Christian] Massachusetts Gen Hosp, Dept Gastroenterol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Massachusetts General Hospital	Lammers, KM (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Mucosal Immunol & Biol Res Ctr, Charlestown, MA 02129 USA.	klammers@mgh.harvard.edu	Chieppa, Marcello/I-8447-2018; Casolaro, Vincenzo/E-9144-2010; Chieppa, Marcello/AAG-9835-2019; Fasano, Alessio/K-5486-2016	Chieppa, Marcello/0000-0001-9819-0823; Casolaro, Vincenzo/0000-0001-9810-0488; Chieppa, Marcello/0000-0001-9819-0823; Fasano, Alessio/0000-0002-2134-0261	National Institutes of Health [DK-078699, DK-48373, DK068181, AI113333, DK033506, DK043351, MFAG 10684]; Center for Cancer Research, NCI, NIH; NATIONAL CANCER INSTITUTE [ZIABC011216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI113333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK078699, P01DK033506, R01DK048373, R01DK068181, P30DK043351] Funding Source: NIH RePORTER; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Cancer Research, NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This research was supported in part by the National Institutes of Health Grants DK-078699 and DK-48373 to AF, DK068181, AI113333, DK033506 and DK043351 to HCR, MFAG 10684 (AIRC) to MC, and the Intramural Research Program of the Center for Cancer Research, NCI, NIH to CAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x; Beitnes ACR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033556; Biesiekierski JR, 2011, AM J GASTROENTEROL, V106, P508, DOI 10.1038/ajg.2010.487; Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340; Carroccio A, 2012, AM J GASTROENTEROL, V107, P1898, DOI 10.1038/ajg.2012.236; Cascella NG, 2011, SCHIZOPHRENIA BULL, V37, P94, DOI 10.1093/schbul/sbp055; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Chladkova B, 2011, J CELL MOL MED, V15, P938, DOI 10.1111/j.1582-4934.2010.01066.x; Cinova J, 2007, J CLIN IMMUNOL, V27, P201, DOI 10.1007/s10875-006-9061-z; de Magistris L, 2010, J PEDIATR GASTR NUTR, V51, P418, DOI 10.1097/MPG.0b013e3181dcc4a5; Diosdado B, 2007, CLIN GASTROENTEROL H, V5, P574, DOI 10.1016/j.cgh.2006.11.014; Drago S, 2006, SCAND J GASTROENTERO, V41, P408, DOI 10.1080/00365520500235334; DUNLEVY JR, 1993, J CELL SCI, V105, P489; El Asmar R, 2002, GASTROENTEROLOGY, V123, P1607, DOI 10.1053/gast.2002.36578; Fasano A, 2005, NAT CLIN PRACT GASTR, V2, P416, DOI 10.1038/ncpgasthep0259; Fasano A, 2000, LANCET, V355, P1518, DOI 10.1016/S0140-6736(00)02169-3; Faust N, 2000, BLOOD, V96, P719; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Hart D, 2008, J IMMUNOL, V181, P8053, DOI 10.4049/jimmunol.181.11.8053; He HQ, 2013, MOL PHARMACOL, V83, P389, DOI 10.1124/mol.112.081315; HORIKAWA T, 1995, J INVEST DERMATOL, V104, P256, DOI 10.1111/1523-1747.ep12612795; Jelinkova L, 2004, FEBS LETT, V571, P81, DOI 10.1016/j.febslet.2004.06.057; Keet CA, 2009, ANN ALLERG ASTHMA IM, V102, P410, DOI 10.1016/S1081-1206(10)60513-3; Kristjansson G, 2005, SCAND J GASTROENTERO, V40, P662, DOI 10.1080/00365520510015566; Kristjansson G, 2005, GUT, V54, P769, DOI 10.1136/gut.2004.057174; Lammers KM, 2008, GASTROENTEROLOGY, V135, P194, DOI 10.1053/j.gastro.2008.03.023; Lammers KM, 2011, IMMUNOLOGY, V132, P432, DOI 10.1111/j.1365-2567.2010.03378.x; Nitta N, 2007, J IMMUNOL METHODS, V320, P155, DOI 10.1016/j.jim.2006.12.010; Picarelli A, 1999, SCAND J GASTROENTERO, V34, P1099, DOI 10.1080/003655299750024896; RALT D, 1994, BIOL REPROD, V50, P774, DOI 10.1095/biolreprod50.4.774; Sapone A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-23; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Silano M, 2009, CURR MED CHEM, V16, P1489, DOI 10.2174/092986709787909613; Southgate EL, 2008, J IMMUNOL, V181, P1429, DOI 10.4049/jimmunol.181.2.1429; Thomas KE, 2006, J IMMUNOL, V176, P2512, DOI 10.4049/jimmunol.176.4.2512; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Vazquez-Roque MI, 2013, GASTROENTEROLOGY, V144, P903, DOI 10.1053/j.gastro.2013.01.049; Visser JT, 2010, DIABETOLOGIA; Wapenaar MC, 2008, GUT, V57, P463, DOI 10.1136/gut.2007.133132; WENZELSEIFERT K, 1993, J IMMUNOL, V150, P4591; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	41	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138338	10.1371/journal.pone.0138338	http://dx.doi.org/10.1371/journal.pone.0138338			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378785	Green Submitted, gold, Green Published			2022-12-27	WOS:000361769400084
J	Learmonth, G; Gallagher, A; Gibson, J; Thut, G; Harvey, M				Learmonth, Gemma; Gallagher, Aodhan; Gibson, Jamie; Thut, Gregor; Harvey, Monika			Intra- and Inter-Task Reliability of Spatial Attention Measures in Pseudoneglect	PLOS ONE			English	Article							TIME-ON-TASK; IN-LINE BISECTION; VIEWING PERCEPTUAL ASYMMETRIES; VISUOSPATIAL ATTENTION; HEMISPATIAL NEGLECT; RIGHTWARD SHIFT; CROSS-OVER; BIAS; SPACE; JUDGMENTS	Healthy young adults display a leftward asymmetry of spatial attention ("pseudoneglect") that has been measured with a wide range of different tasks. Yet at present there is a lack of systematic evidence that the tasks commonly used in research today are i) stable measures over time and ii) provide similar measures of spatial bias. Fifty right-handed young adults were tested on five tasks (manual line bisection, landmark, greyscales, gratingscales and lateralised visual detection) on two different days. All five tasks were found to be stable measures of bias over the two testing sessions, indicating that each is a reliable measure in itself. Surprisingly, no strongly significant inter-task correlations were found. However, principal component analysis revealed left-right asymmetries to be subdivided in 4 main components, namely asymmetries in size judgements (manual line bisection and landmark), luminance judgements (greyscales), stimulus detection (lateralised visual detection) and judgements of global/local features (manual line bisection and grating scales). The results align with recent research on hemispatial neglect which conceptualises the condition as multi-component rather than a single pathological deficit of spatial attention. We conclude that spatial biases in judgment of visual stimulus features in healthy adults (e.g., pseudone-glect) is also a multi-component phenomenon that may be captured by variations in task demands which engage task-dependent patterns of activation within the attention network.	[Learmonth, Gemma; Thut, Gregor] Univ Glasgow, Inst Neurosci & Psychol, Ctr Cognit Neuroimaging, Glasgow, Lanark, Scotland; [Learmonth, Gemma; Gallagher, Aodhan; Gibson, Jamie; Harvey, Monika] Univ Glasgow, Sch Psychol, Glasgow, Lanark, Scotland	University of Glasgow; University of Glasgow	Learmonth, G (corresponding author), Univ Glasgow, Inst Neurosci & Psychol, Ctr Cognit Neuroimaging, Glasgow, Lanark, Scotland.	g.learmonth.1@research.gla.ac.uk	Learmonth, Gemma/J-7227-2019; Thut, Gregor/A-4374-2009	Learmonth, Gemma/0000-0003-4061-4464; Thut, Gregor/0000-0003-1313-4262	University of Glasgow College of Science and Engineering PhD scholarship	University of Glasgow College of Science and Engineering PhD scholarship	The study was supported by a University of Glasgow College of Science and Engineering PhD scholarship to GL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellgrove MA, 2004, NEUROREPORT, V15, P1065, DOI 10.1097/00001756-200404290-00027; Benwell CSY, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00113; Benwell CSY, 2014, NEUROIMAGE, V86, P370, DOI 10.1016/j.neuroimage.2013.10.014; Benwell CSY, 2013, NEUROPSYCHOLOGIA, V51, P2747, DOI 10.1016/j.neuropsychologia.2013.09.030; Benwell CSY, 2013, CORTEX, V49, P827, DOI 10.1016/j.cortex.2011.12.007; Bjoertomt O, 2002, BRAIN, V125, P2012, DOI 10.1093/brain/awf211; Bjoertomt O, 2009, J NEUROPSYCHOL, V3, P31, DOI 10.1348/174866408X394604; Bonato M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00162; Bonato M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00195; Bonato M, 2010, NEUROPSYCHOLOGIA, V48, P3934, DOI 10.1016/j.neuropsychologia.2010.08.022; Borgo M, 2012, MATLAB FOR PSYCHOLOGISTS, P1, DOI 10.1007/978-1-4614-2197-9; BOWERS D, 1980, NEUROPSYCHOLOGIA, V18, P491, DOI 10.1016/0028-3932(80)90151-7; CARRASCO M, 1986, PERCEPTION, V15, P553, DOI 10.1068/p150553; Chechlacz M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00230; Chen JQ, 2014, EXP BRAIN RES, V232, P4001, DOI 10.1007/s00221-014-4082-y; Cicek M, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.007.2009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dambeck N, 2006, BRAIN RES, V1072, P194, DOI 10.1016/j.brainres.2005.05.075; Dellatolas G, 1996, COGNITIVE BRAIN RES, V4, P49, DOI 10.1016/0926-6410(96)00019-5; Dodds CM, 2008, NEUROPSYCHOLOGY, V22, P545, DOI 10.1037/0894-4105.22.4.545; Driver J, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P589; Dufour A, 2007, EXP BRAIN RES, V176, P532, DOI 10.1007/s00221-006-0810-2; Ferre ER, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00660; Fimm B, 2006, NEUROPSYCHOLOGIA, V44, P1261, DOI 10.1016/j.neuropsychologia.2006.01.027; Fink GR, 2000, NEUROLOGY, V54, P1324, DOI 10.1212/WNL.54.6.1324; Foulsham T, 2013, VISION RES, V78, P14, DOI 10.1016/j.visres.2012.12.001; Friedrich Trista E, 2014, Cult Brain, V2, P161; Gamberini L, 2008, NEUROPSYCHOLOGIA, V46, P1298, DOI 10.1016/j.neuropsychologia.2007.12.016; Green DM, 1966, SIGNAL DETECTION THE; Halligan PW, 2003, TRENDS COGN SCI, V7, P125, DOI 10.1016/S1364-6613(03)00032-9; HALLIGAN PW, 1989, COGNITIVE NEUROPSYCH, V6, P423, DOI 10.1080/02643298908253291; Harvey M, 2002, NEUROPSYCHOLOGIA, V40, P705, DOI 10.1016/S0028-3932(01)00189-0; Harvey M, 2000, NEUROPSYCHOLOGIA, V38, P22, DOI 10.1016/S0028-3932(99)00055-X; Heber IA, 2010, BRAIN COGNITION, V73, P160, DOI 10.1016/j.bandc.2010.04.006; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Kerkhoff G, 2001, PROG NEUROBIOL, V63, P1, DOI 10.1016/S0301-0082(00)00028-9; Kinsbourne M, 1970, Trans Am Neurol Assoc, V95, P143; Kinsbourne M, 1977, Adv Neurol, V18, P41; Learmonth G, 2015, NEUROPSYCHOLOGIA, V74, P108, DOI 10.1016/j.neuropsychologia.2015.01.037; Loftus AM, 2012, NEUROPSYCHOLOGIA, V50, P2573, DOI 10.1016/j.neuropsychologia.2012.07.003; Loftus AM, 2009, CORTEX, V45, P537, DOI 10.1016/j.cortex.2007.12.011; Longo MR, 2007, EXP BRAIN RES, V177, P285, DOI 10.1007/s00221-007-0855-x; Longo MR, 2015, NEUROPSYCHOLOGIA, V70, P350, DOI 10.1016/j.neuropsychologia.2014.10.035; Longo MR, 2010, BRAIN COGNITION, V72, P362, DOI 10.1016/j.bandc.2009.10.016; Longo MR, 2006, NEUROPSYCHOLOGIA, V44, P977, DOI 10.1016/j.neuropsychologia.2005.09.003; Lourenco SF, 2011, COGNITION, V119, P448, DOI 10.1016/j.cognition.2011.02.009; Lourenco SF, 2009, COGNITION, V112, P451, DOI 10.1016/j.cognition.2009.05.011; LUH KE, 1995, NEUROPSYCHOLOGY, V9, P435, DOI 10.1037/0894-4105.9.4.435; Macmillan NA, 2005, DETECTION THEORY USE; Manly T, 2005, NEUROPSYCHOLOGIA, V43, P1721, DOI 10.1016/j.neuropsychologia.2005.02.009; MANNING L, 1990, NEUROPSYCHOLOGIA, V28, P647, DOI 10.1016/0028-3932(90)90119-9; Matthias E, 2010, J EXP PSYCHOL HUMAN, V36, P38, DOI 10.1037/a0017602; Mattingley JB, 2004, NEUROPSYCHOLOGIA, V42, P387, DOI 10.1016/j.neuropsychologia.2003.07.007; MATTINGLEY JB, 1992, BRAIN, V115, P1849, DOI 10.1093/brain/115.6.1849; MATTINGLEY JB, 1994, NEUROPSYCHOLOGIA, V32, P805, DOI 10.1016/0028-3932(94)90019-1; McCourt ME, 2001, BRAIN COGNITION, V45, P52, DOI 10.1006/brcg.2000.1255; McCourt ME, 2001, NEUROPSYCHOLOGIA, V39, P1065, DOI 10.1016/S0028-3932(01)00044-6; McCourt ME, 1999, NEUROPSYCHOLOGIA, V37, P843, DOI 10.1016/S0028-3932(98)00140-7; McCourt ME, 2000, FRONT BIOSCI, V5, pD58; Meinhardt G, 2002, EXP BRAIN RES, V142, P539, DOI 10.1007/s00221-001-0945-0; MILNER AD, 1993, NEUROPSYCHOLOGIA, V31, P39, DOI 10.1016/0028-3932(93)90079-F; MILNER AD, 1992, NEUROPSYCHOLOGIA, V30, P515, DOI 10.1016/0028-3932(92)90055-Q; Monaghan P, 2004, PSYCHOL REV, V111, P283, DOI 10.1037/0033-295X.111.2.283; Newman DP, 2013, NEUROPSYCHOLOGIA, V51, P1215, DOI 10.1016/j.neuropsychologia.2013.03.027; Nicholls MER, 2002, CORTEX, V38, P113, DOI 10.1016/S0010-9452(08)70645-2; Nicholls MER, 1999, NEUROPSYCHOLOGIA, V37, P307, DOI 10.1016/S0028-3932(98)00074-8; Nicholls MER, 2014, ERGONOMICS, V57, P876, DOI 10.1080/00140139.2014.899633; Niemeier M, 2008, EXP BRAIN RES, V189, P411, DOI 10.1007/s00221-008-1438-1; Niemeier M, 2008, BRAIN COGNITION, V67, P115, DOI 10.1016/j.bandc.2007.12.002; Niemeier M, 2007, NEUROPSYCHOLOGIA, V45, P1029, DOI 10.1016/j.neuropsychologia.2006.09.006; Okubo M, 2006, EXP BRAIN RES, V172, P49, DOI 10.1007/s00221-005-0303-8; PELLI DG, 1987, VISION RES, V27, P119, DOI 10.1016/0042-6989(87)90148-9; PELLI DG, 1985, J OPT SOC AM A, V2, P1508, DOI 10.1364/JOSAA.2.001508; Perez A, 2008, PSICOLOGICA, V29, P35; Perez A, 2009, NEUROPSYCHOLOGIA, V47, P41, DOI 10.1016/j.neuropsychologia.2008.08.017; RAPCSAK SZ, 1989, ARCH NEUROL-CHICAGO, V46, P178, DOI 10.1001/archneur.1989.00520380082018; REUTERLORENZ PA, 1990, BRAIN COGNITION, V12, P240, DOI 10.1016/0278-2626(90)90018-J; Romei V, 2010, J NEUROSCI, V30, P8692, DOI 10.1523/JNEUROSCI.0160-10.2010; Rueckert L, 2002, NEUROPSYCHOLOGIA, V40, P162, DOI 10.1016/S0028-3932(01)00082-3; Russell C, 2013, CORTEX, V49, P1874, DOI 10.1016/j.cortex.2012.10.005; SERGENT J, 1982, J EXP PSYCHOL HUMAN, V8, P253, DOI 10.1037/0096-1523.8.2.253; Singh VVW, 2011, CORTEX, V47, P547, DOI 10.1016/j.cortex.2010.03.006; Sparing R, 2009, BRAIN, V132, P3011, DOI 10.1093/brain/awp154; Thiebaut de Schotten M, 2011, NAT NEUROSCI, V14, P1245, DOI 10.1038/nn.2905; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Tomer R, 2008, NEUROPSYCHOLOGIA, V46, P2064, DOI 10.1016/j.neuropsychologia.2008.02.005; Tomer R, 2013, CEREB CORTEX, V23, P2899, DOI 10.1093/cercor/bhs277; Varnava A, 2002, NEUROPSYCHOLOGIA, V40, P1372, DOI 10.1016/S0028-3932(01)00204-4; Varnava A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065851; Verdon V, 2010, BRAIN, V133, P880, DOI 10.1093/brain/awp305; Vuilleumier P, 2007, J COGNITIVE NEUROSCI, V19, P1388, DOI 10.1162/jocn.2007.19.8.1388; WILSON B, 1987, ARCH PHYS MED REHAB, V68, P98	93	40	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138379	10.1371/journal.pone.0138379	http://dx.doi.org/10.1371/journal.pone.0138379			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378925	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000361769400092
J	Matson, DJ; Hamamoto, DT; Bregman, H; Cooke, M; DiMauro, EF; Huang, LY; Johnson, D; Li, XW; McDermott, J; Morgan, C; Wilenkin, B; Malmberg, AB; McDonough, SI; Simone, DA				Matson, David J.; Hamamoto, Darryl T.; Bregman, Howard; Cooke, Melanie; DiMauro, Erin F.; Huang, Liyue; Johnson, Danielle; Li, Xingwen; McDermott, Jeff; Morgan, Carrie; Wilenkin, Ben; Malmberg, Annika B.; McDonough, Stefan I.; Simone, Donald A.			Inhibition of Inactive States of Tetrodotoxin-Sensitive Sodium Channels Reduces Spontaneous Firing of C-Fiber Nociceptors and Produces Analgesia in Formalin and Complete Freund's Adjuvant Models of Pain	PLOS ONE			English	Article							OF-FUNCTION MUTATIONS; INFLAMMATORY PAIN; NEUROPATHIC PAIN; SLOW-INACTIVATION; DORSAL-HORN; DRG NEURONS; NA(V)1.7; RAT; EXPRESSION; INJURY	While genetic evidence shows that the Nav1.7 voltage-gated sodium ion channel is a key regulator of pain, it is unclear exactly how Nav1.7 governs neuronal firing and what biophysical, physiological, and distribution properties of a pharmacological Nav1.7 inhibitor are required to produce analgesia. Here we characterize a series of aminotriazine inhibitors of Nav1.7 in vitro and in rodent models of pain and test the effects of the previously reported "compound 52" aminotriazine inhibitor on the spiking properties of nociceptors in vivo. Multiple aminotriazines, including some with low terminal brain to plasma concentration ratios, showed analgesic efficacy in the formalin model of pain. Effective concentrations were consistent with the in vitro potency as measured on partially-inactivated Nav1.7 but were far below concentrations required to inhibit non-inactivated Nav1.7. Compound 52 also reversed thermal hyperalgesia in the complete Freund's adjuvant (CFA) model of pain. To study neuronal mechanisms, electrophysiological recordings were made in vivo from single nociceptive fibers from the rat tibial nerve one day after CFA injection. Compound 52 reduced the spontaneous firing of C-fiber nociceptors from approximately 0.7 Hz to 0.2 Hz and decreased the number of action potentials evoked by suprathreshold tactile and heat stimuli. It did not, however, appreciably alter the C-fiber thresholds for response to tactile or thermal stimuli. Surprisingly, compound 52 did not affect spontaneous activity or evoked responses of Ad-fiber nociceptors. Results suggest that inhibition of inactivated states of TTX-S channels, mostly likely Nav1.7, in the peripheral nervous system produces analgesia by regulating the spontaneous discharge of C-fiber nociceptors.	[Matson, David J.; Johnson, Danielle; McDermott, Jeff; Wilenkin, Ben; Malmberg, Annika B.; McDonough, Stefan I.] Amgen Inc, Dept Neurosci, Cambridge, MA 02141 USA; [Bregman, Howard; DiMauro, Erin F.] Amgen Inc, Dept Med Chem, Cambridge, MA USA; [Cooke, Melanie; Morgan, Carrie] Amgen Inc, Dept Pharmaceut Res & Dev, Cambridge, MA USA; [Huang, Liyue; Li, Xingwen] Amgen Inc, Dept Pharmacokinet & Drug Metab, Cambridge, MA USA; [Hamamoto, Darryl T.; Simone, Donald A.] Univ Minnesota, Sch Dent, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA	Amgen; Amgen; Amgen; Amgen; University of Minnesota System; University of Minnesota Twin Cities	McDonough, SI (corresponding author), Amgen Inc, Dept Neurosci, Cambridge, MA 02141 USA.	stefanm@amgen.com		McDermott, Jeff/0000-0002-6362-3307	Amgen Inc.	Amgen Inc.(Amgen)	Authors DJM, HB, MC, EFD, LH, DJ, XL, JM, CM, BW, ABM, and SIM were Amgen employees at the time the work was performed. This work was fully supported by Amgen Inc. Amgen Inc. provided support in the form of salaries for these authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Amaya F, 2006, J NEUROSCI, V26, P12852, DOI 10.1523/JNEUROSCI.4015-06.2006; Andrew D, 1999, J NEUROPHYSIOL, V82, P2649, DOI 10.1152/jn.1999.82.5.2649; Bagal SK, 2014, BIOORG MED CHEM LETT, V24, P3690, DOI 10.1016/j.bmcl.2014.06.038; Baker MD, 2012, J PHYSIOL-LONDON, V590, P1513, DOI 10.1113/jphysiol.2011.224436; Black JA, 2004, PAIN, V108, P237, DOI 10.1016/j.pain.2003.12.035; Black JA, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-82; Bregman H, 2011, J MED CHEM, V54, P4427, DOI 10.1021/jm200018k; Catterall WA, 2012, J PHYSIOL-LONDON, V590, P2577, DOI 10.1113/jphysiol.2011.224204; Chapman ML, 2012, SOC NEUR ANN M NEW O; Cheng XD, 2011, PROG MOL BIOL TRANSL, V101, P1, DOI 10.1016/B978-0-12-387685-0.00001-9; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; De Col Roberto, 2012, J Physiol, V590, P725, DOI 10.1113/jphysiol.2011.220624; Dib-Hajj SD, 1999, PAIN, V83, P591, DOI 10.1016/S0304-3959(99)00169-4; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; DICKENSON AH, 1987, PAIN, V30, P349, DOI 10.1016/0304-3959(87)90023-6; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Djouhri L, 2006, J NEUROSCI, V26, P1281, DOI 10.1523/JNEUROSCI.3388-05.2006; Dubin AE, 2010, J CLIN INVEST, V120, P3760, DOI 10.1172/JCI42843; Estacion M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-92; Faber CG, 2012, ANN NEUROL, V71, P26, DOI 10.1002/ana.22485; Fertleman CR, 2007, NEUROLOGY, V69, P586, DOI 10.1212/01.wnl.0000268065.16865.5f; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; Gee MD, 1996, NEUROSCIENCE, V73, P667, DOI 10.1016/0306-4522(96)00070-X; Gingras J, 2014, PLOS ONE IN PRESS; Goldberg YP, 2007, CLIN GENET, V71, P311, DOI 10.1111/j.1399-0004.2007.00790.x; Goldberg YP, 2012, CLIN GENET, V82, P367, DOI 10.1111/j.1399-0004.2012.01942.x; Goldberg YP, 2012, PAIN, V153, P80, DOI 10.1016/j.pain.2011.09.008; Han C, 2012, NEUROLOGY, V78, P1635, DOI 10.1212/WNL.0b013e3182574f12; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hirschberg B, 1995, J GEN PHYSIOL, V106, P1053, DOI 10.1085/jgp.106.6.1053; Jo S, 2011, MOL PHARMACOL, V80, P247, DOI 10.1124/mol.110.070276; Jukic M, 2014, CURR MED CHEM, V21, P164; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Lee JH, 2014, CELL, V157, P1393, DOI 10.1016/j.cell.2014.03.064; LEEM JW, 1993, J NEUROPHYSIOL, V70, P2411, DOI 10.1152/jn.1993.70.6.2411; Leo S, 2010, BEHAV BRAIN RES, V208, P149, DOI 10.1016/j.bbr.2009.11.023; Luo S, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-16; Macsari I, 2012, J MED CHEM, V55, P6866, DOI 10.1021/jm300623u; McGowan E, 2009, ANESTH ANALG, V109, P951, DOI 10.1213/ane.0b013e3181b01b02; Morinville A, 2007, J COMP NEUROL, V504, P680, DOI 10.1002/cne.21484; Nardi A, 2012, CHEMMEDCHEM, V7, P1712, DOI 10.1002/cmdc.201200298; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Nassar MA, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-33; Priest BT, 2009, CURR OPIN DRUG DISC, V12, P682; Saab CY, 2012, TRENDS NEUROSCI, V35, P629, DOI 10.1016/j.tins.2012.06.002; Scadding J. W., 2013, WALL MELZACKS TXB PA, P926, DOI DOI 10.1016/B0-443-07287-6/50067-9; Schmalhofer WA, 2008, MOL PHARMACOL, V74, P1476, DOI 10.1124/mol.108.047670; Serra J, 1999, J PHYSIOL-LONDON, V515, P799, DOI 10.1111/j.1469-7793.1999.799ab.x; Shields SD, 2012, J NEUROSCI, V32, P10819, DOI 10.1523/JNEUROSCI.0304-12.2012; Theile JW, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00054; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Watson J, 2009, DRUG METAB DISPOS, V37, P753, DOI 10.1124/dmd.108.022814; WAXMAN SG, 1994, J NEUROPHYSIOL, V72, P466, DOI 10.1152/jn.1994.72.1.466; Waxman SG, 2012, J PHYSIOL-LONDON, V590, P2601, DOI 10.1113/jphysiol.2012.228460; Weiss J, 2011, NATURE, V472, P186, DOI 10.1038/nature09975	56	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138140	10.1371/journal.pone.0138140	http://dx.doi.org/10.1371/journal.pone.0138140			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379236	Green Published, gold, Green Submitted			2022-12-27	WOS:000361769400060
J	Bierle, LA; Reich, KL; Taylor, BE; Blatt, EB; Middleton, SM; Burke, SD; Stultz, LK; Hanson, PK; Partridge, JF; Miller, ME				Bierle, Lindsey A.; Reich, Kira L.; Taylor, Braden E.; Blatt, Eliot B.; Middleton, Sydney M.; Burke, Shawnecca D.; Stultz, Laura K.; Hanson, Pamela K.; Partridge, Janet F.; Miller, Mary E.			DNA Damage Response Checkpoint Activation Drives KP1019 Dependent Pre-Anaphase Cell Cycle Delay in S-cerevisiae	PLOS ONE			English	Article							RUTHENIUM COMPLEX KP1019; BUDDING YEAST RAD9; MITOTIC SPINDLE; GENE-EXPRESSION; COLORECTAL-CARCINOMA; ANTICANCER AGENT; OXIDATIVE STRESS; MEC1 PATHWAY; CROSS-LINKS; PHASE-I	Careful regulation of the cell cycle is required for proper replication, cell division, and DNA repair. DNA damage-including that induced by many anticancer drugs-results in cell cycle delay or arrest, which can allow time for repair of DNA lesions. Although its molecular mechanism of action remains a matter of debate, the anticancer ruthenium complex KP1019 has been shown to bind DNA in biophysical assays and to damage DNA of colorectal and ovarian cancer cells in vitro. KP1019 has also been shown to induce mutations and induce cell cycle arrest in Saccharomyces cerevisiae, suggesting that budding yeast can serve as an appropriate model for characterizing the cellular response to the drug. Here we use a transcriptomic approach to verify that KP1019 induces the DNA damage response (DDR) and find that KP1019 dependent expression of HUG1 requires the Dun1 checkpoint; both consistent with KP1019 DDR in budding yeast. We observe a robust KP1019 dependent delay in cell cycle progression as measured by increase in large budded cells, 2C DNA content, and accumulation of Pds1 which functions to inhibit anaphase. Importantly, we also find that deletion of RAD9, a gene required for the DDR, blocks drug-dependent changes in cell cycle progression, thereby establishing a causal link between the DDR and phenotypes induced by KP1019. Interestingly, yeast treated with KP1019 not only delay in G2/M, but also exhibit abnormal nuclear position, wherein the nucleus spans the bud neck. This morphology correlates with short, misaligned spindles and is dependent on the dynein heavy chain gene DYN1. We find that KP1019 creates an environment where cells respond to DNA damage through nuclear (transcriptional changes) and cytoplasmic (motor protein activity) events.	[Bierle, Lindsey A.; Miller, Mary E.] Rhodes Coll, Dept Biol, Memphis, TN 38112 USA; [Reich, Kira L.; Taylor, Braden E.; Blatt, Eliot B.; Burke, Shawnecca D.; Miller, Mary E.] Rhodes Coll, Program Biochem & Mol Biol, Memphis, TN 38112 USA; [Middleton, Sydney M.; Hanson, Pamela K.] Birmingham Southern Coll, Dept Biol, Birmingham, AL USA; [Stultz, Laura K.] Birmingham Southern Coll, Dept Chem, Birmingham, AL USA; [Partridge, Janet F.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Miller, ME (corresponding author), Rhodes Coll, Dept Biol, Memphis, TN 38112 USA.	millerm@rhodes.edu	Partridge, Janet/M-9352-2018	Partridge, Janet/0000-0003-1102-6305; Stultz, Laura/0000-0002-2901-5949; Hanson, Pamela/0000-0002-9312-1682	Cancer Center support grant [CCSG 2 P30 CA21765]; ALSAC (American Lebanese Syrian Associated Charities) of St. Jude Children's Research Hospital, Rhodes College J. T. and V. B. Robertson Chair of Biological Sciences; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	Cancer Center support grant; ALSAC (American Lebanese Syrian Associated Charities) of St. Jude Children's Research Hospital, Rhodes College J. T. and V. B. Robertson Chair of Biological Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Cancer Center support grant [CCSG 2 P30 CA21765 to St. Jude] (JFP) and by ALSAC (American Lebanese Syrian Associated Charities) of St. Jude Children's Research Hospital (JFP), Rhodes College J. T. and V. B. Robertson Chair of Biological Sciences (MEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Ainsworth WB, 2013, BIOCHEM BIOPH RES CO, V439, P443, DOI 10.1016/j.bbrc.2013.08.089; Alagesan M, 2014, DALTON T, V43, P15829, DOI 10.1039/c4dt01032a; Badin-Larcon AC, 2004, P NATL ACAD SCI USA, V101, P5577, DOI 10.1073/pnas.0307917101; Basrai MA, 1999, MOL CELL BIOL, V19, P7041; Beljanski V, 2004, MOL PHARMACOL, V65, P1496, DOI 10.1124/mol.65.6.1496; BERGER MR, 1989, ANTICANCER RES, V9, P761; Birrell GW, 2002, P NATL ACAD SCI USA, V99, P8778, DOI 10.1073/pnas.132275199; Blankley RT, 2004, J CELL SCI, V117, P601, DOI 10.1242/jcs.00907; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Caba E, 2005, MUTAT RES-FUND MOL M, V575, P34, DOI 10.1016/j.mrfmmm.2005.02.005; Carmelo V, 1997, FEMS MICROBIOL LETT, V149, P85, DOI 10.1016/S0378-1097(97)00059-1; Carter CD, 2005, MOL CELL BIOL, V25, P10273, DOI 10.1128/MCB.25.23.10273-10285.2005; Caydasi AK, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-28; Chen SH, 2007, J BIOL CHEM, V282, P986, DOI 10.1074/jbc.M609322200; Cohen-Fix O, 1997, P NATL ACAD SCI USA, V94, P14361, DOI 10.1073/pnas.94.26.14361; Collins ES, 2012, MOL BIOL CELL, V23, P3380, DOI 10.1091/mbc.E12-02-0109; Demeter J, 2000, MOL CELL, V6, P487, DOI 10.1016/S1097-2765(00)00047-2; Dolz-Edo L, 2013, MOL CELL BIOL, V33, P2228, DOI 10.1128/MCB.00240-13; Dotiwala F, 2007, P NATL ACAD SCI USA, V104, P11358, DOI 10.1073/pnas.0609636104; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Emili A, 1998, MOL CELL, V2, P183, DOI 10.1016/S1097-2765(00)80128-8; ENDOICHIKAWA Y, 1995, BIOCHEM PHARMACOL, V50, P1695, DOI 10.1016/0006-2952(95)02071-3; ESHEL D, 1993, P NATL ACAD SCI USA, V90, P11172, DOI 10.1073/pnas.90.23.11172; Fasullo M, 1999, GENETICS, V152, P909; Finn K, 2012, CELL MOL LIFE SCI, V69, P1447, DOI 10.1007/s00018-011-0875-3; Garay-Arroyo A, 1999, YEAST, V15, P879, DOI 10.1002/(SICI)1097-0061(199907)15:10A<879::AID-YEA428>3.3.CO;2-H; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2; Grossmann KF, 1999, MUTAT RES-DNA REPAIR, V434, P29, DOI 10.1016/S0921-8777(99)00011-7; Grossmann KF, 2000, MUTAT RES-DNA REPAIR, V461, P1, DOI 10.1016/S0921-8777(00)00035-5; Haase Steven B, 2004, Curr Protoc Cytom, VChapter 7, DOI 10.1002/0471142956.cy0723s26; Hartinger CG, 2008, CHEM BIODIVERS, V5, P2140, DOI 10.1002/cbdv.200890195; Hartinger CG, 2006, J INORG BIOCHEM, V100, P891, DOI 10.1016/j.jinorgbio.2006.02.013; Heffeter P, 2005, J PHARMACOL EXP THER, V312, P281, DOI 10.1124/jpet.104.073395; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Jaehnig EJ, 2013, CELL REP, V4, P174, DOI 10.1016/j.celrep.2013.05.041; Kapitza S, 2005, CANCER LETT, V226, P115, DOI 10.1016/j.canlet.2005.01.002; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kimura Akiko, 2006, Journal of Toxicological Sciences, V31, P287, DOI 10.2131/jts.31.287; Kiyomitsu T, 2012, NAT CELL BIOL, V14, P311, DOI 10.1038/ncb2440; Klinkenberg LG, 2006, EUKARYOT CELL, V5, P1007, DOI 10.1128/EC.00045-06; Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266; Kotak S, 2012, J CELL BIOL, V199, P97, DOI 10.1083/jcb.201203166; Lee SJ, 2003, MOL CELL BIOL, V23, P6300, DOI 10.1128/MCB.23.17.6300-6314.2003; Lentz F, 2009, ANTI-CANCER DRUG, V20, P97, DOI 10.1097/CAD.0b013e328322fbc5; LI YY, 1993, P NATL ACAD SCI USA, V90, P10096, DOI 10.1073/pnas.90.21.10096; Lieberman HB, 2006, J CELL BIOCHEM, V97, P690, DOI 10.1002/jcb.20759; Malina J, 2001, J BIOL INORG CHEM, V6, P435, DOI 10.1007/s007750100223; Mialhe A, 2001, CANCER RES, V61, P5024; Moore JK, 2009, CELL MOTIL CYTOSKEL, V66, P546, DOI 10.1002/cm.20364; Ouspenski II, 1999, NUCLEIC ACIDS RES, V27, P3001, DOI 10.1093/nar/27.15.3001; Pearson CG, 2003, MOL BIOL CELL, V14, P4181, DOI 10.1091/mbc.e03-03-0180; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Rep M, 2001, MOL MICROBIOL, V40, P1067, DOI 10.1046/j.1365-2958.2001.02384.x; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Schluga P, 2006, DALTON T, P1796, DOI 10.1039/b511792e; Schumacher DM, 2006, TOXICOL LETT, V166, P268, DOI 10.1016/j.toxlet.2006.08.002; SEELIG MH, 1992, J CANCER RES CLIN, V118, P195, DOI 10.1007/BF01410134; Sertic S, 2012, CELL CYCLE, V11, P668, DOI 10.4161/cc.11.4.19117; Singh V, 2014, EUR J PHARMACOL, V736, P77, DOI 10.1016/j.ejphar.2014.04.032; Singh V, 2014, FEBS LETT, V588, P1044, DOI 10.1016/j.febslet.2014.02.017; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; Smolka MB, 2005, MOL CELL PROTEOMICS, V4, P1358, DOI 10.1074/mcp.M500115-MCP200; Soulier J, 1999, CURR BIOL, V9, P551, DOI 10.1016/S0960-9822(99)80242-5; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stevens SK, 2013, MOL PHARMACOL, V83, P225, DOI 10.1124/mol.112.079657; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Sun ZX, 1998, SCIENCE, V281, P272, DOI 10.1126/science.281.5374.272; SUSEK RE, 1990, MOL CELL BIOL, V10, P6362, DOI 10.1128/MCB.10.12.6362; Suzuki M, 2004, NAT CELL BIOL, V6, P861, DOI 10.1038/ncb1162; Sweeney FD, 2005, CURR BIOL, V15, P1364, DOI 10.1016/j.cub.2005.06.063; Sweet TJ, 2007, RNA, V13, P493, DOI 10.1261/rna.355807; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tinker-Kulberg RL, 1999, GENE DEV, V13, P1936, DOI 10.1101/gad.13.15.1936; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; Toh GWL, 2003, BIOCHEM SOC T, V31, P242, DOI 10.1042/bst0310242; van den Bosch M, 2004, CELL CYCLE, V3, P119; Vialard JE, 1998, EMBO J, V17, P5679, DOI 10.1093/emboj/17.19.5679; Vido K, 2001, J BIOL CHEM, V276, P8469, DOI 10.1074/jbc.M008708200; Wang YC, 2003, CELL, V112, P697, DOI 10.1016/S0092-8674(03)00121-1; Warringer J, 2006, YEAST, V23, P389, DOI 10.1002/yea.1363; Winey M, 2012, GENETICS, V190, P1197, DOI 10.1534/genetics.111.128710; Woodard GE, 2010, MOL CELL BIOL, V30, P3519, DOI 10.1128/MCB.00394-10; Yeh E, 2000, MOL BIOL CELL, V11, P3949, DOI 10.1091/mbc.11.11.3949	88	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138085	10.1371/journal.pone.0138085	http://dx.doi.org/10.1371/journal.pone.0138085			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375390	Green Published, Green Submitted, gold			2022-12-27	WOS:000361610200075
J	Bordehore, C; Fuentes, VL; Segarra, JG; Acevedo, M; Canepa, A; Raventos, J				Bordehore, Cesar; Fuentes, Veronica L.; Segarra, Jose G.; Acevedo, Melisa; Canepa, Antonio; Raventos, Josep			Use of an Inverse Method for Time Series to Estimate the Dynamics of and Management Strategies for the Box Jellyfish Carybdea marsupialis	PLOS ONE			English	Article							POPULATION-DYNAMICS; PARTIAL-PURIFICATION; CNIDARIA; CUBOZOA; GROWTH; AGE	Frequently, population ecology of marine organisms uses a descriptive approach in which their sizes and densities are plotted over time. This approach has limited usefulness for design strategies in management or modelling different scenarios. Population projection matrix models are among the most widely used tools in ecology. Unfortunately, for the majority of pelagic marine organisms, it is difficult to mark individuals and follow them over time to determine their vital rates and built a population projection matrix model. Nevertheless, it is possible to get time-series data to calculate size structure and densities of each size, in order to determine the matrix parameters. This approach is known as a "demographic inverse problem" and it is based on quadratic programming methods, but it has rarely been used on aquatic organisms. We used unpublished field data of a population of cubomedusae Carybdea marsupialis to construct a population projection matrix model and compare two different management strategies to lower population to values before year 2008 when there was no significant interaction with bathers. Those strategies were by direct removal of medusae and by reducing prey. Our results showed that removal of jellyfish from all size classes was more effective than removing only juveniles or adults. When reducing prey, the highest efficiency to lower the C. marsupialis population occurred when prey depletion affected prey of all medusae sizes. Our model fit well with the field data and may serve to design an efficient management strategy or build hypothetical scenarios such as removal of individuals or reducing prey. TThis This sdfsdshis method is applicable to other marine or terrestrial species, for which density and population structure over time are available.	[Bordehore, Cesar; Segarra, Jose G.; Raventos, Josep] Univ Alicante, Dept Ecol, E-03080 Alicante, Spain; [Bordehore, Cesar; Segarra, Jose G.; Raventos, Josep] Univ Alicante, Multidisciplinary Inst Environm Studies Ramon Mar, E-03080 Alicante, Spain; [Fuentes, Veronica L.; Acevedo, Melisa; Canepa, Antonio] CSIC, Inst Marine Sci, Barcelona, Spain	Universitat d'Alacant; Universitat d'Alacant; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Bordehore, C (corresponding author), Univ Alicante, Dept Ecol, E-03080 Alicante, Spain.	cesar.bordehore@ua.es	Fuentes, Verónica L/K-7589-2014; Bordehore, Cesar/H-2773-2014; Canepa, Antonio/R-5260-2018	Fuentes, Verónica L/0000-0002-6380-0174; Bordehore, Cesar/0000-0002-2816-0538; Canepa, Antonio/0000-0002-0608-2743	European Commission [LIFE 08 NAT ES 0064]; Ministerio de Agricultura, Alimentacion y Medio Ambiente; Direccion General del Agua of the Regional Government of Valencia; Fundacion Biodiversidad; Spanish Ministry of Education and Science; FEDER program [CGL2012-31668]	European Commission(European CommissionEuropean Commission Joint Research Centre); Ministerio de Agricultura, Alimentacion y Medio Ambiente; Direccion General del Agua of the Regional Government of Valencia; Fundacion Biodiversidad(European Commission); Spanish Ministry of Education and Science(Spanish Government); FEDER program(European Commission)	This research was carried out under contract LIFE 08 NAT ES 0064 (to CB and VLF) co-financed by the European Commission (www.cubomed.eu), the Ministerio de Agricultura, Alimentacion y Medio Ambiente, the Direccion General del Agua of the Regional Government of Valencia and the Fundacion Biodiversidad. This work was also partially supported by Spanish Ministry of Education and Science co-funded by FEDER program (CGL2012-31668) to JR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo MJ, 2012, INT S MAR SCI ISMS; Ballesteros BJ, 2007, DETERMINACION RELACI, P241; Bentlage B, 2010, P ROY SOC B-BIOL SCI, V277, P493, DOI 10.1098/rspb.2009.1707; Boero F., 1986, Bollettino del Museo Civico di Storia Naturale di Venezia, V35, P179; Boero F, 2013, FAO FISHERIES REPORT, V92, P64; Bordehore C, 2011, MAR BIODIVERS REC, V4, P1, DOI [10.1017/S1755267211000650, DOI 10.1017/S1755267211000650]; Bordehore C, 2015, J TRAVEL MED, V22, P61, DOI 10.1111/jtm.12153; Brinkman D, 2008, TOXICON, V51, P853, DOI 10.1016/j.toxicon.2007.12.017; Brinkman DL, 2009, TOXICON, V54, P1162, DOI 10.1016/j.toxicon.2009.02.006; Cantoral-Uiza EA, 2001, LIMNETICA, V20, P159; Carrette T, 2002, TOXICON, V40, P1547, DOI 10.1016/S0041-0101(02)00168-X; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed., P713; Crone EE, 2011, ECOL LETT, V14, P1, DOI 10.1111/j.1461-0248.2010.01540.x; Erwin S, 2013, J PLANT ECOL, V6, P150, DOI 10.1093/jpe/rts024; Gershwin LA, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1168; Gordon M, 2004, HYDROBIOLOGIA, V530, P339, DOI 10.1007/s10750-004-2655-7; HUGHES TP, 1984, AM NAT, V123, P778, DOI 10.1086/284239; Katsanevakis S, 2006, ICES J MAR SCI, V63, P151, DOI 10.1016/j.icesjms.2005.07.004; Kingsford MJ, 2012, HYDROBIOLOGIA, V690, P257, DOI 10.1007/s10750-012-1041-0; KOKELJ F, 1992, CONTACT DERMATITIS, V27, P195, DOI 10.1111/j.1600-0536.1992.tb05259.x; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Lewis C, 2005, MAR BIOL, V147, P477, DOI 10.1007/s00227-005-1602-0; Lippmann JM, 2011, J TRAVEL MED, V18, P275, DOI 10.1111/j.1708-8305.2011.00531.x; MALEJ A, 1992, OLSEN INT S, P215; Mayo Rios RJ, 2010, OPTIMIZACION ESTACIO, P141; Milla L, 2008, DERMARTOLOGIA REV ME, V44, P167; MOLLER H, 1984, SCIENCE, V224, P621, DOI 10.1126/science.224.4649.621; Neubert MG, 2000, ECOLOGY, V81, P1613, DOI 10.1890/0012-9658(2000)081[1613:DADCAS]2.0.CO;2; Nilsson DE, 2005, NATURE, V435, P201, DOI 10.1038/nature03484; Nogueira M, 2008, BRAZ J OCEANOGR, V56, P157, DOI 10.1590/S1679-87592008000300001; Ortiz-Perez S, 2005, ESTUDIO ALTERNATIVO, P48; Palomares MLD, 2009, HYDROBIOLOGIA, V616, P11, DOI 10.1007/s10750-008-9582-y; Perez-Ruzafa A, 2002, HYDROBIOLOGIA, V475, P359, DOI 10.1023/A:1020343510060; Philippart CJM, 2007, ECOSYSTEMS, V10, P95, DOI 10.1007/s10021-006-9006-7; Purcell JE, 2001, HYDROBIOLOGIA, V451, P27, DOI 10.1023/A:1011883905394; Sanchez-Rodriguez J, 2006, ARCH TOXICOL, V80, P163, DOI 10.1007/s00204-005-0023-7; Straehler-Pohl I, 2005, MAR BIOL, V147, P1271, DOI 10.1007/s00227-005-0031-4; Studebaker JP, 1972, THESIS, P86; Tibballs J, 2006, TOXICON, V48, P830, DOI 10.1016/j.toxicon.2006.07.020; Verity PG, 2002, ENVIRON CONSERV, V29, P207, DOI 10.1017/S0376892902000139; Willcox S, 2008, MAR BIOL, V154, P661, DOI 10.1007/s00227-008-0959-2; Wood S.N., 1997, Population and Community Biology Series, V18, P555	42	5	5	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137272	10.1371/journal.pone.0137272	http://dx.doi.org/10.1371/journal.pone.0137272			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376483	Green Published, gold, Green Submitted			2022-12-27	WOS:000361610200033
J	Grigoriev, P; Andreev, EM				Grigoriev, Pavel; Andreev, Evgeny M.			The Huge Reduction in Adult Male Mortality in Belarus and Russia: Is It Attributable to Anti-Alcohol Measures?	PLOS ONE			English	Article							NATIONAL ALCOHOL POLICY; TIME-SERIES ANALYSIS; PREMATURE MORTALITY; EASTERN-EUROPE; HEART-DISEASE; CONSUMPTION; DRINKING; TRENDS; CRISIS; HEAVY	Background and Aim Harmful alcohol consumption has long been recognized as being the major determinant of male premature mortality in the European countries of the former USSR. Our focus here is on Belarus and Russia, two Slavic countries which continue to suffer enormously from the burden of the harmful consumption of alcohol. However, after a long period of deterioration, mortality trends in these countries have been improving over the past decade. We aim to investigate to what extent the recent declines in adult mortality in Belarus and Russia are attributable to the anti-alcohol measures introduced in these two countries in the 2000s. Data and Methods We rely on the detailed cause-specific mortality series for the period 1980-2013. Our analysis focuses on the male population, and considers only a limited number of causes of death which we label as being alcohol-related: accidental poisoning by alcohol, liver cirrhosis, ischemic heart diseases, stroke, transportation accidents, and other external causes. For each of these causes we computed age-standardized death rates. The life table decomposition method was used to determine the age groups and the causes of death responsible for changes in life expectancy over time. Conclusion Our results do not lead us to conclude that the schedule of anti-alcohol measures corresponds to the schedule of mortality changes. The continuous reduction in adult male mortality seen in Belarus and Russia cannot be fully explained by the anti-alcohol policies implemented in these countries, although these policies likely contributed to the large mortality reductions observed in Belarus and Russia in 2005-2006 and in Belarus in 2012. Thus, the effects of these policies appear to have been modest. We argue that the antialcohol measures implemented in Belarus and Russia simply coincided with fluctuations in alcohol-related mortality which originated in the past. If these trends had not been underway already, these huge mortality effects would not have occurred.	[Grigoriev, Pavel] Max Planck Inst Demog Res, Rostock, Germany; [Andreev, Evgeny M.] New Econ Sch, Moscow, Russia	Max Planck Society; New Economic School	Grigoriev, P (corresponding author), Max Planck Inst Demog Res, Rostock, Germany.	Grigoriev@demogr.mpg.de			'From disparities in mortality trends to future health challenges' (DIMOCHA) - 'Deutsche Forschungsgemeinschaft' (DFG); research grant 'Mortality Divergence and Causes of Death' (MODICOD) - AXA Research Fund; Fund 'Dynasty'	'From disparities in mortality trends to future health challenges' (DIMOCHA) - 'Deutsche Forschungsgemeinschaft' (DFG)(German Research Foundation (DFG)); research grant 'Mortality Divergence and Causes of Death' (MODICOD) - AXA Research Fund; Fund 'Dynasty'	PG was partially supported by research grant 'From disparities in mortality trends to future health challenges' (DIMOCHA) funded by 'Deutsche Forschungsgemeinschaft' (DFG) http://gepris.dfg.de/gepris/projekt/228989852?language = en and research grant 'Mortality Divergence and Causes of Death' (MODICOD) funded by AXA Research Fund http://www.axa-research.org/project/france-mesle. EMA was partially supported by the Fund 'Dynasty' http://www.dynastyfdn.com/programs/education/demographic_research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreev E, 2013, ALCOHOL ALCOHOLISM, V48, P215, DOI 10.1093/alcalc/ags132; Avdeev A, 1998, Popul, V10, P267; BLUM A, 1989, POP STUD-J DEMOG, V43, P211, DOI 10.1080/0032472031000144096; Brainerd E, 2005, J ECON PERSPECT, V19, P107, DOI 10.1257/0895330053147921; Cornia GA., 2000, MORTALITY CRISIS TRA, P3; Eberstadt Nicholas, 1981, INT J EPIDEMIOL, V35, P1384; Grigoriev P, 2015, EUR J PUBLIC HLTH; Grigoriev P, 2012, THESIS U ROSTOCK GER; Grigoriev P, 2012, WP2012023 M PLANCK I; Grigoriev P, 2014, POPUL DEV REV, V40, P107, DOI 10.1111/j.1728-4457.2014.00652.x; Grigoriev P, 2012, POPULATION, V67, P7; Humphreys DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055581; Khalturina DA, 2006, DEMOSKOP WKLY, V5, P265; Korotaev A, 2015, MNOGO VODKI MNOGO SM; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6; Leon DA, 2010, INT J EPIDEMIOL, V39, P1279, DOI 10.1093/ije/dyq102; Levintova M, 2007, ALCOHOL ALCOHOLISM, V42, P500, DOI 10.1093/alcalc/agm040; Lozano R, 2001, MISCODING MISCLASSIF; Malyutina S, 2002, LANCET, V360, P1448, DOI 10.1016/S0140-6736(02)11470-X; McDowall D., 1980, INTERRUPTED TIME SER; McKee M, 1998, J ROY SOC MED, V91, P402, DOI 10.1177/014107689809100802; MESLE F, 1992, EUR J POPUL, V8, P281, DOI 10.1007/BF01796624; Nemtsov A., 2010, PREVRATNOSTI PODSCHE; Nemtsov A.V., 2013, DEMOSKOP WKLY, P567; Nemtsov A. V., 2011, CONT HIST ALCOHOL RU; Nemtsov AV, 2015, PRAVOYYE ASPEKTY NAR, V1, P83; Neufeld M, 2013, ALCOHOL ALCOHOLISM, V48, P222, DOI 10.1093/alcalc/ags134; Pridemore WA, 2002, AM J PUBLIC HEALTH, V92, P1921, DOI 10.2105/AJPH.92.12.1921; Pridemore WA, 2006, ALCOHOL CLIN EXP RES, V2014, P257; Pridemore WA, 2013, ADDICTION, V108, P2112, DOI 10.1111/add.12311; Pridemore WA, 2013, AM J PUBLIC HEALTH, V103, P2021, DOI 10.2105/AJPH.2013.301405; Pridemore WA, 2009, AM J PUBLIC HEALTH, V99, P915, DOI 10.2105/AJPH.2008.146183; Radisauskas R, 2011, ALCOHOL ALCOHOLISM, V46, P614, DOI 10.1093/alcalc/agr068; Razvodovsky YE, 2011, VOPROSY ORGANIZATSII, V3, P38; Razvodovsky YE, 2014, J ALCOHOL DRUG DEPEN, V2, P152, DOI [10.4172/2329-6488.1000152, DOI 10.4172/2329-6488.1000152]; Razvodovsky YE, 2003, ALCOHOL MORTALITY CR; Razvodovsky YE, 2009, ADICCIONES, V21, P229, DOI 10.20882/adicciones.233; Rehm J, 2007, INT J EPIDEMIOL, V36, P458, DOI 10.1093/ije/dyl294; Rehn J, 2006, ADDICTION, V101, P1086, DOI 10.1111/j.1360-0443.2006.01491.x; Rossii Naseleniye, 2011, SEMNADTSATYY YEZHEGO, P241; Russian Federation State Statistics Service (Rosstat), 2014, DEM  YB RUSS STAT YB; Shkolnikov VM, 2013, DEMOGR RES, V28, P917, DOI 10.4054/DemRes.2013.28.32; Shkolnikov VM, 2004, HYGIEA INT, V4, P29, DOI DOI 10.3384/HYGIEA.1403-8668.044129; Shkolnikov VM., 1997, PREMATURE DEATH NEW, P120; SKOG OJ, 1985, BRIT J ADDICT, V80, P83; Stickley A, 2007, EUR J PUBLIC HEALTH, P1; Tomkins S, 2007, ADDICTION, V102, P544, DOI 10.1111/j.1360-0443.2006.01693.x; Vishnevski AG, 2002, DEVYATYY YEZHEGODNYY, P70; Wagenaar AC, 2010, AM J PUBLIC HEALTH, V100, P2270, DOI 10.2105/AJPH.2009.186007; Walberg P, 1998, BRIT MED J, V317, P312, DOI 10.1136/bmj.317.7154.312; Waterhouse JAH, 1976, CANC INCIDENCE 5 CON, VIII, P454; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Zaridze D, 2009, INT J EPIDEMIOL, V38, P143, DOI 10.1093/ije/dyn160	54	30	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138021	10.1371/journal.pone.0138021	http://dx.doi.org/10.1371/journal.pone.0138021			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8NH	26376439	gold, Green Published			2022-12-27	WOS:000361610200071
J	Plotka, M; Kaczorowska, AK; Morzywolek, A; Makowska, J; Kozlowski, LP; Thorisdottir, A; Skirnisdottir, S; Hjorleifsdottir, S; Fridjonsson, OH; Hreggvidsson, GO; Kristjansson, JK; Dabrowski, S; Bujnicki, JM; Kaczorowski, T				Plotka, Magdalena; Kaczorowska, Anna-Karina; Morzywolek, Agnieszka; Makowska, Joanna; Kozlowski, Lukasz P.; Thorisdottir, Audur; Skirnisdottir, Sigurlaug; Hjorleifsdottir, Sigridur; Fridjonsson, Olafur H.; Hreggvidsson, Gudmundur O.; Kristjansson, Jakob K.; Dabrowski, Slawomir; Bujnicki, Janusz M.; Kaczorowski, Tadeusz			Biochemical Characterization and Validation of a Catalytic Site of a Highly Thermostable Ts2631 Endolysin from the Thermus scotoductus Phage vB_Tsc2631	PLOS ONE			English	Article							PEPTIDOGLYCAN RECOGNITION PROTEINS; BACTERIOPHAGE ENDOLYSINS; CRYSTAL-STRUCTURE; IDENTIFICATION; LYSOZYME; STABILITY; VIRUSES	Phage vB_Tsc2631 infects the extremophilic bacterium Thermus scotoductus MAT2631 and uses the Ts2631 endolysin for the release of its progeny. The Ts2631 endolysin is the first endolysin from thermophilic bacteriophage with an experimentally validated catalytic site. In silico analysis and computational modelling of the Ts2631 endolysin structure revealed a conserved Zn2+ binding site (His(30), Tyr(58), His(131) and Cys(139)) similar to Zn2+ binding site of eukaryotic peptidoglycan recognition proteins (PGRPs). We have shown that the Ts2631 endolysin lytic activity is dependent on divalent metal ions (Zn2+ and Ca2+). The Ts2631 endolysin substitution variants H30N, Y58F, H131N and C139S dramatically lost their antimicrobial activity, providing evidence for the role of the aforementioned residues in the lytic activity of the enzyme. The enzyme has proven to be not only thermoresistant, retaining 64.8% of its initial activity after 2 h at 95 degrees C, but also highly thermodynamically stable (T-m = 99.82 degrees C, Delta Hcal = 4.58 x 10(4) cal mol(-1)). Substitutions of histidine residues (H30N and H131N) and a cysteine residue (C139S) resulted in variants aggregating at temperatures >= 75 degrees C, indicating a significant role of these residues in enzyme thermostability. The substrate spectrum of the Ts2631 endolysin included extremophiles of the genus Thermus but also Gram-negative mesophiles, such as Escherichia coli, Salmonella panama, Pseudomonas fluorescens and Serratia marcescens. The broad substrate spectrum and high thermostability of this endolysin makes it a good candidate for use as an antimicrobial agent to combat Gram-negative pathogens.	[Plotka, Magdalena; Morzywolek, Agnieszka; Kaczorowski, Tadeusz] Univ Gdansk, Dept Microbiol, PL-80952 Gdansk, Poland; [Kaczorowska, Anna-Karina] Univ Gdansk, Collect Plasmids & Microorganisms, PL-80952 Gdansk, Poland; [Makowska, Joanna] Univ Gdansk, Fac Chem, PL-80952 Gdansk, Poland; [Kozlowski, Lukasz P.; Bujnicki, Janusz M.] Int Inst Mol & Cell Biol, Lab Bioinformat & Prot Engn, Warsaw, Poland; [Thorisdottir, Audur] VESO Vikan, Namsos, Norway; [Skirnisdottir, Sigurlaug; Fridjonsson, Olafur H.; Hreggvidsson, Gudmundur O.] Matis, Reykjavik, Iceland; [Hjorleifsdottir, Sigridur] ORF Genet, Kopavogur, Iceland; [Hreggvidsson, Gudmundur O.] Univ Iceland, Fac Life & Environm Sci, Reykjavik, Iceland; [Kristjansson, Jakob K.] Prokazyme Ehf, Reykjavik, Iceland; [Dabrowski, Slawomir] A&A Biotechnol, Gdynia, Poland; [Bujnicki, Janusz M.] Adam Mickiewicz Univ, Inst Mol Biol & Biotechnol, Lab Bioinformat, Fac Biol, Poznan, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; University of Iceland; Adam Mickiewicz University	Kaczorowski, T (corresponding author), Univ Gdansk, Dept Microbiol, PL-80952 Gdansk, Poland.	tadeusz.kaczorowski@biol.ug.edu.pl	Kozlowski, Lukasz P./E-1765-2013; Kaczorowski, Tadeusz/AAX-2027-2020; Plotka, Magdalena/AAY-3997-2020	Kozlowski, Lukasz P./0000-0001-8187-1980; Makowska, Joanna/0000-0002-5283-159X; Plotka, Magdalena/0000-0002-2871-8060; Hreggvidsson, Gudmundur Oli/0000-0002-4958-1673; Kaczorowska, Anna-Karina/0000-0002-6598-8449	European Union [286556]; VESO Vikan; ORF Genetics; Prokazyme ehf; AA Biotechnology	European Union(European Commission); VESO Vikan; ORF Genetics; Prokazyme ehf; AA Biotechnology	The work described in the manuscript was supported by funding from the European Union's Seventh Framework Programme managed by REA, Research Executive Agency ([FP7/2007-2013] [FP7/2007-2011]) under grant agreement no 286556 to the EXGENOME project (Exgenome Molecular Enzymes). Audur Thorisdottir is employed by VESO Vikan, Namsos, Norway. Sigridur Hjorleifsdottir is employed by ORF Genetics, Kopavogur, Iceland. Jakob K. Kristjansson is employed by Prokazyme ehf, Reykjavik, Iceland. Slawomir Dabrowski is employed by A&A Biotechnology, Gdynia, Poland. VESO Vikan, ORF Genetics, Prokazyme ehf and A&A Biotechnology provided support in the form of salaries for authors AT, SH, JKK and SD respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allen HK, 2014, ANN NY ACAD SCI, V1323, P91, DOI 10.1111/nyas.12468; Altschul S.F., 1997, NUCLEIC ACIDS RES, V25, P3389, DOI DOI 10.1093/NAR/25.17; Borysowski J, 2006, EXP BIOL MED, V231, P366, DOI 10.1177/153537020623100402; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briers Y, 2006, CELL MOL LIFE SCI, V63, P1899, DOI 10.1007/s00018-006-6183-7; Briers Y, 2015, FUTURE MICROBIOL, V10, P377, DOI [10.2217/FMB.15.8, 10.2217/fmb.15.8]; Bustamante N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046654; CHENG XD, 1994, P NATL ACAD SCI USA, V91, P4034, DOI 10.1073/pnas.91.9.4034; Chowdhury T, 2015, J BIOL INORG CHEM; Claperon M, 2008, BIOCHEM J, V416, P37, DOI 10.1042/BJ20080471; Dalton JAR, 2010, J MOL BIOL, V399, P645, DOI 10.1016/j.jmb.2010.04.047; Dziarski R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-232; Dzwolak W, 2004, PHYS CHEM CHEM PHYS, V6, P1938, DOI 10.1039/b314086e; Farmer RS, 2005, BIOMACROMOLECULES, V6, P1531, DOI 10.1021/bm049216+; Fischetti VA, 2008, CURR OPIN MICROBIOL, V11, P393, DOI 10.1016/j.mib.2008.09.012; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hatfull GF, 2011, CURR OPIN VIROL, V1, P298, DOI 10.1016/j.coviro.2011.06.009; Hjorleifsdottir S, 2001, MICROBIAL ECOL, V42, P117; HOLMQUIST B, 1974, J BIOL CHEM, V249, P4601; Jalasvuori M, 2009, J VIROL, V83, P9388, DOI 10.1128/JVI.00869-09; KIDOKORO S, 1987, BIOPOLYMERS, V26, P213, DOI 10.1002/bip.360260205; Kim MS, 2003, NAT IMMUNOL, V4, P787, DOI 10.1038/ni952; Kropinski AM, 2009, ENVIRON MICROBIOL, V11, P2775, DOI 10.1111/j.1462-2920.2009.01970.x; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Kurata S, 2014, DEV COMP IMMUNOL, V42, P36, DOI 10.1016/j.dci.2013.06.006; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; Lavigne R, 2004, CELL MOL LIFE SCI, V61, P2753, DOI 10.1007/s00018-004-4301-y; Linden SB, 2015, APPL MICROBIOL BIOT, V99, P741, DOI 10.1007/s00253-014-5930-1; Low LY, 2005, J BIOL CHEM, V280, P35433, DOI 10.1074/jbc.M502723200; Matsushita I, 2008, BIOCHEM BIOPH RES CO, V377, P89, DOI 10.1016/j.bbrc.2008.09.101; McCall KA, 2000, J NUTR, V130, p1437S, DOI 10.1093/jn/130.5.1437S; Navarre WW, 1999, J BIOL CHEM, V274, P15847, DOI 10.1074/jbc.274.22.15847; Nelson DC, 2012, ADV VIRUS RES, V83, P299, DOI 10.1016/B978-0-12-394438-2.00007-4; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oliveira H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108376; Oliveira H, 2013, J VIROL, V87, P4558, DOI 10.1128/JVI.03277-12; Plotka M, 2014, APPL ENVIRON MICROB, V80, P886, DOI 10.1128/AEM.03074-13; Plotnikov V, 2002, ASSAY DRUG DEV TECHN, V1, P83, DOI 10.1089/154065802761001338; Reiser JB, 2004, J MOL BIOL, V340, P909, DOI 10.1016/j.jmb.2004.04.077; Royet J, 2011, NAT REV IMMUNOL, V11, P837, DOI 10.1038/nri3089; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SANZ JM, 1993, J BIOL CHEM, V268, P6125; Schmelcher M, 2012, FUTURE MICROBIOL, V7, P1147, DOI [10.2217/fmb.12.97, 10.2217/FMB.12.97]; Schmelcher M, 2012, APPL MICROBIOL BIOT, V93, P633, DOI 10.1007/s00253-011-3372-6; Stefanska A, 2014, J BIOTECHNOL, V182, P1, DOI 10.1016/j.jbiotec.2014.04.015; Sulakvelidze A, 2013, J SCI FOOD AGR, V93, P3137, DOI 10.1002/jsfa.6222; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VALLEE BL, 1990, P NATL ACAD SCI USA, V87, P220, DOI 10.1073/pnas.87.1.220; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Yoong P, 2004, J BACTERIOL, V186, P4808, DOI 10.1128/JB.186.14.4808-4812.2004	52	30	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137374	10.1371/journal.pone.0137374	http://dx.doi.org/10.1371/journal.pone.0137374			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375388	gold, Green Submitted, Green Published			2022-12-27	WOS:000361610200036
J	Ribeiro, AP; Joao, SMA; Dinato, RC; Tessutti, VD; Sacco, ICN				Ribeiro, Ana Paula; Amado Joao, Silvia Maria; Dinato, Roberto Casanova; Tessutti, Vitor Daniel; Neves Sacco, Isabel Camargo			Dynamic Patterns of Forces and Loading Rate in Runners with Unilateral Plantar Fasciitis: A Cross-Sectional Study	PLOS ONE			English	Article							FOOT; THICKNESS; INJURIES; SYMPTOMS; PAIN	Aim/Hypothesis The etiology of plantar fasciitis (PF) has been related to several risk factors, but the magnitude of the plantar load is the most commonly described factor. Although PF is the third most-common injury in runners, only two studies have investigated this factor in runners, and their results are still inconclusive regarding the injury stage. Objective Analyze and compare the plantar loads and vertical loading rate during running of runners in the acute stage of PF to those in the chronic stage of the injury in relation to healthy runners. Methods Forty-five runners with unilateral PF (30 acute and 15 chronic) and 30 healthy control runners were evaluated while running at 12 km/h for 40 meters wearing standardized running shoes and Pedar-X insoles. The contact area and time, maximum force, and force-time integral over the rearfoot, midfoot, and forefoot were recorded and the loading rate (20-80% of the first vertical peak) was calculated. Groups were compared by ANOVAs (p<0.05). Results Maximum force and force-time integral over the rearfoot and the loading rate was higher in runners with PF (acute and chronic) compared with controls (p<0.01). Runners with PF in the acute stage showed lower loading rate and maximum force over the rearfoot compared to runners in the chronic stage (p<0.01). Conclusion Runners with PF showed different dynamic patterns of plantar loads during running over the rearfoot area depending on the injury stage (acute or chronic). In the acute stage of PF, runners presented lower loading rate and forces over the rearfoot, possibly due to dynamic mechanisms related to pain protection of the calcaneal area.	[Ribeiro, Ana Paula; Amado Joao, Silvia Maria; Dinato, Roberto Casanova; Tessutti, Vitor Daniel; Neves Sacco, Isabel Camargo] Univ Sao Paulo, Sch Med, Phys Therapy Speech & Occupat Therapy Dept, Sao Paulo, Brazil; [Ribeiro, Ana Paula] Univ Santo Amaro, Phys Therapy Dept, Sch Med, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Santo Amaro (UNISA)	Ribeiro, AP (corresponding author), Univ Sao Paulo, Sch Med, Phys Therapy Speech & Occupat Therapy Dept, Sao Paulo, Brazil.	apribeiro@usp.br	Ribeiro, Ana Paula/J-6368-2013; Sacco, Isabel/D-7172-2011; Sacco, Isabel/T-2630-2019; João, Sílvia/G-2202-2012	Ribeiro, Ana Paula/0000-0002-1061-3789; Sacco, Isabel/0000-0003-1254-0007; Sacco, Isabel/0000-0003-1254-0007; João, Sílvia/0000-0002-7999-6589	The Agency Coordination of Improvement of Higher Education Personnel (CAPES) [2011/03069-6]; Sao Paulo State Research Foundation (FAPESP) [2010/14044-1]	The Agency Coordination of Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo State Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The Agency Coordination of Improvement of Higher Education Personnel (CAPES) provided support for Ana Paula Ribeiro's scholarship (2011/03069-6) and Sao Paulo State Research Foundation (FAPESP) provided support for Roberto C. Dinato's scholarship (2010/14044-1).	Akfirat M, CLIN IMAGING, V353-7, P353; [Anonymous], 2006, J FAM PRACTICE, V55, P844; Bedi HS, 1998, FOOT ANKLE INT, V19, P153, DOI 10.1177/107110079801900307; CHANDLER TJ, 1993, SPORTS MED, V15, P344, DOI 10.2165/00007256-199315050-00006; Chang R, 2012, CLIN BIOMECH, V27, P500, DOI 10.1016/j.clinbiomech.2011.11.007; Cornwall MW, 1999, J ORTHOP SPORT PHYS, V29, P756, DOI 10.2519/jospt.1999.29.12.756; Crowell HP, 2010, J ORTHOP SPORT PHYS, V40, P206, DOI 10.2519/jospt.2010.3166; Fong DTP, 2012, CLIN BIOMECH, V27, P1072, DOI 10.1016/j.clinbiomech.2012.08.003; Giddings VL, 2000, MED SCI SPORT EXER, V32, P627, DOI 10.1097/00005768-200003000-00012; Grasel RP, 1999, AM J ROENTGENOL, V173, P699, DOI 10.2214/ajr.173.3.10470906; Hong YL, 2012, J SCI MED SPORT, V15, P554, DOI 10.1016/j.jsams.2012.01.004; KIBLER WB, 1991, AM J SPORT MED, V19, P66, DOI 10.1177/036354659101900111; Klein SE, 2012, FOOT ANKLE INT, V33, P693, DOI 10.3113/FAI.2012.0693; Lemont H, 2003, J AM PODIAT MED ASSN, V93, P234, DOI 10.7547/87507315-93-3-234; Lopes AD, 2012, SPORTS MED, V42, P891, DOI [10.2165/11631170-000000000-00000, 10.1007/BF03262301]; Mahowald S, 2011, J AM PODIAT MED ASSN, V101, P385, DOI 10.7547/1010385; Pohl MB, 2009, CLIN J SPORT MED, V19, P372, DOI 10.1097/JSM.0b013e3181b8c270; PRICHASUK S, 1994, CLIN ORTHOP RELAT R, P192; Ribeiro AP, 2011, CLINICS, V66, P1027, DOI 10.1590/S1807-59322011000600018; Ribeiro AP, 2011, CLIN BIOMECH, V26, P194, DOI 10.1016/j.clinbiomech.2010.08.004; Rome K, 2002, FOOT ANKLE INT, V23, P142, DOI 10.1177/107110070202300211; Rome K., 2001, FOOT, V11, P119, DOI 10.1054/foot.2001.0698; Sahin N, 2010, ACTA ORTHOP TRAUMATO, V44, P385, DOI 10.3944/AOTT.2010.2348; SCHEPSIS AA, 1991, CLIN ORTHOP RELAT R, P185; Taunton JE, 2002, PHYS THER SPORT, V3, P57, DOI 10.1054/ptsp.2001.0082; Tessutti V, 2012, J SPORT SCI, V30, P1545, DOI 10.1080/02640414.2012.713975; van Gent RN, 2007, BRIT J SPORT MED, V41, P469, DOI 10.1136/bjsm.2006.033548; Van Middelkoop M, 2008, SCAND J MED SCI SPOR, V18, P691, DOI 10.1111/j.1600-0838.2007.00768.x; VIEL E, 1989, Physiotherapy Practice, V5, P69; WARREN BL, 1990, SPORTS MED, V10, P338, DOI 10.2165/00007256-199010050-00004; WARREN BL, 1984, MED SCI SPORT EXER, V16, P60; Wearing SC, 2003, CLIN ORTHOP RELAT R, P175, DOI 10.1097/01.blo.0000057989.41099.d8; Wearing SC, 2007, PHYS THER, V87, P1002, DOI 10.2522/ptj.20060136; Wearing SC, 2006, SPORTS MED, V36, P585, DOI 10.2165/00007256-200636070-00004; Whittle MW, 1999, GAIT POSTURE, V10, P264, DOI 10.1016/S0966-6362(99)00041-7	35	20	20	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136971	10.1371/journal.pone.0136971	http://dx.doi.org/10.1371/journal.pone.0136971			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375815	Green Submitted, gold, Green Published			2022-12-27	WOS:000361610200027
J	Williams, SM; Holmes, BJ; Pepperell, JG				Williams, Samuel M.; Holmes, Bonnie J.; Pepperell, Julian G.			The Novel Application of Non-Lethal Citizen Science Tissue Sampling in Recreational Fisheries	PLOS ONE			English	Article							MERCURY CONCENTRATIONS; CONSERVATION; MANAGEMENT; GROWTH; MARLIN; GENETICS; PROGRAMS; NEED; AGE	Increasing fishing pressure and uncertainty surrounding recreational fishing catch and effort data promoted the development of alternative methods for conducting fisheries research. A pilot investigation was undertaken to engage the Australian game fishing community and promote the non-lethal collection of tissue samples from the black marlin Istiompax indica, a valuable recreational-only species in Australian waters, for the purpose of future genetic research. Recruitment of recreational anglers was achieved by publicizing the project in magazines, local newspapers, social media, blogs, websites and direct communication workshops at game fishing tournaments. The Game Fishing Association of Australia and the Queensland Game Fishing Association were also engaged to advertise the project and recruit participants with a focus on those anglers already involved in the tag-and-release of marlin. Participants of the program took small tissue samples using non-lethal methods which were stored for future genetic analysis. The program resulted in 165 samples from 49 participants across the known distribution of I. indica within Australian waters which was a sufficient number to facilitate a downstream population genetic analysis. The project demonstrated the potential for the development of citizen science sampling programs to collect tissue samples using non-lethal methods in order to achieve targeted research objects in recreationally caught species.	[Williams, Samuel M.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Holmes, Bonnie J.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Pepperell, Julian G.] Pepperell Res & Consulting Pty Ltd, Noosaville, BC, Australia	University of Queensland; University of Queensland	Williams, SM (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia.	Samuel.williams5@uq.net.au	Holmes, Bonnie/AAZ-5413-2021	Holmes, Bonnie/0000-0002-8559-9950	Game Fishing Association of Australia Research & Development Foundation Inc.; Queensland Game Fishing Association; Sea World Research and Rescue Foundation Inc.; Pepperell Research and Consulting Pty Ltd	Game Fishing Association of Australia Research & Development Foundation Inc.; Queensland Game Fishing Association; Sea World Research and Rescue Foundation Inc.; Pepperell Research and Consulting Pty Ltd	This work was supported by the Game Fishing Association of Australia Research & Development Foundation Inc. The funders assisted the in data collection and provided funds, but had no other manuscript. A grant number was not provided with the funds. This work was supported by the Queensland Game Fishing Association (http://www.qgfa.com.au). The funders assisted the in data collection and provided funds, but had no other manuscript. A grant number was not provided with the funds. This work was supported by the Sea World Research and Rescue Foundation Inc. (http://seaworld.com.au/research-and-rescue.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No grant number was given with the funds. Pepperell Research and Consulting Pty Ltd provided support in the form of salaries for authors [JP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Awruch CA, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou013; Barnett A, 2010, J EXP MAR BIOL ECOL, V393, P188, DOI 10.1016/j.jembe.2010.07.022; Brenden TO, 2006, FISHERIES MANAG ECOL, V13, P31, DOI 10.1111/j.1365-2400.2006.00469.x; Buckworth R.C., 2012, 107 NO TERR GOV; Chin Andrew, 2014, Pacific Conservation Biology, V20, P48; Conrad CC, 2011, ENVIRON MONIT ASSESS, V176, P273, DOI 10.1007/s10661-010-1582-5; Danylchuk AJ, 2011, ANGLER ENV SOCIAL EC; Devictor V, 2010, DIVERS DISTRIB, V16, P354, DOI 10.1111/j.1472-4642.2009.00615.x; Domeier ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031629; Dudgeon CL, 2012, J FISH BIOL, V80, P1789, DOI 10.1111/j.1095-8649.2012.03265.x; Fairclough DV, 2014, SCI REP-UK, V4, DOI 10.1038/srep07249; Fritsches KA, 2000, PHILOS T ROY SOC B, V355, P1253, DOI 10.1098/rstb.2000.0678; Fritsches KA, 2003, MAR FRESHWATER RES, V54, P333, DOI 10.1071/MF02126; Gartside DF, 1999, FISH RES, V41, P47, DOI 10.1016/S0165-7836(99)00007-7; Gledhill DC, 2015, MAR FRESHWATER RES, V66, P195, DOI 10.1071/MF14071; Granek EF, 2008, CONSERV BIOL, V22, P1125, DOI 10.1111/j.1523-1739.2008.00977.x; Griffiths SP, 2010, FISH FISH, V11, P220, DOI 10.1111/j.1467-2979.2010.00354.x; Hammerschlag Neil, 2011, Endangered Species Research, V14, P135, DOI 10.3354/esr00354; Heupel MR, 2010, CONSERV BIOL, V24, P1212, DOI 10.1111/j.1523-1739.2010.01491.x; Holmes BJ, J FISH BIOL IN PRESS; Institute S, 2008, SAS STAT VERS 9 2; IOTC, 2014, STAT IND OC BLACK MA; Jardine TD, 2011, MAR FRESHWATER RES, V62, P83, DOI 10.1071/MF10211; Kopf RK, 2011, ICES J MAR SCI, V68, P1884, DOI 10.1093/icesjms/fsr110; Kruck NC, 2013, MOL ECOL RESOUR, V13, P715, DOI 10.1111/1755-0998.12112; Lake JL, 2006, ARCH ENVIRON CON TOX, V50, P539, DOI 10.1007/s00244-005-5052-y; Ortiz M, 2003, MAR FRESHWATER RES, V54, P489, DOI 10.1071/MF02028; Parsons J, 2011, NATURE, V471, P37, DOI 10.1038/471037a; Pepperell JG, 2013, NSW DPI GAME FISH TA; Piraino MN, 2013, ARCH ENVIRON CON TOX, V65, P715, DOI 10.1007/s00244-013-9946-9; Rotman D., 2012, P ACM 2012 C COMP SU, P217, DOI DOI 10.1145/2145204.2145238; Ryman N, 2006, MOL ECOL NOTES, V6, P600, DOI 10.1111/j.1471-8286.2006.01378.x; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Speare P, 2003, MAR FRESHWATER RES, V54, P307, DOI 10.1071/MF01277; Squire Jr JL, 1983, 772 NOAA NMFS SSRF; Tulloch AIT, 2013, BIOL CONSERV, V165, P128, DOI 10.1016/j.biocon.2013.05.025; Ward RD, 2000, HYDROBIOLOGIA, V420, P191, DOI 10.1023/A:1003928327503; Williams SM, 2014, FISH RES, V166, P29; Zischke MT, 2013, REV FISH BIOL FISHER, V23, P491, DOI 10.1007/s11160-013-9304-z	40	12	12	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0135743	10.1371/journal.pone.0135743	http://dx.doi.org/10.1371/journal.pone.0135743			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376487	Green Submitted, Green Published, gold			2022-12-27	WOS:000361610200007
J	Martins, MVA; Zaaboub, N; Aleya, L; Frontalini, F; Pereira, E; Miranda, P; Mane, M; Rocha, F; Laut, L; El Bour, M				Martins, Maria Virginia Alves; Zaaboub, Noureddine; Aleya, Lotfi; Frontalini, Fabrizio; Pereira, Egberto; Miranda, Paulo; Mane, Miguel; Rocha, Fernando; Laut, Lazaro; El Bour, Monia			Environmental Quality Assessment of Bizerte Lagoon (Tunisia) Using Living Foraminifera Assemblages and a Multiproxy Approach	PLOS ONE			English	Article							ACID-VOLATILE SULFIDE; SIMULTANEOUSLY EXTRACTED METALS; PEARL RIVER ESTUARY; BENTHIC FORAMINIFERA; AVEIRO PORTUGAL; BIOGEOCHEMICAL INDICATORS; CONTAMINATED AREA; SURFACE SEDIMENTS; HEAVY-METALS; SEM-AVS	This study investigated the environmental quality of the Bizerte Lagoon (Tunisia) through an integrated approach that combined environmental, biogeochemical, and living benthic foraminiferal analyses. Specifically, we analyzed the physicochemical parameters of the water and sediment. The textural, mineralogical, and geochemical characteristics of the sediment, including total organic carbon, total nitrogen, simultaneously extracted metals (SEM), acid volatile sulfides (AVS), chlorophyll a, CaCO3, and changes in bacterial populations and carbon isotopes were measured. The SEM/AVS values indicated the presence of relatively high concentrations of toxic metals in only some areas. Foraminiferal assemblages were dominated by species such as A. parkinsoniana (20-91%), Bolivina striatula (<40%), Hopkinsina atlantica (<17%), and Bolivina ordinaria (<15%) that cannot be considered typical of impacted coastal lagoons both in Mediterranean and northeast Atlantic regions. The results of this work suggest that Bizerte Lagoon is a unique setting. This lagoon is populated by typical marine species that invaded this ecosystem, attracted not only by the prevailing favorable environmental conditions but also by the abundance and quality of food. The results indicate that the metal pollution found in some areas have a negative impact on the assemblages of foraminifera. At present, however, this negative impact is not highly alarming.	[Martins, Maria Virginia Alves; Pereira, Egberto; Mane, Miguel] Univ Estado Rio de Janeiro, Fac Geol, BR-20550013 Rio De Janeiro, RJ, Brazil; [Martins, Maria Virginia Alves] Univ Estado Amazonas, BR-69050010 Manaus, Amazonas, Brazil; [Martins, Maria Virginia Alves; Miranda, Paulo; Rocha, Fernando] Univ Aveiro, Dept Geociencias, P-3810193 Aveiro, Portugal; [Zaaboub, Noureddine; El Bour, Monia] Inst Natl Sci & Technol Mer, Salammbo 19342025, Tunisia; [Aleya, Lotfi] Univ Bourgogne Franche Comte, Lab Chrono Environm, CNRS, UMR 6249, F-25030 Besancon, France; [Frontalini, Fabrizio] Univ Urbino Carlo Bo, Dipartimento Sci Terra Vita & Ambiente, I-61029 Urbino, Italy; [Laut, Lazaro] Univ Fed Estado Rio de Janeiro UNIRIO, Lab Micropaleontol LabMicro, BR-22290240 Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Universidade do Estado do Amazonas; Universidade de Aveiro; Institut National des Sciences et Technologies de la Mer; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Franche-Comte; University of Urbino; Universidade Federal do Estado do Rio de Janeiro	Martins, MVA (corresponding author), Univ Estado Rio de Janeiro, Fac Geol, Ave Sao Francisco Xavier 524, BR-20550013 Rio De Janeiro, RJ, Brazil.	virginia.martins@ua.pt	Laut, Lazaro L.M./K-4782-2012; Mane, Miguel Angelo/AAE-2986-2021; Martins, Maria Virginia Alves/O-2893-2013; Frontalini, Fabrizio/C-4819-2008; Laut, Lazaro/O-4193-2019; Rocha, Fernando/A-4532-2009; Alves Martins, Maria Virginia/AAD-3531-2021	Laut, Lazaro L.M./0000-0002-5637-1930; Martins, Maria Virginia Alves/0000-0001-8348-8862; Frontalini, Fabrizio/0000-0002-0425-9306; Laut, Lazaro/0000-0002-5637-1930; Rocha, Fernando/0000-0002-3636-3933; Alves Martins, Maria Virginia/0000-0001-8348-8862	projects Bilateral of Cooperation Tunisian Portuguese [48/TP/09, PEst-OE/CTE/UI4035/2014]; PROTEC Program of Universidade do Estado do Rio de Janeiro-UERJ; Universidade do Amazonas - UEA	projects Bilateral of Cooperation Tunisian Portuguese; PROTEC Program of Universidade do Estado do Rio de Janeiro-UERJ; Universidade do Amazonas - UEA	This work was partially supported by the projects Bilateral of Cooperation Tunisian Portuguese 48/TP/09 and PEst-OE/CTE/UI4035/2014 and by the fellowship from the PROTEC Program of Universidade do Estado do Rio de Janeiro-UERJ and Universidade do Amazonas - UEA.	Abreu SN, 2000, MAR POLLUT BULL, V40, P293, DOI 10.1016/S0025-326X(99)00187-3; Afli A, 2008, ESTUAR COAST SHELF S, V80, P269, DOI 10.1016/j.ecss.2008.08.010; Allen HE, 1991, EPA821R91100 USEPA O; Alve E, 1999, J FORAMIN RES, V29, P186; Martins MVA, 2015, MAR ENVIRON RES, V109, P52, DOI 10.1016/j.marenvres.2015.06.006; Martins MVA, 2015, ENVIRON SCI POLLUT R, V22, P10019, DOI 10.1007/s11356-015-4185-4; Martins MVA, 2014, ENVIRON MONIT ASSESS, V186, P8875, DOI 10.1007/s10661-014-4052-7; Martins MVA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118077; Amend JP, 2004, 379 SP GEOL SOC AM, V379; Ankley GT, 1996, ENVIRON TOXICOL CHEM, V15, P2056, DOI 10.1002/etc.5620151202; Bejaoui B, 2008, ESTUAR COAST SHELF S, V80, P121, DOI 10.1016/j.ecss.2008.07.011; Bernhard JM, 1999, MODERN FORAMINIFERA, P201; Berry WJ, 1996, ENVIRON TOXICOL CHEM, V15, P2067, DOI 10.1002/etc.5620151203; Bickert T, 2004, S ATLANTIC LATE QUAT, P599; Buchmann N., 1998, STABLE ISOTOPES INTE, P203; Burollet PF, 1951, ANN MINES GEOLOGIE T, V7, P5; Chapman PM, 1998, CAN J FISH AQUAT SCI, V55, P2221, DOI 10.1139/cjfas-55-10-2221; Coccioni R, 2009, MAR POLLUT BULL, V59, P257, DOI 10.1016/j.marpolbul.2009.08.009; Curry WB, 1988, PALEOCEANOGRAPHY, V3, P317, DOI 10.1029/PA003i003p00317; Curry WB, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001021; Debenay JP, 2001, J FORAMIN RES, V31, P133, DOI 10.2113/0310133; Dellali M, 2001, J RECH OCEANOGR, V26, P18; den Besten Pieter J., 2003, Journal of Soils and Sediments, V3, P144, DOI 10.1065/jss2003.08.084; DITORO DM, 1990, ENVIRON TOXICOL CHEM, V9, P1487; du Chatelet Eric Armynot, 2009, Revue de Micropaleontologie, V52, P75, DOI 10.1016/j.revmic.2008.10.002; ESSID N, 2002, B I NATN SCI TECH ME, V29, P53; Fang T, 2005, ECOTOX ENVIRON SAFE, V61, P420, DOI 10.1016/j.ecoenv.2004.10.004; Fenchel T., 1995, ECOLOGY EVOLUTION AN; Fernex FE, 2001, HYDROBIOLOGIA, V450, P31, DOI 10.1023/A:1017558413882; Frontalini F, 2008, ESTUAR COAST SHELF S, V76, P404, DOI 10.1016/j.ecss.2007.07.024; Frontalini F, 2014, P BIOL SOC WASH, V127, P7, DOI 10.2988/0006-324X-127.1.7; Frontalini F, 2013, ACTA PROTOZOOL, V52, P147, DOI 10.4467/16890027AP.13.0014.1111; Frontalini F, 2010, ENVIRON MONIT ASSESS, V170, P245, DOI 10.1007/s10661-009-1229-6; Frontalini F, 2009, MAR POLLUT BULL, V58, P858, DOI 10.1016/j.marpolbul.2009.01.015; GANOTE CE, 1987, AM J PATHOL, V129, P327; Garali A.B., 2011, J OCEANOGR MAR SCI, V2, P1; Geslin E, 2014, ENVIRON SCI ENG, P163, DOI 10.1007/978-4-431-54388-6_10; GOODAY AJ, 1989, MAR ECOL PROG SER, V58, P53, DOI 10.3354/meps058053; Gooday AJ, 2003, ADV MAR BIOL, V46, P1, DOI 10.1016/S0065-2881(03)46002-1; Gooday AJ, 2012, ANNU REV MAR SCI, V4, P237, DOI 10.1146/annurev-marine-120709-142737; Grami B, 2008, ESTUAR COAST SHELF S, V79, P101, DOI 10.1016/j.ecss.2008.03.009; GROSSMAN EL, 1987, J FORAMIN RES, V17, P48, DOI 10.2113/gsjfr.17.1.48; Harzallah A., 2003, B INSTITUT NATL SCI, V30, P121; Hinkey LM, 2007, MAR POLLUT BULL, V54, P180, DOI 10.1016/j.marpolbul.2006.09.009; Hlaili-Sakka A., 2003, REV FS BIZERTE TUNIS, V2, P37; Ip CCM, 2004, ENVIRON POLLUT, V132, P157, DOI 10.1016/j.envpol.2004.03.028; Kallel M R, 1989, HYDROLOGY LAGOON BIZ; Larpent JP, 1997, TEC DOC LAVOISIER; Lasorsa B, 1996, MAR CHEM, V52, P211, DOI 10.1016/0304-4203(95)00074-7; Li F, 2014, MAR POLLUT BULL, V84, P424, DOI 10.1016/j.marpolbul.2014.04.030; Linshy VN, 2007, INDIAN J MAR SCI, V36, P301; Liu WX, 2003, ENVIRON POLLUT, V121, P377, DOI 10.1016/S0269-7491(02)00234-8; Mackensen A, 2001, GLOBAL PLANET CHANGE, V30, P197, DOI 10.1016/S0921-8181(01)00102-3; Martins V, 2010, ESTUAR COAST SHELF S, V87, P293, DOI 10.1016/j.ecss.2010.01.011; Martins V, 2007, MAR GEOL, V239, P1, DOI 10.1016/j.margeo.2006.11.001; Martins VA, 2013, MAR POLLUT BULL, V70, P18, DOI 10.1016/j.marpolbul.2013.02.003; Mathlouthi S, 1985, THESIS U TUNIS 1 TUN; Maugeri TL, 2000, J APPL MICROBIOL, V89, P261, DOI 10.1046/j.1365-2672.2000.01096.x; MEYERS PA, 1994, CHEM GEOL, V114, P289, DOI 10.1016/0009-2541(94)90059-0; Monterroso P, 2003, ACTA OECOL, V24, pS351, DOI 10.1016/S1146-609X(03)00033-X; Moodley L, 1998, MAR ECOL PROG SER, V169, P77, DOI 10.3354/meps169077; Murray JW, 2006, ECOLOGY AND APPLICATIONS OF BENTHIC FORAMINIFERA, P1, DOI 10.1017/CBO9780511535529; Murray JW, 2001, MAR MICROPALEONTOL, V41, P1, DOI 10.1016/S0377-8398(00)00057-8; Nigam R, 2005, J COASTAL RES, V21, P853, DOI 10.2112/03-0061.1; Oliveira Leonardo Costa de, 2011, Braz. J. Geol., V41, P447, DOI 10.25249/0375-7536.2011413447462; Ouakad M, 2007, THESIS U TUNIS MANAR; Oueslati W, 2010, SOIL SEDIMENT CONTAM, V19, P696, DOI 10.1080/15320383.2010.515629; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Pereira ME, 2009, ENVIRON MONIT ASSESS, V155, P39, DOI 10.1007/s10661-008-0416-1; Pereira ME, 1998, SCI TOTAL ENVIRON, V213, P157, DOI 10.1016/S0048-9697(98)00087-4; Pereira ME, 1998, WATER SCI TECHNOL, V37, P125, DOI 10.2166/wst.1998.0744; Perez-Ruzafa A, 2011, J COAST CONSERV, V15, P369, DOI 10.1007/s11852-010-0095-2; PRAHL FG, 1994, GEOCHIM COSMOCHIM AC, V58, P3035, DOI 10.1016/0016-7037(94)90177-5; Premuzic E.T., 1982, ORG GEOCHEM, V4, P63, DOI [10.1016/0146-6380(82)90009-2., DOI 10.1016/0146-6380(82)90009-2]; Prescott L.M., 1999, MICROBIOLOGY; Ramalhosa E, 2006, WATER RES, V40, P2893, DOI 10.1016/j.watres.2006.05.023; Ravelo AC, 2007, DEV MARINE GEOL, V1, P735, DOI 10.1016/S1572-5480(07)01023-8; Ribeiro AP, 2013, MAR POLLUT BULL, V68, P55, DOI 10.1016/j.marpolbul.2012.12.023; Schonfeld J, 2012, MAR MICROPALEONTOL, V94-95, P1, DOI 10.1016/j.marmicro.2012.06.001; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Stanhope JW, 2009, J ENVIRON QUAL, V38, P2070, DOI 10.2134/jeq2008.0358; Tucker M. E., 2001, SEDIMENTARY PETROLOG; Viaroli P, 2004, AQUAT CONSERV, V14, pS19, DOI 10.1002/aqc.647	83	69	70	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137250	10.1371/journal.pone.0137250	http://dx.doi.org/10.1371/journal.pone.0137250			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372655	gold, Green Published, Green Submitted			2022-12-27	WOS:000361604400014
J	Oliveira, D; Ferreira, FS; Atouguia, J; Fortes, F; Guerra, A; Centeno-Lima, S				Oliveira, Dinamene; Ferreira, Filipa Santana; Atouguia, Jorge; Fortes, Filomeno; Guerra, Antonio; Centeno-Lima, Sonia			Infection by Intestinal Parasites, Stunting and Anemia in School-Aged Children from Southern Angola	PLOS ONE			English	Article							NUTRITIONAL-STATUS; HYMENOLEPIS-NANA; RISK-FACTORS; EPIDEMIOLOGY; PREVALENCE; HELMINTHS; MODERATE	Introduction Intestinal parasites are responsible for morbidity in children worldwide, especially in low income countries. In the present study we determine the prevalence of intestinal parasites and explore its association with anemia and stunting in school-aged children. Methods A cross-sectional study was conducted from September to October 2010 enrolling 328 children attending the primary school in Lubango, the second largest city after the capital Luanda. Stool samples were collected for parasite detection through microscopy and molecular identification of Entamoeba histolytica and Entamoeba dispar. Stunting was assessed using the z-scores of height for age and hemoglobin concentration was determined using a portable hemoglobin analyzing system. Results The global prevalence of pathogenic intestinal parasites was 44.2%, the most common being Ascaris lumbricoides (22.0%), Giardia lamblia (20.1%) and Hymenolepis nana (8.8%). Molecular detection revealed that 13.1% of the children carried E. dispar and 0.3% were infected with E. histolytica. The prevalence of stunting (mild to severe) was 41.5%. Stunting was more frequent in older children (p = 0.006, OR = 1.886), while anemia was more frequent in younger children (p = 0.005, OR = 2.210). The prevalence of anemia was 21.6%, and we found a significant association with infection by H. nana (p = 0.031, OR = 2.449). Conclusions This is one of the few published studies reporting intestinal parasites infection, nutritional status and anemia in children from Angola. Furthermore, the present work highlights the importance of regular intestinal parasites screening in children.	[Oliveira, Dinamene] Clin Girassol, Lubango, Angola; [Ferreira, Filipa Santana; Atouguia, Jorge; Centeno-Lima, Sonia] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Clin Trop, Global Hlth & Trop Med, P-1200 Lisbon, Portugal; [Fortes, Filomeno] Minist Saude, Luanda, Angola; [Guerra, Antonio] Univ Porto, Fac Med, Dept Pediat, P-4100 Oporto, Portugal	Clinica Girassol; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade do Porto	Oliveira, D (corresponding author), Clin Girassol, Lubango, Angola.	odinamene@gmail.com	Guerra, António/L-8025-2013; Atouguia, Jorge M/J-2877-2012	Guerra, António/0000-0002-7951-3911; Atouguia, Jorge/0000-0001-9854-0854; Centeno Lima, Sonia/0000-0002-4935-4905; Fortes, Fabiane/0000-0001-6217-3474; Oliveira, Dinamene/0000-0002-7765-5991	Sonangol	Sonangol	All financial expenses were supported by Sonangol through a scholarship assigned to the corresponding author. Sonangol does not attribute numbers to their grants (www.sonangol.co.ao). Sonangol had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Ministry of Health of Angola (www.minsa.gov.ao) contributed with drugs for the treatment of children infected with intestinal parasites.	Ali IKM, 2008, INFECT GENET EVOL, V8, P698, DOI 10.1016/j.meegid.2008.05.004; Augusto G, 2009, AM J TROP MED HYG, V81, P799, DOI 10.4269/ajtmh.2009.08-0344; Best C, 2010, FOOD NUTR BULL, V31, P400, DOI 10.1177/156482651003100303; Botero-Garces JH, 2009, REV INST MED TROP SP, V51, P155, DOI 10.1590/S0036-46652009000300006; Brito LL, 2006, AM J TROP MED HYG, V75, P939, DOI 10.4269/ajtmh.2006.75.939; Casapia M, 2007, BRIT J NUTR, V98, P1259, DOI 10.1017/S0007114507795272; Casapia M, 2006, INT J PARASITOL, V36, P741, DOI 10.1016/j.ijpara.2006.03.004; Dawood R, 2005, SAUDE VIAJANTES COMO; Dent A.E., 2011, NELSON TXB PEDIAT, V19th; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Ferreira Filipa Santana, 2013, J Parasitol Res, V2013, P252971, DOI 10.1155/2013/252971; Ferreira FS, 2012, PARASITOL RES, V111, P2173, DOI 10.1007/s00436-012-3068-6; Fleming AF, 2009, MANSONS TROPICAL DIS; Hamid MMA, 2015, TRAVEL MED INFECT DI, V13, P172, DOI 10.1016/j.tmaid.2014.12.011; Hamzah Z, 2006, J CLIN MICROBIOL, V44, P3196, DOI 10.1128/JCM.00778-06; Harhay MO, 2010, EXPERT REV ANTI-INFE, V8, P219, DOI [10.1586/eri.09.119, 10.1586/ERI.09.119]; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Jardim-Botelho A, 2008, TROP MED INT HEALTH, V13, P458, DOI 10.1111/j.1365-3156.2008.02022.x; Katona P, 2008, CLIN INFECT DIS, V46, P1582, DOI 10.1086/587658; Magalhaes RJS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002321; Midzi N, 2010, ACTA TROP, V115, P103, DOI 10.1016/j.actatropica.2010.02.010; Mohammad Mahmoud A., 2007, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V37, P877; Nyarango RM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-237; Parija SC, 2007, BMC MICROBIOL, V7; Sharbatkhori Mitra, 2014, Gastroenterol Hepatol Bed Bench, V7, P164; Sousa-Figueiredo JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033189; Stevens GA, 2012, LANCET, V380, P824, DOI 10.1016/S0140-6736(12)60647-3; Tomlinson M, 2010, PUBLIC HEALTH NUTR, V13, P1314, DOI 10.1017/S1368980010000510; World Health Organization, 2008, WHO GLOBAL DATABASE; World Health Organization, 2011, SER FERR CONC ASS IR; World Health Organization (WHO), 1994, BENCH AIDS DIAGN INT	31	44	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137327	10.1371/journal.pone.0137327	http://dx.doi.org/10.1371/journal.pone.0137327			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371758	Green Published, gold			2022-12-27	WOS:000361604400016
J	Yuan, YH; Che, XJ; Ni, ZH; Zhong, YF; Qi, YH; Shao, XH; Wang, Q; Cao, LO; Zhang, MF; Xie, YY; Qi, CJ; Tian, L; Mou, S				Yuan, Yanhong; Che, Xiajing; Ni, Zhaohui; Zhong, Yifei; Qi, Yinghui; Shao, Xinghua; Wang, Qin; Cao, Liou; Zhang, Minfang; Xie, Yuanyuan; Qi, Chaojun; Tian, Lei; Mou, Shan			Association of Relapse with Renal Outcomes under the Current Therapy Regimen for IgA Nephropathy: A Multi-Center Study	PLOS ONE			English	Article							LUPUS NEPHRITIS; NATURAL-HISTORY; RISK-FACTORS; ACHIEVED REMISSION; DISEASE; COHORT; ADULT; PROGRESSION; PROGNOSIS; SURVIVAL	Background and Objectives Renal relapse is a very common manifestation of IgA nephropathy (IgAN). The clinical characteristics and long-term outcomes of this condition have not yet been carefully explored. Design and Patients Patients with biopsy-proven IgAN between January 2005 and December 2010 from three medical centers in China was a primary cohort of patients. From January 2010 to April 2012, data of an independent cohort of IgAN patients from Ren Ji Hospital, Shanghai, China was collected using the same inclusion and exclusion criteria. These patients formed the validation cohort of this study. Results Of the patients with biopsy-proven IgAN from three medical centers, 489 patients achieved remission within 6 months following the therapy. Additionally, 76 (15.5%) of these patients experienced a relapse after achieving remission. During the median follow-up period of 66 months, 6 patients (1.4%) in the non-relapse group experienced renal deterioration, compared with 22 patients (29.6%) in the relapse group. Our study indicated that each 1-mmHg increase in the baseline diastolic blood pressure (DBP) was associated with a 4.5% increase in the risk of renal relapse; additionally, the male patients had a 3.324-fold greater risk of relapse compared with the female patients according to the adjusted multivariate Cox analysis. The nomogram was based on 489 patients achieved remission. The predictive accuracy and discriminative ability of the nomogram were determined by concordance index (C-index) and calibration curve. The results were validated using bootstrap resampling on the validation cohort. Conclusions This study demonstrated that renal relapse is a potential predictor of prognostic outcomes in patients under the current therapeutic regimens for IgAN. And male patients with higher diastolic blood pressure had a greater risk of experiencing relapse.	[Yuan, Yanhong; Che, Xiajing; Ni, Zhaohui; Shao, Xinghua; Wang, Qin; Cao, Liou; Zhang, Minfang; Xie, Yuanyuan; Qi, Chaojun; Tian, Lei; Mou, Shan] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Nephrol,Mol Cell Lab Kidney Dis, Shanghai 200127, Peoples R China; [Zhong, Yifei] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Dept Nephrol, Shanghai 200032, Peoples R China; [Qi, Yinghui] Punan Hosp Shanghai, Dept Nephrol, Shanghai 200125, Peoples R China	Shanghai Jiao Tong University; Shanghai University of Traditional Chinese Medicine	Mou, S (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Nephrol,Mol Cell Lab Kidney Dis, 160 Pujian Rd, Shanghai 200127, Peoples R China.	shanmou_renji@126.com	shao, xinghua/GVU-8320-2022	mou, shan/0000-0003-4160-1681	National Basic Research Program of China 973 Program [2012CB517600, 2012CB517602]; Hong Kong, Macao; Taiwan Science & Technology Cooperation Program of China [2014DFT30090]; National Natural Science Foundation of China [81102700, 81373865]; Science and Technology Commission of Shanghai Municipality, China [12401906400, 13401906100, 14140903200]; Shanghai Health Bureau [ZYSNXD012-RC-ZXY017]; Shanghai municipal education committee [ZZjdyx13049]	National Basic Research Program of China 973 Program(National Basic Research Program of China); Hong Kong, Macao; Taiwan Science & Technology Cooperation Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality, China(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Health Bureau; Shanghai municipal education committee	This study was supported in part by the National Basic Research Program of China 973 Program No. 2012CB517600 (No. 2012CB517602). The study was also sponsored by Hong Kong, Macao and the Taiwan Science & Technology Cooperation Program of China (2014DFT30090), the National Natural Science Foundation of China (81102700, 81373865), and a grant (12401906400, 13401906100, and 14140903200) from the Science and Technology Commission of Shanghai Municipality, China. Program ZYSNXD012-RC-ZXY017 of the Shanghai Health Bureau and grant ZZjdyx13049 from the Shanghai municipal education committee also aided this study.	[Anonymous], 2012, KIDNEY INT S, V2, P209, DOI DOI 10.1038/KISUP.2012.23; Ballardie FW, 2002, J AM SOC NEPHROL, V13, P142, DOI 10.1681/ASN.V131142; Barbour SJ, 2013, KIDNEY INT, V84, P1017, DOI 10.1038/ki.2013.210; Bartosik LP, 2001, AM J KIDNEY DIS, V38, P728, DOI 10.1053/ajkd.2001.27689; Berthoux F, 2011, J AM SOC NEPHROL, V22, P752, DOI 10.1681/ASN.2010040355; Byun JW, 2012, AM J DERMATOPATH, V34, P139, DOI 10.1097/DAD.0b013e3182157f90; Cattran DC, 1999, KIDNEY INT, V56, P2220, DOI 10.1046/j.1523-1755.1999.00778.x; D'Amico G, 2004, SEMIN NEPHROL, V24, P179, DOI 10.1016/j.semnephrol.2004.01.001; D'Amico G, 2000, AM J KIDNEY DIS, V36, P227, DOI 10.1053/ajkd.2000.8966; DAMICO G, 1992, AM J KIDNEY DIS, V20, P315, DOI 10.1016/S0272-6386(12)70293-7; Donadio JV, 2002, NEPHROL DIAL TRANSPL, V17, P1197, DOI 10.1093/ndt/17.7.1197; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; El Hachmi M, 2003, LUPUS, V12, P692, DOI 10.1191/0961203303lu444oa; Frimat L, 1996, NEPHROL DIAL TRANSPL, V11, P1043; Geddes CC, 2003, NEPHROL DIAL TRANSPL, V18, P1541, DOI 10.1093/ndt/gfg207; Gibson KL, 2009, CLIN J AM SOC NEPHRO, V4, P1962, DOI 10.2215/CJN.00490109; Goto M, 2009, NEPHROL DIAL TRANSPL, V24, P3068, DOI 10.1093/ndt/gfp273; Hemke AC, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-258; Hill GS, 2002, KIDNEY INT, V61, P2176, DOI 10.1046/j.1523-1755.2002.00357.x; Illei GG, 2002, ARTHRITIS RHEUM, V46, P995, DOI 10.1002/art.10142; Kim JK, 2012, CLIN J AM SOC NEPHRO, V7, P427, DOI 10.2215/CJN.04820511; Koyama A, 1997, AM J KIDNEY DIS, V29, P526, DOI 10.1016/S0272-6386(97)90333-4; Le WB, 2012, NEPHROL DIAL TRANSPL, V27, P1479, DOI 10.1093/ndt/gfr527; Lee HS, 2005, NEPHROL DIAL TRANSPL, V20, P342, DOI 10.1093/ndt/gfh633; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li XL, 2014, CLIN J AM SOC NEPHRO, V9, P484, DOI 10.2215/CJN.01990213; Moon SJ, 2013, LUPUS, V22, P527, DOI 10.1177/0961203313476357; Ni ZH, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-194; Reich HN, 2007, J AM SOC NEPHROL, V18, P3177, DOI 10.1681/ASN.2007050526; Ruggenenti P, 1998, KIDNEY INT, V53, P1209, DOI 10.1046/j.1523-1755.1998.00874.x; Sugiyama Hitoshi, 2013, Nihon Naika Gakkai Zasshi, V102, P1083; Waldman M, 2007, CLIN J AM SOC NEPHRO, V2, P445, DOI 10.2215/CJN.03531006; Xie JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038904; Yu HH, 2014, AUTOIMMUN REV, V13, P556, DOI 10.1016/j.autrev.2014.01.030	34	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137870	10.1371/journal.pone.0137870	http://dx.doi.org/10.1371/journal.pone.0137870			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371477	gold, Green Submitted, Green Published			2022-12-27	WOS:000361604400035
J	Cheng, Y; Zhang, SW; Chen, Y; Zhao, G				Cheng, Ye; Zhang, Siwen; Chen, Yong; Zhao, Gang			Safe Corridor to Access Clivus for Endoscopic Trans-Sphenoidal Surgery: A Radiological and Anatomical Study	PLOS ONE			English	Article							INTERNAL CAROTID-ARTERY; SELLAR REGION; CLASSIFICATION; TOMOGRAPHY	Purpose Penetration of the clivus is required for surgical access of the brain stem. The endoscopic transclivus approach is a difficult procedure with high risk of injury to important neurovascular structures. We undertook a novel anatomical and radiological investigation to understand the structure of the clivus and neurovascular structures relevant to the extended trans-nasal trans-sphenoid procedure and determine a safe corridor for the penetration of the clivus. Method We examined the clivus region in the computed tomographic angiography (CTA) images of 220 adults, magnetic resonance (MR) images of 50 adults, and dry skull specimens of 10 adults. Multiplanar reconstruction (MPR) of the CT images was performed, and the anatomical features of the clivus were studied in the coronal, sagittal, and axial planes. The data from the images were used to determine the anatomical parameters of the clivus and neurovascular structures, such as the internal carotid artery and inferior petrosal sinus. Results The examination of the CTA and MR images of the enrolled subjects revealed that the thickness of the clivus helped determine the depth of the penetration, while the distance from the sagittal midline to the important neurovascular structures determined the width of the penetration. Further, data from the CTA and MR images were consistent with those retrieved from the examination of the cadaveric specimens. Conclusion Our findings provided certain pointers that may be useful in guiding the surgery such that inadvertent injury to vital structures is avoided and also provided supportive information for the choice of the appropriate endoscopic equipment.	[Cheng, Ye; Chen, Yong; Zhao, Gang] Jilin Univ, Hosp 1, Dept Neurosurg, Changchun 130023, Jilin Province, Peoples R China; [Zhang, Siwen] Jilin Univ, Hosp 1, Dept Endocrine, Changchun 130023, Jilin Province, Peoples R China	Jilin University; Jilin University	Chen, Y (corresponding author), Jilin Univ, Hosp 1, Dept Neurosurg, Changchun 130023, Jilin Province, Peoples R China.	chenyong_jdyy@163.com; zhaogang_jdyy@163.com						Alfieri A, 1999, J Neurosurg Sci, V43, P85; Bouthillier A, 1996, NEUROSURGERY, V38, P425, DOI 10.1097/00006123-199603000-00001; Cheng Y, 2013, SURG RADIOL ANAT, V35, P797, DOI 10.1007/s00276-013-1193-2; Cobb WS, 2010, NEUROSURGERY, V67, DOI 10.1227/NEU.0b013e3181fa24f4; Danner C, 2004, OTOL NEUROTOL, V25, P762, DOI 10.1097/00129492-200409000-00019; Fraser JF, 2010, J NEUROSURG, V112, P1061, DOI 10.3171/2009.7.JNS081504; Gondim J, 2003, ARQ NEURO-PSIQUIAT, V61, P836, DOI 10.1590/S0004-282X2003000500024; Guldner C, 2012, ACTA RADIOL, V53, P214, DOI 10.1258/ar.2011.110381; Iyer NG, 2012, HEAD NECK-J SCI SPEC, V34, P1071, DOI 10.1002/hed.21878; Locatelli M, 2013, PITUITARY, V16, P146, DOI 10.1007/s11102-012-0390-z; Mason E, 2014, LARYNGOSCOPE, V124, P628, DOI 10.1002/lary.24378; Natarajan SK, 2007, NEUROSURGERY, V60, P965, DOI 10.1227/01.NEU.0000255472.52882.D6; Ogawa Y, 2012, ACTA NEUROCHIR, V154, P621, DOI 10.1007/s00701-011-1266-0; Rhoton AL, 2007, NEUROSURGERY, V61, P37, DOI 10.1227/01.NEU.0000255490.88321.CE; SEKHAR L N, 1989, Contemporary Neurosurgery, V11, P1; Van Gompel JJ, 2014, J NEUROSURG, V120, P1321, DOI 10.3171/2014.2.JNS131773; Wang CY, 2013, J CRANIOFAC SURG, V24, P1418, DOI 10.1097/SCS.0b013e318292c970; Yilmazlar S, 2012, J CRANIO MAXILL SURG, V40, pE198, DOI 10.1016/j.jcms.2011.10.008; Zhang HJ, 2013, J CRANIOFAC SURG, V24, P1011, DOI 10.1097/SCS.0b013e318287d228	19	5	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137962	10.1371/journal.pone.0137962	http://dx.doi.org/10.1371/journal.pone.0137962			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368821	Green Submitted, Green Published, gold			2022-12-27	WOS:000361601100186
J	Du, Y; Ge, MM; Xue, WZ; Yang, QQ; Wang, S; Xu, Y; Wang, HL				Du, Yang; Ge, Meng-Meng; Xue, Weizhen; Yang, Qian-Qian; Wang, Shuang; Xu, Yi; Wang, Hui-Li			Chronic Lead Exposure and Mixed Factors of GenderxAgexBrain Regions Interactions on Dendrite Growth, Spine Maturity and NDR Kinase	PLOS ONE			English	Article							GENDER-DIFFERENCES; CHILDREN; NEUROTOXICITY; RAT; MECHANISMS; BRAIN; INTELLIGENCE; HIPPOCAMPUS; MORPHOLOGY; TOXICITY	NDR1/2 kinase is essential in dendrite morphology and spine formation, which is regulated by cellular Ca2+. Lead (Pb) is a potent blocker of L-type calcium channel and our recent work showed Pb exposure impairs dendritic spine outgrowth in hippocampal neurons in rats. But the sensitivity of Pb-induced spine maturity with mixed factors (genderxagexbrain regions) remains unknown. This study aimed to systematically investigate the effect of Pb exposure on spine maturity in rat brain with three factors (genderxagexbrain regions), as well as the NDR1/2 kinase expression. Sprague-Dawley rats were exposed to Pb from parturition to postnatal day 30, 60, 90, respectively. Golgi-Cox staining was used to examine spine maturity. Western blot assay was applied to measure protein expression and realtime fluorescence quantitative PCR assay was used to examine mRNA levels. The results showed chronic Pb exposure significantly decreased dendritic length and impaired spine maturity in both rat hippocampus and medial prefrontal cortex. The impairment of dendritic length induced by Pb exposure tended to adolescence > adulthood, hippocampus > medial prefrontal cortex and female > male. Pb exposure induced significant damage in spine maturity during adolescence and early adult while little damage during adult in male rat brain and female medial prefrontal cortex. Besides, there was sustained impairment from adolescence to adulthood in female hippocampus. Interestingly, impairment of spine maturity followed by Pb exposure was correlated with NDR1/2 kinase. The reduction of NDR1/2 kinase protein expression after Pb exposure was similar to the result of spine maturity. In addition, NDR2 and their substrate Rabin3 mRNA levels were significantly decreased by Pb exposure in developmental rat brain. Taken together, Pb exposure impaired dendrite growth and maturity which was subject to genderxagexbrain regions effects and related to NDR1/2 signal expression.	[Du, Yang; Ge, Meng-Meng; Xue, Weizhen; Yang, Qian-Qian; Wang, Shuang; Xu, Yi; Wang, Hui-Li] Hefei Univ Technol, Sch Biotechnol & Food Engn, Hefei 230009, Anhui, Peoples R China	Hefei University of Technology	Wang, HL (corresponding author), Hefei Univ Technol, Sch Biotechnol & Food Engn, Hefei 230009, Anhui, Peoples R China.	wanghl@hfut.edu.cn		Wang, Hui-Li/0000-0001-6852-8002	National Key Basic Research Program of China (973 Program) [2012CB525003]; National Science Foundation of China [21477031, 31200851, 31401671]; Program for New Century Excellent Talents in University [NCET-12-0835]; Specialized Research Fund for the Doctoral Program of Higher Education [2013011110024]; Anhui University of Chinese Medicine [2015sbgj005]; Huangshan Young Scholar Fund of Hefei University of Technology [407-037030]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Anhui University of Chinese Medicine; Huangshan Young Scholar Fund of Hefei University of Technology	This work was supported by the National Key Basic Research Program of China (973 Program, No. 2012CB525003), the National Science Foundation of China (No. 21477031, 31200851, 31401671), the Program for New Century Excellent Talents in University (NCET-12-0835), Specialized Research Fund for the Doctoral Program of Higher Education (No. 2013011110024), Anhui University of Chinese Medicine (No. 2015sbgj005), the Huangshan Young Scholar Fund of Hefei University of Technology (407-037030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann L, 1998, NEUROTOXICOL TERATOL, V20, P9, DOI 10.1016/S0892-0362(97)00070-6; Andrade V, 2014, NEUROTOXICOLOGY, V45, P168, DOI 10.1016/j.neuro.2014.10.009; Araya R, 2014, P NATL ACAD SCI USA, V111, pE2895, DOI 10.1073/pnas.1321869111; BAGHURST PA, 1992, NEW ENGL J MED, V327, P1279, DOI 10.1056/NEJM199210293271805; Battaglia FP, 2011, TRENDS COGN SCI, V15, P310, DOI 10.1016/j.tics.2011.05.008; BELLINGER D, 1987, NEW ENGL J MED, V316, P1037, DOI 10.1056/NEJM198704233161701; BELLINGER DC, 1992, PEDIATRICS, V90, P855; Bjorkman L, 2000, ENVIRON HEALTH PERSP, V108, P719, DOI 10.2307/3434724; Bowman RE, 2015, HORM BEHAV, V69, P89, DOI 10.1016/j.yhbeh.2014.12.007; Bressler J, 1999, NEUROCHEM RES, V24, P595, DOI 10.1023/A:1022596115897; BUSSELBERG D, 1994, CELL MOL NEUROBIOL, V14, P711, DOI 10.1007/BF02088679; Chapleau CA, 2008, J NEUROSCI METH, V169, P182, DOI 10.1016/j.jneumeth.2007.12.006; Cressey D, 2013, NATURE, V500, P130, DOI 10.1038/500130a; Dall'Oglio A, 2015, J ANAT, V227, P440, DOI 10.1111/joa.12358; Devroe E, 2004, J BIOL CHEM, V279, P24444, DOI 10.1074/jbc.M401999200; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Fan GQ, 2013, TOXICOL IN VITRO, V27, P387, DOI 10.1016/j.tiv.2012.06.019; Finkelstein Y, 1998, BRAIN RES REV, V27, P168, DOI 10.1016/S0165-0173(98)00011-3; Florea A-M, 2013, J LOCAL GLOBAL HLTH; Ge MM, 2015, RSC ADV, V5, P31622, DOI 10.1039/c5ra00315f; GRANT LD, 1980, TOXICOL APPL PHARM, V56, P42, DOI 10.1016/0041-008X(80)90130-1; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Jedrychowski W, 2009, EARLY HUM DEV, V85, P503, DOI 10.1016/j.earlhumdev.2009.04.006; Jett DA, 1997, PHARMACOL BIOCHEM BE, V57, P271, DOI 10.1016/S0091-3057(96)00350-4; KIRALY E, 1982, EXP NEUROL, V77, P236, DOI 10.1016/0014-4886(82)90158-3; Lidsky TI, 2003, BRAIN, V126, P5, DOI 10.1093/brain/awg014; Liu ZH, 2015, TOXICOL RES-UK, V4, P686, DOI 10.1039/c4tx00093e; Llop S, 2013, TOXICOLOGY, V311, P3, DOI 10.1016/j.tox.2013.04.015; LYNGBYE T, 1990, ACTA PAEDIATR SCAND, V79, P352, DOI 10.1111/j.1651-2227.1990.tb11469.x; Madison JL, 2011, NEUROTOXICOLOGY, V32, P896, DOI 10.1016/j.neuro.2011.05.007; Mason LH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/840547; Matsuo N, 2008, SCIENCE, V319, P1104, DOI 10.1126/science.1149967; McCarthy MM, 2012, J NEUROSCI, V32, P2241, DOI 10.1523/JNEUROSCI.5372-11.2012; Medvedev NI, 2014, BRAIN STRUCT FUNCT, V219, P407, DOI 10.1007/s00429-012-0488-0; Mendola P, 2002, MENT RETARD DEV D R, V8, P188, DOI 10.1002/mrdd.10033; Millward TA, 1998, EMBO J, V17, P5913, DOI 10.1093/emboj/17.20.5913; Muller Dominique, 2002, Current Molecular Medicine (Hilversum), V2, P605, DOI 10.2174/1566524023362041; Paula-Lima AC, 2014, ANTIOXID REDOX SIGN, V21, P892, DOI 10.1089/ars.2013.5796; Peng SQ, 2002, MOL PHARMACOL, V62, P1418, DOI 10.1124/mol.62.6.1418; PETIT TL, 1979, EXP NEUROL, V64, P482, DOI 10.1016/0014-4886(79)90226-7; Rehberg K, 2014, J NEUROSCI, V34, P5342, DOI 10.1523/JNEUROSCI.2728-13.2014; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Schneider JS, 2012, TOXICOL SCI, V129, P108, DOI 10.1093/toxsci/kfs189; Seo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105308; Stork O, 2004, J BIOL CHEM, V279, P45773, DOI 10.1074/jbc.M403552200; Tatsuta N, 2014, ENVIRON RES, V133, P321, DOI 10.1016/j.envres.2014.05.024; Tong SL, 2000, ARCH ENVIRON HEALTH, V55, P330, DOI 10.1080/00039890009604025; Ultanir SK, 2012, NEURON, V73, P1127, DOI 10.1016/j.neuron.2012.01.019; Vahter M, 2007, ENVIRON RES, V104, P85, DOI 10.1016/j.envres.2006.08.003; Wang JX, 2014, SCIENCE, V345, P1054, DOI 10.1126/science.1252900; Yang H, 2013, ENVIRON SCI POLLUT R, V20, P4441, DOI 10.1007/s11356-012-1366-2	53	10	10	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138112	10.1371/journal.pone.0138112	http://dx.doi.org/10.1371/journal.pone.0138112			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368815	Green Submitted, gold, Green Published			2022-12-27	WOS:000361601100228
J	Huang, K; Bi, K; Liang, C; Lin, S; Wang, WJ; Yang, TZ; Liu, J; Zhang, R; Fan, DY; Wang, YG; Lei, M				Huang, K.; Bi, K.; Liang, C.; Lin, S.; Wang, W. J.; Yang, T. Z.; Liu, J.; Zhang, R.; Fan, D. Y.; Wang, Y. G.; Lei, M.			Graphite Carbon-Supported Mo2C Nanocomposites by a Single-Step Solid State Reaction for Electrochemical Oxygen Reduction	PLOS ONE			English	Article							ANION-EXCHANGE MEMBRANES; MOLYBDENUM CARBIDE; CATALYTIC-ACTIVITY; METAL CARBIDES; FACILE ROUTE; FUEL-CELLS; ELECTROCATALYSTS; PERFORMANCE; NITRIDES; GRAPHENE	Novel graphite-molybdenum carbide nanocomposites (G-Mo2C) are synthesized by a typical solid state reaction with melamine and MoO3 as precursors under inert atmosphere. The characterization results indicate that G-Mo2C composites are composed of high crystallization and purity of Mo2C and few layers of graphite carbon. Mo2C nanoparticles with sizes ranging from 5 to 50 nm are uniformly supported by surrounding graphite layers. It is believed that Mo atom resulting from the reduction of MoO3 is beneficial to the immobilization of graphite carbon. Moreover, the electrocatalytic performances of G-Mo2C for ORR in alkaline medium are investigated by cyclic voltammetry (CV), rotating disk electrode (RDE) and chronoamperometry test with 3M methanol. The results show that G-Mo2C has a considerable catalytic activity and superior methanol tolerance performance for the oxygen reduction reaction (ORR) benefiting from the chemical interaction between the carbide nanoparticles and graphite carbon.	[Huang, K.; Bi, K.; Liang, C.; Lin, S.; Zhang, R.; Fan, D. Y.; Wang, Y. G.; Lei, M.] Beijing Univ Posts & Telecommun, State Key Lab Informat Photon & Opt Commun, Beijing 100088, Peoples R China; [Huang, K.; Bi, K.; Liang, C.; Lin, S.; Zhang, R.; Fan, D. Y.; Wang, Y. G.; Lei, M.] Beijing Univ Posts & Telecommun, Sch Sci, Beijing 100088, Peoples R China; [Wang, W. J.; Yang, T. Z.] Chinese Acad Sci, Inst Phys, Beijing Natl Lab Condensed Matter Phys, Beijing 100080, Peoples R China; [Liu, J.] Cent S Univ, Sch Mat Sci & Engn, Changsha, Hunan, Peoples R China	Beijing University of Posts & Telecommunications; Beijing University of Posts & Telecommunications; Chinese Academy of Sciences; Institute of Physics, CAS; Central South University	Wang, WJ (corresponding author), Chinese Acad Sci, Inst Phys, Beijing Natl Lab Condensed Matter Phys, POB 603, Beijing 100080, Peoples R China.	wjwang@iphy.ac.cn; minglei@bupt.edu.cn	Bi, Ke/C-1175-2011	Bi, Ke/0000-0002-3357-5754	National Basic Research Program of China [2013CB932901]; Program for New Century Excellent Talents in University [NCET-13-0684]; State Key Laboratory of Information Photonics and Optical Communications (Beijing University of Posts and Telecommunications, P. R. China); National Natural Science Foundation of China [61376018, 61377097, 51102019, 61177085, 51272031, 51472033]	National Basic Research Program of China(National Basic Research Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); State Key Laboratory of Information Photonics and Optical Communications (Beijing University of Posts and Telecommunications, P. R. China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by The National Basic Research Program of China (Grant No. 2013CB932901), Program for New Century Excellent Talents in University (NCET-13-0684), Fund of State Key Laboratory of Information Photonics and Optical Communications (Beijing University of Posts and Telecommunications, P. R. China), and National Natural Science Foundation of China (Grant nos. 61376018,61377097,51102019, 61177085, 51272031,51472033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao R, 2012, ADV ENERGY MATER, V2, P816, DOI 10.1002/aenm.201200013; Cheekatamarla PK, 2005, APPL CATAL A-GEN, V287, P176, DOI 10.1016/j.apcata.2005.03.043; Cheekatamarla PK, 2006, J POWER SOURCES, V158, P477, DOI 10.1016/j.jpowsour.2005.09.009; Chen R, 2013, SCI ADV MATER, V5, P1788, DOI 10.1166/sam.2013.1632; Cheng FY, 2012, CHEM SOC REV, V41, P2172, DOI 10.1039/c1cs15228a; Politi JRD, 2013, PHYS CHEM CHEM PHYS, V15, P12617, DOI 10.1039/c3cp51389k; Gillan EG, 2000, CHEM MATER, V12, P3906, DOI 10.1021/cm000570y; Hardin WG, 2013, J PHYS CHEM LETT, V4, P1254, DOI 10.1021/jz400595z; Huang K, 2015, SCI REP-UK, V5, DOI 10.1038/srep11351; Jager R, 2013, ELECTROCHEM COMMUN, V35, P97, DOI 10.1016/j.elecom.2013.08.001; Jirkovsky JS, 2010, PHYS CHEM CHEM PHYS, V12, P8042, DOI 10.1039/c002416c; Jurgens B, 2003, J AM CHEM SOC, V125, P10288, DOI 10.1021/ja0357689; Kartachova O, 2014, J MATER CHEM A, V2, P12940, DOI 10.1039/c4ta00220b; Khabashesku VN, 2000, CHEM MATER, V12, P3264, DOI 10.1021/cm000328r; Kong AG, 2014, ACS CATAL, V4, P1793, DOI 10.1021/cs401257j; Lei M, 2009, J EUR CERAM SOC, V29, P195, DOI 10.1016/j.jeurceramsoc.2008.06.002; Lei M, 2008, J ALLOY COMPD, V460, P130, DOI 10.1016/j.jallcom.2007.05.076; Lei M, 2014, SCI REP-UK, V4, DOI 10.1038/srep07415; Lei M, 2014, SCI REP-UK, V4, DOI 10.1038/srep06013; Lei M, 2011, J ALLOY COMPD, V509, P5769, DOI 10.1016/j.jallcom.2011.02.029; Lei M, 2011, J POWER SOURCES, V196, P3548, DOI 10.1016/j.jpowsour.2010.12.026; Li JR, 2013, CHEM COMMUN, V49, P6537, DOI 10.1039/c3cc42011f; Liang C, 2014, J MATER CHEM A, V2, P753, DOI 10.1039/c3ta14064d; Liao L, 2014, PHYS CHEM CHEM PHYS, V16, P10088, DOI 10.1039/c3cp54754j; Lin BC, 2014, J POWER SOURCES, V266, P186, DOI 10.1016/j.jpowsour.2014.05.003; Lin L, 2014, J POWER SOURCES, V268, P269, DOI 10.1016/j.jpowsour.2014.06.062; Lotsch BV, 2005, CHEM MATER, V17, P3976, DOI 10.1021/cm050350q; Ma YF, 2014, J PHYS CHEM C, V118, P9485, DOI 10.1021/jp501021t; Pandey RP, 2014, J MEMBRANE SCI, V469, P478, DOI 10.1016/j.memsci.2014.06.046; Ren XM, 2014, ACS APPL MATER INTER, V6, P13330, DOI 10.1021/am503870g; Savinelli R, 2009, 21 NAM P W 68; Song B, 2008, PHYSICA B, V403, P2897, DOI 10.1016/j.physb.2008.02.032; Song B, 2007, CHEM MATER, V19, P1497, DOI 10.1021/cm062796s; Stottlemyer AL, 2012, SURF SCI REP, V67, P201, DOI 10.1016/j.surfrep.2012.07.001; Tominaga H, 2012, APPL CATAL A-GEN, V423, P192, DOI 10.1016/j.apcata.2012.02.041; Tuci G, 2014, CHEM MATER, V26, P3460, DOI 10.1021/cm500805c; Uhm S, 2011, ELECTROCHIM ACTA, V56, P9186, DOI 10.1016/j.electacta.2011.07.108; Vines F, 2007, J PHYS CHEM C, V111, P16982, DOI 10.1021/jp0754987; Wan C, 2014, ANGEW CHEM INT EDIT, V53, P6407, DOI 10.1002/anie.201402998; Wang JT, 2013, J POWER SOURCES, V240, P381, DOI 10.1016/j.jpowsour.2013.03.189; Wang SY, 2011, J AM CHEM SOC, V133, P5182, DOI 10.1021/ja1112904; Wu P, 2014, SCI REP-UK, V4, DOI 10.1038/srep03968; Xia BY, 2012, ANGEW CHEM INT EDIT, V51, P7213, DOI 10.1002/anie.201201553; Yan ZX, 2013, ELECTROCHIM ACTA, V95, P218, DOI 10.1016/j.electacta.2013.02.031; Yang W, 2012, INT J HYDROGEN ENERG, V37, P942, DOI 10.1016/j.ijhydene.2011.03.103; Yang YQ, 2014, J MEMBRANE SCI, V467, P48, DOI 10.1016/j.memsci.2014.05.017; Zhao HZ, 2006, J MATER CHEM, V16, P4407, DOI 10.1039/b611381h	47	20	20	2	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138330	10.1371/journal.pone.0138330	http://dx.doi.org/10.1371/journal.pone.0138330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381266	Green Published, gold, Green Submitted			2022-12-27	WOS:000361790200092
J	Koo, DH; Sehgal, SK; Friebe, B; Gill, BS				Koo, Dal-Hoe; Sehgal, Sunish K.; Friebe, Bernd; Gill, Bikram S.			Structure and Stability of Telocentric Chromosomes in Wheat	PLOS ONE			English	Article							CENTROMERIC RETROTRANSPOSONS; MAIZE CENTROMERES; CHROMATIN; REPEAT; DNA; HETEROCHROMATIN; NEOCENTROMERES; IDENTIFICATION; NOMENCLATURE; MISDIVISION	In most eukaryotes, centromeres assemble at a single location per chromosome. Naturally occurring telocentric chromosomes (telosomes) with a terminal centromere are rare but do exist. Telosomes arise through misdivision of centromeres in normal chromosomes, and their cytological stability depends on the structure of their kinetochores. The instability of telosomes may be attributed to the relative centromere size and the degree of completeness of their kinetochore. Here we test this hypothesis by analyzing the cytogenetic structure of wheat telosomes. We used a population of 80 telosomes arising from the misdivision of the 21 chromosomes of wheat that have shown stable inheritance overmany generations. We analyzed centromere size by probing with the centromere-specific histone H3 variant, CENH3. Comparing the signal intensity for CENH3 between the intact chromosome and derived telosomes showed that the telosomes had approximately half the signal intensity compared to that of normal chromosomes. Immunofluorescence of CENH3 in a wheat stock with 28 telosomes revealed that none of the telosomes received a complete CENH3 domain. Some of the telosomes lacked centromere specific retrotransposons of wheat in the CENH3 domain, indicating that the stability of telosomes depends on the presence of CENH3 chromatin and not on the presence of CRW repeats. In addition to providing evidence for centromere shift, we also observed chromosomal aberrations including inversions and deletions in the short arm telosomes of double ditelosomic 1D and 6D stocks. The role of centromere-flanking, pericentromeric heterochromatin in mitosis is discussed with respect to genome/chromosome integrity.	[Koo, Dal-Hoe; Friebe, Bernd; Gill, Bikram S.] Kansas State Univ, Throckmorton Plant Sci Ctr, Wheat Genet Resource Ctr, Dept Plant Pathol, Manhattan, KS 66506 USA; [Sehgal, Sunish K.] S Dakota State Univ, Dept Plant Sci, Brookings, SD 57007 USA	Kansas State University; South Dakota State University	Friebe, B (corresponding author), Kansas State Univ, Throckmorton Plant Sci Ctr, Wheat Genet Resource Ctr, Dept Plant Pathol, Manhattan, KS 66506 USA.	friebe@ksu.edu			Kansas Crop Association; National Science Foundation; Wheat Genetics Resource Center, Kansas State University	Kansas Crop Association; National Science Foundation(National Science Foundation (NSF)); Wheat Genetics Resource Center, Kansas State University	This research was financially supported by the Kansas Crop Association and by members of the Wheat Genetics Resource Center Industry/University Cooperative Research Center. The following companies and associations make up the membership: Bayer Cropscience, Dow AgroSciences, General Mills, Limagrain, Syngenta, Heartland Plant Innovations, DuPont Pioneer, Kansas Wheat Commission, Kansas Wheat Alliance, and the Kansas Department of Agriculture. The National Science Foundation also provided financial support. The public/private consortium is aimed at pre-competitive wheat genetics research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dal-Hoe Koo, Bernd Friebe and Bikram S. Gill are affiliated to Wheat Genetics Resource Center, University of Kansas. Wheat Genetics Resource Center, Kansas State University provided support in the form of salaries for authors DHK, BF and BSG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AragonAlcaide L, 1996, CHROMOSOMA, V105, P261, DOI 10.1007/BF02524643; Cheng ZK, 2002, PLANT CELL, V14, P1691, DOI 10.1105/tpc.003079; Cheng ZK, 2001, GENETICS, V157, P361; Danilova TV, 2014, THEOR APPL GENET, V127, P715, DOI 10.1007/s00122-013-2253-z; Darlington CD, 1939, J GENET, V37, P341, DOI 10.1007/BF02982733; Dolezel J, 2004, CHROMOSOME RES, V12, P77, DOI 10.1023/B:CHRO.0000009293.15189.e5; Dolezel J, 2007, CHROMOSOME RES, V15, P51, DOI 10.1007/s10577-006-1106-x; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; Erayman M, 2004, NUCLEIC ACIDS RES, V32, P3546, DOI 10.1093/nar/gkh639; Folco HD, 2008, SCIENCE, V319, P94, DOI 10.1126/science.1150944; Fu SL, 2013, P NATL ACAD SCI USA, V110, P6033, DOI 10.1073/pnas.1303944110; Gill BS, 2004, GENETICS, V168, P1087, DOI 10.1534/genetics.104.034769; GILL BS, 1991, GENOME, V34, P830, DOI 10.1139/g91-128; Gill KS, 1999, THEOR APPL GENET, V98, P1248, DOI 10.1007/s001220051190; Gong ZY, 2012, PLANT CELL, V24, P3559, DOI 10.1105/tpc.112.100511; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Ito H, 2004, GENOME, V47, P747, DOI 10.1139/G04-034; Jiang JM, 2003, TRENDS PLANT SCI, V8, P570, DOI 10.1016/j.tplants.2003.10.011; Jin WW, 2004, PLANT CELL, V16, P571, DOI 10.1105/tpc.018937; Ketel C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000400; Koo DH, 2011, GENOME RES, V21, P908, DOI 10.1101/gr.116202.110; Koo DH, 2009, PLANT J, V59, P509, DOI 10.1111/j.1365-313X.2009.03881.x; Lee HR, 2005, P NATL ACAD SCI USA, V102, P11793, DOI 10.1073/pnas.0503863102; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Li BC, 2013, PLANT J, V73, P952, DOI 10.1111/tpj.12086; Liu WX, 2011, CHROMOSOME RES, V19, P669, DOI 10.1007/s10577-011-9226-3; Liu Z, 2008, CHROMOSOMA, V117, P445, DOI 10.1007/s00412-008-0161-9; Lo AWI, 2001, EMBO J, V20, P2087, DOI 10.1093/emboj/20.8.2087; Lomiento M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r173; Maggert KA, 2001, GENETICS, V158, P1615; MARKS GE, 1957, AM NAT, V91, P223, DOI 10.1086/281981; Marshall OJ, 2008, AM J HUM GENET, V82, P261, DOI 10.1016/j.ajhg.2007.11.009; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Mutti JS, 2010, MOL BREEDING, V26, P177, DOI 10.1007/s11032-009-9389-1; Naranjo T., 1988, Proceedings of the seventh international wheat genetics symposium, held at Cambridge, UK, 13-19 July 1988., P115; Nasuda S, 2005, P NATL ACAD SCI USA, V102, P9842, DOI 10.1073/pnas.0504235102; Neumann P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002777; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Qi LL, 2004, GENETICS, V168, P701, DOI 10.1534/genetics.104.034868; Rayburn A. L., 1986, PLANT MOL BIOL REP, V4, P102, DOI [10.1007/BF02732107, DOI 10.1007/BF02732107, /10.1007/BF02732107]; Rhoades MM, 1940, GENETICS, V25, P483; SCHUBERT I, 1990, GENETICA, V81, P67, DOI 10.1007/BF00055238; Scott KC, 2014, TRENDS GENET, V30, P66, DOI 10.1016/j.tig.2013.11.003; Sears E. R., 1988, Proceedings of the seventh international wheat genetics symposium, held at Cambridge, UK, 13-19 July 1988., P427; Sears E.R., 1978, P 5 INT WHEAT GEN S, P389; Shang WH, 2013, DEV CELL, V24, P635, DOI 10.1016/j.devcel.2013.02.009; Sharp JA, 2003, CURR TOP MICROBIOL, V274, P23; Singh RJ, 2003, PLANT CYTOGENETICS, P216; SOUTHERN DI, 1969, CHROMOSOMA, V26, P140, DOI 10.1007/BF00326451; STEINITZSEARS LM, 1966, GENETICS, V54, P241; STRID A, 1968, BOT NOTISER, V121, P153; TAKAGI N, 1974, CHROMOSOMA, V46, P91, DOI 10.1007/BF00332341; Talbert PB, 2002, PLANT CELL, V14, P1053, DOI 10.1105/tpc.010425; Topp CN, 2009, CYTOGENET GENOME RES, V124, P228, DOI 10.1159/000218128; Tsuchiya R., 1972, Seiken Ziho, P47; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang K, 2014, GENOME RES, V24, P107, DOI 10.1101/gr.160887.113; Wanner G, 2015, CHROMOSOMA, V124, P503, DOI 10.1007/s00412-015-0521-1; WHITE M J D, 1973, P961; Wicker T, 2011, PLANT CELL, V23, P1706, DOI 10.1105/tpc.111.086629; Yu HG, 2000, TRENDS PLANT SCI, V5, P543, DOI 10.1016/S1360-1385(00)01789-1; Zhang P, 2001, CHROMOSOMA, V110, P335, DOI 10.1007/s004120100159	63	10	10	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137747	10.1371/journal.pone.0137747	http://dx.doi.org/10.1371/journal.pone.0137747			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381743	gold, Green Submitted, Green Published			2022-12-27	WOS:000361790200036
J	Shanks, L; Bil, K; Fernhout, J				Shanks, Leslie; Bil, Karla; Fernhout, Jena			Learning without Borders: A Review of the Implementation of Medical Error Reporting in Medecins Sans Frontieres	PLOS ONE			English	Article							ADVERSE EVENTS; PATIENT SAFETY; HOSPITALS	Objective To analyse the results from the first 3 years of implementation of a medical error reporting system in Medecins Sans Frontieres-Operational Centre Amsterdam (MSF) programs. Methodology A medical error reporting policy was developed with input from frontline workers and introduced to the organisation in June 2010. The definition of medical error used was "the failure of a planned action to be completed as intended or the use of a wrong plan to achieve an aim." All confirmed error reports were entered into a database without the use of personal identifiers. Results 179 errors were reported from 38 projects in 18 countries over the period of June 2010 to May 2013. The rate of reporting was 31, 42, and 106 incidents/year for reporting year 1, 2 and 3 respectively. The majority of errors were categorized as dispensing errors (62 cases or 34.6%), errors or delays in diagnosis (24 cases or 13.4%) and inappropriate treatment (19 cases or 10.6%). The impact of the error was categorized as no harm (58, 32.4%), harm (70, 39.1%), death (42, 23.5%) and unknown in 9 (5.0%) reports. Disclosure to the patient took place in 34 cases (19.0%), did not take place in 46 (25.7%), was not applicable for 5 (2.8%) cases and not reported for 94 (52.5%). Remedial actions introduced at headquarters level included guideline revisions and changes to medical supply procedures. At field level improvements included increased training and supervision, adjustments in staffing levels, and adaptations to the organization of the pharmacy. Conclusion It was feasible to implement a voluntary reporting system for medical errors despite the complex contexts in which MSF intervenes. The reporting policy led to system changes that improved patient safety and accountability to patients. Challenges remain in achieving widespread acceptance of the policy as evidenced by the low reporting and disclosure rates.	[Shanks, Leslie; Bil, Karla; Fernhout, Jena] Med Sans Frontieres, Operat Ctr Amsterdam, NL-1001 EA Amsterdam, Netherlands	Doctors Without Borders	Shanks, L (corresponding author), Med Sans Frontieres, Operat Ctr Amsterdam, Plantage Middenlaan 14,POB 10014, NL-1001 EA Amsterdam, Netherlands.	leslie.shanks@amsterdam.msf.org						Al-Mandhari Ahmed S, 2008, BMC Med Ethics, V9, P13, DOI 10.1186/1472-6939-9-13; Aranaz-Andres JM, 2011, BMJ QUAL SAF, V20, P1043, DOI 10.1136/bmjqs.2011.051284; Classen DC, 2011, HEALTH AFFAIR, V30, P581, DOI 10.1377/hlthaff.2011.0190; de Vries EN, 2008, QUAL SAF HEALTH CARE, V17, P216, DOI 10.1136/qshc.2007.023622; Denning MW, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6166; El-Jardali F, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-45; Hammami MM, 2010, BMC MED ETHICS, V11, DOI 10.1186/1472-6939-11-17; Kaldjian LC, 2006, J GEN INTERN MED, V21, P942, DOI 10.1007/BF02743142; Kalra J, 2013, CLIN BIOCHEM, V46, P1161, DOI 10.1016/j.clinbiochem.2013.03.025; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Leape L L, 1993, QRB Qual Rev Bull, V19, P144; Levinson W, 2009, PATIENT EDUC COUNS, V76, P296, DOI 10.1016/j.pec.2009.07.018; Medecins Sans (MSF) Ethics Review Board, 2013, MED SANS FRONT RES E; MSF International, MSF REF BOOKS; *NCC MERP, NCC MERP IND CAT MED; Neuspiel DR, 2011, PEDIATRICS, V128, pE1608, DOI 10.1542/peds.2011-0477; Parmelli E, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005609.pub2; Pham JC, 2010, QUAL SAF HEALTH CARE, V19, P446, DOI 10.1136/qshc.2009.037739; Sari AA, 2010, IRAN J PUBLIC HEALTH, V39, P1; Shanks L., 2014, J HUMANITARIAN ASSIS; Ushie BA, 2013, AFR HEALTH SCI, V13, P820, DOI 10.4314/ahs.v13i3.43; WHO, 2002, QUAL CAR PAT SAF; Wilson RM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e832; World Health Organization, SURG SAF CHECKL; World Health Organization, 2005, WHO DRAFT GUID ADV E; World Health Organization, 2011, WHO PAT SAF CURR GUI; Wu AW, 2011, VALUE CLOSE CALLS IM; Zwart DLM, 2011, BMJ QUAL SAF, V20, P121, DOI 10.1136/bmjqs.2009.033472	28	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137158	10.1371/journal.pone.0137158	http://dx.doi.org/10.1371/journal.pone.0137158			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381622	Green Published, gold, Green Submitted			2022-12-27	WOS:000361790200015
J	van der Steen, M; Leenstra, T; Kluytmans, JAJW; van der Bij, AK				van der Steen, Matthijs; Leenstra, Tjalling; Kluytmans, Jan A. J. W.; van der Bij, Akke K.		ISIS-AR Study Grp	Trends in Expanded-Spectrum Cephalosporin-Resistant Escherichia coli and Klebsiella pneumoniae among Dutch Clinical Isolates, from 2008 to 2012	PLOS ONE			English	Article							BETA-LACTAMASES; RISK-FACTORS; CTX-M; BACTEREMIA; INFECTIONS; SEQUENCE; IMPACT; CARE	We investigated time trends in extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates from different patient settings in The Netherlands from 2008-2012. E. coli and K. pneumoniae isolates from blood and urine samples of patients > = 18 years were selected from the Dutch Infectious Disease Surveillance System-Antimicrobial Resistance (ISIS-AR) database. We used multivariable Poisson regression to study the rate per year of blood stream infections by susceptible and resistant isolates, and generalized estimating equation (GEE) log-binomial regression for trends in the proportion of extended-spectrum cephalosporin-resistant isolates. Susceptibility data of 197,513 E. coli and 38,244 K. pneumoniae isolates were included. The proportion of extended-spectrum cephalosporin-resistant E. coli and K. pneumoniae isolates from urine and blood samples increased in all patient settings, except for K. pneumoniae isolates from patients admitted to intensive care units. For K. pneumoniae, there was a different time trend between various patient groups (p<0.01), with a significantly higher increase in extended-spectrum cephalosporin-resistant isolates from patients attending a general practitioner than in isolates from hospitalized patients. For E. coli, the increasing time trends did not differ among different patient groups. This nationwide study shows a general increase in extended-spectrum cephalosporin-resistant E. coli and K. pneumoniae isolates. However, differences in trends between E. coli en K. pneumoniae underline the importance of E. coli as a community-pathogen and its subsequent influence on hospital resistance level, while for K. pneumoniae the level of resistance within the hospital seems less influenced by the resistance trends in the community.	[van der Steen, Matthijs; Leenstra, Tjalling; van der Bij, Akke K.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control CIb, Bilthoven, Netherlands; [van der Steen, Matthijs] Vrije Univ Amsterdam, Fac Earth & Life Sci, Amsterdam, Netherlands; [Kluytmans, Jan A. J. W.] VU Med Ctr VUmc, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands; [Kluytmans, Jan A. J. W.] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [van der Bij, Akke K.] Reinier de Graaf Grp, Dept Med Microbiol, Delft, Netherlands	Netherlands National Institute for Public Health & the Environment; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Amphia Hospital; Reinier de Graaf Hospital	van der Bij, AK (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control CIb, Bilthoven, Netherlands.	bij@rdgg.nl			Dutch Ministry of Health	Dutch Ministry of Health	ISIS-AR is supported by the Dutch Ministry of Health. This study was conducted as part of the authors' routine work, and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2013, INFECT CONT HOSP EP, V34, P361, DOI 10.1086/669865; Ben-Ami R, 2009, CLIN INFECT DIS, V49, P682, DOI 10.1086/604713; Boyd DA, 2004, ANTIMICROB AGENTS CH, V48, P3758, DOI 10.1128/AAC.48.10.3758-3764.2004; Braykov NP, 2013, INFECT CONT HOSP EP, V34, P259, DOI 10.1086/669523; CASEWELL MW, 1983, J HOSP INFECT, V4, P350, DOI 10.1016/0195-6701(83)90005-1; Dutch College of General Practitioners, GUID UR TRACT INF; Dutch Working party on Infection Prevention, DOCUMENTATION; ECDC, EUR ANT SURV NETW EA; European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2012, BREAKPOINT TABLES IN; Hawser SP, 2010, ANTIMICROB AGENTS CH, V54, P3043, DOI 10.1128/AAC.00265-10; Kang CI, 2004, ANTIMICROB AGENTS CH, V48, P4574, DOI 10.1128/AAC.48.12.4574-4581.2004; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Kronenberg A, 2013, EURO SURVEILL, V18; Laupland KB, 2007, CLIN INVEST MED, V30, pE159, DOI 10.25011/cim.v30i4.1777; Lee SY, 2006, INFECT CONT HOSP EP, V27, P1226, DOI 10.1086/507962; Livermore DM, 2007, J ANTIMICROB CHEMOTH, V59, P165, DOI 10.1093/jac/dkl483; Livermore DM, 2012, INT J ANTIMICROB AG, V39, P283, DOI 10.1016/j.ijantimicag.2011.12.012; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Peirano G, 2010, INT J ANTIMICROB AG, V35, P316, DOI 10.1016/j.ijantimicag.2009.11.003; Pitout JDD, 2009, ANTIMICROB AGENTS CH, V53, P2846, DOI 10.1128/AAC.00247-09; Rodriguez-Bano J, 2006, CLIN INFECT DIS, V43, P1407, DOI 10.1086/508877; Schwaber MJ, 2006, ANTIMICROB AGENTS CH, V50, P1257, DOI 10.1128/AAC.50.4.1257-1262.2006; The Dutch Working Party on Antibiotic Policy (SWAB), GUIDELINES; van der Bij AK, 2012, CLIN MICROBIOL INFEC, V18, pE466, DOI 10.1111/j.1469-0691.2012.03996.x; van der Bij AK, 2012, J ANTIMICROB CHEMOTH, V67, P2090, DOI 10.1093/jac/dks214	25	17	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138088	10.1371/journal.pone.0138088	http://dx.doi.org/10.1371/journal.pone.0138088			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381746	Green Published, gold, Green Submitted			2022-12-27	WOS:000361790200056
J	Belotti, E; Weder, N; Bufka, L; Kaldhusdal, A; Kuchenhoff, H; Seibold, H; Woelfing, B; Heurich, M				Belotti, Elisa; Weder, Nicole; Bufka, Ludek; Kaldhusdal, Arne; Kuechenhoff, Helmut; Seibold, Heidi; Woelfing, Benno; Heurich, Marco			Patterns of Lynx Predation at the Interface between Protected Areas and Multi-Use Landscapes in Central Europe	PLOS ONE			English	Article							BIALOWIEZA PRIMEVAL FOREST; DEER CAPREOLUS-CAPREOLUS; HOME-RANGE SIZE; EURASIAN LYNX; ROE DEER; RED DEER; LARGE CARNIVORES; NATIONAL-PARK; WILDLIFE MANAGEMENT; PARTIAL MIGRATION	In Central Europe, protected areas are too small to ensure survival of populations of large carnivores. In the surrounding areas, these species are often persecuted due to competition with game hunters. Therefore, understanding how predation intensity varies spatio-temporally across areas with different levels of protection is fundamental. We investigated the predation patterns of Eurasian lynx (Lynx lynx) on roe deer (Capreolus capreolus) and red deer (Cervus elaphus) in both protected areas and multi-use landscapes of the Bohemian Forest Ecosystem. Based on 359 roe and red deer killed by 10 GPS-collared lynx, we calculated the species-specific annual kill rates and tested for effects of season and lynx age, sex and reproductive status. Because roe and red deer in the study area concentrate in unprotected lowlands during winter, we modeled spatial distribution of kills separately for summer and winter and calculated-the probability of a deer killed by lynx and-the expected number of kills for areas with different levels of protection. Significantly more roe deer (46.05-74.71/year/individual lynx) were killed than red deer (1.57-9.63/year/individual lynx), more deer were killed in winter than in summer, and lynx family groups had higher annual kill rates than adult male, single adult female and subadult female lynx. In winter the probability of a deer killed and the expected number of kills were higher outside the most protected part of the study area than inside; in summer, this probability did not differ between areas, and the expected number of kills was slightly larger inside than outside the most protected part of the study area. This indicates that the intensity of lynx predation in the unprotected part of the Bohemian Forest Ecosystem increases in winter, thus mitigation of conflicts in these areas should be included as a priority in the lynx conservation strategy.	[Belotti, Elisa; Bufka, Ludek] Czech Univ Life Sci Prague, Fac Forestry & Wood Sci, Prague 16521 6, Czech Republic; [Belotti, Elisa; Bufka, Ludek] Sumava Natl Pk Adm, Dept Res & Nat Protect, Kasperske Hory 34192, Czech Republic; [Weder, Nicole; Woelfing, Benno; Heurich, Marco] Bavarian Forest Natl Pk, Dept Res & Documentat, D-94481 Grafenau, Germany; [Kaldhusdal, Arne; Kuechenhoff, Helmut; Seibold, Heidi] Ludwig Maximilians Univ Munchen, Dept Stat, D-80539 Munich, Germany; [Heurich, Marco] Univ Freiburg, Fac Environm & Nat Resources, Wildlife Ecol & Management, D-79106 Freiburg, Germany	Czech University of Life Sciences Prague; University of Munich; University of Freiburg	Belotti, E (corresponding author), Czech Univ Life Sci Prague, Fac Forestry & Wood Sci, Kamycka 1176, Prague 16521 6, Czech Republic.	belotti@fld.czu.cz	Heurich, Marco/O-4653-2014	Heurich, Marco/0000-0003-0051-2930; Seibold, Heidi/0000-0002-8960-9642; Kuchenhoff, Helmut/0000-0002-6372-2487	EU Program Interreg IV (Objective 3 Czech Republic-the Independent State of Bavaria) [18]; World Wide Fund for Nature Section Germany [533500/53000/10120]; Internal Grant Agency of the Czech University of Life Sciences Prague [IGA CZU 2011 4315013123113]	EU Program Interreg IV (Objective 3 Czech Republic-the Independent State of Bavaria); World Wide Fund for Nature Section Germany; Internal Grant Agency of the Czech University of Life Sciences Prague	Financial support was provided by EU Program Interreg IV (Objective 3 Czech Republic-the Independent State of Bavaria, grant n. 18), by the World Wide Fund for Nature Section Germany (grant n. 533500/53000/10120) and by the Internal Grant Agency of the Czech University of Life Sciences Prague (grant IGA CZU 2011 4315013123113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andera M, 1994, ACTA SCI NATURALIUM, V28; Andersen R, 2007, WILDLIFE BIOL, V13, P467, DOI 10.2981/0909-6396(2007)13[467:SOELLL]2.0.CO;2; Andren H, 2006, BIOL CONSERV, V131, P23, DOI 10.1016/j.biocon.2006.01.025; Andren H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120570; [Anonymous], 2014, R LANG ENV STAT COMP; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Basille M, 2009, ECOGRAPHY, V32, P683, DOI 10.1111/j.1600-0587.2009.05712.x; Belotti E, 2014, EUR J WILDLIFE RES, V60, P441, DOI 10.1007/s10344-014-0801-8; BREITENMOSER U, 1987, Z SAUGETIERKD, V52, P168; BREITENMOSER U, 1993, J WILDLIFE MANAGE, V57, P135, DOI 10.2307/3809010; Breitenmoser U, 1998, BIOL CONSERV, V83, P279, DOI 10.1016/S0006-3207(97)00084-0; Breitenmoser Urs, 2010, P493; Bretz F., 2010, MULTIPLE COMP USING; Bunnefeld N, 2006, J ZOOL, V270, P31, DOI 10.1111/j.1469-7998.2006.00107.x; Cagnacci F, 2015, ANIMAL ECOLOGY UNPUB; Cagnacci F, 2011, OIKOS, V120, P1790, DOI 10.1111/j.1600-0706.2011.19441.x; Carroll C, 2004, CONSERV BIOL, V18, P1110, DOI 10.1111/j.1523-1739.2004.00083.x; Cerveny J., 2002, ACTA ZOOL LITUANICA, V12, P362; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; DEVRIES MFW, 1995, CONSERV BIOL, V9, P25; EEA European Environment Agency, 2009, COR LAND COV 2000 CL; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Ersson L., 2011, THESIS SWEDISH U AGR; European Environment Agency, 2012, EEA REP, V5, P1, DOI [10.2800/55955, DOI 10.2800/55955]; Festetics A., 1981, Saugetierkundliche Mitteilungen, V29, P21; Gerner J, 2011, J NAT CONSERV, V19, P319, DOI 10.1016/j.jnc.2011.06.002; Gervasi V, 2014, J ZOOL, V292, P175, DOI 10.1111/jzo.12088; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Hartova-Nentvichova M, 2010, MAMM BIOL, V75, P334, DOI 10.1016/j.mambio.2009.09.003; Hebblewhite M, 2005, J ANIM ECOL, V74, P226, DOI 10.1111/j.1365-2656.2004.00909.x; Heurich M, 2011, 12 INT FACHT FRAG VE, P142; Heurich M, 2015, PLOSONE IN PRESS; Heurich M, 2005, WALDER NATIONALPARKS; Heurich M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114143; Heurich M, 2012, EUR J WILDLIFE RES, V58, P567, DOI 10.1007/s10344-011-0606-y; Hosmer D. W., 2011, APPL SURVIVAL ANAL R; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jedrzejewski W, 2002, ANN ZOOL FENN, V39, P29; JEDRZEJEWSKI W, 1993, ACTA THERIOL, V38, P385; Jobin A, 2000, ACTA THERIOL, V45, P243, DOI 10.4098/AT.arch.00-26; Kaczensky P, 2013, STATUS MANAGEMENT DI; Kalbfleisch J.D., 2011, STAT ANAL FAILURE TI, DOI DOI 10.1016/0197-2456(81)90009-X; Kamler JF, 2007, WILDLIFE BIOL, V13, P48, DOI 10.2981/0909-6396(2007)13[48:SACMOR]2.0.CO;2; Kjellander P, 2004, OECOLOGIA, V139, P478, DOI 10.1007/s00442-004-1529-z; Kleinbaum DG, 2012, STAT BIOL HEALTH, P1, DOI 10.1007/978-1-4419-6646-9_1; Koubek Petr, 1996, Acta Scientiarum Naturalium Academiae Scientiarum Bohemicae Brno, V30, P1; Krofel M, 2013, ECOLOGICAL RES, V28, P1; Krofel M, 2014, EUR J WILDLIFE RES, V60, P11, DOI 10.1007/s10344-013-0745-4; Krofel M, 2012, BEHAV ECOL SOCIOBIOL, V66, P1297, DOI 10.1007/s00265-012-1384-6; Krofel M, 2011, ACTA THERIOL, V56, P315, DOI 10.1007/s13364-011-0032-2; Laundre John W., 2010, OPEN ECOL J, V3, P1, DOI [10.2174/1874213001003030001, DOI 10.2174/1874213001003030001]; Liberg O, 2012, P ROY SOC B-BIOL SCI, V279, P910, DOI 10.1098/rspb.2011.1275; Linnell JDC, 2001, ANIM CONSERV, V4, P345, DOI 10.1017/S1367943001001408; LITVAITIS JA, 1986, J WILDLIFE MANAGE, V50, P110, DOI 10.2307/3801498; Luccarini S, 2006, ETHOL ECOL EVOL, V18, P127, DOI 10.1080/08927014.2006.9522718; Ludwig M, 2012, ERDKUNDE, V66, P143, DOI 10.3112/erdkunde.2012.02.04; Mattisson J, 2011, BIOL CONSERV, V144, P3009, DOI 10.1016/j.biocon.2011.09.004; Mattisson J, 2011, CAN J ZOOL, V89, P79, DOI 10.1139/Z10-097; Mayer Kathrin, 2012, Saeugetierkundliche Informationen, V8, P447; Melis C, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00099.1; Melis C, 2009, GLOBAL ECOL BIOGEOGR, V18, P724, DOI 10.1111/j.1466-8238.2009.00480.x; Moa PF, 2006, WILDLIFE BIOL, V12, P63, DOI 10.2981/0909-6396(2006)12[63:DTSDOL]2.0.CO;2; Most L, 2015, FOREST ECOL MANAG, V338, P46, DOI 10.1016/j.foreco.2014.11.015; Molinari-Jobin A, 2002, WILDLIFE BIOL, V8, P109, DOI 10.2981/wlb.2002.015; Molinari-Jobin A, 2007, WILDLIFE BIOL, V13, P393, DOI 10.2981/0909-6396(2007)13[393:VIDPSA]2.0.CO;2; Muller J, 2014, BIOL CONSERV, V177, P210, DOI 10.1016/j.biocon.2014.07.007; Mysterud A, 1999, J ZOOL, V247, P479, DOI 10.1111/j.1469-7998.1999.tb01011.x; Mysterud A, 2013, ECOLOGY, V94, P1257, DOI 10.1890/12-0505.1; Mysterud A, 2011, OIKOS, V120, P1817, DOI 10.1111/j.1600-0706.2010.19439.x; Niedzialkowska M, 2006, BIOL CONSERV, V133, P63, DOI 10.1016/j.biocon.2006.05.022; Nilsen EB, 2009, J ANIM ECOL, V78, P741, DOI 10.1111/j.1365-2656.2009.01547.x; Nowicki Piotr, 1997, Journal of Wildlife Research, V2, P161; Odden J, 2008, J WILDLIFE MANAGE, V72, P276, DOI 10.2193/2005-537; Odden J, 2006, EUR J WILDLIFE RES, V52, P237, DOI 10.1007/s10344-006-0052-4; OKARMA H, 1984, ACTA THERIOL, V29, P283, DOI 10.4098/AT.arch.84-28; Okarma H, 1997, ACTA THERIOL, V42, P203, DOI 10.4098/AT.arch.97-22; Ordiz A, 2013, BIOL CONSERV, V168, P128, DOI 10.1016/j.biocon.2013.09.024; Podolski I, 2013, WILDLIFE BIOL, V19, P69, DOI 10.2981/12-049; Post E, 1999, NATURE, V401, P905, DOI 10.1038/44814; Powell R.A., 1997, ECOLOGY BEHAV N AM B; PULLIAINEN E, 1995, ACTA THERIOL, V40, P181, DOI 10.4098/AT.arch.95-19; Ray RR, 2014, ANIM BIODIV CONSERV, V37, P77; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Roder J, 2010, FOREST ECOL MANAG, V259, P1513, DOI 10.1016/j.foreco.2010.01.027; Schmidt K, 1997, ACTA THERIOL, V42, P289, DOI 10.4098/AT.arch.97-30; Schmidt K, 1999, J ZOOL, V249, P417, DOI 10.1017/S0952836999009851; Selva N, 2005, CAN J ZOOL, V83, P1590, DOI 10.1139/Z05-158; Selva N, 2003, ECOSCIENCE, V10, P303, DOI 10.1080/11956860.2003.11682778; Siebert U, 2013, REHWILDZAHLUNG UNPUB; Stahl P, 2001, J APPL ECOL, V38, P674, DOI 10.1046/j.1365-2664.2001.00625.x; Sunquist ME, 2002, WILD CATS WORLD; Therneau T. M., 2015, PACKAGE SURVIVAL ANA; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Weingarth K, 2012, ANIM BIODIV CONSERV, V35, P197; Weingarth K, 2015, BIODIVERSIT IN PRESS; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wienke A., 2010, FRAILTY MODELS SURVI; WILSON RP, 1991, COMP BIOCHEM PHYS A, V100, P151, DOI 10.1016/0300-9629(91)90198-L; Wolfl M, 2001, ACTA THERIOL, V46, P181, DOI 10.1007/BF03192427; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zatloukal V, 2001, SILVA GABRETA S1, P77	101	15	16	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138139	10.1371/journal.pone.0138139	http://dx.doi.org/10.1371/journal.pone.0138139			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379142	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000361769400059
J	Deshpande, RS; Grayson, WL; Spector, AA				Deshpande, Rajiv S.; Grayson, Warren L.; Spector, Alexander A.			A Modeling Insight into Adipose-Derived Stem Cell Myogenesis	PLOS ONE			English	Article							PROCESSED LIPOASPIRATE CELLS; MYOBLAST FUSION; LINEAGE-COMMITMENT; DIFFERENTIATION; TISSUE; FATE; REGENERATION; EXPRESSION; DYNAMICS; RENEWAL	Adipose-derived stem cells (ASCs) are clinically important in regenerative medicine as they are relatively easy to obtain, are characterized by low morbidity, and can differentiate into myogenic progenitor cells. Although studies have elucidated the principal markers, PAX7, Desmin, MyoD, and MHC, the underlying mechanisms are not completely understood. This motivates the application of computational methods to facilitate greater understanding of such processes. In the following, we present a multi-stage kinetic model comprising a system of ordinary differential equations (ODEs). We sought to model ASC differentiation using data from a static culture, where no strain is applied, and a dynamic culture, where 10% strain is applied. The coefficients of the equations have been modulated by those experimental data points. To correctly represent the trajectories, various switches and a feedback factor based on total cell number have been introduced to better represent the biology of ASC differentiation. Furthermore, the model has then been applied to predict ASC fate for strains different from those used in the experimental conditions and for times longer than the duration of the experiment. Analysis of the results reveals unique characteristics of ASC myogenesis under dynamic conditions of the applied strain.	[Deshpande, Rajiv S.; Grayson, Warren L.; Spector, Alexander A.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA	Johns Hopkins University	Spector, AA (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.	aspector@jhu.edu		Deshpande, Rajiv/0000-0002-1232-0875	Department of Biomedical Engineering of Johns Hopkins University	Department of Biomedical Engineering of Johns Hopkins University	Support was provided by funding from the Department of Biomedical Engineering of Johns Hopkins University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agur Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024225; Alon U., 2006, INTRO SYSTEMS BIOL D; Ankam S, 2013, ACTA BIOMATER, V9, P4535, DOI 10.1016/j.actbio.2012.08.018; Ashjian PH, 2003, PLAST RECONSTR SURG, V111, P1922, DOI 10.1097/01.PRS.0000055043.62589.05; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Charrasse S, 2006, MOL BIOL CELL, V17, P749, DOI 10.1091/mbc.E05-04-0284; Dalby MJ, 2014, NAT MATER, V13, P558, DOI [10.1038/NMAT3980, 10.1038/nmat3980]; Doherty JT, 2011, J BIOL CHEM, V286, P25903, DOI 10.1074/jbc.M111.243030; Duan R, 2012, J CELL BIOL, V199, P169, DOI 10.1083/jcb.201204065; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Halevy O, 2004, DEV DYNAM, V231, P489, DOI 10.1002/dvdy.20151; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Huri PY, 2013, BIOCHEM BIOPH RES CO, V438, P180, DOI 10.1016/j.bbrc.2013.07.049; Huri PY, 2014, CELL MOL BIOENG, V7, P497, DOI 10.1007/s12195-014-0362-7; Hutton DL, 2012, TISSUE ENG PT A, V18, P1729, DOI [10.1089/ten.tea.2011.0599, 10.1089/ten.TEA.2011.0599]; Hutton DL, 2013, TISSUE ENG PT A, V19, P2076, DOI [10.1089/ten.tea.2012.0752, 10.1089/ten.TEA.2012.0752]; Hwang M, 2009, CELL MOL BIOENG, V2, P285, DOI 10.1007/s12195-009-0078-2; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Lee WCC, 2007, BIOMECH MODEL MECHAN, V6, P265, DOI 10.1007/s10237-006-0053-y; Marciniak-Czochra A, 2009, STEM CELLS DEV, V18, P377, DOI 10.1089/scd.2008.0143; Maul TM, 2011, BIOMECH MODEL MECHAN, V10, P939, DOI 10.1007/s10237-010-0285-8; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Mizuno H, 2002, PLAST RECONSTR SURG, V109, P199, DOI 10.1097/00006534-200201000-00030; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; Osborne JM, 2010, PHILOS T R SOC A, V368, P5013, DOI 10.1098/rsta.2010.0173; Quach NL, 2009, MOL BIOL CELL, V20, P3422, DOI 10.1091/mbc.E09-02-0175; Wu L, 2013, J CELL PHYSIOL, V228, P938, DOI 10.1002/jcp.24255; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zamir E, 2001, J CELL SCI, V114, P3583; Zandstra PW, 2000, BLOOD, V96, P1215, DOI 10.1182/blood.V96.4.1215.h8001215_1215_1222; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	32	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137918	10.1371/journal.pone.0137918	http://dx.doi.org/10.1371/journal.pone.0137918			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378788	Green Submitted, Green Published, gold			2022-12-27	WOS:000361769400035
J	Li, J; Yang, Y; Dubern, JF; Li, H; Halliday, N; Chernin, L; Gao, KX; Camara, M; Liu, XG				Li, Jun; Yang, Yang; Dubern, Jean-Frederic; Li, Hui; Halliday, Nigel; Chernin, Leonid; Gao, Kexiang; Camara, Miguel; Liu, Xiaoguang			Regulation of GacA in Pseudomonas chlororaphis Strains Shows a Niche Specificity	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAY; SENSOR KINASE GACS; BIOFILM FORMATION; SECONDARY METABOLISM; SERRATIA-PLYMUTHICA; HOMOSERINE LACTONE; PROTEOMIC ANALYSIS; AERUGINOSA; O6; BIOCONTROL	The GacS/GacA two-component system plays a central role in the regulation of a broad range of biological functions in many bacteria. In the biocontrol organism Pseudomonas chlororaphis, the Gac system has been shown to positively control quorum sensing, biofilm formation, and phenazine production, but has an overall negative impact on motility. These studies have been performed with strains originated from the rhizosphere predominantly. To investigate the level of conservation between the GacA regulation of biocontrol-related traits in P. chlororaphis isolates from different habitats, the studies presented here focused on the endophytic isolate G5 of P. chlororaphis subsp. aurantiaca. A gacA mutant deficient in the production of N-acylhomoserine lactones (AHLs) and phenazine was isolated through transposon mutagenesis. Further phenotypic characterization revealed that in strain G5, similar to other P. chlororaphis strains, a gacA mutation caused inability to produce biocontrol factors such as phenazine, HCN and proteases responsible for antifungal activity, but overproduced siderophores. LC-MS/MS analysis revealed that AHL production was also practically abolished in this mutant. However, the wild type exhibited an extremely diverse AHL pattern which has never been identified in P. chlororaphis. In contrast to other isolates of this organism, GacA in strain G5 was shown to negatively regulate biofilm formation and oxidative stress response whilst positively regulating cell motility and biosynthesis of indole3-acetic acid (IAA). To gain a better understanding of the overall impact of GacA in G5, a comparative proteomic analysis was performed revealing that, in addition to some of the traits like phenazine mentioned above, GacA also negatively regulated lipopolysaccharide (LPS) and trehalose biosynthesis whilst having a positive impact on energy metabolism, an effect not previously described in P. chlororaphis. Consequently, GacA regulation shows a differential strain dependency which is likely to be in line with their niche of origin.	[Li, Jun] Jiangsu Univ, Sch Food & Biol Engn, Zhenjiang 212013, Peoples R China; [Li, Jun; Yang, Yang; Liu, Xiaoguang] Jiangsu Univ, Inst Life Sci, Zhenjiang 212013, Peoples R China; [Dubern, Jean-Frederic; Halliday, Nigel; Camara, Miguel] Univ Nottingham, Ctr Biomol Sci, Sch Life Sci, Nottingham NG7 2RD, England; [Li, Hui; Gao, Kexiang] Shandong Agr Univ, Dept Plant Pathol, Tai An 271018, Shandong, Peoples R China; [Chernin, Leonid] Hebrew Univ Jerusalem, Dept Plant Pathol & Microbiol, Robert H Smith Fac Agr, IL-76100 Rehovot, Israel	Jiangsu University; Jiangsu University; University of Nottingham; Shandong Agricultural University; Hebrew University of Jerusalem	Liu, XG (corresponding author), Jiangsu Univ, Inst Life Sci, Zhenjiang 212013, Peoples R China.	xgliu66@yahoo.com		Camara, Miguel/0000-0003-4585-7385	EU [297882]; Jiangsu University [CX10B_022x]; National Natural Science Foundation of China (NSFC) [31240046]; Special Fund for Agro-Scientific Research in the Public Interest of China [201503110]; Priority Academic Program Development of Jiangsu Higher Education Institutions	EU(European Commission); Jiangsu University; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-Scientific Research in the Public Interest of China; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was partially supported by the EU Marie Curie IIF project PROAGROBAC (297882), the Postgraduate Research and Innovation Project of Jiangsu University (CX10B_022x), the National Natural Science Foundation of China (NSFC no. 31240046), the Special Fund for Agro-Scientific Research in the Public Interest of China (201503110), and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasinghe JJ, 2009, INFECT IMMUN, V77, P2896, DOI 10.1128/IAI.00126-09; Bouffartigues E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00630; Brencic A, 2009, MOL MICROBIOL, V73, P434, DOI 10.1111/j.1365-2958.2009.06782.x; Chancey ST, 1999, APPL ENVIRON MICROB, V65, P2294; DASGUPTA T, 1994, INFECT IMMUN, V62, P809, DOI 10.1128/IAI.62.3.809-817.1994; De Araujo C, 2010, RES MICROBIOL, V161, P595, DOI 10.1016/j.resmic.2010.05.014; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; GIWERCMAN B, 1992, FEMS MICROBIOL IMMUN, V89, P225, DOI 10.1016/0378-1097(92)90120-D; Green MR, 2012, MOL CLONING LAB MANU, V1; GULYAEVA NV, 1987, FEBS LETT, V211, P211, DOI 10.1016/0014-5793(87)81438-2; Hassan KA, 2010, ENVIRON MICROBIOL, V12, P899, DOI 10.1111/j.1462-2920.2009.02134.x; Heeb S, 2005, FEMS MICROBIOL LETT, V243, P251, DOI 10.1016/j.femsle.2004.12.008; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Islam N, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-21; Kang BR, 2006, CURR MICROBIOL, V52, P473, DOI 10.1007/s00284-005-0427-x; Khan SR, 2007, APPL ENVIRON MICROB, V73, P7443, DOI 10.1128/AEM.01354-07; Kim CH, 2014, PLANT PATHOLOGY J, V30, P220, DOI 10.5423/PPJ.NT.02.2014.0012; Kim JS, 2014, PLANT PATHOLOGY J, V30, P215, DOI 10.5423/PPJ.NT.11.2013.0109; Kim JS, 2014, CAN J MICROBIOL, V60, P133, DOI 10.1139/cjm-2013-0736; Landini P, 2009, RES MICROBIOL, V160, P259, DOI 10.1016/j.resmic.2009.03.001; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; Li Hui, 2009, Sheng Wu Gong Cheng Xue Bao, V25, P832; Liu X, 2010, WORLD J MICROB BIOT, V26, P1465, DOI 10.1007/s11274-010-0321-y; Liu XG, 2007, FEMS MICROBIOL LETT, V270, P299, DOI 10.1111/j.1574-6968.2007.00681.x; Liu XG, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-26; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Maddula VSRK, 2006, MICROB ECOL, V52, P289, DOI 10.1007/s00248-006-9064-6; Mann EE, 2012, FEMS MICROBIOL REV, V36, P893, DOI 10.1111/j.1574-6976.2011.00322.x; MARTIN DW, 1993, MOL MICROBIOL, V9, P497, DOI 10.1111/j.1365-2958.1993.tb01711.x; Matthias U., 2009, BACTERIAL POLYSACCHA; Mercado-Blanco J, 2007, ANTON LEEUW INT J G, V92, P367, DOI 10.1007/s10482-007-9167-1; Musken M, 2010, NAT PROTOC, V5, P1460, DOI 10.1038/nprot.2010.110; Notley-McRobb L, 2002, J BACTERIOL, V184, P806, DOI 10.1128/JB.184.3.806-811.2002; Poritsanos N, 2006, CAN J MICROBIOL, V52, P1177, DOI 10.1139/W06-079; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Reimmann C, 1997, MOL MICROBIOL, V24, P309, DOI 10.1046/j.1365-2958.1997.3291701.x; Ryan RP, 2008, FEMS MICROBIOL LETT, V278, P1, DOI 10.1111/j.1574-6968.2007.00918.x; Sadykov MR, 2010, J BIOL CHEM, V285, P36616, DOI 10.1074/jbc.M110.152843; Sauer K, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-219; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Seaton SC, 2013, APPL ENVIRON MICROB, V79, P5405, DOI 10.1128/AEM.00819-13; Selin C, 2012, MICROBIOL-SGM, V158, P896, DOI 10.1099/mic.0.054254-0; Selin C, 2010, FEMS MICROBIOL ECOL, V71, P73, DOI 10.1111/j.1574-6941.2009.00792.x; Takeuchi K, 2014, ENVIRON MICROBIOL, V16, P2538, DOI 10.1111/1462-2920.12394; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Wang DP, 2013, MICROBIOLOGYOPEN, V2, P505, DOI 10.1002/mbo3.90; Wei X, 2013, J BACTERIOL, V195, P3387, DOI 10.1128/JB.00214-13; Yang MM, 2011, PHYTOPATHOLOGY, V101, P1481, DOI 10.1094/PHYTO-04-11-0096	48	4	5	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137553	10.1371/journal.pone.0137553	http://dx.doi.org/10.1371/journal.pone.0137553			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379125	gold, Green Submitted, Green Published			2022-12-27	WOS:000361769400017
J	Xia, N; Wang, H; Nie, XH				Xia, Ning; Wang, Hao; Nie, Xiuhong			Inhaled Long-Acting beta 2-Agonists Do Not Increase Fatal Cardiovascular Adverse Events in COPD: A Meta-Analysis	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NECROSIS-FACTOR-ALPHA; CORONARY-ARTERY-DISEASE; TWICE-DAILY SALMETEROL; MU-G; LUNG-FUNCTION; DOUBLE-BLIND; MYOCARDIAL-INFARCTION; CONTROLLED-TRIAL; RANDOMIZED-TRIAL	Background The cardiovascular safety of inhaled long-acting (32-agonists (LABAs) in patients with chronic obstructive pulmonary disease (COPD) is a controversial problem. Certain studies have suggested that inhaled LABAs lead to an increased risk of cardiovascular events in patients with COPD. This meta-analysis aimed to assess the cardiovascular safety of inhaled LABAs in COPD. Methods A meta-analysis of randomized, double-blind, parallel-group, placebo-controlled trials for LABA treatment of COPD with at least 3 months of follow-up was performed. The fixedeffects model was used to evaluate the effects of LABAs on fatal cardiovascular adverse events. Adverse events were collected for each trial, and the relative risk (RR) and 95% confidence intervals (Cl) for LABA/placebo were estimated. Results There were 24 trials included in this meta-analysis. Compared with placebo, inhaled LABAs significantly decreased fatal cardiovascular adverse events in COPD patients (RR 0.65, 95% Cl 0.50 to 0.86, P = 0.002). In sensitivity analysis, there was still no increased risk of fatal cardiovascular events (RR 0.68, 95%)/X10.46 to 1.01, P = 0.06) after excluding the trial with the largest weight. Among the different types of LABAs, only salmeterol had a significant effect (RR 0.64, 95% Cl 0.46 to 0.90). In subgroup analyses, inhaled LABAs were able to significantly decrease fatal cardiovascular events in long-term trials (RR 0.64, 95% Cl 0.47 to 0.87) and in trials with severe COPD patients (RR 0.69, 95% Cl 0.50 to 0.96). Conclusion Inhaled LABAs do not increase the risk of fatal cardiovascular events in COPD patients.	[Xia, Ning; Nie, Xiuhong] Capital Med Univ, Xuanwu Hosp, Dept Resp Dis, Beijing, Peoples R China; [Wang, Hao] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Cardiol, Beijing 100730, Peoples R China; [Wang, Hao] Peking Union Med Coll, Beijing 100021, Peoples R China	Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Nie, XH (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Resp Dis, Beijing, Peoples R China.	xiuhongnie@outlook.com						Au DH, 2002, CHEST, V121, P846, DOI 10.1378/chest.121.3.846; Bateman ED, 2013, EUR RESPIR J, V42, P1484, DOI 10.1183/09031936.00200212; Baumgartner RA, 2007, CLIN THER, V29, P261, DOI 10.1016/j.clinthera.2007.02.009; Bhowmik A, 2000, THORAX, V55, P114, DOI 10.1136/thorax.55.2.114; Boekholdt SM, 2004, ARTERIOSCL THROM VAS, V24, P1503, DOI 10.1161/01.ATV.0000134294.54422.2e; Bogdan MA, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-51; Boschetto P, 2012, RESPIROLOGY, V17, P422, DOI 10.1111/j.1440-1843.2011.02118.x; Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558; Brusasco V, 2003, THORAX, V58, P399, DOI 10.1136/thorax.58.5.399; Calverley P, 2003, LANCET, V361, P449, DOI 10.1016/S0140-6736(03)12459-2; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Campbell SC, 2007, PULM PHARMACOL THER, V20, P571, DOI 10.1016/j.pupt.2006.06.003; Cazzola M, 2005, DRUGS, V65, P1595, DOI 10.2165/00003495-200565120-00001; Celli B, 2014, CHEST, V145, P981, DOI 10.1378/chest.13-1579; Celli B, 2010, CHEST, V137, P20, DOI 10.1378/chest.09-0011; Chapman KR, 2011, CHEST, V140, P68, DOI 10.1378/chest.10-1830; Dahl R, 2010, THORAX, V65, P473, DOI 10.1136/thx.2009.125435; Decramer ML, 2013, INT J CHRONIC OBSTR, V8, P53, DOI 10.2147/COPD.S39018; Donaldson GC, 2010, CHEST, V137, P1091, DOI 10.1378/chest.09-2029; Dong YH, 2013, THORAX, V68, P48, DOI 10.1136/thoraxjnl-2012-201926; Donnelly LE, 2010, EUR RESPIR J, V36, P178, DOI 10.1183/09031936.00158008; Donohue JF, 2013, RESP MED, V107, P1538, DOI 10.1016/j.rmed.2013.06.001; Donohue JF, 2010, AM J RESP CRIT CARE, V182, P155, DOI 10.1164/rccm.200910-1500OC; Donohue JF, 2002, CHEST, V122, P47, DOI 10.1378/chest.122.1.47; Feldman G, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-11; Ferguson GT, 2014, INT J CHRONIC OBSTR, V9, P629, DOI 10.2147/COPD.S61717; Ferguson GT, 2003, CHEST, V123, P1817, DOI 10.1378/chest.123.6.1817; Gershon A, 2013, JAMA INTERN MED, V173, P1175, DOI 10.1001/jamainternmed.2013.1016; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Johnston AK, 2008, THORAX, V63, P599, DOI 10.1136/thx.2007.088112; Keatings VM, 1996, AM J RESP CRIT CARE, V153, P530, DOI 10.1164/ajrccm.153.2.8564092; Kerwin EM, 2013, RESP MED, V107, P560, DOI 10.1016/j.rmed.2012.12.014; Kerwin EM, 2011, CLIN THER, V33, P1974, DOI 10.1016/j.clinthera.2011.11.009; Kew KM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010844.pub2; Kinoshita M, 2012, RESPIROLOGY, V17, P379, DOI 10.1111/j.1440-1843.2011.02107.x; Koch A, 2014, INT J CHRONIC OBSTR, V9, P697, DOI 10.2147/COPD.S62502; Kornmann O, 2011, EUR RESPIR J, V37, P273, DOI 10.1183/09031936.00045810; Lee TA, 2008, ANN INTERN MED, V149, P380, DOI 10.7326/0003-4819-149-6-200809160-00004; Martinez FJ, 2013, RESP MED, V107, P550, DOI 10.1016/j.rmed.2012.12.016; Nelson HS, 2007, CLIN THER, V29, P2167, DOI 10.1016/j.clinthera.2007.10.007; Rennard SI, 2001, AM J RESP CRIT CARE, V163, P1087, DOI 10.1164/ajrccm.163.5.9903053; Ridker PM, 2000, CIRCULATION, V101, P2149, DOI 10.1161/01.CIR.101.18.2149; Rossi A, 2002, CHEST, V121, P1058, DOI 10.1378/chest.121.4.1058; Salpeter SR, 2004, CHEST, V125, P2309, DOI 10.1378/chest.125.6.2309; SHIH HT, 1988, CHEST, V94, P44, DOI 10.1378/chest.94.1.44; Sidney S, 2005, CHEST, V128, P2068, DOI 10.1378/chest.128.4.2068; Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952; Singh D, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-178; Singh S, 2008, JAMA-J AM MED ASSOC, V300, P1439, DOI 10.1001/jama.300.12.1439; STENGER VG, 1974, GEN PHARMACOL, V5, P23; Stockley RA, 2006, THORAX, V61, P122, DOI 10.1136/thx.2004.033266; Tashkin DP, 2008, DRUGS, V68, P1975, DOI 10.2165/00003495-200868140-00004; VADDI K, 1994, CIRCULATION, V90, P694, DOI 10.1161/01.CIR.90.2.694; van Gestel AJR, 2012, DISCOV MED, V14, P359; Worth H, 2011, RESP MED, V105, P571, DOI 10.1016/j.rmed.2010.11.027	56	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137904	10.1371/journal.pone.0137904	http://dx.doi.org/10.1371/journal.pone.0137904			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378450	Green Submitted, Green Published, gold			2022-12-27	WOS:000361769400034
J	Breitling, C; Gross, A; Buttner, P; Weise, S; Schleinitz, D; Kiess, W; Scholz, M; Kovacs, P; Korner, A				Breitling, Clara; Gross, Arnd; Buettner, Petra; Weise, Sebastian; Schleinitz, Dorit; Kiess, Wieland; Scholz, Markus; Kovacs, Peter; Koerner, Antje			Genetic Contribution of Variants near SORT1 and APOE on LDL Cholesterol Independent of Obesity in Children	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN-CHOLESTEROL; HEART-DISEASE RISK; PUBERTAL CHANGES; REDUCTASE GENE; LIPID-LEVELS; ASSOCIATION; LOCI; TRIGLYCERIDES; EXPRESSION; MLXIPL	Objective To assess potential effects of variants in six lipid modulating genes (SORT1, HMGCR, MLXIPL, FADS2, APOE and MAFB) on early development of dyslipidemia independent of the degree of obesity in children, we investigated their association with total (TC), low density lipoprotein (LDL-C), high density lipoprotein (HDL-C) cholesterol and triglyceride (TG) levels in 594 children. Furthermore, we evaluated the expression profile of the candidate genes during human adipocyte differentiation. Results Expression of selected genes increased 10(1) to > 10(4) fold during human adipocyte differentiation, suggesting a potential link with adipogenesis. In genetic association studies adjusted for age, BMI SDS and sex, we identified significant associations for rs599839 near SORT1 with TC and LDL-C and for rs4420638 near APOE with TC and LDL-C. We performed Bayesian modelling of the combined lipid phenotype of HDL-C, LDL-C and TG to identify potentially causal polygenic effects on this multi-dimensional phenotype and considering obesity, age and sex as a-priori modulating factors. This analysis confirmed that rs599839 and rs4420638 affect LDL-C. Conclusion We show that lipid modulating genes are dynamically regulated during adipogenesis and that variants near SORT1 and APOE influence lipid levels independent of obesity in children. Bayesian modelling suggests causal effects of these variants.	[Breitling, Clara; Buettner, Petra; Weise, Sebastian; Kiess, Wieland; Koerner, Antje] Univ Leipzig, Dept Womens & Child Hlth, Univ Hosp Children & Adolescents Leipzig, Ctr Pediat Res CPL, D-04109 Leipzig, Germany; [Gross, Arnd; Scholz, Markus] Univ Leipzig, IMISE, D-04109 Leipzig, Germany; [Gross, Arnd; Scholz, Markus] Univ Leipzig, LIFE Leipzig Res Ctr Civilizat Dis, D-04109 Leipzig, Germany; [Schleinitz, Dorit; Kovacs, Peter] Univ Leipzig, Fac Med, Integrated Res & Treatment Ctr Adipos Dis IFB, D-04109 Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University	Korner, A (corresponding author), Univ Leipzig, Dept Womens & Child Hlth, Univ Hosp Children & Adolescents Leipzig, Ctr Pediat Res CPL, D-04109 Leipzig, Germany.	Antje.Koerner@medizin.uni-leipzig.de	Büttner, Petra/ADR-1721-2022; Körner, Antje/B-3988-2015	Körner, Antje/0000-0001-6001-0356; Buttner, Petra/0000-0003-0799-4725; Gross, Arnd/0000-0002-5961-5507; Kovacs, Peter/0000-0002-0290-5423	German Research Council (DFG) [CRC1052/1 C05]; Federal Ministry of Education and Research (BMBF), Germany (IFB AdiposityDiseases) [FKZ: 01EO1001]; European Community's Seventh Framework Programme (FP7) project Beta-JUDO [279153]; German Federal Research Ministry (BMBF), grant PROGRESS [01KI1010I]; LIFE Leipzig Research Center for Civilization Diseases, University of Leipzig; European Union; European Regional Development Fund (ERDF); Free State of Saxony within the framework of the excellence initiative	German Research Council (DFG)(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF), Germany (IFB AdiposityDiseases)(Federal Ministry of Education & Research (BMBF)); European Community's Seventh Framework Programme (FP7) project Beta-JUDO; German Federal Research Ministry (BMBF), grant PROGRESS(Federal Ministry of Education & Research (BMBF)); LIFE Leipzig Research Center for Civilization Diseases, University of Leipzig; European Union(European Commission); European Regional Development Fund (ERDF)(European Commission); Free State of Saxony within the framework of the excellence initiative	This work was supported by grants from the German Research Council (DFG) for the Clinical Research Center "Obesity Mechanisms" CRC1052/1 C05 and the Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01EO1001 (IFB AdiposityDiseases), and the European Community's Seventh Framework Programme (FP7/2007-2013) project Beta-JUDO under grant agreement no 279153 to A.K. The work of A.G. was supported in part by the German Federal Research Ministry (BMBF), grant PROGRESS (01KI1010I). M.S. was funded by LIFE Leipzig Research Center for Civilization Diseases, University of Leipzig. LIFE is funded by means of the European Union, by the European Regional Development Fund (ERDF) and by means of the Free State of Saxony within the framework of the excellence initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1961, JAMA, V175, P389; Atabek ME, 2012, J CLIN RES PEDIATR E, V4, P8, DOI 10.4274/jcrpe.521; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Bernhard F, 2013, DIABETOLOGIA, V56, P311, DOI 10.1007/s00125-012-2773-0; Conti DV, 2003, HUM HERED, V56, P83, DOI 10.1159/000073736; Cullen P, 2000, AM J CARDIOL, V86, P943, DOI 10.1016/S0002-9149(00)01127-9; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Donnelly LA, 2008, PHARMACOGENET GENOM, V18, P1021, DOI 10.1097/FPC.0b013e3283106071; Dumitrescu L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002138; Greenawalt DM, 2011, GENOME RES, V21, P1008, DOI 10.1101/gr.112821.110; Hiura Y, 2010, CIRC J, V74, P518, DOI 10.1253/circj.CJ-09-0790; Hu P, 2011, INT J MOL SCI, V12, P5604, DOI 10.3390/ijms12095604; Innocenti F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002078; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Ken-Dror G, 2010, MOL MED, V16, P389, DOI 10.2119/molmed.2010.00044; Klein MS, 2014, J PROTEOME RES, V13, P5063, DOI 10.1021/pr500659r; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Lu YC, 2010, AM J CLIN NUTR, V92, P258, DOI 10.3945/ajcn.2009.29130; Lunn DJ, 2009, STAT COMPUT, V19, P395, DOI 10.1007/s11222-008-9100-0; Lunn DJ, 2006, GENET EPIDEMIOL, V30, P231, DOI 10.1002/gepi.20140; LUNN DJ, 2005, EPH200502 IMP COLL L; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Mendivil CO, 2011, CIRCULATION, V124, P2065, DOI 10.1161/CIRCULATIONAHA.111.056986; Molto-Puigmarti C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061671; Moran A, 2008, CIRCULATION, V117, P2361, DOI 10.1161/CIRCULATIONAHA.107.704569; Munir MS, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-66; Polgar N, 2010, EUR J NEUROL, V17, P1033, DOI 10.1111/j.1468-1331.2010.02957.x; Quintana MA, 2012, HUM HERED, V74, P184, DOI 10.1159/000346021; Rippe JM, 1998, J AM DIET ASSOC, V98, pS9, DOI 10.1016/S0002-8223(98)00704-4; Ruderman N, 1998, DIABETES, P699; Schroder A, 2013, PHARMACOGENOMICS J, V13, P12, DOI 10.1038/tpj.2011.44; Standl M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037780; Tan M H, 1980, Ann Acad Med Singap, V9, P491; Vrablik M, 2008, HUM GENET, V124, P553, DOI 10.1007/s00439-008-0577-6; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhang XL, 2014, HUM MOL GENET, V23, P782, DOI 10.1093/hmg/ddt461	44	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138064	10.1371/journal.pone.0138064	http://dx.doi.org/10.1371/journal.pone.0138064			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375028	Green Published, Green Submitted, gold			2022-12-27	WOS:000361610200073
J	Ilie, G; Boak, A; Mann, RE; Adlaf, EM; Hamilton, H; Asbridge, M; Rehm, J; Cusimano, MD				Ilie, Gabriela; Boak, Angela; Mann, Robert E.; Adlaf, Edward M.; Hamilton, Hayley; Asbridge, Mark; Rehm, Juergen; Cusimano, Michael D.			Energy Drinks, Alcohol, Sports and Traumatic Brain Injuries among Adolescents	PLOS ONE			English	Article							EXECUTIVE FUNCTION; UNITED-STATES; CONSUMPTION; RISK; CONSEQUENCES; PATTERNS; BEHAVIOR	Importance The high prevalence of traumatic brain injuries (TBI) among adolescents has brought much focus to this area in recent years. Sports injuries have been identified as a main mechanism. Although energy drinks, including those mixed with alcohol, are often used by young athletes and other adolescents they have not been examined in relation to TBI. Objective We report on the prevalence of adolescent TBI and its associations with energy drinks, alcohol and energy drink mixed in with alcohol consumption. Design, Settings and Participants Data were derived from the Centre for Addiction and Mental Health's 2013 Ontario Student Drug Use and Health Survey (OSDUHS). This population-based cross-sectional school survey included 10,272 7th to 12th graders (ages 11-20) who completed anonymous selfadministered questionnaires in classrooms. Main Outcome Measures Mild to severe TBI were defined as those resulting in a loss of consciousness for at least five minutes, or being hospitalized for at least one night. Mechanism of TBI, prevalence estimates of TBI, and odds of energy drink consumption, alcohol use, and consumption of energy drinks mixed with alcohol are assessed. Results Among all students, 22.4%(95% CI: 20.7, 24.1) reported a history of TBI. Sports injuries remain the main mechanism of a recent (past year) TBI (45.5%, 95% CI: 41.0, 50.1). Multinomial logistic regression showed that relative to adolescents who never sustained a TBI, the odds of sustaining a recent TBI were greater for those consuming alcohol, energy drinks, and energy drinks mixed in with alcohol than abstainers. Odds ratios were higher for these behaviors among students who sustained a recent TBI than those who sustained a former TBI (lifetime but not past 12 months). Relative to recent TBI due to other causes of injury, adolescents who sustained a recent TBI while playing sports had higher odds of recent energy drinks consumption than abstainers. Conclusions and Relevance TBI remains a disabling and common condition among adolescents and the consumption of alcohol, energy drinks, and alcohol mixed with energy drinks further increase the odds of TBI among adolescents. These associations warrant further investigation.	[Ilie, Gabriela] St Michaels Hosp, Injury Prevent Res Off, Toronto, ON M5B 1W8, Canada; [Ilie, Gabriela] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Boak, Angela; Mann, Robert E.; Adlaf, Edward M.; Hamilton, Hayley; Rehm, Juergen] Ctr Addict & Mental Hlth, Social & Epidemiol Res, Toronto, ON, Canada; [Mann, Robert E.; Adlaf, Edward M.; Hamilton, Hayley; Rehm, Juergen; Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Asbridge, Mark] Dalhousie Univ, Halifax, NS, Canada; [Cusimano, Michael D.] Univ Toronto, Div Neurosurg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; Dalhousie University; University of Toronto	Ilie, G (corresponding author), St Michaels Hosp, Injury Prevent Res Off, 30 Bond St, Toronto, ON M5B 1W8, Canada.	ilieg@smh.ca	Ilie, Gabriela/AAM-9122-2021; Meijer, Anna/K-5118-2016; Cusimano, Michael/GWR-1025-2022; Cusimano, Michael/X-4059-2019	Cusimano, Michael/0000-0002-9989-0650	Canadian Institutes of Health Research [TIR103946]; Ontario Neurotrauma Foundation [AUTO21]; Natural Sciences and Engineering Research Council (NSERC); Canadian Institutes of Health Research (CIHR); Social Sciences and Humanities Research Council (SSHRC); Industry Canada; Ontario Ministry of Health and Long-Term Care	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Neurotrauma Foundation; Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Social Sciences and Humanities Research Council (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC)); Industry Canada; Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario)	This work was financially supported by a Team Grant (TIR103946) from Canadian Institutes of Health Research and by funds from the Ontario Neurotrauma Foundation, AUTO21, a member of the Networks of Centres of Excellence (NCE) program that is administered and funded by the Natural Sciences and Engineering Research Council (NSERC), the Canadian Institutes of Health Research (CIHR), and the Social Sciences and Humanities Research Council (SSHRC), in partnership with Industry Canada. Drs. RM, HH and JR also acknowledge ongoing funding support from the Ontario Ministry of Health and Long-Term Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Active Healthy Kids Canada, 2014, IS CAN RUNN 2014 ACT; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Arria AM, 2011, ALCOHOL CLIN EXP RES, V35, P365, DOI 10.1111/j.1530-0277.2010.01352.x; Azagba Sunday, 2013, CMAJ Open, V1, pE19, DOI 10.9778/cmajo.20120017; Azagba S, 2014, PREV MED, V62, P54, DOI 10.1016/j.ypmed.2014.01.019; Beauchamp MH, 2013, BRAIN INJURY, V27, P896, DOI 10.3109/02699052.2013.775486; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Brache K, 2011, ADDICT BEHAV, V36, P1133, DOI 10.1016/j.addbeh.2011.07.003; Cherpitel CJ, 2007, DRUG ALCOHOL REV, V26, P201, DOI 10.1080/09595230601146686; Cook LG, 2013, J INT NEUROPSYCH SOC, V19, P508, DOI 10.1017/S1355617712001452; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061865; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Dicker BG, 1989, HEAD TRAUMA REHABIL, V4, P73; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Frances A, DSM 4 CLASSIFICATION; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hamilton HA, 2013, CAN J PUBLIC HEALTH, V104, pE496, DOI 10.17269/cjph.104.3998; Heeringa SG, 2017, APPL SURVEY DATA ANA, VSecond, DOI DOI 10.1201/9781315153278; Ilie G, 2015, J HEAD TRAUMA REHAB, V30, P293, DOI 10.1097/HTR.0000000000000101; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [DOI 10.1097/00001199-199309000-00010, 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00009]; Kenny DT, 2007, COMTEMPORARY ISSUES, V107, P1; Leon-Carrion J, 2003, BRAIN INJURY, V17, P207, DOI 10.1080/0269905021000010249; MacDonald N, 2010, CAN MED ASSOC J, V182, P1597, DOI 10.1503/cmaj.100953; Meier B, 2012, NY TIMES; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miller KE, 2008, J AM COLL HEALTH, V56, P481, DOI 10.3200/JACH.56.5.481-490; National Center for Injury Prevention & Control, REP C MILD TRAUM BRA; Paglia-Boak A, 2013, CAMH RES DOCUMENT SE; Peacock A, 2013, ALCOHOL CLIN EXP RES, V37, P1234, DOI 10.1111/acer.12086; Pharo H, 2011, BEHAV NEUROSCI, V125, P970, DOI 10.1037/a0025768; Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001; Terry-McElrath YM, 2014, J ADDICT MED, V8, P6, DOI 10.1097/01.ADM.0000435322.07020.53; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Wolk BJ, 2012, CURR OPIN PEDIATR, V24, P243, DOI 10.1097/MOP.0b013e3283506827; Yeates K.O., 2010, PEDIAT NEUROPSYCHOLO, P112	40	19	20	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0135860	10.1371/journal.pone.0135860	http://dx.doi.org/10.1371/journal.pone.0135860			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375286	Green Published, gold, Green Submitted			2022-12-27	WOS:000361610200009
J	Namkoong, E; Shin, YH; Bae, JS; Choi, S; Kim, M; Kim, N; Hwang, SM; Park, K				Namkoong, Eun; Shin, Yong-Hwan; Bae, Jun-Seok; Choi, Seulki; Kim, Minkyoung; Kim, Nahyun; Hwang, Sung-Min; Park, Kyungpyo			Role of Sodium Bicarbonate Cotransporters in Intracellular pH Regulation and Their Regulatory Mechanisms in Human Submandibular Glands	PLOS ONE			English	Article							RENAL NA-HCO3 COTRANSPORTER; NA+-HCO3-COTRANSPORTER; RAT-KIDNEY; SALIVARY; TRANSPORTERS; EXPRESSION; ACINAR; NBCE1; NBCN1; DUCT	Sodium bicarbonate cotransporters (NBCs) are involved in the pH regulation of salivary glands. However, the roles and regulatory mechanisms among different NBC isotypes have not been rigorously evaluated. We investigated the roles of two different types of NBCs, electroneutral (NBCn1) and electrogenic NBC (NBCe1), with respect to pH regulation and regulatory mechanisms using human submandibular glands (hSMGs) and HSG cells. Intracellular pH (pH(i)) was measured and the pH(i) recovery rate from cell acidification induced by an NH4Cl pulse was recorded. Subcellular localization and protein phosphorylation were determined using immunohistochemistry and co-immunoprecipitation techniques. We determined that NBCn1 is expressed on the basolateral side of acinar cells and the apical side of duct cells, while NBCe1 is exclusively expressed on the apical membrane of duct cells. The pH(i) recovery rate in hSMG acinar cells, which only express NBCn1, was not affected by pre-incubation with 5 mu M PP2, an Src tyrosine kinase inhibitor. However, in HSG cells, which express both NBCe1 and NBCn1, the pH(i) recovery rate was inhibited by PP2. The apparent difference in regulatory mechanisms for NBCn1 and NBCe1 was evaluated by artificial overexpression of NBCn1 or NBCe1 in HSG cells, which revealed that the pH(i) recovery rate was only inhibited by PP2 in cells overexpressing NBCe1. Furthermore, only NBCe1 was significantly phosphorylated and translocated by NH4Cl, which was inhibited by PP2. Our results suggest that both NBCn1 and NBCe1 play a role in pH(i) regulation in hSMG acinar cells, and also that Src kinase does not regulate the activity of NBCn1.	[Park, Kyungpyo] Seoul Natl Univ, Sch Dent, Dept Physiol, Seoul 110749, South Korea; Dent Res Inst, Seoul 110749, South Korea	Seoul National University (SNU)	Park, K (corresponding author), Seoul Natl Univ, Sch Dent, Dept Physiol, Seoul 110749, South Korea.	kppark@snu.ac.kr			National Research Foundation of Korea, through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University in Korea [2014050477]	National Research Foundation of Korea, through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University in Korea	This work was supported by a grant from the National Research Foundation of Korea, through the Oromaxillofacial Dysfunction Research Center for the Elderly (No. 2014050477) at Seoul National University in Korea (EN YS JB SC MK NK SH KP).	Abuladze N, 1998, J BIOL CHEM, V273, P17689, DOI 10.1074/jbc.273.28.17689; Bachmann O, 2003, AM J PHYSIOL-GASTR L, V284, pG37, DOI 10.1152/ajpgi.00209.2002; Bae JS, 2013, J BIOL CHEM, V288, P6295, DOI 10.1074/jbc.M112.392001; Bae SH, 2014, FEBS LETT, V588, P86, DOI 10.1016/j.febslet.2013.11.010; Bernardo AA, 2003, J MEMBRANE BIOL, V191, P141, DOI 10.1007/s00232-002-1051-3; Bevensee MO, 2000, AM J PHYSIOL-CELL PH, V278, pC1200, DOI 10.1152/ajpcell.2000.278.6.C1200; Billet A, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.479360; Boron WF, 2009, J EXP BIOL, V212, P1697, DOI 10.1242/jeb.028563; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Catalan MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016549; Chen MM, 2012, J PHYSIOL-LONDON, V590, P3317, DOI 10.1113/jphysiol.2011.226506; DAWES C, 1995, ARCH ORAL BIOL, V40, P699, DOI 10.1016/0003-9969(95)00037-P; Espiritu DJD, 2002, AM J PHYSIOL-RENAL, V283, pF663, DOI 10.1152/ajprenal.00338.2001; Gorbatenko A, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00130; Gresz V, 2002, AM J PHYSIOL-GASTR L, V283, pG473, DOI 10.1152/ajpgi.00421.2001; Gresz V, 2001, AM J PHYSIOL-GASTR L, V281, pG247, DOI 10.1152/ajpgi.2001.281.1.G247; Gross E, 2003, J PHYSIOL-LONDON, V549, P673, DOI 10.1113/jphysiol.2003.042226; Jin M, 2012, BBA-MOL BASIS DIS, V1822, P161, DOI 10.1016/j.bbadis.2011.11.012; Kurtz I, 2014, PFLUG ARCH EUR J PHY, V466, P1501, DOI 10.1007/s00424-014-1448-8; Kwon TH, 2003, AM J PHYSIOL-RENAL, V285, pF152, DOI 10.1152/ajprenal.00307.2002; Lee MG, 2012, PHYSIOL REV, V92, P39, DOI 10.1152/physrev.00011.2011; Lin AL, 2008, AM J PHYSIOL-CELL PH, V294, pC1454, DOI 10.1152/ajpcell.00151.2007; Luo X, 2001, J BIOL CHEM, V276, P9808, DOI 10.1074/jbc.M008548200; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; Muller-Berger S, 2001, PFLUG ARCH EUR J PHY, V442, P718, DOI 10.1007/s004240100592; Park K, 2002, ARCH ORAL BIOL, V47, P1, DOI 10.1016/S0003-9969(01)00098-X; Park M, 2002, J BIOL CHEM, V277, P50503, DOI 10.1074/jbc.M201862200; Parker MD, 2013, PHYSIOL REV, V93, P803, DOI 10.1152/physrev.00023.2012; Perry C, 2007, AM J PHYSIOL-RENAL, V293, pF68, DOI 10.1152/ajprenal.00454.2006; Perry C, 2009, AM J PHYSIOL-CELL PH, V297, pC1409, DOI 10.1152/ajpcell.00028.2009; Perry C, 2008, AM J PHYSIOL-CELL PH, V295, pC1385, DOI 10.1152/ajpcell.00153.2008; Praetorius J, 2004, AM J PHYSIOL-RENAL, V286, pF903, DOI 10.1152/ajprenal.00437.2002; Pushkin A, 1999, AM J PHYSIOL-RENAL, V277, pF974, DOI 10.1152/ajprenal.1999.277.6.F974; Roussa E, 1999, AM J PHYSIOL-GASTR L, V277, pG1288, DOI 10.1152/ajpgi.1999.277.6.G1288; Roussa E, 2001, HISTOCHEM J, V33, P337, DOI 10.1023/A:1012471023913; Roussa E, 2011, CELL TISSUE RES, V343, P263, DOI 10.1007/s00441-010-1089-y; Ruiz OS, 1998, J MEMBRANE BIOL, V162, P201, DOI 10.1007/s002329900357; Ruiz OS, 1999, AM J PHYSIOL-RENAL, V277, pF580, DOI 10.1152/ajprenal.1999.277.4.F580; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Schulz E, 2011, CIRCULATION, V124, P1806, DOI 10.1161/CIRCULATIONAHA.111.061226; SHIRASUNA K, 1981, CANCER, V48, P745, DOI 10.1002/1097-0142(19810801)48:3<745::AID-CNCR2820480314>3.0.CO;2-7; Yamaji Y, 1997, AM J PHYSIOL-CELL PH, V272, pC886, DOI 10.1152/ajpcell.1997.272.3.C886	42	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138368	10.1371/journal.pone.0138368	http://dx.doi.org/10.1371/journal.pone.0138368			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375462	Green Submitted, gold, Green Published			2022-12-27	WOS:000361610200102
J	Velayutham, B; Thomas, B; Nair, D; Thiruvengadam, K; Prashant, S; Kittusami, S; Vijayakumar, H; Chidambaram, M; Shivakumar, SVBY; Jayabal, L; Jhunjhunwala, A; Swaminathan, S				Velayutham, Banurekha; Thomas, Beena; Nair, Dina; Thiruvengadam, Kannan; Prashant, Suma; Kittusami, Sathyapriya; Vijayakumar, Harivanzan; Chidambaram, Meenachi; Shivakumar, Shri Vijay Bala Yogendra; Jayabal, Lavanya; Jhunjhunwala, Ashok; Swaminathan, Soumya			The Usefulness and Feasibility of Mobile Interface in Tuberculosis Notification (MITUN) Voice Based System for Notification of Tuberculosis by Private Medical Practitioners - A Pilot Project	PLOS ONE			English	Article							RESPONSE SYSTEM; INTERVENTION	Introduction Tuberculosis (TB) is a notifiable disease and health care providers are required to notify every TB case to local authorities. We conducted a pilot study to determine the usefulness and feasibility of mobile interface in TB notification (MITUN) voice based system for notification of TB cases by private medical practitioners. Methodology The study was conducted during September 2013 to October 2014 in three zones of Chennai, an urban setting in South India. Private clinics wherein services are provided by single private medical practitioners were approached. The steps involved in MITUN included: Registration of the practitioners and notification of TB cases by them through voice interactions. Pre and post-intervention questionnaires were administered to collect information on TB notification practices and feasibility of MITUN after an implementation period of 6 months. Results A total of 266 private medical practitioners were approached for the study. Of them, 184 (69%) participated in the study; of whom 11 (6%) practitioners used MITUN for TB notification. Reasons for not using MITUN include lack of time, referral of patients to government facility, issues related to patient confidentiality and technical problems. Suggestions for making mobile phone based TB notification process user-friendly included reducing call duration, including only crucial questions and using missed call or SMS options. Conclusion The performance (feasibility and usefulness) of MITUN voice based system for TB notification in the present format was sub-optimal. Perceived problems, logistical and practical issues preclude scale-up of notification of TB by private practitioners.	[Velayutham, Banurekha; Thomas, Beena; Nair, Dina; Thiruvengadam, Kannan; Vijayakumar, Harivanzan; Chidambaram, Meenachi; Shivakumar, Shri Vijay Bala Yogendra; Swaminathan, Soumya] Natl Inst Res TB, Madras, Tamil Nadu, India; [Prashant, Suma; Kittusami, Sathyapriya; Jhunjhunwala, Ashok] Indian Inst Technol Madras, RTBI, Madras, Tamil Nadu, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Swaminathan, S (corresponding author), Natl Inst Res TB, Madras, Tamil Nadu, India.	doctorsoumya@yahoo.com	vijayakumar, harivanzan/T-4968-2019; Thiruvengadam, Kannan/AAQ-8532-2021	Thiruvengadam, Kannan/0000-0002-3758-1094	World Health Organization; United States Agency for International Development (USAID), under the Model DOTS Project [MDP TSA-2013/3130790]	World Health Organization(World Health Organization); United States Agency for International Development (USAID), under the Model DOTS Project(United States Agency for International Development (USAID))	This study was supported by the World Health Organization with financial assistance provided by the United States Agency for International Development (USAID), under the Model DOTS Project (Grant No: MDP TSA-2013/3130790). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender BG, 2010, J AM BOARD FAM MED, V23, P159, DOI 10.3122/jabfm.2010.02.090112; Courtwright A, 2010, PUBLIC HEALTH REP, V125, P34, DOI 10.1177/00333549101250S407; Free C, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001363, 10.1371/journal.pmed.1001362]; Ganesan M., 2011, Journal of Health Informatics in Developing Countries, V5, P219; Jhunjhunwala A, 2011, INFR HLTH CAR GLOB H, P59; Kaminer Y, 2006, AM J ADDICTION, V15, P122, DOI 10.1080/10550490601006121; Patnaik Somani, 2009, Proceedings of the 2009 International Conference on Information and Communication Technologies and Development (ICTD 2009), P74, DOI 10.1109/ICTD.2009.5426700; Regan S, 2011, NICOTINE TOB RES, V13, P255, DOI 10.1093/ntr/ntq248; Reidel K, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-46; Sachdeva KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022061; Skinner C, 2008, P 619 TEL ASS TECHN; Wells WA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018964; World Health Organization, 2011, GLOB OBS EH SER, V3	13	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138274	10.1371/journal.pone.0138274	http://dx.doi.org/10.1371/journal.pone.0138274			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376197	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000361610200095
J	Belin, L; Broet, P; De Rycke, Y				Belin, Lisa; Broet, Philippe; De Rycke, Yann			A Rescue Strategy for Handling Unevaluable Patients in Simon's Two Stage Design	PLOS ONE			English	Article							II CLINICAL-TRIALS; CANCER	For phase II oncology trials, Simon's two-stage design is the most commonly used strategy. However, when clinically unevaluable patients occur, the total number of patients included at each stage differs from what was initially planned. Such situations raise concerns about the operating characteristics of the trial design. This paper evaluates three classical ad hoc strategies and a novel one proposed in this work for handling unevaluable patients. This latter is called the rescue strategy which adapts the critical stopping rules to the number of unevaluable patients at each stage without modifying the planned sample size. blue Simulations show that none of these strategies perfectly match the original target constraints for type I and II error rates. Our rescue strategy is nevertheless the one which best approaches the target error rates requirement. A re-analysis of one real phase II clinical trials on metastatic cancer illustrates the use of the proposed strategy.	[Belin, Lisa] Inst Curie, Biostat Dept, Paris, France; [Belin, Lisa; Broet, Philippe] INSERM, UMR 1178, Villejuif, France; [Broet, Philippe] Univ Paris 11, Villejuif, France; [Broet, Philippe] Hop Paul Brousse, AP HP, Villejuif, France; [De Rycke, Yann] Hop Bichat Claude Bernard, AP HP, Epidemiol & Clin Res Dept, F-75877 Paris, France; [De Rycke, Yann] Hop Bichat Claude Bernard, AP HP, Ctr Pharmacoepidemiol Cephepi, F-75877 Paris, France; [De Rycke, Yann] Univ Paris Diderot, UMR ECEVE 1123, Sorbonne Paris Cite, Paris, France; [De Rycke, Yann] INSERM, UMR ECEVE 1123, Paris, France; [De Rycke, Yann] INSERM, CIC EC 1425, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Belin, L (corresponding author), Inst Curie, Biostat Dept, Paris, France.	lisa.belin@curie.fr		BROET, PHILIPPE/0000-0001-9122-2810; Belin, Lisa/0000-0002-7628-6629				Chen TT, 1998, STAT MED, V17, P2301, DOI 10.1002/(SICI)1097-0258(19981030)17:20<2301::AID-SIM927>3.0.CO;2-X; FLEMING TR, 1982, BIOMETRICS, V38, P143, DOI 10.2307/2530297; Fleming TR, 2011, COUNTING PROCESSES S; Gehan E, 1960, J CHRON DIS, V13, P346, DOI [DOI 10.1016/0021-9681(61)90060-1, 10.1016/0021-9681(61)90060-1]; GREEN SJ, 1992, STAT MED, V11, P853, DOI 10.1002/sim.4780110703; Koyama T, 2008, STAT MED, V27, P3145, DOI 10.1002/sim.3123; Lee JJ, 2005, J CLIN ONCOL, V23, P4450, DOI 10.1200/JCO.2005.03.197; Mariani L, 2000, J CLIN ONCOL, V18, P429, DOI 10.1200/JCO.2000.18.2.429; Masaki N, 2009, J BIOPHARM STAT, V19, P721, DOI 10.1080/10543400902964167; Perrone F, 2003, LANCET ONCOL, V4, P305, DOI 10.1016/S1470-2045(03)01078-7; SIMON R, 1989, CONTROL CLIN TRIALS, V10, P1, DOI 10.1016/0197-2456(89)90015-9; Thezenas S, 2004, EUR J CANCER, V40, P1244, DOI 10.1016/j.ejca.2004.01.008; Wu YJ, 2008, STAT MED, V27, P6190, DOI 10.1002/sim.3426	13	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137586	10.1371/journal.pone.0137586	http://dx.doi.org/10.1371/journal.pone.0137586			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368810	gold, Green Published, Green Submitted			2022-12-27	WOS:000361601100088
J	Larsen, B; Snow, R; Vincent, G; Tran, J; Wolkow, A; Aisbett, B				Larsen, Brianna; Snow, Rod; Vincent, Grace; Tran, Jacqueline; Wolkow, Alexander; Aisbett, Brad			Multiple Days of Heat Exposure on Firefighters' Work Performance and Physiology	PLOS ONE			English	Article							LONGITUDINAL DATA; PROJECT AQUARIUS; EXERCISE; STRESS; MODELS; TEMPERATURE; INGESTION; EXERTION; BUSHFIRE; CAFFEINE	This study assessed the accumulated effect of ambient heat on the performance of, and physiological and perceptual responses to, intermittent, simulated wildfire fighting tasks over three consecutive days. Firefighters (n = 36) were matched and allocated to either the CON (19 degrees C) or HOT (33 degrees C) condition. They performed three days of intermittent, self-paced simulated firefighting work, interspersed with physiological testing. Task repetitions were counted (and converted to distance or area) to determine work performance. Participants were asked to rate their perceived exertion and thermal sensation after each task. Heart rate, core temperature (Ts), and skin temperature (Tsk) were recorded continuously throughout the simulation. Fluids were consumed ad libitum. Urine volume was measured throughout, and urine specific gravity (USG) analysed, to estimate hydration. All food and fluid consumption was recorded. There was no difference in work output between experimental conditions. However, significant variation in performance responses between individuals was observed. All measures of thermal stress were elevated in the HOT, with core and skin temperature reaching, on average, 0.24 0.08 degrees C and 2.81 0.20 degrees C higher than the CON group. Participants' doubled their fluid intake in the HOT condition, and this was reflected in the USG scores, where the HOT participants reported significantly lower values. Heart rate was comparable between conditions at nearly all time points, however the peak heart rate reached each circuit was 7 3% higher in the CON trial. Likewise, RPE was slightly elevated in the CON trial for the majority of tasks. Participants' work output was comparable between the CON and HOT conditions, however the performance change over time varied significantly between individuals. It is likely that the increased fluid replacement in the heat, in concert with frequent rest breaks and task rotation, assisted with the regulation of physiological responses (e.g., heart rate, core temperature).	[Larsen, Brianna; Snow, Rod; Vincent, Grace; Wolkow, Alexander; Aisbett, Brad] Deakin Univ, Ctr Phys Act & Nutr Res C PAN, Melbourne, Vic, Australia; [Larsen, Brianna; Vincent, Grace; Wolkow, Alexander; Aisbett, Brad] Bushfire Cooperat Res Ctr, Melbourne, Australia; [Tran, Jacqueline] Deakin Univ, Ctr Exercise & Sports Sci, Melbourne, Vic, Australia	Deakin University; Deakin University	Larsen, B (corresponding author), Deakin Univ, Ctr Phys Act & Nutr Res C PAN, Melbourne, Vic, Australia.	b.larsen@deakin.edu.au	Snow, Rod J/G-1673-2010; Aisbett, Brad/E-5178-2011	Snow, Rod J/0000-0002-4796-6916; Tran, Jacqueline/0000-0002-5588-542X; Aisbett, Brad/0000-0001-8077-0272; Wolkow, Alexander/0000-0001-7845-3104; Larsen, Brianna/0000-0003-0885-795X; Vincent, Grace/0000-0002-7036-7823	Bushfire Co-operative Research Centre; Deakin University	Bushfire Co-operative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Deakin University	The Bushfire Co-operative Research Centre funded this research as part of a broader study. The Bushfire CRC website is http://www.bushfirecrc.com/. The webpage directly discussing this body of work is http://www.bushfirecrc.com/projects/c-11-1/operational-readiness-rural-firefighters-during-bushfire-suppression. Dr. Brad Aisbett (last author) was one of the project leaders and was awarded the funding on behalf of Deakin University.	Aisbett B, 2012, APPL ERGON, V43, P916, DOI 10.1016/j.apergo.2011.12.013; Aisbett B, 2007, AUST J EMERG MANAG, V22, P31; Bates Graham P, 2008, J Occup Med Toxicol, V3, P21, DOI 10.1186/1745-6673-3-21; Borg G, 1998, BORGS PERCEIVED EXER; Budd GM, 1997, INT J WILDLAND FIRE, V7, P119, DOI 10.1071/WF9970119; Budd GM, 1997, INT J WILDLAND FIRE, V7, P69, DOI 10.1071/WF9970069; Burke LM, 2008, APPL PHYSIOL NUTR ME, V33, P1319, DOI 10.1139/H08-130; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Castle P, 2011, J SPORT SCI, V29, P1125, DOI 10.1080/02640414.2011.583673; Cater H, 2007, FATIGUE FIREGROUND D; Cheung SS, 2000, SPORTS MED, V29, P329, DOI 10.2165/00007256-200029050-00004; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Cuddy JS, 2007, MED SCI SPORT EXER, V39, P1004, DOI 10.1249/mss.0b013e318040b2fb; DeCarlo LT, 1997, PSYCHOL METHODS, V2, P292, DOI 10.1037/1082-989X.2.3.292; Doherty M, 2005, SCAND J MED SCI SPOR, V15, P69, DOI 10.1111/j.1600-0838.2005.00445.x; Field A, 2007, DISCOVERING STAT USI; Garrett AT, 2012, EUR J APPL PHYSIOL, V112, P1827, DOI 10.1007/s00421-011-2153-3; Garrett AT, 2009, EUR J APPL PHYSIOL, V107, P659, DOI 10.1007/s00421-009-1182-7; Gellish RL, 2007, MED SCI SPORT EXER, V39, P822, DOI 10.1097/mss.0b013e31803349c6; HAMILTON MT, 1991, J APPL PHYSIOL, V71, P871, DOI 10.1152/jappl.1991.71.3.871; Hargreaves M, 2008, J SCI MED SPORT, V11, P66, DOI 10.1016/j.jsams.2007.07.002; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Kachman S, 2000, INTRO GENERALIZED LI, P59; Kenefick RW, 2012, NUTR REV, V70, pS137, DOI 10.1111/j.1753-4887.2012.00523.x; Lee S.M.C., 2000, CORE TEMPERATURE MEA; McCulloch CE, 2003, JSTOR, pi; McGregor SJ, 1999, J SPORT SCI, V17, P895, DOI 10.1080/026404199365452; MCLELLAN TM, 1993, AVIAT SPACE ENVIR MD, V64, P587; McLennan J., 2005, Environmental Hazards, V6, P101, DOI 10.1016/j.hazards.2005.10.003; Molenberghs G, 2001, STAT MODEL, V1, P235, DOI 10.1177/1471082X0100100402; MONTAIN SJ, 1992, J APPL PHYSIOL, V73, P1340, DOI 10.1152/jappl.1992.73.4.1340; PAYNE WR, 1994, AM IND HYG ASSOC J, V55, P529, DOI 10.1080/15428119491018808; Phillips M, 2011, BUSHF CRC AFAC C SYD, P205; Phillips M, 2012, APPL ERGON, V43, P435, DOI 10.1016/j.apergo.2011.06.018; Rabe-Hesketh S, 2005, J ECONOMETRICS, V128, P301, DOI 10.1016/j.jeconom.2004.08.017; Rabe-Hesketh S, 2002, STATA J, V2, P1, DOI 10.1177/1536867X0200200101; Raines J, 2013, APPL ERGON, V44, P404, DOI 10.1016/j.apergo.2012.10.002; Raines J, 2012, APPL ERGON, V43, P532, DOI 10.1016/j.apergo.2011.08.007; RAMANATHAN NL, 1964, J APPL PHYSIOL, V19, P531, DOI 10.1152/jappl.1964.19.3.531; Rodriguez-Marroyo JA, 2011, ERGONOMICS, V54, P1101, DOI 10.1080/00140139.2011.611895; Sawka MN, 2007, MED SCI SPORT EXER, V39, P377, DOI 10.1249/mss.0b013e31802ca597; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; SNOOK SH, 1974, AM IND HYG ASSOC J, V35, P681, DOI 10.1080/0002889748507088; Tasca GA, 2009, PSYCHOTHER RES, V19, P429, DOI 10.1080/10503300802641444; Teague B., 2010, 2009 VICTORIAN BUSHF; Van Dongen HPA, 2004, METHOD ENZYMOL, V384, P139; Westfall P, 2013, UNDERSTANDING ADV ST; YOUNG AJ, 1987, J APPL PHYSIOL, V63, P1218, DOI 10.1152/jappl.1987.63.3.1218	48	23	23	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0136413	10.1371/journal.pone.0136413	http://dx.doi.org/10.1371/journal.pone.0136413			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379284	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000361769400005
J	Wanga, S; Ceron, CS; Delgado, C; Joshi, SK; Spaulding, K; Walker, JP; Song, S; Olson, JL; Lovett, DH				Wanga, Shaynah; Ceron, Carla S.; Delgado, Cynthia; Joshi, Sunil K.; Spaulding, Kimberly; Walker, Joy P.; Song, Sangheon; Olson, Jean L.; Lovett, David H.			Two Distinct Isoforms of Matrix Metalloproteinase-2 Are Associated with Human Delayed Kidney Graft Function	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; TUBULOINTERSTITIAL INJURY; RENAL-TRANSPLANTATION; RISK-FACTORS; EXPRESSION; MATRIX-METALLOPROTEINASE-2; CELLS; MODEL; TRANSCRIPTION; INHIBITION	Delayed graft function (DGF) is a frequent complication of renal transplantation, particularly in the setting of transplantation of kidneys derived from deceased donors and expanded-criteria donors. DGF results from tubular epithelial cell injury and has immediate and long term consequences. These include requirement for post-transplantation dialysis, increased incidence of acute rejection, and poorer long-term outcomes. DGF represents one of the clearest clinical examples of renal acute ischemia/reperfusion injury. Experimental studies have demonstrated that ischemia/reperfusion injury induces the synthesis of the full length secreted isoform of matrix metalloproteinase-2 (FL-MMP-2), as well as an intracellular Nterminal truncated MMP-2 isoform (NTT-MMP-2) that initiates an innate immune response. We hypothesized that the two MMP-2 isoforms mediate tubular epithelial cell injury in DGF. Archival renal biopsy sections from 10 protocol biopsy controls and 41 cases with a clinical diagnosis of DGF were analyzed for the extent of tubular injury, expression of the FL-MMP2 and NTT-MMP-2 isoforms by immunohistochemistry (IHC), in situ hybridization, and qPCR to determine isoform abundance. Differences in transcript abundance were related to tubular injury score. Markers of MMP-2-mediated injury included TUNEL staining and assessment of peritubular capillary density. There was a clear relationship between tubular epithelial cell expression of both FL-MMP-2 and NTT-MMP-2 IHC with the extent of tubular injury. The MMP-2 isoforms were detected in the same tubular segments and were present at sites of tubular injury. qPCR demonstrated highly significant increases in both the FL-MMP-2 and NTT-MMP-2 transcripts. Statistical analysis revealed highly significant associations between FL-MMP-2 and NTT-MMP-2 transcript abundance and the extent of tubular injury, with NTT-MMP-2 having the strongest association. We conclude that two distinct MMP-2 isoforms are associated with tubular injury in DGF and offer novel therapeutic targets for the prevention of this disorder.	[Wanga, Shaynah; Ceron, Carla S.; Delgado, Cynthia; Joshi, Sunil K.; Song, Sangheon; Lovett, David H.] Univ Calif San Francisco, Dept Med, San Francisco Dept Vet Affairs Med Ctr, San Francisco, CA 94117 USA; [Spaulding, Kimberly; Walker, Joy P.] Univ Calif San Francisco, Dept Surg, San Francisco Dept Vet Affairs Med Ctr, San Francisco, CA USA; [Olson, Jean L.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lovett, DH (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco Dept Vet Affairs Med Ctr, San Francisco, CA 94117 USA.	david.lovett@va.gov	Ceron, Carla Speroni/F-1160-2015	Ceron, Carla Speroni/0000-0001-8882-5792; Joshi, Sunil/0000-0003-2798-5762	Dutch Kidney Foundation; Ciencias sem Fronteiras; Department of Veterans Affairs [1IK2CX000527-01A2, I-1BX000593]; National Institute of Diabetes, Digestive and Kidney Disease [DK007219, RO1DK39776]; Pusan National University School of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007219, R01DK039776] Funding Source: NIH RePORTER; Veterans Affairs [IK2CX000527] Funding Source: NIH RePORTER	Dutch Kidney Foundation; Ciencias sem Fronteiras; Department of Veterans Affairs(US Department of Veterans Affairs); National Institute of Diabetes, Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Pusan National University School of Medicine(Pusan National University); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	SW was supported by a Kolff Student Fellowship Abroad from the Dutch Kidney Foundation. CSC was supported by a Fellowship Grant from Ciencias sem Fronteiras. CD is supported by the Department of Veterans Affairs Clinical Science Research and Development Program under Career Development Award 1IK2CX000527-01A2. JPW was supported by National Institute of Diabetes, Digestive and Kidney Disease T32 Training Grant DK007219 (Lovett). SS was supported by a grant from Pusan National University School of Medicine. DHL was supported by Department of Veterans Affairs Merit Review Award I-1BX000593 and National Institute of Diabetes, Digestive and Kidney Disease grant RO1DK39776. CD's and DHL's contributions are the result of work supported with the resources and the use of facilities at the San Francisco VA Medical Center.	Alfonso-Jaume MA, 2006, AM J PHYSIOL-HEART C, V291, pH1838, DOI 10.1152/ajpheart.00026.2006; [Anonymous], 2013, ORGAN PROCUREMENT TR; Basile DP, 2001, AM J PHYSIOL-RENAL, V281, pF887, DOI 10.1152/ajprenal.0050.2001; Bergman MR, 2003, BIOCHEM J, V369, P485, DOI 10.1042/BJ20020707; Bronzatto EJM, 2009, TRANSPL P, V41, P849, DOI 10.1016/j.transproceed.2009.02.004; Cheng S, 2006, FASEB J, V20, P1898, DOI 10.1096/fj.06-5898fje; Choi YJ, 2000, HUM PATHOL, V31, P1491, DOI 10.1053/hupa.2000.20373; Dejonckheere E, 2011, DRUG DISCOV TODAY, V16, P762, DOI 10.1016/j.drudis.2011.06.009; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; HARENDZA S, 1995, J BIOL CHEM, V270, P18786, DOI 10.1074/jbc.270.32.18786; Irish WD, 2010, AM J TRANSPLANT, V10, P2279, DOI 10.1111/j.1600-6143.2010.03179.x; Ke QD, 2006, AM J PHYSIOL-LUNG C, V291, pL257, DOI 10.1152/ajplung.00007.2006; Kruger B, 2009, P NATL ACAD SCI USA, V106, P3390, DOI 10.1073/pnas.0810169106; Kunugi S, 2011, LAB INVEST, V91, P170, DOI 10.1038/labinvest.2010.174; Lange PF, 2011, NAT METHODS, V8, P703, DOI 10.1038/nmeth.1669; Lee JG, 2005, P NATL ACAD SCI USA, V102, P16345, DOI 10.1073/pnas.0508085102; Lin H, 2010, BRIT J PHARMACOL, V161, P1661, DOI 10.1111/j.1476-5381.2010.00989.x; Linkermann A, 2014, J AM SOC NEPHROL, V25, P2689, DOI 10.1681/ASN.2014030262; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Liu XH, 2012, J ORTHOP RES, V30, P1440, DOI 10.1002/jor.22096; Llnkermann A, 2013, P NATL ACAD SCI USA, V110, P12; Lovett DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068154; Lovett DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034177; Mertens PR, 1998, J BIOL CHEM, V273, P32957, DOI 10.1074/jbc.273.49.32957; Mertens PR, 2002, J BIOL CHEM, V277, P24875, DOI 10.1074/jbc.M200445200; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Novak KB, 2010, PEDIATR RES, V67, P257, DOI 10.1203/PDR.0b013e3181ca0aa2; Ojo AO, 1997, TRANSPLANTATION, V63, P968, DOI 10.1097/00007890-199704150-00011; PALLER MS, 1984, J CLIN INVEST, V74, P1156, DOI 10.1172/JCI111524; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shoskes DA, 1998, TRANSPLANTATION, V66, P1697, DOI 10.1097/00007890-199812270-00022; Suzuki YJ, 1997, FREE RADICAL BIO MED, V22, P269, DOI 10.1016/S0891-5849(96)00275-4; van der Vliet JA, 2011, CLIN TRANSPLANT, V25, pE612, DOI 10.1111/j.1399-0012.2011.01510.x; Walker LM, 2000, J PHARMACOL EXP THER, V295, P417; Wang WJ, 2002, CIRCULATION, V106, P1543, DOI 10.1161/01.CIR.0000028818.33488.7B; Yarlagadda G, 2008, NEPHROL DIAL TRANSPL, V23, P2995, DOI 10.1093/ndt/gfn158; Yarlagadda SG, 2009, NEPHROL DIAL TRANSPL, V24, P1039, DOI 10.1093/ndt/gfn667	38	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0136276	10.1371/journal.pone.0136276	http://dx.doi.org/10.1371/journal.pone.0136276			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379248	Green Submitted, Green Published, gold			2022-12-27	WOS:000361769400004
J	Babaeian, A; Bayestehtashk, A; Bandarabadi, M				Babaeian, Amir; Bayestehtashk, Alireza; Bandarabadi, Mojtaba			Multiple Manifold Clustering Using Curvature Constrained Path	PLOS ONE			English	Article							TRACKING; MODEL	The problem of multiple surface clustering is a challenging task, particularly when the surfaces intersect. Available methods such as Isomap fail to capture the true shape of the surface near by the intersection and result in incorrect clustering. The Isomap algorithm uses shortest path between points. The main draw back of the shortest path algorithm is due to the lack of curvature constrained where causes to have a path between points on different surfaces. In this paper we tackle this problem by imposing a curvature constraint to the shortest path algorithm used in Isomap. The algorithm chooses several landmark nodes at random and then checks whether there is a curvature constrained path between each landmark node and every other node in the neighborhood graph. We build a binary feature vector for each point where each entry represents the connectivity of that point to a particular landmark. Then the binary feature vectors could be used as a input of conventional clustering algorithm such as hierarchical clustering. We apply our method to simulated and some real datasets and show, it performs comparably to the best methods such as K-manifold and spectral multi-manifold clustering.	[Babaeian, Amir] Univ Calif San Diego, Dept Math, San Diego, CA 92103 USA; [Bayestehtashk, Alireza] Oregon Hlth & Sci Univ, Dept Comp Sci, Portland, OR 97201 USA; [Bandarabadi, Mojtaba] Univ Coimbra, Dept Informat Engn, Coimbra, Portugal	University of California System; University of California San Diego; Oregon Health & Science University; Universidade de Coimbra	Babaeian, A (corresponding author), Univ Calif San Diego, Dept Math, San Diego, CA 92103 USA.	ababaeian@ucsd.edu	Bandarabadi, Mojtaba/C-5024-2011	Bandarabadi, Mojtaba/0000-0002-4608-1374	National Science Foundation [DMS-0915160]	National Science Foundation(National Science Foundation (NSF))	This work was all supported by a grant from the National Science Foundation (DMS-0915160).	Arias-Castro E, 2011, ELECTRON J STAT, V5, P1537, DOI 10.1214/11-EJS651; Babaeean A, 2008, PROCEEDINGS OF THE 40TH SOUTHEASTERN SYMPOSIUM ON SYSTEM THEORY, P366; Babaeean A, 2008, ICNC 2008: FOURTH INTERNATIONAL CONFERENCE ON NATURAL COMPUTATION, VOL 4, PROCEEDINGS, P569, DOI 10.1109/ICNC.2008.584; Babaeian A, 2009, SE SYM SYS THRY, P68, DOI 10.1109/SSST.2009.4806829; Babaeian A, 2009, SE SYM SYS THRY, P59, DOI 10.1109/SSST.2009.4806821; Basri R, 2003, IEEE T PATTERN ANAL, V25, P218, DOI 10.1109/TPAMI.2003.1177153; Bayestehtashk A, 2013, INT CONF ACOUST SPEE, P5750, DOI 10.1109/ICASSP.2013.6638766; Bayestehtashk Alireza, 2013, COMPUTER SPEECH LANG; Beygelzimer A., 2006, P 23 INT C MACH LEAR, P97, DOI [DOI 10.1145/1143844.1143857, 10.1145/1143844.1143857]; Chen GL, 2009, INT J COMPUT VISION, V81, P317, DOI 10.1007/s11263-008-0178-9; de Silva V., 2002, ADV NEURAL INFORM PR, V15, P705; Duc AKH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070059; Epstein R., 1995, Proceedings of the Workshop on Physics-Based Modeling in Computer Vision (Cat. No.95TB8038), P108, DOI 10.1109/PBMCV.1995.514675; Fu ZY, 2005, IEEE IMAGE PROC, P2029; Geman D, 1996, IEEE T PATTERN ANAL, V18, P1, DOI 10.1109/34.476006; Gionis A., 2005, P 11 ACM SIGKDD INT, P51, DOI 10.1145/1081870.1081880; Goldberg A.B., 2009, ARTIF INTELL STAT, V5, P169; Gong D., 2012, P 29 INT C MACH LEAR; Guo QY, 2007, ICMLA 2007: SIXTH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS, PROCEEDINGS, P375, DOI 10.1109/ICMLA.2007.43; Hira ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090562; Ho J, 2003, PROC CVPR IEEE, P11, DOI 10.1109/cvpr.2003.1211332; Kushnir D, 2006, PATTERN RECOGN, V39, P1876, DOI 10.1016/j.patcog.2006.04.007; Ma Y, 2008, SIAM REV, V50, P413, DOI 10.1137/060655523; Maier M, 2009, THEOR COMPUT SCI, V410, P1749, DOI 10.1016/j.tcs.2009.01.009; Martinez VJ, 2002, STATISTICS OF THE GA; Ng AY, 2002, ADV NEUR IN, V14, P849; Perona P., 2001, ADV NEURAL INFORM PR, P1255; Rastegar S, 2009, SE SYM SYS THRY, P64, DOI 10.1109/SSST.2009.4806823; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Sapiro, 2007, ADV NEURAL INFORM PR, V19, P553; Shen HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084096; Souvenir R, 2005, IEEE I CONF COMP VIS, P648; Tashk ARB, 2007, ICSPC: 2007 IEEE INTERNATIONAL CONFERENCE ON SIGNAL PROCESSING AND COMMUNICATIONS, VOLS 1-3, PROCEEDINGS, P1023; Tauro F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091131; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Tipping ME, 1999, NEURAL COMPUT, V11, P443, DOI 10.1162/089976699300016728; Vidal R, 2005, IEEE T PATTERN ANAL, V27, P1945, DOI 10.1109/TPAMI.2005.244; Vidal R, 2006, J MATH IMAGING VIS, V25, P403, DOI 10.1007/s10851-006-8286-z; Wang Y, 2011, IEEE T NEURAL NETWOR, V22, P1149, DOI 10.1109/TNN.2011.2147798; Yang XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047406	41	6	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137986	10.1371/journal.pone.0137986	http://dx.doi.org/10.1371/journal.pone.0137986			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375819	Green Published, Green Submitted, gold			2022-12-27	WOS:000361610200066
J	Biadglegne, F; Merker, M; Sack, U; Rodloff, AC; Niemann, S				Biadglegne, Fantahun; Merker, Matthias; Sack, Ulrich; Rodloff, Arne C.; Niemann, Stefan			Tuberculous Lymphadenitis in Ethiopia Predominantly Caused by Strains Belonging to the Delhi/CAS Lineage and Newly Identified Ethiopian Clades of the Mycobacterium tuberculosis Complex	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; DRUG-RESISTANCE; MIRU-VNTRPLUS; PULMONARY	Background Recently, newly defined clades of Mycobacterium tuberculosis complex (MTBC) strains, namely Ethiopia 1-3 and Ethiopia H37Rv-like strains, and other clades associated with pulmonary TB (PTB) were identified in Ethiopia. In this study, we investigated whether these new strain types exhibit an increased ability to cause TB lymphadenitis (TBLN) and raised the question, if particular MTBC strains derived from TBLN patients in northern Ethiopia are genetically adapted to their local hosts and/or to the TBLN. Methods Genotyping of 196 MTBC strains isolated from TBLN patients was performed by spoligotyping and 24-loci mycobacterial interspersed repetitive unit-variable number of tandem repeats (MIRU-VNTR) typing. A statistical analysis was carried out to see possible associations between patient characteristics and phylogenetic MTBC strain classification. Results Among 196 isolates, the majority of strains belonged to the Delhi/CAS (38.8%) lineage, followed by Ethiopia 1 (9.7%), Ethiopia 3 (8.7%), Ethiopia H37RV-like (8.2%), Ethiopia 2 and Haarlem (7.7% each), URAL (3.6%), Uganda l and LAM (2% each), S-type (1.5%), X-type (1%), and 0.5% isolates of TUR, EAI, and Beijing genotype, respectively. Overall, 15 strains (7.7%) could not be allocated to a previously described phylogenetic lineage. The distribution of MTBC lineages is similar to that found in studies of PTB samples. The cluster rate (35%) in this study is significantly lower (P = 0.035) compared to 45% in the study of PTB in northwestern Ethiopia. Conclusion In the studied area, lymph node samples are dominated by Dehli/CAS genotype strains and strains of largely not yet defined clades based on MIRU-VNTR 24-loci nomenclature. We found no indication that strains of particular genotypes are specifically associated with TBLN. However, a detailed analysis of specific genetic variants of the locally contained Ethiopian clades by whole genome sequencing may reveal new insights into the host-pathogen co-evolution and specific features that are related to the local host immune system.	[Biadglegne, Fantahun] Bahir Dar Univ, Coll Med & Hlth Sci, Bahir Dar, Ethiopia; [Biadglegne, Fantahun; Rodloff, Arne C.] Univ Leipzig, Univ Hosp, Inst Med Microbiol & Epidemiol Infect Dis, D-04109 Leipzig, Germany; [Biadglegne, Fantahun; Sack, Ulrich] Univ Leipzig, Univ Hosp, Inst Clin Immunol, D-04109 Leipzig, Germany; [Merker, Matthias; Niemann, Stefan] Res Ctr Borstel, Mol Mycobacteriol, Borstel, Germany; [Biadglegne, Fantahun; Sack, Ulrich] Univ Leipzig, Translat Ctr Regenerat Med TRM Leipzig, D-04109 Leipzig, Germany; [Niemann, Stefan] Partner Site Borstel, German Ctr Infect Res, Borstel, Germany	Bahir Dar University; Leipzig University; Leipzig University; Forschungszentrum Borstel; Leipzig University; German Center for Infection Research	Biadglegne, F (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Bahir Dar, Ethiopia.	fantahun.degeneh@gmail.com	Degeneh, Fantahun/AAE-6826-2022; Sack, Ulrich/J-6301-2015; Degeneh, Fantahun/AAC-3138-2022; Niemann, Stefan/C-9327-2011; Merker, Matthias/P-7399-2015	Sack, Ulrich/0000-0002-7813-0492; Merker, Matthias/0000-0003-1386-2331; Niemann, Stefan/0000-0002-6604-0684	German Federal Ministry of Education and Research (BMBF) [1315883]; Institute of Medical Microbiology and Epidemiology of Infectious Diseases; Institute of clinical immunology, University Hospital Leipzig, Germany; Translational Centre for Regenerative Medicine (TRM), University Hospital Leipzig, Germany; Molecular Mycobacteriology, Research Center Borstel, Germany; German Academic Exchange Service (DAAD); University of Bahir Dar, Ethiopia	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Institute of Medical Microbiology and Epidemiology of Infectious Diseases; Institute of clinical immunology, University Hospital Leipzig, Germany; Translational Centre for Regenerative Medicine (TRM), University Hospital Leipzig, Germany; Molecular Mycobacteriology, Research Center Borstel, Germany; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); University of Bahir Dar, Ethiopia	The work presented in this paper was made possible by funding from the German Federal Ministry of Education and Research (BMBF, 1315883), the Institute of Medical Microbiology and Epidemiology of Infectious Diseases, Institute of clinical immunology, University Hospital Leipzig, Germany, Translational Centre for Regenerative Medicine (TRM), University Hospital Leipzig, Germany, Molecular Mycobacteriology, Research Center Borstel, Germany, the German Academic Exchange Service (DAAD) and University of Bahir Dar, Ethiopia. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Al-Hajoj S, 2013, INFECT GENET EVOL, V16, P362, DOI 10.1016/j.meegid.2013.03.019; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Annam V, 2009, INDIAN J PATHOL MICR, V52, P349, DOI 10.4103/0377-4929.54991; [Anonymous], 2011, GLOB TUB CONTR 2011; Belay M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/238532; Biadglegne F, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-31; Biadglegne F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106869; Biadglegne F, 2014, TUBERCULOSIS, V94, P502, DOI 10.1016/j.tube.2014.05.002; Biadglegne F, 2014, INDIAN J MED RES, V140, P116; Biadglegne F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081918; Biadglegne F, 2013, INT J MED SCI, V10, P1589, DOI 10.7150/ijms.6806; Bruchfeld J, 2002, J CLIN MICROBIOL, V40, P1636, DOI 10.1128/JCM.40.5.1636-1643.2002; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Chatterjee A, 2013, TUBERCULOSIS, V93, P250, DOI 10.1016/j.tube.2012.10.004; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Deribew A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-54; Diriba B, 2013, INT J TUBERC LUNG D, V17, P246, DOI 10.5588/ijtld.12.0195; Firdessa R, 2013, EMERG INFECT DIS, V19, P460, DOI 10.3201/eid1903.120256; Fitzgibbon MM, 2013, EURO SURVEILL, V18; Garedew L, 2013, INT J TUBERC LUNG D, V17, P1076, DOI 10.5588/ijtld.12.0854; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; HERMANS PWM, 1995, J INFECT DIS, V171, P1504, DOI 10.1093/infdis/171.6.1504; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Maeda S, 2014, TUBERCULOSIS, V94, P649, DOI 10.1016/j.tube.2014.09.005; Mbugi EV, 2014, TUBERCULOSIS EDINB, V29; Mihret A, 2012, AFR HEALTH SCI, V12, P339, DOI 10.4314/ahs.v12i3.15; Reyes JF, 2012, INFECT GENET EVOL, V12, P811, DOI 10.1016/j.meegid.2011.05.018; Sulaiman A, 2010, COMPREHENSIVE CYTOL, V16, P707; Supiyaphun P, 2010, ASIAN BIOMED, V4, P787, DOI 10.2478/abm-2010-0102; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tessema B, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-131; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; WHO, 2010, GLOB TUB CONTR 2010; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; Workalemahu Bereket, 2013, BMC Res Notes, V6, P352, DOI 10.1186/1756-0500-6-352; World Health Organization, 2013, GLOB TUB CONTR 2013	37	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137865	10.1371/journal.pone.0137865	http://dx.doi.org/10.1371/journal.pone.0137865			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376441	gold, Green Published, Green Submitted			2022-12-27	WOS:000361610200058
J	Fleming, S; Gill, P; Jones, C; Taylor, JA; Van den Bruel, A; Heneghan, C; Roberts, N; Thompson, M				Fleming, Susannah; Gill, Peter; Jones, Caroline; Taylor, James A.; Van den Bruel, Ann; Heneghan, Carl; Roberts, Nia; Thompson, Matthew			The Diagnostic Value of Capillary Refill Time for Detecting Serious Illness in Children: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							PREDICTION-RULES; CLINICAL-SIGNS; DEHYDRATION; INFECTIONS; MORTALITY; SEPSIS	Importance Capillary refill time (CRT) is widely recommended as part of the routine assessment of unwell children. Objective To determine the diagnostic value of capillary refill time for a range of serious outcomes in children. Methods We searched Medline, Embase and CINAHL from inception to June 2014. We included studies that measured both capillary refill time and a relevant clinical outcome such as mortality, dehydration, meningitis, or other serious illnesses in children aged up to 18 years of age. We screened 1,265 references, of which 24 papers were included in this review. Where sufficient studies were available, we conducted meta-analysis and constructed hierarchical summary ROC curves. Results Meta-analysis on the relationship between capillary refill time and mortality resulted in sensitivity of 34.6%(95% CI 23.9 to 47.1%), specificity 92.3% (88.6 to 94.8%), positive likelihood ratio 4.49 (3.06 to 6.57), and negative likelihood ratio 0.71 (0.60 to 0.84). Studies of children attending Emergency Departments with vomiting and diarrhea showed that capillary refill time had specificity of 89 to 94% for identifying 5% dehydration, but sensitivity ranged from 0 to 94%. This level of heterogeneity precluded formal meta-analysis of this outcome. Meta-analysis was not possible for other outcomes due to insufficient data, but we found consistently high specificity for a range of outcomes including meningitis, sepsis, admission to hospital, hypoxia, severity of illness and dengue. Conclusions Our results show that capillary refill time is a specific sign, indicating that it can be used as a "red-flag": children with prolonged capillary refill time have a four-fold risk of dying compared to children with normal capillary refill time. The low sensitivity means that a normal capillary refill time should not reassure clinicians.	[Fleming, Susannah; Jones, Caroline; Van den Bruel, Ann; Heneghan, Carl] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, Oxon, England; [Gill, Peter] Univ Toronto, Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Taylor, James A.] Univ Washington, Inst Child Hlth, Seattle, WA 98195 USA; [Roberts, Nia] Univ Oxford, Bodleian Hlth Care Libraries, Oxford, Oxon, England; [Thompson, Matthew] Univ Washington, Dept Family Med, Seattle, WA 98195 USA	University of Oxford; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Washington; University of Washington Seattle; University of Oxford; University of Washington; University of Washington Seattle	Fleming, S (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, Oxon, England.	susannah.fleming@phc.ox.ac.uk	Gill, Peter J./A-6021-2012; Roberts, Nia W/F-9842-2010; Van den Bruel, Ann/AAC-2442-2020	Gill, Peter J./0000-0002-6253-1312; Roberts, Nia W/0000-0002-1142-6440; Van den Bruel, Ann/0000-0001-9012-2009	European Union Seventh Framework Programme (FP7) [305292]; National Institute for Health Research School for Primary Care Research (NIHR SPCR); Rhodes Trust; Alberta Innovates - Health Solutions; Canadian Institute of Health Research; University of Washington Pediatric Endowed Professorship for Research Sabbaticals; NIHR SPCR	European Union Seventh Framework Programme (FP7); National Institute for Health Research School for Primary Care Research (NIHR SPCR); Rhodes Trust; Alberta Innovates - Health Solutions; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); University of Washington Pediatric Endowed Professorship for Research Sabbaticals; NIHR SPCR	This paper presents independent research funded by the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 305292 for the program "Supporting Life" (http://ec.europa.eu/research/fp7/index_en.cfm). SF was funded by a fellowship award from the National Institute for Health Research School for Primary Care Research (NIHR SPCR: http://www.spcr.nihr.ac.uk/). PG received funding from the Rhodes Trust (http://www.rhodeshouse.ox.ac.uk/), Alberta Innovates - Health Solutions (http://www.aihealthsolutions.ca/), and the Canadian Institute of Health Research (http://www.cihr-irsc.gc.ca). JAT was funded by the University of Washington Pediatric Endowed Professorship for Research Sabbaticals (http://depts.washington.edu/givemed/prof-chair/endowments/pediatrics-endowed-professorship-for-researchsabbaticals/). CH also received funding from the NIHR SPCR (http://www.spcr.nihr.ac.uk/). The views expressed in this paper are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. The funders had no role in the design and conduct of the study, collection, management, analysis, and interpretation of the data, and preparation, review, or approval of the manuscript.	Agresti A, 2007, INTRO CATEGORICAL DA; Ahmed Farid Uddin, 2001, Dengue Bulletin, V25, P33; Blacklock C, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X656810; Brierley J, 2009, CRIT CARE MED, V37, P666, DOI 10.1097/CCM.0b013e31819323c6; Carcillo JA, 2009, PEDIATRICS, V124, P500, DOI 10.1542/peds.2008-1967; Carlin JB, 2008, LANCET, V371, P135, DOI 10.1016/S0140-6736(08)60106-3; Colletti JE, 2010, J EMERG MED, V38, P686, DOI 10.1016/j.jemermed.2008.06.015; Craig JC, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1594; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI DOI 10.1007/s00134-012-2769-8; Fleming S, 2015, ARCH DIS CHILD, V100, P239, DOI 10.1136/archdischild-2014-307079; Gorelick MH, 1997, PEDIATR EMERG CARE, V13, P305, DOI 10.1097/00006565-199710000-00001; Gorelick MH, 1997, PEDIATRICS, V99, DOI 10.1542/peds.99.5.e6; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Leonard PA, 2004, EUR J EMERG MED, V11, P158, DOI 10.1097/01.mej.0000127643.38834.86; Mackway-Jones K, 2005, ADV PAEDIAT LIFE SUP; Maitland K, 2006, PLOS MED, V3, P2431, DOI 10.1371/journal.pmed.0030500; Mathur NB, 2007, ACTA PAEDIATR, V96, P172, DOI 10.1111/j.1651-2227.2007.00006.x; Morrison G, 2011, PEDIAT CRITICAL C S1, V12, pA122; National Institute for Health and Care Excellence, 2007, CG47 NAT I HLTH CAR; National Institute for Health and Care Excellence, 2010, CG102 NAT I HLTH CAR; Pamba A, 2004, ARCH DIS CHILD, V89, P950, DOI 10.1136/adc.2003.032516; Ralston M, 2006, PALS PROVIDER MANUAL; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; SAAVEDRA JM, 1991, AM J DIS CHILD, V145, P296, DOI 10.1001/archpedi.1991.02160030064022; Shavit I, 2006, PEDIATRICS, V118, P2402, DOI 10.1542/peds.2006-1108; Steiner MJ, 2004, JAMA-J AM MED ASSOC, V291, P2746, DOI 10.1001/jama.291.22.2746; The World Bank, DAT COUNTR GROUPS; Thompson M, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16150; Thompson M, 2008, BRIT J GEN PRACT, V58, P236, DOI 10.3399/bjgp08X279689; Van den Bruel A, 2010, LANCET, V375, P834, DOI 10.1016/S0140-6736(09)62000-6; Verbakel JY, 2014, PEDIATR EMERG CARE, V30, P373, DOI 10.1097/PEC.0000000000000142; Weber MW, 2003, PEDIATR INFECT DIS J, V22, P711, DOI 10.1097/01.inf.0000078163.80807.88; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; World Health Organization, 2000, MAN CHILD SER INF SE	35	44	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138155	10.1371/journal.pone.0138155	http://dx.doi.org/10.1371/journal.pone.0138155			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375953	Green Submitted, gold, Green Published			2022-12-27	WOS:000361610200080
J	Hiramatsu, Y; Kimura, D; Kadota, K; Ito, T; Kinoshita, H				Hiramatsu, Yuichi; Kimura, Daisuke; Kadota, Koji; Ito, Taro; Kinoshita, Hiroshi			Control of Precision Grip Force in Lifting and Holding of Low-Mass Objects	PLOS ONE			English	Article							SIGNAL-DEPENDENT NOISE; FINGERTIP FORCES; MEDIAN NERVE; HUMAN HAND; MUSCLE; FLUCTUATIONS; COMPRESSION; INFORMATION; ADJUSTMENTS; PERFORMANCE	Few studies have investigated the control of grip force when manipulating an object with an extremely small mass using a precision grip, although some related information has been provided by studies conducted in an unusual microgravity environment. Grip-load force coordination was examined while healthy adults (N = 17) held a moveable instrumented apparatus with its mass changed between 6 g and 200 g in 14 steps, with its grip surface set as either sandpaper or rayon. Additional measurements of grip-force-dependent finger-surface contact area and finger skin indentation, as well as a test of weight discrimination, were also performed. For each surface condition, the static grip force was modulated in parallel with load force while holding the object of a mass above 30 g. For objects with mass smaller than 30 g, on the other hand, the parallel relationship was changed, resulting in a progressive increase in grip-to-load force (GF/LF) ratio. The rayon had a higher GF/LF force ratio across all mass levels. The proportion of safety margin in the static grip force and normalized moment-to-moment variability of the static grip force were also elevated towards the lower end of the object mass for both surfaces. These findings indicate that the strategy of grip force control for holding objects with an extremely small mass differs from that with a mass above 30 g. The data for the contact area, skin indentation, and weight discrimination suggest that a decreased level of cutaneous feedback signals from the finger pads could have played some role in a cost function in efficient grip force control with low-mass objects. The elevated grip force variability associated with signal-dependent and internal noises, and anticipated inertial force on the held object due to acceleration of the arm and hand, could also have contributed to the cost function.	[Hiramatsu, Yuichi; Kimura, Daisuke; Kadota, Koji; Kinoshita, Hiroshi] Osaka Univ, Grad Sch Med, Dept Biomech & Motor Control, Osaka, Japan; [Ito, Taro] Mukogawa Womens Univ, Dept Hlth & Sports Sci, Nishinomiya, Hyogo, Japan	Osaka University; Mukogawa Women's University	Hiramatsu, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Biomech & Motor Control, Osaka, Japan.	specialeverybody@gmail.com	ITO, TARO/AAP-2580-2020	Kimura, Daisuke/0000-0001-5620-8263	Japan Society for the Promotion of Science KAKENHI [23500675]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	H.K. was supported by the Japan Society for the Promotion of Science KAKENHI (http://www.jsps.go.jp/english/index.html) Grant Number 23500675. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0467; Augurelle AS, 2003, EXP BRAIN RES, V148, P533, DOI 10.1007/s00221-002-1322-3; Augurelle AS, 2003, J NEUROPHYSIOL, V89, P665, DOI 10.1152/jn.00249.2002; Birznieks I, 2003, THESIS UMEA U; Burstedt MKO, 1999, J NEUROPHYSIOL, V82, P2393, DOI 10.1152/jn.1999.82.5.2393; Cadoret G, 1996, J NEUROPHYSIOL, V75, P1963, DOI 10.1152/jn.1996.75.5.1963; Cole KJ, 2003, EXP BRAIN RES, V148, P150, DOI 10.1007/s00221-002-1283-6; COLE KJ, 1988, J NEUROPHYSIOL, V60, P1513, DOI 10.1152/jn.1988.60.4.1513; Cole KJ, 1999, J NEUROSCI, V19, P3238; COMAISH S, 1971, BRIT J DERMATOL, V84, P37, DOI 10.1111/j.1365-2133.1971.tb14194.x; Crevecoeur F, 2009, NEUROSCIENCE, V161, P589, DOI 10.1016/j.neuroscience.2009.03.025; Delhaye B, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0698; Derler S, 2012, TRIBOL LETT, V45, P1, DOI 10.1007/s11249-011-9854-y; Dideriksen JL, 2012, J NEUROPHYSIOL, V107, P3357, DOI 10.1152/jn.00938.2011; EDIN BB, 1992, J PHYSIOL-LONDON, V450, P547, DOI 10.1113/jphysiol.1992.sp019142; Engen T., 1971, WOODWORTH SCHLOSBERG, V3rd, P11; Enoka RM, 2003, J ELECTROMYOGR KINES, V13, P1, DOI 10.1016/S1050-6411(02)00084-6; Farina D, 2014, J PHYSIOL-LONDON, V592, P3427, DOI 10.1113/jphysiol.2014.273581; FLANAGAN JR, 1995, EXP BRAIN RES, V105, P455; Flanagan JR, 2001, CAN J EXP PSYCHOL, V55, P87, DOI 10.1037/h0087355; Flanagan JR, 2002, ENCY HUMAN BRAIN, V2, P399, DOI DOI 10.1016/B0-12-227210-2/00157-6; GALGANSKI ME, 1993, J NEUROPHYSIOL, V69, P2108, DOI 10.1152/jn.1993.69.6.2108; Goodwin AW, 1998, J NEUROSCI, V18, P10724; GORDON AM, 1991, EXP BRAIN RES, V83, P477; GREEN DM, 1990, J ACOUST SOC AM, V87, P2662, DOI 10.1121/1.399058; Griffin L, 2009, EXP BRAIN RES, V197, P337, DOI 10.1007/s00221-009-1920-4; HagerRoss C, 1996, EXP BRAIN RES, V110, P131; Hamilton AFD, 2004, EXP BRAIN RES, V157, P417, DOI 10.1007/s00221-004-1856-7; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hermsdorfer J, 1999, EXP BRAIN RES, V126, P205, DOI 10.1007/s002210050730; Hermsdorfer J, 2000, EXP BRAIN RES, V132, P52, DOI 10.1007/s002219900325; Jenmalm P, 1997, J NEUROSCI, V17, P4486; Johansson Roland S., 1996, P381, DOI 10.1016/B978-012759440-8/50025-6; JOHANSSON RS, 1987, EXP BRAIN RES, V66, P141; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P59; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V286, P283, DOI 10.1113/jphysiol.1979.sp012619; JOHANSSON RS, 1990, ATTENTION PERFORM, V8, P677; Jones KE, 2002, J NEUROPHYSIOL, V88, P1533, DOI 10.1152/jn.2002.88.3.1533; Kawashima N, 2012, EXP BRAIN RES, V218, P579, DOI 10.1007/s00221-012-3050-7; Keen A, 1994, TRAINING RELATED ENH; Kinoshita H, 1996, EUR J APPL PHYSIOL, V74, P450; Kinoshita H, 1999, ERGONOMICS, V42, P1372, DOI 10.1080/001401399185018; Kinoshita H, 1997, J NEUROPHYSIOL, V78, P1619, DOI 10.1152/jn.1997.78.3.1619; Kobylecki S, 1906, PSYCHOL STUDIEN, V1, P219; Kuhtz-Buschbeck JP, 2001, EUR J NEUROSCI, V14, P382, DOI 10.1046/j.0953-816x.2001.01639.x; McDonnell MN, 2005, EXP BRAIN RES, V161, P368, DOI 10.1007/s00221-004-2081-0; Moritz CT, 2005, J NEUROPHYSIOL, V93, P2449, DOI 10.1152/jn.01122.2004; Nowak D. A., 2009, SENSORIMOTOR CONTROL; Nowak DA, 2001, EUR J NEUROSCI, V14, P756, DOI 10.1046/j.0953-816x.2001.01697.x; Oberlin KW, 1936, J EXP PSYCHOL, V19, P438, DOI 10.1037/h0056345; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; ROSS HE, 1982, PERCEPT PSYCHOPHYS, V31, P429, DOI 10.3758/BF03204852; Schenker M, 2006, J PLAST RECONSTR AES, V59, P706, DOI 10.1016/j.bjps.2005.12.004; Sezgin M, 2004, J ELECTRON IMAGING, V13, P146, DOI 10.1117/1.1631315; Slifkin A, 1999, J EXP PSYCHOL HUMAN, V25, P837, DOI 10.1037/0096-1523.25.3.837; Taylor AM, 2003, J NEUROPHYSIOL, V90, P1350, DOI 10.1152/jn.00056.2003; Thonnard JL, 1999, EXP BRAIN RES, V128, P61, DOI 10.1007/s002210050817; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; WESTLING G, 1984, EXP BRAIN RES, V53, P277; White O, 2005, EXP BRAIN RES, V163, P324, DOI 10.1007/s00221-004-2175-8; Zatsiorsky VM, 2008, J MOTOR BEHAV, V40, P446, DOI 10.3200/JMBR.40.5.446-476; Zhang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027715	64	24	24	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138506	10.1371/journal.pone.0138506	http://dx.doi.org/10.1371/journal.pone.0138506			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376484	gold, Green Submitted, Green Published			2022-12-27	WOS:000361610200111
J	Pandya, D; Mariani, M; He, SQ; Andreoli, M; Spennato, M; Dowell-Martino, C; Fiedler, P; Ferlini, C				Pandya, Deep; Mariani, Marisa; He, Shiquan; Andreoli, Mirko; Spennato, Manuela; Dowell-Martino, Candice; Fiedler, Paul; Ferlini, Cristiano			Epstein-Barr Virus MicroRNA Expression Increases Aggressiveness of Solid Malignancies	PLOS ONE			English	Article							CERVICAL-CANCER; THERAPY; GENE; CARCINOMA; CELLS; GLYCOLYSIS; MIR-200C; TARGETS; IL-10	The Cancer Genome Atlas (TCGA) microRNA (miRNA) initiative has revealed a pivotal role for miRNAs in cancer. Utilizing the TCGA raw data, we performed the first mapping of viral miRNA sequences within cancer and adjacent normal tissues. Results were integrated with TCGA RNA-seq to link the expression of viral miRNAs to the phenotype. Using clinical data and viral miRNA mapping results we also performed outcome analysis. Three lines of evidence lend credence to an active role of viral miRNAs in solid malignancies. First, expression of viral miRNA is consistently higher in cancerous compared to adjacent noncancerous tissues. Second, viral miRNA expression is associated with significantly worse clinical outcome among patients with early stage malignancy. These patients are also featured by increased expression of PD1/PD-L1, a pathway implicated in tumors escaping immune destruction. Finally, a particular cluster of EBV-miRNA (miR-BART2, miR-BART4, miRBART5, miR-BART18, and miR-BART22) is associated with expression of cytokines known to inhibit host response to cancer. Quantification of specific viral miRNAs may help identify patients who are at risk of poor outcome. These patients may be candidates for novel therapeutic strategies incorporating antiviral agents and/or inhibitors of the PD-1/PD-L1 pathway.	[Pandya, Deep; Mariani, Marisa; He, Shiquan; Andreoli, Mirko; Spennato, Manuela; Dowell-Martino, Candice; Fiedler, Paul; Ferlini, Cristiano] Danbury Hosp, Res Inst, Danbury, CT 06810 USA		Ferlini, C (corresponding author), Danbury Hosp, Res Inst, Danbury, CT 06810 USA.	cristiano.ferlini@danhosp.org			Ruth C. Donovan Cancer Research Program	Ruth C. Donovan Cancer Research Program	This work was partially supported by the Ruth C. Donovan Cancer Research Program and by a liberal donation from Dr. and Mrs. Rudy Ruggles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcocer-Gonzalez JM, 2006, VIRAL IMMUNOL, V19, P481, DOI 10.1089/vim.2006.19.481; Ationu A, 1999, BLOOD, V94, P3193, DOI 10.1182/blood.V94.9.3193.421k26_3193_3198; Bais AG, 2005, J CLIN PATHOL, V58, P1096, DOI 10.1136/jcp.2004.025072; BURKE AP, 1990, MODERN PATHOL, V3, P377; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cortez MA, 2014, MOL THER, V22, P1494, DOI 10.1038/mt.2014.79; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Diaz-Benitez CE, 2009, J CLIN IMMUNOL, V29, P532, DOI 10.1007/s10875-009-9279-7; Elgar G, 2008, TRENDS GENET, V24, P344, DOI 10.1016/j.tig.2008.04.005; Esteban MA, 2012, CURR OPIN GENET DEV, V22, P423, DOI 10.1016/j.gde.2012.09.004; Flores O, 2013, J VIROL, V87, P6589, DOI 10.1128/JVI.00504-13; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Marquitz AR, 2012, P NATL ACAD SCI USA, V109, P9593, DOI 10.1073/pnas.1202910109; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Miller CS, 2006, J CLIN MICROBIOL, V44, P2409, DOI 10.1128/JCM.00256-06; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nallamshetty S, 2013, FREE RADICAL BIO MED, V64, P20, DOI 10.1016/j.freeradbiomed.2013.05.022; Pandya D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114750; Prislei S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-72; Rigopoulou EI, 2005, CLIN IMMUNOL, V117, P57, DOI 10.1016/j.clim.2005.06.003; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Torres-Poveda K, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-32; Xiao L, 2014, ONCOGENE, V33, P4568, DOI 10.1038/onc.2014.32; 2014, NATURE, V513, P202, DOI DOI 10.1038/NATURE13480	26	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136058	10.1371/journal.pone.0136058	http://dx.doi.org/10.1371/journal.pone.0136058			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375401	Green Published, Green Submitted, gold			2022-12-27	WOS:000361610200010
J	Xie, M; Zhang, YJ; Peng, DL; Zhou, J; Zhang, XL; Zhang, ZR; Zhao, JJ; Wu, YH				Xie, Ming; Zhang, Yan-Jun; Peng, De-Liang; Zhou, Jie; Zhang, Xiao-Lin; Zhang, Zhao-Rong; Zhao, Jin-Jin; Wu, Yu-Huan			Persistence and Viability of Lecanicillium lecanii in Chinese Agricultural Soil	PLOS ONE			English	Article							BEAUVERIA-BASSIANA CONIDIA; METARHIZIUM-ANISOPLIAE; PAECILOMYCES-LILACINUS; ENTOMOPATHOGENIC FUNGI; BIOCONTROL AGENTS; SELECTIVE MEDIUM; IN-VITRO; SURVIVAL; BRONGNIARTII; VIRULENCE	The entomopathogenic fungus L. lecanii has been developed as biopesticides and used widely for biological control of several insects in agricultural practice. Due to the lack of isolation/ count methods for L. lecanii in soil, the persistence of this fungus in soil appears to have attracted no attention. A selective medium and count method for L. lecanii in soil based on cetyl trimethyl ammonium bromide (CTAB) was developed, and then the persistence and viability of this fungus in soil were investigated under field conditions between 2012 and 2014. The results showed that the rate of recovery for L. lecanii in soil on the selective CTAB medium was satisfactory. The minimum CFUs for L. lecanii on the selective medium (0.5 g/L CTAB) was about 10(2) conidia/g soil. The L. lecanii density in soil declined quickly in the first month after inoculation with fungal conidia, kept stable for 6 to 10 months, and then decreased gradually until undetectable. L. lecanii could persist for at least 14 months in the agricultural soil of northern China. The colony growth, conidia yield and germination rate on plates, as well as the median lethal concentration or times (LC50 or LT50) to aphids, mycelium growth in aphids and sporulation on aphids of L. lecanii did not change significantly during the persistence in soil. In general, the count method developed here was a very useful tool for monitoring the dynamics of natural or introduced L. lecanii populations in soil, and the data on the persistence of L. lecanii in soil reported here were helpful for biological control and environmental risk assessment.	[Xie, Ming; Zhang, Yan-Jun; Peng, De-Liang; Zhou, Jie; Zhang, Xiao-Lin; Zhang, Zhao-Rong; Zhao, Jin-Jin; Wu, Yu-Huan] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Xie, M (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	xiem406@126.com; yjz2100@163.com			National Hightech R& D Program of China [2011AA10A204]; Special Fund for Agri-scientific Research in the Public Interest of China [201503114]; National Natural Science Foundation of China [31201571]; China International Cooperation Project [2012DFR30810, 2011-G4]; Ministry of Science and Technology of China [2012BAD15B03]; Agricultural Science and Technology Innovation Program (ASTIP)	National Hightech R& D Program of China(National High Technology Research and Development Program of China); Special Fund for Agri-scientific Research in the Public Interest of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China International Cooperation Project; Ministry of Science and Technology of China(Ministry of Science and Technology, China); Agricultural Science and Technology Innovation Program (ASTIP)	This work was funded by National Hightech R& D Program of China (Grant 2011AA10A204), Special Fund for Agri-scientific Research in the Public Interest of China (Grant 201503114), National Natural Science Foundation of China (Grant 31201571), China International Cooperation Project (Grants 2012DFR30810 and 2011-G4), Ministry of Science and Technology of China (2012BAD15B03) and Agricultural Science and Technology Innovation Program (ASTIP-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsellem Z, 2002, NAT BIOTECHNOL, V20, P1035, DOI 10.1038/nbt743; Atkins SD, 2005, FEMS MICROBIOL ECOL, V51, P257, DOI 10.1016/j.femsec.2004.09.002; BEILHARZ VC, 1982, T BRIT MYCOL SOC, V79, P507, DOI 10.1016/S0007-1536(82)80043-0; Bidochka M. J., 2001, Fungi as biocontrol agents: progress, problems and potential, P193, DOI 10.1079/9780851993560.0193; Castrillo LA, 2008, BIOL CONTROL, V45, P163, DOI 10.1016/j.biocontrol.2008.01.005; CHARNLEY A. K., 1997, ENV MICROBIAL RELATI, P185; CHASE AR, 1986, FLA ENTOMOL, V69, P285, DOI 10.2307/3494930; de Faria MR, 2007, BIOL CONTROL, V43, P237, DOI 10.1016/j.biocontrol.2007.08.001; Enkerli J, 2004, BIOL CONTROL, V29, P115, DOI 10.1016/S1049-9644(03)00131-2; FARGUES J, 1983, J INVERTEBR PATHOL, V41, P131, DOI 10.1016/0022-2011(83)90212-4; Fernandes EKK, 2010, BIOL CONTROL, V54, P197, DOI 10.1016/j.biocontrol.2010.05.009; GILLESPIE AT, 1989, PESTIC SCI, V27, P203, DOI 10.1002/ps.2780270210; Goettel MS, 2008, J INVERTEBR PATHOL, V98, P256, DOI 10.1016/j.jip.2008.01.009; Gu Xinghui, 2015, Chinese Journal of Biological Control, V31, P1; Guerrero-Guerra C, 2013, AEROBIOLOGIA, V29, P249, DOI 10.1007/s10453-012-9277-8; Hajek AE, 1997, ADV MICROB ECOL, V15, P193; HALL RA, 1984, ENTOMOPHAGA, V29, P311, DOI 10.1007/BF02372119; Kessler P, 2004, BIOCONTROL, V49, P563, DOI 10.1023/B:BICO.0000036441.40227.ed; Kessler P, 2003, J INVERTEBR PATHOL, V84, P15, DOI 10.1016/j.jip.2003.08.003; Lacey LA, 2001, BIOL CONTROL, V21, P230, DOI 10.1006/bcon.2001.0938; LI DP, 1993, J INVERTEBR PATHOL, V62, P273, DOI 10.1006/jipa.1993.1112; LINGG AJ, 1981, J INVERTEBR PATHOL, V38, P191, DOI 10.1016/0022-2011(81)90122-1; Luz C, 2007, MYCOPATHOLOGIA, V164, P39, DOI 10.1007/s11046-007-9020-0; Martinez-Romero E, 2012, EXPERT OPIN ENV BIOL, DOI [10.4172/2325-9655.1000e103, DOI 10.4172/2325-9655.1000E103]; Mensink BJWGH, 2007, BIOCONTROL SCI TECHN, V17, P3, DOI 10.1080/09583150600936982; Paulitz TC, 2000, EUR J PLANT PATHOL, V106, P401, DOI 10.1023/A:1008733927515; Pilz C, 2011, J APPL ENTOMOL, V135, P393, DOI 10.1111/j.1439-0418.2010.01566.x; Posadas JB, 2012, MYCOLOGIA, V104, P974, DOI 10.3852/11-234; Rangel DEN, 2010, BIOCONTROL SCI TECHN, V20, P375, DOI 10.1080/09583150903518370; Rumbos C, 2008, BIOCONTROL SCI TECHN, V18, P1041, DOI 10.1080/09583150802526979; Safavi SA, 2013, J AGR SCI TECH-IRAN, V15, P1; Shah FA, 2005, FEMS MICROBIOL LETT, V251, P259, DOI 10.1016/j.femsle.2005.08.010; St Leger RJ, 2001, FUNGI BIOCONTROL AGE, P219; STOREY GK, 1988, ENVIRON ENTOMOL, V17, P135, DOI 10.1093/ee/17.1.135; STUDDERT JP, 1990, J INVERTEBR PATHOL, V55, P417, DOI 10.1016/0022-2011(90)90086-L; Tseng MN, 2011, APPL ENVIRON MICROB, V77, P4508, DOI 10.1128/AEM.02033-10; Vanninen I, 2000, BIOCONTROL, V45, P201, DOI 10.1023/A:1009998919531; VEEN KH, 1966, J INVERTEBR PATHOL, V8, P268, DOI 10.1016/0022-2011(66)90145-5; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wraight S.P., 2007, FIELD MANUAL TECHNIQ, V2nd, P223; Xie M, 2015, J PEST SCI, V88, P637, DOI 10.1007/s10340-015-0644-4; Zhang YJ, 2014, J MICROBIOL METH, V105, P168, DOI 10.1016/j.mimet.2014.07.033; ZIMMERMANN G, 1986, J APPL ENTOMOL, V102, P213, DOI 10.1111/j.1439-0418.1986.tb00912.x	43	6	6	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138337	10.1371/journal.pone.0138337	http://dx.doi.org/10.1371/journal.pone.0138337			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375030	Green Published, Green Submitted, gold			2022-12-27	WOS:000361610200099
J	Rosenbloom, JL; Ginther, DK; Juhl, T; Heppert, JA				Rosenbloom, Joshua L.; Ginther, Donna K.; Juhl, Ted; Heppert, Joseph A.			The Effects of Research & Development Funding on Scientific Productivity: Academic Chemistry, 1990-2009	PLOS ONE			English	Article							UNIVERSITIES	This article examines the relationship between Research & Development (R&D) funding and the production of knowledge by academic chemists. Using articles published, either raw counts or adjusted for quality, we find a strong, positive causal effect of funding on knowledge production. This effect is similar across subsets of universities, suggesting a relatively efficient allocation of R&D funds. Finally, we document a rapid acceleration in the rate at which chemical knowledge was produced in the late 1990s and early 2000s relative to the financial and human resources devoted to its production.	[Rosenbloom, Joshua L.] Iowa State Univ, Dept Econ, Ames, IA 50011 USA; [Rosenbloom, Joshua L.; Ginther, Donna K.] NBER, Cambridge, MA 02138 USA; [Ginther, Donna K.; Juhl, Ted] Univ Kansas, Dept Econ, Lawrence, KS 66045 USA; [Heppert, Joseph A.] Univ Kansas, Dept Chem, Lawrence, KS 66045 USA	Iowa State University; National Bureau of Economic Research; University of Kansas; University of Kansas	Rosenbloom, JL (corresponding author), Iowa State Univ, Dept Econ, Ames, IA 50011 USA.	jlrosenb@iastate.edu	Ginther, Donna/W-9055-2019; Ginther, Donna K/F-7317-2016	Ginther, Donna/0000-0002-0881-7969; Ginther, Donna K/0000-0002-0881-7969; Rosenbloom, Joshua/0000-0001-6450-0563	National Science Foundation [1064218]; Direct For Social, Behav & Economic Scie [1064218] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This project was supported by the National Science Foundation, http://www.nsf.gov under award no. 1064218. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adams J. D., 1998, EC ECONOMETRICS INNO, V49, P127; Apon AW, 2014, WORKING PAPER; Arora A., 1998, IMPACT NSF SUPPORT B; BlumeKohout M.E., 2009, 15146 NBER; Couzin J, 2007, SCIENCE, V316, P356, DOI 10.1126/science.316.5823.356; DEGROOT H, 1991, REV ECON STAT, V73, P424, DOI 10.2307/2109566; HARE P, 1988, RES POLICY, V17, P315, DOI 10.1016/0048-7333(88)90030-3; Jacob BA, 2011, J PUBLIC ECON, V95, P1168, DOI 10.1016/j.jpubeco.2011.05.005; Payne A.A., 2003, ADV EC ANAL POLICY, V3, P1, DOI [10.2202/1538-0637.1018, DOI 10.2202/1538-0637.1018]; Popp D, 2015, 21415 NBER; SOLOW RM, 1957, REV ECON STAT, V39, P312, DOI 10.2307/1926047; U.S. National Science and Technology Council Subcommittee on Social Behavioral and Economic Sciences, 2008, SCI SCI POL FED RES; Whalley A, 2014, ECON INQ, V52, P35, DOI 10.1111/ecin.12011	13	33	33	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138176	10.1371/journal.pone.0138176	http://dx.doi.org/10.1371/journal.pone.0138176			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8LR	26372555	Green Published, gold			2022-12-27	WOS:000361604400053
J	Shaikh, S; Nagi, SS; McGlone, F; Mahns, DA				Shaikh, Sumaiya; Nagi, Saad S.; McGlone, Francis; Mahns, David A.			Psychophysical Investigations into the Role of Low-Threshold C Fibres in Non-Painful Affective Processing and Pain Modulation	PLOS ONE			English	Article							HUMAN HAIRY SKIN; UNMYELINATED TACTILE AFFERENTS; CUTANEOUS MECHANORECEPTORS; SOMATOSENSORY CORTEX; ECCENTRIC EXERCISE; INSULAR CORTEX; TOUCH; ALLODYNIA; RESPONSES; NERVE	We recently showed that C low-threshold mechanoreceptors (CLTMRs) contribute to touch-evoked pain (allodynia) during experimental muscle pain. Conversely, in absence of ongoing pain, the activation of CLTMRs has been shown to correlate with a diffuse sensation of pleasant touch. In this study, we evaluated (1) the primary afferent fibre types contributing to positive (pleasant) and negative (unpleasant) affective touch and (2) the effects of tactile stimuli on tonic muscle pain by varying affective attributes and frequency parameters. Psychophysical observations were made in 10 healthy participants. Two types of test stimuli were applied: stroking stimulus using velvet or sandpaper at speeds of 0.1, 1.0 and 10.0 cm/s; focal vibrotactile stimulus at low (20 Hz) or high (200 Hz) frequency. These stimuli were applied in the normal condition (i.e. no experimental pain) and following the induction of muscle pain by infusing hypertonic saline (5%) into the tibialis anterior muscle. These observations were repeated following the conduction block of myelinated fibres by compression of sciatic nerve. In absence of muscle pain, all participants reliably linked velvet-stroking to pleasantness and sandpaper-stroking to unpleasantness (no pain). Likewise, low-frequency vibration was linked to pleasantness and high-frequency vibration to unpleasantness. During muscle pain, the application of previously pleasant stimuli resulted in overall pain relief, whereas the application of previously unpleasant stimuli resulted in overall pain intensification. These effects were significant, reproducible and persisted following the blockade of myelinated fibres. Taken together, these findings suggest the role of low-threshold C fibres in affective and pain processing. Furthermore, these observations suggest that temporal coding need not be limited to discriminative aspects of tactile processing, but may contribute to affective attributes, which in turn predispose individual responses towards excitatory or inhibitory modulation of pain.	[Shaikh, Sumaiya; Nagi, Saad S.; Mahns, David A.] Univ Western Sydney, Sch Med, Sydney, NSW, Australia; [McGlone, Francis] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool L3 5UX, Merseyside, England	Western Sydney University; Liverpool John Moores University	Mahns, DA (corresponding author), Univ Western Sydney, Sch Med, Sydney, NSW, Australia.	d.mahns@uws.edu.au	Mahns, David Anthony/GLS-1616-2022; Nagi, Saad/AAM-7928-2021; /AAD-1766-2020; McGlone, Francis Philip/AAA-5058-2022; McGlone, Francis/F-8349-2011	Mahns, David Anthony/0000-0003-2131-9638; Nagi, Saad/0000-0001-8773-8232; /0000-0001-5221-130X; McGlone, Francis/0000-0002-0881-635X	University of Western Sydney Eminent Research Visitors Grant [P00019329]	University of Western Sydney Eminent Research Visitors Grant	This work was supported by the University of Western Sydney Eminent Research Visitors Grant (P00019329) awarded to DAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerley R, 2014, J NEUROSCI, V34, P2879, DOI 10.1523/JNEUROSCI.2847-13.2014; BESSOU P, 1971, J NEUROPHYSIOL, V34, P116, DOI 10.1152/jn.1971.34.1.116; Cole J, 2006, MUSCLE NERVE, V34, P105, DOI 10.1002/mus.20534; Condon M, 2014, J NEUROPHYSIOL, V111, P1308, DOI 10.1152/jn.00589.2013; CRAIG KD, 1977, PAIN, V3, P127, DOI 10.1016/0304-3959(77)90076-8; Croy I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092975; Delfini MC, 2013, CELL REP, V5, P378, DOI 10.1016/j.celrep.2013.09.013; Essick GK, 1999, NEUROREPORT, V10, P2083, DOI 10.1097/00001756-199907130-00017; Essick GK, 2010, NEUROSCI BIOBEHAV R, V34, P192, DOI 10.1016/j.neubiorev.2009.02.003; Fields HL, 1999, PAIN, pS61, DOI 10.1016/S0304-3959(99)00139-6; Francois A, 2015, CELL REP, V10, P370, DOI 10.1016/j.celrep.2014.12.042; Gaillard S, 2014, NEURON, V84, P123, DOI 10.1016/j.neuron.2014.08.056; IGGO A, 1960, J PHYSIOL-LONDON, V152, P337, DOI 10.1113/jphysiol.1960.sp006491; JOHANSSON RS, 1987, EXP BRAIN RES, V66, P141; Liljencrantz J, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00037; Loken LS, 2009, NAT NEUROSCI, V12, P547, DOI 10.1038/nn.2312; MACKENZIE RA, 1975, J NEUROL NEUROSUR PS, V38, P865, DOI 10.1136/jnnp.38.9.865; Mahns DA, 2006, J NEUROPHYSIOL, V95, P1442, DOI 10.1152/jn.00483.2005; Mahns DA, 2006, J NEUROSCI METH, V156, P140, DOI 10.1016/j.jneumeth.2006.02.019; Mahns DA, 2013, EXP BRAIN RES, V227, P457, DOI 10.1007/s00221-013-3521-5; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; McGlone F, 2014, NEURON, V82, P737, DOI 10.1016/j.neuron.2014.05.001; MERZENICH MM, 1969, EXP BRAIN RES, V9, P236; Morrison I, 2011, J NEUROSCI, V31, P9554, DOI 10.1523/JNEUROSCI.0397-11.2011; Morrison I, 2010, EXP BRAIN RES, V204, P305, DOI 10.1007/s00221-009-2007-y; Nagi SS, 2013, EXP BRAIN RES, V231, P139, DOI 10.1007/s00221-013-3677-z; Nagi SS, 2013, J PAIN, V14, P538, DOI 10.1016/j.jpain.2013.01.009; Nagi SS, 2011, J PHYSIOL-LONDON, V589, P4065, DOI 10.1113/jphysiol.2011.211326; NORDIN M, 1990, J PHYSIOL-LONDON, V426, P229, DOI 10.1113/jphysiol.1990.sp018135; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; Olausson HW, 2008, NEUROSCI LETT, V436, P128, DOI 10.1016/j.neulet.2008.03.015; Peckys D, 1999, NEUROSCIENCE, V88, P1093, DOI 10.1016/S0306-4522(98)00251-6; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Sahai V, 2006, J NEUROPHYSIOL, V95, P1451, DOI 10.1152/jn.00485.2005; Samour MS, 2015, PAIN, V156, P1566, DOI 10.1097/j.pain.0000000000000202; Seal RP, 2009, NATURE, V462, P651, DOI 10.1038/nature08505; TOREBJORK HE, 1973, EXP BRAIN RES, V16, P321; Uhelski ML, 2012, PAIN, V153, P885, DOI 10.1016/j.pain.2012.01.018; Vallbo AB, 1999, J NEUROPHYSIOL, V81, P2753, DOI 10.1152/jn.1999.81.6.2753; Weerakkody NS, 2003, PAIN, V105, P425, DOI 10.1016/S0304-3959(03)00257-4; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	42	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138299	10.1371/journal.pone.0138299	http://dx.doi.org/10.1371/journal.pone.0138299			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372601	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000361604400063
J	Yang, Y; Park, SY; Nguyen, TT; Yu, YH; Nguyen, TV; Sun, EG; Udeni, J; Jeong, MH; Pereira, I; Moon, C; Ha, HH; Kim, KK; Hur, JS; Kim, H				Yang, Yi; Park, So-Yeon; Thanh Thi Nguyen; Yu, Young Hyun; Tru Van Nguyen; Sun, Eun Gene; Udeni, Jayalal; Jeong, Min-Hye; Pereira, Iris; Moon, Cheol; Ha, Hyung-Ho; Kim, Kyung Keun; Hur, Jae-Seoun; Kim, Hangun			Lichen Secondary Metabolite, Physciosporin, Inhibits Lung Cancer Cell Motility	PLOS ONE			English	Article							METASTASIS SUPPRESSOR; SNAIL; PSEUDOCYPHELLARIA; MORPHOGENESIS; STATISTICS; EXPRESSION; MIGRATION; PROTEIN; KITENIN; FAMILY	Lichens produce various unique chemicals that can be used for pharmaceutical purposes. To screen for novel lichen secondary metabolites showing inhibitory activity against lung cancer cell motility, we tested acetone extracts of 13 lichen samples collected in Chile. Physciosporin, isolated from Pseudocyphellaria coriacea (Hook f. & Taylor) D.J. Galloway & P. James, was identified as an effective compound and showed significant inhibitory activity in migration and invasion assays against human lung cancer cells. Physciosporin treatment reduced both protein and mRNA levels of N-cadherin with concomitant decreases in the levels of epithelial-mesenchymal transition markers such as snail and twist. Physciosporin also suppressed KITENIN (KAI1 C-terminal interacting tetraspanin)-mediated AP-1 activity in both the absence and presence of epidermal growth factor stimulation. Quantitative real-time PCR analysis showed that the expression of the metastasis suppressor gene, KAI1, was increased while that of the metastasis enhancer gene, KITENIN, was dramatically decreased by physciosporin. Particularly, the activity of 3'-untranslated region of KITENIN was decreased by physciosporin. Moreover, Cdc42 and Rac1 activities were decreased by physciosporin. These results demonstrated that the lichen secondary metabolite, physciosporin, inhibits lung cancer cell motility through novel mechanisms of action.	[Yang, Yi; Thanh Thi Nguyen; Udeni, Jayalal; Jeong, Min-Hye; Hur, Jae-Seoun] Sunchon Natl Univ, Korean Lichen Res Inst, Sunchon 540950, South Korea; [Park, So-Yeon; Yu, Young Hyun; Tru Van Nguyen; Moon, Cheol; Ha, Hyung-Ho; Kim, Hangun] Sunchon Natl Univ, Coll Pharm, Sunchon 540950, South Korea; [Park, So-Yeon; Yu, Young Hyun; Tru Van Nguyen; Moon, Cheol; Ha, Hyung-Ho; Kim, Hangun] Sunchon Natl Univ, Res Inst Life & Pharmaceut Sci, Sunchon 540950, South Korea; [Thanh Thi Nguyen] Tay Nguyen Univ, Fac Nat Sci & Technol, Buon Ma Thuot, Vietnam; [Sun, Eun Gene; Kim, Kyung Keun] Chonnam Natl Univ, Sch Med, Med Res Ctr Gene Regulat, Gwangju 500872, South Korea; [Pereira, Iris] Univ Talca, Inst Biol Sci, Talca 747721, Chile	Sunchon National University; Sunchon National University; Sunchon National University; Tay Nguyen University; Chonnam National University; Universidad de Talca	Hur, JS (corresponding author), Sunchon Natl Univ, Korean Lichen Res Inst, Sunchon 540950, South Korea.	jshur1@sunchon.ac.kr; hangunkim@sunchon.ac.kr		, Eun-Gene Sun/0000-0002-3396-6966; Moon, Cheol/0000-0003-2342-0860	National Research Foundation of Korea [NRF-2013R1A1A2004677, MRC-2011-0030132]; Korea National Research Resource Center Program [NRF-2014M3A9B8002115]; Sunchon Research Center for Natural Medicine	National Research Foundation of Korea(National Research Foundation of Korea); Korea National Research Resource Center Program; Sunchon Research Center for Natural Medicine	This study was supported by the National Research Foundation of Korea (NRF-2013R1A1A2004677, MRC-2011-0030132) and by the Korea National Research Resource Center Program (NRF-2014M3A9B8002115). This study also received support from a research grant funded by the Sunchon Research Center for Natural Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, LANCET, V382, P659, DOI 10.1016/S0140-6736(13)61759-6; Bae JA, 2014, CLIN CANCER RES, V20, P4115, DOI 10.1158/1078-0432.CCR-13-2863; Brodo I. M., 2001, LICHENS N AM; CULBERSON CF, 1972, J CHROMATOGR, V72, P113, DOI 10.1016/0021-9673(72)80013-X; DONG JT, 1995, SCIENCE, V268, P884, DOI 10.1126/science.7754374; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Galloway D. J., 2007, FLORA NZ LICHENS INC, V2; GALLOWAY DJ, 1989, LICHENOLOGIST, V21, P88, DOI 10.1017/S0024282989000113; Galloway DJ, 2007, FLORA NZ LICHENS INC, V1; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kawai K.I., 1994, HATTORI BOT LAB, V75, P359; Kim H, 2005, J BIOL CHEM, V280, P22462, DOI 10.1074/jbc.M502769200; Kim H., 2015, RECENT ADV LICHENOLO, P201, DOI DOI 10.1007/978-81-322-2235-4_11; Kim H, 2008, J BIOL CHEM, V283, P977, DOI 10.1074/jbc.M707158200; Lee JH, 2004, CANCER RES, V64, P4235, DOI 10.1158/0008-5472.CAN-04-0275; Liu X, 2014, TISSUE BARRIERS, V2, DOI 10.4161/21688362.2014.969112; MAASS WSG, 1977, CAN J CHEM, V55, P2839, DOI 10.1139/v77-394; McCarthy PM, 2001, FLORA OF AUSTR A, V58A; Murali A, 2014, CELL MOL LIFE SCI, V71, P1703, DOI 10.1007/s00018-013-1519-6; NGUYEN TAD, 2014, BIOSCI BIOTECHNOL RE, V11, P11; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Nilsson GMA, 2014, INT J ONCOL, V45, P82, DOI 10.3892/ijo.2014.2424; Orange A., 2001, MICROCHEMICAL METHOD; Park SY, 2014, MOL THER, V22, P1653, DOI 10.1038/mt.2014.105; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Prudnikova TY, 2015, CLIN CANCER RES, V21, P24, DOI 10.1158/1078-0432.CCR-14-0827; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stanojkovic T, 2015, INVESTIGATIONS LICHE, P127; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Ueda T, 1996, AM J PATHOL, V149, P1435; Wang XH, 2004, ONCOGENE, V23, P474, DOI 10.1038/sj.onc.1207128; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; WHITE FJ, 1985, NEW GUIDE MICROCHEMI; WILKINS AL, 1979, LICHENOLOGIST, V11, P271, DOI 10.1017/S0024282979000323; Wu YD, 2010, CELL ADHES MIGR, V4, P199, DOI 10.4161/cam.4.2.10943; Yamamoto Y, 2015, LICHEN SUBSTANCES TH, P181; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yui Y, 2010, CLIN EXP METASTAS, V27, P619, DOI 10.1007/s10585-010-9352-x	41	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137889	10.1371/journal.pone.0137889	http://dx.doi.org/10.1371/journal.pone.0137889			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371759	Green Published, gold, Green Submitted			2022-12-27	WOS:000361604400036
J	Baranyi, A; Meinitzer, A; Breitenecker, RJ; Amouzadeh-Ghadikolai, O; Stauber, R; Rothenhausler, HB				Baranyi, Andreas; Meinitzer, Andreas; Breitenecker, Robert J.; Amouzadeh-Ghadikolai, Omid; Stauber, Rudolf; Rothenhaeusler, Hans-Bernd			Quinolinic Acid Responses during Interferon-alpha-Induced Depressive Symptomatology in Patients with Chronic Hepatitis C Infection - A Novel Aspect for Depression and Inflammatory Hypothesis	PLOS ONE			English	Article							QUALITY-OF-LIFE; LIQUID-CHROMATOGRAPHY; TRYPTOPHAN DEPLETION; OXIDATIVE STRESS; HUMAN SERUM; RAT; KYNURENINE; MECHANISM; PATHOPHYSIOLOGY; VULNERABILITY	Background The aim of this exploratory study is to gain for the first time a more comprehensive picture of the impact of changes of quinolinic acid concentrations on depressive symptomatology during and after IFN-alpha therapy. Methods The quinolinic acid concentrations of 35 HCV patients are examined in a prospective survey over the entire period of IFN-a treatment as well as three months later at six different times (baseline, one, three, six and nine months after the beginning of IFN-a treatment, and after the end of treatment). Results During IFN-alpha treatment Hamilton Depression Rating Scale scores rise significantly. At the same time there is greater activity of indoleamine 2,3-dioxygenase, with a resulting increase in plasma kynurenine concentrations. Compared to baseline values quinolinic acid concentrations increase significantly during therapy, reflecting an increased neurotoxic challenge. In addition, patients with higher scores in the Hamilton Depression Rating Scale at six and nine months after starting therapy show significantly higher levels of quinolinic acid concentration. Conclusions The increase of quinolinic acid during IFN-alpha therapy might contribute to depressive symptomatology through the neurotoxic challenge caused by quinolinic acid. Subsequently, our exploratory study results support the inflammatory hypothesis of depression. The awareness of relevant risk factors of IFN-alpha treatment-induced depression is essential to develop preventative treatment strategies.	[Baranyi, Andreas; Rothenhaeusler, Hans-Bernd] Med Univ Graz, Dept Psychiat, Graz, Austria; [Meinitzer, Andreas] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Breitenecker, Robert J.] Alpen Adria Univ Klagenfurt, Dept Innovat Management & Entrepreneurship, Klagenfurt, Austria; [Amouzadeh-Ghadikolai, Omid] Hosp Bros St John God, Graz, Austria; [Stauber, Rudolf] Med Univ Graz, Dept Internal Med, Div Gastroenterol & Hepatol, Graz, Austria	Medical University of Graz; Medical University of Graz; University of Klagenfurt; Medical University of Graz	Baranyi, A (corresponding author), Med Univ Graz, Dept Psychiat, Graz, Austria.	andreas.baranyi@klinikum-graz.at	Breitenecker, Robert/R-8753-2019; Breitenecker, Robert J/A-5633-2011; Breitenecker, Robert/AAC-8012-2022	Breitenecker, Robert/0000-0003-4485-5388; Breitenecker, Robert J/0000-0003-4485-5388; Breitenecker, Robert/0000-0003-4485-5388; Rothenhausler, Hans-Bernd/0000-0002-8857-8557; Baranyi, Andreas/0000-0003-2389-1945	Pfizer Corporation Austria	Pfizer Corporation Austria	This study was supported by a grant from the Pfizer Corporation Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranyi A, 2013, PSYCHOTHER PSYCHOSOM, V82, P332, DOI 10.1159/000348587; Behan WMH, 1999, BRIT J PHARMACOL, V128, P1754, DOI 10.1038/sj.bjp.0702940; Behan WMH, 2002, BRIT J PHARMACOL, V135, P1435, DOI 10.1038/sj.bjp.0704613; Bonaccorso S, 2002, J AFFECT DISORDERS, V72, P237, DOI 10.1016/S0165-0327(02)00264-1; Bonaccorso S, 2002, J CLIN PSYCHOPHARM, V22, P86, DOI 10.1097/00004714-200202000-00014; Braidy N, 2010, FEBS J, V277, P368, DOI 10.1111/j.1742-4658.2009.07487.x; Braidy N, 2009, NEUROTOX RES, V16, P77, DOI 10.1007/s12640-009-9051-z; Busse M, 2014, EUR ARCH PSYCHIAT CL; Capuron L, 2003, AM J PSYCHIAT, V160, P1342, DOI 10.1176/appi.ajp.160.7.1342; DeCarvalho LP, 1996, NEUROCHEM INT, V28, P445; Dieperink E, 2000, AM J PSYCHIAT, V157, P867, DOI 10.1176/appi.ajp.157.6.867; Dinwiddie SH, 2003, AM J PSYCHIAT, V160, P172, DOI 10.1176/appi.ajp.160.1.172; Eccles J, 2012, EUR NEUROPSYCHOPHARM, V22, P892, DOI 10.1016/j.euroneuro.2012.03.009; Elinos-Calderon D, 2010, J NEURAL TRANSM, V117, P35, DOI 10.1007/s00702-009-0299-5; Fontana RJ, 2001, AM J GASTROENTEROL, V96, P170, DOI 10.1111/j.1572-0241.2001.03473.x; Guillemin GJ, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-16; Guillemin GJ, 2012, FEBS J, V279, P1356, DOI 10.1111/j.1742-4658.2012.08485.x; Hamilton M., 1967, BR J SOC CLIN PSYCHO, V6, P78; Hauser W, 2004, PSYCHOSOM MED, V66, P954, DOI 10.1097/01.psy.0000145824.82125.a8; Herve C, 1996, J CHROMATOGR B, V675, P157, DOI 10.1016/0378-4347(95)00341-X; Lau JYN, 2002, HEPATOLOGY, V35, P1002, DOI 10.1053/jhep.2002.32672; Lee MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014123; Leutscher PDC, 2010, HEPATOLOGY, V52, P430, DOI 10.1002/hep.23699; Malaguarnera M, 2001, J INTERF CYTOK RES, V21, P273, DOI 10.1089/107999001300177457; Mancuso R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130715; Meinitzer A, 2014, CLIN CHIM ACTA, V436, P268, DOI 10.1016/j.cca.2014.06.010; Miyaoka H, 1999, AM J PSYCHIAT, V156, P1120; Moller M, 2012, J CHROMATOGR B, V898, P121, DOI 10.1016/j.jchromb.2012.04.030; Myint AM, 2009, METAB BRAIN DIS, V24, P55, DOI 10.1007/s11011-008-9114-5; Neumeister A, 2005, AM J PSYCHIAT, V162, P805, DOI 10.1176/appi.ajp.162.4.805; PERKINS MN, 1983, J PHARMACOL EXP THER, V226, P551; Pierozan P, 2014, BRAIN RES, V1577, P1, DOI 10.1016/j.brainres.2014.06.024; Pierozan P, 2010, EXP NEUROL, V224, P188, DOI 10.1016/j.expneurol.2010.03.009; POUTIAINEN E, 1994, PHARMACOL BIOCHEM BE, V47, P901, DOI 10.1016/0091-3057(94)90294-1; Rahman A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006344; Raison CL, 2005, J CLIN PSYCHIAT, V66, P41, DOI 10.4088/JCP.v66n0106; Russo S, 2003, PSYCHOSOM MED, V65, P665, DOI 10.1097/01.PSY.0000078188.74020.CC; Santamaria A, 2001, NEUROREPORT, V12, P871, DOI 10.1097/00001756-200103260-00049; Schaefer M, 2012, J HEPATOL, V57, P1379, DOI 10.1016/j.jhep.2012.07.037; SCHURR A, 1993, BRAIN RES, V617, P76, DOI 10.1016/0006-8993(93)90615-T; SCHWARCZ R, 1983, NEUROSCI LETT, V38, P85, DOI 10.1016/0304-3940(83)90115-5; Steiner J, 2012, WORLD J BIOL PSYCHIA, V13, P482, DOI 10.3109/15622975.2011.583941; Steiner J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-94; Sundaram G, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0204-5; Tavares RG, 2002, NEUROCHEM INT, V40, P621, DOI 10.1016/S0197-0186(01)00133-4; Turner EH, 2005, MED HYPOTHESES, V65, P138, DOI 10.1016/j.mehy.2005.01.026; Udina M, 2012, J CLIN PSYCHIAT, V73, P1128, DOI 10.4088/JCP.12r07694; Vandresen-Filho S, 2015, NEUROL SCI; Wichers M, 2002, INT J NEUROPSYCHOPH, V5, P375, DOI 10.1017/S1461145702003103; Wichers MC, 2005, MOL PSYCHIATR, V10, P538, DOI 10.1038/sj.mp.4001600; Wichers MC, 2004, J PSYCHIATR NEUROSCI, V29, P11; Xiao LD, 2008, CLIN CHIM ACTA, V395, P178, DOI 10.1016/j.cca.2008.05.004	52	24	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137022	10.1371/journal.pone.0137022	http://dx.doi.org/10.1371/journal.pone.0137022			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368809	Green Submitted, Green Published, gold			2022-12-27	WOS:000361601100046
J	Lanham, S; Cagampang, FR; Oreffo, ROC				Lanham, Stuart; Cagampang, Felino R.; Oreffo, Richard O. C.			Maternal High Fat Diet Affects Offspring's Vitamin K-Dependent Proteins Expression Levels	PLOS ONE			English	Article							MATRIX GLA-PROTEIN; BONE; METABOLISM; PERIOSTIN; HEALTH	Studies suggest bone growth & development and susceptibility to vascular disease in later life are influenced by maternal nutrition, during intrauterine and early postnatal life. There is evidence for a role of vitamin K-dependent proteins (VKDPs) including Osteocalcin, Matrix-gla protein, Periostin, and Gas6, in bone and vascular development. This study extends the analysis of VKDPs previously conducted in 6 week old offspring, into offspring of 30 weeks of age, to assess the longer term effects of a maternal and postnatal high fat (HF) diet on VKDP expression. Overall a HF maternal diet and offspring diet exacerbated the bone changes observed. Sex specific and tissue specific differences were observed in VKDP expression for both aorta and femoral tissues. In addition, significant correlations were observed between femoral OCN, Periostin Gas6, and Vkor expression levels and measures of femoral bone structure. Furthermore, MGP, OCN, Ggcx and Vkor expression levels correlated to mass and fat volume, in both sexes. In summary the current study has highlighted the importance of the long-term effects of maternal nutrition on offspring bone development and the correlation of VKDPs to bone structure.	[Lanham, Stuart; Oreffo, Richard O. C.] Univ Southampton, Fac Med, Inst Dev Sci, Bone & Joint Res Grp,Human Dev & Hlth, Southampton SO9 5NH, Hants, England; [Cagampang, Felino R.] Univ Southampton, Fac Med, Inst Dev Sci, Maternal Pregnancy & Child Res Grp,Human Dev & Hl, Southampton SO9 5NH, Hants, England	University of Southampton; University of Southampton	Lanham, S (corresponding author), Univ Southampton, Fac Med, Inst Dev Sci, Bone & Joint Res Grp,Human Dev & Hlth, Southampton SO9 5NH, Hants, England.	S.A.Lanham@soton.ac.uk	Oreffo, Richard OC/A-4615-2011; Cagampang, Felino/AAG-5141-2019	Oreffo, Richard OC/0000-0001-5995-6726; Cagampang, Felino/0000-0003-4404-9853	Rosetrees Trust [M425]; Biotechnology and Biological Sciences Research Council [BB/G01812X/1]; BBSRC [BB/G01812X/1, BB/G010579/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G010579/1] Funding Source: researchfish	Rosetrees Trust(Rosetrees Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding: Rosetrees Trust, grant number M425 (http://www.rosetreestrust.co.uk) funded SL. Biotechnology and Biological Sciences Research Council, grant number BB/G01812X/1 (http://www.bbsrc.ac.uk) funded FC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadieh H, 2011, NUTR REV, V69, P584, DOI 10.1111/j.1753-4887.2011.00372.x; BARKER DJP, 1995, MOL MED TODAY, V1, P418, DOI 10.1016/S1357-4310(95)90793-9; Bonnet N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078347; Cea V, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00209; Chango A, 2015, NUTRIENTS, V7, P2748, DOI 10.3390/nu7042748; El Asmar Margueritta S, 2014, Oman Med J, V29, P172, DOI 10.5001/omj.2014.44; Ferron M, 2015, J CELL BIOL, V208, P761, DOI 10.1083/jcb.201409111; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Fusaro M, 2012, J BONE MINER RES, V27, P2271, DOI 10.1002/jbmr.1677; Gerbaix M, 2015, BONE, V71, P94, DOI 10.1016/j.bone.2014.10.011; Gluckman P, 2006, DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE, P1, DOI 10.2277/ 0521847435; Gluckman PD, 2007, P NATL ACAD SCI USA, V104, P12796, DOI 10.1073/pnas.0705667104; Godfrey K M, 2001, Public Health Nutr, V4, P611; Hung YJ, 2010, DIABETES CARE, V33, P1840, DOI 10.2337/dc09-1073; Ismail-Beigi F, 2006, AM J PHYSIOL-ENDOC M, V291, pE439, DOI 10.1152/ajpendo.00105.2006; Karsenty G, 2012, NATURE, V481, P314, DOI 10.1038/nature10763; Korshunov VA, 2012, CLIN SCI, V122, P361, DOI 10.1042/CS20110411; Lanham SA, 2014, ENDOCRINOLOGY, V155, P4749, DOI 10.1210/en.2014-1188; Lanham SA, 2010, OSTEOPOROSIS INT, V21, P1703, DOI 10.1007/s00198-009-1118-4; Lanham Stuart A, 2011, Eur Cell Mater, V22, P321; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Lindqvist PG, 2010, ACTA OBSTET GYN SCAN, V89, P22, DOI 10.3109/00016340903410899; Merle B, 2012, OSTEOPOROSIS INT, V23, P1199, DOI 10.1007/s00198-011-1892-7; Motomura H, 2007, BIOCHEM BIOPH RES CO, V357, P997, DOI 10.1016/j.bbrc.2007.04.035; Novak DA, 2006, J MATERN-FETAL NEO M, V19, P591, DOI 10.1080/14767050600708233; Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004; Ross MG, 2008, SEMIN PERINATOL, V32, P213, DOI 10.1053/j.semperi.2007.11.005; Schurgers LJ, 2008, THROMB HAEMOSTASIS, V100, P593, DOI 10.1160/TH08-02-0087; Sen K, 2011, AM J PATHOL, V179, P1756, DOI 10.1016/j.ajpath.2011.06.002; Shiba S, 2014, BIOCHEM BIOPH RES CO, V453, P350, DOI 10.1016/j.bbrc.2014.09.091; Smith GD, 2007, ARCH DIS CHILD, V92, P876, DOI 10.1136/adc.2006.104869; Snider P, 2009, CIRC RES, V105, P934, DOI 10.1161/CIRCRESAHA.109.201400; Sun YM, 2005, BLOOD, V106, P3811, DOI 10.1182/blood-2005-06-2495; Tarrade A, 2015, J EXP BIOL, V218, P50, DOI 10.1242/jeb.110320; Tie JK, 2011, BLOOD, V117, P2967, DOI 10.1182/blood-2010-08-304303; Viegas CSB, 2013, J BIOL CHEM, V288, P27801, DOI 10.1074/jbc.M113.450213; Wei JW, 2014, J CLIN INVEST, V124, P1781, DOI 10.1172/JCI72323	37	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138730	10.1371/journal.pone.0138730	http://dx.doi.org/10.1371/journal.pone.0138730			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381752	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000361790200156
J	Haddaway, NR; Collins, AM; Coughlin, D; Kirk, S				Haddaway, Neal Robert; Collins, Alexandra Mary; Coughlin, Deborah; Kirk, Stuart			The Role of Google Scholar in Evidence Reviews and Its Applicability to Grey Literature Searching	PLOS ONE			English	Article							WEB-OF-SCIENCE; PUBLICATION; GROWTH; SCOPUS; INDEX	Google Scholar (GS), a commonly used web-based academic search engine, catalogues between 2 and 100 million records of both academic and grey literature (articles not formally published by commercial academic publishers). Google Scholar collates results from across the internet and is free to use. As a result it has received considerable attention as a method for searching for literature, particularly in searches for grey literature, as required by systematic reviews. The reliance on GS as a standalone resource has been greatly debated, however, and its efficacy in grey literature searching has not yet been investigated. Using systematic review case studies from environmental science, we investigated the utility of GS in systematic reviews and in searches for grey literature. Our findings show that GS results contain moderate amounts of grey literature, with the majority found on average at page 80. We also found that, when searched for specifically, the majority of literature identified using Web of Science was also found using GS. However, our findings showed moderate/poor overlap in results when similar search strings were used in Web of Science and GS (10-67%), and that GS missed some important literature in five of six case studies. Furthermore, a general GS search failed to find any grey literature from a case study that involved manual searching of organisations' websites. If used in systematic reviews for grey literature, we recommend that searches of article titles focus on the first 200 to 300 results. We conclude that whilst Google Scholar can find much grey literature and specific, known studies, it should not be used alone for systematic review searches. Rather, it forms a powerful addition to other traditional search methods. In addition, we advocate the use of tools to transparently document and catalogue GS search results to maintain high levels of transparency and the ability to be updated, critical to systematic reviews.	[Haddaway, Neal Robert] Royal Swedish Acad Sci, MISTRA EviEM, Stockholm, Sweden; [Collins, Alexandra Mary] Univ London Imperial Coll Sci Technol & Med, Ctr Environm Policy, London, England; [Collins, Alexandra Mary; Coughlin, Deborah; Kirk, Stuart] Dept Environm Food & Rural Affairs, London, England; [Coughlin, Deborah] Univ London Imperial Coll Sci Technol & Med, Dept Civil & Environm Engn, London, England; [Kirk, Stuart] Environm Agcy, London, England	Royal Swedish Academy of Sciences; Imperial College London; Imperial College London	Haddaway, NR (corresponding author), Royal Swedish Acad Sci, MISTRA EviEM, Stockholm, Sweden.	neal_haddaway@hotmail.com		Haddaway, Neal R/0000-0003-3902-2234	Natural Environment Research Council; UK Department for Environment Food and Rural Affairs; Environment Agency; Defra research project [WT1552]; NERC [NE/L011506/1] Funding Source: UKRI; Natural Environment Research Council [NE/L011506/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); UK Department for Environment Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Environment Agency; Defra research project(Department for Environment, Food & Rural Affairs (DEFRA)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	AMC acknowledges a Policy Placement Fellowship funded by the Natural Environment Research Council, the UK Department for Environment Food and Rural Affairs and the Environment Agency. Some ideas for this project were prompted by a forthcoming Defra research project (WT1552). NH was hosted at Bangor University (http://www.bangor.ac.uk/).	Anders ME, 2010, RESP CARE, V55, P578; Banks Marcus A, 2005, Biomed Digit Libr, V2, P2, DOI 10.1186/1742-5581-2-2; Bernes C, 2015, ENV EVID, V2, P9; Bernes C, 2015, ENVIRON EVID, V4, DOI 10.1186/s13750-014-0030-3; Boeker M, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-131; Collaboration for Environmental Evidence, 2013, GUIDELINES SYSTEMATI; Collins A, 2014, PRODUCTION QUICK SCO; Conservation Evidence, 2015, SYN METH; de Winter JCF, 2014, SCIENTOMETRICS, V98, P1547, DOI 10.1007/s11192-013-1089-2; Lopez-Cozar ED, 2014, J ASSOC INF SCI TECH, V65, P446, DOI 10.1002/asi.23056; Falagas ME, 2008, FASEB J, V22, P338, DOI 10.1096/fj.07-9492LSF; Garcia-Yi J, 2014, ENVIRON EVID, V3, DOI 10.1186/2047-2382-3-24; Gehanno JF, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-7; Giustini Dean, 2013, Online J Public Health Inform, V5, P214, DOI 10.5210/ojphi.v5i2.4623; Gurevitch J, 1999, ECOLOGY, V80, P1142, DOI 10.1890/0012-9658(1999)080[1142:SIIEMA]2.0.CO;2; Haddaway NR, 2014, ENVIRON EVID, V3, DOI 10.1186/2047-2382-3-17; Haddaway NR, 2015, BIOL CONSERV, V191, P827, DOI 10.1016/j.biocon.2015.08.018; Haddaway NR, 2014, ENVIRON EVID, V3, DOI 10.1186/2047-2382-3-5; Haddaway NR., GREY J IN PRESS; Hughes KM, 2014, ENVIRON EVID, V3, DOI 10.1186/2047-2382-3-23; Jacso P, 2005, CURR SCI INDIA, V89, P1537; Jennions MD, 2002, BIOL REV, V77, P211, DOI 10.1017/S1464793101005875; Khabsa M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093949; Larsen PO, 2010, SCIENTOMETRICS, V84, P575, DOI 10.1007/s11192-010-0202-z; Pautasso M, 2012, SUSTAINABILITY-BASEL, V4, P3234, DOI 10.3390/su4123234; Pullin AS, 2013, ENVIRON EVID, V2, DOI 10.1186/2047-2382-2-19; Reed J, 2015, WHAT ARE INTEGRATED, V4, P2; Roe D, 2014, ENVIRON EVID, V3, DOI 10.1186/2047-2382-3-3; Savilaakso S, 2014, ENVIRON EVID, V3, DOI 10.1186/2047-2382-3-4; Sciberras M, 2013, ENVIRON EVID, V2, DOI 10.1186/2047-2382-2-4; Shariff SZ, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2624; Shultz M, 2007, J MED LIBR ASSOC, V95, P442, DOI 10.3163/1536-5050.95.4.442; Van Noorden R, 2013, NATURE, V495, P426, DOI 10.1038/495426a; Whitlock R, 2013, ENVIRON EVID, V2, DOI 10.1186/2047-2382-2-13	34	331	333	7	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138237	10.1371/journal.pone.0138237	http://dx.doi.org/10.1371/journal.pone.0138237			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379270	Green Published, gold, Green Submitted			2022-12-27	WOS:000361769400068
J	Liu, H; Zhang, GM; Sun, WT; Shen, ZY; Shi, MJ				Liu, Huan; Zhang, Gengmin; Sun, Wentao; Shen, Ziyong; Shi, Mingji			ZnO Hierarchical Nanostructure Photoanode in a CdS Quantum Dot-Sensitized Solar Cell	PLOS ONE			English	Article							ZINC-OXIDE NANORODS; ELECTROCHEMICAL DEPOSITION; GROWTH-MECHANISM; AQUEOUS-SOLUTION; SINGLE-CRYSTALS; CHEMICAL BATH; EFFICIENCY; FABRICATION; ARRAYS; TIO2	A hierarchical array of ZnO nanocones covered with ZnO nanospikes was hydrothermally fabricated and employed as the photoanode in a CdS quantum dot-sensitized solar cell (QDSSC). This QDSSC outperformed the QDSSC based on a simple ZnO nanocone photoanode in all the four principal photovoltaic parameters. Using the hierarchical photoanode dramatically increased the short circuit current density and also slightly raised the open circuit voltage and the fill factor. As a result, the conversion efficiency of the QDSSC based on the hierarchical photoanode was more than twice that of the QDSSC based on the simple ZnO nanocone photoanode. This improvement is attributable to both the enlarged specific area of the photoanode and the reduction in the recombination of the photoexcited electrons.	[Liu, Huan; Zhang, Gengmin; Sun, Wentao; Shen, Ziyong] Peking Univ, Key Lab Phys & Chem Nanodevices, Beijing 100871, Peoples R China; [Liu, Huan; Zhang, Gengmin; Sun, Wentao; Shen, Ziyong] Peking Univ, Dept Elect, Beijing 100871, Peoples R China; [Zhang, Gengmin] SIP UCLA, Inst Technol Adv, Suzhou, Peoples R China; [Shi, Mingji] Nanyang Inst Technol, Sch Elect & Elect Engn, Nanyang, Henan Province, Peoples R China	Peking University; Peking University; Nanyang Institute of Technology	Zhang, GM (corresponding author), Peking Univ, Key Lab Phys & Chem Nanodevices, Beijing 100871, Peoples R China.	zgmin@pku.edu.cn			National Natural Science Foundation of China [61171023, 61306079, 61271050]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Nos. 61171023 (GMZ), 61306079 (WTS) and 61271050 (ZYS)) [http://www.nsfc.gov.cn].	Agarwal DC, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/3/035310; Anta JA, 2012, J PHYS CHEM C, V116, P11413, DOI 10.1021/jp3010025; Bierman MJ, 2009, ENERG ENVIRON SCI, V2, P1050, DOI 10.1039/b912095e; Cao BQ, 2006, CRYST GROWTH DES, V6, P1091, DOI 10.1021/cg050246l; Chatterjee A, 2006, DIAM RELAT MATER, V15, P664, DOI 10.1016/j.diamond.2005.11.007; Chen J, 2010, APPL SURF SCI, V256, P7438, DOI 10.1016/j.apsusc.2010.05.086; Chen J, 2009, APPL SURF SCI, V255, P7508, DOI 10.1016/j.apsusc.2009.03.091; Cheng HM, 2012, PHYS CHEM CHEM PHYS, V14, P13539, DOI [10.1039/c2cp41760j, 10.1039/C2CP41760J]; Chou TP, 2007, ADV MATER, V19, P2588, DOI 10.1002/adma.200602927; Dem'yanets LN, 2002, INORG MATER+, V38, P124, DOI 10.1023/A:1014008909633; Demianets LN, 2002, CRYSTALLOGR REP+, V47, pS86, DOI 10.1134/1.1529962; Deng JP, 2014, J COLLOID INTERF SCI, V418, P277, DOI 10.1016/j.jcis.2013.11.017; El Belghiti H, 2008, PHYS STATUS SOLIDI A, V205, P2360, DOI 10.1002/pssa.200879443; Fan K, 2011, J PHYS CHEM C, V115, P17213, DOI 10.1021/jp204725f; FORRO L, 1994, J APPL PHYS, V75, P633, DOI 10.1063/1.355801; Gao HM, 2008, MATER RES BULL, V43, P3345, DOI 10.1016/j.materresbull.2008.02.010; Gedamu D, 2014, ADV MATER, V26, P1541, DOI 10.1002/adma.201304363; Govender K, 2004, J MATER CHEM, V14, P2575, DOI 10.1039/b404784b; Gratzel M, 2001, NATURE, V414, P338, DOI 10.1038/35104607; Greene LE, 2006, INORG CHEM, V45, P7535, DOI 10.1021/ic0601900; Han C, 2015, ADV FUNCT MATER, V25, P221, DOI 10.1002/adfm.201402443; Hodes G, 2008, J PHYS CHEM C, V112, P17778, DOI 10.1021/jp803310s; Izaki M, 1996, J ELECTROCHEM SOC, V143, pL53, DOI 10.1149/1.1836529; Jin X, 2013, ADV MATER, V25, P1342, DOI 10.1002/adma.201203849; Jin X, 2012, ADV MATER, V24, P5676, DOI 10.1002/adma.201201780; Jung SW, 2013, CURR APPL PHYS, V13, P1532, DOI 10.1016/j.cap.2013.05.015; Khajavi MR, 2012, ELECTROCHIM ACTA, V69, P181, DOI 10.1016/j.electacta.2012.02.096; Kilic B, 2014, APPL SURF SCI, V318, P32, DOI 10.1016/j.apsusc.2013.12.065; Ko SH, 2011, NANO LETT, V11, P666, DOI 10.1021/nl1037962; Kumar M, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4922732; Lee J.D., 1996, CONCISE INORGANIC CH; Li CM, 2013, APPL CATAL B-ENVIRON, V138, P175, DOI 10.1016/j.apcatb.2013.02.042; Li LB, 2013, ACS APPL MATER INTER, V5, P11865, DOI 10.1021/am4035653; Li QC, 2005, CHEM MATER, V17, P1001, DOI 10.1021/cm048144q; Li WJ, 1999, J CRYST GROWTH, V203, P186, DOI 10.1016/S0022-0248(99)00076-7; Li ZD, 2015, ELECTROCHIM ACTA, V152, P25, DOI 10.1016/j.electacta.2014.11.106; Li ZD, 2015, J POWER SOURCES, V274, P575, DOI 10.1016/j.jpowsour.2014.10.129; Liao JY, 2012, ENERG ENVIRON SCI, V5, P5750, DOI 10.1039/c1ee02766b; Liao JY, 2011, ENERG ENVIRON SCI, V4, P4079, DOI 10.1039/c1ee01574e; Lin SY, 2015, ELECTROCHIM ACTA, V152, P61, DOI 10.1016/j.electacta.2014.11.108; Liu BK, 2014, RSC ADV, V4, P32773, DOI 10.1039/c4ra05736h; Liu H, 2015, MATER RES BULL, V61, P492, DOI 10.1016/j.materresbull.2014.10.068; Look DC, 1998, SOLID STATE COMMUN, V105, P399, DOI 10.1016/S0038-1098(97)10145-4; Lopez R, 2012, J SOL-GEL SCI TECHN, V61, P1, DOI 10.1007/s10971-011-2582-9; Memarian N., 2011, ANGEW CHEM, V123, P12529, DOI DOI 10.1002/ANGE.201104605; Mishra YK, 2012, J APPL PHYS, V112, DOI 10.1063/1.4752469; Mishra YK, 2015, ACS APPL MATER INTER, V7, P14303, DOI 10.1021/acsami.5b02816; Park YC, 2011, ELECTROCHIM ACTA, V56, P7371, DOI 10.1016/j.electacta.2011.05.113; Pichot F, 2000, J PHYS CHEM B, V104, P6, DOI 10.1021/jp993035y; Reimer T, 2014, ACS APPL MATER INTER, V6, P7806, DOI 10.1021/am5010877; Rodriguez-Fragoso P, 2010, APPL SURF SCI, V257, P581, DOI 10.1016/j.apsusc.2010.07.036; Sauvage F, 2010, NANO LETT, V10, P2562, DOI 10.1021/nl101198b; Seol M, 2010, CHEM COMMUN, V46, P5521, DOI 10.1039/c0cc00542h; Sharrna M, 2012, MATER RES BULL, V47, P1755, DOI 10.1016/j.materresbull.2012.03.044; Skompska M, 2014, ELECTROCHIM ACTA, V127, P467, DOI 10.1016/j.electacta.2014.02.049; Song J, 2013, ADV MATER, V25, P5678, DOI [10.1002/adma.201370252, DOI 10.1002/ADMA.201370252]; Song JZ, 2015, ANGEW CHEM INT EDIT, V54, P462, DOI 10.1002/anie.201408621; Song JZ, 2014, NANO LETT, V14, P6298, DOI 10.1021/nl502647k; Spoerke ED, 2009, J PHYS CHEM C, V113, P16329, DOI 10.1021/jp900564r; Srivastava S, 2015, J ALLOY COMPD, V644, P597, DOI 10.1016/j.jallcom.2015.04.220; Sugunan A, 2006, J SOL-GEL SCI TECHN, V39, P49, DOI 10.1007/s10971-006-6969-y; Sun SR, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3318466; TAUC J, 1970, PHYS REV LETT, V25, P749, DOI 10.1103/PhysRevLett.25.749; Tian JJ, 2014, ACS APPL MATER INTER, V6, P4466, DOI 10.1021/am500209f; Vanalakar SA, 2011, MATER LETT, V65, P548, DOI 10.1016/j.matlet.2010.10.067; Wang J, 2013, J AM CHEM SOC, V135, P15913, DOI 10.1021/ja4079804; Wang Q, 2005, J PHYS CHEM B, V109, P14945, DOI 10.1021/jp052768h; Wang Z, 2004, J SOLID STATE CHEM, V177, P2144, DOI 10.1016/j.jssc.2003.10.026; Wang Z, 2004, LANGMUIR, V20, P3441, DOI 10.1021/la036098n; Willander M, 2009, J MATER CHEM, V19, P1006, DOI 10.1039/b816619f; Wu CT, 2011, J MATER CHEM, V21, P13605, DOI 10.1039/c1jm11681a; Wu LP, 2014, RSC ADV, V4, P20716, DOI 10.1039/c4ra00005f; Wu SJ, 2012, ORG ELECTRON, V13, P1569, DOI 10.1016/j.orgel.2012.04.018; Xu F, 2010, J PHYS CHEM C, V114, P2776, DOI 10.1021/jp910363w; Xu S, 2011, NANO RES, V4, P1013, DOI 10.1007/s12274-011-0160-7; Yan KY, 2013, J AM CHEM SOC, V135, P9531, DOI 10.1021/ja403756s; Ye MD, 2011, NANO LETT, V11, P3214, DOI 10.1021/nl2014845; Yin JB, 2012, SCI CHINA TECHNOL SC, V55, P3176, DOI 10.1007/s11431-012-4920-8; Yu LG, 2007, J CRYST GROWTH, V299, P184, DOI 10.1016/j.jcrysgro.2006.10.237; Zeng HB, 2010, ADV FUNCT MATER, V20, P561, DOI 10.1002/adfm.200901884; Zhang J, 2002, CHEM MATER, V14, P4172, DOI 10.1021/cm020077h; Zhang ML, 2014, RSC ADV, V4, P10462, DOI 10.1039/c3ra47146b; Zhang QF, 2009, ADV MATER, V21, P4087, DOI 10.1002/adma.200803827; Zheng HD, 2010, LANGMUIR, V26, P19148, DOI 10.1021/la103692y	84	5	6	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138298	10.1371/journal.pone.0138298	http://dx.doi.org/10.1371/journal.pone.0138298			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379268	Green Published, Green Submitted, gold			2022-12-27	WOS:000361769400082
J	Agrawal, C; Sen, S; Yadav, S; Rai, S; Rai, LC				Agrawal, Chhavi; Sen, Sonia; Yadav, Shivam; Rai, Shweta; Rai, Lal Chand			A Novel Aldo-Keto Reductase (AKR17A1) of Anabaena sp PCC 7120 Degrades the Rice Field Herbicide Butachlor and Confers Tolerance to Abiotic Stresses in E. coli	PLOS ONE			English	Article							ALDOSE/ALDEHYDE REDUCTASE; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; SP PCC7120; DEGRADATION; EXPRESSION; SOIL; METHYLGLYOXAL; METABOLISM; GENE	Present study deals with the identification of a novel aldo/keto reductase, AKR17A1 from Anabaena sp. PCC7120 and adds on as 17th family of AKR superfamily drawn from a wide variety of organisms. AKR17A1 shares many characteristics of a typical AKR such as-(i) conferring tolerance to multiple stresses like heat, UV-B, and cadmium, (ii) excellent activity towards known AKR substrates (isatin and 2-nitrobenzaldehyde), and (iii) obligate dependence on NADPH as a cofactor for enzyme activity. The most novel attribute of AKR17A1, first reported in this study, is its capability to metabolize butachlor, a persistent rice field herbicide that adversely affects agro-ecosystem and non-target organisms. The AKR17A1 catalyzed-degradation of butachlor resulted into formation of 1,2-benzene dicarboxylic acid and 2,6 bis (1,1, dimethylethyl) 4,-methyl phenol as the major products confirmed by GC-MS analysis.	[Agrawal, Chhavi; Sen, Sonia; Yadav, Shivam; Rai, Shweta; Rai, Lal Chand] Banaras Hindu Univ, Mol Biol Sect, Ctr Adv Study Bot, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Rai, LC (corresponding author), Banaras Hindu Univ, Mol Biol Sect, Ctr Adv Study Bot, Varanasi 221005, Uttar Pradesh, India.	lcrbhu15@gmail.com			Indian Council of Agricultural Research, New Delhi, India [P27/130]	Indian Council of Agricultural Research, New Delhi, India(Indian Council of Agricultural Research (ICAR))	LCR received funds from Indian Council of Agricultural Research, New Delhi, India (Grant no. P27/130).	Agrawal C, 2014, J PROTEOMICS, V96, P271, DOI 10.1016/j.jprot.2013.11.015; Aguilera J, 2001, CURR GENET, V39, P273, DOI 10.1007/s002940100213; Altschul SF, 1996, METHOD ENZYMOL, V266, P460; Anees S, 2014, BIOINFORMATION, V10, P365, DOI 10.6026/97320630010365; Ateeq B, 2002, MUTAT RES-GEN TOX EN, V514, P105, DOI 10.1016/S1383-5718(01)00327-8; Barski OA, 2008, DRUG METAB REV, V40, P553, DOI [10.1080/03602530802431439, 10.1080/03602530802431439 ]; BOHREN KM, 1989, J BIOL CHEM, V264, P9547; CHANG SS, 1985, J PLANT GROWTH REGUL, V4, P1; Di Luccio E, 2006, BIOCHEM J, V400, P105, DOI 10.1042/BJ20060660; Dwivedi S, 2010, LETT APPL MICROBIOL, V51, P54, DOI 10.1111/j.1472-765X.2010.02854.x; Dwivedi S, 2012, TOXICOLOGY, V302, P77, DOI 10.1016/j.tox.2012.07.014; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ford G, 2002, YEAST, V19, P1087, DOI 10.1002/yea.899; Ford G, 2001, CHEM-BIOL INTERACT, V130, P685, DOI 10.1016/S0009-2797(00)00259-3; Gavidia I, 2002, EUR J BIOCHEM, V269, P2842, DOI 10.1046/j.1432-1033.2002.02931.x; Grant AW, 2003, FEMS MICROBIOL LETT, V218, P93, DOI 10.1111/j.1574-6968.2003.tb11503.x; Hegedus A, 2004, PLANT SCI, V166, P1329, DOI 10.1016/j.plantsci.2004.01.013; Hideg E, 2003, PLANT CELL ENVIRON, V26, P513, DOI 10.1046/j.1365-3040.2003.00982.x; Jayakumar R, 1993, P INT S IND SOC WEED, P123; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; Kanayama Y, 2014, PHYTOCHEMISTRY, V104, P30, DOI 10.1016/j.phytochem.2014.04.008; Katoh H, 2004, MICROB ECOL, V47, P164, DOI 10.1007/s00248-003-1043-6; Kim NH, 2013, FEMS MICROBIOL LETT, V344, P114, DOI 10.1111/1574-6968.12163; Kumari N, 2009, CHEMOSPHERE, V77, P1501, DOI 10.1016/j.chemosphere.2009.10.005; Liu HM, 2012, J AGR FOOD CHEM, V60, P12238, DOI 10.1021/jf303936j; Liu WY, 2011, ECOTOXICOLOGY, V20, P377, DOI 10.1007/s10646-010-0589-6; Marino M, 2000, MICROBIOL-SGM, V146, P97, DOI 10.1099/00221287-146-1-97; Nakano M, 1999, J BIOL CHEM, V274, P23185, DOI 10.1074/jbc.274.33.23185; Nei M., 2000, MOL EVOLUTION PHYLOG; Ni Y, 2011, APPL MICROBIOL BIOT, V89, P1111, DOI 10.1007/s00253-010-2941-4; Norbeck J, 1997, J BIOL CHEM, V272, P5544, DOI 10.1074/jbc.272.9.5544; Oberschall A, 2000, PLANT J, V24, P437, DOI 10.1046/j.1365-313x.2000.00885.x; Pal R, 2006, J ENVIRON SCI HEAL B, V41, P1103, DOI 10.1080/03601230600851141; Pandey S, 2012, J PROTEOMICS, V75, P921, DOI 10.1016/j.jprot.2011.10.011; Pandey S, 2013, PLANT MOL BIOL, V83, P417, DOI 10.1007/s11103-013-0100-x; Petrash JM, 2004, CELL MOL LIFE SCI, V61, P737, DOI 10.1007/s00018-003-3402-3; Prakash N. B., 2000, Karnataka Journal of Agricultural Sciences, V13, P575; Rai S, 2014, J PROTEOMICS, V98, P254, DOI 10.1016/j.jprot.2013.12.020; Rai S, 2013, PHOTOSYNTH RES, V118, P105, DOI 10.1007/s11120-013-9931-1; Rajaram H, 2008, MICROBIOL-SGM, V154, P317, DOI 10.1099/mic.0.2007/011064-0; Rao PC, 2012, INDIAN J WEED SCI, V44, P84; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 2001, MOL CLONING LAB MANU; SETHUNATHAN N, 1973, CAN J MICROBIOL, V19, P873, DOI 10.1139/m73-138; Shobha Sondhia, 2006, Annals of Plant Protection Sciences, V14, P206; Shrivastava AK, 2015, J PROTEOMICS, V127, P122, DOI 10.1016/j.jprot.2015.05.014; Shrivastava AK, 2012, GENE, V511, P248, DOI 10.1016/j.gene.2012.09.033; Simpson PJ, 2009, J MOL BIOL, V392, P465, DOI 10.1016/j.jmb.2009.07.023; Singh PK., 2012, PHYKOS, V42, P39; Singh PK, 2015, J PROTEOMICS, V127, P134, DOI 10.1016/j.jprot.2015.05.019; SMILEY KL, 1982, BIOTECHNOL LETT, V4, P607, DOI 10.1007/BF00127793; Srivastava AK, 2007, J APPL PHYCOL, V19, P373, DOI 10.1007/s10811-006-9144-5; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Turoczy Z, 2011, PLANT MOL BIOL, V75, P399, DOI 10.1007/s11103-011-9735-7; Widmer SK, 1996, ACS SYM SER, V630, P271; Xu DY, 2006, MICROBIOL-SGM, V152, P2013, DOI 10.1099/mic.0.28870-0; Xu HD, 2015, AQUAT TOXICOL, V159, P69, DOI 10.1016/j.aquatox.2014.11.020; Yamamoto K, 2013, ARCH BIOCHEM BIOPHYS, V538, P156, DOI 10.1016/j.abb.2013.08.018; Yang CM, 2011, J ENVIRON SCI, V23, P1437, DOI 10.1016/S1001-0742(10)60604-3; Yu YL, 2003, CHEMOSPHERE, V50, P771, DOI 10.1016/S0045-6535(02)00218-7; Zheng JW, 2012, INT BIODETER BIODEGR, V73, P16, DOI 10.1016/j.ibiod.2012.06.003	62	22	24	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137744	10.1371/journal.pone.0137744	http://dx.doi.org/10.1371/journal.pone.0137744			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372161	Green Submitted, Green Published, gold			2022-12-27	WOS:000361604400029
J	Jung, CH; Lee, MJ; Kang, YM; Yang, DH; Kang, JW; Kim, EH; Park, DW; Park, JY; Kim, HK; Lee, WJ				Jung, Chang Hee; Lee, Min Jung; Kang, Yu Mi; Yang, Dong Hyun; Kang, Joon-Won; Kim, Eun Hee; Park, Duk-Woo; Park, Joong-Yeol; Kim, Hong-Kyu; Lee, Woo Je			2013 ACC/AHA versus 2004 NECP ATP III Guidelines in the Assignment of Statin Treatment in a Korean Population with Subclinical Coronary Atherosclerosis	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; PROGNOSTIC VALUE; ARTERY CALCIUM; FOLLOW-UP; CARDIOVASCULAR-DISEASE; HEART-DISEASE; RISK-FACTORS; ANGIOGRAPHY; PREVENTION; ACCURACY	Background The usefulness of the 2013 ACC/AHA guidelines for the management of blood cholesterol in the Asian population remains controversial. In this study, we investigated whether eligibility for statin therapy determined by the 2013 ACC/AHA guidelines is better aligned with the presence of subclinical coronary atherosclerosis detected by CCTA (coronary computed tomography angiography) compared to the previously recommended 2004 NCEP ATP III guidelines. Methods We collected the data from 5,837 asymptomatic subjects who underwent CCTA using MDCT during routine health examinations. Based on risk factor assessment and lipid data, we determined guideline-based eligibility for statin therapy according to the 2013 ACC/AHA and 2004 NCEP ATP III guidelines. We defined the presence and severity of subclinical coronary atherosclerosis detected in CCTA according to the presence of significant coronary artery stenosis (defined as >50% stenosis), plaques, and the degree of coronary calcification. Results As compared to the 2004 ATP III guidelines, a significantly higher proportion of subjects with significant coronary stenosis (61.8% vs. 33.8%), plaques (52.3% vs. 24.7%), and higher CACS (CACS > 100, 63.6% vs. 26.5%) was assigned to statin therapy using the 2013 ACC/AHA guidelines (P < .001 for all variables). The area under the curves of the pooled cohort equation of the new guidelines in detecting significant stenosis, plaques, and higher CACS were significantly higher than those of the Framingham risk calculator. Conclusions Compared to the previous ATP III guidelines, the 2013 ACC/AHA guidelines were more sensitive in identifying subjects with subclinical coronary atherosclerosis detected by CCTA in an Asian population.	[Jung, Chang Hee; Lee, Min Jung; Kang, Yu Mi; Park, Duk-Woo; Park, Joong-Yeol; Lee, Woo Je] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea; [Yang, Dong Hyun; Kang, Joon-Won] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Kim, Eun Hee; Kim, Hong-Kyu] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hlth Screening, Seoul, South Korea; [Kim, Eun Hee; Kim, Hong-Kyu] Univ Ulsan, Coll Med, Asan Med Ctr, Promot Ctr, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Kim, HK (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hlth Screening, Seoul, South Korea.	hkkim0801@amc.seoul.kr; lwjatlas@amc.seoul.kr	Kang, Yu Mi/AAW-2935-2020; Jung, Chang Hee/AAU-7897-2020	Jung, Chang Hee/0000-0003-4043-2396				AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Amin NP, 2014, J AM COLL CARDIOL, V63, P2789, DOI 10.1016/j.jacc.2014.04.010; Arai H, 2014, J ATHEROSCLER THROMB, V21, P79; Bamberg F, 2011, J AM COLL CARDIOL, V57, P2426, DOI 10.1016/j.jacc.2010.12.043; Bittencourt MS, 2014, J AM COLL CARDIOL, V63, P434, DOI 10.1016/j.jacc.2013.08.1640; Chia YC, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-163; Chow BJW, 2010, J AM COLL CARDIOL, V55, P1017, DOI 10.1016/j.jacc.2009.10.039; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Dougoud S, 2014, INT J CARDIOVAS IMAG, V30, P969, DOI 10.1007/s10554-014-0420-1; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Hadamitzky M, 2013, EUR HEART J, V34, P3277, DOI 10.1093/eurheartj/eht293; Johnson KM, 2014, J AM COLL CARDIOL, V64, P910, DOI 10.1016/j.jacc.2014.05.056; Jung CH, 2014, OBESITY, V22, P2613, DOI 10.1002/oby.20883; Kim NH, 2015, J ATHEROSCLER THROMB, V22, P293, DOI 10.5551/jat.26682; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leber AW, 2006, J AM COLL CARDIOL, V47, P672, DOI 10.1016/j.jacc.2005.10.058; Lee SH, 2014, J CLIN ENDOCR METAB, V99, P1615, DOI 10.1210/jc.2013-3608; Lloyd-Jones DM, 2014, LANCET, V383, P600, DOI 10.1016/S0140-6736(13)62348-X; Mollet NR, 2005, CIRCULATION, V112, P2318, DOI 10.1161/CIRCULATIONAHA.105.533471; Moon JS, 2013, DIABETES METAB J, V37, P54, DOI 10.4093/dmj.2013.37.1.54; Muntner P, 2014, CIRCULATION, V129, P266, DOI 10.1161/CIRCULATIONAHA.113.007648; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Newman AB, 2001, CIRCULATION, V104, P2679, DOI 10.1161/hc4601.099464; Oei HHS, 2004, EUR HEART J, V25, P48, DOI 10.1016/j.ehj.2003.10.008; Ostrom MP, 2008, J AM COLL CARDIOL, V52, P1335, DOI 10.1016/j.jacc.2008.07.027; Pencina MJ, 2014, NEW ENGL J MED, V370, P1422, DOI 10.1056/NEJMoa1315665; Pursnani A, 2014, ATHEROSCLEROSIS, V237, P314, DOI 10.1016/j.atherosclerosis.2014.09.023; Raff GL, 2005, J AM COLL CARDIOL, V46, P552, DOI 10.1016/j.jacc.2005.05.056; Ridker PM, 2013, LANCET, V382, P1762, DOI 10.1016/S0140-6736(13)62388-0; Sasayama S, 2008, CIRCULATION, V118, P2669, DOI 10.1161/CIRCULATIONAHA.108.837054; Silverman MG, 2014, EUR HEART J, V35, P2232, DOI 10.1093/eurheartj/eht508; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048; Vaucher J, 2014, EUR HEART J, V35, P958, DOI 10.1093/eurheartj/ehu064	38	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137478	10.1371/journal.pone.0137478	http://dx.doi.org/10.1371/journal.pone.0137478			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372638	Green Published, Green Submitted, gold			2022-12-27	WOS:000361604400024
J	Lazzerini, M; Sonego, M; Pellegrin, MC				Lazzerini, Marzia; Sonego, Michela; Pellegrin, Maria Chiara			Hypoxaemia as a Mortality Risk Factor in Acute Lower Respiratory Infections in Children in Low and Middle-Income Countries: Systematic Review and Meta-Analysis	PLOS ONE			English	Review							SEVERE PNEUMONIA; YOUNG-CHILDREN; OXYGEN SYSTEMS; CHILDHOOD PNEUMONIA; CLINICAL PREDICTORS; PULSE OXIMETRY; ETIOLOGY; MANAGEMENT; DIARRHEA; BURDEN	Objective To evaluate the association between hypoxaemia and mortality from acute lower respiratory infections (ALRI) in children in low- and middle-income countries (LMIC). Design Systematic review and meta-analysis. Study Selection Observational studies reporting on the association between hypoxaemia and death from ALRI in children below five years in LMIC. Data Sources Medline, Embase, Global Health Library, Lilacs, and Web of Science to February 2015. Risk of Bias Assessment Quality In Prognosis Studies tool with minor adaptations to assess the risk of bias; funnel plots and Egger's test to evaluate publication bias. Results Out of 11,627 papers retrieved, 18 studies from 13 countries on 20,224 children met the inclusion criteria. Twelve (66.6%) studies had either low or moderate risk of bias. Hypoxaemia defined as oxygen saturation rate (SpO2) < 90% associated with significantly increased odds of death from ALRI (OR 5.47, 95% CI 3.93 to 7.63) in 12 studies on 13,936 children. An Sp02 < 92% associated with a similar increased risk of mortality (OR 3.66, 95% CI 1.42 to 9.47) in 3 studies on 673 children. Sensitivity analyses (excluding studies with high risk of bias and using adjusted OR) and subgroup analyses (by: altitude, definition of ALRI, country income, HIV prevalence) did not affect results. Only one study was performed on children living at high altitude. Conclusions The results of this review support the routine evaluation of SpO2 for identifying children with ALRI at increased risk of death. Both a Sp02 value of 92% and 90% equally identify children at increased risk of mortality. More research is needed on children living at high altitude. Policy makers in LMIC should aim at improving the regular use of pulse oximetry and the availability of oxygen in order to decrease mortality from ALRI.	[Lazzerini, Marzia; Sonego, Michela] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, WHO Collaborating Ctr Maternal & Child Hlth, I-34137 Trieste, Italy; [Sonego, Michela; Pellegrin, Maria Chiara] Univ Trieste, I-34127 Trieste, Italy	IRCCS Burlo Garofolo; University of Trieste	Lazzerini, M (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, WHO Collaborating Ctr Maternal & Child Hlth, Via Istria 65-1, I-34137 Trieste, Italy.	marzia.lazzerini@burlo.trieste.it	Pellegrin, Maria Chiara/AAC-6557-2022					Camargo Carlos A Jr, 2009, Proc Am Thorac Soc, V6, P357, DOI 10.1513/pats.P09ST2; Catto AG, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S28; Chinn S, 2002, THORAX, V57, P393, DOI 10.1136/thorax.57.5.393; Chisti MJ, 2011, ANN TROP PAEDIATR, V31, P311, DOI 10.1179/1465328111Y.0000000033; Chisti MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073728; Demers AM, 2000, PEDIATR INFECT DIS J, V19, P424, DOI 10.1097/00006454-200005000-00007; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Djelantik IGG, 2003, J TROP PEDIATRICS, V49, P327, DOI 10.1093/tropej/49.6.327; Duke T, 2010, INT J TUBERC LUNG D, V14, P1362; Duke T, 2009, ANN TROP PAEDIATR, V29, P165, DOI 10.1179/027249309X12467994190011; Duke T, 2001, INT J TUBERC LUNG D, V5, P511; Duke T, 2008, LANCET, V372, P1328, DOI 10.1016/S0140-6736(08)61164-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gonzalez de Dios J, 2010, AN PEDIAT BARC, V72; Graham SM, 2011, PEDIATR INFECT DIS J, V30, P33, DOI 10.1097/INF.0b013e3181fcabe4; Harris M, 2011, THORAX, V66, pII1, DOI 10.1136/thoraxjnl-2011-200598; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jackson S, 2013, CROAT MED J, V54, P110, DOI 10.3325/cmj.2013.54.110; Jensen LA, 1998, HEART LUNG, V27, P387, DOI 10.1016/S0147-9563(98)90086-3; Junge S, 2006, TROP MED INT HEALTH, V11, P367, DOI 10.1111/j.1365-3156.2006.01570.x; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lozano JM, 2001, INT J TUBERC LUNG D, V5, P496; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Paredes MCL, 2009, AN PEDIATR, V71, P161, DOI 10.1016/j.anpedi.2009.05.012; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; Mwaniki MK, 2009, B WORLD HEALTH ORGAN, V87, P263, DOI 10.2471/BLT.07.049148; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; Nantanda R, 2008, ANN TROP PAEDIATR, V28, P253, DOI 10.1179/146532808X375404; Nantanda R, 2014, BMC PEDIATR, V14, DOI 10.1186/s12887-014-0285-4; ONYANGO FE, 1993, BRIT MED J, V306, P612, DOI 10.1136/bmj.306.6878.612; Petersen CL, 2013, SENSORS-BASEL, V13, P16882, DOI 10.3390/s131216882; Reed C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027793; Rigau D, 2010, SUMMARY FINDIN UNPUB; Rodriguez CE, 2010, INVESTIG SEGUR SOC S, V12, P21; Sigauque B, 2009, J TROP PEDIATRICS, V55, P379, DOI 10.1093/tropej/fmp030; Smyth A, 1998, ANN TROP PAEDIATR, V18, P31, DOI 10.1080/02724936.1998.11747923; Sonego M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116380; StataCorp, 2011, STAT STAT SOFTW REL, P173; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Subhi R, 2010, SICK CHILDREN UNPUB; Subhi R, 2009, LANCET INFECT DIS, V9, P219, DOI 10.1016/S1473-3099(09)70071-4; The World Bank Country and Lending Groups, 2014, HIST CLASS; Usen S, 1999, BMJ-BRIT MED J, V318, P86, DOI 10.1136/bmj.318.7176.86; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Wonodi CB, 2012, CLIN INFECT DIS, V54, pS124, DOI 10.1093/cid/cir1067; World Health Organization, 2013, TECHN REC MAN COMM C; World Health Organization, 2013, GUIDELINES MANAGEMEN; Zar HJ, 2005, SAMJ S AFR MED J, V95, P977; Zhang L, 2011, INT J TUBERC LUNG D, V15, P317; Zhang QL, 2013, PEDIATR PULM, V48, P390, DOI 10.1002/ppul.22608	53	80	82	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0136166	10.1371/journal.pone.0136166	http://dx.doi.org/10.1371/journal.pone.0136166			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372640	Green Published, gold, Green Submitted			2022-12-27	WOS:000361604400004
J	Torkkeli, PH; Liu, HX; French, AS				Torkkeli, Paeivi H.; Liu, Hongxia; French, Andrew S.			Transcriptome Analysis of the Central and Peripheral Nervous Systems of the Spider Cupiennius salei Reveals Multiple Putative Cys-Loop Ligand Gated Ion Channel Subunits and an Acetylcholine Binding Protein	PLOS ONE			English	Article							X-RAY-STRUCTURE; CHLORIDE CHANNEL; DROSOPHILA-MELANOGASTER; FUNCTIONAL-CHARACTERIZATION; GENE SUPERFAMILY; MOLECULAR CHARACTERIZATION; GLUTAMATE RECEPTORS; RESIDUES CONTRIBUTE; GABA; IDENTIFICATION	Invertebrates possess a diverse collection of pentameric Cys-loop ligand gated ion channel (LGIC) receptors whose molecular structures, evolution and relationships to mammalian counterparts have been intensely investigated in several clinically and agriculturally important species. These receptors are targets for a variety of control agents that may also harm beneficial species. However, little is known about Cys-loop receptors in spiders, which are important natural predators of insects. We assembled de novo transcriptomes from the central and peripheral nervous systems of the Central American wandering spider Cupiennius salei, a model species for neurophysiological, behavioral and developmental studies. We found 15 Cys-loop receptor subunits that are expected to form anion or cation permeable channels, plus a putative acetylcholine binding protein (AChBP) that has only previously been reported in molluscs and one annelid. We used phylogenetic and sequence analysis to compare the spider subunits to homologous receptors in other species and predicted the 3D structures of each protein using the I-Tasser server. The quality of homology models improved with increasing sequence identity to the available high-resolution templates. We found that C. salei has orthologous gamma-aminobutyric acid (GABA), GluCl, pHCl, HisCl and nACha LGIC subunits to other arthropods, but some subgroups are specific to arachnids, or only to spiders. C. salei sequences were phylogenetically closest to gene fragments from the social spider, Stegodyphus mimosarum, indicating high conservation within the Araneomorphae suborder of spiders. C. salei sequences had similar ligand binding and transmembrane regions to other invertebrate and vertebrate LGICs. They also had motifs associated with high sensitivity to insecticides and antiparasitic agents such as fipronil, dieldrin and ivermectin. Development of truly selective control agents for pest species will require information about the molecular structure and pharmacology of Cys-loop receptors in beneficial species.	[Torkkeli, Paeivi H.; Liu, Hongxia; French, Andrew S.] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS B3H 4R2, Canada	Dalhousie University	Torkkeli, PH (corresponding author), Dalhousie Univ, Dept Physiol & Biophys, POB 15000, Halifax, NS B3H 4R2, Canada.	Paivi.Torkkeli@dal.ca		French, Andrew/0000-0001-8190-4084; Torkkeli, Paivi/0000-0002-8205-7339	Canadian Institutes of Health Research [MOP-106602]; Natural Sciences and Engineering Research Council of Canada [RGPIN 05565]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding provided by Canadian Institutes of Health Research, Grant number MOP-106602, http://www.cihr.ca/e/193.html (PHT and ASF); Natural Sciences and Engineering Research Council of Canada RGPIN 05565, http://www.nserc-crsng.gc.ca/index_eng.asp (PHT).	Althoff T, 2014, NATURE, V512, P333, DOI 10.1038/nature13669; Barth F.G., 2002, SPIDERS WORLD SENSES; Bartos M, 2009, MOL NEUROBIOL, V40, P236, DOI 10.1007/s12035-009-8084-x; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Burrows M., 1996, NEUROBIOLOGY INSECT; Casida JE, 2015, PESTIC BIOCHEM PHYS, V121, P22, DOI 10.1016/j.pestbp.2014.11.006; CHEN RT, 1994, P NATL ACAD SCI USA, V91, P6069, DOI 10.1073/pnas.91.13.6069; Comitani F, 2014, J COMPUT AID MOL DES, V28, P35, DOI 10.1007/s10822-013-9704-0; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; Cully DF, 1996, J BIOL CHEM, V271, P20187, DOI 10.1074/jbc.271.33.20187; Dent JA, 2006, J MOL EVOL, V62, P523, DOI 10.1007/s00239-005-0018-2; Dermauw W, 2012, INSECT BIOCHEM MOLEC, V42, P455, DOI 10.1016/j.ibmb.2012.03.002; Eguchi Y, 2006, INSECT MOL BIOL, V15, P773, DOI 10.1111/j.1365-2583.2006.00680.x; Elliott KJ, 1996, J MOL NEUROSCI, V7, P217, DOI 10.1007/BF02736842; Erkkila BE, 2008, BIOPHYS J, V94, P4299, DOI 10.1529/biophysj.107.118455; Fabian-Fine R, 2002, MICROSC RES TECHNIQ, V58, P283, DOI 10.1002/jemt.10137; Fabian-Fine R, 2015, CELL TISSUE RES; Ffrench-Constant RH, 2000, ANNU REV ENTOMOL, V45, P449, DOI 10.1146/annurev.ento.45.1.449; FFRENCHCONSTANT RH, 1993, NATURE, V363, P449, DOI 10.1038/363449a0; Foelix R., 2011, BIOL SPIDERS, V3; French AS, 2014, GENE, V539, P203, DOI 10.1016/j.gene.2014.01.079; French Andrew S, 2012, BMC Res Notes, V5, P673, DOI 10.1186/1756-0500-5-673; French AS, 2002, J COMP PHYSIOL A, V188, P739, DOI 10.1007/s00359-002-0363-1; Gisselmann G, 2004, BRIT J PHARMACOL, V142, P409, DOI 10.1038/sj.bjp.0705818; Gisselmann G, 2002, NAT NEUROSCI, V5, P11, DOI 10.1038/nn787; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; HENIKOFF S, 1993, PROTEINS, V17, P49, DOI 10.1002/prot.340170108; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Hope M, 2010, J ECON ENTOMOL, V103, P1355, DOI 10.1603/EC09267; Hosie AM, 2001, NEUROSCIENCE, V102, P709, DOI 10.1016/S0306-4522(00)00483-8; Jones AK, 2010, HEREDITY, V104, P247, DOI 10.1038/hdy.2009.97; Jones AK, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-327; Jones Andrew K., 2006, Invertebrate Neuroscience, V6, P123, DOI 10.1007/s10158-006-0026-y; Jones Andrew K., 2008, Invertebrate Neuroscience, V8, P41, DOI 10.1007/s10158-008-0068-4; Kaczanowski S, 2010, THEOR CHEM ACC, V125, P643, DOI 10.1007/s00214-009-0656-3; Karlin A., 2001, Pharmacogenomics Journal, V1, P221; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kehoe J, 2009, J MOL EVOL, V69, P125, DOI 10.1007/s00239-009-9256-z; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; Knipple DC, 2010, PESTIC BIOCHEM PHYS, V97, P140, DOI 10.1016/j.pestbp.2009.09.002; Lansdell SJ, 2000, NEUROPHARMACOLOGY, V39, P2604, DOI 10.1016/S0028-3908(00)00111-8; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lees K, 2014, INT J PARASITOL, V44, P75, DOI 10.1016/j.ijpara.2013.11.002; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Ludmerer SW, 2002, BIOCHEMISTRY-US, V41, P6548, DOI 10.1021/bi015920o; Lummis SCR, 2012, ACS CHEM NEUROSCI, V3, P186, DOI 10.1021/cn200103n; Lummis SCR, 2011, J NEUROSCI, V31, P12371, DOI 10.1523/JNEUROSCI.1610-11.2011; Lynagh T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08558; Lynagh T, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00060; Lynagh T, 2010, INT J PARASITOL, V40, P1477, DOI 10.1016/j.ijpara.2010.07.010; McCormack T, 2010, BIOCHEMISTRY-US, V49, P2279, DOI 10.1021/bi902023y; McGonigle I, 2010, BIOCHEMISTRY-US, V49, P2897, DOI 10.1021/bi901698c; McGregor AP, 2008, BIOESSAYS, V30, P487, DOI 10.1002/bies.20744; Meng XK, 2015, NEUROSCI LETT, V584, P123, DOI 10.1016/j.neulet.2014.10.013; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Mounsey Kate E., 2007, Invertebrate Neuroscience, V7, P149, DOI 10.1007/s10158-007-0050-6; Muhire BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108277; Nakao T, 2015, PESTIC BIOCHEM PHYS, V121, P39, DOI 10.1016/j.pestbp.2014.09.010; Olsen RW, 2014, ALCOHOL CLIN EXP RES, V38, P595, DOI 10.1111/acer.12283; Ozoe Y, 2013, ADV INSECT PHYSIOL, V44, P211, DOI 10.1016/B978-0-12-394389-7.00004-1; Ozoe Y, 2010, BIOCHEM BIOPH RES CO, V391, P744, DOI 10.1016/j.bbrc.2009.11.131; Panek I, 2005, EUR J NEUROSCI, V22, P636, DOI 10.1111/j.1460-9568.2005.04258.x; Panek I, 2002, EUR J NEUROSCI, V16, P96, DOI 10.1046/j.1460-9568.2002.02065.x; Pantazis A, 2008, J NEUROSCI, V28, P7250, DOI 10.1523/JNEUROSCI.1654-08.2008; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Pfeiffer K, 2009, J NEUROPHYSIOL, V101, P54, DOI 10.1152/jn.91020.2008; Pierleoni A, 2011, NUCLEIC ACIDS RES, V39, pW375, DOI 10.1093/nar/gkr282; Rayes D, 2009, J NEUROSCI, V29, P6022, DOI 10.1523/JNEUROSCI.0627-09.2009; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sanggaard KW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4765; Saur M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043685; Schnizler K, 2005, J BIOL CHEM, V280, P16254, DOI 10.1074/jbc.M411759200; Shan Q, 2001, J NEUROCHEM, V76, P1109, DOI 10.1046/j.1471-4159.2001.00124.x; Shotkoski F., 1994, Insect Molecular Biology, V3, P283, DOI 10.1111/j.1365-2583.1994.tb00179.x; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Sixma TK, 2003, ANNU REV BIOPH BIOM, V32, P311, DOI 10.1146/annurev.biophys.32.110601.142536; Smart TG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009662; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thany SH, 2011, CURR NEUROPHARMACOL, V9, P706, DOI 10.2174/157015911798376343; Tomizawa M, 2011, J AGR FOOD CHEM, V59, P2825, DOI 10.1021/jf1019455; Tomizawa M, 2009, ACCOUNTS CHEM RES, V42, P260, DOI 10.1021/ar800131p; Torkkeli PH, 2012, EUR J NEUROSCI, V36, P3602, DOI 10.1111/j.1460-9568.2012.08275.x; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wolff C, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-15; Wolstenholme AJ, 2010, INVERTEBR NEUROSCI, V10, P5, DOI 10.1007/s10158-010-0105-y; Wotring VE, 2003, J PHYSIOL-LONDON, V548, P527, DOI 10.1113/jphysiol.2002.032045; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zemkova H, 2014, PHYSIOL RES, V63, pS215, DOI 10.33549/physiolres.932711; ZHANG HG, 1995, MOL PHARMACOL, V48, P835	95	11	11	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138068	10.1371/journal.pone.0138068	http://dx.doi.org/10.1371/journal.pone.0138068			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368804	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100214
J	Wohrle, J; Karakas, M; Trepte, U; Seeger, J; Gonska, B; Koenig, W; Rottbauer, W				Woehrle, Jochen; Karakas, Mahir; Trepte, Ulrike; Seeger, Julia; Gonska, Birgid; Koenig, Wolfgang; Rottbauer, Wolfgang			Midregional-proAtrial Natriuretic Peptide and High Sensitive Troponin T Strongly Predict Adverse Outcome in Patients Undergoing Percutaneous Repair of Mitral Valve Regurgitation	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; CARDIOVASCULAR EVENTS; PROGNOSTIC VALUE; RISK PREDICTION; OPERATIVE RISK; FAILURE; EXPRESSION; SURGERY; SYSTEM	Background It is not known whether biomarkers of hemodynamic stress, myocardial necrosis, and renal function might predict adverse outcome in patients undergoing percutaneous repair of severe mitral valve insufficiency. Thus, we aimed to assess the predictive value of various established and emerging biomarkers for major adverse cardiovascular events (MACE) in these patients. Methods Thirty-four patients with symptomatic severe mitral valve insufficiency with a mean STS-Score for mortality of 12.6% and a mean logistic EuroSCORE of 19.7% undergoing Mitra-Clip therapy were prospectively included in this study. Plasma concentrations of mid regional-proatrial natriuretic peptide (MR-proANP), Cystatin C, high-sensitive C-reactive protein (hsCRP), high-sensitive troponin T (hsTnT), N-terminal B-type natriuretic peptide (NT-proBNP), galectin-3, and soluble ST-2 (interleukin 1 receptor-like 1) were measured directly before procedure. MACE was defined as cardiovascular death and hospitalization for heart failure (HF). Results During a median follow-up of 211 days (interquartile range 133 to 333 days), 9 patients (26.5%) experienced MACE (death: 7 patients, rehospitalization for HF: 2 patients). Thirty day MACE-rate was 5.9% (death: 2 patients, no rehospitalization for HF). Baseline concentrations of hsTnT (Median 92.6 vs 25.2 ng/L), NT-proBNP (Median 11251 vs 1974 pg/mL) and MR-proANP (Median 755.6 vs 318.3 pmol/L, all p<0.001) were clearly higher in those experiencing an event vs event-free patients, while other clinical variables including STS-Score and logistic EuroSCORE did not differ significantly. In Kaplan-Meier analyses, NT-proBNP and in particular hsTnT and MR-proANP above the median discriminated between those experiencing an event vs event-free patients. This was further corroborated by C-statistics where areas under the ROC curve for prediction of MACE using the respective median values were 0.960 for MR-proANP, 0.907 for NT-proBNP, and 0.822 for hsTnT. Conclusions MR-proANP and hsTnT strongly predict cardiovascular death and rehospitalization for HF in patients undergoing percutaneous repair of mitral valve insufficiency. Both markers might be useful components in new scoring systems to better predict short-and potentially long-term mortality and morbidity after MitraClip procedure.	[Woehrle, Jochen; Karakas, Mahir; Trepte, Ulrike; Seeger, Julia; Gonska, Birgid; Koenig, Wolfgang; Rottbauer, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, D-89069 Ulm, Germany	Ulm University	Koenig, W (corresponding author), Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, D-89069 Ulm, Germany.	wolfgang.koenig@uniklinik-ulm.de		Koenig, Wolfgang/0000-0002-2064-9603				Arjamaa Olli, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P191; Bridgewater B, 1998, HEART, V79, P350, DOI 10.1136/hrt.79.4.350; Dieplinger B, 2014, CLIN CHEM, V60, P530, DOI 10.1373/clinchem.2013.209858; Giannitsis E, 2010, CLIN CHEM, V56, P254, DOI 10.1373/clinchem.2009.132654; Karakas M, 2014, CLIN CHEM, V60, P1441, DOI 10.1373/clinchem.2013.220202; Koenig W, 2005, CLIN CHEM, V51, P321, DOI 10.1373/clinchem.2004.041889; Koenig W, 2013, INT J CARDIOL, V168, P5126, DOI 10.1016/j.ijcard.2013.07.113; Koenig W, 2012, CLIN CHEM, V58, P1215, DOI 10.1373/clinchem.2012.183319; Mair J, 2008, CLIN CHEM LAB MED, V46, P1507, DOI 10.1515/CCLM.2008.295; Maisel A, 2010, J AM COLL CARDIOL, V55, P2062, DOI 10.1016/j.jacc.2010.02.025; Mauri L, 2013, J AM COLL CARDIOL, V62, P317, DOI 10.1016/j.jacc.2013.04.030; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Morgenthaler NG, 2004, CLIN CHEM, V50, P234, DOI 10.1373/clinchem.2003.021204; MUKOYAMA M, 1991, J CLIN INVEST, V87, P1402, DOI 10.1172/JCI115146; NARUSE M, 1994, HYPERTENSION, V23, pI231, DOI 10.1161/01.HYP.23.1_Suppl.I231; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Neuss M, 2013, EUR J HEART FAIL, V15, P786, DOI 10.1093/eurjhf/hfs214; Pleger ST, 2013, EUR J HEART FAIL, V15, P919, DOI 10.1093/eurjhf/hft046; Rothenbacher D, 2006, ARCH INTERN MED, V166, P2455, DOI 10.1001/archinte.166.22.2455; Sanchez-Mas J, 2014, INT J CARDIOL, V172, pE98, DOI 10.1016/j.ijcard.2013.12.129; TOTH M, 1994, AM J PHYSIOL, V266, pH1572, DOI 10.1152/ajpheart.1994.266.4.H1572; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Weinberg EO, 2002, CIRCULATION, V106, P2961, DOI 10.1161/01.CIR.0000038705.69871.D9; Xu-Cai YO, 2010, HEART, V96, P419, DOI 10.1136/hrt.2008.164145; YASUE H, 1994, CIRCULATION, V90, P195, DOI 10.1161/01.CIR.90.1.195; Zamora E, 2014, CLIN CHEM, V60, P481, DOI 10.1373/clinchem.2013.212951	26	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137464	10.1371/journal.pone.0137464	http://dx.doi.org/10.1371/journal.pone.0137464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368980	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100075
J	Gebre, M; Gebremariam, A; Abebe, TA				Gebre, Merihun; Gebremariam, Abebe; Abebe, Tsedach Alemu			Birth Preparedness and Complication Readiness among Pregnant Women in Duguna Fango District, Wolayta Zone, Ethiopia	PLOS ONE			English	Article								Background Birth Preparedness and Complication Readiness is a strategy to promote the timely use of skilled maternal and neonatal care, especially during childbirth, based on the theory that preparing for childbirth and being ready for complications reduces delays in obtaining this care. Objective This study was conducted to assess birth preparedness and complication readiness and its associated factors among pregnant woman in Duguna Fango District in Wolayta Zone, South Ethiopia. Methods A community based cross-sectional study was conducted in 2013, on a sample of 578 pregnant women. Data were collected using pre-tested and structured questionnaire. The collected data were analyzed by SPSS for windows version 16.0. The women were asked whether they followed the desired five steps while pregnant: identified a trained birth attendant, identified a health facility, arranged for transport, identified blood donor and saved money for emergency. Taking at least three steps was considered being well-prepared. Results Among 578 pregnant women only one tenth (10.7%) of pregnant women identified skilled provider. Only 103 (18.1%) arranged transportation to health facility. Two hundred forty eight (43.6%) identified health facility for delivery and/or for obstetric emergencies. more than half (54.1%) of families saved money for incurred costs of delivery and emergency if needed. only few 17(3%) identified potential blood donor in case of emergency. Two hundred sixty four (46.4%) of the respondents reported that they intended to deliver at home, and more than half (53.6) planned to deliver at health facilities. Overall less than one fifth 18.3% of pregnant women were well prepared. The adjusted multivariate model showed that significant predictors for being well-prepared were maternal availing of antenatal services (AOR = 2.95, 95% Cl: 1.62-5.37), being pregnant for the first time (AOR = 3.37, 95% Cl: 1.45-7.82), having knowledge of at least two danger signs during pregnancy (AOR = 2.81, 95% Cl: 1.69-4.67) and history of past obstetric complication (AOR = 2.98, 95% Cl: 1.35-6.58). Conclusion Birth preparedness practice in the study area was found to be low. Information, Education and Communication (IEC) on birth preparedness and complication readiness for young people should start early adolescence. The government officials and partners that are working in areas of maternal health should come up with strategies to improve birth preparedness at individual and community level.	[Gebre, Merihun] Duguna Fango Dist Hlth Off, Wolayta, Ethiopia; [Gebremariam, Abebe; Abebe, Tsedach Alemu] Jimma Univ, Coll Publ Hlth & Med Sci, Jimma, Ethiopia	Jimma University	Abebe, TA (corresponding author), Jimma Univ, Coll Publ Hlth & Med Sci, Jimma, Ethiopia.	tsedachalemu@yahoo.com			Jimma University, College of Public Health and Medical Sciences	Jimma University, College of Public Health and Medical Sciences	The authors would like to thank Jimma University, College of Public Health and Medical Sciences, for financial support in undertaking this research.	Agarwal S, 2010, J HEALTH POPUL NUTR, V28, P383; [Anonymous], 2013, DUGUNA FANGO D UNPUB; [Anonymous], 2013, WOLAYTA ZONAL UNPUB; Anya Samuel E, 2008, BMC Pregnancy Childbirth, V8, P9, DOI 10.1186/1471-2393-8-9; Hailu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021432; Hiluf M, 2007, ETHIOP J HEALTH DEV, V22, P14; Johns Hopkins Bloomberg School of Public Health Center for Communication Programs Family Care International Maternal and Neonatal Health, 2004, MON BIRTH PREP COMPL; Kabakyenga JK, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-33; McPherson RA, 2006, J HEALTH POPUL NUTR, V24, P479; Measure communication, 2000, MAK PREGN CHILDB SAF; Mutiso S M, 2008, East Afr Med J, V85, P275; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; The White Ribbon Alliance for Safe Motherhood/India, 2002, WHIT RIBB ALL SAF MO; USAID SCA MOH UKaid UNFPA UNICEF EHNRI CDC., 2012, 5TH DEM HLTH SURV 20; Wang W, 2011, LEVELS TRENDS USE MA; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990	16	32	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137570	10.1371/journal.pone.0137570	http://dx.doi.org/10.1371/journal.pone.0137570			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379231	Green Published, gold, Green Submitted			2022-12-27	WOS:000361769400018
J	Hassan, M; Shamas, M; Khalil, M; El Falou, W; Wendling, F				Hassan, Mahmoud; Shamas, Mohamad; Khalil, Mohamad; El Falou, Wassim; Wendling, Fabrice			EEGNET: An Open Source Tool for Analyzing and Visualizing M/EEG Connectome	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; RICH-CLUB ORGANIZATION; SCALE BRAIN NETWORKS; SMALL-WORLD NETWORKS; FUNCTIONAL CONNECTIVITY; CORTICAL NETWORKS; MATLAB TOOLBOX; MEG; DYNAMICS; SYNCHRONIZATION	The brain is a large-scale complex network often referred to as the "connectome". Exploring the dynamic behavior of the connectome is a challenging issue as both excellent time and space resolution is required. In this context Magneto/Electroencephalography (M/EEG) are effective neuroimaging techniques allowing for analysis of the dynamics of functional brain networks at scalp level and/or at reconstructed sources. However, a tool that can cover all the processing steps of identifying brain networks from M/EEG data is still missing. In this paper, we report a novel software package, called EEGNET, running under MATLAB (Math works, inc), and allowing for analysis and visualization of functional brain networks from M/EEG recordings. EEGNET is developed to analyze networks either at the level of scalp electrodes or at the level of reconstructed cortical sources. It includes i) Basic steps in preprocessing M/EEG signals, ii) the solution of the inverse problem to localize /reconstruct the cortical sources, iii) the computation of functional connectivity among signals collected at surface electrodes or/and time courses of reconstructed sources and iv) the computation of the network measures based on graph theory analysis. EEGNET is the unique tool that combines the M/EEG functional connectivity analysis and the computation of network measures derived from the graph theory. The first version of EEGNET is easy to use, flexible and user friendly. EEGNET is an open source tool and can be freely downloaded from this webpage: https://sites.google.com/site/eegnetworks/.	[Hassan, Mahmoud; Shamas, Mohamad; Wendling, Fabrice] INSERM, U1099, Rennes, France; [Hassan, Mahmoud; Shamas, Mohamad; Wendling, Fabrice] Univ Rennes 1, LTSI, F-35014 Rennes, France; [Shamas, Mohamad; Khalil, Mohamad; El Falou, Wassim] Lebanese Univ, AZM Ctr Biotechnol Res & Its Applicat, Tripoli, Libya	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Hassan, M (corresponding author), INSERM, U1099, Rennes, France.	mahmoud.hassan@univ-rennes1.fr	Wendling, Fabrice/F-8924-2013; WENDLING, Fabrice/P-9574-2019; Hassan, Mahmoud/AAF-4519-2019	WENDLING, Fabrice/0000-0003-2428-9665; Hassan, Mahmoud/0000-0003-0307-5086; Kahlil, Mohamad/0000-0002-9814-1949; Shamas, Mohamad/0000-0001-7564-0932	AZM and SAADE Association (Tripoli, Lebanon); Rennes University Hospital;  [ANR-10-LABX-07-01]	AZM and SAADE Association (Tripoli, Lebanon); Rennes University Hospital; 	This work was supported by AZM and SAADE Association (Tripoli, Lebanon) and the Rennes University Hospital (COREC Project named conneXion, 2012-14). The work has also received a French government support granted to the CominLabs excellence laboratory and managed by the National Research Agency in the "Investing for the Future" program under reference ANR-10-LABX-07-01.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Amblard U, 2004, IEEE T BIO-MED ENG, V51, P427, DOI 10.1109/TBME.2003.820999; BARLOW JS, 1954, ELECTROEN CLIN NEURO, V6, P321, DOI 10.1016/0013-4694(54)90036-X; Barnes GR, 2004, HUM BRAIN MAPP, V23, P120, DOI 10.1002/hbm.20047; Bartolomei F, 2006, ANN NEUROL, V59, P128, DOI 10.1002/ana.20710; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Becker H, 2014, NEUROIMAGE, V96, P143, DOI 10.1016/j.neuroimage.2014.03.043; BRAZIER MAB, 1952, ELECTROEN CLIN NEURO, V4, P201, DOI 10.1016/0013-4694(52)90010-2; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Brunet D, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/813870; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Caparos M, 2006, CLIN NEUROPHYSIOL, V117, P2414, DOI 10.1016/j.clinph.2006.07.305; Chowdhury RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055969; Daducci A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048121; Dai YK, 2012, BRAIN TOPOGR, V25, P157, DOI 10.1007/s10548-011-0211-0; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; ENGEL AK, 1991, SCIENCE, V252, P1177, DOI 10.1126/science.252.5009.1177; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fornito A, 2015, NAT REV NEUROSCI, V16, P159, DOI 10.1038/nrn3901; Gerhard Stephan, 2011, Front Neuroinform, V5, P3, DOI 10.3389/fninf.2011.00003; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Gramfort A, 2014, NEUROIMAGE, V86, P446, DOI 10.1016/j.neuroimage.2013.10.027; Gramfort A, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-45; Guye M, 2010, MAGN RESON MATER PHY, V23, P409, DOI 10.1007/s10334-010-0205-z; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Hassan M, 2010, IRBM, V31, P182, DOI 10.1016/j.irbm.2009.12.004; Hassan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105041; He B, 2011, IEEE T BIO-MED ENG, V58, P1918, DOI 10.1109/TBME.2011.2139210; He B, 2011, J NEUROSCI METH, V195, P261, DOI 10.1016/j.jneumeth.2010.11.015; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; Jung TP, 1998, ADV NEUR IN, V10, P894; Kruschwitz JD, 2015, J NEUROSCI METH, V245, P107, DOI 10.1016/j.jneumeth.2015.02.021; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; LaPlante RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113838; Li XL, 2007, J NEUROSCI METH, V160, P178, DOI 10.1016/j.jneumeth.2006.08.006; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Lu YF, 2012, CLIN NEUROPHYSIOL, V123, P1275, DOI 10.1016/j.clinph.2011.11.007; Mallio CA, 2015, CNS NEUROSCI THER, V21, P837, DOI 10.1111/cns.12397; MARS NJI, 1983, ELECTROEN CLIN NEURO, V56, P194, DOI 10.1016/0013-4694(83)90074-3; Martinovic J, 2009, J COGNITIVE NEUROSCI, V21, P42, DOI 10.1162/jocn.2009.21004; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Mheich A, 2015, J NEUROSCI METH, V242, P77, DOI 10.1016/j.jneumeth.2015.01.002; Mheich A, 2015, IFMBE PROC, V45, P934, DOI 10.1007/978-3-319-11128-5_232; Muller MM, 2001, VIS COGN, V8, P579, DOI 10.1080/13506280143000133; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; PIJN JP, 1993, BASIC MECHANISMS OF THE EEG, P41; Ponten SC, 2007, CLIN NEUROPHYSIOL, V118, P918, DOI 10.1016/j.clinph.2006.12.002; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Scherg M, 1993, Brain Topogr, V5, P419, DOI 10.1007/BF01128700; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Tomasi D, 2012, MOL PSYCHIATR, V17, P549, DOI 10.1038/mp.2011.81; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; van den Heuvel MP, 2013, JAMA PSYCHIAT, V70, P783, DOI 10.1001/jamapsychiatry.2013.1328; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Wendling F, 2001, CLIN NEUROPHYSIOL, V112, P1201, DOI 10.1016/S1388-2457(01)00547-8; Wendling F, 2009, J NEUROSCI METH, V183, P9, DOI 10.1016/j.jneumeth.2009.04.021; Wilke C, 2011, EPILEPSIA, V52, P84, DOI 10.1111/j.1528-1167.2010.02785.x; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223; Zhou DL, 2009, NEUROIMAGE, V47, P1590, DOI 10.1016/j.neuroimage.2009.05.089	74	39	39	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138297	10.1371/journal.pone.0138297	http://dx.doi.org/10.1371/journal.pone.0138297			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379232	Green Published, gold, Green Submitted			2022-12-27	WOS:000361769400081
J	Wang, H; Sethi, G; Loke, WK; Sim, MK				Wang, Hong; Sethi, Gautam; Loke, Weng-Keong; Sim, Meng-Kwoon			Des-Aspartate-Angiotensin I Attenuates Mortality of Mice Exposed to Gamma Radiation via a Novel Mechanism of Action	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; PROSTAGLANDIN-E SYNTHASE; STEM-CELL SURVIVAL; RECEPTOR; INFLAMMATION; EXPRESSION; INJURY; ENZYME; CYCLOOXYGENASE-1; IDENTIFICATION	ACE inhibitors and ARBs (angiotensin receptor blockers) have been shown to attenuate radiation injuries in animal models of lethal gamma irradiation. These two classes of drug act by curtailing the actions of angiotensin II-linked inflammatory pathways that are up-regulated during gamma radiation in organ systems such as the brain, lung, kidney, and bone marrow. ACE inhibitors inhibit ACE and attenuate the formation of angiotensin II from angiotensin I; ARBs block the angiotensin AT(1) receptor and attenuate the actions of angiotensin II that are elicited through the receptor. DAA-I (des-aspartate-angiotensin I), an orally active angiotensin peptide, also attenuates the deleterious actions of angiotensin II. It acts as an agonist on the angiotensin AT(1) receptor and elicits responses that oppose those of angiotensn II. Thus, DAA-I was investigated for its anticipated radioprotection in gamma irradiated mice. DAA-I administered orally at 800 nmole/kg/day for 30 days post exposure (6.4 Gy) attenuated the death of mice during the 30-day period. The attenuation was blocked by losartan (50 nmole/kg/day, i.p.) that was administered sequential to DAA-I administration. This shows that the radioprotection was mediated via the angiotensin AT(1) receptor. Furthermore, the radioprotection correlated to an increase in circulating PGE(2) of surviving animals, and this suggests that PGE(2) is involved in the radioprotection in DAA-I-treated mice. At the hematopoietic level, DAA-I significantly improved two syndromes of myelosuppression (leucopenia and lymphocytopenia), and mice pre-treated with DAA-I prior to gamma irradiation showed significant improvement in the four myelodysplastic syndromes that were investigated, namely leucopenia, lymphocytopenia, monocytopenia and thrombocytopenia. Based on the known ability of PGE(2) to attenuate the loss of functional hematopoietic stem and progenitor cells in radiation injury, we hypothesize that PGE(2) mediated the action of DAA-I. DAA-I completely attenuated the increase in circulating level of two inflammatory cytokines, TNF alpha and IL-6, in irradiated mice; and this shows that DAA-I exerted additional anti-inflammatory actions, which could also have contributed to its radioprotection. These findings show that DAA-I acts via a novel mechanism of action on the angiotensin AT(1) receptor to specifically release PGE(2), which mediates radioprotection in the gamma irradiated mice.	[Wang, Hong; Sethi, Gautam; Sim, Meng-Kwoon] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore; [Loke, Weng-Keong] DSO Natl Labs, Def & Environm Res Inst, Agent Diagnost & Therapeut Lab, Singapore, Singapore	National University of Singapore	Sim, MK (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Block MD11,10 Med Dr, Singapore 117595, Singapore.	phcsimmk@nus.edu.sg	Sethi, Gautam/F-2372-2011	Sethi, Gautam/0000-0002-8677-8475	Defence Innovative Research Programme (DIRP); Defence Science Technology Agency (Singapore); National University of Singapore [MINDEF-NUS-DIRP/2011/01]	Defence Innovative Research Programme (DIRP); Defence Science Technology Agency (Singapore); National University of Singapore(National University of Singapore)	The research was supported by a grant from the Defence Innovative Research Programme (DIRP) that was co-funded by Defence Science Technology Agency (Singapore) and National University of Singapore (MINDEF-NUS-DIRP/2011/01).	Booth C, 2012, HEALTH PHYS, V103, P383, DOI 10.1097/HP.0b013e318266ee13; Charrier S, 2004, BLOOD, V104, P978, DOI 10.1182/blood-2003-11-3828; Cohen EP, 2010, CURR DRUG TARGETS, V11, P1423; Cohn SM, 1997, J CLIN INVEST, V99, P1367, DOI 10.1172/JCI119296; Das U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097599; Davis TA, 2010, EXP HEMATOL, V38, P270, DOI 10.1016/j.exphem.2010.01.004; Fraser CC, 2008, INT REV IMMUNOL, V27, P320, DOI 10.1080/08830180802262765; Hara S, 2010, BIOCHIMIE, V92, P651, DOI 10.1016/j.biochi.2010.02.007; Houchen CW, 2000, AM J PHYSIOL-GASTR L, V279, pG858, DOI 10.1152/ajpgi.2000.279.5.G858; Houchen CW, 2003, AM J PHYSIOL-GASTR L, V284, pG490, DOI 10.1152/ajpgi.00240.2002; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; KRAAN TCTMV, 1995, J EXP MED, V181, P775, DOI 10.1084/jem.181.2.775; Kwoon SM, 2004, REGUL PEPTIDES, V117, P213, DOI 10.1016/j.regpep.2003.10.030; Mirzoeva S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101161; Mishra S, 2016, ENVIRON TOXICOL, V31, P478, DOI 10.1002/tox.22061; Molteni A, 2007, CURR PHARM DESIGN, V13, P1307, DOI 10.2174/138161207780618777; Moore ED, 2014, RADIAT RES, V181, P21, DOI 10.1667/RR13475.1; Moulder JE, 2011, RADIAT RES, V175, P29, DOI 10.1667/RR2400.1; Murakami M, 2006, CURR PHARM DESIGN, V12, P943, DOI 10.2174/138161206776055912; Ng ETL, 2011, J APPL TOXICOL, V31, P568, DOI 10.1002/jat.1599; Noguchi K, 2000, ORAL MICROBIOL IMMUN, V15, P299, DOI 10.1034/j.1399-302x.2000.150505.x; Porter RL, 2013, STEM CELLS, V31, P372, DOI 10.1002/stem.1286; Rodgers KE, 2002, CANCER CHEMOTH PHARM, V49, P403, DOI 10.1007/s00280-002-0434-6; Rosen EM, 2015, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00381; Sim MK, 2007, ENDOCRINOLOGY, V148, P5925, DOI 10.1210/en.2007-0606; Sim MK, 2015, EUR J PHARMACOL, V760, P36, DOI 10.1016/j.ejphar.2015.04.004; Sim MK, 1998, INT J CARDIOL, V63, P223, DOI 10.1016/S0167-5273(97)00324-0; Sim MK, 1996, BRIT J PHARMACOL, V117, P1504, DOI 10.1111/j.1476-5381.1996.tb15313.x; Sim MK, 2009, United States Patent No. US, Patent No. [7553,928, 7553928, US7,553,928B2]; Sim MK, 2013, United States Patent Application Publication, Patent No. [2013/0095,082 A1, 20130095082]; Sinha M, 2012, FREE RADICAL RES, V46, P842, DOI 10.3109/10715762.2012.684245; Sinha M, 2011, J MED FOOD, V14, P1167, DOI 10.1089/jmf.2010.1506; Takahashi HK, 2002, J IMMUNOL, V168, P4446, DOI 10.4049/jimmunol.168.9.4446; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; Wen Q, 2004, REGUL PEPTIDES, V120, P149, DOI 10.1016/j.regpep.2004.03.003; Wen Q, 2011, EUR J PHARMACOL, V658, P193, DOI 10.1016/j.ejphar.2011.02.014; Williams JP, 2010, RADIAT RES, V173, P557, DOI 10.1667/RR1880.1; Wong YC, 2011, BIOCHEM PHARMACOL, V82, P1198, DOI 10.1016/j.bcp.2011.07.080; Zhao WL, 2009, CURR MED CHEM, V16, P130, DOI 10.2174/092986709787002790	39	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138009	10.1371/journal.pone.0138009	http://dx.doi.org/10.1371/journal.pone.0138009			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378927	Green Submitted, gold, Green Published			2022-12-27	WOS:000361769400043
J	Athey, TBT; Auger, JP; Teatero, S; Dumesnil, A; Takamatsu, D; Wasserscheid, J; Dewar, K; Gottschalk, M; Fittipaldi, N				Athey, Taryn B. T.; Auger, Jean-Philippe; Teatero, Sarah; Dumesnil, Audrey; Takamatsu, Daisuke; Wasserscheid, Jessica; Dewar, Ken; Gottschalk, Marcelo; Fittipaldi, Nahuel			Complex Population Structure and Virulence Differences among Serotype 2 Streptococcus suis Strains Belonging to Sequence Type 28	PLOS ONE			English	Article							MURAMIDASE-RELEASED PROTEIN; EXTRACELLULAR PROTEIN; RECOMBINATION EVENTS; DISEASED PIGS; MOUSE MODEL; PATHOGEN; GENOME; IDENTIFICATION; RESISTANCE; ALIGNMENT	Streptococcus suis is a major swine pathogen and a zoonotic agent. Serotype 2 strains are the most frequently associated with disease. However, not all serotype 2 lineages are considered virulent. Indeed, sequence type (ST) 28 serotype 2 S. suis strains have been described as a homogeneous group of low virulence. However, ST28 strains are often isolated from diseased swine in some countries, and at least four human ST28 cases have been reported. Here, we used whole-genome sequencing and animal infection models to test the hypothesis that the ST28 lineage comprises strains of different genetic backgrounds and different virulence. We used 50 S. suis ST28 strains isolated in Canada, the United States and Japan from diseased pigs, and one ST28 strain from a human case isolated in Thailand. We report a complex population structure among the 51 ST28 strains. Diversity resulted from variable gene content, recombination events and numerous genome-wide polymorphisms not attributable to recombination. Phylogenetic analysis using core genome single-nucleotide polymorphisms revealed four discrete clades with strong geographic structure, and a fifth clade formed by US, Thai and Japanese strains. When tested in experimental animal models, strains from this latter clade were significantly more virulent than a Canadian ST28 reference strain, and a closely related Canadian strain. Our results highlight the limitations of MLST for both phylogenetic analysis and virulence prediction and raise concerns about the possible emergence of ST28 strains in human clinical cases.	[Athey, Taryn B. T.; Teatero, Sarah; Fittipaldi, Nahuel] Publ Hlth Ontario, Toronto, ON, Canada; [Auger, Jean-Philippe; Dumesnil, Audrey; Gottschalk, Marcelo] Univ Montreal, Fac Med Vet, Grp Rech Malad Infect Porc, St Hyacinthe, PQ J2S 7C6, Canada; [Takamatsu, Daisuke] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Bacterial & Parasit Dis Res Div, Tsukuba, Ibaraki, Japan; [Takamatsu, Daisuke] Gifu Univ, United Grad Sch Vet Sci, Gifu, Japan; [Wasserscheid, Jessica; Dewar, Ken] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Wasserscheid, Jessica; Dewar, Ken] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Fittipaldi, Nahuel] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON, Canada	Universite de Montreal; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Gifu University; McGill University; University of Toronto	Fittipaldi, N (corresponding author), Publ Hlth Ontario, Toronto, ON, Canada.	nahuel.fittipaldi@oahpp.ca	Gottschalk, Marcelo/I-8116-2012	Fittipaldi, Nahuel/0000-0001-9553-3798	Public Health Ontario [PIF 2014-005]; Natural Sciences and Engineering Research Council of Canada [RPGIN-2015-04435]	Public Health Ontario; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported in part by Public Health Ontario through internal grant PIF 2014-005 to NF and by grants from the Natural Sciences and Engineering Research Council of Canada (RPGIN-2015-04435) to MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander LEC, 2010, J MOL MED, V88, P371, DOI 10.1007/s00109-009-0566-9; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chang B, 2006, JPN J INFECT DIS, V59, P397; Chen C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000315; Chen L, 2013, J VET MED SCI, V75, P583, DOI 10.1292/jvms.12-0279; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; de Been M, 2013, GENOME BIOL EVOL, V5, P1524, DOI 10.1093/gbe/evt111; Dominguez-Punaro MC, 2007, J IMMUNOL, V179, P1842, DOI 10.4049/jimmunol.179.3.1842; Dominguez-Punaro MD, 2008, INFECT IMMUN, V76, P3901, DOI 10.1128/IAI.00350-08; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fittipaldi N, 2008, MOL MICROBIOL, V70, P1120, DOI 10.1111/j.1365-2958.2008.06463.x; Fittipaldi N, 2012, FUTURE MICROBIOL, V7, P259, DOI [10.2217/FMB.11.149, 10.2217/fmb.11.149]; Fittipaldi N, 2011, EMERG INFECT DIS, V17, P2239, DOI 10.3201/eid1712.110609; GOTTSCHALK M, 1989, J CLIN MICROBIOL, V27, P2633, DOI 10.1128/JCM.27.12.2633-2636.1989; Gottschalk M., 2011, DISEASES OF SWINE IN; Gottschalk M, 2013, VET MICROBIOL, V162, P819, DOI 10.1016/j.vetmic.2012.10.028; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; GOTTSCHALK MG, 1995, MICROBIOL-SGM, V141, P189, DOI 10.1099/00221287-141-1-189; Goyette-Desjardins G, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.45; Hanage WP, 2009, SCIENCE, V324, P1454, DOI 10.1126/science.1171908; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6; JACOBS AAC, 1994, INFECT IMMUN, V62, P1742, DOI 10.1128/IAI.62.5.1742-1748.1994; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kerdsin A, 2011, EMERG INFECT DIS, V17, P835, DOI 10.3201/eid1705.100754; King SJ, 2002, J CLIN MICROBIOL, V40, P3671, DOI 10.1128/JCM.40.10.3671-3680.2002; Li S, 2013, MICROB PATHOGENESIS, V63, P8, DOI 10.1016/j.micpath.2013.05.011; Marini E, 2015, VET MICROBIOL, V178, P99, DOI 10.1016/j.vetmic.2015.04.013; Marttinen P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-421; Mostowy R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004300; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Nusbaum C, 2009, NAT METHODS, V6, P67, DOI [10.1038/NMETH.1286, 10.1038/nmeth.1286]; Okura M, 2011, J BACTERIOL, V193, P822, DOI 10.1128/JB.01555-09; Onishi H, 2012, J VET MED SCI, V74, P1681, DOI 10.1292/jvms.12-0301; Palmieri C, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00235; QUESSY S, 1995, INFECT IMMUN, V63, P1975, DOI 10.1128/IAI.63.5.1975-1979.1995; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Seitz M, 2012, J MED MICROBIOL, V61, P1311, DOI 10.1099/jmm.0.043885-0; Silva LMG, 2006, VET MICROBIOL, V115, P117, DOI 10.1016/j.vetmic.2005.12.013; Smith HE, 1996, INFECT IMMUN, V64, P4409, DOI 10.1128/IAI.64.10.4409-4412.1996; SMITH HE, 1993, INFECT IMMUN, V61, P3318, DOI 10.1128/IAI.61.8.3318-3326.1993; SMITH HE, 1992, INFECT IMMUN, V60, P2361, DOI 10.1128/IAI.60.6.2361-2367.1992; Sonnhammer ELL, 2015, NUCLEIC ACIDS RES, V43, pD234, DOI 10.1093/nar/gku1203; Suankratay Chusana, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P868; Takamatsu D, 2008, EMERG INFECT DIS, V14, P181, DOI 10.3201/eid1401.070568; Takamatsu D, 2009, VET MICROBIOL, V138, P132, DOI 10.1016/j.vetmic.2009.02.013; Takeuchi D, 2014, J INFECT DIS, V209, P1509, DOI 10.1093/infdis/jit661; Tang YL, 2011, FOLIA MICROBIOL, V56, P541, DOI 10.1007/s12223-011-0077-2; Teatero S, 2014, J CLIN MICROBIOL, V52, P1441, DOI 10.1128/JCM.03554-13; Tritt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042304; Weinert LA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7740; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763; Wilson DJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002874; Yao XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09835; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; Zhang AD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-523; Zhang AD, 2011, VET MICROBIOL, V148, P436, DOI 10.1016/j.vetmic.2010.09.027; Zhang AD, 2010, VET MICROBIOL, V140, P171, DOI 10.1016/j.vetmic.2009.06.034	63	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137760	10.1371/journal.pone.0137760	http://dx.doi.org/10.1371/journal.pone.0137760			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375680	gold, Green Published, Green Submitted			2022-12-27	WOS:000361610200052
J	Gallego-Delgado, J; Baravian, C; Edagha, I; Ty, MC; Ruiz-Ortega, M; Xu, WY; Rodriguez, A				Gallego-Delgado, Julio; Baravian, Charlotte; Edagha, Innocent; Ty, Maureen C.; Ruiz-Ortega, Marta; Xu, Wenyue; Rodriguez, Ana			Angiotensin II Moderately Decreases Plasmodium Infection and Experimental Cerebral Malaria in Mice	PLOS ONE			English	Article							PATHOGENESIS; RECEPTOR; DISEASE	Angiotensin II, a peptide hormone that regulates blood pressure, has been proposed as a protective factor against cerebral malaria based on a genetic analysis. In vitro studies have documented an inhibitory effect of angiotensin II on Plasmodium growth, while studies using chemical inhibitors of angiotensin II in mice showed protection against experimental cerebral malaria but not major effects on parasite growth. To determine whether the level of angiotensin II affects Plasmodium growth and/or disease outcome in malaria, elevated levels of angiotensin II were induced in mice by intradermal implantation of osmotic mini-pumps providing constant release of this hormone. Mice were then infected with P. berghei and monitored for parasitemia and incidence of cerebral malaria. Mice infused with angiotensin II showed decreased parasitemia seven days after infection. The development of experimental cerebral malaria was delayed and a moderate increase in survival was observed in mice with elevated angiotensin II, as confirmed by decreased number of cerebral hemorrhages compared to controls. The results presented here show for the first time the effect of elevated levels of angiotensin II in an in vivo model of malaria. The decreased pathogenesis observed in mice complements a previous human genetic study, reinforcing the hypothesis of a beneficial effect of angiotensin II in malaria.	[Gallego-Delgado, Julio; Baravian, Charlotte; Edagha, Innocent; Ty, Maureen C.; Xu, Wenyue; Rodriguez, Ana] NYU, Sch Med, Dept Microbiol, Div Parasitol, New York, NY 10016 USA; [Ruiz-Ortega, Marta] Univ Autonoma Madrid, IIS Fdn Jimenez Diaz, Cellular Biol Renal Dis Lab, Madrid, Spain; [Xu, Wenyue] Third Mil Med Univ, Dept Pathogen Biol, Chongqing, Peoples R China	New York University; Autonomous University of Madrid; Fundacion Jimenez Diaz; Army Medical University	Rodriguez, A (corresponding author), NYU, Sch Med, Dept Microbiol, Div Parasitol, New York, NY 10016 USA.	Ana.Rodriguez@nyumc.org	Gallego-Delgado, Julio/AAI-6954-2021; Ruiz-Ortega, Marta/D-3584-2012; Edagha, Innocent/AAM-5344-2020; Rodríguez, Ana/GQR-0554-2022; Ortega, Marta Ruiz/AAN-2136-2020; ruiz-ortega, marta/D-3584-2012	Ruiz-Ortega, Marta/0000-0002-1495-6535; Ortega, Marta Ruiz/0000-0002-1495-6535; Rodriguez, Ana/0000-0002-0060-3405; Xu, Wenyue/0000-0003-3681-5052; Gallego-Delgado, Julio/0000-0002-8914-7740; ruiz-ortega, marta/0000-0002-1403-2690	FECYT (Fundacion Espanola para la Ciencia y la Tecnologia), mobility program, Ministry of Education of Spain; NIH [5T32AI007180-30]; China Scholarship Council; Dana Foundation Program in the Neuroimmunology of Brain Infections and Cancers Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007180] Funding Source: NIH RePORTER	FECYT (Fundacion Espanola para la Ciencia y la Tecnologia), mobility program, Ministry of Education of Spain; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); Dana Foundation Program in the Neuroimmunology of Brain Infections and Cancers Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by FECYT (Fundacion Espanola para la Ciencia y la Tecnologia), mobility program, Ministry of Education of Spain for JGD; NIH Training Grant 5T32AI007180-30 for MT; China Scholarship Council for WX. This work was supported by a Dana Foundation Program in the Neuroimmunology of Brain Infections and Cancers Grant to AR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMERANI SAMA, 1978, J PHYSIOL-LONDON, V278, P471, DOI 10.1113/jphysiol.1978.sp012318; Amani V, 1998, INFECT IMMUN, V66, P4093; Benigni A, 2010, EMBO MOL MED, V2, P247, DOI 10.1002/emmm.201000080; Cassis LA, 2004, REGUL PEPTIDES, V117, P107, DOI 10.1016/j.regpep.2003.09.008; Cassis LA, 2009, AM J PHYSIOL-HEART C, V296, pH1660, DOI 10.1152/ajpheart.00028.2009; de Souza JB, 2010, PARASITOLOGY, V137, P755, DOI 10.1017/S0031182009991715; Dhangadamajhi G, 2010, INFECT GENET EVOL, V10, P337, DOI 10.1016/j.meegid.2010.01.009; Faiz M A, 1998, Bangladesh Med Res Counc Bull, V24, P35; Gramaglia I, 2006, NAT MED, V12, P1417, DOI 10.1038/nm1499; Idro R, 2004, ANN TROP PAEDIATR, V24, P17, DOI 10.1179/027249304225013240; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Jain V, 2008, AM J TROP MED HYG, V79, P636; Maciel C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003296; Newbold C, 1997, AM J TROP MED HYG, V57, P389, DOI 10.4269/ajtmh.1997.57.389; Rasti N, 2004, FEMS IMMUNOL MED MIC, V41, P9, DOI 10.1016/j.femsim.2004.01.010; Saraiva VB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017174; Silva JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062999; Turner L, 2013, NATURE, V498, P502, DOI 10.1038/nature12216; Waknine-Grinberg JH, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-227; Wang Y, 2010, VASCULAR BIOL PLACEN; World Malaria Report WHO, WORLD MAL REP	21	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138191	10.1371/journal.pone.0138191	http://dx.doi.org/10.1371/journal.pone.0138191			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376293	Green Published, Green Submitted, gold			2022-12-27	WOS:000361610200083
J	Li, XW; Wang, P; Fail, J; Shelton, AM				Li, Xiao-Wei; Wang, Ping; Fail, Jozsef; Shelton, Anthony M.			Detection of Gene Flow from Sexual to Asexual Lineages in Thrips tabaci (Thysanoptera: Thripidae)	PLOS ONE			English	Article							VENTURIA-CANESCENS HYMENOPTERA; ONION THRIPS; LINDEMAN THYSANOPTERA; REPRODUCTIVE MODES; NEW-YORK; OBLIGATE PARTHENOGENESIS; POPULATIONS; MAINTENANCE; EVOLUTION; FIELDS	Populations of Thrips tabaci are known to have two sympatric but genetically isolated reproductive modes, arrhenotoky (sexual reproduction) and thelytoky (asexual reproduction). Herein, we report behavioral, ecological and genetic studies to determine whether there is gene flow between arrhenotokous and thelytokous T. tabaci. We did not detect significant preference by arrhenotokous males to mate with females of a particular reproductive mode, nor did we detect significant behavioral differences between arrhenotokous males mated with arrhenotokous or thelytokous females in their pre-copulation, copulation duration and mating frequency. Productive gene transfer resulting from the mating between the two modes was experimentally confirmed. Gene transfer from arrhenotokous T. tabaci to thelytokous T. tabaci was further validated by confirmation of the passage of the arrhenotokous male-originated nuclear gene (histone H3 gene) allele to the F-2 generation. These behavioral, ecological and genetic studies confirmed gene transfer from the sexual arrhenotokous mode to the asexual thelytokous mode of T. tabaci in the laboratory. These results demonstrate that asexual T. tabaci populations may acquire genetic variability from sexual populations, which could offset the long-term disadvantage of asexual reproduction.	[Li, Xiao-Wei; Wang, Ping; Shelton, Anthony M.] Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA; [Li, Xiao-Wei] Northwest A&F Univ, Minist Educ, Key Lab Plant Protect Resources & Pest Management, Yangling, Shaanxi, Peoples R China; [Fail, Jozsef] Corvinus Univ Budapest, Fac Hort Sci, Dept Entomol, Budapest, Hungary	Cornell University; Northwest A&F University - China; Corvinus University Budapest	Shelton, AM (corresponding author), Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA.	ams5@cornell.edu	Fail, Jozsef/A-5429-2011	Fail, Jozsef/0000-0001-8049-5776	China Scholarship Council (CSC); New York State Cabbage Research Association; Hungarian Scientific Research Fund (OTKA) [MB08A-81156, K 109594]	China Scholarship Council (CSC)(China Scholarship Council); New York State Cabbage Research Association; Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	XWL was supported by the China Scholarship Council (CSC) and New York State Cabbage Research Association. PW and AMS were supported by the New York State Cabbage Research Association. JF was supported by the Hungarian Scientific Research Fund (OTKA MB08A-81156 and K 109594) and New York State Cabbage Research Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi-Hagimori T, 2008, J ECON ENTOMOL, V101, P1510, DOI 10.1603/0022-0493(2008)101[1510:DOAMMT]2.0.CO;2; Allen JKM, 2005, PEST MANAG SCI, V61, P809, DOI 10.1002/ps.1068; Balloux F, 2003, GENETICS, V164, P1635; Bell G, 1982, MASTERPIECE NATURE E; Bengtsson BO, 2003, J EVOLUTION BIOL, V16, P189, DOI 10.1046/j.1420-9101.2003.00523.x; Brunner PC, 2004, HEREDITY, V93, P364, DOI 10.1038/sj.hdy.6800512; Butlin R, 2002, NAT REV GENET, V3, P311, DOI 10.1038/nrg749; Chatzivassiliou EK, 2002, PHYTOPATHOLOGY, V92, P603, DOI 10.1094/PHYTO.2002.92.6.603; Chatzivassiliou EK, 1999, PLANT PATHOL, V48, P700, DOI 10.1046/j.1365-3059.1999.00414.x; Copeland CS, 2010, FLA ENTOMOL, V93, P437, DOI 10.1653/024.093.0318; Corley LS, 1999, P ROY SOC B-BIOL SCI, V266, P471, DOI 10.1098/rspb.1999.0661; DAVIS DG, 1969, GENETICS, V61, P577; DAY WH, 1988, ENTOMOPHAGA, V33, P201, DOI 10.1007/BF02372655; Dedryver CA, 2013, HEREDITY, V110, P39, DOI 10.1038/hdy.2012.57; Diaz-Montano J, 2011, J ECON ENTOMOL, V104, P1, DOI 10.1603/EC10269; Dobzhansky T., 1951, COPEIA; Dorit RL, 2001, CURR PROTOC MOL BIOL, V15; Dres M, 2002, PHILOS T R SOC B, V357, P471, DOI 10.1098/rstb.2002.1059; Fekrat L., 2009, Journal of Entomological Society of Iran, V29, P11; Galimov Y, 2011, J EVOLUTION BIOL, V24, P1572, DOI 10.1111/j.1420-9101.2011.02288.x; Glover RH, 2010, MOL ECOL RESOUR, V10, P51, DOI 10.1111/j.1755-0998.2009.02723.x; Goday C, 2001, BIOESSAYS, V23, P242, DOI 10.1002/1521-1878(200103)23:3&lt;242::AID-BIES1034&gt;3.0.CO;2-P; Greeff JM, 1996, HEREDITAS, V124, P99, DOI 10.1111/j.1601-5223.1996.00099.x; Halkett F, 2008, MOL ECOL, V17, P2998, DOI 10.1111/j.1365-294X.2008.03798.x; Herron GA, 2008, AUST J ENTOMOL, V47, P361, DOI 10.1111/j.1440-6055.2008.00669.x; Hoffmann AA, 2008, P ROY SOC B-BIOL SCI, V275, P2473, DOI 10.1098/rspb.2008.0685; Hurst LD, 1996, TRENDS ECOL EVOL, V11, pA46; INNES DJ, 1988, EVOLUTION, V42, P1024, DOI 10.1111/j.1558-5646.1988.tb02521.x; Jacobson AL, 2013, INSECT MOL BIOL, V22, P12, DOI 10.1111/j.1365-2583.2012.01165.x; Jacobson AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054484; Judson OP, 1996, TRENDS ECOL EVOL, V11, pA41; Kobayashi K, 2013, SCI REP-UK, V3, DOI 10.1038/srep03286; Kobayashi K, 2012, J ECON ENTOMOL, V105, P555, DOI 10.1603/EC11320; Lewis T., 1973, THRIPS THEIR BIOL EC; Li XW, 2014, J ECON ENTOMOL, V107, P1526, DOI 10.1603/EC14070; LYNCH M, 1984, Q REV BIOL, V59, P257, DOI 10.1086/413902; Maynard S.J, 1978, EVOLUTION SEX; MORI L, 1980, GENETICS, V94, P663; Mound L. A, 1991, 1991 C THRIPS THYS I, P2; Nault BA, 2006, ENVIRON ENTOMOL, V35, P1264, DOI 10.1603/0046-225X(2006)35[1264:RMIOTT]2.0.CO;2; Nemetschke L, 2010, CURR BIOL, V20, P1687, DOI 10.1016/j.cub.2010.08.014; PARKER ED, 1979, AM ZOOL, V19, P753; Schneider MV, 2003, HEREDITY, V90, P260, DOI 10.1038/sj.hdy.6800245; Schneider MV, 2002, J EVOLUTION BIOL, V15, P191, DOI 10.1046/j.1420-9101.2002.00394.x; Shelton AM, 2006, J ECON ENTOMOL, V99, P1798, DOI 10.1603/0022-0493-99.5.1798; Shelton AM, 2003, J ECON ENTOMOL, V96, P1843, DOI 10.1603/0022-0493-96.6.1843; Sogo K, 2014, APPL ENTOMOL ZOOL; STOUTHAMER R, 1993, ENTOMOPHAGA, V38, P3, DOI 10.1007/BF02373133; Tedeschi R, 2001, PHYTOPARASITICA, V29, P37, DOI 10.1007/BF02981812; Toda S, 2007, APPL ENTOMOL ZOOL, V42, P309, DOI 10.1303/aez.2007.309; Westmore GC, 2013, HEREDITY, V111, P210, DOI 10.1038/hdy.2013.39; WIJKAMP I, 1995, PHYTOPATHOLOGY, V85, P1069, DOI 10.1094/Phyto-85-1069; Wrensch D. L., 1993, EVOLUTION DIVERSITY	53	12	17	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138353	10.1371/journal.pone.0138353	http://dx.doi.org/10.1371/journal.pone.0138353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375283	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000361610200100
J	Liu, F; Xia, WJ; Hu, JJ; Wang, YZ; Yang, F; Sun, SY; Zhang, J; Jiang, N; Wang, HJ; Tian, WD; Wang, X; Ma, D				Liu, Fei; Xia, Wenjun; Hu, Jiongjiong; Wang, Yingzhi; Yang, Fan; Sun, Shaoyang; Zhang, Jin; Jiang, Nan; Wang, Huijun; Tian, Weidong; Wang, Xu; Ma, Duan			Solute Carrier Family 26 Member a2 (slc26a2) Regulates Otic Development and Hair Cell Survival in Zebrafish	PLOS ONE			English	Article							TRANSPORTER DTDST GENE; GUILT-BY-ASSOCIATION; INNER-EAR; CHONDRODYSPLASIA PHENOTYPE; HEARING IMPAIRMENT; LATERAL-LINE; MUTATIONS; DISEASE; NETWORK; MOUSE	Hearing loss is one of the most prevalent human birth defects. Genetic factors contribute to the pathogenesis of deafness. It is estimated that one-third of deafness genes have already been identified. The current work is an attempt to find novel genes relevant to hearing loss using guilt-by-profiling and guilt-by-association bioinformatics analyses of approximately 80 known non-syndromic hereditary hearing loss (NSHL) genes. Among the 300 newly identified candidate deafness genes, slc26a2 were selected for functional studies in zebrafish. The slc26a2 gene was knocked down using an antisense morpholino (MO), and significant defects were observed in otolith patterns, semicircular canal morphology, and lateral neuromast distributions in morphants. Loss-of-function defects are caused primarily by apoptosis, and morphants are insensitive to sound stimulation and imbalanced swimming behaviours. Morphant defects were found to be partially rescued by co-injection of human SLC26A2 mRNA. All the results suggest that bioinformatics is capable of predicting new deafness genes and this showed slc26a2 is to be a critical otic gene whose dysfunction may induce hearing impairment.	[Liu, Fei; Wang, Yingzhi; Sun, Shaoyang; Zhang, Jin; Jiang, Nan; Wang, Xu; Ma, Duan] Fudan Univ, Sch Basic Med Sci, Key Lab Metab & Mol Med,Minist Educ,Inst Mat Sci, Collaborat Innovat Ctr Genet & Dev,Dept Biochem &, Shanghai 200032, Peoples R China; [Xia, Wenjun; Yang, Fan; Ma, Duan] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Hu, Jiongjiong] Tongji Univ, Shanghai East Hosp, Dept Otorhinolaryngol, Shanghai 200092, Peoples R China; [Wang, Huijun] Fudan Univ, Childrens Hosp, Shanghai 200032, Peoples R China; [Tian, Weidong] Fudan Univ, Sch Life Sci, Inst Biostat, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Tongji University; Fudan University; Fudan University	Wang, X (corresponding author), Fudan Univ, Sch Basic Med Sci, Key Lab Metab & Mol Med,Minist Educ,Inst Mat Sci, Collaborat Innovat Ctr Genet & Dev,Dept Biochem &, Shanghai 200032, Peoples R China.	wangxu2013@fudan.edu.cn; duanma@fudan.edu.cn	wang, hui/GRS-4730-2022; Ma, Duan/I-8330-2014	Wang, Xu/0000-0001-6920-0375	East Raising Sun Talents Program of Shanghai East Hospital, Tongji University [2013DFYY-2]; Foundation for Development of Science and Technology, Pudong new district, Shanghai [2013PKJ2013-Y18]; National Basic Research Program of China [2011CB504502]; Basic Key Program of Shanghai Scientific and Technology Committee [14DJ1400103]; Program of Shanghai Municipal Commission of Health and Family Planning [2013ZYJB0015]	East Raising Sun Talents Program of Shanghai East Hospital, Tongji University; Foundation for Development of Science and Technology, Pudong new district, Shanghai; National Basic Research Program of China(National Basic Research Program of China); Basic Key Program of Shanghai Scientific and Technology Committee; Program of Shanghai Municipal Commission of Health and Family Planning	This study was supported by the East Raising Sun Talents Program of Shanghai East Hospital, Tongji University (2013DFYY-2), the Foundation for Development of Science and Technology, Pudong new district, Shanghai (2013PKJ2013-Y18), National Basic Research Program of China (2011CB504502), Basic Key Program of Shanghai Scientific and Technology Committee (14DJ1400103) and Program of Shanghai Municipal Commission of Health and Family Planning (2013ZYJB0015).	Alper SL, 2013, MOL ASPECTS MED, V34, P494, DOI 10.1016/j.mam.2012.07.009; Aman A, 2011, DEV BIOL, V349, P470, DOI 10.1016/j.ydbio.2010.10.022; Amigo JD, 2009, BLOOD, V114, P4654, DOI 10.1182/blood-2008-12-189910; Bang PI, 2002, J NEUROSCI METH, V118, P177, DOI 10.1016/S0165-0270(02)00118-8; Bang PI, 2001, J COMP NEUROL, V438, P173, DOI 10.1002/cne.1308; Bever MM, 2002, DEV DYNAM, V223, P536, DOI 10.1002/dvdy.10062; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Feldman I, 2008, P NATL ACAD SCI USA, V105, P4323, DOI 10.1073/pnas.0701722105; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Forlino A, 2005, HUM MOL GENET, V14, P859, DOI 10.1093/hmg/ddi079; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Jiang LJ, 2014, P NATL ACAD SCI USA, V111, pE1383, DOI 10.1073/pnas.1402898111; Karniski LP, 2001, HUM MOL GENET, V10, P1485, DOI 10.1093/hmg/10.14.1485; Kim MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092984; Kobayashi T, 1997, BIOCHEM BIOPH RES CO, V238, P738, DOI 10.1006/bbrc.1997.7380; Kohashi T, 2008, J NEUROSCI, V28, P10641, DOI 10.1523/JNEUROSCI.1435-08.2008; Korf BR, 2013, JAMA-J AM MED ASSOC, V309, P1511, DOI 10.1001/jama.2013.3239; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Liu QW, 2014, DEV BIOL, V390, P93, DOI 10.1016/j.ydbio.2014.03.010; Liu TX, 2003, DEV CELL, V5, P903, DOI 10.1016/S1534-5807(03)00339-3; Mehra S, 2009, OTOLARYNG HEAD NECK, V140, P461, DOI 10.1016/j.otohns.2008.12.022; Meyer J, 2001, HEARING RES, V161, P10, DOI 10.1016/S0378-5955(01)00338-0; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; Nicolson T, 2005, ANNU REV GENET, V39, P9, DOI 10.1146/annurev.genet.39.073003.105049; O'Donoghue G, 2013, NEW ENGL J MED, V369, P1190, DOI 10.1056/NEJMp1310111; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; Parente V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053748; Park M, 2014, J BIOL CHEM, V289, P1993, DOI 10.1074/jbc.M113.503466; Pera A, 2008, P NATL ACAD SCI USA, V105, P18608, DOI 10.1073/pnas.0805831105; Rossi A, 2001, HUM MUTAT, V17, P159, DOI 10.1002/humu.1; Santos-Cortez RLP, 2013, AM J HUM GENET, V93, P132, DOI 10.1016/j.ajhg.2013.05.018; Seiler C, 2004, DEV BIOL, V272, P328, DOI 10.1016/j.ydbio.2004.05.004; Sotomayor M, 2012, NATURE, V492, P128, DOI 10.1038/nature11590; Streit A, 2004, DEV BIOL, V276, P1, DOI 10.1016/j.ydbio.2004.08.037; Tian WD, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s7; Valdivia LE, 2011, DEVELOPMENT, V138, P3931, DOI 10.1242/dev.062695; Wang XJ, 2012, NAT BIOTECHNOL, V30, P159, DOI 10.1038/nbt.2106; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; WATERMAN RE, 1984, ANAT REC, V210, P101, DOI 10.1002/ar.1092100113	39	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136832	10.1371/journal.pone.0136832	http://dx.doi.org/10.1371/journal.pone.0136832			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375458	Green Submitted, gold, Green Published			2022-12-27	WOS:000361610200024
J	Liu, XH; Qu, XH; Zheng, JW; Zhang, L				Liu, Xiaohan; Qu, Xinhua; Zheng, Jiawei; Zhang, Ling			Effectiveness and Safety of Oral Propranolol versus Other Treatments for Infantile Hemangiomas: A Meta-Analysis	PLOS ONE			English	Article							INTRALESIONAL CORTICOSTEROID-THERAPY; PULSED DYE-LASER; SUBGLOTTIC HEMANGIOMA; INITIAL-EXPERIENCE; NECK HEMANGIOMAS; CONTROLLED-TRIAL; TIMOLOL MALEATE; NDYAG LASER; EFFICACY; HEAD	Background Epidemiological studies evaluating treatments for infantile hemangiomas have produced inconsistent results. A meta-analysis of published data was conducted to investigate the effectiveness and safety of oral propranolol versus other treatments for infantile hemangiomas. Methods A meta-analysis was conducted based on literature (published from 1960 to December 1, 2014) found on the PubMed, EMBASE, and OVID search engines. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were estimated for the outcome measures. Heterogeneity, publication bias and subgroup analysis were performed. Results A total of 61 studies involving 5,130 participants met the inclusion criteria. Propranolol was found to be a more effective modality in treating IHs (ORs = 0.92; 95% CI, 0.89-0.95) and had fewer complications compared to the other treatments including systemic steroids (ORs = 0.68; 95% CI, 0.59-0.76); laser ablation (ORs = 0.55; 95% CI, 0.43-0.67); other beta-adrenergic blockers (ORs = 0.56; 95% CI, 0.50-0.61) and surgery (ORs = 0.55; 95% CI, 0.28-0.81). A subgroup analysis of propranolol showed that a dose of 2 mg/kg/day or more yielded better outcomes (ORs = 0.92; 95% CI, 0.88-0.95; ORs = 0.95; 95% CI, 0.89-1.00), and IHs that had not been previously treated had better responses to propranolol treatment (ORs = 0.95; 95% CI, 0.91-0.98). Conclusions The meta-analysis demonstrated that propranolol was more effective and safer than other therapies in treating IHs. It provides strong evidence for supporting the use of propranolol as a first-line therapy for IHs.	[Liu, Xiaohan; Zheng, Jiawei] Shanghai Jiao Tong Univ, Sch Med, Coll Stomatol, Shanghai 200030, Peoples R China; [Qu, Xinhua; Zhang, Ling] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Shanghai Key Lab Orthoped Implant, Shanghai 200030, Peoples R China; [Zheng, Jiawei] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Oral & Maxillofacial Surg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Qu, XH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Shanghai Key Lab Orthoped Implant, Shanghai 200030, Peoples R China.	xinhua_qu@126.com; davidzhengjw@sjtu.edu.cn	Qu, Xinhua/Q-3950-2016	Qu, Xinhua/0000-0002-8889-0890	National Natural Science Foundation of China [81271163, 81470755]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (81271163, 81470755).	Abarzua-Araya A, 2014, J AM ACAD DERMATOL, V70, P1045, DOI 10.1016/j.jaad.2014.01.905; Alcantara-Gonzalez J, 2013, ACTAS DERMO-SIFILOGR, V104, P504, DOI 10.1016/j.ad.2012.12.010; Blei F, 1999, INT PEDIAT, V14, P146; Buckmiller L, 2009, LARYNGOSCOPE, V119, P2051, DOI 10.1002/lary.20633; Buckmiller LM, 2010, LARYNGOSCOPE, V120, P676, DOI 10.1002/lary.20807; Chai Q, 2014, ANN PLAS SURG, V72, P169, DOI 10.1097/SAP.0b013e31821ee3a5; Chan H, 2013, PEDIATRICS, V131, pE1739, DOI 10.1542/peds.2012-3828; Chantharatanapiboon Wiratt, 2008, J Med Assoc Thai, V91 Suppl 3, pS90; Chatrath P, 2002, INT J PEDIATR OTORHI, V64, P143, DOI 10.1016/S0165-5876(02)00072-1; Chen MT, 2000, J PEDIATR SURG, V35, P420, DOI 10.1016/S0022-3468(00)90205-7; CHOWDRI NA, 1994, ANN PLAS SURG, V33, P46, DOI 10.1097/00000637-199407000-00009; Cushing SL, 2011, OTOLARYNG HEAD NECK, V144, P78, DOI 10.1177/0194599810390445; de Graaf M, 2013, J PLAST RECONSTR AES, V66, P1732, DOI 10.1016/j.bjps.2013.07.035; de Graaf M, 2011, J AM ACAD DERMATOL, V65, P320, DOI 10.1016/j.jaad.2010.06.048; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Frieden Ilona J, 2005, Pediatr Dermatol, V22, P383, DOI 10.1111/j.1525-1470.2005.00102.x; Fuchsmann C, 2011, ARCH OTOLARYNGOL, V137, P471, DOI 10.1001/archoto.2011.55; Georgountzou A, 2012, ACTA PAEDIATR, V101, pE469, DOI 10.1111/j.1651-2227.2012.02783.x; Greene AK, 2011, PLAST RECONSTR SURG, V128, P743, DOI 10.1097/PRS.0b013e3182221398; Hassan BA, 2014, DERMAT RES PRACT, V2014, DOI 10.1155/2014/541810; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hogeling M, 2011, PEDIATRICS, V128, pE259, DOI 10.1542/peds.2010-0029; Hunzeker CM, 2010, DERMATOL SURG, V36, P590, DOI 10.1111/j.1524-4725.2010.01511.x; Jalil Shazia, 2006, J Coll Physicians Surg Pak, V16, P662; Jin Yun-bo, 2011, Zhonghua Zheng Xing Wai Ke Za Zhi, V27, P170; Kaune KM, 2014, J DTSCH DERMATOL GES, V12, P473, DOI 10.1111/ddg.12354; Kulbersh J, 2011, ARCH FACIAL PLAST S, V13, P199, DOI 10.1001/archfacial.2011.23; KUSHNER BJ, 1979, ANN OPHTHALMOL, V11, P1005; Laranjo S, 2014, REV PORT CARDIOL, V33, P289, DOI 10.1016/j.repc.2013.10.018; Leaute-Labreze C, 2015, NEW ENGL J MED, V372, P735, DOI 10.1056/NEJMoa1404710; Leaute-Labreze C, 2008, NEW ENGL J MED, V358, P2649, DOI 10.1056/NEJMc0708819; Li DN, 2010, J COSMET LASER THER, V12, P145, DOI 10.3109/14764172.2010.487908; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liew SH, 2010, PLAST RECONSTR SURG, V126, P671, DOI [10.1097/PRS.0b013e3181de1a32, 10.1097/PRS.0b013e3181dela32]; Lou Y, 2014, BRIT J CLIN PHARMACO, V78, P44, DOI 10.1111/bcp.12235; Luo YQ, 2015, PEDIATR DERMATOL, V32, P151, DOI 10.1111/pde.12308; Lv MM, 2012, INT J PEDIATR OTORHI, V76, P574, DOI 10.1016/j.ijporl.2012.01.020; Ma XR, 2013, EUR J PEDIATR, V172, P653, DOI 10.1007/s00431-012-1928-9; Maturo S, 2010, INT J PEDIATR OTORHI, V74, P323, DOI 10.1016/j.ijporl.2009.12.008; Mazereeuw-Hautier J, 2010, J PEDIATR-US, V157, P340, DOI 10.1016/j.jpeds.2010.04.003; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; McSwiney E, 2014, EUR J PEDIATR, V173, P63, DOI 10.1007/s00431-013-2105-5; Meng J, 2012, WSPOLCZESNA ONKOL, V16, P432, DOI 10.5114/wo.2012.31774; Mistry N, 2010, J LARYNGOL OTOL, V124, P1329, DOI 10.1017/S002221511000068X; Moehrle M, 2013, PEDIATR DERMATOL, V30, P245, DOI 10.1111/j.1525-1470.2012.01723.x; NARCY P, 1985, INT J PEDIATR OTORHI, V9, P157, DOI 10.1016/S0165-5876(85)80016-1; Nguyen J, 2009, SEMIN OPHTHALMOL, V24, P178, DOI 10.1080/08820530902805602; Nieuwenhuis K, 2013, PEDIATR DERMATOL, V30, P64, DOI 10.1111/j.1525-1470.2012.01846.x; Oranje AP, 2011, DERMATOLOGY, V223, P330, DOI 10.1159/000334778; Pandey A, 2009, J PEDIATR SURG, V44, P688, DOI 10.1016/j.jpedsurg.2008.10.038; Park KH, 2014, J DERMATOL TREAT, P1; Peridis S, 2011, INT J PEDIATR OTORHI, V75, P455, DOI 10.1016/j.ijporl.2011.01.028; Pope E, 2007, PEDIATRICS, V119, pE1239, DOI 10.1542/peds.2006-2962; Prasetyono TOH, 2011, ANN PLAS SURG, V66, P98, DOI 10.1097/SAP.0b013e3181d49f52; Price CJ, 2011, ARCH DERMATOL, V147, P1371, DOI 10.1001/archdermatol.2011.203; Qu XH, 2014, J BONE MINER RES, V29, P202, DOI 10.1002/jbmr.2019; Qu XH, 2013, INT J CARDIOL, V166, P385, DOI 10.1016/j.ijcard.2011.10.114; Rossler J, 2012, J EUR ACAD DERMATOL, V26, P1173, DOI 10.1111/j.1468-3083.2011.04314.x; Rossler J, 2008, EUR J PEDIATR, V167, P813, DOI 10.1007/s00431-007-0561-5; Sadan N, 1996, J PEDIATR-US, V128, P141, DOI 10.1016/S0022-3476(96)70446-8; Sadykov RR, 2013, INT J ORAL MAX SURG, V42, P863, DOI 10.1016/j.ijom.2013.03.015; Sagi L, 2014, DERMATOLOGY, V228, P136, DOI 10.1159/000351557; Saint-Jean M, 2011, J AM ACAD DERMATOL, V64, P827, DOI 10.1016/j.jaad.2010.12.040; Sans V, 2009, PEDIATRICS, V124, pE423, DOI 10.1542/peds.2008-3458; SCHEEPERS JH, 1995, PLAST RECONSTR SURG, V95, P305, DOI 10.1097/00006534-199502000-00010; Schiestl C, 2011, EUR J PEDIATR, V170, P493, DOI 10.1007/s00431-010-1324-2; Schupp CJ, 2011, PEDIATR DERMATOL, V28, P640, DOI 10.1111/j.1525-1470.2011.01569.x; Semkova K, 2013, CLIN EXP DERMATOL, V38, P143, DOI 10.1111/j.1365-2230.2012.04425.x; Sharma VK, 2013, CAN J PLAST SURG, V21, P23, DOI 10.1177/229255031302100103; Sondhi V, 2013, J PEDIAT HEMATOL ONC, V35, P493, DOI 10.1097/MPH.0b013e3182a11658; Su WT, 2014, LASER SURG MED, V46, P173, DOI 10.1002/lsm.22221; Szychta P, 2014, PLAST RECONSTR SURG, V133, P852, DOI 10.1097/PRS.0000000000000007; Vercellino N, 2013, INT J DERMATOL, V52, P1140, DOI 10.1111/j.1365-4632.2012.05795.x; Watanabe S, 2009, J CRANIOFAC SURG, V20, P707, DOI 10.1097/SCS.0b013e318193d780; Xiao Q, 2013, PEDIATR SURG INT, V29, P575, DOI 10.1007/s00383-013-3283-y; Yu LJ, 2013, EXP THER MED, V6, P388, DOI 10.3892/etm.2013.1176; Zaher H, 2011, EUR J DERMATOL, V21, P558, DOI 10.1684/ejd.2011.1372; Zhou Q, 2010, ORAL SURG ORAL MED O, V109, P166, DOI 10.1016/j.tripleo.2009.10.026; Zvulunov A, 2011, PEDIATR DERMATOL, V28, P94, DOI 10.1111/j.1525-1470.2010.01379.x	79	18	21	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138100	10.1371/journal.pone.0138100	http://dx.doi.org/10.1371/journal.pone.0138100			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375455	gold, Green Published, Green Submitted			2022-12-27	WOS:000361610200076
J	Preibisch, C; Castrillon, JG; Buhrer, M; Riedl, V				Preibisch, Christine; Castrillon G, J. Gabriel; Buehrer, Martin; Riedl, Valentin			Evaluation of Multiband EPI Acquisitions for Resting State fMRI	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; PHYSIOLOGICAL NOISE; BRAIN ACTIVITY; WHOLE-BRAIN; FAST MRI; 3 T; ROBUST; OPTIMIZATION; RESOLUTION; IMAGES	Functional magnetic resonance imaging (fMRI) and particularly resting state fMRI (rs-fMRI) is widely used to investigate resting state brain networks (RSNs) on the systems level. Echo planar imaging (EPI) is the state-of-the-art imaging technique for most fMRI studies. Therefore, improvements of EPI might lead to increased sensitivity for a large amount of studies performed every day. A number of developments to shorten acquisition time have been recently proposed and the multiband technique, allowing the simultaneous acquisition of multiple slices yielding an equivalent reduction of measurement time, is the most promising among them. While the prospect to significantly reduce acquisition time by means of high multiband acceleration factors (M) appears tempting, signal quality parameters and the sensitivity to detect common RSNs with increasing M-factor have only been partially investigated up to now. In this study, we therefore acquired rs-fMRI data from 20 healthy volunteers to systematically investigate signal characteristics and sensitivity for brain network activity in datasets with increasing M-factor, M = 2 - 4. Combined with an inplane, sensitivity encoding (SENSE), acceleration factor, S = 2, we applied a maximal acceleration factor of 8 (S2xM4). Our results suggest that an M-factor of 2 (total acceleration of 4) only causes negligible SNR decrease but reveals common RSN with increased sensitivity and stability. Further M-factor increase produced random artifacts as revealed by signal quality measures that may affect interpretation of RSNs under common scanning conditions. Given appropriate hardware, a mb-EPI sequence with a total acceleration of 4 significantly reduces overall scanning time and clearly increases sensitivity to detect common RSNs. Together, our results suggest mb-EPI at moderate acceleration factors as a novel standard for fMRI that might increase our understanding of network dynamics in healthy and diseased brains.	[Preibisch, Christine; Castrillon G, J. Gabriel; Riedl, Valentin] Tech Univ Munich, Dept Neuroradiol, D-80290 Munich, Germany; [Preibisch, Christine] Tech Univ Munich, Neurol Clin, D-80290 Munich, Germany; [Buehrer, Martin] Univ Zurich, Inst Biomed Engn, Zurich, Switzerland; [Buehrer, Martin] Swiss Fed Inst Technol, Zurich, Switzerland; [Buehrer, Martin] GyroTools, Zurich, Switzerland; [Riedl, Valentin] Tech Univ Munich, Clin Nucl Med, D-80290 Munich, Germany	Technical University of Munich; Technical University of Munich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Technical University of Munich	Preibisch, C (corresponding author), Tech Univ Munich, Dept Neuroradiol, D-80290 Munich, Germany.	preibisch@tum.de	Jovicich, Jorge/D-2293-2010; Preibisch, Christine/AAD-8851-2020	Preibisch, Christine/0000-0003-4067-1928; Riedl, Valentin/0000-0002-2861-8449; Castrillon, Gabriel/0000-0001-7047-906X	Deutsche Forschungsgemeinschaft [PR 1039/4-1]; GyroTools	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); GyroTools	CP is funded by the Deutsche Forschungsgemeinschaft (PR 1039/4-1). MB is employee of GyroTools (Zurich, Switzerland). Philips Healthcare provided the 32-channel head coil and the multiband EPI patch. GyroTools provided support in the form of salaries for author MB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section."	Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; Baudrexel S, 2009, MAGN RESON MED, V62, P263, DOI 10.1002/mrm.21971; Beckmann C., 2009, NEUROIMAGE, V47; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Boubela RN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00168; Boyacioglu R, 2014, NEUROIMAGE, V97, P142, DOI 10.1016/j.neuroimage.2014.04.011; Breuer FA, 2005, MAGNET RESON MED, V53, P684, DOI 10.1002/mrm.20401; Breuer FA, 2009, MAGN RESON MED, V62, P739, DOI 10.1002/mrm.22066; Chen L, 2015, NEUROIMAGE, V104, P452, DOI 10.1016/j.neuroimage.2014.10.027; Deshmane A, 2012, J MAGN RESON IMAGING, V36, P55, DOI 10.1002/jmri.23639; Dietrich O, 2007, J MAGN RESON IMAGING, V26, P375, DOI 10.1002/jmri.20969; FEINBERG DA, 1986, RADIOLOGY, V161, P527, DOI 10.1148/radiology.161.2.3763926; Feinberg DA, 2013, J MAGN RESON, V229, P90, DOI 10.1016/j.jmr.2013.02.002; Feinberg DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015710; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Glover GH, 1998, MAGN RESON MED, V39, P361, DOI 10.1002/mrm.1910390305; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kalcher K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093375; Kruger G, 2001, MAGNET RESON MED, V46, P631, DOI 10.1002/mrm.1240; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Larkman DJ, 2001, J MAGN RESON IMAGING, V13, P313, DOI 10.1002/1522-2586(200102)13:2<313::AID-JMRI1045>3.0.CO;2-W; Liang ZP, 2003, IEEE T MED IMAGING, V22, P1026, DOI 10.1109/TMI.2003.815896; MANSFIELD P, 1977, J PHYS C SOLID STATE, V10, pL55, DOI 10.1088/0022-3719/10/3/004; MAUDSLEY A, 1981, J COMPUT ASSIST TOMO, V5, P289, DOI 10.1097/00004728-198104000-00035; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; MULLER S, 1988, MAGNET RESON MED, V6, P364, DOI 10.1002/mrm.1910060315; Nunes RG., 2006, P INT SOC MAG RESON, V14, P293; Paley MNJ, 2006, MAGN RESON IMAGING, V24, P557, DOI 10.1016/j.mri.2005.12.019; Preibisch C, 2003, NEUROIMAGE, V19, P412, DOI 10.1016/S1053-8119(03)00080-6; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Setsompop K, 2012, MAGN RESON MED, V67, P1210, DOI 10.1002/mrm.23097; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Tong YJ, 2014, MAGN RESON MED, V72, P1268, DOI 10.1002/mrm.25041; Tong YJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00196; Triantafyllou C, 2005, NEUROIMAGE, V26, P243, DOI 10.1016/j.neuroimage.2005.01.007; Triantafyllou C, 2006, NEUROIMAGE, V32, P551, DOI 10.1016/j.neuroimage.2006.04.182; Triantafyllou C, 2011, NEUROIMAGE, V55, P597, DOI 10.1016/j.neuroimage.2010.11.084; Tsao J, 2012, J MAGN RESON IMAGING, V36, P543, DOI 10.1002/jmri.23640; Ugurbil K, 2013, NEUROIMAGE, V80, P80, DOI 10.1016/j.neuroimage.2013.05.012; VANVAALS JJ, 1993, JMRI-J MAGN RESON IM, V3, P671, DOI 10.1002/jmri.1880030419; Xu JQ, 2013, NEUROIMAGE, V83, P991, DOI 10.1016/j.neuroimage.2013.07.055	47	60	60	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136961	10.1371/journal.pone.0136961	http://dx.doi.org/10.1371/journal.pone.0136961			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375666	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000361610200026
J	Schellens, IMM; Hoof, I; Meiring, HD; Spijkers, SNM; Poelen, MCM; van Gaans-van den Brink, JAM; van der Poel, K; Costa, AI; van Els, CACM; van Baarle, D; Kesmir, C				Schellens, Ingrid M. M.; Hoof, Ilka; Meiring, Hugo D.; Spijkers, Sanne N. M.; Poelen, Martien C. M.; van Gaans-van den Brink, Jacqueline A. M.; van der Poel, Kees; Costa, Ana I.; van Els, Cecile A. C. M.; van Baarle, Debbie; Kesmir, Can			Comprehensive Analysis of the Naturally Processed Peptide Repertoire: Differences between HLA-A and B in the Immunopeptidome	PLOS ONE			English	Article							MHC CLASS-I; T-CELL RESPONSES; ANTIGEN PRESENTATION; HUMAN THYMUS; MOLECULES; MEASLES; COMPLEX; BINDING; IMMUNOGENICITY; EXPRESSION	The cytotoxic T cell (CTL) response is determined by the peptide repertoire presented by the HLA class I molecules of an individual. We performed an in-depth analysis of the peptide repertoire presented by a broad panel of common HLA class I molecules on four B lymphoblastoid cell-lines (BLCL). Peptide elution and mass spectrometry analysis were utilised to investigate the number and abundance of self-peptides. Altogether, 7897 unique self-peptides, derived of 4344 proteins, were eluted. After viral infection, the number of unique selfpeptides eluted significantly decreased compared to uninfected cells, paralleled by a decrease in the number of source proteins. In the overall dataset, the total number of unique self-peptides eluted from HLA-B molecules was larger than from HLA-A molecules, and they were derived from a larger number of source proteins. These results in B cells suggest that HLA-B molecules possibly present a more diverse repertoire compared to their HLA-A counterparts, which may contribute to their immunodominance. This study provides a unique data set giving new insights into the complex system of antigen presentation for a broad panel of HLA molecules, many of which were never studied this extensively before.	[Schellens, Ingrid M. M.; Spijkers, Sanne N. M.; van der Poel, Kees; Costa, Ana I.; van Baarle, Debbie] Univ Med Ctr Utrecht, Dept Immunol, Lab Translat Immunol, Utrecht, Netherlands; [Schellens, Ingrid M. M.; van Baarle, Debbie] Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, Utrecht, Netherlands; [Hoof, Ilka] Univ Utrecht, Theoret Biol & Bioinformat, Utrecht, Netherlands; [Schellens, Ingrid M. M.; Meiring, Hugo D.; Poelen, Martien C. M.; van Gaans-van den Brink, Jacqueline A. M.; van Els, Cecile A. C. M.; van Baarle, Debbie] Natl Inst Publ Hlth & Environm, Ctr Immunol Infect Dis & Vaccines, NL-3720 BA Bilthoven, Netherlands; [Meiring, Hugo D.] Inst Translat Vaccinol Intravacc, Bilthoven, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Netherlands National Institute for Public Health & the Environment	van Baarle, D (corresponding author), Univ Med Ctr Utrecht, Dept Immunol, Lab Translat Immunol, Utrecht, Netherlands.	debbie.van.baarle@rivm.nl	Kesmir, Can/B-9410-2011	Hoof, Ilka/0000-0003-3827-7227	HiPo (High Potential) grant from Utrecht University; NWO grant [823.02.014]	HiPo (High Potential) grant from Utrecht University; NWO grant	This work was supported by a HiPo (High Potential) grant from Utrecht University, and NWO grant 823.02.014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulou E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3039; Admon A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.O111.011833; Ben Dror L, 2010, ARTHRITIS RHEUM-US, V62, P420, DOI 10.1002/art.27257; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Blackwell JM, 2009, CLIN MICROBIOL REV, V22, P370, DOI 10.1128/CMR.00048-08; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Busch DH, 1998, J IMMUNOL, V160, P4441; Caron E, 2005, INT IMMUNOL, V17, P1583, DOI 10.1093/intimm/dxh336; Consortium U., 2012, NUCLEIC ACIDS RES, V41, pD43, DOI [10.1093/nar/gks1068, DOI 10.1093/NAR/GKS1068]; Escobar H, 2008, J IMMUNOL, V181, P4874, DOI 10.4049/jimmunol.181.7.4874; Espinosa G, 2013, J PROTEOMICS, V94, P23, DOI 10.1016/j.jprot.2013.08.023; Gallimore A, 1998, J EXP MED, V187, P1647; Griffin BD, 2010, VET MICROBIOL, V143, P89, DOI 10.1016/j.vetmic.2010.02.017; Harndahl M, 2012, EUR J IMMUNOL, V42, P1405, DOI 10.1002/eji.201141774; Hassan C, 2013, MOL CELL PROTEOMICS, V12, P1829, DOI 10.1074/mcp.M112.024810; Herberts CA, 2003, MOL IMMUNOL, V39, P567, DOI 10.1016/S0161-5890(02)00204-3; Hewitt EW, 2003, IMMUNOLOGY, V110, P163, DOI 10.1046/j.1365-2567.2003.01738.x; Hickman HD, 2004, J IMMUNOL, V172, P2944, DOI 10.4049/jimmunol.172.5.2944; Hillen N, 2008, EUR J IMMUNOL, V38, P2993, DOI 10.1002/eji.200838632; Hoof I, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002517; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; Jacobson RM, 2011, VACCINE, V29, P7982, DOI 10.1016/j.vaccine.2011.08.060; Jaye A, 2003, J VIROL, V77, P5014, DOI 10.1128/JVI.77.8.5014-5016.2003; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Lacey SF, 2003, HUM IMMUNOL, V64, P440, DOI 10.1016/S0198-8859(03)00028-4; Leonhardt RM, 2010, J IMMUNOL, V184, P2985, DOI 10.4049/jimmunol.0900308; Levitsky V, 1996, J EXP MED, V183, P915, DOI 10.1084/jem.183.3.915; Lewinsohn DA, 2007, PLOS PATHOG, V3, P1240, DOI 10.1371/journal.ppat.0030127; Lundegaard C, 2008, BIOINFORMATICS, V24, P1397, DOI 10.1093/bioinformatics/btn128; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Meiring HD, 2002, J SEP SCI, V25, P557, DOI 10.1002/1615-9314(20020601)25:9<557::AID-JSSC557>3.0.CO;2-F; Mester G, 2011, CELL MOL LIFE SCI, V68, P1521, DOI 10.1007/s00018-011-0659-9; Mommen GPM, 2014, P NATL ACAD SCI USA, V111, P4507, DOI 10.1073/pnas.1321458111; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Neisig A, 1998, J IMMUNOL, V160, P171; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Ovsyannikova IG, 2004, VACCINE, V22, P1914, DOI 10.1016/j.vaccine.2003.11.016; Rao XY, 2009, J IMMUNOL, V182, P1526, DOI 10.4049/jimmunol.182.3.1526; Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1222, DOI 10.1093/nar/gks949; Schaefer MR, 2008, J IMMUNOL, V180, P7804, DOI 10.4049/jimmunol.180.12.7804; Scull KE, 2012, MOL IMMUNOL, V51, P136, DOI 10.1016/j.molimm.2012.02.117; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; TSOMIDES TJ, 1994, J EXP MED, V180, P1283, DOI 10.1084/jem.180.4.1283; van der Heeft E, 1998, ANAL CHEM, V70, P3742, DOI 10.1021/ac9801014; van Els CACM, 2000, EUR J IMMUNOL, V30, P1172, DOI 10.1002/(SICI)1521-4141(200004)30:4<1172::AID-IMMU1172>3.0.CO;2-J; vanderBurg SH, 1996, J IMMUNOL, V156, P3308; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Wahl A, 2010, HUM IMMUNOL, V71, P14, DOI 10.1016/j.humimm.2009.08.012; Weiskopf D, 2011, J IMMUNOL, V187, P4268, DOI 10.4049/jimmunol.1101970; Weiss M, 2010, PROTEOMICS, V10, P1297, DOI 10.1002/pmic.200900414; Yewdell JW, 2006, TRENDS IMMUNOL, V27, P368, DOI 10.1016/j.it.2006.06.008	53	34	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136417	10.1371/journal.pone.0136417	http://dx.doi.org/10.1371/journal.pone.0136417			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375851	Green Submitted, gold, Green Published			2022-12-27	WOS:000361610200014
J	Tierney, A; Kraus, N				Tierney, Adam; Kraus, Nina			Evidence for Multiple Rhythmic Skills	PLOS ONE			English	Article							SENSORIMOTOR SYNCHRONIZATION; DEVELOPMENTAL DYSLEXIA; NEURAL REPRESENTATION; MOTOR; PERCEPTION; CHILDREN; SPEECH; CEREBELLUM; BEAT; DISCRIMINATION	Rhythms, or patterns in time, play a vital role in both speech and music. Proficiency in a number of rhythm skills has been linked to language ability, suggesting that certain rhythmic processes in music and language rely on overlapping resources. However, a lack of under-standing about how rhythm skills relate to each other has impeded progress in understanding how language relies on rhythm processing. In particular, it is unknown whether all rhythm skills are linked together, forming a single broad rhythmic competence, or whether there are multiple dissociable rhythm skills. We hypothesized that beat tapping and rhythm memory/sequencing form two separate clusters of rhythm skills. This hypothesis was tested with a battery of two beat tapping and two rhythm memory tests. Here we show that tapping to a metronome and the ability to adjust to a changing tempo while tapping to a metronome are related skills. The ability to remember rhythms and to drum along to repeating rhythmic sequences are also related. However, we found no relationship between beat tapping skills and rhythm memory skills. Thus, beat tapping and rhythm memory are dissociable rhythmic aptitudes. This discovery may inform future research disambiguating how distinct rhythm competencies track with specific language functions.	[Tierney, Adam; Kraus, Nina] Northwestern Univ, Auditory Neurosci Lab, Evanston, IL 60208 USA; [Tierney, Adam; Kraus, Nina] Northwestern Univ, Dept Commun Sci, Evanston, IL USA; [Kraus, Nina] Northwestern Univ, Inst Neurosci, Evanston, IL 60208 USA; [Kraus, Nina] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Kraus, Nina] Northwestern Univ, Dept Otolaryngol, Evanston, IL USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University; Northwestern University	Kraus, N (corresponding author), Northwestern Univ, Auditory Neurosci Lab, Evanston, IL 60208 USA.	nkraus@northwestern.edu		Tierney, Adam/0000-0002-7624-6918	NSF [SMA1015614]; NIH [DC009399]; Mathers Foundation; National Association of Music Merchants; Knowles Hearing Center, Northwestern University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC009399] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; National Association of Music Merchants; Knowles Hearing Center, Northwestern University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research is funded by NSF SMA1015614, NIH DC009399, the Mathers Foundation, the National Association of Music Merchants, and the Knowles Hearing Center, Northwestern University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengtsson SL, 2009, CORTEX, V45, P62, DOI 10.1016/j.cortex.2008.07.002; Bhide A, 2013, MIND BRAIN EDUC, V7, P113, DOI 10.1111/mbe.12016; Bijsterbosch JD, 2011, J COGNITIVE NEUROSCI, V23, P1100, DOI 10.1162/jocn.2010.21506; Brochard R, 2013, COGNITION, V127, P214, DOI 10.1016/j.cognition.2013.01.007; Brown S, 2013, PSYCHOL MUSIC, V41, P229, DOI 10.1177/0305735611425896; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Buonomano DV, 2010, TRENDS COGN SCI, V14, P520, DOI 10.1016/j.tics.2010.09.002; Gonzalez-Trujillo MC, 2014, J RES READ, V37, P316, DOI 10.1111/j.1467-9817.2012.01529.x; Cope TE, 2014, NEUROPSYCHOLOGIA, V52, P73, DOI 10.1016/j.neuropsychologia.2013.09.039; Corriveau KH, 2009, CORTEX, V45, P119, DOI 10.1016/j.cortex.2007.09.008; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; Coull JT, 2011, NEUROPSYCHOPHARMACOL, V36, P3, DOI 10.1038/npp.2010.113; CUTLER A, 1992, J MEM LANG, V31, P218, DOI 10.1016/0749-596X(92)90012-M; David D, 2007, J RES READ, V30, P169, DOI 10.1111/j.1467-9817.2006.00323.x; Dellatolas G, 2009, ARCH CLIN NEUROPSYCH, V24, P555, DOI 10.1093/arclin/acp044; Douglas S., 1994, J RES READ, V17, p99?107, DOI [DOI 10.1111/J.1467-9817.1994.TB00057.X, 10.1111/j.1467-9817.1994.tb00057.x]; Escoffier N, 2010, ACTA PSYCHOL, V135, P12, DOI 10.1016/j.actpsy.2010.04.005; FANT G, 1991, J PHONETICS, V19, P351, DOI 10.1016/S0095-4470(19)30327-4; Fitch WT, 2007, MUSIC PERCEPT, V25, P43, DOI 10.1525/mp.2007.25.1.43; Flaugnacco E, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00392; FRIES W, 1990, NEUROPSYCHOLOGIA, V28, P1317, DOI 10.1016/0028-3932(90)90047-R; Fujii S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00771; Gordon E, 1986, INTERMEDIATE MEASURE; Gordon RL, 2015, DEVELOPMENTAL SCI, V18, P635, DOI 10.1111/desc.12230; Grahn JA, 2012, PSYCHOMUSICOLOGY MUS, V22, P105, DOI [10.1037/a0031188, DOI 10.1037/A0031188]; Grahn JA, 2007, J COGNITIVE NEUROSCI, V19, P893, DOI 10.1162/jocn.2007.19.5.893; Hausen M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00566; Hove MJ, 2013, NEUROIMAGE, V67, P313, DOI 10.1016/j.neuroimage.2012.11.032; Huss M, 2011, CORTEX, V47, P674, DOI 10.1016/j.cortex.2010.07.010; Ivry R B, 1989, J Cogn Neurosci, V1, P136, DOI 10.1162/jocn.1989.1.2.136; Ivry RB, 1996, CURR OPIN NEUROBIOL, V6, P851, DOI 10.1016/S0959-4388(96)80037-7; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; KEELE SW, 1985, ACTA PSYCHOL, V60, P173, DOI 10.1016/0001-6918(85)90054-X; Klatt Dennis H., 1975, STRUCTURE PROCESSP, P69; Koch G, 2007, EXP BRAIN RES, V179, P291, DOI 10.1007/s00221-006-0791-1; Kotz SA, 2010, TRENDS COGN SCI, V14, P392, DOI 10.1016/j.tics.2010.06.005; Launay J, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00018; Lee KH, 2007, J COGNITIVE NEUROSCI, V19, P147, DOI 10.1162/jocn.2007.19.1.147; Lewis PA, 2004, NEUROPSYCHOLOGIA, V42, P1301, DOI 10.1016/j.neuropsychologia.2004.03.001; Lewis PA, 2003, NEUROPSYCHOLOGIA, V41, P1583, DOI 10.1016/S0028-3932(03)00118-0; LIEBERMAN P, 1960, J ACOUST SOC AM, V32, P451, DOI 10.1121/1.1908095; Madison G, 2004, NEUROSCI LETT, V370, P69, DOI 10.1016/j.neulet.2004.07.094; Mangels JA, 1998, COGNITIVE BRAIN RES, V7, P15, DOI 10.1016/S0926-6410(98)00005-6; Mattys SL, 2004, J EXP PSYCHOL HUMAN, V30, P397, DOI 10.1037/0096-1523.30.2.397; MCGIVERN RF, 1991, J LEARN DISABIL, V24, P58, DOI 10.1177/002221949102400110; Moritz C, 2013, READ WRIT, V26, P739, DOI 10.1007/s11145-012-9389-0; NAKATANI LH, 1978, J ACOUST SOC AM, V63, P234, DOI 10.1121/1.381719; Overy K, 2003, ANN NY ACAD SCI, V999, P497, DOI 10.1196/annals.1284.060; Overy K., 2000, PSYCHOL MUSIC, V28, P218, DOI DOI 10.1177/0305735600282010; Patel AD, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00057; Pecenka N, 2011, EXP BRAIN RES, V211, P505, DOI 10.1007/s00221-011-2616-0; Penhune VB, 2005, NEUROIMAGE, V26, P801, DOI 10.1016/j.neuroimage.2005.02.041; Peretz I, 2003, ANN NY ACAD SCI, V999, P58, DOI 10.1196/annals.1284.006; POVEL DJ, 1985, MUSIC PERCEPT, V2, P411; Provasi J, 2014, RES DEV DISABIL, V35, P2053, DOI 10.1016/j.ridd.2014.04.024; Repp BH, 2000, PSYCHOL RES-PSYCH FO, V63, P106, DOI 10.1007/PL00008170; Repp BH, 2001, HUM MOVEMENT SCI, V20, P277, DOI 10.1016/S0167-9457(01)00049-5; Sakai K, 1999, J NEUROSCI, V19, P10074; Schwartze M, 2012, INT J PSYCHOPHYSIOL, V83, P200, DOI 10.1016/j.ijpsycho.2011.11.003; Semjen A, 1998, PSYCHOL RES-PSYCH FO, V61, P44, DOI 10.1007/s004260050012; SMITH MR, 1989, J SPEECH HEAR RES, V32, P912, DOI 10.1044/jshr.3204.912; Sowinski J, 2013, NEUROPSYCHOLOGIA, V51, P1952, DOI 10.1016/j.neuropsychologia.2013.06.027; Spitzer SM, 2007, J ACOUST SOC AM, V122, P3678, DOI 10.1121/1.2801545; Steele C, 2012, THESIS CONCORDIA U M; Steele CJ, 2010, J NEUROSCI, V30, P8332, DOI 10.1523/JNEUROSCI.5569-09.2010; Strait DL, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-44; Thaut MH, 2003, HUM MOVEMENT SCI, V22, P321, DOI 10.1016/S0167-9457(03)00048-4; Thaut MH, 1998, BIOL CYBERN, V79, P241, DOI 10.1007/s004220050474; Thomson JM, 2008, J PHYSIOL-PARIS, V102, P120, DOI 10.1016/j.jphysparis.2008.03.007; Thomson JM, 2006, J RES READ, V29, P334, DOI 10.1111/j.1467-9817.2006.00312.x; Tierney A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00949; Tierney A, 2013, J NEUROSCI, V33, P14981, DOI 10.1523/JNEUROSCI.0612-13.2013; Tierney AT, 2013, BRAIN LANG, V124, P225, DOI 10.1016/j.bandl.2012.12.014; Vaissiere J., 1991, MUSIC LANGUAGE SPEEC, P108, DOI DOI 10.1007/978-1-349-12670-5; Venditti J., 1998, 5 INT C SPOK LANG PR; Wallentin M, 2010, LEARN INDIVID DIFFER, V20, P188, DOI 10.1016/j.lindif.2010.02.004; Wiener M, 2010, NEUROIMAGE, V49, P1728, DOI 10.1016/j.neuroimage.2009.09.064; Wilson SJ, 2002, NEUROPSYCHOLOGIA, V40, P1494, DOI 10.1016/S0028-3932(01)00198-1; Woodcock R, 2001, WOODCOCK JOHNSON PSY	79	22	22	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136645	10.1371/journal.pone.0136645	http://dx.doi.org/10.1371/journal.pone.0136645			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8NH	26376489	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000361610200020
J	Coutinho, RM; Kraenkel, RA; Prado, PI				Coutinho, Renato M.; Kraenkel, Roberto A.; Prado, Paulo I.			Catastrophic Regime Shift in Water Reservoirs and Sao Paulo Water Supply Crisis	PLOS ONE			English	Article							ECOSYSTEMS; VEGETATION; PATTERNS; SYSTEMS	The relation between rainfall and water accumulated in reservoirs comprises nonlinear feedbacks. Here we show that they may generate alternative equilibrium regimes, one of high water-volume, the other of low water-volume. Reservoirs can be seen as socio-environmental systems at risk of regime shifts, characteristic of tipping point transitions. We analyze data from stored water, rainfall, and water inflow and outflow in the main reservoir serving the metropolitan area of Sao Paulo, Brazil, by means of indicators of critical regime shifts, and find a strong signal of a transition. We furthermore build a mathematical model that gives a mechanistic view of the dynamics and demonstrates that alternative stable states are an expected property of water reservoirs. We also build a stochastic version of this model that fits well to the data. These results highlight the broader aspect that reservoir management must account for their intrinsic bistability, and should benefit from dynamical systems theory. Our case study illustrates the catastrophic consequences of failing to do so.	[Coutinho, Renato M.; Kraenkel, Roberto A.] Univ Estadual Paulista UNESP, Inst Fis Teor, Sao Paulo, Brazil; [Prado, Paulo I.] Univ Sao Paulo, Inst Biociencias, LAGE Dept Ecol, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade de Sao Paulo	Coutinho, RM (corresponding author), Univ Estadual Paulista UNESP, Inst Fis Teor, Sao Paulo, Brazil.	renatomc@ift.unesp.br	Prado, Paulo I/G-3353-2012; Coutinho, Renato M/H-9133-2017; Prado, Paulo Inácio/AAN-6512-2021; Kraenkel, Roberto A/B-5479-2010	Coutinho, Renato M/0000-0002-2828-8558; Prado, Paulo Inácio/0000-0002-7174-5005; Kraenkel, Roberto A/0000-0001-5602-5184	Sao Paulo Research Foundation (FAPESP), Brazil [2010/09464-1]; Coordination for the Improvement of Higher Education Personnel (CAPES), Brazil; National Counsel of Technological and Scientific Development (CNPq), Brazil [308180/2013-5, 306183/2014-5]	Sao Paulo Research Foundation (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Education Personnel (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Counsel of Technological and Scientific Development (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	RMC was partially funded through a PhD fellowship, grant 2010/09464-1, Sao Paulo Research Foundation (FAPESP - http://fapesp.br), Brazil, and through a post-doctoral PNPD fellowship from the Coordination for the Improvement of Higher Education Personnel (CAPES - http://capes.gov.br), Brazil. RAK and PIP both hold grants from the National Counsel of Technological and Scientific Development (CNPq - http://cnpq.br), Brazil (RAK: #308180/2013-5; PIP: 306183/2014-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agencia Nacional de Aguas Departamento de Aguas e Energia Eletrica, 2015, DAD REF AC OUT SIST; Beven K. J., 2011, RAINFALL RUNOFF MODE; Boettiger C, 2013, THEOR ECOL-NETH, V6, P255, DOI 10.1007/s12080-013-0192-6; Boettiger C, 2012, J R SOC INTERFACE, V9, P2527, DOI 10.1098/rsif.2012.0125; Carpenter SR, 2011, ECOLOGY, V92, P2196, DOI 10.1890/11-0716.1; Carpenter SR, 2005, P NATL ACAD SCI USA, V102, P10002, DOI 10.1073/pnas.0503959102; Dakos V, 2015, EARLY WARNING SIGNAL; Dakos V, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0263; Dakos V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041010, 10.1371/journal.pone.0045586]; Folke C, 2006, GLOBAL ENVIRON CHANG, V16, P253, DOI 10.1016/j.gloenvcha.2006.04.002; Gordon LJ, 2008, TRENDS ECOL EVOL, V23, P211, DOI 10.1016/j.tree.2007.11.011; King A, 2009, POMP STAT INFERENCE; Klausmeier CA, 1999, SCIENCE, V284, P1826, DOI 10.1126/science.284.5421.1826; Liu J, 2001, STAT ENG IN, P197; Meron E, 2004, CHAOS SOLITON FRACT, V19, P367, DOI 10.1016/S0960-0779(03)00049-3; Osterblom H, 2013, BIOSCIENCE, V63, P735, DOI 10.1093/bioscience/63.9.735; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Scheffer M, 2007, HYDROBIOLOGIA, V584, P455, DOI 10.1007/s10750-007-0616-7; Young P. C., 2004, Environmental modelling - finding simplicity in complexity, P371	20	32	32	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138278	10.1371/journal.pone.0138278	http://dx.doi.org/10.1371/journal.pone.0138278			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372224	Green Published, Green Submitted, gold			2022-12-27	WOS:000361604400060
J	Malerba, F; Paoletti, F; Ercole, BB; Materazzi, S; Nassini, R; Coppi, E; Patacchini, R; Capsoni, S; Lamba, D; Cattaneo, A				Malerba, Francesca; Paoletti, Francesca; Ercole, Bruno Bruni; Materazzi, Serena; Nassini, Romina; Coppi, Elisabetta; Patacchini, Riccardo; Capsoni, Simona; Lamba, Doriano; Cattaneo, Antonino			Functional Characterization of Human ProNGF and NGF Mutants: Identification of NGF P61SR100E as a "Painless" Lead Investigational Candidate for Therapeutic Applications	PLOS ONE			English	Article							NERVE-GROWTH-FACTOR; TOPICAL TREATMENT; GUANIDINE-HYDROCHLORIDE; PRESSURE ULCERS; CLINICAL-TRIAL; EXPRESSION; CELLS; RECEPTOR; DIFFERENTIATION; MOUSE	Background Nerve Growth Factor (NGF) holds a great therapeutic promise for Alzheimer's disease, diabetic neuropathies, ophthalmic diseases, dermatological ulcers. However, the necessity for systemic delivery has hampered the clinical applications of NGF due to its potent pro-nociceptive action. A "painless" human NGF (hNGF R100E) mutant has been engineered. It has equal neurotrophic potency to hNGF but a lower nociceptive activity. We previously described and characterized the neurotrophic and nociceptive properties also of the hNGF P61S and P61SR100E mutants, selectively detectable against wild type hNGF. However, the reduced pain-sensitizing potency of the "painless" hNGF mutants has not been quantified. Objectives and Results Aiming at the therapeutic application of the "painless" hNGF mutants, we report on the comparative functional characterization of the precursor and mature forms of the mutants hNGF R100E and hNGF P61SR100E as therapeutic candidates, also in comparison to wild type hNGF and to hNGF P61S. The mutants were assessed by a number of biochemical, biophysical methods and assayed by cellular assays. Moreover, a highly sensitive ELISA for the detection of the P61S-tagged mutants in biological samples has been developed. Finally, we explored the pro-nociceptive effects elicited by hNGF mutants in vivo, demonstrating an expanded therapeutic window with a ten-fold increase in potency. Conclusions This structure-activity relationship study has led to validate the concept of developing painless NGF as a therapeutic, targeting the NGF receptor system and supporting the choice of hNGF P61S R100E as the best candidate to advance in clinical development. Moreover, this study contributes to the identification of the molecular determinants modulating the properties of the hNGF "painless" mutants.	[Malerba, Francesca; Paoletti, Francesca; Ercole, Bruno Bruni; Cattaneo, Antonino] Rita Levi Montalcini Fdn, European Brain Res Inst, Neurotroph Factors & Neurodegenerat Dis Unit, Rome, Italy; [Malerba, Francesca; Paoletti, Francesca; Capsoni, Simona; Cattaneo, Antonino] Scuola Normale Super Pisa, Neurobiol Lab Biol, Pisa, Italy; [Materazzi, Serena; Nassini, Romina; Coppi, Elisabetta] Univ Florence, Dept Hlth Sci, Sect Clin Pharmacol & Oncol, Florence, Italy; [Patacchini, Riccardo] Chiesi Farmaceut, Dept Pharmacol, Parma, Italy; [Lamba, Doriano] CNR, Ist Cristall, Trieste, Italy	Scuola Normale Superiore di Pisa; University of Florence; Chiesi Pharmaceuticals Inc; Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR)	Cattaneo, A (corresponding author), Rita Levi Montalcini Fdn, European Brain Res Inst, Neurotroph Factors & Neurodegenerat Dis Unit, Rome, Italy.	antonino.cattaneo@sns.it	Lamba, Doriano/L-9808-2018; Coppi, Elisabetta/K-6705-2016; Nassini, Romina/AAC-5051-2022; Cattaneo, Antonino/AAA-7252-2019; Cattaneo, Antonino/K-4471-2016; Lamba, Doriano/B-2961-2011	Lamba, Doriano/0000-0001-6859-7868; Coppi, Elisabetta/0000-0003-4434-5919; Nassini, Romina/0000-0002-9223-8395; Cattaneo, Antonino/0000-0002-6975-8923; Lamba, Doriano/0000-0001-6859-7868; Capsoni, Simona/0000-0003-2670-8237	MIUR [2010N8PBAA_006]; ADDF [20120601]; European Union [603191]	MIUR(Ministry of Education, Universities and Research (MIUR)); ADDF; European Union(European Commission)	This work was supported by the following grants: MIUR, project PRIN (#2010N8PBAA_006) to AC (http://prin.miur.it/); ADDF (grant #20120601) to AC (https://www.alzdiscovery.org/); and European Union, project "PAINCAGE" (GA n. 603191) to AC (http://www.paincage.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALOE L, 1977, BRAIN RES, V133, P358, DOI 10.1016/0006-8993(77)90772-7; [Anonymous], PYMOL MOL GRAPHICS S; Apfel SC, 2002, INT REV NEUROBIOL, V50, P393; Bernabei R, 1999, LANCET, V354, P307, DOI 10.1016/S0140-6736(99)02784-1; Bernardo A, 2003, J NEUROPATH EXP NEUR, V62, P509, DOI 10.1093/jnen/62.5.509; BISCHOFF SC, 1992, BLOOD, V79, P2662; Bonini S, 2000, OPHTHALMOLOGY, V107, P1347, DOI 10.1016/S0161-6420(00)00163-9; Bruno MA, 2006, P NATL ACAD SCI USA, V103, P6735, DOI 10.1073/pnas.0510645103; Capsoni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037555; Capsoni S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017321; CATTANEO A, 1988, J NEUROCHEM, V50, P1003, DOI 10.1111/j.1471-4159.1988.tb10565.x; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; CHEVALIER S, 1994, BLOOD, V83, P1479; Coppi E, 2013, GLIA, V61, P1155, DOI 10.1002/glia.22506; Covaceuszach S, 2010, BIOCHEM BIOPH RES CO, V391, P824, DOI 10.1016/j.bbrc.2009.11.146; Covaceuszach S, 2009, CURR ALZHEIMER RES, V6, P158, DOI 10.2174/156720509787602870; de Andrade DC, 2008, EUR J NEUROL, V15, P712, DOI 10.1111/j.1468-1331.2008.02172.x; DIMARCO E, 1992, CANCER LETT, V65, P189, DOI 10.1016/0304-3835(92)90231-J; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; DREYFUS CF, 1989, TRENDS PHARMACOL SCI, V10, P145, DOI 10.1016/0165-6147(89)90166-1; Einarsdottir E, 2004, HUM MOL GENET, V13, P799, DOI 10.1093/hmg/ddh096; Ferreira J, 2002, NEUROPHARMACOLOGY, V43, P1188, DOI 10.1016/S0028-3908(02)00311-8; Generini S, 2004, EXP CLIN ENDOCR DIAB, V112, P542, DOI 10.1055/s-2004-821313; Jonhagen ME, 1998, DEMENT GERIATR COGN, V9, P246, DOI 10.1159/000017069; KETTENMANN H, 1991, ANN NY ACAD SCI, V633, P64; Kliemannel M, 2006, BIOCHEMISTRY-US, V45, P3517, DOI 10.1021/bi051896t; Kliemannel M, 2007, PROTEIN SCI, V16, P411, DOI 10.1110/ps.062376207; Lambiase A, 1998, NEW ENGL J MED, V338, P1174, DOI 10.1056/NEJM199804233381702; Lambiase A., 2009, P NATL ACAD SCI US; Lambiase A, 2009, ANN I SUPER SANITA, V45, P439; Landi F, 2003, ANN INTERN MED, V139, P635, DOI 10.7326/0003-4819-139-8-200310210-00006; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LINDSAY RM, 1989, NATURE, V337, P362, DOI 10.1038/337362a0; Mande SC, 2000, PROTEIN ENG, V13, P133, DOI 10.1093/protein/13.2.133; McAllister AK, 2001, CELL MOL LIFE SCI, V58, P1054, DOI 10.1007/PL00000920; MONERA OD, 1994, PROTEIN SCI, V3, P1984, DOI 10.1002/pro.5560031110; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; OLSON L, 1991, ARCH NEUROL-CHICAGO, V48, P373, DOI 10.1001/archneur.1991.00530160037011; Paoletti F, 2015, BBA-PROTEINS PROTEOM, V1854, P187, DOI 10.1016/j.bbapap.2014.12.005; Paoletti F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022615; Paoletti F, 2009, PROTEINS, V75, P990, DOI 10.1002/prot.22311; Rattenholl A, 2001, EUR J BIOCHEM, V268, P3296, DOI 10.1046/j.1432-1327.2001.02232.x; Raychaudhuri SK, 2001, ARCH DERMATOL RES, V293, P291, DOI 10.1007/s004030100224; SONTHEIMER H, 1989, J NEUROSCI RES, V24, P496, DOI 10.1002/jnr.490240406; SONTHEIMER H, 1989, NEURON, V2, P1135, DOI 10.1016/0896-6273(89)90180-3; Tanaka Y, 2004, BIOCHEM BIOPH RES CO, V323, P185, DOI 10.1016/j.bbrc.2004.08.081; Fasulo CTL, 2013, CELL DEATH DIFFER, V20, P1017, DOI 10.1038/cdd.2013.22	49	24	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0136425	10.1371/journal.pone.0136425	http://dx.doi.org/10.1371/journal.pone.0136425			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371475	Green Published, gold			2022-12-27	WOS:000361604400005
J	Curtis, KA; Moore, JE; Benson, SR				Curtis, K. Alexandra; Moore, Jeffrey E.; Benson, Scott R.			Estimating Limit Reference Points for Western Pacific Leatherback Turtles (Dermochelys coriacea) in the US West Coast EEZ	PLOS ONE			English	Article							NESTING POPULATION; NATURAL MORTALITY; SEA-TURTLES; CONSERVATION; MANAGEMENT; GROWTH; PAPUA; MODEL	Biological limit reference points (LRPs) for fisheries catch represent upper bounds that avoid undesirable population states. LRPs can support consistent management evaluation among species and regions, and can advance ecosystem-based fisheries management. For transboundary species, LRPs prorated by local abundance can inform local management decisions when international coordination is lacking. We estimated LRPs for western Pacific leatherbacks in the U.S. West Coast Exclusive Economic Zone (WCEEZ) using three approaches with different types of information on local abundance. For the current application, the best-informed LRP used a local abundance estimate derived from nest counts, vital rate information, satellite tag data, and fishery observer data, and was calculated with a Potential Biological Removal estimator. Management strategy evaluation was used to set tuning parameters of the LRP estimators to satisfy risk tolerances for falling below population thresholds, and to evaluate sensitivity of population outcomes to bias in key inputs. We estimated local LRPs consistent with three hypothetical management objectives: allowing the population to rebuild to its maximum net productivity level (4.7 turtles per five years), limiting delay of population rebuilding (0.8 turtles per five years), or only preventing further decline (7.7 turtles per five years). These LRPs pertain to all human-caused removals and represent the WCEEZ contribution to meeting population management objectives within a broader international cooperative framework. We present multi-year estimates, because at low LRP values, annual assessments are prone to substantial error that can lead to volatile and costly management without providing further conservation benefit. The novel approach and the performance criteria used here are not a direct expression of the "jeopardy" standard of the U.S. Endangered Species Act, but they provide useful assessment information and could help guide international management frameworks. Given the range of abundance data scenarios addressed, LRPs should be estimable for many other areas, populations, and taxa.	[Curtis, K. Alexandra] NOAA, Ocean Associates Inc, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA USA; [Curtis, K. Alexandra; Moore, Jeffrey E.; Benson, Scott R.] NOAA, Marine Mammal & Turtle Div, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Curtis, KA (corresponding author), NOAA, Ocean Associates Inc, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA USA.	alex.curtis@noaa.gov		Curtis, Katherine Alexandra/0000-0001-7284-944X	Lenfest Ocean Program [2008-000648-009]; National Marine Fisheries Service (NMFS) Office of Science and Technology	Lenfest Ocean Program; National Marine Fisheries Service (NMFS) Office of Science and Technology	This work was supported by grants to KAC and JEM from the Lenfest Ocean Program (grant reference number 2008-000648-009; www.lenfestocean.org) and the National Marine Fisheries Service (NMFS) Office of Science and Technology (https://www.st.nmfs.noaa.gov), through a contract to KAC from Ocean Associates, Inc. Neither the funders nor Ocean Associates, Inc., had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adler D, 2005, VIOPLOT VIOLIN PLOT; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2005, R NEWS; [Anonymous], 2013, IUCN RED LIST THREAT; Avens Larisa, 2009, Endangered Species Research, V8, P165, DOI 10.3354/esr00202; Becker RA, 2014, MAPDATA EXTRA MAP DA; Becker RA, 2014, MAPS DRAW GEOGRAPHIC; Benson SR, 2007, FISH B-NOAA, V105, P337; Benson SR, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00053.1; Bertalanffy L. v., 1934, ARCH ENTWICKLUNGMECH, V131, P613, DOI DOI 10.1007/BF00650112; Bivand R., 2014, RGEOS INTERFACE GEOM; Bivand R, 2014, RGDAL BINDINGS GEOSP; Caswell, 2000, MATRIX POPULATION MO; Chalmers Matthew, 2003, P UB 2003 WORKSH CRO; Chang W., 2014, EXTRAFONT TOOLS USIN; CROUSE DT, 1987, ECOLOGY, V68, P1412, DOI 10.2307/1939225; Curtis KA, 2013, AQUAT CONSERV, V23, P441, DOI 10.1002/aqc.2308; Curtis KA, MAR POLICY IN PRESS; Dutton DL, 2005, BIOL CONSERV, V126, P186, DOI 10.1016/j.biocon.2005.05.013; Dutton PH, 2007, CHELONIAN CONSERV BI, V6, P47, DOI 10.2744/1071-8443(2007)6[47:SAGSON]2.0.CO;2; Eckert K., 2012, SYNOPSIS BIOL DATA L; Eckert SA, 2002, MAR ECOL PROG SER, V230, P289, DOI 10.3354/meps230289; FAO, 1995, COD COND RESP FISH, P41; Fossette Sabrina, 2008, Endangered Species Research, V4, P33, DOI 10.3354/esr00039; Gallucci VF, 2006, CAN J FISH AQUAT SCI, V63, P931, DOI 10.1139/F05-267; Gaspar P, 2012, MAR ECOL PROG SER, V457, P265, DOI 10.3354/meps09689; Halpin PN, 2009, OCEANOGRAPHY, V22, P104, DOI 10.5670/oceanog.2009.42; Hanan D.A., 1993, CALIF FISH GAME B, V175, P1; Heppell SS, 1998, COPEIA, P367, DOI 10.2307/1447430; Heppell SS, 2005, DEV ALTERNATIVE QUAN, P35; Hijmans R. J., 2014, GEOSPHERE SPHERICAL; Hitipeuw C., 2002, P W PAC SEA TURTL CO, P161; Hitipeuw C, 2007, CHELONIAN CONSERV BI, V6, P28, DOI 10.2744/1071-8443(2007)6[28:PSAIMO]2.0.CO;2; Hobday AJ, 2011, FISH RES, V108, P372, DOI 10.1016/j.fishres.2011.01.013; Jones TT, 2011, J EXP MAR BIOL ECOL, V399, P84, DOI 10.1016/j.jembe.2011.01.007; Kaplan IC, 2005, CAN J FISH AQUAT SCI, V62, P1710, DOI 10.1139/F05-121; Kenchington TJ, 2014, FISH FISH, V15, P533, DOI 10.1111/faf.12027; Kinan I, 2005, P 2 W PAC SEA TURTL, VI; Koch V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056776; Kot CY, 2014, STATE WORLDS SEA TUR; Lewin-Koh N, 2014, MAPTOOLS TOOLS FOR R; Lontoh, 2014, THESIS SAN JOSE STAT; Martien K. K., 2013, Journal of Cetacean Research and Management, V13, P31; Martin SL, 2015, ECOL APPL, V25, P416, DOI 10.1890/14-0059.1; Moore JE, 2013, ENVIRON CONSERV, V40, P329, DOI 10.1017/S037689291300012X; Moore JE, 2014, RECOMMENDATIONS POLL, P11; *NAT MAR FISH SERV, 1999, HAB APPR IMPL SECT 7; National Marine Fisheries Service, 2014, BIOL OP CONT OP HAW; National Marine Fisheries Service, 2005, REV GUID ASS MAR MAM; National Marine Fisheries Service, 2013, BIOL OP CONT MAN DRI; [National Oceanic and Atmospheric Administration National Marine Fisheries Service West Coast Region U. S. Department of Commerce], 2014, CAL SEA TURTL STRAND; National Research Council, 1990, DECL SEA TURT CAUS P; PAULY D, 1980, J CONSEIL, V39, P175; PETERSON I, 1984, CAN J FISH AQUAT SCI, V41, P1117, DOI 10.1139/f84-131; Plate T., 2011, ABIND COMBINE MULTID; Price E. R., 2006, ENDANGER SPECIES RES, V1, P41, DOI DOI 10.3354/ESR001041; Rafferty AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021038; Rivalan P, 2005, OECOLOGIA, V145, P564, DOI 10.1007/s00442-005-0159-4; Rohlf Daniel J, 2001, WASHBURN LJ, V41, P114; RStudio Team, 2012, RSTUDIO INT DEV R; Saba VS, 2008, ECOLOGY, V89, P1414, DOI 10.1890/07-0364.1; Saether BE, 2010, BIOL CONSERV, V143, P1970, DOI 10.1016/j.biocon.2010.04.048; Sainsbury K, 2008, R20010999 AUSTR FISH; Tomillo PS, 2007, CHELONIAN CONSERV BI, V6, P54; Seminoff JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037403; Simons RA, 2015, ERDDAP; Snover ML, 2009, ECOL APPL, V19, P774, DOI 10.1890/07-1111.1; Spotila James R., 1996, Chelonian Conservation and Biology, V2, P209; Steering Committee, 2008, STRAT PLANN LONG TER, P79; Stewart K, 2011, ECOL APPL, V21, P263, DOI 10.1890/09-1838.1; Stewart KR, 2007, THESIS DUKE U; Stubben C, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i11; Tapilatu RF, 2007, CHELONIAN CONSERV BI, V6, P154, DOI 10.2744/1071-8443(2007)6[154:LTDCHS]2.0.CO;2; Tapilatu RF, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00348.1; Taylor BL, 2005, MARINE MAMMAL RES CO, P165; Tiwari M., 2013, IUCN RED LIST THREAT, pT46967817A46967821; Turtle Expert Working Group, 2007, NMFSSEFSC555 TURTL E; *US FISH WILDL SER, 1998, REC PLAN US PAC POP; Venables WN., 2002, MODERN APPL STAT S 4; VLIZ, 2014, MAR BOUND GEOD VERS; Wade PR, 1998, MAR MAMMAL SCI, V14, P1, DOI 10.1111/j.1748-7692.1998.tb00688.x; Wallace BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024510; Wallace BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015465; Warnes GR, 2014, GTOOLS VARIOUS R PRO; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Zug George R., 1996, Chelonian Conservation and Biology, V2, P244	86	13	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136452	10.1371/journal.pone.0136452	http://dx.doi.org/10.1371/journal.pone.0136452			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368557	Green Submitted, Green Published, gold			2022-12-27	WOS:000361601100017
J	Li, LY; Paz, AC; Wilky, BA; Johnson, B; Galoian, K; Rosenberg, A; Hu, GZ; Tinoco, G; Bodamer, O; Trent, JC				Li, Luyuan; Paz, Ana C.; Wilky, Breelyn A.; Johnson, Britt; Galoian, Karina; Rosenberg, Andrew; Hu, Guozhi; Tinoco, Gabriel; Bodamer, Olaf; Trent, Jonathan C.			Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells	PLOS ONE			English	Article							ISOCITRATE DEHYDROGENASE 1; ACUTE MYELOID-LEUKEMIA; MAFFUCCI SYNDROME; OLLIER DISEASE; CODON 132; MUTATIONS; GLIOMA; HYPERMETHYLATION; GROWTH; GENES	Chondrosarcomas are malignant bone tumors that produce cartilaginous matrix. Mutations in isocitrate dehydrogenase enzymes (IDH1/2) were recently described in several cancers including chondrosarcomas. The IDH1 inhibitor AGI-5198 abrogates the ability of mutant IDH1 to produce the oncometabolite D-2 hydroxyglutarate (D-2HG) in gliomas. We sought to determine if treatment with AGI-5198 would similarly inhibit tumorigenic activity and D-2HG production in IDH1-mutant human chondrosarcoma cells. Two human chondrosarcoma cell lines, JJ012 and HT1080 with endogenous IDH1 mutations and a human chondrocyte cell line C28 with wild type IDH1 were employed in our study. Mutation analysis of IDH was performed by PCR-based DNA sequencing, and D-2HG was detected using tandem mass spectrometry. We confirmed that JJ012 and HT1080 harbor IDH1 R132G and R132C mutation, respectively, while C28 has no mutation. D-2HG was detectable in cell pellets and media of JJ012 and HT1080 cells, as well as plasma and urine from an IDH-mutant chondrosarcoma patient, which decreased after tumor resection. AGI-5198 treatment decreased D-2HG levels in JJ012 and HT1080 cells in a dose-dependent manner, and dramatically inhibited colony formation and migration, interrupted cell cycling, and induced apoptosis. In conclusion, our study demonstrates anti-tumor activity of amutant IDH1 inhibitor in human chondrosarcoma cell lines, and suggests that D-2HG is a potential biomarker for IDH mutations in chondrosarcoma cells. Thus, clinical trials of mutant IDH inhibitors are warranted for patients with IDH-mutant chondrosarcomas.	[Li, Luyuan; Paz, Ana C.; Wilky, Breelyn A.; Hu, Guozhi; Tinoco, Gabriel; Trent, Jonathan C.] Univ Miami, Miller Sch Med, Dept Med, Div Hematol & Oncol, Miami, FL 33136 USA; [Li, Luyuan; Paz, Ana C.; Wilky, Breelyn A.; Hu, Guozhi; Tinoco, Gabriel; Trent, Jonathan C.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Li, Luyuan; Trent, Jonathan C.] Univ Miami, Miller Sch Med, Sheila & David Fuente Grad Program Canc Biol, Miami, FL 33136 USA; [Johnson, Britt; Bodamer, Olaf] Univ Miami, Miller Sch Med, Dept Human Genet, Miami, FL 33136 USA; [Galoian, Karina] Univ Miami, Miller Sch Med, Dept Orthopaed Surg, Miami, FL 33136 USA; [Rosenberg, Andrew] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami; University of Miami; University of Miami	Trent, JC (corresponding author), Univ Miami, Miller Sch Med, Dept Med, Div Hematol & Oncol, Miami, FL 33136 USA.	JTrent@med.miami.edu	Tinoco, Gabriel/ABD-2204-2021; Trent, Jonathan/AAR-7113-2021	Tinoco, Gabriel/0000-0002-2565-6124; Trent, Jonathan/0000-0001-6169-5238; Wilky, Breelyn/0000-0001-5080-497X; Johnson, Britt/0000-0003-1883-5201	Department of Medicine, University of Miami Miller School of Medicine; Sheila and David Fuente Graduate Program in Cancer Biology, Sylvester Comprehensive Cancer Center	Department of Medicine, University of Miami Miller School of Medicine; Sheila and David Fuente Graduate Program in Cancer Biology, Sylvester Comprehensive Cancer Center	This study was supported by Department of Medicine, University of Miami Miller School of Medicine. The authors also acknowledge partial support and assistance from the Sheila and David Fuente Graduate Program in Cancer Biology, Sylvester Comprehensive Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2010, BLOOD, V116, P2122, DOI 10.1182/blood-2009-11-250878; Aghili M, 2009, J NEURO-ONCOL, V91, P233, DOI 10.1007/s11060-008-9706-2; Amary MF, 2011, NAT GENET, V43, P1262, DOI 10.1038/ng.994; Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Cairns RA, 2011, COLD SH Q B, V76, P299, DOI 10.1101/sqb.2011.76.012856; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Fathi AT, 2014, ONCOLOGIST, V19, P602, DOI 10.1634/theoncologist.2013-0417; Fathi AT, 2012, BLOOD, V120, P4649, DOI 10.1182/blood-2012-06-438267; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Green A, 2010, NEW ENGL J MED, V362, P369, DOI 10.1056/NEJMc0910063; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Guilhamon P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3166; Ho PA, 2010, LEUKEMIA, V24, P909, DOI 10.1038/leu.2010.56; Ichimura K, 2012, BRAIN TUMOR PATHOL, V29, P131, DOI 10.1007/s10014-012-0090-4; Jamil N, 2010, INT J EXP PATHOL, V91, P387, DOI 10.1111/j.1365-2613.2010.00749.x; Kang MR, 2009, INT J CANCER, V125, P353, DOI 10.1002/ijc.24379; Kaur B, 2005, NEURO-ONCOLOGY, V7, P134, DOI 10.1215/S1152851704001115; Kernytsky A, 2015, BLOOD, V125, P296, DOI 10.1182/blood-2013-10-533604; Kranendijk M, 2012, J INHERIT METAB DIS, V35, P571, DOI 10.1007/s10545-012-9462-5; Ma S, 2015, ONCOTARGET, DOI 10.18632/oncotarget.6284; Murugan AK, 2010, BIOCHEM BIOPH RES CO, V393, P555, DOI 10.1016/j.bbrc.2010.02.095; NYHAN WL, 1995, J CHILD NEUROL, V10, P137, DOI 10.1177/088307389501000216; Pansuriya TC, 2011, NAT GENET, V43, P1256, DOI 10.1038/ng.1004; Pufe T, 2004, J PATHOL, V202, P367, DOI 10.1002/path.1527; Putiri EL, 2011, CLIN EPIGENETICS, V2, P299, DOI 10.1007/s13148-010-0017-z; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Schaap FG, 2013, ADV ANAT PATHOL, V20, P32, DOI 10.1097/PAP.0b013e31827b654d; Scully SP, 2000, CLIN ORTHOP RELAT R, P291; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Turkalp Z, 2014, JAMA NEUROL, V71, P1319, DOI 10.1001/jamaneurol.2014.1205; Van Schaftingen E, 2009, J INHERIT METAB DIS, V32, P135, DOI 10.1007/s10545-008-1042-3; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Waterfall JJ, 2014, BIOCHEM BIOPH RES CO, V455, P16, DOI 10.1016/j.bbrc.2014.08.003; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yen KE, 2010, ONCOGENE, V29, P6409, DOI 10.1038/onc.2010.444; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	43	46	49	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0133813	10.1371/journal.pone.0133813	http://dx.doi.org/10.1371/journal.pone.0133813			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368816	Green Submitted, Green Published, gold			2022-12-27	WOS:000361601100004
J	Rahman, S; Bruce, N				Rahman, Shafin; Bruce, Neil			Visual Saliency Prediction and Evaluation across Different Perceptual Tasks	PLOS ONE			English	Article							MODEL	Saliency maps produced by different algorithms are often evaluated by comparing output to fixated image locations appearing in human eye tracking data. There are challenges in evaluation based on fixation data due to bias in the data. Properties of eye movement patterns that are independent of image content may limit the validity of evaluation results, including spatial bias in fixation data. To address this problem, we present modeling and evaluation results for data derived from different perceptual tasks related to the concept of saliency. We also present a novel approach to benchmarking to deal with some of the challenges posed by spatial bias. The results presented establish the value of alternatives to fixation data to drive improvement and development of models. We also demonstrate an approach to approximate the output of alternative perceptual tasks based on computational saliency and/or eye gaze data. As a whole, this work presents novel benchmarking results and methods, establishes a new performance baseline for perceptual tasks that provide an alternative window into visual saliency, and demonstrates the capacity for saliency to serve in approximating human behaviour for one visual task given data from another.	[Rahman, Shafin; Bruce, Neil] Univ Manitoba, Dept Comp Sci, Winnipeg, MB R3T 2N2, Canada	University of Manitoba	Bruce, N (corresponding author), Univ Manitoba, Dept Comp Sci, Winnipeg, MB R3T 2N2, Canada.	bruce@cs.umanitoba.ca	Rahman, Shafin/N-1939-2019	Rahman, Shafin/0000-0001-7169-0318	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada, NB, http://www.nserc-crsng.gc.ca/ and University of Manitoba, SR NB, http://umanitoba.ca/.	Alpert S, 2007, PROC CVPR IEEE, P359; Borji A, 2013, IEEE T IMAGE PROCESS, V22, P55, DOI 10.1109/TIP.2012.2210727; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bruce NDB, 2009, J VISION, V9, DOI 10.1167/9.3.5; Garcia-Diaz A, 2012, IMAGE VISION COMPUT, V30, P51, DOI 10.1016/j.imavis.2011.11.007; HOU X., 2009, DYNAMIC VISUAL ATTEN, P681; Hou X., 2007, P IEEE COMP SOC C CO; Hou XD, 2012, IEEE T PATTERN ANAL, V34, P194, DOI 10.1109/TPAMI.2011.146; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Judd T., 2012, MITCSAILTR2012001; Kanan C, 2009, VIS COGN, V17, P979, DOI 10.1080/13506280902771138; Koehler K, 2014, J VISION, V14, DOI 10.1167/14.3.14; Le Meur O, 2013, BEHAV RES METHODS, V45, P251, DOI 10.3758/s13428-012-0226-9; Perona, 2007, ADV NEURAL INFORM PR, P545, DOI DOI 10.7551/MITPRESS/7503.003.0073; Rahman S, 2014, IEEE IMAGE PROC, P4082, DOI 10.1109/ICIP.2014.7025829; Seo HJ, 2009, J VISION, V9, DOI 10.1167/9.12.15; Tatler BW, 2007, J VISION, V7, DOI 10.1167/7.14.4; Torralba A, 2003, J OPT SOC AM A, V20, P1407, DOI 10.1364/JOSAA.20.001407; Yan JC, 2010, IEEE IMAGE PROC, P1089, DOI 10.1109/ICIP.2010.5652280; Zhang LY, 2008, J VISION, V8, DOI 10.1167/8.7.32	20	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138053	10.1371/journal.pone.0138053	http://dx.doi.org/10.1371/journal.pone.0138053			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368124	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100211
J	Shi, HL; Jiang, ZQ; Zhou, WX				Shi, Huai-Long; Jiang, Zhi-Qiang; Zhou, Wei-Xing			Profitability of Contrarian Strategies in the Chinese Stock Market	PLOS ONE			English	Article							MOMENTUM; WINNERS	This paper reexamines the profitability of loser, winner and contrarian portfolios in the Chinese stock market using monthly data of all stocks traded on the Shanghai Stock Exchange and Shenzhen Stock Exchange covering the period from January 1997 to December 2012. We find evidence of short-term and long-term contrarian profitability in the whole sample period when the estimation and holding horizons are 1 month or longer than 12 months and the annualized return of contrarian portfolios increases with the estimation and holding horizons. We perform subperiod analysis and find that the long-term contrarian effect is significant in both bullish and bearish states, while the short-term contrarian effect disappears in bullish states. We compare the performance of contrarian portfolios based on different grouping manners in the estimation period and unveil that decile grouping outperforms quintile grouping and tertile grouping, which is more evident and robust in the long run. Generally, loser portfolios and winner portfolios have positive returns and loser portfolios perform much better than winner portfolios. Both loser and winner portfolios in bullish states perform better than those in the whole sample period. In contrast, loser and winner portfolios have smaller returns in bearish states, in which loser portfolio returns are significant only in the long term and winner portfolio returns become insignificant. These results are robust to the one-month skipping between the estimation and holding periods and for the two stock exchanges. Our findings show that the Chinese stock market is not efficient in the weak form. These findings also have obvious practical implications for financial practitioners.	[Shi, Huai-Long; Jiang, Zhi-Qiang; Zhou, Wei-Xing] E China Univ Sci & Technol, Sch Business, Dept Finance, Shanghai 200237, Peoples R China; [Shi, Huai-Long; Jiang, Zhi-Qiang; Zhou, Wei-Xing] E China Univ Sci & Technol, Res Ctr Econophys, Shanghai 300237, Peoples R China; [Zhou, Wei-Xing] E China Univ Sci & Technol, Dept Math, Sch Sci, Shanghai 300237, Peoples R China	East China University of Science & Technology; East China University of Science & Technology; East China University of Science & Technology	Zhou, WX (corresponding author), E China Univ Sci & Technol, Sch Business, Dept Finance, Shanghai 200237, Peoples R China.	wxzhou@ecust.edu.cn	Zhou, Wei-Xing/B-1250-2008; Jiang, Zhi-Qiang/B-5746-2008	Zhou, Wei-Xing/0000-0002-8952-8228; Jiang, Zhi-Qiang/0000-0003-4013-1753	National Natural Science Foundation of China [71131007]; Shanghai "Chen Guang" Project [2012CG34]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai "Chen Guang" Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China under grant No. 71131007 (WXZ) (http://www.nsfc.gov.cn/), Shanghai "Chen Guang" Project under grant No. 2012CG34 (ZQJ) (http://www.shmec.gov.cn/web/xxgk/rows_list.php?node_code = 41212), and Fundamental Research Funds for the Central Universities (WXZ ZQJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asness CS, 2013, J FINANC, V68, P929, DOI 10.1111/jofi.12021; BALL R, 1995, J PORTFOLIO MANAGE, V21, P54, DOI 10.3905/jpm.1995.54; Baytas A, 1999, J BANK FINANC, V23, P1121, DOI 10.1016/S0378-4266(98)00133-2; Chan LKC, 1996, J FINANC, V51, P1681, DOI 10.2307/2329534; Chen H., 2004, J EMPIR FINANC, V11, P483, DOI DOI 10.1016/J.JEMPFIN.2004.04.005; Chou P., 2007, J EMPIR FINANC, V14, P261, DOI DOI 10.1016/J.JEMPFIN.2006.07.003; Conrad J, 1997, J BUS ECON STAT, V15, P379; Cooper MJ, 2004, J FINANC, V59, P1345, DOI 10.1111/j.1540-6261.2004.00665.x; Daniel K., 2000, MARKET EFFICIENCY IR; DEBONDT WFM, 1985, J FINANC, V40, P793, DOI 10.1111/j.1540-6261.1985.tb05004.x; DEBONDT WFM, 1987, J FINANC, V42, P557, DOI 10.1111/j.1540-6261.1987.tb04569.x; FAMA EF, 1991, J FINANC, V46, P1575, DOI 10.2307/2328565; FAMA EF, 1970, J FINANC, V25, P383, DOI 10.2307/2325486; George TJ, 2004, J FINANC, V59, P2145, DOI 10.1111/j.1540-6261.2004.00695.x; Grinblatt M, 1995, AM ECON REV, V85, P1088; Hameed A., 2000, PAC-BASIN FINANC J, V8, P67, DOI [10.1016/S0927-538X(99)00029-3, DOI 10.1016/S0927-538X(99)00029-3]; He XZ, 2015, J BANK FINANC, V53, P140, DOI 10.1016/j.jbankfin.2014.12.017; JEGADEESH N, 1993, J FINANC, V48, P65, DOI 10.1111/j.1540-6261.1993.tb04702.x; JEGADEESH N, 1990, J FINANC, V45, P881, DOI 10.2307/2328797; Jiang ZQ, 2010, J ECON BEHAV ORGAN, V74, P149, DOI 10.1016/j.jebo.2010.02.007; Kang J., 2002, PACIFIC BASIN FINANC, V10, P243, DOI DOI 10.1016/S0927-538X(02)00046-X; Lee CMC, 2000, J FINANC, V55, P2017, DOI 10.1111/0022-1082.00280; LEHMANN BN, 1990, Q J ECON, V105, P1, DOI 10.2307/2937816; Lesmond DA, 2004, J FINANC ECON, V71, P349, DOI 10.1016/S0304-405X(03)00206-X; Levis M, 1999, J PORTFOLIO MANAGE, V26, P73, DOI 10.3905/jpm.1999.319770; Lewellen J, 2002, REV FINANC STUD, V15, P533, DOI 10.1093/rfs/15.2.533; [李诗林 Li Shilin], 2003, [管理评论, Management review], V15, P28; [刘驰 LIU Chi], 2007, [系统管理学报, Journal of Systems & Management], V16, P612; [罗洪浪 Luo Honglang], 2004, [系统工程理论方法应用, Systems engineering theory methodology applications], V13, P495; [马超群 Ma Chaoqun], 2005, [管理工程学报, Journal of Industrial Engineering and Engineering Management], V19, P64; Moskowitz TJ, 1999, J FINANC, V54, P1249, DOI 10.1111/0022-1082.00146; Naughton T, 2008, PACIFIC BASIN FINANC, V16, P472, DOI [DOI 10.1016/j.pacfin.2007.10.001, 10.1016/j.pacfin.2007.10.001, DOI 10.1016/J.PACFIN.2007.10.001]; Novy-Marx R, 2012, J FINANC ECON, V103, P429, DOI 10.1016/j.jfineco.2011.05.003; Pan L., 2011, J FINANC RES, V1, P149; Pan L, 2013, PAC-BASIN FINANC J, V21, P1191, DOI 10.1016/j.pacfin.2012.06.001; Qian Y, 2003, APPL STAT MANAG, V22, P35; Rouwenhorst KG, 1998, J FINANC, V53, P267, DOI 10.1111/0022-1082.95722; THALER RH, 1988, J ECON PERSPECT, V2, P191, DOI 10.1257/jep.2.1.191; Wang C., 2004, PAC BASIN FINANCE J, V12, P541, DOI DOI 10.1016/J.PACFIN.2003.12.002; Wu LL, 2008, S CHINA FIN, V2008, P47; [杨炘 Yang Xin], 2004, [清华大学学报. 自然科学版, Journal of Tsinghua University(Science and Technology)], V44, P758; Yao YQ, 2012, J BANK FINANC, V36, P2757, DOI 10.1016/j.jbankfin.2011.12.004; Yu, 2005, CONT EC MANAG, V2, P96; Zhao XJ, 2001, SECURITIES MARKET HE, V2001, P28; Zhen L., 2007, EC RES J, V9, P145; Zhou WX, 2004, PHYSICA A, V337, P243, DOI 10.1016/j.physa.2004.01.051; Zhu Z. Y., 2003, J WORLD EC, V26, P62; Zhu Zhan-yu, 2005, Journal of Shanghai Jiaotong University, V39, P442; [邹小芃 Zou Xiaopeng], 2003, [数理统计与管理, Application of Statistics and Management], V22, P9; 刘博, 2007, [金融研究, Financial Studies], P154	50	22	22	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137892	10.1371/journal.pone.0137892	http://dx.doi.org/10.1371/journal.pone.0137892			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8KS	26368537	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100170
J	Ke, JT; Lou, J; Chen, XQ; Li, JY; Liu, C; Gong, YJ; Yang, Y; Zhu, Y; Zhang, Y; Gong, J				Ke, Juntao; Lou, Jiao; Chen, Xueqin; Li, Jiaoyuan; Liu, Cheng; Gong, Yajie; Yang, Yang; Zhu, Ying; Zhang, Yi; Gong, Jing			Identification of a Potential Regulatory Variant for Colorectal Cancer Risk Mapping to Chromosome 5q31.1: A Post-GWAS Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HOMEOBOX GENE-EXPRESSION; SUSCEPTIBILITY LOCI; CHINESE POPULATION; ENHANCER ACTIVITY; LUNG-CANCER; EAST ASIANS; PITX1; METAANALYSIS; STATE	Large-scale genome-wide association studies (GWAS) have established chromosome 5q31.1 as a susceptibility locus for colorectal cancer (CRC), which was still lack of causal genetic variants. We searched potentially regulatory single nucleotide polymorphisms (SNPs) in the overlap region between linkage disequilibrium (LD) block of 5q31.1 and regulatory elements predicted by histone modifications, then tested their association with CRC via a case-control study. Among three candidate common variants, we found rs17716310 conferred significantly (heterozygous model: OR = 1.273, 95% confidence interval (95% CI) = 1.016-1.595, P = 0.036) and marginally (dominant model: OR = 1.238, 95% CI = 1.000-1.532, P = 0.050) increase risk for CRC in a Chinese population including 695 cases and 709 controls. This variation was suggested to be regulatory altering the activity of enhancer that control PITX1 expression. Using epigenetic information such as chromatin immunoprecipitation- sequencing (ChIP-seq) data might help researchers to interpret the results of GWAS and locate causal variants for diseases in post-GWAS era.	[Gong, Jing] Huazhong Univ Sci & Technol, State Key Lab Environm Hlth Incubat, MOE Minist Educ,Key Lab Environm & Hlth Wuhan, Key Lab Environm & Hlth,Minist Environm Protect, Wuhan 430074, Peoples R China; Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Gong, J (corresponding author), Huazhong Univ Sci & Technol, State Key Lab Environm Hlth Incubat, MOE Minist Educ,Key Lab Environm & Hlth Wuhan, Key Lab Environm & Hlth,Minist Environm Protect, Wuhan 430074, Peoples R China.	gongj@hust.edu.cn	李, 娇元/GVS-6952-2022		National Natural Science Foundation of China [NSFC-81402744]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC-81402744) to JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder JK, 2011, AM J RESP CRIT CARE, V184, P904, DOI 10.1164/rccm.201103-0520OC; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017; Biancolella M, 2014, HUM MOL GENET, V23, P2198, DOI 10.1093/hmg/ddt584; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Chen WQ, 2015, CHINESE J CANCER RES, V27, P2, DOI 10.3978/j.issn.1000-9604.2015.01.06; Chen YN, 2008, WORLD J GASTROENTERO, V14, P292, DOI 10.3748/wjg.14.292; Chen Y, 2007, LUNG CANCER, V55, P287, DOI 10.1016/j.lungcan.2006.11.001; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cui R, 2011, GUT, V60, P799, DOI 10.1136/gut.2010.215947; Damico R, 2011, AM J RESP CELL MOL, V44, P323, DOI 10.1165/rcmb.2009-0379OC; de la Chapelle A, 2004, NAT REV CANCER, V4, P769, DOI 10.1038/nrc1453; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dunlop MG, 2012, NAT GENET, V44, P770, DOI 10.1038/ng.2293; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Farnham PJ, 2012, J BIOL CHEM, V287, P30885, DOI 10.1074/jbc.R112.365940; Haggar Fatima A, 2009, Clin Colon Rectal Surg, V22, P191, DOI 10.1055/s-0029-1242458; Hardison RC, 2012, J BIOL CHEM, V287, P30932, DOI 10.1074/jbc.R112.352427; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Jia WH, 2013, NAT GENET, V45, P191, DOI 10.1038/ng.2505; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Knosel T, 2012, INT J COLORECTAL DIS, V27, P1391, DOI 10.1007/s00384-012-1460-4; Knol MJ, 2007, INT J EPIDEMIOL, V36, P1111, DOI 10.1093/ije/dym157; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kumar S, 2015, ONCOGENE, V34, P2052, DOI 10.1038/onc.2014.154; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Liu DX, 2007, CELL DEATH DIFFER, V14, P1893, DOI 10.1038/sj.cdd.4402209; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Lord RVN, 2005, SURGERY, V138, P924, DOI 10.1016/j.surg.2005.05.007; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Nagel S, 2011, LEUKEMIA LYMPHOMA, V52, P1348, DOI 10.3109/10428194.2011.566391; Pasquali L, 2014, NAT GENET, V46, P136, DOI 10.1038/ng.2870; Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020; Qi DL, 2011, MOL CELL BIOL, V31, P1624, DOI 10.1128/MCB.00470-10; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Watanabe T, 2011, EUR J CANCER, V47, P1946, DOI 10.1016/j.ejca.2011.03.029; Yao LJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6114; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zhang B, 2014, INT J CANCER, V135, P948, DOI 10.1002/ijc.28733; Zhang B, 2014, NAT GENET, V46, P533, DOI 10.1038/ng.2985; Zhang XY, 2014, TRENDS GENET, V30, P140, DOI 10.1016/j.tig.2014.02.006; Zhong R, 2013, MOL CARCINOGEN, V52, P118, DOI 10.1002/mc.22043; Zhong R, 2013, CARCINOGENESIS, V34, P936, DOI 10.1093/carcin/bgs395; Zhu BB, 2015, MOL CARCINOGEN, V54, P761, DOI 10.1002/mc.22140; Zhu BB, 2014, CLIN GASTROENTEROL H, V12, P1991, DOI 10.1016/j.cgh.2014.03.019	59	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138478	10.1371/journal.pone.0138478	http://dx.doi.org/10.1371/journal.pone.0138478			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381143	Green Submitted, Green Published, gold			2022-12-27	WOS:000361790200111
J	Chen, WC; Yang, GP; He, Y; Zhang, SM; Chen, HY; Shen, P; Chen, XD; Huang, YP				Chen, Wenchao; Yang, Guopeng; He, Yue; Zhang, Shaoming; Chen, Haiyan; Shen, Ping; Chen, Xiangdong; Huang, Yu-Ping			Nucleotides Flanking the Start Codon in hsp70 mRNAs with Very Short 5 '-UTRs Greatly Affect Gene Expression in Haloarchaea	PLOS ONE			English	Article							HALOPHILIC BETA-GALACTOSIDASE; TRANSLATION INITIATION; HALOFERAX-VOLCANII; REPORTER GENE; 70S RIBOSOMES; TRANSCRIPTION; SEQUENCES; ACETYLATION; MECHANISM; EUKARYOTE	Leaderless translation is prevalent in haloarchaea, with many of these leaderless transcripts possessing short 5'-untranslated regions (UTRs) less than 10 nucleotides. Whereas, little is known about the function of this very short 5'-UTR. Our previous studies determined that just four nucleotides preceded the start codon of hsp70 mRNA in Natrinema sp. J7, with residues -3A and +4G, relative to the A of the ATG start codon, acting as the preferred bases around the start codon of all known haloarchaeal hsp70 genes. Here, we examined the effects of nucleotides flanking the start codon on gene expression. The results revealed that shortening and deletion of the short 5'-UTR enhanced transcript levels; however, it led to significant reductions in overall translational efficiency. AUG was efficiently used as start codons, in both the presence and absence of short 5'-UTRs. GUG also could initiate translation, even though it was so inefficient that it would not be detected without considerably elevated transcript. Nucleotide substitutions at position -4 to +6 were shown to affect gene expression by transcript and/or translational levels. Notably, -3A and A/U nucleotides at position +4 similar to+6 were more optimal for gene expression. Nucleotide transversions of -3A to -3C and +4G to +4T with hsp70 promoter from either Haloferax volcanii DS70 or Halobacterium salinarum NRC-1 showed the same effects on gene expression as that of Natrinema sp. J7. Taken together, our results suggest that the nucleotides flanking the start codon in hsp70 mRNAs with very short 5'-UTRs play an important role in haloarchaeal gene expression.	[Chen, Wenchao; Yang, Guopeng; He, Yue; Zhang, Shaoming; Chen, Haiyan; Shen, Ping; Chen, Xiangdong; Huang, Yu-Ping] Wuhan Univ, Coll Life Sci, Dept Microbiol, Wuhan 430072, Peoples R China	Wuhan University	Huang, YP (corresponding author), Wuhan Univ, Coll Life Sci, Dept Microbiol, Wuhan 430072, Peoples R China.	yphuang@whu.edu.cn	Chen, Haiyan/HGB-6216-2022		National Basic Research Program of China (973 Program) [2011CB808800]; National Natural Science Foundation of China [30970070, 30870133]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by National Basic Research Program of China (973 Program) (2011CB808800), National Natural Science Foundation of China (No. 30970070 and 30870133).	Allers T, 2005, NAT REV GENET, V6, P58, DOI 10.1038/nrg1504; Andreev DE, 2006, MOL CELL BIOL, V26, P3164, DOI 10.1128/MCB.26.8.3164-3169.2006; Bartlett MS, 2005, CURR OPIN MICROBIOL, V8, P677, DOI 10.1016/j.mib.2005.10.016; BLUM P, 1992, J BACTERIOL, V174, P7436, DOI 10.1128/jb.174.22.7436-7444.1992; Brenneis M, 2007, PLOS GENET, V3, P2450, DOI 10.1371/journal.pgen.0030229; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Eichler J, 2013, FEMS MICROBIOL REV, V37, P583, DOI 10.1111/1574-6976.12012; Falb M, 2006, J MOL BIOL, V362, P915, DOI 10.1016/j.jmb.2006.07.086; French SL, 2007, MOL BIOL EVOL, V24, P893, DOI 10.1093/molbev/msm007; Gregor D, 2001, MICROBIOL-SGM, V147, P1745, DOI 10.1099/00221287-147-7-1745; Grill S, 2000, EMBO J, V19, P4101, DOI 10.1093/emboj/19.15.4101; Hartman AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009605; Helbig AO, 2010, MOL CELL PROTEOMICS, V9, P928, DOI 10.1074/mcp.M900463-MCP200; Hering O, 2009, MOL MICROBIOL, V71, P1451, DOI 10.1111/j.1365-2958.2009.06615.x; Hickey AJ, 2002, CRIT REV BIOCHEM MOL, V37, P537, DOI 10.1080/10409230290771555; Holmes ML, 1997, BBA-PROTEIN STRUCT M, V1337, P276, DOI 10.1016/S0167-4838(96)00174-4; Holmes ML, 2000, MOL MICROBIOL, V36, P114, DOI 10.1046/j.1365-2958.2000.01832.x; Humbard MA, 2009, J BACTERIOL, V191, P3794, DOI 10.1128/JB.00090-09; Kaberdina AC, 2009, MOL CELL, V33, P227, DOI 10.1016/j.molcel.2008.12.014; Karlin S, 2005, P NATL ACAD SCI USA, V102, P7303, DOI 10.1073/pnas.0502313102; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; KOZAK M, 1981, NUCLEIC ACIDS RES, V9, P5233, DOI 10.1093/nar/9.20.5233; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Kramer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094979; Li L, 2004, J BIOL CHEM, V279, P14656, DOI 10.1074/jbc.M309879200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu QH, 2008, NUCLEIC ACIDS RES, V36, P3031, DOI 10.1093/nar/gkn152; Malys N, 2011, CELL MOL LIFE SCI, V68, P991, DOI 10.1007/s00018-010-0588-z; Moll I, 2004, NUCLEIC ACIDS RES, V32, P3354, DOI 10.1093/nar/gkh663; Moll I, 2002, MOL MICROBIOL, V43, P239, DOI 10.1046/j.1365-2958.2002.02739.x; Nakagawa S, 2008, NUCLEIC ACIDS RES, V36, P861, DOI 10.1093/nar/gkm1102; O'Donnell SA, 2002, J BACTERIOL, V184, P6730, DOI 10.1128/JB.184.23.6730-6733.2002; Patenge N, 2000, MOL MICROBIOL, V36, P105, DOI 10.1046/j.1365-2958.2000.01831.x; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; Qing GL, 2003, J MOL MICROB BIOTECH, V6, P133, DOI 10.1159/000077244; Reeve JN, 2005, CURR OPIN MICROBIOL, V8, P627, DOI 10.1016/j.mib.2005.10.017; SHINE J, 1975, NATURE, V254, P34, DOI 10.1038/254034a0; Slupska MM, 2001, J MOL BIOL, V309, P347, DOI 10.1006/jmbi.2001.4669; Srinivasan G, 2006, MOL MICROBIOL, V59, P1013, DOI 10.1111/j.1365-2958.2005.04992.x; Stenstrom CM, 2002, GENE, V288, P1, DOI 10.1016/S0378-1119(02)00501-2; Sugimoto S, 2008, MICROBIOL-SGM, V154, P1876, DOI 10.1099/mic.0.2008/017376-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tolstrup N, 2000, EXTREMOPHILES, V4, P175, DOI 10.1007/s007920070032; Torarinsson E, 2005, ENVIRON MICROBIOL, V7, P47, DOI 10.1111/j.1462-2920.2004.00674.x; Van Etten WJ, 1998, MOL MICROBIOL, V27, P987, DOI 10.1046/j.1365-2958.1998.00744.x; Wendoloski D, 2001, MICROBIOL-SGM, V147, P959, DOI 10.1099/00221287-147-4-959; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109; Zhang H, 2009, EXTREMOPHILES, V13, P669, DOI 10.1007/s00792-009-0251-5	50	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138473	10.1371/journal.pone.0138473	http://dx.doi.org/10.1371/journal.pone.0138473			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379277	gold, Green Submitted, Green Published			2022-12-27	WOS:000361769400103
J	Gilbert, JL; Guthart, MJ; Gezan, SA; de Carvalho, MP; Schwieterman, ML; Colquhoun, TA; Bartoshuk, LM; Sims, CA; Clark, DG; Olmstead, JW				Gilbert, Jessica L.; Guthart, Matthew J.; Gezan, Salvador A.; de Carvalho, Melissa Pisaroglo; Schwieterman, Michael L.; Colquhoun, Thomas A.; Bartoshuk, Linda M.; Sims, Charles A.; Clark, David G.; Olmstead, James W.			Identifying Breeding Priorities for Blueberry Flavor Using Biochemical, Sensory, and Genotype by Environment Analyses	PLOS ONE			English	Article							VACCINIUM-CORYMBOSUM; VOLATILE COMPOSITION; INSTRUMENTAL MEASUREMENTS; AROMA; QUALITY; FRUIT; ODOR; TEXTURE; TASTE; IDENTIFICATION	Breeding for a subjective goal such as flavor is challenging, as many blueberry cultivars are grown worldwide, and identifying breeding targets relating to blueberry flavor biochemistry that have a high degree of genetic control and low environmental variability are priorities. A variety of biochemical compounds and physical characters induce the sensory responses of taste, olfaction, and somatosensation, all of which interact to create what is perceived flavor. The goal of this study was to identify the flavor compounds with a larger genetic versus environmental component regulating their expression over an array of cultivars, locations, and years. Over the course of three years, consumer panelists rated overall liking, texture, sweetness, sourness, and flavor intensity of 19 southern highbush blueberry (Vaccinium corymbosum hybrids) genotypes in 30 sensory panels. Significant positive correlations to overall liking of blueberry fruit (P<0.001) were found with sweetness (R-2 = 0.70), texture (R-2 = 0.68), and flavor (R-2 = 0.63). Sourness had a significantly negative relationship with overall liking (R-2 = 0.55). The relationship between flavor and texture liking was also linear (R-2 = 0.73, P<0.0001) demonstrating interaction between olfaction and somatosensation. Partial least squares analysis was used to identify sugars, acids, and volatile compounds contributing to liking and sensory intensities, and revealed strong effects of fructose, pH, and several volatile compounds upon all sensory parameters measured. To assess the feasibility of breeding for flavor components, a three year study was conducted to compare genetic and environmental influences on flavor biochemistry. Panelists could discern genotypic variation in blueberry sensory components, and many of the compounds affecting consumer favor of blueberries, such as fructose, pH, beta-caryophyllene oxide and 2-heptanone, were sufficiently genetically controlled that allocating resources for their breeding is worthwhile.	[Gilbert, Jessica L.; Schwieterman, Michael L.; Colquhoun, Thomas A.; Bartoshuk, Linda M.; Sims, Charles A.; Clark, David G.; Olmstead, James W.] Univ Florida, Inst Food & Agr Sci, Plant Innovat Ctr, Gainesville, FL 32611 USA; [Gilbert, Jessica L.; Guthart, Matthew J.; Olmstead, James W.] Univ Florida, Inst Food & Agr Sci, Dept Hort Sci, Gainesville, FL 32611 USA; [Gezan, Salvador A.; de Carvalho, Melissa Pisaroglo] Univ Florida, Inst Food & Agr Sci, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA; [Schwieterman, Michael L.; Colquhoun, Thomas A.; Clark, David G.] Univ Florida, Inst Food & Agr Sci, Dept Environm Hort, Gainesville, FL 32611 USA; [Bartoshuk, Linda M.; Sims, Charles A.] Univ Florida, Inst Food & Agr Sci, Food Sci & Human Nutr, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Olmstead, JW (corresponding author), Univ Florida, Inst Food & Agr Sci, Plant Innovat Ctr, Gainesville, FL 32611 USA.	jwolmstead@ufl.edu			University of Florida Graduate Fellowship in Plant Molecular Breeding	University of Florida Graduate Fellowship in Plant Molecular Breeding	A University of Florida Graduate Fellowship in Plant Molecular Breeding was obtained by DGC and JWO in 2011 to fund this project. http://pmcb.ifas.ufl.edu/funding/index.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almenar E, 2010, J SCI FOOD AGR, V90, P1121, DOI 10.1002/jsfa.3922; Badoc A., 1991, Journal of Essential Oil Research, V3, P269; BALLINGTON JR, 1984, J AM SOC HORTIC SCI, V109, P684; BALOGA DW, 1995, ACS SYM SER, V596, P235; Barrett DM, 2010, CRIT REV FOOD SCI, V50, P369, DOI 10.1080/10408391003626322; Bartoshuk LM, 2005, CURR DIR PSYCHOL SCI, V14, P122, DOI 10.1111/j.0963-7214.2005.00346.x; Bartoshuk LM, 2004, PHYSIOL BEHAV, V82, P109, DOI 10.1016/j.physbeh.2004.02.033; Benn SM, 1996, J AGR FOOD CHEM, V44, P557, DOI 10.1021/jf9504172; Blaker KM, 2014, J SCI FOOD AGR, V94, P2785, DOI 10.1002/jsfa.6626; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; Bojanowski V, 2012, PHYSIOL BEHAV, V107, P484, DOI 10.1016/j.physbeh.2012.03.001; Cebolla-Cornejo J, 2011, J AGR FOOD CHEM, V59, P2440, DOI 10.1021/jf1045427; Colquhoun TA, 2013, POSTHARVEST BIOL TEC, V86, P37, DOI 10.1016/j.postharvbio.2013.06.013; DARNELL RL, 1994, PHYSIOL PLANTARUM, V92, P336, DOI [10.1111/j.1399-3054.1994.tb05345.x, 10.1034/j.1399-3054.1994.920220.x]; de Kermadec F, 1997, FOOD QUAL PREFER, V8, P395, DOI 10.1016/S0950-3293(97)00026-8; DIMICK PS, 1983, CRC CR REV FOOD SCI, V18, P387, DOI 10.1080/10408398309527367; Du XF, 2011, J AGR FOOD CHEM, V59, P8347, DOI 10.1021/jf201184m; Eichholz I, 2011, FOOD CHEM, V126, P60, DOI 10.1016/j.foodchem.2010.10.071; Figueiredo AC, 2008, FLAVOUR FRAG J, V23, P213, DOI 10.1002/ffj.1875; Forney CF, 2001, HORTTECHNOLOGY, V11, P529, DOI 10.21273/HORTTECH.11.4.529; FRANK RA, 1993, PERCEPT PSYCHOPHYS, V54, P343, DOI 10.3758/BF03205269; FRANKE W, 1961, ARCH MIKROBIOL, V40, P73, DOI 10.1007/BF00408834; GALLETTA GJ, 1971, J AM SOC HORTIC SCI, V96, P758; Gilbert JL, 2014, HORTSCIENCE, V49, P864, DOI 10.21273/HORTSCI.49.7.864; Gilbert JL, 2013, HORTSCIENCE, V48, P835, DOI 10.21273/HORTSCI.48.7.835; Golebiowski M, 2008, CHEM NAT COMPD+, V44, P794, DOI 10.1007/s10600-009-9171-y; Gould W.A., 1983, TOMATO PRODUCTION PR; HIRVI T, 1983, J SCI FOOD AGR, V34, P992, DOI 10.1002/jsfa.2740340916; Hongsoongnern P, 2008, J SENS STUD, V23, P205, DOI 10.1111/j.1745-459X.2007.00150.x; HORVAT RJ, 1985, J FOOD SCI, V50, P429, DOI 10.1111/j.1365-2621.1985.tb13419.x; Hough G, 1996, FOOD QUAL PREFER, V7, P47, DOI 10.1016/0950-3293(94)00000-X; KADER F, 1993, FOOD SCI TECHNOL-LEB, V26, P593, DOI 10.1006/fstl.1993.1114; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Klesk K, 2004, J AGR FOOD CHEM, V52, P5155, DOI 10.1021/jf0498721; LARSEN M, 1992, Z LEBENSM UNTERS FOR, V195, P120, DOI 10.1007/BF01201770; Lawless H. T., 2010, SENSORY EVALUATION F; Mahawanich T, 2004, FOOD CHEM, V84, P169, DOI 10.1016/S0308-8146(03)00197-3; Mattheis JP, 1999, POSTHARVEST BIOL TEC, V15, P227, DOI 10.1016/S0925-5214(98)00087-8; Moore PP, 2002, ACTA HORTIC, P511, DOI 10.17660/ActaHortic.2002.585.82; MOSKOWIT.HR, 1970, PERCEPT PSYCHOPHYS, V7, P315, DOI 10.3758/BF03210175; MOSKOWITZ HR, 1971, AM J PSYCHOL, V84, P387, DOI 10.2307/1420470; Murthy CT, 2008, J FOOD ENG, V85, P18, DOI 10.1016/j.jfoodeng.2007.06.020; Niimura Y, 2012, CURR GENOMICS, V13, P103, DOI 10.2174/138920212799860706; Olender T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-414; PANGBORN RM, 1960, FOOD TECHNOL-CHICAGO, V14, pB36; PARLIMENT TH, 1975, J FOOD SCI, V40, P762, DOI 10.1111/j.1365-2621.1975.tb00550.x; Paterson A, 2013, THEOR APPL GENET, V126, P33, DOI 10.1007/s00122-012-1957-9; Payne TJ, 2014, N AM HIGHBUSH BLUEBE; Pirbalouti AG, 2013, IND CROP PROD, V48, P43, DOI 10.1016/j.indcrop.2013.04.004; Qian MC, 2005, J FOOD SCI, V70, pC13, DOI 10.1111/j.1365-2621.2005.tb09013.x; Rohloff J, 2004, J FOOD AGRIC ENVIRON, V2, P74; Ryan D, 2008, TRENDS FOOD SCI TECH, V19, P383, DOI 10.1016/j.tifs.2008.01.007; Saftner R, 2008, POSTHARVEST BIOL TEC, V49, P19, DOI 10.1016/j.postharvbio.2008.01.008; Samykanno K, 2013, SCI HORTIC-AMSTERDAM, V164, P633, DOI 10.1016/j.scienta.2013.09.001; Sanchez G, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-137; SCHIEBERLE P, 1988, J AGR FOOD CHEM, V36, P797, DOI 10.1021/jf00082a031; Schwieterman ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088446; Styger G, 2011, J IND MICROBIOL BIOT, V38, P1145, DOI 10.1007/s10295-011-1018-4; SZCZESNIAK AS, 1988, J TEXTURE STUD, V19, P61, DOI 10.1111/j.1745-4603.1988.tb00925.x; Taylor AJ, 2004, FLAVOR PERCEPTION; Tenenhaus M, 2005, FOOD QUAL PREFER, V16, P315, DOI 10.1016/j.foodqual.2004.05.013; Tieman D, 2012, CURR BIOL, V22, P1035, DOI 10.1016/j.cub.2012.04.016; Togari N, 1995, FOOD RES INT, V28, P485, DOI 10.1016/0963-9969(95)00028-3; Toscas PJ, 1999, MEAT SCI, V52, P173, DOI 10.1016/S0309-1740(98)00165-X; Troje ZS, 1997, J CHROMATOGR A, V775, P101; Van Opstaele F, 2013, J AGR FOOD CHEM, V61, P10555, DOI 10.1021/jf402496t; Vigues S, 2009, RESULTS PROBL CELL D, V47, P187, DOI 10.1007/400_2008_2; Wang L, 2004, J I BREWING, V110, P57, DOI 10.1002/j.2050-0416.2004.tb00181.x; Weel KGC, 2002, J AGR FOOD CHEM, V50, P5149, DOI 10.1021/jf0202786; Werkhoff P, 1998, J AGR FOOD CHEM, V46, P1076, DOI 10.1021/jf970655s; Wolken WAM, 2001, APPL MICROBIOL BIOT, V57, P731, DOI 10.1007/s002530100821; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; YU TH, 1989, J AGR FOOD CHEM, V37, P730, DOI 10.1021/jf00087a033	73	54	56	7	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138494	10.1371/journal.pone.0138494	http://dx.doi.org/10.1371/journal.pone.0138494			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378911	gold, Green Submitted, Green Published			2022-12-27	WOS:000361769400106
J	Ito, D; Cao, PY; Kakihana, T; Sato, E; Suda, C; Muroya, Y; Ogawa, Y; Hu, GZ; Ishii, T; Ito, O; Kohzuki, M; Kiyomoto, H				Ito, Daisuke; Cao, Pengyu; Kakihana, Takaaki; Sato, Emiko; Suda, Chihiro; Muroya, Yoshikazu; Ogawa, Yoshiko; Hu, Gaizun; Ishii, Tadashi; Ito, Osamu; Kohzuki, Masahiro; Kiyomoto, Hideyasu			Chronic Running Exercise Alleviates Early Progression of Nephropathy with Upregulation of Nitric Oxide Synthases and Suppression of Glycation in Zucker Diabetic Rats	PLOS ONE			English	Article							GLOMERULAR PODOCYTE INJURY; OXIDATIVE STRESS; FATTY RATS; KIDNEY; ALBUMINURIA; INHIBITION; ACTIVATION; BLOCKADE; KINASE; ONSET	Exercise training is known to exert multiple beneficial effects including renal protection in type 2 diabetes mellitus and obesity. However, the mechanisms regulating these actions remain unclear. The present study evaluated the effects of chronic running exercise on the early stage of diabetic nephropathy, focusing on nitric oxide synthase (NOS), oxidative stress and glycation in the kidneys of Zucker diabetic fatty (ZDF) rats. Male ZDF rats (6 weeks old) underwent forced treadmill exercise for 8 weeks (Ex-ZDF). Sedentary ZDF (Sed-ZDF) and Zucker lean (Sed-ZL) rats served as controls. Exercise attenuated hyperglycemia (plasma glucose; 242 +/- 43 mg/dL in Sed-ZDF and 115 +/- 5 mg/dL in Ex-ZDF) with increased insulin secretion (plasma insulin; 2.3 +/- 0.7 and 5.3 +/- 0.9 ng/mL), reduced albumin excretion (urine albumin; 492 +/- 70 and 176 +/- 11 mg/g creatinine) and normalized creatinine clearance (9.7 +/- 1.4 and 4.5 +/- 0.8 mL/min per body weight) in ZDF rats. Endothelial (e) and neuronal (n) NOS expression in kidneys of Sed-ZDF rats were lower compared with Sed-ZL rats (p<0.01), while both eNOS and nNOS expression were upregulated by exercise (p<0.01). Furthermore, exercise decreased NADPH oxidase activity, p47(phox) expression (p<0.01) and alpha-oxoaldehydes (the precursors for advanced glycation end products) (p<0.01) in the kidneys of ZDF rats. Additionally, morphometric evidence indicated renal damage was reduced in response to exercise. These data suggest that upregulation of NOS expression, suppression of NADPH oxidase and alpha-oxoaldehydes in the kidneys may, at least in part, contribute to the renal protective effects of exercise in the early progression of diabetic nephropathy in ZDF rats. Moreover, this study supports the theory that chronic aerobic exercise could be recommended as an effective non-pharmacological therapy for renoprotection in the early stages of type 2 diabetes mellitus and obesity.	[Ito, Daisuke; Ishii, Tadashi; Kiyomoto, Hideyasu] Tohoku Univ, Tohoku Univ Grad Sch Med, Dept Miyagi Community Hlth Promot, Sendai, Miyagi 980, Japan; [Ito, Daisuke; Cao, Pengyu; Kakihana, Takaaki; Suda, Chihiro; Muroya, Yoshikazu; Ogawa, Yoshiko; Hu, Gaizun; Ito, Osamu; Kohzuki, Masahiro] Tohoku Univ, Tohoku Univ Grad Sch Med, Dept Internal Med & Rehabil Sci, Sendai, Miyagi 980, Japan; [Sato, Emiko] Tohoku Univ, Tohoku Univ Grad Sch Pharmaceut Sci & Med, Dept Clin Pharmacol & Therapeut, Sendai, Miyagi 980, Japan; [Kiyomoto, Hideyasu] Tohoku Univ, Tohoku Med Megabank Org, Dept Integrated Nephrol & Telemed, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku Medical & Pharmaceutical University; Tohoku University; Tohoku University	Ito, D (corresponding author), Tohoku Univ, Tohoku Univ Grad Sch Med, Dept Miyagi Community Hlth Promot, Sendai, Miyagi 980, Japan.	dairyoub4@hotmail.co.jp	Ito, Daisuke/F-4682-2015	Ito, Osamu/0000-0001-7583-5270; xing zhi, shi zhi/0000-0003-3289-5681	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23700593]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant to DI from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (23700593). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal D, 2012, ANTIOXID REDOX SIGN, V16, P139, DOI 10.1089/ars.2011.3967; Aref ABM, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/429154; BAYLIS C, 1992, J CLIN INVEST, V90, P278, DOI 10.1172/JCI115849; Boor P, 2009, METABOLISM, V58, P1669, DOI 10.1016/j.metabol.2009.05.025; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Coimbra TM, 2000, KIDNEY INT, V57, P167, DOI 10.1046/j.1523-1755.2000.00836.x; Delghingaro-Augusto V, 2012, AM J PHYSIOL-ENDOC M, V302, pE254, DOI 10.1152/ajpendo.00360.2011; Fujihara CK, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000027354.12330.F4; Garvin JL, 2011, ANNU REV PHYSIOL, V73, P359, DOI 10.1146/annurev-physiol-012110-142247; Holdaas H., 2012, KIDNEY INT S, V2, P337, DOI [DOI 10.1038/KISUP.2012.46, 10.1038/kisup.2012.46]; Ihara G, 2010, J HYPERTENS, V28, P2289, DOI 10.1097/HJH.0b013e32833dfcda; Ito D, 2013, CLIN EXP PHARMACOL P, V40, P617, DOI 10.1111/1440-1681.12130; Ito D, 2013, CLIN EXP PHARMACOL P, V40, P74, DOI 10.1111/1440-1681.12040; Ito D, 2010, J HYPERTENS, V28, P2278, DOI 10.1097/HJH.0b013e32833e0924; Kalyanaraman B, 2013, REDOX BIOL, V1, P244, DOI 10.1016/j.redox.2013.01.014; Kamijo H, 2006, NEPHRON PHYSIOL, V104, P12, DOI 10.1159/000093276; Kashihara N, 2010, CURR MED CHEM, V17, P4256, DOI 10.2174/092986710793348581; Kiraly MA, 2008, AM J PHYSIOL-ENDOC M, V294, pE271, DOI 10.1152/ajpendo.00476.2007; Kiraly MA, 2010, AM J PHYSIOL-ENDOC M, V298, pE671, DOI 10.1152/ajpendo.90575.2008; Kohzuki M, 2001, J HYPERTENS, V19, P1877, DOI 10.1097/00004872-200110000-00024; Lee S, 2005, J APPL PHYSIOL, V99, P1220, DOI 10.1152/japplphysiol.00053.2005; Mattson DL, 2000, HYPERTENSION, V35, P337, DOI 10.1161/01.HYP.35.1.337; Mizuno M, 2002, HYPERTENS RES, V25, P271, DOI 10.1291/hypres.25.271; Mori T, 2007, HYPERTENSION, V49, P1336, DOI 10.1161/HYPERTENSIONAHA.106.085811; Mount PF, 2006, ACTA PHYSIOL, V187, P433, DOI 10.1111/j.1748-1716.2006.01582.x; Muhammad AB, 2011, AM J PHYSIOL-RENAL, V300, pF98, DOI 10.1152/ajprenal.00386.2010; Nakayama K, 2008, AM J NEPHROL, V28, P871, DOI 10.1159/000139653; Pold R, 2005, DIABETES, V54, P928, DOI 10.2337/diabetes.54.4.928; Pruijm M, 2010, NEPHROL DIAL TRANSPL, V25, P2225, DOI 10.1093/ndt/gfq008; Rodrigues AM, 2011, EXP BIOL MED, V236, P1180, DOI 10.1258/ebm.2011.011005; Singh DK, 2011, NAT REV ENDOCRINOL, V7, P176, DOI 10.1038/nrendo.2010.212; Siwy J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051334; Sofue T, 2012, AM J HYPERTENS, V25, P604, DOI 10.1038/ajh.2012.1; Takenaka T, 2011, DIABETOLOGIA, V54, P2192, DOI 10.1007/s00125-011-2175-8; Teixeira-Lemos E, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-12; Thent ZC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080436; Tojo A, 2006, MED MOL MORPHOL, V39, P2, DOI 10.1007/s00795-006-0310-2; Tufescu A, 2008, J HYPERTENS, V26, P312, DOI 10.1097/HJH.0b013e3282f2450b; VanHoose L, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-56; VLASSARA H, 1994, P NATL ACAD SCI USA, V91, P11704, DOI 10.1073/pnas.91.24.11704; Wilcox CS, 2005, AM J PHYSIOL-REG I, V289, pR913, DOI 10.1152/ajpregu.00250.2005; Winiarska K, 2014, CHEM-BIOL INTERACT, V218, P12, DOI 10.1016/j.cbi.2014.04.005	42	46	46	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138037	10.1371/journal.pone.0138037	http://dx.doi.org/10.1371/journal.pone.0138037			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379244	Green Published, gold, Green Submitted			2022-12-27	WOS:000361769400046
J	Yin, Q; El-Ashram, S; Liu, HB; Sun, XM; Zhao, XM; Liu, XY; Suo, X				Yin, Qing; El-Ashram, Saeed; Liu, Hongbin; Sun, Ximeng; Zhao, Xinxin; Liu, Xianyong; Suo, Xun			Interferon-Gamma Release Assay: An Effective Tool to Detect Early Toxoplasma gondii Infection in Mice	PLOS ONE			English	Article							CONGENITAL TOXOPLASMOSIS; IMMUNE-RESPONSE; TUBERCULOSIS; DIAGNOSIS; BLOOD; BRADYZOITES; KINETICS; VACCINE; MODEL	Early diagnosis of Toxoplasma gondii infection before the formation of tissue cysts is vital for treatment, as drugs available for toxoplasmosis cannot kill bradyzoites contained in the cysts. However, current methods, such as antibody-based ELISA, are ineffective for detection of early infection. Here, we developed an interferon-gamma release assay (IGRA), measuring the IFN-y released by T lymphocytes stimulated by Toxoplasma antigen peptides in vitro, for the detection of T. gondii infection in mice. Splenocytes isolated from infected mice were stimulated by peptides derived from dense granule proteins GRA4 and GRA6 and rhoptry protein ROP7, and released IFN-y was measured by ELISA. Results showed that both acute and chronic infection could be detected by IGRA. More importantly, IGRA detected infection as early as the third day post infection; while serum IgM and IgG were detected 9 days and 13 days post infection, respectively. Our findings demonstrated that an IGRA-positive and ELISA-negative sample revealed an early infection, indicating the combination of IGRA and ELISA can be employed for the early diagnosis of T. gondii infection in human beings, cats and livestock.	[Yin, Qing; El-Ashram, Saeed; Zhao, Xinxin; Liu, Xianyong; Suo, Xun] China Agr Univ, State Key Lab Agroboitechnol, Beijing 100193, Peoples R China; [Yin, Qing; El-Ashram, Saeed; Zhao, Xinxin; Liu, Xianyong; Suo, Xun] China Agr Univ, Natl Anim Protozoa Lab, Beijing 100193, Peoples R China; [Yin, Qing; El-Ashram, Saeed; Zhao, Xinxin; Liu, Xianyong; Suo, Xun] China Agr Univ, Coll Vet Med, Beijing 100193, Peoples R China; [Liu, Hongbin] Hebei North Univ, Dept Pharmacol, Zhangjiakou 075000, Peoples R China; [Sun, Ximeng] Capital Med Univ, Dept Parasitol, Beijing 100069, Peoples R China; [Suo, Xun] Minist Agr, Key Lab Anim Epidemiol & Zoonosis, Beijing 100193, Peoples R China; [El-Ashram, Saeed] Kafr El Sheikh Univ, Fac Sci, Kafr Al Sheikh, Egypt	China Agricultural University; China Agricultural University; China Agricultural University; Hebei North University; Capital Medical University; Ministry of Agriculture & Rural Affairs; Egyptian Knowledge Bank (EKB); Kafrelsheikh University	Suo, X (corresponding author), China Agr Univ, State Key Lab Agroboitechnol, Beijing 100193, Peoples R China.	suoxun@cau.edu.cn	El-Ashram, Saeed/AAC-6060-2021; Sun, Ximeng/AAA-8449-2022	El-Ashram, Saeed/0000-0003-0389-1980; LIU, XIANYONG/0000-0001-9425-6784; Zhao, Xin-Xin/0000-0002-1901-1784	Special Fund for Agro-scientific Research in the Public Interest [201303042]; National Natural Science Foundation of China [31172309]; Special Cooperation Funds for Science and Technology of Hainan Province [KJHZ2015-31]	Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Cooperation Funds for Science and Technology of Hainan Province	This research was supported by the Special Fund for Agro-scientific Research in the Public Interest (No. 201303042), the National Natural Science Foundation of China (No. 31172309), and the Special Cooperation Funds for Science and Technology of Hainan Province (No. KJHZ2015-31).	Blanchard N, 2008, NAT IMMUNOL, V9, P937, DOI 10.1038/ni.1629; Chapey E, 2010, J CLIN MICROBIOL, V48, P41, DOI 10.1128/JCM.01903-09; CHARDES T, 1990, INFECT IMMUN, V58, P1240; Chirkova TV, 2011, CLIN VACCINE IMMUNOL, V18, P1710, DOI 10.1128/CVI.05116-11; Ciardelli L, 2008, PEDIATR INFECT DIS J, V27, P125, DOI 10.1097/INF.0b013e3181586052; Connell T, 2006, CLIN INFECT DIS, V42, pE82, DOI 10.1086/503910; Corbin GA, 2004, J IMMUNOL, V173, P5679, DOI 10.4049/jimmunol.173.9.5679; Galvan-Ramirez MD, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-271; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569; DEROUIN F, 1991, EXP PARASITOL, V73, P460, DOI 10.1016/0014-4894(91)90070-D; Dubey JP, 1998, INT J PARASITOL, V28, P1019, DOI 10.1016/S0020-7519(98)00023-X; Dubey JP, 1997, J EUKARYOT MICROBIOL, V44, P592, DOI 10.1111/j.1550-7408.1997.tb05965.x; Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267; Frickel EM, 2008, J INFECT DIS, V198, P1625, DOI 10.1086/593019; Gilbert R, 2009, MEM I OSWALDO CRUZ, V104, P305, DOI 10.1590/S0074-02762009000200026; John B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000505; Liesenfeld O, 2002, J INFECT DIS, V185, pS96, DOI 10.1086/338006; Lyons RE, 2002, TRENDS PARASITOL, V18, P198, DOI 10.1016/S1471-4922(02)02248-1; MCLEOD R, 1984, J INFECT DIS, V149, P234, DOI 10.1093/infdis/149.2.234; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pinon JM, 1996, J CLIN MICROBIOL, V34, P579, DOI 10.1128/JCM.34.3.579-583.1996; Remington JS, 2004, J CLIN MICROBIOL, V42, P941, DOI 10.1128/JCM.42.3.941-945.2004; Richeldi L, 2004, ANN INTERN MED, V140, P709, DOI 10.7326/0003-4819-140-9-200405040-00010; Simner PJ, 2014, J CLIN MICROBIOL, V52, P4414, DOI 10.1128/JCM.00967-14; Streeton JA, 1998, INT J TUBERC LUNG D, V2, P443; SUMYUEN MH, 1995, J PARASITOL, V81, P327, DOI 10.2307/3283948; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Unno A, 2010, BIOCHEM BIOPH RES CO, V391, P477, DOI 10.1016/j.bbrc.2009.11.083; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Yin Q, 2015, EXP PARASITOL; Zou J, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-168	31	5	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137808	10.1371/journal.pone.0137808	http://dx.doi.org/10.1371/journal.pone.0137808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378802	Green Submitted, Green Published, gold			2022-12-27	WOS:000361769400028
J	Chen, W; He, SZ; Liu, DG; Patil, GB; Zhai, H; Wang, FB; Stephenson, TJ; Wang, YN; Wang, B; Valliyodan, B; Nguyen, HT; Liu, QC				Chen, Wei; He, Shaozhen; Liu, Degao; Patil, Gunvant B.; Zhai, Hong; Wang, Feibing; Stephenson, Troy J.; Wang, Yannan; Wang, Bing; Valliyodan, Babu; Nguyen, Henry T.; Liu, Qingchang			A Sweetpotato Geranylgeranyl Pyrophosphate Synthase Gene, IbGGPS, Increases Carotenoid Content and Enhances Osmotic Stress Tolerance in Arabidopsis thaliana	PLOS ONE			English	Article							FARNESYL DIPHOSPHATE SYNTHASE; PHYTOENE SYNTHASE; DOWN-REGULATION; SALT-STRESS; FUNCTIONAL-ANALYSIS; ENZYME-ACTIVITY; BETA-CAROTENE; EXPRESSION; CLONING; CDNA	Sweetpotato highly produces carotenoids in storage roots. In this study, a cDNA encoding geranylgeranyl phyrophosphate synthase (GGPS), named IbGGPS, was isolated from sweetpotato storage roots. Green fluorescent protein (GFP) was fused to the C-terminus of IbGGPS to obtain an IbGGPS-GFP fusion protein that was transiently expressed in both epidermal cells of onion and leaves of tobacco. Confocal microscopic analysis determined that the IbGGPS-GFP protein was localized to specific areas of the plasma membrane of onion and chloroplasts in tobacco leaves. The coding region of IbGGPS was cloned into a binary vector under the control of 35S promoter and then transformed into Arabidopsis thaliana to obtain transgenic plants. High performance liquid chromatography (HPLC) analysis showed a significant increase of total carotenoids in transgenic plants. The seeds of transgenic and wild-type plants were germinated on an agar medium supplemented with polyethylene glycol (PEG). Transgenic seedlings grew significantly longer roots than wildtype ones did. Further enzymatic analysis showed an increased activity of superoxide dismutase (SOD) in transgenic seedlings. In addition, the level of malondialdehyde (MDA) was reduced in transgenics. qRT-PCR analysis showed altered expressions of several genes involved in the carotenoid biosynthesis in transgenic plants. These data results indicate that IbGGPS is involved in the biosynthesis of carotenoids in sweetpotato storage roots and likely associated with tolerance to osmotic stress.	[Chen, Wei; He, Shaozhen; Liu, Degao; Zhai, Hong; Wang, Feibing; Wang, Yannan; Wang, Bing; Liu, Qingchang] China Agr Univ, Minist Educ, Lab Crop Heterosis & Utilizat, Beijing Key Lab Crop Genet Improvement, Beijing 100094, Peoples R China; [Patil, Gunvant B.; Stephenson, Troy J.; Valliyodan, Babu; Nguyen, Henry T.] Univ Missouri, Div Plant Sci, Columbia, MO USA; [Patil, Gunvant B.; Stephenson, Troy J.; Valliyodan, Babu; Nguyen, Henry T.] Univ Missouri, Natl Ctr Soybean Biotechnol, Columbia, MO USA	China Agricultural University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Liu, QC (corresponding author), China Agr Univ, Minist Educ, Lab Crop Heterosis & Utilizat, Beijing Key Lab Crop Genet Improvement, Beijing 100094, Peoples R China.	liuqc@cau.edu.cn	Liu, Degao/L-3682-2016; Patil, Gunvant/P-3500-2017	Liu, Degao/0000-0002-0090-9455; Patil, Gunvant/0000-0002-5420-9884; Valliyodan, Babu/0000-0001-9457-9508	China Agriculture Research System [CARS-11]; National High-Tech Research and Development Project of China [2011AA100607]; Beijing Food Crops Innovation Consortium program; Grants-in-Aid for Scientific Research [23659643, 23592747, 26461240, 26304008] Funding Source: KAKEN; EPSRC [EP/I019405/1] Funding Source: UKRI	China Agriculture Research System; National High-Tech Research and Development Project of China(National High Technology Research and Development Program of China); Beijing Food Crops Innovation Consortium program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by China Agriculture Research System Grant No. CARS-11 to QCL, the National High-Tech Research and Development Project of China (Grant No. 2011AA100607) to QCL and Beijing Food Crops Innovation Consortium program (http://219.232.192.143/bpm/main.jsp) to SZH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ament K, 2006, PLANTA, V224, P1197, DOI 10.1007/s00425-006-0301-5; Cao ZP, 2010, MOL BIOL REP, V37, P1089, DOI 10.1007/s11033-009-9848-0; Cazzonelli CI, 2010, TRENDS PLANT SCI, V15, P266, DOI 10.1016/j.tplants.2010.02.003; Chen W, 2013, J INTEGR AGR, V12, P589, DOI 10.1016/S2095-3119(13)60276-2; Cunningham FX, 1998, ANNU REV PLANT PHYS, V49, P557, DOI 10.1146/annurev.arplant.49.1.557; Fang J, 2008, PLANT J, V54, P177, DOI 10.1111/j.1365-313X.2008.03411.x; Farre G, 2010, PLANT SCI, V179, P28, DOI 10.1016/j.plantsci.2010.03.009; Fraser PD, 1999, PLANT MOL BIOL, V40, P687, DOI 10.1023/A:1006256302570; Fu GQ, 2011, PLANT PHYSIOL BIOCH, V49, P792, DOI 10.1016/j.plaphy.2011.01.018; Gao S, 2011, PLANT CELL TISS ORG, V107, P205, DOI 10.1007/s11240-011-9971-1; He SZ, 2009, PLANT CELL TISS ORG, V96, P69, DOI 10.1007/s11240-008-9461-2; Hefner J, 1998, ARCH BIOCHEM BIOPHYS, V360, P62, DOI 10.1006/abbi.1998.0926; Hirschberg J, 2001, CURR OPIN PLANT BIOL, V4, P210, DOI 10.1016/S1369-5266(00)00163-1; Jassbi AR, 2008, PLANT PHYSIOL, V146, P974, DOI 10.1104/pp.107.108811; Jiang T, 2013, SCI HORTIC-AMSTERDAM, V158, P22, DOI 10.1016/j.scienta.2013.04.027; JOLY A, 1993, J BIOL CHEM, V268, P26983; Kim M, 2010, PLANT CELL REP, V29, P1339, DOI 10.1007/s00299-010-0920-y; Kim SH, 2013, PHYSIOL PLANTARUM, V147, P432, DOI 10.1111/j.1399-3054.2012.01688.x; Kim SH, 2012, PHYTOCHEMISTRY, V74, P69, DOI 10.1016/j.phytochem.2011.11.003; KUNTZ M, 1992, PLANT J, V2, P25; Li FQ, 2008, PLANT PHYSIOL, V146, P1333, DOI 10.1104/pp.107.111120; Lindgren LO, 2003, PLANT PHYSIOL, V132, P779, DOI 10.1104/pp.102.017053; Liu DG, 2014, PLANT CELL TISS ORG, V117, P1, DOI 10.1007/s11240-013-0415-y; MISAWA N, 1994, J BIOCHEM-TOKYO, V116, P980, DOI 10.1093/oxfordjournals.jbchem.a124656; Murashige T., 1962, PHYSIOL PLANTARUM, V15, P474, DOI [10.1111/j.1399-3054.1962.tb08052.x, DOI 10.1111/J.1399-3054.1962.TB08052.X]; Oh SK, 2000, J PLANT PHYSIOL, V157, P535, DOI 10.1016/S0176-1617(00)80109-1; Okada K, 2000, PLANT PHYSIOL, V122, P1045, DOI 10.1104/pp.122.4.1045; Singh M, 2003, PLANT CELL, V15, P874, DOI 10.1105/tpc.010249; Sitthithaworn W, 2001, CHEM PHARM BULL, V49, P197, DOI 10.1248/cpb.49.197; Takaya A, 2003, BBA-GENE STRUCT EXPR, V1625, P214, DOI 10.1016/S0167-4781(02)00602-4; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; vonLintig J, 1997, PLANT J, V12, P625, DOI 10.1046/j.1365-313X.1997.00625.x; Walter MH, 2011, NAT PROD REP, V28, P663, DOI 10.1039/c0np00036a; Wang YP, 2007, SCI HORTIC-AMSTERDAM, V111, P173, DOI 10.1016/j.scienta.2006.10.007; Xie YJ, 2012, J EXP BOT, V63, P3869, DOI [10.1093/jxb/ers078, 10.1093/jxb/ers201]; Xu Q, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-246; Yamamizo C, 2010, J EXP BOT, V61, P709, DOI 10.1093/jxb/erp335; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; Yu L, 2013, J INTEGR AGR, V12, P773, DOI 10.1016/S2095-3119(13)60299-3; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhu CF, 2002, PLANT MOL BIOL, V48, P277, DOI 10.1023/A:1013383120392; Zhu XF, 1997, PLANT MOL BIOL, V35, P331, DOI 10.1023/A:1005898805326	42	15	17	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137623	10.1371/journal.pone.0137623	http://dx.doi.org/10.1371/journal.pone.0137623			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376432	gold, Green Published, Green Submitted			2022-12-27	WOS:000361610200045
J	Courteix, D; Valente-dos-Santos, J; Ferry, B; Lac, G; Lesourd, B; Chapier, R; Naughton, G; Marceau, G; Coelho-e-Silva, MJ; Vinet, A; Walther, G; Obert, P; Dutheil, F				Courteix, Daniel; Valente-dos-Santos, Joao; Ferry, Beatrice; Lac, Gerard; Lesourd, Bruno; Chapier, Robert; Naughton, Geraldine; Marceau, Geoffroy; Coelho-e-Silva, Manuel Joao; Vinet, Agnes; Walther, Guillaume; Obert, Philippe; Dutheil, Frederic			Multilevel Approach of a 1-Year Program of Dietary and Exercise Interventions on Bone Mineral Content and Density in Metabolic Syndrome - the RESOLVE Randomized Controlled Trial	PLOS ONE			English	Article							INDUCED WEIGHT-LOSS; CALORIC RESTRICTION; PROTEIN-INTAKE; OBESE MEN; POSTMENOPAUSAL; OVERWEIGHT; MASS; FAT; MAINTENANCE; GEOMETRY	Background Weight loss is a public health concern in obesity-related diseases such as metabolic syndrome (MetS). However, restrictive diets might induce bone loss. The nature of exercise and whether exercise with weight loss programs can protect against potential bone mass deficits remains unclear. Moreover, compliance is essential in intervention programs. Thus, we aimed to investigate the effects that modality and exercise compliance have on bone mineral content (BMC) and density (BMD). Methods We investigated 90 individuals with MetS who were recruited for the 1-year RESOLVE trial. Community-dwelling seniors with MetS were randomly assigned into three different modalities of exercise (intensive resistance, intensive endurance, moderate mixed) combined with a restrictive diet. They were compared to 44 healthy controls who did not undergo the intervention. Results This intensive lifestyle intervention (15-20 hours of training/week + restrictive diet) resulted in weight loss, body composition changes and health improvements. Baseline BMC and BMD for total body, lumbar spine and femoral neck did not differ between MetS groups and between MetS and controls. Despite changes over time, BMC or BMD did not differ between the three modalities of exercise and when compared with the controls. However, independent of exercise modality, compliant participants increased their BMC and BMD compared with their less compliant peers. Decreases in total body lean mass and negative energy balance significantly and independently contributed to decreases in lumbar spine BMC. Conclusion After the one year intervention, differences relating to exercise modalities were not evident. However, compliance with an intensive exercise program resulted in a significantly higher bone mass during energy restriction than non-compliance. Exercise is therefore beneficial to bone in the context of a weight loss program.	[Courteix, Daniel; Ferry, Beatrice; Lac, Gerard; Lesourd, Bruno; Chapier, Robert; Dutheil, Frederic] Univ Blaise Pascal, Clermont Auvergne Univ, Lab Metab Adaptat Exercise Physiol & Pathol Condi, AME2P,EA3533, Clermont Ferrand, France; [Courteix, Daniel; Naughton, Geraldine; Dutheil, Frederic] Australian Catholic Univ, Fac Hlth, Sch Exercise Sci, Melbourne, Vic, Australia; [Courteix, Daniel; Ferry, Beatrice; Lac, Gerard; Lesourd, Bruno; Chapier, Robert; Dutheil, Frederic] Res Ctr Human Nutr CRNH Auvergne, Clermont Ferrand, France; [Valente-dos-Santos, Joao] Lusofona Univ Human & Technol, Fac Phys Educ & Sport, Lisbon, Portugal; [Valente-dos-Santos, Joao; Coelho-e-Silva, Manuel Joao] Univ Coimbra, Fac Sport Sci & Phys Educ, Res Unit Sport & Phys Activ CIDAF, Coimbra, Portugal; [Lesourd, Bruno] Auvergne Univ, Fac Med, Geriatr, Clermont Ferrand, France; [Marceau, Geoffroy] Univ Hosp Clermont Ferrand CHU, Biochem, Clermont Ferrand, France; [Vinet, Agnes; Walther, Guillaume; Obert, Philippe] Univ Avignon, Lab Pharm Ecol Cardiovasc, EA4278, Avignon, France; [Dutheil, Frederic] Univ Hosp Clermont Ferrand CHU, Prevent & Occupat Med, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Australian Catholic University; Lusofona University; Universidade de Coimbra; Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Avignon Universite; CHU Clermont Ferrand	Dutheil, F (corresponding author), Univ Blaise Pascal, Clermont Auvergne Univ, Lab Metab Adaptat Exercise Physiol & Pathol Condi, AME2P,EA3533, Clermont Ferrand, France.	frederic.dutheil@acu.edu.au	Valente-dos-Santos, Joao/ABE-3220-2020; Stefanadis, Christodoulos/ABH-2232-2020; Naughton, Geraldine/M-4094-2017; Dutheil, Frederic/O-9707-2014; WALTHER, Guillaume/J-2647-2016; Silva, Manuel Coelho E/O-2604-2019	Valente-dos-Santos, Joao/0000-0003-0980-0269; Stefanadis, Christodoulos/0000-0001-5974-6454; Naughton, Geraldine/0000-0002-0534-1627; Dutheil, Frederic/0000-0002-1468-6029; WALTHER, Guillaume/0000-0001-7604-8973; Silva, Manuel Coelho E/0000-0003-4512-7331; MARCEAU, GEOFFROY/0000-0003-4713-7162	Heart and Arteries Foundation (Fondation Coeur et Arteres) Loos, France; Portuguese Foundation for Science and Technology [SFRH/BPD/100470/2014]	Heart and Arteries Foundation (Fondation Coeur et Arteres) Loos, France; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	This work was funded by the Heart and Arteries Foundation (Fondation Coeur et Arteres) 59200 Loos, France; www.fondacoeur.com. JVdS was partially supported by a grant from the Portuguese Foundation for Science and Technology: SFRH/BPD/100470/2014. The funding source had no role in the design, conduct, or reporting of the study.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Armamento-Villareal R, 2012, J BONE MINER RES, V27, P1215, DOI 10.1002/jbmr.1560; Baxter-Jones ADG, 2003, ANN HUM BIOL, V30, P160, DOI 10.1080/0301446021000034642; Bemben DA, 2011, OSTEOPOROSIS INT, V22, P179, DOI 10.1007/s00198-010-1182-9; Ben Chihaoui Manel, 2008, Tunis Med, V86, P1031; BEVERLY MC, 1989, BRIT MED J, V299, P233, DOI 10.1136/bmj.299.6693.233; Bielohuby M, 2010, J BONE MINER RES, V25, P275, DOI 10.1359/jbmr.090813; Chaplais E, 2015, J BONE MINERAL METAB; COMPSTON JE, 1992, CLIN SCI, V82, P429, DOI 10.1042/cs0820429; Deng YF, 2010, ANN NY ACAD SCI, V1212, pE1, DOI 10.1111/j.1749-6632.2010.05875.x; Dutheil F, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-112; Dutheil F, 2013, INT J CARDIOL, V168, P3634, DOI 10.1016/j.ijcard.2013.05.012; Dutheil F, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-148; Dutheil F, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-72; Fappa E, 2008, NUTRITION, V24, P286, DOI 10.1016/j.nut.2007.11.008; Guadalupe-Grau A, 2009, SPORTS MED, V39, P439, DOI 10.2165/00007256-200939060-00002; Hamilton KC, 2013, OBESITY, V21, P441, DOI 10.1002/oby.20052; Hinton PS, 2010, EUR J CLIN NUTR, V64, P392, DOI 10.1038/ejcn.2009.156; Hinton PS, 2009, J AM COLL NUTR, V28, P565, DOI 10.1080/07315724.2009.10719788; HYLDSTRUP L, 1993, ACTA ENDOCRINOL-COP, V129, P393, DOI 10.1530/acta.0.1290393; Ishikawa S, 2013, SPORTS MED, V43, P875, DOI 10.1007/s40279-013-0060-y; Jackowski SA, 2015, OSTEOPOROSIS INT; JENSEN LB, 1994, J BONE MINER RES, V9, P459; Kamel EG, 1999, INT J OBESITY, V23, P686, DOI 10.1038/sj.ijo.0800904; Kemmler W, 2014, SCAND J MED SCI SPOR, V24, P526, DOI 10.1111/sms.12024; Labouesse MA, 2014, BONE, V64, P138, DOI 10.1016/j.bone.2014.03.047; Martin TJ, 2008, BEST PRACT RES CL EN, V22, P701, DOI 10.1016/j.beem.2008.07.006; Pedersen SD, 2013, BEST PRACT RES CL EN, V27, P179, DOI 10.1016/j.beem.2013.02.004; Pop LC, 2015, AM J CLIN NUTR, V101, P659, DOI 10.3945/ajcn.114.088534; Pritchard JE, 1996, INT J OBESITY, V20, P513; Redman LM, 2008, ARCH INTERN MED, V168, P1859, DOI 10.1001/archinte.168.17.1859; Ricci TA, 2001, AM J CLIN NUTR, V73, P347; Santhanakrishnan Iswarya, 2014, J Nat Sci Biol Med, V5, P365, DOI 10.4103/0976-9668.136186; Sarkis Karin Sedo, 2012, Endocrinol Nutr, V59, P207, DOI 10.1016/j.endonu.2011.10.010; Shah K, 2011, J BONE MINER RES; Shapses SA, 2006, J NUTR, V136, P1453, DOI 10.1093/jn/136.6.1453; Shapses SA, 2013, AM J CLIN NUTR, V97, P637, DOI 10.3945/ajcn.112.044909; Shapses SA, 2012, ANNU REV NUTR, V32, P287, DOI 10.1146/annurev.nutr.012809.104655; Silcocks P, 2012, BRIT J CANCER, V106, P1259, DOI 10.1038/bjc.2012.84; SLINKER BK, 1985, AM J PHYSIOL, V249, pR1, DOI 10.1152/ajpregu.1985.249.1.R1; Sukumar D, 2011, J BONE MINER RES, V26, P1339, DOI 10.1002/jbmr.318; Swanberg M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047964; Theodoratou E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2035; Villareal DT, 2011, NEW ENGL J MED, V364, P1218, DOI 10.1056/NEJMoa1008234; Villareal DT, 2006, ARCH INTERN MED, V166, P2502, DOI 10.1001/archinte.166.22.2502; Wolff I, 1999, OSTEOPOROSIS INT, V9, P1, DOI 10.1007/s001980050109	46	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136491	10.1371/journal.pone.0136491	http://dx.doi.org/10.1371/journal.pone.0136491			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376093	Green Published, gold, Green Submitted			2022-12-27	WOS:000361610200016
J	Fantozzi, S; Giovanardi, A; Borra, D; Gatta, G				Fantozzi, Silvia; Giovanardi, Andrea; Borra, Davide; Gatta, Giorgio			Gait Kinematic Analysis in Water Using Wearable Inertial Magnetic Sensors	PLOS ONE			English	Article							WALKING SPEED; BIOMECHANICAL CHARACTERISTICS; REACTION FORCES; LAND	Walking is one of the fundamental motor tasks executed during aquatic therapy. Previous kinematics analyses conducted using waterproofed video cameras were limited to the sagittal plane and to only one or two consecutive steps. Furthermore, the set-up and post-processing are time-consuming and thus do not allow a prompt assessment of the correct execution of the movements during the aquatic session therapy. The aim of the present study was to estimate the 3D joint kinematics of the lower limbs and thorax-pelvis joints in sagittal and frontal planes during underwater walking using wearable inertial and magnetic sensors. Eleven healthy adults were measured during walking both in shallow water and in dry-land conditions. Eight wearable inertial and magnetic sensors were inserted in waterproofed boxes and fixed to the body segments by means of elastic modular bands. A validated protocol (Outwalk) was used. Gait cycles were automatically segmented and selected if relevant intraclass correlation coefficients values were higher than 0.75. A total of 704 gait cycles for the lower limb joints were normalized in time and averaged to obtain the mean cycle of each joint, among participants. The mean speed in water was 40% lower than that of the dry-land condition. Longer stride duration and shorter stride distance were found in the underwater walking. In the sagittal plane, the knee was more flexed (approximate to 23 degrees) and the ankle more dorsiflexed (approximate to 9 degrees) at heel strike, and the hip was more flexed at toe-off (approximate to 13 degrees) in water than on land. On the frontal plane in the underwater walking, smoother joint angle patterns were observed for thorax-pelvis and hip, and ankle was more inversed at toe-off (approximate to 7 degrees) and showed a more inversed mean value (approximate to 7 degrees). The results were mainly explained by the effect of the speed in the water as supported by the linear mixed models analysis performed. Thus, it seemed that the combination of speed and environment triggered modifications in the joint angles in underwater gait more than these two factors considered separately. The inertial and magnetic sensors, by means of fast set-up and data analysis, can supply an immediate gait analysis report to the therapist during the aquatic therapy session.	[Fantozzi, Silvia; Borra, Davide] Univ Bologna, Dept Elect Elect & Informat Engn Guglielmo Marcon, Bologna, Italy; [Giovanardi, Andrea] Univ Bologna, Sch Pharm Biotechnol & Sport Sci, Bologna, Italy; [Gatta, Giorgio] Univ Bologna, Dept Life Qual Studies, Bologna, Italy	University of Bologna; University of Bologna; University of Bologna	Fantozzi, S (corresponding author), Univ Bologna, Dept Elect Elect & Informat Engn Guglielmo Marcon, Bologna, Italy.	silvia.fantozzi@unibo.it	Borra, Davide/G-3547-2017; Fantozzi, Silvia/P-2910-2015	Borra, Davide/0000-0003-3791-8555; GATTA, GIORGIO/0000-0001-6322-7761; Fantozzi, Silvia/0000-0002-0660-7204				Alikhajeh Y, 2012, PROCD SOC BEHV, V46, P2220, DOI 10.1016/j.sbspro.2012.05.458; Aminian K, 2002, J BIOMECH, V35, P689, DOI 10.1016/S0021-9290(02)00008-8; Barela AMF, 2008, J ELECTROMYOGR KINES, V18, P446, DOI 10.1016/j.jelekin.2006.10.008; Barela AMF, 2006, J ELECTROMYOGR KINES, V16, P250, DOI 10.1016/j.jelekin.2005.06.013; Becker BE, 2009, INT J AQUATIC RES ED, P324; Becker BE, 2009, PM&R, V1, P859, DOI 10.1016/j.pmrj.2009.05.017; Carneiro LC, 2012, GAIT POSTURE, V35, P225, DOI 10.1016/j.gaitpost.2011.09.011; Chevutschi A, 2009, GAIT POSTURE, V29, P403, DOI 10.1016/j.gaitpost.2008.10.059; Cutti AG, 2010, MED BIOL ENG COMPUT, V48, P17, DOI 10.1007/s11517-009-0545-x; Danna-dos- Santos A, 2007, INT J AQUATIC RES ED, P1198; de Magalhaes FA, 2015, J SPORT SCI, V33, P732, DOI 10.1080/02640414.2014.962574; Ferrari A, 2010, MED BIOL ENG COMPUT, V48, P1, DOI 10.1007/s11517-009-0544-y; Fleiss JL, 1986, DESIGN ANAL CLIN EXP, P10; Konlian C, 1999, Orthop Nurs, V18, P11; Madgwick SOH, 2011, INT C REHAB ROBOT; Magalhaes FA, 2013, J SPORT SCI MED, V12, P660; McGinley JL, 2009, GAIT POSTURE, V29, P360, DOI 10.1016/j.gaitpost.2008.09.003; Miyoshi T, 2004, DISABIL REHABIL, V26, P724, DOI 10.1080/09638280410001704313; Schwartz MH, 2008, J BIOMECH, V41, P1639, DOI 10.1016/j.jbiomech.2008.03.015; Silvatti AP, 2013, COMPUT METHOD BIOMEC, V16, P1240, DOI 10.1080/10255842.2012.664637; Silvatti AP, 2012, J BIOMECH, V45, P1112, DOI 10.1016/j.jbiomech.2012.01.004; Skelton Dawn A., 1999, Physiotherapy Theory and Practice, V15, P105, DOI 10.1080/095939899307801; Tadano S, 2013, SENSORS-BASEL, V13, P9321, DOI 10.3390/s130709321; Tamburella Federica, 2013, Am J Phys Med Rehabil, V92, pe4, DOI 10.1097/PHM.0b013e3182a1e6c3; van Hedel HJA, 2006, GAIT POSTURE, V24, P35, DOI 10.1016/j.gaitpost.2005.06.015; Orselli MIV, 2011, J BIOMECH, V44, P1170, DOI 10.1016/j.jbiomech.2011.01.017; Watanabe E, 2000, PERCEPT MOTOR SKILL, V91, P97, DOI 10.2466/PMS.91.5.97-104	27	21	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138105	10.1371/journal.pone.0138105	http://dx.doi.org/10.1371/journal.pone.0138105			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368131	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100225
J	Gonzalez-Bartulos, M; Aceves-Luquero, C; Qualai, J; Cusso, O; Martinez, MA; de Mattos, SF; Menendez, JA; Villalonga, P; Costas, M; Ribas, X; Massaguer, A				Gonzalez-Bartulos, Marta; Aceves-Luquero, Clara; Qualai, Jamal; Cusso, Olaf; Angeles Martinez, Ma; Fernandez de Mattos, Silvia; Menendez, Javier A.; Villalonga, Priam; Costas, Miquel; Ribas, Xavi; Massaguer, Anna			Pro-Oxidant Activity of Amine-Pyridine-Based Iron Complexes Efficiently Kills Cancer and Cancer Stem-Like Cells	PLOS ONE			English	Article							DNA CLEAVAGE ACTIVITY; OXIDATIVE STRESS; ANTITUMOR-ACTIVITY; COPPER(II) COMPLEX; SELF-RENEWAL; CHELATORS; ANTICANCER; MECHANISMS; RESISTANCE; DOXORUBICIN	Differential redox homeostasis in normal and malignant cells suggests that pro-oxidant-induced upregulation of cellular reactive oxygen species (ROS) should selectively target cancer cells without compromising the viability of untransformed cells. Consequently, a pro-oxidant deviation well-tolerated by nonmalignant cells might rapidly reach a cell-death threshold in malignant cells already at a high setpoint of constitutive oxidative stress. To test this hypothesis, we took advantage of a selected number of amine-pyridine-based Fe (II) complexes that operate as efficient and robust oxidation catalysts of organic substrates upon reaction with peroxides. Five of these Fe(II)-complexes and the corresponding aminopyridine ligands were selected to evaluate their anticancer properties. We found that the iron complexes failed to display any relevant activity, while the corresponding ligands exhibited significant antiproliferative activity. Among the ligands, none of which were hemolytic, compounds 1, 2 and 5 were cytotoxic in the low micromolar range against a panel of molecularly diverse human cancer cell lines. Importantly, the cytotoxic activity profile of some compounds remained unaltered in epithelial-to-mesenchymal (EMT)-induced stable populations of cancer stem-like cells, which acquired resistance to the well-known ROS inducer doxorubicin. Compounds 1, 2 and 5 inhibited the clonogenicity of cancer cells and induced apoptotic cell death accompanied by caspase 3/7 activation. Flow cytometry analyses indicated that ligands were strong inducers of oxidative stress, leading to a 7-fold increase in intracellular ROS levels. ROS induction was associated with their ability to bind intracellular iron and generate active coordination complexes inside of cells. In contrast, extracellular complexation of iron inhibited the activity of the ligands. Iron complexes showed a high proficiency to cleave DNA through oxidative-dependent mechanisms, suggesting a likely mechanism of cytotoxicity. In summary, we report that, upon chelation of intracellular iron, the pro-oxidant activity of amine-pyrimidine-based iron complexes efficiently kills cancer and cancer stem-like cells, thus providing functional evidence for an efficient family of redox-directed anti-cancer metallodrugs.	[Gonzalez-Bartulos, Marta; Angeles Martinez, Ma; Massaguer, Anna] Univ Girona, Dept Biol, Girona, Catalunya, Spain; [Aceves-Luquero, Clara; Fernandez de Mattos, Silvia; Villalonga, Priam] Univ Illes Balears, Dept Biol Fonamental, Illes Balears, Spain; [Aceves-Luquero, Clara; Fernandez de Mattos, Silvia; Villalonga, Priam] Univ Illes Balears, Inst Univ Invest Ciencies Salut IUNICS, Illes Balears, Spain; [Qualai, Jamal; Cusso, Olaf; Angeles Martinez, Ma; Costas, Miquel; Ribas, Xavi] Univ Girona, Dept Chem, Girona, Catalunya, Spain; [Gonzalez-Bartulos, Marta; Cusso, Olaf; Costas, Miquel; Ribas, Xavi] Univ Girona, IQCC, Girona, Catalunya, Spain; [Menendez, Javier A.] ICO, Translat Res Lab, Girona, Catalunya, Spain; [Menendez, Javier A.] Girona Biomed Res Inst IDIBGI, Girona, Catalunya, Spain	Universitat de Girona; Universitat de les Illes Balears; Universitat de les Illes Balears; Universitat de Girona; Universitat de Girona; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI)	Menendez, JA (corresponding author), ICO, Translat Res Lab, Girona, Catalunya, Spain.	jmenendez@idibgi.org; miquel.costas@udg.edu; xavi.ribas@udg.edu; anna.massaguer@udg.edu	Ribas, Xavi/F-3945-2014; Cussó, Olaf/N-3732-2015; martinez lorente, maria angeles/L-4592-2014; Villalonga, Priam/K-4350-2014; de Mattos, Silvia Fernández/K-5153-2014; MENENDEZ, JAVIER A/C-6148-2016; Ribas, Xavi/AAF-4082-2019; Costas, Miquel/H-6920-2012; Massaguer, Anna/L-5993-2014	Ribas, Xavi/0000-0002-2850-4409; Cussó, Olaf/0000-0001-6578-3163; martinez lorente, maria angeles/0000-0002-5696-551X; Villalonga, Priam/0000-0002-7190-6884; de Mattos, Silvia Fernández/0000-0003-4144-3687; MENENDEZ, JAVIER A/0000-0001-8733-4561; Ribas, Xavi/0000-0002-2850-4409; Costas, Miquel/0000-0001-6326-8299; Massaguer, Anna/0000-0003-1312-593X	Spanish Ministerio de Economia y Competitividad (MINECO) [CSD2010-00065]; Ministerio de Ciencia e Innovacion (MICINN) [SAF2012-38914]	Spanish Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants from the Spanish Ministerio de Economia y Competitividad (MINECO), CONSOLIDER-INGENIO 2010 CSD2010-00065, and from the Ministerio de Ciencia e Innovacion (MICINN), SAF2012-38914, Plan Nacional de I+D+I.	Alexandre J, 2006, INT J CANCER, V119, P41, DOI 10.1002/ijc.21685; AUST S D, 1985, Journal of Free Radicals in Biology and Medicine, V1, P3, DOI 10.1016/0748-5514(85)90025-X; Badosa E, 2007, PEPTIDES, V28, P2276, DOI 10.1016/j.peptides.2007.09.010; Barragan F, 2012, BIOCONJUGATE CHEM, V23, P1838, DOI 10.1021/bc300173h; Borras J, 2007, EUR J INORG CHEM, P822, DOI 10.1002/ejic.200600821; Cabantchik ZI, 1996, ANAL BIOCHEM, V233, P221, DOI 10.1006/abio.1996.0032; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Canta M, 2014, ADV SYNTH CATAL, V356, P818, DOI 10.1002/adsc.201300923; Chen MS, 2007, SCIENCE, V318, P783, DOI 10.1126/science.1148597; Chiarugi P, 2012, INTERNATIONAL JOURNA; Chirino YI, 2009, EXP TOXICOL PATHOL, V61, P223, DOI 10.1016/j.etp.2008.09.003; Company A, 2007, J AM CHEM SOC, V129, P15766, DOI 10.1021/ja077761n; Company A, 2014, J AM CHEM SOC, V136, P4624, DOI 10.1021/ja412059c; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Costas M, 2002, ANGEW CHEM INT EDIT, V41, P2179, DOI 10.1002/1521-3773(20020617)41:12<2179::AID-ANIE2179>3.0.CO;2-F; Cusso O, 2013, J AM CHEM SOC, V135, P14871, DOI 10.1021/ja4078446; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Efferth T, 2005, DRUG RESIST UPDATE, V8, P85, DOI 10.1016/j.drup.2005.04.003; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Fang J, 2007, J DRUG TARGET, V15, P475, DOI 10.1080/10611860701498286; Fatfat M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-527; Frau S, 1996, B SOC CHIM FR, V133, P1053; Garcia-Gimenez JL, 2007, INORG CHEM, V46, P7178, DOI 10.1021/ic700751j; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hecht SM, 2000, J NAT PROD, V63, P158, DOI 10.1021/np990549f; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Jin YL, 2010, CANCER RES, V70, P2516, DOI 10.1158/0008-5472.CAN-09-3950; Jungwirth U, 2011, ANTIOXID REDOX SIGN, V15, P1085, DOI 10.1089/ars.2010.3663; Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; KIM SK, 1993, FEBS LETT, V315, P61, DOI 10.1016/0014-5793(93)81133-K; Klaunig JE, 2010, TOXICOL PATHOL, V38, P96, DOI 10.1177/0192623309356453; Laurent A, 2005, CANCER RES, V65, P948; Li Q, 2011, INORG CHEM, V50, P8318, DOI 10.1021/ic2008478; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liem Minh Phan, 2014, Cancer Biology Medicine, V11, P1, DOI 10.7497/j.issn.2095-3941.2014.01.001; Liu ZD, 2002, COORDIN CHEM REV, V232, P151, DOI 10.1016/S0010-8545(02)00050-4; Loor G, 2010, FREE RADICAL BIO MED, V49, P1925, DOI 10.1016/j.freeradbiomed.2010.09.021; Lovejoy DB, 2011, CANCER RES, V71, P5871, DOI 10.1158/0008-5472.CAN-11-1218; Garcia-Gimenez JL, 2009, J INORG BIOCHEM, V103, P923, DOI 10.1016/j.jinorgbio.2009.04.003; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Manoury B, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-11; Merlot AM, 2013, ANTIOXID REDOX SIGN, V18, P973, DOI 10.1089/ars.2012.4540; Mojzisova G, 2014, ACTA BIOCHIM POL, V61, P651, DOI 10.18388/abp.2014_1826; Montero AJ, 2012, BREAST CANCER RES TR, V132, P215, DOI 10.1007/s10549-011-1889-0; Montero AJ, 2011, DRUGS, V71, P1385, DOI 10.2165/11592590-000000000-00000; Nguyen LV, 2012, NATURE REV CANC; Oltra AM, 2001, FREE RADICAL BIO MED, V30, P1286, DOI 10.1016/S0891-5849(01)00521-4; Paris M, 1997, ALTERN MED REV, V2, P155; Podhorecka M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/920161; Powis G, 2001, ANNU REV PHARMACOL, V41, P261, DOI 10.1146/annurev.pharmtox.41.1.261; Richardson DR, 2002, CRIT REV ONCOL HEMAT, V42, P267, DOI 10.1016/S1040-8428(01)00218-9; Shi XK, 2012, ANTIOXID REDOX SIGN, V16, P1215, DOI 10.1089/ars.2012.4529; Sun RWY, 2007, DALTON T, P4884, DOI 10.1039/b705079h; Thomas SR, 2011, EXPERT OPIN DRUG DIS, V6, P195, DOI 10.1517/17460441.2011.546395; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Townsend DM, 2008, CANCER RES, V68, P2870, DOI 10.1158/0008-5472.CAN-07-5957; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.50; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Watson J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120144; Whitnall M, 2006, P NATL ACAD SCI USA, V103, P14901, DOI 10.1073/pnas.0604979103; Wondrak GT, 2009, ANTIOXID REDOX SIGN, V11, P3013, DOI [10.1089/ars.2009.2541, 10.1089/ARS.2009.2541]; Wu J, 2010, INVEST NEW DRUG, V28, P670, DOI 10.1007/s10637-009-9286-9; Yu Y, 2012, CURR MED CHEM, V19, P2689, DOI 10.2174/092986712800609706; Zhang XS, 1997, FREE RADICAL BIO MED, V23, P980, DOI 10.1016/S0891-5849(97)00126-3; Zhou SY, 2001, TOXICOL LETT, V121, P151, DOI 10.1016/S0378-4274(01)00329-0	72	28	28	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137800	10.1371/journal.pone.0137800	http://dx.doi.org/10.1371/journal.pone.0137800			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368127	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100141
J	Nguyen, HT; Dawal, SZM; Nukman, Y; Aoyama, H; Case, K				Nguyen, Huu-Tho; Dawal, Siti Zawiah Md; Nukman, Yusoff; Aoyama, Hideki; Case, Keith			An Integrated Approach of Fuzzy Linguistic Preference Based AHP and Fuzzy COPRAS for Machine Tool Evaluation	PLOS ONE			English	Article							MULTICRITERIA DECISION-MAKING; SUPPORT-SYSTEM; MANUFACTURING SYSTEMS; HYBRID APPROACH; MCDM APPROACH; SELECTION; MODEL; TOPSIS; EQUIPMENT; NUMBERS	Globalization of business and competitiveness in manufacturing has forced companies to improve their manufacturing facilities to respond to market requirements. Machine tool evaluation involves an essential decision using imprecise and vague information, and plays a major role to improve the productivity and flexibility in manufacturing. The aim of this study is to present an integrated approach for decision-making in machine tool selection. This paper is focused on the integration of a consistent fuzzy AHP (Analytic Hierarchy Process) and a fuzzy COmplex PRoportional ASsessment (COPRAS) for multi-attribute decision-making in selecting the most suitable machine tool. In this method, the fuzzy linguistic reference relation is integrated into AHP to handle the imprecise and vague information, and to simplify the data collection for the pair-wise comparison matrix of the AHP which determines the weights of attributes. The output of the fuzzy AHP is imported into the fuzzy COPRAS method for ranking alternatives through the closeness coefficient. Presentation of the proposed model application is provided by a numerical example based on the collection of data by questionnaire and from the literature. The results highlight the integration of the improved fuzzy AHP and the fuzzy COPRAS as a precise tool and provide effective multi-attribute decision-making for evaluating the machine tool in the uncertain environment.	[Nguyen, Huu-Tho; Dawal, Siti Zawiah Md; Nukman, Yusoff] Univ Malaya, Dept Mech Engn, Fac Engn, Kuala Lumpur 50603, Malaysia; [Aoyama, Hideki] Keio Univ, Sch Integrated Design Engn, Tokyo, Japan; [Case, Keith] Univ Loughborough, Mech & Mfg Engn, Loughborough LE11 3TU, Leics, England	Universiti Malaya; Keio University; Loughborough University	Nguyen, HT (corresponding author), Univ Malaya, Dept Mech Engn, Fac Engn, Kuala Lumpur 50603, Malaysia.	nguyenhuutho@siswa.um.edu.my	DAWAL, SITI ZAWIAH MD/B-9816-2010; Bin Yusoff, Nukman/B-5302-2010	DAWAL, SITI ZAWIAH MD/0000-0003-0496-5128; Bin Yusoff, Nukman/0000-0002-7389-2164; NGUYEN, Huu-Tho/0000-0001-8558-5906	High Impact Research MOHE Grant from the Ministry of Education Malaysia [UM.C/625/1/HIR/MOHE/ENG/35 (D000035-16001)]	High Impact Research MOHE Grant from the Ministry of Education Malaysia	This research is supported by High Impact Research MOHE Grant UM.C/625/1/HIR/MOHE/ENG/35 (D000035-16001) from the Ministry of Education Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Malek L, 2000, INT J PROD RES, V38, P323, DOI 10.1080/002075400189437; Abdi MR, 2009, INT J PROD ECON, V117, P1, DOI 10.1016/j.ijpe.2008.06.009; Aghdaie MH, 2013, INZ EKON, V24, P5, DOI 10.5755/j01.ee.24.1.2822; Arslan M. C., 2004, J MANUF TECHNOL MANA, V15, P101, DOI [DOI 10.1108/09576060410512374, 10.1108/09576060410512374]; Ayag Z, 2007, INT J PROD RES, V45, P2029, DOI 10.1080/00207540600724856; Ayag Z, 2006, J INTELL MANUF, V17, P179, DOI 10.1007/s10845-005-6635-1; Ayag Z, 2011, J INTELL MANUF, V22, P163, DOI 10.1007/s10845-009-0269-7; Ayag Z, 2012, INT J PROD ECON, V140, P630, DOI 10.1016/j.ijpe.2012.02.009; Balaji CM, 2009, IEEE INT CON AUTO SC, P171, DOI 10.1109/COASE.2009.5234125; BUCKLEY JJ, 1985, FUZZY SET SYST, V17, P233, DOI 10.1016/0165-0114(85)90090-9; Chakraborty S, 2011, INT J ADV MANUF TECH, V54, P1155, DOI 10.1007/s00170-010-2972-0; Chang KH, 2014, INT J INF TECH DECIS, V13, P1229, DOI 10.1142/S0219622014500758; Chang TH, 2009, INFORM SCIENCES, V179, P355, DOI 10.1016/j.ins.2008.10.012; Chatterjee NC., 2013, DECISION SCI LETT, V2, P1, DOI [DOI 10.5267/J.DSL.2012.11.001, 10.5267/j.dsl.2012.11.001]; Chen YH, 2011, APPL MATH MODEL, V35, P1322, DOI 10.1016/j.apm.2010.09.009; Chen YH, 2012, EXPERT SYST APPL, V39, P3233, DOI 10.1016/j.eswa.2011.09.010; Chtourou H, 2005, EXPERT SYST APPL, V28, P461, DOI 10.1016/j.eswa.2004.12.007; CHUNG CH, 1986, COMPUT IND ENG, V11, P246, DOI 10.1016/0360-8352(86)90087-2; Dagdeviren M, 2008, J INTELL MANUF, V19, P397, DOI 10.1007/s10845-008-0091-7; Deng XY, 2015, KNOWL-BASED SYST, V73, P61, DOI 10.1016/j.knosys.2014.09.007; Duran O, 2008, EXPERT SYST APPL, V34, P1787, DOI 10.1016/j.eswa.2007.01.046; Ekel PY, 2006, COMPUT MATH APPL, V52, P179, DOI 10.1016/j.camwa.2006.08.012; Ertugrul I, 2007, ADV SOFT COMP, V41, P638, DOI 10.1007/978-3-540-72432-2_65; Fouladgar MM, 2012, TECHNOL ECON DEV ECO, V18, P164, DOI 10.3846/20294913.2012.667270; Franco CA, 2014, KNOWL-BASED SYST, V70, P203, DOI 10.1016/j.knosys.2014.06.028; Hajiagha SHR, 2014, INT J INF TECH DECIS, V13, P679, DOI 10.1142/S0219622014500667; Nguyen HT, 2014, EXPERT SYST APPL, V41, P3078, DOI 10.1016/j.eswa.2013.10.039; Ic YT, 2012, INT J PROD RES, V50, P6489, DOI 10.1080/00207543.2011.653011; Ic YT, 2009, EXPERT SYST APPL, V36, P3505, DOI 10.1016/j.eswa.2008.02.022; Jiyang Qi, 2010, Proceedings of the 2010 International Conference on Intelligent Control and Information Processing (ICICIP 2010), P282, DOI 10.1109/ICICIP.2010.5564228; Jo-Peng Tsai, 2010, 2010 International Symposium on Computer, Communication, Control and Automation (3CA 2010), P49, DOI 10.1109/3CA.2010.5533376; Klir G.J., 1995, FUZZY SETS FUZZY LOG, DOI 10.1109/9780470544341.ch11; Krylovas A, 2014, INT J INF TECH DECIS, V13, P1119, DOI 10.1142/S0219622014500825; Liao CN, 2013, INT J INF TECH DECIS, V12, P119, DOI 10.1142/S0219622013500065; Lin ZC, 1996, J MATER PROCESS TECH, V57, P253, DOI 10.1016/0924-0136(95)02076-4; Ma T, 2014, EUR J OPER RES, DOI [10.1016/j.ejor.2014.09.017, DOI 10.1016/J.EJ0R.2014.09.017]; Meng FY, 2015, KNOWL-BASED SYST, V73, P111, DOI 10.1016/j.knosys.2014.09.011; MYINT S, 1994, INT J PROD ECON, V33, P121, DOI 10.1016/0925-5273(94)90125-2; Nieto-Morote A, 2011, INT J INF TECH DECIS, V10, P497, DOI 10.1142/S0219622011004427; Okul D, 2014, INT J INF TECH DECIS, V13, P957, DOI 10.1142/S0219622014500175; Onut S, 2008, J INTELL MANUF, V19, P443, DOI 10.1007/s10845-008-0095-3; Ozgen A, 2011, INT J COMPUT INT SYS, V4, P431, DOI 10.2991/ijcis.2011.4.4.3; Paramasivam V, 2011, INT J ADV MANUF TECH, V54, P1233, DOI 10.1007/s00170-010-2997-4; Peng Y, 2011, INT J INF TECH DECIS, V10, P187, DOI 10.1142/S0219622011004282; Rao R. V., 2006, International Journal of Industrial and Systems Engineering, V1, P502, DOI 10.1504/IJISE.2006.010389; Rao RV, 2007, SPRINGER SER ADV MAN, P139; Rezaei J, 2013, EUR J OPER RES, V225, P75, DOI 10.1016/j.ejor.2012.09.037; Samvedi A, 2012, INT J PROD RES, V50, P3211, DOI 10.1080/00207543.2011.560906; STECKE KE, 1983, MANAGE SCI, V29, P273, DOI 10.1287/mnsc.29.3.273; Sun B, 2008, 2008 INTERNATIONAL SYMPOSIUM ON INTELLIGENT INFORMATION TECHNOLOGY APPLICATION, VOL I, PROCEEDINGS, P530, DOI 10.1109/IITA.2008.421; TABUCANON MT, 1994, COMPUT IND, V25, P131, DOI 10.1016/0166-3615(94)90044-2; Taha Z, 2012, J INTELL MANUF, V23, P2137, DOI 10.1007/s10845-011-0560-2; Taha Z, 2011, INT J ADV MANUF TECH, V57, P719, DOI 10.1007/s00170-011-3323-5; Tao ZF, 2015, COMPUT IND ENG, V83, P184, DOI 10.1016/j.cie.2015.02.016; Turskis Z, 2013, INT J INF TECH DECIS, V12, P45, DOI 10.1142/S021962201350003X; Wang TC, 2008, INFORM SCIENCES, V178, P3755, DOI 10.1016/j.ins.2008.05.028; Wang TY, 2000, INT J PROD RES, V38, P2079, DOI 10.1080/002075400188519; Wu HY, 2009, EXPERT SYST APPL, V36, P10135, DOI 10.1016/j.eswa.2009.01.005; Wu LT, 2010, INT J INF TECH DECIS, V9, P175, DOI 10.1142/S0219622010003683; Xu YJ, 2012, INT J INF TECH DECIS, V11, P627, DOI 10.1142/S0219622012500149; Yazdani M, 2011, ECON RES-EKON ISTRAZ, V24, P27, DOI 10.1080/1331677X.2011.11517478; Yi XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069498; Yurdakul M, 2004, J MATER PROCESS TECH, V146, P365, DOI 10.1016/j.jmatprotec.2003.11.026; Yurdakul M, 2009, J MATER PROCESS TECH, V209, P310, DOI 10.1016/j.jmatprotec.2008.02.006; Zavadskas E. K., 1996, ORGAN MANAG CONSTR, V2, P94; Zavadskas EK, 2012, INT J INF TECH DECIS, V11, P501, DOI 10.1142/S0219622012400135	66	57	58	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0133599	10.1371/journal.pone.0133599	http://dx.doi.org/10.1371/journal.pone.0133599			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368541	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100002
J	Sun, BF; Wang, QQ; Yu, ZJ; Yu, Y; Xiao, CL; Kang, CS; Ge, G; Yan, LH; Zhu, JD; Li, YM; Li, QM; Luo, SP; Yang, D; Li, L; Zhang, WY; Tian, G				Sun, Bao-Fei; Wang, Qing-Qing; Yu, Zi-Jiang; Yu, Yan; Xiao, Chao-Lun; Kang, Chao-Sheng; Ge, Guo; Yan Linghu; Zhu, Jun-De; Li, Yu-Mei; Li, Qiang-Ming; Luo, Shi-Peng; Yang, Dang; Li, Lin; Zhang, Wen-Yan; Tian, Guang			Exercise Prevents Memory Impairment Induced by Arsenic Exposure in Mice: Implication of Hippocampal BDNF and CREB	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; SPATIAL MEMORY; SYNAPTIC-PLASTICITY; NEUROTROPHIC FACTOR; DIETARY RESTRICTION; VOLUNTARY EXERCISE; PROTEIN-SYNTHESIS; GENE-EXPRESSION; RAT; PERFORMANCE	High concentrations of arsenic, which can be occasionally found in drinking water, have been recognized as a global health problem. Exposure to arsenic can disrupt spatial memory; however, the underlying mechanism remains unclear. In the present study, we tested whether exercise could interfere with the effect of arsenic exposure on the long-term memory (LTM) of object recognition in mice. Arsenic (0, 1, 3, and 10 mg/ kg, i.g.) was administered daily for 12 weeks. We found that arsenic at dosages of 1, 3, and 10 mg/kg decreased body weight and increased the arsenic content in the brain. The object recognition LTM (tested 24 h after training) was disrupted by 3 mg/ kg and 10 mg/ kg, but not 1 mg/ kg arsenic exposure. Swimming exercise also prevented LTM impairment induced by 3 mg/kg, but not with 10 mg/ kg, of arsenic exposure. The expression of brain-derived neurotrophic factor (BDNF) and phosphorylated cAMP-response element binding protein (pCREB) in the CA1 and dentate gyrus areas (DG) of the dorsal hippocampus were decreased by 3 mg/ kg and 10 mg/ kg, but not by 1 mg/ kg, of arsenic exposure. The decrease in BDNF and pCREB in the CA1 and DG induced by 3 mg/ kg, but not 10 mg/ kg, of arsenic exposure were prevented by swimming exercise. Arsenic exposure did not affect the total CREB expression in the CA1 or DG. Taken together, these results indicated that swimming exercise prevented the impairment of object recognition LTM induced by arsenic exposure, which may be mediated by BDNF and CREB in the dorsal hippocampus.	[Sun, Bao-Fei; Yu, Zi-Jiang; Yu, Yan; Xiao, Chao-Lun; Kang, Chao-Sheng; Ge, Guo; Yan Linghu; Zhu, Jun-De; Li, Yu-Mei; Li, Qiang-Ming; Luo, Shi-Peng; Yang, Dang; Li, Lin; Zhang, Wen-Yan; Tian, Guang] Guiyang Med Univ, Dept Anat, Guiyang 550004, Peoples R China; [Wang, Qing-Qing] Guiyang Med Univ, Affiliated Hosp, Dept Hosp Infect Management, Guiyang 550004, Peoples R China	Guizhou Medical University; Guizhou Medical University	Yu, ZJ (corresponding author), Guiyang Med Univ, Dept Anat, Guiyang 550004, Peoples R China.	yzj0112@126.com			Natural Science Foundation of China [3066018, 81060108]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the Natural Science Foundation of China (no. 3066018 and 81060108), (URL: http://www.nsfc.gov.cn/). The funder supported the whole study, including study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Adetutu A, 2013, PHARMACOGN RES, V5, P207, DOI 10.4103/0974-8490.112431; Alomari MA, 2013, BEHAV BRAIN RES, V247, P34, DOI 10.1016/j.bbr.2013.03.007; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Asl Naser Ahmadi, 2008, Pathophysiology, V15, P9, DOI 10.1016/j.pathophys.2007.10.002; Bardullas U, 2009, TOXICOL APPL PHARM, V239, P169, DOI 10.1016/j.taap.2008.12.004; Bechara RG, 2014, BEHAV BRAIN RES, V275, P297, DOI 10.1016/j.bbr.2013.11.015; Bechara RG, 2013, BEHAV BRAIN RES; Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; Calderon J, 2001, ENVIRON RES, V85, P69, DOI 10.1006/enrs.2000.4106; Chou CT, 2013, AMINO ACIDS, V45, P811, DOI 10.1007/s00726-013-1524-y; Costa MS, 2008, NEUROCHEM INT, V53, P89, DOI 10.1016/j.neuint.2008.06.006; Das AK, 2010, ENVIRON TOXICOL PHAR, V29, P64, DOI 10.1016/j.etap.2009.10.002; Dhar P, 2005, NEUROTOXICOLOGY, V26, P309, DOI 10.1016/j.neuro.2004.10.005; DIESFELDT H F A, 1977, Age and Ageing, V6, P58, DOI 10.1093/ageing/6.1.58; Ding Q, 2006, NEUROSCIENCE, V140, P823, DOI 10.1016/j.neuroscience.2006.02.084; Dutta M, 2014, FOOD CHEM TOXICOL, V66, P262, DOI 10.1016/j.fct.2014.01.050; Goes ATR, 2014, NEUROSCIENCE, V256, P61, DOI 10.1016/j.neuroscience.2013.09.042; Gomez-Pinilla F, 2008, EUR J NEUROSCI, V28, P2278, DOI 10.1111/j.1460-9568.2008.06524.x; Gora Ravuri Halley, 2014, Toxicol Int, V21, P78, DOI 10.4103/0971-6580.128807; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Hemalatha Pudari, 2013, J Nat Sci Biol Med, V4, P393, DOI 10.4103/0976-9668.116986; Hoveida R, 2011, BEHAV BRAIN RES, V216, P270, DOI 10.1016/j.bbr.2010.08.003; Huo TG, 2014, MOL NEUROBIOL; ITOH T, 1990, TOXICOL LETT, V54, P345; Jiang SF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096041; Jing JF, 2012, NEUROTOXICOLOGY, V33, P1230, DOI 10.1016/j.neuro.2012.07.003; Khabour OF, 2013, BRAIN RES BULL, V90, P19, DOI 10.1016/j.brainresbull.2012.08.005; Khabour OF, 2010, HIPPOCAMPUS, V20, P637, DOI 10.1002/hipo.20657; Kim YM, 2013, J EXERC REHABIL, V9, P243, DOI 10.12965/jer.130006; Leal G, 2014, NEUROPHARMACOLOGY, V76, P639, DOI 10.1016/j.neuropharm.2013.04.005; Lee MC, 2012, J APPL PHYSIOL, V113, P1260, DOI 10.1152/japplphysiol.00869.2012; Luo CX, 2007, J NEUROSCI RES, V85, P1637, DOI 10.1002/jnr.21317; Luo JH, 2012, TOXICOL LETT, V211, P39, DOI 10.1016/j.toxlet.2012.02.021; Luo JH, 2009, TOXICOL LETT, V184, P121, DOI 10.1016/j.toxlet.2008.10.029; Nasehi M, 2014, PHYSIOL BEHAV, V128, P237, DOI 10.1016/j.physbeh.2014.02.011; Noble EE, 2014, NEUROBIOL LEARN MEM, V114, P40, DOI 10.1016/j.nlm.2014.04.006; Owumi SE, 2013, PHARMACOGN RES, V5, P183, DOI 10.4103/0974-8490.112425; Pal S, 2006, DRUG CHEM TOXICOL, V29, P423, DOI 10.1080/01480540600837993; PETRES J, 1977, ENVIRON HEALTH PERSP, V19, P223, DOI 10.2307/3428480; Rahn EJ, 2013, NEUROBIOL LEARN MEM, V105, P133, DOI 10.1016/j.nlm.2013.06.008; Rizwan S, 2014, FOOD CHEM TOXICOL, V68, P99, DOI 10.1016/j.fct.2014.03.011; Rodriguez VM, 2003, TOXICOL LETT, V145, P1, DOI 10.1016/S0378-4274(03)00262-5; Rodriguez VM, 2001, BRAIN RES BULL, V55, P301, DOI 10.1016/S0361-9230(01)00477-4; Rosado JL, 2007, ENVIRON HEALTH PERSP, V115, P1371, DOI 10.1289/ehp.9961; Saadati Hakimeh, 2010, Asian J Sports Med, V1, P137; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; SAMORAJSKI T, 1985, NEUROBIOL AGING, V6, P17, DOI 10.1016/0197-4580(85)90066-1; Tandon Neeraj, 2012, Toxicol Int, V19, P245, DOI 10.4103/0971-6580.103658; Tsai SY, 2003, NEUROTOXICOLOGY, V24, P747, DOI 10.1016/S0161-813X(03)00029-9; Tyler Christina R, 2014, Curr Environ Health Rep, V1, P132; Uygur R, 2013, TOXICOL IND HLTH; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Vaynman S, 2003, NEUROSCIENCE, V122, P647, DOI 10.1016/j.neuroscience.2003.08.001; Wasserman GA, 2004, ENVIRON HEALTH PERSP, V112, P1329, DOI 10.1289/ehp.6964; Xi SH, 2009, ARCH TOXICOL, V83, P549, DOI 10.1007/s00204-009-0403-5; Xu Z, 2013, FOOD CHEM TOXICOL, V58, P1, DOI 10.1016/j.fct.2013.03.048; Yadav RS, 2011, NEUROTOXICOLOGY, V32, P760, DOI 10.1016/j.neuro.2011.07.004; Yadav RS, 2010, NEUROTOXICOLOGY, V31, P533, DOI 10.1016/j.neuro.2010.05.001; Yadav RS, 2009, TOXICOL APPL PHARM, V240, P367, DOI 10.1016/j.taap.2009.07.017; Yau SY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/403120	60	23	26	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137810	10.1371/journal.pone.0137810	http://dx.doi.org/10.1371/journal.pone.0137810			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368803	gold, Green Published, Green Submitted			2022-12-27	WOS:000361601100144
J	Ye, H; Zhao, Q; Wang, YF; Wang, DP; Zheng, ZY; Schroder, PM; Lu, Y; Kong, Y; Liang, WH; Shang, YS; Guo, ZY; He, XS				Ye, Hui; Zhao, Qiang; Wang, Yufang; Wang, Dongping; Zheng, Zhouying; Schroder, Paul Michael; Lu, Yao; Kong, Yuan; Liang, Wenhua; Shang, Yushu; Guo, Zhiyong; He, Xiaoshun			Outcomes of Technical Variant Liver Transplantation versus Whole Liver Transplantation for Pediatric Patients: A Meta-Analysis	PLOS ONE			English	Article							HEPATIC-ARTERY THROMBOSIS; WAITING-LIST MORTALITY; LATE GRAFT LOSS; DONOR LIVER; VASCULAR COMPLICATIONS; LIVING-DONOR; FULL-SIZE; SEGMENTAL GRAFTS; SINGLE-CENTER; EXPERIENCE	Objective To overcome the shortage of appropriate-sized whole liver grafts for children, technical variant liver transplantation has been practiced for decades. We perform a meta-analysis to compare the survival rates and incidence of surgical complications between pediatric whole liver transplantation and technical variant liver transplantation. Methods To identify relevant studies up to January 2014, we searched PubMed/Medline, Embase, and Cochrane library databases. The primary outcomes measured were patient and graft survival rates, and the secondary outcomes were the incidence of surgical complications. The outcomes were pooled using a fixed-effects model or random-effects model. Results The one-year, three-year, five-year patient survival rates and one-year, three-year graft survival rates were significantly higher in whole liver transplantation than technical variant liver transplantation (OR = 1.62, 1.90, 1.65, 1.78, and 1.62, respectively, p<0.05). There was no significant difference in five-year graft survival rate between the two groups (OR = 1.47, p = 0.10). The incidence of portal vein thrombosis and biliary complications were significantly lower in the whole liver transplantation group (OR = 0.45 and 0.42, both p<0.05). The incidence of hepatic artery thrombosis was comparable between the two groups (OR = 1.21, p = 0.61). Conclusions Pediatric whole liver transplantation is associated with better outcomes than technical variant liver transplantation. Continuing efforts should be made to minimize surgical complications to improve the outcomes of technical variant liver transplantation.	[Ye, Hui; Zhao, Qiang; Wang, Yufang; Wang, Dongping; Zheng, Zhouying; Lu, Yao; Kong, Yuan; Liang, Wenhua; Shang, Yushu; Guo, Zhiyong; He, Xiaoshun] Sun Yat Sen Univ, Affiliated Hosp 1, Organ Transplant Ctr, Guangzhou 510080, Guangdong, Peoples R China; [Schroder, Paul Michael] Univ Toledo, Coll Med, Toledo, OH 43614 USA	Sun Yat Sen University; University System of Ohio; University of Toledo	He, XS (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Organ Transplant Ctr, Guangzhou 510080, Guangdong, Peoples R China.	rockyucsf1981@126.com; gdtrc@126.com	Zheng, Zhouying/AAF-5074-2019	Zheng, Zhouying/0000-0001-7101-1493; Wenhua, Liang/0000-0002-1391-8238	National High Technology Research and Development Program of China (863 Program) [2012AA021007, 2012AA021008]; National Natural Science Foundation of China [81373156, 81471583]; Special Fund for Science Research by Ministry of Health [201302009]; Key Clinical Specialty Construction Project of National Health and Family Planning Commission of the People's Republic of China; Guangdong Provincial Key Laboratory Construction Projection on Organ Donation and Transplant Immunology [2013A061401007]; Pearl River Nova Program of Guangzhou; Guangdong Provincial Natural Science Funds for Distinguished Young Scholars	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Science Research by Ministry of Health; Key Clinical Specialty Construction Project of National Health and Family Planning Commission of the People's Republic of China; Guangdong Provincial Key Laboratory Construction Projection on Organ Donation and Transplant Immunology; Pearl River Nova Program of Guangzhou; Guangdong Provincial Natural Science Funds for Distinguished Young Scholars	This study was supported by the National High Technology Research and Development Program of China (863 Program) (2012AA021007 & 2012AA021008), the National Natural Science Foundation of China (81373156 and 81471583), the Special Fund for Science Research by Ministry of Health (201302009), the Key Clinical Specialty Construction Project of National Health and Family Planning Commission of the People's Republic of China, the Guangdong Provincial Key Laboratory Construction Projection on Organ Donation and Transplant Immunology (2013A061401007), Pearl River Nova Program of Guangzhou, and Guangdong Provincial Natural Science Funds for Distinguished Young Scholars. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt PL, 2004, LIVER TRANSPLANT, V10, P1287, DOI 10.1002/lt.20270; [Anonymous], 1983, HEPATOLOGY S, V4, p107S; Asensio M, 2001, Cir Pediatr, V14, P116; Austin MT, 2005, ARCH SURG-CHICAGO, V140, P465, DOI 10.1001/archsurg.140.5.465; BACKMAN L, 1993, TRANSPLANTATION, V55, P1078; Baliga P, 2004, LIVER TRANSPLANT, V10, P1364, DOI 10.1002/lt.20252; Becker NS, 2008, LIVER TRANSPLANT, V14, P1125, DOI 10.1002/lt.21491; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bekker J, 2009, AM J TRANSPLANT, V9, P746, DOI 10.1111/j.1600-6143.2008.02541.x; BISMUTH H, 1984, SURGERY, V95, P367; Bourdeaux C, 2005, TRANSPLANTATION, V79, P1273, DOI 10.1097/00007890-200505150-00060; Buell JF, 2002, ANN SURG, V236, P658, DOI 10.1097/00000658-200211000-00017; Burgos L, 2008, EUR J PEDIATR SURG, V18, P372, DOI 10.1055/s-2008-1038900; Busuttil RW, 1999, ANN SURG, V229, P313, DOI 10.1097/00000658-199903000-00003; Cacciarelli TV, 1997, TRANSPLANTATION, V64, P242, DOI 10.1097/00007890-199707270-00011; Chardot C, 1999, EUR J PEDIATR SURG, V9, P146, DOI 10.1055/s-2008-1072231; D'Alessandro AM, 2007, PEDIATR TRANSPLANT, V11, P661, DOI 10.1111/j.1399-3046.2007.00737.x; de Goyet JD, 2009, CURR OPIN ORGAN TRAN, V14, P507, DOI 10.1097/MOT.0b013e32833067f3; Diamond IR, 2007, ANN SURG, V246, P301, DOI 10.1097/SLA.0b013e3180caa415; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; EMOND JC, 1989, HEPATOLOGY, V10, P867, DOI 10.1002/hep.1840100520; EMOND JC, 1993, TRANSPLANTATION, V55, P835, DOI 10.1097/00007890-199304000-00029; EMOND JC, 1993, SURG GYNECOL OBSTET, V176, P11; EMOND JC, 1990, ANN SURG, V212, P14, DOI 10.1097/00000658-199007000-00003; Goss JA, 1997, TRANSPLANTATION, V64, P871, DOI 10.1097/00007890-199709270-00014; Gridelli B, 2003, TRANSPLANTATION, V75, P1197, DOI 10.1097/01.TP.0000061940.96949.A1; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ko EY, 2003, RADIOLOGY, V229, P806, DOI 10.1148/radiol.2293020700; LANGNAS AN, 1992, TRANSPLANTATION, V53, P387, DOI 10.1097/00007890-199202010-00023; Leal N, 2007, Cir Pediatr, V20, P143; Lucianetti A, 2005, TRANSPLANT P, V37, P1143, DOI 10.1016/j.transproceed.2004.12.307; Otte JB, 2005, PEDIATR TRANSPLANT, V9, P557, DOI 10.1111/j.1399-3046.2005.00354.x; Otte JB, 1998, PEDIATR SURG INT, V13, P308, DOI 10.1007/s003830050328; Pareja E, 2010, TRANSPL P, V42, P2970, DOI 10.1016/j.transproceed.2010.07.063; PICHLMAYR R, 1988, LANGENBECK ARCH CHIR, V373, P127, DOI 10.1007/BF01262776; Pinelli D, 2005, TRANSPL P, V37, P1146, DOI 10.1016/j.transproceed.2004.12.302; Rela M, 1998, ANN SURG, V227, P282, DOI 10.1097/00000658-199802000-00019; Roberts JP, 2004, AM J TRANSPLANT, V4, P373, DOI 10.1111/j.1600-6143.2004.00359.x; Rogiers X, 1996, ANN SURG, V224, P331, DOI 10.1097/00000658-199609000-00009; RYCKMAN FC, 1991, J PEDIATR SURG, V26, P422, DOI 10.1016/0022-3468(91)90989-7; Salzedas-Netto AA, 2010, TRANSPL P, V42, P507, DOI 10.1016/j.transproceed.2010.01.040; SANTAMARIA ML, 1995, TRANSPLANT P, V27, P2292; Sieders E, 2000, LIVER TRANSPLANT, V6, P326, DOI 10.1053/lv.2000.6146; Sieders E, 2002, ANN SURG, V235, P125, DOI 10.1097/00000658-200201000-00016; Sieders E, 1999, TRANSPLANTATION, V68, P540, DOI 10.1097/00007890-199908270-00017; Sindhi R, 1999, J PEDIATR SURG, V34, P107, DOI 10.1016/S0022-3468(99)90238-5; SINGER PA, 1988, CLIN RES, V36, P539; SOKAL EM, 1990, J PEDIATR-US, V117, P205, DOI 10.1016/S0022-3476(05)80531-1; Spada M, 2009, WORLD J GASTROENTERO, V15, P648, DOI 10.3748/wjg.15.648; Squires RH, 2006, J PEDIATR-US, V148, P652, DOI 10.1016/j.jpeds.2005.12.051; STRONG RW, 1990, NEW ENGL J MED, V322, P1505, DOI 10.1056/NEJM199005243222106; SUWATA J, 1994, TRANSPLANT P, V26, P1780; Tannuri U, 2005, PEDIATR TRANSPLANT, V9, P293, DOI 10.1111/j.1399-3046.2005.00306.x; Wallot MA, 2002, LIVER TRANSPLANT, V8, P615, DOI 10.1053/jlts.2002.34149; WHITINGTON PF, 1994, SEMIN LIVER DIS, V14, P303, DOI 10.1055/s-2007-1007320; WOZNEY P, 1986, AM J ROENTGENOL, V147, P657, DOI 10.2214/ajr.147.4.657; Yamauchi Y, 2006, DIGEST SURG, V23, P65, DOI 10.1159/000093496	57	14	15	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138202	10.1371/journal.pone.0138202	http://dx.doi.org/10.1371/journal.pone.0138202			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368552	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100241
J	Buhtz, A; Witzel, K; Strehmel, N; Ziegler, J; Abel, S; Grosch, R				Buhtz, Anja; Witzel, Katja; Strehmel, Nadine; Ziegler, Joerg; Abel, Steffen; Grosch, Rita			Perturbations in the Primary Metabolism of Tomato and Arabidopsis thaliana Plants Infected with the Soil-Borne Fungus Verticillium dahliae	PLOS ONE			English	Article							AMPLIFIED POLYMORPHIC DNA; PROTEIN-TAGGED ISOLATE; VEGETATIVE COMPATIBILITY; GAS-CHROMATOGRAPHY; GENE-EXPRESSION; BRASSICA-NAPUS; AMINO-ACIDS; DEFENSE; PATHOGEN; LONGISPORUM	The hemibiotrophic soil-borne fungus Verticillium dahliae is a major pathogen of a number of economically important crop species. Here, the metabolic response of both tomato and Arabidopsis thaliana to V. dahliae infection was analysed by first using non-targeted GC-MS profiling. The leaf content of both major cell wall components glucuronic acid and xylose was reduced in the presence of the pathogen in tomato but enhanced in A. thaliana. The leaf content of the two tricarboxylic acid cycle intermediates fumaric acid and succinic acid was increased in the leaf of both species, reflecting a likely higher demand for reducing equivalents required for defence responses. A prominent group of affected compounds was amino acids and based on the targeted analysis in the root, it was shown that the level of 12 and four free amino acids was enhanced by the infection in, respectively, tomato and A. thaliana, with leucine and histidine being represented in both host species. The leaf content of six free amino acids was reduced in the leaf tissue of diseased A. thaliana plants, while that of two free amino acids was raised in the tomato plants. This study emphasizes the role of primary plant metabolites in adaptive responses when the fungus has colonized the plant.	[Buhtz, Anja; Witzel, Katja; Grosch, Rita] Leibniz Inst Vegetable & Ornamental Crops, D-14979 Grossbeeren, Germany; [Strehmel, Nadine; Ziegler, Joerg; Abel, Steffen] Leibniz Inst Plant Biochem, D-06120 Halle, Germany	Leibniz Institut fur Gemuse- und Zierpflanzenbau (IGZ); Leibniz Institut fur Pflanzenbiochemie	Witzel, K (corresponding author), Leibniz Inst Vegetable & Ornamental Crops, Theodor Echtermeyer Weg 1, D-14979 Grossbeeren, Germany.	witzel@igzev.de	Grosch, Rita/HHM-5490-2022; Ziegler, Jörg/W-7645-2019	Grosch, Rita/0000-0002-7179-5715	Leibniz Association [SAW-2011-IPB-3]	Leibniz Association	The work was supported by the Leibniz Association (www.leibniz-gemeinschaft.de/en/home/) under the project 'Chemical Communication in the Rhizosphere' (SAW-2011-IPB-3). The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.	Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002; Torres MA, 2010, PHYSIOL PLANTARUM, V138, P414, DOI 10.1111/j.1399-3054.2009.01326.x; Atallah ZK, 2011, PLANT DIS, V95, P784, DOI 10.1094/PDIS-01-11-0075; Berger S, 2007, J EXP BOT, V58, P4019, DOI 10.1093/jxb/erm298; Bhat RG, 1999, PHYTOPATHOLOGY, V89, P1218, DOI 10.1094/PHYTO.1999.89.12.1218; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Bolouri Moghaddam MR, 2012, J EXP BOT, V63, P3989, DOI 10.1093/jxb/ers129; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Chanda B, 2008, PLANT PHYSIOL, V147, P2017, DOI 10.1104/pp.108.121335; DAAYF F, 1995, EUR J PLANT PATHOL, V101, P69, DOI 10.1007/BF01876095; Depuydt S, 2009, PLANT PHYSIOL, V149, P1366, DOI 10.1104/pp.108.131805; Dervis S, 2009, PHYTOPARASITICA, V37, P467, DOI 10.1007/s12600-009-0061-4; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dong XN, 2004, CURR OPIN PLANT BIOL, V7, P547, DOI 10.1016/j.pbi.2004.07.005; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; DUNCAN DR, 1987, CAN J BOT, V65, P1299, DOI 10.1139/b87-182; Dunker S, 2008, J PHYTOPATHOL, V156, P698, DOI 10.1111/j.1439-0434.2008.01429.x; Floerl S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031435; Floerl S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-129; Fradin EF, 2006, MOL PLANT PATHOL, V7, P71, DOI [10.1111/j.1364-3703.2006.00323.x, 10.1111/J.1364-3703.2006.00323.X]; Frost CJ, 2008, PLANT PHYSIOL, V146, P818, DOI 10.1104/pp.107.113027; GEBHARDT C, 1989, THEOR APPL GENET, V78, P65, DOI 10.1007/BF00299755; Gibeaut DM, 1997, PLANT PHYSIOL, V115, P317, DOI 10.1104/pp.115.2.317; Hardham AR, 2007, CURR OPIN PLANT BIOL, V10, P342, DOI 10.1016/j.pbi.2007.05.001; Harper AD, 2002, PLANT PHYSIOL, V130, P2188, DOI 10.1104/pp.009654; Heinz R, 1998, PHYSIOL MOL PLANT P, V52, P385, DOI 10.1006/pmpp.1998.0163; Herbers K, 1996, FEBS LETT, V397, P239, DOI 10.1016/S0014-5793(96)01183-0; Hill MK, 1999, PLANT MOL BIOL, V40, P289, DOI 10.1023/A:1006146419544; Hofmann J, 2010, PLANT J, V62, P1058, DOI 10.1111/j.1365-313X.2010.04217.x; Huot B, 2014, MOL PLANT, V7, P1267, DOI 10.1093/mp/ssu049; Iven T, 2012, MOL PLANT, V5, P1389, DOI 10.1093/mp/sss044; Jimenez-Diaz RM, 2012, PLANT DIS, V96, P304, DOI 10.1094/PDIS-06-11-0496; Johansson A, 2006, MOL PLANT MICROBE IN, V19, P958, DOI 10.1094/MPMI-19-0958; Kangasjarvi S, 2012, J EXP BOT, V63, P1619, DOI 10.1093/jxb/err402; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Li KN, 1999, MYCOL RES, V103, P1361, DOI 10.1017/S0953756299008357; Lommen A, 2009, ANAL CHEM, V81, P3079, DOI 10.1021/ac900036d; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Luedemann A, 2008, BIOINFORMATICS, V24, P732, DOI 10.1093/bioinformatics/btn023; McFadden HG, 2001, PHYSIOL MOL PLANT P, V58, P119, DOI 10.1006/pmpp.2001.0320; Parker D, 2009, PLANT J, V59, P723, DOI 10.1111/j.1365-313X.2009.03912.x; Peluffo L, 2010, PHYTOCHEMISTRY, V71, P70, DOI 10.1016/j.phytochem.2009.09.018; Pieterse CMJ, 2014, ANNU REV PHYTOPATHOL, V52, P347, DOI 10.1146/annurev-phyto-082712-102340; Reusche M, 2014, ENVIRON EXP BOT, V108, P23, DOI 10.1016/j.envexpbot.2013.12.009; Reusche M, 2012, PLANT CELL, V24, P3823, DOI 10.1105/tpc.112.103374; Robb J, 2007, PLANTA, V226, P299, DOI 10.1007/s00425-007-0482-6; Robb J, 2009, BOTANY, V87, P993, DOI 10.1139/B09-056; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; Rojas CM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00017; Schauer N, 2005, J EXP BOT, V56, P297, DOI 10.1093/jxb/eri057; Singh S, 2012, MOL PLANT MICROBE IN, V25, P569, DOI 10.1094/MPMI-08-11-0217; Sun C, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0268-5; TINKER NA, 1993, THEOR APPL GENET, V85, P976, DOI 10.1007/BF00215037; Tischner R, 2010, PHYSIOL MOL PLANT P, V74, P419, DOI 10.1016/j.pmpp.2010.06.004; Tsror L, 2001, PLANT PATHOL, V50, P477, DOI 10.1046/j.1365-3059.2001.00587.x; Tzima AK, 2011, MOL PLANT MICROBE IN, V24, P129, DOI 10.1094/MPMI-09-09-0217; Vallad GE, 2008, PHYTOPATHOLOGY, V98, P871, DOI 10.1094/PHYTO-98-8-0871; van Esse HP, 2009, MOL PLANT MICROBE IN, V22, P245, DOI 10.1094/MPMI-22-3-0245; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Venugopal SC, 2009, PLANT SIGNAL BEHAV, V4, P746, DOI 10.4161/psb.4.8.9111; Wang FX, 2011, PROTEOMICS, V11, P4296, DOI 10.1002/pmic.201100062; Witzel K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071877; Xu L, 2011, J PHYTOPATHOL, V159, P606, DOI 10.1111/j.1439-0434.2011.01813.x; Zhang WW, 2013, EUR J PLANT PATHOL, V135, P867, DOI 10.1007/s10658-012-0131-1; Zhao FA, 2012, PLANT SCI, V185, P176, DOI 10.1016/j.plantsci.2011.10.007; Zhao P, 2014, PROTEIN CELL, V5, P94, DOI 10.1007/s13238-013-0009-9; Zhou L, 2006, PLANT PATHOL, V55, P137, DOI 10.1111/j.1365-3059.2005.01311.x; Ziegler J, 2014, AMINO ACIDS, V46, P2799, DOI 10.1007/s00726-014-1837-5	68	17	17	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138242	10.1371/journal.pone.0138242	http://dx.doi.org/10.1371/journal.pone.0138242			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381754	gold, Green Published, Green Submitted			2022-12-27	WOS:000361790200076
J	Chanakira, A; Kir, D; Barke, RA; Santilli, SM; Ramakrishnan, S; Roy, S				Chanakira, Alice; Kir, Devika; Barke, Roderick A.; Santilli, Steve M.; Ramakrishnan, Sundaram; Roy, Sabita			Hypoxia Differentially Regulates Arterial and Venous Smooth Muscle Cell Migration	PLOS ONE			English	Article							INTERNAL-THORACIC-ARTERY; CORONARY-BYPASS SURGERY; SAPHENOUS-VEIN; RADIAL ARTERY; INTIMAL HYPERPLASIA; VASA VASORUM; SURVIVAL; PROLIFERATION; PATENCY; GRAFTS	Objective Intimal hyperplasia (IH) is a clinical concern leading to failure of up to 50% of vein grafts and 10% of arterial grafts after 10 years with no known current treatment. Recent studies have shown that hypoxia differentially regulates proliferation of vein derived smooth muscle cells (V-SMC) compared to artery derived smooth muscle cells (A-SMC). The objective of this study is to evaluate the effect of hypoxia on cellular migration and the mechanisms underlying the differential effects of hypoxia on A-SMC and V-SMC migration. Methods and Results Hypoxic treatment (3-5% O2) of Smooth Muscle Cells (SMC) resulted in differential migration in scratch wound and electric cell substrate impedance sensing (ECIS) assays. Hypoxia led to greater migration compared to normoxia with venous derived wound closure (V-SMC 30.8% Normoxia to 67% Hypoxia) greater than arterial wound closure (A-SMC 6.2% Normoxia to 24.7% Hypoxia). Paracrine factors secreted by hypoxic endothelial cells induced more migration in SMC compared to factors secreted by normoxic endothelial cells. Migration of V-SMC was greater than A-SMC in the presence of paracrine factors. Neutralizing antibody to Vascular Endothelial Growth Factor Receptor -1 (VEGFR-1) completely inhibited V-SMC migration while there was only partial inhibition of A-SMC migration. A-SMC migration was completely inhibited by Platelet Derived Growth Factor BB (PDGF-BB) neutralizing antibody. p38 Mitogen Activated Protein kinase (p38 MAPK) inhibitor pre-incubation completely inhibited migration induced by paracrine factors in both ASMC and V-SMC. Conclusion Our study determines that SMC migration under hypoxia occurs via both an autocrine and paracrine mechanism and is dependent on Vascular Endothelial Growth Factor-A (VEGFA) in V-SMC and PDGF-BB in A-SMC. Migration of both A-SMC and V-SMC is inhibited by p38 MAPK inhibitor. These studies suggest that pharmacotherapeutic strategies directed at modulating p38 MAPK activity can be exploited to prevent IH in vascular grafts.	[Chanakira, Alice; Kir, Devika; Santilli, Steve M.; Roy, Sabita] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA; [Kir, Devika; Ramakrishnan, Sundaram; Roy, Sabita] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Barke, Roderick A.; Santilli, Steve M.] VA Med Ctr, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Roy, S (corresponding author), Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA.	royxx002@umn.edu	Kir, Devika/AAA-1255-2021	Kir, Devika/0000-0001-7134-7325	National Institutes for Health (National Institute for Drug Abuse) [RO1 DA 12104, RO1 DA 022935, RO1 DA031202, K05DA033881]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012104, R01DA022935, K05DA033881, R01DA031202] Funding Source: NIH RePORTER	National Institutes for Health (National Institute for Drug Abuse); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The work was funded by the following grants from the National Institutes for Health (National Institute for Drug Abuse): RO1 DA 12104, RO1 DA 022935, RO1 DA031202, K05DA033881.	Athanasiou T, 2011, EUR J CARDIO-THORAC, V40, P208, DOI 10.1016/j.ejcts.2010.11.012; Banerjee S, 2008, BIOCHEMISTRY-US, V47, P3345, DOI 10.1021/bi8000352; BARKER SGE, 1993, ARTERIOSCLER THROMB, V13, P70, DOI 10.1161/01.ATV.13.1.70; Bjornheden T, 1999, ARTERIOSCL THROM VAS, V19, P870, DOI 10.1161/01.ATV.19.4.870; Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; Cameron A, 1996, NEW ENGL J MED, V334, P216, DOI 10.1056/NEJM199601253340402; CAMERON AAC, 1995, J AM COLL CARDIOL, V25, P188, DOI 10.1016/0735-1097(94)00332-K; Cao C, 2013, J THORAC CARDIOV SUR, V146, P255, DOI 10.1016/j.jtcvs.2012.07.014; Chanakira A, 2012, AM J PHYSIOL-HEART C, V302, pH1173, DOI 10.1152/ajpheart.00411.2011; Chung KF, 2011, CHEST, V139, P1470, DOI 10.1378/chest.10-1914; CLOWES AW, 1991, J VASC SURG, V13, P885; CORSON JD, 1985, ARCH SURG-CHICAGO, V120, P386; Daniel JM, 2011, J MOL CELL CARDIOL, V50, P273, DOI 10.1016/j.yjmcc.2010.10.030; Deb S, 2012, J AM COLL CARDIOL, V60, P28, DOI 10.1016/j.jacc.2012.03.037; Dimitrova KR, 2012, ANN THORAC SURG, V94, P475, DOI 10.1016/j.athoracsur.2012.04.035; Hedges JC, 1999, J BIOL CHEM, V274, P24211, DOI 10.1074/jbc.274.34.24211; Lee ES, 2000, J SURG RES, V91, P32, DOI 10.1006/jsre.2000.5891; Lemson MS, 2000, EUR J VASC ENDOVASC, V19, P336, DOI 10.1053/ejvs.1999.1040; Liang M, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0431-z; LOOP FD, 1986, NEW ENGL J MED, V314, P1, DOI 10.1056/NEJM198601023140101; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Park SJ, 2015, NEW ENGL J MED, V372, P1204, DOI 10.1056/NEJMoa1415447; Sabik JF, 2005, ANN THORAC SURG, V79, P544, DOI 10.1016/j.athoracsur.2004.07.047; Wan J, 2014, ANN VASC SURG, V28, P725, DOI 10.1016/j.avsg.2013.10.007; Zacharias A, 2004, CIRCULATION, V109, P1489, DOI 10.1161/01.CIR.0000121743.10146.78	25	13	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138587	10.1371/journal.pone.0138587	http://dx.doi.org/10.1371/journal.pone.0138587			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381529	gold, Green Published, Green Submitted			2022-12-27	WOS:000361790200134
J	Li, G; He, NN; Jin, HX; Liu, Y; Guo, YH; Su, YC; Sun, YP				Li, Gang; He, Nannan; Jin, Haixia; Liu, Yan; Guo, Yihong; Su, Yingchun; Sun, Yingpu			The Influence of Single Nucleotide Polymorphism Microarray-Based Molecular Karyotype on Preimplantation Embryonic Development Potential	PLOS ONE			English	Article							GENETIC DIAGNOSIS; CHROMOSOMAL-ABNORMALITIES; BLASTOCYST DEVELOPMENT; NUMBER; AGE; ANEUPLOIDY; MOSAICISM; OOCYTES; GROWTH	In order to investigate the influence of the molecular karyotype based on single nucleotide polymorphism (SNP) microarray on embryonic development potential in preimplantation genetic diagnosis (PGD), we retrospectively analyzed the clinical data generated by PGD using embryos retrieved from parents with chromosome rearrangements in our center. In total, 929 embryos from 119 couples had exact diagnosis and development status. The blastocyst formation rate of balanced molecular karyotype embryos was 56.6% (276/488), which was significantly higher than that of genetic imbalanced embryos 24.5% (108/441) (P<0.001). No significant difference was detected in blastocyst formation rates in the groups of maternal age<30, 30-35 and >35 respectively. Blastocyst formation rates of male and female embryos were 44.5% (183/411) and 38.8% (201/518) respectively, with no significant difference between them (P>0.05). The rates of balanced molecular karyotype embryos vary from groups of embryos with different cell numbers at 68 hours after insemination. The blastocyst formation rate of embryos with 6-8 cells (48.1%) was significantly higher than that of embryos with <6 cells (23.9%) and with >8 cells (42.9%) (P<0.05). As for the unbalanced embryos, there was no significant difference of the distribution of abnormal molecular karyotypes in the subgroup of the arrest, morula and blastocyst. Thus, we conclude that embryos with balanced molecular karyotype have significant higher development potential than those with imbalanced molecular karyotype whilst maternal age, embryo gender and types of abnormal molecular karyotype have no significant influence on blastocyst formation. Compared with embryos with <6 and >8 cells, embryos with 6-8 blastomeres have higher rate of balanced molecular karyotype and blastocyst formation.	[Li, Gang; He, Nannan; Jin, Haixia; Liu, Yan; Guo, Yihong; Su, Yingchun; Sun, Yingpu] Zhengzhou Univ, Affiliated Hosp 1, Reprod Med Ctr, Zhengzhou 450052, Peoples R China	Zhengzhou University	Sun, YP (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Reprod Med Ctr, Zhengzhou 450052, Peoples R China.	syp2008@vip.sina.com	jin, haixia/HGA-9179-2022		National Natural Science Foundation of China [31271605]; key project of Henan Province [112102310103]; medical tackle key problems in science and technology of Henan Province [2011020011, 2011020045]; Youth Innovation Project of the First Affiliated Hospital of Zhengzhou University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); key project of Henan Province; medical tackle key problems in science and technology of Henan Province; Youth Innovation Project of the First Affiliated Hospital of Zhengzhou University	This work was supported by the National Natural Science Foundation of China (Grant No. 31271605), the grants from key project of Henan Province (112102310103), medical tackle key problems in science and technology of Henan Province (2011020011, 2011020045), and Youth Innovation Project of the First Affiliated Hospital of Zhengzhou University.	Alfarawati S, 2011, FERTIL STERIL, V95, P520, DOI 10.1016/j.fertnstert.2010.04.003; Bielanska M, 2002, HUM REPROD, V17, P413, DOI 10.1093/humrep/17.2.413; Dumoulin JCM, 2005, HUM REPROD, V20, P484, DOI 10.1093/humrep/deh614; Eaton JL, 2011, FERTIL STERIL, V95, P936, DOI 10.1016/j.fertnstert.2010.06.063; Janny L, 1996, MOL REPROD DEV, V45, P31; Kearns WG, 2007, FERTIL STERIL, V88, pS237; Li G, 2014, SYST BIOL REPROD MED, V60, P119, DOI 10.3109/19396368.2013.875241; Luna M, 2008, FERTIL STERIL, V89, P358, DOI 10.1016/j.fertnstert.2007.03.030; Magli MC, 2000, HUM REPROD, V15, P1781, DOI 10.1093/humrep/15.8.1781; Magli MC, 1998, J ASSIST REPROD GEN, V15, P297, DOI 10.1023/A:1022596528036; Northrop LE, 2010, MOL HUM REPROD, V16, P590, DOI 10.1093/molehr/gaq037; Pantos K, 1999, FERTIL STERIL, V71, P1144, DOI 10.1016/S0015-0282(99)00121-1; Ribeiro CV, 2006, FERTIL STERIL, V86, pS481, DOI 10.1016/j.fertnstert.2006.07.1329; Sandalinas M, 2001, HUM REPROD, V16, P1954, DOI 10.1093/humrep/16.9.1954; Scholtes MCW, 1998, FERTIL STERIL, V69, P78, DOI 10.1016/S0015-0282(97)00450-0; Shapiro BS, 2000, FERTIL STERIL, V73, P582, DOI 10.1016/S0015-0282(99)00586-5; Shapiro BS, 2002, FERTIL STERIL, V77, P700, DOI 10.1016/S0015-0282(01)03251-4; Tan YQ, 2013, HUM REPROD, V28, P2581, DOI 10.1093/humrep/det271; Treff NR, 2011, FERTIL STERIL, V95, P1606, DOI 10.1016/j.fertnstert.2010.11.004; Treff NR, 2010, MOL HUM REPROD, V16, P583, DOI 10.1093/molehr/gaq039; van Uum CMJ, 2012, EUR J HUM GENET, V20, P938, DOI 10.1038/ejhg.2012.27; Weston G, 2009, FERTIL STERIL, V92, P1302, DOI 10.1016/j.fertnstert.2008.07.1784; Ziebe S, 2003, HUM REPROD, V18, P2575, DOI 10.1093/humrep/deg489	23	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138234	10.1371/journal.pone.0138234	http://dx.doi.org/10.1371/journal.pone.0138234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381524	Green Submitted, Green Published, gold			2022-12-27	WOS:000361790200074
J	Yu, M; Tang, XW; Wang, X; Zhang, XR; Zhang, XB; Sha, WW; Yao, SQ; Shu, N; Zhang, XY; Zhang, ZJ				Yu, Miao; Tang, XiaoWei; Wang, Xiang; Zhang, XiangRong; Zhang, XiaoBin; Sha, WeiWei; Yao, ShuQiao; Shu, Ni; Zhang, XiangYang; Zhang, ZhiJun			Neurocognitive Impairments in Deficit and Non-Deficit Schizophrenia and Their Relationships with Symptom Dimensions and Other Clinical Variables	PLOS ONE			English	Article							STRUCTURAL ABNORMALITIES; COGNITIVE FUNCTION; NONDEFICIT FORMS; NEUROPSYCHOLOGICAL IMPAIRMENTS; PROCESSING IMPAIRMENTS; EXECUTIVE FUNCTION; NEGATIVE SYMPTOMS; PSYCHOPATHOLOGY; SCHEDULE; PATTERNS	Background Deficit schizophrenia (DS) has been proposed as a pathophysiologically distinct subgroup within schizophrenia. Earlier studies focusing on neurocognitive function of DS patients have yielded inconsistent findings ranging from substantial deficits to no significant difference relative to non-deficit schizophrenia patients (NDS). The present study investigated the severity and characteristic patterns of neurocognitive impairments in DS and NDS patients and their relationships with clinical variables. Methods Attention, ideation fluency, cognitive flexibility and visuospatial memory function were assessed in 40 DS patients, 57 NDS patients, and 52 healthy controls by a comprehensive neuropsychological battery. Results Both schizophrenia subgroups had overall more severe cognitive impairments than controls while DS performed worse on every neuropsychological measure except the Stroop interference than the NDS patients with age and education as the covariates. Profile analysis found significantly different patterns of cognitive profiles between two patients group mainly due to their differences in attention and cognitive flexibility functions. Age, education, illness duration and negative symptoms were found to have the correlations with cognitive impairments in the NDS group, while only age and the negative symptoms were correlated with the cognitive impairments in the DS group. Multiple regression analyses revealed that sustained attention and cognitive flexibility were the core impaired cognitive domains mediating other cognitive functions in DS and NDS patients respectively. Conclusions DS patients exemplified worse in almost all cognitive domains than NDS patients. Sustained attention and cognitive flexibility might be the key impaired cognitive domains for DS and NDS patients respectively. The present study suggested the DS as a specific subgroup of schizophrenia.	[Yu, Miao; Zhang, XiangRong; Zhang, ZhiJun] Southeast Univ, Sch Med, Affiliated ZhongDa Hosp, Dept Neuropsychiat, Nanjing, Jiangsu, Peoples R China; [Tang, XiaoWei; Zhang, XiaoBin; Sha, WeiWei] Wutaishan Hosp Yangzhou, Dept Psychiat, Yangzhou, Jiangsu, Peoples R China; [Wang, Xiang; Yao, ShuQiao] Cent South Univ, Xiangya Hosp 2, Inst Med Psychol, Changsha, Hunan, Peoples R China; [Zhang, XiangRong] Nanjing Med Univ, Nanjing Brain Hosp, Dept Geriatr Psychiat, Nanjing, Jiangsu, Peoples R China; [Shu, Ni] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zhang, XiangYang] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA	Southeast University - China; Central South University; Nanjing Medical University; Beijing Normal University; Baylor College of Medicine	Zhang, XR (corresponding author), Southeast Univ, Sch Med, Affiliated ZhongDa Hosp, Dept Neuropsychiat, Nanjing, Jiangsu, Peoples R China.	drxrz@hotmail.com; janemengzhang@vip.163.com			National Basic Research Program of China (973 Program) [2010CB529602]; National Natural Science Foundation of China (NSFC) [81371474, 91132727, 81571314]; Jiangsu Province Natural Science Foundation of China [BK2012747]; Program for New Century Excellent Talents of Central South University; Key Program for Clinical Medicine and Science and Technology: Jiangsu Provence Clinical Medical Research Center [BL2013025]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Jiangsu Province Natural Science Foundation of China(Natural Science Foundation of Jiangsu Province); Program for New Century Excellent Talents of Central South University(Program for New Century Excellent Talents in University (NCET)); Key Program for Clinical Medicine and Science and Technology: Jiangsu Provence Clinical Medical Research Center	This work was supported by National Basic Research Program of China (973 Program 2010CB529602), National Natural Science Foundation of China (NSFC) (No. 81371474, 91132727 and 81571314), Jiangsu Province Natural Science Foundation of China (BK2012747), Program for New Century Excellent Talents of Central South University and Key Program for Clinical Medicine and Science and Technology: Jiangsu Provence Clinical Medical Research Center (No. BL2013025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arango C, 2011, EUR NEUROPSYCHOPHARM, V21, P867, DOI 10.1016/j.euroneuro.2011.03.005; Bombin I, 2013, PSYCHOL MED, V43, P757, DOI 10.1017/S0033291712001535; Bora E, 2009, BRIT J PSYCHIAT, V195, P475, DOI 10.1192/bjp.bp.108.055731; Brebion G, 2013, SCHIZOPHR RES, V147, P81, DOI 10.1016/j.schres.2013.03.014; Brinkman TM, 2012, NEURO-ONCOLOGY, V14, P25, DOI 10.1093/neuonc/nos214; Bryson G, 2001, PSYCHIAT RES, V102, P29, DOI 10.1016/S0165-1781(01)00245-1; BUCHANAN RW, 1994, ARCH GEN PSYCHIAT, V51, P804; BUCHANAN RW, 1993, AM J PSYCHIAT, V150, P59; Buchanan RW, 1997, AM J PSYCHIAT, V154, P363; Bustillo JR, 1997, AM J PSYCHIAT, V154, P647; CARPENTER WT, 1988, AM J PSYCHIAT, V145, P578; Cascella NG, 2008, J PSYCHIATR RES, V42, P930, DOI 10.1016/j.jpsychires.2007.10.002; Cascella NG, 2010, SCHIZOPHR RES, V120, P63, DOI 10.1016/j.schres.2010.03.039; Chen C, 2014, SCHIZOPHR RES, V159, P478, DOI 10.1016/j.schres.2014.09.005; Cohen AS, 2007, SCHIZOPHRENIA BULL, V33, P1201, DOI 10.1093/schbul/sbl066; Cohen AS, 2004, SCHIZOPHRENIA BULL, V30, P827, DOI 10.1093/oxfordjournals.schbul.a007135; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dantas CR, 2011, SCHIZOPHR RES, V128, P124, DOI 10.1016/j.schres.2011.01.023; Dickinson D, 2008, BIOL PSYCHIAT, V64, P823, DOI 10.1016/j.biopsych.2008.04.005; Eack SM, 2013, PSYCHIAT RES, V209, P21, DOI 10.1016/j.psychres.2013.03.020; Ekerholm M, 2012, PSYCHIAT RES, V200, P144, DOI 10.1016/j.psychres.2012.05.008; Farkas M, 2008, NEUROREPORT, V19, P55, DOI 10.1097/WNR.0b013e3282f2dff6; First M.B., 1996, STRUCTURED CLIN INTE, DOI DOI 10.1037/T07827-000; First M. B., 1997, STRUCTURED CLIN INTE; Fischer BA, 2012, SCHIZOPHR RES, V136, P51, DOI 10.1016/j.schres.2012.01.030; Galderisi S, 2002, AM J PSYCHIAT, V159, P983, DOI 10.1176/appi.ajp.159.6.983; Galderisi S, 2009, EUR PSYCHIAT, V24, P493, DOI 10.1016/j.eurpsy.2009.03.001; Galderisi S, 2008, SCHIZOPHRENIA BULL, V34, P393, DOI 10.1093/schbul/sbm097; Galderisi S, 2013, SCHIZOPHR RES, V147, P157, DOI 10.1016/j.schres.2013.03.020; Han M, 2012, PROG NEURO-PSYCHOPH, V39, P358, DOI 10.1016/j.pnpbp.2012.07.010; Hegde S, 2013, ASIAN J PSYCHIATR, V6, P537, DOI 10.1016/j.ajp.2013.07.002; Horan WP, 2003, SCHIZOPHR RES, V65, P125, DOI 10.1016/S0920-9964(02)00410-3; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Jaeger J, 2003, SCHIZOPHR RES, V65, P105, DOI 10.1016/S0920-9964(03)00052-5; Kao YC, 2013, PROG NEURO-PSYCHOPH, V44, P193, DOI 10.1016/j.pnpbp.2013.02.006; Kelland DZ, 1996, ARCH CLIN NEUROPSYCH, V11, P339, DOI 10.1016/0887-6177(95)00032-1; Kimhy D, 2006, SCHIZOPHRENIA BULL, V32, P274, DOI 10.1093/schbul/sbi064; Kirkpatrick B, 2000, SCHIZOPHR RES, V45, P57, DOI 10.1016/S0920-9964(99)00164-4; Kirkpatrick B, 2001, ARCH GEN PSYCHIAT, V58, P165, DOI 10.1001/archpsyc.58.2.165; KIRKPATRICK B, 1989, PSYCHIAT RES, V30, P119, DOI 10.1016/0165-1781(89)90153-4; Lahti AC, 2001, AM J PSYCHIAT, V158, P1797, DOI 10.1176/appi.ajp.158.11.1797; Lin CH, 2013, SCHIZOPHR RES, V146, P231, DOI 10.1016/j.schres.2013.02.009; Messias E, 2004, ARCH GEN PSYCHIAT, V61, P985, DOI 10.1001/archpsyc.61.10.985; Mueser KT, 1997, PSYCHOL ASSESSMENT, V9, P196; Nakaya M, 2008, PSYCHIAT RES, V158, P256, DOI 10.1016/j.psychres.2007.10.008; O'Leary DS, 2000, J NEUROPSYCH CLIN N, V12, P4, DOI 10.1176/jnp.12.1.4; Palmer BW, 2009, NEUROPSYCHOL REV, V19, P365, DOI 10.1007/s11065-009-9109-y; Pegoraro LFL, 2013, SCHIZOPHR RES, V147, P91, DOI 10.1016/j.schres.2013.02.041; Polgar P, 2010, SCHIZOPHR RES, V122, P85, DOI 10.1016/j.schres.2010.06.007; Polgar P, 2008, SCHIZOPHR RES, V99, P200, DOI 10.1016/j.schres.2007.06.027; Quarantelli M, 2002, NEUROIMAGE, V17, P373, DOI 10.1006/nimg.2002.1157; Rajji TK, 2009, BRIT J PSYCHIAT, V195, P286, DOI 10.1192/bjp.bp.108.060723; Rethelyi JM, 2012, EUR ARCH PSY CLIN N, V262, P107, DOI 10.1007/s00406-011-0224-4; Rosnow RL, 1996, PSYCHOL METHODS, V1, P331, DOI 10.1037/1082-989X.1.4.331; Roy MA, 2001, SCHIZOPHR RES, V47, P141, DOI 10.1016/S0920-9964(99)00231-5; Saleem MM, 2013, J PSYCHOPHARMACOL, V27, P366, DOI 10.1177/0269881113477746; Sanchez P, 2014, SCHIZOPHRENIA BULL, V40, P707, DOI 10.1093/schbul/sbt057; Schretlen DJ, 2007, BIOL PSYCHIAT, V62, P179, DOI 10.1016/j.biopsych.2006.09.025; Seckinger RA, 2004, SCHIZOPHR RES, V69, P55, DOI 10.1016/S0920-9964(03)00124-5; Sewell RA, 2010, SCHIZOPHR RES, V124, P1, DOI 10.1016/j.schres.2010.08.036; Sigmundsson T, 2001, AM J PSYCHIAT, V158, P234, DOI 10.1176/appi.ajp.158.2.234; Stevens J.P., 2009, APPL MULTIVARIATE ST, V5th ed.; Strauss GP, 2008, SCHIZOPHR RES, V102, P76, DOI 10.1016/j.schres.2008.01.014; Strauss GP, 2010, SCHIZOPHR RES, V118, P146, DOI 10.1016/j.schres.2010.01.016; Szendi I, 2010, EUR ARCH PSY CLIN N, V260, P257, DOI 10.1007/s00406-009-0073-6; Tek C, 2001, SCHIZOPHR RES, V49, P253, DOI 10.1016/S0920-9964(00)00146-8; Tiryaki A, 2003, EUR ARCH PSY CLIN N, V253, P221, DOI 10.1007/s00406-003-0434-5; van Schouwenburg MR, 2012, J NEUROSCI, V32, P5631, DOI 10.1523/JNEUROSCI.6428-11.2012; Vitzthum FB, 2013, BEHAV COGN PSYCHOTH, P1; Volpe U, 2012, PROG NEURO-PSYCHOPH, V37, P264, DOI 10.1016/j.pnpbp.2012.02.003; Wang X, 2008, PSYCHIAT RES, V158, P195, DOI 10.1016/j.psychres.2006.09.007; Wheeler AL, 2015, JAMA PSYCHIAT, V72, P446, DOI 10.1001/jamapsychiatry.2014.3020	72	37	40	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138357	10.1371/journal.pone.0138357	http://dx.doi.org/10.1371/journal.pone.0138357			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381645	gold, Green Submitted, Green Published			2022-12-27	WOS:000361790200095
J	Chang, CH; Yeh, SY; Lee, BH; Chen, CJ; Su, CT; Lin, YT; Liu, CL; Chen, HY				Chang, Chih-Hao; Yeh, Shu-Yun; Lee, Bing-Heng; Chen, Chia-Jie; Su, Chiao-Tzu; Lin, Yen-Ting; Liu, Chien-Lin; Chen, Hsien-Yeh			Osteogenic Surface Modification Based on Functionalized Poly-P-Xylylene Coating	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; CHEMICAL CROSS-LINKING; OSTEOBLAST DIFFERENTIATION; TITANIUM IMPLANTS; IN-VIVO; IMMOBILIZATION; GROWTH; BMP-2; POLYDOPAMINE; BIOMOLECULES	The biotechnology to immobilize biomolecules on material surfaces has been developed vigorously due to its high potentials in medical applications. In this study, a simple and effective method was designed to immobilize biomolecules via amine-N-hydroxysuccinimide (NHS) ester conjugation reaction using functionalized poly-p-xylylene coating on material surfaces. The NHS ester functionalized coating is synthesized via chemical vapor deposition, a facile and solvent-less method, creating a surface which is ready to perform a onestep conjugation reaction. Bone morphogenetic protein 2 (BMP-2) is immobilized onto material surfaces by this coating method, forming an osteogenic environment. The immobilization process is controlled at a low temperature which does not damage proteins. This modified surface induces differentiation of preosteoblast into osteoblast, manifested by alkaline phosphatase (ALP) activity assay, Alizarin Red S (ARS) staining and the expression of osteogenic gene markers, Alp! and Bglap3. With this coating technology, immobilization of growth factors onto material surface can be achieved more simply and more effectively.	[Chang, Chih-Hao; Lee, Bing-Heng; Chen, Chia-Jie] Natl Taiwan Univ Hosp, Dept Orthoped, Taipei, Taiwan; [Chang, Chih-Hao; Lee, Bing-Heng; Chen, Chia-Jie] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Yeh, Shu-Yun; Su, Chiao-Tzu; Lin, Yen-Ting; Chen, Hsien-Yeh] Natl Taiwan Univ, Dept Chem Engn, Taipei 10764, Taiwan; [Liu, Chien-Lin] Taipei Vet Gen Hosp, Dept Orthopaed & Traumatol, Taipei, Taiwan; [Liu, Chien-Lin] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Chang, CH (corresponding author), Natl Taiwan Univ Hosp, Dept Orthoped, Taipei, Taiwan.	mike920@gmail.com		CHANG, CHIH-HAO/0000-0001-9794-0610; Lin, Yen-Ting/0000-0002-1332-5475	Ministry of Science and Technology of Taiwan [MOST 103-2633-B-002-014, NSC 102-2320-B-002-002-MY2, NSC 101-2628-E-002-034-MY3, NSC-DAAD 102-2911-I-002-507]; National Taiwan University Hospital-Taipei Veterans General Hospital [NTUH-TVGH VN103-10]; National Taiwan University [102R7745, 103R7745]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital-Taipei Veterans General Hospital; National Taiwan University(National Taiwan University)	CHC gratefully acknowledges support from the Ministry of Science and Technology of Taiwan (MOST 103-2633-B-002-014; NSC 102-2320-B-002-002-MY2) and National Taiwan University Hospital-Taipei Veterans General Hospital Joint Research Program (NTUH-TVGH VN103-10). This work is further supported by the Ministry of Science and Technology of Taiwan (NSC 101-2628-E-002-034-MY3; NSC-DAAD 102-2911-I-002-507), and National Taiwan University (102R7745; 103R7745) for HYC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bookout Angie L, 2006, Curr Protoc Mol Biol, VChapter 15, DOI 10.1002/0471142727.mb1508s73; Chang CH, 2014, J MATER CHEM B, V2, P8496, DOI 10.1039/c4tb00992d; Chen HY, 2010, J AM CHEM SOC, V132, P18023, DOI 10.1021/ja108679m; Chen HY, 2011, LANGMUIR, V27, P34, DOI 10.1021/la101623n; Cho HJ, 2014, ACS APPL MATER INTER, V6, P11225, DOI 10.1021/am501391z; Edlund U, 2008, BIOMACROMOLECULES, V9, P901, DOI 10.1021/bm701267u; Fischer MJE, 2010, METHODS MOL BIOL, V627, P55, DOI 10.1007/978-1-60761-670-2_3; Gao GZ, 2011, BIOMACROMOLECULES, V12, P3715, DOI 10.1021/bm2009697; Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002; Haidar ZS, 2009, BIOTECHNOL LETT, V31, P1825, DOI 10.1007/s10529-009-0100-8; Haidar ZS, 2009, BIOTECHNOL LETT, V31, P1817, DOI 10.1007/s10529-009-0099-x; Hall J, 2007, J CLIN PERIODONTOL, V34, P444, DOI 10.1111/j.1600-051X.2007.01064.x; Hsu JM, 2009, IEEE T BIO-MED ENG, V56, P23, DOI 10.1109/TBME.2008.2002155; Hsu WK, 2007, BONE, V40, P931, DOI 10.1016/j.bone.2006.10.030; Jeffrey B., 2004, CHEM VAPOR DEPOSITIO; Jeong CG, 2012, J BIOMED MATER RES A, V100A, P2088, DOI 10.1002/jbm.a.33249; Kalkhof S, 2008, ANAL BIOANAL CHEM, V392, P305, DOI 10.1007/s00216-008-2231-5; Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186; Klein E, 2008, BIOMATERIALS, V29, P204, DOI 10.1016/j.biomaterials.2007.09.013; Kloss FR, 2008, BIOMATERIALS, V29, P2433, DOI 10.1016/j.biomaterials.2008.01.036; Lee H, 2009, ADV MATER, V21, P431, DOI 10.1002/adma.200801222; Lee YB, 2012, BIOMATERIALS, V33, P8343, DOI 10.1016/j.biomaterials.2012.08.011; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; Leventis R, 2010, BIOPHYS J, V99, P2125, DOI 10.1016/j.bpj.2010.07.047; Liberelle B, 2010, BIOCONJUGATE CHEM, V21, P2257, DOI 10.1021/bc1002604; Lim TY, 2009, J MATER SCI-MATER M, V20, P1, DOI 10.1007/s10856-008-3528-9; Lorenz C, 2011, MACROMOL BIOSCI, V11, P234, DOI 10.1002/mabi.201000342; Luo RF, 2013, COLLOID SURFACE B, V106, P66, DOI 10.1016/j.colsurfb.2013.01.033; Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818; Lynge ME, 2011, NANOSCALE, V3, P4916, DOI 10.1039/c1nr10969c; Maeda T, 2004, J CELL BIOCHEM, V92, P458, DOI 10.1002/jcb.20074; Madler S, 2009, J MASS SPECTROM, V44, P694, DOI 10.1002/jms.1544; Masters KS, 2011, MACROMOL BIOSCI, V11, P1149, DOI 10.1002/mabi.201000505; Nishii N, 2009, BIOL PHARM BULL, V32, P10, DOI 10.1248/bpb.32.10; OSHANNESSY DJ, 1992, ANAL BIOCHEM, V205, P132, DOI 10.1016/0003-2697(92)90589-Y; Park YJ, 2006, BIOTECHNOL APPL BIOC, V43, P17, DOI 10.1042/BA20050075; Pohl TLM, 2012, ACTA BIOMATER, V8, P772, DOI 10.1016/j.actbio.2011.10.019; Sask KN, 2010, ACTA BIOMATER, V6, P2911, DOI 10.1016/j.actbio.2010.02.043; Schliephake H, 2005, CLIN ORAL IMPLAN RES, V16, P563, DOI 10.1111/j.1600-0501.2005.01143.x; Schmidmaier G, 2004, J ORTHOP RES, V22, P514, DOI 10.1016/j.orthres.2003.09.009; Schmoekel HG, 2005, BIOTECHNOL BIOENG, V89, P253, DOI 10.1002/bit.20168; Schuessele A, 2009, J BIOMED MATER RES A, V90A, P959, DOI 10.1002/jbm.a.31745; Seymour JP, 2009, BIOMATERIALS, V30, P6158, DOI 10.1016/j.biomaterials.2009.07.061; Shen H, 2009, BIOMATERIALS, V30, P3150, DOI 10.1016/j.biomaterials.2009.02.004; Shi ZL, 2009, BIOMACROMOLECULES, V10, P1603, DOI 10.1021/bm900203w; Shi ZL, 2009, TISSUE ENG PT A, V15, P417, DOI 10.1089/ten.tea.2007.0415; Shields LBE, 2006, SPINE, V31, P542, DOI 10.1097/01.brs.0000201424.27509.72; Shin YM, 2012, BIOMACROMOLECULES, V13, P2020, DOI 10.1021/bm300194b; Smith DM, 2008, J CRANIOFAC SURG, V19, P1244, DOI 10.1097/SCS.0b013e3181843312; Sokolsky-Papkov M, 2007, ADV DRUG DELIVER REV, V59, P187, DOI 10.1016/j.addr.2007.04.001; Sun HY, 2014, ADV MATER INTERFACES, V1, DOI 10.1002/admi.201400093; TERRELL TG, 1993, INT REV EXP PATHOL, V34, P43; Toth JM, 2009, SPINE, V34, P539, DOI 10.1097/BRS.0b013e3181952695; Valeur E, 2009, CHEM SOC REV, V38, P606, DOI 10.1039/b701677h; Verne E, 2010, ACTA BIOMATER, V6, P229, DOI 10.1016/j.actbio.2009.06.025; Vijayendran RA, 2001, ANAL CHEM, V73, P471, DOI 10.1021/ac000523p; WAHL SM, 1994, J EXP MED, V180, P1587, DOI 10.1084/jem.180.5.1587; Wiemann M, 2002, J BIOMED MATER RES, V62, P119, DOI 10.1002/jbm.10251; Wu J-T, 2012, MACROMOLECULAR RAPID, V33, P948, DOI [10.1002/marc.201290033, DOI 10.1002/MARC.201290033]; Xie XZ, 2013, IEEE T BIO-MED ENG, V60, P2943, DOI 10.1109/TBME.2013.2266542; Yang XB, 2001, BONE, V29, P523, DOI 10.1016/S8756-3282(01)00617-2; Yang ZG, 2013, LANGMUIR, V29, P1498, DOI 10.1021/la3041055; Zhang CH, 2011, ACTA BIOMATER, V7, P3746, DOI 10.1016/j.actbio.2011.06.003	63	13	13	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137017	10.1371/journal.pone.0137017	http://dx.doi.org/10.1371/journal.pone.0137017			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379273	gold, Green Published, Green Submitted			2022-12-27	WOS:000361769400012
J	Puig-Ribera, A; Martin-Cantera, C; Puigdomenech, E; Real, J; Romaguera, M; Magdalena-Belio, JF; Recio-Rodriguez, JI; Rodriguez-Martin, B; Arietaleanizbeaskoa, MS; Repiso-Gento, I; Garcia-Ortiz, L				Puig-Ribera, Anna; Martin-Cantera, Carlos; Puigdomenech, Elisa; Real, Jordi; Romaguera, Montserrat; Felix Magdalena-Belio, Jose; Ignacio Recio-Rodriguez, Jose; Rodriguez-Martin, Beatriz; Soledad Arietaleanizbeaskoa, Maria; Repiso-Gento, Irene; Garcia-Ortiz, Luis		EVIDENT Grp	Screening Physical Activity in Family Practice: Validity of the Spanish Version of a Brief Physical Activity Questionnaire	PLOS ONE			English	Article							COMPUTER-SCIENCE; PRIMARY-CARE; RELIABILITY; INACTIVITY; FUTURE; INDEX	Objectives The use of brief screening tools to identify inactive patients is essential to improve the efficiency of primary care-based physical activity (PA) programs. However, the current employment of short PA questionnaires within the Spanish primary care pathway is unclear. This study evaluated the validity of the Spanish version of a Brief Physical Activity Assessment Tool (SBPAAT). Methods A validation study was carried out within the EVIDENT project. A convenience sample of patients (n = 1,184; age 58.9 13.7 years; 60.5% female) completed the SBPAAT and the 7-day Physical Activity Recall (7DPAR) and, in addition, wore an accelerometer (ActiGraph GT3X) for seven consecutive days. Validity was evaluated by measuring agreement, Kappa correlation coefficients, sensitivity and specificity in achieving current PA recommendations with the 7DPAR. Pearson correlation coefficients with the number of daily minutes engaged in moderate and vigorous intensity PA according to the accelerometer were also assessed. Comparison with accelerometer counts, daily minutes engaged in sedentary, light, moderate, and vigorous intensity PA, total daily kilocalories, and total PA and leisure time expenditure (METs-hour-week) between the sufficiently and insufficiently active groups identified by SBPAAT were reported. Results The SBPAAT identified 41.3% sufficiently active (n = 489) and 58.7% insufficiently active (n = 695) patients; it showed moderate validity (k = 0.454, 95% Cl: 0.402-0.505) and a specificity and sensitivity of 74.3% and 74.6%, respectively. Validity was fair for identifying daily minutes engaged in moderate (r = 0.215, 95% CI:0.156 to 0.272) and vigorous PA (r = 0.282, 95% CI:0.165 to 0.391). Insufficiently active patients according to the SBPAAT significantly reported fewer counts/minute (-22%), fewer minutes/day of moderate (-11.38) and vigorous PA (-2.69), spent fewer total kilocalories/day (-753), and reported a lower energy cost (METs-hour-week) of physical activities globally (-26.82) and during leisure time (-19.62). Conclusions The SBPAAT is a valid tool to identify Spanish-speaking patients who are insufficiently active to achieve health benefits.	[Puig-Ribera, Anna] Univ Vic Cent Univ Catalonia UVic UCC, Dept Phys Act Sci, Ctr Hlth & Social Care Res CEES, Sport & Phys Act Res Grp GREAF, Barcelona, Spain; [Martin-Cantera, Carlos] Univ Autonoma Barcelona, Dept Med, Passeig St Joan Hlth Ctr, Catalan Hlth Serv, E-08193 Barcelona, Spain; [Martin-Cantera, Carlos; Puigdomenech, Elisa; Real, Jordi] Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Barcelona, Spain; [Real, Jordi] Univ Int Catalunya, Sch Med & Hlth Sci, Sant Cugat Del Valles, Spain; [Romaguera, Montserrat] Ca NOriac Hlth Ctr, Hlth Serv, Catalan, Spain; [Felix Magdalena-Belio, Jose] Torre Ramona Hlth Ctr, Aragon Hlth Serv, Zaragoza, Spain; [Ignacio Recio-Rodriguez, Jose] Castilla & Leon Hlth Serv SACYL, Alamedilla Hlth Ctr, Primary Care Res Unit, Salamanca, Spain; [Rodriguez-Martin, Beatriz] Univ Castilla La Mancha, Logopedia & Nursing Fac, Occupat Therapy, E-13071 Ciudad Real, Spain; [Soledad Arietaleanizbeaskoa, Maria] Basque Hlth Care Serv Osakidetza, Primary Care Res Unit Bizkaia, Bilbao, Spain; [Repiso-Gento, Irene] Castilla & Leon Hlth Serv, Primary Care Res Unit Valladolid, Valladolid, Spain; [Garcia-Ortiz, Luis] Univ Salamanca, Primary Care Res Unit, Alamedilla Hlth Ctr, Castilla & Leon Hlth Serv SACYL,IBSAL, E-37008 Salamanca, Spain; [Garcia-Ortiz, Luis] Univ Salamanca, Dept Med, E-37008 Salamanca, Spain	Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Autonomous University of Barcelona; Universitat Internacional de Catalunya (UIC); Universidad de Castilla-La Mancha; University of Salamanca; University of Salamanca	Puig-Ribera, A (corresponding author), Univ Vic Cent Univ Catalonia UVic UCC, Dept Phys Act Sci, Ctr Hlth & Social Care Res CEES, Sport & Phys Act Res Grp GREAF, Barcelona, Spain.	annam.puig@uvic.cat	Recio-Rodriguez, Jose I/AAA-8588-2020; Martin Cantera, Carlos/D-2693-2011; Rodríguez-Martin, Beatriz/F-5743-2016; Arietaleanizbeaskoa, Maria Soledad/D-9296-2017; Maderuelo-Fernandez, Jose-Angel/R-8868-2018	Martin Cantera, Carlos/0000-0003-0656-8126; Rodríguez-Martin, Beatriz/0000-0003-3939-0299; Arietaleanizbeaskoa, Maria Soledad/0000-0001-8747-6789; Sierra Quintana, Eva/0000-0002-2572-0982; Recio-Rodriguez, Jose I/0000-0002-3772-8746; Real, Jordi/0000-0002-5979-8948; Cabrejas-Sanchez, Alfredo/0000-0001-7049-063X; Maderuelo-Fernandez, Jose-Angel/0000-0001-7544-8684	Carlos III Health Institute of the Ministry of Health in Spain [FIS: PS09/00233, PS09/01057, PS09/01972, PS09/01376, PS09/0164, PS09/01458, RETICS D06/0018]; Autonomous Government of Castile and Leon [SAN/1778/2009]	Carlos III Health Institute of the Ministry of Health in Spain; Autonomous Government of Castile and Leon	This project was financed by the Carlos III Health Institute of the Ministry of Health in Spain (FIS: PS09/00233, PS09/01057, PS09/01972, PS09/01376, PS09/0164, PS09/01458, RETICS D06/0018) and the Autonomous Government of Castile and Leon (SAN/1778/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen KY, 2005, MED SCI SPORT EXER, V37, pS490, DOI 10.1249/01.mss.0000185571.49104.82; Cordoba Rodrigo, 2014, Aten Primaria, V46 Suppl 4, P16, DOI 10.1016/S0212-6567(14)70048-4; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Garcia-Ortiz L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-233; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Helmerhorst HJF, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-103; Huijg JM, 2014, INT J BEHAV MED; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Mader U, 2006, MED SCI SPORT EXER, V38, P1255, DOI 10.1249/01.mss.0000227310.18902.28; Marshall AL, 2005, BRIT J SPORT MED, V39, P294, DOI 10.1136/bjsm.2004.013771; MARTINMORENO JM, 1993, INT J EPIDEMIOL, V22, P512, DOI 10.1093/ije/22.3.512; Matthews CE, 2005, MED SCI SPORT EXER, V37, pS512, DOI 10.1249/01.mss.0000185659.11982.3d; MELANSON EL, 1995, MED SCI SPORT EXER, V27, P934; Milton K, 2011, BRIT J SPORT MED, V45, P203, DOI 10.1136/bjsm.2009.068395; Milton K, 2013, BRIT J SPORT MED, V47, P44, DOI 10.1136/bjsports-2011-090899; NICE, 2013, PHYS ACT BRIEF ADV A, V44, P44; Orrow G, 2013, BRIT J SPORT MED, V47, P27, DOI 10.1136/bjsports-2012-e1389rep; Plasqui G, 2007, OBESITY, V15, P2371, DOI 10.1038/oby.2007.281; Ribera AP, 2012, ATEN PRIM, V44, P485, DOI 10.1016/j.aprim.2012.01.005; Vinas BR, 2013, GAC SANIT, V27, P254, DOI 10.1016/j.gaceta.2012.05.013; Comellas AR, 2012, REV ESP SALUD PUBLIC, V86, P495, DOI 10.4321/S1135-57272012000500004; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Sanchez A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-108; Shuval K, 2014, BRIT J SPORT MED, V48, P250, DOI 10.1136/bjsports-2013-092901; Smith BJ, 2005, AM J PREV MED, V29, P256, DOI 10.1016/j.amepre.2005.07.005; Vega-Lopez Sonia, 2014, BMC Res Notes, V7, P29, DOI 10.1186/1756-0500-7-29; Wanner M, 2014, BRIT J SPORT MED, V48, P1570, DOI 10.1136/bjsports-2012-092122; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Zuazagoitia A, 2014, EUR J SPORT SCI, V14, pS361, DOI 10.1080/17461391.2012.705332	29	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0136870	10.1371/journal.pone.0136870	http://dx.doi.org/10.1371/journal.pone.0136870			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379036	Green Submitted, Green Published, gold			2022-12-27	WOS:000361769400009
J	Guo, HX; Chen, XH; Tian, RY; Chang, JM; Li, JL; Tan, YH; Xu, ZF; Ren, FG; Zhao, JX; Pan, J; Zhang, N; Wang, XJ; He, JX; Yang, WF; Wang, HW				Guo, Haixiu; Chen, Xiuhua; Tian, Ruiyuan; Chang, Jianmei; Li, Jianlan; Tan, Yanhong; Xu, Zhifang; Ren, Fanggang; Zhao, Junxia; Pan, Jie; Zhang, Na; Wang, Xiaojuan; He, Jianxia; Yang, Wanfang; Wang, Hongwei			Frequencies, Laboratory Features, and Granulocyte Activation in Chinese Patients with CALR-Mutated Myeloproliferative Neoplasms	PLOS ONE			English	Article							LEUKOCYTE ALKALINE-PHOSPHATASE; JAK2 EXON-12 MUTATIONS; ESSENTIAL THROMBOCYTHEMIA; POLYCYTHEMIA-VERA; CLINICAL CHARACTERISTICS; CALRETICULIN MUTATIONS; PRIMARY MYELOFIBROSIS; V617F MUTATION; EXPRESSION; DISORDERS	Somatic mutations in the CALR gene have been recently identified as acquired alterations in myeloproliferative neoplasms (MPNs). In this study, we evaluated mutation frequencies, laboratory features, and granulocyte activation in Chinese patients with MPNs. A combination of qualitative allele-specific polymerase chain reaction and Sanger sequencing was used to detect three driver mutations (i.e., CALR, JAK2V617F, and MPL). CALR mutations were identified in 8.4% of cases with essential thrombocythemia (ET) and 5.3% of cases with primary myelofibrosis (PMF). Moreover, 25% of polycythemia vera, 29.5% of ET, and 48.1% of PMF were negative for all three mutations (JAK2V617F, MPL, and CALR). Compared with those patients with JAK2V617F mutation, CALR-mutated ET patients displayed unique hematological phenotypes, including higher platelet counts, and lower leukocyte counts and hemoglobin levels. Significant differences were not found between Chinese PMF patients with mutants CALR and JAK2V617F in terms of laboratory features. Interestingly, patients with CALR mutations showed markedly decreased levels of leukocyte alkaline phosphatase (LAP) expression, whereas those with JAK2V617F mutation presented with elevated levels. Overall, a lower mutant rate of CALR gene and a higher triple-negative rate were identified in the cohort of Chinese patients with MPNs. This result indicates that an undiscovered mutant gene may have a significant role in these patients. Moreover, these pathological features further imply that the disease biology varies considerably between mutants CALR and JAK2V617F.	[Guo, Haixiu; Chen, Xiuhua; Tian, Ruiyuan; Chang, Jianmei; Li, Jianlan; Tan, Yanhong; Xu, Zhifang; Ren, Fanggang; Zhao, Junxia; Pan, Jie; Zhang, Na; Wang, Xiaojuan; He, Jianxia; Yang, Wanfang; Wang, Hongwei] Shanxi Med Univ, Hosp 2, Inst Hematol, Taiyuan, Peoples R China; [Guo, Haixiu] Shanxi Med Univ, Sch Basic Med, Dept Microbiol & Immunol, Taiyuan, Peoples R China	Shanxi Medical University; Shanxi Medical University	Wang, HW (corresponding author), Shanxi Med Univ, Hosp 2, Inst Hematol, Taiyuan, Peoples R China.	wanghw68@hotmail.com		Pan, Jie/0000-0002-1973-8019				Andrikovics H, 2014, HAEMATOLOGICA, V99, P1184, DOI 10.3324/haematol.2014.107482; Basquiera AL, 2007, HAEMATOL-HEMATOL J, V92, P704, DOI 10.3324/haematol.10991; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Brecqueville M, 2012, GENE CHROMOSOME CANC, V51, P743, DOI 10.1002/gcc.21960; Cabagnols X, 2015, LEUKEMIA, V29, P249, DOI 10.1038/leu.2014.270; Chen CC, 2014, ANN HEMATOL, V93, P2029, DOI 10.1007/s00277-014-2151-8; Chen E, 2015, BLOOD, V125, P327, DOI 10.1182/blood-2014-04-567024; Chen XH, 2011, BLOOD CELL MOL DIS, V47, P67, DOI 10.1016/j.bcmd.2011.04.004; Garattini E, 1996, LEUKEMIA LYMPHOMA, V23, P493, DOI 10.3109/10428199609054858; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Klampfl T, 2013, NEW ENGL J MED, V369, P2379, DOI 10.1056/NEJMoa1311347; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Li B, 2014, HAEMATOLOGICA, V99, P1697, DOI 10.3324/haematol.2014.109249; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Oku S, 2010, BRIT J HAEMATOL, V150, P334, DOI 10.1111/j.1365-2141.2010.08249.x; Pardanani A, 2007, LEUKEMIA, V21, P1960, DOI 10.1038/sj.leu.2404810; Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879; Passamonti F, 2006, BLOOD, V107, P3676, DOI 10.1182/blood-2005-09-3826; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Qiao C, 2014, HAEMATOLOGICA, V99, pE182, DOI 10.3324/haematol.2014.109199; Rumi E, 2014, BLOOD, V124, P1062, DOI 10.1182/blood-2014-05-578435; Rumi E, 2014, BLOOD, V123, P1544, DOI 10.1182/blood-2013-11-539098; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Shen HJ, 2015, LEUKEMIA LYMPHOMA, V56, P820, DOI 10.3109/10428194.2014.939963; STEWART CA, 1974, PATHOLOGY, V6, P287, DOI 10.3109/00313027409068999; Tefferi A, 2010, JAK2 MPL TET2 ASXL1; Tefferi A, 2009, CANCER-AM CANCER SOC, V115, P3842, DOI 10.1002/cncr.24440; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; Wu ZY, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0048-6	29	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138250	10.1371/journal.pone.0138250	http://dx.doi.org/10.1371/journal.pone.0138250			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375990	Green Published, Green Submitted, gold			2022-12-27	WOS:000361610200093
J	Huang, EW; Peng, LY; Zheng, JX; Wang, D; Xu, QY; Huang, L; Wu, QP; Tang, SB; Luo, B; Liu, SP; Liu, XS; Li, ZH; Quan, L; Li, Y; Shi, H; Lv, GL; Zhao, J; Cheng, JD; Liu, C				Huang, Er-Wen; Peng, Long-Yun; Zheng, Jin-Xiang; Wang, Dan; Xu, Qu-Yi; Huang, Lei; Wu, Qiu-Ping; Tang, Shuang-Bo; Luo, Bin; Liu, Shui-Ping; Liu, Xiao-Shan; Li, Zhao-Hui; Quan, Li; Li, Yue; Shi, He; Lv, Guo-Li; Zhao, Jian; Cheng, Jian-Ding; Liu, Chao			Common Variants in Promoter of ADTRP Associate with Early-Onset Coronary Artery Disease in a Southern Han Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CAROTID ATHEROSCLEROSIS; INSULIN; RISK; POLYMORPHISMS; ANDROGENS; HORMONES; LOCI; MEN	The first genome-wide association study for coronary artery disease (CAD) in the Han Chinese population, we reported recently, had identified rs6903956 in gene ADTRP on chromosome 6p24.1 as a novel susceptibility locus for CAD. The risk allele of rs6903956 was associated with decreased mRNA expression of ADTRP. To further study the correlation of ADTRP expression and CAD, in this study we evaluated the associations of eight common variants in the expression-regulating regions of ADTRP with CAD in the Southern Han Chinese population. Rs169790 in 3'UTR, rs2076189 in 5'UTR, four SNPs (rs2076188, rs7753407, rs11966356 and rs1018383) in promoter, and two SNPs (rs3734273, rs80355771) in the last intron of ADTRP were genotyped in 1716 CAD patients and 1572 controls. The correlations between these loci and total or early-onset CAD were investigated. None of these loci was discovered to associate with total CAD (P > 0.05). However, with early-onset CAD, significant both allelic and genotypic associations of rs7753407, rs11966356 and rs1018383 were identified, after adjustment for risk factors of age, gender, hypertension, diabetes, lipid profiles and smoking (adjusted P < 0.05). A haplotype AGCG (constructed by rs2076188, rs7753407, rs11966356 and rs1018383) was identified to protect subjects from early-onset CAD (OR = 0.332, 95% CI = 0.105-0.879, adjusted P = 0.010). Real-time quantitative reverse transcription polymerase chain reaction assay showed that the risk alleles of the associated loci were significantly associated with decreased expression of ADTRP mRNA. Moreover, the average level of ADTRP mRNA expression in early-onset CAD cases was significantly lower than that in controls. Our results provide new evidence supporting the association of ADTRP with the pathogenesis of early-onset CAD.	[Huang, Er-Wen; Zheng, Jin-Xiang; Huang, Lei; Wu, Qiu-Ping; Tang, Shuang-Bo; Luo, Bin; Liu, Shui-Ping; Liu, Xiao-Shan; Li, Zhao-Hui; Quan, Li; Cheng, Jian-Ding] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Forens Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Er-Wen; Xu, Qu-Yi; Li, Yue; Shi, He; Lv, Guo-Li; Zhao, Jian; Liu, Chao] Guangzhou Forens Sci Inst, Guangzhou, Guangdong, Peoples R China; [Peng, Long-Yun] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Dan] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, CardioX Inst, Key Lab Mol Biophys,Minist Educ, Wuhan 430074, Hubei, Peoples R China; [Wang, Dan] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan 430074, Hubei, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Cheng, JD (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Forens Pathol, Guangzhou 510275, Guangdong, Peoples R China.	chengjd@mail.sysu.edu.cn; liuchaogzf@163.com	liu, chao/GQZ-6687-2022		National Natural Science Foundation of China [81302616, 81430046, 81172901]; China Postdoctoral Science Foundation [2013M542226]; China National Science & Technology Pillar Program during the Twelfth Five-year Plan Period [2012BAK02B02-3]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); China National Science & Technology Pillar Program during the Twelfth Five-year Plan Period	This study was funded by the National Natural Science Foundation of China (81302616, 81430046 and 81172901), the China Postdoctoral Science Foundation (2013M542226), and the China National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (2012BAK02B02-3).	Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen CH, 2014, NEW ENGL J MED, V370, P119, DOI 10.1056/NEJMoa1212444; Chinetti-Gbaguidi G, 2015, FEBS LETT, V589, P461, DOI 10.1016/j.febslet.2015.01.002; Dechamethakun S, 2014, J ATHEROSCLER THROMB, V21, P680; English KM, 2000, EUR HEART J, V21, P890, DOI 10.1053/euhj.1999.1873; Griffin MJ, 2004, IUBMB LIFE, V56, P595, DOI 10.1080/15216540400022474; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Guo CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043732; Hak AE, 2002, J CLIN ENDOCR METAB, V87, P3632, DOI 10.1210/jc.87.8.3632; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lu XF, 2012, NAT GENET, V44, P890, DOI 10.1038/ng.2337; Lupu C, 2011, BLOOD, V118, P4463, DOI 10.1182/blood-2011-05-355370; Maddison LA, 2012, DIABETES, V61, P2517, DOI 10.2337/db11-1841; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Muller M, 2004, CIRCULATION, V109, P2074, DOI 10.1161/01.CIR.0000125854.51637.06; Ohta Y, 2011, DIABETES, V60, P3208, DOI 10.2337/db10-1192; Sing CF, 2003, ARTERIOSCL THROM VAS, V23, P1190, DOI 10.1161/01.ATV.0000075081.51227.86; Tayebi N, 2013, CLIN BIOCHEM, V46, P755, DOI 10.1016/j.clinbiochem.2013.01.004; Topol EJ, 2006, HUM MOL GENET, V15, pR117, DOI 10.1093/hmg/ddl183; van den Beld AW, 2003, AM J EPIDEMIOL, V157, P25, DOI 10.1093/aje/kwf160; Wang F, 2011, NAT GENET, V43, P345, DOI 10.1038/ng.783; Wang LJ, 2003, SCIENCE, V302, P1578, DOI 10.1126/science.1088477; Wang Q, 2005, CURR OPIN CARDIOL, V20, P182, DOI 10.1097/01.hco.0000160373.77190.f1; Wang YH, 2013, MOL CELL, V49, P283, DOI 10.1016/j.molcel.2012.10.028; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yoshida S, 2011, DIABETES OBES METAB, V13, P34, DOI 10.1111/j.1463-1326.2010.01315.x	29	12	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137547	10.1371/journal.pone.0137547	http://dx.doi.org/10.1371/journal.pone.0137547			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375920	gold, Green Submitted, Green Published			2022-12-27	WOS:000361610200041
J	Bidinotto, LT; Scapulatempo-Neto, C; Mackay, A; de Almeida, GC; Scheithauer, BW; Berardinelli, GN; Torrieri, R; Clara, CA; Feltrin, LT; Viana-Pereira, M; Varella-Garcia, M; Jones, C; Reis, RM				Bidinotto, Lucas Tadeu; Scapulatempo-Neto, Cristovam; Mackay, Alan; de Almeida, Gisele Caravina; Scheithauer, Bernd Walter; Berardinelli, Gustavo Noriz; Torrieri, Raul; Clara, Carlos Afonso; Feltrin, Leonir Terezinha; Viana-Pereira, Marta; Varella-Garcia, Marileila; Jones, Chris; Reis, Rui Manuel			Molecular Profiling of a Rare Rosette-Forming Glioneuronal Tumor Arising in the Spinal Cord	PLOS ONE			English	Article							KIAA1549-BRAF FUSION; PILOCYTIC ASTROCYTOMAS; 4TH-VENTRICLE RGNT; MUTATIONS; MEDULLOBLASTOMA; EXPRESSION; VENTRICLE; FEATURES; PATHWAY; PATIENT	Rosette-forming glioneuronal tumor (RGNT) of the IV ventricle is a rare and recently recognized brain tumor entity. It is histologically composed by two distinct features: a glial component, resembling pilocytic astrocytoma, and a component forming neurocytic rosettes and/or perivascular rosettes. Herein, we describe a 33-year-old man with RGNT arising in the spinal cord. Following an immunohistochemistry validation, we further performed an extensive genomic analysis, using array-CGH (aCGH), whole exome and cancer-related hotspot sequencing, in order to better understand its underlying biology. We observed the loss of 1p and gain of 1q, as well as gain of the whole chromosomes 7, 9 and 16. Local amplifications in 9q34.2 and 19p13.3 (encompassing the gene SBNO2) were identified. Moreover, we observed focal gains/losses in several chromosomes. Additionally, on chromosome 7, we identified the presence of the KIAA1549: BRAF gene fusion, which was further validated by RT-PCR and FISH. Across all mutational analyses, we detected and validated the somatic mutations of the genesMLL2, CNNM3, PCDHGC4 and SCN1A. Our comprehensive molecular profiling of this RGNT suggests that MAPK pathway and methylome changes, driven by KIAA1549: BRAF fusion and MLL2 mutation, respectively, could be associated with the development of this rare tumor entity.	[Bidinotto, Lucas Tadeu; Scapulatempo-Neto, Cristovam; Berardinelli, Gustavo Noriz; Torrieri, Raul; Reis, Rui Manuel] Barretos Canc Hosp, Mol Oncol Res Ctr, Barretos, SP, Brazil; [Bidinotto, Lucas Tadeu] Dr Paulo Prata FACISB, Barretos Sch Hlth Sci, Barretos, SP, Brazil; [Scapulatempo-Neto, Cristovam; de Almeida, Gisele Caravina] Barretos Canc Hosp, Dept Pathol, Barretos, SP, Brazil; [Mackay, Alan; Jones, Chris] Inst Canc Res, Div Mol Pathol & Canc Therapeut, London SW3 6JB, Surrey, England; [Scheithauer, Bernd Walter] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Clara, Carlos Afonso] Barretos Canc Hosp, Dept Neurosurg, Barretos, SP, Brazil; [Feltrin, Leonir Terezinha] Barretos Canc Hosp, Dept Radiol, Barretos, SP, Brazil; [Viana-Pereira, Marta; Reis, Rui Manuel] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Viana-Pereira, Marta; Reis, Rui Manuel] 3Bs PT Govt Associate Lab, Braga, Portugal; [Varella-Garcia, Marileila] Univ Colorado Anschutz Med Campus, Med Oncol Dept Med, Aurora, CO USA	Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Mayo Clinic; Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; Universidade do Minho; University of Colorado System; University of Colorado Anschutz Medical Campus	Scapulatempo-Neto, C (corresponding author), Barretos Canc Hosp, Mol Oncol Res Ctr, Barretos, SP, Brazil.	cristovamscapula@gmail.com; ruireis.hcb@gmail.com	Bidinotto, Lucas/GRS-5349-2022; Reis, Rui Manuel/AAD-6470-2020; Reis, Rui M/C-2859-2009; Berardinelli, Gustavo/J-1949-2015; Bidinotto, Lucas T/D-3625-2012; Reis, Rui Manuel/B-1744-2018; Jones, Chris/ABE-6059-2021; Viana-Pereira, Marta/E-1317-2014	Reis, Rui Manuel/0000-0002-9639-7940; Reis, Rui M/0000-0002-9639-7940; Berardinelli, Gustavo/0000-0001-5404-9748; Bidinotto, Lucas T/0000-0002-6909-8347; Reis, Rui Manuel/0000-0002-9639-7940; Jones, Chris/0000-0001-8118-2296; Viana-Pereira, Marta/0000-0003-3087-0624; Scapulatempo-Neto, Cristovam/0000-0002-8920-6579	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [475358/2011-2]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/19590-0, 2011/08523-7, 2012/08287-4]; Foundation for Science and Technology (FCT) [PTDC/SAU-ONC/115513/2009]; National Cancer Institute [P30CA046934]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [475358/2011-2] to RMR (www.cnpq.br); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/19590-0] to RMR and [2011/08523-7 and 2012/08287-4] to LTB (www.fapesp.br); the Foundation for Science and Technology (FCT) [PTDC/SAU-ONC/115513/2009] to RMR; and the National Cancer Institute [P30CA046934] to MGV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anan M, 2009, HUM PATHOL, V40, P898, DOI 10.1016/j.humpath.2008.11.010; Arai A, 2010, NEUROL MED-CHIR, V50, P224, DOI 10.2176/nmc.50.224; Becker AP, 2015, J NEUROPATH EXP NEUR, V74, P743, DOI 10.1097/NEN.0000000000000213; Cachia D, 2014, CLIN NEUROPATHOL, V33, P407, DOI 10.5414/NP300767; Cruz GR, 2014, J NEURO-ONCOL, V117, P235, DOI 10.1007/s11060-014-1398-1; El Kasmi KC, 2007, J IMMUNOL, V179, P7215, DOI 10.4049/jimmunol.179.11.7215; Ellezam B, 2012, ACTA NEUROPATHOL, V123, P285, DOI 10.1007/s00401-011-0886-z; Forshew T, 2009, J PATHOL, V218, P172, DOI 10.1002/path.2558; Cabezas SG, 2015, BRAIN TUMOR PATHOL, V32, P124, DOI 10.1007/s10014-014-0195-z; Gessi M, 2014, J NEUROPATH EXP NEUR, V73, P580, DOI 10.1097/NEN.0000000000000080; Gessi M, 2012, J NEURO-ONCOL, V110, P21, DOI 10.1007/s11060-012-0940-2; Gessi M, 2011, NEUROPATHOLOGY, V31, P654, DOI 10.1111/j.1440-1789.2011.01220.x; Hsu C, 2012, BRIT J NEUROSURG, V26, P668, DOI 10.3109/02688697.2012.655808; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Joseph V, 2009, NEUROPATHOLOGY, V29, P309, DOI 10.1111/j.1440-1789.2008.00953.x; Kemp S, 2012, J CLIN NEUROSCI, V19, P1180, DOI 10.1016/j.jocn.2011.12.013; Korbie DJ, 2008, NAT PROTOC, V3, P1452, DOI 10.1038/nprot.2008.133; Ladopoulos V, 2013, MOL CELL BIOL, V33, P1383, DOI 10.1128/MCB.01721-12; Lee JE, 2013, ELIFE, V2, DOI 10.7554/eLife.01503; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Marhold F, 2008, J NEURO-ONCOL, V90, P301, DOI 10.1007/s11060-008-9661-y; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Riddick G, 2011, NAT REV NEUROL, V7, P439, DOI 10.1038/nrneurol.2011.100; Schlamann A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101211; Solis OE, 2011, J NEURO-ONCOL, V102, P477, DOI 10.1007/s11060-010-0335-1; Takano A, 2010, DEV DYNAM, V239, P1789, DOI 10.1002/dvdy.22287; Thurston B, 2013, CHILD NERV SYST, V29, P839, DOI 10.1007/s00381-012-1993-4; Viana-Pereira M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020588; Wang Y, 2009, ACTA NEUROPATHOL, V118, P813, DOI 10.1007/s00401-009-0569-1; Xiong J, 2012, NEUROPATHOLOGY, V32, P301, DOI 10.1111/j.1440-1789.2011.01261.x; Xu JQ, 2012, QUANT IMAGING MED SU, V2, P227, DOI 10.3978/j.issn.2223-4292.2012.09.03; Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611; Zhang J, 2013, J CLIN NEUROSCI, V20, P335, DOI 10.1016/j.jocn.2012.09.003	33	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137690	10.1371/journal.pone.0137690	http://dx.doi.org/10.1371/journal.pone.0137690			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371886	Green Submitted, Green Published, gold			2022-12-27	WOS:000361604400027
J	Estrela, AB; Turck, P; Stutz, E; Abraham, WR				Estrela, Andreia Bergamo; Tuerck, Patrick; Stutz, Elaine; Abraham, Wolf-Rainer			Release of Periplasmic Nucleotidase Induced by Human Antimicrobial Peptide in E-coli Causes Accumulation of the Immunomodulator Adenosine	PLOS ONE			English	Article							INTRACELLULAR-LOCALIZATION; PSEUDOMONAS-AERUGINOSA; IMMUNE MODULATION; GUT MICROBIOTA; PANETH CELLS; DISEASE; 5-NUCLEOTIDASE; PURIFICATION; MECHANISMS; DEFENSINS	Previous work by our group described that human beta-defensin-2 induces accumulation of extracellular adenosine (Ado) in E. coli cultures through a non-lytic mechanism causing severe plasmolysis. Here, we investigate the presence of AMP as a direct precursor and the involvement of a bacterial enzyme in the generation of extracellular Ado by treated bacteria. Following hBD-2 treatment, metabolites were quantified in the supernatants using targeted HPLC-MS/MS analysis. Microbial growth was monitored by optical density and cell viability was determined by colony forming units counts. Phosphatase activity was measured using chromogenic substrate pNPP. The results demonstrate that defensin-treated E. coli strainWreleases AMP in the extracellular space, where it is converted to Ado by a bacterial soluble factor. An increase in phosphatase activity in the supernatant was observed after peptide treatment, similar to the effect of sucrose-induced osmotic stress, suggesting that the periplasmic 5'nucleotidase (5'-NT) is released following the plasmolysis event triggered by the peptide. Ado accumulation was enhanced in the presence of Co2+ ion and inhibited by EDTA, further supporting the involvement of a metallo-phosphatase such as 5'-NT in extracellular AMP conversion into Ado. The comparative analysis of hBD-induced Ado accumulation in different E. coli strains and in Pseudomonas aeruginosa revealed that the response is not correlated to the peptide's effect on cell viability, but indicates it might be dependent on the subcellular distribution of the nucleotidase. Taken together, these data shed light on a yet undescribed mechanism of host-microbial interaction: a human antimicrobial peptide inducing selective release of a bacterial enzyme (E. coli 5'-NT), leading to the formation of a potent immunomodulator metabolite (Ado).	[Estrela, Andreia Bergamo; Tuerck, Patrick; Stutz, Elaine; Abraham, Wolf-Rainer] Helmholtz Ctr Infect Res, Chem Microbiol, D-38124 Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research	Estrela, AB (corresponding author), Univ Fed Rio Grande do Norte, Lab Tecnol & Biotecnol Farmaceut, BR-59072970 Natal, RN, Brazil.	estrela.abe@gmail.com; Wolf-Rainer.Abraham@helmholtz-hzi.de	Turck, Patrick/ABE-3969-2021; Abraham, Wolf-Rainer/I-2179-2019; Estrela, Andreia/A-5162-2016	Abraham, Wolf-Rainer/0000-0002-2850-2649; Turck, Patrick/0000-0001-5994-5218	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	A.B.E. and P.T. acknowledge fellowships from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and E.S. acknowledges a fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), all pertaining to the Brazilian program Science without Borders.	Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; BHATTI AR, 1976, CAN J MICROBIOL, V22, P1425, DOI 10.1139/m76-211; Boudeau J, 1999, INFECT IMMUN, V67, P4499, DOI 10.1128/IAI.67.9.4499-4509.1999; BROAD DF, 1981, J GEN MICROBIOL, V123, P241; Chan ESL, 2002, ARTHRITIS RES, V4, P266, DOI 10.1186/ar419; Crane JK, 2009, FEMS IMMUNOL MED MIC, V57, P214, DOI 10.1111/j.1574-695X.2009.00598.x; Drygiannakis I, 2011, IMMUNOL RES, V50, P69, DOI 10.1007/s12026-011-8207-0; Easton DM, 2009, TRENDS BIOTECHNOL, V27, P582, DOI 10.1016/j.tibtech.2009.07.004; Estrela AB, 2011, CURR MED CHEM, V18, P2791; Estrela AB, 2013, ANTIMICROB AGENTS CH, V57, P4387, DOI 10.1128/AAC.00820-13; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Fredholm BB, 2001, BIOCHEM PHARMACOL, V61, P443, DOI 10.1016/S0006-2952(00)00570-0; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; GLICK J, 1983, J GEN MICROBIOL, V129, P3085; Greenwell-Wild T, 2002, J IMMUNOL, V169, P6286, DOI 10.4049/jimmunol.169.11.6286; Hilchie AL, 2013, NAT CHEM BIOL, V9, P761, DOI [10.1038/NCHEMBIO.1393, 10.1038/nchembio.1393]; Huttenhower C, 2014, IMMUNITY, V40, P843, DOI 10.1016/j.immuni.2014.05.013; Kelly D, 2005, TRENDS IMMUNOL, V26, P326, DOI 10.1016/j.it.2005.04.008; Lee WJ, 2014, NAT CHEM BIOL, V10, P416, DOI 10.1038/nchembio.1535; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; NEU HC, 1967, J BIOL CHEM, V242, P3896; NEU HC, 1968, BIOCHEMISTRY-US, V7, P3766, DOI 10.1021/bi00850a059; Ochoa-Cortes F, 2014, INFLAMM BOWEL DIS, V20, P1259, DOI 10.1097/MIB.0000000000000047; Okamura S, J BIOCH, V73, P915; Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; RINAS U, 1995, APPL ENVIRON MICROB, V61, P4147, DOI 10.1128/AEM.61.12.4147-4151.1995; STROHMEIER GR, 1995, J BIOL CHEM, V270, P2387, DOI 10.1074/jbc.270.5.2387; Thammavongsa V, 2009, J EXP MED, V206, P2417, DOI 10.1084/jem.20090097; WATANABE K, 1986, BIOCHEM BIOPH RES CO, V134, P527, DOI 10.1016/S0006-291X(86)80452-1; Watanabe K, 2011, BIOSCI BIOTECH BIOCH, V75, P7, DOI 10.1271/bbb.100063; Willyard C, 2011, NATURE, V479, pS5, DOI 10.1038/479S5a; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2	35	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138033	10.1371/journal.pone.0138033	http://dx.doi.org/10.1371/journal.pone.0138033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371472	gold, Green Published, Green Submitted			2022-12-27	WOS:000361604400045
J	Qu, YY; Zhang, XW; Ma, Q; Deng, J; Deng, Y; Van Nostrand, JD; Wu, LY; He, ZL; Qin, YJ; Zhou, JT; Zhou, JH				Qu, Yuanyuan; Zhang, Xuwang; Ma, Qiao; Deng, Jie; Deng, Ye; Van Nostrand, Joy D.; Wu, Liyou; He, Zhili; Qin, Yujia; Zhou, Jiti; Zhou, Jizhong			Microbial Community Dynamics and Activity Link to Indigo Production from Indole in Bioaugmented Activated Sludge Systems	PLOS ONE			English	Article							RIBOSOMAL-RNA; NAPHTHALENE; GENES; DEGRADATION; STRAIN; WASTE; BIOSYNTHESIS; EXPRESSION; BACTERIUM; OXIDATION	Biosynthesis of the popular dyestuff indigo from indole has been comprehensively studied using pure cultures, but less has been done to characterize the indigo production by microbial communities. In our previous studies, a wild strain Comamonas sp. MQ was isolated from activated sludge and the recombinant Escherichia coli (nagAc) carrying the naphthalene dioxygenase gene (nag) from strain MQ was constructed, both of which were capable of producing indigo from indole. Herein, three activated sludge systems, G1 (non-augmented control), G2 (augmented with Comamonas sp. MQ), and G3 (augmented with recombinant E. coli (nagAc)), were constructed to investigate indigo production. After 132-day operation, G3 produced the highest yields of indigo (99.5 +/- 3.0 mg/l), followed by G2 (27.3 +/- 1.3 mg/l) and G1 (19.2 +/- 1.2 mg/l). The microbial community dynamics and activities associated with indigo production were analyzed by Illumina Miseq sequencing of 16S rRNA gene amplicons. The inoculated strain MQ survived for at least 30 days, whereas E. coli (nagAc) was undetectable shortly after inoculation. Quantitative real-time PCR analysis suggested the abundance of naphthalene dioxygenase gene (nagAc) from both inoculated strains was strongly correlated with indigo yields in early stages (0-30 days) (P < 0.001) but not in later stages (30-132 days) (P > 0.10) of operation. Based on detrended correspondence analysis (DCA) and dissimilarity test results, the communities underwent a noticeable shift during the operation. Among the four major genera (>1% on average), the commonly reported indigo-producing populations Comamonas and Pseudomonas showed no positive relationship with indigo yields (P > 0.05) based on Pearson correlation test, while Alcaligenes and Aquamicrobium, rarely reported for indigo production, were positively correlated with indigo yields (P < 0.05). This study should provide new insights into our understanding of indigo bio-production by microbial communities.	[Qu, Yuanyuan; Zhang, Xuwang; Ma, Qiao; Zhou, Jiti] Dalian Univ Technol, Sch Environm Sci & Technol, Minist Educ, State Key Lab Fine Chem,Key Lab Ind Ecol & Enviro, Dalian 116024, Peoples R China; [Qu, Yuanyuan; Ma, Qiao; Deng, Jie; Deng, Ye; Van Nostrand, Joy D.; Wu, Liyou; He, Zhili; Qin, Yujia; Zhou, Jizhong] Univ Oklahoma, IEG, Dept Microbiol & Plant Biol, Norman, OK 73019 USA; [Zhou, Jizhong] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Zhou, Jizhong] Tsinghua Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100084, Peoples R China	Dalian University of Technology; University of Oklahoma System; University of Oklahoma - Norman; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Tsinghua University	Qu, YY (corresponding author), Dalian Univ Technol, Sch Environm Sci & Technol, Minist Educ, State Key Lab Fine Chem,Key Lab Ind Ecol & Enviro, Dalian 116024, Peoples R China.	qyy@dlut.edu.cn	Zhang, Xuwang/L-7097-2019; Deng, Ye/X-4358-2019; He, Zhili/C-2879-2012; Van Nostrand, Joy D/F-1740-2016; ma, qiao/AAK-2605-2021	Deng, Ye/0000-0002-7584-0632; He, Zhili/0000-0001-8225-7333; Van Nostrand, Joy D/0000-0001-9548-6450; Ma, Qiao/0000-0003-0614-2192	National Natural Science Foundation of China [21176040]; Program for New Century Excellent Talents in University [NCET-13-0077]; Fundamental Research Funds for the Central Universities [DUT14YQ107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China (No. 21176040), the Program for New Century Excellent Talents in University (No. NCET-13-0077), and the Fundamental Research Funds for the Central Universities (No. DUT14YQ107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CCR, 1997, APPL ENVIRON MICROB, V63, P151, DOI 10.1128/AEM.63.1.151-155.1997; Bai YH, 2011, ENVIRON SCI TECHNOL, V45, P1940, DOI 10.1021/es103150v; Bambauer A, 1998, ARCH MICROBIOL, V169, P293, DOI 10.1007/s002030050575; Bechtold T, 2002, BIORESOURCE TECHNOL, V81, P171, DOI 10.1016/S0960-8524(01)00146-8; Bhushan B, 2000, LETT APPL MICROBIOL, V31, P5, DOI 10.1046/j.1472-765x.2000.00754.x; Boon N, 2003, APPL ENVIRON MICROB, V69, P1511, DOI 10.1128/AEM.69.3.1511-1520.2003; Boon N, 2000, APPL ENVIRON MICROB, V66, P2906, DOI 10.1128/AEM.66.7.2906-2913.2000; Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004; Chang YC, 2013, APPL BIOCHEM BIOTECH, V170, P381, DOI 10.1007/s12010-013-0191-5; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Chase JM, 2010, SCIENCE, V328, P1388, DOI 10.1126/science.1187820; CLAUS G, 1983, SYST APPL MICROBIOL, V4, P169, DOI 10.1016/S0723-2020(83)80046-0; Cosgrove L, 2010, APPL ENVIRON MICROB, V76, P810, DOI 10.1128/AEM.00534-09; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Doukyu N, 2002, APPL MICROBIOL BIOT, V58, P543, DOI 10.1007/s00253-001-0919-y; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; ENSLEY BD, 1983, SCIENCE, V222, P167, DOI 10.1126/science.6353574; Gillam EMJ, 2000, BIOCHEMISTRY-US, V39, P13817, DOI 10.1021/bi001229u; Hai RT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107345; Han GH, 2011, PROCESS BIOCHEM, V46, P788, DOI 10.1016/j.procbio.2010.10.015; Iasur-Kruh L, 2011, APPL ENVIRON MICROB, V77, P3734, DOI 10.1128/AEM.00691-11; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Ma Q, 2015, BIORESOURCE TECHNOL, V179, P436, DOI 10.1016/j.biortech.2014.12.041; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Marshall CW, 2013, CURR OPIN BIOTECH, V24, P391, DOI 10.1016/j.copbio.2013.03.016; Moreno-Ruiz E, 2003, J BACTERIOL, V185, P2026, DOI 10.1128/JB.185.6.2026-2030.2003; MURDOCK D, 1993, BIO-TECHNOL, V11, P381, DOI 10.1038/nbt0393-381; O'Connor KE, 1998, BIOTECHNOL LETT, V20, P219, DOI 10.1023/A:1005361415496; OConnor KE, 1997, APPL ENVIRON MICROB, V63, P4287, DOI 10.1128/AEM.63.11.4287-4291.1997; Pathak H, 2010, APPL BIOCHEM BIOTECH, V160, P1616, DOI 10.1007/s12010-009-8638-4; Philp JC, 2013, TRENDS BIOTECHNOL, V31, P219, DOI 10.1016/j.tibtech.2012.12.007; Purkhold U, 2000, APPL ENVIRON MICROB, V66, P5368, DOI 10.1128/AEM.66.12.5368-5382.2000; Qu YY, 2015, ENVIRON SCI TECHNOL, V49, P4627, DOI 10.1021/es5053045; Qu YY, 2012, J BASIC MICROB, V52, P687, DOI 10.1002/jobm.201100516; Qu YY, 2012, BIOTECHNOL LETT, V34, P353, DOI 10.1007/s10529-011-0778-2; Qu YY, 2010, BIORESOURCE TECHNOL, V101, P4527, DOI 10.1016/j.biortech.2010.01.033; Qu YY, 2012, PLOS ONE, V7, DOI [10. 1371/ journal. pone. 0044313, DOI 10.1371/J0URNAL.P0NE.0044313]; Rhee SK, 2004, APPL ENVIRON MICROB, V70, P4303, DOI 10.1128/AEM.70.7.4303-4317.2004; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Vinas M, 2005, APPL ENVIRON MICROB, V71, P7008, DOI 10.1128/AEM.71.11.7008-7018.2005; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zhang XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138820; Zhang XW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125732; Zhang XW, 2013, PROCESS BIOCHEM, V48, P581, DOI 10.1016/j.procbio.2013.02.008; Zhou JZ, 2015, MBIO, V6, DOI 10.1128/mBio.02288-14; Zhou JZ, 2014, P NATL ACAD SCI USA, V111, pE836, DOI 10.1073/pnas.1324044111; Zhou JZ, 2013, MBIO, V4, DOI 10.1128/mBio.00584-12	48	6	6	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138455	10.1371/journal.pone.0138455	http://dx.doi.org/10.1371/journal.pone.0138455			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372223	gold, Green Submitted, Green Published			2022-12-27	WOS:000361604400070
J	Skaaby, T; Husemoen, LLN; Thuesen, BH; Jorgensen, T; Linneberg, A				Skaaby, Tea; Husemoen, Lise Lotte Nystrup; Thuesen, Betina Heinsbaek; Jorgensen, Torben; Linneberg, Allan			Lifestyle-Related Factors and Atopy in Seven Danish Population-Based Studies from Different Time Periods	PLOS ONE			English	Article							SERUM IMMUNOGLOBULIN-E; ALLERGIC RESPIRATORY-DISEASE; NUTRITION EXAMINATION SURVEY; BODY-MASS INDEX; ALCOHOL-CONSUMPTION; COPENHAGEN-ALLERGY; AEROALLERGEN SENSITIZATION; AIRWAY INFLAMMATION; CHOLESTEROL LEVELS; NATIONAL-HEALTH	Background The prevalence of allergic respiratory disease tends to increase in populations that adopt the so-called Westernized lifestyle. We investigated the association between atopy and several possible lifestyle-related factors in seven Danish population-based studies. Methods A total of 20048 persons participated in the seven studies. We used logistic regression to analyse the associations between possible determinants and atopy defined as serum specific IgE or skin prick test positivity against inhalant allergens. Associations were expressed as odds ratios (ORs) with 95% confidence intervals (95% CIs). In addition, individual participant data meta-analyses were performed. Results Atopy was significantly associated with younger age (OR per 1 year increase in age: 0.97; 95% CI: 0.97, 0.98); male sex (OR for males versus females: 1.34; 95% CI: 1.24, 1.45), heavy drinking (OR for heavy drinkers versus light drinkers: 1.15; 95% CI: 1.04, 1.27), never smoking (OR for current versus never smokers: 0.73; 95% CI: 0.67, 0.80), and higher educational level (OR for educated versus uneducated: 1.27; 95% CI: 1.15, 1.41). Atopy was not associated with blood pressure, serum total cholesterol, physical activity or body mass except in women only, where we found a positive association (OR for obese vs. normal weight: 1.18; 95% CI: 1.00, 1.39) with ptrend = 0.032. Conclusions Of interest for preventive purposes, we found that atopy was associated with some of the reversible lifestyle-related factors that characterize a Westernized lifestyle.	[Skaaby, Tea; Husemoen, Lise Lotte Nystrup; Thuesen, Betina Heinsbaek; Jorgensen, Torben; Linneberg, Allan] Capital Reg Denmark, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Jorgensen, Torben; Linneberg, Allan] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Jorgensen, Torben] Aalborg Univ, Fac Med, Aalborg, Denmark; [Linneberg, Allan] Glostrup Univ Hosp, Dept Clin Expt Res, Glostrup, Denmark	University of Copenhagen; Aalborg University; University of Copenhagen	Skaaby, T (corresponding author), Capital Reg Denmark, Res Ctr Prevent & Hlth, Glostrup, Denmark.	tea.skaaby.01@regionh.dk	Jørgensen, Torben/Z-1335-2018	Linneberg, Allan/0000-0002-0994-0184; Thuesen, Betina/0000-0001-9772-4344; Jorgensen, Torben/0000-0001-9453-2830; Skaaby, Tea/0000-0003-0031-5726	Lundbeck Foundation [R165-2013-15410, R108-A10225]	Lundbeck Foundation(Lundbeckfonden)	Tea Skaaby was supported by a grant from the Lundbeck Foundation (Grant number R165-2013-15410). Betina Heinsbaek Thuesen was supported by a grant from the Lundbeck Foundation (Grant number R108-A10225). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadahl M, 2014, AM J PREV MED, V47, P576, DOI 10.1016/j.amepre.2014.06.020; Aadahl M, 2013, EUR J PREV CARDIOL, V20, P1088, DOI 10.1177/2047487312462825; Assing K, 2007, ANN ALLERG ASTHMA IM, V98, P70, DOI 10.1016/S1081-1206(10)60862-9; Berg ND, 2012, J ALLERGY CLIN IMMUN, V129, P374, DOI 10.1016/j.jaci.2011.08.045; Bergeron C, 2005, J ALLERGY CLIN IMMUN, V115, P1102, DOI 10.1016/j.jaci.2005.03.018; Boulet LP, 2014, CLIN EXP ALLERGY; Bruno A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/607192; Byberg S, 2012, DIABETIC MED, V29, pE354, DOI 10.1111/j.1464-5491.2012.03711.x; Castro-Rodriguez LA, 2001, AM J RESP CRIT CARE, V163, P1344, DOI 10.1164/ajrccm.163.6.2006140; Chen W, 2008, ALLERGY, V63, P1418, DOI 10.1111/j.1398-9995.2008.01880.x; Chen Y, 2010, INT ARCH ALLERGY IMM, V153, P372, DOI 10.1159/000316348; Chen Y, 2009, J AGROMEDICINE, V14, P222, DOI 10.1080/10599240902724051; Drivsholm T, 2006, SCAND J PUBLIC HEALT, V34, P623, DOI 10.1080/14034940600607616; Ferraz E, 2011, J PEDIAT-BRAZIL, V87, P336, DOI [10.2223/JPED.2114, 10.1590/S0021-75572011000400011]; Fessler MB, 2010, ALLERGY, V65, P859, DOI 10.1111/j.1398-9995.2009.02287.x; Flaherman V, 2006, ARCH DIS CHILD, V91, P334, DOI 10.1136/adc.2005.080390; Flexeder C, 2011, INT ARCH ALLERGY IMM, V156, P117, DOI 10.1159/000322296; GERGEN PJ, 1991, ARCH INTERN MED, V151, P487, DOI 10.1001/archinte.151.3.487; Gonzalez-Quintela A, 2008, CLIN EXP ALLERGY, V38, P152, DOI 10.1111/j.1365-2222.2007.02863.x; Gonzalez-Quintela A, 2004, ADDICT BIOL, V9, P195, DOI 10.1080/13556210412331292235; Gonzalez-Quintela A, 2003, CLIN EXP ALLERGY, V33, P199, DOI 10.1046/j.1365-2222.2003.01582.x; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Hancox RJ, 2005, AM J RESP CRIT CARE, V171, P440, DOI 10.1164/rccm.200405-623OC; Hersoug LG, 2007, ALLERGY, V62, P1205, DOI 10.1111/j.1398-9995.2007.01506.x; Husemoen LLN, 2008, ALCOHOL CLIN EXP RES, V32, P1984, DOI 10.1111/j.1530-0277.2008.00780.x; Jahn-Schmid B, 2003, CLIN EXP ALLERGY, V33, P1443, DOI 10.1046/j.1365-2222.2003.01784.x; Jarvis D, 2002, CLIN EXP ALLERGY, V32, P831, DOI 10.1046/j.1365-2222.2002.01380.x; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Lee YW, 2009, CLIN CHIM ACTA, V401, P25, DOI 10.1016/j.cca.2008.10.034; Linneberg A, 2007, CLIN EXP ALLERGY, V37, P1137, DOI 10.1111/j.1365-2222.2007.02760.x; Linneberg A, 2006, ALLERGY, V61, P344, DOI 10.1111/j.1398-9995.2006.00968.x; Linneberg A, 2003, CLIN EXP ALLERGY, V33, P192, DOI 10.1046/j.1365-2222.2003.01515.x; Linneberg A, 2002, CLIN EXP ALLERGY, V32, P1702, DOI 10.1046/j.1365-2222.2002.01537.x; Linneberg A, 2010, INT ARCH ALLERGY IMM, V151, P142, DOI 10.1159/000236004; Linneberg A, 2001, CLIN EXP ALLERGY, V31, P1409, DOI 10.1046/j.1365-2222.2001.01178.x; Linneberg A, 2001, RESP MED, V95, P258, DOI 10.1053/rmed.2001.1031; Linneberg A, 2001, ALLERGY, V56, P328, DOI 10.1034/j.1398-9995.2000.00509.x-i1; Linneberg A, 2008, INT ARCH ALLERGY IMM, V147, P93, DOI 10.1159/000135695; Osler M, 2011, INT J EPIDEMIOL, V40, P602, DOI 10.1093/ije/dyq041; Petersen AB, 2004, CLIN BIOCHEM, V37, P882, DOI 10.1016/j.clinbiochem.2004.06.010; Ring J, 2001, CURR OPIN IMMUNOL, V13, P701, DOI 10.1016/S0952-7915(01)00282-5; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Salam MT, 2006, J ALLERGY CLIN IMMUN, V117, P1001, DOI 10.1016/j.jaci.2006.02.004; Santamaria F, 2007, J ALLERGY CLIN IMMUN, V120, P965, DOI 10.1016/j.jaci.2007.06.002; Saulyte J, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001611; Schachter LM, 2003, THORAX, V58, P1031, DOI 10.1136/thorax.58.12.1031; Schachter LM, 2001, THORAX, V56, P4, DOI 10.1136/thorax.56.1.4; Schafer T, 2003, CLIN EXP ALLERGY, V33, P1360, DOI 10.1046/j.1365-2222.2003.01780.x; Silverberg JI, 2012, BRIT J DERMATOL, V166, P498, DOI 10.1111/j.1365-2133.2011.10694.x; Skaaby T, 2014, CLIN EXP ALLERGY, V44, P1361, DOI 10.1111/cea.12408; Skaaby T, 2014, ENDOCRINE; Skaaby T, 2014, JACI PRACTICE; Skaaby T, 2015, ENDOCRINE; Skaaby T, 2015, AUTOIMMUNITY, V48, P282, DOI 10.3109/08916934.2014.1003640; Thuesen BH, 2010, ALLERGY, V65, P1446, DOI 10.1111/j.1398-9995.2010.02378.x; van Gent R, 2007, J ALLERGY CLIN IMMUN, V119, P591, DOI 10.1016/j.jaci.2006.11.007; van Veen IH, 2008, ALLERGY, V63, P570, DOI 10.1111/j.1398-9995.2007.01597.x; Vidal C, 2002, ALCOHOL CLIN EXP RES, V26, P59, DOI 10.1111/j.1530-0277.2002.tb02432.x; Vieira VJ, 2005, AM J CLIN NUTR, V82, P504, DOI 10.1093/ajcn/82.3.504; Visness CM, 2010, J ASTHMA, V47, P822, DOI 10.3109/02770903.2010.489388; Wuthrich B, 1996, INT ARCH ALLERGY IMM, V111, P396, DOI 10.1159/000237398; Xu BZ, 2002, EUR J PUBLIC HEALTH, V12, P166, DOI 10.1093/eurpub/12.3.166; Yeh YF, 2004, J BIOMED SCI, V11, P599, DOI 10.1007/BF02256124	63	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137406	10.1371/journal.pone.0137406	http://dx.doi.org/10.1371/journal.pone.0137406			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372449	Green Published, gold, Green Submitted			2022-12-27	WOS:000361604400022
J	Varenhorst, AJ; McCarville, MT; O'Neal, ME				Varenhorst, Adam J.; McCarville, Michael T.; O'Neal, Matthew E.			Reduced Fitness of Virulent Aphis glycines (Hemiptera: Aphididae) Biotypes May Influence the Longevity of Resistance Genes in Soybean	PLOS ONE			English	Article							HOST-PLANT RESISTANCE; SEED TRAITS; SINGLE-GENE; RAG1; MANAGEMENT; INSECTICIDES; POPULATIONS; RESPONSES; REFUGE; IMPACT	Sustainable use of insect resistance in crops require insect resistance management plans that may include a refuge to limit the spread of virulence to this resistance. However, without a loss of fitness associated with virulence, a refuge may not prevent virulence from becoming fixed within a population of parthenogenetically reproducing insects like aphids. Aphid-resistance in soybeans (i.e., Rag genes) prevent outbreaks of soybean aphid (Aphis glycines), yet four biotypes defined by their capacity to survive on aphid-resistant soybeans (e.g., biotype-2 survives on Rag1 soybean) are found in North America. Although fitness costs are reported for biotype-3 on aphid susceptible and Rag1 soybean, it is not clear if virulence to aphid resistance in general is associated with a decrease in fitness on aphid susceptible soybeans. In laboratory assays, we measured fitness costs for biotype 2, 3 and 4 on an aphid-susceptible soybean cultivar. In addition, we also observed negative cross-resistance for biotype-2 on Rag3, and biotype-3 on Rag1 soybean. We utilized a simple deterministic, single-locus, four compartment genetic model to account for the impact of these findings on the frequency of virulence alleles. When a refuge of aphid susceptible was included within this model, fitness costs and negative cross-resistance delayed the increase of virulence alleles when virulence was inherited recessively or additively. If virulence were inherited additively, fitness costs decreased the frequency of virulence. Combined, these results suggest that a refuge may prevent virulent A. glycines biotypes from overcoming Rag genes if this aphid-resistance were used commercially in North America.	[Varenhorst, Adam J.; McCarville, Michael T.; O'Neal, Matthew E.] Iowa State Univ, Dept Entomol, Ames, IA 50011 USA	Iowa State University	O'Neal, ME (corresponding author), Iowa State Univ, Dept Entomol, Ames, IA 50011 USA.	oneal@iastate.edu		Varenhorst, Adam/0000-0001-6239-9860	North Central Soybean Research Program USDA National Institute of Food and Agriculture [233507]	North Central Soybean Research Program USDA National Institute of Food and Agriculture	North Central Soybean Research Program USDA National Institute of Food and Agriculture, Hatch Project #233507. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt J, 2013, CROP SCI, V53, P1491, DOI 10.2135/cropsci2012.11.0672; Bansal R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-972; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; Brace RC, 2012, CROP SCI, V52, P2070, DOI 10.2135/cropsci2011.12.0637; Chirumamilla A, 2014, CROP SCI, V54, P2557, DOI 10.2135/cropsci2014.05.0393; Crowder DW, 2009, J THEOR BIOL, V261, P423, DOI 10.1016/j.jtbi.2009.08.017; Donaldson JR, 2007, BIOL CONTROL, V43, P111, DOI 10.1016/j.biocontrol.2007.06.004; Enders L, 2014, ENVIRON ENTOMOL, V43, P47, DOI 10.1603/EN13135; FEHR W. R., 1971, Crop science, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Gassmann AJ, 2009, ANNU REV ENTOMOL, V54, P147, DOI 10.1146/annurev.ento.54.110807.090518; Hesler LS, 2013, ENTOMOL EXP APPL, V147, P201, DOI 10.1111/eea.12073; Hill CB, 2010, J ECON ENTOMOL, V103, P509, DOI 10.1603/EC09179; Hogenhout SA, 2009, MOL PLANT MICROBE IN, V22, P115, DOI 10.1094/MPMI-22-2-0115; Johnson KD, 2009, J ECON ENTOMOL, V102, P2101, DOI 10.1603/029.102.0613; Kim KS, 2008, CROP SCI, V48, P923, DOI 10.2135/cropsci2007.08.0447; Kim KS, 2013, CROP SCI, V53, P1326, DOI 10.2135/cropsci2012.09.0558; Kim KS, 2009, CROP SCI, V49, P1726, DOI 10.2135/cropsci2008.10.0588; Mardorf JL, 2010, CROP SCI, V50, P1891, DOI 10.2135/cropsci2010.02.0079; McCarville MT, 2014, J ECON ENTOMOL, V107, P1680, DOI 10.1603/EC14047; McCarville MT, 2012, J ECON ENTOMOL, V105, P1835, DOI 10.1603/EC12043; McCarville M. T, 2012, SOYBEAN APHID RESIST, V92; McCornack BP, 2004, J ECON ENTOMOL, V97, P854, DOI 10.1603/0022-0493(2004)097[0854:DOSAHA]2.0.CO;2; Michel AP, 2011, SOYBEAN - MOLECULAR ASPECTS OF BREEDING, P355; Michel AP, 2010, J ECON ENTOMOL, V103, P949, DOI 10.1603/EC09337; Mutti NS, 2008, P NATL ACAD SCI USA, V105, P9965, DOI 10.1073/pnas.0708958105; [NASS/USDA] National Agricultural Statistics Service/U.S. Department of Agriculture, 2005, AGR CHEM US 2005 FIE; [NASS/USDA] National Agricultural Statistics Service/U.S. Department of Agriculture, 1999, PEST MAN PRACT; Nicholson SJ, 2012, J PROTEOMICS, V75, P2252, DOI 10.1016/j.jprot.2012.01.031; Ohnesorg WJ, 2009, J ECON ENTOMOL, V102, P1816, DOI 10.1603/029.102.0512; Olson K.D., 2008, FARMERS AWARENESS US; Pittendrigh B. R., 2008, INSECT RESISTANCE MA, P108; Ragsdale DW, 2011, ANNU REV ENTOMOL, V56, P375, DOI 10.1146/annurev-ento-120709-144755; Richardson ML, 2012, J APPL ENTOMOL, V136, P641, DOI 10.1111/j.1439-0418.2011.01692.x; van der Hoorn RAL, 2008, PLANT CELL, V20, P2009, DOI 10.1105/tpc.108.060194; Varenhorst AJ, 2015, ENVIRON ENTOMOL, V44, P658, DOI 10.1093/ee/nvv051; Varenhorst AJ, 2012, ENVIRON ENTOMOL, V41, P1565, DOI 10.1603/EN12068; Wenger J, 2014, J ECON ENTOMOL, V107, P1599, DOI 10.1603/EC13545; Whalen R, 2015, ARTHROPOD-PLANT INTE, V9, P233, DOI 10.1007/s11829-015-9366-z; Wiarda SL, 2012, J ECON ENTOMOL, V105, P252, DOI 10.1603/EC11020	39	27	27	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138252	10.1371/journal.pone.0138252	http://dx.doi.org/10.1371/journal.pone.0138252			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372106	Green Published, gold, Green Submitted			2022-12-27	WOS:000361604400059
J	Wang, YL; Cui, R; Xiao, YY; Fang, JM; Xu, Q				Wang, Yulan; Cui, Ran; Xiao, Yuanyuan; Fang, Juemin; Xu, Qing			Effect of Carotene and Lycopene on the Risk of Prostate Cancer: A Systematic Review and Dose-Response Meta-Analysis of Observational Studies	PLOS ONE			English	Review							DIETARY BETA-CAROTENE; VITAMIN-C; PLASMA CAROTENOIDS; ALPHA-CAROTENE; SERUM MICRONUTRIENTS; RETINOL; ASSOCIATION; NUTRIENTS; CHINESE; FOODS	Background Many epidemiologic studies have investigated the association between carotenoids intake and risk of Prostate cancer (PCa). However, results have been inconclusive. Methods We conducted a systematic review and dose-response meta-analysis of dietary intake or blood concentrations of carotenoids in relation to PCa risk. We summarized the data from 34 eligible studies (10 cohort, 11 nested case-control and 13 case-control studies) and estimated summary Risk Ratios (RRs) and 95% confidence intervals (CIs) using random-effects models. Results Neither dietary beta-carotene intake nor its blood levels was associated with reduced PCa risk. Dietary a-carotene intake and lycopene consumption (both dietary intake and its blood levels) were all associated with reduced risk of PCa (RR for dietary alpha-carotene intake: 0.87, 95% CI: 0.76-0.99; RR for dietary lycopene intake: 0.86, 95% CI: 0.75-0.98; RR for blood lycopene levels: 0.81, 95% CI: 0.69-0.96). However, neither blood a-carotene levels nor blood lycopene levels could reduce the risk of advanced PCa. Dose-response analysis indicated that risk of PCa was reduced by 2% per 0.2mg/day (95% CI: 0.96-0.99) increment of dietary a-carotene intake or 3% per 1mg/day (95% CI: 0.94-0.99) increment of dietary lycopene intake. Conclusions alpha-carotene and lycopene, but not beta-carotene, were inversely associated with the risk of PCa. However, both alpha-carotene and lycopene could not lower the risk of advanced PCa.	[Wang, Yulan] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Clin Lab, Shanghai 200072, Peoples R China; [Cui, Ran; Xiao, Yuanyuan; Fang, Juemin; Xu, Qing] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Oncol, Shanghai 200072, Peoples R China	Tongji University; Tongji University	Xu, Q (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Oncol, 301 Middle Yanchang Rd, Shanghai 200072, Peoples R China.	18221078212@163.com		XU, QING/0000-0002-4785-2994	National Natural Science Foundation of China [81372749]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No.: 81372749).	Agalliu I, 2011, CANCER EPIDEMIOL, V35, P353, DOI 10.1016/j.canep.2010.11.002; Ambrosini GL, 2008, PROSTATE CANCER P D, V11, P61, DOI 10.1038/sj.pcan.4500979; Andersson SO, 1996, INT J CANCER, V68, P716; Beilby J, 2010, EUR J CLIN NUTR, V64, P1235, DOI 10.1038/ejcn.2010.124; Bolhassani A, 2015, ANTICANCER AGENTS ME; Bosetti C, 2004, INT J CANCER, V112, P689, DOI 10.1002/ijc.20486; Chang S, 2005, NUTR CANCER, V53, P127, DOI 10.1207/s15327914nc5302_1; Clinton SK, 1996, CANCER EPIDEM BIOMAR, V5, P823; Cohen JH, 2000, JNCI-J NATL CANCER I, V92, P61, DOI 10.1093/jnci/92.1.61; Daviglus ML, 1996, EPIDEMIOLOGY, V7, P472, DOI 10.1097/00001648-199609000-00003; Deneo-Pellegrini H, 1999, BRIT J CANCER, V80, P591, DOI 10.1038/sj.bjc.6690396; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DI MASCIO P, 1989, ARCH BIOCHEM BIOPHYS, V274, P532, DOI 10.1016/0003-9861(89)90467-0; Druesne-Pecollo N, 2010, INT J CANCER, V127, P172, DOI 10.1002/ijc.25008; Etminan M, 2004, CANCER EPIDEM BIOMAR, V13, P340; Gann PH, 1999, CANCER RES, V59, P1225; Gill Jasmeet K, 2009, Cancer Causes Control, V20, P1161, DOI 10.1007/s10552-009-9304-4; GIOVANNUCCI E, 1995, J NATL CANCER I, V87, P1767, DOI 10.1093/jnci/87.23.1767; Goodman GE, 2003, CANCER EPIDEM BIOMAR, V12, P518; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HSING AW, 1990, J NATL CANCER I, V82, P941, DOI 10.1093/jnci/82.11.941; Huang HY, 2003, AM J EPIDEMIOL, V157, P335, DOI 10.1093/aje/kwf210; Jain MG, 1999, NUTR CANCER, V34, P173, DOI 10.1207/S15327914NC3402_8; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jian L, 2005, INT J CANCER, V113, P1010, DOI 10.1002/ijc.20667; Karppi J, 2009, ANN EPIDEMIOL, V19, P512, DOI 10.1016/j.annepidem.2009.03.017; Key TJ, 2007, AM J CLIN NUTR, V86, P672, DOI 10.1093/ajcn/86.3.672; Kirsh VA, 2006, JNCI-J NATL CANCER I, V98, P245, DOI 10.1093/jnci/djj050; Krinsky NI, 1998, ANN NY ACAD SCI, V854, P443, DOI 10.1111/j.1749-6632.1998.tb09923.x; Lee MM, 2003, CANCER EPIDEM BIOMAR, V12, P665; Li CY, 2011, ARCH INTERN MED, V171, P507, DOI 10.1001/archinternmed.2010.440; Lu QY, 2001, CANCER EPIDEM BIOMAR, V10, P749; Mao XY, 2010, CANCER RES, V70, P5207, DOI 10.1158/0008-5472.CAN-09-4074; McCann SE, 2005, NUTR CANCER, V53, P33, DOI 10.1207/s15327914nc5301_4; METTLIN C, 1989, CANCER, V64, P605, DOI 10.1002/1097-0142(19890801)64:3&lt;605::AID-CNCR2820640307&gt;3.0.CO;2-I; Meyer F, 1997, NUTR CANCER, V29, P120, DOI 10.1080/01635589709514612; MURAKOSHI M, 1989, J NATL CANCER I, V81, P1649, DOI 10.1093/jnci/81.21.1649; MURAKOSHI M, 1992, CANCER RES, V52, P6583; Nomura AMY, 1997, CANCER EPIDEM BIOMAR, V6, P487; NOMURA AMY, 1991, EPIDEMIOL REV, V13, P200, DOI 10.1093/oxfordjournals.epirev.a036069; Norrish AE, 2000, AM J EPIDEMIOL, V151, P119, DOI 10.1093/oxfordjournals.aje.a010176; O'Neill ME, 2001, BRIT J NUTR, V85, P499, DOI 10.1079/BJN2000284; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Palozza P, 2008, CARCINOGENESIS, V29, P2153, DOI 10.1093/carcin/bgn018; Peters U, 2007, CANCER EPIDEM BIOMAR, V16, P962, DOI 10.1158/1055-9965.EPI-06-0861; PETO R, 1981, NATURE, V290, P201, DOI 10.1038/290201a0; POTOSKY AL, 1995, JAMA-J AM MED ASSOC, V273, P548, DOI 10.1001/jama.273.7.548; Rafi MM, 2013, J NUTR BIOCHEM, V24, P1724, DOI 10.1016/j.jnutbio.2013.03.001; Roswall N, 2013, CANCER CAUSE CONTROL, V24, P1129, DOI 10.1007/s10552-013-0190-4; Rubin MA, 2011, J CLIN ONCOL, V29, P3659, DOI 10.1200/JCO.2011.35.1916; Schuurman AG, 2002, CANCER CAUSE CONTROL, V13, P573, DOI 10.1023/A:1016332208339; Shen YY, 2010, CANCER GENET CYTOGEN, V198, P35, DOI 10.1016/j.cancergencyto.2009.12.003; SHIBATA A, 1992, BRIT J CANCER, V66, P673, DOI 10.1038/bjc.1992.336; SIES H, 1992, ANN NY ACAD SCI, V669, P7; Stahl W, 2012, AM J CLIN NUTR, V96, p1179S, DOI 10.3945/ajcn.112.034819; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Umesawa M, 2014, BRIT J CANCER, V110, P792, DOI 10.1038/bjc.2013.685; VANPOPPEL G, 1995, AM J CLIN NUTR, V62, P1393, DOI 10.1093/ajcn/62.6.1393S; Viuda-Martos M, 2014, CRIT REV FOOD SCI, V54, P1032, DOI 10.1080/10408398.2011.623799; Watters JL, 2009, CANCER RES, V69, P3833, DOI 10.1158/0008-5472.CAN-08-4640; World Cancer Research Fund International, 2014, AM I CANC RES CONT U; World Health Organization, 2011, NONC DIS COUNTR PROF, P50; World Health Organization (WHO), WORLD CANC REPORT 20; Wu KN, 2004, CANCER EPIDEM BIOMAR, V13, P260, DOI 10.1158/1055-9965.EPI-03-0012; Xue LY, 2012, AM J CANCER RES, V2, P736; Yang CM, 2012, J NUTR BIOCHEM, V23, P1155, DOI 10.1016/j.jnutbio.2011.06.009; Zhang JJ, 2007, NUTR CANCER, V59, P46, DOI 10.1080/01635580701385900; Zu K, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt430	69	61	66	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137427	10.1371/journal.pone.0137427	http://dx.doi.org/10.1371/journal.pone.0137427			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372549	Green Published, gold, Green Submitted			2022-12-27	WOS:000361604400023
J	Pathak, L; Singh, V; Niwas, R; Osama, K; Khan, S; Haque, S; Tripathi, CKM; Mishra, BN				Pathak, Lakshmi; Singh, Vineeta; Niwas, Ram; Osama, Khwaja; Khan, Saif; Haque, Shafiul; Tripathi, C. K. M.; Mishra, B. N.			Artificial Intelligence versus Statistical Modeling and Optimization of Cholesterol Oxidase Production by using Streptomyces Sp.	PLOS ONE			English	Article							RESPONSE-SURFACE METHODOLOGY; GENETIC ALGORITHM; NEURAL-NETWORKS; ACID; PURIFICATION; TEMPERATURE; PH	Cholesterol oxidase (COD) is a bi-functional FAD-containing oxidoreductase which catalyzes the oxidation of cholesterol into 4-cholesten-3-one. The wider biological functions and clinical applications of COD have urged the screening, isolation and characterization of newer microbes from diverse habitats as a source of COD and optimization and over-production of COD for various uses. The practicability of statistical/artificial intelligence techniques, such as response surface methodology (RSM), artificial neural network (ANN) and genetic algorithm (GA) have been tested to optimize the medium composition for the production of COD from novel strain Streptomyces sp. NCIM5500. All experiments were performed according to the five factor central composite design (CCD) and the generated data was analysed using RSM and ANN. GA was employed to optimize the models generated by RSM and ANN. Based upon the predicted COD concentration, the model developed with ANN was found to be superior to the model developed with RSM. The RSM-GA approach predicted maximum of 6.283 U/mL COD production, whereas the ANN-GA approach predicted a maximum of 9.93 U/mL COD concentration. The optimum concentrations of the medium variables predicted through ANN-GA approach were: 1.431 g/50 mL soybean, 1.389 g/50 mL maltose, 0.029 g/50 mL MgSO4, 0.45 g/50 mL NaCl and 2.235 ml/50 mL glycerol. The experimental COD concentration was concurrent with the GA predicted yield and led to 9.75 U/mL COD production, which was nearly two times higher than the yield (4.2 U/mL) obtained with the un-optimized medium. This is the very first time we are reporting the statistical versus artificial intelligence based modeling and optimization of COD production by Streptomyces sp. NCIM 5500.	[Pathak, Lakshmi; Osama, Khwaja; Mishra, B. N.] Uttar Pradesh Tech Univ, Inst Engn & Technol, Dept Biotechnol, Lucknow 226021, Uttar Pradesh, India; [Singh, Vineeta; Niwas, Ram] CSIR Cent Drug Res Inst, Div Microbiol, Lucknow 226031, Uttar Pradesh, India; [Khan, Saif] Hail Univ, Coll Appl Med Sci, Deratment Clin Nutr, Hail, Saudi Arabia; [Haque, Shafiul] Univ Helsinki, Fac Pharm, Viikki Bioctr 2, Ctr Drug Res, FIN-00014 Helsinki, Finland; [Haque, Shafiul] Jazan Univ, Coll Nursing & Appl Hlth Sci, Res & Sci Studies Unit, Jazan 45142, Saudi Arabia; [Tripathi, C. K. M.] CSIR Cent Drug Res Inst, Fermentat Technol Div, Lucknow 226031, Uttar Pradesh, India	Institute of Engineering & Technology Lucknow; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); University Ha'il; University of Helsinki; Jazan University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Mishra, BN (corresponding author), Uttar Pradesh Tech Univ, Inst Engn & Technol, Dept Biotechnol, Lucknow 226021, Uttar Pradesh, India.	bnmishra@ietlucknow.edu	HAQUE, SHAFIUL/AAN-2946-2020; Khan, Saif/AAD-7960-2020; Singh, Vineeta/AAG-4731-2021; Mishra, Bhartendu Nath/H-9899-2014; Khan, Saif/GPT-3695-2022; OSAMA, KHWAJA/O-3521-2019	HAQUE, SHAFIUL/0000-0002-2989-121X; Khan, Saif/0000-0002-4770-7666; Singh, Vineeta/0000-0001-6787-8203; Mishra, Bhartendu Nath/0000-0003-3191-406X; OSAMA, KHWAJA/0000-0003-3103-808X				Adriaenssens V, 2004, SCI TOTAL ENVIRON, V319, P1, DOI 10.1016/S0048-9697(03)00433-9; ALLAIN CC, 1974, CLIN CHEM, V20, P470; Amiri M, 2008, APPL SCI, V8, P2732; Bas D, 2007, J FOOD ENG, V78, P836, DOI 10.1016/j.jfoodeng.2005.11.024; BURNHAM KP, 1992, DATA BASED SELECTION, P16; Chandrashekar K, 1999, BIOPROCESS ENG, V20, P203, DOI 10.1007/s004490050582; Chauhan AK, 2009, J GEN APPL MICROBIOL, V55, P171; Desai KM, 2008, BIOCHEM ENG J, V41, P266, DOI 10.1016/j.bej.2008.05.009; Dutta JR, 2005, PROCESS BIOCHEM, V40, P879, DOI 10.1016/j.procbio.2004.02.013; El-Shora H, J AGR CHEM BIOTECHNO, V2, P205; Hilbert DW, 2001, ECOL MODEL, V146, P311, DOI 10.1016/S0304-3800(01)00323-4; Honda H, 1999, J BIOSCI BIOENG, V87, P700, DOI 10.1016/S1389-1723(99)80138-8; Huang Y, 2009, ALGORITHMS, V2, P973, DOI 10.3390/algor2030973; Kim MJ, 2011, J ELECTR ENG TECHNOL, V6, P202, DOI 10.5370/JEET.2011.6.2.202; Koksoy O, 2006, APPL MATH COMPUT, V175, P1657, DOI 10.1016/j.amc.2005.09.011; Landin M, 2009, EUR J PHARM SCI, V38, P325, DOI 10.1016/j.ejps.2009.08.004; Lou WG, 2001, FOOD RES INT, V34, P573, DOI 10.1016/S0963-9969(01)00074-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacLachlan J, 2000, J STEROID BIOCHEM, V72, P169, DOI 10.1016/S0960-0760(00)00044-3; Mehrotra S, 2013, PLANT CELL REP, V32, P309, DOI 10.1007/s00299-012-1364-3; Niwas R, 2014, J BASIC MICROB, V54, P1233, DOI 10.1002/jobm.201300847; Niwas R, 2013, WORLD J MICROB BIOT, V29, P2077, DOI 10.1007/s11274-013-1371-8; Osama K., 2013, EUROPEAN J SCI RES, V97, P516; Peng WJ, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-54; Praveen V, 2011, APPL BIOCHEM BIOTECH, V165, P1414, DOI 10.1007/s12010-011-9360-6; Salva TJG, 1999, REV MICROBIOL, V30, P315, DOI 10.1590/S0001-37141999000400005; Singh V, 2008, PROCESS BIOCHEM, V43, P1313, DOI 10.1016/j.procbio.2008.07.015; Singh V, 2008, MED CHEM RES, V17, P94, DOI 10.1007/s00044-007-9040-9; Singh V, 2009, APPL MICROBIOL BIOT, V82, P379, DOI 10.1007/s00253-008-1828-0; Sojo M, 1997, APPL MICROBIOL BIOT, V47, P583, DOI 10.1007/s002530050977; Sojo Mar M, 2002, BMC Biotechnol, V2, P3, DOI 10.1186/1472-6750-2-3; Tripathi CKM, 2012, J MICROBIOL BIOTECHN, V22, P939, DOI 10.4014/jmb.1109.09018; Wang J, 2009, AFR J BIOTECHNOL, V8, P1416; WATANABE K, 1986, J GEN APPL MICROBIOL, V32, P137, DOI 10.2323/jgam.32.137; Yang ChaoHsun, 2003, Food Science and Agricultural Chemistry, V5, P35; Yazdi M., 2008, BIOTECHNOLOGY, V7, P751, DOI DOI 10.3923/biotech.2008.751.756	36	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137268	10.1371/journal.pone.0137268	http://dx.doi.org/10.1371/journal.pone.0137268			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368924	Green Submitted, Green Published, gold			2022-12-27	WOS:000361601100061
J	Dikshit, HK; Singh, A; Singh, D; Aski, MS; Prakash, P; Jain, N; Meena, S; Kumar, S; Sarker, A				Dikshit, Harsh Kumar; Singh, Akanksha; Singh, Dharmendra; Aski, Muraleedhar Sidaram; Prakash, Prapti; Jain, Neelu; Meena, Suresh; Kumar, Shiv; Sarker, Ashutosh			Genetic Diversity in Lens Species Revealed by EST and Genomic Simple Sequence Repeat Analysis	PLOS ONE			English	Article							MICROSATELLITE MARKERS; GENOTYPING APPLICATIONS; LINKAGE MAP; SSR-MARKERS; LENTIL; WILD; RAPD; IDENTIFICATION; AFLP; VARIABILITY	Low productivity of pilosae type lentils grown in South Asia is attributed to narrow genetic base of the released cultivars which results in susceptibility to biotic and abiotic stresses. For enhancement of productivity and production, broadening of genetic base is essentially required. The genetic base of released cultivars can be broadened by using diverse types including bold seeded and early maturing lentils from Mediterranean region and related wild species. Genetic diversity in eighty six accessions of three species of genus Lens was assessed based on twelve genomic and thirty one EST-SSR markers. The evaluated set of genotypes included diverse lentil varieties and advanced breeding lines from Indian programme, two early maturing ICARDA lines and five related wild subspecies/species endemic to the Mediterranean region. Genomic SSRs exhibited higher polymorphism in comparison to EST SSRs. GLLC 598 produced 5 alleles with highest gene diversity value of 0.80. Among the studied subspecies/species 43 SSRs detected maximum number of alleles in L. orientalis. Based on Nei's genetic distance cultivated lentil L. culinaris subsp. culinaris was found to be close to its wild progenitor L. culinaris subsp. orientalis. The Prichard's structure of 86 genotypes distinguished different subspecies/species. Higher variability was recorded among individuals within population than among populations.	[Dikshit, Harsh Kumar; Singh, Akanksha; Singh, Dharmendra; Aski, Muraleedhar Sidaram; Prakash, Prapti; Jain, Neelu; Meena, Suresh] Indian Agr Res Inst, Div Genet, New Delhi 110012, India; [Kumar, Shiv] Rabat Inst, INRA Quich, Expt Stn, ICARDA, Rabat, Morocco; [Sarker, Ashutosh] ICARDA, South Asia & China Reg Program, New Delhi 110012, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; CGIAR; International Center for Agricultural Research in the Dry Areas (ICARDA)	Dikshit, HK (corresponding author), Indian Agr Res Inst, Div Genet, New Delhi 110012, India.	harshgeneticsiari@gmail.com		Singh, Akanksha/0000-0001-6480-2641	Harvest Plus Lentil Biofortification project through ICARDA	Harvest Plus Lentil Biofortification project through ICARDA	There was no specific funding for this work. The work was carried out using Institute fund and partial support from Harvest Plus Lentil Biofortification project funded through ICARDA.	ABOELWAFA A, 1995, THEOR APPL GENET, V90, P335, DOI 10.1007/BF00221974; Ahmad M, 1996, THEOR APPL GENET, V93, P788, DOI 10.1007/BF00224077; Alo F, 2011, J HERED, V102, P315, DOI 10.1093/jhered/esr015; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Asghar MJ, 2010, PAK J BOT, V42, P2681; Barulina E.I., 1930, B APPL BOT GENET PL, V40, P265, DOI DOI 10.1023/A:1018306723777; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Bretting PK, 1995, HORTSCIENCE, V30, P1349, DOI 10.21273/HORTSCI.30.7.1349; Choudhary P, 2012, GENET MOL RES, V11, P891, DOI 10.4238/2012.April.10.5; Cubero J. I., 1981, Lentils, P15; Datta S, 2011, CROP SCI, V51, P2412, DOI 10.2135/cropsci2010.12.0743; DELAROSA L, 1992, EUPHYTICA, V59, P181, DOI 10.1007/BF00041271; DELSENY M, 1983, BIOCHEM BIOPH RES CO, V116, P113, DOI 10.1016/0006-291X(83)90388-1; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Egan AN, 2012, AM J BOT, V99, P175, DOI 10.3732/ajb.1200020; Erskine W, 1997, EUPHYTICA, V93, P107, DOI 10.1023/A:1002939704321; ERSKINE W, 1991, THEOR APPL GENET, V83, P119, DOI 10.1007/BF00229234; Erskine W, 1998, EUPHYTICA, V101, P207, DOI 10.1023/A:1018306723777; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Ferguson ME, 2000, BOT J LINN SOC, V133, P41, DOI 10.1111/j.1095-8339.2000.tb01536.x; Ferguson ME, 1998, GENET RESOUR CROP EV, V45, P549, DOI 10.1023/A:1008640201896; Ford R, 1997, EUPHYTICA, V96, P247, DOI 10.1023/A:1003097600701; Gupta D, 2006, GENET RESOUR CROP EV, V53, P1233, DOI 10.1007/s10722-005-2932-y; Gupta S, 2012, PLANT CELL REP, V31, P323, DOI 10.1007/s00299-011-1168-x; Hamwieh A, 2005, THEOR APPL GENET, V110, P669, DOI 10.1007/s00122-004-1892-5; Hamwieh A, 2009, BREEDING SCI, V59, P77, DOI 10.1270/jsbbs.59.77; Harish Kumar, 2014, Australian Journal of Crop Science, V8, P1005; Harlan JR, 1992, CROPS MAN, V2nd; HAVEY MJ, 1989, THEOR APPL GENET, V77, P395, DOI 10.1007/BF00305835; Hu LF, 2011, GENET MOL BIOL, V34, P624, DOI 10.1590/S1415-47572011005000054; Jain N, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200539; Karp A, 1997, NAT BIOTECHNOL, V15, P625, DOI 10.1038/nbt0797-625; Kaur S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-265; Kujur A, 2013, DNA RES, V20, P355, DOI 10.1093/dnares/dst015; Kumar S., 2006, BOTANICA-VILNIUS, V56, P31; Kumari K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067742; Ladizinski D, 1984, BOT GAZ, V145, P235; Lin HS, 2011, INT J MOL SCI, V12, P7835, DOI 10.3390/ijms12117835; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Pandey G, 2013, DNA RES, V20, P197, DOI 10.1093/dnares/dst002; Parida SK, 2006, THEOR APPL GENET, V112, P808, DOI 10.1007/s00122-005-0182-1; Parida SK, 2010, GENOME, V53, P55, DOI [10.1139/G09-084, 10.1139/g09-084]; Parida SK, 2009, THEOR APPL GENET, V118, P327, DOI 10.1007/s00122-008-0902-4; Phillips RL, 2014, PLANT GENET RESOUR-C, V12, pS6, DOI 10.1017/S1479262114000240; Powell W, 1996, MOL BREEDING, V2, P225, DOI 10.1007/BF00564200; Prevost A, 1999, THEOR APPL GENET, V102, P440; Pritchard JK, 2000, GENETICS, V155, P945; Rahman M. M., 2009, The lentil: botany, production and uses, P121, DOI 10.1079/9781845934873.0121; Saha GC, 2010, EUPHYTICA, V175, P261, DOI 10.1007/s10681-010-0187-y; Scott KD, 2000, THEOR APPL GENET, V100, P723, DOI 10.1007/s001220051344; SHARMA SK, 1995, THEOR APPL GENET, V91, P647, DOI 10.1007/BF00223292; Sharma SK, 1996, THEOR APPL GENET, V93, P751, DOI 10.1007/BF00224072; Shi JQ, 2014, DNA RES, V21, P53, DOI 10.1093/dnares/dst040; SINGH BB, 2006, PLANT GENETIC RESOUR, P240; Singh M, 2011, NAT SEM CONT APPR CR, P365; Singh M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107781; Singh M, 2013, PLANT BREEDING, V132, P667, DOI 10.1111/pbr.12089; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; Tewari K, 2012, J PLANT BIOCHEM BIOT, V21, P198, DOI 10.1007/s13562-011-0087-9; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Van Treuen, 2000, MOL MARKETS; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Varshney RK, 2014, PLOS ONE; Verma P, 2014, MOL BIOL REP, V41, P5607, DOI 10.1007/s11033-014-3431-z; Wong MML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122025; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x; Zhang S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-78; Zhao H, 2015, SCI REP, P5	68	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138101	10.1371/journal.pone.0138101	http://dx.doi.org/10.1371/journal.pone.0138101			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381889	gold, Green Published, Green Submitted			2022-12-27	WOS:000361790200057
J	Chen, JC; Liu, JH; Hsu, DW; Shu, JC; Chen, CY; Chen, CC				Chen, Jung-Chi; Liu, Jyung-Hurng; Hsu, Duen-Wei; Shu, Jwu-Ching; Chen, Chien-Yen; Chen, Chien-Cheng			Methylatable Signaling Helix Coordinated Inhibitory Receiver Domain in Sensor Kinase Modulates Environmental Stress Response in Bacillus Cereus	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; SIGMA(B) TRANSCRIPTION FACTOR; ESCHERICHIA-COLI ASPARTATE; HISTIDINE KINASE; AGROBACTERIUM-TUMEFACIENS; STREPTOMYCES-COELICOLOR; ENERGY STRESS; CHEMOTAXIS RECEPTORS; CONSERVED ASPARTATE; CYTOPLASMIC DOMAIN	sigma(B), an alternative transcription factor, controls the response of the cell to a variety of environmental stresses in Bacillus cereus. Previously, we reported that RsbM negatively regulates al3 through the methylation of RsbK, a hybrid sensor kinase, on a signaling helix (S-helix). However, RsbK comprises a C-terminal receiver (REC) domain whose function remains unclear. In this study, deletion of the C-terminal REC domain of RsbK resulted in high constitutive al3 expression independent of environmental stimuli. Thus, the REC domain may serve as an inhibitory element. Mutagenic substitution was employed to modify the putative phospho-acceptor residue D827 in the REC domain of RsbK. The expression of R5bKD827N and R5bKD827E exhibited high constitutive sigma(B), indicating that D827, if phosphorylatable, possibly participates in sigma(B) regulation. Bacterial two-hybrid analyses demonstrated that RsbK forms a homodimer and the REC domain interacts mainly with the histidine kinase (HK) domain and partly with the S-helix. In particular, co-expression of RsbM strengthens the interaction between the REC domain and the S-helix. Consistently, our structural model predicts a significant interaction between the HK and REC domains of the RsbK intradimer. Here, we demonstrated that coordinated the methylatable S-helix and the REC domain of RsbK is functionally required to modulate sigma(B)-mediated stress response in B. cereus and maybe ubiquitous in microorganisms encoded RsbK-type sensor kinases.	[Chen, Jung-Chi; Hsu, Duen-Wei; Chen, Chien-Cheng] Natl Kaohsiung Normal Univ, Dept Biotechnol, Kaohsiung, Taiwan; [Liu, Jyung-Hurng] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan; [Liu, Jyung-Hurng] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan; [Shu, Jwu-Ching] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan; [Chen, Chien-Yen] Natl Chung Cheng Univ, Dept Earth & Environm Sci, Chiayi, Taiwan	National Kaohsiung Normal University; National Chung Hsing University; National Chung Hsing University; Chang Gung University; National Chung Cheng University	Chen, CC (corresponding author), Natl Kaohsiung Normal Univ, Dept Biotechnol, Kaohsiung, Taiwan.	cheng@nknu.edu.tw	Liu, Jyung-Hurng/C-1340-2010; chen, chien-yen/E-6101-2013	Liu, Jyung-Hurng/0000-0002-7173-0372; chen, chien-yen/0000-0003-1130-669X	Ministry of Science and Technology of Taiwan [NSC 102-2320-B-017-001-MY3]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by a grant of the Ministry of Science and Technology of Taiwan (NSC 102-2320-B-017-001-MY3), (http://www.most.gov.tw/).	Alper S, 1996, J MOL BIOL, V260, P165, DOI 10.1006/jmbi.1996.0390; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anantharaman V, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-25; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bijisma JJE, 2003, TRENDS MICROBIOL, V11, P359, DOI 10.1016/S0966-842X(03)00176-8; Brody MS, 2009, MOL MICROBIOL, V72, P1221, DOI 10.1111/j.1365-2958.2009.06722.x; Brody MS, 2001, J BACTERIOL, V183, P6422, DOI 10.1128/JB.183.21.6422-6428.2001; Casino P, 2012, TWO-COMPONENT SYSTEMS IN BACTERIA, P21; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; CHANG CH, 1992, J BACTERIOL, V174, P7033, DOI 10.1128/JB.174.21.7033-7039.1992; Chaturongakul S, 2008, TRENDS MICROBIOL, V16, P388, DOI 10.1016/j.tim.2008.05.006; Chen LC, 2012, ENVIRON MICROBIOL, V14, P2788, DOI 10.1111/j.1462-2920.2012.02788.x; Cho YH, 2001, MOL MICROBIOL, V42, P205, DOI 10.1046/j.1365-2958.2001.02622.x; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cochran AG, 1996, SCIENCE, V271, P1113, DOI 10.1126/science.271.5252.1113; de Been M, 2011, MICROBIOL-SGM, V157, P3, DOI 10.1099/mic.0.045740-0; de Been M, 2010, ENVIRON MICROBIOL, V12, P730, DOI 10.1111/j.1462-2920.2009.02116.x; Diaz AR, 2008, J BIOL CHEM, V283, P2962, DOI 10.1074/jbc.M709032200; Diensthuber RP, 2013, STRUCTURE, V21, P1127, DOI 10.1016/j.str.2013.04.024; DUFOUR A, 1994, J BACTERIOL, V176, P1813, DOI 10.1128/jb.176.7.1813-1820.1994; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferris HU, 2014, J STRUCT BIOL, V186, P349, DOI 10.1016/j.jsb.2014.03.015; Ferris HU, 2014, J STRUCT BIOL, V186, P376, DOI 10.1016/j.jsb.2014.03.014; Ferris HU, 2012, STRUCTURE, V20, P56, DOI 10.1016/j.str.2011.11.014; Ferris HU, 2011, STRUCTURE, V19, P378, DOI 10.1016/j.str.2011.01.006; Fouet A, 2000, J BACTERIOL, V182, P5036, DOI 10.1128/JB.182.18.5036-5045.2000; Gao R, 2007, J BACTERIOL, V189, P6048, DOI 10.1128/JB.00459-07; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoch A. L., 1995, 2 COMPONENT SIGNAL T; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; HUANG JZ, 1993, J BACTERIOL, V175, P6169, DOI 10.1128/JB.175.19.6169-6178.1993; Inclan YF, 2008, MOL MICROBIOL, V68, P1328, DOI 10.1111/j.1365-2958.2008.06238.x; IUCHI S, 1993, J BIOL CHEM, V268, P23972; KALMAN S, 1990, J BACTERIOL, V172, P5575, DOI 10.1128/jb.172.10.5575-5585.1990; Kanchan K, 2010, J BIOL CHEM, V285, P2090, DOI 10.1074/jbc.M109.051698; Kanoksilapatham W, 2007, SILPAKORN U SCI TECH, V1; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Keilberg D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002951; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim KK, 1999, NATURE, V400, P787, DOI 10.1038/23512; Kim SH, 2002, P NATL ACAD SCI USA, V99, P11611, DOI 10.1073/pnas.132376499; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee EJ, 2005, MOL MICROBIOL, V57, P1252, DOI 10.1111/j.1365-2958.2005.04761.x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lin YH, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00195; Marles-Wright J, 2008, SCIENCE, V322, P92, DOI 10.1126/science.1159572; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; McCullen CA, 2006, ANNU REV CELL DEV BI, V22, P101, DOI 10.1146/annurev.cellbio.22.011105.102022; Mittenhuber G, 2002, J MOL MICROB BIOTECH, V4, P427; Mondejar LG, 2012, J BIOL CHEM, V287, P1022, DOI 10.1074/jbc.M111.284067; Novick RP, 2003, PLASMID, V49, P93, DOI 10.1016/S0147-619X(02)00157-9; PAN SQ, 1993, P NATL ACAD SCI USA, V90, P9939, DOI 10.1073/pnas.90.21.9939; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Storz G, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P157; Thomas SA, 2008, MOL MICROBIOL, V69, P453, DOI 10.1111/j.1365-2958.2008.06296.x; Vijay K, 2000, MOL MICROBIOL, V35, P180, DOI 10.1046/j.1365-2958.2000.01697.x; Viollier PH, 2003, MOL MICROBIOL, V47, P699, DOI 10.1046/j.1365-2958.2003.03302.x; WISE AA, 1995, J BACTERIOL, V177, P123, DOI 10.1128/jb.177.1.123-133.1995; Yang XF, 1996, GENE DEV, V10, P2265, DOI 10.1101/gad.10.18.2265	65	3	3	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137952	10.1371/journal.pone.0137952	http://dx.doi.org/10.1371/journal.pone.0137952			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379238	Green Published, Green Submitted, gold			2022-12-27	WOS:000361769400039
J	Dodge, HH; Zhu, J; Mattek, NC; Austin, D; Kornfeld, J; Kaye, JA				Dodge, Hiroko H.; Zhu, Jian; Mattek, Nora C.; Austin, Daniel; Kornfeld, Judith; Kaye, Jeffrey A.			Use of High-Frequency In-Home Monitoring Data May Reduce Sample Sizes Needed in Clinical Trials	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; BIOMARKER; VARIABILITY; DECLINE; WALKING	Background Trials in Alzheimer's disease are increasingly focusing on prevention in asymptomatic individuals. This poses a challenge in examining treatment effects since currently available approaches are often unable to detect cognitive and functional changes among asymptomatic individuals. Resultant small effect sizes require large sample sizes using biomarkers or secondary measures for randomized controlled trials (RCTs). Better assessment approaches and outcomes capable of capturing subtle changes during asymptomatic disease stages are needed. Objective We aimed to develop a new approach to track changes in functional outcomes by using individual-specific distributions (as opposed to group-norms) of unobtrusive continuously monitored in-home data. Our objective was to compare sample sizes required to achieve sufficient power to detect prevention trial effects in trajectories of outcomes in two scenarios: (1) annually assessed neuropsychological test scores (a conventional approach), and (2) the likelihood of having subject-specific low performance thresholds, both modeled as a function of time. Methods One hundred nineteen cognitively intact subjects were enrolled and followed over 3 years in the Intelligent Systems for Assessing Aging Change (ISAAC) study. Using the difference in empirically identified time slopes between those who remained cognitively intact during follow- up (normal control, NC) and those who transitioned to mild cognitive impairment (MCI), we estimated comparative sample sizes required to achieve up to 80% statistical power over a range of effect sizes for detecting reductions in the difference in time slopes between NC and MCI incidence before transition. Results Sample size estimates indicated approximately 2000 subjects with a follow-up duration of 4 years would be needed to achieve a 30% effect size when the outcome is an annually assessed memory test score. When the outcome is likelihood of low walking speed defined using the individual-specific distributions of walking speed collected at baseline, 262 subjects are required. Similarly for computer use, 26 subjects are required. Conclusions Individual-specific thresholds of low functional performance based on high-frequency in-home monitoring data distinguish trajectories of MCI from NC and could substantially reduce sample sizes needed in dementia prevention RCTs.	[Dodge, Hiroko H.; Mattek, Nora C.; Austin, Daniel; Kornfeld, Judith; Kaye, Jeffrey A.] Oregon Hlth & Sci Univ, Dept Neurol, Layton Aging & Alzheimers Dis Ctr, Portland, OR 97201 USA; [Dodge, Hiroko H.; Mattek, Nora C.; Austin, Daniel; Kornfeld, Judith; Kaye, Jeffrey A.] Oregon Hlth & Sci Univ, Oregon Ctr Aging & Technol ORCATECH, Portland, OR 97201 USA; [Dodge, Hiroko H.] Univ Michigan, Dept Neurol, Michigan Alzheimers Dis Ctr, Ann Arbor, MI USA; [Zhu, Jian] Univ Michigan, Grad Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Kaye, Jeffrey A.] Portland Vet Med Ctr, Portland, OR USA	Oregon Health & Science University; Oregon Health & Science University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Dodge, HH (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, Layton Aging & Alzheimers Dis Ctr, Portland, OR 97201 USA.	hdodge@med.umich.edu			National Institutes of Health, USA [P30-AG024978, R01-AG024059, P30-AG008017, R01-AG033581]; NATIONAL INSTITUTE ON AGING [P30AG008017, R01AG033581, R01AG024059, P30AG024978] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from the National Institutes of Health, USA (P30-AG024978 (JAK), R01-AG024059 (JAK), P30-AG008017 (JAK, HHD), and R01-AG033581 (HHD)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisen PS, 2011, NEUROLOGY, V76, P280, DOI 10.1212/WNL.0b013e318207b1b9; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Ard MC, 2011, J ALZHEIMERS DIS, V26, P369, DOI 10.3233/JAD-2011-0062; Buracchio T, 2010, ARCH NEUROL-CHICAGO, V67, P980, DOI 10.1001/archneurol.2010.159; Camicioli R, 1998, NEUROLOGY, V50, P1496, DOI 10.1212/WNL.50.5.1496; Camicioli R, 1997, NEUROLOGY, V48, P955, DOI 10.1212/WNL.48.4.955; Caroli A, 2015, ALZ DIS ASSOC DIS, V29, P101, DOI 10.1097/WAD.0000000000000071; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Dodge HH, 2012, NEUROLOGY, V78, P1946, DOI 10.1212/WNL.0b013e318259e1de; Dodge HH, 2015, CURR ALZHEIMER RES, V12, P513, DOI 10.2174/1567205012666150530201917; Dodge HH, 2014, ALZHEIMERS DEMENT, V10, P690, DOI 10.1016/j.jalz.2014.04.513; Donohue MC, 2014, JAMA NEUROL, V71, P961, DOI 10.1001/jamaneurol.2014.803; Dorsey ER, 2015, JAMA NEUROL, V72, P582, DOI 10.1001/jamaneurol.2014.4524; Fischer J.S., 2012, NEUROPSYCHOLOGICAL A, V5th; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goodglass H., 1983, BOSTON NAMING TEST; Grill JD, 2013, NEUROBIOL AGING, V34, P62, DOI 10.1016/j.neurobiolaging.2012.03.006; Hagler S, 2010, IEEE T BIO-MED ENG, V57, P813, DOI 10.1109/TBME.2009.2036732; Hayes TL, 2008, ALZHEIMERS DEMENT, V4, P395, DOI 10.1016/j.jalz.2008.07.004; Hayes TL, 2014, ALZ DIS ASSOC DIS, V28, P145, DOI 10.1097/WAD.0000000000000010; Hayes TL, 2009, J AGING HEALTH, V21, P567, DOI 10.1177/0898264309332836; Katz Russell, 2004, NeuroRx, V1, P189, DOI 10.1602/neurorx.1.2.189; Kaye J, 2014, ALZHEIMERS DEMENT, V10, P10, DOI 10.1016/j.jalz.2013.01.011; Kaye JA, 2011, J GERONTOL B-PSYCHOL, V66, P180, DOI [10.1093/geronb/ghq095, 10.1093/geronb/gbq095]; Leoutsakos JMS, 2014, ALZHEIMERS DEMENT, V10, P152, DOI 10.1016/j.jalz.2013.05.1776; Lyons BE, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00102; Mills SM, 2013, REV NEUROL-FRANCE, V169, P737, DOI 10.1016/j.neurol.2013.07.017; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Petersen J, 2014, IEEE J BIOMED HEALTH, V18, P1590, DOI 10.1109/JBHI.2013.2294276; Reiman EM, 2011, J ALZHEIMERS DIS, V26, P321, DOI 10.3233/JAD-2011-0059; REITAN RM, 1985, PERCEPT MOTOR SKILL, V60, P271; Rowe CC, 2010, NEUROBIOL AGING, V31, P1275, DOI 10.1016/j.neurobiolaging.2010.04.007; Schneider LS, 2010, ALZHEIMERS DEMENT, V6, P367, DOI 10.1016/j.jalz.2010.07.004; Sperling RA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007941; Thielke SM, 2014, J AM GERIATR SOC, V62, P685, DOI 10.1111/jgs.12744; Vellas B, 2015, J Prev Alzheimers Dis, V2, P128; Verghese J, 2008, J AM GERIATR SOC, V56, P1244, DOI 10.1111/j.1532-5415.2008.01758.x; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Yi QL, 2002, CONTROL CLIN TRIALS, V23, P481, DOI 10.1016/S0197-2456(02)00223-4	41	46	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138095	10.1371/journal.pone.0138095	http://dx.doi.org/10.1371/journal.pone.0138095			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0RH	26379170	gold, Green Submitted, Green Published			2022-12-27	WOS:000361769400052
J	Eiriksdottir, VH; Valdimarsdottir, UA; Asgeirsdottir, TL; Hauksottir, A; Lund, SH; Bjarnadottir, RI; Cnattingius, S; Zoega, H				Eiriksdottir, Vedis Helga; Valdimarsdottir, Unnur Anna; Asgeirsdottir, Tinna Laufey; Hauksdottir, Arna; Lund, Sigrun Helga; Bjarnadottir, Ragnheidur Ingibjorg; Cnattingius, Sven; Zoega, Helga			Pregnancy-Induced Hypertensive Disorders before and after a National Economic Collapse: A Population Based Cohort Study	PLOS ONE			English	Article							GESTATIONAL HYPERTENSION; PSYCHOSOCIAL STRESS; BUSINESS CYCLES; BIRTH-WEIGHT; RISK-FACTORS; PREECLAMPSIA; MORTALITY; HEALTH; WOMEN; MORBIDITY	Background Data on the potential influence of macroeconomic recessions on maternal diseases during pregnancy are scarce. We aimed to assess potential change in prevalence of pregnancy-induced hypertensive disorders (preeclampsia and gestational hypertension) during the first years of the major national economic recession in Iceland, which started abruptly in October 2008. Methods and Findings Women whose pregnancies resulted in live singleton births in Iceland in 2005-2012 constituted the study population (N = 35,211). Data on pregnancy-induced hypertensive disorders were obtained from the Icelandic Medical Birth Register and use of antihypertensive drugs during pregnancy, including beta-blockers and calcium channel blockers, from the Icelandic Medicines Register. With the pre-collapse period as reference, we used logistic regression analysis to assess change in pregnancy-induced hypertensive disorders and use of antihy-pertensives during the first four years after the economic collapse, adjusting for demographic and pregnancy characteristics, taking aggregate economic indicators into account. Compared with the pre-collapse period, we observed an increased prevalence of gestational hypertension in the first year following the economic collapse (2.4% vs. 3.9%; adjusted odds ratio [aOR] 1.47; 95 percent confidence interval [95% CI] 1.13-1.91) but not in the subsequent years. The association disappeared completely when we adjusted for aggregate unemployment rate (aOR 1.04; 95% CI 0.74-1.47). Similarly, there was an increase in prescription fills of beta-blockers in the first year following the collapse (1.9% vs. 3.1%; aOR 1.43; 95% CI 1.07-1.90), which disappeared after adjusting for aggregate unemployment rate (aOR 1.05; 95% CI 0.72-1.54). No changes were observed for preeclampsia or use of calcium channel blockers between the pre- and post-collapse periods. Conclusions Our data suggest a transient increased risk of gestational hypertension and use of beta-blockers among pregnant women in Iceland in the first and most severe year of the national economic recession.	[Eiriksdottir, Vedis Helga; Valdimarsdottir, Unnur Anna; Hauksdottir, Arna; Lund, Sigrun Helga; Zoega, Helga] Univ Iceland, Fac Med, Ctr Publ Hlth Sci, Reykjavik, Iceland; [Valdimarsdottir, Unnur Anna] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Asgeirsdottir, Tinna Laufey] Univ Iceland, Fac Econ, Reykjavik, Iceland; [Bjarnadottir, Ragnheidur Ingibjorg] Landspitali Univ Hosp, Dept Obstet & Gynecol, Reykjavik, Iceland; [Cnattingius, Sven] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden	University of Iceland; Harvard University; Harvard T.H. Chan School of Public Health; University of Iceland; Landspitali National University Hospital; Karolinska Institutet	Eiriksdottir, VH (corresponding author), Univ Iceland, Fac Med, Ctr Publ Hlth Sci, Reykjavik, Iceland.	vhe2@hi.is	Eiriksdottir, Vedis/M-1964-2015; Lund, Sigrún Helga/AAG-6042-2019; Zoega, Helga/M-1968-2015; Lund, Sigrun Helga/K-9144-2015	Lund, Sigrún Helga/0000-0002-3806-2296; Lund, Sigrun Helga/0000-0002-3806-2296; Valdimarsdottir, Unnur/0000-0001-5382-946X; Hauksdottir, Arna/0000-0002-4253-1059	RANNIS [120452023]	RANNIS	This work was supported by RANNIS grant number: 120452023, http://en.rannis.is/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananth CV, 2014, SEMIN PERINATOL, V38, P151, DOI 10.1053/j.semperi.2014.03.007; Asgeirsdottir TL, 2014, BLOOD PRESSURE, V23, P213, DOI 10.3109/08037051.2013.862913; Asgeirsdottir TL, 2014, ECON HUM BIOL, V13, P1, DOI 10.1016/j.ehb.2013.03.005; Benediktsdottir S, 2011, ECON POLICY, P183, DOI 10.1111/j.1468-0327.2011.00260.x; Cardwell MS, 2013, OBSTET GYNECOL SURV, V68, P119, DOI 10.1097/OGX.0b013e31827f2481; Clarke HM, 2013, THESIS U ICELAND; Clausen T, 2006, ACTA OBSTET GYN SCAN, V85, P526, DOI 10.1080/00016340500523644; Cruces G, 2012, WORLD DEV, V40, P303, DOI 10.1016/j.worlddev.2011.07.014; Directorate of Health, 2014, LYFJ; Directorate of Health Icelandic Food and Veterinary Authority Unit for Nutrition Research, 2011, DIET IC RES NAT NUTR; Economou A, 2008, J ECON STUD, V35, P368, DOI 10.1108/01443580810903536; Eiriksdottir VH, 2015, EUR J PUBLIC HEALTH, V25, P638, DOI 10.1093/eurpub/ckv047; Eiriksdottir VH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080499; Gerdtham UG, 2005, SOC SCI MED, V60, P205, DOI 10.1016/j.socscimed.2004.05.004; Granados JAT, 2011, EUR J POPUL, V27, P157, DOI 10.1007/s10680-011-9231-4; Guojonsdottir GR, 2012, EMERG MED J, V29, P694, DOI 10.1136/emermed-2011-200518; Haelterman E, 2003, EUR J OBSTET GYN R B, V111, P25, DOI 10.1016/S0301-2115(03)00161-1; Hauksdottir A, 2013, AM J EPIDEMIOL, V177, P979, DOI 10.1093/aje/kws347; Hutcheon JA, 2011, BEST PRACT RES CL OB, V25, P391, DOI 10.1016/j.bpobgyn.2011.01.006; KlonoffCohen HS, 1996, EPIDEMIOLOGY, V7, P245, DOI 10.1097/00001648-199605000-00005; Kramer MS, 2000, PAEDIATR PERINAT EP, V14, P194, DOI 10.1046/j.1365-3016.2000.00266.x; Kuklina EV, 2009, OBSTET GYNECOL, V113, P1299, DOI 10.1097/AOG.0b013e3181a45b25; Kurki T, 2000, OBSTET GYNECOL, V95, P487, DOI 10.1016/S0029-7844(99)00602-X; Landsbergis PA, 1996, EPIDEMIOLOGY, V7, P346, DOI 10.1097/00001648-199607000-00002; Laszlo KD, 2013, HYPERTENSION, V62, P183, DOI 10.1161/HYPERTENSIONAHA.111.00550; Leeners B, 2007, HYPERTENS PREGNANCY, V26, P211, DOI 10.1080/10641950701274870; McClure C, 2014, THESIS U ICELAND REY; National Institute for Health and Clinical Excellence: Guidance, 2010, HYP PREGN MAN HYP DI; Neumayer E, 2004, SOC SCI MED, V58, P1037, DOI 10.1016/S0277-9536(03)00276-4; Olafsdottir T, 2015, EUR J HEALTH ECON, V16, P391, DOI 10.1007/s10198-014-0580-x; Park CL, 2014, ANXIETY STRESS COPIN, V27, P123, DOI 10.1080/10615806.2013.860969; Qiu C., 2007, BMC WOMENS HEALTH, V7, DOI [10.1186/1472-6874-7-15, DOI 10.1186/1472-6874-7-15]; Raisanen S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004883; Rogers I, 1998, EUR J CLIN NUTR, V52, P251, DOI 10.1038/sj.ejcn.1600544; Ruhm CJ, 2007, DEMOGRAPHY, V44, P829, DOI 10.1007/BF03208384; Ruhm CJ, 2000, Q J ECON, V115, P617, DOI 10.1162/003355300554872; Shamsi U, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-14; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Silva LM, 2008, J HUM HYPERTENS, V22, P483, DOI 10.1038/jhh.2008.22; Silva LM, 2008, J HYPERTENS, V26, P1200, DOI 10.1097/HJH.0b013e3282fcc36e; Statistic Iceland, NAT ACC PUBL FIN 201; Stuckler D, 2008, GLOBALIZATION HEALTH, V4, DOI 10.1186/1744-8603-4-1; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Tanaka M, 2007, AM J PUBLIC HEALTH, V97, P163, DOI 10.2105/AJPH.2005.068577; Torche F, 2012, HUM REPROD, V27, P558, DOI 10.1093/humrep/der390; Villar J, 2006, AM J OBSTET GYNECOL, V194, P921, DOI 10.1016/j.ajog.2005.10.813; Vollebregt KC, 2008, BJOG-INT J OBSTET GY, V115, P607, DOI 10.1111/j.1471-0528.2008.01665.x; World Health Organization, GLOB DAT BOD MASS IN	48	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138534	10.1371/journal.pone.0138534	http://dx.doi.org/10.1371/journal.pone.0138534			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0RH	26379126	Green Published, Green Submitted, gold			2022-12-27	WOS:000361769400108
J	Ionescu-Tirgoviste, C; Gagniuc, PA; Guja, C				Ionescu-Tirgoviste, Constantin; Gagniuc, Paul Aurelian; Guja, Cristian			Structural Properties of Gene Promoters Highlight More than Two Phenotypes of Diabetes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ISLET-CELL ANTIBODIES; HL-A ANTIGENS; INSULIN-RESISTANCE; DNA METHYLATION; VARIABLE NUMBER; RISK LOCI; TYPE-1; LATENT; ADULTS	Genome-wide association studies (GWAS) published in the last decade raised the number of loci associated with type 1 (Ti D) and type 2 diabetes (T2D) to more than 50 for each of these diabetes phenotypes. The environmental factors seem to play an important role in the expression of these genes, acting through transcription factors that bind to promoters. Using the available databases we examined the promoters of various genes classically associated with the two main diabetes phenotypes. Our comparative analyses have revealed significant architectural differences between promoters of genes classically associated with T1D and T2D. Nevertheless, five gene promoters (about 16%) belonging to T1D and six gene promoters (over 19%) belonging to T2D have shown some intermediary structural properties, suggesting a direct relationship to either LADA (Latent Autoimmune Diabetes in Adults) phenotype or to non-autoimmune type 1 phenotype. The distribution of these promoters in at least three separate classes seems to indicate specific pathogenic pathways. The image-based patterns (DNA patterns) generated by promoters of genes associated with these three phenotypes support the clinical observation of a smooth link between specific cases of typical T1D and T2D. In addition, a global distribution of these DNA patterns suggests that promoters of genes associated with T1D appear to be evolutionary more conserved than those associated with T2D. Though, the image based patterns obtained by our method might be a new useful parameter for understanding the pathogenetic mechanism and the diabetogenic gene networks.	[Ionescu-Tirgoviste, Constantin; Gagniuc, Paul Aurelian; Guja, Cristian] Natl Inst Diabet Nutr & Metab Dis NC Paulescu, Bucharest, Romania; [Gagniuc, Paul Aurelian] Natl Inst Pathol Victor Babes, Bucharest, Romania; [Gagniuc, Paul Aurelian] Univ Bucharest, Dept Genet, Bucharest, Romania	Victor Babes National Institute of Pathology; University of Bucharest	Gagniuc, PA (corresponding author), Natl Inst Diabet Nutr & Metab Dis NC Paulescu, Bucharest, Romania.	pad_gagniuc@acad.ro	Guja, Cristian/K-2334-2019; Gagniuc, Paul A./AAK-3630-2020		postdoctoral program "CERO-Career profile: Romanian Researcher" [POSDRU/159/1.5/S/135760]; European Social Fund for Sectoral Operational Programme Human Resources Development	postdoctoral program "CERO-Career profile: Romanian Researcher"; European Social Fund for Sectoral Operational Programme Human Resources Development	This work was supported by the postdoctoral program "CERO-Career profile: Romanian Researcher", grant number POSDRU/159/1.5/S/135760, cofinanced by the European Social Fund for Sectoral Operational Programme Human Resources Development 2007-2013.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Barratt BJ, 2004, DIABETES, V53, P1884, DOI 10.2337/diabetes.53.7.1884; Billings LK, 2010, ANN NY ACAD SCI, V1212, P59, DOI 10.1111/j.1749-6632.2010.05838.x; BOTTAZZO GF, 1974, LANCET, V2, P1279, DOI 10.1016/S0140-6736(74)90140-8; Cervin C, 2008, DIABETES, V57, P1433, DOI 10.2337/db07-0299; Cleland SJ, 2013, DIABETOLOGIA, V56, P1462, DOI 10.1007/s00125-013-2904-2; Concannon P, 2009, NEW ENGL J MED, V360, P1646, DOI 10.1056/NEJMra0808284; Dayeh TA, 2013, DIABETOLOGIA, V56, P1036, DOI 10.1007/s00125-012-2815-7; Desai M, 2006, DIABETES, V55, P1890, DOI 10.2337/db06-0089; Djekic K, 2012, J CLIN ENDOCR METAB, V97, pE409, DOI 10.1210/jc.2011-2544; Eftychi C, 2004, DIABETES, V53, P870, DOI 10.2337/diabetes.53.3.870; Ellard S, 2013, DIABETOLOGIA, V56, P1958, DOI 10.1007/s00125-013-2962-5; Fourlanos S, 2005, DIABETOLOGIA, V48, P2206, DOI 10.1007/s00125-005-1960-7; Franks PW, 2013, DIABETES CARE, V36, P1413, DOI 10.2337/dc12-2211; Gagniuc P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-278; Gagniuc P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-512; Gagniuc P, 2012, REV ROUM SCI TECH-EL, V57, P100; Gale EAM, 2005, DIABETOLOGIA, V48, P2195, DOI 10.1007/s00125-005-1954-5; Grant RW, 2013, DIABETES CARE, V36, P13, DOI 10.2337/dc12-0884; GROOP LC, 1986, DIABETES, V35, P237, DOI 10.2337/diabetes.35.2.237; GROOP LC, 1991, DIABETOLOGIA, V34, P46, DOI 10.1007/BF00404024; Guja C, 2012, P ROMANIAN ACAD S B, V1, P44; Hanafusa T, 2007, NAT CLIN PRACT ENDOC, V3, P36, DOI 10.1038/ncpendmet0351; Huxtable SJ, 2000, DIABETES, V49, P126, DOI 10.2337/diabetes.49.1.126; Ionescu-Tirgoviste C, 2011, ACTA ENDOCRINOL-BUCH, V7, P123, DOI 10.4183/aeb.2011.123; Juneja R, 1999, AUTOIMMUNITY, V29, P65, DOI 10.3109/08916939908995974; Keene KL, 2012, GENES IMMUN, V13, P66, DOI 10.1038/gene.2011.56; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Lancereaux, 1877, B ACAD MED, V6, P1215; Lancereaux E, 1883, LECONS CLIN MED, P5; Lango H, 2008, DIABETES, V57, P3129, DOI 10.2337/db08-0504; Lecompte S, 2013, DIABETES, V62, P1738, DOI 10.2337/db12-0864; LESLIE RDG, 1994, DIABETES CARE, V17, P1214, DOI 10.2337/diacare.17.10.1214; Lin J, 2008, ANN NY ACAD SCI, V1150, P99, DOI 10.1196/annals.1447.036; Lohmann T, 2000, DIABETES CARE, V23, P1707, DOI 10.2337/diacare.23.11.1707; Meigs JB, 2009, DIABETOLOGIA, V52, P568, DOI 10.1007/s00125-009-1296-9; Mincu I, 1975, Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna, V27, P403; Naik RG, 2009, J CLIN ENDOCR METAB, V94, P4635, DOI 10.1210/jc.2009-1120; NERUP J, 1974, LANCET, V2, P864; Palmer JP, 2003, DIABETES CARE, V26, P536, DOI 10.2337/diacare.26.2.536; Pettersen E, 2010, DIABETES, V59, P302, DOI 10.2337/db09-0923; Pozzilli P, 2001, DIABETES CARE, V24, P1460, DOI 10.2337/diacare.24.8.1460; Raj SM, 2009, DIABETOLOGIA, V52, P2109, DOI 10.1007/s00125-009-1391-y; Redondo MJ, 2013, DIABETES, V62, P339, DOI 10.2337/db12-1171; Saxena R, 2013, DIABETES, V62, P1746, DOI 10.2337/db12-1077; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; SINGAL DP, 1973, DIABETES, V22, P429, DOI 10.2337/diab.22.6.429; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; TEUPE B, 1991, LANCET, V337, P361, DOI 10.1016/0140-6736(91)90988-2; Tsai PC, 2012, EPIGENOMICS-UK, V4, P511, DOI [10.2217/EPI.12.45, 10.2217/epi.12.45]; TUOMI T, 1993, DIABETES, V42, P359, DOI 10.2337/diabetes.42.2.359; van Hoek M, 2008, DIABETES, V57, P3122, DOI 10.2337/db08-0425; Vaxillaire M, 2008, ENDOCR REV, V29, P254, DOI 10.1210/er.2007-0024; Wang J, 2007, DIABETOLOGIA, V50, P1192, DOI 10.1007/s00125-007-0656-6; Wang JF, 2005, DEV BIOL, V286, P182, DOI 10.1016/j.ydbio.2005.07.021; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	59	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137950	10.1371/journal.pone.0137950	http://dx.doi.org/10.1371/journal.pone.0137950			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379145	Green Published, Green Submitted, gold			2022-12-27	WOS:000361769400038
J	Kienstra, N; Imants, J; Karskens, M; van der Heijden, PGM				Kienstra, Natascha; Imants, Jeroen; Karskens, Machiel; van der Heijden, Peter G. M.			Doing Philosophy Effectively: Student Learning in Classroom Teaching	PLOS ONE			English	Article								An important aim of teaching philosophy in Dutch secondary schools is to learn about philosophy (i.e., the great philosophers) by doing philosophy. We examined doing philosophy and focused specifically on the relationship between student learning activities and teacher behavior; in doing so, a qualitative cross-case analysis of eight philosophy lessons was performed. The effectiveness of doing philosophy was operationalized into five learning activities comprising rationalizing, analyzing, testing, producing criticism, and reflecting, and scored by means of qualitative graphical time registration. Using CA we find a quantitative one-dimensional scale for the lessons that contrasts lessons that are more and less effective in terms of learning and teaching. A relationship was found between teaching by teachers and doing philosophy by students. In particular we found students to produce a higher level of doing philosophy with teachers who chose to organize a philosophical discussion with shared guidance by the teacher together with the students.	[Kienstra, Natascha; Imants, Jeroen] Radboud Univ Nijmegen, Grad Sch Educ, NL-6525 ED Nijmegen, Netherlands; [Karskens, Machiel] Radboud Univ Nijmegen, Dept Philosophy, NL-6525 ED Nijmegen, Netherlands; [van der Heijden, Peter G. M.] Univ Utrecht, Dept Methodol & Stat, Utrecht, Netherlands; [van der Heijden, Peter G. M.] Univ Southampton, S3RI, Southampton, Hants, England	Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; University of Southampton	Kienstra, N (corresponding author), Radboud Univ Nijmegen, Grad Sch Educ, NL-6525 ED Nijmegen, Netherlands.	n.kienstra@docentenacademie.ru.nl		Kienstra, Natascha/0000-0002-5458-9194; van der Heijden, Peter/0000-0002-3345-096X				[Anonymous], 2010, VAKDOSSIER FILOSOFIE; Bruning B, 2003, PHILOS SEKUNDARSTUFE; Cerbin W., 2006, INT J TEACHING LEARN, V18, P250; Coenders F, 2010, J SCI TEACH EDUC, V21, P535, DOI 10.1007/s10972-010-9194-z; CvE (College voor Examens), 2014, SYLL FIL HAV 2015; CvE (College voor Examens), 2013, SYLL FIL VWO 2015; Denzin N.K., 2008, LANDSCAPE QUALITATIV; Duffy T. M., 1996, HDB RES ED COMMUNICA; Fernandez ML, 2010, TEACH TEACH EDUC, V26, P351, DOI 10.1016/j.tate.2009.09.012; Fullan M, 2007, 6 SECRETS CHANGE; Gifi A., 1990, NONLINEAR MULTIVARIA; Glaser R., 1991, LEARN INSTR, V1, P129, DOI [10.1016/0959-4752(91)90023-2, DOI 10.1016/0959-4752(91)90023-2]; Greenacre M., 2007, CORRES ANAL PRACTICE; Imants J., 2010, BETER LEREN DOOR LEI; Imants J., 2009, LEREN DENKEN SCHOOLV; Karskens M, 2008, FILOSOFIE VWO SYLLAB; Karskens M, 2006, FILOSOFIE PRAKTIJK, V27, P10; Kessels J, 1989, KENNIS KENNIS ONTWIK; Kienstra N, 2014, TYDSKR GEESTESWET, V54, P787; Kienstra N, 2014, METAPHILOSOPHY, V45, P288, DOI 10.1111/meta.12085; Knezic D, 2010, TEACH TEACH EDUC, V26, P1104, DOI 10.1016/j.tate.2009.11.006; Martens E, 2000, SPELEN MET DENKEN FI; McCall C., 2009, TRANSFORMING THINKIN; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Nieveen, 2009, INTRO ED DESIGN RES; Oakeshott, 1991, HUMAN CONDUCT; Oolbekkink-Marchand HW, 2007, PEDAGOG STUD, V84, P293; Perkins D., 1992, SMART SCH BETTER THI; Rondhuis T, 2005, PHILOS TALENT EMPIRI; St. Edward's University Center for Teaching Excellence, 2004, BLOOMS TASK OR QUEST; Thijs A., 2009, LEERPLAN ONTWIKKELIN; Van de Ven P, 2005, PEDAGOG STUD, V82, P293; Van den Akker J., 2003, CURRICULUM LANDSCAPE, P1; Van der Leeuw K, 1991, VIC TIJDSCHRIFT FILO, V20, P15; Van der Leeuw K, 1988, PHILOSOPHIEREN LEHRE; Vermunt J, 1998, ONDERWIJSKUNDIG LEXI; Weber, 2009, CHILDREN PHILOS WORL, P117; Yin R.K., 2009, CASE STUDY RES DESIG, V4th ed., DOI [10.33524/cjar.v14i1.73, DOI 10.33524/CJAR.V14I1.73]; Young RE, 1989, CRITICAL THEORY ED H	39	10	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137590	10.1371/journal.pone.0137590	http://dx.doi.org/10.1371/journal.pone.0137590			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0RH	26379267	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000361769400019
J	Ma, YC; Wang, Q; Yang, JY; Yan, LN				Ma, Yucheng; Wang, Qing; Yang, Jiayin; Yan, Lunan			Comparison of Different Scoring Systems Based on Both Donor and Recipient Characteristics for Predicting Outcome after Living Donor Liver Transplantation	PLOS ONE			English	Article							SOFT-SCORE; DISEASE SCORE; RISK-INDEX; MELD-SCORE; SURVIVAL; MODEL; ALLOCATION; PATIENT; GRAFTS; TIME	Background and Objectives In order to provide a good match between donor and recipient in liver transplantation, four scoring systems [the product of donor age and Model for End-stage Liver Disease score (DMELD), the score to predict survival outcomes following liver transplantation (SOFT), the balance of risk score (BAR), and the transplant risk index (TR)] based on both donor and recipient parameters were designed. This study was conducted to evaluate the performance of the four scores in living donor liver transplantation (LDLT) and compare them with the MELD score. Patients and Methods The clinical data of 249 adult patients undergoing LDLT in our center were retrospectively evaluated. The area under the receiver operating characteristic curves (AUCs) of each score were calculated and compared at 1-, 3-, 6-month and 1-year after LDLT. Results The BAR at 1-, 3-, 6-month and 1-year after LDLT and the D-MELD and TRI at 1-, 3- and 6month after LDLT showed acceptable performances in the prediction of survival (AUC>0.6), while the SOFT showed poor discrimination at 6-month after LDLT (AUC = 0.569). In addition, the D-MELD and BAR displayed positive correlations with the length of ICU stay (DMELD, p = 0.025; BAR, p = 0.022). The SOFT was correlated with the time of mechanical ventilation (p = 0.022). Conclusion The D-MELD, BAR and TRI provided acceptable performance in predicting survival after LDLT. However, even though these scoring systems were based on both donor and recipient parameters, only the BAR provided better performance than the MELD in predicting 1-year survival after LDLT.	[Ma, Yucheng; Wang, Qing; Yang, Jiayin; Yan, Lunan] Sichuan Univ, Dept Liver Transplantat, West China Hosp, Chengdu 610064, Peoples R China	Sichuan University	Yan, LN (corresponding author), Sichuan Univ, Dept Liver Transplantat, West China Hosp, Chengdu 610064, Peoples R China.	yaniunan@scu.edu.cn			National Science and Technology Major Project of China [2012ZX10002-016]	National Science and Technology Major Project of China	This work was supported by a grant from the National Science and Technology Major Project of China (grant No. 2012ZX10002-016) [http://www.most.gov.cn/].	Abt PL, 2004, AM J TRANSPLANT, V4, P1302, DOI 10.1111/j.1600-6143.2004.00522.x; Chen PX, 2014, WORLD J GASTROENTERO, V20, P282, DOI 10.3748/wjg.v20.i1.282; Dutkowski P, 2012, ANN SURG, V256, P861, DOI 10.1097/SLA.0b013e318272dea2; Dutkowski P, 2011, ANN SURG, V254, P745, DOI 10.1097/SLA.0b013e3182365081; Foxton MR, 2010, LIVER TRANSPLANT, V16, P668, DOI 10.1002/lt.22027; Halldorson JB, 2009, AM J TRANSPLANT, V9, P318, DOI 10.1111/j.1600-6143.2008.02491.x; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Ikegami T., 2013, TRANSPLANTATION; Jochmans I, 2013, ANN SURG; Joo DJ, 2012, TRANSPLANTATION, V94, P402; Liu B, 2007, WORLD J GASTROENTERO, V13, P955, DOI 10.3748/wjg.v13.i6.955; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; Olthoff KM, 2011, LIVER TRANSPLANT, V17, P789, DOI 10.1002/lt.22288; Rana A, 2008, AM J TRANSPLANT, V8, P2537, DOI 10.1111/j.1600-6143.2008.02400.x; Rana A, 2013, CLIN TRANSPLANT, V27, P627, DOI 10.1111/ctr.12181; Reichert B, 2012, ANN TRANSPL, V17, P11; Schrem H, 2012, ANN TRANSPL, V17, P5; Selzner M, 2010, ANN SURG, V251, P153, DOI 10.1097/SLA.0b013e3181bc9c6a; Singal AK, 2013, J CLIN EXP HEPATOL, V3, P50, DOI 10.1016/j.jceh.2012.11.002; Siniscalchi A, 2009, TRANSPL P, V41, P1240, DOI 10.1016/j.transproceed.2009.02.046; Stey AM, 2013, TRANSPL P, V45, P2077, DOI 10.1016/j.transproceed.2013.06.001; Vitale A, 2011, TRANSPL P, V43, P974, DOI 10.1016/j.transproceed.2011.01.138; Wiesner RH, 2001, LIVER TRANSPLANT, V7, P567, DOI 10.1053/jlts.2001.25879; Yang SH, 2007, SURGERY, V141, P598, DOI 10.1016/j.surg.2006.11.006	24	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0136604	10.1371/journal.pone.0136604	http://dx.doi.org/10.1371/journal.pone.0136604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378786	Green Submitted, Green Published, gold			2022-12-27	WOS:000361769400007
J	Reddy, A; Growney, JD; Wilson, NS; Emery, CM; Johnson, JA; Ward, R; Monaco, KA; Korn, J; Monahan, JE; Stump, MD; Mapa, FA; Wilson, CJ; Steiger, J; Ledell, J; Rickles, RJ; Myer, VE; Ettenberg, SA; Schlegel, R; Sellers, WR; Huet, HA; Lehar, J				Reddy, Anupama; Growney, Joseph D.; Wilson, Nick S.; Emery, Caroline M.; Johnson, Jennifer A.; Ward, Rebecca; Monaco, Kelli A.; Korn, Joshua; Monahan, John E.; Stump, Mark D.; Mapa, Felipa A.; Wilson, Christopher J.; Steiger, Janine; Ledell, Jebediah; Rickles, Richard J.; Myer, Vic E.; Ettenberg, Seth A.; Schlegel, Robert; Sellers, William R.; Huet, Heather A.; Lehar, Joseph			Gene Expression Ratios Lead to Accurate and Translatable Predictors of DR5 Agonism across Multiple Tumor Lineages	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; MEDIATED APOPTOSIS; CANCER; CELLS; OVEREXPRESSION; APO2L/TRAIL; SENSITIVITY; CLASSIFIER; RESISTANCE; CLEAVAGE	Death Receptor 5 (DR5) agonists demonstrate anti-tumor activity in preclinical models but have yet to demonstrate robust clinical responses. A key limitation may be the lack of patient selection strategies to identify those most likely to respond to treatment. To overcome this limitation, we screened a DR5 agonist Nanobody across >600 cell lines representing 21 tumor lineages and assessed molecular features associated with response. High expression of DR5 and Casp8 were significantly associated with sensitivity, but their expression thresholds were difficult to translate due to low dynamic ranges. To address the translational challenge of establishing thresholds of gene expression, we developed a classifier based on ratios of genes that predicted response across lineages. The ratio classifier outperformed the DR5+Casp8 classifier, as well as standard approaches for feature selection and classification using genes, instead of ratios. This classifier was independently validated using 11 primary patient-derived pancreatic xenograft models showing perfect predictions as well as a striking linearity between prediction probability and anti-tumor response. A network analysis of the genes in the ratio classifier captured important biological relationships mediating drug response, specifically identifying key positive and negative regulators of DR5 mediated apoptosis, including DR5, CASP8, BID, cFLIP, XIAP and PEA15. Importantly, the ratio classifier shows translatability across gene expression platforms (from Affymetrix microarrays to RNA-seq) and across model systems (in vitro to in vivo). Our approach of using gene expression ratios presents a robust and novel method for constructing translatable biomarkers of compound response, which can also probe the underlying biology of treatment response.	[Reddy, Anupama; Growney, Joseph D.; Wilson, Nick S.; Emery, Caroline M.; Johnson, Jennifer A.; Ward, Rebecca; Monaco, Kelli A.; Korn, Joshua; Monahan, John E.; Stump, Mark D.; Mapa, Felipa A.; Wilson, Christopher J.; Myer, Vic E.; Ettenberg, Seth A.; Schlegel, Robert; Sellers, William R.; Huet, Heather A.; Lehar, Joseph] Novartis Inst Biomed Res, Cambridge, MA USA; [Steiger, Janine; Ledell, Jebediah; Rickles, Richard J.] Horizon CombinatoRx, Cambridge, MA USA	Novartis	Reddy, A (corresponding author), Duke Univ, Med Ctr, Durham, NC 27708 USA.	anupamar@gmail.com		Wilson, Christopher/0000-0002-9146-522X; Monahan, John/0000-0002-3125-8704	Novartis Institutes for Biomedical Research	Novartis Institutes for Biomedical Research	This study was funded by Novartis Institutes for Biomedical Research. All authors were employed by Novartis Institutes for Biomedical Research during the course of the study. Novartis Institutes for Biomedical Research provided support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Adams C, 2008, CELL DEATH DIFFER, V15, P751, DOI 10.1038/sj.cdd.4402306; Al-Harbi S, 2011, BLOOD, V118, P3579, DOI 10.1182/blood-2011-03-340364; Araki S, 2010, CANCER LETT, V292, P269, DOI 10.1016/j.canlet.2009.12.007; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Behbakht K, 2007, CANCER RES, V67, P3036, DOI 10.1158/0008-5472.CAN-06-3755; Bellail AC, 2010, J CELL MOL MED, V14, P1303, DOI 10.1111/j.1582-4934.2009.00777.x; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Herbst RS, 2010, CLIN CANCER RES, V16, P5883, DOI 10.1158/1078-0432.CCR-10-0631; Herbst RS, 2010, J CLIN ONCOL, V28, P2839, DOI 10.1200/JCO.2009.25.1991; Huet HA, 2014, MABS IN PRESS; Hurtado A, 2008, NATURE, V456, P663, DOI 10.1038/nature07483; Kantari C, 2011, BBA-MOL CELL RES, V1813, P558, DOI 10.1016/j.bbamcr.2011.01.026; Korpal M, 2013, CANCER DISCOV, V3, P1030, DOI 10.1158/2159-8290.CD-13-0142; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Lomberk Gwen A, 2011, J Gastrointest Cancer, V42, P93, DOI 10.1007/s12029-011-9256-2; Mao ZG, 2010, APOPTOSIS, V15, P1211, DOI 10.1007/s10495-010-0513-9; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Motoki K, 2005, CLIN CANCER RES, V11, P3126, DOI 10.1158/1078-0432.CCR-04-1867; Natoni A, 2007, BRIT J HAEMATOL, V139, P568, DOI 10.1111/j.1365-2141.2007.06852.x; Nurtdinov RN, 2010, NUCLEIC ACIDS RES, V38, pD726, DOI 10.1093/nar/gkp969; Ozenne P, 2010, INT J CANCER, V127, P2239, DOI 10.1002/ijc.25511; Pitts TM, 2010, CLIN CANCER RES, V16, P3193, DOI 10.1158/1078-0432.CCR-09-3191; Price ND, 2007, P NATL ACAD SCI USA, V104, P3414, DOI 10.1073/pnas.0611373104; Romagosa C, 2011, ONCOGENE, V30, P2087, DOI 10.1038/onc.2010.614; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Soria JC, 2011, J CLIN ONCOL, V29, P4442, DOI 10.1200/JCO.2011.37.2623; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Van Bockstaele F, 2009, CURR OPIN INVEST DR, V10, P1212; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Wiezorek J, 2010, CLIN CANCER RES, V16, P1701, DOI 10.1158/1078-0432.CCR-09-1692; Yang A, 2010, CURR OPIN CELL BIOL, V22, P837, DOI 10.1016/j.ceb.2010.08.001; Yang X, 2005, AM J PATHOL, V167, P705, DOI 10.1016/S0002-9440(10)62045-7	33	8	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138486	10.1371/journal.pone.0138486	http://dx.doi.org/10.1371/journal.pone.0138486			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378449	Green Published, gold			2022-12-27	WOS:000361769400104
J	Cacciani, L; Bargagli, AM; Cesaroni, G; Forastiere, F; Agabiti, N; Davoli, M				Cacciani, Laura; Bargagli, Anna Maria; Cesaroni, Giulia; Forastiere, Francesco; Agabiti, Nera; Davoli, Marina			Education and Mortality in the Rome Longitudinal Study	PLOS ONE			English	Article							SOCIOECONOMIC INEQUALITIES; SOCIAL INEQUALITIES; HEALTH INEQUALITIES; GENDER; COUNTRIES; PATTERNS; SMOKING; DISEASE; AGE	Background A large body of evidence supports an inverse association between socioeconomic status and mortality. We analysed data from a large cohort of residents in Rome followed-up between 2001 and 2012 to assess the relationship between individual education and mortality. We distinguished five causes of death and investigated the role of age, gender, and birthplace. Methods From the Municipal Register we enrolled residents of Rome on October 21st 2001 and collected information on educational level attained from the 2001 Census. We selected Italian citizens aged 30-74 years and followed-up their vital status until 2012 (n = 1,283,767), identifying the cause of death from the Regional Mortality Registry. We calculated hazard ratios (HRs) for overall and cause-specific mortality in relation to education. We used age, gender, and birthplace for adjusted or stratified analyses. We used the inverse probability weighting approach to account for right censoring due to emigration. Results We observed an inverse association between education (none vs. post-secondary+level) and overall mortality (HRs(95% CIs): 2.1(1.98-2.17), males; 1.5(1.46-1.59), females) varying according to demographic characteristics. Cause-specific analysis also indicated an inverse association with education, in particular for respiratory, digestive or circulatory system related-mortality, and the youngest people seemed to be more vulnerable to low education. Conclusion Our results confirm the inverse association between education and overall or cause-specific mortality and show differentials particularly marked among young people compared to the elderly. The findings provide further evidence from the Mediterranean area, and may contribute to national and cross-country comparisons in Europe to understand the mechanisms generating socioeconomic differentials especially during the current recession period.	[Cacciani, Laura; Bargagli, Anna Maria; Cesaroni, Giulia; Forastiere, Francesco; Agabiti, Nera; Davoli, Marina] Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy		Cacciani, L (corresponding author), Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy.	l.cacciani@deplazio.it	Bargagli, Anna Maria/J-9843-2016; Forastiere, Francesco/J-9067-2016; Davoli, Marina/K-1975-2016; Agabiti, Nera/K-1053-2016; Cacciani, Laura/Y-1409-2019; Cesaroni, Giulia/K-1500-2016	Bargagli, Anna Maria/0000-0002-4222-5975; Forastiere, Francesco/0000-0002-9162-5684; Davoli, Marina/0000-0003-4521-032X; Agabiti, Nera/0000-0003-3385-1197; Cacciani, Laura/0000-0002-5800-3285; Cesaroni, Giulia/0000-0001-7361-9072				Benjamins MR, 2004, SOC SCI MED, V59, P1297, DOI 10.1016/j.socscimed.2003.01.001; Bleich SN, 2012, ANNU REV PUBL HEALTH, V33, P7, DOI 10.1146/annurev-publhealth-031811-124658; Bloomfield K, 2006, ALCOHOL ALCOHOLISM, V41, pI26, DOI 10.1093/alcalc/agl073; Borrell C, 2014, SCAND J PUBLIC HEALT, V42, P245, DOI 10.1177/1403494814522556; Cesaroni G, 2010, ENV HLTH, V21, P9; Cesaroni G, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-270; Cesaroni G, 2013, ENVIRON HEALTH PERSP, V121, P324, DOI 10.1289/ehp.1205862; Cologne J, 2012, EPIDEMIOLOGY, V23, P565, DOI 10.1097/EDE.0b013e318253e418; Costa G, 2014, EQUITA NELLA SALUTE; Cutler DM, 2006, ED HLTH EVALUATING T; de Graaf JP, 2013, CURR OPIN OBSTET GYN, V25, P98, DOI 10.1097/GCO.0b013e32835ec9b0; Department of Health and Social Security England, 1980, IN HLTH REP RES WORK; Gallo V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039013; Hernan MA, 2006, J EPIDEMIOL COMMUN H, V60, P578, DOI 10.1136/jech.2004.029496; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; KENT DP, 1971, GERONTOLOGIST, V11, P26, DOI 10.1093/geront/11.1_Part_2.26; Kuh D, 1997, LIFE COURSE APPROACH; Lynch J, 2005, ANNU REV PUBL HEALTH, V26, P1, DOI 10.1146/annurev.publhealth.26.021304.144505; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mackenbach JP, 2015, SOC SCI MED, V127, P51, DOI 10.1016/j.socscimed.2014.05.021; Mackenbach JP, 2015, J EPIDEMIOL COMMUN H, V69, P207, DOI 10.1136/jech-2014-204319; Mackenbach JP, 2013, LANCET, V381, P1125, DOI 10.1016/S0140-6736(12)62082-0; Mackenbach JP, 2012, SOC SCI MED, V75, P761, DOI 10.1016/j.socscimed.2012.02.031; Mackenbach JP, 2004, EUR J CANCER, V40, P126, DOI 10.1016/j.ejca.2003.10.018; Mackenbach JP, 2003, INT J EPIDEMIOL, V32, P830, DOI 10.1093/ije/dyg209; Marinacci C, 2004, J EPIDEMIOL COMMUN H, V58, P199, DOI 10.1136/jech.2003.014928; Marinacci C, 2013, EUR J PUBLIC HEALTH, V23, P582, DOI 10.1093/eurpub/cks184; Marmot M, 2006, LANCET, V368, P341, DOI 10.1016/S0140-6736(06)68976-9; Marmot M, 2012, LANCET, V380, P1011, DOI 10.1016/S0140-6736(12)61228-8; Materia E, 2005, EUR J PUBLIC HEALTH, V15, P411, DOI 10.1093/eurpub/cki007; Montgomery S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003031; Muntaner C, 2004, EPIDEMIOL REV, V26, P53, DOI 10.1093/epirev/mxh001; Pampel FC, 2003, SOC SCI MED, V57, P1505, DOI 10.1016/S0277-9536(02)00543-9; Read JG, 2010, ANNU REV SOCIOL, V36, P371, DOI 10.1146/annurev.soc.012809.102535; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Ross CE, 2012, DEMOGRAPHY, V49, P1157, DOI 10.1007/s13524-012-0130-z; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P153; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; Zarulli V, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002841	39	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137576	10.1371/journal.pone.0137576	http://dx.doi.org/10.1371/journal.pone.0137576			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8NH	26376166	Green Published, gold, Green Submitted			2022-12-27	WOS:000361610200043
J	Corrado, A; Colia, R; Mele, A; Di Bello, V; Trotta, A; Neve, A; Cantatore, FP				Corrado, Addolorata; Colia, Ripalta; Mele, Angiola; Di Bello, Valeria; Trotta, Antonello; Neve, Anna; Cantatore, Francesco Paolo			Relationship between Body Mass Composition, Bone Mineral Density, Skin Fibrosis and 25(OH) Vitamin D Serum Levels in Systemic Sclerosis	PLOS ONE			English	Article							LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS; DISEASE-ACTIVITY; HEALTH; WOMEN; 25-HYDROXYVITAMIN-D; ASSOCIATION; CELLS; RISK	A reduced bone mineral density (BMD) is observed in several rheumatic autoimmune diseases, including Systemic Sclerosis (SSc); nevertheless, data concerning the possible determinants of bone loss in this disease are not fully investigated. The aim of this study is to evaluate the relationship between BMD, body mass composition, skin sclerosis and serum Vitamin D levels in two subsets of SSc patients. 64 post-menopausal SSc patients, classified as limited cutaneous (lcSSc) or diffuse cutaneous (dcSSc) SSc, were studied. As control, 35 healthy post-menopausal women were recruited. Clinical parameters were evaluated, including the extent of skin involvement. BMD at lumbar spine, hip, femoral neck and body mass composition were determined by dual-energy X-ray absorptiometry. Serum calcium, phosphorus, alkaline phosphatase, urine pyridinium cross-links, intact parathyroid hormone and 25-hydroxyvitamin D (25OHD) were measured. BMD at spine, femoral neck and total hip was significantly lower in SSc patients compared to controls. In dcSSc subset, BMD at spine, femoral neck and total hip was significantly lower compared to lcSSc. No differences in both fat and lean mass were found in the three study groups even if patients with dcSSc showed a slightly lower total body mass compared to healthy controls. Total mineral content was significantly reduced in dSSc compared to both healthy subjects and lcSSc group. Hypovitaminosis D was observed both in healthy post-menopausal women and in SSc patients, but 25OHD levels were significantly lower in dcSSc compared to lcSSc and inversely correlated with the extent of skin thickness. These results support the hypothesis that the extent of skin involvement in SSc patients could be an important factor in determining low circulating levels of 25OHD, which in turn could play a significant role in the reduction of BMD and total mineral content.	[Corrado, Addolorata; Colia, Ripalta; Mele, Angiola; Di Bello, Valeria; Trotta, Antonello; Neve, Anna; Cantatore, Francesco Paolo] Univ Foggia, Dept Med & Surg Sci, Rheumatol Clin, Foggia, Italy	University of Foggia	Cantatore, FP (corresponding author), Univ Foggia, Dept Med & Surg Sci, Rheumatol Clin, Foggia, Italy.	francescopaolo.cantatore@unifg.it	Corrado, addolorata/S-8672-2016	Corrado, addolorata/0000-0001-6823-1970				Agmon-Levin N, 2013, CLIN REV ALLERG IMMU, V45, P256, DOI 10.1007/s12016-012-8342-y; Amital H, 2010, ANN RHEUM DIS, V69, P1155, DOI 10.1136/ard.2009.120329; Arnson Y, 2011, AUTOIMMUN REV, V10, P490, DOI 10.1016/j.autrev.2011.02.002; Artaza JN, 2009, J ENDOCRINOL, V200, P207, DOI 10.1677/JOE-08-0241; Atteritano M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066991; Avouac J, 2012, ARTHRIT CARE RES, V64, P1871, DOI 10.1002/acr.21761; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Caramaschi P, 2010, CLIN RHEUMATOL, V29, P1419, DOI 10.1007/s10067-010-1478-3; Carbone L, 1999, RHEUMATOLOGY, V37, P1; Coghlan JG, 2014, ANN RHEUM DIS, V73, P1340, DOI 10.1136/annrheumdis-2013-203301; Costenbader KH, 2008, ANN RHEUM DIS, V67, P530, DOI 10.1136/ard.2007.072736; DIMUNNO O, 1995, CLIN RHEUMATOL, V14, P407, DOI 10.1007/BF02207673; Frediani B, 2004, ANN RHEUM DIS, V63, P326, DOI 10.1136/ard.2003.011064; Fredlani B, 2004, CLIN EXP RHEUMATOL, V22, P313; Hachulla E, 2011, CLIN REV ALLERG IMMU, V40, P78, DOI 10.1007/s12016-010-8198-y; Hajas A, 2011, AUTOIMMUN REV, V10, P317, DOI 10.1016/j.autrev.2010.11.006; Ibn Yacoub Y, 2012, RHEUMATOL INT, V32, P3143, DOI 10.1007/s00296-011-2150-1; Kamen DL, 2006, AUTOIMMUN REV, V5, P114, DOI 10.1016/j.autrev.2005.05.009; LAMONTAGNA G, 1991, CLIN RHEUMATOL, V10, P18, DOI 10.1007/BF02208027; Marie I, 2009, RHEUMATOLOGY, V48, P1314, DOI 10.1093/rheumatology/kep226; Maruotti N, 2010, J RHEUMATOL, V37, P491, DOI 10.3899/jrheum.090797; Mouyis M, 2008, RHEUMATOLOGY, V47, P1348, DOI 10.1093/rheumatology/ken203; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Omair MA, 2013, J RHEUMATOL, V40, P1881, DOI 10.3899/jrheum.130032; Patel S, 2007, ARTHRITIS RHEUM, V56, P2143, DOI 10.1002/art.22722; Pludowski P, 2013, AUTOIMMUN REV, V12, P976, DOI 10.1016/j.autrev.2013.02.004; Ramirez AM, 2010, J STEROID BIOCHEM, V118, P142, DOI 10.1016/j.jsbmb.2009.11.004; Sampaio-Barros PD, 2005, CLIN EXP RHEUMATOL, V23, P180; Shimada A, 2008, J AUTOIMMUN, V30, P207, DOI 10.1016/j.jaut.2007.09.002; Solomon JJ, 2013, EUR RESPIR REV, V22, P6, DOI 10.1183/09059180.00005512; Souza RBC, 2006, SCAND J RHEUMATOL, V35, P384, DOI 10.1080/03009740600704296; Topolski T. D., 2006, Preventing Chronic Disease, V3, pA118; Wacker M, 2013, NUTRIENTS, V5, P111, DOI 10.3390/nu5010111	33	17	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137912	10.1371/journal.pone.0137912	http://dx.doi.org/10.1371/journal.pone.0137912			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375284	Green Published, gold			2022-12-27	WOS:000361610200061
J	Ding, WN; Cao, WW; Wang, Y; Sun, YW; Chen, X; Zhou, Y; Xu, Q; Xu, JR				Ding, Weina; Cao, Wenwei; Wang, Yao; Sun, Yawen; Chen, Xue; Zhou, Yan; Xu, Qun; Xu, Jianrong			Altered Functional Connectivity in Patients with Subcortical Vascular Cognitive Impairment-A Resting-State Functional Magnetic Resonance Imaging Study	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; PROCESSING SPEED; RATING-SCALE; DEMENTIA; SCHIZOPHRENIA; BRAIN; NETWORKS; MRI; ABNORMALITIES; ANATOMY	Recent neuroimaging studies have shown that people with subcortical vascular cognitive impairment (sVCI) have structural and functional abnormalities in the frontal lobe and subcortical brain sites. In this study, we used seed-based resting-state functional connectivity (rsFC) analysis and voxel-mirrored homotopic connectivity (VMHC) techniques to investigate the alteration of rsFC in patients with sVCI. rsFC and structural magnetic resonance images were acquired for 51 patients with subcortical cerebrovascular disease. All patients were subdivided based on cognitive status into 29 with sVCI and 22 controls; patient characteristics were matched. rsFC of the posterior cingulate cortex (PCC) and VMHC were calculated separately, and rsFC of the PCC and VMHC between the two groups were compared. The regions showing abnormal rsFC of the PCC or VMHC in sVCI patients were adopted as regions of interest for correlation analyses. Our results are as follows: The patients with sVCI exhibited increases in rsFC in the left middle temporal lobe, right inferior temporal lobe and left superior frontal gyrus, and significant decreases in rsFC of the left thalamus with the PCC. sVCI patients showed a significant deficit in VMHC between the bilateral lingual gyrus, putamen, and precentral gyrus. Additionally, the z-memory score was significantly positively associated with connectivity between the left thalamus and the PCC (r = 0.41, p = 0.03, uncorrected) in the sVCI group. Our findings suggest that the frontal lobe and subcortical brain sites play an important role in the pathogenesis of sVCI. Furthermore, rsFC between the left thalamus and the PCC might indicate the severity of sVCI.	[Ding, Weina; Wang, Yao; Sun, Yawen; Chen, Xue; Zhou, Yan; Xu, Jianrong] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Radiol, Shanghai 200127, Peoples R China; [Cao, Wenwei; Xu, Qun] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Neurol, Shanghai 200127, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhou, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Radiol, Shanghai 200127, Peoples R China.	clare1475@hotmail.com; xuqun628@hotmail.com			National Natural Science Foundation of China [81171325]; Shanghai Science and Technology Committee Medical Guide Project (western medicine) [14411964400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee Medical Guide Project (western medicine)	This research was supported by the National Natural Science Foundation of China (No. 81171325) (http://www.nsfc.gov.cn/) YZ, Shanghai Science and Technology Committee Medical Guide Project (western medicine) ( No. 14411964400) (http://www.stcsm.gov.cn/) QX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anteraper SA, 2014, BRAIN CONNECT, V4, P81, DOI 10.1089/brain.2013.0180; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cai SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115573; Charlton RA, 2006, NEUROLOGY, V66, P1523, DOI 10.1212/01.wnl.0000216270.02610.7e; Chen YC, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/345647; COCKRELL JR, 1988, PSYCHOPHARMACOL BULL, V24, P689; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Demirci O, 2009, NEUROIMAGE, V46, P419, DOI 10.1016/j.neuroimage.2009.02.014; Duering M, 2013, NEUROIMAGE, V66, P177, DOI 10.1016/j.neuroimage.2012.10.084; Fazekas F, 2002, CEREBROVASC DIS, V13, P31, DOI 10.1159/000049147; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Ganguli M, 2011, PRINCIPLES PRACTICE; Ghosh Shantanu, 2010, Indian J Radiol Imaging, V20, P182, DOI 10.4103/0971-3026.69352; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Herrero MT, 2002, CHILD NERV SYST, V18, P386, DOI 10.1007/s00381-002-0604-1; Hong YJ, 2014, ARCH GERONTOL GERIAT, V58, P415, DOI 10.1016/j.archger.2013.11.005; Hoptman MJ, 2012, SCHIZOPHR RES, V141, P1, DOI 10.1016/j.schres.2012.07.027; Hoptman MJ, 2010, SCHIZOPHR RES, V117, P13, DOI 10.1016/j.schres.2009.09.030; Jellinger KA, 2002, J NEUROL SCI, V203, P153, DOI 10.1016/S0022-510X(02)00282-4; Ji GJ, 2014, RADIOLOGY, V271, P839, DOI 10.1148/radiol.13131638; Jin GW, 2011, RADIOLOGY, V261, P525, DOI 10.1148/radiol.11102186; Kelly C, 2011, BIOL PSYCHIAT, V69, P684, DOI 10.1016/j.biopsych.2010.11.022; Korczyn AD, 2012, J NEUROL SCI, V322, P2, DOI 10.1016/j.jns.2012.03.027; Li R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071009; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mantini D, 2013, NEUROSCIENTIST, V19, P76, DOI 10.1177/1073858412446202; Margolis A, 2006, NEUROPSYCHOLOGY, V20, P66, DOI 10.1037/0894-4105.20.1.66; McGlashan TH, 2000, ARCH GEN PSYCHIAT, V57, P637, DOI 10.1001/archpsyc.57.7.637; Moorhouse P, 2008, LANCET NEUROL, V7, P246, DOI 10.1016/S1474-4422(08)70040-1; Nichtweiss M, 2012, CLIN NEURORADIOL, V22, P193, DOI 10.1007/s00062-012-0134-5; O'Brien JT, 2003, LANCET NEUROL, V2, P89, DOI 10.1016/S1474-4422(03)00305-3; Park JH, 2014, NEUROBIOL AGING, V35, P254, DOI 10.1016/j.neurobiolaging.2013.06.026; Pendlebury ST, 2012, CEREBROVASC DIS, V34, P48, DOI 10.1159/000338905; Peterburs J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021517; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Righart R, 2013, NEUROIMAGE-CLIN, V2, P854, DOI 10.1016/j.nicl.2013.06.006; Rodriguez JJL, 2008, LANCET, V372, P464, DOI 10.1016/S0140-6736(08)61002-8; Roman G, 2012, ARCH MED RES, V43, P671, DOI 10.1016/j.arcmed.2012.10.018; Sachdev PS, 2006, DEMENT GERIATR COGN, V21, P275, DOI 10.1159/000091434; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Schwarzkopf DS, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00200; Sefcsik I., 2009, LEARN PERCEPT, V2, P215, DOI [10.1556/LP.1.2009.2.4, DOI 10.1556/LP.1.2009.2.4, 10.1556/lp.1.2009.2.4]; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sousa RM, 2009, LANCET, V374, P1821, DOI 10.1016/S0140-6736(09)61829-8; Sudo FK, 2013, ARQ NEURO-PSIQUIAT, V71, P431, DOI 10.1590/0004-282X20130057; Sun YW, 2011, BEHAV BRAIN RES, V223, P388, DOI 10.1016/j.bbr.2011.05.006; Thong JYJ, 2014, HUM BRAIN MAPP, V35, P2320, DOI 10.1002/hbm.22330; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Wang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118733; Wei XH, 2015, NEUROSCI LETT, V589, P67, DOI 10.1016/j.neulet.2015.01.034; White T, 2011, SCHIZOPHRENIA BULL, V37, P222, DOI 10.1093/schbul/sbp088; Xue Y, 2015, J MOL NEUROSCIENCE M; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012; Li YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044758; Ystad M, 2010, NEUROIMAGE, V52, P379, DOI 10.1016/j.neuroimage.2010.03.062; Yuan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045476; Zhou Y, 2013, AM J NEURORADIOL, V34, P1180, DOI 10.3174/ajnr.A3386	62	18	22	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138180	10.1371/journal.pone.0138180	http://dx.doi.org/10.1371/journal.pone.0138180			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376180	Green Published, Green Submitted, gold			2022-12-27	WOS:000361610200082
J	McGlynn, N; Kirsh, VA; Cotterchio, M; Harris, MA; Nadalin, V; Kreiger, N				McGlynn, Natalie; Kirsh, Victoria A.; Cotterchio, Michelle; Harris, M. Anne; Nadalin, Victoria; Kreiger, Nancy			Shift Work and Obesity among Canadian Women: A Cross-Sectional Study Using a Novel Exposure Assessment Tool	PLOS ONE			English	Article							BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; RISK-FACTORS; WEIGHT-GAIN; LIFE-STYLE; OVERWEIGHT; NURSES; ASSOCIATION; CANCER; HEALTH	Background/Objectives It has been suggested that the association between shift work and chronic disease is mediated by an increase in obesity. However, investigations of the relationship between shift work and obesity reveal mixed findings. Using a recently developed exposure assessment tool, this study examined the association between shift work and obesity among Canadian women from two studies: a cohort of university alumni, and a population-based study. Methods Self-administered questionnaire data were used from healthy, currently employed females in a population-based study, the Ontario Women's Diet and Health case-control study (n = 1611 controls), and from a subset of a of university alumni from the Canadian Study of Diet, Lifestyle, and Health (n = 1097) cohort study. Overweight was defined as BMI >= 25 to < 30, and obesity as BMI >= 30. Reported occupation was converted to occupational codes and linked to a probability of shift work value derived from Survey of Labour and Income Dynamics data. Regular evenings, nights, or rotating work comprised shift work. Polytomous logistic regression estimated the association between probability of shift work, categorized as near nil, low, medium, and high probability of shift work, on overweight and obesity, controlling for detected confounders. Results In the population-based sample, high probability of shift work was associated with obesity (reference = near nil probability of shift work, OR: 1.88, 95% CI: 1.01-3.51, p = 0.047). In the alumni cohort, no significant association was detected between shift work and overweight or obesity. Conclusions As these analyses found a positive association between high probability of shift work exposure and obesity in a population-based sample, but not in an alumni cohort, it is suggested that the relationship between shift work and obesity is complex, and may be particularly susceptible to occupational and education-related factors within a given population.	[McGlynn, Natalie] Toronto Publ Hlth, Surveillance & Epidemiol Unit, Performance & Stand, Toronto, ON, Canada; [Kirsh, Victoria A.; Cotterchio, Michelle; Kreiger, Nancy] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Cotterchio, Michelle; Nadalin, Victoria] Canc Care Ontario, Prevent & Canc Control, Toronto, ON, Canada; [Harris, M. Anne] Ryerson Univ, Sch Occupat & Publ Hlth, Toronto, ON, Canada	University of Toronto; Cancer Care Ontario; Toronto Metropolitan University	McGlynn, N (corresponding author), Toronto Publ Hlth, Surveillance & Epidemiol Unit, Performance & Stand, Toronto, ON, Canada.	nmcglynn@alumni.uwo.ca			Canadian Institutes for Health Information; Canadian Breast Cancer Research Alliance; Cancer Care Ontario	Canadian Institutes for Health Information(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Research Alliance; Cancer Care Ontario	The Canadian Institutes for Health Information funded the Canadian Study of Diet, Lifestyle and Health. The Canadian Breast Cancer Research Alliance funded the Ontario Women's Diet and Health Study. Support for this research project was provided by Cancer Care Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbadoro P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063289; BOUYER J, 1995, SCAND J WORK ENV HEA, V21, P265, DOI 10.5271/sjweh.36; Caballero B, 2007, EPIDEMIOL REV, V29, P1, DOI 10.1093/epirev/mxm012; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Chee HL, 2004, ASIA PAC J CLIN NUTR, V13, P248; Cotterchio M, 2008, CANCER CAUSE CONTROL, V19, P259, DOI 10.1007/s10552-007-9089-2; Demers PA, 2010, SCI S HLTH EFF SHIFT; Devaux M, 2011, OCED J EC STUD, V2011, P121, DOI DOI 10.1787/19952856; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Ha M, 2005, J OCCUP HEALTH, V47, P89, DOI 10.1539/joh.47.89; Human Resources and Skills Development Canada (HRSDC), 2013, INTR ED 2001 NAT OCC; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747; Katzmarzyk PT, 2002, CAN MED ASSOC J, V166, P1039; Kim MJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1204; Kivimaki M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001138; Knutsson A, 2003, OCCUP MED-OXFORD, V53, P103, DOI 10.1093/occmed/kqg048; Ko GTC, 2007, INT J OBESITY, V31, P254, DOI 10.1038/sj.ijo.0803389; Kouvonen A, 2005, PSYCHOSOM MED, V67, P577, DOI 10.1097/01.psy.0000170330.08704.62; Le Moual N, 2000, OCCUP ENVIRON MED, V57, P126, DOI 10.1136/oem.57.2.126; Luckhaupt SE, 2014, AM J PREV MED, V46, P237, DOI 10.1016/j.amepre.2013.11.002; Miller SK, 2008, J AM ACAD NURSE PRAC, V20, P259, DOI 10.1111/j.1745-7599.2008.00319.x; Niedhammer I, 1996, INT J OBESITY, V20, P625; Pan A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001141; Parkes KR, 2002, SCAND J WORK ENV HEA, V28, P64, DOI 10.5271/sjweh.648; Puttonen S, 2010, SCAND J WORK ENV HEA, V36, P96, DOI 10.5271/sjweh.2894; Rohan TE, 2007, CANCER DETECT PREV, V31, P12, DOI 10.1016/j.cdp.2006.12.006; SAS Institute Inc, 2009, SAS 9 2; Schernhammer ES, 2003, JNCI-J NATL CANCER I, V95, P825, DOI 10.1093/jnci/95.11.825; Shields M, 1999, Health Rep, V11, P33; Shields Margot, 2011, NCHS Data Brief, P1; Smith P, 2013, APPL NURS RES, V26, P24, DOI 10.1016/j.apnr.2012.10.001; Statistics Canada, 2014, HLTH FACT SHEETS BOD; Thaler JP, 2013, DIABETES, V62, P2629, DOI 10.2337/db12-1605; Truong KD, 2005, AM J PUBLIC HEALTH, V95, P1602, DOI 10.2105/AJPH.2004.043935; van Amelsvoort LGPM, 2004, J OCCUP ENVIRON MED, V46, P699, DOI 10.1097/01.jom.0000131794.83723.45; van Drongelen A, 2011, SCAND J WORK ENV HEA, V37, P263, DOI 10.5271/sjweh.3143; Viswanathan AN, 2007, CANCER RES, V67, P10618, DOI 10.1158/0008-5472.CAN-07-2485; Vyas MV, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4800; Watari M, 2006, PREV MED, V43, P107, DOI 10.1016/j.ypmed.2006.04.012; WHO, 2014, OB OV; Williams C, 2008, PERSPECT LABOUR INCO, V9, P5; Wilsgaard T, 2005, AM J EPIDEMIOL, V162, P1179, DOI 10.1093/aje/kwi328; Wong IS, 2011, SCAND J WORK ENV HEA, V37, P54, DOI 10.5271/sjweh.3124; World Health Organization, 2000, WHO TECHN REP SER, V894; World Health Organization International Agency for Research on Canada (IARC), 2010, IARC MONOGR EVAL CAR, V98, P563; Wright SM, 2012, ABDOM IMAGING, V37, P730, DOI 10.1007/s00261-012-9862-x	46	7	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137561	10.1371/journal.pone.0137561	http://dx.doi.org/10.1371/journal.pone.0137561			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8NH	26376050	Green Published, Green Submitted, gold			2022-12-27	WOS:000361610200042
J	Nishijima, T; Yashiro, S; Teruya, K; Kikuchi, Y; Katai, N; Oka, S; Gatanaga, H				Nishijima, Takeshi; Yashiro, Shigeko; Teruya, Katsuji; Kikuchi, Yoshimi; Katai, Naomichi; Oka, Shinichi; Gatanaga, Hiroyuki			Routine Eye Screening by an Ophthalmologist Is Clinically Useful for HIV-1-Infected Patients with CD4 Count Less than 200 /mu L	PLOS ONE			English	Article							HIV-INFECTED INDIVIDUALS; CYTOMEGALOVIRUS RETINITIS; RETINAL MICROANGIOPATHY; ANTIRETROVIRAL THERAPY; RISK-FACTORS; DISEASE; AIDS; ERA; INITIATION	Objective To investigate whether routine eye screening by an ophthalmologist in patients with HIV-1 infection is clinically useful. Methods A single-center, retrospective study in Tokyo, Japan. HIV-1-infected patients aged over 17 years who visited our clinic for the first time between January 2004 and December 2013 and underwent full ophthalmologic examination were enrolled. At our clinic, ophthalmologic examination, including dilated retinal examination by indirect ophthalmoscopy was routinely conducted by ophthalmologists on the first visit. The prevalence of ophthalmologic diseases and associated factors including the existence of ocular symptoms were analyzed. Results Of the 1,515 study patients, cytomegalovirus retinitis (CMV-R) was diagnosed in 24 (2%) patients, HIV retinopathy (HIV-R) in 127 (8%), cataract in 31 (2%), ocular syphilis in 4 (0.3%), and uveitis with unknown cause in 8 (0.5%). Other ocular diseases were diagnosed in 14 patients. The CD4 count was <200 /mu L in all CMV-R cases and 87% of HIV-R. The prevalence of any ocular diseases, CMV-R, and HIV-R in patients with CD4 <200 /mu L were 22%, 3%, and 15%, respectively, whereas for those with CD4 >= 200 /mu L were 5%, 0%, and 2%, respectively. No ocular symptoms were reported by 71% of CMV-R cases and 82% of patients with any ocular diseases. Conclusions Routine ophthalmologic screening is recommended for HIV-1-infected patients with CD4 <200/mu L in resource-rich settings based on the high prevalence of ocular diseases within this CD4 count category and because most patients with ocular diseases, including those with CMV-R, were free of ocular symptoms.	[Nishijima, Takeshi; Teruya, Katsuji; Kikuchi, Yoshimi; Oka, Shinichi; Gatanaga, Hiroyuki] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Yashiro, Shigeko; Katai, Naomichi] Natl Ctr Global Hlth & Med, Dept Ophthalmol, Tokyo, Japan; [Nishijima, Takeshi; Oka, Shinichi; Gatanaga, Hiroyuki] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; Kumamoto University	Gatanaga, H (corresponding author), Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan.	higatana@acc.ncgm.go.jp		Oka, Shinichi/0000-0002-9283-2167	Japanese Ministry of Health, Labour, and Welfare [H23-AIDS-001, H24-AIDS-003]	Japanese Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grant-in-Aids for AIDS research from the Japanese Ministry of Health, Labour, and Welfare (H23-AIDS-001; H24-AIDS-003).	Aberg JA, 2014, CLIN INFECT DIS, V58, pE1, DOI [10.1093/cid/cit665, 10.1093/cid/cit757]; Cunningham ET, 2001, AM J OPHTHALMOL, V132, P727, DOI 10.1016/S0002-9394(01)01217-X; Curtis JR, 2006, ARTHRIT RHEUM-ARTHR, V55, P420, DOI 10.1002/art.21984; Da Silva JAP, 2006, ANN RHEUM DIS, V65, P285, DOI 10.1136/ard.2005.038638; Furrer H, 2003, OPHTHALMOLOGY, V110, P432, DOI 10.1016/S0161-6420(02)01750-5; GALLANT JE, 1992, J INFECT DIS, V166, P1223, DOI 10.1093/infdis/166.6.1223; Goldberg DE, 2005, RETINA-J RET VIT DIS, V25, P633, DOI 10.1097/00006982-200507000-00015; Gomez ML, 2009, OPHTHALMOLOGY, V116, P2407, DOI 10.1016/j.ophtha.2009.05.012; Hall HI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077763; Heiden D, 2007, PLOS MED, V4, P1845, DOI 10.1371/journal.pmed.0040334; Helleberg M, 2015, AIDS, V29, P221, DOI 10.1097/QAD.0000000000000540; Hodge WG, 2004, OPHTHALMOLOGY, V111, P1326, DOI 10.1016/j.ophtha.2004.03.001; Holland GN, 2008, AM J OPHTHALMOL, V145, P397, DOI 10.1016/j.ajo.2007.12.001; Iragui VJ, 1996, NEUROLOGY, V47, P1452, DOI 10.1212/WNL.47.6.1452; Iwasaki Y, 2013, JPN J OPHTHALMOL, V57, P372, DOI 10.1007/s10384-013-0247-7; Jabs D A, 1995, Trans Am Ophthalmol Soc, V93, P623; Jabs DA, 2005, OPHTHALMOLOGY, V112, P771, DOI 10.1016/j.ophtha.2004.10.049; Jabs DA, 2007, OPHTHALMOLOGY, V114, P780, DOI 10.1016/j.ophtha.2006.11.008; Jacobson MA, 1997, LANCET, V349, P1443, DOI 10.1016/S0140-6736(96)11431-8; KALEEM MA, 2012, INT OPHTHALMOL, V32, P145, DOI DOI 10.1007/S10792-012-9543-3; Kestelyn PG, 2001, B WORLD HEALTH ORGAN, V79, P208; Kiss Szilard, 2005, Semin Ophthalmol, V20, P161, DOI 10.1080/08820530500232092; Lahuerta M, 2014, CLIN INFECT DIS, V58, P432, DOI 10.1093/cid/cit724; Lindblad BE, 2008, OPHTHALMOLOGY, V115, P1687, DOI 10.1016/j.ophtha.2008.04.004; Mizushima D, 2015, JAIDS-J ACQ IMM DEF, V68, P140, DOI 10.1097/QAI.0000000000000410; Nishijima T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022661; Rasmussen LD, 2011, CLIN INFECT DIS, V53, P1156, DOI 10.1093/cid/cir675; Stewart MW, 2012, INFECT DIS REP, V4, P92, DOI [10.4081/idr.2012.3853, 10.4081/idr.2012.e25]; Sugar EA, 2012, AM J OPHTHALMOL, V153, P1016, DOI 10.1016/j.ajo.2011.11.014; Thorne JE, 2006, OPHTHALMOLOGY, V113, P1441, DOI 10.1016/j.ophtha.2006.03.022; Tucker JD, 2011, SEX TRANSM INFECT, V87, P4, DOI 10.1136/sti.2010.043042; Vrabec TR, 2004, SURV OPHTHALMOL, V49, P131, DOI 10.1016/j.survophthal.2003.12.008; Wohl DA, 2009, HIV CLIN TRIALS, V10, P143, DOI 10.1310/hct1003-143	33	16	21	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136747	10.1371/journal.pone.0136747	http://dx.doi.org/10.1371/journal.pone.0136747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375282	Green Published, gold, Green Submitted			2022-12-27	WOS:000361610200022
J	Ruzzenenti, F; Joseph, A; Ticci, E; Vozzella, P; Gabbi, G				Ruzzenenti, Franco; Joseph, Andreas; Ticci, Elisa; Vozzella, Pietro; Gabbi, Giampaolo			Interactions between Financial and Environmental Networks in OECD Countries	PLOS ONE			English	Article							RECIPROCITY; DYNAMICS; FDI	We analysed a multiplex of financial and environmental networks between OECD countries from 2002 to 2010. Foreign direct investments and portfolio investment showing the flows in equity securities, short-term, long-term and total debt, these securities represent the financial layers; emissions of NOx, PM10, SO2, CO2 equivalent and the water footprint associated with international trade represent the environmental layers. We present a new measure of cross-layer correlations between flows in different layers based on reciprocity. For the assessment of results, we implement a null model for this measure based on the exponential random graph theory. We find that short-term financial flows are more correlated with environmental flows than long-term investments. Moreover, the correlations between reverse financial and environmental flows (i.e. the flows of different layers going in opposite directions) are generally stronger than correlations between synergic flows (flows going in the same direction). This suggests a trade-off between financial and environmental layers, where, more financialised countries display higher correlations between outgoing financial flows and incoming environmental flows than from lower financialised countries. Five countries are identified as hubs in this finance-environment multiplex: The United States, France, Germany, Belgium-Luxembourg and United Kingdom.	[Ruzzenenti, Franco] Univ Siena, Dept Biotechnol Chem & Pharm, IT-53100 Siena, Italy; [Joseph, Andreas] Bank England, Adv Analyt, London EC2R 8AH, England; [Ticci, Elisa] Univ Siena, Dept Econ & Stat, IT-53100 Siena, Italy; [Vozzella, Pietro; Gabbi, Giampaolo] Univ Siena, Dept Business & Law, IT-53100 Siena, Italy	University of Siena; Bank of England; University of Siena; University of Siena	Ruzzenenti, F (corresponding author), Univ Siena, Dept Biotechnol Chem & Pharm, Via Aldo Moro 1, IT-53100 Siena, Italy.	ruzzenenti@gmail.com		GABBI, GIAMPAOLO/0000-0001-8137-233X				Aichele R, 2014, REV EC STAT; Aizenman J., 2004, 10496 NBER; Aizenman J, 2006, Q REV ECON FINANC, V46, P317, DOI 10.1016/j.qref.2006.02.004; Albuquerque R, 2005, J INT ECON, V66, P267, DOI 10.1016/j.jinteco.2004.07.002; Aviat A, 2007, J INT ECON, V71, P22, DOI 10.1016/j.jinteco.2006.02.002; Barigozzi M, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046104; Battiston S, 2003, PHYSICA A, V322, P567, DOI 10.1016/S0378-4371(02)01930-1; Battiston S, 2013, NAT PHYS, V9, P123, DOI 10.1038/nphys2575; Bianconi G, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062806; Blonigen B. A., 2005, 11299 NBER; Broner F, 2012, NAT BUREAU EC RES; Catanzaro M, 2013, NAT PHYS, V9, P121, DOI 10.1038/nphys2570; Chung S, 2014, J DEV ECON, V108, P222, DOI 10.1016/j.jdeveco.2014.01.003; Coeurdacier N, 2009, J INT ECON, V77, P86, DOI 10.1016/j.jinteco.2008.10.005; Delpini D, 2013, SCI REP-UK, V3, DOI 10.1038/srep01626; Galbiati M, 2013, NAT PHYS, V9, P126, DOI 10.1038/nphys2581; Galstyan V, 2013, EUR ECON REV, V57, P63, DOI 10.1016/j.euroecorev.2012.10.002; Garlaschelli D, 2005, PHYSICA A, V350, P491, DOI 10.1016/j.physa.2004.11.040; Gemmetto V, 2015, SCI REP-UK, V5, DOI 10.1038/srep09120; Gemmetto V, 2014, ARXIV14111282PHYSICS; Hanna R, 2010, AM ECON J-APPL ECON, V2, P158, DOI 10.1257/app.2.3.158; Iori G, 2008, J ECON DYN CONTROL, V32, P259, DOI 10.1016/j.jedc.2007.01.032; Joseph A, ARXIV14030848QFINGN; Joseph AC, 2014, PHYSICA D, V267, P58, DOI 10.1016/j.physd.2013.08.005; Joseph AC, 2014, SCI REP-UK, V4, DOI 10.1038/srep03991; Kaushik R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061815; Lane PR, 2008, REV ECON STAT, V90, P538, DOI 10.1162/rest.90.3.538; Lenzen M, 2013, ECON SYST RES, V25, P20, DOI 10.1080/09535314.2013.769938; Lenzen M, 2012, ENVIRON SCI TECHNOL, V46, P8374, DOI 10.1021/es300171x; Levinson A, 2008, INT ECON REV, V49, P223, DOI 10.1111/j.1468-2354.2008.00478.x; Mulatu A, 2010, ENVIRON RESOUR ECON, V45, P459, DOI 10.1007/s10640-009-9323-3; Nicosia V, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.058701; Ruzzenenti F, 2010, SYMMETRY-BASEL, V2, P1710, DOI 10.3390/sym2031710; Squartini T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03357; Squartini T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02729; Wilde O, 1998, EPIGRAMS OSCAR WILDE	36	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136767	10.1371/journal.pone.0136767	http://dx.doi.org/10.1371/journal.pone.0136767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8NH	26375393	gold, Green Published, Green Submitted			2022-12-27	WOS:000361610200023
J	Hampel, A; Huber, C; Geffers, R; Spona-Friedl, M; Eisenreich, W; Bange, FC				Hampel, Annegret; Huber, Claudia; Geffers, Robert; Spona-Friedl, Marina; Eisenreich, Wolfgang; Bange, Franz-Christoph			Mycobacterium tuberculosis Is a Natural Ornithine Aminotransferase (rocD) Mutant and Depends on Rv2323c for Growth on Arginine	PLOS ONE			English	Article							NITRITE REDUCTASE NIRBD; BOVIS BCG; BACILLUS-SUBTILIS; HUMAN MACROPHAGES; OXIDE SYNTHASE; METABOLISM; BIOSYNTHESIS; SMEGMATIS; AMIDINOTRANSFERASE; CATABOLISM	Mycobacterium tuberculosis (Mtb) possesses a genetic repertoire for metabolic pathways, which are specific and fit to its intracellular life style. Under in vitro conditions, Mtb is known to use arginine as a nitrogen source, but the metabolic pathways for arginine utilization have not been identified. Here we show that, in the presence of arginine, Mtb upregulates a gene cluster which includes an ornithine aminotransferase (rocD) and Rv2323c, a gene of unknown function. Isotopologue analysis by using C-13-or N-15-arginine revealed that in Mtb arginine is not only used as nitrogen source but also as carbon source for the formation of amino acids, in particular of proline. Surprisingly, rocD, which is widespread in other bacteria and is part of the classical arginase pathway turned out to be naturally deleted in Mtb, but not in non-tuberculous mycobacteria. Mtb lacking Rv2323c showed a growth defect on arginine, did not produce proline from arginine, and incorporated less nitrogen derived from arginine in its core nitrogen metabolism. We conclude that the highly induced pathway for arginine utilization in Mtb differs from that of other bacteria including non-tuberculous mycobacteria, probably reflecting a specific metabolic feature of intracellular Mtb.	[Hampel, Annegret; Bange, Franz-Christoph] Hannover Med Sch, Dept Med Microbiol & Hosp Epidemiol, D-30625 Hannover, NH, Germany; [Huber, Claudia; Spona-Friedl, Marina; Eisenreich, Wolfgang] Tech Univ Munich, Lehrstuhl Biochem, Garching, Germany; [Geffers, Robert] Helmholtz Ctr Infect Res, Res Grp Genome Analyt, D-38124 Braunschweig, Germany	Hannover Medical School; Technical University of Munich; Helmholtz Association; Helmholtz-Center for Infection Research	Bange, FC (corresponding author), Hannover Med Sch, Dept Med Microbiol & Hosp Epidemiol, D-30625 Hannover, NH, Germany.	bange.franz@mh-hannover.de	Eisenreich, Wolfgang/A-1258-2013	Eisenreich, Wolfgang/0000-0002-9832-8279	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [Sonderforschungsbereich 587, 900]	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) through the grant Sonderforschungsbereich 587 and 900 to AH and FCB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELAL AT, 1979, ANNU REV MICROBIOL, V33, P139, DOI 10.1146/annurev.mi.33.100179.001035; Akhtar S, 2013, J BACTERIOL, V195, P4592, DOI 10.1128/JB.00698-13; Bange F.-C., 1999, Tubercle and Lung Disease, V79, P171, DOI 10.1054/tuld.1998.0201; Bogdan C, 2015, TRENDS IMMUNOL, V36, P161, DOI 10.1016/j.it.2015.01.003; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cunningham-Bussel A, 2013, P NATL ACAD SCI USA, V110, pE4256, DOI 10.1073/pnas.1316894110; DARBRE A, 1968, BIOCHEM J, V106, P923, DOI 10.1042/bj1060923; DENIS M, 1991, CELL IMMUNOL, V132, P150, DOI 10.1016/0008-8749(91)90014-3; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Eylert E, 2008, MOL MICROBIOL, V69, P1008, DOI 10.1111/j.1365-2958.2008.06337.x; Fritsche E, 1998, BIOCHEMISTRY-US, V37, P17664, DOI 10.1021/bi981949p; GARDAN R, 1995, J MOL BIOL, V249, P843, DOI 10.1006/jmbi.1995.0342; Gordhan BG, 2002, INFECT IMMUN, V70, P3080, DOI 10.1128/IAI.70.6.3080-3084.2002; Gouzy A, 2014, NAT REV MICROBIOL; Gouzy A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003928; Harper CJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-138; Hernandez-Guzman G, 2001, MOL PLANT MICROBE IN, V14, P545, DOI 10.1094/MPMI.2001.14.4.545; Hondalus MK, 2000, INFECT IMMUN, V68, P2888, DOI 10.1128/IAI.68.5.2888-2898.2000; Jagannath C, 1998, NITRIC OXIDE-BIOL CH, V2, P174, DOI 10.1006/niox.1998.9999; Jenkins VA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-301; JeSSberger Nadja, 2013, BMC Res Notes, V6, P482, DOI 10.1186/1756-0500-6-482; Jung JY, 2013, INFECT IMMUN, V81, P3198, DOI 10.1128/IAI.00611-13; Kwon O. Jung, 1997, Journal of Korean Medical Science, V12, P481; LEE WNP, 1991, BIOL MASS SPECTROM, V20, P451, DOI 10.1002/bms.1200200804; Lew JM, 2011, TUBERCULOSIS, V91, P1, DOI 10.1016/j.tube.2010.09.008; Malm S, 2009, MICROBIOL-SGM, V155, P1332, DOI 10.1099/mic.0.023275-0; Muenchhoff J, 2010, FEBS J, V277, P3844, DOI 10.1111/j.1742-4658.2010.07788.x; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Patel CN, 2006, J BACTERIOL, V188, P2355, DOI 10.1128/JB.188.7.2355-2363.2006; Pavelka MS, 1999, J BACTERIOL, V181, P4780, DOI 10.1128/JB.181.16.4780-4789.1999; Peteroy-Kelly MA, 2003, INFECT IMMUN, V71, P1011, DOI 10.1128/IAI.71.2.1011-1015.2003; Rockett KA, 1998, INFECT IMMUN, V66, P5314, DOI 10.1128/IAI.66.11.5314-5321.1998; Scanga CA, 2001, INFECT IMMUN, V69, P7711, DOI 10.1128/IAI.69.12.7711-7717.2001; Schneider BL, 1998, J BACTERIOL, V180, P4278, DOI 10.1128/JB.180.16.4278-4286.1998; Seth A, 2000, J BACTERIOL, V182, P919, DOI 10.1128/JB.182.4.919-927.2000; SHAIBE E, 1985, J BACTERIOL, V163, P933, DOI 10.1128/JB.163.3.933-937.1985; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Surken M, 2008, INT J MED MICROBIOL, V298, P657, DOI 10.1016/j.ijmm.2007.09.003; Talaue MT, 2006, J BACTERIOL, V188, P4830, DOI 10.1128/JB.01687-05; Tiffert Y, 2008, MOL MICROBIOL, V67, P861, DOI 10.1111/j.1365-2958.2007.06092.x; Townsend DE, 1996, MICROBIOL-SGM, V142, P1491, DOI 10.1099/13500872-142-6-1491; World Health Organization, 2015, GLOB TUB REP 2014; Zaprasis A, 2014, ENVIRON MICROBIOL, V16, P701, DOI 10.1111/1462-2920.12193	45	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136914	10.1371/journal.pone.0136914	http://dx.doi.org/10.1371/journal.pone.0136914			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368558	gold, Green Published, Green Submitted			2022-12-27	WOS:000361601100031
J	Lane, A; Mikolajczak, M; Treinen, E; Samson, D; Corneille, O; de Timary, P; Luminet, O				Lane, Anthony; Mikolajczak, Moira; Treinen, Evelyne; Samson, Dana; Corneille, Olivier; de Timary, Philippe; Luminet, Olivier			Failed Replication of Oxytocin Effects on Trust: The Envelope Task Case	PLOS ONE			English	Article							FACIAL TRUSTWORTHINESS; INCREASES TRUST; EMPATHY; VALIDATION; BEHAVIOR	The neurohormone Oxytocin (OT) has been one of the most studied peptides in behavioral sciences over the past two decades. Many studies have suggested that OT could increase trusting behaviors. A previous study, based on the "Envelope Task" paradigm, where trust is assessed by the degree of openness of an envelope containing participant's confidential information, showed that OT increases trusting behavior and reported one of the most powerful effects of OT on a behavioral variable. In this paper we present two failed replications of this effect, despite sufficient power to replicate the original large effect. The non-significant results of these two failed replications clearly exclude a large effect of OT on trust in this paradigm but are compatible with either a null effect of OT on trust, or a small effect, undetectable with small sample size (N = 95 and 61 in Study 1 and 2, respectively). Taken together, our results question the purported size of OT's effect on trust and emphasize the need for replications.	[Lane, Anthony; Mikolajczak, Moira; Samson, Dana; Corneille, Olivier; Luminet, Olivier] Catholic Univ Louvain, Dept Psychol, Louvain La Neuve, Belgium; [Treinen, Evelyne] Univ Denver, Dept Psychol, Denver, CO 80208 USA; [de Timary, Philippe] Catholic Univ Louvain, Dept Neurol & Psychiat, Woluwe St Lambert, Belgium	Universite Catholique Louvain; University of Denver; Universite Catholique Louvain	Lane, A (corresponding author), Catholic Univ Louvain, Dept Psychol, Louvain La Neuve, Belgium.	Anthony.Lane@uclouvain.be		Mikolajczak, Moira/0000-0002-7333-1578; Corneille, Olivier/0000-0003-4005-4372; Samson, Dana/0000-0001-7428-0031	Fonds de la Recherche Scientifique-FNRS; Psychological Sciences Research Institute; Universite Catholique de Louvain	Fonds de la Recherche Scientifique-FNRS(Fonds de la Recherche Scientifique - FNRS); Psychological Sciences Research Institute; Universite Catholique de Louvain	This work was supported by 2 grants from the Fonds de la Recherche Scientifique-FNRS (www.fnrs.be), one awarded to A.L., the other awarded to E.T., by a collaborative grant awarded by the Psychological Sciences Research Institute to O.C. and D.S. (https://www.uclouvain.be/ipsy.html) and by grant awarded by the Universite Catholique de Louvain to M.M. (www.uclouvain.be). All the funds available were put together to support the research (participants remuneration, purchase of the material like synthetic oxytocin and placebo).	BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Barraza JA, 2009, ANN NY ACAD SCI, V1167, P182, DOI 10.1111/j.1749-6632.2009.04504.x; Bartz JA, 2011, TRENDS COGN SCI, V15, P301, DOI 10.1016/j.tics.2011.05.002; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Bodley Scott SE., 2011, THESIS U NOTTINGHAM; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; De Dreu CKW, 2012, PSYCHONEUROENDOCRINO, V37, P871, DOI 10.1016/j.psyneuen.2011.10.003; Domes G, 2007, BIOL PSYCHIAT, V61, P731, DOI 10.1016/j.biopsych.2006.07.015; Doyen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029081; Feldman R, 2010, PSYCHONEUROENDOCRINO, V35, P1133, DOI 10.1016/j.psyneuen.2010.01.013; Goldberg LR, 2006, J RES PERS, V40, P84, DOI 10.1016/j.jrp.2005.08.007; Hurlemann R, 2010, J NEUROSCI, V30, P4999, DOI 10.1523/JNEUROSCI.5538-09.2010; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Klackl J, 2013, BIOL PSYCHOL, V92, P387, DOI 10.1016/j.biopsycho.2012.11.010; Koole SL, 2012, PERSPECT PSYCHOL SCI, V7, P608, DOI 10.1177/1745691612462586; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Leng G, 2016, BIOL PSYCHIAT, V79, P243, DOI 10.1016/j.biopsych.2015.05.003; Luminet O, 2011, BIOL PSYCHOL, V87, P401, DOI 10.1016/j.biopsycho.2011.05.005; McCullough ME, 2013, NEUROSCI BIOBEHAV R, V37, P1485, DOI 10.1016/j.neubiorev.2013.04.018; Mikolajczak M, 2010, PSYCHOL SCI, V21, P1072, DOI 10.1177/0956797610377343; Mikolajczak M, 2010, BIOL PSYCHOL, V85, P182, DOI 10.1016/j.biopsycho.2010.05.010; Nave G., 2015, PERSPECTIVES PSYCHOL; Petrides KV, 2003, EUR J PERSONALITY, V17, P39, DOI 10.1002/per.466; Riem MME, 2013, PSYCHONEUROENDOCRINO, V38, P1418, DOI 10.1016/j.psyneuen.2012.12.023; Samson D, 2010, J EXP PSYCHOL HUMAN, V36, P1255, DOI 10.1037/a0018729; Shamay-Tsoory SG, 2009, BIOL PSYCHIAT, V66, P864, DOI 10.1016/j.biopsych.2009.06.009; Simons DJ, 2014, PERSPECT PSYCHOL SCI, V9, P76, DOI 10.1177/1745691613514755; Simonsohn U, 2015, PSYCHOL SCI, V26, P559, DOI 10.1177/0956797614567341; SNYDER M, 1974, J PERS SOC PSYCHOL, V30, P526, DOI 10.1037/h0037039; Striepens N, 2013, SCI REP-UK, V3, DOI 10.1038/srep03440; Theodoridou A, 2009, HORM BEHAV, V56, P128, DOI 10.1016/j.yhbeh.2009.03.019; Tournois J., 2000, EUR REV APPL PSYCHOL, V50, P219; Treinen E, 2012, COGNITION, V122, P247, DOI 10.1016/j.cognition.2011.10.006; Walum H, 2016, BIOL PSYCHIAT, V79, P251, DOI 10.1016/j.biopsych.2015.06.016; Yao SX, 2014, INT J NEUROPSYCHOPH, V17, P1785, DOI 10.1017/S146114571400090X	36	39	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137000	10.1371/journal.pone.0137000	http://dx.doi.org/10.1371/journal.pone.0137000			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368396	Green Submitted, Green Published, gold			2022-12-27	WOS:000361601100044
J	Grozdanovic, Z; Almanza, LCB; Goyal, S; Hussain, A; Klassert, TE; Driesch, D; Tokaryeva, V; Loschmann, YYN; Sumanlatha, G; Ahmed, N; Valluri, V; Schumann, RR; Lala, B; Slevogt, H				Grozdanovic, Zarko; Almanza, Luis C. Berrocal; Goyal, Surabhi; Hussain, Abid; Klassert, Tilman E.; Driesch, Dominik; Tokaryeva, Viktoriya; Loeschmann, Yvonne Yi-Na; Sumanlatha, Gadamm; Ahmed, Niyaz; Valluri, Vijayalakshmi; Schumann, Ralf R.; Lala, Birgit; Slevogt, Hortense			A Novel Reading Scheme for Assessing the Extent of Radiographic Abnormalities and Its Association with Disease Severity in Sputum Smear-Positive Tuberculosis: An Observational Study in Hyderabad/India	PLOS ONE			English	Article							POST PRIMARY TUBERCULOSIS; PULMONARY TUBERCULOSIS; LUNG-FUNCTION; OBSTRUCTION; PATHOGENESIS; PATHOLOGY; ADULTS	Background Existing reading schemes for chest X-ray (CXR) used to grade the extent of disease severity at diagnosis in patients with pulmonary tuberculosis (PTB) are often based on numerical scores that summate specific radiographic features. However, since PTB is known to exhibit a wide heterogeneity in pathology, certain features might be differentially associated with clinical parameters of disease severity. Objective We aimed to grade disease severity in PTB patients at diagnosis and after completion of DOTS treatment by developing a reading scheme based on five different radiographic manifestations and analyze their association with the clinical parameters of systemic involvement and infectivity. Methods 141 HIV-negative adults with newly diagnosed sputum smear-positive PTB were enrolled in a prospective observational study in Hyderabad, India. The presence and extent on CXRs of five radiographic manifestations, i.e., lung involvement, alveolar infiltration, cavitation, lymphadenopathy and pleural effusion, were classified using the new reading scheme by using a four-quadrant approach. We evaluated the inter-reader reliability of each manifestation, and its association with BMI and sputum smear positivity at diagnosis. The presence and extent of these radiographic manifestations were further compared with CXRs on completion of DOTS treatment. Results At diagnosis, an average lung area of 51.7% +/- 23.3% was affected by radiographic abnormalities. 94% of the patients had alveolar infiltrates, with 89.4% located in the upper quadrants, suggesting post primary PTB and in 34.8% of patients cavities were found. We further showed that the extent of affected lung area was a negative predictor of BMI (beta value - 0.035, p 0.019). No significant association of BMI with any of the other CXR features was found. The extent of alveolar infiltrates, along with the presence of cavitation, were strongly associated with sputum smear positivity. The microbiological cure rate in our cohort after 6 months of DOTS treatment was 95%. The extent of the affected lung area in these patients decreased from 56.0% +/- 21.5% to 31.0 +/- 20% and a decrease was also observed in the extent of alveolar infiltrates from 98.4% to 25.8% in at least one quadrant, presence of cavities from 34.8% to 1.6%, lymphadenopathy from 46.8% to 16.1%, and pleural effusion from 19.4% to 6.5%. Conclusions We established a new assessment scheme for grading disease severity in PTB by specifically considering five radiographic manifestations which were differently associated with the BMI and sputum smear positivity, changed to a different extent after 6 months of treatment and exhibited an excellent agreement between radiologists. Our results suggest that this reading scheme might contribute to the estimation of disease severity with respect to differences in disease pathology. Further studies are needed to determine a correlation with short and long-term pulmonary function impairment and whether there would be any benefit in lengthening or modulating therapy based on this CXR severity assessment.	[Grozdanovic, Zarko; Loeschmann, Yvonne Yi-Na] Charite, Dept Radiol, D-13353 Berlin, Germany; [Almanza, Luis C. Berrocal; Goyal, Surabhi; Schumann, Ralf R.] Charite, Inst Microbiol & Hyg, D-13353 Berlin, Germany; [Almanza, Luis C. Berrocal; Klassert, Tilman E.; Slevogt, Hortense] Jena Univ Hosp, Sept Res Ctr, Jena, Germany; [Hussain, Abid; Sumanlatha, Gadamm; Valluri, Vijayalakshmi] Bhagwan Mahavir Med Res Ctr, Dept Immunol, Hyderabad, Andhra Pradesh, India; [Driesch, Dominik] BioControl Jena GmbH, Jena, Germany; [Tokaryeva, Viktoriya] Helios Klinikum Berlin Buch, Dept Radiol, Berlin, Germany; [Ahmed, Niyaz] Univ Hyderabad, Dept Biotechnol & Bioinformat, Pathogen Biol Lab, Hyderabad 500134, Andhra Pradesh, India; [Valluri, Vijayalakshmi] Blue Peter Res Ctr, Immunol & Mol Biol, LEPRA Soc, Hyderabad, Andhra Pradesh, India; [Lala, Birgit] Charite, Dept Pediat Radiol, Campus Virchow Klinikum, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Friedrich Schiller University of Jena; Helios Kliniken; University of Hyderabad; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Slevogt, H (corresponding author), Jena Univ Hosp, Sept Res Ctr, Jena, Germany.	hortense.slevogt@med.uni-jena.de		Goyal, Surabhi/0000-0002-9596-0156	Deutsche Forschungsgemeinschaft (DFG) International Graduate School (IRTG) [GRK1673]; Federal Ministry for Education and Science [BMBF 03Z2JN22]; BioControl Jena GmbH	Deutsche Forschungsgemeinschaft (DFG) International Graduate School (IRTG)(German Research Foundation (DFG)); Federal Ministry for Education and Science; BioControl Jena GmbH	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) International Graduate School (IRTG) GRK1673 and by the Federal Ministry for Education and Science (grant BMBF 03Z2JN22). BioControl Jena GmbH provided support in the form of salaries for authors [DD], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ANNO H, 1955, AM REV TUBERC PULM, V71, P333; [Anonymous], 2010, TREATMENT OF TUBERCU; Baez-Saldana R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078926; BARNES PF, 1988, CHEST, V94, P316, DOI 10.1378/chest.94.2.316; Bernabe-Ortiz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018474; Bhuniya S, 2012, ANN THORAC MED, V7, P215, DOI 10.4103/1817-1737.102176; BIRATH G, 1966, SCAND J RESPIR DIS, V47, P27; BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9; BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V; Cardinale L, 2015, ACTA RADIOL, V56, P557, DOI 10.1177/0284185114533247; de la Mora IL, 2015, INT J TUBERC LUNG D, V19, P808, DOI 10.5588/ijtld.14.0983; Dittrich N, 2015, TUBERCULOSIS, V95, P328, DOI 10.1016/j.tube.2015.02.045; Donald PR, 2010, LANCET, V375, P1852, DOI 10.1016/S0140-6736(10)60580-6; Gadkowski LB, 2008, CLIN MICROBIOL REV, V21, P305, DOI 10.1128/CMR.00060-07; Geng E, 2005, JAMA-J AM MED ASSOC, V293, P2740, DOI 10.1001/jama.293.22.2740; Grosset J, 2003, ANTIMICROB AGENTS CH, V47, P833, DOI 10.1128/AAC.47.3.833-836.2003; Hamilton CD, 2008, INT J TUBERC LUNG D, V12, P1059; Heo EY, 2009, INT J INFECT DIS, V13, pE371, DOI 10.1016/j.ijid.2009.01.007; Horne DJ, 2010, LANCET INFECT DIS, V10, P387, DOI 10.1016/S1473-3099(10)70071-2; Hunter RL, 2014, ANN CLIN LAB SCI, V44, P365; Hunter RL, 2011, TUBERCULOSIS, V91, P497, DOI 10.1016/j.tube.2011.03.007; Jones BE, 1997, AM J RESP CRIT CARE, V156, P1270, DOI 10.1164/ajrccm.156.4.9609143; Khan A, 2006, AM J RESP CRIT CARE, V174, P344, DOI 10.1164/rccm.200511-1834OC; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee JH, 2003, RESP MED, V97, P1237, DOI 10.1016/S0954-6111(03)00255-5; Lenaerts A, 2015, IMMUNOL REV, V264, P288, DOI 10.1111/imr.12252; Maguire GP, 2009, INT J TUBERC LUNG D, V13, P1500; Ministry of Health India, 2005, TECHN OP GUID TUB CO; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; Nyboe J, 1968, Bull Int Union Tuberc, V41, P115; Ors F, 2007, J THORAC IMAG, V22, P154, DOI 10.1097/01.rti.0000213590.29472.ce; Palaci M, 2007, J CLIN MICROBIOL, V45, P4064, DOI 10.1128/JCM.01780-07; Pinto LM, 2013, EUR RESPIR J, V42, P480, DOI 10.1183/09031936.00107412; Pinto LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054235; Plit ML, 1998, EUR RESPIR J, V12, P351, DOI 10.1183/09031936.98.12020351; Ralph AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080302; Ralph AP, 2010, THORAX, V65, P863, DOI 10.1136/thx.2010.136242; [Revised National Tuberculosis Control Programme (RNTCP)-Training module for general practitioners Ministry of Health India], 2010, REV NAT TUB CONTR PR; Rieder HL, 2006, PRIORITIES TUBERCULO; SHAW NJ, 1990, SCOT MED J, V35, P140, DOI 10.1177/003693309003500505; [Standards for TB care in India World Health Organization], 2014, STAND TB CAR IND 201; Van Lettow M, 2004, INT J TUBERC LUNG D, V8, P211; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Wilcke JTR, 1998, RESP MED, V92, P493, DOI 10.1016/S0954-6111(98)90297-9; WILLCOX PA, 1989, RESP MED, V83, P195, DOI 10.1016/S0954-6111(89)80031-9; World Health Organization, SYST SCREEN ACT TUB; World Health Organization, 2014, GLOBAL TUBERCULOSIS	47	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138070	10.1371/journal.pone.0138070	http://dx.doi.org/10.1371/journal.pone.0138070			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381644	Green Published, gold, Green Submitted			2022-12-27	WOS:000361790200055
J	Nason, G; Stevens, K				Nason, Guy; Stevens, Kara			Bayesian Wavelet Shrinkage of the Haar-Fisz Transformed Wavelet Periodogram	PLOS ONE			English	Article							ADAPTIVE ESTIMATION; TIME-SERIES	It is increasingly being realised that many real world time series are not stationary and exhibit evolving second-order autocovariance or spectral structure. This article introduces a Bayesian approach for modelling the evolving wavelet spectrum of a locally stationary wavelet time series. Our new method works by combining the advantages of a Haar-Fisz transformed spectrum with a simple, but powerful, Bayesian wavelet shrinkage method. Our new method produces excellent and stable spectral estimates and this is demonstrated via simulated data and on differenced infant electrocardiogram data. A major additional benefit of the Bayesian paradigm is that we obtain rigorous and useful credible intervals of the evolving spectral structure. We show how the Bayesian credible intervals provide extra insight into the infant electrocardiogram data.	[Nason, Guy; Stevens, Kara] Univ Bristol, Sch Math, Bristol, Avon, England	University of Bristol	Nason, G (corresponding author), Univ Bristol, Sch Math, Bristol, Avon, England.	g.p.nason@bristol.ac.uk	Nason, Guy/H-6446-2014	Nason, Guy/0000-0002-4664-3154; Stevens, Kara/0000-0003-4898-1795	SuSTaIn Science and Innovation Award [EP/D063485/1]; EPSRC [EP/I01687X/1]; Engineering and Physical Sciences Research Council [EP/I01697X/1, EP/D063485/1, EP/K020951/1] Funding Source: researchfish; EPSRC [EP/I01697X/1, EP/K020951/1, EP/D063485/1] Funding Source: UKRI	SuSTaIn Science and Innovation Award; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Kara Stevens was supported by a studentship funded by the SuSTaIn Science and Innovation Award grant EP/D063485/1. Guy Nason was partially supported by EPSRC grants from EP/I01687X/1: "The Energy Programme, an RCUK cross-council initiative led by EPSRC and contributed to by ESRC, NERC, BBSRC and STFC" and EP/K02951/1.	Barber S, 2002, J R STAT SOC B, V64, P189, DOI 10.1111/1467-9868.00332; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Chipman HA, 1997, J AM STAT ASSOC, V92, P1413, DOI 10.2307/2965411; Clyde M., 1999, BAYESIAN INFERENCE W, V141, P309; Coifman R. R., 1995, TRANSLATION INVARIAN, P125, DOI [10.1007/978-1-4612-2544-7, DOI 10.1007/978-1-4612-2544-7_9, 10.1007/978-1-4612-2544-7_9]; Dahlhaus R, 1997, ANN STAT, V25, P1; Dahlhaus R, 2012, HANDB STAT, V30, P351, DOI 10.1016/B978-0-444-53858-1.00013-2; Daubechies I., 1992, 10 LECT WAVELETS, DOI [10.1137/1.9781611970104.ch1, DOI 10.1137/1.9781611970104.CH1]; Davison AC, 2009, BIOMETRIKA, V96, P479, DOI 10.1093/biomet/asp022; DONOHO DL, 1994, BIOMETRIKA, V81, P425, DOI 10.1093/biomet/81.3.425; Donoho DL, 1995, J AM STAT ASSOC, V90, P1200, DOI 10.1080/01621459.1995.10476626; Eckley IA, 2005, STAT COMPUT, V15, P83, DOI 10.1007/s11222-005-6200-y; Fryzlewicz P, 2003, ANN I STAT MATH, V55, P737, DOI 10.1007/BF02523391; Fryzlewicz P, 2006, J R STAT SOC B, V68, P611, DOI 10.1111/j.1467-9868.2006.00558.x; Johnstone IM, 2005, ANN STAT, V33, P1700, DOI 10.1214/009053605000000345; Muller P, 1998, J COMPUT GRAPH STAT, V7, P456, DOI 10.2307/1390676; Nason G., 1995, SPRINGER LECT NOTES, V103, P281, DOI DOI 10.1007/978-1-4612-2544-7_17; Nason G., 2012, WAVETHRESH WAVELETS; Nason GP, 1999, PHILOS T R SOC A, V357, P2511, DOI 10.1098/rsta.1999.0445; Nason GP, 2000, J ROY STAT SOC B, V62, P271, DOI 10.1111/1467-9868.00231; PAGE CH, 1952, J APPL PHYS, V23, P103, DOI 10.1063/1.1701949; Pensky M, 2007, STAT SINICA, V17, P635; PRIESTLEY MB, 1965, J ROY STAT SOC B, V27, P204; R Development Core Team, 2012, R LANG ENV STAT COMP; Ruggeri F, 2005, HANDB STAT, V25, P315, DOI 10.1016/S0169-7161(05)25011-3; Sawczenko A, 1995, PEDIAT PULMONOL, V20, P341; Semadeni C, 2004, BIOMETRIKA, V91, P497, DOI 10.1093/biomet/91.2.497; SILVERMAN RA, 1957, IRE T INFORM THEOR, V3, P182, DOI 10.1109/TIT.1957.1057413; Van Bellegem S, 2008, ANN STAT, V36, P1879, DOI 10.1214/07-AOS524; Vidakovic B., 1999, STAT MODELING WAVELE; Vidakovic B., 1998, LECT NOTES STAT, V133, P133	31	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137662	10.1371/journal.pone.0137662	http://dx.doi.org/10.1371/journal.pone.0137662			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381141	Green Published, Green Submitted, gold			2022-12-27	WOS:000361790200031
J	Tangena, JAA; Thammavong, P; Hiscox, A; Lindsay, SW; Brey, PT				Tangena, Julie-Anne A.; Thammavong, Phoutmany; Hiscox, Alexandra; Lindsay, Steve W.; Brey, Paul T.			The Human-Baited Double Net Trap: An Alternative to Human Landing Catches for Collecting Outdoor Biting Mosquitoes in Lao PDR	PLOS ONE			English	Article							DIPTERA-CULICIDAE; ANOPHELES-GAMBIAE; AEDES-ALBOPICTUS; BG-SENTINEL; MALARIA; SURVEILLANCE	Estimating the exposure of individuals tomosquito-borne diseases is a key measure used to evaluate the success of vector control operations. The gold standard is to use human landing catches wheremosquitoes are collected off the exposed limbs of human collectors. This is however an unsatisfactory method since it potentially exposes individuals to a range of mosquito-borne diseases. In this study several samplingmethods were compared to find amethod that is representative of the human-biting rate outdoors, but which does not expose collectors to mosquito-borne infections. The sampling efficiency of four odour-baited traps were compared outdoors in rural Lao PDR; the human-baited double net (HDN) trap, CDC light trap, BG sentinel trap and Suna trap. Subsequently the HDN, the best performing trap, was compared directly with human landing catches (HLC), the 'gold standard', for estimating human-biting rates. HDNs collected 11-44 times more mosquitoes than the other traps, with the exception of the HLC. The HDN collected similar numbers of Anopheles (Rate Ratio, RR = 1.16, 95% Confidence Intervals, 95% CI = 0.61-2.20) and Culex mosquitoes (RR = 1.26, 95% CI = 0.74-2.17) as HLC, but under-estimated the numbers of Aedes albopictus (RR = 0.45, 95% CI = 0.27-0.77). Simpson's index of diversity was 0.845 (95% CI 0.836-0.854) for the HDN trap and 0.778 (95% CI 0.769-0.787) for HLC, indicating that the HDN collected a greater diversity of mosquito species than HLC. Both HLC and HDN can distinguish between low and high biting rates and are crude ways to measure human-biting rate. The HDN is a simple and cheap method to estimate the human-biting rate outdoors without exposing collectors tomosquito bites.	[Tangena, Julie-Anne A.; Thammavong, Phoutmany; Brey, Paul T.] Inst Pasteur Laos, Dept Entomol, Viangchan, Laos; [Tangena, Julie-Anne A.; Lindsay, Steve W.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Hiscox, Alexandra] Univ Wageningen & Res Ctr, Entomol Lab, Wageningen, Netherlands	Durham University; Wageningen University & Research	Tangena, JAA (corresponding author), Inst Pasteur Laos, Dept Entomol, Viangchan, Laos.	j.tangena@pasteur.la	Tangena, Julie-Anne/L-1053-2019	Lindsay, Steve/0000-0002-3461-9050; Tangena, Julie-Anne/0000-0002-8188-4498	Agence Francaise de Developpement [CZZ 1809 AA]	Agence Francaise de Developpement	Funding: This work was supported by The Agence Francaise de Developpement; Grant number CZZ 1809 AA; http://www.afd.fr/lang/en/home. This project falls under the project ECOMORE; http://ecomore.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, COMPUTER PROGRAM CAL; [Anonymous], 2012, BG SENT BIOG MOSQ TR; Azil AH, 2011, ASIA-PAC J PUBLIC HE, V23, P827, DOI 10.1177/1010539511426595; Farajollahi A, 2009, J MED ENTOMOL, V46, P919, DOI 10.1603/033.046.0426; Gater BAR, 1935, AIDS IDENTIFICATION; Gimnig JE, 2013, AM J TROP MED HYG, V88, P301, DOI 10.4269/ajtmh.2012.12-0209; HADDOW AJ, 1945, B ENTOMOL RES, V36, P33, DOI 10.1017/S0007485300023907; HAMON JACQUES, 1964, BULL SOC PATHOL EXOTIQUE, V57, P576; Hiscox A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-257; Kilama M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-111; Kim Heung Chul, 2003, Korean Journal of Entomology, V33, P189; Klock J. W., 1953, Mosquito News Albany NY, V13, P157; Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2; Lee RML, 2012, J AM MOSQUITO CONTR, V28, P248, DOI 10.2987/12-6239R.1; LeGoff G, 1997, PARASITE, V4, P75, DOI 10.1051/parasite/1997041075; LINDSAY SW, 1993, T ROY SOC TROP MED H, V87, P45, DOI 10.1016/0035-9203(93)90175-P; LINES JD, 1991, B ENTOMOL RES, V81, P77, DOI 10.1017/S0007485300053268; Mboera LEG, 1998, AM J TROP MED HYG, V59, P595, DOI 10.4269/ajtmh.1998.59.595; McKenzie FE, 2004, MALARIA J, P3; Meeraus WH, 2008, J AM MOSQUITO CONTR, V24, P244, DOI 10.2987/5676.1; Menger DJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-119; Mweresa C, 2014, MALARIA J, P13; Njiru BN, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-39; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Peet R.K., 1974, Annual Rev Ecol Syst, V5, P285, DOI 10.1146/annurev.es.05.110174.001441; Rattanarithikul R, 1996, J AM MOSQUITO CONTR, V12, P52; Rattanarithikul R, 2005, SE ASIAN J TROP MED, p[37, 41, 36]; RUBIOPALIS Y, 1992, J AM MOSQUITO CONTR, V8, P261; Schultz George W., 1993, Southeast Asian Journal of Tropical Medicine and Public Health, V24, P157; Seng Chang Moh, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P454; SERVICE MW, 1977, B ENTOMOL RES, V67, P343, DOI 10.1017/S0007485300011184; Service MW, 1963, B ENTOMOL RES, V54, P601, DOI DOI 10.1017/S000748530004904X; Silver JB., 2008, FIELD SAMPLING METHO; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Singh Neeru, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P196; Smallegange RC, 2010, MALARIA J, P9; Smallegange RC, 2010, J MED ENTOMOL, V47, P338, DOI 10.1603/ME09015; *WHO, 1975, MAN PRACT ENT MAL 2, P191; Williams CR, 2007, J MED ENTOMOL, V44, P345, DOI 10.1603/0022-2585(2007)44[345:AAPSUB]2.0.CO;2; World Health Organization (WHO), 2013, GLOB ACT PLAN PREV C, V1; Zahedi M., 1994, Mosquito Borne Diseases Bulletin, V11, P81	41	58	58	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138735	10.1371/journal.pone.0138735	http://dx.doi.org/10.1371/journal.pone.0138735			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381896	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000361790200157
J	Foster, AJ; Pelletier, G; Tanguay, P; Seguin, A				Foster, Adam J.; Pelletier, Gervais; Tanguay, Philippe; Seguin, Armand			Transcriptome Analysis of Poplar during Leaf Spot Infection with Sphaerulina spp.	PLOS ONE			English	Article							HYBRID POPLAR; EXPRESSION ANALYSIS; INDUCED DEFENSES; SEPTORIA-MUSIVA; DATA SETS; POPULUS; ARABIDOPSIS; SEQUENCE; GENOMICS; RESISTANCE	Diseases of poplar caused by the native fungal pathogen Sphaerulina musiva and related species are of growing concern, particularly with the increasing interest in intensive poplar plantations to meet growing energy demands. Sphaerulina musiva is able to cause infection on leaves, resulting in defoliation and canker formation on stems. To gain a greater understanding of the different responses of poplar species to infection caused by the naturally co-evolved Sphaerulina species, RNA-seq was conducted on leaves of Populus deltoides, P. balsamifera and P. tremuloides infected with S. musiva, S. populicola and a new undescribed species, Ston1, respectively. The experiment was designed to contain the pathogen in a laboratory environment, while replicating disease development in commercial plantations. Following inoculation, trees were monitored for disease symptoms, pathogen growth and host responses. Genes involved in phenylpropanoid, terpenoid and flavonoid biosynthesis were generally upregulated in P. balsamifera and P. tremuloides, while cell wall modification appears to play an important role in the defense of P. deltoides. Poplar defensive genes were expressed early in P. balsamifera and P. tremuloides, but their expression was delayed in P. deltoides, which correlated with the rate of disease symptoms development. Also, severe infection in P. balsamifera led to leaf abscission. This data gives an insight into the large differences in timing and expression of genes between poplar species being attacked by their associated Sphaerulina pathogen.	[Foster, Adam J.; Pelletier, Gervais; Tanguay, Philippe; Seguin, Armand] Nat Resources Canada, Canadian Forest Serv, Laurentian Forestry Ctr, Quebec City, PQ, Canada	Natural Resources Canada; Canadian Forest Service	Seguin, A (corresponding author), Nat Resources Canada, Canadian Forest Serv, Laurentian Forestry Ctr, Quebec City, PQ, Canada.	Armand.Seguin@RNCan-NRCan.ca			Genomics R&D Initiative of Canada; Natural Sciences and Engineering Research Council of Canada	Genomics R&D Initiative of Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding for this research was provided by the Genomics R&D Initiative of Canada (http://grdiirdg.collaboration.gc.ca/eng/) and the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) Discovery Grant program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2008, EUPHYTICA, V159, P167, DOI 10.1007/s10681-007-9469-4; Azaiez A, 2009, MOL PLANT MICROBE IN, V22, P190, DOI 10.1094/MPMI-22-2-0190; Bao H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-359; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; BIER J. E., 1939, CANADIAN JOUR RES SECT C BOT SCI, V17, P195; Borem A, 2014, OMICS IN PLANT BREEDING, P1, DOI 10.1002/9781118820971; Busby PE, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00127.1; Busby PE, 2012, FUNGAL BIOL-UK, V116, P792, DOI 10.1016/j.funbio.2012.04.012; Christopher ME, 2004, PLANTA, V219, P936, DOI 10.1007/s00425-004-1297-3; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cossu RM, 2014, TREE GENET GENOMES, V10, P53, DOI 10.1007/s11295-013-0661-5; Encinas-Villarejo S, 2009, J EXP BOT, V60, P3043, DOI 10.1093/jxb/erp152; Feau N, 2005, MYCOL RES, V109, P1015, DOI 10.1017/S0953756205003242; Feau N, 2007, J MOL EVOL, V64, P489, DOI 10.1007/s00239-005-0309-7; Feau N, 2006, MOL PHYLOGENET EVOL, V40, P808, DOI 10.1016/j.ympev.2006.03.029; Feau N, 2010, CAN J PLANT PATHOL, V32, P122, DOI 10.1080/07060661003740009; Grant M, 2006, CURR OPIN PLANT BIOL, V9, P414, DOI 10.1016/j.pbi.2006.05.013; Hamzeh M, 2004, AM J BOT, V91, P1398, DOI 10.3732/ajb.91.9.1398; Isabel N, 2013, TREE GENET GENOMES, V9, P621, DOI 10.1007/s11295-012-0569-5; Jansson S, 2007, ANNU REV PLANT BIOL, V58, P435, DOI 10.1146/annurev.arplant.58.032806.103956; Kelleher CT, 2007, PLANT J, V50, P1063, DOI 10.1111/j.1365-313X.2007.03112.x; Kim JY, 2005, BIOCHEM BIOPH RES CO, V330, P921, DOI 10.1016/j.bbrc.2005.03.057; Kombrink A, 2011, MICROBES INFECT, V13, P1168, DOI 10.1016/j.micinf.2011.07.010; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li J, 2006, PLANT J, V46, P477, DOI 10.1111/j.1365-313X.2006.02712.x; Li ZH, 2012, J INTEGR PLANT BIOL, V54, P526, DOI 10.1111/j.1744-7909.2012.01136.x; Liang HY, 2014, PLANT SCI, V223, P69, DOI 10.1016/j.plantsci.2014.03.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; LONG R, 1986, CAN J FOREST RES, V16, P405, DOI 10.1139/x86-072; Major IT, 2006, NEW PHYTOL, V172, P617, DOI 10.1111/j.1469-8137.2006.01877.x; Miranda M, 2007, MOL PLANT MICROBE IN, V20, P816, DOI 10.1094/MPMI-20-7-0816; Morant AV, 2008, PHYTOCHEMISTRY, V69, P1795, DOI 10.1016/j.phytochem.2008.03.006; Ojiambo PS, 2005, PHYTOPATHOLOGY, V95, P108, DOI 10.1094/PHYTO-95-0108; OSTRY ME, 1988, PLANT DIS, V72, P497, DOI 10.1094/PD-72-0497; Petre B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044408; Polle A, 2013, APPL MICROBIOL BIOT, V97, P5669, DOI 10.1007/s00253-013-4940-8; Qin RQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103477; Ralph S, 2006, MOL ECOL, V15, P1275, DOI 10.1111/j.1365-294X.2006.02824.x; RIDE JP, 1975, PHYSIOL PLANT PATHOL, V5, P125, DOI 10.1016/0048-4059(75)90016-8; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Royle DJ, 1995, BIOMASS BIOENERG, V9, P69, DOI 10.1016/0961-9534(95)00080-1; Somssich IE, 1996, P NATL ACAD SCI USA, V93, P14199, DOI 10.1073/pnas.93.24.14199; SPIELMAN LJ, 1986, PLANT DIS, V70, P968, DOI 10.1094/PD-70-968; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tuskan GA, 2005, SCIENCE, V313, P1596, DOI [10.1007/s00425-005-1498-4, DOI 10.1007/S00425-005-1498-4]; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Weiland JE, 2007, PLANT DIS, V91, P1524, DOI 10.1094/PDIS-91-12-1524; Zhao J, 2005, BIOTECHNOL ADV, V23, P283, DOI 10.1016/j.biotechadv.2005.01.003; Zhao Q, 2011, TRENDS PLANT SCI, V16, P227, DOI 10.1016/j.tplants.2010.12.005; Zhu S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-382	51	21	23	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138162	10.1371/journal.pone.0138162	http://dx.doi.org/10.1371/journal.pone.0138162			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378446	Green Published, gold, Green Submitted			2022-12-27	WOS:000361769400062
J	Riccomi, A; Palma, C				Riccomi, Antonella; Palma, Carla			B Cells and Programmed Death-Ligand 2 Signaling Are Required for Maximal Interferon-gamma Recall Response by Splenic CD4(+) Memory T Cells of Mice Vaccinated with Mycobacterium tuberculosis Ag85B	PLOS ONE			English	Article							IFN-GAMMA; BCG VACCINATION; CYTOKINE PRODUCTION; IMMUNE-RESPONSES; MOUSE MODEL; EXPRESSION; INFECTION; PROTECTION; MHC; EFFECTOR	CD4(+) T cells producing interferon-y are crucial for protection against Mycobacterium tuberculosis infection and are the cornerstone of tuberculosis vaccination and immunological diagnostic assays. Since emerging evidence indicates that B cells can modulate T cell responses to M. tuberculosis infection, we investigated the contribution of B cells in regulating interferon-y recall response by memory Thelper1 cells specific for Ag85B, a leading candidate for tuberculosis sub-unit vaccines. We found that B cells were able to maximize the reactivation of CD4(+) memory T cells and the interferon-y response against ex vivo antigen recall in spleens of mice vaccinated with Ag85B. B cell-mediated increase of interferon-y response was particular evident for high interferon-y producer CD4(+) memory T cells, likely because those T cells were required for triggering and amplification of B cell activation. A positive-feedback loop of mutual activation between B cells, not necessarily antigenexperienced but with integral phosphatidylinosito1-3 kinase (PI3K) pathway and a peculiar interferon-y-producing CD4high1 cell subset was established. Programed death-ligand 2 (PD-L2), expressed both on B and the highly activated 4high T cells, contributed to the increase of interferon-y recall response through a PD1-independent pathway. In B celldeficient mice, interferon-y production and activation of Ag85B-specific CD4(+) T cells were blunted against ex vivo antigen recall but these responses could be restored by adding B cells. On the other hand, B cells appeared to down-regulate interleukin-22 recall response. Our data point out that nature of antigen presenting cells determines quality and size of T cell cytokine recall responses. Thus, antigen presenting cells, including B cells, deserve to be considered for a better prediction of cytokine responses by peripheral memory T cells specific for M. tuberculosis antigens. We also invite to consider B cells, PD-L2 and PI3K as potential targets for therapeutic modulation of T cell cytokine responses for tuberculosis control.	[Riccomi, Antonella; Palma, Carla] Ist Super Sanita, Dept Infect Parasit & Immunemediated Dis, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS)	Palma, C (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immunemediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	carla.palma@iss.it	PALMA, CARLA/C-8821-2016	PALMA, CARLA/0000-0003-2583-5306	Ministero della Salute (IT) [3H/16]	Ministero della Salute (IT)	This work was supported by the Ministero della Salute (IT) 3H/16.	Aagaard C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005930; Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; Badell E, 2009, VACCINE, V27, P28, DOI 10.1016/j.vaccine.2008.10.034; Barr Tom A., 2012, Infectious Disorders - Drug Targets, V12, P222; Barr TA, 2010, J IMMUNOL, V185, P2783, DOI 10.4049/jimmunol.1001431; Behrends J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057379; Bosio CM, 2000, J IMMUNOL, V164, P6417, DOI 10.4049/jimmunol.164.12.6417; Boussiotis VA, 2000, J CLIN INVEST, V105, P1317, DOI 10.1172/JCI9918; CHANG CH, 1995, INT IMMUNOL, V7, P1515, DOI 10.1093/intimm/7.9.1515; Clayton A, 2001, J IMMUNOL METHODS, V247, P163, DOI 10.1016/S0022-1759(00)00321-5; da Costa AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112848; Dhiman R, 2014, J INFECT DIS, V209, P578, DOI 10.1093/infdis/jit495; Dorman SE, 2004, LANCET, V364, P2113, DOI 10.1016/S0140-6736(04)17552-1; Ehlers S, 2001, J EXP MED, V194, P1847, DOI 10.1084/jem.194.12.1847; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Gotsman I, 2007, J CLIN INVEST, V117, P2974, DOI 10.1172/JCI31344; Hawkridge T, 2008, J INFECT DIS, V198, P544, DOI 10.1086/590185; Henao-Tamayo M, 2012, TUBERCULOSIS, V92, P211, DOI 10.1016/j.tube.2012.02.008; Heuts F, 2013, P NATL ACAD SCI USA, V110, P6482, DOI 10.1073/pnas.1219985110; Hirsch CS, 1999, J INFECT DIS, V180, P2069, DOI 10.1086/315114; Jurado JO, 2008, J IMMUNOL, V181, P116, DOI 10.4049/jimmunol.181.1.116; Jurado JO, 2012, J LEUKOCYTE BIOL, V91, P991, DOI 10.1189/jlb.1211619; Kassiotis G, 2002, NAT IMMUNOL, V3, P244, DOI 10.1038/ni766; Kondratieva TK, 2010, J IMMUNOL, V184, P1227, DOI 10.4049/jimmunol.0902011; Kozakiewicz L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003472; Kumararatne DS, 1997, CLIN EXP IMMUNOL, V107, P11, DOI 10.1046/j.1365-2249.1997.d01-910.x; Lange C, 2009, EUR RESPIR J, V33, P1250, DOI 10.1183/09031936.00019709; Leal IS, 2001, IMMUNOLOGY, V104, P157, DOI 10.1046/j.1365-2567.2001.01305.x; Lejon K, 1999, J IMMUNOL, V163, P5708; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Linton PJ, 2000, J IMMUNOL, V165, P5558, DOI 10.4049/jimmunol.165.10.5558; Linton PJ, 2003, J EXP MED, V197, P875, DOI 10.1084/jem.20021290; Lund FE, 2006, J IMMUNOL, V176, P6147, DOI 10.4049/jimmunol.176.10.6147; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Maglione PJ, 2007, J IMMUNOL, V178, P7222, DOI 10.4049/jimmunol.178.11.7222; Matthews K, 2011, TUBERCULOSIS, V91, P587, DOI 10.1016/j.tube.2011.06.009; McLellan AD, 2009, CRIT REV IMMUNOL, V29, P203, DOI 10.1615/CritRevImmunol.v29.i3.20; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Novak EJ, 2001, INT IMMUNOL, V13, P799, DOI 10.1093/intimm/13.6.799; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Olsen AW, 2001, INFECT IMMUN, V69, P2773, DOI 10.1128/IAI.69.5.2773-2778.2001; Palma C, 2008, VACCINE, V26, P4237, DOI 10.1016/j.vaccine.2008.05.050; Palma C, 2007, CELL MICROBIOL, V9, P1455, DOI 10.1111/j.1462-5822.2007.00884.x; Palma C, 2013, EUR J IMMUNOL, V43, P2386, DOI 10.1002/eji.201243245; Palma C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011019; Qiu YQ, 2013, IMMUNOL LETT, V150, P48, DOI 10.1016/j.imlet.2012.12.008; Reiley WW, 2010, P NATL ACAD SCI USA, V107, P19408, DOI 10.1073/pnas.1006298107; Renno T, 1998, EUR J IMMUNOL, V28, P540, DOI 10.1002/(SICI)1521-4141(199802)28:02<540::AID-IMMU540>3.3.CO;2-P; Ridgway W, 1998, J IMMUNOL, V161, P714; Rohn WM, 1996, CRIT REV IMMUNOL, V16, P311, DOI 10.1615/CritRevImmunol.v16.i3.40; Rosenits K, 2010, EUR J IMMUNOL, V40, P3450, DOI 10.1002/eji.201040743; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Shi L, 2004, INFECT IMMUN, V72, P2420, DOI 10.1128/IAI.72.4.2420-2424.2004; Soares AP, 2013, J INFECT DIS, V207, P1084, DOI 10.1093/infdis/jis941; Sodhi A, 1997, CLIN INFECT DIS, V25, P617, DOI 10.1086/513769; Song WX, 1997, INT IMMUNOL, V9, P1709, DOI 10.1093/intimm/9.11.1709; Stanciu LA, 2006, J INFECT DIS, V193, P404, DOI 10.1086/499275; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Ulrichs T, 2004, J PATHOL, V204, P217, DOI 10.1002/path.1628; van Dissel JT, 2011, VACCINE, V29, P2100, DOI 10.1016/j.vaccine.2010.12.135; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Wang SD, 2003, J EXP MED, V197, P1083, DOI 10.1084/jem.20021752; Wojciechowski W, 2009, IMMUNITY, V30, P421, DOI 10.1016/j.immuni.2009.01.006; Wyndham-Thomas C, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0796-0; Wythe SE, 2012, J IMMUNOL, V188, P1647, DOI 10.4049/jimmunol.1103001; ZHANG M, 1995, INFECT IMMUN, V63, P3231, DOI 10.1128/IAI.63.8.3231-3234.1995; Zhou G, 2011, J IMMUNOL, V186, P2148, DOI 10.4049/jimmunol.1002917	68	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137783	10.1371/journal.pone.0137783	http://dx.doi.org/10.1371/journal.pone.0137783			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379242	Green Published, Green Submitted, gold			2022-12-27	WOS:000361769400025
J	Stanley, FM; Linder, KM; Cardozo, TJ				Stanley, Frederick M.; Linder, Kathryn M.; Cardozo, Timothy J.			Statins Increase Plasminogen Activator Inhibitor Type 1 Gene Transcription through a Pregnane X Receptor Regulated Element	PLOS ONE			English	Article							NUCLEAR HORMONE-RECEPTORS; THYROID-HORMONE; FARNESYL PYROPHOSPHATE; PAI-1 PROMOTER; DIRECT BINDING; EXPRESSION; CELLS; PXR; ALPHA; INSULIN	Plasminogen activator inhibitor type 1 (PAI-1) is a multifunctional protein that has important roles in inflammation and wound healing. Its aberrant regulation may contribute to many disease processes such as heart disease. The PAI-1 promoter is responsive to multiple inputs including cytokines, growth factors, steroids and oxidative stress. The statin drugs, atorvastatin, mevastatin and rosuvastatin, increased basal and stimulated expression of the PAI-1 promoter 3-fold. A statin-responsive, nuclear hormone response element was previously identified in the PAI-1 promoter, but it was incompletely characterized. We characterized this direct repeat (DR) of AGGTCA with a 3-nucleotide spacer at -269/-255 using deletion and directed mutagenesis. Deletion or mutation of this element increased basal transcription from the promoter suggesting that it repressed PAI-1 transcription in the unliganded state. The half-site spacing and the ligand specificity suggested that this might be a pregnane X receptor (PXR) responsive element. Computational molecular docking showed that atorvastatin, mevastatin and rosuvastatin were structurally compatible with the PXR ligand-binding pocket in its agonist conformation. Experiments with Gal4 DNA binding domain fusion proteins showed that Gal4-PXR was activated by statins while other DR + 3 binding nuclear receptor fusions were not. Overexpression of PXR further enhanced PAI-1 transcription in response to statins. Finally, ChIP experiments using Halo-tagged PXR and RXR demonstrated that both components of the PXR-RXR heterodimer bound to this region of the PAI-1 promoter.	[Stanley, Frederick M.; Linder, Kathryn M.; Cardozo, Timothy J.] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10012 USA; [Stanley, Frederick M.; Cardozo, Timothy J.] NYU Langone Med Ctr, Laura & Isaac Perlmutter Canc Ctr, New York, NY USA	New York University; NYU Langone Medical Center	Stanley, FM (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10012 USA.	Frederick.stanley@nyumc.org		Stanley, Frederick/0000-0002-3684-2168	NIH [DK067540, DP2 OD004631]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK067540] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004631] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a grant from the NIH DK067540 to FM Stanley and DP2 OD004631 to TJ Cardozo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Blasi F, 1999, THROMB HAEMOSTASIS, V82, P298; BRUZDZINSKI CJ, 1993, MOL ENDOCRINOL, V7, P1169, DOI 10.1210/me.7.9.1169; Cate JM, 2007, CURR DRUG TARGETS, V8, P971, DOI 10.2174/138945007781662337; Cho KJ, 2011, MOL CELL BIOL, V31, P1110, DOI 10.1128/MCB.00989-10; Cui JY, 2010, NUCLEIC ACIDS RES, V38, P7943, DOI 10.1093/nar/gkq654; Das S, 2007, MOL ENDOCRINOL, V21, P2672, DOI 10.1210/me.2007-0080; de Lorgeril M, 2010, ARCH INTERN MED, V170, P1032, DOI 10.1001/archinternmed.2010.184; Diamond DM, 2015, EXPERT REV CLIN PHAR, V8, P201, DOI 10.1586/17512433.2015.1012494; Dimova EY, 2005, THROMB HAEMOSTASIS, V93, P1176, DOI 10.1160/TH04-11-0761; Eren M, 2002, CIRCULATION, V106, P491, DOI 10.1161/01.CIR.0000023186.60090.FB; Escriva H, 2000, BIOESSAYS, V22, P717; Forman BM, 1997, P NATL ACAD SCI USA, V94, P10588, DOI 10.1073/pnas.94.20.10588; Gan XD, 2001, J BIOL CHEM, V276, P48702, DOI 10.1074/jbc.M109402200; Goyanka R, 2010, PROTEIN ENG DES SEL, V23, P809, DOI 10.1093/protein/gzq056; Gruber F, 2003, BLOOD, V101, P3042, DOI 10.1182/blood-2002-07-2331; Habeos I, 2005, BIOCHEM BIOPH RES CO, V334, P601, DOI 10.1016/j.bbrc.2005.06.129; Hoffart E, 2012, BRIT J PHARMACOL, V165, P1595, DOI 10.1111/j.1476-5381.2011.01665.x; Howe K, 2011, XENOBIOTICA, V41, P519, DOI 10.3109/00498254.2011.569773; Jag U, 2009, MOL ENDOCRI IN PRESS, V23; Juhan-Vague I, 2000, ANN MED, V32, P78; Khatib AM, 2001, INT J CANCER, V91, P300, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1055>3.3.CO;2-E; Li H, 2013, J BIOL CHEM, V288, P13655, DOI 10.1074/jbc.M113.455485; Li JQ, 2006, CLIN CHIM ACTA, V370, P57, DOI 10.1016/j.cca.2006.01.024; Mani S, 2013, DRUG METAB REV, V45, P60, DOI 10.3109/03602532.2012.746363; Martin G, 2001, J CLIN INVEST, V107, P1423, DOI 10.1172/JCI10852; Maser RE, 1997, J DIABETES COMPLICAT, V11, P243, DOI 10.1016/S1056-8727(96)00040-2; Motojima M, 2000, BIOCHEM J, V349, P435, DOI 10.1042/0264-6021:3490435; Okuyama H, 2015, EXPERT REV CLIN PHAR, V8, P189, DOI 10.1586/17512433.2015.1011125; Olman MA, 1999, BLOOD, V94, P2029, DOI 10.1182/blood.V94.6.2029.418k25_2029_2038; Owen GI, 2000, CELL MOL LIFE SCI, V57, P809, DOI 10.1007/s000180050043; Plee-Gautier E, 2012, BIOCHEM PHARMACOL, V84, P571, DOI 10.1016/j.bcp.2012.05.012; Rozen S, 2000, Methods Mol Biol, V132, P365; SAMUELS HH, 1979, ENDOCRINOLOGY, V105, P80, DOI 10.1210/endo-105-1-80; Schaars CF, 2008, CURR OPIN LIPIDOL, V19, P553, DOI 10.1097/MOL.0b013e3283168ecd; Sluder AE, 2001, TRENDS GENET, V17, P206, DOI 10.1016/S0168-9525(01)02242-9; Song CZ, 1998, J BIOL CHEM, V273, P29287, DOI 10.1074/jbc.273.45.29287; STANLEY F, 1989, MOL ENDOCRINOL, V3, P1627, DOI 10.1210/mend-3-10-1627; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; Venkatesh M, 2011, MOL PHARMACOL, V80, P124, DOI 10.1124/mol.111.071787; Vulin AI, 2004, J BIOL CHEM, V279, P25172, DOI 10.1074/jbc.M403184200; Wallace BD, 2013, J MOL BIOL, V425, P2561, DOI 10.1016/j.jmb.2013.04.012; Wang J, 2006, J BIOL CHEM, V281, P33842, DOI 10.1074/jbc.M607873200; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P206; Zaman AKMT, 2007, HISTOCHEM CELL BIOL, V128, P135, DOI 10.1007/s00418-007-0300-z	46	3	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138097	10.1371/journal.pone.0138097	http://dx.doi.org/10.1371/journal.pone.0138097			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379245	Green Published, gold, Green Submitted			2022-12-27	WOS:000361769400053
J	Bairlein, F; Fritz, J; Scope, A; Schwendenwein, I; Stanclova, G; van Dijk, G; Meijer, HAJ; Verhulst, S; Dittami, J				Bairlein, Franz; Fritz, Johannes; Scope, Alexandra; Schwendenwein, Ilse; Stanclova, Gabriela; van Dijk, Gertjan; Meijer, Harro A. J.; Verhulst, Simon; Dittami, John			Energy Expenditure and Metabolic Changes of Free-Flying Migrating Northern Bald Ibis	PLOS ONE			English	Article							DOUBLY LABELED WATER; LONG-DISTANCE MIGRATION; WIND-TUNNEL; HEART-RATE; OXYGEN-CONSUMPTION; OXIDATIVE STRESS; FLIGHT DURATION; PIGEON FLIGHT; BODY-MASS; LACTATE	Many migrating birds undertake extraordinary long flights. How birds are able to perform such endurance flights of over 100-hour durations is still poorly understood. We examined energy expenditure and physiological changes in Northern Bald Ibis Geronticus eremite during natural flights using birds trained to follow an ultra-light aircraft. Because these birds were tame, with foster parents, we were able to bleed them immediately prior to and after each flight. Flight duration was experimentally designed ranging between one and almost four hours continuous flights. Energy expenditure during flight was estimated using doublylabelled- water while physiological properties were assessed through blood chemistry including plasma metabolites, enzymes, electrolytes, blood gases, and reactive oxygen compounds. Instantaneous energy expenditure decreased with flight duration, and the birds appeared to balance aerobic and anaerobic metabolism, using fat, carbohydrate and protein as fuel. This made flight both economic and tolerable. The observed effects resemble classical exercise adaptations that can limit duration of exercise while reducing energetic output. There were also in-flight benefits that enable power output variation from cruising to manoeuvring. These adaptations share characteristics with physiological processes that have facilitated other athletic feats in nature and might enable the extraordinary long flights of migratory birds as well.	[Bairlein, Franz] Inst Avian Res Vogelwarte Helgoland, D-26386 Wilhelmshaven, Germany; [Fritz, Johannes; Dittami, John] Univ Vienna, Ctr Organism Syst Biol, Dept Anthropol, A-1090 Vienna, Austria; [Fritz, Johannes; Dittami, John] Univ Vienna, Ctr Organism Syst Biol, Dept Behav Biol, A-1090 Vienna, Austria; [Scope, Alexandra; Stanclova, Gabriela] Univ Vet Med Vienna, Clin Avian Reptile & Fish Med, A-1210 Vienna, Austria; [Schwendenwein, Ilse] Univ Vet Med Vienna, Cent Lab, A-1210 Vienna, Austria; [van Dijk, Gertjan; Verhulst, Simon] Univ Groningen, CBN, NL-9747 AG Groningen, Netherlands; [van Dijk, Gertjan; Meijer, Harro A. J.] Univ Groningen, CIO, NL-9747 AG Groningen, Netherlands; [Fritz, Johannes] Waldrappteam, A-6162 Mutters, Austria; [Fritz, Johannes] Konrad Lorenz Res Stn, A-4645 Grunau, Austria	University of Vienna; University of Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Groningen; University of Groningen	Bairlein, F (corresponding author), Inst Avian Res Vogelwarte Helgoland, Vogelwarte 21, D-26386 Wilhelmshaven, Germany.	franz.bairlein@ifv-vogelwarte.de	Verhulst, Simon/B-1613-2009; Verhulst, Simon/S-3404-2019; Meijer, Harro A J/A-5787-2012	Verhulst, Simon/0000-0002-1143-6868; Verhulst, Simon/0000-0002-1143-6868; Meijer, Harro A.J./0000-0001-8744-5632; Fritz, Johannes/0000-0003-4691-2892	Austrian Science Fund (FWF) [P20633]; Forderverein Waldrappteam; Heinz Sielmann Foundation; HIT Umweltstiftung; City Council of Burghausen	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Forderverein Waldrappteam; Heinz Sielmann Foundation; HIT Umweltstiftung; City Council of Burghausen	This work was supported by an Austrian Science Fund (FWF P20633) grant to J.D., Forderverein Waldrappteam, Heinz Sielmann Foundation, HIT Umweltstiftung and the City Council of Burghausen.	Adams NJ, 1997, J COMP PHYSIOL B, V167, P444, DOI 10.1007/s003600050095; Alerstam T, 2011, J ORNITHOL, V152, P5, DOI 10.1007/s10336-011-0694-1; Arora K. L., 2010, International Journal of Poultry Science, V9, P828; BAIRLEIN F, 1994, ANNU REV NUTR, V14, P187, DOI 10.1146/annurev.nu.14.070194.001155; BAIRLEIN F, 1992, ORNIS SCAND, V23, P244, DOI 10.2307/3676645; Bairlein F, 2012, BIOL LETTERS, V8, P505, DOI 10.1098/rsbl.2011.1223; BERGER M, 1970, Z VERGL PHYSIOL, V66, P201, DOI 10.1007/BF00297779; Berthold P, 1996, CONTROL BIRD MIGRATI; BIESEL W, 1987, J COMP PHYSIOL B, V157, P117, DOI 10.1007/BF00702736; Billat VL, 2003, SPORTS MED, V33, P407, DOI 10.2165/00007256-200333060-00003; Bordel R, 2000, J COMP PHYSIOL B, V170, P51, DOI 10.1007/s003600050007; BORDEL R, 1993, J COMP PHYSIOL B, V163, P219, DOI 10.1007/BF00261668; Brancaccio P, 2010, CLIN CHEM LAB MED, V48, P757, DOI 10.1515/CCLM.2010.179; BROOKS GA, 1986, MED SCI SPORT EXER, V18, P360, DOI 10.1249/00005768-198606000-00019; Brooks GA, 2002, BIOCHEM SOC T, V30, P258, DOI 10.1042/bst0300258; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; Butler PJ, 2000, COMP BIOCHEM PHYS A, V126, P379, DOI 10.1016/S1095-6433(00)00221-X; BUTLER PJ, 1977, J EXP BIOL, V71, P7; CARMI N, 1995, ISRAEL J ZOOL, V41, P369; CARMI N, 1992, AUK, V109, P268; Costantini D, 2006, J COMP PHYSIOL B, V176, P329, DOI 10.1007/s00360-005-0055-6; Costantini D, 2008, ECOL LETT, V11, P1238, DOI 10.1111/j.1461-0248.2008.01246.x; Costantini D, 2008, J COMP PHYSIOL B, V178, P829, DOI 10.1007/s00360-008-0270-z; COSTILL DL, 1977, J APPL PHYSIOL, V43, P695, DOI 10.1152/jappl.1977.43.4.695; Eckert R, 2002, ANIMAL PHYSL 2002 TH; Engel S, 2006, PHYSIOL BIOCHEM ZOOL, V79, P763, DOI 10.1086/504610; Engel S, 2006, J COMP PHYSIOL B, V176, P415, DOI 10.1007/s00360-006-0063-1; Fair J, 2007, IBIS, V149, P535, DOI 10.1111/j.1474-919X.2007.00680.x; Fritz J, 2004, WAZA MAGAZINE, V5, P16; Gehre M, 2004, RAPID COMMUN MASS SP, V18, P2650, DOI 10.1002/rcm.1672; Gerson AR, 2013, J COMP PHYSIOL B, V183, P983, DOI 10.1007/s00360-013-0767-y; Gerson AR, 2011, SCIENCE, V333, P1434, DOI 10.1126/science.1210449; Giladi I, 1999, J COMP PHYSIOL B, V169, P311, DOI 10.1007/s003600050226; Gill RE, 2009, P ROY SOC B-BIOL SCI, V276, P447, DOI 10.1098/rspb.2008.1142; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; Guglielmo C, 2001, J EXP BIOL, V204, P2683; Guglielmo CG, 2002, AUK, V119, P437, DOI 10.1642/0004-8038(2002)119[0437:EAISOV]2.0.CO;2; Guglielmo CG, 2002, J COMP PHYSIOL B, V172, P409, DOI 10.1007/s00360-002-0266-z; Guglielmo CG, 1998, COMP BIOCHEM PHYS B, V119, P549, DOI 10.1016/S0305-0491(98)00016-9; Guidotti S, 2013, RAPID COMMUN MASS SP, V27, P1055, DOI 10.1002/rcm.6540; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; HURLEY BF, 1986, J APPL PHYSIOL, V60, P562, DOI 10.1152/jappl.1986.60.2.562; Jenni L, 1998, J AVIAN BIOL, V29, P521, DOI 10.2307/3677171; Jenni L, 2000, AM J PHYSIOL-REG I, V278, pR1182, DOI 10.1152/ajpregu.2000.278.5.R1182; Jenni L, 1998, BIOL CONSERV FAUNA, V102, P312; Jenni L, 2006, J ORNITHOL, V147, P531, DOI 10.1007/s10336-006-0076-2; Jenni-Eiermann S, 2003, AVIAN MIGRATION, P293; Jenni-Eiermann S, 2002, J EXP BIOL, V205, P2453; Jenni-Eiermann S, 2001, PHYSIOL BIOCHEM ZOOL, V74, P90, DOI 10.1086/319306; Jenni-Eiermann S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097650; Jenni-Eiermann Susanne, 1999, Biologia e Conservazione della Fauna, V102, P312; JenniEiermann S, 1996, FUNCT ECOL, V10, P62, DOI 10.2307/2390263; JENNIEIERMANN S, 1992, PHYSIOL ZOOL, V65, P112, DOI 10.1086/physzool.65.1.30158242; JENNIEIERMANN S, 1991, J COMP PHYSIOL B, V161, P465; JENNIEIERMANN S, 1994, AUK, V111, P888, DOI 10.2307/4088821; Kasprzak M, 2006, J ORNITHOL, V147, P599, DOI 10.1007/s10336-006-0084-2; Klaassen M, 2000, CONDOR, V102, P444, DOI 10.1650/0010-5422(2000)102[0444:FCAFCO]2.0.CO;2; Klaassen M, 1995, AUK, V112, P260, DOI 10.2307/4088789; Klaassen M, 1996, J EXP BIOL, V199, P57; KLASING K. C., 1998, COMP AVIAN NUTR; Landys MM, 2005, P ROY SOC B-BIOL SCI, V272, P295, DOI 10.1098/rspb.2004.2952; LIFSON N, 1966, J THEOR BIOL, V12, P46, DOI 10.1016/0022-5193(66)90185-8; Lindsell JA, 2009, ORYX, V43, P329, DOI 10.1017/S0030605309001963; Lindstrom A, 1999, FUNCT ECOL, V13, P352, DOI 10.1046/j.1365-2435.1999.00320.x; LUMEIJ JT, 1985, AVIAN PATHOL, V14, P257, DOI 10.1080/03079458508436227; Lyons JE, 2008, OECOLOGIA, V155, P417, DOI 10.1007/s00442-007-0921-x; Martin MP, 2010, AVIAN DIS, V54, P1016, DOI 10.1637/9223-122209-Reg.1; MASMAN D, 1987, AUK, V104, P603, DOI 10.1093/auk/104.4.603; McArdle W.D., 2009, EXERCISE PHYSL NUTR, V7th; McCain SL, 2010, VET CLIN PATH, V39, P474, DOI 10.1111/j.1939-165X.2010.00258.x; Michaeli G, 2001, J EXP BIOL, V204, P3803; Moniello G, 2005, S AFR J ANIM SCI, V35, P268; Myers J, 1997, CHEST, V111, P787, DOI 10.1378/chest.111.3.787; NOLET BA, 1992, PHYSIOL ZOOL, V65, P1188, DOI 10.1086/physzool.65.6.30158275; Norberg U., 1990, VERTEBRATE FLIGHT ME; Pennycuick C.J., 1989, BIRD FLIGHT PERFORMA; Penzlin H, 2005, LEHRBUCH TIERPHYSIOL; ROTHE HJ, 1987, J COMP PHYSIOL B, V157, P99, DOI 10.1007/BF00702734; Schmidt-Wellenburg CA, 2008, J COMP PHYSIOL B, V178, P767, DOI 10.1007/s00360-008-0267-7; Schwilch R, 1996, J COMP PHYSIOL B, V166, P77, DOI 10.1007/BF00301171; Scope A, 2006, VET REC, V159, P839; Scope A, 2002, J AVIAN MED SURG, V16, P10, DOI 10.1647/1082-6742(2002)016[0010:STVOBP]2.0.CO;2; Scope A, 2000, AVIAN DIS, V44, P885, DOI 10.2307/1593061; Speakman J.R., 1997, DOUBLY LABELLED WATE; Steinmetz HW, 2007, J VET DIAGN INVEST, V19, P382, DOI 10.1177/104063870701900407; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Van Hall G, 2000, ACTA PHYSIOL SCAND, V168, P643, DOI 10.1046/j.1365-201x.2000.00716.x; Visser GH, 2000, J COMP PHYSIOL B, V170, P365, DOI 10.1007/s003600000112; Visser GH, 1999, PHYSIOL BIOCHEM ZOOL, V72, P740, DOI 10.1086/316713; Ward S, 2004, J EXP BIOL, V207, P4291, DOI 10.1242/jeb.01281; Ward S, 2002, J EXP BIOL, V205, P3347; Wasserman K., 2012, PRINCIPLES EXERCISE, V1, P8; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a	93	32	33	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0134433	10.1371/journal.pone.0134433	http://dx.doi.org/10.1371/journal.pone.0134433			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376193	Green Published, gold, Green Submitted			2022-12-27	WOS:000361610200004
J	Si, Y; Kim, S; Cui, XQ; Zheng, L; Oh, SJ; Anderson, T; AlSharabati, M; Kazamel, M; Volpicelli-Daley, L; Bamman, MM; Yu, SH; King, PH				Si, Ying; Kim, Soojin; Cui, Xiangqin; Zheng, Lei; Oh, Shin J.; Anderson, Tina; AlSharabati, Mohammad; Kazamel, Mohamed; Volpicelli-Daley, Laura; Bamman, Marcas M.; Yu, Shaohua; King, Peter H.			Transforming Growth Factor Beta (TGF-beta) Is a Muscle Biomarker of Disease Progression in ALS and Correlates with Smad Expression	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SKELETAL-MUSCLE; TRANSCRIPTION FACTORS; SIGNALING PATHWAY; MOTONEURONS; REGENERATION; ACTIVATION; CELLS; BONE; MASS	We recently identified Smads1, 5 and 8 as muscle biomarkers in human ALS. In the ALS mouse, these markers are elevated and track disease progression. Smads are signal transducers and become activated upon receptor engagement of ligands from the TGF-beta superfamily. Here, we sought to characterize ligands linked to activation of Smads in ALS muscle and their role as biomarkers of disease progression. RNA sequencing data of ALS muscle samples were mined for TGF-beta superfamily ligands. Candidate targets were validated by qRT-PCR in a large cohort of human ALS muscle biopsy samples and in the G93A SOD1 mouse. Protein expression was evaluated by Western blot, ELISA and immunohistochemistry. C2C12 muscle cells were used to assess Smad activation and induction. TGF-beta 1, 2 and 3 mRNAs were increased in ALS muscle samples compared to controls and correlated with muscle strength and Smads1, 2, 5 and 8. In the G93A SOD1 mouse, the temporal pattern of TGF-beta expression paralleled the Smads and increased with disease progression. TGF-beta 1 immunoreactivity was detected in mononuclear cells surrounding muscle fibers in ALS samples. In muscle cells, TGF-beta ligands were capable of activating Smads. In conclusion, TGF-beta 1, 2 and 3 are novel biomarkers of ALS in skeletal muscle. Their correlation with weakness in human ALS and their progressive increase with advancing disease in the ALS mouse suggest that they, as with the Smads, can track disease progression. These ligands are capable of upregulating and activating Smads and thus may contribute to the Smad signaling pathway in ALS muscle.	[Si, Ying; Kim, Soojin; Zheng, Lei; Oh, Shin J.; Anderson, Tina; AlSharabati, Mohammad; Kazamel, Mohamed; Volpicelli-Daley, Laura; King, Peter H.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA; [Si, Ying; Zheng, Lei; King, Peter H.] Birmingham VA Med Ctr, Birmingham, AL USA; [Cui, Xiangqin; Yu, Shaohua] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Bamman, Marcas M.; King, Peter H.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA; [King, Peter H.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	King, PH (corresponding author), Univ Alabama Birmingham, Dept Neurol, UAB Stn, Birmingham, AL 35294 USA.	phking@uabmc.edu		Cui, Xiangqin/0000-0003-0621-9313; King, Peter/0000-0001-9391-7464	United States Department of Veterans Affairs Biomedical Laboratory Research and Development Program Merit Review [BX001148]; National Institute of Neurological Disorders [NS064133, R21NS081743, R21NS085497]; National Center for Medical Rehabilitation Research [R01HD084124]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD084124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047466, R01NS064133, R21NS081743, R21NS085497] Funding Source: NIH RePORTER	United States Department of Veterans Affairs Biomedical Laboratory Research and Development Program Merit Review; National Institute of Neurological Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Center for Medical Rehabilitation Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Program Merit Review BX001148 (http://www.research.va.gov/services/blrd/), National Institute of Neurological Disorders NS064133, R21NS081743, R21NS085497 (http://www.ninds.nih.gov/), and National Center for Medical Rehabilitation Research R01HD084124 (https://www.nichd.nih.gov/about/org/ncmrr/Pages/overview.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Blahna MT, 2012, FEBS LETT, V586, P1906, DOI 10.1016/j.febslet.2012.01.041; Burks TN, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-19; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; Day WA, 2005, NEUROBIOL DIS, V19, P323, DOI 10.1016/j.nbd.2005.01.010; Dupuis L, 2009, CURR OPIN PHARMACOL, V9, P341, DOI 10.1016/j.coph.2009.03.007; Elliott JL, 2001, MOL BRAIN RES, V95, P172, DOI 10.1016/S0169-328X(01)00242-X; Frey D, 2000, J NEUROSCI, V20, P2534; FROES MMQ, 1987, NEUROPATH APPL NEURO, V13, P405, DOI 10.1111/j.1365-2990.1987.tb00071.x; Gleizes PE, 1997, STEM CELLS, V15, P190, DOI 10.1002/stem.150190; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Hayworth CR, 2009, NEUROSCIENCE, V164, P975, DOI 10.1016/j.neuroscience.2009.08.031; Hensley K, 2003, NEUROBIOL DIS, V14, P74, DOI 10.1016/S0969-9961(03)00087-1; Ilzecka J, 2002, CYTOKINE, V20, P239, DOI 10.1006/cyto.2002.2005; Iwasaki Y, 1997, J NEUROL SCI, V147, P9, DOI 10.1016/S0022-510X(96)05307-5; Jiang Y, 2000, NEUROSCIENCE, V97, P735, DOI 10.1016/S0306-4522(00)00084-1; Jiang YY, 2000, J NEUROSCI RES, V62, P809, DOI 10.1002/1097-4547(20001215)62:6<809::AID-JNR7>3.3.CO;2-W; Katagiri T, 2013, BIOL CHEM, V394, P703, DOI 10.1515/hsz-2012-0310; Khan Shaukat A, 2012, BMC Res Notes, V5, P636, DOI 10.1186/1756-0500-5-636; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; MARTINOU JC, 1990, DEV BRAIN RES, V52, P175, DOI 10.1016/0165-3806(90)90233-O; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; McLennan IS, 1998, NEUROSCIENCE, V87, P845, DOI 10.1016/S0306-4522(98)00180-8; McLennan IS, 2002, INT J DEV BIOL, V46, P559; Murakami N, 1999, MUSCLE NERVE, V22, P889, DOI 10.1002/(SICI)1097-4598(199907)22:7<889::AID-MUS12>3.0.CO;2-B; Musaro Antonio, 2010, World J Biol Chem, V1, P62, DOI 10.4331/wjbc.v1.i5.62; Sartori R, 2013, NAT GENET, V45, P1309, DOI 10.1038/ng.2772; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Shen W, 2005, AM J PATHOL, V167, P1105, DOI 10.1016/S0002-9440(10)61199-6; Si Y, 2014, ANN CLIN TRANSL NEUR, V1, P778, DOI 10.1002/acn3.117; Winbanks CE, 2013, J CELL BIOL, V203, P345, DOI 10.1083/jcb.201211134; WOHLFART G, 1957, NEUROLOGY, V7, P124, DOI 10.1212/WNL.7.2.124; Wrighton KH, 2009, J BIOL CHEM, V284, P9755, DOI 10.1074/jbc.M809223200; YAMAZAKI M, 1994, AM J PATHOL, V144, P221	38	34	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138425	10.1371/journal.pone.0138425	http://dx.doi.org/10.1371/journal.pone.0138425			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375954	gold, Green Published, Green Submitted			2022-12-27	WOS:000361610200106
J	Skrzypek, G; Wojtun, B; Richter, D; Jakubas, D; Wojczulanis-Jakubas, K; Samecka-Cymerman, A				Skrzypek, Grzegorz; Wojtun, Bronislaw; Richter, Dorota; Jakubas, Dariusz; Wojczulanis-Jakubas, Katarzyna; Samecka-Cymerman, Aleksandra			Diversification of Nitrogen Sources in Various Tundra Vegetation Types in the High Arctic	PLOS ONE			English	Article							PLANT-COMMUNITIES; NITRATE; SEABIRD; DEPOSITION; ISOTOPES; CARBON; VARIABILITY; ACQUISITION; PATTERNS; HORNSUND	Low nitrogen availability in the high Arctic represents a major constraint for plant growth, which limits the tundra capacity for carbon retention and determines tundra vegetation types. The limited terrestrial nitrogen (N) pool in the tundra is augmented significantly by nesting seabirds, such as the planktivorous Little Auk (Alle alle). Therefore, N delivered by these birds may significantly influence the N cycling in the tundra locally and the carbon budget more globally. Moreover, should these birds experience substantial negative environmental pressure associated with climate change, this will adversely influence the tundra N-budget. Hence, assessment of bird-originated N-input to the tundra is important for understanding biological cycles in polar regions. This study analyzed the stable nitrogen composition of the three main N-sources in the High Arctic and in numerous plants that access different N-pools in ten tundra vegetation types in an experimental catchment in Hornsund (Svalbard). The percentage of the total tundra N-pool provided by birds, ranged from 0-21% in Patterned-ground tundra to 100% in Ornithocoprophilous tundra. The total N-pool utilized by tundra plants in the studied catchment was built in 36% by birds, 38% by atmospheric deposition, and 26% by atmospheric N2-fixation. The stable nitrogen isotope mixing mass balance, in contrast to direct methods that measure actual deposition, indicates the ratio between the actual N-loads acquired by plants from different N-sources. Our results enhance our understanding of the importance of different N-sources in the Arctic tundra and the used methodological approach can be applied elsewhere.	[Skrzypek, Grzegorz] Univ Western Australia, Sch Plant Biol, West Australian Biogeochem Ctr, Crawley, WA, Australia; [Wojtun, Bronislaw; Samecka-Cymerman, Aleksandra] Univ Wroclaw, Dept Ecol Biogeochem & Environm Protect, PL-50138 Wroclaw, Poland; [Richter, Dorota] Wroclaw Univ Environm & Life Sci, Dept Bot & Plant Ecol, Wroclaw, Poland; [Jakubas, Dariusz; Wojczulanis-Jakubas, Katarzyna] Univ Gdansk, Dept Vertebrate Ecol & Zool, PL-80952 Gdansk, Poland	University of Western Australia; University of Wroclaw; Wroclaw University of Environmental & Life Sciences; Fahrenheit Universities; University of Gdansk	Skrzypek, G (corresponding author), Univ Western Australia, Sch Plant Biol, West Australian Biogeochem Ctr, Crawley, WA, Australia.	grzegorz.skrzypek@uwa.edu.au	Wojczulanis-Jakubas, Katarzyna/AAO-4126-2021; Skrzypek, Grzegorz/B-4202-2008; Jakubas, Dariusz/N-3680-2019; Richter, Dorota/S-8850-2016; Jakubas, Dariusz/L-9660-2015	Wojczulanis-Jakubas, Katarzyna/0000-0001-6230-0509; Jakubas, Dariusz/0000-0002-1879-4342; Richter, Dorota/0000-0003-3024-9766; Jakubas, Dariusz/0000-0002-1879-4342; Wojtun, Bronislaw/0000-0003-1029-1078; Skrzypek, Grzegorz/0000-0002-5686-2393; Samecka-Cymerman, Aleksandra/0000-0002-5421-0092	Polish National Science Centre [N N304 410139]; ARC Future Fellowship [FT110100352]	Polish National Science Centre; ARC Future Fellowship(Australian Research Council)	This research was supported by the Polish National Science Centre to B.W. (Grant no. N N304 410139), https://www.ncn.gov.pl/? language = en. G. S.'s participation was supported by ARC Future Fellowship (FT110100352), http://www.arc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari AH, 2013, BIOGEOCHEMISTRY, V113, P341, DOI 10.1007/s10533-012-9761-9; Arroniz-Crespo M, 2014, PLOS ONE, V9, DOI [10.1371/ journal. pone. 0096081, DOI 10.1371/J0URNAL.P0NE.0096081]; Asada T, 2005, AQUAT BOT, V82, P297, DOI 10.1016/j.aquabot.2005.05.005; Atkin OK, 1996, PLANT CELL ENVIRON, V19, P695, DOI 10.1111/j.1365-3040.1996.tb00404.x; Ayres E, 2006, BIOL LETT-UK, V2, P286, DOI 10.1098/rsbl.2006.0455; Bjork RG, 2007, NEW PHYTOL, V176, P862, DOI 10.1111/j.1469-8137.2007.02231.x; BUCH H, 1947, COMMENTATIONES BIOL, V9, P1; Buck WR, 2000, BRYOPHYTE BIOL, P71, DOI DOI 10.1017/CBO9781139171304; Burke Chantelle M., 2014, Marine Ornithology, V42, P17; Casciotti KL, 2007, ANAL CHEM, V79, P2427, DOI 10.1021/ac061598h; Caut S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039125; Chapin DM, 1992, ARCTIC ECOSYSTEMS CH, P301, DOI DOI 10.1016/B978-0-12-168250-7.50020-1; Climate change, 2007, SUMM POL MAK; Croll DA, 2005, SCIENCE, V307, P1959, DOI 10.1126/science.1108485; Davey ML, 2009, MYCOL RES, V113, P1254, DOI 10.1016/j.mycres.2009.08.001; DODDS WK, 1995, J PHYCOL, V31, P2, DOI 10.1111/j.0022-3646.1995.00002.x; Elliott EM, 2007, ENVIRON SCI TECHNOL, V41, P7661, DOI 10.1021/es070898t; Elven R, 1996, CATALOGUE SVALBARD P, V198, P9; EUROLA S, 1977, Aquilo Ser Botanica, V15, P1; Evans RD, 1996, PLANT CELL ENVIRON, V19, P1317, DOI 10.1111/j.1365-3040.1996.tb00010.x; Evans RD, 2001, TRENDS PLANT SCI, V6, P121, DOI 10.1016/S1360-1385(01)01889-1; Fort J, 2010, MAR ECOL PROG SER, V414, P293, DOI 10.3354/meps08721; Fritz C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0079991; Gersper P. L., 1980, An Arctic ecosystem. The coastal tundra at Barrow, Alaska., P219; Glime JM, 2017, BRYOPHYTE ECOLOGY; Goffinet B., 2008, BRYOPHYTE BIOL; Graham LE, 2000, ALGAE; Heaton THE, 2004, ATMOS ENVIRON, V38, P5611, DOI 10.1016/j.atmosenv.2004.06.028; Hill MO, 2006, J BRYOL, V28, P198, DOI 10.1179/174328206X119998; Hobbie EA, 2009, BIOGEOCHEMISTRY, V95, P355, DOI 10.1007/s10533-009-9328-6; Hubner H., 1986, HDB ENV ISOTOPE GEOC, P361, DOI DOI 10.1016/B978-0-444-42225-5.50014-0; Ininbergs K, 2011, NEW PHYTOL, V192, P507, DOI 10.1111/j.1469-8137.2011.03809.x; Jakubas D, 2008, POL POLAR RES, V29, P45; Jakubas D, 2011, MAR ECOL PROG SER, V432, P277, DOI 10.3354/meps09082; Kendall C., 1998, ISOTOPE TRACERS CATC, P517; Kendall C, 2007, ECOL METHOD CONCEPT, P375, DOI 10.1002/9780470691854.ch12; Koba K, 2003, ECOSYSTEMS, V6, P457, DOI 10.1007/s10021-002-0132-6; Kohzu A, 2003, ECOL RES, V18, P257, DOI 10.1046/j.1440-1703.2003.00552.x; Kolb G.S., 2011, P212; Kolondra L, 2002, CARTOGRAPHER ORTHO; Kuhnel R, 2011, ADV METEOROL, V2011, DOI 10.1155/2011/406508; Lindo Z, 2013, GLOBAL CHANGE BIOL, V19, P2022, DOI 10.1111/gcb.12175; Liu XY, 2012, FUNCT PLANT BIOL, V39, P598, DOI 10.1071/FP12014; Mariotti A., 1980, Catena, V7, P293, DOI 10.1016/0341-8162(80)90014-4; Marshall JD, 2007, ECOL METHOD CONCEPT, P22, DOI 10.1002/9780470691854.ch2; Matula Jan, 2007, Polish Polar Research, V28, P283; Migala K, 2014, CATENA, V116, P10, DOI [10.1016/j.catena.2013.12.007, 10.1016/j.catena2013.12.007]; Minet E, 2011, J ENVIRON MONITOR, V13, P2062, DOI 10.1039/c1em10289c; Mulvaney RL, 1996, METHODS SOIL ANAL, P1123, DOI DOI 10.2136/SSSAB00KSER5.3.C38; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Reay DS, 2008, NAT GEOSCI, V1, P430, DOI 10.1038/ngeo230; SCHUMACKER R, 2000, IDENTIFICATION KEYS; Shearer G, 1992, ISOTOPES ORGANIC CHE, P133; Sigman DM, 2001, ANAL CHEM, V73, P4145, DOI 10.1021/ac010088e; Skrzypek G, 2006, RAPID COMMUN MASS SP, V20, P2915, DOI 10.1002/rcm.2688; Skrzypek G, 2013, ANAL BIOANAL CHEM, V405, P2815, DOI 10.1007/s00216-012-6517-2; Solheim B, 2002, CYANOBACTERIA IN SYMBIOSIS, P137; Solheim B, 2006, PLANT ECOL, V182, P109, DOI 10.1007/s11258-005-9034-y; STEMPNIEWICZ L, 1990, COLON WATERBIRD, V13, P62, DOI 10.2307/1521421; Stempniewicz L, 1992, LANDSCAPE LIFE WORLD, P255; Stempniewicz L, 2007, DEEP-SEA RES PT II, V54, P2934, DOI 10.1016/j.dsr2.2007.08.012; Stempniewicz Lech, 2001, BWP Update, V3, P175; Stewart KJ, 2014, SOIL BIOL BIOCHEM, V70, P96, DOI 10.1016/j.soilbio.2013.12.005; Szymanski W, 2013, POL POLAR RES, V34, P289, DOI 10.2478/popore-2013-0017; Turetsky MR, 2003, BRYOLOGIST, V106, P395, DOI 10.1639/05; Vankoughnett MR, 2014, BIOGEOCHEMISTRY, V118, P291, DOI 10.1007/s10533-013-9930-5; Vare H., 1992, Mycorrhiza, V1, P93, DOI 10.1007/BF00203256; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; WIRTH V., 2013, FLECHTEN DEUTSCHLAND; Wojczulanis-Jakubas K, 2014, POLAR BIOL, V37, P621, DOI 10.1007/s00300-014-1462-5; Wold A, 2011, POLAR BIOL, V34, P1147, DOI 10.1007/s00300-011-0975-4; Yano Y, 2010, BIOGEOCHEMISTRY, V97, P183, DOI 10.1007/s10533-009-9365-1; ZELICKMAN EA, 1972, MAR BIOL, V17, P265, DOI 10.1007/BF00366302; Zwolicki A, 2015, POLAR BIOL, V38, P1645, DOI 10.1007/s00300-015-1730-z; Zwolicki A, 2013, POLAR BIOL, V36, P363, DOI 10.1007/s00300-012-1265-5	75	40	41	5	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136536	10.1371/journal.pone.0136536	http://dx.doi.org/10.1371/journal.pone.0136536			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376204	Green Published, gold, Green Submitted			2022-12-27	WOS:000361610200017
J	Marshall, KLA; Philpot, KE; Damas-Moreira, I; Stevens, M				Marshall, Kate L. A.; Philpot, Kate E.; Damas-Moreira, Isabel; Stevens, Martin			Intraspecific Colour Variation among Lizards in Distinct Island Environments Enhances Local Camouflage	PLOS ONE			English	Article							PODARCIS-ERHARDII SQUAMATA; VISUAL PIGMENTS; ULTRAVIOLET SENSITIVITY; CROTAPHYTUS-COLLARIS; OIL DROPLETS; POPULATIONS; VISION; EVOLUTION; ECOLOGY; SELECTION	Within-species colour variation is widespread among animals. Understanding how this arises can elucidate evolutionary mechanisms, such as those underlying reproductive isolation and speciation. Here, we investigated whether five island populations of Aegean wall lizards (Podarcis erhardii) have more effective camouflage against their own (local) island substrates than against other (non-local) island substrates to avian predators, and whether this was linked to island differences in substrate appearance. We also investigated whether degree of local substrate matching varied among island populations and between sexes. In most populations, both sexes were better matched against local backgrounds than against non-local backgrounds, particularly in terms of luminance (perceived lightness), which usually occurred when local and non-local backgrounds were different in appearance. This was found even between island populations that historically had a land connection and in populations that have been isolated relatively recently, suggesting that isolation in these distinct island environments has been sufficient to cause enhanced local background matching, sometimes on a rapid evolutionary time-scale. However, heightened local matching was poorer in populations inhabiting more variable and unstable environments with a prolonged history of volcanic activity. Overall, these results show that lizard coloration is tuned to provide camouflage in local environments, either due to genetic adaptation or changes during development. Yet, the occurrence and extent of selection for local matching may depend on specific conditions associated with local ecology and biogeographic history. These results emphasize how anti-predator adaptations to different environments can drive divergence within a species, which may contribute to reproductive isolation among populations and lead to ecological speciation.	[Marshall, Kate L. A.] Univ Cambridge, Dept Zool, Behav Ecol Grp, Cambridge, England; [Philpot, Kate E.; Stevens, Martin] Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Penryn, Cornwall, England; [Damas-Moreira, Isabel] Univ Porto, InBIO, CIBIO Res Ctr Biodivers & Genet Resources, Vila Do Conde, Portugal	University of Cambridge; University of Exeter; Universidade do Porto	Marshall, KLA (corresponding author), Univ Cambridge, Dept Zool, Behav Ecol Grp, Cambridge, England.	km547@cam.ac.uk		Stevens, Martin/0000-0001-7768-3426	Biotechnology and Biological Sciences Research Council; British Herpetological Society; Cambridge Philosophical Society; Magdalene College, Cambridge; David Philips Research Fellowship [BB/G022887/1]; BBSRC [BB/G022887/1, BB/G022887/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G022887/2, 1088693, BB/G022887/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Herpetological Society; Cambridge Philosophical Society; Magdalene College, Cambridge; David Philips Research Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Biotechnology and Biological Sciences Research Council studentship (www.BBSRC.com), the British Herpetological Society (www.thebhs.org), the Cambridge Philosophical Society (http://www.cambridgephilosophicalsociety.org) and Magdalene College, Cambridge (to KLAM), and a Biotechnology and Biological Sciences Research Council and David Philips Research Fellowship (grant number BB/G022887/1) to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, IUCN RED LIST THREAT; ARNOLD NE, 2002, FIELD GUIDE REPTILES; Bergman TJ, 2008, BIOL J LINN SOC, V94, P231, DOI 10.1111/j.1095-8312.2008.00981.x; Brock KM, 2015, EVOLUTION, V69, P216, DOI 10.1111/evo.12555; Castilla AM, 1998, ACTA OECOL, V19, P107, DOI 10.1016/S1146-609X(98)80014-3; Castilla AM, 1999, HERPETOLOGICA, V55, P530; CASTILLA AM, 1991, OECOLOGIA, V85, P366, DOI 10.1007/BF00320612; CHONDROPOULOS B P, 1986, Amphibia-Reptilia, V7, P217, DOI 10.1163/156853886X00028; CLARKE B, 1962, HEREDITY, V17, P319, DOI 10.1038/hdy.1962.35; COLLAR N., 2005, HDB BIRDS WORLD, V10, P514; Cooper W.E. Jr, 1992, P298; Cuthill Innes C., 2006, P3; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Fan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111504; Fitze PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005111; Foufopoulos J, 1999, AM NAT, V153, P1, DOI 10.1086/303149; Garcia JE, 2013, J EXP BIOL, V216, P4290, DOI 10.1242/jeb.094045; Garcia-Munoz E, 2010, ACTA HERPETOL, V5, P259; Grimm A, 2014, NAT CONSERV-BULGARIA, P45, DOI 10.3897/natureconservation.9.8908; Hamilton PS, 2008, AMPHIBIA-REPTILIA, V29, P473, DOI 10.1163/156853808786230488; Handrinos G., 1997, THE BIRDS OF GREECE; Hart NS, 2007, AM NAT, V169, pS7, DOI 10.1086/510141; Hart NS, 2000, J COMP PHYSIOL A, V186, P375, DOI 10.1007/s003590050437; Hart NS, 2002, J EXP BIOL, V205, P3925; Hawlena D, 2006, BEHAV ECOL, V17, P889, DOI 10.1093/beheco/arl023; Hemmi JM, 2006, J EXP BIOL, V209, P4140, DOI 10.1242/jeb.02483; Hernandez-Gallegos O, 2012, REV BIOL TROP, V60, P405; Higgins MD, 1996, GEOLOGICAL COMPANION; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; Houston AI, 2007, BEHAV ECOL, V18, P769, DOI 10.1093/beheco/arm039; Hurston H, 2009, MOL PHYLOGENET EVOL, V52, P395, DOI 10.1016/j.ympev.2009.03.028; Husak JF, 2006, ETHOLOGY, V112, P572, DOI 10.1111/j.1439-0310.2005.01189.x; Huyghe K, 2007, INTEGR COMP BIOL, V47, P211, DOI 10.1093/icb/icm043; Jones CD, 2004, VISION RES, V44, P83, DOI 10.1016/j.visres.2003.08.014; Jordan MA, 2008, MOL ECOL, V17, P1224, DOI 10.1111/j.1365-294X.2007.03658.x; Jordan MA, 2005, MOL ECOL, V14, P859, DOI 10.1111/j.1365-294X.2005.02452.x; Kalogeropoulos S, 1990, P 3 INT C, P164; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; KETTLEWELL H D, 1961, ANNU REV ENTOMOL, V6, P245; KETTLEWELL HBD, 1956, PROC R SOC SER B-BIO, V145, P297, DOI 10.1098/rspb.1956.0037; Komdeur J, 2005, BEHAV ECOL, V16, P805, DOI 10.1093/beheco/ari059; Lind O, 2013, J EXP BIOL, V216, P1819, DOI 10.1242/jeb.082834; Macedonia JM, 2002, BIOL J LINN SOC, V77, P67, DOI 10.1046/j.1095-8312.2002.00092.x; Manceau M, 2011, SCIENCE, V331, P1062, DOI 10.1126/science.1200684; Marshall KLA, 2014, BEHAV ECOL, V25, P1325, DOI 10.1093/beheco/aru126; Martin J, 1996, COPEIA, P722, DOI 10.2307/1447538; Martin J, 1990, AMPHIBIANS REPTILES; McLean CA, 2014, J EVOLUTION BIOL, V27, P2654, DOI 10.1111/jeb.12521; Merilaita S, 1999, BIOL J LINN SOC, V67, P151, DOI 10.1111/j.1095-8312.1999.tb01858.x; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; Odeen A, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-36; Osorio D, 2004, AM NAT, V164, P696, DOI 10.1086/425332; Osorio D, 1999, EVOL ECOL, V13, P673, DOI 10.1023/A:1011059715610; Osorio D, 1996, P ROY SOC B-BIOL SCI, V263, P593, DOI 10.1098/rspb.1996.0089; Perissoratis C, 2003, MAR GEOL, V196, P145, DOI 10.1016/S0025-3227(03)00047-1; Photiades A., 2003, BULL GEOL SOC GREECE, V35, P35; Pike TW, 2011, BEHAV ECOL SOCIOBIOL, V65, P849, DOI 10.1007/s00265-010-1097-7; Poulakakis N, 2005, MOL ECOL NOTES, V5, P549, DOI 10.1111/j.1471-8286.2005.00986.x; Poulakakis N, 2003, MOL PHYLOGENET EVOL, V28, P38, DOI 10.1016/S1055-7903(03)00037-X; Poulakakis N, 2015, J ZOOL SYST EVOL RES, V53, P18, DOI 10.1111/jzs.12071; Rosenblum EB, 2006, AM NAT, V167, P1, DOI 10.1086/498397; Rosenblum EB, 2004, EVOLUTION, V58, P1794, DOI 10.1111/j.0014-3820.2004.tb00462.x; Rosenblum EB, 2010, P NATL ACAD SCI USA, V107, P2113, DOI 10.1073/pnas.0911042107; Rowe MH, 2002, NEWS PHYSIOL SCI, V17, P93, DOI 10.1152/nips.01376.2001; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Ruxton GD, 2008, BEHAV ECOL, V19, P690, DOI 10.1093/beheco/arn020; Sazima I, 2011, REV BRAS ORNITOL, V19, P450; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Siddiqi A, 2004, J EXP BIOL, V207, P2471, DOI 10.1242/jeb.01047; Spottiswoode CN, 2011, P ROY SOC B-BIOL SCI, V278, P3566, DOI 10.1098/rspb.2011.0401; Steiner CC, 2008, PLOS BIOL, V6, P418, DOI 10.1371/journal.pbio.0060036; Stevens M, 2013, SENSORY ECOLOGY, BEHAVIOUR, AND EVOLUTION, P1, DOI 10.1093/acprof:oso/9780199601776.001.0001; Stevens M, 2007, BIOSCIENCE, V57, P501, DOI 10.1641/B570607; Stevens M, 2007, P ROY SOC B-BIOL SCI, V274, P1457, DOI 10.1098/rspb.2007.0220; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; Stevens M, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00014; Stevens M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110325; Stevens M, 2013, BIOL J LINN SOC, V109, P257, DOI 10.1111/bij.12039; Stevens M, 2009, INT J PRIMATOL, V30, P893, DOI 10.1007/s10764-009-9356-z; Stevens M, 2009, PHILOS T R SOC B, V364, P481, DOI 10.1098/rstb.2008.0216; Stuart-Fox D, 2006, BIOL J LINN SOC, V88, P437, DOI 10.1111/j.1095-8312.2006.00631.x; Stuart-Fox DM, 2004, EVOLUTION, V58, P1549; Stuart-Fox DM, 2003, ANIM BEHAV, V66, P541, DOI 10.1006/anbe.2003.2235; VALAKOS E, 1986, HERPETOL J, V1, P118; Valakos Efstratios D., 1999, Herpetological Review, V30, P52; VANDAMME R, 1990, ACTA OECOL, V11, P503; Verwaijen D, 2008, ZOOLOGY, V111, P37, DOI 10.1016/j.zool.2007.04.001; Vignieri SN, 2010, EVOLUTION, V64, P2153, DOI 10.1111/j.1558-5646.2010.00976.x; VON BEDRIAGA J., 1882, B SOC IMP NAT MOSC, V56, P43; VON BEDRIAGA J., 1882, B SOC IMPERIALE NATU, V56, P278; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Vorobyev M, 1998, J COMP PHYSIOL A, V183, P621, DOI 10.1007/s003590050286	93	25	25	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0135241	10.1371/journal.pone.0135241	http://dx.doi.org/10.1371/journal.pone.0135241			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372454	Green Published, gold			2022-12-27	WOS:000361604400002
J	Ndu, U; Barkay, T; Mason, RP; Schartup, AT; Al-Farawati, R; Liu, J; Reinfelder, JR				Ndu, Udonna; Barkay, Tamar; Mason, Robert P.; Schartup, Amina Traore; Al-Farawati, Radwan; Liu, Jie; Reinfelder, John R.			The Use of a Mercury Biosensor to Evaluate the Bioavailability of Mercury-Thiol Complexes and Mechanisms of Mercury Uptake in Bacteria	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; ELEMENTAL MERCURY; ESCHERICHIA-COLI; TRANSPORT; OXIDATION; METHYLATION; RESISTANCE; REDUCTION; MATTER; HG(II)	As mercury (Hg) biosensors are sensitive to only intracellular Hg, they are useful in the investigation of Hg uptake mechanisms and the effects of speciation on Hg bioavailability to microbes. In this study, bacterial biosensors were used to evaluate the roles that several transporters such as the glutathione, cystine/cysteine, and Mer transporters play in the uptake of Hg from Hg-thiol complexes by comparing uptake rates in strains with functioning transport systems to strains where these transporters had been knocked out by deletion of key genes. The Hg uptake into the biosensors was quantified based on the intracellular conversion of inorganic mercury (Hg(II)) to elemental mercury (Hg(0)) by the enzyme MerA. It was found that uptake of Hg from Hg-cysteine (Hg(CYS)(2)) and Hg-glutathione (Hg(GSH)(2)) complexes occurred at the same rate as that of inorganic complexes of Hg(II) into Escherichia coli strains with and without intact Mer transport systems. However, higher rates of Hg uptake were observed in the strain with a functioning Mer transport system. These results demonstrate that thiol-bound Hg is bioavailable to E. coli and that this bioavailability is higher in Hg-resistant bacteria with a complete Mer system than in non-resistant strains. No difference in the uptake rate of Hg from Hg(GSH)(2) was observed in E. coli strains with or without functioning glutathione transport systems. There was also no difference in uptake rates between a wildtype Bacillus subtilis strain with a functioning cystine/cysteine transport system, and a mutant strain where this transport system had been knocked out. These results cast doubt on the viability of the hypothesis that the entire Hg-thiol complex is taken up into the cell by a thiol transporter. It is more likely that the Hg in the Hg-thiol complex is transferred to a transport protein on the cell membrane and is subsequently internalized.	[Ndu, Udonna; Reinfelder, John R.] Rutgers State Univ, Dept Environm Sci, New Brunswick, NJ 08903 USA; [Barkay, Tamar; Liu, Jie] Rutgers State Univ, Dept Biochem & Microbiol, New Brunswick, NJ 08903 USA; [Mason, Robert P.] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Schartup, Amina Traore] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Al-Farawati, Radwan] King Abdulaziz Univ, Marine Chem Dept, Jeddah 21413, Saudi Arabia	Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Connecticut; Harvard University; Harvard T.H. Chan School of Public Health; King Abdulaziz University	Ndu, U (corresponding author), Rutgers State Univ, Dept Environm Sci, New Brunswick, NJ 08903 USA.	udonna.ndu@duke.edu	Reinfelder, John/C-7214-2016; Al-Farawati, Radwan K/J-5813-2012; /AAB-2984-2020	Reinfelder, John/0000-0002-3737-604X; Mason, Robert/0000-0002-7443-4931; Schartup, Amina/0000-0002-9289-8107	NSF-EAR (Geobiology & Low Temperature Geochemistry) [EAR-0952291]; U.S. Department of Energy, Office of Science (BER) [DE-SC0007051]	NSF-EAR (Geobiology & Low Temperature Geochemistry)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); U.S. Department of Energy, Office of Science (BER)(United States Department of Energy (DOE))	This project was supported by grants from NSF-EAR (Geobiology & Low Temperature Geochemistry, EAR-0952291) and the U.S. Department of Energy, Office of Science (BER, DE-SC0007051).	Al-Farawati R, 2001, ENVIRON SCI TECHNOL, V35, P1902, DOI 10.1021/es000073i; Barkay T, 1997, APPL ENVIRON MICROB, V63, P4267, DOI 10.1128/AEM.63.11.4267-4271.1997; Barkay T, 2003, FEMS MICROBIOL REV, V27, P355, DOI 10.1016/S0168-6445(03)00046-9; Benoit JM, 2001, APPL ENVIRON MICROB, V67, P51, DOI 10.1128/AEM.67.1.51-58.2001; BERGER EA, 1972, J BIOL CHEM, V247, P7684; Burguiere P, 2004, J BACTERIOL, V186, P4875, DOI 10.1128/JB.186.15.4875-4884.2004; Chien MF, 2010, J BIOSCI BIOENG, V110, P94, DOI 10.1016/j.jbiosc.2010.01.010; Christine A, 1998, ATLANTIC, V45, P1903, DOI DOI 10.1016/S0967-0637(98)00042-9; Crespo-Medina M, 2009, LIMNOL OCEANOGR, V54, P41, DOI 10.4319/lo.2009.54.1.0041; Deng GF, 2013, CHINESE SCI BULL, V58, P256, DOI 10.1007/s11434-012-5514-3; DYRSSEN D, 1986, ANAL CHIM ACTA, V180, P473, DOI 10.1016/0003-2670(86)80026-5; Endo G, 2003, ACTA BIOTECHNOL, V23, P123, DOI 10.1002/abio.200390018; French TD, 2014, ENVIRON SCI TECHNOL, V48, P3162, DOI 10.1021/es403849d; Fu YJ, 2008, APPL MICROBIOL BIOT, V79, P363, DOI 10.1007/s00253-008-1442-1; Golding GR, 2002, LIMNOL OCEANOGR, V47, P967, DOI 10.4319/lo.2002.47.4.0967; Gu BH, 2011, P NATL ACAD SCI USA, V108, P1479, DOI 10.1073/pnas.1008747108; HAMLETT NV, 1992, J BACTERIOL, V174, P6377, DOI 10.1128/JB.174.20.6377-6385.1992; Han SH, 2006, MAR CHEM, V98, P156, DOI 10.1016/j.marchem.2005.07.004; Hansen LH, 2000, FEMS MICROBIOL LETT, V193, P123; Kiyono M, 2000, BIOL PHARM BULL, V23, P279; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LUTHER GW, 1986, SCIENCE, V232, P746, DOI 10.1126/science.232.4751.746; Mason RP, 1996, ENVIRON SCI TECHNOL, V30, P1835, DOI 10.1021/es950373d; MORBY AP, 1995, MOL MICROBIOL, V17, P25, DOI 10.1111/j.1365-2958.1995.mmi_17010025.x; Morelli E, 2009, SCI TOTAL ENVIRON, V408, P286, DOI 10.1016/j.scitotenv.2009.09.047; NAKAHARA H, 1979, J BACTERIOL, V140, P161, DOI 10.1128/JB.140.1.161-166.1979; Ndu U, 2011, THESIS, P1; Ndu U, 2012, APPL ENVIRON MICROB, V78, P7276, DOI 10.1128/AEM.00362-12; Pernet-Coudrier B, 2013, SCI TOTAL ENVIRON, V463, P997, DOI 10.1016/j.scitotenv.2013.06.053; Poulain AJ, 2007, APPL ENVIRON MICROB, V73, P2230, DOI 10.1128/AEM.02701-06; Priyadarshi H, 2012, J ENVIRON SCI-CHINA, V24, P963, DOI 10.1016/S1001-0742(11)60820-6; Rasmussen LD, 1997, APPL ENVIRON MICROB, V63, P3291, DOI 10.1128/AEM.63.8.3291-3293.1997; Schaefer JK, 2011, P NATL ACAD SCI USA, V108, P8714, DOI 10.1073/pnas.1105781108; Schaefer JK, 2009, NAT GEOSCI, V2, P123, DOI 10.1038/NGEO412; SELIFONOVA O, 1993, APPL ENVIRON MICROB, V59, P3083, DOI 10.1128/AEM.59.9.3083-3090.1993; Simmons-Willis TA, 2002, BIOCHEM J, V367, P239, DOI 10.1042/BJ20020841; Smith T, 1998, APPL ENVIRON MICROB, V64, P1328; Sone Y, 2010, J HEALTH SCI, V56, P123; Suzuki H, 2005, J BACTERIOL, V187, P5861, DOI 10.1128/JB.187.17.5861-5867.2005; Whalin L, 2007, MAR CHEM, V107, P278, DOI 10.1016/j.marchem.2007.04.002; YAMAMOTO M, 1995, B ENVIRON CONTAM TOX, V54, P409; Zheng W, 2013, ENVIRON SCI TECHNOL, V47, P12827, DOI 10.1021/es402697u; Zheng W, 2012, ENVIRON SCI TECHNOL, V46, P292, DOI 10.1021/es203402p	43	24	24	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138333	10.1371/journal.pone.0138333	http://dx.doi.org/10.1371/journal.pone.0138333			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371471	Green Submitted, gold, Green Published			2022-12-27	WOS:000361604400065
J	Stan, K; Sanchez-Azofeifa, A; Espirito-Santo, M; Portillo-Quintero, C				Stan, Kayla; Sanchez-Azofeifa, Arturo; Espirito-Santo, Mario; Portillo-Quintero, Carlos			Simulating Deforestation in Minas Gerais, Brazil, under Changing Government Policies and Socioeconomic Conditions	PLOS ONE			English	Article							LAND-USE CHANGE; BIODIVERSITY CONSERVATION; FOREST; AGRICULTURE; CERRADO; COVER; CHALLENGES; STATE	Agricultural expansion is causing deforestation in Minas Gerais, Brazil, converting savanna and tropical dry forest to farmland, and in 2012, Brazil's Forest Code was revised with the government reducing deforestation restrictions. Understanding the effects of policy change on rates and locations of natural ecosystem loss is imperative. In this paper, deforestation in Minas Gerais was simulated annually until 2020 using Dinamica Environment for Geoprocessing Objects (Dinamica EGO). This system is a state-of-the-art land use and cover change (LUCC) model which incorporates government policy, landscape maps, and other biophysical and anthropogenic datasets. Three studied scenarios: (i) business as usual, (ii) increased deforestation, and (iii) decreased deforestation showed more transition to agriculture from shrubland compared to forests, and consistent locations for most deforestation. The probability of conversion to agriculture is strongly tied to areas with the smallest patches of original biome remaining. Increases in agricultural revenue are projected to continue with a loss of 25% of the remaining Cerrado land in the next decade if profit is maximized. The addition of biodiversity value as a tax on land sale prices, estimated at over $750,000,000 USD using the cost of extracting and maintaining current species ex-situ, can save more than 1 million hectares of shrubland with minimal effects on the economy of the State of Minas Gerais. With environmental policy determining rates of deforestation and economics driving the location of land clearing, site-specific protection or market accounting of externalities is needed to balance economic development and conservation.	[Stan, Kayla; Sanchez-Azofeifa, Arturo; Portillo-Quintero, Carlos] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB, Canada; [Espirito-Santo, Mario] Univ Estadual Montes Claros, Dept Gen Biol, BR-39401089 Claros Montes, MG, Brazil	University of Alberta; Universidade Estadual de Montes Claros	Stan, K (corresponding author), Univ Alberta, Dept Earth & Atmospher Sci, 1-26 Earth Sci Bldg, Edmonton, AB, Canada.	stan@ualberta.ca	Espirito-Santo, Mario/O-4813-2014; Sánchez, Arturo/L-3622-2019; Sanchez-Azofeifa, Arturo/F-4700-2014	Espirito-Santo, Mario/0000-0001-8274-3075; Sánchez, Arturo/0000-0002-4946-1559; Sanchez-Azofeifa, Arturo/0000-0001-7768-6600; Stan, Kayla/0000-0002-2159-3090	NSERC Undergraduate Student Research Award; Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG); Inter American Institute for Global Change Research (IAI) Collaborative Research Network Program [CRN 3 - 025]; US National Science Foundation [GEO-1128040]; University of Alberta; National Science and Engineering Research Council of Canada (NSERC-Discovery); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Directorate For Geosciences [1128040] Funding Source: National Science Foundation	NSERC Undergraduate Student Research Award(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Inter American Institute for Global Change Research (IAI) Collaborative Research Network Program; US National Science Foundation(National Science Foundation (NSF)); University of Alberta(University of Alberta); National Science and Engineering Research Council of Canada (NSERC-Discovery)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding for this research was provided by an NSERC Undergraduate Student Research Award, Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG), and the Inter American Institute for Global Change Research (IAI) Collaborative Research Network Program CRN 3 - 025 which is supported by the US National Science Foundation (Grant GEO-1128040). The authors' acknowledge the support provided by the University of Alberta, and the National Science and Engineering Research Council of Canada (NSERC-Discovery). MES gratefully acknowledges a research scholarship from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklin M, 2013, ECOL ECON, V94, P28, DOI 10.1016/j.ecolecon.2013.05.012; Amacher GS, 2009, ENVIRON DEV ECON, V14, P281, DOI 10.1017/S1355770X0800483X; Barbier EB, 2010, ENVIRON DEV ECON, V15, P635, DOI 10.1017/S1355770X1000032X; Batlle-Bayer L, 2010, AGR ECOSYST ENVIRON, V137, P47, DOI 10.1016/j.agee.2010.02.003; Benhin JKA, 2006, AMBIO, V35, P9, DOI 10.1639/0044-7447(2006)035[0009:AADITT]2.0.CO;2; Beuchle R, 2015, APPL GEOGR, V58, P116, DOI 10.1016/j.apgeog.2015.01.017; Billionnet A, 2013, EUR J OPER RES, V231, P514, DOI 10.1016/j.ejor.2013.03.025; Brandon K, 2005, CONSERV BIOL, V19, P595, DOI 10.1111/j.1523-1739.2005.00710.x; Brannstrom C, 2008, LAND USE POLICY, V25, P579, DOI 10.1016/j.landusepol.2007.11.008; Burgi M, 2004, LANDSCAPE ECOL, V19, P857, DOI 10.1007/s10980-004-0245-8; Carvalho FMV, 2009, BIOL CONSERV, V142, P1392, DOI 10.1016/j.biocon.2009.01.031; Carvalho LMT, 2008, INVENTARIO FLORESTAL, V1; Convention on Biological Diversity, 2010, AICH BIOD TARG STRAT; Damiani O, 2003, LAT AM RES REV, V38, P83, DOI 10.1353/lar.2003.0004; Darwin R, 1996, ECOL ECON, V17, P157, DOI 10.1016/S0921-8009(96)80004-8; De la Barreda-Bautista B., 2011, PLANET EARTH 2011 GL, P231, DOI DOI 10.5772/24283; de Menezes MD, 2009, CIENC AGROTEC, V33, P1544, DOI 10.1590/S1413-70542009000600013; DeFries HMR, 1981, UMD GLOBAL LAND COVE; Espirito-Santo MM, 2013, TROPICAL DRY FORESTS, P69; EVA HD, 2002, VEGETATION MAP S AM; Farfan M., 2012, Journal of Geographic Information System, V4, P358, DOI 10.4236/jgis.2012.44041; Ferreira ME, 2013, J LAND USE SCI, V8, P403, DOI 10.1080/1747423X.2012.675363; Grau HR, 2005, ENVIRON CONSERV, V32, P140, DOI 10.1017/S0376892905002092; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; Hermele K, 2011, REGULATION SUGARCANE; Hewitt R, 2011, APPL GEOGR, V31, P650, DOI 10.1016/j.apgeog.2010.11.002; Hirota MM, 2015, TECHNICAL REPORT FUN; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2004, MAP BIOM BRAS; Klink CA, 2005, CONSERV BIOL, V19, P707, DOI 10.1111/j.1523-1739.2005.00702.x; Lambin EF, 1997, PROG PHYS GEOG, V21, P375, DOI 10.1177/030913339702100303; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Lapola DM, 2010, P NATL ACAD SCI USA, V107, P3388, DOI 10.1073/pnas.0907318107; Laurance WF, 2008, AUSTRAL ECOL, V33, P399, DOI 10.1111/j.1442-9993.2008.01895.x; Leite ME, 2012, REV DEP GEOGRAFIA, V23, P217; Lourival R, 2008, ECOL ECON, V67, P20, DOI 10.1016/j.ecolecon.2008.04.022; Maillard P, 2009, ARID ENV WIND EROSIO, P1; Marris E, 2005, NATURE, V437, P944, DOI 10.1038/437944a; Mishan EJQE, 2007, COST BENEFIT ANAL; Negreiros D, 2008, REV CIENC SUELO NUTR, V8, P30; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Norton PB, MATH PROGRAMMING EC; Pivello VR, 2011, FIRE ECOL, V7, P24, DOI 10.4996/fireecology.0701024; Pohlman CL, 2007, BIOTROPICA, V39, P62, DOI 10.1111/j.1744-7429.2006.00238.x; Pretty J., 2001, Journal of Environmental Planning and Management, V44, P263, DOI 10.1080/09640560120033740; Resende FM, 2014, BRAZ J BIOL, V73, P709, DOI 10.1590/S1519-69842013000400005; Ribeiro K. T., 2009, NAT CONSERVACAO, V7, P30; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rocha G.F., 2011, REV BRASILEIRA CARTO, V63, P341; Rudel TK, 2007, LAND USE POLICY, V24, P35, DOI 10.1016/j.landusepol.2005.11.004; Sano E.E., 2010, MAPEAMENTO USO SOLO; Schooley RL, 2011, BIODIVERS CONSERV, V20, P1611, DOI 10.1007/s10531-011-0049-5; Secretaria de Biodiversidade e Floresta, PROJ MON DEM BIOM BR; Silvestre J, 2012, PUBLIC MICROECONOMICS: EFFICIENCY AND EQUITY IN PUBLIC POLICY; Soares B, 2014, SCIENCE, V344, P363, DOI 10.1126/science.1246663; Soares-Filho BS, 2009, MODELING ENV DYNAMIC; Sonter LJ, 2014, GLOBAL ENVIRON CHANG, V26, P63, DOI 10.1016/j.gloenvcha.2014.03.014; Sparovek G, 2012, ENVIRON SCI POLICY, V16, P65, DOI 10.1016/j.envsci.2011.10.008; Sparovek G, 2010, ENVIRON SCI TECHNOL, V44, P6046, DOI 10.1021/es1007824; SUAREZ A. F., 2013, REV BRASILEIRA CARTO, V65, P417; Thompson J. F., 2000, California Agriculture, V54, P51, DOI 10.3733/ca.v054n03p51; United Nations Environment Programme (UNEP), 2010, NAT BIOD TARG 2010 2; Veldkamp A, 2001, AGR ECOSYST ENVIRON, V85, P1, DOI 10.1016/S0167-8809(01)00199-2; Vosti S, LABOUR REQUIREMENTS; Wintle BA, 2011, NAT CLIM CHANGE, V1, P355, DOI 10.1038/NCLIMATE1227	64	9	10	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137911	10.1371/journal.pone.0137911	http://dx.doi.org/10.1371/journal.pone.0137911			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8LR	26371876	Green Published, Green Submitted, gold			2022-12-27	WOS:000361604400037
J	Cho, S; Kim, T; Woo, HM; Lee, J; Kim, Y; Um, Y				Cho, Sukhyeong; Kim, Taeyeon; Woo, Han Min; Lee, Jinwon; Kim, Yunje; Um, Youngsoon			Enhanced 2,3-Butanediol Production by Optimizing Fermentation Conditions and Engineering Klebsiella oxytoca M1 through Overexpression of Acetoin Reductase	PLOS ONE			English	Article							ALPHA-ACETOLACTATE DECARBOXYLASE; MESO-2,3-BUTANEDIOL DEHYDROGENASE; ACID; BIOSYNTHESIS; DELETION; LACTATE; PATHWAY; GLUCOSE	Microbial production of 2,3-butanediol (2,3-BDO) has been attracting increasing interest because of its high value and various industrial applications. In this study, high production of 2,3-BDO using a previously isolated bacterium Klebsiella oxytoca M1 was carried out by optimizing fermentation conditions and overexpressing acetoin reductase (AR). Supplying complex nitrogen sources and using NaOH as a neutralizing agent were found to enhance specific production and yield of 2,3-BDO. In fed-batch fermentations, 2,3-BDO production increased with the agitation speed (109.6 g/L at 300 rpm vs. 118.5 g/L at 400 rpm) along with significantly reduced formation of by-product, but the yield at 400 rpm was lower than that at 300 rpm (0.40 g/g vs. 0.34 g/g) due to acetoin accumulation at 400 rpm. Because AR catalyzing both acetoin reduction and 2,3-BDO oxidation in K. oxytoca M1 revealed more than 8-fold higher reduction activity than oxidation activity, the engineered K. oxytoca M1 overexpressing the budC encoding AR was used in fed-batch fermentation. Finally, acetoin accumulation was significantly reduced by 43% and enhancement of 2,3-BDO concentration (142.5 g/L), yield (0.42 g/g) and productivity (1.47 g/L/h) was achieved compared to performance with the parent strain. This is by far the highest titer of 2,3-BDO achieved by K. oxytoca strains. This notable result could be obtained by finding favorable fermentation conditions for 2,3-BDO production as well as by utilizing the distinct characteristic of AR in K. oxytoca M1 revealing the nature of reductase.	[Cho, Sukhyeong; Kim, Taeyeon; Woo, Han Min; Kim, Yunje; Um, Youngsoon] Korea Inst Sci & Technol, Clean Energy Res Ctr, Seoul, South Korea; [Kim, Taeyeon] Seoul Natl Univ, Coll Agr & Life Sci, Interdisciplinary Program Agr Biotechnol, Seoul, South Korea; [Woo, Han Min; Um, Youngsoon] Korea Univ Sci & Technol, Clean Energy & Chem Engn, Daejeon, South Korea; [Lee, Jinwon] Sogang Univ, Dept Chem & Biomol Engn, Seoul, South Korea	Korea Institute of Science & Technology (KIST); Seoul National University (SNU); University of Science & Technology (UST); Sogang University	Um, Y (corresponding author), Korea Inst Sci & Technol, Clean Energy Res Ctr, Seoul, South Korea.	yum@kist.re.kr	Woo, Han Min/J-1847-2015	Woo, Han Min/0000-0002-8797-0477; um, youngsoon/0000-0003-1695-1874; Lee, Jinwon/0000-0003-4153-0609	R&D Program of MOTIE/KEIT [10035578]; Creative Allied Project (CAP) of the Korea Research Council of Fundamental Science and Technology (KRCF)/Korea Institute of Science and Technology (KIST)	R&D Program of MOTIE/KEIT; Creative Allied Project (CAP) of the Korea Research Council of Fundamental Science and Technology (KRCF)/Korea Institute of Science and Technology (KIST)	This work was supported by the R&D Program of MOTIE/KEIT (No. 10035578, Development of 2,3-Butanediol and Derivative Production Technology for C-Zero Bio-Platform Industry). This work was also supported by Creative Allied Project (CAP) of the Korea Research Council of Fundamental Science and Technology (KRCF)/Korea Institute of Science and Technology (KIST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cho JH, 2012, BIOPROC BIOSYST ENG, V35, P1081, DOI 10.1007/s00449-012-0691-7; Cho S, 2013, APPL BIOCHEM BIOTECH, V170, P1922, DOI 10.1007/s12010-013-0291-2; Choi O, 2012, BIOTECHNOL BIOENG, V109, P2494, DOI 10.1002/bit.24520; GARG SK, 1995, BIORESOURCE TECHNOL, V51, P103, DOI 10.1016/0960-8524(94)00136-O; GoupilFeuillerat N, 1997, J BACTERIOL, V179, P6285, DOI 10.1128/JB.179.20.6285-6293.1997; Jantama K, 2015, METAB ENG, V30, P16, DOI 10.1016/j.ymben.2015.04.004; Ji XJ, 2008, BIOTECHNOL LETT, V30, P731, DOI 10.1007/s10529-007-9599-8; Ji XJ, 2011, BIOTECHNOL ADV, V29, P351, DOI 10.1016/j.biotechadv.2011.01.007; Ji XJ, 2010, APPL MICROBIOL BIOT, V85, P1751, DOI 10.1007/s00253-009-2222-2; Ji XJ, 2009, BIORESOURCE TECHNOL, V100, P3410, DOI 10.1016/j.biortech.2009.02.031; Jung MY, 2012, APPL MICROBIOL BIOT, V95, P461, DOI 10.1007/s00253-012-3883-9; Kim B, 2012, J MICROBIOL BIOTECHN, V22, P1258, DOI 10.4014/jmb.1201.01044; Li LX, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-123; Liu Z, 2011, BIORESOURCE TECHNOL, V102, P10741, DOI 10.1016/j.biortech.2011.08.110; Lu M, 2014, BIOPROC BIOSYST ENG, V37, P343, DOI 10.1007/s00449-013-0999-y; Ma CQ, 2009, APPL MICROBIOL BIOT, V82, P49, DOI 10.1007/s00253-008-1732-7; Monnet C, 2003, LETT APPL MICROBIOL, V36, P399, DOI 10.1046/j.1472-765X.2003.01326.x; Moon C, 2010, APPL BIOCHEM BIOTECH, V161, P502, DOI 10.1007/s12010-009-8859-6; Nakashimada Y, 2000, J BIOSCI BIOENG, V90, P661, DOI 10.1263/jbb.90.661; Nicholson WL, 2008, APPL ENVIRON MICROB, V74, P6832, DOI 10.1128/AEM.00881-08; Okino S, 2005, APPL MICROBIOL BIOT, V68, P475, DOI 10.1007/s00253-005-1900-y; Park JM, 2013, J IND MICROBIOL BIOT, V40, P1057, DOI 10.1007/s10295-013-1298-y; Park JM, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-20; Petrov K, 2009, APPL MICROBIOL BIOT, V84, P659, DOI 10.1007/s00253-009-2004-x; Qi GF, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-16; QURESHI N, 1989, J FERMENT BIOENG, V67, P415, DOI 10.1016/0922-338X(89)90147-5; Sangproo M, 2012, BIORESOURCE TECHNOL, V119, P191, DOI 10.1016/j.biortech.2012.05.114; Seo JK, 1998, J IND ENG CHEM, V4, P215; Syu MJ, 2001, APPL MICROBIOL BIOT, V55, P10, DOI 10.1007/s002530000486; van Haveren J, 2008, BIOFUEL BIOPROD BIOR, V2, P41, DOI 10.1002/bbb.43; Yang TH, 2014, J BIOTECHNOL, V172, P59, DOI 10.1016/j.jbiotec.2013.12.007; Zhang GL, 2012, BIOTECHNOL LETT, V34, P1519, DOI 10.1007/s10529-012-0933-4; Zhang LY, 2010, J IND MICROBIOL BIOT, V37, P857, DOI 10.1007/s10295-010-0733-6; Zhang X, 2011, WORLD J MICROB BIOT, V27, P2785, DOI 10.1007/s11274-011-0754-y; Zhang XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087788	36	51	54	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138109	10.1371/journal.pone.0138109	http://dx.doi.org/10.1371/journal.pone.0138109			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368397	Green Submitted, Green Published, gold			2022-12-27	WOS:000361601100226
J	Du, SS; Zhao, MM; Zhang, Y; Zhang, P; Hu, Y; Wang, LS; Zhou, Y; Li, QH; Li, Y; Du, YK; He, X; Li, N; Yin, ZF; Wei, YR; Weng, D; Li, HP				Du, Shan-Shan; Zhao, Meng-Meng; Zhang, Yuan; Zhang, Peng; Hu, Yang; Wang, Liu-Sheng; Zhou, Ying; Li, Qiu-Hong; Li, Yan; Du, Yu-Kui; He, Xian; Li, Nan; Yin, Zhao-Fang; Wei, Ya-Ru; Weng, Dong; Li, Hui-Ping			Screening for Differentially Expressed Proteins Relevant to the Differential Diagnosis of Sarcoidosis and Tuberculosis	PLOS ONE			English	Article							SOLUBLE ICAM-1; PULMONARY TUBERCULOSIS; LEPTIN; SERUM; MARKERS; INFLAMMATION; VCAM-1; SYSTEM; SPUTUM; ALPHA	Background In this study, we sought to identify differentially expressed proteins in the serum of patients with sarcoidosis or tuberculosis and to evaluate these proteins as markers for the differential diagnosis of sarcoidosis and sputum-negative tuberculosis. Methods Using protein microarrays, we identified 3 proteins exhibiting differential expression between patients with sarcoidosis and tuberculosis. Elevated expression of these proteins was verified using the enzyme-linked immunosorbent assay (ELISA) and was further confirmed by immunohistochemistry. Receiver operating characteristic (ROC) curve, logistic regression analysis, parallel, and serial tests were used to evaluate the diagnostic efficacy of the proteins. Results Intercellular Adhesion Molecule 1(ICAM-1) and leptin were screened for differentially expressed proteins relevant to sarcoidosis and tuberculosis. Using ROC curves, we found that ICAM-1 (cutoff value: 57740 pg/mL) had an area under the curve (AUC), sensitivity, and specificity of 0.718, 62.3%, and 79.5% respectively, while leptin (cutoff value: 1193.186 pg/mL) had an AUC, sensitivity, and specificity of 0.763, 88.3%, and 65.8%, respectively. Logistic regression analysis revealed that the AUC, sensitivity, and specificity of combined leptin and ICAM-1 were 0.787, 89.6%, and 65.8%, respectively, while those of combined leptin, ICAM-1, and body mass index (BMI) were 0.837, 90.9%, and 64.4%, respectively, which had the greatest diagnostic value. Parallel and serial tests indicated that the BMI-leptin parallel with the ICAM-1 serial was the best diagnostic method, achieving a sensitivity and specificity of 86.5% and 73.1%, respectively. Thus, our results identified elevated expression of ICAM-1 and leptin in serum and granulomas of sarcoidosis patients. Conclusions ICAM-1 and leptin were found to be potential markers for the diagnosis of sarcoidosis and differential diagnosis of sarcoidosis and sputum-negative tuberculosis.	[Du, Shan-Shan; Zhao, Meng-Meng; Zhang, Yuan; Hu, Yang; Wang, Liu-Sheng; Zhou, Ying; Li, Qiu-Hong; Li, Yan; Du, Yu-Kui; Li, Nan; Wei, Ya-Ru; Weng, Dong; Li, Hui-Ping] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Dept Resp Med, Shanghai 200092, Peoples R China; [Zhang, Peng] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Dept Chest Surg, Shanghai 200092, Peoples R China; [He, Xian; Yin, Zhao-Fang] Soochow Univ, Sch Med, Shanghai Pulm Hosp, Dept Resp Med, Suzhou, Peoples R China	Tongji University; Tongji University; Soochow University - China	Weng, D (corresponding author), Tongji Univ, Shanghai Pulm Hosp, Sch Med, Dept Resp Med, Shanghai 200092, Peoples R China.	cruise00@gmail.com; liw2013@126.com			National Science Foundation of China [91442103, 81170011, 81200045]; Science and Technology Commission of Shanghai Municipality [12DJ1400103, 124119a9000, 12DZ1942500, 12411950105]; Health Bureau Program of Shanghai Municipality [SHDC12014120, 2013SY047]; Tongji University [1511219020]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Health Bureau Program of Shanghai Municipality; Tongji University	The study was funded by grants from the National Science Foundation of China (No: 91442103, 81170011, and 81200045), the Science and Technology Commission of Shanghai Municipality (12DJ1400103, 124119a9000, 12DZ1942500 and 12411950105), the Health Bureau Program of Shanghai Municipality (SHDC12014120, 2013SY047), and Tongji University (1511219020).	Arakelyan A, 2009, CLIN EXP IMMUNOL, V155, P457, DOI 10.1111/j.1365-2249.2008.03832.x; Bargagli E, 2008, CLIN CHEST MED, V29, P445, DOI 10.1016/j.ccm.2008.03.004; Baughman RP, 2011, AM J RESP CRIT CARE, V183, P573, DOI 10.1164/rccm.201006-0865CI; Baughman RP, 2003, LANCET, V361, P1111, DOI 10.1016/S0140-6736(03)12888-7; Braun J, 1999, LUNG, V177, P139, DOI 10.1007/PL00007635; Cakir B, 1999, HORM RES, V52, P279, DOI 10.1159/000023495; Calikoglu M, 2004, RESPIRATION, V71, P45, DOI 10.1159/000075648; Costabel U, 1999, EUR RESPIR J, V14, P735, DOI 10.1034/j.1399-3003.1999.14d02.x; DUANMU HJ, 2002, CHIN J TUBERC RESP D, V25, P3; Figeys D, 2002, PROTEOMICS, V2, P373, DOI 10.1002/1615-9861(200204)2:4<373::AID-PROT373>3.0.CO;2-I; Hamzaoui A, 1996, MEDIAT INFLAMM, V5, P276, DOI 10.1155/S0962935196000403; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; ISHII Y, 1995, CHEST, V107, P1636, DOI 10.1378/chest.107.6.1636; Kim DS, 1999, CHEST, V115, P1059, DOI 10.1378/chest.115.4.1059; Kruit A, 2007, RESP MED, V101, P510, DOI 10.1016/j.rmed.2006.06.025; Li QH, 2012, SARCOIDOSIS VASC DIF, V29, P11; MAFFEI M, 1995, P NATL ACAD SCI USA, V92, P6957, DOI 10.1073/pnas.92.15.6957; Martin-Romero C, 2000, CELL IMMUNOL, V199, P15, DOI 10.1006/cimm.1999.1594; Miyoshi S, 2010, CHEST, V137, P1391, DOI 10.1378/chest.09-1975; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; ROTHLEIN R, 1986, J EXP MED, V163, P1132, DOI 10.1084/jem.163.5.1132; Sanchez-Margalet V, 2003, CLIN EXP IMMUNOL, V133, P11, DOI 10.1046/j.1365-2249.2003.02190.x; Sun ZH, 2004, ANTICANCER RES, V24, P1159; Tirumalai RS, 2003, MOL CELL PROTEOMICS, V2, P1096, DOI 10.1074/mcp.M300031-MCP200; van Crevel R, 2002, J CLIN ENDOCR METAB, V87, P758, DOI 10.1210/jc.87.2.758; VANDINTHERJANSSEN ACHM, 1993, J PATHOL, V170, P157, DOI 10.1002/path.1711700210; Yurt S, 2013, CLIN BIOCHEM, V46, P40, DOI 10.1016/j.clinbiochem.2012.09.008; Zandvoort A, 2006, EUR RESPIR J, V28, P113, DOI 10.1183/09031936.06.00116205; Zhang Y, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-18; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhou Y, 2008, SARCOIDOSIS VASC DIF, V25, P93	31	10	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0132466	10.1371/journal.pone.0132466	http://dx.doi.org/10.1371/journal.pone.0132466			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368286	Green Submitted, Green Published, gold			2022-12-27	WOS:000361601100001
J	Iscla, I; Wray, R; Eaton, C; Blount, P				Iscla, Irene; Wray, Robin; Eaton, Christina; Blount, Paul			Scanning MscL Channels with Targeted Post-Translational Modifications for Functional Alterations	PLOS ONE			English	Article							MECHANOSENSITIVE ION-CHANNEL; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; GATING MECHANISM; SINGLE RESIDUE; PORE-SIZE; MEMBRANE; PROTEIN; DOMAINS; TRAAK	Mechanosensitive channels are present in all living organisms and are thought to underlie the senses of touch and hearing as well as various important physiological functions like osmoregulation and vasoregulation. The mechanosensitive channel of large conductance (MscL) from Escherichia coli was the first protein shown to encode mechanosensitive channel activity and serves as a paradigm for how a channel senses and responds to mechanical stimuli. MscL plays a role in osmoprotection in E. coli, acting as an emergency release valve that is activated by membrane tension due to cell swelling after an osmotic down-shock. Using an osmotically fragile strain in an osmotic down-shock assay, channel functionality can be directly determined in vivo. In addition, using thiol reagents and expressed MscL proteins with a single cysteine substitution, we have shown that targeted post-translational modifications can be performed, and that any alterations that lead to dysfunctional proteins can be identified by this in vivo assay. Here, we present the results of such a scan performed on 113 MscL cysteine mutants using five different sulfhydryl-reacting probes to confer different charges or hydrophobicity to each site. We assessed which of these targeted modifications affected channel function and the top candidates were further studied using patch clamp to directly determine how channel activity was affected. This comprehensive screen has identified many residues that are critical for channel function as well as highlighted MscL domains and residues that undergo the most drastic environmental changes upon gating.	[Iscla, Irene; Wray, Robin; Eaton, Christina; Blount, Paul] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Blount, P (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	Paul.Blount@utsouthwestern.edu		Iscla, Irene/0000-0001-8936-430X	Welch Foundation [I-1420]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP100146]; U.S. National Institutes of Health [GM061028]; National American Heart Association [12SDG8740012]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061028] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); Cancer Prevention and Research Institute of Texas (CPRIT); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was funded by grant I-1420 of the Welch Foundation (http://www.welch1.org/), grant RP100146 from the Cancer Prevention and Research Institute of Texas (CPRIT; http://www.cprit.state.tx.us/), and grant GM061028 from the U.S. National Institutes of Health (http://www.nih.gov/). I.I. is supported by Grant 12SDG8740012 from the National American Heart Association (http://www.heart.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajouz B, 2000, J BIOL CHEM, V275, P1015, DOI 10.1074/jbc.275.2.1015; Anishkin A, 2014, P NATL ACAD SCI USA, V111, P7898, DOI 10.1073/pnas.1313364111; Balleza D, 2009, EUR BIOPHYS J BIOPHY, V38, P1013, DOI 10.1007/s00249-009-0460-y; Bartlett JL, 2006, BIOPHYS J, V91, P3684, DOI 10.1529/biophysj.106.088062; Bartlett JL, 2004, P NATL ACAD SCI USA, V101, P10161, DOI 10.1073/pnas.0402040101; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Blount P, 1999, TRENDS MICROBIOL, V7, P420, DOI 10.1016/S0966-842X(99)01594-2; Blount P, 1996, P NATL ACAD SCI USA, V93, P11652, DOI 10.1073/pnas.93.21.11652; Blount P, 1996, EMBO J, V15, P4798, DOI 10.1002/j.1460-2075.1996.tb00860.x; Blount P, 1997, J BIOL CHEM, V272, P32150, DOI 10.1074/jbc.272.51.32150; Brohawn SG, 2014, NATURE, V516, P126, DOI 10.1038/nature14013; Brohawn SG, 2013, P NATL ACAD SCI USA, V110, P2129, DOI 10.1073/pnas.1218950110; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Corry B, 2010, J GEN PHYSIOL, V136, P483, DOI 10.1085/jgp.200910376; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Cruickshank CC, 1997, BIOPHYS J, V73, P1925, DOI 10.1016/S0006-3495(97)78223-7; Dong YY, 2015, SCIENCE, V347, P1256, DOI 10.1126/science.1261512; Enkvetchakul D, 2007, J GEN PHYSIOL, V130, P329, DOI 10.1085/jgp.200709764; Epstein W, 1970, J BACTERIOL, V101, P836, DOI 10.1128/JB.101.3.836-843.1970; Hase CC, 1997, J MEMBRANE BIOL, V157, P17, DOI 10.1007/s002329900212; Iscla I, 2004, BIOPHYS J, V87, P3172, DOI 10.1529/biophysj.104.049833; Iscla I, 2008, BIOPHYS J, V95, P2283, DOI 10.1529/biophysj.107.127423; Iscla I, 2007, BIOPHYS J, V92, P1224, DOI 10.1529/biophysj.106.090316; Iscla I, 2013, BIOSENSORS-BASEL, V3, P171, DOI 10.3390/bios3010171; Iscla I, 2012, CHANNELS, V6, P255, DOI 10.4161/chan.20756; Iscla I, 2012, BIOPHYS J, V103, P169, DOI 10.1016/j.bpj.2012.06.021; Iscla I, 2011, FASEB J, V25, P694, DOI 10.1096/fj.10-170878; Jeon J, 2008, BIOPHYS J, V94, P3497, DOI 10.1529/biophysj.107.109850; Kumanovics A, 2002, FASEB J, V16, P1623, DOI 10.1096/fj.02-0238hyp; Levin G, 2004, BIOPHYS J, V86, P2862, DOI 10.1016/S0006-3495(04)74338-6; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Li YZ, 2009, FASEB J, V23, P2197, DOI 10.1096/fj.09-129296; Ou XR, 1998, P NATL ACAD SCI USA, V95, P11471, DOI 10.1073/pnas.95.19.11471; Park KH, 2004, BIOPHYS J, V86, P2129, DOI 10.1016/S0006-3495(04)74272-1; Perozo E, 2002, NATURE, V418, P942, DOI 10.1038/nature00992; Steinbacher S, 2007, CURR TOP MEMBR, V58, P1, DOI 10.1016/S1063-5823(06)58001-9; Sukharev S, 2001, BIOPHYS J, V81, P917, DOI 10.1016/S0006-3495(01)75751-7; Sukharev S, 2001, NATURE, V409, P720, DOI 10.1038/35055559; Tsai IJ, 2005, EUR BIOPHYS J BIOPHY, V34, P403, DOI 10.1007/s00249-005-0476-x; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Yang LM, 2013, CELL REP, V3, P520, DOI 10.1016/j.celrep.2013.01.018; Yang LM, 2012, ACS NANO, V6, P1134, DOI 10.1021/nn203703j; Yoshimura K, 1999, BIOPHYS J, V77, P1960, DOI 10.1016/S0006-3495(99)77037-2; Yoshimura K, 2004, BIOPHYS J, V86, P2113, DOI 10.1016/S0006-3495(04)74270-8; Zhong DL, 2014, FASEB J, V28, P5234, DOI 10.1096/fj.14-259309; Zhou XL, 2007, P NATL ACAD SCI USA, V104, P15555, DOI 10.1073/pnas.0704039104	48	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137994	10.1371/journal.pone.0137994	http://dx.doi.org/10.1371/journal.pone.0137994			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368283	Green Submitted, Green Published, gold			2022-12-27	WOS:000361601100197
J	Chokhandre, S; Colbrunn, R; Bennetts, C; Erdemir, A				Chokhandre, Snehal; Colbrunn, Robb; Bennetts, Craig; Erdemir, Ahmet			A Comprehensive Specimen-Specific Multiscale Data Set for Anatomical and Mechanical Characterization of the Tibiofemoral Joint	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; MEDIAL COLLATERAL LIGAMENT; HUMAN ARTICULAR-CARTILAGE; HUMAN KNEE-JOINT; CONFINED COMPRESSION; FINITE-ELEMENT; MENISCUS; KINEMATICS; DESIGN; MODEL	Understanding of tibiofemoral joint mechanics at multiple spatial scales is essential for developing effective preventive measures and treatments for both pathology and injury management. Currently, there is a distinct lack of specimen-specific biomechanical data at multiple spatial scales, e.g., joint, tissue, and cell scales. Comprehensive multiscale data may improve the understanding of the relationship between biomechanical and anatomical markers across various scales. Furthermore, specimen-specific multiscale data for the tibiofemoral joint may assist development and validation of specimen-specific computational models that may be useful for more thorough analyses of the biomechanical behavior of the joint. This study describes an aggregation of procedures for acquisition of multiscale anatomical and biomechanical data for the tibiofemoral joint. Magnetic resonance imaging was used to acquire anatomical morphology at the joint scale. A robotic testing system was used to quantify joint level biomechanical response under various loading scenarios. Tissue level material properties were obtained from the same specimen for the femoral and tibial articular cartilage, medial and lateral menisci, anterior and posterior cruciate ligaments, and medial and lateral collateral ligaments. Histology data were also obtained for all tissue types to measure specimen-specific cell scale information, e.g., cellular distribution. This study is the first of its kind to establish a comprehensive multiscale data set for a musculoskeletal joint and the presented data collection approach can be used as a general template to guide acquisition of specimen-specific comprehensive multiscale data for musculoskeletal joints.	[Chokhandre, Snehal; Bennetts, Craig; Erdemir, Ahmet] Cleveland Clin, Lerner Res Inst, Computat Biomodeling CoBi Core, Cleveland, OH 44195 USA; [Chokhandre, Snehal; Colbrunn, Robb; Bennetts, Craig; Erdemir, Ahmet] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA; [Colbrunn, Robb] Cleveland Clin, Lerner Res Inst, BioRobot & Mech Testing Core, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Erdemir, A (corresponding author), Cleveland Clin, Lerner Res Inst, Computat Biomodeling CoBi Core, Cleveland, OH 44195 USA.	erdemira@ccf.org		Erdemir, Ahmet/0000-0002-4629-8055	National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health [1R01EB009643]; National Institute of General Medical Sciences, National Institutes of Health [1R01GM104139]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104139] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was primarily funded by the National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health (1R01EB009643; PI: Erdemir) and was partially supported by the National Institute of General Medical Sciences (1R01GM104139; PI: Erdemir), National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsoum WK, 2011, J ORTHOP RES, V29, P47, DOI 10.1002/jor.21207; BLANKEVOORT L, 1988, J BIOMECH, V21, P705, DOI 10.1016/0021-9290(88)90280-1; Bonifasi-Lista C, 2005, J ORTHOP RES, V23, P67, DOI 10.1016/j.orthres.2004.06.002; Borotikar BS, 2009, SUBJECT SPECIFIC COM; Boschetti F, 2004, BIORHEOLOGY, V41, P159; Buckwalter Joseph A, 2005, Instr Course Lect, V54, P465; Bull AMJ, 2008, CLIN ORTHOP RELAT R, V466, P2491, DOI 10.1007/s11999-008-0440-z; BUTLER DL, 1986, J BIOMECH, V19, P425, DOI 10.1016/0021-9290(86)90019-9; Campo-Ruiz V, 2005, INT J EXP PATHOL, V86, P297, DOI 10.1111/j.0959-9673.2005.00439.x; Chandrashekar N, 2006, J BIOMECH, V39, P2943, DOI 10.1016/j.jbiomech.2005.10.031; Chokhandre S, 2013, ASME 2013 CONFERENCE ON FRONTIERS IN MEDICAL DEVICES: APPLICATIONS OF COMPUTER MODELING AND SIMULATION, DOI 10.1115/FMD2013-16117; Chokhandre S, 2012, PROCEEDINGS OF THE ASME SUMMER BIOENGINEERING CONFERENCE, PTS A AND B, P1089; Danso EK, 2014, J BIOMECH, V47, P200, DOI 10.1016/j.jbiomech.2013.09.015; Deneweth JM, 2013, J ORTHOP RES, V31, P370, DOI 10.1002/jor.22226; Dhaher YY, 2010, J BIOMECH, V43, P3118, DOI 10.1016/j.jbiomech.2010.08.005; Fitzpatrick CK, 2012, J BIOMECH, V45, P2092, DOI 10.1016/j.jbiomech.2012.05.035; Goldblatt JP, 2003, OPER TECHN SPORT MED, V11, P172, DOI 10.1053/otsm.2003.35911; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136, DOI 10.1115/1.3138397; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Halonen KS, 2013, J BIOMECH, V46, P1184, DOI 10.1016/j.jbiomech.2012.12.025; Hamai S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/717546; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P564, DOI 10.1053/joca.2002.0814; Jurvelin J S, 2003, Proc Inst Mech Eng H, V217, P215, DOI 10.1243/095441103765212712; Kiapour A, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4025692; Kondo E, 2014, ARTHROSCOPY, V30, P335, DOI 10.1016/j.arthro.2013.12.003; Korhonen RK, 2002, J BIOMECH, V35, P903, DOI 10.1016/S0021-9290(02)00052-0; Lechner K, 2000, J ORTHOPAED RES, V18, P945, DOI 10.1002/jor.1100180614; Li G, 1999, J BIOMECH ENG-T ASME, V121, P657, DOI 10.1115/1.2800871; Liu P, 2015, KNEE SURG SPORT TR A, V23, P1018, DOI 10.1007/s00167-013-2824-1; Mommersteeg TJA, 1996, J BIOMECH, V29, P1659, DOI 10.1016/S0021-9290(96)80022-4; Morton NA, 2007, J ORTHOP RES, V25, P1221, DOI 10.1002/jor.20396; Nam D, 2012, KNEE, V19, P640, DOI 10.1016/j.knee.2011.09.009; Netravali NA, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003008; Noble LD, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000851; Pachowsky ML, 2014, KNEE SURG SPORT TR A, V22, P1360, DOI 10.1007/s00167-013-2527-7; Pedersen DR, 2013, ORTHOP RES REV, V5, P13, DOI 10.2147/ORR.S38400; Peterfy CG, 2008, OSTEOARTHR CARTILAGE, V16, P1433, DOI 10.1016/j.joca.2008.06.016; Qi W, 2013, J BIOMECH, V46, P1576, DOI 10.1016/j.jbiomech.2013.03.014; Quapp KM, 1998, J BIOMECH ENG-T ASME, V120, P757, DOI 10.1115/1.2834890; Seitz AM, 2013, J MECH BEHAV BIOMED, V26, P68, DOI 10.1016/j.jmbbm.2013.05.027; Sibole SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037538; Smith CD, 2008, CURR ORTHOPAED, V22, P341, DOI 10.1016/j.cuor.2008.07.010; Song YH, 2004, J BIOMECH, V37, P383, DOI 10.1016/S0021-9290(03)00261-6; STROCCHI R, 1992, J ANAT, V180, P515; Thambyah A, 2005, MED ENG PHYS, V27, P329, DOI 10.1016/j.medengphy.2004.09.002; Yao J, 2006, J BIOMECH ENG-T ASME, V128, P399, DOI 10.1115/1.2191077	46	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138226	10.1371/journal.pone.0138226	http://dx.doi.org/10.1371/journal.pone.0138226			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381404	Green Published, gold, Green Submitted			2022-12-27	WOS:000361790200073
J	Meunier, I; Morisseau, O; Garneau, E; Marois, I; Cloutier, A; Richter, MV				Meunier, Isabelle; Morisseau, Olivier; Garneau, Emilie; Marois, Isabelle; Cloutier, Alexandre; Richter, Martin V.			Infection with a Mouse-Adapted Strain of the 2009 Pandemic Virus Causes a Highly Severe Disease Associated with an Impaired T Cell Response	PLOS ONE			English	Article							INFLUENZA-A-VIRUS; DENDRITIC CELLS; EPITHELIAL-CELLS; MEMORY RESPONSES; PROINFLAMMATORY CYTOKINES; ANTIVIRAL RESPONSES; RESPIRATORY VIRUS; HUMAN MACROPHAGES; GLOBAL MORTALITY; IMMUNE-RESPONSE	Despite a relatively low fatality rate, the 2009 H1N1 pandemic virus differed from other seasonal viruses in that it caused mortality and severe pneumonia in the young and middle-aged population (18-59 years old). The mechanisms underlying this increased disease severity are still poorly understood. In this study, a human isolate of the 2009 H1N1 pandemic virus was adapted to the mouse (MAp2009). The pathogenicity of the MAp2009 virus and the host immune responses were evaluated in the mouse model and compared to the laboratory H1N1 strain A/Puerto Rico/8/1934 (PR8). The MAp2009 virus reached consistently higher titers in the lungs over 14 days compared to the PR8 virus, and caused severe disease associated with high morbidity and 85% mortality rate, contrasting with the 0% death rate in the PR8 group. During the early phase of infection, both viruses induced similar pathology in the lungs. However, MAp2009-induced lung inflammation was sustained until the end of the study (day 14), while there was no sign of inflammation in the PR8-infected group by day 10. Furthermore, at day 3 post-infection, MAp2009 induced up to 10- to 40-fold more cytokine and chemokine gene expression, respectively. More importantly, the numbers of CD4(+) T cells and virus-specific CD8(+) T cells were significantly lower in the lungs of MAp2009-infected mice compared to PR8-infected mice. Interestingly, there was no difference in the number of dendritic cells in the lung and in the draining lymph node. Moreover, mice infected with PR8 or MAp2009 had similar numbers of CCR5 and CXCR3-expressing T cells, suggesting that the impaired T cell response was not due to a lack of chemokine responsiveness or priming of T cells. This study demonstrates that a mouse-adapted virus from an isolate of the 2009 pandemic virus interferes with the adaptive immune response leading to a more severe disease.	[Richter, Martin V.] Univ Sherbrooke, Div Pulm, Dept Med, Fac Med & Hlth Sci, Sherbrooke, PQ J1K 2R1, Canada; Ctr Rech CHUS, Sherbrooke, PQ, Canada	University of Sherbrooke	Richter, MV (corresponding author), Univ Sherbrooke, Div Pulm, Dept Med, Fac Med & Hlth Sci, Sherbrooke, PQ J1K 2R1, Canada.	Martin.Richter@usherbrooke.ca			Canadian Institutes of Health Research [MOP-102670]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was funded by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca) through grant number MOP-102670 to MVR. IM (1) was the recipient of a postdoctoral fellowship from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrati C, 2010, J INFECT DIS, V202, P681, DOI 10.1086/655469; ALLAN W, 1990, J IMMUNOL, V144, P3980; Ballesteros-Tato A, 2010, NAT IMMUNOL, V11, P216, DOI 10.1038/ni.1838; Belz GT, 2007, NAT IMMUNOL, V8, P1060, DOI 10.1038/ni1505; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Bermejo-Martin JF, 2010, CRIT CARE, V14, DOI 10.1186/cc9259; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; Braciale TJ, 2012, NAT REV IMMUNOL, V12, P295, DOI 10.1038/nri3166; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Chen H, 2007, VIRUS RES, V128, P159, DOI 10.1016/j.virusres.2007.04.017; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Cottey R, 2001, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1911s42; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; de Wit E, 2010, J VIROL, V84, P1597, DOI 10.1128/JVI.01783-09; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Doherty PC, 2000, ANNU REV IMMUNOL, V18, P561, DOI 10.1146/annurev.immunol.18.1.561; Dolfi DV, 2011, J IMMUNOL, V186, P4599, DOI 10.4049/jimmunol.1001972; Fleury H, 2009, EUROSURVEILLANCE, V14, P14; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Fox A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031535; Fujisawa H, 2008, J VIROL, V82, P2772, DOI 10.1128/JVI.01210-07; Fujiwara H, 2001, INT IMMUNOPHARMACOL, V1, P613, DOI 10.1016/S1567-5769(00)00049-7; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; GARTEN W, 1981, VIROLOGY, V115, P361, DOI 10.1016/0042-6822(81)90117-3; Giamarellos-Bourboulis EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008393; Gill JR, 2010, ARCH PATHOL LAB MED, V134, P235, DOI 10.1043/1543-2165-134.2.235; Goto H, 1998, P NATL ACAD SCI USA, V95, P10224, DOI 10.1073/pnas.95.17.10224; Guan Y, 2010, PROTEIN CELL, V1, P9, DOI 10.1007/s13238-010-0008-z; Guilliams M, 2013, MUCOSAL IMMUNOL, V6, P464, DOI 10.1038/mi.2013.14; Hai R, 2010, J VIROL, V84, P4442, DOI 10.1128/JVI.02717-09; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2010, J VIROL, V84, P6909, DOI 10.1128/JVI.00081-10; Hamada H, 2013, J IMMUNOL, V190, P296, DOI 10.4049/jimmunol.1200571; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Herfst S, 2010, VET PATHOL, V47, P1040, DOI 10.1177/0300985810374836; Herfst S, 2010, J VIROL, V84, P3752, DOI 10.1128/JVI.02634-09; Hillaire MLB, 2013, CURR OPIN VIROL, V3, P430, DOI 10.1016/j.coviro.2013.05.002; Hsieh YC, 2006, J FORMOS MED ASSOC, V105, P1, DOI 10.1016/S0929-6646(09)60102-9; Hui KPY, 2009, J IMMUNOL, V182, P1088, DOI 10.4049/jimmunol.182.2.1088; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kang YM, 2011, ARCH VIROL, V156, P759, DOI 10.1007/s00705-010-0914-7; Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851; Khandaker G, 2011, INFLUENZA OTHER RESP, V5, P148, DOI 10.1111/j.1750-2659.2011.00199.x; Kim Tae Hoon, 2014, Immune Netw, V14, P128, DOI 10.4110/in.2014.14.3.128; La Gruta NL, 2014, TRENDS IMMUNOL, V35, P396, DOI 10.1016/j.it.2014.06.004; Lafon M, 2008, DEV BIOLOGICALS, V131, P413; Lawrence CW, 2005, J IMMUNOL, V174, P5332, DOI 10.4049/jimmunol.174.9.5332; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Li CC, 2010, EMERG INFECT DIS, V16, P1265, DOI 10.3201/eid1608.091918; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; Marois I, 2012, J LEUKOCYTE BIOL, V92, P107, DOI 10.1189/jlb.1011490; Marshall DR, 2001, P NATL ACAD SCI USA, V98, P6313, DOI 10.1073/pnas.101132698; Mauad T, 2010, AM J RESP CRIT CARE, V181, P72, DOI 10.1164/rccm.200909-1420OC; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314; McGill J, 2010, J EXP MED, V207, P521, DOI 10.1084/jem.20091711; MCMICHAEL AJ, 1986, J GEN VIROL, V67, P719, DOI 10.1099/0022-1317-67-4-719; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Meunier I, 2012, VIROLOGY, V422, P125, DOI 10.1016/j.virol.2011.10.018; Munster VJ, 2010, J VIROL, V84, P7953, DOI 10.1128/JVI.00449-10; Neumann G, 2010, CELL RES, V20, P51, DOI 10.1038/cr.2009.124; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Oslund KL, 2011, FUTURE VIROL, V6, P951, DOI 10.2217/FVL.11.63; Ozawa M, 2011, J VIROL, V85, P4596, DOI 10.1128/JVI.00029-11; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Rosseau S, 2000, J IMMUNOL, V164, P427, DOI 10.4049/jimmunol.164.1.427; Safronetz D, 2011, J VIROL, V85, P1214, DOI 10.1128/JVI.01848-10; Sage LK, 2013, J GEN VIROL, V94, P1701, DOI 10.1099/vir.0.049494-0; Sakabe S, 2011, J GEN VIROL, V92, P1428, DOI 10.1099/vir.0.030346-0; Sanders CJ, 2011, CELL TISSUE RES, V343, P13, DOI 10.1007/s00441-010-1043-z; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; Siren J, 2006, MICROBES INFECT, V8, P2013, DOI 10.1016/j.micinf.2006.02.028; Smirnov YA, 2000, ACTA VIROL, V44, P1; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Strutt TM, 2013, IMMUNOL REV, V255, P149, DOI 10.1111/imr.12088; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Sun J, 2013, CURR OPIN VIROL, V3, P425, DOI 10.1016/j.coviro.2013.05.001; Takahashi Yoshimasa, 2012, Infectious Disorders - Drug Targets, V12, P232; Tiwari N, 2014, J MED VIROL, V86, P1034, DOI 10.1002/jmv.23877; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Topham DJ, 1998, J IMMUNOL, V161, P4530; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; von Messling V, 1999, J CLIN MICROBIOL, V37, P1049, DOI 10.1128/JCM.37.4.1049-1056.1999; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; Watanabe T, 2010, J VIRAL HEPATITIS, V17, P453, DOI 10.1111/j.1365-2893.2010.01313.x; Woo PCY, 2010, J INFECT DIS, V201, P346, DOI 10.1086/649785; Xing Z, 2011, AM J RESP CELL MOL, V44, P24, DOI 10.1165/rcmb.2009-0120OC; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785	98	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138055	10.1371/journal.pone.0138055	http://dx.doi.org/10.1371/journal.pone.0138055			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381265	Green Submitted, gold, Green Published			2022-12-27	WOS:000361790200052
J	Moorin, RE; Gibson, DAJ; Forsyth, RK; Fox, R				Moorin, Rachael E.; Gibson, David A. J.; Forsyth, Rene K.; Fox, Richard			The Impact of Iterative Reconstruction on Computed Tomography Radiation Dosimetry: Evaluation in a Routine Clinical Setting	PLOS ONE			English	Article							LOW-TUBE-VOLTAGE; DOSE REDUCTION STRATEGY; IMAGE QUALITY; CHEST CT; IONIZING-RADIATION; EXPOSURE; ALGORITHM; RISK; PROTOCOLS	Purpose To evaluate the effect of introduction of iterative reconstruction as a mandated software upgrade on radiation dosimetry in routine clinical practice over a range of computed tomography examinations. Methods Random samples of scanning data were extracted from a centralised Picture Archiving Communication System pertaining to 10 commonly performed computed tomography examination types undertaken at two hospitals in Western Australia, before and after the introduction of iterative reconstruction. Changes in the mean dose length product and effective dose were evaluated along with estimations of associated changes to annual cancer incidence. Results We observed statistically significant reductions in the effective radiation dose for head computed tomography (22-27%) consistent with those reported in the literature. In contrast the reductions observed for non-contrast chest (37-47%); chest pulmonary embolism study (28%), chest/abdominal/pelvic study (16%) and thoracic spine (39%) computed tomography. Statistically significant reductions in radiation dose were not identified in angiographic computed tomography. Dose reductions translated to substantial lowering of the lifetime attributable risk, especially for younger females, and estimated numbers of incident cancers. Conclusion Reduction of CT dose is a priority Iterative reconstruction algorithms have the potential to significantly assist with dose reduction across a range of protocols. However, this reduction in dose is achieved via reductions in image noise. Fully realising the potential dose reduction of iterative reconstruction requires the adjustment of image factors and forgoing the noise reduction potential of the iterative algorithm. Our study has demonstrated a reduction in radiation dose for some scanning protocols, but not to the extent experimental studies had previously shown or in all protocols expected, raising questions about the extent to which iterative reconstruction achieves dose reduction in real world clinical practice.	[Moorin, Rachael E.; Gibson, David A. J.] Curtin Univ, Sch Publ Hlth, Perth, WA 6845, Australia; [Moorin, Rachael E.] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Forsyth, Rene K.] Curtin Univ, Dept Med Imaging Sci, Perth, WA 6845, Australia; [Fox, Richard] Univ Western Australia, Sch Phys, Perth, WA 6009, Australia	Curtin University; University of Western Australia; Curtin University; University of Western Australia	Moorin, RE (corresponding author), Curtin Univ, Sch Publ Hlth, GPO Box U1987, Perth, WA 6845, Australia.	r.moorin@curtin.edu.au	Moorin, Rachael/AAQ-3650-2020	Moorin, Rachael/0000-0001-8742-7151	National Medical and Research Council [APP 1008394]	National Medical and Research Council	This study was supported by a National Medical and Research Council (http://www.nhmrc.gov.au/) project grant (APP 1008394). The funders had no role in study design, data collection, data analysis, data interpretation or writing the report.	Aroua A, 2002, HEALTH PHYS, V83, P46, DOI 10.1097/00004032-200207000-00005; (ARPANSA) ARPaNSA, 2013, CURR AUSTR NAT DIAGN; Brink JA, 2012, RADIOLOGY, V265, P666, DOI 10.1148/radiol.12121919; Brugmans MJP, 2002, HEALTH PHYS, V82, P500, DOI 10.1097/00004032-200204000-00009; Christner JA, 2012, RADIOLOGY, V265, P841, DOI 10.1148/radiol.12112365; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Desai GS, 2012, EUR RADIOL, V22, P1631, DOI 10.1007/s00330-012-2424-3; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; European Commission, 1999, 16262 EUR EN EUR COM; European Commission, 2008, EUR GUID EST POP DOS; Fletcher JG, 2013, J COMPUT ASSIST TOMO, V37, P203, DOI 10.1097/RCT.0b013e31827e0e93; Froemming AT, 2012, JOURNAL OF COMPUTER, V37, P551; Funama Y, 2011, J COMPUT ASSIST TOMO, V35, P480, DOI 10.1097/RCT.0b013e31821fee94; Hara AK, 2009, AM J ROENTGENOL, V193, P764, DOI 10.2214/AJR.09.2397; Hart D, 2004, EUR J RADIOL, V50, P285, DOI 10.1016/S0720-048X(03)00178-5; Hendee WR, 2013, RADIOLOGY, V267, P326, DOI 10.1148/radiol.13130567; Hendee WR, 2012, RADIOLOGY, V264, P312, DOI 10.1148/radiol.12112678; Hou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056295; Hwang HJ, 2013, J COMPUT ASSIST TOMO, V37, P610, DOI 10.1097/RCT.0b013e31828f4dae; Hwang HJ, 2012, KOREAN J RADIOL, V13, P711, DOI 10.3348/kjr.2012.13.6.711; Imaging and Performance and Assessment of CT scanners (ImPACT), 2001, CT PAT DOS EXC SPREA; International Commission on Radiological Protection, 2007, RECOMENDATIONS OF TH; Kalender WA, 1999, MED PHYS, V26, P2248, DOI 10.1118/1.598738; Kalra MK, 2013, AM J ROENTGENOL, V201, pW235, DOI 10.2214/AJR.12.9569; Kalra MK, 2012, J COMPUT ASSIST TOMO, V36, P339, DOI 10.1097/RCT.0b013e31825586c0; Karpitschka M, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120224; Kaul A, 1997, EUR RADIOL, V7, P1127, DOI 10.1007/s003300050267; Kilic K, 2011, AM J NEURORADIOL, V32, P1578, DOI 10.3174/ajnr.A2585; Kilic K, 2013, J COMPUT ASSIST TOMO, V37, P377, DOI 10.1097/RCT.0b013e31828426de; Kim YK, 2013, AM J ROENTGENOL, V200, P537, DOI 10.2214/AJR.12.9237; Kligerman S, 2013, J THORAC IMAG, V28, P49, DOI 10.1097/RTI.0b013e31825412b2; Lee Y, 2012, J COMPUT ASSIST TOMO, V36, P512, DOI 10.1097/RCT.0b013e318260ce39; Leipsic J, 2010, AM J ROENTGENOL, V195, P1095, DOI 10.2214/AJR.09.4050; Lin C, 2013, AM J NEURORADIOLOGY; Little MP, 2009, RADIOLOGY, V251, P6, DOI [10.1148/radiol.2511081686, 10.1148/radiol.1.2511081686]; Martinsen ACT, 2012, EUR J RADIOL, V81, P1483, DOI 10.1016/j.ejrad.2011.04.021; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Mettler Fred A. Jr., 2000, Journal of Radiological Protection, V20, P353, DOI 10.1088/0952-4746/20/4/301; Mieville FA, 2013, PHYS MEDICA, V29, P99, DOI 10.1016/j.ejmp.2011.12.004; Moorin RE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097691; Moorin RE, 2014, EUR J RADIOL, V83, P329, DOI 10.1016/j.ejrad.2013.11.003; Moorin RE, 2013, J RADIOL PROT, V33, P295, DOI 10.1088/0952-4746/33/2/295; Namimoto T, 2012, J COMPUT ASSIST TOMO, V36, P495, DOI 10.1097/RCT.0b013e31825b821f; National Research Council, 2006, HLTH RISKS EXP LOW L; Neroladaki A, 2013, EUR RADIOL, V23, P360, DOI 10.1007/s00330-012-2627-7; Noel PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081141; Pontana F, 2013, RADIOLOGY, V267, P609, DOI 10.1148/radiol.12120414; Pontana F, 2011, EUR RADIOL, V21, P636, DOI 10.1007/s00330-010-1991-4; Prakash P, 2010, J COMPUT ASSIST TOMO, V34, P40, DOI 10.1097/RCT.0b013e3181b26c67; Qi LP, 2012, BRIT J RADIOL, V85, pE906, DOI 10.1259/bjr/66327067; Ren QG, 2012, EUR J RADIOL, V81, P2597, DOI 10.1016/j.ejrad.2011.12.041; Sawilowsky S, 2007, ENCY MEASUREMENT STA, P566; Shen J, 2012, EUROPEAN JOURNAL OF; Shrimpton PC, 2006, BRIT J RADIOL, V79, P968, DOI 10.1259/bjr/93277434; SHRIMPTON PC, 1995, RADIAT PROT DOSIM, V57, P413; Shrimpton PC, 1999, APPL RADIAT ISOTOPES, V50, P261, DOI 10.1016/S0969-8043(98)00028-1; Shrimpton PC, 1991, CHILTON NRPB R249; Silva AC, 2010, AM J ROENTGENOL, V194, P191, DOI 10.2214/AJR.09.2953; Singh S, 2011, RADIOLOGY, V259, P565, DOI 10.1148/radiol.11101450; Smith AB, 2008, RADIOLOGY, V247, P499, DOI 10.1148/radiol.2472071054; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Takx RA, 2012, EUROPEAN J RADIOLOGY; Tzedakis A, 2005, MED PHYS, V32, P1621, DOI 10.1118/1.1924309; United Nations Scientific Committee on the Effects of Atomic Radiation, 2000, SOURC EFF ION RAD; von Falck C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056875; Winklehner A, 2011, EUR RADIOL, V21, P2521, DOI 10.1007/s00330-011-2227-y; Yamada Y, 2012, EUROPEAN J RADIOLOGY; Yu MH, 2013, AM J ROENTGENOL, V201, P23, DOI 10.2214/AJR.12.10000; Zammit-Maempel I, 2003, BRIT J RADIOL, V76, P418, DOI 10.1259/bjr/82798696	69	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138329	10.1371/journal.pone.0138329	http://dx.doi.org/10.1371/journal.pone.0138329			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381145	Green Published, Green Submitted, gold			2022-12-27	WOS:000361790200091
J	Rajput, MS; Iyer, B; Pandya, M; Jog, R; Kumar, GN; Rajkumar, S				Rajput, Mahendrapal Singh; Iyer, Bhagya; Pandya, Maharshi; Jog, Rahul; Kumar, Naresh G.; Rajkumar, Shalini			Derepression of Mineral Phosphate Solubilization Phenotype by Insertional Inactivation of iclR in Klebsiella pneumoniae	PLOS ONE			English	Article							ESCHERICHIA-COLI; CATABOLITE REPRESSION; PLANT-GROWTH; PROTEIN-PHOSPHORYLATION; DENSITY FERMENTATION; ACETATE METABOLISM; GLYOXYLATE CYCLE; BACTERIA; GLUCOSE; ACID	The mode of succinate mediated repression of mineral phosphate solubilization and the role of repressor in suppressing phosphate solubilization phenotype of two free-living nitrogen fixing Klebsiella pneumoniae strains was studied. Organic acid mediated mineral phosphate solubilization phenotype of oxalic acid producing Klebsiella pneumoniae SM6 and SM11 were transcriptionally repressed by IclR in presence of succinate as carbon source. Oxalic acid production and expression of genes of the glyoxylate shunt (aceBAK) was found only in glucose but not in succinate-and glucose+succinate-grown cells. IclR, repressor of aceBAK operon, was inactivated using an allelic exchange system resulting in derepressed mineral phosphate solubilization phenotype through constitutive expression of the glyoxylate shunt. Insertional inactivation of iclR resulted in increased activity of the glyoxylate shunt enzymes even in succinate-grown cells. An augmented phosphate solubilization up to 54 and 59% soluble phosphate release was attained in glucose+succinate-grown SM6 Delta and SM11 Delta strains respectively, compared to glucose-grown cells, whereas phosphate solubilization was absent or negligible in wildtype cells grown in glucose+succinate. Both wildtype and iclR deletion strains showed similar indole-3-acetic acid production. Wheat seeds inoculated with wildtype SM6 and SM11 improved both root and shoot length by 1.2 fold. However, iclR deletion SM6 Delta and SM11 Delta strains increased root and shoot length by 1.5 and 1.4 folds, respectively, compared to uninoculated controls. The repressor inactivated phosphate solubilizers better served the purpose of constitutive phosphate solubilization in pot experiments, where presence of other carbon sources (e.g., succinate) might repress mineral phosphate solubilization phenotype of wildtype strains.	[Rajput, Mahendrapal Singh; Iyer, Bhagya; Pandya, Maharshi; Jog, Rahul; Rajkumar, Shalini] Nirma Univ, Inst Sci, Ahmadabad, Gujarat, India; [Jog, Rahul] Hokkaido Univ, Fac Environm Earth Sci, Div Biosphere, Environm Mol Biol Lab, Sapporo, Hokkaido, Japan; [Kumar, Naresh G.] Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Biochem, Mol Microbial Biochem Lab, Vadodara, Gujarat, India	Nirma University; Hokkaido University; Maharaja Sayajirao University Baroda	Rajkumar, S (corresponding author), Nirma Univ, Inst Sci, Ahmadabad, Gujarat, India.	shalini.rjk@nirmauni.ac.in	Gattupalli, Naresh Kumar/AAF-5987-2020	Gattupalli, Nareshkumar/0000-0001-7317-7438	Department of Science and Technology (Ministry of Science, India) [SERB/F/1433/1014-15]; Council of Scientific and Industrial Research (CSIR), Government of India [113827/2K12/1]; Department of Science and Technology (DST), Government of India [IF130895]	Department of Science and Technology (Ministry of Science, India)(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines); Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (DST), Government of India(Department of Science & Technology (India))	Dr. SR received the financial grant from the Department of Science and Technology (Ministry of Science, India) (Project Sanction number SERB/F/1433/1014-15). The authors would like to acknowledge the Council of Scientific and Industrial Research (CSIR), Government of India, for providing senior research fellowship to Mahendrapal Singh Rajput (Ack No. 113827/2K12/1) and the Department of Science and Technology (DST), Government of India for providing INSPIRE fellowship to Bhagya Iyer (IF130895). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahemad M, 2012, J PEST SCI, V85, P29, DOI 10.1007/s10340-011-0402-1; Ahemad M, 2011, PESTIC BIOCHEM PHYS, V100, P51, DOI 10.1016/j.pestbp.2011.02.004; Ahemad M, 2011, CURR MICROBIOL, V62, P532, DOI 10.1007/s00284-010-9740-0; AKAMATSU Y, 1994, PHYTOCHEMISTRY, V37, P649, DOI 10.1016/S0031-9422(00)90332-7; Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; An QL, 2001, ACTA BOT SIN, V43, P558; Ando S, 2005, SOIL SCI PLANT NUTR, V51, P303, DOI 10.1111/j.1747-0765.2005.tb00034.x; ARISTIDOU AA, 1995, BIOTECHNOL PROGR, V11, P475, DOI 10.1021/bp00034a019; Brinkrolf K, 2006, GENET MOL RES, V5, P773; BROWN TDK, 1977, J GEN MICROBIOL, V102, P327, DOI 10.1099/00221287-102-2-327; Buch A, 2008, RES MICROBIOL, V159, P635, DOI 10.1016/j.resmic.2008.09.012; Chelius MK, 2000, APPL ENVIRON MICROB, V66, P783, DOI 10.1128/AEM.66.2.783-787.2000; Chen GZ, 2004, MUTAT RES-FUND MOL M, V554, P193, DOI 10.1016/j.mrfmmm.2004.04.013; Collier DN, 1996, RES MICROBIOL, V147, P551, DOI 10.1016/0923-2508(96)84011-3; CORTAY JC, 1991, EMBO J, V10, P675, DOI 10.1002/j.1460-2075.1991.tb07996.x; Cozzone AJ, 1998, ANNU REV MICROBIOL, V52, P127, DOI 10.1146/annurev.micro.52.1.127; DIXON GH, 1959, BIOCHEM J, V72, pP3; Fischer E, 2003, J BIOL CHEM, V278, P46446, DOI 10.1074/jbc.M307968200; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; GORDON SA, 1951, PLANT PHYSIOL, V26, P192, DOI 10.1104/pp.26.1.192; Gory L, 2001, FEMS MICROBIOL LETT, V194, P127, DOI 10.1111/j.1574-6968.2001.tb09457.x; Gyaneshwar P, 2002, PLANT SOIL, V245, P83, DOI 10.1023/A:1020663916259; HAN K, 1992, BIOTECHNOL BIOENG, V39, P663, DOI 10.1002/bit.260390611; Holms WH, 1989, BIOTECHNOL BIOENG, V35, P732; Iniguez AL, 2004, MOL PLANT MICROBE IN, V17, P1078, DOI 10.1094/MPMI.2004.17.10.1078; Khan MS, 2007, AGRON SUSTAIN DEV, V27, P29, DOI 10.1051/agro:2006011; KLEMAN GL, 1994, APPL ENVIRON MICROB, V60, P3952, DOI 10.1128/AEM.60.11.3952-3958.1994; KORNBERG HL, 1966, BIOCHEM J, V99, P1; Krell T, 2006, PROTEIN SCI, V15, P1207, DOI 10.1110/ps.051857206; Maharjan RP, 2005, RES MICROBIOL, V156, P178, DOI 10.1016/j.resmic.2004.09.004; MAJEWSKI RA, 1990, BIOTECHNOL BIOENG, V35, P732, DOI 10.1002/bit.260350711; MALOY SR, 1982, J BACTERIOL, V149, P173, DOI 10.1128/JB.149.1.173-180.1982; MANDAL NC, 1993, CURR MICROBIOL, V26, P247, DOI 10.1007/BF01575912; Martinez L, 2003, PLANT SOIL, V257, P35, DOI 10.1023/A:1026283311770; McKenzie GJ, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-39; Mii K., 1996, Wood Research, P23; Molina-Henares AJ, 2006, FEMS MICROBIOL REV, V30, P157, DOI 10.1111/j.1574-6976.2005.00008.x; PIKOVSKAIA R. I., 1948, Mikrobiologiya, V17, P362; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Rajput MS, 2013, ARCH MICROBIOL, V195, P81, DOI 10.1007/s00203-012-0850-x; Rittinger K, 1996, EUR J BIOCHEM, V237, P247, DOI 10.1111/j.1432-1033.1996.0247n.x; Rodriguez H, 1999, BIOTECHNOL ADV, V17, P319, DOI 10.1016/S0734-9750(99)00014-2; Sachdev DP, 2009, INDIAN J EXP BIOL, V47, P993; SAIER MH, 1989, MICROBIOL REV, V53, P109, DOI 10.1128/MMBR.53.1.109-120.1989; Sarkar D, 2008, ARCH MICROBIOL, V190, P559, DOI 10.1007/s00203-008-0406-2; Seth GN, 1990, P NATL ACAD SCI USA, V87, P4645; Stulke J, 1999, CURR OPIN MICROBIOL, V2, P195, DOI 10.1016/S1369-5274(99)80034-4; SUNNARBORG A, 1990, J BACTERIOL, V172, P2642, DOI 10.1128/jb.172.5.2642-2649.1990; vandeWalle M, 1998, BIOTECHNOL BIOENG, V57, P71, DOI 10.1002/(SICI)1097-0290(19980105)57:1<71::AID-BIT9>3.0.CO;2-S; VIEIRA J, 1991, GENE, V100, P189, DOI 10.1016/0378-1119(91)90365-I; Yamamoto K, 2003, MOL MICROBIOL, V47, P183, DOI 10.1046/j.1365-2958.2003.03287.x; Zhang HB, 2002, P NATL ACAD SCI USA, V99, P4638, DOI 10.1073/pnas.022056699	52	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138235	10.1371/journal.pone.0138235	http://dx.doi.org/10.1371/journal.pone.0138235			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381651	gold, Green Published, Green Submitted			2022-12-27	WOS:000361790200075
J	Bartlett, SJ; Orbai, AM; Duncan, T; DeLeon, E; Ruffing, V; Clegg-Smith, K; Bingham, CO				Bartlett, Susan J.; Orbai, Ana-Maria; Duncan, Trisha; DeLeon, Elaine; Ruffing, Victoria; Clegg-Smith, Katherine; Bingham, Clifton O., III			Reliability and Validity of Selected PROMIS Measures in People with Rheumatoid Arthritis	PLOS ONE			English	Article							PATIENT-REPORTED OUTCOMES; INTERNATIONAL PATIENT; PHYSICAL FUNCTION; AMERICAN-COLLEGE; ITEM BANKS; FLARE; PERSPECTIVE; PREVALENCE; FATIGUE; METAANALYSIS	Purpose To evaluate the reliability and validity of 11 PROMIS measures to assess symptoms and impacts identified as important by people with rheumatoid arthritis (RA). Methods Consecutive patients (N = 177) in an observational study completed PROMIS computer adapted tests (CATs) and a short form (SF) assessing pain, fatigue, physical function, mood, sleep, and participation. We assessed test-test reliability and internal consistency using correlation and Cronbach's alpha. We assessed convergent validity by examining Pearson correlations between PROMIS measures and existing measures of similar domains and known groups validity by comparing scores across disease activity levels using ANOVA. Results Participants were mostly female (82%) and white (83%) with mean (SD) age of 56 (13) years; 24% had <= high school, 29% had RA <= 5 years with 13% <= 2 years, and 22% were disabled. PROMIS Physical Function, Pain Interference and Fatigue instruments correlated moderately to strongly (rho's >= 0.68) with corresponding PROs. Test-retest reliability ranged from .725-.883, and Cronbach's alpha from .906-.991. A dose-response relationship with disease activity was evident in Physical Function with similar trends in other scales except Anger. Conclusions These data provide preliminary evidence of reliability and construct validity of PROMIS CATs to assess RA symptoms and impacts, and feasibility of use in clinical care. PROMIS instruments captured the experiences of RA patients across the broad continuum of RA symptoms and function, especially at low disease activity levels. Future research is needed to evaluate performance in relevant subgroups, assess responsiveness and identify clinically meaningful changes.	[Bartlett, Susan J.] McGill Univ, Ctr Hlth, Dept Med, Div Clin Epidemiol, Montreal, PQ, Canada; [Bartlett, Susan J.] McGill Univ, Ctr Hlth, Dept Med, Div Rheumatol, Montreal, PQ, Canada; [Bartlett, Susan J.] McGill Univ, Ctr Hlth, Dept Med, Div Resp Epidemiol, Montreal, PQ, Canada; [Bartlett, Susan J.; Orbai, Ana-Maria; Duncan, Trisha; DeLeon, Elaine; Ruffing, Victoria; Bingham, Clifton O., III] Johns Hopkins Sch Med, Dept Med, Div Rheumatol, Baltimore, MD USA; [Clegg-Smith, Katherine] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Ctr Qualitat Studies Hlth & Med, Baltimore, MD USA	McGill University; McGill University; McGill University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bartlett, SJ (corresponding author), McGill Univ, Ctr Hlth, Dept Med, Div Clin Epidemiol, Montreal, PQ, Canada.	susan.bartlett@mcgill.ca	Bartlett, Susan J./J-9864-2012; Bartlett, Susan Joan/AAD-4103-2020	Bartlett, Susan Joan/0000-0001-9755-2490; Orbai, Ana-Maria/0000-0001-8644-8567	Patient-Centered Outcomes Research Institute (PCORI) Pilot Project Program Award [1IP2-PI000737-01]; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [P30-AR053503]; Ira J. Fine Discovery Fund; Donald and Dorothy Stabler Foundation; Johns Hopkins Arthritis Center Discovery Fund; Rheumatology Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053503] Funding Source: NIH RePORTER	Patient-Centered Outcomes Research Institute (PCORI) Pilot Project Program Award(Patient-Centered Outcomes Research Institute - PCORI); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Ira J. Fine Discovery Fund; Donald and Dorothy Stabler Foundation; Johns Hopkins Arthritis Center Discovery Fund; Rheumatology Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part through a Patient-Centered Outcomes Research Institute (PCORI) Pilot Project Program Award (1IP2-PI000737-01). Additional support for this work was provided through Grant Number P30-AR053503 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the Ira J. Fine Discovery Fund, the Donald and Dorothy Stabler Foundation, and the Johns Hopkins Arthritis Center Discovery Fund. AMO was supported in part by a Scientist Development Award from the Rheumatology Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2008, ANN RHEUM DIS, V67, P1360, DOI 10.1136/ard.2008.091454; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Alonso J, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-210; Alten R, 2011, J RHEUMATOL, V38, P1745, DOI 10.3899/jrheum.110400; [Anonymous], PROMIS INSTRUMENT DE; Bartlett SJ, 2012, ANN RHEUM DIS, V71, P1855, DOI 10.1136/annrheumdis-2011-201201; Basch E, 2012, JAMA-J AM MED ASSOC, V307, P1636, DOI 10.1001/jama.2012.466; Berthelot JM, 2012, ANN RHEUM DIS, V71, P1110, DOI 10.1136/ard.2011.150656; Bingham CO, 2012, ANN RHEUM DIS, V71, P1107, DOI 10.1136/annrheumdis-2011-200870; Bingham CO, 2011, J RHEUMATOL, V38, P1751, DOI 10.3899/jrheum.110401; Bykerk VP, EULAR 2014; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P421; Choi SW, 2014, PSYCHOL ASSESS; FELSON DT, 1993, ARTHRITIS RHEUM-US, V36, P729, DOI 10.1002/art.1780360601; Fries JF, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3461; Fries JF, 2009, J RHEUMATOL, V36, P2061, DOI 10.3899/jrheum.090358; Fries JF, 2005, CLIN EXP RHEUMATOL, V23, pS53; Gossec L, 2009, ANN RHEUM DIS, V68, P1680, DOI 10.1136/ard.2008.100271; Helmick CG, 2008, ARTHRITIS RHEUM-US, V58, P15, DOI 10.1002/art.23177; Hewlett S, 2005, ARTHRIT RHEUM-ARTHR, V53, P697, DOI 10.1002/art.21450; Hewlett S, 2012, RHEUMATOLOGY, V51, P69, DOI 10.1093/rheumatology/keq455; Hootman JM, 2006, ARTHRITIS RHEUM-US, V54, P226, DOI 10.1002/art.21562; Kirwan JR, 2007, J RHEUMATOL, V34, P1174; Lai JS, 2011, ARCH PHYS MED REHAB, V92, pS20, DOI 10.1016/j.apmr.2010.08.033; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Orbai AM, 2014, ARTHRIT CARE RES, V66, P1662, DOI 10.1002/acr.22374; Patrick DL, 2011, VALUE HEALTH, V14, P978, DOI 10.1016/j.jval.2011.06.013; Pilkonis PA, 2011, ASSESSMENT, V18, P263, DOI 10.1177/1073191111411667; Sanderson T, 2010, ARTHRIT CARE RES, V62, P640, DOI 10.1002/acr.20034; Sanderson T, 2009, ARTHRIT RHEUM-ARTHR, V61, P1, DOI 10.1002/art.24270; Santana MJ, 2015, QUAL LIFE RES, V24, P1707, DOI 10.1007/s11136-014-0903-5; Schalet BD, 2014, J ANXIETY DISORD, V28, P88, DOI 10.1016/j.janxdis.2013.11.006; Schipper LG, 2010, RHEUMATOLOGY, V49, P2154, DOI 10.1093/rheumatology/keq195; Schwartz C, 2006, QUAL LIFE RES, V15, P1503, DOI 10.1007/s11136-006-0008-x; Selby JV, 2012, JAMA-J AM MED ASSOC, V307, P1583, DOI 10.1001/jama.2012.500; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; U.S. Food and Drug Administration. Guidance for Industry, 2009, FED REGISTER, V74, P65132	41	132	132	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138543	10.1371/journal.pone.0138543	http://dx.doi.org/10.1371/journal.pone.0138543			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0RH	26379233	Green Submitted, Green Published, gold			2022-12-27	WOS:000361769400109
J	Bochnia, M; Ziegler, J; Sander, J; Uhlig, A; Schaefer, S; Vollstedt, S; Glatter, M; Abel, S; Recknagel, S; Schusser, GF; Wensch-Dorendorf, M; Zeyner, A				Bochnia, M.; Ziegler, J.; Sander, J.; Uhlig, A.; Schaefer, S.; Vollstedt, S.; Glatter, M.; Abel, S.; Recknagel, S.; Schusser, G. F.; Wensch-Dorendorf, M.; Zeyner, A.			Hypoglycin A Content in Blood and Urine Discriminates Horses with Atypical Myopathy from Clinically Normal Horses Grazing on the Same Pasture	PLOS ONE			English	Article							COA DEHYDROGENASE-DEFICIENCY; EUROPEAN OUTBREAKS; MYOGLOBINURIA; SEEDS; IDENTIFICATION; TOXICITY; HISTORY	Hypoglycin A (HGA) in seeds of Acer spp. is suspected to cause seasonal pasture myopathy in North America and equine atypical myopathy (AM) in Europe, fatal diseases in horses on pasture. In previous studies, this suspicion was substantiated by the correlation of seed HGA content with the concentrations of toxic metabolites in urine and serum (MCPA-conjugates) of affected horses. However, seed sampling was conducted after rather than during an outbreak of the disease. The aim of this study was to further confirm the causality between HGA occurrence and disease outbreak by seed sampling during an outbreak and the determination of i) HGA in seeds and of ii) HGA and MCPA-conjugates in urine and serum of diseased horses. Furthermore, cograzing healthy horses, which were present on AM affected pastures, were also investigated. AM-pastures in Germany were visited to identify seeds of Acer pseudoplatanus and serum (n = 8) as well as urine (n = 6) from a total of 16 diseased horses were analyzed for amino acid composition by LC-ESI-MS/MS, with a special focus on the content of HGA. Additionally, the content of its toxic metabolite was measured in its conjugated form in body fluids (UPLC-MS/MS). The seeds contained 1.7-319.8 pg HGA/g seed. The content of HGA in serum of affected horses ranged from 387.8-8493.8 pg/L (controls < 10 mu g/L), and in urine from 143.8-926.4 mu g/L (controls < 10 mu g/L), respectively. Healthy cograzing horses on AM-pastures showed higher serum (108.8 83.76 mu g/L) and urine concentrations (26.9 7.39 mu g/L) compared to control horses, but lower concentrations compared to diseased horses. The range of MCPA-carnitine and creatinine concentrations found in diseased horses in serum and urine were 0.17 0.65 mmol/L (controls <0.01), and 0.34-2.05 mu gmol/mmoL (controls <0.001), respectively. MCPA-glycine levels in urine of cograzing horses were higher compared to controls. Thus, the causal link between HGA intoxication and disease outbreak could be further substantiated, and the early detection of HGA in cograzing horses, which are clinically normal, might be a promising step in prophylaxis.	[Bochnia, M.; Schaefer, S.; Glatter, M.; Wensch-Dorendorf, M.; Zeyner, A.] Univ Halle Wittenberg, Inst Agr & Nutr Sci, D-06108 Halle, Saale, Germany; [Ziegler, J.; Abel, S.] Leibniz Inst Plant Biochem, Dept Mol Signal Proc, Halle, Saale, Germany; [Sander, J.] Screening Lab, Hannover, NH, Germany; [Uhlig, A.; Recknagel, S.; Schusser, G. F.] Fac Vet Med, Dept Large Anim Med, Leipzig, Germany; [Vollstedt, S.] Tradit Chinese Equine Med, Bokholt Hanredder, Germany	Martin Luther University Halle Wittenberg; Leibniz Institut fur Pflanzenbiochemie	Bochnia, M (corresponding author), Univ Halle Wittenberg, Inst Agr & Nutr Sci, D-06108 Halle, Saale, Germany.	mandy.bochnia@landw.uni-halle.de	Ziegler, Jörg/W-7645-2019					Aboling S., 2015, Proceedings of the Society of Nutrition Physiology, V24, P124; Aboling S, 2015, PFERDEHEILKUNDE, V31, P135, DOI 10.21836/PEM20150204; Blake OA, 2006, FOOD CHEM TOXICOL, V44, P207, DOI 10.1016/j.fct.2005.07.002; Bowen-Forbes CS, 2011, J AGR FOOD CHEM, V59, P3869, DOI 10.1021/jf104623c; Brandt K, 1997, PFERDEHEILKUNDE, V13, P27, DOI 10.21836/PEM19970104; BRESSLER R, 1969, PHARMACOL REV, V21, P105; Carlier J, 2015, J CHROMATOGR B, V978, P70, DOI 10.1016/j.jchromb.2014.11.029; Cassart D, 2007, EQUINE VET J, V39, P26, DOI 10.2746/042516407X157765; CHASE GW, 1990, J ASSOC OFF ANA CHEM, V73, P318; Craig, 1942, VET REC, V35, P354; Delguste C, 2002, ANN MED VET, V146, P235; Elliott AC, 2011, COMPUT METH PROG BIO, V102, P75, DOI 10.1016/j.cmpb.2010.11.002; FENG PC, 1958, BRIT J PHARM CHEMOTH, V13, P125, DOI 10.1111/j.1476-5381.1958.tb00206.x; FENG PC, 1955, BRIT J NUTR, V9, P368, DOI 10.1079/BJN19550052; FINCHAM AG, 1977, W INDIAN MED J, V26, P62; Finno CJ, 2006, JAVMA-J AM VET MED A, V229, P1134, DOI 10.2460/javma.229.7.1134; FRERMAN FE, 1985, P NATL ACAD SCI USA, V82, P4517, DOI 10.1073/pnas.82.13.4517; HARRIS P, 1990, VET REC, V127, P603; HILLAM RA, 1991, VET REC, V128, P166, DOI 10.1136/vr.128.7.166-a; HOSIE BD, 1986, VET REC, V119, P444, DOI 10.1136/vr.119.18.444; Joskow R, 1999, CLIN TOXICOL, V44, P267; Koller G, 2014, PFERDEHEILKUNDE, V30, P381; Meda HA, 1999, LANCET, V353, P536, DOI 10.1016/S0140-6736(99)01088-0; Palencia P, 2007, VET REC, V161, P346, DOI 10.1136/vr.161.10.346; Sander J, 2015, RAPID DIAGNOSI UNPUB; Sponseller BT, 2012, J VET INTERN MED, V26, P1012, DOI 10.1111/j.1939-1676.2012.00957.x; Unger L, 2014, J VET INTERN MED, V28, P1289, DOI 10.1111/jvim.12367; Valberg SJ, 2013, EQUINE VET J, V45, P419, DOI 10.1111/j.2042-3306.2012.00684.x; van der Kolk JH, 2010, MOL GENET METAB, V101, P289, DOI 10.1016/j.ymgme.2010.06.019; van Galen G, 2012, EQUINE VET J, V44, P621, DOI 10.1111/j.2042-3306.2012.00555.x; van Galen G, 2012, EQUINE VET J, V44, P614, DOI 10.1111/j.2042-3306.2012.00556.x; Verheyen T, 2012, J VET INTERN MED, V26, P1019, DOI 10.1111/j.1939-1676.2012.00945.x; Votion DM, 2014, EQUINE VET J, V46, P146, DOI 10.1111/evj.12117; Votion DM, 2003, ANN MED VET, V147, P183; Votion DM, 2007, J VET INTERN MED, V21, P1380, DOI 10.1892/07-053.1; Votion DM, 2008, VET J, V178, P185, DOI 10.1016/j.tvjl.2008.02.004; Westermann CM, 2008, NEUROMUSCULAR DISORD, V18, P355, DOI 10.1016/j.nmd.2008.02.007; WHITWELL KE, 1988, EQUINE VET J, V20, P357, DOI 10.1111/j.2042-3306.1988.tb01545.x; Zeller R, 1964, ZENTRALBLATT VET A, V11, P523; Ziegler J, 2014, AMINO ACIDS, V46, P2799, DOI 10.1007/s00726-014-1837-5	40	41	41	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0136785	10.1371/journal.pone.0136785	http://dx.doi.org/10.1371/journal.pone.0136785			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378918	Green Published, Green Submitted, gold			2022-12-27	WOS:000361769400008
J	Gomes, M; Conceicao, CS; Carvalhom, VO; Brites, C				Gomes Neto, Mansueto; Conceicao, Cristiano Sena; Carvalhom, Vitor Oliveira; Brites, Carlos			Effects of Combined Aerobic and Resistance Exercise on Exercise Capacity, Muscle Strength and Quality of Life in HIV-Infected Patients: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; BODY-COMPOSITION; HEART-DISEASE; IMPAIRMENT; HIV/AIDS; REHABILITATION; GUIDELINES; FITNESS; IMPACT; TRIALS	Background Many HIV-infected patients demonstrate disability and lower aerobic capacity. The inclusion of resistance training combined with aerobic exercise in a single program is known as combined aerobic and resistance exercise (CARE) and seems to be an effective strategy to improve muscle weakness, as well as aerobic capacity in HIV-infected patients. We performed a meta-analysis to investigate the effects of CARE in HIV-infected patients. Methods We searched MEDLINE, Cochrane Controlled Trials Register, EMBASE, CINAHL (from the earliest date available to august 2014) for controlled trials that evaluated the effects of CARE in HIV-infected patients. Weighted mean differences (WMD) and 95% confidence intervals (CIs) were calculated, and heterogeneity was assessed using the I-2 test. Results Seven studies met the study criteria. CARE resulted in improvement in Peak VO2 WMD (4.48 mL.kg(-1).min(-1) 95% CI: 2.95 to 6.0), muscle strength of the knee extensors WMD (25.06 Kg 95% CI: 10.46 to 39.66) and elbow flexors WMD (4.44 Kg 95% CI: 1.22 to 7.67) compared with no exercise group. The meta-analyses also showed significant improvement in Health status, Energy/Vitality and physical function domains of quality of life for participants in the CARE group compared with no exercise group. A nonsignificant improvement in social function domain of quality of life was found for participants in the CARE group compared with no exercise group. Conclusions Combined aerobic and resistance exercise may improve peak VO2, muscle strength and health status, energy and physical function domains of quality of life and should be considered as a component of care of HIV-infected individuals.	[Gomes Neto, Mansueto; Conceicao, Cristiano Sena] Univ Fed Bahia, UFBA, Curso Fisioterapia, Dept Biofunc O, Salvador, BA, Brazil; [Gomes Neto, Mansueto; Brites, Carlos] Univ Fed Bahia, Programa Pos Grad Med & Saude, Salvador, BA, Brazil; [Gomes Neto, Mansueto; Carvalhom, Vitor Oliveira] Univ Fed Sergipe, GREAT Grp, GRp Estudos ATividade Fis, Aracaju, SE, Brazil; [Carvalhom, Vitor Oliveira] Univ Fed Sergipe, Dept Fisioterapia, Aracaju, SE, Brazil	Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal de Sergipe; Universidade Federal de Sergipe	Gomes, M (corresponding author), Univ Fed Bahia, UFBA, Curso Fisioterapia, Dept Biofunc O, Salvador, BA, Brazil.	mansueto.neto@ufba.br	Brites, Carlos/D-1353-2013; Gomes-Neto, Mansueto/I-5235-2014; Carvalho, Vitor Oliveira/CAH-3162-2022	Brites, Carlos/0000-0002-4673-6991; Gomes-Neto, Mansueto/0000-0002-0717-9694; carvalho, vitor/0000-0003-0007-2541				Achttien RJ, 2013, NETH HEART J, V21, P429, DOI 10.1007/s12471-013-0467-y; Bopp Christopher M, 2003, J Assoc Nurses AIDS Care, V14, P73, DOI 10.1177/1055329002239192; Cade WT, 2003, ARCH PHYS MED REHAB, V84, P1831, DOI 10.1016/j.apmr.2003.03.004; Ciccolo JT, 2004, SPORTS MED, V34, P487, DOI 10.2165/00007256-200434080-00001; Crystal S, 2000, MED CARE, V38, P1210, DOI 10.1097/00005650-200012000-00008; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Diller GP, 2005, CIRCULATION, V112, P828, DOI 10.1161/CIRCULATIONAHA.104.529800; Dolan SE, 2006, ARCH INTERN MED, V166, P1225, DOI 10.1001/archinte.166.11.1225; Driscoll SD, 2004, AIDS, V18, P465, DOI 10.1097/00002030-200402200-00013; Dudgeon WD, 2004, AIDS PATIENT CARE ST, V18, P81, DOI 10.1089/108729104322802515; Erlandson KM, 2014, CURR HIV-AIDS REP, V11, P279, DOI 10.1007/s11904-014-0215-y; Fillipas S, 2006, AUST J PHYSIOTHER, V52, P185, DOI 10.1016/S0004-9514(06)70027-7; Frankenstein L, 2007, INT J CARDIOL, V122, P125, DOI 10.1016/j.ijcard.2006.11.038; Garvey C, 2013, J CARDIOPULM REHABIL, V33, P314, DOI 10.1097/HCR.0b013e318297fea4; Neto MG, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/319524; Gomes-Neto M, 2013, CLINICS, V68, P1157, DOI 10.6061/clinics/2013(08)16; GRAU JM, 1993, ANN NEUROL, V34, P206, DOI 10.1002/ana.410340217; Grinspoon S, 2000, ANN INTERN MED, V133, P348, DOI 10.7326/0003-4819-133-5-200009050-00010; Hand GA, 2008, AIDS CARE, V20, P1066, DOI 10.1080/09540120701796900; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jin Y, 2014, INT J STD AIDS, V5; JOHNSON JE, 1990, AM REV RESPIR DIS, V141, P618, DOI 10.1164/ajrccm/141.3.618; de Souza PML, 2008, CLINICS, V63, P619, DOI 10.1590/S1807-59322008000500009; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; Maher CG, 2003, PHYS THER, V83, P713, DOI 10.1093/ptj/83.8.713; McCarthy JP, 2002, MED SCI SPORT EXER, V34, P511, DOI 10.1097/00005768-200203000-00019; Mendes EL, 2013, REV BRAS MED ESPORTE, V19, P16, DOI 10.1590/S1517-86922013000100003; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mutimura E, 2008, QUAL LIFE RES, V17, P377, DOI 10.1007/s11136-008-9319-4; O'Brien K, 2008, AIDS CARE, V20, P631, DOI 10.1080/09540120701661708; O'Brien K, 2004, MED SCI SPORT EXER, V36, P1659, DOI 10.1249/01.MSS.0000142404.28165.9B; O'Brien K, 2004, COCHRANE DB SYST REV, V18; O'Brien Kelly, 2010, Cochrane Database Syst Rev, pCD001796, DOI 10.1002/14651858.CD001796.pub3; Ogalha C, 2011, JAIDS-J ACQ IMM DEF, V57, pS179, DOI 10.1097/QAI.0b013e31821e9bca; Oguntibeju OO, 2012, HIV AIDS-RES PALLIAT, V4, P117, DOI 10.2147/HIV.S32321; Olivo SA, 2008, PHYS THER, V88, P156, DOI 10.2522/ptj.20070147; Perez-Moreno F, 2007, INT J SPORTS MED, V28, P1046, DOI 10.1055/s-2007-965129; POTHOFF G, 1994, RESPIRATION, V61, P80; Raso V, 2013, CLINICS, V68, P359, DOI 10.6061/clinics/2013(03)OA12; RIGSBY LW, 1992, MED SCI SPORT EXER, V24, P6; Rojas R, 2003, J SPORT EXERCISE PSY, V25, P440, DOI 10.1123/jsep.25.4.440; Sillanpaa E, 2009, EUR J APPL PHYSIOL, V106, P285, DOI 10.1007/s00421-009-1013-x; Stringer WW, 2000, MED SCI SPORT EXER, V32, pS412, DOI 10.1097/00005768-200007001-00006; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; Warburton DER, 2006, CAN MED ASSOC J, V174, P961, DOI 10.1503/cmaj.1040750; Zonta Marise Bueno, 2003, Braz J Infect Dis, V7, P301, DOI 10.1590/S1413-86702003000500004	46	52	53	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138066	10.1371/journal.pone.0138066	http://dx.doi.org/10.1371/journal.pone.0138066			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0RH	26378794	Green Published, gold, Green Submitted			2022-12-27	WOS:000361769400049
J	Koukourakis, MI; Kalamida, D; Giatromanolaki, A; Zois, CE; Sivridis, E; Poulilioul, S; Mitrakas, A; Gatter, KC; Harris, AL				Koukourakis, Michael I.; Kalamida, Dimitra; Giatromanolaki, Alexandra; Zois, Christos E.; Sivridis, Efthimios; Poulilioul, Stamatia; Mitrakas, Achilleas; Gatter, Kevin C.; Harris, Adrian L.			Autophagosome Proteins LC3A, LC3B and LC3C Have Distinct Subcellular Distribution Kinetics and Expression in Cancer Cell Lines	PLOS ONE			English	Article							LIPIDATION; MEMBRANES	LC3s (MAP1-LC3A, B and C) are structural proteins of autophagosomal membranes, widely used as biomarkers of autophagy. Whether these three LC3 proteins have a similar biological role in autophagy remains obscure. We examine in parallel the subcellular expression patterns of the three LC3 proteins in a panel of human cancer cell lines, as well as in normal MRC5 fibroblasts and HUVEC, using confocal microscopy and western blot analysis of cell fractions. In the cytoplasm, there was a minimal co-localization between LC3A, B and C staining, suggesting that the relevant autophagosomes are formed by only one out of the three LC3 proteins. LC3A showed a perinuclear and nuclear localization, while LC3B was equally distributed throughout the cytoplasm and localized in the nucleolar regions. LC3C was located in the cytoplasm and strongly in the nuclei (excluding nucleoli), where it extensively co-localized with the LC3A and the Beclin-1 autophagy initiating protein. Beclin 1 is known to contain a nuclear trafficking signal. Blocking nuclear export function by Leptomycin B resulted in nuclear accumulation of all LC3 and Beclin-1 proteins, while lvermectin that blocks nuclear import showed reduction of accumulation, but not in all cell lines. Since endogenous LC3 proteins are used as major markers of autophagy in clinical studies and cell lines, it is essential to check the specificity of the antibodies used, as the kinetics of these molecules are not identical and may have distinct biological roles. The distinct subcellular expression patterns of LC3s provide a basis for further studies.	[Koukourakis, Michael I.; Kalamida, Dimitra; Zois, Christos E.; Poulilioul, Stamatia; Mitrakas, Achilleas] Democritus Univ Thrace, Sch Med, Univ Gen Hosp Alexandroupolis, Dept Radiotherapy Oncol, Alexandroupolis, Greece; [Giatromanolaki, Alexandra; Sivridis, Efthimios] Democritus Univ Thrace, Sch Med, Univ Gen Hosp Alexandroupolis, Dept Pathol, Alexandroupolis, Greece; [Gatter, Kevin C.] John Radcliffe Hosp, Nuffield Dept Cellular Sci, Oxford 0X3 9DU, England; [Zois, Christos E.; Harris, Adrian L.] Univ Oxford, Weatherall Inst Mol Med, Canc Res United Kingdom Mol Oncol Labs, Oxford 0X3 9DU, England	Democritus University of Thrace; Democritus University of Thrace; University of Oxford	Koukourakis, MI (corresponding author), Democritus Univ Thrace, Sch Med, Univ Gen Hosp Alexandroupolis, Dept Radiotherapy Oncol, Alexandroupolis, Greece.	targ@her.forthnet.gr	Mitrakas, Achilleas/GPC-8600-2022; Harris, Adrian L/ABA-3343-2020	Harris, Adrian L/0000-0003-1376-8409; Mitrakas, Achilleas/0000-0002-9980-7773; Pouliliou, Stamatia/0000-0001-8900-2202	"TRAINING AND LIFELONG LEARNING - ARISTEIA" project [520, 12605/26.09.2012]; Cancer Research UK [11359, 16466] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10163] Funding Source: researchfish	"TRAINING AND LIFELONG LEARNING - ARISTEIA" project; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	The study has been funded by the "TRAINING AND LIFELONG LEARNING - ARISTEIA" project, code no 520, ESPA 2007-2013, GGET decision number 12605/26.09.2012 (URL: http://www.espa.gr/el/pages/proclamationsfs.aspx?item=1736). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki H, 2008, AUTOPHAGY, V4, P467, DOI 10.4161/auto.5668; Bai H, 2012, ONCOGENE, V31, P4397, DOI 10.1038/onc.2011.613; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Drake KR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009806; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; Ferguson CJ, 2009, HUM MOL GENET, V18, P4868, DOI 10.1093/hmg/ddp460; He H, 2003, J BIOL CHEM, V278, P29278, DOI 10.1074/jbc.M303800200; He W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113089; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karim MR, 2007, AUTOPHAGY, V3, P553, DOI 10.4161/auto.4615; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Liang XH, 2001, CANCER RES, V61, P3443; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Tanida I, 2004, J BIOL CHEM, V279, P47704, DOI 10.1074/jbc.M407016200; Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150; Wu JX, 2006, BIOCHEM BIOPH RES CO, V339, P437, DOI 10.1016/j.bbrc.2005.10.211; Zois CE, 2011, AUTOPHAGY, V7, P1371, DOI 10.4161/auto.7.11.16664	19	101	107	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137675	10.1371/journal.pone.0137675	http://dx.doi.org/10.1371/journal.pone.0137675			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378792	Green Published, Green Submitted, gold			2022-12-27	WOS:000361769400021
J	Lim, CK; Ruan, SY; Lin, FC; Wu, CL; Chang, HT; Jerng, JS; Wu, HD; Yu, CJ				Lim, Chor-Kuan; Ruan, Sheng-Yuan; Lin, Feng-Ching; Wu, Chao-Ling; Chang, Hou-Tai; Jerng, Jih-Shuin; Wu, Huey-Dong; Yu, Chong-Jen			Effect of Tracheostomy on Weaning Parameters in Difficult-to-Wean Mechanically Ventilated Patients: A Prospective Observational Study	PLOS ONE			English	Article							TRACHEOTOMY; SUPPORT; EXTUBATION; PRESSURE; TRIAL	Background and Objective Weaning parameters are commonly measured through an endotracheal tube in mechanically ventilated patients recovering from acute respiratory failure, however this practice has rarely been evaluated in tracheostomized patients. This study aimed to investigate changes in weaning parameters measured before and after tracheostomy, and to explore whether the data measured after tracheostomy were associated with weaning outcomes in difficult-to-wean patients. Methods In a two-year study period, we enrolled orotracheally intubated patients who were prepared for tracheostomy due to difficult weaning. Weaning parameters were measured before and after the conversion to tracheostomy and compared, and the post-tracheostomy data were tested for associations with weaning outcomes. Results A total of 86 patients were included. After tracheostomy, maximum inspiratory pressure (mean difference (Delta) = 4.4, 95% Cl, 2.7 to 6.1, P<0.001), maximum expiratory pressure (Delta= 5.4, 95% Cl, 2.9 to 8.0, P<0.001) and tidal volume (Delta = 33.7, 95% Cl, 9.0 to 58.5, P<0.008) significantly increased, and rapid shallow breathing index (Delta = -14.6, 95% Cl, -25.4 to -3.7, P<0.009) and airway resistance (Delta = -4.9, 95% Cl, -5.8 to -4.0, P<0.001) significantly decreased. The patients who were successfully weaned within 90 days of the initiation of mechanical ventilation had greater increments in maximum inspiratory pressure (5.9 vs. 2.4, P = 0.04) and maximum expiratory pressure (8.0 vs. 2.0, P = 0.02) after tracheostomy than those who were unsuccessfully weaned. Conclusions In conclusion, the conversion from endotracheal tube to tracheostomy significantly improved the measured values of weaning parameters in difficult-to-wean patients who subsequently weaned successfully from the mechanical ventilator. The change was significant only for airway resistance in patients who failed weaning.	[Lim, Chor-Kuan; Chang, Hou-Tai] Far Eastern Mem Hosp, Div Chest Med, Dept Internal Med, New Taipei City, Taiwan; [Ruan, Sheng-Yuan; Jerng, Jih-Shuin; Wu, Huey-Dong; Yu, Chong-Jen] Natl Taiwan Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taipei 100, Taiwan; [Lin, Feng-Ching; Wu, Chao-Ling; Wu, Huey-Dong] Natl Taiwan Univ Hosp, Dept Integrated Diagnost & Therapeut, Taipei, Taiwan	Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Jerng, JS (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taipei 100, Taiwan.	jsjerng@ntu.edu.tw	houtai, chang/AAB-1479-2019					ASTRACHAN DI, 1988, LARYNGOSCOPE, V98, P1165; Boles JM, 2007, EUR RESPIR J, V29, P1033, DOI 10.1183/09031936.00010206; BROCHARD L, 1994, AM J RESP CRIT CARE, V150, P896, DOI 10.1164/ajrccm.150.4.7921460; Chadda K, 2002, INTENS CARE MED, V28, P1761, DOI 10.1007/s00134-002-1545-6; Coplin WM, 2000, AM J RESP CRIT CARE, V161, P1530, DOI 10.1164/ajrccm.161.5.9905102; Davis K, 1999, ARCH SURG-CHICAGO, V134, P59, DOI 10.1001/archsurg.134.1.59; Diehl JL, 1999, AM J RESP CRIT CARE, V159, P383, DOI 10.1164/ajrccm.159.2.9707046; ESTEBAN A, 1995, NEW ENGL J MED, V332, P345, DOI 10.1056/NEJM199502093320601; Gomes Silva BN, 2012, THE COCHRANE DATABAS, V3, DOI [10.1002/14651858.CD007271.pub2, DOI 10.1002/14651858.CD007271.PUB2]; Heffner JE, 2001, CHEST, V120, p477S, DOI 10.1378/chest.120.6_suppl.477S; Hoo GWS, 2002, CHEST, V121, P1947, DOI 10.1378/chest.121.6.1947; Jaeger J Michael, 2002, Respir Care, V47, P469; Jaeger JM, 2002, RESP CARE, V47, P81; Jubran A, 2013, JAMA-J AM MED ASSOC, V309, P671, DOI 10.1001/jama.2013.159; MacIntyre N, 2007, CHEST, V132, P1049, DOI 10.1378/chest.06-2862; Pierson David J, 2005, Respir Care, V50, P526; Tobin MJ, 2012, AM J RESP CRIT CARE, V185, P349, DOI 10.1164/rccm.201201-0050ED; TRUWIT JD, 1992, CHEST, V102, P1216, DOI 10.1378/chest.102.4.1216; Vallverdu I, 1998, AM J RESP CRIT CARE, V158, P1855, DOI 10.1164/ajrccm.158.6.9712135; YANG KL, 1992, CHEST, V102, P1829, DOI 10.1378/chest.102.6.1829	20	13	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138294	10.1371/journal.pone.0138294	http://dx.doi.org/10.1371/journal.pone.0138294			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379127	gold, Green Submitted, Green Published			2022-12-27	WOS:000361769400080
J	Sriramula, S; Francis, J				Sriramula, Srinivas; Francis, Joseph			Tumor Necrosis Factor - Alpha Is Essential for Angiotensin II-Induced Ventricular Remodeling: Role for Oxidative Stress	PLOS ONE			English	Article							CARDIAC RESTRICTED OVEREXPRESSION; BLOOD-PRESSURE; NADPH OXIDASE; TRANSGENIC MICE; NITRIC-OXIDE; INDUCED HYPERTENSION; XANTHINE-OXIDASE; NAD(P)H OXIDASE; GENE-EXPRESSION; CTGF EXPRESSION	The functional crosstalk between angiotensin II (Ang II) and tumor necrosis factor (TNF)-alpha has been shown to cause adverse left ventricular remodeling and hypertrophy in hypertension. Previous studies from our lab showed that mice lacking TNF-alpha (TNF-alpha(-/-)) have attenuated hypertensive response to Ang II; however, the signaling mechanisms involved are not known. In this study, we investigated the signaling pathways involved in the Ang II and TNF-alpha interaction. Chronic Ang II infusion (1 mu g/kg/min, 14 days) significantly increased cardiac collagen I, collagen III, CTGF and TGF-beta mRNA and protein expression in wild-type (WT) mice, whereas these changes were decreased in TNF-alpha(-/-) mice. TNF-alpha(-/-) mice with Ang II infusion showed reduced myocardial perivascular and interstitial fibrosis compared to WT mice with Ang II infusion. In WT mice, Ang II infusion increased reactive oxygen species formation and the expression of NADPH oxidase subunits, indicating increased oxidative stress, but not in TNF-alpha(-/-) mice. In addition, treatment with etanercept (8 mg/kg, every 3 days) for two weeks blunted the Ang II-induced hypertension (133 +/- 4 vs 154 +/- 3 mmHg, p<0.05) and cardiac hypertrophy (heart weight to body weight ratio, 4.8 +/- 0.2 vs 5.6 +/- 0.3, p<0.05) inWT mice. Furthermore, Ang II-induced activation of NF-kappa B, p38 MAPK, and JNK were reduced in both TNF-alpha(-/-) mice and mice treated with etanercept. Together, these findings indicate that TNF-alpha contributes to Ang II-induced hypertension and adverse cardiac remodeling, and that these effects are associated with changes in the oxidative stress dependent MAPK/TGF-beta/NF-kappa B pathway. These results may provide new insight into the mechanisms of Ang II and TNF-alpha interaction.	[Sriramula, Srinivas; Francis, Joseph] Louisiana State Univ, Sch Vet Med, Comparat Biomed Sci, Baton Rouge, LA 70803 USA; [Sriramula, Srinivas] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Sriramula, S (corresponding author), Louisiana State Univ, Sch Vet Med, Comparat Biomed Sci, Baton Rouge, LA 70803 USA.	ssrira@lsuhsc.edu; jfrancis@lsu.edu	Sriramula, Srinivas/N-1297-2019	Sriramula, Srinivas/0000-0001-9937-1589	National Heart, Lung, and Blood Institute [HL-80544]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080544] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart, Lung, and Blood Institute Grant HL-80544 to JF.	Brandes RP, 2002, FREE RADICAL BIO MED, V32, P1116, DOI 10.1016/S0891-5849(02)00789-X; Bryant D, 1998, CIRCULATION, V97, P1375, DOI 10.1161/01.CIR.97.14.1375; Chen MM, 2000, J MOL CELL CARDIOL, V32, P1805, DOI 10.1006/jmcc.2000.1215; Chou DHI, 1996, J IMMUNOL, V156, P4354; Cifuentes ME, 2000, AM J PHYSIOL-HEART C, V279, pH2234, DOI 10.1152/ajpheart.2000.279.5.H2234; Dobrian AD, 2001, HYPERTENSION, V38, P361, DOI 10.1161/01.HYP.38.3.361; Elks CM, 2009, AM J PHYSIOL-RENAL, V296, pF298, DOI 10.1152/ajprenal.90628.2008; Elmarakby AA, 2006, HYPERTENSION, V47, P557, DOI 10.1161/01.HYP.0000198545.01860.90; Flesch M, 2003, CIRCULATION, V108, P598, DOI 10.1161/01.CIR.0000081768.13378.BF; Frey RS, 2002, CIRC RES, V90, P1012, DOI 10.1161/01.RES.0000017631.28815.8E; Griendling KK, 2000, ARTERIOSCL THROM VAS, V20, P2175, DOI 10.1161/01.ATV.20.10.2175; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Gu J, 2012, EXP CELL RES, V318, P2105, DOI 10.1016/j.yexcr.2012.06.015; Gurantz D, 1999, CIRC RES, V85, P272, DOI 10.1161/01.RES.85.3.272; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Heymes C, 2003, J AM COLL CARDIOL, V41, P2164, DOI 10.1016/S0735-1097(03)00471-6; Kakishita M, 2003, J CARDIOVASC PHARM, V42, pS67, DOI 10.1097/00005344-200312001-00015; Kalra D, 2000, CIRCULATION, V102, P1302, DOI 10.1161/01.CIR.102.11.1302; Kubota T, 1997, CIRC RES, V81, P627, DOI 10.1161/01.RES.81.4.627; Landmesser U, 2002, HYPERTENSION, V40, P511, DOI 10.1161/01.HYP.0000032100.23772.98; Lassegue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299; Li JM, 2002, CIRC RES, V90, P143, DOI 10.1161/hh0202.103615; Mariappan N, 2010, CARDIOVASC RES, V85, P473, DOI 10.1093/cvr/cvp305; Mariappan N, 2009, FREE RADICAL BIO MED, V46, P462, DOI 10.1016/j.freeradbiomed.2008.10.049; Marvar PJ, 2010, CIRC RES, V107, P263, DOI 10.1161/CIRCRESAHA.110.217299; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Nakamura K, 1998, CIRCULATION, V98, P794, DOI 10.1161/01.CIR.98.8.794; NAKAZONO K, 1991, P NATL ACAD SCI USA, V88, P10045, DOI 10.1073/pnas.88.22.10045; Papaharalambus CA, 2007, TRENDS CARDIOVAS MED, V17, P48, DOI 10.1016/j.tcm.2006.11.005; Schnackenberg CG, 1998, HYPERTENSION, V32, P59, DOI 10.1161/01.HYP.32.1.59; Sekiguchi K, 2004, CARDIOVASC RES, V63, P433, DOI 10.1016/j.cardiores.2004.02.005; Sivasubramanian N, 2001, CIRCULATION, V104, P826, DOI 10.1161/hc3401.093154; Sriramula S, 2008, HYPERTENSION, V51, P1345, DOI 10.1161/HYPERTENSIONAHA.107.102152; Sriramula S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063847; Sun M, 2007, CIRCULATION, V115, P1398, DOI 10.1161/CIRCULATIONAHA.106.643585; Suzuki H, 1998, P NATL ACAD SCI USA, V95, P4754, DOI 10.1073/pnas.95.8.4754; Touyz Rhian M, 2003, Expert Rev Cardiovasc Ther, V1, P91, DOI 10.1586/14779072.1.1.91; Tran LT, 2009, MOL CELL BIOCHEM, V330, P219, DOI 10.1007/s11010-009-0136-z; Venegas-Pont M, 2010, HYPERTENSION, V56, P643, DOI 10.1161/HYPERTENSIONAHA.110.157685; VILLARREAL FJ, 1992, AM J PHYSIOL, V262, pH1861, DOI 10.1152/ajpheart.1992.262.6.H1861; Xiao L, 2002, AM J PHYSIOL-CELL PH, V282, pC926, DOI 10.1152/ajpcell.00254.2001; Zhang CH, 2006, ARTERIOSCL THROM VAS, V26, P475, DOI 10.1161/01.ATV.0000201932.32678.7e; Zhang CH, 2006, J MOL CELL CARDIOL, V40, P247, DOI 10.1016/j.yjmcc.2005.11.010	43	63	67	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138372	10.1371/journal.pone.0138372	http://dx.doi.org/10.1371/journal.pone.0138372			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378790	Green Published, gold, Green Submitted			2022-12-27	WOS:000361769400091
J	Walitt, B; Nahin, RL; Katz, RS; Bergman, MJ; Wolfe, F				Walitt, Brian; Nahin, Richard L.; Katz, Robert S.; Bergman, Martin J.; Wolfe, Frederick			The Prevalence and Characteristics of Fibromyalgia in the 2012 National Health Interview Survey	PLOS ONE			English	Article							CHRONIC WIDESPREAD PAIN; POLYSYMPTOMATIC DISTRESS; RHEUMATOID-ARTHRITIS; PHARMACEUTICAL-INDUSTRY; BODILY DISTRESS; SYMPTOMS; CRITERIA; COMORBIDITIES; CATEGORIES; DISORDERS	Background Most knowledge of fibromyalgia comes from the clinical setting, where healthcare-seeking behavior and selection issues influence study results. The characteristics of fibromyalgia in the general population have not been studied in detail. Methods We developed and tested surrogate study specific criteria for fibromyalgia in rheumatology practices using variables from the US National Health Interview Survey (NHIS) and the modification (for surveys) of the 2010 American College of Rheumatology (ACR) preliminary fibromyalgia criteria. The surrogate criteria were applied to the 2012 NHIS and identified persons who satisfied criteria from symptom data. The NHIS weighted sample of 8446 persons represents 225.7 million US adults. Results Fibromyalgia was identified in 1.75%(95% CI 1.42, 2.07), or 3.94 million persons. However, 73% of identified cases self-reported a physician's diagnosis other than fibromyalgia. Identified cases had high levels of self-reported pain, non-pain symptoms, comorbidity, psychological distress, medical costs, Social Security and work disability. Caseness was associated with gender, education, ethnicity, citizenship and unhealthy behaviors. Demographics, behaviors, and comorbidity were predictive of case status. Examination of the surrogate polysymptomatic distress scale (PSD) of the 2010 ACR criteria found fibromyalgia symptoms extending through the full length of the scale. Conclusions Persons identified with criteria-based fibromyalgia have severe symptoms, butmost (73%) have not received a clinical diagnosis of fibromyalgia. The association of fibromyalgia-like symptoms over the full length of the PSD scale with physiological as well as mental stressors suggests PSD may be a universal response variable rather than one restricted to fibromyalgia.	[Walitt, Brian; Nahin, Richard L.] NIH, Natl Ctr Complementary & Integrat Hlth, Bldg 10, Bethesda, MD 20892 USA; [Katz, Robert S.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Bergman, Martin J.] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA; [Wolfe, Frederick] Natl Data Bank Rheumat Dis, Wichita, KS USA	National Institutes of Health (NIH) - USA; Rush University; Drexel University; National Data Bank for Rheumatic Diseases	Walitt, B (corresponding author), NIH, Natl Ctr Complementary & Integrat Hlth, Bldg 10, Bethesda, MD 20892 USA.	brian.walitt@nih.gov		Wolfe, Frederick/0000-0002-2801-6413				Aaron LA, 2001, ANN INTERN MED, V134, P868, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00011; Aceves-Avila FJ, 2004, BEST PRACT RES CL RH, V18, P155, DOI 10.1016/j.berh.2004.02.004; Aronowitz RA, 2001, ANN INTERN MED, V134, P803, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00002; Barker KK, 2011, SOC SCI MED, V73, P833, DOI 10.1016/j.socscimed.2011.05.055; Berger A, 2007, INT J CLIN PRACT, V61, P1498, DOI 10.1111/j.1742-1241.2007.01480.x; Brummett CM, 2013, ANESTHESIOLOGY, V119, P1434, DOI 10.1097/ALN.0b013e3182a8eb1f; Buskila D, 2007, PHARMACOGENOMICS, V8, P67, DOI 10.2217/14622416.8.1.67; Clauw DJ, 2014, JAMA-J AM MED ASSOC, V311, P1547, DOI 10.1001/jama.2014.3266; Corporation S., 2013, STAT STAT SOFTW REL; Dumit J, 2006, SOC SCI MED, V62, P577, DOI 10.1016/j.socscimed.2005.06.018; Ehrlich GE, 2003, J RHEUMATOL, V30, P1666; English B, 2014, PAIN MANAG NURS, V15, P530, DOI 10.1016/j.pmn.2012.07.009; Epstein SA, 1999, PSYCHOSOMATICS, V40, P57, DOI 10.1016/S0033-3182(99)71272-7; Fietta Pierluigi, 2007, Acta Biomed, V78, P88; Fink P, 2007, PSYCHOSOM MED, V69, P30, DOI 10.1097/PSY.0b013e31802e46eb; Fink P, 2010, J PSYCHOSOM RES, V68, P415, DOI 10.1016/j.jpsychores.2010.02.004; Hadler NM, 2005, SPINE, V30, P1; Holliday KL, 2010, J PSYCHOSOM RES, V68, P469, DOI 10.1016/j.jpsychores.2010.01.024; Jeffery DD, 2014, MIL MED, V179, P1021, DOI 10.7205/MILMED-D-13-00419; Kato K, 2009, PSYCHOL MED, V39, P497, DOI 10.1017/S0033291708003784; Kato K, 2006, ARCH INTERN MED, V166, P1649, DOI 10.1001/archinte.166.15.1649; Kendler KS, 2012, MOL PSYCHIATR, V17, P377, DOI 10.1038/mp.2011.182; Kendler KS, 2014, PERSPECTIVES, V171; Kirmayer LJ, 2007, PSYCHOSOM MED, V69, P832, DOI 10.1097/PSY.0b013e31815b002c; Kleinman A., 1988, ILLNESS NARRATIVES; Kroenke K, 2006, J PSYCHOSOM RES, V60, P335, DOI 10.1016/j.jpsychores.2006.01.022; Kroenke K, 2007, PSYCHIAT CLIN N AM, V30, P593, DOI 10.1016/j.psc.2007.08.002; Macfarlane GJ, 2009, ANN RHEUM DIS, V68, P1591, DOI 10.1136/ard.2008.093088; Macfarlane GJ, 1999, J RHEUMATOL, V26, P413; Maeland S, 2012, ISRN PUBLIC HLTH, V2012; McBeth J, 2001, Curr Rheumatol Rep, V3, P157, DOI 10.1007/s11926-001-0011-8; McBeth J, 2001, ARTHRITIS RHEUM, V44, P940, DOI 10.1002/1529-0131(200104)44:4<940::AID-ANR151>3.0.CO;2-S; Moynihan R, 2002, BRIT MED J, V324, P886, DOI 10.1136/bmj.324.7342.886; Moynihan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3502; NAT'L CONF. OF STATE LEGISLATURES, 2013, DAT BOOK HLTH CAR SP, P1; Nicholl BI, 2009, PAIN, V141, P119, DOI 10.1016/j.pain.2008.10.022; Nimnuan C, 2001, J PSYCHOSOM RES, V51, P361, DOI 10.1016/S0022-3999(01)00223-9; Pollard LC, 2010, RHEUMATOLOGY, V49, P924, DOI 10.1093/rheumatology/kep458; Raphael KG, 2006, PAIN, V124, P117, DOI 10.1016/j.pain.2006.04.004; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Sacks JJ, 2005, J RHEUMATOL, V32, P340; Schaefer C, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-71; Segura-Jimenez V, 2014, RHEUMATOLOGY; Walitt B, 2014, 2014 AM COLL RHEUM A; Wessely S, 1999, BEST PRACT RES CL RH, V13, P427, DOI 10.1053/berh.1999.0032; Wessely S, 2004, BRIT J PSYCHIAT, V185, P95, DOI 10.1192/bjp.185.2.95; WHO. World Health Organization, 1995, TECHNICAL REPORT SER, V854; Wolfe F, 1999, CLIN EXP RHEUMATOL, V17, P297; Wolfe F, 2004, J RHEUMATOL, V31, P695; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2014, ARTHRITIS CARE RES; Wolfe F, 2015, J RHEUMATOL, V42, P1494, DOI 10.3899/jrheum.141519; Wolfe F, 2014, ARTHRIT CARE RES, V66, P1465, DOI 10.1002/acr.22300; Wolfe F, 2013, ARTHRIT CARE RES, V65, P777, DOI 10.1002/acr.21931; Wolfe F, 2011, J RHEUMATOL, V38, P1113, DOI 10.3899/jrheum.100594; Wolfe F, 2011, RHEUMATOLOGY, V50, P16, DOI 10.1093/rheumatology/keq155; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Wolinsky H, 2005, EMBO REP, V6, P612, DOI 10.1038/sj.embor.7400476; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	59	135	138	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138024	10.1371/journal.pone.0138024	http://dx.doi.org/10.1371/journal.pone.0138024			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0RH	26379048	Green Published, Green Submitted, gold			2022-12-27	WOS:000361769400044
J	Wu, J; Li, HH; Sun, XR; Zhang, H; Hao, SY; Ji, MH; Yang, JJ; Li, KY				Wu, Jing; Li, Huihui; Sun, Xiaoru; Zhang, Hui; Hao, Shuangying; Ji, Muhuo; Yang, Jianjun; Li, Kuanyu			A Mitochondrion-Targeted Antioxidant Ameliorates Isoflurane-Induced Cognitive Deficits in Aging Mice	PLOS ONE			English	Article							NLRP3 INFLAMMASOME ACTIVATION; DEVELOPING RAT-BRAIN; NEURODEGENERATIVE DISEASES; ANESTHETIC ISOFLURANE; CELL-DEATH; IMPAIRMENT; DYSFUNCTION; STRATEGIES; MECHANISM; APOPTOSIS	Isoflurane possesses neurotoxicity and can induce cognitive deficits, particularly in aging mammals. Mitochondrial reactive oxygen species (mtROS) have been linked to the early pathogenesis of this disorder. However, the role of mtROS remains to be evaluated due to a lack of targeted method to treat mtROS. Here, we determined in aging mice the effects of the mitochondrion-targeted antioxidant SS-31, on cognitive deficits induced by isoflurane, a general inhalation anesthetic. We further investigated the possible mechanisms underlying the effects of SS-31 on hippocampal neuro-inflammation and apoptosis. The results showed that isoflurane induced hippocampus-dependent memory deficit, which was associated with mitochondrial dysfunction including reduced ATP contents, increased ROS levels, and mitochondrial swelling. Treatment with SS-31 significantly ameliorated isoflurane-induced cognitive deficits through the improvement of mitochondrial integrity and function. Mechanistically, SS-31 treatment suppressed pro-inflammatory responses by decreasing the levels of NF-kappa B, NLRP3, caspase 1, IL-1 beta, and TNF-alpha; and inhibited the apoptotic pathway by decreasing the Bax/Bcl-2 ratio, reducing the release of cytochrome C, and blocking the cleavage of caspase 3. Our results indicate that isoflurane-induced cognitive deficits may be attenuated by mitochondrion-targeted antioxidants, such as SS-31. Therefore, SS-31 may have therapeutic potentials in preventing injuries from oxidative stresses that contribute to anesthetic-induced neurotoxicity.	[Wu, Jing; Li, Huihui; Hao, Shuangying; Li, Kuanyu] Nanjing Univ, Jiangsu Key Lab Mol Med, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Wu, Jing; Sun, Xiaoru; Zhang, Hui; Ji, Muhuo; Yang, Jianjun] Nanjing Univ, Dept Anesthesiol, Jinling Hosp, Sch Med, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Yang, JJ (corresponding author), Nanjing Univ, Dept Anesthesiol, Jinling Hosp, Sch Med, Nanjing 210008, Jiangsu, Peoples R China.	yjyangjj@126.com; likuanyu@nju.edu.cn	sun, xiaoru/GZL-0771-2022; Yang, Jianjun/AAN-4960-2021; Li, Kuanyu/AAL-2051-2020		National Nature Science foundation of China [31071085, 31371060, 81271216, 81300946]	National Nature Science foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science foundation of China; grant numbers: 31071085, 31371060, 81271216, and 81300946. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mansoori KM, 2013, CURR ALZHEIMER RES, V10, P559; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Blum FE, 2013, MED GAS RES, V3, DOI 10.1186/2045-9912-3-16; Boscolo A, 2012, NEUROBIOL DIS, V45, P1031, DOI 10.1016/j.nbd.2011.12.022; Boscolo A, 2013, ANESTHESIOLOGY, V118, P1086, DOI 10.1097/ALN.0b013e318289bc9b; CAMPO ML, 1992, J BIOL CHEM, V267, P8123; Dashdorj A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-178; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; Fodale V, 2010, ANAESTHESIA, V65, P388, DOI 10.1111/j.1365-2044.2010.06244.x; Jevtovic-Todorovic V, 2012, FRONTIERS NEUROLOGY, V3; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kim SR, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.460; Li XM, 2014, ANESTHESIOLOGY, V121, P79, DOI 10.1097/ALN.0000000000000191; Li XM, 2014, J MOL NEUROSCI, V52, P286, DOI 10.1007/s12031-013-0141-2; Li XY, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-19; Li ZQ, 2013, BIOCHEM BIOPH RES CO, V438, P628, DOI 10.1016/j.bbrc.2013.08.003; Lin DW, 2011, NEUROPHARMACOLOGY, V61, P1354, DOI 10.1016/j.neuropharm.2011.08.011; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Loop T, 2005, ANESTHESIOLOGY, V102, P1147, DOI 10.1097/00000542-200506000-00014; Manczak M, 2010, J ALZHEIMERS DIS, V20, pS609, DOI 10.3233/JAD-2010-100564; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Naik E, 2011, J EXP MED, V208, P417, DOI 10.1084/jem.20110367; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Petri S, 2006, J NEUROCHEM, V98, P1141, DOI 10.1111/j.1471-4159.2006.04018.x; Popova EN, 2010, ANTIOXID REDOX SIGN, V13, P1297, DOI 10.1089/ars.2009.2949; Reddy PH, 2007, ANTIOXID REDOX SIGN, V9, P1647, DOI 10.1089/ars.2007.1754; Sato T, 2004, J IMMUNOL, V173, P285, DOI 10.4049/jimmunol.173.1.285; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shen X, 2013, ANESTHESIOLOGY, V118, P502, DOI 10.1097/ALN.0b013e3182834d77; Siegel MP, 2013, AGING CELL, V12, P763, DOI 10.1111/acel.12102; Smith RAJ, 2011, ANTIOXID REDOX SIGN, V15, P3021, DOI 10.1089/ars.2011.3969; Sorbara MT, 2011, CELL RES, V21, P558, DOI 10.1038/cr.2011.20; Sun YX, 2014, BRAIN SCI, V4, P311, DOI 10.3390/brainsci4020311; Szeto HH, 2011, J AM SOC NEPHROL, V22, P1041, DOI 10.1681/ASN.2010080808; Wu X, 2014, MATH PROBL ENG, V2014, P1; Yang LC, 2009, ANTIOXID REDOX SIGN, V11, P2095, DOI [10.1089/ars.2009.2445, 10.1089/ARS.2009.2445]; Yon JH, 2005, NEUROSCIENCE, V135, P815, DOI 10.1016/j.neuroscience.2005.03.064; Zhang YY, 2012, ANN NEUROL, V71, P687, DOI 10.1002/ana.23536; Zhang YY, 2010, J BIOL CHEM, V285, P4025, DOI 10.1074/jbc.M109.065664; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	41	30	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138256	10.1371/journal.pone.0138256	http://dx.doi.org/10.1371/journal.pone.0138256			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379247	Green Published, Green Submitted, gold			2022-12-27	WOS:000361769400074
J	Cancarini, I; Krogh, V; Agnoli, C; Grioni, S; Matullo, G; Pala, V; Pedraglio, S; Contiero, P; Riva, C; Muti, P; Sieri, S				Cancarini, Ilaria; Krogh, Vittorio; Agnoli, Claudia; Grioni, Sara; Matullo, Giuseppe; Pala, Valeria; Pedraglio, Samuele; Contiero, Paolo; Riva, Cristina; Muti, Paola; Sieri, Sabina			Micronutrients Involved in One-Carbon Metabolism and Risk of Breast Cancer Subtypes	PLOS ONE			English	Article							DIETARY-FOLATE INTAKE; ESTROGEN-RECEPTOR GENE; B-VITAMINS; METHYLATION; DNA; ALCOHOL; WOMEN; CARCINOGENESIS; LYMPHOCYTES; DEFICIENCY	Background Vitamins involved in one-carbon metabolism are hypothesized to influence breast cancer (BC) risk. However, epidemiologic studies that examined associations between B vitamin intake and BC risk have provided inconsistent results. We prospectively examined, in the Italian ORDET cohort, whether B vitamin consumption was associated with risk of BC and BC subtypes. Methods After a mean follow-up of 16.5 years, 391 BCs were diagnosed among 10,786 cohort women. B vitamin intakes were estimated from food frequency questionnaires. Cox proportional hazard models adjusted for energy intake and confounders, estimated hazard ratios (HR) with 95% confidence intervals (CIs) for BC according to intake. Results RRs were 0.61 (95% CI 0.38-0.97 highest vs. lowest quartile; P trend 0.025) for thiamine; 0.48 (95% CI 0.32-0.71; P trend <0.001) for riboflavin; 0.59 (95% CI 0.39-0.90; P trend 0.008) for vitamin B6, and 0.65 (95% CI 0.44-0.95; P trend 0.021) for folate. As regards risk of BC subtypes, high riboflavin and folate were significantly associated with lower risk of estrogen receptor positive (ER+) and progesterone receptor positive (PR+) cancers, and high thiamine was associated with lower risk of ER-PR-cancers. High riboflavin was associated with lower risk of both HER2+ and HER2-cancers, high folate with lower risk of HER2-disease, and high thiamine with HER2+ disease. Conclusions These findings support protective effects of thiamine and one-carbon metabolism vitamins (folate, riboflavin, and vitamin B6) against BC in general; while folate may also protect against ER+PR+ and HER2-disease; and thiamine against ER-PR-, and HER2+ disease.	[Cancarini, Ilaria; Krogh, Vittorio; Agnoli, Claudia; Grioni, Sara; Pala, Valeria; Pedraglio, Samuele; Sieri, Sabina] Fdn IRCSS Ist Nazl Tumori, Dept Prevent & Predict Med, Epidemiol & Prevent Unit, Milan, Italy; [Matullo, Giuseppe] Univ Turin, Dept Med Sci, Turin, Italy; [Matullo, Giuseppe] Human Genet Fdn, Turin, Italy; [Contiero, Paolo] Fdn IRCSS Ist Nazl Tumori, Environm Epidemiol Unit, Dept Prevent & Predict Med, Turin, Italy; [Riva, Cristina] Univ Insubria, Dept Surg & Morphol Sci, Varese, Italy; [Muti, Paola] McMaster Univ, Fac Hlth Sci, Dept Oncol, Hamilton, ON, Canada	Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Turin; University of Insubria; McMaster University	Sieri, S (corresponding author), Fdn IRCSS Ist Nazl Tumori, Dept Prevent & Predict Med, Epidemiol & Prevent Unit, Milan, Italy.	sabina.sieri@istitutotumori.mi.it	Agnoli, Claudia/K-5916-2016; Krogh, Vittorio/K-2628-2016; Krogh, Vittorio/AAA-9171-2019; Grioni, Sara/K-5320-2016; Muti, Paola/AAD-9108-2020; Matullo, Giuseppe/K-6383-2016; Contiero, Paolo/F-6721-2016; Sieri, Sabina/K-4667-2016; Pala, Valeria/K-4738-2016; RIVA, CRISTINA/K-5063-2016	Agnoli, Claudia/0000-0003-4472-1179; Krogh, Vittorio/0000-0003-0122-8624; Krogh, Vittorio/0000-0003-0122-8624; Grioni, Sara/0000-0002-5891-8426; Matullo, Giuseppe/0000-0003-0674-7757; Contiero, Paolo/0000-0001-6760-3605; Sieri, Sabina/0000-0001-5201-172X; Pala, Valeria/0000-0001-5438-970X; RIVA, CRISTINA/0000-0001-9884-038X	Italian Ministry of Public Health	Italian Ministry of Public Health(Ministry of Health, Italy)	This study was funded by the Italian Ministry of Public Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames BN, 2001, MUTAT RES-FUND MOL M, V475, P7, DOI 10.1016/S0027-5107(01)00070-7; Bassett JK, 2013, CANCER CAUSE CONTROL, V24, P1555, DOI 10.1007/s10552-013-0232-y; Chen P, 2014, BRIT J CANCER, V110, P2327, DOI 10.1038/bjc.2014.155; Cho EY, 2007, CANCER EPIDEM BIOMAR, V16, P2787, DOI 10.1158/1055-9965.EPI-07-0683; Choi SW, 2000, J NUTR, V130, P129, DOI 10.1093/jn/130.2.129; Chou YC, 2007, BREAST CANCER RES TR, V101, P199, DOI 10.1007/s10549-006-9278-9; Contiero P, 2008, J BIOMED INFORM, V41, P24, DOI 10.1016/j.jbi.2007.03.003; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Batlle J, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju367; de Kruijf EM, 2014, MOL ONCOL; Doke S, 1998, BIOSCI BIOTECH BIOCH, V62, P1008, DOI 10.1271/bbb.62.1008; Duffy CM, 2009, BREAST CANCER RES TR, V116, P551, DOI 10.1007/s10549-008-0167-2; Duthie SJ, 1998, FASEB J, V12, P1491, DOI 10.1096/fasebj.12.14.1491; Ericson U, 2007, AM J CLIN NUTR, V86, P434, DOI 10.1093/ajcn/86.2.434; FERGUSON AT, 1995, CANCER RES, V55, P2279; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370; Kabat GC, 2008, BRIT J CANCER, V99, P816, DOI 10.1038/sj.bjc.6604540; Kim YI, 2004, CANCER EPIDEM BIOMAR, V13, P511; Kim YI, 2007, MOL NUTR FOOD RES, V51, P267, DOI 10.1002/mnfr.200600191; Kwak HK, 2002, J NUTR, V132, P3308, DOI 10.1093/jn/132.11.3308; Lajous M, 2006, CANCER EPIDEM BIOMAR, V15, P443, DOI 10.1158/1055-9965.EPI-05-0532; Lajous M, 2006, CANCER CAUSE CONTROL, V17, P1209, DOI 10.1007/s10552-006-0053-3; Lapidus RG, 1998, CANCER RES, V58, P2515; Lapidus RG, 1996, CLIN CANCER RES, V2, P805; Larsson SC, 2007, JNCI-J NATL CANCER I, V99, P64, DOI 10.1093/jnci/djk006; Larsson SC, 2008, CANCER EPIDEM BIOMAR, V17, P3444, DOI 10.1158/1055-9965.EPI-08-0692; Layfield Lester J., 2000, Breast J, V6, P189, DOI 10.1046/j.1524-4741.2000.99097.x; Levi F, 2001, INT J CANCER, V91, P260, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1041&gt;3.3.CO;2-R; Lin J, 2008, AM J CLIN NUTR, V87, P734, DOI 10.1093/ajcn/87.3.734; Liu SQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085702; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Ma E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-122; Maruti SS, 2009, AM J CLIN NUTR, V89, P624, DOI 10.3945/ajcn.2008.26568; Mason J B, 1996, Oncology (Williston Park), V10, P1727; Mason JB, 2003, J NUTR, V133, p941S, DOI 10.1093/jn/133.3.941S; Mason JB, 2000, ADV ENZYME REGUL, V40, P127, DOI 10.1016/S0065-2571(99)00037-0; MCCORMICK DB, 1989, PHYSIOL REV, V69, P1170, DOI 10.1152/physrev.1989.69.4.1170; Negri E, 1996, INT J CANCER, V65, P140, DOI 10.1002/(SICI)1097-0215(19960117)65:2&lt;140::AID-IJC3&gt;3.0.CO;2-Z; OTTAVIANO YL, 1994, CANCER RES, V54, P2552; Paul L, 2013, NUTR REV, V71, P239, DOI 10.1111/nure.12014; PIVA R, 1990, BRIT J CANCER, V61, P270, DOI 10.1038/bjc.1990.50; Rohan TE, 2000, J NATL CANCER I, V92, P266, DOI 10.1093/jnci/92.3.266; Roswall N, 2010, EUR J CANCER PREV, V19, P360, DOI 10.1097/CEJ.0b013e32833ade68; Salvini S, 1998, BANCA DATI DI COMPOS; Sellers TA, 2002, CANCER EPIDEM BIOMAR, V11, P1104; Sellers TA, 2001, EPIDEMIOLOGY, V12, P420, DOI 10.1097/00001648-200107000-00012; Shrubsole MJ, 2011, AM J EPIDEMIOL, V173, P1171, DOI 10.1093/aje/kwq491; Shrubsole MJ, 2001, CANCER RES, V61, P7136; Sieri S, 2002, NUTR CANCER, V42, P10, DOI 10.1207/S15327914NC421_2; Taherian-Fard A, 2014, BRIEF BIOINFORM; Tio M, 2014, BREAST CANC RES TREA; Vona-Davis L, 2007, ENDOCR-RELAT CANCER, V14, P189, DOI 10.1677/ERC-06-0068; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Zastre JA, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-16; Zhang SM, 2005, CANCER EPIDEM BIOMAR, V14, P2004, DOI 10.1158/1055-9965.EPI-05-0083; Zhang SM, 1999, JAMA-J AM MED ASSOC, V281, P1632, DOI 10.1001/jama.281.17.1632; Zhang YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100044	59	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138318	10.1371/journal.pone.0138318	http://dx.doi.org/10.1371/journal.pone.0138318			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376452	Green Published, Green Submitted, gold			2022-12-27	WOS:000361610200097
J	Carters, MA; Rieger, E; Bell, J				Carters, Megan A.; Rieger, Elizabeth; Bell, Jason			Reduced Inhibition of Return to Food Images in Obese Individuals	PLOS ONE			English	Article							ATTENTIONAL BIAS MODIFICATION; QUESTIONNAIRE EDE-Q; EATING-DISORDER; WEIGHT-LOSS; TIME-COURSE; OVERWEIGHT; VALIDITY; DISENGAGEMENT; THREAT; CUES	Previous research has shown that obese individuals may be biased towards attending to food over non-food information, and this bias may contribute to the development and/or maintenance of obesity. The present study sought to extend our understanding of maladaptive attentional processing in this population by investigating whether obese individuals have difficulty in disengaging attention from food compared with non-food images, relative to normal-weight controls. To address this question, we measured inhibition of return (IOR) in an attentional cueing task. The participants were 29 obese and 35 normal-weight satiated females without eating disorders. The obese group displayed less IOR to food images than the normal-weight group, while there was no difference in IOR between the groups for non-food images. This suggests that obese females have greater difficulty disengaging attention from food than normal-weight females. Our findings provide a new focus for studies investigating maintenance factors in obesity and are discussed in relation to a theory of incentive-sensitisation.	[Carters, Megan A.; Rieger, Elizabeth; Bell, Jason] Australian Natl Univ, Res Sch Psychol, Canberra, ACT, Australia; [Bell, Jason] Univ Western Australia, Sch Psychol, ARC Ctr Excellence Cognit & Its Disorders, Perth, WA 6009, Australia	Australian National University; University of Western Australia	Carters, MA (corresponding author), Australian Natl Univ, Res Sch Psychol, Canberra, ACT, Australia.	megan.carters@anu.edu.au	Rieger, Elizabeth/ABE-7589-2020	Rieger, Elizabeth/0000-0002-8865-5831; Bell, Jason/0000-0002-1583-5292	Australian National University	Australian National University(Australian National University)	The participant payments in the present research were funded by The Australian National University (http://www.anu.edu.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aardoom JJ, 2012, EAT BEHAV, V13, P305, DOI 10.1016/j.eatbeh.2012.09.002; Algom D, 2004, J EXP PSYCHOL GEN, V133, P323, DOI 10.1037/0096-3445.133.3.323; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Ayyad C, 2000, Obes Rev, V1, P113, DOI 10.1046/j.1467-789x.2000.00019.x; Beard C, 2012, BEHAV THER, V43, P724, DOI 10.1016/j.beth.2012.01.002; Berridge KC, 2009, PHYSIOL BEHAV, V97, P537, DOI 10.1016/j.physbeh.2009.02.044; Boeka AG, 2008, ARCH CLIN NEUROPSYCH, V23, P467, DOI 10.1016/j.acn.2008.03.003; Braet C, 2008, J HEALTH PSYCHOL, V13, P733, DOI 10.1177/1359105308093850; Brooks SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060393; Browning M, 2012, BIOL PSYCHIAT, V72, P572, DOI 10.1016/j.biopsych.2012.04.014; Burger Kyle S, 2011, Curr Drug Abuse Rev, V4, P182; Burton P, 2007, APPETITE, V49, P191, DOI 10.1016/j.appet.2007.01.007; Calitri R, 2010, OBESITY, V18, P2282, DOI 10.1038/oby.2010.78; Castel AD, 2003, J GERONTOL B-PSYCHOL, V58, pP256, DOI 10.1093/geronb/58.5.P256; Castellanos EH, 2009, INT J OBESITY, V33, P1063, DOI 10.1038/ijo.2009.138; Cohen J.E., 1988, STAT POWER ANAL BEHA; Costa A, 2003, LANG COGNITIVE PROC, V18, P205, DOI 10.1080/01690960143000524; Curioni CC, 2005, INT J OBESITY, V29, P1168, DOI 10.1038/sj.ijo.0803015; Dai Q, 2009, PROG NEURO-PSYCHOPH, V33, P921, DOI 10.1016/j.pnpbp.2009.04.012; de Wit L, 2010, PSYCHIAT RES, V178, P230, DOI 10.1016/j.psychres.2009.04.015; Devlin MJ, 2007, INT J EAT DISORDER, V40, pS83, DOI 10.1002/eat.20430; FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363; Fairburn CG, 2013, BEHAV RES THER, V51, pR2, DOI 10.1016/j.brat.2012.09.010; Fairburn Christopher G., 1993, P317; Field M, 2008, DRUG ALCOHOL DEPEN, V97, P1, DOI 10.1016/j.drugalcdep.2008.03.030; Fontaine KR, 1996, J FAM PRACTICE, V43, P265; Fox E, 2002, COGNITION EMOTION, V16, P355, DOI 10.1080/02699930143000527; Gao XA, 2011, BEHAV RES THER, V49, P252, DOI 10.1016/j.brat.2011.01.009; Gariepy G, 2010, INT J OBESITY, V34, P407, DOI 10.1038/ijo.2009.252; Geliebter A, 2013, BEHAV BRAIN RES, V243, P91, DOI 10.1016/j.bbr.2012.12.023; Grilo CM, 2001, OBES RES, V9, P418, DOI 10.1038/oby.2001.55; Hansson M, 2009, BRIT J GEN PRACT, V59, P650, DOI 10.3399/bjgp09X454070; HEATHCOTE A, 1991, PSYCHOL BULL, V109, P340, DOI 10.1037/0033-2909.109.2.340; Hilbert A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029125; Hill AJ, 2007, P NUTR SOC, V66, P277, DOI 10.1017/S0029665107005502; Hume DJ, 2015, APPETITE, V85, P126, DOI 10.1016/j.appet.2014.11.012; Jordan H, 1998, PSYCHON B REV, V5, P504, DOI 10.3758/BF03208829; Kakoschke N, 2014, EAT BEHAV, V15, P120, DOI 10.1016/j.eatbeh.2013.11.001; Kelley AE, 2002, PHYSIOL BEHAV, V76, P365, DOI 10.1016/S0031-9384(02)00751-5; Kemps E, 2014, HEALTH PSYCHOL, V33, P1391, DOI 10.1037/hea0000069; Kemps E, 2014, J EXP PSYCHOL-APPL, V20, P94, DOI 10.1037/xap0000005; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; Koelstra S, 2012, IEEE T AFFECT COMPUT, V3, P18, DOI 10.1109/T-AFFC.2011.15; Koster EHW, 2005, EMOTION, V5, P446, DOI 10.1037/1528-3542.5.4.446; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lang P.J., 2008, INT AFFECTIVE PICTUR; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Lowe B, 2004, J AFFECT DISORDERS, V78, P131, DOI 10.1016/S0165-0327(02)00237-9; Lowe MR, 2007, PHYSIOL BEHAV, V91, P432, DOI 10.1016/j.physbeh.2007.04.006; Luce KH, 1999, INT J EAT DISORDER, V25, P349, DOI 10.1002/(SICI)1098-108X(199904)25:3&lt;349::AID-EAT15&gt;3.0.CO;2-M; Lupianez J, 1997, PERCEPT PSYCHOPHYS, V59, P1241, DOI 10.3758/BF03214211; Marcus MD, 2009, INT J EAT DISORDER, V42, P739, DOI 10.1002/eat.20725; Martin A, 2006, GEN HOSP PSYCHIAT, V28, P71, DOI 10.1016/j.genhosppsych.2005.07.003; Martin CK, 2008, APPETITE, V51, P324, DOI 10.1016/j.appet.2008.03.002; McNaughton N, 2004, NEUROSCI BIOBEHAV R, V28, P285, DOI 10.1016/j.neubiorev.2004.03.005; Mobbs O, 2011, APPETITE, V57, P263, DOI 10.1016/j.appet.2011.04.023; Mogg K, 2008, BEHAV RES THER, V46, P656, DOI 10.1016/j.brat.2008.02.011; Mond JM, 2004, BEHAV RES THER, V42, P551, DOI 10.1016/S0005-7967(03)00161-X; Mond JM, 2004, INT J EAT DISORDER, V36, P195, DOI 10.1002/eat.20017; Murdaugh DL, 2012, NEUROIMAGE, V59, P2709, DOI 10.1016/j.neuroimage.2011.10.071; Nijs IMT, 2012, CURR OBES REP, V1, P106, DOI 10.1007/s13679-012-0011-1; Nijs IMT, 2010, EAT BEHAV, V11, P258, DOI 10.1016/j.eatbeh.2010.07.002; Nijs IMT, 2010, APPETITE, V54, P243, DOI 10.1016/j.appet.2009.11.004; Nijs Ilse M T, 2008, Eat Behav, V9, P462, DOI 10.1016/j.eatbeh.2008.07.009; Norman G, 2010, ADV HEALTH SCI EDUC, V15, P625, DOI 10.1007/s10459-010-9222-y; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Perez-Duenas C, 2009, J ANXIETY DISORD, V23, P782, DOI 10.1016/j.janxdis.2009.03.002; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1987, PSYCHOBIOLOGY, V15, P107; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rose JS, 2013, J EAT DISORD, V1, DOI 10.1186/2050-2974-1-42; Roth J, 2004, OBES RES, V12, p88S, DOI 10.1038/oby.2004.273; Samuel AG, 2003, PSYCHON B REV, V10, P897, DOI 10.3758/BF03196550; Schoenmakers TM, 2010, DRUG ALCOHOL DEPEN, V109, P30, DOI 10.1016/j.drugalcdep.2009.11.022; Stice E, 2008, SCIENCE, V322, P449, DOI 10.1126/science.1161550; Stingl KT, 2012, NEUROIMAGE, V60, P362, DOI 10.1016/j.neuroimage.2011.12.012; Stoyanova RS, 2007, EMOTION, V7, P49, DOI 10.1037/1528-3542.7.1.49; Streiner DL, 2003, J PERS ASSESS, V80, P217, DOI 10.1207/S15327752JPA8003_01; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; Tsai AG, 2005, ANN INTERN MED, V142, P56, DOI 10.7326/0003-4819-142-1-200501040-00012; Verkuil B, 2009, BEHAV RES THER, V47, P146, DOI 10.1016/j.brat.2008.11.003; Walley AJ, 2009, NAT REV GENET, V10, P431, DOI 10.1038/nrg2594; Wells A, 2007, COGN BEHAV PRACT, V14, P134, DOI 10.1016/j.cbpra.2006.01.010; Werthmann J, 2014, J BEHAV THER EXP PSY, V45, P136, DOI 10.1016/j.jbtep.2013.09.009; Werthmann J, 2011, HEALTH PSYCHOL, V30, P561, DOI 10.1037/a0024291; World Health Organization, 2013, OBESITY AND OVERWEIG; Zuithoff NPA, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-98	89	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137821	10.1371/journal.pone.0137821	http://dx.doi.org/10.1371/journal.pone.0137821			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8NH	26376082	gold, Green Published, Green Submitted			2022-12-27	WOS:000361610200055
J	Travenzoli, NM; Silva, PC; Santos, U; Zanuncio, JC; Oliveira, C; Dergam, JA				Travenzoli, Natalia Martins; Silva, Priscilla Caroline; Santos, Udson; Zanuncio, Jose Cola; Oliveira, Claudio; Dergam, Jorge Abdala			Cytogenetic and Molecular Data Demonstrate that the Bryconinae (Ostariophysi, Bryconidae) Species from Southeastern Brazil Form a Phylogenetic and Phylogeographic Unit	PLOS ONE			English	Article							PROCHILODUS-LINEATUS CHARACIFORMES; HOPLIAS-MALABARICUS; ERYTHRINIDAE FISH; EASTERN BRAZIL; CHARACIDAE; PISCES; DNA; BIOGEOGRAPHY; KARYOTYPE; TELEOSTEI	Brycon spp. occur in Neotropical watersheds to the west and east of the Andes, and as they are sensitive to anthropogenic changes, many these species are endangered in southeastern Brazil. Coastal rivers in southeastern Brazil are characterized by the presence of relatively few freshwater fish species and high endemism of this fauna. The objective of this study was to examine whether Brycon spp. occurring in the coastal basins of southeastern Brazil are monophyletic, using cytogenetic data, mitochondrial, and nuclear molecular markers. All the species showed a diploid number of 50 chromosomes, a conserved number within the subfamily Bryconinae. However, the karyotypic formulas were unique to most species, including Brycon devillei (26m+22sm+2st), Brycon ferox (26m+12sm+12st), Brycon insignis (22m+20sm+8st), Brycon opalinus, and Brycon vermelha (24m+20sm+6st), indicating the prevalence of pericentric and paracentric inversions in the chromosomal evolution of these species. All of them had nucleolar organizer regions in the first pair of subtelocentric chromosomes and no equilocal distribution of heterochromatin in the first pair of chromosomes of the karyotype. These two features, not seen in any other Brycon spp. examined to date, indicate that Bryconinae species from the Brazilian southeastern coastal basins, including the monotypic genus Henochilus, are monophyletic. Also, this is the first study that reports NOR location and C-banding patterns as synapomorphies for a Neotropical fish species group. The monophyly was also supported by a phylogenetic analysis of 16S rDNA (16S), cytochrome oxidase subunit I (COI), alpha-myosin (MYH6) genes and S72 intron molecular data. Our results partially corroborate the "Brycon acuminatus" group proposed by Howes in 1982: our proposed clade keeps B. devillei, B. ferox, and B. insignis; but it also includes B. opalinus, B. vermelha, and H. weatlandii whereas it excludes B. nattereri. The phylogeographic unit formed by Bryconinae species in southeastern Brazil reflects the long and isolated paleohydrological history of these coastal basins relative to the continental watersheds.	[Travenzoli, Natalia Martins; Silva, Priscilla Caroline; Santos, Udson; Zanuncio, Jose Cola; Dergam, Jorge Abdala] Univ Fed Vicosa, Dept Biol Anim, Lab Sistemat Mol Beagle, BR-36570000 Vicosa, MG, Brazil; [Oliveira, Claudio] Univ Estadual Paulista UNESP, Inst Biociencias, Dept Morfol, BR-18618970 Botucatu, SP, Brazil	Universidade Federal de Vicosa; Universidade Estadual Paulista	Dergam, JA (corresponding author), Univ Fed Vicosa, Dept Biol Anim, Lab Sistemat Mol Beagle, BR-36570000 Vicosa, MG, Brazil.	jdergam@gmail.com	Fapesp, Biota/F-8655-2017; Oliveira, Claudio/D-7713-2012	Fapesp, Biota/0000-0002-9887-8449; Oliveira, Claudio/0000-0002-7010-8880	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Pesquisa (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Pesquisa (CNPq), and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG).	Abe KT, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-152; Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Albert JS, 2011, MAJOR BIOGEOGRAFIC P, P45; AlmeidaToledo LF, 1996, CARYOLOGIA, V49, P35, DOI 10.1080/00087114.1996.10797348; Artoni RF, 2006, NEOTROP ICHTHYOL, V4, P197, DOI 10.1590/S1679-62252006000200005; Artoni RF, 2009, REV FISH BIOL FISHER, V19, P393, DOI 10.1007/s11160-009-9109-2; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bertollo LAC, 2000, CHROMOSOME RES, V8, P603, DOI 10.1023/A:1009233907558; Bertollo LAC., 1978, BRAZIL J GENET, V1, P103; Bizerril CRSF, 1994, ACTA BIOL LEOPOLDENS, V16, P51; Botero-Botero A, 2011, REV MVZ CORDOBA, V16, P2349; BOYCE TM, 1989, GENETICS, V123, P825; Buckup PA, 2011, BIOGEOGRAPHY NEOTROP; Buckup PA, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P203; Carvalho ML, 2002, GENET MOL BIOL, V25, P49, DOI 10.1590/S1415-47572002000100010; Carvalho T. P., 2007, DARWINIANA, V45, P65; Castro RMC, 2004, COPEIA, P496, DOI 10.1643/CI-03-202R2; Cioffi MD, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-28; Cooke GM, 2007, J FISH BIOL, V71, P132, DOI 10.1111/j.1095-8649.2007.01478.x; Lopez DD, 2008, REV BIOL TROP, V56, P1619; de Barros LC, 2015, ZEBRAFISH, V12, P102, DOI 10.1089/zeb.2014.1030; De Rosa LVS, 2007, Braz. J. Biol., V67, P333, DOI 10.1590/S1519-69842007000200020; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Garcia Caroline, 2005, Neotrop. ichthyol., V3, P285, DOI 10.1590/S1679-62252005000200006; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; Howes G., 1982, Bulletin of the British Museum (Natural History) Zoology, V43, P1; Ingenito LFS, 2007, J BIOGEOGR, V34, P1173, DOI 10.1111/j.1365-2699.2007.01686.x; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jacobina UP, 2009, NEOTROP ICHTHYOL, V7, P617, DOI 10.1590/S1679-62252009000400009; Kavalco KF, 2005, GENETICA, V124, P85, DOI 10.1007/s10709-005-0176-6; Kowsmann RO, 1979, SERIE PROJETO REMAC, V8; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Li CH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-44; Lima F.C.T., 2003, CHECK LIST FRESHWATE, P174; Lima Flavio C.T., 2000, Ichthyological Exploration of Freshwaters, V11, P155; Lucena CAS, 2013, B SOC BRAS ICTIOL, V105, P20; Margarido Vladimir P., 1996, Cytobios, V85, P219; Margarido VP, 1999, GENET MOL BIOL, V22, P357, DOI 10.1590/S1415-47571999000300012; Mariguela TC, 2010, COMP CYTOGENET, V4, P185, DOI 10.3897/compcytogen.v4i2.49; Menezes N.A., 1988, P295; Miller M.A., 2010, P GAT COMP ENV WORKS; Molina WF, 2004, J EXP MAR BIOL ECOL, V309, P109, DOI 10.1016/j.jembe.2004.03.011; Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498; Oliveira Claudio, 2003, Neotrop. ichthyol., V1, P47, DOI 10.1590/S1679-62252003000100005; Oliveira C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-275; Palumbi Stephen R., 1996, P205; Parada S, 2003, ORINOQUIA, V7, P42; Pereira TL, 2013, J BIOGEOGR, V40, P905, DOI 10.1111/jbi.12044; Rambaut A., 2007, TRACER V1 4; Ribeiro AC, 2006, NEOTROP ICHTHYOL, V4, P225, DOI 10.1590/S1679-62252006000200009; Santos U, 2009, J FISH BIOL, V75, P2326, DOI 10.1111/j.1095-8649.2009.02489.x; Sessions SK, 2008, CHROMOSOME RES, V16, P183, DOI 10.1007/s10577-007-1205-3; Hilsdorf AWS, 2008, GENET MOL BIOL, V31, P366; Silva PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042278; Souza IL, 2008, MICRON, V39, P1036, DOI 10.1016/j.micron.2007.09.007; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vicari MR, 2006, GENET MOL BIOL, V29, P621, DOI 10.1590/S1415-47572006000400008; Voltolin TA, 2010, GENETICA, V138, P281, DOI 10.1007/s10709-009-9420-9; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Wasko AP, 2000, GENET MOL BIOL, V23, P135, DOI 10.1590/S1415-47572000000100025; Wasko AP, 2001, GENOME, V44, P893, DOI 10.1139/gen-44-5-893; Weitzman S.H., 1988, P379; White BJ, 2009, GENETICS, V183, P275, DOI 10.1534/genetics.109.105817; Zander R. H., 2004, PHYLOINFORMATICS, V2, P1	70	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137843	10.1371/journal.pone.0137843	http://dx.doi.org/10.1371/journal.pone.0137843			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372558	Green Published, gold, Green Submitted			2022-12-27	WOS:000361604400033
J	Wang, Y; Tang, YY; Wang, JJ				Wang, Yan; Tang, Yi-Yuan; Wang, Jinjun			Cultural Differences in Donation Decision-Making	PLOS ONE			English	Article							PERSPECTIVE; VICTIM; IDENTIFIABILITY; MOTIVATION; PERCEPTION; COGNITION; SYMPATHY; CONTEXT; THOUGHT; IMPACT	Decisions to help those in need are essential for human development and survival. Previous studies have demonstrated the "identified effect", in which one identifiable individual typically invokes stronger feelings of compassion and receives greater aid than statistical victim. However, this preference might be influenced by cultural differences. In the current study, Chinese respondents' ratings of distress and sympathy and their willingness to contribute are greater for a group of sick children than an individual. In the U.S., greater willingness to help and sympathy are elicited by an identified victim in comparison with an unidentified one. The different results may demonstrate the importance of cultural differences when trying to understand people's prosocial behavior.	[Wang, Yan] Dongbei Univ Finance & Econ, Interdisciplinary Ctr Social & Behav Studies, Dalian, Liaoning, Peoples R China; [Tang, Yi-Yuan] Texas Tech Univ, Dept Psychol Sci, Lubbock, TX 79409 USA; [Wang, Jinjun] Dalian Univ Technol, Sch Elect Engn, Dalian, Liaoning, Peoples R China	Dongbei University of Finance & Economics; Texas Tech University System; Texas Tech University; Dalian University of Technology	Tang, YY (corresponding author), Texas Tech Univ, Dept Psychol Sci, Lubbock, TX 79409 USA.	yiyuan.tang@ttu.edu			National Natural Science Foundation of China; Office of Naval Research	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Office of Naval Research(Office of Naval Research)	This research was supported by National Natural Science Foundation of China and the Office of Naval Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett DW, 2004, PERS INDIV DIFFER, V37, P19, DOI 10.1016/j.paid.2003.08.024; Bedford O, 2003, J THEOR SOC BEHAV, V33, P127, DOI 10.1111/1468-5914.00210; Chua HF, 2005, P NATL ACAD SCI USA, V102, P12629, DOI 10.1073/pnas.0506162102; Dworkin Ronald, 1977, TAKING RIGHTS SERIOU; Federici S, 2011, COGN PROCESS, V12, P203, DOI 10.1007/s10339-010-0374-8; Freeman JB, 2013, J EXP SOC PSYCHOL, V49, P206, DOI 10.1016/j.jesp.2012.10.015; Hernandez M, 2001, SOC COGNITION, V19, P269, DOI 10.1521/soco.19.3.269.21468; Jenni KE, 1997, J RISK UNCERTAINTY, V14, P235, DOI 10.1023/A:1007740225484; Kim Y, 2011, COMPUT HUM BEHAV, V27, P365, DOI 10.1016/j.chb.2010.08.015; Kitayama S, 2003, PSYCHOL SCI, V14, P201, DOI 10.1111/1467-9280.02432; Kogut T, 2005, J BEHAV DECIS MAKING, V18, P157, DOI 10.1002/bdm.492; Kogut T, 2005, ORGAN BEHAV HUM DEC, V97, P106, DOI 10.1016/j.obhdp.2005.02.003; Kogut T, 2007, ORGAN BEHAV HUM DEC, V104, P150, DOI 10.1016/j.obhdp.2007.04.006; Kogut T, 2011, J EXP SOC PSYCHOL, V47, P748, DOI 10.1016/j.jesp.2011.02.011; Levine RV, 2001, J CROSS CULT PSYCHOL, V32, P543, DOI 10.1177/0022022101032005002; Loewenstein G, 2007, REV GEN PSYCHOL, V11, P112, DOI 10.1037/1089-2680.11.2.112; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Menon T, 1999, J PERS SOC PSYCHOL, V76, P701, DOI 10.1037/0022-3514.76.5.701; Miller JG, 1998, J EXP SOC PSYCHOL, V34, P443, DOI 10.1006/jesp.1998.1359; Miyamoto Y, 2006, PSYCHOL SCI, V17, P113, DOI 10.1111/j.1467-9280.2006.01673.x; MORRIS MW, 1994, J PERS SOC PSYCHOL, V67, P949, DOI 10.1037/0022-3514.67.6.949; Nisbett RE, 2005, TRENDS COGN SCI, V9, P467, DOI 10.1016/j.tics.2005.08.004; Nisbett RE, 2001, PSYCHOL REV, V108, P291, DOI 10.1037//0033-295X.108.2.291; Nisbett RE, 2003, P NATL ACAD SCI USA, V100, P11163, DOI 10.1073/pnas.1934527100; Peng KP, 1999, AM PSYCHOL, V54, P741, DOI 10.1037/0003-066X.54.9.741; Ritov I, 2011, ORGAN BEHAV HUM DEC, V116, P96, DOI 10.1016/j.obhdp.2011.05.005; Schelling TC, 1968, PROBLEMS PUBLIC EXPE, DOI DOI 10.1037/12069-015; Small DA, 2003, J RISK UNCERTAINTY, V26, P5, DOI 10.1023/A:1022299422219; Small DA, 2007, ORGAN BEHAV HUM DEC, V102, P143, DOI 10.1016/j.obhdp.2006.01.005; Wang Y, 2014, NEUROREPORT, V25, P110, DOI 10.1097/WNR.0000000000000077; Zhang Z., 1998, ASIAN J SOC PSYCHOL, V1, P253, DOI DOI 10.1111/1467-839X.00017	31	4	4	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138219	10.1371/journal.pone.0138219	http://dx.doi.org/10.1371/journal.pone.0138219			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8LR	26372014	Green Submitted, Green Published, gold			2022-12-27	WOS:000361604400058
J	Yang, L; Shi, GF; Zhou, T; Li, Y; Li, Y				Yang, Li; Shi, Gaofeng; Zhou, Tao; Li, Yang; Li, Yong			Quantification of the Iodine Content of Perigastric Adipose Tissue by Dual-Energy CT: A Novel Method for Preoperative Diagnosis of T4-Stage Gastric Cancer	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; ACCURACY	This study investigated the utility of quantifying iodine concentration (IC) in perigastric adipose tissue, using dual-energy computed tomography (DECT), for the detection of T4astage gastric cancer. Fifty-four patients with gastric cancer were enrolled at the Fourth Hospital of Hebei Medical University between January and June 2013. Patients were imaged preoperatively with conventional computed tomography (CT) scans and DECT, and the IC in perigastric fat adjacent to the tumor calculated from arterial phase (AP) and portal venous phase (PVP) images. The patients subsequently received surgical treatment (gastrectomy), and histologic analysis of resected specimens was used as a 'gold standard' reference for cancer staging. Receiver operating characteristic (ROC) curve analysis was employed to assess the utility of DECT for identifying T4a-stage gastric cancer, with optimal IC thresholds determined from the area under the ROC curve (AUC). Postoperative histology revealed that 32 patients had serosal invasion (group A), and 22 did not (group B). The accuracy of conventional CT for distinguishing stage T4 from non-T4 stages was 68.5% (37/54). IC was significantly higher in group A than in group B (AP: 0.60 +/- 0.34 vs. 0.09 +/- 0.19 mg/mL, p < 0.001; PVP: 0.83 +/- 0.41 vs. 0.27 +/- 0.21 mg/mL, p < 0.001). The sensitivity, specificity and AUC for detecting serosal invasion were 77.1%, 79.2% and 0.89 at an IC threshold of 0.25 mg/mL for AP images; and 80.0%, 79.2% and 0.90 at an IC threshold of 0.45 mg/mL for PVP images. These results indicated that Iodine quantification in perigastric fat using DECT is an accurate method for detecting serosal invasion by gastric cancer.	[Yang, Li; Shi, Gaofeng; Li, Yang] Hebei Med Univ, Hosp 4, Dept CT, Shijiazhuang, Hebei Province, Peoples R China; [Zhou, Tao; Li, Yong] Hebei Med Univ, Hosp 4, Dept Surg, Shijiazhuang, Hebei Province, Peoples R China	Hebei Medical University; Hebei Medical University	Shi, GF (corresponding author), Hebei Med Univ, Hosp 4, Dept CT, Shijiazhuang, Hebei Province, Peoples R China.	yangli8008@hotmail.com						Allum WH, 2011, GUT, V60, P1449, DOI 10.1136/gut.2010.228254; Bauer RW, 2011, EUR RADIOL, V21, P2139, DOI 10.1007/s00330-011-2162-y; Catalano V, 2009, CRIT REV ONCOL HEMAT, V71, P127, DOI 10.1016/j.critrevonc.2009.01.004; Edge SB, 2009, AJCC CANC STAGING MA, P648; Ho LM, 2012, AM J ROENTGENOL, V198, P840, DOI 10.2214/AJR.11.7316; Hur J, 2006, J COMPUT ASSIST TOMO, V30, P372, DOI 10.1097/00004728-200605000-00005; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim AY, 2005, ABDOM IMAGING, V30, P465, DOI 10.1007/s00261-004-0273-5; Kim JH, 2012, ABDOM IMAGING, V37, P541, DOI 10.1007/s00261-011-9823-9; Kim YH, 2009, RADIOLOGY, V250, P767, DOI 10.1148/radiol.2502071872; Kumano S, 2005, RADIOLOGY, V237, P961, DOI 10.1148/radiol.2373041380; Li MZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107061; Lin XZ, 2012, EUR J RADIOL, V81, P2487, DOI 10.1016/j.ejrad.2011.10.028; Lv PJ, 2012, EUR RADIOL, V22, P2117, DOI 10.1007/s00330-012-2485-3; Makino T, 2011, SURGERY, V149, P672, DOI 10.1016/j.surg.2010.12.003; Park SR, 2010, ANN SURG, V251, P428, DOI 10.1097/SLA.0b013e3181ca69a7; Schmid-Bindert G, 2012, EUR RADIOL, V22, P93, DOI 10.1007/s00330-011-2230-3; Seevaratnam R, 2012, GASTRIC CANCER, V15, pS3, DOI 10.1007/s10120-011-0069-6; Washington K, 2010, ANN SURG ONCOL, V17, P3077, DOI 10.1245/s10434-010-1362-z; Yang DM, 2007, J COMPUT ASSIST TOMO, V31, P98, DOI 10.1097/01.rct.0000234072.16209.ab	20	9	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0136871	10.1371/journal.pone.0136871	http://dx.doi.org/10.1371/journal.pone.0136871			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372042	Green Published, Green Submitted, gold			2022-12-27	WOS:000361604400008
J	Aguinagalde, L; Corsini, B; Domenech, A; Domenech, M; Camara, J; Ardanuy, C; Garcia, E; Linares, J; Fenoll, A; Yuste, J				Aguinagalde, Leire; Corsini, Bruno; Domenech, Arnau; Domenech, Mirian; Camara, Jordi; Ardanuy, Carmen; Garcia, Ernesto; Linares, Josefina; Fenoll, Asuncion; Yuste, Jose			Emergence of Amoxicillin-Resistant Variants of Spain(9V)-ST156 Pneumococci Expressing Serotype 11A Correlates with Their Ability to Evade the Host Immune Response	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; BIOFILM FORMATION; CONJUGATE VACCINE; CLONES; CHILDREN; DISEASE; IDENTIFICATION; COLONIZATION; PHAGOCYTOSIS; SPREAD	Capsular switching allows pre-existing clones of Streptococcus pneumoniae expressing vaccine serotypes to escape the vaccine-induced immunity by acquisition of capsular genes from pneumococci of a non-vaccine serotype. Here, we have analysed the clonal composition of 492 clinical isolates of serotype 11A causing invasive disease in Spain (2000-2012), and their ability to evade the host immune response. Antibiograms, serotyping and molecular typing were performed. The restriction profiles of pbp2x, pbp1a and pbp2b genes were also analysed. Interaction with the complement components C1q, C3b, C4BP, and factor H was explored whereas opsonophagocytosis assays were performed using a human cell line differentiated to neutrophils. Biofilm formation and the polymorphisms of the major autolysin LytA were evaluated. The main genotypes of the 11A pneumococci were: ST62 (447 isolates, 90.6%), followed by ST6521 (35 isolates, 7.3%) and ST838 (10 isolates, 2.1%). Beta lactam resistant serotype 11A variants of genotypes ST838 and ST6521 closely related to the Spain(9V)-ST156 clone were first detected in 2005. A different pattern of evasion of complement immunity and phagocytosis was observed between genotypes. The emergence of one vaccine escape variant of Spain(9V)-ST156 (ST6521(11A)), showing a high potential to avoid the host immune response, was observed. In addition, isolates of ST6521(11A) showed higher ability to produce biofilms than ST838(11A) or ST62(11A), which may have contributed to the emergence of this PEN-resistant ST6521(11A) genotype in the last few years. The emergence of penicillin-resistant 11A invasive variants of the highly successful ST156 clonal complex merits close monitoring.	[Aguinagalde, Leire; Corsini, Bruno; Fenoll, Asuncion; Yuste, Jose] Inst Salud Carlos III, Ctr Nacl Microbiol, Spanish Pneumococcal Reference Lab, Madrid, Spain; [Domenech, Arnau; Camara, Jordi; Ardanuy, Carmen; Linares, Josefina] Univ Barcelona, Dept Microbiol, IDIBELL, Hosp Univ Bellvitge, Barcelona, Spain; [Domenech, Arnau; Domenech, Mirian; Camara, Jordi; Ardanuy, Carmen; Garcia, Ernesto; Linares, Josefina; Yuste, Jose] CIBERES, Madrid, Spain; [Domenech, Mirian; Garcia, Ernesto] CSIC, Ctr Invest Biol, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Yuste, J (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Spanish Pneumococcal Reference Lab, Madrid, Spain.	jyuste@isciii.es	Ardanuy, Carmen/C-4463-2015; Liñares, Josefina/N-9450-2014; YUSTE, JOSE/ABG-9851-2020; Aguinagalde, Leire/B-2966-2015; Domenech, Mirian/G-2561-2018	Domenech, Arnau/0000-0002-0829-511X; YUSTE, JOSE/0000-0001-7996-0837; Ardanuy, Carmen/0000-0003-0225-607X; Aguinagalde, Leire/0000-0002-4596-8336; Camara, Jordi/0000-0002-0817-0931; Partearroyo Lacaba, Olvido/0000-0002-1692-4481; Domenech, Mirian/0000-0002-0942-8180	Ministerio de Economia y Competitividad (MINECO) [SAF2012-39444-C01/02]; Fondo de Investigaciones Sanitarias de la Seguridad Social [PI11/00763]; FPI fellowship from MINECO; Brazilian Program Ciencia Sem Fronteiras (CsF) from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Fondo de Investigaciones Sanitarias de la Seguridad Social(Instituto de Salud Carlos III); FPI fellowship from MINECO(Spanish Government); Brazilian Program Ciencia Sem Fronteiras (CsF) from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	This work was supported by grants SAF2012-39444-C01/02 from Ministerio de Economia y Competitividad (MINECO) to EG and JY and PI11/00763 from Fondo de Investigaciones Sanitarias de la Seguridad Social to CA and JL. Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES) is an initiative of ISCIII. LA and BC were supported, respectively, by an FPI fellowship from MINECO and a fellowship from the Brazilian Program Ciencia Sem Fronteiras (CsF) from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).	Ardanuy C, 2009, CLIN INFECT DIS, V48, P57, DOI 10.1086/594125; Ardanuy C, 2014, EMERG INFECT DIS, V20, P1848, DOI 10.3201/eid2011.131215; Brown JS, 2002, P NATL ACAD SCI USA, V99, P16969, DOI 10.1073/pnas.012669199; Brueggemann AB, 2003, J CLIN MICROBIOL, V41, P4966, DOI 10.1128/JCM.41.11.4966-4970.2003; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; COFFEY TJ, 1991, MOL MICROBIOL, V5, P2255, DOI 10.1111/j.1365-2958.1991.tb02155.x; Coffey TJ, 1995, MICROB DRUG RESIST, V1, P29, DOI 10.1089/mdr.1995.1.29; de la Campa AG, 2009, EMERG INFECT DIS, V15, P905, DOI 10.3201/eid1506.080684; Domenech M, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0125636, DOI 10.1371/J0URNAL.P0NE.0125636]; Domenech M, 2014, ENVIRON MICROBIOL, V16, P1193, DOI 10.1111/1462-2920.12370; Domenech M, 2013, INFECT IMMUN, V81, P2606, DOI 10.1128/IAI.00491-13; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Farrell DJ, 2005, EMERG INFECT DIS, V11, P851, DOI 10.3201/eid1106.050222; Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517; Fenoll A, 1997, J CLIN MICROBIOL, V35, P764, DOI 10.1128/JCM.35.3.764-766.1997; Fenoll A, 2009, J CLIN MICROBIOL, V47, P1012, DOI 10.1128/JCM.01454-08; Golubchik T, 2012, NAT GENET, V44, P352, DOI 10.1038/ng.1072; Gounder PP, 2014, J INFECT DIS, V209, P1251, DOI 10.1093/infdis/jit642; Hanage WP, 2005, INFECT IMMUN, V73, P431, DOI 10.1128/IAI.73.1.431-435.2005; Henriques-Normark B, 2008, NAT REV MICROBIOL, V6, P827, DOI 10.1038/nrmicro2011; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; O'Brien KL, 2006, LANCET, V368, P1469, DOI 10.1016/S0140-6736(06)69614-1; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Park IH, 2015, CLIN VACCINE IMMUNOL, V22, P313, DOI 10.1128/CVI.00647-14; Porat N, 2004, J INFECT DIS, V190, P2154, DOI 10.1086/425908; Ramos-Sevillano E, 2015, INFECT IMMUN, V83, P591, DOI 10.1128/IAI.02811-14; Ramos-Sevillano E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023626; RomeroSteiner S, 1997, CLIN DIAGN LAB IMMUN, V4, P415, DOI 10.1128/CDLI.4.4.415-422.1997; Sanz JC, 2011, CLIN MICROBIOL INFEC, V17, P1094, DOI 10.1111/j.1469-0691.2011.03495.x; Scott JR, 2012, VACCINE, V30, P2376, DOI 10.1016/j.vaccine.2011.11.004; Sjostrom K, 2007, P NATL ACAD SCI USA, V104, P12907, DOI 10.1073/pnas.0705589104; Stanhope MJ, 2008, INFECT GENET EVOL, V8, P331, DOI 10.1016/j.meegid.2008.02.001; Tarrago D, 2008, CLIN MICROBIOL INFEC, V14, P828, DOI 10.1111/j.1469-0691.2008.02028.x; Tarrago D, 2011, ANTIMICROB AGENTS CH, V55, P2297, DOI 10.1128/AAC.01494-10; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Yuste J, 2008, INFECT IMMUN, V76, P3761, DOI 10.1128/IAI.00291-08; Yuste J, 2010, INFECT IMMUN, V78, P283, DOI 10.1128/IAI.00541-09; zur Wiesch PS, 2010, ANTIMICROB AGENTS CH, V54, P2085, DOI 10.1128/AAC.01460-09	42	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137565	10.1371/journal.pone.0137565	http://dx.doi.org/10.1371/journal.pone.0137565			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368279	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100085
J	Cherel, G; Cottineau, C; Reuillon, R				Cherel, Guillaume; Cottineau, Clementine; Reuillon, Romain			Beyond Corroboration: Strengthening Model Validation by Looking for Unexpected Patterns	PLOS ONE			English	Article							EMPIRICAL VALIDATION; PARAMETER SPACE; SIMULATION; EXPLORATION	Models of emergent phenomena are designed to provide an explanation to global-scale phenomena from local-scale processes. Model validation is commonly done by verifying that the model is able to reproduce the patterns to be explained. We argue that robust validation must not only be based on corroboration, but also on attempting to falsify the model, i.e. making sure that the model behaves soundly for any reasonable input and parameter values. We propose an open-ended evolutionary method based on Novelty Search to look for the diverse patterns a model can produce. The Pattern Space Exploration method was tested on a model of collective motion and compared to three common a priori sampling experiment designs. The method successfully discovered all known qualitatively different kinds of collective motion, and performed much better than the a priori sampling methods. The method was then applied to a case study of city system dynamics to explore the model's predicted values of city hierarchisation and population growth. This case study showed that the method can provide insights on potential predictive scenarios as well as falsifiers of the model when the simulated dynamics are highly unrealistic.	[Cherel, Guillaume; Cottineau, Clementine; Reuillon, Romain] CNRS, Geog Cites, Paris, France; [Cherel, Guillaume; Reuillon, Romain] ISC PIF, Paris, France; [Cottineau, Clementine] UCL, Ctr Adv Spatial Anal, London, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of London; University College London	Cherel, G (corresponding author), Inst Syst Complexes Paris Ile de France, 113 Rue Natl, F-75013 Paris, France.	guillaume.cherel@iscpif.fr		Cottineau, Clementine/0000-0002-2452-3901	ERC [269826]	ERC(European Research Council (ERC)European Commission)	The study was funded by the ERC advanced grant 269826 GeoDiverCity (PI Denise Pumain).	Axtell R., 1996, COMPUT MATH ORGAN TH, V2, P123, DOI DOI 10.1007/BF01299065; Bairoch P., 1985, JERICHO MEXICO VILLE; Callaghan, 2014, COMPLEXITY THEORY SO; Calvez B, 2005, LECT NOTES ARTIF INT, V3684, P633; Castro PD, 2013, CONCURR COMP-PRACT E, V25, P2345, DOI 10.1002/cpe.3097; Ciccone A, 1996, AM ECON REV, V86, P54; Combes PP, 2012, REV LIT ACAD QUANTIF; Cottineau C, 2015, J ARTIFICIA IN PRESS, V18; Cottineau C, 2014, THESIS U PARIS 1 PAN; Czirok A, 1997, J PHYS A-MATH GEN, V30, P1375, DOI 10.1088/0305-4470/30/5/009; Deb K, 2000, COMPUT METHOD APPL M, V186, P311, DOI 10.1016/S0045-7825(99)00389-8; Eiben AE, 1999, IEEE T EVOLUT COMPUT, V3, P124, DOI 10.1109/4235.771166; Gerstner W, 2012, SCIENCE, V338, P60, DOI 10.1126/science.1227356; GOSS S, 1989, NATURWISSENSCHAFTEN, V76, P579, DOI 10.1007/BF00462870; Gramacy R. B., 2004, P 21 INT C MACHINE L, P45, DOI [10.1145/1015330.1015367, DOI 10.1145/1015330.1015367]; Gramacy RB, 2009, TECHNOMETRICS, V51, P130, DOI 10.1198/TECH.2009.0015; Gregoire G, 2003, PHYSICA D, V181, P157, DOI 10.1016/S0167-2789(03)00102-7; Grimm V, 2012, PHILOS T R SOC B, V367, P298, DOI 10.1098/rstb.2011.0180; Hinterding R, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON EVOLUTIONARY COMPUTATION, VOLS 1 AND 2, P384, DOI 10.1109/ICEC.1995.489178; Kleijnen JPC, 2005, INFORMS J COMPUT, V17, P263, DOI 10.1287/ijoc.1050.0136; Lehman J, 2010, P 12 ANN C GENETIC E, P837; Lehman J, 2011, EVOL COMPUT, V19, P189, DOI 10.1162/EVCO_a_00025; Loeuille N, 2010, ECOL LETT, V13, P1536, DOI 10.1111/j.1461-0248.2010.01545.x; Marchionni C, 2013, PHILOS SOC SCI, V43, P323, DOI 10.1177/0048393113488873; MENAUT JC, 1990, J BIOGEOGR, V17, P471, DOI 10.2307/2845379; Miller JH, 1998, MANAGE SCI, V44, P820, DOI 10.1287/mnsc.44.6.820; Moriconi-Ebrard F, 1993, URBANISATION MONDE D; Moss S, 2008, JASSS-J ARTIF SOC S, V11; Pumain D, 2003, GEOCARREFOUR, V78, P25, DOI [10.4000/geocarrefour.75, DOI 10.4000/GE0CARREF0UR.75]; Pumain D., 2006, CYBERGEO EUROPEAN J; Reuillon R, 2013, FUTURE GENER COMP SY, V29, P1981, DOI 10.1016/j.future.2013.05.003; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; Rossiter S, 2010, JASSS-J ARTIF SOC S, V13, DOI 10.18564/jasss.1590; Saltelli A, 2008, GLOBAL SENSITIVITY A, P53; Sanchez SM, 2009, WINT SIMUL C PROC, P60, DOI 10.1109/WSC.2009.5429316; Schelling T., 1978, MICROMOTIVES MACROBE, P137; Schmitt C, 2015, ENVIRON PLANN B, V42, P300, DOI 10.1068/b130064p; Slepukhina I., 2014, THESIS POLITECNICO M; Soo KT, 2005, REG SCI URBAN ECON, V35, P239, DOI 10.1016/j.regsciurbeco.2004.04.004; Spulber D. F., 2007, GLOBAL COMPETITIVE S; Stonedahl Forrest, 2011, Multi-Agent-Based Simulation XI. International Workshop, MABS 2010. Revised Selected Papers, P61, DOI 10.1007/978-3-642-18345-4_5; Stonedahl F., 2010, AAAI FALL S COMPL AD, P120; Terano T, 2007, LECT NOTES ARTIF INT, V4442, P1, DOI 10.1109/ICMECH.2007.4280030; Toner J, 2005, ANN PHYS-NEW YORK, V318, P170, DOI 10.1016/j.aop.2005.04.011; Torrens PM, 2001, CYBERGEO EUROPEAN J, DOI [10.4000/cybergeo.1035, DOI 10.4000/CYBERGEO.1035]; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; WARF B, 1993, TIJDSCHR ECON SOC GE, V84, P162, DOI 10.1111/j.1467-9663.1993.tb00646.x; Wilensky U, 1998, NETLOGO FLOCKING MOD; Wilensky U., 1999, NETLOGO SOFTWARE; Windrum P, 2007, JASSS-J ARTIF SOC S, V10	50	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138212	10.1371/journal.pone.0138212	http://dx.doi.org/10.1371/journal.pone.0138212			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368917	Green Submitted, gold, Green Published			2022-12-27	WOS:000361601100243
J	Devauchelle-Pensec, V; Gottenberg, JE; Jousse-Joulin, S; Berthelot, JM; Perdriger, A; Hachulla, E; Hatron, PY; Puechal, X; Le Guern, V; Sibilia, J; Chiche, L; Goeb, V; Vittecoq, O; Larroche, C; Fauchais, AL; Hayem, G; Morel, J; Zarnitsky, C; Dubost, JJ; Dieude, P; Pers, JO; Cornec, D; Seror, R; Mariette, X; Nowak, E; Saraux, A				Devauchelle-Pensec, Valerie; Gottenberg, Jacques-Eric; Jousse-Joulin, Sandrine; Berthelot, Jean-Marie; Perdriger, Aleth; Hachulla, Eric; Hatron, Pierre Yves; Puechal, Xavier; Le Guern, Veronique; Sibilia, Jean; Chiche, Laurent; Goeb, Vincent; Vittecoq, Olivier; Larroche, Claire; Fauchais, Anne Laure; Hayem, Gilles; Morel, Jacques; Zarnitsky, Charles; Dubost, Jean Jacques; Dieude, Philippe; Pers, Jacques Olivier; Cornec, Divi; Seror, Raphaele; Mariette, Xavier; Nowak, Emmanuel; Saraux, Alain			Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjogren's Syndrome?	PLOS ONE			English	Article							SALIVARY-GLAND ULTRASONOGRAPHY; QUALITY-OF-LIFE; RITUXIMAB TREATMENT; DOUBLE-BLIND; DISEASE-ACTIVITY; CLINICAL-TRIAL; B-CELLS; LYMPHOID ORGANIZATION; THERAPY; CLASSIFICATION	Objective The goal of this study was to determine how the choice of the primary endpoint influenced sample size estimates in randomised controlled trials (RCTs) of treatments for primary Sjogren's syndrome (pSS). Methods We reviewed all studies evaluating biotechnological therapies in pSS to identify their inclusion criteria and primary endpoints. Then, in a large cohort (ASSESS), we determined the proportion of patients who would be included in RCTs using various inclusion criteria sets. Finally, we used the population of a large randomised therapeutic trial in pSS (TEARS) to assess the impact of various primary objectives and endpoints on estimated sample sizes. These analyses were performed only for the endpoints indicating greater efficacy of rituximab compared to the placebo. Results We identified 18 studies. The most common inclusion criteria were short disease duration; systemic involvement; high mean visual analogue scale (VAS) scores for dryness, pain, and fatigue; and biological evidence of activity. In the ASSESS cohort, 35 percent of patients had recent-onset disease (lower than 4 years), 68 percent systemic manifestations, 68 percent high scores on two of three VASs, and 52 percent biological evidence of activity. The primary endpoints associated with the smallest sample sizes (nlower than 200) were a VAS dryness score improvement higher to 20 mm by week 24 or variable improvements (10, 20, or 30 mm) in fatigue VAS by week 6 or 16. For patients with systemic manifestations, the ESSDAI change may be the most logical endpoint, as it reflects all domains of disease activity. However, the ESSDAI did not improve significantly with rituximab therapy in the TEARS study. Ultrasound score improvement produced the smallest sample size estimate in the TEARS study. Conclusion This study provides valuable information for designing future RCTs on the basis of previously published studies. Previous RCTs used inclusion criteria that selected a small part of the entire pSS population. The endpoint was usually based on VASs assessing patient complaints. In contrast to VAS dryness cut-offs, VAS fatigue cut-offs did not affect estimated sample sizes. SGUS improvement produced the smallest estimated sample size. Further studies are required to validate standardised SGUS modalities and assessment criteria. Thus, researchers should strive to develop a composite primary endpoint and to determine its best cut-off and assessment time point.	[Devauchelle-Pensec, Valerie; Jousse-Joulin, Sandrine; Cornec, Divi; Saraux, Alain] CHU Cavale Blanche, Dept Rheumatol, F-29609 Brest, France; [Devauchelle-Pensec, Valerie; Jousse-Joulin, Sandrine; Pers, Jacques Olivier; Cornec, Divi; Saraux, Alain] Univ Bretagne Occidentale, INSERM ESPRI, EA 2216, ERI29, F-29200 Brest, France; [Gottenberg, Jacques-Eric; Sibilia, Jean] Strasbourg Univ Hosp, Dept Rheumatol, Strasbourg, France; [Berthelot, Jean-Marie] CHU Nantes, Dept Rheumatol, Hotel Dieu, F-44093 Nantes 01, France; [Perdriger, Aleth] CHU Hop Sud, Dept Rheumatol, F-35000 Rennes, France; [Hachulla, Eric; Hatron, Pierre Yves] Univ Lille 2, Claude Huriez Hosp, Dept Internal Med, F-59037 Lille, France; [Puechal, Xavier; Le Guern, Veronique] Hop Cochin, Dept Internal Med, F-75674 Paris, France; [Chiche, Laurent] Hop Conception, Dept Internal Med, F-13005 Marseille, France; [Goeb, Vincent] CHRU Amiens, Dept Rheumatol, F-76230 Bois Guillaume, France; [Vittecoq, Olivier] CHRU Rouen, Dept Rheumatol, F-76230 Bois Guillaume, France; [Larroche, Claire] Bobigny Univ Hosp, Dept Internal Med, Paris, France; [Fauchais, Anne Laure] Limoges Univ Hosp, Dept Internal Med, Limoges, France; [Hayem, Gilles] Ambroise Pare Univ Hosp, Dept Rheumatol, Paris, France; [Morel, Jacques] CHU Lapeyronie, Immunorhumatol Dept, F-34295 Montpellier, France; [Zarnitsky, Charles] CHJ Monod, Dept Rheumatol, Montivilliers, France; [Dubost, Jean Jacques] Gabriel Montpied Teaching Hosp, Dept Rheumatol, F-63000 Clermont Ferrand, France; [Dieude, Philippe] Bichat Claude Bernard Hosp, Dept Rheumatol, Paris, France; [Seror, Raphaele; Mariette, Xavier] Univ Paris 11, Dept Rheumatol, INSERM, AP HP,U1012, F-94275 Le Kremlin Bicetre, France; [Nowak, Emmanuel] CHU Brest, INSERM, CIC 0502, F-29285 Brest, France	CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Nantes Universite; CHU de Nantes; CHU Rennes; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; CHU Limoges; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Universite de Montpellier; CHU de Montpellier; CHU Clermont Ferrand; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale	Saraux, A (corresponding author), CHU Cavale Blanche, Dept Rheumatol, Blvd Tanguy Prigent, F-29609 Brest, France.	alain.saraux@chu-brest.fr	HACHULLA, ERIC/R-8488-2018; SEROR, Raphaele/E-2283-2017; Puechal, Xavier/P-1555-2017	HACHULLA, ERIC/0000-0001-7432-847X; SEROR, Raphaele/0000-0002-5523-1856; Goeb, Vincent/0000-0002-3807-545X; Sibilia, Jean/0000-0002-1601-4795; Puechal, Xavier/0000-0003-3573-9203; Fauchais, Anne Laure/0000-0002-0489-8570; Dieude, Philippe/0000-0002-4814-0307	French Ministry of Health (Programme Hospitalier de Recherche Clinique)	French Ministry of Health (Programme Hospitalier de Recherche Clinique)	This work was supported by grants from the French Ministry of Health (Programme Hospitalier de Recherche Clinique) awarded in 2005 and 2010 to both the ASSESS national cohort and the TEARS study. Roche donated the rituximab used in the TEARS study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boers M, 2014, J RHEUMATOL, V41, P1025, DOI 10.3899/jrheum.131314; Bombardieri M, 2011, ANN RHEUM DIS, V70, P1857, DOI 10.1136/ard.2011.150219; Bowman SJ, 2004, RHEUMATOLOGY, V43, P758, DOI 10.1093/rheumatology/keh170; Brown S, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-21; Carubbi F, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4359; Champey J, 2006, ARTHRIT RHEUM-ARTHR, V55, P451, DOI 10.1002/art.21990; Cornec D, 2015, RHEUMATOLOGY OXFORD; Cornec D, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2014-206860; Cornec D, 2013, ARTHRITIS RHEUM-US, V65, P216, DOI [10.1002/art.37698, 10.1002/art.37944]; Daridon C, 2006, ARTHRITIS RHEUM-US, V54, P2280, DOI 10.1002/art.21936; Dass S, 2008, ANN RHEUM DIS, V67, P1541, DOI 10.1136/ard.2007.083865; Devauchelle-Pensec V, 2011, CLIN EXP RHEUMATOL, V29, P6; Devauchelle-Pensec V, 2008, REV MED INTERNE, V29, P967, DOI 10.1016/j.revmed.2008.02.022; Devauchelle-Pensec V, 2007, ARTHRIT RHEUM-ARTHR, V57, P310, DOI 10.1002/art.22536; Devauchelle-Pensec V, 2014, ANN INTERN MED, V160, P233, DOI 10.7326/M13-1085; FLEISS, 1981, STAT METHODS RATES P; Gottenberg JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059868; Guellec D, 2013, AUTOIMMUN REV, V12, P416, DOI 10.1016/j.autrev.2012.08.001; Jonsson MV, 2005, J CLIN IMMUNOL, V25, P189, DOI 10.1007/s10875-005-4091-5; Jousse-Joulin S, 2015, ARTHRITIS RHEUMATOL; Jousse-Joulin S, 2013, ULTRASOUND MED BIOL, V39, P2485, DOI 10.1016/j.ultrasmedbio.2013.05.013; Kirwan JR, 2014, J RHEUMATOL, V41, P1011, DOI 10.3899/jrheum.131312; Le Pottier L, 2009, J IMMUNOL, V182, P3540, DOI 10.4049/jimmunol.0803588; Lee SY, 2013, AM J OPHTHALMOL, V156, P247, DOI 10.1016/j.ajo.2013.04.003; Mariette X, 2004, ARTHRITIS RHEUM, V50, P1270, DOI 10.1002/art.20146; Mariette X, 2015, ANN RHEUM DIS, V74, P526, DOI 10.1136/annrheumdis-2013-203991; Meijer JM, 2010, ARTHRITIS RHEUM-US, V62, P960, DOI 10.1002/art.27314; Meiners PM, 2014, ANN RHEUM DIS, V73, P1393, DOI 10.1136/annrheumdis-2013-204653; Meiners PM, 2012, ANN RHEUM DIS, V71, P1297, DOI 10.1136/annrheumdis-2011-200460; Moerman RV, 2014, ANN RHEUM DIS, V73, P472, DOI 10.1136/annrheumdis-2013-203736; Norheim KB, 2012, PLOS ONE, V7, P429, DOI 10.1371/journal.pone.0030123; Pijpe J, 2005, ARTHRITIS RHEUM-US, V52, P2740, DOI 10.1002/art.21260; Ramos-Casals M, 2010, JAMA-J AM MED ASSOC, V304, P452, DOI 10.1001/jama.2010.1014; Ray A, 2012, J IMMUNOL, V188, P3188, DOI 10.4049/jimmunol.1103354; Sankar V, 2004, ARTHRITIS RHEUM-US, V50, P2240, DOI 10.1002/art.20299; Saraux A, 2014, ANN INTERN MED, V161, P377, DOI 10.7326/L14-5017-4; Seror R, 2011, ANN RHEUM DIS, V70, P968, DOI 10.1136/ard.2010.143743; Seror R, 2010, ANN RHEUM DIS, V69, P1103, DOI 10.1136/ard.2009.110619; St Clair EW, 2013, ARTHRITIS RHEUM-US, V65, P1097, DOI 10.1002/art.37850; Steinfeld SD, 2001, ARTHRITIS RHEUM, V44, P2371, DOI 10.1002/1529-0131(200110)44:10<2371::AID-ART401>3.0.CO;2-W; Steinfeld SD, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2018; Steinfeld SD, 2013, ARTHRITIS RHEUM-US, V65, P814, DOI 10.1002/art.37874; Theander E, 2011, ANN RHEUM DIS, V70, P1363, DOI 10.1136/ard.2010.144782; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Vitali C, 2013, ARTHRITIS RHEUM-US, V65, P1950, DOI 10.1002/art.37945; Voulgarelis M, 2012, MEDICINE, V91, P1, DOI 10.1097/MD.0b013e31824125e4; Zandbelt MM, 2004, J RHEUMATOL, V31, P96	47	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0133907	10.1371/journal.pone.0133907	http://dx.doi.org/10.1371/journal.pone.0133907			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368934	Green Submitted, gold, Green Published			2022-12-27	WOS:000361601100005
J	Gruber, T; Balbach, J				Gruber, Tobias; Balbach, Jochen			Protein Folding Mechanism of the Dimeric AmphiphysinII/Bin1 N-BAR Domain	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; PROLYL ISOMERIZATION; MEMBRANE CURVATURE; ENERGY LANDSCAPES; CRYSTAL-STRUCTURE; ON-PATHWAY; INTERMEDIATE; ASSOCIATION; STABILITY; KINETICS	The human AmphyphisinII/Bin1 N-BAR domain belongs to the BAR domain superfamily, whose members sense and generate membrane curvatures. The N-BAR domain is a 57 kDa homodimeric protein comprising a six helix bundle. Here we report the protein folding mechanism of this protein as a representative of this protein superfamily. The concentration dependent thermodynamic stability was studied by urea equilibrium transition curves followed by fluorescence and far-UV CD spectroscopy. Kinetic unfolding and refolding experiments, including rapid double and triple mixing techniques, allowed to unravel the complex folding behavior of N-BAR. The equilibrium unfolding transition curve can be described by a two-state process, while the folding kinetics show four refolding phases, an additional burst reaction and two unfolding phases. All fast refolding phases show a rollover in the chevron plot but only one of these phases depends on the protein concentration reporting the dimerization step. Secondary structure formation occurs during the three fast refolding phases. The slowest phase can be assigned to a proline isomerization. All kinetic experiments were also followed by fluorescence anisotropy detection to verify the assignment of the dimerization step to the respective folding phase. Based on these experiments we propose for NBAR two parallel folding pathways towards the homodimeric native state depending on the proline conformation in the unfolded state.	[Gruber, Tobias; Balbach, Jochen] Univ Halle Wittenberg, Inst Phys, D-06120 Halle, Germany	Martin Luther University Halle Wittenberg	Balbach, J (corresponding author), Univ Halle Wittenberg, Inst Phys, Betty Heimann Str 7, D-06120 Halle, Germany.	jochen.balbach@physik.uni-halle.de			Deutsche Forschungsgemeinschaft [BA 1821/5-2]; Bundesministerium fur Forschung un Bildung (ZIK HALOMem); European Regional Development Fund; State Saxony-Anhalt	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Forschung un Bildung (ZIK HALOMem); European Regional Development Fund(European Commission); State Saxony-Anhalt	This work was supported by Deutsche Forschungsgemeinschaft (BA 1821/5-2) (www.dfg.de) (TG and JB); Bundesministerium fur Forschung un Bildung (ZIK HALOMem) (http://www.unternehmen-region.de/de/350.php) (JB); European Regional Development Fund (http://www.foerderdatenbank.de) (JB); and State Saxony-Anhalt (http://www.exzellenznetzwerk-biowissenschaften.uni-halle.de/) (TG and JB).	Bachmann A, 2002, BIOPHYS CHEM, V96, P141, DOI 10.1016/S0301-4622(02)00020-0; Bachmann A, 2005, PROTEIN FOLDING HANDBOOK, P379; Baldwin RL, 1996, FOLD DES, V1, pR1, DOI 10.1016/S1359-0278(96)00003-X; Beitlich T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078384; Bollen YJM, 2004, BIOCHEMISTRY-US, V43, P10475, DOI 10.1021/bi049545m; BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026; Brockwell DJ, 2007, CURR OPIN STRUC BIOL, V17, P30, DOI 10.1016/j.sbi.2007.01.003; Casal E, 2006, BIOCHEMISTRY-US, V45, P12917, DOI 10.1021/bi060717k; CHAZIN WJ, 1989, P NATL ACAD SCI USA, V86, P2195, DOI 10.1073/pnas.86.7.2195; DeVries I, 2011, J MOL BIOL, V408, P163, DOI 10.1016/j.jmb.2011.02.021; Dill KA, 2007, CURR OPIN STRUC BIOL, V17, P342, DOI 10.1016/j.sbi.2007.06.001; Doyle SM, 2004, J MOL BIOL, V341, P199, DOI 10.1016/j.jmb.2004.06.021; Feige MJ, 2010, TRENDS BIOCHEM SCI, V35, P189, DOI 10.1016/j.tibs.2009.11.005; Ferguson N, 1999, J MOL BIOL, V286, P1597, DOI 10.1006/jmbi.1998.2548; Fernandes FM, 2008, BIOPHYS J IN PRESS; Fersht AR, 2002, CELL, V108, P573, DOI 10.1016/S0092-8674(02)00620-7; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Gloss LM, 2001, J MOL BIOL, V312, P1121, DOI 10.1006/jmbi.2001.4974; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; GRANT SK, 1992, BIOCHEMISTRY-US, V31, P9491, DOI 10.1021/bi00154a023; Guthe S, 2004, J MOL BIOL, V337, P905, DOI 10.1016/j.jmb.2004.02.020; Jakob RP, 2009, J MOL BIOL, V387, P1017, DOI 10.1016/j.jmb.2009.02.021; Jao CC, 2010, J BIOL CHEM, V285, P20164, DOI 10.1074/jbc.M110.127811; Krantz BA, 2002, J MOL BIOL, V324, P359, DOI 10.1016/S0022-2836(02)01029-X; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Lorenz T, 2008, J MOL BIOL, V381, P443, DOI 10.1016/j.jmb.2008.06.001; Low C, 2008, BIOPHYS J, V95, P4315, DOI 10.1529/biophysj.108.134155; Mallam AL, 2006, J MOL BIOL, V359, P1420, DOI 10.1016/j.jmb.2006.04.032; Martin A, 2003, J MOL BIOL, V331, P1131, DOI 10.1016/S0022-2836(03)00864-7; Masuda M, 2010, SEMIN CELL DEV BIOL, V21, P391, DOI 10.1016/j.semcdb.2010.01.010; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; MILLA ME, 1994, BIOCHEMISTRY-US, V33, P1125, DOI 10.1021/bi00171a011; Mok YK, 1996, NAT STRUCT BIOL, V3, P711, DOI 10.1038/nsb0896-711; Mukaiyama A, 2013, J MOL BIOL, V425, P257, DOI 10.1016/j.jmb.2012.11.004; Najera H, 2003, BIOCHEM J, V370, P785, DOI 10.1042/BJ20021439; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Placek BJ, 2005, J MOL BIOL, V345, P827, DOI 10.1016/j.jmb.2004.11.006; Qualmann B, 2011, EMBO J, V30, P3501, DOI 10.1038/emboj.2011.266; Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770; Rumfeldt JAO, 2008, PROG BIOPHYS MOL BIO, V98, P61, DOI 10.1016/j.pbiomolbio.2008.05.004; Sanchez IE, 2003, J MOL BIOL, V325, P367, DOI 10.1016/S0022-2836(02)01230-5; Schmid F X, 1986, Methods Enzymol, V131, P70; Schmid F, 2005, PROTEIN FOLDING HANDBOOK, P916, DOI 10.1002/9783527619498.ch25; Schmid Franz X., 1992, P197; SCHMID FX, 1983, BIOCHEMISTRY-US, V22, P4690, DOI 10.1021/bi00289a013; Schulenburg C, 2009, BIOCHEMISTRY-US, V48, P8449, DOI 10.1021/bi900596j; STARK GR, 1965, BIOCHEMISTRY-US, V4, P1030, DOI 10.1021/bi00882a008; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Thies MJW, 1999, J MOL BIOL, V293, P67, DOI 10.1006/jmbi.1999.3128; Topping TB, 2004, J MOL BIOL, V342, P247, DOI 10.1016/j.jmb.2004.07.045; Topping TB, 2004, J MOL BIOL, V335, P1065, DOI 10.1016/j.jmb.2003.11.013; VIGUERA AR, 1994, BIOCHEMISTRY-US, V33, P2142, DOI 10.1021/bi00174a022; WARREN JR, 1966, J PHYS CHEM-US, V70, P297, DOI 10.1021/j100873a507; Weininger U, 2009, P NATL ACAD SCI USA, V106, P12335, DOI 10.1073/pnas.0902102106; Weissenhorn W, 2005, J MOL BIOL, V351, P653, DOI 10.1016/j.jmb.2005.06.013; Wigge P, 1998, TRENDS NEUROSCI, V21, P339, DOI 10.1016/S0166-2236(98)01264-8; Wildegger G, 1997, J MOL BIOL, V270, P294, DOI 10.1006/jmbi.1997.1030; Zeeb M, 2004, J MOL BIOL, V336, P227, DOI 10.1016/j.jmb.2003.12.003	58	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136922	10.1371/journal.pone.0136922	http://dx.doi.org/10.1371/journal.pone.0136922			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368922	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100033
J	Zhang, YJ; Zhang, SY; Yang, J; Yan, Y; Fu, XP; Lu, SB				Zhang, Yan-Jie; Zhang, Su-Yan; Yang, Jie; Yan, Yue; Fu, Xiang-ping; Lu, Shun-Bao			Patterns and Drivers of Soil Respiration under Long-Term Citrus reticulate in Southern China	PLOS ONE			English	Article							MICROBIAL BIOMASS; CARBON-CYCLE; LAND; ORCHARD; AREA; DECOMPOSITION; TERRESTRIAL; FERTILITY; PROVINCE; FORESTS	Soil respiration (Rs) is a major source of carbon emission in terrestrial ecosystems. Despite the fact that the influence of land use practice on Rs has been widely studied, the patterns and drivers on Rs of Citrus reticulata cultivation, a worldwide land use practice are unclear. In this current study, we investigated the influence of long-term cultivation of Citrus reticulata (CO) and of CO intercropped with soybean (CB) on soil nutrients, water availability, and Rs in southern China. Results indicated that after 21 years of cultivation, CO and CB significantly increased total soil carbon (TC), total soil nitrogen (TN), and soil organic matter (OM) at 0-20 cm and 20-40 cm, both at upslope and downslope compared with bare soil (CK). However, soil moisture (SM), dissolved organic carbon (DOC), and microbial biomass carbon (MBC) decreased under CB. In addition, no significant variation was found in soil pH between CK, CO, and CB. Across incubation time (56 days), Rs decreased exponentially with incubation time and CB showed the highest Rs rate irrespective of soil depth or topography. Linear regression further showed TC and TN as the two major factors influencing Rs upslope, while DOC was the dominant factor in regulating Rs downslope. These findings demonstrated that long-term cultivation of citrus significantly changed soil nutrients, water availability, and Rs rate.	[Zhang, Yan-Jie; Zhang, Su-Yan; Yan, Yue; Lu, Shun-Bao] Jiangxi Normal Univ, Coll Life Sci, Key Lab Protect & Utilizat Subtrop Plant Resource, Minist Educ,Key Lab Poyang Lake Wetland & Watersh, Nanchang 330022, Peoples R China; [Yang, Jie] Jiangxi Res Inst Soil & Water Conservat, Nanchang 330029, Peoples R China; [Fu, Xiang-ping] Jiangxi Agr Univ, Coll Foreign Languages, Nanchang 330022, Peoples R China	Jiangxi Normal University; Jiangxi Agricultural University	Lu, SB (corresponding author), Jiangxi Normal Univ, Coll Life Sci, Key Lab Protect & Utilizat Subtrop Plant Resource, Minist Educ,Key Lab Poyang Lake Wetland & Watersh, Nanchang 330022, Peoples R China.	luxunbao8012@126.com			National Natural Science Foundation of China [31360136]; China Postdoctoral Science Foundation [2013M541080, 2014T70139]; open foundation of Jiangxi Province Key Lab of Protection and Utilization of Subtropical Plant Resources, Key Laboratory of Poyang Lake Wetland and Watershed Research, Ministry of Education, Jiangxi Normal University [PK2014002]; Jiangxi Research Institute for Soil and Water Conservation [201105]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); open foundation of Jiangxi Province Key Lab of Protection and Utilization of Subtropical Plant Resources, Key Laboratory of Poyang Lake Wetland and Watershed Research, Ministry of Education, Jiangxi Normal University; Jiangxi Research Institute for Soil and Water Conservation	This work was funded by The work has been funded by National Natural Science Foundation of China (31360136), China Postdoctoral Science Foundation (2013M541080 and 2014T70139), open foundation of Jiangxi Province Key Lab of Protection and Utilization of Subtropical Plant Resources, Key Laboratory of Poyang Lake Wetland and Watershed Research, Ministry of Education (PK2014002), Jiangxi Normal University and Jiangxi Research Institute for Soil and Water Conservation (201105).	Allen AS, 2004, SOIL BIOL BIOCHEM, V36, P581, DOI 10.1016/j.soilbio.2003.12.002; China NBoSo, 2006, STAT CHIN AGR 1949 2; China Soil Census Office, 1998, CHIN SOIL; Ekblad A, 2002, PLANT SOIL, V242, P115, DOI 10.1023/A:1019698108838; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; [韩庆忠 HAN Qingzhong], 2008, [土壤, Soils], V40, P602; Iqbal J, 2010, AGR ECOSYST ENVIRON, V137, P294, DOI 10.1016/j.agee.2010.02.015; Li YL, 2008, PEDOSPHERE, V18, P273, DOI 10.1016/S1002-0160(08)60017-X; [林清山 Lin Qingshan], 2010, [生态学报, Acta Ecologica Sinica], V30, P309; Liu H, 2008, AGR ECOSYST ENVIRON, V124, P125, DOI 10.1016/j.agee.2007.09.002; Loecke TD, 2009, SOIL BIOL BIOCHEM, V41, P228, DOI 10.1016/j.soilbio.2008.10.017; Lu SB, 2012, GEODERMA, V170, P136, DOI 10.1016/j.geoderma.2011.11.023; Luo XX, 2015, CROP RES, V29, P284; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Postgate J., 1998, NITROGEN FIXATION; Raizada A, 2013, TROP ECOL, V54, P251; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Sheng H, 2010, GLOBAL CHANGE BIOL, V16, P1107, DOI 10.1111/j.1365-2486.2009.01988.x; Soil Survey Staff, 1975, HANDBOOK; Srivastava AK, 2002, J SUSTAIN AGR, V19, P5, DOI 10.1300/J064v19n03_03; Wang Chao, 2012, Yingyong Shengtai Xuebao, V23, P1469; Wu DM, 2011, PEDOSPHERE, V21, P782, DOI 10.1016/S1002-0160(11)60182-3; Wu Zhi-dan, 2010, Journal of Ecology and Rural Environment, V26, P231; Xu LK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002281; Yang Jie, 2012, Yingyong Shengtai Xuebao, V23, P468; ZHANG Ting, 2013, J JIANGXI NORMAL U N, V37, P93	26	0	0	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137574	10.1371/journal.pone.0137574	http://dx.doi.org/10.1371/journal.pone.0137574			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368561	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100087
J	Aires, RF; Oliveira, GA; Oliveira, TF; Res, AFH; Oliveira, RF				Aires, Rui F.; Oliveira, Goncalo A.; Oliveira, Tania F.; Res, Albert F. H.; Oliveira, Rui F.			Dear Enemies Elicit Lower Androgen Responses to Territorial Challenges than Unfamiliar Intruders in a Cichlid Fish	PLOS ONE			English	Article							OREOCHROMIS-MOSSAMBICUS; SOCIAL MODULATION; NEIGHBORS; STRANGERS; STEROIDS; RECOGNITION; ATTRITION; BEHAVIOR; PLASMA; PETERS	In many territorial species androgen hormones are known to increase in response to territorial intrusions as a way to adjust the expression of androgen-dependent behaviour to social challenges. The dear enemy effect has also been described in territorial species and posits that resident individuals show a more aggressive response to intrusions by strangers than by other territorial neighbours. Therefore, we hypothesized that the dear enemy effect may also modulate the androgen response to a territorial intrusion. Here we tested this hypothesis in male cichlid fish (Mozambique tilapia, Oreochromis mossambicus) using a paradigm of four repeated territorial intrusions, either by the same neighbour or by four different unfamiliar intruders. Neighbour intruders elicited lower aggression and a weaker androgen response than strangers on the first intrusion of the experiment. With repeated intrusions, the agonistic behaviour of the resident males against familiar intruders was similar to that displayed towards strangers. By the fourth intrusion the androgen response was significantly reduced and there was no longer a difference between the responses to the two types of intruders. These results suggest that the dear enemy effect modulates the androgen response to territorial intrusions and that repeated intrusions lead to a habituation of the androgen response.	[Aires, Rui F.; Oliveira, Goncalo A.; Oliveira, Tania F.; Res, Albert F. H.; Oliveira, Rui F.] ISPA Inst Univ, Lisbon, Portugal; [Oliveira, Goncalo A.; Oliveira, Rui F.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Oliveira, Rui F.] Champalimaud Fdn, Lisbon, Portugal	Instituto Superior Psicologia Aplicada (ISPA); Instituto Gulbenkian de Ciencia; Fundacao Champalimaud	Oliveira, RF (corresponding author), ISPA Inst Univ, Lisbon, Portugal.	ruiol@ispa.pt	Oliveira, Rui/A-3581-2013; Ros, Albert FH/I-7726-2015; Oliveira, Tania F./W-1153-2018	Oliveira, Rui/0000-0003-1528-618X; Ros, Albert FH/0000-0003-3241-9722; Oliveira, Tania F./0000-0002-4724-6935; Oliveira, Goncalo/0000-0002-6462-0546	Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) [SFRH/BD/68528/2010, SFRH/BD/36746/2007]; FCT [EXCL/BIA-ANM/0549/2012]; Fundação para a Ciência e a Tecnologia [EXCL/BIA-ANM/0549/2012] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	GAO and TFO were supported by doctoral fellowships (SFRH/BD/68528/2010 and SFRH/BD/36746/2007, respectively) from Fundacao para a Ciencia e a Tecnologia (FCT, Portugal). This research was funded by the FCT grant EXCL/BIA-ANM/0549/2012 awarded to RFO.	Akcay C, 2009, ANIM BEHAV, V78, P97, DOI 10.1016/j.anbehav.2009.03.023; Almeida O, 2014, HORM BEHAV, V66, P369, DOI 10.1016/j.yhbeh.2014.05.007; [Anonymous], 2012, ANIM BEHAV, V83, P301, DOI 10.1016/j.anbehav.2011.10.031; Antunes RA, 2009, P NATL ACAD SCI USA, V106, P15985, DOI 10.1073/pnas.0900817106; Baerends G.P., 1950, BEHAVIOUR          S, V1, P1; Booksmythe I, 2010, ANIM BEHAV, V79, P419, DOI 10.1016/j.anbehav.2009.11.020; BORG B, 1994, COMP BIOCHEM PHYS C, V109, P219, DOI 10.1016/0742-8413(94)00063-G; Brandt Yoni, 1999, Animal Behaviour Forum, V57, pF13, DOI 10.1006/anbe.1998.1073; Briefer E, 2008, ANIM BEHAV, V76, P1319, DOI 10.1016/j.anbehav.2008.06.017; BRONSTEIN PM, 1994, J COMP PSYCHOL, V108, P45, DOI 10.1037/0735-7036.108.1.45; BRUTON MN, 1975, J FISH BIOL, V7, P423, DOI 10.1111/j.1095-8649.1975.tb04618.x; Carazo P, 2008, ANIM BEHAV, V76, P1953, DOI 10.1016/j.anbehav.2008.08.018; Frostman P, 2004, ICHTHYOL RES, V51, P283, DOI 10.1007/s10228-004-0223-9; Galhardo L, 2008, ANIM WELFARE, V17, P239; GETTY T, 1989, ANIM BEHAV, V37, P337, DOI 10.1016/0003-3472(89)90125-5; Goncalves DM, 2011, HORMONES AND REPRODUCTION OF VERTEBRATES, VOL 1: FISHES, P119; Hirschenhauser K, 2006, ANIM BEHAV, V71, P265, DOI 10.1016/j.anbehav.2005.04.014; Leiser JK, 1999, BEHAVIOUR, V136, P983, DOI 10.1163/156853999501685; Leiser JK, 2003, ANIM BEHAV, V65, P453, DOI 10.1006/anbe.2003.2087; Monclus R, 2014, BEHAV PROCESS, V106, P17, DOI 10.1016/j.beproc.2014.04.004; Neat FC, 1998, ANIM BEHAV, V55, P883, DOI 10.1006/anbe.1997.0669; NEIL E. H., 1964, UNIV CALIF PUBLICATIONS ZOOL, V75, P1; Nelson CM, 1995, ANIM BEHAV, V50, P1587, DOI 10.1016/0003-3472(95)80013-1; Oliveira GA, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00209; Oliveira R. F., 2001, NATURE, V409, P2001, DOI DOI 10.1038/35054128; Oliveira RF, 1996, HORM BEHAV, V30, P2, DOI 10.1006/hbeh.1996.0002; Oliveira RF, 1998, P ROY SOC B-BIOL SCI, V265, P1045, DOI 10.1098/rspb.1998.0397; Oliveira RF, 1998, J FISH BIOL, V52, P1115, DOI 10.1111/j.1095-8649.1998.tb00959.x; Oliveira RF, 2009, INTEGR COMP BIOL, V49, P423, DOI 10.1093/icb/icp055; Oliveira RF, 2009, P ROY SOC B-BIOL SCI, V276, P2249, DOI 10.1098/rspb.2009.0132; Owen PC, 1998, BEHAV ECOL SOCIOBIOL, V44, P209, DOI 10.1007/s002650050533; Oyegbile TO, 2005, HORM BEHAV, V48, P259, DOI 10.1016/j.yhbeh.2005.04.007; Parker G.A., 1984, BEHAVIOURAL ECOLOGY, P30; Rocha MJ, 1996, COMP BIOCHEM PHYS C, V115, P257, DOI 10.1016/S0742-8413(96)00133-8; SCOTT AP, 1989, GEN COMP ENDOCR, V73, P46, DOI 10.1016/0016-6480(89)90054-3; SCOTT AP, 1994, GEN COMP ENDOCR, V96, P309, DOI 10.1006/gcen.1994.1186; TEMELES EJ, 1994, ANIM BEHAV, V47, P339, DOI 10.1006/anbe.1994.1047; TEMELES EJ, 1990, BEHAV ECOL SOCIOBIOL, V26, P57; TURNER GF, 1986, J FISH BIOL, V29, P573, DOI 10.1111/j.1095-8649.1986.tb04974.x; YDENBERG RC, 1988, ANIM BEHAV, V36, P343, DOI 10.1016/S0003-3472(88)80004-6	40	15	15	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137705	10.1371/journal.pone.0137705	http://dx.doi.org/10.1371/journal.pone.0137705			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379045	Green Submitted, Green Published, gold			2022-12-27	WOS:000361769400023
J	Choi, SO; Jeon, HS; Hyon, JY; Oh, YJ; Wee, WR; Chung, TY; Shin, YJ; Kim, JW				Choi, Sang Ouk; Jeon, Hyun Sun; Hyon, Joon Young; Oh, Yun-Jung; Wee, Won Ryang; Chung, Tae-Young; Shin, Young Joo; Kim, Jeong Won			Recovery of Corneal Endothelial Cells from Periphery after Injury	PLOS ONE			English	Article							BULLOUS KERATOPATHY; REGENERATION; TISSUE; KERATOPLASTY; CAPACITY	Background Wound healing of the endothelium occurs through cell enlargement and migration. However, the peripheral corneal endothelium may act as a cell resource for the recovery of corneal endothelium in endothelial injury. Aim To investigate the recovery process of corneal endothelial cells (CECs) from corneal endothelial injury. Methods Three patients with unilateral chemical eye injuries, and 15 rabbit eyes with corneal endothelial chemical injuries were studied. Slit lamp examination, specular microscopy, and ultrasound pachymetry were performed immediately after chemical injury and 1, 3, 6, and 9 months later. The anterior chambers of eyes from New Zealand white rabbits were injected with 0.1 mL of 0.05 N NaOH for 10 min (NaOH group). Corneal edema was evaluated at day 1, 7, and 14. Vital staining was performed using alizarin red and trypan blue. Results Specular microscopy did not reveal any corneal endothelial cells immediately after injury. Corneal edema subsided from the periphery to the center, CEC density increased, and central corneal thickness decreased over time. In the animal study, corneal edema was greater in the NaOH group compared to the control at both day 1 and day 7. At day 1, no CECs were detected at the center and periphery of the corneas in the NaOH group. Two weeks after injury, small, hexagonal CECs were detected in peripheral cornea, while CECs in mid-periphery were large and non-hexagonal. Conclusions CECs migrated from the periphery to the center of the cornea after endothelial injury. The peripheral corneal endothelium may act as a cell resource for the recovery of corneal endothelium.	[Choi, Sang Ouk; Shin, Young Joo] Hallym Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Jeon, Hyun Sun; Hyon, Joon Young; Oh, Yun-Jung] Seoul Natl Univ, Bundang Hosp, Dept Ophthalmol, Songnam, Gyeonggi, South Korea; [Hyon, Joon Young; Wee, Won Ryang] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Chung, Tae-Young] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea; [Kim, Jeong Won] Hallym Univ, Coll Med, Dept Pathol, Seoul, South Korea	Hallym University; Seoul National University (SNU); Seoul National University (SNU); Sungkyunkwan University (SKKU); Samsung Medical Center; Hallym University	Shin, YJ (corresponding author), Hallym Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.	schinn@hanmail.net		Hyon, Joon Young/0000-0003-3620-1536	National Research Foundation (NRF) - Korea government [2012R1A1A2040118]; Hallym University Research Fund	National Research Foundation (NRF) - Korea government; Hallym University Research Fund	This study was supported by the National Research Foundation (NRF) grant (2012R1A1A2040118) funded by the Korea government and Hallym University Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bredow L, 2014, OPHTHALMIC RES, V52, P60, DOI 10.1159/000360739; Bredow L, 2014, MOL VIS, V20, P683; Edelhauser HF, 2006, INVEST OPHTH VIS SCI, V47, P1755, DOI 10.1167/iovs.05-1139; Engelmann K, 1999, OPHTHALMOLOGE, V96, P555, DOI 10.1007/s003470050452; Eslani M, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/196827; Freddo TF, 2013, PROG RETIN EYE RES, V32, P181, DOI 10.1016/j.preteyeres.2012.10.004; Guinebretiere JM, 1997, ANN PATHOL, V17, P25; Hara S, 2014, STEM CELLS DEV, V23, P2190, DOI 10.1089/scd.2013.0387; He ZG, 2012, STEM CELLS, V30, P2523, DOI 10.1002/stem.1212; HONDA H, 1982, J MORPHOL, V174, P25, DOI 10.1002/jmor.1051740104; HUGHES WF, 1946, ARCH OPHTHALMOL-CHIC, V35, P423, DOI 10.1001/archopht.1946.00890200430010; IKEBE H, 1988, EXP EYE RES, V47, P205, DOI 10.1016/0014-4835(88)90004-8; IWAMOTO TAKEO, 1965, INVEST OPHTHALMOL, V4, P270; Joyce NC, 2003, PROG RETIN EYE RES, V22, P359, DOI 10.1016/S1350-9462(02)00065-4; Joyce NC, 2002, INVEST OPHTH VIS SCI, V43, P2152; KANAI A, 1982, American Journal of Ophthalmology, V93, P600; Lin A, 2011, J BURN CARE RES, V32, P547, DOI 10.1097/BCR.0b013e31822b0f29; McGowan SL, 2007, MOL VIS, V13, P1984; Mimura T, 2013, PROG RETIN EYE RES, V35, P1, DOI 10.1016/j.preteyeres.2013.01.003; Okumura N, 2013, INVEST OPHTH VIS SCI, V54, P2493, DOI 10.1167/iovs.12-11320; Roper-Hall M J, 1965, Trans Ophthalmol Soc U K, V85, P631; Senoo T, 2000, INVEST OPHTH VIS SCI, V41, P660; Srinivas SP, 2010, OPTOMETRY VISION SCI, V87, P239, DOI 10.1097/OPX.0b013e3181d39464; Swaminathan SS, 2014, J CATARACT REFR SURG, V40, P1263, DOI 10.1016/j.jcrs.2014.06.020; Tamori Y, 2014, TRENDS CELL BIOL, V24, P230, DOI 10.1016/j.tcb.2013.10.005; TAYLOR MJ, 1981, BRIT J OPHTHALMOL, V65, P815, DOI 10.1136/bjo.65.12.815; VANHORN DL, 1977, INVEST OPHTH VIS SCI, V16, P597; Wagoner MD, 1997, SURV OPHTHALMOL, V41, P275, DOI 10.1016/S0039-6257(96)00007-0	28	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138076	10.1371/journal.pone.0138076	http://dx.doi.org/10.1371/journal.pone.0138076			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378928	Green Published, Green Submitted, gold			2022-12-27	WOS:000361769400050
J	do Amaral, FR; Neves, LG; Resende, MFR; Mobili, F; Miyaki, CY; Pellegrino, KCM; Biondo, C				do Amaral, Fabio Raposo; Neves, Leandro G.; Resende, Marcio F. R., Jr.; Mobili, Flavia; Miyaki, Cristina Y.; Pellegrino, Katia C. M.; Biondo, Cibele			Ultraconserved Elements Sequencing as a Low-Cost Source of Complete Mitochondrial Genomes and Microsatellite Markers in Non-Model Amniotes	PLOS ONE			English	Article							GENETIC-MARKERS; DNA; PHYLOGEOGRAPHY; PERSPECTIVE; ANNOTATION; GENERATION; TIME; HETEROPLASMY; INFORMATION; SYSTEMATICS	Sequence capture of ultraconserved elements (UCEs) associated with massively parallel sequencing has become a common source of nuclear data for studies of animal systematics and phylogeography. However, mitochondrial and microsatellite variation are still commonly used in various kinds of molecular studies, and probably will complement genomic data in years to come. Here we show that besides providing abundant genomic data, UCE sequencing is an excellent source of both sequences for microsatellite loci design and complete mitochondrial genomes with high sequencing depth. Identification of dozens of microsatellite loci and assembly of complete mitogenomes is exemplified here using three species of Poospiza warbling finches from southern and southeastern Brazil. This strategy opens exciting opportunities to simultaneously analyze genome-wide nuclear datasets and traditionally used mtDNA and microsatellite markers in non-model amniotes at no additional cost.	[do Amaral, Fabio Raposo; Mobili, Flavia; Pellegrino, Katia C. M.] Univ Fed Sao Paulo, Inst Ciencias Ambientais Quim & Farmaceut, Lab Genet Evolut, BR-09972270 Diadema, SP, Brazil; [Neves, Leandro G.; Resende, Marcio F. R., Jr.] RAPiD Genom LLC, Gainesville, FL 32601 USA; [Miyaki, Cristina Y.] Univ Sao Paulo, Dept Genet & Biol Evolut, BR-05508090 Sao Paulo, SP, Brazil; [Biondo, Cibele] Univ Fed ABC, Ctr Ciencias Nat & Humanas, BR-09606070 Sao Bernardo Do Campo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	do Amaral, FR (corresponding author), Univ Fed Sao Paulo, Inst Ciencias Ambientais Quim & Farmaceut, Lab Genet Evolut, Rua Prof Artur Riedel 275, BR-09972270 Diadema, SP, Brazil.	fabioraposo@gmail.com	Amaral, Fabio Raposo do/B-9817-2012; Miyaki, Cristina Y/J-2431-2015; Pellegrino, Katia Cristina M/D-7566-2013; Biondo, Cibele/G-3811-2015	Amaral, Fabio Raposo do/0000-0002-1133-3789; Miyaki, Cristina Y/0000-0002-9708-9202; Biondo, Cibele/0000-0003-4020-4246; Resende Jr., Marcio/0000-0002-2367-0766	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011-50143-7, 2011/23155-4, 2013/50297-0]; National Science Foundation [DOB 1343578]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Science Foundation(National Science Foundation (NSF))	Funding was provided by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, grant numbers 2011-50143-7 and 2011/23155-4 to FR, website: http://www.bv.fapesp.br/21144; grant number 2013/50297-0 to CYM, website: http://www.bv.fapesp.br/7387) and National Science Foundation (DOB 1343578 to CYM, http://nsf.gov/awardsearch/showAward?AWD_ID=1343578). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. RAPiD Genomics provided support in the form of salaries for authors LGN and MFRR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrews S., 2015, FASTQC QUALITY CONTR; [Anonymous], 2010, P GATEWAY COMPUTING; ARMOUR JAL, 1994, HUM MOL GENET, V3, P599, DOI 10.1093/hmg/3.4.599; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Bolger AM, BIOINFORMAT IN PRESS; BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101; Burns KJ, 2014, MOL PHYLOGENET EVOL, V75, P41, DOI 10.1016/j.ympev.2014.02.006; Chilamakuri CSR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-449; Crawford NG, 2012, BIOL LETTERS, V8, P783, DOI 10.1098/rsbl.2012.0331; do Amaral FR, 2013, MOL ECOL, V22, P3996, DOI 10.1111/mec.12361; do Amaral FR, 2012, J FIELD ORNITHOL, V83, P403, DOI 10.1111/j.1557-9263.2012.00390.x; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edwards S, 2009, MOL ECOL, V18, P2930, DOI 10.1111/j.1365-294X.2009.04270.x; Edwards SV, 2000, EVOLUTION, V54, P1839; ESTOUP A, 1993, HEREDITY, V71, P488, DOI 10.1038/hdy.1993.167; Etter PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018561; Faircloth BC, 2014, PHYLUCE PHYLOGENETIC; Faircloth BC, 2014, ILLUMIPROCESSOR TRIM; Faircloth BC, 2015, MOL ECOL RESOUR, V15, P489, DOI 10.1111/1755-0998.12328; Faircloth BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065923; Faircloth BC, 2012, SYST BIOL, V61, P717, DOI 10.1093/sysbio/sys004; Falk MJ, 2012, DISCOV MED, V14, P389; Gardner MG, 2011, MOL ECOL RESOUR, V11, P1093, DOI 10.1111/j.1755-0998.2011.03037.x; Garrison E, 2014, ARXIV12073907; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griffin HR, 2014, GENET MED, V16, P962, DOI 10.1038/gim.2014.66; Guo Y, 2013, BIOINFORMATICS, V29, P1210, DOI 10.1093/bioinformatics/btt118; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Harvey MG, 2013, SEQUENCE CAPTURE VER, P1; Jennings TN, 2011, MOL ECOL RESOUR, V11, P1060, DOI 10.1111/j.1755-0998.2011.03033.x; Jex AR, 2010, NUCLEIC ACIDS RES, V38, P522, DOI 10.1093/nar/gkp883; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kmiec B, 2006, CURR GENET, V50, P149, DOI 10.1007/s00294-006-0082-1; Knowles LL, 2009, ANNU REV ECOL EVOL S, V40, P593, DOI 10.1146/annurev.ecolsys.38.091206.095702; Koskinen MT, 2004, HEREDITAS, V141, P61, DOI 10.1111/j.1601-5223.2004.01804.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lerner HRL, 2011, CURR BIOL, V21, P1838, DOI 10.1016/j.cub.2011.09.039; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; McCormack JE, 2013, MOL PHYLOGENET EVOL, V66, P526, DOI 10.1016/j.ympev.2011.12.007; Meglecz E, 2010, BIOINFORMATICS, V26, P403, DOI 10.1093/bioinformatics/btp670; Meikejohn KA, 2014, MOL PHYLOGENET EVOL, V78, P314, DOI 10.1016/j.ympev.2014.06.003; Miller MJ, 2014, MITOCHONDR DNA, P1; Nylander J. A. A., 2004, MRMODELTEST V2; Pan T, 2013, MITOCHONDR DNA, V24, P382, DOI 10.3109/19401736.2013.763238; Parrini R., 2007, ARARAJUBA, V15, P103; Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435; Picardi E, 2012, NAT METHODS, V9, P523, DOI 10.1038/nmeth.2029; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Samuels DC, 2013, TRENDS GENET, V29, P593, DOI 10.1016/j.tig.2013.07.006; Smith BT, 2014, SYST BIOL, V63, P83, DOI 10.1093/sysbio/syt061; Sorenson MD, 1999, MOL PHYLOGENET EVOL, V12, P105, DOI 10.1006/mpev.1998.0602; Sorenson MD, 1998, AUK, V115, P214, DOI 10.2307/4089130; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vollmer NL, 2011, CURR GENET, V57, P115, DOI 10.1007/s00294-010-0331-1; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371	60	35	35	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138446	10.1371/journal.pone.0138446	http://dx.doi.org/10.1371/journal.pone.0138446			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379155	Green Published, gold, Green Submitted			2022-12-27	WOS:000361769400101
J	Zmora, P; Moldenhauer, AS; Hofmann-Winkler, H; Pohlmann, S				Zmora, Pawel; Moldenhauer, Anna-Sophie; Hofmann-Winkler, Heike; Poehlmann, Stefan			TMPRSS2 Isoform 1 Activates Respiratory Viruses and Is Expressed in Viral Target Cells	PLOS ONE			English	Article							CORONAVIRUS SPIKE PROTEIN; INFLUENZA-A VIRUS; SERINE-PROTEASE; PROTEOLYTIC ACTIVATION; TRANSMEMBRANE; ENTRY; CLONING; GENE; H7N9	The cellular protease TMPRSS2 cleaves and activates the influenza virus hemagglutinin (HA) and TMPRSS2 expression is essential for viral spread and pathogenesis in mice. Moreover, severe acute respiratory syndrome coronavirus (SARS-CoV) and other respiratory viruses are activated by TMPRSS2. However, previous studies on viral activation by TMPRSS2 focused on a 492 amino acids comprising form of the protein (isoform 2) while other TMPRSS2 isoforms, generated upon alternative splicing of the tmprss2 mRNA, have not been characterized. Here, we show that the mRNA encoding a TMPRSS2 isoform with an extended N-terminal cytoplasmic domain (isoform 1) is expressed in lung-derived cell lines and tissues. Moreover, we demonstrate that TMPRSS2 isoform 1 colocalizes with HA and cleaves and activates HA. Finally, we show that isoform 1 activates the SARS-CoV spike protein for cathepsin L-independent entry into target cells. Our results indicate that TMPRSS2 isoform 1 is expressed in viral target cells and might contribute to viral activation in the host.	[Zmora, Pawel; Moldenhauer, Anna-Sophie; Hofmann-Winkler, Heike; Poehlmann, Stefan] German Primate Ctr, Infect Biol Unit, Gottingen, Germany	Deutsches Primatenzentrum (DPZ)	Pohlmann, S (corresponding author), German Primate Ctr, Infect Biol Unit, Gottingen, Germany.	spoehlmann@dpz.eu	Pöhlmann, Stefan/H-2395-2011; Zmora, Pawel/V-3843-2019	Pöhlmann, Stefan/0000-0001-6086-9136; Zmora, Pawel/0000-0002-2012-7223	DFG [PO 716/6-1]; Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (DFG) [GSC 226/1, GSC 226/2]	DFG(German Research Foundation (DFG)); Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (DFG)	This work was supported by DFG (PO 716/6-1) and the Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (DFG Grant GSC 226/1 and DFG Grant GSC 226/2).	Abe M, 2013, J VIROL, V87, P11930, DOI 10.1128/JVI.01490-13; Bertram S, 2013, J VIROL, V87, P6150, DOI 10.1128/JVI.03372-12; Bertram S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035876; Bertram S, 2010, J VIROL, V84, P10016, DOI 10.1128/JVI.00239-10; Bertram S, 2010, REV MED VIROL, V20, P298, DOI 10.1002/rmv.657; Bottcher-Friebertshauser E, 2011, J VIROL, V85, P1554, DOI 10.1128/JVI.01294-10; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; Chaipan C, 2009, J VIROL, V83, P3200, DOI 10.1128/JVI.02205-08; Cheng Z, 2015, J INFECT DIS; Edinger TO, 2014, J GEN VIROL, V95, P263, DOI 10.1099/vir.0.059477-0; Esumi M, 2015, HEPATOLOGY, V61, P437, DOI 10.1002/hep.27426; Gierer S, 2013, J VIROL, V87, P5502, DOI 10.1128/JVI.00128-13; Glowacka I, 2011, J VIROL, V85, P4122, DOI 10.1128/JVI.02232-10; Hatesuer B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003774; Jacquinet E, 2001, EUR J BIOCHEM, V268, P2687, DOI 10.1046/j.1432-1327.2001.02165.x; Kim TS, 2006, MOL CELL BIOL, V26, P965, DOI 10.1128/MCB.26.3.965-975.2006; Lapointe J, 2007, MODERN PATHOL, V20, P467, DOI 10.1038/modpathol.3800759; Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10; Matthaei M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056659; Morens DM, 2010, CRIT CARE MED, V38, pE10, DOI 10.1097/CCM.0b013e3181ceb25b; PaoloniGiacobino A, 1997, GENOMICS, V44, P309, DOI 10.1006/geno.1997.4845; Qi XF, 2011, J BIOL CHEM, V286, P20963, DOI 10.1074/jbc.M110.217570; Sakai K, 2014, J VIROL, V88, P5608, DOI 10.1128/JVI.03677-13; Shirato K, 2013, J VIROL, V87, P12552, DOI 10.1128/JVI.01890-13; Shirogane Y, 2008, J VIROL, V82, P8942, DOI 10.1128/JVI.00676-08; Shulla A, 2011, J VIROL, V85, P873, DOI 10.1128/JVI.02062-10; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Tarnow C, 2014, J VIROL, V88, P4744, DOI 10.1128/JVI.03799-13; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Vaarala MH, 2001, J PATHOL, V193, P134, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH743>3.0.CO;2-T; Wrensch F, 2014, VIRUSES-BASEL, V6, P3683, DOI 10.3390/v6093683; Zmora P, 2014, J VIROL, V88, P12087, DOI 10.1128/JVI.01427-14	32	21	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138380	10.1371/journal.pone.0138380	http://dx.doi.org/10.1371/journal.pone.0138380			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379044	gold, Green Submitted, Green Published			2022-12-27	WOS:000361769400093
J	Onodera, K; Arimura, Y; Isshiki, H; Kawakami, K; Nagaishi, K; Yamashita, K; Yamamoto, E; Niinuma, T; Naishiro, Y; Suzuki, H; Imai, K; Shinomura, Y				Onodera, Kei; Arimura, Yoshiaki; Isshiki, Hiroyuki; Kawakami, Kentaro; Nagaishi, Kanna; Yamashita, Kentaro; Yamamoto, Eiichiro; Niinuma, Takeshi; Naishiro, Yasuyoshi; Suzuki, Hiromu; Imai, Kohzoh; Shinomura, Yasuhisa			Low-Frequency IL23R Coding Variant Associated with Crohn's Disease Susceptibility in Japanese Subjects Identified by Personal Genomics Analysis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; WIDE ASSOCIATION; LOCI; POLYMORPHISMS; IL-23R; GENE; PRIORITIZATION; STRATEGIES; DISORDERS; ATG16L1	Background The common disease-common variant hypothesis is insufficient to explain the complexities of Crohn's disease (CD) genetics; therefore, rare variants are expected to be important in the disease. We explored rare variants associated with susceptibility to CD in Japanese individuals by personal genomic analysis. Methods Two-step analyses were performed. The first step was a trio analysis with whole-exome sequence (WES) analysis and the second was a follow-up case-control association study. The WES analysis pipeline comprised Burrows-Wheeler Aligner, Picard, Genome Analysis Toolkit, and SAMTOOLS. Single nucleotide variants (SNVs)/indels were annotated and filtered by using programs implemented in ANNOVAR in combination with identity-by-descent (IBD), subsequently were subjected to the linkage based, and de novo based strategies. Finally, we conducted an association study that included 176 unrelated subjects with CD and 358 healthy control subjects. Results In family members, 234,067-297,523 SNVs/indels were detected and they were educed to 106-146 by annotation based filtering. Fifty-four CD variants common to both individuals of the affected sib pair were identified. The linkage based strategy detected five candidate variants whereas the de novo based strategy identified no variants. Consequently, five candidates were analyzed in the case-control association study. CD showed a significant association with one variant in exon 4 of IL23R, G149R [rs76418789, P = 3.9E-5, odds ratio (OR) 0.21, 95% confidence interval (CI) 0.09-0.47 for the dominant model (AA + AG versus GG), and P = 7.3E-5, OR 0.21, 95% CI 0.10-0.48 for AG versus GG, and P = 7.2E-5, OR 0.23, 95% CI 0.10-0.50 for the allele model]. Conclusions The present study, using personal genomics analysis of a small CD pedigree, is the first to show that the low-frequency non-synonymous variant of IL23R, rs76418789, protects against CD development in Japanese subjects.	[Onodera, Kei; Arimura, Yoshiaki; Isshiki, Hiroyuki; Kawakami, Kentaro; Yamashita, Kentaro; Yamamoto, Eiichiro; Shinomura, Yasuhisa] Sapporo Med Univ, Dept Gastroenterol Rheumatol & Clin Immunol, Sapporo, Hokkaido, Japan; [Nagaishi, Kanna] Sapporo Med Univ, Dept Anat, Sapporo, Hokkaido, Japan; [Niinuma, Takeshi; Suzuki, Hiromu] Sapporo Med Univ, Dept Mol Biol, Sapporo, Hokkaido, Japan; [Naishiro, Yasuyoshi] Sapporo Med Univ, Dept Educ Dev, Sapporo, Hokkaido, Japan; [Imai, Kohzoh] Univ Tokyo, Inst Med Sci, Ctr Antibody & Vaccine Therapy, Tokyo, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; University of Tokyo	Arimura, Y (corresponding author), Sapporo Med Univ, Dept Gastroenterol Rheumatol & Clin Immunol, Sapporo, Hokkaido, Japan.	arimura@sapmed.ac.jp			Grants-in-Aid for Scientific Research [25460954, 221S0001] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Adzhubei Ivan A., 1994, NAT MED, V7, P248, DOI [10.1038/nmeth0410-248.A, DOI 10.1038/NMETH0410-248.A]; Arimura Y, 2014, J GASTROENTEROL, V49, P1217, DOI 10.1007/s00535-013-0866-2; Bailey SL, 2007, NAT IMMUNOL, V8, P172, DOI 10.1038/ni1430; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chen B, 2009, J GENET, V88, P191, DOI 10.1007/s12041-009-0027-9; Cheng R, 2005, FINE MAPPING FUNCTIO, P102; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; Dainel Podolsky, 2007, NEW ENGL J MED, V347, P1; Do R, 2012, HUM MOL GENET, V21, pR1, DOI 10.1093/hmg/dds387; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Gasche C, 2000, INFLAMM BOWEL DIS, V6, P8, DOI 10.1097/00054725-200002000-00002; Gilissen C, 2012, EUR J HUM GENET, V20, P490, DOI 10.1038/ejhg.2011.258; Group NW, 2007, REPLICATING GENOTYPE, V447, P655; Ju YS, 2011, NAT GENET, V43, P745, DOI 10.1038/ng.872; Kim SW, 2011, GUT, V60, P1527, DOI 10.1136/gut.2011.238477; Koboldt DC, 2014, AM J HUM GENET, V94, P373, DOI 10.1016/j.ajhg.2014.01.016; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Little J, 2006, ANN INTERN MED, V2006, P50; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Nakahara S, 2008, DIS COLON RECTUM, V51, P598, DOI 10.1007/s10350-008-9208-5; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Okazaki T, 2008, INFLAMM BOWEL DIS, V14, P1528, DOI 10.1002/ibd.20512; Ott J, 2011, NAT REV GENET, V12, P465, DOI 10.1038/nrg2989; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Pidasheva S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025038; Roedelsperger C, 2011, BIOINFORMATICS, V27, P829, DOI 10.1093/bioinformatics/btr022; Santoni FA, 2014, GENOME RES, V24, P349, DOI 10.1101/gr.163832.113; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Smith RL, 2008, J INVEST DERMATOL, V128, P1325, DOI 10.1038/sj.jid.5701140; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yamazaki K, 2007, J HUM GENET, V52, P575, DOI 10.1007/s10038-007-0156-z; Yang SK, 2014, GUT, V63, P80, DOI 10.1136/gutjnl-2013-305193; Zollner S, 2012, EUR J HUM GENET, V20, P1085, DOI 10.1038/ejhg.2012.58	35	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137801	10.1371/journal.pone.0137801	http://dx.doi.org/10.1371/journal.pone.0137801			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375822	Green Published, Green Submitted, gold			2022-12-27	WOS:000361610200053
J	Park, HW; Choi, YS; Kim, KS; Kim, SN				Park, Hye Won; Choi, Yong-Sung; Kim, Kyo Sun; Kim, Soo-Nyung			Chorioamnionitis and Patent Ductus Arteriosus: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; CHRONIC LUNG-DISEASE; PRETERM INFANTS; HISTOLOGICAL CHORIOAMNIONITIS; ANTENATAL STEROIDS; RISK-FACTOR; CLINICAL CHORIOAMNIONITIS; PLACENTAL INFLAMMATION; AMNIOTIC INFECTION; GESTATIONAL-AGE	Background Chorioamnionitis has recently been reported as a risk factor for various neonatal diseases, including cerebral palsy, bronchopulmonary dysplasia, and necrotizing enterocolitis, but its effect on patent ductus arteriosus (PDA) is unclear. We performed a systematic review and meta-analysis to evaluate the effect of chorioamnionitis on PDA. Methods We searched PubMed, EMBASE, Cochrane Library, and KoreaMed databases using the terms: "intrauterine infection" or "maternal infection" or "antenatal infection" or "chorioamnionitis" or "placenta inflammation" or "placenta pathology" or "neonatal outcome" or "neonatal morbidity" or "PDA or patent ductus arteriosus" or "ductus arteriosus," and "prematurity" or "very low birth weight infant." Studies were included if they were randomized controlled trials, case-control studies, or cohort studies that included information relating to chorioamnionitis and PDA. Results Among 1,571 studies, a total of 23 studies (17,708 cases) were included in the meta-analysis to analyze the relationship between chorioamnionitis and PDA, except one study that only included PDA requiring surgical ligation. The association between chorioamnionitis and PDA was statistically significant (odds ratio [OR] 1.43; 95% confidence interval [CI] 1.19, 1.72; P < 0.0001). In subgroup analysis, clinical chorioamnionitis was not associated with PDA (OR 1.28; 95% CI 1.00, 1.64, 1.790; P = 0.05), whereas histologic chorioamnionitis (OR 1.54; 95% CI 1.10, 2.15; P = 0.01) and chorioamnionitis diagnosed from both clinical and histologic findings (OR 1.75; 95% CI 1.07, 2.86; P = 0.03) showed significant associations with PDA. Chorioamnionitis did not increase the risk of PDA requiring surgical ligation (OR 1.23; 95% CI 0.69, 2.17; P = 0.48), and antenatal steroid use reduced the risk of PDA (OR 0.62; 95% CI 0.42, 0.90; P = 0.01) after chorioamnionitis. Conclusions The results from this meta-analysis support an association between maternal chorioamnionitis and PDA in offspring.	[Park, Hye Won; Kim, Kyo Sun] Konkuk Univ, Med Ctr, Dept Pediat, Seoul, South Korea; [Park, Hye Won; Kim, Kyo Sun; Kim, Soo-Nyung] Konkuk Univ, Sch Med, Seoul, South Korea; [Choi, Yong-Sung] Kyung Hee Univ, Sch Med, Dept Pediat, Seoul, South Korea; [Kim, Soo-Nyung] Konkuk Univ, Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea	Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University Medical Center; Kyung Hee University; Konkuk University; Konkuk University Medical Center	Kim, SN (corresponding author), Konkuk Univ, Sch Med, Seoul, South Korea.	snkim@kuh.ac.kr						Ahn HM, 2012, NEONATOLOGY, V102, P259, DOI 10.1159/000339577; Arayici S, 2014, J MATERN-FETAL NEO M, V27, P1129, DOI 10.3109/14767058.2013.850668; Barrera-Reyes Rene H, 2011, Ginecol Obstet Mex, V79, P31; Been JV, 2011, BJOG-INT J OBSTET GY, V118, P113, DOI 10.1111/j.1471-0528.2010.02751.x; Been JV, 2013, J PEDIATR-US, V162, P236, DOI 10.1016/j.jpeds.2012.07.012; Been JV, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.025; Benitz WE, 2012, ARCH DIS CHILD-FETAL, V97, pF80, DOI 10.1136/archdischild-2011-300381; Blanc W A, 1981, Monogr Pathol, P67; Botet F, 2010, J PERINAT MED, V38, P269, DOI [10.1515/JPM.2010.029, 10.1515/jpm.2010.029]; Bustamante SA, 1996, CIRCULATION, V94, P1948, DOI 10.1161/01.CIR.94.8.1948; Chung HR, 2014, J PEDIAT, V57, P425, DOI [10.3345/kjp.2014.57.10.425, DOI 10.3345/KJP.2014.57.10.425]; Clyman RI, 2000, NEW ENGL J MED, V343, P728, DOI 10.1056/NEJM200009073431009; Clyman RI, 1998, PEDIATR RES, V43, P633, DOI 10.1203/00006450-199805000-00012; Clyman RI, 2006, BIOL NEONATE, V89, P330, DOI 10.1159/000092870; De Felice Claudio, 2005, Pediatr Crit Care Med, V6, P298, DOI 10.1097/01.PCC.0000160658.35437.65; Dessardo NS, 2012, AM J PERINAT, V29, P133, DOI 10.1055/s-0031-1295654; Ecevit A, 2014, TURKISH J PEDIATR, V56, P56; Elimian A, 2000, OBSTET GYNECOL, V96, P333, DOI 10.1016/S0029-7844(00)00928-5; Erdemir G, 2013, PEDIATR NEONATOL, V54, P267, DOI 10.1016/j.pedneo.2013.03.012; Rodrigo FGM, 2014, NEONATOLOGY, V106, P229, DOI 10.1159/000363127; GIBBS RS, 1982, J INFECT DIS, V145, P1, DOI 10.1093/infdis/145.1.1; Goldenberg RL, 2006, AM J OBSTET GYNECOL, V195, P1020, DOI 10.1016/j.ajog.2006.06.033; Gonzalez A, 1996, J PEDIATR-US, V128, P470, DOI 10.1016/S0022-3476(96)70356-6; Halliday HL, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001146.pub3; Halliday HL, 2001, COCHRANE DB SYST REV; Hamrick SEG, 2010, PEDIATRICS, V125, P1020, DOI 10.1542/peds.2009-3506; Hartling L, 2012, ARCH DIS CHILD-FETAL, V97, pF8, DOI 10.1136/adc.2010.210187; Hendson L, 2011, J PEDIATR-US, V158, P397, DOI 10.1016/j.jpeds.2010.09.010; 선한수, 2013, Perinatology, V24, P158; Kim ES, 2010, J PEDIATR-US, V157, P745, DOI 10.1016/j.jpeds.2010.05.020; Lahra MM, 2009, PEDIATRICS, V123, P1314, DOI 10.1542/peds.2008-0656; Lievense S, 2010, PEDIATR RES, V68, P615, DOI 10.1203/00006450-201011001-01241; Liu ZW, 2014, PEDIATR NEONATOL, V55, P35, DOI 10.1016/j.pedneo.2013.05.007; Mitra S, 2014, NEONATOLOGY, V105, P189, DOI 10.1159/000357556; Mu SC, 2008, J FORMOS MED ASSOC, V107, P304, DOI 10.1016/S0929-6646(08)60091-1; Ogunyemi D, 2003, J Matern Fetal Neonatal Med, V13, P102, DOI 10.1080/jmf.13.2.102.109; Pappas A, 2014, JAMA PEDIATR, V168, P137, DOI 10.1001/jamapediatrics.2013.4248; Perrone S, 2012, J MATERN-FETAL NEO M, V25, P110, DOI 10.3109/14767058.2012.664344; Prendergast M, 2011, ARCH DIS CHILD-FETAL, V96, pF270, DOI 10.1136/adc.2010.189480; Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Rocha Gustavo, 2006, Acta Med Port, V19, P207; SALAFIA CM, 1989, OBSTET GYNECOL, V73, P383; Sato M, 2011, J OBSTET GYNAECOL RE, V37, P1313, DOI 10.1111/j.1447-0756.2010.01519.x; Schlapbach LJ, 2010, ACTA PAEDIATR, V99, P1504, DOI 10.1111/j.1651-2227.2010.01861.x; Seliga-Siwecka JP, 2013, EARLY HUM DEV, V89, P271, DOI 10.1016/j.earlhumdev.2012.10.003; Soraisham AS, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.11.034; Stephens BE, 2008, J PERINATOL, V28, P123, DOI 10.1038/sj.jp.7211895; Tita ATN, 2010, CLIN PERINATOL, V37, P339, DOI 10.1016/j.clp.2010.02.003; Tsiartas P, 2013, J MATERN-FETAL NEO M, V26, P1332, DOI 10.3109/14767058.2013.784741; Wu YW, 2000, JAMA-J AM MED ASSOC, V284, P1417, DOI 10.1001/jama.284.11.1417; Yeung M.Y., 2006, WORLD J PEDIATR, V1, P8	52	47	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138114	10.1371/journal.pone.0138114	http://dx.doi.org/10.1371/journal.pone.0138114			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375582	Green Submitted, Green Published, gold			2022-12-27	WOS:000361610200077
J	Pusparini, W; Sievert, PR; Fuller, TK; Randhir, TO; Andayani, N				Pusparini, Wulan; Sievert, Paul R.; Fuller, Todd K.; Randhir, Timothy O.; Andayani, Noviar			Rhinos in the Parks: An Island-Wide Survey of the Last Wild Population of the Sumatran Rhinoceros	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; DICERORHINUS-SUMATRENSIS; EXTINCTION	In the 200 years since the Sumatran rhinoceros was first scientifically described (Fisher 1814), the range of the species has contracted from a broad region in Southeast Asia to three areas on the island of Sumatra and one in Kalimantan, Indonesia. Assessing population and spatial distribution of this very rare species is challenging because of their elusiveness and very low population number. Using an occupancy model with spatial dependency, we assessed the fraction of the total landscape occupied by Sumatran rhinos over a 30,345-km(2) survey area and the effects of covariates in the areas where they are known to occur. In the Leuser Landscape (surveyed in 2007), the model averaging result of conditional occupancy estimate was (psi) over cap (SE[(psi) over cap]) = 0.151(0.109) or 2,371.47 km(2), and the model averaging result of replicated level detection probability (p) over cap (SE[(p) over cap]) = 0.252(0.267); in Way Kambas National Park-2008: (psi) over cap (SE[(psi) over cap]) = 0.468(0.165) or 634.18 km(2), and (p) over cap (SE[(p) over cap]) = 0.138(0.571); and in Bukit Barisan Selatan National Park-2010. (psi) over cap (SE[(psi) over cap]) = 0.322(0.049) or 819.67 km(2), and (p) over cap (SE[(p) over cap]) = 0.365(0.42). In the Leuser Landscape, rhino occurrence was positively associated with primary dry land forest and rivers, and negatively associated with the presence of a road. In Way Kambas, occurrence was negatively associated with the presence of a road. In Bukit Barisan Selatan, occurrence was negatively associated with presence of primary dry-land forest and rivers. Using the probabilities of site occupancy, we developed spatially explicit maps that can be used to outline intensive protection zones for in-situ conservation efforts, and provide a detailed assessment of conserving Sumatran rhinos in the wild. We summarize our core recommendation in four points: consolidate small population, strong protection, determine the percentage of breeding females, and recognize the cost of doing nothing. To reduce the probability of poaching, here we present only the randomized location of site level occupancy in our result while retaining the overall estimation of occupancy for a given area.	[Pusparini, Wulan; Sievert, Paul R.; Fuller, Todd K.; Randhir, Timothy O.] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [Pusparini, Wulan; Andayani, Noviar] Wildlife Conservat Soc Indonesia Program, Bogor, Indonesia	University of Massachusetts System; University of Massachusetts Amherst; Wildlife Conservation Society - Indonesia	Pusparini, W (corresponding author), Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA.	wpusparini@wcs.org	Randhir, Timothy O/A-7145-2009	Randhir, Timothy O/0000-0002-1084-9716; Pusparini, Wulan/0000-0001-9909-0920; Andayani, Noviar/0000-0002-1888-193X	Rhinoceros-Tiger Conservation Fund; Asian Elephant Conservation Fund of the USFWS	Rhinoceros-Tiger Conservation Fund; Asian Elephant Conservation Fund of the USFWS	The funding for field work was provided by the Rhinoceros-Tiger Conservation Fund and the Asian Elephant Conservation Fund of the USFWS.	Ahmad A.H., 2013, J INDONES NAT HIST, V1, P11; Andriansyah, 2013, J ZOO WILDLIFE MED, V44, P280, DOI 10.1638/2012-0046R2.1; [Anonymous], 1989, ANIMAL KINGDOM, V92, P2; Borner MA, 1979, THESIS U BASEL; BPS (Badan Pusat Statistik), 2013, TRENDS SEL SOC IND I; Brook SM, 2014, BIOL CONSERV, V174, P21, DOI 10.1016/j.biocon.2014.03.014; Buckland ST, 2005, PHILOS T R SOC B, V360, P243, DOI 10.1098/rstb.2004.1589; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Clements R, 2010, BIODIVERS CONSERV, V19, P1115, DOI 10.1007/s10531-009-9775-3; Ditjen PHKA Kemenhut RI (Direktorat Jenderal Perlindungan Hutan dan Konservasi Alam Kementrian Kehutanan Republik Indonesia), 2012, TAM NAS BUK BAR SEL; Doherty JG, 1992, ZOO VIEW, V26, P24; Evans JS, TOOLBOX SURFAC UNPUB; Foose T. J., 1997, ASIAN RHINOS STATUS; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Hance J, 2015, MONGABAY; Hines JE, 2010, ECOL APPL, V20, P1456, DOI 10.1890/09-0321.1; Hines J. E., 2006, PRESENCE4 SOFTWARE E; HUTCHINS M, 1995, CONSERV BIOL, V9, P977, DOI 10.1046/j.1523-1739.1995.9050977_1.x; Hutchins Michael, 1995, International Zoo Yearbook, V34, P117, DOI 10.1111/j.1748-1090.1995.tb00669.x; Karanth KU, 2010, TIGERS OF THE WORLD: THE SCIENCE, POLITICS, AND CONSERVATION OF PANTHERA TIGRIS, 2ND EDITION, P241; Karanth KU, 2011, J APPL ECOL, V48, P1048, DOI 10.1111/j.1365-2664.2011.02002.x; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kery M., 2010, INTRO WINBUGS ECOLOG; Laumonier Y., 1997, GEOBOTANY, P22; Lessee J, 1995, REALLY RHINOS, V9, P1; MacKenzie D.I., 2004, SAMPLING RARE ELUSIV; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2005, AUST NZ J STAT, V47, P65, DOI 10.1111/j.1467-842X.2005.00372.x; MacKenzie DI, 2005, ECOLOGY, V86, P1101, DOI 10.1890/04-1060; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2387, DOI 10.2307/3071800; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Margono BA, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034010; McDonald-Madden E, 2008, CONSERV BIOL, V22, P656, DOI 10.1111/j.1523-1739.2008.00918.x; McGarigal K, 2009, LANDSCAPE ECOL, V24, P433, DOI 10.1007/s10980-009-9327-y; Meijaard E, 2014, BIOL CONSERV, V175, P21, DOI 10.1016/j.biocon.2014.03.021; Merz A, 1997, REF J, V11, P4; Miller PS, 2015, POPULATION VIABILITY, P65; MoF RI (Ministry of Forestry Republic of Indonesia), 2007, STRAT ACT PLAN CONS, P1; Nicholls H, 2012, NATURE, V485, P566, DOI 10.1038/485566a; O'Brien JK, 2000, J REPROD FERTIL, V118, P263, DOI 10.1530/reprod/118.2.263; Orlando L, 2003, MOL PHYLOGENET EVOL, V28, P485, DOI 10.1016/S1055-7903(03)00023-X; Payne J, 2012, COMMENT SEX SINGLE R; Pusparini W, 2010, THESIS U INDONESIA; Pusparini W, 2013, PACHYDERM, P59; RABINOWITZ A, 1995, CONSERV BIOL, V9, P482, DOI 10.1046/j.1523-1739.1995.09030482.x; Reilly J, 1997, ORYX, V31, P143, DOI 10.1046/j.1365-3008.1997.d01-8.x; Roth TL, 2004, ZOO BIOL, V23, P219, DOI 10.1002/zoo.10131; Roth TL, 2003, BIOL REPROD, V68, P95; ROTH TL, 2002, P AZA ANN C, P63; Royle J. A., 2008, HIERARCHICAL MODELIN; Stauffer HB, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P357; Stoops MA, 2011, J ZOO WILDLIFE MED, V42, P723, DOI 10.1638/2010-0186.1; Strategic Asia, 2012, IMPL IND EC MAST PLA; Talukdar BK, 2010, P AS RHIN SPEC GROUP, P30; van Strien N. J., 1986, SUMATRAN RHINOCEROS; vanStrien N. J., 2008, IUCN RED LIST THREAT; WCS-IP, 2012, ACC CONS MON SUM TIG, P31; Wibisono HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025931; Wibisono HT, 2008, SURVEY PROTOCOL SUMA; Wibisono HT, 2012, MANAGING TIGER CONSE, P14; Wich S. A., 2011, ORANGUTANS EC SUSTAI; Zafir AWA, 2011, ORYX, V45, P225, DOI 10.1017/S0030605310000864	63	7	7	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136643	10.1371/journal.pone.0136643	http://dx.doi.org/10.1371/journal.pone.0136643			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376453	gold, Green Published			2022-12-27	WOS:000361610200019
J	Stewart, L; MacLean, EL; Ivy, D; Woods, V; Cohen, E; Rodriguez, K; McIntyre, M; Mukherjee, S; Call, J; Kaminski, J; Miklosi, A; Wrangham, RW; Hare, B				Stewart, Laughlin; MacLean, Evan L.; Ivy, David; Woods, Vanessa; Cohen, Eliot; Rodriguez, Kerri; McIntyre, Matthew; Mukherjee, Sayan; Call, Josep; Kaminski, Juliane; Miklosi, Adam; Wrangham, Richard W.; Hare, Brian			Citizen Science as a New Tool in Dog Cognition Research	PLOS ONE			English	Article							CANIS-FAMILIARIS; DOMESTIC DOG; SOCIAL DOG; WOLVES; TRAITS; COMPREHENSION; VALIDATION; HYPOTHESIS; BEHAVIOR; STATE	Family dogs and dog owners offer a potentially powerful way to conduct citizen science to answer questions about animal behavior that are difficult to answer with more conventional approaches. Here we evaluate the quality of the first data on dog cognition collected by citizen scientists using the Dognition. com website. We conducted analyses to understand if data generated by over 500 citizen scientists replicates internally and in comparison to previously published findings. Half of participants participated for free while the other half paid for access. The website provided each participant a temperament questionnaire and instructions on how to conduct a series of ten cognitive tests. Participation required internet access, a dog and some common household items. Participants could record their responses on any PC, tablet or smartphone from anywhere in the world and data were retained on servers. Results from citizen scientists and their dogs replicated a number of previously described phenomena from conventional lab-based research. There was little evidence that citizen scientists manipulated their results. To illustrate the potential uses of relatively large samples of citizen science data, we then used factor analysis to examine individual differences across the cognitive tasks. The data were best explained by multiple factors in support of the hypothesis that nonhumans, including dogs, can evolve multiple cognitive domains that vary independently. This analysis suggests that in the future, citizen scientists will generate useful datasets that test hypotheses and answer questions as a complement to conventional laboratory techniques used to study dog psychology.	[Stewart, Laughlin; Ivy, David; Woods, Vanessa; Cohen, Eliot; Hare, Brian] Canines Inc, Canine Res Dept, Durham, NC 27701 USA; [MacLean, Evan L.; Woods, Vanessa; Rodriguez, Kerri; Hare, Brian] Duke Univ, Dept Evolutionary Anthropol, Durham, NC USA; [MacLean, Evan L.] Univ Arizona, Sch Anthropol, Tucson, AZ USA; [McIntyre, Matthew] 23 & Me Inc, Dept Stat, Mountain View, CA USA; [Mukherjee, Sayan] Duke Univ, Dept Stat Sci, Durham, NC USA; [Mukherjee, Sayan] Duke Univ, Dept Comp Sci, Durham, NC USA; [Mukherjee, Sayan] Duke Univ, Dept Math, Durham, NC USA; [Call, Josep] Univ St Andrews, Dept Psychol & Neurosci, St Andrews, Fife, Scotland; [Call, Josep] Max Planck Inst Evolutionary Anthropol, Dept Psychol, Leipzig, Germany; [Kaminski, Juliane] Univ Portsmouth, Dept Psychol, Portsmouth, Hants, England; [Miklosi, Adam] MTA ELTE Comparat Ethol Res Grp, Budapest, Hungary; [Wrangham, Richard W.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Hare, Brian] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA	Duke University; University of Arizona; Duke University; Duke University; Duke University; University of St Andrews; Max Planck Society; University of Portsmouth; MTA-ELTE Comparative Ethology Research Group; Harvard University; Duke University	Hare, B (corresponding author), Canines Inc, Canine Res Dept, Durham, NC 27701 USA.	b.hare@duke.edu	Rodriguez, Kerri E/AAF-6893-2020; Miklosi, Adam/N-5147-2017	Rodriguez, Kerri E/0000-0002-3395-4818; Call Balaguer, Josep/0000-0002-8597-8336; MacLean, Evan/0000-0001-7595-662X; Kaminski, Juliane/0000-0002-3437-3484; Miklosi, Adam/0000-0003-4831-8985	Hungarian Academy of Sciences [MTA 01 031]; 23 and me, Inc.	Hungarian Academy of Sciences(Hungarian Academy of Sciences); 23 and me, Inc.	The work of A.M. was supported by the Hungarian Academy of Sciences (MTA 01 031). Co-authors Laughlin Stewart, David Ivy, Vanessa Woods, and Eliot Cohen are employed by Canines, Inc. Co-author Matthew McIntyre is employed by 23 and me, Inc. Canines, Inc., and 23 and me, Inc., provided support in the form of salaries for authors LS, DI, VW, EC and MM respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aust U, 2008, ANIM COGN, V11, P587, DOI 10.1007/s10071-008-0149-0; Bonney R, 2009, BIOSCIENCE, V59, P977, DOI 10.1525/bio.2009.59.11.9; Bonter DN, 2012, FRONT ECOL ENVIRON, V10, P305, DOI 10.1890/110273; Brauer J, 2006, J COMP PSYCHOL, V120, P38, DOI 10.1037/0735-7036.120.1.38; Burghardt GM, 2012, ETHOLOGY, V118, P511, DOI 10.1111/j.1439-0310.2012.02040.x; Call J, 2003, J COMP PSYCHOL, V117, P257, DOI 10.1037/0735-7036.117.3.257; Cohn JP, 2008, BIOSCIENCE, V58, P192, DOI 10.1641/B580303; Cooper CB, 2007, ECOL SOC, V12; Cooper JJ, 2003, APPL ANIM BEHAV SCI, V81, P229, DOI 10.1016/S0168-1591(02)00284-8; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; Erdohegyi A, 2007, ANIM BEHAV, V74, P725, DOI 10.1016/j.anbehav.2007.03.004; Gacsi M, 2009, ANIM COGN, V12, P471, DOI 10.1007/s10071-008-0208-6; Hare B, 2005, TRENDS COGN SCI, V9, P439, DOI 10.1016/j.tics.2005.07.003; Hare B, 2002, COGNITIVE ANIMAL, P363; Hare B., 2013, GENIUS DOGS DISCOVER; Hare B, 2010, ANIM BEHAV, V79, pE1, DOI 10.1016/j.anbehav.2009.06.031; Hauser MD, 2011, BEHAV PROCESS, V86, P7, DOI 10.1016/j.beproc.2010.07.011; Hecht J, 2015, BEHAV PROCESS, V110, P125, DOI 10.1016/j.beproc.2014.10.014; Hegedus D, 2013, BEHAVIOUR, V150, P427, DOI 10.1163/1568539X-00003060; Herrmann E, 2009, PSYCHOL SCI; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; Joly-Mascheroni RM, 2008, BIOL LETTERS, V4, P446, DOI 10.1098/rsbl.2008.0333; Kaminski J, 2004, SCIENCE, V304, P1682, DOI 10.1126/science.1097859; Kaminski J., 2014, SOCIAL DOG BEHAV COG; Kubinyi E, 2009, BEHAV PROCESS, V81, P392, DOI 10.1016/j.beproc.2009.04.004; Lintott CJ, 2008, MON NOT R ASTRON SOC, V389, P1179, DOI 10.1111/j.1365-2966.2008.13689.x; MacLean EL, 2014, J COMP PSYCHOL, V128, P285, DOI 10.1037/a0035742; MacLean EL, 2014, P NATL ACAD SCI USA, V111, pE2140, DOI 10.1073/pnas.1323533111; MacLean EL, 2012, ANIM COGN, V15, P223, DOI 10.1007/s10071-011-0448-8; Martin P., 1993, MEASURING BEHAV, V2nd, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Miklosi A., 2014, DOG BEHAV EVOLUTION; Miklosi A, 2013, TRENDS COGN SCI, V17, P287, DOI 10.1016/j.tics.2013.04.005; O'Hara SJ, 2011, ANIM BEHAV, V81, P335, DOI 10.1016/j.anbehav.2010.11.005; Osthaus B, 2010, ANIM COGN, V13, P881, DOI 10.1007/s10071-010-0331-z; Romero T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071365; Schmidjell T, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00558; Schwab C, 2006, J COMP PSYCHOL, V120, P169, DOI 10.1037/0735-7036.120.3.169; Silvertown J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018927; Stevens J. P., 2012, APPL MULTIVARIATE ST; Sullivan BL, 2009, BIOL CONSERV, V142, P2282, DOI 10.1016/j.biocon.2009.05.006; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P133, DOI 10.1016/S0168-1591(02)00121-1; Szetei V, 2003, APPL ANIM BEHAV SCI, V83, P141, DOI 10.1016/S0168-1591(03)00114-X; Tempelmann S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091014; Tomasello M, 1997, PRIMATE COGNITION; Topal J, 2009, SCIENCE, V325, P1269, DOI 10.1126/science.1176960; Turcsan B, 2011, APPL ANIM BEHAV SCI, V132, P61, DOI 10.1016/j.applanim.2011.03.006; Udell MAR, 2008, ANIM BEHAV, V76, P1767, DOI 10.1016/j.anbehav.2008.07.028; Viranyi Z, 2008, ANIM COGN, V11, P373, DOI 10.1007/s10071-007-0127-y; Wobber V, 2009, BEHAV PROCESS, V81, P423, DOI 10.1016/j.beproc.2009.04.003	51	34	34	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0135176	10.1371/journal.pone.0135176	http://dx.doi.org/10.1371/journal.pone.0135176			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376443	Green Published, Green Submitted, gold			2022-12-27	WOS:000361610200006
J	Zhang, XL; Liu, RH; Su, ZX; Zhang, YC; Zhang, WF; Liu, XY; Wang, FW; Guo, YJ; Li, CG; Hao, J				Zhang, Xiaoli; Liu, Ruihua; Su, Zhongxue; Zhang, Yuecun; Zhang, Wenfang; Liu, Xinyu; Wang, Fuwu; Guo, Yuji; Li, Chuangang; Hao, Jing			Immunohistochemical Study of Expression of Sohlh1 and Sohlh2 in Normal Adult Human Tissues	PLOS ONE			English	Article							PREMATURE OVARIAN FAILURE; SPERMATOGONIAL DIFFERENTIATION; NONOBSTRUCTIVE AZOOSPERMIA; TRANSCRIPTIONAL REGULATORS; GERM; GENE; FOLLICULOGENESIS; SPERMATOGENESIS; VARIANTS; CELLS	The expression pattern of Sohlh1 (spermatogenesis and oogenesis specific basic helix-loop-helix 1) and Sohlh2 in mice has been reported in previous studies. Sohlh1 and Sohlh2 are specifically expressed in spermatogonia, prespermatogonia in male mice and oocytes of primordial and primary follicles in female mice. In this report, we studied the expression pattern of Sohlh1 and Sohlh2 in human adult tissues. Immunohistochemical staining of Sohlh1 and Sohlh2 was performed in 5 samples of normal ovaries and testes, respectively. The results revealed that Sohlh genes are not only expressed in oocytes and spermatogonia, but also in granular cells, theca cells, Sertoli cells and Leydig cells, and in smooth muscles of blood vessel walls. To further investigate the expression of Sohlh genes in other adult human tissues, we collected representative normal adult tissues developed from three embryonic germ layers. Compared with the expression in mice, Sohlhs exhibited a much more extensive expression pattern in human tissues. Sohlhs were detected in testis, ovary and epithelia developed from embryonic endoderm, ectoderm and tissues developed from embryonic mesoderm. Sohlh signals were found in spermatogonia, Sertoli cells and also Leydig cells in testis, while in ovary, the expression was mainly in oocytes of primordial and primary follicles, granular cells and theca cells of secondary follicles. Compared with Sohlh2, the expression of Sohlh1 was stronger and more extensive. Our study explored the expression of Sohlh genes in human tissues and might provide insights for functional studies of Sohlh genes.	[Zhang, Xiaoli; Zhang, Wenfang; Liu, Xinyu; Wang, Fuwu; Guo, Yuji; Hao, Jing] Shandong Univ, Dept Histol & Embryol, Minist Educ Expt Teratol, Key Lab,Sch Med, Jinan 250100, Peoples R China; [Liu, Ruihua] Yantai Yuhuangding Hosp, Dept Ultrasound, Yantai, Peoples R China; [Su, Zhongxue] Shandong Univ, Dept Hepatobiliary Surg, Shandong Prov Hosp, Jinan 250100, Peoples R China; [Zhang, Yuecun] Dongnan Univ, Sch Med, Nanjing Tongren Hosp, Dept Gynecol & Obstet, Nanjing, Jiangsu, Peoples R China; [Li, Chuangang] Shandong Univ, Affiliated Hosp 2, Dept Anesthesiol, Jinan 250100, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Southeast University - China; Shandong University	Hao, J (corresponding author), Shandong Univ, Dept Histol & Embryol, Minist Educ Expt Teratol, Key Lab,Sch Med, Jinan 250100, Peoples R China.	haojing@sdu.edu.cn			Natural Science Foundation 1 of Shandong Province [ZR2014HM082]; Shandong Department of Science and Technology Plan Project [2014GSF118085]; Shandong Province Outstanding Young Scientist Research Award Fund Project [2011BSE27084]	Natural Science Foundation 1 of Shandong Province; Shandong Department of Science and Technology Plan Project; Shandong Province Outstanding Young Scientist Research Award Fund Project	This study was supported by the Natural Science Foundation 1 of Shandong Province (NO. ZR2014HM082), the Shandong Department of Science and Technology Plan Project (NO. 2014GSF118085), and the Shandong Province Outstanding Young Scientist Research Award Fund Project (2011BSE27084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballow D, 2006, DEV BIOL, V294, P161, DOI 10.1016/j.ydbio.2006.02.027; Ballow DJ, 2006, GENE EXPR PATTERNS, V6, P1014, DOI 10.1016/j.modgep.2006.04.007; Barrios F, 2012, J CELL SCI, V125, P1455, DOI 10.1242/jcs.092593; Bonnet A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-417; Choi Y, 2010, HUM MUTAT, V31, P788, DOI 10.1002/humu.21264; Choi Y, 2008, BIOL REPROD, V79, P1176, DOI 10.1095/biolreprod.108.071217; Hao J, 2008, STEM CELLS, V26, P1587, DOI 10.1634/stemcells.2007-0502; Jagarlamudi K, 2012, MOL CELL ENDOCRINOL, V356, P31, DOI 10.1016/j.mce.2011.07.049; Lim Eun-Jin, 2012, Clin Exp Reprod Med, V39, P127, DOI 10.5653/cerm.2012.39.4.127; Matson CK, 2010, DEV CELL, V19, P612, DOI 10.1016/j.devcel.2010.09.010; Pan B, 2011, MOL HUM REPROD, V17, P550, DOI 10.1093/molehr/gar017; Pangas SA, 2006, P NATL ACAD SCI USA, V103, P8090, DOI 10.1073/pnas.0601083103; Qin YY, 2014, FERTIL STERIL, V101, P1104, DOI 10.1016/j.fertnstert.2014.01.001; Rajkovic A, 2001, FERTIL STERIL, V76, P550, DOI 10.1016/S0015-0282(01)01966-5; Ramaswamy S, 2014, MOL HUM REPROD, V20, P350, DOI 10.1093/molehr/gat093; Shen L, 2007, PLOS GENET, V3, P2023, DOI 10.1371/journal.pgen.0030181; Song B, 2015, EUR J OBSTET GYN R B, V184, P48, DOI 10.1016/j.ejogrb.2014.11.003; Song HW, 2014, SEMIN CELL DEV BIOL, V30, P14, DOI 10.1016/j.semcdb.2014.02.005; Suzuki H, 2012, DEV BIOL, V361, P301, DOI 10.1016/j.ydbio.2011.10.027; Suzumori N, 2007, CURR MED CHEM, V14, P353, DOI 10.2174/092986707779941087; Toyoda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101681; Toyoda S, 2009, DEV BIOL, V325, P238, DOI 10.1016/j.ydbio.2008.10.019; Woloszynska-Read A, 2011, CLIN CANCER RES, V17, P2170, DOI 10.1158/1078-0432.CCR-10-2315; Zhang HY, 2014, CARCINOGENESIS, V35, P1863, DOI 10.1093/carcin/bgu113; Zhang T, 2014, DEVELOPMENT, V141, P3662, DOI 10.1242/dev.113936; Zheng P, 2007, SEMIN REPROD MED, V25, P243, DOI 10.1055/s-2007-980218; Zheng WJ, 2014, HUM MOL GENET, V23, P920, DOI 10.1093/hmg/ddt486	27	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137431	10.1371/journal.pone.0137431	http://dx.doi.org/10.1371/journal.pone.0137431			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375665	Green Published, Green Submitted, gold			2022-12-27	WOS:000361610200039
J	Bakhchane, A; Charif, M; Salime, S; Boulouiz, R; Nahili, H; Roky, R; Lenaers, G; Barakat, A				Bakhchane, Amina; Charif, Majida; Salime, Sara; Boulouiz, Redouane; Nahili, Halima; Roky, Rachida; Lenaers, Guy; Barakat, Abdelhamid			Recessive TBC1D24 Mutations Are Frequent in Moroccan Non-Syndromic Hearing Loss Pedigrees	PLOS ONE			English	Article							GENE	Mutations in the TBC1D24 gene are responsible for four neurological presentations: infantile epileptic encephalopathy, infantile myoclonic epilepsy, DOORS (deafness, onychodystrophy, osteodystrophy, mental retardation and seizures) and NSHL (non-syndromic hearing loss). For the latter, two recessive (DFNB86) and one dominant (DFNA65) mutations have so far been identified in consanguineous Pakistani and European/Chinese families, respectively. Here we report the results of a genetic study performed on a large Moroccan cohort of deaf patients that identified three families with compound heterozygote mutations in TBC1D24. Four novel mutations were identified, among which, one c.641G>A (p.Arg214His) was present in the three families, and has a frequency of 2% in control Moroccan population with normal hearing, suggesting that it acts as an hypomorphic variant leading to restricted deafness when combined with another recessive severe mutation. Altogether, our results show that mutations in TBC1D24 gene are a frequent cause (>2%) of NSHL in Morocco, and that due to its possible compound heterozygote recessive transmission, this gene should be further considered and screened in other deaf cohorts.	[Bakhchane, Amina; Charif, Majida; Salime, Sara; Boulouiz, Redouane; Nahili, Halima; Barakat, Abdelhamid] Inst Pasteur Maroc, Lab Genet Mol Humaine, Dept Rech Sci, Casablanca, Morocco; [Roky, Rachida] Univ Hassan II Ain Chock, Lab Physiol & Genet Mol, Casablanca 20100, Morocco; [Charif, Majida; Salime, Sara; Lenaers, Guy] Univ Montpellier, Inst Neurosci Montpellier, INSERM, U1051, F-34091 Montpellier 05, France; [Charif, Majida; Lenaers, Guy] Univ Angers, Mitochondrial Med Res Ctr, PREMMi, CHU Bat IRIS IBS, F-49933 Angers 9, France	Hassan II University of Casablanca; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite d'Angers	Barakat, A (corresponding author), Inst Pasteur Maroc, Lab Genet Mol Humaine, Dept Rech Sci, Casablanca, Morocco.	hamid.barakat@pasteur.ma	Lenaers, guy/X-4727-2019; LENAERS, Guy/K-2421-2015	LENAERS, Guy/0000-0003-2736-3349; BOULOUIZ, Redouane/0000-0003-4430-3612	Pasteur Institute of Morocco; French National Institute of Health and Medical research (INSERM); Moroccan National center of Technical research (CNRST); Region Pays de la Loire, Angers Loire Metropole, Angers University and Hospital	Pasteur Institute of Morocco; French National Institute of Health and Medical research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Moroccan National center of Technical research (CNRST); Region Pays de la Loire, Angers Loire Metropole, Angers University and Hospital(Region Pays de la Loire)	This work was supported by Pasteur Institute of Morocco and the collaborative project between the French National Institute of Health and Medical research (INSERM) and the Moroccan National center of Technical research (CNRST). GL acknowledges the support from the Region Pays de la Loire, Angers Loire Metropole, Angers University and Hospital.	Abidi O, 2007, INT J PEDIATR OTORHI, V71, P1239, DOI 10.1016/j.ijporl.2007.04.019; Azaiez H, 2014, HUM MUTAT, V35, P819, DOI 10.1002/humu.22557; Boulouiz R, 2008, AM J MED GENET A, V146A, P3086, DOI 10.1002/ajmg.a.32525; Campeau PM, 2014, LANCET NEUROL, V13, P44, DOI 10.1016/S1474-4422(13)70265-5; Charif M, 2013, GENE, V523, P103, DOI 10.1016/j.gene.2013.03.123; Charif M, 2012, BIOCHEM BIOPH RES CO, V419, P643, DOI 10.1016/j.bbrc.2012.02.066; Corbett MA, 2010, AM J HUM GENET, V87, P371, DOI 10.1016/j.ajhg.2010.08.001; Falace A, 2010, AM J HUM GENET, V87, P365, DOI 10.1016/j.ajhg.2010.07.020; Guven A, 2013, J MED GENET, V50, P199, DOI 10.1136/jmedgenet-2012-101313; Li Y, 2010, AM J HUM GENET, V86, P479, DOI 10.1016/j.ajhg.2010.02.003; Nahili H, 2010, INT J PEDIATR OTORHI, V74, P1071, DOI 10.1016/j.ijporl.2010.06.008; Rehman AU, 2014, AM J HUM GENET, V94, P144, DOI 10.1016/j.ajhg.2013.12.004; Zhang LP, 2014, HUM MUTAT, V35, P814, DOI 10.1002/humu.22558	13	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138072	10.1371/journal.pone.0138072	http://dx.doi.org/10.1371/journal.pone.0138072			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371875	Green Published, Green Submitted, gold			2022-12-27	WOS:000361604400047
J	Gonzalez, JEH; Garcia-Fernandez, R; Valiente, PA				Hernandez Gonzalez, Jorge Enrique; Garcia-Fernandez, Rossana; Alberto Valiente, Pedro			Polar Desolvation and Position 226 of Pancreatic and Neutrophil Elastases Are Crucial to their Affinity for the Kunitz-Type Inhibitors ShPI-1 and ShPI-1/K13L	PLOS ONE			English	Article							FREE-ENERGY DECOMPOSITION; GENERALIZED BORN MODELS; MOLECULAR-DYNAMICS; TRYPSIN-INHIBITOR; SUBSTRATE-SPECIFICITY; PROTEINASE-INHIBITORS; CRYSTAL-STRUCTURES; HUMAN-LEUKOCYTE; LIGAND-BINDING; SOLVATION	The Kunitz-type protease inhibitor ShPI-1 inhibits human neutrophil elastase (HNE, K-i = 2.35.10(-8) M) but does not interact with the porcine pancreatic elastase (PPE); whereas its P1 site variant, ShPI-1/K13L, inhibits both HNE and PPE (K-i = 1.3.10(-9) M, and K-i = 1.2.10(-8) M, respectively). By employing a combination of molecular modeling tools, e.g., structural alignment, molecular dynamics simulations and Molecular Mechanics Generalized-Born/Poisson-Boltzmann Surface Area free energy calculations, we showed that D226 of HNE plays a critical role in the interaction of this enzyme with ShPI-1 through the formation of a strong salt bridge and hydrogen bonds with K13 at the inhibitor's P1 site, which compensate the unfavorable polar-desolvation penalty of the latter residue. Conversely, T226 of PPE is unable to establish strong interactions with K13, thereby precluding the insertion of K13 side-chain into the S1 subsite of this enzyme. An alternative conformation of K13 site-chain placed at the entrance of the S1 subsite of PPE, similar to that observed in the crystal structure of ShPI-1 in complex with chymotrypsin (PDB:3T62), is also unfavorable due to the lack of stabilizing pair-wise interactions. In addition, our results suggest that the higher affinity of ShPI-1/K13L for both elastases mainly arises from the lower polar-desolvation penalty of L13 compared to that of K13, and not from stronger pair-wise interactions of the former residue with those of each enzyme. These results provide insights into the PPE and HNE inhibition and may contribute to the design of more potent and/or specific inhibitors toward one of these proteases.	[Hernandez Gonzalez, Jorge Enrique; Garcia-Fernandez, Rossana; Alberto Valiente, Pedro] Univ La Habana, Fac Biol, Ctr Estudios Prot, Havana, Cuba	Universidad de la Habana	Gonzalez, JEH (corresponding author), Univ La Habana, Fac Biol, Ctr Estudios Prot, Havana, Cuba.	jehg@fbio.uh.cu; valiente@fbio.uh.cu	García-Fernández, Rossana/A-8920-2011; González, Jorge Enrique Hernández/AAB-2705-2019; , pedro/AAK-9885-2020	, pedro/0000-0002-4776-6017; Hernandez Gonzalez, Jorge Enrique/0000-0002-4770-8677				Abbenante Giovanni, 2005, Med Chem, V1, P71, DOI 10.2174/1573406053402569; Aloy P, 2003, J MOL BIOL, V332, P989, DOI 10.1016/j.jmb.2003.07.006; ANTUCH W, 1993, EUR J BIOCHEM, V212, P675, DOI 10.1111/j.1432-1033.1993.tb17705.x; Bachovchin WW, 2001, MAGN RESON CHEM, V39, pS199, DOI 10.1002/mrc.951; Bashford D, 2000, ANNU REV PHYS CHEM, V51, P129, DOI 10.1146/annurev.physchem.51.1.129; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Biela A, 2012, J MOL BIOL, V418, P350, DOI 10.1016/j.jmb.2012.01.054; Bissantz C, 2010, J MED CHEM, V53, P5061, DOI 10.1021/jm100112j; BODE W, 1989, BIOCHEMISTRY-US, V28, P1951, DOI 10.1021/bi00431a001; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Case DA, 2012, AMBER 12; Chughtai B, 2004, J AEROSOL MED, V17, P289, DOI 10.1089/jam.2004.17.289; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Delfin J, 1996, TOXICON, V34, P1367, DOI 10.1016/S0041-0101(96)00114-6; Delfin J, 1994, Arch Med Res, V25, P199; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Fulle S, 2013, J CHEM INF MODEL, V53, P573, DOI 10.1021/ci300581z; Garcia-Fernandez R, 2015, J BIOL CHEM, V290, P14154, DOI 10.1074/jbc.M115.647586; Genheden S, 2011, J CHEM THEORY COMPUT, V7, P3768, DOI 10.1021/ct200163c; Genheden S, 2010, J COMPUT CHEM, V31, P837, DOI 10.1002/jcc.21366; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Gonzalez Y, 2007, BIOL CHEM, V388, P1183, DOI 10.1515/BC.2007.129; HAKANSSON HO, 1993, SCAND J CLIN LAB INV, V53, P17, DOI 10.3109/00365519309092527; Hayes J.M., 2012, MOL DYNAMICS STUDIES, P171; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Alvarez LH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003759; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HOCKNEY RW, 1974, J COMPUT PHYS, V14, P148, DOI 10.1016/0021-9991(74)90010-2; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hou TJ, 2011, J COMPUT CHEM, V32, P866, DOI 10.1002/jcc.21666; HUBER R, 1974, J MOL BIOL, V89, P73, DOI 10.1016/0022-2836(74)90163-6; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Humphris EL, 2008, STRUCTURE, V16, P1777, DOI 10.1016/j.str.2008.09.012; Jayaram B, 1998, J PHYS CHEM B, V102, P9571, DOI 10.1021/jp982007x; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Kiczak L, 2001, BBA-PROTEIN STRUCT M, V1550, P153, DOI 10.1016/S0167-4838(01)00282-5; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Kraunsoe JAE, 1996, BIOCHEMISTRY-US, V35, P9090, DOI 10.1021/bi953013b; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; Lane AA, 2003, CELL, V115, P305, DOI 10.1016/S0092-8674(03)00852-3; Laskowski Jr M, 2000, INTERACTION STANDARD; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Ley AC, 2003, US patent, Patent No. [003/0175919 A1, 0030175919]; Lindahl Erik R., 2008, V443, P3, DOI 10.1007/978-1-59745-177-2_1; Lu WY, 1997, J MOL BIOL, V266, P441, DOI 10.1006/jmbi.1996.0781; MARK AE, 1994, J MOL BIOL, V240, P167, DOI 10.1006/jmbi.1994.1430; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Moroy G, 2012, ANTI-CANCER AGENT ME, V12, P565, DOI 10.2174/187152012800617696; Nguyen H, 2013, J CHEM THEORY COMPUT, V9, P2020, DOI 10.1021/ct3010485; Norberg J, 2003, Q REV BIOPHYS, V36, P257, DOI 10.1017/S0033583503003895; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Oehme DP, 2012, J COMPUT CHEM, V33, P2566, DOI 10.1002/jcc.23095; Onufriev A, 2000, J PHYS CHEM B, V104, P3712, DOI 10.1021/jp994072s; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Onufriev AV, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3578686; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schaefer M, 1996, J PHYS CHEM-US, V100, P1578, DOI 10.1021/jp9521621; Scheidig AJ, 1997, PROTEIN SCI, V6, P1806, DOI 10.1002/pro.5560060902; SCHNEIDER T, 1978, PHYS REV B, V17, P1302, DOI 10.1103/PhysRevB.17.1302; Shapiro SD, 1995, P ASSOC AM PHYSICIAN, V107, P346; Sun ZF, 2004, LANCET ONCOL, V5, P182, DOI 10.1016/S1470-2045(04)01414-7; TSCHESCHE H, 1987, BIOCHIM BIOPHYS ACTA, V913, P97, DOI 10.1016/0167-4838(87)90238-X; van der Spoel D., 2010, GROMACS USER MANUAL; Wang JM, 2012, J CHEM INF MODEL, V52, P1199, DOI 10.1021/ci300064d; Weiser J, 1999, J COMPUT CHEM, V20, P217, DOI 10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A; Wodak SJ, 2004, CURR OPIN STRUC BIOL, V14, P242, DOI 10.1016/j.sbi.2004.02.003; Wolfram Research Inc., 2008, MATH VERS 7 0; Yang TY, 2011, PROTEINS, V79, P1940, DOI 10.1002/prot.23018; Zoete V, 2007, PROTEINS, V67, P1026, DOI 10.1002/prot.21395; Zou XQ, 1999, J AM CHEM SOC, V121, P8033, DOI 10.1021/ja984102p	78	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137787	10.1371/journal.pone.0137787	http://dx.doi.org/10.1371/journal.pone.0137787			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372354	Green Submitted, Green Published, gold			2022-12-27	WOS:000361604400031
J	Hurford, A; Lin, AL; Wu, JH				Hurford, Amy; Lin, Alice L.; Wu, Jianhong			Determinants of the Final Size and Case Rate of Nosocomial Outbreaks	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; INTENSIVE-CARE UNITS; HEALTH-CARE; TRANSMISSION; INFECTIONS; HOSPITALS; COMMUNITY; DYNAMICS; ROUTES	Different nosocomial pathogen species have varying infectivity and durations of infectiousness, while the transmission route determines the contact rate between pathogens and susceptible patients. To determine if the pathogen species and transmission route affects the size and spread of outbreaks, we perform a meta-analysis that examines data from 933 outbreaks of hospital-acquired infection representing 14 pathogen species and 8 transmission routes. We find that the mean number of cases in an outbreak is best predicted by the pathogen species and the mean number of cases per day is best predicted by the species-transmission route combination. Our fitted model predicts the largest mean number of cases for Salmonella outbreaks (22.3) and the smallest mean number of cases for Streptococci outbreaks (8.5). The largest mean number of cases per day occurs during Salmonella outbreaks spread via the environment (0.33) and the smallest occurs for Legionella outbreaks spread by multiple transmission routes (0.005). When combined with information on the frequency of outbreaks these findings could inform the design of infection control policies in hospitals.	[Hurford, Amy] Mem Univ Newfoundland, Dept Biol, St John, NF, Canada; [Hurford, Amy] Mem Univ Newfoundland, Dept Math & Stat, St John, NF A1C 5S7, Canada; [Lin, Alice L.] Queens Univ, Life Sci Program, Kingston, ON, Canada; [Wu, Jianhong] York Univ, Dept Math & Stat, York Inst Hlth Res, Ctr Dis Modelling, Toronto, ON M3J 2R7, Canada	Memorial University Newfoundland; Memorial University Newfoundland; Queens University - Canada; York University - Canada	Hurford, A (corresponding author), Mem Univ Newfoundland, Dept Biol, St John, NF, Canada.	ahurford@mun.ca	Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 2014-05413]; Canadian Institutes for Health Research (CIHR); NSERC [CHRP 446610-13]; Canada Research Chairs Program [950230720]; Public Health Agency of Canada; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001120, KL2TR001118] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs Program(Canada Research Chairs); Public Health Agency of Canada; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	AH was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC; RGPIN 2014-05413). JW and AH were supported by funding jointly from the Canadian Institutes for Health Research (CIHR) and NSERC (CHRP 446610-13). JH was supported by CIHR, NSERC, the Canada Research Chairs Program (950230720), and the Public Health Agency of Canada. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin DJ, 1999, P NATL ACAD SCI USA, V96, P6908, DOI 10.1073/pnas.96.12.6908; Bolker B, 2008, ECOLOGICAL MODELS DA; Bootsma MCJ, 2011, J R SOC INTERFACE, V8, P578, DOI 10.1098/rsif.2010.0349; Cook AR, 2007, P NATL ACAD SCI USA, V104, P20392, DOI 10.1073/pnas.0706461104; Cooper BS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002454; Cooper BS, 2004, P NATL ACAD SCI USA, V101, P10223, DOI 10.1073/pnas.0401324101; de Celles MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045758; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Gastmeier P, 2006, AM J INFECT CONTROL, V34, P603, DOI 10.1016/j.ajic.2006.01.014; Goldmann DA, 1996, JAMA-J AM MED ASSOC, V275, P234, DOI 10.1001/jama.275.3.234; Hetem DJ, 2013, EMERG INFECT DIS, V19, P1797, DOI 10.3201/eid1911.121085; Hetem DJ, 2012, J ANTIMICROB CHEMOTH, V67, P1775, DOI 10.1093/jac/dks125; Kiss IZ, 2006, MATH BIOSCI, V203, P124, DOI 10.1016/j.mbs.2006.03.002; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; KREGER BE, 1980, AM J MED, V68, P332, DOI 10.1016/0002-9343(80)90101-1; Lankford MG, 2006, AM J INFECT CONTROL, V34, P258, DOI 10.1016/j.ajic.2005.10.008; Lanzas C, 2011, INFECT CONT HOSP EP, V32, P553, DOI 10.1086/660013; Muto CA, 2003, INFECT CONT HOSP EP, V24, P362, DOI 10.1086/502213; Pelupessy I, 2002, P NATL ACAD SCI USA, V99, P5601, DOI 10.1073/pnas.082412899; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; Richards MJ, 1999, CRIT CARE MED, V27, P887, DOI 10.1097/00003246-199905000-00020; Ueno T, 2008, J THEOR BIOL, V254, P655, DOI 10.1016/j.jtbi.2008.07.001; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Wisplinghoff H, 2005, CLIN INFECT DIS, V40, P1077	24	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138216	10.1371/journal.pone.0138216	http://dx.doi.org/10.1371/journal.pone.0138216			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371880	gold, Green Published, Green Submitted			2022-12-27	WOS:000361604400057
J	Richard, V; Viallon, J; Cao-Lormeau, VM				Richard, Vaea; Viallon, Jerome; Cao-Lormeau, Van-Mai			Use of Centrifugal Filter Devices to Concentrate Dengue Virus in Mosquito per os Infection Experiments	PLOS ONE			English	Article							AEDES-ALBOPICTUS; GENE-TRANSFER; SUSCEPTIBILITY; TRANSMISSION; AEGYPTI; ISLAND	Dengue virus (DENV) is an arbovirus transmitted to humans by the bite of infected Aedes mosquitoes. Experimental per os infection of mosquitoes with DENV is usually a preliminary step in virus/vector studies but it requires being able to prepare artificial blood-meals with high virus titers. We report here the convenient use of centrifugal filter devices to quickly concentrate DENV particles in cell-culture supernatants. The median viral titer in concenntrated-supernatants was 8.50 log(10) TCID50/mL. By using these DENV concentrated-supernatants to prepare infectious blood-meals in Aedes aegypti per os infection experiments, we obtained a mean mosquito-infection rate of 94%. We also evaluated the use of centrifugal filter devices to recover DENV particles from non-infectious blood-meals presented to infected mosquitoes through a feeding membrane to collect their saliva.	[Richard, Vaea; Viallon, Jerome; Cao-Lormeau, Van-Mai] Inst Louis Malarde, Papeete, France		Richard, V (corresponding author), Inst Louis Malarde, Papeete, France.	vrichard@ilm.pf	Cao-Lormeau, Van-Mai/H-4879-2018	Cao-Lormeau, Van-Mai/0000-0001-5606-7480; Richard, Vaea/0000-0001-8132-0740				AITKEN THG, 1977, MOSQ NEWS, V37, P130; Anderson JR, 2006, AM J TROP MED HYG, V75, P886, DOI 10.4269/ajtmh.2006.75.886; Anderson SL, 2010, J AM MOSQUITO CONTR, V26, P108, DOI 10.2987/09-5935.1; Aubry M, 2012, J CLIN VIROL, V55, P23, DOI 10.1016/j.jcv.2012.05.010; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108; Chu THT, 1997, J VIROL, V71, P720, DOI 10.1128/JVI.71.1.720-725.1997; Cox J, 2012, J VIROL, V86, P7637, DOI 10.1128/JVI.00534-12; Doggett S.L., 2001, Arbovirus Research in Australia, V8, P126; GUBLER DJ, 1979, AM J TROP MED HYG, V28, P1045, DOI 10.4269/ajtmh.1979.28.1045; Huang KJ, 2008, AM J INFECT DIS, V4, P50, DOI 10.3844/ajidsp.2008.50.59; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; Jansen CC, 2010, MICROBES INFECT, V12, P272, DOI 10.1016/j.micinf.2009.12.011; Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005; Lambrechts L, 2012, J VIROL, V86, P1853, DOI 10.1128/JVI.06458-11; Musso D, 2014, TRANSFUSION, V54, P2924, DOI 10.1111/trf.12713; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reiser J, 1996, P NATL ACAD SCI USA, V93, P15266, DOI 10.1073/pnas.93.26.15266; Reiser J, 2000, GENE THER, V7, P910, DOI 10.1038/sj.gt.3301188; Russell BJ, 2007, J VIROL METHODS, V145, P62, DOI 10.1016/j.jviromet.2007.05.008; SAHA K, 1994, J VIROL METHODS, V46, P349, DOI 10.1016/0166-0934(94)90005-1; Van den Hurk AF, 2007, J MED ENTOMOL, V44, P845, DOI 10.1603/0022-2585(2007)44[845:EOFDSF]2.0.CO;2; Vazeille M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000706; Vazeille-Falcoz M, 1999, AM J TROP MED HYG, V60, P292, DOI 10.4269/ajtmh.1999.60.292; WHO, DENG SEV DENG	26	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138161	10.1371/journal.pone.0138161	http://dx.doi.org/10.1371/journal.pone.0138161			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372347	Green Submitted, Green Published, gold			2022-12-27	WOS:000361604400051
J	Tang, XF; Yang, FH; Tang, T; Yang, XM; Zhang, WJ; Wang, XH; Ji, L; Xiao, Y; Ma, K; Wang, Y; Kong, XL; Wang, JP; Liu, J; Xu, Q; Tian, DH; Qu, ZY				Tang, Xinfeng; Yang, Fahui; Tang, Tan; Yang, Xuemei; Zhang, Weijun; Wang, Xiaohua; Ji, Li; Xiao, Yun; Ma, Kun; Wang, Ying; Kong, Xianglei; Wang, Jianping; Liu, Jun; Xu, Qian; Tian, Donghua; Qu, Zhiyong			Advantages and Challenges of A Village Doctor-Based Cognitive Behavioral Therapy for Late-Life Depression in Rural China: A Qualitative Study	PLOS ONE			English	Article							MENTAL-HEALTH; CONSENSUS STATEMENT; LOW-INCOME; INTERVENTION; METAANALYSIS; DISORDERS; DIAGNOSIS; SERVICES; PAKISTAN; SUICIDE	Background The delivery of mental health services in rural China has been notably limited due to lack of qualified mental health professionals among other impeding factors. A village doctor-based cognitive behavioral therapy intervention may be one way of improving accessibility. The purpose of this study was to explore the advantages and challenges of implementing this intervention, as delivered by trained village doctors, to treat late-life depression in rural China. Methods We conducted one focus group discussion with 10 village doctors, 10 individual interviews with each of the village doctors, and individual interviews with 19 older adults. The topic guides were advantages and challenges of the intervention program from the perspective of the village doctors and older adults. Interviews were audio-recorded, transcribed, coded using NVivo 8, and analyzed using thematic analysis. Results The village doctors stressed the importance of role-playing and using instructive manuals in the training. Proper supervision was also a key component of the program. The benefits received from the intervention for the village doctors and the elders were positive such that both the doctors and the older adults were willing to implement/receive this intervention. Cultural and political factors (renqing and perceived policy consideration) facilitated the elders' access to mental health services. Challenges included a lack of real therapy (in contrast to role-playing) demonstrated in the training and lack of a step-by-step manual based on different types of problems encountered. Other impediments to the successful implementation of the intervention included the time constraints of village doctors and the presence of other people when conducting the intervention. Conclusions The present study has demonstrated that the intervention program is likely to be an acceptable geriatric depression intervention in rural China if several challenges are appropriately addressed.	[Tang, Xinfeng; Zhang, Weijun; Wang, Xiaohua; Ma, Kun; Wang, Ying; Kong, Xianglei; Tian, Donghua; Qu, Zhiyong] Beijing Normal Univ, Ctr Behav Hlth, Beijing 100875, Peoples R China; [Tang, Xinfeng; Zhang, Weijun; Wang, Xiaohua; Ma, Kun; Wang, Ying; Kong, Xianglei; Tian, Donghua; Qu, Zhiyong] Beijing Normal Univ, Sch Social Dev & Publ Policy, Beijing 100875, Peoples R China; [Yang, Fahui] City Univ Macau, Fac Human & Social Sci, Macau, Peoples R China; [Tang, Tan] Chinese Univ Hong Kong, Dept Social Work, Hong Kong, Hong Kong, Peoples R China; [Yang, Xuemei] Sichuan Normal Univ, Mental Hlth Educ Ctr Coll Student, Chengdu, Peoples R China; [Zhang, Weijun; Tian, Donghua; Qu, Zhiyong] Beijing Normal Univ, China Inst Hlth, Beijing 100875, Peoples R China; [Ji, Li] Mianzhu Ankang Hosp, Deyang, Peoples R China; [Xiao, Yun] Mianzhu Maternal & Child Hlth Hosp, Mianzhu, Sichuan, Peoples R China; [Wang, Jianping] Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China; [Wang, Jianping] Capital Med Univ, Dept Clin Psychol, Beijing, Peoples R China; [Liu, Jun] Capital Med Univ, Beijing Anding Hosp, Dept Psychiat & Clin Psychol, Beijing, Peoples R China; [Xu, Qian] Southwestern Univ Finance & Econ, Ctr Mental Hlth, Chengdu, Peoples R China	Beijing Normal University; Beijing Normal University; City University of Macau; Chinese University of Hong Kong; Sichuan Normal University; Beijing Normal University; Beijing Normal University; Capital Medical University; Capital Medical University; Southwestern University of Finance & Economics - China	Qu, ZY (corresponding author), Beijing Normal Univ, Ctr Behav Hlth, Beijing 100875, Peoples R China.	qzy@bnu.edu.cn	wang, xiao/HGB-7081-2022; zhang, weijun/AFU-6997-2022; Linong, Ji/AAB-6543-2020	wang, xiao/0000-0002-4088-3341; zhang, weijun/0000-0003-3436-3371; Tang, Xinfeng/0000-0001-5017-1295	Fundamental Research Funds for the Central Universities;  [SKZZB2014011]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); 	This work was supported by grants to ZQ from the Fundamental Research Funds for the Central Universities. The grant number is SKZZB2014011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos GS, 1996, AM J PSYCHIAT, V153, P877; [栗克清 Li Keqing], 2012, [中国心理卫生杂志, Chinese Mental Health Journal], V26, P321; Aschim B, 2011, SCAND J PRIM HEALTH, V29, P176, DOI 10.3109/02813432.2011.595582; Beck A, 1979, COGNITIVE THERAPY DE; Beidas RS, 2010, CLIN PSYCHOL-SCI PR, V17, P1, DOI 10.1111/j.1468-2850.2009.01187.x; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Charney DS, 2003, ARCH GEN PSYCHIAT, V60, P664, DOI 10.1001/archpsyc.60.7.664; Crowther MR, 2010, J CLIN PSYCHOL, V66, P502, DOI 10.1002/jclp.20678; Cuijpers P, 2013, CAN J PSYCHIAT, V58, P376, DOI 10.1177/070674371305800702; Ding Y, 2013, B WORLD HEALTH ORGAN, V91, P64, DOI 10.2471/BLT.12.109447; Draper B, 1996, INT J GERIATR PSYCH, V11, P577; Eaton J, 2011, LANCET, V378, P1592, DOI 10.1016/S0140-6736(11)60891-X; Fang Y, 2013, COLLABORATIVE CARE G; Gould RL, 2012, J AM GERIATR SOC, V60, P1817, DOI 10.1111/j.1532-5415.2012.04166.x; Henggeler SW, 2002, J CLIN CHILD ADOLESC, V31, P155, DOI 10.1207/153744202753604449; [黄希庭 Huang Xiting], 2007, [心理科学, Psychological Science], V30, P2; HWANG KK, 1987, AM J SOCIOL, V92, P944, DOI 10.1086/228588; Jacobson NS, 1996, J CONSULT CLIN PSYCH, V64, P295, DOI 10.1037/0022-006X.64.2.295; Kakuma R, 2011, LANCET, V378, P1654, DOI 10.1016/S0140-6736(11)61093-3; Kleinman A, 1986, SOCIAL ORIGINS DISTR; Lebowitz BD, 1997, JAMA-J AM MED ASSOC, V278, P1186, DOI 10.1001/jama.278.14.1186; Lin YN, 2002, AM J PSYCHOTHER, V56, P46, DOI 10.1176/appi.psychotherapy.2002.56.1.46; Ma X, 2008, PSYCHOL MED, V38, P1723, DOI 10.1017/S0033291708003164; Moss K. S., 2008, HDB BEHAV COGNITIVE, P1; Naeem F, 2015, J AFFECT DISORDERS, V177, P101, DOI 10.1016/j.jad.2015.02.012; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Patel V, 2011, BEHAV RES THER, V49, P523, DOI 10.1016/j.brat.2011.06.012; Perepletchikova F, 2005, CLIN PSYCHOL-SCI PR, V12, P365, DOI 10.1093/clipsy/bpi045; Rahman A, 2007, ARCH WOMEN MENT HLTH, V10, P211, DOI 10.1007/s00737-007-0193-9; Rahman A, 2008, LANCET, V372, P902, DOI 10.1016/S0140-6736(08)61400-2; ROKKE PD, 1995, J CLIN GEROPSYCHOLOG, V1, P243; Rusch N, 2005, EUR PSYCHIAT, V20, P529, DOI 10.1016/j.eurpsy.2005.04.004; Waern M, 2002, BMJ-BRIT MED J, V324, P1355, DOI 10.1136/bmj.324.7350.1355; Waller H, 2013, BEHAV COGN PSYCHOTH, V23, P1; Wilson KCM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004853.pub2; Wu F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074176; Xu HW, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-36; Yang LH, 2008, SOC SCI MED, V67, P398, DOI 10.1016/j.socscimed.2008.03.011; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1	39	6	6	7	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137555	10.1371/journal.pone.0137555	http://dx.doi.org/10.1371/journal.pone.0137555			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8LR	26371473	Green Submitted, gold, Green Published			2022-12-27	WOS:000361604400025
J	Butler, MW; Ligon, RA				Butler, Michael W.; Ligon, Russell A.			Interactions between Biliverdin, Oxidative Damage, and Spleen Morphology after Simulated Aggressive Encounters in Veiled Chameleons	PLOS ONE			English	Article							HISTORY TRADE-OFFS; ANTIOXIDANT CAPACITY; ACUTE STRESS; BEHAVIOR; PROTEIN; REPRODUCTION; STIMULATION; MECHANISMS; CORTISOL; ECOLOGY	Stressors frequently increase oxidative damage-unless organisms simultaneously mount effective antioxidant responses. One putative mitigative mechanism is the use of biliverdin, an antioxidant produced in the spleen during erythrocyte degradation. We hypothesized that both wild and captive-bred male veiled chameleons (Chamaeleo calyptratus), which are highly aggressive to conspecifics, would respond to agonistic displays with increased levels of oxidative damage, but that increased levels of biliverdin would limit this increase. We found that even just visual exposure to a potential combatant resulted in decreased body mass during the subsequent 48-hour period, but that hematocrit, biliverdin concentration in the bile, relative spleen size, and oxidative damage in plasma, liver, and spleen were unaffected. Contrary to our predictions, we found that individuals with smaller spleens exhibited greater decreases in hematocrit and higher bile biliverdin concentrations, suggesting a revision to the idea of spleen-dependent erythrocyte processing. Interestingly, individuals with larger spleens had reduced oxidative damage in both the liver and spleen, demonstrating the spleen's importance in modulating oxidative damage. We also uncovered differences in spleen size and oxidative damage between wild and captive-bred chameleons, highlighting environmentally dependent differences in oxidative physiology. Lastly, we found no relationship between oxidative damage and biliverdin concentration, calling into question biliverdin's antioxidant role in this species.	[Butler, Michael W.] Lafayette Coll, Dept Biol, Easton, PA 18042 USA; [Ligon, Russell A.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Lafayette College; Arizona State University; Arizona State University-Tempe	Butler, MW (corresponding author), Lafayette Coll, Dept Biol, Easton, PA 18042 USA.	butlermw@lafayette.edu	Ligon, Russell/M-1233-2013	Ligon, Russell/0000-0002-0195-8275; Butler, Michael/0000-0002-8390-2960	Lafayette College	Lafayette College	Funding provided to MWB by Lafayette College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakovic D, 2013, J PHYSIOL PHARMACOL, V64, P649; Berlec A, 2014, J VET DIAGN INVEST, V26, P521, DOI 10.1177/1040638714535403; Bonkovsky HL, 2013, COMPR PHYSIOL, V3, P365, DOI 10.1002/cphy.c120006; Brenes A, 2010, SPAN J AGRIC RES, V8, P326, DOI 10.5424/sjar/2010082-1199; Catoni C, 2008, ANIM BEHAV, V76, P1107, DOI 10.1016/j.anbehav.2008.05.027; Costantini D, 2008, ECOL LETT, V11, P1238, DOI 10.1111/j.1461-0248.2008.01246.x; Costantini D, 2008, J COMP PHYSIOL B, V178, P829, DOI 10.1007/s00360-008-0270-z; Costantini D, 2008, J EXP BIOL, V211, P377, DOI 10.1242/jeb.012856; Costantini D, 2008, BIOL LETTERS, V4, P119, DOI 10.1098/rsbl.2007.0513; Costantini D, 2011, J COMP PHYSIOL B, V181, P447, DOI 10.1007/s00360-011-0566-2; Costantini D, 2010, FUNCT ECOL, V24, P950, DOI 10.1111/j.1365-2435.2010.01746.x; Costantini D, 2009, FUNCT ECOL, V23, P506, DOI 10.1111/j.1365-2435.2009.01546.x; Creel S, 2013, FUNCT ECOL, V27, P66, DOI 10.1111/j.1365-2435.2012.02029.x; Cuadrado M, 2000, HERPETOLOGICA, V56, P387; Daly MJ, 2012, DNA REPAIR, V11, P12, DOI 10.1016/j.dnarep.2011.10.024; Davies S, 2013, PHYSIOL BIOCHEM ZOOL, V86, P47, DOI 10.1086/667990; Dickens MJ, 2009, GEN COMP ENDOCR, V160, P76, DOI 10.1016/j.ygcen.2008.10.023; Douxfils J, 2011, FISH SHELLFISH IMMUN, V31, P1113, DOI 10.1016/j.fsi.2011.10.001; Fan YP, 2014, INT J BIOL MACROMOL, V65, P200, DOI 10.1016/j.ijbiomac.2014.01.041; Fendel R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010038; Fernandez-Llario P, 2004, EUR J WILDLIFE RES, V50, P13, DOI 10.1007/s10344-003-0028-6; Foller M, 2010, FASEB J, V24, P3351, DOI 10.1096/fj.10-159483; Hamalainen A, 2012, BEHAV ECOL SOCIOBIOL, V66, P1577, DOI 10.1007/s00265-012-1411-7; Hardy ICW, 2013, ANIMAL CONTESTS, P1, DOI 10.1017/CBO9781139051248; HILLENIUS D., 1966, BEAUFORTIA SEE MISC PUBLICATIONS ZOOL MUS AMSTERDAM, V13, P91; Horak P, 2007, AM NAT, V170, P625, DOI 10.1086/521232; Isaksson C, 2011, BEHAVIOUR, V148, P713, DOI 10.1163/000579511X574204; Jennings DJ, 2010, ANIM BEHAV, V79, P1293, DOI 10.1016/j.anbehav.2010.02.031; Jiang SZ, 2011, J ANIM SCI, V89, P3008, DOI 10.2527/jas.2010-3658; Juttner F, 2013, EUR FOOD RES TECHNOL, V236, P943, DOI 10.1007/s00217-013-1932-y; Laguerre M, 2007, PROG LIPID RES, V46, P244, DOI 10.1016/j.plipres.2007.05.002; Ligon RA, 2014, BEHAV ECOL SOCIOBIOL, V68, P1007, DOI 10.1007/s00265-014-1713-z; Ligon RA, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0892; Mancuso C, 2012, NEUROSCI LETT, V518, P101, DOI 10.1016/j.neulet.2012.04.062; Mateo R, 2004, J CHROMATOGR B, V810, P305, DOI 10.1016/j.jchromb.2004.08.019; McDonagh A. F., 1979, PORPHYRINS, VVI; MCDONAGH AF, 1980, BIOCHEM J, V189, P193, DOI 10.1042/bj1890193; McEwen BS, 1997, BRAIN RES REV, V23, P79, DOI 10.1016/S0165-0173(96)00012-4; McGraw KJ, 2011, J COMP PHYSIOL A, V197, P683, DOI 10.1007/s00359-011-0631-z; McGraw KJ, 2010, FUNCT ECOL, V24, P947, DOI 10.1111/j.1365-2435.2010.01772.x; Metcalfe NB, 2010, FUNCT ECOL, V24, P984, DOI 10.1111/j.1365-2435.2010.01750.x; Molzer C, 2012, FREE RADICAL RES, V46, P1369, DOI 10.3109/10715762.2012.715371; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Moore IT, 2003, HORM BEHAV, V43, P39, DOI 10.1016/S0018-506X(02)00038-7; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Necas P, 1999, CHAMELEONS NATURES H; Oishi K, 1999, ACTA PHYSIOL SCAND, V165, P65; Orr AL, 2009, COMP BIOCHEM PHYS A, V153, P213, DOI 10.1016/j.cbpa.2009.02.016; Page MM, 2009, COMP BIOCHEM PHYS A, V152, P115, DOI 10.1016/j.cbpa.2008.09.032; Pennacchio M, 2003, HERPETOL J, V13, P161; Rammal H, 2010, EUR J PHARMACOL, V627, P173, DOI 10.1016/j.ejphar.2009.11.001; Ros AFH, 2014, J EXP BIOL, V217, P1768, DOI 10.1242/jeb.093666; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schoech SJ, 2011, CURR ZOOL, V57, P514, DOI 10.1093/czoolo/57.4.514; Selman C, 2012, TRENDS ECOL EVOL, V27, P570, DOI 10.1016/j.tree.2012.06.006; Sharma S, 2009, ENVIRON TOXICOL, V24, P1, DOI 10.1002/tox.20383; Small TW, 2015, J COMP PHYSIOL B, V185, P119, DOI 10.1007/s00360-014-0866-4; Summers CH, 2005, EUR J PHARMACOL, V526, P21, DOI 10.1016/j.ejphar.2005.09.059; Tolosano E, 2002, BLOOD, V100, P4201, DOI 10.1182/blood-2002-04-1270; Turkan H, 2004, BIOL TRACE ELEM RES, V102, P105, DOI 10.1385/BTER:102:1-3:105; Wilhelm D, 2007, COMP BIOCHEM PHYS C, V146, P214, DOI 10.1016/j.cbpc.2006.11.015; Williams RB, 2005, AVIAN PATHOL, V34, P29, DOI 10.1080/03079450400025430; Wolff JO, 1998, OIKOS, V83, P529, DOI 10.2307/3546680	64	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138007	10.1371/journal.pone.0138007	http://dx.doi.org/10.1371/journal.pone.0138007			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368930	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100201
J	Campagna, D; Gasparini, F; Franchi, N; Manni, L; Telatin, A; Vitulo, N; Ballarin, L; Valle, G				Campagna, Davide; Gasparini, Fabio; Franchi, Nicola; Manni, Lucia; Telatin, Andrea; Vitulo, Nicola; Ballarin, Loriano; Valle, Giorgio			SATRAP: SOLiD Assembler TRAnslation Program	PLOS ONE			English	Article							SEQUENCES; GENOME	SOLiD DNA sequences are typically analyzed using a reference genome, while they are not recommended for de novo assembly of genomes or transcriptomes. This is mainly due to the difficulty in translating the SOLiD color-space data into normal base-space sequences. In fact, the nature of color-space is such that any misinterpreted color leads to a chain of further translation errors, producing totally wrong results. Here we describe SATRAP, a computer program designed to efficiently translate de novo assembled color-space sequences into a base-space format. The program was tested and validated using simulated and real transcriptomic data; its modularity allows an easy integration into more complex pipelines, such as Oases for RNA-seq de novo assembly. SATRAP is available at http://satrap.cribi.unipd.it, either as a multi-step pipeline incorporating several tools for RNA-seq assembly or as an individual module for use with the Oases package.	[Campagna, Davide; Telatin, Andrea; Valle, Giorgio] Univ Padua, CRIBI Biotechnol Ctr, Padua, Italy; [Campagna, Davide; Gasparini, Fabio; Franchi, Nicola; Manni, Lucia; Vitulo, Nicola; Ballarin, Loriano; Valle, Giorgio] Univ Padua, Dept Biol, Padua, Italy	University of Padua; University of Padua	Campagna, D (corresponding author), Univ Padua, CRIBI Biotechnol Ctr, Padua, Italy.	davide@cribi.unipd.it	Telatin, Andrea/I-7438-2013; Gasparini, Fabio/F-4485-2011; Vitulo, Nicola/GVT-2319-2022; Ballarin, Loriano/D-7106-2011	Telatin, Andrea/0000-0001-7619-281X; Gasparini, Fabio/0000-0002-7574-0834; Ballarin, Loriano/0000-0002-3287-8550; VALLE, GIORGIO/0000-0003-4377-5685; Manni, Lucia/0000-0003-4257-8946; Vitulo, Nicola/0000-0002-9571-0747	Universita degli Studi di Padova, Progetto Strategico BIOINFOGEN; Consiglio Nazionale delle Ricerche, Progetto EPIGEN; Fondazione Cassa di Risparmio di Padova e Rovigo, Progetti di eccellenza	Universita degli Studi di Padova, Progetto Strategico BIOINFOGEN; Consiglio Nazionale delle Ricerche, Progetto EPIGEN; Fondazione Cassa di Risparmio di Padova e Rovigo, Progetti di eccellenza	This work was funded by Universita degli Studi di Padova, Progetto Strategico 2011 BIOINFOGEN (to GV) (http://www.unipd.it/ricerca/finanziamenti/finanziamenti-ateneo/progetti-strategiciateneo); Consiglio Nazionale delle Ricerche, Progetto EPIGEN (to GV) (http://www.epigen.it/); and Fondazione Cassa di Risparmio di Padova e Rovigo, Progetti di eccellenza 2008 (to LB) (http://www.fondazionecariparo.net/).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Campagna D, 2009, BIOINFORMATICS, V25, P967, DOI 10.1093/bioinformatics/btp087; Dayarian A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-345; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Umemura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063673; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Zerbino DR, 2010, CURR PROTOC BIOINFOR, V11, P11	9	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137436	10.1371/journal.pone.0137436	http://dx.doi.org/10.1371/journal.pone.0137436			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368549	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100072
J	Choudhury, NA; Parascando, JA; Benasich, AA				Choudhury, Naseem A.; Parascando, Jessica A.; Benasich, April A.			Effects of Presentation Rate and Attention on Auditory Discrimination: A Comparison of Long-Latency Auditory Evoked Potentials in School-Aged Children and Adults	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; MISMATCH-NEGATIVITY MMN; LANGUAGE-LEARNING IMPAIRMENTS; SELECTIVE ATTENTION; PROCESSING DEFICITS; SPEECH STIMULI; NEUROPHYSIOLOGICAL INDEXES; FREQUENCY DISCRIMINATION; READING DISABILITIES; SENSORY MEMORY	Decoding human speech requires both perception and integration of brief, successive auditory stimuli that enter the central nervous system as well as the allocation of attention to language-relevant signals. This study assesses the role of attention on processing rapid transient stimuli in adults and children. Cortical responses (EEG/ERPs), specifically mismatch negativity (MMN) responses, to paired tones (standard 100-100Hz; deviant 100-300Hz) separated by a 300, 70 or 10ms silent gap (ISI) were recorded under Ignore and Attend conditions in 21 adults and 23 children (6-11 years old). In adults, an attention-related enhancement was found for all rate conditions and laterality effects (L>R) were observed. In children, 2 auditory discrimination-related peaks were identified from the difference wave (deviant-standard): an early peak (eMMN) at about 100-300ms indexing sensory processing, and a later peak (LDN), at about 400-600ms, thought to reflect reorientation to the deviant stimuli or "second-look" processing. Results revealed differing patterns of activation and attention modulation for the eMMN in children as compared to the MMN in adults: The eMMN had a more frontal topography as compared to adults and attention played a significantly greater role in childrens' rate processing. The pattern of findings for the LDN was consistent with hypothesized mechanisms related to further processing of complex stimuli. The differences between eMMN and LDN observed here support the premise that separate cognitive processes and mechanisms underlie these ERP peaks. These findings are the first to show that the eMMN and LDN differ under different temporal and attentional conditions, and that a more complete understanding of children's responses to rapid successive auditory stimulation requires an examination of both peaks.	[Choudhury, Naseem A.] Ramapo Coll New Jersey Mahwah, SSHS, Psychol, Mahwah, NJ 07430 USA; [Choudhury, Naseem A.; Parascando, Jessica A.; Benasich, April A.] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Ramapo College New Jersey (RCNJ); Rutgers State University Newark; Rutgers State University New Brunswick	Choudhury, NA (corresponding author), Ramapo Coll New Jersey Mahwah, SSHS, Psychol, Mahwah, NJ 07430 USA.	nchoudhu@ramapo.edu	Choudhury, Naseem A/GOV-7222-2022	Benasich, April A/0000-0002-5137-776X	Elizabeth H. Solomon Center for Neurodevelopmental Research	Elizabeth H. Solomon Center for Neurodevelopmental Research	Funding was provided by the Elizabeth H. Solomon Center for Neurodevelopmental Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHO K, 1995, EAR HEARING, V16, P38, DOI 10.1097/00003446-199502000-00004; Alho K., 1992, ELECTROENCEPHALOGRAP, V5, P356; Allen J, 2000, PERCEPT PSYCHOPHYS, V62, P1383, DOI 10.3758/BF03212140; Alonso-Bua B, 2006, INT J PSYCHOPHYSIOL, V59, P159, DOI 10.1016/j.ijpsycho.2005.03.020; Banai K, 2006, CEREB CORTEX, V16, P1718, DOI 10.1093/cercor/bhj107; Benasich A. A., 2012, DEV DYSLEXIA EARLY P, P99; Benasich AA, 2006, NEUROPSYCHOLOGIA, V44, P396, DOI 10.1016/j.neuropsychologia.2005.06.004; Benasich AA, 2002, BEHAV BRAIN RES, V136, P31, DOI 10.1016/S0166-4328(02)00098-0; Benasich AA, 2002, DEV PSYCHOBIOL, V40, P278, DOI 10.1002/dev.10032; Benasich AA, 2014, J NEUROSCI, V34, P13349, DOI 10.1523/JNEUROSCI.0972-14.2014; BERG P, 1994, ELECTROEN CLIN NEURO, V90, P229, DOI 10.1016/0013-4694(94)90094-9; Bishop DVM, 2011, DEVELOPMENTAL SCI, V14, P402, DOI 10.1111/j.1467-7687.2010.00990.x; Bitz U, 2007, NEUROREPORT, V18, P911, DOI 10.1097/WNR.0b013e32810f2e25; Ceponiene R, 1998, EVOKED POTENTIAL, V108, P345, DOI 10.1016/S0168-5597(97)00081-6; Ceponiene R, 2004, PSYCHOPHYSIOLOGY, V41, P130, DOI 10.1111/j.1469-8986.2003.00138.x; Ceponiene R, 2002, INT J PSYCHOPHYSIOL, V43, P199, DOI 10.1016/S0167-8760(01)00172-6; Cheour M, 2000, CLIN NEUROPHYSIOL, V111, P4, DOI 10.1016/S1388-2457(99)00191-1; Cheour M, 2001, AUDIOL NEURO-OTOL, V6, P2, DOI 10.1159/000046804; Choudhury N, 2003, J SPEECH LANG HEAR R, V46, P261, DOI 10.1044/1092-4388(2003/021); Choudhury N, 2011, CLIN NEUROPHYSIOL, V122, P320, DOI 10.1016/j.clinph.2010.05.035; Csepe V, 1995, EEG CL N SU, P204; Eggermont JJ, 1998, NEUROSCI BIOBEHAV R, V22, P355, DOI 10.1016/S0149-7634(97)00021-3; EGGERMONT JJ, 1992, ACTA OTO-LARYNGOL, V112, P197, DOI 10.1080/00016489.1992.11665403; EGGERMONT JJ, 1988, ELECTROEN CLIN NEURO, V70, P293, DOI 10.1016/0013-4694(88)90048-X; Eggermont JJ, 1988, AUDITORY DEV INFANCY, P21; Fitch R Holly, 2003, Behav Cogn Neurosci Rev, V2, P155, DOI 10.1177/1534582303258736; Friedman J., 2009, THESIS RUTGERS U NEW; Giraud AL, 1995, BRAIN RES, V705, P15, DOI 10.1016/0006-8993(95)01091-2; Gomes H, 2000, FRONT BIOSCI-LANDMRK, V5, pD108, DOI 10.2741/Gomes; Gomot M, 2000, NEUROREPORT, V11, P3109, DOI 10.1097/00001756-200009280-00014; Grady CL, 1997, NEUROREPORT, V8, P2511, DOI 10.1097/00001756-199707280-00019; HALGREN E, 1995, ELECTROEN CLIN NEURO, V94, P229, DOI 10.1016/0013-4694(95)98475-N; Hamalainen JA, 2008, CLIN NEUROPHYSIOL, V119, P100, DOI 10.1016/j.clinph.2007.09.064; Hamalainen JA, 2013, DEV NEUROPSYCHOL, V38, P550, DOI 10.1080/87565641.2012.718817; Hamalainen JA, 2013, J LEARN DISABIL-US, V46, P413, DOI 10.1177/0022219411436213; Heim S., 2006, DEV PSYCHOPATHOL, P268; Hommet C, 2009, NEUROPSYCHOLOGIA, V47, P761, DOI 10.1016/j.neuropsychologia.2008.12.010; HUTTENLOCHER PR, 1982, NEUROSCI LETT, V33, P247, DOI 10.1016/0304-3940(82)90379-2; Ille N, 2002, J CLIN NEUROPHYSIOL, V19, P113, DOI 10.1097/00004691-200203000-00002; ILLE N, 1997, BIOMED TECH S, V42, P80; Jancke L, 1999, NEUROSCI LETT, V266, P125, DOI 10.1016/S0304-3940(99)00288-8; Kauramaki J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000909; Korpilahti P, 2001, BRAIN LANG, V76, P332, DOI 10.1006/brln.2000.2426; KORPILAHTI P, 1994, ELECTROEN CLIN NEURO, V91, P256, DOI 10.1016/0013-4694(94)90189-9; Korpilahti P, 1998, PATHOPHYSIOL, V5, P202; Kraus N, 1996, SCIENCE, V273, P971, DOI 10.1126/science.273.5277.971; KRAUS N, 1993, ELECTROEN CLIN NEURO, V88, P123, DOI 10.1016/0168-5597(93)90063-U; KRAUS N, 1994, J ACOUST SOC AM, V96, P2758, DOI 10.1121/1.411282; KRAUS N, 1994, J NEUROPHYSIOL, V72, P1270, DOI 10.1152/jn.1994.72.3.1270; KRAUS N, 1993, EAR HEARING, V14, P223, DOI 10.1097/00003446-199308000-00001; KRAUS N, 1992, EAR HEARING, V13, P158, DOI 10.1097/00003446-199206000-00004; Kraus N, 1995, ELECTROENCEPHALOGR C, V88, P123; Kuhl PK, 2010, NEURON, V67, P713, DOI 10.1016/j.neuron.2010.08.038; Leonard L.B., 1998, CHILDREN SPECIFIC LA; Luu P., 2000, DETERMINATION GEODES; Martin BA, 2003, EAR HEARING, V24, P463, DOI 10.1097/01.AUD.0000100306.20188.0E; Moore JK, 2002, ANN OTO RHINOL LARYN, V111, P7, DOI 10.1177/00034894021110S502; Moore JK, 2001, JARO-J ASSOC RES OTO, V2, P297, DOI 10.1007/s101620010052; Morr ML, 2002, EAR HEARING, V23, P118, DOI 10.1097/00003446-200204000-00005; Muenssinger J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00377; Musacchia G, 2013, NEUROPSYCHOLOGIA, V51, P2812, DOI 10.1016/j.neuropsychologia.2013.09.006; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1993, NEUROREPORT, V4, P503; Naatanen R, 2012, CLIN NEUROPHYSIOL, V123, P424, DOI 10.1016/j.clinph.2011.09.020; NAATANEN R, 1989, NEUROSCI LETT, V98, P217, DOI 10.1016/0304-3940(89)90513-2; NAATANEN R, 1993, PSYCHOPHYSIOLOGY, V30, P436, DOI 10.1111/j.1469-8986.1993.tb02067.x; Naatanen R., 2018, ATTENTION BRAIN FUNC; Niebur E, 2002, CURR OPIN NEUROBIOL, V12, P190, DOI 10.1016/S0959-4388(02)00310-0; Oades RD, 1997, PSYCHOPHYSIOLOGY, V34, P677, DOI 10.1111/j.1469-8986.1997.tb02143.x; Ortiz-Mantilla S, 2010, BRAIN RES, V1362, P78, DOI 10.1016/j.brainres.2010.09.031; PAAVILAINEN P, 1989, ELECTROEN CLIN NEURO, V73, P129, DOI 10.1016/0013-4694(89)90192-2; Paavilainen P, 2013, INT J PSYCHOPHYSIOL, V88, P109, DOI 10.1016/j.ijpsycho.2013.03.015; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; Raschle NM, 2014, CEREB CORTEX, V24, P2489, DOI 10.1093/cercor/bht104; Rinker T, 2007, NEUROSCI LETT, V413, P99, DOI 10.1016/j.neulet.2006.11.033; Sadia G, 2013, BIOL PSYCHOL, V92, P191, DOI 10.1016/j.biopsycho.2012.10.008; Sams M, 1991, Ann N Y Acad Sci, V620, P102, DOI 10.1111/j.1749-6632.1991.tb51577.x; SAMS M, 1985, ELECTROEN CLIN NEURO, V61, P254, DOI 10.1016/0013-4694(85)91092-2; Scherg M, 1989, J Cogn Neurosci, V1, P336, DOI 10.1162/jocn.1989.1.4.336; Sculthorpe LD, 2009, INTELLIGENCE, V37, P405, DOI 10.1016/j.intell.2009.03.006; Shafer VL, 2000, EAR HEARING, V21, P242, DOI 10.1097/00003446-200006000-00008; Shafer VL, 2005, J COGNITIVE NEUROSCI, V17, P1168, DOI 10.1162/0898929054475217; ShafeR VL, 2001, ACTA OTO-LARYNGOL, V121, P297; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Sussman E, 2008, HEARING RES, V236, P61, DOI 10.1016/j.heares.2007.12.001; Sussman E, 2015, INT J PSYCHOPHYSIOL, V95, P113, DOI 10.1016/j.ijpsycho.2014.02.002; Sussman E, 2009, NEUROPSYCHOLOGIA, V47, P771, DOI 10.1016/j.neuropsychologia.2008.12.007; Sussman ES, 2007, J PSYCHOPHYSIOL, V21, P164, DOI 10.1027/0269-8803.21.34.164; Sussman ES, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00333; Sussman ES, 2011, DEV COGN NEUROS-NETH, V1, P351, DOI 10.1016/j.dcn.2011.01.003; Sutcliffe P, 2005, J EXP CHILD PSYCHOL, V91, P249, DOI 10.1016/j.jecp.2005.03.004; Tallal P, 2002, DEV PSYCHOPATHOL, V14, P559, DOI 10.1017/S0954579402003097; Thomas David G., 1994, P207; Thomas JJ, 2001, SOC NEUR SAN DIEG CA; TREHUB SE, 1995, J ACOUST SOC AM, V98, P2532, DOI 10.1121/1.414396; TREJO LJ, 1995, PSYCHOPHYSIOLOGY, V32, P319, DOI 10.1111/j.1469-8986.1995.tb01214.x; Uwer R, 2002, DEV MED CHILD NEUROL, V44, P527; Vandermosten M, 2010, P NATL ACAD SCI USA, V107, P10389, DOI 10.1073/pnas.0912858107; Werner L. A., 1996, HUMAN AUDITORY DEV; WERNER LA, 1992, CHILD DEV, V63, P260, DOI 10.1111/j.1467-8624.1992.tb01625.x; Wetzel N, 2014, PSYCH J, V3, P72, DOI 10.1002/pchj.49; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722; Woodruff PWR, 1996, NEUROREPORT, V7, P1909, DOI 10.1097/00001756-199608120-00007; Woods DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005183; WOODS DL, 1992, ELECTROEN CLIN NEURO, V82, P341, DOI 10.1016/0013-4694(92)90004-2	105	16	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138160	10.1371/journal.pone.0138160	http://dx.doi.org/10.1371/journal.pone.0138160			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8KS	26368126	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100239
J	Gram, M; Anderson, UD; Johansson, ME; Edstrom-Hagerwall, A; Larsson, I; Jalmby, M; Hansson, SR; Akerstrom, B				Gram, Magnus; Anderson, Ulrik Dolberg; Johansson, Maria E.; Edstrom-Hagerwall, Anneli; Larsson, Irene; Jalmby, Maya; Hansson, Stefan R.; Akerstrom, Bo			The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators	PLOS ONE			English	Article							PREGNANCY-INDUCED HYPERTENSION; NITRIC-OXIDE BIOAVAILABILITY; LIPOCALIN ALPHA(1)-MICROGLOBULIN; SCAVENGER RECEPTOR; OXYGENASE SYSTEM; CARBON-MONOXIDE; ANGIOTENSIN-II; IX-ALPHA; IN-VITRO; HEMOPEXIN	Preeclampsia (PE) complicates 3-8% of all pregnancies and manifests clinically as hypertension and proteinuria in the second half of gestation. The pathogenesis of PE is not fully understood but recent studies have described the involvement of cell-free fetal hemoglobin (HbF). Hypothesizing that PE is associated with prolonged hemolysis we have studied the response of the cell-free Hb- and heme defense network. Thus, we have investigated the levels of cell-free HbF (both free, denoted HbF, and in complex with Hp, denoted Hp-HbF) as well as the major human endogenous Hb-and heme-scavenging systems: haptoglobin (Hp), hemopexin (Hpx), alpha(1)-microglobulin (A1M) and CD163 in plasma of PE women (n = 98) and women with normal pregnancies (n = 47) at term. A significant increase of the mean plasma HbF concentration was observed in women with PE. Plasma levels of Hp and Hpx were statistically significantly reduced, whereas the level of the extravascular heme-and radical scavenger A1M was significantly increased in plasma of women with PE. The Hpx levels significantly correlated with maternal blood pressure. Furthermore, HbF and the related scavenger proteins displayed a potential to be used as clinical biomarkers for more precise diagnosis of PE and are candidates as predictors of identifying pregnancies with increased risk of obstetrical complications. The results support that PE pathophysiology is associated with increased HbF-concentrations and an activation of the physiological Hb-heme defense systems.	[Gram, Magnus; Johansson, Maria E.; Edstrom-Hagerwall, Anneli; Akerstrom, Bo] Lund Univ, Dept Clin Sci Lund, Infect Med, Lund, Sweden; [Anderson, Ulrik Dolberg; Larsson, Irene; Jalmby, Maya; Hansson, Stefan R.] Lund Univ, Dept Clin Sci Lund, Obstet & Gynecol, Lund, Sweden	Lund University; Lund University	Gram, M (corresponding author), Lund Univ, Dept Clin Sci Lund, Infect Med, Lund, Sweden.	magnus.gram@med.lu.se	Gram, Magnus/AAM-4825-2021	Gram, Magnus/0000-0002-5880-2925	Swedish Research Council; Region Skane (ALF); Marianne & Marcus Wallenberg Foundation; Torsten Soderbergs Foundation; Maggie Stephens Foundation; Greta and Johan Kocks Foundation; Fanny Ekdahls Foundation; Crafoordska Foundation; Osterlunds Foundation; A1M Pharma	Swedish Research Council(Swedish Research CouncilEuropean Commission); Region Skane (ALF); Marianne & Marcus Wallenberg Foundation; Torsten Soderbergs Foundation; Maggie Stephens Foundation; Greta and Johan Kocks Foundation; Fanny Ekdahls Foundation; Crafoordska Foundation; Osterlunds Foundation; A1M Pharma	This work was supported by The Swedish Research Council, Region Skane (ALF), the Marianne & Marcus Wallenberg Foundation, the Torsten Soderbergs Foundation, the Maggie Stephens Foundation, the Greta and Johan Kocks Foundation, the Fanny Ekdahls Foundation, the Crafoordska Foundation, the Osterlunds Foundation and A1M Pharma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTROM B, 1995, FEBS LETT, V362, P50, DOI 10.1016/0014-5793(95)00206-O; Akerstrom B, 2007, J BIOL CHEM, V282, P31493, DOI 10.1074/jbc.M702624200; Alayash AI, 2011, CLIN CHIM ACTA, V412, P493, DOI 10.1016/j.cca.2010.12.011; Allhorn M, 2005, FREE RADICAL BIO MED, V38, P557, DOI 10.1016/j.freeradbiomed.2004.12.013; Allhorn M, 2003, J INVEST DERMATOL, V121, P640, DOI 10.1046/j.1523-1747.2003.12409.x; Allhorn M, 2002, BLOOD, V99, P1894, DOI 10.1182/blood.V99.6.1894; Anderson UD, 2012, PLACENTA, V33, pS42, DOI 10.1016/j.placenta.2011.11.021; Anderson UD, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.058; Ascenzi P, 2005, IUBMB LIFE, V57, P749, DOI 10.1080/15216540500380871; Baek JH, 2012, J CLIN INVEST, V122, P1444, DOI 10.1172/JCI59770; Bakker WW, 2013, REPROD SCI, V20, P234, DOI 10.1177/1933719112446081; Bakker WW, 2009, HYPERTENSION, V53, P959, DOI 10.1161/HYPERTENSIONAHA.108.127951; Berggard T, 1997, EUR J BIOCHEM, V245, P676, DOI 10.1111/j.1432-1033.1997.00676.x; BJORCK L, 1977, SCAND J IMMUNOL, V6, P1063; Brown MA, 2012, NAT REV NEPHROL, V8, P563, DOI 10.1038/nrneph.2012.190; Bunn H., 1992, HEMOGLOBIN; Centlow M, 2008, FERTIL STERIL, V90, P1834, DOI 10.1016/j.fertnstert.2007.09.030; Chen CW, 2014, CARDIOVASC RES, V101, P579, DOI 10.1093/cvr/cvu018; Chintagari NR, 2015, BLOOD CELL MOL DIS, V54, P302, DOI 10.1016/j.bcmd.2014.12.001; Cimen MYB, 2008, CLIN CHIM ACTA, V390, P1, DOI 10.1016/j.cca.2007.12.025; Delanghe JR, 2001, CLIN CHIM ACTA, V312, P13, DOI 10.1016/S0009-8981(01)00586-1; Di Santo S, 2007, PLACENTA, V28, pS23, DOI 10.1016/j.placenta.2007.01.009; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Faivre B, 1998, ARTIF CELL BLOOD SUB, V26, P17, DOI 10.3109/10731199809118943; FOIDART M, 1983, J LAB CLIN MED, V102, P838; GRUBB AO, 1983, J BIOL CHEM, V258, P4698; Guideline NICE, 2013, HYPERTENSION PREGNAN; Hansson SR, 2013, CURR OPIN OBSTET GYN; Hansson SR, 2015, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00516; Hawkins TLA, 2012, BJOG-INT J OBSTET GY, V119, P484, DOI 10.1111/j.1471-0528.2011.03232.x; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; Jain A, 2012, AM J PATHOL, V180, P2309, DOI 10.1016/j.ajpath.2012.03.005; Jozwik M, 1997, CLIN CHIM ACTA, V267, P129, DOI 10.1016/S0009-8981(97)00148-4; KAJITA A, 1969, BIOCHIM BIOPHYS ACTA, V175, P41, DOI 10.1016/0005-2795(69)90143-3; Krikken JA, 2013, J HYPERTENS, V31, P537, DOI 10.1097/HJH.0b013e32835c1727; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; KUTTY RK, 1981, J BIOL CHEM, V256, P3956; Larsson J, 2004, ARCH BIOCHEM BIOPHYS, V432, P196, DOI 10.1016/j.abb.2004.09.021; Linzke N, 2014, HYPERTENSION, V63, P580, DOI 10.1161/HYPERTENSIONAHA.113.02403; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; MAINES MD, 1974, P NATL ACAD SCI USA, V71, P4293, DOI 10.1073/pnas.71.11.4293; May K, 2011, PLACENTA, V32, P323, DOI 10.1016/j.placenta.2011.01.017; Minneci PC, 2005, J CLIN INVEST, V115, P3409, DOI 10.1172/JCI25040; Moestrup SK, 2004, ANN MED, V36, P347, DOI 10.1080/07853890410033171; Moller HJ, 2002, BLOOD, V99, P378, DOI 10.1182/blood.V99.1.378; Muller-Deile Janina, 2014, World J Nephrol, V3, P169, DOI 10.5527/wjn.v3.i4.169; Newstead J, 2007, Expert Rev Cardiovasc Ther, V5, P283, DOI 10.1586/14779072.5.2.283; NOBLE RW, 1971, J BIOL CHEM, V246, P2972; NOGUCHI M, 1982, J BIOCHEM-TOKYO, V91, P1479, DOI 10.1093/oxfordjournals.jbchem.a133839; Olsson MG, 2008, FREE RADICAL RES, V42, P725, DOI 10.1080/10715760802337265; Olsson MG, 2013, ANTIOXID REDOX SIGN, V18, P2017, DOI 10.1089/ars.2012.4658; Olsson MG, 2012, ANTIOXID REDOX SIGN, V17, P813, DOI 10.1089/ars.2011.4282; Olsson MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027505; Olsson MG, 2010, FREE RADICAL BIO MED, V48, P284, DOI 10.1016/j.freeradbiomed.2009.10.052; Piantadosi CA, 2008, FREE RADICAL BIO MED, V45, P562, DOI 10.1016/j.freeradbiomed.2008.05.013; Rana S, 2014, HYPERTENSION, V63, P198, DOI 10.1161/HYPERTENSIONAHA.113.02293; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Roberts JM, 2009, PLACENTA, V30, pS32, DOI 10.1016/j.placenta.2008.11.009; SANO S, 1986, P NATL ACAD SCI USA, V83, P531, DOI 10.1073/pnas.83.3.531; Schaer DJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00415; Schaer DJ, 2013, BLOOD, V121, P1276, DOI 10.1182/blood-2012-11-451229; Sertorio JT, 2013, J HUM HYPERTENS, V27, P349, DOI 10.1038/jhh.2012.57; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Sverrisson K, 2014, AM J PHYSIOL-RENAL, V306, pF442, DOI 10.1152/ajprenal.00502.2013; Talosi G, 1997, BIOCHEM MOL MED, V62, P58, DOI 10.1006/bmme.1997.2602; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; THATCHER CD, 1986, AM J OBSTET GYNECOL, V155, P201, DOI 10.1016/0002-9378(86)90111-0; Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.02.001, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.04.017]; Van Gorp H, 2010, MOL IMMUNOL, V47, P1650, DOI 10.1016/j.molimm.2010.02.008; Wagener FADTG, 2001, BLOOD, V98, P1802, DOI 10.1182/blood.V98.6.1802; Walker JJ, 2000, LANCET, V356, P1260, DOI 10.1016/S0140-6736(00)02800-2; Wester-Rosenlof L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086353; WINTERBOURN CC, 1990, METHOD ENZYMOL, V186, P265; YOSHIDA T, 1974, J BIOCHEM, V75, P1187, DOI 10.1093/oxfordjournals.jbchem.a130494	76	35	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138111	10.1371/journal.pone.0138111	http://dx.doi.org/10.1371/journal.pone.0138111			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368565	Green Published, gold			2022-12-27	WOS:000361601100227
J	Radowsky, JS; Caruso, JD; Luthra, R; Bradley, MJ; Elster, EA; Forsberg, JA; Crane, NJ				Radowsky, Jason S.; Caruso, Joseph D.; Luthra, Rajiv; Bradley, Matthew J.; Elster, Eric A.; Forsberg, Jonathan A.; Crane, Nicole J.			Noninvasive Multimodal Imaging to Predict Recovery of Locomotion after Extended Limb Ischemia	PLOS ONE			English	Article							POSTOCCLUSIVE REACTIVE HYPEREMIA; PERIPHERAL VASCULAR-DISEASE; ARTERIAL OCCLUSIVE DISEASE; SPINAL-CORD-INJURY; SKIN MICROCIRCULATION; INDOCYANINE GREEN; TISSUE OXYGENATION; HEALTHY-VOLUNTEERS; NITRIC-OXIDE; PERFUSION	Acute limb ischemia is a common cause of morbidity and mortality following trauma both in civilian centers and in combat related injuries. Rapid determination of tissue viability and surgical restoration of blood flow are desirable, but not always possible. We sought to characterize the response to increasing periods of hind limb ischemia in a porcine model such that we could define a period of critical ischemia (the point after which irreversible neuromuscular injury occurs), evaluate non-invasive methods for characterizing that ischemia, and establish a model by which we could predict whether or not the animal's locomotion would return to baselines levels post-operatively. Ischemia was induced by either application of a pneumatic tourniquet or vessel occlusion (performed by clamping the proximal iliac artery and vein at the level of the inguinal ligament). The limb was monitored for the duration of the procedure with both 3-charge coupled device (3CCD) and infrared (IR) imaging for tissue oxygenation and perfusion, respectively. The experimental arms of this model are effective at inducing histologically evident muscle injury with some evidence of expected secondary organ damage, particularly in animals with longer ischemia times. Noninvasive imaging data shows excellent correlation with post-operative functional outcomes, validating its use as a non-invasive means of viability assessment, and directly monitors postocclusive reactive hyperemia. A classification model, based on partial-least squares discriminant analysis (PLSDA) of imaging variables only, successfully classified animals as "returned to normal locomotion" or "did not return to normal locomotion" with 87.5% sensitivity and 66.7% specificity after cross-validation. PLSDA models generated from non-imaging data were not as accurate (AUC of 0.53) compared the PLSDA model generated from only imaging data (AUC of 0.76). With some modification, this limb ischemia model could also serve as a means on which to test therapies designed to prolong the time before critical ischemia.	[Radowsky, Jason S.; Bradley, Matthew J.; Elster, Eric A.; Forsberg, Jonathan A.; Crane, Nicole J.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [Caruso, Joseph D.; Bradley, Matthew J.; Elster, Eric A.] Walter Reed Natl Mil Med Ctr, Gen Surg, Bethesda, MD USA; [Luthra, Rajiv; Bradley, Matthew J.; Forsberg, Jonathan A.; Crane, Nicole J.] Naval Med Res Ctr, Regenerat Med Dept, Silver Spring, MD USA; [Forsberg, Jonathan A.] Walter Reed Natl Mil Med Ctr, Orthopaed & Rehabil, Bethesda, MD USA; [Crane, Nicole J.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA	Uniformed Services University of the Health Sciences - USA; Walter Reed National Military Medical Center; Naval Medical Research Center (NMRC); Walter Reed National Military Medical Center; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Crane, NJ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA.	nicole.j.crane@gmail.com	Radowsky, Jason/ABX-5157-2022; Elster, Eric/ABG-6091-2021	Elster, Eric/0000-0002-0981-2748	Congressionally Directed Medical Research Program [W81XWH-10-2-0162];  [602115HP.3720.001.A1015]	Congressionally Directed Medical Research Program(United States Department of Defense); 	This work was supported/funded by work unit number 602115HP.3720.001.A1015. Funding support includes Congressionally Directed Medical Research Program award number W81XWH-10-2-0162.	Boas DA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3285504; Burkhardt GE, 2010, J TRAUMA, V69, pS146, DOI 10.1097/TA.0b013e3181e6a09b; Cadeddu JA, 2001, J ENDOUROL, V15, P111, DOI 10.1089/08927790150501033; Cheng R, 2013, APPL OPTICS, V52, P7324, DOI 10.1364/AO.52.007324; Cheng XF, 2004, CLIN HEMORHEOL MICRO, V31, P11; Cracowski JL, 2006, TRENDS PHARMACOL SCI, V27, P503, DOI 10.1016/j.tips.2006.07.008; Crane NJ, 2008, J AM COLL SURGEONS, V206, P1159, DOI 10.1016/j.jamcollsurg.2008.01.013; Crane NJ, 2007, APPL SPECTROSC, V61, P797, DOI 10.1366/000370207781540204; Crane NJ, 2010, J UROLOGY, V184, P1279, DOI 10.1016/j.juro.2010.06.010; Crane Nicole J, 2008, BMC Surg, V8, P8, DOI 10.1186/1471-2482-8-8; CRIQUI MH, 1985, CIRCULATION, V71, P510, DOI 10.1161/01.CIR.71.3.510; Favazza CP, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3536522; Forsberg JA, 2014, CLIN ORTHOP RELAT R, V472, P2845, DOI 10.1007/s11999-014-3694-7; FRONEK A, 1973, CIRCULATION, V48, P149, DOI 10.1161/01.CIR.48.1.149; Gifford SM, 2009, J TRAUMA, V67, P259, DOI 10.1097/TA.0b013e3181a5e99b; Gorbach AM, 2003, ANN NEUROL, V54, P297, DOI 10.1002/ana.10646; Gurley K, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.075010; HAGISAWA S, 1994, J REHABIL RES DEV, V31, P1; HOPEROSS M, 1994, OPHTHALMOLOGY, V101, P529; Ince C, 2005, CRIT CARE, V9, pS13, DOI 10.1186/cc3753; Isenberg JS, 2005, MICROSURG, V25, P442, DOI 10.1002/micr.20168; Jarm T, 2003, ADV EXP MED BIOL, V530, P661; Joyal Christian C, 2013, Open Neuroimag J, V7, P1, DOI 10.2174/1874440001307010001; Kiyatkin EA, 2002, EUR J NEUROSCI, V16, P164, DOI 10.1046/j.1460-9568.2002.02066.x; Kragelj R, 2001, ANN BIOMED ENG, V29, P311, DOI 10.1114/1.1359451; Liu DZ, 2011, J RECONSTR MICROSURG, V27, P355, DOI 10.1055/s-0031-1281515; Love TJ, 1980, ANN NY ACAD SCI, V335, P429; MALAN E, 1963, J CARDIOVASC SURG, V4, P212; Millendez MB, 2012, J PEDIATR SURG, V47, P142, DOI 10.1016/j.jpedsurg.2011.10.033; Moyer HR, 2012, PLAST RECONSTR SURG, V129, P1043, DOI 10.1097/PRS.0b013e31824a2b02; Nguyen JT, 2012, J SURG RES, V178, pE43, DOI 10.1016/j.jss.2012.05.014; Rizk M, 2004, WORLD J SURG, V28, P301, DOI 10.1007/s00268-003-7396-7; Roustit M, 2013, TRENDS PHARMACOL SCI, V34, P373, DOI 10.1016/j.tips.2013.05.007; Roustit M, 2012, MICROCIRCULATION, V19, P47, DOI 10.1111/j.1549-8719.2011.00129.x; Sae-Sia W, 2007, ARCH PHYS MED REHAB, V88, P1673, DOI 10.1016/j.apmr.2007.07.037; Sakr Y, 2004, CRIT CARE MED, V32, P1825, DOI 10.1097/01.CCM.0000138558.16257.3F; SCHUBERT V, 1991, SCAND J REHABIL MED, V23, P33; SCULLY RE, 1956, AM J PATHOL, V32, P805; TARLOV IM, 1953, AMA ARCH NEUROL PSY, V70, P813, DOI 10.1001/archneurpsyc.1953.02320360128010; Thomas KN, 2015, ULTRASOUND MED BIOL, V41, P26, DOI 10.1016/j.ultrasmedbio.2014.06.012; WAHLBERG E, 1990, VASA-J VASCULAR DIS, V19, P301; Watson JC, 2002, J NEUROSURG, V96, P918, DOI 10.3171/jns.2002.96.5.0918; Wu C, 2013, ANN PLAS SURG, V70, P613, DOI 10.1097/SAP.0b013e31827565f3	43	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137430	10.1371/journal.pone.0137430	http://dx.doi.org/10.1371/journal.pone.0137430			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368024	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100070
J	Song, ZL; Zhang, C; Liu, GB; Qu, D; Xue, S				Song, Zilin; Zhang, Chao; Liu, Guobin; Qu, Dong; Xue, Sha			Fractal Feature of Particle-Size Distribution in the Rhizospheres and Bulk Soils during Natural Recovery on the Loess Plateau, China	PLOS ONE			English	Article							LAND-USE PATTERNS; MICROBIAL COMMUNITIES; MOISTURE; SUCCESSION; CATCHMENT; REGION; RIVER	The application of fractal geometry to describe soil structure is an increasingly useful tool for better understanding the performance of soil systems. Only a few studies, however, have focused on the structure of rhizospheric zones, where energy flow and nutrient recycling most frequently occur. We used fractal dimensions to investigate the characteristics of particle-size distribution (PSD) in the rhizospheres and bulk soils of six croplands abandoned for 1, 5, 10, 15, 20, and 30 years on the Loess Plateau of China and evaluated the changes over successional time. The PSDs of the rhizospheres and the fractal dimensions between rhizosphere soil and bulk soils during the natural succession differed significantly due to the influence of plant roots. The rhizospheres had higher sand (0.05-1.00 mm) contents, lower silt (<0.002 mm) contents, and lower fractal dimensions than the bulk soils during the early and intermediate successional stages (1-15 years). The fractal dimensions of the rhizosphere soil and bulk soil ranged from 2.102 to 2.441 and from 2.214 to 2.459, respectively, during the 30-year restoration. Rhizospheric clay and silt contents and fractal dimension tended to be higher and sand content tended to be lower as abandonment age increased, but the bulk soils had the opposite trend. Linear regression analysis indicated that the fractal dimensions of both the rhizospheres and bulk soils were significantly linearly correlated with clay, sand, organic-carbon, and total-nitrogen contents, with R-2 ranging from 0.526 to 0.752 (P<0.001). In conclusion, PSD differed significantly between the rhizosphere soil and bulk soil. The fractal dimension was a sensitive and useful index for quantifying changes in the properties of the different soil zones. This study will greatly aid the application of the fractal method for describing soil structure and nutrient status and the understanding of the performance of rhizospheric zones during ecological restoration.	[Song, Zilin; Qu, Dong] Northwest A&F Univ, Coll Nat Resources & Environm, Yangling, Peoples R China; [Zhang, Chao; Liu, Guobin; Xue, Sha] Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Peoples R China	Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China	Zhang, C (corresponding author), Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Peoples R China.	zhangchaolynn@163.com						An SS, 2008, PEDOSPHERE, V18, P809, DOI 10.1016/S1002-0160(08)60077-6; Bird N, 2006, J HYDROL, V322, P211, DOI 10.1016/j.jhydrol.2005.02.039; Cutler NA, 2014, SOIL BIOL BIOCHEM, V69, P359, DOI 10.1016/j.soilbio.2013.11.022; Delgado-Baquerizo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059807; Du F, 2007, COLLOID SURFACE B, V58, P278, DOI 10.1016/j.colsurfb.2007.04.002; Falconer K. J., 2003, FRACTAL GEOMETRY MAT; Fu BJ, 2003, CATENA, V54, P197, DOI 10.1016/S0341-8162(03)00065-1; Gao GL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088559; Hinsinger P, 2009, PLANT SOIL, V321, P117, DOI 10.1007/s11104-008-9885-9; Jin K, SOIL TILLAGE RES, V104, P115; Ladygina N, 2010, SOIL BIOL BIOCHEM, V42, P162, DOI 10.1016/j.soilbio.2009.10.009; Liu X, 2009, GEODERMA, V154, P123, DOI 10.1016/j.geoderma.2009.10.005; MANDELBORT B. B., 1982, FRACTAL GEOMETRY NAT, P45; Marriott CA, 1997, PLANT SOIL, V196, P151, DOI 10.1023/A:1004288610550; Peng G, 2014, J SOIL SEDIMENT, V14, P1116, DOI 10.1007/s11368-014-0876-6; PERFECT E, 1991, SOIL SCI SOC AM J, V55, P1552, DOI 10.2136/sssaj1991.03615995005500060009x; RIEU M, 1991, SOIL SCI SOC AM J, V55, P1231, DOI 10.2136/sssaj1991.03615995005500050006x; Rosenvald K, 2011, ECOL ENG, V37, P1027, DOI 10.1016/j.ecoleng.2010.05.011; Su YZ, 2004, GEODERMA, V122, P43, DOI 10.1016/j.geoderma.2003.12.003; Tscherko D, 2004, SOIL BIOL BIOCHEM, V36, P1685, DOI 10.1016/j.soilbio.2004.07.004; TURCOTTE DL, 1986, J GEOPHYS RES-SOLID, V91, P1921, DOI 10.1029/JB091iB02p01921; TYLER SW, 1992, SOIL SCI SOC AM J, V56, P362, DOI 10.2136/sssaj1992.03615995005600020005x; Uren NC, 2007, RHIZOSPHERE BIOCH OR, P1, DOI [10.1201/9781420005585.ch1, DOI 10.1201/9781420005585.CH1]; Walker LR, 2010, J ECOL, V98, P725, DOI 10.1111/j.1365-2745.2010.01664.x; Wang B, 2011, ENVIRON EARTH SCI, V62, P915, DOI 10.1007/s12665-010-0577-4; Wang XD, 2006, GEODERMA, V134, P56, DOI 10.1016/j.geoderma.2005.08.014; Wang YQ, 2009, GEODERMA, V150, P141, DOI 10.1016/j.geoderma.2009.01.021; [吴彩霞 WU Cai-xia], 2009, [草业科学, Pratacultural Science], V26, P24; Xu GC, 2013, CATENA, V101, P17, DOI 10.1016/j.catena.2012.09.013; Yang P.L, 1993, CHINESE SCI BULL, V38, P1896, DOI DOI 10.1360/csb1993-38-20-1896; Zhang C, 2012, EUR J SOIL BIOL, V50, P127, DOI 10.1016/j.ejsobi.2012.01.002; Zhang Chao, 2011, Scientia Agricultura Sinica, V44, P507; Zhang C, 2011, GEODERMA, V161, P115, DOI 10.1016/j.geoderma.2010.12.003; Zhao QO, 2010, APPL SOIL ECOL, V46, P341, DOI 10.1016/j.apsoil.2010.10.007; Zheng FL, 2006, PEDOSPHERE, V16, P420, DOI 10.1016/S1002-0160(06)60071-4; Zhou Ping, 2008, Acta Agrestia Sinica, V16, P396; Zhu BB, 2010, ECOL RES, V25, P531, DOI 10.1007/s11284-009-0683-5; Zhu YJ, 2008, GEODERMA, V147, P185, DOI 10.1016/j.geoderma.2008.08.012	38	16	16	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138057	10.1371/journal.pone.0138057	http://dx.doi.org/10.1371/journal.pone.0138057			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368339	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100212
J	Koshimori, Y; Ko, JH; Mizrahi, R; Rusjan, P; Mabrouk, R; Jacobs, MF; Christopher, L; Hamani, C; Lang, AE; Wilson, AA; Houle, S; Strafella, AP				Koshimori, Yuko; Ko, Ji-Hyun; Mizrahi, Romina; Rusjan, Pablo; Mabrouk, Rostom; Jacobs, Mark F.; Christopher, Leigh; Hamani, Clement; Lang, Anthony E.; Wilson, Alan A.; Houle, Sylvain; Strafella, Antonio P.			Imaging Striatal Microglial Activation in Patients with Parkinson's Disease	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; TRANSLOCATOR PROTEIN TSPO; HUMAN BRAIN; BINDING-AFFINITY; PET RADIOLIGAND; FACTOR-ALPHA; POLYMORPHISM; ALZHEIMERS; INTERLEUKIN-1-BETA; NEUROINFLAMMATION	This study investigated whether the second-generation translocator protein 18kDa (TSPO) radioligand, [F-18]-FEPPA, could be used in neurodegenerative parkinsonian disorders as a biomarker for detecting neuroinflammation in the striatum. Neuroinflammation has been implicated as a potential mechanism for the progression of Parkinson's disease (PD). Positron Emission Tomography (PET) radioligand targeting for TSPO allows for the quantification of neuroinflammation in vivo. Based on genotype of the rs6791 polymorphism in the TSPO gene, 16 mixed-affinity binders (MABs) (8 PD and age-matched 8 healthy controls (HCs)), 16 high-affinity binders (HABs) (8 PD and age-matched 8 HCs) and 4 low-affinity binders (LABs) (3 PD and 1 HCs) were identified. Total distribution volume (V-T) values in the striatum were derived from a two-tissue compartment model with arterial plasma as an input function. There was a significant main effect of genotype on [F-18]-FEPPA VT values in the caudate nucleus (p = 0.001) and putamen (p < 0.001), but no main effect of disease or disease x genotype interaction in either ROI. In the HAB group, the percentage difference between PD and HC was 16% in both caudate nucleus and putamen; in the MAB group, it was -8% and 3%, respectively. While this PET study showed no evidence of increased striatal TSPO expression in PD patients, the current findings provide some insights on the possible interactions between rs6791 polymorphism and neuroinflammation in PD.	[Koshimori, Yuko; Christopher, Leigh; Strafella, Antonio P.] Univ Toronto, Div Brain Imaging & Behav Syst Neurosci, Toronto Western Res Inst, Univ Hosp Network, Toronto, ON, Canada; [Koshimori, Yuko; Mizrahi, Romina; Rusjan, Pablo; Mabrouk, Rostom; Jacobs, Mark F.; Christopher, Leigh; Wilson, Alan A.; Houle, Sylvain; Strafella, Antonio P.] Univ Toronto, Ctr Addict & Mental Hlth, Res Imaging Ctr, Toronto, ON, Canada; [Ko, Ji-Hyun] Univ Manitoba, Dept Human Anat & Cell Sci, Fac Hlth Sci, Winnipeg, MB, Canada; [Hamani, Clement] Univ Toronto, Toronto Western Hosp, Div Neurosurg, Univ Hosp Network, Toronto, ON M5T 2S8, Canada; [Lang, Anthony E.; Strafella, Antonio P.] Univ Toronto, Toronto Western Hosp, Morton & Gloria Shulman Movement Disorder Unit, Univ Hosp Network, Toronto, ON M5T 2S8, Canada; [Lang, Anthony E.; Strafella, Antonio P.] Univ Toronto, Toronto Western Hosp, Edmond J Safra Program Parkinson Dis, Univ Hosp Network, Toronto, ON M5T 2S8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Manitoba; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Strafella, AP (corresponding author), Univ Toronto, Div Brain Imaging & Behav Syst Neurosci, Toronto Western Res Inst, Univ Hosp Network, Toronto, ON, Canada.	antonio.strafella@uhn.ca	Lang, Anthony/ABF-8114-2021; Ko, Ji Hyun/E-5150-2011; Mabrouk, Rostom/M-1674-2019	Ko, Ji Hyun/0000-0002-9700-7692; Mizrahi, Romina/0000-0001-6667-7928; Houle, Sylvain/0000-0002-4231-6316; Lang, Anthony/0000-0003-1229-3667; Rusjan, Pablo/0000-0003-0075-2918	Canadian Institutes of Health Research [INE 117891]; Weston Brain Institute; Canada Research Chair program from Canadian Institutes of Health Research; Doctoral Research Award from Canadian Institutes of Health Research [GDS-D 128684]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Weston Brain Institute; Canada Research Chair program from Canadian Institutes of Health Research; Doctoral Research Award from Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) (INE 117891) and Weston Brain Institute (http://westonbraininstitute.ca). AS is supported by the Canada Research Chair program from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html). YK is supported by a Doctoral Research Award from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) (GDS-D 128684). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bencherif B, 2004, J NUCL MED, V45, P402; BlumDegen D, 1995, NEUROSCI LETT, V202, P17, DOI 10.1016/0304-3940(95)12192-7; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Choi HB, 2002, J NEUROCHEM, V83, P546, DOI 10.1046/j.1471-4159.2002.01122.x; Costa B, 2009, ENDOCRINOLOGY, V150, P5438, DOI 10.1210/en.2009-0752; Dobbs RJ, 1999, ACTA NEUROL SCAND, V100, P34, DOI 10.1111/j.1600-0404.1999.tb00721.x; Hatano K, 2010, NEUROIMAGE, V52, pS138, DOI 10.1016/j.neuroimage.2010.04.112; Huang XM, 2015, MOVEMENT DISORD, V30, P552, DOI 10.1002/mds.26152; Imamura K, 2003, ACTA NEUROPATHOL, V106, P518, DOI 10.1007/s00401-003-0766-2; Ko JH, 2013, J CEREBR BLOOD F MET, V33, P348, DOI 10.1038/jcbfm.2012.203; Kobylecki C, 2013, PARKINSONISM RELAT D, V19, P527, DOI 10.1016/j.parkreldis.2013.01.017; Kreisl WC, 2013, J CEREBR BLOOD F MET, V33, P53, DOI 10.1038/jcbfm.2012.131; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Mizrahi R, 2012, J CEREBR BLOOD F MET, V32, P968, DOI 10.1038/jcbfm.2012.46; MOGI M, 1994, NEUROSCI LETT, V180, P147, DOI 10.1016/0304-3940(94)90508-8; Narendran R, 2014, J NEUROSCI, V34, P9945, DOI 10.1523/JNEUROSCI.0928-14.2014; Ouchi Y, 2005, ANN NEUROL, V57, P168, DOI 10.1002/ana.20338; Owen DR, 2012, J CEREBR BLOOD F MET, V32, P1, DOI 10.1038/jcbfm.2011.147; Rone MB, 2009, BBA-MOL CELL BIOL L, V1791, P646, DOI 10.1016/j.bbalip.2009.03.001; Rusjan P, 2006, PSYCHIAT RES-NEUROIM, V147, P79, DOI 10.1016/j.pscychresns.2006.01.011; Rusjan PM, 2014, J CEREBR BLOOD F MET, V34, P883, DOI 10.1038/jcbfm.2014.34; Rusjan PM, 2011, J CEREBR BLOOD F MET, V31, P1807, DOI 10.1038/jcbfm.2011.55; Schumacher M, 2000, J NEUROCYTOL, V29, P307, DOI 10.1023/A:1007152904926; Setiawan E, 2015, JAMA PSYCHIAT, V72, P268, DOI 10.1001/jamapsychiatry.2014.2427; Streit WJ, 2000, TOXICOL PATHOL, V28, P28, DOI 10.1177/019262330002800104; Suridjan I., 2015, MOL PSYCHIAT; Varrone A, 2015, EUR J NUCL MED MOL I, V42, P438, DOI 10.1007/s00259-014-2955-8; Wilson AA, 2008, NUCL MED BIOL, V35, P305, DOI 10.1016/j.nucmedbio.2007.12.009	30	71	72	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138721	10.1371/journal.pone.0138721	http://dx.doi.org/10.1371/journal.pone.0138721			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381267	Green Submitted, Green Published, gold			2022-12-27	WOS:000361790200152
J	Ge, Z; Guo, XL; Chen, XR; Zhang, JY; Yan, LX; Tang, JL; Cai, XN; Xu, AQ; Ma, JX				Ge, Zeng; Guo, Xiaolei; Chen, Xiaorong; Zhang, Jiyu; Yan, Liuxia; Tang, Junli; Cai, Xiaoning; Xu, Aiqiang; Ma, Jixiang			Are Microalbuminuria and Elevated 24 H Urinary Microalbumin Excretion within Normal Range Associated with Metabolic Syndrome in Chinese Adults?	PLOS ONE			English	Article							HYPERTENSION; ALBUMINURIA; RISKS	The association of microalbuminuria and elevated 24 h urinary microalbumin excretion (UAE) with metabolic syndrome (MetS) has not been well examined in Chinese Adults. In the present study, a population-based cross-sectional study was conducted among Chinese adults aged 18-69 years in Shandong province in 2011 to determine the relationship between them. Data on 24 h UAE and other variables were obtained and components of MetS were examined. The prevalence of MetS and mean 24 h UAE was 24.7% and 6.7 mg, respectively. Compared with participants with normoalbuminuria, the odds of MetS and its components including central obesity, elevated blood pressure and elevated fasting glucose, but not the odds of low HDL cholesterol and elevated triglycerides, significantly increased in those with microalbuminuria. Additionally, the odds of MetS and its three components significantly increased across increasing quartiles of 24 h UAE within normal range (1.00, 1.11, 1.02 and 1.58, respectively, for MetS; 1.00, 1.14, 1.21, and 1.68, respectively, for central obesity; 1.00, 1.35, 1.26 and 1.68, respectively, for elevated blood pressure; and 1.00, 1.32, 1.06 and 1.47, respectively, for elevated triglycerides; p for linear trend <= 0.05 for all). Furthermore, for each increment of 10 mg 24 h UAE within normal range, the odds of MetS and its components including central obesity, elevated blood pressure, and elevated triglycerides significantly increased by 53%, 65%, 55%, and 41%, respectively. These findings suggest that both microalbuminuria and elevated 24 h UAE within normal range might be important risk factors for MetS in Chinese adults.	[Ge, Zeng; Chen, Xiaorong; Yan, Liuxia; Cai, Xiaoning; Ma, Jixiang] Chinese Ctr Dis Control & Prevent, Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing, Peoples R China; [Guo, Xiaolei; Zhang, Jiyu; Tang, Junli; Xu, Aiqiang] Shandong Ctr Dis Control & Prevent, Jinan, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Xu, AQ (corresponding author), Shandong Ctr Dis Control & Prevent, Jinan, Peoples R China.	aqxuepi@163.com; majix@163.com	zhang, jiyu/W-9297-2018; Stefanadis, Christodoulos/ABH-2232-2020	zhang, jiyu/0000-0001-6236-8781; Stefanadis, Christodoulos/0000-0001-5974-6454	Chinese Center for Disease Control and Prevention, Beijing, China; People's Government of Shandong Province, Jinan, China [2012GSF11828]	Chinese Center for Disease Control and Prevention, Beijing, China; People's Government of Shandong Province, Jinan, China	The present study was supported by a grant from the Chinese Center for Disease Control and Prevention, Beijing, China, and a provincial technical development plan grant (2012GSF11828) from the People's Government of Shandong Province, Jinan, China. The sponsors had no role in the design and conduct of the study; in the collection, management, analysis, or interpretation of the data; or in the preparation of the manuscript.	Choi HS, 2006, NEPHRON CLIN PRACT, V104, pC85, DOI 10.1159/000093995; Ford ES, 2005, DIABETES CARE, V28, P1769, DOI 10.2337/diacare.28.7.1769; Ge Z, 2015, BRIT J NUTR, V113, P996, DOI 10.1017/S0007114514003833; He J, 2004, CIRCULATION, V110, P405, DOI 10.1161/01.CIR.0000136583.52681.0D; Lambers Heerspink HJ, 2008, AM J EPIDEMIOL, V168, P897, DOI 10.1093/aje/kwn209; Li MF, 2015, J DIABETES INVEST, V6, P354, DOI 10.1111/jdi.12307; Meng De-jing, 2013, Zhonghua Yu Fang Yi Xue Za Zhi, V47, P312; Oh CM, 2014, MATURITAS, V77, P149, DOI 10.1016/j.maturitas.2013.10.013; Palaniappan L, 2003, AM J HYPERTENS, V16, P952, DOI 10.1016/S0895-7061(03)01009-4; Park SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125615; Sheng CS, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-6; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Vyssoulis G, 2010, J CLIN HYPERTENS, V12, P597, DOI 10.1111/j.1751-7176.2010.00306.x; Wang TJ, 2005, CIRCULATION, V111, P1370, DOI 10.1161/01.CIR.0000158434.69180.2D; Zhang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065597	15	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138410	10.1371/journal.pone.0138410	http://dx.doi.org/10.1371/journal.pone.0138410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379278	Green Published, Green Submitted, gold			2022-12-27	WOS:000361769400096
J	Lala, SG; Little, KM; Tshabangu, N; Moore, DP; Msandiwa, R; van der Watt, M; Chaisson, RE; Martinson, NA				Lala, Sanjay G.; Little, Kristen M.; Tshabangu, Nkeko; Moore, David P.; Msandiwa, Reginah; van der Watt, Martin; Chaisson, Richard E.; Martinson, Neil A.			Integrated Source Case Investigation for Tuberculosis (TB) and HIV in the Caregivers and Household Contacts of Hospitalised Young Children Diagnosed with TB in South Africa: An Observational Study	PLOS ONE			English	Article							PEDIATRIC TUBERCULOSIS; CHILDHOOD TUBERCULOSIS; TRANSMISSION; INFECTION; METAANALYSIS; INDEX; YIELD; DELAY	Background Contact tracing, to identify source cases with untreated tuberculosis (TB), is rarely performed in high disease burden settings when the index case is a young child with TB. As TB is strongly associated with HIV infection in these settings, we used source case investigation to determine the prevalence of undiagnosed TB and HIV in the caregivers and household contacts of hospitalised young children diagnosed with TB in South Africa. Methods Caregivers and household contacts of 576 young children (age <7 years) with TB diagnosed between May 2010 and August 2012 were screened for TB and HIV. The primary outcome was the detection of laboratory-confirmed, newly-diagnosed TB disease and/or HIV-infection in close contacts. Results Of 576 caregivers, 301 (52-3%) self-reported HIV-positivity. Newly-diagnosed HIV infection was detected in 63 (22-9%) of the remaining 275 caregivers who self-reported an unknown or negative HIV status. Screening identified 133 (23-1%) caregivers eligible for immediate anti-retroviral therapy (ART). Newly-diagnosed TB disease was detected in 23 (4-0%) caregivers. In non-caregiver household contacts (n = 1341), the prevalence of newly-diagnosed HIV infection and TB disease was 10-0% and 3-2% respectively. On average, screening contacts of every nine children with TB resulted in the identification of one case of newly-diagnosed TB disease, three cases of newly diagnosed HIV-infection, and three HIV-infected persons eligible for ART. Conclusion In high burden countries, source case investigation yields high rates of previously undiagnosed HIV and TB infection in the close contacts of hospitalised young children diagnosed with TB. Furthermore, integrated screening identifies many individuals who are eligible for immediate ART. Similar studies, with costing analyses, should be undertaken in other high burden settings integrated source case investigation for TB and HIV should be routinely undertaken if our findings are confirmed.	[Lala, Sanjay G.; Moore, David P.] Chris Hani Baragwanath Acad Hosp, Dept Paediat & Child Hlth, Johannesburg, South Africa; [Lala, Sanjay G.; Moore, David P.] Univ Witwatersrand, Johannesburg, South Africa; [Little, Kristen M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Tshabangu, Nkeko; Msandiwa, Reginah; van der Watt, Martin; Martinson, Neil A.] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Chaisson, Richard E.; Martinson, Neil A.] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD USA; [Martinson, Neil A.] Univ Witwatersrand, Ctr Excellence Biomed TB Res, Natl Res Fdn DST NRF, Dept Sci & Technol, Johannesburg, South Africa	University of Witwatersrand; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Witwatersrand; Johns Hopkins University; University of Witwatersrand	Lala, SG (corresponding author), Chris Hani Baragwanath Acad Hosp, Dept Paediat & Child Hlth, Johannesburg, South Africa.	sanjay.lala@wits.ac.za	Moore, David/AAU-7186-2020	Moore, David/0000-0001-6091-1605	Unites States Agency for International Development (USAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER	Unites States Agency for International Development (USAID)(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Unites States Agency for International Development (USAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, S AFR ANT TREATM GUI; [Anonymous], 2011, GUID INT TUB CAS FIN; Barron P, 2013, B WORLD HEALTH ORGAN, V91, P70, DOI 10.2471/BLT.12.106807; Dahiwale Nishikant, 2011, Indian Pediatr, V48, P387; De Cock KM, 1999, INT J TUBERC LUNG D, V3, P457; De Debalina, 2014, Tuberc Res Treat, V2014, P182836, DOI 10.1155/2014/182836; Doherty T, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-406; Eckhoff CT, 2000, INT J TUBERC LUNG D, V4, P1143; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Goga A, 2012, EVALUATION EFFECTIVE; Hatherill M, 2010, B WORLD HEALTH ORGAN, V88, P312, DOI 10.2471/BLT.09.062893; Jeena PM, 2002, INT J TUBERC LUNG D, V6, P672; Kranzer K, 2010, LANCET INFECT DIS, V10, P93, DOI 10.1016/S1473-3099(09)70326-3; Landes M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047337; Massyn N, 2013, DISTRICT HLTH BAROME; Meintjes G, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-72; Middelkoop K, 2009, SAMJ S AFR MED J, V99, P738; Moore DP, 2010, PEDIATR INFECT DIS J, V29, P1099, DOI 10.1097/INF.0b013e3181eaefff; Musenge E, 2013, GLOBAL HEALTH ACTION, V6, P38, DOI 10.3402/gha.v6i0.19266; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Paz-Soldan VA, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00281; Puryear S, 2013, INT J TUBERC LUNG D, V17, P1049, DOI 10.5588/ijtld.12.0933; Schaaf HS, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-140; Seddon JA, 2014, INFECT DRUG RESIST, V7, P153, DOI 10.2147/IDR.S45090; Somu N, 1997, Indian Pediatr, V34, P819; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Swaminathan S, 2010, CLIN INFECT DIS, V50, pS184, DOI 10.1086/651490; Wood R, 2010, CLIN INFECT DIS, V51, P401, DOI 10.1086/655129; World Health Organization(WHO), 2014, GUID NAT TUB PROGR M, V2nd	29	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137518	10.1371/journal.pone.0137518	http://dx.doi.org/10.1371/journal.pone.0137518			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378909	Green Submitted, gold, Green Published			2022-12-27	WOS:000361769400015
J	Neve, EPA; Kofeler, H; Hendriks, DFG; Nordling, A; Gogvadze, V; Mkrtchian, S; Naslund, E; Ingelman-Sundberg, M				Neve, Etienne P. A.; Koefeler, Harald; Hendriks, Delilah F. G.; Nordling, Asa; Gogvadze, Vladimir; Mkrtchian, Souren; Naslund, Erik; Ingelman-Sundberg, Magnus			Expression and Function of mARC: Roles in Lipogenesis and Metabolic Activation of Ximelagatran	PLOS ONE			English	Article							INDUCED LIVER-INJURY; MASS-SPECTROMETRY; AMIDOXIME; PATHOGENESIS; THIOREDOXIN; REDUCTASE; PROTEIN; STRESS; SYSTEM; CELLS	Recently two novel enzymes were identified in the outer mitochondrial membrane, mARC1 and mARC2. These molybdenum containing enzymes can reduce a variety of N-hydroxylated compounds, such as N-hydroxy-guanidines and sulfohydroxamic acids, as well as convert nitrite into nitric oxide (NO). However, their endogenous functions remain unknown. Here we demonstrate a specific developmental pattern of expression of these enzymes. mARC1, but not mARC2, was found to be expressed in fetal human liver, whereas both, in particular mARC2, are abundant in adult liver and also expressed in omental and subcutaneous fat. Caloric diet restriction of obese patients caused a decreased expression of mARC2 in liver, similar to that seen in the livers of starved rats. Knock down of mARC2 expression by siRNA in murine adipocytes had statistically significant effect on the level of diglycerides and on the fatty acid composition of some triglycerides, concomitantly a clear trend toward the reduced formation of most of triglyceride and phospholipid species was observed. The involvement of mARC2 in the metabolism of the hepatotoxic drug ximelagatran was evaluated in hepatocytes and adipocytes. Ximelagatran was shown to cause oxidative stress and knock down of mARC2 in adipocytes prevented ximelagatran induced inhibition of mitochondrial respiration. In conclusion, our data indicate that mARC1 and mARC2 have different developmental expression profiles, and that mARC2 is involved in lipogenesis, is regulated by nutritional status and responsible for activation of ximelagatran into a mitotoxic metabolite(s).	[Neve, Etienne P. A.; Hendriks, Delilah F. G.; Nordling, Asa; Mkrtchian, Souren; Ingelman-Sundberg, Magnus] Karolinska Inst, Dept Physiol & Pharmacol, Pharmacogenet Sect, Stockholm, Sweden; [Koefeler, Harald] Med Univ Graz, Ctr Med Res ZMF, Graz, Austria; [Gogvadze, Vladimir] Karolinska Inst, Inst Environm Med, Sect Toxicol, S-10401 Stockholm, Sweden; [Naslund, Erik] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Stockholm, Sweden	Karolinska Institutet; Medical University of Graz; Karolinska Institutet; Danderyds Hospital; Karolinska Institutet	Ingelman-Sundberg, M (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Pharmacogenet Sect, Stockholm, Sweden.	magnus.ingelman-sundberg@ki.se	Ingelman-Sundberg, Magnus/ABD-9302-2021; Gogvadze, Vladimir/A-4392-2014	Hendriks, Delilah/0000-0003-1159-5946; Kofeler, Harald/0000-0002-2725-9616; Mkrtchian, Souren/0000-0001-9801-2736	IMI MIP-DILI project [115336]; Swedish Research Council; Stockholm County Council (ALF)	IMI MIP-DILI project; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council (ALF)(Stockholm County Council)	This work was supported by the IMI MIP-DILI project (Grant Agreement number 115336), The Swedish Research Council and Stockholm County Council (ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S, 2005, DRUG METAB DISPOS, V33, P570, DOI 10.1124/dmd.104.002972; Bersani NA, 2002, METHOD ENZYMOL, V347, P317; Clement B, 2003, DRUG METAB DISPOS, V31, P645, DOI 10.1124/dmd.31.5.645; Du YT, 2013, J BIOL CHEM, V288, P32241, DOI 10.1074/jbc.M113.495150; Fauland A, 2011, J LIPID RES, V52, P2314, DOI 10.1194/jlr.D016550; Fontana RJ, 2014, GASTROENTEROLOGY, V146, P914, DOI 10.1053/j.gastro.2013.12.032; Ghisla S, 2004, EUR J BIOCHEM, V271, P494, DOI 10.1046/j.1432-1033.2003.03946.x; Goldkind L, 2006, PHARMACOEPIDEM DR S, V15, P213, DOI 10.1002/pds.1207; Jakobs HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105371; Kindmark A, 2008, PHARMACOGENOMICS J, V8, P186, DOI 10.1038/sj.tpj.6500458; Krompholz N, 2012, CHEM RES TOXICOL, V25, P2443, DOI 10.1021/tx300298m; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Mkrtchian S, 1998, EUR J BIOCHEM, V251, P304, DOI 10.1046/j.1432-1327.1998.2510304.x; Neve EPA, 2012, J BIOL CHEM, V287, P6307, DOI 10.1074/jbc.M111.328237; Plitzko B, 2015, J BIOL CHEM, V290, P10126, DOI 10.1074/jbc.M115.640052; Sparacino-Watkins CE, 2014, J BIOL CHEM, V289, P10345, DOI 10.1074/jbc.M114.555177; Stephens C, 2014, CURR OPIN ALLERGY CL, V14, P286, DOI 10.1097/ACI.0000000000000070; Testa L, 2007, EXPERT OPIN DRUG SAF, V6, P397, DOI 10.1517/14740338.6.4.397; Wahl B, 2010, J BIOL CHEM, V285, P37847, DOI 10.1074/jbc.M110.169532	21	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138487	10.1371/journal.pone.0138487	http://dx.doi.org/10.1371/journal.pone.0138487			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378779	gold, Green Published, Green Submitted			2022-12-27	WOS:000361769400105
J	Smith, GT; Rahman, AR; Li, M; Moore, B; Gietema, H; Veronesi, G; Massion, PP; Walker, RC				Smith, Gary T.; Rahman, Ahmad R.; Li, Ming; Moore, Brandon; Gietema, Hester; Veronesi, Giulia; Massion, Pierre P.; Walker, Ronald C.			Reproducibility of Volumetric Computed Tomography of Stable Small Pulmonary Nodules with Implications on Estimated Growth Rate and Optimal Scan Interval	PLOS ONE			English	Article							LUNG-CANCER; FLEISCHNER-SOCIETY; DOUBLING TIMES; CT; MANAGEMENT; PERFORMANCE; STATEMENT; LEVEL	Purpose To use clinically measured reproducibility of volumetric CT (vCT) of lung nodules to estimate error in nodule growth rate in order to determine optimal scan interval for patient follow-up. Methods We performed quantitative vCT on 89 stable non-calcified nodules and 49 calcified nodules measuring 3-13 mm diameter in 71 patients who underwent 3-9 repeat vCT studies for clinical evaluation of pulmonary nodules. Calculated volume standard deviation as a function of mean nodule volume was used to compute error in estimated growth rate. This error was then used to determine the optimal patient follow-up scan interval while fixing the false positive rate at 5%. Results Linear regression of nodule volume standard deviation versus the mean nodule volume for stable non-calcified nodules yielded a slope of 0.057 +/- 0.002 (r(2) = 0.79, p<0.001). For calcified stable nodules, the regression slope was 0.052 +/- 0.005 (r(2) = 0.65, p = 0.03). Using this with the error propagation formula, the optimal patient follow-up scan interval was calculated to be 81 days, independent of initial nodule volume. Conclusions Reproducibility of vCT is excellent, and the standard error is proportional to the mean calculated nodule volume for the range of nodules examined. This relationship constrains statistical certainty of vCT calculated doubling times and results in an optimal scan interval that is independent of the initial nodule volume.	[Smith, Gary T.; Rahman, Ahmad R.; Moore, Brandon; Walker, Ronald C.] Tennessee Valley Healthcare Syst, Dept Med Imaging, Dept Vet Affairs, Nashville, TN 37212 USA; [Li, Ming] Vanderbilt Univ, Med Ctr, Ctr Quantitat Sci, Nashville, TN USA; [Gietema, Hester] Med Spectrum Twente, Enschede, Netherlands; [Veronesi, Giulia] European Inst Oncol, Milan, Italy; [Massion, Pierre P.] Tennessee Valley Healthcare Syst, Med Serv, Pulm & Crit Care Med Sect, Nashville, TN USA; [Massion, Pierre P.] Thorac Program Vanderbilt Ingram Canc Ctr, Dept Med, Nashville, TN USA; [Massion, Pierre P.] Thorac Program Vanderbilt Ingram Canc Ctr, Dept Canc Biol, Nashville, TN USA; [Smith, Gary T.; Walker, Ronald C.] Vanderbilt Univ, Med Ctr, Dept Radiol & Radiol Sci, Nashville, TN USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Medical Spectrum Twente; IRCCS European Institute of Oncology (IEO); US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University	Smith, GT (corresponding author), Tennessee Valley Healthcare Syst, Dept Med Imaging, Dept Vet Affairs, Nashville, TN 37212 USA.	gary.t.smith@vanderbilt.edu	Li, Ming/P-9514-2019; Veronesi, Giulia/AAA-6327-2021	Li, Ming/0000-0001-8270-2070; Veronesi, Giulia/0000-0001-9032-1278	National Cancer Institute [U01CA152662]; NATIONAL CANCER INSTITUTE [U01CA152662] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support was provided by National Cancer Institute U01CA152662 awarded to PPM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Ashraf H, 2011, THORAX, V66, P315, DOI 10.1136/thx.2010.136747; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Gavrielides MA, 2009, RADIOLOGY, V251, P26, DOI 10.1148/radiol.2511071897; Gietema HA, 2007, RADIOLOGY, V245, P888, DOI 10.1148/radiol.2452061054; Grogan EL, 2011, J THORAC ONCOL, V6, P1720, DOI 10.1097/JTO.0b013e318226b48a; Henschke CI, 2012, RADIOLOGY, V263, P578, DOI 10.1148/radiol.12102489; Horeweg N, 2014, LANCET ONCOL, V15, P1342, DOI 10.1016/S1470-2045(14)70387-0; Kostis WJ, 2004, RADIOLOGY, V231, P446, DOI 10.1148/radiol.2312030553; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; Marchiano A, 2009, RADIOLOGY, V251, P919, DOI 10.1148/radiol.2513081313; Naidich DP, 2013, RADIOLOGY, V266, P304, DOI 10.1148/radiol.12120628; Nietert PJ, 2009, CHEST, V135, P1580, DOI 10.1378/chest.08-2040; Pecot CV, 2012, CANCER EPIDEM BIOMAR, V21, P786, DOI 10.1158/1055-9965.EPI-11-0932; Revel MP, 2006, AM J ROENTGENOL, V187, P135, DOI 10.2214/AJR.05.1228; Revel MP, 2004, RADIOLOGY, V231, P459, DOI 10.1148/radiol.2312030241; Revel MP, 2004, RADIOLOGY, V231, P453, DOI 10.1148/radiol.2312030167; van Klaveren RJ, 2009, NEW ENGL J MED, V361, P2221, DOI 10.1056/NEJMoa0906085; Veronesi G, 2012, ANN INTERN MED, V157, P776, DOI 10.7326/0003-4819-157-11-201212040-00005; Wang JB, 2012, LUNG CANCER, V78, P51, DOI 10.1016/j.lungcan.2012.06.010; Xie X, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20130160; Yankelevitz DF, 2000, RADIOLOGY, V217, P251, DOI 10.1148/radiology.217.1.r00oc33251	23	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138144	10.1371/journal.pone.0138144	http://dx.doi.org/10.1371/journal.pone.0138144			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379272	gold, Green Published, Green Submitted			2022-12-27	WOS:000361769400061
J	Zhang, L; Morrison, AJ; Thibodeau, PH				Zhang, Liang; Morrison, Anneliese J.; Thibodeau, Patrick H.			Interdomain Contacts and the Stability of Serralysin Protease from Serratia marcescens	PLOS ONE			English	Article							AERUGINOSA ALKALINE PROTEASE; ADENYLATE-CYCLASE TOXIN; PSEUDOMONAS-AERUGINOSA; ERWINIA-CHRYSANTHEMI; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; EXTRACELLULAR PROTEINS; SECRETION SYSTEM; METALLOPROTEASE; METZINCINS	The serralysin family of bacterial metalloproteases is associated with virulence in multiple modes of infection. These extracellular proteases are members of the Repeats-in-ToXin (RTX) family of toxins and virulence factors, which mediated virulence in E. coli, B. pertussis, and P. aeruginosa, as well as other animal and plant pathogens. The serralysin proteases are structurally dynamic and their folding is regulated by calcium binding to a C-terminal domain that defines the RTX family of proteins. Previous studies have suggested that interactions between N-terminal sequences and this C-terminal domain are important for the high thermal and chemical stabilities of the RTX proteases. Extending from this, stabilization of these interactions in the native structure may lead to hyperstabilization of the folded protein. To test this hypothesis, cysteine pairs were introduced into the N-terminal helix and the RTX domain and protease folding and activity were assessed. Under stringent pH and temperature conditions, the disulfide-bonded mutant showed increased protease activity and stability. This activity was dependent on the redox environment of the refolding reaction and could be blocked by selective modification of the cysteine residues before protease refolding. These data demonstrate that the thermal and chemical stability of these proteases is, in part, mediated by binding between the RTX domain and the N-terminal helix and demonstrate that stabilization of this interaction can further stabilize the active protease, leading to additional pH and thermal tolerance.	[Zhang, Liang; Morrison, Anneliese J.; Thibodeau, Patrick H.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Thibodeau, PH (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA.	thibodea@pitt.edu			National Institutes of Health, National Institutes of Diabetes, Digestive and Kidney Diseases [DK083284]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK083284, R01DK083284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007759] Funding Source: NIH RePORTER	National Institutes of Health, National Institutes of Diabetes, Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by National Institutes of Health, National Institutes of Diabetes, Digestive and Kidney Diseases, DK083284. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIYAPPA PS, 1976, MOL CELL BIOCHEM, V13, P95, DOI 10.1007/BF01837059; Angkawidjaja C, 2007, FEBS LETT, V581, P5060, DOI 10.1016/j.febslet.2007.09.048; Balaban NP, 2012, BIOCHEMISTRY-MOSCOW+, V77, P119, DOI 10.1134/S0006297912020010; Bardoel BW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002206; BAUMANN U, 1993, EMBO J, V12, P3357, DOI 10.1002/j.1460-2075.1993.tb06009.x; BAUMANN U, 1994, J MOL BIOL, V242, P244, DOI 10.1006/jmbi.1994.1576; BAUMANN U, 1995, J MOL BIOL, V248, P653, DOI 10.1006/jmbi.1995.0249; Butterworth MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100313; Butterworth MB, 2012, J BIOL CHEM, V287, P32556, DOI 10.1074/jbc.M112.369520; Chenal A, 2009, J BIOL CHEM, V284, P1781, DOI 10.1074/jbc.M807312200; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; GENTSCHEV I, 1992, MOL GEN GENET, V232, P40, DOI 10.1007/BF00299135; HASE CC, 1993, MICROBIOL REV, V57, P823; Hege T, 2001, J MOL BIOL, V314, P187, DOI 10.1006/jmbi.2001.5124; HESS J, 1990, MOL GEN GENET, V224, P201, DOI 10.1007/BF00271553; HINES DA, 1988, J BACTERIOL, V170, P4141, DOI 10.1128/jb.170.9.4141-4146.1988; Hobden JA, 2002, DNA CELL BIOL, V21, P391, DOI 10.1089/10445490260099674; Jaswal SS, 2002, NATURE, V415, P343, DOI 10.1038/415343a; KREGER AS, 1986, INVEST OPHTH VIS SCI, V27, P932; Kuwahara K, 2008, PROTEIN ENG DES SEL, V21, P737, DOI 10.1093/protein/gzn057; LAZDUNSKI A, 1990, BIOCHIMIE, V72, P147, DOI 10.1016/0300-9084(90)90140-C; Leidal KG, 2003, J INTERF CYTOK RES, V23, P307, DOI 10.1089/107999003766628151; LETOFFE S, 1991, J BACTERIOL, V173, P2160; Lilie H, 2000, FEBS LETT, V470, P173, DOI 10.1016/S0014-5793(00)01308-9; Linhartova I, 2010, FEMS MICROBIOL REV, V34, P1076, DOI 10.1111/j.1574-6976.2010.00231.x; LYERLY D, 1981, INFECT IMMUN, V33, P927, DOI 10.1128/IAI.33.3.927-932.1981; LYERLY DM, 1983, INFECT IMMUN, V40, P113, DOI 10.1128/IAI.40.1.113-119.1983; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Motyan JA, 2013, BIOMOLECULES, V3, P923, DOI 10.3390/biom3040923; Palacios JL, 2001, J BACTERIOL, V183, P1346, DOI 10.1128/JB.183.4.1346-1358.2001; PARMELY M, 1990, INFECT IMMUN, V58, P3009, DOI 10.1128/IAI.58.9.3009-3014.1990; Petersen LM, 2013, CAN J MICROBIOL, V59, P627, DOI 10.1139/cjm-2013-0343; SEBO P, 1993, MOL MICROBIOL, V9, P999, DOI 10.1111/j.1365-2958.1993.tb01229.x; Sotomayor Perez AC, 2010, J MOL BIOL, V397, P534, DOI 10.1016/j.jmb.2010.01.031; STOCKER W, 1995, PROTEIN SCI, V4, P823; SUH YS, 1992, J BACTERIOL, V174, P2361, DOI 10.1128/JB.174.7.2361-2366.1992; Zhang L, 2014, BIOCHEMISTRY-US, V53, P6452, DOI 10.1021/bi5007546; Zhang L, 2012, J BIOL CHEM, V287, P4311, DOI 10.1074/jbc.M111.310300	38	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138419	10.1371/journal.pone.0138419	http://dx.doi.org/10.1371/journal.pone.0138419			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378460	Green Submitted, Green Published, gold			2022-12-27	WOS:000361769400097
J	Dingemanse, M; Roberts, SG; Baranova, J; Blythe, J; Drew, P; Floyd, S; Gisladottir, RS; Kendrick, KH; Levinson, SC; Manrique, E; Rossi, G; Enfield, NJ				Dingemanse, Mark; Roberts, Sean G.; Baranova, Julija; Blythe, Joe; Drew, Paul; Floyd, Simeon; Gisladottir, Rosa S.; Kendrick, Kobin H.; Levinson, Stephen C.; Manrique, Elizabeth; Rossi, Giovanni; Enfield, N. J.			Universal Principles in the Repair of Communication Problems	PLOS ONE			English	Article							LANGUAGE DIVERSITY; TURN-TAKING; ORGANIZATION	There would be little adaptive value in a complex communication system like human language if there were no ways to detect and correct problems. A systematic comparison of conversation in a broad sample of the world's languages reveals a universal system for the real-time resolution of frequent breakdowns in communication. In a sample of 12 languages of 8 language families of varied typological profiles we find a system of ` other-initiated repair', where the recipient of an unclear message can signal trouble and the sender can repair the original message. We find that this system is frequently used (on average about once per 1.4 minutes in any language), and that it has detailed common properties, contrary to assumptions of radical cultural variation. Unrelated languages share the same three functionally distinct types of repair initiator for signalling problems and use them in the same kinds of contexts. People prefer to choose the type that is the most specific possible, a principle that minimizes cost both for the sender being asked to fix the problem and for the dyad as a social unit. Disruption to the conversation is kept to a minimum, with the two-utterance repair sequence being on average no longer that the single utterance which is being fixed. The findings, controlled for historical relationships, situation types and other dependencies, reveal the fundamentally cooperative nature of human communication and offer support for the pragmatic universals hypothesis: while languages may vary in the organization of grammar and meaning, key systems of language use may be largely similar across cultural groups. They also provide a fresh perspective on controversies about the core properties of language, by revealing a common infrastructure for social interaction which may be the universal bedrock upon which linguistic diversity rests.	[Dingemanse, Mark; Roberts, Sean G.; Baranova, Julija; Floyd, Simeon; Gisladottir, Rosa S.; Kendrick, Kobin H.; Levinson, Stephen C.; Manrique, Elizabeth; Rossi, Giovanni; Enfield, N. J.] Max Planck Inst Psycholinguist, Language & Cognit Dept, Nijmegen, Netherlands; [Blythe, Joe] Univ Melbourne, Sch Language & Linguist, Melbourne, Vic, Australia; [Drew, Paul] Univ Loughborough, Dept Social Sci, Loughborough, Leics, England; [Levinson, Stephen C.] Radboud Univ Nijmegen, Nijmegen, Netherlands; [Levinson, Stephen C.; Enfield, N. J.] Donders Inst, Nijmegen, Netherlands; [Enfield, N. J.] Univ Sydney, Dept Linguist, Sydney, NSW 2006, Australia	Max Planck Society; University of Melbourne; Loughborough University; Radboud University Nijmegen; University of Sydney	Dingemanse, M (corresponding author), Max Planck Inst Psycholinguist, Language & Cognit Dept, Nijmegen, Netherlands.	mark.dingemanse@mpi.nl; nick.enfield@sydney.edu.au	Dingemanse, M./U-5176-2018; Rossi, Giovanni/F-4220-2015	Dingemanse, M./0000-0002-3290-5723; Rossi, Giovanni/0000-0001-5990-1637; Gisladottir, Rosa Signy/0000-0003-0941-1888; Enfield, N. J./0000-0003-3891-6973; Blythe, Joe/0000-0003-1281-9681; Roberts, Sean/0000-0001-5990-9161	ERC [240853, 269484]; Max Planck Gesellschaft	ERC(European Research Council (ERC)European Commission); Max Planck Gesellschaft(Max Planck Society)	This research was supported by ERC projects HSSLU (240853, to NJE) and INTERACT (269484, to SCL) and by the Max Planck Gesellschaft.	[Anonymous], 2013, MER WAT MAST; Arbib MA, 2008, CURR ANTHROPOL, V49, P1052, DOI 10.1086/593015; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baron-Cohen S., 1999, DESCENT MIND PSYCHOL; Benjamin T., 2013, SIGNALING TROUBLE LI; Benjamin T, 2012, RES LANG SOC INTERAC, V45, P82, DOI 10.1080/08351813.2012.646742; BESNIER N, 1989, LANG SOC, V18, P315, DOI 10.1017/S0047404500013634; Bickel B., 2014, CAMBRIDGE HDB LINGUI; Boeckx C., 2010, LANGUAGE COGNITION U; BRATMAN ME, 1992, PHILOS REV, V101, P327, DOI 10.2307/2185537; Carazo P, 2014, ANIM BEHAV, V87, P17, DOI 10.1016/j.anbehav.2013.10.027; CHENEY DL, 1988, ANIM BEHAV, V36, P477, DOI 10.1016/S0003-3472(88)80018-6; Chomsky N, 2011, LANG LEARN DEV, V7, P263, DOI 10.1080/15475441.2011.584041; Chomsky Noam., 1965, ASPECTS THEORY SYNTA; Clark Herbert H., 1991, PERSPECT SOC SHARED, P127, DOI DOI 10.1037/10096-006; CLARK HH, 1989, COGNITIVE SCI, V13, P259, DOI 10.1207/s15516709cog1302_7; Clark HH., 1987, LANG COGNITIVE PROC, V2, P19, DOI DOI 10.1080/01690968708406350; Colman Marcus, 2011, P ANN M COGNITIVE SC, V33, P1563; Corrin J., 2010, FIRST LANG, V30, P312, DOI [DOI 10.1177/0142723710370526), 10.1177/0142723710370526, DOI 10.1177/0142723710370526]; CROFT W., 2001, RADICAL CONSTRUCTION; Curl TS, 2005, DISCOURSE PROCESS, V39, P1, DOI 10.1207/s15326950dp3901_1; Dawkins R., 1978, P282; Dingemanse M., OPEN LINGUI IN PRESS, V1; Dingemanse M, 2015, OPEN LINGUIST, V1, P96, DOI 10.2478/opli-2014-0007; Dingemanse M, 2014, STUD LANG, V38, P5, DOI 10.1075/sl.38.1.01din; Dingemanse M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078273; Drew P, 1997, J PRAGMATICS, V28, P69, DOI 10.1016/S0378-2166(97)89759-7; ENFIELD NJ, 2010, SCIENCE, V329, P1600, DOI DOI 10.1126/SCIENCE.1194229); Evans N, 2009, BEHAV BRAIN SCI, V32, P429, DOI 10.1017/S0140525X0999094X; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Feng GC, 2014, QUAL QUANT, V48, P1803, DOI 10.1007/s11135-013-9956-8; Fox B., 1996, STUD INTERACT SOCIOL, V13, P185, DOI DOI 10.1017/CBO9780511620874.004; Frank MC, 2012, SCIENCE, V336, P998, DOI 10.1126/science.1218633; Frith C, 2005, CURR BIOL, V15, pR644, DOI 10.1016/j.cub.2005.08.041; Gordon P, 2004, SCIENCE, V306, P496, DOI 10.1126/science.1094492; HAIMOFF EH, 1988, SEMIOTICA, V68, P89, DOI 10.1515/semi.1988.68.1-2.89; Hasson U, 2012, TRENDS COGN SCI, V16, P114, DOI 10.1016/j.tics.2011.12.007; Hayashi M., 2013, J PRAGMATICS, DOI 1016/j.pragma.2013.11.014; Hayes AF, 2007, COMMUN METHODS MEAS, V1, P77, DOI 10.1080/19312450709336664; Healey PGT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098598; Healey PGT, 2003, PROCEEDINGS OF THE TWENTY-FIFTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, PTS 1 AND 2, P539; Hockett C.F., 1968, ANIMAL COMMUNICATION, P61; Hutchins Edwin., 2006, ROOTS HUMAN SOCIALIT; Jakobson R., 1960, STYLE LANG, P350; Jefferson G., 1972, STUDIES SOCIAL INTER, P294; Kendrick KH, 2015, OPEN LINGUIST, V1, P164, DOI 10.2478/opli-2014-0009; Levinson S. C., 2000, PRESUMPTIVE MEANINGS; Levinson SC., 2006, ROOTS HUM SOC CULT C, P39, DOI [DOI 10.3389/FPSYG.2015.00731, DOI 10.4324/9781003135517-3]; Liebal K, 2013, PRIMATE COMMUNICATIO, DOI [10.1016/j.applanim.2016.02.005, DOI 10.1016/J.APPLANIM.2016.02.005]; Mark Dingemanse, 2014, CAMBRIDGE HDB LINGUI, P434; Marler P. R, 1985, COMPREHENSIVE TXB PS, P237; Mills G. J., 2008, P 8 SIGDIAL COL OH U; Ochs E., 1984, GURT 84 MEANING FORM; Piantadosi ST, 2011, P NATL ACAD SCI USA, V108, P3526, DOI 10.1073/pnas.1012551108; Pickering MJ, 2004, BEHAV BRAIN SCI, V27, P169; Popper K. R., 1954, MIND, V63, P162; Robinson JD, 2006, COMMUN MONOGR, V73, P137, DOI 10.1080/03637750600581206; Roque LS, 2015, COGN LINGUIST, V26, P31, DOI 10.1515/cog-2014-0089; SACKS H, 1974, LANGUAGE, V50, P696, DOI 10.2307/412243; Schegloff E. A., 1993, RES LANG SOC INTERAC, V26, P99, DOI [10.1207/s15327973rlsi2601_5, DOI 10.1207/S15327973RLSI2601_5]; SCHEGLOFF EA, 1977, LANGUAGE, V53, P361, DOI 10.2307/413107; Schegloff EA, 1997, DISCOURSE PROCESS, V23, P499, DOI 10.1080/01638539709545001; Schegloff EA, 2000, APPL LINGUIST, V21, P205, DOI 10.1093/applin/21.2.205; Schegloff EA, 2004, RES LANG SOC INTERAC, V37, P95, DOI 10.1207/s15327973rlsi3702_2; Schegloff EA, 2004, BEHAV BRAIN SCI, V27, P207, DOI 10.1017/S0140525X04400053; SCHEGLOFF EA, 1992, AM J SOCIOL, V97, P1295, DOI 10.1086/229903; Schegloff EA, 2006, ROOTS HUMAN SOCIALIT, P70; Setting Margret, 1987, LINGUISTISCHE BERICH, V108, P128; Sidnell J, 2012, CURR ANTHROPOL, V53, P302, DOI 10.1086/665697; Stivers T, 2009, P NATL ACAD SCI USA, V106, P10587, DOI 10.1073/pnas.0903616106; Tinbergen N., 1963, Zeitschrift fuer Tierpsychologie, V20, P410; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Tomasello M, 2014, EUR J SOC PSYCHOL, V44, P187, DOI 10.1002/ejsp.2015; Tylor EB, 1889, J ROYAL ANTHR I, V18, P245, DOI [DOI 10.2307/2842423, 10.2307/2842423]; Wetherby AM., 1998, TRANSITIONS PRELINGU, P135; Wierzbicka A., 1991, CROSS CULTURAL PRAGM; Wiley R. Haven, 1994, P157	78	114	114	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136100	10.1371/journal.pone.0136100	http://dx.doi.org/10.1371/journal.pone.0136100			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CR8NH	26375483	gold, Green Published, Green Accepted			2022-12-27	WOS:000361610200011
J	Farris, ZJ; Golden, CD; Karpanty, S; Murphy, A; Stauffer, D; Ratelolahy, F; Andrianjakarivelo, V; Holmes, CM; Kelly, MJ				Farris, Zach J.; Golden, Christopher D.; Karpanty, Sarah; Murphy, Asia; Stauffer, Dean; Ratelolahy, Felix; Andrianjakarivelo, Vonjy; Holmes, Christopher M.; Kelly, Marcella J.			Hunting, Exotic Carnivores, and Habitat Loss: Anthropogenic Effects on a Native Carnivore Community, Madagascar	PLOS ONE			English	Article							EASTERN RAIN-FORESTS; ACTIVITY PATTERNS; EXTINCTION RISK; DOMESTIC DOGS; FRAGMENTATION; BIODIVERSITY; CONSERVATION; IMPACTS; DENSITY; DEFORESTATION	The wide-ranging, cumulative, negative effects of anthropogenic disturbance, including habitat degradation, exotic species, and hunting, on native wildlife has been well documented across a range of habitats worldwide with carnivores potentially being the most vulnerable due to their more extinction prone characteristics. Investigating the effects of anthropogenic pressures on sympatric carnivores is needed to improve our ability to develop targeted, effective management plans for carnivore conservation worldwide. Utilizing photographic, line-transect, and habitat sampling, as well as landscape analyses and village-based bushmeat hunting surveys, we provide the first investigation of how multiple forms of habitat degradation (fragmentation, exotic carnivores, human encroachment, and hunting) affect carnivore occupancy across Madagascar's largest protected area: the Masoala-Makira landscape. We found that as degradation increased, native carnivore occupancy and encounter rates decreased while exotic carnivore occupancy and encounter rates increased. Feral cats (Felis species) and domestic dogs (Canis familiaris) had higher occupancy than half of the native carnivore species across Madagascar's largest protected landscape. Bird and small mammal encounter rates were negatively associated with exotic carnivore occupancy, but positively associated with the occupancy of four native carnivore species. Spotted fanaloka (Fossa fossana) occupancy was constrained by the presence of exotic feral cats and exotic small Indian civet (Viverricula indica). Hunting was intense across the four study sites where hunting was studied, with the highest rates for the small Indian civet ((x) over bar = 90 individuals consumed/year), the ring-tailed vontsira (Galidia elegans) ((x) over bar = 58 consumed/year), and the fosa (Cryptoprocta ferox) ((x) over bar = 31 consumed/year). Our modeling results suggest hunters target intact forest where carnivore occupancy, abundance, and species richness, are highest. These various anthropogenic pressures and their effects on carnivore populations, especially increases in exotic carnivores and hunting, have wide-ranging, global implications and demand effective management plans to target the influx of exotic carnivores and unsustainable hunting that is affecting carnivore populations across Madagascar and worldwide.	[Farris, Zach J.; Karpanty, Sarah; Murphy, Asia; Stauffer, Dean; Kelly, Marcella J.] Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA; [Golden, Christopher D.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Golden, Christopher D.] Wildlife Conservat Soc, Wildlife Hlth & Hlth Policy Program, HEAL, New York, NY USA; [Ratelolahy, Felix; Andrianjakarivelo, Vonjy] Wildlife Conservat Soc Madagascar Program, Antananarivo, Madagascar; [Holmes, Christopher M.] Wildlife Conservat Soc Asia Program, Viangchan, Laos	Virginia Polytechnic Institute & State University; Harvard University; Harvard T.H. Chan School of Public Health; Wildlife Conservation Society	Farris, ZJ (corresponding author), Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA.	zjfarris@vt.edu	Farris, Zach J./AAW-6579-2020; Kelly, Marcella/B-4891-2011	Kelly, Marcella/0000-0001-9044-3873; Karpanty, Sarah/0000-0003-3831-8914; Golden, Christopher/0000-0002-2258-7493; Golden, Christopher/0000-0002-0358-4625	Cleveland Metroparks Zoo African Seed Grant; Mohammed bin Zayed Species Conservation Fund [1025935]; National Geographic Society-Waitts grant [W96-10]; National Geographic Society Conservation Trust [C135-08]; National Science Foundation [1011714]; National Science Foundation Coupled Human Natural Systems grant [NSF-GEO 1115057]	Cleveland Metroparks Zoo African Seed Grant; Mohammed bin Zayed Species Conservation Fund; National Geographic Society-Waitts grant(National Geographic Society); National Geographic Society Conservation Trust(National Geographic Society); National Science Foundation(National Science Foundation (NSF)); National Science Foundation Coupled Human Natural Systems grant	Cleveland Metroparks Zoo African Seed Grant (http://www.clevelandmetroparks.com/Zoo/Grants/Africa-Seed-Grants-Program-3.aspx): The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. European Association for Zoos and Aquariums (www.eaza.net): Idea Wild (www.ideawild.org): The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Margot Marsh Biodiversity Fund (grant #023815) (http://www.conservation.org/Pages/default.aspx): The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Mohammed bin Zayed Species Conservation Fund (grant #1025935) (http://www.speciesconservation.org/): The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Geographic Society-Waitts grant (#W96-10) (http://www.nationalgeographic.com/explorers/grantsprograms/waitt-grants-application/): The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Geographic Society Conservation Trust (grant #C135-08) (http://www.nationalgeographic.com/explorers/grants-programs/conservation-trust/): The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Science Foundation Doctoral Dissertation Improvement grant (#1011714) (http://www.nsf.gov/): The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Science Foundation Coupled Human Natural Systems grant (NSF-GEO 1115057) (www.nsf.gov): The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. People's Trust for Endangered Species (http://ptes.org/): The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Virginia Tech Chapter of Sigma Xi (http://www.vtnews.vt.edu/articles/2010/04/2010-266.html): The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Virginia Tech McGinnes fellowship (http://fishwild.vt.edu/): The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Virginia Tech Mosby fellowship (www.fishwild.vt.edu): The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Allnutt TF, 2008, CONSERV LETT, V1, P173, DOI 10.1111/j.1755-263X.2008.00027.x; Angerbjorn A, 2013, J APPL ECOL, V50, P59, DOI 10.1111/1365-2664.12033; [Anonymous], 2015, IUCN IUCN RED LIST T; Bailey LL, 2004, ECOL APPL, V14, P692, DOI 10.1890/03-5012; Barrett MA, 2009, NATURE, V461, P470, DOI 10.1038/461470a; Becker M, 2013, BIOL CONSERV, V158, P26, DOI 10.1016/j.biocon.2012.08.017; Brockman DK, 2008, INT J PRIMATOL, V29, P135, DOI 10.1007/s10764-007-9145-5; Brooke ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093195; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Campbell K.J., 2011, Occasional Papers of the IUCN Species Survival Commission, V42, P37; Carbone C, 2011, BIOL LETTERS, V7, P312, DOI 10.1098/rsbl.2010.0996; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Courchamp F, 2003, BIOL REV, V78, P347, DOI 10.1017/S1464793102006061; Crooks KR, 2011, PHILOS T R SOC B, V366, P2642, DOI 10.1098/rstb.2011.0120; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Davis ML, 2011, ANIM CONSERV, V14, P56, DOI 10.1111/j.1469-1795.2010.00389.x; Dehgan A, 2003, BEHAV EXTINCTION PRE; Di Bitetti MS, 2006, J ZOOL, V270, P153, DOI 10.1111/j.1469-7998.2006.00102.x; Fa JE, 2002, CONSERV BIOL, V16, P232, DOI 10.1046/j.1523-1739.2002.00275.x; Fa JE, 2009, MAMMAL REV, V39, P231, DOI 10.1111/j.1365-2907.2009.00149.x; Farris ZJ, 2015, J ZOOL, V296, P45, DOI 10.1111/jzo.12216; Farris Z. J., 2012, Small Carnivore Conservation, V47, P82; Farris ZJ, 2014, INT J PRIMATOL, V35, P859, DOI 10.1007/s10764-014-9786-0; Farris ZJ, ANIM CONSER IN PRESS; Farris ZJ, 2014, THESIS VIRGINIA POLY; Forero-Medina German, 2009, Biota Neotrop., V9, P45, DOI 10.1590/S1676-06032009000200004; Ganzhorn JU, 2001, ORYX, V35, P346, DOI 10.1046/j.1365-3008.2001.00201.x; Garbutt N, 2007, MAMMALS MADAGASCAR C; Gardner CJ, 2014, HUM ECOL, V42, P21, DOI 10.1007/s10745-013-9629-1; Gerber BD, 2011, THESIS; Gerber B, 2010, ORYX, V44, P219, DOI 10.1017/S0030605309991037; Gerber BD, 2012, ORYX, V46, P414, DOI 10.1017/S0030605311001116; Gerber BD, 2012, J MAMMAL, V93, P667, DOI 10.1644/11-MAMM-A-265.1; Gerber BD, 2012, POPUL ECOL, V54, P43, DOI 10.1007/s10144-011-0276-3; Godfrey LR, 2007, FOLIA PRIMATOL, V78, P405, DOI 10.1159/000105152; Golden CD, 2014, CONSERV BIOL, V28, P234, DOI 10.1111/cobi.12174; Golden CD, 2011, P NATL ACAD SCI USA, V108, P19653, DOI 10.1073/pnas.1112586108; Golden CD, 2009, ORYX, V43, P386, DOI 10.1017/S0030605309000131; Gompper ME, 2014, FREE-RANGING DOGS AND WILDLIFE CONSERVATION, P1; Goodman SM, 2005, ORYX, V39, P73, DOI 10.1017/S0030605305000128; Goodman SM, 2003, NATURAL HIST MADAGAS, P1351; Goodman SM, 2012, CARNIVORA MADAGASCAR; Goodrich JM, 2008, J ZOOL, V276, P323, DOI 10.1111/j.1469-7998.2008.00458.x; GREEN GM, 1990, SCIENCE, V248, P212, DOI 10.1126/science.248.4952.212; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; Hawkins CE, 2005, ORYX, V39, P35, DOI 10.1017/S0030605305000074; Hines J. E., 2006, PROGRAM PRESENCE; Holmes C., 2007, LINKING LIVELIHOODS; Hughes J, 2013, BIOL CONSERV, V157, P341, DOI 10.1016/j.biocon.2012.07.005; Irwin MT, 2010, BIOL CONSERV, V143, P2351, DOI 10.1016/j.biocon.2010.01.023; Kelly M. J., 2011, ASSESSING CARN UNPUB; Kerridge F, 2003, NATURAL HIST MADAGAS, P1363; Kolby JE, 2014, NATURE, V509, P563, DOI 10.1038/509563a; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Kremen C, 1999, CONSERV BIOL, V13, P1055, DOI 10.1046/j.1523-1739.1999.98374.x; Kremen C., 2003, NATURAL HIST MADAGAS, P1459; Logan MK, 2015, ANIM CONSERV, V18, P82, DOI 10.1111/acv.12137; Longcore T, 2009, CONSERV BIOL, V23, P887, DOI 10.1111/j.1523-1739.2009.01174.x; Lowry E, 2013, ECOL EVOL, V3, P182, DOI 10.1002/ece3.431; Luhrs ML, 2013, BEHAV ECOL SOCIOBIOL, V67, P1731, DOI 10.1007/s00265-013-1581-y; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; McGarigal K., 2012, TECH REP; Michalski F, 2005, BIOL CONSERV, V124, P383, DOI 10.1016/j.biocon.2005.01.045; Mudappa D, 2007, SMALL CARNIVORE CONS, V36, P18; Oehler JD, 1996, CAN J ZOOL, V74, P2070, DOI 10.1139/z96-235; Palmer C, 2014, VALUE CONFLICTS FERA; POLLARD JH, 1971, BIOMETRICS, V27, P991, DOI 10.2307/2528833; Rakotomanana H, 2013, CONSERVATION BIOLOGY: VOICES FROM THE TROPICS, P33; Randriamanalina Malatatiana H., 2000, Lemur News, V5, P11; Randrianandrianina FH, 2010, ORYX, V44, P411, DOI 10.1017/S003060531000044X; Ray JC, 2001, OECOLOGIA, V127, P395, DOI 10.1007/s004420000604; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Roemer GW, 2002, P NATL ACAD SCI USA, V99, P791, DOI 10.1073/pnas.012422499; Ryall KL, 2006, ECOLOGY, V87, P1086, DOI 10.1890/0012-9658(2006)87[1086:ROPTLA]2.0.CO;2; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Schwitzer C., 2013, LEMURS MADAGASCAR ST; Silva-Rodriguez EA, 2012, BIOL CONSERV, V150, P103, DOI 10.1016/j.biocon.2012.03.008; Tilman D, 1995, BIOL CONSERV, V72, P409; Vanak AT, 2010, J APPL ECOL, V47, P1225, DOI 10.1111/j.1365-2664.2010.01870.x; Vanak AT, 2009, MAMMAL REV, V39, P265, DOI 10.1111/j.1365-2907.2009.00148.x; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Winter L, 2004, JAVMA-J AM VET MED A, V225, P1369, DOI 10.2460/javma.2004.225.1369; Woodroffe R, 2001, CONSERV BIOL SER, V5, P61; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Young JK, 2011, BIOSCIENCE, V61, P125, DOI 10.1525/bio.2011.61.2.7	89	50	53	3	141	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136456	10.1371/journal.pone.0136456	http://dx.doi.org/10.1371/journal.pone.0136456			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375991	Green Submitted, Green Published, gold			2022-12-27	WOS:000361610200015
J	Ishizawa, J; Kojima, K; McQueen, T; Ruvolo, V; Chachad, D; Nogueras-Gonzalez, GM; Huang, XL; Pierceall, WE; Dettman, EJ; Cardone, MH; Shacham, S; Konopleva, M; Andreeff, M				Ishizawa, Jo; Kojima, Kensuke; McQueen, Teresa; Ruvolo, Vivian; Chachad, Dhruv; Nogueras-Gonzalez, Graciela M.; Huang, Xuelin; Pierceall, William E.; Dettman, E. J.; Cardone, Michael H.; Shacham, Sharon; Konopleva, Marina; Andreeff, Michael			Mitochondrial Profiling of Acute Myeloid Leukemia in the Assessment of Response to Apoptosis Modulating Drugs	PLOS ONE			English	Article							ACUTE MYELOGENOUS LEUKEMIA; BCL-2; AML; SENSITIVITY; PROTEINS; ABT-199; MDM2; INHIBITION; MECHANISMS; DEPENDENCE	BH3 profiling measures the propensity of transformed cells to undergo intrinsic apoptosis and is determined by exposing cells to BH3-mimicking peptides. We hypothesized that basal levels of prosurvival BCL-2 family proteins may modulate the predictive power of BH3 profiling and termed it mitochondrial profiling. We investigated the correlation between cell sensitivity to apoptogenic agents and mitochondrial profiling, using a panel of acute myeloid leukemias induced to undergo apoptosis by exposure to cytarabine, the BH3 mimetic ABT-199, the MDM2 inhibitor Nutlin-3a, or the CRM1 inhibitor KPT-330. We found that the apoptogenic efficacies of ABT-199 and cytarabine correlated well with BH3 profiling reflecting BCL2, but not BCL-XL or MCL-1 dependence. Baseline BCL-2 protein expression analysis increased the ability of BH3 profiling to predict resistance mediated by MCL-1. By utilizing engineered cells with overexpression or knockdown of BCL-2 family proteins, Ara-C was found to be independent, while ABT-199 was dependent on BCL-XL. BCL-2 and BCL-XL overexpression mediated resistance to KPT-330 which was not reflected in the BH3 profiling assay, or in baseline BCL-2 protein levels. In conclusion, mitochondrial profiling, the combination of BH3 profiling and prosurvival BCL-2 family protein analysis, represents an improved approach to predict efficacy of diverse agents in AML and may have utility in the design of more effective drug combinations.	[Ishizawa, Jo; Kojima, Kensuke; McQueen, Teresa; Ruvolo, Vivian; Chachad, Dhruv; Konopleva, Marina; Andreeff, Michael] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Sect Mol Hematol & Therapy, Houston, TX 77030 USA; [Nogueras-Gonzalez, Graciela M.; Huang, Xuelin] Univ Texas MD Anderson Canc Ctr, Div Quantitat Sci, Dept Biostat, Houston, TX 77030 USA; [Pierceall, William E.; Dettman, E. J.; Cardone, Michael H.] Eutrop Pharmaceut, Cambridge, MA USA; [Shacham, Sharon] Karyopharm Therapeut, Boston, MA USA; [Kojima, Kensuke] Saga Univ, Dept Med, Hematol Resp Med & Oncol, Saga 840, Japan	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Saga University	Andreeff, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Sect Mol Hematol & Therapy, Houston, TX 77030 USA.	mandreef@mdanderson.org		Dettman, E.J./0000-0002-0059-836X; Chachad, Dhruv/0000-0003-3131-7679	Japan Society for the Promotion of Science Postdoctoral Fellowship; Ministry of Education, Culture, Sports, Science and Technology in Japan [26461425]; Princess Takamatsu Cancer Research Fund [14-24610]; National Institutes of Health USA [CA49639, 100632, CA136411, CA16672]; Paul and Mary Haas Chair in Genetics; NATIONAL CANCER INSTITUTE [P50CA136411, P30CA016672, P01CA049639, P50CA100632] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science Postdoctoral Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Princess Takamatsu Cancer Research Fund; National Institutes of Health USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul and Mary Haas Chair in Genetics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported in part by grants from the Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad Award (to JI); the Ministry of Education, Culture, Sports, Science and Technology in Japan (26461425) and the Princess Takamatsu Cancer Research Fund (14-24610) (to KK); and the National Institutes of Health USA (CA49639, 100632, CA136411, and CA16672), and the Paul and Mary Haas Chair in Genetics (to MA).	Andreeff M, 2011, BLOOD; Bogenberger JM, 2014, LEUKEMIA, V28, P1657, DOI 10.1038/leu.2014.44; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chonghaile TN, 2014, CANCER DISCOV, V4, P1074, DOI 10.1158/2159-8290.CD-14-0353; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Kojima K, 2005, BLOOD, V106, P3150, DOI 10.1182/blood-2005-02-0553; Kojima K, 2010, LEUKEMIA, V24, P33, DOI 10.1038/leu.2009.212; Kojima K, 2006, CELL CYCLE, V5, P2778, DOI 10.4161/cc.5.23.3520; Kojima K, 2013, BLOOD, V121, P4166, DOI 10.1182/blood-2012-08-447581; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Konopleva M, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.118.118; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Long JT, 2010, BLOOD, V116, P71, DOI 10.1182/blood-2010-01-261628; Mau-Soerensen M, 2014, ASCO M, V32, P482, DOI DOI 10.1200/JCO.2013.53.3448; Pan R, 2014, BLOOD; Pan RQ, 2014, CANCER DISCOV, V4, P362, DOI 10.1158/2159-8290.CD-13-0609; Pierceall WE, 2014, LEUKEMIA RES, V38, P564, DOI 10.1016/j.leukres.2014.02.007; Pierceall WE, 2013, MOL CANCER THER, V12, P2940, DOI 10.1158/1535-7163.MCT-13-0692; Ryan J, 2013, METHODS, V61, P156, DOI 10.1016/j.ymeth.2013.04.006; Ryan JA, 2010, P NATL ACAD SCI USA, V107, P12895, DOI 10.1073/pnas.0914878107; Seymour JF DM, 2014, J CLIN ONCOL S, V32, p5s; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Vo TT, 2012, CELL, V151, P344, DOI 10.1016/j.cell.2012.08.038	26	21	30	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138377	10.1371/journal.pone.0138377	http://dx.doi.org/10.1371/journal.pone.0138377			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375587	Green Published, gold, Green Submitted			2022-12-27	WOS:000361610200103
J	Nakase, K; Kita, K; Kyo, T; Ueda, T; Tanaka, I; Katayama, N				Nakase, Kazunori; Kita, Kenkichi; Kyo, Taiichi; Ueda, Takanori; Tanaka, Isao; Katayama, Naoyuki			Prognostic Relevance of Cytokine Receptor Expression in Acute Myeloid Leukemia: Interleukin-2 Receptor alpha-Chain (CD25) Expression Predicts a Poor Prognosis	PLOS ONE			English	Article							ACUTE MYELOGENOUS LEUKEMIA; MAINTENANCE INTENSIFICATION THERAPY; INDIVIDUALIZED INDUCTION THERAPY; HEMATOPOIETIC GROWTH-FACTORS; SOLUBLE INTERLEUKIN-2-RECEPTOR; CONSOLIDATION THERAPY; CLINICAL IMPORTANCE; GM-CSF; CELLS; PROLIFERATION	A variety of cytokine/cytokine receptor systems affect the biological behavior of acute leukemia cells. However, little is known about the clinical relevance of cytokine receptor expression in acute myeloid leukemia (AML). We quantitatively examined the expression of interleukin-2 receptor alpha-chain (IL-2R alpha, also known as CD25), IL-2R beta, IL-3R alpha, IL-4R alpha, IL5R alpha, IL-6R alpha, IL-7R alpha, the common beta-chain (beta c), gamma c, granulocyte-macrophage colony-stimulating factor (GM-CSF)R alpha, G-CSFR, c-fms, c-mpl, c-kit, FLT3, and GP130 in leukemia cells from 767 adult patients with AML by flow cytometry and determined their prevalence and clinical significance. All cytokine receptors examined were expressed at varying levels, whereas the levels of IL-3R alpha, GM-CSFR alpha, IL-2R alpha, gamma c, c-kit, and G-CSFR exhibited a wide spectrum of >= 10,000 sites/cell. In terms of their French-American-British classification types, GM-CSFR alpha and c-fms were preferentially expressed in M4/M5 patients, G-CSF in M3 patients, and IL-2R alpha in non-M3 patients. Elevated levels of IL-3R alpha, GM-CSFR alpha, and IL-2R alpha correlated with leukocytosis. In patients <= 60 years old, higher levels of these 3 receptors correlated with poor responses to conventional chemotherapy, but only IL-2R alpha was associated with a shorter overall survival. By incorporating IL-2R alpha status into cytogenetic risk stratification, we could sort out a significantly adverse-risk cohort from the cytogenetically intermediate-risk group. Analyses with various phenotypical risk markers revealed the expression of IL-2R alpha as an independent prognostic indicator in patients with intermediaterisk cytogenetics. These findings were not observed in patients >60 years old. Our results indicate that several cytokine receptors were associated with certain cellular and clinical features, but IL-2R alpha alone had prognostic value that provides an additional marker to improve current risk evaluation in AML patients <= 60 years old.	[Nakase, Kazunori] Mie Univ Hosp, Ctr Canc, Tsu, Mie, Japan; [Kita, Kenkichi] Japan Baptist Hosp, Dept Internal Med, Kyoto, Japan; [Kita, Kenkichi] Hiroshima Red Cross & Atom Bomb Survivors Hosp, Dept Internal Med 4, Hiroshima, Japan; [Ueda, Takanori] Univ Fukui, Sch Med, Dept Internal Med 1, Fukui 910, Japan; [Tanaka, Isao] Suzuka Kaisei Hosp, Dept Internal Med, Suzuka, Japan; [Nakase, Kazunori; Kita, Kenkichi; Katayama, Naoyuki] Mie Univ, Grad Sch Med, Dept Hematol & Oncol, Tsu, Mie 514, Japan	Mie University; University of Fukui; Mie University	Nakase, K (corresponding author), Mie Univ Hosp, Ctr Canc, Tsu, Mie, Japan.	k2nakase@clin.medic.mie-u.ac.jp			Japan Society for the promotion of Science [63570570, 06454346]	Japan Society for the promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the promotion of Science (Grant 63570570 and 06454346)(www.jsps.go.jp/j-grantsinaid/). KK received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMITAGE RJ, 1986, BRIT J HAEMATOL, V64, P799, DOI 10.1111/j.1365-2141.1986.tb02242.x; BRADSTOCK K, 1994, BLOOD, V84, P1220; CARRON JA, 1989, BRIT J HAEMATOL, V73, P168, DOI 10.1111/j.1365-2141.1989.tb00248.x; Cerny J, 2013, BRIT J HAEMATOL, V160, P262, DOI 10.1111/bjh.12109; Derolf AR, 2014, SCAND J IMMUNOL, V80, P424, DOI 10.1111/sji.12223; Djunic I, 2012, MED ONCOL, V29, P2077, DOI 10.1007/s12032-011-0104-9; DUBREUIL P, 1988, BLOOD, V72, P1081; Engelhardt M, 2002, LEUKEMIA, V16, P1603, DOI 10.1038/sj.leu.2402620; ERBER WN, 1988, AM J CLIN PATHOL, V89, P645, DOI 10.1093/ajcp/89.5.645; Feller N, 2004, LEUKEMIA, V18, P1380, DOI 10.1038/sj.leu.2403405; FOA R, 1990, BRIT J HAEMATOL, V75, P34, DOI 10.1111/j.1365-2141.1990.tb02613.x; Gonen M, 2012, BLOOD, V120, P2297, DOI 10.1182/blood-2012-02-414425; Graf M, 2004, EUR J HAEMATOL, V72, P89, DOI 10.1046/j.0902-4441.2003.00184.x; Greenwood MJ, 2006, LEUKEMIA LYMPHOMA, V47, P1245, DOI 10.1080/10428190600572673; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Hoshino S, 1990, BLOOD, V7; Ikegawa S, 2015, LEUKEMIA LYMPHOMA, V56, P1874, DOI 10.3109/10428194.2014.974044; Katayama N, 1998, AM J HEMATOL, V58, P31, DOI 10.1002/(SICI)1096-8652(199805)58:1<31::AID-AJH6>3.0.CO;2-1; KITA K, 1993, BLOOD, V81, P2399; Kobayashi T, 1996, J CLIN ONCOL, V14, P204, DOI 10.1200/JCO.1996.14.1.204; Koubek K, 1998, NEOPLASMA, V45, P198; KYO T, 1988, ACTA HAEMATOL JAPON, V51, P1641; Lanza F, 1997, LEUKEMIA, V11, P1700, DOI 10.1038/sj.leu.2400794; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Lotem J, 2002, ONCOGENE, V21, P3284, DOI 10.1038/sj.onc.1205319; LOWENBERG B, 1993, BLOOD, V81, P281; Maegawa S, 2014, GENOME RES, V24, P580, DOI 10.1101/gr.157529.113; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Miwa H, 1998, LEUKEMIA, V12, P44, DOI 10.1038/sj.leu.2400877; Miyawaki S, 2005, CANCER-AM CANCER SOC, V104, P2726, DOI 10.1002/cncr.21493; Miyawaki S, 1999, INT J HEMATOL, V70, P97; Moon Y, 2004, ANN CLIN LAB SCI, V34, P410; Mrozek K, 2007, BLOOD, V109, P431, DOI 10.1182/blood-2006-06-001149; Nakase K, 2007, LEUKEMIA, V21, P326, DOI 10.1038/sj.leu.2404497; NAKASE K, 1993, LEUKEMIA RES, V17, P17, DOI 10.1016/0145-2126(93)90136-9; NAKASE K, 1992, BRIT J HAEMATOL, V80, P317, DOI 10.1111/j.1365-2141.1992.tb08139.x; Nakase K, 2000, LEUKEMIA, V14, P163, DOI 10.1038/sj.leu.2401638; Nakase K, 2006, IMMUNOLOGY, V2, P64; Nakase K, 2012, CANCER EPIDEMIOL, V36, pE306, DOI 10.1016/j.canep.2012.03.011; OHNO R, 1993, CANCER, V71, P3888, DOI 10.1002/1097-0142(19930615)71:12<3888::AID-CNCR2820711216>3.0.CO;2-G; Ohtake S, 2010, INT J HEMATOL, V91, P276, DOI 10.1007/s12185-009-0480-5; PADROS MR, 1989, EUR J HAEMATOL, V42, P436; Paietta E, 1997, LEUKEMIA, V11, P1887, DOI 10.1038/sj.leu.2400836; PARK LS, 1989, BLOOD, V74, P56; Riaz W, 2014, CANCER CONTROL, V21, P279, DOI 10.1177/107327481402100404; Saito Y, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000349; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Schnittger S, 2005, BLOOD, V106, P3733, DOI 10.1182/blood-2005-06-2248; Taussig DC, 2005, BLOOD, V106, P4086, DOI 10.1182/blood-2005-03-1072; Terwijn M, 2009, EUR J CANCER, V45, P1692, DOI 10.1016/j.ejca.2009.02.021; Testa U, 2002, BLOOD, V100, P2980, DOI 10.1182/blood-2002-03-0852; Tsuzuki M, 1997, LEUKEMIA, V11, P2125, DOI 10.1038/sj.leu.2400870; UCHIYAMA T, 1981, J IMMUNOL, V126, P1393; WEIDMANN E, 1995, LEUKEMIA RES, V19, P469, DOI 10.1016/0145-2126(95)00012-D; Yanada M, 2005, LEUKEMIA, V19, P1345, DOI 10.1038/sj.leu.2403838; Yang ZZ, 2011, BLOOD, V118, P2809, DOI 10.1182/blood-2011-03-340885	56	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0128998	10.1371/journal.pone.0128998	http://dx.doi.org/10.1371/journal.pone.0128998			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375984	gold, Green Published, Green Submitted			2022-12-27	WOS:000361610200002
J	Sanchez, DJ; Miranda, D; Marsden, MD; Dizon, TMA; Bontemps, JR; Davila, SJ; Del Mundo, LE; Ha, T; Senaati, A; Zack, JA; Cheng, GH				Sanchez, David Jesse; Miranda, Daniel, Jr.; Marsden, Matthew D.; Dizon, Thomas Michael A.; Bontemps, Johnny R.; Davila, Sergio J.; Del Mundo, Lara E.; Thai Ha; Senaati, Ashkon; Zack, Jerome A.; Cheng, Genhong			Disruption of Type I Interferon Induction by HIV Infection of T Cells	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; ANTIVIRAL SIGNALING PROTEIN; TOLL-LIKE RECEPTORS; ADAPTER PROTEIN; GENE; DNA; IDENTIFICATION; ACTIVATION; TRAF3; NEF	Our main objective of this study was to determine how Human Immunodeficiency Virus (HIV) avoids induction of the antiviral Type I Interferon (IFN) system. To limit viral infection, the innate immune system produces important antiviral cytokines such as the IFN. IFN set up a critical roadblock to virus infection by limiting further replication of a virus. Usually, IFN production is induced by the recognition of viral nucleic acids by innate immune receptors and subsequent downstream signaling. However, the importance of IFN in the defense against viruses has lead most pathogenic viruses to evolve strategies to inhibit host IFN induction or responses allowing for increased pathogenicity and persistence of the virus. While the adaptive immune responses to HIV infection have been extensively studied, less is known about the balance between induction and inhibition of innate immune defenses, including the antiviral IFN response, by HIV infection. Here we show that HIV infection of T cells does not induce significant IFN production even IFN I Interferon production. To explain this paradox, we screened HIV proteins and found that two HIV encoded proteins, Vpu and Nef, strongly antagonize IFN induction, with expression of these proteins leading to loss of expression of the innate immune viral RNA sensing adaptor protein, IPS-1 (IFN-beta promoter stimulator-1). We hypothesize that with lower levels of IPS-1 present, infected cells are defective inmounting antiviral responses allowing HIV to replicate without the normal antiviral actions of the host IFN response. Using cell lines as well as primary human derived cells, we show that HIV targeting of IPS-1 is key to limiting IFN induction. These findings describe how HIV infection modulates IFN induction providing insight into the mechanisms by which HIV establishes infection and persistence in a host.	[Sanchez, David Jesse; Dizon, Thomas Michael A.; Del Mundo, Lara E.] Western Univ Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Pomona, CA 91766 USA; [Miranda, Daniel, Jr.; Bontemps, Johnny R.; Davila, Sergio J.; Thai Ha; Senaati, Ashkon; Zack, Jerome A.; Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA; [Miranda, Daniel, Jr.; Marsden, Matthew D.; Zack, Jerome A.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA AIDS Inst, Los Angeles, CA 90095 USA; [Marsden, Matthew D.; Zack, Jerome A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA	Western University of Health Sciences; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Sanchez, DJ (corresponding author), Western Univ Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Pomona, CA 91766 USA.	sanchezd@westernu.edu		Sanchez, David/0000-0002-6032-4600	NIH [AI069120-03, AI70010]; UCLA Center for AIDS Research (CFAR); UCLA CFAR [NIH/NIAID AI028697]; UCLA AIDS Institute; Western University of Health Sciences College of Pharmacy startup funding; UCLA Interdisciplinary Training in Virology and Gene Therapy grant [NIH 5T32AI060567-05]; UCLA Tumor Cell Biology Training grant [NIH 5T32CA009056-29]; UCLA Clinical Immunology and Allergy Training grant [NIH 5T32AI007126-30]; NATIONAL CANCER INSTITUTE [T32CA009056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007126, P30AI028697, R01AI069120, T32AI060567, R01AI070010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008563, R25GM055052] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA Center for AIDS Research (CFAR); UCLA CFAR; UCLA AIDS Institute; Western University of Health Sciences College of Pharmacy startup funding; UCLA Interdisciplinary Training in Virology and Gene Therapy grant; UCLA Tumor Cell Biology Training grant; UCLA Clinical Immunology and Allergy Training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NIH Grants AI069120-03 (G.C.) and AI70010 (J.A.Z.) as well as by the UCLA Center for AIDS Research (CFAR) including a Seed grant by the UCLA CFAR (NIH/NIAID AI028697) and UCLA AIDS Institute (D.J.S.) as well as the Western University of Health Sciences College of Pharmacy startup funding (D.J.S.). Additional support was provided by UCLA Interdisciplinary Training in Virology and Gene Therapy grant (NIH 5T32AI060567-05) (D.J.S.), UCLA Tumor Cell Biology Training grant (NIH 5T32CA009056-29) (D.J.S.), and UCLA Clinical Immunology and Allergy Training grant (NIH 5T32AI007126-30) (D.M.). A.S. was a Van Trees Scholar and T.H. was a Boyer Scholar through the UCLA Undergraduate Research Scholars Program. J.R.B. was a Maximizing Student Diversity Scholar (NIH 5R25GM055052-10) and S.J.D. was a Minority Access to Research Careers Scholar (NIH 5T34GM008563-13) though the UCLA Center for Academic and Research Excellence.	Alonso K, 1997, IMMUNOL INVEST, V26, P341, DOI 10.3109/08820139709022691; An DS, 1999, J VIROL, V73, P7671, DOI 10.1128/JVI.73.9.7671-7677.1999; Arpaia N, 2011, CURR OPIN VIROL, V1, P447, DOI 10.1016/j.coviro.2011.10.006; Baenziger S, 2009, BLOOD, V113, P377, DOI 10.1182/blood-2008-04-151712; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Berg RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029291; Brooks DG, 2001, NAT MED, V7, P459, DOI 10.1038/86531; Burke B, 2007, J VIROL, V81, P7424, DOI 10.1128/JVI.02838-06; Chang JJ, 2010, J INFECT DIS, V202, pS297, DOI 10.1086/655657; Doehle BP, 2009, J VIROL, V83, P10395, DOI 10.1128/JVI.00849-09; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Gandhi RT, 1998, J EXP MED, V187, P1113, DOI 10.1084/jem.187.7.1113; GIBBS JS, 1994, AIDS RES HUM RETROV, V10, P343, DOI 10.1089/aid.1994.10.343; Grandvaux N, 2002, CURR OPIN INFECT DIS, V15, P259, DOI 10.1097/00001432-200206000-00008; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; Hardy AW, 2007, P NATL ACAD SCI USA, V104, P17453, DOI 10.1073/pnas.0707244104; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Havlir D, 2012, NEW ENGL J MED, V367, P685, DOI 10.1056/NEJMp1207138; Herbeuval JP, 2007, CLIN IMMUNOL, V123, P121, DOI 10.1016/j.clim.2006.09.016; Herbeuval JP, 2005, BLOOD, V106, P3524, DOI 10.1182/blood-2005-03-1243; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Kamga I, 2005, J INFECT DIS, V192, P303, DOI 10.1086/430931; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kedzierska Katherine, 2001, Antiviral Chemistry and Chemotherapy, V12, P133; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Lepelley A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001284; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Lindwasser OW, 2007, CURR MOL MED, V7, P171; Liu SY, 2012, P NATL ACAD SCI USA, V109, P4239, DOI 10.1073/pnas.1114981109; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; Marsden MD, 2007, J VIROL, V81, P6146, DOI 10.1128/JVI.00203-07; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Nabel GJ, 2013, NEW ENGL J MED, V368, P551, DOI 10.1056/NEJMra1204186; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Okumura A, 2008, VIROLOGY, V373, P85, DOI 10.1016/j.virol.2007.10.042; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Solis M, 2011, J VIROL, V85, P1224, DOI 10.1128/JVI.01635-10; vandenBroek MF, 1995, IMMUNOL REV, V148, P5; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Zeng M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002437	49	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137951	10.1371/journal.pone.0137951	http://dx.doi.org/10.1371/journal.pone.0137951			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375588	Green Submitted, gold, Green Published			2022-12-27	WOS:000361610200064
J	Vucemilo, L; Borovecki, A				Vucemilo, Luka; Borovecki, Ana			Readability and Content Assessment of Informed Consent Forms for Medical Procedures in Croatia	PLOS ONE			English	Article							PATIENT EDUCATION MATERIALS; HEALTH LITERACY; QUALITY	Background High quality of informed consent form is essential for adequate information transfer between physicians and patients. Current status of medical procedure consent forms in clinical practice in Croatia specifically in terms of the readability and the content is unknown. The aim of this study was to assess the readability and the content of informed consent forms for diagnostic and therapeutic procedures used with patients in Croatia. Methods 52 informed consent forms from six Croatian hospitals on the secondary and tertiary health-care level were tested for reading difficulty using Simple Measure of Gobbledygook (SMOG) formula adjusted for Croatian language and for qualitative analysis of the content. Results The averaged SMOG grade of analyzed informed consent forms was 13.25 (SD 1.59, range 10-19). Content analysis revealed that informed consent forms included description of risks in 96% of the cases, benefits in 81%, description of procedures in 78%, alternatives in 52%, risks and benefits of alternatives in 17% and risks and benefits of not receiving treatment or undergoing procedures in 13%. Conclusions Readability of evaluated informed consent forms is not appropriate for the general population in Croatia. The content of the forms failed to include in high proportion of the cases description of alternatives, risks and benefits of alternatives, as well as risks and benefits of not receiving treatments or undergoing procedures. Data obtained from this research could help in development and improvement of informed consent forms in Croatia especially now when Croatian hospitals are undergoing the process of accreditation.	[Vucemilo, Luka] Univ Hosp Merkur, Dept Otorhinolaryngol, Zagreb, Croatia; [Borovecki, Ana] Univ Zagreb, Sch Med, Andrija Stampar Sch Publ Hlth, Zagreb 41001, Croatia	University of Zagreb	Vucemilo, L (corresponding author), Univ Hosp Merkur, Dept Otorhinolaryngol, Zagreb, Croatia.	lukavucemilo@yahoo.com	Borovecki, Ana/ABF-6921-2020	Borovecki, Ana/0000-0001-8635-195X; Vucemilo, Luka/0000-0002-9089-7477	Croatian Ministry of Science, Education and Sport [108-1081871-90]; University of Zagreb School of Medicine	Croatian Ministry of Science, Education and Sport(Ministry of Science, Education and Sports, Republic of Croatia); University of Zagreb School of Medicine	This study was supported by the Croatian Ministry of Science, Education and Sport (Project No. 108-1081871-90, "The effect of organization on the quality and effectiveness of health care"), http://public.mzos.hr/Default.aspx?sec=2428, and the University of Zagreb School of Medicine, http://www.mef.unizg.hr/eng/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Bottrell MM, 2000, ARCH SURG-CHICAGO, V135, P26, DOI 10.1001/archsurg.135.1.26; Brangan Sanja, 2015, Coll Antropol, V39, P11; Brown H, 2004, J MED ETHICS, V30, P218, DOI 10.1136/jme.2003.003723; COY JA, 1989, PHYS THER, V69, P826, DOI 10.1093/ptj/69.10.826; Denzen EM, 2012, BIOL BLOOD MARROW TR, V18, P183, DOI 10.1016/j.bbmt.2011.07.022; Estrada CA, 2000, STROKE, V31, P2966, DOI 10.1161/01.STR.31.12.2966; Ezeome ER, 2011, NIGER J CLIN PRACT, V14, P311, DOI 10.4103/1119-3077.86775; Fleisher L., PRACTICAL GUIDE INFO; Friedman DB, 2006, HEALTH EDUC BEHAV, V33, P352, DOI 10.1177/1090198105277329; Friedman Daniela B, 2008, Prev Chronic Dis, V5, pA07; Glick A, 2010, J DENT EDUC, V74, P849; HLS-EU CONSORTIUM, 2012, COMP REP HLTH LIT 8; Kim SP, 2001, CANCER INVEST, V19, P684, DOI 10.1081/CNV-100106143; MacDougall DS, 2012, GYNECOL ONCOL, V125, P600, DOI 10.1016/j.ygyno.2012.02.030; San Norberto EM, 2014, CIR ESPAN, V92, P201, DOI 10.1016/j.ciresp.2013.02.027; MCLAUGHLIN GH, 1969, J READING, V12, P639; Nishimura A, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-28; Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80; Stossel LM, 2012, J GEN INTERN MED, V27, P1165, DOI 10.1007/s11606-012-2046-0; Terranova G, 2012, JACC-CARDIOVASC IMAG, V5, P649, DOI 10.1016/j.jcmg.2012.03.007; Vucemilo Luka, 2014, Lijec Vjesn, V136, P104; Vucemilo L, 2014, CAMB Q HEALTHC ETHIC, V23, P356, DOI 10.1017/S0963180113000972; Vucemilo L, 2013, CROAT MED J, V54, P185, DOI 10.3325/cmj.2013.54.185; Wallace LS, 2004, FAM MED, V36, P571; Wang C, 2011, PUBLIC HEALTH GENOM, V14, P222, DOI 10.1159/000273689	26	14	14	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138017	10.1371/journal.pone.0138017	http://dx.doi.org/10.1371/journal.pone.0138017			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8NH	26376183	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000361610200069
J	Bianca, RDD; Mitidieri, E; Esposito, D; Donnarumm, E; Russo, A; Fusco, F; Ianaro, A; Mirone, V; Cirino, G; Russo, G; Sorrentino, R				Bianca, Roberta d'Emmanuele di Villa; Mitidieri, Emma; Esposito, Davide; Donnarumm, Erminia; Russo, Annapina; Fusco, Ferdinando; Ianaro, Angela; Mirone, Vincenzo; Cirino, Giuseppe; Russo, Giulia; Sorrentino, Raffaella			Human Cystathionine-beta-Synthase Phosphorylation on Serine227 Modulates Hydrogen Sulfide Production in Human Urothelium	PLOS ONE			English	Article							URINARY-BLADDER; HNRNP H1; PROTEIN; PATHWAY; H2S; GASOTRANSMITTER; HYPERTENSION; RELAXATION; ACTIVATION; EXPRESSION	Urothelium, the epithelial lining the inner surface of human bladder, plays a key role in bladder physiology and pathology. It responds to chemical, mechanical and thermal stimuli by releasing several factors and mediators. Recently it has been shown that hydrogen sulfide contributes to human bladder homeostasis. Hydrogen sulfide ismainly produced in human bladder by the action of cystathionine-beta-synthase. Here, we demonstrate that human cystathionine-beta-synthase activity is regulated in a cGMP/PKG-dependentmanner through phosphorylation at serine 227. Incubation of human urothelium or T24 cell line with 8-Bromo-cyclic-guanosine monophosphate (8-Br-cGMP) but not dibutyryl-cyclic-adenosinemonophosphate (d-cAMP) causes an increase in hydrogen sulfide production. This result is congruous with the finding that PKG is robustly expressed but PKA only weakly present in human urothelium as well as in T24 cells. The cGMP/PKG-dependent phosphorylation elicited by 8-Br-cGMP is selectively reverted by KT5823, a specific PKG inhibitor. Moreover, the silencing of cystathionine-beta-synthase in T24 cells leads to a marked decrease in hydrogen sulfide production either in basal condition or following 8-Br-cGMP challenge. In order to identify the phosphorylation site, recombinant mutant proteins of cystathionine-beta-synthase in which Ser32, Ser227 or Ser525 was mutated in Ala were generated. The Ser227Ala mutant cystathionine-beta-synthase shows a notable reduction in basal biosynthesis of hydrogen sulfide becoming unresponsive to the 8-Br-cGMP challenge. A specific antibody that recognizes the phosphorylated form of cystathionine-beta-synthase has been produced and validated by using T24 cells and human urothelium. In conclusion, human cystathionine-beta-synthase can be phosphorylated in a PKGdependent manner at Ser227 leading to an increased catalytic activity.	[Bianca, Roberta d'Emmanuele di Villa; Mitidieri, Emma; Donnarumm, Erminia; Russo, Annapina; Ianaro, Angela; Cirino, Giuseppe; Russo, Giulia; Sorrentino, Raffaella] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Bianca, Roberta d'Emmanuele di Villa; Fusco, Ferdinando; Mirone, Vincenzo; Cirino, Giuseppe; Sorrentino, Raffaella] Univ Naples Federico II, Interdept Ctr Sexual Med, Naples, Italy; [Esposito, Davide] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Fusco, Ferdinando; Mirone, Vincenzo] Univ Naples Federico II, Dept Neurosci Human Reprod & Odontostomatol, Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; University of Naples Federico II	Cirino, G (corresponding author), Univ Naples Federico II, Dept Pharm, Via D Montesano 49, Naples, Italy.	cirino@unina.it	Russo, Annapina/O-7545-2015; ianaro, angela/ABC-2713-2020	Russo, Annapina/0000-0002-7509-3702; Fusco, Ferdinando/0000-0002-5158-5526; D'EMMANUELE DI VILLA BIANCA, Roberta/0000-0003-0992-6400	Ministero della Universita e della Ricerca (MIUR) [Y4WMCR]; Ministero della Universita e della Ricerca [4 AE23N_006]; European Network on Gasotransmitters (ENOG) COST Action [BM1005]	Ministero della Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Ministero della Universita e della Ricerca; European Network on Gasotransmitters (ENOG) COST Action	This work was supported by Ministero della Universita e della Ricerca (MIUR) PRIN 2012 (Y4WMCR) to GC; Ministero della Universita e della Ricerca PRIN 2010 (4 AE23N_006) to GR; European Network on Gasotransmitters (ENOG) COST Action BM1005 to GC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004032; Andersson KE, 2004, PHYSIOL REV, V84, P935, DOI 10.1152/physrev.00038.2003; Asimakopoulou A, 2013, BRIT J PHARMACOL, V169, P922, DOI 10.1111/bph.12171; Bianca RDD, 2015, HANDB EXP PHARMACOL, V230, P111, DOI 10.1007/978-3-319-18144-8_5; Bianca RDD, 2015, NITRIC OXIDE-BIOL CH, V46, P80, DOI 10.1016/j.niox.2014.11.013; Bianca RDD, 2013, P NATL ACAD SCI USA, V110, P15812, DOI 10.1073/pnas.1309049110; Bianca RDD, 2011, NAT REV UROL, V8, P286, DOI 10.1038/nrurol.2011.45; Bianca RDD, 2010, BRIT J PHARMACOL, V161, P1835, DOI 10.1111/j.1476-5381.2010.01016.x; Bianca RDD, 2010, J SEX MED, V7, P1778, DOI 10.1111/j.1743-6109.2009.01450.x; Bianca RDD, 2009, P NATL ACAD SCI USA, V106, P4513, DOI 10.1073/pnas.0807974105; Birder LA, 2012, NEUROUROL URODYNAM, V31, P293, DOI 10.1002/nau.22195; Birder L, 2013, PHYSIOL REV, V93, P653, DOI 10.1152/physrev.00030.2012; Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127; De Filippis D, 2014, EUR J PHARMACOL, V725, P64, DOI 10.1016/j.ejphar.2013.12.021; Eto K, 2002, J BIOL CHEM, V277, P42680, DOI 10.1074/jbc.M205835200; Fusco F, 2012, EUR UROL, V62, P1174, DOI 10.1016/j.eururo.2012.07.025; Gai JW, 2013, ASIAN J ANDROL, V15, P692, DOI 10.1038/aja.2013.32; Grol S, 2008, BJU INT, V102, P870, DOI 10.1111/j.1464-410X.2008.07752.x; Guo H, 2012, UROLOGY, V79, DOI 10.1016/j.urology.2011.10.013; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Kabil O, 2006, BIOCHEMISTRY-US, V45, P13528, DOI 10.1021/bi0615644; Kajimura M, 2010, ANTIOXID REDOX SIGN, V13, P157, DOI 10.1089/ars.2009.2657; Lavecchia A, 2013, J MED CHEM, V56, P2861, DOI 10.1021/jm3017199; MAGGI CA, 1987, J PHARM PHARMACOL, V39, P653, DOI 10.1111/j.2042-7158.1987.tb03447.x; Mikami Y, 2013, BIOCHEM BIOPH RES CO, V431, P131, DOI 10.1016/j.bbrc.2013.01.010; Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w; Russo A, 2006, BBA-MOL CELL RES, V1763, P833, DOI 10.1016/j.bbamcr.2006.05.010; Russo A, 2013, CELL CYCLE, V12, P76, DOI 10.4161/cc.22963; Russo A, 2011, NUCLEIC ACIDS RES, V39, P7576, DOI 10.1093/nar/gkr461; Russo A, 2010, BBA-GENE REGUL MECH, V1799, P419, DOI 10.1016/j.bbagrm.2010.01.008; Russo A, 2008, BBA-GENE REGUL MECH, V1779, P820, DOI 10.1016/j.bbagrm.2008.08.006; Sassone-Corsi P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011148; SCOTT JD, 1991, PHARMACOL THERAPEUT, V50, P123, DOI 10.1016/0163-7258(91)90075-W; Singh S, 2011, BBA-PROTEINS PROTEOM, V1814, P1518, DOI 10.1016/j.bbapap.2011.02.004; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; Vandiver MS, 2012, J MOL MED, V90, P255, DOI 10.1007/s00109-012-0873-4; Wang R, 2003, ANTIOXID REDOX SIGN, V5, P493, DOI 10.1089/152308603768295249; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yetik-Anacak G, 2015, BRIT J PHARMACOL, V172, P1434, DOI 10.1111/bph.12700	40	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136859	10.1371/journal.pone.0136859	http://dx.doi.org/10.1371/journal.pone.0136859			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368121	Green Published, gold			2022-12-27	WOS:000361601100029
J	de Lange, MJ; Razzaq, L; Versluis, M; Verlinde, S; Dogrusoz, M; Bohringer, S; Marinkovic, M; Luyten, GPM; de Keizer, RJW; de Gruijl, FR; Jager, MJ; van der Velden, PA				de Lange, Mark J.; Razzaq, Lubna; Versluis, Mieke; Verlinde, Sven; Dogrusoz, Mehmet; Bohringer, Stefan; Marinkovic, Marina; Luyten, Gregorius P. M.; de Keizer, Rob J. W.; de Gruijl, Frank R.; Jager, Martine J.; van der Velden, Pieter A.			Distribution of GNAQ and GNA11 Mutation Signatures in Uveal Melanoma Points to a Light Dependent Mutation Mechanism	PLOS ONE			English	Article							ULTRAVIOLET-RADIATION; OCULAR MELANOMA; DNA; BRAF; SKIN; MELANOGENESIS; PATTERNS; RISK	Uveal melanomas (UM) originate from melanocytes in the interior wall of the eye, namely from the iris, ciliary body and the choroid with marked differences in light exposure (from dark anterior to illuminated posterior). In contrast to UV radiation, focused or converging visible light readily reaches the retina and can damage DNA which possibly contributes to UM development. In this report choroidal, ciliochoroidal and iridociliary melanomas were analyzed for GNAQ and GNA11 mutations which were subsequently correlated to the location of tumor origin. Hotspot mutations in GNAQ and GNA11 can be divided in A>T and in A>C mutation signatures. The GNAQ A626C mutation (Q209P) was almost exclusively observed in choroidal melanomas from the illuminated posterior side. On the other hand, ciliochoroidal UM from the dark anterior side with mostly A>T mutations were clearly associated with light-colored eyes. Combined these data suggest a light and a pigment dependent etiology in UM development.	[de Lange, Mark J.; Razzaq, Lubna; Versluis, Mieke; Verlinde, Sven; Dogrusoz, Mehmet; Marinkovic, Marina; Luyten, Gregorius P. M.; de Keizer, Rob J. W.; Jager, Martine J.; van der Velden, Pieter A.] Leiden Univ, Dept Ophthalmol, Med Ctr, Leiden, Netherlands; [Bohringer, Stefan] Leiden Univ, Dept Med Stat, Med Ctr, NL-2300 RA Leiden, Netherlands; [de Gruijl, Frank R.] Leiden Univ, Dept Dermatol, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van der Velden, PA (corresponding author), Leiden Univ, Dept Ophthalmol, Med Ctr, Leiden, Netherlands.	velden@lumc.nl	Jager, Martine/AAR-3525-2020	Jager, Martine/0000-0003-2261-3820; van der Velden, Pieter/0000-0002-5710-9256	KWF kankerbestrijding [UL2011-4991]	KWF kankerbestrijding(KWF Kankerbestrijding)	This work was supported by KWF kankerbestrijding grant no.: UL2011-4991, received by PAvdV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki H, 2009, DEVELOPMENT, V136, P2511, DOI 10.1242/dev.037168; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Cruz F, 2003, CANCER RES, V63, P5761; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; EGAN KM, 1988, SURV OPHTHALMOL, V32, P239, DOI 10.1016/0039-6257(88)90173-7; FEENEY L, 1978, INVEST OPHTH VIS SCI, V17, P583; Guenel P, 2001, CANCER CAUSE CONTROL, V12, P451, DOI 10.1023/A:1011271420974; Janssen CS, 2008, BRIT J CANCER, V99, P1673, DOI 10.1038/sj.bjc.6604731; KAMIYA H, 1995, NUCLEIC ACIDS RES, V23, P2893, DOI 10.1093/nar/23.15.2893; Krohn J, 2008, BRIT J OPHTHALMOL, V92, P751, DOI 10.1136/bjo.2007.133025; Li WJ, 2000, CANCER RES, V60, P3757; Maat W, 2008, INVEST OPHTH VIS SCI, V49, P23, DOI 10.1167/iovs.07-0722; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; Mitra D, 2012, NATURE, V491, P449, DOI 10.1038/nature11624; Onken MD, 2008, INVEST OPHTH VIS SCI, V49, P5230, DOI 10.1167/iovs.08-2145; RAIVIO I, 1977, ACTA OPHTHALMOL, P1; Rimoldi D, 2003, CANCER RES, V63, P5712; RONES B, 1958, ARCH OPHTHALMOL-CHIC, V60, P193; RYDBERG B, 1982, EMBO J, V1, P211, DOI 10.1002/j.1460-2075.1982.tb01149.x; Shields CL, 2009, ARCH OPHTHALMOL-CHIC, V127, P981, DOI 10.1001/archophthalmol.2009.151; Slominski A, 2014, ARCH BIOCHEM BIOPHYS, V563, P79, DOI 10.1016/j.abb.2014.06.030; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; SOPARKER CN, 1993, INVEST OPHTH VIS SCI, V34, P2203; Sparrow JR, 2003, INVEST OPHTH VIS SCI, V44, P2245, DOI 10.1167/iovs.02-0746; STRICKLAND D, 1981, AM J EPIDEMIOL, V113, P700, DOI 10.1093/oxfordjournals.aje.a113150; Vajdic CM, 2002, INT J CANCER, V101, P175, DOI 10.1002/ijc.10579; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586	30	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138002	10.1371/journal.pone.0138002	http://dx.doi.org/10.1371/journal.pone.0138002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368812	gold, Green Published, Green Submitted			2022-12-27	WOS:000361601100200
J	DeAmicis, S; Foggo, A				DeAmicis, Stacey; Foggo, Andrew			Long-Term Field Study Reveals Subtle Effects of the Invasive Alga Sargassum muticum upon the Epibiota of Zostera marina	PLOS ONE			English	Article							SEAGRASS POSIDONIA-OCEANICA; EPIPHYTIC ALGAE; INTRODUCED SEAWEED; PHENOLIC-COMPOUNDS; CAULERPA-RACEMOSA; MOBILE EPIFAUNA; HABITAT; EELGRASS; ASSEMBLAGES; COMMUNITIES	Invasive species can alter coastal ecosystems both directly, e.g. through competition for substratum and nutrients, and indirectly. Indirect effects may be mediated by creation of dissimilar or inimical habitats, changes in predator and/or prey assemblages, alterations in associated biota, and perturbations of water movement and thermal regimes. Previous studies have shown that invasive algae can modify native habitat architecture, disrupt intricately linked food webs and alter epibiotic assemblages. In the UK, the seagrass Zostera marina supports a diverse epibiotic assemblage, influencing key factors such as sediment dynamics, depositional regime and trophic linkages. Increasing encroachment of the invasive alga Sargassum muticum into seagrass meadows changes the physical and chemical characteristics of the local environment and creates the potential for changes in the epibionts associated with the seagrass blades, threatening the integrity of the seagrass ecosystem. We investigated the effects of S. muticum invasion upon the epibiota of Z. marina in a drowned river valley in SW England seasonally from spring to autumn over four years in an in-situ manipulative experiment, comparing permanent quadrats with and without artificially introduced S. muticum. Epibiota were weighed, identified to the most detailed operational taxonomic unit (OTU) possible, and unitary organisms were enumerated. Multivariate PERMANOVA+ analysis revealed significant differences in epibiont assemblages between Sargassum treatments. Linear mixed effects models indicated that differences in epibiota assemblage composition were not reflected as significant differences in mean biomass per sample, or number of epibiont OTUs per sample. We conclude that S. muticum invasion into Z. marina meadows may significantly alter the species composition and abundance distribution of epibiotic assemblages found on the blades of the seagrass. Thus S. muticum invasion could have more wide-reaching effects on processes within coastal ecosystems than predicted purely by direct effects.	[DeAmicis, Stacey; Foggo, Andrew] Univ Plymouth, Sch Marine Sci & Engn, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England	University of Plymouth	DeAmicis, S (corresponding author), Univ Plymouth, Sch Marine Sci & Engn, Marine Biol & Ecol Res Ctr, 620 Davy Bldg, Plymouth PL4 8AA, Devon, England.	stacey.deamicis@plymouth.ac.uk	DeAmicis, Stacey/F-3553-2015	DeAmicis, Stacey/0000-0002-3447-5085	Jack Kent Cooke Graduate Scholarship; Jack Kent Cooke Foundation	Jack Kent Cooke Graduate Scholarship; Jack Kent Cooke Foundation	This study was funded by (SD) Jack Kent Cooke Graduate Scholarship, Jack Kent Cooke Foundation: http://www.jkcf.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsler CD, 2006, ADV BOT RES, V43, P1, DOI 10.1016/S0065-2296(05)43001-3; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 2014, R LANG ENV STAT COMP; Attrill MJ, 2000, ECOGRAPHY, V23, P114, DOI 10.1034/j.1600-0587.2000.230112.x; Bax N, 2003, MAR POLICY, V27, P313, DOI 10.1016/S0308-597X(03)00041-1; Bell JD., 1989, BIOL SEAGRASSES TREA, P565; Bologna PAX, 1999, J EXP MAR BIOL ECOL, V242, P21, DOI 10.1016/S0022-0981(99)00092-1; BRAITHWAITE RW, 1989, BIOL CONSERV, V48, P189, DOI 10.1016/0006-3207(89)90118-3; Britton-Simmons KH, 2004, MAR ECOL PROG SER, V277, P61, DOI 10.3354/meps277061; Buschbaum C, 2006, MAR BIOL, V148, P743, DOI 10.1007/s00227-005-0128-9; Castejon-Silvo I, 2012, ESTUAR COAST SHELF S, V112, P225, DOI 10.1016/j.ecss.2012.07.028; Christie H, 2009, MAR ECOL PROG SER, V396, P221, DOI 10.3354/meps08351; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; CRITCHLEY AT, 1986, BIOL CONSERV, V35, P313, DOI 10.1016/0006-3207(86)90092-3; Cuny P, 1995, AQUAT BOT, V52, P237, DOI 10.1016/0304-3770(95)00504-8; De Falco G, 2000, GEO-MAR LETT, V20, P50, DOI 10.1007/s003670000030; DeAmicis S, 2012, LONG TERM EFFECTS SA; Drouin A, 2012, OECOLOGIA, V168, P491, DOI 10.1007/s00442-011-2086-x; Dumay O, 2004, PHYTOCHEMISTRY, V65, P3211, DOI 10.1016/j.phytochem.2004.09.003; Fagundez J, 2013, ANN BOT-LONDON, V111, P151, DOI 10.1093/aob/mcs257; Gartner A, 2013, J EXP MAR BIOL ECOL, V439, P143, DOI 10.1016/j.jembe.2012.11.009; Gestoso I, 2011, HELGOLAND MAR RES, V66, P1; Gestoso I, 2010, MAR FRESHWATER RES, V61, P724, DOI 10.1071/MF09251; GORHAM J, 1984, MAR BIOL, V80, P103, DOI 10.1007/BF00393133; HACKER SD, 1990, ECOLOGY, V71, P2269, DOI 10.2307/1938638; HALL MO, 1988, J MAR RES, V46, P613, DOI 10.1357/002224088785113531; HARRISON PG, 1989, AQUAT BOT, V35, P409, DOI 10.1016/0304-3770(89)90012-0; HARRISON PG, 1982, MAR BIOL, V67, P225, DOI 10.1007/BF00401288; Hauxwell J, 2001, ECOLOGY, V82, P1007, DOI 10.2307/2679899; Hemminga M.A., 2000, SEAGRASS ECOLOGY, DOI [10.1017/CBO9780511525551, DOI 10.1017/CBO9780511525551]; Hirst JA, 2008, ESTUAR COAST SHELF S, V78, P811, DOI 10.1016/j.ecss.2008.02.020; Jackson EL, 2006, J EXP MAR BIOL ECOL, V330, P38, DOI 10.1016/j.jembe.2005.12.016; JACOBS RPWM, 1983, AQUAT BOT, V15, P157, DOI 10.1016/0304-3770(83)90026-8; Jaschinski S, 2008, MAR BIOL, V154, P475, DOI 10.1007/s00227-008-0942-y; Jones E, 2010, MAR ECOL PROG SER, V400, P87, DOI 10.3354/meps08391; Keller RP, 2011, DIVERS DISTRIB, V17, P93, DOI 10.1111/j.1472-4642.2010.00696.x; KLUMPP DW, 1992, AQUAT BOT, V43, P327, DOI 10.1016/0304-3770(92)90046-L; Lee SY, 2001, J EXP MAR BIOL ECOL, V259, P23, DOI 10.1016/S0022-0981(01)00221-0; Lewis III R. R., 1982, CREATION RESTORATION; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; Lutz ML, 2010, MAR BIOL, V157, P1095, DOI 10.1007/s00227-010-1391-y; McClintock JB, 2001, MARINE CHEM ECOLOGY; McGlathery KJ, 2001, J PHYCOL, V37, P453, DOI 10.1046/j.1529-8817.2001.037004453.x; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Mittermayr A, 2014, MAR ECOL PROG SER, V505, P95, DOI 10.3354/meps10797; Moncreiff CA, 2001, MAR ECOL PROG SER, V215, P93, DOI 10.3354/meps215093; Monteiro CA, 2009, MAR BIOL, V156, P2505, DOI 10.1007/s00227-009-1275-1; NORTON TA, 1977, J EXP MAR BIOL ECOL, V26, P41, DOI 10.1016/0022-0981(77)90079-X; NORTON TA, 1983, MAR BIOL, V75, P169, DOI 10.1007/BF00405999; NOVAK R, 1984, MAR ECOL-P S Z N I, V5, P143, DOI 10.1111/j.1439-0485.1984.tb00313.x; ORTH RJ, 1984, ESTUARIES, V7, P339, DOI 10.2307/1351618; Parker JD, 2001, MAR ECOL PROG SER, V224, P55, DOI 10.3354/meps224055; Pergent Gerard, 2008, BMC Ecology, V8, P20, DOI 10.1186/1472-6785-8-20; Plouguerne E, 2006, AQUAT BOT, V85, P337, DOI 10.1016/j.aquabot.2006.06.011; Polte P, 2008, AQUAT BIOL, V3, P11, DOI 10.3354/ab00071; Raniello R, 2007, BIOL INVASIONS, V9, P361, DOI 10.1007/s10530-006-9044-2; Ruesink JL, 2006, MAR ECOL PROG SER, V311, P203, DOI 10.3354/meps311203; Saunders JE, 2003, MAR ECOL PROG SER, V249, P107, DOI 10.3354/meps249107; Scheibling RE, 2006, BOT MAR, V157, P1095; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Shen GC, 2009, ECOLOGY, V90, P3033, DOI 10.1890/08-1646.1; STENECK RS, 1994, OIKOS, V69, P476, DOI 10.2307/3545860; Strong JA, 2006, MAR ECOL PROG SER, V321, P87, DOI 10.3354/meps321087; TAYLOR RB, 1994, MAR ECOL PROG SER, V115, P271, DOI 10.3354/meps115271; Thomsen MS, 2011, J EXP MAR BIOL ECOL, V400, P322, DOI 10.1016/j.jembe.2011.02.033; THURSBY G B, 1984, Florida Scientist, V47, P130; Tomas F, 2005, MAR ECOL PROG SER, V287, P115, DOI 10.3354/meps287115; Tweedley JR, 2008, MAR ECOL PROG SER, V354, P305, DOI 10.3354/meps07242; Valentine JF, 2002, B MAR SCI, V71, P1361; Vazquez-Luis M, 2008, MAR ENVIRON RES, V65, P416, DOI 10.1016/j.marenvres.2008.01.006; Verges A, 2007, MAR ECOL PROG SER, V343, P107, DOI 10.3354/meps06885; Viejo RM, 1999, AQUAT BOT, V64, P131, DOI 10.1016/S0304-3770(99)00011-X; Wikstrom SA, 2004, BIOL INVASIONS, V6, P141, DOI 10.1023/B:BINV.0000022132.00398.14	73	7	7	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137861	10.1371/journal.pone.0137861	http://dx.doi.org/10.1371/journal.pone.0137861			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368805	gold, Green Submitted, Green Published			2022-12-27	WOS:000361601100158
J	Hallstrom, T; Uhde, M; Singh, B; Skerka, C; Riesbeck, K; Zipfel, PF				Hallstroem, Teresia; Uhde, Melanie; Singh, Birendra; Skerka, Christine; Riesbeck, Kristian; Zipfel, Peter F.			Pseudomonas aeruginosa Uses Dihydrolipoamide Dehydrogenase (Lpd) to Bind to the Human Terminal Pathway Regulators Vitronectin and Clusterin to Inhibit Terminal Pathway Complement Attack	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; STAPHYLOCOCCUS-AUREUS; ALKALINE PROTEASE; IMMUNE EVASION; FACTOR-H; SURFACE; ACTIVATION; INTERACTS; DOMAIN	The opportunistic human pathogen Pseudomonas aeruginosa controls host innate immune and complement attack. Here we identify Dihydrolipoamide dehydrogenase (Lpd), a 57 kDa moonlighting protein, as the first P. aeruginosa protein that binds the two human terminal pathway inhibitors vitronectin and clusterin. Both human regulators when bound to the bacterium inhibited effector function of the terminal complement, blocked C5b-9 deposition and protected the bacterium from complement damage. P. aeruginosa when challenged with complement active human serum depleted from vitronectin was severely damaged and bacterial survival was reduced by over 50%. Similarly, when in human serum clusterin was blocked by a mAb, bacterial survival was reduced by 44%. Thus, demonstrating that Pseudomonas benefits from attachment of each human regulator and controls complement attack. The Lpd binding site in vitronectin was localized to the C-terminal region, i.e. to residues 354-363. Thus, Lpd of P. aeruginosa is a surface exposed moonlighting protein that binds two human terminal pathway inhibitors, vitronectin and clusterin and each human inhibitor when attached protected the bacterial pathogen from the action of the terminal complement pathway. Our results showed insights into the important function of Lpd as a complement regulator binding protein that might play an important role in virulence of P. aeruginosa.	[Hallstroem, Teresia; Uhde, Melanie; Skerka, Christine; Zipfel, Peter F.] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, Jena, Germany; [Singh, Birendra; Riesbeck, Kristian] Lund Univ, Skane Univ Hosp, Dept Translat Med Malmo, Med Microbiol, Malmo, Sweden; [Zipfel, Peter F.] Univ Jena, Fac Biol, Jena, Germany	Hans Knoll Institute (HKI); Lund University; Skane University Hospital; Friedrich Schiller University of Jena	Zipfel, PF (corresponding author), Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, Jena, Germany.	peter.zipfel@hki-jena.de	; Singh, Birendra/H-3592-2011	Riesbeck, Kristian/0000-0001-6274-6965; Singh, Birendra/0000-0002-7246-1442				Akesson P, 1996, J BIOL CHEM, V271, P1081, DOI 10.1074/jbc.271.2.1081; ARKO RJ, 1991, J CLIN MICROBIOL, V29, P70, DOI 10.1128/JCM.29.1.70-75.1991; Attia AS, 2006, INFECT IMMUN, V74, P1597, DOI 10.1128/IAI.74.3.1597-1611.2006; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Bubeck D, 2014, BIOCHEMISTRY-US, V53, P1908, DOI 10.1021/bi500157z; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; CHOI NH, 1989, MOL IMMUNOL, V26, P835; ENGELS W, 1985, J IMMUNOL METHODS, V81, P43, DOI 10.1016/0022-1759(85)90120-6; Fujitani S, 2011, CHEST, V139, P909, DOI 10.1378/chest.10-0166; Griffiths NJ, 2011, MOL MICROBIOL, V82, P1129, DOI 10.1111/j.1365-2958.2011.07876.x; Guo W, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/293637; Hadders MA, 2012, CELL REP, V1, P200, DOI 10.1016/j.celrep.2012.02.003; Hallstrom T, 2012, J IMMUNOL, V189, P4939, DOI 10.4049/jimmunol.1200386; Hallstrom T, 2009, J IMMUNOL, V183, P2593, DOI 10.4049/jimmunol.0803226; Hassett DJ, 2010, EXPERT OPIN THER TAR, V14, P117, DOI 10.1517/14728220903454988; HONG YQ, 1992, CLIN IMMUNOL IMMUNOP, V62, P133, DOI 10.1016/0090-1229(92)90065-V; JENNE DE, 1989, P NATL ACAD SCI USA, V86, P7123, DOI 10.1073/pnas.86.18.7123; KOSTRZYNSKA M, 1992, MICROBIOS, V71, P179; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Kurosu T, 2007, BIOCHEM BIOPH RES CO, V362, P1051, DOI 10.1016/j.bbrc.2007.08.137; Laarman AJ, 2012, J IMMUNOL, V188, P386, DOI 10.4049/jimmunol.1102162; Leroy-Dudal J, 2004, MICROBES INFECT, V6, P875, DOI 10.1016/j.micinf.2004.05.004; Li DQ, 2001, CURR MICROBIOL, V42, P361, DOI 10.1007/s002840010230; Li DQ, 2001, FEMS IMMUNOL MED MIC, V31, P197; LIANG OD, 1995, BBA-PROTEIN STRUCT M, V1250, P110, DOI 10.1016/0167-4838(95)00076-7; Liang OD, 1997, FEBS LETT, V407, P169, DOI 10.1016/S0014-5793(97)00330-X; Liszewski MK, 2015, J INTERN MED, V277, P294, DOI 10.1111/joim.12338; Lopez CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090796; MCCULLY V, 1986, BIOCHEM J, V233, P737, DOI 10.1042/bj2330737; Millis AJT, 2001, J CELL PHYSIOL, V186, P210, DOI 10.1002/1097-4652(200102)186:2<210::AID-JCP1019>3.0.CO;2-N; Nishida N, 2006, P NATL ACAD SCI USA, V103, P19737, DOI 10.1073/pnas.0609791104; Partridge SR, 1996, INFECT IMMUN, V64, P4324, DOI 10.1128/IAI.64.10.4324-4329.1996; Pier GB, 2005, PSEUDOMONAS AERUGINO; PODACK ER, 1984, ACTA PATH MICRO IM C, V92, P89; PREISSNER KT, 1991, THROMB HAEMOSTASIS, V66, P123; PREISSNER KT, 1985, J IMMUNOL, V135, P445; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; SCHILLER NL, 1986, INFECT IMMUN, V54, P689, DOI 10.1128/IAI.54.3.689-694.1986; Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9; SHEEHAN M, 1995, CLIN EXP IMMUNOL, V101, P136; Silkensen JR, 1995, J CLIN INVEST, V96, P2646, DOI 10.1172/JCI118330; Singh B, 2011, MOL MICROBIOL, V81, P80, DOI 10.1111/j.1365-2958.2011.07678.x; Singh B, 2010, MOL MICROBIOL, V78, P545, DOI 10.1111/j.1365-2958.2010.07373.x; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Styriak I, 2003, CURR MICROBIOL, V46, P435, DOI 10.1007/s00284-002-3879-2; Voss S, 2013, J BIOL CHEM, V288, P15614, DOI 10.1074/jbc.M112.443507; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Zipfel PF, 2014, INT J MED MICROBIOL, V304, P188, DOI 10.1016/j.ijmm.2013.11.004; Zipfel PF, 2013, MOL IMMUNOL, V56, P152, DOI 10.1016/j.molimm.2013.05.222; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	51	18	19	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137630	10.1371/journal.pone.0137630	http://dx.doi.org/10.1371/journal.pone.0137630			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368530	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100100
J	Bader, AM; Klose, K; Bieback, K; Korinth, D; Schneider, M; Seifert, M; Choi, YH; Kurtz, A; Falk, V; Stamm, C				Bader, Andreas Matthaeus; Klose, Kristin; Bieback, Karen; Korinth, Dirk; Schneider, Maria; Seifert, Martina; Choi, Yeong-Hoon; Kurtz, Andreas; Falk, Volkmar; Stamm, Christof			Hypoxic Preconditioning Increases Survival and Pro-Angiogenic Capacity of Human Cord Blood Mesenchymal Stromal Cells In Vitro	PLOS ONE			English	Article							PROTECTS ENDOTHELIAL-CELLS; INFARCTED HEART FUNCTION; STEM-CELLS; BONE-MARROW; ISCHEMIC CARDIOMYOPATHY; RANDOMIZED-TRIAL; LIMB ISCHEMIA; APOPTOSIS; TRANSPLANTATION; EXPRESSION	Hypoxic preconditioning was shown to improve the therapeutic efficacy of bone marrow-derived multipotent mesenchymal stromal cells (MSCs) upon transplantation in ischemic tissue. Given the interest in clinical applications of umbilical cord blood-derived MSCs, we developed a specific hypoxic preconditioning protocol and investigated its anti-apoptotic and pro-angiogenic effects on cord blood MSCs undergoing simulated ischemia in vitro by subjecting them to hypoxia and nutrient deprivation with or without preceding hypoxic preconditioning. Cell number, metabolic activity, surface marker expression, chromosomal stability, apoptosis (caspases-3/7 activity) and necrosis were determined, and phosphorylation, mRNA expression and protein secretion of selected apoptosis and angiogenesis-regulating factors were quantified. Then, human umbilical vein endothelial cells (HUVEC) were subjected to simulated ischemia in co-culture with hypoxically preconditioned or naive cord blood MSCs, and HUVEC proliferation was measured. Migration, proliferation and nitric oxide production of HUVECs were determined in presence of cord blood MSC-conditioned medium. Cord blood MSCs proved least sensitive to simulated ischemia when they were preconditioned for 24 h, while their basic behavior, immunophenotype and karyotype in culture remained unchanged. Here, "post-ischemic" cell number and metabolic activity were enhanced and caspase-3/7 activity and lactate dehydrogenase release were reduced as compared to non-preconditioned cells. Phosphorylation of AKT and BAD, mRNA expression of BCL-XL, BAG1 and VEGF, and VEGF protein secretion were higher in preconditioned cells. Hypoxically preconditioned cord blood MSCs enhanced HUVEC proliferation and migration, while nitric oxide production remained unchanged. We conclude that hypoxic preconditioning protects cord blood MSCs by activation of anti-apoptotic signaling mechanisms and enhances their angiogenic potential. Hence, hypoxic preconditioning might be a translationally relevant strategy to increase the tolerance of cord blood MSCs to ischemia and improve their therapeutic efficacy in clinical applications.	[Bader, Andreas Matthaeus; Klose, Kristin; Schneider, Maria; Seifert, Martina; Kurtz, Andreas; Stamm, Christof] Charite, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany; [Bieback, Karen] Heidelberg Univ, Inst Transfus Med & Immunol, Mannheim, Germany; [Korinth, Dirk] Labor Berlin GmbH, Berlin, Germany; [Choi, Yeong-Hoon] Univ Cologne, Ctr Heart, D-50931 Cologne, Germany; [Bader, Andreas Matthaeus; Falk, Volkmar; Stamm, Christof] Deutsch Herzzentrum Berlin, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruprecht Karls University Heidelberg; University of Cologne; University of Hamburg; University Medical Center Hamburg-Eppendorf; German Heart Center Berlin	Stamm, C (corresponding author), Charite, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany.	stamm@dhzb.de		Kurtz, Andreas/0000-0003-3301-6546; , Martina/0000-0002-6372-9769; Falk, Volkmar/0000-0002-7911-8620	Federal Ministry of Education and Research; federal state of Berlin [FKZ 0315848A, FKZ 1315848A, FKZ 1315848B]; federal state of Brandenburg [FKZ 0315848A, FKZ 1315848A, FKZ 1315848B]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); federal state of Berlin; federal state of Brandenburg	This study was jointly funded by the Federal Ministry of Education and Research and the federal states of Berlin and Brandenburg [FKZ 0315848A, FKZ 1315848A, FKZ 1315848B] (http://www.bmbf.de/en/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader AM, 2014, CELL PHYSIOL BIOCHEM, V34, P646, DOI 10.1159/000363030; Bader AM, 2014, EUR J CARDIO-THORAC, V45, P983, DOI 10.1093/ejcts/ezt576; Beegle J, 2015, STEM CELLS, V33, P1818, DOI 10.1002/stem.1976; Bellis A, 2009, ARTERIOSCL THROM VAS, V29, P1207, DOI 10.1161/ATVBAHA.109.184135; Burlacu A, 2013, STEM CELLS DEV, V22, P643, DOI 10.1089/scd.2012.0273; Chacko SM, 2010, AM J PHYSIOL-CELL PH, V299, pC1562, DOI 10.1152/ajpcell.00221.2010; Chen PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103587; De Barros S, 2013, MOL THER, V21, P399, DOI 10.1038/mt.2012.213; Gaebel R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015652; Gupta PK, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-143; Haque N, 2013, SCI WORLD J, DOI 10.1155/2013/632972; Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321; He AN, 2009, CAN J CARDIOL, V25, P353, DOI 10.1016/S0828-282X(09)70094-7; Heldman AW, 2014, JAMA-J AM MED ASSOC, V311, P62, DOI 10.1001/jama.2013.282909; Heldring N, 2015, HUM GENE THER, V26, P506, DOI 10.1089/hum.2015.072; Hu XY, 2008, J THORAC CARDIOV SUR, V135, P799, DOI 10.1016/j.jtcvs.2007.07.071; Hu XY, 2014, STEM CELLS, V32, P2702, DOI 10.1002/stem.1784; Hu XY, 2011, AM J PHYSIOL-CELL PH, V301, pC362, DOI 10.1152/ajpcell.00013.2010; Huang WH, 2014, CARDIOVASC RES, V101, P266, DOI 10.1093/cvr/cvt250; Jaussaud J, 2013, EUR J CARDIO-THORAC, V43, P1050, DOI 10.1093/ejcts/ezs549; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kim HW, 2012, ANTIOXID REDOX SIGN, V17, P1053, DOI 10.1089/ars.2012.4518; Kim HW, 2012, J MOL MED, V90, P997, DOI 10.1007/s00109-012-0920-1; Kim HW, 2009, J BIOL CHEM, V284, P33161, DOI 10.1074/jbc.M109.020925; Kim SW, 2006, STEM CELLS, V24, P1620, DOI 10.1634/stemcells.2005-0365; Kim YS, 2015, MOL NEUROBIOL, V52, P792, DOI 10.1007/s12035-014-8912-5; Klose K, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-236; Lee MW, 2005, INT J HEMATOL, V81, P126, DOI 10.1532/IJH97.A10404; Lee MW, 2004, BIOCHEM BIOPH RES CO, V320, P273, DOI 10.1016/j.bbrc.2004.04.206; Leroux L, 2010, MOL THER, V18, P1545, DOI 10.1038/mt.2010.108; Li WZ, 2007, STEM CELLS, V25, P2118, DOI 10.1634/stemcells.2006-0771; Liu HB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034608, 10.1371/journal.pone.0050785]; Liu HB, 2010, BIOCHEM BIOPH RES CO, V401, P509, DOI 10.1016/j.bbrc.2010.09.076; Luetzkendorf J, 2015, CYTOTHERAPY, V17, P186, DOI 10.1016/j.jcyt.2014.10.018; Pan YX, 2007, LIFE SCI, V81, P1042, DOI 10.1016/j.lfs.2007.08.015; Peterson KM, 2011, LIFE SCI, V88, P65, DOI 10.1016/j.lfs.2010.10.023; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Sart S, 2014, BIORESEARCH OPEN ACC, V3, P137, DOI 10.1089/biores.2014.0012; Silva MT, 2010, FEBS LETT, V584, P4491, DOI 10.1016/j.febslet.2010.10.046; Uchiyama T, 2004, CIRCULATION, V109, P3042, DOI 10.1161/01.CIR.0000130647.29030.90; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; Wang JA, 2008, ACTA PHARMACOL SIN, V29, P74, DOI 10.1111/j.1745-7254.2008.00716.x; Wang JA, 2009, INT J CARDIOL, V133, P410, DOI 10.1016/j.ijcard.2007.11.096; Wang LH, 2014, SCI CHINA LIFE SCI, V57, P171, DOI 10.1007/s11427-014-4607-4; Wei L, 2012, NEUROBIOL DIS, V46, P635, DOI 10.1016/j.nbd.2012.03.002; Yang Shin-Seok, 2013, International Journal of Stem Cells, V6, P37; Zhang WB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/462472; Zhu HM, 2014, ARTERIOSCL THROM VAS, V34, P870, DOI 10.1161/ATVBAHA.114.303194	48	71	80	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138477	10.1371/journal.pone.0138477	http://dx.doi.org/10.1371/journal.pone.0138477			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26380983	Green Submitted, Green Published, gold			2022-12-27	WOS:000361790200110
J	Robertson, E; Morgan, L; New, S; Pickering, S; Hadi, M; Collins, G; Arias, OR; Griffin, D; McCulloch, P				Robertson, Eleanor; Morgan, Lauren; New, Steve; Pickering, Sharon; Hadi, Mohammed; Collins, Gary; Rivero Arias, Oliver; Griffin, Damian; McCulloch, Peter			Quality Improvement in Surgery Combining Lean Improvement Methods with Teamwork Training: A Controlled Before-After Study	PLOS ONE			English	Article							ADVERSE EVENTS; SYSTEM; CARE; CHECKLIST; SAFETY; TIME	Background To investigate the effectiveness of combining teamwork training and lean process improvement, two distinct approaches to improving surgical safety. We conducted a controlled interrupted time series study in a specialist UK Orthopaedic hospital incorporating a plastic surgery team (which received the intervention) and an Orthopaedic theatre team acting as a control. Study Design We used a 3 month intervention with 3 months data collection period before and after it. A combined teamwork training and lean process improvement intervention was delivered by an experienced specialist team. Before and after the intervention we evaluated team nontechnical skills using NOTECHS II, technical performance using the glitch rate and WHO checklist compliance using a simple 3 point scale. We recorded complication rate, readmission rate and length of hospital stay data for 6 months before and after the intervention. Results In the active group, but not the control group, full compliance with WHO Time Out (T/O) increased from 14 to 71% (p = 0.032), Sign Out attempt rate (S/O) increased from 0% to 50% (p<0.001) and Oxford NOTECHS II scores increased after the intervention (P = 0.058). Glitch rate decreased in the active group and increased in the control group (p = 0.001). Complications and length of stay appeared to rise in the control group and fall in the active group. Conclusions Combining teamwork training and systems improvement enhanced both technical and nontechnical operating team process measures, and were associated with a trend to better safety outcome measures in a controlled study comparison. We suggest that approaches which address both system and culture dimensions of safety may prove valuable in reducing risks to patients.	[Robertson, Eleanor; Morgan, Lauren; McCulloch, Peter] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [New, Steve] Univ Oxford, Said Business Sch, Oxford, England; [Pickering, Sharon; Hadi, Mohammed; Griffin, Damian] Univ Coventry & Warwick, Warwick Med Sch, Warwick, England; [Collins, Gary] Univ Oxford, Ctr Stat Med, Oxford, England; [Rivero Arias, Oliver] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Rivero Arias, Oliver] Red Invest Serv Sanitarios Cronicidad REDISSEC, Madrid, Spain	University of Oxford; University of Oxford; University of Warwick; University of Oxford; University of Oxford	McCulloch, P (corresponding author), Univ Oxford, Nuffield Dept Surg Sci, Oxford, England.	peter.mcculloch@nds.ox.ac.uk	Collins, Gary Stephen/A-2258-2014	Collins, Gary Stephen/0000-0002-2772-2316; McCulloch, Peter/0000-0002-3210-8273; Morgan, Lauren/0000-0001-8395-9492	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research programme [RP-PG-0108-10020]	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research programme(National Institute for Health Research (NIHR))	This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research programme (Reference Number RP-PG-0108-10020). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Amalberti R, 2005, ANN INTERN MED, V142, P756, DOI 10.7326/0003-4819-142-9-200505030-00012; Benning A., 2011, BMJ-BRIT MED J, P342; Bion J, 2012, BMJ QUALITY SAFETY; Bloodworth Kerry, 2011, J Perioper Pract, V21, P97; de Vries EN, 2008, QUAL SAF HEALTH CARE, V17, P216, DOI 10.1136/qshc.2007.023622; Department of Health Expert Group, 2000, ORG MEM REP EXP GROU; Gawande AA, 1999, SURGERY, V126, P66, DOI 10.1067/msy.1999.98664; Gowen CR, 2006, J OPER MANAG, V24, P765, DOI 10.1016/j.jom.2005.09.005; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Hollnagel E, 2007, RESILIENCE ENGINEERI; Hollnagel E, 2010, RESILIENCE ENGINEERI, pxxix; Kohn LT, 2000, ERR IS HUMAN BUILDIN, Vxxi; Kreckler S, 2013, BMJ QUALITY SAFETY; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; McCulloch P, 2011, BRIT J SURG, V98, P469, DOI 10.1002/bjs.7434; McCulloch P, 2011, BMC SURG, V11, DOI 10.1186/1471-2482-11-23; Mishra A, 2009, QUAL SAF HEALTH CARE, V18, P104, DOI 10.1136/qshc.2007.024760; Morgan L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003519; New SJ, 2007, INT J PROD RES, V45, P3545, DOI 10.1080/00207540701223386; Pickering SP, 2013, BRIT J SURG, V100, P1664, DOI 10.1002/bjs.9305; Robertson E, 2011, INT J SURG, V9, P549; Robertson ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090320; SUGIMORI Y, 1977, INT J PROD RES, V15, P553, DOI 10.1080/00207547708943149; Vincent C, 2001, BRIT MED J, V322, P517, DOI 10.1136/bmj.322.7285.517; Wilson G, 2009, J NURS MANAGE, V17, P647, DOI 10.1111/j.1365-2834.2009.01026.x; Womack JP, 1990, MACH CHANGED WORLD B	26	19	19	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138490	10.1371/journal.pone.0138490	http://dx.doi.org/10.1371/journal.pone.0138490			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381643	Green Published, gold, Green Submitted			2022-12-27	WOS:000361790200115
J	Chang, CW; Tran, ENH; Ericsson, DJ; Casey, LW; Lonhienne, T; Benning, F; Morona, R; Kobe, B				Chang, Chiung-Wen; Tran, Elizabeth N. H.; Ericsson, Daniel J.; Casey, Lachlan W.; Lonhienne, Thierry; Benning, Friederike; Morona, Renato; Kobe, Bostjan			Structural and Biochemical Analysis of a Single Amino-Acid Mutant of WzzB(SF) That Alters Lipopolysaccharide O-Antigen Chain Length in Shigella flexneri	PLOS ONE			English	Article							POLYSACCHARIDE CO-POLYMERASES; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; CROSS-LINKING; WZZ; PROTEIN; BIOSYNTHESIS; MUTAGENESIS; DETERMINANT; VIRULENCE	Lipopolysaccharide (LPS), a surface polymer of Gram-negative bacteria, helps bacteria survive in different environments and acts as a virulence determinant of host infection. The O-antigen (Oag) component of LPS exhibits a modal chain-length distribution that is controlled by polysaccharide co-polymerases (PCPs). The molecular basis of the regulation of Oag chain-lengths remains unclear, despite extensive mutagenesis and structural studies of PCPs from Escherichia coli and Shigella. Here, we identified a single mutation (A107P) of the Shigella flexneri WzzB(SF), by a random mutagenesis approach, that causes a shortened Oag chain-length distribution in bacteria. We determined the crystal structures of the penplasmic domains domains of wild-type WzzBsF and the A107P mutant. Both structures form a highly similar open trimeric assembly in the crystals, and show a similar tendency to self-associate in solution. Binding studies by bio-layer interferometry reveal cooperative binding of very short (VS)-core-plus-O-antigen polysaccharide (COPS) to the periplasmic domains of both proteins, but with decreased affinity for the A107P mutant. Our studies reveal that subtle and localized structural differences in PCPs can have dramatic effects on LPS chain-length distribution in bacteria, for example by altering the affinity for the substrate, which supports the role of the structure of the growing Oag polymer in this process.	[Chang, Chiung-Wen; Ericsson, Daniel J.; Casey, Lachlan W.; Lonhienne, Thierry; Benning, Friederike; Kobe, Bostjan] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Chang, Chiung-Wen; Ericsson, Daniel J.; Casey, Lachlan W.; Benning, Friederike; Kobe, Bostjan] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Chang, Chiung-Wen; Ericsson, Daniel J.; Casey, Lachlan W.; Benning, Friederike; Kobe, Bostjan] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia; [Tran, Elizabeth N. H.; Morona, Renato] Univ Adelaide, Sch Biol Sci, Dept Mol & Cellular Biol, Adelaide, SA 5005, Australia	University of Queensland; University of Queensland; University of Queensland; University of Adelaide	Morona, R (corresponding author), Univ Adelaide, Sch Biol Sci, Dept Mol & Cellular Biol, Adelaide, SA 5005, Australia.	renato.morona@adelaide.edu.au; b.kobe@uq.edu.au	Morona, Renato/B-7746-2013; Casey, Lachlan/N-3396-2015; Kobe, Bostjan/D-1292-2009; Ericsson, Daniel/F-7458-2011	Morona, Renato/0000-0001-7009-7440; Casey, Lachlan/0000-0002-4458-0137; Kobe, Bostjan/0000-0001-9413-9166; Ericsson, Daniel/0000-0001-5101-9244; Benning, Friederike/0000-0002-1002-4204; Tran, Elizabeth Ngoc Hoa/0000-0003-1644-2287	National Health and Medical Research Council (NHMRC) [565526, 1071659]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	As listed in the "Funding information" section online, this work was supported by the National Health and Medical Research Council (NHMRC) Program grants 565526 to R.M. and B.K. and 1071659 to B.K. B.K. is a NHMRC Senior Research Fellow (1003326). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASTIN DA, 1993, MOL MICROBIOL, V7, P725, DOI 10.1111/j.1365-2958.1993.tb01163.x; Bengoechea JA, 2002, J BACTERIOL, V184, P4277, DOI 10.1128/JB.184.15.4277-4287.2002; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Daniels C, 2002, ENVIRON MICROBIOL, V4, P883, DOI 10.1046/j.1462-2920.2002.00288.x; Daniels C, 1999, MOL MICROBIOL, V34, P181, DOI 10.1046/j.1365-2958.1999.01591.x; DARVEAU RP, 1983, J BACTERIOL, V155, P831, DOI 10.1128/JB.155.2.831-838.1983; Diederichs K, 2003, ACTA CRYSTALLOGR D, V59, P903, DOI 10.1107/S0907444903006516; DONER LW, 1992, ANAL BIOCHEM, V202, P50, DOI 10.1016/0003-2697(92)90204-K; Edelstein SJ, 2013, J MOL BIOL, V425, P1424, DOI 10.1016/j.jmb.2013.03.011; Tran ENH, 2014, MICROBIOL-SGM, V160, P589, DOI 10.1099/mic.0.074955-0; Tran ENH, 2013, MICROBIOL-SGM, V159, P701, DOI 10.1099/mic.0.065631-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson DJ, 2012, CURR DRUG TARGETS, V13, P1421; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Franco AV, 1998, J BACTERIOL, V180, P2670, DOI 10.1128/JB.180.10.2670-2675.1998; Guo H, 2008, CURR TOP MED CHEM, V8, P141; Guo H, 2006, PROTEIN EXPRES PURIF, V48, P49, DOI 10.1016/j.pep.2006.01.015; Hagelueken G, 2015, NAT STRUCT MOL BIOL, V22, P50, DOI 10.1038/nsmb.2935; Hong M, 1997, MOL MICROBIOL, V24, P779, DOI 10.1046/j.1365-2958.1997.3731744.x; Islam ST, 2014, CAN J MICROBIOL, V60, P697, DOI 10.1139/cjm-2014-0595; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalynych S, 2015, PROTEIN SCI, V24, P58, DOI 10.1002/pro.2586; Kalynych S, 2014, FEMS MICROBIOL REV, V38, P1048, DOI 10.1111/1574-6976.12070; Kalynych S, 2012, PROTEIN ENG DES SEL, V25, P797, DOI 10.1093/protein/gzs075; Kalynych S, 2012, J BIOL CHEM, V287, P15696, DOI 10.1074/jbc.M112.354837; Kalynych S, 2011, J BACTERIOL, V193, P3710, DOI 10.1128/JB.00059-11; Kintz EN, 2011, J BIOL CHEM, V286, P44277, DOI 10.1074/jbc.M111.273979; Larue K, 2009, J BIOL CHEM, V284, P7395, DOI 10.1074/jbc.M809068200; LUGTENBERG B, 1975, FEBS LETT, V58, P254, DOI 10.1016/0014-5793(75)80272-9; Marolda CL, 2008, J BACTERIOL, V190, P2128, DOI 10.1128/JB.01746-07; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOORE RA, 1986, ANTIMICROB AGENTS CH, V29, P496, DOI 10.1128/AAC.29.3.496; MORONA R, 1995, MOL MICROBIOL, V18, P209, DOI 10.1111/j.1365-2958.1995.mmi_18020209.x; Morona R, 2003, MICROBIOL-SGM, V149, P925, DOI 10.1099/mic.0.26141-0; MORONA R, 1995, J BACTERIOL, V177, P1059, DOI 10.1128/jb.177.4.1059-1068.1995; Murray GL, 2003, MOL MICROBIOL, V47, P1395, DOI 10.1046/j.1365-2958.2003.03383.x; Newman J, 2004, ACTA CRYSTALLOGR D, V60, P610, DOI 10.1107/S0907444903029640; Papadopoulos M, 2010, J BACTERIOL, V192, P3385, DOI 10.1128/JB.01134-09; Purins L, 2008, MICROBIOL-SGM, V154, P1104, DOI 10.1099/mic.0.2007/014225-0; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Smajs D, 1997, J BACTERIOL, V179, P4919, DOI 10.1128/jb.179.15.4919-4928.1997; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Sperandeo P, 2009, BBA-MOL CELL BIOL L, V1791, P594, DOI 10.1016/j.bbalip.2009.01.011; STEVENSON G, 1995, FEMS MICROBIOL LETT, V125, P23, DOI 10.1016/0378-1097(94)00485-A; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tang KH, 2007, BIOCHEMISTRY-US, V46, P11744, DOI 10.1021/bi701181r; Tocilj A, 2008, NAT STRUCT MOL BIOL, V15, P130, DOI 10.1038/nsmb.1374; Van Den Bosch L, 2003, MICROB PATHOGENESIS, V35, P11, DOI 10.1016/S0882-4010(03)00064-0; VanDenBosch L, 1997, MOL MICROBIOL, V23, P765, DOI 10.1046/j.1365-2958.1997.2541625.x; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Woodward R, 2010, NAT CHEM BIOL, V6, P418, DOI 10.1038/nchembio.351	51	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138266	10.1371/journal.pone.0138266	http://dx.doi.org/10.1371/journal.pone.0138266			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378781	gold, Green Submitted, Green Published			2022-12-27	WOS:000361769400077
J	Kellett-Clarke, H; Stegmann, M; Barclay, AN; Metcalfe, C				Kellett-Clarke, Helena; Stegmann, Monika; Barclay, A. Neil; Metcalfe, Clive			CD44 Binding to Hyaluronic Acid Is Redox Regulated by a Labile Disulfide Bond in the Hyaluronic Acid Binding Site	PLOS ONE			English	Article							IN-VIVO; RHEUMATOID-ARTHRITIS; PROTEIN FUNCTION; DISEASE-ACTIVITY; T-CELLS; RECEPTOR; ACTIVATION; MODULATION; ADHESION; ANTIBODY	CD44 is the primary leukocyte cell surface receptor for hyaluronic acid (HA), a component of the extracellular matrix. Enzymatic post translational cleavage of labile disulfide bonds is a mechanism by which proteins are structurally regulated by imparting an allosteric change and altering activity. We have identified one such disulfide bond in CD44 formed by Cys77 and Cys97 that stabilises the HA binding groove. This bond is labile on the surface of leukocytes treated with chemical and enzymatic reducing agents. Analysis of CD44 crystal structures reveal the disulfide bond to be solvent accessible and in the-LH hook configuration characteristic of labile disulfide bonds. Kinetic trapping and binding experiments on CD44-Fc chimeric proteins show the bond is preferentially reduced over the other disulfide bonds in CD44 and reduction inhibits the CD44-HA interaction. Furthermore cells transfected with CD44 no longer adhere to HA coated surfaces after pre-treatment with reducing agents. The implications of CD44 redox regulation are discussed in the context of immune function, disease and therapeutic strategies.	[Kellett-Clarke, Helena; Stegmann, Monika; Barclay, A. Neil; Metcalfe, Clive] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Metcalfe, C (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	clive.metcalfe@path.ox.ac.uk		Metcalfe, Clive/0000-0002-7856-8574	Medical Research Council [G9826026]; MRC [G9826026] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant No. G9826026. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini G, 2002, P NATL ACAD SCI USA, V99, P1491, DOI 10.1073/pnas.022630299; Baaten BJG, 2010, IMMUNITY, V32, P104, DOI 10.1016/j.immuni.2009.10.011; Banerji S, 2007, NAT STRUCT MOL BIOL, V14, P234, DOI 10.1038/nsmb1201; Butera D, 2014, BLOOD, V123, P2000, DOI 10.1182/blood-2014-01-549816; Castellani P, 2008, EUR J IMMUNOL, V38, P2419, DOI 10.1002/eji.200838439; Consortium U., 2014, NUCL ACIDS RES; Cook KM, 2013, ANTIOXID REDOX SIGN, V18, P1987, DOI 10.1089/ars.2012.4807; DeGrendele HC, 1997, J IMMUNOL, V159, P2549; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; English NM, 1998, CANCER RES, V58, P3736; Essex DW, 2009, ANTIOXID REDOX SIGN, V11, P1191, DOI [10.1089/ars.2008.2322, 10.1089/ARS.2008.2322]; Essex DW, 2003, BIOCHEMISTRY-US, V42, P129, DOI 10.1021/bi0205045; Estess P, 1998, J CLIN INVEST, V102, P1173, DOI 10.1172/JCI4235; Faller CE, 2014, PROTEINS, V82, P3079, DOI 10.1002/prot.24668; HAYNES BF, 1991, ARTHRITIS RHEUM, V34, P1434; Hogg PJ, 2013, NAT REV CANCER, V13, P425, DOI 10.1038/nrc3519; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; Isacke CM, 2002, INT J BIOCHEM CELL B, V34, P718, DOI 10.1016/S1357-2725(01)00166-2; Jothy S, 2003, CLIN EXP METASTAS, V20, P195, DOI 10.1023/A:1022931016285; Lawrence DA, 1996, J LEUKOCYTE BIOL, V60, P611, DOI 10.1002/jlb.60.5.611; LESLEY J, 1993, EUR J IMMUNOL, V23, P1902, DOI 10.1002/eji.1830230826; LESLEY J, 1994, J EXP MED, V180, P383, DOI 10.1084/jem.180.1.383; Maekawa A, 2006, J IMMUNOL, V176, P6873, DOI 10.4049/jimmunol.176.11.6873; Matthias LJ, 2010, J BIOL CHEM, V285, P40793, DOI 10.1074/jbc.M110.190579; Metcalfe C, 2012, OPEN BIOL, P2, DOI DOI 10.1098/RSOB.110036; Metcalfe C, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110010; MIKECZ K, 1995, NAT MED, V1, P558, DOI 10.1038/nm0695-558; Mikecz K, 1999, ARTHRITIS RHEUM, V42, P659, DOI 10.1002/1529-0131(199904)42:4<659::AID-ANR8>3.0.CO;2-Z; Misra S, 2011, FEBS J, V278, P1429, DOI 10.1111/j.1742-4658.2011.08071.x; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Pellom ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081134; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Wild MK, 1999, J EXP MED, V190, P31, DOI 10.1084/jem.190.1.31; Wong J.W.H., 2010, J THROMB HAEMOSTASIS, V8, P2345, DOI [10.1111/j.1538-7836.2010.03894.x, DOI 10.1111/J.1538-7836.2010.03894.X]; Yan ZH, 2009, NAT CHEM BIOL, V5, P721, DOI 10.1038/nchembio.212; Yung S, 2012, AUTOIMMUNE DIS, V2012; Zhang SP, 2013, P NATL ACAD SCI USA, V110, P6127, DOI 10.1073/pnas.1221841110; Zhou BF, 2014, BIOPHYS J, V107, P672, DOI 10.1016/j.bpj.2014.06.025	38	19	20	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138137	10.1371/journal.pone.0138137	http://dx.doi.org/10.1371/journal.pone.0138137			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379032	Green Submitted, Green Published, gold			2022-12-27	WOS:000361769400058
J	Xu, J; Ding, Y; Malic, V				Xu, Jian; Ding, Ying; Malic, Vincent			Author Credit for Transdisciplinary Collaboration	PLOS ONE			English	Article							H-INDEX; CITATION; SCIENCE; INTERDISCIPLINARITY; PUBLICATION; QUANTIFY	Transdisciplinary collaboration is the key for innovation. An evaluation mechanism is necessary to ensure that academic credit for this costly process can be allocated fairly among coauthors. This paper proposes a set of quantitative measures (e.g., t_credit and t_index) to reflect authors' transdisciplinary contributions to publications. These measures are based on paper-topic probability distributions and author-topic probability distributions. We conduct an empirical analysis of the information retrieval domain which demonstrates that these measures effectively improve the results of harmonic_credit and h_index measures by taking into account the transdisciplinary contributions of authors. The definitions of t_credit and t_index provide a fair and effective way for research organizations to assign credit to authors of transdisciplinary publications.	[Xu, Jian] Sun Yat Sen Univ, Sch Informat Management, Guangzhou 510275, Guangdong, Peoples R China; [Ding, Ying; Malic, Vincent] Indiana Univ, Dept Informat & Lib Sci, Bloomington, IN USA; [Ding, Ying] Tongji Univ, Univ Lib, Shanghai 200092, Peoples R China	Sun Yat Sen University; Indiana University System; Indiana University Bloomington; Tongji University	Xu, J (corresponding author), Sun Yat Sen Univ, Sch Informat Management, Guangzhou 510275, Guangdong, Peoples R China.	issxj@mail.sysu.edu.cn			National Natural Science Foundation of China [71173249]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is sponsored by the project titled Research on Knowledge Organization and Service Innovation in the Big Data Environments funded by the National Natural Science Foundation of China (No. 71173249). YD received the funding. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AM, 2011, ARXIV11032848; Ali OA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000359; Barry A, 2008, ECON SOC, V37, P20, DOI 10.1080/03085140701760841; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Bornmann L, 2014, J INFORMETR, V8, P749, DOI 10.1016/j.joi.2014.07.004; Bredereck R, 2014, TSINGHUA SCI TECHNOL, V19, P358, DOI 10.1109/TST.2014.6867518; Bridle H, 2013, FUTURES, V53, P22, DOI 10.1016/j.futures.2013.09.003; Chang YW, 2012, J AM SOC INF SCI TEC, V63, P22, DOI 10.1002/asi.21649; Chua AYK, 2008, J AM SOC INF SCI TEC, V59, P2156, DOI 10.1002/asi.20929; Derry S. J., 2014, INTERDISCIPLINARY CO; Ding Y., 2014, SPSS 211 UYGULAMALI; Ding Y, 2011, J INFORMETR, V5, P498, DOI 10.1016/j.joi.2011.02.006; Ding Y, 2011, J AM SOC INF SCI TEC, V62, P449, DOI 10.1002/asi.21467; Egghe L, 2000, J AM SOC INFORM SCI, V51, P145, DOI 10.1002/(SICI)1097-4571(2000)51:2<145::AID-ASI6>3.0.CO;2-9; Gauffriau M, 2005, SCIENTOMETRICS, V64, P85, DOI 10.1007/s11192-005-0239-6; Bote VPG, 2013, J AM SOC INF SCI TEC, V64, P392, DOI 10.1002/asi.22754; Hagen NT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004021; Harris F, 2013, ENVIRON SCI POLICY, V31, P109, DOI 10.1016/j.envsci.2013.02.006; He B, 2013, J INFORMETR, V7, P117, DOI 10.1016/j.joi.2012.09.005; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Huang MH, 2011, J INF SCI, V37, P369, DOI 10.1177/0165551511407141; Kessel F, 2008, AM J PREV MED, V35, pS225, DOI 10.1016/j.amepre.2008.05.005; Lee ES, 2009, INT J MED INFORM, V78, P10, DOI 10.1016/j.ijmedinf.2008.06.011; Levitt JM, 2011, J AM SOC INF SCI TEC, V62, P1118, DOI 10.1002/asi.21539; Leydesdorff L, 2011, J AM SOC INF SCI TEC, V62, P1146, DOI 10.1002/asi.21511; Lin T., 2013, QUANTA MAGAZINE; LINDSEY D, 1980, SOC STUD SCI, V10, P145, DOI 10.1177/030631278001000202; Liu XZ, 2012, SCIENTOMETRICS, V91, P37, DOI 10.1007/s11192-011-0571-y; Lyall C, 2012, FUTURES, V44, P608, DOI 10.1016/j.futures.2012.03.011; Nowotny H, 2003, MINERVA, V41, P179, DOI 10.1023/A:1025505528250; Pohl C, 2008, ENVIRON SCI POLICY, V11, P46, DOI 10.1016/j.envsci.2007.06.001; Schaltegger S, 2013, BUS STRATEG ENVIRON, V22, P219, DOI 10.1002/bse.1772; Schubert A, 2015, SCIENTOMETRICS, V102, P1647, DOI 10.1007/s11192-014-1373-9; Stokols D, 2006, AM J COMMUN PSYCHOL, V38, P63, DOI 10.1007/s10464-006-9060-5; Stokols Daniel, 2003, Nicotine Tob Res, V5 Suppl 1, pS21; Tang J, 2008, IEEE DATA MINING, P1055, DOI 10.1109/ICDM.2008.71; Tscharntke T, 2007, PLOS BIOL, V5, P13, DOI 10.1371/journal.pbio.0050018; VanHooydonk G, 1997, J AM SOC INFORM SCI, V48, P944, DOI 10.1002/(SICI)1097-4571(199710)48:10<944::AID-ASI8>3.0.CO;2-1; Wagner CS, 2011, J INFORMETR, V5, P14, DOI 10.1016/j.joi.2010.06.004; Wan XJ, 2014, J ASSOC INF SCI TECH, V65, P2509, DOI 10.1002/asi.23151; Wickson F, 2006, FUTURES, V38, P1046, DOI 10.1016/j.futures.2006.02.011; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099; Xu J, 2015, J ASS INFORM SCI TEC; Yan E, 2012, J INFORMETR, V6, P140, DOI 10.1016/j.joi.2011.10.001; Yu L, 2013, TSINGHUA SCI TECHNOL, V18, P387, DOI 10.1109/TST.2013.6574677; Yu Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101214	47	15	15	6	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137968	10.1371/journal.pone.0137968	http://dx.doi.org/10.1371/journal.pone.0137968			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8NH	26375678	Green Published, gold, Green Submitted			2022-12-27	WOS:000361610200065
J	Crossa, A; Kessler, J; Harris, TG				Crossa, Aldo; Kessler, Jason; Harris, Tiffany G.			Enhanced Tuberculosis Infection Treatment Outcomes after Implementation of QuantiFERON (R)-Gold Testing	PLOS ONE			English	Article							LATENT TUBERCULOSIS; UNITED-STATES; SKIN-TEST; COST-EFFECTIVENESS; HEALTH; GOLD; COMPLETION; ACCEPTANCE; PREDICTORS; ADHERENCE	Background Use of the tuberculin skin test (TST) for diagnosis of latent tuberculosis infection (LTBI) among individuals who received the Bacille Calmette-Guerin (BCG) vaccine is complicated by its potential cross-reaction with TST antigens which may cause false-positive results and lead to patient and physician reluctance to initiate LTBI treatment. QuantiFERON (R)-TB Gold (QFT-G) lacks this cross-reaction. We sought to study the impact of implementing QFT-G testing in 2006 on LTBI treatment initiation and completion at NYC chest clinics. Methods QFT-G results from 10/2006-12/2008 in NYC Department of Health and Mental Hygiene chest clinics were obtained from the electronic medical record system. The proportions of patients who initiated and completed treatment among patients tested with QFT-G were compared to those tested with TST from 10/2004-9/2006. Results Among 36,167 patients tested with QFT-G, 2,300 (6%) tested positive, 33,327 (93%) tested negative, and 540 (1%) had an indeterminate result. Among those who had a positive QFT-G test and deemed eligible, 985 (80%) initiated LTBI treatment and 490 (40%) completed treatment. Historically, among patients tested with TST, 7,073 (19%) tested positive (p<0.0001 compared to QFT-G); 3,182 (79%) of those eligible initiated LTBI treatment and 1,210 (30%) completed treatment (p<0.0001 compared to QFT-G). Conclusions QFT-G implementation increased the proportion of patients completing LTBI treatment. Additional studies are needed in more settings to determine whether using QFT-G leads to a sustained increase in treatment completion.	[Crossa, Aldo; Kessler, Jason; Harris, Tiffany G.] New York City Dept Hlth & Mental Hyg, New York, NY 10013 USA; [Kessler, Jason] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	New York City Department of Health & Mental Hygiene; Columbia University	Crossa, A (corresponding author), New York City Dept Hlth & Mental Hyg, New York, NY 10013 USA.	acrossa@health.nyc.gov		Harris, Tiffany/0000-0003-2212-0874	New York City Department of Health and Mental Hygiene program funds; T32 training grant [5T32AI049821]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI049821] Funding Source: NIH RePORTER	New York City Department of Health and Mental Hygiene program funds; T32 training grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by New York City Department of Health and Mental Hygiene program funds. JK was supported by a T32 training grant (5T32AI049821) during the period of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, GOLD QUANT TB IN TUB; Banach DB, 2011, INT J TUBERC LUNG D, V15, P1623, DOI 10.5588/ijtld.11.0017; Bennett DE, 2008, AM J RESP CRIT CARE, V177, P348, DOI 10.1164/rccm.200701-057OC; Carvalho ACC, 2007, J INFECTION, V55, P164, DOI 10.1016/j.jinf.2007.02.004; Deuffic-Burban S, 2010, INT J TUBERC LUNG D, V14, P471; Dobler CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048900; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Goswami ND, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-468; Grinsdale JA, 2011, INT J TUBERC LUNG D, V15, P1614, DOI 10.5588/ijtld.11.0102; Hardy AB, 2010, THORAX, V65, P178, DOI 10.1136/thx.2009.119677; Hirsch-Moverman Y, 2008, INT J TUBERC LUNG D, V12, P1235; Hirsch-Moverman Y, 2015, INT J TUBERC LUNG D, V19, P31, DOI 10.5588/ijtld.14.0373; Horsburgh CR, 2010, CHEST, V137, P401, DOI 10.1378/chest.09-0394; Jereb J, 2003, INT J TUBERC LUNG D, V7, pS384; Jereb John A., 2011, Morbidity and Mortality Weekly Report, V60, P1650; Katapodi MC, 2004, PREV MED, V38, P388, DOI 10.1016/j.ypmed.2003.11.012; Landry J, 2008, INT J TUBERC LUNG D, V12, P1352; Lardizabal A, 2006, CHEST, V130, P1712, DOI 10.1378/chest.130.6.1712; Li JH, 2010, INT J INFECT DIS, V14, pE292, DOI 10.1016/j.ijid.2009.05.007; Lonnroth K, 2015, EUR RESPIR J, V45, P928, DOI 10.1183/09031936.00214014; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Martinson NA, 2011, NEW ENGL J MED, V365, P11, DOI 10.1056/NEJMoa1005136; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; McGinnis B, 2007, ANN PHARMACOTHER, V41, P1805, DOI 10.1345/aph.1K209; NYC Bureau of Tuberculosis Control, 1999, CLIN POL PROT; NYC Bureau of Tuberculosis Control, 2006, TEST TREATM LAT TUB; NYC Bureau of Tuberculosis Control, 2008, CLIN POL PROT; NYC Bureau of Tuberculosis Control, 2000, TEST TREATM LAT TUB; Pooran A, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-7; Sahni R, 2009, INFECT CONT HOSP EP, V30, P197, DOI 10.1086/593965; Salazar-Schicchi J, 2004, INT J TUBERC LUNG D, V8, P1443; Schousboe JT, 2010, OSTEOPOROSIS INT, V21, P1899, DOI 10.1007/s00198-009-1141-5; Seyhan EC, 2010, TRANSPL INFECT DIS, V12, P98, DOI 10.1111/j.1399-3062.2009.00469.x; Shabaro J, 2006, HIST TB CONTROL TUBE; Shah M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036551; Sharma Surendra K, 2014, Evid Based Child Health, V9, P169, DOI 10.1002/ebch.1962; Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Vinton P, 2009, INFECT CONT HOSP EP, V30, P215, DOI 10.1086/595695	39	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138349	10.1371/journal.pone.0138349	http://dx.doi.org/10.1371/journal.pone.0138349			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371760	Green Published, Green Submitted, gold			2022-12-27	WOS:000361604400066
J	Deng, PC; Wang, L; Cui, LC; Feng, KW; Liu, FY; Du, XH; Tong, W; Nie, XJ; Ji, WQ; Weining, S				Deng, Pingchuan; Wang, Le; Cui, Licao; Feng, Kewei; Liu, Fuyan; Du, Xianghong; Tong, Wei; Nie, Xiaojun; Ji, Wanquan; Weining, Song			Global Identification of MicroRNAs and Their Targets in Barley under Salinity Stress	PLOS ONE			English	Article							HORDEUM-VULGARE L.; SMALL RNA; PLANT-RESPONSES; SALT STRESS; MIRNAS; EXPRESSION; DROUGHT; WHEAT; ADAPTATION; GENES	Salinity is a major limiting factor for agricultural production worldwide. A better understanding of the mechanisms of salinity stress response will aid efforts to improve plant salt tolerance. In this study, a combination of small RNA and mRNA degradome sequencing was used to identify salinity responsive-miRNAs and their targets in barley. A total of 152 miRNAs belonging to 126 families were identified, of which 44 were found to be salinity responsive with 30 up-regulated and 25 down-regulated respectively. The majority of the salinity-responsive miRNAs were up-regulated at the 8h time point, while down-regulated at the 3h and 27h time points. The targets of these miRNAs were further detected by degradome sequencing coupled with bioinformatics prediction. Finally, qRT-PCR was used to validate the identified miRNA and their targets. Our study systematically investigated the expression profile of miRNA and their targets in barley during salinity stress phase, which can contribute to understanding how miRNAs respond to salinity stress in barley and other cereal crops.	[Deng, Pingchuan; Wang, Le; Cui, Licao; Feng, Kewei; Liu, Fuyan; Du, Xianghong; Tong, Wei; Nie, Xiaojun; Ji, Wanquan; Weining, Song] Northwest A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Deng, Pingchuan; Wang, Le; Cui, Licao; Feng, Kewei; Liu, Fuyan; Du, Xianghong; Tong, Wei; Nie, Xiaojun; Ji, Wanquan; Weining, Song] Northwest A&F Univ, China Wheat Improvement Ctr, Yangling Branch, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Du, XH (corresponding author), Northwest A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.; Du, XH (corresponding author), Northwest A&F Univ, China Wheat Improvement Ctr, Yangling Branch, Yangling, Shaanxi, Peoples R China.	xianghongdu@nwsuaf.edu.cn; sweining2002@yahoo.com	Wang, Le/AAX-2622-2020; Nie, Xiaojun/ABE-2666-2021	Nie, Xiaojun/0000-0002-4787-7550	National Natural Science Foundation of China [31571647, 31401373]; 863 program from the Chinese of Ministry of Science Technology [2012AA10A308]; 948 Program from the Chinese Ministry of Agriculture [2010-S1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K24NS064050] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 program from the Chinese of Ministry of Science Technology; 948 Program from the Chinese Ministry of Agriculture; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was mainly funded by the National Natural Science Foundation of China (31571647 and 31401373), and partially supported by the 863 program (2012AA10A308) from the Chinese of Ministry of Science & Technology and the 948 Program (2010-S1) from the Chinese Ministry of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Chen X, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r78; Cui LY, 2006, NUCLEIC ACIDS RES, V34, pD692, DOI 10.1093/nar/gkj055; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Deng PC, 2014, PLANT MOL BIOL REP, V32, P487, DOI 10.1007/s11105-013-0669-x; Ding D, 2009, ANN BOT-LONDON, V103, P29, DOI 10.1093/aob/mcn205; Dryanova A, 2008, GENOME, V51, P433, DOI 10.1139/G08-025; Eren H, 2015, ANN APPL BIOL; Fedoroff Nina V, 2002, Sci STKE, V2002, pre10, DOI 10.1126/stke.2002.140.re10; Frazier TP, 2011, MOL BIOTECHNOL, V49, P159, DOI 10.1007/s12033-011-9387-5; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; GREENWAY H, 1980, ANNU REV PLANT PHYS, V31, P149, DOI 10.1146/annurev.pp.31.060180.001053; Grondin M, 2015, BIOTECHNOL J, V10, P801, DOI 10.1002/biot.201400562; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Ha S, 2012, TRENDS PLANT SCI, V17, P172, DOI 10.1016/j.tplants.2011.12.005; Hackenberg M, 2015, PLANT BIOTECHNOL J, V13, P2, DOI 10.1111/pbi.12220; Jain R, 2007, BIOCHEM BIOPH RES CO, V359, P486, DOI 10.1016/j.bbrc.2007.05.142; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kantar M, 2010, FUNCT INTEGR GENOMIC, V10, P493, DOI 10.1007/s10142-010-0181-4; KONING AJ, 1992, PLANT PHYSIOL, V100, P801, DOI 10.1104/pp.100.2.801; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Liu HJ, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-433, 10.1186/1471-2164-15-25]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Lv SZ, 2012, INT J MOL SCI, V13, P2973, DOI 10.3390/ijms13032973; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Munns R, 1999, AUST J PLANT PHYSIOL, V26, P459, DOI 10.1071/PP99049; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Ouyang S, 2004, NUCLEIC ACIDS RES, V32, pD360, DOI 10.1093/nar/gkh099; Ozhuner E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059543; Ozturk ZN, 2002, PLANT MOL BIOL, V48, P551, DOI 10.1023/A:1014875215580; Schreiber AW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-129; Shannon MC, 1997, ADV AGRON, V60, P75, DOI 10.1016/S0065-2113(08)60601-X; Si JN, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S1-S6; Ueda A, 2004, J EXP BOT, V55, P2213, DOI 10.1093/jxb/erh242; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; VIERLING E, 1991, ANNU REV PLANT PHYS, V42, P579, DOI 10.1146/annurev.pp.42.060191.003051; Walia Harkamal, 2006, Functional & Integrative Genomics, V6, P143, DOI 10.1007/s10142-005-0013-0; Wang L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-289; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Witzel K, 2009, J EXP BOT, V60, P3545, DOI 10.1093/jxb/erp198; Xie FL, 2015, J EXP BOT, V66, P789, DOI 10.1093/jxb/eru437; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Yin ZJ, 2012, MOL BIOL REP, V39, P4961, DOI 10.1007/s11033-011-1292-2; Zhang BH, 2015, J EXP BOT, V66, P1749, DOI 10.1093/jxb/erv013; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	53	45	48	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137990	10.1371/journal.pone.0137990	http://dx.doi.org/10.1371/journal.pone.0137990			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372557	gold, Green Submitted, Green Published			2022-12-27	WOS:000361604400043
J	Gras, R; Golestani, A; Hendry, AP; Cristescu, ME				Gras, Robin; Golestani, Abbas; Hendry, Andrew P.; Cristescu, Melania E.			Speciation without Pre-Defined Fitness Functions	PLOS ONE			English	Article							SEXUAL SELECTION; MODELS; EVOLUTION; PATTERNS; ORIGIN; SIMULATION	The forces promoting and constraining speciation are often studied in theoretical models because the process is hard to observe, replicate, and manipulate in real organisms. Most models analyzed to date include pre-defined functions influencing fitness, leaving open the question of how speciation might proceed without these built-in determinants. To consider the process of speciation without pre-defined functions, we employ the individual-based ecosystem simulation platform EcoSim. The environment is initially uniform across space, and an evolving behavioural model then determines how prey consume resources and how predators consume prey. Simulations including natural selection (i.e., an evolving behavioural model that influences survival and reproduction) frequently led to strong and distinct phenotypic/genotypic clusters between which hybridization was low. This speciation was the result of divergence between spatially-localized clusters in the behavioural model, an emergent property of evolving ecological interactions. By contrast, simulations without natural selection (i.e., behavioural model turned off) but with spatial isolation (i.e., limited dispersal) produced weaker and overlapping clusters. Simulations without natural selection or spatial isolation (i.e., behaviour model turned off and high dispersal) did not generate clusters. These results confirm the role of natural selection in speciation by showing its importance even in the absence of pre-defined fitness functions.	[Gras, Robin; Golestani, Abbas] Univ Windsor, Sch Comp Sci, Windsor, ON N9B 3P4, Canada; [Gras, Robin] Univ Windsor, Dept Biol, Windsor, ON N9B 3P4, Canada; [Gras, Robin] Great Lakes Inst Environm Res, Windsor, ON, Canada; [Hendry, Andrew P.; Cristescu, Melania E.] McGill Univ, Redpath Museum, Montreal, PQ H3A 2K6, Canada; [Hendry, Andrew P.; Cristescu, Melania E.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	University of Windsor; University of Windsor; McGill University; McGill University	Gras, R (corresponding author), Univ Windsor, Sch Comp Sci, Windsor, ON N9B 3P4, Canada.	rgras@uwindsor.ca		Cristescu, Melania/0000-0002-0854-4040	Natural Sciences and Engineering Research Council of Canada [ORGPIN 341854]; Canada Research Chairs [9502-3617]; Canada Foundation for Innovation grant [203617]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs(Canada Research ChairsCGIAR); Canada Foundation for Innovation grant(Canada Foundation for Innovation)	RG funded by Natural Sciences and Engineering Research Council of Canada grant ORGPIN 341854 (http://www.nserc-crsng.gc.ca/index_eng.asp), Canada Research Chairs grant 9502-3617 (http://www.chairs-chaires.gc.ca/homeaccueil-eng.aspx), and Canada Foundation for Innovation grant 203617 (http://www.innovation.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspinall A, 2010, LECT NOTES COMPUT SC, V6335, P318, DOI 10.1007/978-3-642-15470-6_33; Bascompte J, 1997, J THEOR BIOL, V187, P213, DOI 10.1006/jtbi.1997.0430; Biktashev VN, 2004, CHAOS, V14, P988, DOI 10.1063/1.1793751; Clune J, 2011, P ROY SOC B-BIOL SCI, V278, P666, DOI 10.1098/rspb.2010.1557; Clune J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000187; Coyne J.A., 2004, SPECIATION; de Aguiar MAM, 2009, NATURE, V460, P384, DOI 10.1038/nature08168; Devaurs D, 2010, SIMUL MODEL PRACT TH, V18, P100, DOI 10.1016/j.simpat.2009.09.012; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Dieckmann U., 2004, ADAPTIVE SPECIATION; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; Duckworth RA, 2009, EVOLUTION, V63, P968, DOI 10.1111/j.1558-5646.2009.00625.x; Gavrilets S, 2000, NATURE, V403, P886, DOI 10.1038/35002564; Gavrilets S, 2004, FITNESS LANDSCAPES O; Gavrilets S, 2014, J HERED, V105, P743, DOI 10.1093/jhered/esu045; Gavrilets Sergey, 2000, EVOLUTION, V54; Golestani A, 2012, INT C MOD SIM CONTR, P1275; Golestani A, 2011, INT C ART INT ICAI, P991; Golestani A, 2012, P ROY SOC B-BIOL SCI, V279, P3055, DOI 10.1098/rspb.2012.0466; Golestani A, 2010, CHAOS, V20, DOI 10.1063/1.3514011; Gras R, 2009, ARTIF LIFE, V15, P423, DOI 10.1162/artl.2009.Gras.012; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Hughes BD, 1995, RANDOM WALKS RANDOM, V1, DOI [10.1079/PNS19950063, DOI 10.1079/PNS19950063]; Kantz H., 1997, NONLINEAR TIME SERIE; Kirkpatrick M, 2002, AM NAT, V159, pS22, DOI 10.1086/338370; KOSKO B, 1986, INT J MAN MACH STUD, V24, P65, DOI 10.1016/S0020-7373(86)80040-2; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Lenski RE, 1999, NATURE, V400, P661, DOI 10.1038/23245; Lenski RE, 2003, NATURE, V423, P139, DOI 10.1038/nature01568; Lotka AJ, 1910, J PHYS CHEM-US, V14, P271, DOI 10.1021/j150111a004; MacPherson B, 2015, J THEOR BIOL UNPUB; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; Nosil P, 2012, PHILOS T R SOC B, V367, P332, DOI 10.1098/rstb.2011.0263; Nosil P, 2011, P ROY SOC B-BIOL SCI, V278, P399, DOI 10.1098/rspb.2010.1215; Price T, 2007, SPECIATION BIRDS; Ray T.S., 1991, SANTA FE I STUDIES S, VXI, P371; Rohani P, 1997, TRENDS ECOL EVOL, V12, P70, DOI 10.1016/S0169-5347(96)20103-X; Schluter D, 2000, AM NAT, V156, pS4, DOI 10.1086/303412; Servedio MR, 2014, P NATL ACAD SCI USA, V111, P8113, DOI 10.1073/pnas.1316484111; Seuront L, 1996, GEOPHYS RES LETT, V23, P3591, DOI 10.1029/96GL03473; Thibert-Plante X, 2009, J EVOLUTION BIOL, V22, P109, DOI 10.1111/j.1420-9101.2008.01627.x; Turelli M, 2001, TRENDS ECOL EVOL, V16, P330, DOI 10.1016/S0169-5347(01)02177-2; van Doorn GS, 2009, SCIENCE, V326, P1704, DOI 10.1126/science.1181661; VOLTERRA V, 1928, J CONS INT EXPLOR ME, V3, P3, DOI DOI 10.1093/ICESJMS/3.1.3; Volterra V., 1927, VARIAZIONI FLUTTUAZI; Yaeger L, 1992, SANTA FE I STUDIES S, V17, P263	46	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137838	10.1371/journal.pone.0137838	http://dx.doi.org/10.1371/journal.pone.0137838			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372462	gold, Green Submitted, Green Published			2022-12-27	WOS:000361604400032
J	Sankaranarayanan, A; Mancuso, S; Wilding, H; Ghuloum, S; Castle, D				Sankaranarayanan, Anoop; Mancuso, Serafino; Wilding, Helen; Ghuloum, Suhaila; Castle, David			Smoking, Suicidality and Psychosis: A Systematic Meta-Analysis	PLOS ONE			English	Article							PROBLEM-SOLVING DEFICITS; CIGARETTE-SMOKING; BIPOLAR DISORDER; TOBACCO SMOKING; CHRONIC-SCHIZOPHRENIA; NICOTINE DEPENDENCE; COMPLETED SUICIDE; ANXIETY DISORDERS; MAJOR DEPRESSION; MENTAL-DISORDERS	The aim of this study is to systematically review the literature that explored the association between smoking and suicidal risk among those with serious mental illness and to estimate the risk of suicidal behaviors attributable to smoking among this patient group. Multiple databases (CINAHL, PsycINFO, EMBASE, Informit Health Collection and the Cochrane Library databases) were searched from 1 January 1975 through 15 January 2014, along with references from relevant articles for observational studies that ascertained the association between smoking and suicidal behaviors among patients with psychotic disorders conducted in adult patients. Thirteen studies involving 6813 patients with severe mental illness were included. We found that smoking was significantly associated with suicidality in psychosis with an Odds Ratio of 2.12 (95% CI 1.67-2.7). Smoking is associated with suicidal risk amongst individuals with a severe mental illness; however, it is still unclear whether this represents a true risk factor or a confounder or a mediator via mechanisms, hitherto unknown, needs to be studied further.	[Sankaranarayanan, Anoop] Hamad Med Corp, Dept Geriatr, Doha, Qatar; [Sankaranarayanan, Anoop; Ghuloum, Suhaila] Weill Cornell Med Coll, Dept Psychiat, Doha, Qatar; [Mancuso, Serafino; Wilding, Helen; Castle, David] St Vincents Hosp, Melbourne, Vic, Australia; [Mancuso, Serafino; Castle, David] Univ Melbourne, Dept Psychiat, Melbourne, Vic, Australia; [Ghuloum, Suhaila] Hamad Med Corp, Dept Psychiat, Doha, Qatar; [Castle, David] Australian Catholic Univ, Dept Psychiat, Melbourne, Vic, Australia	Hamad Medical Corporation; Qatar Foundation (QF); Weill Cornell Medical College Qatar; St Vincent's Hospital Melbourne; University of Melbourne; Hamad Medical Corporation; Australian Catholic University	Sankaranarayanan, A (corresponding author), Hamad Med Corp, Dept Geriatr, Doha, Qatar.	anoopshank2000@gmail.com		Wilding, Helen/0000-0003-3894-1239; Sankaranarayanan, Anoop/0000-0002-7495-8073	Hamad Medical Corporation Medical Research Centre [14486/14]	Hamad Medical Corporation Medical Research Centre	This study was approved funding by the Hamad Medical Corporation Medical Research Centre (Research Proposal # 14486/14) to cover publication charges. None of the authors received any financial benefits, incentives or salary from the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamura AC, 2007, SCHIZOPHR RES, V89, P140, DOI 10.1016/j.schres.2006.08.023; Altamura AC, 2003, SCHIZOPHR RES, V60, P47, DOI 10.1016/S0920-9964(02)00164-0; Andriopoulos I, 2011, COMPR PSYCHIAT, V52, P479, DOI 10.1016/j.comppsych.2010.10.011; Araya R, 2007, SOC PSYCH PSYCH EPID, V42, P874, DOI 10.1007/s00127-007-0238-4; Baek JH, 2013, DEPRESS ANXIETY, V30, P982, DOI 10.1002/da.22107; Baethge C, 2009, BIPOLAR DISORD, V11, P494, DOI 10.1111/j.1399-5618.2009.00727.x; BELLACK AS, 1994, J ABNORM PSYCHOL, V103, P371, DOI 10.1037/0021-843X.103.2.371; BENWELL MEM, 1990, PSYCHOPHARMACOLOGY, V102, P68, DOI 10.1007/BF02245746; Beratis S, 2001, COMPR PSYCHIAT, V42, P393, DOI 10.1053/comp.2001.26273; Berlin I, 2006, ADDICTION, V101, P1814, DOI 10.1111/j.1360-0443.2006.01616.x; Borenstein M., 2009, INTRO METAANALYSIS; Chan RCK, 2004, EUR ARCH PSY CLIN N, V254, P236, DOI 10.1007/s00406-004-0486-1; Cooper J, 2012, AUST NZ J PSYCHIAT, V46, P851, DOI 10.1177/0004867412449876; Costa LD, 2015, J AFFECT DISORDERS, V170, P237, DOI 10.1016/j.jad.2014.09.003; Cuijpers P, 2007, ADDICTION, V102, P1303, DOI 10.1111/j.1360-0443.2007.01885.x; D'Zurilla TJ, 1998, J CLIN PSYCHOL, V54, P1091, DOI 10.1002/(SICI)1097-4679(199812)54:8<1091::AID-JCLP9>3.0.CO;2-J; Davis RN, 2000, COGNITIVE THER RES, V24, P699, DOI 10.1023/A:1005591412406; de Leon J, 2005, SCHIZOPHR RES, V76, P135, DOI 10.1016/j.schres.2005.02.010; de Leon J, 2002, J CLIN PSYCHIAT, V63, P812, DOI 10.4088/JCP.v63n0911; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DOLL R, 1976, BRIT MED J, V2, P1525, DOI 10.1136/bmj.2.6051.1525; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fassberg MM, 2012, INT J ENV RES PUB HE, V9, P722, DOI 10.3390/ijerph9030722; Getz GE, 2003, J INT NEUROPSYCH SOC, V9, P623, DOI 10.1017/S1355617703940021; Gibbs LM, 2009, INT J GERIATR PSYCH, V24, P1396, DOI 10.1002/gps.2276; Gilbert DG, 1995, BEHAV GENET, V5, P33; GOFF DC, 1992, AM J PSYCHIAT, V149, P1189; Goldstein BI, 2008, AM J ADDICTION, V17, P364, DOI 10.1080/10550490802266151; Goodman E, 2000, PEDIATRICS, V106, P748, DOI 10.1542/peds.106.4.748; Goodwin RD, 2004, J PSYCHIATR RES, V38, P295, DOI 10.1016/j.jpsychires.2003.09.002; Gutierrez L, 2012, INT CLIN PSYCHOPHA S, V28; HAAGA DAF, 1995, COGNITIVE THER RES, V19, P147, DOI 10.1007/BF02229691; Haw C, 2005, SUICIDE LIFE-THREAT, V35, P50, DOI 10.1521/suli.35.1.50.59260; Hawton K, 2005, BRIT J PSYCHIAT, V187, P9, DOI 10.1192/bjp.187.1.9; Hawton K, 2005, J CLIN PSYCHIAT, V66, P693, DOI 10.4088/JCP.v66n0604; Hawton K, 2013, J AFFECT DISORDERS, V147, P17, DOI 10.1016/j.jad.2013.01.004; Heberlein AS, 2008, J COGNITIVE NEUROSCI, V20, P721, DOI 10.1162/jocn.2008.20049; HENNINGFIELD JE, 1984, ADV BEHAV PHARMACOL, V4, P131; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hor K, 2010, J PSYCHOPHARMACOL, V24, P81, DOI 10.1177/1359786810385490; Hughes JR, 2008, DRUG ALCOHOL DEPEN, V98, P169, DOI 10.1016/j.drugalcdep.2008.06.003; Iancu I, 2006, CLIN NEUROPHARMACOL, V29, P230, DOI 10.1097/01.WNF.0000228178.75711.EB; Isensee B, 2003, ARCH GEN PSYCHIAT, V60, P692, DOI 10.1001/archpsyc.60.7.692; Iwasaki M, 2005, ANN EPIDEMIOL, V15, P286, DOI 10.1016/j.annepidem.2004.08.011; Jarbin H, 2004, NORD J PSYCHIAT, V58, P115, DOI 10.1080/08039480410005611; Kanwar J, 2013, SCHIZOPHR RES, V149, P194, DOI 10.1016/j.schres.2013.06.010; Kao YC, 2011, PSYCHIAT RES, V190, P193, DOI 10.1016/j.psychres.2011.05.016; Kassel JD, 1997, CLIN PSYCHOL REV, V17, P451, DOI 10.1016/S0272-7358(97)00032-9; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P36; Kessler RC, 2007, J NERV MENT DIS, V195, P369, DOI 10.1097/NMD.0b013e3180303eb8; Klungsoyr O, 2006, AM J EPIDEMIOL, V163, P421, DOI 10.1093/aje/kwj058; Kuhn S, 2010, BIOL PSYCHIAT, V68, P1061, DOI 10.1016/j.biopsych.2010.08.004; Kumari V, 2005, NEUROSCI BIOBEHAV R, V29, P1021, DOI 10.1016/j.neubiorev.2005.02.006; Large MM, 2012, AM J PSYCHIAT, V169, P662, DOI 10.1176/appi.ajp.2012.11111674; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; Leistikow B, 2003, INT J EPIDEMIOL, V32, P1005, DOI 10.1093/ije/dyg326; Levin ED, 1996, NEUROPSYCHOPHARMACOL, V15, P429, DOI 10.1016/S0893-133X(96)00018-8; Lezak MD., 2004, NEUROPSYCHOLOGICAL A, V(4th ed.), P429; Li DJ, 2012, J PSYCHIATR RES, V46, P1257, DOI 10.1016/j.jpsychires.2012.03.013; LINNOILA VMI, 1992, J CLIN PSYCHIAT, V53, P46; Lotfipour S, 2009, ARCH GEN PSYCHIAT, V66, P1244, DOI 10.1001/archgenpsychiatry.2009.124; Lyon ER, 1999, PSYCHIATR SERV, V50, P1346, DOI 10.1176/ps.50.10.1346; Malik S, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-18; Malone KM, 2003, AM J PSYCHIAT, V160, P773, DOI 10.1176/appi.ajp.160.4.773; McClave AK, 2010, AM J PUBLIC HEALTH, V100, P2464, DOI 10.2105/AJPH.2009.188136; McClure EB, 2005, AM J PSYCHIAT, V162, P1644, DOI 10.1176/appi.ajp.162.9.1644; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Morissette SB, 2007, PSYCHOL BULL, V133, P245, DOI 10.1037/0033-2909.133.2.245; MORRIS RG, 1995, SCHIZOPHR RES, V14, P235, DOI 10.1016/0920-9964(94)00044-9; Myles N, 2012, J CLIN PSYCHIAT, V73, P468, DOI 10.4088/JCP.11r07222; Ostacher MJ, 2009, BIPOLAR DISORD, V11, P766, DOI 10.1111/j.1399-5618.2009.00744.x; Ostacher MJ, 2006, J CLIN PSYCHIAT, V67, P1907, DOI 10.4088/JCP.v67n1210; Palmer BA, 2005, ARCH GEN PSYCHIAT, V62, P247, DOI 10.1001/archpsyc.62.3.247; Pollock LR, 2004, PSYCHOL MED, V34, P163, DOI 10.1017/S0033291703008092; Rosenthal JA, 1996, J SOC SERV RES, V21, P37, DOI 10.1300/J079v21n04_02; Sankaranarayanan A, 2014, PSYCHIAT RES, V215, P634, DOI 10.1016/j.psychres.2013.12.032; SCHOTTE DE, 1982, J CONSULT CLIN PSYCH, V50, P690, DOI 10.1037/0022-006X.50.5.690; SCHOTTE DE, 1987, J CONSULT CLIN PSYCH, V55, P49, DOI 10.1037/0022-006X.55.1.49; Shamay-Tsoory SG, 2006, SOC NEUROSCI-UK, V1, P149, DOI 10.1080/17470910600985589; SMITH GD, 1992, LANCET, V340, P709; STANLEY M, 1983, LANCET, V1, P214; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; Tanskanen A, 1998, AM J PSYCHIAT, V155, P129, DOI 10.1176/ajp.155.1.129; Tanskanen A, 2000, ACTA PSYCHIAT SCAND, V101, P243, DOI 10.1046/j.0902-4441.2000.ap9s003.x; Upadhyaya HP, 2002, J AM ACAD CHILD PSY, V41, P1294, DOI 10.1097/00004583-200211000-00010; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Waxmonsky JA, 2005, GEN HOSP PSYCHIAT, V27, P321, DOI 10.1016/j.genhosppsych.2005.05.003; Whitfield JB, 2000, PSYCHOL MED, V30, P443, DOI 10.1017/S0033291799001798; Wilhelm K, 2003, J AFFECT DISORDERS, V75, P155, DOI 10.1016/S0165-0327(02)00040-X; Wu LT, 1999, AM J PUBLIC HEALTH, V89, P1837, DOI 10.2105/AJPH.89.12.1837; Xian H, 2007, ADDICT BEHAV, V32, P137, DOI 10.1016/j.addbeh.2006.03.031	92	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138147	10.1371/journal.pone.0138147	http://dx.doi.org/10.1371/journal.pone.0138147			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8LR	26372218	gold, Green Published			2022-12-27	WOS:000361604400050
J	Suzuki, M; Takahashi, S; Kondo, T; Dohra, H; Ito, Y; Kiriiwa, Y; Hayashi, M; Kamiya, S; Kato, M; Fujiwara, M; Fukao, Y; Kobayashi, M; Nagata, N; Motohashi, R				Suzuki, Miho; Takahashi, Sachiko; Kondo, Takanori; Dohra, Hideo; Ito, Yumihiko; Kiriiwa, Yoshikazu; Hayashi, Marina; Kamiya, Shiori; Kato, Masaya; Fujiwara, Masayuki; Fukao, Yoichiro; Kobayashi, Megumi; Nagata, Noriko; Motohashi, Reiko			Plastid Proteomic Analysis in Tomato Fruit Development	PLOS ONE			English	Article							CAROTENOID-ASSOCIATED PROTEIN; CHROMOPLAST DIFFERENTIATION; SOLANUM-LYCOPERSICON; ARABIDOPSIS-THALIANA; MOLECULAR-BIOLOGY; PROVIDES INSIGHTS; INDUCED LIPOCALIN; GENE-EXPRESSION; SWEET ORANGE; MICRO-TOM	To better understand the mechanism of plastid differentiation from chloroplast to chromoplast, we examined proteome and plastid changes over four distinct developmental stages of 'Micro-Tom' fruit. Additionally, to discover more about the relationship between fruit color and plastid differentiation, we also analyzed and compared 'Micro-Tom' results with those from two other varieties, 'Black' and 'White Beauty'. We confirmed that proteins related to photosynthesis remain through the orange maturity stage of 'Micro-Tom', and also learned that thylakoids no longer exist at this stage. These results suggest that at a minimum there are changes in plastid morphology occurring before all related proteins change. We also compared 'Micro-Tom' fruits with 'Black' and 'White Beauty' using twodimensional gel electrophoresis. We found a decrease of CHRC (plastid-lipid-associated protein) and HrBP1 (harpin binding protein-1) in the 'Black' and 'White Beauty' varieties. CHRC is involved in carotenoid accumulation and stabilization. HrBP1 in Arabidopsis has a sequence similar to proteins in the PAP/fibrillin family. These proteins have characteristics and functions similar to lipocalin, an example of which is the transport of hydrophobic molecules. We detected spots of TIL (temperature-induced lipocalin) in 2D-PAGE results, however the number of spots and their isoelectric points differed between 'Micro-Tom' and 'Black'/'White Beauty'. Lipocalin has various functions including those related to environmental stress response, apoptosis induction, membrane formation and fixation, regulation of immune response, cell growth, and metabolism adjustment. Lipocalin related proteins such as TIL and HrBP1 could be related to the accumulation of carotenoids, fruit color and the differentiation of chromoplast.	[Suzuki, Miho; Takahashi, Sachiko; Kondo, Takanori; Ito, Yumihiko; Kiriiwa, Yoshikazu; Hayashi, Marina; Kamiya, Shiori; Kato, Masaya; Motohashi, Reiko] Shizuoka Univ, Fac Agr, Shizuoka, Shizuoka 4228529, Japan; [Dohra, Hideo] Shizuoka Univ, Res Inst Green Sci & Technol, Instrumental Res Support Off, Shizuoka, Shizuoka, Japan; [Fujiwara, Masayuki; Fukao, Yoichiro] Nara Inst Sci & Technol, Plant Sci Educ Unit, Ikoma City, Nara, Japan; [Kobayashi, Megumi; Nagata, Noriko] Japan Womens Univ, Fac Sci, Bunkyo Ku, Tokyo, Japan	Shizuoka University; Shizuoka University; Nara Institute of Science & Technology; Japan Womens University	Motohashi, R (corresponding author), Shizuoka Univ, Fac Agr, Shizuoka, Shizuoka 4228529, Japan.	armotoh@ipc.shizuoka.ac.jp		Nagata, Noriko/0000-0002-0894-2049; Dohra, Hideo/0000-0002-3919-3538	Japanese Ministry of Education [20510190, 23580039]	Japanese Ministry of Education(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was made possible by the Grant-in-Aid for Scientific Research, a program administered by the Japanese Ministry of Education (No. 20510190 and 23580039 to RM), http://www.jsps.go.jp/english/e-grants/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Phillips L, 2004, TRENDS PLANT SCI, V9, P331, DOI 10.1016/j.tplants.2004.05.004; Adato A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000777; Akerstrom B, 2006, BIOCHIM BIOPHYS ACTA, V163, P895; Aoki K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-210; Baginsky S, 2004, J PROTEOME RES, V3, P1128, DOI 10.1021/pr0499186; Balmer Y, 2006, J EXP BOT, V57, P1591, DOI 10.1093/jxb/erj156; Barsan C, 2012, PLANT PHYSIOL, V160, P708, DOI 10.1104/pp.112.203679; Barsan C, 2010, J EXP BOT, V61, P2413, DOI 10.1093/jxb/erq070; Behrens C, 2013, J PROTEOMICS, V91, P73, DOI 10.1016/j.jprot.2013.07.001; BLANKE MM, 1989, PLANT CELL ENVIRON, V12, P31, DOI 10.1111/j.1365-3040.1989.tb01914.x; Borisjuk L, 2009, NEW PHYTOL, V182, P17, DOI 10.1111/j.1469-8137.2008.02752.x; Camara B, 1995, INT REV CYTOL, V163, P175, DOI 10.1016/S0074-7696(08)62211-1; Carrara S, 2001, PHOTOSYNTHETICA, V39, P75, DOI 10.1023/A:1012495903093; Charron JBF, 2005, PLANT PHYSIOL, V139, P2017, DOI 10.1104/pp.105.070466; Charron JBF, 2002, FEBS LETT, V517, P129, DOI 10.1016/S0014-5793(02)02606-6; Charron JBF, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-86; Chi WT, 2009, PLANT CELL ENVIRON, V32, P917, DOI 10.1111/j.1365-3040.2009.01972.x; Egea I, 2010, PLANT CELL PHYSIOL, V51, P1601, DOI 10.1093/pcp/pcq136; Ferro M, 2010, MOL CELL PROTEOMICS, V9, P1063, DOI 10.1074/mcp.M900325-MCP200; Flower DR, 1996, BIOCHEM J, V318, P1; FRAY RG, 1993, PLANT MOL BIOL, V22, P589, DOI 10.1007/BF00047400; Fujiwara M, 2009, PLANT CELL PHYSIOL, V50, P1191, DOI 10.1093/pcp/pcp077; Gady ALF, 2012, MOL BREEDING, V29, P801, DOI 10.1007/s11032-011-9591-9; Giovannoni J, 2001, ANNU REV PLANT PHYS, V52, P725, DOI 10.1146/annurev.arplant.52.1.725; Grzyb J, 2006, J PLANT PHYSIOL, V163, P895, DOI 10.1016/j.jplph.2005.12.007; HUNT GM, 1980, PHYTOCHEMISTRY, V19, P1415, DOI 10.1016/0031-9422(80)80185-3; Iijima Y, 2008, PLANT J, V54, P949, DOI 10.1111/j.1365-313X.2008.03434.x; Jones AME, 2006, PROTEOMICS, V6, P4155, DOI 10.1002/pmic.200500172; Joyard J, 2009, MOL PLANT, V2, P1154, DOI 10.1093/mp/ssp088; Kahlau S, 2008, PLANT CELL, V20, P856, DOI 10.1105/tpc.107.055202; Kahlau S, 2006, J MOL EVOL, V63, P194, DOI 10.1007/s00239-005-0254-5; Kalachanis D, 2010, PHYSIOL PLANTARUM, V139, P313, DOI 10.1111/j.1399-3054.2010.01362.x; Karlova R, 2011, PLANT CELL, V23, P923, DOI 10.1105/tpc.110.081273; Kato M, 2004, PLANT PHYSIOL, V134, P824, DOI 10.1104/pp.103.031104; Kilambi HV, 2013, PLANT PHYSIOL, V161, P2085, DOI 10.1104/pp.112.212191; Kleffmann T, 2006, PLANT CELL PHYSIOL, V47, P432, DOI 10.1093/pcp/pcj005; Komatsu S, 2003, MOL CELL PROTEOMICS, V2, P2, DOI 10.1074/mcp.R200008-MCP200; Leitner-Dagan Y, 2006, PLANT PHYSIOL, V142, P233, DOI 10.1104/pp.106.082404; LIVNE A, 1988, PLANT PHYSIOL, V87, P239, DOI 10.1104/pp.87.1.239; LORD JM, 1973, J CELL BIOL, V57, P659, DOI 10.1083/jcb.57.3.659; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Marti E, 2006, J EXP BOT, V57, P2037, DOI 10.1093/jxb/erj154; Marti MC, 2009, PLANT BIOLOGY, V11, P613, DOI 10.1111/j.1438-8677.2008.00149.x; Matas AJ, 2011, PLANT CELL, V23, P3893, DOI 10.1105/tpc.111.091173; Mintz-Oron S, 2008, PLANT PHYSIOL, V147, P823, DOI 10.1104/pp.108.116004; Motohashi R, 2007, PLANT MOL BIOL, V64, P481, DOI 10.1007/s11103-007-9166-7; Motohashi R, 2012, PLANT PHYSIOL, V160, P2189, DOI 10.1104/pp.112.204032; Mueller LA, 2005, COMP FUNCT GENOM, V6, P153, DOI 10.1002/cfg.468; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Poole Rebecca L., 2007, V406, P179; RAY PM, 1969, P NATL ACAD SCI USA, V64, P605, DOI 10.1073/pnas.64.2.605; Ruuska SA, 2004, PLANT PHYSIOL, V136, P2700, DOI 10.1104/pp.104.047977; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Siddique MA, 2006, PLANT CELL PHYSIOL, V47, P1663, DOI 10.1093/pcp/pcl033; Simkin AJ, 2007, PHYTOCHEMISTRY, V68, P1545, DOI 10.1016/j.phytochem.2007.03.014; Stensballe A, 2008, FEBS J, V275, P1723, DOI 10.1111/j.1742-4658.2008.06332.x; Tetlow IJ, 2003, PLANT SCI, V165, P383, DOI 10.1016/S0168-9452(03)00199-7; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Vasquez-Caicedo AL, 2006, J AGR FOOD CHEM, V54, P5769, DOI 10.1021/jf060747u; Vishnevetsky M, 1996, PLANT J, V10, P1111, DOI 10.1046/j.1365-313X.1996.10061111.x; Vishnevetsky M, 1999, PLANT J, V20, P423, DOI 10.1046/j.1365-313x.1999.00615.x; Vogel JT, 2010, J SCI FOOD AGR, V90, P2233, DOI 10.1002/jsfa.4076; von Zychlinski A, 2005, MOL CELL PROTEOMICS, V4, P1072, DOI 10.1074/mcp.M500018-MCP200; Wang YQ, 2013, J EXP BOT, V64, P949, DOI 10.1093/jxb/ers375; You JJ, 2010, ELECTROPHORESIS, V31, P1853, DOI 10.1002/elps.200900755; Zeng YL, 2014, PHYSIOL PLANTARUM, V150, P252, DOI 10.1111/ppl.12080; Zeng YL, 2011, J EXP BOT, V62, P5297, DOI 10.1093/jxb/err140	67	27	28	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137266	10.1371/journal.pone.0137266	http://dx.doi.org/10.1371/journal.pone.0137266			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371478	Green Submitted, Green Published, gold			2022-12-27	WOS:000361604400015
J	Barron, EV; Roman-Bassaure, E; Sanchez-Sandoval, AL; Espinosa, AM; Guardado-Estrada, M; Medina, I; Juarez, E; Alfaro, A; Bermudez, M; Zamora, R; Garcia-Ruiz, C; Gomora, JC; Kofman, S; Perez-Armendariz, EM; Berumen, J				Valeria Barron, Eira; Roman-Bassaure, Edgar; Laura Sanchez-Sandoval, Ana; Maria Espinosa, Ana; Guardado-Estrada, Mariano; Medina, Ingrid; Juarez, Eligia; Alfaro, Ana; Bermudez, Miriam; Zamora, Ruben; Garcia-Ruiz, Carlos; Carlos Gomora, Juan; Kofman, Susana; Martha Perez-Armendariz, E.; Berumen, Jaime			CDKN3 mRNA as a Biomarker for Survival and Therapeutic Target in Cervical Cancer	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; PROTEIN PHOSPHATASE; HEPATOCELLULAR-CARCINOMA; NEOADJUVANT CHEMOTHERAPY; CELL-PROLIFERATION; AMPLIFICATION; QUADRIVALENT; INHIBITION; VACCINE; GENE	The cyclin-dependent kinase inhibitor 3 (CDKN3) gene, involved in mitosis, is upregulated in cervical cancer (CC). We investigated CDKN3 mRNA as a survival biomarker and potential therapeutic target for CC. CDKN3 mRNA was measured in 134 CC and 25 controls by quantitative PCR. A 5-year survival study was conducted in 121 of these CC patients. Furthermore, CDKN3-specific siRNAs were used to investigate whether CDKN3 is involved in proliferation, migration, and invasion in CC-derived cell lines (SiHa, CaSki, HeLa). CDKN3 mRNA was on average 6.4-fold higher in tumors than in controls (p = 8 x 10(-6), Mann-Whitney). A total of 68.2% of CC patients over expressing CDKN3 gene (fold change >= 17) died within two years of diagnosis, independent of the clinical stage and HPV type (Hazard Ratio = 5.0, 95% CI: 2.5-10, p = 3.3 x 10(-6), Cox proportional-hazards regression). In contrast, only 19.2% of the patients with lower CDKN3 expression died in the same period. In vitro inactivation of CDKN3 decreased cell proliferation on average 67%, although it had no effect on cell migration and invasion. CDKN3 mRNA may be a good survival biomarker and potential therapeutic target in CC.	[Valeria Barron, Eira; Maria Espinosa, Ana; Guardado-Estrada, Mariano; Medina, Ingrid; Juarez, Eligia; Alfaro, Ana; Bermudez, Miriam; Garcia-Ruiz, Carlos; Berumen, Jaime] Univ Nacl Autonoma Mexico, Hosp Gen Mexico, Fac Med, Unidad Med Genom, Mexico City 04510, DF, Mexico; [Valeria Barron, Eira; Martha Perez-Armendariz, E.; Berumen, Jaime] Univ Nacl Autonoma Mexico, Dept Med Expt, Fac Med, Mexico City 04510, DF, Mexico; [Roman-Bassaure, Edgar] Hosp Gen Mexico City, Serv Oncol, Mexico City, DF, Mexico; [Laura Sanchez-Sandoval, Ana; Carlos Gomora, Juan] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Div Neurociencias, Dept Neuropatol Mol, Mexico City 04510, DF, Mexico; [Zamora, Ruben] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City 04510, DF, Mexico; [Zamora, Ruben] Mexico Hosp Dr Luis Sanchez Bulnes, Asociac Evitar Ceguera, Lab Biol Mol, Mexico City, DF, Mexico; [Kofman, Susana] Univ Nacl Autonoma Mexico, Hosp Gen Mexico, Fac Med, Serv Genet, Mexico City 04510, DF, Mexico	Hospital General de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Hospital General de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Hospital General de Mexico; Universidad Nacional Autonoma de Mexico	Berumen, J (corresponding author), Univ Nacl Autonoma Mexico, Hosp Gen Mexico, Fac Med, Unidad Med Genom, Mexico City 04510, DF, Mexico.	jaimeberumen@hotmail.com	Sanchez-Sandoval, Ana Laura/GPK-6264-2022; Berumen, Jaime/AAL-5577-2020; Berumen, Jaime/F-7914-2018	Sanchez-Sandoval, Ana Laura/0000-0002-9478-4779; Berumen, Jaime/0000-0001-6707-3317; Berumen, Jaime/0000-0001-6707-3317; ESPINOSA GARCIA, ANA MARIA/0000-0003-3255-4051; Gomora, Juan Carlos/0000-0002-9871-1307; Barron, Eira Valeria/0000-0001-7901-4947	National Council of Science and Technology (CONACYT) [8135/A1, 24341]; National University of Mexico [SDI.PTID.05.2]; National Council of Science and Technology (CONACYT), scholarship	National Council of Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National University of Mexico; National Council of Science and Technology (CONACYT), scholarship	This work was supported by the National Council of Science and Technology (CONACYT, www.conacyt.mx), grant numbers 8135/A1, 24341 (to JB), National University of Mexico (www.unam.mx), grant number SDI.PTID.05.2 (to JB), and National Council of Science and Technology (CONACYT, www.conacyt.mx), scholarship (to EVB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrae B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e900; Berumen J, 2014, EXPERT OPIN THER TAR, V18, P1149, DOI 10.1517/14728222.2014.941808; Bruni L, ICO INFORM CTR HPV C; Bryant C, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-147; Cao TW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103793; Chen QH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111611; Chhavi, 2010, J CANCER RES THER, V6, P167, DOI 10.4103/0973-1482.65242; Crosbie EJ, 2013, LANCET, V382, P889, DOI 10.1016/S0140-6736(13)60022-7; Cuzick J, 2010, GYNECOL ONCOL, V117, pS11, DOI 10.1016/j.ygyno.2010.01.025; Feng MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108502; Ferlay J., 2013, IARC CANCERBASE, V11; Gavrilov Kseniya, 2012, Yale Journal of Biology and Medicine, V85, P187; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Guardado-Estrada M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109406; Guardado-Estrada M, 2012, J HUM GENET, V57, P269, DOI 10.1038/jhg.2012.17; Hu Q, 2014, INT J CLIN EXP PATHO, V7, P5057; Hunter KD, 2006, CANCER RES, V66, P7405, DOI 10.1158/0008-5472.CAN-06-0186; Hwang SJ, 2012, J ONCOL, V2012, DOI 10.1155/2012/507286; Jackson MW, 2014, ONCOTARGETS THER, V7, P751, DOI 10.2147/OTT.S49429; Kjaer SK, 2009, CANCER PREV RES, V2, P868, DOI 10.1158/1940-6207.CAPR-09-0031; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Lai MW, 2012, UROL ONCOL-SEMIN ORI, V30, P871, DOI 10.1016/j.urolonc.2010.09.010; Lee JW, 2012, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2012-7; Lee SW, 2000, MOL CELL BIOL, V20, P1723, DOI 10.1128/MCB.20.5.1723-1732.2000; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Li TR, 2014, ONCOL REP, V31, P1825, DOI 10.3892/or.2014.3045; Lin WR, 2013, ONCOL REP, V29, P903, DOI 10.3892/or.2012.2208; Liu L, 2014, INT J NANOMED, V9, P3509, DOI 10.2147/IJN.S63717; MacDermed DM, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-16; Espinosa AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055975; Markowitz Lauri E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Mathew M, 2013, APOPTOSIS, V18, P882, DOI 10.1007/s10495-013-0840-8; McCormack M, 2013, BRIT J CANCER, V108, P2464, DOI 10.1038/bjc.2013.230; Medina-Martinez I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097842; Nalepa G, 2013, J CELL BIOL, V201, P997, DOI 10.1083/jcb.201205125; Natunen Kari, 2011, Infect Dis Obstet Gynecol, V2011, P675858, DOI 10.1155/2011/675858; Nogueira-Rodrigues A, 2014, CANCER-AM CANCER SOC, V120, P1187, DOI 10.1002/cncr.28471; Pappano WN, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-430; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P103, DOI 10.1016/j.ijgo.2009.02.012; Phillips GDL, 2008, CANCER RES, V68, P9280, DOI 10.1158/0008-5472.CAN-08-1776; Romanowski B, 2011, HUM VACCINES, V7, P161, DOI 10.4161/hv.7.2.13690; Santin AD, 2005, VIROLOGY, V331, P269, DOI 10.1016/j.virol.2004.09.045; Saxena R, 2012, MED RES REV, V32, P166, DOI 10.1002/med.20209; Schiffman M, 2011, JNCI-J NATL CANCER I, V103, P368, DOI 10.1093/jnci/djq562; Schimmack S, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-15; Schmitt M, 2008, J CLIN MICROBIOL, V46, P1050, DOI 10.1128/JCM.02227-07; Shen SN, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-69; Singh RB, 2013, GYNECOL ONCOL, V129, P124, DOI 10.1016/j.ygyno.2013.01.011; Suh DH, 2014, J GYNECOL ONCOL, V25, P236, DOI 10.3802/jgo.2014.25.3.236; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Torti D, 2011, EMBO MOL MED, V3, P623, DOI 10.1002/emmm.201100176; Tsai CJ, 2013, GYNECOL ONCOL, V131, P645, DOI 10.1016/j.ygyno.2013.04.056; Van de Velde N, 2012, JNCI-J NATL CANCER I, V104, P1712, DOI 10.1093/jnci/djs395; Wan HY, 2014, CANCER LETT, V355, P148, DOI 10.1016/j.canlet.2014.09.005; Weaver BA, 2014, MOL BIOL CELL, V25, P2677, DOI 10.1091/mbc.E14-04-0916; Wen XX, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0092-7; Wu Z, 2013, INT J GYNECOL CANCER, V23, P906, DOI 10.1097/IGC.0b013e318292da82; Xing CY, 2012, BIOCHEM BIOPH RES CO, V420, P29, DOI 10.1016/j.bbrc.2012.02.107; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Yeh CT, 2000, CANCER RES, V60, P4697; Yeh CT, 2003, BIOCHEM BIOPH RES CO, V305, P311, DOI 10.1016/S0006-291X(03)00757-5; YOSHIKAWA H, 1991, JPN J CANCER RES, V82, P524, DOI 10.1111/j.1349-7006.1991.tb01882.x; Yu Y, 2007, CANCER RES, V67, P130, DOI 10.1158/0008-5472.CAN-06-2478; Yu Y, 2014, CARCINOGENESIS, V35, P1416, DOI 10.1093/carcin/bgu065	64	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137397	10.1371/journal.pone.0137397	http://dx.doi.org/10.1371/journal.pone.0137397			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372210	Green Published, Green Submitted, gold			2022-12-27	WOS:000361604400020
J	Wood, JP; Meyer, KM; Kelly, TJ; Choi, YW; Rogers, JV; Riggs, KB; Willenberg, ZJ				Wood, Joseph P.; Meyer, Kathryn M.; Kelly, Thomas J.; Choi, Young W.; Rogers, James V.; Riggs, Karen B.; Willenberg, Zachary J.			Environmental Persistence of Bacillus anthracis and Bacillus subtilis Spores	PLOS ONE			English	Article							GEOBACILLUS-STEAROTHERMOPHILUS SPORES; SOLAR ULTRAVIOLET-RADIATION; ARTIFICIAL UV-C; HYDROGEN-PEROXIDE; INACTIVATION; RESISTANCE; SURVIVAL; LIGHT; EFFICACY; REPAIR	There is a lack of data for how the viability of biological agents may degrade over time in different environments. In this study, experiments were conducted to determine the persistence of Bacillus anthracis and Bacillus subtilis spores on outdoor materials with and without exposure to simulated sunlight, using ultraviolet (UV)-A/B radiation. Spores were inoculated onto glass, wood, concrete, and topsoil and recovered after periods of 2, 14, 28, and 56 days. Recovery and inactivation kinetics for the two species were assessed for each surface material and UV exposure condition. Results suggest that with exposure to UV, decay of spore viability for both Bacillus species occurs in two phases, with an initial rapid decay, followed by a slower inactivation period. The exception was with topsoil, in which there was minimal loss of spore viability in soil over 56 days, with or without UV exposure. The greatest loss in viable spore recovery occurred on glass with UV exposure, with nearly a four log(10) reduction after just two days. In most cases, B. subtilis had a slower rate of decay than B. anthracis, although less B. subtilis was recovered initially.	[Wood, Joseph P.] US EPA, Off Res & Dev, Natl Homeland Secur Res Ctr, Res Triangle Pk, NC 27711 USA; [Meyer, Kathryn M.] Oak Ridge Inst Sci & Educ, Res Triangle Pk, NC USA; [Kelly, Thomas J.; Choi, Young W.; Rogers, James V.; Riggs, Karen B.; Willenberg, Zachary J.] Battelle Mem Inst, Columbus, OH 43201 USA	United States Environmental Protection Agency; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; Battelle Memorial Institute	Wood, JP (corresponding author), US EPA, Off Res & Dev, Natl Homeland Secur Res Ctr, Res Triangle Pk, NC 27711 USA.	wood.joe@epa.gov		Wood, Joseph/0000-0001-6316-9418	Battelle Memorial Institute [GS23F001L-3]; Oak Ridge Institute for Science and Education	Battelle Memorial Institute; Oak Ridge Institute for Science and Education(General Electric)	The US EPA funded Battelle Memorial Institute to perform this work via contract GS23F001L-3. Kathryn Meyer was funded as a postdoc through the Oak Ridge Institute for Science and Education. Joseph Wood of the EPA was the sponsor and technical director of the study, and was involved in the study design, data analysis, decision to publish, and preparation of manuscript.	[Anonymous], UV B MON RES PROGR; Balasaraswathy P, 2002, INDIAN J DERMATOLVEN, V68, P201; Blatchley ER, 2005, J ENVIRON ENG, V131, P1245, DOI 10.1061/(ASCE)0733-9372(2005)131:9(1245); Block S.S., 2001, DISINFECTION STERILI, P65; Brown GS, 2007, APPL ENVIRON MICROB, V73, P706, DOI 10.1128/AEM.01082-06; Coohill TP, 2008, PHOTOCHEM PHOTOBIOL, V84, P1084, DOI 10.1111/j.1751-1097.2008.00387.x; Coohill TP, 2009, PHOTOCHEM PHOTOBIOL, V85, P1043, DOI 10.1111/j.1751-1097.2009.00586.x; DIETZ P, 1980, ZBL BAKT MIK HYG B, V171, P455; Gardner DWM, 1998, J APPL MICROBIOL, V84, P633, DOI 10.1046/j.1365-2672.1998.00391.x; JEANMOUGIN M, 1987, ANN DERMATOL VENER, V114, P671; KNUDSON GB, 1986, APPL ENVIRON MICROB, V52, P444, DOI 10.1128/AEM.52.3.444-449.1986; KOLARI PJ, 1986, PHOTODERMATOLOGY, V3, P340; Lee SD, 2011, APPL ENVIRON MICROB, V77, P1638, DOI 10.1128/AEM.02237-10; MANCHEE RJ, 1994, APPL ENVIRON MICROB, V60, P4167, DOI 10.1128/AEM.60.11.4167-4171.1994; Mattle MJ, 2012, ENVIRON SCI TECHNOL, V46, P10022, DOI 10.1021/es302058v; McKenzie RL, 2003, PHOTOCH PHOTOBIO SCI, V2, P5, DOI 10.1039/b211155c; Moeller R, 2011, J APPL MICROBIOL, V110, P1485, DOI 10.1111/j.1365-2672.2011.05004.x; Moeller R, 2009, APPL ENVIRON MICROB, V75, P5202, DOI 10.1128/AEM.00789-09; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Nicholson WL, 2003, APPL ENVIRON MICROB, V69, P1327, DOI 10.1128/AEM.69.2.1327-1330.2003; Rentschler HC, 1941, J BACTERIOL, V41, P745, DOI 10.1128/JB.41.6.745-774.1941; Riesenman PJ, 2000, APPL ENVIRON MICROB, V66, P620, DOI 10.1128/AEM.66.2.620-626.2000; Rogers JV, 2007, J APPL MICROBIOL, V103, P1104, DOI 10.1111/j.1365-2672.2007.03332.x; Rogers JV, 2005, J APPL MICROBIOL, V99, P739, DOI 10.1111/j.1365-2672.2005.02686.x; Rose LJ, 2009, APPL ENVIRON MICROB, V75, P2987, DOI 10.1128/AEM.02180-08; Ryan SP, 2014, WORLD J MICROB BIOT, V30, P2609, DOI 10.1007/s11274-014-1684-2; Sagripanti JL, 2011, ARCH VIROL, V156, P489, DOI 10.1007/s00705-010-0847-1; Setlow P, 2001, ENVIRON MOL MUTAGEN, V38, P97, DOI 10.1002/em.1058; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Slieman TA, 2001, APPL ENVIRON MICROB, V67, P1274, DOI 10.1128/AEM.67.3.1274-1279.2001; Slieman TA, 2000, APPL ENVIRON MICROB, V66, P199, DOI 10.1128/AEM.66.1.199-205.2000; Stuart AL, 2005, ENVIRON SCI TECHNOL, V39, P2736, DOI 10.1021/es048705e; The United States Department of Justice, 2010, AM INV SUMM; Tomasino SF, 2006, J AOAC INT, V89, P1373; U.S. Environmental Protection Agency, 2013, EPA600R13110; Whitney EAS, 2003, EMERG INFECT DIS, V9, P623; Wood JP, 2011, J APPL MICROBIOL, V110, P1262, DOI 10.1111/j.1365-2672.2011.04980.x; Wood JP, 2010, ENVIRON SCI TECHNOL, V44, P7515, DOI 10.1021/es1016153; Xue YM, 1996, APPL ENVIRON MICROB, V62, P2221, DOI 10.1128/AEM.62.7.2221-2227.1996	39	22	23	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138083	10.1371/journal.pone.0138083	http://dx.doi.org/10.1371/journal.pone.0138083			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372011	Green Submitted, Green Published, gold			2022-12-27	WOS:000361604400048
J	Cunningham, TJ; Brade, T; Sandell, LL; Lewandoski, M; Trainor, PA; Colas, A; Mercola, M; Duester, G				Cunningham, Thomas J.; Brade, Thomas; Sandell, Lisa L.; Lewandoski, Mark; Trainor, Paul A.; Colas, Alexandre; Mercola, Mark; Duester, Gregg			Retinoic Acid Activity in Undifferentiated Neural Progenitors Is Sufficient to Fulfill Its Role in Restricting Fgf8 Expression for Somitogenesis	PLOS ONE			English	Article							STEM-CELL DIFFERENTIATION; BODY AXIS EXTENSION; MOUSE EMBRYO; FATE SPECIFICATION; SIGNALING PATHWAYS; MESODERM FORMATION; PRIMITIVE STREAK; LIMB DEVELOPMENT; SEGMENTATION; RECEPTOR	Bipotent axial stem cells residing in the caudal epiblast during late gastrulation generate neuroectodermal and presomitic mesodermal progeny that coordinate somitogenesis with neural tube formation, but the mechanism that controls these two fates is not fully understood. Retinoic acid (RA) restricts the anterior extent of caudal fibroblast growth factor 8 (Fgf8) expression in both mesoderm and neural plate to control somitogenesis and neurogenesis, however it remains unclear where RA acts to control the spatial expression of caudal Fgf8. Here, we found that mouse Raldh2-/- embryos, lacking RA synthesis and displaying a consistent small somite defect, exhibited abnormal expression of key markers of axial stem cell progeny, with decreased Sox2+ and Sox1+ neuroectodermal progeny and increased Tbx6+ presomitic mesodermal progeny. The Raldh2-/- small somite defect was rescued by treatment with an FGF receptor antagonist. Rdh10 mutants, with a less severe RA synthesis defect, were found to exhibit a small somite defect and anterior expansion of caudal Fgf8 expression only for somites 1-6, with normal somite size and Fgf8 expression thereafter. Rdh10 mutants were found to lack RA activity during the early phase when somites are small, but at the 6-somite stage RA activity was detected in neural plate although not in presomitic mesoderm. Expression of a dominant-negative RA receptor in mesoderm eliminated RA activity in presomitic mesoderm but did not affect somitogenesis. Thus, RA activity in the neural plate is sufficient to prevent anterior expansion of caudal Fgf8 expression associated with a small somite defect. Our studies provide evidence that RA restriction of Fgf8 expression in undifferentiated neural progenitors stimulates neurogenesis while also restricting the anterior extent of the mesodermal Fgf8 mRNA gradient that controls somite size, providing new insight into the mechanism that coordinates somitogenesis with neurogenesis.	[Cunningham, Thomas J.; Brade, Thomas; Colas, Alexandre; Mercola, Mark; Duester, Gregg] Sanford Burnham Prebys Med Discovery Inst, Dev Aging & Regenerat Program, La Jolla, CA 92037 USA; [Trainor, Paul A.] Stowers Inst Med Res, Kansas City, MO USA; [Trainor, Paul A.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [Sandell, Lisa L.] Univ Louisville, Dept Mol Cellular & Craniofacial Biol, Louisville, KY 40292 USA; [Lewandoski, Mark] NCI, Lab Canc & Dev Biol, NIH, Frederick, MD 21701 USA; [Colas, Alexandre; Mercola, Mark] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of Louisville; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Diego	Duester, G (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Dev Aging & Regenerat Program, La Jolla, CA 92037 USA.	duester@SBPdiscovery.org	Sandell, Lisa L/M-4238-2013	Sandell, Lisa L/0000-0002-1735-8223; Duester, Gregg/0000-0003-4335-3650; Cunningham, Thomas/0000-0002-4751-3140; Trainor, Paul/0000-0003-2774-3624; Lewandoski, Mark/0000-0002-1066-3735	National Institutes of Health [GM062848, DE016082]; Stowers Institute for Medical Research; NATIONAL CANCER INSTITUTE [ZIABC010338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062848] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stowers Institute for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM062848 (GD) and DE016082 (PT) (www.nih.gov), and the Stowers Institute for Medical Research (PT) (www.stowers.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Bard JBL, 1999, DEVELOPMENT, P103; Benazeraf B, 2010, NATURE, V466, P248, DOI 10.1038/nature09151; Boulet AM, 2012, DEV BIOL, V371, P235, DOI 10.1016/j.ydbio.2012.08.017; Buters JTM, 1999, P NATL ACAD SCI USA, V96, P1977, DOI 10.1073/pnas.96.5.1977; Chambers D, 2007, DEVELOPMENT, V134, P1369, DOI 10.1242/dev.02815; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Chatzi C, 2013, DEV DYNAM, V242, P1056, DOI 10.1002/dvdy.23999; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Cunningham TJ, 2015, NAT REV MOL CELL BIO, V16, P110, DOI 10.1038/nrm3932; Cunningham TJ, 2013, CELL REP, V3, P1503, DOI 10.1016/j.celrep.2013.03.036; DELCORRAL RD, 2003, NEURON, V40, P65, DOI DOI 10.1016/S0896-6273(03)00565-8; DETHE H, 1989, EMBO J, V8, P429, DOI 10.1002/j.1460-2075.1989.tb03394.x; Dubrulle J, 2004, NATURE, V427, P419, DOI 10.1038/nature02216; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Dunty WC, 2008, DEVELOPMENT, V135, P85, DOI 10.1242/dev.009266; Gudas LJ, 2011, J CELL PHYSIOL, V226, P322, DOI 10.1002/jcp.22417; Hayashi Shigemi, 2002, Gene Expression Patterns, V2, P93, DOI 10.1016/S0925-4773(02)00292-7; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; HORTON C, 1995, DEV DYNAM, V202, P312, DOI 10.1002/aja.1002020310; Jurberg AD, 2014, DEV BIOL, V394, P253, DOI 10.1016/j.ydbio.2014.08.012; Kumar S, 2014, DEVELOPMENT, V141, P2972, DOI 10.1242/dev.112367; KURLANDSKY SB, 1995, J BIOL CHEM, V270, P17850, DOI 10.1074/jbc.270.30.17850; Martin BL, 2012, DEV CELL, V22, P223, DOI 10.1016/j.devcel.2011.11.001; Martin BL, 2010, GENE DEV, V24, P2778, DOI 10.1101/gad.1962910; Martin BL, 2009, CURR BIOL, V19, pR215, DOI 10.1016/j.cub.2009.01.052; MENDELSOHN C, 1991, DEVELOPMENT, V113, P723; Mic FA, 2003, P NATL ACAD SCI USA, V100, P7135, DOI 10.1073/pnas.1231422100; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Moreno TA, 2004, DEV CELL, V6, P205, DOI 10.1016/S1534-5807(04)00026-7; Naiche LA, 2011, P NATL ACAD SCI USA, V108, P4018, DOI 10.1073/pnas.1007417108; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Oginuma M, 2008, DEVELOPMENT, V135, P2555, DOI 10.1242/dev.019877; Olivera-Martinez I, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001415; Patel NS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003614; Perantoni AO, 2005, DEVELOPMENT, V132, P3859, DOI 10.1242/dev.01945; Rajaii F, 2008, DEV BIOL, V316, P371, DOI 10.1016/j.ydbio.2008.01.041; Ribes V, 2009, DEVELOPMENT, V136, P665, DOI 10.1242/dev.016204; Rochette-Egly C, 2015, BBA-MOL CELL BIOL L, V1851, P66, DOI 10.1016/j.bbalip.2014.04.003; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; Sheikh BN, 2014, STEM CELLS, V32, P1451, DOI 10.1002/stem.1604; Shifley ET, 2008, DEVELOPMENT, V135, P899, DOI 10.1242/dev.006742; Sirbu IO, 2006, NAT CELL BIOL, V8, P271, DOI 10.1038/ncb1374; Szeto DP, 2006, GENE DEV, V20, P1923, DOI 10.1101/gad.1435306; Takemoto T, 2011, NATURE, V470, P394, DOI 10.1038/nature09729; Tsakiridis A, 2014, DEVELOPMENT, V141, P1209, DOI 10.1242/dev.101014; Tzouanacou E, 2009, DEV CELL, V17, P365, DOI 10.1016/j.devcel.2009.08.002; Vermot J, 2005, SCIENCE, V308, P563, DOI 10.1126/science.1108363; Vermot J, 2005, NATURE, V435, P215, DOI 10.1038/nature03488; Wahl MB, 2007, DEVELOPMENT, V134, P4033, DOI 10.1242/dev.009167; Wilson V, 2009, DEVELOPMENT, V136, P1591, DOI 10.1242/dev.021246; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Yoshida M, 2014, MECH DEVELOP, V132, P59, DOI 10.1016/j.mod.2014.01.003; Yu SR, 2009, NATURE, V461, P533, DOI 10.1038/nature08391	56	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137894	10.1371/journal.pone.0137894	http://dx.doi.org/10.1371/journal.pone.0137894			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368825	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100172
J	Ishibashi, D; Homma, T; Nakagaki, T; Fuse, T; Sano, K; Takatsuki, H; Atarashi, R; Nishida, N				Ishibashi, Daisuke; Homma, Takujiro; Nakagaki, Takehiro; Fuse, Takayuki; Sano, Kazunori; Takatsuki, Hanae; Atarashi, Ryuichiro; Nishida, Noriyuki			Strain-Dependent Effect of Macroautophagy on Abnormally Folded Prion Protein Degradation in Infected Neuronal Cells	PLOS ONE			English	Article							AGGREGATE-PRONE PROTEINS; REGULATES AUTOPHAGY; SIGNALING PATHWAYS; ALZHEIMER-DISEASE; ALPHA-SYNUCLEIN; CLEARANCE; PRPSC; NEURODEGENERATION; POLYGLUTAMINE; ACTIVATION	Prion diseases are neurodegenerative disorders caused by the accumulation of abnormal prion protein (PrPSc) in the central nervous system. With the aim of elucidating the mechanism underlying the accumulation and degradation of PrPSc, we investigated the role of autophagy in its degradation, using cultured cells stably infected with distinct prion strains. The effects of pharmacological compounds that inhibit or stimulate the cellular signal transduction pathways that mediate autophagy during PrPSc degradation were evaluated. The accumulation of PrPSc in cells persistently infected with the prion strain Fukuoka-1 (FK), derived from a patient with Gerstmann-Straussler-Scheinker syndrome, was significantly increased in cultures treated with the macroautophagy inhibitor 3-methyladenine (3MA) but substantially reduced in those treated with the macroautophagy inducer rapamycin. The decrease in FK-derived PrPSc levels was mediated, at least in part, by the phosphatidylinositol 3-kinase/MEK signalling pathway. By contrast, neither rapamycin nor 3MA had any apparently effect on PrPSc from either the 22L or the Chandler strain, indicating that the degradation of PrPSc in host cells might be strain-dependent.	[Ishibashi, Daisuke; Homma, Takujiro; Nakagaki, Takehiro; Fuse, Takayuki; Sano, Kazunori; Takatsuki, Hanae; Atarashi, Ryuichiro; Nishida, Noriyuki] Nagasaki Univ, Dept Mol Microbiol & Immunol, Grad Sch Biomed Sci, Nagasaki 852, Japan	Nagasaki University	Ishibashi, D (corresponding author), Nagasaki Univ, Dept Mol Microbiol & Immunol, Grad Sch Biomed Sci, Nagasaki 852, Japan.	dishi@nagasaki-u.ac.jp	Homma, Takujiro/AAH-7386-2019	Homma, Takujiro/0000-0003-3886-7411; Nakagaki, Takehiro/0000-0003-1960-8326	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24591482]; Takeda Science Foundation; Japan Intractable Disease Research Foundation; Tokyo Biochemical Research Foundation; Ichiro Kanehara Foundation; Research Committee of Molecular Pathogenesis and Therapies for Prion Disease and Slow Virus Infection; Research Committee of Prion Disease and Slow Virus Infection, Research on Rare and Intractable Diseases, Health and Labour Sciences Research Commissions, The Ministry of Health, Labour and Welfare, Japan; Grants-in-Aid for Scientific Research [25461514] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Intractable Disease Research Foundation; Tokyo Biochemical Research Foundation; Ichiro Kanehara Foundation; Research Committee of Molecular Pathogenesis and Therapies for Prion Disease and Slow Virus Infection; Research Committee of Prion Disease and Slow Virus Infection, Research on Rare and Intractable Diseases, Health and Labour Sciences Research Commissions, The Ministry of Health, Labour and Welfare, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	D. I. received research support from a grant-in aid for science research (C; grant no. 24591482) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; a grant from Takeda Science Foundation; a grant from the Japan Intractable Disease Research Foundation; a grant-in-aid from the Tokyo Biochemical Research Foundation and a grant provided by The Ichiro Kanehara Foundation. This study was supported by Grants-in-Aid from the Research Committee of Molecular Pathogenesis and Therapies for Prion Disease and Slow Virus Infection and from the Research Committee of Prion Disease and Slow Virus Infection, Research on Rare and Intractable Diseases, Health and Labour Sciences Research Commissions, The Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguib Y, 2009, AUTOPHAGY, V5, P361, DOI 10.4161/auto.5.3.7662; Allard EK, 2013, NEUROBIOL DIS, V58, P116, DOI 10.1016/j.nbd.2013.05.014; Atarashi R, 2006, J VIROL, V80, P7854, DOI 10.1128/JVI.00424-06; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Cortes Constanza J, 2013, Int J Cell Biol, V2013, P560421, DOI 10.1155/2013/560421; Cortes CJ, 2012, J NEUROSCI, V32, P12396, DOI 10.1523/JNEUROSCI.6189-11.2012; Cui Q, 2007, J PHARMACOL SCI, V105, P317, DOI 10.1254/jphs.FP0070336; Heiseke A, 2010, CURR ISSUES MOL BIOL, V12, P87; Heiseke A, 2009, J NEUROCHEM, V109, P25, DOI 10.1111/j.1471-4159.2009.05906.x; Homma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04504; Ishibashi D, 2012, J VIROL, V86, P4947, DOI 10.1128/JVI.06326-11; Ishibashi D, 2011, VACCINE, V29, P9321, DOI 10.1016/j.vaccine.2011.10.017; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Karapetyan YE, 2013, P NATL ACAD SCI USA, V110, P7044, DOI 10.1073/pnas.1303510110; Kawasaki Y, 2007, J VIROL, V81, P12889, DOI 10.1128/JVI.01563-07; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Marzo L, 2013, J CELL SCI, V126, P1345, DOI 10.1242/jcs.114801; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Munafo DB, 2001, J CELL SCI, V114, P3619; Nakagaki T, 2013, AUTOPHAGY, V9, P1386, DOI 10.4161/auto.25381; Nishida N, 2000, J VIROL, V74, P320, DOI 10.1128/JVI.74.1.320-325.2000; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Oberle C, 2010, CELL DEATH DIFFER, V17, P1167, DOI 10.1038/cdd.2009.214; Pan TH, 2008, BRAIN, V131, P1969, DOI 10.1093/brain/awm318; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Qiang YW, 2004, BLOOD, V103, P301, DOI 10.1182/blood-2003-06-2066; Qin ZH, 2003, HUM MOL GENET, V12, P3231, DOI 10.1093/hmg/ddg346; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Rubinszfein DC, 2005, AUTOPHAGY, V1, P11, DOI 10.4161/auto.1.1.1513; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Sarkar S, 2011, MOL CELL, V43, P19, DOI 10.1016/j.molcel.2011.04.029; Shindoh R, 2009, J VIROL, V83, P3852, DOI 10.1128/JVI.01740-08; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Tang GM, 2008, HUM MOL GENET, V17, P1540, DOI 10.1093/hmg/ddn042; TARABOULOS A, 1990, J CELL BIOL, V110, P2117, DOI 10.1083/jcb.110.6.2117; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Weissmann C, 2002, ACTA NEUROBIOL EXP, V62, P153; Xu XH, 2013, CARDIOVASC RES, V99, P412, DOI 10.1093/cvr/cvt116; Xu Y, 2016, MOL NEUROBIOL, V53, P706, DOI 10.1007/s12035-014-9028-7; Xu Y, 2012, AUTOPHAGY, V8, P1604, DOI 10.4161/auto.21482; Yamasaki T, 2012, J GEN VIROL, V93, P668, DOI 10.1099/vir.0.037101-0	47	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137958	10.1371/journal.pone.0137958	http://dx.doi.org/10.1371/journal.pone.0137958			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368533	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100184
J	Mitra, A; Ruhnow, F; Nitzsche, B; Diez, S				Mitra, Aniruddha; Ruhnow, Felix; Nitzsche, Bert; Diez, Stefan			Impact-Free Measurement of Microtubule Rotations on Kinesin and Cytoplasmic-Dynein Coated Surfaces	PLOS ONE			English	Article							MOTOR PROTEIN; TORQUE GENERATION; PROCESSIVITY; MOVEMENTS; MOLECULE; PROTOFILAMENTS; PRECISION; TRANSPORT; DOMAIN; FORCE	Knowledge about the three-dimensional stepping of motor proteins on the surface of microtubules (MTs) as well as the torsional components in their power strokes can be inferred from longitudinal MT rotations in gliding motility assays. In previous studies, optical detection of these rotations relied on the tracking of rather large optical probes present on the outer MT surface. However, these probes may act as obstacles for motor stepping and may prevent the unhindered rotation of the gliding MTs. To overcome these limitations, we devised a novel, impact-free method to detect MT rotations based on fluorescent speckles within the MT structure in combination with fluorescence-interference contrast microscopy. We (i) confirmed the rotational pitches of MTs gliding on surfaces coated by kinesin-1 and kinesin-8 motors, (ii) demonstrated the superiority of our method over previous approaches on kinesin-8 coated surfaces at low ATP concentration, and (iii) identified MT rotations driven by mammalian cytoplasmic dynein, indicating that during collective motion cytoplasmic dynein side-steps with a bias in one direction. Our novel method is easy to implement on any state-of-the-art fluorescence microscope and allows for high-throughput experiments.	[Mitra, Aniruddha; Ruhnow, Felix; Diez, Stefan] Tech Univ Dresden, CUBE Ctr Mol Bioengn B, D-01062 Dresden, Germany; [Nitzsche, Bert; Diez, Stefan] Max Plank Inst Mol Cell Biol & Genet, Dresden, Germany	Technische Universitat Dresden; Max Planck Society	Diez, S (corresponding author), Tech Univ Dresden, CUBE Ctr Mol Bioengn B, D-01062 Dresden, Germany.	diez@bcube-dresden.de	Diez, Stefan/E-8172-2010	Diez, Stefan/0000-0002-0750-8515; Mitra, Aniruddha/0000-0002-6623-2918; Ruhnow, Felix/0000-0002-0856-5511	European Research Council [242933]; European Social Funds [100111059]; German Research Foundation [DI 1226/4, SFG 877, DI 1226/5]; Max Planck Society; Technische Universitat Dresden	European Research Council(European Research Council (ERC)European Commission); European Social Funds(European Social Fund (ESF)); German Research Foundation(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Technische Universitat Dresden	The authors acknowledge financial support from the European Research Council (starting grant 242933, NanoTrans, to SD), the European Social Funds (grant 100111059, MindNano), the German Research Foundation (Cluster of Excellence Center for Advancing Electronics Dresden, Heisenberg programme grant DI 1226/4 and research unit SFG 877 grant DI 1226/5) as well as the Max Planck Society and the Technische Universitat Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bormuth V, 2012, BIOPHYS J, V103, pL04, DOI 10.1016/j.bpj.2012.05.024; Bormuth V, 2009, SCIENCE, V325, P870, DOI 10.1126/science.1174923; Brunnbauer M, 2012, MOL CELL, V46, P147, DOI 10.1016/j.molcel.2012.04.005; Bugiel M, 2015, BIOPHYS J, V108, P2019, DOI 10.1016/j.bpj.2015.03.022; Can S, 2014, ELIFE, V3, DOI 10.7554/eLife.03205; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Crevenna AH, 2008, BIOPHYS J, V95, P5216, DOI 10.1529/biophysj.108.132449; Derr ND, 2012, SCIENCE, V338, P662, DOI 10.1126/science.1226734; DeWitt MA, 2012, SCIENCE, V335, P221, DOI 10.1126/science.1215804; Furuta K, 2013, P NATL ACAD SCI USA, V110, P501, DOI 10.1073/pnas.1201390110; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; Hancock WO, 1998, J CELL BIOL, V140, P1395, DOI 10.1083/jcb.140.6.1395; HYMAN AA, 1995, J CELL BIOL, V128, P117, DOI 10.1083/jcb.128.1.117; Jannasch A, 2013, BIOPHYS J, V104, P2456, DOI 10.1016/j.bpj.2013.02.040; Kerssemakers J, 2006, P NATL ACAD SCI USA, V103, P15812, DOI 10.1073/pnas.0510400103; Korten T, 2011, METHODS MOL BIOL, V783, P121, DOI 10.1007/978-1-61779-282-3_7; Mayr MI, 2011, PLOS ONE, P6, DOI [10.1371/journal.pone.0027471, DOI 10.1371/J0URNAL.P0NE.0027471]; MIMORI Y, 1995, CELL MOTIL CYTOSKEL, V30, P17, DOI 10.1002/cm.970300104; NISHIZAKA T, 1993, NATURE, V361, P269, DOI 10.1038/361269a0; Nitzsche B, 2008, NAT NANOTECHNOL, V3, P552, DOI 10.1038/nnano.2008.216; Nitzsche B, 2010, METHOD CELL BIOL, V95, P247, DOI 10.1016/S0091-679X(10)95014-0; Ori-McKenney KM, 2010, NAT CELL BIOL, V12, P1228, DOI 10.1038/ncb2127; Peters C, 2010, EMBO J, V29, P3437, DOI 10.1038/emboj.2010.220; Qiu WH, 2012, NAT STRUCT MOL BIOL, V19, P193, DOI 10.1038/nsmb.2205; Rai AK, 2013, CELL, V152, P172, DOI 10.1016/j.cell.2012.11.044; RAY S, 1993, J CELL BIOL, V121, P1083, DOI 10.1083/jcb.121.5.1083; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Ruhnow F, 2011, BIOPHYS J, V100, P2820, DOI 10.1016/j.bpj.2011.04.023; Schneider R, 2015, BIOPHYS J, V108, P2249, DOI 10.1016/j.bpj.2015.03.048; Seitz A, 2006, EMBO J, V25, P267, DOI 10.1038/sj.emboj.7600937; Su XL, 2011, MOL CELL, V43, P751, DOI 10.1016/j.molcel.2011.06.027; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; VALE RD, 1988, CELL, V52, P459, DOI 10.1016/S0092-8674(88)80038-2; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; WALKER RA, 1990, NATURE, V347, P780, DOI 10.1038/347780a0; Walter WJ, 2012, P NATL ACAD SCI USA, V109, P5289, DOI 10.1073/pnas.1116315109; Wang ZH, 1995, BIOPHYS J, V69, P2011, DOI 10.1016/S0006-3495(95)80071-8; Yajima J, 2005, NAT CHEM BIOL, V1, P338, DOI 10.1038/nchembio740; Yamaguchi S, 2015, BIOPHYS J, V108, P872, DOI 10.1016/j.bpj.2014.12.038; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753	41	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136920	10.1371/journal.pone.0136920	http://dx.doi.org/10.1371/journal.pone.0136920			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368807	Green Submitted, Green Published, gold			2022-12-27	WOS:000361601100032
J	Das, S; Rundell, MS; Mirza, AH; Pingle, MR; Shigyo, K; Garrison, AR; Paragas, J; Smith, SK; Olson, VA; Larone, DH; Spitzer, ED; Barany, F; Golightly, LM				Das, Sanchita; Rundell, Mark S.; Mirza, Aashiq H.; Pingle, Maneesh R.; Shigyo, Kristi; Garrison, Aura R.; Paragas, Jason; Smith, Scott K.; Olson, Victoria A.; Larone, Davise H.; Spitzer, Eric D.; Barany, Francis; Golightly, Linnie M.			A Multiplex PCR/LDR Assay for the Simultaneous Identification of Category A Infectious Pathogens: Agents of Viral Hemorrhagic Fever and Variola Virus	PLOS ONE			English	Article							LIGASE DETECTION REACTION; REVERSE-TRANSCRIPTASE PCR; POLYMERASE-CHAIN-REACTION; EBOLA-VIRUS; BIOTERRORISM AGENTS; SMALLPOX-VIRUS; DIAGNOSIS; DISEASE; DNA; OUTBREAK	CDC designated category A infectious agents pose a major risk to national security and require special action for public health preparedness. They include viruses that cause viral hemorrhagic fever (VHF) syndrome as well as variola virus, the agent of smallpox. VHF is characterized by hemorrhage and fever with multi-organ failure leading to high morbidity and mortality. Smallpox, a prior scourge, has been eradicated for decades, making it a particularly serious threat if released nefariously in the essentially non-immune world population. Early detection of the causative agents, and the ability to distinguish them from other pathogens, is essential to contain outbreaks, implement proper control measures, and prevent morbidity and mortality. We have developed a multiplex detection assay that uses several species-specific PCR primers to generate amplicons from multiple pathogens; these are then targeted in a ligase detection reaction (LDR). The resultant fluorescently-labeled ligation products are detected on a universal array enabling simultaneous identification of the pathogens. The assay was evaluated on 32 different isolates associated with VHF (ebolavirus, marburgvirus, Crimean Congo hemorrhagic fever virus, Lassa fever virus, Rift Valley fever virus, Dengue virus, and Yellow fever virus) as well as variola virus and vaccinia virus (the agent of smallpox and its vaccine strain, respectively). The assay was able to detect all viruses tested, including 8 sequences representative of different variola virus strains from the CDC repository. It does not cross react with other emerging zoonoses such as monkeypox virus or cowpox virus, or six flaviviruses tested (St. Louis encephalitis virus, Murray Valley encephalitis virus, Powassan virus, Tick-borne encephalitis virus, West Nile virus and Japanese encephalitis virus).	[Das, Sanchita; Shigyo, Kristi; Golightly, Linnie M.] Cornell Univ, Dept Med, Div Infect Dis, Weill Med Coll, New York, NY 10021 USA; [Rundell, Mark S.; Mirza, Aashiq H.; Pingle, Maneesh R.; Larone, Davise H.; Barany, Francis; Golightly, Linnie M.] Cornell Univ, Dept Microbiol & Immunol, Weill Med Coll, New York, NY 10021 USA; [Garrison, Aura R.] US Army Med Res Inst Infect Dis, Frederick, MD USA; [Paragas, Jason] NIAID, Integrated Res Facil, Div Clin Res, NIH, Ft Detrick, MD USA; [Smith, Scott K.; Olson, Victoria A.] Ctr Dis Control & Prevent, Poxvirus Team, Poxvirus & Rabies Branch,Natl Ctr Emerging Zoonot, Div High Consequence Pathogens & Pathol, Atlanta, GA USA; [Larone, Davise H.] Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; [Spitzer, Eric D.] SUNY Stony Brook, Dept Pathol, Med Ctr, Stony Brook, NY 11794 USA	Cornell University; Cornell University; United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Centers for Disease Control & Prevention - USA; Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Golightly, LM (corresponding author), Cornell Univ, Dept Med, Div Infect Dis, Weill Med Coll, New York, NY 10021 USA.	lgolight@med.cornell.edu	Spitzer, Eric/T-7455-2019; Garrison, Aura/O-4123-2019	Garrison, Aura/0000-0003-3034-6400; Spitzer, Eric/0000-0002-8794-2441	National Institute of Allergy and Infectious Diseases of the National Institute of Health [UC1-AI062579]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI110732, UC1AI062579] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institute of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by contract UC1-AI062579 awarded to FB by the National Institute of Allergy and Infectious Diseases of the National Institute of Health (http://www.niaid.nih.gov/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. At no time during the study did they receive salary support, other funds, or research materials from Beckman Coulter or Coferon Inc. to support the study, nor do either of these entities have any commercial rights or interest in developing a product from the current study.	[Anonymous], 2009, WHO AD COMM VAR VIR; [Anonymous], 2014, FILMARRAY BIOTHREAT; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Bannister B, 2010, BRIT MED BULL, V95, P193, DOI 10.1093/bmb/ldq022; BARANY F, 1991, P NATL ACAD SCI USA, V88, P189, DOI 10.1073/pnas.88.1.189; Barany F, 1991, PCR Methods Appl, V1, P5, DOI 10.1101/gr.1.1.5; Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391; Bowick GC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/236528; Briand S, 2014, NEW ENGL J MED, V371, P1180, DOI 10.1056/NEJMp1409858; Burt FJ, 2005, EPIDEMIOL INFECT, V133, P659, DOI 10.1017/S0950268805003730; Busti E, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-27; Castiglioni B, 2004, APPL ENVIRON MICROB, V70, P7161, DOI 10.1128/AEM.70.12.7161-7172.2004; Cosgrove SE, 2005, ARCH INTERN MED, V165, P2002, DOI 10.1001/archinte.165.17.2002; Damon I.K., 2007, POXVIRUSES BIRKHAUSE, P47; Das S, 2008, J CLIN MICROBIOL, V46, P3276, DOI 10.1128/JCM.00163-08; EISHUBINGER AM, 1990, LANCET, V336, P880, DOI 10.1016/0140-6736(90)92387-W; Esposito JJ, 2006, SCIENCE, V313, P807, DOI 10.1126/science.1125134; Essbauer S., 2007, POXVIRUSES, P65; Fauci AS, 2014, NEW ENGL J MED, V371, P1084, DOI 10.1056/NEJMp1409494; Favis R, 2000, NAT BIOTECHNOL, V18, P561, DOI 10.1038/75452; Feldmann H, 2014, NEW ENGL J MED, V371, P1375, DOI 10.1056/NEJMp1405314; Fujita N., 2009, Morbidity and Mortality Weekly Report, V58, P1377; Garrison AR, 2007, AM J TROP MED HYG, V77, P514, DOI 10.4269/ajtmh.2007.77.514; GEAR JSS, 1975, BRIT MED J, V4, P489, DOI 10.1136/bmj.4.5995.489; Gerry NP, 1999, J MOL BIOL, V292, P251, DOI 10.1006/jmbi.1999.3063; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Goodman JL, 2014, NEW ENGL J MED, V371, P1086, DOI 10.1056/NEJMp1409817; Green A, 2014, LANCET, V384, P118, DOI 10.1016/S0140-6736(14)61147-8; Hartman AL, 2010, CLIN LAB MED, V30, P161, DOI 10.1016/j.cll.2009.12.001; Hasib L, 2011, MOL BIOTECHNOL, V49, P176, DOI 10.1007/s12033-011-9389-3; He J, 2009, VIRUSES-BASEL, V1, P441, DOI 10.3390/v1030441; LEGUENNO B, 1995, LANCET, V345, P1271, DOI 10.1016/S0140-6736(95)90925-7; Maltezou HC, EURO SURVEILL, V15, P19504; Mardani M, 2009, AM J TROP MED HYG, V81, P675, DOI 10.4269/ajtmh.2009.09-0051; McFadden G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000727; Narayanan A, 2011, EXPERT OPIN INV DRUG, V20, P239, DOI 10.1517/13543784.2011.547852; Nisii C, 2009, CLIN MICROBIOL INFEC, V15, P720, DOI 10.1111/j.1469-0691.2009.02946.x; Olson VA, 2004, J CLIN MICROBIOL, V42, P1940, DOI 10.1128/JCM.42.5.1940-1946.2004; Outbreak news, 2009, WKLY EPIDEMIOL REC, V84, P49; Palacios G, 2006, EMERG INFECT DIS, V12, P692, DOI 10.3201/eid1204.051515; Pang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095635; Pelkonen PM, 2003, EMERG INFECT DIS, V9, P1458, DOI 10.3201/eid0911.020814; Pingle M, 2010, METHODS MOL BIOL, V632, P141, DOI 10.1007/978-1-60761-663-4_9; Pingle MR, 2007, J CLIN MICROBIOL, V45, P1927, DOI 10.1128/JCM.00226-07; Riemann K, 2007, J CLIN LAB ANAL, V21, P244, DOI 10.1002/jcla.20174; Rondini S, 2008, J CLIN MICROBIOL, V46, P2269, DOI 10.1128/JCM.02335-07; Rundell MS, 2014, DIAGN MICR INFEC DIS, V79, P135, DOI 10.1016/j.diagmicrobio.2014.02.022; Sall AA, 2002, CLIN DIAGN LAB IMMUN, V9, P713, DOI 10.1128/CDLI.9.3.713-715.2002; Schlaurman T, 2007, J MICROBIOL METH, V71, P238, DOI 10.1016/j.mimet.2007.09.003; SMITH DH, 1982, LANCET, V1, P816; Teets Frank D, 2014, Virol Rep, V1-2, P2; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004; Trombley AR, 2010, AM J TROP MED HYG, V82, P954, DOI 10.4269/ajtmh.2010.09-0636; Watt A, 2014, J VIROL, V88, P10511, DOI 10.1128/JVI.01272-14; Weidmann M, 2008, J CLIN VIROL, V42, P326, DOI 10.1016/j.jcv.2008.03.005; Yang S, 2004, LANCET INFECT DIS, V4, P337, DOI 10.1016/S1473-3099(04)01044-8	57	13	14	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138484	10.1371/journal.pone.0138484	http://dx.doi.org/10.1371/journal.pone.0138484			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381398	Green Published, Green Submitted, gold			2022-12-27	WOS:000361790200113
J	Jindra, C; Huber, B; Shafti-Keramat, S; Wolschek, M; Ferko, B; Muster, T; Brandt, S; Kirnbauer, R				Jindra, Christoph; Huber, Bettina; Shafti-Keramat, Saeed; Wolschek, Markus; Ferko, Boris; Muster, Thomas; Brandt, Sabine; Kirnbauer, Reinhard			Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach	PLOS ONE			English	Article							RETINOBLASTOMA TUMOR-SUPPRESSOR; IMMUNE-RESPONSES; TRUNCATED NS1; PROTEIN; CELLS; REPLICATION; PARTICLES; EPITOPES; GENE; ONCOPROTEIN	Persistent infection with high-risk human papillomavirus (HPV) types, most often HPV16 and HPV18, causes all cervical and most anal cancers, and a subset of vulvar, vaginal, penile and oropharyngeal carcinomas. Two prophylactic virus-like particle (VLPs)-based vaccines, are available that protect against vaccine type-associated persistent infection and associated disease, yet have no therapeutic effect on existing lesions or infections. We have generated recombinant live-attenuated influenza A viruses expressing the HPV16 oncogenes E6 and E7 as experimental immunotherapeutic vaccine candidates. The influenza A virus life cycle lacks DNA intermediates as important safety feature. Different serotypes were generated to ensure efficient prime and boost immunizations. The immune response to vaccination in C57BL/6 mice was characterized by peptide ELISA and IFN-gamma ELISpot, demonstrating induction of cell-mediated immunity to HPV16 E6 and E7 oncoproteins. Prophylactic and therapeutic vaccine efficacy was analyzed in the murine HPV16-positive TC-1 tumor challenge model. Subcutaneous (s.c.) prime and boost vaccinations of mice with recombinant influenza A serotypes H1N1 and H3N2, followed by challenge with TC-1 cells resulted in complete protection or significantly reduced tumor growth as compared to control animals. In a therapeutic setting, s.c. vaccination of mice with established TC-1 tumors decelerated tumor growth and significantly prolonged survival. Importantly, intralesional vaccine administration induced complete tumor regression in 25% of animals, and significantly reduced tumor growth in 50% of mice. These results suggest recombinant E6E7 influenza viruses as a promising new approach for the development of a therapeutic vaccine against HPV-induced disease.	[Jindra, Christoph; Huber, Bettina; Shafti-Keramat, Saeed; Kirnbauer, Reinhard] Med Univ Vienna, Lab Viral Oncol, Div Immunol Allergy & Infect Dis, Dept Dermatol, Vienna, Austria; [Wolschek, Markus; Brandt, Sabine] Vet Univ Vienna, Res Grp Oncol, Equine Clin, A-1030 Vienna, Austria; [Wolschek, Markus; Ferko, Boris; Muster, Thomas] Bluesky Vaccines, Vienna, Austria	Medical University of Vienna; University of Veterinary Medicine Vienna	Kirnbauer, R (corresponding author), Med Univ Vienna, Lab Viral Oncol, Div Immunol Allergy & Infect Dis, Dept Dermatol, Vienna, Austria.	reinhard.kirnbauer@meduniwien.ac.at		Brandt, Sabine/0000-0002-3837-3422; FERKO, Boris/0000-0001-5340-4437; Shafti-Keramat, Saeed/0000-0002-4180-8853; Huber, Bettina/0000-0002-8086-7848	Austrian Science Fund; Translational Research Project Vienna Science and Technology Fund [L545]; Life Science Call [LS11-006]; BlueSky Vaccines	Austrian Science Fund(Austrian Science Fund (FWF)); Translational Research Project Vienna Science and Technology Fund; Life Science Call; BlueSky Vaccines	Funded by Austrian Science Fund (www.fwf.ac.at) Translational Research Project L545 Vienna Science and Technology Fund (www.wwtf.at) Life Science Call 2011 LS11-006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BlueSky Vaccines provided support in the form of salaries for authors [MW, BF, TM], research materials and technical know how, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Azoury-Ziadeh R, 1999, VIRAL IMMUNOL, V12, P297, DOI 10.1089/vim.1999.12.297; Bergot Anne-Sophie, 2011, Cancers (Basel), V3, P3461, DOI 10.3390/cancers3033461; Bodily J, 2011, TRENDS MICROBIOL, V19, P33, DOI 10.1016/j.tim.2010.10.002; Carter JR, 2011, AUST NZ J OBSTET GYN, V51, P103, DOI 10.1111/j.1479-828X.2010.01269.x; Chambers TM, 2009, EQUINE VET J, V41, P87, DOI 10.2746/042516408X371937; Efferson CL, 2006, J VIROL, V80, P383, DOI 10.1128/JVI.80.1.383-394.2006; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; Ferko B, 1998, J INFECT DIS, V178, P1359, DOI 10.1086/314445; Ferko B, 2001, J VIROL, V75, P8899, DOI 10.1128/JVI.75.19.8899-8908.2001; Ferko B, 2006, J VIROL, V80, P11621, DOI 10.1128/JVI.01645-06; Forcier M, 2010, DERMATOL THER, V23, P458, DOI 10.1111/j.1529-8019.2010.01350.x; FOSTER SA, 1994, J VIROL, V68, P5698, DOI 10.1128/JVI.68.9.5698-5705.1994; GAO L, 1994, J GEN VIROL, V75, P157, DOI 10.1099/0022-1317-75-1-157; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Govorkova EA, 1996, J VIROL, V70, P5519, DOI 10.1128/JVI.70.8.5519-5524.1996; Greenstone HL, 1998, P NATL ACAD SCI USA, V95, P1800, DOI 10.1073/pnas.95.4.1800; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Helt AM, 2002, J VIROL, V76, P10559, DOI 10.1128/JVI.76.20.10559-10568.2002; Hung CF, 2008, EXPERT OPIN BIOL TH, V8, P421, DOI [10.1517/14712598.8.4.421, 10.1517/14712598.8.4.421 ]; James MA, 2006, INT J CANCER, V119, P1878, DOI 10.1002/ijc.22064; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; Kittel C, 2004, VIROLOGY, V324, P67, DOI 10.1016/j.virol.2004.03.035; Kwak K, 2011, CURR OPIN IMMUNOL, V23, P244, DOI 10.1016/j.coi.2010.11.009; Lin KY, 1996, CANCER RES, V56, P21; Louie JK, 2010, ARCH PEDIAT ADOL MED, V164, P1023, DOI 10.1001/archpediatrics.2010.203; Maamary J, 2012, J VIROL, V86, P5782, DOI 10.1128/JVI.00190-12; Monie A, 2009, EXPERT REV VACCINES, V8, P1221, DOI 10.1586/ERV.09.76; Monroy-Garcia A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-59; MUNGER K, 1989, EMBO J, V8, P4099, DOI 10.1002/j.1460-2075.1989.tb08594.x; Nguyen ML, 2003, J VIROL, V77, P6957, DOI 10.1128/JVI.77.12.6957-6964.2003; Ogbomo H, 2010, MED MICROBIOL IMMUN, V199, P93, DOI 10.1007/s00430-009-0139-0; Palese Peter, 1997, Journal of Infectious Diseases, V176, pS45, DOI 10.1086/514175; Peng SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116389; Richt JA, 2009, CURR TOP MICROBIOL, V333, P177, DOI 10.1007/978-3-540-92165-3_9; Roethl E, 2011, J VIROL, V85, P11139, DOI 10.1128/JVI.00169-11; Romanova J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005984; Samuel CE, 2010, J BIOL CHEM, V285, P28399, DOI 10.1074/jbc.R110.149625; Schellenbacher C, 2009, J VIROL, V83, P10085, DOI 10.1128/JVI.01088-09; Sereinig S, 2006, CLIN VACCINE IMMUNOL, V13, P898, DOI 10.1128/CVI.00056-06; Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08; Stukova MA, 2006, TUBERCULOSIS, V86, P236, DOI 10.1016/j.tube.2006.01.010; Sturlan S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004122; TINDLE RW, 1990, J GEN VIROL, V71, P1347, DOI 10.1099/0022-1317-71-6-1347; Valenciano M, 2013, EUROSURVEILLANCE, V18, P12; van Rikxoort M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036506; Wacheck V, 2010, J INFECT DIS, V201, P354, DOI 10.1086/649428; Wlazlo AP, 2001, HYBRIDOMA, V20, P257, DOI 10.1089/027245701753179848; Wolschek M, 2011, J VIROL, V85, P2469, DOI 10.1128/JVI.01650-10	48	11	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138722	10.1371/journal.pone.0138722	http://dx.doi.org/10.1371/journal.pone.0138722			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381401	gold, Green Published, Green Submitted			2022-12-27	WOS:000361790200153
J	Valdivia, N; Diaz, MJ; Garrido, I; Gomez, I				Valdivia, Nelson; Jose Diaz, Maria; Garrido, Ignacio; Gomez, Ivan			Consistent Richness-Biomass Relationship across Environmental Gradients in a Marine Macroalgal-Dominated Subtidal Community on the Western Antarctic Peninsula	PLOS ONE			English	Article							KING-GEORGE ISLAND; ECOSYSTEM PRODUCTIVITY; FUNCTIONAL DIVERSITY; BIODIVERSITY LOSS; CURRENT KNOWLEDGE; SPECIES RICHNESS; ICE SCOUR; PERFORMANCE; HYPOTHESIS; INSURANCE	Biodiversity loss has spurred the biodiversity-ecosystem functioning research over a range of ecosystems. In Antarctica, however, the relationship of taxonomic and functional diversity with ecosystem properties (e.g., community biomass) has received less attention, despite the presence of sharp and dynamic environmental stress gradients that might modulate these properties. Here, we investigated whether the richness-biomass relationship in macrobenthic subtidal communities is still apparent after accounting for environmental stress gradients in Fildes Bay, King George Island, Antarctica. Measurements of biomass of mobile and sessile macrobenthic taxa were conducted in the austral summer 2013/4 across two environmental stress gradients: distance from nearest glaciers and subtidal depth (from 5 to 30 m). In general, community biomass increased with distance from glaciers and water depth. However, generalised additive models showed that distance from glaciers and depth accounted for negligible proportions of variation in the number of functional groups (i.e., functional richness) and community biomass when compared to taxonomic richness. Functional richness and community biomass were positive and saturating functions of taxonomic richness. Large endemic, canopy-forming brown algae of the order Desmarestiales dominated the community biomass across both gradients. Accordingly, differences in the composition of taxa accounted for a significant and large proportion (51%) of variation in community biomass in comparison with functional richness (10%). Our results suggest that the environmental factors here analysed may be less important than biodiversity in shaping mesoscale (several km) biomass patterns in this Antarctic system. We suggest that further manipulative, hypothesis-driven research should address the role of biodiversity and species' functional traits in the responses of Antarctic subtidal communities to environmental variation.	[Valdivia, Nelson; Jose Diaz, Maria; Garrido, Ignacio; Gomez, Ivan] Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile	Universidad Austral de Chile	Valdivia, N (corresponding author), Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile.	nelson.valdivia@uach.cl	Valdivia, Nelson/C-3613-2009	Valdivia, Nelson/0000-0002-5394-2072; Gomez, Ivan/0000-0001-8381-3792	Programa de Investigacion Asociativa-Comision Nacional de Investigacion Cientifica y Tecnologica [ART1101]; Programa de Mejoramiento de la Calidad y la Equidad de la Educacion Superior [AUS0805]; Fondo Nacional de Desarrollo Cientifico y Tecnologico [1141037]	Programa de Investigacion Asociativa-Comision Nacional de Investigacion Cientifica y Tecnologica; Programa de Mejoramiento de la Calidad y la Equidad de la Educacion Superior; Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This study was financially supported by the Programa de Investigacion Asociativa-Comision Nacional de Investigacion Cientifica y Tecnologica (www.conicyt.cl) grant # ART1101 to IG and NV. While writing, NV was supported by the Programa de Mejoramiento de la Calidad y la Equidad de la Educacion Superior (www.mecesup.cl), grant # AUS0805, and the Fondo Nacional de Desarrollo Cientifico y Tecnologico (www.conicyt.cl/fondecyt), grant # 1141037. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; AMSLER CD, 1995, PHYCOLOGIA, V34, P424, DOI 10.2216/i0031-8884-34-5-424.1; Amsler CD, 2014, J PHYCOL, V50, P1, DOI 10.1111/jpy.12137; Amsler MO, 2015, POLAR BIOL, V38, P1171, DOI 10.1007/s00300-015-1681-4; [Anonymous], 2014, R LANG ENV STAT COMP; ARNTZ WE, 1994, OCEANOGR MAR BIOL, V32, P241; Barnes DKA, 2011, CURR BIOL, V21, pR451, DOI 10.1016/j.cub.2011.04.012; Barnes DKA, 2007, RINGBINDUNG BRIT ANT; Bick A, 2013, POLAR BIOL, V36, P673, DOI 10.1007/s00300-013-1293-9; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Bremner J, 2006, J MARINE SYST, V60, P302, DOI 10.1016/j.jmarsys.2006.02.004; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Clarke Andrew, 1996, Antarctic Research Series, V70, P373; Deregibus D, 2015, PHOTOSYNTHETIC LIGHT; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Fridley JD, 2001, OIKOS, V93, P514, DOI 10.1034/j.1600-0706.2001.930318.x; Gomez I, 1997, MAR ECOL PROG SER, V148, P281, DOI 10.3354/meps148281; Gomez I, 2011, MAR ECOL PROG SER, V422, P77, DOI 10.3354/meps08937; Gomez I, 2009, BOT MAR, V52, P593, DOI 10.1515/BOT.2009.073; Hastie T., 1986, STAT SCI, V1, P297; Hector A, 2002, ECOL LETT, V5, P502, DOI 10.1046/j.1461-0248.2002.00337.x; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hubbell SP, 2006, ECOLOGY, V87, P1387, DOI 10.1890/0012-9658(2006)87[1387:NTATEO]2.0.CO;2; Huovinen P, 2013, POLAR BIOL, V36, P1319, DOI 10.1007/s00300-013-1351-3; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Jenkins A, 2010, NAT GEOSCI, V3, P468, DOI 10.1038/NGEO890; Johnston EL, 2007, POLAR BIOL, V30, P781, DOI 10.1007/s00300-006-0237-z; Kennicutt MC, 2014, NATURE, V512, P23, DOI 10.1038/512023a; Khim BK, 2007, ESTUAR COAST SHELF S, V73, P111, DOI 10.1016/j.ecss.2006.12.015; Kim D., 2001, SEASONALITY MARINE A; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Kloser H, 1996, HYDROBIOLOGIA, V333, P1, DOI 10.1007/BF00020959; Konar B, 2014, HYDROBIOLOGIA, V724, P91, DOI 10.1007/s10750-013-1727-y; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Marra G, 2011, COMPUT STAT DATA AN, V55, P2372, DOI 10.1016/j.csda.2011.02.004; MCCLINTOCK JB, 1994, MAR ECOL PROG SER, V111, P191, DOI 10.3354/meps111191; Molina-Montenegro MA, 2005, MAR ECOL PROG SER, V292, P173, DOI 10.3354/meps292173; Nonato EF, 2000, POLAR BIOL, V23, P580, DOI 10.1007/s003000000129; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Perez-Matus A, 2010, J EXP MAR BIOL ECOL, V388, P1, DOI 10.1016/j.jembe.2010.03.013; Petchey OL, 2002, P ROY SOC B-BIOL SCI, V269, P1721, DOI 10.1098/rspb.2002.2073; Quartino ML, 2013, PLOS ONE, V8; Sakurai Hiroshi, 1996, Proceedings of the NIPR Symposium on Polar Biology, V9, P231; Scrosati RA, 2011, ECOGRAPHY, V34, P151, DOI 10.1111/j.1600-0587.2010.06119.x; Sicinski J, 2011, DEEP-SEA RES PT II, V58, P30, DOI 10.1016/j.dsr2.2010.09.005; Smale DA, 2008, SCIENCE, V321, P371, DOI 10.1126/science.1158647; Smale DA, 2007, AUSTRAL ECOL, V32, P878, DOI 10.1111/j.1442-9993.2007.01776.x; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Stachowicz JJ, 2007, ANNU REV ECOL EVOL S, V38, P739, DOI 10.1146/annurev.ecolsys.38.091206.095659; Tegner M.J., 1987, Advances in Ecological Research, V17, P243, DOI 10.1016/S0065-2504(08)60247-0; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Valdivia N, 2009, J SEA RES, V61, P216, DOI 10.1016/j.seares.2008.12.001; Wahl M, 2013, BIOGEOSCIENCES, V10, P5227, DOI 10.5194/bg-10-5227-2013; WIENCKE C, 2002, SYNOPSES ANTARCTIC B, P239; Wiencke C., 2012, SEAWEED BIOL ECOLOGI, P265, DOI [10.1007/978-3-642-28451-9_13, DOI 10.1007/978-3-642-28451-9_13]; Wood SN, 2002, ECOL MODEL, V157, P157, DOI 10.1016/S0304-3800(02)00193-X; Worm B, 2003, TRENDS ECOL EVOL, V18, P628, DOI 10.1016/j.tree.2003.09.003; Wu X, 2014, ECOGRAPHY, P602; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Zacher K, 2009, BOT MAR, V52, P483, DOI 10.1515/BOT.2009.082	62	13	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138582	10.1371/journal.pone.0138582	http://dx.doi.org/10.1371/journal.pone.0138582			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381149	Green Published, gold, Green Submitted			2022-12-27	WOS:000361790200131
J	Clark, BR; White, ML; Royer, NK; Burlis, TL; DuPont, NC; Wallendorf, M; Racette, SB				Clark, B. Ruth; White, M. Leanne; Royer, Nathaniel K.; Burlis, Tamara L.; DuPont, Nicholas C.; Wallendorf, Michael; Racette, Susan B.			Obesity and Aerobic Fitness among Urban Public School Students in Elementary, Middle, and High School	PLOS ONE			English	Article							BLOOD-PRESSURE; ADOLESCENTS; CHILDREN; TRENDS; PREVALENCE; HEALTH; YOUTH	Aims and Objectives To assess the prevalence of cardiovascular disease risk among urban public school students through a collaborative school district and university partnership. Methods Children and adolescents in grades K-12 from 24 urban public schools participated in measurements of height, weight, and other health metrics during the 2009-2010 school year. Body mass index (BMI) percentiles and z-scores were computed for 4673 students. President's Challenge 1-mile endurance run was completed by 1075 students ages 9-19 years. Maximal oxygen consumption ((V)overdotO(2)max) was predicted using an age-, sex-, and BMI-specific formula to determine health-related fitness. Resting blood pressure (BP) was assessed in 1467 students. Regression analyses were used to compare BMI z-scores, fitness, and age-and sex-specific BP percentiles across grade levels. Chi-square tests were used to explore the effect of sex and grade-level on health-related outcomes. Results Based on BMI, 19.8% were categorized as overweight and 24.4% were obese. Included in the obese category were 454 students (9.7% of sample) classified with severe obesity. Using FITNESSGRAM criteria, 50.2% of students did not achieve the Healthy Fitness Zone (HFZ); the proportion of students in the Needs Improvement categories increased from elementary to middle school to high school. Male students demonstrated higher fitness than female students, with 61.4% of boys and only 35.4% of girls meeting HFZ standards. Elevated BP was observed among 24% of 1467 students assessed. Systolic and diastolic BP z-scores revealed low correlation with BMI z-scores. Conclusions A community-university collaboration identified obesity, severe obesity, overweight, and low aerobic fitness to be common risk factors among urban public school students.	[Clark, B. Ruth; Royer, Nathaniel K.; Burlis, Tamara L.; Racette, Susan B.] Washington Univ, Sch Med, Program Phys Therapy, St Louis, MO 63130 USA; [White, M. Leanne] St Louis Publ Sch, St Louis, MO USA; [DuPont, Nicholas C.; Wallendorf, Michael] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Clark, BR (corresponding author), Washington Univ, Sch Med, Program Phys Therapy, St Louis, MO 63130 USA.	clarkru@wustl.edu	Racette, Susan B/GLS-6669-2022; Racette, Susan/GXV-8800-2022	Racette, Susan B/0000-0002-6932-1887; 	Institute for Public Health at Washington University in St. Louis [0309-02]; St. Louis Community/University Health Research Partnerships grant	Institute for Public Health at Washington University in St. Louis; St. Louis Community/University Health Research Partnerships grant	This work was funded by 1) Institute for Public Health at Washington University in St. Louis [grant no. 0309-02] (https://publichealth.wustl.edu/); 2) St. Louis Community/University Health Research Partnerships grant (http://icts.wustl.edu/icts-researchers/funding/funding-opportunities/cuhrp).	[Anonymous], 2012, PUBLIC HEALTH UNDERS; [Anonymous], 2014, SAS PROGR 2000 GROWT; [Anonymous], 2002, VITAL HLTH STAT; Carnethon MR, 2005, JAMA-J AM MED ASSOC, V294, P2981, DOI 10.1001/jama.294.23.2981; Choose a Challenge: Physical Fitness Test Award Benchmarks Bloomington, 2014, PRES CHALL PROGR; Cummings DM, 2010, J OBES, V2010, DOI 10.1155/2010/195729; Day SE, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130439; Din-Dzietham R, 2007, CIRCULATION, V116, P1488, DOI 10.1161/CIRCULATIONAHA.106.683243; Falkner B, 2006, J PEDIATR-US, V148, P195, DOI 10.1016/j.jpeds.2005.10.030; Gahche Jaime, 2014, NCHS Data Brief, P1; Kelly AS, 2013, CIRCULATION, V128, P1689, DOI 10.1161/CIR.0b013e3182a5cfb3; Kohl HW, 2012, LANCET, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Meredith MD., 2010, FITNESSGRAM ACTIVITY; Missouri Department of Elementary and Secondary Education, MISS COMPR DAT SYST; National Physical Activity Plan Alliance, 2014, 2014 US REP CARD PHY; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Ostchega Y, 2009, AM J HYPERTENS, V22, P59, DOI 10.1038/ajh.2008.312; Plowman SA., 2013, FITNESSGRAM ACTIVITY, V3, P7; Plowman SA, 2006, J PHYS ACT HLTH S2, pS5; Raitakari OT, 2009, STROKE, V40, P1519, DOI 10.1161/STROKEAHA.108.525253; Redwine KM, 2012, J CLIN HYPERTENS, V14, P360, DOI 10.1111/j.1751-7176.2012.00663.x; Robbins JM, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.120118; Skinner AC, 2014, JAMA PEDIATR, V168, P561, DOI 10.1001/jamapediatrics.2014.21; Thompson M, 2013, PEDIATRICS, V131, P490, DOI 10.1542/peds.2012-3523; Tu WZ, 2011, HYPERTENSION, V58, P818, DOI 10.1161/HYPERTENSIONAHA.111.175695; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; Welk GJ, 2011, AM J PREV MED, V41, pS111, DOI 10.1016/j.amepre.2011.07.007	28	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138175	10.1371/journal.pone.0138175	http://dx.doi.org/10.1371/journal.pone.0138175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378914	gold, Green Submitted, Green Published			2022-12-27	WOS:000361769400064
J	He, XM; Lv, GH; Qin, L; Chang, SL; Yang, M; Yang, JJ; Yang, XD				He, Xuemin; Lv, Guanghui; Qin, Lu; Chang, Shunli; Yang, Min; Yang, Jianjun; Yang, Xiaodong			Effects of Simulated Nitrogen Deposition on Soil Respiration in a Populus euphratica Community in the Ebinur Lake Area, a Desert Ecosystem of Northwestern China	PLOS ONE			English	Article							RAINY AREA; MICROBIAL COMMUNITY; TROPICAL FOREST; CARBON STORAGE; N DEPOSITION; LIMITATION; RESPONSES; ADDITIONS; IMPACT; PRECIPITATION	One of the primary limiting factors for biological activities in desert ecosystems is nitrogen (N). This study therefore examined the effects of N and investigated the responses of an arid ecosystem to global change. We selected the typical desert plant Populus euphratica in a desert ecosystem in the Ebinur Lake area to evaluate the effects of N deposition on desert soil respiration. Three levels of N deposition (0, 37.5 and 112.5 kg-NI-ha-11(1) were randomly artificially provided to simulate natural N deposition. Changes in the soil respiration rates were measured from July to September in both 2010 and 2013, after N deposition in April 2010. The different levels of N deposition affected the total soil N, soil organic matter, soil C/N ratio, microorganism number, and microbial community structure and function. However, variable effects were observed over time in relation to changes in the magnitude of N deposition. Simulated high N deposition significantly reduced the soil respiration rate by approximately 23.6 2.5% (P<0.05), whereas low N deposition significantly increased the soil respiration rate by approximately 66.7 2.7% (P<0.05). These differences were clearer in the final growth stage (September). The different levels of N deposition had little effect on soil moisture, whereas N deposition significantly increased the soil temperature in the 0-5 cm layer (P<0.05). These results suggest that in the desert ecosystem of the Ebinur Lake area, N deposition indirectly changes the soil respiration rate by altering soil properties.	[He, Xuemin; Lv, Guanghui; Qin, Lu; Chang, Shunli; Yang, Min; Yang, Jianjun] Xinjiang Univ, Xinjiang Key Lab Oasis Ecol, Urumqi, Xinjiang, Peoples R China; [He, Xuemin; Lv, Guanghui; Qin, Lu; Chang, Shunli; Yang, Min; Yang, Jianjun; Yang, Xiaodong] Xinjiang Univ, Coll Resources & Environm Sci, Urumqi, Xinjiang, Peoples R China; [Qin, Lu] Xinjiang Acad Environm Protect Sci, Xinjiang Dept Environm Protect, Urumqi, Xinjiang, Peoples R China	Xinjiang University; Xinjiang University	Lv, GH (corresponding author), Xinjiang Univ, Xinjiang Key Lab Oasis Ecol, Urumqi, Xinjiang, Peoples R China.	ler@xju.edu.cn	yang, jian/HIK-0188-2022		International Science & Technology Cooperation Program of China [2010DFA92720]; Key Laboratory of the Xinjiang Uygur Autonomous Region [2015KL004]; National Natural Science Foundation of China [41571034]; State Key Program of National Natural Science of China [41130531]; Ministry of Education [IRT1180]	International Science & Technology Cooperation Program of China; Key Laboratory of the Xinjiang Uygur Autonomous Region; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); Ministry of Education	This work was supported by grants from the International Science & Technology Cooperation Program of China (2010DFA92720), the Open Project from Key Laboratory of the Xinjiang Uygur Autonomous Region (2015KL004), the National Natural Science Foundation of China (41571034), the State Key Program of National Natural Science of China (41130531), and the Ministry of Education Innovation Team Project (IRT1180). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AS, 2004, SOIL BIOL BIOCHEM, V36, P581, DOI 10.1016/j.soilbio.2003.12.002; Baez S, 2007, J ARID ENVIRON, V68, P640, DOI 10.1016/j.jaridenv.2006.06.011; Bowden RD, 2004, FOREST ECOL MANAG, V196, P43, DOI 10.1016/j.foreco.2004.03.011; Cao YuSong, 2006, Acta Agriculturae Universitatis Jiangxiensis, V28, P101; Chen WW, 2013, GEODERMA, V192, P335, DOI 10.1016/j.geoderma.2012.08.018; DeForest JL, 2004, SOIL SCI SOC AM J, V68, P132, DOI 10.2136/sssaj2004.1320; Deng Qi, 2009, Chinese Journal of Plant Ecology, V33, P1023, DOI 10.3773/j.issn.1005-264x.2009.06.002; Deng Xiao-wen, 2007, Shengtaixue Zazhi, V26, P1622; Di CH, 2010, J AGROENVIRONMENT SC, V29, P1601; Du ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087975; Fan HB, 2014, PLANT SOIL, V379, P361, DOI 10.1007/s11104-014-2076-y; Frey SD, 2004, FOREST ECOL MANAG, V196, P159, DOI 10.1016/j.foreco.2004.03.018; Giasson MA, 2013, ECOSPHERE, V4, DOI 10.1890/ES13.00183.1; Gundale MJ, 2014, GLOBAL CHANGE BIOL, V20, P276, DOI 10.1111/gcb.12422; Hooper DU, 1999, BIOGEOCHEMISTRY, V46, P247, DOI 10.1007/BF01007582; Huang YZ, 2009, IMPACTS SIMULATED NI; Institute of Soil Science in Chinese Academy of Sciences, 1978, AN SOIL PHYS CHEM; Kamble PN, 2014, SOIL BIOL BIOCHEM, V74, P11, DOI 10.1016/j.soilbio.2014.02.015; Kivimaki SK, 2013, ENVIRON EXP BOT, V90, P53, DOI 10.1016/j.envexpbot.2012.09.003; Lemanski K, 2014, SOIL BIOL BIOCHEM, V69, P38, DOI 10.1016/j.soilbio.2013.10.034; Li HM, 2010, IMPACTS SIMULATED NI; Li QT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079746; Li Ren-hong, 2010, Yingyong Shengtai Xuebao, V21, P1649; Liu XJ, 2011, ENVIRON POLLUT, V159, P2251, DOI 10.1016/j.envpol.2010.08.002; Liu XJ, 2010, J ARID LAND, V2, P137, DOI 10.3724/SP.J.1227.2010.00137; Lu Chao-Qun, 2007, Zhiwu Shengtai Xuebao, V31, P205; [雒守华 Luo Shouhua], 2010, [农业环境科学学报, Journal of Agro-Environment Science], V29, P1834; Luo Yand, 2006, SOIL RESP ENV; Ma Xu, 2006, Arid Land Geography, V29, P439; Maestrini B, 2014, BIOGEOSCIENCES DISCU, V11, P1, DOI DOI 10.5194/BGD-11-1-2014; Magill AH, 1997, ECOL APPL, V7, P402, DOI 10.1890/1051-0761(1997)007[0402:BROFET]2.0.CO;2; Matson PA, 1999, BIOGEOCHEMISTRY, V46, P67, DOI 10.1007/BF01007574; Midgley MG, 2014, BIOGEOCHEMISTRY, V117, P241, DOI 10.1007/s10533-013-9931-4; Mo J, 2008, GLOBAL CHANGE BIOL, V14, P403, DOI 10.1111/j.1365-2486.2007.01503.x; Mo JM, 2007, PLANT SOIL, V296, P125, DOI 10.1007/s11104-007-9303-8; Neff JC, 2002, NATURE, V419, P915, DOI 10.1038/nature01136; Pinder RW, 2013, BIOGEOCHEMISTRY, V114, P25, DOI 10.1007/s10533-012-9787-z; Pregitzer KS, 2008, GLOBAL CHANGE BIOL, V14, P142, DOI 10.1111/j.1365-2486.2007.01465.x; Reay DS, 2008, NAT GEOSCI, V1, P430, DOI 10.1038/ngeo230; Schaeffer SM, 2005, OECOLOGIA, V145, P425, DOI 10.1007/s00442-005-0140-2; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Schrumpf M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089364; Shen Ping, 1978, MICROBIOLOGY EXPT; Tietema A, 1998, FOREST ECOL MANAG, V101, P29, DOI 10.1016/S0378-1127(97)00122-9; Townsend AR, 1996, ECOL APPL, V6, P806, DOI 10.2307/2269486; Tu Li-hua, 2011, Yingyong Shengtai Xuebao, V22, P829; Tu Li-Hua, 2009, Chinese Journal of Plant Ecology, V33, P728, DOI 10.3773/j.issn.1005-264x.2009.04.011; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Wallenstein MD, 2006, FOREST ECOL MANAG, V222, P459, DOI 10.1016/j.foreco.2005.11.002; [魏书精 Wei Shujing], 2013, [生态环境学报, Ecology and Environmental Sciences], V22, P689; Wright RF, 1998, FOREST ECOL MANAG, V101, P1, DOI 10.1016/S0378-1127(97)00120-5; Xu Guoliang, 2005, Yingyong Shengtai Xuebao, V16, P1235; Yan CongWei, 2012, Research of Environmental Sciences, V25, P678; Yan LM, 2011, PLANT SOIL, V349, P227, DOI 10.1007/s11104-011-0864-1; Yu E. T., 2008, STUDY VAPOR TRANSFER; Zhang NY, 2013, SOIL BIOL BIOCHEM, V65, P96, DOI 10.1016/j.soilbio.2013.05.015; Zhang QM, 2012, J INEQUAL APPL, DOI 10.1186/1029-242X-2012-5; Zhou Xiao-Bing, 2010, Chinese Journal of Plant Ecology, V34, P1394, DOI 10.3773/j.issn.1005-264x.2010.12.005; [周晓兵 ZHOU Xiao-Bing], 2009, [生态学报, Acta Ecologica Sinica], V29, P3835	60	16	16	4	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137827	10.1371/journal.pone.0137827	http://dx.doi.org/10.1371/journal.pone.0137827			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379186	gold, Green Published, Green Submitted			2022-12-27	WOS:000361769400031
J	Maggio, S; Takeda, K; Stark, F; Meierovics, AI; Yabe, I; Cowley, SC				Maggio, Savannah; Takeda, Kazuyo; Stark, Felicity; Meierovics, Anda I.; Yabe, Idalia; Cowley, Siobhan C.			Control of Francisella tularensis Intracellular Growth by Pulmonary Epithelial Cells	PLOS ONE			English	Article							SYNTHASE GENE-EXPRESSION; NITRIC-OXIDE; REACTIVE NITROGEN; IFN-GAMMA; II CELLS; MURINE MACROPHAGES; IN-VITRO; SCHU S4; LUNG; ACTIVATION	The virulence of F. tularensis is often associated with its ability to grow in macrophages, although recent studies show that Francisella proliferates in multiple host cell types, including pulmonary epithelial cells. Thus far little is known about the requirements for killing of F. tularensis in the non-macrophage host cell types that support replication of this organism. Here we sought to address this question through the use of a murine lung epithelial cell line (TC-1 cells). Our data show that combinations of the cytokines IFN-gamma, TNF, and IL-17A activated murine pulmonary epithelial cells to inhibit the intracellular growth of the F. tularensis Live Vaccine Strain (LVS) and the highly virulent F. tularensis Schu S4 strain. Although paired combinations of IFN-gamma, TNF, and IL-17A all significantly controlled LVS growth, simultaneous treatment with all three cytokines had the greatest effect on LVS growth inhibition. In contrast, Schu S4 was more resistant to cytokine-induced growth effects, exhibiting significant growth inhibition only in response to all three cytokines. Since one of the main antimicrobial mechanisms of activated macrophages is the release of reactive nitrogen intermediates (RNI) via the activity of iNOS, we investigated the role of RNI and iNOS in Francisella growth control by pulmonary epithelial cells. NOS2 gene expression was significantly up-regulated in infected, cytokine-treated pulmonary epithelial cells in a manner that correlated with LVS and Schu S4 growth control. Treatment of LVS-infected cells with an iNOS inhibitor significantly reversed LVS killing in cytokine-treated cultures. Further, we found that mouse pulmonary epithelial cells produced iNOS during in vivo respiratory LVS infection. Overall, these data demonstrate that lung epithelial cells produce iNOS both in vitro and in vivo, and can inhibit Francisella intracellular growth via reactive nitrogen intermediates.	[Maggio, Savannah; Meierovics, Anda I.; Cowley, Siobhan C.] US FDA, Lab Mucosal Pathogens & Cellular Immunol, Div Bacterial Parasit & Allergen Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Takeda, Kazuyo] US FDA, Microscopy & Imaging Core Facil, Div Bacterial Parasit & Allergen Prod, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Stark, Felicity] Natl Res Council Canada, Human Hlth Therapeut Portfolio, Ottawa, ON K1A 0R6, Canada; [Yabe, Idalia] NHLBI, NIH, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); National Research Council Canada; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Cowley, SC (corresponding author), US FDA, Lab Mucosal Pathogens & Cellular Immunol, Div Bacterial Parasit & Allergen Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	siobhan.cowley@fda.hhs.gov	Stark, Felicity/AAT-2342-2021	Stark, Felicity/0000-0002-7547-8493; Cowley, Siobhan/0000-0003-3073-0269	FDA Medical Countermeasures Initiative	FDA Medical Countermeasures Initiative	This work was supported by the FDA Medical Countermeasures Initiative. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer LS, 2010, BIOCHEM BIOPH RES CO, V396, P246, DOI 10.1016/j.bbrc.2010.04.073; ANTHONY LSD, 1992, J IMMUNOL, V148, P1829; ASANO K, 1994, P NATL ACAD SCI USA, V91, P10089, DOI 10.1073/pnas.91.21.10089; BEATTY WL, 1994, INFECT IMMUN, V62, P3705, DOI 10.1128/IAI.62.9.3705-3711.1994; Binesse J, 2015, INFECT IMMUN, V83, P2255, DOI 10.1128/IAI.02488-14; Conlan J Wayne, 2004, Expert Rev Vaccines, V3, P307; Craven RR, 2008, INFECT IMMUN, V76, P2833, DOI 10.1128/IAI.00043-08; DENIS M, 1991, CELL IMMUNOL, V132, P150, DOI 10.1016/0008-8749(91)90014-3; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Edwards JA, 2010, MICROBIOL-SGM, V156, P327, DOI 10.1099/mic.0.031716-0; FORTIER AH, 1992, INFECT IMMUN, V60, P817, DOI 10.1128/IAI.60.3.817-825.1992; Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08; Hall JD, 2007, INFECT IMMUN, V75, P1034, DOI 10.1128/IAI.01254-06; Horzempa J, 2010, INFECT IMMUN, V78, P2607, DOI 10.1128/IAI.00134-10; KALINA M, 1992, AM J RESP CELL MOL, V6, P594, DOI 10.1165/ajrcmb/6.6.594; Kolls JK, 2008, NAT REV IMMUNOL, V8, P829, DOI 10.1038/nri2433; LIEW FY, 1990, J IMMUNOL, V145, P4306; Lin KY, 1996, CANCER RES, V56, P21; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; Lindgren H, 2005, MICROBES INFECT, V7, P467, DOI 10.1016/j.micinf.2004.11.020; Lindgren H, 2004, INFECT IMMUN, V72, P7172, DOI 10.1128/IAI.72.12.7172-7182.2004; Lindgren H, 2007, INFECT IMMUN, V75, P1303, DOI 10.1128/IAI.01717-06; Mason RJ, 2006, RESPIROLOGY, V11, pS12, DOI 10.1111/j.1440-1843.2006.00800.x; Paradkar PN, 2008, BLOOD, V112, P866, DOI 10.1182/blood-2007-12-126854; POLSINELLI T, 1994, J IMMUNOL, V153, P1238; Prolo C, 2014, BIOFACTORS, V40, P215, DOI 10.1002/biof.1150; Roy S, 2004, IMMUNOLOGY, V112, P471, DOI 10.1046/j.1365-2567.2004.01905.x; Toga H, 2001, EXP LUNG RES, V27, P485, DOI 10.1080/019021401750414029; Tsutsumi H, 1999, J LEUKOCYTE BIOL, V66, P99, DOI 10.1002/jlb.66.1.99; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yu JJ, 2008, INFECT IMMUN, V76, P4206, DOI 10.1128/IAI.01209-07; Yu JJ, 2007, BLOOD, V109, P3794, DOI 10.1182/blood-2005-09-010116; Zhang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039214	33	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138565	10.1371/journal.pone.0138565	http://dx.doi.org/10.1371/journal.pone.0138565			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379269	gold, Green Submitted, Green Published			2022-12-27	WOS:000361769400110
J	Nighot, MP; Nighot, PK; Ma, TY; Malinowska, DH; Shull, GE; Cuppoletti, J; Blikslager, AT				Nighot, Meghali P.; Nighot, Prashant K.; Ma, Thomas Y.; Malinowska, Danuta H.; Shull, Gary E.; Cuppoletti, John; Blikslager, Anthony T.			Genetic Ablation of the ClC-2 Cl-Channel Disrupts Mouse Gastric Parietal Cell Acid Secretion	PLOS ONE			English	Article							APICAL CANALICULAR MEMBRANE; MUCOSAL BARRIER FUNCTION; RECOMBINANT HUMAN CLC-2; MURINE SMALL-INTESTINE; KIR2.1 K+ CHANNELS; CHLORIDE CHANNEL; ARACHIDONIC-ACID; PORCINE ILEUM; BETA-SUBUNIT; PKA	The present studies were designed to examine the effects of ClC-2 ablation on cellular morphology, parietal cell abundance, H/K ATPase expression, parietal cell ultrastructure and acid secretion using WT and ClC-2(-/-) mouse stomachs. Cellular histology, morphology and proteins were examined using imaging techniques, electron microscopy and western blot. The effect of histamine on the pH of gastric contents was measured. Acid secretion was also measured using methods and secretagogues previously established to give maximal acid secretion and morphological change. Compared to WT, ClC-2(-/-) gastric mucosal histological organization appeared disrupted, including dilation of gastric glands, shortening of the gastric gland region and disorganization of all cell layers. Parietal cell numbers and H/K ATPase expression were significantly reduced by 34% (P<0.05) and 53% (P<0.001) respectively and cytoplasmic tubulovesicles appeared markedly reduced on electron microscopic evaluation without evidence of canalicular expansion. In WT parietal cells, ClC-2 was apparent in a similar cellular location as the H/K ATPase by immunofluorescence and appeared associated with tubulovesicles by immunogold electron microscopy. Histamine-stimulated [ H+] of the gastric contents was significantly (P<0.025) lower by 9.4 fold (89%) in the ClC-2(-/-) mouse compared to WT. Histamine/carbachol stimulated gastric acid secretion was significantly reduced (range 84-95%, P<0.005) in ClC-2(-/-) compared to WT, while pepsinogen secretion was unaffected. Genetic ablation of ClC-2 resulted in reduced gastric gland region, reduced parietal cell number, reduced H/K ATPase, reduced tubulovesicles and reduced stimulated acid secretion.	[Nighot, Meghali P.; Nighot, Prashant K.; Blikslager, Anthony T.] N Carolina State Univ, Coll Vet Med, Raleigh, NC 27695 USA; [Malinowska, Danuta H.; Shull, Gary E.; Cuppoletti, John] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Ma, Thomas Y.] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA	University of North Carolina; North Carolina State University; University System of Ohio; University of Cincinnati; University of New Mexico	Blikslager, AT (corresponding author), N Carolina State Univ, Coll Vet Med, Raleigh, NC 27695 USA.	anthony_blikslager@ncsu.edu		Blikslager, Anthony/0000-0002-0867-7310	Sucampo Pharmaceuticals Inc., Bethesda MD, USA; NIH NIDDK [DK43816]; Sucampo AG, Zug Switzerland; NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043816] Funding Source: NIH RePORTER	Sucampo Pharmaceuticals Inc., Bethesda MD, USA; NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Sucampo AG, Zug Switzerland; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by a grant to Anthony Blikslager from Sucampo Pharmaceuticals Inc., Bethesda MD, USA; by NIH NIDDK DK43816 grant to John Cuppoletti and Danuta H. Malinowska; and a grant to John Cuppoletti from Sucampo AG, Zug Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anson ML, 1932, J GEN PHYSIOL, V16, P59, DOI 10.1085/jgp.16.1.59; Aoyama F, 2011, BIOL PHARM BULL, V34, P813, DOI 10.1248/bpb.34.813; Bali MZ, 2001, AM J PHYSIOL-CELL PH, V280, pC1588, DOI 10.1152/ajpcell.2001.280.6.C1588; Beil W, 1998, PROSTAG LEUKOTR ESS, V59, P119, DOI 10.1016/S0952-3278(98)90090-4; Bosl MR, 2001, EMBO J, V20, P1289, DOI 10.1093/emboj/20.6.1289; Cuppoletti J, 2004, AM J PHYSIOL-CELL PH, V287, pC1173, DOI 10.1152/ajpcell.00528.2003; Cuppoletti J, 2004, J BIOL CHEM, V279, P21849, DOI 10.1074/jbc.M312567200; CUPPOLETTI J, 1993, AM J PHYSIOL, V264, pC1609, DOI 10.1152/ajpcell.1993.264.6.C1609; Cuppoletti J, 2001, AM J PHYSIOL-CELL PH, V281, pC46, DOI 10.1152/ajpcell.2001.281.1.C46; Cuppoletti J, 2014, AM J PHYSIOL-CELL PH, V307, pC479, DOI 10.1152/ajpcell.00077.2014; Cuppoletti J, 2013, CELL BIOCHEM BIOPHYS, V66, P53, DOI 10.1007/s12013-012-9406-6; Dykstra MJ, 1993, MANUAL APPL TECHNIQU; Forte JG, 2004, AM J PHYSIOL-CELL PH, V286, pC478, DOI 10.1152/ajpcell.00531.2003; Forte JG, 2010, ANNU REV PHYSIOL, V72, P273, DOI 10.1146/annurev-physiol-021909-135744; Franic TV, 2001, AM J PHYSIOL-GASTR L, V281, pG1502, DOI 10.1152/ajpgi.2001.281.6.G1502; Fujii T, 2009, J BIOL CHEM, V284, P619, DOI 10.1074/jbc.M806562200; Gyomorey K, 2000, AM J PHYSIOL-CELL PH, V279, pC1787, DOI 10.1152/ajpcell.2000.279.6.C1787; Gyomorey K, 2001, PFLUG ARCH EUR J PHY, V443, pS103, DOI 10.1007/s004240100654; ITO S, 1974, J CELL BIOL, V63, P364, DOI 10.1083/jcb.63.2.364; Jain RN, 2008, J CLIN INVEST, V118, P2459, DOI 10.1172/JCI33569; Jordt SE, 1997, EMBO J, V16, P1582, DOI 10.1093/emboj/16.7.1582; Lipecka J, 2002, AM J PHYSIOL-CELL PH, V282, pC805, DOI 10.1152/ajpcell.00291.2001; Malinowska DH, 2004, AM J PHYSIOL-CELL PH, V286, pC495, DOI 10.1152/ajpcell.00386.2003; MALINOWSKA DH, 1990, AM J PHYSIOL, V259, pG536, DOI 10.1152/ajpgi.1990.259.4.G536; MALINOWSKA DH, 1995, AM J PHYSIOL-CELL PH, V268, pC191, DOI 10.1152/ajpcell.1995.268.1.C191; Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V292, pG647, DOI 10.1152/ajpgi.00183.2006; Moeser AJ, 2004, GASTROENTEROLOGY, V127, P802, DOI 10.1053/j.gastro.2004.06.004; Murray CB, 1996, AM J PHYSIOL-LUNG C, V271, pL829, DOI 10.1152/ajplung.1996.271.5.L829; MURRAY CB, 1995, AM J RESP CELL MOL, V12, P597, DOI 10.1165/ajrcmb.12.6.7766424; Nehrke K, 2002, J BIOL CHEM, V277, P23604, DOI 10.1074/jbc.M202900200; Nighot M, 2012, WORLD J GASTROENTERO, V18, P4684, DOI 10.3748/wjg.v18.i34.4684; Nighot PK, 2010, AM J PHYSIOL-GASTR L, V299, pG449, DOI 10.1152/ajpgi.00520.2009; Nighot PK, 2009, EXP CELL RES, V315, P110, DOI 10.1016/j.yexcr.2008.10.001; Nishizawa T, 2000, J BIOL CHEM, V275, P11164, DOI 10.1074/jbc.275.15.11164; Olsen ML, J NEUROSCI, V23, P5572; Scarff KL, 1999, GASTROENTEROLOGY, V117, P605, DOI 10.1016/S0016-5085(99)70453-1; SCHOFIELD GC, 1979, J ANAT, V128, P669; Schultheis PJ, 1998, J CLIN INVEST, V101, P1243, DOI 10.1172/JCI1249; Sherry AM, 1997, AM J PHYSIOL-CELL PH, V273, pC384, DOI 10.1152/ajpcell.1997.273.2.C384; Sherry AM, 2001, AM J PHYSIOL-CELL PH, V280, pC1599, DOI 10.1152/ajpcell.2001.280.6.C1599; Sidani SM, 2007, J BIOL CHEM, V282, P6068, DOI 10.1074/jbc.M608427200; Spicer Z, 2000, J BIOL CHEM, V275, P21555, DOI 10.1074/jbc.M001558200; Takahashi Y, 2014, BIOL OPEN, V3, P12, DOI 10.1242/bio.20136205; Tewari KP, 2000, AM J PHYSIOL-CELL PH, V279, pC40, DOI 10.1152/ajpcell.2000.279.1.C40; THIEMANN A, 1992, NATURE, V356, P57, DOI 10.1038/356057a0; WOLOSIN JM, 1985, J MEMBRANE BIOL, V83, P261, DOI 10.1007/BF01868700; WOLOSIN JM, 1984, AM J PHYSIOL, V246, pC537, DOI 10.1152/ajpcell.1984.246.5.C537; Xu J, 2008, P NATL ACAD SCI USA, V105, P17955, DOI 10.1073/pnas.0800616105	48	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138174	10.1371/journal.pone.0138174	http://dx.doi.org/10.1371/journal.pone.0138174			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378782	gold, Green Published, Green Submitted			2022-12-27	WOS:000361769400063
J	Takagi, Y; Kinoshita, K; Ozaki, N; Seino, Y; Murata, Y; Oshida, Y; Hayashi, Y				Takagi, Yusuke; Kinoshita, Keita; Ozaki, Nobuaki; Seino, Yusuke; Murata, Yoshiharu; Oshida, Yoshiharu; Hayashi, Yoshitaka			Mice Deficient in Proglucagon-Derived Peptides Exhibit Glucose Intolerance on a High-Fat Diet but Are Resistant to Obesity	PLOS ONE			English	Article							RECEPTOR KNOCKOUT MICE; GLP-1 RECEPTOR; INSULIN-RESISTANCE; ENERGY-EXPENDITURE; ADIPOSE-TISSUE; GLUCAGON; HYPERGLUCAGONEMIA; THERMOGENESIS; HYPERGLYCEMIA; ANTAGONISM	Homozygous glucagon-GFP knock-in mice (Gcg(gfp/gfp)) lack proglucagon derived-peptides including glucagon and GLP-1, and are normoglycemic. We have previously shown that Gcg(gfp/gfp) show improved glucose tolerance with enhanced insulin secretion. Here, we studied glucose and energy metabolism in Gcg(gfp/gfp) mice fed a high-fat diet (HFD). Male Gcg(gfp/gfp) and Gcg(gfp/+) mice were fed either a normal chow diet (NCD) or an HFD for 15-20 weeks. Regardless of the genotype, mice on an HFD showed glucose intolerance, and Gcg(gfp/gfp) mice on HFD exhibited impaired insulin secretion whereas Gcg(gfp/+) mice on HFD exhibited increased insulin secretion. A compensatory increase in b-cell mass was observed in Gcg(gfp/+) mice on HFD, but not in Gcg(gfp/gfp) mice on the same diet. Weight gain was significantly lower in Gcg(gfp/gfp) mice than in Gcg(gfp/+) mice. Oxygen consumption was enhanced in Gcg(gfp/gfp) mice compared to Gcg(gfp/+) mice on an HFD. HFD feeding significantly increased uncoupling protein 1 mRNA expression in brown adipose and inguinal white adipose tissues of Gcg(gfp/gfp) mice, but not of Gcg(gfp/+) mice. Treatment with the glucagon-like peptide-1 receptor agonist liraglutide (200 mg/kg) improved glucose tolerance in Gcg(gfp/gfp) mice and insulin content in Gcg(gfp/gfp) and Gcg(gfp/+) mice was similar after liraglutide treatment. Our findings demonstrate that Gcg(gfp/gfp) mice develop diabetes upon HFD-feeding in the absence of proglucagon-derived peptides, although they are resistant to diet-induced obesity.	[Takagi, Yusuke; Kinoshita, Keita; Ozaki, Nobuaki; Oshida, Yoshiharu] Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Nagoya, Aichi 4648601, Japan; [Takagi, Yusuke; Kinoshita, Keita; Murata, Yoshiharu; Hayashi, Yoshitaka] Nagoya Univ, Environm Med Res Inst, Div Stress Adaptat & Recognit, Dept Genet, Nagoya, Aichi 4648601, Japan; [Seino, Yusuke] Nagoya Univ, Sch Med, Dept Metab Med, Nagoya, Aichi 466, Japan	Nagoya University; Nagoya University; Nagoya University	Ozaki, N (corresponding author), Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Nagoya, Aichi 4648601, Japan.	n-ozaki@med.nagoya-u.ac.jp	Hayashi, Yoshitaka/I-6168-2014	Hayashi, Yoshitaka/0000-0002-7557-4303; Kinoshita, Keita/0000-0001-8373-1789	Japan Society for the Promotion of Science [22590974, 24659451]; Ministry of Education, Culture, Sports, Science, and Technology [23122507, 25122708]; Grants-in-Aid for Scientific Research [15K15356] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (22590974 to NO and 24659451 to YH), and by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (23122507 and 25122708 to YH).	Abegg K, 2013, PHYSIOL BEHAV, V121, P70, DOI 10.1016/j.physbeh.2013.03.027; Auffret J, 2012, FASEB J, V26, P3728, DOI 10.1096/fj.12-204958; Ayala JE, 2010, ENDOCRINOLOGY, V151, P4678, DOI 10.1210/en.2010-0289; BARON AD, 1987, DIABETES, V36, P274, DOI 10.2337/diabetes.36.3.274; Basu A, 1996, J CLIN INVEST, V97, P2351, DOI 10.1172/JCI118678; Bradley DP, 2012, APPL PHYSIOL NUTR ME, V37, P893, DOI [10.1139/H2012-068, 10.1139/h2012-068]; Buteau J, 2008, DIABETES METAB, V34, pS73, DOI 10.1016/S1262-3636(08)73398-6; BUTLER PC, 1991, DIABETES, V40, P73, DOI 10.2337/diabetes.40.1.73; Chatzigeorgiou A, 2014, OBES REV; Conarello SL, 2007, DIABETOLOGIA, V50, P142, DOI 10.1007/s00125-006-0481-3; Fukami A, 2013, DIABETES, V62, P510, DOI 10.2337/db12-0294; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Habegger KM, 2010, NAT REV ENDOCRINOL, V6, P689, DOI 10.1038/nrendo.2010.187; Hansotia T, 2004, DIABETES, V53, P1326, DOI 10.2337/diabetes.53.5.1326; Hansotia T, 2007, J CLIN INVEST, V117, P143, DOI 10.1172/JCI25483; Hayashi Y, 2009, MOL ENDOCRINOL, V23, P1990, DOI 10.1210/me.2009-0296; Heppner KM, 2010, PHYSIOL BEHAV, V100, P545, DOI 10.1016/j.physbeh.2010.03.019; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; JOHNSON DG, 1982, SCIENCE, V215, P1115, DOI 10.1126/science.6278587; Jun LS, 2015, DIABETES, V64, P819, DOI 10.2337/db14-1052; Kanoski SE, 2011, ENDOCRINOLOGY, V152, P3103, DOI 10.1210/en.2011-0174; Kinoshita K, 2014, ENDOCRINOLOGY, V155, P3484, DOI 10.1210/en.2014-1175; Knauf C, 2008, ENDOCRINOLOGY, V149, P4768, DOI 10.1210/en.2008-0180; Lamont BJ, 2012, J CLIN INVEST, V122, P388, DOI 10.1172/JCI42497; Larsson H, 2000, DIABETES CARE, V23, P650, DOI 10.2337/diacare.23.5.650; Lee Y, 2011, DIABETES, V60, P391, DOI 10.2337/db10-0426; Li XC, 2013, CURR HYPERTENS REP, V15, P522, DOI 10.1007/s11906-013-0383-y; Lo KA, 2013, BIOSCIENCE REP, V33, P711, DOI 10.1042/BSR20130046; Lockie SH, 2013, ADIPOCYTE, V2, P196, DOI 10.4161/adip.25417; Mu J, 2011, DIABETOLOGIA, V54, P2381, DOI 10.1007/s00125-011-2217-2; Omar BA, 2014, DIABETES, V63, P101, DOI 10.2337/db13-0710; Osaka T, 2005, PEPTIDES, V26, P1623, DOI 10.1016/j.peptides.2005.02.016; Parker JC, 2002, BIOCHEM BIOPH RES CO, V290, P839, DOI 10.1006/bbrc.2001.6265; Peschechera A, 2013, ARCH PHYSIOL BIOCHEM, V119, P151, DOI 10.3109/13813455.2013.796995; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Sachdeva MM, 2009, MOL ENDOCRINOL, V23, P747, DOI 10.1210/me.2008-0400; Sakamoto E, 2012, J DIABETES INVEST, V3, P432, DOI 10.1111/j.2040-1124.2012.00208.x; Sakamoto T, 2013, AM J PHYSIOL-CELL PH, V304, pC729, DOI 10.1152/ajpcell.00312.2012; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; VanTine BA, 1996, ENDOCRINOLOGY, V137, P3316, DOI 10.1210/en.137.8.3316; Watanabe C, 2012, DIABETES, V61, P74, DOI 10.2337/db11-0739; Winzell MS, 2007, DIABETOLOGIA, V50, P1453, DOI 10.1007/s00125-007-0675-3	42	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138322	10.1371/journal.pone.0138322	http://dx.doi.org/10.1371/journal.pone.0138322			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378455	Green Submitted, gold, Green Published			2022-12-27	WOS:000361769400083
J	Alt, KW; Benz, M; Vach, W; Simmons, TL; Goring-Morris, AN				Alt, Kurt W.; Benz, Marion; Vach, Werner; Simmons, Tal L.; Goring-Morris, A. Nigel			Insights into the Social Structure of the PPNB Site of Kfar HaHoresh, Israel, Based on Dental Remains	PLOS ONE			English	Article							VARIABILITY; AGE	One of the central questions of the transition from mobile hunter-gatherers to sedentary farming communities concerns the establishment of new social structures and group identities. Along with other important factors, such as territory, ideology or economy, biological relationships might have played a decisive role in defining social groups. We therefore systematically analyzed teeth and jaw remains from nine sites in the Near East dating from the Natufian to the Late PPNB as primary proxy data for the reconstruction of familial relationships. This paper presents the results of morphological analyses on the teeth of the individuals from Kfar HaHoresh, one of the investigated Pre-Pottery Neolithic B sites. Kfar HaHoresh is located in the Nazareth hills of Galilee (32 degrees 42'20 '' N 35 degrees 16'28 '' E), Israel. Different statistical methods were applied to our data of epigenetic traits with the aim of determining biological relationships within the community, whereby the data of the eight other sites were used as cross-references. Our comparison of the traits of all individuals from Kfar HaHoresh indicates a rather heterogeneous community, but clearly shows one cluster belonging to a quite homogenous group, suggesting close biological relations between females and sub-adults. Interestingly, none of the male individuals belongs to this cluster, although their number outweighs that of the female individuals. This might suggest matrilocal residence patterns. However, due to the incomplete preservation of the teeth along with several other uncertainties, our conclusion must be seen as preliminary. A cross-examination of the results on skeletons excavated after our investigation should also be taken into consideration.	[Alt, Kurt W.] Danube Private Univ, Ctr Nat & Cultural Hist Teeth, Krems Stein, Austria; [Alt, Kurt W.] Univ Basel, IPAS, Basel, Switzerland; [Alt, Kurt W.] Saxony Anhalt & Heritage Museum, State Off Heritage Management & Archaeol, Halle, Germany; [Benz, Marion] Univ Freiburg, Dept Near Eastern Archaeol, D-79106 Freiburg, Germany; [Vach, Werner] Univ Freiburg, Univ Med Ctr, Ctr Med Biometry & Med Informat, D-79106 Freiburg, Germany; [Simmons, Tal L.] Hebrew Univ Jerusalem, Inst Adv Studies, Jerusalem, Israel; [Goring-Morris, A. Nigel] Hebrew Univ Jerusalem, Inst Archaeol, Jerusalem, Israel	University of Basel; University of Freiburg; University of Freiburg; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Alt, KW (corresponding author), Danube Private Univ, Ctr Nat & Cultural Hist Teeth, Krems Stein, Austria.	kurt.alt@dp-uni.ac.at	Simmons, Tal/AAD-9780-2019; Vach, Werner/F-2512-2011	Vach, Werner/0000-0003-1865-8399; Goring-Morris, Adrian Nigel/0000-0003-1673-7747	Eliteprogramme for Postdocs; Baden-Wurttemberg Stiftung; Irene Levi-Sala CARE Foundation; National Geographic Society [8625/09]; Israel Science Foundation (Israel Academy of Sciences and Humanities) [840/01, 558/04, 755/07, 1161/10]	Eliteprogramme for Postdocs; Baden-Wurttemberg Stiftung; Irene Levi-Sala CARE Foundation; National Geographic Society(National Geographic Society); Israel Science Foundation (Israel Academy of Sciences and Humanities)(Israel Science Foundation)	The SIGN-Project ("Social Identities of Neolithic Groups in the Near East") was funded by the "Eliteprogramme for Postdocs" (2007-2009). MB is indebted to the Baden-Wurttemberg Stiftung for this generous support (http://www.bwstiftung.de). Investigations at Kfar HaHoresh have been funded by generous grants (to ANGM) from the Irene Levi-Sala CARE Foundation (http://prehistory.org.il/?page_id=894), the National Geographic Society (Grant #8625/09) (www.nationalgeographic.com) and the Israel Science Foundation (Israel Academy of Sciences and Humanities Grants #840/01, #558/04, #755/07 and #1161/10) (www.isf.org.il). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersen V., 1988, ACTA REGIAE SOC HUMA, V79, P106; Alt K. W., 1997, ODONTOLOGISCHE VERWA; Alt KW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065649; ALT KW, 1995, FORENSIC SCI INT, V74, P99, DOI 10.1016/0379-0738(95)01740-A; Alt KW, 1998, DENTAL ANTHROPOLOGY, P537; Alt KW, 1996, HOMO, V46, P256; Alt KW, 2004, BASLER HEFTE ARCHAOL, V3; Alt KW, 1997, CAHIERS ASS PROMOTIO, P1; [Anonymous], 2004, MONOGRAPH FACULTY AR; Arensburg B., 1989, BAR INT SERIES, V508, P115; Belfer-Cohen A., 1988, PALEORIENT, V14, P297, DOI DOI 10.3406/PALE0.1988.4476; Belfer-Cohen A, 2013, NATUFIAN CULTURE LEV, VII, P554; Bentley AR, 2012, P NATL ACAD SCI USA, V109, DOI [10.1073/pnas, DOI 10.1073/PNAS]; Benz M., 2010, STUDIES EARLY NEAR E, V14, P249; Bienert H. D., 1991, J PREHISTORIC RELIG, V5, P9; Birkenfeld M, 2015, ARCHAEOLOGICAL REV C, V30, P95; Biton R, 2014, J ARCHAEOL SCI, V41, P740, DOI 10.1016/j.jas.2013.10.005; Bonogofsky M, 2006, BAR INT SERIES, V1539; Bouwman AS, 2009, ANNU BRIT SCH ATHENS, V104, P291; Boyd B, 2006, WORLD ARCHAEOL, V38, P164, DOI 10.1080/00438240600688398; Buikstra J, 1994, ARKAN; Cucina A., 2014, ARCHAEOLOGY BIOARCHA; Diaz E, 2014, COLOMB MEDICA, V45, P15; Dunbar Robin I. M., 2013, NEOLITHICS, V2, P25; Fernandez E, 2013, MEMORIA CIENTIFICA, P470; Fernandez E, 2006, ANALISIS GENETICO PO, V83, P07; Finlayson B., 2011, PALE ORIENT, V37, P123; Flannery KV, 2002, AM ANTIQUITY, V67, P417, DOI 10.2307/1593820; FLANNERY KV, 1972, MAN SETTLEMENT URBAN, P23; Garfinkel Y., 2006, J ISRAEL PREHISTORIC, V36, P109; Gebel HGK., 2002, THESIS U LIB FREIBUR; Gopher A., 1990, J ISRAEL PREHISTORIC, V23, P9; Goren Y, 2001, J ARCHAEOL SCI, V28, P671, DOI 10.1006/jasc.1999.0573; Goring-Morris, 2008, PALEORIENT, V34, P91; Goring-Morris A. N., 1998, NEOLITHICS, V3, P1; Goring-Morris A.N., 2014, NEOLITHIC TRANSITION, P59; Goring-Morris A.N., 2000, LIFE NEOLITHIC FARMI, P103, DOI DOI 10.1007/0-306-47166-3_5; Goring-Morris A. N., 2008, NEW ENCY ARCHAEOLOGI, V5, P1907; Goring-Morris A. N., 2008, ANTIQUITY, V82; Goring-Morris A.N., 2005, ARCHAEOLOGICAL PERSP, P89; Goring-Morris AN, 2008, NEOLITHIC DEMOGRAPHIC TRANSITION AND ITS CONSEQUENCES, P239, DOI 10.1007/978-1-4020-8539-0_10; Goring-Morris AN, 2008, NEOLITHICS, V2, P17; Goring-Morris AN, 2007, ANTIQUITY, V81, P1; Haak W, 2008, P NATL ACAD SCI USA, V105, P18226, DOI 10.1073/pnas.0807592105; Hanihara K., 1997, OROFACIAL GROWTH DEV, P195; Hauser G., 1989, EPIGENETIC VARIANTS; Hughes T., 2013, ANTHR PERSPECTIVES T, P31, DOI [10.1017/CBO9780511984464.003, DOI 10.1017/CBO9780511984464.003]; Kuijt I, 1996, J ANTHROPOL ARCHAEOL, V15, P313, DOI 10.1006/jaar.1996.0012; Kuijt I., 2001, LIFE NEOLITHIC FARMI, P311; Leroux H, 2012, THESIS LEIDEN U LEID; Lukacs J R, 1987, Anthropol Anz, V45, P97; Meyer C, 2012, BAR INT SER, V2325, P11; MIZOGUCHI Y, 1977, J ANTHROPOL SOC NIP, V85, P301; Molleson TI, 2000, VILLAGE EUPHRATES, P533; NICHOL CR, 1989, AM J PHYS ANTHROPOL, V78, P37, DOI 10.1002/ajpa.1330780106; Nirmala SVSG, 2013, CONTEMP CLIN DENT, V4, P349, DOI 10.4103/0976-237X.118338; PILLOUD MA, 2009, THESIS OHIO STATE U; Pilloud MA, 2011, AM J PHYS ANTHROPOL, V145, P519, DOI 10.1002/ajpa.21520; Renfrew Colin, 2013, NEOLITHICS, V13, P30; Rohrer-Ertl O, 1978, NEOLITHISCHE REVOLUT; Rollefson G. O., 1983, PALEORIENT, V9, P29, DOI [DOI 10.3406/paleo.1983.4339, DOI 10.3406/PALE0.1983.4339]; Rollefson G. O., 1986, PALEORIENT, V12, P45, DOI DOI 10.3406/paleo.1986.4397; Rollefson G. O., 2000, LIFE NEOLITHIC FARMI, P165; Rollefson GO., 2010, STUDIES EARLY NEAR E, V14, P182; Rosing F, 1990, QUBBET HAWA ELEPHANT; Saunders S.R., 1989, RECONSTRUCTION LIFE, P95; Saunders SR, 1998, RECONSTRUCTION LIFE, P95; Schulze C., 1987, ANOMALIEN MISSBILDUN; Scott GR, 2013, ANTHR PERSPECTIVE TO; Scott GR, 2008, BIOL ANTHR HUMAN SKE, P265, DOI DOI 10.1002/9780470245842; Scott GR, 1973, THEISS TEMPE; SCOTT GR, 1982, TEETH FORM FUNCTION, P259; Scott GR., 1984, ANTHROPOLOGIE, V22, P223, DOI [10.1080/03014460.2022.2032339, DOI 10.1080/03014460.2022.2032339]; Simmons AH, 2007, NEOLITHIC REVOLUTION; Simmons T., 2007, BAR INT SERIES, V1603, P1; Slon V, PLOS ONE, V9, DOI DOI 10.1371/J0URNAL.P0NE.0089242; Stojanowski CM, 2006, YEARB PHYS ANTHROPOL, V49, P49, DOI 10.1002/ajpa.20517; Stordeur D., 2007, SYRIA, V84, P5, DOI DOI 10.4000/SYRIA.321; TOWNSEND G, 1990, AM J PHYS ANTHROPOL, V82, P267, DOI 10.1002/ajpa.1330820305; VACH W, 1993, COMPUTING PAST, P287; Van Tuinen M, 2005, BRIT I ARCHAEOLOGY A, V38, P307; Verhoeven M., 2002, PALEORIENT, V28, P5, DOI DOI 10.3406/PALEO.2002.4735; Watkins T., 2010, LEVANT SUPPLEMENTARY, V8, P106; Wiltschke-Schrotta K, 1988, THESIS U VIENNA	84	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0134528	10.1371/journal.pone.0134528	http://dx.doi.org/10.1371/journal.pone.0134528			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CR8NH	26376321	Green Published, gold, Green Submitted			2022-12-27	WOS:000361610200005
J	d'Ettorre, G; Ceccarelli, G; Giustini, N; Serafino, S; Calantone, N; De Girolamo, G; Bianchi, L; Bellelli, V; Ascoli-Bartoli, T; Marcellini, S; Turriziani, O; Brenchley, JM; Vullo, V				d'Ettorre, Gabriella; Ceccarelli, Giancarlo; Giustini, Noemi; Serafino, Sara; Calantone, Nina; De Girolamo, Gabriella; Bianchi, Luigi; Bellelli, Valeria; Ascoli-Bartoli, Tommaso; Marcellini, Sonia; Turriziani, Ombretta; Brenchley, Jason M.; Vullo, Vincenzo			Probiotics Reduce Inflammation in Antiretroviral Treated, HIV-Infected Individuals: Results of the "Probio-HIV" Clinical Trial	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MUCOSAL IMMUNE RECONSTITUTION; REGULATORY T-CELLS; MICROBIAL TRANSLOCATION; DOUBLE-BLIND; IN-VIVO; ACTIVATION; THERAPY; COAGULATION; DECLINE	Background HIV infection results in damage to the gastrointestinal (GI) tract, microbial translocation and immune activation. These are not completely normalized with combined antiretroviral therapy (cART). Moreover, increate morbidity and mortality of cART-treated HIV-infected individuals is associated with inflammation. Methods In order to enhance GI tract immunity, we recruited and treated 20 HIV-infected humans with cART supplemented with probiotics and followed inflammation and immunological parameters (clinical trial number NCT02164344). 11 HIV seronegative subjects were included as control group. The enumeration of CD4+, CD8+, CD38+ and HLA-DR+ lymphocytes were evaluated on peripheral blood; HIV-RNA levels, sCD14, d-dimer, C-reactive protein (CRP) high sensitivity C-reactive protein (hsCRP), IL-6 and Lipopolysaccharide Binding Protein (LBP) were assayed on plasma. Results We observe that cART does not normalize the levels of immune activation in HIV positive patients anyway inflammation and markers of microbial translocation were significantly reduced with probiotic supplementation. Patients show a clear and statistically significant reduction in the levels of immune activation on CD4 T-lymphocytes, for both markers CD38 and HLA-DR and their simultaneous expression, LBP and hsCRP plasma levels after probiotic diet supplementation settling to values comparable to controls. Conclusions Supplementing cART with probiotics in HIV-infected individuals may improve GI tract immunity and there by mitigate inflammatory sequelae, ultimately improving prognosis.	[d'Ettorre, Gabriella; Ceccarelli, Giancarlo; Giustini, Noemi; Serafino, Sara; De Girolamo, Gabriella; Bianchi, Luigi; Bellelli, Valeria; Ascoli-Bartoli, Tommaso; Marcellini, Sonia; Vullo, Vincenzo] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, I-00185 Rome, Italy; [Turriziani, Ombretta] Univ Roma La Sapienza, Dept Virol, I-00185 Rome, Italy; [Calantone, Nina; Brenchley, Jason M.] NIAID, Program Barrier Immun & Repair, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA	Sapienza University Rome; Sapienza University Rome; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Ceccarelli, G (corresponding author), Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	giancarlo.ceccarelli@uniroma1.it	Brenchley, Jason/AAC-5085-2019; Ceccarelli, Giancarlo/ABD-8347-2020; Ceccarelli, Giancarlo/K-6454-2016; d'Ettorre, Gabriella/K-4511-2016	Ceccarelli, Giancarlo/0000-0001-5921-3180; Ceccarelli, Giancarlo/0000-0001-5921-3180; d'Ettorre, Gabriella/0000-0002-3571-5677; Calantone Lund, Nina/0000-0001-7491-7071; Brenchley, Jason/0000-0001-8357-2984	Division of Intramural Research / National Institute of Allergy and Infectious Diseases (NIAID) / National Institutes of Health (NIH)	Division of Intramural Research / National Institute of Allergy and Infectious Diseases (NIAID) / National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this study (NC) was provided in part by the Division of Intramural Research / National Institute of Allergy and Infectious Diseases (NIAID) / National Institutes of Health (NIH).	Anukam KC, 2008, J CLIN GASTROENTEROL, V42, P239, DOI 10.1097/MCG.0b013e31802c7465; Belmonte L, 2007, AIDS, V21, P2106, DOI 10.1097/QAD.0b013e3282efb74b; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Cahn P, 2013, CLIN INFECT DIS, V57, P139, DOI 10.1093/cid/cit171; d'Ettorre G, 2011, AIDS RES HUM RETROV, V27, P355, DOI 10.1089/aid.2010.0342; d'Ettorre G, 2011, CURR HIV RES, V9, P148, DOI 10.2174/157016211795945296; Dai C, 2012, INT J MOL MED, V29, P202, DOI 10.3892/ijmm.2011.839; de Roock S, 2010, CLIN EXP ALLERGY, V40, P103, DOI 10.1111/j.1365-2222.2009.03344.x; Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; French MA, 2009, J INFECT DIS, V200, P1212, DOI 10.1086/605890; Funderburg NT, 2010, BLOOD, V115, P161, DOI 10.1182/blood-2009-03-210179; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Goicoechea M, 2006, J INFECT DIS, V194, P29, DOI 10.1086/504718; Gori A, 2011, MUCOSAL IMMUNOL, V4, P554, DOI 10.1038/mi.2011.15; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Hummelen R, 2011, GUT MICROBES, V2, P80, DOI 10.4161/gmic.2.2.15787; Hunt PW, 2014, J INFECT DIS, V210, P1228, DOI 10.1093/infdis/jiu238; Hunt PW, 2012, CURR HIV-AIDS REP, V9, P139, DOI 10.1007/s11904-012-0118-8; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Ipp H, 2014, CRIT REV CL LAB SCI, V51, P98, DOI 10.3109/10408363.2013.865702; Irvine SL, 2011, NUTR RES, V31, P875, DOI 10.1016/j.nutres.2011.10.005; Lane H Clifford, 2010, Top HIV Med, V18, P2; Mavigner M, 2012, J CLIN INVEST, V122, P62, DOI 10.1172/JCI59011; Mehandru S, 2006, PLOS MED, V3, P2335, DOI 10.1371/journal.pmed.0030484; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Monachese M, 2011, GUT MICROBES, V2, P198, DOI 10.4161/gmic.2.3.16106; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Prendergast A, 2010, AIDS, V24, P491, DOI 10.1097/QAD.0b013e3283344895; Rodger AJ, 2009, J INFECT DIS, V200, P973, DOI 10.1086/605447; Sandler NG, 2012, NAT REV MICROBIOL, V10, P655, DOI 10.1038/nrmicro2848; Smith K, 2004, AIDS, V18, P1953, DOI 10.1097/00002030-200409240-00012; Villar-Garcia J, 2015, JAIDS-J ACQ IMM DEF, V68, P256, DOI 10.1097/QAI.0000000000000468; Wittkop L, 2013, J INFECT DIS, V207, P622, DOI 10.1093/infdis/jis732	34	93	95	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137200	10.1371/journal.pone.0137200	http://dx.doi.org/10.1371/journal.pone.0137200			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376436	Green Published, gold, Green Submitted			2022-12-27	WOS:000361610200032
J	Garlapow, ME; Huang, W; Yarboro, MT; Peterson, KR; Mackay, TFC				Garlapow, Megan E.; Huang, Wen; Yarboro, Michael T.; Peterson, Kara R.; Mackay, Trudy F. C.			Quantitative Genetics of Food Intake in Drosophila melanogaster	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; GENOME-WIDE ASSOCIATION; SINGLE-NUCLEOTIDE POLYMORPHISMS; ADIPOSE-TISSUE DEVELOPMENT; INSULIN-PRODUCING CELLS; SHORT NEUROPEPTIDE-F; FEEDING-BEHAVIOR; DEVELOPMENTAL STABILITY; TRANSCRIPTION FACTORS; DIABETIC-NEPHROPATHY	Food intake is an essential animal activity, regulated by neural circuits that motivate food localization, evaluate nutritional content and acceptance or rejection responses through the gustatory system, and regulate neuroendocrine feedback loops that maintain energy homeostasis. Excess food consumption in people is associated with obesity and metabolic and cardiovascular disorders. However, little is known about the genetic basis of natural variation in food consumption. To gain insights in evolutionarily conserved genetic principles that regulate food intake, we took advantage of a model system, Drosophila melanogaster, in which food intake, environmental conditions and genetic background can be controlled precisely. We quantified variation in food intake among 182 inbred, sequenced lines of the Drosophila melanogaster Genetic Reference Panel (DGRP). We found significant genetic variation in the mean and within-line environmental variance of food consumption and observed sexual dimorphism and genetic variation in sexual dimorphism for both food intake traits (mean and variance). We performed genome wide association (GWA) analyses for mean food intake and environmental variance of food intake (using the coefficient of environmental variation, CVE, as the metric for environmental variance) and identified molecular polymorphisms associated with both traits. Validation experiments using RNAi-knockdown confirmed 24 of 31 (77%) candidate genes affecting food intake and/or variance of food intake, and a test cross between selected DGRP lines confirmed a SNP affecting mean food intake identified in the GWA analysis. The majority of the validated candidate genes were novel with respect to feeding behavior, and many had mammalian orthologs implicated in metabolic diseases.	[Garlapow, Megan E.; Huang, Wen; Mackay, Trudy F. C.] N Carolina State Univ, Genet Program, Raleigh, NC 27695 USA; [Garlapow, Megan E.; Huang, Wen; Yarboro, Michael T.; Peterson, Kara R.; Mackay, Trudy F. C.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Garlapow, Megan E.; Huang, Wen; Mackay, Trudy F. C.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Mackay, TFC (corresponding author), N Carolina State Univ, Genet Program, Raleigh, NC 27695 USA.	trudy_mackay@ncsu.edu		Huang, Wen/0000-0001-6788-8364	National Institute of General Medical Sciences [R01 GM45146]; National Institute on Alcohol Abuse and Alcoholism [R01 AA016560]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016560] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Institute of General Medical Sciences R01 GM45146 to TFCM, and by the National Institute on Alcohol Abuse and Alcoholism R01 AA016560 to TFCM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI H, 1995, J ENDOCRINOL, V146, P381, DOI 10.1677/joe.0.1460381; Aguilera CM, 2015, INT J MOL SCI, V16, P7723, DOI 10.3390/ijms16047723; Al-Anzi B, 2006, CURR BIOL, V16, P1034, DOI 10.1016/j.cub.2006.04.002; Al-Anzi B, 2010, CURR BIOL, V20, P969, DOI 10.1016/j.cub.2010.04.039; Al-Anzi B, 2009, NEURON, V63, P329, DOI 10.1016/j.neuron.2009.07.021; Andres SF, 2015, AM J PHYSIOL-GASTR L, V308, pG100, DOI 10.1152/ajpgi.00287.2014; Ansel J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000049; Ayroles JF, 2015, P NATL ACAD SCI USA, V112, P6706, DOI 10.1073/pnas.1503830112; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; Azadbakht L, 2013, INT J FOOD SCI NUTR, V64, P392, DOI 10.3109/09637486.2012.753039; Baltzer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006935; Barrett AL, 2008, DEV BIOL, V317, P234, DOI 10.1016/j.ydbio.2008.02.025; BASIOTIS PP, 1987, J NUTR, V117, P1638, DOI 10.1093/jn/117.9.1638; Beavis W. D., 1994, P 49 ANN CORN SORGH, P250; Beavis William D., 1998, P145; Bharucha KN, 2009, PEDIATR RES, V65, P132, DOI 10.1203/PDR.0b013e318191fc68; BIRD AR, 1994, J NUTR, V124, P231, DOI 10.1093/jn/124.2.231; Birsoy K, 2011, DEVELOPMENT, V138, P4709, DOI 10.1242/dev.067710; Brankatschk M, 2014, ELIFE, V3, DOI 10.7554/eLife.02862; Bray GA, 2008, AM J CLIN NUTR, V88, P1504, DOI 10.3945/ajcn.2008.26289; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; BRUNNER D, 1994, NATURE, V370, P386, DOI 10.1038/370386a0; Buti E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092682; Carvalho GB, 2006, CURR BIOL, V16, P692, DOI 10.1016/j.cub.2006.02.064; Carvalho GB, 2005, NAT METHODS, V2, P813, DOI 10.1038/NMETH798; Champagne CM, 2013, J ACAD NUTR DIET, V113, P1532, DOI 10.1016/j.jand.2013.07.001; Chen KL, 2013, ENDOCR RES, V38, P59, DOI 10.3109/07435800.2012.681824; Chung AWY, 2009, EUR J PHARMACOL, V613, P114, DOI 10.1016/j.ejphar.2009.04.029; Clemente-Postigo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024783; Constantinou C, 2014, J LIPID RES, V55, P1434, DOI 10.1194/jlr.M050047; DEBELLE JS, 1989, GENETICS, V123, P157; Delgado-Lista J, 2014, J CLIN ENDOCR METAB, V99, pE384, DOI 10.1210/jc.2013-3165; Deshpande SA, 2014, NAT METHODS, V11, P535, DOI [10.1038/NMETH.2899, 10.1038/nmeth.2899]; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dionisio N, 2012, CURR MOL MED, V12, P1319, DOI 10.2174/156652412803833616; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Du ZJ, 2007, OPHTHALMIC RES, V39, P224, DOI 10.1159/000104831; Dus M, 2011, P NATL ACAD SCI USA, V108, P11644, DOI 10.1073/pnas.1017096108; Do DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071509; Estella E, 2006, DIABETES, V55, P2212, DOI 10.2337/db06-0129; Flood TF, 2013, NATURE, V499, P83, DOI 10.1038/nature12208; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; Frazier-Wood AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030732; Gasque Gabriel, 2013, Sci Rep, V3, psrep02120, DOI 10.1038/srep02120; Geiger-Thornsberry GL, 2002, GENET RES, V79, P211, DOI 10.1017/S0016672302005621; Goergen P, 2014, BEHAV GENET, V44, P155, DOI 10.1007/s10519-014-9643-0; Goncalves Helen, 2012, J Adolesc Health, V51, pS46, DOI 10.1016/j.jadohealth.2012.08.015; Gray KA, 2015, NUCLEIC ACIDS RES, V43, pD1079, DOI 10.1093/nar/gku1071; Hall MC, 2007, P NATL ACAD SCI USA, V104, P13717, DOI 10.1073/pnas.0701936104; Harbison ST, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-281; Harris DT, 2015, NEURON, V86, P1449, DOI 10.1016/j.neuron.2015.05.026; Harris RH, 2013, INT J EAT DISORDER, V46, P369, DOI 10.1002/eat.22073; He F, 2014, DIABETOLOGIA, V57, P1726, DOI 10.1007/s00125-014-3282-0; Hergarden AC, 2012, P NATL ACAD SCI USA, V109, P3967, DOI 10.1073/pnas.1200778109; Hirota Y, 2002, MECH DEVELOP, V119, pS279, DOI 10.1016/S0925-4773(03)00129-1; Hodin CM, 2011, J PATHOL, V225, P276, DOI 10.1002/path.2917; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; Hong SH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002857; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113; Huetteroth W, 2015, CURR BIOL, V25, P751, DOI 10.1016/j.cub.2015.01.036; Iijima K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008498; Itskov PM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5560; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Jaeken J, 2015, EUR J HUM GENET, V23, pE1, DOI 10.1038/ejhg.2015.9; Jonker JW, 2012, NATURE, V485, P391, DOI 10.1038/nature10998; Jordan KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038722; Joseph BK, 2015, J BIOL CHEM, V290, P10588, DOI 10.1074/jbc.M114.626259; Jumbo-Lucioni P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-297; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kaczkowski CH, 2000, J NUTR, V130, P802, DOI 10.1093/jn/130.4.802; Kapan N, 2012, CELL MOL LIFE SCI, V69, P4051, DOI 10.1007/s00018-012-1097-z; Kato M, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003389; Kaun KR, 2007, J EXP BIOL, V210, P3547, DOI 10.1242/jeb.006924; KIM W W, 1984, American Journal of Clinical Nutrition, V40, P1333, DOI 10.1093/ajcn/40.6.1333; Konieczna J, 2014, GENES NUTR, V9, DOI 10.1007/s12263-013-0366-2; Kramer Jamie M, 2003, BMC Dev Biol, V3, P5, DOI 10.1186/1471-213X-3-5; Kubrak OI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113051; Kulyte A, 2014, DIABETES, V63, P1248, DOI 10.2337/db13-0702; KURACHI H, 1993, AM J PHYSIOL, V265, pE323, DOI 10.1152/ajpendo.1993.265.2.E323; Lai CQ, 2009, OBESITY, V17, P593, DOI 10.1038/oby.2008.561; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Lerner IM, 1954, GENETIC HOMEOSTASIS; LEWONTIN RC, 1964, GENETICS, V50, P757; Li AJ, 2006, ENDOCRINOLOGY, V147, P3428, DOI 10.1210/en.2006-0235; Li SY, 2015, J AM SOC NEPHROL, V26, P3072, DOI 10.1681/ASN.2014100989; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Liu QA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000575; Liu YT, 2015, J COMP NEUROL, V523, P1840, DOI 10.1002/cne.23768; Locke JM, 2015, DIABETES, V64, P1484, DOI 10.2337/db14-0957; Luo JN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099732; Lushchak OV, 2015, CELL MOL LIFE SCI, V72, P3143, DOI 10.1007/s00018-015-1884-4; Mackay TFC, 2005, PHILOS T R SOC B, V360, P1513, DOI 10.1098/rstb.2005.1672; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Mackay TFC, 2010, PHILOS T R SOC B, V365, P1229, DOI 10.1098/rstb.2009.0315; Maklakov AA, 2008, CURR BIOL, V18, P1062, DOI 10.1016/j.cub.2008.06.059; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Manzo A, 2012, P NATL ACAD SCI USA, V109, P6307, DOI 10.1073/pnas.1120305109; Maqueira B, 2005, J NEUROCHEM, V94, P547, DOI 10.1111/j.1471-4159.2005.03251.x; Marella S, 2012, NEURON, V73, P941, DOI 10.1016/j.neuron.2011.12.032; Masek P, 2015, CURR BIOL, V25, P1535, DOI 10.1016/j.cub.2015.04.027; Masek P, 2010, P NATL ACAD SCI USA, V107, P14833, DOI 10.1073/pnas.1009318107; Masson O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007422; McNeill H, 2008, GENETICS, V179, P843, DOI 10.1534/genetics.107.083097; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Melcher C, 2007, J ENDOCRINOL, V192, P467, DOI 10.1677/JOE-06-0066; Memon AA, 2015, J DIABETES, V7, P369, DOI 10.1111/1753-0407.12184; Meunier N, 2007, J EXP BIOL, V210, P1424, DOI 10.1242/jeb.02755; Mita M, 2010, CLIN EXP PHARMACOL P, V37, P670, DOI 10.1111/j.1440-1681.2010.05373.x; Miyamoto T, 2012, CELL, V151, P1113, DOI 10.1016/j.cell.2012.10.024; Miyazawa-Hoshimoto S, 2003, DIABETOLOGIA, V46, P1483, DOI 10.1007/s00125-003-1221-6; Moore T, 2008, CANCER PREV RES, V1, P65, DOI 10.1158/1940-6207.CAPR-08-0022; Morava E, 2012, PEDIATRICS, V130, pE1034, DOI 10.1542/peds.2011-2711; Morgante F, 2015, SCI REP-UK, V5, DOI 10.1038/srep09785; Mueller LD, 2015, GENETICA, V143, P93, DOI 10.1007/s10709-015-9818-5; Mukherjee T, 2012, G3-GENES GENOM GENET, V2, P23, DOI 10.1534/g3.111.001495; Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013; Naja F, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-111; Nassel DR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00252; Neckameyer WS, 2010, DEV NEUROSCI-BASEL, V32, P217, DOI 10.1159/000304888; Norga KK, 2003, CURR BIOL, V13, P1388, DOI 10.1016/S0960-9822(03)00546-3; Ohta H, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00018; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Ordas B, 2008, GENET RES, V90, P385, DOI 10.1017/S0016672308009762; Ostojic I, 2014, P NATL ACAD SCI USA, V111, P8143, DOI 10.1073/pnas.1315466111; Ozawa T, 2003, J GASTROENTEROL, V38, P844, DOI 10.1007/s00535-003-1159-y; Padilla J, 2013, PHYSIOL GENOMICS, V45, P434, DOI 10.1152/physiolgenomics.00038.2013; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Pihlajamaki J, 2009, J CLIN ENDOCR METAB, V94, P3521, DOI 10.1210/jc.2009-0212; Pool AH, 2014, NEURON, V83, P164, DOI 10.1016/j.neuron.2014.05.006; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Potdar S, 2013, J NEUROGENET, V27, P23, DOI 10.3109/01677063.2013.791692; Potes CS, 2010, AM J PHYSIOL-REG I, V299, pR623, DOI 10.1152/ajpregu.00791.2009; Rajan A, 2012, CELL, V151, P123, DOI 10.1016/j.cell.2012.08.019; Ramanathan G, 2012, J THROMB HAEMOST, V10, P419, DOI 10.1111/j.1538-7836.2011.04596.x; Ribeiro C, 2010, CURR BIOL, V20, P1000, DOI 10.1016/j.cub.2010.03.061; Riemensperger T, 2011, P NATL ACAD SCI USA, V108, P834, DOI 10.1073/pnas.1010930108; Ritter S, 2006, PHYSIOL BEHAV, V89, P490, DOI 10.1016/j.physbeh.2006.05.036; Rodenfels J, 2014, GENE DEV, V28, P2636, DOI 10.1101/gad.249763.114; Root CM, 2011, CELL, V145, P133, DOI 10.1016/j.cell.2011.02.008; Ryuda M, 2011, J BIOL CHEM, V286, P38417, DOI 10.1074/jbc.M111.267344; Sangster TA, 2008, P NATL ACAD SCI USA, V105, P2963, DOI 10.1073/pnas.0712200105; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; Scheiner R, 2014, J INSECT PHYSIOL, V69, P107, DOI 10.1016/j.jinsphys.2014.03.011; SCHOELLER DA, 1995, METABOLISM, V44, P18, DOI 10.1016/0026-0495(95)90204-X; SCHOELLER DA, 1990, NUTR REV, V48, P373, DOI 10.1111/j.1753-4887.1990.tb02882.x; Schoofs A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001893; Schubert ML, 2008, GASTROENTEROLOGY, V134, P1842, DOI 10.1053/j.gastro.2008.05.021; Seale JL, 2002, NUTRITION, V18, P568, DOI 10.1016/S0899-9007(02)00804-3; Seeger FH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004529; Singh H, 2013, BIOINFORMATION, V9, P37, DOI 10.6026/97320630009037; Smith CE, 2013, INT J OBESITY, V37, P1211, DOI 10.1038/ijo.2012.215; Smith CE, 2013, OBESITY, V21, P602, DOI 10.1002/oby.20001; Soderberg Jeannette A E, 2012, Front Endocrinol (Lausanne), V3, P109, DOI 10.3389/fendo.2012.00109; Strumia R, 2013, CLIN DERMATOL, V31, P80, DOI 10.1016/j.clindermatol.2011.11.011; Suh JM, 2014, NATURE, V513, P436, DOI 10.1038/nature13540; Suh JM, 2006, CELL METAB, V3, P25, DOI 10.1016/j.cmet.2005.11.012; Swarup S, 2014, CHEM SENSES, V39, P125, DOI 10.1093/chemse/bjt061; Thomas HE, 2010, CELL DEATH DIFFER, V17, P577, DOI 10.1038/cdd.2009.165; Thomas HE, 2011, DIABETES-METAB RES, V27, P790, DOI 10.1002/dmrr.1253; Tian C, 2008, HUM MOL GENET, V17, pR143, DOI 10.1093/hmg/ddn268; Toshima N, 2014, J INSECT PHYSIOL, V69, P89, DOI 10.1016/j.jinsphys.2014.06.019; Ueno K, 2006, J NEUROSCI, V26, P6143, DOI 10.1523/JNEUROSCI.0857-06.2006; Unckless RL, 2015, G3-GENES GENOM GENET, V5, P417, DOI 10.1534/g3.114.016477; Vairaktaris E, 2007, IN VIVO, V21, P615; Vattikuti S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002637; Vemana HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125764; Visscher PM, 2010, GENET RES, V92, P371, DOI 10.1017/S0016672310000571; Wang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036059; Wang YH, 2013, CELL REP, V3, P820, DOI 10.1016/j.celrep.2013.02.003; Weber AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034745; Whitaker R, 2014, AGING-US, V6, P355, DOI 10.18632/aging.100662; Wong R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006063; Wuensch T, 2010, DIABETES, V59, P844, DOI 10.2337/db09-1100; Xu J, 2008, NAT NEUROSCI, V11, P676, DOI 10.1038/nn.2119; Xu SZ, 2003, GENETICS, V165, P2259; Yan L, 2012, BIOCHEM J, V444, P239, DOI 10.1042/BJ20111606; Yang Z, 2015, P NATL ACAD SCI USA, V112, P5219, DOI 10.1073/pnas.1417838112; Zbidi H, 2009, BLOOD CELL MOL DIS, V43, P211, DOI 10.1016/j.bcmd.2009.04.005; Zeng CY, 2011, FLY, V5, P174, DOI 10.4161/fly.5.3.15572; Zhang CF, 2014, CURR VASC PHARMACOL; Zhang D, 2009, AM J NEPHROL, V29, P244, DOI 10.1159/000157627; Zhang LF, 2014, INT J BIOL SCI, V10, P236, DOI 10.7150/ijbs.7744; Zhang T, 2013, P NATL ACAD SCI USA, V110, P15431, DOI 10.1073/pnas.1308816110; Zhang W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002429; Zhang YV, 2013, NAT NEUROSCI, V16, P1468, DOI 10.1038/nn.3513; Zhang YM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7704; Zhou C, 2008, NAT NEUROSCI, V11, P1059, DOI 10.1038/nn.2164; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	190	57	57	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138129	10.1371/journal.pone.0138129	http://dx.doi.org/10.1371/journal.pone.0138129			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375667	Green Published, Green Submitted, gold			2022-12-27	WOS:000361610200078
J	Hwang, SH; Cho, HK; Park, SH; Lee, W; Lee, HJ; Lee, DC; Park, SH; Lim, MH; Back, SA; Yun, BG; Sun, DI; Kang, JM; Kim, SW				Hwang, Se Hwan; Cho, Hye Kyung; Park, Sang Hi; Lee, WeonSun; Lee, Hee Jin; Lee, Dong Chang; Park, Sun Hwa; Lim, Mi Hyun; Back, Sang A.; Yun, Byeong Gon; Sun, Dong Il; Kang, Jun Myung; Kim, Sung Won			Characteristics of Human Turbinate-Derived Mesenchymal Stem Cells Are Not Affected by Allergic Condition of Donor	PLOS ONE			English	Article							INFERIOR TURBINATE; STROMAL CELLS; UP-REGULATION; RHINITIS; TISSUE; DIFFERENTIATION; MULTIPOTENT; EXPRESSION; MUCOSA	The characteristics of mesenchymal stem cells (MSCs) derived from human turbinates (hTMSCs) have not been investigated in allergic rhinitis. We evaluated the influence of allergic state of the donor on the characteristics, proliferation, and differentiation potential of hTMSCs, compared with hTMSCs derived from non-allergic patients. hTMSCs were isolated from five non-allergic and five allergic patients. The expression of toll-like receptors (TLRs) in hTMSCs was measured by FACS, and cell proliferation was measured using a cell counting kit. Cytokine secretion was analyzed using multiplex immunoassays. The osteogenic, chondrogenic, and adipogenic differentiation potentials of hTMSCs were evaluated by histology and gene expression analysis. In allergic patients, FACS analysis showed that TLR3 and TLR4 were more highly expressed on the surface of hTMSCs than TLR2 and TLR5. The proliferation of hTMSCs was not influenced by the presence of TLR priming. The expression of IL-6, IL-8, IL-12, IP-10, and RANTES was upregulated after the TLR4 priming. The differentiation potential of hTMSCs was not influenced by TLR priming. These characteristics of hTMSCs were similar to those of hTMSCs from non-allergic patients. We conclude that the allergic condition of the donor does not influence TLR expression, proliferation, or immunomodulatory potential of hTMSCs.	[Hwang, Se Hwan; Lee, Dong Chang; Park, Sun Hwa; Lim, Mi Hyun; Back, Sang A.; Yun, Byeong Gon; Sun, Dong Il; Kang, Jun Myung; Kim, Sung Won] Catholic Univ Korea, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea; [Cho, Hye Kyung] Gachon Univ, Grad Sch Med, Dept Pediat, Inchon, South Korea; [Park, Sang Hi; Lee, WeonSun; Lee, Hee Jin] Catholic Univ Korea, Coll Med, Inst Clin Med Res, Seoul, South Korea; [Park, Sun Hwa; Lim, Mi Hyun; Yun, Byeong Gon] Catholic Univ Korea, Coll Med, Dept Biomed Sci, Seoul, South Korea	Catholic University of Korea; Gachon University; Catholic University of Korea; Catholic University of Korea	Kang, JM (corresponding author), Catholic Univ Korea, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea.	entkjm@catholic.ac.kr; kswent@catholic.ac.kr		Hwang, Se Hwan/0000-0002-2838-7820	Catholic Medical Center Research Foundation; Institute of Clinical Medicine Research of Bucheon St. Mary's Hospital, Research Fund; National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [2014R1A2A2A01004325]; Korea Health Industry Development Institute - Ministry of Health and Welfare [HI14C3228]	Catholic Medical Center Research Foundation; Institute of Clinical Medicine Research of Bucheon St. Mary's Hospital, Research Fund; National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning; Korea Health Industry Development Institute - Ministry of Health and Welfare	The authors wish to acknowledge the financial support of the Catholic Medical Center Research Foundation made in the program year of 2014, the Institute of Clinical Medicine Research of Bucheon St. Mary's Hospital, Research Fund, 2015 and the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT, and Future Planning (2014R1A2A2A01004325), and the Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare (HI14C3228). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auletta JJ, 2012, BLOOD, V119, P1801, DOI 10.1182/blood-2011-10-384354; Berger G, 2003, LARYNGOSCOPE, V113, P1192, DOI 10.1097/00005537-200307000-00015; Businco LD, 2014, AM J RHINOL ALLERGY, V28, P164, DOI 10.2500/ajra.2014.28.3990; Cho KS, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/436476; Deenadayal DS, 2014, INDIAN J OTOLARYNGOL, V66, pS231, DOI 10.1007/s12070-011-0445-x; Duffy MM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt75; Egeli E, 2004, LARYNGOSCOPE, V114, P113, DOI 10.1097/00005537-200401000-00020; Fransson M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-100; Gao ZW, 2010, APPL CLIN GENET, V3, P109, DOI 10.2147/TACG.S8380; Hwang SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101558; Hwang SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074330; Hwang SH, 2012, OTOLARYNG HEAD NECK, V147, P568, DOI 10.1177/0194599812447172; Hwang SH, 2011, TISSUE ENG REGEN MED, V8, P544; Hwang SH, 2011, TISSUE ENG REGEN MED, V8, P536; Kafle P, 2007, Kathmandu Univ Med J (KUMJ), V5, P501; Kim SW, 2008, OTOLARYNG HEAD NECK, V139, P143, DOI 10.1016/j.otohns.2008.04.015; Leong SC, 2010, CURR OPIN OTOLARYNGO, V18, P54, DOI 10.1097/MOO.0b013e328334db14; Liu YC, 2014, BIOSCI TRENDS, V8, P138, DOI 10.5582/bst.2014.01047; Ma S, 2014, CELL DEATH DIFFER, V21, P216, DOI 10.1038/cdd.2013.158; Makihara S, 2014, ALLERGY RHINOL, V5, pE22, DOI 10.2500/ar.2014.5.0078; Najar M, 2012, STEM CELL REV REP, V8, P1188, DOI 10.1007/s12015-012-9408-1; PAWANKAR RU, 1995, AM J RESP CRIT CARE, V152, P2049, DOI 10.1164/ajrccm.152.6.8520775; Raicevic G, 2010, HUM IMMUNOL, V71, P235, DOI 10.1016/j.humimm.2009.12.005; Renkonen J, 2015, APMIS, V123, P716, DOI 10.1111/apm.12408; Skoner DR, 2001, J ALLERGY CLIN IMMUN, V108, pS2, DOI 10.1067/mai.2001.115569; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088; Wei HQ, 2014, ULTRASOUND MED BIOL, V40, P2425, DOI 10.1016/j.ultrasmedbio.2014.05.016; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379	29	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138041	10.1371/journal.pone.0138041	http://dx.doi.org/10.1371/journal.pone.0138041			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376485	Green Published, Green Submitted, gold			2022-12-27	WOS:000361610200072
J	Kudo, N; Arai, Y; Suhara, Y; Ishii, T; Nakayama, T; Osakabe, N				Kudo, Naoto; Arai, Yasunori; Suhara, Yoshitomo; Ishii, Takeshi; Nakayama, Tsutomu; Osakabe, Naomi			A Single Oral Administration of Theaflavins Increases Energy Expenditure and the Expression of Metabolic Genes	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; DIETARY POLYPHENOLS; BLACK TEA; PROANTHOCYANIDINS; FLAVAN-3-OLS; CHOLESTEROL; CATECHINS; REDUCE; LEAVES; MICE	Theaflavins are polyphenols found in black tea, whose physiological activities are not well understood. This study on mice evaluated the influence of a single oral administration of theaflavins on energy metabolism by monitoring the initial metabolic changess in skeletal muscle and brown adipose tissue (BAT). Oxygen consumption (VO2) and energy expenditure (EE) were increased significantly in mice treated with theaflavin rich fraction (TF) compared with the group administered vehicle alone. There was no difference in locomotor activity. Fasting mice were euthanized under anesthesia before and 2 and 5, 20-hr after treatment with TF or vehicle. The mRNA levels of uncoupling protein-1 (UCP-1) and peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) in BAT were increased significantly 2-hr after administration ofTF. The levels of UCP-3 and PGC-1 alpha in the gastrocnemius muscle were increased significantly 2 and 5-hr after administration of TF. The concentration of phosphorylated AMP-activated protein kinase (AMPK) 1 alpha was also increased significantly in the gastrocnemius 2 and 5-hr after treatment with TF. These results indicate that TF significantly enhances systemic energy expenditure, as evidenced by an increase in expression of metabolic genes.	[Kudo, Naoto; Arai, Yasunori; Suhara, Yoshitomo; Osakabe, Naomi] Shibaura Inst Technol, Dept Biosci & Engn, Munuma Ku, Saitama 3378570, Japan; [Ishii, Takeshi] Univ Shizuoka, Dept Food & Nutr Sci, Suruga Ku, Shizuoka 4228526, Japan; [Nakayama, Tsutomu] Nippon Vet & Life Sci Univ, Sch Food Sci & Technol, Tokyo 1808602, Japan	Shibaura Institute of Technology; University of Shizuoka; Nippon Veterinary & Life Science University	Osakabe, N (corresponding author), Shibaura Inst Technol, Dept Biosci & Engn, Munuma Ku, 307 Fukasaku, Saitama 3378570, Japan.	nao-osa@sic.shibaura-it.ac.jp		Suhara, Yoshitomo/0000-0002-4770-2910	Japan Science and Technology Agency (JST) under the Broader Collaboration of Regional Entities for the Advancement of Technological Excellence (CREATE) Program; National Agriculture and Food Research Organization (NARO); Grant of Cross-Ministerial Strategic Innovation Promotion Program (SIP), Council for Science, Technology and Innovation, Cabinet Office, Government of Japan	Japan Science and Technology Agency (JST) under the Broader Collaboration of Regional Entities for the Advancement of Technological Excellence (CREATE) Program; National Agriculture and Food Research Organization (NARO); Grant of Cross-Ministerial Strategic Innovation Promotion Program (SIP), Council for Science, Technology and Innovation, Cabinet Office, Government of Japan	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Science and Technology Agency (JST) under the Broader Collaboration of Regional Entities for the Advancement of Technological Excellence (CREATE) Program, the Research Project on Development of Agricultural Products and Foods with Health-promoting Benefits from the National Agriculture and Food Research Organization (NARO), and the Grant of Cross-Ministerial Strategic Innovation Promotion Program (SIP), Council for Science, Technology and Innovation, Cabinet Office, Government of Japan. CREAT: http://www.shizuoka-tiikikesshu.jp/outline/index.html. SIP: http://www8.cao.go.jp/cstp/gaiyo/sip/. NARO: http://www.naro.affrc.go.jp/project/f_foodpro/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braicu C, 2013, FOOD CHEM, V141, P3282, DOI 10.1016/j.foodchem.2013.05.122; Davy KP, 2009, NEUROSCI BIOBEHAV R, V33, P116, DOI 10.1016/j.neubiorev.2008.05.024; Fukushima Y, 2009, J AGR FOOD CHEM, V57, P1253, DOI 10.1021/jf802418j; Hartley L, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009934.pub2; Haslam E, 2003, PHYTOCHEMISTRY, V64, P61, DOI 10.1016/S0031-9422(03)00355-8; Islam Mohammed A, 2012, Recent Pat Cardiovasc Drug Discov, V7, P88; Li SM, 2013, FOOD FUNCT, V4, P10, DOI 10.1039/c2fo30093a; Loke WM, 2010, ARTERIOSCL THROM VAS, V30, P749, DOI 10.1161/ATVBAHA.109.199687; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Maron DJ, 2003, ARCH INTERN MED, V163, P1448, DOI 10.1001/archinte.163.12.1448; Matsumura Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112180; Matsuura K, 2014, J CLIN BIOCHEM NUTR, V55, P103, DOI 10.3164/jcbn.13-101; Miyata Y, 2013, J AGR FOOD CHEM, V61, P9366, DOI 10.1021/jf400123y; Most J, 2014, INT J OBESITY, V38, P698, DOI 10.1038/ijo.2013.231; Neilson AP, 2006, J CHROMATOGR A, V1132, P132, DOI 10.1016/j.chroma.2006.07.059; Nishimura M, 2007, J AGR FOOD CHEM, V55, P7252, DOI 10.1021/jf070312m; Sanchez AMJ, 2012, AM J PHYSIOL-CELL PH, V303, pC475, DOI 10.1152/ajpcell.00125.2012; Sang SM, 2011, PHARMACOL RES, V64, P87, DOI 10.1016/j.phrs.2011.02.007; Santesso Nancy, 2014, Glob Adv Health Med, V3, P66, DOI 10.7453/gahmj.2014.003; Sawada K, 2014, MOL CELL ENDOCRINOL, V393, P99, DOI 10.1016/j.mce.2014.06.009; Tamaru S, 2013, J AGR FOOD CHEM, V61, P5817, DOI 10.1021/jf400938h; Tentolouris N, 2006, ANN NY ACAD SCI, V1083, P129, DOI 10.1196/annals.1367.010; Torronen R, 2013, J NUTR, V143, P430, DOI 10.3945/jn.112.169771; Vermeer MA, 2008, J AGR FOOD CHEM, V56, P12031, DOI 10.1021/jf8022035; Vernarelli JA, 2013, EUR J NUTR, V52, P1039, DOI 10.1007/s00394-012-0410-9; Vogiatzoglou A, 2014, BRIT J NUTR, V111, P1463, DOI 10.1017/S0007114513003930; Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001; Zamora-Ros R, 2011, BRIT J NUTR, V106, P1090, DOI [10.1017/S0007114511001437, 10.1017/S0007114511006386]	28	29	32	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137809	10.1371/journal.pone.0137809	http://dx.doi.org/10.1371/journal.pone.0137809			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375960	gold, Green Published, Green Submitted			2022-12-27	WOS:000361610200054
J	Park, WY; Koh, ES; Kim, SH; Kim, YO; Jin, DC; Song, HC; Choi, EJ; Kim, YL; Kim, YS; Kang, SW; Kim, NH; Yang, CW; Kim, YK				Park, Woo Yeong; Koh, Eun Sil; Kim, Su-Hyun; Kim, Young Ok; Jin, Dong Chan; Song, Ho Chul; Choi, Euy Jin; Kim, Yong-Lim; Kim, Yon-Su; Kang, Shin-Wook; Kim, Nam-Ho; Yang, Chul Woo; Kim, Yong Kyun			Serum Gamma-Glutamyltransferase Levels Predict Clinical Outcomes in Hemodialysis Patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; ALANINE AMINOTRANSFERASE; OXIDANT STRESS; MORTALITY; CANCER; RISK; ABSTAINERS; COHORT	Background Gamma-glutamyltransferase (GGT) is a biomarker of liver injury. GGT has also been reported to be a marker of oxidative stress and a predictor of mortality in the general population. Hemodialysis (HD) patients suffer from oxidative stress. The aim of our study was to investigate the relationship between serum GGT levels and clinical outcomes in HD patients. Methods A total of 1,634 HD patients were enrolled from the Clinical Research Center registry for end-stage renal disease, a prospective cohort in Korea. Patients were categorized into three groups by tertiles of serum GGT levels. The primary outcome was all-cause, cardiovascular, or infection-related mortality and hospitalization. Results During the median follow-up period of 30 months, the highest tertile of serum GGT levels had a significantly higher risk for all-cause mortality (hazard ratio (HR) 2.39, 95% confidence interval (CI), 1.55-3.69, P<0.001), cardiovascular mortality (HR 2.14, 95% CI, 1.07-4.26, P = 0.031) and infection-related mortality (HR 3.07, 95% CI, 1.30-7.25, P = 0.011) using tertile 1 as the reference group after adjusting for clinical variables including liver diseases. The highest tertile also had a significantly higher risk for first hospitalization (HR 1.22, 95% CI, 1.00-1.48, P = 0.048) and cardiovascular hospitalization (HR 1.42, 95% CI, 1.06-1.92, P = 0.028). Conclusions Our data demonstrate that high serum GGT levels were an independent risk factor for all-cause, cardiovascular, and infection-related mortality, as well as cardiovascular hospitalization in HD patients. These findings suggest that serum GGT levels might be a useful biomarker to predict clinical outcomes in HD patients.	[Park, Woo Yeong; Koh, Eun Sil; Kim, Young Ok; Jin, Dong Chan; Song, Ho Chul; Choi, Euy Jin; Yang, Chul Woo; Kim, Yong Kyun] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Su-Hyun] Chung Ang Univ, Coll Med, Dept Internal Med, Seoul 156756, South Korea; [Kim, Yong-Lim] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea; [Kim, Yon-Su; Kang, Shin-Wook] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Kang, Shin-Wook] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Nam-Ho] Chonnam Natl Univ, Sch Med, Dept Internal Med, Gwangju, South Korea; [Kim, Yong Kyun] Catholic Univ Korea, Cell Death Dis Res Ctr, Seoul, South Korea	Catholic University of Korea; Chung Ang University; Chung Ang University Hospital; Kyungpook National University; Seoul National University (SNU); Yonsei University; Yonsei University Health System; Chonnam National University; Catholic University of Korea	Kim, YK (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea.	drkimyk@catholic.ac.kr			Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI10C2020]	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI10C2020).	Alatalo P, 2009, ALCOHOL ALCOHOLISM, V44, P199, DOI 10.1093/alcalc/agn099; Sette LHBC, 2014, CLINICS, V69, P271, DOI 10.6061/clinics/2014(04)09; Breitling LP, 2011, J HEPATOL, V55, P594, DOI 10.1016/j.jhep.2010.12.029; Canaud B, 1999, BLOOD PURIFICAT, V17, P99, DOI 10.1159/000014381; Dalrymple LS, 2015, AM J KIDNEY DIS, V65, P754, DOI 10.1053/j.ajkd.2014.11.030; Del Vecchio L, 2011, SEMIN DIALYSIS, V24, P56, DOI 10.1111/j.1525-139X.2010.00819.x; Dominici S, 2005, METHOD ENZYMOL, V401, P484, DOI 10.1016/S0076-6879(05)01029-3; Emdin M, 2005, CIRCULATION, V112, P2078, DOI 10.1161/CIRCULATIONAHA.105.571919; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Franzini M, 2013, DRUG ALCOHOL DEPEN, V127, P239, DOI 10.1016/j.drugalcdep.2012.06.004; Handelman GJ, 2000, BLOOD PURIFICAT, V18, P343, DOI 10.1159/000014460; Hann HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047687; Harel Z, 2015, J AM SOC NEPHROL, V26, P3141, DOI 10.1681/ASN.2014060614; Huang CF, 2014, J HEPATOL, V61, P67, DOI 10.1016/j.jhep.2014.02.022; Jiang SY, 2013, EXP CLIN CARDIOL, V18, P53; Lee DH, 2004, FREE RADICAL RES, V38, P535, DOI 10.1080/10715760410001694026; Locatelli F, 2000, NEPHROL DIAL TRANSPL, V15, P69, DOI 10.1093/ndt/15.suppl_5.69; Locatelli F, 2003, NEPHROL DIAL TRANSPL, V18, P1272, DOI 10.1093/ndt/gfg074; Long Y, 2014, FREE RADICAL RES, V48, P716, DOI 10.3109/10715762.2014.902055; Nakayama E, 2000, J AM SOC NEPHROL, V11, P1896, DOI 10.1681/ASN.V11101896; Petta S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051165; Pohanka M, 2013, FOLIA MICROBIOL, V58, P503, DOI 10.1007/s12223-013-0239-5; Postorino M, 2008, KIDNEY INT, V74, pS64, DOI 10.1038/ki.2008.515; Ruhl CE, 2009, GASTROENTEROLOGY, V136, P477, DOI 10.1053/j.gastro.2008.10.052; Ruttmann E, 2005, CIRCULATION, V112, P2130, DOI 10.1161/CIRCULATIONAHA.105.552547; Sluik D, 2012, DIABETES-METAB RES, V28, P284, DOI 10.1002/dmrr.2261; Strasak AM, 2008, INT J CANCER, V123, P1902, DOI 10.1002/ijc.23714; Tetta C, 1999, BLOOD PURIFICAT, V17, P118, DOI 10.1159/000014383; Van Hemelrijck M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-895; Van Hemelrijck M, 2011, EUR J CANCER, V47, P2033, DOI 10.1016/j.ejca.2011.03.010; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Yun KE, 2009, ATHEROSCLEROSIS, V205, P533, DOI 10.1016/j.atherosclerosis.2008.12.012	32	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138159	10.1371/journal.pone.0138159	http://dx.doi.org/10.1371/journal.pone.0138159			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376075	gold, Green Submitted, Green Published			2022-12-27	WOS:000361610200081
J	Ragavan, ND; Kumar, S; Chye, TT; Mahadeva, S; Shiaw-Hooi, H				Ragavan, Nanthiney Devi; Kumar, Suresh; Chye, Tan Tian; Mahadeva, Sanjiv; Shiaw-Hooi, Ho			Blastocystis sp. in Irritable Bowel Syndrome (IBS) - Detection in Stool Aspirates during Colonoscopy	PLOS ONE			English	Article							HOMINIS; CLASSIFICATION; RELEVANCE	Blastocystis is one of the most common gut parasites found in the intestinal tract of humans and animals. Its' association with IBS is controversial, possibly as a result of irregular shedding of parasites in stool and variation in stool detection. We aimed to screen for Blastocystis in colonic stool aspirate samples in adult patients with and without IBS undergoing colonoscopy for various indications and measure the interleukin levels (IL-8, IL-3 and IL-5). In addition to standard stool culture techniques, polymerase chain reaction (PCR) techniques were employed to detect and subtype Blastocystis. All the serum samples collected were subjected for ELISA studies to measure the interleukin levels (IL-8, IL-3 and IL-5). Among 109 (IBS n = 35 and non-IBS n = 74) adults, direct stool examination and culture of colonic aspirates were initially negative for Blastocystis. However, PCR analysis detected Blastocystis in 6 (17%) IBS and 4 (5.5%) non-IBS patients. In the six positive IBS patients by PCR method, subtype 3 was shown to be the most predominant (3/6: 50%) followed by subtype 4 (2/6; 33.3%) and subtype 5 (1/6; 16.6%). IL-8 levels were significantly elevated in the IBS Blasto group and IBS group (p<0.05) compared to non-IBS and non-IBS Blasto group. The level of IL-3 in were seen to be significantly higher in than IBS Blasto group and IBS group (p<0.05) compared to non-IBS. Meanwhile, the IL-5 levels were significantly higher in IBS Blasto group (p<0.05) compared to non-IBS and non-IBS Blasto group. This study implicates that detecting Blastosystis by PCR method using colonic aspirate samples during colonoscopy, suggests that this may be a better method for sample collection due to the parasite's irregular shedding in Blastocystis-infected stools. Patients with IBS infected with parasite showed an increase in the interleukin levels demonstrate that Blastocystis does have an effect in the immune system.	[Ragavan, Nanthiney Devi; Kumar, Suresh; Chye, Tan Tian] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur 50603, Malaysia; [Mahadeva, Sanjiv; Shiaw-Hooi, Ho] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya	Kumar, S (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur 50603, Malaysia.	suresh@um.edu.my	TAN, TIAN CHYE/B-9920-2010; Mahadeva, Sanjiv/E-1711-2011; Ho, Shiaw-Hooi/B-1606-2017	Mahadeva, Sanjiv/0000-0001-5824-0590; Ho, Shiaw-Hooi/0000-0003-4992-7627	High Impact Research (HIR) [UM.C/625/1/HIR/044]; Postgraduate Research Grant (PPP) [PG108-2012B]	High Impact Research (HIR); Postgraduate Research Grant (PPP)	The study would not have been possible without the support of High Impact Research (HIR) grant UM.C/625/1/HIR/044 and Postgraduate Research Grant (PPP) PG108-2012B.	Al Funda Dogruman, 2007, Turkiye Parazitoloji Dergisi, V31, P28; Chan KH, 2012, PARASITOL RES, V110, P2475, DOI 10.1007/s00436-011-2788-3; Chandramathi S, 2010, PARASITOL RES, V106, P1459, DOI 10.1007/s00436-010-1825-y; Chandramathi S, 2010, PARASITOLOGY, V137, P605, DOI 10.1017/S0031182009991351; Chandramathi S, 2012, T ROY SOC TROP MED H, V106, P267, DOI 10.1016/j.trstmh.2011.12.008; Chandramathi S, 2010, PARASITOL RES, V106, P941, DOI 10.1007/s00436-010-1764-7; Graczyk TK, 2005, PARASITOL RES, V98, P38, DOI 10.1007/s00436-005-0003-0; Gwee KA, 2003, GUT, V52, P523, DOI 10.1136/gut.52.4.523; Gwee KA, 2005, NEUROGASTROENT MOTIL, V17, P1; Jones MS, 2009, PARASITOL RES, V104, P341, DOI 10.1007/s00436-008-1198-7; Kollmar O, 2006, WORLD J GASTROENTERO, V12, P858, DOI 10.3748/wjg.v12.i6.858; Kumarasamy V, 2013, PARASITOL RES, V112, P3551, DOI 10.1007/s00436-013-3538-5; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; NANTHINEY DR, 2014, J PARASITES VECTORS, V7, P404; Oppenheim JJ, 2010, MED IMMUNOLOGY, P148; Rajilic-Stojanovic M, 2011, GASTROENTEROLOGY, V141, P1792, DOI 10.1053/j.gastro.2011.07.043; Simren M, 2006, CLIN GASTROENTEROL H, V4, P187, DOI 10.1016/S1542-3565(05)00981-X; Singh BN, 2009, GLYCOCONJUGATE J, V26, P3, DOI 10.1007/s10719-008-9157-1; Stensvold CR, 2007, TRENDS PARASITOL, V23, P93, DOI 10.1016/j.pt.2007.01.004; Surangsrirat Surapon, 2010, J Med Assoc Thai, V93 Suppl 6, pS119; Tan KSW, 2008, CLIN MICROBIOL REV, V21, P639, DOI 10.1128/CMR.00022-08; Tan TC, 2007, PARASITOL RES, V101, P1521, DOI 10.1007/s00436-007-0670-0; Tungtrongchitr Anchalee, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P705; van Gool T, 2003, EUR J CLIN MICROBIOL, V22, P284, DOI 10.1007/s10096-003-0919-1; Vennila GD, 1999, PARASITOL RES, V85, P162, DOI 10.1007/s004360050528; WINDSOR JJ, 2007, BRIT J BIOMED SCI, V64, P524; Wong KHS, 2008, PARASITOL RES, V102, P663, DOI 10.1007/s00436-007-0808-0; Yan YM, 2006, PARASITOL RES, V99, P597, DOI 10.1007/s00436-006-0186-z; Yoshikawa H, 2004, PARASITOL RES, V92, P22, DOI 10.1007/s00436-003-0995-2	29	14	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0121173	10.1371/journal.pone.0121173	http://dx.doi.org/10.1371/journal.pone.0121173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375823	Green Published, gold			2022-12-27	WOS:000361610200001
J	Seemann, S; Lupp, A				Seemann, Semjon; Lupp, Amelie			Administration of a CXCL12 Analog in Endotoxemia Is Associated with Anti-Inflammatory, Anti- Oxidative and Cytoprotective Effects In Vivo	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; CELL-DERIVED FACTOR-1; NECROSIS-FACTOR-ALPHA; NADPH OXIDASE; LIPOPOLYSACCHARIDE INHIBITION; HEPATIC CYTOCHROME-P-450; SENSITIVE ASSAY; GLUTATHIONE; EXPRESSION; CXCR4	Background The chemokine receptor CXCR4 is a multifunctional receptor which is activated by its natural ligand C-X-C motif chemokine 12 (CXCL12). As CXCR4 is part of the lipopolysaccharide sensing complex and CXCL12 analogs are not well characterized in inflammation, we aimed to uncover the systemic effects of a CXCL12 analog in severe systemic inflammation and to evaluate its impact on endotoxin induced organ damages by using a sublethal LPS dose. Methods The plasma stable CXCL12 analog CTCE-0214D was synthesized and administered subcutaneously shortly before LPS treatment. After 24 hours, mice were sacrificed and blood was obtained for TNF alpha, IFN gamma and blood glucose evaluation. Oxidative stress in the liver and spleen was assessed and liver biotransformation capacity was determined. Finally, CXCR4, CXCL12 and TLR4 expression patterns in liver, spleen and thymus tissue as well as the presence of different markers for apoptosis and oxidative stress were determined by means of immunohistochemistry. Results CTCE-0214D distinctly reduced the LPS mediated effects on TNF alpha, IFN gamma, ALAT and blood glucose levels. It attenuated oxidative stress in the liver and spleen tissue and enhanced liver biotransformation capacity unambiguously. Furthermore, in all three organs investigated, CTCE-0214D diminished the LPS induced expression of CXCR4, CXCL12, TLR4, NF-.B, cleaved caspase-3 and gp91 phox, whereas heme oxygenase 1 expression and activity was induced above average. Additionally, TUNEL staining revealed anti-apoptotic effects of CTCE-0214D. Conclusions In summary, CTCE-0214D displayed anti-inflammatory, anti-oxidative and cytoprotective features. It attenuated reactive oxygen species, induced heme oxygenase 1 activity and mitigated apoptosis. Thus, the CXCR4/CXCL12 axis seems to be a promising target in the treatment of acute systemic inflammation, especially when accompanied by a hepatic dysfunction and an excessive production of free radicals.	[Seemann, Semjon; Lupp, Amelie] Univ Jena, Jena Univ Hosp, Inst Pharmacol & Toxicol, Jena, Germany	Friedrich Schiller University of Jena	Seemann, S (corresponding author), Univ Jena, Jena Univ Hosp, Inst Pharmacol & Toxicol, Jena, Germany.	semjon.seemann@yahoo.com						AITIO A, 1978, ANAL BIOCHEM, V85, P488, DOI 10.1016/0003-2697(78)90245-2; Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Anrather J, 2006, J BIOL CHEM, V281, P5657, DOI 10.1074/jbc.M506172200; Bach HH, 2012, MOL MED, V18, P1056, DOI 10.2119/molmed.2011.00497; Bosisio D, 2002, BLOOD, V99, P3427, DOI 10.1182/blood.V99.9.3427; CASTELEIJN E, 1988, J BIOL CHEM, V263, P6953; Chang Thomas K H, 2006, Methods Mol Biol, V320, P127; Choi SH, 1998, BIOCHEM PHARMACOL, V56, P1427, DOI 10.1016/S0006-2952(98)00204-4; Chung SW, 2008, J CLIN INVEST, V118, P239, DOI 10.1172/JCI32730; Dalton TP, 2004, FREE RADICAL BIO MED, V37, P1511, DOI 10.1016/j.freeradbiomed.2004.06.040; DApuzzo M, 1997, EUR J IMMUNOL, V27, P1788, DOI 10.1002/eji.1830270729; Datla SR, 2007, HYPERTENSION, V50, P636, DOI 10.1161/HYPERTENSIONAHA.107.092296; De Cruz Sharon J, 2009, Expert Rev Respir Med, V3, P511, DOI 10.1586/ers.09.39; Delano MJ, 2011, J IMMUNOL, V187, P911, DOI 10.4049/jimmunol.1100588; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fan HK, 2014, AM J RESP CRIT CARE, V189, P1509, DOI 10.1164/rccm.201312-2163OC; Fan HK, 2012, INFLAMMATION, V35, P130, DOI 10.1007/s10753-011-9297-5; Garnica MR, 2002, IMMUNOL LETT, V83, P47, DOI 10.1016/S0165-2478(02)00067-6; Glawe JD, 2013, DIABETOLOGIA, V56, P2222, DOI 10.1007/s00125-013-2978-x; Gonnert FA, 2011, J SURG RES, V170, pE123, DOI 10.1016/j.jss.2011.05.019; Guan SW, 2015, IMMUNOLOGY, V144, P405, DOI 10.1111/imm.12382; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Huang XQ, 2003, BIOPHYS J, V84, P171, DOI 10.1016/S0006-3495(03)74840-1; Jacob A, 2009, INT J CLIN EXP MED, V2, P203; Karin N, 2010, J LEUKOCYTE BIOL, V88, P463, DOI 10.1189/jlb.0909602; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; Kishore SP, 2005, FEBS LETT, V579, P699, DOI 10.1016/j.febslet.2004.12.047; KLEEBERG U, 1982, J PHARMACOL METHOD, V8, P19, DOI 10.1016/0160-5402(82)90004-3; KLINGER W, 1974, Z VERSUCHSTIERKD, V16, P149; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; LUBET RA, 1985, ARCH BIOCHEM BIOPHYS, V238, P43, DOI 10.1016/0003-9861(85)90138-9; Lupp A, 2001, TOXICOLOGY, V161, P53, DOI 10.1016/S0300-483X(01)00333-X; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Majetschak M, 2004, SURGERY, V135, P536, DOI 10.1016/j.surg.2003.09.006; Mao WF, 2014, INT J NEUROSCI, V124, P281, DOI 10.3109/00207454.2013.838236; MCMANUS JFA, 1948, STAIN TECHNOL, V23, P99, DOI 10.3109/10520294809106232; Mikami S, 2008, J PHARMACOL EXP THER, V327, P383, DOI 10.1124/jpet.108.141085; Morgan ET, 2001, DRUG METAB DISPOS, V29, P207; Muyderman H, 2007, J NEUROCHEM, V102, P1369, DOI 10.1111/j.1471-4159.2007.04641.x; Nanki T, 2001, CELL IMMUNOL, V214, P145, DOI 10.1006/cimm.2001.1890; Novoa B, 2009, FISH SHELLFISH IMMUN, V26, P326, DOI 10.1016/j.fsi.2008.12.004; Park BS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.97; Perez LE, 2004, EXP HEMATOL, V32, P300, DOI 10.1016/j.exphem.2003.12.005; POHL RJ, 1980, ANAL BIOCHEM, V107, P150, DOI 10.1016/0003-2697(80)90505-9; Raetzsch CF, 2009, HEPATOLOGY, V50, P592, DOI 10.1002/hep.22999; Reinhart K, 2012, CLIN MICROBIOL REV, V25, P609, DOI 10.1128/CMR.00016-12; SHOJI Y, 1995, IMMUNOLOGY, V84, P543; Tamamura H, 2004, FEBS LETT, V569, P99, DOI 10.1016/j.febslet.2004.05.056; Tamion F, 2006, J TRAUMA, V61, P1078, DOI 10.1097/01.ta.0000239359.41464.ef; Triantafilou M, 2002, J CELL SCI, V115, P2603; Triantafilou M, 2008, EUR J IMMUNOL, V38, P192, DOI 10.1002/eji.200636821; Tunc T, 2014, J MATERN-FETAL NEO M, V22, P1; Vabulas RM, 2002, CURR TOP MICROBIOL, V270, P169; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wang A, 2009, J IMMUNOL, V182, P4448, DOI 10.4049/jimmunol.0801920; Wittebole X, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/568396; Xu L, 2013, MOL BIOSYST, V9, P2107, DOI 10.1039/c3mb70120d; YAGI T, 1987, MUTAT RES, V184, P223, DOI 10.1016/0167-8817(87)90020-4; Yan ZQ, 2006, ARTERIOSCL THROM VAS, V26, P2582, DOI 10.1161/01.ATV.0000250933.92917.dd; Yano T, 2007, DIABETES, V56, P2946, DOI 10.2337/db07-0291; YOSHIDA T, 1974, FEBS LETT, V48, P256, DOI 10.1016/0014-5793(74)80481-3; Zhou M, 2008, INT J MOL MED, V21, P423	63	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138389	10.1371/journal.pone.0138389	http://dx.doi.org/10.1371/journal.pone.0138389			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375818	gold, Green Submitted, Green Published			2022-12-27	WOS:000361610200105
J	Chen, F; Zhang, XF; Zhang, N; Wang, SS; Yin, GH; Dong, ZD; Cui, DQ				Chen, Feng; Zhang, Xiangfen; Zhang, Ning; Wang, Shasha; Yin, Guihong; Dong, Zhongdong; Cui, Dangqun			Combined Small RNA and Degradome Sequencing Reveals Novel MiRNAs and Their Targets in the High-Yield Mutant Wheat Strain Yunong 3114	PLOS ONE			English	Article							MICRORNA REGULATION; PLANT MICRORNAS; GENE-EXPRESSION; MESSENGER-RNA; ARABIDOPSIS-THALIANA; FLOWERING TIME; IDENTIFICATION; STRESS; ARCHITECTURE; RESPONSES	Wheat is one of the main food sources worldwide; large amount studies have been conducted to improve wheat production. MicroRNAs (miRNAs) with about 20-30 nucleotide are a class of regulatory small RNAs (sRNAs), which could regulate gene expression through sequence-specific base pairing with target mRNAs, playing important roles in plant growth. An ideal plant architecture (IPA) is crucial to enhance yield in bread wheat. In this study, the high-yield wheat strain Yunong 3114 was EMS-mutagenesis from the wild-type strain Yunong 201, exhibiting a preferable plant structure compared with the wild-type strain. We constructed small RNA and degradome libraries from Yunong 201 and Yunong 3114, and performed small RNA sequencing of these libraries in order identify miRNAs and their targets related to IPA in wheat. Totally, we identified 488 known and 837 novel miRNAs from Yunong 3114 and 391 known and 533 novel miRNAs from Yunong 201. The number of miRNAs in the mutant increased. A total of 37 known and 432 putative novel miRNAs were specifically expressed in the mutant strain; furthermore, 23 known and 159 putative novel miRNAs were specifically expressed in the wild-type strain. A total of 150 known and 100 novel miRNAs were differentially expressed between mutant and wild-type strains. Among these differentially expressed novel miRNAs, 4 and 8 predict novel miRNAs were evidenced by degradome sequencing and showed up-regulated and down-regulated expressions in the mutant strain Yunong 3114, respectively. Targeted gene annotation and previous results indicated that this set of miRNAs is related to plant structure. Our results further suggested that miRNAs may be necessary to obtain an optimal wheat structure.	[Chen, Feng; Zhang, Xiangfen; Zhang, Ning; Wang, Shasha; Dong, Zhongdong; Cui, Dangqun] Henan Agr Univ, Natl Key Lab Wheat & Maize Crop Sci, Collaborat Innovat Ctr Henan Grain Crops, Agron Coll, Zhengzhou, Peoples R China; [Yin, Guihong] Zhoukou Acad Agr Sci, Zhoukou, Peoples R China	Henan Agricultural University	Chen, F (corresponding author), Henan Agr Univ, Natl Key Lab Wheat & Maize Crop Sci, Collaborat Innovat Ctr Henan Grain Crops, Agron Coll, Zhengzhou, Peoples R China.	chf0088@163.com; cdq62@sohu.com			973 project [2014CB138105, 2014CB160303]; National Natural Science Foundation [31370031]; Program for New Century Excellent Talents in University in the University of China [NCET-13-0776]	973 project(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University in the University of China(Program for New Century Excellent Talents in University (NCET))	This project was funded by the 973 project (2014CB138105 and 2014CB160303), the National Natural Science Foundation (31370031), and the Program for New Century Excellent Talents in University (NCET-13-0776) in the University of China.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Baker CC, 2005, CURR BIOL, V15, P303, DOI 10.1016/j.cub.2005.02.017; Barrera-Figueroa BE, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-132; Bonnet E, 2004, P NATL ACAD SCI USA, V101, P11511, DOI 10.1073/pnas.0404025101; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Chen XM, 2012, CURR OPIN GENET DEV, V22, P361, DOI 10.1016/j.gde.2012.04.004; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; Curaba J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-120; Feng H, 2014, MOL PLANT PATHOL, V15, P284, DOI 10.1111/mpp.12089; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Gifford ML, 2008, P NATL ACAD SCI USA, V105, P803, DOI 10.1073/pnas.0709559105; Gutierrez L, 2012, PLANT CELL, V24, P2515, DOI 10.1105/tpc.112.099119; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hao DC, 2012, PHYSIOL PLANTARUM, V146, P388, DOI 10.1111/j.1399-3054.2012.01668.x; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Jover-Gil S, 2005, INT J DEV BIOL, V49, P733, DOI 10.1387/ijdb.052015sj; Kang MM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-360; Kato Y, 2004, PLANTA, V220, P97, DOI 10.1007/s00425-004-1328-0; Kim J, 2005, PLANT J, V42, P84, DOI 10.1111/j.1365-313X.2005.02354.x; Kim JH, 2009, SCIENCE, V323, P1053, DOI 10.1126/science.1166386; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kurtoglu KY, 2014, FUNCT INTEGR GENOMIC, V14, P363, DOI 10.1007/s10142-013-0357-9; Laufs P, 2004, DEVELOPMENT, V131, P4311, DOI 10.1242/dev.01320; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Li AL, 2014, PLANT CELL, V26, P1878, DOI 10.1105/tpc.114.124388; Li YF, 2013, PLANT SCI, V203, P17, DOI 10.1016/j.plantsci.2012.12.014; Li YF, 2010, PLANT J, V62, P742, DOI 10.1111/j.1365-313X.2010.04187.x; Liu DM, 2009, PHYSIOL PLANTARUM, V136, P223, DOI 10.1111/j.1399-3054.2009.01229.x; Liu HJ, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-433, 10.1186/1471-2164-15-25]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu ZF, 2013, PLANT CELL, V25, P3743, DOI 10.1105/tpc.113.113639; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Malone Colin, 2012, Cold Spring Harb Protoc, V2012, P1067, DOI 10.1101/pdb.prot071431; Meng FR, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-140; Meng YJ, 2013, NEW PHYTOL, V197, P441, DOI 10.1111/nph.12018; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Nair SK, 2010, P NATL ACAD SCI USA, V107, P490, DOI 10.1073/pnas.0909097107; Nakano T, 1997, PLANT CELL, V9, P1673, DOI 10.1105/tpc.9.9.1673; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pandey B, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23932; Pant BD, 2009, PLANT PHYSIOL, V150, P1541, DOI 10.1104/pp.109.139139; Pei HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064290; Peng T, 2011, J EXP BOT, V62, P4943, DOI 10.1093/jxb/err205; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Shao CG, 2013, GENE, V515, P123, DOI 10.1016/j.gene.2012.11.015; Sieber P, 2007, DEVELOPMENT, V134, P1051, DOI 10.1242/dev.02817; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Tang Hai-Ming, 2012, Yichuan, V34, P784, DOI 10.3724/SP.J.1005.2012.00784; Tang ZH, 2012, PLANT PHYSIOL, V159, P721, DOI 10.1104/pp.112.196048; Vidal EA, 2010, WIRES SYST BIOL MED, V2, P683, DOI 10.1002/wsbm.87; Vidal EA, 2010, P NATL ACAD SCI USA, V107, P4477, DOI 10.1073/pnas.0909571107; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang XW, 2005, BIOINFORMATICS, V21, P3610, DOI 10.1093/bioinformatics/bti562; Wang YH, 2005, PLANT MOL BIOL, V59, P75, DOI 10.1007/s11103-004-4038-x; Wang YH, 2008, ANNU REV PLANT BIOL, V59, P253, DOI 10.1146/annurev.arplant.59.032607.092902; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048445; Wang Y, 2012, NEW PHYTOL, V196, P914, DOI 10.1111/j.1469-8137.2012.04304.x; Xin MM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-61; Xue LJ, 2009, NUCLEIC ACIDS RES, V37, P916, DOI 10.1093/nar/gkn998; Yamaguchi K, 2003, EUR J BIOCHEM, V270, P190, DOI 10.1046/j.1432-1033.2003.03359.x; Yang XY, 2013, J EXP BOT, V64, P1521, DOI 10.1093/jxb/ert013; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P152, DOI 10.1093/nar/gkl1032; Yuan C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-511; Zhang WX, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r81; Zhao YP, 2013, ANN BOT-LONDON, V112, P633, DOI 10.1093/aob/mct133; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhu C, 2011, PHYSIOL PLANTARUM, V143, P1, DOI 10.1111/j.1399-3054.2011.01477.x; Zhu QH, 2011, J EXP BOT, V62, P487, DOI 10.1093/jxb/erq295	76	10	11	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137773	10.1371/journal.pone.0137773	http://dx.doi.org/10.1371/journal.pone.0137773			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372220	Green Published, Green Submitted, gold			2022-12-27	WOS:000361604400030
J	Scherzer, MT; Waigel, S; Donninger, H; Arumugam, V; Zacharias, W; Clark, G; Siskind, LJ; Soucy, P; Beverly, L				Scherzer, Michael T.; Waigel, Sabine; Donninger, Howard; Arumugam, Vennila; Zacharias, Wolfgang; Clark, Geoffrey; Siskind, Leah J.; Soucy, Patricia; Beverly, Levi			Fibroblast-Derived Extracellular Matrices: An Alternative Cell Culture System That Increases Metastatic Cellular Properties	PLOS ONE			English	Article							LUNG-CANCER; TUMOR PROGRESSION; GROWTH; COMPLEMENT; THERAPY	Poor survival rates from lung cancer can largely be attributed to metastatic cells that invade and spread throughout the body. The tumor microenvironment (TME) is composed of multiple cell types, as well as non-cellular components. The TME plays a critical role in the development of metastatic cancers by providing migratory cues and changing the properties of the tumor cells. The Extracellular Matrix (ECM), a main component of the TME, has been shown to change composition during tumor progression, contributing to cancer cell invasion and survival away from the primary cancer site. Although the ECM is well-known to influence the fate of tumor progression, little is known about the molecular mechanisms that are affected by the cancer cell-ECM interactions. It is imperative that these mechanisms are elucidated in order to properly understand and prevent lung cancer dissemination. However, common in vitro studies do not incorporate these interactions into everyday cell culture assays. We have adopted a model that examines decellularized human fibroblast-derived ECM as a 3-dimensional substrate for growth of lung adenocarcinoma cell lines. Here, we have characterized the effect of fibroblast-derived matrices on the properties of various lung-derived epithelial cell lines, including cancerous and non-transformed cells. This work highlights the significance of the cell-ECM interaction and its requirement for incorporation into in vitro experiments. Implementation of a fibroblast-derived ECM as an in vitro technique will provide researchers with an important factor to manipulate to better recreate and study the TME.	[Scherzer, Michael T.; Waigel, Sabine; Donninger, Howard; Arumugam, Vennila; Zacharias, Wolfgang; Clark, Geoffrey; Siskind, Leah J.; Beverly, Levi] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40202 USA; [Scherzer, Michael T.; Soucy, Patricia; Beverly, Levi] Univ Louisville, Dept Bioengn, Louisville, KY 40202 USA; [Donninger, Howard; Zacharias, Wolfgang; Beverly, Levi] Univ Louisville, Dept Med, Louisville, KY 40202 USA; [Zacharias, Wolfgang; Clark, Geoffrey; Siskind, Leah J.; Beverly, Levi] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40202 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville	Beverly, L (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40202 USA.	Levi.Beverly@Louisville.edu	Donninger, Howard/I-9874-2019	Donninger, Howard/0000-0002-8589-1660; Siskind, Leah/0000-0001-5026-5187	National Institutes of Health, National Institute of General Medicine [1P30GM106396]; National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [R01DK093462]; National Institutes of Health, National Cancer Institute [R01CA133171, R01CA193220]; NATIONAL CANCER INSTITUTE [R01CA193220, R01CA133171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106396] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	WZ was supported by National Institutes of Health, National Institute of General Medicine, #1P30GM106396; LJS by National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, #R01DK093462; GC by National Institutes of Health, National Cancer Institute, #R01CA133171; LJB by National Institutes of Health, National Cancer Institute, #R01CA193220. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2015, NONSM CELL LUNG CANC; Blaauboer ME, 2014, MATRIX BIOL, V34, P170, DOI 10.1016/j.matbio.2013.11.002; Braun F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023577; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Caccavari F, 2010, CELL ADHES MIGR, V4, P124, DOI 10.4161/cam.4.1.10976; Copland IB, 2007, J CELL PHYSIOL, V210, P133, DOI 10.1002/jcp.20840; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Gao YJ, 2010, P NATL ACAD SCI USA, V107, P18892, DOI 10.1073/pnas.1004952107; Hadler-Olsen E, 2013, TUMOR BIOL, V34, P2041, DOI 10.1007/s13277-013-0842-8; Hoelder S, 2012, MOL ONCOL, V6, P155, DOI 10.1016/j.molonc.2012.02.004; Huijbers IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009808; IHDE DC, 1992, NEW ENGL J MED, V327, P1434; Jin DC, 2010, CANCER RES, V70, P2245, DOI 10.1158/0008-5472.CAN-09-3109; Lee HO, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-245; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Luppi F, 2007, LUNG CANCER, V56, P25, DOI 10.1016/j.lungcan.2006.11.014; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Oskarsson T, 2013, BREAST, V22, pS66, DOI 10.1016/j.breast.2013.07.012; Pasqualato A, 2013, CELL ADHES MIGR, V7, P450, DOI 10.4161/cam.26765; Pio R, 2014, ADV EXP MED BIOL, V772, P229, DOI 10.1007/978-1-4614-5915-6_11; Pio R, 2013, SEMIN IMMUNOL, V25, P54, DOI 10.1016/j.smim.2013.04.001; Serebriiskii I, 2008, MATRIX BIOL, V27, P573, DOI 10.1016/j.matbio.2008.02.008; Soucy PA, 2015, ACTA BIOMATER, V11, P264, DOI 10.1016/j.actbio.2014.08.037; Soucy PA, 2009, MATRIX BIOL, V28, P273, DOI 10.1016/j.matbio.2009.04.005; Xiao Dakai, 2010, J Thorac Dis, V2, P154, DOI 10.3978/j.issn.2072-1439.2010.02.03.7; Yin Z, 2013, NAT CELL BIOL, V15, P860, DOI 10.1038/ncb2764	27	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138065	10.1371/journal.pone.0138065	http://dx.doi.org/10.1371/journal.pone.0138065			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371754	Green Submitted, gold, Green Published			2022-12-27	WOS:000361604400046
J	Kondo, M; Das, G; Imai, R; Santana, E; Nakashita, T; Imawaka, M; Ueda, K; Ohtsuka, H; Sakai, K; Aihara, T; Kato, K; Sugimoto, M; Ueno, S; Nishizawa, Y; Aguirre, GD; Miyadera, K				Kondo, Mineo; Das, Gautami; Imai, Ryoetsu; Santana, Evelyn; Nakashita, Tomio; Imawaka, Miho; Ueda, Kosuke; Ohtsuka, Hirohiko; Sakai, Kazuhiko; Aihara, Takehiro; Kato, Kumiko; Sugimoto, Masahiko; Ueno, Shinji; Nishizawa, Yuji; Aguirre, Gustavo D.; Miyadera, Keiko			A Naturally Occurring Canine Model of Autosomal Recessive Congenital Stationary Night Blindness	PLOS ONE			English	Article							ROD BIPOLAR CELLS; METABOTROPIC GLUTAMATE-RECEPTOR; DEPOLARIZING BIPOLAR; LIGHT RESPONSE; SYNAPTIC-TRANSMISSION; RETINITIS-PIGMENTOSA; FRAMESHIFT MUTATION; MAMMALIAN RETINA; GENE-EXPRESSION; RABBIT RETINA	Congenital stationary night blindness (CSNB) is a non-progressive, clinically and genetically heterogeneous disease of impaired night vision. We report a naturally-occurring, stationary, autosomal recessive phenotype in beagle dogs with normal daylight vision but absent night vision. Affected dogs had normal retinas on clinical examination, but showed no detectable rod responses. They had "negative-type" mixed rod and cone responses in full-field ERGs. Their photopic long-flash ERGs had normal OFF-responses associated with severely reduced ON-responses. The phenotype is similar to the Schubert-Bornschein form of complete CSNB in humans. Homozygosity mapping ruled out most known CSNB candidates as well as CACNA2D4 and GNB3. Three remaining genes were excluded based on sequencing the open reading frame and intron-exon boundaries (RHO, NYX), causal to a different form of CSNB (RHO) or X-chromosome (NYX, CACNA1F) location. Among the genes expressed in the photoreceptors and their synaptic terminals, and mGluR6 cascade and modulators, reduced expression of GNAT1, CACNA2D4 and NYX was observed by qRT-PCR in both carrier (n = 2) and affected (n = 2) retinas whereas CACNA1F was down-regulated only in the affecteds. Retinal morphology revealed normal cellular layers and structure, and electron microscopy showed normal rod spherules and synaptic ribbons. No difference from normal was observed by immunohistochemistry (IHC) for antibodies labeling rods, cones and their presynaptic terminals. None of the retinas showed any sign of stress. Selected proteins of mGluR6 cascade and its modulators were examined by IHC and showed that PKC alpha weakly labeled the rod bipolar somata in the affected, but intensely labeled axonal terminals that appeared thickened and irregular. Dendritic terminals of ON-bipolar cells showed increased Goa labeling. Both PKC alpha and Go alpha labeled the more prominent bipolar dendrites that extended into the OPL in affected but not normal retinas. Interestingly, RGS11 showed no labeling in the affected retina. Our results indicate involvement of a yet unknown gene in this canine model of complete CSNB.	[Kondo, Mineo; Kato, Kumiko; Sugimoto, Masahiko] Mie Univ, Grad Sch Med, Dept Ophthalmol, Tsu, Mie 514, Japan; [Das, Gautami; Santana, Evelyn; Aguirre, Gustavo D.; Miyadera, Keiko] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [Imai, Ryoetsu; Nakashita, Tomio; Imawaka, Miho; Ueda, Kosuke; Ohtsuka, Hirohiko] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Fujisawa, Kanagawa, Japan; [Sakai, Kazuhiko; Aihara, Takehiro] Kitayama Labes Co Ltd, Ina, Saitama, Japan; [Ueno, Shinji] Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Nagoya, Aichi 4648601, Japan; [Nishizawa, Yuji] Chubu Univ, Dept Biomed Sci, Kasugai, Aichi 487, Japan	Mie University; University of Pennsylvania; Takeda Pharmaceutical Company Ltd; Nagoya University; Chubu University	Kondo, M (corresponding author), Mie Univ, Grad Sch Med, Dept Ophthalmol, Tsu, Mie 514, Japan.	mineo@clin.medic.mie-u.ac.jp; gda@vet.upenn.edu	Miyadera, Keiko/AAQ-8196-2020; Ueno, Shinji/M-5063-2014; Kato, Kumiko/AAE-9079-2019	Kato, Kumiko/0000-0003-4172-3443; Aguirre, Gustavo/0000-0002-5228-256X; Das, Rueben/0000-0001-9204-0605	Ministry of Education, Culture, Sports, Science and Technology of Japan [C20592603]; NIH [RO1EY-017549, RO1EY-06855]; Foundation Fighting Blindness Center grant; Career Development Award; Hope for Vision grant; Takeda Pharmaceutical Co., Ltd; Kitayama Labes Co., Ltd; NATIONAL EYE INSTITUTE [R01EY017549, P30EY001583, R01EY006855] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness Center grant; Career Development Award; Hope for Vision grant; Takeda Pharmaceutical Co., Ltd(Takeda Pharmaceutical Company Ltd); Kitayama Labes Co., Ltd; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by a Grant-in-Aid for Scientific Research from Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.jsps.go.jp, #C20592603, MK), NIH grants (http://grants.nih.gov) RO1EY-017549 (GDA), and RO1EY-06855 (GDA). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Eye Institute or the National Institutes of Health. Work was also funded by a Foundation Fighting Blindness (http://www.blindness.org) Center grant (GDA) and Career Development Award (KM), and Hope for Vision grant (http://hopeforvision.org, GDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Takeda Pharmaceutical Co., Ltd and Kitayama Labes Co., Ltd provided support in the form of salaries for authors RI, TN, MI, KU, HO and KS and TA respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aguirre G D, 1998, Mol Vis, V4, P23; Audo I, 2012, AM J HUM GENET, V90, P321, DOI 10.1016/j.ajhg.2011.12.007; Audo I, 2009, AM J HUM GENET, V85, P720, DOI 10.1016/j.ajhg.2009.10.013; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; Bech-Hansen NT, 1998, HUM GENET, V103, P124, DOI 10.1007/s004390050794; Bellone RR, 2008, GENETICS, V179, P1861, DOI 10.1534/genetics.108.088807; Bellone RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078280; Beltran WA, 2006, INVEST OPHTH VIS SCI, V47, P1669, DOI 10.1167/iovs.05-0845; Bloomfield SA, 2001, PROG RETIN EYE RES, V20, P351, DOI 10.1016/S1350-9462(00)00031-8; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Cao Y, 2009, J NEUROSCI, V29, P9301, DOI 10.1523/JNEUROSCI.1367-09.2009; Chen FS, 2010, INVEST OPHTH VIS SCI, V51, P686, DOI 10.1167/iovs.09-4084; DACHEUX RF, 1986, J NEUROSCI, V6, P331; DeVries SH, 1999, NATURE, V397, P157, DOI 10.1038/16462; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; Dhingra A, 2002, J NEUROSCI, V22, P4878, DOI 10.1523/JNEUROSCI.22-12-04878.2002; Dhingra A, 2000, J NEUROSCI, V20, P9053; Dhingra A, 2012, J NEUROSCI, V32, P11343, DOI 10.1523/JNEUROSCI.1436-12.2012; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; Drogemuller C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000579; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; DRYJA TP, 1993, NAT GENET, V4, P280, DOI 10.1038/ng0793-280; Genini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085408; Genini S, 2010, INVEST OPHTH VIS SCI, V51, P6038, DOI 10.1167/iovs.10-5443; Ghosh KK, 2004, J COMP NEUROL, V469, P70, DOI 10.1002/cne.10985; Gregg RG, 2007, J NEUROPHYSIOL, V98, P3023, DOI 10.1152/jn.00608.2007; Koike C, 2010, CELL CALCIUM, V48, P95, DOI 10.1016/j.ceca.2010.08.004; Komaromy AM, 2013, MOL THER, V21, P1131, DOI 10.1038/mt.2013.50; Kondo M, 2000, JPN J OPHTHALMOL, V44, P20, DOI 10.1016/S0021-5155(99)00172-0; Kuznetsova T, 2012, INVEST OPHTH VIS SCI, V53, P5486, DOI 10.1167/iovs.12-10178; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; Miyadera K, 2012, MAMM GENOME, V23, P40, DOI 10.1007/s00335-011-9361-3; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; Morigiwa K, 1999, J COMP NEUROL, V405, P173, DOI 10.1002/(SICI)1096-9861(19990308)405:2<173::AID-CNE3>3.0.CO;2-L; Naeem MA, 2012, INVEST OPHTH VIS SCI, V53, P1353, DOI 10.1167/iovs.11-8026; NAKAJIMA Y, 1993, J BIOL CHEM, V268, P11868; NARFSTROM K, 1989, BRIT J OPHTHALMOL, V73, P750, DOI 10.1136/bjo.73.9.750; Nawy S, 1999, J NEUROSCI, V19, P2938; NELSON R, 1978, J NEUROPHYSIOL, V41, P472, DOI 10.1152/jn.1978.41.2.472; Neuille M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090342; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; Okawa H, 2010, J GEN PHYSIOL, V136, P443, DOI 10.1085/jgp.201010477; Pang JJ, 2004, J PHYSIOL-LONDON, V558, P897, DOI 10.1113/jphysiol.2003.059543; Peachey NS, 2012, J NEUROPHYSIOL, V108, P2442, DOI 10.1152/jn.00137.2012; Pusch CM, 2000, NAT GENET, V26, P324, DOI 10.1038/81627; Rampino MAF, 2011, J NEUROSCI, V31, P13596, DOI 10.1523/JNEUROSCI.2655-11.2011; Rao A, 2007, J NEUROSCI, V27, P14199, DOI 10.1523/JNEUROSCI.4934-07.2007; Riazuddin SA, 2010, AM J HUM GENET, V87, P523, DOI 10.1016/j.ajhg.2010.08.013; RIGGS LA, 1954, AM J OPHTHALMOL, V38, P70, DOI 10.1016/0002-9394(54)90011-2; Ritchey ER, 2010, NEUROSCIENCE, V169, P1376, DOI 10.1016/j.neuroscience.2010.05.081; Ruether K, 2010, INVEST OPHTH VIS SCI, V51, P6051, DOI 10.1167/iovs.09-4704; SCHUBERT G, 1952, OPHTHALMOLOGICA, V123, P396, DOI 10.1159/000301211; Shen Y, 2012, P NATL ACAD SCI USA, V109, P8752, DOI 10.1073/pnas.1117433109; Shen Y, 2009, J NEUROSCI, V29, P6088, DOI 10.1523/JNEUROSCI.0132-09.2009; Shim H, 2012, J BIOL CHEM, V287, P14873, DOI 10.1074/jbc.M112.345751; Sieving P A, 1993, Trans Am Ophthalmol Soc, V91, P701; Specht D, 2009, INVEST OPHTH VIS SCI, V50, P505, DOI 10.1167/iovs.08-2758; STRETTOI E, 1990, J COMP NEUROL, V295, P449, DOI 10.1002/cne.902950309; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Szabo V, 2007, HUM MUTAT, V28, P741, DOI 10.1002/humu.9499; van Genderen MM, 2009, AM J HUM GENET, V85, P730, DOI 10.1016/j.ajhg.2009.10.012; WITZEL DA, 1978, INVEST OPHTH VIS SCI, V17, P788; Zeitz C, 2007, HUM MUTAT, V28, P771, DOI 10.1002/humu.20499; Zeitz C, 2006, AM J HUM GENET, V79, P657, DOI 10.1086/508067; Zeitz C, 2013, AM J HUM GENET, V92, P67, DOI 10.1016/j.ajhg.2012.10.023; Zeitz C, 2009, INVEST OPHTH VIS SCI, V50, P5919, DOI 10.1167/iovs.09-3548	71	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137072	10.1371/journal.pone.0137072	http://dx.doi.org/10.1371/journal.pone.0137072			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368928	gold, Green Published, Green Submitted			2022-12-27	WOS:000361601100047
J	Li, XR; Zhao, XP; Duan, XB; Wang, XL				Li, Xiangrong; Zhao, Xupei; Duan, Xiabin; Wang, Xiaoliang			A Conjugate Gradient Algorithm with Function Value Information and N-Step Quadratic Convergence for Unconstrained Optimization	PLOS ONE			English	Article							QUASI-NEWTON METHODS; GLOBAL CONVERGENCE; SUPERLINEAR CONVERGENCE; BFGS METHOD; DESCENT; SEGMENTATION; MINIMIZATION	It is generally acknowledged that the conjugate gradient (CG) method achieves global convergence-with at most a linear convergence rate-because CG formulas are generated by linear approximations of the objective functions. The quadratically convergent results are very limited. We introduce a new PRP method in which the restart strategy is also used. Moreover, the method we developed includes not only n-step quadratic convergence but also both the function value information and gradient value information. In this paper, we will show that the new PRP method (with either the Armijo line search or the Wolfe line search) is both linearly and quadratically convergent. The numerical experiments demonstrate that the new PRP algorithm is competitive with the normal CG method.	[Li, Xiangrong; Duan, Xiabin; Wang, Xiaoliang] Guangxi Univ, Coll Math & Informat Sci, Guangxi Coll & Univ Key Lab Math & Its Applicat, Nanning 530004, Guangxi, Peoples R China; [Zhao, Xupei] Henan Univ Urban Construct, Math & Phys Inst, Pingdingshan, Henan, Peoples R China	Guangxi University; Henan University of Urban Construction	Wang, XL (corresponding author), Guangxi Univ, Coll Math & Informat Sci, Guangxi Coll & Univ Key Lab Math & Its Applicat, Nanning 530004, Guangxi, Peoples R China.	xliangwang@126.com		Wang, XiaoLiang/0000-0002-6926-1765	Guangxi NSF [2012GXNSFAA053002]; China NSF [11261006, 11161003]; Fund of Henan University of Urban Construction [2014JBS003]	Guangxi NSF; China NSF(National Natural Science Foundation of China (NSFC)); Fund of Henan University of Urban Construction	Mrs. Li and Dr. Zhao are the members of the Guangxi NSF (Grant No. 2012GXNSFAA053002) and the China NSF (Grant No. 11261006 and 11161003). Moreover Dr. Zhao is one member of the Fund of Henan University of Urban Construction (Grant No. 2014JBS003).	Broyden C. G., 1973, Journal of the Institute of Mathematics and Its Applications, V12, P223; BURMEISTER W, 1973, Z ANGEW MATH MECH, V53, P693, DOI 10.1002/zamm.19730531007; BYRD RH, 1987, SIAM J NUMER ANAL, V24, P1171, DOI 10.1137/0724077; BYRD RH, 1989, SIAM J NUMER ANAL, V26, P727, DOI 10.1137/0726042; COHEN AI, 1972, SIAM J NUMER ANAL, V9, P248, DOI 10.1137/0709024; Dai Y., 1997, THESIS CHESE ACAD SC; Dai Y., 1998, NONLINEAR CONJUGATE; Dai YH, 2003, SIAM J OPTIMIZ, V13, P693; Dai YH, 1999, SIAM J OPTIMIZ, V10, P177, DOI 10.1137/S1052623497318992; FLETCHER R, 1964, COMPUT J, V7, P149, DOI 10.1093/comjnl/7.2.149; Fletcher R., 1997, PRACTICAL METHODS OP, V1; Fu ZJ, 2015, IEICE T COMMUN, VE98B, P190, DOI 10.1587/transcom.E98.B.190; Gilbert JC, 1992, SIAM J OPTIMIZ, V2, P21, DOI 10.1137/0802003; Gu B, 2013, IEEE T NEUR NET LEAR, V24, P1304, DOI 10.1109/TNNLS.2013.2250300; Hager WW, 2006, ACM T MATH SOFTWARE, V32, P113, DOI 10.1145/1132973.1132979; Hager WW, 2005, SIAM J OPTIMIZ, V16, P170, DOI 10.1137/030601880; HESTENES MR, 1952, J RES NAT BUR STAND, V49, P409, DOI 10.6028/jres.049.044; Li DH, 2001, SIAM J OPTIMIZ, V11, P1054, DOI 10.1137/S1052623499354242; Li DH, 2001, J COMPUT APPL MATH, V129, P15, DOI 10.1016/S0377-0427(00)00540-9; Li DH, 2011, J COMPUT APPL MATH, V235, P4978, DOI 10.1016/j.cam.2011.04.026; Li J, 2015, IEEE T INF FOREN SEC, V10, P507, DOI 10.1109/TIFS.2014.2381872; Liu G., 1995, Optimization, V34, P147, DOI 10.1080/02331939508844101; Nicholas I, 2003, ACM T MATH SOFTWARE, V29, P373; POLAK E, 1969, REV FR INFORM RECH O, V3, P35; Polyak BT., 1969, USSR COMP MATH MATH, V9, P94, DOI [10.1016/0041-5553(69)90035-4, DOI 10.1016/0041-5553(69)90035-4]; POWELL MJD, 1984, LECT NOTES MATH, V1066, P122; POWELL MJD, 1986, SIAM REV, V28, P487, DOI 10.1137/1028154; RITTER K, 1980, NUMER MATH, V35, P293, DOI 10.1007/BF01396414; Storey C, 1992, J APPL MATH COMPUT, V69, P17; Tian BS, GLOBAL CONVERGENCE S; Wei ZX, 2006, APPL MATH COMPUT, V183, P1341, DOI 10.1016/j.amc.2006.05.150; Wei ZX, 2006, APPL MATH COMPUT, V175, P1156, DOI 10.1016/j.amc.2005.08.027; Wei ZX, 2004, COMPUT OPTIM APPL, V29, P315, DOI 10.1023/B:COAP.0000044184.25410.39; Wen XZ, 2015, IEEE T CIRC SYST VID, V25, P508, DOI 10.1109/TCSVT.2014.2358031; Yu GH, 2007, THESIS SUN YAT SEN U; Yuan GL, 2014, IIE TRANS, V46, P397, DOI 10.1080/0740817X.2012.726757; Yuan GL, 2014, J COMPUT APPL MATH, V255, P86, DOI 10.1016/j.cam.2013.04.032; Yuan GL, 2013, NUMER FUNC ANAL OPT, V34, P914, DOI 10.1080/01630563.2013.777350; Yuan GL, 2009, OPTIM LETT, V3, P11, DOI 10.1007/s11590-008-0086-5; Yuan GL, 2010, COMPUT OPTIM APPL, V47, P237, DOI 10.1007/s10589-008-9219-0; Yuan GL, 2009, J COMPUT APPL MATH, V233, P519, DOI 10.1016/j.cam.2009.08.001; Yuan GL, 2009, ANN OPER RES, V166, P73, DOI 10.1007/s10479-008-0420-4; Yuan Y., 1993, OPTIM METHOD SOFTW, V2, P19, DOI [DOI 10.1080/10556789308805532, 10.1080/10556789308805532]; Zhang H, 2014, IEEE T GEOSCI REMOTE, V52, P4391, DOI 10.1109/TGRS.2013.2281854; Zhang L, 2006, IMA J NUMER ANAL, V26, P629, DOI 10.1093/imanum/dr1016	46	1	1	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137166	10.1371/journal.pone.0137166	http://dx.doi.org/10.1371/journal.pone.0137166			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381742	Green Submitted, Green Published, gold			2022-12-27	WOS:000361790200016
J	Li, LH; Ren, JX; Liu, J; Wang, H; Wang, XW; Liu, Z; Sun, TS				Li, Lianhua; Ren, Jixin; Liu, Jia; Wang, Hao; Wang, Xiaowei; Liu, Zhi; Sun, Tiansheng			Results of Vertebral Augmentation Treatment for Patients of Painful Osteoporotic Vertebral Compression Fractures: A Meta-Analysis of Eight Randomized Controlled Trials	PLOS ONE			English	Article							PERCUTANEOUS VERTEBROPLASTY; BALLOON KYPHOPLASTY; FOLLOW-UP; CEMENT; OUTCOMES; VOLUME	Background In 2009 two RCTs were publicated to question the efficacy of vertebroplasty comparing with sham treatment (ST) in the New England Journal of Medicine (NEJM), which provoked an academic debate on the efficacy of PVA. The purposes of our study were to compare clinical differences in pain relief, spinal functional outcomes, and overall quality of life between PVA and CT for painful osteoporotic VCFs. Methods We searched PubMed, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials and Web of Knowledge from January 1980 to June 2013 with Medical Subject Headings terms and keywords. Risk of bias in the included studies was assessed in accordance with the Cochrane risk of bias tool. In this Meta-analysis dichotomous and continuous variables were calculated using the risk ratio (RR) and standardized mean difference (SMD), respectively. Results Eight studies involving 987 patients met the criteria for inclusion. The VAS SMD was favoring the experimental group significantly (p < 0.001). Subgroup analysis suggested that the patients performed PVA with mean fracture age less than 3 months would got pain relief earlier and more durable than the control group (P < 0.05). The SMD of spinal function assessed with RDQ and Oswestry LBP data was in favor of the experimental groups. QOL outcome improvement was demonstrated statistically significant at early, middle and late-term follow-up for PVA than the control group (P < 0.05). Conclusions In conclusion, this meta-analysis, which evaluated PVA for osteoporotic VCFs, demonstrated significant improvement regarding VAS, spinal function and QOL outcomes. The optimal fracture age was less than 12 weeks.	[Li, Lianhua; Ren, Jixin; Liu, Jia; Wang, Hao; Wang, Xiaowei; Liu, Zhi; Sun, Tiansheng] Beijing Army Gen Hosp, PLA Inst Orthoped, Beijing 100700, Peoples R China		Sun, TS (corresponding author), Beijing Army Gen Hosp, PLA Inst Orthoped, Beijing 100700, Peoples R China.	suntiansheng-@163.com	lianhua, li/I-8930-2014	li, Lianhua/0000-0002-5596-9172	Beijing Municipal Science and Technology Commission [D101100049910004]	Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission)	This research was supported by a grant from Beijing Municipal Science and Technology Commission (No. D101100049910004). The funding source had no role in the study design, collection, analysis, data interpretation, or the writing of the report. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams KR, 2005, STAT MED, V24, P3823, DOI 10.1002/sim.2423; Anderson PA, 2013, J BONE MINER RES, V28, P372, DOI 10.1002/jbmr.1762; Anselmetti GC, 2011, J VASC INTERV RADIOL, V22, P1714, DOI 10.1016/j.jvir.2011.09.001; Baerlocher MO, 2009, J VASC INTERV RADIOL, V20, P1277, DOI 10.1016/j.jvir.2009.08.017; Belkoff SM, 2001, SPINE, V26, P1537, DOI 10.1097/00007632-200107150-00007; Belkoff SM, 2001, SPINE, V26, P1542, DOI 10.1097/00007632-200107150-00008; Blasco J, 2012, J BONE MINER RES, V27, P1159, DOI 10.1002/jbmr.1564; Bolster MB, 2010, CLEV CLIN J MED, V77, P12, DOI 10.3949/ccjm.77a.09161; Bono CM, 2010, SPINE J, V10, P238, DOI 10.1016/j.spinee.2009.09.007; Boonen S, 2011, J BONE MINER RES, V26, P1627, DOI 10.1002/jbmr.364; Boszczyk B, 2010, EUR SPINE J, V19, P1837, DOI 10.1007/s00586-010-1525-4; Brodano GB, 2011, EUR SPINE J, V20, P1265, DOI 10.1007/s00586-011-1705-x; Buchbinder R, 2009, NEW ENGL J MED, V361, P557, DOI 10.1056/NEJMoa0900429; Clark W, 2010, J VASC INTERV RADIOL, V21, P1330, DOI 10.1016/j.jvir.2010.06.008; Esses Stephen I, 2011, J Bone Joint Surg Am, V93, P1934, DOI 10.2106/JBJS.9320ebo; Farahmand BY, 2005, OSTEOPOROSIS INT, V16, P1583, DOI 10.1007/s00198-005-2024-z; Farrokhi MR, 2011, J NEUROSURG-SPINE, V14, P561, DOI 10.3171/2010.12.SPINE10286; Fritzell P, 2011, SPINE, V36, P2243, DOI 10.1097/BRS.0b013e3182322d0f; Furukawa TA, 2006, J CLIN EPIDEMIOL, V59, P7, DOI 10.1016/j.jclinepi.2005.06.006; Gerling MC, 2011, SPINE, V36, pE1266, DOI 10.1097/BRS.0b013e31820a0b3f; Jensen ME, 2009, J NEUROINTERV SURG, V1, P181, DOI 10.1016/j.jvir.2009.04.022; Kallmes DF, 2009, NEW ENGL J MED, V361, P569, DOI 10.1056/NEJMoa0900563; Klazen CAH, 2010, LANCET, V376, P1085, DOI 10.1016/S0140-6736(10)60954-3; Lad SP, 2009, SURG NEUROL, V71, P580, DOI 10.1016/j.surneu.2008.02.043; Luetmer MT, 2011, AM J NEURORADIOL, V32, P647, DOI 10.3174/ajnr.A2371; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Philbrook HT, 2007, J CLIN EPIDEMIOL, V60, P228, DOI 10.1016/j.jclinepi.2006.06.018; Rousing R, 2010, SPINE, V35, P478, DOI 10.1097/BRS.0b013e3181b71bd1; Rousing Rikke, 2009, Spine (Phila Pa 1976), V34, P1349, DOI 10.1097/BRS.0b013e3181a4e628; Tanigawa N, 2011, AM J ROENTGENOL, V196, P1415, DOI 10.2214/AJR.10.5586; Taylor RS, 2007, EUR SPINE J, V16, P1085, DOI 10.1007/s00586-007-0308-z; Togawa D, 2003, SPINE, V28, P1521, DOI 10.1097/00007632-200307150-00009; Tsai YW, 2013, J AM MED DIR ASSOC, V14, P41, DOI 10.1016/j.jamda.2012.09.007; Van Meirhaeghe J, 2013, SPINE, V38, P971, DOI 10.1097/BRS.0b013e31828e8e22; Voormolen MHJ, 2007, AM J NEURORADIOL, V28, P555; Wardlaw D, 2009, LANCET, V373, P1016, DOI 10.1016/S0140-6736(09)60010-6	37	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138126	10.1371/journal.pone.0138126	http://dx.doi.org/10.1371/journal.pone.0138126			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378444	gold, Green Published, Green Submitted			2022-12-27	WOS:000361769400055
J	Saito, T; Kasamatsu, A; Ogawara, K; Miyamoto, I; Saito, K; Lyoda, M; Suzuki, T; Endo-Sakamoto, Y; Shiiba, M; Tanzawa, H; Uzawa, K				Saito, Tomoaki; Kasamatsu, Atsushi; Ogawara, Katsunori; Miyamoto, Isao; Saito, Kengo; Lyoda, Manabu; Suzuki, Takane; Endo-Sakamoto, Yosuke; Shiiba, Masashi; Tanzawa, Hideki; Uzawa, Katsuhiro			Semaphorin7A Promotion of Tumoral Growth and Metastasis in Human Oral Cancer by Regulation of G1 Cell Cycle and Matrix Metalloproteases: Possible Contribution to Tumoral Angiogenesis	PLOS ONE			English	Article							PROGNOSTIC MARKER; EXPRESSION; 7A; PROGRESSION; D1; INHIBITION; SUPPRESSOR; INDUCTION; INTEGRINS; CARCINOMA	Background Semaphorins (SEMAs) consist of a large family of secreted and membrane-anchored proteins that are important in neuronal pathfinding and axon guidance in selected areas of the developing nervous system. Of them, SEMA7A has been reported to have a chemotactic activity in neurogenesis and to be an immunomodulator; however, little is known about the relevance of SEMA7A in the behaviors of oral squamous cell carcinoma (OSCC). Methods We evaluated SEMA7A expression in OSCC-derived cell lines and primary OSCC samples using quantitative reverse transcriptase-polymerase chain reaction, immunoblotting, and semiquantitative immunohistochemistry (sq-IHC). In addition, SEMA7A knockdown cells (5hSEMA7A cells) were used for functional experiments, including cellular proliferation, invasiveness, and migration assays. We also analyzed the clinical correlation between SEMA7A status and clinical behaviors in patients with OSCC. Results SEMA7A mRNA and protein were up-regulated significantly (P<0.05) in OSCC-derived cell lines compared with human normal oral keratinocytes. The shSEMA7A cells showed decreased cellular growth by cell-cycle arrest at the G1 phase, resulting from up-regulation of cyclin-dependent kinase inhibitors (p21c1P1 and p27KiP1) and down-regulation of cyclins (cyclin Dl, cyclin E) and cyclin-dependent kinases (CDK2, CDK4, and CDK6); and decreased invasiveness and migration activities by reduced secretion of matrix metalloproteases (MMPs) (MMP-2, proMMP-2, pro-MMP-9), and expression of membrane type 1MMP (MT1-MMP). We also found inactivation of the extracellular regulated kinase 1/2 and AKT pathways, an upstream molecule of cell-cycle arrest at the G1 phase, and reduced secretion of MMPs in shSEMA7A cells. sq-IHC showed that SEMA7A expression in the primary OSCCs was significantly (P = 0.001) greater than that in normal counterparts and was correlated with primary tumoral size (P = 0.0254) and regional lymph node metastasis (P = 0.0002). Conclusion Our data provide evidence for an essential role of SEMA7A in tumoral growth and metastasis in OSCC and indicated that SEMA7A may play a potential diagnostic/therapeutic target for use in patients with OSCC.	[Saito, Tomoaki; Miyamoto, Isao; Tanzawa, Hideki; Uzawa, Katsuhiro] Chiba Univ, Grad Sch Med, Dept Oral Sci, Chuo Ku, Chiba 2608670, Japan; [Kasamatsu, Atsushi; Tanzawa, Hideki; Uzawa, Katsuhiro] Chiba Univ Hosp, Dept Dent & Oral Maxillofacial Surg, Chuo Ku, Chiba 2608670, Japan; [Ogawara, Katsunori] Funabashi Cent Hosp, Div Oral Surg, Funabashi, Chiba 2738556, Japan; [Ogawara, Katsunori] Funabashi Cent Hosp, Oral Implant Ctr, Funabashi, Chiba 2738556, Japan; [Saito, Kengo] Chiba Univ, Grad Sch Med, Dept Mol Virol, Chuo Ku, Chiba 2608670, Japan; [Lyoda, Manabu] Chiba Rosai Hosp, Div Oral Surg, Ichihara, Chiba 2900003, Japan; [Suzuki, Takane] Chiba Univ, Grad Sch Med, Dept Environm Hlth Sci, Chuo Ku, Chiba 2608670, Japan; [Shiiba, Masashi] Chiba Univ, Grad Sch Med, Dept Clin Oncol, Chuo Ku, Chiba 2608670, Japan	Chiba University; Chiba University; Chiba University; Chiba University	Uzawa, K (corresponding author), Chiba Univ, Grad Sch Med, Dept Oral Sci, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	uzawak@faculty.chibau.jp		Suzuki, Takane/0000-0002-0365-2544; Uzawa, Katsuhiro/0000-0002-7036-0859				Baba T, 2013, MOL CARCINOG; Choi HJ, 2006, GLYCOBIOLOGY, V16, P573, DOI 10.1093/glycob/cwj105; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; De Minicis S, 2013, AM J PATHOL, V183, P820, DOI 10.1016/j.ajpath.2013.05.030; Diaz-Rodriguez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027583; Endo Y, 2004, INT J CANCER, V110, P225, DOI 10.1002/ijc.20118; Epstein JA, 2015, CELL METAB, V21, P163, DOI 10.1016/j.cmet.2014.12.015; Ferrero M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028602; Garcia-Areas R, 2012, CANCER RES, V72, DOI 10.1158/1538-7445.AM2012-346; Garcia-Areas R, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00017; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Iyoda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014082; Kasamatsu A, 2005, INT J MOL MED, V16, P269; Kim S, 2010, BBA-MOL CELL RES, V1803, P1287, DOI 10.1016/j.bbamcr.2010.06.011; Koppel AM, 1997, NEURON, V19, P531, DOI 10.1016/S0896-6273(00)80369-4; Kouzu Y, 2006, BRIT J CANCER, V94, P717, DOI 10.1038/sj.bjc.6602991; Lange C, 1998, GENOMICS, V51, P340, DOI 10.1006/geno.1998.5256; Lombardi DP, 1999, CANCER RES, V59, P5724; Ma B, 2015, CANCER RES, V75, P487, DOI 10.1158/0008-5472.CAN-13-3339; Minakawa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085951; Moller MN, 2010, LARYNGOSCOPE, V120, P657, DOI 10.1002/lary.20834; MUSGROVE EA, 1994, P NATL ACAD SCI USA, V91, P8022, DOI 10.1073/pnas.91.17.8022; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Norii T, 2012, BIOL TRACE ELEM RES, V146, P207, DOI 10.1007/s12011-011-9236-1; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Pindborg JJ, 1997, HISTOLOGICAL TYPING; Pozzi A, 2011, CURR OPIN CELL BIOL, V23, P547, DOI 10.1016/j.ceb.2011.04.003; Rajashekhar G, 2014, EXP EYE RES, V122, P77, DOI 10.1016/j.exer.2014.03.004; Sakuma K, 2010, J CANCER RES CLIN, V136, P553, DOI 10.1007/s00432-009-0689-y; Sauter ER, 2002, CANCER RES, V62, P3200; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Scott GA, 2009, J INVEST DERMATOL, V129, P954, DOI 10.1038/jid.2008.329; Serini G, 2008, CARDIOVASC RES, V78, P213, DOI 10.1093/cvr/cvn045; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shimada K, 2005, BRIT J CANCER, V92, P1915, DOI 10.1038/sj.bjc.6602594; Shimizu F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083187; Shimizu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045510; Sobin LH., 2009, TNM CLASSIFICATION M, V7th edition; Sounni NE, 2005, BIOCHIMIE, V87, P329, DOI 10.1016/j.biochi.2004.07.012; Stetler-Stevenson WG, 2001, SEMIN CANCER BIOL, V11, P143, DOI 10.1006/scbi.2000.0365; TAM SW, 1994, ONCOGENE, V9, P2663; Tseng CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019396; Ventura I, 2014, ALLERGY, V69, P898, DOI 10.1111/all.12414; Wilson MJ, 2002, J CELL PHYSIOL, V191, P208, DOI 10.1002/jcp.10092; Xu XM, 1998, J BIOL CHEM, V273, P22428, DOI 10.1074/jbc.273.35.22428; Yamatoji M, 2012, INT J CANCER, V130, P2903, DOI 10.1002/ijc.26328; Yamatoji M, 2010, ONCOL REP, V23, P61, DOI 10.3892/or_00000606; Yue H, 2005, WORLD J GASTROENTERO, V11, P5057, DOI 10.3748/wjg.v11.i32.5057; Zhang SJ, 2014, MOL BIOL REP, V41, P2101, DOI 10.1007/s11033-014-3059-z; Zhou YP, 2008, TRENDS BIOCHEM SCI, V33, P161, DOI 10.1016/j.tibs.2008.01.006	51	40	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137923	10.1371/journal.pone.0137923	http://dx.doi.org/10.1371/journal.pone.0137923			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378920	Green Published, gold, Green Submitted			2022-12-27	WOS:000361769400036
J	Yang, DW; Song, DH; Kind, T; Ma, Y; Hoefkens, J; Fiehn, O				Yang, Dawei; Song, Donghui; Kind, Tobias; Ma, Yan; Hoefkens, Jens; Fiehn, Oliver			Lipidomic Analysis of Chlamydomonas reinhardtii under Nitrogen and Sulfur Deprivation	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; FATTY-ACID-COMPOSITION; SHOTGUN LIPIDOMICS; TRIACYLGLYCEROL ACCUMULATION; MEMBRANE-LIPIDS; STARVATION; PHASE; ALGAE	Chlamydomonas reinhardtii accumulates lipids under complete nutrient starvation conditions while overall growth in biomass stops. In order to better understand biochemical changes under nutrient deprivation that maintain production of algal biomass, we used a lipidomic assay for analyzing the temporal regulation of the composition of complex lipids in C. reinhardtii in response to nitrogen and sulfur deprivation. Using a chip-based nanoelectrospray direct infusion into an ion trap mass spectrometer, we measured a diversity of lipid species reported for C. reinhardtii, including PG phosphatidylglycerols, PI Phosphatidylinositols, MGDG monogalactosyldiacylglycerols, DGDG digalactosyldiacylglycerols, SQDG sulfoquinovosyldiacylglycerols, DGTS homoserine ether lipids and TAG triacylglycerols. Individual lipid species were annotated by matching mass precursors and MS/MS fragmentations to the in-house LipidBlast mass spectral database and MS2Analyzer. Multivariate statistics showed a clear impact on overall lipidomic phenotypes on both the temporal and the nutrition stress level. Homoserine-lipids were found up-regulated at late growth time points and higher cell density, while triacyclglycerols showed opposite regulation of unsaturated and saturated fatty acyl chains under nutritional deprivation.	[Yang, Dawei] Taishan Med Univ, Affiliated Liaocheng Hosp, Liaocheng Peoples Hosp, Zhong Yuan Acad Biol Med, Liaocheng 252000, Shandong, Peoples R China; [Song, Donghui] Tianjin Univ Sci & Technol, TEDA, Coll Marine Sci & Engn, Dept Marine Sci, Tianjin 300457, Peoples R China; [Kind, Tobias; Ma, Yan; Fiehn, Oliver] UC Davis Genome Ctr Metabol, Davis, CA 95616 USA; [Fiehn, Oliver] King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah 21589, Saudi Arabia; [Hoefkens, Jens] Genedata Inc, Waltham, MA USA	Shandong First Medical University & Shandong Academy of Medical Sciences; Tianjin University Science & Technology; King Abdulaziz University	Fiehn, O (corresponding author), UC Davis Genome Ctr Metabol, Davis, CA 95616 USA.	ofiehn@ucdavis.edu	Kind, Tobias/A-7553-2010	Kind, Tobias/0000-0002-1908-4916	US National Science Foundation [MCB 1139644]; Genedata Inc.	US National Science Foundation(National Science Foundation (NSF)); Genedata Inc.	The work was supported by US National Science Foundation MCB 1139644. Genedata Inc. provided support in the form of a salary for author JH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section.	Barupal DK, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-40; Bolling C, 2005, PLANT PHYSIOL, V139, P1995, DOI 10.1104/pp.105.071589; Boyle NR, 2012, J BIOL CHEM, V287, P15811, DOI 10.1074/jbc.M111.334052; Dean AP, 2010, BIORESOURCE TECHNOL, V101, P4499, DOI 10.1016/j.biortech.2010.01.065; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Fabregas J, 2004, WORLD J MICROB BIOT, V20, P31, DOI 10.1023/B:WIBI.0000013288.67536.ed; Fan JL, 2011, FEBS LETT, V585, P1985, DOI 10.1016/j.febslet.2011.05.018; GIROUD C, 1989, PLANT CELL PHYSIOL, V30, P121, DOI 10.1093/oxfordjournals.pcp.a077705; GIROUD C, 1988, PLANT CELL PHYSIOL, V29, P587; Guschina IA, 2006, PROG LIPID RES, V45, P160, DOI 10.1016/j.plipres.2006.01.001; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; James GO, 2011, BIORESOURCE TECHNOL, V102, P3343, DOI 10.1016/j.biortech.2010.11.051; Khotimchenko SV, 2005, PHYTOCHEMISTRY, V66, P73, DOI 10.1016/j.phytochem.2004.10.024; Khozin-Goldberg I, 2006, PHYTOCHEMISTRY, V67, P696, DOI 10.1016/j.phytochem.2006.01.010; Kind T, 2013, NAT METHODS, V10, P755, DOI 10.1038/nmeth.2551; Kind T, 2012, J CHROMATOGR A, V1244, P139, DOI 10.1016/j.chroma.2012.04.074; Kind Tobias, 2010, Bioanal Rev, V2, P23, DOI 10.1007/s12566-010-0015-9; Kropat J, 2011, PLANT J, V66, P770, DOI 10.1111/j.1365-313X.2011.04537.x; Lee DY, 2012, MOL CELL PROTEOMICS, V11, P973, DOI 10.1074/mcp.M111.016733; Lee DY, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-7; Li XB, 2012, PLANT CELL, V24, P4670, DOI 10.1105/tpc.112.105106; Li Y, 2008, BIOTECHNOL PROGR, V24, P815, DOI 10.1021/bp070371k; Li YT, 2010, BIOTECHNOL BIOENG, V107, P258, DOI 10.1002/bit.22807; Li YT, 2010, METAB ENG, V12, P387, DOI 10.1016/j.ymben.2010.02.002; Liu BS, 2013, BIORESOURCE TECHNOL, V146, P310, DOI 10.1016/j.biortech.2013.07.088; Lopez-Lara IM, 2005, MOL PLANT MICROBE IN, V18, P973, DOI 10.1094/MPMI-18-0973; Ma Y, 2014, ANAL CHEM, V86, P10724, DOI 10.1021/ac502818e; MacDougall KM, 2011, ANAL BIOANAL CHEM, V401, P2609, DOI 10.1007/s00216-011-5376-6; Mata TM, 2010, RENEW SUST ENERG REV, V14, P217, DOI 10.1016/j.rser.2009.07.020; Matthew T, 2009, J BIOL CHEM, V284, P23415, DOI 10.1074/jbc.M109.003541; Meuser JE, 2009, J BIOTECHNOL, V142, P21, DOI 10.1016/j.jbiotec.2009.01.015; Moellering E. R., 2010, LIPIDS PHOTOSYNTHESI, P139; Paik MJ, 2009, J CHROMATOGR A, V1216, P5917, DOI 10.1016/j.chroma.2009.06.051; REITAN KI, 1994, J PHYCOL, V30, P972, DOI 10.1111/j.0022-3646.1994.00972.x; Riekhof WR, 2005, EUKARYOT CELL, V4, P242, DOI 10.1128/EC.4.2.242-252.2005; Sato N, 2000, BIOCHEM SOC T, V28, P912, DOI 10.1042/0300-5127:0280912; Schiopu C, 2009, ANAL BIOANAL CHEM, V395, P2465, DOI 10.1007/s00216-009-3188-8; Schwudke D, 2007, METHOD ENZYMOL, V433, P175, DOI 10.1016/S0076-6879(07)33010-3; Stahlman M, 2009, J CHROMATOGR B, V877, P2664, DOI 10.1016/j.jchromb.2009.02.037; Sugimoto K, 2008, BIOCHEM BIOPH RES CO, V369, P660, DOI 10.1016/j.bbrc.2008.02.058; Sugimoto K, 2007, FEBS LETT, V581, P4519, DOI 10.1016/j.febslet.2007.08.035; Sushchik NN, 2003, RUSS J PLANT PHYSL+, V50, P374, DOI 10.1023/A:1023830405898; Tatsuzawa H, 1996, J PHYCOL, V32, P598, DOI 10.1111/j.0022-3646.1996.00598.x; Urzica EI, 2013, J BIOL CHEM, V288, P30246, DOI 10.1074/jbc.M113.490425; Vieler A, 2007, CHEM PHYS LIPIDS, V150, P143, DOI 10.1016/j.chemphyslip.2007.06.224; Wang ZT, 2009, EUKARYOT CELL, V8, P1856, DOI 10.1128/EC.00272-09; Welti R, 2005, HIGH THROUGHPUT LIPI, P307	48	40	44	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137948	10.1371/journal.pone.0137948	http://dx.doi.org/10.1371/journal.pone.0137948			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375463	Green Published, gold, Green Submitted			2022-12-27	WOS:000361610200063
J	Balakrishnan, SR; Hashim, U; Gopinath, SCB; Poopalan, P; Ramayya, HR; Omar, MI; Haarindraprasad, R; Veeradasan, P				Balakrishnan, S. R.; Hashim, U.; Gopinath, Subash C. B.; Poopalan, P.; Ramayya, H. R.; Omar, M. Iqbal; Haarindraprasad, R.; Veeradasan, P.			A Point-of-Care Immunosensor for Human Chorionic Gonadotropin in Clinical Urine Samples Using a Cuneated Polysilicon Nanogap Lab-on-Chip	PLOS ONE			English	Article							SENSITIVE DETECTION; BETA-HCG; AMPEROMETRIC IMMUNOSENSOR; PROTEIN ADSORPTION; MICROPIPETTE TIP; CARBON NANOTUBES; PHOTOMASK DESIGN; HIGH-THROUGHPUT; BIOSENSOR; IMMUNOASSAY	Human chorionic gonadotropin (hCG), a glycoprotein hormone secreted from the placenta, is a key molecule that indicates pregnancy. Here, we have designed a cost-effective, label-free, in situ point-of-care (POC) immunosensor to estimate hCG using a cuneated 25 nm polysilicon nanogap electrode. A tiny chip with the dimensions of 20.5 x 12.5 mm was fabricated using conventional lithography and size expansion techniques. Furthermore, the sensing surface was functionalized by (3-aminopropyl) triethoxysilane and quantitatively measured the variations in hCG levels from clinically obtained human urine samples. The dielectric properties of the present sensor are shown with a capacitance above 40 nF for samples from pregnant women; it was lower with samples from non-pregnant women. Furthermore, it has been proven that our sensor has a wide linear range of detection, as a sensitivity of 835.88 mu A mIU(-1) ml(-2) cm(-2) was attained, and the detection limit was 0.28 mIU/ml (27.78 pg/ml). The dissociation constant K-d of the specific antigen binding to the anti-hCG was calculated as 2.23 +/- 0.66 mIU, and the maximum number of binding sites per antigen was B-max = 22.54 +/- 1.46 mIU. The sensing system shown here, with a narrow nanogap, is suitable for high-throughput POC diagnosis, and a single injection can obtain triplicate data or parallel analyses of different targets.	[Balakrishnan, S. R.; Hashim, U.; Gopinath, Subash C. B.; Haarindraprasad, R.; Veeradasan, P.] Univ Malaysia Perlis, Inst Nano Elect Engn INEE, Biomed Nano Diagnost Res Grp, Kangar, Perlis, Malaysia; [Poopalan, P.] Univ Malaysia Perlis, Sch Microelect Engn, Kuala Perlis, Perlis, Malaysia; [Ramayya, H. R.] Hosp Tuanku Fauziah, Dept Obstet & Gynaecol, Kangar, Perlis, Malaysia; [Omar, M. Iqbal] Univ Malaysia Perlis, Univ Hlth Ctr, Kuala Perlis, Perlis, Malaysia	Universiti Malaysia Perlis; Universiti Malaysia Perlis; Universiti Malaysia Perlis	Hashim, U (corresponding author), Univ Malaysia Perlis, Inst Nano Elect Engn INEE, Biomed Nano Diagnost Res Grp, Kangar, Perlis, Malaysia.	uda@unimap.edu.my	Balakrishnan, Sharma Rao/G-4561-2015; Balakrishnan, Sharma Rao/AAP-2889-2021; Gopinath, Subash/D-2953-2015; omar, Mohammad iqbal/AAD-9283-2019; Omar, ye htut @ Mohammad Iqbal/D-1610-2015	Balakrishnan, Sharma Rao/0000-0002-6796-2277; Balakrishnan, Sharma Rao/0000-0002-6796-2277; Gopinath, Subash/0000-0002-8347-4687; POOPALAN, PRABAKARAN/0000-0003-1698-0632; Omar, ye htut @ Mohammad Iqbal/0000-0001-7149-419X; Perumal, Veeradasan/0000-0003-4492-0282	Ministry of Higher Education of Malaysia (MTUN-COE) [9016-00004]	Ministry of Higher Education of Malaysia (MTUN-COE)	This study was supported by Ministry of Higher Education of Malaysia (MTUN-COE grant 9016-00004). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azimi P, 2011, AFRICAN REV PHYS, P4; Balakrishnan SR, 2014, SENSOR ACTUAT A-PHYS, V220, P101, DOI 10.1016/j.sna.2014.09.027; Bourinbaiar AS, 1997, LIFE SCI, V61, pPL149, DOI 10.1016/S0024-3205(97)00568-7; Cate FL, 2013, CLIN CHIM ACTA, V421, P104, DOI 10.1016/j.cca.2013.02.026; Chai R, 2008, TALANTA, V74, P1330, DOI 10.1016/j.talanta.2007.08.046; Chen J, 2005, BIOSENS BIOELECTRON, V21, P330, DOI 10.1016/j.bios.2004.10.023; Cole LA, 2012, REPROD BIOL ENDOCRIN, P10; Cole LA, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-8; Davison CM, 2004, J EMERG MED, V27, P43, DOI 10.1016/j.jemermed.2004.02.009; Docoslis A, 1999, COLLOID SURFACE B, V13, P83, DOI 10.1016/S0927-7765(98)00111-8; Docoslis A, 2001, COLLOID SURFACE B, V22, P267, DOI 10.1016/S0927-7765(01)00150-3; Foo KL, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-429; Gopinath SCB, 2008, ACS NANO, V2, P1885, DOI 10.1021/nn800285p; Gopinath SCB, 2014, BIOSENS BIOELECTRON, V57, P292, DOI 10.1016/j.bios.2014.02.029; Gopinath SCB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081396; Greene DN, 2013, CLIN CHIM ACTA, V415, P317, DOI 10.1016/j.cca.2012.10.053; Gregor CR, 2011, J BIOL CHEM, V286, P25016, DOI 10.1074/jbc.M111.246637; Haarindraprasad R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132755; Hsu CW, 2014, BIOSENS BIOELECTRON, V56, P204, DOI 10.1016/j.bios.2014.01.023; Hsu PY, 2009, SENSOR ACTUAT B-CHEM, V142, P273, DOI 10.1016/j.snb.2009.08.003; Jiang ZL, 2008, CLIN CHIM ACTA, V387, P24, DOI 10.1016/j.cca.2007.08.017; Kaushik A, 2014, BIOSENS BIOELECTRON, V53, P499, DOI 10.1016/j.bios.2013.09.060; Kelly LS, 2005, ANAL BIOCHEM, V338, P253, DOI 10.1016/j.ab.2004.12.011; Lei JQ, 2014, BIOSENS BIOELECTRON, V54, P72, DOI 10.1016/j.bios.2013.10.033; Li N, 2008, BIOPROC BIOSYST ENG, V31, P551, DOI 10.1007/s00449-008-0201-0; Li R, 2011, ANAL BIOCHEM, V414, P196, DOI 10.1016/j.ab.2011.03.019; Liao JY, 2007, APPL MICROBIOL BIOT, V74, P1385, DOI 10.1007/s00253-006-0778-7; Lim TK, 2001, BIOSENS BIOELECTRON, V16, P1063, DOI 10.1016/S0956-5663(01)00228-7; Liu D, 2013, SENSOR ACTUAT B-CHEM, V186, P235, DOI 10.1016/j.snb.2013.05.094; Liu JM, 2012, ANAL BIOCHEM, V431, P19, DOI 10.1016/j.ab.2012.08.007; Liu W, 2012, 2012 THIRD CYBERCRIME AND TRUSTWORTHY COMPUTING WORKSHOP (CTC 2012), P56, DOI 10.1109/CTC.2012.9; Lonappan A, 2007, MICROW OPT TECHN LET, V49, P786, DOI 10.1002/mop.22279; Viet NX, 2013, BIOSENS BIOELECTRON, V42, P592, DOI 10.1016/j.bios.2012.11.017; Oh S, 2003, PROC IEEE MICR ELECT, P52; Pan C, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028827, DOI 10.1371/J0URNAL.P0NE.0028827]; Perumal V, 2015, SCI REP-UK, V5, DOI 10.1038/srep12231; Perumal V, 2014, J APPL BIOMED, V12, P1, DOI 10.1016/j.jab.2013.02.001; Piliarik M, 2005, BIOSENS BIOELECTRON, V20, P2104, DOI 10.1016/j.bios.2004.09.025; Prasad PV, 2007, CLIN CHIM ACTA, V376, P52, DOI 10.1016/j.cca.2006.07.013; Qin QP, 1997, J IMMUNOL METHODS, V205, P169, DOI 10.1016/S0022-1759(97)00073-2; Qureshi A, 2010, BIOSENS BIOELECTRON, V25, P2318, DOI 10.1016/j.bios.2010.03.018; Rao B. S., 2012, INT J ENHANCED RES S, V1, P1; Rao BS, 2014, ADV MATER RES-SWITZ, V925, P533, DOI 10.4028/www.scientific.net/AMR.925.533; Rao BS, 2013, ADV MATER RES-SWITZ, V795, P397, DOI 10.4028/www.scientific.net/AMR.795.397; Rao BS, 2013, ADV MATER RES-SWITZ, V795, P388, DOI 10.4028/www.scientific.net/AMR.795.388; Rao BS, 2014, ADV MATER RES-SWITZ, V832, P95, DOI 10.4028/www.scientific.net/AMR.832.95; Rao BS, 2014, ADV MATER RES-SWITZ, V832, P89, DOI 10.4028/www.scientific.net/AMR.832.89; Rao BS, 2013, 2013 IEEE REGIONAL SYMPOSIUM ON MICRO AND NANOELECTRONICS (RSM 2013), P54, DOI 10.1109/RSM.2013.6706471; Rao BS, 2013, 2013 IEEE REGIONAL SYMPOSIUM ON MICRO AND NANOELECTRONICS (RSM 2013), P17, DOI 10.1109/RSM.2013.6706462; Rao BS, 2012, IEEE EMBS CONF BIO; Sanchez S, 2008, ANAL CHEM, V80, P6508, DOI 10.1021/ac7025282; Santandreu M, 1999, ANAL CHIM ACTA, V396, P181, DOI 10.1016/S0003-2670(99)00436-5; SEVERS AH, 1993, BIOSENS BIOELECTRON, V8, P365, DOI 10.1016/0956-5663(93)80075-Z; Sharma MK, 2011, SENSOR LETT, V9, P1363, DOI 10.1166/sl.2011.1681; Tan F, 2007, BIOSENS BIOELECTRON, V22, P2945, DOI 10.1016/j.bios.2006.12.010; Tao ML, 2011, CLIN CHIM ACTA, V412, P550, DOI 10.1016/j.cca.2010.12.004; Teixeira S, 2014, SENSOR ACTUAT B-CHEM, V190, P723, DOI 10.1016/j.snb.2013.09.019; Truong LTN, 2011, TALANTA, V85, P2576, DOI 10.1016/j.talanta.2011.08.018; Wei Q, 2011, SENSOR ACTUAT B-CHEM, V153, P256, DOI 10.1016/j.snb.2010.09.073; Wu YL, 2011, SENSOR ACTUAT B-CHEM, V155, P709, DOI 10.1016/j.snb.2011.01.035; Yang GM, 2011, COLLOID SURFACE A, V389, P195, DOI 10.1016/j.colsurfa.2011.08.027; Yang HC, 2011, ELECTROCHIM ACTA, V56, P1973, DOI 10.1016/j.electacta.2010.12.003; Yang HC, 2011, COLLOID SURFACE B, V82, P463, DOI 10.1016/j.colsurfb.2010.10.003; Yang L, 2014, BIOSENS BIOELECTRON, V57, P199, DOI 10.1016/j.bios.2014.02.019; Yi MQ, 2005, BIOSENS BIOELECTRON, V20, P1320, DOI 10.1016/j.bios.2004.05.003; Yuhi T, 2006, SCI TECHNOL ADV MAT, V7, P276, DOI 10.1016/j.stam.2005.12.008; Yuhi T, 2006, J IMMUNOL METHODS, V312, P54, DOI 10.1016/j.jim.2006.02.011; Zhang GJ, 2012, ANAL CHIM ACTA, V749, P1, DOI 10.1016/j.aca.2012.08.035; Zhu QD, 2015, BIOSENS BIOELECTRON, V66, P370, DOI 10.1016/j.bios.2014.10.083	69	39	39	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137891	10.1371/journal.pone.0137891	http://dx.doi.org/10.1371/journal.pone.0137891			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368287	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100169
J	Furman, BT; Peterson, BJ				Furman, Bradley T.; Peterson, Bradley J.			Sexual Recruitment in Zostera marina: Progress toward a Predictive Model	PLOS ONE			English	Article							INDIAN RIVER LAGOON; WATER-QUALITY; CYMODOCEA-NODOSA; GENETIC NEIGHBORHOOD; POSIDONIA-OCEANICA; SIMULATION-MODEL; SEED PRODUCTION; NORTH-CAROLINA; CHESAPEAKE BAY; L EELGRASS	Ecophysiological stress and physical disturbance are capable of structuring meadows through a combination of direct biomass removal and recruitment limitation; however, predicting these effects at landscape scales has rarely been successful. To model environmental influence on sexual recruitment in perennial Zostera marina, we selected a sub-tidal, light-replete study site with seasonal extremes in temperature and wave energy. During an 8-year observation period, areal coverage increased from 4.8 to 42.7%. Gains were stepwise in pattern, attributable to annual recruitment of patches followed by centrifugal growth and coalescence. Recruitment varied from 13 to 4,894 patches per year. Using a multiple linear regression approach, we examined the association between patch appearance and relative wave energy, atmospheric condition and water temperature. Two models were developed, one appropriate for the dispersal of naked seeds, and another for rafted flowers. Results indicated that both modes of sexual recruitment varied as functions of wind, temperature, rainfall and wave energy, with a regime shift in wind-wave energy corresponding to periods of rapid colonization within our site. Temporal correlations between sexual recruitment and time-lagged climatic summaries highlighted floral induction, seed bank and small patch development as periods of vulnerability. Given global losses in seagrass coverage, regions of recovery and re-colonization will become increasingly important. Lacking land-scape-scale process models for seagrass recruitment, temporally explicit statistical approaches presented here could be used to forecast colonization trajectories and to provide managers with real-time estimates of future meadow performance; i.e., when to expect a good year in terms of seagrass expansion. To facilitate use as forecasting tools, we did not use statistical composites or normalized variables as our predictors. This study, therefore, represents a first step toward linking remotely acquired environmental data to sexual recruitment, an important measure of seagrass performance that translates directly into landscape-scale coverage change.	[Furman, Bradley T.; Peterson, Bradley J.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Peterson, BJ (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA.	bradley.peterson@stonybrook.edu		Furman, Bradley/0000-0002-9284-8388	Nature Conservancy; Shinnecock Bay Restoration Program	Nature Conservancy; Shinnecock Bay Restoration Program	The authors received no specific funding for this work. Partial support for investigator salaries were provided by The Nature Conservancy and the Shinnecock Bay Restoration Program.	Becheler R, 2010, MOL ECOL, V19, P2394, DOI 10.1111/j.1365-294X.2010.04649.x; Bekkby T, 2008, ICES J MAR SCI, V65, P1093, DOI 10.1093/icesjms/fsn095; Bell SS, 1997, RESTOR ECOL, V5, P318, DOI 10.1046/j.1526-100X.1997.00545.x; Bergenius MAJ, 2005, MAR BIOL, V147, P291, DOI 10.1007/s00227-005-1575-z; Biber PD, 2008, ESTUAR COAST, V31, P177, DOI 10.1007/s12237-007-9023-6; Billingham MR, 2007, MAR BIOL, V152, P793, DOI 10.1007/s00227-007-0730-0; Brun FG, 2006, MAR ECOL PROG SER, V323, P133, DOI 10.3354/meps323133; Burdick DM, 2006, INTERACTIVE GIS BASE; Burke MK, 1996, MAR ECOL PROG SER, V137, P195, DOI 10.3354/meps137195; Cheplick Gregory P., 1998, P84, DOI 10.1017/CBO9780511525445.005; CHURCHILL AC, 1978, AQUAT BOT, V4, P83; Clarke KR, 2006, J EXP MAR BIOL ECOL, V338, P179, DOI 10.1016/j.jembe.2006.06.019; Costello CT, 2011, ESTUAR COAST, V34, P232, DOI 10.1007/s12237-010-9371-5; Cunha AH, 2009, ESTUAR COAST SHELF S, V84, P584, DOI 10.1016/j.ecss.2009.07.030; Doheny TE, 1968, CONTR DEP CONSERV WA; Downie AL, 2013, ESTUAR COAST SHELF S, V121, P8, DOI 10.1016/j.ecss.2012.12.020; Duarte CM, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P271; Duarte CM, 2007, ESTUAR COAST, V30, P652, DOI 10.1007/BF02841962; DUARTE CM, 1990, MAR ECOL PROG SER, V67, P97, DOI 10.3354/meps067097; Fonseca MS, 1998, MAR ECOL PROG SER, V171, P109, DOI 10.3354/meps171109; FONSECA MS, 1995, RESTOR ECOL, V3, P70; Fourqurean JW, 2003, ECOL APPL, V13, P474, DOI 10.1890/1051-0761(2003)013[0474:FROSDT]2.0.CO;2; Furman BT, 2015, LIMNOLOGICAL OCEANOG, V60; Gallegos CL, 1996, ESTUAR COAST SHELF S, V42, P267, DOI 10.1006/ecss.1996.0020; Goodenough AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034338; Granger S, 2003, PRACTICAL GUIDE USE, P20; Grech A, 2010, AQUAT CONSERV, V20, P437, DOI 10.1002/aqc.1107; Greve TM, 2005, AQUAT BOT, V82, P143, DOI 10.1016/j.aquabot.2005.03.004; Greve TM, 2005, MAR BIOL, V146, P849, DOI 10.1007/s00227-004-1498-0; Guidetti P, 2002, MAR ECOL-P S Z N I, V23, P51, DOI 10.1046/j.1439-0485.2002.02722.x; Hammerli A, 2003, HEREDITY, V91, P448, DOI 10.1038/sj.hdy.6800310; HARRISON PG, 1993, AQUAT BOT, V45, P63, DOI 10.1016/0304-3770(93)90053-Y; Infantes E, 2011, LIMNOL OCEANOGR, V56, P2223, DOI 10.4319/lo.2011.56.6.2223; Infantes E, 2009, BOT MAR, V52, P419, DOI 10.1515/BOT.2009.050; Jarvis JC, 2014, AQUAT BOT, V113, P32, DOI 10.1016/j.aquabot.2013.10.010; Kemp WM, 2004, ESTUARIES, V27, P363; Kendrick GA, 2005, MAR ECOL PROG SER, V290, P291, DOI 10.3354/meps290291; Kendrick GA, 2012, BIOSCIENCE, V62, P56, DOI 10.1525/bio.2012.62.1.10; LANYON JM, 1995, AQUAT BOT, V49, P217, DOI 10.1016/0304-3770(94)00435-O; Lee KS, 2007, J EXP MAR BIOL ECOL, V350, P144, DOI 10.1016/j.jembe.2007.06.016; Lee KS, 2007, MAR ECOL PROG SER, V342, P105, DOI 10.3354/meps342105; Marba N, 2003, AQUAT BOT, V77, P87, DOI 10.1016/S0304-3770(03)00079-2; March D, 2013, ESTUAR COAST SHELF S, V131, P206, DOI 10.1016/j.ecss.2013.08.009; McMahon K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0878; Mills KE, 2003, MAR ECOL PROG SER, V255, P127, DOI 10.3354/meps255127; Moore KA, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P361; Morris LJ, 2004, ESTUARIES, V27, P915, DOI 10.1007/BF02803418; OLESEN B, 1994, MAR ECOL PROG SER, V106, P147, DOI 10.3354/meps106147; Orth RJ, 2000, MAR ECOL PROG SER, V200, P277, DOI 10.3354/meps200277; ORTH RJ, 1983, AQUAT BOT, V15, P117, DOI 10.1016/0304-3770(83)90023-2; PHILLIPS RC, 1983, AQUAT BOT, V16, P1, DOI 10.1016/0304-3770(83)90047-5; Plus M, 2003, AQUAT BOT, V77, P121, DOI 10.1016/S0304-3770(03)00089-5; R Development Core Team, 2012, R LANG ENV STAT COMP; Rasheed MA, 2011, MAR ECOL PROG SER, V422, P93, DOI 10.3354/meps08925; Reusch TBH, 1999, MAR BIOL, V133, P519, DOI 10.1007/s002270050492; Ruckelshaus MH, 1996, EVOLUTION, V50, P856, DOI 10.1111/j.1558-5646.1996.tb03894.x; Short FT, 1999, AQUAT BOT, V63, P169, DOI 10.1016/S0304-3770(98)00117-X; SILBERHORN GM, 1983, AQUAT BOT, V15, P133, DOI 10.1016/0304-3770(83)90024-4; Sintes T, 2006, ESTUAR COAST, V29, P72, DOI 10.1007/BF02784700; USACE, 2004, SUBM AQ VEG SAV BED; van Katwijk MM, 2010, BIOL CONSERV, V143, P248, DOI 10.1016/j.biocon.2009.08.014; VERHAGEN JHG, 1983, MAR ECOL PROG SER, V10, P187, DOI 10.3354/meps010187; Vermaat JE, 2009, PERSPECT PLANT ECOL, V11, P137, DOI 10.1016/j.ppees.2009.01.002; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Waycott M, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P25; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wong S, 2011, ECOL INFORM, V6, P127, DOI 10.1016/j.ecoinf.2010.11.004; Zar JH, 1999, BIOSTATISTICAL ANAL; Zharova N, 2001, AQUAT BOT, V70, P135, DOI 10.1016/S0304-3770(01)00151-6; Zipperle AM, 2011, ANN BOT-LONDON, V107, P127, DOI 10.1093/aob/mcq214	70	7	7	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138206	10.1371/journal.pone.0138206	http://dx.doi.org/10.1371/journal.pone.0138206			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368792	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100242
J	Guruge, KS; Yamanaka, N; Sonobe, M; Fujizono, W; Yoshioka, M; Akiba, M; Yamamoto, T; Joshua, DI; Balakrishna, K; Yamashita, N; Kannan, K; Tsutsui, T				Guruge, Keerthi S.; Yamanaka, Noriko; Sonobe, Miyuki; Fujizono, Wataru; Yoshioka, Miyako; Akiba, Masato; Yamamoto, Takehisa; Joshua, Derrick I.; Balakrishna, Keshava; Yamashita, Nobuyoshi; Kannan, Kurunthachalam; Tsutsui, Toshiyuki			Source-Related Effects of Wastewater on Transcription Factor (AhR, CAR and PXR)-Mediated Induction of Gene Expression in Cultured Rat Hepatocytes and Their Association with the Prevalence of Antimicrobial-Resistant Escherichia coli	PLOS ONE			English	Article							TREATMENT-PLANT EFFLUENTS; SEWAGE-TREATMENT PLANTS; IN-VITRO ASSESSMENT; MUNICIPAL WASTE; ORGANIC MICROPOLLUTANTS; ANTIBIOTIC-RESISTANCE; DRINKING-WATER; PHARMACEUTICALS; SURFACE; IDENTIFICATION	Extracts of wastewater collected from 4 sewage treatment plants (STPs) receiving effluents from different sources in South India were investigated for their levels of transcription factor-mediated gene induction in primary cultured rat hepatocytes. In addition, the relation between gene induction levels and the prevalence of antimicrobial-resistant Escherichia coli (E. coli) in wastewater was examined. STP-3, which treats only hospital wastewater, exhibited significantly greater induction potency of all 6 drug metabolizing cytochrome P450 (CYP) genes examined, CYP1A1, 1A2, 1B1, 2B15, 3A1, and 3A2, whereas the wastewater at STP-1, which exclusively receives domestic sewage, showed significantly diminished levels of induction of 3 CYP genes when compared to the levels of CYP induction at STP-2, which receives mixed wastewater. Samples collected during the monsoon season showed a significantly altered gene induction capacity compared to that of samples from the pre-monsoon period. The data suggest that the toxicity of wastewater in STPs was not significantly diminished during the treatment process. The chemical-gene interaction data predicted that a vast number of chemicals present in the wastewater would stimulate the genes studied in the rat hepatocytes. The multivariable logistic regression analysis demonstrated that the prevalence of isolates resistant to cefotaxime, imipenem and streptomycin was significantly correlated with the levels of induction of at least three CYP-isozymes in STP wastewater. In addition, the resistance of isolates in treatment plants was not altered by the treatment steps, whereas the sampling season did have an impact on the resistance to specific antimicrobials. The identification of receptor-mediated gene regulation capacities offers important data not limited to the (synergistic) physiological role of chemicals in biological systems but may provide new insight into the link between the effects of known/unknown drugs and prevalence of antimicrobial-resistant bacteria in wastewater.	[Guruge, Keerthi S.; Yamanaka, Noriko; Sonobe, Miyuki; Fujizono, Wataru; Yoshioka, Miyako] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Pathol & Pathophysiol Res Div, Tsukuba, Ibaraki, Japan; [Sonobe, Miyuki] Cent Livestock Hyg Serv Ctr, Wakakusu, Japan; [Fujizono, Wataru] Cent Livestock Hyg Serv Ctr, Minami Ku, Kumamoto, Japan; [Akiba, Masato] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Bacterial & Parasit Dis Res Div, Tsukuba, Ibaraki, Japan; [Yamamoto, Takehisa; Tsutsui, Toshiyuki] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Viral Dis & Epidemiol Res Div, Tsukuba, Ibaraki, Japan; [Joshua, Derrick I.; Balakrishna, Keshava] Manipal Univ, Manipal Inst Technol, Dept Civil Engn, Manipal, Karnataka, India; [Yamashita, Nobuyoshi] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan; [Kannan, Kurunthachalam] SUNY Albany, New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12222 USA; [Kannan, Kurunthachalam] SUNY Albany, Dept Environm Hlth Sci, Albany, NY 12222 USA	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Manipal Academy of Higher Education (MAHE); National Institute of Advanced Industrial Science & Technology (AIST); State University of New York (SUNY) System; State University of New York (SUNY) Albany; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Guruge, KS (corresponding author), Natl Agr & Food Res Org, Natl Inst Anim Hlth, Pathol & Pathophysiol Res Div, Tsukuba, Ibaraki, Japan.	guruge@affrc.go.jp	Guruge, Keerthi/AAW-4155-2021; Balakrishna, K/H-4796-2019; Yamashita, Nobuyoshi/L-3290-2018	Balakrishna, K/0000-0002-5399-0808; Yamashita, Nobuyoshi/0000-0003-3448-8713; Kannan, Kurunthachalam/0000-0002-1926-7456	Japan Society for the Promotion of Science [24256004]; Dr. TMA Pai Endowment Chair Earth Sciences-Manipal University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Dr. TMA Pai Endowment Chair Earth Sciences-Manipal University	This work was supported by the Japan Society for the Promotion of Science, a Grant-in-Aid for Scientific Research (A), 2012 to 2015 (24256004). Dr. TMA Pai Endowment Chair Earth Sciences-Manipal University, is thanked for supporting this study at Manipal, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens L, 2009, MAR POLLUT BULL, V58, P1326, DOI 10.1016/j.marpolbul.2009.04.028; Akiba M, 2015, ECOTOX ENVIRON SAFE, V115, P203, DOI 10.1016/j.ecoenv.2015.02.018; Amos GCA, 2015, ISME J, V9, P1467, DOI 10.1038/ismej.2014.237; Behnisch PA, 2003, ENVIRON INT, V29, P861, DOI 10.1016/S0160-4120(03)00105-3; Bouki C, 2013, ECOTOX ENVIRON SAFE, V91, P1, DOI 10.1016/j.ecoenv.2013.01.016; Brack W, 2003, ANAL BIOANAL CHEM, V377, P397, DOI 10.1007/s00216-003-2139-z; Budinsky RA, 2010, TOXICOL SCI, V118, P224, DOI 10.1093/toxsci/kfq238; Clarke BO, 2011, ENVIRON INT, V37, P226, DOI 10.1016/j.envint.2010.06.004; Escher BI, 2008, J ENVIRON MONITOR, V10, P622, DOI 10.1039/b800951a; Escher BI, 2014, ENVIRON SCI TECHNOL, V48, P1940, DOI 10.1021/es403899t; Escher BI, 2011, WATER RES, V45, P75, DOI 10.1016/j.watres.2010.08.019; Fick J, 2009, ENVIRON TOXICOL CHEM, V28, P2522, DOI 10.1897/09-073.1; Gahrs M, 2013, TOXICOL APPL PHARM, V272, P77, DOI 10.1016/j.taap.2013.05.034; Ganguly NK, 2011, INDIAN J MED RES, V134, P281; Guengrich FP, 1999, ANNU REV PHARMACOL, V39, P1, DOI 10.1146/annurev.pharmtox.39.1.1; Gunnarsson L, 2009, ENVIRON TOXICOL CHEM, V28, P2639, DOI 10.1897/09-120.1; Guruge KS, 2009, TOXICOL LETT, V185, P193, DOI 10.1016/j.toxlet.2009.01.002; Hasegawa J, 2007, CHEMOSPHERE, V69, P1188, DOI 10.1016/j.chemosphere.2007.06.021; Hilscherova K, 2000, ENVIRON SCI POLLUT R, V7, P159, DOI 10.1065/espr2000.02.017; Hirsch R, 1999, SCI TOTAL ENVIRON, V225, P109, DOI 10.1016/S0048-9697(98)00337-4; Hu WY, 2007, MOL PHARMACOL, V71, P1475, DOI 10.1124/mol.106.032748; Jacobs JM, 1999, TOXICOL APPL PHARM, V157, P51, DOI 10.1006/taap.1999.8659; Jalova V, 2013, ENVIRON INT, V59, P372, DOI 10.1016/j.envint.2013.06.024; Jarosova B, 2014, ENVIRON SCI POLLUT R, V21, P10970, DOI 10.1007/s11356-014-3056-8; Kido T, 2013, ENVIRON TOXICOL, V28, P21, DOI 10.1002/tox.20693; Kitani H., 2011, J VISUAL EXP JVE, V51, P2757; Kostich MS, 2014, ENVIRON POLLUT, V184, P354, DOI 10.1016/j.envpol.2013.09.013; Kumar V, 2008, TOXICOL APPL PHARM, V226, P60, DOI 10.1016/j.taap.2007.08.023; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Kumari Ranjeeta, 2012, J Family Med Prim Care, V1, P86, DOI 10.4103/2249-4863.104943; Lin JH, 2006, PHARM RES-DORDR, V23, P1089, DOI 10.1007/s11095-006-0277-7; Loos R, 2013, WATER RES, V47, P6475, DOI 10.1016/j.watres.2013.08.024; Luo Y, 2014, ENVIRON SCI TECH LET, V1, P26, DOI 10.1021/ez400152e; McClellan K, 2010, WATER RES, V44, P658, DOI 10.1016/j.watres.2009.12.032; Morisseau C, 2009, ENVIRON HEALTH PERSP, V117, P1867, DOI 10.1289/ehp.0900834; Nakada N, 2006, WATER RES, V40, P3297, DOI 10.1016/j.watres.2006.06.039; Nishimura M, 2007, DRUG METAB PHARMACOK, V22, P178, DOI 10.2133/dmpk.22.178; Pustylnyak VO, 2007, LIFE SCI, V80, P324, DOI 10.1016/j.lfs.2006.09.015; R Core Team, 2013, R LANG ENV STAT COMP; Ratola N, 2012, J HAZARD MATER, V239, P1, DOI 10.1016/j.jhazmat.2012.05.040; Rizzo L, 2013, SCI TOTAL ENVIRON, V447, P345, DOI 10.1016/j.scitotenv.2013.01.032; Schriks M, 2010, ENVIRON SCI TECHNOL, V44, P4766, DOI 10.1021/es100013x; SEGLEN PO, 1973, EXP CELL RES, V82, P391, DOI 10.1016/0014-4827(73)90357-1; Smital T, 2011, ECOTOX ENVIRON SAFE, V74, P844, DOI 10.1016/j.ecoenv.2010.11.010; Stalder T, 2014, ISME J, V8, P768, DOI 10.1038/ismej.2013.189; Subedi B, 2014, ENVIRON SCI TECHNOL, V48, P6661, DOI 10.1021/es501709a; Suzuki G, 2010, ENVIRON SCI TECHNOL, V44, P8330, DOI 10.1021/es102021c; Van der Linden SC, 2008, ENVIRON SCI TECHNOL, V42, P5814, DOI 10.1021/es702897y; Villeneuve DL, 2000, ARCH ENVIRON CON TOX, V39, P273; Willson TM, 2002, NAT REV DRUG DISCOV, V1, P259, DOI 10.1038/nrd753; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060368; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zhang J G, 2010, Drug Metab Lett, V4, P185; Zhou SF, 2008, CURR DRUG METAB, V9, P310, DOI 10.2174/138920008784220664	54	4	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138391	10.1371/journal.pone.0138391	http://dx.doi.org/10.1371/journal.pone.0138391			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381891	Green Published, Green Submitted, gold			2022-12-27	WOS:000361790200097
J	Wang, Y; Dong, WZ; Mauk, K; Li, PY; Wan, J; Yang, G; Fang, LY; Huan, W; Chen, C; Hao, M				Wang, Ying; Dong, Weizhen; Mauk, Kristen; Li, Peiying; Wan, Jin; Yang, Guang; Fang, Lyuying; Huan, Wan; Chen, Chun; Hao, Mo			Nurses' Practice Environment and Their Job Satisfaction: A Study on Nurses Caring for Older Adults in Shanghai	PLOS ONE			English	Article							LONG-TERM-CARE; REGISTERED NURSES; HEALTH-SERVICE; WORK; LEAVE; INTENTIONS; PREDICTORS; CHINA; QUIT	Aim To examine the job satisfaction of nurses who are caring for older adults in healthcare settings in Shanghai, and to explore the underlying factors in order to explain and predict nurses' job satisfaction. Background China has the largest elderly population in the world, and its population is aging rapidly. Studies on job satisfaction of nurses providing care for the elderly in China can help to identify problem areas and develop strategies for the improvement of nurses' working conditions. However, to date, this subject matter has not been thoroughly studied in the Chinese context. Previous studies in other countries show that many factors impact nurses' job satisfaction, with the practice environment being a critical factor. There is a serious nursing shortage in China, especially in the big cities such as Shanghai. Given the increasing care demand of the aging population, learning about the job satisfaction level among nurses who are caring for older adults can provide essential information to help attract and retain nurses in this specialty area. Methods A cross-sectional survey was conducted among 444 nurses in 22 elderly care institutions in Shanghai. The Chinese version of the Index of Work Satisfaction (IWS) and the Nursing Practice Environment Scale were instruments used. Inferential statistical tests used to analyze the data included Spearman correlation analysis, one-way analysis of variance, and hierarchical regression tests. Results The average overall IWS (part B) score was 135.21 +/- 19.34. Personality, job and organizational characteristics were found to be the most influential factors, and the practice environment was identified as having the strongest impact on job satisfaction (Beta = 0.494). Conclusion Job satisfaction level among nurses who are caring for older adults in Shanghai is moderate, but the data suggest that this could be greatly increased if the nursing practice environment was improved.	[Wang, Ying; Wan, Jin; Yang, Guang; Fang, Lyuying; Huan, Wan; Hao, Mo] Fudan Univ, Res Inst Hlth Dev Strategies, Shanghai 200433, Peoples R China; [Dong, Weizhen] Univ Toronto, Munk Sch Global Affairs, Toronto, ON M5S 0A7, Canada; [Mauk, Kristen] Valparaiso Univ, Coll Nursing & Hlth Profess, Valparaiso, IN 46383 USA; [Li, Peiying] Hangzhou Vocat & Tech Coll, Sch Nursing, Hangzhou, Zhejiang, Peoples R China; [Chen, Chun] Wenzhou Med Coll, Coll Humanities & Management, Hangzhou, Zhejiang, Peoples R China	Fudan University; University of Toronto; Valparaiso University; Hangzhou Vocational & Technical College; Wenzhou Medical University	Chen, C (corresponding author), Wenzhou Med Coll, Coll Humanities & Management, Hangzhou, Zhejiang, Peoples R China.	chenchun408@126.com; haomo03@fudan.edu.cn	Chen, Chun/E-9759-2011; Hao, Mo/GRR-6669-2022		National Natural Science Foundation of China [70733002, 70703005]; Program for Changjiang Scholars, and Innovative Research Team in University (PCSIRT) [IRT_13R11]; Humanities and Social Sciences Research from the Ministry of Education of China [12YJCZH100]; National Social Science Fund of China [13AZD081]; Collaborative Innovation Center of Social Risks Governance in Health	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars, and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Humanities and Social Sciences Research from the Ministry of Education of China(Ministry of Education, China); National Social Science Fund of China; Collaborative Innovation Center of Social Risks Governance in Health	The project team is grateful to all of the participants in the study. This project was supported by the National Natural Science Foundation of China (grant number 70733002, 70703005), the Program for Changjiang Scholars, and Innovative Research Team in University (PCSIRT) (NO. IRT_13R11); the Humanities and Social Sciences Research (12YJCZH100) from the Ministry of Education of China; Program of National Social Science Fund of China [13AZD081]; and Collaborative Innovation Center of Social Risks Governance in Health also provided funding for the original research project. Mo Hao contributed in the study design, data collection.	Altier ME, 2006, J NURSES PROF DEV, V22, P70, DOI 10.1097/00124645-200603000-00006; Andrews Diane Randall, 2005, J Nurs Manag, V13, P286, DOI 10.1111/j.1365-2934.2005.00567.x; [Anonymous], 2011, CHINAS MAIN DEMOGRAP; Asadi A., 2008, J SOCIAL SCI, V4, P246; Burke Ronald J, 2003, Health Care Manag (Frederick), V22, P99; Caers R, 2008, J ADV NURS, V62, P521, DOI 10.1111/j.1365-2648.2008.04620.x; CARR KK, 1994, J ADV NURS, V19, P878, DOI 10.1111/j.1365-2648.1994.tb01164.x; Chan MF, 2009, J CLIN NURS, V18, P893, DOI 10.1111/j.1365-2702.2008.02463.x; China MoHo, 2013, CHIN HLTH STAT YB 20; Choi SPP, 2013, J NURS MANAGE, V21, P429, DOI 10.1111/j.1365-2834.2012.01415.x; Cimete G, 2003, J NURS CARE QUAL, V18, P151, DOI 10.1097/00001786-200304000-00009; Cohen JD, 2006, J HEALTHC MANAG, V51, P233, DOI 10.1097/00115514-200607000-00006; Curtis EA, 2007, INT NURS REV, V54, P92, DOI 10.1111/j.1466-7657.2007.00507.x; Evans MG, 1995, NURSING RES; Feng ZL, 2012, HEALTH AFFAIR, V31, P2764, DOI 10.1377/hlthaff.2012.0535; Fillion Lise, 2006, Palliat Support Care, V4, P333; Flanagan NA, 2002, RES NURS HEALTH, V25, P282, DOI 10.1002/nur.10042; Friese CR, 2005, ONCOLOGY NURSING FOR; Gardner Jane K, 2007, Nephrol Nurs J, V34, P271; Government SMPs, 2012, 5 YEAR PLAN 2011 201; Grant D, 2009, J HEALTH ECON, V28, P244, DOI 10.1016/j.jhealeco.2008.09.005; Hall Debra S, 2007, Nurs Adm Q, V31, P68; Happell B, 2003, INT J MENT HEALTH NU, V12, P39, DOI 10.1046/j.1440-0979.2003.00267.x; Hong T, 2010, CHINESE PRIMARY HLTH, V24, P17; IskraGolec I, 1996, WORK STRESS, V10, P251; Kacel Barbara, 2005, J Am Acad Nurse Pract, V17, P27, DOI 10.1111/j.1041-2972.2005.00007.x; Karanikola Maria N, 2007, J Nurs Manag, V15, P78, DOI 10.1111/j.1365-2934.2006.00673.x; Kash BA, 2010, HEALTH CARE MANAGE R, V35, P246, DOI 10.1097/HMR.0b013e3181dc826d; Lake ET, 2002, RES NURS HEALTH, V25, P176, DOI 10.1002/nur.10032; Larrabee JH, 2003, J NURS ADMIN, V33, P271, DOI 10.1097/00005110-200305000-00003; Ma CC, 2003, J NURS ADMIN, V33, P293, DOI 10.1097/00005110-200305000-00005; Manojlovich M, 2005, J NURS SCHOLARSHIP, V37, P367, DOI 10.1111/j.1547-5069.2005.00063.x; Manojlovich M, 2002, J NURS ADMIN, V32, P586, DOI 10.1097/00005110-200211000-00006; March JG., 1958, ORGANIZATIONS; Microbell, 2012, SER POP AG CHIN INL; Ministry of Health of the Peoples Republic of China, 2006, NOT WEB CTR PEOPL GO; Mittra R, 2010, DIMENTION ED, P137; Patrician PA, 2010, RES NURS HEALTH, V33, P99, DOI 10.1002/nur.20370; PETTERSON IL, 1995, PSYCHOTHER PSYCHOSOM, V64, P9, DOI 10.1159/000288986; Ruggiero JS, 2005, J NURS ADMIN, V35, P254; Sheng z, 2012, CHINESE J NURSING ED, V9, P319; Shields MA, 2002, ECONOMICA, V69, P295, DOI 10.1111/1468-0335.00284; Shields MA, 2001, J HEALTH ECON, V20, P677, DOI 10.1016/S0167-6296(01)00092-3; Stamps P.L., 1997, NURSES WORK SATISFAC, V2nd ed.; Upenieks VV, 2002, J NURS ADMIN, V32, P564, DOI 10.1097/00005110-200211000-00004; Wu B, 2008, J AGING SOC POLICY, V20, P218, DOI 10.1080/08959420801977632; Wu L, 2007, STUDY WORK SATISFACT; Xinhua, CHIN POP AG HIGHL SH; Yang Y., 2011, RES STATUS POLICIES; Zangaro GA, 2005, J NURS MEAS, V13, P7, DOI 10.1891/jnum.2005.13.1.7; Zangaro GA, 2007, RES NURS HEALTH, V30, P445, DOI 10.1002/nur.20202; Zeng Q, 2008, STUDY WORK SATISFACT; Zheng X, 2009, NURSE JOB SATISFACTI	53	17	17	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138035	10.1371/journal.pone.0138035	http://dx.doi.org/10.1371/journal.pone.0138035			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0ZE	26380980	Green Submitted, gold, Green Published			2022-12-27	WOS:000361790200050
J	Daniels, CML; Paffenrothl, E; Austin, EV; Glebov, K; Lewis, D; Walter, J; Messing, A				Daniels, Christine M. LaPash; Paffenrothl, Elizabeth; Austin, Elizabeth V.; Glebov, Konstantin; Lewis, Diana; Walter, Jochen; Messing, Albee			Lithium Decreases Glial Fibrillary Acidic Protein in a Mouse Model of Alexander Disease	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; AGGREGATE-PRONE PROTEINS; ALPHA-B-CRYSTALLIN; SIGNALING PATHWAY; GFAP ACCUMULATION; STRESS-RESPONSE; IN-VIVO; AUTOPHAGY; BRAIN; INHIBITION	Alexander disease is a fatal neurodegenerative disease caused by mutations in the astrocyte intermediate filament glial fibrillary acidic protein (GFAP). The disease is characterized by elevated levels of GFAP and the formation of protein aggregates, known as Rosenthal fibers, within astrocytes. Lithium has previously been shown to decrease protein aggregates by increasing the autophagy pathway for protein degradation. In addition, lithium has also been reported to decrease activation of the transcription factor STAT3, which is a regulator of GFAP transcription and astrogliogenesis. Here we tested whether lithium treatment would decrease levels of GFAP in a mouse model of Alexander disease. Mice with the Gfap-R236H point mutation were fed lithium food pellets for 4 to 8 weeks. Four weeks of treatment with LiCl at 0.5% in food pellets decreased GFAP protein and transcripts in several brain regions, although with mild side effects and some mortality. Extending the duration of treatment to 8 weeks resulted in higher mortality, and again with a decrease in GFAP in the surviving animals. Indicators of autophagy, such as LC3, were not increased, suggesting that lithium may decrease levels of GFAP through other pathways. Lithium reduced the levels of phosphorylated STAT3, suggesting this as one pathway mediating the effects on GFAP. In conclusion, lithium has the potential to decrease GFAP levels in Alexander disease, but with a narrow therapeutic window separating efficacy and toxicity.	[Daniels, Christine M. LaPash; Paffenrothl, Elizabeth; Austin, Elizabeth V.; Lewis, Diana; Messing, Albee] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Messing, Albee] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53706 USA; [Glebov, Konstantin; Walter, Jochen] Univ Bonn, Dept Neurol, Bonn, Germany	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Bonn	Messing, A (corresponding author), Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA.	amessing@wisc.edu	Walter, Jochen/B-3677-2014; Wang, Caihong/T-5837-2019	Wang, Caihong/0000-0002-6808-3709; Walter, Jochen/0000-0002-4678-2912	National Institute of Neurological Disorders and Stroke [NS060120, NS042803]; National Institute of Child Health and Human Development [P30 HD003352]; Juanma Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060120, P01NS042803] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Juanma Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institute of Neurological Disorders and Stroke (ninds.nih.gov; NS060120 and NS042803 to AM), the National Institute of Child Health and Human Development (nichd.nih.gov; P30 HD003352 to the Waisman Center), and the Juanma Fund (AM). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assadi M, 2010, EUR J PAEDIATR NEURO, V14, P354, DOI 10.1016/j.ejpn.2009.11.006; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; Bersudsky Y, 2007, BEHAV PHARMACOL, V18, P77, DOI 10.1097/FBP.0b013e32801416ed; Beurel E, 2008, J BIOL CHEM, V283, P21934, DOI 10.1074/jbc.M802481200; Beurel E, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-9; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Brenner M, 2001, NAT GENET, V27, P117, DOI 10.1038/83679; Carmichael J, 2002, J BIOL CHEM, V277, P33791, DOI 10.1074/jbc.m204861200; Chalecka-Franaszek E, 1999, P NATL ACAD SCI USA, V96, P8745, DOI 10.1073/pnas.96.15.8745; Chandana R, 2009, INDIAN J MED RES, V129, P189; Daniels CML, 2012, J NEUROSCI, V32, P10507, DOI 10.1523/JNEUROSCI.1494-12.2012; DEARMOND SJ, 1986, J NEUROCHEM, V47, P1749, DOI 10.1111/j.1471-4159.1986.tb13084.x; Festing MFW, 2003, TRENDS PHARMACOL SCI, V24, P341, DOI 10.1016/S0165-6147(03)00159-7; Festing Michael F W, 2002, ILAR J, V43, P244; Forlenza OV, 2014, ACS CHEM NEUROSCI, V5, P443, DOI 10.1021/cn5000309; Fornai F, 2008, P NATL ACAD SCI USA, V105, P2052, DOI 10.1073/pnas.0708022105; Gao M, 2013, NEUROSCIENCE, V254, P301, DOI 10.1016/j.neuroscience.2013.09.033; Gould TD, 2007, NEUROPSYCHOPHARMACOL, V32, P1321, DOI 10.1038/sj.npp.1301254; Hagemann TL, 2005, HUM MOL GENET, V14, P2443, DOI 10.1093/hmg/ddi248; Hagemann TL, 2006, J NEUROSCI, V26, P11162, DOI 10.1523/JNEUROSCI.3260-06.2006; Hagemann TL, 2009, HUM MOL GENET, V18, P1190, DOI 10.1093/hmg/ddp013; He F, 2005, NAT NEUROSCI, V8, P616, DOI 10.1038/nn1440; Hirschfeld R., 2002, PRACTICE GUIDELINE T; Jany PL, 2013, ASN NEURO, V5, P81, DOI 10.1042/AN20130003; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kyllerman M, 2005, NEUROPEDIATRICS, V36, P319, DOI 10.1055/s-2005-872876; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; MARTIN PM, 1995, J NEUROSCI METH, V58, P181, DOI 10.1016/0165-0270(94)00175-G; Messing A, 1998, AM J PATHOL, V152, P391; Messing A, 2012, J NEUROSCI, V32, P5017, DOI 10.1523/JNEUROSCI.5384-11.2012; Messing A, 2010, NEUROTHERAPEUTICS, V7, P507, DOI 10.1016/j.nurt.2010.05.013; Nicolas Celine S, 2013, JAKSTAT, V2, pe22925, DOI 10.4161/jkst.22925; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Price JC, 2010, P NATL ACAD SCI USA, V107, P14508, DOI 10.1073/pnas.1006551107; Prust M, 2011, NEUROLOGY, V77, P1287, DOI 10.1212/WNL.0b013e3182309f72; Quiroz JA, 2010, NEUROPSYCHOBIOLOGY, V62, P50, DOI 10.1159/000314310; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; ROIZIN L, 1970, Diseases of the Nervous System, V31, P38; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; SCHOU M, 1958, ACTA PHARMACOL TOX, V15, P70; Sriram K, 2004, J BIOL CHEM, V279, P19936, DOI 10.1074/jbc.M309304200; Stromhaug PE, 2001, TRAFFIC, V2, P524, DOI 10.1034/j.1600-0854.2001.20802.x; Tajes M, 2008, J NEUROPATH EXP NEUR, V67, P612, DOI 10.1097/NEN.0b013e3181776293; Tang GM, 2008, HUM MOL GENET, V17, P1540, DOI 10.1093/hmg/ddn042; Tang GM, 2006, J BIOL CHEM, V281, P38634, DOI 10.1074/jbc.M604942200; Tang GM, 2010, J BIOL CHEM, V285, P10527, DOI 10.1074/jbc.M109.067975; THELLIER M, 1980, BRAIN RES, V199, P175, DOI 10.1016/0006-8993(80)90239-5; WOOD AJ, 1986, NEUROPHARMACOLOGY, V25, P1285, DOI 10.1016/0028-3908(86)90149-8; Yoshida T, 2011, J NEUROL, V258, P1998, DOI 10.1007/s00415-011-6056-3; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200; Zhu LY, 2004, NEUROSCI LETT, V367, P210, DOI 10.1016/j.neulet.2004.06.020; Zhu ZZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023341	56	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138132	10.1371/journal.pone.0138132	http://dx.doi.org/10.1371/journal.pone.0138132			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378915	Green Submitted, gold, Green Published			2022-12-27	WOS:000361769400057
J	Gebeyehu, E; Bantie, L; Azage, M				Gebeyehu, Endalew; Bantie, Laychiluh; Azage, Muluken			Inappropriate Use of Antibiotics and Its Associated Factors among Urban and Rural Communities of Bahir Dar City Administration, Northwest Ethiopia	PLOS ONE			English	Article							SELF-MEDICATION PRACTICES; KHARTOUM STATE; KNOWLEDGE; PRESCRIPTION; RESISTANCE; ATTITUDES; CHILDREN; MISUSE; NONADHERENCE; BEHAVIOR	Background Inappropriate use of antibiotics in the community plays a role in the emergence and spread of bacteria resistant to antibiotics which threatens human health significantly. The present study was designed to determine inappropriate use of antibiotics and its associated factors among urban and rural communities of Bahir Dar city administration. Methods A comparative cross sectional study design was conducted in urban and rural kebeles of Bahir Dar city administration from February 1 to March 28, 2014. A total of 1082 participants included in the study using a systematic random sampling technique. Data was collected using pre-tested and structured questionnaire. Data was coded and entered into SPSSS version 16 for statistical analysis. Bivariate and multivariate logistic regression model were used to identify factors associated with inappropriate use of antibiotics. Results Inappropriate use of antibiotics was 30.9% without significant difference between urban (33.1%) and rural (29.2%) communities. From the inappropriate antibiotic use practice, self-medication was 18.0% and the remaining (12.9%) was for family member medication. Respiratory tract symptoms (74.6%), diarrhea (74.4%), and physical injury/wound (64.3%) were the three main reasons that the communities had used antibiotics inappropriately. Factors associated with inappropriate use of antibiotics were low educational status, younger age, unsatisfaction with the health care services, engagement with a job, and low knowledge on the use of antibiotic preparations of human to animals. Conclusions Inappropriate use of antibiotic exists in the study area with no significant difference between urban and rural communities. The study indicated an insight on what factors that intervention should be made to reduce inappropriate use of antibiotics in the community. Interventions that consider age groups, educational status, common health problems and their jobs together with improvement of health care services should be areas of focus to reduce inappropriate use of antibiotics.	[Gebeyehu, Endalew; Bantie, Laychiluh] Bahir Dar Univ, Dept Pharmacol, Coll Med & Hlth Sci, Bahir Dar, Ethiopia; [Azage, Muluken] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Bahir Dar, Ethiopia	Bahir Dar University; Bahir Dar University	Gebeyehu, E (corresponding author), Bahir Dar Univ, Dept Pharmacol, Coll Med & Hlth Sci, POB 79, Bahir Dar, Ethiopia.	endalew2008@gmail.com	Azage, Muluken/AAF-6515-2020; Mekonnen, Laychiluh/AGO-0752-2022	Azage, Muluken/0000-0003-3222-0158; 	Bahir Dar University	Bahir Dar University	Bahir Dar University paid perdium for data collectors during data collection. Thus, Bahir Dar University had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abula T., 2001, Ethiopian Journal of Health Development, V15, P25; Ahiabu MA, 2016, HEALTH POLICY PLANN, V31, P250, DOI 10.1093/heapol/czv048; Al-Tawfiq JA, 2010, EXPERT REV ANTI-INFE, V8, P765, DOI 10.1586/ERI.10.56; Awad A, 2005, J PHARM PHARM SCI, V8, P326; Awad AI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117910; Awad AI, 2006, EUR J CLIN PHARMACOL, V62, P317, DOI 10.1007/s00228-006-0107-1; Barah F., 2010, Eastern Mediterranean Health Journal, V16, P516; Berzanskyte Ausra, 2006, International Journal of Occupational Medicine and Environmental Health, V19, P246, DOI [10.2478/v10001-006-0030-9, 10.2478/v10001-006-0030.9]; Bi P, 2000, SOC SCI MED, V50, P1445, DOI 10.1016/S0277-9536(99)00304-4; Buke AC, 2003, INT J ANTIMICROB AG, V21, P63, DOI 10.1016/S0924-8579(02)00272-8; Cizman M, 2003, INT J ANTIMICROB AG, V21, P297, DOI 10.1016/S0924-8579(02)00394-1; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; CSA, 2014, SUMM STAT REP 2007 P; DACA, 2009, ANT US RES CONT BAS; de Loyola AI, 2002, REV SAUDE PUBL, V36, P55, DOI 10.1590/S0034-89102002000100009; Desalegn AA, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-170; Endale Getachew, 2013, African Journal of Pharmacy and Pharmacology, V7, P2657; Fatokun O, 2014, INT J CLIN PHARM-NET, V36, P564, DOI 10.1007/s11096-014-9937-6; Fenta Ayaleneh, 2013, Ethiop Med J, V51, P33; Ferech M, 2006, J ANTIMICROB CHEMOTH, V58, P401, DOI 10.1093/jac/dkl188; Fernandes M, 2014, INT J CLIN PHARM-NET, V36, P86, DOI 10.1007/s11096-013-9850-4; Foroutan B, 2014, E MEDITERR HEALTH J, V20, P547, DOI 10.26719/2014.20.9.547; Grosso G, 2012, MOL MED REP, V5, P1305, DOI 10.3892/mmr.2012.818; Hennessy TW, 2002, CLIN INFECT DIS, V34, P1543, DOI 10.1086/340534; Jafari Faranak, 2015, Glob J Health Sci, V7, P360, DOI 10.5539/gjhs.v7n2p360; Jose Jimmy, 2013, Oman Med J, V28, P324, DOI 10.5001/omj.2013.95; Kardas P, 2005, INT J ANTIMICROB AG, V26, P106, DOI 10.1016/j.ijantimicag.2005.04.017; Liu YC, 1999, LANCET, V354, P1360, DOI 10.1016/S0140-6736(99)07446-2; Lyu H, 2013, JAMA SURG, V148, P362, DOI 10.1001/2013.jamasurg.270; Mistretta A, 2008, Ann Ig, V20, P287; Mitsi G, 2005, INT J ANTIMICROB AG, V25, P439, DOI 10.1016/j.ijantimicag.2005.02.009; Mossa D. A., 2012, Turk Silahli Kuvvetleri,  Koruyucu Hekimlik Bulteni, V11, P529; Napolitano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084177; Nyazema N, 2007, J ANTIMICROB CHEMOTH, V59, P718, DOI 10.1093/jac/dkm013; Ocan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092323; Okumura J, 2002, SOC SCI MED, V54, P1875, DOI 10.1016/S0277-9536(01)00155-1; Panagakou Sotiria G, 2012, ISRN Pediatr, V2012, P685302, DOI 10.5402/2012/685302; Pechere JC, 2001, CLIN INFECT DIS, V33, pS170, DOI 10.1086/321844; Pechere JC, 2007, INT J ANTIMICROB AG, V29, P245, DOI 10.1016/j.ijantimicag.2006.09.026; Radyowijati A, 2002, DETERMINANTS ANTIMIC; Ramalhinho I, 2014, INT J CLIN PHARM-NET, V36, P1039, DOI 10.1007/s11096-014-9992-z; Ramay BM, 2015, BMC PHARMACOL TOXICO, V16, DOI 10.1186/s40360-015-0011-3; Sabry NA, 2014, RES SOC ADMIN PHARM, V10, P168, DOI 10.1016/j.sapharm.2013.03.004; Saradamma RD, 2000, SOC SCI MED, V50, P891, DOI 10.1016/S0277-9536(99)00380-9; Scicluna Elizabeth Anne, 2009, J Infect Public Health, V2, P189, DOI 10.1016/j.jiph.2009.09.004; Shehadeh M, 2012, SAUDI PHARM J, V20, P125, DOI 10.1016/j.jsps.2011.11.005; Skliros E, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-58; Spellberg B, 2014, JAMA INTERN MED, V174, P432, DOI 10.1001/jamainternmed.2013.14019; Togoobaatar G, 2010, B WORLD HEALTH ORGAN, V88, P930, DOI 10.2471/BLT.10.079004; Vaandnen MH, 2006, HEALTH POLICY, V77, P166, DOI 10.1016/j.healthpol.2005.07.001; van Bijnen EME, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-293; Widayati Aris, 2011, BMC Res Notes, V4, P491, DOI 10.1186/1756-0500-4-491; World Health Organization, 2007, WORLD HLTH REP 2007; World Health Organization (WHO), 2000, OV ANT RES; Wun YT, 2013, PHARMACOEPIDEM DR S, V22, P241, DOI 10.1002/pds.3339; You JHS, 2008, INFECTION, V36, P153, DOI 10.1007/s15010-007-7214-5; Yu M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-112	57	70	71	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138179	10.1371/journal.pone.0138179	http://dx.doi.org/10.1371/journal.pone.0138179			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0RH	26379031	Green Published, Green Submitted, gold			2022-12-27	WOS:000361769400065
J	Montoya, V; Fan, HL; Bryar, PJ; Weinstein, JL; Mets, MB; Feng, G; Martin, J; Martin, A; Jiang, HM; Laurie, NA				Montoya, Vanessa; Fan, Hanli; Bryar, Paul J.; Weinstein, Joanna L.; Mets, Marilyn B.; Feng, Gang; Martin, Joshua; Martin, Alissa; Jiang, Hongmei; Laurie, Nikia A.			Novel miRNA-31 and miRNA-200a-Mediated Regulation of Retinoblastoma Proliferation	PLOS ONE			English	Article							CELL-LINE; SERINE/THREONINE KINASE; ILLUMINA MICROARRAY; GENE; EXPRESSION; INVASION; MICRORNA-31; MIGRATION; INACTIVATION; CHEMOTHERAPY	Retinoblastoma is the most common intraocular tumor in children. Current management includes broad-based treatments such as chemotherapy, enucleation, laser therapy, or cryotherapy. However, therapies that target specific pathways important for retinoblastoma progression could provide valuable alternatives for treatment. MicroRNAs are short, noncoding RNA transcripts that can regulate the expression of target genes, and their aberrant expression often facilitates disease. The identification of post-transcriptional events that occur after the initiating genetic lesions could further define the rapidly aggressive growth displayed by retinoblastoma tumors. In this study, we used two phenotypically different retinoblastoma cell lines to elucidate the roles of miRNA-31 and miRNA-200a in tumor proliferation. Our approach confirmed thatmiRNAs-31 and -200a expression is significantly reduced in human retinoblastomas. Moreover, overexpression of these two miRNAs restricts the expansion of a highly proliferative cell line (Y79), but does not restrict the growth rate of a less aggressive cell line (Weri1). Gene expression profiling of miRNA-31 and/or miRNA-200a-overexpressing cells identified differentially expressed mRNAs associated with the divergent response of the two cell lines. This work has the potential to enhance the development of targeted therapeutic approaches for retinoblastoma and improve the efficacy of treatment.	[Montoya, Vanessa; Fan, Hanli; Martin, Joshua; Laurie, Nikia A.] Lurie Childrens Res Ctr, Human Mol Genet Program, Chicago, IL 60611 USA; [Montoya, Vanessa; Weinstein, Joanna L.; Laurie, Nikia A.] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA; [Bryar, Paul J.; Mets, Marilyn B.] Northwestern Univ, Feinberg Sch Med, Dept Ophthalmol, Chicago, IL 60611 USA; [Bryar, Paul J.] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Weinstein, Joanna L.; Martin, Alissa; Laurie, Nikia A.] Ann & Robert H Lurie Childrens Hosp Chicago, Div Hematol Oncol & Stem Cell Transplantat, Chicago, IL 60611 USA; [Mets, Marilyn B.] Ann & Robert H Lurie Childrens Hosp Chicago, Div Ophthalmol, Chicago, IL 60611 USA; [Feng, Gang] Northwestern Univ, Feinberg Sch Med, Clin & Translat Sci Inst, Chicago, IL 60611 USA; [Jiang, Hongmei] Northwestern Univ, Weinberg Coll Arts & Sci, Dept Stat, Evanston, IL 60208 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Northwestern University	Laurie, NA (corresponding author), Lurie Childrens Res Ctr, Human Mol Genet Program, Chicago, IL 60611 USA.	n-laurie@northwestern.edu	Jiang, Hongmei/AAU-2911-2021	Bryar, Paul/0000-0001-8494-3089	Illinois Department of Public Health - Excellence in Academic Medicine Award; National Institutes of Health/National Cancer Institute grant [R21 CA167225]; National Institute of General Medical Sciences grant [R25 GM079300]; Research to Prevent Blindness Inc. NY, NY; NATIONAL CANCER INSTITUTE [R21CA167225] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM079300] Funding Source: NIH RePORTER	Illinois Department of Public Health - Excellence in Academic Medicine Award; National Institutes of Health/National Cancer Institute grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Research to Prevent Blindness Inc. NY, NY(Research to Prevent Blindness (RPB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Illinois Department of Public Health - Excellence in Academic Medicine Award (to NAL); National Institutes of Health/National Cancer Institute grant R21 CA167225, (www.nih.gov) (to NAL); National Institute of General Medical Sciences grant R25 GM079300, (www.nih.gov) (to VM); and the Research to Prevent Blindness Inc. NY, NY, (http://www.rpbusa.org) (to PB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adithi M, 2006, EXP EYE RES, V83, P1446, DOI 10.1016/j.exer.2006.08.003; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chevez-Barrios P, 2000, AM J PATHOL, V157, P1405, DOI 10.1016/S0002-9440(10)64653-6; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; Creighton CJ, 2010, CANCER RES, V70, P1906, DOI 10.1158/0008-5472.CAN-09-3875; Du P, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-16; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Ellis JM, 2013, MOL CELL BIOL, V33, P1869, DOI 10.1128/MCB.01548-12; FRANCOIS J, 1975, OPHTHALMOLOGICA, V170, P405, DOI 10.1159/000307248; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hua DS, 2012, ONCOL REP, V27, P700, DOI 10.3892/or.2011.1555; Huang J, 2003, BIOCHEM BIOPH RES CO, V309, P774, DOI 10.1016/j.bbrc.2003.08.069; Ivanov SV, 2010, J BIOL CHEM, V285, P22807, DOI 10.1074/jbc.M110.100354; Jo DH, 2011, J PEDIAT HEMATOL ONC, V33, P529, DOI 10.1097/MPH.0b013e318228280a; Kaliki S, 2013, OPHTHALMOLOGY, V120, P997, DOI 10.1016/j.ophtha.2012.10.044; Kivela T, 2009, BRIT J OPHTHALMOL, V93, P1129, DOI 10.1136/bjo.2008.150292; Klein R, 2012, DEVELOPMENT, V139, P4105, DOI 10.1242/dev.074997; Korner C, 2013, J BIOL CHEM, V288, P8750, DOI 10.1074/jbc.M112.414128; Lambertz I, 2010, CELL DEATH DIFFER, V17, P633, DOI 10.1038/cdd.2009.202; Laurie NA, 2005, CLIN CANCER RES, V11, P7569, DOI 10.1158/1078-0432.CCR-05-0849; Laurie N, 2009, MOL CELL BIOL, V29, P6268, DOI 10.1128/MCB.00374-09; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Laurila EM, 2012, GENE CHROMOSOME CANC, V51, P557, DOI 10.1002/gcc.21941; LEE EYHP, 1988, P NATL ACAD SCI USA, V85, P6017, DOI 10.1073/pnas.85.16.6017; LEE WH, 1984, NATURE, V309, P458, DOI 10.1038/309458a0; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Martin A, 2013, BIOCHEM BIOPH RES CO, V440, P599, DOI 10.1016/j.bbrc.2013.09.117; Martin J, 2013, GENE, V512, P294, DOI 10.1016/j.gene.2012.09.129; MCFALL RC, 1977, CANCER RES, V37, P1003; Nittner D, 2012, NAT CELL BIOL, V14, P958, DOI 10.1038/ncb2556; Peng CG, 2012, J NEUROSCI, V32, P13292, DOI 10.1523/JNEUROSCI.2124-12.2012; REID TW, 1974, J NATL CANCER I, V53, P347, DOI 10.1093/jnci/53.2.347; Roubelakis MG, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S20; Rushlow DE, 2013, LANCET ONCOL, V14, P327, DOI 10.1016/S1470-2045(13)70045-7; Saydam O, 2009, MOL CELL BIOL, V29, P5923, DOI 10.1128/MCB.00332-09; Shields CL, 2010, CURR OPIN OPHTHALMOL, V21, P203, DOI 10.1097/ICU.0b013e328338676a; SHIELDS CL, 1994, CANCER, V73, P692, DOI 10.1002/1097-0142(19940201)73:3<692::AID-CNCR2820730331>3.0.CO;2-8; Silva AK, 2010, MOL VIS, V16, P36; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Xu N, 2013, J IMMUNOL, V190, P678, DOI 10.4049/jimmunol.1202695; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733; Zhao X, 2009, DEV CELL, V17, P210, DOI 10.1016/j.devcel.2009.07.009	44	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138366	10.1371/journal.pone.0138366	http://dx.doi.org/10.1371/journal.pone.0138366			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379276	gold, Green Published, Green Submitted			2022-12-27	WOS:000361769400089
J	Pires, BM; Silva, DM; Visentin, LC; Rodrigues, BL; Carvalho, NMF; Faria, RB				Pires, Bianca M.; Silva, Daniel M.; Visentin, Lorenzo C.; Rodrigues, Bernardo L.; Carvalho, Nakedia M. F.; Faria, Roberto B.			Synthesis and Characterization of Cobalt(III), Nickel(II) and Copper(II) Mononuclear Complexes with the Ligand 1,3-bis[(2-aminoethypamino]-2-propanol and Their Catalase-Like Activity	PLOS ONE			English	Article							ABSORPTION-SPECTROSCOPY; CRYSTAL-STRUCTURE; EXCITED-STATES; BASE COMPLEXES; COORDINATION; PEROXIDE; ACID; OXIDATION; ALCOHOL; MIMICS	In this work, we present the synthesis and characterization of two new mononuclear complexes with the ligand 1,3-bis[(2-aminoethypamino]-2-propanol (HL), [Co(L)(H2O)](CIO4)(2) (1), [Ni(HL)](CIO4)2 (2), as well as the known complex [Cu(HL)](CIO4)2 (3) for comparison. Their abilities to catalyze the dismutation of H2O2 and the oxidation of cyclohexane were investigated. The complexes were characterized by X-ray diffraction, elemental analysis, electronic and infrared spectroscopy, cyclic voltammetry, electrospray ionization mass spectrometry (ESI-MS) and conductivity measurements. The X-ray structures showed that the nickel (2) and copper (3) complexes are tetracoordinated, with the metal ion bound to the nitrogen atoms of the ligand. On the other hand, the cobalt complex (1) is hexacoordinated, possessing additional bonds to the alkoxo group of the ligand and to a water molecule. Neither of the complexes was able to catalyze the oxidation of cyclohexane, but all of them exhibited catalase-like activity, following Michaelis-Menten kinetics, which suggest resemblance with the catalase natural enzymes. The catalytic activity followed the order: > [Cu(HIA(CIOO2 (3) [Ni(HLTCIO4)2 (2) > [Co(L)(H2O)](CIO2 (1). As far as we know, this is the first description of a nickel complex presenting a significant catalase-like activity.	[Pires, Bianca M.; Silva, Daniel M.; Carvalho, Nakedia M. F.; Faria, Roberto B.] Univ Fed Rio de Janeiro, Inst Quim, Rio De Janeiro, RJ, Brazil; [Visentin, Lorenzo C.] NanoBusiness Informacao & Inovacao Ltda, Rio De Janeiro, RJ, Brazil; [Rodrigues, Bernardo L.] Univ Fed Minas Gerais, Dept Quim, Belo Horizonte, MG, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal de Minas Gerais	Faria, RB (corresponding author), Univ Fed Rio de Janeiro, Inst Quim, Rio De Janeiro, RJ, Brazil.	faria@iq.ufrj.br	Faria, Roberto B./B-5455-2013; Visentin, Lorenzo C/L-4657-2016; Carvalho, Nakédia M F/G-8260-2012; Rodrigues, Bernardo Lages/U-1471-2019	Visentin, Lorenzo C/0000-0003-0727-2108; Carvalho, Nakédia M F/0000-0001-5229-5689; FARIA, ROBERTO/0000-0001-9337-4324	Conselho Nacional de Pesquisas e Desenvolvimento Tecnologico (CNPQ) [308.497/2013-9, 132.749/2010-6, 140.797/2012-2]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/200.171/2015]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [APQ-01778-12]; NanoBusiness Informacao e Inovacao Ltda	Conselho Nacional de Pesquisas e Desenvolvimento Tecnologico (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); NanoBusiness Informacao e Inovacao Ltda	This work was supported by Conselho Nacional de Pesquisas e Desenvolvimento Tecnologico (CNPQ), Grants 308.497/2013-9, 132.749/2010-6, 140.797/2012-2; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Grant E-26/200.171/2015; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Grant APQ-01778-12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare that NanoBusiness Informacao e Inovacao Ltda provided support in the form of salaries for the author LCV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Allen F.H., 1995, INT TABLES CRYSTALLO, VC, P685; Bernhardt PV, 1998, J CHEM SOC DALTON, P1087, DOI 10.1039/a800297e; Bussiere G, 1998, J AM CHEM SOC, V120, P6306, DOI 10.1021/ja9740733; Carvalho NMF, 2006, APPL CATAL A-GEN, V305, P140, DOI 10.1016/j.apcata.2006.02.053; Choua S, 1997, J INORG BIOCHEM, V65, P79, DOI 10.1016/S0162-0134(96)00091-8; Dede B, 2009, APPL ORGANOMET CHEM, V23, P512, DOI 10.1002/aoc.1557; Dede B, 2009, J HAZARD MATER, V163, P1148, DOI 10.1016/j.jhazmat.2008.07.070; Demetgul C, 2012, CARBOHYD POLYM, V89, P354, DOI 10.1016/j.carbpol.2012.03.013; Duisenberg AJM, 2003, J APPL CRYSTALLOGR, V36, P220, DOI 10.1107/S0021889802022628; DUISENBERG AJM, 1992, J APPL CRYSTALLOGR, V25, P92, DOI 10.1107/S0021889891010634; Duisenberg AJM, 2000, J APPL CRYSTALLOGR, V33, P893, DOI 10.1107/S0021889800002363; Espenson J.H., 2002, CHEM KINETICS REACTI; FEIG AL, 1994, CHEM REV, V94, P759, DOI 10.1021/cr00027a011; Gao J, 2003, INORG CHIM ACTA, V346, P32, DOI 10.1016/S0020-1693(02)01393-2; Gao J, 2002, INORG CHEM COMMUN, V5, P1095; GEARY WJ, 1971, COORDIN CHEM REV, V7, P81, DOI 10.1016/S0010-8545(00)80009-0; Gonzalez E, 2007, COORDIN CHEM REV, V251, P351, DOI 10.1016/j.ccr.2006.08.011; Griesser R., 1974, J COORD CHEM, V3, P235; Hadadzadeh H, 2011, POLYHEDRON, V30, P2535, DOI 10.1016/j.poly.2011.06.037; Harrowfield JM, 2004, INORG CHEM, V43, P1689, DOI 10.1021/ic034912o; Heineman W.R., 1996, LAB TECHNIQUES ELECT; Johansson FB, 2008, INORG CHEM, V47, P5079, DOI 10.1021/ic7020534; Kaizer J, 2005, J MOL CATAL A-CHEM, V236, P12, DOI 10.1016/j.molcata.2005.04.006; Kaizer J, 2006, INORG CHEM COMMUN, V9, P1037, DOI 10.1016/j.inoche.2006.06.005; Karipcin F, 2012, HELV CHIM ACTA, V95, P647, DOI 10.1002/hlca.201100314; Krabbe JG, 2007, J AM SOC MASS SPECTR, V18, P707, DOI 10.1016/j.jasms.2006.12.006; LEKCHIRI A, 1991, EUR POLYM J, V27, P1271, DOI 10.1016/0014-3057(91)90065-V; Lever A.B.P., 1985, INORGANIC ELECT SPEC, V2nd; Lieberman RL, 2005, NATURE, V434, P177, DOI 10.1038/nature03311; NISHIDA Y, 1989, INORG CHIM ACTA, V163, P9, DOI 10.1016/S0020-1693(00)87136-4; NISHIDA Y, 1994, POLYHEDRON, V13, P1539, DOI 10.1016/S0277-5387(00)83448-8; Oliveira M.C.B., 2005, INORG CHEM, V44, P921; Padhi SK, 2011, INORG CHIM ACTA, V367, P57, DOI 10.1016/j.ica.2010.11.035; Pires BM, 2013, INORG CHIM ACTA, V407, P69, DOI 10.1016/j.ica.2013.07.034; Ray A, 2011, INORG CHIM ACTA, V375, P20, DOI 10.1016/j.ica.2011.04.008; Senaratne C, 1996, J PHYS CHEM-US, V100, P5849, DOI 10.1021/jp951923x; SHANK M, 1994, BIOCHEMISTRY-US, V33, P15433, DOI 10.1021/bi00255a025; Sheldrick G.M., 1996, PROGRAM EMPIRICAL AB; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SIGEL H, 1979, INORG CHEM, V18, P1354, DOI 10.1021/ic50195a040; Signorella S, 2007, INORG CHEM, V46, P10864, DOI 10.1021/ic070180e; Taran MN, 2008, PHYS CHEM MINER, V35, P117, DOI 10.1007/s00269-007-0202-6; TAYLOR R, 1982, J AM CHEM SOC, V104, P5063, DOI 10.1021/ja00383a012; Xie YS, 2005, POLYHEDRON, V24, P165, DOI 10.1016/j.poly.2004.11.009; Yamami M, 1997, J CHEM SOC DALTON, P4595, DOI 10.1039/a703842i; Zamocky M, 2008, ANTIOXID REDOX SIGN, V10, P1527, DOI 10.1089/ars.2008.2046	46	9	9	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137926	10.1371/journal.pone.0137926	http://dx.doi.org/10.1371/journal.pone.0137926			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379038	Green Published, Green Submitted, gold			2022-12-27	WOS:000361769400037
J	Schmidt, M; Eckardt, R; Scholtzl, K; Neunerl, B; von Dossow-Hanfsting, V; Sehouli, J; Stief, CG; Wernecke, KD; Spies, CD				Schmidt, Maren; Eckardt, Rahel; Scholtzl, Kathrin; Neunerl, Bruno; von Dossow-Hanfsting, Vera; Sehouli, Jalid; Stief, Christian G.; Wernecke, Klaus-Dieter; Spies, Claudia D.		PERATECS Grp	Patient Empowerment Improved Perioperative Quality of Care in Cancer Patients Aged >= 65 Years A Randomized Controlled Trial	PLOS ONE			English	Article							POSTOPERATIVE COMPLICATIONS; PREOPERATIVE EDUCATION; COLORECTAL SURGERY; SURGICAL-PATIENTS; ELDERLY-PATIENTS; SCREENING SCALE; LIFE; MORTALITY; DELIRIUM; OUTCOMES	Purpose This randomized controlled, clinical prospective interventional trial was aimed at exploring the effect of patient empowerment on short- and long-term outcomes after major oncologic surgery in elderly cancer patients. Methods This trial was performed from February 2011 to January 2014 at two tertiary medical centers in Germany. The study included patients aged 65 years and older undergoing elective surgery for gastro-intestinal, genitourinary, and thoracic cancer. The patients were randomly assigned to the intervention group, i.e. patient empowerment through information booklet and diary keeping, or to the control group, which received standard care. Randomization was done by block randomization in blocks of four in order of enrollment. The primary outcome were 1,postoperative length of hospital stay (LOS) and 2. long-term global healthrelated quality of life (HRQoL) one year postoperatively. HRQoL was assessed using the EORTC QLQ C30 questionnaire. Secondary outcomes encompassed postoperative stress and complications. Further objectives were the identification of predictors of LOS, and HRQoL at 12 months. Results Overall 652 patients were included. The mean age was 72 +/- 4.9 years, and the majority of patients were male (68.6%, n = 447). The boolean AND median of postoperative length of stay was 9 days (IQR 7-14 day). There were no significant differences between the intervention and the control groups in postoperative LOS (p = 0.99) or global HRQoL after one year (women: p = 0.54, men: p = 0.94). While overall complications and major complications occurred in 74% and 24% of the cases, respectively, frequency and severity of complications did not differ significantly between the groups. Patients in the intervention group reported significantly less postoperative pain (p = 0.03) than the control group. Independent predictors for LOS were identified as severity of surgery, length of anesthesia, major postoperative complications, nutritional state, and pre-operative physical functional capacity measured by the Timed Up and Go-test by multiple robust regressions. Conclusion Patient empowerment through information booklet and diary keeping did not shorten the postoperative LOS in elderly onco-surgical patients, but improved quality of care regarding postoperative pain. Postoperative length of stay is influenced by pre-operative nutritional state, pre-operative functional impairment, severity of surgery, and length of anesthesia.	[Schmidt, Maren; Scholtzl, Kathrin; Neunerl, Bruno; Spies, Claudia D.] Charite, Campus Charite Mitte & Campus Virchow Klinikum, Dept Anesthesiol & Intens Care Med, D-13353 Berlin, Germany; [Eckardt, Rahel] Charite, Charite Res Grp Geriatr, D-13353 Berlin, Germany; [von Dossow-Hanfsting, Vera] Univ Munich, Univ Hosp Munich Grosshadern, Dept Anesthesiol, Munich, Germany; [Sehouli, Jalid] Charite, Charite Campus Virchow Klinikum, European Competence Ctr Ovarian Canc, Dept Gynecol, D-13353 Berlin, Germany; [Stief, Christian G.] Univ Munich, Dept Urol, Univ Hosp Munich Grosshadern, Munich, Germany; [Wernecke, Klaus-Dieter] Charite, D-13353 Berlin, Germany; [Wernecke, Klaus-Dieter] SoStAna GmbH, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Sostana GmbH	Spies, CD (corresponding author), Charite, Campus Charite Mitte & Campus Virchow Klinikum, Dept Anesthesiol & Intens Care Med, D-13353 Berlin, Germany.	claudia.spies@charite.de		Schmidt, Maren/0000-0002-7821-9577; Spies, Claudia/0000-0002-1062-0495	Deutsche Krebshilfe (German Cancer Aid) [DKH- 108474]; SoStAna GmbH	Deutsche Krebshilfe (German Cancer Aid)(Deutsche Krebshilfe); SoStAna GmbH	CDS received fundings from the Deutsche Krebshilfe (German Cancer Aid; DKH- 108474). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. SoStAna GmbH provided support in the form of a salary for author KDW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Alves A, 2005, ARCH SURG-CHICAGO, V140, P278, DOI 10.1001/archsurg.140.3.278; [Anonymous], 2015, J AM COLL SURGEONS, V220, P136, DOI 10.1016/j.jamcollsurg.2014.10.019; Bainbridge D, 2012, LANCET, V380, P1075, DOI 10.1016/S0140-6736(12)60990-8; Borghans I, 2012, HEALTH POLICY, V104, P222, DOI 10.1016/j.healthpol.2011.12.010; BREEMHAAR B, 1991, PATIENT EDUC COUNS, V18, P199, DOI 10.1016/0738-3991(91)90129-S; Carlson LE, 2007, BRAIN BEHAV IMMUN, V21, P1038, DOI 10.1016/j.bbi.2007.04.002; Chanques G, 2010, PAIN, V151, P711, DOI 10.1016/j.pain.2010.08.039; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Copeland G P, 1991, Br J Surg, V78, P355, DOI 10.1002/bjs.1800780327; Costa M J, 2001, AORN J, V74, P874, DOI 10.1016/S0001-2092(06)61505-6; DEVINE EC, 1992, PATIENT EDUC COUNS, V19, P129, DOI 10.1016/0738-3991(92)90193-M; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; EGBERT LD, 1964, NEW ENGL J MED, V270, P825, DOI 10.1056/NEJM196404162701606; Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012; Extermann M, 1998, J CLIN ONCOL, V16, P1582, DOI 10.1200/JCO.1998.16.4.1582; Fayers P, 2001, EORTC QLQ C30 SCORIN; Fink C, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-271; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forasassi C, 2009, ARCH GERONTOL GERIAT, V48, P406, DOI 10.1016/j.archger.2008.03.011; Gaudreau JD, 2005, J PAIN SYMPTOM MANAG, V29, P368, DOI 10.1016/j.jpainsymman.2004.07.009; GIBSON CH, 1991, J ADV NURS, V16, P354, DOI 10.1111/j.1365-2648.1991.tb01660.x; Griffiths R, 2014, ANAESTHESIA, V69, P81, DOI 10.1111/anae.12524; Guigoz Y, 2002, CLIN GERIATR MED, V18, P737, DOI 10.1016/S0749-0690(02)00059-9; Guo P, 2012, INT J NURS STUD, V49, P129, DOI 10.1016/j.ijnurstu.2011.08.008; GURUSAMY KS, 2014, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858; Gustafsson UO, 2013, WORLD J SURG, V37, P259, DOI 10.1007/s00268-012-1772-0; Holloway S, 2002, J SURG RES, V108, P273, DOI 10.1006/jsre.2002.6549; Huisman M, 2014, PLOS ONE, V9; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Janis IL., 1958, PSYCHOL STRESS PSYCH; Kehlet H, 1997, BRIT J ANAESTH, V78, P606, DOI 10.1093/bja/78.5.606; Kristjansson SR, 2010, CRIT REV ONCOL HEMAT, V76, P208, DOI 10.1016/j.critrevonc.2009.11.002; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Leino-Kilpi H, 2005, J NURS CARE QUAL, V20, P307, DOI 10.1097/00001786-200510000-00005; Lutz A, 2008, ANASTH INTENSIV NOTF, V43, P98, DOI 10.1055/s-2008-1060551; Macefield RC, 2013, BRIT J SURG, V100, P28, DOI 10.1002/bjs.8989; MAHONEY F I, 1965, Md State Med J, V14, P61; McDonald S, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003526.pub3; Mendoza TR, 1999, CANCER-AM CANCER SOC, V85, P1186, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Osoba D, 1998, J CLIN ONCOL, V16, P139, DOI 10.1200/JCO.1998.16.1.139; Pallis AG, 2010, EUR J CANCER, V46, P1502, DOI 10.1016/j.ejca.2010.02.022; Pearse RM, 2012, LANCET, V380, P1059, DOI 10.1016/S0140-6736(12)61148-9; PERRY EK, 1980, AGE AGEING, V9, P1, DOI 10.1093/ageing/9.1.1; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Ponzetto M, 2003, J GERONTOL A-BIOL, V58, P1049; Quinten C, 2009, LANCET ONCOL, V10, P865, DOI 10.1016/S1470-2045(09)70200-1; Robinson TN, 2009, ANN SURG, V250, P449, DOI 10.1097/SLA.0b013e3181b45598; Ronco M, 2012, INT J EVID-BASED HEA, V10, P309, DOI 10.1111/j.1744-1609.2012.00286.x; Schmidt M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085456; Shuldham CM, 2002, EUR HEART J, V23, P666, DOI 10.1053/euhj.2001.2897; Spies C., 2013, SOPS AN STHESIOLOGIE; Steward B.W., 2014, WORLD CANC REPORT 20; Story DA, 2008, CURR OPIN ANESTHESIO, V21, P375, DOI 10.1097/ACO.0b013e3282f889f8; Tan E, 2007, EUR J CANCER, V43, P2285, DOI 10.1016/j.ejca.2007.06.009; Tan K, 2009, INT J COLORECTAL DIS, V24, P185, DOI 10.1007/s00384-008-0615-9; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; Ullman Amanda J, 2014, COCHRANE DATABASE SY; Waldmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074149; Walters CL, 2013, INT J GYNECOL CANCER, V23, P1006, DOI 10.1097/IGC.0b013e3182980fac; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	63	30	31	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137824	10.1371/journal.pone.0137824	http://dx.doi.org/10.1371/journal.pone.0137824			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0RH	26378939	gold, Green Published, Green Submitted			2022-12-27	WOS:000361769400029
J	Shehata, N; Forster, AJ; Lawrence, N; Ducharme, R; Fergusson, DA; Chasse, M; Rothwell, DM; Hebert, PC; Tinmouth, AT; Wilson, K				Shehata, Nadine; Forster, Alan J.; Lawrence, Nadine; Ducharme, Robin; Fergusson, Dean A.; Chasse, Michael; Rothwell, Deanna M.; Hebert, Paul C.; Tinmouth, Alan T.; Wilson, Kumanan			Transfusion Patterns in All Patients Admitted to the Intensive Care Unit and in Those Who Die in Hospital: A Descriptive Analysis	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; BLOOD-TRANSFUSION; HEALTH-CARE; ANEMIA; MORTALITY; ICD-9-CM; SURGERY; LIFE	While it is known that the use of health care resources increases at the end of life in patients admitted to the Intensive Care Unit (ICU), the allocation of blood products at the end of life has not been described. The objective of this study was to describe overall transfusion patterns in the ICU, and specifically in patients who die in hospital. We conducted a retrospective cohort study of adult patients admitted to the ICU of a university-affiliated hospital, who were discharged or died between November 1, 2006 and June 30, 2012. During the study period, 10,642 patients were admitted at least once to the ICU. Of these patients, 4079 (38.3%) received red blood cells (RBCs), plasma or platelets in the ICU. The ICU mortality rate was 28.1% and in-hospital mortality rate was 32.3%. Among 39,591 blood product units transfused over the course of the study in the ICU (18,144 RBC units, 16,920 plasma units and 4527 platelet units), 46.2% were administered to patients who later died within the same hospitalization (41.2% of RBCs, 50.4% of plasma and 50.8% of platelets). Of all blood product units (RBCs, plasma and platelets) administered in the ICU over the study period, 11% were given within the last 24 hours before death. A large proportion of blood products used in the ICU are administered to patients who ultimately succumb to their illness in hospital, and many of these blood units are given in close proximity to death.	[Shehata, Nadine] Univ Toronto, Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Shehata, Nadine] Univ Toronto, Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Shehata, Nadine] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Shehata, Nadine] Canadian Blood Serv, Toronto, ON, Canada; [Forster, Alan J.; Lawrence, Nadine; Ducharme, Robin; Fergusson, Dean A.; Chasse, Michael; Rothwell, Deanna M.; Tinmouth, Alan T.; Wilson, Kumanan] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Forster, Alan J.; Ducharme, Robin; Wilson, Kumanan] Inst Clin Evaluat Sci, Ottawa, ON, Canada; [Forster, Alan J.; Fergusson, Dean A.; Tinmouth, Alan T.; Wilson, Kumanan] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Fergusson, Dean A.; Chasse, Michael] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Fergusson, Dean A.] Univ Ottawa, Dept Surg, Ottawa, ON, Canada; [Hebert, Paul C.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Canadian Blood Services; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa; Universite de Montreal	Wilson, K (corresponding author), Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.	kwilson@ohri.ca	Shehata, Nadine/AAG-1124-2019; Chassé, Michaël/L-7906-2017; Chassé, Michaël/Y-7820-2019	Chassé, Michaël/0000-0001-7075-1924; Shehata, Nadine/0000-0002-9267-6256; Fergusson, Dean/0000-0002-3389-2485; Ducharme, Robin/0000-0002-5665-7429	Canadian Institute of Health Research/Canadian Blood Services New Investigator Award; Canadian Blood Services' [XT0085]	Canadian Institute of Health Research/Canadian Blood Services New Investigator Award(Canadian Institutes of Health Research (CIHR)); Canadian Blood Services'	Nadine Shehata received support from the Canadian Institute of Health Research/Canadian Blood Services New Investigator Award. This study is funded by a Canadian Blood Services' (www.blood.ca.) intramural grant XT0085. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold DM, 2006, TRANSFUSION, V46, P1286, DOI 10.1111/j.1537-2995.2006.00892.x; Christensen Steffen, 2011, Clin Epidemiol, V3, P203, DOI 10.2147/CLEP.S20247; Como JJ, 2004, TRANSFUSION, V44, P809, DOI 10.1111/j.1537-2995.2004.03409.x; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Fergusson DA, 2008, NEW ENGL J MED, V358, P2319, DOI 10.1056/NEJMoa0802395; Forster AJ, 2012, CAN MED ASSOC J, V184, P37, DOI 10.1503/cmaj.110543; Lauzier F, 2007, CRIT CARE MED, V35, P1655, DOI 10.1097/01.CCM.0000269370.59214.97; Middelburg RA, 2010, TRANSFUSION, V50, P1181, DOI 10.1111/j.1537-2995.2010.02675.x; Misset B, 2008, CRIT CARE, V12, DOI 10.1186/cc6969; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Reimche L, 2011, J CLIN PHARMACOL, V51, P1043, DOI 10.1177/0091270010378858; Reuben DB, 2011, JAMA-J AM MED ASSOC, V306, P430, DOI 10.1001/jama.2011.999; Schneeweiss S, 2003, HEALTH SERV RES, V38, P1103, DOI 10.1111/1475-6773.00165; Shehata N, 2013, TRANSFUSION, V53, P1688, DOI 10.1111/trf.12007; Stanworth SJ, 2013, TRANSFUSION, V53, P1050, DOI 10.1111/j.1537-2995.2012.03866.x; Stanworth SJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10129; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624; Unroe KT, 2011, ARCH INTERN MED, V171, P196, DOI 10.1001/archinternmed.2010.371; van Klei WA, 2009, ANESTHESIOLOGY, V111, P717, DOI 10.1097/ALN.0b013e3181b6a761; van Walraven C, 2011, J HOSP MED, V6, P389, DOI 10.1002/jhm.917; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499; Zhang BH, 2009, ARCH INTERN MED, V169, P480, DOI 10.1001/archinternmed.2008.587	23	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138427	10.1371/journal.pone.0138427	http://dx.doi.org/10.1371/journal.pone.0138427			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378791	Green Submitted, Green Published, gold			2022-12-27	WOS:000361769400098
J	Gonzalez-Prieto, C; Agundez, L; Llosa, M				Gonzalez-Prieto, Coral; Agundez, Leticia; Llosa, Matxalen			Chloramphenicol Selection of IS10 Transposition in the cat Promoter Region of Widely Used Cloning Vectors	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; CONJUGATIVE RELAXASE; PLASMID; DNA; CONSTRUCTION; MUTANTS; PROTEIN; IDENTIFICATION	The widely used pSU8 family of cloning vectors is based on a p15A replicon and a chloramphenicol acetyltransferase (cat) gene conferring chloramphenicol resistance. We frequently observed an increase in the size of plasmids derived from these vectors. Analysis of the bigger molecular species shows that they have an IS10 copy inserted at a specific site between the promoter and the cat open reading frame. Promoter activity from both ends of IS10 has been reported, suggesting that the insertion events could lead to higher CAT production. Insertions were observed in certain constructions containing inserts that could lead to plasmid instability. To test the possibility that IS10 insertions were selected as a response to chloramphenicol selection, we have grown these constructs in the presence of different amounts of antibiotic and we observed that insertions arise promptly under higher chloramphenicol selective pressure. IS10 is present in many E. coli laboratory strains, so the possibility of insertion in constructions involving cat-containing vectors should be taken into account. Using lower chloramphenicol concentrations could solve this problem.	[Gonzalez-Prieto, Coral; Agundez, Leticia; Llosa, Matxalen] Univ Cantabria, Dept Biol Mol, E-39005 Santander, Spain; [Gonzalez-Prieto, Coral; Agundez, Leticia; Llosa, Matxalen] Inst Biomed & Biotecnol Cantabria UC CSIC SODERCA, Santander, Spain; [Agundez, Leticia] UCL, Inst Ophthalmol, Dept Genet, London, England	Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); University of London; University College London	Llosa, M (corresponding author), Univ Cantabria, Dept Biol Mol, E-39005 Santander, Spain.	llosam@unican.es	, matxalen/ABG-5541-2020; Gonzalez-Prieto, Coral/ABD-1690-2020	, matxalen/0000-0002-4826-2240; 	Spanish Ministry of Economy and Competitiveness [BIO2013-46414-P]; University of Cantabria, Spain	Spanish Ministry of Economy and Competitiveness(Spanish Government); University of Cantabria, Spain	This work was supported by grant BIO2013-46414-P from the Spanish Ministry of Economy and Competitiveness to ML. CGP was a recipient of a predoctoral fellowship from the University of Cantabria, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agundez L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031047; BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BOLIVAR F, 1977, P NATL ACAD SCI USA, V74, P5265, DOI 10.1073/pnas.74.12.5265; CAMPBELL JL, 1978, P NATL ACAD SCI USA, V75, P2276, DOI 10.1073/pnas.75.5.2276; Cesar CE, 2007, J BACTERIOL, V189, P9037, DOI 10.1128/JB.01152-07; Cesar CE, 2006, MOL MICROBIOL, V62, P984, DOI 10.1111/j.1365-2958.2006.05437.x; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; de Paz HD, 2010, J BACTERIOL, V192, P2655, DOI 10.1128/JB.01692-09; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Demarre G, 2005, RES MICROBIOL, V156, P245, DOI 10.1016/j.resmic.2004.09.007; Draper O, 2005, P NATL ACAD SCI USA, V102, P16385, DOI 10.1073/pnas.0506081102; Eichenbaum Z, 1998, GENETICS, V149, P1173; FOSTER TJ, 1981, CELL, V23, P201, DOI 10.1016/0092-8674(81)90285-3; Francia MV, 2002, J BACTERIOL, V184, P5187, DOI 10.1128/JB.184.18.5187-5193.2002; Francia MV, 2002, MOL MICROBIOL, V45, P375, DOI 10.1046/j.1365-2958.2002.03007.x; Furuya N, 2003, J BACTERIOL, V185, P3871, DOI 10.1128/JB.185.13.3871-3877.2003; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; HALLING SM, 1982, CELL, V28, P155, DOI 10.1016/0092-8674(82)90385-3; Kobori Shungo, 2009, Open Microbiol J, V3, P146, DOI 10.2174/1874285800903010146; Kovarik A, 2001, MOL GENET GENOMICS, V266, P216, DOI 10.1007/s004380100542; Larrea D, 2013, INTERFASE MOL ENTRE; Larrea D, 2013, PLASMID, V70, P146, DOI 10.1016/j.plasmid.2013.03.006; MARTINEZ E, 1988, GENE, V68, P159, DOI 10.1016/0378-1119(88)90608-7; Martinez-Garcia E, 2003, J BACTERIOL, V185, P2046, DOI 10.1128/JB.185.6.2046-2050.2003; MATSUTANI S, 1991, J BACTERIOL, V173, P7802, DOI 10.1128/jb.173.24.7802-7809.1991; Moncalian G, 1999, J BIOL CHEM, V274, P36117, DOI 10.1074/jbc.274.51.36117; Olliver A, 2005, ANTIMICROB AGENTS CH, V49, P289, DOI 10.1128/AAC.49.1.289-301.2005; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; RODRIGUEZ H, 1992, MUTAT RES, V270, P219, DOI 10.1016/0027-5107(92)90133-M; SHEN MM, 1987, GENETICS, V116, P359; SIMONS RW, 1983, CELL, V34, P673, DOI 10.1016/0092-8674(83)90400-2; SKALITER R, 1992, MUTAT RES, V267, P139, DOI 10.1016/0027-5107(92)90118-L; Stoebel DM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000671; Zechner E. L., 2000, HORIZONTAL GENE POOL, P87	35	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138615	10.1371/journal.pone.0138615	http://dx.doi.org/10.1371/journal.pone.0138615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375469	gold, Green Published, Green Submitted			2022-12-27	WOS:000361610200115
J	Kalarus, K; Nowicki, P				Kalarus, Konrad; Nowicki, Piotr			How Do Landscape Structure, Management and Habitat Quality Drive the Colonization of Habitat Patches by the Dryad Butterfly (Lepidoptera: Satyrinae) in Fragmented Grassland?	PLOS ONE			English	Article							CALCAREOUS GRASSLANDS; RESOURCE USE; POPULATION-DENSITY; DISPERSAL; CONSERVATION; MATRIX; OCCUPANCY; MIGRATION; WOODLAND; SCALE	Most studies dealing with species distribution patterns on fragmented landscapes focus on the characteristics of habitat patches that influence local occurrence and abundance, but they tend to neglect the question of what drives colonization of previously unoccupied patches. In a study of the dryad butterfly, we combined classical approaches derived from metapopulation theory and landscape ecology to investigate the factors driving colonization from a recent refugium. In three consecutive transect surveys, we recorded the presence and numbers of imagos in 27 patches of xerothermic grassland and 26 patches of wet meadow. Among the predictors affecting the occurrence and abundance of the dryad, we considered environmental variables reflecting (i) habitat patch quality (e.g., goldenrod cover, shrub density, vegetation height); (ii) factors associated with habitat spatial structure (patch size, patch isolation and fragmentation); and (iii) features of patch surroundings (100-m buffers around patches) that potentially pose barriers or provide corridors. Patch colonization by the dryad was strongly limited by the distance from the species refugium in the region; there was a slight positive effect of shrub density in this respect. Butterfly abundance increased in smaller and more fragmented habitat patches; it was negatively impacted by invasive goldenrod cover, and positively influenced by the density of watercourses in patch surroundings. Nectar plant availability was positively related to species abundance in xerothermic grassland, while in wet meadow the effect was the reverse. We conclude that dryad colonization of our study area is very recent, since the most important factor limiting colonization was distance from the refugium, while the habitat quality of target patches had less relevance. In order to preserve the species, conservation managers should focus on enhancing the quality of large patches and should also direct their efforts on smaller and more fragmented ones, including those with relatively low resource availability, because such habitat fragments have an important role to play for specialist species.	[Kalarus, Konrad; Nowicki, Piotr] Jagiellonian Univ, Inst Environm Sci, Krakow, Poland	Jagiellonian University	Kalarus, K (corresponding author), Jagiellonian Univ, Inst Environm Sci, Krakow, Poland.	klaus.vk5@gmail.com	Nowicki, Piotr/AFP-2530-2022	Nowicki, Piotr/0000-0002-9797-886X; Kalarus, Konrad/0000-0002-6211-1019	Polish National Science Centre [DEC-2013/11/B/NZ8/00912]; Jagiellonian University [DS/WBINOZ/INOS/761/12-13]	Polish National Science Centre; Jagiellonian University	The study was funded by the Polish National Science Centre grant DEC-2013/11/B/NZ8/00912. The fieldwork was additionally supported by the Jagiellonian University through its DS/WBINOZ/INOS/761/12-13 funds.	Akeboshi A, 2015, J INSECT CONSERV, V19, P15, DOI 10.1007/s10841-014-9732-7; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Baguette M, 2000, J APPL ECOL, V37, P100, DOI 10.1046/j.1365-2664.2000.00478.x; Baum KA, 2004, ECOLOGY, V85, P2671, DOI 10.1890/04-0500; Bergerot B, 2013, POPUL ECOL, V55, P193, DOI 10.1007/s10144-012-0349-y; Bergerot B, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-5; Bommarco R, 2014, DIVERS DISTRIB, V20, P591, DOI 10.1111/ddi.12187; Boughton DA, 2000, AM NAT, V156, P131, DOI 10.1086/303380; Boughton DA, 1999, ECOLOGY, V80, P2727; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Chong KY, 2014, BIOL CONSERV, V171, P299, DOI 10.1016/j.biocon.2014.01.037; Cizek O, 2012, J INSECT CONSERV, V16, P215, DOI 10.1007/s10841-011-9407-6; Clarke SA, 2011, J INSECT CONSERV, V15, P23, DOI 10.1007/s10841-010-9300-8; Collinge SK, 2003, CONSERV BIOL, V17, P178, DOI 10.1046/j.1523-1739.2003.01315.x; Concepcion ED, 2008, LANDSCAPE ECOL, V23, P135, DOI 10.1007/s10980-007-9150-2; Cozzi G, 2008, LANDSCAPE ECOL, V23, P269, DOI 10.1007/s10980-007-9178-3; Dabrowski Jerzy S., 1999, Chronmy Przyrode Ojczysta, V55, P91; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; Dennis R.L.H., 2010, BUTTERFLIES BRIT LAN; Dennis RLH, 2006, BIOL CONSERV, V129, P291, DOI 10.1016/j.biocon.2005.10.043; Eastman J.R., 1997, IDRISI WINDOWS USERS; Eycott AE, 2012, LANDSCAPE ECOL, V27, P1263, DOI 10.1007/s10980-012-9781-9; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fartmann T, 2006, ANN ZOOL FENN, V43, P335; Gaggiotti O.E., 2004, ECOLOGY GENETICS EVO; Grill A, 2008, J INSECT CONSERV, V12, P617, DOI 10.1007/s10841-007-9098-1; Grundel R, 2007, BIOL CONSERV, V135, P135, DOI 10.1016/j.biocon.2006.10.003; Habel JC, 2011, GLOBAL CHANGE BIOL, V17, P194, DOI 10.1111/j.1365-2486.2010.02233.x; Haddad N, 2000, CONSERV BIOL, V14, P738, DOI 10.1046/j.1523-1739.2000.99041.x; Hamback PA, 2005, ECOL LETT, V8, P1057, DOI 10.1111/j.1461-0248.2005.00811.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HANSKI I, 1994, ECOLOGY, V75, P747, DOI 10.2307/1941732; Hanski I., 1999, METAPOPULATION ECOLO; Hanski I., 2009, SPATIAL ECOLOGY, P167; Hill JK, 1996, J ANIM ECOL, V65, P725, DOI 10.2307/5671; Kalarus K, 2013, J INSECT CONSERV, V17, P1221, DOI 10.1007/s10841-013-9603-7; Kalarus K, 2013, J INSECT CONSERV, V17, P777, DOI 10.1007/s10841-013-9560-1; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kindt R., 2005, WORLD; Krauss J, 2003, J BIOGEOGR, V30, P889, DOI 10.1046/j.1365-2699.2003.00878.x; Krauss J, 2004, BIOL CONSERV, V120, P355, DOI 10.1016/j.biocon.2004.03.007; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Kuras T, 2003, POPUL ECOL, V45, P115, DOI 10.1007/s10144-003-0144-x; Legendre P., 2012, NUMERICAL ECOLOGY; Leps J, 2003, MULTIVARIATE ANAL EC; Lindman L, 2015, INSECT CONSERV DIVER, V8, P3, DOI 10.1111/icad.12087; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Matter SF, 2009, OIKOS, V118, P1461, DOI 10.1111/j.1600-0706.2009.17438.x; Moron D, 2009, BIOL CONSERV, V142, P1322, DOI 10.1016/j.biocon.2008.12.036; Nowicki P, 2008, ISR J ECOL EVOL, V54, P69, DOI 10.1560/IJEE.54.1.69; Nowicki P, 2007, BIOL CONSERV, V140, P119, DOI 10.1016/j.biocon.2007.08.001; Nowicki P, 2014, LANDSCAPE ECOL, V29, P401, DOI 10.1007/s10980-013-9971-0; Nowicki P, 2011, OECOLOGIA, V167, P657, DOI 10.1007/s00442-011-2025-x; Ockinger E, 2008, LANDSCAPE ECOL, V23, P27, DOI 10.1007/s10980-007-9167-6; Ockinger E, 2009, LANDSCAPE URBAN PLAN, V93, P31, DOI 10.1016/j.landurbplan.2009.05.021; POLLARD E, 1994, MONITORING BUTTERFLI; R Core Team, 2021, R LANGUAGE ENV STAT; Ries L, 2001, J ANIM ECOL, V70, P840, DOI 10.1046/j.0021-8790.2001.00546.x; Rosin ZM, 2012, J INSECT CONSERV, V16, P321, DOI 10.1007/s10841-011-9416-5; Schultz CB, 1998, CONSERV BIOL, V12, P284, DOI 10.1046/j.1523-1739.1998.96266.x; Schultz CB, 2005, CONSERV BIOL, V19, P887, DOI 10.1111/j.1523-1739.2005.00462.x; Schwarzwalder B, 1997, BIOL CONSERV, V82, P157, DOI 10.1016/S0006-3207(97)00023-2; Settele J, 1999, TAGFALTER DEUTSCHLAN; Shreeve TG, 2011, J INSECT CONSERV, V15, P179, DOI 10.1007/s10841-010-9336-9; Skorka P, 2007, AGR ECOSYST ENVIRON, V121, P319, DOI 10.1016/j.agee.2006.11.001; Slamova I, 2013, INSECT CONSERV DIVER, V6, P243, DOI 10.1111/j.1752-4598.2012.00212.x; Slancarova J, 2014, J INSECT CONSERV, V18, P1, DOI 10.1007/s10841-013-9607-3; Spitzer L, 2009, ECOL INDIC, V9, P1056, DOI 10.1016/j.ecolind.2008.12.006; Stefanescu C, 2011, ECOGRAPHY, V34, P353, DOI 10.1111/j.1600-0587.2010.06264.x; Suhonen J, 2014, CONSERV BIOL, V28, P783, DOI 10.1111/cobi.12231; Swift TL, 2010, BIOL REV, V85, P35, DOI 10.1111/j.1469-185X.2009.00093.x; THOMAS CD, 1992, OECOLOGIA, V92, P563, DOI 10.1007/BF00317850; Thomas CD, 2012, P NATL ACAD SCI USA, V109, P14063, DOI 10.1073/pnas.1210251109; Thomas JA, 2001, P ROY SOC B-BIOL SCI, V268, P1791, DOI 10.1098/rspb.2001.1693; Turlure C, 2009, OIKOS, V118, P950, DOI 10.1111/j.1600-0706.2009.17269.x; Van Swaay C.A.M., 2003, J INSECT CONSERV, V10, P5; van Swaay CAM, 2002, BIOL CONSERV, V104, P315, DOI 10.1016/S0006-3207(01)00196-3; Vandewoestijne S, 2004, BASIC APPL ECOL, V5, P581, DOI 10.1016/j.baae.2004.07.004; Vanreusel W, 2007, BIOL CONSERV, V135, P202, DOI 10.1016/j.biocon.2006.10.035; Verhagen R, 2007, THESIS U GRONINGEN N; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; WallisDeVries MF, 2002, BIOL CONSERV, V104, P265, DOI 10.1016/S0006-3207(01)00191-4; WallisDeVries MF, 2010, RESTOR ECOL, V18, P390, DOI 10.1111/j.1526-100X.2008.00447.x; Warecki Adam, 2008, Polish Journal of Entomology, V77, P191; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239	85	12	12	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138557	10.1371/journal.pone.0138557	http://dx.doi.org/10.1371/journal.pone.0138557			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375036	gold, Green Published			2022-12-27	WOS:000361610200112
J	Kim, JY; Choi, JY; Lee, HJ; Byun, CJ; Park, JH; Park, JH; Cho, HS; Cho, SJ; Jo, SA; Jo, I				Kim, Jee-Youn; Choi, Ji-Young; Lee, Hyeon-Ju; Byun, Catherine Jeonghae; Park, Jung-Hyun; Park, Jae Hoon; Cho, Ho-Seong; Cho, Sung-Jin; Jo, Sangmee Ahn; Jo, Inho			The Green Tea Component (-)-Epigallocatechin-3-Gallate Sensitizes Primary Endothelial Cells to Arsenite-Induced Apoptosis by Decreasing c-Jun N-Terminal Kinase-Mediated Catalase Activity	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; PROMOTES APOPTOSIS; DOWN-REGULATION; CANCER-CELLS; JNK; ABL; ACTIVATION; INHIBITION; PHOSPHORYLATION; ANGIOPOIETIN-1	The green tea component (-)-epigallocatechin-3-gallate (EGCG) has been shown to sensitize many different types of cancer cells to anticancer drug-induced apoptosis, although it protects against non-cancerous primary cells against toxicity from certain conditions such as exposure to arsenic (As) or ultraviolet irradiation. Here, we found that EGCG promotes As-induced toxicity of primary-cultured bovine aortic endothelial cells (BAEC) at doses in which treatment with each chemical alone had no such effect. Increased cell toxicity was accompanied by an increased condensed chromatin pattern and fragmented nuclei, cleaved poly(ADP-ribose) polymerase (PARP), activity of the pro-apoptotic enzymes cas-pases 3, 8 and 9, and Bax translocation into mitochondria, suggesting the involvement of an apoptotic signaling pathway. Fluorescence activated cell sorting analysis revealed that compared with EGCG or As alone, combined EGCG and As (EGCG/As) treatment significantly induced production of reactive oxygen species (ROS), which was accompanied by decreased catalase activity and increased lipid peroxidation. Pretreatment with N-acetyl-L-cysteine or catalase reversed EGCG/As-induced caspase activation and EC toxicity. EGCG/As also increased the phosphorylation of c-Jun N-terminal kinase (JNK), which was not reversed by catalase. However, pretreatment with the JNK inhibitor SP600125 reversed all of the observed effects of EGCG/As, suggesting that JNK may be the most upstream protein examined in this study. Finally, we also found that all the observed effects by EGCG/As are true for other types of EC tested. In conclusion, this is firstly to show that EGCG sensitizes non-cancerous EC to As-induced toxicity through ROS-mediated apoptosis, which was attributed at least in part to a JNK-activated decrease in catalase activity.	[Kim, Jee-Youn; Choi, Ji-Young; Lee, Hyeon-Ju; Byun, Catherine Jeonghae; Park, Jung-Hyun; Jo, Inho] Ewha Womans Univ, Sch Med, Dept Mol Med, Seoul, South Korea; [Kim, Jee-Youn] Yonsei Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea; [Choi, Ji-Young; Jo, Sangmee Ahn] Dankook Univ, Dept Nanobiomed Sci, Cheonan, Chungnam, South Korea; [Choi, Ji-Young; Jo, Sangmee Ahn] Dankook Univ, PLUS NBM Global Res Ctr Regenerat Med BK21, Cheonan, Chungnam, South Korea; [Jo, Sangmee Ahn] Dankook Univ, Coll Pharm, Dept Pharmacol, Cheonan, Chungnam, South Korea; [Park, Jae Hoon] Kyung Hee Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Cho, Ho-Seong] Chonbuk Natl Univ, Biosafety Res Inst, Jeonju, Chonbuk, South Korea; [Cho, Ho-Seong] Chonbuk Natl Univ, Coll Vet Med, Jeonju, Chonbuk, South Korea; [Cho, Sung-Jin] Chungbuk Natl Univ, Coll Nat Sci, Dept Biol, Cheongju, South Korea	Ewha Womans University; Yonsei University; Yonsei University Health System; Dankook University; Dankook University; Dankook University; Kyung Hee University; Jeonbuk National University; Jeonbuk National University; Chungbuk National University	Jo, SA (corresponding author), Dankook Univ, Dept Nanobiomed Sci, Cheonan, Chungnam, South Korea.	smahn@dankook.ac.kr; inhojo@ewha.ac.kr	Jo, Inho/R-3581-2019	Jo, Inho/0000-0001-6060-6416	Cooperative Research Program for Agriculture Science & Technology Development, Rural Development Administration, Republic of Korea [PJ01052302]	Cooperative Research Program for Agriculture Science & Technology Development, Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was carried out with the support of Cooperative Research Program (PJ01052302) for Agriculture Science & Technology Development, Rural Development Administration, Republic of Korea (http://www.rda.go.kr; JYK, JYC, J-HP, HSC, SJC, IJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, ARTHRITIS RHEUM-US, V60, P1282, DOI 10.1002/art.24488; Cao C, 2003, BIOCHEMISTRY-US, V42, P10348, DOI 10.1021/bi035023f; Cao C, 2003, J BIOL CHEM, V278, P29667, DOI 10.1074/jbc.M301292200; Chen HP, 2013, J ONCOL, V2013, DOI 10.1155/2013/872957; Chen Nan-Yue, 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P287; Chen SC, 2014, CARDIOVASC TOXICOL, V14, P222, DOI 10.1007/s12012-014-9246-2; Choi JY, 2013, APOPTOSIS, V18, P99, DOI 10.1007/s10495-012-0768-4; Choi JY, 2002, NEUROTOXICOLOGY, V23, P367, DOI 10.1016/S0161-813X(02)00079-7; Elbling L, 2011, TOXICOL LETT, V205, P173, DOI 10.1016/j.toxlet.2011.06.001; Eom DW, 2014, BMB REP IN PRESS; Hagen RM, 2013, INT J ONCOL, V43, P194, DOI 10.3892/ijo.2013.1920; Juneja J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026085; Katiyar S, 2007, J NUTR BIOCHEM, V18, P287, DOI 10.1016/j.jnutbio.2006.08.004; Kim HP, 1999, BIOCHEM BIOPH RES CO, V263, P257; Kim SD, 2005, BIOCHEM BIOPH RES CO, V328, P326, DOI 10.1016/j.bbrc.2004.11.173; Lee TC, 2011, TOXICOL APPL PHARM, V250, P69, DOI 10.1016/j.taap.2010.10.005; Li L, 2006, REDOX REP, V11, P173, DOI 10.1179/135100006X116682; Lu LDY, 2013, SCI REP-UK, V3, DOI 10.1038/srep03169; Luo T, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2473; Min NY, 2012, BIOCHEM BIOPH RES CO, V421, P91, DOI 10.1016/j.bbrc.2012.03.120; Murakami T, 2005, J BIOL CHEM, V280, P31841, DOI 10.1074/jbc.M503108200; Murata Y, 2012, J NEUROSCI, V32, P8112, DOI 10.1523/JNEUROSCI.0219-12.2012; Nakagawa H, 2002, BIOCHEM BIOPH RES CO, V292, P94, DOI 10.1006/bbrc.2002.6622; Nakazato T, 2005, CLIN CANCER RES, V11, P6040, DOI 10.1158/1078-0432.CCR-04-2273; Orloff K, 2009, J TOXICOL ENV HEAL B, V12, P509, DOI 10.1080/10937400903358934; Park JS, 2009, TOXICOLOGY, V264, P26, DOI 10.1016/j.tox.2009.07.008; Park JH, 2013, NITRIC OXIDE-BIOL CH, V32, P36, DOI 10.1016/j.niox.2013.04.003; Seo J, 2014, BIOMOL THER, V22, P510, DOI 10.4062/biomolther.2014.106; Sinha Dona, 2003, Asian Pac J Cancer Prev, V4, P233; Suriyo T, 2012, TOXICOL IN VITRO, V26, P386, DOI 10.1016/j.tiv.2011.12.017; Tang CL, 2014, INT J CLIN EXP PATHO, V7, P959; Tsai KH, 2012, J CELL PHYSIOL, V227, P1347, DOI 10.1002/jcp.22847; Tsou TC, 2005, TOXICOL APPL PHARM, V208, P277, DOI 10.1016/j.taap.2005.03.001; VANETTEN RA, 1994, J CELL BIOL, V124, P325, DOI 10.1083/jcb.124.3.325; Wang J, 2011, MOL MED, V17, P990, DOI 10.2119/molmed.2011.00073; Wang SP, 2014, AM J CHINESE MED, V42, P1279, DOI 10.1142/S0192415X14500803; Wu XX, 2014, INT IMMUNOPHARMACOL, V23, P434, DOI 10.1016/j.intimp.2014.09.014; Yamamoto T, 2003, J PHARMACOL EXP THER, V307, P230, DOI 10.1124/jpet.103.054676; Yang EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086062; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Zhang TP, 2009, APOPTOSIS, V14, P1245, DOI 10.1007/s10495-009-0391-1	41	10	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138590	10.1371/journal.pone.0138590	http://dx.doi.org/10.1371/journal.pone.0138590			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375285	gold, Green Submitted, Green Published			2022-12-27	WOS:000361610200113
J	Pierce, EC; LaFayette, PR; Ortega, MA; Joyce, BL; Kopsell, DA; Parrott, WA				Pierce, Emily C.; LaFayette, Peter R.; Ortega, Maria A.; Joyce, Blake L.; Kopsell, Dean A.; Parrott, Wayne A.			Ketocarotenoid Production in Soybean Seeds through Metabolic Engineering	PLOS ONE			English	Article							BETA-CAROTENE; PHYTOENE SYNTHASE; POTATO-TUBERS; ASTAXANTHIN PRODUCTION; TRANSGENIC PLANTS; BIOSYNTHESIS; GENES; EXPRESSION; PATHWAY; OVEREXPRESSION	The pink or red ketocarotenoids, canthaxanthin and astaxanthin, are used as feed additives in the poultry and aquaculture industries as a source of egg yolk and flesh pigmentation, as farmed animals do not have access to the carotenoid sources of their wild counterparts. Because soybean is already an important component in animal feed, production of these carotenoids in soybean could be a cost-effective means of delivery. In order to characterize the ability of soybean seed to produce carotenoids, soybean cv. Jack was transformed with the crtB gene from Pantoea ananatis, which codes for phytoene synthase, an enzyme which catalyzes the first committed step in the carotenoid pathway. The crtB gene was engineered together in combinations with ketolase genes (crtW from Brevundimonas sp. strain SD212 and bkt1 from Haematococcus pluvialis) to produce ketocarotenoids; all genes were placed under the control of seed-specific promoters. HPLC results showed that canthaxanthin is present in the transgenic seeds at levels up to 52 mu g/g dry weight. Transgenic seeds also accumulated other compounds in the carotenoid pathway, such as astaxanthin, lutein, beta-carotene, phytoene, alpha-carotene, lycopene, and beta-cryptoxanthin, whereas lutein was the only one of these detected in non-transgenic seeds. The accumulation of astaxanthin, which requires a beta-carotene hydroxylase in addition to a beta-carotene ketolase, in the transgenic seeds suggests that an endogenous soybean enzyme is able to work in combination with the ketolase transgene. Soybean seeds that accumulate ketocarotenoids could potentially be used in animal feed to reduce or eliminate the need for the costly addition of these compounds.	[Pierce, Emily C.; LaFayette, Peter R.; Ortega, Maria A.; Parrott, Wayne A.] Univ Georgia, Ctr Appl Genet Technol, Athens, GA 30602 USA; [Pierce, Emily C.; LaFayette, Peter R.; Ortega, Maria A.; Parrott, Wayne A.] Univ Georgia, Inst Plant Breeding Genet & Genom, Athens, GA 30602 USA; [Joyce, Blake L.] Univ Arizona, Sch Plant Sci, Inst BIO5, Tucson, AZ USA; [Kopsell, Dean A.] Univ Tennessee, Dept Plant Sci, Knoxville, TN USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Arizona; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Parrott, WA (corresponding author), Univ Georgia, Ctr Appl Genet Technol, Athens, GA 30602 USA.	wparrott@uga.edu		Weiss, Emily C.P./0000-0002-9960-0270; Kopsell, Dean/0000-0002-0299-1624; Joyce, Blake/0000-0002-4784-2251	state and federal funds	state and federal funds	Research support was provided by the state and federal funds allocated to the Georgia Agricultural Experiment Stations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluru M, 2008, J EXP BOT, V59, P3551, DOI 10.1093/jxb/ern212; Beardsworth P. M., 2004, International Poultry Production, V12, P17; Bjerkeng B, 1997, AQUACULTURE, V157, P297, DOI 10.1016/S0044-8486(97)00162-2; Brufau J, 1997, INT POULT PROD, V5, P17; Burt AJ, 2013, CROP SCI, V53, P554, DOI 10.2135/cropsci2012.02.0069; Cho EY, 2008, AM J CLIN NUTR, V87, P1837, DOI 10.1093/ajcn/87.6.1837; Cunningham FX, 2005, PLANT J, V41, P478, DOI 10.1111/j.1365-313X.2004.02309.x; Cunningham FX, 1998, ANNU REV PLANT PHYS, V49, P557, DOI 10.1146/annurev.arplant.49.1.557; Davies B.H., 1988, HDB CHROMATOGRAPHY P, V1, P1; Diretto G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000350; Ducreux LJM, 2005, J EXP BOT, V56, P81, DOI 10.1093/jxb/eri016; Emenhiser C, 1996, J AGR FOOD CHEM, V44, P3887, DOI 10.1021/jf960104m; Farre G, 2010, PLANT SCI, V179, P28, DOI 10.1016/j.plantsci.2010.03.009; Fraser PD, 2002, P NATL ACAD SCI USA, V99, P1092, DOI 10.1073/pnas.241374598; Fujisawa M, 2008, J BIOSCI BIOENG, V105, P636, DOI 10.1263/jbb.105.636; Fujisawa M, 2009, J EXP BOT, V60, P1319, DOI 10.1093/jxb/erp006; Fukatsu T, 2010, SCIENCE, V328, P574, DOI 10.1126/science.1190417; Fuller Bryan, 2006, J Cosmet Dermatol, V5, P30, DOI 10.1111/j.1473-2165.2006.00220.x; GARBARINO JE, 1994, PLANT MOL BIOL, V24, P119, DOI 10.1007/BF00040579; Grashorn MA, 2002, ARCH GEFLUGELKD, V66, P258; Hasunuma T, 2008, PLANT J, V55, P857, DOI 10.1111/j.1365-313X.2008.03559.x; Jayaraj J, 2008, TRANSGENIC RES, V17, P489, DOI 10.1007/s11248-007-9120-0; Kim MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048287; Kopsell DA, 2007, J AGR FOOD CHEM, V55, P10628, DOI 10.1021/jf072793f; Kurilich AC, 1999, J AGR FOOD CHEM, V47, P1948, DOI 10.1021/jf981029d; Lassner MW., 1989, PLANT MOL BIOL REP, V7, P116, DOI DOI 10.1007/BF02669627; Li J, 2011, BIOTECHNOL ADV, V29, P568, DOI 10.1016/j.biotechadv.2011.04.001; Lopez AB, 2008, J EXP BOT, V59, P213, DOI 10.1093/jxb/erm299; Mann V, 2000, NAT BIOTECHNOL, V18, P888, DOI 10.1038/78515; MISAWA N, 1993, PLANT J, V4, P833, DOI 10.1046/j.1365-313X.1993.04050833.x; MONMA M, 1994, BIOSCI BIOTECH BIOCH, V58, P926, DOI 10.1271/bbb.58.926; Moran NA, 2010, SCIENCE, V328, P624, DOI 10.1126/science.1187113; Morris WL, 2006, METAB ENG, V8, P253, DOI 10.1016/j.ymben.2006.01.001; Nishino H, 2002, CANCER METAST REV, V21, P257, DOI 10.1023/A:1021206826750; Nys Y, 2000, ARCH GEFLUGELKD, V64, P45; Paine JA, 2005, NAT BIOTECHNOL, V23, P482, DOI 10.1038/nbt1082; Ravanello MP, 2003, METAB ENG, V5, P255, DOI 10.1016/j.ymben.2003.08.001; Robert F., 2007, World Poultry Science Association, Proceedings of the 16th European Symposium on Poultry Nutrition, Strasbourg, France, 26-30 August, 2007, P731; Rosa AP, 2012, POULTRY SCI, V91, P660, DOI 10.3382/ps.2011-01582; Samoylov VM, 1998, PLANT CELL REP, V18, P49, DOI 10.1007/s002990050530; Scaife MA, 2009, BIOTECHNOL BIOENG, V103, P944, DOI 10.1002/bit.22330; Schmidt MA, 2005, PLANT CELL REP, V24, P383, DOI 10.1007/s00299-005-0950-z; Schmidt MA, 2015, PLANT BIOTECHNOL J, V13, P590, DOI 10.1111/pbi.12286; Shewmaker CK, 1999, PLANT J, V20, P401, DOI 10.1046/j.1365-313x.1999.00611.x; Sommer A, 1997, NUTRITION, V13, P484, DOI 10.1016/S0899-9007(97)00013-0; SUNDE ML, 1992, POULTRY SCI, V71, P709, DOI 10.3382/ps.0710709; Trick HN, 1997, PLANT TISSUE CULT BI, V3, P9; Uchiyama S, 2004, BIOL PHARM BULL, V27, P232, DOI 10.1248/bpb.27.232; Ukibe K, 2009, APPL ENVIRON MICROB, V75, P7205, DOI 10.1128/AEM.01249-09; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; Yoshino M, 2006, GENES GENET SYST, V81, P135, DOI 10.1266/ggs.81.135	51	22	25	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138196	10.1371/journal.pone.0138196	http://dx.doi.org/10.1371/journal.pone.0138196			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376481	Green Published, gold, Green Submitted			2022-12-27	WOS:000361610200085
J	Saito, K; Tamaki, T; Hirata, M; Hashimoto, H; Nakazato, K; Nakajima, N; Kazuno, A; Sakai, A; Iida, M; Okami, K				Saito, Kosuke; Tamaki, Tetsuro; Hirata, Maki; Hashimoto, Hiroyuki; Nakazato, Kenei; Nakajima, Nobuyuki; Kazuno, Akihito; Sakai, Akihiro; Iida, Masahiro; Okami, Kenji			Reconstruction of Multiple Facial Nerve Branches Using Skeletal Muscle-Derived Multipotent Stem Cell Sheet-Pellet Transplantation	PLOS ONE			English	Article							COMPENSATORY HYPERTROPHIED MUSCLE; PERIPHERAL-NERVES; SCIATIC-NERVE; REGENERATION; RAT; GROWTH; INJURY; REPAIR; TUBE; RECONSTITUTION	Head and neck cancer is often diagnosed at advanced stages, and surgical resection with wide margins is generally indicated, despite this treatment being associated with poor postoperative quality of life (QOL). We have previously reported on the therapeutic effects of skeletal muscle-derived multipotent stem cells (Sk-MSCs), which exert reconstitution capacity for muscle-nerve-blood vessel units. Recently, we further developed a 3D patchtransplantation system using Sk-MSC sheet-pellets. The aim of this study is the application of the 3D Sk-MSC transplantation system to the reconstitution of facial complex nerve-vascular networks after severe damage. Mouse experiments were performed for histological analysis and rats were used for functional examinations. The Sk-MSC sheet-pellets were prepared from GFP-Tg mice and SD rats, and were transplanted into the facial resection model (ST). Culture medium was transplanted as a control (NT). In the mouse experiment, facial-nerve-palsy (FNP) scoring was performed weekly during the recovery period, and immunohistochemistry was used for the evaluation of histological recovery after 8 weeks. In rats, contractility of facial muscles was measured via electrical stimulation of facial nerves root, as the marker of total functional recovery at 8 weeks after transplantation. The ST-group showed significantly higher FNP (about three fold) scores when compared to the NT-group after 2-8 weeks. Similarly, significant functional recovery of whisker movement muscles was confirmed in the ST-group at 8 weeks after transplantation. In addition, engrafted GFP(+) cells formed complex branches of nerve-vascular networks, with differentiation into Schwann cells and perineurial/endoneurial cells, as well as vascular endothelial and smooth muscle cells. Thus, Sk-MSC sheet-pellet transplantation is potentially useful for functional reconstitution therapy of large defects in facial nerve-vascular networks.	[Saito, Kosuke; Sakai, Akihiro; Iida, Masahiro; Okami, Kenji] Tokai Univ, Sch Med, Dept Otolaryngol, Isehara, Kanagawa 2591193, Japan; [Saito, Kosuke; Tamaki, Tetsuro; Hirata, Maki; Hashimoto, Hiroyuki; Nakazato, Kenei; Nakajima, Nobuyuki; Kazuno, Akihito] Tokai Univ, Sch Med, Muscle Physiol & Cell Biol Unit, Isehara, Kanagawa 2591193, Japan; [Tamaki, Tetsuro] Tokai Univ, Sch Med, Dept Physiol Sci, Isehara, Kanagawa 2591193, Japan; [Hirata, Maki; Hashimoto, Hiroyuki] Tokai Univ, Sch Med, Dept Orthoped, Isehara, Kanagawa 2591193, Japan; [Nakazato, Kenei] Tokai Univ, Sch Med, Dept Gen Thorath Surg, Isehara, Kanagawa 2591193, Japan; [Nakajima, Nobuyuki] Tokai Univ, Sch Med, Dept Urol, Isehara, Kanagawa 2591193, Japan; [Sakai, Akihiro] Tokai Univ, Sch Med, Dept Surg Gastroenterol, Isehara, Kanagawa 2591193, Japan	Tokai University; Tokai University; Tokai University; Tokai University; Tokai University; Tokai University; Tokai University	Tamaki, T (corresponding author), Tokai Univ, Sch Med, Muscle Physiol & Cell Biol Unit, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	tamaki@is.icc.u-tokai.ac.jp	Tamaki, Tetsuro/I-2615-2019	Tamaki, Tetsuro/0000-0002-9071-049X	Ministry of Education, Science and Culture of Japan [C-24592610]	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-aid for Scientific Research (C-24592610) from the Ministry of Education, Science and Culture of Japan (KO).	Araki T, 1996, NEURON, V17, P353, DOI 10.1016/S0896-6273(00)80166-X; Costa MP, 2009, ACTA ORTOP BRAS, V17, P286, DOI 10.1590/S1413-78522009000500007; Lucena EED, 2014, J ORAL MAXIL SURG, V72, P1001, DOI 10.1016/j.joms.2013.11.006; Dubovy P, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-58; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ghoreishian M, 2013, J ORAL MAXIL SURG, V71, P577, DOI 10.1016/j.joms.2012.05.025; Gordon T, 2010, J COMMUN DISORD, V43, P265, DOI 10.1016/j.jcomdis.2010.04.003; Grosheva M, 2008, BIOL CHEM, V389, P873, DOI 10.1515/BC.2008.100; Horie H, 1999, J NEUROSCI, V19, P9964; Hoshi A, 2008, TRANSPLANTATION, V85, P1617, DOI 10.1097/TP.0b013e318170572b; Husseman J, 2008, FACIAL PLAST SURG, V24, P242, DOI 10.1055/s-2008-1075840; Ichihara S, 2008, INJURY, V39, pS29, DOI 10.1016/j.injury.2008.08.029; Jungnickel J, 2006, J NEUROBIOL, V66, P940, DOI 10.1002/neu.20265; Most Sam P, 2004, Arch Facial Plast Surg, V6, P82, DOI 10.1001/archfaci.6.2.82; Nakamura K, 2003, OTOLARYNG HEAD NECK, V128, P539, DOI 10.1016/S0194-5998(02)23254-4; Nitta M, 2010, TRANSPLANTATION, V89, P1043, DOI 10.1097/TP.0b013e3181d45a7f; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pfister Bryan J., 2011, Critical Reviews in Biomedical Engineering, V39, P81, DOI 10.1615/CritRevBiomedEng.v39.i2.20; Salomone R, 2013, MUSCLE NERVE, V48, P423, DOI 10.1002/mus.23768; Sasaki R, 2011, J TISSUE ENG REGEN M, V5, P823, DOI 10.1002/term.387; Schroder K, 2011, ANTIOXID REDOX SIGN, V15, P915, DOI 10.1089/ars.2010.3533; Shichinohe R, 2012, J PLAST RECONSTR AES, V65, P763, DOI 10.1016/j.bjps.2011.12.009; Soeda S., 2013, THE J, V3, P142, DOI [DOI 10.4172/2157-7633.1000142, 10.4172/2157-7633.1000142]; Sun F, 2011, NEUROSCI LETT, V499, P104, DOI 10.1016/j.neulet.2011.05.043; Tamaki T, 1996, ANAT REC, V246, P325; Tamaki T, 2005, CIRCULATION, V112, P2857, DOI 10.1161/CIRCULATIONAHA.105.554832; Tamaki T, 1996, ANAT REC, V246, P335, DOI 10.1002/(SICI)1097-0185(199611)246:3<335::AID-AR4>3.0.CO;2-X; Tamaki T, 2007, HISTOCHEM CELL BIOL, V128, P349, DOI 10.1007/s00418-007-0331-5; Tamaki T, 2007, STEM CELLS, V25, P2283, DOI 10.1634/stemcells.2006-0746; Tamaki T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091257; Tamaki T, 2013, REGEN MED, V8, P437, DOI 10.2217/rme.13.30; Tamaki T, 2009, HISTOCHEM CELL BIOL, V132, P59, DOI 10.1007/s00418-009-0585-1; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tosaki T, 2008, EXP NEUROL, V213, P381, DOI 10.1016/j.expneurol.2008.06.017; Wang XM, 2011, BRAIN RES, V1383, P71, DOI 10.1016/j.brainres.2011.01.098; Xu K, 2014, SCIENCE, V344, P1275, DOI 10.1126/science.1255149; Costa HJZR, 2013, BRAIN RES, V1510, P10, DOI 10.1016/j.brainres.2013.03.025; Zhang JY, 2000, EUR J NEUROSCI, V12, P4171, DOI 10.1046/j.1460-9568.2000.01312.x	38	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138371	10.1371/journal.pone.0138371	http://dx.doi.org/10.1371/journal.pone.0138371			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372044	Green Published, gold, Green Submitted			2022-12-27	WOS:000361604400068
J	Shan, HB; Zhang, R; Li, Y; Gao, XY; Lin, SY; Luo, GY; Li, JJ; Xu, GL				Shan, Hong-Bo; Zhang, Rong; Li, Yin; Gao, Xiao-Yan; Lin, Shi-Yong; Luo, Guang-Yu; Li, Jian-Jun; Xu, Guo-Liang			Application of Endobronchial Ultrasonography for the Preoperative Detecting Recurrent Laryngeal Nerve Lymph Node Metastasis of Esophageal Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; DISSECTION; LYMPHADENECTOMY; EUS	Background The preoperative detection of recurrent laryngeal nerve lymph node (RLN LN) metastasis provides important information for the treatment of esophageal cancer. We investigated the possibility of applying endobronchial ultrasonography (EBUS) with conventional preoperative endoscopic ultrasonography (EUS) and computerized tomography (CT) examination to evaluate RLN LN metastasis in patients with esophageal cancer. Methods A total of 115 patients with advanced thoracic esophageal cancer underwent EBUS examinations. Patients also underwent EUS and CT imaging as reference diagnostic methods. Positron emission tomography /computed tomography (PET/CT) was also introduced in partial patients as reference method. The preoperative evaluation of RLN LN metastasis was compared with the surgical and pathological staging in 94 patients who underwent radical surgery. Results The sensitivities of the preoperative evaluations of RLN LN metastasis by EBUS, EUS and CT were 67.6%, 32.4% and 29.4%, respectively. The sensitivity of EBUS was significantly different from that of EUS or CT, especially in the detection of right RLN LNs. In addition, according to the extra data from reference method, PET/CT was not superior to EBUS or EUS in detecting RLN LN metastasis. Among all 115 patients, 21 patients who were diagnosed with tracheal invasions by EUS or EBUS avoided radical surgery. Another 94 patients who were diagnosed as negative for tracheobronchial tree invasion by EUS and EBUS had no positive findings in radical surgery. Conclusions EBUS can enhance the preoperative sensitivity of the detection of RLN LN metastasis in cases of thoracic esophageal cancer and is a useful complementary examination to conventional preoperative EUS and CT, which can alert thoracic surgeons to the possibility of a greater range of preoperative lymph node dissection. EBUS may also indicate tracheal invasion in cases of esophageal stricture.	[Shan, Hong-Bo; Zhang, Rong; Li, Yin; Gao, Xiao-Yan; Lin, Shi-Yong; Luo, Guang-Yu; Li, Jian-Jun; Xu, Guo-Liang] Sun Yat Sen Univ, Ctr Canc, Dept Endoscopy, Guangzhou 510275, Guangdong, Peoples R China; [Shan, Hong-Bo; Zhang, Rong; Li, Yin; Gao, Xiao-Yan; Lin, Shi-Yong; Luo, Guang-Yu; Li, Jian-Jun; Xu, Guo-Liang] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Shan, Hong-Bo; Zhang, Rong; Li, Yin; Gao, Xiao-Yan; Lin, Shi-Yong; Luo, Guang-Yu; Li, Jian-Jun; Xu, Guo-Liang] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Zhang, R (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Endoscopy, Guangzhou 510275, Guangdong, Peoples R China.	zhangrong@sysucc.org.cn	LI, JIAN/GRY-2197-2022; li, jian/GSE-0245-2022		Science and Technology Plan Projects of Guangdong Province of China [2009B030801158, 2012B031800097, 2012B031800282]	Science and Technology Plan Projects of Guangdong Province of China	This work was supported by Science and Technology Plan Projects of Guangdong Province of China (No. 2009B030801158, 2012B031800097, 2012B031800282) for these authors: Rong Zhang, Hong-Bo Shan, Yin Li, Xiao-Yan Gao, Shi-Yong Lin, Guang-Yu Luo, Jian-Jun Li, and Guo-Liang Xu.	Austwick MR, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3463005; Faigel DO, 2001, GASTROINTEST ENDOSC, V53, P593, DOI 10.1067/mge.2001.114060; Garrido T, 2009, CLINICS, V64, P499, DOI 10.1590/S1807-59322009000600003; Kuge K, 2003, J THORAC CARDIOV SUR, V125, P1343, DOI 10.1016/S0022-5223(03)00036-9; Law S, 2001, DIS ESOPHAGUS, V14, P98, DOI 10.1046/j.1442-2050.2001.00164.x; Li HC, 2012, J SURG ONCOL, V105, P548, DOI 10.1002/jso.22148; Miyata M, 2006, J SURG ONCOL, V93, P437; Mizutani M, 2006, SURG RADIOL ANAT, V28, P333, DOI 10.1007/s00276-006-0115-y; Ohnishi R, 2011, ENDOSCOPY, V43, P1082, DOI 10.1055/s-0030-1256766; Pfau PR, 2007, GASTROINTEST ENDOSC, V65, P377, DOI 10.1016/j.gie.2006.12.015; Shimada H, 2009, J GASTROINTEST SURG, V13, P619, DOI 10.1007/s11605-008-0790-6; Shimizu S, 2009, INT J CLIN ONCOL, V14, P421, DOI 10.1007/s10147-009-0893-4; Shiozaki H, 2001, DIS ESOPHAGUS, V14, P191, DOI 10.1046/j.1442-2050.2001.00206.x; Takemura M, 2003, ONCOL REP, V10, P75; Tamiya M, 2013, RESPIROLOGY, V18, P834, DOI 10.1111/resp.12095; Tan ZH, 2014, J GASTROINTEST SURG, V18, P187, DOI 10.1007/s11605-013-2411-2; Taniyama Y, 2013, ANN THORAC SURG, V95, P1930, DOI 10.1016/j.athoracsur.2013.03.069	17	5	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137400	10.1371/journal.pone.0137400	http://dx.doi.org/10.1371/journal.pone.0137400			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372339	Green Published, gold, Green Submitted			2022-12-27	WOS:000361604400021
J	Lim, CAA; Awan, TH; Cruz, PCS; Chauhan, BS				Lim, Charlemagne Alexander A.; Awan, Tahir Hussain; Cruz, Pompe C. Sta.; Chauhan, Bhagirath Singh			Influence of Environmental Factors, Cultural Practices, and Herbicide Application on Seed Germination and Emergence Ecology of Ischaemum rugosum Salisb	PLOS ONE			English	Article							LIGHT SENSITIVITY; WEED; INDUCTION; DORMANCY; GROWTH; RICE; CROP	Ischaemum rugosum Salisb. (Saramolla grass) is a noxious weed of rice that is difficult to control by chemical or mechanical means once established. A study was conducted to determine the effect of light, temperature, salt, drought, flooding, rice residue mulch, burial depth, and pre-emergence herbicides on seed germination and emergence of I. rugosum. Germination was stimulated by light and inhibited under complete darkness. Optimum temperature for germination was 30/20 degrees C (97.5% germination). Germination reduced from 31 to 3.5% when the osmotic potential of the growing medium decreased from -0.1 to -0.6 MPa and no germination occurred at -0.8 MPa. Germination was 18 and 0.5% at 50 and 100 mM NaCl concentrations, respectively, but was completely inhibited at 150 mM or higher. Residue application at 1-6 t ha(-1) reduced weed emergence by 35-88% and shoot biomass by 55-95%. The efficacy of pre-emergence herbicides increased with increasing application rates and decreased with increasing rice residue mulching. The efficacy of herbicides was in the order of oxadiazon> pendimethalin> pretilachlor. At 6 t ha(-1), all herbicides, regardless of rates, did not differ from the control treatment. I. rugosum seeds buried at 2 cm or deeper did not emerge; however, they emerged by 4.5 and 0.5% at 0.5 and 1 cm depths, respectively, compared to the 39% germination for soil surface seeding. Flooding at 4 DAS or earlier reduced seedling emergence and shoot biomass while flooding at 8 DAS reduced only seedling emergence. The depth and timing of flooding independently reduced root biomass. Flooding at 4 and 6 cm depths reduced the root biomass. Relative to flooding on the day of sowing, flooding at 8 DAS increased root biomass by 89%. Similarly, flooding on the day of sowing and at 2 DAS reduced the root-shoot biomass ratio. Under the no-flood treatment, increasing rates of pretilachlor from 0.075 to 0.3 kg ai ha(-1) reduced weed emergence by 61- 79%. At the flooding depth of 2-4 cm, pretilachlor reduced weed emergence and shoot and root biomass, but the differences across rates were non-significant. Information generated in this study will be helpful in developing integrated weed management strategies for managing this weed.	[Lim, Charlemagne Alexander A.; Awan, Tahir Hussain] Int Rice Res Inst, Weed Sci Crop & Environm Sci Div, Los Banos, Philippines; [Lim, Charlemagne Alexander A.; Awan, Tahir Hussain; Cruz, Pompe C. Sta.] Univ Philippines, Coll Agr, Crop Sci Cluster, Los Banos, Philippines; [Chauhan, Bhagirath Singh] Univ Queensland, Queensland Alliance Agr & Food Innovat, Toowoomba, Qld, Australia	CGIAR; International Rice Research Institute (IRRI); University of the Philippines System; University of the Philippines Los Banos; University of the Philippines Open University; University of Queensland	Awan, TH (corresponding author), Int Rice Res Inst, Weed Sci Crop & Environm Sci Div, Los Banos, Philippines.	t.awan@irri.org; pompestacruz@yahoo.com	Chauhan, Bhagirath/G-8892-2014	Chauhan, Bhagirath/0000-0003-1540-4668				Abdul Shukor Juraimi, 2013, Australian Journal of Crop Science, V7, P989; Agardh VC, 2012, FEDERAL NOXIOUS WEED; Ampong-Nyarko K., 1991, HDB WEED CONTROL RIC; Anwar MP, 2012, ACTA AGR SCAND B-S P, V62, P604, DOI 10.1080/09064710.2012.681060; Awan TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090305; Awan TH, 2006, PAKISTAN J SCI, V58, P50; Ballare CL, 2000, FIELD CROP RES, V67, P149, DOI 10.1016/S0378-4290(00)00090-3; Baskin CC, 1998, SEEDS ECOLOGY BIOGEO; Arnold RLB, 1988, FUNCT ECOL, V2, P311, DOI 10.2307/2389403; Benech-Arnold RL, 2000, FIELD CROP RES, V67, P105, DOI 10.1016/S0378-4290(00)00087-3; BENVENUTI S, 1995, WEED RES, V35, P343, DOI 10.1111/j.1365-3180.1995.tb01629.x; BOTHA FC, 1992, PLANT GROWTH REGUL, V11, P211, DOI 10.1007/BF00024560; Botto JF, 1998, WEED SCI, V46, P351, DOI 10.1017/S0043174500089530; Brecke BJ, 2005, P TROP SPID S TIFT G; Chauhan BS, 2006, AUST J EXP AGR, V46, P1557, DOI 10.1071/EA05291; Chauhan B. S., 2013, American Journal of Plant Sciences, V4, P1345; Chauhan BS, 2008, WEED SCI, V56, P699, DOI 10.1614/WS-08-048.1; Chauhan BS, 2007, WEED TECHNOL, V21, P53, DOI 10.1614/WT-06-016.1; Chauhan BS, 2006, WEED SCI, V54, P1032, DOI 10.1614/WS-06-060R1.1; Chauhan BS, 2006, WEED SCI, V54, P854, DOI 10.1614/WS-06-047R.1; Chauhan BS, 2006, WEED SCI, V54, P891, DOI 10.1614/WS-06-053R.1; Chauhan BS, 2013, WEED SCI, V61, P403, DOI 10.1614/WS-D-12-00147.1; Chauhan BS, 2012, WEED TECHNOL, V26, P1, DOI 10.1614/WT-D-11-00105.1; Chauhan BS, 2011, WEED SCI, V59, P119, DOI 10.1614/WS-D-10-00075.1; Chauhan BS, 2010, ADV AGRON, V105, P221, DOI 10.1016/S0065-2113(10)05006-6; Chauhan BS, 2009, WEED SCI, V57, P235, DOI 10.1614/WS-08-141.1; Chauhan BS, 2008, WEED SCI, V56, P820, DOI 10.1614/WS-08-070.1; Clavijo J, 2004, COMALFI J, V31, P13; Dorji S, 2013, CANADIAN J PLANT PRO, V1, P35; Egley G. H., 1986, WEED SCI, V2, P67; Flinn JC, 1986, WEEDS ENV TROPICS, P51; Galinato MI, 1999, UPLAND RICE WEEDS S, P86; Hennig L, 2002, PLANT PHYSIOL, V128, P194, DOI 10.1104/pp.010559; Hill J. E., 2001, Rice research for food security and poverty alleviation. Proceedings of the International Rice Research Conference, Los Banos, Philippines, 31 March-3 April, 2000, P491; Holm L, 1977, WORLDS WORST WEED DO; Ismail AM, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls019; Itoh K, 1991, ISCHAEMUM RUGOSUM LI, P55; Liebman M., 2001, WEEDS SOIL ENV; Locke Martin A., 2002, Weed Biology and Management, V2, P123, DOI 10.1046/j.1445-6664.2002.00061.x; Lubigan RT, 1990, ISCHAEMUM RUGOSUM SO; Marenco Ricardo A., 1998, Revista Brasileira de Fisiologia Vegetal, V10, P107; Matsuo Mitsuhiro, 2004, Weed Biology and Management, V4, P148, DOI 10.1111/j.1445-6664.2004.00135.x; Mennan H, 2006, WEED SCI, V54, P114, DOI 10.1614/WS-05-107R1.1; Milberg P, 1997, CAN J BOT, V75, P1998, DOI 10.1139/b97-911; Opena JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092261; Pandey S, 1995, RESEARCH, V10, P73; Rengasamy P, 2002, AUST J EXP AGR, V42, P351, DOI 10.1071/EA01111; ROBERTS EH, 1981, PLANT CELL ENVIRON, V4, P97, DOI 10.1111/j.1365-3040.1981.tb01044.x; SHARMA MP, 1978, CAN J PLANT SCI, V58, P141, DOI 10.4141/cjps78-022; SHINOMURA T, 1994, PLANT PHYSIOL, V104, P363, DOI 10.1104/pp.104.2.363; Singh Y, 2008, DIRECT SEEDING RICE, P107; Tarlok Singh, 1991, Indian Journal of Weed Science, V23, P1; TAYLORSON RB, 1969, WEED SCI, V17, P48, DOI 10.1017/S0043174500030873; Wang QingYa, 2004, Rice Science, V11, P331; WESSON G, 1969, J EXP BOT, V20, P414, DOI 10.1093/jxb/20.2.414; WOOLLEY JT, 1978, PLANT PHYSIOL, V61, P597, DOI 10.1104/pp.61.4.597	56	6	7	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137256	10.1371/journal.pone.0137256	http://dx.doi.org/10.1371/journal.pone.0137256			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368808	gold, Green Submitted, Green Published			2022-12-27	WOS:000361601100060
J	Walsh, JM; Segurado, R; Mahony, RM; Foley, ME; McAuliffe, FM				Walsh, Jennifer M.; Segurado, Ricardo; Mahony, Rhona M.; Foley, Michael E.; McAuliffe, Fionnuala M.			The Effects of Fetal Gender on Maternal and Fetal Insulin Resistance	PLOS ONE			English	Article							SEX; CHILDREN; ADOLESCENTS; PREVALENCE; PREVENTION; YOUTH; GIRLS; BIRTH; RISK; BOYS	Objective Gender plays a role in the development of a number of cardiovascular andmetabolic diseases and it has been suggested that females may bemore insulin resistant in utero. We sought to assess the relationship between infant gender and insulin resistance in a large pregnancy cohort. Study Design This is a secondary analysis of a cohort from the ROLO randomized control trial of low GI diet in pregnancy. Serum insulin, glucose and leptin were measured in early pregnancy and at 28 weeks. At delivery cord blood C-peptide and leptin were measured. A comparison of maternal factors, fetal biometry, insulin resistance and leptin was made between male and female offspring. A multivariate regression model was built to account for the possible effects of maternal BMI, birthweight and original study group assignment on findings. Results A total of 582 women were included in this secondary analysis, of whom 304 (52.2%) gave birth to male and 278 (47.8%) gave birth to female infants. Compared to male infants at birth, female infants were significantly lighter, (3945 +/- 436 vs. 4081 +/- 549g, p<0.001), shorter in length (52.36 +/- 2.3 vs. 53.05 +/- 2.4cm, p<0.001) and with smaller head circumferences (35.36 +/- 1.5 vs. 36.10 +/- 1.1cm, p<0.001) than males. On multiple regression analysis, women pregnant with female fetuses were less insulin resistant in early pregnancy, i.e. had lower HOMA indices (B = -0.19, p = 0.01). Additionally female fetuses had higher concentrations of both cord blood leptin and C-peptide at birth when compared to male offspring (B = 0.38, p<0.001 and B = 0.31, p = 0.03 respectively). Conclusion These findings suggest gender is a risk factor for insulin resistance in-utero. Additionally, carrying a female fetus decreases the risk of insulin resistance in the mother, from as early as the first trimester.	[Walsh, Jennifer M.; Foley, Michael E.; McAuliffe, Fionnuala M.] Univ Coll Dublin, Natl Matern Hosp, Sch Med & Med Sci, UCD Obstet & Gynaecol, Dublin 2, Ireland; [Segurado, Ricardo] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, CSTAR, Dublin 2, Ireland; [Mahony, Rhona M.] Natl Matern Hosp, Dublin 2, Ireland	National Maternity Hospital, Dublin; University College Dublin; University College Dublin; National Maternity Hospital, Dublin	McAuliffe, FM (corresponding author), Univ Coll Dublin, Natl Matern Hosp, Sch Med & Med Sci, UCD Obstet & Gynaecol, Dublin 2, Ireland.	fionnuala.mcauliffe@ucd.ie	Segurado, Ricardo/K-6116-2014	Segurado, Ricardo/0000-0002-3547-6733	Health Research Board Ireland [HRC/2007/13]	Health Research Board Ireland	The Health Research Board Ireland funded this research, grant number HRC/2007/13.	Barrett-Connor E, 2013, GLOB HEART, V8, P95, DOI 10.1016/j.gheart.2012.12.002; Barrett-Connor E, 2013, BEST PRACT RES CL EN, V27, P481, DOI 10.1016/j.beem.2013.05.013; Bavdekar A, 1999, DIABETES, V48, P2422, DOI 10.2337/diabetes.48.12.2422; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Buhling KJ, 2012, ULTRASOUND OBST GYN, V39, P558, DOI 10.1002/uog.10092; Dabelea D, 2014, JAMA-J AM MED ASSOC, V311, P1778, DOI 10.1001/jama.2014.3201; Ehtisham S, 2004, ARCH DIS CHILD, V89, P526, DOI 10.1136/adc.2003.027821; Fagot-Campagna A, 2000, J PEDIATR-US, V136, P664, DOI 10.1067/mpd.2000.105141; Fakhouri Tala H I, 2014, NCHS Data Brief, P1; Higgins MF, 2008, EUR J OBSTET GYN R B, V140, P43, DOI 10.1016/j.ejogrb.2008.02.021; HOUGHTON DJ, 1984, PLACENTA, V5, P455, DOI 10.1016/S0143-4004(84)80026-0; Ibanez L, 2008, J CLIN ENDOCR METAB, V93, P2774, DOI 10.1210/jc.2008-0526; Levi J, 2011, ENDOCRINOLOGY, V152, P3385, DOI 10.1210/en.2011-0185; Linnemann K, 2000, J CLIN ENDOCR METAB, V85, P4298, DOI 10.1210/jc.85.11.4298; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Murphy MJ, 2004, PEDIATRICS, V113, P82, DOI 10.1542/peds.113.1.82; Perreault L, 2008, DIABETES CARE, V31, P1416, DOI 10.2337/dc07-2390; Petrikovsky BM, 1997, J CLIN ULTRASOUND, V25, P378, DOI 10.1002/(SICI)1097-0096(199709)25:7<378::AID-JCU5>3.0.CO;2-7; Pettitt DJ, 2014, DIABETES CARE, V37, P402, DOI 10.2337/dc13-1838; Retnakaran R, 2015, J CLIN ENDOCR METAB; Retnakaran R, 2015, DIABETES CARE, V38, P844, DOI 10.2337/dc14-2551; Sheiner E, 2004, FETAL DIAGN THER, V19, P366, DOI 10.1159/000077967; Shields BM, 2007, DIABETES CARE, V30, P2661, DOI 10.2337/dc06-1501; Stofkova A, 2009, Endocr Regul, V43, P157; Telama R, 2014, MED SCI SPORT EXER, V46, P955, DOI 10.1249/MSS.0000000000000181; Toriola AT, 2011, OBSTET GYNECOL, V118, P1029, DOI 10.1097/AOG.0b013e3182342b7f; Walsh J, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-16; Walsh JM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5605; Xiao L, 2014, DIABETIC MED, V31, P1696, DOI 10.1111/dme.12562; Young-Hyman D, 2001, DIABETES CARE, V24, P1359, DOI 10.2337/diacare.24.8.1359	30	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137215	10.1371/journal.pone.0137215	http://dx.doi.org/10.1371/journal.pone.0137215			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368559	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100059
J	Yan, PZ; Li, MC; Wei, GS; Li, H; Gao, Z				Yan, Pengze; Li, Mingcong; Wei, Guangshan; Li, Han; Gao, Zheng			Molecular Fingerprint and Dominant Environmental Factors of Nitrite-Dependent Anaerobic Methane- Oxidizing Bacteria in Sediments from the Yellow River Estuary, China	PLOS ONE			English	Article							DENITRIFYING METHANOTROPHIC BACTERIA; OXIDATION; DIVERSITY; ENRICHMENT; COOCCURRENCE; ABUNDANCE; LAKE	Nitrite-dependent anaerobic methane oxidation (n-damo) is performed by "Candidatus Methylomirabilis oxyfera" (M. oxyfera), which connects the carbon and nitrogen global nutrient cycles. In the present study, M. oxyfera- like bacteria sequences were successfully recovered from Yellow River Estuary sediments using specific primers for 16S rRNA and pmoA genes. A M. oxyfera- like sequences analysis based on the 16S rRNA gene revealed greater diversity compared with the pmoA gene; the 16S rRNA gene sequences retrieved from the Yellow River Estuary sediments belong to groups A as well as B and were mainly found in freshwater habitats. Quantitative PCR showed that 16S rRNA gene abundance varied from 9.28 +/- 0.11x10(3) to 2.10 +/- 0.13x10(5) copies g(-1) (dry weight), and the pmoA gene abundance ranged from 8.63 +/- 0.50x10(3) to 1.83 +/- 0.18x10(5) copies g(-1) (dry weight). A correlation analysis showed that the total organic carbon (TOC) and ammonium (NH4+) as well as the ratio of total phosphorus to total nitrogen (TP/TN) influenced the M. oxyfera- like bacteria distribution in the Yellow River Estuary sediments. These findings will aid in understanding the n- damo bacterial distribution pattern as well as their correlation with surrounding environmental factors in temperate estuarine ecosystems.	[Yan, Pengze; Li, Mingcong; Wei, Guangshan; Li, Han; Gao, Zheng] Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Li, H (corresponding author), Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	lihan@sdau.edu.cn; gaozheng@sdau.edu.cn	Yan, Pengze/AGZ-6962-2022	Yan, Pengze/0000-0001-8142-0944	National Natural Science Foundation Project of China [41306150]; Promotive Research Fund for Excellent Young and Middle-aged Scientists of Shandong Province, China [BS2012HZ011]; Shandong Province Higher Educational Science and Technology Program, China [J10LC09]	National Natural Science Foundation Project of China(National Natural Science Foundation of China (NSFC)); Promotive Research Fund for Excellent Young and Middle-aged Scientists of Shandong Province, China; Shandong Province Higher Educational Science and Technology Program, China	This work was supported by the National Natural Science Foundation Project of China (No. 41306150); Promotive Research Fund for Excellent Young and Middle-aged Scientists of Shandong Province, China (No. BS2012HZ011); A Project of Shandong Province Higher Educational Science and Technology Program, China (No. J10LC09). ZG received the three fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boetius A., 2002, OCEAN MARGIN SYSTEMS, P457, DOI [DOI 10.1007/978-3-662-05127-6_28, 10.1007/978-3-662-05127-6_28]; Chen J, 2015, APPL MICROBIOL BIOT, V99, P1463, DOI 10.1007/s00253-014-6051-6; Chen J, 2014, APPL MICROBIOL BIOT, V98, P5685, DOI 10.1007/s00253-014-5733-4; Cui BS, 2009, ECOL ENG, V35, P1090, DOI 10.1016/j.ecoleng.2009.03.022; Deutzmann JS, 2011, APPL ENVIRON MICROB, V77, P4429, DOI 10.1128/AEM.00340-11; Dong J, 2015, APPL BIOCHEM BIOTECH, V175, P2729, DOI 10.1007/s12010-014-1456-3; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ettwig KF, 2010, NATURE, V464, P543, DOI 10.1038/nature08883; Ettwig KF, 2009, APPL ENVIRON MICROB, V75, P3656, DOI 10.1128/AEM.00067-09; Field C. B., 2014, TECHNICAL SUMMARY A, P35; Hammer O, 2001, PALEONTOLOGY ELECT, V4, P1; Han P, 2013, APPL MICROBIOL BIOT, V97, P10155, DOI 10.1007/s00253-013-5260-8; He ZF, 2015, WATER RES, V68, P554, DOI 10.1016/j.watres.2014.09.055; Hu BL, 2014, P NATL ACAD SCI USA, V111, P4495, DOI 10.1073/pnas.1318393111; Hu SH, 2009, ENV MICROBIOL REP, V1, P377, DOI 10.1111/j.1758-2229.2009.00083.x; Jetten MS, 2004, ANNU REV MICROBIOL, P58; Juretschko S, 1998, APPL ENVIRON MICROB, V64, P3042; Kampman C, 2012, J HAZARD MATER, V227, P164, DOI 10.1016/j.jhazmat.2012.05.032; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Kojima H, 2012, SYST APPL MICROBIOL, V35, P233, DOI 10.1016/j.syapm.2012.03.005; Liu Y, 2015, APPL MICROBIOL BIOT, V99, P2371, DOI 10.1007/s00253-014-6141-5; Luesken FA, 2011, APPL ENVIRON MICROB, V77, P3877, DOI 10.1128/AEM.02960-10; Raghoebarsing AA, 2006, NATURE, V440, P918, DOI 10.1038/nature04617; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shen LD, 2015, APPL MICROBIOL BIOT, V99, P349, DOI 10.1007/s00253-014-6031-x; Shen LD, 2015, APPL MICROBIOL BIOT, V99, P133, DOI 10.1007/s00253-014-6200-y; Shen LD, 2014, APPL MICROBIOL BIOT, V98, P5029, DOI 10.1007/s00253-014-5556-3; Shen LD, 2014, MICROB ECOL, V67, P341, DOI 10.1007/s00248-013-0330-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang Y, 2012, FEMS MICROBIOL LETT, V336, P79, DOI 10.1111/j.1574-6968.2012.02654.x; Xia WW, 2011, ISME J, V5, P1226, DOI 10.1038/ismej.2011.5; Xu XueGong, 2002, GeoJournal, V56, P177, DOI 10.1023/A:1025175409094; Yang J, 2012, FRONT EARTH SCI-PRC, V6, P383, DOI 10.1007/s11707-012-0336-9; Zhou LL, 2014, FEMS MICROBIOL LETT, V360, P33, DOI 10.1111/1574-6968.12567; Zhu BL, 2012, APPL ENVIRON MICROB, V78, P8657, DOI 10.1128/AEM.02102-12; Zhu GB, 2015, ENV MICROBIOL REP, V7, P128, DOI 10.1111/1758-2229.12214; [朱群 Zhu Qun], 2013, [环境科学学报, Acta Scientiae Circumstantiae], V33, P1321	37	31	41	6	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137996	10.1371/journal.pone.0137996	http://dx.doi.org/10.1371/journal.pone.0137996			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368535	gold, Green Published, Green Submitted			2022-12-27	WOS:000361601100198
J	Kim, IY; Kim, BR; Kim, YW				Kim, Ik Yong; Kim, Bo Ra; Kim, Young Wan			Factors Affecting Use and Delay (>= 8 Weeks) of Adjuvant Chemotherapy after Colorectal Cancer Surgery and the Impact of Chemotherapy-Use and Delay on Oncologic Outcomes	PLOS ONE			English	Article							III COLON-CANCER; STAGE-II; SURVIVAL; THERAPY; FLUOROURACIL; INITIATION; COMPLICATIONS; LEUCOVORIN; RESECTION	Purpose To evaluate factors affecting the use and delay >= 8 weeks of adjuvant chemotherapy and the impact of chemotherapy use and delay on survival. Methods Between 2005 and 2012, consecutive patients with stage II and III colorectal cancer who were treated with major curative resection were enrolled. Results Among 750 patients with stage II (n = 318) and III (n = 432) disease, 153 (20.4%) did not receive chemotherapy. Among 597 patients with adjuvant chemotherapy, 31 (5.2%) began chemotherapy 8 weeks or more after surgery. Factors associated with not receiving chemotherapy were: age >= 80 years (hazard ratio [HR] = 5.2), American Society of Anesthesiologists score >= 3 (HR = 1.9), underlying cerebrovascular disease (HR = 1.7), stage II disease (HR = 2.0), presence of postoperative complications (HR = 2.2), or intensive care unit admission (HR = 2.4). Factors associated with chemotherapy delay >= 8 weeks were: male sex (HR = 4.2), rectal primary cancer (HR = 5.4), or presence of postoperative complications (HR = 2.5). Independent prognostic factors for overall survival included TNM III stage (HR = 2.04) and chemotherapy delay >= 8 weeks (HR = 0.39) or <8 weeks (HR = 0.22). Independent prognostic factors for recurrence-free survival were TNM III stage (HR = 2.26) and chemotherapy delay <8 weeks (HR = 0.35). Conclusions Postoperative complications were associated with both lack of and delayed chemotherapy. Timely initiation of chemotherapy, defined as <8 weeks, was a favorable prognostic factor for overall and recurrence-free survival. To increase the proportion of patients receiving chemotherapy and timely initiation of chemotherapy, surgical complications should be minimized after curative resection.	[Kim, Ik Yong; Kim, Young Wan] Yonsei Univ, Wonju Coll Med, Dept Surg, Div Colorectal Surg, Wonju, South Korea; [Kim, Bo Ra] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Div Gastroenterol, Wonju, South Korea	Yonsei University; Yonsei University	Kim, YW (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Surg, Div Colorectal Surg, Wonju, South Korea.	youngwkim@yonsei.ac.kr						Ahmed S, 2010, DIS COLON RECTUM, V53, P1432, DOI 10.1007/DCR.0b013e3181e78815; Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Ayanian JZ, 2003, J CLIN ONCOL, V21, P1293, DOI 10.1200/JCO.2003.06.178; Baldwin LM, 2005, J NATL CANCER I, V97, P1211, DOI 10.1093/jnci/dji241; Bayraktar UD, 2011, CANCER-AM CANCER SOC, V117, P2364, DOI 10.1002/cncr.25720; Biagi JJ, 2011, JAMA-J AM MED ASSOC, V305, P2335, DOI 10.1001/jama.2011.749; Chau I, 2005, ANN ONCOL, V16, P549, DOI 10.1093/annonc/mdi116; Cheung WY, 2009, DIS COLON RECTUM, V52, P1054, DOI 10.1007/DCR.0b013e3181a51173; Czaykowski PM, 2011, DIS COLON RECTUM, V54, P1082, DOI 10.1097/DCR.0b013e318223c3d6; Des Guetz G, 2010, EUR J CANCER, V46, P1049, DOI 10.1016/j.ejca.2010.01.020; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Dobie SA, 2006, JNCI-J NATL CANCER I, V98, P610, DOI 10.1093/jnci/djj159; Dube S, 1997, DIS COLON RECTUM, V40, P35, DOI 10.1007/BF02055679; Etzioni DA, 2008, CANCER-AM CANCER SOC, V113, P3279, DOI 10.1002/cncr.23958; Gray R, 2007, LANCET, V370, P2020, DOI 10.1016/s0140-6736(07)61866-2; Gross CP, 2007, CANCER-AM CANCER SOC, V109, P2410, DOI 10.1002/cncr.22726; Hendren S, 2010, DIS COLON RECTUM, V53, P1587, DOI 10.1007/DCR.0b013e3181f2f202; Hershman D, 2006, CANCER-AM CANCER SOC, V107, P2581, DOI 10.1002/cncr.22316; Kim YW, 2013, ANN COLOPROCTOL, V29, P44, DOI 10.3393/ac.2013.29.2.44; Law WL, 2007, ANN SURG ONCOL, V14, P2559, DOI 10.1245/s10434-007-9434-4; Law WL, 2000, AM J SURG, V179, P92, DOI 10.1016/S0002-9610(00)00252-X; Luo RL, 2006, ONCOLOGIST, V11, P1025, DOI 10.1634/theoncologist.11-9-1025; McGory ML, 2006, DIS COLON RECTUM, V49, P319, DOI 10.1007/s10350-005-0283-6; National Comprehensive Cancer Network, RECT CANC VERS 1 201; National Comprehensive Cancer Network, COL CANC VERS 2 2015; Schrag D, 2001, J NATL CANCER I, V93, P850, DOI 10.1093/jnci/93.11.850; Taal BG, 2001, BRIT J CANCER, V85, P1437, DOI 10.1054/bjoc.2001.2117; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; WOLMARK N, 1993, J CLIN ONCOL, V11, P1879, DOI 10.1200/JCO.1993.11.10.1879; Zeig-Owens Rachel, 2009, J Registry Manag, V36, P30	30	44	44	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138720	10.1371/journal.pone.0138720	http://dx.doi.org/10.1371/journal.pone.0138720			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381146	Green Submitted, Green Published, gold			2022-12-27	WOS:000361790200151
J	Nishio, A; Yamamoto, M; Honta, R; Sado, T; Ueki, H; Watanabe, T; Uehara, R; Shioiri, T				Nishio, Akihiro; Yamamoto, Mayumi; Honta, Ryo; Sado, Tadahiro; Ueki, Hirofumi; Watanabe, Takahiro; Uehara, Ryosuke; Shioiri, Toshiki			Prevalence of Mental Illness, Cognitive Disability, and Their Overlap among the Homeless in Nagoya, Japan	PLOS ONE			English	Article							GERMANY; HEALTH; PEOPLE	Background While the prevalence of mental illness or cognitive disability is higher among homeless people than the general population in Western countries, few studies have investigated its prevalence in Japan or other Asian countries. The present study conducted a survey to comprehensively assess prevalence of mental illness, cognitive disability, and their overlap among homeless individuals living in Nagoya, Japan. Methods Participants were 114 homeless individuals. Mental illness was diagnosed based on semi-structured interviews conducted by psychiatrists. The Wechsler Adult Intelligence Scale-III (WAIS-III, simplified version) was used to diagnose intellectual/cognitive disability. Results Among all participants, 42.1%(95% CI 33.4-51.3%) were diagnosed with a mental illness: 4.4% (95% CI 1.9-9.9%) with schizophrenia or other psychotic disorder, 17.5% (95% CI 11.6-25.6%) with a mood disorder, 2.6% (95% CI 0.9-7.5%) with an anxiety disorder, 14.0% (95% CI 8.8-21.6%) with a substance-related disorder, and 3.5% (95% CI 1.4-8.8%) with a personality disorder. Additionally, 34.2% (95% CI 26.1-43.3%) demonstrated cognitive disability: 20.2%(95% CI 13.8-28.5%) had mild and 14.0% (95% CI 8.8-21.6%) had moderate or severe disability. The percent overlap between mental illness and cognitive disability was 15.8%(95% CI 10.2-23.6%). Only 39.5%(95% CI 26.1-43.3%) of the participants were considered to have no psychological or cognitive dysfunction. Participants were divided into four groups based on the presence or absence of mental illness and/or cognitive disability. Only individuals with a cognitive disability reported a significant tendency toward not wanting to leave their homeless life. Conclusion This is the first report showing that the prevalence of mental illness and/or cognitive disability among homeless individuals is much higher than in the general Japanese population. Appropriate support strategies should be devised and executed based on the specificities of an individual's psychological and cognitive condition.	[Nishio, Akihiro; Yamamoto, Mayumi; Honta, Ryo; Sado, Tadahiro] Gifu Univ, Hlth Adm Ctr, Gifu 5011193, Japan; [Nishio, Akihiro; Ueki, Hirofumi; Shioiri, Toshiki] Gifu Univ, Grad Sch Med, Dept Psychopathol, Div Neurosci, Gifu 5011193, Japan; [Yamamoto, Mayumi] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu 5011193, Japan; [Watanabe, Takahiro] Tokoha Univ, Fac Hlth Promot Sci, Hamamatsu, Shizuoka 4312102, Japan; [Watanabe, Takahiro] Midori Hosp, Gifu 5013113, Japan; [Uehara, Ryosuke] Yoshida Hosp, Nara 6310818, Japan	Gifu University; Gifu University; Gifu University	Nishio, A (corresponding author), Gifu Univ, Hlth Adm Ctr, 1-1 Yanagido, Gifu 5011193, Japan.	a_nishio@gifu-u.ac.jp			Japan Federation of the Democratic Medical Institute; Health Administration Center, Gifu University; Grants-in-Aid for Scientific Research [26780382] Funding Source: KAKEN	Japan Federation of the Democratic Medical Institute; Health Administration Center, Gifu University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The Japan Federation of the Democratic Medical Institute and the Health Administration Center, Gifu University, financed the survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, RES NAT SURV NUTR MI; [Anonymous], 2012, FACT FIND HOM PERS L, P12; Baggett TP, 2013, NEW ENGL J MED, V369, P569, DOI [10.1176/appi.ps.201100398, DOI 10.1176/APPI.PS.201100398]; Dairoku H, 2008, JAP PSYCH ASS M MEM, P433; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Dunne E, 2012, Ir Med J, V105, P71; Edidin JP, 2012, CHILD PSYCHIAT HUM D, V43, P354, DOI 10.1007/s10578-011-0270-1; Fazel S, 2008, PLOS MED, V5, P1670, DOI 10.1371/journal.pmed.0050225; Fichter MM, 2001, ACTA PSYCHIAT SCAND, V103, P94, DOI 10.1034/j.1600-0447.2001.00217.x; Fukue T, 2013, JPN J GEN HOSP PSYCH, V25, P55; Langle G, 2005, SOC PSYCH PSYCH EPID, V40, P382, DOI 10.1007/s00127-005-0902-5; Maulik PK, 2011, RES DEV DISABIL, V32, P419, DOI 10.1016/j.ridd.2010.12.018; Mercier C, 2011, J INTELL DISABIL RES, V55, P441, DOI 10.1111/j.1365-2788.2010.01366.x; Morikawa Suimei, 2011, Nihon Koshu Eisei Zasshi, V58, P331; NAKANE Y, 1992, SCHIZOPHRENIA BULL, V18, P75, DOI 10.1093/schbul/18.1.75; Nishio A, 2015, PSYCHIAT CLIN NEUROS, V69, P534, DOI 10.1111/pcn.12265; Oakes PM, 2008, J INTELLECT DISABILI, V12, P325, DOI 10.1177/1744629508100496; Ohota T, 2011, PSYCHIAT NEUROL JPN, V113, P1137; Okuda K, 2010, HOMELESSNESS SOC, V3, P90; Rohde P, 1999, J ADOLESCENCE, V22, P319, DOI 10.1006/jado.1999.0224; Salize HJ, 2002, ADDICTION, V97, P1593, DOI 10.1046/j.1360-0443.2002.00235.x; Tsai J, 2012, PSYCHIAT SERV, V63, P569, DOI 10.1176/appi.ps.201100398; Van Straaten B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086112; Wechsler D., 1997, WECHSLER ADULT INTEL; Wuensch Karl L., WHAT IS LIKERT SCALE	25	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138052	10.1371/journal.pone.0138052	http://dx.doi.org/10.1371/journal.pone.0138052			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0RH	26378447	Green Published, Green Submitted, gold			2022-12-27	WOS:000361769400048
J	Swanson, DK				Swanson, David K.			Environmental Limits of Tall Shrubs in Alaska's Arctic National Parks	PLOS ONE			English	Article							KUPARUK RIVER-BASIN; VEGETATION CHANGE; TUNDRA; TEMPERATURE; EXPANSION; THAW; PRECIPITATION; FIRE; PERMAFROST; ECOSYSTEMS	We sampled shrub canopy volume (height times area) and environmental factors (soil wetness, soil depth of thaw, soil pH, mean July air temperature, and typical date of spring snow loss) on 471 plots across five National Park Service units in northern Alaska. Our goal was to determine the environments where tall shrubs thrive and use this information to predict the location of future shrub expansion. The study area covers over 80,000 km(2) and has mostly tundra vegetation. Large canopy volumes were uncommon, with volumes over 0.5 m(3)/m(2) present on just 8% of plots. Shrub canopy volumes were highest where mean July temperatures were above 10.5 degrees C and on weakly acid to neutral soils (pH of 6 to 7) with deep summer thaw (>80 cm) and good drainage. On many sites, flooding helped maintain favorable soil conditions for shrub growth. Canopy volumes were highest where the typical snow loss date was near 20 May; these represent sites that are neither strongly wind-scoured in the winter nor late to melt from deep snowdrifts. Individual species varied widely in the canopy volumes they attained and their response to the environmental factors. Betula sp. shrubs were the most common and quite tolerant of soil acidity, cold July temperatures, and shallow thaw depths, but they did not form high-volume canopies under these conditions. Alnus viridis formed the largest canopies and was tolerant of soil acidity down to about pH 5, but required more summer warmth (over 12 degrees C) than the other species. The Salix species varied widely from S. pulchra, tolerant of wet and moderately acid soils, to S. alaxensis, requiring well-drained soils with near neutral pH. Nearly half of the land area in ARCN has mean July temperatures of 10.5 to 12.5 degrees C, where 2 degrees C of warming would bring temperatures into the range needed for all of the potential tall shrub species to form large canopies. However, limitations in the other environmental factors would probably prevent the formation of large shrub canopies on at least half of the land area with newly favorable temperatures after 2 degrees C of warming.	Natl Pk Serv, Arctic Inventory & Monitoring Network, Fairbanks, AK 99709 USA	United States Department of the Interior	Swanson, DK (corresponding author), Natl Pk Serv, Arctic Inventory & Monitoring Network, Fairbanks, AK 99709 USA.	david_k_swanson@nps.gov			U.S. Department of Interior, National Park Service, Inventory and Monitoring program	U.S. Department of Interior, National Park Service, Inventory and Monitoring program	This study was funded entirely by base funding from the U.S. Department of Interior, National Park Service, Inventory and Monitoring program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaska Fire Service, 2014, FIR HIST AL; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], USDA HDB; Bartleman AP, 2001, ARCTIC, V54, P149; Benham E. C, 2012, SOIL SURVEY STAFF FI; Bockheim JG, 1998, ARCTIC ALPINE RES, V30, P166, DOI 10.2307/1552131; Bryant JP, 2014, ECOGRAPHY, V37, P204, DOI 10.1111/j.1600-0587.2013.00436.x; BRYANT JP, 1980, ANNU REV ECOL SYST, V11, P261, DOI 10.1146/annurev.es.11.110180.001401; Burn CR, 1998, CAN J EARTH SCI, V35, P184, DOI 10.1139/e97-105; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Chapin FS, 2005, SCIENCE, V310, P657, DOI 10.1126/science.1117368; Cornelissen JHC, 2001, J ECOL, V89, P984, DOI 10.1111/j.1365-2745.2001.00625.x; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; DYRNESS CT, 1983, CAN J FOREST RES, V13, P879, DOI 10.1139/x83-118; DYRNESS CT, 1979, CAN J BOT, V57, P2644, DOI 10.1139/b79-314; Elmendorf SC, 2012, NAT CLIM CHANGE, V2, P453, DOI 10.1038/NCLIMATE1465; Frost GV, 2014, GLOBAL CHANGE BIOL, V20, P1264, DOI 10.1111/gcb.12406; Frost GV, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/015035; FS-R10-FHP, 2022, USDA SERV PUBL; Harden JW, 2001, SOIL DRAINAGE ITS PO, P139; Higuera PE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001744; HINKEL KM, 1995, ARCTIC ALPINE RES, V27, P72, DOI 10.2307/1552069; Joly Kyle, 2007, Rangifer, P199; Jones BM, 2013, J GEOPHYS RES-BIOGEO, V118, P1334, DOI 10.1002/jgrg.20113; Jorgenson M. T., 2008, P 9 INT C PERM, V29, P869; Jorgenson MT, 2015, CLIMATIC CHANGE, V130, P131, DOI 10.1007/s10584-014-1302-1; Jorgenson MT, 2009, ARCNNRTR2009270; Kaplan JO, 2006, CLIMATIC CHANGE, V79, P213, DOI 10.1007/s10584-006-9113-7; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; LaMotte, 2014, MORGAN SOIL PH TEST; Lantz TC, 2013, ECOSYSTEMS, V16, P47, DOI 10.1007/s10021-012-9595-2; Lantz TC, 2010, J BIOGEOGR, V37, P1597, DOI 10.1111/j.1365-2699.2010.02317.x; Lantz TC, 2009, GLOBAL CHANGE BIOL, V15, P1664, DOI 10.1111/j.1365-2486.2009.01917.x; Liang E, 2014, ECOLOGY, V95, P2453, DOI 10.1890/13-1904.1; Liang EY, 2009, ANN BOT-LONDON, V104, P665, DOI 10.1093/aob/mcp158; Macander MJ, NPSARCNNRTR2012643; Mack MC, 2011, NATURE, V475, P489, DOI 10.1038/nature10283; Marchenko S., 2008, P 9 INT C PERM I NO, V2, P1125, DOI DOI 10.5194/TC-6-613-2012; Myers-Smith IH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045509; Naito AT, 2015, ECOL EVOL, V5, P87, DOI 10.1002/ece3.1341; Nelson FE, 1997, ARCTIC ALPINE RES, V29, P367, DOI 10.2307/1551985; Parker CL., 2006, VASCULAR PLANT INVEN; Pearson RG, 2013, NAT CLIM CHANGE, V3, P673, DOI [10.1038/NCLIMATE1858, 10.1038/nclimate1858]; PRISM Climate Group, 2009, JULY MEAN AV TEMP AL; Racine C, 2004, ARCT ANTARCT ALP RES, V36, P1, DOI 10.1657/1523-0430(2004)036[0001:TFAVCA]2.0.CO;2; Simpson JJ, 2005, ARCTIC, V58, P137; SONESSON M, 1991, ARCTIC, V44, P95; Stafford JM, 2000, THEOR APPL CLIMATOL, V67, P33, DOI 10.1007/s007040070014; Sturm M, 2001, J CLIMATE, V14, P336, DOI 10.1175/1520-0442(2001)014<0336:SSIIAT>2.0.CO;2; Swanson D.K., 2014, NATURAL RESOURCE DAT, P122; Swanson D.K, 2013, NPSARCNNRTR2013668; Swanson DK, 1996, ARCTIC ALPINE RES, V28, P217, DOI 10.2307/1551763; Swanson DK, 2014, NPSARCNNRDS2014634; Swanson DK., NPSARCNNRDS2013580; Swanson DK, 2012, VEGETATON SAMPLING A; Tape K, 2006, GLOBAL CHANGE BIOL, V12, P686, DOI 10.1111/j.1365-2486.2006.01128.x; Tape KD, 2016, GLOBAL CHANGE BIOL, V22, P208, DOI 10.1111/gcb.13058; Tape KD, 2012, ECOSYSTEMS, V15, P711, DOI 10.1007/s10021-012-9540-4; Tape KD, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001795; Tape KD, 2010, ECOSCIENCE, V17, P186, DOI 10.2980/17-2-3323; van Oldenborgh GJ, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1311; VANCLEVE K, 1983, BIOSCIENCE, V33, P39, DOI 10.2307/1309243; Viereck L. A., 2007, ALASKA TREES SHRUBS, V2nd; Walker DA, 2005, J VEG SCI, V16, P267, DOI 10.1111/j.1654-1103.2005.tb02365.x; Wang YF, 2015, GLOBAL PLANET CHANGE, V132, P20, DOI 10.1016/j.gloplacha.2015.06.007; Western Regional Climate Center (WRCC), 2015, W US CLIM HIST SUMM	66	30	30	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138387	10.1371/journal.pone.0138387	http://dx.doi.org/10.1371/journal.pone.0138387			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379243	Green Published, Green Submitted, gold			2022-12-27	WOS:000361769400095
J	Vohra, R; Accorsi, A; Kumar, A; Walter, G; Girgenrath, M				Vohra, Ravneet; Accorsi, Anthony; Kumar, Ajay; Walter, Glenn; Girgenrath, Mahasweta			Magnetic Resonance Imaging Is Sensitive to Pathological Amelioration in a Model for Laminin-Deficient Congenital Muscular Dystrophy (MDC1A)	PLOS ONE			English	Article							SKELETAL-MUSCLE; MOUSE MODEL; T2; MICE; REGENERATION; LOSARTAN; FIBROSIS; DAMAGE	Purpose To elucidate the reliability of MRI as a non-invasive tool for assessing in vivo muscle health and pathological amelioration in response to Losartan (Angiotensin II Type 1 receptor blocker) in DyW mice (mouse model for Laminin-deficient Congenital Muscular Dystrophy Type 1A). Methods Multiparametric MR quantifications along with histological/biochemical analyses were utilized to measure muscle volume and composition in untreated and Losartan-treated 7-week old DyW mice. Results MRI shows that DyW mice have significantly less hind limb muscle volume and areas of hyperintensity that are absent in WT muscle. DyW mice also have significantly elevated muscle levels (suggestive of inflammation and edema). Muscle T-2 returned to WT levels in response to Losartan treatment. When considering only muscle pixels without T-2 elevation, DyW T-2 levels are significantly lower than WT (suggestive of fibrosis) whereas Losartan-treated animals do not demonstrate this decrease in muscle T-2. MRI measurements suggestive of elevated inflammation and fibrosis corroborate with increased Mac-1 positive cells as well as increased Picrosirius red staining/COL1a gene expression that is returned to WT levels in response to Losartan. Conclusions MRI is sensitive to and tightly corresponds with pathological changes in DyW mice and thus is a viable and effective non-invasive tool for assessing pathological changes.	[Accorsi, Anthony; Kumar, Ajay; Girgenrath, Mahasweta] Boston Univ, Dept Hlth Sci, Sargent Coll, Boston, MA 02215 USA; [Vohra, Ravneet; Walter, Glenn] Univ Florida, Dept Physiol & Funct Genom, Coll Med, Gainesville, FL USA	Boston University; State University System of Florida; University of Florida	Girgenrath, M (corresponding author), Boston Univ, Dept Hlth Sci, Sargent Coll, Boston, MA 02215 USA.	swetag@bu.edu	Vohra, Ravneet/AAD-5864-2019	Vohra, Ravneet/0000-0001-6258-2710	Cure CMD; Struggle Against Muscular Dystrophy (SAM); Muscular Dystrophy Association [218938]; Paul D. Wellstone Muscular Dystrophy Cooperative Research Center [U54AR052646]; National High Magnetic Field Laboratory - NSF [DMR-1157490]; State of Florida; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646] Funding Source: NIH RePORTER	Cure CMD; Struggle Against Muscular Dystrophy (SAM); Muscular Dystrophy Association(Muscular Dystrophy Association); Paul D. Wellstone Muscular Dystrophy Cooperative Research Center; National High Magnetic Field Laboratory - NSF; State of Florida; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported with the research grants awarded to M.G. from Cure CMD, Struggle Against Muscular Dystrophy (SAM), Muscular Dystrophy Association (218938), the Paul D. Wellstone Muscular Dystrophy Cooperative Research Center (U54AR052646) and the National High Magnetic Field Laboratory, which is supported by NSF DMR-1157490 and the State of Florida.	Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Bish LT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020856; Bryant ND, 2014, NMR BIOMED, V27, P716, DOI 10.1002/nbm.3113; Bun SS, 2012, INVEST RADIOL, V47, P319, DOI 10.1097/RLI.0b013e318243e062; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Connolly AM, 2001, NEUROMUSCULAR DISORD, V11, P703, DOI 10.1016/S0960-8966(01)00232-2; Elbaz M, 2012, ANN NEUROL, V71, P699, DOI 10.1002/ana.22694; Elliott MA, 1999, MAGN RESON MED, V41, P450, DOI 10.1002/(SICI)1522-2594(199903)41:3<450::AID-MRM4>3.0.CO;2-9; FISHER MJ, 1990, INVEST RADIOL, V25, P480, DOI 10.1097/00004424-199005000-00003; Forbes SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106435; Girgenrath M, 2004, J CLIN INVEST, V114, P1635, DOI 10.1172/JCI200422928; Gupta RK, 2012, NEURORADIOLOGY, V54, P565, DOI 10.1007/s00234-011-0952-1; Hayashi YK, 2001, NEUROMUSCULAR DISORD, V11, P350, DOI 10.1016/S0960-8966(00)00203-0; Kuang W, 1998, J CLIN INVEST, V102, P844, DOI 10.1172/JCI3705; Kumar A, 2011, HUM MOL GENET, V20, P2333, DOI 10.1093/hmg/ddr126; Loganathan R, 2006, INT J CARDIOVAS IMAG, V22, P81, DOI 10.1007/s10554-005-5386-6; Mathur S, 2011, MUSCLE NERVE, V43, P878, DOI 10.1002/mus.21986; Mavrogeni S, 2005, CHEST, V127, P143, DOI 10.1378/chest.127.1.143; Mavrogeni S, 2009, EUR J PAEDIATR NEURO, V13, P34, DOI 10.1016/j.ejpn.2008.02.006; Mehuron T, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-14; Meinen S, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-18; Miyagoe Y, 1997, FEBS LETT, V415, P33, DOI 10.1016/S0014-5793(97)01007-7; Mourkioti F, 2008, J MOL MED, V86, P747, DOI 10.1007/s00109-008-0308-4; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; Philpot J, 1999, ARCH DIS CHILD, V80, P542, DOI 10.1136/adc.80.6.542; Pratt Stephen J P, 2013, BMC Res Notes, V6, P262, DOI 10.1186/1756-0500-6-262; Rooney JE, 2009, P NATL ACAD SCI USA, V106, P7991, DOI 10.1073/pnas.0811599106; Saab G, 1999, MAGNET RESON MED, V42, P150, DOI 10.1002/(SICI)1522-2594(199907)42:1<150::AID-MRM20>3.0.CO;2-5; Spurney CF, 2011, J CARDIOVASC PHARM T, V16, P87, DOI 10.1177/1074248410381757; TOME FMS, 1994, CR ACAD SCI III-VIE, V317, P351; van Nierop BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129899; Vohra RS, 2016, MUSCLE NERVE, V53, P84, DOI 10.1002/mus.24675; Walter G, 2005, MAGN RESON MED, V54, P1369, DOI 10.1002/mrm.20721; Wang X.D., 2014, J APPL MATH, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0096463; Wansapura JP, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-14; Ye F, 2013, EXP PHYSIOL, V98, P1038, DOI 10.1113/expphysiol.2012.070722	36	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138254	10.1371/journal.pone.0138254	http://dx.doi.org/10.1371/journal.pone.0138254			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379183	Green Published, gold, Green Submitted			2022-12-27	WOS:000361769400073
J	Fu, MH; Li, CL; Lin, HL; Tsai, SJ; Lai, YY; Chang, YF; Cheng, PH; Chen, CM; Yang, SH				Fu, Mu-Hui; Li, Chia-Ling; Lin, Hsiu-Lien; Tsai, Shaw-Jeng; Lai, Yen-Yu; Chang, Yu-Fan; Cheng, Pei-Hsun; Chen, Chuan-Mu; Yang, Shang-Hsun			The Potential Regulatory Mechanisms of miR-196a in Huntington's Disease through Bioinformatic Analyses	PLOS ONE			English	Article							TRANSGENIC ANIMAL-MODELS; NEURODEGENERATION; MUTANT; PATHOGENESIS; INHIBITION; TRANSPORT; ABCB1; CELL	High throughput screening is a powerful tool to identify the potential candidate molecules involved during disease progression. However, analysis of complicated data is one of the most challenging steps on the way to obtaining useful results from this approach. Previously, we showed that a specific miRNA, miR-196a, could ameliorate the pathological phenotypes of Huntington's disease (HD) in different models, and performed high throughput screening by using the striatum of transgenic mice. In this study, we further tried to identify the potential regulatory mechanisms using different bioinformatic tools, including Database for Annotation, Visualization and Integrated Discovery (DAVID), Molecular Signatures Database (MSigDB), TargetScan and MetaCore. The results showed that miR-196a dominantly altered "ABC transporters", "RIG-I-like receptor signaling pathway", immune system", "adaptive immune system","tissue remodeling and wound repair" and "cytoskeleton remodeling". In addition, miR-196a also changed the expression of several well-defined pathways of HD, such as apoptosis and cell adhesion. Since these analyses showed the regulatory pathways are highly related to the modification of the cytoskeleton, we further confirmed that miR-196a could enhance the neurite outgrowth in neuroblastoma cells, suggesting miR-196a might provide beneficial functions through the alteration of cytoskeleton structures. Since impairment of the cytoskeleton has been reported in several neuronal diseases, this study will provide not only the potential working mechanisms of miR-196a but also insights for therapeutic strategies for use with different neuronal diseases.	[Fu, Mu-Hui; Li, Chia-Ling; Lin, Hsiu-Lien; Tsai, Shaw-Jeng; Yang, Shang-Hsun] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Tsai, Shaw-Jeng; Lai, Yen-Yu; Chang, Yu-Fan; Cheng, Pei-Hsun; Yang, Shang-Hsun] Natl Cheng Kung Univ, Dept Physiol, Coll Med, Tainan 70101, Taiwan; [Fu, Mu-Hui] Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Kaohsiung, Taiwan; [Fu, Mu-Hui] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Lin, Hsiu-Lien] Council Agr, Div Breeding & Genet, Livestock Res Inst, Tainan 71246, Taiwan; [Chen, Chuan-Mu] Natl Chung Hsing Univ, Dept Life Sci, Agr Biotechnol Ctr, Taichung 40227, Taiwan	National Cheng Kung University; National Cheng Kung University; Chang Gung Memorial Hospital; Chang Gung University; Taiwan Livestock Research Institute; National Chung Hsing University	Yang, SH (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan.	syang@mail.ncku.edu.tw	Chen, Chuan-Mu/K-7049-2013; Tsai, Shaw-Jenq/AAG-6569-2019; Yang, Shang-Hsun/AAV-3763-2020	Chen, Chuan-Mu/0000-0003-2461-9150; Yang, Shang-Hsun/0000-0002-1601-3653; TSAI, SHAW-JENQ/0000-0002-3569-5813	Ministry of Science and Technology [MOST 102-2628-B-006-010-MY3, MOST 103-2320-B-006 -010, MOST 97-3122-B-006 -011-]; Ministry of Education, Taiwan, R.O.C.	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Education, Taiwan, R.O.C.(Ministry of Education, Taiwan)	This work was supported by Ministry of Science and Technology (MOST 102-2628-B-006-010-MY3 and MOST 103-2320-B-006 -010) and, in part, the Ministry of Education, Taiwan, R.O.C. The Aim for the Top University Project to the National Cheng Kung University (NCKU). Computational analyses and data mining were done using the system provided by the Bioinformatics Core at National Cheng Kung University, supported by a Ministry of Science and Technology grant (MOST 97-3122-B-006 -011-).	Bagashev A, 2014, APOPTOSIS, V19, P1202, DOI 10.1007/s10495-014-1003-2; Boudreau RL, 2009, MOL THER, V17, P1053, DOI 10.1038/mt.2009.17; Buckley NJ, 2010, NEUROBIOL DIS, V39, P28, DOI 10.1016/j.nbd.2010.02.003; Chang RB, 2015, DRUG DES DEV THER, V9, P2179, DOI 10.2147/DDDT.S58470; Cheng PH, 2013, AM J HUM GENET, V93, P306, DOI 10.1016/j.ajhg.2013.05.025; Didiano D, 2008, RNA, V14, P1297, DOI 10.1261/rna.1082708; DiProspero NA, 2004, J NEUROCYTOL, V33, P517, DOI 10.1007/s11068-004-0514-8; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Drouet V, 2009, ANN NEUROL, V65, P276, DOI 10.1002/ana.21569; Duan YM, 2015, CANCER LETT, V361, P67, DOI 10.1016/j.canlet.2015.02.037; Dutheil F, 2010, ARCH NEUROL-CHICAGO, V67, P739, DOI 10.1001/archneurol.2010.101; Ellrichmann G, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/541259; Fiszer A, 2011, NUCLEIC ACIDS RES, V39, P5578, DOI 10.1093/nar/gkr156; Fu YH, 2015, J ALZHEIMERS DIS, V43, P857, DOI 10.3233/JAD-141320; Gil JM, 2008, EUR J NEUROSCI, V27, P2803, DOI 10.1111/j.1460-9568.2008.06310.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iyengar BR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00047; Jablonski M, 2015, BRAIN RES, V1607, P1, DOI 10.1016/j.brainres.2014.08.060; Kwan W, 2012, J CLIN INVEST, V122, P4737, DOI 10.1172/JCI64484; Leoni V, 2015, BBA-MOL CELL BIOL L, V1851, P1095, DOI 10.1016/j.bbalip.2014.12.018; Li SH, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-19; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Li Y, 2014, NEUROSCI LETT, V566, P61, DOI 10.1016/j.neulet.2014.02.025; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Maciotta S, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00265; McMurray CT, 2000, CELL DEATH DIFFER, V7, P861, DOI 10.1038/sj.cdd.4400764; Miyazaki Y, 2012, NAT MED, V18, P1136, DOI 10.1038/nm.2791; Mukherjee A, 2009, J BIOL CHEM, V284, P6486, DOI 10.1074/jbc.M807547200; Pfrieger FW, 2011, PROG LIPID RES, V50, P357, DOI 10.1016/j.plipres.2011.06.002; Rikani AA, 2014, ANN NEUROSCI, V21, P112, DOI 10.5214/ans.0972.7531.210308; Ross CA, 2014, MOVEMENT DISORD, V29, P1351, DOI 10.1002/mds.26012; Singh T, 2014, CNS NEUROL DISORD-DR, V13, P96, DOI 10.2174/18715273113126660190; Tarling EJ, 2013, TRENDS ENDOCRIN MET, V24, P342, DOI 10.1016/j.tem.2013.01.006; Trager U, 2014, BRAIN, V137, P819, DOI 10.1093/brain/awt355; Trager Ulrike, 2013, PLoS Curr, V5, DOI 10.1371/currents.hd.5791c897b5c3bebeed93b1d1da0c0648; Trager U, 2015, NEUROBIOL DIS, V73, P388, DOI 10.1016/j.nbd.2014.10.012; Tukamoto T, 1997, MOL BRAIN RES, V51, P8, DOI 10.1016/S0169-328X(97)00205-2; Wang YT, 2012, J IMMUNOL, V189, P5304, DOI 10.4049/jimmunol.1201445; Wanker EE, 1997, HUM MOL GENET, V6, P487, DOI 10.1093/hmg/6.3.487; Williams AE, 2008, CELL MOL LIFE SCI, V65, P545, DOI 10.1007/s00018-007-7355-9; Willyerd FA, 2016, J NEUROTRAUM, V33, P226, DOI 10.1089/neu.2015.3879; Yang SH, 2011, CURR TOP BEHAV NEURO, V7, P61, DOI 10.1007/7854_2010_105	42	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137637	10.1371/journal.pone.0137637	http://dx.doi.org/10.1371/journal.pone.0137637			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376480	Green Published, Green Submitted, gold			2022-12-27	WOS:000361610200046
J	Millen, SH; Watanabe, M; Komatsu, E; Yamaguchi, F; Nagasawa, Y; Suzuki, E; Monaco, H; Weiss, AA				Millen, Scott H.; Watanabe, Mineo; Komatsu, Eiji; Yamaguchi, Fuminori; Nagasawa, Yuki; Suzuki, Eri; Monaco, Haleigh; Weiss, Alison A.			Single Amino Acid Polymorphisms of Pertussis Toxin Subunit S2 (PtxB) Affect Protein Function	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; BORDETELLA-PERTUSSIS; IMMUNE-RESPONSES; UNITED-STATES; WHOLE-CELL; T-CELLS; VACCINE; PERTACTIN; STRAINS; ADULTS	Whooping cough due to Bordetella pertussis is increasing in incidence, in part due to accumulation of mutations which increase bacterial fitness in highly vaccinated populations. Polymorphisms in the pertussis toxin, ptxA and ptxB genes, and the pertactin, prn genes of clinical isolates of Bordetella pertussis collected in Cincinnati from 1989 through 2005 were examined. While the ptxA and prn genotypes were variable, all 48 strains had the ptxB2 genotype; ptxB1 encodes glycine at amino acid 18 of the S2 subunit of pertussis toxin, while ptxB2 encodes serine. We investigated antigenic and functional differences of PtxB1 and PtxB2. The S2 protein was not very immunogenic. Only a few vaccinated or individuals infected with B. pertussis developed antibody responses to the S2 subunit, and these sera recognized both polymorphic forms equally well. Amino acid 18 of S2 is in a glycan binding domain, and the PtxB forms displayed differences in receptor recognition and toxicity. PtxB1 bound better to the glycoprotein, fetuin, and Jurkat T cells in vitro, but the two forms were equally effective at promoting CHO cell clustering. To investigate in vivo activity of Ptx, one mu g of Ptx was administered to DDY mice and blood was collected on 4 days after injection. PtxB2 was more effective at promoting lymphocytosis in mice.	[Millen, Scott H.; Monaco, Haleigh; Weiss, Alison A.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45220 USA; [Watanabe, Mineo; Komatsu, Eiji; Yamaguchi, Fuminori; Nagasawa, Yuki; Suzuki, Eri] Kitasato Univ, Grad Sch Infect Control Sci, Minato Ku, Tokyo, Japan	University System of Ohio; University of Cincinnati; Kitasato University	Weiss, AA (corresponding author), Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45220 USA.	alison.weiss@uc.edu		Weiss, Alison/0000-0002-4726-8376; Millen, Scott/0000-0001-5072-6844	United States National Institutes of Health, Institute of Allergy and Infectious Diseases [R01AI23695]; Ministry of Education, Science, Sports and Culture [2007-19590463]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023695] Funding Source: NIH RePORTER	United States National Institutes of Health, Institute of Allergy and Infectious Diseases; Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by R01AI23695 United States National Institutes of Health, Institute of Allergy and Infectious Diseases (PI: AAW), and the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (C) 2007-19590463 (PI: MW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bart MJ, 2014, MBIO, V5, DOI 10.1128/mBio.01074-14; Bart MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-627; Bisgard KM, 2001, J INFECT DIS, V183, P1360, DOI 10.1086/319858; Bodilis H, 2013, EMERG INFECT DIS, V19, P471, DOI 10.3201/1903.121475; Bottero D, 2007, CLIN VACCINE IMMUNOL, V14, P1490, DOI 10.1128/CVI.00177-07; Boursaux-Eude C, 1999, VACCINE, V17, P2651, DOI 10.1016/S0264-410X(99)00038-9; Cassiday P, 2000, J INFECT DIS, V182, P1402, DOI 10.1086/315881; CHONG P, 1989, BIOCHEM CELL BIOL, V67, P387, DOI 10.1139/o89-061; CHRISTIE CDC, 1994, NEW ENGL J MED, V331, P16, DOI 10.1056/NEJM199407073310104; CUMMING DA, 1989, BIOCHEMISTRY-US, V28, P6500, DOI 10.1021/bi00441a051; GILLENIUS P, 1985, J BIOL STAND, V13, P61, DOI 10.1016/S0092-1157(85)80034-2; Guiso N, 2001, VACCINE, V19, P3248, DOI 10.1016/S0264-410X(01)00013-5; Gzyl A, 2001, VACCINE, V20, P299, DOI 10.1016/S0264-410X(01)00356-5; HEERZE LD, 1992, J BIOL CHEM, V267, P25810; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; KALININ NL, 1995, ANAL BIOCHEM, V228, P238, DOI 10.1006/abio.1995.1345; KASUGA TADAYOSHI, 1953, KITASATO ARCH EXPTL MED, V26, P121; Keitel WA, 1999, J INFECT DIS, V180, P397, DOI 10.1086/314869; King AJ, 2001, MICROBIOL-SGM, V147, P2885, DOI 10.1099/00221287-147-11-2885; Komatsu E, 2010, CLIN VACCINE IMMUNOL, V17, P807, DOI 10.1128/CVI.00449-09; Le T, 2004, J INFECT DIS, V190, P535, DOI 10.1086/422035; Liko J, 2013, NEW ENGL J MED, V368, P581, DOI 10.1056/NEJMc1212006; LOCHT C, 1986, NUCLEIC ACIDS RES, V14, P3251, DOI 10.1093/nar/14.8.3251; MENOZZI FD, 1991, FEMS MICROBIOL LETT, V78, P59; Millen SH, 2010, BIOCHEMISTRY-US, V49, P5954, DOI 10.1021/bi100474z; Millen SH, 2004, INFECT IMMUN, V72, P615, DOI 10.1128/IAI.72.1.615-620.2004; MOOI FR, 2007, PHYLOGENY EVOLUTION, P17; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; MORSE SI, 1976, J EXP MED, V143, P1483, DOI 10.1084/jem.143.6.1483; MUSSER JM, 1986, J BACTERIOL, V166, P230, DOI 10.1128/jb.166.1.230-237.1986; NICOSIA A, 1986, P NATL ACAD SCI USA, V83, P4631, DOI 10.1073/pnas.83.13.4631; Octavia S, 2012, J INFECT DIS, V205, P1220, DOI 10.1093/infdis/jis178; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Queenan AM, 2013, NEW ENGL J MED, V368, P583, DOI 10.1056/NEJMc1209369; Schneider OD, 2007, INFECT IMMUN, V75, P4040, DOI 10.1128/IAI.00414-07; Schneider OD, 2012, BIOCHEMISTRY-US, V51, P4126, DOI 10.1021/bi3002693; Sheridan SL, 2012, JAMA-J AM MED ASSOC, V308, P454, DOI 10.1001/jama.2012.6364; STEIN PE, 1994, STRUCTURE, V2, P45, DOI 10.1016/S0969-2126(00)00007-1; Ward JI, 2005, NEW ENGL J MED, V353, P1555, DOI 10.1056/NEJMoa050824; Watanabe M, 2006, CLIN VACCINE IMMUNOL, V13, P341, DOI 10.1128/CVI.13.3.341-348.2006; Watanabe M, 2000, VACCINE, V19, P1199, DOI 10.1016/S0264-410X(00)00308-X; Weingart CL, 2000, INFECT IMMUN, V68, P7175, DOI 10.1128/IAI.68.12.7175-7179.2000; Weiss AA, 2004, INFECT IMMUN, V72, P7346, DOI 10.1128/IAI.72.12.7346-7351.2004; World Health Organization, 2011, IMM VACC BIOL PERT; Zhang SM, 2011, J BACTERIOL, V193, P4017, DOI 10.1128/JB.05184-11	45	4	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137379	10.1371/journal.pone.0137379	http://dx.doi.org/10.1371/journal.pone.0137379			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375454	Green Published, Green Submitted, gold			2022-12-27	WOS:000361610200037
J	Nouet, J; Chevallard, C; Farre, B; Nehrke, G; Campmas, E; Stoetzel, E; El Hajraoui, MA; Nespoulet, R				Nouet, Julius; Chevallard, Corinne; Farre, Bastien; Nehrke, Gernot; Campmas, Emilie; Stoetzel, Emmanuelle; El Hajraoui, Mohamed Abdeljalil; Nespoulet, Roland			Limpet Shells from the Aterian Level 8 of El Harhoura 2 Cave (Temara, Morocco): Preservation State of Crossed-Foliated Layers	PLOS ONE			English	Article							MIDDLE STONE-AGE; MODERN HUMAN-BEHAVIOR; SOUTH-AFRICA; BLOMBOS CAVE; ACRIDINE-ORANGE; PINNACLE POINT; NORTH-AFRICA; CALCITE; GROWTH; SEA	The exploitation of mollusks by the first anatomically modern humans is a central question for archaeologists. This paper focuses on level 8 (dated around similar to 100 ka BP) of El Harhoura 2 Cave, located along the coastline in the Rabat-Temara region (Morocco). The large quantity of Patella sp. shells found in this level highlights questions regarding their origin and preservation. This study presents an estimation of the preservation status of these shells. We focus here on the diagenetic evolution of both the microstructural patterns and organic components of crossed-foliated shell layers, in order to assess the viability of further investigations based on shell layer minor elements, isotopic or biochemical compositions. The results show that the shells seem to be well conserved, with microstructural patterns preserved down to sub-micrometric scales, and that some organic components are still present in situ. But faint taphonomic degradations affecting both mineral and organic components are nonetheless evidenced, such as the disappearance of organic envelopes surrounding crossed-foliated lamellae, combined with a partial recrystallization of the lamellae. Our results provide a solid case-study of the early stages of the diagenetic evolution of crossed-foliated shell layers. Moreover, they highlight the fact that extreme caution must be taken before using fossil shells for palaeoenvironmental or geochronological reconstructions. Without thorough investigation, the alteration patterns illustrated here would easily have gone unnoticed. However, these degradations are liable to bias any proxy based on the elemental, isotopic or biochemical composition of the shells. This study also provides significant data concerning human subsistence behavior: the presence of notches and the good preservation state of limpet shells (no dissolution/recrystallization, no bioerosion and no abrasion/fragmentation aspects) would attest that limpets were gathered alive with tools by Middle Palaeolithic (Aterian) populations in North Africa for consumption.	[Nouet, Julius] Univ Paris 11, CNRS UMR GEOPS 8148, F-91405 Orsay, France; [Chevallard, Corinne] CEA Saclay, LIONS, UMR SIS2M 3299, CEA,CNRS IRAMIS, F-91191 Gif Sur Yvette, France; [Farre, Bastien] ISTO, CNRS UMR 7327, F-45071 Orleans 2, France; [Nehrke, Gernot] Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; [Campmas, Emilie] Univ Toulouse Jean Jaures, CNRS UMR TRACES 5608, Maison Rech, F-31058 Toulouse, France; [El Hajraoui, Mohamed Abdeljalil] Inst Natl Sci Archeol & Patrimoine, Madinat Al Irfane, Rabat Hay Riyad, Morocco; [Stoetzel, Emmanuelle; Nespoulet, Roland] Museum Natl Hist Nat, Dept Prehist, CNRS UMR 7194, F-75231 Paris, France	UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; UDICE-French Research Universities; PSL Research University Paris; Ecole des Hautes Etudes en Sciences Sociales (EHESS); Universite de Toulouse; Universite de Toulouse - Jean Jaures; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN)	Nouet, J (corresponding author), Univ Paris 11, CNRS UMR GEOPS 8148, Batiment 504,Campus Univ, F-91405 Orsay, France.	julius.nouet@u-psud.fr	Stoetzel, Emmanuelle/ABG-2518-2020	Stoetzel, Emmanuelle/0000-0002-2724-5994; El Hajraoui, Mohamed Abdeljalil/0000-0002-6519-2264; Nehrke, Gernot/0000-0002-2851-3049; Nouet, Julius/0000-0001-5435-542X	CNRS through the interdisciplinary action AIR-Archaeometry; European Community Research Infrastructure Action under FP7 Integrating Activities Programme; mineralogy department of NHM, London; Commission consultative des recherches archeologiques a l'eatranger of Ministere des Affaires Etrangeres et Europeennes of France; Ministry of Culture of Morocco; French Agence Nationale de la Recherche; MOHMIE project [ANR-09-PEXT-004]	CNRS through the interdisciplinary action AIR-Archaeometry; European Community Research Infrastructure Action under FP7 Integrating Activities Programme; mineralogy department of NHM, London; Commission consultative des recherches archeologiques a l'eatranger of Ministere des Affaires Etrangeres et Europeennes of France; Ministry of Culture of Morocco; French Agence Nationale de la Recherche(French National Research Agency (ANR)); MOHMIE project	This research received support from CNRS through the interdisciplinary action AIR-Archaeometry and from the SYNTHESIS Project http://www.synthesis.info/ which is financed by European Community Research Infrastructure Action under FP7 Integrating Activities Programme (the authors especially thank J. Spratt, A. Ball and L. Howard from the mineralogy department of NHM, London for their support). The authors would like to thank the Institut National des Sciences de l'Archeologie et du Patrimoine (dir. A. Akerraz), the Mission archeologique El Harhoura-Temara, funded by the Commission consultative des recherches archeologiques a l'eatranger of Ministere des Affaires Etrangeres et Europeennes of France and the Ministry of Culture of Morocco. The authors also would like to thank the French Agence Nationale de la Recherche and the ANR-09-PEXT-004 MOHMIE project (dir. C. Denys) for the funding provided in the field work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addadi L, 1991, P 6 INT S BIOM OD OC, P29; ALEXANDERSSON ET, 1979, SEDIMENTOLOGY, V26, P845, DOI 10.1111/j.1365-3091.1979.tb00977.x; Avery G., 2008, S AFRI ARCHAEOL SOC, V10, P66, DOI [10.2307/40650020, DOI 10.2307/40650020]; Balbo A, 2011, QUATERN INT, V239, P147, DOI 10.1016/j.quaint.2011.03.032; Balter M, 2011, SCIENCE, V331, P20, DOI 10.1126/science.331.6013.20; Baronnet A, 2008, MINERAL MAG, V72, P617, DOI 10.1180/minmag.2008.072.2.617; Barton N, 2012, DEV QUATER SCI, V16, P23, DOI 10.1016/B978-0-444-53821-5.00003-8; Blamart D, 2005, ERLANGEN EARTH C SER, P1005, DOI 10.1007/3-540-27673-4_50; Boggild B., 1930, KONGELIGE DANSKE, V9, P231; Bouzouggar A., 2012, MODERN ORIGINS N AFR, P93; BRADLEY DF, 1961, T NEW YORK ACAD SCI, V24, P64, DOI 10.1111/j.2164-0947.1961.tb00751.x; BRANDES G, 1990, HISTOCHEM J, V22, P106, DOI 10.1007/BF01885789; Campmas E, 2012, THESIS U BORDEAUX 1; Campmas E, 2014, J HUMAN EVO IN PRESS; Colfen H., 2008, MESOCRYSTALS NONCLAS, DOI DOI 10.1002/9780470994603; COUTTS PJF, 1970, NATURE, V226, P874, DOI 10.1038/226874a0; Cuenca D, 2013, SERIE TESIS DOCTORAL; Cuif J., 2011, BIOMINERALS FOSSILS; Cuif J, 2003, ETAPES DECOUVERTE RA; Cuif JP, 2005, J STRUCT BIOL, V150, P319, DOI 10.1016/j.jsb.2005.03.004; CUIF JP, 1980, CR ACAD SCI D NAT, V290, P759; Cusack M, 2008, J STRUCT BIOL, V164, P96, DOI 10.1016/j.jsb.2008.06.010; Cutler Alan H., 1995, Senckenbergiana Maritima, V25, P115; d'Errico F, 2005, J HUM EVOL, V48, P3, DOI 10.1016/j.jhevol.2004.09.002; d'Errico F, 2009, P NATL ACAD SCI USA, V106, P16051, DOI 10.1073/pnas.0903532106; Dauphin Y, 2008, MINERAL MAG, V72, P243, DOI 10.1180/minmag.2008.072.1.243; Dauphin Y, 2008, MICRON, V39, P891, DOI 10.1016/j.micron.2007.11.007; DEBENATH A, 1992, ANTHROPOLOGIE, V96, P711; Debenath A., 1979, B ARCHEOLOGIE MAROCA, V12, P1; Demarchi B, 2013, QUAT GEOCHRONOL, V16, P158, DOI 10.1016/j.quageo.2012.08.001; Dibble HL, 2013, J HUM EVOL, V64, P194, DOI 10.1016/j.jhevol.2012.10.010; DRISCOLL EG, 1973, PALAEOGEOGR PALAEOCL, V13, P275, DOI 10.1016/0031-0182(73)90029-1; Ehrlich H, 2010, BIOL MAT MARINE ORIG, DOI [10.1007/978/90/481/9130, DOI 10.1007/978/90/481/9130]; El Hajraoui A, 2012, VILLES SITES ARCHEOL, P194; El Hajraoui A, 2012, VILLES SITES ARCHEOL, P234; El Hajraoui M. A., 2012, PREHISTOIRE REGION R, VIII, P91; El Hajraoui M.A., 2012, VILLES SITES ARCHEOL, VIII; El Hajraoui MA, 1994, PREHISTOIRE ANTHR ME, V3, P91; Fa DA, 2002, J MOLLUS STUD, V68, P95, DOI 10.1093/mollus/68.1.95; Fa DA, 2008, QUATERNARY SCI REV, V27, P2194, DOI 10.1016/j.quascirev.2008.07.015; Friedman G, 1959, J SEDIMENT PETROL, V29, P87, DOI DOI 10.1306/74D70894-2B21-11D7-86480001020C1865D; Fuchigami Takeshi, 2005, Paleontological Research, V9, P143, DOI 10.2517/prpsj.9.143; Gautret P, 2000, ACTA PALAEONTOL POL, V45, P107; Gilis M, 2011, J STRUCT BIOL, V176, P315, DOI 10.1016/j.jsb.2011.08.008; Goldberg P, 2000, J HUM EVOL, V38, P43, DOI 10.1006/jhev.1999.0350; Hedegaard C, 2006, J MOLLUS STUD, V72, P157, DOI 10.1093/mollus/eyi062; Henshilwood CS, 2001, J HUM EVOL, V41, P631, DOI 10.1006/jhev.2001.0515; Henshilwood CS, 2001, J ARCHAEOL SCI, V28, P421, DOI 10.1006/jasc.2000.0638; Jacobs Z, 2012, J HUM EVOL, V62, P377, DOI 10.1016/j.jhevol.2011.12.001; Janati-Idrissi N., 2012, QUATERNAIRE, V23, P25; Jerardino A, 2010, J HUM EVOL, V59, P412, DOI 10.1016/j.jhevol.2010.07.003; Karampelas S, 2008, THESIS U NANTES; KAUFMAN A, 1971, GEOCHIM COSMOCHIM AC, V35, P1155, DOI 10.1016/0016-7037(71)90031-7; Klein RG, 2004, P NATL ACAD SCI USA, V101, P5708, DOI 10.1073/pnas.0400528101; Kobayashi I, 2006, MAT SCI ENG C-BIO S, V26, P692, DOI 10.1016/j.msec.2005.09.101; KOTLER E, 1992, Palaios, V7, P244, DOI 10.2307/3514972; Lescinsky HL, 2002, PALAIOS, V17, P171, DOI 10.1669/0883-1351(2002)017<0171:MSEABR>2.0.CO;2; Lima FP, 2006, J BIOGEOGR, V33, P812, DOI 10.1111/j.1365-2699.2006.01457.x; Linstadter J, 2012, QUATERN INT, V274, P158, DOI 10.1016/j.quaint.2012.02.017; MacClintock C., 1967, Bulletin of the Peabody Museum of Natural History, V22, P1; Marean CW, 2011, INTERD CONTRIB ARCH, P421, DOI 10.1007/978-1-4419-8219-3_18; Marean CW, 2010, J HUM EVOL, V59, P425, DOI 10.1016/j.jhevol.2010.07.011; MARLOWE RL, 1995, INVERTEBR BIOL, V114, P79, DOI 10.2307/3226956; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Meibom A, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028657; MERLIN JC, 1985, PURE APPL CHEM, V57, P785, DOI 10.1351/pac198557050785; Michel P, 2010, HIST BIOL, V22, P327, DOI 10.1080/08912960903570500; Mutvei H., 1969, STOCKHOLM CONTR GEOL, V20, P1; Nehrke G, 2011, BIOGEOSCIENCES, V8, P3761, DOI 10.5194/bg-8-3761-2011; Nespoulet R, 2007, ACT 4 RENC QUAT MAR, P15; Nespoulet R, 2008, AFR ARCHAEOL REV, V25, P21, DOI 10.1007/s10437-008-9025-1; Nouet J, 2012, MICRON, V43, P456, DOI 10.1016/j.micron.2011.10.027; Oujaa A, 2012, VILLES SITES ARCHEOL, P136; Oujaa A, 2012, VILLES SITES ARCHEOL, P234; Plaziat J. C., 2008, LECT NOTES EARTH SCI, P359; Pramatarova R, 2003, THESIS U HAMBURG; Ricciardi A, 1999, MAR ECOL PROG SER, V185, P21, DOI 10.3354/meps185021; Roche J, 1976, CR HEBD ACAD SCI, P45; Scerri EML, 2013, QUATERN INT, V300, P111, DOI 10.1016/j.quaint.2012.09.008; Schwenninger J, 2010, S E MEDITERRANEAN PE; Seilacher A., 1973, EVOLVING CONCEPTS SE, V21, P159; Sethmann I, 2006, J INORG BIOCHEM, V100, P88, DOI 10.1016/j.jinorgbio.2005.10.005; Sethmann I, 2005, AM MINERAL, V90, P1213, DOI 10.2138/am.2005.1833; Shopov Y.Y., 2004, INT J SPELEOL, V33, P25, DOI 10.5038/1827-806X.33.1.3; Siani G, 2001, SCIENCE, V294, P1917, DOI 10.1126/science.1063649; Sidike A, 2006, PHYS CHEM MINER, V33, P559, DOI 10.1007/s00269-006-0103-0; Steele T., 2012, PREHISTOIRE REGION R, VIII, P223; Steele TE, 2011, INTERD CONTRIB ARCH, P383, DOI 10.1007/978-1-4419-8219-3_16; Steele Teresa E., 2006, Munibe (Antropologia - Arkeologia), V57, P221; Stemmer K, 2014, J MOLLUS STUD, P1; Stoetzel E, 2012, INT J OSTEOARCHAEOL, V22, P616, DOI 10.1002/oa.1275; Stoetzel E, 2014, QUATERN INT, V320, P143, DOI 10.1016/j.quaint.2013.05.017; Stoetzel E, 2011, J HUM EVOL, V60, P1, DOI 10.1016/j.jhevol.2010.07.016; Surge D, 2008, JOINT M GEOL SOC AM; Suzuki M, 2011, CRYST GROWTH DES, V11, P4850, DOI 10.1021/cg2010997; Suzuki M, 2010, J STRUCT BIOL, V171, P223, DOI 10.1016/j.jsb.2010.04.008; TAYLOR JD, 1969, B BRIT MUSEUM NATU S, V3, P1; Uozumi S, 1971, CONTRIB DEP GEOL MIN, V1236, P447; WEINER S, 1991, TRENDS BIOCHEM SCI, V16, P252, DOI 10.1016/0968-0004(91)90098-G; Weiner S., 2010, MICROARCHAEOLOGY VIS; Weiner S, 2008, J STRUCT BIOL, V163, P229, DOI 10.1016/j.jsb.2008.02.001; WOLF MK, 1961, J HISTOCHEM CYTOCHEM, V9, P22, DOI 10.1177/9.1.22; YESNER DR, 1980, CURR ANTHROPOL, V21, P727, DOI 10.1086/202568; Zuschin M, 2003, EARTH-SCI REV, V63, P33, DOI 10.1016/S0012-8252(03)00014-X	104	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137162	10.1371/journal.pone.0137162	http://dx.doi.org/10.1371/journal.pone.0137162			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376294	Green Submitted, Green Published, gold			2022-12-27	WOS:000361610200031
J	Wang, JJ; Liu, YL; Sun, YC; Ge, W; Wang, YY; Dyce, PW; Hou, R; Shen, W				Wang, Jun-Jie; Liu, Yu-Liang; Sun, Yuan-Chao; Ge, Wei; Wang, Yong-Yong; Dyce, Paul W.; Hou, Rong; Shen, Wei			Basic Fibroblast Growth Factor Stimulates the Proliferation of Bone Marrow Mesenchymal Stem Cells in Giant Panda (Ailuropoda melanoleuca)	PLOS ONE			English	Article							GERM-CELLS; IN-VITRO; CHONDROGENIC DIFFERENTIATION; CULTURE; REGENERATION; PROGENITORS; POTENTIALS; PHENOTYPE; CHICKEN; TISSUE	It has been widely known that the giant panda (Ailuropoda melanoleuca) is one of the most endangered species in the world. An optimized platform for maintaining the proliferation of giant panda mesenchymal stemcells (MSCs) is very necessary for current giant panda protection strategies. Basic fibroblast growth factor (bFGF), a member of the FGF family, is widely considered as a growth factor and differentiation inducer within the stemcell research field. However, the role of bFGF on promoting the proliferation ofMSCs derived from giant panda bone marrow (BM) has not been reported. In this study, we aimed to investigate the role of bFGF on the proliferation of BM-MSCs derived from giant panda. MSCs were cultured for cell proliferation analysis at 24, 48 and 72 hrs following the addition of bFGF. With increasing concentrations of bFGF, cell numbers gradually increased. This was further demonstrated by performing 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) cell proliferation assay, 5-Bromo-2-deoxyUridine (BrdU) labeling and cell cycle testing. Furthermore, the percentage ofMSCs that were OCT4 positive increased slightly following treatment with 5 ng/ml bFGF. Moreover, we demonstrated that the extracellular signal-regulated kinase (ERK) signaling pathway may play an important role in the proliferation of panda MSCs stimulated by bFGF. In conclusion, this study suggests that giant panda BM-MSCs have a high proliferative capacity with the addition of 5 ng/ml bFGF in vitro.	[Wang, Jun-Jie; Sun, Yuan-Chao; Ge, Wei; Wang, Yong-Yong; Shen, Wei] Qingdao Agr Univ, Inst Reprod Sci, Qingdao 266109, Shandong, Peoples R China; [Wang, Jun-Jie; Sun, Yuan-Chao; Ge, Wei; Shen, Wei] Qingdao Agr Univ, Coll Anim Sci & Technol, Key Lab Anim Reprod & Germplasm Enhancement Univ, Qingdao 266109, Shandong, Peoples R China; [Liu, Yu-Liang; Hou, Rong] Chengdu Res Base Giant Panda Breeding, Chengdu 610081, Sichuan, Peoples R China; [Wang, Yong-Yong] Qingdao Agr Univ, Coll Life Sci, Qingdao 266109, Shandong, Peoples R China; [Dyce, Paul W.] Auburn Univ, Dept Anim Sci, Auburn, AL 36849 USA	Qingdao Agricultural University; Qingdao Agricultural University; Qingdao Agricultural University; Auburn University System; Auburn University	Hou, R (corresponding author), Chengdu Res Base Giant Panda Breeding, Chengdu 610081, Sichuan, Peoples R China.	hourong2000@panda.org.cn; wshen@qau.edu.cn		Ge, Wei/0000-0002-4610-7933; Dyce, Paul/0000-0002-4574-3321; Wang, Jun-Jie/0000-0002-7145-5702	Program for New Century Excellent Talents in University [NCET-12-1026]; Taishan Scholar Construction Foundation of Shandong Province; program of the Chengdu Science and Technology Bureau [12GGYB810SW-002]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Taishan Scholar Construction Foundation of Shandong Province; program of the Chengdu Science and Technology Bureau	This work was supported by Program for New Century Excellent Talents in University (NCET-12-1026) and the Taishan Scholar Construction Foundation of Shandong Province to W. Shen, and the program of the Chengdu Science and Technology Bureau (12GGYB810SW-002) to Y.L. Liu.	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Anjos-Afonso F, 2007, BLOOD, V109, P1298, DOI 10.1182/blood-2006-06-030551; Bara JJ, 2014, STEM CELLS, V32, P1713, DOI 10.1002/stem.1649; Becker AD, 2015, STEM CELLS DEV, V49, P1547; Bianchi G, 2003, EXP CELL RES, V287, P98, DOI 10.1016/S0014-4827(03)00138-1; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Chen H, 2015, MOL MED REP, V12, P819, DOI 10.3892/mmr.2015.3528; Chiou M, 2006, BIOCHEM BIOPH RES CO, V343, P644, DOI 10.1016/j.bbrc.2006.02.171; Colenci R, 2014, ARCH ORAL BIOL, V59, P268, DOI 10.1016/j.archoralbio.2013.11.017; Delaune E, 2005, DEVELOPMENT, V132, P299, DOI 10.1242/dev.01582; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; Ito T, 2008, CYTOTECHNOLOGY, V56, P1, DOI 10.1007/s10616-007-9092-1; Johnson J, 2005, CELL, V122, P303, DOI 10.1016/j.cell.2005.06.031; Kim JH, 2011, TISSUE ENG PT A, V17, P991, DOI [10.1089/ten.tea.2010.0277, 10.1089/ten.TEA.2010.0277]; Kotobuki N, 2004, ARTIF ORGANS, V28, P33, DOI 10.1111/j.1525-1594.2004.07320.x; Lee TH, 2015, BIOCH CELL BIOL, V26, P1; Liu YL, 2013, STEM CELLS DEV, V22, P2394, DOI 10.1089/scd.2013.0102; Park HJ, 2006, MOL REPROD DEV, V73, P452, DOI 10.1002/mrd.20441; Park TS, 2000, MOL REPROD DEV, V56, P475, DOI 10.1002/1098-2795(200008)56:4&lt;475::AID-MRD5&gt;3.0.CO;2-M; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Reifers F, 1998, DEVELOPMENT, V125, P2381; Shimabukuro Y, 2009, J ENDODONT, V35, P1529, DOI 10.1016/j.joen.2009.08.010; Solchaga LA, 2005, J CELL PHYSIOL, V203, P398, DOI 10.1002/jcp.20238; Solchaga LA, 2010, TISSUE ENG PT A, V16, P1009, DOI [10.1089/ten.tea.2009.0100, 10.1089/ten.TEA.2009.0100]; Sotiropoulou PA, 2006, STEM CELLS, V24, P462, DOI 10.1634/stemcells.2004-0331; Tsutsumi S, 2001, BIOCHEM BIOPH RES CO, V288, P413, DOI 10.1006/bbrc.2001.5777; Umezaki Y, 2015, INT J MOL SCI, V16, P13633, DOI 10.3390/ijms160613633; van de Lavoir MC, 2006, NATURE, V441, P766, DOI 10.1038/nature04831; van den Bos C, 1997, Hum Cell, V10, P45; Wang L, 2010, ANN BIOMED ENG, V38, P77, DOI 10.1007/s10439-009-9841-8; Wei X, 2013, ACTA PHARMACOL SIN, V34, P747, DOI 10.1038/aps.2013.50; Wu JY, 2012, J ENDODONT, V38, P614, DOI 10.1016/j.joen.2012.01.014; Wu YJ, 2010, STEM CELLS, V28, P905, DOI 10.1002/stem.420; Xie LC, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-014-0080-6; Xin HQ, 2006, J NEUROSCI RES, V83, P1485, DOI 10.1002/jnr.20834; Yuan SH, 2013, INDIAN J MED RES, V138, P103; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	38	10	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137712	10.1371/journal.pone.0137712	http://dx.doi.org/10.1371/journal.pone.0137712			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375397	gold, Green Published, Green Submitted			2022-12-27	WOS:000361610200049
J	Noubiap, JJN; Aka, PV; Nanfack, AJ; Agyingi, LA; Ngai, JN; Nyambi, PN				Noubiap, Jean Jacques N.; Aka, Peter V.; Nanfack, Aubin J.; Agyingi, Lucy A.; Ngai, Johnson N.; Nyambi, Phillipe N.			Hepatitis B and C Co-Infections in Some HIV-Positive Populations in Cameroon, West Central Africa: Analysis of Samples Collected Over More Than a Decade	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; EQUATORIAL RAIN-FORESTS; ANTIRETROVIRAL THERAPY; NATURAL-HISTORY; RURAL VILLAGES; BLOOD-DONORS; RISK-FACTORS; INFECTION; PREVALENCE; ASSOCIATION	As people infected with the human immunodeficiency virus (HIV) in Sub-Saharan Africa live longer due to availability of antiretroviral treatment (ART), so is the rise of associated infections with their burdens on patients. But reliable data on the prevalence of co-infection with hepatitis B (HBV) or C (HCV) still remains sparse and many individuals with HIV do not know their co-infection status. This study attempted to estimate the seroprevalence and identify risk factors associated with hepatitis B and/or C co-infections in HIV-infected individuals from five Regions of Cameroon by screening 531 HIV infected subjects for the presence of HBV surface antigen (HBsAg) and antibodies to HCV (HCV-Ab). A Screening and a confirmatory Enzyme linked immunosorbent assay were used to detect presence of markers of infection. CD4 count levels were also examined. The results indicate that of the 531 participants, 68% were females and 32% males. Mean CD4 count was similar to 400 cells/mu l. Seroprevalence rates for HBsAg and HCV-Ab were 23.7%, and 7.2%, respectively. Associations assessed using logistic regression revealed that HBsAg but not HCV-Ab positivity was linked to age, lower CD4 count and residing in an urban rather than in a rural setting. This high prevalence of co-infection with HBV raises the urgent need to systematically screen all newly diagnosed HIV cases for co-infection in Cameroon and other regions of sub-Saharan Africa where HIV accounts for the majority of the global infection, so as to improve management strategies for HBV infection and ART implementation.	[Noubiap, Jean Jacques N.; Agyingi, Lucy A.; Ngai, Johnson N.] Med Diagnost Ctr, Serol Unit, Yaounde, Cameroon; [Aka, Peter V.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Nanfack, Aubin J.; Nyambi, Phillipe N.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Nanfack, Aubin J.] Univ Roma Tor Vergata, Dept Immunol & Appl Biotechnol, Fac Med & Surg, Rome, Italy; [Agyingi, Lucy A.] Univ Dschang, Fac Sci, Dschang, Cameroon; [Nyambi, Phillipe N.] Vet Affairs New York Harbor Healthcare Syst, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); New York University; University of Rome Tor Vergata	Nyambi, PN (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.	phillipe.nyambi@nyumc.org		Noubiap, Jean Jacques/0000-0002-7722-9757	National Institutes of Health from the National Cancer Institute [CA153726]; National Institute of Allergy and Infectious Diseases [AI083142]; FOGARTY INTERNATIONAL CENTER [D43TW009604] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [D43CA153726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI083142, R01AI083142] Funding Source: NIH RePORTER	National Institutes of Health from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health grant CA153726 from the National Cancer Institute (http://www.cancer.gov/) and grant AI083142 from the National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov/) (PNN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyingi L, 2014, J MED VIROL, V86, P385, DOI 10.1002/jmv.23846; Allison RD, 2009, J INFECT DIS, V200, P619, DOI 10.1086/600107; Balagopal A, 2008, GASTROENTEROLOGY, V135, P226, DOI 10.1053/j.gastro.2008.03.022; Barth RE, 2010, INT J INFECT DIS, V14, pE1024, DOI 10.1016/j.ijid.2010.06.013; Chun HM, 2012, J INFECT DIS, V205, P185, DOI 10.1093/infdis/jir720; Colin JF, 1999, HEPATOLOGY, V29, P1306, DOI 10.1002/hep.510290447; Daghestani L, 1999, AM J MED, V106, P347, DOI 10.1016/S0002-9343(99)00014-5; ESKILD A, 1992, AIDS, V6, P571, DOI 10.1097/00002030-199206000-00008; Gillis J, 2014, ANTIVIR THER, V19, P309, DOI 10.3851/IMP2724; Hargreaves JR, 2002, TROP MED INT HEALTH, V7, P793, DOI 10.1046/j.1365-3156.2002.00943.x; Jauncey M, 2004, J INFECT DIS, V190, P1270, DOI 10.1086/423943; Kapembwa KC, 2011, J GLOB INFECT DIS, V3, P269, DOI 10.4103/0974-777X.83534; Kim AY, 2005, BLOOD, V105, P1170, DOI 10.1182/blood-2004-06-2336; Konings FAJ, 2004, AIDS RES HUM RETROV, V20, P105, DOI 10.1089/088922204322749558; Konopnicki D, 2005, AIDS, V19, P593, DOI 10.1097/01.aids.0000163936.99401.fe; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Laurent C, 2010, HIV MED, V11, P85, DOI 10.1111/j.1468-1293.2009.00742.x; Matthews PC, 2014, J CLIN VIROL, V61, P20, DOI 10.1016/j.jcv.2014.05.018; Measure D, 2012, HIV PREVALENCE CAMER; Muriuki Beatrice Mukami, 2013, BMC Res Notes, V6, P363, DOI 10.1186/1756-0500-6-363; Neaigus A, 2014, SEX TRANSM DIS, V41, P433, DOI 10.1097/OLQ.0000000000000144; Noubiap JJN, 2013, INT J INFECT DIS, V17, pE832, DOI 10.1016/j.ijid.2012.12.007; Nyambi P, 2002, JAIDS-J ACQ IMM DEF, V31, P506, DOI 10.1097/00126334-200212150-00008; Nyirenda M, 2008, J INFECTION, V57, P72, DOI 10.1016/j.jinf.2008.05.004; Pattanapanyasat K, 2007, CYTOM PART B-CLIN CY, V72B, P387, DOI 10.1002/cyto.b.20167; Puoti M, 2006, J HEPATOL, V44, pS65, DOI 10.1016/j.jhep.2005.11.015; Reilly KH, 2014, AIDS EDUC PREV, V26, P134, DOI 10.1521/aeap.2014.26.2.134; Rockstroh JK, 2005, J INFECT DIS, V192, P992, DOI 10.1086/432762; Rusine J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063303; Shirin T, 2000, J HEALTH POPUL NUTR, V18, P145; Soriano V, 2011, ENFERM INFEC MICR CL, V29, P691, DOI 10.1016/j.eimc.2011.07.003; Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74; Thio CL, 2013, AIDS, V27, P191, DOI 10.1097/QAD.0b013e32835a9984; Thio CL, 2009, HEPATOLOGY, V49, pS138, DOI 10.1002/hep.22883; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Tremeau-Bravard A, 2012, AFR HEALTH SCI, V12, P312, DOI 10.4314/ahs.v12i3.10; Tsui JI, 2007, ARCH INTERN MED, V167, P1271, DOI 10.1001/archinte.167.12.1271; Verucchi G, 2004, INFECTION, V32, P33, DOI 10.1007/s15010-004-3063-7; Yami A, 2011, ETHIOP J HEALTH SCI, V21, P67; Zhong P, 2003, AIDS RES HUM RETROV, V19, P1167, DOI 10.1089/088922203771881284; Zhong P, 2002, JAIDS-J ACQ IMM DEF, V31, P495, DOI 10.1097/00126334-200212150-00007	41	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137375	10.1371/journal.pone.0137375	http://dx.doi.org/10.1371/journal.pone.0137375			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371878	Green Published, Green Submitted, gold			2022-12-27	WOS:000361604400017
J	Pielecka-Fortuna, J; Kalogeraki, E; Greifzu, F; Lowel, S				Pielecka-Fortuna, Justyna; Kalogeraki, Evgenia; Greifzu, Franziska; Loewel, Siegrid			A Small Motor Cortex Lesion Abolished Ocular Dominance Plasticity in the Adult Mouse Primary Visual Cortex and Impaired Experience-Dependent Visual Improvements	PLOS ONE			English	Article							ELECTROPHYSIOLOGICAL TRANSCORTICAL DIASCHISIS; CEREBRAL-ARTERY OCCLUSION; MONOCULAR DEPRIVATION; INTRINSIC SIGNAL; CORTICAL STROKE; CRITICAL-PERIOD; MICE; BRAIN; VISION; EXCITABILITY	It was previously shown that a small lesion in the primary somatosensory cortex (S1) prevented both cortical plasticity and sensory learning in the adult mouse visual system: While 3-month-old control mice continued to show ocular dominance (OD) plasticity in their primary visual cortex (V1) after monocular deprivation (MD), age-matched mice with a small photothrombotically induced (PT) stroke lesion in S1, positioned at least 1 mm anterior to the anterior border of V1, no longer expressed OD-plasticity. In addition, in the S1-lesioned mice, neither the experience-dependent increase of the spatial frequency threshold ("visual acuity") nor of the contrast threshold ("contrast sensitivity") of the optomotor reflex through the open eye was present. To assess whether these plasticity impairments can also occur if a lesion is placed more distant from V1, we tested the effect of a PT-lesion in the secondary motor cortex (M2). We observed that mice with a small M2-lesion restricted to the superficial cortical layers no longer expressed an OD-shift towards the open eye after 7 days of MD in V1 of the lesioned hemisphere. Consistent with previous findings about the consequences of an S1-lesion, OD-plasticity in V1 of the nonlesioned hemisphere of the M2-lesioned mice was still present. In addition, the experience-dependent improvements of both visual acuity and contrast sensitivity of the open eye were severely reduced. In contrast, sham-lesioned mice displayed both an OD-shift and improvements of visual capabilities of their open eye. To summarize, our data indicate that even a very small lesion restricted to the superficial cortical layers and more than 3mm anterior to the anterior border of V1 compromised V1-plasticity and impaired learning-induced visual improvements in adult mice. Thus both plasticity phenomena cannot only depend on modality-specific and local nerve cell networks but are clearly influenced by long-range interactions even from distant brain regions.	[Pielecka-Fortuna, Justyna] Univ Gottingen, Dept Syst Neurosci, Johann Friedrich Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany; Univ Gottingen, Bernstein Fokus Neurotechnol, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen	Pielecka-Fortuna, J (corresponding author), Univ Gottingen, Dept Syst Neurosci, Johann Friedrich Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany.	jpielec@gwdg.de			Federal Ministry of Education and Research, Germany [01GQ0921, 01GQ0810]; Alexander von Humboldt Research Fellowship; Open Access Publication Funds of the Gottingen University	Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); Alexander von Humboldt Research Fellowship(Alexander von Humboldt Foundation); Open Access Publication Funds of the Gottingen University	This work was supported by the Federal Ministry of Education and Research, Germany, grant numbers 01GQ0921 (F.G., E.K., J.P.-F) and 01GQ0810 (S.L.) and an Alexander von Humboldt Research Fellowship for Postdoctoral Researchers (J.P.-F.). We acknowledge support by the Open Access Publication Funds of the Gottingen University.	ANDREWS RJ, 1991, STROKE, V22, P943, DOI 10.1161/01.STR.22.7.943; BuchkremerRatzmann I, 1996, STROKE, V27, P1105, DOI 10.1161/01.STR.27.6.1105; Budinger E, 2006, NEUROSCIENCE, V143, P1065, DOI 10.1016/j.neuroscience.2006.08.035; Budinger E, 2008, BRAIN RES, V1220, P2, DOI 10.1016/j.brainres.2007.07.084; Cang JH, 2005, VISUAL NEUROSCI, V22, P685, DOI 10.1017/S0952523805225178; Carmichael ST, 2012, ARCH NEUROL-CHICAGO, V69, P161, DOI 10.1001/archneurol.2011.1175; Charbonneau V, 2012, EUR J NEUROSCI, V36, P2949, DOI 10.1111/j.1460-9568.2012.08215.x; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; DAW NW, 1992, J NEUROPHYSIOL, V67, P197, DOI 10.1152/jn.1992.67.1.197; Di Garbo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025285; Espinosa JS, 2012, NEURON, V75, P230, DOI 10.1016/j.neuron.2012.06.009; Fu Y, 2015, ELIFE, V4, DOI 10.7554/eLife.05558; GARCIA JH, 1975, HUM PATHOL, V6, P583, DOI 10.1016/S0046-8177(75)80043-8; Gordon JA, 1996, J NEUROSCI, V16, P3274; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Greifzu F, 2014, P NATL ACAD SCI USA, V111, P1150, DOI 10.1073/pnas.1313385111; Greifzu F, 2011, P NATL ACAD SCI USA, V108, P15450, DOI 10.1073/pnas.1016458108; He HY, 2006, J NEUROSCI, V26, P2951, DOI 10.1523/JNEUROSCI.5554-05.2006; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; Hofer SB, 2006, CURR OPIN NEUROBIOL, V16, P451, DOI 10.1016/j.conb.2006.06.007; Imbrosci B, 2015, BRAIN STRUCT FUNCT, V220, P1649, DOI 10.1007/s00429-014-0750-8; Jablonka J, 2006, ACTA NEUROBIOL EXP, V66, P261; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; Lehmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003120; Levelt CN, 2012, ANNU REV NEUROSCI, V35, P309, DOI 10.1146/annurev-neuro-061010-113813; Lim DH, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00011; LIU T, 1993, STROKE, V24, P1746, DOI 10.1161/01.STR.24.11.1746; Neumann-Haefelin T, 2000, J CEREBR BLOOD F MET, V20, P45, DOI 10.1097/00004647-200001000-00008; Pham TA, 2004, LEARN MEMORY, V11, P738, DOI 10.1101/lm.75304; Prusky GT, 2006, J NEUROSCI, V26, P11554, DOI 10.1523/JNEUROSCI.3396-06.2006; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Reinecke S, 1999, NEUROSCI LETT, V261, P85, DOI 10.1016/S0304-3940(99)00014-2; Ruscher K, 2009, J CEREBR BLOOD F MET, V29, P1796, DOI 10.1038/jcbfm.2009.96; Sato M, 2008, J NEUROSCI, V28, P10278, DOI 10.1523/JNEUROSCI.2451-08.2008; Silasi G, 2014, NEURON, V83, P1354, DOI 10.1016/j.neuron.2014.08.052; Stehberg J, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00093; Stodieck SK, 2014, EXP GERONTOL, V60, P1, DOI 10.1016/j.exger.2014.09.007; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Vinters HV, 2000, J NEUROPATH EXP NEUR, V59, P931, DOI 10.1093/jnen/59.11.931; von Monakow C, 1914, J AM MED ASS, VLXIII, P797; WANG XK, 1994, MOL BRAIN RES, V26, P61, DOI 10.1016/0169-328X(94)90074-4; WATSON BD, 1985, ANN NEUROL, V17, P497, DOI 10.1002/ana.410170513; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003	44	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137961	10.1371/journal.pone.0137961	http://dx.doi.org/10.1371/journal.pone.0137961			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368569	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100185
J	Taylor, JET; Lam, TK; Chasteen, AL; Pratt, J				Taylor, J. Eric T.; Lam, Timothy K.; Chasteen, Alison L.; Pratt, Jay			Bow Your Head in Shame, or, Hold Your Head Up with Pride: Semantic Processing of Self-Esteem Concepts Orients Attention Vertically	PLOS ONE			English	Article							TIME; REPRESENTATIONS; NUMBERS; SHIFTS; SPACE	Embodied cognition holds that abstract concepts are grounded in perceptual-motor simulations. If a given embodied metaphor maps onto a spatial representation, then thinking of that concept should bias the allocation of attention. In this study, we used positive and negative self-esteem words to examine two properties of conceptual cueing. First, we tested the orientation-specificity hypothesis, which predicts that conceptual cues should selectively activate certain spatial axes (in this case, valenced self-esteem concepts should activate vertical space), instead of any spatial continuum. Second, we tested whether conceptual cueing requires semantic processing, or if it can be achieved with shallow visual processing of the cue words. Participants viewed centrally presented words consisting of high or low self-esteem traits (e.g., brave, timid) before detecting a target above or below the cue in the vertical condition, or on the left or right of the word in the horizontal condition. Participants were faster to detect targets when their location was compatible with the valence of the word cues, but only in the vertical condition. Moreover, this effect was observed when participants processed the semantics of the word, but not when processing its orthography. The results show that conceptual cueing by spatial metaphors is orientation-specific, and that an explicit consideration of the word cues' semantics is required for conceptual cueing to occur.	[Taylor, J. Eric T.; Lam, Timothy K.; Chasteen, Alison L.; Pratt, Jay] Univ Toronto, Toronto, ON, Canada	University of Toronto	Taylor, JET (corresponding author), Univ Toronto, Toronto, ON, Canada.	j.eric.t.taylor@gmail.com			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	ALC and JP were funded by the Natural Sciences and Engineering Research Council of Canada.	[Anonymous], 1988, STAT POWER SOCIAL SC; Barsalou L, 1999, BEHAV BRAIN SCI, V22; Bergen BK, 2007, COGNITIVE SCI, V31, P733, DOI 10.1080/03640210701530748; Boroditsky L, 2000, COGNITION, V75, P1, DOI 10.1016/S0010-0277(99)00073-6; Broookshire G, 2010, COGNITION IN FLUX, P1940; Brunye TT, 2012, COGNITION, V123, P229, DOI [10.1016/j.cognition.2011.07.01, 10.1016/j.cognition.2011.07.013]; Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004; Casasanto D, 2009, J EXP PSYCHOL GEN, V138, P351, DOI 10.1037/a0015854; Chasteen AL, 2010, NEUROPSYCHOLOGIA, V48, P627, DOI 10.1016/j.neuropsychologia.2009.09.029; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Dodd MD, 2008, COGNITION, V108, P810, DOI 10.1016/j.cognition.2008.04.006; Dudschig C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056872; Dudschig C, 2012, COGN PROCESS, V13, pS151, DOI 10.1007/s10339-012-0480-x; Estes Z, 2008, PSYCHOL SCI, V19, P93, DOI 10.1111/j.1467-9280.2008.02051.x; Fischer MH, 2003, NAT NEUROSCI, V6, P555, DOI 10.1038/nn1066; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Gozli DG, 2013, J EXP PSYCHOL GEN, V142, P1028, DOI 10.1037/a0030362; Hertz R, 2013, HAU-J ETHNOGR THEORY, V3, P335, DOI 10.14318/hau3.2.024; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Hommel B, 2001, PSYCHOL SCI, V12, P360, DOI 10.1111/1467-9280.00367; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; Lachmair M, 2011, PSYCHON B REV, V18, P1180, DOI 10.3758/s13423-011-0158-x; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Lakoff G., 1999, PHILOS FLESH; Lu A, 2014, CAN J EXP PSYCHOL, V68, P77, DOI 10.1037/cep0000008; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Meier BP, 2004, PSYCHOL SCI, V15, P243, DOI 10.1111/j.0956-7976.2004.00659.x; Ouellet M, 2010, J EXP PSYCHOL HUMAN, V36, P17, DOI 10.1037/a0017176; Pecher D, 2014, FRONT PSYCHOL, P5; Pecher D, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00030; Proctor RW, 2006, PSYCHOL BULL, V132, P416, DOI 10.1037/0033-2909.132.3.416; Sasin E, 2015, PSYCHONOMIC B REV; Schubert TW, 2005, J PERS SOC PSYCHOL, V89, P1, DOI 10.1037/0022-3514.89.1.1; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Taylor J. E.T., 2015, ATTENTION PERCEPTION; Verges M, 2009, COGNITIVE SCI, V33, P1157, DOI 10.1111/j.1551-6709.2009.01038.x; Weger UW, 2008, PSYCHON B REV, V15, P426, DOI 10.3758/PBR.15.2.426; Zanolie K, 2012, BRAIN COGNITION, V78, P50, DOI 10.1016/j.bandc.2011.10.006	38	7	8	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137704	10.1371/journal.pone.0137704	http://dx.doi.org/10.1371/journal.pone.0137704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8KS	26368276	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100113
J	White, MA; Bell, PR; Cook, AG; Barnes, DG; Tischler, TR; Bassam, BJ; Elliott, DA				White, Matt A.; Bell, Phil R.; Cook, Alex G.; Barnes, David G.; Tischler, Travis R.; Bassam, Brant J.; Elliott, David A.			Forearm Range of Motion in Australovenator wintonensis (Theropoda, Megaraptoridae)	PLOS ONE			English	Article							ORNITHOLESTES-HERMANNI; FORELIMB FUNCTION; DINOSAURS; EVOLUTION; JOINT	The hypertrophied manual claws and modified manus of megaraptoran theropods represent an unusual morphological adaptation among carnivorous dinosaurs. The skeleton of Australovenator wintonensis from the Cenomanian of Australia is among the most complete of any megaraptorid. It presents the opportunity to examine the range of motion of its forearm and the function of its highly modified manus. This provides the basis for behavioural inferences, and comparison with other Gondwanan theropod groups. Digital models created from computed tomography scans of the holotype reveal a humerus range of motion that is much greater than Allosaurus, Acrocanthosaurus, Tyrannosaurus but similar to that of the dromaeosaurid Bambiraptor. During flexion, the radius was forced distally by the radial condyle of the humerus. This movement is here suggested as a mechanism that forced a medial movement of the wrist. The antebrachium possessed a range of motion that was close to dromaeosaurids; however, the unguals were capable of hyper-extension, in particular manual phalanx I-2, which is a primitive range of motion characteristic seen in allosaurids and Dilophosaurus. During flexion, digits I and II slightly converge and diverge when extended which is accentuated by hyperextension of the digits in particular the unguals. We envision that prey was dispatched by its hands and feet with manual phalanx I2 playing a dominant role. The range of motion analysis neither confirms nor refutes current phylogenetic hypotheses with regards to the placement of Megaraptoridae; however, we note Australovenator possessed, not only a similar forearm range of motion to some maniraptorans and basal coelurosaurs, but also similarities with Tetanurans (Allosauroids and Dilophosaurus).	[White, Matt A.] Univ Newcastle, Sch Engn, Callaghan, NSW 2308, Australia; [White, Matt A.; Tischler, Travis R.; Bassam, Brant J.; Elliott, David A.] Australian Age Dinosaurs Museum Nat Hist, Winton, Qld 4735, Australia; [Bell, Phil R.] Univ New England, Sch Environm & Rural Sci, Armidale, NSW 2351, Australia; [Cook, Alex G.] Univ Queensland, Sch Earth Sci, St Lucia, Qld 4072, Australia; [Barnes, David G.] Monash Univ, Monash Biomed Imaging, Clayton, Vic 3168, Australia; [Barnes, David G.] Monash Univ, Monash E Res Ctr, Clayton, Vic 3168, Australia; [Barnes, David G.] Life Sci Computat Ctr, Parkville, Vic 3052, Australia	University of Newcastle; University of New England; University of Queensland; Monash University; Monash University	White, MA (corresponding author), Univ Newcastle, Sch Engn, Callaghan, NSW 2308, Australia.	fossilised@hotmail.com		White, Matt/0000-0002-4765-0356; Barnes, David/0000-0002-4594-3438				Agnolin FL, 2010, J SYST PALAEONTOL, V8, P257, DOI 10.1080/14772011003594870; ALTANGEREL P, 1993, NATURE, V362, P623, DOI 10.1038/362623a0; Barnes DG, 2008, NEW ASTRON, V13, P599, DOI 10.1016/j.newast.2008.03.008; Barnes DG, 2006, PUBL ASTRON SOC AUST, V23, P82, DOI 10.1071/AS06009; Barnes DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069446; Benson RBJ, 2010, NATURWISSENSCHAFTEN, V97, P71, DOI 10.1007/s00114-009-0614-x; BONAPARTE JF, 1985, NATL GEOGR RES, V1, P149; Bonnan MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075216; Bonnan MF, 2010, ANAT REC, V293, P2044, DOI 10.1002/ar.21266; Bryan SE, 2012, EPISODES, V35, P142, DOI 10.18814/epiiugs/2012/v35i1/013; Burnham D. A., 2000, PALEONTOLOGICAL CONT, V13, P1, DOI DOI 10.17161/PCNS.1808.3761; Carpenter Kenneth, 2002, Senckenbergiana Lethaea, V82, P59; Carpenter Kenneth, 2001, P90; Carrano MT, 2010, J SYSTEMATIC PALAEON, V10, P211; Colbert E. H, 1989, MUSEUM NO ARIZONA B, V57, P1; COPE ED, 1889, AM NAT, V23, P626; Currie Philip J., 2000, Geodiversitas, V22, P207; GALTON P M, 1971, Arnoldia (Rhodesia), V5, P1; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Hocknull SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006190; Holliday CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013120; Hutchinson JR, 2009, NATURWISSENSCHAFTEN, V96, P423, DOI 10.1007/s00114-008-0488-3; Hutson JD, 2013, J EXP BIOL, V216, P275, DOI 10.1242/jeb.074229; Hutson JD, 2014, ANAT REC, V297, P1228, DOI 10.1002/ar.22903; JENKINS FA, 1988, SCIENCE, V241, P1495, DOI 10.1126/science.241.4872.1495; Kobayashi Y, 2005, LIFE O PAST, P97; Lambe LM., 1902, CONTRIBUTIONS CANADI, V2, P25; Lipkin C., 2008, TYRANNOSAURUS REX TY, P166; Manning PL, 2009, ANAT REC, V292, P1397, DOI 10.1002/ar.20986; NICHOLLS EL, 1985, PALAEONTOLOGY, V28, P643; Novas FE, 2013, CRETACEOUS RES, V45, P174, DOI 10.1016/j.cretres.2013.04.001; Osborn HF, 1903, B AM MUS NAT HIST, V19, P459; Osborn HF, 1905, B AM MUS NAT HIST, V21, P259; Ostrom J. H., 1969, Postilla, V128, P1; Poore SO, 1997, NATURE, V387, P799, DOI 10.1038/42930; Porfiri JD, 2014, CRETACEOUS RES, V51, P35, DOI 10.1016/j.cretres.2014.04.007; Senter P, 2005, PALEOBIOLOGY, V31, P373, DOI 10.1666/0094-8373(2005)031[0373:FITSFO]2.0.CO;2; Senter P, 2005, J ZOOL, V266, P307, DOI 10.1017/S0952836905006989; Senter P, 2006, ACTA PALAEONTOL POL, V51, P305; Senter P, 2006, J VERTEBR PALEONTOL, V26, P897, DOI 10.1671/0272-4634(2006)26[897:COFFBD]2.0.CO;2; Senter Phil, 2006, Paleobios, V26, P7; Senter Phil, 2005, Paleobios, V25, P9; Senter P, 2006, PALAEONTOLOGY, V49, P1029, DOI 10.1111/j.1475-4983.2006.00585.x; Senter Phil, 2009, Bulletin of Gunma Museum of Natural History, V13, P1; Sereno PC., 1994, J VERTEBR PALEONTOL, V13, P425, DOI DOI 10.1080/02724634.1994.10011524; STOVALL JW, 1950, AM MIDL NAT, V43, P696, DOI 10.2307/2421859; Sullivan C, 2010, P ROY SOC B-BIOL SCI, V277, P2027, DOI 10.1098/rspb.2009.2281; WELLES S P, 1984, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V185, P85; White MA, 2013, ALCHERINGA, V37, P435, DOI 10.1080/03115518.2013.770221; White MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068649; White MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039364	51	19	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137709	10.1371/journal.pone.0137709	http://dx.doi.org/10.1371/journal.pone.0137709			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368529	gold, Green Submitted, Green Published			2022-12-27	WOS:000361601100114
J	Youk, JH; Son, EJ; Gweon, HM; Han, KH; Kim, JA				Youk, Ji Hyun; Son, Eun Ju; Gweon, Hye Mi; Han, Kyung Hwa; Kim, Jeong-Ah			Quantitative Lesion-to-Fat Elasticity Ratio Measured by Shear-Wave Elastography for Breast Mass: Which Area Should Be Selected as the Fat Reference?	PLOS ONE			English	Article							DIAGNOSTIC PERFORMANCE; DIFFERENTIAL-DIAGNOSIS; PATTERN-CLASSIFICATION; CLINICAL-APPLICATION; BENIGN; QUANTIFICATION; TECHNOLOGY; PARAMETER	Objectives To investigate whether the diagnostic performance of lesion-to-fat elasticity ratio (Eratio) was affected by the location of the reference fat. Methods For 257 breast masses in 250 women who underwent shear-wave elastography before biopsy or surgery, multiple E(ratio)s were measured with a fixed region-of-interest (ROI) in the mass along with multiple ROIs over the surrounding fat in different locations. Logistic regression analysis was used to determine that E-ratio was independently associated with malignancy adjusted for the location of fat ROI (depth, laterality, and distance from lesion or skin). Mean (E-mean) and maximum (E-max) elasticity values of fat were divided into four groups according to their interquartile ranges. Diagnostic performance of each group was evaluated using the area under the ROC curve (AUC). False diagnoses of E-ratio were reviewed for ROIs on areas showing artifactual high or low stiffness and analyzed by logistic regression analysis to determine variables (associated palpable abnormality, lesion size, the vertical distance from fat ROI to skin, and elasticity values of lesion or fat) independently associated with false results. Results E-ratio was independently associated with malignancy adjusted for the location of fat ROI (P<0.0001). Among four groups of fat elasticity values, the AUC showed no significant difference (<25th percentile, 25th percentile similar to median, median similar to 75th percentile, and >= 75th percentile; 0.973, 0.982, 0.967, and 0.954 for E-mean; 0.977, 0.967, 0.966, and 0.957 for E-max). Fat elasticity values were independently associated with false results of E-ratio with the cutoff of 3.18 from ROC curve (P<0.0001). ROIs were set on fat showing artifactual high stiffness in 90% of 10 false negatives and on lesion showing vertical striped artifact or fat showing artifactual low stiffness in 77.5% of 71 false positives. Conclusion E-ratio shows good diagnostic performance regardless of the location of reference fat, except when it is placed in areas of artifacts.	[Youk, Ji Hyun; Son, Eun Ju; Gweon, Hye Mi; Kim, Jeong-Ah] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Radiol, Seoul, South Korea; [Han, Kyung Hwa] Yonsei Univ, Coll Med, Gangnam Med Res Ctr, Biostat Collaborat Unit, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Youk, JH (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Radiol, Seoul, South Korea.	jhyouk@yuhs.ac		Han, Kyunghwa/0000-0002-5687-7237; Son, Eun Ju/0000-0002-7895-0335; Gweon, Hye Mi/0000-0002-3054-1532; Kim, Jeong-Ah/0000-0003-4949-4913	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [20110007602]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (20110007602) (https://ernd.nrf.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiou A, 2010, RADIOLOGY, V256, P297, DOI 10.1148/radiol.10090385; Au FWF, 2014, AM J ROENTGENOL, V203, pW328, DOI 10.2214/AJR.13.11693; Bamber J, 2013, ULTRASCHALL MED, V34, P169, DOI 10.1055/s-0033-1335205; Barr RG, 2014, RADIOL CLIN N AM, V52, P1145, DOI 10.1016/j.rcl.2014.07.002; Barr RG, 2012, J ULTRAS MED, V31, P773; Berg WA, 2012, RADIOLOGY, V262, P435, DOI 10.1148/radiol.11110640; Cho N, 2010, J ULTRAS MED, V29, P1; Comstock C, 2011, ULTRASOUND CLIN, V6, P407; Cosgrove DO, 2012, EUR RADIOL, V22, P1023, DOI 10.1007/s00330-011-2340-y; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Gweon HM, 2013, EUR J RADIOL, V82, pE680, DOI 10.1016/j.ejrad.2013.08.004; Gweon HM, 2013, EUR RADIOL, V23, P658, DOI 10.1007/s00330-012-2647-3; Havre RF, 2012, ULTRASCHALL MED, V33, P559, DOI 10.1055/s-0031-1273247; Kim H, 2013, EUR J RADIOL, V82, pE326, DOI 10.1016/j.ejrad.2013.03.007; Lee EJ, 2013, EUR RADIOL, V23, P1803, DOI 10.1007/s00330-013-2782-5; Lee SH, 2014, ULTRASONOGRAPHY, V33, P3, DOI 10.14366/usg.13012; Olgun DC, 2014, DIAGN INTERV RADIOL, V20, P239, DOI 10.5152/dir.2014.13306; Tozaki M, 2011, ACTA RADIOL, V52, P1069, DOI 10.1258/ar.2011.110276; Tozaki M, 2011, JPN J RADIOL, V29, P598, DOI 10.1007/s11604-011-0591-9; Yoon JH, 2013, EUR J RADIOL, V82, P2199, DOI 10.1016/j.ejrad.2013.08.047; Yoon JH, 2013, EUR RADIOL, V23, P2432, DOI 10.1007/s00330-013-2854-6; Youk JH, 2013, EUR RADIOL, V23, P2695, DOI 10.1007/s00330-013-2873-3	22	10	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138074	10.1371/journal.pone.0138074	http://dx.doi.org/10.1371/journal.pone.0138074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368920	Green Submitted, Green Published, gold			2022-12-27	WOS:000361601100215
J	Zhao, HP; Zhang, XY; Xue, M; Zhang, X				Zhao, Haipeng; Zhang, Xiaoying; Xue, Ming; Zhang, Xiao			Feeding of Whitefly on Tobacco Decreases Aphid Performance via Increased Salicylate Signaling	PLOS ONE			English	Article							TABACI BIOTYPE-B; PATHOGENESIS-RELATED PROTEINS; SYSTEMIC ACQUIRED-RESISTANCE; INTERSPECIFIC INTERACTIONS; TRIALEURODES-VAPORARIORUM; GENE-EXPRESSION; PLANT DEFENSE; HEMIPTERA ALEYRODIDAE; MYZUS-PERSICAE; RESPONSES	Background The feeding of Bemisia tabaci nymphs trigger the SA pathway in some plant species. A previous study showed that B. tabaci nymphs induced defense against aphids (Myzus persicae) in tobacco. However, the mechanism underlying this defense response is not well understood. Methodology/Principal Findings Here, the effect of activating the SA signaling pathway in tobacco plants through B. tabaci nymph infestation on subsequent M. persicae colonization is investigated. Performance assays showed that B. tabaci nymphs pre-infestation significantly reduced M. persicae survival and fecundity systemically in wild-type (WT) but not salicylate-deficient (NahG) plants compared with respective control. However, pre-infestation had no obvious local effects on subsequent M. persicae in eitherWT or NahG tobacco. SA quantification results indicated that the highest accumulation of SA was induced by B. tabaci nymphs in WT plants after 15 days of infestation. These levels were 8.45-and 6.14-fold higher in the local and systemic leaves, respectively, than in controls. Meanwhile, no significant changes of SA levels were detected in NahG plants. Further, biochemical analysis of defense enzymes polyphenol oxidase (PPO), peroxidase (POD), beta-1,3-glucanase, and chitinase demonstrated that B. tabaci nymph infestation increased these enzymes' activity locally and systemically in WT plants, and there was more chitinase and beta-1, 3-glucanase activity systemically than locally, which was opposite to the changing trends of PPO. However, B. tabaci nymph infestation caused no obvious increase in enzyme activity in any NahG plants except POD. Conclusions/Significance In conclusion, these results underscore the important role that induction of the SA signaling pathway by B. tabaci nymphs plays in defeating aphids. It also indicates that the activity of beta-1, 3-glucanase and chitinase may be positively correlated with resistance to aphids.	[Zhao, Haipeng; Zhang, Xiaoying; Xue, Ming; Zhang, Xiao] Shandong Agr Univ, Coll Plant Protect, Shandong Prov Key Lab Biol Vegetable Dis & Insect, Tai An, Shandong, Peoples R China; [Zhang, Xiaoying] Chinese Acad Sci, Kunming Inst Bot, Kunming, Yunnan, Peoples R China	Shandong Agricultural University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Xue, M (corresponding author), Shandong Agr Univ, Coll Plant Protect, Shandong Prov Key Lab Biol Vegetable Dis & Insect, Tai An, Shandong, Peoples R China.	xueming@sdau.edu.cn			Nature Science Foundation of China [30971906]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The Nature Science Foundation of China (30971906) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES FB, 1971, PLANT PHYSIOL, V47, P129, DOI 10.1104/pp.47.1.129; Almagro L, 2009, J EXP BOT, V60, P377, DOI 10.1093/jxb/ern277; Alon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076619; Alvarez ME, 2000, PROGRAMMED CELL DEAT, P185; Antony B, 2006, INDIAN J BIOCHEM BIO, V43, P182; Bergey DR, 1999, P NATL ACAD SCI USA, V96, P1756, DOI 10.1073/pnas.96.4.1756; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; Cooper WC, 2004, J CHEM ECOL, V30, P2527, DOI 10.1007/s10886-004-7948-9; Cui XH, 2008, J INSECT SCI, V8; Diezel C, 2009, PLANT PHYSIOL, V150, P1576, DOI 10.1104/pp.109.139550; Duan CX, 2014, CROP J, V2, P55, DOI 10.1016/j.cj.2013.12.001; Dugravot S, 2007, ENTOMOL EXP APPL, V123, P271, DOI 10.1111/j.1570-7458.2007.00542.x; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Elsayed G., 2011, Archives of Phytopathology and Plant Protection, V44, P1534, DOI 10.1080/03235408.2010.507957; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Estrada-Hernandez MG, 2009, PHYSIOL PLANTARUM, V137, P44, DOI 10.1111/j.1399-3054.2009.01260.x; Hebert SL, 2007, ENVIRON ENTOMOL, V36, P458, DOI 10.1603/0046-225X(2007)36[458:QDIAVA]2.0.CO;2; Inbar M, 1999, J CHEM ECOL, V25, P1961, DOI 10.1023/A:1020998219928; Inbar M, 1999, ENVIRON ENTOMOL, V28, P353, DOI 10.1093/ee/28.3.353; JIMENEZ DR, 1995, PHYSIOL MOL PLANT P, V46, P227, DOI 10.1006/pmpp.1995.1018; Jones DR, 2003, EUR J PLANT PATHOL, V109, P195, DOI 10.1023/A:1022846630513; Kaloshian I, 2004, J CHEM ECOL, V30, P2419, DOI 10.1007/s10886-004-7943-1; Kaloshian I, 2005, ANNU REV PHYTOPATHOL, V43, P491, DOI 10.1146/annurev.phyto.43.040204.135944; Kant R., 2008, New Zealand Plant Protection, V61, P355; Kaplan I, 2007, ECOL LETT, V10, P977, DOI 10.1111/j.1461-0248.2007.01093.x; Karban R, 1999, INDUCED PLANT DEFENSES AGAINST PATHOGENS AND HERBIVORES, P1; KARBAN R, 1989, ANNU REV ECOL SYST, V20, P331, DOI 10.1146/annurev.es.20.110189.001555; Kempema LA, 2007, PLANT PHYSIOL, V143, P849, DOI 10.1104/pp.106.090662; Kerchev PI, 2013, ANTIOXID REDOX SIGN, V18, P2091, DOI 10.1089/ars.2012.5097; Li Q, 2006, MOL PLANT MICROBE IN, V19, P655, DOI 10.1094/MPMI-19-0655; Liu SS, 2012, J INTEGR AGR, V11, P176, DOI 10.1016/S2095-3119(12)60002-1; MALAMY J, 1992, PLANT CELL, V4, P359, DOI 10.1105/tpc.4.3.359; Mayer RT, 2002, ARCH INSECT BIOCHEM, V51, P151, DOI 10.1002/arch.10065; Mayer RT, 1996, BEMISIA 1995 TAXONOM; Mithofer A, 2012, ANNU REV PLANT BIOL, V63, P431, DOI 10.1146/annurev-arplant-042110-103854; Moran PJ, 2002, ARCH INSECT BIOCHEM, V51, P182, DOI 10.1002/arch.10064; Penninckx IAMA, 1996, PLANT CELL, V8, P2309, DOI 10.1105/tpc.8.12.2309; Puthoff DP, 2010, J CHEM ECOL, V36, P1271, DOI 10.1007/s10886-010-9868-1; Rostas M, 2008, CHEMOECOLOGY, V18, P29, DOI 10.1007/s00049-007-0390-z; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; SABOROWSKI R, 1993, COMP BIOCHEM PHYS B, V105, P673, DOI 10.1016/0305-0491(93)90104-D; Sampson MN, 1998, MICROBIOL-SGM, V144, P2189, DOI 10.1099/00221287-144-8-2189; Schaller A., 2008, INDUCED PLANT RESIST; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; Stout MJ, 1998, ENTOMOL EXP APPL, V86, P267, DOI 10.1023/A:1003199023355; Tarchevsky IA, 2010, BIOCHEMISTRY-MOSCOW+, V75, P590, DOI 10.1134/S0006297910050081; Thaler JS, 2012, TRENDS PLANT SCI, V17, P260, DOI 10.1016/j.tplants.2012.02.010; Thaler JS, 2010, ECOLOGY, V91, P1075, DOI 10.1890/08-2347.1; Thompson GA, 2006, J EXP BOT, V57, P755, DOI 10.1093/jxb/erj135; van de Ven WTG, 2000, PLANT CELL, V12, P1409, DOI 10.1105/tpc.12.8.1409; van der Westhuizen AJ, 1998, PLANT CELL REP, V18, P132, DOI 10.1007/s002990050545; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Walling LL, 2009, ADV BOT RES, V51, P551, DOI 10.1016/S0065-2296(09)51013-0; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Wang CX, 2010, ACTA ENTOMOL SINICA, V3; Wang XR, 1996, INSECT BIOCHEM MOLEC, V26, P1055, DOI 10.1016/S0965-1748(96)00056-2; Wu JQ, 2009, PLANT CELL ENVIRON, V32, P1161, DOI 10.1111/j.1365-3040.2009.01943.x; Xue M, 2010, ENVIRON ENTOMOL, V39, P883, DOI 10.1603/EN09307; Zarate SI, 2007, PLANT PHYSIOL, V143, P866, DOI 10.1104/pp.106.090035; Zhang CL, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-11; Zhang GF, 2014, PEST MANAG SCI, V70, P1797, DOI 10.1002/ps.3713; Zhang LP, 2005, J APPL ENTOMOL, V129, P443, DOI 10.1111/j.1439-0418.2005.00991.x; Zhang PJ, 2013, J CHEM ECOL, V39, P612, DOI 10.1007/s10886-013-0283-2; Zhang SZ, 2013, ENTOMOL EXP APPL, V147, P293, DOI 10.1111/eea.12067; Zhang T, 2012, MOL ECOL, V21, P1294, DOI 10.1111/j.1365-294X.2012.05457.x; Zhu F, 2014, NEW PHYTOL, P1	67	16	16	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138584	10.1371/journal.pone.0138584	http://dx.doi.org/10.1371/journal.pone.0138584			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381273	Green Submitted, gold, Green Published			2022-12-27	WOS:000361790200132
J	Coady, A; Xu, M; Phung, Q; Cheung, TK; Bakalarski, C; Alexander, MK; Lehar, SM; Kim, J; Park, S; Tan, MW; Nishiyama, M				Coady, Alison; Xu, Min; Phung, Qui; Cheung, Tommy K.; Bakalarski, Corey; Alexander, Mary Kate; Lehar, Sophie M.; Kim, Janice; Park, Summer; Tan, Man-Wah; Nishiyama, Mireille			The Staphylococcus aureus ABC-Type Manganese Transporter MntABC Is Critical for Reinitiation of Bacterial Replication Following Exposure to Phagocytic Oxidative Burst	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; STRESS RESISTANCE; ESCHERICHIA-COLI; RIBONUCLEOTIDE REDUCTASE; SUPEROXIDE DISMUTASES; EPITHELIAL-CELLS; REACTIVE OXYGEN; NADPH-OXIDASE; HOST-DEFENSE; AMINO-ACIDS	Manganese plays a central role in cellular detoxification of reactive oxygen species (ROS). Therefore, manganese acquisition is considered to be important for bacterial pathogenesis by counteracting the oxidative burst of phagocytic cells during host infection. However, detailed analysis of the interplay between bacterial manganese acquisition and phagocytic cells and its impact on bacterial pathogenesis has remained elusive for Staphylococcus aureus, a major human pathogen. Here, we show that a mntC mutant, which lacks the functional manganese transporter MntABC, was more sensitive to killing by human neutrophils but not murine macrophages, unless the mntC mutant was pre-exposed to oxidative stress. Notably, the mntC mutant formed strikingly small colonies when recovered from both type of phagocytic cells. We show that this phenotype is a direct consequence of the inability of the mntC mutant to reinitiate growth after exposure to phagocytic oxidative burst. Transcript and quantitative proteomics analyses revealed that the manganese-dependent ribonucleotide reductase complex NrdEF, which is essential for DNA synthesis and repair, was highly induced in the mntC mutant under oxidative stress conditions including after phagocytosis. Since NrdEF proteins are essential for S. aureus viability we hypothesize that cells lacking MntABC might attempt to compensate for the impaired function of NrdEF by increasing their expression. Our data suggest that besides ROS detoxification, functional manganese acquisition is likely crucial for S. aureus pathogenesis by repairing oxidative damages, thereby ensuring efficient bacterial growth after phagocytic oxidative burst, which is an attribute critical for disseminating and establishing infection in the host.	[Coady, Alison; Alexander, Mary Kate; Lehar, Sophie M.; Tan, Man-Wah; Nishiyama, Mireille] Genentech Inc, Dept Infect Dis, San Francisco, CA 94080 USA; [Xu, Min; Kim, Janice; Park, Summer] Genentech Inc, Dept Translat Immunol, San Francisco, CA 94080 USA; [Phung, Qui; Cheung, Tommy K.; Bakalarski, Corey] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Bakalarski, Corey] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Nishiyama, M (corresponding author), Genentech Inc, Dept Infect Dis, San Francisco, CA 94080 USA.	nishiyama.mireille@gene.com		Bakalarski, Corey/0000-0003-1085-7828; Coady, Alison/0000-0003-1871-5576	Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	All work was supported by internal funds at Genentech, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript The funder provided support in the form of salaries for authors CA, MX, QP, TKC, CB, MKA, SML, JK, SP, MWT, MN], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahuja S, 2015, STRUCTURE, V23, P713, DOI 10.1016/j.str.2015.01.020; Badwey JA, 1980, ANNU REV BIOCHEM, V49, P16366; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Bakalarski CE, 2008, J PROTEOME RES, V7, P4756, DOI 10.1021/pr800333e; Barlett AH, 2010, PEDIATR INFECT DIS J, V29, P860, DOI [10.1097/INF.0b013e3181ef2477, DOI 10.1097/INF.0B013E3181EF2477]; BAYLES KW, 1994, GENE, V147, P13, DOI 10.1016/0378-1119(94)90033-7; BERLETT BS, 1990, P NATL ACAD SCI USA, V87, P389, DOI 10.1073/pnas.87.1.389; Boyer E, 2002, INFECT IMMUN, V70, P6032, DOI 10.1128/IAI.70.11.6032-6042.2002; Chang W, 2006, J BACTERIOL, V188, P1648, DOI 10.1128/JB.188.4.1648-1659.2006; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Christiansen MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089018; Clements MO, 1999, J BACTERIOL, V181, P3898, DOI 10.1128/JB.181.13.3898-3903.1999; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Cosgrove K, 2007, J BACTERIOL, V189, P1025, DOI 10.1128/JB.01524-06; Deleo FR, 2009, INFECT DIS CLIN N AM, V23, P17, DOI 10.1016/j.idc.2008.10.003; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2014, J INFECT DIS, V209, P1533, DOI 10.1093/infdis/jit662; Dukan S, 1998, GENE DEV, V12, P3431, DOI 10.1101/gad.12.21.3431; DuMont AL, 2013, INFECT IMMUN, V81, P1830, DOI 10.1128/IAI.00095-13; DuMont AL, 2011, MOL MICROBIOL, V79, P814, DOI 10.1111/j.1365-2958.2010.07490.x; Fang FC, 2011, MBIO, V2, DOI 10.1128/mBio.00141-11; Fey PD, 2013, MBIO, V4, DOI 10.1128/mBio.00537-12; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; Freltas M, 2008, CLIN BIOCHEM, V41, P570, DOI 10.1016/j.clinbiochem.2007.12.021; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Govoni G, 1997, J LEUKOCYTE BIOL, V62, P277, DOI 10.1002/jlb.62.2.277; Gray JP, 2007, J BIOL CHEM, V282, P7939, DOI 10.1074/jbc.M611817200; Gresham HD, 2000, J IMMUNOL, V164, P3713, DOI 10.4049/jimmunol.164.7.3713; Hampton MB, 1996, INFECT IMMUN, V64, P3512, DOI 10.1128/IAI.64.9.3512-3517.1996; HASSAN HM, 1979, J BIOL CHEM, V254, P846; HASSETT DJ, 1989, FASEB J, V3, P2574, DOI 10.1096/fasebj.3.14.2556311; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Horsburgh MJ, 2001, INFECT IMMUN, V69, P3744, DOI 10.1128/IAI.69.6.3744-3754.2001; Horsburgh MJ, 2002, MOL MICROBIOL, V44, P1269, DOI 10.1046/j.1365-2958.2002.02944.x; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Imlay JA, 2002, ADV MICROB PHYSIOL, V46, P111, DOI 10.1016/S0065-2911(02)46003-1; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jakubovics NS, 2001, MICROBIOL-SGM, V147, P1709, DOI 10.1099/00221287-147-7-1709; JOHANSSON A, 1995, CELL IMMUNOL, V161, P61, DOI 10.1006/cimm.1995.1009; Karavolos MH, 2003, MICROBIOL-SGM, V149, P2749, DOI 10.1099/mic.0.26353-0; Kehl-Fie TE, 2013, INFECT IMMUN, V81, P3395, DOI 10.1128/IAI.00420-13; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Kobayashi SD, 2010, J INNATE IMMUN, V2, P560, DOI 10.1159/000317134; Kubica M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001409; Lim KHL, 2008, INFECT IMMUN, V76, P3569, DOI 10.1128/IAI.01725-07; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MALO D, 1994, GENOMICS, V23, P51, DOI 10.1006/geno.1994.1458; Martin JE, 2011, MOL MICROBIOL, V80, P319, DOI 10.1111/j.1365-2958.2011.07593.x; Masalha M, 2001, J BACTERIOL, V183, P7260, DOI 10.1128/JB.183.24.7260-7272.2001; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; McAllister LJ, 2012, MOL MICROBIOL, V53, P215; Mohanty K., 2012, OXIDANTS ANTIOXIDANT, V1, P21; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nordenfelt P, 2011, J LEUKOCYTE BIOL, V90, P271, DOI 10.1189/jlb.0810457; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; ODONNELL VB, 1993, BIOCHEM J, V290, P41, DOI 10.1042/bj2900041; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Palazzolo-Ballance AM, 2008, J IMMUNOL, V180, P500, DOI 10.4049/jimmunol.180.1.500; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Pham VC, 2012, J PROTEOME RES, V11, P2947, DOI 10.1021/pr300035k; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Rigby KM, 2012, SEMIN IMMUNOPATHOL, V34, P237, DOI 10.1007/s00281-011-0295-3; Rolfe MD, 2012, J BACTERIOL, V194, P686, DOI 10.1128/JB.06112-11; Silva MT, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00174; Silva MT, 2010, J LEUKOCYTE BIOL, V87, P93, DOI 10.1189/jlb.0809549; Sobota JM, 2011, P NATL ACAD SCI USA, V108, P5402, DOI 10.1073/pnas.1100410108; STANLEY PE, 1989, J BIOLUM CHEMILUM, V4, P375, DOI 10.1002/bio.1170040151; STEINBECK MJ, 1991, J BIOL CHEM, V266, P16336; Valderas MW, 2001, J BACTERIOL, V183, P3399, DOI 10.1128/JB.183.11.3399-3407.2001; VanderVen BC, 2009, TRAFFIC, V10, P372, DOI [10.1111/j.1600-0854.2008.00877.x, 10.1111/j.1600-0854.2009.00877.x]; Yui S, 2003, BIOL PHARM BULL, V26, P753	72	20	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138350	10.1371/journal.pone.0138350	http://dx.doi.org/10.1371/journal.pone.0138350			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379037	Green Submitted, Green Published, gold			2022-12-27	WOS:000361769400086
J	Nagayama, K; Kyotani, Y; Zhao, J; Ito, S; Ozawa, K; Bolstad, FA; Yoshizumi, M				Nagayama, Kosuke; Kyotani, Yoji; Zhao, Jing; Ito, Satoyasu; Ozawa, Kentaro; Bolstad, Francesco A.; Yoshizumi, Masanori			Exendin-4 Prevents Vascular Smooth Muscle Cell Proliferation and Migration by Angiotensin II via the Inhibition of ERK1/2 and JNK Signaling Pathways	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; ACTIVATED PROTEIN-KINASE; GLP-1 RECEPTOR AGONISTS; ENDOTHELIAL-CELLS; BETA-CELLS; SRC; ATHEROSCLEROSIS; TRANSDUCTION; REGENERATION; MECHANISMS	Angiotensin 11 (Ang II) is a main pathophysiological culprit peptide for hypertension and atherosclerosis by causing vascular smooth muscle cell (VSMC) proliferation and migration. Exendin-4, a glucagon-like peptide-1 (GLP-1) receptor agonist, is currently used for the treatment of type-2 diabetes, and is believed to have beneficial effects for cardiovascular diseases. However, the vascular protective mechanisms of GLP-1 receptor agonists remain largely unexplained. In the present study, we examined the effect of exendin-4 on Ang IIinduced proliferation and migration of cultured rat aortic smooth muscle cells (RASMC). The major findings of the present study are as follows: (1) Angllcaused a phenotypic switch of RASMC from contractile type to synthetic proliferative type cells; (2) Ang II caused concentration-dependent RASMC proliferation, which was significantly inhibited by the pretreatment with exendin-4; (3) Ang II caused concentration-dependent RASMC migration, which was effectively inhibited by the pretreatment with exendin-4; (4) exendin-4 inhibited Ang IIinduced phosphorylation of ERK1/2 and JNK in a pre-incubation time-dependent manner; and (5) U0126 (an ERK1/2 kinase inhibitor) and SP600125 (a JNK inhibitor) also inhibited both RASMC proliferation and migration induced by Ang II stimulation. These results suggest that exendin-4 prevented Ang II-induced VSMC proliferation and migration through the inhibition of ERK1/2 and JNK phosphorylation caused by Ang II stimulation. This indicates that GLP-1 receptor agonists should be considered for use in the treatment of cardiovascular diseases in addition to their current use in the treatment of diabetes mellitus.	[Nagayama, Kosuke; Kyotani, Yoji; Zhao, Jing; Ito, Satoyasu; Ozawa, Kentaro; Yoshizumi, Masanori] Nara Med Univ, Dept Pharmacol, Sch Med, Kashihara, Nara 634, Japan; [Bolstad, Francesco A.] Nara Med Univ, Dept Clin English, Sch Med, Kashihara, Nara 634, Japan	Nara Medical University; Nara Medical University	Yoshizumi, M (corresponding author), Nara Med Univ, Dept Pharmacol, Sch Med, Kashihara, Nara 634, Japan.	yoshizu@naramed-u.ac.jp	Kyotani, Yoji/AAR-3830-2020	Kyotani, Yoji/0000-0002-7771-6889	JPJS KAKENHI [23590306, 26460345]	JPJS KAKENHI	The study was supported by JPJS KAKENHI Grants, number 23590306 and 26460345, to M.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2001, P NATL ACAD SCI USA, V98, P48, DOI 10.1073/pnas.240458597; Arakawa M, 2010, DIABETES, V59, P1030, DOI 10.2337/db09-1694; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Berk BC, 2000, J CLIN INVEST, V105, P1525, DOI 10.1172/JCI9820; Bojanowska E, 2000, REGUL PEPTIDES, V91, P75, DOI 10.1016/S0167-0115(00)00119-1; Buteau J, 2001, DIABETES, V50, P2237, DOI 10.2337/diabetes.50.10.2237; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Egan JM, 2003, DIABETES-METAB RES, V19, P115, DOI 10.1002/dmrr.357; ENG J, 1992, J BIOL CHEM, V267, P7402; FRODIN M, 1995, J BIOL CHEM, V270, P7882, DOI 10.1074/jbc.270.14.7882; Gardiner SM, 2006, J PHARMACOL EXP THER, V316, P852, DOI 10.1124/jpet.105.093104; Goto H, 2011, BIOCHEM BIOPH RES CO, V405, P79, DOI 10.1016/j.bbrc.2010.12.131; Grieve DJ, 2009, BRIT J PHARMACOL, V157, P1340, DOI 10.1111/j.1476-5381.2009.00376.x; Hattori Y, 2010, DIABETOLOGIA, V53, P2256, DOI 10.1007/s00125-010-1831-8; Hirata Y, 2013, EUR J PHARMACOL, V699, P106, DOI 10.1016/j.ejphar.2012.11.057; Kang JH, 2009, J ENDOCRINOL, V202, P65, DOI 10.1677/JOE-08-0507; KIEFFER TJ, 1995, ENDOCRINOLOGY, V136, P3585, DOI 10.1210/en.136.8.3585; Kobayashi S, 2000, J BIOL CHEM, V275, P10723, DOI 10.1074/jbc.275.15.10723; Kyaw M, 2004, MOL PHARMACOL, V65, P832, DOI 10.1124/mol.65.4.832; Kyotani Y, 2010, J PHARMACOL SCI, V113, P161, DOI 10.1254/jphs.09332FP; Meier JJ, 2012, NAT REV ENDOCRINOL, V8, P728, DOI 10.1038/nrendo.2012.140; Nagashima M, 2011, DIABETOLOGIA, V54, P2649, DOI 10.1007/s00125-011-2241-2; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sauve M, 2010, DIABETES, V59, P1063, DOI 10.2337/db09-0955; Schmitz U, 1997, TRENDS ENDOCRIN MET, V8, P261, DOI 10.1016/S1043-2760(97)00101-X; Touyz RM, 2000, PHARMACOL REV, V52, P639; TSUDA T, 1992, CIRC RES, V71, P620, DOI 10.1161/01.RES.71.3.620; Viedt C, 2000, ARTERIOSCL THROM VAS, V20, P940, DOI 10.1161/01.ATV.20.4.940; Xie CQ, 2012, J BIOL CHEM, V287, P14598, DOI 10.1074/jbc.M111.329268; Yao HL, 2012, MOL CELL BIOCHEM, V366, P355, DOI 10.1007/s11010-012-1315-x; Yoshizumi M, 2002, BIOCHEM BIOPH RES CO, V293, P1458, DOI 10.1016/S0006-291X(02)00407-2; Yoshizumi M, 2000, J BIOL CHEM, V275, P11706, DOI 10.1074/jbc.275.16.11706; Yu M, 2003, J HYPERTENS, V21, P1125, DOI 10.1097/00004872-200306000-00012; Zhao L, 2014, AM J PHYSIOL-CELL PH, V307, pC1130, DOI 10.1152/ajpcell.00151.2014	34	38	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137960	10.1371/journal.pone.0137960	http://dx.doi.org/10.1371/journal.pone.0137960			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379274	Green Published, gold, Green Submitted			2022-12-27	WOS:000361769400040
J	Pook, M; Teino, I; Kailas, A; Maimets, T; Ingerpuu, S; Jaks, V				Pook, Martin; Teino, Indrek; Kailas, Ade; Maimets, Toivo; Ingerpuu, Sulev; Jaks, Viljar			Changes in Laminin Expression Pattern during Early Differentiation of Human Embryonic Stem Cells	PLOS ONE			English	Article							BASEMENT-MEMBRANES; RETINOIC ACID; EXTRACELLULAR-MATRIX; GROWTH-FACTORS; EMBRYOGENESIS; ISOFORMS; NANOG	Laminin isoforms laminin-511 and -521 are expressed by human embryonic stem cells (hESC) and can be used as a growth matrix to culture these cells under pluripotent conditions. However, the expression of these laminins during the induction of hESC differentiation has not been studied in detail. Furthermore, the data regarding the expression pattern of laminin chains in differentiating hESC is scarce. In the current study we aimed to fill this gap and investigated the potential changes in laminin expression during early hESC differentiation induced by retinoic acid (RA). We found that laminin-511 but not -521 accumulates in the committed cells during early steps of hESC differentiation. We also performed a comprehensive analysis of the laminin chain repertoire and found that pluripotent hESC express a more diverse range of laminin chains than shown previously. In particular, we provide the evidence that in addition to alpha 1, alpha 5, beta 1, beta 2 and gamma 1 chains, hESC express alpha 2, alpha 3, beta 3, gamma 2 and gamma 3 chain proteins and mRNA. Additionally, we found that a variant of laminin alpha 3 chain-145 kDa-accumulated in RA-treated hESC showing that these cells produce prevalently specifically modified version of alpha 3 chain in early phase of differentiation.	[Pook, Martin; Teino, Indrek; Kailas, Ade; Maimets, Toivo; Ingerpuu, Sulev; Jaks, Viljar] Univ Tartu, Inst Mol & Cell Biol, Dept Cell Biol, EE-51010 Tartu, Estonia; [Jaks, Viljar] Karolinska Inst, Dept Biosci & Nutr, SE-14183 Huddinge, Sweden	University of Tartu; Karolinska Institutet	Pook, M (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Dept Cell Biol, Riia 23, EE-51010 Tartu, Estonia.	pookm@ut.ee	Kallas-Kivi, Ade/F-2411-2017; Maimets, Toivo/E-9268-2017; Pook, Martin/G-3467-2017; Pook, Martin/Q-9707-2019; Jaks, Viljar/H-2467-2012; Teino, Indrek/AAJ-1106-2021	Kallas-Kivi, Ade/0000-0002-0536-5020; Maimets, Toivo/0000-0001-6461-3365; Pook, Martin/0000-0002-8386-0203; Jaks, Viljar/0000-0002-2221-6262; Teino, Indrek/0000-0002-2381-4715	EMBO Installation Grant [1819]; Estonian Research Council [PUT4, ETF8932, PUT374]; Estonian Ministry of Higher Education and Research [SF0180100s08]	EMBO Installation Grant; Estonian Research Council; Estonian Ministry of Higher Education and Research	This work was supported by the EMBO Installation Grant No1819 and grants no. ETF8932 and PUT4 from the Estonian Research Council (to V. J.), and research grants PUT374 from Estonian Research Council and SF0180100s08 from Estonian Ministry of Higher Education and Research (to T.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2010, GENES CELLS, V15, P455, DOI 10.1111/j.1365-2443.2010.01400.x; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Aumailley M, 2003, MATRIX BIOL, V22, P49, DOI 10.1016/S0945-053X(03)00013-1; Baharvand H, 2007, INT J DEV BIOL, V51, P371, DOI 10.1387/ijdb.072280hb; Bakre MM, 2007, J BIOL CHEM, V282, P31703, DOI 10.1074/jbc.M704287200; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brizzi MF, 2012, CURR OPIN CELL BIOL, V24, P645, DOI 10.1016/j.ceb.2012.07.001; Church HJ, 1997, PLACENTA, V18, P143, DOI [DOI 10.1016/S0143-4004(97)80085-9, DOI 10.1016/S0143-4004(97)80085-9)]; COOPER AR, 1983, DEV BIOL, V96, P467, DOI 10.1016/0012-1606(83)90183-5; Darr H, 2006, DEVELOPMENT, V133, P1193, DOI 10.1242/dev.02286; DZIADEK M, 1985, DEV BIOL, V111, P372, DOI 10.1016/0012-1606(85)90491-9; ENGVALL E, 1993, KIDNEY INT, V43, P2, DOI 10.1038/ki.1993.2; Evseenko D, 2009, STEM CELLS DEV, V18, P919, DOI 10.1089/scd.2008.0293; Geberhiwot T, 1999, EXP CELL RES, V253, P723, DOI 10.1006/excr.1999.4653; Higuchi Y, 2010, J CELL SCI, V123, P2733, DOI 10.1242/jcs.066886; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Inanc B, 2008, TISSUE ENG PT A, V14, P955, DOI [10.1089/ten.tea.2007.0213, 10.1089/tea.2007.0213]; Jagtap S, 2013, STEM CELL RES, V10, P228, DOI 10.1016/j.scr.2012.12.002; Jain AK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001268; Kikkawa Y, 1998, J BIOL CHEM, V273, P15854, DOI 10.1074/jbc.273.25.15854; Laperle A, 2015, STEM CELL REP, V5, P195, DOI 10.1016/j.stemcr.2015.06.009; Li S, 2002, J CELL BIOL, V157, P1279, DOI 10.1083/jcb.200203073; Li SH, 2003, DEV CELL, V4, P613, DOI 10.1016/S1534-5807(03)00128-X; Miner JH, 2011, ORGANOGENESIS, V7, P75, DOI 10.4161/org.7.2.15275; Miner JH, 1998, J CELL BIOL, V143, P1713, DOI 10.1083/jcb.143.6.1713; Miner JH, 2004, DEVELOPMENT, V131, P2247, DOI 10.1242/dev.01112; Miyazaki T, 2008, BIOCHEM BIOPH RES CO, V375, P27, DOI 10.1016/j.bbrc.2008.07.111; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; PIKARSKY E, 1994, MOL CELL BIOL, V14, P1026, DOI 10.1128/MCB.14.2.1026; Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009; Rodin S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4195; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Rodriguez RT, 2007, EXP BIOL MED, V232, P1368, DOI 10.3181/0703-RM-63; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Shiraki N, 2011, PLOS ONE, V6, P1; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vuoristo S, 2009, J CELL MOL MED, V13, P2622, DOI 10.1111/j.1582-4934.2008.00643.x; Wondimu Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053648; Yamashita H, 2010, J ONCOL, V2010, DOI 10.1155/2010/107075; YURCHENCO PD, 1993, J BIOL CHEM, V268, P17286; Zhang SC, 2008, PHILOS T R SOC B, V363, P87, DOI 10.1098/rstb.2006.2014	41	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138346	10.1371/journal.pone.0138346	http://dx.doi.org/10.1371/journal.pone.0138346			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378917	Green Published, Green Submitted, gold			2022-12-27	WOS:000361769400085
J	Rehan, M; Ahmad, E; Sheikh, IA; Abuzenadah, AM; Damanhouri, GA; Bajouh, OS; AlBasri, SF; Assiri, MM; Beg, MA				Rehan, Mohd; Ahmad, Ejaz; Sheikh, Ishfaq A.; Abuzenadah, Adel M.; Damanhouri, Ghazi A.; Bajouh, Osama S.; AlBasri, Samera F.; Assiri, Mansour M.; Beg, Mohd A.			Androgen and Progesterone Receptors Are Targets for Bisphenol A (BPA), 4-Methyl-2,4-bis-(P-Hydroxyphenyl)Pent-1-Ene-A Potent Metabolite of BPA, and 4-Tert-Octylphenol: A Computational Insight	PLOS ONE			English	Article							ENDOCRINE DISRUPTORS; REPRODUCTIVE FUNCTION; WIDESPREAD EXPOSURE; SCORING FUNCTIONS; URINARY; INFERTILITY; CHEMICALS; WOMEN; NONYLPHENOL; POPULATION	Exposure to toxic industrial chemicals that have capacity to disrupt the endocrine system, also known as endocrine disrupting chemicals (EDCs), has been increasingly associated with reproductive problems in human population. Bisphenol A (BPA; 4,4'-(propane-2,2-diyl)diphenol) and 4-tert-octylphenol (OP; 4-(1,1,3,3-tetramethylbutyl)phenol) are among the most common environmental contaminants possessing endocrine disruption properties and are present in plastics, epoxy resins, detergents and other commercial products of common personal and industrial use. A metabolite of BPA, 4-Methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP) is about 1000 times more biologically active compared to BPA. Epidemiological, clinical, and experimental studies have shown association of BPA and OP with adverse effects on male and female reproductive system in human and animals. The endocrine disruption activity can occur through multiple pathways including binding to steroid receptors. Androgen receptor (AR) and progesterone receptor (PR) are critical for reproductive tract growth and function. Structural binding characterization of BPA, MBP, and OP with AR and PR using molecular docking simulation approaches revealed novel interactions of BPA with PR, and MBP and OP with AR and PR. For BPA, MBP, and OP, five AR interacting residues Leu-701, Leu-704, Asn-705, Met-742, and Phe-764 overlapped with those of native AR ligand testosterone, and four PR interacting residues Leu-715, Leu-718, Met-756, and Met-759 overlapped with those of PR co-complex ligand, norethindrone. For both the receptors the binding strength of MBP was maximum among the three compounds. Thus, these compounds have the potential to block or interfere in the binding of the endogenous native AR and PR ligands and, hence, resulting in dysfunction. The knowledge of the key interactions and the important amino-acid residues also allows better prediction of potential of xenobiotic molecules for disrupting AR- and PR-mediated pathways, thus, helping in design of less potent alternatives for commercial use.	[Rehan, Mohd; Ahmad, Ejaz; Sheikh, Ishfaq A.; Damanhouri, Ghazi A.; Beg, Mohd A.] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21413, Saudi Arabia; [Abuzenadah, Adel M.] King Abdulaziz Univ, KACST Technol Innovat Ctr Personalized Med, Jeddah 21413, Saudi Arabia; [Bajouh, Osama S.; AlBasri, Samera F.; Assiri, Mansour M.] King Abdulaziz Univ, Fac Med, Dept Obstet & Gynecol, Jeddah 21413, Saudi Arabia	King Abdulaziz University; King Abdulaziz University; King Abdulaziz University	Beg, MA (corresponding author), King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21413, Saudi Arabia.	mabeg51@gmail.com	Ahmad, Ejaz/P-2730-2015; Rehan, Mohd/H-9835-2012; Sheikh, Ishfaq A/H-9611-2012; Damanhouri, Ghazi/Q-7901-2019; Beg, Mohd A/K-3366-2013	Beg, Mohd A/0000-0002-8495-4738; Rehan, Mohd/0000-0003-4898-6043	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [434/019-T]; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	This project was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant no. 434/019-T. The authors, therefore, acknowledge with thanks DSR technical and financial support.	Asimakopoulos AG, 2012, TOXICOL LETT, V210, P141, DOI 10.1016/j.toxlet.2011.07.032; Baker ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046078; Ben Maamar M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117226; Bergman A., 2013, STATE SCI ENDOCRINE, DOI DOI 10.1016/J; Bian Q, 2006, FOOD CHEM TOXICOL, V44, P1355, DOI 10.1016/j.fct.2006.02.014; Blake CA, 1997, BIOL REPROD, V57, P255, DOI 10.1095/biolreprod57.2.255; Bloom MS, 2011, FERTIL STERIL, V96, P672, DOI 10.1016/j.fertnstert.2011.06.063; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Cantonwine D, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-62; Caserta D, 2013, GYNECOL ENDOCRINOL, V29, P444, DOI 10.3109/09513590.2012.758702; Chou WC, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-94; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cobellis L, 2009, BIOMED CHROMATOGR, V23, P1186, DOI 10.1002/bmc.1241; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Delfosse V, 2012, P NATL ACAD SCI USA, V109, P14930, DOI 10.1073/pnas.1203574109; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ehrlich S, 2012, ENVIRON HEALTH PERSP, V120, P978, DOI 10.1289/ehp.1104307; Ellmann S, 2009, CELL MOL LIFE SCI, V66, P2405, DOI 10.1007/s00018-009-0017-3; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Fang H, 2003, CHEM RES TOXICOL, V16, P1338, DOI 10.1021/tx030011g; Forti G, 1998, J CLIN ENDOCR METAB, V83, P4177, DOI 10.1210/jc.83.12.4177; Ghosh KS, 2009, BIOPOLYMERS, V91, P737, DOI 10.1002/bip.21220; Gurunath S, 2011, HUM REPROD UPDATE, V17, P575, DOI 10.1093/humupd/dmr015; Hao Junxia, 2011, Wei Sheng Yan Jiu, V40, P312; Hubbard S. J., 1993, TECHNICAL REPORT; Jung YW, 2005, TOXICOL SCI, V83, P78, DOI 10.1093/toxsci/kfi015; Kamel RM, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-21; Kandaraki E, 2011, J CLIN ENDOCR METAB, V96, pE480, DOI 10.1210/jc.2010-1658; Kitamura S, 2005, TOXICOL SCI, V84, P249, DOI 10.1093/toxsci/kfi074; Kolsek K, 2015, TOXICOL IN VITRO, V29, P8, DOI 10.1016/j.tiv.2014.08.009; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Laws SC, 2000, TOXICOL SCI, V54, P154, DOI 10.1093/toxsci/54.1.154; Lee HJ, 2003, TOXICOL SCI, V75, P40, DOI 10.1093/toxsci/kfg150; Li DK, 2011, FERTIL STERIL, V95, P625, DOI 10.1016/j.fertnstert.2010.09.026; Li DK, 2010, J ANDROL, V31, P500, DOI 10.2164/jandrol.110.010413; Luccio-Camelo DC, 2011, J STEROID BIOCHEM, V127, P74, DOI 10.1016/j.jsbmb.2011.04.004; Manfo FPT, 2014, REV ENVIRON CONTAM T, V228, P57, DOI 10.1007/978-3-319-01619-1_3; Marques-Pinto A, 2013, ENDOCR CONNECT, V2, DOI 10.1530/EC-13-0036; Meeker JD, 2010, REPROD TOXICOL, V30, P532, DOI 10.1016/j.reprotox.2010.07.005; Meeker JD, 2010, ENVIRON SCI TECHNOL, V44, P1458, DOI 10.1021/es9028292; Mendiola J, 2010, ENVIRON HEALTH PERSP, V118, P1286, DOI 10.1289/ehp.1002037; Miao MH, 2011, BIRTH DEFECTS RES A, V91, P867, DOI 10.1002/bdra.22845; Mok-Lin E, 2010, INT J ANDROL, V33, P385, DOI 10.1111/j.1365-2605.2009.01014.x; Mueller S.O., 2001, HDB ENV CHEM, P3; Myllymaki SA, 2005, TOXICOL APPL PHARM, V207, P59, DOI 10.1016/j.taap.2004.12.001; Oberpenning R, 2010, ANDROLOGY: MALE REPRODUCTIVE HEALTH AND DYSFUNCTION, THIRD EDITION, P521, DOI 10.1007/978-3-540-78355-8_25; Okuda K, 2010, TOXICOL LETT, V197, P7, DOI 10.1016/j.toxlet.2010.04.017; Patel S, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.130336; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pihlajamaa P., 2015, ENDOCR REV, V2015; Qiao Lili, 2010, Wei Sheng Yan Jiu, V39, P9; Rochester JR, 2013, REPROD TOXICOL, V42, P132, DOI 10.1016/j.reprotox.2013.08.008; Rubin BS, 2011, J STEROID BIOCHEM, V127, P27, DOI 10.1016/j.jsbmb.2011.05.002; Takeuchi T, 2004, ENDOCR J, V51, P165, DOI 10.1507/endocrj.51.165; Tang CY, 2012, BIOMED ENVIRON SCI, V25, P291, DOI 10.3967/0895-3988.2012.03.006; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang H, 2010, ASIAN J ANDROL, V12, P535, DOI 10.1038/aja.2010.14; Wang RX, 2003, J MED CHEM, V46, P2287, DOI 10.1021/jm0203783; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; Wang XX, 2013, ECOTOX ENVIRON SAFE, V89, P143, DOI 10.1016/j.ecoenv.2012.11.020; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; YI BY, 2013, MATH PROBL ENG, DOI DOI 10.1155/2013/; Yoshihara S, 2004, TOXICOL SCI, V78, P50, DOI 10.1093/toxsci/kfh047; Zheng Yan-min, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P841; Zhuang WL, 2015, ARCH ENVIRON CON TOX, V68, P38, DOI 10.1007/s00244-014-0078-7	67	39	41	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138438	10.1371/journal.pone.0138438	http://dx.doi.org/10.1371/journal.pone.0138438			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379041	gold, Green Published, Green Submitted			2022-12-27	WOS:000361769400100
J	Shukla, S; Shankar, E; Fu, PF; MacLennan, GT; Gupta, S				Shukla, Sanjeev; Shankar, Eswar; Fu, Pingfu; MacLennan, Gregory T.; Gupta, Sanjay			Suppression of NF-kappa B and NF-kappa B-Regulated Gene Expression by Apigenin through I kappa B alpha and IKK Pathway in TRAMP Mice	PLOS ONE			English	Article							PROSTATE-CANCER PROGRESSION; CONSTITUTIVE ACTIVATION; DIETARY FLAVONOIDS; INDUCED APOPTOSIS; PROGNOSTIC-SIGNIFICANCE; NUCLEAR-LOCALIZATION; TRANSCRIPTION FACTOR; DOWN-REGULATION; ANGIOGENESIS; BLOCKADE	Aberrant Nuclear Factor-kappa appaB (NF-kappa B) activation due to rapid I kappa B alpha turnover and high basal I kappa B alpha kinase (IKK) activity has been frequently observed in prostate cancer. Apigenin, a naturally occurring plant flavone, exhibits anti-proliferative, anti-inflammatory and anti-carcinogenic activities by inhibiting NF-kappa B pathway, through a mechanism not fully understood. We found that apigenin feeding in microgram doses (bioavailable in humans) inhibited prostate tumorigenesis in TRAMP mice by interfering with NF-kappa B signaling. Apigenin feeding to TRAMP mice (20 and 50 mu g/mouse/day, 6 days/week for 20 weeks) exhibited significant decrease in tumor volumes of the prostate and completely abolished metastasis, which correlated with inhibition of NF-kappa B activation and binding to the DNA. Apigenin intake blocked phosphorylation and degradation of I kappa B alpha by inhibiting IKK activation, which in turn led to suppression of NF-kappa B activation. The expression of NF-kappa B-regulated gene products involved in proliferation (cyclin D1, and COX-2), anti-apoptosis (Bcl-2 and Bcl-xL), and angiogenesis (vascular endothelial growth factor) were also downregulated after apigenin feeding. These events correlated with the induction of apoptosis in tumor cells, as evident by increased cleaved caspase-3 labeling index in the dorsolateral prostate. Our results provide convincing evidence that apigenin inhibits IKK activation and restores the expression of I kappa B alpha, preventing it's phosphorylation in a fashion similar to that elicited by IKK and proteasomal inhibitors through suppression of NF-kappa B signaling pathway.	[Shukla, Sanjeev; Shankar, Eswar; Gupta, Sanjay] Case Western Reserve Univ, Dept Urol, Cleveland, OH 44106 USA; [Shukla, Sanjeev; Shankar, Eswar; Gupta, Sanjay] Univ Hosp Case Med Ctr, Inst Urol, Cleveland, OH USA; [Fu, Pingfu] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [MacLennan, Gregory T.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Gupta, Sanjay] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Fu, Pingfu; Gupta, Sanjay] Case Comprehens Canc Ctr, Div Gen Med Sci, Cleveland, OH USA; [Gupta, Sanjay] Louis Stokes Cleveland Vet Affairs Med Ctr, Dept Urol, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Gupta, S (corresponding author), Case Western Reserve Univ, Dept Urol, Cleveland, OH 44106 USA.	sanjay.gupta@case.edu	Shankar, Eswar/E-5139-2015; Fu, Pingfu/O-5415-2019	Shankar, Eswar/0000-0001-8968-838X; Fu, Pingfu/0000-0002-2334-5218; MacLennan, Gregory T./0000-0003-0089-449X; Gupta, Sanjay/0000-0002-9492-3249	NATIONAL CANCER INSTITUTE [R01CA108512] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002494] Funding Source: NIH RePORTER; VA [5I01BX002494-03] Funding Source: Federal RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs); VA(US Department of Veterans Affairs)		Abu-Yousif AO, 2008, CANCER RES, V68, P3057, DOI 10.1158/0008-5472.CAN-07-2763; American Cancer Society, 2015, CANC FACTS FIG 2015; Bosetti C, 2006, NUTR CANCER, V56, P123, DOI 10.1207/s15327914nc5602_1; Chang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054318; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Cooks T, 2013, CANCER CELL, V23, P634, DOI 10.1016/j.ccr.2013.03.022; Sempere MC, 2008, CLIN TRANSL ONCOL, V10, P143, DOI 10.1007/s12094-008-0171-3; Das S, 2012, EXP BIOL MED, V237, P1433, DOI 10.1258/ebm.2012.012148; Domingo-Domenech J, 2005, BRIT J CANCER, V93, P1285, DOI 10.1038/sj.bjc.6602851; Fang J, 2007, CARCINOGENESIS, V28, P858, DOI 10.1093/carcin/bgl205; Fonseca Gilvan Neiva, 2004, Sao Paulo Med. J., V122, P124, DOI 10.1590/S1516-31802004000300009; Gasparian AV, 2009, CELL CYCLE, V8, P1559, DOI 10.4161/cc.8.10.8415; Gasparian AV, 2002, J CELL SCI, V115, P141; Gates MA, 2009, INT J CANCER, V124, P1918, DOI 10.1002/ijc.24151; Gonzalez-Vallinas M, 2013, NUTR REV, V71, P585, DOI 10.1111/nure.12051; Gradolatto A, 2005, DRUG METAB DISPOS, V33, P49, DOI 10.1124/dmd.104.000893; Hinz M, 1999, MOL CELL BIOL, V19, P2690; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hollman PCH, 1999, FOOD CHEM TOXICOL, V37, P937, DOI 10.1016/S0278-6915(99)00079-4; Hu M, 2003, J PHARMACOL EXP THER, V307, P314, DOI 10.1124/jpet.103.053496; Huang SY, 2001, ONCOGENE, V20, P4188, DOI 10.1038/sj.onc.1204535; Hussain AR, 2010, CELL PROLIFERAT, V43, P170, DOI 10.1111/j.1365-2184.2009.00662.x; Janssen PLTMK, 1998, AM J CLIN NUTR, V67, P255, DOI 10.1093/ajcn/67.2.255; Joyce D, 2001, CYTOKINE GROWTH F R, V12, P73, DOI 10.1016/S1359-6101(00)00018-6; Kallakury BVS, 1997, CANCER-AM CANCER SOC, V80, P753, DOI 10.1002/(SICI)1097-0142(19970815)80:4<753::AID-CNCR15>3.0.CO;2-S; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim BR, 2011, FOOD CHEM TOXICOL, V49, P1626, DOI 10.1016/j.fct.2011.04.015; Kim SH, 2013, MOL CELL ENDOCRINOL, V369, P130, DOI 10.1016/j.mce.2013.01.012; Kimura Y, 2010, FOOD CHEM TOXICOL, V48, P429, DOI 10.1016/j.fct.2009.10.041; Kumar M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068597; Kuo SH, 2012, GYNECOL ONCOL, V126, P245, DOI 10.1016/j.ygyno.2012.04.047; Kyle JAA, 2010, BRIT J NUTR, V103, P429, DOI 10.1017/S0007114509991784; Leclercq G, 2014, J STEROID BIOCHEM, V139, P237, DOI 10.1016/j.jsbmb.2012.12.010; Lee BH, 2015, EUR UROL, V67, P204, DOI 10.1016/j.eururo.2014.09.017; Lessard L, 2003, BJU INT, V91, P417, DOI 10.1046/j.1464-410X.2003.04104.x; Lessard L, 2006, CLIN CANCER RES, V12, P5741, DOI 10.1158/1078-0432.CCR-06-0330; Liang YC, 1999, CARCINOGENESIS, V20, P1945, DOI 10.1093/carcin/20.10.1945; Liu HD, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-98; Meyer H, 2006, ANN NUTR METAB, V50, P167, DOI 10.1159/000090736; Moon YJ, 2006, TOXICOL IN VITRO, V20, P187, DOI 10.1016/j.tiv.2005.06.048; Nielsen SE, 1999, BRIT J NUTR, V81, P447, DOI 10.1017/S000711459900080X; Pomerantz MM, 2011, CANCER PREV RES, V4, P719, DOI 10.1158/1940-6207.CAPR-10-0292; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Romagnolo Donato F., 2012, Journal of Nutrition in Gerontology and Geriatrics, V31, P206, DOI 10.1080/21551197.2012.702534; Ross JA, 2002, ANNU REV NUTR, V22, P19, DOI 10.1146/annurev.nutr.22.111401.144957; Ross JS, 2004, CLIN CANCER RES, V10, P2466, DOI 10.1158/1078-0432.CCR-0543-3; Ruela-de-Sousa RR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.18; Seo HS, 2012, MOL CELL BIOCHEM, V366, P319, DOI 10.1007/s11010-012-1310-2; Shukla S, 2005, PROSTATE, V64, P224, DOI 10.1002/pros.20217; Shukla S, 2004, NEOPLASIA, V6, P390, DOI 10.1593/neo.04112; Shukla S, 2004, CLIN CANCER RES, V10, P3169, DOI 10.1158/1078-0432.CCR-03-0586; Shukla S, 2008, FREE RADICAL BIO MED, V44, P1833, DOI 10.1016/j.freeradbiomed.2008.02.007; Shukla S, 2007, CANCER RES, V67, P6925, DOI 10.1158/0008-5472.CAN-07-0717; Shukla S, 2007, CELL CYCLE, V6, P1102, DOI 10.4161/cc.6.9.4146; Shukla S, 2014, APOPTOSIS, V19, P883, DOI 10.1007/s10495-014-0971-6; Shukla S, 2014, CARCINOGENESIS, V35, P452, DOI 10.1093/carcin/bgt316; Shukla S, 2010, PHARM RES-DORDR, V27, P962, DOI 10.1007/s11095-010-0089-7; Si DY, 2009, DRUG METAB DISPOS, V37, P629, DOI 10.1124/dmd.108.023416; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Suh JH, 2002, PROSTATE, V52, P183, DOI 10.1002/pros.10082; Sur I, 2008, INT REV IMMUNOL, V27, P205, DOI 10.1080/08830180802130319; Thakur VS, 2014, AAPS J, V16, P151, DOI 10.1208/s12248-013-9548-5; Tong X, 2013, ANTI-CANCER AGENT ME, V13, P971, DOI 10.2174/18715206113139990119; Vinall Ruth L., 2011, Hormones & Cancer, V2, P224, DOI 10.1007/s12672-011-0076-4; Yang SH, 2013, ONCOLOGY-BASEL, V85, P86, DOI 10.1159/000353452; Zhou YM, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-59	67	57	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138710	10.1371/journal.pone.0138710	http://dx.doi.org/10.1371/journal.pone.0138710			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379052	Green Published, gold, Green Submitted			2022-12-27	WOS:000361769400114
J	Smit, IPJ; Prins, HHT				Smit, Izak P. J.; Prins, Herbert H. T.			Predicting the Effects of Woody Encroachment on Mammal Communities, Grazing Biomass and Fire Frequency in African Savannas	PLOS ONE			English	Article							KRUGER-NATIONAL-PARK; IRREVERSIBLE VEGETATION CHANGE; DISTRIBUTION PATTERNS; PLANT ENCROACHMENT; BUSH ENCROACHMENT; SOUTH-AFRICA; LANDSCAPE; HETEROGENEITY; GRAZERS; TREES	With grasslands and savannas covering 20% of the world's land surface, accounting for 30-35% of worldwide Net Primary Productivity and supporting hundreds of millions of people, predicting changes in tree/grass systems is priority. Inappropriate land management and rising atmospheric CO2 levels result in increased woody cover in savannas. Although woody encroachment occurs world-wide, Africa's tourism and livestock grazing industries may be particularly vulnerable. Forecasts of responses of African wildlife and available grazing biomass to increases in woody cover are thus urgently needed. These predictions are hard to make due to non-linear responses and poorly understood feedback mechanisms between woody cover and other ecological responders, problems further amplified by the lack of long-term and large-scale datasets. We propose that a space-for-time analysis along an existing woody cover gradient overcomes some of these forecasting problems. Here we show, using an existing woody cover gradient (0-65%) across the Kruger National Park, South Africa, that increased woody cover is associated with (i) changed herbivore assemblage composition, (ii) reduced grass biomass, and (iii) reduced fire frequency. Furthermore, although increased woody cover is associated with reduced livestock production, we found indigenous herbivore biomass (excluding elephants) remains unchanged between 20-65% woody cover. This is due to a significant reorganization in the herbivore assemblage composition, mostly as a result of meso-grazers being substituted by browsers at increasing woody cover. Our results suggest that woody encroachment will have cascading consequences for Africa's grazing systems, fire regimes and iconic wildlife. These effects will pose challenges and require adaptation of livelihoods and industries dependent on conditions currently prevailing.	[Smit, Izak P. J.] Sci Serv, Skukuza, South Africa; [Smit, Izak P. J.] Univ Witwatersrand, Sch Anim Plant & Environm Sci, Ctr African Ecol, ZA-2050 Johannesburg, South Africa; [Prins, Herbert H. T.] Wageningen UR, Resource Ecol Grp, Wageningen, Netherlands	University of Witwatersrand; Wageningen University & Research	Smit, IPJ (corresponding author), Sci Serv, South African Natl Parks, Skukuza, South Africa.	izak.smit@sanparks.org		Prins, Herbert/0000-0003-1131-5107				Anadon JD, 2014, P NATL ACAD SCI USA, V111, P12948, DOI 10.1073/pnas.1320585111; Asner GP, 2007, J APPL REMOTE SENS, V1, DOI 10.1117/1.2794018; BENSHAHAR R, 1992, ECOL APPL, V2, P95, DOI 10.2307/1941892; Bond WJ, 2012, PHILOS T R SOC B, V367, P601, DOI 10.1098/rstb.2011.0182; Bond WJ, 2008, ANNU REV ECOL EVOL S, V39, P641, DOI 10.1146/annurev.ecolsys.39.110707.173411; Bothma JDP, 2004, WILDLIFE SOC B, V32, P840, DOI 10.2193/0091-7648(2004)032[0840:UDAPRT]2.0.CO;2; Browne C., 2011, VELD FLORA, V97, P62; Bucini G., 2011, ECOSYSTEM FUNCTION S, P219; Buitenwerf R, 2012, GLOBAL CHANGE BIOL, V18, P675, DOI 10.1111/j.1365-2486.2011.02561.x; CACHIER H, 1995, J ATMOS CHEM, V22, P123, DOI 10.1007/BF00708185; Codron J, 2006, J MAMMAL, V87, P27, DOI 10.1644/05-MAMM-A-017R1.1; CREEL S, 1995, ANIM BEHAV, V50, P1325, DOI 10.1016/0003-3472(95)80048-4; Cromsigt JPGM, 2006, ECOLOGY, V87, P1532, DOI 10.1890/0012-9658(2006)87[1532:RPASGM]2.0.CO;2; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; de Knegt HJ, 2011, J ANIM ECOL, V80, P270, DOI 10.1111/j.1365-2656.2010.01764.x; du Toit J.T., 2003, KRUGER EXPERIENCE EC; du Toit JT, 2014, CONSERV SC PR SER, V14, P30; Edenhofer O., 2014, CONTRIBUTION WORKING; Eldridge DJ, 2006, ECOL LETT, V14, P709; Gillson L, 2015, ECOL COMPLEX, V21, P78, DOI 10.1016/j.ecocom.2014.12.005; Gordon Iain J., 2008, V195, P309, DOI 10.1007/978-3-540-72422-3_12; Govender N, 2012, AFR J RANGE FOR SCI, V29, P63, DOI 10.2989/10220119.2012.697918; Gray EF, 2013, KOEDOE, V55, DOI 10.4102/koedoe.v55i1.1106; Higgins SI, 2000, J ECOL, V88, P213, DOI 10.1046/j.1365-2745.2000.00435.x; House JI, 2003, J BIOGEOGR, V30, P1763, DOI 10.1046/j.1365-2699.2003.00873.x; Kulmatiski Andrew, 2013, Oecologia, V171, P25, DOI 10.1007/s00442-012-2390-0; Loarie SR, 2013, ANIM BEHAV, V85, P899, DOI 10.1016/j.anbehav.2013.01.018; Ludwig F, 2003, OECOLOGIA, V134, P293, DOI 10.1007/s00442-002-1119-x; Mills MGL, WILDLIFE RES, V195, P75; Moleele NM, 2002, J ENVIRON MANAGE, V64, P3, DOI 10.1006/jema.2001.0486; Moncrieff GR, 2014, NEW PHYTOL, V201, P908, DOI 10.1111/nph.12551; O'Connor TG, 2014, AFR J RANGE FOR SCI, V31, P67, DOI 10.2989/10220119.2014.939996; Owen-Smith N, 2008, ECOLOGY, V89, P1120, DOI 10.1890/07-0970.1; Parr CL, 2003, AUSTRAL ECOL, V28, P384, DOI 10.1046/j.1442-9993.2003.01296.x; Prins Herbert H.T., 2000, Conservation Biology Series (Dordrecht), V12, P51; PRINS HHT, 1990, OECOLOGIA, V83, P392, DOI 10.1007/BF00317566; Radloff FGT, 2004, J ANIM ECOL, V73, P410, DOI 10.1111/j.0021-8790.2004.00817.x; Ratajczak Z, 2012, ECOLOGY, V93, P697, DOI 10.1890/11-1199.1; Redfern JV, 2002, S AFR J SCI, V98, P455; Rietkerk M, 2002, AM NAT, V160, P524, DOI 10.1086/342078; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Seydack A. H., 2012, Koedoe, V54, P1047; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; Skinner JD, 2000, THE MAMMALS OF THE S; Smit IPJ, 2007, BIOL CONSERV, V136, P85, DOI 10.1016/j.biocon.2006.11.009; Smit IPJ, 2013, ECOGRAPHY, V36, P447, DOI 10.1111/j.1600-0587.2012.07555.x; Smit IPJ, 2011, ECOGRAPHY, V34, P67, DOI 10.1111/j.1600-0587.2010.06029.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Trollope W. S. W., 1986, Journal of the Grassland Society of Southern Africa, V3, P148; van de Koppel J, 2002, AM NAT, V159, P209, DOI 10.1086/324791; van de Koppel J, 2000, OIKOS, V90, P253, DOI 10.1034/j.1600-0706.2000.900205.x; van Langevelde F, 2003, ECOLOGY, V84, P337, DOI 10.1890/0012-9658(2003)084[0337:EOFAHO]2.0.CO;2; Venter F.J., 2003, KRUGER EXPERIENCE EC, P83, DOI DOI 10.2989/10220110409485835; Wessels KJ, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014007; Whyte Ian J., 2003, P332; Wigley BJ, 2010, GLOBAL CHANGE BIOL, V16, P964, DOI 10.1111/j.1365-2486.2009.02030.x	57	53	54	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137857	10.1371/journal.pone.0137857	http://dx.doi.org/10.1371/journal.pone.0137857			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379249	Green Published, gold, Green Submitted			2022-12-27	WOS:000361769400032
J	Wang, WJ; Mandel, J; Bouaziz, J; Commenges, D; Nabirotchkine, S; Chumakov, I; Cohen, D; Guedj, M				Wang, Wenjia; Mandel, Jonas; Bouaziz, Jan; Commenges, Daniel; Nabirotchkine, Serguei; Chumakov, Ilya; Cohen, Daniel; Guedj, Mickael		Alzheimer's Dis Neuroimaging Initi	A Multi-Marker Genetic Association Test Based on the Rasch Model Applied to Alzheimer's Disease	PLOS ONE			English	Article							WHOLE-GENOME ASSOCIATION; PATHWAY ANALYSIS; GLUCOSE-METABOLISM; MAMMALIAN TARGET; WIDE ASSOCIATION; SUSCEPTIBILITY; SET; CHOLESTEROL; REGULATOR; MIGRATION	Results from Genome-Wide Association Studies (GWAS) have shown that the genetic basis of complex traits often include many genetic variants with small to moderate effects whose identification remains a challenging problem. In this context multi-marker analysis at the gene and pathway level can complement traditional point-wise approaches that treat the genetic markers individually. In this paper we propose a novel statistical approach for multi-marker analysis based on the Rasch model. The method summarizes the categorical genotypes of SNPs by a generalized logistic function into a genetic score that can be used for association analysis. Through different sets of simulations, the false-positive rate and power of the proposed approach are compared to a set of existing methods, and shows good performances. The application of the Rasch model on Alzheimer's Disease (AD) ADNI GWAS dataset also allows a coherent interpretation of the results. Our analysis supports the idea that APOE is a major susceptibility gene for AD. In the top genes selected by proposed method, several could be functionally linked to AD. In particular, a pathway analysis of these genes also highlights the metabolism of cholesterol, that is known to play a key role in AD pathogenesis. Interestingly, many of these top genes can be integrated in a hypothetic signalling network.	[Wang, Wenjia; Mandel, Jonas; Bouaziz, Jan; Nabirotchkine, Serguei; Chumakov, Ilya; Cohen, Daniel; Guedj, Mickael] Pharnext, Issy Les Moulineaux, Ile De France, France; [Wang, Wenjia; Commenges, Daniel] Univ Bordeaux, INSERM, U897, Bordeaux, Aquitaine, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Wang, WJ (corresponding author), Pharnext, Issy Les Moulineaux, Ile De France, France.	wenjia.wang@pharnext.com	Commenges, Daniel/T-6536-2019		Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; NATIONAL INSTITUTE ON AGING [U01AG024904] Funding Source: NIH RePORTER	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DOD ADNI (Department of Defense); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). Pharnext provided support in the form of salaries for authors WW, MG, JM, JB, D. Cohen, SN, and IC but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Allison AC, 2001, MED HYPOTHESES, V57, P151, DOI 10.1054/mehy.2001.1307; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andrich D, 2000, RUMM A WINDOWS BASED; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Blazquez E, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00161; Bouaziz Matthieu, 2012, Methods Mol Biol, V888, P213, DOI 10.1007/978-1-61779-870-2_13; Bouaziz M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028845; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Caccamo A, 2014, J NEUROSCI, V34, P7988, DOI 10.1523/JNEUROSCI.0777-14.2014; Carbonetto P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003770; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Chen ZC, 2013, PROG NEUROBIOL, V108, P21, DOI 10.1016/j.pneurobio.2013.06.004; Chumakov I, 2015, SCI REP-UK, V5, DOI 10.1038/srep07608; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Corneveaux JJ, 2010, HUMAN MOLECULAR GENE; Crameri A, 2006, EMBO J, V25, P432, DOI 10.1038/sj.emboj.7600938; El Hour M, 2010, ONCOGENE, V29, P3025, DOI 10.1038/onc.2010.49; Eleftherohorinou H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008068; Evangelou M, 2014, GENET EPIDEMIOL, V38, P661, DOI 10.1002/gepi.21853; Evangelou M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041018; Fridley BL, 2011, EUR J HUM GENET, V19, P837, DOI 10.1038/ejhg.2011.57; Gama L, 2001, J BIOL CHEM, V276, P39053, DOI 10.1074/jbc.M105662200; Gil OD, 1998, J NEUROSCI, V18, P9312; Gomes CM, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/487534; Guedj M, 2006, STATISTICAL APPLICAT, V5, DOI [10.2202/1544-6115.1192, DOI 10.2202/1544-6115.1192]; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hobart JC, 2007, LANCET NEUROL, V6, P1094, DOI 10.1016/S1474-4422(07)70290-9; Hong MG, 2009, HUM GENET, V126, P289, DOI 10.1007/s00439-009-0676-z; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang GR, 2011, J CLIN INVEST, V121, P769, DOI 10.1172/JCI45096; Jorgenson E, 2006, NAT REV GENET, V7, P885, DOI 10.1038/nrg1962; Lee JH, 2011, ARCH NEUROL-CHICAGO, V68, P320, DOI 10.1001/archneurol.2010.292; Lehne B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020133; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Maiese K, 2014, ANN MED, V46, P587, DOI 10.3109/07853890.2014.941921; Mason BJ, 2001, J CLIN PSYCHIAT, V62, P42; Moncada-Pazos A, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.408625; Morote-Garcia JC, 2012, P NATL ACAD SCI USA, V109, P14146, DOI 10.1073/pnas.1202165109; Moskvina V, 2011, GENET EPIDEMIOL, V35, P861, DOI 10.1002/gepi.20636; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Oba S, 2003, BIOINFORMATICS, V19, P2088, DOI 10.1093/bioinformatics/btg287; Olah J, 2011, J BIOL CHEM, V286, P34088, DOI 10.1074/jbc.M111.243907; Pan W, 2009, GENET EPIDEMIOL, V33, P497, DOI 10.1002/gepi.20402; Pan Y, 2011, PROG NEURO-PSYCHOPH, V35, P154, DOI 10.1016/j.pnpbp.2010.10.016; Pasterkamp RJ, 2009, CURR OPIN NEUROBIOL, V19, P263, DOI 10.1016/j.conb.2009.06.001; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Huy PDQ, 2013, BBA-GEN SUBJECTS, V1830, P2960, DOI 10.1016/j.bbagen.2012.12.026; Potkin SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006501; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rasch G, 1960, STUDIES IN MATHEMATI; Rogaeva E, 2002, NEUROMOL MED, V2, P1, DOI 10.1385/NMM:2:1:01; Rubin DB, 2004, MULTIPLE IMPUTATION, V81; Salek RM, 2010, NEUROCHEM INT, V56, P937, DOI 10.1016/j.neuint.2010.04.001; Scart-Gres C, 2014, THE JOURNAL OF PREVE, V1, P232; Schwender H, 2012, J TOXICOL ENV HEAL A, V75, P438, DOI 10.1080/15287394.2012.674910; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Shiba S, 2014, BIOCHEM BIOPH RES CO, V453, P350, DOI 10.1016/j.bbrc.2014.09.091; Stefani M, 2009, CURR ALZHEIMER RES, V6, P15, DOI 10.2174/156720509787313899; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suh JM, 2007, CELL METAB, V6, P195, DOI 10.1016/j.cmet.2007.08.001; Sun JP, 2014, ELECTRON J DIFFER EQ, P1; Suzuki K, 2007, NATURE, V446, P680, DOI 10.1038/nature05652; Tcherkezian J, 2014, GENE DEV, V28, P357, DOI 10.1101/gad.231407.113; Tharmalingam S, 2011, J BIOL CHEM, V286, P40922, DOI 10.1074/jbc.M111.265454; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Van Gassen G, 1999, NEUROBIOL DIS, V6, P376, DOI 10.1006/nbdi.1999.0265; Wang T, 2007, AM J HUM GENET, V80, P353, DOI 10.1086/511312; Weale ME, 2010, METHODS MOL BIOL, V628, P341, DOI 10.1007/978-1-60327-367-1_19; Westhofen P, 2011, J BIOL CHEM, V286, P15085, DOI 10.1074/jbc.M110.210971; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Woods A., 1985, LANG TEST, V2, P117, DOI [10.1177/ 026553228500200202, DOI 10.1177/026553228500200202, 10.1177/026553228500200202]; Wright B. D., 1982, RATING SCALE ANALYSI; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu YL, 2015, NEUROBIOL AGING, V36, P169, DOI 10.1016/j.neurobiolaging.2014.07.029	82	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138223	10.1371/journal.pone.0138223	http://dx.doi.org/10.1371/journal.pone.0138223			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379234	Green Submitted, Green Published, gold			2022-12-27	WOS:000361769400067
J	Alehagen, U; Lindahl, TL; Aaseth, J; Svensson, E; Johansson, P				Alehagen, Urban; Lindahl, Tomas L.; Aaseth, Jan; Svensson, Erland; Johansson, Peter			Levels of sP-selectin and hs-CRP Decrease with Dietary Intervention with Selenium and Coenzyme Q10 Combined: A Secondary Analysis of a Randomized Clinical Trial	PLOS ONE			English	Article							C-REACTIVE PROTEIN; OXIDATIVE STRESS; SERUM SELENIUM; HEART-FAILURE; CARDIOVASCULAR-DISEASE; THIOREDOXIN REDUCTASE; SYSTEMIC INFLAMMATION; DIASTOLIC DYSFUNCTION; GENE-EXPRESSION; SELENOPROTEIN-P	Background/Objectives Inflammation and oxidative stress are central in many disease states. The major anti-oxidative enzymes contain selenium. The selenium intake in Europe is low, and supplementation with selenium and coenzyme Q(10) , important anti-oxidants, was evaluated in a previous study. The aim of this study was to evaluate response on the inflammatory biomarkers C-reactive protein, and sP-selectin, and their possible impact on cardiovascular mortality. Subjects/Methods 437 elderly individuals were included in the study. Clinical examination, echocardiography, electrocardiography and blood samples were drawn. The intervention time was 48 months, and median follow-up was 5.2 years. The effects on inflammation/atherosclerosis were evaluated through analyses of CRP and sP-selectin. Evaluations of the effect of the intervention was performed using repeated measures of variance. All mortality was registered, and endpoints of mortality were assessed by Kaplan-Meier plots. Results The placebo group showed a CRP level of 4.8 ng/mL at the start, and 5.1 ng/mL at the study end. The active supplementation group showed a CRP level of 4.1 ng/mL at the start, and 2.1 ng/mL at the study end. SP-selectin exhibited a level of 56.6mg/mL at the start in the placebo group and 72.3 mg/mL at the study end, and in the active group the corresponding figures were 55.9 mg/mL and 58.0 mg/mL. A significantly smaller increase was demonstrated through repeated measurements of the two biomarkers in those on active supplementation. Active supplementation showed an effect on the CRP and sP-selectin levels, irrespective of the biomarker levels. Reduced cardiovascular mortality was demonstrated in both those with high and low levels of CRP and sP-selectin in the active supplementation group. Conclusion CRP and sP-selectin showed significant changes reflecting effects on inflammation and atherosclerosis in those given selenium and coenzyme Q(10) combined. A reduced cardiovascular mortality could be demonstrated in the active group, irrespective of biomarker level. This result should be regarded as hypothesis-generating, and it is hoped it will stimulate more research in the area.	[Alehagen, Urban; Johansson, Peter] Linkoping Univ, Dept Cardiol, Linkoping, Sweden; [Alehagen, Urban; Johansson, Peter] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Lindahl, Tomas L.] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Lindahl, Tomas L.] Cty Council Ostergotlan, Dept Clin Chem, Linkoping, Sweden; [Aaseth, Jan] Innlandet Hosp Trust, Res Dept, Tromso, Norway; [Aaseth, Jan] Hedmark Univ Coll, Tromso, Norway; [Svensson, Erland] Swedish Def Res Agcy, Stockholm, Sweden	Linkoping University; Linkoping University; Linkoping University; City Council Ostergotland; Innlandet Hospital Trust; Inland Norway University of Applied Sciences; Saab Group	Alehagen, U (corresponding author), Linkoping Univ, Dept Cardiol, Linkoping, Sweden.	urban.alehagen@liu.se	Lindahl, Tomas L/H-5150-2012; Johansson, Peter/ABH-4364-2020; Aaseth, Jan/J-6764-2017	Lindahl, Tomas L/0000-0003-0174-8152; Aaseth, Jan/0000-0002-7518-5703	County Council of Ostergotland, Linkoping University	County Council of Ostergotland, Linkoping University	This work was supported by the County Council of Ostergotland, Linkoping University. The funder had no role in the design, management, analysis, interpretation of the data, preparation, review or approval of the manuscript.	Abramson JL, 2005, ATHEROSCLEROSIS, V178, P115, DOI 10.1016/j.atherosclerosis.2004.08.007; Akbaraly NT, 2005, CLIN CHEM, V51, P2117, DOI 10.1373/clinchem.2005.055301; Alehagen U, 2016, EUR J CLIN NUTR, V70, P91, DOI 10.1038/ejcn.2015.92; Alehagen U, 2015, CARDIOVASC ENDOCRINO, V4, P22, DOI 10.1097/XCE.0000000000000042; Alehagen U, 2013, INT J CARDIOL, V167, P1860, DOI 10.1016/j.ijcard.2012.04.156; Alissa EM, 2003, MED SCI MONITOR, V9, pRA9; Arteel GE, 1999, FEBS LETT, V445, P226, DOI 10.1016/S0014-5793(99)00073-3; Askevold Erik Tandberg, 2014, Curr Heart Fail Rep, V11, P146, DOI 10.1007/s11897-014-0185-9; Brigelius-Flohe R, 2003, ANTIOXID REDOX SIGN, V5, P205, DOI 10.1089/152308603764816569; Chen W., 2013, CHINESE J ECOL, V6, P36, DOI DOI 10.4103/2319-4170.113231; Duran-Prado M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109223; Eaton CB, 2010, ATHEROSCLEROSIS, V212, P689, DOI 10.1016/j.atherosclerosis.2010.07.008; Fairweather-Tait SJ, 2011, ANTIOXID REDOX SIGN, V14, P1337, DOI 10.1089/ars.2010.3275; Gao Y, 2006, CYTOKINE, V33, P246, DOI 10.1016/j.cyto.2006.02.005; Glezeva N, 2015, J CARD FAIL, V21, P167, DOI 10.1016/j.cardfail.2014.11.004; Guarner V, 2015, INTERD T GERONT GERI, V40, P99, DOI 10.1159/000364934; Hayashi S, 2000, CIRCULATION, V102, P1710, DOI 10.1161/01.CIR.102.14.1710; Hurst R, 2010, AM J CLIN NUTR, V91, P923, DOI 10.3945/ajcn.2009.28169; Johansson P, 2013, SCAND CARDIOVASC J, V47, P281, DOI 10.3109/14017431.2013.820838; KALEN A, 1989, LIPIDS, V24, P579, DOI 10.1007/BF02535072; Kalogeropoulos AP, 2014, J CARD FAIL, V20, P319, DOI 10.1016/j.cardfail.2014.02.002; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Lee BJ, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-142; Lee BJ, 2012, NUTRITION, V28, P250, DOI 10.1016/j.nut.2011.06.004; Lewin MH, 2002, BBA-MOL CELL RES, V1593, P85, DOI 10.1016/S0167-4889(02)00333-6; Libby P, 2014, CIRC RES, V114, P1867, DOI 10.1161/CIRCRESAHA.114.302699; Manzanares W, 2009, INTENS CARE MED, V35, P882, DOI 10.1007/s00134-008-1356-5; Matera G, 2013, CRIT CARE, V17, DOI 10.1186/cc12596; Matsubara J, 2011, J AM COLL CARDIOL, V57, P861, DOI 10.1016/j.jacc.2010.10.018; Adame EM, 2012, NUTR HOSP, V27, P524, DOI [10.3305/nh.2012.27.2.5529, 10.1590/S0212-16112012000200026]; Navas-Acien A, 2008, CURR OPIN LIPIDOL, V19, P43, DOI 10.1097/MOL.0b013e3282f2b261; NEVE J, 1991, EXPERIENTIA, V47, P187, DOI 10.1007/BF01945424; NORMAN JA, 1991, BIOCHEM BIOPH RES CO, V175, P22, DOI 10.1016/S0006-291X(05)81194-5; Onur Simone, 2014, BMC Res Notes, V7, P427, DOI 10.1186/1756-0500-7-427; Rafieian-Kopaei M, 2014, INT J PREVENTIVE MED, V5, P927; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Rees K, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009671.pub2; SALONEN JT, 1982, LANCET, V2, P175; Sanoobar M, 2015, NUTR NEUROSCI, V18, P169, DOI 10.1179/1476830513Y.0000000106; Shantsila E, 2015, INT J CARDIOL, V185, P322, DOI 10.1016/j.ijcard.2015.03.105; Stranges S, 2006, AM J EPIDEMIOL, V163, P694, DOI 10.1093/aje/kwj097; SUADICANI P, 1992, ATHEROSCLEROSIS, V96, P33, DOI 10.1016/0021-9150(92)90035-F; Traulsen H, 2004, FREE RADICAL RES, V38, P123, DOI 10.1080/10715760320001634852; Venardos KM, 2007, CURR MED CHEM, V14, P1539, DOI 10.2174/092986707780831078; Vunta H, 2008, MOL NUTR FOOD RES, V52, P1316, DOI 10.1002/mnfr.200700346; Vunta H, 2007, J BIOL CHEM, V282, P17964, DOI 10.1074/jbc.M703075200; Wallby L, 2013, CARDIOL RES PRACT, V2013, DOI 10.1155/2013/895215; Xia L, 2003, J BIOL CHEM, V278, P2141, DOI 10.1074/jbc.M210456200; Xia YM, 2010, AM J CLIN NUTR, V92, P525, DOI 10.3945/ajcn.2010.29642; Zamani P, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.003103	50	37	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137680	10.1371/journal.pone.0137680	http://dx.doi.org/10.1371/journal.pone.0137680			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375288	gold, Green Submitted, Green Published			2022-12-27	WOS:000361610200048
J	Marneweck, M; Knelange, E; Lee-Miller, T; Santello, M; Gordon, AM				Marneweck, Michelle; Knelange, Elisabeth; Lee-Miller, Trevor; Santello, Marco; Gordon, Andrew M.			Generalization of Dexterous Manipulation Is Sensitive to the Frame of Reference in Which It Is Learned	PLOS ONE			English	Article							CENTER-OF-MASS; OBJECT MANIPULATION; SENSORIMOTOR MEMORY; PRECISION GRIP; ANTICIPATORY CONTROL; FINGERTIP FORCES; GRASP STABILITY; MOTOR; REPRESENTATIONS; ADAPTATION	Studies have shown that internal representations of manipulations of objects with asymmetric mass distributions that are generated within a specific orientation are not generalizable to novel orientations, i.e., subjects fail to prevent object roll on their first grasp-lift attempt of the object following 180 degrees object rotation. This suggests that representations of these manipulations are specific to the reference frame in which they are formed. However, it is unknown whether that reference frame is specific to the hand, the body, or both, because rotating the object 180 degrees modifies the relation between object and body as well as object and hand. An alternative, untested explanation for the above failure to generalize learned manipulations is that any rotation will disrupt grasp performance, regardless if the reference frame in which the manipulation was learned is maintained or modified. We examined the effect of rotations that (1) maintain and (2) modify relations between object and body, and object and hand, on the generalizability of learned two-digit manipulation of an object with an asymmetric mass distribution. Following rotations that maintained the relation between object and body and object and hand (e.g., rotating the object and subject 180 degrees), subjects continued to use appropriate digit placement and load force distributions, thus generating sufficient compensatory moments to minimize object roll. In contrast, following rotations that modified the relation between (1) object and hand (e.g. rotating the hand around to the opposite object side), (2) object and body (e.g. rotating subject and hand 180 degrees), or (3) both (e.g. rotating the subject 180 degrees), subjects used the same, yet inappropriate digit placement and load force distribution, as those used prior to the rotation. Consequently, the compensatory moments were insufficient to prevent large object rolls. These findings suggest that representations of learned manipulation of objects with asymmetric mass distributions are specific to the body-and hand-reference frames in which they were learned.	[Marneweck, Michelle; Lee-Miller, Trevor; Gordon, Andrew M.] Columbia Univ, Teachers Coll, Dept Biobehav Sci, New York, NY 10027 USA; [Knelange, Elisabeth] Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst, Amsterdam, North Holland, Netherlands; [Santello, Marco] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ USA	Columbia University; Columbia University Teachers College; Vrije Universiteit Amsterdam; Arizona State University; Arizona State University-Tempe	Marneweck, M (corresponding author), Columbia Univ, Teachers Coll, Dept Biobehav Sci, New York, NY 10027 USA.	michelle.marneweck@uwa.edu.au		Marneweck, Michelle/0000-0002-3953-5956; Knelange, Elisabeth/0000-0002-4133-5136; Gordon, Andrew/0000-0003-1041-0479	National Science Foundation (NSF) [BCS-1153034, BCS 1152916]; Direct For Social, Behav & Economic Scie [1152916] Funding Source: National Science Foundation; Division Of Behavioral and Cognitive Sci [1153034] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This research was supported by a Collaborative Research Grant BCS-1153034 (MS) and BCS 1152916 (AG) from the National Science Foundation (NSF; http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert F, 2009, NEUROSCI LETT, V463, P188, DOI 10.1016/j.neulet.2009.07.080; Berniker M, 2014, J NEUROPHYSIOL, V112, P2791, DOI 10.1152/jn.00615.2013; Berniker M, 2014, J NEUROPHYSIOL, V111, P1165, DOI 10.1152/jn.00493.2013; Bursztyn LLCD, 2008, EXP BRAIN RES, V184, P127, DOI 10.1007/s00221-007-1173-z; Caithness G, 2004, J NEUROSCI, V24, P8662, DOI 10.1523/JNEUROSCI.2214-04.2004; Craje C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076855; EDIN BB, 1992, J PHYSIOL-LONDON, V450, P547, DOI 10.1113/jphysiol.1992.sp019142; Flanagan JR, 2000, NAT NEUROSCI, V3, P737, DOI 10.1038/76701; Fu QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108222; Fu QS, 2011, J NEUROSCI, V31, P13576, DOI 10.1523/JNEUROSCI.1143-11.2011; Fu QS, 2010, J NEUROSCI, V30, P9117, DOI 10.1523/JNEUROSCI.4159-09.2010; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; Goodbody SJ, 1998, J NEUROPHYSIOL, V79, P1825, DOI 10.1152/jn.1998.79.4.1825; GORDON AM, 1991, EXP BRAIN RES, V83, P477; GORDON AM, 1991, EXP BRAIN RES, V83, P483; GORDON AM, 1993, J NEUROPHYSIOL, V69, P1789, DOI 10.1152/jn.1993.69.6.1789; Gordon AM, 2004, P ANN INT IEEE EMBS, V26, P4641; Haruno M, 2001, NEURAL COMPUT, V13, P2201, DOI 10.1162/089976601750541778; Ingram JN, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002196; Ingram JN, 2010, CURR BIOL, V20, P618, DOI 10.1016/j.cub.2010.01.054; Jenmalm P, 1998, J NEUROPHYSIOL, V79, P1643, DOI 10.1152/jn.1998.79.4.1643; Jenmalm P, 1997, J NEUROSCI, V17, P4486; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; Johansson RS, 1999, EXP BRAIN RES, V128, P20, DOI 10.1007/s002210050813; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P59; Krakauer J, 1996, DIFFERENCES GEN ADAP, P899; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; Lee JY, 2009, J NEUROSCI, V29, P10396, DOI 10.1523/JNEUROSCI.1294-09.2009; Lukos J, 2007, J NEUROSCI, V27, P3894, DOI 10.1523/JNEUROSCI.4693-06.2007; Lukos JR, 2008, J NEUROSCI, V28, P12765, DOI 10.1523/JNEUROSCI.4335-08.2008; Mattar AAG, 2007, J NEUROPHYSIOL, V98, P3321, DOI 10.1152/jn.00576.2007; Miall RC, 2004, EXP BRAIN RES, V154, P201, DOI 10.1007/s00221-003-1630-2; Sainburg RL, 1999, J NEUROPHYSIOL, V81, P1045, DOI 10.1152/jn.1999.81.3.1045; Salimi I, 2003, EXP BRAIN RES, V150, P9, DOI 10.1007/s00221-003-1394-8; Salimi I, 2000, J NEUROPHYSIOL, V84, P2390, DOI 10.1152/jn.2000.84.5.2390; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Wing AM, 1998, J EXP PSYCHOL HUMAN, V24, P1571, DOI 10.1037/0096-1523.24.6.1571; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Zhang W, 2010, J NEUROPHYSIOL, V103, P2953, DOI 10.1152/jn.00140.2010	40	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138258	10.1371/journal.pone.0138258	http://dx.doi.org/10.1371/journal.pone.0138258			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376089	gold, Green Published, Green Submitted			2022-12-27	WOS:000361610200094
J	Philip, P; Micoulaud-Franchi, JA; Lagarde, E; Taillard, J; Canel, A; Sagaspe, P; Bioulac, S				Philip, Pierre; Micoulaud-Franchi, Jean-Arthur; Lagarde, Emmanuel; Taillard, Jacques; Canel, Annick; Sagaspe, Patricia; Bioulac, Stephanie			Attention Deficit Hyperactivity Disorder Symptoms, Sleepiness and Accidental Risk in 36140 Regularly Registered Highway Drivers	PLOS ONE			English	Article							RESTLESS LEGS SYNDROME; DRIVING-RELATED RISKS; YOUNG-ADULT DRIVERS; DEFICIT/HYPERACTIVITY-DISORDER; GENERAL-POPULATION; DAYTIME SLEEPINESS; DOUBLE-BLIND; LISDEXAMFETAMINE DIMESYLATE; INTERNATIONAL SURVEY; EXTENDED-RELEASE	Background Attention Deficit Hyperactivity Disorder (ADHD) is a frequent neurodevelopmental disorder that increases accidental risk. Recent studies show that some patients with ADHD can also suffer from excessive daytime sleepiness but there are no data assessing the role of sleepiness in road safety in patients with ADHD. We conducted an epidemiological study to explore sleep complaints, inattention and driving risks among automobile drivers. Methods and Findings From August to September 2014, 491186 regular highway users were invited to participate in an Internet survey on driving habits. 36140 drivers answered a questionnaire exploring driving risks, sleep complaints, sleepiness at the wheel, ADHD symptoms (Adult ADHD Self-Report Scale) and distraction at the wheel. 1.7% of all drivers reported inattention-related driving accidents and 0.3% sleep-related driving accidents in the previous year. 1543 drivers (4.3%) reported ADHD symptoms and were more likely to report accidents than drivers without ADHD symptoms (adjusted OR = 1.24, [1.03-1.51], p < .021). 14.2% of drivers with ADHD symptoms reported severe excessive daytime sleepiness (Epworth Sleepiness Scale >15) versus 3.2% of drivers without ADHD symptoms and 20.5% reported severe sleepiness at the wheel versus 7.3%. Drivers with ADHD symptoms reported significantly more sleep-related (adjusted OR = 1.4, [1.21-1.60], p < .0001) and inattentionrelated (adjusted OR = 1.9, [1.71-2.14], p < 0001) near misses than drivers without ADHD symptoms. The fraction of near-misses attributable to severe sleepiness at the wheel was 4.24% for drivers without ADHD symptoms versus 10,35% for drivers with ADHD symptoms. Conclusion Our study shows that drivers with ADHD symptoms have more accidents and a higher level of sleepiness at the wheel than drivers without ADHD symptoms. Drivers with ADHD symptoms report more sleep-related and inattention-related near misses, thus confirming the clinical importance of exploring both attentional deficits and sleepiness at the wheel in these drivers. Road safety campaigns should be improved to better inform drivers of these accidental risks.	[Philip, Pierre; Micoulaud-Franchi, Jean-Arthur; Taillard, Jacques; Sagaspe, Patricia] CHU Bordeaux, Clin Sommeil, Serv Explorat Fonct Syst Nerveux, F-33076 Bordeaux, France; [Philip, Pierre; Micoulaud-Franchi, Jean-Arthur; Taillard, Jacques; Sagaspe, Patricia; Bioulac, Stephanie] Univ Bordeaux, CHU Pellegrin, USR CNRS SANPSY 3413, F-33000 Bordeaux, France; [Lagarde, Emmanuel] Univ Bordeaux, Equipe PPCT, ISPED, INSERM U897, F-33000 Bordeaux, France; [Canel, Annick] Assoc Soc Francaises Autoroutes, Paris, France; [Bioulac, Stephanie] Ctr Hosp Charles Perrens, Pole Univ Psychiat Enfants & Adolescents, F-33076 Bordeaux, France	CHU Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Bioulac, S (corresponding author), Univ Bordeaux, CHU Pellegrin, USR CNRS SANPSY 3413, F-33000 Bordeaux, France.	stephaniebioulac@hotmail.com	PHILIP, Pierre/AAS-8889-2020; Taillard, Jacques/H-5063-2018; Lagarde, Emmanuel/F-7132-2013	PHILIP, Pierre/0000-0003-3267-634X; Taillard, Jacques/0000-0001-9067-8189; Lagarde, Emmanuel/0000-0001-8031-7400; bioulac, stephanie/0000-0003-2618-4234; MICOULAUD-FRANCHI, Jean-Arthur/0000-0002-5203-8444; SAGASPE, Patricia/0000-0003-2845-1199	"ASFA" Association des Societes Francaises d'Autoroutes, Paris, France	"ASFA" Association des Societes Francaises d'Autoroutes, Paris, France	This work was supported by "ASFA" Association des Societes Francaises d'Autoroutes, Paris, France.	Adler LA, 2008, J CLIN PSYCHIAT, V69, P1364, DOI 10.4088/JCP.v69n0903; Adler Lenard A, 2006, Ann Clin Psychiatry, V18, P145, DOI 10.1080/10401230600801077; Akerstedt T, 2010, CHRONOBIOL INT, V27, P987, DOI 10.3109/07420528.2010.489423; ALDRICH MS, 1989, SLEEP, V12, P487, DOI 10.1093/sleep/12.6.487; Alexandre C, 2013, CURR OPIN NEUROBIOL, V23, P752, DOI 10.1016/j.conb.2013.04.008; American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; Barkley R, 2005, ATTENTION DEFICIT HY; Barkley R.A., 2006, ADHD REP, V14, P1, DOI DOI 10.1521/ADHD.2006.14.2.1; BARKLEY RA, 1993, PEDIATRICS, V92, P212; Barkley RA, 2002, J INT NEUROPSYCH SOC, V8, P655, DOI 10.1017/S1355617702801345; Biederman J, 2006, J CLIN PSYCHIAT, V67, P524, DOI 10.4088/JCP.v67n0403; Biederman J, 2012, J PSYCHIATR RES, V46, P484, DOI 10.1016/j.jpsychires.2012.01.007; Bioulac S, 2015, J CLIN PSYCHIAT, V76, P943, DOI 10.4088/JCP.14m09087; Brown TE, 2001, ANN NY ACAD SCI, V931, P271; Caci HM, 2014, J NERV MENT DIS, V202, P324, DOI 10.1097/NMD.0000000000000126; Connor J, 2002, BRIT MED J, V324, P1125, DOI 10.1136/bmj.324.7346.1125; Connor J, 2001, ACCIDENT ANAL PREV, V33, P31, DOI 10.1016/S0001-4575(00)00013-0; Cortese S, 2008, MED HYPOTHESES, V71, P770, DOI 10.1016/j.mehy.2008.06.017; Cortese S, 2013, J AM ACAD CHILD PSY, V52, P784, DOI 10.1016/j.jaac.2013.06.001; Cox DJ, 2006, PEDIATRICS, V118, pE704, DOI 10.1542/peds.2005-2947; Cox DJ, 2012, J CLIN PSYCHOPHARM, V32, P225, DOI 10.1097/JCP.0b013e3182496dc5; Cox DJ, 2004, J AM ACAD CHILD PSY, V43, P269, DOI 10.1097/00004583-200403000-00007; Cox DJ, 2000, J NERV MENT DIS, V188, P230, DOI 10.1097/00005053-200004000-00006; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Faraone SV, 2006, PSYCHOL MED, V36, P159, DOI 10.1017/S003329170500471X; Fischer M, 2007, ACCIDENT ANAL PREV, V39, P94, DOI 10.1016/j.aap.2006.06.008; Galera C, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8105; Golan N, 2004, SLEEP, V27, P261, DOI 10.1093/sleep/27.2.261; HORNE JA, 1995, BRIT MED J, V310, P565, DOI 10.1136/bmj.310.6979.565; Hvolby A, 2015, ADHD-ATTEND DEFICIT, V7, P1, DOI 10.1007/s12402-014-0151-0; Jerome L, 2006, J CAN ACAD CHILD ADO, V15, P105; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Kotterba S, 2004, CLIN NEUROL NEUROSUR, V106, P275, DOI 10.1016/j.clineuro.2003.12.003; Lara C, 2009, BIOL PSYCHIAT, V65, P46, DOI 10.1016/j.biopsych.2008.10.005; Lecendreux M, 2000, J CHILD PSYCHOL PSYC, V41, P803, DOI 10.1111/1469-7610.00667; Leger D, 2008, CURR MED RES OPIN, V24, P307, DOI 10.1185/030079907X253771; Leger D, 2005, CURR MED RES OPIN, V21, P1785, DOI 10.1185/030079905X65637; Man KKC, 2015, PEDIATRICS, V135, P40, DOI 10.1542/peds.2014-1738; Miano S, 2006, SLEEP, V29, P797; Morgenthaler TI, 2007, SLEEP, V30, P1705, DOI 10.1093/sleep/30.12.1705; Nabi H, 2006, BRIT MED J, V333, P75, DOI 10.1136/bmj.38863.638194.AE; NadaRaja S, 1997, J AM ACAD CHILD PSY, V36, P515, DOI 10.1097/00004583-199704000-00014; Ohayon MM, 2004, ENCEPHALE, V30, P222; Ohayon MM, 2002, J PSYCHOSOM RES, V53, P547, DOI 10.1016/S0022-3999(02)00443-9; Ohayon MM, 1997, ARCH INTERN MED, V157, P2645, DOI 10.1001/archinte.157.22.2645; Pack AI, 1995, ACCIDENT ANAL PREV, V27, P769, DOI 10.1016/0001-4575(95)00034-8; Philip P, 2001, BRIT MED J, V322, P829, DOI 10.1136/bmj.322.7290.829; Philip P, 2010, SLEEP MED, V11, P973, DOI 10.1016/j.sleep.2010.07.010; Powell NB, 2001, LARYNGOSCOPE, V111, P887, DOI 10.1097/00005537-200105000-00024; Powell NB, 2007, SLEEP, V30, P331, DOI 10.1093/sleep/30.3.331; Reimer B, 2010, ACCIDENT ANAL PREV, V42, P842, DOI 10.1016/j.aap.2009.06.021; Reimer Bryan, 2007, Traffic Inj Prev, V8, P290, DOI 10.1080/15389580701257842; Reynolds AC, 2010, PROG BRAIN RES, V185, P91, DOI 10.1016/B978-0-444-53702-7.00006-3; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Sagaspe P, 2010, J SLEEP RES, V19, P578, DOI 10.1111/j.1365-2869.2009.00818.x; Sobanski E, 2008, J NEURAL TRANSM, V115, P347, DOI 10.1007/s00702-007-0834-1; Sobanski E, 2013, EUR PSYCHIAT, V28, P379, DOI 10.1016/j.eurpsy.2012.08.001; Sobanski E, 2012, PHARMACOPSYCHIATRY, V45, P100, DOI 10.1055/s-0031-1291319; Spencer TJ, 2007, BIOL PSYCHIAT, V61, P1380, DOI 10.1016/j.biopsych.2006.07.032; Tison F, 2005, NEUROLOGY, V65, P239, DOI 10.1212/01.wnl.0000168910.48309.4a; Verster JC, 2008, J PSYCHOPHARMACOL, V22, P230, DOI 10.1177/0269881107082946; WEINBERG WA, 1990, J PEDIATR-US, V116, P720, DOI 10.1016/S0022-3476(05)82654-X; Woods SP, 2002, ARCH CLIN NEUROPSYCH, V17, P351, DOI 10.1016/S0887-6177(01)00120-2; Woodward LJ, 2000, J AM ACAD CHILD PSY, V39, P627, DOI 10.1097/00004583-200005000-00017; Yoon SYR, 2012, SLEEP MED REV, V16, P371, DOI 10.1016/j.smrv.2011.07.001; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	67	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138004	10.1371/journal.pone.0138004	http://dx.doi.org/10.1371/journal.pone.0138004			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8NH	26376078	Green Published, gold			2022-12-27	WOS:000361610200068
J	Yuan, FS; Sui, HX; Li, ZK; Yang, HF; Lu, PJ; Wang, Y; Sun, YC				Yuan, Fusong; Sui, Huaxin; Li, Zhongke; Yang, Huifang; Lu, Peijun; Wang, Yong; Sun, Yuchun			A Method of Three-Dimensional Recording of Mandibular Movement Based on Two-Dimensional Image Feature Extraction	PLOS ONE			English	Article								Background and Objective To develop a real-time recording system based on computer binocular vision and two-dimensional image feature extraction to accurately record mandibular movement in three dimensions. Methods A computer-based binocular vision device with two digital cameras was used in conjunction with a fixed head retention bracket to track occlusal movement. Software was developed for extracting target spatial coordinates in real time based on two-dimensional image feature recognition. A plaster model of a subject's upper and lower dentition were made using conventional methods. A mandibular occlusal splint was made on the plaster model, and then the occlusal surface was removed. Temporal denture base resin was used to make a 3-cm handle extending outside the mouth connecting the anterior labial surface of the occlusal splint with a detection target with intersecting lines designed for spatial coordinate extraction. The subject's head was firmly fixed in place, and the occlusal splint was fully seated on the mandibular dentition. The subject was then asked to make various mouth movements while the mandibular movement target locus point set was recorded. Comparisons between the coordinate values and the actual values of the 30 intersections on the detection target were then analyzed using paired t-tests. Results The three-dimensional trajectory curve shapes of the mandibular movements were consistent with the respective subject movements. Mean XYZ coordinate values and paired t-test results were as follows: X axis: -0.0037 +/- 0.02953, P = 0.502; Y axis: 0.0037 +/- 0.05242, P = 0.704; and Z axis: 0.0007 +/- 0.06040, P = 0.952. The t-test result showed that the coordinate values of the 30 cross points were considered statistically no significant. (P<0.05) Conclusions Use of a real-time recording system of three-dimensional mandibular movement based on computer binocular vision and two-dimensional image feature recognition technology produced a recording accuracy of approximately +/- 0.1 mm, and is therefore suitable for clinical application. Certainly, further research is necessary to confirm the clinical applications of the method.	[Yuan, Fusong; Sui, Huaxin; Yang, Huifang; Lu, Peijun; Wang, Yong; Sun, Yuchun] Peking Univ Sch & Hosp Stomatol, Ctr Digital Dent, Beijing, Peoples R China; [Yuan, Fusong; Sui, Huaxin; Yang, Huifang; Lu, Peijun; Wang, Yong; Sun, Yuchun] Peking Univ Sch & Hosp Stomatol, Fac Prosthodont, Beijing, Peoples R China; [Yuan, Fusong; Sui, Huaxin; Yang, Huifang; Lu, Peijun; Wang, Yong; Sun, Yuchun] Natl Engn Lab Digital & Mat Technol Stomatol, Beijing, Peoples R China; [Yuan, Fusong; Sui, Huaxin; Yang, Huifang; Lu, Peijun; Wang, Yong; Sun, Yuchun] Minist Hlth, Res Ctr Engn & Technol Digital Dent, Beijing, Peoples R China; [Li, Zhongke] Second Artillery Engn Coll, Xian, Peoples R China	Peking University; Peking University	Wang, Y (corresponding author), Peking Univ Sch & Hosp Stomatol, Ctr Digital Dent, Beijing, Peoples R China.	kqcadc@bjmu.edu.cn; polarshining@163.com	, 孙玉春/AAX-5280-2020		National Natural Science Foundation of China [51475004]; National High Technology Research and Development Program ("863" Program) of China [2013AA040802]; Scientific Research Staring Foundation for the Returned Overseas Chinese Scholars, Peking University School and Hospital of Stomatology [YS0401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program ("863" Program) of China(National High Technology Research and Development Program of China); Scientific Research Staring Foundation for the Returned Overseas Chinese Scholars, Peking University School and Hospital of Stomatology	This study received support from the National Natural Science Foundation of China, grant No. 51475004; the National High Technology Research and Development Program ("863" Program) of China, grant No. 2013AA040802; Scientific Research Staring Foundation for the Returned Overseas Chinese Scholars, Peking University School and Hospital of Stomatology, grant No. YS0401. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang WSW, 2004, J PROSTHET DENT, V92, P83, DOI 10.1016/j.prosdent.2004.04.011; Gallo LM, 2005, CELLS TISSUES ORGANS, V180, P54, DOI 10.1159/000086199; GIBBS CH, 1971, J PROSTHET DENT, V26, P604, DOI 10.1016/0022-3913(71)90085-0; Hanssen N, 2014, INT J COMPUT DENT, V17, P65; Kordass Bernd, 2002, Dent Clin North Am, V46, P493, DOI 10.1016/S0011-8532(02)00006-X; MESSERMAN T, 1967, J PROSTHET DENT, V17, P36, DOI 10.1016/0022-3913(67)90048-0; Missaka Reinaldo, 2008, Braz. oral res., V22, P151, DOI 10.1590/S1806-83242008000200010; Miyashita K, 1998, J ORAL REHABIL, V25, P545, DOI 10.1046/j.1365-2842.1998.00273.x; Naeije M, 2002, J ORAL REHABIL, V29, P534, DOI 10.1046/j.1365-2842.2002.00895.x; PIEHSLINGER E, 1991, CRANIO, V9, P344, DOI 10.1080/08869634.1991.11678382; Pinheiro A. P., 2011, Journal of Medical Engineering & Technology, V35, P125, DOI 10.3109/03091902.2010.542270; Pinheiro AP, 2008, J APPL ORAL SCI, V16, P321, DOI 10.1590/S1678-77572008000500004; Zhang H, 2014, OCCLUSAL THEORY CLIN	13	11	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137507	10.1371/journal.pone.0137507	http://dx.doi.org/10.1371/journal.pone.0137507			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375800	gold, Green Submitted, Green Published			2022-12-27	WOS:000361610200040
J	Chaar, LJ; Alves, TP; Batista, AM; Michelini, LC				Chaar, Laiali Jurdi; Alves, Tatiana Pereira; Batista Junior, Alvaro Martins; Michelini, Lisete Compagno			Early Training-Induced Reduction of Angiotensinogen in Autonomic Areas-The Main Effect of Exercise on Brain Renin-Angiotensin System in Hypertensive Rats	PLOS ONE			English	Article							ROSTRAL VENTROLATERAL MEDULLA; SYMPATHETIC-NERVE ACTIVITY; MESSENGER-RNA EXPRESSION; HEART-RATE-VARIABILITY; TYPE-1 AT(1) RECEPTOR; BLOOD-PRESSURE; BLOCKADE; NUCLEUS; BALANCE; RESPONSES	Background Exercise training (T) blunts functional deficits and renin-angiotensin system (RAS) hyperactivity in hypertensive individuals. There is no information on T-induced temporal changes of brain RAS. We evaluate now the simultaneous effects of T on functional responses and time course changes in the expression/activity of brain RAS components in autonomic cardiovascular- controlling areas. Methods and Results Spontaneously hypertensive rats (SHR) and age-matched normotensive controls (WKY) were trained for 0, 1, 2, 4, 8 and 12 weeks. Sedentary (S) groups served as time-controls. After arterial pressure (AP) and heart rate (HR) recordings at rest, fresh and fixed brains were harvested for qPCR and immunofluorescence assays. SHR-S vs. WKY-S exhibited higher mean AP (MAP) and HR, increased pressure variability and sympathetic activity, elevated AT(1) receptor (AT(1)) expression in nucleus tractus solitarii (NTS) and higher Mas receptor expression in the rostroventrolateral medulla (RVLM). In SHR, T promptly (T-2 on) reduced sympathetic variability to heart/vessels and largely decreased angiotensinogen expression in the paraventricular hypothalamic nucleus (PVN) and NTS, with a late RVLM reduction (T-4). AT(1) expression was only reduced at T-12 (PVN and NTS) with transient, not maintained Mas receptor changes in PVN and RVLM. These responses were accompanied by baseline MAP and HR reduction in the SHR-T (from T-4 on). In the SHR group, PVN angiotensinogen expression correlated positively with sympathetic activity, resting MAP and HR. In WKY-T, a precocious (T-2-T-12) RVLM AT(1) decrease preceded the appearance of resting bradycardia (from T-8 on). Conclusions Early and maintained reduction of angiotensinogen content in autonomic areas of the SHR is the most prominent effect of training on brain RAS. Down-regulation of PVN RAS expression is an essential factor to drive cardiovascular benefits in SHR-T, while resting bradycardia in WKY-T is correlated to RVLM AT(1) reduction.	[Chaar, Laiali Jurdi; Michelini, Lisete Compagno] Univ Sao Paulo, Dept Physiol & Biophys, Inst Biomed Sci, Sao Paulo, Brazil; [Alves, Tatiana Pereira; Batista Junior, Alvaro Martins] Univ Sao Paulo, Dept Anat, Inst Biomed Sci, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Michelini, LC (corresponding author), Univ Sao Paulo, Dept Physiol & Biophys, Inst Biomed Sci, Sao Paulo, Brazil.	michelin@usp.br	Chaar, Laiali/F-3457-2013	Chaar, Laiali/0000-0002-9054-6386	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2009/03708-9, 2009/54299-1, 2011/51410-9]; Conselho Nacional de Pesquisa - CNPq [304060/2011-9]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the following research grants: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (2009/03708-9; 2009/54299-1; 2011/51410-9), Conselho Nacional de Pesquisa - CNPq (304060/2011-9). L.C. Michelini is a research fellow from CNPq.	Agarwal D, 2011, BASIC RES CARDIOL, V106, P1069, DOI 10.1007/s00395-011-0231-7; Arnold AC, 2013, HYPERTENS RES, V36, P5, DOI 10.1038/hr.2012.161; AVERILL DB, 1994, BRAIN RES, V665, P245, DOI 10.1016/0006-8993(94)91344-7; Bader M, 2013, PFLUG ARCH EUR J PHY, V465, P79, DOI 10.1007/s00424-012-1120-0; Baltatu O, 2001, HYPERTENSION, V37, P408, DOI 10.1161/01.HYP.37.2.408; Bezerra SMMS, 2001, HYPERTENSION, V38, P569, DOI 10.1161/hy09t1.095393; Cardinale JP, 2012, HYPERTENSION, V59, P113, DOI 10.1161/HYPERTENSIONAHA.111.182154; CAULFIELD M, 1995, J CLIN INVEST, V96, P687, DOI 10.1172/JCI118111; Cavalleri MT, 2011, AM J PHYSIOL-REG I, V301, pR958, DOI 10.1152/ajpregu.00104.2011; Felix JVC, 2007, HYPERTENSION, V50, P780, DOI 10.1161/HYPERTENSIONAHA.107.094474; Chen QH, 2003, AM J PHYSIOL-REG I, V285, pR1231, DOI 10.1152/ajpregu.00028.2003; Dias-Peixoto MF, 2012, PEPTIDES, V35, P196, DOI 10.1016/j.peptides.2012.03.022; dos Santos CM, 1998, HYPERTENSION, V31, P973; Ferrario CM, 2011, CURR OPIN NEPHROL HY, V20, P1, DOI 10.1097/MNH.0b013e3283406f57; Ferrario CM, 2006, J RENIN-ANGIO-ALDO S, V7, P3, DOI 10.3317/jraas.2006.003; FERRARIO CM, 1990, DRUGS, V39, P1, DOI 10.2165/00003495-199000392-00002; Filho AG, 2008, EXP PHYSIOL, V93, P589, DOI 10.1113/expphysiol.2007.014293; Gomes-Santos IL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098012; Hu L, 2002, J APPL PHYSIOL, V92, P2153, DOI 10.1152/japplphysiol.00261.2001; Huang CL, 2006, J PHYSIOL-LONDON, V574, P597, DOI 10.1113/jphysiol.2006.107326; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; KIMURA S, 1992, EMBO J, V11, P821, DOI 10.1002/j.1460-2075.1992.tb05119.x; Kleiber AC, 2010, AM J PHYSIOL-HEART C, V298, pH1546, DOI 10.1152/ajpheart.01006.2009; Kuba K, 2013, CIRC J, V77, P301, DOI 10.1253/circj.CJ-12-1544; Masson GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094927; McKinley MJ, 2003, INT J BIOCHEM CELL B, V35, P901, DOI 10.1016/S1357-2725(02)00306-0; MICHELINI LC, 1990, HYPERTENSION, V15, pI45, DOI 10.1161/01.HYP.15.2_Suppl.I45; MICHELINI LC, 1992, HYPERTENSION, V19, P159; MONTANO N, 1994, CIRCULATION, V90, P1826, DOI 10.1161/01.CIR.90.4.1826; Nohara R, 2014, CIRC J, V78, P2022, DOI 10.1253/circj.CJ-66-0094; O'Callaghan EL, 2013, AUTON NEUROSCI-BASIC, V175, P85, DOI 10.1016/j.autneu.2013.01.010; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Petriz BD, 2013, CURR PROTEIN PEPT SC, V14, P459, DOI 10.2174/13892037113149990063; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qu L, 1996, J NEUROPHYSIOL, V75, P2220, DOI 10.1152/jn.1996.75.6.2220; Sangaleti CT, 2004, HYPERTENSION, V43, P317, DOI 10.1161/01.HYP.0000112030.79692.21; SANTOS CM, 1995, AM J PHYSIOL-HEART C, V269, pH812, DOI 10.1152/ajpheart.1995.269.3.H812; Shah A, 2012, AM J PHYSIOL-HEART C, V302, pH2372, DOI 10.1152/ajpheart.00846.2011; Shan ZY, 2013, HYPERTENSION, V61, P1328, DOI 10.1161/HYPERTENSIONAHA.111.00156; Sheriff MJ, 2006, AM J PHYSIOL-REG I, V290, pR733, DOI 10.1152/ajpregu.00410.2005; Silva DMR, 2011, J APPL PHYSIOL, V111, P1272, DOI 10.1152/japplphysiol.00034.2011; Silva SD, 2015, CIRC J, V79, P1372, DOI 10.1253/circj.CJ-14-1179; Tezini GCSV, 2013, EXP GERONTOL, V48, P147, DOI 10.1016/j.exger.2012.11.009; Xia HJ, 2010, CURR HYPERTENS REP, V12, P170, DOI 10.1007/s11906-010-0105-7	44	25	27	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137395	10.1371/journal.pone.0137395	http://dx.doi.org/10.1371/journal.pone.0137395			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372108	Green Submitted, Green Published, gold			2022-12-27	WOS:000361604400019
J	Zhao, T; Liu, C; Chen, LY				Zhao, Tong; Liu, Chang; Chen, Lingyi			Roles of Klf5 Acetylation in the Self-Renewal and the Differentiation of Mouse Embryonic Stem Cells	PLOS ONE			English	Article							KRUPPEL-LIKE FACTOR-5; TRANSCRIPTIONAL NETWORK; EPITHELIAL-CELLS; PLURIPOTENCY; NANOG; BLASTOCYST; CIRCUITRY; KRUPPEL-LIKE-FACTOR-5; SUMOYLATION; EXPRESSION	Transcription factor Kruppel-like factor 5 (Klf5) plays important roles in the formation of the inner cell mass (ICM) and the trophectoderm during embryogenesis, as well as the self-renewal and the differentiation of mouse embryonic stem cells (ESCs). Acetylation of KLF5 has been shown to reverse the transcriptional activity of KLF5 in human epidermal cells and prostate cancer cells. Whether Klf5 acetylation contributes to the lineage specification in the blastocyst and pluripotency maintenance in ESCs remains unexplored. Here, we showed the ubiquitous expression of acetylated Klf5 in the ICM and the trophectoderm, ruling out the possibility that differential acetylation status of Klf5 leads to the lineage specification in the blastocyst. We found that K358Q mutation, mimicking acetylation, enhances the transcriptional activity of Klf5 for pluripotency genes in ESCs, and that K358Q Klf5 is more potent in pluripotency maintenance and in somatic cell reprogramming, compared to K358R Klf5. In ESCs, Klf5 acetylation, stimulated by TGF-beta signaling, is involved in enhancing Sox2 expression. Moreover, upon ESC differentiation, acetylation of Klf5 facilitates the suppression of many differentiation genes, except for that K358Q Klf5 activates Cdx2, promoting trophectodermal differentiation. In summary, our results revealed the regulatory functions of Klf5 acetylation in ESC self-renewal and differentiation.	[Zhao, Tong; Liu, Chang; Chen, Lingyi] Nankai Univ, Collaborat Innovat Ctr Biotherapy, State Key Lab Med Chem Biol, 2011 Collaborat Innovat Ctr Tianjin Med Epigenet, Tianjin 300071, Peoples R China; [Zhao, Tong; Liu, Chang; Chen, Lingyi] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Chen, Lingyi] CAMS, Canc Inst Hosp, State Key Lab Mol Oncol, Beijing, Peoples R China	Nankai University; Nankai University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Chen, LY (corresponding author), Nankai Univ, Collaborat Innovat Ctr Biotherapy, State Key Lab Med Chem Biol, 2011 Collaborat Innovat Ctr Tianjin Med Epigenet, Tianjin 300071, Peoples R China.	lingyichen@nankai.edu.cn			National Natural Science Foundation of China [31271547, 31470081]; Natural Science Foundation of Tianjin, China [14JCYBJC23600]; Program for New Century Excellent Talents [NCET-13-0293]; Nankai University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin, China(Natural Science Foundation of Tianjin); Program for New Century Excellent Talents(Program for New Century Excellent Talents in University (NCET)); Nankai University	LC was supported by the National Natural Science Foundation of China (Grant No. 31271547 and 31470081), the Natural Science Foundation of Tianjin, China (No. 14JCYBJC23600), and the Program for New Century Excellent Talents (NCET-13-0293). TZ was supported by the Ph.D. Candidate Research Innovation Fund of Nankai University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4719; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M506183200; Chen LY, 2009, CELL RES, V19, P1052, DOI 10.1038/cr.2009.79; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cockburn K, 2010, J CLIN INVEST, V120, P995, DOI 10.1172/JCI41229; Du JX, 2008, J BIOL CHEM, V283, P31991, DOI 10.1074/jbc.M803612200; Du JX, 2007, J BIOL CHEM, V282, P4782, DOI 10.1074/jbc.M603413200; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Guo P, 2009, J BIOL CHEM, V284, P18184, DOI 10.1074/jbc.M109.007096; Guo P, 2009, J BIOL CHEM, V284, P6071, DOI 10.1074/jbc.M806270200; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Li X, 2015, INT J CANCER, V136, P536, DOI 10.1002/ijc.29028; Lin SCJ, 2010, DEVELOPMENT, V137, P3953, DOI 10.1242/dev.054775; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Long XL, 2013, MOL CELL BIOCHEM, V382, P113, DOI 10.1007/s11010-013-1724-5; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matsumura T, 2005, J BIOL CHEM, V280, P12123, DOI 10.1074/jbc.M410578200; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miyamoto S, 2003, MOL CELL BIOL, V23, P8528, DOI 10.1128/MCB.23.23.8528-8541.2003; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Oishi Y, 2008, NAT MED, V14, P656, DOI 10.1038/nm1756; Parisi S, 2008, J CELL SCI, V121, P2629, DOI 10.1242/jcs.027599; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Yeo JC, 2014, CELL STEM CELL, V14, P864, DOI 10.1016/j.stem.2014.04.015; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zernicka-Goetz M, 2009, NAT REV GENET, V10, P467, DOI 10.1038/nrg2564; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958; Zhang ZP, 2003, NUCLEIC ACIDS RES, V31, P2196, DOI 10.1093/nar/gkg310	34	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138168	10.1371/journal.pone.0138168	http://dx.doi.org/10.1371/journal.pone.0138168			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372456	gold, Green Submitted, Green Published			2022-12-27	WOS:000361604400052
J	Ahmad, R; Naz, S; Afzal, MZ; Amin, SH; Breuel, T				Ahmad, Riaz; Naz, Saeeda; Afzal, Muhammad Zeshan; Amin, Sayed Hassan; Breuel, Thomas			Robust Optical Recognition of Cursive Pashto Script Using Scale, Rotation and Location Invariant Approach	PLOS ONE			English	Article								The presence of a large number of unique shapes called ligatures in cursive languages, along with variations due to scaling, orientation and location provides one of the most challenging pattern recognition problems. Recognition of the large number of ligatures is often a complicated task in oriental languages such as Pashto, Urdu, Persian and Arabic. Research on cursive script recognition often ignores the fact that scaling, orientation, location and font variations are common in printed cursive text. Therefore, these variations are not included in image databases and in experimental evaluations. This research uncovers challenges faced by Arabic cursive script recognition in a holistic framework by considering Pashto as a test case, because Pashto language has larger alphabet set than Arabic, Persian and Urdu. A database containing 8000 images of 1000 unique ligatures having scaling, orientation and location variations is introduced. In this article, a feature space based on scale invariant feature transform (SIFT) along with a segmentation framework has been proposed for overcoming the above mentioned challenges. The experimental results show a significantly improved performance of proposed scheme over traditional feature extraction techniques such as principal component analysis (PCA).	[Ahmad, Riaz; Afzal, Muhammad Zeshan; Breuel, Thomas] Univ Technol, Kaiserslautern, Germany; [Ahmad, Riaz] Shaheed Benazir Bhutto Univ, Sheringal, Pakistan; [Naz, Saeeda] Hazara Univ, Dept IT, Mansehra, Pakistan; [Naz, Saeeda] GGPGC 1, Abbottabad, Pakistan; [Amin, Sayed Hassan] Genie Technol Pvt Ltd, Lahore, Pakistan	Hazara University	Naz, S (corresponding author), Hazara Univ, Dept IT, Mansehra, Pakistan.	saeedanaz292@gmail.com	Ahmad, Riaz/R-8199-2018; Rather, R A/J-3509-2019		Higher Education Commission of Pakistan; Shaheed Benazir Bhutto University, Sheringal Dir Pakistan [SBBU/Estb/Ord/13- 315]; Genie Technologies (Pvt) Ltd	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Shaheed Benazir Bhutto University, Sheringal Dir Pakistan; Genie Technologies (Pvt) Ltd	This work is sponsored by Higher Education Commission of Pakistan and Shaheed Benazir Bhutto University, Sheringal Dir Pakistan under Award Letter No: SBBU/Estb/Ord/13- 315. Genie Technologies (Pvt) Ltd provided support in the form of a salary for author SHA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sayed Hassan Amin has contributed voluntarily in his private capacity. The specific roles of all authors are articulated in the "author contributions" section.	Ahmad Riaz, 2010, 2010 6th International Conference on Emerging Technologies (ICET), P299, DOI 10.1109/ICET.2010.5638470; Decerbo M., 2004, P 1 ACM WORKSH HARDC, P29; Durrani N, 2010, HUMAN LANGUAGE TECHN, P528; Gillies A, 1999, PROCEEDINGS OF THE S; Graves A., 2009, ADV NEURAL INFORM PR, P1; Graves A, 2009, IEEE T PATTERN ANAL, V31, P855, DOI 10.1109/TPAMI.2008.137; Guan T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098806; Guan T, 2014, IEEE MULTIMEDIA, V21, P32, DOI 10.1109/MMUL.2013.31; Guan T, 2013, IEEE T MULTIMEDIA, V15, P1688, DOI 10.1109/TMM.2013.2265674; Husain SA, 2002, MULT C 2002 INMIC 20, P84, DOI DOI 10.1109/INMIC.2002.1310191; Ji RR, 2012, INT J COMPUT VISION, V96, P290, DOI 10.1007/s11263-011-0472-9; Ji RR, 2013, IEEE T MULTIMEDIA, V15, P153, DOI 10.1109/TMM.2012.2225035; Ji RR, 2012, IEEE T IMAGE PROCESS, V21, P2282, DOI 10.1109/TIP.2011.2176950; Lehal G.S., 2012, P WORKSH DOC AN REC, P79; Liwicki M, 2007, PROC INT CONF DOC, P367; Lorigo LM, 2006, IEEE T PATTERN ANAL, V28, P712, DOI 10.1109/TPAMI.2006.102; Lowe D., 1999, P INT C COMP VIS, V2, P1150, DOI DOI 10.1109/ICCV.1999.790410; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Luo YW, 2015, NEUROCOMPUTING, V156, P105, DOI 10.1016/j.neucom.2014.12.079; Margner V, 2008, LECT NOTES COMPUT SC, V4768, P82, DOI 10.1007/978-3-540-78199-8_6; Margner V, 2007, PROC INT CONF DOC, P1274; Margner V, 2005, PROC INT CONF DOC, P70, DOI 10.1109/ICDAR.2005.52; Naz S, 2015, SPRINGER J ED INF TE, P1; Naz S, 2014, PATTERN RECOGN, V47, P1229, DOI 10.1016/j.patcog.2013.09.037; Pal U, 2003, PROC INT CONF DOC, P1183; Penzl H., 1955, GRAMMAR PASHTO DESCR, V2; Ul-Hasan A, 2013, PROC INT CONF DOC, P1061, DOI 10.1109/ICDAR.2013.212; Wahab M, 2009, 2009 INTERNATIONAL C; Wei BC, 2014, IEEE MULTIMEDIA, V21, P41, DOI 10.1109/MMUL.2013.65; Yousefi MR, 2015, IS T SPIE ELECTRONIC; Zhiyi Zhang, 2009, 2009 10th International Conference on Document Analysis and Recognition (ICDAR), P763, DOI 10.1109/ICDAR.2009.27	31	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0133648	10.1371/journal.pone.0133648	http://dx.doi.org/10.1371/journal.pone.0133648			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368566	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100003
J	Dhanapal, AP; Ray, JD; Singh, SK; Hoyos-Villegas, V; Smith, JR; Purcell, LC; King, CA; Fritschi, FB				Dhanapal, Arun Prabhu; Ray, Jeffery D.; Singh, Shardendu K.; Hoyos-Villegas, Valerio; Smith, James R.; Purcell, Larry C.; King, C. Andy; Fritschi, Felix B.			Association Mapping of Total Carotenoids in Diverse Soybean Genotypes Based on Leaf Extracts and High-Throughput Canopy Spectral Reflectance Measurements	PLOS ONE			English	Article							ABSCISIC-ACID BIOSYNTHESIS; GENOME-WIDE ASSOCIATION; XANTHOPHYLL CYCLE; WAVELET DECOMPOSITION; POPULATION-STRUCTURE; OPTICAL-PROPERTIES; NITROGEN-CONTENT; BETA-CAROTENE; PHOTOSYSTEM-I; CHLOROPHYLL-B	Carotenoids are organic pigments that are produced predominantly by photosynthetic organisms and provide antioxidant activity to a wide variety of plants, animals, bacteria, and fungi. The carotenoid biosynthetic pathway is highly conserved in plants and occurs mostly in chromoplasts and chloroplasts. Leaf carotenoids play important photoprotective roles and targeted selection for leaf carotenoids may offer avenues to improve abiotic stress tolerance. A collection of 332 soybean [Glycine max (L.) Merr.] genotypes was grown in two years and total leaf carotenoid content was determined using three different methods. The first method was based on extraction and spectrophotometric determination of carotenoid content (eCaro) in leaf tissue, whereas the other two methods were derived from high-throughput canopy spectral reflectance measurements using wavelet transformed reflectance spectra (tCaro) and a spectral reflectance index (iCaro). An association mapping approach was employed using 31,253 single nucleotide polymorphisms (SNPs) to identify SNPs associated with total carotenoid content using a mixed linear model based on data from two growing seasons. A total of 28 SNPs showed a significant association with total carotenoid content in at least one of the three approaches. These 28 SNPs likely tagged 14 putative loci for carotenoid content. Six putative loci were identified using eCaro, five loci with tCaro, and nine loci with iCaro. Three of these putative loci were detected by all three carotenoid determination methods. All but four putative loci were located near a known carotenoid-related gene. These results showed that carotenoid markers can be identified in soybean using extract-based as well as by high-throughput canopy spectral reflectance-based approaches, demonstrating the utility of field-based canopy spectral reflectance phenotypes for association mapping.	[Dhanapal, Arun Prabhu; Fritschi, Felix B.] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA; [Ray, Jeffery D.; Smith, James R.] USDA ARS, Crop Genet Res Unit, Stoneville, MS 38776 USA; [Singh, Shardendu K.] USDA ARS, Crop Syst & Global Change Lab, Beltsville, MD USA; [Hoyos-Villegas, Valerio] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA; [Purcell, Larry C.; King, C. Andy] Univ Arkansas, Dept Crop Soil & Environm Sci, Fayetteville, AR 72701 USA	University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Michigan State University; University of Arkansas System; University of Arkansas Fayetteville	Fritschi, FB (corresponding author), Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA.	fritschif@missouri.edu	Dhanapal, Arun Prabhu/F-5030-2012; Purcell, Larry/AAA-5986-2022; Hoyos-Villegas, Valerio/O-6138-2018	Dhanapal, Arun Prabhu/0000-0002-9686-7260; Hoyos-Villegas, Valerio/0000-0003-1080-9148	United States Department of Agriculture-Agriculture Research Service (USDA-ARS) [6066-21220-012-00D]; United Soybean Board project [9274, 1274]; ARS [ARS-0425092] Funding Source: Federal RePORTER	United States Department of Agriculture-Agriculture Research Service (USDA-ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service); United Soybean Board project; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by United States Department of Agriculture-Agriculture Research Service (USDA-ARS) project number 6066-21220-012-00D and United Soybean Board project numbers 9274 and 1274. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aal EM, 2013, NUTRIENTS, V5, P1169, DOI 10.3390/nu5041169; Andrade-Sanchez P, 2014, FUNCT PLANT BIOL, V41, P68, DOI 10.1071/FP13126; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blackburn GA, 2007, INT J REMOTE SENS, V28, P2831, DOI 10.1080/01431160600928625; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Buckler E, 2009, EVOLUTION LINKAGE TA; Carter GA, 2001, AM J BOT, V88, P677, DOI 10.2307/2657068; Cazzaniga S, 2012, PLANT PHYSIOL, V159, P1745, DOI 10.1104/pp.112.201137; Cazzonelli CI, 2010, PLANT DEVELOPMENTAL BIOLOGY: BIOTECHNOLOGICAL PERSPECTIVES VOL 2, P117, DOI 10.1007/978-3-642-04670-4_7; Cazzonelli CI, 2011, FUNCT PLANT BIOL, V38, P833, DOI 10.1071/FP11192; CHAPPELLE EW, 1992, REMOTE SENS ENVIRON, V39, P239, DOI 10.1016/0034-4257(92)90089-3; Chen XY, 2011, J PLANT PHYSIOL, V168, P1828, DOI 10.1016/j.jplph.2011.05.019; Cunningham FX, 1998, ANNU REV PLANT PHYS, V49, P557, DOI 10.1146/annurev.arplant.49.1.557; Czyczylo-Mysza I, 2013, MOL BREEDING, V32, P189, DOI 10.1007/s11032-013-9862-8; Dall'Osto L, 2010, MOL PLANT, V3, P576, DOI 10.1093/mp/ssp117; Daughtry CST, 2000, REMOTE SENS ENVIRON, V74, P229, DOI 10.1016/S0034-4257(00)00113-9; Davison PA, 2002, NATURE, V418, P203, DOI 10.1038/nature00861; DellaPenna D, 2006, ANNU REV PLANT BIOL, V57, P711, DOI 10.1146/annurev.arplant.56.032604.144301; Demmig-Adams B, 2002, SCIENCE, V298, P2149, DOI 10.1126/science.1078002; DemmigAdams B, 1996, FASEB J, V10, P403, DOI 10.1096/fasebj.10.4.8647339; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; DemmigAdams B, 1996, TRENDS PLANT SCI, V1, P21, DOI 10.1016/S1360-1385(96)80019-7; Dhanapal AP, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2014.11.0086; Dhanapal AP, 2015, THEOR APPL GENET, V128, P73, DOI 10.1007/s00122-014-2413-9; Dhanapal AP, 2013, 3 BIOTECH, V3, P481, DOI 10.1007/s13205-012-0109-x; Endelman JB, 2012, G3-GENES GENOM GENET, V2, P1405, DOI 10.1534/g3.112.004259; ESKINS K, 1981, PLANT PHYSIOL, V67, P759, DOI 10.1104/pp.67.4.759; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Fernandez-Marin B, 2011, PLANTA, V234, P579, DOI 10.1007/s00425-011-1420-1; Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002; GAUSMAN HW, 1984, ACS SYM SER, V257, P215; Giuliano G, 2014, CURR OPIN PLANT BIOL, V19, P111, DOI 10.1016/j.pbi.2014.05.006; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Gotz T, 2002, PLANT MOL BIOL, V50, P129, DOI 10.1023/A:1016072218801; Grant D, 2010, NUCLEIC ACIDS RES, V38, pD843, DOI 10.1093/nar/gkp798; Guo J, 2012, ANN BOT-LONDON, V110, P777, DOI 10.1093/aob/mcs142; Hao DR, 2012, THEOR APPL GENET, V124, P447, DOI 10.1007/s00122-011-1719-0; Hirschberg J, 2001, CURR OPIN PLANT BIOL, V4, P210, DOI 10.1016/S1369-5266(00)00163-1; Holland JB, 2002, PL BRED RE, V22, P9; Howitt CA, 2006, PLANT CELL ENVIRON, V29, P435, DOI 10.1111/j.1365-3040.2005.01492.x; Hwang EY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Jahns P, 2012, BBA-BIOENERGETICS, V1817, P182, DOI 10.1016/j.bbabio.2011.04.012; Johnson MP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702831200; Kannan B, 2014, SCI WORLD J, DOI 10.1155/2014/562327; Krinsky NI, 2004, CAROTENOIDS HLTH DIS, P576; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Matthews PD, 2003, J EXP BOT, V54, P2215, DOI 10.1093/jxb/erg235; MIDDLETON EM, 1993, PLANT PHYSIOL, V103, P741, DOI 10.1104/pp.103.3.741; Murchie EH, 2002, PLANT PHYSIOL, V130, P1999, DOI 10.1104/pp.011098; Murchie EH, 1999, PLANT PHYSIOL, V119, P553, DOI 10.1104/pp.119.2.553; Musa A., 2012, International Journal of Biology, V4, P130; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Penuelas J, 1998, TRENDS PLANT SCI, V3, P151, DOI 10.1016/S1360-1385(98)01213-8; Piepho HP, 2008, EUPHYTICA, V161, P209, DOI 10.1007/s10681-007-9449-8; Piepho HP, 2007, GENETICS, V177, P1881, DOI 10.1534/genetics.107.074229; Pogson B.J., 2005, PHOTOSYSTEM, P515; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roelofsen HD, 2014, ECOL EVOL, V4, P706, DOI 10.1002/ece3.932; Ryu C, 2011, FIELD CROP RES, V122, P214, DOI 10.1016/j.fcr.2011.03.013; Sandmann G, 2001, TRENDS PLANT SCI, V6, P14, DOI 10.1016/S1360-1385(00)01817-3; Schwartz SH, 2001, J BIOL CHEM, V276, P25208, DOI 10.1074/jbc.M102146200; Sims DA, 2002, REMOTE SENS ENVIRON, V81, P337, DOI 10.1016/S0034-4257(02)00010-X; Singh SK, 2013, FIELD CROP RES, V149, P20, DOI 10.1016/j.fcr.2013.04.019; Song QJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054985; Spurgeon S.L., 1980, BIOCH ISOPRENOID COM, P1; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Telfer A, 2005, PHOTOCH PHOTOBIO SCI, V4, P950, DOI 10.1039/b507888c; Vigneau N, 2011, FIELD CROP RES, V122, P25, DOI 10.1016/j.fcr.2011.02.003; Wang LY, 2014, PLANT CELL REP, V33, P1441, DOI 10.1007/s00299-014-1627-2; Wang YL, 2004, BIOPHYS J, V86, P3097, DOI 10.1016/S0006-3495(04)74358-1; Wen ZX, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-809; White JW, 2012, FIELD CROP RES, V133, P101, DOI 10.1016/j.fcr.2012.04.003; Wongsen W., 2013, International Food Research Journal, V20, P1113; YAMAMOTO HY, 1962, ARCH BIOCHEM BIOPHYS, V97, P168, DOI 10.1016/0003-9861(62)90060-7; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Zhang JP, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1441-4; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	82	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137213	10.1371/journal.pone.0137213	http://dx.doi.org/10.1371/journal.pone.0137213			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368323	gold, Green Published, Green Submitted			2022-12-27	WOS:000361601100058
J	Du, J; Ligmann-Zielinska, A				Du, Jing; Ligmann-Zielinska, Arika			The Volatility of Data Space: Topology Oriented Sensitivity Analysis	PLOS ONE			English	Article							AGENT-BASED MODEL	Despite the difference among specific methods, existing Sensitivity Analysis (SA) technologies are all value-based, that is, the uncertainties in the model input and output are quantified as changes of values. This paradigm provides only limited insight into the nature of models and the modeled systems. In addition to the value of data, a potentially richer information about the model lies in the topological difference between pre-model data space and post-model data space. This paper introduces an innovative SA method called Topology Oriented Sensitivity Analysis, which defines sensitivity as the volatility of data space. It extends SA into a deeper level that lies in the topology of data.	[Du, Jing] Texas A&M Univ, Dept Construct Sci, College Stn, TX 77840 USA; [Ligmann-Zielinska, Arika] Michigan State Univ, Dept Geog, E Lansing, MI 48824 USA	Texas A&M University System; Texas A&M University College Station; Michigan State University	Du, J (corresponding author), Texas A&M Univ, Dept Construct Sci, Francis Hall 334, College Stn, TX 77840 USA.	dujing@tamu.edu	Du, Jing/AHE-6199-2022		National Science Foundation [1416730]; SBE Off Of Multidisciplinary Activities [1416730] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); SBE Off Of Multidisciplinary Activities(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This study is supported by the National Science Foundation under Grant No. 1416730. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation.	Beyer K, 1999, LECT NOTES COMPUT SC, V1540, P217; Borgonovo E, 2012, ENVIRON MODELL SOFTW, V34, P105, DOI 10.1016/j.envsoft.2011.06.006; Borgonovo E, 2006, RISK ANAL, V26, P1349, DOI 10.1111/j.1539-6924.2006.00806.x; Chan K., 2000, SENSITIVITY ANAL; Chen W, 2005, J MECH DESIGN, V127, P875, DOI 10.1115/1.1904642; Du J, 2011, J URBAN PLAN DEV, V137, P390, DOI 10.1061/(ASCE)UP.1943-5444.0000084; Lempert R.J., 2003, SHAPING NEXT 100 YEA; Ligmann-Zielinska A, 2010, INT J GEOGR INF SCI, V24, P1829, DOI 10.1080/13658816.2010.490533; Ligmann-Zielinska A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109779; Ligmann-Zielinska A, 2014, ENVIRON MODELL SOFTW, V57, P235, DOI 10.1016/j.envsoft.2014.03.007; Ligmann-Zielinska A, 2013, INT J GEOGR INF SCI, V27, P1764, DOI 10.1080/13658816.2013.782613; Lilburne L, 2009, INT J GEOGR INF SCI, V23, P151, DOI 10.1080/13658810802094995; Mahalanobis PC, 1936, P NATL I SCI INDIA, V2; Marrel A, 2011, ENVIRONMETRICS, V22, P383, DOI 10.1002/env.1071; Miller JH, 2007, PRINC STUD COMPLEX, P1, DOI 10.1007/1-4020-5602-8_1; R Core Team, 2013, R LANG ENV STAT COMP; Raich A, 1997, COMPUT CHEM ENG, V21, P661, DOI 10.1016/S0098-1354(96)00299-2; Ravalico JK, 2005, MODSIM 2005: INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION: ADVANCES AND APPLICATIONS FOR MANAGEMENT AND DECISION MAKING, P2533; Sallaberry CJ, 2006, 24 C EXP STRUCT DYN; Saltelli A., 1999, J MULTI-CRITERIA DEC, V8, P139, DOI [3.0.CO;2-C, DOI 10.1002/(SICI)1099-1360(199905)8:33.0.CO;2-C]; Saltelli A., 2008, GLOBAL SENSITIVITY A; Saltelli A, 2006, RELIAB ENG SYST SAFE, V91, P1109, DOI 10.1016/j.ress.2005.11.014; Saltelli A, 2010, ENVIRON MODELL SOFTW, V25, P1508, DOI 10.1016/j.envsoft.2010.04.012; Thogmartin WE, 2010, ECOL MODEL, V221, P173, DOI 10.1016/j.ecolmodel.2009.09.013; Varella H, 2010, ENVIRON MODELL SOFTW, V25, P310, DOI 10.1016/j.envsoft.2009.09.012	25	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137591	10.1371/journal.pone.0137591	http://dx.doi.org/10.1371/journal.pone.0137591			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368929	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100089
J	Mackey, AP; Singley, ATM; Wendelken, C; Bunge, SA				Mackey, Allyson P.; Singley, Alison T. Miller; Wendelken, Carter; Bunge, Silvia A.			Characterizing Behavioral and Brain Changes Associated with Practicing Reasoning Skills	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; DEFAULT NETWORK; ROBUST; OPTIMIZATION; REGISTRATION; PATTERNS; ACCURATE; GAINS	We have reported previously that intensive preparation for a standardized test that taxes reasoning leads to changes in structural and functional connectivity within the frontoparietal network. Here, we investigated whether reasoning instruction transfers to improvement on unpracticed tests of reasoning, and whether these improvements are associated with changes in neural recruitment during reasoning task performance. We found behavioral evidence for transfer to a transitive inference task, but no evidence for transfer to a rule generation task. Across both tasks, we observed reduced lateral prefrontal activation in the trained group relative to the control group, consistent with other studies of practice-related changes in brain activation. In the transitive inference task, we observed enhanced suppression of task-negative, or default-mode, regions, consistent with work suggesting that better cognitive skills are associated with more efficient switching between networks. In the rule generation task, we found a pattern consistent with a training-related shift in the balance between phonological and visuospatial processing. Broadly, we discuss general methodological considerations related to the analysis and interpretation of training-related changes in brain activation. In summary, we present preliminary evidence for changes in brain activation associated with practice of high-level cognitive skills.	[Mackey, Allyson P.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Singley, Alison T. Miller; Wendelken, Carter; Bunge, Silvia A.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Wendelken, Carter; Bunge, Silvia A.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley; University of California System; University of California Berkeley	Mackey, AP (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	amackey@mit.edu			National Institute of Neurological Disorders and Stroke Program Project Grant [NS040813]; National Science Foundation Graduate Research Fellowship; National Institute of Child Health and Human Development [F32HD079143-01]; James S. McDonnell Foundation Scholar Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD079143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS040813] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke Program Project Grant; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); James S. McDonnell Foundation Scholar Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institute of Neurological Disorders and Stroke Program Project Grant (NS040813, Lead Principal Investigator: M. D'Esposito; Co-Investigator: S.A.B) (http://www.ninds.nih.gov); National Science Foundation Graduate Research Fellowship to A.P.M. (http://www.nsf.gov); National Institute of Child Health and Human Development F32HD079143-01 to A.P.M. (https://www.nichd.nih.gov); James S. McDonnell Foundation Scholar Award to S.A.B. (https://www.jsmf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach TM, 1997, MANUAL YOUNG ADULT S, DOI DOI 10.1126/science.aap8757; Bi Taiyong, 2013, [Frontiers in Biology, 生物学前沿], V8, P434; Bishop SJ, 2008, CEREB CORTEX, V18, P2132, DOI 10.1093/cercor/bhm240; Buschkuehl M, 2012, DEV COGN NEUROS-NETH, V2, pS167, DOI 10.1016/j.dcn.2011.10.001; Byers A, 2012, VISION RES, V74, P30, DOI 10.1016/j.visres.2012.07.008; Cattell AKS, 1959, CULTURE FAIR INTELLI; Chein JM, 2005, COGNITIVE BRAIN RES, V25, P607, DOI 10.1016/j.cogbrainres.2005.08.013; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; de Koning E, 2002, DEV REV, V22, P211, DOI 10.1006/drev.2002.0548; Ferreira N, 2015, INT J GERIATR PSYCH, V30, P422, DOI 10.1002/gps.4155; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Halford GS, 1998, BEHAV BRAIN SCI, V21, P803, DOI 10.1017/S0140525X98001769; Halpern DF, 1992, J GEN EDUC, V42, P239; Hsu NS, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00221; Jansma JM, 2001, J COGNITIVE NEUROSCI, V13, P730, DOI 10.1162/08989290152541403; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kelly C, 2006, ARCH PHYS MED REHAB, V87, pS20, DOI 10.1016/j.apmr.2006.08.333; Klauer KJ, 2008, REV EDUC RES, V78, P85, DOI 10.3102/0034654307313402; Krawczyk DC, 2012, BRAIN RES, V1428, P13, DOI 10.1016/j.brainres.2010.11.080; Kuhn D, 2011, PSYCHOL SCI, V22, P545, DOI 10.1177/0956797611402512; Mackey AP, 2013, J NEUROSCI, V33, P4796, DOI 10.1523/JNEUROSCI.4141-12.2013; Mackey AP, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00032; Mackey AP, 2011, DEVELOPMENTAL SCI, V14, P582, DOI 10.1111/j.1467-7687.2010.01005.x; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; Morrison AB, 2011, PSYCHON B REV, V18, P46, DOI 10.3758/s13423-010-0034-0; NOVICK LR, 1988, J EXP PSYCHOL LEARN, V14, P510, DOI 10.1037/0278-7393.14.3.510; Nutley SB, 2011, DEVELOPMENTAL SCI, V14, P591, DOI 10.1111/j.1467-7687.2010.01022.x; Oei AC, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00054; Petersen SE, 1998, P NATL ACAD SCI USA, V95, P853, DOI 10.1073/pnas.95.3.853; Poldrack RA, 2015, DEV COGN NEUROS-NETH, V11, P12, DOI 10.1016/j.dcn.2014.06.001; Prado J, 2011, J COGNITIVE NEUROSCI, V23, P3483, DOI 10.1162/jocn_a_00063; Rebok GW, 2014, J AM GERIATR SOC, V62, P16, DOI 10.1111/jgs.12607; Schmiedek F, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00027; Shipstead Z, 2012, PSYCHOL BULL, V138, P628, DOI 10.1037/a0027473; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Udell W, 2011, DEV ARGUMENT SKILLS, V74, P1245; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; Vendetti MS, 2014, NEURON, V84, P906, DOI 10.1016/j.neuron.2014.09.035; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D., 2012, WAIS 4 KASIKIRJA; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Wendelken C, 2010, J COGNITIVE NEUROSCI, V22, P837, DOI 10.1162/jocn.2009.21226; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Woodcock R. W., 2001, WOODCOCK JOHNSON 3 T, P371; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Worsley K.J., 2001, FUNCTIONAL MRI AN IN, P251, DOI [10.1093/acprof:oso/ 9780192630711.003.0014, DOI 10.1093/ACPROF:OSO/9780192630711.003.0014]	50	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137627	10.1371/journal.pone.0137627	http://dx.doi.org/10.1371/journal.pone.0137627			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8KS	26368278	gold, Green Published, Green Submitted			2022-12-27	WOS:000361601100099
J	Schmucker, CM; Rucker, G; Sommer, H; Virgili, G; Loke, YK; Oeller, P; Agostini, H; Ehlken, C				Schmucker, Christine M.; Ruecker, Gerta; Sommer, Harriet; Virgili, Gianni; Loke, Yoon K.; Oeller, Patrick; Agostini, Hansjuergen; Ehlken, Christoph			Treatment as Required versus Regular Monthly Treatment in the Management of Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							2.0 MG RANIBIZUMAB; ANTI-VEGF; EFFICACY; SAFETY; VERTEPORFIN	Background To investigate whether treatment as required 'pro re nata' (PRN) versus regular monthly treatment regimens lead to differences in outcomes in neovascular age-related macular degeneration (nAMD). Regular monthly administration of vascular endothelial growth factor (VEGF) inhibitors is an established gold standard treatment, but this approach is costly. Replacement of monthly by PRN treatment can only be justified if there is no difference in patient relevant outcomes. Methods Systematic review and meta-analysis. The intervention was PRN treatment and the comparator was monthly treatment with VEGF-inhibitors. Four bibliographic databases were searched for randomised controlled trials comparing both treatment regimens directly (head-to-head studies). The last literature search was conducted in December 2014. Risk of bias assessment was performed after the Cochrane Handbook for Systematic Reviews of Interventions. Findings We included 3 head-to-head studies (6 reports) involving more than 2000 patients. After 2 years, the weighted mean difference in best corrected visual acuity (BCVA) was 1.9 (95% CI 0.5 to 3.3) ETDRS letters in favour of monthly treatment. Systemic adverse events were higher in PRN treated patients, but these differences were not statistically significant. After 2 years, the total number of intravitreal injections required by the patients in the PRN arms were 8.4 (95% CI 7.9 to 8.9) fewer than those having monthly treatment. The studies were considered to have a moderate risk of bias. Conclusions PRN treatment resulted in minor but statistically significant decrease in mean BCVA which may not be clinically meaningful. There is a small increase in risk of systemic adverse events for PRN treated patients. Overall, the results indicate that an individualized treatment approach with anti-VEGF using visual acuity and OCT-guided re-treatment criteria may be appropriate for most patients with nAMD.	[Schmucker, Christine M.; Oeller, Patrick] Univ Freiburg, Med Ctr, Cochrane Germany, D-79110 Freiburg, Germany; [Ruecker, Gerta; Sommer, Harriet] Univ Freiburg, Med Ctr, Inst Med Biometry & Stat, D-79104 Freiburg, Germany; [Virgili, Gianni] Univ Florence, Dept Translat Surg & Med, Florence, Italy; [Loke, Yoon K.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Agostini, Hansjuergen; Ehlken, Christoph] Univ Eye Ctr Freiburg, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Florence; University of East Anglia	Schmucker, CM (corresponding author), Univ Freiburg, Med Ctr, Cochrane Germany, Berliner Allee 29, D-79110 Freiburg, Germany.	schmucker@cochrane.de	Rücker, Gerta/B-2965-2009; Virgili, Gianni/P-6607-2014	Rücker, Gerta/0000-0002-2192-2560; Schmucker, Christine/0000-0002-1188-3158; Virgili, Gianni/0000-0002-9960-2989	German National Association of Statutory Health Insurance Funds; German Health Technology Assessment	German National Association of Statutory Health Insurance Funds; German Health Technology Assessment	This systematic review is based on a broader research project funded by the German National Association of Statutory Health Insurance Funds http://www.gkvspitzenverband.de/english/about_us/about_us.jsp). The research project in full is published in a German Health Technology Assessment (https://www.g-ba.de/downloads/40-2683191/2015-04-16_135-SN_Einleitung-Beratungsverfahren_OCT_Antrag-Anlage.pdf.). The views and opinions expressed in the present systematic review are those of the authors and do not necessarily reflect those of the funding organization. The funding organization had no role in the design or conduct of the present systematic review.	Abraham P, 2010, AM J OPHTHALMOL, V150, P315, DOI 10.1016/j.ajo.2010.04.011; Berkman ND, 2014, AHRQ METHODS EFFECTI; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Brown DM, 2009, OPHTHALMOLOGY, V116, P57, DOI 10.1016/j.ophtha.2008.10.018; Busbee BG, 2013, OPHTHALMOLOGY, V120, P1046, DOI 10.1016/j.ophtha.2012.10.014; Chakravarthy U, 2013, LANCET, V382, P1258, DOI 10.1016/S0140-6736(13)61501-9; Chakravarthy U, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.04.015; Haller JA, 2013, OPHTHALMOLOGY, V120, pS3, DOI 10.1016/j.ophtha.2013.01.057; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ho AC, 2014, OPHTHALMOLOGY, V121, P2181, DOI 10.1016/j.ophtha.2014.05.009; Holz FG, 2011, OPHTHALMOLOGY, V118, P663, DOI 10.1016/j.ophtha.2010.12.019; Jiang S, 2014, J CLIN PHARM THER, V39, P234, DOI 10.1111/jcpt.12146; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Moja L, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011230.pub2; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Schmucker C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042701; Sigford DK, 2015, CLIN OPHTHALMOL, V9, P773, DOI 10.2147/OPTH.S77067; Silva R, 2013, OPHTHALMOLOGY, V120, P130, DOI 10.1016/j.ophtha.2012.07.026; Solomon SD, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005139.pub3; Thulliez M, 2014, JAMA OPHTHALMOL, V132, P1317, DOI 10.1001/jamaophthalmol.2014.2333	22	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137866	10.1371/journal.pone.0137866	http://dx.doi.org/10.1371/journal.pone.0137866			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368921	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000361601100159
J	Li, P; Wu, YH; Li, MX; Qiu, XJ; Bai, XY; Zhao, XJ				Li, Ping; Wu, Yonghong; Li, Manxiang; Qiu, Xiaojuan; Bai, Xiaoyan; Zhao, Xiaojing			AS-703026 Inhibits LPS-Induced TNFa Production through MEK/ERK Dependent and Independent Mechanisms	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; FACTOR (TNF)-ALPHA PRODUCTION; COPD PATIENTS; IN-VIVO; IMMUNOLOGICAL ASPECTS; MEK1/2 INHIBITOR; ALPHA; LIPOPOLYSACCHARIDE; AS703026; PROTEIN	Chronic obstructive pulmonary disease (COPD) is characterized by intense lung infiltrations of immune cells (macrophages and monocytes). Lipopolysaccharide (LPS) activates macrophages/monocytes, leading to production of tumor necrosis factor a (TNF alpha) and other cytokines, which cause subsequent lung damages. In the current study, our results demonstrated that AS-703026, a novel MEK/ERK inhibitor, suppressed LPS-induced TNF alpha mRNA expression and protein secretion in RAW 264.7 murine macrophages, and in murine bone marrow-derived macrophages (BMDMs). Meanwhile, TNF alpha production in LPS-stimulated COPD patents' peripheral blood mononuclear cells (PBMCs) was also repressed by AS-703026. At the molecular level, we showed that AS-703026 blocked LPS-induced MEK/ERK activation in above macrophages/monocytes. However, restoring ERK activation in AS-703026-treated RAW 264.7 cells by introducing a constitutive-actively (CA)-ERK1 only partially reinstated LPS-mediated TNF alpha production. Meanwhile, AS-703026 could still inhibit TNF alpha response in ERK1/2-depleted (by shRNA) RAW 264.7 cells. Significantly, we found that AS-703026 inhibited LPS-induced nuclear factor kappa B (NF kappa B) activation in above macrophages and COPD patients' PBMCs. In vivo, oral administration of AS-703026 inhibited LPS-induced TNF alpha production and endotoxin shock in BALB/c mice. Together, we show that AS-703026 in vitro inhibits LPS-induced TNF alpha production in macrophages/monocytes, and in vivo protects mice from LPS-induced endotoxin shock. Thus, it could be further studied as a useful anti-inflammatory therapy for COPD patients.	[Li, Ping; Qiu, Xiaojuan; Bai, Xiaoyan; Zhao, Xiaojing] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Emergency, Xian 710049, Peoples R China; [Wu, Yonghong] Xian Med Univ, Dept Clin Immunol & Pathogen Examinat, Xian, Peoples R China; [Li, Manxiang] Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian 710049, Peoples R China	Xi'an Jiaotong University; Xi'an Medical University; Xi'an Jiaotong University	Zhao, XJ (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Emergency, Xian 710049, Peoples R China.	Zhao_xiandr@163.com			Natural Science Foundation of Xian	Natural Science Foundation of Xian	This study is supported by the Natural Science Foundation of Xian. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2013, NAT REV DRUG DISCOV, V12, P543, DOI 10.1038/nrd4025; Brusasco V, 2014, COMPR PHYSIOL, V4, P1, DOI 10.1002/cphy.c110037; Bryant CE, 2010, NAT REV MICROBIOL, V8, P8, DOI 10.1038/nrmicro2266; Cho MK, 2004, INT IMMUNOPHARMACOL, V4, P1419, DOI 10.1016/j.intimp.2004.06.011; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; Du SL, 2015, BIOCHEM BIOPH RES CO, V458, P667, DOI 10.1016/j.bbrc.2015.01.160; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Kim K, 2010, BRIT J HAEMATOL, V149, P537, DOI 10.1111/j.1365-2141.2010.08127.x; Lamela J, 2009, NEW ENGL J MED, V361, P1024, DOI 10.1056/NEJMc091370; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Ouagued M, 2005, PULM PHARMACOL THER, V18, P49, DOI 10.1016/j.pupt.2004.09.031; Park SJ, 2013, AM J MED SCI, V346, P494, DOI 10.1097/MAJ.0b013e318298a185; Profita M, 2003, THORAX, V58, P573, DOI 10.1136/thorax.58.7.573; Rabinovich RA, 2003, EUR RESPIR J, V21, P789, DOI 10.1183/09031936.03.00042702; Roversi S, 2014, EUR J CLIN INVEST, V44, P93, DOI 10.1111/eci.12181; Ruiz N, 2009, NAT REV MICROBIOL, V7, P677, DOI 10.1038/nrmicro2184; Sato AY, 2015, BONE, V73, P60, DOI 10.1016/j.bone.2014.12.012; Singh D, 2010, J CLIN PHARMACOL, V50, P94, DOI 10.1177/0091270009347873; Tsai EY, 2000, MOL CELL BIOL, V20, P6084, DOI 10.1128/MCB.20.16.6084-6094.2000; Yoon J, 2011, CANCER RES, V71, P445, DOI 10.1158/0008-5472.CAN-10-3058; Zhang JL, 2014, INT J MOL SCI, V15, P12119, DOI 10.3390/ijms150712119	22	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137107	10.1371/journal.pone.0137107	http://dx.doi.org/10.1371/journal.pone.0137107			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381508	Green Submitted, gold, Green Published			2022-12-27	WOS:000361790200014
J	Polla, DL; Cardoso, MTO; Silva, MCB; Cardoso, ICC; Medina, CTN; Araujo, R; Fernandes, CC; Reis, AMM; de Andrade, RV; Pereira, RW; Pogue, R				Polla, Daniel L.; Cardoso, Maria T. O.; Silva, Mayara C. B.; Cardoso, Isabela C. C.; Medina, Cristina T. N.; Araujo, Rosenelle; Fernandes, Camila C.; Reis, Alessandra M. M.; de Andrade, Rosangela V.; Pereira, Rinaldo W.; Pogue, Robert			Use of Targeted Exome Sequencing for Molecular Diagnosis of Skeletal Disorders	PLOS ONE			English	Article							IMPERFECTA TYPE-V; PHENOTYPIC VARIABILITY; CAMPOMELIC DYSPLASIA; GENETIC-VARIATIONS; MUTATIONS; DELETION; CAPTURE; MICRODELETION; LIBRARY; DISEASE	Genetic disorders of the skeleton comprise a large group of more than 450 clinically distinct and genetically heterogeneous diseases associated with mutations in more than 300 genes. Achieving a definitive diagnosis is complicated due to the genetic heterogeneity of these disorders, their individual rarity and their diverse radiographic presentations. We used targeted exome sequencing and designed a 1.4Mb panel for simultaneous testing of more than 4,800 exons in 309 genes involved in skeletal disorders. DNA from 69 individuals from 66 families with a known or suspected clinical diagnosis of a skeletal disorder was analyzed. Of 36 cases with a specific clinical hypothesis with a known genetic basis, mutations were identified for eight cases (22%). Of 20 cases with a suspected skeletal disorder but without a specific diagnosis, four causative mutations were identified. Also included were 11 cases with a specific skeletal disorder but for which there was at the time no known associated gene. For these cases, one mutation was identified in a known skeletal disease genes, and re-evaluation of the clinical phenotype in this case changed the diagnoses from osteodys-plasia syndrome to Apert syndrome. These results suggest that the NGS panel provides a fast, accurate and cost-effective molecular diagnostic tool for identifying mutations in a highly genetically heterogeneous set of disorders such as genetic skeletal disorders. The data also stress the importance of a thorough clinical evaluation before DNA sequencing. The strategy should be applicable to other groups of disorders in which the molecular basis is largely known.	[Polla, Daniel L.; Silva, Mayara C. B.; Cardoso, Isabela C. C.; Reis, Alessandra M. M.; de Andrade, Rosangela V.; Pereira, Rinaldo W.; Pogue, Robert] Univ Catolica Brasilia, Programa Posgrad Ciencias Genom & Biotecnol, Brasilia, DF, Brazil; [Cardoso, Maria T. O.; Medina, Cristina T. N.; Araujo, Rosenelle] Nucleo Genet Secretaria Saude Dist Fed, Brasilia, DF, Brazil; [Cardoso, Maria T. O.] Univ Catolica Brasilia, Curso Med, Taguatinga, DF, Brazil; [Fernandes, Camila C.] Univ Estadual Paulista, Fac Ciencias Agr & Vet, Dept Tecnol, Lab Multiusuario Centralizado Sequenciamento DNA, Jaboticabal, SP, Brazil	Universidade Catolica de Brasilia; Universidade Catolica de Brasilia; Universidade Estadual Paulista	Pogue, R (corresponding author), Univ Catolica Brasilia, Programa Posgrad Ciencias Genom & Biotecnol, Brasilia, DF, Brazil.	redward@ucb.br	Polla, Daniel L./B-3887-2015; Pogue, Robert/C-3860-2016; Pereira, Rinaldo W/B-9255-2011	Polla, Daniel L./0000-0002-5552-3488; Pogue, Robert/0000-0002-8789-3512; Pereira, Rinaldo W/0000-0003-3704-2848; Cardoso, Isabela/0000-0003-4494-5287; Batista da Silva, Mayara Cristina/0000-0002-0192-6767	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [564537/2010-1]; Fundacao de Apoio a Pesquisa do Distrito Federal [19300 487/2011]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio a Pesquisa do Distrito Federal(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	RP-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-564537/2010-1-http://www.cnpq.br/. RP-Fundacao de Apoio a Pesquisa do Distrito Federal-19300 487/2011-http://www.fap.df.gov.br/. RP DLP-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-http://www.capes.gov.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2003, AM J MED GENET A, V117A, P295, DOI 10.1002/ajmg.a.10915; Alanay Y, 2011, J CLIN RES PEDIATR E, V3, P163, DOI 10.4274/jcrpe.463; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Alvarado DM, 2010, AM J HUM GENET, V87, P154, DOI 10.1016/j.ajhg.2010.06.010; Balemans W, 2005, BONE, V36, P943, DOI 10.1016/j.bone.2005.02.019; Barroso E, 2010, EUR J MED GENET, V53, P204, DOI 10.1016/j.ejmg.2010.04.003; Becker J, 2011, AM J HUM GENET, V88, P362, DOI 10.1016/j.ajhg.2011.01.015; Bedoyan JK, 2011, AM J MED GENET A, V155A, P154, DOI 10.1002/ajmg.a.33751; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Biesecker LG, 2014, NEW ENGL J MED, V370, P2418, DOI 10.1056/NEJMra1312543; Biesecker LG, 2010, NAT GENET, V42, P13, DOI 10.1038/ng0110-13; Bleyl SB, 2007, AM J MED GENET A, V143A, P2785, DOI 10.1002/ajmg.a.32036; Bodi K, 2013, J Biomol Tech, V24, P73, DOI 10.7171/jbt.13-2402-002; Bonnefond A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013630; Brett M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093409; Campeau PM, 2012, HUM MOL GENET, V21, P4904, DOI 10.1093/hmg/dds326; Carmichael H, 2013, CLIN GENET, V84, P213, DOI 10.1111/cge.12064; Chen XJ, 2013, INVEST OPHTH VIS SCI, V54, P2186, DOI 10.1167/iovs.12-10967; Cho TJ, 2012, AM J HUM GENET, V91, P343, DOI 10.1016/j.ajhg.2012.06.005; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Collins JS, 2002, AM J HUM GENET, V71, P1251, DOI 10.1086/344344; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Manta FSD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075145; Eggermann T, 2012, CLIN GENET, V81, P298, DOI 10.1111/j.1399-0004.2011.01719.x; Fattahi Z, 2014, J HUM GENET, V59, P368, DOI 10.1038/jhg.2014.28; Foulquier F, 2012, AM J HUM GENET, V91, P15, DOI 10.1016/j.ajhg.2012.05.002; Grover CE, 2012, AM J BOT, V99, P312, DOI 10.3732/ajb.1100323; Hannes F, 2012, AM J MED GENET A, V158A, P996, DOI 10.1002/ajmg.a.35299; Hassed SJ, 2012, AM J HUM GENET, V91, P391, DOI 10.1016/j.ajhg.2012.07.005; Hilton MJ, 2002, J HUM GENET, V47, P103, DOI 10.1007/s100380200010; Iqbal Z, 2010, AM J HUM GENET, V86, P254, DOI 10.1016/j.ajhg.2010.01.009; Isidor B, 2010, AM J HUM GENET, V87, P95, DOI 10.1016/j.ajhg.2010.05.012; Jones WD, 2012, AM J HUM GENET, V91, P358, DOI 10.1016/j.ajhg.2012.06.008; Kannu P, 2006, AM J MED GENET A, V140A, P1955, DOI 10.1002/ajmg.a.31411; Kinning E, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.033829; Kircher M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-382; Klopocki E, 2010, AM J HUM GENET, V86, P434, DOI 10.1016/j.ajhg.2010.01.023; Korf BR, 2013, JAMA-J AM MED ASSOC, V309, P1511, DOI 10.1001/jama.2013.3239; Krakow D, 2010, GENET MED, V12, P327, DOI 10.1097/GIM.0b013e3181daae9b; Krakow D, 2009, AM J HUM GENET, V84, P307, DOI 10.1016/j.ajhg.2009.01.021; Ku CS, 2012, ANN NEUROL, V71, P5, DOI 10.1002/ana.22647; Kurian AW, 2014, J CLIN ONCOL, V32, P2001, DOI 10.1200/JCO.2013.53.6607; Laurell T, 2012, HUM MUTAT, V33, P1063, DOI 10.1002/humu.22097; Lecointre C, 2009, AM J MED GENET A, V149A, P1183, DOI 10.1002/ajmg.a.32830; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; Lemke JR, 2012, EPILEPSIA, V53, P1387, DOI 10.1111/j.1528-1167.2012.03516.x; Lin X, 2012, HEARING RES, V288, P67, DOI 10.1016/j.heares.2012.01.004; Linden H, 2009, AM J MED GENET A, V149A, P2809, DOI 10.1002/ajmg.a.33096; Lins TC, 2010, AM J HUM BIOL, V22, P187, DOI 10.1002/ajhb.20976; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Lynch SA, 2011, EUR J HUM GENET, V19, P534, DOI 10.1038/ejhg.2010.215; Makitie O, 2011, ENDOCR DEV, V21, P78, DOI 10.1159/000328131; Malik TH, 2002, MOL CELL BIOL, V22, P8592, DOI 10.1128/MCB.22.24.8592-8600.2002; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Millat G, 2014, MOL DIAGN THER, V18, P533, DOI 10.1007/s40291-014-0099-y; Millat G, 2014, CLIN CHIM ACTA, V433, P266, DOI 10.1016/j.cca.2014.03.032; Mook ORF, 2013, J MED GENET, V50, P614, DOI 10.1136/jmedgenet-2012-101231; Natsoulis G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021088; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nigro Vincenzo, 2012, Acta Myol, V31, P196; Norton N, 2011, AM J HUM GENET, V88, P273, DOI 10.1016/j.ajhg.2011.01.016; Oyola SO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-1; Pauli RM, 1993, ACHONDROPLASIA; Pena SDJ, 2009, BRAZ J MED BIOL RES, V42, P870, DOI 10.1590/S0100-879X2009005000026; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Pop R, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013185; Qi XP, 2013, GENE, V516, P93, DOI 10.1016/j.gene.2012.12.060; Rauch F, 2013, J MED GENET, V50, P21, DOI 10.1136/jmedgenet-2012-101307; Redin C, 2014, J MED GENET, V51, P724, DOI 10.1136/jmedgenet-2014-102554; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rimoin DL, 2007, ANN NY ACAD SCI, V1117, P302, DOI 10.1196/annals.1402.072; Rizzo JM, 2012, CANCER PREV RES, V5, P887, DOI 10.1158/1940-6207.CAPR-11-0432; Sanlaville D, 2005, EUR J HUM GENET, V13, P690, DOI 10.1038/sj.ejhg.5201383; Sarig O, 2012, AM J HUM GENET, V91, P337, DOI 10.1016/j.ajhg.2012.06.003; Schmidts M, 2013, J MED GENET, V50, P309, DOI 10.1136/jmedgenet-2012-101284; Schwartz CE, 2000, EUR J HUM GENET, V8, P869, DOI 10.1038/sj.ejhg.5200553; Semler O, 2012, AM J HUM GENET, V91, P349, DOI 10.1016/j.ajhg.2012.06.011; Shaheen R, 2012, AM J HUM GENET, V91, P330, DOI 10.1016/j.ajhg.2012.05.025; Shashi V, 2014, GENET MED, V16, P176, DOI 10.1038/gim.2013.99; Shen PD, 2011, P NATL ACAD SCI USA, V108, P6549, DOI 10.1073/pnas.1018981108; Sikkema-Raddatz B, 2013, HUM MUTAT, V34, P1035, DOI 10.1002/humu.22332; Simpson MA, 2011, NAT GENET, V43, P303, DOI 10.1038/ng.779; Skuse GR, 1997, HUM MOL GENET, V6, P1707, DOI 10.1093/hmg/6.10.1707; Smyk M, 2007, AM J MED GENET A, V143A, P866, DOI 10.1002/ajmg.a.31631; South ST, 2008, AM J MED GENET A, V146A, P2691, DOI 10.1002/ajmg.a.32516; Srivastava S, 2014, ANN NEUROL, V76, P473, DOI 10.1002/ana.24251; Steichen-Gersdorf E, 2008, CLIN GENET, V74, P560, DOI 10.1111/j.1399-0004.2008.01050.x; Stevenson RE, 2006, HUMAN MALFORMATIONS, pxiv; Sule G, 2013, OSTEOPOROSIS INT, V24, P2253, DOI 10.1007/s00198-013-2290-0; Teer JK, 2010, HUM MOL GENET, V19, pR145, DOI 10.1093/hmg/ddq333; Thomas S, 2012, AM J HUM GENET, V91, P372, DOI 10.1016/j.ajhg.2012.06.017; Valstar MJ, 2010, ANN NEUROL, V68, P876, DOI 10.1002/ana.22092; Vilain E, 1999, J CLIN ENDOCR METAB, V84, P4335, DOI 10.1210/jc.84.12.4335; Wang JL, 2010, BRAIN, V133, P3510, DOI 10.1093/brain/awq323; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Watson Michael S, 2004, Genet Med, V6, P387, DOI 10.1097/01.GIM.0000139506.11694.7C; Wei XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029500; Wooderchak-Donahue WL, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-50; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Wunderle VM, 1998, P NATL ACAD SCI USA, V95, P10649, DOI 10.1073/pnas.95.18.10649; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015; Xue Y, 2015, GENET MED, V17, P444, DOI 10.1038/gim.2014.122; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Yang Y, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/145641; Zemojtel T, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009262; Zhou G, 1999, HUM MOL GENET, V8, P2311, DOI 10.1093/hmg/8.12.2311	107	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138314	10.1371/journal.pone.0138314	http://dx.doi.org/10.1371/journal.pone.0138314			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26380986	gold, Green Published, Green Submitted			2022-12-27	WOS:000361790200090
J	Tako, E; Reed, S; Anandaraman, A; Beebe, SE; Hart, JJ; Glahn, RP				Tako, Elad; Reed, Spenser; Anandaraman, Amrutha; Beebe, Steve E.; Hart, Jonathan J.; Glahn, Raymond P.			Studies of Cream Seeded Carioca Beans (Phaseolus vulgaris L.) from a Rwandan Efficacy Trial: In Vitro and In Vivo Screening Tools Reflect Human Studies and Predict Beneficial Results from Iron Biofortified Beans	PLOS ONE			English	Article							DIETARY POLYPHENOLIC COMPOUNDS; BIOAVAILABLE IRON; ASCORBIC-ACID; GALLUS-GALLUS; COMMON BEANS; ABSORPTION; RED; DEFICIENCY; PHYTATE; WOMEN	Iron (Fe) deficiency is a highly prevalent micronutrient insufficiency predominantly caused by a lack of bioavailable Fe from the diet. The consumption of beans as a major food crop in some populations suffering from Fe deficiency is relatively high. Therefore, our objective was to determine whether a biofortified variety of cream seeded carioca bean (Phaseolus vulgaris L.) could provide more bioavailable-Fe than a standard variety using in-vivo (broiler chicken, Gallus gallus) and in-vitro (Caco-2 cell) models. Studies were conducted under conditions designed to mimic the actual human feeding protocol. Two carioca-beans, a standard (G4825; 58 mu g Fe/g) and a biofortified (SMC; 106 mu g Fe/g), were utilized. Diets were formulated to meet the nutrient requirements of Gallus gallus except for Fe (33.7 and 48.7 mu g Fe/g, standard and biofortified diets, respectively). In-vitro observations indicated that more bioavailable- Fe was present in the biofortified beans and diet (P<0.05). In-vivo, improvements in Fe-status were observed in the biofortified bean treatment, as indicated by the increased total-body-Hemoglobin-Fe, and hepatic Fe-concentration (P<0.05). Also, DMT-1 mRNA-expression was increased in the standard bean treatment (P< 0.05), indicating an upregulation of absorption to compensate for less bioavailable-Fe. These results demonstrate that the biofortified beans provided more bioavailable Fe; however, the in vitro results revealed that ferritin formation values were relatively low. Such observations are indicative of the presence of high levels of polyphenols and phytate that inhibit Fe absorption. Indeed, we identified higher levels of phytate and quercetin 3-glucoside in the Fe biofortified bean variety. Our results indicate that the biofortified bean line was able to moderately improve Fe-status, and that concurrent increase in the concentration of phytate and polyphenols in beans may limit the benefit of increased Fe-concentration. Therefore, specific targeting of such compounds during the breeding process may yield improved dietary Fe-bioavailability. Our findings are in agreement with the human efficacy trial that demonstrated that the biofortified carioca beans improved the Fe-status of Rwandan women. We suggest the utilization of these in vitro and in vivo screening tools to guide studies aimed to develop and evaluate biofortified staple food crops. This approach has the potential to more effectively utilize research funds and provides a means to monitor the nutritional quality of the Fe-biofortified crops once released to farmers.	[Tako, Elad; Reed, Spenser; Hart, Jonathan J.; Glahn, Raymond P.] Cornell Univ, USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA; [Anandaraman, Amrutha] Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA; [Beebe, Steve E.] CIAT Int Ctr Trop Agr, Cali 6713, Colombia	Cornell University; United States Department of Agriculture (USDA); Cornell University; Alliance; International Center for Tropical Agriculture - CIAT	Tako, E (corresponding author), Cornell Univ, USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA.	et79@cornell.edu			ARS [ARS-0426380] Funding Source: Federal RePORTER	ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)		Beebe Stephen, 2000, Food and Nutrition Bulletin, V21, P387; Bhargava A, 2001, J NUTR, V131, P758, DOI 10.1093/jn/131.3.758; Blair MW, 2013, J AGR FOOD CHEM, V61, P8287, DOI 10.1021/jf400774y; Blair MW, 2012, THEOR APPL GENET, V125, P1015, DOI 10.1007/s00122-012-1891-x; Blair MW, 2010, THEOR APPL GENET, V121, P237, DOI 10.1007/s00122-010-1305-x; Blair MW, 2010, J PLANT REGIST, V4, P55, DOI 10.3198/jpr2008.09.0562crg; Bouis HE, 2002, J NUTR, V132, p491S, DOI 10.1093/jn/132.3.491S; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; BRUNE M, 1989, EUR J CLIN NUTR, V43, P547; BRUNE M, 1989, AM J CLIN NUTR, V49, P542, DOI 10.1093/ajcn/49.3.542; Cercamondi CI, 2014, BRIT J NUTR, V111, P481, DOI 10.1017/S0007114513002705; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; Danquah I, 2014, TROP MED INT HEALTH, V19, P117, DOI 10.1111/tmi.12216; De Moura FF, 2014, ADV NUTR, V5, P568, DOI 10.3945/an.114.006627; Della Valle DM, 2014, FOOD NUTR BULL, V35, P431, DOI 10.1177/156482651403500405; DellaValle DM, 2013, J AGR FOOD CHEM, V61, P8084, DOI 10.1021/jf4022916; Fanzo J, 2011, COMBATING MICRONUTRIENT DEFICIENCIES: FOOD-BASED APPROACHES, P76, DOI 10.1079/9781845937140.0076; Fleming RE, 1999, P NATL ACAD SCI USA, V96, P3143, DOI 10.1073/pnas.96.6.3143; Glahn RP, 2002, J AGR FOOD CHEM, V50, P3586, DOI 10.1021/jf0116496; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Haas J, 2014, FASEB J, V28; Hart J. J., 2013, FASEB J, V634, P13; Hart JJ, 2015, J AGR FOOD CHEM, V63, P5950, DOI 10.1021/acs.jafc.5b00531; Hu Y, 2006, J AGR FOOD CHEM, V54, P9254, DOI 10.1021/jf0612981; HURRELL RF, 1992, AM J CLIN NUTR, V56, P573, DOI 10.1093/ajcn/56.3.573; Kim EY, 2008, J NUTR, V138, P1647, DOI 10.1093/jn/138.9.1647; Kim E, 2011, J NUTR, V141, P828, DOI 10.3945/jn.110.134031; Kumar V, 2010, FOOD CHEM, V120, P945, DOI 10.1016/j.foodchem.2009.11.052; Lesjak R, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0102900, DOI 10.1371/J0URNAL.P0NE.0102900]; LOZOFF B, 1991, NEW ENGL J MED, V325, P687, DOI 10.1056/NEJM199109053251004; Ma XY, 2014, POULTRY SCI, V93, P556, DOI 10.3382/ps.2013-03296; Mira L, 2002, FREE RADICAL RES, V36, P1199, DOI 10.1080/1071576021000016463; Mladenka P, 2011, J INORG BIOCHEM, V105, P693, DOI 10.1016/j.jinorgbio.2011.02.003; Murgia I, 2012, TRENDS PLANT SCI, V17, P47, DOI 10.1016/j.tplants.2011.10.003; Nestel P, 2006, J NUTR, V136, P1064, DOI 10.1093/jn/136.4.1064; Park SS, 2008, J CELL BIOCHEM, V103, P1989, DOI 10.1002/jcb.21588; Petry N, 2015, NUTRIENTS, V7, P1144, DOI 10.3390/nu7021144; Petry N, 2014, J NUTR, V144, P1681, DOI 10.3945/jn.114.192989; Petry N, 2012, J NUTR, V142, P492, DOI 10.3945/jn.111.149286; Petry N, 2010, J NUTR, V140, P1977, DOI 10.3945/jn.110.125369; Reed S, 2014, NUTRIENTS, V6, P1164, DOI 10.3390/nu6031164; Ryan P, 2008, J INORG BIOCHEM, V102, P127, DOI 10.1016/j.jinorgbio.2007.07.041; Samman S, 2001, AM J CLIN NUTR, V73, P607; Scalbert A, 2005, AM J CLIN NUTR, V81, p215S, DOI 10.1093/ajcn/81.1.215S; Sharp PA, 2010, INT J VITAM NUTR RES, V80, P231, DOI 10.1024/0300-9831/a000029; Tako E., 2011, International Journal of Poultry Science, V10, P42; Tako E, 2010, POULTRY SCI, V89, P514, DOI 10.3382/ps.2009-00326; Tako E, 2015, NUTR J, V14, DOI 10.1186/1475-2891-14-11; Tako E, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-28; Tako E, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-113; Tako E, 2010, INT J VITAM NUTR RES, V80, P416, DOI 10.1024/0300-9831/a000028; Tako E, 2009, J AGR FOOD CHEM, V57, P3134, DOI 10.1021/jf803647m; Welch RM, 2000, J AGR FOOD CHEM, V48, P3576, DOI 10.1021/jf0000981; WHO, 2001, GUIDE PROGRAM MANAGE, P15; Wortmann C.S., 1998, ATLAS COMMON BEAN PH; Zimmermann MB, 2005, AM J CLIN NUTR, V81, P115	56	41	42	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138479	10.1371/journal.pone.0138479	http://dx.doi.org/10.1371/journal.pone.0138479			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381264	Green Published, Green Submitted, gold			2022-12-27	WOS:000361790200112
J	Tsai, FM; Chen, ML; Wang, LK; Lee, MC				Tsai, Fu-Ming; Chen, Mao-Liang; Wang, Lu-Kai; Lee, Ming-Cheng			H-rev107 Regulates Cytochrome P450 Reductase Activity and Increases Lipid Accumulation	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PROTEIN; FUNCTIONAL-CHARACTERIZATION; DOWN-REGULATION; GENE; CLONING; ACTIVATION; P450; METABOLISM; APOPTOSIS; ENZYMES	H-rev107 is a member of the HREV107 type II tumor suppressor gene family and acts as a phospholipase to catalyze the release of fatty acids from glycerophospholipid. H-rev107 has been shown to play an important role in fat metabolism in adipocytes through the PGE2/cAMP pathway, but the detailed molecular mechanism underlying H-rev107-mediated lipid degradation has not been studied. In this study, the interaction between H-rev107 and cytochrome P450 reductase (POR), which is involved in hepatic lipid content regulation, was determined by yeast two-hybrid screen and confirmed by using in vitro pull down assays and immunofluorescent staining. The expression of POR in H-rev107-expressing cells enhanced the H-rev107-mediated release of arachidonic acid. However, H-rev107 inhibited POR activity and relieved POR-mediated decreased triglyceride content in HtTA and HeLa cervical cells. The inhibitory effect of H-rev107 will be abolished when POR-expressing cells transfected with PLA(2)-lacking pH-rev107 or treated with PLA(2) inhibitor. Silencing of H-rev107 using siRNA resulted in increased glycerol production and reversion of free fatty acid-mediated growth suppression in Huh7 hepatic cells. In summary, our results revealed that H-rev107 is also involved in lipid accumulation in liver cells through the POR pathway via its PLA(2) activity.	[Tsai, Fu-Ming; Chen, Mao-Liang; Lee, Ming-Cheng] Buddhist Tzuchi Med Fdn, Taipei Tzuchi Hosp, Dept Res, New Taipei City, Taiwan; [Wang, Lu-Kai] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan	National Taiwan University	Tsai, FM (corresponding author), Buddhist Tzuchi Med Fdn, Taipei Tzuchi Hosp, Dept Res, New Taipei City, Taiwan.	afu2215@gmail.com	Chen, Mao-Liang/AAH-1283-2019	Tsai, Fu-Ming/0000-0002-4563-0458				Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Baer-Dubowska W, 2013, EXPERT OPIN DRUG MET, V9, P927, DOI 10.1517/17425255.2013.795219; Cao RS, 2014, CELL PHYSIOL BIOCHEM, V34, P1427, DOI 10.1159/000366348; Chavez-Tapia NC, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-20; Clark SR, 2011, BLOOD, V117, P2033, DOI 10.1182/blood-2010-04-278887; Dai ZY, 2013, INT J BIOCHEM CELL B, V45, P2076, DOI 10.1016/j.biocel.2013.07.008; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Deucher A, 2000, INT J ONCOL, V17, P1195; Duncan RE, 2008, J BIOL CHEM, V283, P25428, DOI 10.1074/jbc.M804146200; Fluck CE, 2004, NAT GENET, V36, P228, DOI 10.1038/ng1300; Furge LL, 2006, BIOCHEM MOL BIOL EDU, V34, P66, DOI 10.1002/bmb.2006.49403402066; GELB MH, 1994, FASEB J, V8, P916, DOI 10.1096/fasebj.8.12.8088457; Guengerich FP, 2009, NAT PROTOC, V4, P1245, DOI 10.1038/nprot.2009.121; HAJNAL A, 1994, ONCOGENE, V9, P479; Huang SL, 2002, ANTICANCER RES, V22, P799; Huang SL, 2000, MOL CELL ENDOCRINOL, V159, P15, DOI 10.1016/S0303-7207(99)00207-5; Hughes PJ, 2000, J GEN VIROL, V81, P201, DOI 10.1099/0022-1317-81-1-201; Ito H, 2001, CYTOGENET CELL GENET, V93, P36, DOI 10.1159/000056944; Jans R, 2008, J INVEST DERMATOL, V128, P517, DOI 10.1038/sj.jid.5701035; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jin XH, 2009, BBA-MOL CELL BIOL L, V1791, P32, DOI 10.1016/j.bbalip.2008.09.006; Kroetz DL, 2002, CURR OPIN LIPIDOL, V13, P273, DOI 10.1097/00041433-200206000-00007; LIU J, 1995, J PHARMACOL EXP THER, V275, P768; LU AYH, 1969, J BIOL CHEM, V244, P3714; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; Mutch DM, 2007, J PROTEOME RES, V6, P3976, DOI 10.1021/pr0700448; Nazarenko I, 2007, J CELL SCI, V120, P1393, DOI 10.1242/jcs.000018; Pikuleva I, 1999, Mol Aspects Med, V20, P33; Porter TD, 2011, DRUG METAB DISPOS, V39, P966, DOI 10.1124/dmd.111.038562; Ren XB, 2010, BIOMOL NMR ASSIGN, V4, P175, DOI 10.1007/s12104-010-9238-5; Scharadin TM, 2012, J CELL SCI, V125, P2604, DOI 10.1242/jcs.096495; Scharadin TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023230; Sers C, 1997, J CELL BIOL, V136, P935, DOI 10.1083/jcb.136.4.935; Shen AL, 2002, J BIOL CHEM, V277, P6536, DOI 10.1074/jbc.M111408200; Shinohara N, 2011, J LIPID RES, V52, P1927, DOI 10.1194/jlr.M015081; Shyu RY, 2008, AMINO ACIDS, V35, P129, DOI 10.1007/s00726-007-0612-2; Shyu RY, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-30; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Spector AA, 2009, J LIPID RES, V50, pS52, DOI 10.1194/jlr.R800038-JLR200; Sturniolo MT, 2003, J BIOL CHEM, V278, P48066, DOI 10.1074/jbc.M307215200; Tsai FM, 2006, CELL SIGNAL, V18, P349, DOI 10.1016/j.cellsig.2005.05.005; Tsai FM, 2007, CELL SIGNAL, V19, P989, DOI 10.1016/j.cellsig.2006.11.005; Tsai FM, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-15; Uyama T, 2015, J BIOL CHEM, V290, P17520, DOI 10.1074/jbc.M114.635433; Uyama T, 2012, J BIOL CHEM, V287, P2706, DOI 10.1074/jbc.M111.267575; Uyama T, 2009, BBA-MOL CELL BIOL L, V1791, P1114, DOI 10.1016/j.bbalip.2009.07.001; Uyama T, 2009, J LIPID RES, V50, P685, DOI 10.1194/jlr.M800453-JLR200; Wang CH, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-36; WAXMAN DJ, 1992, J STEROID BIOCHEM, V43, P1055, DOI 10.1016/0960-0760(92)90333-E; Weng Y, 2005, J BIOL CHEM, V280, P31686, DOI 10.1074/jbc.M504447200; Wu CC, 2012, BBA-MOL CELL RES, V1823, P2227, DOI 10.1016/j.bbamcr.2012.08.013	52	3	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138586	10.1371/journal.pone.0138586	http://dx.doi.org/10.1371/journal.pone.0138586			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381418	Green Submitted, Green Published, gold			2022-12-27	WOS:000361790200133
J	Wang, HF; Jacobs, DR; Gaffo, AL; Gross, MD; Goff, DC; Carr, JJ				Wang, Huifen; Jacobs, David R., Jr.; Gaffo, Angelo L.; Gross, Myron D.; Goff, David C., Jr.; Carr, J. Jeffrey			Serum Urate and Incident Cardiovascular Disease: The Coronary Artery Risk Development in Young Adults (CARDIA) Study	PLOS ONE			English	Article							URIC-ACID LEVELS; HEART-DISEASE; SUBCLINICAL ATHEROSCLEROSIS; BLOOD-PRESSURE; HYPERURICEMIA; ASSOCIATION; MORTALITY; PLASMA; STROKE	Objective There is controversy about whether serum urate (sUA) predicts future cardiovascular disease (CVD) independently of classical risk factors, and the age at which any prediction starts. We studied the sUA-CVD association among generally healthy adults. Methods CARDIA recruited 5115 black and white individuals aged 18-30 years in 1985-1986 (year-). Fatal and nonfatal CVD events by year 27 (n = 164) were ascertained during annual contacts and classified using medical records. The association with sUA (year-0, 10, 15 and 20) was modeled using Cox proportional hazards regression, pooling over gender-specific quartiles. Results Mean sUA concentration was higher in men than women, but increased over time in both genders. Those with elevated sUA had worse metabolic profiles that substantially deteriorated over time. Adjusting for demographic and lifestyle factors (the minimal model), baseline sUA concentration was positively associated with incident CVD (hazard ratio (HR) per mg/dL = 1.21; 95% confidence interval: 1.05, 1.39; P = 0.005). This positive association attenuated to nonsignificance in the full model accounting simultaneously for classical CVD risk factors (HR = 1.09; 0.94, 1.27; P = 0.24). Both the minimal and full models appeared to show stronger associations (than year-0 sUA) between year-10 sUA and incident CVD (HR = 1.27 and 1.12, respectively), but sUA was not statistically significant in the full model. Despite fewer events, year-15 sUA showed a significant sUA-CVD association pattern, with minimal model association magnitude comparable to year-10, and remained significant in the full model (HR = 1.19; 1.02, 1.40; P = 0.03). Hyperuricemia at year-15 strongly predicted CVD risk (HR = 2.11; 1.34, 3.33; P = 0.001), with some attenuation in the full model (HR = 1.68; P = 0.04). Conclusions sUA may be an early biomarker for CVD in adults entering middle age. The prediction of CVD by sUA appeared to strengthen with aging. The potential complex relation of sUA with deterioration of a cluster of metabolic abnormalities warrants future exploration.	[Wang, Huifen] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Nutr Epidemiol Lab, Boston, MA 02111 USA; [Jacobs, David R., Jr.] Univ Minnesota Twin Cities, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Gaffo, Angelo L.] Univ Alabama Birmingham, Div Rheumatol, Birmingham, AL USA; [Gross, Myron D.] Univ Minnesota Twin Cities, Lab Med & Pathol, Minneapolis, MN USA; [Goff, David C., Jr.] Univ Colorado Denver, Colorado Sch Publ Hlth, Aurora, CO USA; [Carr, J. Jeffrey] Vanderbilt Univ, Med Ctr, Dept Radiol, Nashville, TN 37232 USA	Tufts University; United States Department of Agriculture (USDA); University of Minnesota System; University of Minnesota Twin Cities; University of Alabama System; University of Alabama Birmingham; University of Minnesota System; University of Minnesota Twin Cities; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Vanderbilt University	Jacobs, DR (corresponding author), Univ Minnesota Twin Cities, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	jacob004@umn.edu	Gaffo, Angelo/ABD-1653-2021; Carr, John Jeffrey/A-1938-2012; Carr, John/AAN-7531-2021	Gaffo, Angelo/0000-0001-7365-7212; Carr, John Jeffrey/0000-0002-4398-8237; Carr, John/0000-0002-4398-8237; Jacobs, David/0000-0002-7232-0543	National Heart, Lung, and Blood Institute [HHSN268201300025C, HHSN268201300026C, HHSN268201300027C, HHSN268201300028C, HHSN268201300029C, HHSN268200900041C, RO1- HL53560]; Cymabay, Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053560] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cymabay, Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	CARDIA is supported by contracts HHSN268201300025C, HHSN268201300026C, HHSN268201300027C, HHSN268201300028C, HHSN268201300029C, and HHSN268200900041C from the National Heart, Lung, and Blood Institute. DRJ and MDG are the joint principal investigators for YALTA supported by RO1- HL53560 from the National Heart, Lung, and Blood Institute. The funding organization participated in the design of study, choice of enrolled patients, and review and interpretation of data. The CARDIA Publications and Presentations Committee, in which National Heart, Lung, and Blood Institute and academic members participate as equal partners, reviewed and approved the manuscript. Cymabay, Inc provided support in the form of consulting fees for activities unrelated to this paper or its general topic for one author (ALG), but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section.	ADAMOPOULOS D, 1977, ACTA ENDOCRINOL-COP, V85, P198; Archer SL, 1998, ARTERIOSCL THROM VAS, V18, P1119, DOI 10.1161/01.ATV.18.7.1119; Baena CP, 2015, AM J HYPERTENS; Baker JF, 2005, AM J MED, V118, P816, DOI 10.1016/j.amjmed.2005.03.043; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; Berry CE, 2004, J PHYSIOL-LONDON, V555, P589, DOI 10.1113/jphysiol.2003.055913; Bos MJ, 2006, STROKE, V37, P1503, DOI 10.1161/01.STR.0000221716.55088.d4; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Dutta A, 2013, J AM GERIATR SOC, V61, P319, DOI 10.1111/jgs.12149; DYER AR, 1990, J CLIN EPIDEMIOL, V43, P1, DOI 10.1016/0895-4356(90)90050-Y; Elsurer R, 2014, BLOOD PRESS MONIT, V19, P271, DOI 10.1097/MBP.0000000000000056; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Feig DI, 2012, J CLIN HYPERTENS, V14, P346, DOI 10.1111/j.1751-7176.2012.00662.x; FOSSATI P, 1980, CLIN CHEM, V26, P227; Gaffo AL, 2012, ANN RHEUM DIS; Gaffo AL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3552; Green D, 2009, ATHEROSCLEROSIS, V202, P623, DOI 10.1016/j.atherosclerosis.2008.05.039; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Huang H, 2014, EUR J HEART FAIL, V16, P15, DOI 10.1093/eurjhf/hft132; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; Johnson RJ, 2013, DIABETES, V62, P3307, DOI 10.2337/db12-1814; Kim SY, 2010, ARTHRIT CARE RES, V62, P170, DOI 10.1002/acr.20065; Kim SY, 2009, ARTHRIT RHEUM-ARTHR, V61, P885, DOI 10.1002/art.24612; Kleber ME, 2015, J AM SOC NEPHROL; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MCDONALD A, 1991, J AM DIET ASSOC, V91, P1104; Mehta T, 2014, AM J HYPERTENS; Mercuro G, 2010, J CARDIOVASC MED, V11, P207, DOI 10.2459/JCM.0b013e32833178ed; Moriarity JT, 2000, ANN EPIDEMIOL, V10, P136, DOI 10.1016/S1047-2797(99)00037-X; Musser A W, 1966, Tech Bull Regist Med Technol, V36, P21; Odden MC, 2014, AM J KIDNEY DIS, V64, P550, DOI 10.1053/j.ajkd.2014.04.024; Oikonen M, 2012, ATHEROSCLEROSIS, V223, P497, DOI 10.1016/j.atherosclerosis.2012.05.036; Osgood K, 2013, METAB SYNDR RELAT D, V11, P157, DOI 10.1089/met.2012.0151; Palmer TM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4262; Reaven G, 2014, J INTERN MED; Sattui SE, 2014, RHEUM DIS CLIN N AM, V40, P251, DOI 10.1016/j.rdc.2014.01.005; The CARDIA Endpoints Surveillance and Adjudication Committee (ESAS), 2012, CARDIA ENDP EV MAN O; Thornley S, 2013, RHEUMATOLOGY, V52, P135, DOI 10.1093/rheumatology/kes269; Wang H, 2013, J INTERN MED; Wheeler JG, 2005, PLOS MED, V2, P236, DOI 10.1371/journal.pmed.0020076; Yang QO, 2010, CIRC-CARDIOVASC GENE, V3, P523, DOI 10.1161/CIRCGENETICS.109.934455; ZAVARONI I, 1993, J INTERN MED, V234, P25, DOI 10.1111/j.1365-2796.1993.tb00700.x	43	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138067	10.1371/journal.pone.0138067	http://dx.doi.org/10.1371/journal.pone.0138067			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381512	gold, Green Published, Green Submitted			2022-12-27	WOS:000361790200054
J	Carnes, MU; Campbell, T; Huang, W; Butler, DG; Carbone, MA; Duncan, LH; Harbajan, SV; King, EM; Peterson, KR; Weitzel, A; Zhou, SS; Mackay, TFC				Carnes, Megan Ulmer; Campbell, Terry; Huang, Wen; Butler, Daniel G.; Carbone, Mary Anna; Duncan, Laura H.; Harbajan, Sasha V.; King, Edward M.; Peterson, Kara R.; Weitzel, Alexander; Zhou, Shanshan; Mackay, Trudy F. C.			The Genomic Basis of Postponed Senescence in Drosophila melanogaster	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; AFFECTING LIFE-SPAN; AGE-SPECIFIC PATTERNS; CAENORHABDITIS-ELEGANS; INSULIN-RECEPTOR; HUMAN LONGEVITY; OXIDATIVE STRESS; EXPRESSION ANALYSIS; IMMUNE-RESPONSE; CALORIE RESTRICTION	Natural populations harbor considerable genetic variation for lifespan. While evolutionary theory provides general explanations for the existence of this variation, our knowledge of the genes harboring naturally occurring polymorphisms affecting lifespan is limited. Here, we assessed the genetic divergence between five Drosophila melanogaster lines selected for postponed senescence for over 170 generations (O lines) and five lines from the same base population maintained at a two week generation interval for over 850 generations (B lines). On average, O lines live 70% longer than B lines, are more productive at all ages, and have delayed senescence for other traits than reproduction. We performed population sequencing of pools of individuals from all B and O lines and identified 6,394 genetically divergent variants in or near 1,928 genes at a false discovery rate of 0.068. A 2.6 Mb region at the tip of the X chromosome contained many variants fixed for alternative alleles in the two populations, suggestive of a hard selective sweep. We also assessed genome wide gene expression of O and B lines at one and five weeks of age using RNA sequencing and identified genes with significant (false discovery rate < 0.05) effects on gene expression with age, population and the age by population interaction, separately for each sex. We identified transcripts that exhibited the transcriptional signature of postponed senescence and integrated the gene expression and genetic divergence data to identify 98 (175) top candidate genes in females (males) affecting postponed senescence and increased lifespan. While several of these genes have been previously associated with Drosophila lifespan, most are novel and constitute a rich resource for future functional validation.	[Carnes, Megan Ulmer; Campbell, Terry; Huang, Wen; Butler, Daniel G.; Carbone, Mary Anna; Duncan, Laura H.; Harbajan, Sasha V.; King, Edward M.; Peterson, Kara R.; Weitzel, Alexander; Zhou, Shanshan; Mackay, Trudy F. C.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Huang, Wen; Carbone, Mary Anna; Zhou, Shanshan; Mackay, Trudy F. C.] N Carolina State Univ, Genet Program, Raleigh, NC 27695 USA; [Carbone, Mary Anna; Zhou, Shanshan; Mackay, Trudy F. C.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Mackay, TFC (corresponding author), N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA.	trudy_mackay@ncsu.edu		Carnes, Megan/0000-0002-7270-132X; Huang, Wen/0000-0001-6788-8364	National Institutes of Health [R01 AG043490, R01 GM45146]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG043490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants R01 AG043490 and R01 GM45146 to TFCM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersen SL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002315; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; Ayyadevara S, 2001, GENETICS, V157, P655; Beekman M, 2013, AGING CELL, V12, P184, DOI 10.1111/acel.12039; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Burke MK, 2010, NATURE, V467, P587, DOI 10.1038/nature09352; Carbone MA, 2006, CURR BIOL, V16, P912, DOI 10.1016/j.cub.2006.03.051; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Charlesworth B., 1994, EVOLUTION AGE STRUCT, V2nd ed, edited by C. Cannings, F. C. Hoppensteadt, and L. A. Segel.; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Curtsinger JW, 2002, MECH AGEING DEV, V123, P81, DOI 10.1016/S0047-6374(01)00345-1; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; De Luca M, 2003, NAT GENET, V34, P429, DOI 10.1038/ng1218; Deelen J, 2014, HUM MOL GENET, V23, P4420, DOI 10.1093/hmg/ddu139; Deelen J, 2013, BIOESSAYS, V35, P386, DOI 10.1002/bies.201200148; Deelen J, 2011, AGING CELL, V10, P686, DOI 10.1111/j.1474-9726.2011.00705.x; Defossez PA, 2001, BIOESSAYS, V23, P327, DOI 10.1002/bies.1047; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Doria G, 2004, AGEING RES REV, V3, P143, DOI 10.1016/j.arr.2003.04.001; Drysdale Rachel, 2008, V420, P45, DOI 10.1007/978-1-59745-583-1_3; Durham MF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5338; Eikenes AH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004904; Fagan JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107311; Felix TM, 2012, GENETICS, V191, P989, DOI 10.1534/genetics.112.140640; Feng YQ, 2007, P NATL ACAD SCI USA, V104, P20362, DOI 10.1073/pnas.0706722105; Finch CE, 1997, SCIENCE, V278, P407, DOI 10.1126/science.278.5337.407; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Forbes SN, 2004, GENETICS, V168, P301, DOI 10.1534/genetics.103.023218; Force AG, 1995, DEV GENET, V17, P340, DOI 10.1002/dvg.1020170407; FOWLER K, 1989, NATURE, V338, P760, DOI 10.1038/338760a0; FRIEDMAN DB, 1988, GENETICS, V118, P75; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Gems D, 1996, NATURE, V379, P723, DOI 10.1038/379723a0; Ghiglione C, 2008, EMBO REP, V9, P676, DOI 10.1038/embor.2008.79; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Gil EB, 1999, P NATL ACAD SCI USA, V96, P2925, DOI 10.1073/pnas.96.6.2925; GRAVES JL, 1992, PHYSIOL ZOOL, V65, P268, DOI 10.1086/physzool.65.2.30158253; GRISWOLD CM, 1993, GENETICS, V134, P781; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Gudmundsson H, 2000, EUR J HUM GENET, V8, P743, DOI 10.1038/sj.ejhg.5200527; Gundner AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097332; HARRISON DE, 1987, J NUTR, V117, P376, DOI 10.1093/jn/117.2.376; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hori K, 2011, J CELL BIOL, V195, P1005, DOI 10.1083/jcb.201104146; Horn L, 2014, AGING CELL, V13, P719, DOI 10.1111/acel.12227; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Issman-Zecharya N, 2014, DEV CELL, V31, P461, DOI 10.1016/j.devcel.2014.10.013; Ivanov DK, 2015, J GERONTOL A-BIOL; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Jackson AU, 2002, J GERONTOL A-BIOL, V57, pB9, DOI 10.1093/gerona/57.1.B9; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; KEIGHTLEY PD, 1993, GENET RES, V62, P195, DOI 10.1017/S0016672300031906; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kharade SV, 2005, FEBS LETT, V579, P6809, DOI 10.1016/j.febslet.2005.11.017; Khazaeli AA, 1997, J GERONTOL A-BIOL, V52, pB48, DOI 10.1093/gerona/52A.1.B48; Kim S, 1999, MOL BIOL CELL, V10, P3125, DOI 10.1091/mbc.10.10.3125; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KIRKWOOD TBL, 1991, PHILOS T R SOC B, V332, P15, DOI 10.1098/rstb.1991.0028; KYLSTEN P, 1990, EMBO J, V9, P217, DOI 10.1002/j.1460-2075.1990.tb08098.x; Lai CQ, 2007, MECH AGEING DEV, V128, P237, DOI 10.1016/j.mad.2006.12.003; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; Landis GN, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r8; Lang DH, 2010, AGING CLIN EXP RES, V22, P8, DOI 10.1007/BF03324809; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Leips J, 2000, GENETICS, V155, P1773; Leips J, 2002, EXP AGING RES, V28, P361, DOI 10.1080/03610730290080399; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; Libert S, 2006, AGING CELL, V5, P533, DOI 10.1111/j.1474-9726.2006.00251.x; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Ljungquist B, 1998, J GERONTOL A-BIOL, V53, pM441, DOI 10.1093/gerona/53A.6.M441; LUCKINBILL LS, 1984, EVOLUTION, V38, P996, DOI 10.1111/j.1558-5646.1984.tb00369.x; Magwire MM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001037; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Massouras A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003055; Matakatsu H, 2004, DEVELOPMENT, V131, P3785, DOI 10.1242/dev.01254; Matakatsu H, 2006, DEVELOPMENT, V133, P2315, DOI 10.1242/dev.02401; Matias NR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004653; MCGUE M, 1993, J GERONTOL, V48, pB237, DOI 10.1093/geronj/48.6.B237; Medawar P., 1952, UNSOLVED PROBLEM BIO; Mockett RJ, 2006, EXP GERONTOL, V41, P566, DOI 10.1016/j.exger.2006.03.015; Morgan TJ, 2006, HEREDITY, V96, P232, DOI 10.1038/sj.hdy.6800786; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Nuzhdin SV, 1997, P NATL ACAD SCI USA, V94, P9734, DOI 10.1073/pnas.94.18.9734; Okamoto N, 2009, DEV CELL, V17, P885, DOI 10.1016/j.devcel.2009.10.008; Paik D, 2012, MECH AGEING DEV, V133, P234, DOI 10.1016/j.mad.2012.02.001; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Partridge L, 2002, CURR BIOL, V12, pR544, DOI 10.1016/S0960-9822(02)01048-5; PARTRIDGE L, 1981, NATURE, V294, P580, DOI 10.1038/294580a0; Pasyukova EG, 2004, AGING CELL, V3, P297, DOI 10.1111/j.1474-9728.2004.00114.x; Pasyukova EG, 2000, GENETICS, V156, P1129; Perls T, 2000, J AM GERIATR SOC, V48, P1483, DOI 10.1111/jgs.2000.48.11.1483; Perls T, 2002, CURR OPIN GENET DEV, V12, P362, DOI 10.1016/S0959-437X(02)00310-6; Philips JA, 2008, P NATL ACAD SCI USA, V105, P3070, DOI 10.1073/pnas.0707206105; Pitt JN, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002131; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Promislow DEL, 1996, GENETICS, V143, P839; Puca AA, 2001, P NATL ACAD SCI USA, V98, P10505, DOI 10.1073/pnas.181337598; Reis RJS, 2006, EXP GERONTOL, V41, P1046, DOI 10.1016/j.exger.2006.06.047; Remolina SC, 2012, EVOLUTION, V66, P3390, DOI 10.1111/j.1558-5646.2012.01710.x; Rockman MV, 2008, NATURE, V456, P738, DOI 10.1038/nature07633; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rollmann SM, 2006, NAT GENET, V38, P824, DOI 10.1038/ng1823; ROSE M, 1980, NATURE, V287, P141, DOI 10.1038/287141a0; ROSE MR, 1992, EXP GERONTOL, V27, P241, DOI 10.1016/0531-5565(92)90048-5; ROSE MR, 1984, EVOLUTION, V38, P1004, DOI 10.1111/j.1558-5646.1984.tb00370.x; Rosenbaum EE, 2011, NEURON, V72, P602, DOI 10.1016/j.neuron.2011.09.016; Rusten TE, 2007, CURR BIOL, V17, P1817, DOI 10.1016/j.cub.2007.09.032; SAMAKOVLIS C, 1990, EMBO J, V9, P2969, DOI 10.1002/j.1460-2075.1990.tb07489.x; SAS Institute Inc, 2002, SAS 9 2 SOFTW; Schlotterer C, 2015, HEREDITY, V114, P431, DOI 10.1038/hdy.2014.86; Schlotterer C, 2014, NAT REV GENET, V15, P749, DOI 10.1038/nrg3803; Schmidt PS, 2008, P NATL ACAD SCI USA, V105, P16207, DOI 10.1073/pnas.0805485105; Sepp KJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000111; Service PM, 1996, BEHAV GENET, V26, P39, DOI 10.1007/BF02361157; SERVICE PM, 1988, EVOLUTION, V42, P708, DOI 10.1111/j.1558-5646.1988.tb02489.x; SERVICE PM, 1985, PHYSIOL ZOOL, V58, P380, DOI 10.1086/physzool.58.4.30156013; Shook DR, 1996, GENETICS, V142, P801; Sidyelyeva G, 2006, J BIOL CHEM, V281, P13844, DOI 10.1074/jbc.M513499200; Sidyelyeva G, 2010, CELL MOL LIFE SCI, V67, P2991, DOI 10.1007/s00018-010-0369-8; Sieberts SK, 2007, MAMM GENOME, V18, P389, DOI 10.1007/s00335-007-9040-6; Simon AF, 2003, SCIENCE, V299, P1407, DOI 10.1126/science.1080539; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; Sun JT, 2002, GENETICS, V161, P661; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Tatar M, 1996, GENETICS, V143, P849; Teotonio H, 2009, NAT GENET, V41, P251, DOI 10.1038/ng.289; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tissenbaum HA, 1998, GENETICS, V148, P703; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turner TL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001336; Valenzuela RK, 2004, GENETICS, V168, P313, DOI 10.1534/genetics.103.023291; Verleyen P, 2006, J INSECT PHYSIOL, V52, P379, DOI 10.1016/j.jinsphys.2005.12.007; Vieira C, 2000, GENETICS, V154, P213; Westendorp RGJ, 1998, NATURE, V396, P743, DOI 10.1038/25519; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Wilson RH, 2006, GENETICS, V173, P1455, DOI 10.1534/genetics.105.055111; Wilson RH, 2013, MECH AGEING DEV, V134, P79, DOI 10.1016/j.mad.2012.11.003; WOODHEAD AD, 1985, J NATL CANCER I, V75, P1141; Yan J, 2008, GENETICS, V180, P219, DOI 10.1534/genetics.108.091314; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Zerofsky M, 2005, AGING CELL, V4, P103, DOI 10.1111/j.1474-9728.2005.00147.x; Zou S, 2000, P NATL ACAD SCI USA, V97, P13726, DOI 10.1073/pnas.260496697; ZWAAN B, 1995, EVOLUTION, V49, P635, DOI 10.2307/2410317	170	26	26	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138569	10.1371/journal.pone.0138569	http://dx.doi.org/10.1371/journal.pone.0138569			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378456	gold, Green Published, Green Submitted			2022-12-27	WOS:000361769400111
J	Ilgen, P; Grotjohann, T; Jans, DC; Kilisch, M; Hell, SW; Jakobs, S				Ilgen, Peter; Grotjohann, Tim; Jans, Daniel C.; Kilisch, Markus; Hell, Stefan W.; Jakobs, Stefan			RESOLFT Nanoscopy of Fixed Cells Using a Z-Domain Based Fusion Protein for Labelling	PLOS ONE			English	Article							FLUORESCENCE MICROSCOPY; STED MICROSCOPY; LIGHT; GFP	RESOLFT super-resolution microscopy allows subdiffraction resolution imaging of living cells using low intensities of light. It relies on the light-driven switching of reversible switchable fluorescent proteins (RSFPs). So far, RESOLFT imaging was restricted to living cells, because chemical fixation typically affects the switching characteristics of RSFPs. In this study we created a fusion construct (FLASR) consisting of the RSFP rsEGFP2 and the divalent form of the antibody binding Z domain from protein A. FLASR can be used analogous to secondary antibodies in conventional immunochemistry, facilitating simple and robust sample preparation. We demonstrate RESOLFT super-resolution microscopy on chemically fixed mammalian cells. The approach may be extended to other super-resolution approaches requiring fluorescent proteins in an aqueous environment.	[Ilgen, Peter; Grotjohann, Tim; Jans, Daniel C.; Hell, Stefan W.; Jakobs, Stefan] Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany; [Jans, Daniel C.; Jakobs, Stefan] Univ Med Ctr Gottingen, Dept Neurol, Gottingen, Germany; [Kilisch, Markus] Univ Med Ctr Gottingen, Dept Mol Biol, Gottingen, Germany	Max Planck Society; University of Gottingen; University of Gottingen	Jakobs, S (corresponding author), Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany.	sjakobs@gwdg.de	Jakobs, Stefan/F-4898-2012	Jakobs, Stefan/0000-0002-8028-3121; Jans, Daniel C./0000-0002-6356-9742	Cluster of Excellence; DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain; Max Planck Society; DFG [FOR 1086/2, SCHW 823/2-1, SR7000DC]	Cluster of Excellence; DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX); DFG(German Research Foundation (DFG))	This work was supported by the Cluster of Excellence and DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain (to SJ), by the Max Planck Society, and by the DFG FOR 1086/2 (Grant SCHW 823/2-1) (MK, SPR Biosensor SR7000DC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbe E., 1873, ARCH F MIKROSK ANAT, V9, P413, DOI [10.1007/ BF02956173, DOI 10.1007/BF02956173]; AKERSTROM B, 1986, J BIOL CHEM, V261, P240; Andresen M, 2005, P NATL ACAD SCI USA, V102, P13070, DOI 10.1073/pnas.0502772102; Andresen M, 2007, P NATL ACAD SCI USA, V104, P13005, DOI 10.1073/pnas.0700629104; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Born M., 2002, PRINCIPLES OPTICS; Bourgeois D, 2012, IUBMB LIFE, V64, P482, DOI 10.1002/iub.1023; Brakemann T, 2011, NAT BIOTECHNOL, V29, P942, DOI 10.1038/nbt.1952; Dyba M, 2003, NAT BIOTECHNOL, V21, P1303, DOI 10.1038/nbt897; EY PL, 1978, IMMUNOCHEMISTRY, V15, P429, DOI 10.1016/0161-5890(78)90070-6; Geissbuehler S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6830; Grotjohann T, 2012, ELIFE, V1, DOI 10.7554/eLife.00248; Grotjohann T, 2011, NATURE, V478, P204, DOI 10.1038/nature10497; Grover RK, 2014, SCIENCE, V343, P656, DOI 10.1126/science.1246135; Hell SW, 2003, APPL PHYS A-MATER, V77, P859, DOI 10.1007/s00339-003-2292-4; Hell SW., 2009, SINGLE MOL SPECTROSC, P298; Hober S, 2007, J CHROMATOGR B, V848, P40, DOI 10.1016/j.jchromb.2006.09.030; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Huang QL, 2006, BIOTECHNOL APPL BIOC, V43, P121, DOI 10.1042/BA20050136; JENDEBERG L, 1995, J MOL RECOGNIT, V8, P270, DOI 10.1002/jmr.300080405; Lofblom J, 2010, FEBS LETT, V584, P2670, DOI 10.1016/j.febslet.2010.04.014; NILSSON B, 1987, PROTEIN ENG, V1, P107, DOI 10.1093/protein/1.2.107; Rankin BR, 2009, OPT EXPRESS, V17, P15679, DOI 10.1364/OE.17.015679; Ratz M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09592; Testa I, 2012, NEURON, V75, P992, DOI 10.1016/j.neuron.2012.07.028; Tiwari DK, 2015, NAT METHODS, V12, P515, DOI 10.1038/nmeth.3362; Wurm CA, 2010, METHODS MOL BIOL, V591, P185, DOI 10.1007/978-1-60761-404-3_11	28	3	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136233	10.1371/journal.pone.0136233	http://dx.doi.org/10.1371/journal.pone.0136233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375606	Green Submitted, Green Published, gold			2022-12-27	WOS:000361610200012
J	Rho, CR; Park, MY; Kang, S				Rho, Chang Rae; Park, Mi-young; Kang, Seungbum			Effects of Granulocyte-Macrophage Colony-Stimulating (GM-CSF) Factor on Corneal Epithelial Cells in Corneal Wound Healing Model	PLOS ONE			English	Article							PARTIAL-THICKNESS BURN; GROWTH-FACTOR; C-KIT; RECEPTOR; PLANTS; MICE; MAINTENANCE; EXPRESSION; MIGRATION; CYTOKINE	Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a pleiotropic cytokine that activates granulocyte and macrophage cell lineages. It is also known to have an important function in wound healing. This study investigated the effect of GM-CSF in wound healing of human corneal epithelial cells (HCECs). We used human GM-CSF derived from rice cells (rice cell-derived recombinant human GM-CSF; rhGM-CSF). An in vitro migration assay was performed to investigate the migration rate of HCECs treated with various concentrations of rhGM-CSF (0.1, 1.0, and 10.0 mu g/ml). MTT assay and flow cytometric analysis were used to evaluate the proliferative effect of rhGM-CSF. The protein level of p38MAPK was analyzed by western blotting. For in vivo analysis, 100 golden Syrian hamsters were divided into four groups, and their corneas were de-epithelialized with alcohol and a blade. The experimental groups were treated with 10, 20, or 50 mu g/ml rhGM-CSF four times daily, and the control group was treated with phosphate-buffered saline. The corneal wound-healing rate was evaluated by fluorescein staining at the initial wounding and 12, 24, 36, and 48 hours after epithelial debridement. rhGM-CSF accelerated corneal epithelial wound healing both in vitro and in vivo. MTT assay and flow cytometric analysis revealed that rhGM-CSF treatment had no effects on HCEC proliferation. Western blot analysis demonstrated that the expression level of phosphorylated p38MAPK increased with rhGM-CSF treatment. These findings indicate that rhGM-CSF enhances corneal wound healing by accelerating cell migration.	[Rho, Chang Rae; Kang, Seungbum] Catholic Univ Korea, Coll Med, Daejeon St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea; [Rho, Chang Rae; Park, Mi-young; Kang, Seungbum] Catholic Univ Korea, Coll Med, Daejeon St Marys Hosp, Clin Res Inst, Taejon, South Korea	Catholic University of Korea; Catholic University of Korea	Kang, S (corresponding author), Catholic Univ Korea, Coll Med, Daejeon St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea.	john0730@catholic.ac.kr			Daejeon TechnoPark [5-2013-A0230-00001]; Clinical Research Institute [CMCDJ-P-2013-024]; Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea [CMCDJ-P-2013-024]	Daejeon TechnoPark; Clinical Research Institute; Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea	This work was supported by Daejeon TechnoPark (5-2013-A0230-00001), (http://www.cukrnd-iacf.ac.kr/index.jsp); Clinical Research Institute (CMCDJ-P-2013-024), Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea (CMCDJ-P-2013-024), (www.cmcdj.or.kr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker H, 2001, P NATL ACAD SCI USA, V98, P2899, DOI 10.1073/pnas.031419998; Carreno E, 2010, ACTA OPHTHALMOL, V88, pe250, DOI 10.1111/j.1755-3768.2010.01978.x; Choi JS, 2013, OCUL SURF, V11, P16, DOI 10.1016/j.jtos.2012.08.006; Fang Y, 2007, BRIT J DERMATOL, V157, P458, DOI 10.1111/j.1365-2133.2007.07979.x; Groves R W, 2000, Adv Skin Wound Care, V13, P107; Hood EE, 1999, CURR OPIN BIOTECH, V10, P382, DOI 10.1016/S0958-1669(99)80069-X; Hu XL, 2011, BURNS, V37, P729, DOI 10.1016/j.burns.2010.08.016; Imanishi J, PROG RETIN EYE RES, V200, P113; Kim HJ, 2008, BIOL PHARM BULL, V31, P290, DOI 10.1248/bpb.31.290; Klenkler B, 2007, OCUL SURF, V5, P228, DOI 10.1016/S1542-0124(12)70613-4; KRUSE FE, 1993, INVEST OPHTH VIS SCI, V34, P1963; LaFrance MW, 2008, CURR EYE RES, V33, P525, DOI 10.1080/02713680802190085; Lee HK, 2006, INVEST OPHTH VIS SCI, V47, P873, DOI 10.1167/iovs.05-0826; Yuan L, 2015, BURNS, V41, P1086, DOI 10.1016/j.burns.2014.12.004; Masucci G, 1996, MED ONCOL, V13, P149; Medrano G, 2012, METHODS MOL BIOL, V824, P535, DOI 10.1007/978-1-61779-433-9_29; METCALF D, 1987, EXP HEMATOL, V15, P1; Miele L, 1997, TRENDS BIOTECHNOL, V15, P45, DOI 10.1016/S0167-7799(97)84202-3; Miyamoto K, 2012, MOL VIS, V18, P1505; MIYAZAWA K, 1991, EXP HEMATOL, V19, P1110; NISHIDA T, 1992, INVEST OPHTH VIS SCI, V33, P2464; Saika S, 2004, INVEST OPHTH VIS SCI, V45, P100, DOI 10.1167/iovs.03-0700; SCHULTZ GS, 1988, CORNEA, V7, P96; Stepp MA, 2006, EXP EYE RES, V83, P3, DOI 10.1016/j.exer.2006.01.010; Trusolino L, 1998, J CELL BIOL, V142, P1145, DOI 10.1083/jcb.142.4.1145; Wilson SE, 1999, EXP EYE RES, V68, P377, DOI 10.1006/exer.1998.0603; WILSON SE, 1993, INVEST OPHTH VIS SCI, V34, P2544; WILSON SE, 1992, INVEST OPHTH VIS SCI, V33, P1756; Won JH, 2013, BIOL PHARM BULL, V36, P425, DOI 10.1248/bpb.b12-00869; Yan H, 2012, BURNS, V38, P877, DOI 10.1016/j.burns.2012.02.001	30	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138020	10.1371/journal.pone.0138020	http://dx.doi.org/10.1371/journal.pone.0138020			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376304	Green Published, Green Submitted, gold			2022-12-27	WOS:000361610200070
J	Dimitri, N				Dimitri, Nicola			The Economics of Epidemic Diseases	PLOS ONE			English	Article								Epidemic, infectious, diseases affect a large number of individuals across developing as well as developed countries. With reference to some very simple diffusion models, in this paper we consider how available economic resources could be optimally allocated by health authorities to mitigate, possibly eradicate, the disease. Optimality was defined as the minimization of the long run number of infected people. The main goal of the work has been to introduce a methodology for deciding if it would be best to concentrate resources to prevent contact between individuals and with an external source, or to develop a new treatment for curing the disease, or both. The analysis suggests that this depends on the cost functions, that is the available technology, for controlling the relevant parameters underlying the epidemics as well as on the available financial resources. In the case of the recent Ebola outbreak, the suggestions of the model have been consistent with the policies adopted.	Univ Siena, Dept Polit Econ & Stat, I-53100 Siena, Italy	University of Siena	Dimitri, N (corresponding author), Univ Siena, Dept Polit Econ & Stat, Via Laterina 8, I-53100 Siena, Italy.	dimitri@unisi.it						BAILEY N, 1975, MATH THEORY EPIDEMIC; Bernoulli D., 1760, MEMOIRES MATHEMATIQU, P1; Daley DJ, 1999, EPIDEMIC MODELING; Easly D., 2010, NETWORKS CROWDS MARK; Goldman SC., 2002, BE J TOP EC ANAL POL, V2, P889, DOI [10.2202/1538-0653.1007, DOI 10.2202/1538-0653.1007]; Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5; Isham V, 2004, STOCHASTIC MOD UNPUB; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Klepac P, 2011, P NATL ACAD SCI USA, V108, P14366, DOI 10.1073/pnas.1101694108; Pandey A, 2014, SCIENCE, V346, P991, DOI 10.1126/science.1260612; Rowthorn RE, 2009, J R SOC INTERFACE, V6, P1135, DOI 10.1098/rsif.2008.0402	12	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137964	10.1371/journal.pone.0137964	http://dx.doi.org/10.1371/journal.pone.0137964			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372353	Green Published, gold, Green Submitted			2022-12-27	WOS:000361604400041
J	Hsu, JL; Lee, WJ; Liao, YC; Lirng, JF; Wang, SJ; Fuh, JL				Hsu, Jung-Lung; Lee, Wei-Ju; Liao, Yi-Chu; Lirng, Jiing-Feng; Wang, Shuu-Jiun; Fuh, Jong-Ling			Posterior Atrophy and Medial Temporal Atrophy Scores Are Associated with Different Symptoms in Patients with Alzheimer's Disease and Mild Cognitive Impairment	PLOS ONE			English	Article							WHITE-MATTER HYPERINTENSITIES; VERBAL-LEARNING TEST; LOBE ATROPHY; NEUROPSYCHIATRIC INVENTORY; PSYCHOLOGICAL SYMPTOMS; DEMENTIA; MRI; SCHIZOPHRENIA; DYSFUNCTION; POPULATION	Background Whether the occurrence of posterior atrophy (PA) and medial temporal lobe atrophy (MTA) was correlated with cognitive and non-cognitive symptoms in Alzheimer's disease (AD) and mild cognitive impairment (MCI) patients are unclear. Methods Patients with probable AD and MCI from a medical center outpatient clinic received attention, memory, language, executive function evaluation and Mini-Mental Status Examination (MMSE). The severity of dementia was rated by the Clinical Dementia Rating (CDR) Sum of Box (CDR-SB). The neuropsychiatric inventory (NPI) subscale of agitation/aggression and mood symptoms was also applied. Magnetic resonance imaging (MRI) was scored visually for the MTA, PA and white matter hyperintensity (WMH) scores. Results We recruited 129 AD and 31MCI (mean age 78.8 years, 48% female) patients. MMSE scores, memory, language and executive function were all significantly decreased in individuals with AD than those with MCI (p < 0.01). MTA and PA scores reflected significant atrophy in AD compared to MCI; however, theWMHscores did not differ. The MTA scores were significantly correlated with the frontal, parieto-occipital and globalWMHscores (p < 0.01) while the PA scores showed a correlation with the parieto-occipital and temporal WMH scores (p < 0.01). After adjusting for age, education, APOE4 gene and diagnostic group covariates, the MTA scores showed a significant association with MMSE and CDR-SB, while the right side PA scores were significantly associated with NPI-agitation/aggression subscales (p < 0.01). Conclusion Regional atrophy is related to different symptoms in patients with AD or MCI. PA score is useful as a complementary measure for non-cognitive symptom.	[Hsu, Jung-Lung] Taipei Med Univ, Grad Inst Human Med, Taipei, Taiwan; [Hsu, Jung-Lung] Chang Gung Mem Hosp, Dept Neurol, Sect Dementia & Cognit Impairment, Linkou, Taiwan; [Hsu, Jung-Lung] Taipei Med Univ, Shuang Ho Hosp, Brain & Consciousness Res Ctr, New Taipei City, Taiwan; [Lee, Wei-Ju] Taichung Vet Gen Hosp, Neurol Inst, Taichung, Taiwan; [Lee, Wei-Ju; Liao, Yi-Chu; Lirng, Jiing-Feng; Wang, Shuu-Jiun; Fuh, Jong-Ling] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei 112, Taiwan; [Lee, Wei-Ju] Natl Yang Ming Univ, Inst Clin Med, Sch Med, Taipei 112, Taiwan; [Wang, Shuu-Jiun] Natl Yang Ming Univ, Inst Brain Sci, Sch Med, Taipei 112, Taiwan; [Liao, Yi-Chu; Wang, Shuu-Jiun; Fuh, Jong-Ling] Natl Yang Ming Univ, Brain Res Ctr, Sch Med, Taipei 112, Taiwan; [Liao, Yi-Chu; Wang, Shuu-Jiun; Fuh, Jong-Ling] Taipei Vet Gen Hosp, Dept Neurol, Neurol Inst, Taipei, Taiwan; [Lirng, Jiing-Feng] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan	Taipei Medical University; Chang Gung Memorial Hospital; Taipei Medical University; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Wang, SJ (corresponding author), Natl Yang Ming Univ, Fac Med, Sch Med, Taipei 112, Taiwan.	sjwang@vghtpe.gov.tw; jlfuh@vghtpe.gov.tw		Wang, Shuu-Jiun/0000-0001-5179-5358; Liao, Yi-Chu/0000-0002-9644-2086; Lee, Wei-Ju/0000-0002-3720-4539	Ministry of Science and Technology of Taiwan (NSC) [101-2314-B-075-037-MY2, 102-2321-B-010-030, 103-2314-B-075-063-]; Taipei Veterans General Hospital [V103E9-006, V103E3-005, V103C-083]; Ministry of Science and Technology support for the Centre for Dynamical Biomarkers and Translational Medicine; National Central University, Taiwan (NSC) [102-2911-I-008-001]; Brain Research Center, National Yang-Ming University; Ministry of Education, Aim for the Top University Plan	Ministry of Science and Technology of Taiwan (NSC); Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Science and Technology support for the Centre for Dynamical Biomarkers and Translational Medicine; National Central University, Taiwan (NSC); Brain Research Center, National Yang-Ming University; Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	Ministry of Science and Technology of Taiwan (NSC 101-2314-B-075-037-MY2, 102-2321-B-010-030, 103-2314-B-075-063-), Taipei Veterans General Hospital (V103E9-006, V103E3-005, V103C-083), Ministry of Science and Technology support for the Centre for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan (NSC 102-2911-I-008-001), Brain Research Center, National Yang-Ming University and a grant from Ministry of Education, Aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel J, 2009, AM J NEURORADIOL, V30, P1870, DOI 10.3174/ajnr.A1693; Barr A, 1996, J CLIN EXP NEUROPSYC, V18, P810, DOI 10.1080/01688639608408304; Berlow YA, 2010, INT J GERIATR PSYCH, V25, P780, DOI 10.1002/gps.2418; Bouwman FH, 2010, DEMENT GERIATR COGN, V30, P1, DOI 10.1159/000315542; Bruen PD, 2008, BRAIN, V131, P2455, DOI 10.1093/brain/awn151; BURKE WJ, 1988, ARCH NEUROL-CHICAGO, V45, P31, DOI 10.1001/archneur.1988.00520250037015; Cavallin L, 2012, ACTA RADIOL, V53, P318, DOI 10.1258/ar.2012.110552; Chen CS, 2012, ALZ DIS ASSOC DIS, V26, P135, DOI 10.1097/WAD.0b013e31821f5787; Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Davies RR, 2009, NEURORADIOLOGY, V51, P491, DOI 10.1007/s00234-009-0521-z; Dickerson BC, 2011, J NEUROL NEUROSUR PS, V82, P45, DOI 10.1136/jnnp.2009.199505; Feczko E, 2009, NEUROBIOL AGING, V30, P420, DOI 10.1016/j.neurobiolaging.2007.07.023; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fuh JL, 2005, J NEUROL NEUROSUR PS, V76, P1337, DOI 10.1136/jnnp.2004.056408; Fuh JL, 2001, INT PSYCHOGERIATR, V13, P121, DOI 10.1017/S1041610201007517; Galton CJ, 2000, BRAIN, V123, P484, DOI 10.1093/brain/123.3.484; Good CD, 2002, NEUROIMAGE, V17, P29, DOI 10.1006/nimg.2002.1202; Hart DJ, 2003, INT J GERIATR PSYCH, V18, P1037, DOI 10.1002/gps.1013; Harting C., 2000, WMS R MANUAL; Hirono N, 2000, ARCH NEUROL-CHICAGO, V57, P861, DOI 10.1001/archneur.57.6.861; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Jang JW, 2013, EUR NEUROL, V69, P229, DOI 10.1159/000345999; Kandiah N, 2014, J NEUROL SCI, V337, P162, DOI 10.1016/j.jns.2013.11.042; Koedam ELGE, 2011, EUR RADIOL, V21, P2618, DOI 10.1007/s00330-011-2205-4; Koedam ELGE, 2010, J ALZHEIMERS DIS, V19, P1401, DOI 10.3233/JAD-2010-1337; Kumari V, 2006, SCHIZOPHR RES, V84, P144, DOI 10.1016/j.schres.2006.02.017; Lanctot KL, 2004, ARCH NEUROL-CHICAGO, V61, P1731, DOI 10.1001/archneur.61.11.1731; LAUNER LJ, 1995, NEUROLOGY, V45, P747, DOI 10.1212/WNL.45.4.747; Lehmann M, 2013, NEUROBIOL AGING, V34, P73, DOI 10.1016/j.neurobiolaging.2012.03.010; Lehmann M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.04.003; Liao YC, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.05.009; MACK WJ, 1992, J GERONTOL, V47, pP154, DOI 10.1093/geronj/47.3.P154; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mychack P, 2001, NEUROLOGY, V56, pS11, DOI 10.1212/WNL.56.suppl_4.S11; Neill E, 2014, COGN NEUROPSYCHIATRY, V19, P81, DOI 10.1080/13546805.2013.807233; Oosterman JM, 2012, INT PSYCHOGERIATR, V24, P1474, DOI 10.1017/S1041610212000506; Pereira JB, 2014, J INTERN MED, V275, P317, DOI 10.1111/joim.12148; Prins ND, 2013, J ALZHEIMERS DIS, V36, P79, DOI 10.3233/JAD-122233; Rafii MS, 2014, AM J ALZHEIMERS DIS, V29, P159, DOI 10.1177/1533317513507373; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Shim YS, 2011, EUR NEUROL, V66, P75, DOI 10.1159/000329277; Smits LL, 2013, ALZHEIMERS DEMENTIA; Soyka M, 2011, SCHIZOPHRENIA BULL, V37, P913, DOI 10.1093/schbul/sbr103; Sun Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100303; Trzepacz Paula T, 2013, Alzheimers Dement, V9, pS95, DOI 10.1016/j.jalz.2012.10.005; Trzepacz PT, 2013, AM J GERIAT PSYCHIAT, V21, P607, DOI 10.1016/j.jagp.2012.10.027; Tsai C F, 2013, East Asian Arch Psychiatry, V23, P86; VAKIL E, 1993, J CLIN PSYCHOL, V49, P883, DOI 10.1002/1097-4679(199311)49:6<883::AID-JCLP2270490616>3.0.CO;2-6; Vanderploeg RD, 2000, CLIN NEUROPSYCHOL, V14, P318, DOI 10.1076/1385-4046(200008)14:3;1-P;FT318; Varon D, 2014, INT J GERIATRIC PSYC; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Wattjes MP, 2011, INT PSYCHOGERIATR, V23, pS13, DOI 10.1017/S1041610211000913; Wechsler D., 1997, WECHSLER ADULT INTEL; Wechsler D, 1998, WECHSLER MEMORY SCAL; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x	57	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137121	10.1371/journal.pone.0137121	http://dx.doi.org/10.1371/journal.pone.0137121			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8LR	26372372	gold, Green Published, Green Submitted			2022-12-27	WOS:000361604400011
J	Merlo, C; Trummler, M; Essig, S; Zeller, A				Merlo, Christoph; Trummler, Michael; Essig, Stefan; Zeller, Andreas			Vitamin D Deficiency in Unselected Patients from Swiss Primary Care: A Cross-Sectional Study in Two Seasons	PLOS ONE			English	Article							BODY-MASS INDEX; PAIN; 25-HYDROXYVITAMIN-D; PREVENTION; PREVALENCE; DEPENDENCY; PRODUCE; SKIN	Background As published data on 25-hydroxy-cholecalciferol (25(OH)D) Deficiency in primary care settings is scarce, we assessed the prevalence of hypovitaminosis D, potential associations with clinical symptoms, body mass index, age, Vitamin D intake, and skin type in unselected patients from primary care, and the extent of seasonal variations of serum 25(OH)D concentrations. Methodology/Principal Findings 25(OH)D was measured at the end of summer and/or winter in 1682 consecutive patients from primary care using an enzyme-linked immunosorbant assay. Clinical symptoms were assessed by self-report (visual analogue scale 0 to 10), and vitamin D deficiency was defined as 25(OH)D concentrations < 50 nmol/l. 25(OH)D deficiency was present in 995 (59.2%) patients. 25(OH)D deficient patients reported more intense muscle weakness (visual analogue scale 2.7, 95% confidence interval 2.5 to 2.9) and had a higher body mass index (25.9kg/m(2), 25.5 to 26.2) than non-deficient patients (2.5, 2.3 to 2.7; and 24.2, 23.9 to 24.5, respectively). 25(OH)D concentrations also weakly correlated with muscle weakness (Spearman's rho -0.059, 95% confidence interval -0.107 to -0.011) and body mass index (-0.156, -0.202 to -0.108). Self-reported musculoskeletal pain, fatigue, and age were not associated with deficiency, nor with concentrations. Mean 25(OH)D concentrations in patients with vitamin D containing medication were higher (60.6 +/- 22.2 nmol/l) than in patients without medication (44.8 +/- 19.2 nmol/l, p < 0.0001) but still below the targeted level of 75 nmol/l. Summer and winter 25(OH)D concentrations differed (53.4 +/- 19.9 vs. 41.6 +/- 19.3nmol/l, p < 0.0001), which was confirmed in a subgroup of 93 patients who were tested in both seasons (p = 0.01). Conclusion/Significance Nearly 60% of unselected patients from primary care met the criteria for 25(OH)D deficiency. Self-reported muscle weakness and high body mass index were associated with lower 25(OH)D levels. As expected 25(OH)D concentrations were lower in winter compared to summer.	[Merlo, Christoph; Essig, Stefan] Inst Primary & Community Care, CH-6004 Luzern, Switzerland; [Trummler, Michael] Labs Bioanalyt, CH-6006 Luzern, Switzerland; [Essig, Stefan] Swiss Parapleg Res, CH-6207 Nottwil, Switzerland; [Zeller, Andreas] Univ Basel, Ctr Primary Hlth Care, CH-4410 Liestal, Switzerland	Swiss Paraplegic Research; University of Basel	Essig, S (corresponding author), Inst Primary & Community Care, Schwanenpl 7, CH-6004 Luzern, Switzerland.	stefan.essig@iham-cc.ch		Essig, Stefan/0000-0003-3228-7010				Al Faraj S, 2003, SPINE, V28, P177, DOI 10.1097/00007632-200301150-00015; Alemzadeh R, 2008, METABOLISM, V57, P183, DOI 10.1016/j.metabol.2007.08.023; Arvold DS, 2009, ENDOCR PRACT, V15, P203, DOI 10.4158/EP.15.3.203; Bischoff-Ferrari HA, 2008, BONE, V42, P597, DOI 10.1016/j.bone.2007.10.026; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Bischoff-Ferrari HA, 2012, REV ENDOCR METAB DIS, V13, P71, DOI 10.1007/s11154-011-9200-6; Bischoff-Ferrari HA, 2009, ARCH INTERN MED, V169, P551, DOI 10.1001/archinternmed.2008.600; Chen TC, 2007, ARCH BIOCHEM BIOPHYS, V460, P213, DOI 10.1016/j.abb.2006.12.017; Dawson-Hughes B, 2010, Osteoporos Int, V21, P1151, DOI 10.1007/s00198-010-1285-3; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Giovannucci E, 2006, JNCI-J NATL CANCER I, V98, P451, DOI 10.1093/jnci/djj101; Girgis CM, 2013, ENDOCR REV, V34, P33, DOI 10.1210/er.2012-1012; GLOTH FM, 1991, ARCH INTERN MED, V151, P1662, DOI 10.1001/archinte.151.8.1662; Hewison M, 2008, CURR OPIN INVEST DR, V9, P485; Holick MF, 2006, MAYO CLIN PROC, V81, P353, DOI 10.4065/81.3.353; Holick MF, 2008, BRIT MED J, V336, P1318, DOI 10.1136/bmj.39581.411424.80; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; IDS, AC57F1AC57F22O10 IDS; Lagunova Z, 2009, ANTICANCER RES, V29, P3713, DOI 10.14341/2071-8713-4886; MACLAUGHLIN J, 1985, J CLIN INVEST, V76, P1536, DOI 10.1172/JCI112134; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; Myers KJ, 2004, MAYO CLIN PROC, V79, P695, DOI 10.4065/79.5.695; Nutrition FCf, 2012, NUTR FCF EXP REP 25; Parikh SJ, 2004, J CLIN ENDOCR METAB, V89, P1196, DOI 10.1210/jc.2003-031398; Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298; Plotnikoff GA, 2003, MAYO CLIN PROC, V78, P1463, DOI 10.4065/78.12.1463; Prabhala A, 2000, ARCH INTERN MED, V160, P1199, DOI 10.1001/archinte.160.8.1199; Rabow MW MS, 2013, CURRENT MED DIAGNOSI; Roberts WE, 2009, DERMATOL CLIN, V27, P529, DOI 10.1016/j.det.2009.08.006; Saneei P, 2013, OBES REV, V14, P393, DOI 10.1111/obr.12016; Shinchuk L, 2007, NUTR CLIN PRACT, V22, P297, DOI 10.1177/0115426507022003297; Stoll D, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13196; VANDERWIELEN RPJ, 1995, LANCET, V346, P207, DOI 10.1016/S0140-6736(95)91266-5; Vimaleswaran Karani S, 2013, PLoS Med, V10, pe1001383, DOI 10.1371/journal.pmed.1001383; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Warner AE, 2008, JCR-J CLIN RHEUMATOL, V14, P12, DOI 10.1097/RHU.0b013e31816356a9; Webb AR, 2006, PROG BIOPHYS MOL BIO, V92, P17, DOI 10.1016/j.pbiomolbio.2006.02.004	39	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138613	10.1371/journal.pone.0138613	http://dx.doi.org/10.1371/journal.pone.0138613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372355	gold, Green Published, Green Submitted			2022-12-27	WOS:000361604400071
J	Liu, R; Liu, ZZ; Xu, Y; Liao, YQ; Hu, QH; Huang, JW; Shi, XL; Li, YH; Niu, JJ; Li, QG				Liu, Ran; Liu, Zanzan; Xu, Ye; Liao, Yiqun; Hu, Qinghua; Huang, Jianwei; Shi, Xiaolu; Li, Yinghui; Niu, Jianjun; Li, Qingge			Multicolor Melting Curve Analysis-Based Multilocus Melt Typing of Vibrio parahaemolyticus	PLOS ONE			English	Article							REAL-TIME-PCR; SEQUENCE; IDENTIFICATION; BACTERIAL; STRAINS; EBURST; O3-K6; INTERROGATION	Vibrio parahaemolyticus is the leading cause of seafood-borne gastroenteritis outbreaks. To track the source of these diseases in a timely manner, a high throughput typing method is critical. We hereby describe a novel genotyping method for V. parahaemolyticus, termed multilocus melt typing (MLMT), based on multilocus sequence typing (MLST). MLMT utilizes melting curve analysis to interrogate the allelic types of a set of informative single nucleotide polymorphisms (SNPs) derived from the housekeeping genes used in MLST. For each SNP, one allelic type generates distinct Tm values, which are converted into a binary code. Multiple SNPs thus generate a series of binary codes, forming a melt type (MT) corresponding with a sequence type (ST) of MLST. Using a set of 12 SNPs, the MLMT scheme could resolve 218 V. parahaemolyticus isolates into 50 MTs corresponding with 56 STs. The discriminatory power of MLMT and MLST was similar with Simpson's index of diversity of 0.638 and 0.646, respectively. The global (adjusted Rand index = 0.982) and directional congruence (adjusted Wallace coefficient, MT -> ST = 0.965; ST -> MT = 1.000) between the two typing approaches was high. The entire procedure of MLMT could be finished within 3 h with negligible hands on time in a real-time PCR machine. We conclude that MLMT provides a reliable and efficient approach for V. parahaemolyticus genotyping and might also find use in other pathogens.	[Liu, Ran; Liu, Zanzan; Xu, Ye; Liao, Yiqun; Li, Qingge] Xiamen Univ, Sch Life Sci, Engn Res Ctr Mol Diagnost, Minist Educ,State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China; [Liao, Yiqun; Li, Qingge] Xiamen Univ, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen, Fujian, Peoples R China; [Hu, Qinghua; Shi, Xiaolu; Li, Yinghui] Shenzhen Ctr Dis Control & Prevent, Shenzhen Major Infect Dis Control Key Lab, Shenzhen, Guangdong, Peoples R China; [Hu, Qinghua] Shenzhen Univ, Sch Life Sci, Shenzhen, Guangdong, Peoples R China; [Huang, Jianwei] Xiamen Ctr Dis Control & Prevent, Xiamen, Fujian, Peoples R China; [Niu, Jianjun] Xiamen Univ, Zhongshan Hosp Xiamen, Xiamen, Fujian, Peoples R China; [Li, Qingge] Xiamen Univ, Shenzhen Res Inst, Shenzhen, Guangdong, Peoples R China	Xiamen University; Xiamen University; Shenzhen Center for Disease Control & Prevention (SZCDC); Shenzhen University; Xiamen University; Xiamen University	Niu, JJ (corresponding author), Xiamen Univ, Zhongshan Hosp Xiamen, Xiamen, Fujian, Peoples R China.	niujianjun@xmu.edu.cn; qgli@xmu.edu.cn			National Natural Science Foundation [81271929]; Project of Science and Technology Innovation Commission of Shenzhen Municipality [JC201104220329A]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Project of Science and Technology Innovation Commission of Shenzhen Municipality	This study was partially supported by National Natural Science Foundation (http://www.nsfc.gov.cn/) No. 81271929 (to QL) and Project of Science and Technology Innovation Commission of Shenzhen Municipality (http://www.szsti.gov.cn/) No. JC201104220329A (to QL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bag PK, 1999, J CLIN MICROBIOL, V37, P2354, DOI 10.1128/JCM.37.7.2354-2357.1999; Daniels NA, 2000, J INFECT DIS, V181, P1661, DOI 10.1086/315459; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Gavilan RG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002210; Gil AI, 2007, INT J INFECT DIS, V11, P324, DOI 10.1016/j.ijid.2006.08.003; Gonzalez-Escalona N, 2008, J BACTERIOL, V190, P2831, DOI 10.1128/JB.01808-07; Hu SY, 2014, J CLIN MICROBIOL, V52, P1644, DOI 10.1128/JCM.03395-13; Huang QY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019206; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Huygens F, 2006, J CLIN MICROBIOL, V44, P3712, DOI 10.1128/JCM.00843-06; Jensen RV, 2013, GENOME ANNOUNC, V1, P1, DOI [10.1128/genomeA.00159-14.Copyright, DOI 10.1128/GEN0MEA.00002-12]; Letchumanan V, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00705; Levesque S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016167; Liao YQ, 2013, J CLIN MICROBIOL, V51, P429, DOI 10.1128/JCM.02115-12; Lilliebridge RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019749; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Martinez-Urtaza J, 2005, EMERG INFECT DIS, V11, P1319, DOI 10.3201/eid1108.050322; Price EP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-278; Rapa RA, 2015, ENVIRON MICROBIOL, V17, P1090, DOI 10.1111/1462-2920.12512; Richardson LJ, 2011, CLIN MICROBIOL INFEC, V17, P1426, DOI 10.1111/j.1469-0691.2010.03433.x; Robertson GA, 2004, J MED MICROBIOL, V53, P35, DOI 10.1099/jmm.0.05365-0; Sanchez JA, 2004, P NATL ACAD SCI USA, V101, P1933, DOI 10.1073/pnas.0305476101; Sara Urmersbach TA, 2014, BMC MICROBIOL, V59, DOI [10.1186/1471-2180-14-59, DOI 10.1186/1471-2180-14-59]; Severiano A, 2011, J CLIN MICROBIOL, V49, P3997, DOI 10.1128/JCM.00624-11; Severiano A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019539; Sheludchenko MS, 2010, APPL ENVIRON MICROB, V76, P4337, DOI 10.1128/AEM.00128-10; Singh SK, 1998, CHEM COMMUN, P455, DOI 10.1039/a708608c; Su YC, 2007, FOOD MICROBIOL, V24, P549, DOI 10.1016/j.fm.2007.01.005; Theethakaew C, 2013, APPL ENVIRON MICROB, V79, P2358, DOI 10.1128/AEM.03067-12; Tong SYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029189; Turner JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055726; Velazquez-Roman J, 2014, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00110; Xiong F, 2011, J MOL DIAGN, V13, P427, DOI 10.1016/j.jmoldx.2011.03.005; Yu Y, 2011, FOODBORNE PATHOG DIS, V8, P1169, DOI 10.1089/fpd.2011.0865	36	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136998	10.1371/journal.pone.0136998	http://dx.doi.org/10.1371/journal.pone.0136998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368129	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100043
J	Nagata, N; Watanabe, K; Nishijima, T; Tadokoro, K; Watanabe, K; Shimbo, T; Niikura, R; Sekine, K; Akiyama, J; Teruya, K; Gatanaga, H; Kikuchi, Y; Uemura, N; Oka, S				Nagata, Naoyoshi; Watanabe, Kazuhiro; Nishijima, Takeshi; Tadokoro, Kenichi; Watanabe, Koji; Shimbo, Takuro; Niikura, Ryota; Sekine, Katsunori; Akiyama, Junichi; Teruya, Katsuji; Gatanaga, Hiroyuki; Kikuchi, Yoshimi; Uemura, Naomi; Oka, Shinichi			Prevalence of Anal Human Papillomavirus Infection and Risk Factors among HIV-positive Patients in Tokyo, Japan	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HOMOSEXUAL-MEN; CANCER PRECURSORS; NATURAL-HISTORY; WOMEN; EPIDEMIOLOGY; ASSOCIATION; PREVENTION; SYPHILIS; IMPACT	Background Oncogenic human papillomavirus (HPV) infection, particularly multiple HPV types, is recognized as a necessary cause of anal cancer. However, a limited number of studies have reported the prevalence of anal HPV infection in Asia. We determined the prevalence, genotypes, and risk factors for anal HPV infection in Japanese HIV-positive men who have sex with men (MSM), heterosexual men, and women. Methods This cross-sectional study included 421 HIV-positive patients. At enrollment, we collected data on smoking, alcohol, co-morbidities, drugs, CD4 cell counts, HIV RNA levels, highly active anti-retroviral therapy (HAART) duration, sexually transmitted infections (STIs), and serological screening (syphilis, hepatitis B virus, Chlamydia trachomatis, Entamoeba histolytica). Anal swabs were collected for oncogenic HPV genotyping. Results Oncogenic HPV rate was 75.9% in MSM, 20.6% in heterosexual men, and 19.2% in women. HPV 16/18 types were detected in 34.9% of MSM, 17.7% of heterosexual men, and 11.5% of women. Multiple oncogenic HPV (>= 2 oncogenic types) rate was 54.6% in MSM, 8.8% in heterosexual men, and 0% in women. In univariate analysis, younger age, male sex, MSM, CD4 <100, HIV viral load >50,000, no administration of HAART, and having >= 2 sexually transmitted infections (STIs) were significantly associated with oncogenic HPV infection, whereas higher smoking index and corticosteroid use were marginally associated with oncogenic HPV infection. In multivariate analysis, younger age (OR, 0.98 [0.96-0.99]), MSM (OR, 5.85 [2.33-14.71]), CD4 < 100 (OR, 2.24 [1.00-5.01]), and having >= 2 STIs (OR, 2.81 [1.72-4.61]) were independently associated with oncogenic HPV infection. These 4 variables were also significant risk factors for multiple oncogenic HPV infection. Conclusions Among Japanese HIV-infected patients, approximately two-thirds of MSM, one-fifth of heterosexual men, and one-fifth of women have anal oncogenic HPV infection. Younger age, MSM, >= 2 STIs, and immunosuppression confer a higher risk of infection with oncogenic HPV and multiple oncogenic types.	[Nagata, Naoyoshi; Watanabe, Kazuhiro; Niikura, Ryota; Sekine, Katsunori; Akiyama, Junichi] Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Nishijima, Takeshi; Watanabe, Koji; Teruya, Katsuji; Gatanaga, Hiroyuki; Kikuchi, Yoshimi; Oka, Shinichi] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Tadokoro, Kenichi] BML, Tokyo, Japan; [Shimbo, Takuro] Ohta Nishinouchi Hosp, Fukushima, Japan; [Uemura, Naomi] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Chiba, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Nagata, N (corresponding author), Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Tokyo, Japan.	nnagata_ncgm@yahoo.co.jp		Oka, Shinichi/0000-0002-9283-2167	Ministry of Health, Labour and Welfare of Japan [H26-003]; National Center for Global Health and Medicine [26-120]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan)	This work was supported in part by a Grant-in-Aid for AIDS research from the Ministry of Health, Labour and Welfare of Japan (H26-003) and a grant from the National Center for Global Health and Medicine (26-120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananworanich J, 2014, JAIDS-J ACQ IMM DEF, V67, pS99, DOI 10.1097/QAI.0000000000000262; BREESE PL, 1995, SEX TRANSM DIS, V22, P7, DOI 10.1097/00007435-199501000-00002; Canadas MP, 2010, SEX TRANSM DIS, V37, P311, DOI 10.1097/OLQ.0b013e3181c9c23f; CAUSSY D, 1990, INT J CANCER, V46, P214, DOI 10.1002/ijc.2910460212; Cheng SH, 2014, J MED VIROL, V86, P193, DOI 10.1002/jmv.23825; Critchlow CW, 1998, AIDS, V12, P1177, DOI 10.1097/00002030-199810000-00010; D'Souza G, 2008, JAIDS-J ACQ IMM DEF, V48, P491, DOI 10.1097/QAI.0b013e31817aebfe; Fife KH, 2001, J MED VIROL, V64, P550, DOI 10.1002/jmv.1085; Fujisaki S, 2011, J CLIN MICROBIOL, V49, P1017, DOI 10.1128/JCM.02149-10; Gao L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015256; Gatanaga H, 2013, CLIN INFECT DIS, V56, P1812, DOI 10.1093/cid/cit145; Gilmour S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043473; Godbole SV, 2014, JAIDS-J ACQ IMM DEF, V67, pE111, DOI 10.1097/QAI.0000000000000328; Hamada Y, 2014, JAIDS-J ACQ IMM DEF, V65, P312, DOI 10.1097/QAI.0000000000000016; Hessol NA, 2013, AIDS, V27, P1743, DOI 10.1097/QAD.0b013e3283601b09; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Hu YF, 2013, JAIDS-J ACQ IMM DEF, V64, P103, DOI 10.1097/QAI.0b013e31829b6298; Johnson LG, 2004, CANCER-AM CANCER SOC, V101, P281, DOI 10.1002/cncr.20364; Joseph DA, 2008, CANCER-AM CANCER SOC, V113, P2892, DOI 10.1002/cncr.23744; Juckett G, 2010, AM FAM PHYSICIAN, V82, P1209; KIVIAT N, 1990, J INFECT DIS, V162, P358, DOI 10.1093/infdis/162.2.358; Koga I, 2006, MICROBES INFECT, V8, P2872, DOI 10.1016/j.micinf.2006.09.003; LAW CLH, 1991, GENITOURIN MED, V67, P92; Mortimer J Y, 1997, Commun Dis Rep CDR Rev, V7, pR130; Nagata N, 2012, DIAGN MICR INFEC DIS, V74, P374, DOI 10.1016/j.diagmicrobio.2012.08.020; Negata N, 2012, EMERG INFECT DIS, V18, P717, DOI 10.3201/eid1805.111275; Nielson CM, 2009, CANCER EPIDEM BIOMAR, V18, P1077, DOI 10.1158/1055-9965.EPI-08-0447; Nishijima T, 2015, INT J INFECT DIS, V37, P70, DOI 10.1016/j.ijid.2015.06.009; Palefsky JM, 1998, J INFECT DIS, V177, P361, DOI 10.1086/514194; Phanuphak N, 2013, JAIDS-J ACQ IMM DEF, V63, P472, DOI 10.1097/QAI.0b013e3182918a5a; Pieriangeli A, 2008, AIDS, V22, P1929, DOI 10.1097/QAD.0b013e32830fbd7a; Piketty C, 2003, ANN INTERN MED, V138, P453, DOI 10.7326/0003-4819-138-6-200303180-00008; Poizot-Martin I, 2009, J CLIN VIROL, V44, P314, DOI 10.1016/j.jcv.2009.02.003; Schmid G, 2004, B WORLD HEALTH ORGAN, V82, P402; Suguimoto SP, 2014, CURR HIV-AIDS REP, V11, P134, DOI 10.1007/s11904-014-0201-4; Supindham T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124499; Tadokoro K, 2010, DIAGN MICR INFEC DIS, V66, P58, DOI 10.1016/j.diagmicrobio.2009.05.001; Trottier H, 2008, J INFECT DIS, V197, P1436, DOI 10.1086/587698; Wilkin T, 2010, J INFECT DIS, V202, P1246, DOI 10.1086/656320; Yu CT, 2013, AIDS BEHAV, V17, P1211, DOI 10.1007/s10461-012-0173-6; Zhang DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096364	41	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137434	10.1371/journal.pone.0137434	http://dx.doi.org/10.1371/journal.pone.0137434			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368294	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100071
J	Visvabharathy, L; Xayarath, B; Weinberg, G; Shilling, RA; Freitag, NE				Visvabharathy, Lavanya; Xayarath, Bobbi; Weinberg, Guy; Shilling, Rebecca A.; Freitag, Nancy E.			Propofol Increases Host Susceptibility to Microbial Infection by Reducing Subpopulations of Mature Immune Effector Cells at Sites of Infection	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES INFECTION; STAPHYLOCOCCUS-AUREUS; BACTERIAL-INFECTION; PROCEDURAL SEDATION; DENDRITIC CELLS; DEFENSE; MACROPHAGE; EXPRESSION; RESPONSES; PHOSPHORYLATION	Anesthetics are known to modulate host immune responses, but separating the variables of surgery from anesthesia when analyzing hospital acquired infections is often difficult. Here, the bacterial pathogen Listeria monocytogenes (Lm) was used to assess the impact of the common anesthetic propofol on host susceptibility to infection. Brief sedation of mice with physiologically relevant concentrations of propofol increased bacterial burdens in target organs by more than 10,000-fold relative to infected control animals. The adverse effects of propofol sedation on immune clearance of Lm persisted after recovery from sedation, as animals given the drug remained susceptible to infection for days following anesthesia. In contrast to propofol, sedation with alternative anesthetics such as ketamine/xylazine or pentobarbital did not increase susceptibility to systemic Lm infection. Propofol altered systemic cytokine and chemokine expression during infection, and prevented effective bacterial clearance by inhibiting the recruitment and/or activity of immune effector cells at sites of infection. Propofol exposure induced a marked reduction in marginal zone macrophages in the spleens of Lm infected mice, resulting in bacterial dissemination into deep tissue. Propofol also significantly increased mouse kidney abscess formation following infection with the common nosocomial pathogen Staphylococcus aureus. Taken together, these data indicate that even brief exposure to propofol severely compromises host resistance to microbial infection for days after recovery from sedation.	[Visvabharathy, Lavanya; Xayarath, Bobbi; Shilling, Rebecca A.; Freitag, Nancy E.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA; [Weinberg, Guy] Univ Illinois, Dept Anesthesiol, Chicago, IL USA; [Shilling, Rebecca A.] Univ Illinois, Dept Pulm Crit Care Sleep & Allergy, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Freitag, NE (corresponding author), Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA.	nfreitag@uic.edu		Visvabharathy, Lavanya/0000-0002-8157-4385	Public Health Service [AI097160]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI097160] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grant AI097160 (N. E. F). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the funding sources.	Alonzo F, 2011, INFECT IMMUN, V79, P1458, DOI 10.1128/IAI.01140-10; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Brown EN, 2011, ANNU REV NEUROSCI, V34, P601, DOI 10.1146/annurev-neuro-060909-153200; BRUNDAGE RA, 1993, P NATL ACAD SCI USA, V90, P11890, DOI 10.1073/pnas.90.24.11890; BRYSON HM, 1995, DRUGS, V50, P513, DOI 10.2165/00003495-199550030-00008; Busch DH, 1999, IMMUNOL LETT, V65, P93, DOI 10.1016/S0165-2478(98)00130-8; Carrero JA, 2012, ADV IMMUNOL, V113, P157, DOI 10.1016/B978-0-12-394590-7.00001-4; Chen RM, 2003, ANESTHESIOLOGY, V98, P1178, DOI 10.1097/00000542-200305000-00021; Cheng AG, 2009, FASEB J, V23, P3393, DOI 10.1096/fj.09-135467; Chong SZ, 2011, EUR J IMMUNOL, V41, P1639, DOI 10.1002/eji.201041022; Conlan JW, 1996, J MED MICROBIOL, V44, P295, DOI 10.1099/00222615-44-4-295; Cope A, 2011, TRENDS IMMUNOL, V32, P278, DOI 10.1016/j.it.2011.03.010; Cox CE, 2008, CRIT CARE MED, V36, P706, DOI 10.1097/CCM.0B013E3181544248; Di YM, 2009, CURR DRUG METAB, V10, P754, DOI 10.2174/138920009789895507; Edwards JR, 2009, AM J INFECT CONTROL, V37, P783, DOI 10.1016/j.ajic.2009.10.001; Favetta P, 2002, BRIT J ANAESTH, V88, P653, DOI 10.1093/bja/88.5.653; FDA, 2005, EST MAX SAF START DO; Green SM, 2007, ANN EMERG MED, V49, P454, DOI 10.1016/j.annemergmed.2006.08.017; Hedi H, 2004, CELL IMMUNOL, V228, P99, DOI 10.1016/j.cellimm.2004.04.003; Heuss LT, 2004, AM J GASTROENTEROL, V99, P511, DOI 10.1111/j.1572-0241.2004.04088.x; Heuss LT, 2004, DIGESTION, V69, P20, DOI 10.1159/000076543; Hong DM, 2011, ANESTH ANALG, V112, P1096, DOI 10.1213/ANE.0b013e31820fcc3e; Kambara Tomoko, 2009, Immunopharmacol Immunotoxicol, V31, P117, DOI 10.1080/08923970802452046; Kubota K, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00026; KUNKEL SL, 1988, J BIOL CHEM, V263, P5380; Lara-Tejero M, 2004, CURR OPIN MICROBIOL, V7, P45, DOI 10.1016/j.mib.2003.12.002; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Liu Y, 2012, EFFICACY NMDA RECEPT; MCLEISH KR, 1987, FREE RADICAL BIO MED, V3, P15, DOI 10.1016/0891-5849(87)90034-7; McQuaid KR, 2008, GASTROINTEST ENDOSC, V67, P910, DOI 10.1016/j.gie.2007.12.046; Mendu SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042959; Miner JR, 2007, ACAD EMERG MED, V14, P170, DOI 10.1197/j.aem.2006.10.101; Nigam R, 2010, ARCH DERMATOL RES, V302, P507, DOI 10.1007/s00403-010-1052-5; Ostermann ME, 2000, JAMA-J AM MED ASSOC, V283, P1451, DOI 10.1001/jama.283.11.1451; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Perencevich EN, 2003, EMERG INFECT DIS, V9, P196; Qiu J, 2011, CLIN VACCINE IMMUNOL, V18, P640, DOI 10.1128/CVI.00254-10; Rigby KM, 2012, SEMIN IMMUNOPATHOL, V34, P237, DOI 10.1007/s00281-011-0295-3; RUTLEDGE BJ, 1995, J IMMUNOL, V155, P4838; Schlapfer M, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0751-x; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2012, ADV IMMUNOL, V113, P119, DOI 10.1016/B978-0-12-394590-7.00003-8; Serbina NV, 2009, J IMMUNOL, V183, P1900, DOI 10.4049/jimmunol.0900612; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shaughnessy LM, 2007, FRONT BIOSCI-LANDMRK, V12, P2683, DOI 10.2741/2364; Shi C, 2011, J IMMUNOL, V187, P5293, DOI 10.4049/jimmunol.1101721; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shiratsuchi H, 2009, AM J PHYSIOL-CELL PH, V296, pC1400, DOI 10.1152/ajpcell.00345.2008; SUN AN, 1990, INFECT IMMUN, V58, P3770, DOI 10.1128/IAI.58.11.3770-3778.1990; Yu GX, 2011, SURGERY, V150, P887, DOI 10.1016/j.surg.2011.04.002	50	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138043	10.1371/journal.pone.0138043	http://dx.doi.org/10.1371/journal.pone.0138043			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381144	gold, Green Published, Green Submitted			2022-12-27	WOS:000361790200051
J	McManus, BA; Coleman, DC; Deasy, EC; Brennan, GI; Connell, BO; Monecke, S; Ehricht, R; Leggett, B; Leonard, N; Shore, AC				McManus, Brenda A.; Coleman, David C.; Deasy, Emily C.; Brennan, Grainne I.; Connell, Brian O.; Monecke, Stefan; Ehricht, Ralf; Leggett, Bernadette; Leonard, Nola; Shore, Anna C.			Comparative Genotypes, Staphylococcal Cassette Chromosome mec (SCCmec) Genes and Antimicrobial Resistance amongst Staphylococcus epidermidis and Staphylococcus haemolyticus Isolates from Infections in Humans and Companion Animals	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; METHICILLIN-RESISTANT; POPULATION-STRUCTURE; ANTIBIOTIC-RESISTANCE; RAPID IDENTIFICATION; AUREUS STRAINS; PCR STRATEGY; PIG FARMS; DIVERSITY; MULTIPLEX	This study compares the characteristics of Staphylococcus epidermidis (SE) and Staphylococcus haemolyticus (SH) isolates from epidemiologically unrelated infections in humans (Hu) (28 SE-Hu; 8 SH-Hu) and companion animals (CpA) (12 SE-CpA; 13 SH-CpA). All isolates underwent antimicrobial susceptibility testing, multilocus sequence typing and DNA microarray profiling to detect antimicrobial resistance and SCCmec-associated genes. All methicillin-resistant (MR) isolates (33/40 SE, 20/21 SH) underwent dru and mecA allele typing. Isolates were predominantly assigned to sequence types (STs) within a single clonal complex (CC2, SE, 84.8%; CC1, SH, 95.2%). SCCmec IV predominated among MRSE with ST2-MRSE-IVc common to both Hu (40.9%) and CpA (54.5%). Identical mecA alleles and nontypeable dru types (dts) were identified in one ST2-MRSE-IVc Hu and CpA isolate, however, all mecA alleles and 2/4 dts detected among 18 ST2-MRSE-IVc isolates were closely related, sharing >96.5% DNA sequence homology. Although only one ST-SCCmec type combination (ST1 with a non-typeable [NT] SCCmec NT9 [class C mec and ccrB4]) was common to four MRSH-Hu and one MRSH-CpA, all MRSH isolates were closely related based on similar STs, SCCmec genes (V/V-T or components thereof), mecA alleles and dts. Overall, 39.6% of MR isolates harbored NT SCCmec elements, and ACME was more common amongst MRSE and CpA isolates. Multidrug resistance (MDR) was detected among 96.7% of isolates but they differed in the prevalence of specific macrolide, aminoglycoside and trimethoprim resistance genes amongst SE and SH isolates. Ciprofloxacin, rifampicin, chloramphenicol [fexA, cat-pC221], tetracycline [tet(K)], aminoglycosides [aadD, aphA3] and fusidic acid [fusB] resistance was significantly more common amongst CpA isolates. SE and SH isolates causing infections in Hu and CpA hosts belong predominantly to STs within a single lineage, harboring similar but variable SCCmec genes, mecA alleles and dts. Host and staphylococcal species-specific characteristics were identified in relation to antimicrobial resistance genes and phenotypes, SCCmec and ACME.	[McManus, Brenda A.; Coleman, David C.; Deasy, Emily C.; Brennan, Grainne I.; Shore, Anna C.] Univ Dublin, Trinity Coll Dublin, Dublin Dent Univ Hosp, Microbiol Res Unit, Dublin 9, Ireland; [Brennan, Grainne I.; Connell, Brian O.; Shore, Anna C.] St James Hosp, Natl MRSA Reference Lab, Dublin 8, Ireland; [Connell, Brian O.] St James Hosp, Trinity Coll Dublin, Sch Med, Dept Clin Microbiol, Dublin 8, Ireland; [Monecke, Stefan; Ehricht, Ralf] Alere Technol GmbH, Jena, Germany; [Monecke, Stefan] Tech Univ Dresden, Inst Med Microbiol & Hyg, Med Fak Carl Gustav Carus, D-01062 Dresden, Germany; [Monecke, Stefan; Ehricht, Ralf] InfectoGnost Res Campus, Jena, Germany; [Leggett, Bernadette; Leonard, Nola] Univ Coll Dublin, Sch Vet Med, Pathobiol, Dublin 4, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Alere; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University College Dublin	Shore, AC (corresponding author), Univ Dublin, Trinity Coll Dublin, Dublin Dent Univ Hosp, Microbiol Res Unit, Dublin 9, Ireland.	anna.shore@dental.tcd.ie	Coleman, David C./C-2008-2009; McManus, Brenda/H-8600-2019	Coleman, David C./0000-0003-1797-2888; McManus, Brenda/0000-0003-3969-054X	Mircobiology Research unit, Dublin Dental University Hospital; Alere Technologies GmbH	Mircobiology Research unit, Dublin Dental University Hospital; Alere Technologies GmbH	The Mircobiology Research unit, Dublin Dental University Hospital provided all funding for staff, materials and DNA sequencing for this study apart from the mecA allele typing. The mecA Allele typing was undertaken and funded by S. Monecke and R. Ehricht at Alere Technologies GmbH. There was no external funding for this project.	Aanensen DM, 2005, NUCLEIC ACIDS RES, V33, pW728, DOI 10.1093/nar/gki415; Al-Bakri AG, 2013, EPIDEMIOL INFECT, V141, P2384, DOI 10.1017/S0950268813000010; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Argudin MA, 2014, MICROB PATHOGENESIS, V74, P8, DOI 10.1016/j.micpath.2014.06.005; Argudin MA, 2015, VET J, V203, P302, DOI 10.1016/j.tvjl.2015.01.008; Bagcigil FA, 2007, VET MICROBIOL, V121, P307, DOI 10.1016/j.vetmic.2006.12.007; Bartels MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061860; Bouchami O, 2011, FOLIA MICROBIOL, V56, P122, DOI 10.1007/s12223-011-0017-1; Bouchami O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021940; Brzychczy-Wloch M, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-41; Burns K, 2012, POINT PREVALENCE SUR; Busscher JF, 2006, VET MICROBIOL, V113, P131, DOI 10.1016/j.vetmic.2005.10.028; Cavanagh JP, 2014, J ANTIMICROB CHEMOTH, V69, P2920, DOI 10.1093/jac/dku271; Cavanagh JP, 2012, J MICROBIOL METH, V89, P159, DOI 10.1016/j.mimet.2012.03.014; Clinical and Laboratory Standards Institute, 2013, M100S23 CLSI; De Briyne N, 2014, VET REC, V175, DOI 10.1136/vr.102462; European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2014, BREAKPOINT TABLES FO; Garza-Gonzalez E, 2010, EPIDEMIOL INFECT, V138, P645, DOI 10.1017/S0950268809991361; Goering RV, 2008, CLIN MICROBIOL INFEC, V14, P964, DOI 10.1111/j.1469-0691.2008.02073.x; Higuchi W, 2008, BIOCHEM BIOPH RES CO, V377, P752, DOI 10.1016/j.bbrc.2008.10.009; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Kern A, 2013, J ANTIMICROB CHEMOTH, V68, P1256, DOI 10.1093/jac/dkt020; Kinnevey PM, 2014, ANTIMICROB AGENTS CH, V58, P1907, DOI 10.1128/AAC.02653-13; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Kristof K, 2011, EUR J CLIN MICROBIOL, V30, P691, DOI 10.1007/s10096-010-1142-5; Le Bouter A, 2011, INT J ANTIMICROB AG, V37, P118, DOI 10.1016/j.ijantimicag.2010.10.008; Leonard FC, 2006, VET REC, V158, P155, DOI 10.1136/vr.158.5.155; Li SS, 2011, ANTIMICROB AGENTS CH, V55, P3046, DOI 10.1128/AAC.01475-10; Lindgren JK, 2014, J BACTERIOL, V196, P2277, DOI 10.1128/JB.00051-14; Ma XX, 2006, J CLIN MICROBIOL, V44, P4515, DOI 10.1128/JCM.00985-06; Ma XX, 2002, ANTIMICROB AGENTS CH, V46, P1147, DOI 10.1128/AAC.46.4.1147-1152.2002; Malachowa N, 2010, CELL MOL LIFE SCI, V67, P3057, DOI 10.1007/s00018-010-0389-4; May L, 2014, ANTIMICROB AGENTS CH, V58, P1404, DOI 10.1128/AAC.01908-13; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Miragaia M, 2008, J CLIN MICROBIOL, V46, P118, DOI 10.1128/JCM.01685-07; Miragaia M, 2007, J BACTERIOL, V189, P2540, DOI 10.1128/JB.01484-06; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke S, 2012, ANTIMICROB AGENTS CH, V56, P5547, DOI 10.1128/AAC.00574-12; Moodley A, 2009, VET MICROBIOL, V137, P397, DOI 10.1016/j.vetmic.2009.01.034; Nahvi MD, 2001, MICROB DRUG RESIST, V7, P1, DOI 10.1089/107662901750152684; O'Mahony R, 2005, VET MICROBIOL, V109, P285, DOI 10.1016/j.vetmic.2005.06.003; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Otto M, 2013, BIOESSAYS, V35, P4, DOI 10.1002/bies.201200112; Peel TN, 2012, ANTIMICROB AGENTS CH, V56, P2386, DOI 10.1128/AAC.06246-11; Planet PJ, 2013, MBIO, V4, DOI 10.1128/mBio.00889-13; Rossney AS, 2007, J CLIN MICROBIOL, V45, P2554, DOI 10.1128/JCM.00245-07; Ruppe E, 2009, ANTIMICROB AGENTS CH, V53, P442, DOI 10.1128/AAC.00724-08; Shore A, 2005, ANTIMICROB AGENTS CH, V49, P2070, DOI 10.1128/AAC.49.5.2070-2083.2005; Shore AC, 2008, ANTIMICROB AGENTS CH, V52, P4407, DOI 10.1128/AAC.00447-08; Shore AC, 2013, INT J MED MICROBIOL, V303, P350, DOI 10.1016/j.ijmm.2013.02.002; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P3765, DOI 10.1128/AAC.00187-11; Shore AC, 2010, J CLIN MICROBIOL, V48, P1839, DOI 10.1128/JCM.02155-09; Singh R, 2003, APPL ENVIRON MICROB, V69, P3412, DOI 10.1128/AEM.69.6.3412-3420.2003; Spratt BG, 2004, FEMS MICROBIOL LETT, V241, P129, DOI 10.1016/j.femsle.2004.11.015; Stevens NT, 2008, CLIN MICROBIOL INFEC, V14, P719, DOI 10.1111/j.1469-0691.2008.02012.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas JC, 2007, J CLIN MICROBIOL, V45, P616, DOI 10.1128/JCM.01934-06; Tulinski P, 2012, APPL ENVIRON MICROB, V78, P299, DOI 10.1128/AEM.05594-11; Urushibara N, 2011, MICROB DRUG RESIST, V17, P291, DOI 10.1089/mdr.2010.0144; Veterinary Ireland-AMR Working Group, 2014, POLICY DOCUMENT ON A; von Eiff C, 2001, POSTGRAD MED, V110, P63, DOI 10.3810/pgm.2001.10.1046; Weiss S, 2013, VET MICROBIOL, V167, P680, DOI 10.1016/j.vetmic.2013.07.036; Yu DL, 2014, GENOMICS, V104, P8, DOI 10.1016/j.ygeno.2014.04.003; Zhang M, 2012, EPIDEMIOL INFECT, V140, P1366, DOI 10.1017/S095026881100207X; Zhang YF, 2011, RES VET SCI, V90, P23, DOI 10.1016/j.rvsc.2010.05.018; Zong ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020191	68	40	42	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138079	10.1371/journal.pone.0138079	http://dx.doi.org/10.1371/journal.pone.0138079			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379051	gold, Green Submitted, Green Published			2022-12-27	WOS:000361769400051
J	Hallee, S; Richard, D				Hallee, Stephanie; Richard, Dave			Evidence that the Malaria Parasite Plasmodium falciparum Putative Rhoptry Protein 2 Localizes to the Golgi Apparatus throughout the Erythrocytic Cycle	PLOS ONE			English	Article							INFECTED ERYTHROCYTES; CELL INVASION; LIFE-CYCLE; REVEALS; EXPORT; HOST; EVENTS; PTEX; IDENTIFICATION; APICOMPLEXA	Invasion of a red blood cell by Plasmodium falciparum merozoites is an essential step in the malaria lifecycle. Several of the proteins involved in this process are stored in the apical complex of the merozoite, a structure containing secretory organelles that are released at specific times during invasion. The molecular players involved in erythrocyte invasion thus represent potential key targets for both therapeutic and vaccine-based strategies to block parasite development. In our quest to identify and characterize new effectors of invasion, we investigated the P. falciparum homologue of a P. berghei protein putatively localized to the rhoptries, the Putative rhoptry protein 2 (PbPRP2). We show that in P. falciparum, the protein colocalizes extensively with the Golgi apparatus across the asexual erythrocytic cycle. Furthermore, imaging of merozoites caught at different times during invasion show that PfPRP2 is not secreted during the process instead staying associated with the Golgi apparatus. Our evidence therefore suggests that PfPRP2 is a Golgi protein and that it is likely not a direct effector in the process of merozoite invasion.	[Hallee, Stephanie; Richard, Dave] CHU Univ Laval, Ctr Rech Infectiol, Quebec City, PQ, Canada	Laval University	Richard, D (corresponding author), CHU Univ Laval, Ctr Rech Infectiol, Quebec City, PQ, Canada.	dave.richard@crchul.ulaval.ca		Richard, Dave/0000-0003-2269-6240	National Science and Engineering Research Council of Canada [418192]; Canadian Foundation for Innovation [29837]; Banting Foundation New Investigator award; Fond de la Recherche du Quebec-Sante Junior 1 career award	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Banting Foundation New Investigator award; Fond de la Recherche du Quebec-Sante Junior 1 career award	Funding for the study was provided to D.R. by the National Science and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca), grant number 418192, the Canadian Foundation for Innovation (www.innovation.ca), grant number 29837 and the Banting Foundation New Investigator award. D.R. is supported by a Fond de la Recherche du Quebec-Sante Junior 1 career award (http://www.frqs.gouv.qc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200; Beck JR, 2014, NATURE, V511, P592, DOI 10.1038/nature13574; Blackman MJ, 2001, MOL BIOCHEM PARASIT, V117, P11, DOI 10.1016/S0166-6851(01)00328-0; Botha M, 2007, INT J BIOCHEM CELL B, V39, P1781, DOI 10.1016/j.biocel.2007.02.011; Bowyer PW, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001636; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Bunnik EM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r128; Collins CR, 2013, MOL MICROBIOL, V88, P687, DOI 10.1111/mmi.12206; Counihan NA, 2013, TRENDS PARASITOL, V29, P228, DOI 10.1016/j.pt.2013.03.003; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; de Azevedo MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040981; ELMENDORF HG, 1993, EMBO J, V12, P4763, DOI 10.1002/j.1460-2075.1993.tb06165.x; Elsworth B, 2014, NATURE, V511, P587, DOI 10.1038/nature13555; Florens L, 2004, MOL BIOCHEM PARASIT, V135, P1, DOI 10.1016/j.molbiopara.2003.12.007; Gilberger TW, 2003, J CELL BIOL, V162, P317, DOI 10.1083/jcb.200301046; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Jimenez-Ruiz E., 2014, PARASITOLOGY, V13, P1, DOI DOI 10.1017/S0031182014000559; KUMAR N, 1991, MOL BIOCHEM PARASIT, V48, P47, DOI 10.1016/0166-6851(91)90163-Z; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Liu J, 2005, J BIOL CHEM, V280, P1432, DOI 10.1074/jbc.M409740200; Lobo CA, 2003, MOL BIOCHEM PARASIT, V128, P59, DOI 10.1016/S0166-6851(03)00050-1; Muralidharan V, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2306; Muralidharan V, 2011, P NATL ACAD SCI USA, V108, P4411, DOI 10.1073/pnas.1018449108; Oehring SC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r108; PERLMANN H, 1984, J EXP MED, V159, P1686, DOI 10.1084/jem.159.6.1686; Proellocks NI, 2007, INT J PARASITOL, V37, P1233, DOI 10.1016/j.ijpara.2007.03.013; Prommana P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073783; Richard D, 2011, J BIOL CHEM, V286, P11746, DOI 10.1074/jbc.M110.198499; Riglar DT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2449; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; Sam-Yellowe TY, 2008, EXP PARASITOL, V120, P113, DOI 10.1016/j.exppara.2008.05.001; Sam-Yellowe TY, 2004, J PROTEOME RES, V3, P995, DOI 10.1021/pr049926m; SCHOFIELD L, 1986, MOL BIOCHEM PARASIT, V18, P183, DOI 10.1016/0166-6851(86)90037-X; Sharma P, 2013, CURR OPIN MICROBIOL, V16, P432, DOI 10.1016/j.mib.2013.07.004; Silvestrini F, 2010, MOL CELL PROTEOMICS, V9, P1437, DOI 10.1074/mcp.M900479-MCP200; Sleebs BE, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001897; Struck NS, 2008, MOL MICROBIOL, V67, P1320, DOI 10.1111/j.1365-2958.2008.06125.x; Struck NS, 2005, J CELL SCI, V118, P5603, DOI 10.1242/jcs.02673; Taraschi TF, 1998, EXP PARASITOL, V88, P184, DOI 10.1006/expr.1998.4254; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; Topolska AE, 2004, J BIOL CHEM, V279, P4648, DOI 10.1074/jbc.M307859200; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tufet-Bayona M, 2009, MOL BIOCHEM PARASIT, V166, P22, DOI 10.1016/j.molbiopara.2009.02.009; VanWye J, 1996, MOL BIOCHEM PARASIT, V83, P107, DOI 10.1016/S0166-6851(96)02759-4; Webster WAJ, 2014, J EUKARYOT MICROBIOL, V61, P655, DOI 10.1111/jeu.12176; Zuccala ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046160	49	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138626	10.1371/journal.pone.0138626	http://dx.doi.org/10.1371/journal.pone.0138626			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375591	Green Published, Green Submitted, gold			2022-12-27	WOS:000361610200116
J	Hammerman, A; Greenberg-Dotan, S; Feldhamer, I; Bitterman, H; Yerushalmi, R				Hammerman, Ariel; Greenberg-Dotan, Sari; Feldhamer, Ilan; Bitterman, Haim; Yerushalmi, Rinat			Second-Line Treatment of Her2-Positive Metastatic Breast Cancer: Trastuzumab beyond Progression or Lapatinib? A Population Based Cohort Study	PLOS ONE			English	Article							PLUS CAPECITABINE; DISEASE PROGRESSION; COMORBIDITY INDEX; PHASE-III; HER-2; SURVIVAL; THERAPY	Background The relative efficacy of lapatinib vs. continuing trastuzumab beyond progression (TBP) in HER2-positive metastatic breast cancer (MBC) patients, who progressed on first-line trastuzumab, is still unclear. The objective of this population based cohort study was to compare outcomes of lapatinib vs. TBP in daily practice. Methods All HER2-positive MBC patients who began second-line anti HER2 therapy between 1st January 2010 and 30th August 2013 were selected from Clalit Health Services' (CHS) electronic database. Available data on patient and disease characteristics and treatments were analyzed. The primary endpoint was overall survival (OS). Outcomes were compared using the Kaplan-Meier (log-rank) method and Cox proportional hazards model. Results 64 patients received second-line lapatinib and 93 TBP. The two treatment groups were similar in age and co-morbidity rates, but differed in proportion of prior adjuvant trastuzumab (lapatinib: 29.7%, TBP: 16.1%, P = 0.043) and rates of prior brain metastases (lapatinib: 32.8%, TBP: 10.8%, P = 0.01). Lapatinib median OS was 13.0 months (95% CI: 9.5-16.5) vs. 31.0 for TBP (95% CI: 20.6-41.4), P<0.001. On multivariate analysis, longer OS was preserved for TBP, after controlling for differences in age, adjuvant trastuzumab, duration of first-line trastuzumab therapy, brain metastases, visceral metastases and hormonal treatment [Hazard Ratio (HR) = 0.63, 95% CI: 0.40-0.99, P = 0.045]. Conclusion In this comparative cohort study, OS of HER2-positive MBC patients treated with TBP was significantly longer than with lapatinib. These results might be especially relevant in settings where ado-trastuzumab-emtansine (TDM-1), the current preferred agent in this setting, is not available yet for patients.	[Hammerman, Ariel; Greenberg-Dotan, Sari; Feldhamer, Ilan; Bitterman, Haim] Clalit Hlth Serv Headquarters, Phys Off, Tel Aviv, Israel; [Bitterman, Haim] Technion Israel Inst Technol, Bruce & Ruth Rappaport Fac Med, Haifa, Israel; [Yerushalmi, Rinat] Rabin Med Ctr, Beilinson Hosp, Davidoff Canc Ctr, Inst Oncol, Petah Tiqwa, Israel; [Yerushalmi, Rinat] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Clalit Health Services; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rabin Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Hammerman, A (corresponding author), Clalit Hlth Serv Headquarters, Phys Off, Tel Aviv, Israel.	arielha@clalit.org.il	Hammerman, Ariel/AAG-4399-2020	Hammerman, Ariel/0000-0002-4396-5246				[Anonymous], 2015, NCCN CLIN PRACT GUID; Cameron D, 2010, ONCOLOGIST, V15, P924, DOI 10.1634/theoncologist.2009-0181; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Fabi A, 2008, BREAST, V17, P499, DOI 10.1016/j.breast.2008.03.006; Gelmon KA, 2015, J CLIN ONCOL, V33, P1574, DOI 10.1200/JCO.2014.56.9590; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Giordano SH, 2014, J CLIN ONCOL, V32, P2078, DOI 10.1200/JCO.2013.54.0948; Gonzalez-Angulo AM, 2009, J CLIN ONCOL, V27, P5700, DOI 10.1200/JCO.2009.23.2025; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Lin NU, 2009, CLIN CANCER RES, V15, P1452, DOI 10.1158/1078-0432.CCR-08-1080; Pivot X, 2015, J CLIN ONCOL, V33, P1564, DOI 10.1200/JCO.2014.57.1794; Ryan Q, 2008, ONCOLOGIST, V13, P1114, DOI 10.1634/theoncologist.2008-0816; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Tripathy D, 2004, J CLIN ONCOL, V22, P1063, DOI 10.1200/JCO.2004.06.557; von Minckwitz G, 2009, J CLIN ONCOL, V27, P1999, DOI 10.1200/JCO.2008.19.6618; Yerushalmi R, 2010, ONCOLOGIST, V15, P796, DOI 10.1634/theoncologist.2010-0137	17	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138229	10.1371/journal.pone.0138229	http://dx.doi.org/10.1371/journal.pone.0138229			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375590	Green Submitted, gold, Green Published			2022-12-27	WOS:000361610200090
J	Palti, Y; Vallejo, RL; Gao, GT; Liu, SX; Hernandez, AG; Rexroad, CE; Wiens, GD				Palti, Yniv; Vallejo, Roger L.; Gao, Guangtu; Liu, Sixin; Hernandez, Alvaro G.; Rexroad, Caird E., III; Wiens, Gregory D.			Detection and Validation of QTL Affecting Bacterial Cold Water Disease Resistance in Rainbow Trout Using Restriction-Site Associated DNA Sequencing	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; WHOLE-GENOME DUPLICATION; ONCORHYNCHUS-MYKISS; LINKAGE MAPS; IDENTIFICATION; STRESS; FISH; ADAPTATION; DIVERGENCE; GENERATION	Bacterial cold water disease (BCWD) causes significant economic loss in salmonid aquaculture. Using microsatellite markers in a genome scan, we previously detected significant and suggestive QTL affecting phenotypic variation in survival following challenge with Flavobacterium psychrophilum, the causative agent of BCWD in rainbow trout. In this study, we performed selective genotyping of SNPs from restriction-site associated DNA (RAD) sequence data from two pedigreed families (2009070 and 2009196) to validate the major QTL from the previous work and to detect new QTL. The use of RAD SNPs in the genome scans increased the number of mapped markers from similar to 300 to similar to 5,000 per family. The significant QTL detected in the microsatellites scan on chromosome Omy8 in family 2009070 was validated explaining up to 58% of the phenotypic variance in that family, and in addition, a second QTL was also detected on Omy8. Two novel QTL on Omy11 and 14 were also detected, and the previously suggestive QTL on Omy1, 7 and 25 were also validated in family 2009070. In family 2009196, the microsatellite significant QTL on Omy6 and 12 were validated and a new QTL on Omy8 was detected, but none of the previously detected suggestive QTL were validated. The two Omy8 QTL from family 2009070 and the Omy12 QTL from family 2009196 were found to be co-localized with handling and confinement stress response QTL that our group has previously identified in a separate pedigreed family. With the currently available data we cannot determine if the co-localized QTL are the result of genes with pleiotropic effects or a mere physical proximity on the same chromosome segment. The genetic markers linked to BCWD resistance QTL were used to query the scaffolds of the rainbow trout reference genome assembly and the QTL-positive scaffold sequences were found to include 100 positional candidate genes. Several of the candidate genes located on or near the two Omy8 QTL detected in family 2009070 suggest potential linkages between stress response and the regulation of immune response in rainbow trout.	[Palti, Yniv; Vallejo, Roger L.; Gao, Guangtu; Liu, Sixin; Rexroad, Caird E., III; Wiens, Gregory D.] USDA ARS, Natl Ctr Cool & Cold Water Aquaculture, Kearneysville, WV 25430 USA; [Hernandez, Alvaro G.] Univ Illinois, Roy J Carver Biotechnol Ctr, Urbana, IL 61801 USA	United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign	Palti, Y (corresponding author), USDA ARS, Natl Ctr Cool & Cold Water Aquaculture, 11861 Leetown Rd, Kearneysville, WV 25430 USA.	yniv.palti@ars.usda.gov	Vallejo, Roger/AAE-7591-2020; Gao, Guangtu/F-4541-2012	Vallejo, Roger/0000-0002-5399-3531; Wiens, Gregory/0000-0002-5478-7780	USDA Agricultural Research Service, CRIS Project [1930-31000-012]; ARS [ARS-0427931] Funding Source: Federal RePORTER	USDA Agricultural Research Service, CRIS Project; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was funded by USDA Agricultural Research Service, CRIS Project 1930-31000-012 (http://www.ars.usda.gov/research/projects/projects.htm?accn_no=427931). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barnes M. E., 2011, The Open Fish Science Journal, V4, P40, DOI 10.2174/1874401X01104010040; Barton BA, 2002, INTEGR COMP BIOL, V42, P517, DOI 10.1093/icb/42.3.517; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Brieuc MSO, 2014, G3-GENES GENOM GENET, V4, P447, DOI 10.1534/g3.113.009316; Campbell NR, 2014, G3-GENES GENOM GENET, V4, P2473, DOI 10.1534/g3.114.014621; DARVASI A, 1992, THEOR APPL GENET, V85, P353, DOI 10.1007/BF00222881; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; de Koning DJ, 1999, GENETICS, V152, P1679; Gonen S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-166; Hale MC, 2013, G3-GENES GENOM GENET, V3, P1273, DOI 10.1534/g3.113.006817; Hecht BC, 2013, MOL ECOL, V22, P3061, DOI 10.1111/mec.12082; Hecht BC, 2012, G3-GENES GENOM GENET, V2, P1113, DOI 10.1534/g3.112.003137; Houston RD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-90; Houston RD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-244; Knott SA, 1997, THEOR APPL GENET, V94, P810, DOI 10.1007/s001220050482; Knott SA, 1996, THEOR APPL GENET, V93, P71, DOI 10.1007/BF00225729; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Liu SX, 2015, MAR BIOTECHNOL, V17, P328, DOI 10.1007/s10126-015-9621-4; Liu SX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088492; Marancik D, 2015, FRONT GENET, V5, DOI 10.3389/fgene.2014.00453; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Miller MR, 2012, MOL ECOL, V21, P237, DOI 10.1111/j.1365-294X.2011.05305.x; Narum SR, 2013, MOL ECOL, V22, P3090, DOI 10.1111/mec.12240; Nematollahi A, 2003, J FISH DIS, V26, P563, DOI 10.1046/j.1365-2761.2003.00488.x; Palti Y, 2015, MOL ECOL RESOUR, V15, P662, DOI 10.1111/1755-0998.12337; Palti Y, 2006, AQUACULTURE, V255, P548, DOI 10.1016/j.aquaculture.2005.11.029; Palti Y, 2014, MOL ECOL RESOUR, V14, P588, DOI 10.1111/1755-0998.12204; Palti Y, 2012, MAR BIOTECHNOL, V14, P343, DOI 10.1007/s10126-011-9418-z; Philip AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129299; Rexroad CE, 2013, MAR BIOTECHNOL, V15, P613, DOI 10.1007/s10126-013-9512-5; Rexroad CE, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-74; Seaton G, 2006, GRIDQTL A GRID PORTA; Svishcheva GR, 2012, NAT GENET, V44, P1166, DOI 10.1038/ng.2410; Tort L, 2011, DEV COMP IMMUNOL, V35, P1366, DOI 10.1016/j.dci.2011.07.002; Vallejo RL, 2010, J ANIM SCI, V88, P3814, DOI 10.2527/jas.2010-2951; Vallejo RL, 2014, AQUACULTURE, V432, P139, DOI 10.1016/j.aquaculture.2014.05.003; Vallejo RL, 2014, MAR BIOTECHNOL, V16, P349, DOI 10.1007/s10126-013-9553-9; Wang TH, 2010, FISH SHELLFISH IMMUN, V29, P656, DOI 10.1016/j.fsi.2010.06.015; Wiens GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075749; Zhang H, 2012, JOURNAL OF ANIMAL SC, V3	43	60	64	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138435	10.1371/journal.pone.0138435	http://dx.doi.org/10.1371/journal.pone.0138435			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376182	gold, Green Published, Green Submitted			2022-12-27	WOS:000361610200108
J	Parikh, NA; Kennedy, KA; Lasky, RE; Tyson, JE				Parikh, Nehal A.; Kennedy, Kathleen A.; Lasky, Robert E.; Tyson, Jon E.			Neurodevelopmental Outcomes of Extremely Preterm Infants Randomized to Stress Dose Hydrocortisone	PLOS ONE			English	Article							CHRONIC LUNG-DISEASE; BIRTH-WEIGHT INFANTS; POSTNATAL DEXAMETHASONE THERAPY; REGIONAL BRAIN VOLUMES; BRONCHOPULMONARY DYSPLASIA; SCHOOL-AGE; CEREBRAL-PALSY; INTENSIVE-CARE; PREMATURITY; CHILDREN	Objective To compare the effects of stress dose hydrocortisone therapy with placebo on survival without neurodevelopmental impairments in high-risk preterm infants. Study Design We recruited 64 extremely low birth weight (birth weight <= 1000g) infants between the ages of 10 and 21 postnatal days who were ventilator-dependent and at high-risk for bronchopulmonary dysplasia. Infants were randomized to a tapering 7-day course of stress dose hydrocortisone or saline placebo. The primary outcome at follow-up was a composite of death, cognitive or language delay, cerebral palsy, severe hearing loss, or bilateral blindness at a corrected age of 18-22 months. Secondary outcomes included continued use of respiratory therapies and somatic growth. Results Fifty-seven infants had adequate data for the primary outcome. Of the 28 infants randomized to hydrocortisone, 19 (68%) died or survived with impairment compared with 22 of the 29 infants (76%) assigned to placebo (relative risk: 0.83; 95% CI, 0.61 to 1.14). The rates of death for those in the hydrocortisone and placebo groups were 31% and 41%, respectively (P = 0.42). Randomization to hydrocortisone also did not significantly affect the frequency of supplemental oxygen use, positive airway pressure support, or need for respiratory medications. Conclusions In high-risk extremely low birth weight infants, stress dose hydrocortisone therapy after 10 days of age had no statistically significant effect on the incidence of death or neurodevelopmental impairment at 18-22 months. These results may inform the design and conduct of future clinical trials.	[Parikh, Nehal A.] Univ Texas Med Sch Houston, Dept Pediat, Houston, TX 77030 USA; [Parikh, Nehal A.] Nationwide Childrens Hosp, Res Inst, Ctr Perinatal Res, Columbus, OH USA; [Parikh, Nehal A.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Parikh, Nehal A.] Nationwide Childrens Hosp, Div Neonatol, Columbus, OH USA; [Kennedy, Kathleen A.; Lasky, Robert E.; Tyson, Jon E.] Univ Texas Med Sch Houston, Ctr Clin Res & Evidence Based Med, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University of Texas System; University of Texas Health Science Center Houston	Parikh, NA (corresponding author), Univ Texas Med Sch Houston, Dept Pediat, Houston, TX 77030 USA.	nehal.parikh@nationwidechildrens.org	Parikh, Nehal/AAB-9981-2022	Parikh, Nehal/0000-0002-1375-1247	National Institutes of Health (National Institutes of Neurological Disorders and Stroke) [K23-NS048152]; Research Institute at Nationwide Children's Hospital; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS048152] Funding Source: NIH RePORTER	National Institutes of Health (National Institutes of Neurological Disorders and Stroke)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Research Institute at Nationwide Children's Hospital(Ohio State University); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (National Institutes of Neurological Disorders and Stroke) K23-NS048152 grant and The Research Institute at Nationwide Children's Hospital (to NAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel-Tison C, 1987, FOLLOW UP MANAGEMENT; Ball G, 2010, NEUROIMAGE, V53, P94, DOI 10.1016/j.neuroimage.2010.05.055; Bayley N., 2019, BAYLEY SCALES INFANT; Benders MJNL, 2009, PEDIATR RES, V66, P555, DOI 10.1203/PDR.0b013e3181b3aec5; Doyle LW, 2010, NEONATOLOGY, V98, P111, DOI 10.1159/000279992; Doyle LW, 2005, PEDIATRICS, V115, P655, DOI 10.1542/peds.2004-1238; Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2011, HYDR BPD NICHD NEON; Hack M, 2005, PEDIATRICS, V116, P333, DOI 10.1542/peds.2005-0173; Halliday HL, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001146.pub3; Higgins S, 2010, J PERINATOL, V30, P373, DOI 10.1038/jp.2009.126; Hsieh EM, 2014, AM J PERINAT, V31, P811, DOI 10.1055/s-0033-1361933; Laughon MM, 2011, AM J RESP CRIT CARE, V183, P1715, DOI 10.1164/rccm.201101-0055OC; Lind A, 2011, PEDIATR RADIOL, V41, P953, DOI 10.1007/s00247-011-2071-x; Lodygensky GA, 2005, PEDIATRICS, V116, P1, DOI 10.1542/peds.2004-1275; Murphy BP, 2001, PEDIATRICS, V107, P217, DOI 10.1542/peds.107.2.217; O'Shea TM, 2009, EARLY HUM DEV, V85, P719, DOI 10.1016/j.earlhumdev.2009.08.060; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Papile LA, 1998, NEW ENGL J MED, V338, P1112, DOI 10.1056/NEJM199804163381604; Parikh NA, 2007, PEDIATRICS, V119, P265, DOI 10.1542/peds.2006-1354; Parikh NA, 2013, J PEDIATR-US, V162, P685, DOI 10.1016/j.jpeds.2012.09.054; Patra K, 2015, J PERINATOL, V35, P77, DOI 10.1038/jp.2014.133; Peralta-Carcelen M, 2009, PEDIATRICS, V123, pE887, DOI 10.1542/peds.2008-0135; Peterson BS, 2003, PEDIATRICS, V111, P939, DOI 10.1542/peds.111.5.939; Pogribna U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072974; Rademaker KJ, 2007, J PEDIATR-US, V150, P351, DOI 10.1016/j.jpeds.2006.10.051; Tyson JE, 2008, NEW ENGL J MED, V358, P1672, DOI 10.1056/NEJMoa073059; van der Heide-Jalving M, 2003, ACTA PAEDIATR, V92, P827, DOI 10.1080/08035250310002425; Vohr BR, 2012, J PEDIATR-US, V161, P222, DOI 10.1016/j.jpeds.2012.01.057; Watterberg KL, 2007, PEDIATRICS, V120, P40, DOI 10.1542/peds.2006-3158; Watterberg KL, 2010, PEDIATRICS, V126, P800, DOI 10.1542/peds.2010-1534; Woodward LJ, 2005, BRAIN, V128, P2578, DOI 10.1093/brain/awh618; Yeh TF, 2004, NEW ENGL J MED, V350, P1304, DOI 10.1056/NEJMoa032089; Yoder BA, 2009, PEDIATRICS, V124, P673, DOI 10.1542/peds.2008-2793	33	15	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137051	10.1371/journal.pone.0137051	http://dx.doi.org/10.1371/journal.pone.0137051			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376074	gold, Green Submitted, Green Published			2022-12-27	WOS:000361610200029
J	Lee, SML; Schelcher, C; Thasler, R; Schiergens, TS; Thasler, WE				Lee, Serene M. L.; Schelcher, Celine; Thasler, Reinhard; Schiergens, Tobias S.; Thasler, Wolfgang E.			Pre-Analytical Determination of the Effect of Extended Warm or Cold Ischaemia on RNA Stability in the Human Ileum Mucosa	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS; C-MYC OVEREXPRESSION; FRESH-FROZEN TISSUE; BREAST-CANCER; IMPACT; TIME; DEGRADATION; BIOBANKING; INTEGRITY; QUALITY	The use of banked human tissue, obtained with informed consent after elective surgical procedures, represents a powerful model for understanding underlying mechanisms of diseases or therapeutic interventions and for establishing prognostic markers. However, donated tissues typically have varying times of warm ischaemia in situ due to blood arrest or cold ischaemia due to procurement and transportation. Hence, before using these tissues, it is important to carry out pre-analytical studies to ensure that they are representative of the in vivo state. In particular, tissues of the gastrointestinal tract have been thought to have low RNA stability. Therefore, this study aimed to determine if extended warm or cold ischaemia times and snap-freezing or banking in RNA stabilization solution affects RNA integrity or gene expression in human ileum mucosa. In short, ileum mucosa was collected for up to 1.5 h and 6 h of simulated warm or cold ischaemia respectively. Subsequently, RNA integrity and gene expressions were determined. It was found that RNA integrity remained high over the course of warm and cold ischaemia examined and there were in general no significant differences between snap-freezing and banking in RNA stabilization solution. Following the same trend, there were in general no significant changes in gene expressions measured (MYC, HIF1 alpha, CDX, HMOX1 and IL1 beta). In conclusion, RNA in the ileum mucosa is maintained at a high integrity and has stable gene expression over the examined time course of warm or cold ischaemia when banked in RNA stabilization solution or snap-frozen in liquid nitrogen. As the average warm and cold ischaemia times imposed by surgery and the process of tissue banking are shorter than the time period examined in this study, human ileum mucosa samples collected after surgeries could be used for gene expression studies.	[Lee, Serene M. L.; Schiergens, Tobias S.; Thasler, Wolfgang E.] Hosp Univ Munich, Dept Gen Visceral Transplantat Vasc & Thorac Surg, Munich, Germany; [Schelcher, Celine; Thasler, Reinhard; Thasler, Wolfgang E.] Hosp Univ Munich, Dept Gen Visceral Transplantat Vasc & Thorac Surg, Human Tissue & Cell Res HTCR Fdn, Biobank Adm, Munich, Germany	University of Munich; University of Munich	Thasler, WE (corresponding author), Hosp Univ Munich, Dept Gen Visceral Transplantat Vasc & Thorac Surg, Munich, Germany.	Wolfgang.Thasler@med.uni-muenchen.de		Lee, Serene/0000-0001-5231-0607	German Federal Ministry of Education and Research (BMBF grant: M4 Munich Biotech Excellence Cluster Biobank Alliance) [01EX1020B]	German Federal Ministry of Education and Research (BMBF grant: M4 Munich Biotech Excellence Cluster Biobank Alliance)	This work was carried out with financial support from the German Federal Ministry of Education and Research (BMBF grant: M4 Munich Biotech Excellence Cluster Biobank Alliance, grant number 01EX1020B). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Almeida A, 2004, ANAL BIOCHEM, V328, P101, DOI 10.1016/j.ab.2004.02.004; Bao WG, 2013, ANN SURG ONCOL, V20, P1737, DOI 10.1245/s10434-012-2440-1; Botling J, 2009, DIAGN MOL PATHOL, V18, P44, DOI 10.1097/PDM.0b013e3181857e92; Bray SE, 2010, HISTOPATHOLOGY, V56, P240, DOI 10.1111/j.1365-2559.2009.03470.x; Cho S, 2007, MOL BIOL EVOL, V24, P1259, DOI 10.1093/molbev/msm047; De Cecco L, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-409; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Futami J, 1997, DNA CELL BIOL, V16, P413, DOI 10.1089/dna.1997.16.413; Gopee NV, 2007, EXP MOL PATHOL, V83, P4, DOI 10.1016/j.yexmp.2006.11.001; Harder J, 2002, J BIOL CHEM, V277, P46779, DOI 10.1074/jbc.M207587200; Hoffmann Gaby, 2009, Comp Hepatol, V8, P3, DOI 10.1186/1476-5926-8-3; Hong Sang Hyun, 2010, J Korean Soc Coloproctol, V26, P316, DOI 10.3393/jksc.2010.26.5.316; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Ibberson D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-102; Lawson MH, 2010, J THORAC ONCOL, V5, P956, DOI 10.1097/JTO.0b013e3181ddbbe9; Lee J, 2005, FASEB J, V19, P1356, DOI 10.1096/fj.04-3552fje; Lee SML, 2013, MOL BIOTECHNOL, V53, P1, DOI 10.1007/s12033-011-9493-4; Lin DW, 2006, J CLIN ONCOL, V24, P3763, DOI 10.1200/JCO.2005.05.1458; MAESTRO R, 1991, BRIT J CANCER, V63, P185, DOI 10.1038/bjc.1991.45; Micke P, 2006, LAB INVEST, V86, P202, DOI 10.1038/labinvest.3700372; Opitz L, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-36; Rudloff U, 2010, ANN SURG ONCOL, V17, P2229, DOI 10.1245/s10434-010-0959-6; Schlomm T, 2008, EUR UROL, V53, P333, DOI 10.1016/j.eururo.2007.03.075; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sewart S, 2009, INT J ONCOL, V35, P381, DOI 10.3892/ijo_00000350; Spruessel A, 2004, BIOTECHNIQUES, V36, P1030, DOI 10.2144/04366RR04; Strand C, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-38; Thasler Wolfgang E., 2003, Cell and Tissue Banking, V4, P49, DOI 10.1023/A:1026392429112; Thasler WE, 2013, LANGENBECK ARCH SURG, V398, P487, DOI 10.1007/s00423-013-1060-y; Thompson KL, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-57; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VIEL A, 1990, J CANCER RES CLIN, V116, P288, DOI 10.1007/BF01612905; Wolfe LM, 2014, PLACENTA, V35, P645, DOI 10.1016/j.placenta.2014.05.005	33	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138214	10.1371/journal.pone.0138214	http://dx.doi.org/10.1371/journal.pone.0138214			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371767	gold, Green Published, Green Submitted			2022-12-27	WOS:000361604400056
J	Mayrose, I; Freilich, S				Mayrose, Itay; Freilich, Shiri			The Interplay between Scientific Overlap and Cooperation and the Resulting Gain in Co-Authorship Interactions	PLOS ONE			English	Article							RESEARCH COLLABORATION; NETWORKS; PRODUCTIVITY; IMPACT; INDICATOR; COMMUNITY; KNOWLEDGE	Considering the importance of scientific interactions, understanding the principles that govern fruitful scientific research is crucial to policy makers and scientists alike. The outcome of an interaction is to a large extent dependent on the balancing of contradicting motivations accompanying the establishment of collaborations. Here, we assembled a dataset of nearly 20,000 publications authored by researchers affiliated with ten top universities. Based on this data collection, we estimated the extent of different interaction types between pairwise combinations of researchers. We explored the interplay between the overlap in scientific interests and the tendency to collaborate, and associated these estimates with measures of scientific quality and social accessibility aiming at studying the typical resulting gain of different interaction patterns. Our results show that scientists tend to collaborate more often with colleagues with whom they share moderate to high levels of mutual interests and knowledge while cooperative tendency declines at higher levels of research-interest overlap, suggesting fierce competition, and at the lower levels, suggesting communication gaps. Whereas the relative number of alliances dramatically differs across a gradient of research overlap, the scientific impact of the resulting articles remains similar. When considering social accessibility, we find that though collaborations between remote researchers are relatively rare, their quality is significantly higher than studies produced by close-circle scientists. Since current collaboration patterns do not necessarily overlap with gaining optimal scientific quality, these findings should encourage scientists to reconsider current collaboration strategies.	[Mayrose, Itay] Tel Aviv Univ, Dept Mol Biol & Ecol Plants, IL-69978 Tel Aviv, Israel; [Freilich, Shiri] Agr Res Org, Inst Plant Sci, Newe Yaar Res Ctr, IL-30095 Ramat Yishay, Israel	Tel Aviv University	Mayrose, I (corresponding author), Tel Aviv Univ, Dept Mol Biol & Ecol Plants, IL-69978 Tel Aviv, Israel.	itaymay@post.tau.ac.il; shiri@volcani.agri.gov.il		Mayrose, Itay/0000-0002-8460-1502	Marie Curie Reintegration Grant; Israel Science Foundation [1265/12, 1481/13, 1416/14]	Marie Curie Reintegration Grant(European Commission); Israel Science Foundation(Israel Science Foundation)	This study was supported by a Marie Curie Reintegration Grant (I.M) and by Israel Science Foundation grants (1265/12 to I.M and 1481/13 and 1416/14 to S.F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bammer G, 2008, RES POLICY, V37, P875, DOI 10.1016/j.respol.2008.03.004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bornmann L, 2014, EMBO REP, V15, P1228, DOI 10.15252/embr.201439608; Bozeman B, 2004, RES POLICY, V33, P599, DOI 10.1016/j.respol.2004.01.008; Egghe L, 2008, COLLNET J SCIENTOMET, V2, P83, DOI 10.1080/09737766.2008.10700843; Freilich S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1597; Gonzalez-Pereira B, 2010, J INFORMETR, V4, P379, DOI 10.1016/j.joi.2010.03.002; Guerrero-Bote VP, 2012, J INFORMETR, V6, P674, DOI 10.1016/j.joi.2012.07.001; Guimera R, 2005, SCIENCE, V308, P697, DOI 10.1126/science.1106340; Han H, 2004, ACM-IEEE J CONF DIG, P296, DOI 10.1145/996350.996419; Hauptman R, 2005, J SCHOLARLY PUBL, V36, P115, DOI 10.1353/scp.2005.0002; Hoekman J, 2010, RES POLICY, V39, P662, DOI 10.1016/j.respol.2010.01.012; Jansen D, 2010, SCIENTOMETRICS, V83, P219, DOI 10.1007/s11192-009-0022-1; Katz JS, 1997, RES POLICY, V26, P1, DOI 10.1016/S0048-7333(96)00917-1; Kozak M, 2015, SCIENTOMETRICS, V102, P1101, DOI 10.1007/s11192-014-1439-8; KRETSCHMER H, 1985, SCIENTOMETRICS, V7, P39, DOI 10.1007/BF02020140; KRETSCHMER H, 1987, SCIENTOMETRICS, V12, P355, DOI 10.1007/BF02016679; Lee S, 2005, SOC STUD SCI, V35, P673, DOI 10.1177/0306312705052359; Liao CH, 2012, J INFORMETR, V6, P27, DOI 10.1016/j.joi.2011.09.003; Liu XM, 2005, INFORM PROCESS MANAG, V41, P1462, DOI 10.1016/j.ipm.2005.03.012; Lv P, 2013, SCI PUBL POLICY; Mali F, 2012, UNDERST COMPLEX SYST, P195, DOI 10.1007/978-3-642-23068-4_6; Mann GS, 2003, UNSUPERVISED PERSONA, P33; Mazloumian A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01167; Mazloumian A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049246; Moed HF, 2010, J INFORMETR, V4, P265, DOI 10.1016/j.joi.2010.01.002; Mowery DC, 1998, RES POLICY, V27, P507, DOI 10.1016/S0048-7333(98)00066-3; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Oh WS, 2006, J MANAGE INFORM SYST, V22, P271, DOI 10.2753/MIS0742-1222220410; Rotolo D, 2013, J ORGAN BEHAV, V34, P648, DOI 10.1002/job.1822; Smalheiser NR, 2009, ANNU REV INFORM SCI, V43, P287; Sonnenwald DH, 2007, ANNU REV INFORM SCI, V41, P643, DOI 10.1002/aris.2007.1440410121; Uzzi B, 2013, SCIENCE, V342, P468, DOI 10.1126/science.1240474; Waltman L, 2013, J INFORMETR, V7, P272, DOI 10.1016/j.joi.2012.11.011; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099; Molina-Morales FX, 2009, STRATEGIC MANAGE J, V30, P1013, DOI 10.1002/smj.766	37	10	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137856	10.1371/journal.pone.0137856	http://dx.doi.org/10.1371/journal.pone.0137856			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8LR	26372643	Green Submitted, Green Published, gold			2022-12-27	WOS:000361604400034
J	Debevec, T; Pialoux, V; Saugy, J; Schmitt, L; Cejuela, R; Mury, P; Ehrstrom, S; Faiss, R; Millet, GP				Debevec, Tadej; Pialoux, Vincent; Saugy, Jonas; Schmitt, Laurent; Cejuela, Roberto; Mury, Pauline; Ehrstroem, Sabine; Faiss, Raphael; Millet, Gregoire P.			Prooxidant/Antioxidant Balance in Hypoxia: A Cross-Over Study on Normobaric vs. Hypobaric "Live High-Train Low"	PLOS ONE			English	Article							OXIDATIVE STRESS; NITRIC-OXIDE; SIMULATED ALTITUDE; EXERCISE; PERFORMANCE; CONFINEMENT; VENTILATION; RESPONSES; EXPOSURE; HUMANS	"Live High-Train Low" (LHTL) training can alter oxidative status of athletes. This study compared prooxidant/antioxidant balance responses following two LHTL protocols of the same duration and at the same living altitude of 2250 m in either normobaric (NH) or hypobaric (HH) hypoxia. Twenty-four well-trained triathletes underwent the following two 18-day LHTL protocols in a cross-over and randomized manner: Living altitude (PIO2 = 111.9 +/- 0.6 vs. 111.6 +/- 0.6 mmHg in NH and HH, respectively); training "natural" altitude (similar to 1000-1100 m) and training loads were precisely matched between both LHTL protocols. Plasma levels of oxidative stress [advanced oxidation protein products (AOPP) and nitrotyrosine] and antioxidant markers [ferric-reducing antioxidant power (FRAP), superoxide dismutase (SOD) and catalase], NO metabolism end-products (NOx) and uric acid (UA) were determined before (Pre) and after (Post) the LHTL. Cumulative hypoxic exposure was lower during the NH (229 +/- 6 hrs.) compared to the HH (310 +/- 4 hrs.; P < 0.01) protocol. Following the LHTL, the concentration of AOPP decreased (-27%; P < 0.01) and nitrotyrosine increased (+67%; P < 0.05) in HH only. FRAP was decreased (-27%; P < 0.05) after the NH while was SOD and UA were only increased following the HH (SOD: +54%; P < 0.01 and UA: +15%; P < 0.01). Catalase activity was increased in the NH only (+20%; P < 0.05). These data suggest that 18-days of LHTL performed in either NH or HH differentially affect oxidative status of athletes. Higher oxidative stress levels following the HH LHTL might be explained by the higher overall hypoxic dose and different physiological responses between the NH and HH.	[Debevec, Tadej] Jozef Stefan Inst, Dept Automat Biocybernet & Robot, Ljubljana, Slovenia; [Pialoux, Vincent; Mury, Pauline; Ehrstroem, Sabine] Univ Lyon 1, Ctr Res & Innovat Sports, F-69622 Villeurbanne, France; [Pialoux, Vincent] Inst Univ France, Paris, France; [Saugy, Jonas; Schmitt, Laurent; Faiss, Raphael; Millet, Gregoire P.] Univ Lausanne, ISSUL, Inst Sport Sci, Fac Biol & Med, Lausanne, Switzerland; [Saugy, Jonas; Faiss, Raphael; Millet, Gregoire P.] Univ Lausanne, Dept Physiol, Fac Biol & Med, Lausanne, Switzerland; [Schmitt, Laurent] Natl Ski Nordic Ctr, Natl Sch Mt Sports, Premanon, France; [Cejuela, Roberto] Univ Alicante, Dept Sect Phys Educ & Sports, E-03080 Alicante, Spain	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut Universitaire de France; University of Lausanne; University of Lausanne; Universitat d'Alacant	Millet, GP (corresponding author), Univ Lausanne, ISSUL, Inst Sport Sci, Fac Biol & Med, Lausanne, Switzerland.	gregoire.millet@unil.ch	Millet, Gregoire P/F-4104-2012; Millet, Grégoire/M-3220-2019; Cejuela, Roberto/AAE-7727-2022; Debevec, Tadej/D-7917-2013; Faiss, Raphaël/AAX-3714-2021	Millet, Gregoire P/0000-0001-8081-4423; Millet, Grégoire/0000-0001-8081-4423; Cejuela, Roberto/0000-0003-4315-6307; Debevec, Tadej/0000-0001-7053-3978; Faiss, Raphaël/0000-0001-6029-9516	Ministere des Sports; Ministere des Sports, de la Jeunesse, de l'Education Populaire et de la Vie Associative (MSJEPVA; France); Institut National du Sport, de l'Expertise et de la Performance (INSEP; France); Institut Universitaire de France (IUF; France)	Ministere des Sports; Ministere des Sports, de la Jeunesse, de l'Education Populaire et de la Vie Associative (MSJEPVA; France); Institut National du Sport, de l'Expertise et de la Performance (INSEP; France); Institut Universitaire de France (IUF; France)	The study was funded by grants from the Ministere des Sports, de la Jeunesse, de l'Education Populaire et de la Vie Associative (MSJEPVA; France; to L.S. and G.P.M.), Institut National du Sport, de l'Expertise et de la Performance (INSEP; France; to L.S. and G.P.M.) and Institut Universitaire de France (IUF; France; to V.P.).	Bonetti DL, 2009, SPORTS MED, V39, P107, DOI 10.2165/00007256-200939020-00002; Anta RC, 2011, J HUM SPORT EXERC, V6, P218, DOI 10.4100/jhse.2011.62.03; Chapman RF, 2014, J APPL PHYSIOL, V116, P595, DOI 10.1152/japplphysiol.00634.2013; Debevec T, 2014, MED SCI SPORT EXER, V46, P33, DOI 10.1249/MSS.0b013e31829f87ef; Faiss R, 2013, MED SCI SPORT EXER, V45, P253, DOI 10.1249/MSS.0b013e31826d5aa2; Godycki-Cwirko M, 2010, J AM COLL NUTR, V29, P397, DOI 10.1080/07315724.2010.10719857; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Hassan W, 2009, DRUG CHEM TOXICOL, V32, P438, DOI 10.1080/01480540903127332; Hemmingsson T, 2009, RESP PHYSIOL NEUROBI, V169, P74, DOI 10.1016/j.resp.2009.08.006; Ji LL, 1996, AM J SPORT MED, V24, pS20, DOI 10.1177/036354659602406S05; KEHRER JP, 1994, FREE RADICAL BIO MED, V17, P65, DOI 10.1016/0891-5849(94)90008-6; Kellum JA, 2004, CRIT CARE, V8, P331, DOI 10.1186/cc2900; Levine BD, 1997, J APPL PHYSIOL, V83, P102, DOI 10.1152/jappl.1997.83.1.102; LEVINE BD, 1988, J APPL PHYSIOL, V64, P419, DOI 10.1152/jappl.1988.64.1.419; Loeppky JA, 1997, RESP PHYSIOL, V107, P231, DOI 10.1016/S0034-5687(97)02523-1; Magalhaes J, 2004, AVIAT SPACE ENVIR MD, V75, P16; Marzatico F, 1997, J SPORT MED PHYS FIT, V37, P235; Mazzeo RS, 1998, J APPL PHYSIOL, V84, P1151, DOI 10.1152/jappl.1998.84.4.1151; Millet GP, 2013, BRIT J SPORT MED, V47, P6; Millet GP, 2012, J APPL PHYSIOL, V112, P1783, DOI 10.1152/japplphysiol.00067.2012; Nikolaidis MG, 2012, J EXP BIOL, V215, P1615, DOI 10.1242/jeb.067470; Pialoux V, 2006, EUR J CLIN NUTR, V60, P1345, DOI 10.1038/sj.ejcn.1602462; Pialoux V, 2009, INT J SPORTS MED, V30, P87, DOI 10.1055/s-0028-1103284; Pialoux V, 2009, EUR J CLIN NUTR, V63, P756, DOI 10.1038/ejcn.2008.30; Pialoux V, 2010, EUR J NUTR, V49, P285, DOI 10.1007/s00394-009-0085-z; Pialoux V, 2009, RESP PHYSIOL NEUROBI, V167, P217, DOI 10.1016/j.resp.2009.04.012; Pialoux V, 2009, EUR J APPL PHYSIOL, V106, P517, DOI 10.1007/s00421-009-1046-1; Pialoux V, 2009, FREE RADICAL BIO MED, V46, P321, DOI 10.1016/j.freeradbiomed.2008.10.047; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Richalet JP, 2008, SCAND J MED SCI SPOR, V18, P29, DOI 10.1111/j.1600-0838.2008.00830.x; Saugy JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114418; Savourey G, 2003, EUR J APPL PHYSIOL, V89, P122, DOI 10.1007/s00421-002-0789-8; Schmitt L, 2012, J APPL PHYSIOL, V112, P527, DOI 10.1152/japplphysiol.01431.2011; SEN CK, 1995, J APPL PHYSIOL, V79, P675, DOI 10.1152/jappl.1995.79.3.675; Sohn HY, 2003, CARDIOVASC RES, V58, P638, DOI 10.1016/S0008-6363(03)00262-1; Subudhi AW, 2004, AVIAT SPACE ENVIR MD, V75, P881; Wang J, 1997, CLIN EXP PHARMACOL P, V24, P418, DOI 10.1111/j.1440-1681.1997.tb01212.x; Yuan GX, 2004, J PHYSIOL-LONDON, V557, P773, DOI 10.1113/jphysiol.2003.058503	38	29	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137957	10.1371/journal.pone.0137957	http://dx.doi.org/10.1371/journal.pone.0137957			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368280	gold, Green Submitted, Green Published			2022-12-27	WOS:000361601100183
J	Gregory, A; Mehrmohammadi, M; Denis, M; Bayat, M; Stan, DL; Fatemi, M; Alizad, A				Gregory, Adriana; Mehrmohammadi, Mohammad; Denis, Max; Bayat, Mahdi; Stan, Daniela L.; Fatemi, Mostafa; Alizad, Azra			Effect of Calcifications on Breast Ultrasound Shear Wave Elastography: An Investigational Study	PLOS ONE			English	Article							BI-RADS CLASSIFICATION; VIBRO-ACOUSTOGRAPHY; DIFFERENTIAL-DIAGNOSIS; KIDNEY-STONES; MICROCALCIFICATIONS; MASSES; LESIONS; BENIGN; TISSUE; CANCER	Purpose To investigate the effects of macrocalcifications and clustered microcalcifications associated with benign breast masses on shear wave elastography (SWE). Methods SuperSonic Imagine (SSI) and comb-push ultrasound shear elastography (CUSE) were performed on three sets of phantoms to investigate how calcifications of different sizes and distributions influence measured elasticity. To demonstrate the effect in vivo, three female patients with benign breast masses associated with mammographically-identified calcifications were evaluated by CUSE. Results Apparent maximum elasticity (E-max) estimates resulting from individual macrocalcifications (with diameters of 2mm, 3mm, 5mm, 6mm, 9mm, 11mm, and 15mm) showed values over 50 kPa for all cases, which represents more than 100% increase over background (similar to 21kPa). We considered a 2cm-diameter circular region of interest for all phantom experiments. Mean elasticity (E-mean) values varied from 26 kPa to 73 kPa, depending on the macrocalcification size. Highly dense clusters of microcalcifications showed higher E-max values than clusters of microcalcification with low concentrations, but the difference in E-mean values was not significant. Conclusions Our results demonstrate that the presence of large isolated macrocalcifications and highly concentrated clusters of microcalcifications can introduce areas with apparent high elasticity in SWE. Considering that benign breast masses normally have significantly lower elasticity values than malignant tumors, such areas with high elasticity appearing due to presence of calcification in benign breast masses may lead to misdiagnosis.	[Gregory, Adriana; Mehrmohammadi, Mohammad; Denis, Max; Bayat, Mahdi; Fatemi, Mostafa; Alizad, Azra] Mayo Clin, Dept Physiol & Biomed Engn, Coll Med, Rochester, MN USA; [Stan, Daniela L.; Alizad, Azra] Mayo Clin, Dept Internal Med, Coll Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Alizad, A (corresponding author), Mayo Clin, Dept Physiol & Biomed Engn, Coll Med, Rochester, MN USA.	Alizad.Azra@mayo.edu		Fatemi, Mostafa/0000-0002-6603-9077; Mehrmohammadi, Mohammad/0000-0002-9264-9354	Mayo Clinic; NATIONAL CANCER INSTITUTE [R01CA168575] Funding Source: NIH RePORTER	Mayo Clinic; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Mayo Clinic has financial interest in the technology described here.	Alizad A, 2005, TECHNOL CANCER RES T, V4, P151, DOI 10.1177/153303460500400204; Alizad A, 2004, IEEE T MED IMAGING, V23, P307, DOI 10.1109/TMI.2004.824241; Alizad A, 2004, J ULTRAS MED, V23, P267, DOI 10.7863/jum.2004.23.2.267; Alizad A, 2006, ULTRASONICS, V44, pE217, DOI 10.1016/j.ultras.2006.06.021; Alizad A, 2014, BMC MED IMAGING, V14, DOI 10.1186/s12880-014-0040-1; Alizad A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3323; Anwar, 2011, INT J PATHOL, V9, P63, DOI DOI 10.4103/IJU.IJU_363_16; Athanasiou A, 2010, RADIOLOGY, V256, P297, DOI 10.1148/radiol.10090385; Bai M, 2012, J ULTRAS MED, V31, P289, DOI 10.7863/jum.2012.31.2.289; Baker R, 2010, BRIT J CANCER, V103, P1034, DOI 10.1038/sj.bjc.6605873; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Bercoff J, 2003, ULTRASOUND MED BIOL, V29, P1387, DOI 10.1016/S0301-5629(03)00978-5; Berg W. A., 2012, RADIOLOGY, P1; Berg WA, 2012, RADIOLOGY, V262, P435, DOI 10.1148/radiol.11110640; Chang JM, 2013, AM J ROENTGENOL, V201, pW347, DOI 10.2214/AJR.12.10416; Chang JM, 2011, BREAST CANCER RES TR, V129, P89, DOI 10.1007/s10549-011-1627-7; Chang JM, 2011, RADIOLOGY, V259, P59, DOI 10.1148/radiol.10101414; Cosgrove DO, 2012, EUR RADIOL, V22, P1023, DOI 10.1007/s00330-011-2340-y; Cox RF, 2012, BRIT J CANCER, V106, P525, DOI 10.1038/bjc.2011.583; Craciun II, 2002, BREAST CALCIFICATI 1; Demetri-Lewis A, 2012, AM J ROENTGENOL, V198, pW325, DOI 10.2214/AJR.10.5732; Denis M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119398; Ellis I., 2002, BREAST CALCIFICATION, P1; Evans A, 2012, BRIT J CANCER, V107, P224, DOI 10.1038/bjc.2012.253; Evans A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2787; FANDOSMORERA A, 1988, RADIOLOGY, V169, P325, DOI 10.1148/radiology.169.2.2845471; Farshid G, 2011, BRIT J CANCER, V105, P1669, DOI 10.1038/bjc.2011.466; Fatemi M, 1998, SCIENCE, V280, P82, DOI 10.1126/science.280.5360.82; Fatemi M, 2002, IEEE T MED IMAGING, V21, P1, DOI 10.1109/42.981229; Fink M, 2010, PHYS TODAY, V63, P28, DOI 10.1063/1.3326986; Harris JE, 2014, MEDSCAPE; Heimbach D, 2000, J UROLOGY, V164, P537, DOI 10.1016/S0022-5347(05)67419-8; Ianculescu V, 2014, EUR J RADIOL, V83, P773, DOI 10.1016/j.ejrad.2014.01.021; Joon Park RSL, 2007, BIOMATERIALS INTRO; Ko KH, 2014, EUR RADIOL, V24, P305, DOI 10.1007/s00330-013-3034-4; Krouskop TA, 1998, ULTRASONIC IMAGING, V20, P260, DOI 10.1177/016173469802000403; Lee EJ, 2013, EUR RADIOL, V23, P1803, DOI 10.1007/s00330-013-2782-5; Lee SH, 2013, EUR RADIOL, V23, P1015, DOI 10.1007/s00330-012-2686-9; Li GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076322; Manglaviti G, 2011, AM J ROENTGENOL, V197, pW76, DOI 10.2214/AJR.10.5217; Mehrmohammadi M., 2014, IEEE T MED IMAGING, P1; Mehrmohammadi M, 2014, ULTRASOUND MED BIOL, V40, P2819, DOI 10.1016/j.ultrasmedbio.2014.07.005; Morgan MP, 2005, J MAMMARY GLAND BIOL, V10, P181, DOI 10.1007/s10911-005-5400-6; Mosli HA, 2013, RES REP UROL, V5, P11, DOI 10.2147/RRU.S39581; Olgun DC, 2014, DIAGN INTERV RADIOL, V20, P239, DOI 10.5152/dir.2014.13306; Orlando MTD, 2008, POWDER DIFFR, V23, pS59, DOI 10.1154/1.2903738; da Silva SFR, 2010, ACTA CIR BRAS, V25, P444, DOI 10.1590/S0102-86502010000500011; Sarvazyan AP, 1998, ULTRASOUND MED BIOL, V24, P1419, DOI 10.1016/S0301-5629(98)00110-0; Schaefer FKW, 2011, EUR J RADIOL, V77, P450, DOI 10.1016/j.ejrad.2009.08.026; Scimeca M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-286; SEWELL CW, 1995, RADIOL CLIN N AM, V33, P1067; SICKLES EA, 1986, RADIOLOGY, V160, P289, DOI 10.1148/radiology.160.2.3726103; Song PF, 2013, IEEE T MED IMAGING, V32, P1435, DOI 10.1109/TMI.2013.2257831; Song PF, 2012, IEEE T MED IMAGING, V31, P1821, DOI 10.1109/TMI.2012.2205586; Tanter M, 2008, ULTRASOUND MED BIOL, V34, P1373, DOI 10.1016/j.ultrasmedbio.2008.02.002; Xiao Y, 2013, ENG MED BIOL SOC EMB; Yao M, 2014, BIOMED RES INT, V2014, P7; Youk JH, 2013, EUR RADIOL, V23, P2695, DOI 10.1007/s00330-013-2873-3	58	27	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137898	10.1371/journal.pone.0137898	http://dx.doi.org/10.1371/journal.pone.0137898			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368939	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100173
J	Moodie, Z; Metch, B; Bekker, LG; Churchyard, G; Nchabeleng, M; Mlisana, K; Laher, F; Roux, S; Mngadi, K; Innes, C; Mathebula, M; Allen, M; Bentley, C; Gilbert, PB; Robertson, M; Kublin, J; Corey, L; Gray, GE				Moodie, Zoe; Metch, Barbara; Bekker, Linda-Gail; Churchyard, Gavin; Nchabeleng, Maphoshane; Mlisana, Koleka; Laher, Fatima; Roux, Surita; Mngadi, Kathryn; Innes, Craig; Mathebula, Matsontso; Allen, Mary; Bentley, Carter; Gilbert, Peter B.; Robertson, Michael; Kublin, James; Corey, Lawrence; Gray, Glenda E.			Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men	PLOS ONE			English	Article							DOUBLE-BLIND; T-CELLS; HVTN 503/PHAMBILI; IMMUNE ACTIVATION; HEALTHY-ADULTS; EFFICACY TRIAL; SOUTH-AFRICA; ADENOVIRUS; SAFETY; IMMUNOGENICITY	Background The Phase 2b double-blinded, randomized Phambili/HVTN 503 trial evaluated safety and efficacy of the MRK Ad5 gag/pol/nef subtype B HIV-1 preventive vaccine vs placebo in sexually active HIV-1 seronegative participants in South Africa. Enrollment and vaccinations stopped and participants were unblinded but continued follow-up when the Step study evaluating the same vaccine in the Americas, Caribbean, and Australia was unblinded for non-efficacy. Final Phambili analyses found more HIV-1 infections amongst vaccine than placebo recipients, impelling the HVTN 503-S recall study. Methods HVTN 503-S sought to enroll all 695 HIV-1 uninfected Phambili participants, provide HIV testing, risk reduction counseling, physical examination, risk behavior assessment and treatment assignment recall. After adding HVTN 503-S data, HIV-1 infection hazard ratios (HR vaccine vs. placebo) were estimated by Cox models. Results Of the 695 eligible, 465 (67%) enrolled with 230 from the vaccine group and 235 from the placebo group. 38% of the 184 Phambili dropouts were enrolled. Enrollment did not differ by treatment group, gender, or baseline HSV-2. With the additional 1286 person years of 503-S follow-up, the estimated HR over Phambili and HVTN 503-S follow-up was 1.52 (95% CI 1.08-2.15, p = 0.02, 82 vaccine/54 placebo infections). The HR was significant for men (HR = 2.75, 95% CI 1.49, 5.06, p = 0.001) but not for women (HR = 1.12, 95% CI 0.73, 1.72, p = 0.62). Conclusion The additional follow-up from HVTN 503-S supported the Phambili finding of increased HIV-1 acquisition among vaccinated men and strengthened the evidence of lack of vaccine effect among women.	[Moodie, Zoe; Metch, Barbara; Bentley, Carter; Gilbert, Peter B.; Kublin, James; Corey, Lawrence] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Bekker, Linda-Gail; Roux, Surita] Univ Cape Town, Desmond Tutu HIV Fdn, ZA-7925 Cape Town, South Africa; [Churchyard, Gavin] Aurum Inst Hlth Res, Johannesburg, South Africa; [Churchyard, Gavin] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Churchyard, Gavin] London Sch Hyg & Trop Med, London WC1, England; [Nchabeleng, Maphoshane; Mathebula, Matsontso] Sefako Makgatho Hlth Sci Univ, Mecru Clin Res Unit, Pretoria, South Africa; [Mngadi, Kathryn] CAPRISA, Durban, South Africa; [Mlisana, Koleka; Mngadi, Kathryn] Univ KwaZulu Natal, Sch Lab Med & Med Sci, Durban, South Africa; [Mlisana, Koleka; Mngadi, Kathryn] Natl Hlth Lab Serv, Durban, South Africa; [Laher, Fatima; Gray, Glenda E.] Univ Witwatersrand, Fac Hlth Sci, Perinatal HIV Res Unit, Johannesburg, South Africa; [Innes, Craig] Aurum Inst Clin Res Site, Klerksdorp, South Africa; [Allen, Mary] NIAID, Vaccine Res Program, Div Aids, NIH, Rockville, MD USA; [Robertson, Michael] Merck Res Labs, West Point, PA USA; [Gray, Glenda E.] South African Med Res Council, Cape Town, South Africa	Fred Hutchinson Cancer Center; University of Cape Town; University of Witwatersrand; University of London; London School of Hygiene & Tropical Medicine; Sefako Makgatho Health Sciences University; University of Kwazulu Natal; University of Witwatersrand; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Merck & Company; South African Medical Research Council	Moodie, Z (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.	zoe@fredhutch.org	Corey, Lawrence/AAE-1796-2020; Bekker, Linda-Gail/AAZ-8929-2020; Mlisana, Koleka/N-6204-2013	Corey, Lawrence/0000-0002-2179-2436; BEKKER, LINDA-GAIL/0000-0002-0755-4386; Mlisana, Koleka/0000-0002-8436-3268; Churchyard, Gavin/0000-0002-4269-3699	National Institute of Allergy and Infectious Diseases [UM1 AI068614, UM1 AI068618, UM1 AI068635, UM1 AI069453, UM1 AI069519, UM1 AI069469]; Merck and Co Inc.; Division of Acquired Immunodeficiency Syndrome of the US National Institute of Allergy and Infectious Diseases (NIAID); Merck Research Laboratories; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069469, UM1AI068618, UM1AI068614, UM1AI069519, UM1AI068635, UM1AI069453] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Merck and Co Inc.(Merck & Company); Division of Acquired Immunodeficiency Syndrome of the US National Institute of Allergy and Infectious Diseases (NIAID); Merck Research Laboratories(Merck & Company); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institute of Allergy and Infectious Diseases to the HIV Vaccine Trials Network (UM1 AI068614, UM1 AI068618, UM1 AI068635, UM1 AI069453, UM1 AI069519, UM1 AI069469) as well as Merck and Co Inc. Role of the funding source: The study and report were reviewed by the Division of Acquired Immunodeficiency Syndrome of the US National Institute of Allergy and Infectious Diseases (NIAID) and Merck Research Laboratories. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication. Merck Research Laboratories provided support in the form of salary for author Robertson [MR] and provision of study products. NIAID and MR contributed to the study design, review of data analysis, the decision to publish, and review of the manuscript. The specific roles of the NIAID and MR authors are articulated in the 'author contributions' section.	Benlahrech A, 2009, P NATL ACAD SCI USA, V106, P19940, DOI 10.1073/pnas.0907898106; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Calcedo R, 2009, J VIROL, V83, P2623, DOI 10.1128/JVI.02160-08; Churchyard GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021225; Cohen CR, 2010, AIDS, V24, P2069, DOI 10.1097/QAD.0b013e32833c323b; Duerr A, 2012, J INFECT DIS, V206, P258, DOI 10.1093/infdis/jis342; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Ganguly S, 2011, MUCOSAL IMMUNOL, V4, P528, DOI 10.1038/mi.2011.1; Gray GE, 2014, LANCET INFECT DIS, V14, P388, DOI 10.1016/S1473-3099(14)70020-9; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Harro C, 2009, CLIN VACCINE IMMUNOL, V16, P1285, DOI 10.1128/CVI.00144-09; Harro CD, 2009, AIDS RES HUM RETROV, V25, P103, DOI 10.1089/aid.2008.0212; Jaoko W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012873; Kibuuka H, 2010, J INFECT DIS, V201, P600, DOI 10.1086/650299; Koup RA, 2009, J VIROL, V83, P6318, DOI 10.1128/JVI.00384-09; Lemos MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108954; Lewis GK, 2014, P NATL ACAD SCI USA, V111, P15614, DOI 10.1073/pnas.1413550111; Nicholson O, 2011, AIDS RES HUM RETROV, V27, P557, DOI [10.1089/aid.2010.0151, 10.1089/AID.2010.0151]; Peiperl L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013579; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Zak DE, 2012, P NATL ACAD SCI USA, V109, pE3503, DOI 10.1073/pnas.1208972109	23	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137666	10.1371/journal.pone.0137666	http://dx.doi.org/10.1371/journal.pone.0137666			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368824	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000361601100102
J	Munroe, SH; Morales, CH; Duyck, TH; Waters, PD				Munroe, Stephen H.; Morales, Christopher H.; Duyck, Tessa H.; Waters, Paul D.			Evolution of the Antisense Overlap between Genes for Thyroid Hormone Receptor and Rev-erb alpha and Characterization of an Exonic G-Rich Element That Regulates Splicing of TR alpha 2 mRNA	PLOS ONE			English	Article							G-QUADRUPLEX STRUCTURES; R-LOOPS; STRUCTURAL BASIS; OPPOSITE STRAND; EXPRESSION; BINDING; TRANSCRIPTION; GENOME; MECHANISMS; STABILITY	The alpha-thyroid hormone receptor gene (TR alpha) codes for two functionally distinct proteins: TR alpha 1, the alpha-thyroid hormone receptor; and TR alpha 2, a non-hormone-binding variant. The final exon of TR alpha 2 mRNA overlaps the 3' end of Rev-erb alpha mRNA, which encodes another nuclear receptor on the opposite strand of DNA. To understand the evolution of this antisense overlap, we sequenced these genes and mRNAs in the platypus Orthorhynchus anatinus. Despite its strong homology with other mammals, the platypus TR alpha/Rev-erb alpha locus lacks elements essential for expression of TR alpha 2. Comparative analysis suggests that alternative splicing of TR alpha 2 mRNA expression evolved in a stepwise fashion before the divergence of eutherian and marsupial mammals. A short G-rich element (G30) located downstream of the alternative 3' splice site of TR alpha 2 mRNA and antisense to the 3' UTR of Rev-erb alpha plays an important role in regulating TR alpha 2 splicing. G30 is tightly conserved in eutherian mammals, but is absent in marsupials and monotremes. Systematic deletions and substitutions within G30 have dramatically different effects on TR alpha 2 splicing, leading to either its inhibition or its enhancement. Mutations that disrupt one or more clusters of G residues enhance splicing two- to three-fold. These results suggest the G30 sequence can adopt a highly structured conformation, possibly a G-quadruplex, and that it is part of a complex splicing regulatory element which exerts both positive and negative effects on TR alpha 2 expression. Since mutations that strongly enhance splicing in vivo have no effect on splicing in vitro, it is likely that the regulatory role of G30 is mediated through linkage of transcription and splicing.	[Munroe, Stephen H.; Morales, Christopher H.; Duyck, Tessa H.] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA; [Waters, Paul D.] UNSW Australia, Sch Biotechnol & Biomol Sci, Fac Sci, Sydney, NSW, Australia	Marquette University; University of New South Wales Sydney	Munroe, SH (corresponding author), Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA.	stephen.munroe@marquette.edu	Waters, Paul D/B-7871-2015	Waters, Paul D/0000-0002-4689-8747	National Institutes of Health [1R15 DK075418]; Marquette University Klingler College of Arts and Sciences; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK075418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marquette University Klingler College of Arts and Sciences; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by the National Institutes of Health (1R15 DK075418; http://grants.nih.gov/grants/oer.htm) and the Marquette University Klingler College of Arts and Sciences (http://www.marquette.edu/arts-sciences).	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Alekseyenko AV, 2007, RNA, V13, P661, DOI 10.1261/rna.325107; Phan AT, 2011, NAT STRUCT MOL BIOL, V18, P796, DOI 10.1038/nsmb.2064; Bi SD, 2014, NATURE, V514, P579, DOI 10.1038/nature13718; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Chan YA, 2014, TRENDS GENET, V30, P245, DOI 10.1016/j.tig.2014.03.005; Cifelli RL, 2013, NATURE, V500, P160, DOI 10.1038/500160a; Decorsiere A, 2011, GENE DEV, V25, P220, DOI 10.1101/gad.607011; Dominguez C, 2010, NAT STRUCT MOL BIOL, V17, P853, DOI 10.1038/nsmb.1814; Everett LJ, 2014, TRENDS ENDOCRIN MET, V25, P586, DOI 10.1016/j.tem.2014.06.011; Expert-Bezancon A, 2004, J BIOL CHEM, V279, P38249, DOI 10.1074/jbc.M405377200; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Fairbrother WG, 2004, NUCLEIC ACIDS RES, V32, pW187, DOI 10.1093/nar/gkh393; Fisette JF, 2012, J NEUROCHEM, V121, P763, DOI 10.1111/j.1471-4159.2012.07680.x; Flamant F, 2003, TRENDS ENDOCRIN MET, V14, P85, DOI 10.1016/S1043-2760(02)00043-7; Galgano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003164; Ginno PA, 2013, GENOME RES, V23, P1590, DOI 10.1101/gr.158436.113; Gray L.T., 2013, PLOS GENET, V9, DOI DOI 10.1371/J0URNAL.PGEN.1003468; Han K, 2005, PLOS BIOL, V3, P843, DOI 10.1371/journal.pbio.0030158; Hastings ML, 1997, NUCLEIC ACIDS RES, V25, P4296, DOI 10.1093/nar/25.21.4296; Hastings ML, 2001, RNA, V7, P859, DOI 10.1017/S1355838201002084; Hastings ML, 2000, J BIOL CHEM, V275, P11507, DOI 10.1074/jbc.275.15.11507; Hobson DJ, 2012, MOL CELL, V48, P365, DOI 10.1016/j.molcel.2012.08.027; Huttenhofer A, 2006, NAT REV GENET, V7, P475, DOI 10.1038/nrg1855; IZUMO S, 1988, NATURE, V334, P539, DOI 10.1038/334539a0; KATZ D, 1993, J BIOL CHEM, V268, P20904; Keijzer R, 2007, J MOL ENDOCRINOL, V38, P523, DOI 10.1677/jme.1.02125; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Khorkova O, 2014, HUM MOL GENET, V23, pR54, DOI 10.1093/hmg/ddu207; Lavorgna G, 2004, TRENDS BIOCHEM SCI, V29, P88, DOI 10.1016/j.tibs.2003.12.002; LAZAR MA, 1990, J BIOL CHEM, V265, P12859; LAZAR MA, 1989, MOL CELL BIOL, V9, P1128, DOI 10.1128/MCB.9.3.1128; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; Livernois AM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003635; Marcel V, 2011, CARCINOGENESIS, V32, P271, DOI 10.1093/carcin/bgq253; Mauger DM, 2008, MOL CELL BIOL, V28, P5403, DOI 10.1128/MCB.00739-08; McCullough AJ, 1997, MOL CELL BIOL, V17, P4562, DOI 10.1128/MCB.17.8.4562; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Millevoi S, 2012, WIRES RNA, V3, P495, DOI 10.1002/wrna.1113; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Munroe SH, 2006, CELL MOL LIFE SCI, V63, P2102, DOI 10.1007/s00018-006-6070-2; MUNROE SH, 1991, J BIOL CHEM, V266, P22083; Munroe SH, 2004, J CELL BIOCHEM, V93, P664, DOI 10.1002/jcb.20252; Murat P, 2014, CURR OPIN GENET DEV, V25, P22, DOI 10.1016/j.gde.2013.10.012; Nurtdinov RN, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-142; Osato N, 2007, GENETICS, V176, P1299, DOI 10.1534/genetics.106.069484; Pelechano V, 2013, NAT REV GENET, V14, P880, DOI 10.1038/nrg3594; Portal MM, 2015, NAT STRUCT MOL BIOL, V22, P89, DOI 10.1038/nsmb.2934; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Rindfleisch BC, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-97; Salato VK, 2010, RNA BIOL, V7, P179, DOI 10.4161/rna.7.2.11182; Samatanga B, 2013, NUCLEIC ACIDS RES, V41, P2505, DOI 10.1093/nar/gks1289; Samollow PB, 2008, GENOME RES, V18, P1199, DOI 10.1101/gr.065326.107; Sasaki-Haraguchi N, 2012, BIOCHEM BIOPH RES CO, V423, P289, DOI 10.1016/j.bbrc.2012.05.112; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Skourti-Stathaki K, 2014, NATURE, V516, P436, DOI 10.1038/nature13787; Skourti-Stathaki K, 2014, GENE DEV, V28, P1384, DOI 10.1101/gad.242990.114; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Sorek R, 2007, RNA, V13, P1603, DOI 10.1261/rna.682507; STRAIT KA, 1990, J BIOL CHEM, V265, P10514; Warner KD, 2014, NAT STRUCT MOL BIOL, V21, P658, DOI 10.1038/nsmb.2865; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Weidmann CA, 2014, RNA, V20, P1298, DOI 10.1261/rna.046029.114; Xiao XS, 2009, NAT STRUCT MOL BIOL, V16, P1094, DOI 10.1038/nsmb.1661; Xing Y, 2006, NAT REV GENET, V7, P499, DOI 10.1038/nrg1896; Xu B, 2005, MOL CELL ENDOCRINOL, V245, P147, DOI 10.1016/j.mce.2005.11.010; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Zamore PD, 1997, RNA, V3, P1421; Zhang AYQ, 2011, BIOCHEMISTRY-US, V50, P7251, DOI 10.1021/bi200805j; Zhang JS, 2000, ANNU REV PHYSIOL, V62, P439, DOI 10.1146/annurev.physiol.62.1.439; Zheng KW, 2013, NUCLEIC ACIDS RES, V41, P5533, DOI 10.1093/nar/gkt264; Zheng XT, 2013, NATURE, V500, P199, DOI 10.1038/nature12353; Zhou CF, 2013, NATURE, V500, P163, DOI 10.1038/nature12429	78	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137893	10.1371/journal.pone.0137893	http://dx.doi.org/10.1371/journal.pone.0137893			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368571	gold, Green Published, Green Submitted			2022-12-27	WOS:000361601100171
J	O'Donnell, LE; Robertson, D; Nile, CJ; Cross, LJ; Riggio, M; Sherriff, A; Bradshaw, D; Lambert, M; Malcolm, J; Buijs, MJ; Zaura, E; Crielaard, W; Brandt, BW; Ramage, G				O'Donnell, Lindsay E.; Robertson, Douglas; Nile, Christopher J.; Cross, Laura J.; Riggio, Marcello; Sherriff, Andrea; Bradshaw, David; Lambert, Margaret; Malcolm, Jennifer; Buijs, Mark J.; Zaura, Egija; Crielaard, Wim; Brandt, Bernd W.; Ramage, Gordon			The Oral Microbiome of Denture Wearers Is Influenced by Levels of Natural Dentition	PLOS ONE			English	Article							CANDIDA-ALBICANS; ANTIMICROBIAL PEPTIDES; HOST-DEFENSE; HEALTH; SUSCEPTIBILITY; COLONIZATION; STOMATITIS; SEQUENCES; BIOFILMS; ETIOLOGY	Objectives The composition of dental plaque has been well defined, whereas currently there is limited understanding of the composition of denture plaque and how it directly influences denture related stomatitis (DS). The aims of this study were to compare the microbiomes of denture wearers, and to understand the implications of these towards inter-kingdom and host-pathogen interactions within the oral cavity. Methods Swab samples were obtained from 123 participants wearing either a complete or partial denture; the bacterial composition of each sample was determined using bar-coded illumina MiSeq sequencing of the bacterial hypervariable V4 region of 16S rDNA. Sequencing data processing was undertaken using QIIME, clustered in Operational Taxonomic Units (OTUs) and assigned to taxonomy. The dentures were sonicated to remove the microbial flora residing on the prosthesis, sonicate was then cultured using diagnostic colorex Candida media. Samples of unstimulated saliva were obtained and antimicrobial peptides (AMP) levels were measured by ELISA. Results We have shown that dental and denture plaques are significantly distinct both in composition and diversity and that the oral microbiome composition of a denture wearer is variable and is influenced by the location within the mouth. Dentures and mucosa were predominantly made up of Bacilli and Actinobacteria. Moreover, the presence of natural teeth has a significant impact on the overall microbial composition, when compared to the fully edentulous. Furthermore, increasing levels of Candida spp. positively correlate with Lactobacillus spp. AMPs were quantified, though showed no specific correlations. Conclusions This is the first study to provide a detailed understanding of the oral microbiome of denture wearers and has provided evidence that DS development is more complex than simply a candidal infection. Both fungal and bacterial kingdoms clearly play a role in defining the progression of DS, though we were unable to show a defined role for AMPs.	[O'Donnell, Lindsay E.; Robertson, Douglas; Nile, Christopher J.; Cross, Laura J.; Riggio, Marcello; Sherriff, Andrea; Malcolm, Jennifer; Ramage, Gordon] Univ Glasgow, Glasgow Dent Sch, Sch Med, Coll Med Vet & Life Sci, Glasgow G2 3JZ, Lanark, Scotland; [Bradshaw, David; Lambert, Margaret] GlaxoSmithKline, Weybridge, Surrey, England; [Buijs, Mark J.; Zaura, Egija; Crielaard, Wim; Brandt, Bernd W.] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Prevent Dent, Amsterdam, Netherlands; [Buijs, Mark J.; Zaura, Egija; Crielaard, Wim; Brandt, Bernd W.] Vrije Univ Amsterdam, Amsterdam, Netherlands	University of Glasgow; GlaxoSmithKline; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Ramage, G (corresponding author), Univ Glasgow, Glasgow Dent Sch, Sch Med, Coll Med Vet & Life Sci, 378 Sauchiehall St, Glasgow G2 3JZ, Lanark, Scotland.	gordon.ramage@glasgow.ac.uk	Ramage, Gordon/AAX-1315-2020; Nile, Christopher John/AAJ-5982-2020; Malcolm, Jennifer/AAD-1435-2021	Nile, Christopher John/0000-0001-8218-2167; Malcolm, Jennifer/0000-0003-0020-0283; Robertson, Douglas/0000-0002-7121-7413; Brandt, Bernd/0000-0002-1155-1989; Zaura, Egija/0000-0003-1432-6194	BBSRC CASE studentship [BB/K501013/1]; GlaxoSmithKline (GSK)	BBSRC CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GlaxoSmithKline (GSK)(GlaxoSmithKline)	This study was funded by the BBSRC CASE studentship (BB/K501013/1) awarded to Prof Gordon Ramage and Dr Douglas Robertson. GlaxoSmithKline (GSK) also supported this project. GSK were involved in the initial discussions at the conception of the study. GlaxoSmithKline provided support in the form of salaries for authors DB and ML, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Alves CT, 2014, J INFECTION, V69, P396, DOI 10.1016/j.jinf.2014.06.002; Bals R, 2000, Respir Res, V1, P141, DOI 10.1186/rr25; Bilhan H, 2009, CLIN ORAL INVEST, V13, P363, DOI 10.1007/s00784-008-0240-6; Bingle CD, 2004, INT J BIOCHEM CELL B, V36, P2144, DOI 10.1016/j.biocel.2004.05.002; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Campos MS, 2008, ORAL MICROBIOL IMMUN, V23, P419, DOI 10.1111/j.1399-302X.2008.00445.x; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castelo-Branco C, 2014, GYNECOL ENDOCRINOL, V30, P16, DOI 10.3109/09513590.2013.852531; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P101; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Coulthwaite L, 2007, BRIT J BIOMED SCI, V64, P180, DOI 10.1080/09674845.2007.11732784; Dale BA, 2005, CURR ISSUES MOL BIOL, V7, P119; Daniluk T, 2006, Adv Med Sci, V51 Suppl 1, P86; Davidopoulou S, 2013, ARCH ORAL BIOL, V58, P930, DOI 10.1016/j.archoralbio.2013.01.003; Diamond G, 2008, J DENT RES, V87, P915, DOI 10.1177/154405910808701011; Diaz PI, 2006, APPL ENVIRON MICROB, V72, P2837, DOI 10.1128/AEM.72.4.2837-2848.2006; Dickinson BC, 2011, MOL ORAL MICROBIOL, V26, P210, DOI 10.1111/j.2041-1014.2011.00609.x; Divaris K, 2012, GERODONTOLOGY, V29, pE192, DOI 10.1111/j.1741-2358.2010.00440.x; Ealla Kranti Kiran Reddy, 2013, J Contemp Dent Pract, V14, P601; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Felton D, 2011, J PROSTHODONT, V20, pS1, DOI 10.1111/j.1532-849X.2010.00683.x; Gendreau L, 2011, J PROSTHODONT, V20, P251, DOI 10.1111/j.1532-849X.2011.00698.x; Griffin SO, 2012, AM J PUBLIC HEALTH, V102, P411, DOI 10.2105/AJPH.2011.300362; Guzman J.M., 2012, AGEING 21 CENTURY CE; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hans Mayank, 2014, Int J Pept, V2014, P370297, DOI 10.1155/2014/370297; Humphrey SP, 2001, J PROSTHET DENT, V85, P162, DOI 10.1067/mpr.2001.113778; JEGANATHAN S, 1992, AUST DENT J, V37, P107, DOI 10.1111/j.1834-7819.1992.tb03046.x; Jiang Q, 2015, BENEF MICROBES, V6, P361, DOI 10.3920/BM2014.0054; Kinane DF, 2008, FRONT BIOSCI-LANDMRK, V13, P966, DOI 10.2741/2736; Klingspor L, 2015, Clin Microbiol Infect, V21, DOI 10.1016/j.cmi.2014.08.011; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kraneveld EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042770; Lamfon H, 2005, FEMS MICROBIOL LETT, V242, P345, DOI 10.1016/j.femsle.2004.11.032; Lewis James S 2nd, 2013, Antimicrob Agents Chemother, V57, P4559, DOI 10.1128/AAC.01144-13; Malcolm J, 2014, MOL ORAL MICROBIOL, V29, P284, DOI 10.1111/omi.12058; Meurman Jukka H, 2006, Gerodontology, V23, P3, DOI 10.1111/j.1741-2358.2006.00102.x; Morales DK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000886; Muller L, 2014, BRAIN BEHAV IMMUN, V39, P8, DOI 10.1016/j.bbi.2013.11.015; Muenz R., 2007, AGING DEMOGRAPHIC CH; Newton A.V, 1962, BRIT DENT J, V112, P357; Nikawa H, 1998, J DENT, V26, P299, DOI 10.1016/S0300-5712(97)00026-2; Orsi CF, 2014, J BIOL REG HOMEOS AG, V28, P743; Pereira-Cenci T, 2008, J APPL ORAL SCI, V16, P86, DOI 10.1590/S1678-77572008000200002; Peters BM, 2010, FEMS YEAST RES, V10, P597, DOI 10.1111/j.1567-1364.2010.00632.x; Petersen PE, 2005, B WORLD HEALTH ORGAN, V83, P661; Petersen PE, 2003, COMMUNITY DENT ORAL, V31, P3, DOI 10.1046/j..2003.com122.x; Pfaller MA, 2012, J CLIN MICROBIOL, V50, P1199, DOI 10.1128/JCM.06112-11; Radek K, 2007, SEMIN IMMUNOPATHOL, V29, P27, DOI 10.1007/s00281-007-0064-5; Sachdeo Amit, 2008, J Prosthodont, V17, P348, DOI 10.1111/j.1532-849X.2008.00301.x; Salerno C, 2011, MED ORAL PATOL ORAL, V16, pE139, DOI 10.4317/medoral.16.e139; Shirtliff ME, 2009, FEMS MICROBIOL LETT, V299, P1, DOI 10.1111/j.1574-6968.2009.01668.x; Shulman JD, 2004, J AM DENT ASSOC, V135, P1279, DOI 10.14219/jada.archive.2004.0403; Signat B, 2011, CURR ISSUES MOL BIOL, V13, P25; Sumi Y, 2002, Gerodontology, V19, P25, DOI 10.1111/j.1741-2358.2002.00025.x; Sumi Yasunori, 2003, Gerodontology, V20, P84, DOI 10.1111/j.1741-2358.2003.00084.x; Teles FR, 2012, J PERIODONTOL, V83, P1139, DOI 10.1902/jop.2012.110506; Visvanathan V, 2010, INT J CLIN PRACT, V64, P404, DOI 10.1111/j.1742-1241.2009.02132.x; Wade WG, 2013, PHARMACOL RES, V69, P137, DOI 10.1016/j.phrs.2012.11.006; Watzinger F, 2004, J CLIN MICROBIOL, V42, P5189, DOI 10.1128/JCM.42.11.5189-5198.2004; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	64	63	63	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137717	10.1371/journal.pone.0137717	http://dx.doi.org/10.1371/journal.pone.0137717			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368937	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000361601100117
J	Tahita, MC; Tinto, H; Erhart, A; Kazienga, A; Fitzhenry, R; VanOvermeir, C; Rosanas-Urgell, A; Ouedraogo, JB; Guiguemde, RT; Van Geertruyden, JP; D'Alessandro, U				Tahita, Marc C.; Tinto, Halidou; Erhart, Annette; Kazienga, Adama; Fitzhenry, Robert; VanOvermeir, Chantal; Rosanas-Urgell, Anna; Ouedraogo, Jean-Bosco; Guiguemde, Robert T.; Van Geertruyden, Jean-Pierre; D'Alessandro, Umberto			Prevalence of the dhfr and dhps Mutations among Pregnant Women in Rural Burkina Faso Five Years after the Introduction of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine	PLOS ONE			English	Article							FALCIPARUM DIHYDROFOLATE-REDUCTASE; DIHYDROPTEROATE SYNTHASE GENE; PLASMODIUM-FALCIPARUM; POINT MUTATIONS; MALARIA; RESISTANCE; SYNTHETASE; EFFICACY; POLICY; LINE	Background The emergence and spread of drug resistance represents one of the biggest challenges for malaria control in endemic regions. Sulfadoxine-pyrimethamine (SP) is currently deployed as intermittent preventive treatment in pregnancy (IPTp) to prevent the adverse effects of malaria on the mother and her offspring. Nevertheless, its efficacy is threatened by SP resistance which can be estimated by the prevalence of dihydropteroate synthase (dhps) and dihydrofolate reductase (dhfr) mutations. This was measured among pregnant women in the health district of Nanoro, Burkina Faso. Methods From June to December 2010, two hundred and fifty six pregnant women in the second and third trimester, attending antenatal care with microscopically confirmed malaria infection were invited to participate, regardless of malaria symptoms. A blood sample was collected on filter paper and analyzed by PCR-RFLP for the alleles 51, 59, 108, 164 in the pfdhfr gene and 437, 540 in the pfdhps gene. Results The genes were successfully genotyped in all but one sample (99.6%; 255/256) for dhfr and in 90.2% (231/256) for dhps. The dhfr C59R and S108N mutations were the most common, with a prevalence of 61.2%(156/255) and 55.7%(142/255), respectively; 12.2%(31/255) samples had also the dhfr N51I mutation while the I164L mutation was absent. The dhps A437G mutation was found in 34.2%(79/231) isolates, but none of them carried the codon K540E. The prevalence of the dhfr double mutations NRNI and the triple mutations IRNI was 35.7% (91/255) and 11.4% (29/255), respectively. Conclusion Though the mutations in the pfdhfr and pfdhps genes were relatively common, the prevalence of the triple pfdhfr mutation was very low, indicating that SP as IPTp is still efficacious in Burkina Faso.	[Tahita, Marc C.; Tinto, Halidou; Ouedraogo, Jean-Bosco] IRSS, DRO, Bobo Dioulasso, Burkina Faso; [Tahita, Marc C.; Tinto, Halidou; Kazienga, Adama; Ouedraogo, Jean-Bosco; Guiguemde, Robert T.] IRSS CRUN, Clin Res Unit Nanoro, Nanoro, Burkina Faso; [Tahita, Marc C.; Tinto, Halidou; Guiguemde, Robert T.] Ctr Muraz, Unite Rech Paludisme & Malad Trop Negligees, Bobo Dioulasso, Burkina Faso; [Tahita, Marc C.; Erhart, Annette; Fitzhenry, Robert; VanOvermeir, Chantal; Rosanas-Urgell, Anna; D'Alessandro, Umberto] Inst Trop Med, Malariol Unit, B-2000 Antwerp, Belgium; [Tahita, Marc C.; Van Geertruyden, Jean-Pierre] Univ Antwerp, Int Hlth Unit, B-2020 Antwerp, Belgium; [Guiguemde, Robert T.] Inst Super Sci Sante INSSA, Bobo Dioulasso, Burkina Faso; [D'Alessandro, Umberto] London Sch Hyg & Trop Med, London WC1, England; [D'Alessandro, Umberto] MRC Unit, Banjul, Gambia	Centre Muraz; Institute of Tropical Medicine (ITM); University of Antwerp; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Tahita, MC (corresponding author), IRSS, DRO, Bobo Dioulasso, Burkina Faso.	marctahita@yahoo.fr	Van geertruyden, Jean-Pierre/S-3254-2019; Kazienga, Adama/HGB-6079-2022; Van geertruyden, Jean-Pierre/K-6425-2014; Rosanas-Urgell, Anna/D-3193-2015; Tahita, Marc/AAG-6549-2019	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Rosanas-Urgell, Anna/0000-0002-0432-5203; Tahita, Marc/0000-0003-2158-0182; Tinto, Halidou/0000-0002-0472-3586; Ouedraogo, Jean Bosco/0000-0003-0412-8733; Kazienga, Adama/0000-0002-6093-9648				Artimovich E, 2015, J INFECT DIS, V212, P694, DOI 10.1093/infdis/jiv078; Aziken ME, 2011, INT J GYNECOL OBSTET, V112, P30, DOI 10.1016/j.ijgo.2010.07.027; Bacon DJ, 2009, ANTIMICROB AGENTS CH, V53, P2042, DOI 10.1128/AAC.01677-08; Basco LK, 1998, AM J TROP MED HYG, V58, P374, DOI 10.4269/ajtmh.1998.58.374; BROOKS DR, 1994, EUR J BIOCHEM, V224, P397, DOI 10.1111/j.1432-1033.1994.00397.x; Coulibaly SO, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-41; COWMAN AF, 1988, P NATL ACAD SCI USA, V85, P9109, DOI 10.1073/pnas.85.23.9109; Cuzin-Ouattara N, 1999, T ROY SOC TROP MED H, V93, P473, DOI 10.1016/S0035-9203(99)90343-7; Duraisingh MT, 1998, EXP PARASITOL, V89, P1, DOI 10.1006/expr.1998.4274; FOOTE SJ, 1990, P NATL ACAD SCI USA, V87, P3014, DOI 10.1073/pnas.87.8.3014; Geiger C, 2014, TROP MED INT HEALTH, V19, P690, DOI 10.1111/tmi.12305; Gregson A, 2005, PHARMACOL REV, V57, P117, DOI 10.1124/pr.57.1.4; Harrington WE, 2011, CLIN INFECT DIS, V53, P224, DOI 10.1093/cid/cir376; Kayentao K, 2005, J INFECT DIS, V191, P109, DOI 10.1086/426400; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Maiga OM, 2011, CLIN INFECT DIS, V53, P215, DOI 10.1093/cid/cir374; Nzila AM, 2000, ANTIMICROB AGENTS CH, V44, P991, DOI 10.1128/AAC.44.4.991-996.2000; Omar SA, 2001, T ROY SOC TROP MED H, V95, P315, DOI 10.1016/S0035-9203(01)90250-0; Pearce RJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000055; PETERSON DS, 1990, P NATL ACAD SCI USA, V87, P3018, DOI 10.1073/pnas.87.8.3018; Pfeiffer K, 2008, TROP MED INT HEALTH, V13, P418, DOI 10.1111/j.1365-3156.2008.02017.x; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Plowe CV, 2004, BRIT MED J, V328, P545, DOI 10.1136/bmj.37977.653750.EE; Plowe CV, 1997, J INFECT DIS, V176, P1590, DOI 10.1086/514159; Programme National de Lutte contre le Paludisme (PNLP), 2010, DIR NAT PRIS CHARG P; Sibley CH, 2001, TRENDS PARASITOL, V17, P582, DOI 10.1016/S1471-4922(01)02085-2; Sicuri E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013407; Tahita MC, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-464; Tinto H, 2007, AM J TROP MED HYG, V76, P608, DOI 10.4269/ajtmh.2007.76.608; Tinto H, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-113; TRIGLIA T, 1994, P NATL ACAD SCI USA, V91, P7149, DOI 10.1073/pnas.91.15.7149; Vinayak S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000830; Wang P, 1997, MOL BIOCHEM PARASIT, V89, P161, DOI 10.1016/S0166-6851(97)00114-X; White NJ, 2005, PLOS MED, V2, P28, DOI 10.1371/journal.pmed.0020003; Zhou ZY, 2008, ANTIMICROB AGENTS CH, V52, P739, DOI 10.1128/AAC.00975-07	35	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137440	10.1371/journal.pone.0137440	http://dx.doi.org/10.1371/journal.pone.0137440			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368675	Green Accepted, Green Published, gold			2022-12-27	WOS:000361601100073
J	Wang, TH; Zhang, Y; Chin, FYL; Ting, HF; Tsin, YH; Poon, SH				Wang, Tianhao; Zhang, Yong; Chin, Francis Y. L.; Ting, Hing-Fung; Tsin, Yung H.; Poon, Sheung-Hung			A Simple Algorithm for Finding All k-Edge-Connected Components	PLOS ONE			English	Article								The problem of finding k-edge-connected components is a fundamental problem in computer science. Given a graph G = (V, E), the problem is to partition the vertex set V into {V-1, V-2, ..., V-h}, where each V-i is maximized, such that for any two vertices x and y in V-i, there are k edge-disjoint paths connecting them. In this paper, we present an algorithm to solve this problem for all k. The algorithm preprocesses the input graph to construct an Auxiliary Graph to store information concerning edge-connectivity among every vertex pair in O(Fn) time, where F is the time complexity to find the maximum flow between two vertices in graph G and n = vertical bar V vertical bar. For any value of k, the k-edge-connected components can then be determined by traversing the auxiliary graph in O(n) time. The input graph can be a directed or undirected, simple graph or multigraph. Previous works on this problem mainly focus on fixed value of k.	[Zhang, Yong] Chinese Acad Sci, Shenzhen Inst Adv Technol, Res Ctr High Performance Comp, Shenzhen, Peoples R China; [Wang, Tianhao] Fudan Univ, Software Sch, Shanghai 200433, Peoples R China; [Zhang, Yong] Hebei Univ, Coll Math & Informat Sci, Baoding, Peoples R China; [Chin, Francis Y. L.; Ting, Hing-Fung] Univ Hong Kong, Dept Comp Sci, Hong Kong, Hong Kong, Peoples R China; [Chin, Francis Y. L.] Hang Seng Management Coll, Hong Kong, Hong Kong, Peoples R China; [Tsin, Yung H.] Univ Windsor, Sch Comp Sci, Windsor, ON N9B 3P4, Canada; [Poon, Sheung-Hung] Inst Teknol Brunei, Sch Comp & Informat, Gadong, Brunei	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Fudan University; Hebei University; University of Hong Kong; Hang Seng University of Hong Kong; University of Windsor; University of Technology Brunei	Zhang, Y (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Res Ctr High Performance Comp, Shenzhen, Peoples R China.	yzhang.hku@gmail.com	Wang, Tianhao/AAU-5463-2021	Poon, Sheung-Hung/0000-0002-1777-9394	National Natural Science Foundation of China [11171086, 61433012, U1435215]; Research Grants Council of Hong Kong [HKU 7114/13E, HKU 7164/12E, HKU 7111/12E]; Natural Sciences and Engineering Research Council of Canada; NSERC [7811-2009]; Natural Science Foundation of Hebei Province [A2013201218]; Chinese Academy of Sciences research grant [KGZD-EW-103-5(9)]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); Chinese Academy of Sciences research grant	This work is supported by National Natural Science Foundation of China (No. 11171086, 61433012, U1435215), Research Grants Council of Hong Kong (No. HKU 7114/13E, HKU 7164/12E, HKU 7111/12E), Natural Sciences and Engineering Research Council of Canada, NSERC 7811-2009, Natural Science Foundation of Hebei Province (No. A2013201218), and Chinese Academy of Sciences research grant (No. KGZD-EW-103-5(9)).	Chang L., 2013, SIGMOD, P205; Ford L. R. J., 1962, FLOWS NETWORKS; Ford LR, 1956, CAN J MATH, V8, P399, DOI [10.4153/CJM-1956-045-5, 10.4153/CJM-1956-045-5., DOI 10.4153/CJM-1956-045-5]; Galil Z., 1991, SIGACT News, V22, P57, DOI 10.1145/122413.122416; GOLDBERG AV, 1988, J ACM, V35, P921, DOI 10.1145/48014.61051; GOMORY RE, 1961, J SOC IND APPL MATH, V9, P551, DOI 10.1137/0109047; GUSFIELD D, 1990, SIAM J COMPUT, V19, P143, DOI 10.1137/0219009; GUSFIELD D, 1991, NETWORKS, V21, P505, DOI 10.1002/net.3230210503; Matula D. W., 1987, P FOCS; NAGAMOCHI H, 1992, ALGORITHMICA, V7, P583, DOI 10.1007/BF01758778; Nagamochi H., 1992, JAPAN J IND APPL MAT, V9, P163, DOI DOI 10.1007/BF03167564; SCHNORR CP, 1979, SIAM J COMPUT, V8, P265, DOI 10.1137/0208019; Stoer M, 1997, J ACM, V44, P585, DOI 10.1145/263867.263872; Tarjan R. E., 1974, Information Processing Letters, V2, P160, DOI 10.1016/0020-0190(74)90003-9; Tsin YH, 2007, THEOR COMPUT SYST, V40, P125, DOI 10.1007/s00224-005-1269-4; Tsin YH, 2009, J DISCRET ALGORITHMS, V7, P130, DOI 10.1016/j.jda.2008.04.003; Watanabe T., 1992, IEICE T FUND ELECTR, VE76-A, P513; Zhou RG, 2012, COMM COM INF SC, V321, P480	18	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136264	10.1371/journal.pone.0136264	http://dx.doi.org/10.1371/journal.pone.0136264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368134	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100015
J	Koo, T; Song, C; Kim, JS; Kim, K; Chie, EK; Kang, SB; Lee, KW; Kim, JH; Jeong, SY; Kim, TY				Koo, Taeryool; Song, Changhoon; Kim, Jae-Sung; Kim, Kyubo; Chie, Eui Kyu; Kang, Sung-Bum; Lee, Keun-Wook; Kim, Jee Hyun; Jeong, Seung-Yong; Kim, Tae-You			Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy	PLOS ONE			English	Article							PREOPERATIVE CHEMORADIOTHERAPY; CURATIVE RESECTION; COLORECTAL-CANCER; PROGNOSTIC-FACTOR; TUMOR RESPONSE; CHEMORADIATION; TRIAL; RADIOCHEMOTHERAPY; OXALIPLATIN; RETRIEVAL	Purpose To evaluate the prognostic impact of the lymph node ratio (LNR) in ypStage III rectal cancer patients who were treated with neoadjuvant chemoradiotherapy (NCRT). Materials and Methods We retrospectively reviewed the data of 638 consecutive patients who underwent NCRT followed by total mesorectal excision, and postoperative adjuvant chemotherapy for rectal cancer from 2004 to 2011. Of these, 125 patients were positive for lymph node (LN) metastasis and were analyzed in this study. Results The median numbers of examined and metastatic LNs were 17 and 2, respectively, and the median LNR was 0.143 (range, 0.02-1). Median follow-up time was 55 months. In multivariate analyses, LNR was an independent prognostic factor for overall survival (OS) (hazard ratio [HR] 2.17, p = 0.041), disease-free survival (DFS) (HR 2.28, p = 0.005), and distant metastasis-free survival (DMFS) (HR 2.30, p = 0.010). When ypN1 patients were divided into low (low LNR ypN1 group) and high LNR (high LNR ypN1 group) according to a cut-off value of 0.152, the high LNR ypN1 group had poorer OS (p = 0.043) and DFS (p = 0.056) compared with the low LNR ypN1 group. And there were no differences between the high LNR ypN1 group and the ypN2 group in terms of the OS (p = 0.703) and DFS (p = 0.831). Conclusions For ypN-positive rectal cancer patients, the LNR was a more effective prognostic marker than the ypN stage, circumferential resection margin, or tumor regression grade after NCRT, and could be used to discern the high-risk group among ypN1 patients.	[Koo, Taeryool; Kim, Kyubo; Chie, Eui Kyu] Seoul Natl Univ, Dept Radiat Oncol, Coll Med, Seoul, South Korea; [Song, Changhoon; Kim, Jae-Sung] Seoul Natl Univ, Bundang Hosp, Dept Radiat Oncol, Songnam, South Korea; [Kang, Sung-Bum] Seoul Natl Univ, Bundang Hosp, Dept Surg, Songnam, South Korea; [Lee, Keun-Wook; Kim, Jee Hyun] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea; [Jeong, Seung-Yong] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea; [Kim, Tae-You] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, JS (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Radiat Oncol, Songnam, South Korea.	jskim@snubh.org	Kim, Kyubo/R-8061-2019	Kim, Jae-Sung/0000-0001-5348-9178; Song, Changhoon/0000-0002-0714-8775; Chie, Eui Kyu/0000-0003-2027-7472				Aschele C, 2011, J CLIN ONCOL, V29, P2773, DOI 10.1200/JCO.2010.34.4911; Bhatti I, 2010, WORLD J SURG, V34, P768, DOI 10.1007/s00268-009-0336-4; Chang GJ, 2007, J NATL CANCER I, V99, P433, DOI 10.1093/jnci/djk092; Chang GJ, 2009, CANCER, V115, P5432, DOI 10.1002/cncr.24622; de la Fuente SG, 2009, J GASTROINTEST SURG, V13, P269, DOI 10.1007/s11605-008-0717-2; Fokas E, 2014, J CLIN ONCOL, V32, P1554, DOI 10.1200/JCO.2013.54.3769; Frederique P, 2008, ANN SURG, V248, P1067, DOI 10.1097/SLA.0b013e31818842ec; Glynne-Jones R, 2006, ANN ONCOL, V17, P1239, DOI 10.1093/annonc/mdl173; Hong YS, 2014, LANCET ONCOL, V15, P1245, DOI 10.1016/S1470-2045(14)70377-8; Jang NY, 2011, DIS COLON RECTUM, V54, P245, DOI 10.1007/DCR.0b013e3181fcee68; Kang J, 2011, J SURG ONCOL, V104, P53, DOI 10.1002/jso.21913; Kim H, 2014, CANCER RES TREAT, V46, P148, DOI 10.4143/crt.2014.46.2.148; Kim TH, 2010, INT J RADIAT ONCOL, V77, P1158, DOI 10.1016/j.ijrobp.2009.06.019; Kim YS, 2009, INT J RADIAT ONCOL, V74, P796, DOI 10.1016/j.ijrobp.2008.08.065; Klos CL, 2011, DIS COLON RECTUM, V54, P171, DOI 10.1007/DCR.0b013e3181fd677d; Laska E, 2012, STAT MED, V31, P3178, DOI 10.1002/sim.5384; Lee JH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-576; Lee SD, 2012, EJSO-EUR J SURG ONC, V38, P478, DOI 10.1016/j.ejso.2012.03.002; Lim SB, 2012, J SURG ONCOL, V106, P667, DOI 10.1002/jso.23198; Madbouly KM, 2014, AM J SURG, V207, P824, DOI 10.1016/j.amjsurg.2013.07.022; Moug SJ, 2009, BRIT J CANCER, V100, P1530, DOI 10.1038/sj.bjc.6605049; Nadoshan JJ, 2013, ASIAN PAC J CANCER P, V14, P3769, DOI 10.7314/APJCP.2013.14.6.3769; Nagtegaal ID, 2008, J CLIN ONCOL, V26, P303, DOI 10.1200/JCO.2007.12.7027; Rosenberg R, 2010, ANN SURG, V251, P1070, DOI 10.1097/SLA.0b013e3181d7789d; Rosenberg R, 2008, ANN SURG, V248, P968, DOI 10.1097/SLA.0b013e318190eddc; Sun Z, 2009, ANN ONCOL, V20, P897, DOI 10.1093/annonc/mdn707; Tong LL, 2011, ANN SURG ONCOL, V18, P2453, DOI 10.1245/s10434-011-1687-2; Wichmann MW, 2002, ARCH SURG-CHICAGO, V137, P206, DOI 10.1001/archsurg.137.2.206; Wu SG, 2014, CANC RES TREAT	29	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138728	10.1371/journal.pone.0138728	http://dx.doi.org/10.1371/journal.pone.0138728			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381522	Green Submitted, Green Published, gold			2022-12-27	WOS:000361790200154
J	Matthews, L; Kolind, S; Brazier, A; Leite, MI; Brooks, J; Traboulsee, A; Jenkinson, M; Johansen-Berg, H; Palace, J				Matthews, Lucy; Kolind, Shannon; Brazier, Alix; Leite, Maria Isabel; Brooks, Jonathan; Traboulsee, Anthony; Jenkinson, Mark; Johansen-Berg, Heidi; Palace, Jacqueline			Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis	PLOS ONE			English	Article							CEREBRAL WHITE-MATTER; BRAIN ATROPHY; SPECTRUM DISORDER; SPINAL-CORD; DIFFUSION; MRI; DAMAGE; PATHOGENESIS; DISABILITY; ASTROCYTOPATHY	Inflammatory demyelinating lesions of the central nervous system are a common feature of both neuromyelitis optica and multiple sclerosis. Despite this similarity, it is evident clinically that the accumulation of disability in patients with neuromyelitis optica is relapse related and that a progressive phase is very uncommon. This poses the question whether there is any pathological evidence of disease activity or neurodegeneration in neuromyelitis optica between relapses. To investigate this we conducted a longitudinal advanced MRI study of the brain and spinal cord in neuromyelitis optica patients, comparing to patients with multiple sclerosis and controls. We found both cross-sectional and longitudinal evidence of diffusely distributed neurodegenerative surrogates in the multiple sclerosis group (including thalamic atrophy, cervical cord atrophy and progressive widespread diffusion and myelin water imaging abnormalities in the normal appearing white matter) but not in those with neuromyelitis optica, where localised abnormalities in the optic radiations of those with severe visual impairment were noted. In addition, between relapses, there were no new silent brain lesions in the neuromyelitis optica group. These findings indicate that global central nervous system neurodegeneration is not a feature of neuromyelitis optica. The work also questions the theory that neurodegeneration in multiple sclerosis is a chronic sequela to prior inflammatory and demyelinating pathology, as this has not been found to be the case in neuromyelitis optica where the lesions are often more destructive.	[Matthews, Lucy; Brazier, Alix; Leite, Maria Isabel; Jenkinson, Mark; Johansen-Berg, Heidi; Palace, Jacqueline] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England; [Matthews, Lucy; Leite, Maria Isabel; Palace, Jacqueline] Oxford Univ Hosp NHS Trust, Dept Neurol, Oxford, England; [Kolind, Shannon; Traboulsee, Anthony] Univ British Columbia, Dept Med, Div Neurol, Vancouver, BC V6T 1W5, Canada; [Brooks, Jonathan] Univ Bristol, Clin Res & Imaging Ctr CRiCBristol, Bristol, Avon, England	University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of British Columbia; University of Bristol	Palace, J (corresponding author), Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England.	jacqueline.palace@ndcn.ox.ac.uk	Jenkinson, Mark/AAC-8861-2019; Traboulsee, Anthony L/AAB-2051-2020	Jenkinson, Mark/0000-0001-6043-0166; Brooks, Jonathan/0000-0003-3335-6209; Johansen-Berg, Heidi/0000-0002-4134-9730	Medical Research Council UK [G0901996]; MS Society of Canada; NHS National Specialised Commissioning Group for Neuromyelitis optica; NIHR Oxford Biomedical Research Centre; Wellcome Trust; NIHR; MRC [G0901996, G0700238] Funding Source: UKRI; Medical Research Council [G0700238, G0901996] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MS Society of Canada; NHS National Specialised Commissioning Group for Neuromyelitis optica; NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); NIHR(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Lucy Matthews was funded by a research training fellowship from the Medical Research Council UK whilst conducting this research (G0901996). Shannon Kolind was funded by a postgraduate fellowship from the MS Society of Canada during this research. Maria Isabel Leite is is supported by NHS National Specialised Commissioning Group for Neuromyelitis optica and by NIHR Oxford Biomedical Research Centre. Heidi Johansen-Berg is funded by a fellowship from the Wellcome Trust and is also supported by a grant from the NIHR.	Alonso-Ortiz E, 2015, MAGN RESON MED, V73, P70, DOI 10.1002/mrm.25198; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Blanc F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033878; Calabrese M, 2012, NEUROLOGY, V79, P1671, DOI 10.1212/WNL.0b013e31826e9a96; Chanson JB, 2013, EUR J NEUROL, V20, P361, DOI 10.1111/j.1468-1331.2012.03867.x; Chard DT, 2002, BRAIN, V125, P327, DOI 10.1093/brain/awf025; Confavreux C, 2006, CLIN NEUROL NEUROSUR, V108, P327, DOI 10.1016/j.clineuro.2005.11.018; de Seze J, 2010, J NEUROL NEUROSUR PS, V81, P409, DOI 10.1136/jnnp.2008.168070; De Stefano N, 2010, NEUROLOGY, V74, P1868, DOI 10.1212/WNL.0b013e3181e24136; De Stefano N, 2007, J NEUROIMAGING, V17, p10S, DOI 10.1111/j.1552-6569.2007.00130.x; Deoni SCL, 2008, MAGN RESON MED, V60, P1372, DOI 10.1002/mrm.21704; Duan YY, 2012, EUR J RADIOL, V81, pE110, DOI 10.1016/j.ejrad.2011.01.065; Evangelou N, 2000, BRAIN, V123, P1845, DOI 10.1093/brain/123.9.1845; Filippi M, 2004, NEUROL SCI, V25, pS371, DOI 10.1007/s10072-004-0344-y; Filippi M, 1999, NEUROLOGY, V53, P1705, DOI 10.1212/WNL.53.8.1705; Filippi M, 2012, LANCET NEUROL, V11, P349, DOI 10.1016/S1474-4422(12)70003-0; Fisniku LK, 2008, BRAIN, V131, P808, DOI 10.1093/brain/awm329; Fisniku LK, 2008, ANN NEUROL, V64, P247, DOI 10.1002/ana.21423; Franklin RJM, 2012, NAT REV NEUROL, V8, P624, DOI 10.1038/nrneurol.2012.200; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Fujihara K, 2011, J NEUROL SCI, V306, P183, DOI 10.1016/j.jns.2011.02.018; Gelineau-Morel R, 2012, HUM BRAIN MAPP, V33, P2802, DOI 10.1002/hbm.21402; Harrison DM, 2011, NEUROLOGY, V76, P179, DOI 10.1212/WNL.0b013e318206ca61; Horsfield MA, 2010, NEUROIMAGE, V50, P446, DOI 10.1016/j.neuroimage.2009.12.121; Kitley J, 2012, BRAIN, V135, P1834, DOI 10.1093/brain/aws109; Kolind S, 2012, NEUROIMAGE, V60, P263, DOI 10.1016/j.neuroimage.2011.11.070; Kremer S, 2015, JAMA NEUROL, V72, P815, DOI 10.1001/jamaneurol.2015.0248; Lassmann H, 2013, J NEUROL SCI, V333, P1, DOI 10.1016/j.jns.2013.05.010; Le Bihan D, 2012, NEUROIMAGE, V61, P324, DOI 10.1016/j.neuroimage.2011.11.006; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Liu Y, 2012, MULT SCLER J, V18, P1013, DOI 10.1177/1352458511431731; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; Lucchinetti CF, 2014, BRAIN PATHOL, V24, P83, DOI 10.1111/bpa.12099; Maggs FG, 2004, MULT SCLER J, V10, P326, DOI 10.1191/1352458504ms1019rr; Matsuoka T, 2011, BRAIN PATHOL, V21, P516, DOI 10.1111/j.1750-3639.2011.00475.x; Matthews L, 2013, NEUROLOGY, V80, P1330, DOI 10.1212/WNL.0b013e3182887957; Matthews LA, 2014, MULT SCLER RELAT DIS, V3, P284, DOI 10.1016/j.msard.2013.11.003; Miller DH, 2002, BRAIN, V125, P1676, DOI 10.1093/brain/awf177; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Pichiecchio A, 2012, MULT SCLER J, V18, P817, DOI 10.1177/1352458511431072; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Poloni G, 2011, NEUROLOGIST, V17, P185, DOI 10.1097/NRL.0b013e31821a2643; Lopes FCR, 2012, RADIOLOGY, V263, P235, DOI 10.1148/radiol.12111241; Scalfari A, 2014, J NEUROL NEUROSUR PS, V85, P67, DOI 10.1136/jnnp-2012-304333; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; Simon JH, 1999, NEUROLOGY, V53, P139, DOI 10.1212/WNL.53.1.139; Smith SA, 2005, MAGN RESON MED, V54, P201, DOI 10.1002/mrm.20553; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Waters P, 2008, ARCH NEUROL-CHICAGO, V65, P913, DOI 10.1001/archneur.65.7.913; Wingerchuk DM, 2007, NEUROLOGY, V68, P603, DOI 10.1212/01.wnl.0000254502.87233.9a; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Yu CS, 2006, AM J NEURORADIOL, V27, P1009; Yu CS, 2007, RADIOLOGY, V244, P249, DOI 10.1148/radiol.2441060930; Yu CS, 2008, RADIOLOGY, V246, P222, DOI 10.1148/radiol.2461062075	57	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137715	10.1371/journal.pone.0137715	http://dx.doi.org/10.1371/journal.pone.0137715			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381510	Green Published, gold, Green Submitted			2022-12-27	WOS:000361790200034
J	Weiland, A; Blankenstein, AH; Van Saase, JLCM; Van der Molen, HT; Jacobs, ME; Abels, DC; Kose, N; Van Dulmen, S; Vernhout, RM; Arends, LR				Weiland, Anne; Blankenstein, Annette H.; Van Saase, Jan L. C. M.; Van der Molen, Henk T.; Jacobs, Maril E.; Abels, Dineke C.; Kose, Nedim; Van Dulmen, Sandra; Vernhout, Rene M.; Arends, Lidia R.			Training Medical Specialists to Communicate Better with Patients with Medically Unexplained Physical Symptoms (MUPS). A Randomized, Controlled Trial	PLOS ONE			English	Article							SKILLS; SOMATIZATION; CARE; GPS	Background Patients with medically unexplained physical symptoms (MUPS) are prevalent 25-50% in general and specialist care. Medical specialists and residents often find patients without underlying pathology difficult to deal with, whereas patients sometimes don't feel understood. We developed an evidence-based communication training, aimed to improve specialists' interviewing, information-giving and planning skills in MUPS consultations, and tested its effectiveness. Methods The intervention group in this multi-center randomized controlled trial received a 14-hour training program to which experiential learning and feedback were essential. Using techniques from Cognitive Behavioral Therapy, they were stimulated to seek interrelating factors (symptoms, cognitions, emotions, behavior, and social environment) that reinforced a patient's symptoms. They were taught to explain MUPS understandably, reassure patients effectively and avoid unnecessary diagnostic testing. Before and after the intervention training, specialists videotaped a total of six consultations with different MUPS patients. These were evaluated to assess doctors' MUPS-focused communicating skills using an adapted version of the Four Habit Coding Scheme on five-point Likert scales. Participants evaluated the training by self-report on three-point Likert scales. Doctors in the control group received training after completion of the study. Results 123 doctors (40% specialists, 60% residents) and 478 MUPS patients from 11 specialties were included; 98 doctors completed the study (80%) and 449 videotaped consultations were assessed. Trained doctors interviewed patients more effectively than untrained ones (p < 0.001), summarized information in a more patient-centered way (p = 0.001), and better explained MUPS and the role of perpetuating factors (p < 0.05). No effects on planning skills were found. On a 3-point scale the training was evaluated with 2.79. Conclusion MUPS-focused communication training increases the interviewing and information-giving skills of medical specialists. We recommend that the training is incorporated in postgraduate education for medical specialists and residents who frequently encounter patients with MUPS.	[Weiland, Anne; Van Saase, Jan L. C. M.; Jacobs, Maril E.; Abels, Dineke C.; Kose, Nedim] Univ Med Ctr Rotterdam, Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Weiland, Anne; Van der Molen, Henk T.; Arends, Lidia R.] Erasmus Univ, Fac Social Sci, Inst Psychol, Rotterdam, Netherlands; [Blankenstein, Annette H.; Jacobs, Maril E.] VU Univ Med Ctr Amsterdam, Dept Gen Practice & Elderly Care Med, Amsterdam, Netherlands; [Abels, Dineke C.; Kose, Nedim] Open Univ, Fac Psychol, Heerlen, Netherlands; [Van Dulmen, Sandra] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands; [Van Dulmen, Sandra] NIVEL Netherlands Inst Hlth Serv Res, Utrecht, Netherlands; [Van Dulmen, Sandra] Buskerud & Vestfold Univ Coll, Fac Hlth Sci, Drammen, Norway; [Vernhout, Rene M.] Univ Med Ctr Rotterdam, Clin Trial Ctr, Erasmus MC, Rotterdam, Netherlands; [Arends, Lidia R.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Biostat, Rotterdam, Netherlands; [Arends, Lidia R.] Erasmus Univ, Fac Social Sci, Inst Pedag Sci, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Open University Netherlands; Radboud University Nijmegen; Netherlands Institute for Health Services Research; University College of Southeast Norway; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam	Weiland, A (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Internal Med, Rotterdam, Netherlands.	info@anneweiland.nl	van Dulmen, A.M./L-4287-2015	van Dulmen, A.M./0000-0002-1651-7544	ZonMw [171101012]; Health Care Organisation CZ, CZ-Fund [AFVV10-089]; Fund NutsOhra [1004-099]	ZonMw(Netherlands Organization for Health Research and Development); Health Care Organisation CZ, CZ-Fund; Fund NutsOhra	Funding provided by grant 171101012 from ZonMw, www.zonmw.nl; AW, grant AFVV10-089 from Health Care Organisation CZ, CZ-Fund, www.cz.nl; AW and grant 1004-099 from Fund NutsOhra, www.fno.nl; AW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiarzaguena JM, 2007, PSYCHOL MED, V37, P283, DOI 10.1017/S0033291706009536; Aiarzaguena JM, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-73; [Anonymous], 2010, DUTCH MULTIDISCIPLIN; Burton C, 2012, J PSYCHOSOM RES, V72, P242, DOI 10.1016/j.jpsychores.2011.12.009; Carson AJ, 2004, J NEUROL NEUROSUR PS, V75, P1776, DOI 10.1136/jnnp.2003.032169; Haller H, 2015, DTSCH ARZTEBL INT, V112, P279, DOI 10.3238/arztebl.2015.0279; Hartman TCO, 2013, BRIT J GEN PRACT, V63, P625, DOI 10.3399/bjgp13X675241; Hartman TCO, 2009, J PSYCHOSOM RES, V66, P363, DOI 10.1016/j.jpsychores.2008.09.018; Jensen BF, 2011, PATIENT EDUC COUNS, V84, P163, DOI 10.1016/j.pec.2010.08.028; Kouyanou K, 1998, PAIN, V76, P417, DOI 10.1016/S0304-3959(98)00074-8; Kroenke K, 2014, ANN INTERN MED, V161, P579, DOI 10.7326/M14-0461; Krupat E, 2006, PATIENT EDUC COUNS, V62, P38, DOI 10.1016/j.pec.2005.04.015; MILLER GE, 1990, ACAD MED, V65, pS63, DOI 10.1097/00001888-199009000-00045; Nimnuan C, 2001, J PSYCHOSOM RES, V51, P361, DOI 10.1016/S0022-3999(01)00223-9; Rief W, 2006, PSYCHOSOMATICS, V47, P304, DOI 10.1176/appi.psy.47.4.304; Rolfe A, 2013, JAMA INTERN MED, V173, P407, DOI 10.1001/jamainternmed.2013.2762; Rosendal M, 2005, FAM PRACT, V22, P419, DOI 10.1093/fampra/cmi033; Salmon P, 2007, PATIENT EDUC COUNS, V67, P246, DOI 10.1016/j.pec.2007.03.008; Siproudhis L, 2002, GASTROEN CLIN BIOL, V26, P1125; Stone J, 2002, BRIT MED J, V325, P1449, DOI 10.1136/bmj.325.7378.1449; van Dessel N, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011142.pub2; Weiland A, 2013, PATIENT EDUC COUNS, V92, P355, DOI 10.1016/j.pec.2013.06.027; Weiland A, 2012, PERSPECT MED EDUC, V1, P192, DOI 10.1007/s40037-012-0025-0; Zonneveld LNL, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-520	24	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138342	10.1371/journal.pone.0138342	http://dx.doi.org/10.1371/journal.pone.0138342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0ZE	26381400	Green Published, Green Submitted, gold			2022-12-27	WOS:000361790200093
J	Chiu, CH; Siow, TY; Weng, SJ; Hsu, YH; Huang, YS; Chang, KW; Cheng, CY; Ma, KH				Chiu, Chuang-Hsin; Siow, Tiing-Yee; Weng, Shao-Ju; Hsu, Yi-Hua; Huang, Yuahn-Sieh; Chang, Kang-Wei; Cheng, Cheng-Yi; Ma, Kuo-Hsing			Effect of MDMA-Induced Axotomy on the Dorsal Raphe Forebrain Tract in Rats: An In Vivo Manganese-Enhanced Magnetic Resonance Imaging Study	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; EXHIBIT DIFFERENTIAL VULNERABILITY; AXON TERMINALS; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; SUBSTITUTED AMPHETAMINES; ASCENDING PROJECTIONS; DOPAMINERGIC-NEURONS; SUBSTANTIA-NIGRA; BRAIN ACTIVATION; CAUDATE-PUTAMEN	3,4-Methylenedioxymethamphetamine (MDMA), also known as "Ecstasy", is a common recreational drug of abuse. Several previous studies have attributed the central serotonergic neurotoxicity of MDMA to distal axotomy, since only fine serotonergic axons ascending from the raphe nucleus are lost without apparent damage to their cell bodies. However, this axotomy has never been visualized directly in vivo. The present study examined the axonal integrity of the efferent projections from the midbrain raphe nucleus after MDMA exposure using in vivo manganese-enhanced magnetic resonance imaging (MEMRI). Rats were injected subcutaneously six times with MDMA (5 mg/kg) or saline once daily. Eight days after the last injection, manganese ions (Mn2+) were injected stereotactically into the raphe nucleus, and a series of MEMRI images was acquired over a period of 38 h to monitor the evolution of Mn2+-induced signal enhancement across the ventral tegmental area, the medial forebrain bundle (MFB), and the striatum. The MDMA-induced loss of serotonin transporters was clearly evidenced by immunohistological staining consistent with the Mn2+-induced signal enhancement observed across the MFB and striatum. MEMRI successfully revealed the disruption of the serotonergic raphe-striatal projections and the variable effect of MDMA on the kinetics of Mn2+ accumulation in the MFB and striatum.	[Chiu, Chuang-Hsin] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Chiu, Chuang-Hsin; Cheng, Cheng-Yi] Triserv Gen Hosp, Natl Def Med Ctr, Dept Nucl Med, Taipei, Taiwan; [Siow, Tiing-Yee] Chang Gung Univ, Chang Gung Mem Hosp, Dept Med Imaging & Intervent, Taoyuan, Taiwan; [Weng, Shao-Ju; Huang, Yuahn-Sieh; Ma, Kuo-Hsing] Natl Def Med Ctr, Dept Biol & Anat, Taipei, Taiwan; [Hsu, Yi-Hua] Acad Sinica, Inst Biomed Sci, Funct Micromagnet Resonance Imaging Ctr, Taipei, Taiwan; [Hsu, Yi-Hua] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chang, Kang-Wei] Inst Nucl Energy Res, Taoyaun, Taiwan	National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; Chang Gung Memorial Hospital; Chang Gung University; National Defense Medical Center; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Institute of Nuclear Energy Research - Taiwan	Cheng, CY (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Nucl Med, Taipei, Taiwan.	kuohsing91@yahoo.com.tw; steveccy60@gmail.com		Chang, Kang-Wei/0000-0002-4476-3603	Ministry of Science and Technology of Taiwan [99-2314-B-016-030-MY3]; Tri-Service General Hospital, National Defense Medical Center [TSGH-C104-179]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital, National Defense Medical Center	This work was supported by the Ministry of Science and Technology of Taiwan (Grant: 99-2314-B-016-030-MY3) (http://www.most.gov.tw/) and Tri-Service General Hospital, National Defense Medical Center (Grant: TSGH-C104-179). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adori C, 2011, PSYCHOPHARMACOLOGY, V213, P377, DOI 10.1007/s00213-010-2041-2; AXEL L, 1987, AM J ROENTGENOL, V148, P418, DOI 10.2214/ajr.148.2.418; AZMITIA EC, 1978, J COMP NEUROL, V179, P641, DOI 10.1002/cne.901790311; Bankson MG, 2004, J NEUROCHEM, V91, P852, DOI 10.1111/j.1471-4159.2004.02763.x; Baumann MH, 2007, PSYCHOPHARMACOLOGY, V189, P407, DOI 10.1007/s00213-006-0322-6; Baumann MH, 2009, DRUG METAB DISPOS, V37, P2163, DOI 10.1124/dmd.109.028506; BERGER UV, 1992, EUR J PHARMACOL, V215, P153, DOI 10.1016/0014-2999(92)90023-W; CALLAWAY CW, 1990, J PHARMACOL EXP THER, V254, P456; Concheiro M, 2014, DRUG METAB DISPOS, V42, P119, DOI 10.1124/dmd.113.053678; de la Torre R, 2004, TRENDS PHARMACOL SCI, V25, P505, DOI 10.1016/j.tips.2004.08.001; de la Torre R, 2004, THER DRUG MONIT, V26, P137, DOI 10.1097/00007691-200404000-00009; Gervais J, 2000, SYNAPSE, V35, P281, DOI 10.1002/(SICI)1098-2396(20000315)35:4<281::AID-SYN6>3.0.CO;2-A; GOLD LH, 1988, J PHARMACOL EXP THER, V247, P547; Gudelsky GA, 1996, J NEUROCHEM, V66, P243; HERVE D, 1987, BRAIN RES, V435, P71, DOI 10.1016/0006-8993(87)91588-5; Hrometz SL, 2004, NEUROSCI LETT, V367, P56, DOI 10.1016/j.neulet.2004.05.075; Hsu YH, 2008, PSYCHOPHARMACOLOGY, V196, P543, DOI 10.1007/s00213-007-0990-x; IMAI H, 1986, J COMP NEUROL, V243, P363, DOI 10.1002/cne.902430307; Inoue T, 2011, REV NEUROSCIENCE, V22, P675, DOI 10.1515/RNS.2011.048; Koch S, 1997, J NEURAL TRANSM, V104, P135, DOI 10.1007/BF01273176; KOSOFSKY BE, 1987, SYNAPSE, V1, P153, DOI 10.1002/syn.890010204; Lehallier B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048491; Li IH, 2010, NEUROIMAGE, V49, P1259, DOI 10.1016/j.neuroimage.2009.07.072; Li YX, 2009, MAGN RESON IMAGING, V27, P293, DOI 10.1016/j.mri.2008.07.011; Lin YJ, 1997, MAGN RESON MED, V38, P378, DOI 10.1002/mrm.1910380305; Lu HB, 2007, P NATL ACAD SCI USA, V104, P2489, DOI 10.1073/pnas.0606983104; MAMOUNAS LA, 1991, J COMP NEUROL, V314, P558, DOI 10.1002/cne.903140312; Molliver M.E., 1990, ANN NY ACAD SCI, V600, P661; Nixdorf WL, 2001, J NEUROCHEM, V77, P647, DOI 10.1046/j.1471-4159.2001.00262.x; OHEARN E, 1988, J NEUROSCI, V8, P2788; Pardo-Lozano R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047599; Pautler RG, 2004, NMR BIOMED, V17, P595, DOI 10.1002/nbm.942; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Rietjens SJ, 2012, CRIT REV TOXICOL, V42, P854, DOI 10.3109/10408444.2012.725029; Sarkar S, 2010, CURR PHARM BIOTECHNO, V11, P460, DOI 10.2174/138920110791591490; Schenk S, 2011, NEUROSCI BIOBEHAV R, V35, P1203, DOI 10.1016/j.neubiorev.2010.12.010; Schindler CW, 2014, BRIT J PHARMACOL, V171, P83, DOI 10.1111/bph.12423; SCHMIDT CJ, 1986, EUR J PHARMACOL, V124, P175, DOI 10.1016/0014-2999(86)90140-8; Simmons JM, 2008, J NEUROSCI, V28, P7637, DOI 10.1523/JNEUROSCI.1488-08.2008; Sprague JE, 1998, NEUROTOXICOLOGY, V19, P427; STEINBUSCH HWM, 1980, NEUROSCI LETT, V19, P137, DOI 10.1016/0304-3940(80)90184-6; Takeda A, 1998, BRAIN RES, V811, P147, DOI 10.1016/S0006-8993(98)00881-6; Van der Linden A, 2002, NEUROSCIENCE, V112, P467, DOI 10.1016/S0306-4522(02)00070-2; Van der Linden A, 2004, NMR BIOMED, V17, P602, DOI 10.1002/nbm.936; VANDERKOOY D, 1980, BRAIN RES, V186, P1, DOI 10.1016/0006-8993(80)90250-4; VERTES RP, 1991, J COMP NEUROL, V313, P643, DOI 10.1002/cne.903130409; Weng SJ, 2013, CELL TRANSPLANT, V22, P1295, DOI 10.3727/096368912X658683; WIKLUND L, 1981, J COMP NEUROL, V203, P613, DOI 10.1002/cne.902030405; WILSON MA, 1989, NEUROSCIENCE, V28, P121, DOI 10.1016/0306-4522(89)90237-6; Xie T, 2006, NEUROPSYCHOPHARMACOL, V31, P2639, DOI 10.1038/sj.npp.1301031	50	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138431	10.1371/journal.pone.0138431	http://dx.doi.org/10.1371/journal.pone.0138431			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378923	Green Published, gold, Green Submitted			2022-12-27	WOS:000361769400099
J	Depiereux, S; Le Gac, F; De Meulder, B; Pierre, M; Helaers, R; Guiguen, Y; Kestemont, P; Depiereux, E				Depiereux, Sophie; Le Gac, Florence; De Meulder, Bertrand; Pierre, Michael; Helaers, Raphael; Guiguen, Yann; Kestemont, Patrick; Depiereux, Eric			Meta-Analysis of Microarray Data of Rainbow Trout Fry Gonad Differentiation Modulated by Ethynylestradiol	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; MOLECULAR SEX-DIFFERENTIATION; GENE-EXPRESSION; STEROIDOGENIC ENZYMES; TEMPORAL PATTERNS; POWERFUL APPROACH; CHINOOK SALMON; T-TEST; FISH; SPERMATOGENESIS	Sex differentiation in fish is a highly labile process easily reversed by the use of exogenous hormonal treatment and has led to environmental concerns since low doses of estrogenic molecules can adversely impact fish reproduction. The goal of this study was to identify pathways altered by treatment with ethynylestradiol (EE2) in developing fish and to find new target genes to be tested further for their possible role in male-to-female sex transdifferentiation. To this end, we have successfully adapted a previously developed bioinformatics workflow to a meta-analysis of two datasets studying sex reversal following exposure to EE2 in juvenile rainbow trout. The meta-analysis consisted of retrieving the intersection of the top gene lists generated for both datasets, performed at different levels of stringency. The intersecting gene lists, enriched in true positive differentially expressed genes (DEGs), were subjected to over-representation analysis (ORA) which allowed identifying several statistically significant enriched pathways altered by EE2 treatment and several new candidate pathways, such as progesterone-mediated oocyte maturation and PPAR signalling. Moreover, several relevant key genes potentially implicated in the early transdifferentiation process were selected. Altogether, the results show that EE2 has a great effect on gene expression in juvenile rainbow trout. The feminization process seems to result from the altered transcription of genes implicated in normal female gonad differentiation, resulting in expression similar to that observed in normal females (i.e. the repression of key testicular markers cypl7a1, cypl 1 b, tbxl), as well as from other genes (including transcription factors) that respond specifically to the EE2 treatment. The results also showed that the bioinformatics workflow can be applied to different types of microarray platforms and could be generalized to (eco)toxicogenomics studies for environmental risk assessment purposes.	[Depiereux, Sophie; Kestemont, Patrick] Univ Namur, Res Unit Environm & Evolutionary Biol, URBE NARILIS, B-5000 Namur, Belgium; [De Meulder, Bertrand; Pierre, Michael; Helaers, Raphael; Depiereux, Eric] Univ Namur, Res Unit Mol Biol, URBE NARILIS, B-5000 Namur, Belgium; [Le Gac, Florence; Guiguen, Yann] INRA, INRA LPGP, UPR1037, F-35042 Rennes, France	University of Namur; University of Namur; INRAE	Depiereux, S (corresponding author), Univ Namur, Res Unit Environm & Evolutionary Biol, URBE NARILIS, 61 Rue Bruxelles, B-5000 Namur, Belgium.	sophie.depiereux@unamur.be		Helaers, Raphael/0000-0002-7046-7867; Guiguen, Yann/0000-0001-5464-6219	'Fond de la recherche scientifique', (FNRS); FNRS; FRIA; FRS-FNRS Televie	'Fond de la recherche scientifique', (FNRS)(Fonds de la Recherche Scientifique - FNRS); FNRS(Fonds de la Recherche Scientifique - FNRS); FRIA(Fonds de la Recherche Scientifique - FNRS); FRS-FNRS Televie(Fonds de la Recherche Scientifique - FNRS)	SD was funded by a grant from the 'Fond de la recherche scientifique', (FNRS): http://www.fnrs.be/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work is supported by the FNRS (SD), FRIA (MP) and FRS-FNRS Televie (BDM).	Adamski J, 2001, MOL CELL ENDOCRINOL, V171, P1, DOI 10.1016/S0303-7207(00)00383-X; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Baron D, 2005, BIOL REPROD, V73, P959, DOI 10.1095/biolreprod.105.041830; Baron D, 2005, MOL REPROD DEV, V71, P471, DOI 10.1002/mrd.20229; Baron D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-357; Baron D, 2008, GEN COMP ENDOCR, V156, P369, DOI 10.1016/j.ygcen.2008.01.016; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger F, 2008, CENT EUR J BIOL, V3, P327, DOI 10.2478/s11535-008-0030-9; Berger F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-510; Brennan J, 2004, NAT REV GENET, V5, P509, DOI 10.1038/nrg1381; Cajaraville MP, 2003, MICROSC RES TECHNIQ, V61, P191, DOI 10.1002/jemt.10329; Campbell B, 2003, BIOL REPROD, V69, P2109, DOI 10.1095/biolreprod.103.020560; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Cavileer T, 2009, SEX DEV, V3, P214, DOI 10.1159/000228722; De Hertogh B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-17; De Meulder B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086699; de Waal PP, 2009, J ENDOCRINOL, V202, P287, DOI 10.1677/JOE-09-0050; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Denslow ND, 2007, MOL BIOSYST, V3, P172, DOI 10.1039/b612802p; Depiereux S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128598; Depiereux S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098531; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Dong W, 2008, AQUAT TOXICOL, V88, P289, DOI 10.1016/j.aquatox.2008.05.006; Dudoit S, 2002, STAT SINICA, V12, P111; Fertuck KC, 2003, PHYSIOL GENOMICS, V15, P127, DOI 10.1152/physiolgenomics.00058.2003; Filby AL, 2007, ENVIRON SCI TECHNOL, V41, P8187, DOI 10.1021/es071278v; Filby AL, 2007, AQUAT TOXICOL, V81, P219, DOI 10.1016/j.aquatox.2006.12.003; Flicek P, 2012, NUCLEIC ACIDS RES, V2012, P40; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Govoroun M, 2001, ENDOCRINOLOGY, V142, P1841, DOI 10.1210/en.142.5.1841; Guiguen Y, MICROARRAY BASED ANA; Gur-Dedeoglu B, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-396; Hidaka Y, 2004, GENE EXPR PATTERNS, V5, P29, DOI 10.1016/j.modgep.2004.06.012; Hinfray N, 2011, GEN COMP ENDOCR, V174, P309, DOI 10.1016/j.ygcen.2011.09.008; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ibabe A, 2005, TOXICOL IN VITRO, V19, P725, DOI 10.1016/j.tiv.2005.03.019; Iglesias T, 2000, J BIOL CHEM, V275, P40048, DOI 10.1074/jbc.M005261200; Ingley E, 1999, FEBS LETT, V459, P69, DOI 10.1016/S0014-5793(99)01188-6; Jobling S, 1998, ENVIRON SCI TECHNOL, V32, P2498, DOI 10.1021/es9710870; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Katsiadaki I, 2010, AQUAT TOXICOL, V97, P174, DOI 10.1016/j.aquatox.2009.07.005; Kazeto YK, 2001, BIOCHEM BIOPH RES CO, V288, P503, DOI 10.1006/bbrc.2001.5796; Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104; Koskinen H, 2004, BIOCHEM BIOPH RES CO, V320, P745, DOI 10.1016/j.bbrc.2004.06.024; Kurosaki M, 2013, CELL MOL LIFE SCI, V70, P1807, DOI 10.1007/s00018-012-1229-5; Kusakabe M, 2006, J ENDOCRINOL, V189, P541, DOI 10.1677/joe.1.06684; Lalancette C, 2008, MOL GENET GENOMICS, V280, P263, DOI 10.1007/s00438-008-0361-2; Larkin P, 2003, COMP BIOCHEM PHYS B, V136, P149, DOI 10.1016/S1096-4959(03)00228-8; Larsson M, 2000, EUR J CELL BIOL, V79, P718, DOI 10.1078/0171-9335-00097; Le Gac F, 2008, CYBIUM, V32, P119; Leaver MJ, 2005, ENDOCRINOLOGY, V146, P3150, DOI 10.1210/en.2004-1638; Lemberger T, 1996, ANNU REV CELL DEV BI, V12, P335, DOI 10.1146/annurev.cellbio.12.1.335; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Liu SJ, 2000, J STEROID BIOCHEM, V75, P291, DOI 10.1016/S0960-0760(00)00186-2; Mayon N, 2006, SCI TOTAL ENVIRON, V367, P715, DOI 10.1016/j.scitotenv.2006.03.005; Miller KM, 2008, J FISH BIOL, V72, P2039, DOI 10.1111/j.1095-8649.2008.01913.x; Moens LN, 2007, CHEMOSPHERE, V67, P2293, DOI 10.1016/j.chemosphere.2006.09.092; Moggs JG, 2005, TOXICOLOGY, V213, P177, DOI 10.1016/j.tox.2005.05.020; Mu YM, 2000, BIOCHEM BIOPH RES CO, V271, P710, DOI 10.1006/bbrc.2000.2701; Nguyen C., 2010, NANOSCIENCE NANOBIOT, P911; Opgen-Rhein R, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1252; Osachoff HL, 2013, COMP BIOCHEM PHYS D, V8, P32, DOI 10.1016/j.cbd.2012.10.002; Pandian T J, 2013, ENDOCRINE SEX DIFFER; Pettersson M, 2000, GENOMICS, V68, P351, DOI 10.1006/geno.2000.6278; Pierre M, 2011, J PROTEOM BIOINFORM, V04, P36; Pierre M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-176; Rolland AD, 2010, TRANSCRIPTOME WIDE P; Rolland AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053302; Rolland AD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-546; Rubin GL, 2002, ENDOCRINOLOGY, V143, P2863, DOI 10.1210/en.143.8.2863; Ruggeri B, 2008, GEN COMP ENDOCR, V158, P138, DOI 10.1016/j.ygcen.2008.05.012; Salinas AE, 1999, CURR MED CHEM, V6, P279; Schulz RW, 2010, GEN COMP ENDOCR, V165, P390, DOI 10.1016/j.ygcen.2009.02.013; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Tilton SC, 2006, TOXICOL SCI, V90, P61, DOI 10.1093/toxsci/kfi341; Van den Belt K, 2003, ECOTOX ENVIRON SAFE, V56, P271, DOI 10.1016/S0147-6513(03)00004-6; Villeneuve DL, 2007, TOXICOL SCI, V98, P395, DOI 10.1093/toxsci/kfm124; Vizziano D, 2008, BIOL REPROD, V78, P939, DOI 10.1095/biolreprod.107.065961; Vizziano D, 2007, DEV DYNAM, V236, P2198, DOI 10.1002/dvdy.21212; Vizziano-Cantonnet D, 2008, J MOL ENDOCRINOL, V41, P277, DOI 10.1677/JME-08-0039; Wang RL, 2008, ENVIRON TOXICOL CHEM, V27, P652, DOI 10.1897/07-191.1; Wang RL, 2010, AQUAT TOXICOL, V98, P230, DOI 10.1016/j.aquatox.2010.02.021; Yamamoto T. O., 1969, P117; Yang TC, 2008, INT J DEV NEUROSCI, P867; Yano A, 2012, CURR BIOL, V22, P1423, DOI 10.1016/j.cub.2012.05.045; Yano A, 2011, MOL REPROD DEV, V78, P172, DOI 10.1002/mrd.21279	87	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0135799	10.1371/journal.pone.0135799	http://dx.doi.org/10.1371/journal.pone.0135799			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379055	Green Published, Green Submitted, gold			2022-12-27	WOS:000361769400002
J	Moreira, F; Calado, G; Dias, S				Moreira, Francisco; Calado, Goncalo; Dias, Susana			Conservation Status of a Recently Described Endemic Land Snail, Candidula coudensis, from the Iberian Peninsula	PLOS ONE			English	Article							FIRE; PROJECTIONS; COMMUNITIES; GASTROPODA; DISPERSAL; PORTUGAL; CLIMATE	We assessed the distribution, population size and conservation status of Candidula coudensis, a recently described endemic land snail from Portugal. From March 2013 to April 2014, surveys were carried out in the region where the species was described. We found an extent of occurrence larger than originally described, but still quite small (13.5 km(2)). The species was found mainly in olive groves, although it occurred in a variety of other habitats with limestone soils, including grasslands, scrublands and stone walls. Minimum population estimate ranged from 110,000-311,000 individuals. The main identified potential threats to the species include wildfires, pesticides and quarrying. Following the application of IUCN criteria, we advise a conservation status of either "Least Concern" or "Near-threatened" under criterion D (restricted population).	[Moreira, Francisco; Calado, Goncalo; Dias, Susana] Lusofona Univ, Dept Life Sci, Lisbon, Portugal; [Moreira, Francisco] Univ Porto, CIBIO InBIO Associate Lab, REN Biodivers Chair, Vairao, Portugal; [Moreira, Francisco; Dias, Susana] Univ Lisbon, Inst Super Agron, Ctr Ecol Aplicada Prof Baeta Neves, InBIO Associate Lab, P-1699 Lisbon, Portugal	Lusofona University; Universidade do Porto; Universidade de Lisboa	Moreira, F (corresponding author), Lusofona Univ, Dept Life Sci, Lisbon, Portugal.	fmoreira@isa.ulisboa.pt	Moreira, Francisco/B-2873-2008; Dias, Susana/ABG-6916-2020; Dias, Susana/L-7156-2013; Calado, Goncalo/F-5368-2011	Moreira, Francisco/0000-0003-4393-8018; Dias, Susana/0000-0002-5600-4444; Dias, Susana/0000-0002-5600-4444; Calado, Goncalo/0000-0001-9727-6051				Amatulli G, 2013, SCI TOTAL ENVIRON, V450, P209, DOI 10.1016/j.scitotenv.2013.02.014; [Anonymous], 2012, IUCN RED LIST CAT CR, V2nd, P32; Aubry S, 2006, J ANIM ECOL, V75, P802, DOI 10.1111/j.1365-2656.2006.01100.x; Bahl A., 1996, P329; BAUR B, 1995, ECOGRAPHY, V18, P123, DOI 10.1111/j.1600-0587.1995.tb00332.x; Bros V, 2011, FOREST ECOL MANAG, V261, P611, DOI 10.1016/j.foreco.2010.11.014; Buttner G., 2007, CLC2006 TECHNICAL GU; Cardoso P, 2011, BIOL CONSERV, V144, P2432, DOI 10.1016/j.biocon.2011.06.020; Cuttelod A, 2011, EUROPEAN RED LIST NO, DOI 10.2779/84538; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Holyoak G, 2014, J CONCHOL, V41, P1; Holyoak Geraldine A., 2010, Iberus, V28, P67; Hylander K, 2011, FOREST ECOL MANAG, V261, P1811, DOI 10.1016/j.foreco.2011.02.003; IUCN Standards and Petitions Subcommittee, 2017, GUID US IUCN RED LIS; Kiss L, 2003, J MOLLUS STUD, V69, P43, DOI 10.1093/mollus/69.1.43; Kiss L, 2006, BIODIVERS CONSERV, V15, P2925, DOI 10.1007/s10531-005-3430-4; Limondin-Lozouet N, 2011, J MOLLUS STUD, V80, P224; Martinez-Orti A, 2011, ANIM BIODIV CONSERV, V34, P1; Oliveira SLJ, 2012, INT J WILDLAND FIRE, V21, P48, DOI 10.1071/WF10131; Orlowsky B, 2013, HYDROL EARTH SYST SC, V17, P1765, DOI 10.5194/hess-17-1765-2013; POLLARD E, 1975, J ANIM ECOL, V44, P305, DOI 10.2307/3865; Santos X, 2012, CONTRIB ZOOL, V81, P167, DOI 10.1163/18759866-08103004; Santos X, 2009, BIODIVERS CONSERV, V18, P3153, DOI 10.1007/s10531-009-9634-2; Watters GT, 2005, BIOL CONSERV, V126, P166, DOI 10.1016/j.biocon.2005.05.005	24	3	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138464	10.1371/journal.pone.0138464	http://dx.doi.org/10.1371/journal.pone.0138464			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379241	Green Published, gold, Green Submitted			2022-12-27	WOS:000361769400102
J	Shrestha, Y; Wirshing, HH; Harasewych, MG				Shrestha, Yesha; Wirshing, Herman H.; Harasewych, M. G.			The Genus Cerion (Gastropoda: Cerionidae) in the Florida Keys	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PARTITIONING SCHEMES; PULMONATA CERIONIDAE; NATURAL-HISTORY; LAND; PHYLOGEOGRAPHY; HYBRIDIZATION; RECORD	The systematic relationships and phylogeography of Cerion incanum, the only species of Cerion native to the Florida Keys, are reviewed based on partial sequences of the mitochondrial COI and 16S genes derived from 18 populations spanning the range of this species and including the type localities of all four described subspecies. Our samples included specimens of Cerion casablancae, a species introduced to Indian Key in 1912, and a population of C. incanum x C. casablancae hybrids descended from a population of C. casablancae introduced onto Bahia Honda Key in the same year. Molecular data did not support the partition of C. incanum into subspecies, nor could populations be apportioned reliably into subspecies based on morphological features used to define the subspecies. Phylogenetic analyses affirmed the derived relationship of C. incanum relative to other cerionids, and indicated a Bahamian origin for the Cerion fauna of southern Florida. Relationships among the populations throughout the Keys indicate that the northernmost populations, closest to the Tomeu paleoislands that had been inhabited by Cerion petuchi during the Calabrian Pleistocene, are the oldest. The range of Cerion incanum expanded as the archipelago that is the Florida Keys was formed since the lower Tarantian Pleistocene by extension from the northeast to the southwest, with new islands populated as they were formed. The faunas of the High Coral Keys in the northeast and the Oolite Keys in the southwest, both with large islands that host multiple discontinuous populations of Cerion, are each composed of well supported clades that are characterized by distinctive haplotypes. In contrast, the fauna of the intervening Low Coral Keys consist of a heterogeneous series of populations, some with haplotypes derived from the High Coral Keys, others from the Oolite Keys. Individuals from the C. incanum x C. casablancae hybrid population inhabiting the southeastern coast of Bahia Honda Key were readily segregated based on their mitogenome lineage, grouping either with C. incanum or with C. casablancae from Indian Key. Hybrids with C. casablancae mitogenomes had haplotypes that were more divergent from their parent mitogenome than were hybrids with C. incanum mitogenomes.	[Shrestha, Yesha] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Med, Washington, DC 20052 USA; [Wirshing, Herman H.; Harasewych, M. G.] Smithsonian Inst, Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC 20560 USA	George Washington University; Smithsonian Institution; Smithsonian National Museum of Natural History	Harasewych, MG (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC 20560 USA.	Harasewych@si.edu		Shrestha, Yesha/0000-0002-9714-8516; Wirshing, Herman H./0000-0003-4926-4237	Harasewych lab	Harasewych lab	General research funds from the Harasewych lab supported field work in the Florida Keys and laboratory expenses. The authors received no grant funding for this work.	Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bartsch P., 1912, CARNEGIE I WASHINGTO, V11, P129; Bartsch P, 1931, ANN REPORT TORTUGAS, V30, P373; Bartsch P., 1920, DEP MARINE BIOL CARN, VXVI, P1; Bartsch P, 1949, AM MALACOLOGICAL UNI, V1948, P2; Binney A, 1851, TERRESTIAL AIR BREAT, V1, p[153, 162]; Binney WG, 1859, BOSTON J NATURAL HIS, V4, p[i, 1]; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Clench W. J., 1938, Bulletin of the Museum of Comparative Zoology, V80, P481; Clench W. J., 1957, Bulletin of the Museum of Comparative Zoology, V116, P121; Dall W. H., 1905, P23; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Goodfriend GA, 1996, SCIENCE, V274, P1894, DOI 10.1126/science.274.5294.1894; Gould S.J., 1983, Natural History, V92, P10; GOULD S J, 1987, Bulletin of the Museum of Comparative Zoology, V151, P321; GOULD S J, 1978, Bulletin of the Museum of Comparative Zoology, V148, P371; GOULD S J, 1986, Bulletin of the American Museum of Natural History, V182, P389; Harasewych MG, 2006, NAUTILUS, V120, P94; Harasewych MG, 2015, J MOLLUS STUD, V81, P66, DOI 10.1093/mollus/eyu062; Harasewych MG, 2014, NAUTILUS, V128, P18; Harasewych MG, 2012, NAUTILUS, V126, P119; Harasewych MG, 2011, NAUTILUS, V125, P173; Harasewych MG., 2009, CERION WEB BASED RES; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Lanfear R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-82; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leidy J, 1851, TERRESTRIAL AIR BREA, V1, P198; Mayr E, 1956, GEOGRAPHIC VAIRATION, V1806, P1; Palumbi Stephen R., 1996, P205; Petuch E.J., 2007, GEOLOGY EVERGLADES A; Pilsbry H. A., 1907, Proceedings of the Academy of Natural Sciences of Philadelphia, V59; Pilsbry HA, 1946, ACAD NATURAL SCI PHI, V2, P158; Pilsbry HA, 1902, FAMILY CERIONIDAE 2, V2, P215; Pilsbry HA, 1899, P ACAD NAT SCI PHILA, V1898, P477; Prevot V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060736; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rambaut A, 2009, TRACER VERSION 1 5 0; Rokas A, 2003, TRENDS ECOL EVOL, V18, P411, DOI 10.1016/S0169-5347(03)00125-3; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schilthuizen M, 1999, P ROY SOC B-BIOL SCI, V266, P2181, DOI 10.1098/rspb.1999.0906; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Woodruff D.S., 1981, P171; WOODRUFF DS, 1978, MALACOLOGIA, V17, P223; WOODRUFF DS, 1980, BIOL J LINN SOC, V14, P389, DOI 10.1111/j.1095-8312.1980.tb00115.x; WOODRUFF DS, 1989, BIOL J LINN SOC, V36, P281, DOI 10.1111/j.1095-8312.1989.tb00495.x; WOODRUFF DS, 1987, EVOLUTION, V41, P1022, DOI 10.1111/j.1558-5646.1987.tb05874.x	50	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137325	10.1371/journal.pone.0137325	http://dx.doi.org/10.1371/journal.pone.0137325			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378443	Green Published, gold, Green Submitted			2022-12-27	WOS:000361769400013
J	Andersen, SW; Shu, XO; Gao, YT; Zhang, XL; Cai, H; Yang, G; Li, HL; Xiang, YB; Zheng, W				Andersen, Shaneda Warren; Shu, Xiao-Ou; Gao, Yu-Tang; Zhang, Xianglan; Cai, Hui; Yang, Gong; Li, Hong-Lan; Xiang, Yong-Bing; Zheng, Wei			Prospective Cohort Study of Central Adiposity and Risk of Death in Middle Aged and Elderly Chinese	PLOS ONE			English	Article							BODY-MASS INDEX; ALL-CAUSE MORTALITY; WAIST CIRCUMFERENCE; ABDOMINAL ADIPOSITY; FOLLOW-UP; OBESITY; ADULTS; HEALTH; FAT	Asians have high prevalence of central obesity despite the low prevalence of general obesity. We evaluated associations between the central obesity measure, waist-hip ratio (WHR) with total and cause-specific mortality in middle-aged and elderly Chinese participants. Data arise from two prospective population-based cohort studies: the Shanghai Men's Health Study involves 53,425 men (participation rate = 74.0%), age 40-74 at baseline, and the Shanghai Women's Health Study involves 63,017 women (participation rate = 92.7%), age 40-70 at baseline. Information on lifestyle factors and anthropometric measurements were taken at baseline interview. Vital status and causes of death were obtained via surveys and annual linkages to relevant Shanghai registries through December 31, 2011. After median follow-up time of 7.5 years for the Shanghai Men's Health Study and 13.2 years for the Shanghai Women's Health Study, there were 2,058 and 3,167 deaths, respectively. In models adjusted for BMI and other potential confounders, WHR was associated with all-cause mortality; hazard ratios (HRs) (95% confidence intervals) across the first to fifth quintile increased from 1 (Reference), 1.10 (0.95,1.27), 1.21 (1.04,1.41), 1.11 (0.96,1.30), to 1.42 (1.22,1.65) in men and from 1 (Reference), 1.10 (0.96,1.27), 1.11 (0.97,1.27), 1.20 (1.05,1.37), to 1.48 (1.30,1.69) in women. WHR had a stronger association with cardiovascular disease, with multivariate-adjusted HRs of 1.5 to 1.7 observed for the highest versus lowest quintile of WHR. Dose-response associations were also seen for cancer and other-cause deaths. Stratified analyses suggested a stronger association with mortality among normal weight (BMI <25) than over-weight (BMI >= 25) individuals. Positive associations with mortality were observed in subgroups defined by follow-up duration, comorbidity, age, smoking, and physical activity. Greater central adiposity is associated with increased mortality in Chinese adults, even among individuals with low BMI. Physicians and the public should be aware of central adiposity's independent effects on health.	[Andersen, Shaneda Warren; Shu, Xiao-Ou; Zhang, Xianglan; Cai, Hui; Yang, Gong; Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Div Epidemiol,Dept Med,Vanderbilt Epidemiol Ctr, Nashville, TN 37212 USA; [Gao, Yu-Tang; Li, Hong-Lan; Xiang, Yong-Bing] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Epidemiol,Shanghai Canc Inst, Shanghai 200030, Peoples R China	Vanderbilt University; Shanghai Jiao Tong University	Zheng, W (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Div Epidemiol,Dept Med,Vanderbilt Epidemiol Ctr, Nashville, TN 37212 USA.	wei.zheng@vanderbilt.edu	Gao, Yu/HGE-1937-2022; Gao, Y./GWZ-3665-2022; Zheng, Wei/O-3351-2013; gao, yi/HCI-8298-2022; zhang, weihua/GXV-1334-2022	Zheng, Wei/0000-0003-1226-070X; 	US National Institutes of Health [R37 CA070867, R01 CA082729, UM1 CA173640]; Vanderbilt Molecular and Genetic Epidemiology of Cancer training program (U.S. National Institutes of Health) [R25 CA160056]; NATIONAL CANCER INSTITUTE [R01CA082729, R25CA160056, UM1CA182910, R37CA070867, UM1CA173640] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Molecular and Genetic Epidemiology of Cancer training program (U.S. National Institutes of Health); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study is supported by US National Institutes of Health grants R37 CA070867, R01 CA082729 and UM1 CA173640. Dr. Warren Andersen is supported by the Vanderbilt Molecular and Genetic Epidemiology of Cancer training program (U.S. National Institutes of Health grant R25 CA160056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2014, AM J EPIDEMIOL, V179, P135, DOI 10.1093/aje/kwt254; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bei-Fan Z, 2002, ASIA PAC J CLIN NUTR, V11, pS685, DOI 10.1046/j.1440-6047.11.s8.9.x; Bellocco R, 2010, EUR J EPIDEMIOL, V25, P777, DOI 10.1007/s10654-010-9497-6; Cai H, 2007, BRIT J NUTR, V98, P1006, DOI 10.1017/S0007114507750900; Cerhan JR, 2014, MAYO CLIN PROC, V89, P335, DOI 10.1016/j.mayocp.2013.11.011; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Desquilbet L, 2010, STAT MED, V29, P1037, DOI 10.1002/sim.3841; FOLSOM AR, 1993, JAMA-J AM MED ASSOC, V269, P483, DOI 10.1001/jama.269.4.483; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Jacobs EJ, 2010, ARCH INTERN MED, V170, P1293, DOI 10.1001/archinternmed.2010.201; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Lim U, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2011.2; Ntuk UE, 2014, DIABETES CARE, V37, P2500, DOI 10.2337/dc13-2966; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Reis JP, 2009, OBESITY, V17, P1232, DOI 10.1038/oby.2008.664; Simpson JA, 2007, OBESITY, V15, P994, DOI 10.1038/oby.2007.622; Strickler HD, 2005, JAMA-J AM MED ASSOC, V294, P551, DOI 10.1001/jama.294.5.551-b; WANG J, 1994, AM J CLIN NUTR, V60, P23, DOI 10.1093/ajcn/60.1.23; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714; Zhang XL, 2007, ARCH INTERN MED, V167, P886, DOI 10.1001/archinte.167.9.886; Zheng W, 2005, AM J EPIDEMIOL, V162, P1123, DOI 10.1093/aje/kwi322; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679	25	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138429	10.1371/journal.pone.0138429	http://dx.doi.org/10.1371/journal.pone.0138429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376077	Green Published, gold, Green Submitted			2022-12-27	WOS:000361610200107
J	Angione, C; Costanza, J; Carapezza, G; Lio, P; Nicosia, G				Angione, Claudio; Costanza, Jole; Carapezza, Giovanni; Lio, Pietro; Nicosia, Giuseppe			Multi-Target Analysis and Design of Mitochondrial Metabolism	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; PARETO OPTIMALITY; IMMUNE ALGORITHM; NETWORK BIOLOGY; IDENTIFIABILITY; EXPRESSION; FRAMEWORK; CALCIUM; HEART; LIFE	Analyzing and optimizing biological models is often identified as a research priority in biomedical engineering. An important feature of a model should be the ability to find the best condition in which an organism has to be grown in order to reach specific optimal output values chosen by the researcher. In this work, we take into account a mitochondrial model analyzed with flux-balance analysis. The optimal design and assessment of these models is achieved through single-and/or multi-objective optimization techniques driven by epsilondominance and identifiability analysis. Our optimization algorithm searches for the values of the flux rates that optimize multiple cellular functions simultaneously. The optimization of the fluxes of the metabolic network includes not only input fluxes, but also internal fluxes. A faster convergence process with robust candidate solutions is permitted by a relaxed Pareto dominance, regulating the granularity of the approximation of the desired Pareto front. We find that the maximum ATP production is linked to a total consumption of NADH, and reaching the maximum amount of NADH leads to an increasing request of NADH from the external environment. Furthermore, the identifiability analysis characterizes the type and the stage of three monogenic diseases. Finally, we propose a new methodology to extend any constraint-based model using protein abundances.	[Angione, Claudio; Lio, Pietro] Univ Cambridge, Comp Lab, Cambridge CB2 3QG, England; [Costanza, Jole] Ist Italiano Tecnol, Ctr Genom Sci IIT SEMM, Milan, Italy; [Carapezza, Giovanni; Nicosia, Giuseppe] Univ Catania, Dept Math & Comp Sci, Catania, Italy	University of Cambridge; Istituto Italiano di Tecnologia - IIT; University of Catania	Angione, C (corresponding author), Univ Cambridge, Comp Lab, Pembroke St, Cambridge CB2 3QG, England.	claudio.angione@cl.cam.ac.uk	P. Lió, Pietro Lio/AAV-3358-2021; Nicosia, Giuseppe/AAD-1625-2019; Nicosia, Giuseppe/F-1161-2011	P. Lió, Pietro Lio/0000-0002-0540-5053; Nicosia, Giuseppe/0000-0002-0650-3157; Nicosia, Giuseppe/0000-0002-0650-3157; Costanza, Jole/0000-0002-0290-3970; Angione, Claudio/0000-0002-3140-7909	FP7-Health-F5 (MIMOmics) [305280]	FP7-Health-F5 (MIMOmics)	PL has received funding from (FP7-Health-F5-2012) under grant agreement no. 305280 (MIMOmics). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angione C, 2013, IEEE ACM T COMPUT BI, V10, P1032, DOI 10.1109/TCBB.2013.95; Angione C, 2013, MOL BIOSYST, V9, P2554, DOI 10.1039/c3mb25558a; Borthwick GM, 1999, ANN NEUROL, V46, P787, DOI 10.1002/1531-8249(199911)46:5<787::AID-ANA17>3.0.CO;2-8; Brandes A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036947; BREIMAN L, 1985, J AM STAT ASSOC, V80, P580, DOI 10.2307/2288473; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Carapezza G, 2013, ACS SYNTH BIOL, V2, P274, DOI 10.1021/sb300102k; Chang RL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.52; Costanza J, 2012, BIOINFORMATICS, V28, P3097, DOI 10.1093/bioinformatics/bts590; Cutello V, 2006, J R SOC INTERFACE, V3, P139, DOI 10.1098/RSIF.2005.0083; Cutello V, 2007, J COMB OPTIM, V14, P9, DOI 10.1007/s10878-006-9036-2; Cutello V, 2007, IEEE T EVOLUT COMPUT, V11, P101, DOI 10.1109/TEVC.2006.880328; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Dumas ME, 2012, MOL BIOSYST, V8, P2494, DOI 10.1039/c2mb25167a; Esteves AR, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/693761; Galluzzi L, 2012, CIRC RES, V111, P1198, DOI 10.1161/CIRCRESAHA.112.268946; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Hengl S, 2007, BIOINFORMATICS, V23, P2612, DOI 10.1093/bioinformatics/btm382; Ingalls, 2013, MATH MODELING SYSTEM; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Johnston DS, 2009, PHARMACOGENOMICS, V10, P1645, DOI [10.2217/pgs.09.112, 10.2217/PGS.09.112]; Katic M, 2007, AGING CELL, V6, P827, DOI 10.1111/j.1474-9726.2007.00346.x; Keasling JD, 2012, METAB ENG, V14, P189, DOI 10.1016/j.ymben.2012.01.004; Kirchmair J, 2015, NAT REV DRUG DISCOV, V14, P387, DOI 10.1038/nrd4581; Laumanns M, 2002, EVOL COMPUT, V10, P263, DOI 10.1162/106365602760234108; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Lun DS, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.57; MORRIS MD, 1991, TECHNOMETRICS, V33, P161, DOI 10.2307/1269043; Murphy AN, 1999, J CEREBR BLOOD F MET, V19, P231, DOI 10.1097/00004647-199903000-00001; Navid A, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-150; Nicosia G, 2008, BIOPHYS J, V95, P4988, DOI 10.1529/biophysj.107.124016; NUUTILA P, 1992, J CLIN INVEST, V89, P1767, DOI 10.1172/JCI115780; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Palsson B, 2015, SYSTEMS BIOLOGY: CONSTRAINT-BASED RECONSTRUCTION AND ANALYSIS, pXV; Pavone M, 2012, J GLOBAL OPTIM, V53, P769, DOI 10.1007/s10898-011-9736-8; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Sengupta U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008100; Sherry AD, 1998, AM J PHYSIOL-HEART C, V274, pH591, DOI 10.1152/ajpheart.1998.274.2.H591; Shi P, 2010, BIOCHIM BIOPHYS ACTA, V1802; Shoval O, 2012, SCIENCE, V336, P1157, DOI 10.1126/science.1217405; Smith AC, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-102; Sobol IM, 2001, MATH COMPUT SIMULAT, V55, P271, DOI 10.1016/S0378-4754(00)00270-6; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Stephanopoulos G, 1999, METAB ENG, V1, P1, DOI 10.1006/mben.1998.0101; Stracquadanio G, 2011, COMPUT CHEM ENG, V35, P464, DOI 10.1016/j.compchemeng.2010.04.005; Supnet C, 2010, CELL CALCIUM, V47, P183, DOI 10.1016/j.ceca.2009.12.014; Tyo KEJ, 2010, METAB ENG, V12, P187, DOI 10.1016/j.ymben.2009.10.005	48	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0133825	10.1371/journal.pone.0133825	http://dx.doi.org/10.1371/journal.pone.0133825			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376088	Green Published, gold, Green Submitted			2022-12-27	WOS:000361610200003
J	Frebortova, J; Greplova, M; Seidl, MF; Heyl, A; Frebort, I				Frebortova, Jitka; Greplova, Marta; Seidl, Michael F.; Heyl, Alexander; Frebort, Ivo			Biochemical Characterization of Putative Adenylate Dimethylallyltransferase and Cytokinin Dehydrogenase from Nostoc sp PCC 7120	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; TRANSFER-RNA; PHYLOGENETIC ANALYSES; ESCHERICHIA-COLI; PLANT-GROWTH; EXPRESSION; PROTEIN; BIOSYNTHESIS; ARABIDOPSIS; EVOLUTION	Cytokinins, a class of phytohormones, are adenine derivatives common to many different organisms. In plants, these play a crucial role as regulators of plant development and the reaction to abiotic and biotic stress. Key enzymes in the cytokinin synthesis and degradation in modern land plants are the isopentyl transferases and the cytokinin dehydrogenases, respectively. Their encoding genes have been probably introduced into the plant lineage during the primary endosymbiosis. To shed light on the evolution of these proteins, the genes homologous to plant adenylate isopentenyl transferase and cytokinin dehydrogenase were amplified from the genomic DNA of cyanobacterium Nostoc sp. PCC 7120 and expressed in Escherichia coli. The putative isopentenyl transferase was shown to be functional in a biochemical assay. In contrast, no enzymatic activity was detected for the putative cytokinin dehydrogenase, even though the principal domains necessary for its function are present. Several mutant variants, in which conserved amino acids in land plant cytokinin dehydrogenases had been restored, were inactive. A combination of experimental data with phylogenetic analysis indicates that adenylate-type isopentenyl transferases might have evolved several times independently. While the Nostoc genome contains a gene coding for protein with characteristics of cytokinin dehydrogenase, the organism is not able to break down cytokinins in the way shown for land plants.	[Frebortova, Jitka] Palacky Univ, Fac Sci, Dept Chem Biol & Genet, Ctr Reg Hana Biotechnol & Agr Res, CR-77147 Olomouc, Czech Republic; [Greplova, Marta; Frebort, Ivo] Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Dept Mol Biol, CR-77147 Olomouc, Czech Republic; [Seidl, Michael F.] Wageningen Univ, Lab Phytopathol, NL-6700 AP Wageningen, Netherlands; [Heyl, Alexander] Free Univ Berlin, Dahlem Ctr Plant Sci, Inst Biol Appl Genet, Berlin, Germany	Palacky University Olomouc; Palacky University Olomouc; Wageningen University & Research; Free University of Berlin	Frebortova, J (corresponding author), Palacky Univ, Fac Sci, Dept Chem Biol & Genet, Ctr Reg Hana Biotechnol & Agr Res, CR-77147 Olomouc, Czech Republic.	jitka.frebortova@upol.cz; alexander.heyl@fu-berlin.de	Seidl, Michael F./ABD-6042-2021; Frébortová, Jitka/H-2435-2014; Heyl, Alexander/ABD-2145-2020; Frébort, Ivo/G-6382-2018	Frébortová, Jitka/0000-0002-2909-9337; Frébort, Ivo/0000-0002-4032-4961; Seidl, Michael F/0000-0002-5218-2083	Czech Science Foundation [P501/12/0161]; National Program of Sustainability I from the Ministry of Education, Youth and Sports, Czech Republic [LO1204]; Operational Program Education for Competitiveness - European Social Fund [CZ.1.07/2.3.00/20.0165]; Dahlem Centre of Plant Sciences	Czech Science Foundation(Grant Agency of the Czech Republic); National Program of Sustainability I from the Ministry of Education, Youth and Sports, Czech Republic; Operational Program Education for Competitiveness - European Social Fund(European Social Fund (ESF)); Dahlem Centre of Plant Sciences	This study was supported by research grant P501/12/0161 from the Czech Science Foundation (www.gacr.cz) to IF and by grant LO1204 from the National Program of Sustainability I from the Ministry of Education, Youth and Sports, Czech Republic (www.msmt.cz). JF and IF were partly supported by the Operational Program Education for Competitiveness - European Social Fund (project CZ.1.07/2.3.00/20.0165 to IF; www.msmt.cz) and the work of AH was supported by the Dahlem Centre of Plant Sciences (www.dcps.fu-berlin.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYOSHI DE, 1984, P NATL ACAD SCI-BIOL, V81, P5994, DOI 10.1073/pnas.81.19.5994; Akiyoshi DE, 1989, NUCLEIC ACIDS RES, V17, P88; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; BARNES MF, 1980, PHYTOCHEMISTRY, V19, P409, DOI 10.1016/0031-9422(80)83190-6; BARRY GF, 1984, P NATL ACAD SCI-BIOL, V81, P4776, DOI 10.1073/pnas.81.15.4776; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beres T, 2012, ANAL CHIM ACTA, V751, P176, DOI 10.1016/j.aca.2012.08.049; Beres T, 2010, ANAL BIOANAL CHEM, V398, P2071, DOI 10.1007/s00216-010-4126-5; Bilyeu KD, 2001, PLANT PHYSIOL, V125, P378, DOI 10.1104/pp.125.1.378; Bondos SE, 2003, ANAL BIOCHEM, V316, P223, DOI 10.1016/S0003-2697(03)00059-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chen XJS, 2001, J MOL BIOL, V307, P173, DOI 10.1006/jmbi.2000.4464; Chu HM, 2010, NUCLEIC ACIDS RES, V38, P1738, DOI 10.1093/nar/gkp1093; Clark ED, 2001, CURR OPIN BIOTECH, V12, P202, DOI 10.1016/S0958-1669(00)00200-7; CRESPI M, 1992, EMBO J, V11, P795, DOI 10.1002/j.1460-2075.1992.tb05116.x; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fiore MF, 2000, J MICROBIOL METH, V39, P159, DOI 10.1016/S0167-7012(99)00110-4; Frebort I, 2002, ANAL BIOCHEM, V306, P1, DOI 10.1006/abio.2002.5670; Frebort I, 2011, J EXP BOT, V62, P2431, DOI 10.1093/jxb/err004; Frebortova J, 2007, BIOL PLANTARUM, V51, P673, DOI 10.1007/s10535-007-0141-6; Galuszka P, 2001, EUR J BIOCHEM, V268, P450, DOI 10.1046/j.1432-1033.2001.01910.x; Galuszka P, EUR J BIOCH, V204, P3990; GEHRKE CW, 1982, J CHROMATOGR, V230, P297, DOI 10.1016/S0378-4347(00)80479-X; Goble AM, 2011, ACS CHEM BIOL, V6, P1036, DOI 10.1021/cb200198c; Gruhn N, 2014, PLANT PHYSIOL, V165, P227, DOI 10.1104/pp.113.228080; Gruhn N, 2013, CURR OPIN PLANT BIOL, V16, P569, DOI 10.1016/j.pbi.2013.09.001; Gu RL, 2010, J PLANT GROWTH REGUL, V29, P428, DOI 10.1007/s00344-010-9155-y; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Heuts DPHM, 2009, FEBS J, V276, P3405, DOI 10.1111/j.1742-4658.2009.07053.x; Hussain A, 2010, CURR MICROBIOL, V61, P361, DOI 10.1007/s00284-010-9620-7; Joseph RE, 2008, PROTEIN EXPRES PURIF, V60, P194, DOI 10.1016/j.pep.2008.04.001; Joshi MV, 2007, MOL PLANT MICROBE IN, V20, P751, DOI 10.1094/MPMI-20-7-0751; Kakimoto T, 2003, J PLANT RES, V116, P233, DOI 10.1007/s10265-003-0095-5; Kamada-Nobusada T, 2009, PHYTOCHEMISTRY, V70, P444, DOI 10.1016/j.phytochem.2009.02.007; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; KLINE LK, 1969, BIOCHEMISTRY-US, V8, P4361, DOI 10.1021/bi00839a021; Koenig RL, 2002, J BACTERIOL, V184, P1832, DOI 10.1128/JB.184.7.1832-1842.2002; Kowalska M, 2010, PHYTOCHEMISTRY, V71, P1970, DOI 10.1016/j.phytochem.2010.08.013; Krall L, 2002, FEBS LETT, V527, P315, DOI 10.1016/S0014-5793(02)03258-1; LICHTER A, 1995, J BACTERIOL, V177, P4457, DOI 10.1128/jb.177.15.4457-4465.1995; Lindner AC, 2014, J EXP BOT, V65, P2533, DOI 10.1093/jxb/eru142; Lisitskaya TB, 2013, RUSS J GEN CHEM+, V83, P2765, DOI 10.1134/S1070363213130252; Malito E, 2004, J MOL BIOL, V341, P1237, DOI 10.1016/j.jmb.2004.06.083; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Miyawaki K, 2006, P NATL ACAD SCI USA, V103, P16598, DOI 10.1073/pnas.0603522103; Novak O, 2003, ANAL CHIM ACTA, V480, P207, DOI 10.1016/S0003-2670(03)00025-4; Novak O, 2008, PHYTOCHEMISTRY, V69, P2214, DOI 10.1016/j.phytochem.2008.04.022; PERSSON BC, 1994, BIOCHIMIE, V76, P1152, DOI 10.1016/0300-9084(94)90044-2; Pertry I, 2010, MOL PLANT MICROBE IN, V23, P1164, DOI 10.1094/MPMI-23-9-1164; Pospisilova H, 2008, BIOSCIENCE REP, V28, P335, DOI 10.1042/BSR20080081; POWELL GK, 1986, NUCLEIC ACIDS RES, V14, P2555, DOI 10.1093/nar/14.6.2555; RIPPKA R, 1971, ARCH MIKROBIOL, V76, P341, DOI 10.1007/BF00408530; Samanovic MI, 2015, MOL CELL, V57, P984, DOI 10.1016/j.molcel.2015.01.024; Schmulling T, 2003, J PLANT RES, V116, P241, DOI 10.1007/s10265-003-0096-4; Soderberg T, 2001, BIOCHEMISTRY-US, V40, P1734, DOI 10.1021/bi002149t; Spichal L, 2012, FUNCT PLANT BIOL, V39, P267, DOI 10.1071/FP11276; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stirk WA, 1999, J PHYCOL, V35, P89, DOI 10.1046/j.1529-8817.1999.3510089.x; Sugawara H, 2008, P NATL ACAD SCI USA, V105, P2734, DOI 10.1073/pnas.0707374105; Takei K, 2001, J BIOL CHEM, V276, P26405, DOI 10.1074/jbc.M102130200; TAYA Y, 1978, NATURE, V271, P545, DOI 10.1038/271545a0; Voller J, 2010, PHYTOCHEMISTRY, V71, P1350, DOI 10.1016/j.phytochem.2010.04.018; von Schwartzenberg K, 2009, ANNU PLANT REV, V36, P246, DOI 10.1111/b.9781405181891.2009.000010.x; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Werner T, 2001, P NATL ACAD SCI USA, V98, P10487, DOI 10.1073/pnas.171304098; Werner T, 2009, CURR OPIN PLANT BIOL, V12, P527, DOI 10.1016/j.pbi.2009.07.002; WHITTY CD, 1974, CAN J BIOCHEM CELL B, V52, P789, DOI 10.1139/o74-112; Zalabak D, 2014, PLANT PHYSIOL BIOCH, V74, P283, DOI 10.1016/j.plaphy.2013.11.020	69	13	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138468	10.1371/journal.pone.0138468	http://dx.doi.org/10.1371/journal.pone.0138468			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376297	Green Published, gold, Green Submitted			2022-12-27	WOS:000361610200109
J	Hartvig, I; Czako, M; Kjaer, ED; Nielsen, LR; Theilade, I				Hartvig, Ida; Czako, Mihaly; Kjaer, Erik Dahl; Nielsen, Lene Rostgaard; Theilade, Ida			The Use of DNA Barcoding in Identification and Conservation of Rosewood (Dalbergia spp.)	PLOS ONE			English	Article							PLANTS; DISCRIMINATE; TAXONOMY; ORIGIN; SPACER; ACACIA; WOOD	The genus Dalbergia contains many valuable timber species threatened by illegal logging and deforestation, but knowledge on distributions and threats is often limited and accurate species identification difficult. The aim of this study was to apply DNA barcoding methods to support conservation efforts of Dalbergia species in Indochina. We used the recommended rbcL, matK and ITS barcoding markers on 95 samples covering 31 species of Dalbergia, and tested their discrimination ability with both traditional distance-based as well as different model-based machine learning methods. We specifically tested whether the markers could be used to solve taxonomic confusion concerning the timber species Dalbergia oliveri, and to identify the CITES-listed Dalbergia cochinchinensis. We also applied the barcoding markers to 14 samples of unknown identity. In general, we found that the barcoding markers discriminated among Dalbergia species with high accuracy. We found that ITS yielded the single highest discrimination rate (100%), but due to difficulties in obtaining high-quality sequences from degraded material, the better overall choice for Dalbergia seems to be the standard rbcL+matK barcode, as this yielded discrimination rates close to 90% and amplified well. The distance-based method TaxonDNA showed the highest identification rates overall, although a more complete specimen sampling is needed to conclude on the best analytic method. We found strong support for a monophyletic Dalbergia oliveri and encourage that this name is used consistently in Indochina. The CITES-listed Dalbergia cochinchinensis was successfully identified, and a species-specific assay can be developed from the data generated in this study for the identification of illegally traded timber. We suggest that the use of DNA barcoding is integrated into the work flow during floristic studies and at national herbaria in the region, as this could significantly increase the number of identified specimens and improve knowledge about species distributions.	[Hartvig, Ida; Kjaer, Erik Dahl; Nielsen, Lene Rostgaard] Univ Copenhagen, Dept Geosci & Nat Resource Management, Forest Genet & Divers, Frederiksberg, Denmark; [Czako, Mihaly] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Theilade, Ida] Univ Copenhagen, Dept Food & Resource Econ, Global Dev, Frederiksberg, Denmark	University of Copenhagen; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Copenhagen	Hartvig, I (corresponding author), Univ Copenhagen, Dept Geosci & Nat Resource Management, Forest Genet & Divers, Frederiksberg, Denmark.	ihla@ign.ku.dk	Theilade, Ida/A-6498-2010; Czako, Mihaly/AAB-6956-2020; Theilade, Ida/N-5882-2019; Czako, Mihaly/Q-9025-2019; Kjaer, Erik D/D-6534-2017; Hartvig, Ida/E-4080-2015; Nielsen, Lene/E-6769-2015	Theilade, Ida/0000-0003-3502-1277; Theilade, Ida/0000-0003-3502-1277; Czako, Mihaly/0000-0003-4655-3674; Kjaer, Erik D/0000-0001-8624-1611; Hartvig, Ida/0000-0002-1509-6864; Nielsen, Lene/0000-0002-7214-8691	University of Copenhagen scholarship	University of Copenhagen scholarship	This work was part of Ida Hartvig's PhD project funded by a University of Copenhagen scholarship. The authors received no specific funding for this work.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amaral W, 2004, FOREST GENETIC RESOU, V1, P37; [Anonymous], 2015, IUCN RED LIST THREAT; Ashfaq M, 2013, MOL ECOL RESOUR, V13, P573, DOI 10.1111/1755-0998.12089; Aubriot X, 2013, MOL ECOL RESOUR, V13, P57, DOI 10.1111/1755-0998.12028; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bentham G., 1860, P LINN SOC LONDON, P1; Bosser J, 2002, LEGUMINOSAE MADAGASC; Burgess KS, 2011, METHODS ECOL EVOL, V2, P333, DOI 10.1111/j.2041-210X.2011.00092.x; Chen D, 2010, FLORA CHINA, V10; Cohen W. W., 1995, Machine Learning. Proceedings of the Twelfth International Conference on Machine Learning, P115; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Collins RA, 2012, METHODS ECOL EVOL, V3, P457, DOI 10.1111/j.2041-210X.2011.00176.x; Costion C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026841; DeCarvalho AM, 1997, BRITTONIA, V49, P87, DOI 10.2307/2807701; Deguilloux MF, 2002, P ROY SOC B-BIOL SCI, V269, P1039, DOI 10.1098/rspb.2002.1982; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Evans TD, 2013, EVIDENCE BASED CONSE, P157, DOI DOI 10.4324/9780203128466; FA CTSP, 2004, CAMB TREE SPEC MON; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feng JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071710; Finkeldey R, 2010, APPL MICROBIOL BIOT, V85, P1251, DOI 10.1007/s00253-009-2328-6; Gagnepain F, 1913, FLORE GEN INDOCHINE, V2; Gao T, 2011, PLANTA MED, V77, P92, DOI 10.1055/s-0030-1250050; Gasson P, 2010, ANN BOT-LONDON, V105, P45, DOI 10.1093/aob/mcp270; Gillett JB, 1971, FLORA TROPICAL E AFR; Gu J, 2011, J SYST EVOL, V49, P213, DOI 10.1111/j.1759-6831.2011.00136.x; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Holtken AM, 2012, HOLZFORSCHUNG, V66, P97, DOI 10.1515/HF.2011.142; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Jiao LC, 2014, HOLZFORSCHUNG, V68, P487, DOI 10.1515/hf-2013-0129; John GH, 1993, 11 C UNC ART INT; Kelchner SA, 1997, MOL PHYLOGENET EVOL, V8, P385, DOI 10.1006/mpev.1997.0432; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Kim HM, 2014, MOL ECOL RESOUR, V14, P499, DOI 10.1111/1755-0998.12207; Krawczyk K, 2014, MOL ECOL RESOUR, V14, P272, DOI 10.1111/1755-0998.12175; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kuzmina ML, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-25; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Layton KKS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095003; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Little DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020552; Lock J, 1994, LEGUMES INDOCHINA CH; Lowe AJ, 2011, IAWA J, V32, P251, DOI 10.1163/22941932-90000055; Maddison W., 2018, MESQUITE MODULAR SYS; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Muellner AN, 2011, MOL ECOL RESOUR, V11, P450, DOI 10.1111/j.1755-0998.2011.02984.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nei M, 2000, MOL EVOLUTION PHYLOG; Nevill PG, 2013, MOL ECOL RESOUR, V13, P1033, DOI 10.1111/1755-0998.12060; Newmaster SG, 2009, MOL ECOL RESOUR, V9, P172, DOI 10.1111/j.1755-0998.2009.02642.x; Niyomdham C, 1997, LEGUMINOSEAE PAPILIO; Ogden Rob, 2010, Endangered Species Research, V9, P255, DOI 10.3354/esr00141; Phillips OL, 2003, J TROP ECOL, V19, P629, DOI 10.1017/S0266467403006035; Platt JC, 1999, ADVANCES IN KERNEL METHODS, P185; Prain D., 1904, ANN ROYAL BOT GARDEN, V10, P1; Puillandre N, 2012, MOL ECOL RESOUR, V12, P396, DOI 10.1111/j.1755-0998.2011.03105.x; Quinlan R, 1993, C4 5 PROGRAMS MACHIN; Ribeiro RA, 2007, SYST BOT, V32, P762, DOI 10.1600/036364407783390700; Saha S, 2013, PHYTOPHARMACOL, V4, P291; Schrire B, 2005, LEGUMES WORLD; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Starr JR, 2009, MOL ECOL RESOUR, V9, P151, DOI 10.1111/j.1755-0998.2009.02640.x; Stech M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053134; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Thothathri K, 1987, TAXONOMIC REVISION T; UNEP-WCMC, 2014, NONCITES TIMB SPEC S; Van Sam H, 2004, BLUMEA, V49, P201; van Velzen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030490; Vatanparast M, 2013, S AFR J BOT, V89, P143, DOI 10.1016/j.sajb.2013.07.001; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Webb CO, 2010, BIODIVERS CONSERV, V19, P955, DOI 10.1007/s10531-010-9817-x; Weitschek E, 2014, BIODATA MIN, V7, DOI 10.1186/1756-0381-7-4; Weitschek E, 2013, MOL ECOL RESOUR, V13, P1043, DOI 10.1111/1755-0998.12073; Yu M, 2015, TESTING 3 PROPOSED D; Zhang CY, 2012, MOL ECOL RESOUR, V12, P98, DOI 10.1111/j.1755-0998.2011.03076.x	84	72	74	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138231	10.1371/journal.pone.0138231	http://dx.doi.org/10.1371/journal.pone.0138231			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375850	gold, Green Submitted, Green Published			2022-12-27	WOS:000361610200092
J	Jemberu, WT; Mourits, MCM; Hogeveen, H				Jemberu, Wudu T.; Mourits, M. C. M.; Hogeveen, H.			Farmers' Intentions to Implement Foot and Mouth Disease Control Measures in Ethiopia	PLOS ONE			English	Article							HEALTH BELIEF MODEL; RISK-MANAGEMENT; PERCEPTIONS; ATTITUDES; CATTLE; MOTIVATORS; EFFICACY; ADOPTION	The objectives of this study were to explore farmers' intentions to implement foot and mouth disease (FMD) control in Ethiopia, and to identify perceptions about the disease and its control measures that influence these intentions using the Health Belief Model (HBM) framework. Data were collected using questionnaires from 293 farmers in three different production systems. The influence of perceptions on the intentions to implement controlmeasures were analyzed using binary logistic regression. The effect of socio-demographic and husbandry variables on perceptions that were found to significantly influence the intentions were analyzed using ordinal logistic regression. Almost all farmers (99%) intended to implement FMD vaccination free of charge. The majority of farmers in the pastoral (94%) and market oriented (92%) systems also had the intention to implement vaccination with charge but only 42% of the crop-livestockmixed farmers had the intention to do so. Only 2% of pastoral and 18% of crop-livestock mixed farmers had the intention to implement herd isolation and animal movement restriction continuously. These proportions increased to 11% for pastoral and 50% for crop-livestock mixed farmers when the measure is applied only during an outbreak. The majority of farmers in the market oriented system (>80%) had the intention to implement herd isolation and animal movement restriction measure, both continuously and during an outbreak. Among the HBM perception constructs, perceived barrier was found to be the only significant predictor of the intention to implement vaccination. Perceived susceptibility, perceived benefit and perceived barrier were the significant predictors of the intention for herd isolation and animalmovement restriction measure. In turn, the predicting perceived barrier on vaccination control varied significantly with the production systemand the age of farmers. The significant HBM perception predictors on herd isolation and animalmovement restriction control were significantly influenced only by the type of production system. The results of this study indicate that farmers' intentions to apply FMD controlmeasures are variable among production systems, an insight which is relevant in the development of future control programs. Promotion programs aimed at increasing farmers' motivation to participate in FMD control by charged vaccination or animal movement restriction should give attention to the perceived barriers influencing the intentions to apply these measures.	[Jemberu, Wudu T.; Mourits, M. C. M.; Hogeveen, H.] Wageningen Univ, Business Econ Grp, NL-6700 AP Wageningen, Netherlands; [Jemberu, Wudu T.] Univ Gondar, Fac Vet Med, Dept Vet Epidemiol & Publ Hlth, Gondar, Ethiopia; [Hogeveen, H.] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands	Wageningen University & Research; University of Gondar; Utrecht University	Jemberu, WT (corresponding author), Wageningen Univ, Business Econ Grp, NL-6700 AP Wageningen, Netherlands.	Wudu.Jemberu@wur.nl	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; Jemberu, Wudu Temesgen/0000-0002-3769-307X; Mourits, Monique/0000-0001-5213-2927; Hogeveen, Henk/0000-0002-9443-1412	University of Gondar Ethiopia; Nuffic (Netherlands organization for international cooperation in higher education)	University of Gondar Ethiopia; Nuffic (Netherlands organization for international cooperation in higher education)	The study was funded by University of Gondar Ethiopia: www.uog.edu.et/en/ and Nuffic (Netherlands organization for international cooperation in higher education) https://www.nuffic.nl/en.	ADESINA AA, 1995, AGR ECON, V13, P1, DOI 10.1016/0169-5150(95)01142-8; Alarcon P, 2014, PREV VET MED, V116, P223, DOI 10.1016/j.prevetmed.2013.08.004; Ayelet G, 2012, REV SCI TECH OIE, V31, P789; Bruijnis M, 2013, LIVEST SCI, V155, P103, DOI 10.1016/j.livsci.2013.04.005; Carpenter CJ, 2010, HEALTH COMMUN, V25, P661, DOI 10.1080/10410236.2010.521906; Champion VL., 2008, HLTH BEHAV HLTH ED T, V4th ed., P45; CSA, 2013, REPORT LIVESTOCK CHA, V570; Delabbio JL, 2005, J AQUAT ANIM HEALTH, V17, P153, DOI 10.1577/H04-005.1; Delgado AH, 2014, PREV VET MED, V117, P505, DOI 10.1016/j.prevetmed.2014.09.011; Dohoo I.R., 2003, VET EPIDEMIOLOGIC RE; Ellis-Iversen J, 2010, PREV VET MED, V93, P276, DOI 10.1016/j.prevetmed.2009.11.005; Fandamu P, 2006, TROP ANIM HEALTH PRO, V38, P9, DOI 10.1007/s11250-006-4341-4; FAO/OIE, 2012, GLOB FOOT MOUTH DIS; Field A, 2013, DISCOVERING STAT USI; Garforth CJ, 2013, PREV VET MED, V110, P456, DOI 10.1016/j.prevetmed.2013.02.018; Glanz K., 2008, HLTH BEHAV HLTH ED T; Glanz K, 2010, ANNU REV PUBL HEALTH, V31, P399, DOI 10.1146/annurev.publhealth.012809.103604; Howley P., 2012, Journal of Agricultural Science (Toronto), V4, P171, DOI 10.5539/jas.v4n6p171; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Jemberu WT, 2016, TRANSBOUND EMERG DIS, V63, pE246, DOI 10.1111/tbed.12338; Jemberu WT, 2014, PREV VET MED, V116, P26, DOI 10.1016/j.prevetmed.2014.06.004; MoARD, 2007, LIV DEV MAST PLAN ST; Paton DJ, 2011, PHILOS T R SOC B, V366, P2774, DOI 10.1098/rstb.2011.0107; Roeder PL, 2007, REV SCI TECH OIE, V26, P253, DOI 10.20506/rst.26.1.1738; Sheeran P., 2002, EUR REV SOC PSYCHOL, V12, P1, DOI [DOI 10.1080/14792772143000003, 10.1080/14792772143000003]; Tanner-Smith EE, 2010, SOC THEOR HEALTH, V8, P95, DOI 10.1057/sth.2009.23; Thomson G. R., 2014, TCPETH3401B3; Valeeva NI, 2011, PREV VET MED, V102, P284, DOI 10.1016/j.prevetmed.2011.08.005	28	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138363	10.1371/journal.pone.0138363	http://dx.doi.org/10.1371/journal.pone.0138363			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375391	Green Submitted, gold, Green Published			2022-12-27	WOS:000361610200101
J	van den Broek, E; Dijkstra, MJJ; Krijgsman, O; Sie, D; Haan, JC; Traets, JJH; van de Wiel, MA; Nagtegaal, ID; Punt, CJA; Carvalho, B; Ylstra, B; Abeln, S; Meijer, GA; Fijneman, RJA				van den Broek, Evert; Dijkstra, Maurits J. J.; Krijgsman, Oscar; Sie, Daoud; Haan, Josien C.; Traets, Joleen J. H.; van de Wiel, Mark A.; Nagtegaal, Iris D.; Punt, Cornelis J. A.; Carvalho, Beatriz; Ylstra, Bauke; Abeln, Sanne; Meijer, Gerrit A.; Fijneman, Remond J. A.			High Prevalence and Clinical Relevance of Genes Affected by Chromosomal Breaks in Colorectal Cancer	PLOS ONE			English	Article							MACRODOMAIN-CONTAINING PROTEINS; BRAF MUTATION; CHEMOTHERAPY; ABERRATIONS; EXPRESSION; STAT3; CAIRO	Background Cancer is caused by somatic DNA alterations such as gene point mutations, DNA copy number aberrations (CNA) and structural variants (SVs). Genome-wide analyses of SVs in large sample series with well-documented clinical information are still scarce. Consequently, the impact of SVs on carcinogenesis and patient outcome remains poorly understood. This study aimed to perform a systematic analysis of genes that are affected by CNA-associated chromosomal breaks in colorectal cancer (CRC) and to determine the clinical relevance of recurrent breakpoint genes. Methods Primary CRC samples of patients with metastatic disease from CAIRO and CAIRO2 clinical trials were previously characterized by array-comparative genomic hybridization. These data were now used to determine the prevalence of CNA-associated chromosomal breaks within genes across 352 CRC samples. In addition, mutation status of the commonly affected APC, TP53, KRAS, PIK3CA, FBXW7, SMAD4, BRAF and NRAS genes was determined for 204 CRC samples by targeted massive parallel sequencing. Clinical relevance was assessed upon stratification of patients based on gene mutations and gene breakpoints that were observed in >3% of CRC cases. Results In total, 748 genes were identified that were recurrently affected by chromosomal breaks (FDR < 0.1). MACROD2 was affected in 41% of CRC samples and another 169 genes showed breakpoints in >3% of cases, indicating that prevalence of gene breakpoints is comparable to the prevalence of well-known gene point mutations. Patient stratification based on gene breakpoints and point mutations revealed one CRC subtype with very poor prognosis. Conclusions We conclude that CNA-associated chromosomal breaks within genes represent a highly prevalent and clinically relevant subset of SVs in CRC.	[van den Broek, Evert; Krijgsman, Oscar; Sie, Daoud; Haan, Josien C.; Traets, Joleen J. H.; Carvalho, Beatriz; Ylstra, Bauke; Meijer, Gerrit A.; Fijneman, Remond J. A.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Dijkstra, Maurits J. J.; Abeln, Sanne] Vrije Univ Amsterdam, Dept Comp Sci, Amsterdam, Netherlands; [van de Wiel, Mark A.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [van de Wiel, Mark A.] Vrije Univ Amsterdam, Dept Math, Amsterdam, Netherlands; [Nagtegaal, Iris D.] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 ED Nijmegen, Netherlands; [Punt, Cornelis J. A.] Univ Amsterdam, Acad Med Ctr, Dept Med Oncol, NL-1105 AZ Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam	Fijneman, RJA (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands.	R.Fijneman@nki.nl	Fijneman, Remond/X-4199-2019; Carvalho, Beatriz/GXA-0720-2022; Ylstra, Bauke/D-2906-2012; Nagtegaal, Iris D/A-2448-2014	Fijneman, Remond/0000-0003-2076-5521; Ylstra, Bauke/0000-0001-9479-3010; Nagtegaal, Iris D/0000-0003-0887-4127; van de Wiel, Mark/0000-0003-4780-8472; Sie, Daoud/0000-0001-6762-2582; Meijer, Gerrit/0000-0003-0330-3130; Abeln, Sanne/0000-0002-2779-7174	VUmc-Cancer Center Amsterdam; Dutch Cancer Society [KWF-2007-3832]; Center for Translational Molecular Medicine, DeCoDe project [03O-101]; Dutch Colorectal Cancer Group (DCCG)	VUmc-Cancer Center Amsterdam; Dutch Cancer Society(KWF Kankerbestrijding); Center for Translational Molecular Medicine, DeCoDe project; Dutch Colorectal Cancer Group (DCCG)	This study was financially supported by grants from the VUmc-Cancer Center Amsterdam (E. van den Broek) and the Dutch Cancer Society (KWF-2007-3832), and performed within the framework of the Center for Translational Molecular Medicine, DeCoDe project (grant 03O-101) and the Dutch Colorectal Cancer Group (DCCG). These funders had no role in study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Drusco A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/984505; Edwards PAW, 2010, J PATHOL, V220, P244, DOI 10.1002/path.2632; Feijs KLH, 2013, NAT REV MOL CELL BIO, V14, P443, DOI 10.1038/nrm3601; Gilbert PB, 2005, J R STAT SOC C-APPL, V54, P143, DOI 10.1111/j.1467-9876.2005.00475.x; Haan JC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6457; Hofree M, 2013, NAT METHODS, V10, P1108, DOI [10.1038/NMETH.2651, 10.1038/nmeth.2651]; Hu MM, 2014, P NATL ACAD SCI USA, V111, P1509, DOI 10.1073/pnas.1318227111; Ibrahem S, 2014, INT J EXP PATHOL, V95, P392, DOI 10.1111/iep.12102; Jankevicius G, 2013, NAT STRUCT MOL BIOL, V20, P508, DOI 10.1038/nsmb.2523; Knijn N, 2011, BRIT J CANCER, V104, P1020, DOI 10.1038/bjc.2011.26; Koopman M, 2007, LANCET, V370, P135, DOI 10.1016/S0140-6736(07)61086-1; Krijgsman O, 2014, BBA-MOL CELL RES, V1843, P2698, DOI 10.1016/j.bbamcr.2014.08.001; Kuiper RP, 2010, CURR OPIN GENET DEV, V20, P282, DOI 10.1016/j.gde.2010.03.005; Kumar R, 2010, CANCER RES, V70, P6598, DOI 10.1158/0008-5472.CAN-10-0907; Leiserson MDM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003054; Mekenkamp LJM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086833; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Polgar B, 2003, J IMMUNOL, V171, P5956, DOI 10.4049/jimmunol.171.11.5956; Romero I, 2012, J PATHOL, V227, P367, DOI 10.1002/path.4029; Rosenthal F, 2013, NAT STRUCT MOL BIOL, V20, P502, DOI 10.1038/nsmb.2521; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Sie D, 2014, CELL ONCOL, V37, P353, DOI 10.1007/s13402-014-0196-2; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; Tran B, 2011, CANCER-AM CANCER SOC, V117, P4623, DOI 10.1002/cncr.26086; van de Wiel MA, 2007, BIOINFORMATICS, V23, P892, DOI 10.1093/bioinformatics/btm030; Venderbosch S, 2014, CLIN CANCER RES, V20, P5322, DOI 10.1158/1078-0432.CCR-14-0332; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Yang Z, 2013, CELL IMMUNOL, V285, P1, DOI 10.1016/j.cellimm.2013.07.015; Zhang XD, 2007, P NATL ACAD SCI USA, V104, P4060, DOI 10.1073/pnas.0611665104	33	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138141	10.1371/journal.pone.0138141	http://dx.doi.org/10.1371/journal.pone.0138141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375816	Green Submitted, Green Published, gold			2022-12-27	WOS:000361610200079
J	Yamamura, A; Ohara, N; Tsukamoto, K				Yamamura, Aya; Ohara, Naoki; Tsukamoto, Kikuo			Inhibition of Excessive Cell Proliferation by Calcilytics in Idiopathic Pulmonary Arterial Hypertension	PLOS ONE			English	Article							CALCIUM-SENSING RECEPTOR; SMOOTH-MUSCLE-CELLS; OPERATED CA2+ ENTRY; CA2+-SENSING RECEPTOR; TRPC EXPRESSION; POTENTIAL CHANNELS; BLOOD-PRESSURE; ACTIVATION; CALCIMIMETICS; RATS	Idiopathic pulmonary arterial hypertension (IPAH) is a rare and progressive disease of unknown pathogenesis. Vascular remodeling due to excessive proliferation of pulmonary arterial smooth muscle cells (PASMCs) is a critical pathogenic event that leads to early morbidity and mortality. The excessive cell proliferation is closely linked to the augmented Ca2+ signaling in PASMCs. More recently, we have shown by an siRNA knockdown method that the Ca2+-sensing receptor (CaSR) is upregulated in PASMCs from IPAH patients, involved in the enhanced Ca2+ response and subsequent excessive cell proliferation. In this study, we examined whether pharmacological blockade of CaSR attenuated the excessive proliferation of PASMCs from IPAH patients by MTT assay. The proliferation rate of PASMCs from IPAH patients was much higher (similar to 1.5-fold) than that of PASMCs from normal subjects and patients with chronic thromboembolic pulmonary hypertension (CTEPH). Treatment with NPS2143, an antagonist of CaSR or calcilytic, clearly suppressed the cell proliferation in a concentration-dependent manner (IC50 = 2.64 mu M) in IPAH-PASMCs, but not in normal and CTEPH PASMCs. Another calcilytic, Calhex 231, which is structurally unrelated to NPS2143, also concentration-dependently inhibited the excessive proliferation of IPAH-PASMCs (IC50 = 1.89 mu M). In contrast, R568, an activator of CaSR or calcimimetic, significantly facilitated the proliferation of IPAH-PASMCs (EC50 = 0.33 mu M). Similar results were obtained by BrdU incorporation assay. These results reveal that the excessive PASMC proliferation was modulated by pharmacological tools of CaSR, showing us that calcilytics are useful for a novel therapeutic approach for pulmonary arterial hypertension.	[Yamamura, Aya; Ohara, Naoki; Tsukamoto, Kikuo] Kinjo Gakuin Univ, Coll Pharm, Dept Pharm, Nagoya, Aichi, Japan		Yamamura, A (corresponding author), Kinjo Gakuin Univ, Coll Pharm, Dept Pharm, Nagoya, Aichi, Japan.	yamamura@kinjo-u.ac.jp			Japan Society for the Promotion of Science [25860068, 15K18881]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science (25860068 and 15K18881; to A.Y.).	Awumey EM, 2013, J PHARMACOL EXP THER, V346, P38, DOI 10.1124/jpet.113.205534; Badesch DB, 2010, CHEST, V137, P376, DOI 10.1378/chest.09-1140; Brauner-Osborne H, 2007, CURR DRUG TARGETS, V8, P169, DOI 10.2174/138945007779315614; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Chow JYC, 2011, AM J PHYSIOL-CELL PH, V301, pC461, DOI 10.1152/ajpcell.00389.2010; Firth AL, 2007, BBA-MOL BASIS DIS, V1772, P895, DOI 10.1016/j.bbadis.2007.02.009; Fryer RM, 2007, J PHARMACOL EXP THER, V323, P217, DOI 10.1124/jpet.107.123901; Guo Q, 2014, HYPERTENS RES, V37, P116, DOI 10.1038/hr.2013.129; Hassoun PM, 2009, J AM COLL CARDIOL, V54, pS10, DOI 10.1016/j.jacc.2009.04.006; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Ko EA, 2013, AM J PHYSIOL-CELL PH, V304, pC1042, DOI 10.1152/ajpcell.00304.2012; Li GW, 2011, BASIC CLIN PHARMACOL, V108, P185, DOI 10.1111/j.1742-7843.2010.00639.x; Li GW, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-16; Lin MJ, 2004, CIRC RES, V95, P496, DOI 10.1161/01.RES.0000138952.16382.ad; Lu WJ, 2008, AM J PHYSIOL-LUNG C, V295, pL104, DOI 10.1152/ajplung.00058.2008; Magno AL, 2011, ENDOCR REV, V32, P3, DOI 10.1210/er.2009-0043; Molostvov G, 2007, AM J PHYSIOL-RENAL, V293, pF946, DOI 10.1152/ajprenal.00474.2006; Montani D, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-97; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Nemeth EF, 2001, J PHARMACOL EXP THER, V299, P323; Nemeth EF, 1998, P NATL ACAD SCI USA, V95, P4040, DOI 10.1073/pnas.95.7.4040; Ogawa A, 2009, AM J PHYSIOL-LUNG C, V297, pL666, DOI 10.1152/ajplung.90548.2008; Ohanian J, 2005, AM J PHYSIOL-HEART C, V288, pH1756, DOI 10.1152/ajpheart.00739.2004; Petrel C, 2003, J BIOL CHEM, V278, P49487, DOI 10.1074/jbc.M308010200; RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Smajilovic S, 2006, BIOCHEM BIOPH RES CO, V348, P1215, DOI 10.1016/j.bbrc.2006.07.192; Smajilovic S, 2011, BRIT J PHARMACOL, V164, P884, DOI 10.1111/j.1476-5381.2011.01317.x; Smith KA, 2015, AM J RESP CELL MOL, V53, P355, DOI 10.1165/rcmb.2014-0235OC; Sun YH, 2010, BIOCHEM BIOPH RES CO, V394, P955, DOI 10.1016/j.bbrc.2010.03.096; Urwyler S, 2011, PHARMACOL REV, V63, P59, DOI 10.1124/pr.109.002501; Wan J, 2013, AM J PHYSIOL-LUNG C, V305, pL154, DOI 10.1152/ajplung.00313.2012; Wang J, 2006, CIRC RES, V98, P1528, DOI 10.1161/01.RES.0000227551.68124.98; Weston AH, 2008, BRIT J PHARMACOL, V154, P652, DOI 10.1038/bjp.2008.108; Wonneberger K, 2000, J MEMBRANE BIOL, V175, P203, DOI 10.1007/s002320001068; Yamamura Aya, 2014, J Smooth Muscle Res, V50, P8; Yamamura A, 2013, CIRC RES, V112, P640, DOI 10.1161/CIRCRESAHA.113.300897; Yamamura A, 2012, CIRC RES, V111, P469, DOI 10.1161/CIRCRESAHA.112.266361; Yamamura Aya, 2011, Pulm Circ, V1, P269, DOI 10.4103/2045-8932.83447; Yamamura H, 2008, AM J PHYSIOL-CELL PH, V295, pC296, DOI 10.1152/ajpcell.00499.2007; Yamamura H, 2014, AM J PHYSIOL-CELL PH, V306, pC871, DOI 10.1152/ajpcell.00221.2013; Yang XR, 2010, ADV EXP MED BIOL, V661, P109, DOI 10.1007/978-1-60761-500-2_7; Yu Y, 2004, P NATL ACAD SCI USA, V101, P13861, DOI 10.1073/pnas.0405908101; Zhang S, 2007, AM J PHYSIOL-LUNG C, V292, pL1202, DOI 10.1152/ajplung.00214.2006	45	24	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138384	10.1371/journal.pone.0138384	http://dx.doi.org/10.1371/journal.pone.0138384			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375676	gold, Green Submitted, Green Published			2022-12-27	WOS:000361610200104
J	Elshahabi, A; Klamer, S; Sahib, AK; Lerche, H; Braun, C; Focke, NK				Elshahabi, Adham; Klamer, Silke; Sahib, Ashish Kaul; Lerche, Holger; Braun, Christoph; Focke, Niels K.			Magnetoencephalography Reveals a Widespread Increase in Network Connectivity in Idiopathic/Genetic Generalized Epilepsy	PLOS ONE			English	Article							JUVENILE MYOCLONIC EPILEPSY; SCALE BRAIN NETWORKS; FUNCTIONAL CONNECTIVITY; WAVE DISCHARGES; FRONTAL-LOBE; EEG; SPIKE; STATE; ACTIVATION; TOPOLOGY	Idiopathic/genetic generalized epilepsy (IGE/GGE) is characterized by seizures, which start and rapidly engage widely distributed networks, and result in symptoms such as absences, generalized myoclonic and primary generalized tonic-clonic seizures. Although routine magnetic resonance imaging is apparently normal, many studies have reported structural alterations in IGE/GGE patients using diffusion tensor imaging and voxel-based morphometry. Changes have also been reported in functional networks during generalized spike wave discharges. However, network function in the resting-state without epileptiforme discharges has been less well studied. We hypothesize that resting-state networks are more representative of the underlying pathophysiology and abnormal network synchrony. We studied functional network connectivity derived from whole-brain magnetoencephalography recordings in thirteen IGE/GGE and nineteen healthy controls. Using graph theoretical network analysis, we found a widespread increase in connectivity in patients compared to controls. These changes were most pronounced in the motor network, the mesio-frontal and temporal cortex. We did not, however, find any significant difference between the normalized clustering coefficients, indicating preserved gross network architecture. Our findings suggest that increased resting state connectivity could be an important factor for seizure spread and/or generation in IGE/GGE, and could serve as a biomarker for the disease.	[Elshahabi, Adham; Klamer, Silke; Sahib, Ashish Kaul; Lerche, Holger; Focke, Niels K.] Univ Tubingen, Dept Neurol & Epileptol, Hertie Inst Clin Brain Res, Tubingen, Germany; [Elshahabi, Adham; Sahib, Ashish Kaul; Lerche, Holger; Braun, Christoph; Focke, Niels K.] Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany; [Elshahabi, Adham; Braun, Christoph] Univ Tubingen, MEG Ctr, Tubingen, Germany; [Elshahabi, Adham; Sahib, Ashish Kaul] Int Max Planck Res Sch Cognit & Syst Neurosci, Tubingen, Germany; [Braun, Christoph] Univ Trento, Ctr Mind Brain Sci, CIMeC, Trento, Italy	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; University of Trento	Elshahabi, A (corresponding author), Univ Tubingen, Dept Neurol & Epileptol, Hertie Inst Clin Brain Res, Tubingen, Germany.	adham.elshahabi@med.uni-tuebingen.de; niels.focke@uni-tuebingen.de	Focke, Niels/AAO-7012-2020; Ethofer, Silke/AAC-4570-2022; Braun, Christoph/J-4160-2014	Ethofer, Silke/0000-0002-6726-0531; Braun, Christoph/0000-0002-7836-4010; Sahib, Ashish Kaul/0000-0003-0622-9634	Werner Reichardt Centre for Integrative Neuroscience [PP 2011-14, PP 2014-02]; Deutsche Forschungsgemeinschaft [CIN EXC 307]; Open Access Publishing Fund of University of Tubingen	Werner Reichardt Centre for Integrative Neuroscience; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of University of Tubingen	AE was supported by the Werner Reichardt Centre for Integrative Neuroscience (URL: http://www.cin.uni-tuebingen.de, Grants: PP 2011-14 and PP 2014-02), and Deutsche Forschungsgemeinschaft (URL: http://www.dfg.de, Grant: CIN EXC 307). The authors acknowledge support by Open Access Publishing Fund of University of Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghakhani Y, 2004, BRAIN, V127, P1127, DOI 10.1093/brain/awh136; Berkovic SF, 2014, BRAIN, V137, P2400, DOI 10.1093/brain/awu194; Bernhardt BC, 2009, NEUROIMAGE, V46, P373, DOI 10.1016/j.neuroimage.2009.01.055; Betting LE, 2006, NEUROIMAGE, V32, P498, DOI 10.1016/j.neuroimage.2006.04.174; Blumenfeld H, 2005, EPILEPSIA, V46, P21, DOI 10.1111/j.1528-1167.2005.00311.x; Chavez M, 2003, J NEUROSCI METH, V124, P113, DOI 10.1016/S0165-0270(02)00367-9; Chavez M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.118701; Chowdhury FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110136; Ciumas C, 2006, NEUROLOGY, V67, P683, DOI 10.1212/01.wnl.0000230171.23913.cf; Clemens B, 2011, EPILEPSY RES, V96, P11, DOI 10.1016/j.eplepsyres.2011.04.011; David O, 2004, NEUROIMAGE, V21, P659, DOI 10.1016/j.neuroimage.2003.10.006; Deppe M, 2008, NEUROLOGY, V71, P1981, DOI 10.1212/01.wnl.0000336969.98241.17; Douw L, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-103; Focke NK, 2014, HUM BRAIN MAPP, V35, P3332, DOI 10.1002/hbm.22405; Gambardella A, 2009, EPILEPSIA, V50, P20, DOI 10.1111/j.1528-1167.2009.02115.x; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gotman J, 2005, P NATL ACAD SCI USA, V102, P15236, DOI 10.1073/pnas.0504935102; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Hamandi K, 2006, NEUROIMAGE, V31, P1700, DOI 10.1016/j.neuroimage.2006.02.016; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Huang W, 2011, J NEURORADIOLOGY, V38, P298, DOI 10.1016/j.neurad.2010.12.007; Laufs H, 2006, EPILEPSIA, V47, P444, DOI 10.1111/j.1528-1167.2006.00443.x; Li YH, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011014, 10.1371/journal.pone.0015219]; Liu M, 2011, EPILEPSIA, V52, P2267, DOI 10.1111/j.1528-1167.2011.03313.x; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Moeller F, 2008, NEUROIMAGE, V39, P1839, DOI 10.1016/j.neuroimage.2007.10.058; Moeller F, 2011, EPILEPSIA, V52, P515, DOI 10.1111/j.1528-1167.2010.02938.x; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Niso G, 2015, NEUROIMAGE-CLIN, V8, P503, DOI 10.1016/j.nicl.2015.05.008; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; O'Muircheartaigh J, 2011, NEUROLOGY, V76, P34, DOI 10.1212/WNL.0b013e318203e93d; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; PAPANICOLAOU AC, 1986, INT J NEUROSCI, V30, P81, DOI 10.3109/00207458608985658; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sakurai K, 2010, EPILEPSY RES, V89, P176, DOI 10.1016/j.eplepsyres.2009.12.004; Song M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017294; Stefan H, 2009, EPILEPSY RES, V85, P187, DOI 10.1016/j.eplepsyres.2009.03.015; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vollmar C, 2012, NEUROLOGY, V78, P1555, DOI 10.1212/WNL.0b013e3182563b44; Vollmar C, 2011, BRAIN, V134, P1710, DOI 10.1093/brain/awr098; Vulliemoz S, 2011, EPILEPSIA, V52, P507, DOI 10.1111/j.1528-1167.2010.02770.x; Wandschneider B, 2014, BRAIN, V137, P2469, DOI 10.1093/brain/awu175; Wang ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039701; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	47	36	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138119	10.1371/journal.pone.0138119	http://dx.doi.org/10.1371/journal.pone.0138119			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368933	gold, Green Published, Green Submitted			2022-12-27	WOS:000361601100229
J	Jayasundara, N; Kozal, JS; Arnold, MC; Chan, SSL; Di Giulio, RT				Jayasundara, Nishad; Kozal, Jordan S.; Arnold, Mariah C.; Chan, Sherine S. L.; Di Giulio, Richard T.			High-Throughput Tissue Bioenergetics Analysis Reveals Identical Metabolic Allometric Scaling for Teleost Hearts and Whole Organisms	PLOS ONE			English	Article							ZEBRAFISH DANIO-RERIO; BODY-MASS; MITOCHONDRIAL DYSFUNCTION; GENERAL-MODEL; BRAIN; CELLS; SIZE; DISEASE; BIOLOGY; FISH	Organismal metabolic rate, a fundamental metric in biology, demonstrates an allometric scaling relationship with body size. Fractal-like vascular distribution networks of biological systems are proposed to underlie metabolic rate allometric scaling laws from individual organisms to cells, mitochondria, and enzymes. Tissue-specific metabolic scaling is notably absent from this paradigm. In the current study, metabolic scaling relationships of hearts and brains with body size were examined by improving on a high-throughput whole-organ oxygen consumption rate (OCR) analysis method in five biomedically and environmentally relevant teleost model species. Tissue-specific metabolic scaling was compared with organismal routine metabolism (RMO2), which was measured using whole organismal respirometry. Basal heart OCR and organismal RMO2 scaled identically with body mass in a species-specific fashion across all five species tested. However, organismal maximum metabolic rates (MMO2) and pharmacologically-induced maximum cardiac metabolic rates in zebrafish Danio rerio did not show a similar relationship with body mass. Brain metabolic rates did not scale with body size. The identical allometric scaling of heart and organismal metabolic rates with body size suggests that hearts, the power generator of an organism's vascular distribution network, might be crucial in determining teleost metabolic rate scaling under routine conditions. Furthermore, these findings indicate the possibility of measuring heart OCR utilizing the high-throughput approach presented here as a proxy for organismal metabolic rate-a useful metric in characterizing organismal fitness. In addition to heart and brain OCR, the current approach was also used to measure whole liver OCR, partition cardiac mitochondrial bioenergetic parameters using pharmacological agents, and estimate heart and brain glycolytic rates. This high-throughput whole-organ bioenergetic analysis method has important applications in toxicology, evolutionary physiology, and biomedical sciences, particularly in the context of investigating pathogenesis of mitochondrial diseases.	[Jayasundara, Nishad; Kozal, Jordan S.; Arnold, Mariah C.; Di Giulio, Richard T.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Chan, Sherine S. L.] Med Univ S Carolina, Charleston, SC 29425 USA	Duke University; Medical University of South Carolina	Jayasundara, N (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	Nishad.Jayasundara@duke.edu	Jayasundara, Nishad/AAR-7871-2021	Jayasundara, Nishad/0000-0003-2485-6893	National Institutes of Environmental Health (Duke University Superfund Research Center) [P42-ES010356]; Duke University Program in Environmental Health Training grant [T32-ES021432]; Office of Research Support; Nicholas School of the Environment, Duke University; NIH [P20RR024485/P20 GM103542, R21DA037706, R01GM111672]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010356, T32ES021432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111672, P20GM103542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA037706] Funding Source: NIH RePORTER	National Institutes of Environmental Health (Duke University Superfund Research Center); Duke University Program in Environmental Health Training grant; Office of Research Support; Nicholas School of the Environment, Duke University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The Di Giulio lab is supported by National Institutes of Environmental Health awards P42-ES010356 (Duke University Superfund Research Center) and Duke University Program in Environmental Health Training grant (T32-ES021432). Purchase of the XFe24 Extracellular Flux Analyzer was supported by funds provided by the Office of Research Support and the Nicholas School of the Environment, Duke University. The Chan lab is supported by NIH awards P20RR024485/P20 GM103542, R21DA037706, and R01GM111672.	Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Clarke A, 1999, J ANIM ECOL, V68, P893, DOI 10.1046/j.1365-2656.1999.00337.x; Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008; da Silva JKL, 2006, PHYS LIFE REV, V3, P229, DOI 10.1016/j.plrev.2006.08.001; Darveau CA, 2002, NATURE, V417, P166, DOI 10.1038/417166a; Dodds PS, 2001, J THEOR BIOL, V209, P9, DOI 10.1006/jtbi.2000.2238; Driedzic William R., 1992, P219; DRIEDZIC WR, 1987, AM J PHYSIOL, V252, pR930, DOI 10.1152/ajpregu.1987.252.5.R930; GOULD SJ, 1966, BIOL REV, V41, P587, DOI 10.1111/j.1469-185X.1966.tb01624.x; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; HEUSNER AA, 1987, ANNU REV PHYSIOL, V49, P121; Hill BG, 2012, BIOL CHEM, V393, P1485, DOI 10.1515/hsz-2012-0198; HOCHACHKA PW, 2014, BIOCH ADAPTATION; HOPPELER H, 1984, RESP PHYSIOL, V55, P131, DOI 10.1016/0034-5687(84)90018-5; Karbowski J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026709; Karbowski J, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-18; Killen SS, 2010, ECOL LETT, V13, P184, DOI 10.1111/j.1461-0248.2009.01415.x; Kitambi Satish Srinivas, 2012, BMC Physiology, V12, P3, DOI 10.1186/1472-6793-12-3; Kleiber M, 1932, HILGARDIA, V6; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Little AG, 2014, J EXP BIOL, V217, P718, DOI 10.1242/jeb.096602; Lucas J, 2014, J FISH BIOL, V84, P1171, DOI 10.1111/jfb.12306; MCNAB BK, 1989, AM NAT, V133, P157, DOI 10.1086/284907; Meyer JN, 2013, TOXICOL SCI, V134, P1, DOI 10.1093/toxsci/kft102; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; REIDY SP, 1995, J FISH BIOL, V47, P377, DOI 10.1111/j.1095-8649.1995.tb01907.x; Rousset S, 2004, DIABETES, V53, pS130, DOI 10.2337/diabetes.53.2007.S130; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; SIDELL BD, 1987, PHYSIOL ZOOL, V60, P221, DOI 10.1086/physzool.60.2.30158646; SOMERO GN, 1980, PHYSIOL ZOOL, V53, P322, DOI 10.1086/physzool.53.3.30155794; Stackley KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025652; Steele SL, 2014, TRANSL RES, V163, P79, DOI 10.1016/j.trsl.2013.08.008; Weibel ER, 2005, J EXP BIOL, V208, P1635, DOI 10.1242/jeb.01548; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; West GB, 2002, P NATL ACAD SCI USA, V99, P2473, DOI 10.1073/pnas.012579799; White CR, 2005, J EXP BIOL, V208, P1611, DOI 10.1242/jeb.01501; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; Zar J. H., 1984, BIOSTAT ANAL, V2, P292; Zupanc GKH, 2005, J COMP NEUROL, V488, P290, DOI 10.1002/cne.20571	46	17	17	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137710	10.1371/journal.pone.0137710	http://dx.doi.org/10.1371/journal.pone.0137710			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368567	gold, Green Published, Green Submitted			2022-12-27	WOS:000361601100115
J	Wernerehl, RW; Givnish, TJ				Wernerehl, Robert W.; Givnish, Thomas J.			Relative Roles of Soil Moisture, Nutrient Supply, Depth, and Mechanical Impedance in Determining Composition and Structure of Wisconsin Prairies	PLOS ONE			English	Article							CARBON-ISOTOPE DISCRIMINATION; RAINFALL GRADIENT; GRASSLAND ECOSYSTEM; TALLGRASS PRAIRIE; ROOT ELONGATION; WATER-STRESS; PLANTS; LEAF; PATTERNS; CLIMATE	Ecologists have long classified Midwestern prairies based on compositional variation assumed to reflect local gradients in moisture availability. The best known classification is based on Curtis' continuum index (CI), calculated using the presence of indicator species thought centered on different portions of an underlying moisture gradient. Direct evidence of the extent to which CI reflects differences in moisture availability has been lacking, however. Many factors that increase moisture availability (e.g., soil depth, silt content) also increase nutrient supply and decrease soil mechanical impedance; the ecological effects of the last have rarely been considered in any ecosystem. Decreased soil mechanical impedance should increase the availability of soil moisture and nutrients by reducing the root costs of retrieving both. Here we assess the relative importance of soil moisture, nutrient supply, and mechanical impedance in determining prairie composition and structure. We used leaf delta C-13 of C-3 plants as a measure of growing-season moisture availability, cation exchange capacity (CEC) x soil depth as a measure of mineral nutrient availability, and penetrometer data as a measure of soil mechanical impedance. Community composition and structure were assessed in 17 remnant prairies in Wisconsin which vary little in annual precipitation. Ordination and regression analyses showed that delta C-13 increased with CI toward "drier" sites, and decreased with soil depth and% silt content. Variation in delta C-13 among remnants was 2.0 parts per thousand, comparable to that along continental gradients from ca. 500-1500 mm annual rainfall. As predicted, LAI and average leaf height increased significantly toward "wetter" sites. CI accounted for 54% of compositional variance but delta C-13 accounted for only 6.2%, despite the strong relationships of delta C-13 to CI and CI to composition. Compositional variation reflects soil fertility and mechanical impedance more than moisture availability. This study is the first to quantify the effects of soil mechanical impedance on community ecology.	[Wernerehl, Robert W.] Massachusetts State Botanist, Nat Heritage & Endangered Species Program, Westborough, MA 01581 USA; [Givnish, Thomas J.] Univ Wisconsin, Dept Bot, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison	Wernerehl, RW (corresponding author), Massachusetts State Botanist, Nat Heritage & Endangered Species Program, Westborough, MA 01581 USA.	robert.wernerehl@state.ma.us			Hertel Gift Fund of the University of Wisconsin-Madison; Davis Fund of the UW-Madison Department of Botany	Hertel Gift Fund of the University of Wisconsin-Madison; Davis Fund of the UW-Madison Department of Botany	Support was provided by the Hertel Gift Fund of the University of Wisconsin-Madison and the Davis Fund of the UW-Madison Department of Botany.	ANDERSON RC, 1984, OECOLOGIA, V64, P111, DOI 10.1007/BF00377552; [Anonymous], 2015, PC ORD MULTIVARIATE; Bengough AG, 2011, J EXP BOT, V62, P59, DOI 10.1093/jxb/erq350; Bowling DR, 2002, OECOLOGIA, V131, P113, DOI 10.1007/s00442-001-0851-y; BRIGGS JM, 1995, AM J BOT, V82, P1024, DOI 10.2307/2446232; Carr SC, 2009, J BIOGEOGR, V36, P1600, DOI 10.1111/j.1365-2699.2009.02085.x; Casper BB, 2012, OECOLOGIA, V169, P85, DOI 10.1007/s00442-011-2183-x; COMSTOCK JP, 1992, P NATL ACAD SCI USA, V89, P7747, DOI 10.1073/pnas.89.16.7747; Corbett E, 2006, J TORREY BOT SOC, V133, P267, DOI 10.3159/1095-5674(2006)133[267:LAOIAW]2.0.CO;2; CURTIS JT, 1949, ECOLOGY, V30, P83, DOI 10.2307/1932279; CURTIS JT, 1955, ECOLOGY, V36, P558, DOI 10.2307/1931295; Curtis JT, 1959, VEGETATION WISCONSIN; DAWSON TE, 1993, ECOLOGY, V74, P798, DOI 10.2307/1940807; Devices Decagon, 2008, ACCUPAR PAR LAI CEPT; Di Luzio M, 2008, J APPL METEOROL CLIM, V47, P475, DOI 10.1175/2007JAMC1356.1; Diefendorf AF, 2010, P NATL ACAD SCI USA, V107, P5738, DOI 10.1073/pnas.0910513107; Dybzinski R, 2007, AM NAT, V170, P305, DOI 10.1086/519857; EHLERINGER JR, 1988, OECOLOGIA, V76, P562, DOI 10.1007/BF00397870; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; Fay PA, 2000, ECOSYSTEMS, V3, P308, DOI 10.1007/s100210000028; Fay PA, 2008, GLOBAL CHANGE BIOL, V14, P1600, DOI 10.1111/j.1365-2486.2008.01605.x; Flanagan LB, 1997, OECOLOGIA, V111, P481, DOI 10.1007/s004420050261; Givnish TJ, 2014, ECOLOGY, V95, P2991, DOI 10.1890/14-0240.1; Givnish Thomas J., 1995, P3, DOI 10.1016/B978-012276460-8/50003-5; GIVNISH TJ, 1982, AM NAT, V120, P353, DOI 10.1086/283995; Gonfiantini R., 1995, REFERENCE INTERCOMPA, P13, DOI DOI 10.1029/2001JD001156; Grace JB., 2015, STRUCTURAL EQUATION; Guix-Herard N, 2007, EUR J AGRON, V27, P187, DOI 10.1016/j.eja.2007.03.005; Hartman G, 2010, OECOLOGIA, V162, P837, DOI 10.1007/s00442-009-1514-7; Henderson RA, 1998, PLANT SPECIES COMPOS; Hopkins E., 2009, TEMPERATURE PRECIPIT; Howe HF, 2006, ECOLOGY, V87, P3007, DOI 10.1890/0012-9658(2006)87[3007:MADEOM]2.0.CO;2; Knapp AK, 2004, FRONT ECOL ENVIRON, V2, P483, DOI 10.1890/1540-9295(2004)002[0483:GIETNA]2.0.CO;2; KNIGHT DH, 1965, ECOLOGY, V46, P744, DOI 10.2307/1935018; Kohn MJ, 2010, P NATL ACAD SCI USA, V107, P19691, DOI 10.1073/pnas.1004933107; Lai CT, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006436; Leach MK, 1996, SCIENCE, V273, P1555, DOI 10.1126/science.273.5281.1555; Leng X, 2013, J VEG SCI, V24, P138, DOI 10.1111/j.1654-1103.2012.01439.x; Mckenzie BM, 2013, PLANT CELL ENVIRON, V36, P1085, DOI 10.1111/pce.12037; MCNULTY SG, 1995, ECOLOGY, V76, P1581, DOI 10.2307/1938159; Miller JM, 2001, FUNCT ECOL, V15, P222, DOI 10.1046/j.1365-2435.2001.00508.x; Mueller KE, 2013, GLOBAL CHANGE BIOL, V19, P1249, DOI 10.1111/gcb.12096; NELSON DC, 1983, AM MIDL NAT, V109, P367, DOI 10.2307/2425417; Nippert JB, 2007, OECOLOGIA, V153, P261, DOI 10.1007/s00442-007-0745-8; Nippert JB, 2007, ENVIRON EXP BOT, V60, P412, DOI 10.1016/j.envexpbot.2006.12.012; Nippert JB, 2012, PLANT SOIL, V355, P385, DOI 10.1007/s11104-011-1112-4; Nippert JB, 2009, ACTA OECOL, V35, P400, DOI 10.1016/j.actao.2009.01.010; Partch ML, 1949, THESIS U WISCONSIN M; Partch ML, 1962, MINN ACAD SCI, V30, P38; PEET R K, 1988, P233; Peters J, 2013, WISCONSIN PROCEDURES; Prentice IC, 2011, NEW PHYTOL, V190, P169, DOI 10.1111/j.1469-8137.2010.03579.x; Santesteban LG, 2014, ACTA HORTIC, V1038, P677, DOI 10.17660/ActaHortic.2014.1038.86; Schulze ED, 1998, AUST J PLANT PHYSIOL, V25, P413, DOI 10.1071/PP97113; Schulze ED, 2006, TREE PHYSIOL, V26, P479, DOI 10.1093/treephys/26.4.479; Sherry RA, 2008, GLOBAL CHANGE BIOL, V14, P2923, DOI 10.1111/j.1365-2486.2008.01703.x; STEWART GR, 1995, AUST J PLANT PHYSIOL, V22, P51, DOI 10.1071/PP9950051; TILMAN D, 1988; Tracy SR, 2012, ANN BOT-LONDON, V110, P511, DOI 10.1093/aob/mcs031; Turner CL, 1997, ECOLOGY, V78, P1832, DOI 10.1890/0012-9658(1997)078[1832:SNAPRT]2.0.CO;2; Turner NC, 2008, PHYSIOL PLANTARUM, V132, P440, DOI 10.1111/j.1399-3054.2007.01027.x; UMBANHOWAR CE, 1992, AM MIDL NAT, V127, P268, DOI 10.2307/2426533; Valentine TA, 2012, ANN BOT-LONDON, V110, P259, DOI 10.1093/aob/mcs118; Vereecken H, 2008, WATER RESOUR RES, V44, DOI 10.1029/2008WR006829; von Fischer JC, 2008, GLOBAL CHANGE BIOL, V14, P1141, DOI 10.1111/j.1365-2486.2008.01552.x; Wang N, 2013, PLANT BIOLOGY, V15, P144, DOI 10.1111/j.1438-8677.2012.00605.x; Warren JM, 2011, OECOLOGIA, V166, P899, DOI 10.1007/s00442-011-1953-9; Weng ES, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000539; WHITE JA, 1984, VEGETATIO, V57, P65, DOI 10.1007/BF00047300	70	11	11	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137963	10.1371/journal.pone.0137963	http://dx.doi.org/10.1371/journal.pone.0137963			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368936	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100187
J	Westrop, GD; Williams, RAM; Wang, LJ; Zhang, T; Watson, DG; Silva, AM; Coombs, GH				Westrop, Gareth D.; Williams, Roderick A. M.; Wang, Lijie; Zhang, Tong; Watson, David G.; Silva, Ana Marta; Coombs, Graham H.			Metabolomic Analyses of Leishmania Reveal Multiple Species Differences and Large Differences in Amino Acid Metabolism	PLOS ONE			English	Article							INTERACTION LIQUID-CHROMATOGRAPHY; GLOBAL BIOCHEMICAL APPROACH; MASS-SPECTROMETRY; INDOLEAMINE 2,3-DIOXYGENASE; VISCERAL LEISHMANIASIS; TRYPTOPHAN CATABOLISM; PROTOZOAN PARASITE; OSMOTIC-STRESS; HOST IMMUNITY; DONOVANI	Comparative genomic analyses of Leishmania species have revealed relatively minor heterogeneity amongst recognised housekeeping genes and yet the species cause distinct infections and pathogenesis in their mammalian hosts. To gain greater information on the biochemical variation between species, and insights into possible metabolic mechanisms underpinning visceral and cutaneous leishmaniasis, we have undertaken in this study a comparative analysis of the metabolomes of promastigotes of L. donovani, L. major and L. mexicana. The analysis revealed 64 metabolites with confirmed identity differing 3-fold or more between the cell extracts of species, with 161 putatively identified metabolites differing similarly. Analysis of the media from cultures revealed an at least 3-fold difference in use or excretion of 43 metabolites of confirmed identity and 87 putatively identified metabolites that differed to a similar extent. Strikingly large differences were detected in their extent of amino acid use and metabolism, especially for tryptophan, aspartate, arginine and proline. Major pathways of tryptophan and arginine catabolism were shown to be to indole-3-lactate and arginic acid, respectively, which were excreted. The data presented provide clear evidence on the value of global metabolomic analyses in detecting species-specific metabolic features, thus application of this technology should be a major contributor to gaining greater understanding of how pathogens are adapted to infecting their hosts.	[Westrop, Gareth D.; Williams, Roderick A. M.; Wang, Lijie; Zhang, Tong; Watson, David G.; Silva, Ana Marta; Coombs, Graham H.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Williams, Roderick A. M.] Univ West Scotland, Inst Biomed & Environm Hlth Res, Paisley, Renfrew, Scotland; [Silva, Ana Marta] Univ Porto, Inst Biol Mol & Celular, P-4100 Porto, Portugal	University of Strathclyde; University of West Scotland; Universidade do Porto	Coombs, GH (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland.	graham.coombs@strath.ac.uk	Williams, Roderick/V-4317-2019; Silva, Ana/J-5017-2013	Williams, Roderick/0000-0001-5065-9768; Silva, Ana/0000-0002-1840-1473; Westrop, Gareth/0000-0002-8011-6219	Scottish Universities Life Sciences Alliance (SULSA)	Scottish Universities Life Sciences Alliance (SULSA)	This work was funded by the Scottish Universities Life Sciences Alliance (SULSA; www.sulsa.ac.uk) to DGW and GHC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu NK, 1997, FEMS MICROBIOL LETT, V156, P43, DOI 10.1016/S0378-1097(97)00401-1; Berg M, 2013, MOL MICROBIOL, V90, P428, DOI 10.1111/mmi.12374; Blum JJ, 1996, BIOL CELL, V87, P9, DOI 10.1016/S0248-4900(97)89833-4; Bringaud F, 2012, FRONT BIOSCI-LANDMRK, V17, P349, DOI 10.2741/3931; Burchmore RJS, 2001, INT J PARASITOL, V31, P1311, DOI 10.1016/S0020-7519(01)00259-4; Creek DJ, 2012, BIOINFORMATICS, V28, P1048, DOI 10.1093/bioinformatics/bts069; Creek DJ, 2012, MOL BIOCHEM PARASIT, V181, P73, DOI 10.1016/j.molbiopara.2011.10.003; Creek DJ, 2011, ANAL CHEM, V83, P8703, DOI 10.1021/ac2021823; Depledge DP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000476; Divanovic S, 2012, J INFECT DIS, V205, P152, DOI 10.1093/infdis/jir621; Donovan MJ, 2012, PARASITE IMMUNOL, V34, P464, DOI 10.1111/j.1365-3024.2012.01380.x; Downing T, 2012, INFECT GENET EVOL, V12, P149, DOI 10.1016/j.meegid.2011.11.005; Downing T, 2011, GENOME RES, V21, P2143, DOI 10.1101/gr.123430.111; Gazanion E, 2011, MOL MICROBIOL, V82, P21, DOI 10.1111/j.1365-2958.2011.07799.x; Genestra M, 2003, MED MICROBIOL IMMUN, V192, P217, DOI 10.1007/s00430-003-0176-z; Genestra M, 2006, ARCH MICROBIOL, V185, P348, DOI 10.1007/s00203-006-0105-9; Ginger ML, 2000, EUR J BIOCHEM, V267, P2555, DOI 10.1046/j.1432-1327.2000.01261.x; GREEN SJ, 1990, J IMMUNOL, V144, P278; Grohmann U, 2010, IMMUNOL REV, V236, P243, DOI 10.1111/j.1600-065X.2010.00915.x; Inbar E, 2013, BIOCHEM J, V449, P555, DOI 10.1042/BJ20121262; Jankevics A, 2012, METABOLOMICS, V8, pS29, DOI 10.1007/s11306-011-0341-0; Kaddurah-Daouk R, 2008, ANNU REV PHARMACOL, V48, P653, DOI 10.1146/annurev.pharmtox.48.113006.094715; Kaddurah-Daouk R, 2009, NEUROPSYCHOPHARMACOL, V34, P173, DOI 10.1038/npp.2008.174; Kamleh A, 2008, RAPID COMMUN MASS SP, V22, P1912, DOI 10.1002/rcm.3564; Kedzierski L, 2010, J GLOB INFECT DIS, V2, P177, DOI 10.4103/0974-777X.62881; Kloehn J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004683; LEELAYOOVA S, 1992, J PROTOZOOL, V39, P350, DOI 10.1111/j.1550-7408.1992.tb01329.x; Leroux A, 2006, MOL BIOCHEM PARASIT, V149, P74, DOI 10.1016/j.molbiopara.2006.04.010; Liu X, 2009, CURR CANCER DRUG TAR, V9, P938, DOI 10.2174/156800909790192374; Liu XD, 2010, BLOOD, V115, P3520, DOI 10.1182/blood-2009-09-246124; Lye LF, 2011, MOL BIOCHEM PARASIT, V175, P58, DOI 10.1016/j.molbiopara.2010.09.004; Makala LHC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-5; Makala LHC, 2011, J INFECT DIS, V203, P715, DOI 10.1093/infdis/jiq095; McConville MJ, 2007, TRENDS PARASITOL, V23, P368, DOI 10.1016/j.pt.2007.06.009; McConville MJ, 2011, ANNU REV MICROBIOL, V65, P543, DOI 10.1146/annurev-micro-090110-102913; MCCONVILLE MJ, 1992, EMBO J, V11, P3593, DOI 10.1002/j.1460-2075.1992.tb05443.x; McGaha TL, 2012, IMMUNOL REV, V249, P135, DOI 10.1111/j.1600-065X.2012.01149.x; Mellor AL, 2003, J IMMUNOL, V170, P5809, DOI 10.4049/jimmunol.170.12.5809; Mieulet V, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000934; Moffett JR, 2003, IMMUNOL CELL BIOL, V81, P247, DOI 10.1046/j.1440-1711.2003.t01-1-01177.x; Moreno MA, 2014, INT J PARASITOL-DRUG, V4, P347, DOI 10.1016/j.ijpddr.2014.06.001; Munder M, 2009, EUR J IMMUNOL, V39, P2161, DOI 10.1002/eji.200839041; Nowicki C, 2008, COMP BIOCHEM PHYS A, V151, P381, DOI 10.1016/j.cbpa.2007.03.010; Opperdoes FR, 2007, TRENDS PARASITOL, V23, P149, DOI 10.1016/j.pt.2007.02.004; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Pearson RD, 1996, CLIN INFECT DIS, V22, P1, DOI 10.1093/clinids/22.1.1; Rijal S, 2007, MICROBES INFECT, V9, P529, DOI 10.1016/j.micinf.2007.01.009; Rogers MB, 2011, GENOME RES, V21, P2129, DOI 10.1101/gr.122945.111; Rojas-Bernabe A, 2014, PARASITOLOGY, V141, P788, DOI 10.1017/S0031182013002187; Rosenzweig D, 2008, FASEB J, V22, P590, DOI 10.1096/fj.07-9254com; SACKS DL, 1995, J EXP MED, V181, P685, DOI 10.1084/jem.181.2.685; Saunders EC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003888; Saunders EC, 2011, J BIOL CHEM, V286, P27706, DOI 10.1074/jbc.M110.213553; Saunders EC, 2010, PARASITOLOGY, V137, P1303, DOI 10.1017/S0031182010000077; Scheltema RA, 2011, ANAL CHEM, V83, P2786, DOI 10.1021/ac2000994; Scott DA, 2008, J BIOL CHEM, V283, P155, DOI 10.1074/jbc.M708014200; Silva AM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001451; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Szkop M, 2012, FOLIA MICROBIOL, V57, P1, DOI 10.1007/s12223-011-0089-y; t'Kindt R, 2010, ANAL BIOANAL CHEM, V398, P2059, DOI 10.1007/s00216-010-4139-0; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; tKindt R, 2010, PLOS NEGLECT TROP D, V4, P11; Vieira LL, 1996, BIOCHEM J, V319, P691, DOI 10.1042/bj3190691; Vincent IM, 2015, J BIOMOL SCREEN, V20, P44, DOI 10.1177/1087057114551519; Vincent IM, 2014, INT J PARASITOL-DRUG, V4, P20, DOI 10.1016/j.ijpddr.2013.11.002; Vouldoukis I, 1996, ANTIMICROB AGENTS CH, V40, P253, DOI 10.1128/AAC.40.1.253; Wanasen N, 2008, IMMUNOL RES, V41, P15, DOI 10.1007/s12026-007-8012-y; Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002; Xu H, 2008, IMMUNOL LETT, V121, P1, DOI 10.1016/j.imlet.2008.08.008; Zhang R, 2014, J CHROMATOGR A, V1362, P168, DOI 10.1016/j.chroma.2014.08.039; Zhang T, 2012, ANAL CHEM, V84, P1994, DOI 10.1021/ac2030738; Zhang WW, 2010, MOL MICROBIOL, V77, P505, DOI 10.1111/j.1365-2958.2010.07230.x; Zhang WW, 2003, J BIOL CHEM, V278, P35508, DOI 10.1074/jbc.M305030200; Zhang YJJ, 2013, CELL, V155, P1296, DOI 10.1016/j.cell.2013.10.045; Zhang YJJ, 2013, CELL MICROBIOL, V15, P1079, DOI 10.1111/cmi.12140	75	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136891	10.1371/journal.pone.0136891	http://dx.doi.org/10.1371/journal.pone.0136891			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368322	Green Accepted, Green Published, gold			2022-12-27	WOS:000361601100030
J	Wood, SW; Prior, LD; Stephens, HC; Bowman, DMJS				Wood, Sam W.; Prior, Lynda D.; Stephens, Helen C.; Bowman, David M. J. S.			Macroecology of Australian Tall Eucalypt Forests: Baseline Data from a Continental-Scale Permanent Plot Network	PLOS ONE			English	Article							TREE MORTALITY-RATES; CLIMATE-CHANGE; CARBON STOCKS; GLOBAL-CHANGE; FIRE; TEMPERATE; DROUGHT; BIOMASS; GROWTH; WORLDS	Tracking the response of forest ecosystems to climate change demands large (>= 1 ha) monitoring plots that are repeatedly measured over long time frames and arranged across macro-ecological gradients. Continental scale networks of permanent forest plots have identified links between climate and carbon fluxes by monitoring trends in tree growth, mortality and recruitment. The relationship between tree growth and climate in Australia has been recently articulated through analysis of data from smaller forest plots, but conclusions were limited by (a) absence of data on recruitment and mortality, (b) exclusion of non-eucalypt species, and (c) lack of knowledge of stand age or disturbance histories. To remedy these gaps we established the Ausplots Forest Monitoring Network: a continental scale network of 48 1 ha permanent plots in highly productive tall eucalypt forests in the mature growth stage. These plots are distributed across cool temperate, Mediterranean, subtropical and tropical climates (mean annual precipitation 850 to 1900 mm per year; mean annual temperature 6 to 21 degrees C). Aboveground carbon stocks (AGC) in these forests are dominated by eucalypts (90% of AGC) whilst non-eucalypts in the understorey dominated species diversity and tree abundance (84% of species; 60% of stems). Aboveground carbon stocks were negatively related to mean annual temperature, with forests at the warm end of the temperature range storing approximately half the amount of carbon as forests at the cool end of the temperature range. This may reflect thermal constraints on tree growth detected through other plot networks and physiological studies. Through common protocols and careful sampling design, the Ausplots Forest Monitoring Network will facilitate the integration of tall eucalypt forests into established global forest monitoring initiatives. In the context of projections of rapidly warming and drying climates in Australia, this plot network will enable detection of links between climate and growth, mortality and carbon dynamics of eucalypt forests.	[Wood, Sam W.; Prior, Lynda D.; Stephens, Helen C.; Bowman, David M. J. S.] Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia; [Wood, Sam W.; Stephens, Helen C.; Bowman, David M. J. S.] Terr Ecosyst Res Network, Brisbane, Qld, Australia	University of Tasmania	Wood, SW (corresponding author), Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia.	swwood@utas.edu.au	Bowman, David M.J.S./A-2930-2011; Prior, Lynda/A-7460-2012	Bowman, David M.J.S./0000-0001-8075-124X; Prior, Lynda/0000-0002-5511-2320; Stephens, Helen/0000-0001-8112-3931	Terrestrial Ecosystem Research Network (TERN)	Terrestrial Ecosystem Research Network (TERN)	The establishment of the Ausplots Forest Monitoring Network was funded by the Terrestrial Ecosystem Research Network (TERN; www.tern.org.au). All authors involved in the study design, data collection, data analysis and manuscript preparation were supported by TERN.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anderegg WRL, 2013, NAT CLIM CHANGE, V3, P30, DOI 10.1038/nclimate1635; Ashton D.H., 1994, AUSTR VEGETATION, P157; ATTIWILL PM, 1994, FOREST ECOL MANAG, V63, P247, DOI 10.1016/0378-1127(94)90114-7; Bond-Lamberty B, 2007, NATURE, V450, P89, DOI 10.1038/nature06272; Bond-Lamberty B, 2014, GLOBAL CHANGE BIOL, V20, P216, DOI 10.1111/gcb.12404; Bowman DMJS, 2014, GLOBAL ECOL BIOGEOGR, V23, P925, DOI 10.1111/geb.12171; Bowman DMJS, 2014, GLOBAL CHANGE BIOL, V20, P1008, DOI 10.1111/gcb.12433; Bradford MG, 2014, J TROP FOR SCI, V26, P543; Bradshaw F. J., 1997, Australian Forestry, V60, P178; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Brouwers N, 2013, LANDSCAPE ECOL, V28, P69, DOI 10.1007/s10980-012-9815-3; BURGMAN MA, 1994, FOREST ECOL MANAG, V67, P319, DOI 10.1016/0378-1127(94)90026-4; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Butt N, 2013, ECOL EVOL, V3, P5011, DOI 10.1002/ece3.873; Cochrane MA, 2008, AMBIO, V37, P522, DOI 10.1579/0044-7447-37.7.522; Condit R, 2014, FOREST ECOL MANAG, V316, P21, DOI 10.1016/j.foreco.2013.09.011; Crous KY, 2013, GLOBAL CHANGE BIOL, V19, P3790, DOI 10.1111/gcb.12314; Cruz MG, 2012, FOREST ECOL MANAG, V284, P269, DOI 10.1016/j.foreco.2012.02.035; Curtis JT, 1959, VEGETATION WISCONSIN; Dean C, 2012, PLANT BIOSYST, V146, P223, DOI 10.1080/11263504.2011.638332; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Fahey TJ, 2010, FRONT ECOL ENVIRON, V8, P245, DOI 10.1890/080169; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Fedrigo M, 2014, FOREST ECOL MANAG, V334, P129, DOI 10.1016/j.foreco.2014.08.025; Florence R., 1996, ECOLOGY SILVICULTURE, DOI DOI 10.1071/9780643100893; Getzin S, 2006, ECOGRAPHY, V29, P671, DOI 10.1111/j.2006.0906-7590.04675.x; Haberle SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097925; Hammill KA, 2006, INT J WILDLAND FIRE, V15, P213, DOI 10.1071/WF05051; Harrington Graham N., 2000, Proceedings of the Royal Society of Queensland, V109, P59; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Horton BM, 2013, FOREST ECOL MANAG, V302, P329, DOI 10.1016/j.foreco.2013.04.006; Hughes L, 1996, GLOBAL ECOL BIOGEOGR, V5, P128, DOI 10.2307/2997395; Hutchinson M, 2014, ANUCLIM VERSION 6 1; Hutchinson MF, 2005, GLOBAL ECOL BIOGEOGR, V14, P197, DOI [10.1111/j.1466-822X.2005.00154.x, 10.1111/j.1466-822x.2005.00154.x]; Illian J, 2008, STAT ANAL MODELLING; Keith H, 2000, REV ALLOMETRIC RELAT; Keith H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107126; Keith H, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00051.1; Keith H, 2010, GLOBAL CHANGE BIOL, V16, P2971, DOI 10.1111/j.1365-2486.2009.02146.x; Keith H, 2009, P NATL ACAD SCI USA, V106, P11635, DOI 10.1073/pnas.0901970106; Kirkpatrick J.B., 1988, WET EUCALYPT FORESTS; Lewis SL, 2011, SCIENCE, V331, P554, DOI 10.1126/science.1200807; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Lewis SL, 2004, PHILOS T R SOC B, V359, P437, DOI 10.1098/rstb.2003.1432; Lindenmayer D, 2009, FOREST PATTERN AND ECOLOGICAL PROCESS: A SYNTHESIS OF 25 YEARS OF RESEARCH, P1; Lindenmayer DB, 2010, EFFECTIVE ECOLOGICAL MONITORING, P1; Liu YC, 2014, GLOBAL ECOL BIOGEOGR, V23, P323, DOI 10.1111/geb.12113; Lutz JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036131; Malhi Y, 2002, J VEG SCI, V13, P439, DOI 10.1111/j.1654-1103.2002.tb02068.x; Malhi Y, 2004, GLOBAL CHANGE BIOL, V10, P563, DOI 10.1111/j.1529-8817.2003.00778.x; Marthews T., 2012, MEASURING TROPICAL F; Matusick G, 2013, EUR J FOREST RES, V132, P497, DOI 10.1007/s10342-013-0690-5; May B., 2012, TASMANIAN FOREST CAR; Monserud RA, 1996, FOREST ECOL MANAG, V80, P57, DOI 10.1016/0378-1127(95)03638-5; Montreal Process Implementation Group for Australia and National Forest Inventory Steering Committee, 2013, AUSTR STAT FOR REP 2; Mueller-Dombois D., 1974, AIMS METHODS VEGETAT; Murphy S., 2014, VALIDATING ABOVE GRO; Pan YD, 2013, ANNU REV ECOL EVOL S, V44, P593, DOI 10.1146/annurev-ecolsys-110512-135914; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Peng CH, 2011, NAT CLIM CHANGE, V1, P467, DOI 10.1038/NCLIMATE1293; Phillips O., 2009, RAINFOR FIELD MANUAL; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; Phillips OL, 2008, PHILOS T R SOC B, V363, P1819, DOI 10.1098/rstb.2007.0033; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Popescu SC, 2011, PHOTOGRAMM ENG REM S, V77, P217; Popkin G, 2015, NATURE, V523, P20, DOI 10.1038/523020a; Prior L.D., 2011, USING PERMANENT FORE; PRIOR LD, 2014, FRONT PLANT SCI, V5; Prior LD, 2014, GLOBAL CHANGE BIOL, V20, P2793, DOI 10.1111/gcb.12540; Raich JW, 2006, ECOLOGY, V87, P76, DOI 10.1890/05-0023; Sileshi GW, 2014, FOREST ECOL MANAG, V329, P237, DOI 10.1016/j.foreco.2014.06.026; Sillett SC, 2010, FOREST ECOL MANAG, V259, P976, DOI 10.1016/j.foreco.2009.12.003; Stegen JC, 2011, GLOBAL ECOL BIOGEOGR, V20, P744, DOI 10.1111/j.1466-8238.2010.00645.x; Tng DYP, 2012, NEW PHYTOL, V196, P1001, DOI 10.1111/j.1469-8137.2012.04359.x; Tng DYP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084378; Turner PAM, 2009, FOREST ECOL MANAG, V258, P366, DOI 10.1016/j.foreco.2009.04.021; van Mantgem PJ, 2007, ECOL LETT, V10, P909, DOI 10.1111/j.1461-0248.2007.01080.x; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; Vertessy RA, 1996, TREE PHYSIOL, V16, P221; Weiskittel AR, 2011, FOREST GROWTH AND YIELD MODELING, P1, DOI 10.1002/9781119998518; Wiegand T., 2013, HDB SPATIAL POINT PA; Williams AP, 2013, NAT CLIM CHANGE, V3, P292, DOI [10.1038/nclimate1693, 10.1038/NCLIMATE1693]; Williams J. E., 1997, EUCALYPT ECOLOGY IND; Williamson G, 2014, ENV CHANGE BIOL TOOL; Wood SW, 2010, FOREST ECOL MANAG, V260, P438, DOI 10.1016/j.foreco.2010.04.037; Wood SW, 2015, AUSPLOTS FOREST MONI; Wood SW, 2014, BIODIVERSITY ENV CHA, P531	88	25	26	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137811	10.1371/journal.pone.0137811	http://dx.doi.org/10.1371/journal.pone.0137811			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368919	Green Submitted, gold, Green Published			2022-12-27	WOS:000361601100145
J	Yang, CC; Tsai, WL; Su, WW; Huang, CF; Cheng, PN; Lo, CC; Tseng, KC; Mo, LR; Wang, CH; Hsu, SJ; Lai, HC; Su, CW; Liu, CJ; Peng, CY; Yu, ML				Yang, Chi-Chieh; Tsai, Wei-Lun; Su, Wei-Wen; Huang, Chung-Feng; Cheng, Pin-Nan; Lo, Ching-Chu; Tseng, Kuo-Chih; Mo, Lein-Ray; Wang, Chun-Hsiang; Hsu, Shih-Jer; Lai, Hsueh-Chou; Su, Chien-Wei; Liu, Chun-Jen; Peng, Cheng-Yuan; Yu, Ming-Lung			Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients	PLOS ONE			English	Article							INTERLEUKIN-28B GENETIC-VARIANTS; VIROLOGICAL RESPONSE; 1 INFECTION; THERAPY; SAFETY; ASSAY	The efficacy and safety of the boceprevir (BOC)-containing triple therapy in Taiwanese treatment-experienced patients remains elusive. After 4 weeks of peginterferon/ribavirin lead-in therapy, patients with cirrhosis or previous null-response received triple therapy for 44 weeks; whereas others received 32 weeks of triple therapy followed by 12 weeks of peginterferon/ribavirin therapy. Patients with HCV RNA > 100 IU/mL at week 12 or with detectable HCV RNA at week 24 of treatment were viewed as futile. A total of 123 patients received treatment. The rates of sustained virological response (SVR) and relapse were 66.7% and 8.9%, respectively by using intention-to-treat analysis. Multivariate analysis revealed that factors associated with SVR included HCV-1b (odds ratio [OR]/95% confidence intervals [CI]: 19.23/1.76-525.15, P = 0.01), BOC adherence (7.69/1.55-48.78, P = 0.01), serum albumin (OR/CI: 6.25/1.14-40.07, P = 0.03) levels and HCV RNA levels (OR/CI: 0.34/0.12-0.79, P = 0.01). Twenty-six (21.1%) patients experienced severe adverse events (SAEs). Multivariate analysis revealed that APRI > 1.5 was the single factor associated with occurring SAEs (OR/CI: 3.77/0.97-14.98, P = 0.05). Merging the cut-off values of HCV RNA > 7 log IU/mL at baseline and HCV RNA > 6 log IU/mL at week 4 provided the earliest and best combing viral kinetics in predicting week 12/24 futility with the PPV of 100% and accuracy of 93.5%. HCV-1 treatment experienced Taiwanese patients treated with boceprevir-containing triple therapy in real world had comparable efficacy and safety profiles with those reported in clinical trials. Early viral kinetics before week 4 of treatment highly predicted futility at week 12 or 24 of treatment.	[Yang, Chi-Chieh] Show Chwan Mem Hosp, Div Gastroenterol, Dept Internal Med, Changhua, Taiwan; [Tsai, Wei-Lun] Kaohsiung Vet Gen Hosp, Div Gastroenterol, Dept Internal Med, Kaohsiung, Taiwan; [Tsai, Wei-Lun] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Su, Wei-Wen] Changhua Christian Hosp, Div Gastroenterol & Hepatol, Dept Internal Med, Changhua, Taiwan; [Huang, Chung-Feng; Yu, Ming-Lung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan; [Huang, Chung-Feng] Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung, Taiwan; [Huang, Chung-Feng] Kaohsiung Med Univ, Sch Med, Coll Med, Kaohsiung, Taiwan; [Cheng, Pin-Nan] Natl Cheng Kung Univ Hosp, Div Gastroenterol & Hepatol, Dept Internal Med, Tainan 70428, Taiwan; [Lo, Ching-Chu] St Martin De Porres Hosp, Div Gastroenterol, Dept Internal Med, Chiayi, Taiwan; [Lo, Ching-Chu] Natl Yang Ming Univ, Chung Jen Jr Coll Nursing, Hlth Sci & Management, Taipei 112, Taiwan; [Lo, Ching-Chu] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Tseng, Kuo-Chih] Buddhist Tzu Chi Med Fdn, Dept Internal Med, Dalin Tzu Chi Hosp, Chiayi, Taiwan; [Tseng, Kuo-Chih] Tzuchi Univ, Sch Med, Hualien, Taiwan; [Mo, Lein-Ray] E Da Hosp, Div Gastroenterol, Dept Internal Med, Kaohsiung, Taiwan; [Wang, Chun-Hsiang] Tainan Municipal Hosp, Dept Hepatogastroenterol, Tainan, Taiwan; [Hsu, Shih-Jer] Natl Taiwan Univ Hosp Yun Lin Branch, Dept Internal Med, Yunlin, Taiwan; [Lai, Hsueh-Chou] China Med Univ Hosp, Div Gastroenterol & Hepatol, Dept Internal Med, Taichung, Taiwan; [Lai, Hsueh-Chou] China Med Univ, Sch Chinese Med, Coll Chinese Med, Taichung, Taiwan; [Su, Chien-Wei] Taipei Vet Gen Hosp, Div Gastroenterol, Dept Med, Taipei, Taiwan; [Liu, Chun-Jen] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei 10764, Taiwan; [Liu, Chun-Jen] Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei, Taiwan; [Liu, Chun-Jen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Peng, Cheng-Yuan] China Med Univ Hosp, Div Hepatogastroenterol, Dept Internal Med, Taichung, Taiwan; [Peng, Cheng-Yuan] China Med Univ, Sch Med, Taichung, Taiwan; [Yu, Ming-Lung] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan	Show Chwan Memorial Hospital; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Changhua Christian Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; National Cheng Kung University; National Cheng Kung University Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; E-Da Hospital; National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Taipei Veterans General Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Sun Yat Sen University	Yu, ML (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan.	fish6069@gmail.com	Su, Chien-Wei/AHC-8307-2022; Yu, Ming-Lung/AAZ-4306-2020; su, wei/GZM-3986-2022	Su, Chien-Wei/0000-0003-3889-7004; Yu, Ming-Lung/0000-0001-8145-1900; LIU, CHUN-JEN/0000-0002-6202-0993				Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Gonzalez V, 2013, J CLIN VIROL, V58, P249, DOI 10.1016/j.jcv.2013.05.005; Gordon SC, 2013, ALIMENT PHARM THER, V38, P16, DOI 10.1111/apt.12342; Hezode C, 2014, GASTROENTEROLOGY, V147, P132, DOI 10.1053/j.gastro.2014.03.051; Hezode C, 2013, J HEPATOL, V59, P434, DOI 10.1016/j.jhep.2013.04.035; Huang CF, 2013, J GASTROEN HEPATOL, V28, P1515, DOI 10.1111/jgh.12211; Huang CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058882; Huang CF, 2013, J CLIN VIROL, V56, P293, DOI 10.1016/j.jcv.2012.11.015; Huang CF, 2012, ANTIVIR RES, V93, P239, DOI 10.1016/j.antiviral.2011.12.002; Huang CF, 2012, J HEPATOL, V56, P34, DOI 10.1016/j.jhep.2011.03.029; Jacobson IM, 2012, HEPATOLOGY, V56, P567, DOI 10.1002/hep.25865; Lok AS, 2014, J HEPATOL, V60, P490, DOI 10.1016/j.jhep.2013.10.019; Manns MP, 2014, LIVER INT, V34, P707, DOI 10.1111/liv.12300; Mutimer D, 2014, J HEPATOL, V60, P392, DOI 10.1016/j.jhep.2013.11.003; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Vermehren J, 2011, J CLIN VIROL, V52, P133, DOI 10.1016/j.jcv.2011.07.007; Vierling JM, 2014, J HEPATOL, V61, P200, DOI 10.1016/j.jhep.2014.03.022; Wedemeyer H, 2015, LANCET; Younossi ZM, 2014, J HEPATOL, V60, P530, DOI 10.1016/j.jhep.2013.11.009; Yu ML, 2008, HEPATOLOGY, V47, P1884, DOI 10.1002/hep.22319; Yu ML, 2007, GUT, V56, P553, DOI 10.1136/gut.2006.102558; Yu ML, 2006, HEPATOLOGY, V44, P1086, DOI 10.1002/hep.21363; Yu ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052048; Yu ML, 2011, HEPATOLOGY, V53, P7, DOI 10.1002/hep.23976	25	5	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137852	10.1371/journal.pone.0137852	http://dx.doi.org/10.1371/journal.pone.0137852			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368130	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100155
J	Espie, E; Sarr, FD; Diop, F; Faye, J; Richard, V; Tall, A; Balde, AT				Espie, Emmanuelle; Sarr, Fatoumata Diene; Diop, Fode; Faye, Joseph; Richard, Vincent; Tall, Adama; Balde, Aissatou Toure			Spatio-Temporal Variations in Malaria Incidence in Children Less than 10 Years Old, Health District of Sokone, Senegal, 2010-2013	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; CONTROLLED-TRIAL; VILLAGE LEVEL; TRANSMISSION; AREA; DISEASE	Introduction Malaria is a leading cause of morbidity and mortality in sub-Saharan Africa. Detailed characterization of the risks for malaria, among populations living in areas where the disease is endemic, is an important priority, especially for planning and evaluating future malaria-control tools. A prospective cohort study was implemented in children under ten years living in rural areas with high Plasmodium falciparum transmission in Senegal. Methods Malaria incidence was prospectively evaluated over three year follow-up among a cohort of children aged less than 10 years old living in eight villages of the Sokone health district. The parents of 1316 children comprising a passive case detection cohort were encouraged to seek care from the study health centers at any time their child felt sick. In the event of reported history of fever within 24 hours or measured axillary temperature >= 37.5 degrees C, a Rapid Diagnostic Test (RDT) was performed. Results From November 2010 to October 2013, among the 1468 reported febrile episodes, 264 were confirmed malaria episodes. Over the 3 years, 218 (16.9%) children experienced at least one clinical malaria episode. Cumulative malaria incidence was 7.3 episodes per 100 children-year at risk, with remarkably heterogeneous rates from 2.5 to 10.5 episodes per 100 children-year at risk. Clinical malaria prevalence ranged from 11.5 to 28.4% in the high transmission season versus from 9.6 to 21.2% in the low transmission season. Conclusion This longitudinal community-based study shows that occurrence of clinical malaria was not evenly distributed among all the cohort children in the eight villages. It demonstrates the complexity of spatial distribution of malaria incidence at a local level, even in a region of vegetation and altitudinal homogeneity.	[Espie, Emmanuelle; Sarr, Fatoumata Diene; Faye, Joseph; Richard, Vincent; Tall, Adama] Pasteur Inst Dakar, Epidemiol Unit, Dakar, Senegal; [Diop, Fode; Balde, Aissatou Toure] Pasteur Inst Dakar, Immunol Unit, Dakar, Senegal; [Diop, Fode] Univ Cheikh Anta Diop, Fac Sci & Technol, Lab Parasitol Biol, Dakar, Senegal	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; University Cheikh Anta Diop Dakar	Espie, E (corresponding author), Pasteur Inst Dakar, Epidemiol Unit, Dakar, Senegal.	emmanuelle.espie@gmail.com		Vincent, RICHARD/0000-0002-6961-1753	European and Developing Countries Clinical Trials Partnership (EDCTP) [CB.2007.41700.007]	European and Developing Countries Clinical Trials Partnership (EDCTP)	This work was supported by grant No CB.2007.41700.007 (Capacity building to prepare West African sites for clinical trials on HIV, TB and malaria) from European and Developing Countries Clinical Trials Partnership (EDCTP, http://www.edctp.org/) in the framework of West African Network of Excellence for TB, AIDS, and Malaria (WANETAM) awarded to ATB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Bloland PB, 1999, AM J TROP MED HYG, V60, P641, DOI 10.4269/ajtmh.1999.60.641; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; Giardina F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032625; Greenwood B, 2005, ACTA TROP, V95, P298, DOI 10.1016/j.actatropica.2005.04.017; Greenwood B.M., 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene, V83, P25, DOI 10.1016/0035-9203(89)90599-3; Kreuels B, 2008, J INFECT DIS, V197, P85, DOI 10.1086/524066; LINDSAY SW, 1990, ANN TROP MED PARASIT, V84, P553, DOI 10.1080/00034983.1990.11812510; Miiro GM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-258; Mirghani SE, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-172; Ndiaye S., 2009, ENQUETE NATL PALUDIS; Niang el HA, 2013, J TROP MED, V2013, DOI [10.1155/2013/907375, DOI 10.1155/2013/907375]; Roucher C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087169; Roucher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046188; Schellenberg D, 2005, LANCET, V365, P1481, DOI 10.1016/S0140-6736(05)66418-5; Trape JF, 2014, LANCET INFECT DIS, V14, P476, DOI DOI 10.1016/S1473-3099(14)70712-1; Wangdi K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-89; Wen L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-88; WHO, 2013, WHO GLOB MAL PROGR W; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Yeshiwondim AK, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-5	23	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137737	10.1371/journal.pone.0137737	http://dx.doi.org/10.1371/journal.pone.0137737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381623	Green Published, Green Submitted, gold			2022-12-27	WOS:000361790200035
J	Mamdani, M; Williamson, V; McMichael, GO; Blevins, T; Aliev, F; Adkins, A; Hack, L; Bigdeli, T; van der Vaart, AD; Web, BT; Bacanu, SA; Kalsi, G; Kendler, KS; Miles, MF; Dick, D; Riley, BP; Dumur, C; Vladimirov, VI				Mamdani, Mohammed; Williamson, Vernell; McMichael, Gowon O.; Blevins, Tana; Aliev, Fazil; Adkins, Amy; Hack, Laura; Bigdeli, Tim; van der Vaart, Andrew D.; Web, Bradley Todd; Bacanu, Silviu-Alin; Kalsi, Gursharan; Kendler, Kenneth S.; Miles, Michael F.; Dick, Danielle; Riley, Brien P.; Dumur, Catherine; Vladimirov, Vladimir I.		COGA Consortium	Integrating mRNA and miRNA Weighted Gene Co-Expression Networks with eQTLs in the Nucleus Accumbens of Subjects with Alcohol Dependence	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SET ENRICHMENT ANALYSIS; PREFRONTAL CORTEX; EPIGENETIC REGULATION; FRONTAL-CORTEX; ACUTE ETHANOL; USE DISORDERS; EXPRESSION; BRAIN; MICRORNAS	Alcohol consumption is known to lead to gene expression changes in the brain. After performing weighted gene co-expression network analyses (WGCNA) on genome-wide mRNA and microRNA (miRNA) expression in Nucleus Accumbens (NAc) of subjects with alcohol dependence (AD; N = 18) and of matched controls (N = 18), six mRNA and three miRNA modules significantly correlated with AD were identified (Bonferoni-adj. p <= 0.05). Cell-type-specific transcriptome analyses revealed two of the mRNA modules to be enriched for neuronal specific marker genes and downregulated in AD, whereas the remaining four mRNA modules were enriched for astrocyte and microglial specific marker genes and upregulated in AD. Gene set enrichment analysis demonstrated that neuronal specific modules were enriched for genes involved in oxidative phosphorylation, mitochondrial dysfunction and MAPK signaling. Glial-specific modules were predominantly enriched for genes involved in processes related to immune functions, i.e. cytokine signaling (all adj. p <= 0.05). In mRNA and miRNA modules, 461 and 25 candidate hub genes were identified, respectively. In contrast to the expected biological functions of miRNAs, correlation analyses between mRNA and miRNA hub genes revealed a higher number of positive than negative correlations (chi(2) test p <= 0.0001). Integration of hub gene expression with genome-wide genotypic data resulted in 591 mRNA cis-eQTLs and 62 miRNA cis-eQTLs. mRNA cis-eQTLs were significantly enriched for AD diagnosis and AD symptom counts (adj. p=0.014 and p=0.024, respectively) in AD GWAS signals in a large, independent genetic sample from the Collaborative Study on Genetics of Alcohol (COGA). In conclusion, our study identified putative gene network hubs coordinating mRNA and miRNA co-expression changes in the NAc of AD subjects, and our genetic (cis-eQTL) analysis provides novel insights into the etiological mechanisms of AD.	[Mamdani, Mohammed; Williamson, Vernell; McMichael, Gowon O.; Aliev, Fazil; Adkins, Amy; Hack, Laura; Bigdeli, Tim; Web, Bradley Todd; Bacanu, Silviu-Alin; Kendler, Kenneth S.; Miles, Michael F.; Dick, Danielle; Riley, Brien P.; Vladimirov, Vladimir I.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23284 USA; [Blevins, Tana; Dumur, Catherine] Virginia Commonwealth Univ, Dept Pathol, Richmond, VA USA; [Aliev, Fazil; Kendler, Kenneth S.; Dick, Danielle; Riley, Brien P.; Vladimirov, Vladimir I.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Kendler, Kenneth S.; Dick, Danielle; Riley, Brien P.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA USA; [van der Vaart, Andrew D.; Miles, Michael F.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA USA; [Dick, Danielle] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Vladimirov, Vladimir I.] Virginia Commonwealth Univ, Ctr Biomarker Res & Personalized Med, Richmond, VA USA; [Kalsi, Gursharan] Inst Psychiat, Dept Social Genet & Dev Psychiat, London SE5 8AF, England; [Vladimirov, Vladimir I.] Johns Hopkins Univ, Lieber Inst Brain Dev, Baltimore, MD USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; University of London; King's College London; Johns Hopkins University	Mamdani, M (corresponding author), Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23284 USA.	mamdanim@vcu.edu; vivladimirov@vcu.edu	Dumur, Catherine/AAH-9489-2020; Bigdeli, Tim B./AAX-7761-2020; Aliev, Fazil/D-7172-2013; Kendler, Kenneth/AAF-2876-2019; Webb, Bradley T/B-1459-2009; Rangaswamy, Madhavi/W-3197-2019	Bigdeli, Tim B./0000-0003-2215-5946; Aliev, Fazil/0000-0001-8357-4699; Webb, Bradley T/0000-0002-0576-5366; Rangaswamy, Madhavi/0000-0002-6140-889X; Reilly, Muredach/0000-0002-3035-9386; Nurnberger, John/0000-0002-7674-1767; Bacanu, Silviu-Alin/0000-0002-4364-1583; Kuperman, Samuel/0000-0002-5995-1981; Tischfield, Jay/0000-0003-3217-8287; Edenberg, Howard/0000-0003-0344-9690	NIH from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) [P50AA022537, P20AA017828, K02AA018755, 1R21AA022717, VIVU10AA008401]; National Institute on Drug Abuse (NIDA); National Institutes of Mental Health [5T32MH020030]; National Institute on Alcohol Abuse and Alcoholism; NIH GEI [U01HG004438]; NIH [HHSN268200782096C]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020634, K02AA018755, P50AA022537, P20AA017828, R21AA022717, U10AA008401, R21AA022749, R28AA012725] Funding Source: NIH RePORTER	NIH from the National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIH GEI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This national collaborative study is supported by NIH Grants P50AA022537 to KSK, MFM, BPR; P20AA017828 to KSK, MFM, BPR, VIV; K02AA018755 to DD; 1R21AA022717 to SAB, and VIVU10AA008401 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute on Drug Abuse (NIDA), and by grant 5T32MH020030 from the National Institutes of Mental Health to MM. Funding support for GWAS genotyping, which was performed at the Johns Hopkins University Center for Inherited Disease Research, was provided by the National Institute on Alcohol Abuse and Alcoholism, the NIH GEI (U01HG004438), and the NIH contract "High throughput genotyping for studying the genetic contributions to human disease" (HHSN268200782096C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho L, 2009, J NEUROSCI RES, V87, P2786, DOI 10.1002/jnr.22091; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Aroor AR, 2010, ALCOHOL CLIN EXP RES, V34, P1543, DOI 10.1111/j.1530-0277.2010.01239.x; Aroor AR, 2004, LIFE SCI, V74, P2339, DOI 10.1016/j.lfs.2003.11.001; Blednov YA, 2011, BRAIN BEHAV IMMUN, V25, pS92, DOI 10.1016/j.bbi.2011.01.008; Blednov YA, 2012, ADDICT BIOL, V17, P108, DOI 10.1111/j.1369-1600.2010.00284.x; Buckley ST, 2000, ANN NY ACAD SCI, V914, P58, DOI 10.1111/j.1749-6632.2000.tb05183.x; Chen C, 2013, MOL PSYCHIATR, V18, P1308, DOI 10.1038/mp.2012.146; Cheng C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001989; Chevyreva I, 2008, EXP MOL PATHOL, V84, P71, DOI 10.1016/j.yexmp.2007.08.019; Clarke C, 2011, J BIOTECHNOL, V155, P350, DOI 10.1016/j.jbiotec.2011.07.011; Cox NJ, 2012, CLIN PHARMACOL THER, V92, P425, DOI 10.1038/clpt.2012.115; Crews FT, 2011, BRAIN BEHAV IMMUN, V25, pS4, DOI 10.1016/j.bbi.2011.03.003; Crews FT, 2009, ALCOHOL ALCOHOLISM, V44, P115, DOI 10.1093/alcalc/agn079; Darcq E, 2015, MOL PSYCHIATR, V20, P1240, DOI 10.1038/mp.2014.120; Dumur CI, 2009, LARYNGOSCOPE, V119, P91, DOI 10.1002/lary.20005; Edenberg HJ, 2010, ALCOHOL CLIN EXP RES, V34, P840, DOI 10.1111/j.1530-0277.2010.01156.x; Eisenberger NI, 2010, BIOL PSYCHIAT, V68, P748, DOI 10.1016/j.biopsych.2010.06.010; Enoch M A, 2001, Curr Psychiatry Rep, V3, P144, DOI 10.1007/s11920-001-0012-3; Enright AJ, 2004, GENOME BIOL, V5; Eriksson AK, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-190; Fan L, 1999, ALCOHOL CLIN EXP RES, V23, P408, DOI 10.1111/j.1530-0277.1999.tb04130.x; Fan LI, 2004, ADDICT BIOL, V9, P11, DOI 10.1080/13556210410001674040; Farris SP, 2010, INT REV NEUROBIOL, V91, P95, DOI 10.1016/S0074-7742(10)91004-0; Flatscher-Bader T, 2006, GENES BRAIN BEHAV, V5, P78, DOI 10.1111/j.1601-183X.2006.00197.x; Flatscher-Bader T, 2005, J NEUROCHEM, V93, P359, DOI 10.1111/j.1471-4159.2004.03021.x; Flatscher-Bader T, 2010, ALCOHOL CLIN EXP RES, V34, P1291, DOI 10.1111/j.1530-0277.2010.01207.x; Friedman Y, 2013, ADV EXP MED BIOL, V774, P317, DOI 10.1007/978-94-007-5590-1_16; Gray KA, 2013, NUCLEIC ACIDS RES, V41, pD545, DOI 10.1093/nar/gks1066; Guo AY, 2009, NUCLEIC ACIDS RES, V37, pD840, DOI 10.1093/nar/gkn816; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guo L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/907420; Himes BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056179; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hodgkinson CA, 2010, P NATL ACAD SCI USA, V107, P8695, DOI 10.1073/pnas.0908134107; Hollander JA, 2010, NATURE, V466, P197, DOI 10.1038/nature09202; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Hung JH, 2012, BRIEF BIOINFORM, V13, P281, DOI 10.1093/bib/bbr049; Iwamoto K, 2004, NEUROSCI RES, V49, P379, DOI 10.1016/j.neures.2004.04.002; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jung ME, 2008, J APPL PHYSIOL, V105, P510, DOI 10.1152/japplphysiol.90317.2008; Jung ME, 2007, NEUROSCI LETT, V416, P160, DOI 10.1016/j.neulet.2007.01.065; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P929, DOI 10.1001/archpsyc.60.9.929; Kerns RT, 2005, J NEUROSCI, V25, P2255, DOI 10.1523/JNEUROSCI.4372-04.2005; Kim AH, 2010, SCHIZOPHR RES, V124, P183, DOI 10.1016/j.schres.2010.07.002; Kim SR, 2011, BMB REP, V44, P135, DOI 10.5483/BMBRep.2011.44.2.135; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kumar V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003201; Kuo PH, 2009, DRUG ALCOHOL DEPEN, V101, P80, DOI 10.1016/j.drugalcdep.2008.11.009; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee DY, 2008, FEBS LETT, V582, P4185, DOI 10.1016/j.febslet.2008.11.007; Lewohl JM, 2000, ALCOHOL CLIN EXP RES, V24, P1873, DOI 10.1111/j.1530-0277.2000.tb01993.x; Lewohl JM, 2011, ALCOHOL CLIN EXP RES, V35, P1928, DOI 10.1111/j.1530-0277.2011.01544.x; Li H, 2013, THEOR BIOSCI, V132, P1, DOI 10.1007/s12064-012-0168-x; Li JY, 2013, EMBO MOL MED, V5, P1402, DOI 10.1002/emmm.201201900; Liu CY, 2011, NEUROSCI BULL, V27, P123, DOI 10.1007/s12264-011-1203-5; Loh EW, 2006, ALCOHOL CLIN EXP RES, V30, P1817, DOI 10.1111/j.1530-0277.2006.00218.x; Mansouri A, 2001, J PHARMACOL EXP THER, V298, P737; Manzardo AM, 2013, GENE, V526, P356, DOI 10.1016/j.gene.2013.05.052; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Martinelli D, 2013, BRAIN, V136, P872, DOI 10.1093/brain/awt012; Marty VN, 2012, ALCOHOL, V46, P317, DOI 10.1016/j.alcohol.2011.12.002; Mason MJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-327; Mayfield RD, 2008, BRIT J PHARMACOL, V154, P275, DOI 10.1038/bjp.2008.88; Mayfield RD, 2002, J NEUROCHEM, V81, P802, DOI 10.1046/j.1471-4159.2002.00860.x; Minones-Moyano E, 2011, HUM MOL GENET, V20, P3067, DOI 10.1093/hmg/ddr210; Miura P, 2013, GENOME RES, V23, P812, DOI 10.1101/gr.146886.112; Mizuo Keisuke, 2012, Japanese Journal of Alcohol Studies & Drug Dependence, V47, P155; Nica AC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0362; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Nowak JS, 2013, BIOCHEM SOC T, V41, P815, DOI 10.1042/BST20130044; Nunez YO, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-725; Oyang EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024879; Pietrzykowski AZ, 2008, NEURON, V59, P274, DOI 10.1016/j.neuron.2008.05.032; Plaisier CL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000642; Ponomarev I, 2012, J NEUROSCI, V32, P1884, DOI 10.1523/JNEUROSCI.3136-11.2012; Presson AP, 2009, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-95; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Remenyi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062509; Ron D, 2013, CURR TOP BEHAV NEURO, V13, P87, DOI 10.1007/7854_2011_161; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Saito Yoshimasa, 2012, Frontiers in Genetics, V3, P194, DOI 10.3389/fgene.2012.00194; Schmitz U, 2014, NUCLEIC ACIDS RES, V42, P7539, DOI 10.1093/nar/gku465; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Shastry BS, 2009, METHODS MOL BIOL, V578, P3, DOI 10.1007/978-1-60327-411-1_1; Sheedy D, 2012, ALCOHOL CLIN EXP RES, V36, P55, DOI 10.1111/j.1530-0277.2011.01580.x; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Stan AD, 2006, BRAIN RES, V1123, P1, DOI 10.1016/j.brainres.2006.09.025; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sutherland GT, 2014, ALCOHOL CLIN EXP RES, V38, P994, DOI 10.1111/acer.12341; Tabakoff B, 2013, PHARMACOL BIOCHEM BE, V113, P20, DOI 10.1016/j.pbb.2013.10.009; Tapocik JD, 2013, PHARMACOGENOMICS J, V13, P286, DOI 10.1038/tpj.2012.17; Tapocik JD, 2014, J NEUROSCI, V34, P4581, DOI 10.1523/JNEUROSCI.0445-14.2014; Tardito D, 2013, EXPERT OPIN INV DRUG, V22, P217, DOI 10.1517/13543784.2013.749237; Torkamani A, 2010, GENOME RES, V20, P403, DOI 10.1101/gr.101956.109; Tu K, 2009, NUCLEIC ACIDS RES, V37, P5969, DOI 10.1093/nar/gkp638; Vardhanabhuti S, 2006, OMICS, V10, P555, DOI 10.1089/omi.2006.10.555; Wang ZF, 2013, CANCER LETT, V331, P1, DOI 10.1016/j.canlet.2012.12.006; Winden KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020763; Wolen AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033575; Wong HKA, 2013, HUM MOL GENET, V22, P3077, DOI 10.1093/hmg/ddt164; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yadav S, 2011, J BIOL CHEM, V286, P37347, DOI 10.1074/jbc.M111.235531; Yan J, 2014, ADDICT BIOL, V19, P708, DOI 10.1111/adb.12035; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang HP, 2014, HUM GENET, V133, P1383, DOI 10.1007/s00439-014-1473-x	108	59	59	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137671	10.1371/journal.pone.0137671	http://dx.doi.org/10.1371/journal.pone.0137671			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381263	Green Submitted, Green Published, gold			2022-12-27	WOS:000361790200032
J	Grandez-Rios, JM; Bergamini, LL; de Araujo, WS; Villalobos, F; Almeida-Neto, M				Grandez-Rios, Julio Miguel; Bergamini, Leonardo Lima; de Araujo, Walter Santos; Villalobos, Fabricio; Almeida-Neto, Mario			The Effect of Host-Plant Phylogenetic Isolation on Species Richness, Composition and Specialization of Insect Herbivores: A Comparison between Native and Exotic Hosts	PLOS ONE			English	Article							DIVERSITY; COMMUNITIES; EVOLUTION; FAUNA; TREES; CONSERVATISM; RELATEDNESS; ASSEMBLAGES; SPECIFICITY; TOOLS	Understanding the drivers of plant-insect interactions is still a key issue in terrestrial ecology. Here, we used 30 well-defined plant-herbivore assemblages to assess the effects of host plant phylogenetic isolation and origin (native vs. exotic) on the species richness, composition and specialization of the insect herbivore fauna on co-occurring plant species. We also tested for differences in such effects between assemblages composed exclusively of exophagous and endophagous herbivores. We found a consistent negative effect of the phylogenetic isolation of host plants on the richness, similarity and specialization of their insect herbivore faunas. Notably, except for Jaccard dissimilarity, the effect of phylogenetic isolation on the insect herbivore faunas did not vary between native and exotic plants. Our findings show that the phylogenetic isolation of host plants is a key factor that influences the richness, composition and specialization of their local herbivore faunas, regardless of the host plant origin.	[Grandez-Rios, Julio Miguel; Bergamini, Leonardo Lima] Univ Fed Goias, Inst Ciencias Biol, Programa Posgrad Ecol & Evolucao, Goiania, Go, Brazil; [de Araujo, Walter Santos; Villalobos, Fabricio; Almeida-Neto, Mario] Univ Fed Goias, Inst Ciencias Biol, Dept Ecol, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias	Grandez-Rios, JM (corresponding author), Univ Fed Goias, Inst Ciencias Biol, Programa Posgrad Ecol & Evolucao, Goiania, Go, Brazil.	jgrandezrios@yahoo.com	Bergamini, Leonardo Lima/H-4932-2019; Villalobos, Fabricio/J-6246-2012; de Araújo, Walter Santos/AAA-4606-2020; Bergamini, Leonardo L/D-1036-2019; Almeida-Neto, M./A-6389-2009; de Araújo, Walter S/C-8546-2013	Bergamini, Leonardo Lima/0000-0001-8505-5059; Villalobos, Fabricio/0000-0002-5230-2217; de Araújo, Walter Santos/0000-0003-0157-6151; Bergamini, Leonardo L/0000-0001-8505-5059; Almeida-Neto, M./0000-0002-2161-2968; 	Organization of American States (OAS); Brazilian Universities Coimbra Group (GCUB); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Brazilian Research Council (CNPq)	Organization of American States (OAS); Brazilian Universities Coimbra Group (GCUB); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	JMGR wishes to thank the Organization of American States (OAS) and the Brazilian Universities Coimbra Group (GCUB) for a scholarship permitting post-graduate studies in Brazil. The authors are also grateful to the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for a grant to WSdA and LLB, and to the Brazilian Research Council (CNPq) for a BJT-"Science without Borders" fellowship to FV and productivity grant to MAN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2003, ECOL LETT, V6, P712, DOI 10.1046/j.1461-0248.2003.00498.x; Agrawal AA, 2007, TRENDS ECOL EVOL, V22, P103, DOI 10.1016/j.tree.2006.10.012; Agrawal AA, 2006, Q REV BIOL, V81, P349, DOI 10.1086/511529; Barone JA, 1998, J ANIM ECOL, V67, P400, DOI 10.1046/j.1365-2656.1998.00197.x; Basset Y, 1999, BIOL J LINN SOC, V67, P477, DOI 10.1111/j.1095-8312.1999.tb01943.x; Becerra JX, 2007, P NATL ACAD SCI USA, V104, P7483, DOI 10.1073/pnas.0608253104; Becerra JX, 2015, P NATL ACAD SCI USA, V112, P6098, DOI 10.1073/pnas.1418643112; BERNAYS EA, 1994, Q REV BIOL, V69, P187, DOI 10.1086/418539; Bezemer TM, 2014, ANNU REV ENTOMOL, V59, P119, DOI 10.1146/annurev-ento-011613-162104; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Brandle M, 2008, DIVERS DISTRIB, V14, P905, DOI 10.1111/j.1472-4642.2008.00511.x; Castagneyrol B, 2014, J APPL ECOL, V51, P134, DOI 10.1111/1365-2664.12175; CONNOR EF, 1980, ECOL ENTOMOL, V5, P205, DOI 10.1111/j.1365-2311.1980.tb01143.x; Cripps MG, 2006, J BIOGEOGR, V33, P2107, DOI 10.1111/j.1365-2699.2006.01560.x; DALIN P, 2006, INVASIVE FOREST INSE, P63; de Araujo WS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115606; de Araujo WS, 2013, ARTHROPOD-PLANT INTE, V7, P373, DOI 10.1007/s11829-013-9259-y; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Fine PVA, 2013, ECOLOGY, V94, P1764, DOI 10.1890/12-1920.1; Forister ML, 2015, P NATL ACAD SCI USA, V112, P442, DOI 10.1073/pnas.1423042112; Futuyma D.J., 1983, P227; GASTON KJ, 1992, ECOL ENTOMOL, V17, P86, DOI 10.1111/j.1365-2311.1992.tb01044.x; Gontijo L, 2014, ECOL ENTOMOL, V39, P716, DOI 10.1111/een.12152; Gossner MM, 2009, AM NAT, V173, P599, DOI 10.1086/597603; Hackathon R, 2015, PHYLOBASE BASE PACKA; Hansen SO, 2006, EUR J ENTOMOL, V103, P387, DOI 10.14411/eje.2006.052; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Harvey JA, 2012, ENTOMOL EXP APPL, V144, P14, DOI 10.1111/j.1570-7458.2012.01252.x; Helden AJ, 2012, URBAN ECOSYST, V15, P611, DOI 10.1007/s11252-012-0231-x; HESPENHEIDE HA, 1991, ANNU REV ENTOMOL, V36, P535, DOI 10.1146/annurev.en.36.010191.002535; Hill SB, 2010, BIOL INVASIONS, V12, P3333, DOI 10.1007/s10530-010-9726-7; Hill SB, 2009, OECOLOGIA, V161, P581, DOI 10.1007/s00442-009-1403-0; JANZEN DH, 1968, AM NAT, V102, P592, DOI 10.1086/282574; Jobin A, 1996, ENTOMOL EXP APPL, V79, P33, DOI 10.1007/BF00333819; Jombart T, 2010, BIOINFORMATICS, V26, P1907, DOI 10.1093/bioinformatics/btq292; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Leffler AJ, 2014, ECOLOGY, V95, P298, DOI 10.1890/13-0102.1; Lewinsohn TM, 2005, ANNU REV ECOL EVOL S, V36, P597, DOI 10.1146/annurev.ecolsys.36.091704.175520; Liu H, 2006, BIOL INVASIONS, V8, P1535, DOI 10.1007/s10530-005-5845-y; Memmott J, 2000, ACTA OECOL, V21, P213, DOI 10.1016/S1146-609X(00)00124-7; Morais HC, 2011, BIOTROPICA, V43, P467, DOI 10.1111/j.1744-7429.2010.00736.x; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Novotny V, 2002, NATURE, V416, P841, DOI 10.1038/416841a; Novotny V, 2010, J ANIM ECOL, V79, P1193, DOI 10.1111/j.1365-2656.2010.01728.x; Odegaard F, 2005, ECOL LETT, V8, P612, DOI 10.1111/j.1461-0248.2005.00758.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pardo B., 2002, Computer Music Journal, V26, P27, DOI 10.1162/014892602760137167; Perre P, 2011, URBAN ECOSYST, V14, P711, DOI 10.1007/s11252-011-0179-2; Proches S, 2008, AUSTRAL ECOL, V33, P691, DOI 10.1111/j.1442-9993.2008.01836.x; R Development Core Team, 2014, R LANG ENV STAT COMP; Rasmann S, 2011, AM NAT, V177, P728, DOI 10.1086/659948; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Roques A, 2006, CAN J FOREST RES, V36, P299, DOI 10.1139/x05-277; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; SOUTHWOOD TRE, 1961, J ANIM ECOL, V30, P1, DOI 10.2307/2109; Spafford Ryan D., 2013, NeoBiota, V16, P81; Vialatte A, 2010, P ROY SOC B-BIOL SCI, V277, P2227, DOI 10.1098/rspb.2010.0365; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Yguel B, 2014, OECOLOGIA, V176, P521, DOI 10.1007/s00442-014-3026-3; Yguel B, 2011, ECOL LETT, V14, P1117, DOI 10.1111/j.1461-0248.2011.01680.x; Zanne AE, 2014, NATURE, V506, P89, DOI 10.1038/nature12872	63	14	14	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138031	10.1371/journal.pone.0138031	http://dx.doi.org/10.1371/journal.pone.0138031			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379159	Green Submitted, gold, Green Published			2022-12-27	WOS:000361769400045
J	McMorrow, ML; Emukule, GO; Njuguna, HN; Bigogo, G; Montgomeryz, JM; Nyawanda, B; Audi, A; Breiman, RF; Katz, MA; Cosmas, L; Waiboci, LW; Duque, J; Widdowson, MA; Mott, JA				McMorrow, Meredith L.; Emukule, Gideon O.; Njuguna, Henry N.; Bigogo, Godfrey; Montgomeryz, Joel M.; Nyawanda, Bryan; Audi, Allan; Breiman, Robert F.; Katz, Mark A.; Cosmas, Leonard; Waiboci, Lilian W.; Duque, Jazmin; Widdowson, Marc-Alain; Mott, Joshua A.			The Unrecognized Burden of Influenza in Young Kenyan Children, 2008-2012	PLOS ONE			English	Article							LABORATORY-CONFIRMED INFLUENZA; WESTERN KENYA; RESPIRATORY-INFECTIONS; HOSPITALIZED CHILDREN; SEASONAL INFLUENZA; EPIDEMIOLOGY; AFRICA; SURVEILLANCE; PNEUMONIA; ETIOLOGY	Influenza-associated disease burden among children in tropical sub-Saharan Africa is not well established, particularly outside of the 2009 pandemic period. We estimated the burden of influenza in children aged 0-4 years through population-based surveillance for influenza-like illness (ILI) and acute lower respiratory tract illness (ALRI). Household members meeting ILI or ALRI case definitions were referred to health facilities for evaluation and collection of nasopharyngeal and oropharyngeal swabs for influenza testing by real-time reverse transcription polymerase chain reaction. Estimates were adjusted for health-seeking behavior and those with ILI and ALRI who were not tested. During 2008-2012, there were 9,652 person-years of surveillance among children aged 0-4 years. The average adjusted rate of influenza-associated hospitalization was 4.3 (95% Cl 3.0-6.0) per 1,000 person-years in children aged 0-4 years. Hospitalization rates were highest in the 0-5 month and 6-23 month age groups, at 7.6 (95% Cl 3.2-18.2) and 8.4 (95% Cl 5.4-13.0) per 1,000 personyears, respectively. The average adjusted rate of influenza-associated medically attended (inpatient or outpatient) ALRI in children aged 0-4 years was 17.4 (95% Cl 14.2-19.7) per 1,000 person-years. Few children who had severe laboratory-confirmed influenza were clinically diagnosed with influenza by the treating clinician in the inpatient (0/33, 0%) or outpatient (1/109, 0.9%) settings. Influenza-associated hospitalization rates from 2008-2012 were 5-10 times higher than contemporaneous U.S. estimates. Many children with danger signs were not hospitalized; thus, influenza-associated severe disease rates in Kenyan children are likely higher than hospital-based estimates suggest.	[McMorrow, Meredith L.; Widdowson, Marc-Alain; Mott, Joshua A.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [McMorrow, Meredith L.; Montgomeryz, Joel M.; Mott, Joshua A.] US PHS, Rockville, MD USA; [Emukule, Gideon O.; Njuguna, Henry N.; Montgomeryz, Joel M.; Breiman, Robert F.; Katz, Mark A.; Cosmas, Leonard; Waiboci, Lilian W.; Mott, Joshua A.] Kenya Country Off, Ctr Dis Control & Prevent, Nairobi, Kenya; [Bigogo, Godfrey; Nyawanda, Bryan; Audi, Allan] Kenya Med Res Inst KEMRI, Nairobi, Kenya; [Bigogo, Godfrey; Nyawanda, Bryan; Audi, Allan] Kenya Med Res Inst KEMRI, Kisumu, Kenya; [Montgomeryz, Joel M.] Ctr Dis Control & Prevent, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA; [Breiman, Robert F.] Emory Univ, Emory Global Hlth Inst, Atlanta, GA 30322 USA; [Duque, Jazmin] Battelle Mem Inst, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; United States Public Health Service; Kenya Medical Research Institute; Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA; Emory University	McMorrow, ML (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	mmcmorrow@cdc.gov	McMorrow, Meredith/M-1274-2019; Bigogo, Godfrey/W-3591-2019	Duque, Jazmin/0000-0003-3484-276X; Audi, Allan/0000-0003-1683-554X; McMorrow, Meredith/0000-0001-6363-4033	Centers for Disease Control and Prevention (CDC) Cooperative Agreement; Kenya Medical Research Institute (KEMRI) [1U01 GH000048]	Centers for Disease Control and Prevention (CDC) Cooperative Agreement(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Kenya Medical Research Institute (KEMRI)	The work was supported by Centers for Disease Control and Prevention (CDC) Cooperative Agreement with Kenya Medical Research Institute (KEMRI) 1U01 GH000048.	ADEGBOLA RA, 1994, PEDIATR INFECT DIS J, V13, P975, DOI 10.1097/00006454-199411000-00008; Ampofo K, 2006, PEDIATRICS, V118, P2409, DOI 10.1542/peds.2006-1475; [Anonymous], 2003, Wkly Epidemiol Rec, V78, P94; CDC, 2013, FLUVIEW INT LAB CONF; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1016; Chaves SS, 2014, PEDIAT INFECT DIS J; Cohen C, 2013, EMERGING INFECT DIS, V19; Cohen C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118884; Cohen C, 2015, PEDIATR INFECT DIS J, V34, P66, DOI 10.1097/INF.0000000000000478; Cox CM, 2012, J INFECT DIS, V206, P1350, DOI 10.1093/infdis/jis517; Dawood FS, 2010, J PEDIATR-US, V157, P808, DOI 10.1016/j.jpeds.2010.05.012; Emukule GO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105543; Feikin DR, 2013, PEDIATR INFECT DIS J, V32, pE14, DOI 10.1097/INF.0b013e31826fd39b; Feikin DR, 2012, B WORLD HEALTH ORGAN, V90, P256, DOI 10.2471/BLT.11.094326; Feikin DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016085; Feikin DR, 2010, INT J EPIDEMIOL, V39, P450, DOI 10.1093/ije/dyp374; Fuller JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056882; Gentile A, 2011, ARCH ARGENT PEDIATR, V109, P198, DOI 10.1590/S0325-00752011000300003; Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1; Heikkinen T, 2004, J INFECT DIS, V190, P1369, DOI 10.1086/424527; Katz MA, 2012, J INFECT DIS, V206, pS53, DOI 10.1093/infdis/jis530; Katz MA, 2012, J INFECT DIS, V206, pS1, DOI 10.1093/infdis/jis548; Miranda-Choque Edwin, 2011, Rev. perú. med. exp. salud publica, V28, P610; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Neuzil KM, 2002, J INFECT DIS, V185, P147, DOI 10.1086/338363; Niang MN, 2010, J MED VIROL, V82, P866, DOI 10.1002/jmv.21665; O'Brien MA, 2004, PEDIATRICS, V113, P585, DOI 10.1542/peds.113.3.585; O'Callaghan-Gordo C, 2011, PEDIATR INFECT DIS J, V30, P39, DOI 10.1097/INF.0b013e3181f232fe; Onyango CO, 2012, J INFECT DIS, V206, pS61, DOI 10.1093/infdis/jis536; Opwora AS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-272; Ortiz JR, 2012, INFLUENZA OTHER RESP, V6, P11, DOI 10.1111/j.1750-2659.2011.00257.x; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Poehling KA, 2013, PEDIATRICS, V131, P207, DOI 10.1542/peds.2012-1255; Radin JM, 2012, J INFECT DIS, V206, pS14, DOI 10.1093/infdis/jis606; ROOTH IB, 1992, AM J TROP MED HYG, V47, P675, DOI 10.4269/ajtmh.1992.47.675; Schanzer DL, 2006, PEDIATR INFECT DIS J, V25, P795, DOI 10.1097/01.inf.0000232632.86800.8c; Silvennoinen H, 2012, EUR J CLIN MICROBIOL, V31, P225, DOI 10.1007/s10096-011-1297-8; Silvennoinen H, 2011, PEDIATR INFECT DIS J, V30, pE24, DOI 10.1097/INF.0b013e3181fe37c8; Thompson MG, 2012, J INFECT DIS, V206, P1674, DOI 10.1093/infdis/jis591; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Waitumbi JN, 2010, AM J TROP MED HYG, V83, P1010, DOI 10.4269/ajtmh.2010.10-0174; Walaza S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129173; Walaza S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0746-x; World Health Organization (WHO), WHO INF MOL DIAGN IN; World Health Organization (WHO), 2002, WHO WKLY EPIDEMIOL R	45	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138272	10.1371/journal.pone.0138272	http://dx.doi.org/10.1371/journal.pone.0138272			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379030	Green Submitted, Green Published, gold			2022-12-27	WOS:000361769400079
J	John, G; Louis, C; Berner, A; Genne, D				John, Gregor; Louis, Celine; Berner, Amandine; Genne, Daniel			Tobacco Stained Fingers and Its Association with Death and Hospital Admission: A Retrospective Cohort Study	PLOS ONE			English	Article							SMOKING; ALCOHOL; READMISSION; MORTALITY; OUTCOMES; FRAILTY; PNEUMONIA; DRINKING; HISTORY; RISK	Background Among smokers, the presence of tobacco stains on fingers has recently been associated with a high prevalence of tobacco related conditions and alcohol abuse. Objective we aimed to explore tobacco stains as a marker of death and hospital readmission. Method Seventy-three smokers presenting tobacco-tar staining on their fingers and 70 control smokers were followed during a median of 5.5 years in a retrospective cohort study. We used the Kaplan-Meier survival analysis and the log-rank test to compare mortality and hospital readmission rates among smokers with and smokers without tobacco stains. Multivariable Cox models were used to adjust for confounding factors: age, gender, pack-year unit smoked, cancer, harmful alcohol use and diabetes. The number of hospital admissions was compared through a negative binomial regression and adjusted for the follow-up time, diabetes, and alcohol use. Results Forty-three patients with tobacco-stained fingers died compared to 26 control smokers (HR 1.6; 95% CI: 1.0 to 2.7; p 0.048). The association was not statistically significant after adjustment. Patients with tobacco-stained fingers needed a readmission earlier than smokers without stains (HR 2.1; 95% CI: 1.4 to 3.1; p<0.001), and more often (incidence rate ratio (IRR) 1.6; 95% CI: 1.1 to 2.1). Associations between stains and the first hospital readmission (HR 1.6; 95% CI: 1.0 to 2.5), and number of readmissions (IRR 1.5; 95% CI: 1.1 to 2.1) persisted after adjustment for confounding factors. Conclusions Compared to other smokers, those presenting tobacco-stained fingers have a high unadjusted mortality rate and need early and frequent hospital readmission even when controlling for confounders.	[John, Gregor; Louis, Celine; Berner, Amandine] Hop Neuchatelois, Dept Internal Med, CH-2300 La Chaux De Fonds, Switzerland; [John, Gregor] Univ Hosp Geneva, Dept Internal Med Geriatr & Rehabil, CH-1205 Geneva, Switzerland; [Genne, Daniel] Ctr Hosp Bienne, Dept Internal Med, CH-2501 Biel, Switzerland	University of Geneva	John, G (corresponding author), Hop Neuchatelois, Dept Internal Med, CH-2300 La Chaux De Fonds, Switzerland.	Gregor.John@h-ne.ch	Berner, Amandine/AHC-8435-2022; Genne, Daniel/O-2305-2014; John, Gregor/AAJ-6424-2021	John, Gregor/0000-0002-1548-7339				Abrams L, 2000, Nurs Stand, V14, P59; Abrams P, 2000, AM J MANAG CARE, V6, pS580; Bisson EF, 2015, FRONT SURG, V2, DOI 10.3389/fsurg.2015.00020; Burke RE, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-423; Calvillo-King L, 2013, J GEN INTERN MED, V28, P269, DOI 10.1007/s11606-012-2235-x; Dawson DA, 2000, DRUG ALCOHOL DEPEN, V59, P235, DOI 10.1016/S0376-8716(99)00130-1; El Solh AA, 2004, J AM GERIATR SOC, V52, P2010, DOI 10.1111/j.1532-5415.2004.52556.x; Evangelista LS, 2000, AM J CARDIOL, V86, P1339, DOI 10.1016/S0002-9149(00)01238-8; FRIEDMAN GD, 1991, DRUG ALCOHOL DEPEN, V27, P283, DOI 10.1016/0376-8716(91)90011-M; Guessous Idris, 2014, J Aging Res, V2014, P198603, DOI 10.1155/2014/198603; Hubbard RE, 2009, J NUTR HEALTH AGING, V13, P468, DOI 10.1007/s12603-009-0085-y; John G, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003304; Jorgensen CC, 2013, ACTA ANAESTH SCAND, V57, P631, DOI 10.1111/aas.12086; Jurschik P, 2012, ARCH GERONTOL GERIAT, V55, P625, DOI 10.1016/j.archger.2012.07.002; Kobayashi M, 2010, INT J PSYCHIAT MED, V40, P247, DOI 10.2190/PM.40.3.b; Kulaylat AN, 2015, COLORECTAL DIS; Lawder R, 2011, PUBLIC HEALTH, V125, P533, DOI 10.1016/j.puhe.2011.05.007; Leow JJ, 2014, CAN J UROL, V21, P7537; Long J.S., 2006, REGRESSION MODELS CA; Nelson JA, 2015, HERNIA, V19, P125, DOI 10.1007/s10029-014-1329-2; NIL R, 1984, PHARMACOL BIOCHEM BE, V20, P583, DOI 10.1016/0091-3057(84)90308-3; Prochaska JJ, 2014, AM J PUBLIC HEALTH, V104, P1557, DOI 10.2105/AJPH.2013.301403; Qiao Q, 2000, EUR HEART J, V21, P1621, DOI 10.1053/euhj.2000.2151; Rigotti NA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001837.pub2; Shen L, 2013, AM HEART J, V166, P1056, DOI 10.1016/j.ahj.2013.09.011; Sule S, 2011, CLIN CARDIOL, V34, P35, DOI 10.1002/clc.20872; The Criteria Committee of the New York Heart Association, 1994, NOM CRIT DAGN DIS HE; Wang CX, 2013, J GERONTOL A-BIOL, V68, P338, DOI 10.1093/gerona/gls166; Wood D, 1960, PROJECT WHEAT 1; World Health Organization, 2019, INT STAT CLASS DIS R, V11th Edn; World Health Organization (WHO), 2011, REP GLOB TOB EP; Yadav D, 2012, AM J GASTROENTEROL, V107, P1096, DOI 10.1038/ajg.2012.126	32	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138211	10.1371/journal.pone.0138211	http://dx.doi.org/10.1371/journal.pone.0138211			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8NH	26375287	gold, Green Published, Green Submitted			2022-12-27	WOS:000361610200087
J	Pope, LC; Riginos, C; Ovenden, J; Keyse, J; Blomberg, SP				Pope, Lisa C.; Riginos, Cynthia; Ovenden, Jennifer; Keyse, Jude; Blomberg, Simon P.			Population Genetic Diversity in the Australian 'Seascape': A Bioregion Approach	PLOS ONE			English	Article							SPECIES RICHNESS; GLOBAL PATTERNS; CLIMATE-CHANGE; BIODIVERSITY; SIZE; CONSERVATION; DIVERGENCE; PREDICTORS; EVOLUTION; FRAMEWORK	Genetic diversity within species may promote resilience to environmental change, yet little is known about how such variation is distributed at broad geographic scales. Here we develop a novel Bayesian methodology to analyse multi-species genetic diversity data in order to identify regions of high or low genetic diversity. We apply this method to co-distributed taxa from Australian marine waters. We extracted published summary statistics of population genetic diversity from 118 studies of 101 species and > 1000 populations from the Australian marine economic zone. We analysed these data using two approaches: a linear mixed model for standardised data, and a mixed beta-regression for unstandardised data, within a Bayesian framework. Our beta-regression approach performed better than models using standardised data, based on posterior predictive tests. The best model included region (Integrated Marine and Coastal Regionalisation of Australia (IMCRA) bioregions), latitude and latitude squared. Removing region as an explanatory variable greatly reduced model performance (delta DIC 23.4). Several bioregions were identified as possessing notably high genetic diversity. Genetic diversity increased towards the equator with a 'hump' in diversity across the range studied (-9.4 to -43.7 degrees S). Our results suggest that factors correlated with both region and latitude play a role in shaping intra-specific genetic diversity, and that bioregion can be a useful management unit for intra-specific as well as species biodiversity. Our novel statistical model should prove useful for future analyses of within species genetic diversity at broad taxonomic and geographic scales.	[Pope, Lisa C.; Riginos, Cynthia; Keyse, Jude; Blomberg, Simon P.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Ovenden, Jennifer] Univ Queensland, Mol Fisheries Lab, Sch Biomed Sci, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Pope, LC (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.	l.pope@uq.edu.au	Riginos, Cynthia/G-3320-2010; Pope, Lisa C/A-7533-2011; Ovenden, Jennifer/A-3717-2010; Blomberg, Simone P/B-7613-2008	Riginos, Cynthia/0000-0002-5485-4197; Pope, Lisa C/0000-0002-1791-3979; Ovenden, Jennifer/0000-0001-7538-1504; Blomberg, Simone P/0000-0003-1062-0839	University of Queensland, UQ Postdoctoral Research Fellowships for Women	University of Queensland, UQ Postdoctoral Research Fellowships for Women	LP was funded to perform this work by The University of Queensland, UQ Postdoctoral Research Fellowships for Women, part-time (http://www.uq.edu.au/research/research-management/uq-postdoctoral-research-fellowships-for-women). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RI, 2013, EVOL ECOL, V27, P133, DOI 10.1007/s10682-012-9587-x; [Anonymous], 2014, R LANG ENV STAT COMP; April J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070296; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Barr LM, 2013, MAR POLICY, V42, P39, DOI 10.1016/j.marpol.2013.01.012; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Begg GA, 1999, FISH RES, V43, P35, DOI 10.1016/S0165-7836(99)00065-X; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Butler AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011831; Campbell AK, 2003, J APPL ECOL, V40, P193, DOI 10.1046/j.1365-2664.2003.00803.x; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Coyle T, 1997, STOCK IDENTIFICATION, P173; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Evans KL, 2005, BIOL REV, V80, P1, DOI 10.1017/S1464793104006517; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Figueroa-Zuniga JI, 2012, ARXIV12012375V4; Flood M, 2012, STATUS KEY FISH STOC; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Gaither MR, 2013, J BIOGEOGR, V40, P1638, DOI 10.1111/jbi.12126; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gelman A., 2004, BAYESIAN DATA ANAL, V2nd, P157; Gelman A., 2021, BAYESIAN DATA ANAL; Gillman LN, 2014, J BIOGEOGR, V41, P39, DOI 10.1111/jbi.12173; Gillman LN, 2009, P R SOC B, V276, P3353, DOI 10.1098/rspb.2009.0674; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Harrisson KA, 2014, EVOL APPL, V7, P1008, DOI 10.1111/eva.12149; Hawkins BA, 2001, TRENDS ECOL EVOL, V16, P470, DOI 10.1016/S0169-5347(01)02197-8; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Jansson R, 2002, ANNU REV ECOL SYST, V33, P741, DOI 10.1146/annurev.ecolsys.33.010802.150520; Keyse J, 2014, B MAR SCI, V90, P47, DOI 10.5343/bms.2012.1107; Kimura M., 1983, NEUTRAL THEORY MOL E; Last PR, 2011, J BIOGEOGR, V38, P1484, DOI 10.1111/j.1365-2699.2011.02484.x; Last PR, 2010, BIOL CONSERV, V143, P1675, DOI 10.1016/j.biocon.2010.04.008; Lawson AB, 2003, WINBUGS BASICS DIS M; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mapstone B. D., 2010, NATL CLIMATE CHANGE; Marshall JL, 2006, ACTA OECOL, V29, P33, DOI 10.1016/j.actao.2005.07.008; Martin PR, 2004, EVOLUTION, V58, P938; McCallum AW, 2013, MAR ECOL-EVOL PERSP, V34, P298, DOI 10.1111/maec.12016; McCusker MR, 2010, MOL ECOL, V19, P4852, DOI 10.1111/j.1365-294X.2010.04822.x; Miller MJ, 2010, ECOL LETT, V13, P576, DOI 10.1111/j.1461-0248.2010.01454.x; Mirams AGK, 2011, CORAL REEFS, V30, P937, DOI 10.1007/s00338-011-0767-x; Murtagh F, 2011, WARDS HIERARCHICAL C; Nabholz B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-54; NEI M, 1981, GENETICS, V97, P145; NEI M, 1978, GENETICS, V89, P583; NUNNEY L, 1993, EVOLUTION, V47, P1329, DOI 10.1111/j.1558-5646.1993.tb02158.x; O'Corry-Crowe G, 2008, ECOL APPL, V18, pS56, DOI 10.1890/06-0795.1; O'Hara TD, 2011, CURR BIOL, V21, P226, DOI 10.1016/j.cub.2011.01.002; Oksanen J., **DATA OBJECT**; Ovenden JR, 2013, FISH FISH, V16, P125, DOI DOI 10.1111/FAF.12052; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pinsky ML, 2014, MOL ECOL, V23, P29, DOI 10.1111/mec.12509; Pope LC, 2015, MOL ECOL, V24, P3802, DOI 10.1111/mec.13254; Reed DH, 2001, EVOLUTION, V55, P1095, DOI 10.1111/j.0014-3820.2001.tb00629.x; Riginos C, 2011, ECOGRAPHY, V34, P566, DOI 10.1111/j.1600-0587.2010.06511.x; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Romiguier J, 2014, NATURE, V515, P261, DOI 10.1038/nature13685; RUBIN DB, 1984, ANN STAT, V12, P1151, DOI 10.1214/aos/1176346785; Ryman N, 2014, MOL ECOL RESOUR, V14, P87, DOI 10.1111/1755-0998.12154; Selkoe KA, 2008, FISH FISH, V9, P363, DOI 10.1111/j.1467-2979.2008.00300.x; Sgro CM, 2011, EVOL APPL, V4, P326, DOI 10.1111/j.1752-4571.2010.00157.x; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stuart-Smith RD, 2013, NATURE, V501, P539, DOI 10.1038/nature12529; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Taberlet P, 2012, ECOL LETT, V15, P1439, DOI 10.1111/ele.12004; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; United Nations, 2012, FUTURE WE WANT; Vandergast AG, 2011, MOL ECOL RESOUR, V11, P158, DOI 10.1111/j.1755-0998.2010.02904.x; Vellend M, 2003, AM NAT, V162, P358, DOI 10.1086/377189; Vellend M, 2014, MOL ECOL, V23, P2890, DOI 10.1111/mec.12756; Volkmann L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088945; Vucetich JA, 2003, CONSERVATION GENETIC, V45; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; Whitlock R, 2014, J ECOL, V102, P857, DOI 10.1111/1365-2745.12240; Wilcox B. A., 1984, NATL PARKS CONSERVAT, P18; Woolley SNC, 2013, DIVERS DISTRIB, V19, P1506, DOI 10.1111/ddi.12119	83	13	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136275	10.1371/journal.pone.0136275	http://dx.doi.org/10.1371/journal.pone.0136275			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375711	gold, Green Published, Green Submitted			2022-12-27	WOS:000361610200013
J	Shiferaw, MB; Hailu, HA; Fola, AA; Derebe, MM; Kebede, AT; Kebede, AA; Emiru, MA; Gelaw, ZD				Shiferaw, Melashu Balew; Hailu, Hiwot Amare; Fola, Abebe Alemu; Derebe, Mulatu Melese; Kebede, Aimro Tadese; Kebede, Abayneh Admas; Emiru, Manamnot Agegne; Gelaw, Zelalem Dessie			Tuberculosis Laboratory Diagnosis Quality Assurance among Public Health Facilities in West Amhara Region, Ethiopia	PLOS ONE			English	Article							SPUTUM SMEAR MICROSCOPY; ACID-FAST BACILLI	Introduction Reliable smear microscopy is an important component of Directly Observed Treatment Scheme (DOTS) strategy for TB control program in countries with limited resources. Despite external quality assessment is established in Ethiopia, there is lower TB detection rate (48%) in Amhara region compared to the World Health Organization (WHO) estimate (70%). This highlights the quality of smear microscopy needs to be evaluated. Therefore, the aim of this study was to assess the quality of sputum smear microscopy performance among health center laboratories in West Amhara region, Ethiopia. Materials and Methods A cross sectional study was conducted from July 08, 2013 to July 07, 2014. Data were collected from 201 public health center laboratories using a structured questionnaire. Slides were collected based on Lot Quality Assurance Sampling (LQAS) method and rechecked blindly by trained laboratory technologists. The data were entered into EPI info V. 7 and smear quality indicators and AFB results were analyzed by SPSS version 20. Results Among 201 laboratories enrolled in this study, 47 (23.4%) laboratories had major errors. Forty one (20.4%) laboratories had a total of 67 false negative and 29 (14.4%) laboratories had a total of 68 false positive results. Specimen quality, smear thickness and evenness were found poor in 134 (66.7%), 133 (66.2%) and 126 (62.7%) laboratories, respectively. Unavailability of microscope lens cleaning solution (AOR: 2.90; 95% CI: 1.25-6.75; P: 0.013) and dirty smears (AOR: 2.65; 95% CI: 1.14-6.18; P: 0.024) were correlated with false negative results whereas no previous EQA participation (AOR: 3.43; 95% CI: 1. 39-8.45; P: 0.007) was associated with false positive results. Conclusion The performance of health facilities for sputum smear microscopy was relatively poor in West Amhara region. Hence, strengthening the EQA program and technical support on sputum smear microscopy are recommended to ensure quality tuberculosis diagnostic service.	[Shiferaw, Melashu Balew; Hailu, Hiwot Amare; Derebe, Mulatu Melese; Kebede, Aimro Tadese; Emiru, Manamnot Agegne; Gelaw, Zelalem Dessie] Bahir Dar Reg Hlth Res Lab Ctr, Bahir Dar, Ethiopia; [Fola, Abebe Alemu] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Kebede, Abayneh Admas] Amhara Reg State Hlth Bur, Bahir Dar, Ethiopia	Walter & Eliza Hall Institute	Shiferaw, MB (corresponding author), Bahir Dar Reg Hlth Res Lab Ctr, Bahir Dar, Ethiopia.	bmelashu@gmail.com	Shiferaw, Melashu/GPT-3320-2022; Fola, Abebe/AAV-8048-2021	Shiferaw, Melashu Balew/0000-0002-5066-0758				Ajaykumar T, 2006, NTI B, V42, P15; Amhara Regional Health Bureau, 2013, TUB ANN REP; Basra D, 2006, East Afr Med J, V83, P306; Ethiopian Health and Nutrition Research Institute, 2009, AFB SMEAR MICR MAN; Ethiopian Health and Nutrition Research Institute Federal Ministry of Health, 2009, GUID QUAL ASS SMEAR; Farnia P, 2003, TANAFFOS, V2, P29; Federal Ministry of Health, 2012, GUID CLIN PROGR MAN; Jha K, 2011, SAARC J TUBER LUNG D, V8, P20; Kusznierz GF, 2004, INT J TUBERC LUNG D, V8, P1234; Lan NTN, 1999, INT J TUBERC LUNG D, V3, P55; PHL CDC IUATLD KNCV RIT, 2002, EXT QUAL ASS AFB SME; Rohit Sarin, 2002, Indian Journal of Tuberculosis, V49, P143; Selvakumar N, 2005, J CLIN MICROBIOL, V43, P913, DOI 10.1128/JCM.43.2.913-915.2005; Steingart KR, 2007, EXPERT REV ANTI-INFE, V5, P327, DOI 10.1586/14787210.5.3.327; Van Rie A, 2008, J CLIN MICROBIOL, V46, P897, DOI 10.1128/JCM.01553-07; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2003, QUAL ASS SPUT MICR D; World Health Organization Stop TB Partnership, 2006, STOP TB STRAT BUILD; Wu MH, 2009, INT J TUBERC LUNG D, V13, P606	19	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138488	10.1371/journal.pone.0138488	http://dx.doi.org/10.1371/journal.pone.0138488			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376438	Green Submitted, Green Published, gold			2022-12-27	WOS:000361610200110
J	Chen, MJ; Lu, YQ; Simpson, NE; Beveridge, MJ; Elshikha, AS; Akbar, MA; Tsai, HY; Hinske, S; Qin, JL; Grunwitz, CR; Chen, TN; Brantly, ML; Song, SH				Chen, Mong-Jen; Lu, Yuanqing; Simpson, Nicholas E.; Beveridge, Mark J.; Elshikha, Ahmed S.; Akbar, Mohammad Ahsanul; Tsai, Hsin-Yin; Hinske, Stephanie; Qin, Junling; Grunwitz, Christian R.; Chen, Tina; Brantly, Mark L.; Song, Sihong			In Situ Transplantation of Alginate Bioencapsulated Adipose Tissues Derived Stem Cells (ADSCs) via Hepatic Injection in a Mouse Model	PLOS ONE			English	Article							HEPATOCYTE-LIKE CELLS; LIVER FIBROSIS; DIFFERENTIATION; MICROSPHERES; REPOPULATION; ENGRAFTMENT; GENERATION; DISEASE; VIVO	Objective Adipose tissue derived stem cells (ADSCs) transplantation has recently gained widespread enthusiasm, particularly in the perspective to use them as potential alternative cell sources for hepatocytes in cell based therapy, mainly because of their capability of hepatogenic differentiation in vitro and in vivo. But some challenges remain to be addressed, including whether ADSCs can be provided effectively to the target organ and whether subsequent proliferation of transplanted cells can be achieved. To date, intrasplenic injection is the conventional method to deliver ADSCs into the liver; however, a number of donor cells retained in the spleen has been reported. In this study, our objective is to evaluate a novel route to transplant ADSCs specifically to the liver. We aimed to test the feasibility of in situ transplantation of ADSCs by injecting bioencapsulated ADSCs into the liver in mouse model. Methods The ADSCs isolated from human alpha 1 antitrypsin (M-hAAT) transgenic mice were used to allow delivered ADSCs be readily identified in the liver of recipient mice, and alginate was selected as a cell carrier. We first evaluated whether alginate microspheres are implantable into the liver tissue by injection and whether ADSCs could migrate from alginate microspheres (study one). Once proven, we then examined the in vivo fate of ADSCs loaded microspheres in the liver. Specifically, we evaluated whether transplanted, undifferentiated ASDCs could be induced by the local microenvironment toward hepatogenic differentiation and the distribution of surviving ADSCs in major tissue organs (study two). Results Our results indicated ADSCs loaded alginate microspheres were implantable into the liver. Both degraded and residual alginate microspheres were observed in the liver up to three weeks. The viable ADSCs were detectable surrounding degraded and residual alginate microspheres in the liver and other major organs such as bone marrow and the lungs. Importantly, transplanted ADSCs underwent hepatogenic differentiation to become cells expressing albumin in the liver. These findings improve our understanding of the interplay between ADSCs (donor cells), alginate (biomaterial), and local microenvironment in a hepatectomized mouse model, and might improve the strategy of in situ transplantation of ADSCs in treating liver diseases.	[Chen, Mong-Jen; Lu, Yuanqing; Elshikha, Ahmed S.; Akbar, Mohammad Ahsanul; Tsai, Hsin-Yin; Hinske, Stephanie; Qin, Junling; Grunwitz, Christian R.; Chen, Tina; Song, Sihong] Univ Florida, Coll Pharm, Dept Pharmaceut, Gainesville, FL 32610 USA; [Simpson, Nicholas E.; Beveridge, Mark J.; Brantly, Mark L.] Univ Florida, Dept Med, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Song, SH (corresponding author), Univ Florida, Coll Pharm, Dept Pharmaceut, Gainesville, FL 32610 USA.	shsong@ufl.edu	Brantly, Mark/AAH-2922-2020					Allen KJ, 2004, J GASTROEN HEPATOL, V19, P1283, DOI 10.1111/j.1440-1746.2004.03451.x; Aurich H, 2009, GUT, V58, P570, DOI 10.1136/gut.2008.154880; Banas A, 2007, HEPATOLOGY, V46, P219, DOI 10.1002/hep.21704; Chen MJ, 2014, HUM GENE THER METHOD, V25, P72, DOI 10.1089/hgtb.2013.011; De Vree JML, 2000, GASTROENTEROLOGY, V119, P1720, DOI 10.1053/gast.2000.20222; Dvir-Ginzberg M, 2003, TISSUE ENG, V9, P757, DOI 10.1089/107632703768247430; Grayson WL, 2007, BIOCHEM BIOPH RES CO, V358, P948, DOI 10.1016/j.bbrc.2007.05.054; Grompe M, 1999, Hum Cell, V12, P171; Harn HJ, 2012, CELL TRANSPLANT, V21, P2753, DOI 10.3727/096368912X652959; Jain E, 2014, HEPATOL INT, V8, P185, DOI 10.1007/s12072-013-9503-7; Ji R, 2012, BIOMATERIALS, V33, P8995, DOI 10.1016/j.biomaterials.2012.08.058; Joseph B, 2006, HEPATOLOGY, V44, P1411, DOI 10.1002/hep.21416; KAHN D, 1984, J SURG RES, V37, P290, DOI 10.1016/0022-4804(84)90191-4; Kim SJ, 2011, J KOREAN SURG SOC, V81, P176, DOI 10.4174/jkss.2011.81.3.176; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Li H, 2011, J HEPATOL, V54, P930, DOI 10.1016/j.jhep.2010.07.051; Li KG, 2004, BIOTECHNOL LETT, V26, P879, DOI 10.1023/B:bile.0000025896.61490.6d; Li YS, 2013, CELL TRANSPLANT, V22, P685, DOI 10.3727/096368912X655163; Lin N, 2010, CELL PROLIFERAT, V43, P427, DOI 10.1111/j.1365-2184.2010.00692.x; Meier RPH, 2015, J HEPATOL, V62, P634, DOI 10.1016/j.jhep.2014.10.030; Meier RPH, 2013, STEM CELL RES, V11, P1348, DOI 10.1016/j.scr.2013.08.011; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Moshaverinia A, 2013, BIOMATERIALS, V34, P6572, DOI 10.1016/j.biomaterials.2013.05.048; Moya ML, 2012, J MATER SCI-MATER M, V23, P903, DOI 10.1007/s10856-012-4575-9; Moyer HR, 2010, ANN PLAS SURG, V65, P497, DOI 10.1097/SAP.0b013e3181d37713; PONDER KP, 1991, P NATL ACAD SCI USA, V88, P1217, DOI 10.1073/pnas.88.4.1217; Simpson NE, 2004, BIOMATERIALS, V25, P2603, DOI 10.1016/j.biomaterials.2003.09.046; Sohni A, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/130763; Soltys KA, 2010, J HEPATOL, V53, P769, DOI 10.1016/j.jhep.2010.05.010; Stock P, 2010, NAT PROTOC, V5, P617, DOI 10.1038/nprot.2010.7; Sugii S, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.199; Waelzlein JH, 2009, CURR OPIN NEPHROL HY, V18, P481, DOI 10.1097/MNH.0b013e3283318e1c; Yao R, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/2/025007; Yin LB, 2015, MOL MED REP, V11, P1722, DOI 10.3892/mmr.2014.2935; Yu JS, 2010, BIOMATERIALS, V31, P7012, DOI 10.1016/j.biomaterials.2010.05.078; Zhao YS, 2010, TISSUE ENG PART C-ME, V16, P653, DOI 10.1089/ten.TEC.2009.0053; Zhou P, 2011, LIVER TRANSPLANT, V17, P418, DOI 10.1002/lt.22270	37	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138184	10.1371/journal.pone.0138184	http://dx.doi.org/10.1371/journal.pone.0138184			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372641	Green Published, Green Submitted, gold			2022-12-27	WOS:000361604400054
J	Hodkinson, DJ; Veggeberg, R; Wilcox, SL; Scrivani, S; Burstein, R; Becerra, L; Borsook, D				Hodkinson, Duncan J.; Veggeberg, Rosanna; Wilcox, Sophie L.; Scrivani, Steven; Burstein, Rami; Becerra, Lino; Borsook, David			Primary Somatosensory Cortices Contain Altered Patterns of Regional Cerebral Blood Flow in the Interictal Phase of Migraine	PLOS ONE			English	Article							HUMAN BRAIN; ARTERIAL; CORTEX; ALLODYNIA; PAIN; PATHOPHYSIOLOGY; QUESTIONNAIRE; SENSITIZATION; POPULATION; MECHANISMS	The regulation of cerebral blood flow (CBF) is a complex integrated process that is critical for supporting healthy brain function. Studies have demonstrated a high incidence of alterations in CBF in patients suffering from migraine with and without aura during different phases of attacks. However, the CBF data collected interictally has failed to show any distinguishing features or clues as to the underlying pathophysiology of the disease. In this study we used the magnetic resonance imaging (MRI) technique-arterial spin labeling (ASL)-to non-invasively and quantitatively measure regional CBF (rCBF) in a case-controlled study of interictal migraine. We examined both the regional and global CBF differences between the groups, and found a significant increase in rCBF in the primary somatosensory cortex (S1) of migraine patients. The CBF values in S1 were positively correlated with the headache attack frequency, but were unrelated to the duration of illness or age of the patients. Additionally, 82% of patients reported skin hypersensitivity (cutaneous allodynia) during migraine, suggesting atypical processing of somatosensory stimuli. Our results demonstrate the presence of a disease-specific functional deficit in a known region of the trigemino-cortical pathway, which may be driven by adaptive or maladaptive functional plasticity. These findings may in part explain the altered sensory experiences reported between migraine attacks.	[Hodkinson, Duncan J.; Veggeberg, Rosanna; Wilcox, Sophie L.; Scrivani, Steven; Becerra, Lino; Borsook, David] Harvard Univ, Sch Med, Boston Childrens Hosp, Ctr Pain & Brain,Dept Anesthesiol Perioperat & Pa, Boston, MA 02163 USA; [Scrivani, Steven] Massachusetts Gen Hosp, Dept Oral & Maxillofacial Surg, Boston, MA 02114 USA; [Burstein, Rami] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Anesthesia & Crit Care, Boston, MA 02215 USA; [Becerra, Lino; Borsook, David] Harvard Univ, Sch Med, Dept Psychiat, McLean Hosp, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; McLean Hospital	Hodkinson, DJ (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Ctr Pain & Brain,Dept Anesthesiol Perioperat & Pa, Boston, MA 02163 USA.	duncan.hodkinson@childrens.harvard.edu			National Institutes of Health [RO1 NS073977, K24 NS064050]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K24NS064050] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by National Institutes of Health (RO1 NS073977 and K24 NS064050).	Akerman S, 2011, NAT REV NEUROSCI, V12, P570, DOI 10.1038/nrn3057; Alsop DC, 2014, MAGN RESON MED, DOI [10.1002/mrm.25197, DOI 10.1002/MRM.25197]; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Ashkenazi A, 2007, CEPHALALGIA, V27, P325, DOI 10.1111/j.1468-2982.2007.01291.x; Aslan S, 2010, MAGN RESON MED, V63, P765, DOI 10.1002/mrm.22245; Asllani I, 2008, MAGN RESON MED, V60, P1362, DOI 10.1002/mrm.21670; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bartolini M, 2005, FUNCT NEUROL, V20, P209; Bashir A, 2013, NEUROLOGY, V81, P1260, DOI 10.1212/WNL.0b013e3182a6cb32; Bigal ME, 2008, NEUROLOGY, V70, P1525, DOI 10.1212/01.wnl.0000310645.31020.b1; Brennan KC, 2010, CURR OPIN NEUROL, V23, P266, DOI 10.1097/WCO.0b013e32833821c1; Burstein R, 2015, J NEUROSCI, V35, P6619, DOI 10.1523/JNEUROSCI.0373-15.2015; Burstein R, 2010, ANN NEUROL, V68, P81, DOI 10.1002/ana.21994; Buxton RB, 1998, MAGNET RESON MED, V40, P383, DOI 10.1002/mrm.1910400308; Cavestri R, 1995, Minerva Med, V86, P257; Chappell MA, 2011, MAGN RESON MED, V65, P1173, DOI 10.1002/mrm.22641; Coppola G, 2007, Cephalalgia, V27, P1427, DOI 10.1111/j.1468-2982.2007.01500.x; Coppola G, 2005, BRAIN, V128, P98, DOI 10.1093/brain/awh334; Coppola G, 2009, NEUROBIOL LEARN MEM, V92, P249, DOI 10.1016/j.nlm.2008.07.006; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; DaSilva AFM, 2007, NEUROLOGY, V69, P1990, DOI 10.1212/01.wnl.0000291618.32247.2d; DaSilva AFM, 2007, NEUROREPORT, V18, P301, DOI 10.1097/WNR.0b013e32801776bb; Donahue MJ, 2006, NMR BIOMED, V19, P1043, DOI 10.1002/nbm.1075; Ferrari MD, 2015, LANCET NEUROL, V14, P65, DOI 10.1016/S1474-4422(14)70220-0; Friberg L, 1994, Eur J Neurol, V1, P35, DOI 10.1111/j.1468-1331.1994.tb00048.x; Goadsby Peter J, 2013, Handb Clin Neurol, V117, P193, DOI 10.1016/B978-0-444-53491-0.00016-X; Goadsby PJ, 2002, NEW ENGL J MED, V346, P257, DOI 10.1056/NEJMra010917; Golay Xavier, 2004, Top Magn Reson Imaging, V15, P10, DOI 10.1097/00002142-200402000-00003; Hansen JM, 2015, CEPHALALGIA INT J HE, DOI [10.1177/0333102415584601, DOI 10.1177/0333102415584601]; Hendrikse J, 2012, NEUROIMAG CLIN N AM, V22, P259, DOI 10.1016/j.nic.2012.02.003; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; Hickmott PW, 2005, NAT NEUROSCI, V8, P140, DOI 10.1038/nn1384; Hodkinson DJ, 2015, PAIN, V156, P1301, DOI 10.1097/j.pain.0000000000000176; Hodkinson DJ, 2013, NEUROIMAGE-CLIN, V3, P301, DOI 10.1016/j.nicl.2013.09.004; Jakubowski M, 2005, NEUROLOGY, V65, P1419, DOI 10.1212/01.wnl.0000183358.53939.38; Jenkins BG, 2012, NEUROIMAGE, V62, P1072, DOI 10.1016/j.neuroimage.2012.03.075; Kim JH, 2014, CEPHALALGIA, V34, P1125, DOI 10.1177/0333102414531155; LEVINE SR, 1987, CEPHALALGIA, V7, P245, DOI 10.1046/j.1468-2982.1987.0704245.x; Liang X, 2013, P NATL ACAD SCI USA, V110, P1929, DOI 10.1073/pnas.1214900110; Liang XY, 2014, NEUROIMAGE, V87, P265, DOI 10.1016/j.neuroimage.2013.11.013; Lipton RB, 2008, ANN NEUROL, V63, P148, DOI 10.1002/ana.21211; Lord LD, 2013, J CEREBR BLOOD F MET, V33, P1347, DOI 10.1038/jcbfm.2013.94; Lu HZ, 2006, MAGN RESON MED, V56, P546, DOI 10.1002/mrm.20976; Lu HZ, 2004, MAGN RESON MED, V52, P679, DOI 10.1002/mrm.20178; Maleki N, 2012, CEPHALALGIA, V32, P607, DOI 10.1177/0333102412445622; Noseda R, 2011, J NEUROSCI, V31, P14204, DOI 10.1523/JNEUROSCI.3285-11.2011; Penfield W, 1937, BRAIN, V60, P383; Petr J, 2013, MAGN RESON MED, V70, P1535, DOI 10.1002/mrm.24601; Prescot A, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-34; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reyngoudt H, 2012, CEPHALALGIA, V32, P845, DOI 10.1177/0333102412452048; ROBERTSON WM, 1989, NEUROLOGY, V39, P947, DOI 10.1212/WNL.39.7.947; Schwedt TJ, 2013, CURR OPIN NEUROL, V26, P248, DOI 10.1097/WCO.0b013e328360edb1; Soriani S, 1997, HEADACHE, V37, P31, DOI 10.1046/j.1526-4610.1997.3701031.x; Strassman AM, 1996, NATURE, V384, P560, DOI 10.1038/384560a0; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; Valentini E, 2012, NEUROIMAGE, V59, P1571, DOI 10.1016/j.neuroimage.2011.08.069; Wu WC, 2007, MAGN RESON MED, V58, P1020, DOI 10.1002/mrm.21403	59	34	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137971	10.1371/journal.pone.0137971	http://dx.doi.org/10.1371/journal.pone.0137971			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372461	Green Published, Green Submitted, gold			2022-12-27	WOS:000361604400042
J	Li, JY; Hu, JP				Li, Jiying; Hu, Jianping			Using Co-Expression Analysis and Stress-Based Screens to Uncover Arabidopsis Peroxisomal Proteins Involved in Drought Response	PLOS ONE			English	Article							PLANT PEROXISOMES; GENE-EXPRESSION; ENDOPLASMIC-RETICULUM; SIGNAL-TRANSDUCTION; NONHOST RESISTANCE; PROTEOME ANALYSIS; BETA-OXIDATION; DEFENSE; MUTANT; PHOTORESPIRATION	Peroxisomes are essential organelles that house a wide array of metabolic reactions important for plant growth and development. However, our knowledge regarding the role of peroxisomal proteins in various biological processes, including plant stress response, is still incomplete. Recent proteomic studies of plant peroxisomes significantly increased the number of known peroxisomal proteins and greatly facilitated the study of peroxisomes at the systems level. The objectives of this study were to determine whether genes that encode peroxisomal proteins with related functions are co-expressed in Arabidopsis and identify peroxisomal proteins involved in stress response using in silico analysis and mutant screens. Using microarray data from online databases, we performed hierarchical clustering analysis to generate a comprehensive view of transcript level changes for Arabidopsis peroxisomal genes during development and under abiotic and biotic stress conditions. Many genes involved in the same metabolic pathways exhibited co-expression, some genes known to be involved in stress response are regulated by the corresponding stress conditions, and function of some peroxisomal proteins could be predicted based on their co-expression pattern. Since drought caused expression changes to the highest number of genes that encode peroxisomal proteins, we subjected a subset of Arabidopsis peroxisomal mutants to a drought stress assay. Mutants of the LON2 protease and the photorespiratory enzyme hydroxypyruvate reductase 1 (HPR1) showed enhanced susceptibility to drought, suggesting the involvement of peroxisomal quality control and photorespiration in drought resistance. Our study provided a global view of how genes that encode peroxisomal proteins respond to developmental and environmental cues and began to reveal additional peroxisomal proteins involved in stress response, thus opening up new avenues to investigate the role of peroxisomes in plant adaptation to environmental stresses.	[Li, Jiying; Hu, Jianping] Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA; [Li, Jiying] Michigan State Univ, Grad Program Genet, E Lansing, MI 48824 USA; [Hu, Jianping] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Hu, JP (corresponding author), Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA.	huji@msu.edu			Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy [DE-FG02-91ER20021]	Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by the Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy (DE-FG02-91ER20021; http://energy.gov/) to JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attaran E, 2014, PLANT PHYSIOL, V165, P1302, DOI 10.1104/pp.114.239004; Bauwe H, 2010, TRENDS PLANT SCI, V15, P330, DOI 10.1016/j.tplants.2010.03.006; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Cassin-Ross G, 2014, PLANT PHYSIOL, V166, P1546, DOI 10.1104/pp.114.250183; Cassin-Ross G, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.29464; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Coca M, 2010, PLANT J, V63, P526, DOI 10.1111/j.1365-313X.2010.04255.x; Dammann C, 2003, PLANT PHYSIOL, V132, P1840, DOI 10.1104/pp.103.020008; del Rio LA, 2011, ARCH BIOCHEM BIOPHYS, V506, P1, DOI 10.1016/j.abb.2010.10.022; Desai M, 2008, PLANT PHYSIOL, V146, P1117, DOI 10.1104/pp.107.113555; Farmer LM, 2013, PLANT CELL, V25, P4085, DOI 10.1105/tpc.113.113407; Gehan MA, 2015, CURR OPIN PLANT BIOL, V24, P39, DOI 10.1016/j.pbi.2015.01.004; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goto-Yamada S, 2014, PLANT CELL PHYSIOL, V55, P482, DOI 10.1093/pcp/pcu017; Hu JP, 2012, PLANT CELL, V24, P2279, DOI 10.1105/tpc.112.096586; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kaur Navneet, 2013, Subcell Biochem, V69, P195, DOI 10.1007/978-94-007-6889-5_11; Kaur N, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00103; Kaur Navneet, 2009, Arabidopsis Book, V7, pe0123, DOI 10.1199/tab.0123; Kotchoni SO, 2006, J BIOSCIENCES, V31, P389, DOI 10.1007/BF02704112; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; Lingard MJ, 2009, PLANT PHYSIOL, V151, P1354, DOI 10.1104/pp.109.142505; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; Ma CL, 2006, PLANT PHYSIOL, V141, P47, DOI 10.1104/pp.105.073841; Maeda K, 2009, MOL PLANT MICROBE IN, V22, P1331, DOI 10.1094/MPMI-22-11-1331; McCartney AW, 2005, PLANT CELL, V17, P3513, DOI 10.1105/tpc.105.036350; Okinaka Y, 2002, MOL PLANT MICROBE IN, V15, P1213, DOI 10.1094/MPMI.2002.15.12.1213; Pandey N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-216; Pieuchot L, 2012, ANNU REV MICROBIOL, V66, P237, DOI 10.1146/annurev-micro-092611-150126; Pracharoenwattana I, 2008, TRENDS PLANT SCI, V13, P522, DOI 10.1016/j.tplants.2008.07.003; Quan S, 2013, PLANT PHYSIOL, V163, P1518, DOI 10.1104/pp.113.223453; Quan S, 2010, PLANT SIGNAL BEHAV, V5, P151, DOI 10.4161/psb.5.2.10412; Queval G, 2007, PLANT J, V52, P640, DOI 10.1111/j.1365-313X.2007.03263.x; Reumann S, 2004, PLANT PHYSIOL, V135, P783, DOI 10.1104/pp.103.035584; Reumann S, 2009, PLANT PHYSIOL, V150, P125, DOI 10.1104/pp.109.137703; Rochon D, 2014, VIROLOGY, V452, P133, DOI 10.1016/j.virol.2013.12.035; Rojas CM, 2012, PLANT CELL, V24, P336, DOI 10.1105/tpc.111.093245; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sinclair AM, 2009, PLANT J, V59, P231, DOI 10.1111/j.1365-313X.2009.03863.x; Smith JJ, 2013, NAT REV MOL CELL BIO, V14, P803, DOI 10.1038/nrm3700; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sorhagen K, 2013, PLANT BIOLOGY, V15, P723, DOI 10.1111/j.1438-8677.2012.00723.x; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; Taler D, 2004, PLANT CELL, V16, P172, DOI 10.1105/tpc.016352; Warnes GR, 2015, GPLOTS VARIOUS R PRO; Westphal L, 2008, PLANT CELL, V20, P824, DOI 10.1105/tpc.107.056895; Willekens H, 1997, EMBO J, V16, P4806, DOI 10.1093/emboj/16.16.4806; Xiong LM, 2002, J BIOL CHEM, V277, P8588, DOI 10.1074/jbc.M109275200; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	52	28	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137762	10.1371/journal.pone.0137762	http://dx.doi.org/10.1371/journal.pone.0137762			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368942	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100131
J	Min, J; Zhang, QQ; Qiu, XL; Zhu, MH; Yu, HY; Gao, SS				Min, Jie; Zhang, Qianqian; Qiu, Xiaoli; Zhu, Minhao; Yu, Haiyang; Gao, Shanshan			Investigation on the Tribological Behavior and Wear Mechanism of Five Different Veneering Porcelains	PLOS ONE			English	Article							DENTAL CERAMICS; HUMAN ENAMEL; NORMAL FORCE; FRICTION; COEFFICIENT; MODES	Objectives The primary aim of this research was to investigate the wear behavior and wear mechanism of five different veneering porcelains. Methods Five kinds of veneering porcelains were selected in this research. The surface microhardness of all the samples was measured with a microhardness tester. Wear tests were performed on a ball-on-flat PLINT fretting wear machine, with lubrication of artificial saliva at 37 degrees C. The friction coefficients were recorded by the testing system. The microstructure features, wear volume, and damage morphologies were recorded and analyzed with a confocal laser scanning microscope and a scanning electron microscope. The wear mechanism was then elucidated. Results The friction coefficients of the five veneering porcelains differ significantly. No significant correlation between hardness and wear volume was found for these veneering porcelains. Under lubrication of artificial saliva, the porcelain with higher leucite crystal content exhibited greater wear resistance. Additionally, leucite crystal size and distribution in glass matrix influenced wear behavior. The wear mechanisms for these porcelains were similar: abrasive wear dominates the early stage, whereas delamination was the main damage mode at the later stage. Furthermore, delamination was more prominent for porcelains with larger crystal sizes. Significance Wear compatibility between porcelain and natural teeth is important for dental restorative materials. Investigation on crystal content, size, and distribution in glass matrix can provide insight for the selection of dental porcelains in clinical settings.	[Min, Jie; Zhang, Qianqian; Qiu, Xiaoli; Yu, Haiyang; Gao, Shanshan] Sichuan Univ, State Key Lab Oral Dis, West China Hosp Stomatol, Chengdu 610064, Peoples R China; [Zhu, Minhao] Southwest Jiaotong Univ, State Key Lab Tract Power, Chengdu, Peoples R China; [Qiu, Xiaoli] Second Peoples Hosp Nanning City, Dept Stomatol, Guangxi, Peoples R China	Sichuan University; Southwest Jiaotong University	Gao, SS (corresponding author), Sichuan Univ, State Key Lab Oral Dis, West China Hosp Stomatol, Chengdu 610064, Peoples R China.	christina12357@163.com			National Natural Science Foundation of China [81100777]; Research Fund for the Doctoral Program of Higher Education of China [20110181120076]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was supported by the National Natural Science Foundation of China (81100777), Research Fund for the Doctoral Program of Higher Education of China (20110181120076).	Cattell MJ, 2001, DENT MATER, V17, P21, DOI 10.1016/S0109-5641(00)00046-4; Cozza RC, 2009, WEAR, V267, P61, DOI 10.1016/j.wear.2009.01.055; Cozza RC, 2014, TRIBOL INT, V70, P52, DOI 10.1016/j.triboint.2013.09.010; Dahl B L, 1994, Quintessence Int, V25, P561; Elmaria A, 2006, J PROSTHET DENT, V96, P345, DOI 10.1016/j.prosdent.2006.09.002; Ghazal M, 2008, DENT MATER, V24, P502, DOI 10.1016/j.dental.2007.04.012; Giordano R A, 1996, Compend Contin Educ Dent, V17, P779; He YJ, 1996, J AM CERAM SOC, V79, P3090, DOI 10.1111/j.1151-2916.1996.tb08081.x; Ho WF, 2011, CERAM INT, V37, P1169, DOI 10.1016/j.ceramint.2010.11.027; Kalin M, 2003, WEAR, V255, P669, DOI 10.1016/S0043-1648(03)00069-3; Kim MJ, 2012, J DENT, V40, P979, DOI 10.1016/j.jdent.2012.08.004; Lee H H, 1997, Dent Mater J, V16, P134; Mackert Jr JR, 1996, J DENT RES, V75, P126; Oscar BL, 2005, J AM CERAM SOC, V88, P2159; Park S, 2008, DENT MATER, V24, P1477, DOI 10.1016/j.dental.2008.03.007; Sednda T, 1999, J AM CERAM SOC, V82, P1505; SEGHI RR, 1991, J DENT RES, V70, P221, DOI 10.1177/00220345910700031301; Sinmazisik G, 2006, DENT MATER, V22, P735, DOI 10.1016/j.dental.2005.08.007; Soler VC, 2010, MAT SCI ENG A-STRUCT, V527, P1730; Suh MS, 2008, WEAR, V264, P800, DOI 10.1016/j.wear.2006.12.079; Susmel L, 2014, INT J FATIGUE, V58, P94, DOI 10.1016/j.ijfatigue.2013.05.007; Tanaka R, 2010, ARCH ORAL BIOL, V55, P300, DOI 10.1016/j.archoralbio.2010.02.009; Wang L, 2012, J EUR CERAM SOC, V32, P2599, DOI 10.1016/j.jeurceramsoc.2012.03.021; Yap AUJ, 1997, J ORAL REHABIL, V24, P574, DOI 10.1046/j.1365-2842.1997.00528.x; Yoshimura HN, 2005, J AM CERAM SOC, V88, P1680, DOI 10.1111/j.1551-2916.2005.00334.x; Yu HY, 2006, WEAR, V261, P611, DOI 10.1016/j.wear.2006.01.024; Zhang Y, 2008, J AM CERAM SOC, V91, P1678, DOI 10.1111/j.1551-2916.2008.02312.x; [No title captured]	28	9	10	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137566	10.1371/journal.pone.0137566	http://dx.doi.org/10.1371/journal.pone.0137566			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368532	Green Submitted, gold, Green Published			2022-12-27	WOS:000361601100086
J	Niikura, R; Nagata, N; Shimbo, T; Sakurai, T; Aoki, T; Moriyasu, S; Sekine, K; Okubo, H; Watanabe, K; Yokoi, C; Yamada, A; Hirata, Y; Koike, K; Akiyama, J; Uemura, N				Niikura, Ryota; Nagata, Naoyoshi; Shimbo, Takuro; Sakurai, Toshiyuki; Aoki, Tomonori; Moriyasu, Shiori; Sekine, Katsunori; Okubo, Hidetaka; Watanabe, Kazuhiro; Yokoi, Chizu; Yamada, Atsuo; Hirata, Yoshihiro; Koike, Kazuhiko; Akiyama, Junichi; Uemura, Naomi			Adverse Events during Bowel Preparation and Colonoscopy in Patients with Acute Lower Gastrointestinal Bleeding Compared with Elective Non-Gastrointestinal Bleeding	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; URGENT COLONOSCOPY; HEMORRHAGE; DIVERTICULA; MANAGEMENT; ENDOSCOPY; DIAGNOSIS; RISK	Background There are limited data on the safety of colonoscopy in patients with lower gastrointestinal bleeding (LGIB). We examined the various adverse events associated with colonoscopy in acute LGIB compared with non-GIB patients. Methods Emergency hospitalized LGIB patients (n = 161) and age-and gender-matched non-GIB controls (n = 161) were selected. Primary outcomes were any adverse events during preparation and colonoscopy procedure. Secondary outcomes were five bowel preparationrelated adverse events-hypotension, systolic blood pressure < 100 mmHg, volume overload, vomiting, aspiration pneumonia and loss of consciousness-and four colonoscopyrelated adverse events-including hypotension, perforation, cerebrocardiovascular events and sepsis. Results During bowel preparation, 16 (9%) LGIB patients experienced an adverse event. None of the LGIB patients experienced volume overload, aspiration pneumonia or loss of consciousness; however, 12 (7%) had hypotension and 4 (2%) vomited. There were no significant differences in the five bowel preparation-related adverse events between LGIB and non-GIB patients. During colonoscopy, 25 (15%) LGIB patients experienced an adverse event. None LGIB patient had perforation or sepsis; however, 23 (14%) had hypotension and 2 (1%) experienced a cerebrocardiovascular event. There was no significant difference in the four colonoscopy-related adverse events between LGIB and non-GIB patients. In addition, no significant difference in any of the nine adverse events was found among subgroups: patients aged >= 65 years, those with comorbidities, and those with antithrombotic drug use. Conclusions Adverse events in bowel preparation and colonoscopy among acute LGIB patients were low. No significant difference was found in adverse events between LGIB and non-GIB patients. These adverse events were also low in elderly LGIB patients, as well as in those with co-morbidities and antithrombotic drug use, suggesting that colonoscopy performed during acute LGIB did not increase adverse events.	[Niikura, Ryota; Nagata, Naoyoshi; Sakurai, Toshiyuki; Aoki, Tomonori; Moriyasu, Shiori; Sekine, Katsunori; Okubo, Hidetaka; Watanabe, Kazuhiro; Yokoi, Chizu; Akiyama, Junichi] Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Niikura, Ryota; Yamada, Atsuo; Hirata, Yoshihiro; Koike, Kazuhiko] Univ Tokyo, Dept Gastroenterol, Grad Sch Med, Tokyo, Japan; [Shimbo, Takuro] Ohta Nishinouchi Hosp, Koriyama, Fukushima, Japan; [Uemura, Naomi] Kohnodai Hosp, Dept Gastroenterol & Hepatol, Natl Ctr Global Hlth & Med, Chiba, Japan	National Center for Global Health & Medicine - Japan; University of Tokyo; National Center for Global Health & Medicine - Japan	Nagata, N (corresponding author), Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Tokyo, Japan.	nnagata_ncgm@yahoo.co.jp			National Center for Global Health and Medicine [26A-201]	National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan)	This work was supported in part by a Grant-in-Aid for Research from the National Center for Global Health and Medicine (26A-201). The funders had no role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Anderson MA, 2009, GASTROINTEST ENDOSC, V70, P1060, DOI 10.1016/j.gie.2009.09.040; Belsey J, 2009, ALIMENT PHARM THER, V29, P15, DOI 10.1111/j.1365-2036.2008.03837.x; Chan FKL, 2010, J RHEUMATOL, V37, P167, DOI 10.3899/jrheum.090168; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Gabel A, 1999, DIGESTION, V60, P284, DOI 10.1159/000007672; Green BT, 2005, AM J GASTROENTEROL, V100, P2395, DOI 10.1111/j.1572-0241.2005.00306.x; JENSEN DM, 1988, GASTROENTEROLOGY, V95, P1569, DOI 10.1016/S0016-5085(88)80079-9; Jensen DM, 2000, NEW ENGL J MED, V342, P78, DOI 10.1056/NEJM200001133420202; Jepsen P, 2014, GASTROENTEROLOGY, V146, P147, DOI 10.1053/j.gastro.2013.09.019; Lhewa DY, 2012, WORLD J GASTROENTERO, V18, P1185, DOI 10.3748/wjg.v18.i11.1185; Loffeld RJLF, 2011, ENDOSCOPY, V43, P240, DOI 10.1055/s-0030-1255939; Longstreth GF, 1997, AM J GASTROENTEROL, V92, P419; Marschall HU, 1998, GASTROINTEST ENDOSC, V47, P408, DOI 10.1016/S0016-5107(98)70229-9; McQuaid KR, 2008, GASTROINTEST ENDOSC, V67, P910, DOI 10.1016/j.gie.2007.12.046; Nagata N, 2014, GASTROINTEST ENDOSC, V80, P1124, DOI 10.1016/j.gie.2014.06.039; Nagata N, 2014, J GASTROEN HEPATOL, V29, P1786, DOI 10.1111/jgh.12595; Nagata N, 2014, INT J CANCER, V135, P2273, DOI 10.1002/ijc.28872; Nagata N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081137; Niikura R, 2015, J CLIN GASTROENTEROL, V49, pE24, DOI 10.1097/MCG.0000000000000140; Niikura R, 2013, WORLD J GASTROENTERO, V19, P2362, DOI 10.3748/wjg.v19.i15.2362; Pasha SF, 2014, GASTROINTEST ENDOSC, V79, P875, DOI 10.1016/j.gie.2013.10.039; VELLACOTT KD, 1986, ANN ROY COLL SURG, V68, P243; Wexner SD, 2006, GASTROINTEST ENDOSC, V63, P894, DOI 10.1016/j.gie.2006.03.918; Witt DM, 2012, ARCH INTERN MED, V172, P1484, DOI 10.1001/archinternmed.2012.4261; Zuckerman GR, 1998, GASTROINTEST ENDOSC, V48, P606, DOI 10.1016/S0016-5107(98)70043-4	25	19	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138000	10.1371/journal.pone.0138000	http://dx.doi.org/10.1371/journal.pone.0138000			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368562	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100199
J	van Oeffelen, AAM; Rittersma, S; Vaartjes, I; Stronks, K; Bots, ML; Agyemang, C				van Oeffelen, Aloysia A. M.; Rittersma, Saskia; Vaartjes, Ilonca; Stronks, Karien; Bots, Michiel L.; Agyemang, Charles			Are There Ethnic Inequalities in Revascularisation Procedure Rate after an ST-Elevation Myocardial Infarction?	PLOS ONE			English	Article							INVASIVE CARDIAC PROCEDURES; RACIAL-DIFFERENCES; PRIMARY ANGIOPLASTY; CORONARY-DISEASE; DISPARITIES; PREVALENCE; MANAGEMENT; MORTALITY; VETERANS; SURVIVAL	Background Previously, ethnic inequalities in prognosis after a first acute myocardial infarction were observed in the Netherlands. This might be due to differences in revascularisation rate between ethnic minority groups and ethnic Dutch. Therefore, we investigated inequalities in revascularisation rate after occurrence of an ST-elevation myocardial infarction (STEMI) between first generation ethnic minority groups (henceforth, migrants) and ethnic Dutch. Methods All STEMI events between 2006 and 2011 were identified in a subset of the Achmea Health Database, which records medical care to persons insured at the Achmea health insurance company, a major health insurance company in the central part of the Netherlands. Ethnic Dutch and migrants from Suriname (Hindustani Surinamese and non-Hindustani Surinamese), Morocco, and Turkey were included (n = 1,765). Multivariable Cox proportional hazards regression analyses were used to identify ethnic inequalities in revascularisation rate (percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG)) after a STEMI event. Results On average, 73.2% of STEMI events were followed by a revascularisation procedure. After adjustment for confounders (age, sex, degree of urbanization) no significant differences in revascularisation rate were found between the ethnic Dutch population and Hindustani Surinamese (HR: 1.04; 0.85-1.27), non-Hindustani Surinamese (HR: 0.98; 0.63-1.51), Moroccan (HR: 0.94; 0.77-1.14), and Turkish migrants (HR: 1.04; 0.88-1.24). Additional adjustment for comorbidity and neighborhood income did not change our findings. Conclusion Our study suggests no ethnic inequalities in revascularisation rate after a STEMI event. This finding is in agreement with the universally accessible health care system in the Netherlands.	[van Oeffelen, Aloysia A. M.; Vaartjes, Ilonca; Bots, Michiel L.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Rittersma, Saskia] Univ Med Ctr Utrecht, Dept Cardiol, NL-3508 GA Utrecht, Netherlands; [Stronks, Karien; Agyemang, Charles] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1100 DD Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam	van Oeffelen, AAM (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands.	L.vanOeffelen@umcutrecht.nl		Stronks, Karien/0000-0002-0921-2232	Dutch Heart Foundation [2010B296]	Dutch Heart Foundation(Netherlands Heart Foundation)	This work was supported by the Dutch Heart Foundation [grant number 2010B296]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyemang C, 2005, J HYPERTENS, V23, P1971, DOI 10.1097/01.hjh.0000186835.63996.d4; Bansal N, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003415; Boelman L, 2012, EUR J PSYCHIAT, V26, P236, DOI 10.4321/S0213-61632012000400003; Boersma E, 2006, EUR HEART J, V27, P779, DOI 10.1093/eurheartj/ehi810; Chan MY, 2009, CIRCULATION, V119, P3110, DOI 10.1161/CIRCULATIONAHA.108.799981; Cram P, 2009, J NATL MED ASSOC, V101, P1132, DOI 10.1016/S0027-9684(15)31109-3; De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20; Echols MR, 2007, AM J CARDIOL, V99, P315, DOI 10.1016/j.amjcard.2006.08.031; Feder G, 2002, BRIT MED J, V324, P511, DOI 10.1136/bmj.324.7336.511; Freund KM, 2012, J WOMENS HEALTH, V21, P126, DOI 10.1089/jwh.2010.2580; Iribarren C, 2005, ARCH INTERN MED, V165, P2105, DOI 10.1001/archinte.165.18.2105; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Kendall H, 2013, EUR J PREV CARDIOL, V20, P737, DOI 10.1177/2047487312447844; Kessels W, 2008, REGIONAAL INKOMENSON; Mandelzweig L, 2006, EUR HEART J, V27, P2285, DOI 10.1093/eurheartj/ehl196; Mindell J, 2008, J PUBLIC HEALTH-UK, V30, P45, DOI 10.1093/pubmed/fdm077; Peniston RL, 2000, AM HEART J, V139, P840, DOI 10.1016/S0002-8703(00)90016-4; Quadri G, 2013, ACTA CARDIOL, V68, P151, DOI 10.1080/AC.68.2.2967272; Sedlis SP, 1997, J CLIN EPIDEMIOL, V50, P899, DOI 10.1016/S0895-4356(97)00089-9; Smeets HM, 2011, J CLIN EPIDEMIOL, V64, P424, DOI 10.1016/j.jclinepi.2010.04.023; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Stenestrand U, 2002, LANCET, V359, P1805, DOI 10.1016/S0140-6736(02)08710-X; Stronks K, 2009, ETHNIC HEALTH, V14, P255, DOI 10.1080/13557850802509206; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Thomas KL, 2010, AM HEART J, V160, P744, DOI 10.1016/j.ahj.2010.06.014; Ting HH, 2008, AM J CARDIOL, V101, P286, DOI 10.1016/j.amjcard.2007.09.084; Trevelyan J, 2001, INT J CARDIOL, V77, P275, DOI 10.1016/S0167-5273(00)00444-7; US Census Bureau, 2010, INC POV HLTH INS COV; van Oeffelen AAM, 2014, HEART, V100, P1436, DOI 10.1136/heartjnl-2013-305444; Whittle J, 2006, J AM COLL CARDIOL, V47, P2034, DOI 10.1016/j.jacc.2005.12.059; Wijns W, 2010, EUR HEART J, V31, P2501, DOI 10.1093/eurheartj/ehq277	31	6	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136415	10.1371/journal.pone.0136415	http://dx.doi.org/10.1371/journal.pone.0136415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368504	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100016
J	Brenk-Franz, K; Strauss, B; Tiesler, F; Fleischhauer, C; Ciechanowski, P; Schneider, N; Gensichen, J				Brenk-Franz, Katja; Strauss, Bernhard; Tiesler, Fabian; Fleischhauer, Christian; Ciechanowski, Paul; Schneider, Nico; Gensichen, Jochen			The Influence of Adult Attachment on Patient Self-Management in Primary Care The Need for a Personalized Approach and Patient-Centred Care	PLOS ONE			English	Article							ILLNESS RATING-SCALE; CHRONIC DISEASE; HEALTH-CARE; PATTERNS; STYLES; MODEL	Objective Self-management strategies are essential elements of evidence-based treatment in patients with chronic conditions in primary care. Our objective was to analyse different self-management skills and behaviours and their association to adult attachment in primary care patients with multiple chronic conditions. Methods In the apricare study (Adult Attachment in Primary Care) we used a prospective longitudinal design to examine the association between adult attachment and self-management in primary care patients with multimorbidity. The attachment dimensions avoidance and anxiety were measured using the ECR-RD. Self-management skills were measured by the FERUS (motivation to change, coping, self-efficacy, hope, social support) and self-management-behaviour by the DSMQ (glucose management, dietary control, physical activity, health-care use). Clinical diagnosis and severity of disease were assessed by the patients' GPs. Multivariate analyses (GLM) were used to assess the relationship between the dimensions of adult attachment and patient self-management. Results 219 patients in primary care with multiple chronic conditions (type II diabetes, hypertension and at least one other chronic condition) between the ages of 50 and 85 were included in the study. The attachment dimension anxiety was positively associated with motivation to change and negatively associated with coping, self-efficacy and hope, dietary control and physical activity. Avoidance was negatively associated with coping, self-efficacy, social support and health care use. Conclusion The two attachment dimensions anxiety and avoidance are associated with different components of self-management. A personalized, attachment-based view on patients with chronic diseases could be the key to effective, individual self-management approaches in primary care.	[Brenk-Franz, Katja; Tiesler, Fabian; Fleischhauer, Christian; Schneider, Nico; Gensichen, Jochen] Univ Hosp, Inst Gen Practice & Family Med, Jena, Germany; [Brenk-Franz, Katja; Strauss, Bernhard] Univ Hosp, Inst Psychosocial Med & Psychotherapy, Jena, Germany; [Ciechanowski, Paul] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; University of Washington; University of Washington Seattle	Brenk-Franz, K (corresponding author), Univ Hosp, Inst Gen Practice & Family Med, Jena, Germany.	katja.brenk-franz@med.uni-jena.de			German Research Foundation (DFG) [FZ GE 2073/5-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	Financial support (about 100.000 Euro) was provided by the German Research Foundation, (http://www.dfg.de/en/index.jsp) DFG: FZ GE 2073/5-1.	BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A., 1997, PSYCHOL REV, V12, P8; BARTHOLOMEW K, 1991, J PERS SOC PSYCHOL, V61, P226, DOI 10.1037/0022-3514.61.2.226; Berman WH, 1994, ATTACHEMENT ADULTS T; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; BOWLBY J, 1977, BRIT J PSYCHIAT, V130, P201, DOI 10.1192/bjp.130.3.201; Bowlby J, 1988, SECURE BASE CLIN APP; Campbell L, 2005, J PERS SOC PSYCHOL, V88, P510, DOI 10.1037/0022-3514.88.3.510; Ciechanowski P, 1999, PSYCHOSOM MED, V61, P110, DOI 10.1097/00006842-199901000-00145; Ciechanowski PS, 2002, PSYCHOSOM MED, V64, P660, DOI 10.1097/01.PSY.0000021948.90613.76; Ciechanowski PS, 2002, DIABETES CARE, V25, P731, DOI 10.2337/diacare.25.4.731; Consedine NS, 2013, J BEHAV HLTH, V2, P308; Ehrenthal Johannes C, 2009, Psychother Psychosom Med Psychol, V59, P215, DOI 10.1055/s-2008-1067425; Fraley RC, 2000, J PERS SOC PSYCHOL, V78, P350, DOI 10.1037/0022-3514.78.2.350; Gensichen Jochen, 2006, Z Arztl Fortbild Qualitatssich, V100, P365; Gilks WR, 1996, MARKOV CHAIN MONTE C; Henderson SJ, 2009, ATTACHMENT SECURITY; Hudon C, 2007, J CLIN EPIDEMIOL, V60, P212, DOI 10.1016/j.jclinepi.2005.12.021; Jack M., 2007, FERUS QUESTIONNAIRE; Ju┬ckel KH., 1998, MESSUNG SOZIODEMOGRA, P7; Kanfer FH., 2006, SELBSTMANAGEMENT THE; Konig CJ, 2006, LEHRBUCH PERSONALPSY; Maunder RG, 2001, PSYCHOSOM MED, V63, P556, DOI 10.1097/00006842-200107000-00006; MIKULINCER M, 1991, J PERS SOC PSYCHOL, V61, P321, DOI 10.1037/0022-3514.61.2.321; Mikulincer M, 2003, MOTIV EMOTION, V27, P77, DOI 10.1023/A:1024515519160; Mikulincer M., 2007, ATTACHMENT ADULTHOOD; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; OLSON CL, 1976, PSYCHOL BULL, V83, P579, DOI 10.1037/0033-2909.83.4.579; Rholes W.S., 1998, ATTACHMENT THEORY CL, P166; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; Rubin DB, 2004, MULTIPLE IMPUTATION; Schafer I, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-145; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Schmidt S, 2002, J PSYCHOSOM RES, V53, P763, DOI 10.1016/S0022-3999(02)00335-5; Schmitt A, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-138; Schwarzer R, 2002, HLTH PSYCHOL A Z; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64	37	26	27	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0136723	10.1371/journal.pone.0136723	http://dx.doi.org/10.1371/journal.pone.0136723			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0ZE	26381140	gold, Green Published, Green Submitted			2022-12-27	WOS:000361790200011
J	Kreel, NE; Tabita, R				Kreel, Nathan E.; Tabita, Robert			Serine 363 of a Hydrophobic Region of Archaeal Ribulose 1,5-Bisphosphate Carboxylase/Oxygenase from Archaeoglobus fulgidus and Thermococcus kodakaraensis Affects CO2/O-2 Substrate Specificity and Oxygen Sensitivity	PLOS ONE			English	Article							RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; HYPERTHERMOPHILIC ARCHAEON; BISPHOSPHATE CARBOXYLASE/OXYGENASE; CRYSTAL-STRUCTURE; III RUBISCO; FORM-III; MECHANISM; PROTEINS; SUBSTITUTIONS; TEMPERATURE	Archaeal ribulose 1,5-bisphospate carboxylase/oxygenase (RubisCO) is differentiated from other RubisCO enzymes and is classified as a form III enzyme, as opposed to the form I and form II RubisCOs typical of chemoautotrophic bacteria and prokaryotic and eukaryotic phototrophs. The form III enzyme from archaea is particularly interesting as several of these proteins exhibit unusual and reversible sensitivity to molecular oxygen, including the enzyme from Archaeoglobus fulgidus. Previous studies with A. fulgidus RbcL2 had shown the importance of Met-295 in oxygen sensitivity and pointed towards the potential significance of another residue (Ser-363) found in a hydrophobic pocket that is conserved in all RubisCO proteins. In the current study, further structure/function studies have been performed focusing on Ser-363 of A. fulgidus RbcL2; various changes in this and other residues of the hydrophobic pocket point to and definitively establish the importance of Ser-363 with respect to interactions with oxygen. In addition, previous findings had indicated discrepant CO2/O-2 specificity determinations of the Thermococcus kodakaraensis RubisCO, a close homolog of A. fulgidus RbcL2. It is shown here that the T. kodakaraensis enzyme exhibits a similar substrate specificity as the A. fulgidus enzyme and is also oxygen sensitive, with equivalent residues involved in oxygen interactions.	[Kreel, Nathan E.; Tabita, Robert] Ohio State Univ, Ohio State Univ Biochem Program, Columbus, OH 43210 USA; [Tabita, Robert] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Tabita, R (corresponding author), Ohio State Univ, Ohio State Univ Biochem Program, 484 West 12th Ave, Columbus, OH 43210 USA.	tabita.1@osu.edu			Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U. S. Department of Energy [DE-FG02-08ER15976]	Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U. S. Department of Energy(United States Department of Energy (DOE))	This study was supported by grant DE-FG02-08ER15976 from the Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U. S. Department of Energy.	Alonso H, 2009, J BIOL CHEM, V284, P33876, DOI 10.1074/jbc.M109.050989; Aono A, 2015, NATURE CHEM BIOL, DOI [10.1038/nchembio.1786, DOI 10.1038/NCHEMBI0.1786]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BROOKS A, 1985, PLANTA, V165, P397, DOI 10.1007/BF00392238; Cleland WW, 1998, CHEM REV, V98, P549, DOI 10.1021/cr970010r; Deppenmeier U, 2002, J MOL MICROB BIOTECH, V4, P453; Estelmann S, 2011, FEMS MICROBIOL LETT, V319, P65, DOI 10.1111/j.1574-6968.2011.02268.x; Ezaki S, 1999, J BIOL CHEM, V274, P5078, DOI 10.1074/jbc.274.8.5078; Finn MW, 2004, J BACTERIOL, V186, P6360, DOI 10.1128/JB.186.19.6360-6366.2004; Finn MW, 2003, J BACTERIOL, V185, P3049, DOI 10.1128/JB.185.10.3049-3059.2003; Galagan JE, 2002, GENOME RES, V12, P532, DOI 10.1101/gr.223902; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; GUTTERIDGE S, 1995, PLANT CELL, V7, P809, DOI 10.1105/tpc.7.7.809; HARPEL MR, 1993, ANAL BIOCHEM, V209, P367, DOI 10.1006/abio.1993.1136; HARPEL MR, 1992, J BIOL CHEM, V267, P6475; Hauser T, 2015, NAT PLANTS, V1, P1, DOI [10.1038/NPLANTS.2015.65, 10.1038/nplants.2015.65]; JORDAN DB, 1981, NATURE, V291, P513, DOI 10.1038/291513a0; JORDAN DB, 1984, PLANTA, V161, P308, DOI 10.1007/BF00398720; Kitano K, 2001, STRUCTURE, V9, P473, DOI 10.1016/S0969-2126(01)00608-6; Kreel NE, 2007, J BIOL CHEM, V282, P1341, DOI 10.1074/jbc.M609399200; KUNG SD, 1976, SCIENCE, V191, P429; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE GJ, 1992, BIOCHEMISTRY-US, V31, P2304, DOI 10.1021/bi00123a014; Lin MT, 2014, NATURE, V513, P547, DOI 10.1038/nature13776; Maeda N, 1999, J MOL BIOL, V293, P57, DOI 10.1006/jmbi.1999.3145; Maeda N, 2002, J BIOL CHEM, V277, P31656, DOI 10.1074/jbc.M203117200; Nishitani Y, 2010, J BIOL CHEM, V285, P39339, DOI 10.1074/jbc.M110.147587; Papworth C.B., 1996, STRATEGIES, V9, P3, DOI DOI 10.1080/08924562.1996.11000299; Satagopan S, 2014, J BIOL CHEM, V289, P21433, DOI 10.1074/jbc.M114.578625; Satagopan S, 2009, BIOCHEMISTRY-US, V48, P9076, DOI 10.1021/bi9006385; Sato T, 2007, SCIENCE, V315, P1003, DOI 10.1126/science.1135999; Smith SA, 2003, J MOL BIOL, V331, P557, DOI 10.1016/S0022-2836(03)00786-1; Stec B, 2012, P NATL ACAD SCI USA, V109, P18785, DOI 10.1073/pnas.1210754109; Tabita FR, 2008, J EXP BOT, V59, P1515, DOI 10.1093/jxb/erm361; Tabita FR, 2007, MICROBIOL MOL BIOL R, V71, P576, DOI 10.1128/MMBR.00015-07; Tabita FR, 1999, PHOTOSYNTH RES, V60, P1, DOI 10.1023/A:1006211417981; Tabita FR, 2008, PHILOS T R SOC B, V363, P563; Tcherkez G, 2016, PLANT CELL ENVIRON, V39, P983, DOI 10.1111/pce.12629; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Watson GMF, 1997, FEMS MICROBIOL LETT, V146, P13, DOI 10.1016/S0378-1097(96)00417-X; Watson GMF, 1999, J BACTERIOL, V181, P1569, DOI 10.1128/JB.181.5.1569-1575.1999; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yoshida S, 2007, APPL ENVIRON MICROB, V73, P6254, DOI 10.1128/AEM.00044-07; ZHANG KYJ, 1994, PROTEIN SCI, V3, P64; ZHU GH, 1994, J BIOL CHEM, V269, P3952	45	13	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138351	10.1371/journal.pone.0138351	http://dx.doi.org/10.1371/journal.pone.0138351			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381513	Green Published, Green Submitted, gold			2022-12-27	WOS:000361790200094
J	Su, LQ; Gao, SJ; Unverzagt, FW; Cheng, YB; Hake, AM; Xin, PJ; Chen, C; Liu, JY; Ma, F; Bian, JC; Li, P; Jin, YL				Su, Liqin; Gao, Sujuan; Unverzagt, Frederick W.; Cheng, Yibin; Hake, Ann M.; Xin, Pengju; Chen, Chen; Liu, Jingyi; Ma, Feng; Bian, Jianchao; Li, Ping; Jin, Yinlong			Selenium Level and Dyslipidemia in Rural Elderly Chinese	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; APOLIPOPROTEIN-E GENOTYPES; SERUM SELENIUM; CARDIOVASCULAR-DISEASE; LIPID-PEROXIDATION; METABOLIC SYNDROME; PLASMA SELENIUM; PROSTATE-CANCER; RISK-FACTORS; VITAMIN-E	Objective Higher selenium level has been hypothesized to have the potential to reduce the risk of cardiovascular diseases including dyslipidemia. However, results from previous studies are inconsistent. This study aims to determine the association between selenium level and dyslipidemia in elderly Chinese with relatively low selenium status. Methods A cross-sectional study of 1859 participants aged 65 or older from four rural counties in China was conducted. Serum total cholesterol (TC), triglycerides (TG), high density lipoprotein-cholesterol (HDLC) and low-density lipoprotein-cholesterol (LDLC), nail selenium concentration and APOE genotype were measured in all subjects. The four types of dyslipidemia were defined as > 5.17mmol/L for High-TC, > 1.69 mmol/L for High-TG, > 3.36 mmol/L for High-LDLC, and < 1.04 mmol/L for Low-HDLC according to Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults. Logistic models adjusting for age, gender, APOE genotype, body mass index, alcohol consumption, smoking, physical activity, medication use for cardiovascular diseases were used to examine the relationship between selenium levels and the risk of dyslipidemia. Results Mean nail selenium concentration was 0.465 mu g/gin this sample. Rates for High-TC, High-LDLC, High-TG, Low-HDLC were 18.13%, 13.23%, 12.21% and 32.76% respectively. Results from logistic models indicated that higher selenium levels were significantly associated with higher risk of High-TC, High-LDLC and lower risk of Low-HDLC adjusting for covariates (p < 0.0001). Compared with the lowest selenium quartile group, participants in selenium quartile groups 2, 3 and 4 had significantly higher rates of High-TC, High-LDLC, High-TG, and lower rate of Low-HDLC adjusting for covariates. No significant association was observed between selenium level and the risk of High-TG. APOE epsilon 4 carriers had higher rates of High-TC and High-LDLC. There was no interaction between selenium level and APOE with the rates of dyslipidemia. Conclusions Our results suggest long-term selenium exposure level may be associated with the risk of dyslipidemia in elderly population. Future studies are needed to examine the underlying mechanism of the association.	[Su, Liqin] Chinese Ctr Dis Control & Prevent, Inst Environm Hlth & Related Prod Safety, Dept Environm Impact Assessment, Beijing, Peoples R China; [Gao, Sujuan] Indiana Univ Sch Med, Dept Biostat, Indianapolis, IN 46202 USA; [Unverzagt, Frederick W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Cheng, Yibin; Xin, Pengju; Chen, Chen; Liu, Jingyi; Ma, Feng; Jin, Yinlong] Chinese Ctr Dis Control & Prevent, Inst Environm Hlth & Related Prod Safety, Dept Environm Epidemiol, Beijing, Peoples R China; [Hake, Ann M.] Indiana Univ Sch Med, Dept Neurol, Indianapolis, IN 46202 USA; [Bian, Jianchao] Shandong Inst Prevent & Treatment Endem Dis China, Jinan, Peoples R China; [Li, Ping] Sichuan Prov Ctr Dis Control & Prevent China, Chengdu, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute of Environmental Health, Chinese Center for Disease Control & Prevention; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Chinese Center for Disease Control & Prevention; National Institute of Environmental Health, Chinese Center for Disease Control & Prevention; Indiana University System; Indiana University Bloomington	Jin, YL (corresponding author), Chinese Ctr Dis Control & Prevent, Inst Environm Hlth & Related Prod Safety, Dept Environm Epidemiol, Beijing, Peoples R China.	jinyinlong1951@sina.com	Li, Ping/GYV-4914-2022		National Institutes of Health [2R01 AG019181]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a grant from the National Institutes of Health, with grant number 2R01 AG019181, URL: http://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alissa EM, 2003, MED SCI MONITOR, V9, pRA9; [Anonymous], 2007, ZHONGHUA XIN XUE GUA, V35, P390, DOI DOI 10.3760/J.ISSN:0253-3758.2007.05.003; Arnaud J, 2009, J TRACE ELEM MED BIO, V23, P21, DOI 10.1016/j.jtemb.2008.08.001; Ayaz M, 2004, ARCH BIOCHEM BIOPHYS, V426, P83, DOI 10.1016/j.abb.2004.03.030; Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P145, DOI 10.1081/CLT-100102417; Bates CJ, 2002, J TRACE ELEM MED BIO, V16, P1, DOI 10.1016/S0946-672X(02)80002-5; Bleys J, 2008, AM J CLIN NUTR, V88, P416; Bleys J, 2006, AM J CLIN NUTR, V84, P880, DOI 10.1093/ajcn/84.4.880; Brown K M, 2001, Public Health Nutr, V4, P593; Coudray C, 1997, J AM COLL NUTR, V16, P584; Dhingra S, 2006, MOL CELL BIOCHEM, V282, P75, DOI 10.1007/s11010-006-1266-1; Dhingra S, 2006, BIOMETALS, V19, P493, DOI 10.1007/s10534-005-5393-z; Dhingra S, 2006, CHEM-BIOL INTERACT, V161, P49, DOI 10.1016/j.cbi.2006.02.008; Djeffal A, 2012, TOXICOL IND HLTH; Ducros V, 2000, J INORG BIOCHEM, V81, P105, DOI 10.1016/S0162-0134(00)00071-4; El-Demerdash FM, 2014, J TRACE ELEM MED BIO, V28, P89, DOI 10.1016/j.jtemb.2013.10.001; Flores-Mateo G, 2006, AM J CLIN NUTR, V84, P762, DOI 10.1093/ajcn/84.4.762; Fulop P, 2013, J CELL MOL MED, V17, P350, DOI 10.1111/jcmm.12013; Galan-Chilet I, 2014, FREE RADICAL BIO MED, V74, P229, DOI 10.1016/j.freeradbiomed.2014.07.005; Gao SJ, 2007, AM J EPIDEMIOL, V165, P955, DOI 10.1093/aje/kwk073; Gao SJ, 2009, PUBLIC HEALTH NUTR, V12, P2371, DOI 10.1017/S1368980009005102; He K, 2011, EUR J CLIN INVEST, V41, P98, DOI 10.1111/j.1365-2362.2010.02373.x; Henriques AD, 2014, GENE, V539, P275, DOI 10.1016/j.gene.2014.01.077; Hu M, 2012, J CLIN LIPIDOL, V6, P585, DOI 10.1016/j.jacl.2012.02.005; Huang KX, 2002, ATHEROSCLEROSIS, V162, P137, DOI 10.1016/S0021-9150(01)00707-9; Hubacek Jaroslav A., 2011, Drug Metabolism and Drug Interactions, V26, P13, DOI 10.1515/DMDI.2011.107; IPAQ group, 2005, GUIDELINES FOR DATA; Ji A, 1991, CHINESE JOURNAL OF C, V6, P327; 曹静祥, 2007, [中华预防医学杂志, Chinese Journal of Preventive Medicine], V41, P419; JOSSA F, 1991, ATHEROSCLEROSIS, V87, P129, DOI 10.1016/0021-9150(91)90015-U; Karita K, 2008, MENOPAUSE, V15, P119, DOI 10.1097/gme.0b013e31806bf32c; Kim SW, 2010, J TOXICOL ENV HEAL A, V73, P1502, DOI 10.1080/15287394.2010.511573; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Kofler BM, 2012, ATHEROSCLEROSIS, V221, P467, DOI 10.1016/j.atherosclerosis.2012.01.042; Kotaska K, 2012, GENET TEST MOL BIOMA, V16, P210, DOI 10.1089/gtmb.2011.0129; Krogh Vittorio, 2003, Journal of Trace Elements in Medicine and Biology, V17, P31; Laclaustra M, 2010, ATHEROSCLEROSIS, V210, P643, DOI 10.1016/j.atherosclerosis.2010.01.005; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Moosmann B, 2004, LANCET, V363, P892, DOI 10.1016/S0140-6736(04)15739-5; Mozaffarian D, 2009, INT J ENV RES PUB HE, V6, P1894, DOI 10.3390/ijerph6061894; Navas-Acien A, 2008, CURR OPIN LIPIDOL, V19, P43, DOI 10.1097/MOL.0b013e3282f2b261; Obeid O, 2008, BIOL TRACE ELEM RES, V123, P58, DOI 10.1007/s12011-008-8112-0; Olson GE, 2008, J BIOL CHEM, V283, P6854, DOI 10.1074/jbc.M709945200; OVASKAINEN ML, 1993, AM J CLIN NUTR, V57, P662, DOI 10.1093/ajcn/57.5.662; Petkeviciene J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041525; Rayman MP, 2011, ANN INTERN MED, V154, P656, DOI 10.7326/0003-4819-154-10-201105170-00005; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; SALONEN JT, 1988, ATHEROSCLEROSIS, V70, P155, DOI 10.1016/0021-9150(88)90109-8; Seale LA, 2012, MOL CELL BIOL, V32, P4141, DOI 10.1128/MCB.00293-12; Sengupta A, 2008, BIOCHEM BIOPH RES CO, V365, P446, DOI 10.1016/j.bbrc.2007.10.189; Slotnick MJ, 2006, ENVIRON RES, V102, P125, DOI 10.1016/j.envres.2005.12.001; Smalinskiene A, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-120; Stranges S, 2011, J INTERN MED, V270, P469, DOI 10.1111/j.1365-2796.2011.02398.x; Stranges S, 2010, NUTR METAB CARDIOVAS, V20, P754, DOI 10.1016/j.numecd.2010.10.001; Stranges S, 2006, AM J EPIDEMIOL, V163, P694, DOI 10.1093/aje/kwj097; Stranges S, 2010, J NUTR, V140, P81, DOI 10.3945/jn.109.111252; Su L, 2013, HYGIENE, V3, P84; SUADICANI P, 1992, ATHEROSCLEROSIS, V96, P33, DOI 10.1016/0021-9150(92)90035-F; Tanguy S, 2004, ANTIOXID REDOX SIGN, V6, P792, DOI 10.1089/1523086041361631; Tanguy S, 2003, AGE AGEING, V32, P273, DOI 10.1093/ageing/32.3.273; Thomson CD, 2004, EUR J CLIN NUTR, V58, P391, DOI 10.1038/sj.ejcn.1601800; Vegh Csaba, 2012, Orvosi Hetilap, V153, P2070, DOI 10.1556/OH.2012.29508; Venardos KM, 2007, CURR MED CHEM, V14, P1539, DOI 10.2174/092986707780831078; Ward H, 2009, ARCH INTERN MED, V169, P1424, DOI 10.1001/archinternmed.2009.234; World Health Organization, 1987, ENV HLTH; Yilmaz-Aydogan H, 2013, GENE, V523, P20, DOI 10.1016/j.gene.2013.03.136; Zhuo HJ, 2004, CANCER EPIDEM BIOMAR, V13, P771	67	18	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0136706	10.1371/journal.pone.0136706	http://dx.doi.org/10.1371/journal.pone.0136706			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26380972	gold, Green Published			2022-12-27	WOS:000361790200010
J	Martinez-Briseno, D; Fernandez-Plata, R; Gochicoa-Rangel, L; Torre-Bouscoulet, L; Rojas-Martinez, R; Mendoza-Alvarado, L; Garcia-Sancho, C; Perez-Padilla, R				Martinez-Briseno, David; Fernandez-Plata, Rosario; Gochicoa-Rangel, Laura; Torre-Bouscoulet, Luis; Rojas-Martinez, Rosalba; Mendoza-Alvarado, Laura; Garcia-Sancho, Cecilia; Perez-Padilla, Rogelio			Socioeconomic Status and Longitudinal Lung Function of Healthy Mexican Children	PLOS ONE			English	Article							SCHOOL-CHILDREN; RESPIRATORY HEALTH; GROWTH STATUS; LEG LENGTH; PROPORTION; EXPOSURE; DISEASE; COHORT; BEAUTY; OAXACA	Introduction Our aim was to estimate the longitudinal effect of Socioeconomic status (SES) on lung function growth of Mexican children and adolescents. Materials and Methods A cohort of Mexican children in third grade of primary school was followed with spirometry twice a year for 6 years through secondary school. Multilevel mixed-effects lineal models were fitted for the spirometric variables of 2,641 respiratory-healthy Mexican children. Monthly family income (in 2002 U.S. dollars [USD]) and parents' years completed at school were used as proxies of SES. Results Individuals with higher SES tended to have greater height for age, and smaller sitting height/standing height and crude lung function. For each 1-year increase of parents' schooling, Forced expiratory volume in 1 sec (FEV1) and Forced vital capacity (FVC) increased 8.5 (0.4%) and 10.6 mL (0.4%), respectively (p <0.05) when models were adjusted for gender. Impact of education on lung function was reduced drastically or abolished on adjusting by anthropometric variables and ozone. Conclusions Higher parental schooling and higher monthly family income were associated with higher lung function in healthy Mexican children, with the majority of the effect likely due to the increase in height-for-age.	[Martinez-Briseno, David; Fernandez-Plata, Rosario; Gochicoa-Rangel, Laura; Torre-Bouscoulet, Luis; Garcia-Sancho, Cecilia; Perez-Padilla, Rogelio] Natl Inst Resp Dis INER, Epidemiol & Social Sci Hlth, Mexico City, DF, Mexico; [Rojas-Martinez, Rosalba; Mendoza-Alvarado, Laura] Natl Inst Publ Hlth INSP, Populat Hlth Res Ctr, Mexico City, DF, Mexico	Instituto Nacional de Salud Publica	Perez-Padilla, R (corresponding author), Natl Inst Resp Dis INER, Epidemiol & Social Sci Hlth, Mexico City, DF, Mexico.	perezpad@gmail.com	Rojas, Rosalba/C-8714-2014; Gochicoa, Laura/O-6810-2019	Gochicoa-Rangel, Laura/0000-0003-3009-5867	National Council for Science and Technology (CONACyT)-Mexico; National Institute of Respiratory Diseases (INER)	National Council for Science and Technology (CONACyT)-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institute of Respiratory Diseases (INER)	Funding provided by National Council for Science and Technology (CONACyT)-Mexico, http://www.conacyt.mx/ and National Institute of Respiratory Diseases (INER), http://www.iner.gob.mx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogin B, 2009, ANTHROPOL ANZ, V67, P439, DOI 10.1127/0003-5548/2009/0036; Bogin B, 2010, INT J ENV RES PUB HE, V7, P1047, DOI 10.3390/ijerph7031047; Demissie K, 1996, AM J RESP CRIT CARE, V153, P719, DOI 10.1164/ajrccm.153.2.8564123; Gehring U, 2013, ENVIRON HEALTH PERSP, V121, P1357, DOI 10.1289/ehp.1306770; Hegewald MJ, 2007, CHEST, V132, P1608, DOI 10.1378/chest.07-1405; Krieger N, 2001, J EPIDEMIOL COMMUN H, V55, P693, DOI 10.1136/jech.55.10.693; Kuczmarski RJ, 2000, VITAL HLTH STAT, V11, P1; Lebowitz MD, 1996, AM J RESP CRIT CARE, V154, pS273, DOI 10.1164/ajrccm/154.6_Pt_2.S273; Lum S, 2010, EUR RESPIR MONOGR, P46, DOI 10.1183/1025448x.00020909; MALINA RM, 1980, ANN HUM BIOL, V7, P367, DOI 10.1080/03014468000004441; Malina RM, 2009, AM J HUM BIOL, V21, P805, DOI 10.1002/ajhb.20897; Martinez-Briseno D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077403; Menezes AMB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-596; Perez-Padilla R, 2003, CHEST, V123, P1090, DOI 10.1378/chest.123.4.1090; Perez-Padilla R, 2003, PEDIATR PULM, V35, P177, DOI 10.1002/ppul.10232; Raju PS, 2005, PEDIATR PULM, V39, P528, DOI 10.1002/ppul.20206; Rojas-Martinez R, 2007, AM J RESP CRIT CARE, V176, P377, DOI 10.1164/rccm.200510-1678OC; Sacks JD, 2011, ENVIRON HEALTH PERSP, V119, P446, DOI 10.1289/ehp.1002255; Standardization of Spirometry, 1994, AM J RESP CRIT CARE, V152, P1107; STEINBERG M, 1986, S AFR MED J, V70, P270; Stocks J, 2013, LANCET RESP MED, V1, P728, DOI 10.1016/S2213-2600(13)70118-8; Stocks J, 2013, THER ADV RESPIR DIS, V7, P161, DOI 10.1177/1753465813479428; Ware JH, 1996, AM J RESP CRIT CARE, V154, pS212, DOI 10.1164/ajrccm/154.6_Pt_2.S212	23	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0136935	10.1371/journal.pone.0136935	http://dx.doi.org/10.1371/journal.pone.0136935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379144	Green Published, gold, Green Submitted			2022-12-27	WOS:000361769400010
J	Xu, DD; Wang, C; Jiang, F; Wei, LL; Shi, LY; Yu, XM; Liu, CM; Liu, XH; Feng, XM; Ping, ZP; Jiang, TT; Chen, ZL; Li, ZJ; Li, JC				Xu, Dan-Dan; Wang, Chong; Jiang, Feng; Wei, Li-Liang; Shi, Li-Ying; Yu, Xiao-Mei; Liu, Chang-Ming; Liu, Xue-Hong; Feng, Xian-Min; Ping, Ze-Peng; Jiang, Ting-Ting; Chen, Zhong-Liang; Li, Zhong-Jie; Li, Ji-Cheng			Association of the FCN2 Gene Single Nucleotide Polymorphisms with Susceptibility to Pulmonary Tuberculosis	PLOS ONE			English	Article							MANNOSE-BINDING-LECTIN; L-FICOLIN; CHINESE-HAN; FUNCTIONAL POLYMORPHISMS; NRAMP1 GENE; COMPLEMENT; VARIANTS; RISK; SARCOIDOSIS; PATHWAY	Ficolin-2 (FCN2) is an innate immune pattern recognition molecule that can activate the complement pathway, opsonophagocytosis, and elimination of the pathogens. The present study aimed to investigate the association of the FCN2 gene single nucleotide polymorphisms (SNPs) with susceptibility to pulmonary tuberculosis (TB). A total of seven SNPs in exon 8 (+6359 C>T and +6424 G>T) and in the promoter region (-986 G>A, -602 G>A, -557 A>G, -64 A>C and -4 A>G) of the FCN2 gene were genotyped using the PCR amplification and DNA sequencing methods in the healthy controls group (n = 254) and the pulmonary TB group (n = 282). The correlation between SNPs and pulmonary TB was analyzed using the logistic regression method. The results showed that there were no significant differences in the distribution of allelic frequencies of seven SNPs between the pulmonary TB group and the healthy controls group. However, the frequency of the variant homozygous genotype (P = 0.037, -557 A>G; P = 0.038, -64 A>C; P = 0.024, +6424 G>T) in the TB group was significantly lower than the control group. After adjustment for age and gender, these variant homozygous genotypes were found to be recessive models in association with pulmonary TB. In addition, -64 A>C (P = 0.047) and +6424 G>T (P = 0.03) were found to be codominant models in association with pulmonary TB. There was strong linkage disequilibrium (r(2) > 0.80, P < 0.0001) between 7 SNPs except the -602 G>A site. Therefore, -557 A>G, -64 A>C and +6424 G>T SNPs of the FCN2 gene were correlated with pulmonary TB, and may be protective factors for TB. This study provides a novel idea for the prevention and control of TB transmission from a genetics perspective.	[Xu, Dan-Dan; Wang, Chong; Liu, Chang-Ming; Ping, Ze-Peng; Jiang, Ting-Ting; Chen, Zhong-Liang; Li, Zhong-Jie; Li, Ji-Cheng] Zhejiang Univ, Inst Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China; [Jiang, Feng] Beijing Univ Chinese Med, Dongzhimen Hosp, Beijing 100700, Peoples R China; [Wei, Li-Liang] Sixth Hosp Shaoxing, Dept Resp Med, Shaoxing 312000, Peoples R China; [Shi, Li-Ying; Yu, Xiao-Mei] Zhejiang Hosp, Dept Clin Lab, Hangzhou 310013, Zhejiang, Peoples R China; [Liu, Xue-Hong] Shaoxing Univ, Sch Med, Shaoxing 312000, Peoples R China; [Feng, Xian-Min] Jilin Med Coll, Sch Lab Med, Jilin 132013, Peoples R China	Zhejiang University; Beijing University of Chinese Medicine; Shaoxing University; Jilin Medical University	Li, JC (corresponding author), Zhejiang Univ, Inst Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China.	lijichen@zju.edu.cn	Liu, Xuehong/GVS-4500-2022		National Special Sci-Tech Projects [2012ZX10005001-006]; National Basic Research Program of China [2014CB543002]; National Natural Science Foundation of China [81273882]; Medical & hygienic Foundation of Zhejiang Province [2013KYA209]; Education Department of Jilin Province [2014367]	National Special Sci-Tech Projects; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical & hygienic Foundation of Zhejiang Province; Education Department of Jilin Province	This work was supported by the following sources of funding: 1. National Special Sci-Tech Projects (No. 2012ZX10005001-006; http://www.most.gov.cn/; LJC); 2. National Basic Research Program of China (No. 2014CB543002; http://www.most.gov.cn/; LJC); 3. National Natural Science Foundation of China (No. 81273882; http://www.nsfc.gov.cn/; LJC); 4. Medical & hygienic Foundation of Zhejiang Province (No. 2013KYA209; http://www.zjwst.gov.cn/; WLL); and 5. Education Department of Jilin Province (No. 2014367; http://www.jledu.gov.cn/jyt/; FXM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Ouf E, 2012, J INFECT DIS, V206, P562, DOI 10.1093/infdis/jis396; Alavi-Naini R, 2012, INT J TUBERC LUNG D, V16, P1383, DOI 10.5588/ijtld.11.0827; Amirzargar AA, 2006, EUR CYTOKINE NETW, V17, P84; Assaf A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034113; Azad AK, 2012, INFECT IMMUN, V80, P3343, DOI 10.1128/IAI.00443-12; Ben-Selma W, 2011, MOL BIOL REP, V38, P5413, DOI 10.1007/s11033-011-0695-4; Carroll MV, 2009, MOL IMMUNOL, V46, P3367, DOI 10.1016/j.molimm.2009.07.015; Cedzynski M, 2007, CLIN EXP IMMUNOL, V150, P99, DOI 10.1111/j.1365-2249.2007.03471.x; Cedzynski M, 2009, MOL IMMUNOL, V47, P415, DOI 10.1016/j.molimm.2009.08.028; Chalmers JD, 2015, INFLAMMATION, V38, P1731, DOI 10.1007/s10753-015-0150-0; Chen X, 2006, J DERMATOL SCI, V43, P201, DOI 10.1016/j.jdermsci.2006.05.010; Chu SF, 2007, GENES IMMUN, V8, P475, DOI 10.1038/sj.gene.6364412; Cliff JM, 2015, IMMUNOL REV, V264, P88, DOI 10.1111/imr.12269; de Messias-Reason I, 2009, J INFECT DIS, V199, P801, DOI 10.1086/597070; Dubaniewicz A, 2005, EUR J HUM GENET, V13, P829, DOI 10.1038/sj.ejhg.5201370; Dubaniewicz A, 2006, SARCOIDOSIS VASC DIF, V23, P180; Dubaniewicz A, 2013, EXPERT REV CLIN IMMU, V9, P349, DOI [10.1586/eci.13.8, 10.1586/ECI.13.8]; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; El Sahly HM, 2004, SCAND J INFECT DIS, V36, P106, DOI 10.1080/00365540310018860; Eum SY, 2010, CHEST, V137, P122, DOI 10.1378/chest.09-0903; Faik I, 2011, HUM IMMUNOL, V72, P74, DOI 10.1016/j.humimm.2010.10.003; Ferguson JS, 2004, INFECT IMMUN, V72, P2564, DOI 10.1128/IAI.72.5.2564-2573.2004; Gomez LM, 2007, TUBERCULOSIS, V87, P288, DOI 10.1016/j.tube.2007.03.002; Herpers BL, 2006, MOL IMMUNOL, V43, P851, DOI 10.1016/j.molimm.2005.06.035; Hummelshoj T, 2005, HUM MOL GENET, V14, P1651, DOI 10.1093/hmg/ddi173; Hummelshoj T, 2008, MOL IMMUNOL, V45, P2508, DOI 10.1016/j.molimm.2008.01.003; Hummelshoj T, 2007, MOL IMMUNOL, V44, P401, DOI 10.1016/j.molimm.2006.02.023; Kilpatrick DC, 2013, HUM IMMUNOL, V74, P867, DOI 10.1016/j.humimm.2013.04.011; Kilpatrick DC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/138797; Larcombe LA, 2008, J INFECT DIS, V198, P1175, DOI 10.1086/592049; Liu J, 2009, CELL MOL IMMUNOL, V6, P235, DOI 10.1038/cmi.2009.32; Liu W, 2004, INT J TUBERC LUNG D, V8, P428; Luo FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073859; Ma X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001318; Ma YJ, 2009, J BIOL CHEM, V284, P28263, DOI 10.1074/jbc.M109.009225; Maertzdorf J, 2012, P NATL ACAD SCI USA, V109, P7853, DOI 10.1073/pnas.1121072109; Malik S, 2006, HUM GENET, V118, P752, DOI 10.1007/s00439-005-0092-y; Malik S, 2005, P NATL ACAD SCI USA, V102, P12183, DOI 10.1073/pnas.0503368102; Matsushita M, 2000, J IMMUNOL, V164, P2281, DOI 10.4049/jimmunol.164.5.2281; Messias-Reason IJ, 2009, CLIN EXP IMMUNOL, V157, P395, DOI 10.1111/j.1365-2249.2009.03975.x; Metzger ML, 2015, CLIN EXP IMMUNOL, V179, P256, DOI 10.1111/cei.12459; Moller M, 2009, TUBERCULOSIS, V89, P189, DOI 10.1016/j.tube.2008.10.001; Mosaad YM, 2010, SCAND J IMMUNOL, V72, P358, DOI 10.1111/j.1365-3083.2010.02426.x; Munthe-Fog L, 2007, SCAND J IMMUNOL, V65, P383, DOI 10.1111/j.1365-3083.2007.01915.x; Ojurongbe O, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-37; Ren Yushan, 2014, Virologica Sinica, V29, P25, DOI 10.1007/s12250-014-3421-2; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Runza VL, 2008, IMMUNOBIOLOGY, V213, P297, DOI 10.1016/j.imbio.2007.10.009; Tang NLS, 2009, CLIN CHIM ACTA, V406, P98, DOI 10.1016/j.cca.2009.06.006; Tong HV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028113; Vynnycky E, 2000, AM J EPIDEMIOL, V152, P247, DOI 10.1093/aje/152.3.247; Wang C, 2012, INT J BIOL SCI, V8, P945, DOI 10.7150/ijbs.4390; Xue Y, 2010, GENET MOL RES, V9, P1584, DOI 10.4238/vol9-3gmr771; Xue Y, 2010, INT J IMMUNOGENET, V37, P135, DOI 10.1111/j.1744-313X.2009.00892.x; Xue Y, 2010, CLIN CHEM LAB MED, V48, P785, DOI 10.1515/CCLM.2010.154; Yim JJ, 2010, RESPIROLOGY, V15, P241, DOI 10.1111/j.1440-1843.2009.01690.x; Zhang DF, 2013, HUM GENET, V132, P629, DOI 10.1007/s00439-013-1273-8; Zhang J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000282; Zhang X, 2012, INT J BIOL SCI, V8, P375, DOI 10.7150/ijbs.4047; Zhang YX, 2011, GENET MOL RES, V10, P7, DOI 10.4238/vol10-1gmr980; Zhao MY, 2012, GENET MOL RES, V11, P3425, DOI 10.4238/2012.September.25.11; Zhao MY, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-91; Zumla A, 2013, LANCET, V382, P1765, DOI 10.1016/S0140-6736(13)62078-4	63	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138356	10.1371/journal.pone.0138356	http://dx.doi.org/10.1371/journal.pone.0138356			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379154	Green Published, gold, Green Submitted			2022-12-27	WOS:000361769400087
J	Mora, M; Adam, V; Palomera, E; Blesa, S; Diaz, G; Buquet, X; Serra-Prat, M; Martin-Escudero, JC; Palanca, A; Chaves, JF; Puig-Domingo, M				Mora, Mireia; Adam, Victoria; Palomera, Elisabet; Blesa, Sebastian; Diaz, Gonzalo; Buquet, Xavier; Serra-Prat, Mateu; Carlos Martin-Escudero, Juan; Palanca, Ana; Felipe Chaves, Javier; Puig-Domingo, Manuel		Mataro Aging Study Grp	Ghrelin Gene Variants Influence on Metabolic Syndrome Components in Aged Spanish Population	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; BODY-MASS INDEX; LEU72MET POLYMORPHISM; INSULIN SENSITIVITY; ASSOCIATION; FAT; PREPROGHRELIN; HYPERTENSION; CHOLESTEROL; OBESTATIN	Background The role of genetic variations within the ghrelin gene on cardiometabolic profile and nutritional status is still not clear in humans, particularly in elderly people. Objectives We investigated six SNPs of the ghrelin gene and their relationship with metabolic syndrome (MS) components. Subjects and Methods 824 subjects (413 men/411 women, age 77.31 +/- 5.04) participating in the Mataro aging study (n = 310) and the Hortega study (n = 514) were analyzed. Anthropometric variables, ghrelin, lipids, glucose and blood pressure levels were measured, and distribution of SNPs -994CT (rs26312), -604GA (rs27647), -501AC (rs26802), R51Q (rs34911341), M72L (rs696217) and L90G (rs4684677) of the ghrelin gene evaluated. Genotypes were determined by multiplex PCR and SNaPshot minisequencing. MS (IDF criteria) was found in 54.9%. Results No association between any of the SNPs and levels of total fasting circulating ghrelin levels was found. C/A-A/A genotype of M72L was associated with increased risk of central obesity according to IDF criteria, while G/A-G/G genotypes of -604GA with reduced risk. A/Agenotype of -501AC polymorphism was associated to decreased BMI. In relation to lipid profile, the same genotypes of -604GA were associated with increased total cholesterol and LDL-cholesterol and -501AC with reduced triglycerides. There were no associations with systolic or diastolic blood pressure levels or with hypertension, glucose levels or diabetes and ghrelin polymorphisms. However, G/G genotype of -604GA was associated with glucose >100 mg/dL. Haplotype analysis showed that only one haplotype is associated with increased risk of waist circumference and central obesity. The analysis of subjects by gender showed an important and different association of these polymorphisms regarding MS parameters. Conclusion Ghrelin gene variants -604GA, -501AC and M72L are associated with certain components of MS, in particular to BMI and lipid profile in elderly Spanish subjects.	[Mora, Mireia; Diaz, Gonzalo] Hosp Clin Barcelona, Dept Endocrinol & Nutr, Barcelona, Spain; [Adam, Victoria; Blesa, Sebastian; Felipe Chaves, Javier] Hosp Clinic Valencia INCLIVA, Genotyping & Genet Diag Unit, Res Fdn, Valencia, Spain; [Palomera, Elisabet; Serra-Prat, Mateu] Hosp Mataro, Res Unit, Mataro, Spain; [Palomera, Elisabet; Serra-Prat, Mateu] Hosp Mataro, Ciberhep, Mataro, Spain; [Diaz, Gonzalo] Hosp Clin Valladolid, Valladolid, Spain; [Buquet, Xavier] Hosp Mataro, Serv Biochem, Mataro, Spain; [Carlos Martin-Escudero, Juan] Univ Valladolid, Hosp Rio Hortega, Dept Internal Med, Valladolid, Spain; [Puig-Domingo, Manuel] Hosp Badalona Germans Trias & Pujol, Dept Endocrinol & Nutr, Badalona, Spain; [Felipe Chaves, Javier] CIBER Diabet & Associated Metab Dis CIBERDEM, Barcelona, Spain; [Puig-Domingo, Manuel] Ctr Invest Biomed Enfermedades Raras CIBER ER, Madrid, Spain	University of Barcelona; Hospital Clinic de Barcelona; Hospital del Rio Hortega; Universidad de Valladolid; Hospital Germans Trias i Pujol; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Puig-Domingo, M (corresponding author), Hosp Badalona Germans Trias & Pujol, Dept Endocrinol & Nutr, Badalona, Spain.	mpuigd@gmail.com	Blesa, Sebastián/AAC-3857-2019; Puig-Domingo, Manel/S-2169-2019; Chaves-Martinez, Felipe Javier/ABC-3294-2021; Palanca, Ana/E-1541-2018; Mora, Mireia/R-6696-2018	Blesa, Sebastián/0000-0002-5219-0796; Puig-Domingo, Manel/0000-0002-6744-7195; Chaves-Martinez, Felipe Javier/0000-0001-8009-3689; Palanca, Ana/0000-0003-3513-4458; Martin-Escudero, Juan Carlos/0000-0002-6209-6509; Mora, Mireia/0000-0002-5887-5016; PALOMERA FANEGAS, ELISABET/0000-0002-4384-5746; Serra-Prat, Mateu/0000-0002-6554-9913	Fondo Investigaciones Sanitarias [07/0601, PI11/00726]; CIBER de Diabetes y Enfermedades Metabolicas Relacionadas (CIBERDEM); CIBERDEM is an initiative by Carlos III Health Institute in Madrid; Spanish Health Ministry; Valencian Government [PROMETEO/2009/029, AP-091/11, ACOMP/2013/039]	Fondo Investigaciones Sanitarias(Instituto de Salud Carlos III); CIBER de Diabetes y Enfermedades Metabolicas Relacionadas (CIBERDEM); CIBERDEM is an initiative by Carlos III Health Institute in Madrid; Spanish Health Ministry(Instituto de Salud Carlos IIISpanish Government); Valencian Government	Fondo Investigaciones Sanitarias Grants 07/0601 And PI11/00726, by CIBER de Diabetes y Enfermedades Metabolicas Relacionadas (CIBERDEM); CIBERDEM is an initiative by Carlos III Health Institute in Madrid and the Spanish Health Ministry, by PROMETEO/2009/029, AP-091/11, and ACOMP/2013/039 from the Valencian Government.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Ando T, 2007, AM J CLIN NUTR, V86, P25, DOI 10.1093/ajcn/86.1.25; Barazzoni R, 2007, J CLIN ENDOCR METAB, V92, P3935, DOI 10.1210/jc.2006-2527; Berthold HK, 2010, HYPERTENS RES, V33, P155, DOI 10.1038/hr.2009.194; Bertoli S, 2006, EUR J ENDOCRINOL, V155, P321, DOI 10.1530/eje.1.02220; Bing C, 2005, DIABETIC MED, V22, P1157, DOI 10.1111/j.1464-5491.2005.01575.x; Chen CY, 2000, PHARMACOL REV, V61, P430; Choi HJ, 2006, J CLIN ENDOCR METAB, V91, P4657, DOI 10.1210/jc.2005-2549; del Giudice EM, 2004, INT J OBESITY, V28, P447, DOI 10.1038/sj.ijo.0802572; Garcia EA, 2009, EUR J ENDOCRINOL, V161, P307, DOI 10.1530/EJE-09-0122; Hosoda H, 2000, BIOCHEM BIOPH RES CO, V279, P909, DOI 10.1006/bbrc.2000.4039; Hubacek JA, 2007, FOLIA BIOL-PRAGUE, V53, P202; Hubacek JA, 2008, METABOLISM, V57, P1016, DOI 10.1016/j.metabol.2008.04.004; Korbonits M, 2002, J CLIN ENDOCR METAB, V87, P4005, DOI 10.1210/jc.87.8.4005; Li WJ, 2008, CHINESE MED J-PEKING, V121, P1666, DOI 10.1097/00029330-200809010-00015; Liao N, 2013, GENE, V517, P179, DOI 10.1016/j.gene.2012.12.094; Liu J, 2012, GENE, V504, P309, DOI 10.1016/j.gene.2012.03.025; Mager U, 2006, DIABETIC MED, V23, P685, DOI 10.1111/j.1464-5491.2006.01870.x; Mager U, 2006, AM J HYPERTENS, V19, P920, DOI 10.1016/j.amjhyper.2006.02.017; Martin GR, 2008, OBESITY, V16, P908, DOI 10.1038/oby.2007.125; Mena-Martin FJ, 2003, J HYPERTENS, V21, P1283, DOI 10.1097/00004872-200307000-00015; Mora M, 2014, AGING CLIN EXP RES, V26, P161, DOI 10.1007/s40520-014-0203-5; Mora M, 2013, CLIN ENDOCRINOL, V78, P882, DOI 10.1111/j.1365-2265.2012.04489.x; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Puig-Domingo M, 2008, AGING CLIN EXP RES, V20, P439; Rigamonti AE, 2002, J ENDOCRINOL, V175, pR1, DOI 10.1677/joe.0.175R001; Rodriguez A, 2009, INT J OBESITY, V33, P541, DOI 10.1038/ijo.2009.40; Rozen S, 2003, BIOINFORMATICS METHO, P365; Serra-Prat M, 2007, J ENDOCRINOL INVEST, V30, P484, DOI 10.1007/BF03346332; Serra-Prat M, 2009, CLIN ENDOCRINOL, V70, P227, DOI 10.1111/j.1365-2265.2008.03307.x; Serra-Prat M, 2009, AM J CLIN NUTR, V89, P1410, DOI 10.3945/ajcn.2008.27076; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; St-Pierre DH, 2007, J CLIN ENDOCR METAB, V92, P264, DOI 10.1210/jc.2006-1603; Steinle NI, 2005, J CLIN ENDOCR METAB, V90, P6672, DOI 10.1210/jc.2005-0549; Strum K, 2003, J CLIN ENDOCR METAB, V88, P3747, DOI 10.1210/jc.2002-021656; Ukkola O, 2002, OBES RES, V10, P782, DOI 10.1038/oby.2002.106; Ukkola O, 2006, ANN MED, V38, P274, DOI 10.1080/07853890600622192; Vivenza D, 2004, EUR J ENDOCRINOL, V151, P127, DOI 10.1530/eje.0.1510127; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; Xu LL, 2008, BIOMED ENVIRON SCI, V21, P188, DOI 10.1016/S0895-3988(08)60027-6; Zavarella S, 2008, INT J OBESITY, V32, P663, DOI 10.1038/sj.ijo.0803766; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255; Zhu JF, 2010, IRISH J MED SCI, V179, P345, DOI 10.1007/s11845-010-0494-2	43	17	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136931	10.1371/journal.pone.0136931	http://dx.doi.org/10.1371/journal.pone.0136931			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375586	gold, Green Submitted, Green Published			2022-12-27	WOS:000361610200025
J	Oltolina, F; Zamperone, A; Colangelo, D; Gregoletto, L; Reano, S; Pietronave, S; Merlin, S; Talmon, M; Novelli, E; Diena, M; Nicoletti, C; Musaro, A; Filigheddu, N; Follenzi, A; Prat, M				Oltolina, Francesca; Zamperone, Andrea; Colangelo, Donato; Gregoletto, Luca; Reano, Simone; Pietronave, Stefano; Merlin, Simone; Talmon, Maria; Novelli, Eugenio; Diena, Marco; Nicoletti, Carmine; Musaro, Antonio; Filigheddu, Nicoletta; Follenzi, Antonia; Prat, Maria			Human Cardiac Progenitor Spheroids Exhibit Enhanced Engraftment Potential	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; EXTRACELLULAR-MATRIX; IN-VITRO; MONOCLONAL-ANTIBODIES; ENDOTHELIAL-CELLS; REPAIR; HEART; MIGRATION; MUSCLE; MULTIPOTENT	A major obstacle to an effective myocardium stem cell therapy has always been the delivery and survival of implanted stem cells in the heart. Better engraftment can be achieved if cells are administered as cell aggregates, which maintain their extra-cellular matrix (ECM). We have generated spheroid aggregates in less than 24 h by seeding human cardiac progenitor cells (hCPCs) onto methylcellulose hydrogel-coated microwells. Cells within spheroids maintained the expression of stemness/mesenchymal and ECM markers, growth factors and their cognate receptors, cardiac commitment factors, and metalloproteases, as detected by immunofluorescence, q-RT-PCR and immunoarray, and expressed a higher, but regulated, telomerase activity. Compared to cells in monolayers, 3D spheroids secreted also bFGF and showed MMP2 activity. When spheroids were seeded on culture plates, the cells quickly migrated, displaying an increased wound healing ability with or without pharmacological modulation, and reached confluence at a higher rate than cells from conventional monolayers. When spheroids were injected in the heart wall of healthy mice, some cells migrated from the spheroids, engrafted, and remained detectable for at least 1 week after transplantation, while, when the same amount of cells was injected as suspension, no cells were detectable three days after injection. Cells from spheroids displayed the same engraftment capability when they were injected in cardiotoxin-injured myocardium. Our study shows that spherical in vivo ready-to-implant scaffold-less aggregates of hCPCs able to engraft also in the hostile environment of an injured myocardium can be produced with an economic, easy and fast protocol.	[Oltolina, Francesca; Zamperone, Andrea; Colangelo, Donato; Gregoletto, Luca; Pietronave, Stefano; Merlin, Simone; Talmon, Maria; Follenzi, Antonia; Prat, Maria] Univ Piemonte Orientale, Dept Hlth Sci, Novara, Italy; [Reano, Simone; Filigheddu, Nicoletta] Univ Piemonte Orientale, Dept Translat Med, Novara, Italy; [Novelli, Eugenio; Diena, Marco] Clin S Gaudenzio, Dept Cardiac Surg, Novara, Italy; [Nicoletti, Carmine; Musaro, Antonio] DAHFMO, Inst Pasteur Cenci Bolognetti, Rome, Italy; [Nicoletti, Carmine; Musaro, Antonio] Univ Roma La Sapienza, IIM, Unit Histol & Med Embryol, I-00185 Rome, Italy; [Follenzi, Antonia; Prat, Maria] Ctr Biotecnol Ric Med Applicata BRMA, Novara, Italy	University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; Fondazione Cenci Bolognetti; Sapienza University Rome	Prat, M (corresponding author), Univ Piemonte Orientale, Dept Hlth Sci, Novara, Italy.	mprat@med.unipmn.it	Filigheddu, Nicoletta/N-7219-2015; Musarò, Antonio/K-9598-2016; Colangelo, Donato/ABB-2772-2020; Musaro, Antonio/P-2953-2019	Filigheddu, Nicoletta/0000-0002-3848-611X; Musarò, Antonio/0000-0002-2944-9739; Colangelo, Donato/0000-0003-2277-3226; Musaro, Antonio/0000-0002-2944-9739; Merlin, Simone/0000-0001-5209-3921; Reano, Simone/0000-0002-5059-3620; NICOLETTI, Carmine/0000-0001-5896-2040; Follenzi, Antonia/0000-0001-9780-300X; Talmon, Maria/0000-0002-3914-5034	European Commission: Starting Consolidator ERC Grant [261178 CGT-HA]; AIRC [13166]; Clinica S. Gaudenzio - Novara (Gruppo Policlinico di Monza)	European Commission: Starting Consolidator ERC Grant; AIRC(Fondazione AIRC per la ricerca sul cancro); Clinica S. Gaudenzio - Novara (Gruppo Policlinico di Monza)	Funding was provided by a grant of the European Commission: Starting Consolidator ERC Grant n. 261178 CGT-HA, "Cell and gene therapy foe Hemophilia", http://erc.europa.eu/starting-grants and a grant from AIRC: IG n. 13166, "Development of engineered magnetic nanoparticles for cancer therapy", http://www.airc.it to A.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. S.P. was supported by a fellowship from Clinica S. Gaudenzio - Novara (Gruppo Policlinico di Monza).	Anversa P, 2005, BASIC RES CARDIOL, V100, P482, DOI 10.1007/s00395-005-0554-3; Baxter RC, 2014, NAT REV CANCER, V14, P329, DOI 10.1038/nrc3720; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; BUSSOLINO F, 1991, J CLIN INVEST, V87, P986, DOI 10.1172/JCI115107; Cao ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082949; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cheng K, 2012, STEM CELLS, V30, P2835, DOI 10.1002/stem.1184; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Colangelo D, 2005, CURR MED CHEM, V12, P3091, DOI 10.2174/092986705774933416; Daley WP, 2013, CURR OPIN GENET DEV, V23, P408, DOI 10.1016/j.gde.2013.05.005; Di Scipio F, 2014, BBA-GEN SUBJECTS, V1840, P2152, DOI 10.1016/j.bbagen.2014.03.005; Forte G, 2006, STEM CELLS, V24, P23, DOI 10.1634/stemcells.2004-0176; Forte G, 2011, STEM CELLS, V29, P2051, DOI 10.1002/stem.763; Giardini MA, 2014, PROG MOL BIOL TRANSL, V125, P1, DOI 10.1016/B978-0-12-397898-1.00001-3; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Hindi SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072121; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Keith MCL, 2015, CIRC RES, V116, P1216, DOI 10.1161/CIRCRESAHA.116.305557; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Kutys ML, 2013, EXP CELL RES, V319, P2434, DOI 10.1016/j.yexcr.2013.05.030; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lee WY, 2011, BIOMATERIALS, V32, P5558, DOI 10.1016/j.biomaterials.2011.04.031; Lee WY, 2009, BIOMATERIALS, V30, P5505, DOI 10.1016/j.biomaterials.2009.07.006; Leor J, 2000, CIRCULATION, V102, P56; Li TS, 2010, STEM CELLS, V28, P2088, DOI 10.1002/stem.532; Linke A, 2005, P NATL ACAD SCI USA, V102, P8966, DOI 10.1073/pnas.0502678102; Madonna R, 2011, EUR HEART J, V32, P1190, DOI 10.1093/eurheartj/ehq450; Malliaras K, 2014, STEM CELL TRANSL MED, V3, P2, DOI 10.5966/sctm.2013-0104; Malliaras K, 2014, J AM COLL CARDIOL, V63, P110, DOI 10.1016/j.jacc.2013.08.724; Masuda S, 2008, ADV DRUG DELIVER REV, V60, P277, DOI 10.1016/j.addr.2007.08.031; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Miyamoto S, 1998, ANN NY ACAD SCI, V857, P119, DOI 10.1111/j.1749-6632.1998.tb10112.x; Mosqueira D, 2014, ACS NANO, V8, P2033, DOI 10.1021/nn4058984; Mu XD, 2011, AM J PATHOL, V179, P931, DOI 10.1016/j.ajpath.2011.05.004; Nabel Elizabeth G, 2012, Trans Am Clin Climatol Assoc, V123, P221; Nakamura T, 2010, P JPN ACAD B-PHYS, V86, P588, DOI 10.2183/pjab.86.588; Ni AG, 2014, STEM CELLS DEV, V23, P3065, DOI 10.1089/scd.2014.0064; Pavo N, 2014, J MOL CELL CARDIOL, V75, P12, DOI 10.1016/j.yjmcc.2014.06.016; Pietronave S, 2014, STEM CELLS DEV, V23, P888, DOI 10.1089/scd.2013.0375; Pietronave S, 2010, AM J PHYSIOL-HEART C, V298, pH1155, DOI 10.1152/ajpheart.01323.2008; Potapova IA, 2007, STEM CELLS, V25, P1761, DOI 10.1634/stemcells.2007-0022; Prat M, 1998, J CELL SCI, V111, P237; Ratajczak MZ, 2012, ADV MED SCI-POLAND, V57, P1, DOI 10.2478/v10039-012-0020-z; Sadat S, 2007, BIOCHEM BIOPH RES CO, V363, P674, DOI 10.1016/j.bbrc.2007.09.058; Samsonraj RM, 2013, GENE, V519, P348, DOI 10.1016/j.gene.2013.01.039; Santini MP, 2007, CIRC RES, V100, P1732, DOI 10.1161/CIRCRESAHA.107.148791; Shirvaikar N, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/685267; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Taghavi S, 2013, AM J TRANSL RES, V5, P404; Takehara N, 2008, J AM COLL CARDIOL, V52, P1858, DOI 10.1016/j.jacc.2008.06.052; Terrovitis JV, 2010, CIRC RES, V106, P479, DOI 10.1161/CIRCRESAHA.109.208991; Valente M, 2014, STEM CELLS DEV, V23, P2263, DOI 10.1089/scd.2014.0197; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Wang CC, 2009, STEM CELLS, V27, P724, DOI 10.1634/stemcells.2008-0944; Wojakowski W, 2004, CIRCULATION, V110, P3213, DOI 10.1161/01.CIR.0000147609.39780.02; Wu KH, 2006, EUR J CARDIO-THORAC, V30, P770, DOI 10.1016/j.ejcts.2006.08.003; Xin M, 2013, P NATL ACAD SCI USA, V110, P13839, DOI 10.1073/pnas.1313192110; Yamaguchi Y, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/s12896-014-0105-9; Yang MJ, 2007, BIOMACROMOLECULES, V8, P2746, DOI 10.1021/bm0704166; Yeh YC, 2010, BIOMATERIALS, V31, P6444, DOI 10.1016/j.biomaterials.2010.04.069; Zakharova L, 2010, CARDIOVASC RES, V87, P40, DOI 10.1093/cvr/cvq027; Zimmermann WH, 2006, CARDIOVASC RES, V71, P419, DOI 10.1016/j.cardiores.2006.03.023	66	18	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137999	10.1371/journal.pone.0137999	http://dx.doi.org/10.1371/journal.pone.0137999			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375957	Green Published, Green Submitted, gold			2022-12-27	WOS:000361610200067
J	King, N; Dewey, C; Borish, D				King, Nia; Dewey, Cate; Borish, David			Determinants of Primary School Non-Enrollment and Absenteeism: Results from a Retrospective, Convergent Mixed Methods, Cohort Study in Rural Western Kenya	PLOS ONE			English	Article							PROGRAM; HEALTH; SCHOOLCHILDREN; BREAKFAST; NUTRITION; EDUCATION; CHILDREN; MALARIA; TRIAL	Background Education is a key element in the socioeconomic development required to improve quality of life in Kenya. Despite the introduction of free primary education, primary school enrollment and attendance levels remain low. Drawing on qualitative and quantitative data, this study explores the determinants of non-enrollment and absenteeism in rural western Kenya and potential mitigation strategies to address these issues. Methods The study was conducted in Bwaliro village in rural western Kenya. A random sample of 64 students was obtained by blocking the village primary school's student population according to grade level, gender, and orphan status. Qualitative and quantitative data were collected through interviews with parents, guardians, and key informants, and focus group discussions with students. Quantitative data were compared using chi-square tests, Student's T-test, and Poisson regressions. Qualitative data were analyzed using thematic content analysis. Results Malaria, menstruation, and lack of money were among the most notable determinants of primary school dropout and absenteeism, and these factors disproportionately impacted orphans and female students. Potential mitigation strategies suggested by the community included provision of malaria treatment or prevention, reduction in education costs, expansion of the established school-feeding program, and provision of sanitary pads. Conclusion Despite free primary education, numerous factors continue to prevent children in rural western Kenya from attending primary school. The findings suggest that interventions should primarily target orphaned and female students. Prior to implementation, suggested mitigation strategies should be assessed for cost-effectiveness.	[King, Nia; Dewey, Cate; Borish, David] Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON N1G 2W1, Canada; [Dewey, Cate] Univ Guelph, Ctr Publ Hlth & Zoonoses, Guelph, ON N1G 2W1, Canada	University of Guelph; University of Guelph	King, N (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON N1G 2W1, Canada.	nking@mail.uoguelph.ca			University of Guelph	University of Guelph	The University of Guelph funded the project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikins MKS, 1995, THESIS LONDON SCH HY; Alexander KT, 2014, WATER-SUI, V6, P1453, DOI 10.3390/w6051453; Ayi I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-98; Baird S, 2010, HEALTH ECON, V19, P55, DOI 10.1002/hec.1569; Baker DP., 2008, PROSPECTS, V38, P467, DOI [10.1007/s11125-009-9097-y, DOI 10.1007/S11125-009-9097-Y]; Beegle K, 2006, AM J AGR ECON, V88, P1266, DOI 10.1111/j.1467-8276.2006.00943.x; Benoit LA, 2013, STUDENS DEV BLOG ASS; Bicego G, 2003, SOC SCI MED, V56, P1235, DOI 10.1016/S0277-9536(02)00125-9; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brooker S, 2000, PARASITOL TODAY, V16, P183, DOI 10.1016/S0169-4758(00)01663-X; Case A, 2004, DEMOGRAPHY, V41, P483, DOI 10.1353/dem.2004.0019; Chepleting S, 2013, INT J BUS COM, V2, P20; Cho H, 2011, J ADOLESCENT HEALTH, V48, P523, DOI 10.1016/j.jadohealth.2010.08.007; Clarke SE, 2008, LANCET, V372, P127, DOI 10.1016/S0140-6736(08)61034-X; Commission on Revenue Allocation, 2011, KEN COUNT FACT SHEET; Creswell W. C., 2011, DESIGNING CONDUCTING; Dinkelman T, 2014, REV ECON STAT, V96, P244, DOI 10.1162/REST_a_00384; Duflo E., 2006, 4024 WORLD BANK; Hallfors D, 2011, AM J PUBLIC HEALTH, V101, P1082, DOI 10.2105/AJPH.2010.300042; Halliday KE, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001594; Hari P., 1998, PARENTS COMMUNITY AT; Houlihan NG, 2011, FOCUS GROUP KIT, V23, P42; Hunter S. S., 2000, CHILDREN BRINK STRAT; Jacoby ER, 1998, AM J CLIN NUTR, V67, p795S, DOI 10.1093/ajcn/67.4.795S; Jensen Robert, 2010, Q J EC; Kain J, 2002, NUTR RES, V22, P599, DOI 10.1016/S0271-5317(01)00377-3; Kenya National Bureau of Statistics, 2010, KEN DEM HLTH SURV 20; Kenya National Bureau of Statistics (KNBS), 2007, BAS REP WELLB KEN; KNBS (Kenya National Bureau of Statistics), 2014, KEN FACTS FIG 2014; Makori A, IMPLEMENTATION UNIVE; Mason L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079132; McMahon SA, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-7; Ministry of Devolution and Planning, 2013, 2 MED TERM PLAN 2013; Ministry of Public Health and Sanitation and Ministry of Education, 2010, NAT SCH HLTH STRAT I; Mukudi E., 2004, INT REV EDUC, V50, P447; Mwita PN, 2011, PAK J STAT OPER RES, V7, P331, DOI 10.18187/pjsor.v7i2.241; NACC, 2014, KEN AIDS RESP PROGR; NACC NASCOP, 2012, KEN AIDS EP UPD 2011; Nelson M, 2000, P NUTR SOC, V59, P307, DOI 10.1017/S0029665100000343; Nguyen T., 2008, INFORM ROLE MODELS P; Omwami EM, 2011, NUTRITION, V27, P188, DOI 10.1016/j.nut.2010.01.009; Onyango-Ouma W, 2005, SOC SCI MED, V61, P1711, DOI 10.1016/j.socscimed.2005.03.041; Onyango-Ouma W, 2004, HEALTH EDUC RES, V19, P326, DOI 10.1093/her/cyg034; Oster E, 2011, AM ECON J-APPL ECON, V3, P91, DOI 10.1257/app.3.1.91; PanterBrick C, 1996, SOC SCI MED, V43, P441, DOI 10.1016/0277-9536(95)00410-6; Powell CA, 1998, AM J CLIN NUTR, V68, P873, DOI 10.1093/ajcn/68.4.873; Purhonen O, 2010, MAINSTREAMING COORDI; Scott L, 2009, THESIS U OXFORD OXFO; United Nations, 2014, MILL DEV GOALS REP 2; UWEZO, 2012, AR OUR CHILDR LEARN; Were M, 2007, ECON HUM BIOL, V5, P322, DOI 10.1016/j.ehb.2007.03.005; White MT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-337; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wilson E., 2012, SCHARR REPORT SERIES, V27	54	19	19	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138362	10.1371/journal.pone.0138362	http://dx.doi.org/10.1371/journal.pone.0138362			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8LR	26371885	Green Published, Green Submitted, gold			2022-12-27	WOS:000361604400067
J	Vaz, S; Falkmer, M; Ciccarelli, M; Passmore, A; Parsons, R; Black, M; Cuomo, B; Tan, T; Falkmer, T				Vaz, Sharmila; Falkmer, Marita; Ciccarelli, Marina; Passmore, Anne; Parsons, Richard; Black, Melissa; Cuomo, Belinda; Tan, Tele; Falkmer, Torbjorn			Belongingness in Early Secondary School: Key Factors that Primary and Secondary Schools Need to Consider	PLOS ONE			English	Article							PERCEIVED SOCIAL SUPPORT; JUNIOR-HIGH-SCHOOL; DIFFICULTIES-QUESTIONNAIRE; MIDDLE-SCHOOL; MENTAL-HEALTH; SOCIOEMOTIONAL ADJUSTMENT; MULTIDIMENSIONAL SCALE; ACADEMIC MOTIVATION; ADOLESCENTS; TRANSITION	It is unknown if, and how, students redefine their sense of school belongingness after negotiating the transition to secondary school. The current study used longitudinal data from 266 students with, and without, disabilities who negotiated the transition from 52 primary schools to 152 secondary schools. The study presents the 13 most significant personal student and contextual factors associated with belongingness in the first year of secondary school. Student perception of school belongingness was found to be stable across the transition. No variability in school belongingness due to gender, disability or household-socio-economic status (SES) was noted. Primary school belongingness accounted for 22% of the variability in secondary school belongingness. Several personal student factors (competence, coping skills) and school factors (low-level classroom task-goal orientation), which influenced belongingness in primary school, continued to influence belongingness in secondary school. In secondary school, effort-goal orientation of the student and perception of their school's tolerance to disability were each associated with perception of school belongingness. Family factors did not influence belongingness in secondary school. Findings of the current study highlight the need for primary schools to foster belongingness among their students at an early age, and transfer students' belongingness profiles as part of the handover documentation. Most of the factors that influenced school belongingness before and after the transition to secondary are amenable to change.	[Vaz, Sharmila; Falkmer, Marita; Ciccarelli, Marina; Passmore, Anne; Parsons, Richard; Black, Melissa; Cuomo, Belinda; Falkmer, Torbjorn] Curtin Univ, Sch Occupat Therapy & Social Work, Perth, WA 6845, Australia; [Falkmer, Marita] Jonkoping Univ, Inst Disabil Res, CHILD Programme, Sch Educ & Commun, Jonkoping, Sweden; [Parsons, Richard] Curtin Univ, Sch Pharm, Perth, WA 6845, Australia; [Tan, Tele] Curtin Univ, Dept Mech Engn, Perth, WA 6845, Australia; [Falkmer, Torbjorn] Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci IMH, Rehabil Med, Linkoping, Sweden; [Falkmer, Torbjorn] Cty Council, UHL, Pain & Rehabil Ctr, Linkoping, Sweden	Curtin University; Jonkoping University; Curtin University; Curtin University; Linkoping University	Vaz, S (corresponding author), Curtin Univ, Sch Occupat Therapy & Social Work, Perth, WA 6845, Australia.	s.vaz@curtin.edu.au	Black, Melissa/U-5318-2019; Cuomo, Belinda/AAI-2876-2021	Black, Melissa/0000-0003-0293-4053; Vaz, Sharmila/0000-0003-1003-9593; Cuomo, Belinda/0000-0003-2841-7484; Tan, Tele/0000-0003-3195-3480				ABRAMSON LY, 1978, J ABNORM PSYCHOL, V87, P49, DOI 10.1037/0021-843X.87.1.49; ABS, 2003, AUSTR DEM STAT; Ali J., 2005, AARE 2005 INT ED C S; Anderman EM, 1997, CONTEMP EDUC PSYCHOL, V22, P269, DOI 10.1006/ceps.1996.0926; Anderman EM, 2002, J EDUC PSYCHOL, V94, P795, DOI 10.1037//0022-0663.94.4.795; Anderman LH, 2003, J EXP EDUC, V72, P5, DOI 10.1080/00220970309600877; Anderman LH, 1999, CONTEMP EDUC PSYCHOL, V24, P21, DOI 10.1006/ceps.1998.0978; [Anonymous], 2004, J SCHOOL HEALTH, V74, P233; [Anonymous], 2005, INT J EDUC RES, DOI [DOI 10.1016/J.IJER.2006.06.008, 10.1016/j.ijer.2006.06.008]; Ashton R, 2008, SUPPORT LEARN, V23, P176, DOI 10.1111/j.1467-9604.2008.00391.x; Australian Bureau of Statistics, 2009, ANZSCO AUSTR NZ STAN; Australian Bureau of Statistics [ABS], 2001, ABS 2001 CENS DICT; Barber BK, 2004, J ADOLESCENT RES, V19, P3, DOI 10.1177/0743558403258113; Battistich V, 1997, EDUC PSYCHOL-US, V32, P137, DOI 10.1207/s15326985ep3203_1; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; BERNDT TJ, 1982, CHILD DEV, V53, P1447, DOI 10.2307/1130071; Black R., 2007, ENGAGING STUDENTS SC; Blum RW, 2005, EDUC LEADERSHIP, V62, P16; Bronfenbrenner U., 1999, MEASURING ENV LIFE S; BROWN SD, 1988, J COUNS PSYCHOL, V35, P472, DOI 10.1037/0022-0167.35.4.472; BYLES J, 1988, FAM PROCESS, V27, P97, DOI 10.1111/j.1545-5300.1988.00097.x; CAUCE AM, 1986, AM J COMMUN PSYCHOL, V14, P607, DOI 10.1007/BF00931339; Chung H, 1998, J SCH PSYCHOL, V92, P20; Cormack P., 1996, ALIENATION ENGAGEMEN; Crockett L. J., 1989, J EARLY ADOLESCENCE, V9, P181, DOI [DOI 10.1177/0272431689093002, 10.1177/0272431689093002]; De Sousa SCD, 2004, ED RES Q, V27, P23; Eccles J. S., 1989, RES MOTIVATION ED, V3, P139, DOI DOI 10.1037/0003-066X.48.2.90; Emerson E, 2005, J INTELLECT DEV DIS, V30, P14, DOI 10.1080/13668250500033169; Epstein J. L, 1983, FRIENDS SCH PATTERNS; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; FELNER RD, 1985, AM J COMMUN PSYCHOL, V13, P365, DOI 10.1007/BF00911214; Felner RD, 1989, PRIMARY PREVENTION P, P13; Fenzel L. M., 1989, J EARLY ADOLESC, V9, P13, DOI [10.1177/0272431689091003, DOI 10.1177/0272431689091003]; Ferguson PD, 1998, THESIS; FINN JD, 1989, REV EDUC RES, V59, P117, DOI 10.3102/00346543059002117; Forgan JW, 2000, J LEARN DISABIL-US, V33, P33, DOI 10.1177/002221940003300107; Frydenberg E., 1993, ADOLESCENT COPING SC; Gale G, 1998, EXCELLENCE EFFECTIVE, P118; Gill S, 1999, J SCHOOL PSYCHOL, V37, P403, DOI 10.1016/S0022-4405(99)00027-8; GOODENOW C, 1993, PSYCHOL SCHOOLS, V30, P79, DOI 10.1002/1520-6807(199301)30:1<79::AID-PITS2310300113>3.0.CO;2-X; GOODENOW C, 1993, J EXP EDUC, V62, P60, DOI 10.1080/00220973.1993.9943831; Goodenow C., 1993, J EARLY ADOLESCENCE, V13, P21, DOI [10. 1177/0272431693013001002, DOI 10.1177/0272431693013001002]; Gottfredson G.D., 1985, VICTIMIZATION SCH; HAGBORG WJ, 1994, J PSYCHOEDUC ASSESS, V12, P312, DOI 10.1177/073428299401200401; Harel-Fisch Y, 2011, J ADOLESCENCE, V34, P639, DOI 10.1016/j.adolescence.2010.09.008; Hargreaves A., 1986, 2 CULTURES SCH CASE; Hargreaves A, 1996, SCH CHANGE REINVENTI; HARTER S, 1982, CHILD DEV, V53, P87, DOI 10.1111/j.1467-8624.1982.tb01295.x; Harter S, 1998, AM EDUC RES J, V35, P653, DOI 10.2307/1163462; Harter S, 1989, PERCEPTIONS COMPETEN, P67; Hine P, 2001, THESIS CURTIN U TECH; Howard S, 2004, AARE 2004; Kaptein S, 2008, J INTELL DISABIL RES, V52, P125, DOI 10.1111/j.1365-2788.2007.00978.x; King A., 1999, TECHNICAL PAPER; Kirkpatrick D, 1993, AUSTR ASS RES ED C G; Kirkpatrick D, 1997, ED AUSTR, V36, P17; Lamb S, 2007, INTERNATIONAL STUDIES IN EDUCATIONAL INEQUALITY, THEORY AND POLICY, VOL 3, P1, DOI 10.1007/1-4020-5916-7_1; Leary T., 1957, INTERPERSONAL DIAGNO; Lenerz K, 1987, BIOL PSYCHOL INTERAC, P212; Lester LJ, 2012, BULLYING TRANSITION; Lodge J, 2007, ENHANCING WELLBEING; Loukas A, 2013, J EARLY ADOLESCENCE, V33, P245, DOI 10.1177/0272431611435117; Mallinckrodt B, 2005, J COUNS PSYCHOL, V52, P358, DOI 10.1037/0022-0167.52.3.358; Manz PH, 2004, J SCHOOL PSYCHOL, V42, P461, DOI 10.1016/j.jsp.2004.08.002; MARSH HW, 1989, J EDUC PSYCHOL, V81, P417, DOI 10.1037/0022-0663.81.3.417; Marsh HW, 2004, BIG FISH LITTLE POND; Marston J, 2008, PERCEPTIONS STUDENTS; Martinez RS, 2011, J YOUTH ADOLESCENCE, V40, P519, DOI 10.1007/s10964-010-9572-z; Martinez RS, 2006, PSYCHOL SCHOOLS, V43, P197, DOI 10.1002/pits.20142; Mathai J, 2008, ADV MENT HEALTH, V7, P200, DOI 10.5172/jamh.7.3.200; McInerney D M, 2001, J Appl Meas, V2, P135; McInerney D. M., 2006, EDUC PSYCHOL-UK, V26, P717, DOI [10.1080/01443410500342559, DOI 10.1080/01443410500342559]; McInerney Dennis M, 2003, J Appl Meas, V4, P335; McInerney DM, 2003, ADOLESCENT MOTIVATIO, P25; McMahon SD, 2008, PSYCHOL SCH, V45, P26; McNeely CA, 2002, J SCHOOL HEALTH, V72, P138, DOI 10.1111/j.1746-1561.2002.tb06533.x; Mellor D, 2005, AUST PSYCHOL, V40, P215, DOI 10.1080/00050060500243475; MIDGLEY C, 1988, J YOUTH ADOLESCENCE, V17, P543, DOI 10.1007/BF01537831; Mizelle N, 1997, WHAT RES SAYS MIDDLE, P303; Nichols SL, 2008, J EXP EDUC, V76, P145, DOI 10.3200/JEXE.76.2.145-169; Norman K, 1998, SCI EDUC, V82, P127, DOI 10.1002/(SICI)1098-237X(199804)82:2<127::AID-SCE1>3.0.CO;2-G; O'Dea JA, 2000, INT J EAT DISORDER, V28, P43, DOI 10.1002/(SICI)1098-108X(200007)28:1<43::AID-EAT6>3.0.CO;2-D; Osterman KF, 2000, REV EDUC RES, V70, P323, DOI 10.2307/1170786; Passmore A, 1998, RELATIONSHIP LEISURE; Pellegrini AD, 2000, AM EDUC RES J, V37, P699, DOI 10.3102/00028312037003699; Petrocelli JV, 2003, MEAS EVAL COUNS DEV, V36, P9, DOI 10.1080/07481756.2003.12069076; Resnick MD, 1997, JAMA-J AM MED ASSOC, V278, P823, DOI 10.1001/jama.278.10.823; Rice F, 2011, BRIT J EDUC PSYCHOL, V81, P244, DOI 10.1348/000709910X519333; Rigby K., 2002, NEW PERSPECTIVES BUL; Rigby K, 2003, CAN J PSYCHIAT, V48, P583, DOI 10.1177/070674370304800904; Roberts C., 2002, AUSSIE OPTIMISM SOCI; Roberts R, 2002, AUSSIE OPTIMISM OPTI; Roeser RW, 2002, ANXIETY STRESS COPIN, V15, P345, DOI 10.1080/1061580021000056519; Roeser RW, 1998, J RES ADOLESCENCE, V8, P123, DOI 10.1207/s15327795jra0801_6; Seidman E, 2004, DEV PSYCHOPATHOL, V16, P1141, DOI 10.1017/S0954579404040179; Seiffge-Krenke I., 1995, STRESS COPING RELATI, DOI 10.4324/9780203773123; Shochet IM, 2006, J CLIN CHILD ADOLESC, V35, P170, DOI 10.1207/s15374424jccp3502_1; Simons-Morton BG, 1999, HEALTH EDUC RES, V14, P99, DOI 10.1093/her/14.1.99; Simpson KB, 2004, 3 BIENN C SELF RES B; Soodak LC, 1998, J SPEC EDUC, V31, P480, DOI 10.1177/002246699803100405; Sullivan H. S., 1953, INTERPERSONAL THEORY; Tobbell J., 2003, EDUC CHILD PSYCHOL, V20, P4; Tur-Kaspa H, 2002, J LEARN DISABIL-US, V35, P87, DOI 10.1177/002221940203500107; Vaz S, 2010, FACTORS AFFECTING ST; Vaz S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123353; Vaz S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099576; Vaz S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089874; Walker JMT, 2005, ELEM SCHOOL J, V106, P85, DOI 10.1086/499193; Wehlange G, 1990, REDUCING RISK SCH CO; WEINER B, 1985, PSYCHOL REV, V92, P548, DOI 10.1037/0033-295X.92.4.548; WEINER B, 1988, J PERS SOC PSYCHOL, V55, P738, DOI 10.1037/0022-3514.55.5.738; Wolters N, 2012, J DEAF STUD DEAF EDU, V17, P463, DOI 10.1093/deafed/ens021; ZIMET GD, 1990, J PERS ASSESS, V55, P610, DOI 10.1207/s15327752jpa5503&4_17; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2; Zubrick S, 1993, FIELD INSTRUMENT DEV; Zubrick S, 2000, INDICATORS SOCIAL FA	116	19	21	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0136053	10.1371/journal.pone.0136053	http://dx.doi.org/10.1371/journal.pone.0136053			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8LR	26372554	Green Published, gold, Green Submitted			2022-12-27	WOS:000361604400003
J	Ruairuen, W; Fochesatto, GJ; Sparrow, EB; Schnabel, W; Zhang, MC; Kim, Y				Ruairuen, Watcharee; Fochesatto, Gilberto J.; Sparrow, Elena B.; Schnabel, William; Zhang, Mingchu; Kim, Yongwon			Evapotranspiration Cycles in a High Latitude Agroecosystem: Potential Warming Role	PLOS ONE			English	Article							ENERGY-BALANCE CLOSURE; SURFACE FLUX MEASUREMENTS; WATER-BALANCE; EDDY COVARIANCE; ARCTIC TUNDRA; PRIESTLEY-TAYLOR; PENMAN-MONTEITH; CLIMATE-CHANGE; BOREAL FOREST; BOUNDARY-LAYER	As the acreages of agricultural lands increase, changes in surface energetics and evapotranspiration (ET) rates may arise consequently affecting regional climate regimes. The objective of this study was to evaluate summertime ET dynamics and surface energy processes in a subarctic agricultural farm in Interior Alaska. The study includes micrometeorological and hydrological data. Results covering the period from June to September 2012 and 2013 indicated consistent energy fractions: LE/R-net (67%), G/R-net (6%), H/R-net (27%) where LE is latent heat flux, R-net is the surface net radiation, G is ground heat flux and H is the sensible heat flux. Additionally actual surface evapotranspiration from potential evaporation was found to be in the range of 59 to 66%. After comparing these rates with those of most prominent high latitude ecosystems it is argued here that if agroecosystem in high latitudes become an emerging feature in the land-use, the regional surface energy balance will significantly shift in comparison to existing Arctic natural ecosystems.	[Ruairuen, Watcharee; Sparrow, Elena B.; Zhang, Mingchu] Univ Alaska Fairbanks, Sch Nat Resources & Extens, Fairbanks, AK 99775 USA; [Fochesatto, Gilberto J.] Univ Alaska Fairbanks, Inst Geophys, Dept Atmospher Sci, Fairbanks, AK 99775 USA; [Fochesatto, Gilberto J.] Univ Alaska Fairbanks, Coll Nat Sci & Math, Fairbanks, AK 99775 USA; [Schnabel, William] Univ Alaska Fairbanks, Inst Northern Engn, Water & Environm Res Ctr, Fairbanks, AK 99775 USA; [Sparrow, Elena B.; Kim, Yongwon] Univ Alaska Fairbanks, Int Arctic Res Ctr, Fairbanks, AK 99775 USA	University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks	Fochesatto, GJ (corresponding author), Univ Alaska Fairbanks, Inst Geophys, Dept Atmospher Sci, Fairbanks, AK 99775 USA.	foch@gi.alaska.edu	Kim, Yongwon/F-4683-2010	Kim, Yongwon/0000-0002-6513-4777; Ruairuen, Watcharee/0000-0003-3448-5686	Suratthani Rajabhat University, Thailand PhD Scholarship; Alaska EPSCOR [NSF-OIA-1208927]; Geophysical Institute University of Alaska Fairbanks; International Arctic Research Center; JAMSTEC-IARC Collaboration Study (JICS) project by the Japan Agency for Marine-Earth Science and Technology (JAMSTEC); Office Of The Director [1208927] Funding Source: National Science Foundation	Suratthani Rajabhat University, Thailand PhD Scholarship; Alaska EPSCOR; Geophysical Institute University of Alaska Fairbanks; International Arctic Research Center; JAMSTEC-IARC Collaboration Study (JICS) project by the Japan Agency for Marine-Earth Science and Technology (JAMSTEC); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	Watcharee Ruairuen was funded by Suratthani Rajabhat University, Thailand PhD Scholarship and the Alaska EPSCOR (NSF-OIA-1208927 for Alaska Adapting to Changing Environments). Gilberto J. Fochesatto was funded by the Geophysical Institute University of Alaska Fairbanks. Elena B. Sparrow was supported by the International Arctic Research Center and the Alaska EPSCOR (NSF-OIA-1208927 for Alaska Adapting to Changing Environments). Yongwon Kim was partially supported under the JAMSTEC-IARC Collaboration Study (JICS) project by the Japan Agency for Marine-Earth Science and Technology (JAMSTEC).	Adegoke JO, 2007, AGR FOREST METEOROL, V142, P203, DOI 10.1016/j.agrformet.2006.07.013; Adegoke JO, 2003, MON WEATHER REV, V131, P556, DOI 10.1175/1520-0493(2003)131<0556:IOIOMS>2.0.CO;2; Alaska Climate Research Center (ACRC), CLIMATE NORMAL; Alfieri JG, 2012, ADV WATER RESOUR, V50, P62, DOI 10.1016/j.advwatres.2012.07.008; Allen R. G., 2005, Irrigation and Drainage Systems, V19, P251, DOI 10.1007/s10795-005-5187-z; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Alves I, 2000, AGR WATER MANAGE, V42, P371, DOI 10.1016/S0378-3774(99)00041-4; Anadranistakis M., 2000, AGR WATER MANAGE, V42, P371; Aubinet M, 2000, ADV ECOL RES, V30, P113, DOI 10.1016/S0065-2504(08)60018-5; Baldocchi DD, 1997, AGR FOREST METEOROL, V83, P147, DOI 10.1016/S0168-1923(96)02335-0; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Beringer J, 2005, AGR FOREST METEOROL, V131, P143, DOI 10.1016/j.agrformet.2005.05.006; BEVEN K, 1979, J HYDROL, V44, P169, DOI 10.1016/0022-1694(79)90130-6; BLANKEN PD, 1995, INT J CLIMATOL, V15, P97, DOI 10.1002/joc.3370150110; Boike J, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000540; BOLLE HJ, 1990, SOILS AND THE GREENHOUSE EFFECT, P329; Bolton WR, 2004, IAHS-AISH P, V290, P213; Braley WA, 1980, THESIS; Bunn A.G., 2007, EOS T AM GEOPHYS UN, V88, P333, DOI [10.1029/2007EO340001, DOI 10.1029/2007EO340001]; Chapin F. S., 2005, ECOSYSTEMS HUMAN WEL, P717; Chapin F. S., 2014, 3 NATL CLIMATE ASSES, P514, DOI [10.7930/J00Z7150, DOI 10.7930/J00Z7150]; Chapin FS, 2005, SCIENCE, V310, P657, DOI 10.1126/science.1117368; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chapin FS, 2011, PRINCIPLES OF TERRES; Cook BI, 2011, CLIM DYNAM, V37, P1587, DOI 10.1007/s00382-010-0932-x; CULF AD, 1993, AGR FOREST METEOROL, V66, P65, DOI 10.1016/0168-1923(93)90082-S; Doorenbos J, 1986, FAO IRRIGATION AND D; DUGAS WA, 1993, AGR FOREST METEOROL, V67, P115, DOI 10.1016/0168-1923(93)90053-K; Dugas WA, 1991, AGR FOREST METEOROL, V56, P12; Eaton AK, 2001, J CLIMATE, V14, P3692, DOI 10.1175/1520-0442(2001)014<3692:SEBOTW>2.0.CO;2; Engstrom RN, 2002, J AM WATER RESOUR AS, V38, P1647, DOI 10.1111/j.1752-1688.2002.tb04371.x; Eugster W, 2000, GLOBAL CHANGE BIOL, V6, P84, DOI 10.1046/j.1365-2486.2000.06015.x; Euskirchen ES, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00202.1; Euskirchen ES, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD005793; Euskirchen ES, 2006, GLOBAL CHANGE BIOL, V12, P731, DOI 10.1111/j.1365-2486.2006.01113.x; Evans JP, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006671; Farahani HJ, 2007, T ASABE, V50, P1627, DOI 10.13031/2013.23965; FLINT AL, 1991, AGR FOREST METEOROL, V56, P247, DOI 10.1016/0168-1923(91)90094-7; Fochesatto GJ, 2015, METEOROL ATMOS PHYS, V127, P369, DOI 10.1007/s00703-013-0274-4; Foken T, 2008, ECOL APPL, V18, P1351, DOI 10.1890/06-0922.1; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Goyal M., 2014, EVAPOTRANSPIRATION P; Grunwald T, 2007, TELLUS B, V59, P387, DOI 10.1111/j.1600-0889.2007.00259.x; Haddeland I, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026047; Hammond T, 1996, ECOSCIENCE, V3, P490, DOI 10.1080/11956860.1996.11682368; Harazono Y, 1998, HYDROL PROCESS, V12, P2163, DOI 10.1002/(SICI)1099-1085(19981030)12:13/14&lt;2163::AID-HYP727&gt;3.0.CO;2-Y; Hatch E., 2011, THESIS; Heusinkveld BG, 2004, AGR FOREST METEOROL, V122, P21, DOI 10.1016/j.agrformet.2003.09.005; Hinzman LD, 2005, CLIMATIC CHANGE, V72, P251, DOI 10.1007/s10584-005-5352-2; Holloway PS, 1993, GEORGESON BOTANICAL; Irmak S, 2008, AGR FOREST METEOROL, V148, P1034, DOI 10.1016/j.agrformet.2008.02.001; Ishii Y, 2004, IAHS-AISH P, V290, P50; Jalota SK, 2002, AGR WATER MANAGE, V57, P75, DOI 10.1016/S0378-3774(02)00049-5; Juday GP, 2005, ARCTIC CLIMATE IMPAC, P782; KANE DL, 1990, NORD HYDROL, V21, P253; Kane DL, 2004, IAHS-AISH P, V290, P224; Kane DL, 2004, IAHS-AISH P, V290, P1; Knight CW, 2004, AEFF BULLETIN, V111; Langer M, 2011, CRYOSPHERE, V5; Lei HM, 2010, AGR FOREST METEOROL, V150, P581, DOI 10.1016/j.agrformet.2010.01.022; Lewan E, 1996, WATER RESOUR RES, V32, P2067, DOI 10.1029/96WR00803; Li S, 2008, AGR WATER MANAGE, V95, P1214, DOI 10.1016/j.agwat.2008.04.014; Liljedahl AK, 2011, BIOGEOSCIENCES, V8, P3375, DOI 10.5194/bg-8-3375-2011; Liu S, 2010, HYDROL EARTH SYST SC, V14, P573, DOI 10.5194/hess-14-573-2010; Lloyd CR, 2001, THEOR APPL CLIMATOL, V70, P19, DOI 10.1007/s007040170003; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Loring PA, 2009, ENVIRON SCI POLICY, V12, P466, DOI 10.1016/j.envsci.2008.10.006; Lu JB, 2003, J AM WATER RESOUR AS, V39, P887, DOI 10.1111/j.1752-1688.2003.tb04413.x; Lui H, 2005, J GEOPHYS RES-ATMOS, V110, DOI [10.1029/2004JD005158, DOI 10.1029/2004JD005158]; Lund M, 2014, TELLUS B, V66, DOI 10.3402/tellusb.v66.21631; Ma Y, 2009, HYDROL EARTH SYST SC, V13, P1103, DOI 10.5194/hess-13-1103-2009; Mahrt L, 1998, J ATMOS OCEAN TECH, V15, P416, DOI 10.1175/1520-0426(1998)015<0416:FSEFAA>2.0.CO;2; MALEK E, 1993, J HYDROL, V146, P209, DOI 10.1016/0022-1694(93)90276-F; Marsh P, 2004, IAHS-AISH P, V290, P205; Martinez-Cob A, 2010, AGR WATER MANAGE, V97, P410, DOI 10.1016/j.agwat.2009.10.013; Mayfield JA, 2013, J APPL METEOROL CLIM, V52, P953, DOI 10.1175/JAMC-D-12-01.1; McFadden JP, 1998, J GEOPHYS RES-ATMOS, V103, P28947, DOI 10.1029/98JD02400; Meyers TP, 2004, AGR FOREST METEOROL, V125, P105, DOI 10.1016/j.agrformet.2004.03.001; Moderow U, 2009, THEOR APPL CLIMATOL, V98, P397, DOI 10.1007/s00704-009-0175-0; Monteith J L, 1965, Symp Soc Exp Biol, V19, P205; Monteith J. L, 1973, PRINCIPLES OF ENVIRO; MOORE KE, 1994, J GEOPHYS RES-ATMOS, V99, P1937, DOI 10.1029/93JD01442; Mulligan D., 2004, SOIL SURVEY OF THE G, P101; Nakai T, 2013, POLAR SCI, V7, P136, DOI 10.1016/j.polar.2013.03.003; NOAA Climatological Data, 2013, CLIMATOLOGICAL DATA, V5; NOAA Climatological Data, 2012, CLIMATOLOGICAL DATA, V4; Ortega-Farias S, 2004, IRRIGATION SCI, V23, P1, DOI 10.1007/s00271-003-0087-1; Overland JE, 2004, CLIMATIC CHANGE, V63, P291, DOI 10.1023/B:CLIM.0000018512.40506.d2; Overpeck J, 1997, SCIENCE, V278, P1251, DOI 10.1126/science.278.5341.1251; Ozdogan M, 2010, J HYDROMETEOROL, V11, P171, DOI 10.1175/2009JHM1116.1; Parent AC, 2012, AGR WATER MANAGE, V113, P45, DOI 10.1016/j.agwat.2012.06.014; Patric JH, 1968, U S DEPARTMENT OF AG; Pielke RA, 2007, TELLUS B, V59, P587, DOI 10.1111/j.1600-0889.2007.00251.x; PRIESTLEY CHB, 1972, MON WEATHER REV, V100, P81, DOI 10.1175/1520-0493(1972)100<0081:OTAOSH>2.3.CO;2; Quinton WL, 2004, IAHS-AISH P, V290, P186; Randerson JT, 2006, SCIENCE, V314, P1130, DOI 10.1126/science.1132075; Rouse WR, 2000, GLOBAL CHANGE BIOL, V6, P59, DOI 10.1046/j.1365-2486.2000.06013.x; Rouse WR, 1997, WATER RESOUR RES, V13, P909; Sanchez JM, 2010, HYDROL EARTH SYST SC, V14, P1487, DOI 10.5194/hess-14-1487-2010; Segal M, 1998, J APPL METEOROL, V37, P325, DOI 10.1175/1520-0450-37.3.325; Serreze MC, 2006, CLIMATIC CHANGE, V76, P241, DOI 10.1007/s10584-005-9017-y; Serreze MC, 2000, J CLIMATE, V13, P182, DOI 10.1175/1520-0442(2000)013<0182:ROMAPF>2.0.CO;2; Seuna P, 2004, IAHS-AISH P, V290, P111; Sharratt BS, 1998, SOIL TILL RES, V46, P225, DOI 10.1016/S0167-1987(98)00102-0; SHARRATT BS, 1992, ARCTIC, V45, P124; Shulski M, 2007, THE CLIMATE OF ALASK; Slingo JM, 2005, PHILOS T R SOC B, V360, P1983, DOI 10.1098/rstb.2005.1755; Smith NV, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004472; STANNARD DI, 1994, WATER RESOUR RES, V30, P1227, DOI 10.1029/93WR03037; Starkenburg D, 2014, J GEOPHYS RES, V20, P1348; STATSGO, 2011, STATE SOIL GEOGRAPHI; Stevenson KT, 2014, ARCTIC, V67, P296, DOI 10.14430/arctic4408; STEWART RB, 1977, J APPL METEOROL, V16, P649, DOI 10.1175/1520-0450(1977)016&lt;0649:SOTPAT&gt;2.0.CO;2; Stow DA, 2004, REMOTE SENS ENVIRON, V89, P281, DOI 10.1016/j.rse.2003.10.018; Stoy PC, 2006, GLOBAL CHANGE BIOL, V12, P2115, DOI 10.1111/j.1365-2486.2006.01244.x; Sumner DM, 2005, J HYDROL, V308, P81, DOI 10.1016/j.jhydrol.2004.10.023; Sun G, 2002, J HYDROL, V263, P92, DOI 10.1016/S0022-1694(02)00064-1; Sun HY, 2006, AGR WATER MANAGE, V85, P211, DOI 10.1016/j.agwat.2006.04.008; Suyker AE, 2008, AGR FOREST METEOROL, V148, P417, DOI 10.1016/j.agrformet.2007.10.005; Suyker AE, 2009, AGR FOREST METEOROL, V149, P443, DOI 10.1016/j.agrformet.2008.09.010; SWANK WT, 1974, SCIENCE, V185, P857, DOI 10.1126/science.185.4154.857; Tanana Valley Irrigation Study Team, 1972, REPORT OF A FEDERAL; Thorne G, 2004, IAHS-AISH P, V290, P164; Twine TE, 2000, AGR FOREST METEOROL, V103, P279, DOI 10.1016/S0168-1923(00)00123-4; Vasilenko NG, 2004, IAHS-AISH P, V290, P65; Vourlitis GL, 1999, ECOLOGY, V80, P686, DOI 10.1890/0012-9658(1999)080[0686:ECMOCA]2.0.CO;2; Wagle P, 2014, ECOHYDROLOGY, V7, P64, DOI 10.1002/eco.1322; Walsh JE, 2008, J CLIMATE, V21, P6156, DOI 10.1175/2008JCLI2163.1; Wendler G, 2009, ARCTIC, V62, P295; Wever LA, 2002, AGR FOREST METEOROL, V112, P31, DOI 10.1016/S0168-1923(02)00041-2; Wilson K, 2002, AGR FOREST METEOROL, V113, P223, DOI 10.1016/S0168-1923(02)00109-0; Wolken JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00288.1; Yan HF, 2015, METEOROL ATMOS PHYS, V127, P305, DOI 10.1007/s00703-015-0369-1; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115; Zhuravin SA, 2004, IAHS-AISH P, V290, P78	135	2	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137209	10.1371/journal.pone.0137209	http://dx.doi.org/10.1371/journal.pone.0137209			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368123	gold, Green Published, Green Submitted			2022-12-27	WOS:000361601100057
J	Vodonos, A; Friger, M; Katra, I; Krasnov, H; Zahger, D; Schwartz, J; Novack, V				Vodonos, Alina; Friger, Michael; Katra, Itzhak; Krasnov, Helena; Zahger, Doron; Schwartz, Joel; Novack, Victor			Individual Effect Modifiers of Dust Exposure Effect on Cardiovascular Morbidity	PLOS ONE			English	Article							PARTICULATE AIR-POLLUTION; CASE-CROSSOVER DESIGN; SAHARAN DUST; HOSPITAL ADMISSIONS; MEASUREMENT ERROR; DESERT DUST; DISEASE; MORTALITY; RISK; ASSOCIATION	Background High concentrations of particulate matter (PM) air pollution have been associated with death and hospital admissions due to cardiovascular morbidity. However, it is not clear a) whether high levels of non-anthropogenic PM from dust storms constitute a health risk; and b) whether these health risks are exacerbated in a particular demographic. Methods This study comprised all patients above 18 years old admitted to Soroka University Medical Center (1000 bed tertiary hospital, Be'er-Sheva, Israel, 2001-2010) with a primary diagnosis of acute coronary syndrome (ACS). Data on meteorological parameters and PM10 (particulate matter < 10 mu m in aerodiameter) were obtained from monitoring stations in the city of Be'er-Sheva. Data were analyzed using a case crossover analysis to examine the effect of dust exposure on hospitalization due to ACS and the interaction with co-morbidities and demographic factors. Results There were 16,734 hospitalizations due to ACS during the study period. The estimated odds of hospitalization due to ACS was significantly associated with PM10 during non dust storm days at the same day of the exposure (lag0); OR = 1.014 (95% CI 1.001-1.027) for a 10 mu g/m(3) increase, while a delayed response (lag1) was found during the dust storm days; OR = 1.007 (95% CI 1.002-1.012). The effect size for the dust exposure association was larger for older (above the age of 65), female or Bedouin patients. Conclusions Exposure to non-anthropogenic PM is associated with cardiovascular morbidity. Health risk associated dust exposure is gender and age specific with older women and Bedouin patients being the most vulnerable groups.	[Vodonos, Alina; Friger, Michael] Ben Gurion Univ Negev, Dept Publ Hlth, IL-84105 Beer Sheva, Israel; [Vodonos, Alina; Novack, Victor] Soroka Univ, Med Ctr, Clin Res Ctr, Beer Sheva, Israel; [Katra, Itzhak; Krasnov, Helena] Ben Gurion Univ Negev, Dept Geog & Environm Dev, IL-84105 Beer Sheva, Israel; [Zahger, Doron] Soroka Univ, Med Ctr, Dept Cardiol, Intens Cardiac Care Unit, Beer Sheva, Israel; [Schwartz, Joel] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Harvard University; Harvard T.H. Chan School of Public Health	Novack, V (corresponding author), Soroka Univ, Med Ctr, Clin Res Ctr, Beer Sheva, Israel.	victorno@clalit.org.il	KATRA, ITZHAK/F-1547-2012		Israeli Environment and Health Fund (EHF) [RGA 1004]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002] Funding Source: NIH RePORTER	Israeli Environment and Health Fund (EHF); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Israeli Environment and Health Fund (EHF) Grant # RGA 1004. IK received the funding (http://www.ehf.org.il/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandrini ER, 2013, OCCUP ENVIRON MED, V70, P432, DOI 10.1136/oemed-2012-101182; Alpert P, 2004, INT J CLIMATOL, V24, P1013, DOI 10.1002/joc.1037; Bateson TF, 1999, EPIDEMIOLOGY, V10, P539, DOI 10.1097/00001648-199909000-00013; Bateson TF, 2004, EPIDEMIOLOGY, V15, P143, DOI 10.1097/01.ede.0000112210.68754.fa; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; BURNETT RT, 1995, AM J EPIDEMIOL, V142, P15, DOI 10.1093/oxfordjournals.aje.a117540; Cadelis G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091136; Chen LH, 2005, ENVIRON HEALTH PERSP, V113, P1723, DOI 10.1289/ehp.8190; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Ganor E, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012638; Ganor E, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012500; Goldberg MS, 2001, ENVIRON HEALTH PERSP, V109, P487, DOI 10.2307/3454658; Jimenez E, 2010, SCIENCE OF THE TOTAL; KANNEL WB, 1976, ANN INTERN MED, V85, P447, DOI 10.7326/0003-4819-85-4-447; Krasnov H, 2015, BUILD ENVIRON, V87, P169, DOI 10.1016/j.buildenv.2015.01.035; Krasnov H, 2014, J AIR WASTE MANAGE, V64, P89, DOI 10.1080/10962247.2013.841599; Kwan M.-P., 2004, SPAT INTEGR SOC SCI, V27, P721; Lepeule J, 2012, ENVIRON HEALTH PERSP, V120, P965, DOI 10.1289/ehp.1104660; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lumley T, 2000, ENVIRONMETRICS, V11, P689, DOI 10.1002/1099-095X(200011/12)11:6<689::AID-ENV439>3.0.CO;2-N; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Middleton N, 2008, ENV HLTH, V22, P7; Novack V, 2007, ETHNIC DIS, V17, P441; Perez L, 2008, EPIDEMIOLOGY, V19, P800, DOI 10.1097/EDE.0b013e31818131cf; Peters A, 2001, CIRCULATION, V103, P2810; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Reyes M, 2014, INT J ENVIRON HEAL R, V24, P63, DOI 10.1080/09603123.2013.782604; Sajani SZ, 2011, OCCUP ENVIRON MED, V68, P446, DOI 10.1136/oem.2010.058156; Samoli E, 2011, SCI TOTAL ENVIRON, V409, P2049, DOI 10.1016/j.scitotenv.2011.02.031; Sandstrom T, 2008, EPIDEMIOLOGY, V19, P808, DOI 10.1097/EDE.0b013e31818809e0; Schwartz J, 1997, EPIDEMIOLOGY, V8, P371, DOI 10.1097/00001648-199707000-00004; Shao YP, 2011, AEOLIAN RES, V2, P181, DOI 10.1016/j.aeolia.2011.02.001; Sunyer J, 2000, AM J EPIDEMIOL, V151, P50, DOI 10.1093/oxfordjournals.aje.a010121; Suwa T, 2002, J AM COLL CARDIOL, V39, P935, DOI 10.1016/S0735-1097(02)01715-1; THOMAS D, 1993, ANNU REV PUBL HEALTH, V14, P69, DOI 10.1146/annurev.pu.14.050193.000441; Vodonos A, 2014, AIR QUAL ATMOS HLTH, V7, P433, DOI 10.1007/s11869-014-0253-z; WHO, 2006, INDIAN J MED RES; Yitshak-Sade M, 2015, EUR RESPIR J, V45, P652, DOI 10.1183/09031936.00078614; Zanobetti A, 2000, ENVIRON HEALTH PERSP, V108, P841, DOI 10.2307/3434991; Zanobetti A, 2005, ENVIRON HEALTH PERSP, V113, P978, DOI 10.1289/ehp.7550; Zanobetti A, 2000, J OCCUP ENVIRON MED, V42, P469, DOI 10.1097/00043764-200005000-00002; Zeger SL, 2000, ENVIRON HEALTH PERSP, V108, P419, DOI 10.2307/3454382	43	41	41	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137714	10.1371/journal.pone.0137714	http://dx.doi.org/10.1371/journal.pone.0137714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381397	gold, Green Published, Green Submitted			2022-12-27	WOS:000361790200033
J	Abdelgawad, A; Hermes, R; Damiani, A; Lamglait, B; Czirjak, GA; East, M; Aschenborn, O; Wenker, C; Kasem, S; Osterrieder, N; Greenwood, AD				Abdelgawad, Azza; Hermes, Robert; Damiani, Armando; Lamglait, Benjamin; Czirjak, Gabor A.; East, Marion; Aschenborn, Ortwin; Wenker, Christian; Kasem, Samy; Osterrieder, Nikolaus; Greenwood, Alex D.			Comprehensive Serology Based on a Peptide ELISA to Assess the Prevalence of Closely Related Equine Herpesviruses in Zoo and Wild Animals	PLOS ONE			English	Article							KRUGER-NATIONAL-PARK; TYPE-1 EHV-1; EXPERIMENTAL-INFECTION; GAZELLE HERPESVIRUS-1; SERENGETI ECOSYSTEM; EQUUS-BURCHELLI; ZEBRA; ANTIBODIES; VIRUS; ENCEPHALITIS	Equine herpesvirus type 1 (EHV-1) causes respiratory disorders and abortion in equids while EHV-1 regularly causes equine herpesvirus myeloencephalopathy (EHM), a stroke-like syndrome following endothelial cell infection in horses. Both EHV-1 and EHV-9 infections of non-definitive hosts often result in neuronal infection and high case fatality rates. Hence, EHV-1 and EHV-9 are somewhat unusual herpesviruses and lack strict host specificity, and the true extent of their host ranges have remained unclear. In order to determine the seroprevalence of EHV-1 and EHV-9, a sensitive and specific peptide-based ELISA was developed and applied to 428 sera from captive and wild animals representing 30 species in 12 families and five orders. Members of the Equidae, Rhinocerotidae and Bovidae were serologically positive for EHV-1 and EHV-9. The prevalence of EHV-1 in the sampled wild zebra populations was significantly higher than in zoos suggesting captivity may reduce exposure to EHV-1. Furthermore, the seroprevalence for EHV-1 was significantly higher than for EHV-9 in zebras. In contrast, EHV-9 antibody prevalence was high in captive and wild African rhinoceros species suggesting that they may serve as a reservoir or natural host for EHV-9. Thus, EHV-1 and EHV-9 have a broad host range favoring African herbivores and may have acquired novel natural hosts in ecosystems where wild equids are common and are in close contact with other perissodactyls.	[Abdelgawad, Azza; Hermes, Robert; Czirjak, Gabor A.; East, Marion; Greenwood, Alex D.] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Damiani, Armando; Osterrieder, Nikolaus] Free Univ Berlin, Inst Virol, Berlin, Germany; [Lamglait, Benjamin] Reserve Africaine Sigean, Sigean, France; [Aschenborn, Ortwin] Bwabwata Ecol Inst, Susuwe, Zambezi Region, Namibia; [Wenker, Christian] Zoo Basel, Basel, Switzerland; [Kasem, Samy] Kafrelsheikh Univ, Fac Vet Med, Dept Virol, Kafrelsheikh, Egypt	Leibniz Institut fur Zoo und Wildtierforschung; Free University of Berlin; Egyptian Knowledge Bank (EKB); Kafrelsheikh University	Greenwood, AD (corresponding author), Leibniz Inst Zoo & Wildlife Res, Berlin, Germany.	greenwood@izw-berlin.de	Kasem, Samy/AAF-9650-2019; Greenwood, Alex/GWU-8292-2022; Kasem, Samy/AAA-3910-2021; Czirják, Gábor Árpád/F-5440-2011	Kasem, Samy/0000-0002-8730-7333; Kasem, Samy/0000-0002-8730-7333; Czirják, Gábor Árpád/0000-0001-9488-0069; Osterrieder, Nikolaus/0000-0002-5313-2176	Leibniz Gemeinschaft [SAW-2015-IZW-1 440]	Leibniz Gemeinschaft	AA, GAC, ME, OA, NO and ADG were supported by a grant from the Leibniz Gemeinschaft SAW-2015-IZW-1 440. Benjamin Lamglait is an employee of the Reserve Africaine de Sigean, a commercial entity. The funder provided support in the form of salaries for authors [BL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgawad A, 2014, VET MICROBIOL, V169, P102, DOI 10.1016/j.vetmic.2013.12.011; BARNARD BJH, 1993, ONDERSTEPOORT J VET, V60, P111; BARNARD BJH, 1993, ONDERSTEPOORT J VET, V60, P175; Becker SD, 2007, LAB ANIM-UK, V41, P229, DOI 10.1258/002367707780378203; Blunden AS, 1998, J COMP PATHOL, V119, P485, DOI 10.1016/S0021-9975(98)80043-1; Borchers K, 2005, J WILDLIFE DIS, V41, P80, DOI 10.7589/0090-3558-41.1.80; Borchers K, 2008, J VET MED SCI, V70, P1377, DOI 10.1292/jvms.70.1377; Carvalho R, 2000, ARQ BRAS MED VET ZOO, P52; CHOWDHURY SI, 1988, VIRUS RES, V11, P127, DOI 10.1016/0168-1702(88)90038-X; CRABB BS, 1993, J VIROL, V67, P6332, DOI 10.1128/JVI.67.10.6332-6338.1993; CRANDELL RA, 1988, AM J VET RES, V49, P1807; CROUCH AC, 1995, EPIDEMIOL INFECT, V115, P185, DOI 10.1017/S0950268800058258; El-Nahass E, 2011, J COMP PATHOL; Fischer-Tenhagen C, 2000, J WILDLIFE DIS, V36, P316, DOI 10.7589/0090-3558-36.2.316; Fukushi H, 1997, VIROLOGY, V227, P34, DOI 10.1006/viro.1996.8296; Fukushi H, 2000, J NEUROVIROL, V6, P314, DOI 10.3109/13550280009030757; Ghanem Y, 2008, ARCH VIROL, V153, P2297, DOI 10.1007/s00705-008-0247-y; Gilbert AT, 2013, ECOHEALTH, V10, P298, DOI 10.1007/s10393-013-0856-0; Goltenboth R, 1996, P AM ASS ZOO VETS PU, P18; Greenwood AD, 2012, CURR BIOL, V22, P1727, DOI 10.1016/j.cub.2012.07.035; Kasem S, 2008, EMERG INFECT DIS, V14, P1948, DOI 10.3201/eid1412.080801; Lang A, 2013, J VIROL METHODS, V193, P667, DOI 10.1016/j.jviromet.2013.07.044; Ma GG, 2013, VET MICROBIOL, V167, P123, DOI 10.1016/j.vetmic.2013.06.018; Narita M, 2000, VET PATHOL, V37, P476, DOI 10.1354/vp.37-5-476; Office International des Epizooties, 2008, MAN DIAGN TESTS VACC, P894; Perkins GA, 2013, AM J VET RES, V74, P248, DOI 10.2460/ajvr.74.2.248; Pusterla N, 2009, VET J, V179, P230, DOI 10.1016/j.tvjl.2007.09.018; REBHUN WC, 1988, J AM VET MED ASSOC, V192, P953; Reed SM, 2004, VET CLIN N AM-EQUINE, V20, P631, DOI 10.1016/j.cveq.2004.09.001; Schrenzel MD, 2008, EMERG INFECT DIS, V14, P1616, DOI 10.3201/eid1410.080703; Stobel K, 2002, INT J MED MICROBIOL, V291, P88; Taniguchi A, 2000, J VET MED SCI, V62, P215, DOI 10.1292/jvms.62.215; Taniguchi A, 2000, ARCH VIROL, V145, P2619, DOI 10.1007/s007050070011; van Maanen C, 2002, VET QUART, V24, P57, DOI 10.1080/01652176.2002.9695126; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666, DOI 10.1128/JCM.34.7.1666-1671.1996; Wohlsein P, 2011, VET MICROBIOL, V149, P456, DOI 10.1016/j.vetmic.2010.11.024; Wright P F, 1993, Rev Sci Tech, V12, P435; Yanai T, 2003, VET PATHOL, V40, P263, DOI 10.1354/vp.40-3-263; Yanai T, 2003, J COMP PATHOL, V128, P113, DOI 10.1053/jcpa.2002.0613; Yasunaga S, 1998, J VET MED SCI, V60, P1133, DOI 10.1292/jvms.60.1133	40	21	21	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138370	10.1371/journal.pone.0138370	http://dx.doi.org/10.1371/journal.pone.0138370			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378452	Green Published, gold, Green Submitted			2022-12-27	WOS:000361769400090
J	Fong, MY; Ahmed, MA; Wong, SS; Lau, YL; Sitam, F				Fong, Mun Yik; Ahmed, Md Atique; Wong, Shen Siang; Lau, Yee Ling; Sitam, Frankie			Genetic Diversity and Natural Selection of the Plasmodium knowlesi Circumsporozoite Protein Nonrepeat Regions	PLOS ONE			English	Article							CELL EPITOPE POLYMORPHISMS; P. FALCIPARUM; MALARIA; INFECTION; HUMANS; VIVAX; TRANSMISSION; SPOROZOITE; PARASITES; INVASION	Background Plasmodium knowlesi is a simian malaria parasite that has been identified to cause malaria in humans. To date, several thousand cases of human knowlesi malaria have been reported around Southeast Asia. Thus far, there is no detailed study on genetic diversity and natural selection of P. knowlesi circumsporozoite protein (CSP), a prominent surface antigen on the sporozoite of the parasite. In the present study, the genetic diversity and natural selection acting on the nonrepeat regions of the gene encoding P. knowlesi CSP were investigated, focusing on the T-cell epitope regions at the C-terminal of the protein. Methods Blood samples from 32 knowlesi malaria patients and 2 wild monkeys (Macaca fascicularis) were used. The CSP of the P. knowlesi isolates was amplified by PCR, cloned into Escherichia coil, and sequenced. The nonrepeat regions of the CSP gene were analysed for genetic diversity, natural selection and haplotypic grouping using MEGA5 and DnaSP version 5.10.00 programmes. A haplotype network was constructed based on the C-terminal (Th2R/Th3R) T-cell epitope regions using the Median-Joining method in the NETVVORK version 4.6.1.2 programme. Previously published sequences from other regions (Malaysia Borneo, Singapore) were also included in the analysis. Results A total of 123 P. knowlesi CSP sequences were analysed. Multiple sequence alignment revealed 58 amino acid changes, and 42 novel amino acid haplotypes were identified. Polymorphism was higher in the C-terminal Th2R/Th3R epitope (ii = 0.0293, n = 123) region compared to the overall combined nonrepeat regions (ii = 0.0120, n = 123). Negative natural selection was observed within the nonrepeat regions of the CSP gene. Within the C-terminal Th2R/Th3R epitope regions, there was evidence of slight positive selection. Based on haplotype network analysis of the Th2R/Th3R regions, five abundant haplotypes were identified. Sharing of haplotypes between humans and macaques were observed. Conclusion This study contributes to the understanding of the type and distribution of naturally occurring polymorphism in the P. knowlesi CSP gene. This study also provides a measurement of the genetic diversity of P. knowlesi and identifies the predominant haplotypes within Malaysia based on the C-terminal Th2R/Th3R regions.	[Fong, Mun Yik; Ahmed, Md Atique; Wong, Shen Siang; Lau, Yee Ling] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia; [Sitam, Frankie] Dept Wildlife & Natl Pk Peninsular Malaysia, Kuala Lumpur, Malaysia	Universiti Malaya	Fong, MY (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia.	fongmy@um.edu.my	Sitam, Frankie Thomas/AAF-6279-2021; Ahmed, Atique/L-7820-2015; Singh, Balbir/A-3610-2009; FONG, MUN YIK/B-5443-2010; Lau, Yee Ling/C-6996-2009	Sitam, Frankie Thomas/0000-0001-7160-6243; Lau, Yee Ling/0000-0002-2037-2165; Ahmed, Md Atique/0000-0002-3407-7220	University of Malaya [UM-MOHE UM.C/625/1/HIR/MOHE/MED/09]	University of Malaya(Universiti Malaya)	This study was funded by the University of Malaya High Impact Research Fund, UM-MOHE UM.C/625/1/HIR/MOHE/MED/09). MYF is the recipient of the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003086; Ahmed MA, 2015, ISBT SCI SER, V10, P134, DOI 10.1111/voxs.12115; Aldrich C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032524; Alloueche A, 2000, MOL BIOCHEM PARASIT, V106, P273, DOI 10.1016/S0166-6851(99)00221-2; de Brito CFA, 2011, MEM I OSWALDO CRUZ, V106, P12, DOI 10.1590/S0074-02762011000900003; ARNOT DE, 1985, SCIENCE, V230, P815, DOI 10.1126/science.2414847; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Baum J, 2003, GENETICS, V163, P1327; Bowman NM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01990; DAME JB, 1984, SCIENCE, V225, P593, DOI 10.1126/science.6204383; Dias S, 2013, GENE, V518, P381, DOI 10.1016/j.gene.2013.01.003; DOOLAN DL, 1992, INFECT IMMUN, V60, P675, DOI 10.1128/IAI.60.2.675-682.1992; Escalante AA, 2002, MOL BIOCHEM PARASIT, V125, P83, DOI 10.1016/S0166-6851(02)00216-5; Figtree M, 2010, EMERG INFECT DIS, V16, P672, DOI 10.3201/eid1604.091624; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; HUGHES AL, 1991, GENETICS, V127, P345; Jalloh A, 2006, J CLIN MICROBIOL, V44, P1229, DOI 10.1128/JCM.44.4.1229-1235.2006; JONGWUTIWES S, 1994, AM J TROP MED HYG, V51, P659, DOI 10.4269/ajtmh.1994.51.659; Khim N, 2011, EMERG INFECT DIS, V17, P1900, DOI 10.3201/eid1710.110355; Kumkhaek C, 2005, J IMMUNOL, V175, P3935, DOI 10.4049/jimmunol.175.6.3935; Kumkhaek Chutima, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P281; Lee KS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002015; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LOCKYER MJ, 1989, MOL BIOCHEM PARASIT, V37, P275, DOI 10.1016/0166-6851(89)90159-X; Luchavez J, 2008, EMERG INFECT DIS, V14, P811, DOI 10.3201/eid1405.071407; MCCONKEY GA, 1990, ANNU REV MICROBIOL, V44, P479, DOI 10.1146/annurev.mi.44.100190.002403; McCutchan TF, 1996, P NATL ACAD SCI USA, V93, P11889, DOI 10.1073/pnas.93.21.11889; Myung JM, 2004, MOL BIOCHEM PARASIT, V133, P53, DOI 10.1016/j.molbiopara.2003.09.002; Nardin EH, 1998, MALARIA PARASITE BIO, P495; NEI M, 1986, MOL BIOL EVOL, V3, P418; Ng OT, 2008, EMERG INFECT DIS, V14, P814, DOI 10.3201/eid1405.070863; OZAKI LS, 1983, CELL, V34, P815, DOI 10.1016/0092-8674(83)90538-X; Sallum MAM, 2005, MED VET ENTOMOL, V19, P158, DOI 10.1111/j.0269-283X.2005.00551.x; Sermwittayawong N, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-36; SHI YP, 1992, AM J TROP MED HYG, V47, P844, DOI 10.4269/ajtmh.1992.47.844; Sidjanski SP, 1997, MOL BIOCHEM PARASIT, V90, P33, DOI 10.1016/S0166-6851(97)00124-2; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tyagi RK, 2013, J ANTIMICROB CHEMOTH, V68, P1081, DOI 10.1093/jac/dks508; Van den Eede P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-249; Vythilingam I, 2006, T ROY SOC TROP MED H, V100, P1087, DOI 10.1016/j.trstmh.2006.02.006; Vythilingam I, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-26; Waitumbi JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007849; William T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002026; Willmann M, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-363; Zakeri S, 2007, AM J TROP MED HYG, V76, P1046, DOI 10.4269/ajtmh.2007.76.1046; Zeeshan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043430	49	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137734	10.1371/journal.pone.0137734	http://dx.doi.org/10.1371/journal.pone.0137734			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379157	Green Published, Green Submitted, gold			2022-12-27	WOS:000361769400024
J	Shinchi, H; Yuki, N; Ishida, H; Hirata, K; Wakao, M; Suda, Y				Shinchi, Hiroyuki; Yuki, Nobuhiro; Ishida, Hideharu; Hirata, Koichi; Wakao, Masahiro; Suda, Yasuo			Visual Detection of Human Antibodies Using Sugar Chain-Immobilized Fluorescent Nanoparticles: Application as a Point of Care Diagnostic Tool for Guillain-Barre Syndrome	PLOS ONE			English	Article							ABO BLOOD-GROUP; NATURAL ANTIBODIES; LINKER LENGTH; LECTIN; LIPOPOLYSACCHARIDE; OLIGOSACCHARIDES; EPITOPES; ANTIGENS; LIGANDS; BINDING	Sugar chain binding antibodies have gained substantial attention as biomarkers due to their crucial roles in various disorders. In this study, we developed simple and quick detection method of anti-sugar chain antibodies in sera using our previously developed sugar chain-immobilized fluorescent nanoparticles (SFNPs) for the point-of-care diagnostics. Sugar chain structure on SFNPs was modified with the sugar moieties of the GM1 ganglioside via our original linker molecule to detect anti-GM1 antibodies. The structures and densities of the sugar moieties immobilized on the nanoparticles were evaluated in detail using lectins and sera containing anti-GM1 antibodies from patients with Guillain-Barre syndrome, a neurological disorder, as an example of disease involving anti-sugar chain antibodies. When optimized SFNPs were added to sera from patients with Guillain-Barre syndrome, fluorescent aggregates were able to visually detect under UV light in three hours. The sensitivity of the detection method was equivalent to that of the current ELISA method used for the diagnosis of Guillain-Barre syndrome. These results suggest that our method using SFNPs is suitable for the point-of-care diagnostics of diseases involving anti-sugar chain antibodies.	[Shinchi, Hiroyuki; Wakao, Masahiro; Suda, Yasuo] Kagoshima Univ, Dept Chem Biotechnol & Chem Engn, Kagoshima 8900065, Japan; [Yuki, Nobuhiro; Hirata, Koichi] Dokkyo Med Univ, Dept Neurol, Mibu, Tochigi 3210293, Japan; [Yuki, Nobuhiro] Univ Sydney, Brain & Mind Res Inst, Camperdown, NSW 2050, Australia; [Ishida, Hideharu] Gifu Univ, Dept Appl Bioorgan Chem, Gifu 5011193, Japan; [Suda, Yasuo] SUDx Biotec Corp, Kagoshima 8900013, Japan	Kagoshima University; Dokkyo Medical University; University of Sydney; Gifu University	Suda, Y (corresponding author), Kagoshima Univ, Dept Chem Biotechnol & Chem Engn, 1-21-40 Kohrimoto, Kagoshima 8900065, Japan.	ysuda@eng.kagoshimau.ac.jp		Shinchi, Hiroyuki/0000-0001-5204-9170	Japan Society for the Promotion of Science [23300356]; Japan Science and Technology Agency [V07-05, AS2416907P, AS251Z02372P, 16-057]; Japan Ministry of Health, Labor, and Welfare [H21-Nano-Ippan-002]; Singapore National Medical Research Council [IRG 10nov086, CSA/047/2012]; Yong Loo Lin School of Medicine [R-172-000-264-733]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Singapore National Medical Research Council(National Medical Research Council, Singapore); Yong Loo Lin School of Medicine(National University of Singapore)	This study was supported in part by grants from the Japan Society for the Promotion of Science (23300356 to YS, http://www.jsps.go.jp/english/), the Japan Science and Technology Agency (V07-05 and AS2416907P to YS and AS251Z02372P and 16-057 to MW, http://www.jst.go.jp/EN/), the Japan Ministry of Health, Labor, and Welfare (H21-Nano-Ippan-002 to YS, http://www.mhlw.go.jp/english/), the Singapore National Medical Research Council (IRG 10nov086 and CSA/047/2012 to NY, http://www.nmrc.gov.sg/content/nmrc_internet/home.html), and Yong Loo Lin School of Medicine (start-up grant, R-172-000-264-733 to NY, http://medicine.nus.edu.sg/corporate/). All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The SUDx-bitec Corporation provided support in the form of travel expenses for YS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adamczyk B, 2012, BBA-GEN SUBJECTS, V1820, P1347, DOI 10.1016/j.bbagen.2011.12.001; Alaedini A, 2002, J NEUROL SCI, V196, P41, DOI 10.1016/S0022-510X(02)00022-9; Barrientos AG, 2009, CARBOHYD RES, V344, P1474, DOI 10.1016/j.carres.2009.04.029; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P225, DOI 10.1073/pnas.012540899; Hakomori S, 2000, GLYCOCONJUGATE J, V17, P143, DOI 10.1023/A:1026524820177; Houseman BT, 1999, ANGEW CHEM INT EDIT, V38, P782, DOI 10.1002/(SICI)1521-3773(19990315)38:6<782::AID-ANIE782>3.0.CO;2-N; Huflejt ME, 2009, MOL IMMUNOL, V46, P3037, DOI 10.1016/j.molimm.2009.06.010; Hughes RAC, 2007, BRAIN, V130, P2245, DOI 10.1093/brain/awm004; ILYAS AA, 1988, ANN NEUROL, V23, P440, DOI 10.1002/ana.410230503; Imamura A, 2008, GLYCOCONJUGATE J, V25, P269, DOI 10.1007/s10719-007-9102-8; Janshoff A, 1996, EUR BIOPHYS J BIOPHY, V25, P105, DOI 10.1007/s002490050022; Kimoto K, 2006, NEUROLOGY, V67, P1837, DOI 10.1212/01.wnl.0000244468.22377.6b; Kitov PI, 2000, NATURE, V403, P669, DOI 10.1038/35001095; KORNBERG AJ, 1994, ANN NEUROL, V35, P234, DOI 10.1002/ana.410350217; Krishnamurthy VM, 2007, J AM CHEM SOC, V129, P1312, DOI 10.1021/ja066780e; Lawrie CH, 2006, INT J CANCER, V118, P3161, DOI 10.1002/ijc.21762; Lundquist JJ, 2002, CHEM REV, V102, P555, DOI 10.1021/cr000418f; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Milland J, 2006, TISSUE ANTIGENS, V68, P459, DOI 10.1111/j.1399-0039.2006.00721.x; Pochechueva T, 2011, ANALYST, V136, P560, DOI 10.1039/c0an00758g; Reynolds M, 2012, CHEM-EUR J, V18, P4264, DOI 10.1002/chem.201102034; SANDRIN MS, 1994, IMMUNOL REV, V141, P169, DOI 10.1111/j.1600-065X.1994.tb00877.x; SANDRIN MS, 1993, P NATL ACAD SCI USA, V90, P11391, DOI 10.1073/pnas.90.23.11391; Sato M, 2009, J BIOCHEM, V146, P33, DOI 10.1093/jb/mvp041; Shewmake TA, 2008, BIOMACROMOLECULES, V9, P3057, DOI 10.1021/bm800529b; Shinchi H, 2012, CHEM-ASIAN J, V7, P2678, DOI 10.1002/asia.201200362; SIMM S, 1979, Ginekologia Polska, V50, P1029; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Wakao M, 2008, BIOORG MED CHEM LETT, V18, P2499, DOI 10.1016/j.bmcl.2008.01.069; WANG WT, 1984, ANAL BIOCHEM, V141, P366, DOI 10.1016/0003-2697(84)90057-5; WATANABE A, 1975, ANN NY ACAD SCI, V259, P95, DOI 10.1111/j.1749-6632.1975.tb25406.x; Watkins WM, 2001, TRANSFUSION MED, V11, P243, DOI 10.1046/j.1365-3148.2001.00321.x; WEIGEL PH, 1979, J BIOL CHEM, V254, P830; WERNER TC, 1972, P NATL ACAD SCI USA, V69, P795, DOI 10.1073/pnas.69.4.795; Willison HJ, 1999, EUR J NEUROL, V6, P71, DOI 10.1046/j.1468-1331.1999.610071.x; Woller EK, 2003, J AM CHEM SOC, V125, P8820, DOI 10.1021/ja0352496; WOODWARD MP, 1985, J IMMUNOL METHODS, V78, P143, DOI 10.1016/0022-1759(85)90337-0; Yu WW, 2003, CHEM MATER, V15, P2854, DOI 10.1021/cm034081k; YUKI N, 1992, BIOMED RES-TOKYO, V13, P451, DOI 10.2220/biomedres.13.451; YUKI N, 1993, J EXP MED, V178, P1771, DOI 10.1084/jem.178.5.1771; Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525	42	1	1	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137966	10.1371/journal.pone.0137966	http://dx.doi.org/10.1371/journal.pone.0137966			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378448	gold, Green Published, Green Submitted			2022-12-27	WOS:000361769400041
J	Thomas, MP; Parzynski, CS; Curtis, JP; Seth, M; Nallamothu, BK; Chan, PS; Spertus, JA; Patel, MR; Bradley, SM; Gurm, HS				Thomas, Michael P.; Parzynski, Craig S.; Curtis, Jeptha P.; Seth, Milan; Nallamothu, Brahmajee K.; Chan, Paul S.; Spertus, John A.; Patel, Manesh R.; Bradley, Steven M.; Gurm, Hitinder S.			Percutaneous Coronary Intervention Utilization and Appropriateness across the United States	PLOS ONE			English	Article							TASK-FORCE; REVASCULARIZATION; ANGIOGRAPHY; ASSOCIATION; CRITERIA; OUTCOMES	Background Substantial geographic variation exists in percutaneous coronary intervention (PCI) use across the United States. It is unclear the extent to which high PCI utilization can be explained by PCI for inappropriate indications. The objective of this study was to examine the relationship between PCI rates across regional healthcare markets utilizing hospital referral regions (HRRs) and PCI appropriateness. Methods The number of PCI procedures in each HRR was obtained from the 2010 100% Medicare limited data set. HRRs were divided into quintiles of PCI utilization with increasing rates of utilization progressing to quintile 5. NCDR CathPCI Registry (R) data were used to evaluate patient characteristics, appropriate use criteria (AUC), and outcomes across the HRR quintiles defined by PCI utilization with the study population restricted to HRRs where >= 80% of the PCIs were performed at institutions participating in the registry. PCI appropriateness was defined using 2012 AUC by the American College of Cardiology (ACC)/American Heart Association (AHA)/The Society for Cardiovascular Angiography and Interventions (SCAI). Results Our study cohort comprised of 380,981 patients treated at 178 HRRs. Mean PCI rates per 1,000 increased from 4.6 in Quintile 1 to 10.8 in Quintile 5. The proportion of non-acute PCIs was 27.7% in Quintile 1 increasing to 30.7% in Quintile 5. Significant variation (p < 0.001) existed across the quintiles in the categorization of appropriateness across HRRs of utilization with more appropriate PCI in lower utilization areas (Appropriate: Q1, 76.53%, Q2, 75.326%, Q3, 75.23%, Q4, 73.95%, Q5, 72.768%; Inappropriate: Q1 3.92%, Q2 4.23%, Q3 4.32%, Q4 4.35%, Q5 4.05%; Uncertain: Q1 8.29%, Q2 8.84%, Q3 8.08%, Q4 9.01%, Q5 8.93%; Not Mappable: Q1 11.26%, Q2 11.67%, Q3 12.37%, Q4 12.69%, Q5 14.34%). There was no difference in risk-adjusted mortality across quintiles of PCI utilization. Conclusions Geographic regions with lower PCI rates have a higher proportion of PCIs performed for appropriate indications. Areas that perform more PCIs also appear to perform more elective PCI and many could not be mapped by the AUC.	[Thomas, Michael P.; Seth, Milan; Nallamothu, Brahmajee K.; Gurm, Hitinder S.] Univ Michigan, Cardiovasc Med, Ann Arbor, MI 48109 USA; [Thomas, Michael P.; Nallamothu, Brahmajee K.; Gurm, Hitinder S.] VA Ann Arbor Healthcare Syst, Cardiovasc Med, Ann Arbor, MI USA; [Parzynski, Craig S.; Curtis, Jeptha P.] Yale Univ, Sch Med, Cardiovasc Med, New Haven, CT USA; [Chan, Paul S.; Spertus, John A.] St Lukes Mid Amer Heart & Vasc Inst, Kansas City, MO USA; [Patel, Manesh R.] Duke Clin Res Inst, Durham, NC USA; [Bradley, Steven M.] Univ Colorado, Cardiovasc Med, Denver, CO 80202 USA; [Bradley, Steven M.] VA Eastern Colorado Healthcare Syst, Denver, CO USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Yale University; Saint Luke's Mid America Heart Institute; Duke University; University of Colorado System; University of Colorado Denver	Thomas, MP (corresponding author), Univ Michigan, Cardiovasc Med, Ann Arbor, MI 48109 USA.	michptho@med.umich.edu	Spertus, John/ABD-3075-2021; Patel, Manesh/AAC-5385-2019; Bradley, Steven/AID-7839-2022	Gurm, Hitinder/0000-0002-1646-0218	American College of Cardiology; National Institutes of Health; Agency for Research Healthcare and Quality; Blue Cross Blue Shield of Michigan	American College of Cardiology(General Electric); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Research Healthcare and Quality; Blue Cross Blue Shield of Michigan	Dr. Curtis receives salary support from the American College of Cardiology for data analytic services and has equity stock in Medtronic. Dr. Nallamothu serves on United Healthcare's Scientific Cardiac Advisory Board. Dr. Gurm receives research support from the National Institutes of Health, Agency for Research Healthcare and Quality, and Blue Cross Blue Shield of Michigan. All other authors have no relationships relevant to the contents of this paper to disclose. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.	Abdallah MS, 2014, AM J CARDIOL, V114, P348, DOI 10.1016/j.amjcard.2014.04.047; Bradley SM, 2012, CIRC-CARDIOVASC QUAL, V5, P445, DOI 10.1161/CIRCOUTCOMES.111.964320; Bradley SM, 2012, CIRC-CARDIOVASC QUAL, V5, P290, DOI 10.1161/CIRCOUTCOMES.112.966044; Brindis R G, 2001, J Am Coll Cardiol, V37, P2240, DOI 10.1016/S0735-1097(01)01372-9; Chan PS, 2011, JAMA-J AM MED ASSOC, V306, P53, DOI 10.1001/jama.2011.916; Hannan EL, 2012, J AM COLL CARDIOL, V59, P1870, DOI 10.1016/j.jacc.2012.01.050; Hendel RC, 2013, J AM COLL CARDIOL, V61, P1305, DOI 10.1016/j.jacc.2013.01.025; Ko DT, 2012, J AM COLL CARDIOL, V60, P1876, DOI 10.1016/j.jacc.2012.06.056; LEAPE LL, 1990, JAMA-J AM MED ASSOC, V263, P669, DOI 10.1001/jama.263.5.669; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Matlock DD, 2013, JAMA-J AM MED ASSOC, V310, P155, DOI 10.1001/jama.2013.7837; Patel Manesh R, 2012, J Am Coll Cardiol, V59, P857, DOI 10.1016/j.jacc.2011.12.001; Patel MR, 2009, J AM COLL CARDIOL, V53, P530, DOI 10.1016/j.jacc.2008.10.005; Peterson ED, 2010, J AM COLL CARDIOL, V55, P1923, DOI 10.1016/j.jacc.2010.02.005; Weintraub WS, 1997, J AM COLL CARDIOL, V29, P459; Wennberg DE BJ, 1999, DARTMOUTH ATLAS CARD	16	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138251	10.1371/journal.pone.0138251	http://dx.doi.org/10.1371/journal.pone.0138251			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379053	Green Submitted, Green Published, gold			2022-12-27	WOS:000361769400072
J	Yeomans, MR; Brace, A				Yeomans, Martin R.; Brace, Aaron			Cued to Act on Impulse: More Impulsive Choice and Risky Decision Making by Women Susceptible to Overeating after Exposure to Food Stimuli	PLOS ONE			English	Article							3-FACTOR EATING QUESTIONNAIRE; ORBITOFRONTAL CORTEX; BULIMIA-NERVOSA; TASK BART; OBESE WOMEN; BEHAVIORAL MEASURES; INHIBITORY CONTROL; DIETARY RESTRAINT; DOPAMINE RELEASE; FUTURE REWARDS	There is increasing evidence that individual differences in tendency to overeat relate to impulsivity, possibly by increasing reactivity to food-related cues in the environment. This study tested whether acute exposure to food cues enhanced impulsive and risky responses in women classified on tendency to overeat, indexed by scores on the three factor eating questionnaire disinhibition (TFEQ-D), restraint (TFEQ-R) and hunger scales. Ninety six healthy women completed two measures of impulsive responding (delayed discounting, DDT and a Go No-Go, GNG, task) and a measure of risky decision making (the balloon analogue risk task, BART) as well as questionnaire measures of impulsive behaviour either after looking at a series of pictures of food or visually matched controls. Impulsivity (DDT) and risk-taking (BART) were both positively associated with TFEQ-D scores, but in both cases this effect was exacerbated by prior exposure to food cues. No effects of restraint were found. TFEQ-D scores were also related to more commission errors on the GNG, while restrained women were slower on the GNG, but neither effect was modified by cue exposure. Overall these data suggest that exposure to food cues act to enhance general impulsive responding in women at risk of overeating and tentatively suggest an important interaction between tendency for impulsive decision making and food cues that may help explain a key underlying risk factor for overeating.	[Yeomans, Martin R.; Brace, Aaron] Univ Sussex, Sch Psychol, Brighton BN1 9QH, E Sussex, England	University of Sussex	Yeomans, MR (corresponding author), Univ Sussex, Sch Psychol, Brighton BN1 9QH, E Sussex, England.	martin@sussex.ac.uk	Yeomans, Martin/A-5291-2012	Yeomans, Martin/0000-0003-1436-1483				Ames SL, 2014, APPETITE, V81, P180, DOI 10.1016/j.appet.2014.06.013; Appelhans BM, 2011, OBESITY, V19, P2175, DOI 10.1038/oby.2011.57; Ballard K, 2009, NEUROIMAGE, V45, P143, DOI 10.1016/j.neuroimage.2008.11.004; Batterink L, 2010, NEUROIMAGE, V52, P1696, DOI 10.1016/j.neuroimage.2010.05.059; Blechert J, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00617; Blundell J, 2010, OBESITY PREVENTION: THE ROLE OF BRAIN AND SOCIETY ON INDIVIDUAL BEHAVIOR, P231, DOI 10.1016/B978-0-12-374387-9.00018-0; Bond MJ, 2001, INT J OBESITY, V25, P900, DOI 10.1038/sj.ijo.0801611; Carrard I, 2012, EAT BEHAV, V13, P13, DOI 10.1016/j.eatbeh.2011.10.004; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Claes Laurence, 2006, Eat Behav, V7, P196, DOI 10.1016/j.eatbeh.2006.05.001; Cunningham SA, 2014, NEW ENGL J MED, V370, P403, DOI [10.1056/NEJMoa1309753, 10.1056/NEJMc1402397]; Davis C, 2010, APPETITE, V54, P208, DOI 10.1016/j.appet.2009.11.002; Dietrich A., 2014, FRONTIERS PSYCHOL, V5; Dougherty DM, 2005, BEHAV RES METHODS, V37, P82, DOI 10.3758/BF03206401; Engel SG, 2005, INT J EAT DISORDER, V38, P244, DOI 10.1002/eat.20169; Epstein LH, 2012, APPETITE, V58, P157, DOI 10.1016/j.appet.2011.09.025; Epstein LH, 2010, PHYSIOL BEHAV, V100, P438, DOI 10.1016/j.physbeh.2010.04.029; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Guerrieri R, 2007, APPETITE, V49, P66, DOI 10.1016/j.appet.2006.11.008; Hendrick OM, 2012, OBESITY, V20, P1796, DOI 10.1038/oby.2011.180; Hopko DR, 2006, J PSYCHOPATHOL BEHAV, V28, P95, DOI 10.1007/s10862-006-7487-5; Ito R, 2000, J NEUROSCI, V20, P7489; Jansen A, 2009, BEHAV RES THER, V47, P105, DOI 10.1016/j.brat.2008.10.016; Karlsson J, 2000, INT J OBESITY, V24, P1715, DOI 10.1038/sj.ijo.0801442; Kemps E, 2010, J CLIN EXP NEUROPSYC, V32, P515, DOI 10.1080/13803390903264122; King BM, 2013, AM PSYCHOL, V68, P88, DOI 10.1037/a0030684; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Lattimore P, 2015, APPETITE, V90, P248, DOI 10.1016/j.appet.2015.02.020; Leitch MA, 2013, APPETITE, V69, P54, DOI 10.1016/j.appet.2013.05.007; Lejuez C, 2003, J ADOLESCENCE, V26, P475, DOI 10.1016/S0140-1971(03)00036-8; Lejuez CW, 2003, EXP CLIN PSYCHOPHARM, V11, P26, DOI 10.1037/1064-1297.11.1.26; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Loeber S, 2013, APPETITE, V71, P32, DOI 10.1016/j.appet.2013.07.008; Lowe MR, 2009, APPETITE, V53, P114, DOI 10.1016/j.appet.2009.05.016; Lyke JA, 2004, INT J EAT DISORDER, V36, P229, DOI 10.1002/eat.20025; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Meule A, 2011, EAT BEHAV, V12, P152, DOI 10.1016/j.eatbeh.2011.01.006; Mobini S, 2002, PSYCHOPHARMACOLOGY, V160, P290, DOI 10.1007/s00213-001-0983-0; Nederkoorn C, 2004, PERS INDIV DIFFER, V37, P1651, DOI 10.1016/j.paid.2004.02.020; Nederkoorn C, 2009, INT J OBESITY, V33, P905, DOI 10.1038/ijo.2009.98; Nederkoorn Chantal, 2006, Eat Behav, V7, P315, DOI 10.1016/j.eatbeh.2005.11.005; Nederkoorn C, 2006, APPETITE, V47, P253, DOI 10.1016/j.appet.2006.05.008; Nicola SM, 2005, NEUROSCIENCE, V135, P1025, DOI 10.1016/j.neuroscience.2005.06.088; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Reynolds B, 2006, PERS INDIV DIFFER, V40, P305, DOI 10.1016/j.paid.2005.03.024; Robbins TW, 2012, TRENDS COGN SCI, V16, P81, DOI 10.1016/j.tics.2011.11.009; Rolls ET, 2006, PHILOS T R SOC B, V361, P1123, DOI 10.1098/rstb.2006.1852; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Sellitto M, 2010, J NEUROSCI, V30, P16429, DOI 10.1523/JNEUROSCI.2516-10.2010; Siep N, 2009, BEHAV BRAIN RES, V198, P149, DOI 10.1016/j.bbr.2008.10.035; Speakman JR, 2012, DIS MODEL MECH, V5, P569, DOI 10.1242/dmm.010553; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; van den Berg L, 2011, INT J OBESITY, V35, P1301, DOI 10.1038/ijo.2011.116; Van den Eynde F, 2012, J CLIN EXP NEUROPSYC, V34, P67, DOI 10.1080/13803395.2011.621891; Weller RE, 2008, APPETITE, V51, P563, DOI 10.1016/j.appet.2008.04.010; Wiederman MW, 1996, INT J EAT DISORDER, V20, P359, DOI 10.1002/(SICI)1098-108X(199612)20:4<359::AID-EAT3>3.0.CO;2-M; Winstanley CA, 2004, J NEUROSCI, V24, P4718, DOI 10.1523/JNEUROSCI.5606-03.2004; Yeomans MR, 2008, APPETITE, V50, P469, DOI 10.1016/j.appet.2007.10.002; Zeeb FD, 2010, PSYCHOPHARMACOLOGY, V211, P87, DOI 10.1007/s00213-010-1871-2	62	25	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137626	10.1371/journal.pone.0137626	http://dx.doi.org/10.1371/journal.pone.0137626			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0RH	26378459	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000361769400020
J	Eshoo, MW; Carolan, HE; Massire, C; Chou, DM; Crowder, CD; Rounds, MA; Phillipson, CA; Schutzer, SE; Ecker, DJ				Eshoo, Mark W.; Carolan, Heather E.; Massire, Christian; Chou, Danny M.; Crowder, Chris D.; Rounds, Megan A.; Phillipson, Curtis A.; Schutzer, Steven E.; Ecker, David J.			Survey of Ixodes pacificus Ticks in California Reveals a Diversity of Microorganisms and a Novel and Widespread Anaplasmataceae Species	PLOS ONE			English	Article							IONIZATION MASS-SPECTROMETRY; CANDIDATUS NEOEHRLICHIA-MIKURENSIS; BURGDORFERI SENSU-LATO; BORRELIA-BURGDORFERI; PHYLOGENETIC ANALYSIS; RAPID IDENTIFICATION; LYME-DISEASE; INFECTION; EHRLICHIA; PATHOGENS	Ixodes pacificus ticks can harbor a wide range of human and animal pathogens. To survey the prevalence of tick-borne known and putative pathogens, we tested 982 individual adult and nymphal I. pacificus ticks collected throughout California between 2007 and 2009 using a broad-range PCR and electrospray ionization mass spectrometry (PCR/ESI-MS) assay designed to detect a wide range of tick-borne microorganisms. Overall, 1.4% of the ticks were found to be infected with Borrelia burgdorferi, 2.0% were infected with Borrelia miyamotoi and 0.3% were infected with Anaplasma phagocytophilum. In addition, 3.0% were infected with Babesia odocoilei. About 1.2% of the ticks were co-infected with more than one pathogen or putative pathogen. In addition, we identified a novel Anaplasmataceae species that we characterized by sequencing of its 16S rRNA, groEL, gltA, and rpoB genes. Sequence analysis indicated that this organism is phylogenetically distinct from known Anaplasma species with its closest genetic near neighbors coming from Asia. The prevalence of this novel Anaplasmataceae species was as high as 21% at one site, and it was detected in 4.9% of ticks tested statewide. Based upon this genetic characterization we propose that this organism be called 'Candidatus Cryptoplasma californiense'. Knowledge of this novel microbe will provide awareness for the community about the breadth of the I. pacificus microbiome, the concept that this bacterium could be more widely spread; and an opportunity to explore whether this bacterium also contributes to human or animal disease burden.	[Eshoo, Mark W.; Carolan, Heather E.; Massire, Christian; Chou, Danny M.; Crowder, Chris D.; Rounds, Megan A.; Phillipson, Curtis A.; Ecker, David J.] Ibis Biosci, Carlsbad, CA 92008 USA; [Schutzer, Steven E.] Rutgers New Jersey Med Sch, Dept Med, Newark, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Eshoo, MW (corresponding author), Ibis Biosci, Carlsbad, CA 92008 USA.	mark.eshoo@abbott.com		Ecker, David/0000-0003-4350-9037	National Institutes of Health [2R44AI077156]; Abbott; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI077156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abbott(Abbott Laboratories); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant number 2R44AI077156 and Abbott.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; BURGDORFER W, 1985, AM J TROP MED HYG, V34, P925, DOI 10.4269/ajtmh.1985.34.925; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Crowder CD, 2014, EMERG INFECT DIS, V20, P1678, DOI 10.3201/eid2010.131583; Crowder CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010650; Crowder CD, 2010, J MED ENTOMOL, V47, P89, DOI 10.1603/033.047.0112; Crowder CD, 2012, AM J VET RES, V73, P854, DOI 10.2460/ajvr.73.6.854; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dumler JS, 2001, INT J SYST EVOL MICR, V51, P2145, DOI 10.1099/00207713-51-6-2145; Duncan DD, 2013, LETT APPL MICROBIOL, V56, P128, DOI 10.1111/lam.12022; Ecker D, 2006, J ASS LAB AUTOM, P341; Ecker DJ, 2005, P NATL ACAD SCI USA, V102, P8012, DOI 10.1073/pnas.0409920102; Eckert DJ, 2010, EXPERT REV MOL DIAGN, V10, P399, DOI [10.1586/erm.10.24, 10.1586/ERM.10.24]; Eshoo MW, 2007, VIROLOGY, V368, P286, DOI 10.1016/j.virol.2007.06.016; Eshoo MW, 2014, VECTOR-BORNE ZOONOT, V14, P584, DOI 10.1089/vbz.2013.1498; Eshoo MW, 2013, EXPERT REV MOL DIAGN, V13, P875, DOI 10.1586/14737159.2013.850418; Eshoo MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036825; Eshoo MW, 2010, J CLIN MICROBIOL, V48, P472, DOI 10.1128/JCM.01669-09; Fritzen C, 2014, J PARASITOL, V100, P106, DOI 10.1645/12-158.1; Grant-Klein RJ, 2010, MOL CELL PROBE, V24, P219, DOI 10.1016/j.mcp.2010.04.003; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Inokuma H, 2001, J CLIN MICROBIOL, V39, P3031, DOI 10.1128/JCM.39.9.3031-3039.2001; Jiang J, 2005, ANN NY ACAD SCI, V1063, P337, DOI 10.1196/annals.1355.054; Kawahara M, 2004, INT J SYST EVOL MICR, V54, P1837, DOI 10.1099/ijs.0.63260-0; Lane RS, 2013, TICKS TICK-BORNE DIS, V4, P377, DOI 10.1016/j.ttbdis.2013.02.005; Lane RS, 2010, TICKS TICK-BORNE DIS, V1, P159, DOI 10.1016/j.ttbdis.2010.09.004; LANE RS, 1991, J MED ENTOMOL, V28, P719, DOI 10.1093/jmedent/28.5.719; Li H, 2015, LANCET INFECT DIS, V15, P663, DOI 10.1016/S1473-3099(15)70051-4; Marques A, 2014, CLIN INFECT DIS, V58, P937, DOI 10.1093/cid/cit939; 오재영, 2009, Journal of Bacteriology and Virology, V39, P257; MURRAY RGE, 1995, INT J SYST BACTERIOL, V45, P186, DOI 10.1099/00207713-45-1-186; Naitou H, 2006, MICROBIOL IMMUNOL, V50, P45, DOI 10.1111/j.1348-0421.2006.tb03769.x; Padgett K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110853; Palomar AM, 2012, TICKS TICK-BORNE DIS, V3, P318, DOI 10.1016/j.ttbdis.2012.10.025; Pattullo KM, 2013, J VET DIAGN INVEST, V25, P535, DOI 10.1177/1040638713491746; Postic D, 2007, INT J MED MICROBIOL, V297, P263, DOI 10.1016/j.ijmm.2007.01.006; Reis C, 2011, VECTOR-BORNE ZOONOT, V11, P907, DOI 10.1089/vbz.2010.0103; Rounds MA, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.49; Rounds MA, 2012, J MED ENTOMOL, V49, P843, DOI 10.1603/ME12038; Rudenko N, 2009, J CLIN MICROBIOL, V47, P3875, DOI 10.1128/JCM.01050-09; Sampath R, 2005, EMERG INFECT DIS, V11, P373, DOI 10.3201/eid1103.040629; Sampath R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000489; Sampath R, 2007, ANN NY ACAD SCI, V1102, P109, DOI 10.1196/annals.1408.008; Sarih MH, 2005, J CLIN MICROBIOL, V43, P1127, DOI 10.1128/JCM.43.3.1127-1132.2005; Schoelkopf L, 2005, J WILDLIFE DIS, V41, P683, DOI 10.7589/0090-3558-41.4.683; Stefancikova A, 2008, FOLIA MICROBIOL, V53, P493, DOI 10.1007/s12223-008-0077-z; Steiner FE, 2006, J MED ENTOMOL, V43, P437, DOI 10.1603/0022-2585(2006)043[0437:DOAPAB]2.0.CO;2; Tindall BJ, 2010, INT J SYST EVOL MICR, V60, P249, DOI 10.1099/ijs.0.016949-0; TULLY JG, 1995, INT J SYST BACTERIOL, V45, P23, DOI 10.1099/00207713-45-1-23; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Whitehouse CA, 2012, LETT APPL MICROBIOL, V54, P313, DOI 10.1111/j.1472-765X.2012.03214.x; Ybanez AP, 2014, J VET MED SCI, V76, P307, DOI 10.1292/jvms.13-0411	53	32	32	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0135828	10.1371/journal.pone.0135828	http://dx.doi.org/10.1371/journal.pone.0135828			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375033	Green Submitted, Green Published, gold			2022-12-27	WOS:000361610200008
J	Mambres, DH; Machelart, A; Vanderwinden, JM; De Trez, C; Ryffel, B; Letesson, JJ; Muraille, E				Mambres, Delphine Hanot; Machelart, Arnaud; Vanderwinden, Jean-Marie; De Trez, Carl; Ryffel, Bernhard; Letesson, Jean-Jacques; Muraille, Eric			In Situ Characterization of Splenic Brucella melitensis Reservoir Cells during the Chronic Phase of Infection in Susceptible Mice	PLOS ONE			English	Article							DENDRITIC CELLS; MACROPHAGE POLARIZATION; ABORTUS INFECTION; FOAMY MACROPHAGES; EXPRESSION; ARGINASE; TH2; CHOLESTEROL; METABOLISM; GRANULOMAS	Brucella are facultative intracellular Gram-negative coccobacilli that chronically infect humans as well as domestic and wild-type mammals, and cause brucellosis. Alternatively activated macrophages (M2a) induced by IL-4/IL-13 via STAT6 signaling pathways have been frequently described as a favorable niche for long-term persistence of intracellular pathogens. Based on the observation that M2a-like macrophages are induced in the spleen during the chronic phase of B. abortus infection in mice and are strongly infected in vitro, it has been suggested that M2a macrophages could be a potential in vivo niche for Brucella. In order to test this hypothesis, we used a model in which infected cells can be observed directly in situ and where the differentiation of M2a macrophages is favored by the absence of an IL-12-dependent Th1 response. We performed an in situ analysis by fluorescent microscopy of the phenotype of B. melitensis infected spleen cells from intranasally infected IL-12p40(-/-) BALB/c mice and the impact of STAT6 deficiency on this phenotype. Most of the infected spleen cells contained high levels of lipids and expressed CD11c and CD205 dendritic cell markers and Arginase1, but were negative for the M2a markers Fizz1 or CD301. Furthermore, STAT6 deficiency had no effect on bacterial growth or the reservoir cell phenotype in vivo, leading us to conclude that, in our model, the infected cells were not Th2-induced M2a macrophages. This characterization of B. melitensis reservoir cells could provide a better understanding of Brucella persistence in the host and lead to the design of more efficient therapeutic strategies.	[Mambres, Delphine Hanot; Machelart, Arnaud; Letesson, Jean-Jacques; Muraille, Eric] Univ Namur, Lab Immunol & Microbiol, Unite Rech Biol Microorganismes, Namur, Belgium; [Vanderwinden, Jean-Marie] Univ Libre Bruxelles, Neurophysiol Lab, Brussels, Belgium; [De Trez, Carl] Vrije Univ Brussel, Vlaams Interuniv Inst Biotechnol, Dept Mol & Cellular Interact, B-1050 Brussels, Belgium; [Ryffel, Bernhard] CNRS, UMR7355, F-45071 Orleans, France; [Ryffel, Bernhard] Univ Orleans, Expt & Mol Immunol & Neurogenet, Orleans, France; [Ryffel, Bernhard] IDM, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Muraille, Eric] Univ Libre Bruxelles, Parasitol Lab, Brussels, Belgium	University of Namur; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Orleans; University of Cape Town; Universite Libre de Bruxelles	Muraille, E (corresponding author), Univ Namur, Lab Immunol & Microbiol, Unite Rech Biol Microorganismes, Namur, Belgium.	emuraille@hotmail.com	Jean-Jacques, LETESSON/AHB-6921-2022; Machelart, Arnaud/L-3539-2019; Mrl, Eric/ABC-5458-2021	Machelart, Arnaud/0000-0002-4444-0011; Muraille, Eric/0000-0003-1250-5228; LETESSON, Jean-Jacques/0000-0002-5838-0224; De Trez, Carl/0000-0002-3899-1968	Fonds National de la Recherche Scientifique (FNRS) (Belgium) [FRSM FNRS 3.4.600.06.F]; Communaute Francaise de Belgique (Action de Recherches Concertees) [08/13-015]; Belgian Science Policy Office; Agence Nationale pour la Recherche [ANR 2007 MIME-103-02]; "Fondation pour la Recherche Medicale" (FRM allergy) [DAL 2007 0822007]; "Fonds Europeen de Developpement Regional" (FEDER Asthme) [1575-32168]; Le Studium, Orleans; FRS-FNRS (Belgium); FRIA (Belgium); Interuniversity Attraction Poles Programme	Fonds National de la Recherche Scientifique (FNRS) (Belgium)(Fonds de la Recherche Scientifique - FNRS); Communaute Francaise de Belgique (Action de Recherches Concertees); Belgian Science Policy Office(Belgian Federal Science Policy Office); Agence Nationale pour la Recherche(French National Research Agency (ANR)); "Fondation pour la Recherche Medicale" (FRM allergy); "Fonds Europeen de Developpement Regional" (FEDER Asthme); Le Studium, Orleans; FRS-FNRS (Belgium)(Fonds de la Recherche Scientifique - FNRS); FRIA (Belgium)(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office)	This work was supported by grants from the Fonds National de la Recherche Scientifique (FNRS) (convention FRSM FNRS 3.4.600.06.F, Belgium), Communaute Francaise de Belgique (Action de Recherches Concertees 08/13-015) and by the Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office. E.M. is a Research Associate from the FRS-FNRS (Belgium). B.R. is supported by the "Agence Nationale pour la Recherche" (ANR 2007 MIME-103-02), "Fondation pour la Recherche Medicale" (FRM allergy DAL 2007 0822007), "Fonds Europeen de Developpement Regional" (FEDER Asthme 1575-32168) and Le Studium, Orleans (BR). D.H.M. holds PhD grants from the FRS-FNRS (Belgium). A.M. holds PhD grants from the FRIA (Belgium).	Archambaud C, 2010, EUR J IMMUNOL, V40, P3458, DOI 10.1002/eji.201040497; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Biswas SK, 2012, CELL METAB, V15, P432, DOI 10.1016/j.cmet.2011.11.013; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Caire-Brandli I, 2014, INFECT IMMUN, V82, P476, DOI 10.1128/IAI.01196-13; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Colmenero JD, 1996, MEDICINE, V75, P195, DOI 10.1097/00005792-199607000-00003; Copin R, 2007, J IMMUNOL, V178, P5182, DOI 10.4049/jimmunol.178.8.5182; Copin R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002575; D'Avila H, 2006, J IMMUNOL, V176, P3087, DOI 10.4049/jimmunol.176.5.3087; De Trez C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000494; Eisele NA, 2013, CELL HOST MICROBE, V14, P171, DOI 10.1016/j.chom.2013.07.010; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; El Kasmi KC, 2014, J IMMUNOL, V193, P597, DOI 10.4049/jimmunol.1303048; Eng TR, 1989, PREV VET MED, V7, P311, DOI [10.1016/0167-5877(89)90014-7, DOI 10.1016/0167-5877(89)90014-7]; Ferrero MC, 2014, INFECT IMMUN, V82, P626, DOI 10.1128/IAI.01237-13; Grandl M, 2010, CYTOM PART A, V77A, P231, DOI 10.1002/cyto.a.20828; Hasko G, 2000, SHOCK, V14, P144, DOI 10.1097/00024382-200014020-00012; Hespel C, 2012, EUR J IMMUNOL, V42, P2535, DOI 10.1002/eji.201242480; INABA K, 1995, CELL IMMUNOL, V163, P148, DOI 10.1006/cimm.1995.1109; Iniesta V, 2002, PARASITE IMMUNOL, V24, P113, DOI 10.1046/j.1365-3024.2002.00444.x; Jablonska J, 2007, INFECT IMMUN, V75, P462, DOI 10.1128/IAI.00443-06; Jensen KDC, 2011, CELL HOST MICROBE, V9, P472, DOI 10.1016/j.chom.2011.04.015; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kiss M, 2013, J ALLERGY CLIN IMMUN, V132, P264, DOI 10.1016/j.jaci.2013.05.044; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Maya-Monteiro CM, 2008, J BIOL CHEM, V283, P2203, DOI 10.1074/jbc.M706706200; Melo RCN, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002729; METLAY JP, 1990, J EXP MED, V171, P1753, DOI 10.1084/jem.171.5.1753; Muraille E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00603; Naroeni A, 2002, INFECT IMMUN, V70, P1640, DOI 10.1128/IAI.70.3.1640-1644.2002; Nugent R, 2008, ANN NY ACAD SCI, V1136, P70, DOI 10.1196/annals.1425.027; Oliveira SC, 2011, EXPERT REV VACCINES, V10, P1291, DOI [10.1586/erv.11.110, 10.1586/ERV.11.110]; Ordway D, 2005, J IMMUNOL, V175, P3873, DOI 10.4049/jimmunol.175.6.3873; Pei JW, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00115; Pessanha AP, 2012, FEMS IMMUNOL MED MIC, V66, P265, DOI 10.1111/j.1574-695X.2012.01012.x; Qualls JE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000955; Raes G, 2002, J LEUKOCYTE BIOL, V71, P597; Raes G, 2005, J LEUKOCYTE BIOL, V77, P321, DOI 10.1189/jlb.0304212; Rath M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00532; Rodriguez-Sosa M, 2002, J IMMUNOL, V168, P3135, DOI 10.4049/jimmunol.168.7.3135; Ronneau S, 2016, CRIT REV MICROBIOL, V42, P507, DOI 10.3109/1040841X.2014.962480; Santos RL, 2011, J BIOMED BIOTECHNOL, V2011; Sathe P, 2008, MUCOSAL IMMUNOL, V1, P425, DOI 10.1038/mi.2008.56; Seleem MN, 2010, VET MICROBIOL, V140, P392, DOI 10.1016/j.vetmic.2009.06.021; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Takeda K, 1996, J IMMUNOL, V157, P3220; Vitry MA, 2012, INFECT IMMUN, V80, P4271, DOI 10.1128/IAI.00761-12; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Watarai M, 2002, INFECT IMMUN, V70, P4818, DOI 10.1128/IAI.70.9.4818-4825.2002; Xavier MN, 2013, CELL HOST MICROBE, V14, P159, DOI 10.1016/j.chom.2013.07.009; Zhang MH, 1997, J EXP MED, V185, P1759, DOI 10.1084/jem.185.10.1759	52	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137835	10.1371/journal.pone.0137835	http://dx.doi.org/10.1371/journal.pone.0137835			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376185	gold, Green Published, Green Submitted			2022-12-27	WOS:000361610200056
J	Marton, J; Albert, D; Wiltshire, SA; Park, R; Bergen, A; Qureshi, S; Malo, D; Burelle, Y; Vidal, SM				Marton, Jennifer; Albert, Danica; Wiltshire, Sean A.; Park, Robin; Bergen, Arthur; Qureshi, Salman; Malo, Danielle; Burelle, Yan; Vidal, Silvia M.			Cyclosporine A Treatment Inhibits Abcc6-Dependent Cardiac Necrosis and Calcification following Coxsackievirus B3 Infection in Mice	PLOS ONE			English	Article							CAUSE PSEUDOXANTHOMA ELASTICUM; VIRAL MYOCARDITIS; CELL-DEATH; PERMEABILITY TRANSITION; B3-INDUCED MYOCARDITIS; ABCC6; VIRUS; APOPTOSIS; MOUSE; GENE	Coxsackievirus type B3 (CVB3) is a cardiotropic enterovirus. Infection causes cardiomyocyte necrosis and myocardial inflammation. The damaged tissue that results is replaced with fibrotic or calcified tissue, which can lead to permanently altered cardiac function. The extent of pathogenesis among individuals exposed to CVB3 is dictated by a combination of host genetics, viral virulence, and the environment. Here, we aimed to identify genes that modulate cardiopathology following CVB3 infection. 129S1 mice infected with CVB3 developed increased cardiac pathology compared to 129X1 substrain mice despite no difference in viral burden. Linkage analysis identified a major locus on chromosome 7 (LOD: 8.307, P<0.0001) that controlled the severity of cardiac calcification and necrosis following infection. Sub-phenotyping and genetic complementation assays identified Abcc6 as the underlying gene. Microarray expression profiling identified genotype-dependent regulation of genes associated with mitochondria. Electron microscopy examination showed elevated deposition of hydroxyapatite-like material in the mitochondrial matrices of infected Abcc6 knockout (Abcc6-/-) mice but not in wildtype littermates. Cyclosporine A (CsA) inhibits mitochondrial permeability transition pore opening by inhibiting cyclophilin D (CypD). Treatment of Abcc6 -/- mice with CsA reduced cardiac necrosis and calcification by more than half. Furthermore, CsA had no effect on the CVB3-induced phenotype of doubly deficient CypD-/-Abcc6-/- mice. Altogether, our work demonstrates that mutations in Abcc6 render mice more susceptible to cardiac calcification following CVB3 infection. Moreover, we implicate CypD in the control of cardiac necrosis and calcification in Abcc6-deficient mice, whereby CypD inhibition is required for cardioprotection.	[Marton, Jennifer; Albert, Danica; Wiltshire, Sean A.; Park, Robin; Malo, Danielle; Vidal, Silvia M.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Marton, Jennifer; Albert, Danica; Wiltshire, Sean A.; Park, Robin; Malo, Danielle; Vidal, Silvia M.] McGill Univ, Complex Traits Grp, Montreal, PQ, Canada; [Bergen, Arthur] Netherlands Inst Neurosci, Dept Ophthalmogenet, Amsterdam, Netherlands; [Qureshi, Salman] McGill Univ, Ctr Host Resistance, Montreal, PQ, Canada; [Qureshi, Salman] McGill Univ, Div Expt Med, Montreal, PQ, Canada; [Burelle, Yan] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada	McGill University; McGill University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); McGill University; McGill University; Universite de Montreal	Vidal, SM (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.	silvia.vidal@mcgill.ca	Burelle, Yan/AAF-8104-2021	Burelle, Yan/0000-0001-9379-146X; Park, Robin/0000-0002-3004-3285; Bergen, Arthur/0000-0002-6333-9576; Malo, Danielle/0000-0003-3980-6610	Canadian Institutes of Health Research [MOP-86592, HSD-63192]; Fonds de Recherche en Sante du Quebec; Tier 1 Canada Research Chair in Host Responses to Virus Infections	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Tier 1 Canada Research Chair in Host Responses to Virus Infections	These studies were supported by the Canadian Institutes of Health Research grants MOP-86592 and HSD-63192: http://www.cihr-irsc.gc.ca/. J.M. is supported by the Fonds de Recherche en Sante du Quebec: http://www.frqs.gouv.qc.ca/. S.M.V. is supported by a Tier 1 Canada Research Chair in Host Responses to Virus Infections: http://www.chairs-chaires.gc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherrahrou Z, 2008, J BIOL CHEM, V283, P7608, DOI 10.1074/jbc.M708290200; Aly M, 2007, GENES IMMUN, V8, P193, DOI 10.1038/sj.gene.6364374; Aziz KU, 2010, CARDIOL YOUNG, V20, P509, DOI 10.1017/S1047951110000594; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Barnabei MS, 2010, PHYSIOL GENOMICS, V42A, P103, DOI 10.1152/physiolgenomics.00071.2010; Belinsky MG, 2002, CANCER RES, V62, P6172; Bergen AAB, 2000, NAT GENET, V25, P228, DOI 10.1038/76109; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Calandria C, 2004, VIRUS RES, V104, P39, DOI 10.1016/j.virusres.2004.02.042; Chau DHW, 2007, APOPTOSIS, V12, P513, DOI 10.1007/s10495-006-0013-0; Cox KL, 1996, CLIN INVEST MED, V19, P389; Elrod JW, 2010, J CLIN INVEST, V120, P3680, DOI 10.1172/JCI43171; ESTRIN M, 1987, EUR HEART J, V8, P259, DOI 10.1093/eurheartj/8.suppl_J.259; Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908; Flisiak R, 2010, EXPT CLIN HEPATOLOGY, V6, P11; Gorgels TGMF, 2005, HUM MOL GENET, V14, P1763, DOI 10.1093/hmg/ddi183; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Halestrap AP, 2010, BIOCHEM SOC T, V38, P841, DOI 10.1042/BST0380841; Halestrap AP, 2009, BBA-BIOENERGETICS, V1787, P1402, DOI 10.1016/j.bbabio.2008.12.017; HERZUM M, 1991, EUR HEART J, V12, P200, DOI 10.1093/eurheartj/12.suppl_D.200; Jansen RS, 2014, ARTERIOSCL THROM VAS, V34, P1985, DOI 10.1161/ATVBAHA.114.304017; Jansen RS, 2013, P NATL ACAD SCI USA, V110, P20206, DOI 10.1073/pnas.1319582110; Jensen KJ, 2013, CELL HOST MICROBE, V13, P67, DOI 10.1016/j.chom.2012.11.009; Jiang QJ, 2010, AM J PATHOL, V176, P1855, DOI 10.2353/ajpath.2010.090983; Jiang QJ, 2009, J INVEST DERMATOL, V129, P348, DOI 10.1038/jid.2008.212; KAWAI C, 1978, JPN CIRC J, V42, P43, DOI 10.1253/jcj.42.43; Kindermann I, 2012, J AM COLL CARDIOL, V59, P779, DOI 10.1016/j.jacc.2011.09.074; Lauring AS, 2013, NAT REV MICROBIOL, V11, P327, DOI 10.1038/nrmicro3003; Le Saux O, 2000, NAT GENET, V25, P223, DOI 10.1038/76102; Li QL, 2009, EXP DERMATOL, V18, P1, DOI 10.1111/j.1600-0625.2008.00795.x; Marcil M, 2006, AM J PHYSIOL-HEART C, V290, pH1549, DOI 10.1152/ajpheart.00913.2005; Martin LJ, 2012, CIRC RES, V111, P516, DOI 10.1161/CIRCRESAHA.112.276667; MASON JW, 1995, NEW ENGL J MED, V333, P269, DOI 10.1056/NEJM199508033330501; Matsuzaki Y, 2005, J INVEST DERMATOL, V125, P900, DOI 10.1111/j.0022-202X.2005.23897.x; MCCAFFREY FM, 1991, AM J DIS CHILD, V145, P177, DOI 10.1001/archpedi.1991.02160020069020; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Meng HJ, 2007, P NATL ACAD SCI USA, V104, P4530, DOI 10.1073/pnas.0607620104; Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736; Mungrue IN, 2011, ARTERIOSCL THROM VAS, V31, P2806, DOI 10.1161/ATVBAHA.111.237420; Nguyen TTM, 2013, CIRC RES, V113, P1308, DOI 10.1161/CIRCRESAHA.113.301867; OCONNELL JB, 1986, CIRCULATION, V73, P353, DOI 10.1161/01.CIR.73.2.353; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Ruf Nico, 2005, Hum Mutat, V25, P98, DOI 10.1002/humu.9297; Schrader J, 2011, NEW ENGL J MED, V364, P1578, DOI 10.1056/NEJMc1102515; Si XN, 2005, J VIROL, V79, P8014, DOI 10.1128/JVI.79.13.8014-8023.2005; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; Wang JP, 2010, J VIROL, V84, P254, DOI 10.1128/JVI.00631-09; White P, 2002, J IMMUNOL, V168, P869, DOI 10.4049/jimmunol.168.2.869; Whitton JL, 2005, NAT REV MICROBIOL, V3, P765, DOI 10.1038/nrmicro1284; Wiltshire SA, 2011, J IMMUNOL, V186, P6398, DOI 10.4049/jimmunol.1100159; WOLFGRAM LJ, 1986, J IMMUNOL, V136, P1846; Yajima T, 2011, FUTURE MICROBIOL, V6, P551, DOI [10.2217/FMB.11.40, 10.2217/fmb.11.40]; Yajima T, 2009, CIRCULATION, V119, P2615, DOI 10.1161/CIRCULATIONAHA.108.766022; Zhang HFM, 2010, J VIROL, V84, P8446, DOI 10.1128/JVI.01416-09	54	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138222	10.1371/journal.pone.0138222	http://dx.doi.org/10.1371/journal.pone.0138222			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375467	Green Published, gold, Green Submitted			2022-12-27	WOS:000361610200089
J	Pedersen, PJ; Thomsen, KB; Olander, ER; Hauser, F; Tejada, MD; Poulsen, KL; Grubb, S; Buhl, R; Calloe, K; Klaerke, DA				Pedersen, Philip Juul; Thomsen, Kirsten Brolin; Olander, Emma Rie; Hauser, Frank; Tejada, Maria de los Angeles; Poulsen, Kristian Lundgaard; Grubb, Soren; Buhl, Rikke; Calloe, Kirstine; Klaerke, Dan Arne			Molecular Cloning and Functional Expression of the Equine K+ Channel K(V)11.1 (Ether a Go-Go-Related/KCNH2 Gene) and the Regulatory Subunit KCNE2 from Equine Myocardium	PLOS ONE			English	Article							LONG QT SYNDROME; POTASSIUM CHANNELS; SUDDEN-DEATH; HERG; RECTIFIER; PROTEIN; FAMILY; KCNQ1; TRAFFICKING; MODULATION	The KCNH2 and KCNE2 genes encode the cardiac voltage-gated K+ channel K(V)11.1 and its auxiliary beta subunit KCNE2. K(V)11.1 is critical for repolarization of the cardiac action potential. In humans, mutations or drug therapy affecting the K(V)11.1 channel are associated with prolongation of the QT intervals on the ECG and increased risk of ventricular tachyarrhythmia and sudden cardiac death-conditions known as congenital or acquired Long QT syndrome (LQTS), respectively. In horses, sudden, unexplained deaths are a well-known problem. We sequenced the cDNA of the KCNH2 and KCNE2 genes using RACE and conventional PCR on mRNA purified from equine myocardial tissue. Equine K(V)11.1 and KCNE2 cDNA had a high homology to human genes (93 and 88%, respectively). Equine and human K(V)11.1 and K(V)11.1/KCNE2 were expressed in Xenopus laevis oocytes and investigated by two-electrode voltage-clamp. Equine K(V)11.1 currents were larger compared to human K(V)11.1, and the voltage dependence of activation was shifted to more negative values with V-1/2 = -14.2 +/- 1.1 mV and -17.3 +/- 0.7, respectively. The onset of inactivation was slower for equine K(V)11.1 compared to the human homolog. These differences in kinetics may account for the larger amplitude of the equine current. Furthermore, the equine K(V)11.1 channel was susceptible to pharmacological block with terfenadine. The physiological importance of K(V)11.1 was investigated in equine right ventricular wedge preparations. Terfenadine prolonged action potential duration and the effect was most pronounced at slow pacing. In conclusion, these findings indicate that horses could be disposed to both congenital and acquired LQTS.	[Pedersen, Philip Juul; Thomsen, Kirsten Brolin; Olander, Emma Rie; Tejada, Maria de los Angeles; Poulsen, Kristian Lundgaard; Grubb, Soren; Calloe, Kirstine; Klaerke, Dan Arne] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Frederiksberg C, Denmark; [Hauser, Frank] Univ Copenhagen, Fac Sci, Dept Biol, Ctr Funct & Comparat Insect Genom, Copenhagen, Denmark; [Buhl, Rikke] Univ Copenhagen, Fac Hlth & Med Sci, Dept Large Anim Sci, Taastrup, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Calloe, K (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Frederiksberg C, Denmark.	kirstinec@sund.ku.dk	Calloe, Kirstine/H-8643-2016; Hauser, Frank/M-2952-2014	Calloe, Kirstine/0000-0002-1777-7938; Hauser, Frank/0000-0001-5563-2345; Grubb, Soren/0000-0002-6710-9655; Buhl, Rikke/0000-0002-8201-0186	Foreningen Kustos af 1881; Danish Strategic Research Foundation; Fraenkel Foundation; Medical Research Council; Lundbeck Foundation; National Danish Foundation for Advanced Technology	Foreningen Kustos af 1881; Danish Strategic Research Foundation(Danske Strategiske Forskningsrad (DSF)); Fraenkel Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); National Danish Foundation for Advanced Technology	Work in the authors' labs was funded by grants from Foreningen Kustos af 1881, the Danish Strategic Research Foundation, the Fraenkel Foundation, the Medical Research Council, the Lundbeck Foundation and the National Danish Foundation for Advanced Technology.	Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Buhl R, 2013, J EQUINE VET SCI, V33, P590, DOI 10.1016/j.jevs.2012.09.009; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Eldstrom J, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002092; Fernandez D, 2004, J BIOL CHEM, V279, P10120, DOI 10.1074/jbc.M310683200; Finley MR, 2003, J VET INTERN MED, V17, P473, DOI 10.1892/0891-6640(2003)017&lt;0473:SAFBFT&gt;2.3.CO;2; Finley MR, 2002, AM J PHYSIOL-HEART C, V283, pH126, DOI 10.1152/ajpheart.00622.2001; Grunnet M, 2001, PFLUG ARCH EUR J PHY, V441, P544, DOI 10.1007/s004240000447; Gustina AS, 2011, J GEN PHYSIOL, V137, P315, DOI 10.1085/jgp.201010582; Hedley PL, 2009, HUM MUTAT, V30, P1486, DOI 10.1002/humu.21106; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; Jones EMC, 2004, J BIOL CHEM, V279, P44690, DOI 10.1074/jbc.M408344200; Jonsson MKB, 2012, J MOL CELL CARDIOL, V53, P369, DOI 10.1016/j.yjmcc.2012.06.011; Kallergis EM, 2012, SCI WORLD J, DOI 10.1100/2012/212178; Kamiya K, 2008, J PHARMACOL SCI, V108, P301, DOI 10.1254/jphs.08102FP; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Ke Y, 2014, J BIOL CHEM, V289, P13782, DOI 10.1074/jbc.M113.531277; Kiryu K, 1999, J VET MED SCI, V61, P921, DOI 10.1292/jvms.61.921; Larsen AP, 2010, PFLUG ARCH EUR J PHY, V460, P803, DOI 10.1007/s00424-010-0855-8; Liu WL, 2002, HUM MUTAT, V20, DOI 10.1002/humu.9085; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lyle CH, 2011, EQUINE VET J, V43, P324, DOI 10.1111/j.2042-3306.2010.00164.x; McDonald TV, 1997, NATURE, V388, P289, DOI 10.1038/40882; Nerbonne JM, 2000, J PHYSIOL-LONDON, V525, P285, DOI 10.1111/j.1469-7793.2000.t01-1-00285.x; Pedersen PJ, 2013, J VET CARDIOL, V15, P23, DOI 10.1016/j.jvc.2012.08.002; Pedersen PJ, 2014, J VET CARDIOL OFF J; Roden DM, 1998, PACE, V21, P1029, DOI 10.1111/j.1540-8159.1998.tb00148.x; Rosati B, 2008, PHYSIOL GENOMICS, V35, P262, DOI 10.1152/physiolgenomics.00159.2007; Roy ML, 1996, CIRCULATION, V94, P817, DOI 10.1161/01.CIR.94.4.817; Saenen JB, 2006, BIOPHYS J, V91, P4381, DOI 10.1529/biophysj.106.087247; Sale H, 2008, CIRC RES, V103, pE81, DOI 10.1161/CIRCRESAHA.108.185249; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Stoebner R, 2012, CURR SPORT MED REP, V11, P70, DOI 10.1249/JSR.0b013e31824cf347; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Viloria CG, 2000, BIOPHYS J, V79, P231, DOI 10.1016/S0006-3495(00)76286-2; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Ware WA, 2015, J VET INTERN MED, V29, P561, DOI 10.1111/jvim.12550; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Weerapura M, 2002, J PHYSIOL-LONDON, V540, P15, DOI 10.1113/jphysiol.2001.013296; Zhang M, 2012, AM J PHYSIOL-HEART C, V302, pH910, DOI 10.1152/ajpheart.00691.2011	46	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138320	10.1371/journal.pone.0138320	http://dx.doi.org/10.1371/journal.pone.0138320			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376488	Green Submitted, Green Published, gold			2022-12-27	WOS:000361610200098
J	Wang, QQ; Zhang, W; Yang, RD; Huang, YX; Zhang, L; Ning, PS; Cheng, XJ; Schwebel, DC; Hu, GQ; Yao, HY				Wang, Qiqi; Zhang, Wei; Yang, Rendong; Huang, Yuanxiu; Zhang, Lin; Ning, Peishan; Cheng, Xunjie; Schwebel, David C.; Hu, Guoqing; Yao, Hongyan			Common Traffic Violations of Bus Drivers in Urban China: An Observational Study	PLOS ONE			English	Article							ACCIDENTS; BEHAVIOR; MODEL; FLOW	Objective To report common traffic violations in bus drivers and the factors that influence those violations in urban China. Methods We conducted an observational study to record three types of traffic violations among bus drivers in Changsha City, China: illegal stopping at bus stations, violating traffic light signals, and distracted driving. The behaviors of bus drivers on 32 routes (20% of bus routes in the city) were observed. A two-level Poisson regression examined factors that predicted bus driver violations. Results The incidence of illegal stopping at bus stations was 20.2%. Illegal stopping was less frequent on weekends, sunny days, and at stations with cameras, with adjusted incidence rate ratios (IRRs) of 0.81, 0.65 and 0.89, respectively. The incidence of violating traffic light signals was 2.2%, and was lower on cloudy than sunny days (adjusted IRR: 0.60). The incidence of distracted driving was 3.3%. The incidence of distracted driving was less common on cloudy days, rainy or snowy days, and foggy/windy/dusty days compared to sunny days, with adjusted IRRs of 0.54, 0.55 and 0.07, respectively. Conclusion Traffic violations are common in bus drivers in urban China and they are associated with the date, weather, and presence of traffic cameras at bus station. Further studies are recommended to understand the behavioral mechanisms that may explain bus driver violations and to develop feasible prevention measures.	[Wang, Qiqi; Yao, Hongyan] Chinese Ctr Dis Control & Prevent, Off Epidemiol, Beijing, Peoples R China; [Zhang, Wei; Yang, Rendong; Zhang, Lin; Ning, Peishan; Cheng, Xunjie; Hu, Guoqing] Cent S Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China; [Huang, Yuanxiu] Changsha Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Schwebel, David C.] Univ Alabama Birmingham, Dept Psychol, Coll Arts & Sci, Birmingham, AL 35294 USA	Chinese Center for Disease Control & Prevention; Central South University; University of Alabama System; University of Alabama Birmingham	Hu, GQ (corresponding author), Cent S Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China.	huguoqing009@gmail.com; yaohy@chinacdc.cn	Schwebel, David/GXH-9944-2022	Hu, Guoqing/0000-0002-5002-8015				Aeron-Thomas AS, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003862.pub2; Edwards J. B., 1999, TRANSPORT RES F-TRAF, V2, P1, DOI [10.1016/S1369-8478(99)00003-0, DOI 10.1016/S1369-8478(99)00003-0]; Gao GF, 2005, P 4 AS PAC TRANSP SU, P637; Levine N, 1995, ACCIDENT ANAL PREV, V27, P785, DOI 10.1016/0001-4575(95)00038-0; Li H., 2010, THESIS CENTRAL S U; Ministry of Transport of PRC, STAT B TRANSP DEV CH; Mirza S, 1999, ACCIDENT ANAL PREV, V31, P329, DOI 10.1016/S0001-4575(98)00025-6; SATTERTHWAITE SP, 1976, ACCIDENT ANAL PREV, V8, P87, DOI 10.1016/0001-4575(76)90002-6; Sharma S, 2015, PHYSICA A, V421, P401, DOI 10.1016/j.physa.2014.11.003; Tang TQ, 2014, PHYSICA A, V413, P583, DOI 10.1016/j.physa.2014.07.035; Tang TQ, 2012, COMMUN THEOR PHYS, V58, P583, DOI 10.1088/0253-6102/58/4/24; Tang TQ, 2012, NONLINEAR DYNAM, V67, P2255, DOI 10.1007/s11071-011-0143-y; The Peoples' Government of Changsha City, ANN REP TRAFF SIT CH; Wang DQ, 2004, CHINESE J DIS CONTRO, V8, P519; World Health Organization, 2013, GLOB STAT REP ROAD S; Yan FF, 2016, ACCIDENT ANAL PREV, V95, P381, DOI 10.1016/j.aap.2015.06.006; Zeng YZ, 2015, PHYSICA A, V424, P113, DOI 10.1016/j.physa.2015.01.010; Zhang G, 2014, MOD PHYS LETT B, V28, DOI 10.1142/S0217984914501917; Zheng YL, 2006, P BEIJ INT TRAFF SAF, P216	19	8	8	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137954	10.1371/journal.pone.0137954	http://dx.doi.org/10.1371/journal.pone.0137954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8LR	26372105	Green Published, gold, Green Submitted			2022-12-27	WOS:000361604400039
J	Gray, EM; Diaz-Vazquez, G; Veatch, SL				Gray, Erin M.; Diaz-Vazquez, Gladys; Veatch, Sarah L.			Growth Conditions and Cell Cycle Phase Modulate Phase Transition Temperatures in RBL-2H3 Derived Plasma Membrane Vesicles	PLOS ONE			English	Article							BASOPHILIC LEUKEMIA-CELLS; LIQUID-ORDERED DOMAINS; LATERAL DIFFUSION; HISTAMINE-RELEASE; CORTICAL ACTIN; MAST-CELLS; PROTEINS; PROLIFERATION; CHOLESTEROL; CERAMIDE	Giant plasma membrane vesicle (GPMV) isolated from a flask of RBL-2H3 cells appear uniform at physiological temperatures and contain coexisting liquid-ordered and liquid-disordered phases at low temperatures. While a single GPMV transitions between these two states at a well-defined temperature, there is significant vesicle-to-vesicle heterogeneity in a single preparation of cells, and average transition temperatures can vary significantly between preparations. In this study, we explore how GPMV transition temperatures depend on growth conditions, and find that average transition temperatures are negatively correlated with average cell density over 15 degrees C in transition temperature and nearly three orders of magnitude in average surface density. In addition, average transition temperatures are reduced by close to 10 degrees C when GPMVs are isolated from cells starved of serum overnight, and elevated transition temperatures are restored when serum-starved cells are incubated in serum-containing media for 12h. We also investigated variation in transition temperature of GPMVs isolated from cells synchronized at the G1/S border through a double Thymidine block and find that average transition temperatures are systematically higher in GPMVs produced from G1 or M phase cells than in GPMVs prepared from S or G1 phase cells. Reduced miscibility transition temperatures are also observed in GPMVs prepared from cells treated with TRAIL to induce apoptosis or sphingomyelinase, and in some cases a gel phase is observed at temperatures above the miscibility transition in these vesicles. We conclude that at least some variability in GPMV transition temperature arises from variation in the local density of cells and asynchrony of the cell cycle. It is hypothesized that GPMV transition temperatures are a proxy for the magnitude of lipid-mediated membrane heterogeneity in intact cell plasma membranes at growth temperatures. If so, these results suggest that cells tune their plasma membrane composition in order to control the magnitude of membrane heterogeneity in response to different growth conditions.	[Gray, Erin M.; Diaz-Vazquez, Gladys; Veatch, Sarah L.] Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Veatch, SL (corresponding author), Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA.	sveatch@umich.edu	Veatch, Sarah L/G-9512-2016	Veatch, Sarah L/0000-0002-9317-2308	REU from the NSF [NSF 12-569]; NIH [R00GM87810, R01GM110052]; startup funds through the University of Michigan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM087810, R01GM110052] Funding Source: NIH RePORTER	REU from the NSF; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); startup funds through the University of Michigan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	GDV was supported through an REU from the NSF (NSF 12-569). Research was funded through grants from the NIH (R00GM87810 and R01GM110052) and startup funds through the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2013, MOL CELL, V52, P529, DOI 10.1016/j.molcel.2013.09.015; Arumugam S, 2015, BIOPHYS J, V108, P1104, DOI 10.1016/j.bpj.2014.12.050; Atilla-Gokcumen GE, 2014, CELL, V156, P428, DOI 10.1016/j.cell.2013.12.015; BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; BOSTOCK CJ, 1971, EXP CELL RES, V68, P163, DOI 10.1016/0014-4827(71)90599-4; Chen BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049232; Chiantia S, 2006, BIOPHYS J, V90, P4500, DOI 10.1529/biophysj.106.081026; Del Piccolo N, 2012, ANAL CHEM, V84, P8650, DOI [10.1021/ac301776j, 10.1021/ac301776J]; DELAAT SW, 1980, P NATL ACAD SCI-BIOL, V77, P1526; Dumitru CA, 2006, ONCOGENE, V25, P5612, DOI 10.1038/sj.onc.1209568; EAGLE H, 1967, NATURE, V213, P1102, DOI 10.1038/2131102a0; Frechin M, 2015, NATURE, V523, P88, DOI 10.1038/nature14429; Fridriksson EK, 1999, BIOCHEMISTRY-US, V38, P8056, DOI 10.1021/bi9828324; Gautreau A, 2002, CURR OPIN CELL BIOL, V14, P104, DOI 10.1016/S0955-0674(01)00300-3; Gniadecki R, 2004, BIOCHEM BIOPH RES CO, V320, P165, DOI 10.1016/j.bbrc.2004.05.145; Gray E, 2013, BIOPHYS J, V105, P2751, DOI 10.1016/j.bpj.2013.11.005; HOLOWKA D, 1983, BIOCHEMISTRY-US, V22, P3466, DOI 10.1021/bi00283a025; Honigmann A, 2014, ELIFE, V3, DOI 10.7554/eLife.01671; ISERSKY C, 1975, J EXP MED, V141, P1147, DOI 10.1084/jem.141.5.1147; Jackowski S, 1996, J BIOL CHEM, V271, P20219, DOI 10.1074/jbc.271.34.20219; JACOBSON K, 1984, J CELL BIOL, V99, P1624, DOI 10.1083/jcb.99.5.1624; JAYADEV S, 1995, J BIOL CHEM, V270, P2047, DOI 10.1074/jbc.270.5.2047; Jolly PS, 2005, BLOOD, V105, P4736, DOI 10.1182/blood-2004-12-4686; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; Koeberle A, 2013, P NATL ACAD SCI USA, V110, P2546, DOI 10.1073/pnas.1216182110; Levental I, 2011, P NATL ACAD SCI USA, V108, P11411, DOI 10.1073/pnas.1105996108; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Levental KR, 2015, METHODS MOL BIOL, V1232, P65, DOI 10.1007/978-1-4939-1752-5_6; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu WF, 2006, J CELL BIOL, V173, P431, DOI 10.1083/jcb.200510087; London M, 2004, J BIOL CHEM, V279, P9997, DOI 10.1074/jbc.M309992200; Machta BB, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.138101; Machta BB, 2011, BIOPHYS J, V100, P1668, DOI 10.1016/j.bpj.2011.02.029; McClatchey AI, 2012, CURR OPIN CELL BIOL, V24, P685, DOI 10.1016/j.ceb.2012.06.009; MEYER C, 1983, J IMMUNOL, V131, P911; Robinson DN, 2000, TRENDS CELL BIOL, V10, P228, DOI 10.1016/S0962-8924(00)01747-5; Sengupta P, 2008, BBA-BIOMEMBRANES, V1778, P20, DOI 10.1016/j.bbamem.2007.08.028; Sezgin E, 2012, NAT PROTOC, V7, P1042, DOI 10.1038/nprot.2012.059; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SLOTTE JP, 1990, BIOCHIM BIOPHYS ACTA, V1030, P251, DOI 10.1016/0005-2736(90)90301-4; Sot J, 2008, FEBS LETT, V582, P3230, DOI 10.1016/j.febslet.2008.08.016; Spiegel S, 1996, FASEB J, V10, P1388, DOI 10.1096/fasebj.10.12.8903509; Tserkovnyak Y, 2006, P NATL ACAD SCI USA, V103, P15002, DOI 10.1073/pnas.0606992103; Veatch SL, 2008, ACS CHEM BIOL, V3, P287, DOI 10.1021/cb800012x; Veatch SL, 2003, BIOPHYS J, V85, P3074, DOI 10.1016/S0006-3495(03)74726-2; Veatch SL, 2005, BBA-MOL CELL RES, V1746, P172, DOI 10.1016/j.bbamcr.2005.06.010; Zhao J, 2013, BIOPHYS J, V104, P825, DOI 10.1016/j.bpj.2012.12.047; Zhou Y, 2013, J BIOL CHEM, V288, P35660, DOI 10.1074/jbc.M113.519116	49	30	30	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137741	10.1371/journal.pone.0137741	http://dx.doi.org/10.1371/journal.pone.0137741			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368288	gold, Green Published, Green Submitted			2022-12-27	WOS:000361601100127
J	Abraham, MK; Nolte, A; Reus, R; Behring, A; Zengerle, D; Avci-Adali, M; Hohmann, JD; Peter, K; Schlensak, C; Wendel, HP; Krajewski, S				Abraham, Meike-Kristin; Nolte, Andrea; Reus, Rebekka; Behring, Andreas; Zengerle, Diane; Avci-Adali, Meltem; Hohmann, Jan David; Peter, Karlheinz; Schlensak, Christian; Wendel, Hans Peter; Krajewski, Stefanie			In vitro Study of a Novel Stent Coating Using Modified CD39 Messenger RNA to Potentially Reduce Stent Angioplasty-Associated Complications	PLOS ONE			English	Article							TRIPHOSPHATE DIPHOSPHOHYDROLASE-1; CELL-PROLIFERATION; ATHEROSCLEROSIS; TRANSFECTION; EXPRESSION; PROTEINS; DELIVERY; MICE; ATP	Background Stent angioplasty provides a minimally invasive treatment for atherosclerotic vessels. However, no treatment option for atherosclerosis-associated endothelial dysfunction, which is accompanied by a loss of CD39, is available, and hence, adverse effects like thromboembolism and restenosis may occur. Messenger RNA (mRNA)-based therapy represents a novel strategy, whereby de novo synthesis of a desired protein is achieved after delivery of a modified mRNA to the target cells. Methods and Findings Our study aimed to develop an innovative bioactive stent coating that induces overexpression of CD39 in the atherosclerotic vessel. Therefore, a modified CD39-encodingmRNA was produced by in vitro transcription. Different endothelial cells (ECs) were transfected with the mRNA, and CD39 expression and functionality were analyzed using various assays. Furthermore, CD39 mRNA was immobilized using poly(lactic-co-glycolic-acid) (PLGA), and the transfection efficiency in ECs was analyzed. Our data show that ECs successfully translate in vitro-generated CD39 mRNA after transfection. The overexpressed CD39 protein is highly functional in hydrolyzing ADP and in preventing platelet activation. Furthermore, PLGA-immobilized CD39mRNA can be delivered to ECs without losing its functionality. Summary In summary, we present a novel and promising concept for a stent coating for the treatment of atherosclerotic blood vessels, whereby patients could be protected against angioplasty-associated complications.	[Abraham, Meike-Kristin; Nolte, Andrea; Reus, Rebekka; Behring, Andreas; Zengerle, Diane; Avci-Adali, Meltem; Schlensak, Christian; Wendel, Hans Peter; Krajewski, Stefanie] Univ Hosp Tuebingen, Dept Thorac Cardiac & Vasc Surg, Clin Res Lab, Teubingen, Germany; [Hohmann, Jan David; Peter, Karlheinz] Baker IDI Heart & Diabet Inst, Atherothrombosis & Vasc Biol, Melbourne, Vic, Australia	Baker Heart and Diabetes Institute	Nolte, A (corresponding author), Univ Hosp Tuebingen, Dept Thorac Cardiac & Vasc Surg, Clin Res Lab, Teubingen, Germany.	andrea.nolte@thg-lab.de	/S-2765-2019; Krajewski, Stefanie/AAF-1877-2019	/0000-0002-8040-2258; Avci-Adali, Meltem/0000-0003-4008-4272	German research association (Deutsche Forschungsgemeinschaft) [KR 4296/1-1]	German research association (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	The study was funded by the German research association (Deutsche Forschungsgemeinschaft, grant number KR 4296/1-1).	Alfonso F, 2014, J AM COLL CARDIOL, V63, P2659, DOI 10.1016/j.jacc.2014.02.545; Avci-Adali M, 2014, J BIOL ENG, V8, DOI 10.1186/1754-1611-8-8; Avci-Adali M, 2013, J BIOMED MATER RES B, V101B, P1061, DOI 10.1002/jbm.b.32916; Burnstock G, 2002, ARTERIOSCL THROM VAS, V22, P364, DOI 10.1161/hq0302.105360; Cui S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/428619; Drosopoulos JHF, 2010, THROMB HAEMOSTASIS, V103, P426, DOI 10.1160/TH09-05-0305; Dwyer KM, 2004, J CLIN INVEST, V113, P1440, DOI 10.1172/JCI200419560; Erlinge D, 1998, GEN PHARMACOL-VASC S, V31, P1, DOI 10.1016/S0306-3623(97)00420-5; Fortier A, 2014, IJC HEART VESSELS; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Kaczmarek E, 1996, J BIOL CHEM, V271, P33116, DOI 10.1074/jbc.271.51.33116; Khan W, 2012, J CONTROL RELEASE, V161, P703, DOI 10.1016/j.jconrel.2012.02.010; Kormann MSD, 2011, NAT BIOTECHNOL, V29, P154, DOI 10.1038/nbt.1733; Koziak K, 2008, J THROMB HAEMOST, V6, P1191, DOI 10.1111/j.1538-7836.2008.03019.x; Krajewski S, 2014, ANAL BIOANAL CHEM, V406, P3395, DOI 10.1007/s00216-014-7769-9; Marcus AJ, 2003, J PHARMACOL EXP THER, V305, P9, DOI 10.1124/jpet.102.043729; Marcus AJ, 1997, J CLIN INVEST, V99, P1351, DOI 10.1172/JCI119294; McLean Dougal R, 2002, Rev Cardiovasc Med, V3 Suppl 5, pS16; Nilsson PH, 2013, BIOMATERIALS, V34, P985, DOI 10.1016/j.biomaterials.2012.10.040; Patrono C, 2011, EUR HEART J, V32, P2922, DOI 10.1093/eurheartj/ehr373; Rha SW, 2014, WORLD J CARDIOL, V6, P148, DOI 10.4330/wjc.v6.i4.148; Rodriguez-Granillo A, 2011, WORLD J CARDIOL, V3, P84, DOI 10.4330/wjc.v3.i3.84; Sampram ESK, 2004, J VASC INTERV RADIOL, V15, P379, DOI 10.1097/01.RVI.0000121409.46920.B8; Simard T, 2014, CAN J CARDIOL, V30, P35, DOI 10.1016/j.cjca.2013.09.012; Tavernier G, 2011, J CONTROL RELEASE, V150, P238, DOI 10.1016/j.jconrel.2010.10.020; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Zohra FT, 2007, BIOCHEM BIOPH RES CO, V358, P373, DOI 10.1016/j.bbrc.2007.04.059; Zohra FT, 2009, BIOMATERIALS, V30, P4006, DOI 10.1016/j.biomaterials.2009.02.050	28	13	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138375	10.1371/journal.pone.0138375	http://dx.doi.org/10.1371/journal.pone.0138375			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381750	Green Published, gold			2022-12-27	WOS:000361790200096
J	Shi, JD; Sun, J; Wu, MN; Hu, NZ; Li, JF; Li, YH; Wang, HX; Hu, YZ				Shi, Jiandong; Sun, Jing; Wu, Meini; Hu, Ningzhu; Li, Jianfan; Li, Yanhan; Wang, Haixuan; Hu, Yunzhang			Inferring Protective CD8(+) T-Cell Epitopes for NS5 Protein of Four Serotypes of Dengue Virus Chinese Isolates Based on HLA-A, -B and -C Allelic Distribution: Implications for Epitope-Based Universal Vaccine Design	PLOS ONE			English	Article							ORIGINAL ANTIGENIC SIN; HEMORRHAGIC-FEVER; RESPONSES; IDENTIFICATION; FLAVIVIRUS; PREDICTION; INFECTION; REVEALS; CD4(+); ORGANIZATION	Dengue is one of the most globally serious vector-borne infectious diseases in tropical and subtropical areas for which there are currently no effective vaccines. The most highly conserved flavivirus protein, NS5, is an indispensable target of CD8(+) T-cells, making it an ideal vaccine design target. Using the Immune Epitope Database (IEDB), CD8(+) T-cell epitopes of the dengue virus (DENV) NS5 protein were predicted by genotypic frequency of the HLA-A,-B, and-C alleles in Chinese population. Antigenicity scores of all predicted epitopes were analyzed using VaxiJen v2.0. The IEDB analysis revealed that 116 antigenic epitopes for HLA-A (21),-B (53), and-C (42) had high affinity for HLA molecules. Of them, 14 had 90.97-99.35% conversancy among the four serotypes. Moreover, five candidate epitopes, including (200)NS5(210) (94.84%, A*11:01), (515)NS5(525) (98.71%, A*24:02), (225)NS5(232) (99.35%, A*33:03), (516)NS5(523) (98.71%, A*33:03), and (284)NS5(291) (98.06%, A*33:03), were presented by HLA-A. Four candidate epitopes, including (234)NS5(241) (96.77%, B*13:01), (92)NS5(99) (98.06%, B*15:01, B*15:02, and B*46:01), (262)NS5(269) (92.90%, B*38:02), and (538)NS5(547) (90.97%, B*51:01), were presented by HLA-B. Another 9 candidate epitopes, including (514)NS5(522) (98.71%, C*01:02), (514)NS5(524) (98.71%, C*01:02 and C*14:02), (92)NS5(99) (98.06%, C*03:02 and C*15:02), (362)NS5(369) (44.84%, C*03:04 and C*08:01), (225)NS5(232) (99.35%, C*04:01), (234)NS5(241)(96.77%, C*04:01), (361)NS5(369) (94.84%, C*04:01), (515)NS5(522) (98.71%, C*14:02), (515)NS5(524) (98.71%, C*14:02), were presented by HLA-C. Further data showed that the four-epitope combination of (92)NS5(99) (B*15:01, B*15:02, B*46:01, C*03:02 and C*15:02), (200)NS5(210) (A*11:01), (362)NS5(369) (C*03:04, C*08:01), and (514)NS5(524) (C*01:02, C*14:02) could vaccinate >90% of individuals in China. Further in vivo study of our inferred novel epitopes will be needed for a T-cell epitope-based universal vaccine development that may prevent all four China-endemic DENV serotypes.	[Shi, Jiandong; Sun, Jing; Wu, Meini; Hu, Ningzhu; Li, Jianfan; Li, Yanhan; Wang, Haixuan; Hu, Yunzhang] Chinese Acad Med Sci, Inst Med Biol, Kunming 650118, Peoples R China; [Shi, Jiandong; Sun, Jing; Wu, Meini; Hu, Ningzhu; Li, Jianfan; Li, Yanhan; Wang, Haixuan; Hu, Yunzhang] Peking Union Med Coll, Kunming 650118, Peoples R China; [Shi, Jiandong; Sun, Jing; Wu, Meini; Hu, Ningzhu; Li, Jianfan; Li, Yanhan; Wang, Haixuan; Hu, Yunzhang] Chinese Acad Med Sci, Inst Med Biol, Yunnan Prov Key Lab Arbo Infect Dis Control Res P, Kunming 650118, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS	Hu, YZ (corresponding author), Chinese Acad Med Sci, Inst Med Biol, Kunming 650118, Peoples R China.	huyunzhangym@126.com			Applied and Fundamental Research program of Yunnan Province [2013FA025]	Applied and Fundamental Research program of Yunnan Province	This research was supported by a grant from the Applied and Fundamental Research program of Yunnan Province (Grant No. 2013FA025), which was received by YZH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Chang CXL, 2013, EUR J IMMUNOL, V43, P1109, DOI 10.1002/eji.201243088; Duan ZL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-259; Duan ZL, 2015, J MED VIROL, V87, P1077, DOI 10.1002/jmv.24167; Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107; Gededzha MP, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-187; Ghosh A, 2015, INDIAN J MED MICROBI, V33, P3, DOI 10.4103/0255-0857.148369; Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438; KOONIN EV, 1993, J GEN VIROL, V74, P733, DOI 10.1099/0022-1317-74-4-733; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Luo L, 2012, J VECTOR ECOL, V37, P230, DOI 10.1111/j.1948-7134.2012.00221.x; Molero-Abraham Magdalena, 2014, Methods Mol Biol, V1184, P319, DOI 10.1007/978-1-4939-1115-8_18; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; National Health and Family Planning Commission of the Peoples Republic of China, REP PROGR DENG FEV C; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Okamoto Y, 1998, J GEN VIROL, V79, P697, DOI 10.1099/0022-1317-79-4-697; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Prestwood TR, 2012, J VIROL, V86, P12561, DOI 10.1128/JVI.06743-11; QIU FX, 1993, B WORLD HEALTH ORGAN, V71, P349; QIU FX, 1991, AM J TROP MED HYG, V44, P364, DOI 10.4269/ajtmh.1991.44.364; Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12; Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014; RUSSELL PK, 1967, J IMMUNOL, V99, P291; Sidney John, 2008, Immunome Res, V4, P2, DOI 10.1186/1745-7580-4-2; Simmons CP, 2005, J VIROL, V79, P5665, DOI 10.1128/JVI.79.9.5665-5675.2005; Tian J, 2012, INT IMMUNOL, V24, P207, DOI 10.1093/intimm/dxr115; Townsley E, 2014, IMMUNOLOGY, V141, P27, DOI 10.1111/imm.12161; Wang BH, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0908-x; Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110; Xu G, 2007, AM J TROP MED HYG, V76, P1182; Yao YF, 2013, VACCINE, V31, P2289, DOI 10.1016/j.vaccine.2013.02.065; Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709; Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974; Zellweger RM, 2014, J IMMUNOL, V193, P4117, DOI 10.4049/jimmunol.1401597; Zellweger RM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003723; Zivna I, 2002, J IMMUNOL, V168, P5959, DOI 10.4049/jimmunol.168.11.5959; Zompi S, 2012, J IMMUNOL, V188, P404, DOI 10.4049/jimmunol.1102124	43	5	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138729	10.1371/journal.pone.0138729	http://dx.doi.org/10.1371/journal.pone.0138729			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381649	Green Published, Green Submitted, gold			2022-12-27	WOS:000361790200155
J	Baez-Saldana, R; Villafuerte-Garcia, A; Cruz-Hervert, P; Delgado-Sanchez, G; Ferreyra-Reyes, L; Ferreira-Guerrero, E; Mongua-Rodriguez, N; Montero-Campos, R; Melchor-Romero, A; Garcia-Garcia, L				Baez-Saldana, Renata; Villafuerte-Garcia, Adriana; Cruz-Hervert, Pablo; Delgado-Sanchez, Guadalupe; Ferreyra-Reyes, Leticia; Ferreira-Guerrero, Elizabeth; Mongua-Rodriguez, Norma; Montero-Campos, Rogelio; Melchor-Romero, Ada; Garcia-Garcia, Lourdes			Association between Highly Active Antiretroviral Therapy and Type of Infectious Respiratory Disease and All-Cause In-Hospital Mortality in Patients with HIV/AIDS: A Case Series	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; MIDDLE-INCOME COUNTRIES; BACTERIAL PNEUMONIA; HIV-INFECTION; ERA; OUTCOMES; ADULTS; AIDS; EPIDEMIOLOGY; PREVENTION	Background Respiratory manifestations of HIV disease differ globally due to differences in current availability of effective highly active antiretroviral therapy (HAART) programs and epidemiology of infectious diseases. Objective To describe the association between HAART and discharge diagnosis and all-cause in-hospital mortality among hospitalized patients with infectious respiratory disease and HIV/AIDS. Material and Methods We retrospectively reviewed the records of patients hospitalized at a specialty hospital for respiratory diseases in Mexico City between January 1st, 2010 and December 31st, 2011. We included patients whose discharge diagnosis included HIV or AIDS and at least one infectious respiratory diagnosis. The information source was the clinical chart. We analyzed the association between HAART for 180 days or more and type of respiratory disease using polytomous logistic regression and all-cause hospital mortality by multiple logistic regressions. Results We studied 308 patients, of whom 206 (66.9%) had been diagnosed with HIV infection before admission to the hospital. The CD4+ lymphocyte median count was 68 cells/mm(3) [interquartile range (IQR): 30-150]. Seventy-five (24.4%) cases had received HAART for more than 180 days. Pneumocystis jirovecii pneumonia (PJP) (n = 142), tuberculosis (n = 63), and bacterial community-acquired pneumonia (n = 60) were the most frequent discharge diagnoses. Receiving HAART for more than 180 days was associated with a lower probability of PJP [Adjusted odd ratio (aOR): 0.245, 95% Confidence Interval (CI): 0.08-0.8, p = 0.02], adjusted for sociodemographic and clinical covariates. HAART was independently associated with reduced odds (aOR 0.214, 95% CI 0.06-0.75) of all-cause in-hospital mortality, adjusting for HIV diagnosis previous to hospitalization, age, access to social security, low socioeconomic level, CD4 cell count, viral load, and discharge diagnoses. Conclusions HAART for 180 days or more was associated with 79% decrease in all-cause in-hospital mortality and lower frequency of PJP as discharge diagnosis. The prevalence of poorly controlled HIV was high, regardless of whether HIV was diagnosed before or during admission. HIV diagnosis and treatment resources should be improved, and strengthening of HAART program needs to be promoted.	[Baez-Saldana, Renata; Villafuerte-Garcia, Adriana; Cruz-Hervert, Pablo; Delgado-Sanchez, Guadalupe; Ferreyra-Reyes, Leticia; Ferreira-Guerrero, Elizabeth; Mongua-Rodriguez, Norma; Montero-Campos, Rogelio; Melchor-Romero, Ada; Garcia-Garcia, Lourdes] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico; [Baez-Saldana, Renata] Inst Nacl Enfermedades Resp, Serv Clin Neumol Oncol, Mexico City, DF, Mexico; [Baez-Saldana, Renata; Mongua-Rodriguez, Norma] Univ Nacl Autonoma Mexico, Fac Med, Div Posgrad, Mexico City 04510, DF, Mexico; [Cruz-Hervert, Pablo] Univ Nacl Autonoma Mexico, Fac Odontol, Div Posgrad, Mexico City 04510, DF, Mexico	Instituto Nacional de Salud Publica; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Garcia-Garcia, L (corresponding author), Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico.	garcigarml@gmail.com	García, Maria de Lourdes/I-2724-2019; Cruz-Hervert, Luis Pablo/AEI-4595-2022	García, Maria de Lourdes/0000-0001-5262-1157; Cruz-Hervert, Luis Pablo/0000-0002-6094-958X	National Council of Science and Technology (CONACyT)	National Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	AVG received a scholarship from the National Council of Science and Technology (CONACyT).	Adebamowo CA, 2014, JAIDS-J ACQ IMM DEF, V67, pS17, DOI 10.1097/QAI.0000000000000255; Baez SR, 2013, NEUMOL CIR TORAX S1, V72, P6; Bartlett J, 2004, DEP HLTH HUMAN SERVI, P13; Bower M, 2003, AIDS, V17, P371, DOI 10.1097/00002030-200302140-00011; Corbett EL, 2002, CLIN INFECT DIS, V34, P1251, DOI 10.1086/339540; Crabtree-Ramirez B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020272; Crothers K, 2006, CHEST, V130, P1326, DOI 10.1378/chest.130.5.1326; Crothers K, 2011, AM J RESP CRIT CARE, V183, P388, DOI 10.1164/rccm.201006-0836OC; Fink VI, 2011, JAIDS-J ACQ IMM DEF, V56, P467, DOI 10.1097/QAI.0b013e31820bb1c3; FISCHL MA, 1988, JAMA-J AM MED ASSOC, V259, P1185, DOI 10.1001/jama.259.8.1185; Hassani AS, 2015, JAIDS-J ACQ IMM DEF, V68, pS257, DOI 10.1097/QAI.0000000000000486; Hull MW, 2008, CHEST, V134, P1287, DOI 10.1378/chest.08-0364; Iglesias Chiesa M, 2011, 30 ANOS VIH SIDA PER, P61; Jiang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083078; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Kohli R, 2006, CLIN INFECT DIS, V43, P90, DOI 10.1086/504871; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Ledergerber B, 1999, JAMA-J AM MED ASSOC, V282, P2220, DOI 10.1001/jama.282.23.2220; Madeddu G, 2008, INFECTION, V36, P231, DOI 10.1007/s15010-007-7162-0; Madeddu G, 2010, CURR OPIN PULM MED, V16, P201, DOI 10.1097/MCP.0b013e3283375825; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Morris A, 2004, EMERG INFECT DIS, V10, P1713, DOI 10.3201/eid1010.030985; Palella FJ, 2003, ANN INTERN MED, V138, P620, DOI 10.7326/0003-4819-138-8-200304150-00007; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Secretaria de Salud, GUIA MAN ANT PERS CO; Shiels MS, 2011, J NATL CANCER I, V103, P753, DOI 10.1093/jnci/djr076; Shorr AF, 2004, CHEST, V125, P260, DOI 10.1378/chest.125.1.260; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Sullivan JH, 2000, AM J RESP CRIT CARE, V162, P64, DOI 10.1164/ajrccm.162.1.9904101; Tuboi SH, 2009, JAIDS-J ACQ IMM DEF, V51, P615, DOI 10.1097/QAI.0b013e3181a44f0a; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; WHO UNAIDS UNICEF, 2007, UN ACC SCAL PRIOR HI; World Health Organization, 2007, GUID PROV IN HIV TES; World Health Organization, INT STAT CLASS DIS R, V10th	35	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138115	10.1371/journal.pone.0138115	http://dx.doi.org/10.1371/journal.pone.0138115			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379281	gold, Green Submitted, Green Published			2022-12-27	WOS:000361769400054
J	Duru, AD; Sutlu, T; Wallblom, A; Uttervall, K; Lund, J; Stellan, B; Gahrton, G; Nahi, H; Alici, E				Duru, Adil Doganay; Sutlu, Tolga; Wallblom, Ann; Uttervall, Katarina; Lund, Johan; Stellan, Birgitta; Gahrton, Gosta; Nahi, Hareth; Alici, Evren			Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated with Upregulated Decoy TRAIL Receptor Expression in Patients with Multiple Myeloma	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; NF-KAPPA-B; PROTEASOME INHIBITOR BORTEZOMIB; NATURAL-KILLER-CELL; SURVIVIN EXPRESSION; GENE-EXPRESSION; C-MYC; DEATH; DR5; P53	Loss of the chromosomal region 8p21 negatively effects survival in patients with multiple myeloma (MM) that undergo autologous stem cell transplantation (ASCT). In this study, we aimed to identify the immunological and molecular consequences of del(8)(p21) with regards to treatment response and bortezomib resistance. In patients receiving bortezomib as a single first line agent without any high-dose therapy, we have observed that patients with del(8)(p21) responded poorly to bortezomib with 50% showing no response while patients without the deletion had a response rate of 90%. In vitro analysis revealed a higher resistance to bortezomib possibly due to an altered gene expression profile caused by del(8)(p21) including genes such as TRAIL-R4, CCDC25, RHOBTB2, PTK2B, SCARA3, MYC, BCL2 and TP53. Furthermore, while bortezomib sensitized MM cells without del(8)(p21) to TRAIL/APO2L mediated apoptosis, in cells with del (8)(p21) bortezomib failed to upregulate the pro-apoptotic death receptors TRAIL-R1 and TRAIL-R2 which are located on the 8p21 region. Also expressing higher levels of the decoy death receptor TRAIL-R4, these cells were largely resistant to TRAIL/APO2L mediated apoptosis. Corroborating the clinical outcome of the patients, our data provides a potential explanation regarding the poor response of MM patients with del(8)(p21) to bortezomib treatment. Furthermore, our clinical analysis suggests that including immunomodulatory agents such as Lenalidomide in the treatment regimen may help to overcome this negative effect, providing an alternative consideration in treatment planning of MM patients with del(8)(p21).	[Duru, Adil Doganay; Sutlu, Tolga; Wallblom, Ann; Uttervall, Katarina; Lund, Johan; Stellan, Birgitta; Gahrton, Gosta; Nahi, Hareth; Alici, Evren] Karolinska Univ Hosp Huddinge, Karolinska Inst, Ctr Hematol & Regenerat Med, Stockholm, Sweden; [Duru, Adil Doganay; Alici, Evren] Inst Florida, Ctr Dis Aging Vaccine & Gene Therapy, Port St Lucie, FL USA; [Sutlu, Tolga] Sabanci Univ, Nanotechnol Res & Applicat Ctr, Istanbul, Turkey; [Uttervall, Katarina; Lund, Johan; Gahrton, Gosta; Nahi, Hareth; Alici, Evren] Karolinska Univ Hosp, Haematol Ctr, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Sabanci University; Karolinska Institutet; Karolinska University Hospital	Alici, E (corresponding author), Karolinska Univ Hosp Huddinge, Karolinska Inst, Ctr Hematol & Regenerat Med, Stockholm, Sweden.	evren.alici@ki.se	Sutlu, Tolga/E-1190-2012; nahi, hareth/AAA-3445-2020; Alici, Evren/A-4696-2010	Sutlu, Tolga/0000-0002-7813-8734; Alici, Evren/0000-0001-5307-6648; Duru, Adil/0000-0002-5844-913X; nahi, hareth/0000-0003-4711-5094	Swedish Cancer Fund (Cancerfonden) [CAN 2013/487]; Swedish Cancer Society in Stockholm (Cancerforeningen/ Radiumhemmets forskningsfonder) [141022]; Swedish Research Council [2011-2784]; VINNOVA [2010-00501]; Karolinska Institutet Foundation [2014fobi41694]; State of Florida [COHH6]	Swedish Cancer Fund (Cancerfonden); Swedish Cancer Society in Stockholm (Cancerforeningen/ Radiumhemmets forskningsfonder); Swedish Research Council(Swedish Research CouncilEuropean Commission); VINNOVA(Vinnova); Karolinska Institutet Foundation(Karolinska Institutet); State of Florida	Swedish Cancer Fund (Cancerfonden): HN, CAN 2013/487, (www.cancerfonden.sse), Swedish Cancer Society in Stockholm (Cancerforeningen/ Radiumhemmets forskningsfonder): EA, 141022 (http://www.rahfo.se/; Om-oss/Cancerforeningen-i-Stockholmli), Swedish Research Council: EA, 2011-2784 (www.vr.se), VINNOVA: EA FH Dnr 2010-00501 (www.vinnova.se), Karolinska Institutet Foundation: HN 2014fobi41694 (https://fonder.ki.se/), State of Florida: COHH6 (http://www.floridahealth.gov/).	Ailawadhi S, 2012, LEUKEMIA LYMPHOMA, V53, P1174, DOI 10.3109/10428194.2011.637212; An JB, 2004, MOL CANCER THER, V3, P727; Anderson KC, 2011, HEMATOL-AM SOC HEMAT, P184, DOI 10.1182/asheducation-2011.1.184; Balsas P, 2009, BIOCHEM PHARMACOL, V77, P804, DOI 10.1016/j.bcp.2008.11.024; Berges C, 2008, IMMUNOLOGY, V124, P234, DOI 10.1111/j.1365-2567.2007.02761.x; Blade Joan, 1998, British Journal of Haematology, V102, P1115, DOI 10.1046/j.1365-2141.1998.00930.x; Brown CO, 2013, LEUKEMIA RES, V37, P963, DOI 10.1016/j.leukres.2013.03.004; de Wilt LHAM, 2013, CRIT REV ONCOL HEMAT, V85, P363, DOI 10.1016/j.critrevonc.2012.08.001; Degli-Esposti MA, 1997, IMMUNITY, V7, P813, DOI 10.1016/S1074-7613(00)80399-4; Feng XL, 2010, MOL IMMUNOL, V47, P2388, DOI 10.1016/j.molimm.2010.05.003; Fulda S, 2011, ONCOTARGET, V2, P418; Gazitt Y, 1999, LEUKEMIA, V13, P1817, DOI 10.1038/sj.leu.2401501; Gmidene A, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0489-8; Harousseau Jean-Luc, 2004, Hematology Am Soc Hematol Educ Program, P237; Holien T, 2012, BLOOD, V120, P2450, DOI 10.1182/blood-2011-08-371567; Holien T, 2012, ONCOTARGET, V3, P739; Hu WH, 1999, J BIOL CHEM, V274, P30603, DOI 10.1074/jbc.274.43.30603; Jungkunz-Stier I, 2014, LEUKEMIA LYMPHOMA, V55, P168, DOI 10.3109/10428194.2013.794270; Kandasamy K, 2008, MOL CANCER THER, V7, P1091, DOI 10.1158/1535-7163.MCT-07-2368; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Ling X, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-8; Liu XG, 2007, CANCER RES, V67, P4981, DOI 10.1158/0008-5472.CAN-06-4274; Markovina S, 2008, MOL CANCER RES, V6, P1356, DOI 10.1158/1541-7786.MCR-08-0108; Martinez-Garcia E, 2011, BLOOD, V117, P211, DOI 10.1182/blood-2010-07-298349; Morales JC, 2007, MOL IMMUNOL, V44, P2587, DOI 10.1016/j.molimm.2006.12.015; Nawrocki ST, 2008, BLOOD, V112, P2917, DOI 10.1182/blood-2007-12-130823; Neben K, 2010, HAEMATOL-HEMATOL J, V95, P1150, DOI 10.3324/haematol.2009.016436; Oerlemans R, 2008, BLOOD, V112, P2489, DOI 10.1182/blood-2007-08-104950; San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479; Shaughnessy JD, 2007, BLOOD, V109, P2276, DOI 10.1182/blood-2006-07-038430; Smith AJ, 2011, J BIOL CHEM, V286, P17682, DOI 10.1074/jbc.M110.189092; Surget S, 2012, CANCER RES, V72, P4562, DOI 10.1158/0008-5472.CAN-12-0487; Sutlu T, 2009, BRIT J HAEMATOL, V144, P266, DOI 10.1111/j.1365-2141.2008.07454.x; Sutlu T, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0569-9; Takeda K, 2002, J EXP MED, V195, P161, DOI 10.1084/jem.20011171; Teoh PJ, 2014, LEUKEMIA, V28, P2066, DOI 10.1038/leu.2014.102; Wu L, 2008, CLIN CANCER RES, V14, P4650, DOI 10.1158/1078-0432.CCR-07-4405; Xu DH, 2012, BIOCHEM BIOPH RES CO, V428, P518, DOI 10.1016/j.bbrc.2012.10.071; Zhang XD, 2000, J IMMUNOL, V164, P3961, DOI 10.4049/jimmunol.164.8.3961; Zhang Y, 2014, BLOOD, V124, P2675, DOI 10.1182/blood-2014-03-563981; Zlei M, 2007, EXP HEMATOL, V35, P1550, DOI 10.1016/j.exphem.2007.06.016	41	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138248	10.1371/journal.pone.0138248	http://dx.doi.org/10.1371/journal.pone.0138248			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378933	Green Submitted, gold, Green Published			2022-12-27	WOS:000361769400071
J	Gregory, NS; Whitley, PE; Sluka, KA				Gregory, Nicholas S.; Whitley, Phillip E.; Sluka, Kathleen A.			Effect of Intramuscular Protons, Lactate, and ATP on Muscle Hyperalgesia in Rats	PLOS ONE			English	Article							RHEUMATOID KNEE-JOINTS; THERMAL HYPERALGESIA; POSTOPERATIVE PAIN; DYNAMIC EXERCISE; TISSUE ACIDOSIS; SKELETAL-MUSCLE; SENSORY NEURONS; ACIDIC SALINE; ION CHANNELS; NA+ CHANNEL	Chronic muscle pain is a significant health problem leading to disability[1]. Muscle fatigue can exacerbate muscle pain. Metabolites, including ATP, lactate, and protons, are released during fatiguing exercise and produce pain in humans. These substances directly activate purinergic (P2X) and acid sensing ion channels (ASICs) on muscle nociceptors, and when combined, produce a greater increase in neuron firing than when given alone. Whether the enhanced effect of combining protons, lactate, and ATP is the sum of individual effects (additive) or more than the sum of individual effects (synergistic) is unknown. Using a rat model of muscle nociceptive behavior, we tested each of these compounds individually over a range of physiologic and supra-physiologic concentrations. Further, we combined all three compounds in a series of dilutions and tested their effect on muscle nociceptive behavior. We also tested a non-hydrolyzable form of ATP (alpha,beta-meATP) alone and in combination with lactate and acidic pH. Surprisingly, we found no dose-dependent effect on muscle nociceptive behavior for protons, lactate, or ATP when given alone. We similarly found no effect after application of each two-metabolite combination. Only pH 4 saline and alpha,beta-meATP produced hyperalgesia when given alone. When all 3 substances were combined, however, ATP (2.4 mu m), lactate (10mM), and acidic pH (pH 6.0) produced an enhanced effect greater than the sum of the effects of the individual components, i.e. synergism. alpha,beta me ATP (3nmol), on the other hand, showed no enhanced effects when combined with lactate (10mM) or acidic pH (pH 6.0), i.e. additive. These data suggest that combining fatigue metabolites in muscle produces a synergistic effect on muscle nociception.	[Gregory, Nicholas S.; Sluka, Kathleen A.] Univ Iowa, Grad Program Neurosci, Iowa City, IA 52242 USA; [Sluka, Kathleen A.] Univ Iowa, Dept Phys Therapy & Rehabil Sci, Iowa City, IA USA; [Whitley, Phillip E.] CFD Res Corp, Huntsville, AL USA	University of Iowa; University of Iowa; CFD Research Corporation	Sluka, KA (corresponding author), Univ Iowa, Grad Program Neurosci, Iowa City, IA 52242 USA.	kathleen-sluka@uiowa.edu		Whitley, Phillip/0000-0001-9202-5085; Sluka, Kathleen/0000-0003-0207-8728; Gregory, Nicholas/0000-0001-9392-6504	United States Navy Small Business Innovative Research Contract [N68335-13-C-0062]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS045549] Funding Source: NIH RePORTER	United States Navy Small Business Innovative Research Contract; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the United States Navy Small Business Innovative Research Contract N68335-13-C-0062 (KS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CFD Research Corporation provided support in the form of a salary for author PEW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	BANGSBO J, 1993, J PHYSIOL-LONDON, V462, P115, DOI 10.1113/jphysiol.1993.sp019546; Birdsong WT, 2010, NEURON, V68, P739, DOI 10.1016/j.neuron.2010.09.029; Brennan TJ, 1996, PAIN, V64, P493, DOI 10.1016/0304-3959(95)01441-1; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; GOLDIE I, 1970, ACTA ORTHOP SCAND, V41, P354, DOI 10.3109/17453677008991521; GOLDIE I, 1969, ACTA ORTHOP SCAND, V40, P634, DOI 10.3109/17453676908989529; Gregory NS, 2013, PAIN, V154, P2668, DOI 10.1016/j.pain.2013.07.047; Gregory NS, 2015, MOL NEUROBIOL; Gregory NS, 2014, CURR TOP BEHAV NEURO; Hamamoto DT, 1998, PAIN, V74, P225, DOI 10.1016/S0304-3959(97)00185-1; Hanna RL, 2004, J APPL PHYSIOL, V96, P1166, DOI 10.1152/japplphysiol.01020.2003; Hilliges M, 2002, PAIN, V98, P59, DOI 10.1016/S0304-3959(01)00469-9; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Institute of Medicine (IOM), 2011, REL PAIN AM BLUEPR T; Issberner U, 1996, NEUROSCI LETT, V208, P191, DOI 10.1016/0304-3940(96)12576-3; Jankowski MP, 2012, PAIN, V153, P410, DOI 10.1016/j.pain.2011.10.042; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Juel C, 2004, AM J PHYSIOL-ENDOC M, V286, pE245, DOI 10.1152/ajpendo.00303.2003; Kido K, 2013, ANESTHESIOLOGY, V119, P1186, DOI 10.1097/ALN.0b013e31829bd791; Kim TJ, 2007, J PAIN, V8, P59, DOI 10.1016/j.jpain.2006.06.003; Kwon SG, 2014, NEUROPHARMACOLOGY, V79, P368, DOI 10.1016/j.neuropharm.2013.12.005; Kwon SG, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-2; Law LAF, 2008, PAIN, V140, P254, DOI 10.1016/j.pain.2008.08.014; Light AR, 2008, J NEUROPHYSIOL, V100, P1184, DOI 10.1152/jn.01344.2007; Lin C-CJ, 2011, P NATL ACAD SCI US; Molliver DC, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-35; Mork H, 2003, EUR J PAIN, V7, P145, DOI 10.1016/S1090-3801(02)00096-4; Pollak KA, 2014, EXP PHYSIOL, V99, P368, DOI 10.1113/expphysiol.2013.075812; PORRECA F, 1990, EUR J PHARMACOL, V179, P463, DOI 10.1016/0014-2999(90)90190-H; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Reinohl J, 2003, NEUROSCI LETT, V338, P25, DOI 10.1016/S0304-3940(02)01360-5; Reitz M, 2009, CEPHALALGIA, V29, P58, DOI 10.1111/j.1468-2982.2008.01700.x; SAHLIN K, 1976, PFLUG ARCH EUR J PHY, V367, P143, DOI 10.1007/BF00585150; Schiavuzzo JG, 2015, NEUROSCIENCE, V285, P24, DOI 10.1016/j.neuroscience.2014.11.020; Seo HS, 2011, NEUROPHARMACOLOGY, V60, P580, DOI 10.1016/j.neuropharm.2010.12.009; Shinoda M, 2008, PAIN, V134, P148, DOI 10.1016/j.pain.2007.04.006; Skyba DA, 2002, PAIN, V98, P69, DOI 10.1016/S0304-3959(01)00471-7; Sluka KA, 2003, PAIN, V106, P229, DOI 10.1016/S0304-3959(03)00269-0; Sluka KA, 2001, MUSCLE NERVE, V24, P37, DOI 10.1002/1097-4598(200101)24:1<37::AID-MUS4>3.0.CO;2-8; Sluka KA, 2007, PAIN, V129, P102, DOI 10.1016/j.pain.2006.09.038; Sluka KA, 2010, PAIN, V148, P188, DOI 10.1016/j.pain.2009.07.001; Tallarida RJ., 2000, DRUG SYNERGISM DOSE; Tsuda M, 2010, BRAIN RES REV, V63, P222, DOI 10.1016/j.brainresrev.2009.11.003; VICTOR RG, 1988, J CLIN INVEST, V82, P1301, DOI 10.1172/JCI113730; Walder RY, 2010, J PAIN, V11, P210, DOI 10.1016/j.jpain.2009.07.004; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Woo YC, 2004, ANESTHESIOLOGY, V101, P468, DOI 10.1097/00000542-200408000-00029; Yokoyama T, 2007, J PAIN, V8, P692, DOI 10.1016/j.jpain.2007.05.008	50	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138576	10.1371/journal.pone.0138576	http://dx.doi.org/10.1371/journal.pone.0138576			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378796	Green Published, Green Submitted, gold			2022-12-27	WOS:000361769400112
J	Nemutlu, E; Gupta, A; Zhang, S; Viqar, M; Holmuhamedov, E; Terzic, A; Jahangir, A; Dzeja, P				Nemutlu, Emirhan; Gupta, Anu; Zhang, Song; Viqar, Maria; Holmuhamedov, Ekhson; Terzic, Andre; Jahangir, Arshad; Dzeja, Petras			Decline of Phosphotransfer and Substrate Supply Metabolic Circuits Hinders ATP Cycling in Aging Myocardium	PLOS ONE			English	Article							O-18-ASSISTED P-31 NMR; ADENYLATE KINASE; HEART-FAILURE; OXIDATIVE-PHOSPHORYLATION; MITOCHONDRIAL DYSFUNCTION; ENERGY-METABOLISM; CELL ENERGETICS; PROTECTIVE ROLE; FAILING ATRIAL; KNOCKOUT HEART	Integration of mitochondria with cytosolic ATP-consuming/ATP-sensing and substrate supply processes is critical for muscle bioenergetics and electrical activity. Whether age-dependent muscle weakness and increased electrical instability depends on perturbations in cellular energetic circuits is unknown. To define energetic remodeling of aged atrial myocardium we tracked dynamics of ATP synthesis-utilization, substrate supply, and phosphotransfer circuits through adenylate kinase (AK), creatine kinase (CK), and glycolytic/ glycogenolytic pathways using O-18 stable isotope-based phosphometabolomic technology. Samples of intact atrial myocardium from adult and aged rats were subjected to O-18-labeling procedure at resting basal state, and analyzed using the O-18-assisted HPLC-GC/MS technique. Characteristics for aging atria were lower inorganic phosphate Pi[O-18], y-ATP[O-18], 3-ADP[O-18], and creatine phosphate CrP[O-18] O-18-labeling rates indicating diminished ATP utilization-synthesis and AK and CK phosphotransfer fluxes. Shift in dynamics of glycolytic phosphotransfer was reflected in the diminished G6P[O-18] turnover with relatively constant glycogenolytic flux or G1 P[O-18] O-18-labeling. Labeling of G3P[O-18], an indicator of G3Pshuttle activity and substrate supply to mitochondria, was depressed in aged myocardium. Aged atrial myocardium displayed reduced incorporation of O-18 into second (O-18(2)), third (O-18(3)), and fourth (O-18(4)) positions of Pi[O-18] and a lower Pi[O-18]/y-ATP[O-18]-labeling ratio, indicating delayed energetic communication and ATP cycling between mitochondria and cellular ATPases. Adrenergic stress alleviated diminished CK flux, AK catalyzed 3-ATP turnover and energetic communication in aging atria. Thus, O-18-assisted phosphometabolomics uncovered simultaneous phosphotransfer through AK, CK, and glycolytic pathways and G3P substrate shuttle deficits hindering energetic communication and ATP cycling, which may underlie energetic vulnerability of aging atrial myocardium.	[Nemutlu, Emirhan; Gupta, Anu; Zhang, Song; Viqar, Maria; Terzic, Andre; Dzeja, Petras] Mayo Clin, Dept Internal Med, Div Cardiovasc Dis, Rochester, MN 55905 USA; [Holmuhamedov, Ekhson; Jahangir, Arshad] Aurora Univ Wisconsin Med Grp, Aurora Hlth Care, Ctr Integrat Res Cardiovasc Aging, Milwaukee, WI USA	Mayo Clinic	Dzeja, P (corresponding author), Mayo Clin, Dept Internal Med, Div Cardiovasc Dis, Rochester, MN 55905 USA.	arshad.jahangir@aurora.org; dzeja.petras@mayo.edu	Jahangir, Arshad/M-7916-2016; Nemutlu, Emirhan/D-3218-2013; Holmuhamedov, Ekhson L/P-5228-2016	Nemutlu, Emirhan/0000-0002-7337-6215; Holmuhamedov, Ekhson L/0000-0002-0809-350X	National Institutes of Health [R01HL 85744, U24DK100469]; Marriott Heart Disease Research Program; Marriott Foundation; Mayo Clinic; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK100469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marriott Heart Disease Research Program; Marriott Foundation; Mayo Clinic; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (R01HL 85744 and U24DK100469 Mayo Clinic Metabolomics Resource Core), Marriott Heart Disease Research Program, Marriott Foundation, and Mayo Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham MR, 2002, J BIOL CHEM, V277, P24427, DOI 10.1074/jbc.M201777200; AMCHENKOVA AA, 1988, J CELL BIOL, V107, P481, DOI 10.1083/jcb.107.2.481; Aon MA, 2006, BBA-MOL BASIS DIS, V1762, P232, DOI 10.1016/j.bbadis.2005.06.008; Ausma J, 2000, CARDIOVASC RES, V47, P788, DOI 10.1016/S0008-6363(00)00139-5; Bak MI, 1998, J MOL CELL CARDIOL, V30, P661, DOI 10.1006/jmcc.1997.0633; Carley AN, 2014, CIRC RES, V114, P717, DOI 10.1161/CIRCRESAHA.114.301863; Carrasco AJ, 2001, P NATL ACAD SCI USA, V98, P7623, DOI 10.1073/pnas.121038198; Cha YM, 2006, AM J PHYSIOL-HEART C, V290, pH1686, DOI 10.1152/ajpheart.00384.2005; Cha YM, 2003, AM J PHYSIOL-HEART C, V284, pH1313, DOI 10.1152/ajpheart.00337.2002; Cha YM, 2007, J CARDIOVASC ELECTR, V18, P1015, DOI 10.1111/j.1540-8167.2007.00926.x; Chung S, 2010, J MOL CELL CARDIOL, V48, P725, DOI 10.1016/j.yjmcc.2009.12.014; Corradi D, 2011, J CARDIOVASC ELECTR, V22, P223, DOI 10.1111/j.1540-8167.2010.01887.x; Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376; Dzeja P P, 2000, Curr Cardiol Rep, V2, P212, DOI 10.1007/s11886-000-0071-9; Dzeja P, 2009, INT J MOL SCI, V10, P1729, DOI 10.3390/ijms10041729; Dzeja PP, 2007, J BIOL CHEM, V282, P31366, DOI 10.1074/jbc.M705268200; Dzeja PP, 2011, J PHYSIOL-LONDON, V589, P5193, DOI 10.1113/jphysiol.2011.212829; Dzeja PP, 1996, J BIOL CHEM, V271, P12847, DOI 10.1074/jbc.271.22.12847; Dzeja PP, 1999, MOL CELL BIOCHEM, V201, P33, DOI 10.1023/A:1007016703229; Dzeja PP, 1998, MOL CELL BIOCHEM, V184, P169, DOI 10.1023/A:1006859632730; Dzeja PP, 2003, J EXP BIOL, V206, P2039, DOI 10.1242/jeb.00426; Dzeja PP, 1998, FASEB J, V12, P523, DOI 10.1096/fasebj.12.7.523; Figueiredo PA, 2009, J GERONTOL A-BIOL, V64, P21, DOI 10.1093/gerona/gln048; Flagg TP, 2010, PHYSIOL REV, V90, P799, DOI 10.1152/physrev.00027.2009; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Huang JH, 2009, IUBMB LIFE, V61, P201, DOI 10.1002/iub.164; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; Ingwall JS, 2004, J MOL CELL CARDIOL, V37, P613, DOI 10.1016/j.yjmcc.2004.05.020; Jahangir A, 2001, MECH AGEING DEV, V122, P1073, DOI 10.1016/S0047-6374(01)00242-1; Kane GC, 2004, DIABETES, V53, pS169, DOI 10.2337/diabetes.53.suppl_3.S169; Kanski J, 2005, AM J PHYSIOL-HEART C, V288, pH371, DOI 10.1152/ajpheart.01030.2003; KARL DM, 1985, APPL ENVIRON MICROB, V50, P706, DOI 10.1128/AEM.50.3.706-709.1985; Kuiper JWP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005030; Lagresle-Peyrou C, 2009, NAT GENET, V41, P106, DOI 10.1038/ng.278; London B, 2007, CIRCULATION, V116, P2260, DOI 10.1161/CIRCULATIONAHA.107.703330; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Mihm MJ, 2001, CIRCULATION, V104, P174, DOI 10.1161/01.CIR.104.2.174; Mirza M, 2011, J INTERV CARD ELECTR, V31, P197, DOI 10.1007/s10840-011-9560-6; Montaigne D, 2013, J AM COLL CARDIOL, V62, P1466, DOI 10.1016/j.jacc.2013.03.061; Nemutlu E, 2012, PHYSL GENOMICS; Nemutlu E, 2012, ANAL BIOANAL CHEM, V403, P697, DOI 10.1007/s00216-012-5899-5; Nemutlu E, 2012, PHYSIOL GENOMICS, V44, P386, DOI 10.1152/physiolgenomics.00152.2011; NEUBAUER S, 1992, CIRCULATION, V86, P302, DOI 10.1161/01.CIR.86.1.302; Nichtova Z, 2012, GEN PHYSIOL BIOPHYS, V31, P141, DOI 10.4149/gpb_2012_015; Olson LK, 1996, J BIOL CHEM, V271, P16544, DOI 10.1074/jbc.271.28.16544; OROURKE B, 1994, SCIENCE, V265, P962, DOI 10.1126/science.8052856; Peart JN, 2014, EXP GERONTOL, V50, P72, DOI 10.1016/j.exger.2013.11.015; Picard M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7259; PODEROSO JJ, 1995, CRIT CARE MED, V23, P1726, DOI 10.1097/00003246-199510000-00018; Preston CC, 2008, MECH AGEING DEV, V129, P304, DOI 10.1016/j.mad.2008.02.010; Pucar D, 2004, MOL CELL BIOCHEM, V256, P281, DOI 10.1023/B:MCBI.0000009875.30308.7a; Pucar D, 2002, AM J PHYSIOL-HEART C, V283, pH776, DOI 10.1152/ajpheart.00116.2002; Pucar D, 2000, J BIOL CHEM, V275, P41424, DOI 10.1074/jbc.M007903200; Pucar D, 2001, J BIOL CHEM, V276, P44812, DOI 10.1074/jbc.M104425200; Roosimaa M, 2013, MITOCHONDRION, V13, P399, DOI 10.1016/j.mito.2012.12.005; ROSSI A, 1975, J MOL CELL CARDIOL, V7, P891, DOI 10.1016/0022-2828(75)90150-9; Saks V, 2006, J PHYSIOL-LONDON, V571, P253, DOI 10.1113/jphysiol.2005.101444; Saks V, 2012, J MOL CELL CARDIOL, V52, P419, DOI 10.1016/j.yjmcc.2011.07.015; Scholz TD, 1997, J MOL CELL CARDIOL, V29, P1605, DOI 10.1006/jmcc.1997.0394; Sharma S, 2014, CARDIOVASCULAR PATHO; Shen WQ, 2005, J MOL CELL CARDIOL, V39, P537, DOI 10.1016/j.yjmcc.2005.05.003; Shibayama J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057821; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Steeghs K, 1997, CELL, V89, P93, DOI 10.1016/S0092-8674(00)80186-5; Taegtmeyer H, 2005, ANN NY ACAD SCI, V1047, P208, DOI 10.1196/annals.1341.019; Tsuboi M, 2001, EUR J CLIN INVEST, V31, P489, DOI 10.1046/j.1365-2362.2001.00844.x; Valdivia CR, 2009, AM J PHYSIOL-HEART C, V297, pH1446, DOI 10.1152/ajpheart.00513.2009; van Horssen R, 2009, J BIOL CHEM, V284, P1620, DOI 10.1074/jbc.M806974200; Van Norstrand DW, 2007, CIRCULATION, V116, P2253, DOI 10.1161/CIRCULATIONAHA.107.704627; Wang QS, 2010, NEUROCHEM RES, V35, P13, DOI 10.1007/s11064-009-0023-8; Yang JH, 2008, J BIOL CHEM, V283, P36321, DOI 10.1074/jbc.M804794200; Yaniv Y, 2013, TRENDS ENDOCRIN MET, V24, P495, DOI 10.1016/j.tem.2013.06.001; ZELEZNIKAR RJ, 1991, J BIOL CHEM, V266, P15110; Zhang S, 2014, SPRINGER SER BIOPHYS, V16, P145, DOI 10.1007/978-3-642-38505-6_6; Zilversmit DB, 1943, J GEN PHYSIOL, V26, P325, DOI 10.1085/jgp.26.3.325; Zingman LV, 2002, P NATL ACAD SCI USA, V99, P13278, DOI 10.1073/pnas.212315199	76	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0136556	10.1371/journal.pone.0136556	http://dx.doi.org/10.1371/journal.pone.0136556			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378442	Green Published, gold, Green Submitted			2022-12-27	WOS:000361769400006
J	Pham, T; Sheridan, P; Shimodaira, H				Pham, Thong; Sheridan, Paul; Shimodaira, Hidetoshi			PAFit: A Statistical Method for Measuring Preferential Attachment in Temporal Complex Networks	PLOS ONE			English	Article							POWER; DISTRIBUTIONS; EXTREMALITY; EVOLUTION; FITNESS; GROWTH	Preferential attachment is a stochastic process that has been proposed to explain certain topological features characteristic of complex networks from diverse domains. The systematic investigation of preferential attachment is an important area of research in network science, not only for the theoretical matter of verifying whether this hypothesized process is operative in real-world networks, but also for the practical insights that follow from knowledge of its functional form. Here we describe a maximum likelihood based estimation method for the measurement of preferential attachment in temporal complex networks. We call the method PAFit, and implement it in an R package of the same name. PAFit constitutes an advance over previous methods primarily because we based it on a nonparametric statistical framework that enables attachment kernel estimation free of any assumptions about its functional form. We show this results in PAFit outperforming the popular methods of Jeong and Newman in Monte Carlo simulations. What is more, we found that the application of PAFit to a publically available Flickr social network dataset yielded clear evidence for a deviation of the attachment kernel from the popularly assumed log-linear form. Independent of our main work, we provide a correction to a consequential error in Newman's original method which had evidently gone unnoticed since its publication over a decade ago.	[Pham, Thong; Shimodaira, Hidetoshi] Osaka Univ, Div Math Sci, Grad Sch Engn Sci, Osaka, Japan; [Sheridan, Paul] Univ Tokyo, Inst Med Sci, Tokyo, Japan	Osaka University; University of Tokyo	Pham, T (corresponding author), Osaka Univ, Div Math Sci, Grad Sch Engn Sci, Osaka, Japan.	thongpham@sigmath.es.osaka-u.ac.jp	Shimodaira, Hidetoshi/B-9127-2008; Pham, Thong/AAU-4229-2021	Shimodaira, Hidetoshi/0000-0002-3371-7724; Pham, Thong/0000-0002-1940-9290	Japan Society for the Promotion of Science KAKENHI [26120523, 24300106]; Grants-in-Aid for Scientific Research [26120523] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from Japan Society for the Promotion of Science KAKENHI (26120523 and 24300106 to HS, URL: http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backes AR, 2013, INFORM SCIENCES, V219, P168, DOI 10.1016/j.ins.2012.07.003; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bianconi G, 2001, EUROPHYS LETT, V54, P436, DOI 10.1209/epl/i2001-00260-6; Boyd S, 2000, CONVEX OPTIMIZATION; Caldarelli G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.258702; Caldarelli G., 2007, SCALE FREE NETWORKS; Cao SJ, 2014, INFORM SCIENCES, V278, P22, DOI 10.1016/j.ins.2014.03.133; Capocci A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036116; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Dehmer M, 2013, MATCH-COMMUN MATH CO, V69, P785; Dehmer M, 2011, INFORM SCIENCES, V181, P57, DOI 10.1016/j.ins.2010.08.041; Eagle N, 2010, SCIENCE, V328, P1029, DOI 10.1126/science.1186605; Eisenberg E, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.138701; Eom YH, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.056105; Eom YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024926; Gomez V., 2011, P 22 ACM C HYP HYP H, P181, DOI DOI 10.1145/1995966.1995992; Gong PL, 2003, PHYSICA A, V321, P679, DOI 10.1016/S0378-4371(02)01735-1; Herdagdelen A, 2007, EPL-EUROPHYS LETT, V78, DOI 10.1209/0295-5075/78/60007; Hunter DR, 2004, AM STAT, V58, P30, DOI 10.1198/0003130042836; Hunter DR, 2000, J COMPUT GRAPH STAT, V9, P60; Jeong H, 2003, EUROPHYS LETT, V61, P567, DOI 10.1209/epl/i2003-00166-9; Kaza S, 2009, IEEE T INTELL TRANSP, V10, P83, DOI 10.1109/TITS.2008.2011695; Nguyen K, 2012, SPRINGER SER OPTIM A, V57, P39, DOI 10.1007/978-1-4614-0754-6_2; Kong J, 2008, P NATL ACAD SCI USA, V37, P105; Kou ZB, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.036117; Krapivsky PL, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066123; Kraus V, 2013, MATCH-COMMUN MATH CO, V70, P885; Kunegis J, 2013, WEBSCI 13; Lima-Mendez G, 2009, MOL BIOSYST, V5, P1482, DOI 10.1039/b908681a; Lopes FM, 2014, INFORM SCIENCES, V272, P1, DOI 10.1016/j.ins.2014.02.096; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; Massen CP, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2773721; Menghui L, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/4/043029; Mislove A, 2008, P 1 WORKSHOP ONLINE, P25, DOI [10.1145/1397735.1397742, DOI 10.1145/1397735.1397742]; Mitzenmacher M., 2003, INTERNET MATH, V2, P226, DOI [10.1080/15427951.2004.10129088, DOI 10.1080/15427951.2004.10129088]; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Pastor-Satorras R, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066117; Pastor-Satorras R, ARXIV14082701; Perc M, 2012, J R SOC INTERFACE, V9, P3323, DOI 10.1098/rsif.2012.0491; Pham T, 2015, SPRINGER P IN PRESS; Pham T., 2015, PAFIT NONPARAMETRIC; PRICE DJD, 1976, J AM SOC INFORM SCI, V27, P292, DOI 10.1002/asi.4630270505; PRICE DJD, 1965, SCIENCE, V149, P510; Redner S, 2005, PHYS TODAY, V58, P49, DOI 10.1063/1.1996475; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Sheridan P, 2012, PHYSICA A, V391, P5031, DOI 10.1016/j.physa.2012.05.041; Sheridan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013580; Valverde S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046118; Wang MY, 2008, PHYSICA A, V387, P4692, DOI 10.1016/j.physa.2008.03.017; Woodbury MA, 1950, 42 PRINC U STAT RES; Wu XF, 2011, IEEE INFOCOM SER, P2096, DOI 10.1109/INFCOM.2011.5935019; Xia CY, 2012, NONLINEAR DYNAM, V69, P927, DOI 10.1007/s11071-011-0313-y; Zhou H, 2011, STAT COMPUT, V21, P261, DOI 10.1007/s11222-009-9166-3	54	28	31	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137796	10.1371/journal.pone.0137796	http://dx.doi.org/10.1371/journal.pone.0137796			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378457	Green Submitted, Green Published, gold			2022-12-27	WOS:000361769400027
J	Stahl, J; Bergmann, H; Gottig, S; Ebersberger, I; Averhoff, B				Stahl, Julia; Bergmann, Holger; Goettig, Stephan; Ebersberger, Ingo; Averhoff, Beate			Acinetobacter baumannii Virulence Is Mediated by the Concerted Action of Three Phospholipases D	PLOS ONE			English	Article							GALLERIA-MELLONELLA; EPITHELIAL-CELLS; GENETIC-ANALYSIS; PHOSPHATIDYLCHOLINE; IDENTIFICATION; PATHOGENESIS; MUTAGENESIS; INFECTIONS; EXPRESSION; EMERGENCE	Acinetobacter baumannii causes a broad range of opportunistic infections in humans. Its success as an emerging pathogen is due to a combination of increasing antibiotic resistance, environmental persistence and adaptation to the human host. To date very little is known about the molecular basis of the latter. Here we demonstrate that A. baumannii can use phosphatidylcholine, an integral part of human cell membranes, as sole carbon and energy source. We report on the identification of three phospholipases belonging to the PLD superfamily. PLD1 and PLD2 appear restricted to the bacteria and display the general features of bacterial phospholipases D. They possess two PLDc_2 PFAM domains each encompassing the HxKx(4)Dx(6)GS/GGxN (HKD) motif necessary for forming the catalytic core. The third candidate, PLD3, is found in bacteria as well as in eukaryotes and harbours only one PLDc_2 PFAM domain and one conserved HKD motif, which however do not overlap. Employing a markerless mutagenesis system for A. baumannii ATCC 19606(T), we generated a full set of PLD knock-out mutants. Galleria mellonella infection studies as well as invasion experiments using A549 human lung epithelial cells revealed that the three PLDs act in a concerted manner as virulence factors and are playing an important role in host cell invasion.	[Stahl, Julia; Averhoff, Beate] Goethe Univ Frankfurt, Inst Mol Biosci, Dept Mol Microbiol & Bioenerget, D-60054 Frankfurt, Germany; [Bergmann, Holger; Ebersberger, Ingo] Goethe Univ Frankfurt, Dept Appl Bioinformat, Inst Cell Biol & Neurosci, D-60054 Frankfurt, Germany; [Goettig, Stephan] Goethe Univ Frankfurt, Inst Med Microbiol & Infect Control, Univ Hosp Frankfurt, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Averhoff, B (corresponding author), Goethe Univ Frankfurt, Inst Mol Biosci, Dept Mol Microbiol & Bioenerget, D-60054 Frankfurt, Germany.	averhoff@bio.uni-frankfurt.de		Averhoff, Beate/0000-0003-1460-3649	German Research Council (DFG) [FOR2251]	German Research Council (DFG)(German Research Foundation (DFG))	This study was supported by a grant by the German Research Council (DFG) - FOR2251 (www.acinetobacter.de).	Antunes LCS, 2014, PATHOG DIS, V71, P292, DOI 10.1111/2049-632X.12125; Antunes LCS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022674; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berendes F, 1998, APPL ENVIRON MICROB, V64, P2454; Bernhard W, 2001, AM J RESP CELL MOL, V25, P725, DOI 10.1165/ajrcmb.25.6.4616; Boeris PS, 2012, MICROBIOL-SGM, V158, P1249, DOI 10.1099/mic.0.054072-0; Brown SA, 2008, NAT REV MICROBIOL, V6, P657, DOI 10.1038/nrmicro1955; Camarena L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000834; Carruthers MD, 2013, GENOME ANNOUNC, P1; Carruthers MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059388; Choi CH, 2005, CELL MICROBIOL, V7, P1127, DOI 10.1111/j.1462-5822.2005.00538.x; Choi CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-216; Clemmer KM, 2011, MICROBIOL-SGM, V157, P2534, DOI 10.1099/mic.0.049791-0; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Dorsey CW, 2003, J CLIN MICROBIOL, V41, P4188, DOI 10.1128/JCM.41.9.4188-4193.2003; Ebersberger I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-157; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edwards JL, 2006, CELL MICROBIOL, V8, P1253, DOI 10.1111/j.1462-5822.2006.00707.x; Edwards JL, 2003, INFECT IMMUN, V71, P6381, DOI 10.1128/IAI.71.11.6381-6391.2003; Falagas ME, 2006, CRIT CARE, V10, DOI [10.1186/cc4910, 10.1186/cc4869]; Gaddy JA, 2012, INFECT IMMUN, V80, P1015, DOI 10.1128/IAI.06279-11; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; GIROD S, 1992, PEDIATR PULM, V13, P22, DOI 10.1002/ppul.1950130107; Gottig S, 2014, J ANTIMICROB CHEMOTH, V69, P2578, DOI 10.1093/jac/dku170; Jacobs AC, 2010, INFECT IMMUN, V78, P1952, DOI 10.1128/IAI.00889-09; Jawad A, 1998, J CLIN MICROBIOL, V36, P1938, DOI 10.1128/JCM.36.7.1938-1941.1998; Jiang F, 2014, CELL HOST MICROBE, V15, P600, DOI 10.1016/j.chom.2014.04.010; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kempf M, 2012, INT J ANTIMICROB AG, V39, P105, DOI 10.1016/j.ijantimicag.2011.10.004; Lee JC, 2006, RES MICROBIOL, V157, P360, DOI 10.1016/j.resmic.2005.09.011; Mahankali M, 2015, CELL SIGNAL, V27, P69, DOI 10.1016/j.cellsig.2014.09.008; McConnell MJ, 2013, FEMS MICROBIOL REV, V37, P130, DOI 10.1111/j.1574-6976.2012.00344.x; Metzgar D, 2004, NUCLEIC ACIDS RES, V32, P5780, DOI 10.1093/nar/gkh881; Moore AD, 2014, BIOINFORMATICS, V30, P282, DOI 10.1093/bioinformatics/btt640; Muller T, 2000, J COMPUT BIOL, V7, P761, DOI 10.1089/10665270050514918; Nishimasu H, 2012, NATURE, V491, P284, DOI 10.1038/nature11509; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Peleg AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046984; Peleg AY, 2009, ANTIMICROB AGENTS CH, V53, P2605, DOI 10.1128/AAC.01533-08; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ponting CP, 1996, PROTEIN SCI, V5, P914; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ross RJ, 2014, NATURE, V505, P353, DOI 10.1038/nature12987; Rudolph AE, 1999, J BIOL CHEM, V274, P11824, DOI 10.1074/jbc.274.17.11824; Sand M, 2014, ENVIRON MICROBIOL, V16, P1490, DOI 10.1111/1462-2920.12188; Sand M, 2011, ARCH MICROBIOL, V193, P723, DOI 10.1007/s00203-011-0713-x; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Songer JG, 1997, TRENDS MICROBIOL, V5, P156, DOI 10.1016/S0966-842X(97)01005-6; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stuckey JA, 1999, NAT STRUCT BIOL, V6, P278; Sun ZX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103778; Sung TC, 1997, EMBO J, V16, P4519, DOI 10.1093/emboj/16.15.4519; Titball RW, 1998, J APPL MICROBIOL, V84, p127S; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; van Dijk MCM, 1998, CURR BIOL, V8, P386, DOI 10.1016/S0960-9822(98)70157-5; Vance DE, 2008, CURR OPIN LIPIDOL, V19, P229, DOI 10.1097/MOL.0b013e3282fee935	59	50	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138360	10.1371/journal.pone.0138360	http://dx.doi.org/10.1371/journal.pone.0138360			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379240	gold, Green Submitted, Green Published			2022-12-27	WOS:000361769400088
J	Bisson, M; Almeras, N; Dufresne, SS; Robitaille, J; Rheaume, C; Bujold, E; Frenette, J; Tremblay, A; Marc, I				Bisson, Michele; Almeras, Natalie; Dufresne, Sebastien S.; Robitaille, Julie; Rheaume, Caroline; Bujold, Emmanuel; Frenette, Jerome; Tremblay, Angelo; Marc, Isabelle			A 12-Week Exercise Program for Pregnant Women with Obesity to Improve Physical Activity Levels: An Open Randomised Preliminary Study	PLOS ONE			English	Article							BIRTH-WEIGHT; AEROBIC EXERCISE; BODY-COMPOSITION; CONTROLLED-TRIAL; META-ANALYSIS; OVERWEIGHT; INTERVENTIONS; FITNESS; QUESTIONNAIRE; METAANALYSIS	Objective To evaluate whether a 12-week supervised exercise program promotes an active lifestyle throughout pregnancy in pregnant women with obesity. Methods In this preliminary randomised trial, pregnant women (body mass index >= 30 kg/m(2)) were allocated to either standard care or supervised training, from 15 to 27 weeks of gestation. Physical activity was measured by accelerometry at 14, 28 and 36 weeks, while fitness (oxygen consumption (VO2) at the anaerobic threshold), nutrition (caloric intake and macro-nutrients percentage) and anthropometry were assessed at 14 and 28 weeks of gestation. Analyses were performed using repeated measures ANOVA. Results A total of fifty (50) women were randomised, 25 in each group. There was no time-group interaction for time spent at moderate and vigorous activity (p(interaction) = 0.064), but the exercise group's levels were higher than controls' at all times (p(group) (effect) = 0.014). A significant time-group interaction was found for daily physical activity (p = 0.023); similar at baseline ((22.0 +/- 6.7 vs 21.8 +/- 7.3) x 10(4) counts/day) the exercise group had higher levels than the control group following the intervention ((22.8 +/- 8.3 vs 19.2 +/- 4.5) x 10(4) counts/day, p = 0.020) and at 36 weeks of gestation ((19.2 +/- 1.5 vs 14.9 +/- 1.5) x 10(4) counts/day, p = 0.034). Exercisers also gained less weight than controls during the intervention period despite similar nutritional intakes (difference in weight change = -0.1 kg/week, 95% CI -0.2; -0.02, p = 0.016) and improved cardiorespiratory fitness (difference in fitness change = 8.1%, 95% CI 0.7; 9.5, p = 0.041). Conclusions Compared with standard care, a supervised exercise program allows pregnant women with obesity to maintain fitness, limit weight gain and attenuate the decrease in physical activity levels observed in late pregnancy.	[Bisson, Michele; Marc, Isabelle] Univ Laval, Dept Pediat, CHU Quebec, Quebec City, PQ, Canada; [Bisson, Michele; Almeras, Natalie; Tremblay, Angelo] Univ Laval, Dept Kinesiol, Quebec City, PQ, Canada; [Dufresne, Sebastien S.; Frenette, Jerome] Univ Laval, Dept Rehabil, CHU Quebec, Quebec City, PQ, Canada; [Robitaille, Julie] Univ Laval, Dept Food Sci & Nutr, Quebec City, PQ, Canada; [Rheaume, Caroline] Univ Laval, Dept Family Med & Emergency Med, Quebec City, PQ, Canada; [Bujold, Emmanuel] Univ Laval, Dept Obstet & Gynecol, CHU Quebec, Quebec City, PQ, Canada	Laval University; Laval University; Laval University; Laval University; Laval University; Laval University	Marc, I (corresponding author), Univ Laval, Dept Pediat, CHU Quebec, Quebec City, PQ, Canada.	isabelle.marc@crchudequebec.ulaval.ca	Dufresne, Sebastien S./AAL-7005-2021; Robitaille, Julie/O-4892-2016	Dufresne, Sebastien S./0000-0001-5924-7962; Robitaille, Julie/0000-0001-7035-0477; Rheaume, Caroline/0000-0002-1863-4410; Bujold, Emmanuel/0000-0002-6936-4369; Frenette, Jerome/0000-0002-4308-9418; Marc, Isabelle/0000-0001-6060-8550	Fondation des Etoiles [F-61359]; Canadian Institutes of Health Research; Fonds de Recherche du Quebec-Sante clinician scientist award	Fondation des Etoiles; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec-Sante clinician scientist award	This study was funded by an operating grant from the Fondation des Etoiles (grant number F-61359, URL: http://www.fondationdesetoiles.ca/fr). Salaries were supported by the following sources: MB is a doctoral scholarship holder from the Canadian Institutes of Health Research (URL http://www.cihrirsc.gc.ca/e/193.html). IM and EB are recipients of a Fonds de Recherche du Quebec-Sante clinician scientist award (URL http://www.frqs.gouv.qc.ca/en/accueil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; [Anonymous], 2002, PARMED X PREGANCY PH; Aune D, 2014, EPIDEMIOLOGY, V25, P331, DOI 10.1097/EDE.0000000000000036; Bell R, 2013, EUR J OBSTET GYN R B, V170, P90, DOI 10.1016/j.ejogrb.2013.05.018; Bessinger RC, 2002, AM J OBSTET GYNECOL, V186, P757, DOI 10.1067/mob.2002.122093; Bisson M, 2013, PEDIATR OBES, V8, P464, DOI 10.1111/j.2047-6310.2012.00129.x; Bisson M, 2014, J HYPERTENS, V32, P1450, DOI 10.1097/HJH.0000000000000185; Bohannon RW, 2001, PERCEPT MOTOR SKILL, V93, P323, DOI 10.2466/PMS.93.5.323-328; Bouchard C, 2001, MED SCI SPORT EXER, V33, pS446, DOI 10.1097/00005768-200106001-00013; CATALANO PM, 1995, AM J OBSTET GYNECOL, V173, P1176, DOI 10.1016/0002-9378(95)91348-3; Chandonnet N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038818; Chasan-Taber L, 2004, MED SCI SPORT EXER, V36, P1750, DOI 10.1249/01.MSS.0000142303.49306.0D; Choi J, 2013, PREV MED, V56, P351, DOI 10.1016/j.ypmed.2013.02.021; Comm Obstetric Practice, 2002, INT J GYNECOL OBSTET, V77, P79; Danneskiold-Samsoe B, 2009, ACTA PHYSIOL, V197, P1, DOI 10.1111/j.1748-1716.2009.02022.x; Evenson KR, 2009, RES Q EXERCISE SPORT, V80, P355, DOI 10.1080/02701367.2009.10599570; FULLER NJ, 1991, EUR J CLIN NUTR, V45, P43; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Goulet J, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-13; Halse RE, 2014, MED SCI SPORT EXER, V46, P1702, DOI 10.1249/MSS.0000000000000302; Harbo T, 2012, EUR J APPL PHYSIOL, V112, P267, DOI 10.1007/s00421-011-1975-3; Hawkins M, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0576-2; Holowko N, 2014, INT J OBESITY, V38, P91, DOI 10.1038/ijo.2013.62; JACKSON AS, 1980, MED SCI SPORT EXER, V12, P175; Kaminsky L A, 1998, J Cardiopulm Rehabil, V18, P438, DOI 10.1097/00008483-199811000-00006; Kramer MS, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000180.pub2; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Matthews CE, 2005, MED SCI SPORT EXER, V37, pS512, DOI 10.1249/01.mss.0000185659.11982.3d; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Ministere de l'Education du Loisir et du Sport., 2008, PROGR FORM 21 SIECL; Mottola MF, 2009, OBSTET GYN CLIN N AM, V36, P301, DOI 10.1016/j.ogc.2009.03.005; Oostdam N, 2012, BJOG-INT J OBSTET GY, V119, P1098, DOI 10.1111/j.1471-0528.2012.03366.x; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Renault K, 2012, J OBSTET GYNAECOL, V32, P430, DOI 10.3109/01443615.2012.668580; Richards J, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010392.pub2; Robic T, 2013, ANN NUTR METAB, V63, P341, DOI 10.1159/000358339; Sanabria-Martinez G, 2015, BJOG; Santos IA, 2005, OBSTET GYNECOL, V106, P243, DOI 10.1097/01.AOG.0000171113.36624.86; Sisson SB, 2009, MED SCI SPORT EXER, V41, P539, DOI 10.1249/MSS.0b013e3181896c4e; Thangaratinam S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2088; Thangaratinam S, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16310; Thompson WR, 2010, ACSMS GUIDELINES EXE, P183; US Department of Health and Human Services, 2008, PHYS ACT GUID AM, P76; van Poppel MNM, 2014, DIABETES CARE, V37, P1132, DOI 10.2337/dc13-2140; Vinter CA, 2011, DIABETES CARE, V34, P2502, DOI 10.2337/dc11-1150; WASSERMAN K, 1994, Z KARDIOL, V83, P1; Wiebe HW, 2015, OBSTET GYNECOL, V125, P1185, DOI 10.1097/AOG.0000000000000801; WILSON RC, 1989, CLIN SCI, V76, P277, DOI 10.1042/cs0760277	48	46	46	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137742	10.1371/journal.pone.0137742	http://dx.doi.org/10.1371/journal.pone.0137742			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375471	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000361610200050
J	Liu, YH; Tam, YH; Yuan, J; Chen, FL; Cai, WF; Liu, JP; Ma, XW; Xie, CJ; Zheng, CL; Zhuo, L; Cao, XB; Tan, HL; Li, BS; Xie, HP; Liu, YF; Ip, D				Liu, Yanhui; Tam, Yat Hung; Yuan, Jun; Chen, Fengling; Cai, Wenfeng; Liu, Jianping; Ma, Xiaowei; Xie, Chaojun; Zheng, Chuangliang; Zhuo, Li; Cao, Xianbang; Tan, Hailing; Li, Baisheng; Xie, Huaping; Liu, Yufei; Ip, Dennis			A Foodborne Outbreak of Gastroenteritis Caused by Vibrio parahaemolyticus and Norovirus through Non-Seafood Vehicle	PLOS ONE			English	Article							UNITED-STATES; DISEASE OUTBREAKS; PATHOGENESIS; INFECTIONS	Foodborne outbreaks caused by a mixed infection of Vibrio parahaemolyticus and norovirus have rarely been described. We reported a mixed outbreak of Vibrio parahaemolyticus and norovirus causing acute gastroenteritis in 99 staff members of a company in Guangdong, China, in May 2013, following consumption of roasted duck, an uncommon non-seafood vehicle for such mixed infection, in one meal served in the company's catering service. Epidemiological and laboratory findings indicated that a single asymptomatic food handler was the source of both pathogens, and the high rate of infection of both pathogens was exacerbated by the setting's suboptimal food hygiene practice.	[Liu, Yanhui; Yuan, Jun; Cai, Wenfeng; Liu, Jianping; Ma, Xiaowei; Xie, Chaojun; Xie, Huaping; Liu, Yufei] Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Liu, Yanhui; Yuan, Jun] Sun Yat Sen Univ, Guangzhou 510275, Guangdong, Peoples R China; [Tam, Yat Hung; Ip, Dennis] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Chen, Fengling] Foshan Chancheng Dist Ctr Dis Control & Prevent, Foshan, Guangdong, Peoples R China; [Zheng, Chuangliang; Cao, Xianbang] Guangzhou Luogang Dist Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Zhuo, Li] Eighth Peoples Hosp Guangzhou, Guangzhou, Guangdong, Peoples R China; [Tan, Hailing; Li, Baisheng] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; University of Hong Kong; Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention	Liu, YF (corresponding author), Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China.	gzliuyufei@hotmail.com	Ip, Dennis Kai Ming/C-4283-2009	Ip, Dennis Kai Ming/0000-0003-3592-8709; /0000-0001-6098-9701	Medical Science and Technology Research Project of Guangzhou Municipality [20151A011047]	Medical Science and Technology Research Project of Guangzhou Municipality	This work was supported by the grant from the Medical Science and Technology Research Project of Guangzhou Municipality (Grant No. 20151A011047).	Daniels NA, 2000, J INFECT DIS, V181, P1661, DOI 10.1086/315459; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Guo ZN, 2014, INT J INFECT DIS, V28, P101, DOI 10.1016/j.ijid.2014.06.022; Hall AJ, 2014, MMWR-MORBID MORTAL W, V63, P491; Khan AA, 2002, FEMS MICROBIOL LETT, V206, P209, DOI [10.1111/j.1574-6968.2002.tb11011.x, 10.1016/S0378-1097(01)00545-6]; Letchumanan V, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00705; Ma Cong, 2011, Zhonghua Weishengwuxue He Mianyixue Zazhi, V31, P1093, DOI 10.3760/cma.j.issn.0254-5101.2011.12.009; Ozawa K, 2007, J CLIN MICROBIOL, V45, P3996, DOI 10.1128/JCM.01516-07; Pan TM, 1997, J CLIN MICROBIOL, V35, P1260, DOI 10.1128/JCM.35.5.1260-1262.1997; My PVT, 2013, EMERG INFECT DIS, V19, P977, DOI 10.3201/eid1906.111862; Qiu JF, 2008, FOODBORNE INFECT EME; Sala MR, 2009, EPIDEMIOL INFECT, V137, P626, DOI 10.1017/S0950268808001040; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Stals A, 2013, J FOOD PROTECT, V76, P1202, DOI 10.4315/0362-028X.JFP-12-392; Wang RZ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00144; Yeung P S Marie, 2004, Foodborne Pathog Dis, V1, P74, DOI 10.1089/153531404323143594	16	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137848	10.1371/journal.pone.0137848	http://dx.doi.org/10.1371/journal.pone.0137848			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376317	Green Submitted, Green Published, gold			2022-12-27	WOS:000361610200057
J	Mazzara, S; Sinisi, A; Cardaci, A; Rossi, RL; Muratori, L; Abrignani, S; Bombaci, M				Mazzara, Saveria; Sinisi, Antonia; Cardaci, Angela; Rossi, Riccardo Lorenzo; Muratori, Luigi; Abrignani, Sergio; Bombaci, Mauro			Two of Them Do It Better: Novel Serum Biomarkers Improve Autoimmune Hepatitis Diagnosis	PLOS ONE			English	Article							PARTIAL LEAST-SQUARES; LEUCINE-RICH PROTEOGLYCANS; GENE-EXPRESSION; IDENTIFICATION; GROWTH; CLASSIFICATION; AUTOANTIGENS; TGF-BETA-1; SEROLOGY; REVEALS	Background Autoimmune hepatitis (AIH) is a chronic liver disease of unknown aetiology and characterized by continuing hepatocellular inflammation and necrosis. Autoantibodies represent accessible markers to measure the adaptive immune responses in the clinical investigation. Protein microarrays have become an important tool to discriminate the disease state from control groups, even though there is no agreed-upon standard to analyze the results. Results In the present study 15 sera of patients with AIH and 78 healthy donors (HD) have been tested against 1626 proteins by an in house-developed array. Using a Partial Least Squares Discriminant Analysis (PLS-DA) the resulting data interpretation led to the identification of both new and previously identified proteins. Two new proteins AHPA9419 and Chondroadherin precursor (UNQ9419 and CHAD, respectively), and previously identified candidates as well, have been confirmed in a validation phase by DELFIA assay using a new cohort of AIH patients. A receiver operating characteristic analysis was used for the evaluation of biomarker candidates. The sensitivity of each autoantigen in AIH ranged from 65 to 88%; moreover, when the combination of the two new autoantigens was analyzed, the sensitivity increased to 95%. Conclusions Our findings demonstrate that the detection of autoantibodies against the two autoantigens could improve the performance in discriminating AIH patients from control classes and in combination with previously identified autoantigens and they could be used in diagnostic/prognostic markers.	[Mazzara, Saveria; Sinisi, Antonia; Cardaci, Angela; Rossi, Riccardo Lorenzo; Abrignani, Sergio; Bombaci, Mauro] Ist Nazl Genet Mol Romeo & Enr Invernizzi, Milan, Italy; [Abrignani, Sergio] Univ Milan, Dept Clin Sci & Community Hlth, DISSCO, Milan, Italy; [Muratori, Luigi] Univ Bologna, Ctr Study & Treatment Autoimmune Dis Liver & Bili, Dept Med & Surg Sci DIMEC, Policlin St Orsola,Alma Mater Studiorum, Bologna, Italy	University of Milan; University of Bologna	Bombaci, M (corresponding author), Ist Nazl Genet Mol Romeo & Enr Invernizzi, Milan, Italy.	bombaci@ingm.org	Rossi, Riccardo/M-8999-2019; Bombaci, Mauro/K-6106-2016	Rossi, Riccardo/0000-0002-4964-3264; Bombaci, Mauro/0000-0002-9887-4165; Abrignani, Sergio/0000-0002-0794-3285; mazzara, saveria/0000-0003-1799-2360				Ayoglu B, 2013, MOL CELL PROTEOMICS, V12, P2657, DOI 10.1074/mcp.M112.026757; Baghy K, 2012, J HISTOCHEM CYTOCHEM, V60, P262, DOI 10.1369/0022155412438104; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Baumgartner C., 2011, J CLIN BIOINFORMATIC, V1, P1; Bogdanos DP, 2008, WORLD J GASTROENTERO, V14, P3374, DOI 10.3748/wjg.14.3374; Bombaci M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006332; Carbonell WS, 2013, CANCER RES, V73, P3145, DOI 10.1158/0008-5472.CAN-13-0011; Chen J, 2011, J PROTEOME RES, V10, P2625, DOI 10.1021/pr200173q; Christin C, 2013, MOL CELL PROTEOMICS, V12, P263, DOI 10.1074/mcp.M112.022566; Duda R.O., 2006, PATTERN CLASSIFICATI; Eriksson L, 2006, BASIC PRINCIPLES APP; Fernandez-Perez L, 2010, CLIN ENDOCRINOL, V72, P800, DOI 10.1111/j.1365-2265.2009.03732.x; Grifantini R, 2011, J PROTEOMICS, V75, P532, DOI 10.1016/j.jprot.2011.08.018; Hastie T., 2009, UNSUPERVISED LEARNIN; Hennes EM, 2008, HEPATOLOGY, V48, P169, DOI 10.1002/hep.22322; Hilario M, 2008, BRIEF BIOINFORM, V9, P102, DOI 10.1093/bib/bbn005; Horiguchi K, 2013, CELL TISSUE RES, V351, P207, DOI 10.1007/s00441-012-1513-6; Hu CJ, 2012, MOL CELL PROTEOMICS, V11, P669, DOI 10.1074/mcp.M111.015529; Hu CJ, 2010, WORLD J GASTROENTERO, V16, P3616, DOI 10.3748/wjg.v16.i29.3616; Hyung SW, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011023; Inza I, 2010, METHODS MOL BIOL, V593, P25, DOI 10.1007/978-1-60327-194-3_2; Iozzo RV, 2010, FEBS J, V277, P3864, DOI 10.1111/j.1742-4658.2010.07797.x; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Jeong JS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016253; Joliffe I. T., 2002, PRINCIPAL COMPONENT, V2nd; MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037; Makol Ashima, 2011, Hepat Res Treat, V2011, P390916, DOI 10.1155/2011/390916; Mazzra S., 2011, J PROTEOM BIOINFORM, V4, P16; Moreth K, 2012, CELL CYCLE, V11, P2084, DOI 10.4161/cc.20316; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Muratori P, 2009, AM J GASTROENTEROL, V104, P1420, DOI 10.1038/ajg.2009.126; Nguyen DV, 2002, BIOINFORMATICS, V18, P1216, DOI 10.1093/bioinformatics/18.9.1216; Nguyen DV, 2002, BIOINFORMATICS, V18, P39, DOI 10.1093/bioinformatics/18.1.39; Pacchiarotta T, 2012, J PROTEOMICS, V75, P1067, DOI 10.1016/j.jprot.2011.10.021; Perez-Enciso M, 2003, HUM GENET, V112, P581, DOI 10.1007/s00439-003-0921-9; Poynard T, 2007, CLIN CHEM, V53, P1615, DOI 10.1373/clinchem.2007.085795; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rosenberg LH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-468; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Shi YF, 2006, BBA-GEN SUBJECTS, V1760, P1587, DOI 10.1016/j.bbagen.2006.09.012; Song QF, 2010, J PROTEOME RES, V9, P30, DOI 10.1021/pr900131e; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; TENENHAUS M., 1998, REGRESSION PLS THEOR; Vergani D, 2004, J HEPATOL, V41, P677, DOI 10.1016/j.jhep.2004.08.002; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Wu Lin, 2012, Methods Mol Biol, V909, P227, DOI 10.1007/978-1-61779-959-4_15; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Zachou Kalliopi, 2004, J Autoimmune Dis, V1, P2, DOI 10.1186/1740-2557-1-2; Zhang XG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-197; Zhang Z, 2007, BURNS, V33, P634, DOI 10.1016/j.burns.2006.08.018; Zheng P, 2013, MOL CELL PROTEOMICS, V12, P207, DOI 10.1074/mcp.M112.021816; Zingaretti C, 2012, MOL CELL PROTEOMICS, V11, P1885, DOI 10.1074/mcp.M112.018713	52	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137927	10.1371/journal.pone.0137927	http://dx.doi.org/10.1371/journal.pone.0137927			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375394	gold, Green Published, Green Submitted			2022-12-27	WOS:000361610200062
J	Mei, L; Tang, YC; Li, M; Yang, PC; Liu, ZQ; Yuan, JL; Zheng, PY				Mei, Lu; Tang, Youcai; Li, Ming; Yang, Pingchang; Liu, Zhiqiang; Yuan, Jieli; Zheng, Pengyuan			Co-Administration of Cholesterol-Lowering Probiotics and Anthraquinone from Cassia obtusifolia L. Ameliorate Non-Alcoholic Fatty Liver	PLOS ONE			English	Article							INSULIN-RESISTANCE; METABOLIC SYNDROME; SERUM-CHOLESTEROL; GENE-EXPRESSION; DISEASE; RECEPTOR; OBESITY; DIET; 7-ALPHA-HYDROXYLASE; STEATOHEPATITIS	Non-alcoholic fatty liver disease (NAFLD) has become a common liver disease in recent decades. No effective treatment is currently available. Probiotics and natural functional food may be promising therapeutic approaches to this disease. The present study aims to investigate the efficiency of the anthraquinone from Cassia obtusifolia L. (AC) together with cholesterol- lowering probiotics (P) to improve high-fat diet (HFD)-induced NAFLD in rat models and elucidate the underlying mechanism. Cholesterol-lowering probiotics were screened out by MRS-cholesterol broth with ammonium ferric sulfate method. Male Sprague-Dawley rats were fed with HFD and subsequently administered with AC and/or P. Lipid metabolism parameters and fat synthesis related genes in rat liver, as well as the diversity of gut microbiota were evaluated. The results demonstrated that, compared with the NAFLD rat, the serumlipid levels of treated rats were reduced effectively. Besides, cholesterol 7 alpha-hydroxylase (CYP7A1), low density lipoprotein receptor (LDL-R) and farnesoid X receptor (FXR) were up-regulated while the expression of 3-hydroxy-3-methyl glutaryl coenzyme A reductase (HMGCR) was reduced. The expression of peroxisome proliferator activated receptor (PPAR)-alpha protein was significantly increased while the expression of PPAR-gamma and sterol regulatory element binding protein- 1c (SREBP-1c) was down-regulated. In addition, compared with HFD group, in AC, P and AC+P group, the expression of intestinal tight-junction protein occludin and zonula occluden-1 (ZO-1) were up-regulated. Furthermore, altered gut microbiota diversity after the treatment of probiotics and AC were analysed. The combination of cholesterol-lowering probiotics and AC possesses a therapeutic effect on NAFLD in rats by up-regulating CYP7A1, LDL-R, FXR mRNA and PPAR-a protein produced in the process of fat metabolism while down-regulating the expression of HMGCR, PPAR-gamma and SREBP-1c, and through normalizing the intestinal dysbiosis and improving the intestinal mucosal barrier function.	[Mei, Lu; Tang, Youcai; Zheng, Pengyuan] Zhengzhou Univ, Affiliated Hosp 2, Dept Gastroenterol, Zhengzhou 450052, Peoples R China; [Mei, Lu; Li, Ming; Yuan, Jieli] Dalian Med Univ, Sch Basic Med Sci, Dept Microecol, Dalian, Peoples R China; [Zheng, Pengyuan] Zhengzhou Univ, Med Microecol & Clin Nutr Res Inst, Zhengzhou 450052, Peoples R China; [Liu, Zhiqiang] ENT Hosp, Shenzhen ENT Inst, Longgang Cent Hosp, Shenzhen, Peoples R China; [Yang, Pingchang] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	Zhengzhou University; Dalian Medical University; Zhengzhou University; McMaster University	Yuan, JL (corresponding author), Dalian Med Univ, Sch Basic Med Sci, Dept Microecol, Dalian, Peoples R China.	zgwst@126.com; medp7123@126.com	Yang, Ping-Chang/K-4669-2019; zheng, pengyuan/ABE-9595-2020	zheng, pengyuan/0000-0003-1647-0253; Tang, Youcai/0000-0003-2087-6029	National Science & Technology Pillar Program [2012BAI35B02, 2012BAI35B03]; 973 Program of China [2011CB512006]; National Natural Science Foundation of China [81370494, 31070799]; Science and Technology Department key research projects of Henan province [102102310400]; Science and technology innovation and outstanding talents funds of Henan province [134200510022]; National High Technology Research and Development Program of China 863 Program [2014AA022200]; Research Fund for the Doctoral Program of Higher Education, China (RFDP) [20132105120012]	National Science & Technology Pillar Program; 973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department key research projects of Henan province; Science and technology innovation and outstanding talents funds of Henan province; National High Technology Research and Development Program of China 863 Program(National High Technology Research and Development Program of China); Research Fund for the Doctoral Program of Higher Education, China (RFDP)(Research Fund for the Doctoral Program of Higher Education of China (RFDP))	This study was supported by grants from National Science & Technology Pillar Program during the Twelve Five-year Plan Period (2012BAI35B02, 2012BAI35B03), 973 Program (2011CB512006) of China, the National Natural Science Foundation of China (No. 81370494, 31070799), Science and Technology Department key research projects of Henan province (102102310400), Science and technology innovation and outstanding talents funds of Henan province (134200510022), the National High Technology Research and Development Program of China 863 Program (2014AA022200), and the Research Fund for the Doctoral Program of Higher Education, China (RFDP, 20132105120012).	ABBOTT RD, 1988, ARTERIOSCLEROSIS, V8, P207, DOI 10.1161/01.ATV.8.3.207; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Astrup A, 2014, AM J CLIN NUTR, V99, p1235S, DOI 10.3945/ajcn.113.073015; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Cordero A, 2008, AM J CARDIOL, V102, P424, DOI 10.1016/j.amjcard.2008.03.079; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dhanasekaran M, 2009, PHYTOMEDICINE, V16, P891, DOI 10.1016/j.phymed.2009.02.006; Eckard C, 2013, THER ADV GASTROENTER, V6, P249, DOI 10.1177/1756283X13484078; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; El Khoury D, 2013, CRITICAL RE IN PRESS; FENG HW, 1973, CLIN CHEM, V19, P121; Finelli C, 2012, WORLD J GASTROENTERO, V18, P6790, DOI 10.3748/wjg.v18.i46.6790; Fouts DE, 2012, J HEPATOL, V56, P1283, DOI 10.1016/j.jhep.2012.01.019; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gurnell M, 2005, BEST PRACT RES CL EN, V19, P501, DOI 10.1016/j.beem.2005.10.001; Han KH, 2005, BRIT J NUTR, V94, P902, DOI 10.1079/BJN20051598; Hashimoto E, 2011, J GASTROENTEROL, V46, P63, DOI 10.1007/s00535-010-0311-8; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Jang DS, 2007, BIOL PHARM BULL, V30, P2207, DOI 10.1248/bpb.30.2207; Ju MS, 2010, FOOD CHEM TOXICOL, V48, P2037, DOI 10.1016/j.fct.2010.05.002; Kim I, 2007, J LIPID RES, V48, P2664, DOI 10.1194/jlr.M700330-JLR200; Le Roy T, 2013, GUT, V62, P1787, DOI 10.1136/gutjnl-2012-303816; Lesmana CRA, 2009, J DIGEST DIS, V10, P201, DOI 10.1111/j.1751-2980.2009.00386.x; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105577; Li TG, 2010, HEPATOLOGY, V52, P678, DOI 10.1002/hep.23721; Liong MT, 2007, NUTR REV, V65, P316, DOI 10.1111/j.1753-4887.2007.tb00309.x; Luo Xianqin, 2011, Zhongguo Zhong Yao Za Zhi, V36, P1654; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Moore JB, 2010, P NUTR SOC, V69, P211, DOI 10.1017/S0029665110000030; Patil UK, 2004, J ETHNOPHARMACOL, V90, P249, DOI 10.1016/j.jep.2003.10.007; Andrade MER, 2015, CLIN NUTR, V34, P1080, DOI 10.1016/j.clnu.2015.01.012; Ritze Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0101702, 10.1371/journal.pone.0080169]; SHANMUGASUNDARAM KR, 1986, AM J CLIN NUTR, V44, P805, DOI 10.1093/ajcn/44.6.805; Song KH, 2009, HEPATOLOGY, V49, P297, DOI 10.1002/hep.22627; Stoeckman AK, 2002, J BIOL CHEM, V277, P27029, DOI 10.1074/jbc.M202638200; Tarantino G, 2009, EUR J GASTROEN HEPAT, V21, P504, DOI 10.1097/MEG.0b013e3283229b40; Tilg H, 2000, NEW ENGL J MED, V343, P1467, DOI 10.1056/NEJM200011163432007; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Tzeng TF, 2013, FOOD CHEM TOXICOL, V51, P194, DOI 10.1016/j.fct.2012.09.024; Wagnerberger S, 2013, J NUTR BIOCHEM, V24, P531, DOI 10.1016/j.jnutbio.2012.01.014; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Xu ZJ, 2010, DIGEST DIS SCI, V55, P931, DOI 10.1007/s10620-009-0815-3	48	44	63	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138078	10.1371/journal.pone.0138078	http://dx.doi.org/10.1371/journal.pone.0138078			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375281	Green Published, gold, Green Submitted			2022-12-27	WOS:000361610200074
J	Rosier, E; Loix, S; Develter, W; Van de Voorde, W; Tytgat, J; Cuypers, E				Rosier, E.; Loix, S.; Develter, W.; Van de Voorde, W.; Tytgat, J.; Cuypers, E.			The Search for a Volatile Human Specific Marker in the Decomposition Process	PLOS ONE			English	Article							2-DIMENSIONAL GAS-CHROMATOGRAPHY; FLIGHT MASS-SPECTROMETRY; ORGANIC-COMPOUNDS PRESENT; HUMAN REMAINS; ODOR ANALYSIS; TIME; HEADSPACE; PRODUCTS; SOIL	In this study, a validated method using a thermal desorber combined with a gas chromatograph coupled to mass spectrometry was used to identify the volatile organic compounds released during decomposition of 6 human and 26 animal remains in a laboratory environment during a period of 6 months. 452 compounds were identified. Among them a human specific marker was sought using principle component analysis. We found a combination of 8 compounds (ethyl propionate, propyl propionate, propyl butyrate, ethyl pentanoate, pyridine, diethyl disulfide, methyl(methylthio) ethyl disulfide and 3-methylthio-1-propanol) that led to the distinction of human and pig remains from other animal remains. Furthermore, it was possible to separate the pig remains from human remains based on 5 esters (3-methylbutyl pentanoate, 3-methylbutyl 3-methylbutyrate, 3-methylbutyl 2-methylbutyrate, butyl pentanoate and propyl hexanoate). Further research in the field with full bodies has to corroborate these results and search for one or more human specific markers. These markers would allow a more efficiently training of cadaver dogs or portable detection devices could be developed.	[Rosier, E.; Loix, S.; Tytgat, J.; Cuypers, E.] Univ Leuven KU Leuven, Dept Pharmaceut & Pharmacol Sci Toxicol & Pharmac, Leuven, Belgium; [Develter, W.; Van de Voorde, W.] Univ Leuven KU Leuven, Div Forens Biomed Sci, Imaging & Pathol Dept, Leuven, Belgium	KU Leuven; KU Leuven	Cuypers, E (corresponding author), Univ Leuven KU Leuven, Dept Pharmaceut & Pharmacol Sci Toxicol & Pharmac, Leuven, Belgium.	eva.cuypers@pharm.kuleuven.be	Cuypers, Eva/AAK-9134-2021	Tytgat, Jan/0000-0003-1778-6022; Cuypers, Eva/0000-0002-6411-2461				Brasseur C, 2012, J CHROMATOGR A, V1255, P163, DOI 10.1016/j.chroma.2012.03.048; Cablk ME, 2012, FORENSIC SCI INT, V220, P118, DOI 10.1016/j.forsciint.2012.02.007; DeGreeff LE, 2011, ANAL BIOANAL CHEM, V401, P1295, DOI 10.1007/s00216-011-5167-0; Dekeirsschieter J, 2009, FORENSIC SCI INT, V189, P46, DOI 10.1016/j.forsciint.2009.03.034; Dekeirsschieter J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039005; Dent BB, 2004, ENVIRON GEOL, V45, P576, DOI 10.1007/s00254-003-0913-z; Etschmann MMW, 2008, APPL MICROBIOL BIOT, V80, P579, DOI 10.1007/s00253-008-1573-4; Forbes SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113681; Forbes SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095107; Hoffman EM, 2009, FORENSIC SCI INT, V186, P6, DOI 10.1016/j.forsciint.2008.12.022; Hudson DT, 2009, J FORENSIC SCI, V54, P1270, DOI 10.1111/j.1556-4029.2009.01153.x; Kasper J, 2012, FORENSIC SCI INT, V223, P64, DOI 10.1016/j.forsciint.2012.08.001; Moreira N, 2002, ANAL CHIM ACTA, V458, P157, DOI 10.1016/S0003-2670(01)01618-X; Paczkowski S, 2011, APPL MICROBIOL BIOT, V91, P917, DOI 10.1007/s00253-011-3417-x; Perrault KA, 2015, ANAL METHODS-UK, V7, P690, DOI 10.1039/c4ay02321h; Perrault KA, 2015, J SEP SCI, V38, P73, DOI 10.1002/jssc.201400935; Rosier E, 2014, ANAL BIOANAL CHEM, V406, P3611, DOI 10.1007/s00216-014-7741-8; Stadler S, 2013, ANAL CHEM, V85, P998, DOI 10.1021/ac302614y; Stadler S, 2012, J CHROMATOGR A, V1255, P202, DOI 10.1016/j.chroma.2012.04.001; Statheropoulos M, 2007, SCI TOTAL ENVIRON, V385, P221, DOI 10.1016/j.scitotenv.2007.07.003; Statheropoulos M, 2005, FORENSIC SCI INT, V153, P147, DOI 10.1016/j.forsciint.2004.08.015; Statheropoulos M, 2011, FORENSIC SCI INT, V210, P154, DOI 10.1016/j.forsciint.2011.02.023; Swann LM, 2010, ANAL CHIM ACTA, V682, P9, DOI 10.1016/j.aca.2010.09.052; Vass AA, 2004, J FORENSIC SCI, V49, P760; Vass AA, 2008, J FORENSIC SCI, V53, P384, DOI 10.1111/j.1556-4029.2008.00680.x; Vass AA, 2012, FORENSIC SCI INT, V222, P234, DOI 10.1016/j.forsciint.2012.06.006	26	27	27	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137341	10.1371/journal.pone.0137341	http://dx.doi.org/10.1371/journal.pone.0137341			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375029	gold, Green Published, Green Submitted			2022-12-27	WOS:000361610200034
J	Sylwester, K; Purver, M				Sylwester, Karolina; Purver, Matthew			Twitter Language Use Reflects Psychological Differences between Democrats and Republicans	PLOS ONE			English	Article							SOCIAL-DOMINANCE ORIENTATION; POLITICAL CONSERVATISM; LIBERALS; PERSONALITY; AUTHORITARIANISM; IDEOLOGY; CREATIVITY; HAPPIER; VALUES; WORDS	Previous research has shown that political leanings correlate with various psychological factors. While surveys and experiments provide a rich source of information for political psychology, data from social networks can offer more naturalistic and robust material for analysis. This research investigates psychological differences between individuals of different political orientations on a social networking platform, Twitter. Based on previous findings, we hypothesized that the language used by liberals emphasizes their perception of uniqueness, contains more swear words, more anxiety-related words and more feeling-related words than conservatives' language. Conversely, we predicted that the language of conservatives emphasizes group membership and contains more references to achievement and religion than liberals' language. We analysed Twitter timelines of 5,373 followers of three Twitter accounts of the American Democratic and 5,386 followers of three accounts of the Republican parties' Congressional Organizations. The results support most of the predictions and previous findings, confirming that Twitter behaviour offers valid insights to offline behaviour.	[Sylwester, Karolina; Purver, Matthew] Queen Mary Univ London, Sch Elect Engn & Comp Sci, Cognit Sci Res Grp, London, England	University of London; Queen Mary University London	Sylwester, K (corresponding author), Queen Mary Univ London, Sch Elect Engn & Comp Sci, Cognit Sci Res Grp, Mile End Rd, London, England.	karolina.sylwester@gmail.com		Purver, Matthew/0000-0003-2297-1273	ConCreTe project; Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission, under FET [611733]; Engineering and Physical Sciences Research Council [EP/J010383/1] Funding Source: researchfish; EPSRC [EP/J010383/1] Funding Source: UKRI	ConCreTe project; Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission, under FET; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors received no specific funding for this work. This work was part of KS MSc degree. During the conduct of this study, Purver was partly supported by the ConCreTe project; the project ConCreTe acknowledges the financial support of the Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission, under FET grant number 611733.	Altemeyer R., 1981, RIGHT WING AUTHORITA; Aubin ED, 1996, J PERS SOC PSYCHOL, V71, P152; Broniatowski DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083672; Carney DR, 2008, POLIT PSYCHOL, V29, P807, DOI 10.1111/j.1467-9221.2008.00668.x; Conover M. D., 2011, 5 INT AAAI C WEBLOGS; Dimock M., 2014, POLITICAL POLARIZATI; Dollinger SJ, 2007, PERS INDIV DIFFER, V43, P1025, DOI 10.1016/j.paid.2007.02.023; Duggan M, 2014, SOCIAL MEDIA UPDATE; FURNHAM A, 1986, PERS INDIV DIFFER, V7, P385, DOI 10.1016/0191-8869(86)90014-0; Garcia-Gavilanes R, 2006, CULTURAL DIMENSIONS; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Gonzales AL, 2010, COMMUN RES, V37, P3, DOI 10.1177/0093650209351468; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Haidt J., 2013, VINTAGE; Heaven PCL, 2001, EUR J PERSONALITY, V15, P49, DOI 10.1002/per.389; Helmbrecht J., 2002, GRAMMAR FUNCTION WE; Hibbing JR, 2014, BEHAV BRAIN SCI, V37, P297, DOI 10.1017/S0140525X13001192; Hirsh JB, 2013, SOC PSYCHOL PERS SCI, V4, P14, DOI 10.1177/1948550612444138; Hirsh JB, 2010, PERS SOC PSYCHOL B, V36, P655, DOI 10.1177/0146167210366854; Inbar Y, 2012, SOC PSYCHOL PERS SCI, V3, P537, DOI 10.1177/1948550611429024; Iyer R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042366; Jost JT, 2007, PERS SOC PSYCHOL B, V33, P989, DOI 10.1177/0146167207301028; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Kahan D. M., 2007, J EMPIR LEGAL STUD, V4, P465, DOI DOI 10.1111/J.1740-1461.2007.00097.X; Kugler M, 2014, SOC JUSTICE RES, V27, P413, DOI 10.1007/s11211-014-0223-5; LECESSIE S, 1991, BIOMETRICS, V47, P1267, DOI 10.2307/2532385; Leone L, 2008, J RES PERS, V42, P755, DOI 10.1016/j.jrp.2007.08.001; McCann SJH, 2011, CREATIVITY RES J, V23, P339, DOI 10.1080/10400419.2011.621831; MCCRAE RR, 1992, J PERS, V60, P175, DOI 10.1111/j.1467-6494.1992.tb00970.x; Mitchell G, 2012, PERSPECT PSYCHOL SCI, V7, P109, DOI 10.1177/1745691611432343; Na J, 2009, PERS SOC PSYCHOL B, V35, P1492, DOI 10.1177/0146167209343810; Napier JL, 2008, PSYCHOL SCI, V19, P565, DOI 10.1111/j.1467-9280.2008.02124.x; Pennebaker J. W., 2007, DEV PSYCHOMETRIC PRO; Pennebaker JW, 2003, ANNU REV PSYCHOL, V54, P547, DOI 10.1146/annurev.psych.54.101601.145041; PORTER MF, 1980, PROGRAM-AUTOM LIBR, V14, P130, DOI 10.1108/eb046814; PRATTO F, 1994, J PERS SOC PSYCHOL, V67, P741, DOI 10.1037/0022-3514.67.4.741; Qiu L, 2012, J RES PERS, V46, P710, DOI 10.1016/j.jrp.2012.08.008; Quercia D., 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P180, DOI 10.1109/PASSAT/SocialCom.2011.26; Ritter RS, 2014, SOC PSYCHOL PERS SCI, V5, P243, DOI 10.1177/1948550613492345; Rule NO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008733; Schlenker BR, 2012, J RES PERS, V46, P127, DOI 10.1016/j.jrp.2011.12.009; Schutze H., 2008, INTRO INFORM RETRIEV, V39; SCHWARTZ SH, 1992, ADV EXP SOC PSYCHOL, V25, P1, DOI 10.1016/s0065-2601(08)60281-6; Schwartz SH, 2010, POLIT PSYCHOL, V31, P421, DOI 10.1111/j.1467-9221.2010.00764.x; Stern C, 2014, PERS SOC PSYCHOL B, V40, P1162, DOI 10.1177/0146167214537834; Stern C, 2014, PSYCHOL SCI, V25, P137, DOI 10.1177/0956797613500796; Tausczik YR, 2010, J LANG SOC PSYCHOL, V29, P24, DOI 10.1177/0261927X09351676; Uz I, 2014, J CROSS CULT PSYCHOL, V45, P1671, DOI 10.1177/0022022114550481; Van Hiel A, 2006, PERS INDIV DIFFER, V40, P919, DOI 10.1016/j.paid.2005.09.014; Van Lange PAM, 2012, EUR J PERSONALITY, V26, P461, DOI 10.1002/per.845; Verhulst B, 2012, AM J POLIT SCI, V56, P34, DOI 10.1111/j.1540-5907.2011.00568.x; Wojcik SP, 2015, SCIENCE, V347, P1243, DOI 10.1126/science.1260817	52	73	73	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137422	10.1371/journal.pone.0137422	http://dx.doi.org/10.1371/journal.pone.0137422			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8NH	26375581	gold, Green Published, Green Submitted			2022-12-27	WOS:000361610200038
J	Bertrand, S; Aldea, D; Oulion, S; Subirana, L; de Lera, AR; Somorjai, I; Escriva, H				Bertrand, Stephanie; Aldea, Daniel; Oulion, Silvan; Subirana, Lucie; de Lera, Angel R.; Somorjai, Ildiko; Escriva, Hector			Evolution of the Role of RA and FGF Signals in the Control of Somitogenesis in Chordates	PLOS ONE			English	Article							RETINOIC ACID CONTROLS; LEFT-RIGHT ASYMMETRY; BRANCHIOSTOMA-LANCEOLATUM; DEVELOPMENTAL EXPRESSION; CIONA-INTESTINALIS; POSTERIOR AXIS; AMPHIOXUS; GENE; SEGMENTATION; CLOCK	During vertebrate development, the paraxial mesoderm becomes segmented, forming somites that will give rise to dermis, axial skeleton and skeletal muscles. Although recently challenged, the "clock and wavefront" model for somitogenesis explains how interactions between several cell-cell communication pathways, including the FGF, RA, Wnt and Notch signals, control the formation of these bilateral symmetric blocks. In the cephalochordate amphioxus, which belongs to the chordate phylum together with tunicates and vertebrates, the dorsal paraxial mesendoderm also periodically forms somites, although this process is asymmetric and extends along the whole body. It has been previously shown that the formation of the most anterior somites in amphioxus is dependent upon FGF signalling. However, the signals controlling somitogenesis during posterior elongation in amphioxus are still unknown. Here we show that, contrary to vertebrates, RA and FGF signals act independently during posterior elongation and that they are not mandatory for posterior somites to form. Moreover, we show that RA is not able to buffer the left/right asymmetry machinery that is controlled through the asymmetric expression of Nodal pathway actors. Our results give new insights into the evolution of the somitogenesis process in chordates. They suggest that RA and FGF pathways have acquired specific functions in the control of somitogenesis in vertebrates. We propose that the "clock and wavefront" system was selected specifically in vertebrates in parallel to the development of more complex somite-derived structures but that it was not required for somitogenesis in the ancestor of chordates.	[Bertrand, Stephanie; Aldea, Daniel; Oulion, Silvan; Subirana, Lucie; Somorjai, Ildiko; Escriva, Hector] Univ Paris 06, BIOM, Observ Oceanol Banyuls Mer, UMR 7232, F-66650 Banyuls Sur Mer, France; [de Lera, Angel R.] Univ Vigo, CINBIO, Fac Quim, Dept Quim Organ, Vigo 36310, Spain; [de Lera, Angel R.] Invest Biomed Vigo IBIV, Vigo 36310, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Universidade de Vigo; CINBIO	Bertrand, S (corresponding author), Univ Paris 06, BIOM, Observ Oceanol Banyuls Mer, UMR 7232, F-66650 Banyuls Sur Mer, France.	stephanie.bertrand@obs-banyuls.fr; hector.escriva@obs-banyuls.fr	Escriva, Hector/K-8325-2013; Aldea, Daniel/L-4040-2015; Bertrand, Stephanie/D-8482-2014	Escriva, Hector/0000-0001-7577-5028; Aldea, Daniel/0000-0001-5101-0194; Bertrand, Stephanie/0000-0002-0689-0126; Somorjai, Ildiko/0000-0001-5243-6664; Subirana, Lucie/0000-0002-9942-1125	ANR [BLAN 1716 01]; MASTS (Marine Alliance for Science and Technology Scotland)	ANR(French National Research Agency (ANR)); MASTS (Marine Alliance for Science and Technology Scotland)	The laboratory of HE is supported by the ANR BLAN 1716 01. IMLS's laboratory is currently supported by MASTS (Marine Alliance for Science and Technology Scotland).	Aulehla A, 2004, GENE DEV, V18, P2060, DOI 10.1101/gad.1217404; Beaster-Jones L, 2008, DEV GENES EVOL, V218, P599, DOI 10.1007/s00427-008-0257-5; Bertrand S, 2011, P NATL ACAD SCI USA, V108, P9160, DOI 10.1073/pnas.1014235108; Boorman CJ, 2002, EVOL DEV, V4, P354, DOI 10.1046/j.1525-142X.2002.02021.x; Canestro C, 2007, DEV BIOL, V305, P522, DOI 10.1016/j.ydbio.2007.02.032; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; Davidson B, 2006, GENE DEV, V20, P2728, DOI 10.1101/gad.1467706; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Dias AS, 2014, SCIENCE, V343, P791, DOI 10.1126/science.1247575; Diez del Corral R, 2003, NEURON, V40, P65; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Escriva H, 2002, DEVELOPMENT, V129, P2905; Fuentes M, 2004, J EXP ZOOL PART B, V302B, P384, DOI 10.1002/jez.b.20025; Fuentes M, 2007, J EXP ZOOL PART B, V308B, P484, DOI 10.1002/jez.b.21179; Hirakow R, 1994, Kaibogaku Zasshi, V69, P1; HIRAKOW R, 1991, J MORPHOL, V207, P37, DOI 10.1002/jmor.1052070106; Holland LZ, 2000, DEV GENES EVOL, V210, P522, DOI 10.1007/s004270000089; Holland LZ, 1996, MOL ZOOLOGY ADV STRA; HOLLAND PWH, 1992, DEVELOPMENT, V116, P653; Hubaud A, 2014, NAT REV MOL CELL BIO, V15, P709, DOI 10.1038/nrm3891; Imai KS, 2006, SCIENCE, V312, P1183, DOI 10.1126/science.1123404; Kawakami Y, 2005, NATURE, V435, P165, DOI 10.1038/nature03512; Keyte AL, 2014, SEMIN CELL DEV BIOL, V34, P99, DOI 10.1016/j.semcdb.2014.06.015; Kumar S, 2014, DEVELOPMENT, V141, P2972, DOI 10.1242/dev.112367; Le Petillon Y, 2013, GENE EXPR PATTERNS, V13, P377, DOI 10.1016/j.gep.2013.07.005; Levin M, 2002, CELL, V111, P77, DOI 10.1016/S0092-8674(02)00939-X; Lin HC, 2006, DEV DYNAM, V235, P3396, DOI 10.1002/dvdy.20971; Maden M, 2000, INT J DEV BIOL, V44, P151; Martin BL, 2010, GENE DEV, V24, P2778, DOI 10.1101/gad.1962910; Martinez-Morales PL, 2011, J CELL BIOL, V194, P489, DOI 10.1083/jcb.201011077; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Moreno TA, 2004, DEV CELL, V6, P205, DOI 10.1016/S1534-5807(04)00026-7; MORII M, 1993, J BIOL CHEM, V268, P21553; Morris SC, 2012, BIOL REV, V87, P480, DOI 10.1111/j.1469-185X.2012.00220.x; Nagatomo K, 2003, GENE EXPR PATTERNS, V3, P273, DOI 10.1016/S1567-133X(03)00051-6; Nagatomo K, 2003, MECH DEVELOP, V120, P363, DOI 10.1016/S0925-4773(02)00441-0; Namigai EKO, 2014, GENESIS, V52, P458, DOI 10.1002/dvg.22748; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Onai T, 2010, DEV BIOL, V344, P377, DOI 10.1016/j.ydbio.2010.05.016; Osborne PW, 2009, DEV BIOL, V327, P252, DOI 10.1016/j.ydbio.2008.11.027; Oulion Silvan, 2012, International Journal of Evolutionary Biology, P1, DOI 10.1155/2012/298147; Pascual-Anaya J, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-28; Pasini A, 2013, PLOS ONE, V7; Passamaneck YJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000714; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Pourquie O, 2011, CELL, V145, P650, DOI 10.1016/j.cell.2011.05.011; Qian GH, 2013, GENE EXPR PATTERNS, V13, P445, DOI 10.1016/j.gep.2013.08.003; Sakai Y, 2001, GENE DEV, V15, P213, DOI 10.1101/gad.851501; Satoh N, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1729; Schubert M, 2000, GENESIS, V27, P1; Schubert M, 2005, DEVELOPMENT, V132, P61, DOI 10.1242/dev.01554; Schubert M, 2001, DEV BIOL, V240, P262, DOI 10.1006/dbio.2001.0460; Schubert M, 2006, DEV BIOL, V296, P190, DOI 10.1016/j.ydbio.2006.04.457; Shimeld SM, 2006, DEV DYNAM, V235, P1543, DOI 10.1002/dvdy.20792; Sirbu IO, 2008, DEV DYNAM, V237, P1627, DOI 10.1002/dvdy.21570; Somorjai I, 2008, DEV GENES EVOL, V218, P703, DOI 10.1007/s00427-008-0256-6; Soukup V, 2015, EVODEVO, V6, DOI 10.1186/2041-9139-6-5; Vermot J, 2005, SCIENCE, V308, P563, DOI 10.1126/science.1108363; Vermot J, 2005, NATURE, V435, P215, DOI 10.1038/nature03488; Watanabe H, 2014, NATURE, V515, P112, DOI 10.1038/nature13666; Wilson V, 2009, DEVELOPMENT, V136, P1591, DOI 10.1242/dev.021246; Wu HR, 2011, DEV BIOL, V353, P147, DOI 10.1016/j.ydbio.2011.02.014; Yu JK, 2002, EVOL DEV, V4, P418, DOI 10.1046/j.1525-142X.2002.02030.x; Zhao XL, 2009, CURR BIOL, V19, P1050, DOI 10.1016/j.cub.2009.04.059	65	28	28	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0136587	10.1371/journal.pone.0136587	http://dx.doi.org/10.1371/journal.pone.0136587			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371756	Green Published, Green Submitted, gold			2022-12-27	WOS:000361604400006
J	Rosenbaum, JT; Choi, D; Wong, A; Wilson, DJ; Grossniklaus, HE; Harrington, CA; Dailey, RA; Ng, JD; Steele, EA; Czyz, CN; Foster, JA; Tse, D; Alabiad, C; Dubovy, S; Parekh, PK; Harris, GJ; Kazim, M; Patel, PJ; White, VA; Dolman, PJ; Edward, DP; Alkatan, HM; al Hussain, H; Selva, D; Yeatts, RP; Korn, BS; Kikkawa, DO; Stauffer, P; Planck, SR				Rosenbaum, James T.; Choi, Dongseok; Wong, Amanda; Wilson, David J.; Grossniklaus, Hans E.; Harrington, Christina A.; Dailey, Roger A.; Ng, John D.; Steele, Eric A.; Czyz, Craig N.; Foster, Jill A.; Tse, David; Alabiad, Chris; Dubovy, Sander; Parekh, Prashant K.; Harris, Gerald J.; Kazim, Michael; Patel, Payal J.; White, Valerie A.; Dolman, Peter J.; Edward, Deepak P.; Alkatan, Hind M.; al Hussain, Hailah; Selva, Dinesh; Yeatts, R. Patrick; Korn, Bobby S.; Kikkawa, Don O.; Stauffer, Patrick; Planck, Stephen R.			The Role of the Immune Response in the Pathogenesis of Thyroid Eye Disease: A Reassessment	PLOS ONE			English	Article							ORBITAL ADIPOSE-TISSUE; GRAVES OPHTHALMOPATHY; GENE-EXPRESSION; ORBITOPATHY; OVEREXPRESSION; CYTOKINES; PROFILES; ALPHA; FAT	Background Although thyroid eye disease is a common complication of Graves' disease, the pathogenesis of the orbital disease is poorly understood. Most authorities implicate the immune response as an important causal factor. We sought to clarify pathogenesis by using gene expression microarray. Methods An international consortium of ocular pathologists and orbital surgeons contributed formalin fixed orbital biopsies. RNA was extracted from orbital tissue from 20 healthy controls, 25 patients with thyroid eye disease (TED), 25 patients with nonspecific orbital inflammation (NSOI), 7 patients with sarcoidosis and 6 patients with granulomatosis with polyangiitis (GPA). Tissue was divided into a discovery set and a validation set. Gene expression was quantified using Affymetrix U133 Plus 2.0 microarrays which include 54,000 probe sets. Results Principal component analysis showed that gene expression from tissue from patients with TED more closely resembled gene expression from healthy control tissue in comparison to gene expression characteristic of sarcoidosis, NSOI, or granulomatosis with polyangiitis. Unsupervised cluster dendrograms further indicated the similarity between TED and healthy controls. Heat maps based on gene expression for cytokines, chemokines, or their receptors showed that these inflammatory markers were associated with NSOI, sarcoidosis, or GPA much more frequently than with TED. Conclusion This is the first study to compare gene expression in TED to gene expression associated with other causes of exophthalmos. The juxtaposition shows that inflammatory markers are far less characteristic of TED relative to other orbital inflammatory diseases.	[Rosenbaum, James T.; Choi, Dongseok; Wong, Amanda; Wilson, David J.; Dailey, Roger A.; Ng, John D.; Steele, Eric A.; Stauffer, Patrick; Planck, Stephen R.] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA; [Rosenbaum, James T.; Planck, Stephen R.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA; [Rosenbaum, James T.; Planck, Stephen R.] Legacy Hlth Syst, Devers Eye Inst, Portland, OR USA; [Choi, Dongseok] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA; [Grossniklaus, Hans E.] Emory Univ, Dept Ophthalmol, Atlanta, GA 30322 USA; [Harrington, Christina A.] Oregon Hlth & Sci Univ, Integrated Genom Lab, Portland, OR 97201 USA; [Czyz, Craig N.] Oregon Hlth & Sci Univ, Div Ophthalmol, Portland, OR 97201 USA; [Foster, Jill A.] Oregon Hlth & Sci Univ, Dept Ophthalmol, Portland, OR 97201 USA; [Tse, David; Alabiad, Chris; Dubovy, Sander; Parekh, Prashant K.] Univ Miami, Dept Ophthalmol, Miami, FL USA; [Harris, Gerald J.] Med Coll Wisconsin, Dept Ophthalmol, Milwaukee, WI 53226 USA; [Kazim, Michael; Patel, Payal J.] Columbia Univ, Dept Ophthalmol, New York, NY 10027 USA; [White, Valerie A.; Dolman, Peter J.] Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC V5Z 1M9, Canada; [Edward, Deepak P.; Alkatan, Hind M.; al Hussain, Hailah] King Khalid Eye Specialist Hosp, Res Dept, Riyadh, Saudi Arabia; [Selva, Dinesh] Royal Adelaide Hosp, Ophthalmol Network, Adelaide, SA 5000, Australia; [Yeatts, R. Patrick] Wake Forrest Univ, Dept Ophthalmol, Winston Salem, NC USA; [Korn, Bobby S.; Kikkawa, Don O.] Univ Calif San Diego, Dept Ophthalmol, San Diego, CA 92103 USA	Oregon Health & Science University; Oregon Health & Science University; Devers Eye Institute; Legacy Health; Oregon Health & Science University; Emory University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of Miami; Medical College of Wisconsin; Columbia University; University of British Columbia; King Khaled Eye Specialist Hospital; Royal Adelaide Hospital; University of California System; University of California San Diego	Rosenbaum, JT (corresponding author), Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA.	rosenbaj@ohsu.edu	ALKATAN, HIND M/AAU-3752-2021; Tse, David/GMW-9987-2022	ALKATAN, HIND M/0000-0002-9968-4099; Choi, Dongseok/0000-0002-1552-4072; Czyz, Craig/0000-0001-6357-8019	National Institutes of Health USA [EY020249, EY010572, RR024140]; Research to Prevent Blindness (Casey Eye Institute, OHSU); Stan and Madelle Rosenfeld Family Trust; William and Mary Bauman Foundation; MAS Family Foundation; NATIONAL EYE INSTITUTE [P30EY010572, R01EY020249] Funding Source: NIH RePORTER	National Institutes of Health USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness (Casey Eye Institute, OHSU); Stan and Madelle Rosenfeld Family Trust; William and Mary Bauman Foundation; MAS Family Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by funding from National Institutes of Health USA Grants (www.nih.gov), EY020249 (JTR), EY010572 (JTR) and RR024140 (E.S. Orwoll); and Research to Prevent Blindness (www.rpbusa.org) (Casey Eye Institute, OHSU), the Stan and Madelle Rosenfeld Family Trust (JTR), the William and Mary Bauman Foundation (JTR), the MAS Family Foundation (JTR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli A, 2014, AUTOIMMUN REV, V13, P1160, DOI 10.1016/j.autrev.2014.08.025; Beck IM, 2013, EUR J PHARMACOL, V715, P1, DOI 10.1016/j.ejphar.2013.06.032; Chen MH, 2008, INVEST OPHTH VIS SCI, V49, P4760, DOI 10.1167/iovs.08-2020; Du P, 2014, INT J GENOMICS, V2014, DOI [10.1155/2014/537969, DOI 10.1155/2014/537969]; Ezra DG, 2012, J CLIN PATHOL, V65, P608, DOI 10.1136/jclinpath-2012-200719; Hiromatsu Y, 2000, J CLIN ENDOCR METAB, V85, P1194, DOI 10.1210/jc.85.3.1194; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kumar S, 2005, J CLIN ENDOCR METAB, V90, P4730, DOI 10.1210/jc.2004-2239; Kumar S, 2003, J CLIN ENDOCR METAB, V88, P4246, DOI 10.1210/jc.2003-030380; Lantz M, 2005, J CLIN ENDOCR METAB, V90, P4784, DOI 10.1210/jc.2004-2275; Li B, 2014, J CLIN ENDOCR METAB, V99, P3363, DOI 10.1210/jc.2014-1257; Li R, 2014, GENE, V538, P150, DOI 10.1016/j.gene.2013.12.027; Linquist RA, 2014, ORBIT, V33, P363, DOI 10.3109/01676830.2014.937877; MARDIA KV, 1978, COMMUN STAT A-THEOR, V7, P1233, DOI 10.1080/03610927808827707; Minakaran N, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009226.pub2; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Niyazoglu M, 2014, GENE, V547, P226, DOI 10.1016/j.gene.2014.06.038; Planck T, 2011, THYROID, V21, P663, DOI 10.1089/thy.2010.0217; Ponto KA, 2014, CLIN EXP IMMUNOL, V178, P57, DOI 10.1111/cei.12395; Rosenbaum JT, 2015, EXP MOL PATHOL, V99, P271, DOI 10.1016/j.yexmp.2015.07.002; Rosenbaum JT, 2015, EXP MOL PATHOL, V98, P225, DOI 10.1016/j.yexmp.2015.01.009; Salvi M, 2014, CURR OPIN ENDOCRINOL, V21, P409, DOI 10.1097/MED.0000000000000097; Shan Shannon J C, 2014, J Neuroophthalmol, V34, P177, DOI 10.1097/WNO.0000000000000132; Stan MN, 2015, J CLIN ENDOCR METAB, V100, P432, DOI 10.1210/jc.2014-2572; Stone JH, 2012, SEMIN DIAGN PATHOL, V29, P177, DOI 10.1053/j.semdp.2012.08.002; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wei HF, 2014, ENDOCR J, V61, P1087, DOI 10.1507/endocrj.EJ14-0246; Wong AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109847; Zhang L, 2014, J CLIN ENDOCR METAB, V99, pE1183, DOI 10.1210/jc.2013-4182	29	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137654	10.1371/journal.pone.0137654	http://dx.doi.org/10.1371/journal.pone.0137654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371757	Green Submitted, Green Published, gold			2022-12-27	WOS:000361604400026
J	Scacchetti, PC; Utsunomia, R; Pansonato-Alves, JC; Silva, GJD; Vicari, MR; Artoni, RF; Oliveira, C; Foresti, F				Scacchetti, Priscilla Cardim; Utsunomia, Ricardo; Pansonato-Alves, Jose Carlos; da Costa Silva, Guilherme Jose; Vicari, Marcelo Ricardo; Artoni, Roberto Ferreira; Oliveira, Claudio; Foresti, Fausto			Repetitive DNA Sequences and Evolution of ZZ/ZW Sex Chromosomes in Characidium (Teleostei: Characiformes)	PLOS ONE			English	Article							DETERMINING MECHANISMS; COASTAL DRAINAGES; CRENUCHIDAE; SYSTEM; DIVERSIFICATION; DIFFERENTIATION; FISHES; LINKAGE; PISCES; BRAZIL	Characidium constitutes an interesting model for cytogenetic studies, since a large degree of karyotype variation has been detected in this group, like the presence/absence of sex and supernumerary chromosomes and variable distribution of repetitive sequences in different species/populations. In this study, we performed a comparative cytogenetic analysis in 13 Characidium species collected at different South American river basins in order to investigate the karyotype diversification in this group. Chromosome analyses involved the karyotype characterization, cytogenetic mapping of repetitive DNA sequences and cross-species chromosome painting using a W-specific probe obtained in a previous study from Characidium gomesi. Our results evidenced a conserved diploid chromosome number of 2n = 50, and almost all the species exhibited homeologous ZZ/ZW sex chromosomes in different stages of differentiation, except C. cf. zebra, C. tenue, C. xavante and C. stigmosum. Notably, some ZZ/ZW sex chromosomes showed 5S and/or 18S rDNA clusters, while no U2 snDNA sites could be detected in the sex chromosomes, being restricted to a single chromosome pair in almost all the analyzed species. In addition, the species Characidium sp. aff. C. vidali showed B chromosomes with an inter-individual variation of 1 to 4 supernumerary chromosomes per cell. Notably, these B chromosomes share sequences with theWspecific probe, providing insights about their origin. Results presented here further confirm the extensive karyotype diversity within Characidium in contrast with a conserved diploid chromosome number. Such chromosome differences seem to constitute a significant reproductive barrier, since several sympatric Characidium species had been described during the last few years and no interespecific hybrids were found.	[Scacchetti, Priscilla Cardim; Utsunomia, Ricardo; Pansonato-Alves, Jose Carlos; da Costa Silva, Guilherme Jose; Oliveira, Claudio; Foresti, Fausto] Univ Estadual Paulista UNESP, Inst Biociencias Botucatu IBB, Dept Morfol, Botucatu, SP, Brazil; [Vicari, Marcelo Ricardo; Artoni, Roberto Ferreira] Univ Estadual Ponta Grossa, Dept Biol Estrut Mol Genet, Ponta Grossa, PR, Brazil	Universidade Estadual Paulista; Universidade Estadual de Ponta Grossa	Scacchetti, PC (corresponding author), Univ Estadual Paulista UNESP, Inst Biociencias Botucatu IBB, Dept Morfol, Botucatu, SP, Brazil.	pcardim@ibb.unesp.br	Fapesp, Biota/F-8655-2017; Vicari, Marcelo Ricardo/I-2299-2015; Artoni, Roberto Ferreira/N-1693-2019; Oliveira, Claudio/D-7713-2012; Utsunomia, Ricardo/O-8955-2015	Fapesp, Biota/0000-0002-9887-8449; Vicari, Marcelo Ricardo/0000-0003-3913-9889; Artoni, Roberto Ferreira/0000-0002-2528-9846; Oliveira, Claudio/0000-0002-7010-8880; Utsunomia, Ricardo/0000-0003-4565-6065	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) from Brazil; Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) from Brazil; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) from Brazil	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) from Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) from Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) from Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) from Brazil.	Merlo MA, 2010, GENES GENET SYST, V85, P341, DOI 10.1266/ggs.85.341; BUCKUP PA, 1993, ZOOL J LINN SOC-LOND, V108, P225; Buckup PA., 2003, CHECK LIST FRESHWATE, P87; Bueno D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066532; Camacho JPM, 2000, PHILOS T R SOC B, V355, P163, DOI 10.1098/rstb.2000.0556; Centofante L, 2003, HEREDITAS, V138, P213, DOI 10.1034/j.1601-5223.2003.01714.x; Centofante L, 2001, CARYOLOGIA, V54, P253, DOI 10.1080/00087114.2001.10589233; FORESTI F, 1981, CYTOGENET CELL GENET, V31, P137, DOI 10.1159/000131639; Henning F, 2008, CYTOGENET GENOME RES, V121, P55, DOI 10.1159/000124382; Koubova M, 2014, CHROMOSOME RES, V22, P441, DOI 10.1007/s10577-014-9430-z; Leitao RP, 2014, COPEIA, P14, DOI 10.1643/CI-12-137; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Lopez-Flores I, 2012, GENOME DYNAM, V7, P1, DOI 10.1159/000337118; Machado TC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-65; Maistro Edson Luis, 2004, Cytologia (Tokyo), V69, P181, DOI 10.1508/cytologia.69.181; Maistro EL, 1998, GENETICA, V104, P1, DOI 10.1023/A:1003242020259; Manchado M, 2006, GENOME, V49, P79, DOI 10.1139/G05-068; Mank JE, 2006, BIOL J LINN SOC, V87, P83, DOI 10.1111/j.1095-8312.2006.00558.x; Miyazawa C. S., 1994, Cytologia (Tokyo), V59, P73; Netto-Ferreira AL, 2013, ZOOTAXA, V3664, P361, DOI 10.11646/zootaxa.3664.3.6; Noleto RB, 2009, J FISH BIOL, V75, P448, DOI 10.1111/j.1095-8649.2009.02342.x; Oliveira C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-275; Palacios-Gimenez OM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-167; Alves JCP, 2010, NEOTROP ICHTHYOL, V8, P77, DOI 10.1590/S1679-62252010000100010; Pansonato-Alves JC, 2011, J FISH BIOL, V78, P183, DOI 10.1111/j.1095-8649.2010.02847.x; Pansonato-Alves JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107169; Pansonato-Alves JC, 2011, GENET MOL BIOL, V34, P208, DOI 10.1590/S1415-47572011005000005; Parise-Maltempi PP, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-60; Pazian MF, 2013, GENETICA, V141, P1, DOI 10.1007/s10709-013-9701-1; Pelliccia F, 2001, GENOME, V44, P331, DOI 10.1139/gen-44-3-331; PENDAS AM, 1994, CYTOGENET CELL GENET, V67, P31, DOI 10.1159/000133792; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Pokorna M, 2009, ZOOL J LINN SOC-LOND, V156, P168, DOI 10.1111/j.1096-3642.2008.00481.x; Pucci MB, 2014, BIOL J LINN SOC, V111, P541, DOI 10.1111/bij.12218; Ribeiro AC, 2006, NEOTROP ICHTHYOL, V4, P225, DOI 10.1590/S1679-62252006000200009; Scacchetti PC, 2015, CYTOGENET GENOME RES, V146, P136, DOI 10.1159/000437165; Scacchetti PC, 2015, GENETICA, V143, P263, DOI 10.1007/s10709-014-9812-3; Schemberger MO, 2011, GENETICA, V139, P1499, DOI 10.1007/s10709-012-9649-6; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Utsunomia R, 2014, CYTOGENET GENOME RES, V142, P286, DOI 10.1159/000362258; Vicari MR, 2008, GENETICA, V134, P311, DOI 10.1007/s10709-007-9238-2; Vicoso B, 2013, NATURE, V499, P332, DOI 10.1038/nature12235; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Zanata AM, 2014, NEOTROP ICHTHYOL, V12, P333, DOI 10.1590/1982-0224-20130168	44	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137231	10.1371/journal.pone.0137231	http://dx.doi.org/10.1371/journal.pone.0137231			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372604	gold, Green Published, Green Submitted			2022-12-27	WOS:000361604400013
J	Smith, D; Aherrera, A; Lopez, A; Neptune, E; Winickoff, JP; Klein, JD; Chen, G; Lazarus, P; Collaco, JM; McGrath-Morrow, SA				Smith, Dani; Aherrera, Angela; Lopez, Armando; Neptune, Enid; Winickoff, Jonathan P.; Klein, Jonathan D.; Chen, Gang; Lazarus, Philip; Collaco, Joseph M.; McGrath-Morrow, Sharon A.			Adult Behavior in Male Mice Exposed to E-Cigarette Nicotine Vapors during Late Prenatal and Early Postnatal Life	PLOS ONE			English	Article							C57BL/6J MICE; SMOKE EXPOSURE; TERATOGENICITY; HYPERACTIVITY; PERFORMANCE; COTININE; ANXIETY; BRAIN; RISK; TIME	Nicotine exposure has been associated with an increased likelihood of developing attention deficit hyperactivity disorder (ADHD) in offspring of mothers who smoked during pregnancy. The goal of this study was to determine if exposure to E-cigarette nicotine vapors during late prenatal and early postnatal life altered behavior in adult mice. Methods Timed-pregnant C57BL/6J mice were exposed to 2.4% nicotine in propylene glycol (PG) or 0% nicotine/PG once a day from gestational day 15 until delivery. After delivery, offspring and mothers were exposed to E-cigarette vapors for an additional 14 days from postnatal day 2 through 16. Following their last exposure serum cotinine levels were measured in female juvenile mice. Male mice underwent behavioral testing at 14 weeks of age to assess sensorimotor, affective, and cognitive functional domains. Results Adult male mice exposed to 2.4% nicotine/PG E-cigarette vapors had significantly more head dips in the zero maze test and higher levels of rearing activity in the open field test compared to 0% nicotine/ PG exposed mice and untreated controls. In the water maze test after reversal training, the 2.4% nicotine/ PG mice spent more than 25% of time in the new location whereas the other groups did not. Conclusion Adult male mice exhibited increased levels of activity in the zero maze and open field tests when exposed to E-cigarette vapor containing nicotine during late prenatal and early postnatal life. These findings indicate that nicotine exposure from E-cigarettes may cause persistent behavioral changes when exposure occurs during a period of rapid brain growth.	[Smith, Dani] Johns Hopkins Univ, Dept Psychol & Brain Sci, Neurogenet & Behav Ctr, Baltimore, MD USA; [Aherrera, Angela; Lopez, Armando; Collaco, Joseph M.; McGrath-Morrow, Sharon A.] Johns Hopkins Univ, Sch Med, Eudowood Div Pediat Resp Sci, Baltimore, MD 21218 USA; [Lopez, Armando; Neptune, Enid] Johns Hopkins Med Inst, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA; [Winickoff, Jonathan P.; Klein, Jonathan D.; Collaco, Joseph M.; McGrath-Morrow, Sharon A.] Amer Acad Pediat, Julius B Richmond Ctr Excellence, Elk Grove Village, IL USA; [Winickoff, Jonathan P.] Massachusetts Gen Hosp, Div Gen Pediat, Boston, MA 02114 USA; [Winickoff, Jonathan P.] Harvard Univ, Sch Med, Boston, MA USA; [Chen, Gang; Lazarus, Philip] Washington State Univ, Dept Pharmacol, Pullman, WA 99164 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; American Academy of Pediatrics; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Washington State University	McGrath-Morrow, SA (corresponding author), Johns Hopkins Univ, Sch Med, Eudowood Div Pediat Resp Sci, Baltimore, MD 21218 USA.	smcgrath@jhmi.edu		Klein, Jonathan/0000-0003-4185-1998	Flight Attendant Medical Research Institute; National Institutes of Health, NIH [RHL114800A]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES025460] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute; National Institutes of Health, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by a Center of Excellence Grant to the American Academy of Pediatrics from the Flight Attendant Medical Research Institute (SAM, JMC, JDK, JPW); and National Institutes of Health, NIH RHL114800A (SAM).	Ajarem JS, 1998, PHARMACOL BIOCHEM BE, V59, P313, DOI 10.1016/S0091-3057(97)00408-5; Alkam T, 2013, PSYCHOPHARMACOLOGY, V230, P451, DOI 10.1007/s00213-013-3175-9; Allison C, 2013, NEUROPHARMACOLOGY, V64, P314, DOI 10.1016/j.neuropharm.2012.06.055; Ballbe M, 2014, ENVIRON RES, V135, P76, DOI 10.1016/j.envres.2014.09.005; Bergvall N, 2006, PEDIATRICS, V117, pE460, DOI 10.1542/peds.2005-0737; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Damaj MI, 2001, J PHARMACOL EXP THER, V296, P132; de Chazeron I, 2008, PULM PHARMACOL THER, V21, P485, DOI 10.1016/j.pupt.2007.11.001; Eppolito AK, 2010, NEUROTOXICOL TERATOL, V32, P336, DOI 10.1016/j.ntt.2009.12.009; Eriksson P, 2000, BRAIN RES, V853, P41, DOI 10.1016/S0006-8993(99)02231-3; Etter JF, 2014, ADDICTION, V109, P825, DOI 10.1111/add.12475; Flores-Montoya MG, 2015, J APPL TOXICOL, V35, P759, DOI 10.1002/jat.3064; Herrmann M, 2008, CURR OPIN PEDIATR, V20, P184, DOI 10.1097/MOP.0b013e3282f56165; Ivorra C, 2014, DRUG ALCOHOL DEPEN, V134, P275, DOI 10.1016/j.drugalcdep.2013.10.017; Levin ED, 2013, BIOCHEM PHARMACOL, V86, P1145, DOI 10.1016/j.bcp.2013.07.021; Linnet KM, 2003, AM J PSYCHIAT, V160, P1028, DOI 10.1176/appi.ajp.160.6.1028; Lv JX, 2008, NEUROTOXICOLOGY, V29, P722, DOI 10.1016/j.neuro.2008.04.015; Marchenko Y, 2006, STATA J, V6, P1; McIlwain KL, 2001, PHYSIOL BEHAV, V73, P705, DOI 10.1016/S0031-9384(01)00528-5; Ortega LA, 2013, BEHAV BRAIN RES, V238, P134, DOI 10.1016/j.bbr.2012.10.032; Paavonen EJ, 2007, PEDIATRICS, V120, P778, DOI 10.1542/peds.2007-0540; Paz R, 2007, NEUROPSYCHOPHARMACOL, V32, P693, DOI 10.1038/sj.npp.1301066; Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9; Ross EJ, 2015, NEUROPSYCHOPHARMACOL, V40, P61, DOI 10.1038/npp.2014.147; Schneider T, 2012, PSYCHOPHARMACOLOGY, V223, P401, DOI 10.1007/s00213-012-2728-7; Vaglenova J, 2004, BEHAV BRAIN RES, V150, P159, DOI 10.1016/j.bbr.2003.07.005; Wainwright PE, 2007, DEV PSYCHOBIOL, V49, P664, DOI 10.1002/dev.20245; WEITZMAN M, 1992, PEDIATRICS, V90, P342; Yochum C, 2014, EXP NEUROL, V254, P145, DOI 10.1016/j.expneurol.2014.01.016	29	61	63	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137953	10.1371/journal.pone.0137953	http://dx.doi.org/10.1371/journal.pone.0137953			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372012	Green Published, gold, Green Submitted			2022-12-27	WOS:000361604400038
J	Chong, GO; Jeong, SY; Park, SH; Lee, YH; Lee, SW; Hong, DG; Kim, JC; Lee, YS; Cho, YL				Chong, Gun Oh; Jeong, Shin Young; Park, Shin-Hyung; Lee, Yoon Hee; Lee, Sang-Woo; Hong, Dae Gy; Kim, Jae-Chul; Lee, Yoon Soon; Cho, Young Lae			Comparison of the Prognostic Value of F-18 Pet Metabolic Parameters of Primary Tumors and Regional Lymph Nodes in Patients with Locally Advanced Cervical Cancer Who Are Treated with Concurrent Chemoradiotherapy	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; STANDARDIZED UPTAKE VALUE; F-18-FLUORODEOXYGLUCOSE UPTAKE; STAGE IB; PRETREATMENT; CARCINOMA; RECURRENCE; SURVIVAL; FLUORODEOXYGLUCOSE; AGGRESSIVENESS	Objective This study investigated the metabolic parameters of primary tumors and regional lymph nodes, as measured by pre-treatment F-18 fluorodeoxyglucose positron emission tomography/computed tomography (F-18 FDG PET/CT) to compare the prognostic value for the prediction of tumor recurrence. This study also identified the most powerful parameter in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy. Methods Fifty-six patients who were diagnosed with cervical cancer with pelvic and/or paraaortic lymph node metastasis were enrolled in this study. Metabolic parameters including the maximum standardized uptake value (SUVmax), the metabolic tumor volume (MTV), and total lesion glycolysis (TLG) of the primary tumors and lymph nodes were measured by pre-treatment F-18 FDG PET/CT. Univariate and multivariate analyses for disease-free survival (DFS) were performed using the clinical and metabolic parameters. Results The metabolic parameters of the primary tumors were not associated with DFS. However, DFS was significantly longer in patients with low values of nodal metabolic parameters than in those with high values of nodal metabolic parameters. A univariate analysis revealed that nodal metabolic parameters (SUVmax, MTV and TLG), paraaortic lymph node metastasis, and post-treatment response correlated significantly with DFS. Among these parameters, nodal SUVmax (hazard ratio [HR], 4.158; 95% confidence interval [CI], 1.1-22.7; p = 0.041) and post-treatment response (HR, 7.162; 95% CI, 1.5-11.3; p = 0.007) were found to be determinants of DFS according to a multivariate analysis. Only nodal SUVmax was an independent pre-treatment prognostic factor for DFS, and the optimal cutoff for nodal SUVmax to predict progression was 4.7. Conclusion Nodal SUVmax according to pre-treatment F-18 FDG PET/CT may be a prognostic biomarker for the prediction of disease recurrence in patients with locally advanced cervical cancer.	[Chong, Gun Oh; Lee, Yoon Hee; Hong, Dae Gy; Lee, Yoon Soon; Cho, Young Lae] Kyungpook Natl Univ, Dept Obstet & Gynecol, Med Ctr, Sch Med, Daegu, South Korea; [Jeong, Shin Young; Lee, Sang-Woo] Kyungpook Natl Univ, Dept Nucl Med, Med Ctr, Sch Med, Daegu, South Korea; [Park, Shin-Hyung; Kim, Jae-Chul] Kyungpook Natl Univ, Dept Radiat Oncol, Med Ctr, Sch Med, Daegu, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University	Jeong, SY (corresponding author), Kyungpook Natl Univ, Dept Nucl Med, Med Ctr, Sch Med, Daegu, South Korea.	syjeong@knu.ac.kr			Biomedical Research Institute grant; Kyungpook National University Hospital [15-11]	Biomedical Research Institute grant; Kyungpook National University Hospital	This work was supported by a Biomedical Research Institute grant, Kyungpook National University Hospital (2015, grant number 15-11; bmri.knu.ac.kr).	Choi HJ, 2006, CANCER-AM CANCER SOC, V106, P914, DOI 10.1002/cncr.21641; Endo D, 2015, J GYNECOL ONCOL, V26, P12, DOI 10.3802/jgo.2015.26.1.12; Grabellus F, 2010, J NUCL MED, V51, P1191, DOI 10.2967/jnumed.110.075721; Green JA, 2001, LANCET, V358, P781, DOI 10.1016/S0140-6736(01)05965-7; Groves AM, 2011, EUR J NUCL MED MOL I, V38, P46, DOI 10.1007/s00259-010-1590-2; Guo JF, 2006, J NUCL MED, V47, P419; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kidd EA, 2007, CANCER, V110, P1738, DOI 10.1002/cncr.22974; Kidd EA, 2010, CANCER-AM CANCER SOC, V116, P1469, DOI 10.1002/cncr.24972; Kim SM, 2000, INT J GYNECOL CANCER, V10, P305, DOI 10.1046/j.1525-1438.2000.010004305.x; Lee DW, 2010, J GYNECOL ONCOL, V21, P18, DOI 10.3802/jgo.2010.21.1.18; Lee DW, 2015, INT J GYNECOL CANCER, V25, P843, DOI 10.1097/IGC.0000000000000301; Lv K, 2014, NUCL MED COMMUN, V35, P1204, DOI 10.1097/MNM.0000000000000198; Nakamura K, 2010, GYNECOL ONCOL, V119, P81, DOI 10.1016/j.ygyno.2010.04.020; Onal C, 2015, GYNECOL ONCOL, V137, P40, DOI 10.1016/j.ygyno.2015.01.542; Onal C, 2013, INT J GYNECOL CANCER, V23, P1104, DOI 10.1097/IGC.0b013e3182989483; Roh JW, 2005, EUR J CANCER, V41, P2086, DOI 10.1016/j.ejca.2005.05.013; Samlal RAK, 1997, CANCER, V80, P1234, DOI 10.1002/(SICI)1097-0142(19971001)80:7<1234::AID-CNCR6>3.0.CO;2-K; Schwarz JK, 2007, JAMA-J AM MED ASSOC, V298, P2289, DOI 10.1001/jama.298.19.2289; Siva S, 2011, CANCER-AM CANCER SOC, V117, P3981, DOI 10.1002/cncr.25991; Song BI, 2012, J NUCL MED, V53, P1337, DOI 10.2967/jnumed.111.098640; Soret M, 2007, J NUCL MED, V48, P932, DOI 10.2967/jnumed.106.035774; Whitney CW, 1999, J CLIN ONCOL, V17, P1339, DOI 10.1200/JCO.1999.17.5.1339; Wong TZ, 2004, MOL IMAGING BIOL, V6, P55, DOI 10.1016/j.mibio.2003.12.004; Yen TC, 2008, EUR J NUCL MED MOL I, V35, P493, DOI 10.1007/s00259-007-0612-1; Yilmaz M, 2010, NUCL MED COMMUN, V31, P526, DOI 10.1097/MNM.0b013e32833800e7	26	22	24	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137743	10.1371/journal.pone.0137743	http://dx.doi.org/10.1371/journal.pone.0137743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368542	Green Submitted, Green Published, gold			2022-12-27	WOS:000361601100128
J	Lee, J; Narang, S; Martinez, J; Rao, G; Rao, A				Lee, Joonsang; Narang, Shivali; Martinez, Juan; Rao, Ganesh; Rao, Arvind			Spatial Habitat Features Derived from Multiparametric Magnetic Resonance Imaging Data Are Associated with Molecular Subtype and 12-Month Survival Status in Glioblastoma Multiforme	PLOS ONE			English	Article							TUMOR HETEROGENEITY; POINT PATTERNS; CANCER; IMAGES; DYNAMICS; MODELS; EGFR	One of the most common and aggressive malignant brain tumors is Glioblastoma multi-forme. Despite the multimodality treatment such as radiation therapy and chemotherapy (temozolomide: TMZ), the median survival rate of glioblastoma patient is less than 15 months. In this study, we investigated the association between measures of spatial diversity derived from spatial point pattern analysis of multiparametric magnetic resonance imaging (MRI) data with molecular status as well as 12-month survival in glioblastoma. We obtained 27 measures of spatial proximity (diversity) via spatial point pattern analysis of multiparametric T1 post-contrast and T2 fluid-attenuated inversion recovery MRI data. These measures were used to predict 12-month survival status (<= 12 or > 12 months) in 74 glioblastoma patients. Kaplan-Meier with receiver operating characteristic analyses was used to assess the relationship between derived spatial features and 12-month survival status as well as molecular subtype status in patients with glioblastoma. Kaplan-Meier survival analysis revealed that 14 spatial features were capable of stratifying overall survival in a statistically significant manner. For prediction of 12-month survival status based on these diversity indices, sensitivity and specificity were 0.86 and 0.64, respectively. The area under the receiver operating characteristic curve and the accuracy were 0.76 and 0.75, respectively. For prediction of molecular subtype status, proneural subtype shows highest accuracy of 0.93 among all molecular subtypes based on receiver operating characteristic analysis. We find that measures of spatial diversity from point pattern analysis of intensity habitats from T1 post-contrast and T2 fluid-attenuated inversion recovery images are associated with both tumor subtype status and 12-month survival status and may therefore be useful indicators of patient prognosis, in addition to providing potential guidance for molecularly-targeted therapies in Glioblastoma multiforme.	[Lee, Joonsang; Narang, Shivali; Rao, Arvind] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Martinez, Juan; Rao, Ganesh] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Rao, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA.	aruppore@mdanderson.org		Lee, Joonsang/0000-0001-9694-4425	NIH/NCI Cancer Center [NCI P30 CA016672]; UTMDACC Institution Research Grant; UTMDACC Brain SPORE Career Development Award; NIH [K08NS070928]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS070928] Funding Source: NIH RePORTER	NIH/NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UTMDACC Institution Research Grant; UTMDACC Brain SPORE Career Development Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by NIH/NCI Cancer Center Support Grant (NCI P30 CA016672), UTMDACC Institution Research Grant, and UTMDACC Brain SPORE Career Development Award to Arvind Rao, and NIH award (K08NS070928) to Ganesh Rao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Affronti ML, 2009, CANCER, V115, P3501, DOI 10.1002/cncr.24398; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Baddeley A, 2007, LECT NOTES MATH, V1892, P1; Bedard PL, 2013, NATURE, V501, P355, DOI 10.1038/nature12627; CHEN CC, 1989, IEEE T MED IMAGING, V8, P133, DOI 10.1109/42.24861; Cheng NM, 2013, J NUCL MED, V54, P1703, DOI 10.2967/jnumed.112.119289; Eo SH, 2013, ARXIV13064615; Figueiredo MAT, 2002, IEEE T PATTERN ANAL, V24, P381, DOI 10.1109/34.990138; Gatenby RA, 2013, RADIOLOGY, V269, P8, DOI 10.1148/radiol.13122697; Gatrell AC, 1996, T I BRIT GEOGR, V21, P256, DOI 10.2307/622936; Gonzalez-Garcia I, 2002, P NATL ACAD SCI USA, V99, P13085, DOI 10.1073/pnas.202139299; Grove O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118261; Held K, 1997, IEEE T MED IMAGING, V16, P878, DOI 10.1109/42.650883; Illian J, 2008, STAT ANAL MODELLING; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Jiao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027323; Johnson DR, 2012, J NEURO-ONCOL, V107, P359, DOI 10.1007/s11060-011-0749-4; Mazurowski MA, 2013, NEURO-ONCOLOGY, V15, P1389, DOI 10.1093/neuonc/nos335; McAuliffe MJ, 2001, COMP MED SY, P381; Miles KA, 2009, RADIOLOGY, V250, P444, DOI 10.1148/radiol.2502071879; Moeur M., 1993, Forest Science, V39, P756; Rajala T, 2012, ENVIRON ECOL STAT, V19, P545, DOI 10.1007/s10651-012-0200-9; Reynolds DA., 2009, ENCY BIOMETRICS, P659, DOI DOI 10.1007/978-0-387-73003-5_196; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Van Lieshout MNM, 1999, SCAND J STAT, V26, P511, DOI 10.1111/1467-9469.00165; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Zhou M, 2014, TRANSL ONCOL, V7, P5, DOI 10.1593/tlo.13730	29	30	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136557	10.1371/journal.pone.0136557	http://dx.doi.org/10.1371/journal.pone.0136557			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368923	Green Submitted, Green Published, gold			2022-12-27	WOS:000361601100019
J	Guo, SM; Han, M; Chen, MX; Ning, Y; Pei, GC; Li, YQ; Dai, W; Ge, SW; Deng, YJ; Guo, YY; Li, XQ; Haller, H; Xu, G; Rong, S				Guo, Shui-Ming; Han, Min; Chen, Mei-Xue; Ning, Yong; Pei, Guang-Chang; Li, Yue-Qiang; Dai, Wei; Ge, Shu-Wang; Deng, Yuan-Jun; Guo, Yan-Yan; Li, Xiao-Qing; Haller, Hermann; Xu, Gang; Rong, Song			Soluble Urokinase Receptor Levels Are Correlated with Focal Segmental Glomerulosclerosis Lesions in IgA Nephropathy: A Cohort Study from China	PLOS ONE			English	Article							OXFORD CLASSIFICATION; GLOMERULAR-DISEASE; NATURAL-HISTORY; VALIDATION; SUPAR; ACTIVATION; EXPRESSION; PODOCYTES; FSGS	Background Soluble urokinase receptor (suPAR) may be involved in the pathological mechanisms of focal segmental glomerulosclerosis (FSGS) changes. However, it remains unclear whether suPAR is correlated with the FSGS-like lesions in IgA nephropathy (IgAN). 3 Methods We measured the plasma suPAR levels in 138 patients with IgAN, and then their clinical and pathological relationships were analyzed. Results We found that the plasma suPAR levels were significantly correlated with age and renal function by both univariate and multivariate analysis in our IgAN patient cohort. Female had higher plasma suPAR levels and no significant correlation was observed between plasma suPAR levels and 24-h urine protein and highly sensitive C-reaction protein with multivariate analysis. In our cohort, sixty of these IgAN patients could be diagnosed with a type of FSGS lesions. The plasma suPAR levels were higher in the IgAN patients with FSGS lesions than in the IgAN patients without FSGS lesions by univariate (P < 0.0001) and multivariate (P < 0.001) analysis adjusting for other predictor variables, which might be helpful to differentiate the pathological changes with and without FSGS lesions. And the optimal cutoff value was 1806 pg/ml in this study. The plasma suPAR concentrations were also associated with the degree of tubular atrophy/interstitial fibrosis in both univariate and multivariate analysis. In multivariate analysis, the plasma suPAR levels were correlated with the percentage of crescents, not global sclerosis and arterial lesions. Conclusions Our study suggested that the plasma suPAR levels were associated with age, gender, renal function, the degree of tubular atrophy/interstitial fibrosis and the percentage of crescent formation. The plasma suPAR might be a potential predictor for the presence of FSGS pathological lesions in Chinese patients with IgAN.	[Guo, Shui-Ming; Han, Min; Chen, Mei-Xue; Ning, Yong; Pei, Guang-Chang; Li, Yue-Qiang; Dai, Wei; Ge, Shu-Wang; Deng, Yuan-Jun; Guo, Yan-Yan; Li, Xiao-Qing; Xu, Gang; Rong, Song] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Nephrol,Div Internal Med, Wuhan 430074, Hubei, Peoples R China; [Haller, Hermann; Rong, Song] Hannover Med Sch, Dept Nephrol, Hannover, Germany	Huazhong University of Science & Technology; Hannover Medical School	Han, M (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Nephrol,Div Internal Med, Wuhan 430074, Hubei, Peoples R China.	minhan@tjh.tjmu.edu.cn; xugang@tjh.tjmu.edu.cn	deng, qiongxia/A-3206-2017	/0000-0001-9985-1515	National Natural Science Foundation of China [81370798, 81470948]; National Natural Science Foundation of China for Young Scholar [81100485]; Scientific Research Starting Foundation of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology [2014KYQD01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China for Young Scholar; Scientific Research Starting Foundation of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology	This work was supported by grants of the National Natural Science Foundation of China (No. 81370798, 81470948), National Natural Science Foundation of China for Young Scholar (No. 81100485), Scientific Research Starting Foundation of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (No. 2014KYQD01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1982, KIDNEY INT, V22, P643; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Coppo R, 2014, KIDNEY INT, V86, P828, DOI 10.1038/ki.2014.63; Coppo R, 2010, KIDNEY INT, V77, P417, DOI 10.1038/ki.2009.473; D'Amico G, 2000, AM J KIDNEY DIS, V36, P227, DOI 10.1053/ajkd.2000.8966; Deegens JK, 2014, NAT REV NEPHROL, V10, P431, DOI 10.1038/nrneph.2014.113; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; El Karoui K, 2011, KIDNEY INT, V79, P643, DOI 10.1038/ki.2010.460; Floege J, 2013, NAT REV NEPHROL, V9, P320, DOI 10.1038/nrneph.2013.59; Haas M, 1997, AM J KIDNEY DIS, V29, P829, DOI 10.1016/S0272-6386(97)90456-X; Herzenberg AM, 2011, KIDNEY INT, V80, P310, DOI 10.1038/ki.2011.126; Hill GS, 2011, KIDNEY INT, V79, P635, DOI 10.1038/ki.2010.466; Huang J, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-81; Huang J, 2013, KIDNEY INT, V84, P366, DOI 10.1038/ki.2013.55; Kang SH, 2012, NEPHROL DIAL TRANSPL, V27, P252, DOI 10.1093/ndt/gfr295; Lai KN, 2008, AM J PHYSIOL-RENAL, V294, pF945, DOI 10.1152/ajprenal.00423.2007; Li PKT, 2002, NEPHROL DIAL TRANSPL, V17, P64, DOI 10.1093/ndt/17.1.64; Maas RJH, 2014, KIDNEY INT, V85, P711, DOI 10.1038/ki.2013.513; Meijers B, 2015, KIDNEY INT, V87, P210, DOI 10.1038/ki.2014.197; Meijers B, 2014, KIDNEY INT, V85, P636, DOI 10.1038/ki.2013.505; Palacios CRF, 2013, TRANSPLANTATION, V96, P394, DOI 10.1097/TP.0b013e3182977ab1; Qin DD, 2015, LUPUS, V24, P546, DOI 10.1177/0961203314558857; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; SCHENA FP, 1990, AM J MED, V89, P209; Shi SF, 2011, CLIN J AM SOC NEPHRO, V6, P2175, DOI 10.2215/CJN.11521210; Shushakova N, 2005, J CELL SCI, V118, P2743, DOI 10.1242/jcs.02409; Sinniah R, 1984, Contrib Nephrol, V40, P156; Spinale JM, 2015, KIDNEY INT, V87, P564, DOI 10.1038/ki.2014.346; Theilade S, 2015, J INTERN MED, V277, P362, DOI 10.1111/joim.12269; Wada T, 2014, KIDNEY INT, V85, P641, DOI 10.1038/ki.2013.544; Weber CL, 2009, NEPHROL DIAL TRANSPL, V24, P483, DOI 10.1093/ndt/gfn513; Wei CL, 2012, J AM SOC NEPHROL, V23, P2051, DOI 10.1681/ASN.2012030302; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Ye ZC, 2009, CLIN INVEST MED, V32, pE20; Yoo TH, 2015, J AM SOC NEPHROL, V26, P133, DOI 10.1681/ASN.2013111213; Zeng CH, 2012, AM J KIDNEY DIS, V60, P812, DOI 10.1053/j.ajkd.2012.06.011	37	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138718	10.1371/journal.pone.0138718	http://dx.doi.org/10.1371/journal.pone.0138718			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26380984	Green Published, Green Submitted, gold			2022-12-27	WOS:000361790200150
J	Porter, JR; Weitzner, BD; Lange, OF				Porter, Justin R.; Weitzner, Brian D.; Lange, Oliver F.			A Framework to Simplify Combined Sampling Strategies in Rosetta	PLOS ONE			English	Article							PROTEIN-PROTEIN DOCKING; COMPUTATIONAL DESIGN; STRUCTURE PREDICTION; MOLECULAR-DYNAMICS; CS-ROSETTA; LOOP; ALGORITHMS; EPITOPE	A core task in computational structural biology is the search of conformational space for low energy configurations of a biological macromolecule. Because conformational space has a very high dimensionality, the most successful search methods integrate some form of prior knowledge into a general sampling algorithm to reduce the effective dimensionality. However, integrating multiple types of constraints can be challenging. To streamline the incorporation of diverse constraints, we developed the Broker: an extension of the Rosetta macromolecular modeling suite that can express a wide range of protocols using constraints by combining small, independent modules, each of which implements a different set of constraints. We demonstrate expressiveness of the Broker through several code vignettes. The framework enables rapid protocol development in both biomolecular design and structural modeling tasks and thus is an important step towards exposing the rich functionality of Rosetta's core libraries to a growing community of users addressing a diverse set of tasks in computational biology.	[Porter, Justin R.] Washington Univ, Sch Med, St Louis, MO 63130 USA; [Weitzner, Brian D.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA; [Lange, Oliver F.] Tech Univ Munich, Fak Chem, Lehrstuhl Biomol NMR Spektroskopie, D-80290 Munich, Germany	Washington University (WUSTL); Johns Hopkins University; Technical University of Munich	Porter, JR (corresponding author), Washington Univ, Sch Med, St Louis, MO 63130 USA.	justinrporter@wustl.edu		Weitzner, Brian/0000-0002-1909-0961; Porter, Justin/0000-0002-0340-951X	DAAD [A/11/84304]; RosettaCommons; Human Frontiers in Science Program; DFG [LA 1817/3-1];  [R01 GM078221]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078221, P41GM103311] Funding Source: NIH RePORTER	DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); RosettaCommons; Human Frontiers in Science Program(Human Frontier Science Program); DFG(German Research Foundation (DFG)); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JRP was supported by DAAD grant A/11/84304 and a grant from the RosettaCommons. BDW was supported by R01 GM078221. OFL was supported by the Human Frontiers in Science Program and DFG grant LA 1817/3-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock SA, 2006, CHEM REV, V106, P1589, DOI 10.1021/cr040426m; ALDER BJ, 1959, J CHEM PHYS, V31, P459, DOI 10.1063/1.1730376; Andre I, 2007, P NATL ACAD SCI USA, V104, P17656, DOI 10.1073/pnas.0702626104; Azoitei ML, 2014, PROTEINS, V82, P2770, DOI 10.1002/prot.24641; Azoitei ML, 2012, J MOL BIOL, V415, P175, DOI 10.1016/j.jmb.2011.10.003; Azoitei ML, 2011, SCIENCE, V334, P373, DOI 10.1126/science.1209368; Baker D, 2012, PROT STRUCT FUNCT BI, DOI [10.1002/prot.23245, DOI 10.1002/PR0T.23245]; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berrondo M, 2008, STRUCTURE, V16, P513, DOI 10.1016/j.str.2008.01.012; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Chaudhury S, 2010, BIOINFORMATICS, V26, P689, DOI 10.1093/bioinformatics/btq007; Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966; Das R, 2009, P NATL ACAD SCI USA, V106, P18978, DOI 10.1073/pnas.0904407106; DiMaio F, 2013, NAT METHODS, V10, P1102, DOI [10.1038/nmeth.2648, 10.1038/NMETH.2648]; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Honegger A, 2001, J MOL BIOL, V309, P657, DOI 10.1006/jmbi.2001.4662; Huang P-S, 2011, J MOL BIOL, V6, DOI [10.1371/journal.pone.0024109, DOI 10.1371/J0URNAL.P0NE.0024109]; Inbar Y, 2005, PHYS BIOL, V2, pS156, DOI 10.1088/1478-3975/2/4/S10; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lange OF, 2012, P NATL ACAD SCI USA, V109, P10873, DOI 10.1073/pnas.1203013109; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; MOULT J, 1995, PROTEINS, V23, pR2, DOI 10.1002/prot.340230303; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ponting CP, 2002, ANNU REV BIOPH BIOM, V31, P45, DOI 10.1146/annurev.biophys.31.082901.134314; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Russel D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001244; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Sircar A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000644; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Vernon R, 2013, J BIOMOL NMR, V57, P117, DOI 10.1007/s10858-013-9772-4; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Weitzner BD, 2014, PROTEINS, V82, P1611, DOI 10.1002/prot.24534; Wollacott AM, 2007, PROTEIN SCI, V16, P165, DOI 10.1110/ps.062270707; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106; Zhang ZY, 2014, J BIOMOL NMR, V59, P135, DOI 10.1007/s10858-014-9832-4	47	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138220	10.1371/journal.pone.0138220	http://dx.doi.org/10.1371/journal.pone.0138220			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381271	Green Published, gold			2022-12-27	WOS:000361790200072
J	Salali, GD; Migliano, AB				Salali, Gul Deniz; Migliano, Andrea Bamberg			Future Discounting in Congo Basin Hunter-Gatherers Declines with Socio-Economic Transitions	PLOS ONE			English	Article							TIME PREFERENCE; NEURAL SYSTEMS; LIFE-HISTORY; RISK; MORTALITY; SUBSISTENCE; PATIENCE; ORIGINS; EXPLAIN; CHOICE	Humans have a tendency to discount the future; that is we value small, short-term rewards over larger, long-term rewards. The degree of future discounting, however, changes in response to socio-ecological factors. Here, we study Mbendjele BaYaka hunter-gatherers of northern Congo and their farmer neighbours to investigate adaptations in inter-temporal preferences in humans. We argue that in immediate-return systems, where food storage is absent and egalitarianism is enforced through levelling mechanisms, future discounting is an adaptive strategy to prevent wealth accumulation and the emergence of hierarchies. This ensures food sharing and allows for survival in unpredictable environments where there is risk of an energy shortfall. On the other hand, when food storage is made possible by the emergence of agriculture or as seen in some delayed-return hunter-gatherer populations, wealth accumulation, hierarchies and lower discount rates become the adaptive strategy. Therefore, individuals in immediate-return, egalitarian societies will discount the future more than those in non-egalitarian, delayed-return societies. Consistent with the predictions we found that market integration and socio-economic transitions decrease the future discounting in Mbendjele hunter-gatherers. Our measures of socio-economic differences marked this transition in hunter-gatherers living in a logging town. The degree of future-discounting was the same between more market-integrated hunter-gatherers and their farmer neighbours.	[Salali, Gul Deniz; Migliano, Andrea Bamberg] UCL, Dept Anthropol, London, England	University of London; University College London	Salali, GD (corresponding author), UCL, Dept Anthropol, London, England.	guldeniz.salali.12@ucl.ac.uk		Migliano, Andrea/0000-0003-4364-2735; Salali, Gul Deniz/0000-0001-9538-3064	Leverhulme Trust Foundation [RP2011-R-045]	Leverhulme Trust Foundation	This work was funded by the Leverhulme Trust Foundation Grant RP2011-R-045 to ABM.	AINSLIE GW, 1974, J EXP ANAL BEHAV, V21, P485, DOI 10.1901/jeab.1974.21-485; Alvard MS, 2001, AM ANTHROPOL, V103, P295, DOI 10.1525/aa.2001.103.2.295; APTER A, 1990, PSYCHIAT RES, V32, P191, DOI 10.1016/0165-1781(90)90086-K; Becker GS, 1997, Q J ECON, V112, P729, DOI 10.1162/003355397555334; Bickel WK, 2007, DRUG ALCOHOL DEPEN, V90, pS85, DOI 10.1016/j.drugalcdep.2006.09.016; BOEHM C, 1993, CURR ANTHROPOL, V34, P227, DOI 10.1086/204166; Boehm C., 1999, HIERARCHY FOREST EVO; Chaudhary N, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150054; Daly M, 2005, Q REV BIOL, V80, P55, DOI 10.1086/431025; Dyble M, 2015, SCIENCE, V348, P796, DOI 10.1126/science.aaa5139; ERDAL D, 1994, CURR ANTHROPOL, V35, P175, DOI 10.1086/204255; Evans TA, 2007, BIOLOGY LETT, V3, P599, DOI 10.1098/rsbl.2007.0399; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Gavrilets S, 2012, P NATL ACAD SCI USA, V109, P14069, DOI 10.1073/pnas.1201718109; Godoy R, 2004, J ANTHROPOL RES, V60, P179, DOI 10.1086/jar.60.2.3630815; Godoy R, 1999, EVOL HUM BEHAV, V20, P249, DOI 10.1016/S1090-5138(99)00009-4; Griskevicius V, 2011, J PERS SOC PSYCHOL, V100, P1015, DOI 10.1037/a0022403; Hill K., 1996, ACHE LIFE HIST ECOLO, DOI 10.4324/9781351329248; Hill K, 2007, J HUM EVOL, V52, P443, DOI 10.1016/j.jhevol.2006.11.003; Kaplan H. S., 2005, HDB EVOLUTIONARY PSY, P68, DOI DOI 10.1002/9780470939376.CH2; Kelly Robert L, 2013, LIFEWAYS HUNTER GATH; Kirby KN, 2002, J ECON PSYCHOL, V23, P291, DOI 10.1016/S0167-4870(02)00078-8; KITANISHI K, 2006, AFR STUD MONOGR S, V33, P121, DOI DOI 10.14989/68472; Laporte NT, 2007, SCIENCE, V316, P1451, DOI 10.1126/science.1141057; Lee Richard, 2004, CAMBRIDGE ENCY HUNTE, pxiii; Lewis HM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6789; Lewis J., 2005, PROPERTY EQUALITY, P56; Lewis J, 2008, J ROY ANTHROPOL INST, V14, P297, DOI 10.1111/j.1467-9655.2008.00502.x; Lewis J, 2017, HUNTER-GATHERERS OF THE CONGO BASIN: CULTURES, HISTORIES, AND BIOLOGY OF AFRICAN PYGMIES, P219; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Migliano AB, 2007, P NATL ACAD SCI USA, V104, P20216, DOI 10.1073/pnas.0708024105; Migliano AB, 2012, CURR ANTHROPOL, V53, pS359, DOI 10.1086/667694; Muhlhoff N, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00068; PETERSON N, 1993, AM ANTHROPOL, V95, P860, DOI 10.1525/aa.1993.95.4.02a00050; Reyes-Garcia V, 2007, EVOL HUM BEHAV, V28, P37, DOI 10.1016/j.evolhumbehav.2006.07.001; Riddell M, 2013, CONSERV SOC, V11, P199, DOI 10.4103/0972-4923.121002; SHODA Y, 1990, DEV PSYCHOL, V26, P978, DOI 10.1037/0012-1649.26.6.978; Stevens J. R., 2010, ENCY ANIMAL BEHAV, V2, P203, DOI DOI 10.1016/B978-0-08-045337-8.00093-0; Stevens JR, 2012, BEHAV PROCESS, V89, P121, DOI 10.1016/j.beproc.2011.10.002; Stock JT, 2009, CURR ANTHROPOL, V50, P713, DOI 10.1086/605429; Tanaka T, 2010, AM ECON REV, V100, P557, DOI 10.1257/aer.100.1.557; TOBIN H, 1994, J COMP PSYCHOL, V108, P126, DOI 10.1037/0735-7036.108.2.126; Tucker B, 2006, ORIG HUM BEHAV, V1, P22; Tucker B, 2012, CURR ANTHROPOL, V53, P149, DOI 10.1086/664569; van der Wal AJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2295; Wiessner P, 2005, HUM NATURE-INT BIOS, V16, P115, DOI 10.1007/s12110-005-1000-9; Wilson M, 2004, P ROY SOC B-BIOL SCI, V271, pS177, DOI 10.1098/rsbl.2003.0134; WINTERHALDER B, 1986, J ANTHROPOL ARCHAEOL, V5, P369, DOI 10.1016/0278-4165(86)90017-6; Winterhalder B, 1999, J ARCHAEOL RES, V7, P301, DOI 10.1023/A:1021910301700; WOODBURN J, 1982, MAN, V17, P431, DOI 10.2307/2801707	51	15	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137806	10.1371/journal.pone.0137806	http://dx.doi.org/10.1371/journal.pone.0137806			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0ZE	26381883	Green Published, Green Submitted, gold			2022-12-27	WOS:000361790200037
J	Baum, G; Januar, HI; Ferse, SCA; Kunzmann, A				Baum, Gunilla; Januar, Hedi I.; Ferse, Sebastian C. A.; Kunzmann, Andreas			Local and Regional Impacts of Pollution on Coral Reefs along the Thousand Islands North of the Megacity Jakarta, Indonesia	PLOS ONE			English	Article							BAY; STRESS; EUTROPHICATION; CLASSIFICATION; COMMUNITIES; ASSEMBLAGES; DISTURBANCE; DIVERSITY; HERBIVORY; VARIABLES	Worldwide, coral reefs are challenged by multiple stressors due to growing urbanization, industrialization and coastal development. Coral reefs along the Thousand Islands off Jakarta, one of the largest megacities worldwide, have degraded dramatically over recent decades. The shift and decline in coral cover and composition has been extensively studied with a focus on large-scale gradients (i.e. regional drivers), however special focus on local drivers in shaping spatial community composition is still lacking. Here, the spatial impact of anthropogenic stressors on local and regional scales on coral reefs north of Jakarta was investigated. Results indicate that the direct impact of Jakarta is mainly restricted to inshore reefs, separating reefs in Jakarta Bay from reefs along the Thousand Islands further north. A spatial patchwork of differentially degraded reefs is present along the islands as a result of localized anthropogenic effects rather than regional gradients. Pollution is the main anthropogenic stressor, with over 80% of variation in benthic community composition driven by sedimentation rate, NO2, PO4 and Chlorophyll a. Thus, the spatial structure of reefs is directly related to intense anthropogenic pressure from local as well as regional sources. Therefore, improved spatial management that accounts for both local and regional stressors is needed for effective marine conservation.	[Baum, Gunilla; Ferse, Sebastian C. A.; Kunzmann, Andreas] Bremen GmbH, Dept Ecol, Leibniz Ctr Trop Marine Ecol ZMT, Bremen, Germany; [Baum, Gunilla] Univ Bremen, Fac Biol & Chem FB2, D-28359 Bremen, Germany; [Januar, Hedi I.] Indonesian Res Ctr Marine & Fisheries Prod Proc &, Slipi, Jakarta Pusat, Indonesia	Leibniz Zentrum fur Marine Tropenforschung (ZMT); University of Bremen	Baum, G (corresponding author), Bremen GmbH, Dept Ecol, Leibniz Ctr Trop Marine Ecol ZMT, Bremen, Germany.	gunilla.baum@gmail.com	Kunzmann, Andreas/O-1345-2013; Ferse, Sebastian/AAH-8048-2021; Kunzmann, Andreas/O-5459-2019	Kunzmann, Andreas/0000-0002-9500-4332; Ferse, Sebastian/0000-0003-0930-5356; Kunzmann, Andreas/0000-0002-9500-4332	German Federal Ministry of Education and Research (BMBF) as part of the Science for the Protection of Indonesian Coastal Marine Ecosystems (SPICE) project [03F0641A]	German Federal Ministry of Education and Research (BMBF) as part of the Science for the Protection of Indonesian Coastal Marine Ecosystems (SPICE) project	This study was funded by the German Federal Ministry of Education and Research (BMBF, Grant no. 03F0641A, http://www.bmbf.de/en/) as part of the Science for the Protection of Indonesian Coastal Marine Ecosystems (SPICE) project. The grant was received by AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrar M, 2011, J INDONESIAN CORAL R, V1, P7; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; [Anonymous], 2013, DAILY MAIL; Arifin Z., 2004, LOCAL MILLENIUM ECOS; Badan Pusat Statistik (BPS), 2012, JUML PEND MEN JEN KE; BAK RPM, 1989, NETH J SEA RES, V23, P95, DOI 10.1016/0077-7579(89)90004-5; Ban SS, 2014, GLOBAL CHANGE BIOL, V20, P681, DOI 10.1111/gcb.12453; Bell PRF, 2007, AMBIO, V36, P416, DOI 10.1579/0044-7447(2007)36[416:ROESFT]2.0.CO;2; Bell PRF, 2014, AMBIO, V43, P361, DOI 10.1007/s13280-013-0443-1; Bengen DG, 2006, ENVIRONMENT IN ASIA PACIFIC HARBOURS, P413, DOI 10.1007/1-4020-3655-8_24; Berkelmans R, 2004, CORAL REEFS, V23, P74, DOI 10.1007/s00338-003-0353-y; Blackburn S, 2013, MEGACITIES AND THE COAST: RISK, RESILIENCE AND TRANSFORMATION, P1; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Brinkhoff T, 2011, PRINCIPAL AGGLOMERAT; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Burke L, 2012, REEFS RISK REVISITED; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; CLARKE KR, 1988, MAR ECOL PROG SER, V46, P213, DOI 10.3354/meps046213; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cleary DFR, 2006, BIODIVERS CONSERV, V15, P3653, DOI 10.1007/s10531-004-4692-y; Cleary DFR, 2014, MAR ECOL PROG SER, V501, P89, DOI 10.3354/meps10678; Cleary DFR, 2008, AQUAT SCI, V70, P419, DOI 10.1007/s00027-008-8077-2; Cordova M. R., 2012, INT C AGR ENG CIGR A; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Damar A, 2012, J TROP BIOL CONSERV, V9, P61; Damar A., 2003, THESIS FORSCHUNGS UN; Death G., 2008, GREAT BARRIER REEF M; DeVantier L, 1995, CONTENDING GLOBAL CH, V10, P1; Dikou A, 2006, MAR POLLUT BULL, V52, P7, DOI 10.1016/j.marpolbul.2005.07.021; Djohani RH, 1994, P IOC WESTPAC 3 INT, P265; Done T.J., 1982, Coral Reefs, V1, P95, DOI 10.1007/BF00301691; Dutton I. M., 2005, The politics and economics of Indonesia's natural resources, P162; Edinger EN, 2000, BIOL CONSERV, V92, P1, DOI 10.1016/S0006-3207(99)00067-1; Edmunds PJ, 2002, CORAL REEFS, V21, P357, DOI 10.1007/s00338-002-0258-1; English D, 1994, REFERENCE METHODS MA, V61, P72; English S., 1997, SURVEY MANUAL TROPIC, V2; Erdmann M. V., 1998, P COR REEF EV WORKSH, P84; Fabricius KE, 2012, MAR POLLUT BULL, V65, P320, DOI 10.1016/j.marpolbul.2011.09.004; Fabricius KE, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P493, DOI 10.1007/978-94-007-0114-4_28; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Farhan AR, 2012, OCEAN COAST MANAGE, V65, P1, DOI 10.1016/j.ocecoaman.2012.04.015; Fauzi A, 2002, COAST MANAGE, V30, P167, DOI 10.1080/089207502753504698; Fox HE, 2006, ECOL APPL, V16, P1631, DOI 10.1890/1051-0761(2006)016[1631:RFBFOC]2.0.CO;2; GESAMP, 2001, PROT OC LAND BAS ACT, P71; Gomez ED, 1988, CORAL REEF MANAGEMEN, P171; Gorley C.K., 2006, GETTING STARTED PRIM; Graham NAJ, 2014, CURR OPIN ENV SUST, V7, P9, DOI 10.1016/j.cosust.2013.11.023; Hosono T, 2011, ESTUAR COAST SHELF S, V92, P297, DOI 10.1016/j.ecss.2011.01.010; Huang DW, 2009, RAFFLES B ZOOL, P69; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; KARLSON RH, 1993, CORAL REEFS, V12, P117, DOI 10.1007/BF00334469; KKP, 2011, STAT PER TANGK IND 2; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Koropitan AF, 2009, ICES J MAR SCI, V66, P336, DOI 10.1093/icesjms/fsp011; Kusumanti I, 2013, THESIS U BREMEN; Madduppa Hawis H., 2013, Biodiversitas, V14, P17; Madduppa HH, 2012, ENVIRON BIOL FISH, V95, P383, DOI 10.1007/s10641-012-0012-7; Ministry of Marine Affairs and Fisheries, 2009, COR TRIANGL IN IND N; Moll H., 1986, UNESCO Reports in Marine Science, V40, P112; Moll H, 1983, THESIS LEIDEN; Murdoch TJT, 1999, CORAL REEFS, V18, P341, DOI 10.1007/s003380050210; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; Ongkosongo OSR, 1986, P MAB COMAR REG WORK, P133; Pelling M, 2013, MEGACITIES AND THE COAST: RISK, RESILIENCE AND TRANSFORMATION, P200; Rachello-Dolmen PG, 2007, ESTUAR COAST SHELF S, V73, P816, DOI 10.1016/j.ecss.2007.03.017; Rasher DB, 2012, OECOLOGIA, V169, P187, DOI 10.1007/s00442-011-2174-y; Rees JG, 1999, OCEANOL ACTA, V22, P627, DOI 10.1016/S0399-1784(00)88954-9; Rinawati, 2012, J HAZARD MATER, V217, P208, DOI 10.1016/j.jhazmat.2012.03.023; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; Sale PF, 2014, MAR POLLUT BULL, V85, P8, DOI 10.1016/j.marpolbul.2014.06.005; Selig ER, 2006, CORAL REEFS CLIMATE, V61, P111, DOI DOI 10.1029/61CE07; SLUITER CP, 1888, NATUURK TIJDSCHR NED, V47, P181; Stoddart DR, 1986, HUMAN INDUCED DAMAGE, V40, P112; Storlazzi CD, 2011, CORAL REEFS, V30, P23, DOI 10.1007/s00338-010-0705-3; Tomascik Tomas, 1994, P304; Umbgrove J. H. F., 1939, Zool Med Mus Leiden, V22, P1; Uneputty PA, 1997, MAR POLLUT BULL, V34, P652, DOI 10.1016/S0025-326X(97)00006-4; UNESCO, 1994, PROT JOINT GLOB OC F, V29; United Nations, 2014, DEMOGR RES; van der Meij SET, 2010, MAR POLLUT BULL, V60, P1442, DOI 10.1016/j.marpolbul.2010.05.011; Veron JEN, 1986, CORALS AUSTR INDOPAC, P644; VERSTAPPEN HT, 1988, J COASTAL RES, V4, P573; Verstappen HT, 1953, THESIS U UTRECHT, P1; Wenger AS, 2014, J EXP BIOL, V217, P1122, DOI 10.1242/jeb.094409; Wilkinson C.R., 2008, STATUS CORAL REEFS W; Williams GJ, 2015, ECOGRAPHY, V38, P751, DOI 10.1111/ecog.01353; Williams TM, 2000, MAR POLLUT BULL, V40, P277, DOI 10.1016/S0025-326X(99)00226-X; Zaneveld JS, 1952, J SCI RES, V3, P58	89	49	51	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138271	10.1371/journal.pone.0138271	http://dx.doi.org/10.1371/journal.pone.0138271			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378910	Green Published, gold, Green Submitted			2022-12-27	WOS:000361769400078
J	Rutten, NBMM; Gorissen, DMW; Eck, A; Niers, LEM; Vlieger, AM; Besseling-van der Vaart, I; Budding, AE; Savelkoul, PHM; van der Ent, CK; Rijkers, GT				Rutten, N. B. M. M.; Gorissen, D. M. W.; Eck, A.; Niers, L. E. M.; Vlieger, A. M.; Besseling-van der Vaart, I.; Budding, A. E.; Savelkoul, P. H. M.; van der Ent, C. K.; Rijkers, G. T.			Long Term Development of Gut Microbiota Composition in Atopic Children: Impact of Probiotics	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; REDUCED DIVERSITY; ALLERGIC DISEASE; FECAL MICROBIOTA; EARLY-LIFE; INFANTS; ECZEMA; RISK; SUPPLEMENTATION; DERMATITIS	Introduction Imbalance of the human gut microbiota in early childhood is suggested as a risk factor for immune-mediated disorders such as allergies. With the objective to modulate the intestinal microbiota, probiotic supplementation during infancy has been used for prevention of allergic diseases in infants, with variable success. However, not much is known about the longterm consequences of neonatal use of probiotics on the microbiota composition. The aim of this study was to assess the composition and microbial diversity in stool samples of infants at high-risk for atopic disease, from birth onwards to six years of age, who were treated with probiotics or placebo during the first year of life. Methods In a double-blind, randomized, placebo-controlled trial, a probiotic mixture consisting of B. bifidum W23, B. lactis W52 and Lc. Lactis W58 (Ecologic Panda) was administered to pregnant women during the last 6 weeks of pregnancy and to their offspring during the first year of life. During follow-up, faecal samples were collected from 99 children over a 6-year period with the following time points: first week, second week, first month, three months, first year, eighteen months, two years and six years. Bacterial profiling was performed by IS-pro. Differences in bacterial abundance and diversity were assessed by conventional statistics. Results The presence of the supplemented probiotic strains in faecal samples was confirmed, and the probiotic strains had a higher abundance and prevalence in the probiotic group during supplementation. Only minor and short term differences in composition of microbiota were found between the probiotic and placebo group and between children with or without atopy. The diversity of Bacteroidetes was significantly higher after two weeks in the placebo group, and at the age of two years atopic children had a significantly higher Proteobacteria diversity (p <0.05). Gut microbiota development continued between two and six years, whereby microbiota composition at phylum level evolved more and more towards an adult-like configuration. Conclusion Perinatal supplementation with Ecologic Panda, to children at high-risk for atopic disease, had minor effects on gut microbiota composition during the supplementation period. No long lasting differences were identified. Regardless of intervention or atopic disease status, children had a shared microbiota development over time determined by age that continued to develop between two and six years.	[Rutten, N. B. M. M.; Gorissen, D. M. W.; Niers, L. E. M.; van der Ent, C. K.] Univ Med Ctr, Wilhelmina Childrens Hosp, Dept Pediat Pulmonol & Allergol, Utrecht, Netherlands; [Rutten, N. B. M. M.; Vlieger, A. M.] St Antonius Hosp, Dept Pediat, Nieuwegein, Netherlands; [Eck, A.; Budding, A. E.; Savelkoul, P. H. M.] Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands; [Besseling-van der Vaart, I.] Winclove Probiot BV, Amsterdam, Netherlands; [Savelkoul, P. H. M.] Maastricht Univ, Med Ctr, Sch Nutr & Translat Res Metab NUTRIM, Dept Med Microbiol, Maastricht, Netherlands; [Rijkers, G. T.] Univ Coll Roosevelt Acad, Dept Sci, Middelburg, Netherlands; [Rijkers, G. T.] St Antonius Hosp, Dept Med Microbiol & Immunol, Nieuwegein, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; St. Antonius Hospital Utrecht; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Maastricht University; St. Antonius Hospital Utrecht	Rutten, NBMM (corresponding author), Univ Med Ctr, Wilhelmina Childrens Hosp, Dept Pediat Pulmonol & Allergol, Utrecht, Netherlands.	n.rutten@antoniusziekenhuis.nl	Rijkers, Ger/AAW-6143-2020; vlieger, arine/ABE-8079-2020; Rijkers, Ger/R-7236-2019	Rijkers, Ger/0000-0001-6948-6123; Budding, Andries/0000-0001-5128-5411; Van der Ent, Cornelis/0000-0002-2501-4121	Netherlands Enterprise Agency (Agentschap NL) [FND06015]; Winclove Probiotics	Netherlands Enterprise Agency (Agentschap NL); Winclove Probiotics	This research was supported financially by the Netherlands Enterprise Agency (Agentschap NL), grant number FND06015, http://english.rvo.nl/. Employees of this agency did not play any role in study design, data collection and analysis, nor in preparation of the manuscript and decision to publish. IB is an employee of Winclove Probiotics. Winclove Probiotics offers evidence based probiotic solutions for consumers, health professionals and business partners. This funder provided support in the form of salary for one author (IB) and did play a supportive role in the study design, as a public-private consortium of four parties (two hospitals and two companies) which together performed an innovative project entitled "Translational research to study the effect and mechanism of microbiota in paediatric immune-mediated diseases." The parties had a cooperation agreement in the context of the grant scheme Food & Nutrition Delta Phase 2 from SenterNovem (Agentschap NL, nowadays RVO). The current study was designed as part of the above mentioned innovative project, in consultation with all the participating parties. Winclove Probiotics did not have any additional role in data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'authors contributions' section.	Abrahamsson TR, 2012, J ALLERGY CLIN IMMUN, V129, P434, DOI 10.1016/j.jaci.2011.10.025; Adlerberth I, 2007, J ALLERGY CLIN IMMUN, V120, P343, DOI 10.1016/j.jaci.2007.05.018; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Bezirtzoglou E, 2011, ANAEROBE, V17, P369, DOI 10.1016/j.anaerobe.2011.03.010; Bisgaard H, 2011, J ALLERGY CLIN IMMUN, V128, P646, DOI 10.1016/j.jaci.2011.04.060; Boyle RJ, 2006, CLIN EXP ALLERGY, V36, P568, DOI 10.1111/j.1365-2222.2006.02472.x; Boyle RJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006135.pub2; Budding AE, 2010, FASEB J, V24, P4556, DOI 10.1096/fj.10-156190; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; D'haeseleer P, 2005, NAT BIOTECHNOL, V23, P1499, DOI 10.1038/nbt1205-1499; Elazab N, 2013, PEDIATRICS, V132, pE666, DOI 10.1542/peds.2013-0246; Enomoto T, 2014, ALLERGOL INT, V63, P575, DOI 10.2332/allergolint.13-OA-0683; Fouhy F, 2012, LANDES BIOSCIENCE, P203; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gorissen DMW, 2014, CLIN EXP ALLERGY, V44, P1431, DOI 10.1111/cea.12413; Haegeman B, 2013, ISME J, V7, P1092, DOI 10.1038/ismej.2013.10; Ismail IH, 2012, PEDIAT ALLERG IMM-UK, V23, P674, DOI 10.1111/j.1399-3038.2012.01328.x; Kalliomaki M, 2010, J NUTR, V140, p713S, DOI 10.3945/jn.109.113761; Kirjavainen PV, 2002, GUT, V51, P51, DOI 10.1136/gut.51.1.51; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kolokotroni O, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-179; Lahtinen SJ, 2009, J ALLERGY CLIN IMMUN, V123, P499, DOI 10.1016/j.jaci.2008.11.034; Li M, 2014, SEMIN REPROD MED, V32, P74, DOI 10.1055/s-0033-1361825; Makino H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078331; Nermes M, 2011, CLIN EXP ALLERGY, V41, P370, DOI 10.1111/j.1365-2222.2010.03657.x; Niers L, 2009, ALLERGY, V64, P1349, DOI 10.1111/j.1398-9995.2009.02021.x; Nylund L, 2015, ALLERGY, V70, P241, DOI 10.1111/all.12549; Nylund L, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-12; Osborn DA, 2007, COCHRANE DATABASE SY; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Pelucchi C, 2012, EPIDEMIOLOGY, V23, P402, DOI 10.1097/EDE.0b013e31824d5da2; Ringel-Kulka T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064315; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Wang M, 2008, J ALLERGY CLIN IMMUN, V121, P129, DOI 10.1016/j.jaci.2007.09.011; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	36	35	39	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137681	10.1371/journal.pone.0137681	http://dx.doi.org/10.1371/journal.pone.0137681			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378926	Green Published, gold			2022-12-27	WOS:000361769400022
J	Tourmente, M; Roldan, ERS				Tourmente, Maximiliano; Roldan, Eduardo R. S.			Mass-Specific Metabolic Rate Influences Sperm Performance through Energy Production in Mammals	PLOS ONE			English	Article							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE-S; GLYCOLYTIC-ENZYMES; MOUSE SPERMATOZOA; BODY-MASS; FIBROUS SHEATH; SIZE; COMPETITION; MOTILITY; PHOSPHORYLATION; CAPACITATION	Mass-specific metabolic rate, the rate at which organisms consume energy per gram of body weight, is negatively associated with body size in metazoans. As a consequence, small species have higher cellular metabolic rates and are able to process resources at a faster rate than large species. Since mass-specific metabolic rate has been shown to constrain evolution of sperm traits, and most of the metabolic activity of sperm cells relates to ATP production for sperm motility, we hypothesized that mass-specific metabolic rate could influence sperm energetic metabolism at the cellular level if sperm cells maintain the metabolic rate of organisms that generate them. We compared data on sperm straight-line velocity, mass-specific metabolic rate, and sperm ATP content from 40 mammalian species and found that the mass-specific metabolic rate positively influences sperm swimming velocity by (a) an indirect effect of sperm as the result of an increased sperm length, and (b) a direct effect independent of sperm length. In addition, our analyses show that species with higher mass-specific metabolic rate have higher ATP content per sperm and higher concentration of ATP per mu m of sperm length, which are positively associated with sperm velocity. In conclusion, our results suggest that species with high mass-specific metabolic rate have been able to evolve both long and fast sperm. Moreover, independently of its effect on the production of larger sperm, the mass-specific metabolic rate is able to influence sperm velocity by increasing sperm ATP content in mammals.	[Tourmente, Maximiliano; Roldan, Eduardo R. S.] CSIC, Museo Nacl Ciencias Nat, Reprod Ecol & Biol Grp, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Roldan, ERS (corresponding author), CSIC, Museo Nacl Ciencias Nat, Reprod Ecol & Biol Grp, E-28006 Madrid, Spain.	roldane@mncn.csic.es	Roldan, Eduardo R.S./M-7947-2014; Tourmente, Maximiliano/I-2852-2019	Roldan, Eduardo R.S./0000-0002-7545-4248; Tourmente, Maximiliano/0000-0002-5833-9117	Spanish Ministry of Economy and Competitiveness	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This study was funded by the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown MF, 2007, AM J PHYSIOL-REG I, V292, pR2115, DOI 10.1152/ajpregu.00568.2006; Bunch DO, 1998, BIOL REPROD, V58, P834, DOI 10.1095/biolreprod58.3.834; Calder W.A., 1984, SIZE FUNCTION LIFE H; Clarke A, 2010, J ANIM ECOL, V79, P610, DOI 10.1111/j.1365-2656.2010.01672.x; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, P567, DOI DOI 10.1234/12345678; Cooper TG., 2012, EPIDIDYMIS SPERM MAT; COUTURE P, 1995, AM J PHYSIOL-REG I, V268, pR641, DOI 10.1152/ajpregu.1995.268.3.R641; DeLong JP, 2010, P NATL ACAD SCI USA, V107, P12941, DOI 10.1073/pnas.1007783107; DU JY, 1994, J REPROD FERTIL, V101, P37, DOI 10.1530/jrf.0.1010037; Else PL, 1985, AM J PHYSIOL, V248, pR1; EMMETT B, 1981, RESP PHYSIOL, V45, P261, DOI 10.1016/0034-5687(81)90010-4; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Ford WCL, 2006, HUM REPROD UPDATE, V12, P269, DOI 10.1093/humupd/dmi053; FRASER LR, 1981, J REPROD FERTIL, V61, P25, DOI 10.1530/jrf.0.0610025; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Garrett LJA, 2008, J ANDROL, V29, P449, DOI 10.2164/jandrol.107.003533; Gatti JL, 2004, ANIM REPROD SCI, V82-3, P321, DOI 10.1016/j.anireprosci.2004.05.011; Gomendio M, 2008, INT J DEV BIOL, V52, P439, DOI 10.1387/ijdb.082595mg; Gomendio M, 2011, P ROY SOC B-BIOL SCI, V278, P3135, DOI 10.1098/rspb.2011.0275; HALANGK W, 1985, BIOMED BIOCHIM ACTA, V44, P411; Harvey P.H., 1991, COMP METHOD EVOLUTIO; HEUSNER AA, 1991, J EXP BIOL, V160, P25; HOCHACHKA PW, 1988, CAN J ZOOL, V66, P1128, DOI 10.1139/z88-165; Hulbert AJ, 2007, PHYSIOL REV, V87, P1175, DOI 10.1152/physrev.00047.2006; Hulbert AJ, 2000, ANNU REV PHYSIOL, V62, P207, DOI 10.1146/annurev.physiol.62.1.207; JEULIN C, 1992, CELL MOTIL CYTOSKEL, V21, P210, DOI 10.1002/cm.970210305; Kamp G, 1996, EXPERIENTIA, V52, P487, DOI 10.1007/BF01919321; KLEIBER MAX, 1932, HILGARDIA, V6, P315; Kolokotrones T, 2010, NATURE, V464, P753, DOI 10.1038/nature08920; Konarzewski M, 2013, J COMP PHYSIOL B, V183, P27, DOI 10.1007/s00360-012-0698-z; KREBS HA, 1950, BIOCHIM BIOPHYS ACTA, V4, P249, DOI 10.1016/0006-3002(50)90032-1; Krisfalusi M, 2006, BIOL REPROD, V75, P270, DOI 10.1095/biolreprod.105.049684; Lupold S, 2013, EVOLUTION, V67, P3052, DOI 10.1111/evo.12132; Makarieva AM, 2008, P NATL ACAD SCI USA, V105, P16994, DOI 10.1073/pnas.0802148105; Malo AF, 2005, P ROY SOC B-BIOL SCI, V272, P149, DOI 10.1098/rspb.2004.2933; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Miki Kiyoshi, 2007, Soc Reprod Fertil Suppl, V65, P309; Mukai C, 2004, BIOL REPROD, V71, P540, DOI 10.1095/biolreprod.103.026054; Orme C. D. L., 2013, CAPER PACKAGE COMP A; Parapanov R, 2008, REPROD FERT DEVELOP, V20, P431, DOI 10.1071/RD07207; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; PORTER RK, 1995, AM J PHYSIOL-REG I, V269, pR1213, DOI 10.1152/ajpregu.1995.269.5.R1213; Ramm SA, 2010, BIOL LETTERS, V6, P219, DOI 10.1098/rsbl.2009.0635; RIKMENSPOEL R, 1978, BIOPHYS J, V23, P177, DOI 10.1016/S0006-3495(78)85442-3; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Rosnow RL, 2003, CAN J EXP PSYCHOL, V57, P221, DOI 10.1037/h0087427; Ruiz-Pesini E, 2007, CURR TOP DEV BIOL, V77, P3, DOI 10.1016/S0070-2153(06)77001-6; Savage VM, 2007, P NATL ACAD SCI USA, V104, P4718, DOI 10.1073/pnas.0611235104; Schmidt-Nielsen K., 1990, ANIMAL PHYSL ADAPTAT; SCHOCH G, 1990, EUR J CLIN NUTR, V44, P647; Smithson M, 2002, CONFIDENCE INTERVALS; Storey BT, 2008, INT J DEV BIOL, V52, P427, DOI 10.1387/ijdb.072522bs; Tomkins JL, 2002, ANIM BEHAV, V63, P1009, DOI 10.1006/anbe.2001.1994; Tourmente M, 2013, EVOLUTION, V67, P1838, DOI 10.1111/evo.12079; Tourmente M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021244; Tourmente M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-12; Travis AJ, 1998, MOL BIOL CELL, V9, P263, DOI 10.1091/mbc.9.2.263; Travis AJ, 2001, J BIOL CHEM, V276, P7630, DOI 10.1074/jbc.M006217200; Turner N, 2005, AM J PHYSIOL-REG I, V288, pR301, DOI 10.1152/ajpregu.00297.2004; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; WATERLOW JC, 1984, Q J EXP PHYSIOL CMS, V69, P409, DOI 10.1113/expphysiol.1984.sp002829; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; West GB, 2002, P NATL ACAD SCI USA, V99, P2473, DOI 10.1073/pnas.012579799; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; White CR, 2013, J COMP PHYSIOL B, V183, P1, DOI 10.1007/s00360-012-0676-5; Yeung CH, 2002, J ANDROL, V23, P522	66	15	15	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138185	10.1371/journal.pone.0138185	http://dx.doi.org/10.1371/journal.pone.0138185			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371474	Green Published, Green Submitted, gold			2022-12-27	WOS:000361604400055
J	Jiang, YF; Pun, RYK; Peariso, K; Holland, KD; Lian, QQ; Danzer, SC				Jiang, Yifei; Pun, Raymund Y. K.; Peariso, Katrina; Holland, Katherine D.; Lian, Qingquan; Danzer, Steve C.			Olfactory Bulbectomy Leads to the Development of Epilepsy in Mice	PLOS ONE			English	Article							SPONTANEOUS RECURRENT SEIZURES; TEMPORAL-LOBE EPILEPSY; PILOCARPINE MODEL; GRANULE CELLS; DEPRESSION; RAT; BEHAVIOR; BRAIN; EPILEPTOGENESIS; COMORBIDITIES	There is a clear link between epilepsy and depression. Clinical data demonstrate a 30-35% lifetime prevalence of depression in patients with epilepsy, and patients diagnosed with depression have a three to sevenfold higher risk of developing epilepsy. Traditional epilepsy models partially replicate the clinical observations, with the demonstration of depressive traits in epileptic animals. Studies assessing pro-epileptogenic changes in models of depression, however, are more limited. Here, we examined whether a traditional rodent depression model-bilateral olfactory bulbectomy-predisposes the animals towards the development of epilepsy. Past studies have demonstrated increased neuronal excitability after bulbectomy, but continuous seizure monitoring had not been conducted. For the present study, we monitored control and bulbectomized animals by video-EEG 24/7 for approximately two weeks following the surgery to determine whether they develop spontaneous seizures. All seven bulbectomized mice exhibited seizures during the monitoring period. Seizures began about one week after surgery, and occurred in clusters with severity increasing over the monitoring period. These results suggest that olfactory bulbectomy could be a useful model of TBI-induced epilepsy, with advantages of relatively rapid seizure onset and a high number of individuals developing the disease. The model may also be useful for investigating the mechanisms underlying the bidirectional relationship between epilepsy and depression.	[Jiang, Yifei; Lian, Qingquan] Wenzhou Med Univ, Dept Anesthesia, Affiliated Hosp 2, Wenzhou, Zhejiang, Peoples R China; [Jiang, Yifei; Pun, Raymund Y. K.; Danzer, Steve C.] Cincinnati Childrens Hosp Med Ctr, Dept Anesthesia, Cincinnati, OH USA; [Peariso, Katrina] Univ Cincinnati, Med Ctr, Div Neurocrit Care, Cincinnati, OH 45267 USA; [Holland, Katherine D.] Cincinnati Childrens Hosp Med Ctr, Dept Neurol, Cincinnati, OH 45229 USA; [Danzer, Steve C.] Univ Cincinnati, Dept Anesthesia, Cincinnati, OH USA; [Danzer, Steve C.] Univ Cincinnati, Dept Pediat, Cincinnati, OH USA	Wenzhou Medical University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Lian, QQ (corresponding author), Wenzhou Med Univ, Dept Anesthesia, Affiliated Hosp 2, Wenzhou, Zhejiang, Peoples R China.	lianqingquanmz@163.com; steve.danzer@cchmc.org	Peariso, Katrina/Y-1516-2019; Peariso, Katrina/AAQ-2090-2021	Peariso, Katrina/0000-0003-1616-8329; 	National Institutes of Health;  [1R01-NS-062806];  [2R01-NS-065020]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065020, R01NS062806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health in the form of grant awards to SD; award numbers 1R01-NS-062806 and 2R01-NS-065020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKI Y, 1972, JPN J PHARMACOL, V22, P447, DOI 10.1254/jjp.22.447; Badea A, 2007, NEUROIMAGE, V37, P683, DOI 10.1016/j.neuroimage.2007.05.046; CAIN DP, 1978, BEHAV BIOL, V22, P264, DOI 10.1016/S0091-6773(78)92320-9; Castro OW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046044; Cryan JF, 2004, MOL PSYCHIATR, V9, P326, DOI 10.1038/sj.mp.4001457; Epps SA, 2013, BIOCHEM PHARMACOL, V85, P135, DOI 10.1016/j.bcp.2012.08.016; Epps SA, 2012, NEUROPSYCHOPHARMACOL, V37, P2756, DOI 10.1038/npp.2012.141; Fox J., 2006, MOUSE BIOMEDICAL RES; Goffin K, 2007, EXP NEUROL, V205, P501, DOI 10.1016/j.expneurol.2007.03.008; Groticke I, 2007, EXP NEUROL, V207, P329, DOI 10.1016/j.expneurol.2007.06.021; Haut SR, 2005, NEUROLOGY, V65, P1313, DOI 10.1212/01.wnl.0000180685.84547.7f; Hesdorffer DC, 2006, ANN NEUROL, V59, P35, DOI 10.1002/ana.20685; Hester MS, 2014, EPILEPSY BEHAV, V38, P105, DOI 10.1016/j.yebeh.2013.12.022; Hester MS, 2013, J NEUROSCI, V33, P8926, DOI 10.1523/JNEUROSCI.5161-12.2013; Islam MR, 2014, NEUROSCIENCE, V272, P116, DOI 10.1016/j.neuroscience.2014.04.046; Jarosik J, 2007, EXP NEUROL, V204, P20, DOI 10.1016/j.expneurol.2006.09.008; Kanner AM, 2014, EPILEPSY BEHAV, V38, P3, DOI 10.1016/j.yebeh.2014.06.027; Kelly JP, 1999, EUR NEUROPSYCHOPHARM, V9, P101, DOI 10.1016/S0924-977X(98)00010-8; LEONARD CM, 1975, J COMP NEUROL, V162, P467, DOI 10.1002/cne.901620405; Lin JJ, 2012, LANCET, V380, P1180, DOI 10.1016/S0140-6736(12)61455-X; Loscher W, 1996, PROG NEUROBIOL, V50, P427, DOI 10.1016/S0301-0082(96)00036-6; Machado DG, 2012, PHARMACOL BIOCHEM BE, V103, P220, DOI 10.1016/j.pbb.2012.08.024; MILLAN MH, 1986, BRAIN RES, V398, P204, DOI 10.1016/0006-8993(86)91271-0; Morales-Medina JC, 2013, J CHEM NEUROANAT, V52, P80, DOI 10.1016/j.jchemneu.2013.07.001; NAKANISHI H, 1990, BRAIN RES, V532, P69, DOI 10.1016/0006-8993(90)91743-Z; OTMAKHOVA NA, 1992, PHYSIOL BEHAV, V52, P441, DOI 10.1016/0031-9384(92)90329-Z; Pause BM, 2001, J PSYCHIAT RES, V35, P271, DOI 10.1016/S0022-3956(01)00029-2; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; Pitkanen A, 2011, NEUROSCI LETT, V497, P163, DOI 10.1016/j.neulet.2011.02.033; Powell KL, 2014, EPILEPSIA, V55, P1959, DOI 10.1111/epi.12840; Pun RYK, 2012, NEURON, V75, P1022, DOI 10.1016/j.neuron.2012.08.002; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Restrepo D, 2014, EPILEPSY BEHAV, V38, P37, DOI 10.1016/j.yebeh.2013.08.036; Roche M, 2008, PHARMACOL REP, V60, P404; Romeas T, 2009, PSYCHOPHARMACOLOGY, V205, P293, DOI 10.1007/s00213-009-1539-y; Sankar R, 2010, EPILEPSIA, V51, P81, DOI 10.1111/j.1528-1167.2010.02867.x; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Song C, 2005, NEUROSCI BIOBEHAV R, V29, P627, DOI 10.1016/j.neubiorev.2005.03.010; WATANABE S, 1982, PHYSIOL BEHAV, V28, P687, DOI 10.1016/0031-9384(82)90052-X; WATANABE S, 1980, TOHOKU J EXP MED, V130, P41, DOI 10.1620/tjem.130.41; Watson JB, 1907, PSYCHOL REV MONOGRAP, V8, pi; Williams PA, 2009, J NEUROSCI, V29, P2103, DOI 10.1523/JNEUROSCI.0980-08.2009	43	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138178	10.1371/journal.pone.0138178	http://dx.doi.org/10.1371/journal.pone.0138178			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368332	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100240
J	Yang, LX; Yang, XF				Yang, Lu-Xing; Yang, Xiaofan			A Novel Virus-Patch Dynamic Model	PLOS ONE			English	Article							COMPUTER VIRUSES; PROPAGATION; INFORMATION; EPIDEMICS; NETWORKS	The distributed patch dissemination strategies are a promising alternative to the conventional centralized patch dissemination strategies. This paper aims to establish a theoretical framework for evaluating the effectiveness of distributed patch dissemination mechanism. Assuming that the Internet offers P2P service for every pair of nodes on the network, a dynamic model capturing both the virus propagation mechanism and the distributed patch dissemination mechanism is proposed. This model takes into account the infected removable storage media and hence captures the interaction of patches with viruses better than the original SIPS model. Surprisingly, the proposed model exhibits much simpler dynamic properties than the original SIPS model. Specifically, our model admits only two potential (viral) equilibria and undergoes a fold bifurcation. The global stabilities of the two equilibria are determined. Consequently, the dynamical properties of the proposed model are fully understood. Furthermore, it is found that reducing the probability per unit time of disconnecting a node from the Internet benefits the containment of electronic viruses.	[Yang, Lu-Xing] Chongqing Univ, Coll Comp Sci, Chongqing 630044, Peoples R China; [Yang, Xiaofan] Chongqing Univ, Sch Software Engn, Chongqing 630044, Peoples R China	Chongqing University; Chongqing University	Yang, XF (corresponding author), Chongqing Univ, Sch Software Engn, Chongqing 630044, Peoples R China.	xfyang1964@gmail.com		Yang, Lu-Xing/0000-0002-9229-5787	China Scholarship Council [201406050107]; Natural Science Foundation of China [61379158, 71301177, 61572006]; Science and Technology Support Program of China [2014BAH25F01]	China Scholarship Council(China Scholarship Council); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Support Program of China	This work was supported by China Scholarship Council, grant number 201406050107 (http://en.csc.edu.cn/,receiver: LY); Natural Science Foundation of China, grant numbers 61379158, 71301177, and 61572006 (http://www.nsfc.gov.cn/publish/portal1/,receiver XY); and Science and Technology Support Program of China, grant number 2014BAH25F01 (receiver: XY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen LC, 2004, IEEE T SYST MAN CY B, V34, P823, DOI 10.1109/TSMCB.2003.817098; Chen LJ, 2014, PHYS LETT A, V378, P3028, DOI 10.1016/j.physleta.2014.09.002; Dong T, 2012, ABSTR APPL ANAL, DOI 10.1155/2012/841987; Feng LP, 2012, MATH COMPUT MODEL, V56, P167, DOI 10.1016/j.mcm.2011.12.010; Gan CQ, 2014, NONLINEAR DYNAM, V78, P1349, DOI 10.1007/s11071-014-1521-z; Goldenberg J, 2005, NAT PHYS, V1, P184, DOI 10.1038/nphys177; Kephart J. O., 1991, Proceedings. 1991 IEEE Computer Society Symposium on Research in Security and Privacy (Cat. No.91CH2986-8), P343, DOI 10.1109/RISP.1991.130801; Kuznetsov, 2013, ELEMENTS APPL BIFURC; Marceau V, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.026105; Mishra BK, 2011, APPL MATH COMPUT, V217, P8438, DOI 10.1016/j.amc.2011.03.041; Pastor-Satorras R, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066117; Piqueira JRC, 2008, COMPUT SECUR, V27, P355, DOI 10.1016/j.cose.2008.07.006; Piqueira JRC, 2009, APPL MATH COMPUT, V213, P355, DOI 10.1016/j.amc.2009.03.023; Ren JG, 2012, NONLINEAR ANAL-REAL, V13, P376, DOI 10.1016/j.nonrwa.2011.07.048; Robinson RC, 2004, INTRO DYNAMICAL SYST; Szor P., 2005, ART COMPUTER VIRUS R; THIEME HR, 1994, ROCKY MT J MATH, V24, P351; Toutonji OA, 2012, APPL MATH MODEL, V36, P2751, DOI 10.1016/j.apm.2011.09.058; Van Mieghem P, 2009, IEEE ACM T NETWORK, V17, P1, DOI 10.1109/TNET.2008.925623; Wen S, 2015, IEEE T COMPUT, V64, P640, DOI 10.1109/TC.2013.2295802; Wen S, 2014, IEEE T PARALL DISTR, V25, P3306, DOI 10.1109/TPDS.2013.2297115; Wen S, 2014, IEEE NETWORK, V28, P64, DOI 10.1109/MNET.2014.6915441; Yang LX, 2014, NONLINEAR DYNAM, V76, P1379, DOI 10.1007/s11071-013-1216-x; Yang LX, 2013, APPL MATH COMPUT, V219, P8705, DOI 10.1016/j.amc.2013.02.031; Yang LX, 2013, NONLINEAR ANAL-REAL, V14, P414, DOI 10.1016/j.nonrwa.2012.07.005; Yao Y, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/408183; Yao Y, 2012, COMPUT ELECTR ENG, V38, P1047, DOI 10.1016/j.compeleceng.2011.07.009; Yao Y, 2013, MATH COMPUT MODEL, V57, P2635, DOI 10.1016/j.mcm.2011.06.044; Youssef M, 2011, J THEOR BIOL, V283, P136, DOI 10.1016/j.jtbi.2011.05.029; Yuan H, 2008, APPL MATH COMPUT, V206, P357, DOI 10.1016/j.amc.2008.09.025; ZHANG CM, 2012, DISCRETE DYN NAT SOC, DOI DOI 10.1155/2012/260962; Zhu QY, 2013, NONLINEAR DYNAM, V73, P1433, DOI 10.1007/s11071-013-0874-z	32	19	19	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137858	10.1371/journal.pone.0137858	http://dx.doi.org/10.1371/journal.pone.0137858			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368556	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100157
J	Hardcastle, SJ; McNamara, K; Tritton, L				Hardcastle, Sarah J.; McNamara, Keira; Tritton, Larette			Using Visual Methods to Understand Physical Activity Maintenance following Cardiac Rehabilitation	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; REFERRAL STRATEGIES; EXERCISE; WOMEN; INTERVENTION; METAANALYSIS; ADHERENCE; PROGRAMS; BELIEFS	Few studies have explored the factors associated with long-term maintenance of exercise following cardiac rehabilitation. The present study used auto-photography and interviews to explore the factors that influence motivation and continued participation in physical activity among post cardiac rehabilitation patients. Twenty-three semi-structured interviews were conducted alongside participant-selected photographs or drawings with participants that had continued participation in physical activity for at least two years following the cardiac rehabilitation programme. Participants were recruited from circuit training classes in East Sussex in the UK. Thematic content analysis revealed seven main themes: fear of death and ill health avoidance, critical incidents, overcoming aging, social influences, being able to enjoy life, provision of routine and structure, enjoyment and psychological well-being. Fear of death, illness avoidance, overcoming aging, and being able to enjoy life were powerful motives for continued participation in exercise. The social nature of the exercise class was also identified as a key facilitator of continued participation. Group-based exercise suited those that continued exercise participation post cardiac rehabilitation and fostered adherence.	[Hardcastle, Sarah J.] Curtin Univ, Sch Psychol & Speech Pathol, Hlth Psychol & Behav Med Res Grp, Perth, WA 6845, Australia; [McNamara, Keira] Brunel Univ, Dept Clin Sci, London, England; [Tritton, Larette] Univ Brighton, Sch Sport & Serv Management, Brighton, E Sussex, England	Curtin University; Brunel University; University of Brighton	Hardcastle, SJ (corresponding author), Curtin Univ, Sch Psychol & Speech Pathol, Hlth Psychol & Behav Med Res Grp, Perth, WA 6845, Australia.	sarah.hardcastle@curtin.edu.au		Hardcastle, Sarah/0000-0001-8378-3781				Abraham C, 2008, HLTH PSYCHOL; Anfara V. A., 2002, ED RES, V31, P28, DOI DOI 10.3102/0013189X031007028; Angus JE, 2015, J ADV NURS, V71, P1758, DOI 10.1111/jan.12620; Angus JE, 2009, INT J ENV RES PUB HE, V6, P2481, DOI 10.3390/ijerph6092481; Beswick A, 2002, J ADV NUR, V49, P538; Bethell HJN, 1990, BRIT J SPORT MED, V33, P79; Bjarnason-Wehrens B, 2010, EUR J CARDIOV PREV R, V17, P410, DOI [DOI 10.1097/HJR.0b013e328334f42d, 10.1097/HJR.0b013e328334f42d]; Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Cassidy A, 2011, VISUAL METHODS PSYCH, P208; Clark AM, 2013, CLIN REHABIL, V27, P948, DOI 10.1177/0269215513481046; Clark AM, 2005, ANN INTERN MED, V143, P659, DOI 10.7326/0003-4819-143-9-200511010-00010; Cooper AF, 2005, CLIN REHABIL, V19, P87, DOI 10.1191/0269215505cr818oa; Dalal HM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5631; Daly John, 2002, Prog Cardiovasc Nurs, V17, P8, DOI 10.1111/j.0889-7204.2002.00614.x; Darr A, 2008, HEART LUNG, V37, P91, DOI 10.1016/j.hrtlng.2007.03.004; Davidson P, 2008, J WOMENS HEALTH, V17, P123, DOI 10.1089/jwh.2007.0386; Doiron-Maillet Nancy, 2003, Can J Cardiovasc Nurs, V13, P14; Everett B, 2008, J CARDIOPULM REHABIL, V28, P61, DOI 10.1097/01.HCR.0000311511.23849.35; Fleury Julie, 2004, J Cardiopulm Rehabil, V24, P296, DOI 10.1097/00008483-200409000-00002; Fleury J, 2009, QUAL HEALTH RES, V19, P677, DOI 10.1177/1049732309334471; Ganesh TG, 2011, SAGE HDB VISUAL RES, P237; Gauntlett D, 2007, CREATIVE EXPLORATION, P92; Grace Sherry L, 2004, J Cardiopulm Rehabil, V24, P171, DOI 10.1097/00008483-200405000-00006; Grace SL, 2011, ARCH INTERN MED, V171, P235, DOI 10.1001/archinternmed.2010.501; Gravely-Witte S, 2010, NAT REV CARDIOL, V7, P87, DOI 10.1038/nrcardio.2009.223; Gregory S, 2006, FAM PRACT, V23, P220, DOI 10.1093/fampra/cmi089; Griffin M, 2010, QUAL RES SPORT EXERC, V2, P153, DOI 10.1080/19398441.2010.488024; Hagger MS, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00254; Hardcastle S, 2011, PSYCHOL SPORT EXERC, V12, P314, DOI 10.1016/j.psychsport.2011.01.001; Harper D., 2002, VISUAL STUD, V17, P13, DOI [10.1080/14725860220137345, DOI 10.1080/14725860220137345]; Heran BS, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800.pub2, 10.1002/14651858.CD001800.pub3]; Hevey D, 2007, CARDIOVASCULAR PREVE, P294; Hudson J, 1998, J SPORTS SCI, V16, P83; Jones M, 2007, FAM PRACT, V24, P343, DOI 10.1093/fampra/cmm021; Kwasnicka D, 2015, HEALTH PSYCHOL, V34, P1191, DOI 10.1037/hea0000234; Lysack C, 2015, CANADIAN J OCCUPATIO, V81, P247; Marcus BH, 2000, HEALTH PSYCHOL, V19, P32, DOI 10.1037/0278-6133.19.Suppl1.32; Martin AM, 2012, J AGING PHYS ACTIV, V20, P135, DOI 10.1123/japa.20.2.135; McSweeney J C, 2001, Rehabil Nurs, V26, P132; Mitchell R, 1999, Rehabil Nurs, V24, P236; Moore Shirley M, 2003, J Cardiopulm Rehabil, V23, P40, DOI 10.1097/00008483-200301000-00008; Morse J. M., 2002, INT J QUAL METHODS, P13, DOI 10.1177/160940690200100202; Neubeck L, 2012, EUR J PREV CARDIOL, V19, P494, DOI 10.1177/1741826711409326; Padgett DK, 2013, QUAL HEALTH RES, V23, P1435, DOI 10.1177/1049732313507752; Petter M, 2009, EUR J CARDIOV PREV R, V16, P515, DOI 10.1097/HJR.0b013e3283299585; Phoenix C, 2014, QUALITATIVE RES, P1; Phoenix C, 2010, J AGING STUD, V24, P167, DOI 10.1016/j.jaging.2008.12.007; Rogerson MC, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-140; Sniehotta FF, 2006, BRIT J HEALTH PSYCH, V11, P23, DOI 10.1348/135910705X43804; Sparkes A.C., 2014, QUALITATIVE RES METH; Spencer, 2011, VISUAL RES METHODS S; Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009; Thow M, 2008, PHYSIOTHERAPY, V94, P281, DOI 10.1016/j.physio.2008.06.001; Tierney S, 2011, HEALTH PSYCHOL, V30, P401, DOI 10.1037/a0022848; Tolmie Elizabeth P, 2006, Eur J Cardiovasc Nurs, V5, P228, DOI 10.1016/j.ejcnurse.2006.01.007; Whittemore R, 2000, QUAL HEALTH RES, V10, P260, DOI 10.1177/104973200129118408; Willich S, 2001, EUROPEAN HEART J, V22, P276; Wingham Jenny, 2006, Eur J Cardiovasc Nurs, V5, P289, DOI 10.1016/j.ejcnurse.2006.02.002; Yohannes AM, 2007, CLIN REHABIL, V21, P222, DOI 10.1177/0269215506070771	60	10	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138218	10.1371/journal.pone.0138218	http://dx.doi.org/10.1371/journal.pone.0138218			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0ZE	26381147	Green Submitted, Green Published, gold			2022-12-27	WOS:000361790200071
J	Liu, BH; Lin, YC; Ho, CS; Yang, CC; Chang, YT; Chang, JF; Li, CY; Cheng, CS; Huang, JY; Lee, YF; Hsu, MH; Lin, FC; Wang, HC; Lo, CF; Yang, SY; Wang, HC				Liu, Bing-Hsien; Lin, Yu-Chen; Ho, Chia-Shin; Yang, Che-Chuan; Chang, Yun-Tsui; Chang, Jui-Feng; Li, Chun-Yuan; Cheng, Cheng-Shun; Huang, Jiun-Yan; Lee, Yen-Fu; Hsu, Ming-Hung; Lin, Feng-Chun; Wang, Hao-Ching; Lo, Chu-Fang; Yang, Shieh-Yueh; Wang, Han-Ching			A Novel Detection Platform for Shrimp White Spot Syndrome Virus Using an ICP11-Dependent Immunomagnetic Reduction (IMR) Assay	PLOS ONE			English	Article							NERVOUS NECROSIS VIRUS; REAL-TIME PCR; MONOCLONAL-ANTIBODIES; ENVELOPE PROTEIN; WSSV; ICP11; WSBV	Shrimp white spot disease (WSD), which is caused by white spot syndrome virus (WSSV), is one of the world's most serious shrimp diseases. Our objective in this study was to use an immunomagnetic reduction (IMR) assay to develop a highly sensitive, automatic WSSV detection platform targeted against ICP11 (the most highly expressed WSSV protein). After characterizing the magnetic reagents (Fe3O4 magnetic nanoparticles coated with anti ICP11), the detection limit for ICP11 protein using IMR was approximately 2 x 10(-3) ng/ml, and the linear dynamic range of the assay was 0.1 similar to 1 x 10(6) ng/ml. In assays of ICP11 protein in pleopod protein lysates from healthy and WSSV-infected shrimp, IMR signals were successfully detected from shrimp with low WSSV genome copy numbers. We concluded that this IMR assay targeting ICP11 has potential for detecting the WSSV.	[Liu, Bing-Hsien; Lin, Yu-Chen; Ho, Chia-Shin; Yang, Che-Chuan; Chang, Yun-Tsui; Chang, Jui-Feng; Lee, Yen-Fu; Hsu, Ming-Hung; Lin, Feng-Chun; Yang, Shieh-Yueh] MagQu Co Ltd, New Taipei City 231, Taiwan; [Li, Chun-Yuan; Cheng, Cheng-Shun; Wang, Han-Ching] Natl Cheng Kung Univ, Inst Biotechnol, Tainan 701, Taiwan; [Huang, Jiun-Yan; Lo, Chu-Fang] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Tainan 701, Taiwan; [Wang, Hao-Ching] Taipei Med Univ, Grad Inst Translat Med, Coll Med Sci & Technol, Taipei 110, Taiwan	National Cheng Kung University; National Cheng Kung University; Taipei Medical University	Wang, HC (corresponding author), Natl Cheng Kung Univ, Inst Biotechnol, Tainan 701, Taiwan.	wanghc@mail.ncku.edu.tw	Wang, Han-Ching/AAT-6086-2021; Lo, Chu-Fang/G-3088-2014	Lo, Chu-Fang/0000-0001-5136-8129; Wang, Han-Ching/0000-0001-7283-4942; Wang, Hao-Ching/0000-0003-2396-717X	Agricultural Technology Research Institute in Taiwan [103AG-a5.2-08]	Agricultural Technology Research Institute in Taiwan	This work was supported by Agricultural Technology Research Institute in Taiwan (grant 103AG-a5.2-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BHL, YCL, CSH, CCY, YTC, JFC, YFL, MHH, FCL and SYY are employed by MagQu Co. The funder provided support in the form of salaries for authors [BHL, YCL, CSH, CCY, JFC, YFL, MHH, FCL and SYY], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Chaivisuthangkura Parin, 2014, World J Virol, V3, P1, DOI 10.5501/wjv.v3.i1.1; Chaivisuthangkura P, 2010, AQUACULTURE, V299, P15, DOI 10.1016/j.aquaculture.2009.12.005; Chang CH, 2012, INT J NANOMED, V7, P4335, DOI 10.2147/IJN.S31030; Chen IT, 2011, J VIROL, V85, P12919, DOI 10.1128/JVI.05385-11; Escobedo-Bonilla CM, 2008, J FISH DIS, V31, P1, DOI 10.1111/j.1365-2761.2007.00877.x; Gnoth C, 2014, GEBURTSH FRAUENHEILK, V74, P661, DOI 10.1055/s-0034-1368589; Hong CY, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2206557; Leal CAG, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-150; Liu W, 2002, DIS AQUAT ORGAN, V49, P11, DOI 10.3354/dao049011; Lo CF, 1996, DIS AQUAT ORGAN, V25, P133, DOI 10.3354/dao025133; Lo CF, 1997, DIS AQUAT ORGAN, V30, P53, DOI 10.3354/dao030053; Lo CF, 1998, FISH PATHOL, V33, P365, DOI 10.3147/jsfp.33.365; Lu MW, 2012, J VIROL METHODS, V181, P68, DOI 10.1016/j.jviromet.2012.01.012; Nunan LM, 2011, J VIROL METHODS, V171, P318, DOI 10.1016/j.jviromet.2010.11.015; Poulos BT, 2001, DIS AQUAT ORGAN, V47, P13, DOI 10.3354/dao047013; Powell JWB, 2006, AQUACULTURE, V257, P167, DOI 10.1016/j.aquaculture.2006.03.010; Pradeep B, 2012, INDIAN J VIROL, V23, P161, DOI 10.1007/s13337-012-0079-y; Sanchez-Paz A, VIROL J, V213, P186; Siriwattanarat R, 2013, ARCH VIROL, V158, P967, DOI 10.1007/s00705-012-1569-3; Sithigorngul P, 2011, J VIROL METHODS, V173, P85, DOI 10.1016/j.jviromet.2011.01.011; Su MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004196; Tsai YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090545; Wang HC, 2007, DIS AQUAT ORGAN, V74, P179, DOI 10.3354/dao074179; Wang HC, 2008, P NATL ACAD SCI USA, V105, P20758, DOI 10.1073/pnas.0811233106; Yang CC, 2012, J APPL PHYS, V112, DOI 10.1063/1.4739735; Yang CC, 2012, J NANOBIOTECHNOL, V12, P44; Yang CC, 2011, ACS CHEM NEUROSCI, V2, P500, DOI 10.1021/cn200028j; Yang SY, 2008, J MAGN MAGN MATER, V320, P2688, DOI 10.1016/j.jmmm.2008.05.048; Yang SY, 2012, J VET DIAGN INVEST, V24, P911, DOI 10.1177/1040638712455796	29	68	69	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138207	10.1371/journal.pone.0138207	http://dx.doi.org/10.1371/journal.pone.0138207			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26380977	Green Published, gold, Green Submitted			2022-12-27	WOS:000361790200070
J	Gemzell-Danielsson, K; Apter, D; Hauck, B; Schmelter, T; Rybowski, S; Rosen, K; Nelson, A				Gemzell-Danielsson, Kristina; Apter, Dan; Hauck, Brian; Schmelter, Thomas; Rybowski, Sarah; Rosen, Kimberly; Nelson, Anita			The Effect of Age, Parity and Body Mass Index on the Efficacy, Safety, Placement and User Satisfaction Associated With Two Low-Dose Levonorgestrel Intrauterine Contraceptive Systems: Subgroup Analyses of Data From a Phase III Trial	PLOS ONE			English	Article							NULLIPAROUS WOMEN	Objective Two low-dose levonorgestrel intrauterine contraceptive systems (LNG-IUSs; total content 13.5 mg [average approx. 8 pg124 hours over the first year; LNG-IUS 8] and total content 19.5 mg [average approx. 13 pg124 hours over the first year; LNG-IUS 13]) have previously been shown to be highly effective (3-year Pearl Indices: 0.33 and 0.31, respectively), safe and well tolerated. The present subgroup analyses evaluated whether or not outcomes were affected by parity, age (18-25 vs 26-35 years), or body mass index (BMI, <30 vs >30 kg/m(2)). Methods Nulliparous and parous women aged 18-35 years with regular menstrual cycles (21-35 days) requesting contraception were randomized to 3 years of LNG-IUS 8 or LNG-IUS 13 use. Results In the LNG-IUS 8 and LNG-IUS 13 groups, 1432 and 1452 women, respectively, had a placement attempted and were included in the full analysis set; 39.2%, 39.2% and 17.1% were 18-25 years old, nulliparous and had a BMI >30 kg/m(2), respectively. Both systems were similarly effective regardless of age, parity or BMI; the subgroup Pearl Indices had widely overlapping 95% confidence intervals. Placement of LNG-IUS 8 and LNG-IUS 13 was easier (p < 0.0001) and less painful (p <0.0001) in women who had delivered vaginally than in women who had not. The complete/partial expulsion rate was 2.2-4.2% across all age and parity subgroups and higher in parous than in nulliparous women (p = 0.004). The incidence of pelvic inflammatory disease was 0.1-0.6% across all age and parity subgroups: nulliparous and younger women were not at higher risk than parous and older women, respectively. The ectopic pregnancy rate was 0.3-0.4% across all age and parity subgroups. Across all age and parity subgroups, the 3-year completion rate was 50.961.3% for LNG-IUS 8 and 57.9-61.1% for LNG-IUS 13, and was higher (p = 0.0001) among older than younger women in the LNG-IUS 8 group only. Conclusions LNG-IUS 8 and LNG-IUS 13 were highly effective, safe and well tolerated regardless of age or parity.	[Gemzell-Danielsson, Kristina] Karolinska Inst, Div Obstet & Gynecol, Dept Womens & Childrens Hlth, SE-17176 Stockholm, Sweden; [Gemzell-Danielsson, Kristina] Karolinska Univ Hosp, SE-17176 Stockholm, Sweden; [Apter, Dan] Sexual Hlth Clin Family Federat Finland, Helsinki 00101, Finland; [Hauck, Brian] Univ Calgary, Foothills Hosp, Dept Obstet & Gynecol, Calgary, AB T2N 4J8, Canada; [Schmelter, Thomas] Bayer Pharma AG, D-13353 Berlin, Germany; [Rybowski, Sarah; Rosen, Kimberly] Bayer HealthCare Pharmaceut, Whippany, NJ USA; [Nelson, Anita] Harbor UCLA, Los Angeles Biomed Res Inst, Torrance, CA 90405 USA	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Calgary; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute	Gemzell-Danielsson, K (corresponding author), Karolinska Inst, Div Obstet & Gynecol, Dept Womens & Childrens Hlth, SE-17176 Stockholm, Sweden.	Kristina.Gemzell@ki.se	Schmelter, Thomas/AAS-3728-2021; Apter, Dan/D-6269-2017	Apter, Dan/0000-0002-5175-8845; Schmelter, Thomas/0000-0003-1358-3172	Bayer HealthCare Pharmaceuticals; Bayer HealthCare	Bayer HealthCare Pharmaceuticals(Bayer AGBayer Healthcare Pharmaceuticals); Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals)	The study was funded by Bayer HealthCare Pharmaceuticals. The authors also acknowledge medical writing support in the development of the manuscript, provided by Chameleon Communications, with the financial support of Bayer HealthCare. The authors Thomas Schmelter, Sarah Rybowski and Kimberly Rosen are employees of Bayer HealthCare. Kimberly Rosen was involved in the design of the study and verified the data included in the manuscript, Thomas Schmelter was the study statistician and Sarah Rybowski verified the data included in the manuscript. In addition, they all contributed to the writing of the manuscript.	[Anonymous], 2010, CONTRACEPTION, V81, P367, DOI 10.1016/j.contraception.2010.01.010; Bahamondes M Valeria, 2011, Contraception, V84, pe11, DOI 10.1016/j.contraception.2011.05.012; Bayer Health Care Pharmaceuticals Inc, 2013, SKYL PRESCR INF; Bayer Health Care Pharmaceuticals Inc, 2012, COST UN PREGN MOD TE; Black K, 2012, EUR J CONTRACEP REPR, V17, P340, DOI 10.3109/13625187.2012.700744; Faculty of the Royal College of Obstetricians and Gynaecologists, 2009, UK MED EL CONTR US; Gemzell-Danielsson K, 2013, HUM REPROD UPDATE, V19, P419, DOI 10.1093/humupd/dmt022; Gemzell-Danielsson K, 2012, FERTIL STERIL, V97, P616, DOI 10.1016/j.fertnstert.2011.12.003; Larimore WL, 2000, BRIT MED J, V321, P450, DOI 10.1136/bmj.321.7258.450; Madden T, 2010, CONTRACEPTION, V82, P187, DOI 10.1016/j.contraception.2010.04.041; MMWR, 2010, MMWR SEX TRANSM DIS; Nelson A, 2013, OBSTET GYNECOL, V122, P1205, DOI 10.1097/AOG.0000000000000019; Prager S, 2007, CONTRACEPTION, V75, pS12, DOI 10.1016/j.contraception.2007.01.018; Tyler CP, 2012, OBSTET GYNECOL, V119, P762, DOI 10.1097/AOG.0b013e31824aca39; Veldhuis H M, 2004, Eur J Gen Pract, V10, P82; World Health Organization (WHO), 2010, MED EL CRIT CONTR US	16	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0135309	10.1371/journal.pone.0135309	http://dx.doi.org/10.1371/journal.pone.0135309			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378938	gold, Green Published, Green Submitted			2022-12-27	WOS:000361769400001
J	Gomez-Vicente, V; Lax, P; Fernandez-Sanchez, L; Rondon, N; Esquiva, G; Germain, F; de la Villa, P; Cuenca, N				Gomez-Vicente, Violeta; Lax, Pedro; Fernandez-Sanchez, Laura; Rondon, Netxibeth; Esquiva, Gema; Germain, Francisco; de la Villa, Pedro; Cuenca, Nicolas			Neuroprotective Effect of Tauroursodeoxycholic Acid on N-Methyl-D-Aspartate-Induced Retinal Ganglion Cell Degeneration	PLOS ONE			English	Article							NMDA RECEPTOR SUBUNITS; OXIDATIVE STRESS; MOUSE MODEL; ACTIVATION; TUDCA; DEATH; NEUROTOXICITY; LOCALIZATION; DYSFUNCTION; APOPTOSIS	Retinal ganglion cell degeneration underlies the pathophysiology of diseases affecting the retina and optic nerve. Several studies have previously evidenced the anti-apoptotic properties of the bile constituent, tauroursodeoxycholic acid, in diverse models of photoreceptor degeneration. The aim of this study was to investigate the effects of systemic administration of tauroursodeoxycholic acid on N-methyl-D-aspartate (NMDA)-induced damage in the rat retina using a functional and morphological approach. Tauroursodeoxycholic acid was administered intraperitoneally before and after intravitreal injection of NMDA. Three days after insult, full-field electroretinograms showed reductions in the amplitudes of the positive and negative-scotopic threshold responses, scotopic alpha- and beta-waves and oscillatory potentials. Quantitative morphological evaluation of whole-mount retinas demonstrated a reduction in the density of retinal ganglion cells. Systemic administration of tauroursodeoxycholic acid attenuated the functional impairment induced by NMDA, which correlated with a higher retinal ganglion cell density. Our findings sustain the efficacy of tauroursodeoxycholic acid administration in vivo, suggesting it would be a good candidate for the pharmacological treatment of degenerative diseases coursing with retinal ganglion cell loss.	[Gomez-Vicente, Violeta] Univ Alicante, Dept Opt Farmacol & Anat, E-03080 Alicante, Spain; [Lax, Pedro; Fernandez-Sanchez, Laura; Rondon, Netxibeth; Esquiva, Gema; Cuenca, Nicolas] Univ Alicante, Dept Fisiol Genet & Microbiol, E-03080 Alicante, Spain; [Germain, Francisco; de la Villa, Pedro] Univ Alcala de Henares, Dept Biol Sistemas, E-28801 Alcala De Henares, Spain	Universitat d'Alacant; Universitat d'Alacant; Universidad de Alcala	Cuenca, N (corresponding author), Univ Alicante, Dept Fisiol Genet & Microbiol, E-03080 Alicante, Spain.	cuenca@ua.es	Fernandez-Sanchez, Laura/AAB-5663-2019; Esquiva, Gema/AAE-5642-2020; Gómez-Vicente, Violeta/A-6089-2013; Lax, Pedro/M-9074-2014; Cuenca, Nicolas/I-2007-2015; Germain, Francisco/J-7152-2019; de la Villa, Pedro/G-2322-2016; Esquiva, Gema/ABA-6317-2020	Fernandez-Sanchez, Laura/0000-0002-3629-0156; Esquiva, Gema/0000-0002-3951-6464; Gómez-Vicente, Violeta/0000-0002-5696-8673; Lax, Pedro/0000-0001-6931-1008; Cuenca, Nicolas/0000-0002-6767-5710; de la Villa, Pedro/0000-0001-9856-6616; 	Spanish Ministerio de Economia y Competitividad-FEDER [BFU2012-36845]; Instituto de Salud Carlos III RETICS [RD12/0034/0010]; Organizacion Nacional de Ciegos Espanoles; Ministerio de Ciencia e Innovacion [JCI-2009-05224]; Universidad de Alicante [2010-48536273]; Instituto de Salud Carlos III [PI13/02098, RD12/0034/0006]; FUNDALUCE	Spanish Ministerio de Economia y Competitividad-FEDER(Spanish Government); Instituto de Salud Carlos III RETICS(Instituto de Salud Carlos III); Organizacion Nacional de Ciegos Espanoles; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Universidad de Alicante; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); FUNDALUCE	This work was supported by project grants from Spanish Ministerio de Economia y Competitividad-FEDER (http://www.mineco.gob.es) #BFU2012-36845, Instituto de Salud Carlos III RETICS (http://www.oftared.com) #RD12/0034/0010 and Organizacion Nacional de Ciegos Espanoles (http://www.once.es) to NC; Ministerio de Ciencia e Innovacion #JCI-2009-05224 to VGV; Universidad de Alicante (http://www.ua.es) #2010-48536273 to GE; Instituto de Salud Carlos III (http://www.isciii.es) #PI13/02098 and RETICS #RD12/0034/0006 to PdV; and FUNDALUCE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon-Martinez L, 2009, MOL VIS, V15, P2373; Baxter PS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7761; Boatright JH, 2006, MOL VIS, V12, P1706; Boatright JH, 2005, INVEST OPHTHALMOL VI, V46; Bui BV, 2004, J PHYSIOL-LONDON, V555, P153, DOI 10.1113/jphysiol.2003.052738; Cheng HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108090; Drack AV, 2012, INVEST OPHTH VIS SCI, V53, P100, DOI 10.1167/iovs.11-8544; El-Azab MF, 2014, BRIT J PHARMACOL, V171, P1299, DOI 10.1111/bph.12535; Farah MH, 2006, BRAIN RES REV, V52, P264, DOI 10.1016/j.brainresrev.2006.04.002; Fernaandez-Saanchez L, 2014, INVEST OPHTH VIS SCI, V55, P6059, DOI 10.1167/iovs.14-14421; Fernandez-Sanchez L, 2011, INVEST OPHTH VIS SCI, V52, P4998, DOI 10.1167/iovs.11-7496; Ferreira IL, 1996, EUR J PHARMACOL, V302, P153, DOI 10.1016/0014-2999(96)00044-1; Fletcher EL, 2000, J COMP NEUROL, V420, P98; Germain F, 2013, CLIN EXP OPHTHALMOL, V41, P593, DOI 10.1111/ceo.12046; Ghaffarieh A, 2012, INT REV NEUROBIOL, V105, P1, DOI 10.1016/B978-0-12-398309-1.00002-0; Kalloniatis M, 2004, VISUAL NEUROSCI, V21, P587, DOI 10.1017/S0952523804214080; Kern TS, 2008, J PHYSIOL-LONDON, V586, P4401, DOI 10.1113/jphysiol.2008.156695; KOROL S, 1975, BRAIN RES, V97, P235, DOI 10.1016/0006-8993(75)90447-3; Kwong JMK, 2011, INVEST OPHTH VIS SCI, V52, P9694, DOI 10.1167/iovs.11-7869; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; Lam TT, 1999, INVEST OPHTH VIS SCI, V40, P2391; Li Y, 1999, INVEST OPHTH VIS SCI, V40, P1004; Mantopoulos D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024245; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Nakazawa T, 2007, J NEUROCHEM, V100, P1018, DOI 10.1111/j.1471-4159.2006.04274.x; Noailles A, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0186-3; Ohno Y, 2012, EUR J PHARMACOL, V690, P84, DOI 10.1016/j.ejphar.2012.06.035; Oveson BC, 2011, J NEUROCHEM, V116, P144, DOI 10.1111/j.1471-4159.2010.07092.x; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; de Lara MJP, 2014, EXP EYE RES, V122, P40, DOI 10.1016/j.exer.2014.02.022; Phillips MJ, 2008, INVEST OPHTH VIS SCI, V49, P2148, DOI 10.1167/iovs.07-1012; Reyes RC, 2012, J NEUROSCI, V32, P12973, DOI 10.1523/JNEUROSCI.1597-12.2012; Rodrigues CMP, 2003, BIOCHEMISTRY-US, V42, P3070, DOI 10.1021/bi026979d; Rodriguez AR, 2014, J COMP NEUROL, V522, P1411, DOI 10.1002/cne.23521; Salinas-Navarro M, 2009, VISION RES, V49, P637, DOI 10.1016/j.visres.2009.01.010; Saszik SM, 2002, J PHYSIOL-LONDON, V543, P899, DOI 10.1113/jphysiol.2002.019703; Schinder AF, 1996, J NEUROSCI, V16, P6125; Schlamp CL, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-66; Schoemaker MH, 2004, HEPATOLOGY, V39, P1563, DOI 10.1002/hep.20246; Seki M, 2008, PROG BRAIN RES, V173, P495, DOI 10.1016/S0079-6123(08)01134-5; SILIPRANDI R, 1992, VISUAL NEUROSCI, V8, P567, DOI 10.1017/S0952523800005666; Sucher NJ, 1997, VISION RES, V37, P3483, DOI 10.1016/S0042-6989(97)00047-3; Wachtmeister L, 1998, PROG RETIN EYE RES, V17, P485, DOI 10.1016/S1350-9462(98)00006-8; Yamashita H, 2011, EXP EYE RES, V93, P75, DOI 10.1016/j.exer.2011.04.006; Yanguas-Casas N, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-50; Yie Q, 2002, HEPATOLOGY, V36, P592, DOI 10.1053/jhep.2002.35441; You Y, 2013, REV NEUROSCIENCE, V24, P301, DOI 10.1515/revneuro-2013-0003; Zhang T, 2012, INVEST OPHTH VIS SCI, V53, P3349, DOI 10.1167/iovs.12-9851; Zheng SJ, 2015, INVEST OPHTH VIS SCI, V56, P1168, DOI 10.1167/iovs.14-15612	49	27	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137826	10.1371/journal.pone.0137826	http://dx.doi.org/10.1371/journal.pone.0137826			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379056	Green Published, gold			2022-12-27	WOS:000361769400030
J	Wolkow, A; Ferguson, SA; Vincent, GE; Larsen, B; Aisbett, B; Main, LC				Wolkow, Alexander; Ferguson, Sally A.; Vincent, Grace E.; Larsen, Brianna; Aisbett, Brad; Main, Luana C.			The Impact of Sleep Restriction and Simulated Physical Firefighting Work on Acute Inflammatory Stress Responses	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; C-REACTIVE PROTEIN; BLOOD-CELL COUNT; ANTIINFLAMMATORY CYTOKINES; WILDFIRE SUPPRESSION; CAPILLARY BLOOD; HEART-DISEASE; HEALTHY-MEN; INTERLEUKIN-6; DEPRIVATION	Objectives This study investigated the effect restricted sleep has on wildland firefighters' acute cytokine levels during 3 days and 2 nights of simulated physical wildfire suppression work. Methods Firefighters completed multiple days of physical firefighting work separated by either an 8-h (Control condition; n = 18) or 4-h (Sleep restriction condition; n = 17) sleep opportunity each night. Blood samples were collected 4 times a day (i.e., 06: 15, 11: 30, 18: 15, 21: 30) from which plasma cytokine levels (IL-6, IL-8, IL-1 beta, TNF-alpha, IL-4, IL-10) were measured. Results The primary findings for cytokine levels revealed a fixed effect for condition that showed higher IL-8 levels among firefighters who received an 8-h sleep each night. An interaction effect demonstrated differing increases in IL-6 over successive days of work for the SR and CON conditions. Fixed effects for time indicated that IL-6 and IL-4 levels increased, while IL-1 beta, TNF-alpha and IL-8 levels decreased. There were no significant effects for IL-10 observed. Conclusion Findings demonstrate increased IL-8 levels among firefighters who received an 8-h sleep when compared to those who had a restricted 4-h sleep. Firefighters' IL-6 levels increased in both conditions which may indicate that a 4-h sleep restriction duration and/or period (i.e., 2 nights) was not a significant enough stressor to affect this cytokine. Considering the immunomodulatory properties of IL-6 and IL-4 that inhibit pro-inflammatory cytokines, the rise in IL-6 and IL-4, independent of increases in IL-1 beta and TNF-alpha, could indicate a non-damaging response to the stress of simulated physical firefighting work. However, given the link between chronically elevated cytokine levels and several diseases, further research is needed to determine if firefighters' IL-8 and IL-6 levels are elevated following repeated fire-fighting deployments across a fire season and over multiple fire seasons.	[Wolkow, Alexander; Vincent, Grace E.; Larsen, Brianna; Aisbett, Brad; Main, Luana C.] Deakin Univ, Ctr Phys Act & Nutr Res, Burwood, Vic 3125, Australia; [Wolkow, Alexander; Ferguson, Sally A.; Vincent, Grace E.; Larsen, Brianna; Aisbett, Brad] Bushfire Cooperat Res Ctr, East Melbourne, Vic 3002, Australia; [Ferguson, Sally A.] Cent Queensland Univ, Appleton Inst, Wayville, Qld 5034, Australia	Deakin University; Central Queensland University	Wolkow, A (corresponding author), Deakin Univ, Ctr Phys Act & Nutr Res, 221 Burwood Hwy, Burwood, Vic 3125, Australia.	awolkow@deakin.edu.au	Main, L.C./L-2359-2015; Aisbett, Brad/E-5178-2011	Main, L.C./0000-0002-9576-9466; Aisbett, Brad/0000-0001-8077-0272; Wolkow, Alexander/0000-0001-7845-3104; Ferguson, Sally/0000-0002-9682-7971; Larsen, Brianna/0000-0003-0885-795X; Vincent, Grace/0000-0002-7036-7823	Bushfire Co-operative Research Centre	Bushfire Co-operative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	The authors (AW, SAF, GEV, BL, BA and LCM) received funding for this study from the Bushfire Co-operative Research Centre, http://www.bushfirecrc.com/. The funders provided financial and logistical support for the study, but had no role in the study design, data collection or preparation of the manuscript.	Abedelmalek S, 2013, CHRONOBIOL INT, V30, P502, DOI 10.3109/07420528.2012.742102; Aisbett B, 2012, APPL ERGON, V43, P916, DOI 10.1016/j.apergo.2011.12.013; Akerstedt T, 2010, CHRONOBIOL INT, V27, P975, DOI 10.3109/07420528.2010.489001; [Anonymous], 2017, GUIDE REML GENSTAT; [Anonymous], 2011, P BUSHF CRC AFAC C S; Apostolakis S, 2009, CARDIOVASC RES, V84, P353, DOI 10.1093/cvr/cvp241; Axelsson J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082291; Baune BT, 2011, AGE, V33, P209, DOI 10.1007/s11357-010-9165-5; Bishop NC, 2001, INT J SPORT NUTR EXE, V11, P503, DOI 10.1123/ijsnem.11.4.503; Boudjeltia KZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028230; Boyum A, 1996, SCAND J IMMUNOL, V43, P228, DOI 10.1046/j.1365-3083.1996.d01-32.x; Brown MA, 1997, CRIT REV IMMUNOL, V17, P1; Bruunsgaard H, 2003, IMMUNOL ALLERGY CLIN, V23, P15, DOI 10.1016/S0889-8561(02)00056-5; Bruunsgaard H, 2005, J LEUKOCYTE BIOL, V78, P819, DOI 10.1189/jlb.0505247; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cater H, 2007, AUSTR FIR AUTH COUNC; Chrousos GP, 2000, INT J OBESITY, V24, pS50, DOI 10.1038/sj.ijo.0801278; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Corsini E, 2014, PHARMACOL RES, V81, P10, DOI 10.1016/j.phrs.2014.01.002; Cuddy JS, 2007, MED SCI SPORT EXER, V39, P1004, DOI 10.1249/mss.0b013e318040b2fb; Cullen T, 2015, CYTOKINE, V71, P397, DOI 10.1016/j.cyto.2014.10.011; Elenkov IJ, 2002, ANN NY ACAD SCI, V966, P290, DOI 10.1111/j.1749-6632.2002.tb04229.x; Elenkov IJ, 2008, NEUROCHEM INT, V52, P40, DOI 10.1016/j.neuint.2007.06.037; Eriksson M, 2007, CLIN EXP IMMUNOL, V150, P469, DOI 10.1111/j.1365-2249.2007.03515.x; FAO, 2004, REP HUM EN REQ; Faraut B, 2011, BRAIN BEHAV IMMUNITY, V25; Farhangi MA, 2013, J HEALTH POPUL NUTR, V31, P58; Faulkner SH, 2014, EUR J APPL PHYSIOL, V114, P1207, DOI 10.1007/s00421-014-2851-8; Febbraio MA, 2002, FASEB J, V16, P1335, DOI 10.1096/fj.01-0876rev; FRY RW, 1994, BRIT J SPORT MED, V28, P241, DOI 10.1136/bjsm.28.4.241; Glass DC., 2014, AUSTR FIREFIGHTERS H; Gundersen Y, 2006, EUR J APPL PHYSIOL, V97, P151, DOI 10.1007/s00421-006-0150-8; Haack M, 2007, SLEEP, V30, P1145, DOI 10.1093/sleep/30.9.1145; Huang CJ, 2010, INT J PSYCHOPHYSIOL, V75, P312, DOI 10.1016/j.ijpsycho.2009.12.013; Inoue T, 2008, INT J CARDIOL, V124, P319, DOI 10.1016/j.ijcard.2007.02.012; Kales SN, 2007, NEW ENGL J MED, V356, P1207, DOI 10.1056/NEJMoa060357; Laskowski R, 2011, J HUM KINET, V30, P65, DOI 10.2478/v10078-011-0074-1; Lundeland B, 2012, SCAND J CLIN LAB INV, V72, P547, DOI 10.3109/00365513.2012.705017; Main L, 2013, AUSTR FIR AUTH COUNC; Miles MP, 2006, INT J SPORT NUTR EXE, V16, P36, DOI 10.1123/ijsnem.16.1.36; Mullington JM, 2010, BEST PRACT RES CL EN, V24, P775, DOI 10.1016/j.beem.2010.08.014; National Health and Medical Research Council, 2013, AUSTR DIET GUID; Nguyen HP, 2010, PLOS CURRENTS, V2; Nieman DC, 2014, BRAIN BEHAV IMMUN, V39, P180, DOI 10.1016/j.bbi.2013.09.004; Ohshita K, 2004, DIABETES CARE, V27, P491, DOI 10.2337/diacare.27.2.491; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Padgett D, 2003, TRENDS IMMUNOLOGY, V24; Pandey AK, 2011, BIOCHEM BIOPH RES CO, V410, P242, DOI 10.1016/j.bbrc.2011.05.123; PAUL WE, 1991, BLOOD, V77, P1859; Pedersen B, 2008, PHYSL REV; Pedersen BK, 2007, TRENDS PHARMACOL SCI, V28, P152, DOI 10.1016/j.tips.2007.02.002; Pejovic S, 2013, AM J PHYSIOL-ENDOC M, V305, pE890, DOI 10.1152/ajpendo.00301.2013; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Phillips M, 2011, AUSTR FIR AUTH BUSHF; Phillips M, 2012, APPL ERGON, V43, P435, DOI 10.1016/j.apergo.2011.06.018; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Raines J, 2013, APPL ERGON, V44, P404, DOI 10.1016/j.apergo.2012.10.002; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Ruby BC, 2002, MED SCI SPORT EXER, V34, P1048, DOI 10.1097/00005768-200206000-00023; Shearer WT, 2001, J ALLERGY CLIN IMMUN, V107, P165, DOI 10.1067/mai.2001.112270; Silverman MN, 2012, ANN NY ACAD SCI, V1261, P55, DOI 10.1111/j.1749-6632.2012.06633.x; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Starkie R, 2003, FASEB J, V17, P884, DOI 10.1096/fj.02-0670fje; Tauler P, 2013, MED SCI SPORT EXER, V45, P1269, DOI 10.1249/MSS.0b013e3182857c8a; Tilg H, 1997, IMMUNOL TODAY, V18, P428, DOI 10.1016/S0167-5699(97)01103-1; Turnbull AV, 1999, PHYSIOL REV, V79, P1, DOI 10.1152/physrev.1999.79.1.1; US Fire Administration National Fire Programs National Fallen Firefighters Foundation., 2014, FIREF FAT US 2013; van Leeuwen WMA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004589; Verbyla AP, 1999, J ROY STAT SOC C-APP, V48, P269, DOI 10.1111/1467-9876.00154; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562; Vgontzas AN, 2002, METABOLISM, V51, P887, DOI 10.1053/meta.2002.33357; Vincent G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115329; Willerson JT, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000129535.04194.38; Wolkow A, 2014, 4 INT C HLTH WELLN S; Wolkow A, 2014, ARCH ENVIRON OCCUP H, V69, P112, DOI 10.1080/19338244.2012.750588; Wu H, 2010, PHYSIOL RES, V59, P821, DOI 10.33549/physiolres.931895; Yehuda S, 2009, J INTERF CYTOK RES, V29, P393, DOI 10.1089/jir.2008.0080; Zhou X, 2010, CURR OPIN CLIN NUTR, V13, P541, DOI 10.1097/MCO.0b013e32833cf3bc	78	22	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138128	10.1371/journal.pone.0138128	http://dx.doi.org/10.1371/journal.pone.0138128			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378783	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000361769400056
J	Martinez-Heras, E; Varriano, F; Prckovska, V; Laredo, C; Andorra, M; Martinez-Lapiscina, EH; Calvo, A; Lampert, E; Villoslada, P; Saiz, A; Prats-Galino, A; Llufriu, S				Martinez-Heras, Eloy; Varriano, Federico; Prckovska, Vesna; Laredo, Carlos; Andorra, Magi; Martinez-Lapiscina, Elena H.; Calvo, Anna; Lampert, Erika; Villoslada, Pablo; Saiz, Albert; Prats-Galino, Alberto; Llufriu, Sara			Improved Framework for Tractography Reconstruction of the Optic Radiation	PLOS ONE			English	Article							DIFFUSION TENSOR TRACTOGRAPHY; WHITE-MATTER TRACTS; HUMAN BRAIN; MULTIPLE-SCLEROSIS; FIBER TRACTOGRAPHY; MRI; RESOLUTION; SEGMENTATION; CONNECTIVITY; DEGENERATION	The optic radiation (OR) is one of the major components of the visual system and a key structure at risk in white matter diseases such as multiple sclerosis (MS). However, it is challenging to perform track reconstruction of the OR using diffusion MRI due to a sharp change of direction in the Meyer's loop and the presence of kissing and crossing fibers along the pathway. As such, we aimed to provide a highly precise and reproducible framework for tracking the OR from thalamic and visual cortex masks. The framework combined the generation of probabilistic streamlines by high order fiber orientation distributions estimated with constrained spherical deconvolution and an automatic post-processing based on anatomical exclusion criteria (AEC) to compensate for the presence of anatomically implausible streamlines. Specifically, those ending in the contralateral hemisphere, cerebrospinal fluid or grey matter outside the visual cortex were automatically excluded. We applied the framework to two distinct high angular resolution diffusion- weighted imaging (HARDI) acquisition protocols on one cohort, comprised of ten healthy volunteers and five MS patients. The OR was successfully delineated in both HARDI acquisitions in the healthy volunteers and MS patients. Quantitative evaluation of the OR position was done by comparing the results with histological reference data. Compared with histological mask, the OR reconstruction into a template (OR-TCT) was highly precise (percentage of voxels within the OR-TCT correctly defined as OR), ranging from 0.71 to 0.83. The sensitivity (percentage of voxels in histological reference mask correctly defined as OR in OR-TCT) ranged from 0.65 to 0.81 and the accuracy (measured by F1 score) was 0.73 to 0.77 in healthy volunteers. When AEC was not applied the precision and accuracy decreased. The absolute agreement between both HARDI datasets measured by the intraclass correlation coefficient was 0.73. This improved framework allowed us to reconstruct the OR with high reliability and accuracy independently of the acquisition parameters. Moreover, the reconstruction was possible even in the presence of tissue damage due to MS. This framework could also be applied to other tracts with complex configuration.	[Martinez-Heras, Eloy; Prckovska, Vesna; Andorra, Magi; Martinez-Lapiscina, Elena H.; Lampert, Erika; Villoslada, Pablo; Saiz, Albert; Llufriu, Sara] Hosp Clin Barcelona, Serv Neurol, Ctr Neuroimmunol, Barcelona, Spain; [Martinez-Heras, Eloy; Prckovska, Vesna; Laredo, Carlos; Andorra, Magi; Martinez-Lapiscina, Elena H.; Lampert, Erika; Villoslada, Pablo; Saiz, Albert; Llufriu, Sara] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Varriano, Federico; Prats-Galino, Alberto] Univ Barcelona, Fac Med, Lab Surg NeuroAnat LSNA, Barcelona 7, Spain; [Laredo, Carlos] Hosp Clin Barcelona, Dept Neurosci, Comprehens Stroke Ctr, Barcelona, Spain; [Calvo, Anna] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Med Imaging Platform, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Llufriu, S (corresponding author), Hosp Clin Barcelona, Serv Neurol, Ctr Neuroimmunol, Barcelona, Spain.	SLLUFRIU@clinic.ub.es	Llufriu, Sara/K-2987-2014; Llufriu, Sara/T-6761-2019; Martinez-Heras, Eloy/AAN-1849-2020; Martínez-Lapiscina, Elena H/L-1161-2014; Prats-Galino, Alberto/J-6319-2013; Villoslada, Pablo/AAF-9547-2019; Laredo, Carlos/AAB-4456-2019; Andorra, Magi/D-8726-2015	Llufriu, Sara/0000-0003-4273-9121; Martinez-Heras, Eloy/0000-0001-9937-3162; Martínez-Lapiscina, Elena H/0000-0003-4272-0826; Prats-Galino, Alberto/0000-0002-2710-6433; Laredo, Carlos/0000-0002-4626-6360; Lampert, Erika/0000-0001-9406-5371; Varriano, Federico/0000-0001-6742-4746; Andorra, Magi/0000-0002-0491-3144	Asociacion Esclerosis Multiple Isla de Menorca (AEMIM); FP7 Marie Curie Intra-European Fellowship, project acronym: ConnectMS [328060]	Asociacion Esclerosis Multiple Isla de Menorca (AEMIM); FP7 Marie Curie Intra-European Fellowship, project acronym: ConnectMS	This work was partially funded by a donation from the Asociacion Esclerosis Multiple Isla de Menorca (AEMIM, http://www.esclerosismultiple.com/) to AS. It was also funded by the FP7 Marie Curie Intra-European Fellowship, project acronym: ConnectMS, project number: 328060 to VP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; Alvarez I, 2014, BRAIN STRUCTURE FUNC; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bastiani M, 2012, NEUROIMAGE, V62, P1732, DOI 10.1016/j.neuroimage.2012.06.002; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Benjamin CFA, 2014, HUM BRAIN MAPP, V35, P683, DOI 10.1002/hbm.22204; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; Burgel U, 1999, NEUROIMAGE, V10, P489, DOI 10.1006/nimg.1999.0497; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Clatworthy PL, 2010, NEUROIMAGE, V49, P2001, DOI 10.1016/j.neuroimage.2009.10.083; Craddock RC, 2013, NAT METHODS, V10, P524, DOI [10.1038/nmeth.2482, 10.1038/NMETH.2482]; Dayan M, 2015, BRAIN STRUCT FUNCT, V220, P291, DOI 10.1007/s00429-013-0655-y; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Farquharson S, 2013, J NEUROSURG, V118, P1367, DOI 10.3171/2013.2.JNS121294; Fernandez-Miranda JC, 2008, NEUROSURGERY, V62, P989, DOI [10.1227/01.NEU.0000297076.98175.67, 10.1227/01.neu.0000333767.05328.49]; Gabilondo I, 2014, ANN NEUROL, V75, P98, DOI 10.1002/ana.24030; Girard G, 2014, NEUROIMAGE, V98, P266, DOI 10.1016/j.neuroimage.2014.04.074; Goga C, 2015, J NEUROSURG, V122, P1253, DOI 10.3171/2014.12.JNS14281; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Hodaie M, 2010, NEUROSURGERY, V66, P788, DOI 10.1227/01.NEU.0000367613.09324.DA; Hofer S, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00015; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Jenkinson M, 2003, MAGNET RESON MED, V49, P193, DOI 10.1002/mrm.10354; Jeurissen B, 2011, HUM BRAIN MAPP, V32, P461, DOI 10.1002/hbm.21032; Jones DK, 2011, METHODS MOL BIOL, V711, P127, DOI 10.1007/978-1-61737-992-5_6; Jones DK, 2010, DIFFUSION MRI THEORY; Kim M, 2006, NEUROIMAGE, V32, P1243, DOI 10.1016/j.neuroimage.2006.06.006; Klein E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055455; Kolbe S, 2012, HUM BRAIN MAPP, V33, P2047, DOI 10.1002/hbm.21343; Kovalev VA, 2003, NEUROIMAGE, V19, P895, DOI 10.1016/S1053-8119(03)00140-X; Lawes INC, 2008, NEUROIMAGE, V39, P62, DOI 10.1016/j.neuroimage.2007.06.041; Lazar M, 2003, HUM BRAIN MAPP, V18, P306, DOI 10.1002/hbm.10102; Lilja Y, 2015, QUANT IMAG MED SURG, V5, P288, DOI 10.3978/j.issn.2223-4292.2015.01.08; Lilja Y, 2014, EPILEPSY RES, V108, P481, DOI 10.1016/j.eplepsyres.2014.01.017; Llufriu S, 2014, MULT SCLER J, V20, P424, DOI 10.1177/1352458513503722; Mandelstam SA, 2012, AM J NEURORADIOL, V33, P1204, DOI 10.3174/ajnr.A2652; Markov NT, 2011, CEREB CORTEX, V21, P1254, DOI 10.1093/cercor/bhq201; Martinez-Lapiscina EH, 2014, MULTIPLE SCLEROSIS H; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2009, CURR OPIN NEUROL, V22, P362, DOI 10.1097/WCO.0b013e32832d954b; Pagani E, 2005, NEUROIMAGE, V26, P258, DOI 10.1016/j.neuroimage.2005.01.008; Rocca MA, 2013, MULT SCLER J, V19, P1610, DOI 10.1177/1352458513485146; Schreiber J, 2014, NEUROIMAGE, V90, P163, DOI 10.1016/j.neuroimage.2014.01.002; Sdika M, 2009, HUM BRAIN MAPP, V30, P1060, DOI 10.1002/hbm.20566; Sherbondy AJ, 2008, J VISION, V8, DOI 10.1167/8.9.15; Sherbondy AJ, 2008, J VISION, V8, DOI 10.1167/8.10.12; Smith RE, 2015, NEUROIMAGE, V104, P253, DOI 10.1016/j.neuroimage.2014.10.004; Smith RE, 2012, NEUROIMAGE, V62, P1924, DOI 10.1016/j.neuroimage.2012.06.005; Tax CMW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101524; Thiebaut de Schotten M, 2011, NEUROIMAGE, V54, P49, DOI 10.1016/j.neuroimage.2010.07.055; Tournier J.-.D., 2010, IMPROVED PROBABILIST; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Winston GP, 2011, EPILEPSY RES, V97, P124, DOI 10.1016/j.eplepsyres.2011.07.019; Wu WT, 2012, NEUROSURGERY, V70, DOI 10.1227/NEU.0b013e31822efcae; Yogarajah M, 2009, BRAIN, V132, P1656, DOI 10.1093/brain/awp114; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	60	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137064	10.1371/journal.pone.0137064	http://dx.doi.org/10.1371/journal.pone.0137064			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376179	Green Published, gold, Green Submitted			2022-12-27	WOS:000361610200030
J	Ostrbenk, A; Kocjan, BJ; Hosnjak, L; Li, JJ; Deng, QJ; Sterbenc, A; Poljak, M				Ostrbenk, Anja; Kocjan, Bostjan J.; Hosnjak, Lea; Li, Jingjing; Deng, Qiuju; Sterbenc, Anja; Poljak, Mario			Identification of a Novel Human Papillomavirus, Type HPV199, Isolated from a Nasopharynx and Anal Canal, and Complete Genomic Characterization of Papillomavirus Species Gamma-12	PLOS ONE			English	Article							RENAL-TRANSPLANT RECIPIENTS; MULTIPLE SEQUENCE ALIGNMENT; HEALTHY SKIN; NUCLEAR-LOCALIZATION; ANOGENITAL HAIRS; BINDING DOMAIN; CAPSID PROTEIN; PCR ASSAY; DNA; DIVERSITY	The novel human papillomavirus type 199 (HPV199) was initially identified in a nasopharyngeal swab sample obtained from a 25 year-old immunocompetent male. The complete genome of HPV199 is 7,184 bp in length with a GC content of 36.5%. Comparative genomic characterization of HPV199 and its closest relatives showed the classical genomic organization of Gammapapillomaviruses (Gamma-PVs). HPV199 has seven major open reading frames (ORFs), encoding five early (E1, E2, E4, E6, and E7) and two late (L1 and L2) proteins, while lacking the E5 ORF. The long control region (LCR) of 513 bp is located between the L1 and E6 ORFs. Phylogenetic analysis additionally confirmed that HPV-199 clusters into the Gamma-PV genus, species Gamma-12, additionally containing HPV127, HV132, HPV148, HPV165, and three putative HPV types: KC5, CG2 and CG3. HPV199 is most closely related to HPV127 (nucleotide identity 77%). The complete viral genome sequence of additional HPV199 isolate was determined from anal canal swab sample. Two HPV199 complete viral sequences exhibit 99.4% nucleotide identity. To the best of our knowledge, this is the first member of Gamma-PV with complete nucleotide sequences determined from two independent clinical samples. To evaluate the tissue tropism of the novel HPV type, 916 clinical samples were tested using HPV199 type-specific real-time PCR: HPV199 was detected in 2/76 tissue samples of histologically confirmed common warts, 2/108 samples of eyebrow hair follicles, 2/137 anal canal swabs obtained from individuals with clinically evident anal pathology, 4/184 nasopharyngeal swabs and 3/411 cervical swabs obtained from women with normal cervical cytology. Although HPV199 was found in 1.4% of cutaneous and mucosal samples only, it exhibits dual tissue tropism. According to the results of our study and literature data, dual tropism of all Gamma-12 members is highly possible.	[Ostrbenk, Anja; Kocjan, Bostjan J.; Hosnjak, Lea; Sterbenc, Anja; Poljak, Mario] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia; [Li, Jingjing; Deng, Qiuju] Peking Univ, Canc Hosp & Inst, Minist Educ, Key Lab Carcinogenesis & Translat Res, Beijing 100871, Peoples R China	University of Ljubljana; Peking University	Poljak, M (corresponding author), Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia.	mario.poljak@mf.uni-lj.si			Slovenian Research Agency (ARRS); Young Researcher Training Program; CoheaHr Project (European Commission) [603019]	Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia); Young Researcher Training Program; CoheaHr Project (European Commission)	This work is the result of PhD research and is financially supported by the Slovenian Research Agency (ARRS), which funded AO through the Young Researcher Training Program, and in part by the CoheaHr Project (European Commission FP7 Program, grant number: 603019) (MP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonsson A, 2003, J GEN VIROL, V84, P1881, DOI 10.1099/vir.0.18836-0; Antonsson A, 2000, J VIROL, V74, P11636, DOI 10.1128/JVI.74.24.11636-11641.2000; Bao YM, 2014, ARCH VIROL, V159, P3293, DOI 10.1007/s00705-014-2197-x; Bergvall M, 2013, VIROLOGY, V445, P35, DOI 10.1016/j.virol.2013.07.020; Bernard HU, 2013, VIROLOGY, V445, P197, DOI 10.1016/j.virol.2013.04.035; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Boxman ILA, 1999, J CLIN MICROBIOL, V37, P2270, DOI 10.1128/JCM.37.7.2270-2273.1999; Boxman ILA, 1997, J INVEST DERMATOL, V108, P712, DOI 10.1111/1523-1747.ep12292090; Bronnimann MP, 2013, J VIROL, V87, P464, DOI 10.1128/JVI.01539-12; Buck CB, 2013, VIROLOGY, V445, P169, DOI 10.1016/j.virol.2013.05.038; Bzhalava D, 2015, VIROLOGY, V476, P341, DOI 10.1016/j.virol.2014.12.028; Chen Z, 2007, J GEN VIROL, V88, P2952, DOI 10.1099/vir.0.83178-0; Chen ZG, 2007, VIROLOGY, V360, P447, DOI 10.1016/j.virol.2006.10.022; Chouhy D, 2013, J GEN VIROL, V94, P524, DOI 10.1099/vir.0.048157-0; Cubie HA, 2013, VIROLOGY, V445, P21, DOI 10.1016/j.virol.2013.06.007; Doorbar J., 1996, HUMAN PAPILLOMAVIRUS, P58; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekstrom J, 2011, INT J CANCER, V129, P2643, DOI 10.1002/ijc.26204; Forslund O, 2003, J VIROL METHODS, V110, P129, DOI 10.1016/S0166-0934(03)00109-5; Forslund O, 1999, J GEN VIROL, V80, P2437, DOI 10.1099/0022-1317-80-9-2437; Forslund O, 2013, J INFECT DIS, V208, P1335, DOI 10.1093/infdis/jit326; Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harwood CA, 1999, J CLIN MICROBIOL, V37, P3545, DOI 10.1128/JCM.37.11.3545-3555.1999; HEINZEL PA, 1995, J CLIN MICROBIOL, V33, P1746, DOI 10.1128/JCM.33.7.1746-1754.1995; Hosnjak L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119154; KASHER MS, 1988, J VIROL, V62, P3295, DOI 10.1128/JVI.62.9.3295-3300.1988; Kocjan Bogtjan J., 2005, Infection Genetics and Evolution, V5, P255, DOI 10.1016/j.meegid.2004.05.009; Kocjan BJ, 2010, J VIROL METHODS, V163, P492, DOI 10.1016/j.jviromet.2009.10.024; Kocjan BJ, 2009, VIROLOGY, V391, P274, DOI 10.1016/j.virol.2009.06.030; Kohler A, 2009, BRIT J DERMATOL, V161, P528, DOI 10.1111/j.1365-2133.2009.09297.x; Kohler A, 2011, J GEN VIROL, V92, P1585, DOI 10.1099/vir.0.030593-0; Komlos KF, 2013, ACTA DERMATOVEN ALP, V21, P31, DOI 10.2478/v10162-012-0028-x; Kovanda A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022414; Li JJ, 2013, J VIROL METHODS, V193, P633, DOI 10.1016/j.jviromet.2013.06.026; Li JJ, 2012, J VIROL, V86, P11936, DOI 10.1128/JVI.01988-12; Ma YF, 2014, J VIROL, V88, P4786, DOI 10.1128/JVI.00093-14; McLaughlin-Drubin ME, 2009, VIROLOGY, V384, P335, DOI 10.1016/j.virol.2008.10.006; Milosevic M, 2010, CENT EUR J MED, V5, P698, DOI 10.2478/s11536-010-0019-4; Mitsuishi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079592; Narechania A, 2004, J GEN VIROL, V85, P1243, DOI 10.1099/vir.0.19765-0; Nelson LM, 2000, J CELL BIOCHEM, V79, P225, DOI 10.1002/1097-4644(20001101)79:2<225::AID-JCB60>3.0.CO;2-A; Nobre RJ, 2009, J VIROL, V83, P2907, DOI 10.1128/JVI.02490-08; Nordin P, 2007, ACTA DERM-VENEREOL, V87, P219, DOI 10.2340/00015555-0235; O'Connor M, 1995, HUMAN PAPILLOMAVIRUS, pIII21; OBALEK S, 1992, J INVEST DERMATOL, V98, P936, DOI 10.1111/1523-1747.ep12460892; Odar K, 2014, J CELL MOL MED, V18, P635, DOI 10.1111/jcmm.12211; Ogawa T, 2007, J GEN VIROL, V88, P1934, DOI 10.1099/vir.0.82794-0; Platt AR, 2007, BIOTECHNIQUES, V43, P58, DOI 10.2144/000112499; Poljak M, 2011, J CLIN MICROBIOL, V49, P1721, DOI 10.1128/JCM.00012-11; Poljak M, 2009, J INFECT DIS, V199, P1270, DOI 10.1086/597619; Potocnik M, 2006, J MED VIROL, V78, P1673, DOI 10.1002/jmv.20753; Rector A, 2004, J VIROL, V78, P4993, DOI 10.1128/JVI.78.10.4993-4998.2004; Roman A, 2013, VIROLOGY, V445, P138, DOI 10.1016/j.virol.2013.04.013; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; SHAMANIN V, 1994, J GEN VIROL, V75, P1149, DOI 10.1099/0022-1317-75-5-1149; Sichero L, 2015, CLIN MICROBIOL INFEC, V21, P502, DOI 10.1016/j.cmi.2014.12.023; Sichero L, 2013, VIROLOGY, V443, P214, DOI 10.1016/j.virol.2013.04.024; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terai M, 2002, J INFECT DIS, V185, P1794, DOI 10.1086/340824; Titolo S, 1999, J VIROL, V73, P5282, DOI 10.1128/JVI.73.7.5282-5293.1999; Torres M, 2015, J CLIN VIROL, V67, P47, DOI 10.1016/j.jcv.2015.04.005; Ure AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089342; Van Doorslaer K, 2013, NUCLEIC ACIDS RES, V41, pD571, DOI 10.1093/nar/gks984; van Duin M, 2002, INT J CANCER, V98, P590, DOI 10.1002/ijc.10232; Venuti A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-140; Wang JW, 2013, VIROLOGY, V445, P175, DOI 10.1016/j.virol.2013.04.017; ZHOU J, 1991, VIROLOGY, V185, P625, DOI 10.1016/0042-6822(91)90533-H; Zou NX, 2000, J VIROL, V74, P3761, DOI 10.1128/JVI.74.8.3761-3770.2000	69	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138628	10.1371/journal.pone.0138628	http://dx.doi.org/10.1371/journal.pone.0138628			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375679	Green Published, Green Submitted, gold			2022-12-27	WOS:000361610200117
J	Rainard, P; Cunha, P; Ledresseur, M; Staub, C; Touze, JL; Kempf, F; Gilbert, FB; Foucras, G				Rainard, Pascal; Cunha, Patricia; Ledresseur, Marion; Staub, Christophe; Touze, Jean-Luc; Kempf, Florent; Gilbert, Florence B.; Foucras, Gilles			Antigen-Specific Mammary Inflammation Depends on the Production of IL-17A and IFN-gamma by Bovine CD4+T Lymphocytes	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; INTERFERON-GAMMA; EPITHELIAL-CELLS; MUCOSAL IMMUNITY; GUINEA-PIGS; T-CELLS; GLAND; MASTITIS; NEUTROPHILS; TUBERCULOSIS	Intramammary infusion of the antigen used to sensitize cows by the systemic route induces a local inflammation associated with neutrophil recruitment. We hypothesize that this form of delayed type hypersensitivity, which may occur naturally during infections or could be induced intentionally by vaccination, can impact the outcome of mammary gland infections. We immunized cows with ovalbumin to identify immunological correlates of antigen-specific mammary inflammation. Intraluminal injection of ovalbumin induced a mastitis characterized by a prompt tissue reaction (increase in teat wall thickness) and an intense influx of leukocytes into milk of 10 responder cows out of 14 immunized animals. The magnitude of the local inflammatory reaction, assessed through milk leukocytosis, correlated with antibody titers, skin thickness test, and production of IL-17A and IFN-gamma in a whole-blood antigen stimulation assay (WBA). The production of these two cytokines significantly correlated with the magnitude of the milk leukocytosis following the ovalbumin intramammary challenge. The IL-17A and IFN-gamma production in the WBA was dependent on the presence of CD4+ cells in blood samples. In vitro stimulation of peripheral blood lymphocytes with ovalbumin followed by stimulation with PMA/ionomycin allowed the identification by flow cytometry of CD4+ T cells producing either IL-17A, IFN-gamma, or both cytokines. The results indicate that the antigen-specific WBA, and specifically IL-17A and IFN-gamma production by circulating CD4+ cells, can be used as a predictor of mammary hypersensitivity to protein antigens. This prompts further studies aiming at determining how Th17 and/or Th1 lymphocytes modulate the immune response of the mammary gland to infection.	[Rainard, Pascal; Cunha, Patricia; Ledresseur, Marion; Kempf, Florent; Gilbert, Florence B.] INRA, UMR1282, Infectiol & Sante Publ, F-37380 Nouzilly, France; [Staub, Christophe] INRA, UEPAO, Unite Expt Physiol Anim, UE1297, F-37380 Nouzilly, France; [Rainard, Pascal; Cunha, Patricia; Ledresseur, Marion; Touze, Jean-Luc; Kempf, Florent; Gilbert, Florence B.] Univ Tours, Tours, France; [Touze, Jean-Luc] INRA, UMR0085, Physiol Reprod & Comportement, F-37380 Nouzilly, France; [Foucras, Gilles] Univ Toulouse, ENVT, INP, Toulouse, France; [Foucras, Gilles] INRA, UMR1225, Interact Hote Agents Pathogenes, F-31931 Toulouse, France	INRAE; INRAE; Universite de Tours; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; INRAE	Rainard, P (corresponding author), INRA, UMR1282, Infectiol & Sante Publ, F-37380 Nouzilly, France.	pascal.rainard@tours.inra.fr	FOUCRAS, Gilles/A-3061-2014	FOUCRAS, Gilles/0000-0002-0363-0337; Rainard, Pascal/0000-0002-5477-2626	Region Centre (Mamimmunotypage project) [2012 00073634]; National Institute for Agricultural Research (INRA)	Region Centre (Mamimmunotypage project)(Region Centre-Val de Loire); National Institute for Agricultural Research (INRA)	This work was funded by the Region Centre (Mamimmunotypage project, Convention 2012 00073634, www.regioncentre.fr) and by the National Institute for Agricultural Research (INRA, www.paris.inra.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013418; Bougarn S, 2011, CYTOKINE, V56, P749, DOI 10.1016/j.cyto.2011.09.020; Bougarn S, 2010, CLIN VACCINE IMMUNOL, V17, P1797, DOI 10.1128/CVI.00268-10; Bradley AJ, 2002, VET J, V164, P116, DOI 10.1053/tvjl.2002.0724; Bruno DR, 2010, VET IMMUNOL IMMUNOP, V138, P15, DOI 10.1016/j.vetimm.2010.06.009; Chessel D., 2004, R NEWS, V4, P5; COLDITZ IG, 1982, RES VET SCI, V33, P146, DOI 10.1016/S0034-5288(18)32327-0; CRAVEN N, 1985, VET IMMUNOL IMMUNOP, V10, P71, DOI 10.1016/0165-2427(85)90039-X; DECUENINCK BJ, 1979, INT ARCH ALLER A IMM, V59, P394, DOI 10.1159/000232286; DECUENINCK BJ, 1982, AM J VET RES, V43, P1696; Dray S, 2008, COMPUT STAT DATA AN, V52, P2228, DOI 10.1016/j.csda.2007.07.015; Dubin PJ, 2008, IMMUNOL REV, V226, P160, DOI 10.1111/j.1600-065X.2008.00703.x; Geherin SA, 2013, VET IMMUNOL IMMUNOP, V155, P87, DOI 10.1016/j.vetimm.2013.06.008; Gilbert FB, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-40; Gunther J, 2011, INFECT IMMUN, V79, P695, DOI 10.1128/IAI.01071-10; Halasa T, 2007, VET QUART, V29, P18, DOI 10.1080/01652176.2007.9695224; Hellings PW, 2003, AM J RESP CELL MOL, V28, P42, DOI 10.1165/rcmb.4832; Herbelin C, 1997, J DAIRY SCI, V80, P2025, DOI 10.3168/jds.S0022-0302(97)76147-2; Jungersen G, 2012, VET IMMUNOL IMMUNOP, V148, P48, DOI 10.1016/j.vetimm.2011.05.010; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Kumar P, 2013, CURR OPIN IMMUNOL, V25, P373, DOI 10.1016/j.coi.2013.03.011; Lind M, 2015, INNATE IMMUN-LONDON, V21, P322, DOI 10.1177/1753425914539820; LUTJE V, 1991, VET IMMUNOL IMMUNOP, V28, P275, DOI 10.1016/0165-2427(91)90120-2; Masopust D, 2013, NAT REV IMMUNOL, V13, P309, DOI 10.1038/nri3442; Masopust D, 2012, J IMMUNOL, V188, P5811, DOI 10.4049/jimmunol.1102695; NONNECKE BJ, 1984, AM J REPROD IMMUNOL, V6, P9, DOI 10.1111/j.1600-0897.1984.tb00101.x; Oviedo-Boyso J, 2007, J INFECTION, V54, P399, DOI 10.1016/j.jinf.2006.06.010; Pareek Ravi, 2005, Journal of Applied Genetics, V46, P171; PLASTRIDGE WN, 1958, J DAIRY SCI, V41, P1141, DOI 10.3168/jds.S0022-0302(58)91071-3; Rainard P, 2006, VET RES, V37, P369, DOI 10.1051/vetres:2006007; Rainard P, 1997, VET RES, V28, P231; Rainard P, 2010, CLIN VACCINE IMMUNOL, V17, P848, DOI 10.1128/CVI.00447-09; Rainard P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063471; Rinaldi M, 2010, FUNCT INTEGR GENOMIC, V10, P21, DOI 10.1007/s10142-009-0133-z; Riollet C, 2006, J INTERF CYTOK RES, V26, P141, DOI 10.1089/jir.2006.26.141; Roussel P, 2015, VET RES, V46, DOI 10.1186/s13567-015-0201-4; Schiller I, 2010, VET REC, V167, P322, DOI 10.1136/vr.c3403; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Soltani MH, 2012, IRAN J IMMUNOL, V9, P168; STEINBECK MJ, 1986, CELL IMMUNOL, V98, P137, DOI 10.1016/0008-8749(86)90274-1; Tao WJ, 2007, VET IMMUNOL IMMUNOP, V120, P201, DOI 10.1016/j.vetimm.2007.06.019; TARGOWSKI SP, 1975, AM J VET RES, V36, P1561; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Wedlock DN, 2002, VET IMMUNOL IMMUNOP, V86, P79, DOI 10.1016/S0165-2427(02)00017-X; Wu WH, 2012, AM J RESP CRIT CARE, V186, P420, DOI 10.1164/rccm.201202-0182OC; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	46	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137755	10.1371/journal.pone.0137755	http://dx.doi.org/10.1371/journal.pone.0137755			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375594	Green Published, gold, Green Submitted			2022-12-27	WOS:000361610200051
J	Wang, L; Groenewald, M; Wang, QM; Boekhout, T				Wang, Long; Groenewald, Marizeth; Wang, Qi-Ming; Boekhout, Teun			Reclassification of Saccharomycodes sinensis, Proposal of Yueomyces sinensis gen. nov., comb. nov within Saccharomycetaceae (Saccharomycetales, Saccharomycotina)	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; YEASTS; GENERA	The phylogenetic position of Saccharomycodes sinensis has been debated by yeast taxonomists. In this study, a multigene phylogenetic analysis based on four regions, namely the 18S ribosomal DNA (rDNA), the D1/D2 domains of the 26S rDNA, the second largest subunit of RNA polymerase II gene (RPB2) and translation elongation factor 1-alpha gene (EF1-alpha), were performed to address the phylogenetic placement of S. sinensis. Our result indicated that S. sinensis belongs to Saccharomycetaceae instead of Saccharomycodaceae, and forms a single species lineage divergent from the other genera within Saccharomycetaceae. Yueomyces gen. nov. (MycoBank No. MB 811648) is proposed in the Saccharomycetaceae with Y. sinensis comb. nov. (MycoBank No. MB 811649, type strain CGMCC 2.01395(T) = IFO 10111(T) = CBS 7075(T)) as the type species.	[Wang, Long; Wang, Qi-Ming] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China; [Groenewald, Marizeth; Boekhout, Teun] CBS KNAW Fungal Biodivers Ctr, Yeast Div, Utrecht, Netherlands	Chinese Academy of Sciences; Institute of Microbiology, CAS; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW)	Wang, QM (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China.	wangqm@im.ac.cn	Boekhout, Teunis/ABF-2538-2020; Groenewald, Marizeth/G-4976-2012	Boekhout, Teunis/0000-0002-0476-3609; Groenewald, Marizeth/0000-0003-0835-5925	Youth Innovation Promotion Association of the Chinese Academy of Sciences [2012078]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-J-6]	Youth Innovation Promotion Association of the Chinese Academy of Sciences; Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	This study was supported by grants no. 2012078 from the Youth Innovation Promotion Association of the Chinese Academy of Sciences and by no. KSCX2-EW-J-6 from the Knowledge Innovation Program of the Chinese Academy of Sciences.	Boundy-Mills K, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P747, DOI 10.1016/B978-0-444-52149-1.00062-8; Cannon PF, 2007, FUNGAL FAMILIES WORL; Kudryavtsev VI, 1960, SYSTEMATIK HEFEN, V270; Kurtzman C.P., 1998, YEASTS TAXONOMIC STU; Kurtzman CP, 2013, FEMS YEAST RES, V13, P23, DOI 10.1111/1567-1364.12006; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P887, DOI 10.1016/B978-0-444-52149-1.00078-1; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P293, DOI 10.1016/B978-0-444-52149-1.00013-6; Kurtzman CP, 2003, FEMS YEAST RES, V4, P233, DOI 10.1016/S1567-1356(03)00175-2; Kurtzman CP, 2003, FEMS YEAST RES, V3, P417, DOI 10.1016/S1567-1356(03)00012-6; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Lumbsch H. T., 2007, MYCONET, V13, P1, DOI DOI 10.3158/1557.1; McNeill J, 2012, REGNUM VEG, V154, P1; Miller M. W., 1998, P372, DOI 10.1016/B978-044481312-1/50049-6; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Smith MT, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P629, DOI 10.1016/B978-0-444-52149-1.00049-5; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132653; Wang QM, 2014, PERSOONIA, V33, P41, DOI 10.3767/003158514X682313; Wang QM, 2008, FEMS YEAST RES, V8, P799, DOI 10.1111/j.1567-1364.2008.00403.x; YAMADA Y, 1992, J GEN APPL MICROBIOL, V38, P585, DOI 10.2323/jgam.38.585; Yamazaki T, 2005, J GEN APPL MICROBIOL, V51, P35, DOI 10.2323/jgam.51.35; Yue J.-Z., 1977, ACTA MICROBIOL SIN, V17, P89	22	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136987	10.1371/journal.pone.0136987	http://dx.doi.org/10.1371/journal.pone.0136987			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375944	Green Submitted, Green Published, gold			2022-12-27	WOS:000361610200028
J	Zhou, XL; Ding, HX; Wu, WQ; Zhang, YT				Zhou, Xiaolin; Ding, Hongxia; Wu, Wanqing; Zhang, Yuanting			A Real-Time Atrial Fibrillation Detection Algorithm Based on the Instantaneous State of Heart Rate	PLOS ONE			English	Article							STROKE SEVERITY; RISK	Atrial fibrillation (AF), the most frequent cause of cardioembolic stroke, is increasing in prevalence as the population ages, and presents with a broad spectrum of symptoms and severity. The early identification of AF is an essential part for preventing the possibility of blood clotting and stroke. In this work, a real-time algorithm is proposed for accurately screening AF episodes in electrocardiograms. This method adopts heart rate sequence, and it involves the application of symbolic dynamics and Shannon entropy. Using novel recursive algorithms, a low-computational complexity can be obtained. Four publicly-accessible sets of clinical data (Long-Term AF, MIT-BIH AF, MIT-BIH Arrhythmia, and MIT-BIH Normal Sinus Rhythm Databases) were used for assessment. The first database was selected as a training set; the receiver operating characteristic (ROC) curve was performed, and the best performance was achieved at the threshold of 0.639: the sensitivity (Se), specificity (Sp), positive predictive value (PPV) and overall accuracy (ACC) were 96.14%, 95.73%, 97.03% and 95.97%, respectively. The other three databases were used for independent testing. Using the obtained decision-making threshold (i.e., 0.639), for the second set, the obtained parameters were 97.37%, 98.44%, 97.89% and 97.99%, respectively; for the third database, these parameters were 97.83%, 87.41%, 47.67% and 88.51%, respectively; the Sp was 99.68% for the fourth set. The latest methods were also employed for comparison. Collectively, results presented in this study indicate that the combination of symbolic dynamics and Shannon entropy yields a potent AF detector, and suggest this method could be of practical use in both clinical and out-of-clinical settings.	[Zhou, Xiaolin; Ding, Hongxia; Wu, Wanqing; Zhang, Yuanting] Chinese Acad Sci, Shenzhen Inst Adv Technol, CAS CUHK Res Ctr Biosensors & Med Instruments, Shenzhen, Guangdong, Peoples R China; [Zhou, Xiaolin; Ding, Hongxia; Wu, Wanqing; Zhang, Yuanting] Chinese Acad Sci, Key Lab Hlth Informat, Shenzhen Inst Adv Technol, Shenzhen, Guangdong, Peoples R China; [Zhang, Yuanting] Chinese Univ Hong Kong, Dept Elect Engn, Shatin, Hong Kong, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese University of Hong Kong	Zhou, XL (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, CAS CUHK Res Ctr Biosensors & Med Instruments, Shenzhen, Guangdong, Peoples R China.	xl.zhou@siat.ac.cn; wq.wu@siat.ac.cn	zhou, xiaolin/GNP-3201-2022	ZHANG, Yuanting/0000-0003-4150-5470	National Natural Science Foundation of China [61401453]; STS Key Health Program of Chinese Academy of Sciences [KFJEW-STS-097, KFJ-EW-STS-095]; External Cooperation Program of the Chinese Academy of Sciences [GJHZ1212]; Guangdong Innovation Research Team Fund for Low-Cost Healthcare Technologies in China; Key Lab for Health Informatics of Chinese Academy of Sciences; Enhancing Program of Key Laboratories of Shenzhen City [ZDSY20120617113021359]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); STS Key Health Program of Chinese Academy of Sciences; External Cooperation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Guangdong Innovation Research Team Fund for Low-Cost Healthcare Technologies in China; Key Lab for Health Informatics of Chinese Academy of Sciences; Enhancing Program of Key Laboratories of Shenzhen City	This work was supported in part by the National Natural Science Foundation of China (no. 61401453), the STS Key Health Program of Chinese Academy of Sciences (no. KFJEW-STS-097 and KFJ-EW-STS-095), the External Cooperation Program of the Chinese Academy of Sciences (GJHZ1212), the Guangdong Innovation Research Team Fund for Low-Cost Healthcare Technologies in China, and the Key Lab for Health Informatics of Chinese Academy of Sciences, the Enhancing Program of Key Laboratories of Shenzhen City (no. ZDSY20120617113021359).	Babaeizadeh S, 2009, J ELECTROCARDIOL, V42, P522, DOI 10.1016/j.jelectrocard.2009.06.006; Dash S, 2009, ANN BIOMED ENG, V37, P1701, DOI 10.1007/s10439-009-9740-z; Fuster V, 2001, J AM COLL CARDIOL, V38, P1231, DOI 10.1016/S0735-1097(01)01587-X; Huang C, 2011, IEEE T BIO-MED ENG, V58, P1113, DOI 10.1109/TBME.2010.2096506; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; Lake DE, 2011, AM J PHYSIOL-HEART C, V300, pH319, DOI 10.1152/ajpheart.00561.2010; Larburu N, 2011, COMPUT CARDIOL CONF, V38, P265; Larburu N, 2011, THESIS PUBLIC U NAVA; Lee J, 2013, IEEE T BIO-MED ENG, V60, P2783, DOI 10.1109/TBME.2013.2264721; Lee J, 2013, IEEE T BIO-MED ENG, V60, P203, DOI 10.1109/TBME.2012.2208112; Lian J, 2011, AM J CARDIOL, V107, P1494, DOI 10.1016/j.amjcard.2011.01.028; Lin HJ, 1996, STROKE, V27, P1760, DOI 10.1161/01.STR.27.10.1760; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Marini C, 2005, STROKE, V36, P1115, DOI 10.1161/01.STR.0000166053.83476.4a; Mathew ST, 2009, EUR J INTERN MED, V20, P672, DOI 10.1016/j.ejim.2009.07.011; Park J, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-38; Petrenas A., 2015, COMPUT BIOL MED, V60, P2783; Petrutiu S, 2006, IEEE ENG MED BIOL, V25, P24, DOI 10.1109/EMB-M.2006.250505; Voss A, 1996, CARDIOVASC RES, V31, P419; WHO (World Health Organization), ATLAS HEART DIS STRO; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yaghouby F, 2012, EXPERT SYST, V29, P183, DOI 10.1111/j.1468-0394.2010.00571.x; Yaghouby F, 2010, COMPUT BIOL MED, V40, P919, DOI 10.1016/j.compbiomed.2010.10.004; Zhou XL, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-18	24	48	50	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136544	10.1371/journal.pone.0136544	http://dx.doi.org/10.1371/journal.pone.0136544			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376341	gold, Green Published, Green Submitted			2022-12-27	WOS:000361610200018
J	Chen, N; Liu, Y; Cheng, YJ; Liu, L; Yan, Z; Tao, LX; Guo, XH; Luo, YX; Yan, AS				Chen, Ning; Liu, Yun; Cheng, Yijie; Liu, Long; Yan, Zhe; Tao, Lixin; Guo, Xiuhua; Luo, Yanxia; Yan, Aoshuang			Technology Resource, Distribution, and Development Characteristics of Global Influenza Virus Vaccine: A Patent Bibliometric Analysis	PLOS ONE			English	Article							RESEARCH-AND-DEVELOPMENT; NANOTECHNOLOGY; PUBLICATIONS; PATTERNS	Influenza virus vaccine (IVV) is a promising research domain that is closely related to global health matters, which has been acknowledged not only by scientists and technology developers, but also by policy-makers. Meanwhile, patents encompass valuable technological information and reflect the latest technological inventions as well as the innovative capability of a nation. However, little research has examined this up- and-coming research field using patent bibliometric method. Thus, this paper (a) designs the technology classification system and search strategy for the identification of IVV; and (b) presents a longitudinal analysis of the global IVV development based on the European Patent Office (EPO) patents. Bibliometric analysis is used to rank countries, institutions, inventors and technology subfields contributing to IVV technical progress. The results show that the global trends of IVV are a multi-developing feature of variety but an uneven technical resource distribution. Although the synthetic peptide vaccine is a comparatively young field, it already demonstrates the powerful vitality and the enormous development space. With the worldwide competition increasing, all nations especially China should be looking to increase devotion, enhance capability and regard effectiveness of technological innovation.	[Chen, Ning; Liu, Long; Tao, Lixin; Guo, Xiuhua; Luo, Yanxia; Yan, Aoshuang] Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China; [Chen, Ning; Liu, Long; Tao, Lixin; Guo, Xiuhua; Luo, Yanxia; Yan, Aoshuang] Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China; [Chen, Ning; Yan, Aoshuang] Beijing Municipal Sci & Technol Commiss, Beijing, Peoples R China; [Liu, Yun; Cheng, Yijie; Yan, Zhe] Beijing Inst Technol, Sch Management & Econ, Beijing 100081, Peoples R China	Capital Medical University; Beijing Municipal Science & Technology Commission; Beijing Institute of Technology	Liu, Y (corresponding author), Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China.	liuyun@bit.edu.cn; lyx100@ccmu.edu.cn; Yanas@139.com	TAO, Li/HIR-4254-2022		National Natural Science Foundation of China [71273030]; National International S&T Cooperation Program [2012DFG11750]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National International S&T Cooperation Program	This paper was funded by the project of National Natural Science Foundation of China (No. 71273030) and the project of National International S&T Cooperation Program (No. 2012DFG11750).	Blind K, 2009, RES POLICY, V38, P428, DOI 10.1016/j.respol.2008.12.003; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Cheng YJ, 2014, PORTL INT CONF MANAG, P1373; Couch RB, 2008, VACCINE, V26, pD5, DOI 10.1016/j.vaccine.2008.05.076; De Solla Price D. J., 1963, LITTLE SCI BIG SCI, DOI 10.7312/pric91844; Dekker T, 2012, J ENVIRON ECON MANAG, V64, P45, DOI 10.1016/j.jeem.2011.11.005; Du J, 2014, J CANCER RES THER, V10, P27, DOI 10.4103/0973-1482.139750; Dubourg L, 2008, SURF COAT TECH, V202, P5863, DOI 10.1016/j.surfcoat.2008.06.122; Gambaryan AS, 1999, VIROLOGY, V258, P232, DOI 10.1006/viro.1999.9732; Guan JC, 2007, SCIENTOMETRICS, V72, P403, DOI 10.1007/s11192-007-1741-1; Harhoff D, 2003, RES POLICY, V32, P1343, DOI 10.1016/S0048-7333(02)00124-5; Huang MC, 2011, SCIENTOMETRICS, V88, P805, DOI 10.1007/s11192-011-0400-3; Meyer M, 1998, SCIENTOMETRICS, V42, P195, DOI 10.1007/BF02458355; Narin F, 1996, SCIENTOMETRICS, V36, P293, DOI 10.1007/BF02129596; Partei O D OT, 2004, EUR PAT OFF BIOT LAW; Piergiovanni R, 2013, SCIENTOMETRICS, V94, P497, DOI 10.1007/s11192-012-0711-z; Porter AL, 2008, J NANOPART RES, V10, P715, DOI 10.1007/s11051-007-9266-y; Shaw A, 2012, VACCINE, V30, P4927, DOI 10.1016/j.vaccine.2012.04.095; Wareing MD, 2001, VACCINE, V19, P3320, DOI 10.1016/S0264-410X(01)00045-7; WINNER EP, 1980, J PATENT TRADEMARK, V62, P419; Ye XT, 2012, INT J TECHNOL MANAGE, V59, P255, DOI 10.1504/IJTM.2012.047246; Yesil-Celiktas O, 2010, IND ENG CHEM RES, V49, P7017, DOI 10.1021/ie100115x	22	6	6	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0136953	10.1371/journal.pone.0136953	http://dx.doi.org/10.1371/journal.pone.0136953			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8LR	26372160	gold, Green Published, Green Submitted			2022-12-27	WOS:000361604400009
J	Guo, GY; Xu, K; Zhang, XM; Zhu, JL; Lu, MY; Chen, FL; Liu, LP; Xi, ZY; Bachmair, A; Chen, QS; Fu, YF				Guo, Guangyu; Xu, Kun; Zhang, Xiaomei; Zhu, Jinlong; Lu, Mingyang; Chen, Fulu; Liu, Linpo; Xi, Zhang-Ying; Bachmair, Andreas; Chen, Qingshan; Fu, Yong-Fu			Extensive Analysis of GmFTL and GmCOL Expression in Northern Soybean Cultivars in Field Conditions	PLOS ONE			English	Article							FLOWERING-LOCUS-T; TIME GENE CONSTANS; MAP-BASED CLONING; MOLECULAR-BASIS; GLYCINE-MAX; FT PROTEIN; ARABIDOPSIS; MATURITY; EVOLUTION; PHOTOPERIOD	The FLOWERING LOCUS T (FT) gene is a highly conserved florigen gene among flowering plants. Soybean genome encodes six homologs of FT, which display flowering activity in Arabidopsis thaliana. However, their contributions to flowering time in different soybean cultivars, especially in field conditions, are unclear. We employed six soybean cultivars with different maturities to extensively investigate expression patterns of GmFTLs (Glycine max FT-like) and GmCOLs (Glycine max CO-like) in the field conditions. The results show that GmFTL3 is an FT homolog with the highest transcript abundance in soybean, but other GmFTLs may also contribute to flower induction with different extents, because they have more or less similar expression patterns in developmental-, leaf-, and circadian-specific modes. And four GmCOL genes (GmCOL1/2/5/13) may confer to the expression of GmFTL genes. Artificial manipulation of GmFTL expression by transgenic strategy (overexpression and RNAi) results in a distinct change in soybean flowering time, indicating that GmFTLs not only impact on the control of flowering time, but have potential applications in the manipulation of photoperiodic adaptation in soybean. Additionally, transgenic plants show that GmFTLs play a role in formation of the first flowers and in vegetative growth.	[Guo, Guangyu; Chen, Qingshan] Northeast Agr Univ, Coll Agr, Harbin, Peoples R China; [Xu, Kun; Zhang, Xiaomei; Zhu, Jinlong; Lu, Mingyang; Chen, Fulu; Liu, Linpo; Fu, Yong-Fu] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resource & Genet Improve, MOA Key Lab Soybean Biol Beijing, Beijing 100193, Peoples R China; [Xu, Kun; Lu, Mingyang] Chinese Acad Agr Sci, Grad Sch, Beijing 100193, Peoples R China; [Xi, Zhang-Ying] Henan Agr Univ, Coll Agron, Zhengzhou, Peoples R China; [Bachmair, Andreas] Univ Vienna, Vienna Bioctr, Max F Perutz Labs, Dept Biochem & Cell Biol, A-1030 Vienna, Austria	Northeast Agricultural University - China; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences; Graduate School, CAAS; Henan Agricultural University; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Chen, QS (corresponding author), Northeast Agr Univ, Coll Agr, Harbin, Peoples R China.	qshchen@126.com; fufu19cn@163.com		Bachmair, Andreas/0000-0001-7731-1841	Transgenic Projects [2014ZX08004-005, 2014ZX08009-001]; Project 863 [2013AA102602]; National Natural Science Foundation [31371703, 31301200, 31371629]; Austrian Science Fund [P25488]	Transgenic Projects; Project 863(National High Technology Research and Development Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported by Transgenic Projects (2014ZX08004-005 and 2014ZX08009-001), by Project 863 (2013AA102602), and by the National Natural Science Foundation (31371703, 31301200, and 31371629). A.B. was supported by the Austrian Science Fund (grant P25488).	Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; [Anonymous], 2004, SOYBEANS IMPROVEMENT; Ballerini ES, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00081; BERNARD RL, 1971, CROP SCI, V11, P242, DOI 10.2135/cropsci1971.0011183X001100020022x; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Bonato ER, 1999, GENET MOL BIOL, V22, P229, DOI 10.1590/S1415-47571999000200016; Buzzell R. I., 1980, SOYBEAN GENETICS NEW, V7, P26, DOI DOI 10.1093/JHERED/ESP113; BUZZELL RI, 1971, CAN J GENET CYTOL, V13, P703, DOI 10.1139/g71-100; Chardon F, 2005, J MOL EVOL, V61, P579, DOI 10.1007/s00239-004-0179-4; Cober ER, 2010, CROP SCI, V50, P524, DOI 10.2135/cropsci2009.04.0174; Cober ER, 2001, CROP SCI, V41, P698, DOI 10.2135/cropsci2001.413698x; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; D'Aloia M, 2011, PLANT J, V65, P972, DOI 10.1111/j.1365-313X.2011.04482.x; Fan CM, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-9; Greenup A, 2009, ANN BOT-LONDON, V103, P1165, DOI 10.1093/aob/mcp063; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; Hayama R, 2004, PLANT PHYSIOL, V135, P677, DOI 10.1104/pp.104.042614; Hiraoka K, 2013, PLANT CELL PHYSIOL, V54, P352, DOI 10.1093/pcp/pcs168; Hsu CY, 2011, P NATL ACAD SCI USA, V108, P10756, DOI 10.1073/pnas.1104713108; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Jiang BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106042; Jiang BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077474; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Karlgren A, 2011, PLANT PHYSIOL, V156, P1967, DOI 10.1104/pp.111.176206; Kim MY, 2011, BREEDING SCI, V61, P445, DOI 10.1270/jsbbs.61.445; Kinoshita T, 2011, CURR BIOL, V21, P1232, DOI 10.1016/j.cub.2011.06.025; Komiya R, 2008, DEVELOPMENT, V135, P767, DOI 10.1242/dev.008631; Komiya R, 2009, DEVELOPMENT, V136, P3443, DOI 10.1242/dev.040170; Kong FJ, 2014, CROP SCI, V54, P2529, DOI 10.2135/cropsci2014.03.0228; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Krieger U, 2010, NAT GENET, V42, P459, DOI 10.1038/ng.550; Lagercrantz U, 2000, MOL BIOL EVOL, V17, P1499, DOI 10.1093/oxfordjournals.molbev.a026249; Langewisch T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094150; Li F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079036; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Liu B, 2008, GENETICS, V180, P995, DOI 10.1534/genetics.108.092742; Liu H, 2009, J PLANT PHYSIOL, V166, P278, DOI 10.1016/j.jplph.2008.06.003; Liu LY, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00164; Martinez-Garcia JF, 2002, P NATL ACAD SCI USA, V99, P15211, DOI 10.1073/pnas.222390599; Matsoukas IG, 2012, PLANT CELL PHYSIOL, V53, P1827, DOI 10.1093/pcp/pcs130; MCBLAIN BA, 1987, J HERED, V78, P160, DOI 10.1093/oxfordjournals.jhered.a110349; Meng X, 2011, PLANT CELL, V23, P942, DOI 10.1105/tpc.110.081406; Nan HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097669; Navarro C, 2011, NATURE, V478, P119, DOI 10.1038/nature10431; OGAWA Y, 1990, PLANT CELL PHYSIOL, V31, P129; Olhoft PM, 2006, METH MOL B, V343, P385; Owen FV, 1927, GENETICS, V12, P519; PATON DM, 1971, AUST J BIOL SCI, V24, P609, DOI 10.1071/BI9710609; Paz MM, 2006, PLANT CELL REP, V25, P206, DOI 10.1007/s00299-005-0048-7; Pin PA, 2012, PLANT CELL ENVIRON, V35, P1742, DOI 10.1111/j.1365-3040.2012.02558.x; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; RAY JD, 1995, CROP SCI, V35, P1001, DOI 10.2135/cropsci1995.0011183X003500040012x; Roulin A, 2013, PLANT J, V73, P143, DOI 10.1111/tpj.12026; Schlueter JA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-330; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Serrano G, 2009, CURR BIOL, V19, P359, DOI 10.1016/j.cub.2009.01.044; Simpson GG, 2003, BIOESSAYS, V25, P829, DOI 10.1002/bies.10330; Song YH, 2013, TRENDS PLANT SCI, V18, P575, DOI 10.1016/j.tplants.2013.05.003; Sun HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029238; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Thomas B, 1997, PHOTOPERIODISM PLANT, P355; Thomas B., 1997, PHOTOPERIODISM PLANT, P11; Tsubokura Y, 2014, ANN BOT-LONDON, V113, P429, DOI 10.1093/aob/mct269; Wang K, AGROBACTERIUM MEDIAT, P1; Wang Z, 2015, PLANT CELL, V27, P323, DOI 10.1105/tpc.114.135103; Watanabe S, 2011, BREEDING SCI, V61, P531, DOI 10.1270/jsbbs.61.531; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Xi WY, 2009, PLANT SIGNAL BEHAV, V4, P1142, DOI 10.4161/psb.4.12.9901; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yoo SJ, 2013, PLANT CELL PHYSIOL, V54, P119, DOI 10.1093/pcp/pcs158; Zhai H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097636	74	13	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0136601	10.1371/journal.pone.0136601	http://dx.doi.org/10.1371/journal.pone.0136601			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371882	Green Submitted, Green Published, gold			2022-12-27	WOS:000361604400007
J	Goetz, T; Becker, ES; Bieg, M; Keller, MM; Frenzel, AC; Hall, NC				Goetz, Thomas; Becker, Eva S.; Bieg, Madeleine; Keller, Melanie M.; Frenzel, Anne C.; Hall, Nathan C.			The Glass Half Empty: How Emotional Exhaustion Affects the State-Trait Discrepancy in Self-Reports of Teaching Emotions	PLOS ONE			English	Article							EXPERIENCE; RELIABILITY; BURNOUT; GIRLS	Following from previous research on intensity bias and the accessibility model of emotional self-report, the present study examined the role of emotional exhaustion in explaining the discrepancy in teachers' reports of their trait (habitual) versus state (momentary, "real") emotions. Trait reports (habitual emotions, exhaustion) were assessed via trait questionnaires, and state reports (momentary emotions) were assessed in real time via the experience sampling method by using personal digital assistants (N = 69 high school teachers; 1,089 measures within teachers). In line with our assumptions, multi-level analyses showed that, as compared to the state assessment, teachers reported higher levels of habitual teaching-related emotions of anger, anxiety, shame, boredom, enjoyment, and pride. Additionally, the state-trait discrepancy in self-reports of negative emotions was accounted for by teachers' emotional exhaustion, with high exhaustion levels corresponding with a greater state-trait discrepancy. Exhaustion levels did not moderate the state-trait discrepancy in positive emotions indicating that perceived emotional exhaustion may reflect identity-related cognitions specific to the negative belief system. Implications for research and educational practice are discussed.	[Goetz, Thomas; Becker, Eva S.; Bieg, Madeleine; Keller, Melanie M.] Univ Konstanz, Dept Empir Educ Res, Constance, Germany; [Goetz, Thomas; Becker, Eva S.; Bieg, Madeleine; Keller, Melanie M.] Thurgau Univ Teacher Educ, Kreuzlingen, Switzerland; [Frenzel, Anne C.] Univ Munich, Dept Psychol, Munich, Germany; [Hall, Nathan C.] McGill Univ, Dept Educ & Counselling Psychol, Montreal, PQ, Canada	University of Konstanz; University of Munich; McGill University	Goetz, T (corresponding author), Univ Konstanz, Dept Empir Educ Res, Constance, Germany.	Thomas.Goetz@Uni-Konstanz.de	Becker, Eva Susann/ABC-7685-2020	Becker, Eva Susann/0000-0001-6080-1481; Goetz, Thomas/0000-0002-8908-2166				Barrett LF, 1997, PERS SOC PSYCHOL B, V23, P1100, DOI 10.1177/01461672972310010; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; Beck J, 2020, COGNITIVE BEHAV THER, V3rd; Bieg M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092563; Bieg M, 2013, LEARN INDIVID DIFFER, V28, P102, DOI 10.1016/j.lindif.2013.09.006; Buehler R, 2001, PERS SOC PSYCHOL B, V27, P1480, DOI 10.1177/01461672012711009; Carson RL, 2010, INT J RES METHOD EDU, V33, P165, DOI 10.1080/1743727X.2010.484548; Chang ML, 2009, EDUC PSYCHOL REV, V21, P193, DOI 10.1007/s10648-009-9106-y; Cohen J.E., 1988, STAT POWER ANAL BEHA; Conner TS, 2012, PSYCHOSOM MED, V74, P327, DOI 10.1097/PSY.0b013e3182546f18; CSIKSZENTMIHALYI M, 1987, J NERV MENT DIS, V175, P526, DOI 10.1097/00005053-198709000-00004; Enzmann D, 1989, STRESS BURNOUT PSYCH; Federal Statistical Office [Statistisches Bundesamt], 2014, SCH BLICK; Frenzel AC., 2010, ACHIEVEMENT EMOTIONS; Frenzel AC, 2015, ANN M AM ED RES ASS; Frenzel AC, 2007, Z PADAGOG PSYCHOL, V21, P283, DOI 10.1024/1010-0652.21.3.283; Frenzel AC, 2007, EUR J PSYCHOL EDUC, V22, P497, DOI 10.1007/BF03173468; Frenzel AC, 2014, EDUC PSYCHOL HANDB, P494; Frenzel AC, 2009, ADVANCES IN TEACHER EMOTION RESEARCH: THE IMPACT ON TEACHERS' LIVES, P129, DOI 10.1007/978-1-4419-0564-2_7; Goetz T, 2013, PSYCHOL SCI, V24, P2079, DOI 10.1177/0956797613486989; Gogol K, 2014, CONTEMP EDUC PSYCHOL, V39, P188, DOI 10.1016/j.cedpsych.2014.04.002; Hakanen JJ, 2006, J SCHOOL PSYCHOL, V43, P495, DOI 10.1016/j.jsp.2005.11.001; Hargreaves A, 1998, TEACH TEACH EDUC, V14, P835, DOI 10.1016/S0742-051X(98)00025-0; Hargreaves A, 2005, EXTENDING EDUCATIONAL CHANGE: INTERNATIONAL HANBOOK OF EDUCATIONAL CHANGE, P278, DOI 10.1007/1-4020-4453-4_14; Hektner J. M., 2007, EXPERIENCE SAMPLING, DOI [10.4135/9781412984201, DOI 10.4135/9781412984201]; Kahneman D., 1999, WELL BEING FDN HEDON, P3, DOI DOI 10.7758/9781610443258; Keller MM, 2014, TEACHER MOTIVATION: THEORY AND PRACTICE, P69; Ludtke O, 2006, Z PADAGOG PSYCHOL, V20, P85, DOI 10.1024/1010-0652.20.12.85; Maas C.J.M., 2005, METHODOLOGY, V1, P86, DOI [10.1027/1614-2241.1.3.86, DOI 10.1027/1614-2241.1.3.86]; Maslach C.J.S., 1997, MASLACH BURNOUT INVE, V3rd; Pekrun R, 2002, EDUC PSYCHOL-US, V37, P91, DOI 10.1207/S15326985EP3702_4; Pekrun R, 2014, EDUC PSYCHOL HANDB, P1; Pekrun R, 2011, CONTEMP EDUC PSYCHOL, V36, P36, DOI 10.1016/j.cedpsych.2010.10.002; Raudenbush S. W., 2002, HIERARCHICAL LINEAR, V1; Raudenbush SW, 2009, HLM 6 08 HIERARCHICA; Robinson MD, 2002, PSYCHOL BULL, V128, P934, DOI 10.1037//0033-2909.128.6.934; Schutz P., 2007, EMOTION ED, P223, DOI [DOI 10.1016/B978-012372545-5/50014-9, https://doi.org/10.1016/B978-012372545-5/50014-9]; Sutton R.E., 2007, EMOTION ED, P251; Sutton RE., 2004, SOC PSYCHOL EDUC, V7, P379, DOI [10.1007/s11218-004-4229-y, DOI 10.1007/S11218-004-4229-Y]; Weisberg J, 1999, J PSYCHOL, V133, P333, DOI 10.1080/00223989909599746; Wilson TD, 2005, CURR DIR PSYCHOL SCI, V14, P131, DOI 10.1111/j.0963-7214.2005.00355.x; Wirtz D, 2003, PSYCHOL SCI, V14, P520, DOI 10.1111/1467-9280.03455	42	27	29	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137441	10.1371/journal.pone.0137441	http://dx.doi.org/10.1371/journal.pone.0137441			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8KS	26368911	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000361601100074
J	Komalapriya, C; Kaloriti, D; Tillmann, AT; Yin, ZK; Herrero-de-Dios, C; Jacobsen, MD; Belmonte, RC; Cameron, G; Haynes, K; Grebogi, C; de Moura, APS; Gow, NAR; Thiel, M; Quinn, J; Brown, AJP; Romano, MC				Komalapriya, Chandrasekaran; Kaloriti, Despoina; Tillmann, Anna T.; Yin, Zhikang; Herrero-de-Dios, Carmen; Jacobsen, Mette D.; Belmonte, Rodrigo C.; Cameron, Gary; Haynes, Ken; Grebogi, Celso; de Moura, Alessandro P. S.; Gow, Neil A. R.; Thiel, Marco; Quinn, Janet; Brown, Alistair J. P.; Romano, M. Carmen			Integrative Model of Oxidative Stress Adaptation in the Fungal Pathogen Candida albicans	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; HYDROGEN-PEROXIDE; TRANSCRIPTION FACTOR; ALTERNATIVE-PATHWAYS; SIGNALING PATHWAYS; OSMOTIC-STRESS; GLUTATHIONE; CELL; MAPK; H2O2	The major fungal pathogen of humans, Candida albicans, mounts robust responses to oxidative stress that are critical for its virulence. These responses counteract the reactive oxygen species (ROS) that are generated by host immune cells in an attempt to kill the invading fungus. Knowledge of the dynamical processes that instigate C. albicans oxidative stress responses is required for a proper understanding of fungus-host interactions. Therefore, we have adopted an interdisciplinary approach to explore the dynamical responses of C. albicans to hydrogen peroxide (H2O2). Our deterministic mathematical model integrates two major oxidative stress signalling pathways (Cap1 and Hog1 pathways) with the three major antioxidant systems (catalase, glutathione and thioredoxin systems) and the pentose phosphate pathway, which provides reducing equivalents required for oxidative stress adaptation. The model encapsulates existing knowledge of these systems with new genomic, proteomic, transcriptomic, molecular and cellular datasets. Our integrative approach predicts the existence of alternative states for the key regulators Cap1 and Hog1, thereby suggesting novel regulatory behaviours during oxidative stress. The model reproduces both existing and new experimental observations under a variety of scenarios. Time-and dose-dependent predictions of the oxidative stress responses for both wild type and mutant cells have highlighted the different temporal contributions of the various antioxidant systems during oxidative stress adaptation, indicating that catalase plays a critical role immediately following stress imposition. This is the first model to encapsulate the dynamics of the transcriptional response alongside the redox kinetics of the major antioxidant systems during H2O2 stress in C. albicans.	[Komalapriya, Chandrasekaran; Grebogi, Celso; de Moura, Alessandro P. S.; Thiel, Marco; Romano, M. Carmen] Univ Aberdeen, Inst Complex Syst & Math Biol, Aberdeen, Scotland; [Komalapriya, Chandrasekaran; Kaloriti, Despoina; Tillmann, Anna T.; Yin, Zhikang; Herrero-de-Dios, Carmen; Jacobsen, Mette D.; Belmonte, Rodrigo C.; Gow, Neil A. R.; Brown, Alistair J. P.; Romano, M. Carmen] Univ Aberdeen, Sch Med Sci, Aberdeen, Scotland; [Cameron, Gary] Univ Aberdeen, Sch Med & Dent, Aberdeen, Scotland; [Haynes, Ken] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Quinn, Janet] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Aberdeen; University of Aberdeen; University of Aberdeen; University of Exeter; Newcastle University - UK	Brown, AJP (corresponding author), Univ Aberdeen, Sch Med Sci, Aberdeen, Scotland.	al.brown@abdn.ac.uk; m.romano@abdn.ac.uk	GOW, Neil/AAS-5323-2021; Quinn, Janet/AAR-9957-2021; Herrero, Carmen/N-4724-2018	GOW, Neil/0000-0002-2776-5850; Brown, Alistair JP/0000-0003-1406-4251; Herrero, Carmen/0000-0002-2042-8480; Komalapriya, Chandrasekaran/0000-0002-9289-1693; Romano, M. Carmen/0000-0002-6261-2147; Quinn, Janet/0000-0002-8732-7676; Grebogi, Celso/0000-0002-9811-4617	CRISP project (Combinatorial Responses In Stress Pathways); UK Biotechnology and Biological Research Council [BB/F00513X/1, BB/F005210/1-2]; BBSRC [BB/K016393/1, BB/K017365/1]; Wellcome Trust [080088, 097377]; European Research Council [ERC-2009-AdG-249793]; BBSRC [BB/F005210/2, BB/F00513X/1, BB/F005210/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K016393/1, BB/K017365/1, BB/F005210/2, BB/F00513X/1, BB/F005210/1] Funding Source: researchfish	CRISP project (Combinatorial Responses In Stress Pathways); UK Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the CRISP project (Combinatorial Responses In Stress Pathways), which was funded by the UK Biotechnology and Biological Research Council (www.bbsrc.ac.uk): AJPB, KH, CG, ADM, NARG, MT, MCR. (Research Grants; BB/F00513X/1, BB/F005210/1-2). AJPB and JQ received additional support from the BBSRC (Research Grants; BB/K016393/1; BB/K017365/1). NARG and AJPB were also supported by the Wellcome Trust (www.wellcome.ac.uk), (Grants: 080088; 097377). AJPB was also supported by the European Research Council (http://erc.europa.eu/), (STRIFE Advanced Grant; ERC-2009-AdG-249793). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimora NJ, 2010, ANTIOXID REDOX SIGN, V13, P731, DOI 10.1089/ars.2009.2968; Alarco AM, 1999, J BACTERIOL, V181, P700, DOI 10.1128/JB.181.3.700-708.1999; Alonso-Monge R, 2003, EUKARYOT CELL, V2, P351, DOI 10.1128/EC.2.2.351-361.2003; Antunes F, 2000, FEBS LETT, V475, P121, DOI 10.1016/S0014-5793(00)01638-0; Arana DM, 2007, CELL MICROBIOL, V9, P1647, DOI 10.1111/j.1462-5822.2007.00898.x; Ask M, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-87; Bienert GP, 2006, BBA-BIOMEMBRANES, V1758, P994, DOI 10.1016/j.bbamem.2006.02.015; Branco MR, 2004, J BIOL CHEM, V279, P6501, DOI 10.1074/jbc.M311818200; Brown AJP, 2012, STRESS RESPONSES CAN; Brown AJP, 2014, TRENDS MICROBIOL, V22, P614, DOI 10.1016/j.tim.2014.07.001; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Brown GD, 2011, ANNU REV IMMUNOL, V29, P1, DOI 10.1146/annurev-immunol-030409-101229; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Chechik G, 2008, NAT BIOTECHNOL, V26, P1251, DOI 10.1038/nbt.1499; Cheetham J, 2007, MOL BIOL CELL, V18, P4603, DOI 10.1091/mbc.E07-06-0581; Crowe JD, 2003, MOL MICROBIOL, V47, P1637, DOI 10.1046/j.1365-2958.2003.03390.x; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dantas AD, 2010, MOL CELL BIOL, V30, P4550, DOI 10.1128/MCB.00313-10; Day AM, 2010, J BIOL CHEM, V285, P7505, DOI 10.1074/jbc.M109.040840; Dickinson DA, 2002, BIOCHEM PHARMACOL, V64, P1019, DOI 10.1016/S0006-2952(02)01172-3; Enjalbert B, 2006, MOL BIOL CELL, V17, P1018, DOI 10.1091/mbc.E05-06-0501; Enjalbert B, 2003, MOL BIOL CELL, V14, P1460, DOI 10.1091/mbc.E02-08-0546; Enjalbert B, 2007, INFECT IMMUN, V75, P2143, DOI 10.1128/IAI.01680-06; Flohe L, 2013, BBA-GEN SUBJECTS, V1830, P3139, DOI 10.1016/j.bbagen.2012.10.020; Gilchrist CA, 2012, BMC MICROBIOL, V12, DOI [10.1186/1471-2180-12-151, 10.5402/2012/538694]; Godon C, 1998, J BIOL CHEM, V273, P22480, DOI 10.1074/jbc.273.35.22480; Gough DR, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.96; Grant CM, 2001, MOL MICROBIOL, V39, P533, DOI 10.1046/j.1365-2958.2001.02283.x; Gulshan K, 2011, J BIOL CHEM, V286, P34071, DOI 10.1074/jbc.M111.251298; de Dios CH, 2010, CURR PROTEIN PEPT SC, V11, P693; Jamieson DJ, 1996, FEMS MICROBIOL LETT, V138, P83, DOI 10.1111/j.1574-6968.1996.tb08139.x; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Kaloriti D, 2014, MBIO, V5, DOI 10.1128/mBio.01334-14; Kaloriti D, 2012, MED MYCOL, V50, P699, DOI 10.3109/13693786.2012.672770; Ke RA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002879; Kim BJ, 2005, DEV BIOL, V284, P387, DOI 10.1016/j.ydbio.2005.05.034; Klipp E, 2005, NAT BIOTECHNOL, V23, P975, DOI 10.1038/nbt1114; Kowald A, 2006, J THEOR BIOL, V238, P828, DOI 10.1016/j.jtbi.2005.06.034; Kowald A, 2004, ANN NY ACAD SCI, V1019, P370, DOI 10.1196/annals.1297.065; Leach MD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003069; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Miramon P, 2014, MED MYCOL, V52, P223, DOI 10.1093/mmy/myt021; Moller MNL-JJDA, 2008, INTERACTION REACTIVE; Nicholls P, 2001, ADV INORG CHEM, V51, P51; Nicholls S, 2004, EUKARYOT CELL, V3, P1111, DOI 10.1128/EC.3.5.1111-1123.2004; Nikolaou E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-44; Okazaki S, 2007, MOL CELL, V27, P675, DOI 10.1016/j.molcel.2007.06.035; Patterson MJ, 2013, ANTIOXID REDOX SIGN, V19, P2244, DOI 10.1089/ars.2013.5199; Peltoniemi MJ, 2006, J BIOL CHEM, V281, P33107, DOI 10.1074/jbc.M605602200; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Phillips AJ, 2006, P NATL ACAD SCI USA, V103, P726, DOI 10.1073/pnas.0506405103; Phillips AJ, 2003, P NATL ACAD SCI USA, V100, P14327, DOI 10.1073/pnas.2332326100; Radmaneshfar E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068067; Raftos JE, 2010, J BIOL CHEM, V285, P23557, DOI 10.1074/jbc.M109.067017; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Ralser M, 2009, NAT BIOTECHNOL, V27, P604, DOI 10.1038/nbt0709-604; Reed MC, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-8; Rietsch A, 1998, ANNU REV GENET, V32, P163, DOI 10.1146/annurev.genet.32.1.163; Rinnerthaler M, 2012, P NATL ACAD SCI USA, V109, P8658, DOI 10.1073/pnas.1201629109; Rodaki A, 2006, EUKARYOT CELL, V5, P1371, DOI 10.1128/EC.00115-06; Roman E, 2007, TRENDS MICROBIOL, V15, P181, DOI 10.1016/j.tim.2007.02.001; Schaber J, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.53; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schulze J, 2009, DTSCH ARZTEBL INT, V106, P837, DOI 10.3238/arztebl.2009.0837; Seaver LC, 2001, J BACTERIOL, V183, P7182, DOI 10.1128/JB.183.24.7182-7189.2001; Smith DA, 2004, MOL BIOL CELL, V15, P4179, DOI 10.1091/mbc.E04-03-0181; Smith DA, 2010, FEMS MICROBIOL LETT, V306, P1, DOI 10.1111/j.1574-6968.2010.01937.x; Steghens JP, 2003, J CHROMATOGR B, V798, P343, DOI 10.1016/j.jchromb.2003.10.007; Tillmann AT, 2013, NITROSATIVE COMBINAT; Urban C, 2005, MOL MICROBIOL, V57, P1318, DOI 10.1111/j.1365-2958.2005.04771.x; Wang Y, 2006, FREE RADICAL BIO MED, V40, P1201, DOI 10.1016/j.freeradbiomed.2005.11.019; Watson WH, 2003, FEBS LETT, V543, P144, DOI 10.1016/S0014-5793(03)00430-7; Wijeratne SSK, 2005, J AGR FOOD CHEM, V53, P8768, DOI 10.1021/jf0512003; Wysong DR, 1998, INFECT IMMUN, V66, P1953, DOI 10.1128/IAI.66.5.1953-1961.1998; Yin ZK, 2009, PROTEOMICS, V9, P4686, DOI 10.1002/pmic.200800958; Zhang XT, 2000, MOL MICROBIOL, V36, P618, DOI 10.1046/j.1365-2958.2000.01877.x; Zhang Z, 2004, P NATL ACAD SCI USA, V101, P9491, DOI 10.1073/pnas.0402961101; Zi ZK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009522; Znaidi S, 2009, EUKARYOT CELL, V8, P806, DOI 10.1128/EC.00002-09	80	37	38	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137750	10.1371/journal.pone.0137750	http://dx.doi.org/10.1371/journal.pone.0137750			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368573	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100129
J	Pandis, N; Fleming, PS; Worthington, H; Dwan, K; Salanti, G				Pandis, Nikolaos; Fleming, Padhraig S.; Worthington, Helen; Dwan, Kerry; Salanti, Georgia			Discrepancies in Outcome Reporting Exist Between Protocols and Published Oral Health Cochrane Systematic Reviews	PLOS ONE			English	Article							RANDOMIZED-TRIALS; EMPIRICAL-EVIDENCE; BIAS; QUALITY; METAANALYSES; PUBLICATION; ABSTRACTS; ISSUES	Objectives To assess discrepancies in the analyzed outcomes between protocols and published reviews within Cochrane oral health systematic reviews (COHG) on the Cochrane Database of Systematic Reviews (CDSR). Study Design and Setting All COHG systematic reviews on the CDSR and the corresponding protocols were retrieved in November 2014 and information on the reported outcomes was recorded. Data was collected at the systematic review level by two reviewers independently. Results One hundred and fifty two reviews were included. In relation to primary outcomes, 11.2% were downgraded to secondary outcomes, 9.9% were omitted altogether in the final publication and new primary outcomes were identified in 18.4% of publications. For secondary outcomes, 2% were upgraded to primary, 12.5% were omitted and 30.9% were newly introduced in the publication. Overall, 45.4% of reviews had at least one discrepancy when compared to the protocol; these were reported in 14.5% reviews. The number of review updates appears to be associated with discrepancies between final review and protocol (OR: 3.18, 95% CI: 1.77, 5.74, p < 0.001). The risk of reporting significant results was lower for both downgraded outcomes [RR: 0.52, 95% CI: 0.17, 1.58, p = 0.24] and upgraded or newly introduced outcomes [RR: 0.77, 95% CI: 0.36, 1.64, p = 0.50] compared to outcomes with no discrepancies. The risk of reporting significant results was higher for upgraded or newly introduced outcomes compared to downgraded outcomes (RR = 1.19, 95% CI: 0.65, 2.16, p = 0.57). None of the comparisons reached statistical significance. Conclusion While no evidence of selective outcome reporting was found in this study, based on the present analysis of SRs published within COHG systematic reviews, discrepancies between outcomes in pre-published protocols and final reviews continue to be common. Solutions such as the use of standardized outcomes to reduce the prevalence of this issue may need to be explored.	[Pandis, Nikolaos; Salanti, Georgia] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Pandis, Nikolaos] Univ Bern, Fac Med, Dent Sch, Dept Orthodont & Dentofacial Orthoped, Bern, Switzerland; [Fleming, Padhraig S.] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England; [Worthington, Helen] Univ Manchester, Sch Dent, Cochrane Oral Hlth Grp, Manchester, Lancs, England; [Dwan, Kerry] Univ Liverpool, Dept Biostat, Inst Translat Med, Liverpool L69 3BX, Merseyside, England	University of Ioannina; University of Bern; University of Geneva; University of London; Queen Mary University London; University of Manchester; University of Liverpool	Pandis, N (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece.	npandis@yahoo.com	Dwan, Kerry/AFK-6469-2022; Dwan, Kerry/AAG-4726-2022; Worthington, Helen/U-8971-2019	Dwan, Kerry/0000-0001-6918-1215; Dwan, Kerry/0000-0001-6918-1215; Worthington, Helen/0000-0002-4851-7469; Salanti, Georgia/0000-0002-3830-8508	Papavramides Foundation, Bern, Switzerland; European Research Council (ERC) [IMMA 260559]	Papavramides Foundation, Bern, Switzerland; European Research Council (ERC)(European Research Council (ERC)European Commission)	This study was supported by a grant of the Papavramides Foundation, Bern, Switzerland, for Nikolaos Pandis. Georgia Salanti has received funding from the European Research Council (ERC Starting Grant IMMA 260559).	Bender R, 2008, J CLIN EPIDEMIOL, V61, P857, DOI 10.1016/j.jclinepi.2008.03.004; Booth A, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-2; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; Dwan K, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001666; Dwan K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002709; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Fleming PS, 2013, EUR J ORTHODONT, V35, P244, DOI 10.1093/ejo/cjs016; Fleming PS, 2013, ANGLE ORTHOD, V83, P158, DOI 10.2319/032612-251.1; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hutton JL, 2000, J ROY STAT SOC C-APP, V49, P359, DOI 10.1111/1467-9876.00197; Kiriakou J, 2013, J DENT, V41, P1181, DOI 10.1016/j.jdent.2013.09.006; Kirkham JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009810; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; Millett D, 2011, J ORTHOD, V38, P158, DOI 10.1179/14653121141407; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Norris SL, 2013, RES SYNTH METHODS, V4, P36, DOI 10.1002/jrsm.1062; Page MJ, 2013, J CLIN EPIDEMIOL, V66, P524, DOI 10.1016/j.jclinepi.2012.10.010; Page MJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000035.pub2; Papageorgiou SN, 2014, EUR J ORTHODONT, V36, P74, DOI 10.1093/ejo/cjt008; Parmelli ELA, 2007, 15 COCHR C 2007 OCT, P23; Remschmidt C, 2014, VACCINE, V32, P1678, DOI 10.1016/j.vaccine.2014.01.060; Saldanha IJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109400; Seehra J, 2013, EUR J ORAL SCI, V121, P57, DOI 10.1111/eos.12027; Silagy CA, 2002, JAMA-J AM MED ASSOC, V287, P2831, DOI 10.1001/jama.287.21.2831; Smith V, 2015, J CLIN EPIDEMIOL, V68, P237, DOI 10.1016/j.jclinepi.2014.09.022; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Tendal B, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3128; Wuytack F, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0060-0	30	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137667	10.1371/journal.pone.0137667	http://dx.doi.org/10.1371/journal.pone.0137667			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368938	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100103
J	Chen, ZX; Tang, N; You, YM; Lan, JB; Liu, YQ; Li, ZG				Chen, Zexiong; Tang, Ning; You, Yuming; Lan, Jianbin; Liu, Yiqing; Li, Zhengguo			Transcriptome Analysis Reveals the Mechanism Underlying the Production of a High Quantity of Chlorogenic Acid in Young Leaves of Lonicera macranthoides Hand.-Mazz	PLOS ONE			English	Article							QUINATE HYDROXYCINNAMOYL TRANSFERASE; PHENYLPROPANOID BIOSYNTHESIS; FUNCTIONAL-CHARACTERIZATION; ANTIOXIDANT ACTIVITY; JAPONICA THUNB; FLOS-LONICERAE; SWEET-POTATO; RNA-SEQ; COFFEE; GENES	Lonicera macranthoides Hand.-Mazz (L. macranthoides) is a medicinal herb that is widely distributed in southern China. The biosynthetic and metabolic pathways for a core secondary metabolite in L. macranthoides, chlorogenic acid (CGA), have been elucidated in many species. However, the mechanisms of CGA biosynthesis and the related gene regulatory network in L. macranthoides are still not well understood. In this study, CGA content was quantified by high performance liquid chromatography (HPLC), and CGA levels differed significantly among three tissues; specifically, the CGA content in young leaves (YL) was greater than that in young stems (YS), which was greater than that in mature flowers (MF). Transcriptome analysis of L. macranthoides yielded a total of 53,533,014 clean reads (average length 90 bp) and 76,453 unigenes (average length 703 bp). A total of 3,767 unigenes were involved in biosynthesis pathways of secondary metabolites. Of these unigenes, 80 were possibly related to CGA biosynthesis. Furthermore, differentially expressed genes (DEGs) were screened in different tissues including YL, MF and YS. In these tissues, 24 DEGs were found to be associated with CGA biosynthesis, including six phenylalanine ammonia lyase (PAL) genes, six 4-coumarate coenzyme A ligase (4CL) genes, four cinnamate 4-Hydroxylase (C4H) genes, seven hydroxycinnamoyl transferase/hydroxycinnamoyl-CoA quinate transferase HCT/HQT genes and one coumarate 3-hydroxylase (C3H) gene. These results further the understanding of CGA biosynthesis and the related regulatory network in L. macranthoides.	[Chen, Zexiong; Tang, Ning; Li, Zhengguo] Chongqing Univ, Sch Life Sci, Genet Engn Res Ctr, Chongqing 400044, Peoples R China; [Chen, Zexiong; You, Yuming; Lan, Jianbin; Liu, Yiqing] Chongqing Univ Arts & Sci, Coll Forestry & Life Sci, Chongqing 402160, Peoples R China	Chongqing University; Chongqing University of Arts & Sciences	Li, ZG (corresponding author), Chongqing Univ, Sch Life Sci, Genet Engn Res Ctr, Chongqing 400044, Peoples R China.	zhengguoli@cqu.edu.cn	Li, Zhengguo/A-5572-2017; Li, Zhengguo/AAR-5191-2020	Zhengguo, Li/0000-0002-4643-9540	National Natural Science Foundation of China [31200512]; Chongqing City Board of Education [KJ1401103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing City Board of Education	This work was supported by the National Natural Science Foundation of China (31200512) and Chongqing City Board of Education (KJ1401103).	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bandyopadhyay G, 2004, BLOOD, V104, P2514, DOI 10.1182/blood-2003-11-4065; Chen Qiu-Zhu, 2010, Zhong Yao Cai, V33, P920; Clifford MN, 2006, J AGR FOOD CHEM, V54, P1957, DOI 10.1021/jf0601665; Clifford MN, 2004, PLANTA MED, V70, P1103, DOI 10.1055/s-2004-835835; Clifford MN, 2000, J SCI FOOD AGR, V80, P1033, DOI [10.1002/(SICI)1097-0010(20000515)80:7&lt;1033::AID-JSFA595&gt;3.0.CO;2-T, 10.1002/(SICI)1097-0010(20000515)80:7<1033::AID-JSFA595>3.0.CO;2-T]; Comino C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-30; Comino C, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-14; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Couteau D, 2001, J APPL MICROBIOL, V90, P873, DOI 10.1046/j.1365-2672.2001.01316.x; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Farah A, 2006, J AGR FOOD CHEM, V54, P374, DOI 10.1021/jf0518305; Feng RT, 2005, J BIOL CHEM, V280, P27888, DOI 10.1074/jbc.M503347200; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; He L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062922; Hoffmann L, 2004, PLANT CELL, V16, P1446, DOI 10.1105/tpc.020297; Hoffmann L, 2003, J BIOL CHEM, V278, P95, DOI 10.1074/jbc.M209362200; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kishimoto Noriaki, 2005, Biocontrol Science, V10, P155; Ku SK, 2009, WORLD J GASTROENTERO, V15, P4799, DOI 10.3748/wjg.15.4799; Kurata R, 2007, J AGR FOOD CHEM, V55, P185, DOI 10.1021/jf0620259; Lan W, 2007, DRUG DEV IND PHARM, V33, P841, DOI 10.1080/03639040701378019; Lepelley M, 2007, PLANT SCI, V172, P978, DOI 10.1016/j.plantsci.2007.02.004; Lepelley M, 2012, PLANTA, V236, P313, DOI 10.1007/s00425-012-1613-2; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu ZL, 2009, J HAZARD MATER, V169, P170, DOI 10.1016/j.jhazmat.2009.03.090; Mahesh V, 2007, PLANT MOL BIOL, V64, P145, DOI 10.1007/s11103-007-9141-3; MOLGAARD P, 1988, PHYTOCHEMISTRY, V27, P2411, DOI 10.1016/0031-9422(88)87005-5; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nardini M, 2002, J AGR FOOD CHEM, V50, P5735, DOI 10.1021/jf0257547; Niggeweg R, 2004, NAT BIOTECHNOL, V22, P746, DOI 10.1038/nbt966; Peng XX, 2010, PLANTA MED, V76, P1921, DOI 10.1055/s-0030-1250020; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Qiu F, 2013, BIOMED CHROMATOGR, V27, P311, DOI 10.1002/bmc.2793; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sonnante G, 2010, PLANT PHYSIOL, V153, P1224, DOI 10.1104/pp.109.150144; STRACK D, 1990, PLANT PHYSIOL, V92, P41, DOI 10.1104/pp.92.1.41; Tang D, 2008, J SEP SCI, V31, P3519, DOI 10.1002/jssc.200800173; Tian, 2011, CHINA J CHINESE MAT, V3, P1406; Tong Q, 2006, ZHONG YAO CAI, V28, P300; Tsuchiya T, 1996, BIOSCI BIOTECH BIOCH, V60, P765, DOI 10.1271/bbb.60.765; VILLEGAS RJA, 1986, J BIOL CHEM, V261, P8729; Wan DG, 2008, LISHIZHEN MED MAT ME, V19, P122; Wang GF, 2009, ANTIVIR RES, V83, P186, DOI 10.1016/j.antiviral.2009.05.002; [王颖 WANG Ying], 2011, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V22, P1606; Wang Z XC, 2008, STUDY OPTIMAL HARVES, V19, P3; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yuan Y, 2014, GENE, V534, P408, DOI 10.1016/j.gene.2012.09.051; Yuan Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-195; Zhang Cong, 2009, Zhongguo Zhong Yao Za Zhi, V34, P3051; Zhang YQ, 2003, SHANDONG PHARMACEUTI, V22, P32; Zhou RBTQ, 2003, CHINESE HERBAL MED, V26, P399; 向增旭, 2007, [中国中药杂志, China Journal of Chinese Materia Medica], V32, P2554	53	23	25	7	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0137212	10.1371/journal.pone.0137212	http://dx.doi.org/10.1371/journal.pone.0137212			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381882	Green Published, gold, Green Submitted			2022-12-27	WOS:000361790200017
J	Kieselbach, T; Zijnge, V; Granstrom, E; Oscarsson, J				Kieselbach, Thomas; Zijnge, Vincent; Granstrom, Elisabeth; Oscarsson, Jan			Proteomics of Aggregatibacter actinomycetemcomitans Outer Membrane Vesicles	PLOS ONE			English	Article							CYTOLETHAL DISTENDING TOXIN; ASSISTED-LASER-DESORPTION/IONIZATION; GROEL-LIKE PROTEIN; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; ESCHERICHIA-COLI; JP2 CLONE; SUBCELLULAR-LOCALIZATION; MORAXELLA-CATARRHALIS; LEUKOTOXIN; VIRULENCE	Aggregatibacter actinomycetemcomitans is an oral and systemic pathogen associated with aggressive forms of periodontitis and with endocarditis. Outer membrane vesicles (OMVs) released by this species have been demonstrated to deliver effector proteins such as cytolethal distending toxin (CDT) and leukotoxin (LtxA) into human host cells and to act as triggers of innate immunity upon carriage of NOD1-and NOD2-active pathogen-associated molecular patterns (PAMPs). To improve our understanding of the pathogenicity-associated functions that A. actinomycetemcomitans exports via OMVs, we studied the proteome of density gradient-purified OMVs from a rough-colony type clinical isolate, strain 173 (serotype e) using liquid chromatography-tandem mass spectrometry (LC-MS/MS). This analysis yielded the identification of 151 proteins, which were found in at least three out of four independent experiments. Data are available via ProteomeXchange with identifier PXD002509. Through this study, we not only confirmed the vesicle-associated release of LtxA, and the presence of proteins, which are known to act as immunoreactive antigens in the human host, but we also identified numerous additional putative virulence-related proteins in the A. actinomycetemcomitans OMV proteome. The known and putative functions of these proteins include immune evasion, drug targeting, and iron/nutrient acquisition. In summary, our findings are consistent with an OMV-associated proteome that exhibits several offensive and defensive functions, and they provide a comprehensive basis to further disclose roles of A. actinomycetemcomitans OMVs in periodontal and systemic disease.	[Kieselbach, Thomas] Umea Univ, Dept Chem, Umea, Sweden; [Zijnge, Vincent] Univ Groningen, Univ Med Ctr Groningen, Ctr Dent & Oral Hyg, NL-9713 AV Groningen, Netherlands; [Granstrom, Elisabeth; Oscarsson, Jan] Umea Univ, Dept Odontol, Oral Microbiol, Umea, Sweden	Umea University; University of Groningen; Umea University	Oscarsson, J (corresponding author), Umea Univ, Dept Odontol, Oral Microbiol, Umea, Sweden.	jan.oscarsson@umu.se	Kieselbach, Thomas/O-6023-2015	Kieselbach, Thomas/0000-0001-5577-2938	TUA grants from the County Council of Vasterbotten, Sweden; Insamlingsstiftelsen, Medical Faculty, Umea University; Magnus Bergvalls Stiftelse; Faculty of Science and Technology of Umea University; Kempe Foundations	TUA grants from the County Council of Vasterbotten, Sweden; Insamlingsstiftelsen, Medical Faculty, Umea University; Magnus Bergvalls Stiftelse; Faculty of Science and Technology of Umea University; Kempe Foundations	This work was supported by TUA grants from the County Council of Vasterbotten, Sweden (JO), Insamlingsstiftelsen, Medical Faculty, Umea University (JO), and Magnus Bergvalls Stiftelse (JO). The proteomics part of this study was performed at the KBC Proteomics Core facility at Umea University and the Swedish University of Agricultural Sciences. We thank the Faculty of Science and Technology of Umea University, and the Kempe Foundations for grants for instruments and bioinformatics resources of this facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg CH, 2014, J CLIN PERIODONTOL, V41, P232, DOI 10.1111/jcpe.12209; Aberg CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065781; Asakawa R, 2003, MOL MICROBIOL, V50, P1125, DOI 10.1046/j.1365-2958.2003.03748.x; Asikainen SE, 2009, FUTURE MICROBIOL, V4, P495, DOI [10.2217/fmb.09.21, 10.2217/FMB.09.21]; Bai DY, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftu006; Bai J, 2014, INFECT IMMUN, V82, P4001, DOI 10.1128/IAI.01416-13; Belibasakis GN, 2004, APMIS, V112, P674, DOI 10.1111/j.1600-0463.2004.apm1121006.x; Bielig H, 2011, INFECT IMMUN, V79, P1418, DOI 10.1128/IAI.00754-10; Biller SJ, 2014, SCIENCE, V343, P183, DOI 10.1126/science.1243457; BIRDSELL DC, 1967, J BACTERIOL, V93, P427, DOI 10.1128/JB.93.1.427-437.1967; Bonnington KE, 2014, BBA-MOL CELL RES, V1843, P1612, DOI 10.1016/j.bbamcr.2013.12.011; Brage M, 2011, J PERIODONTAL RES, V46, P170, DOI 10.1111/j.1600-0765.2010.01325.x; BROGAN JM, 1994, INFECT IMMUN, V62, P501, DOI 10.1128/IAI.62.2.501-508.1994; Bulkley D, 2014, CELL REP, V6, P357, DOI 10.1016/j.celrep.2013.12.024; Choi DS, 2011, PROTEOMICS, V11, P3424, DOI 10.1002/pmic.201000212; Chopra I, 2007, CURR OPIN INVEST DR, V8, P600; Collin F, 2011, APPL MICROBIOL BIOT, V92, P479, DOI 10.1007/s00253-011-3557-z; Crosby JA, 2007, GENE, V388, P83, DOI 10.1016/j.gene.2006.10.004; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Deatherage BL, 2012, INFECT IMMUN, V80, P1948, DOI 10.1128/IAI.06014-11; Demuth DR, 2003, CELL MICROBIOL, V5, P111, DOI 10.1046/j.1462-5822.2003.00259.x; den Blaauwen T, 2014, BIOORG CHEM, V55, P27, DOI 10.1016/j.bioorg.2014.03.007; DiRienzo JM, 2014, CELLS-BASEL, V3, P476, DOI 10.3390/cells3020476; DORWARD DW, 1990, APPL ENVIRON MICROB, V56, P1960, DOI 10.1128/AEM.56.6.1960-1962.1990; DORWARD DW, 1989, J BACTERIOL, V171, P2499, DOI 10.1128/jb.171.5.2499-2505.1989; Du DJ, 2014, NATURE, V509, P512, DOI 10.1038/nature13205; Duperthuy M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003620; Elmi A, 2012, INFECT IMMUN, V80, P4089, DOI 10.1128/IAI.00161-12; Farrell DJ, 2011, CLIN INFECT DIS, V52, pS487, DOI 10.1093/cid/cir164; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; Garg A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-62; Ghosal A, 2015, MICROBIOLOGYOPEN, V4, P252, DOI 10.1002/mbo3.235; Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4; Goulhen F, 1998, INFECT IMMUN, V66, P5307, DOI 10.1128/IAI.66.11.5307-5313.1998; Guerra L, 2011, TOXINS, V3, P172, DOI 10.3390/toxins3030172; Gurung M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027958; Haubek D, 2008, LANCET, V371, P237, DOI 10.1016/S0140-6736(08)60135-X; Haubek D, 2010, APMIS, V118, P1, DOI 10.1111/j.1600-0463.2010.02665.x; Haurat MF, 2015, BIOL CHEM, V396, P95, DOI 10.1515/hsz-2014-0183; Henderson B, 2010, PERIODONTOL 2000, V54, P78, DOI 10.1111/j.1600-0757.2009.00331.x; Horstman AL, 2000, J BIOL CHEM, V275, P12489, DOI 10.1074/jbc.275.17.12489; Huang Y, 2013, MOL ORAL MICROBIOL, V28, P1, DOI 10.1111/omi.12005; Jang KS, 2014, J PROTEOMICS, V98, P90, DOI 10.1016/j.jprot.2013.12.014; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Jin JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017027; Johansson A, 2000, J PERIODONTAL RES, V35, P85, DOI 10.1034/j.1600-0765.2000.035002085.x; Johansson A, 2011, TOXINS, V3, P242, DOI 10.3390/toxins3030242; KADURUGAMUWA JL, 1995, J BACTERIOL, V177, P3998, DOI 10.1128/jb.177.14.3998-4008.1995; KADURUGAMUWA JL, 1993, J BACTERIOL, V175, P5798, DOI 10.1128/JB.175.18.5798-5805.1993; Kaparakis M, 2010, CELL MICROBIOL, V12, P372, DOI 10.1111/j.1462-5822.2009.01404.x; Kaparakis-Liaskos M, 2015, NAT REV IMMUNOL, V15, P375, DOI 10.1038/nri3837; Karched M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-18; Kato S, 2002, MICROB PATHOGENESIS, V32, P1, DOI 10.1006/mpat.2001.0474; Kebschull M, 2010, J DENT RES, V89, P879, DOI 10.1177/0022034510375281; Kelk P, 2008, INT J MED MICROBIOL, V298, P529, DOI 10.1016/j.ijmm.2007.06.005; Kim JH, 2015, SEMIN CELL DEV BIOL, V40, P97, DOI 10.1016/j.semcdb.2015.02.006; Kim SW, 2009, FEMS MICROBIOL LETT, V301, P224, DOI 10.1111/j.1574-6968.2009.01820.x; KIRBY AC, 1995, J CLIN INVEST, V96, P1185, DOI 10.1172/JCI118150; Kittichotirat W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022420; KNOX KW, 1966, J BACTERIOL, V92, P1206, DOI 10.1128/JB.92.4.1206-1217.1966; KOGA T, 1993, J PERIODONTAL RES, V28, P475, DOI 10.1111/j.1600-0765.1993.tb02107.x; Kolling GL, 1999, APPL ENVIRON MICROB, V65, P1843; Komatsuzawa H, 2002, GENE, V288, P195, DOI 10.1016/S0378-1119(02)00500-0; Kulkarni HM, 2014, MICROBIOL-SGM, V160, P2109, DOI 10.1099/mic.0.079400-0; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LALLY ET, 1989, J BIOL CHEM, V264, P15451; Lee EY, 2007, PROTEOMICS, V7, P3143, DOI [10.1002/pmic.200700196, 10.1002/pmic.200790083]; Lee EY, 2009, PROTEOMICS, V9, P5425, DOI 10.1002/pmic.200900338; Lee J, 2013, ANTIMICROB AGENTS CH, V57, P2589, DOI 10.1128/AAC.00522-12; Lin FY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0102450, DOI 10.1371/J0URNAL.P0NE.0102450]; Lo Sciuto A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103784; MacDonald IA, 2012, RES MICROBIOL, V163, P607, DOI 10.1016/j.resmic.2012.10.020; Mani M, 2015, NUCLEIC ACIDS RES, V43, pD277, DOI 10.1093/nar/gku954; MAYRAND D, 1989, CAN J MICROBIOL, V35, P607, DOI 10.1139/m89-097; McNeil LK, 2013, MICROBIOL MOL BIOL R, V77, P234, DOI 10.1128/MMBR.00056-12; Munksgaard PS, 2012, CELL MICROBIOL, V14, P1904, DOI 10.1111/cmi.12021; Nakao R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026163; Nalbant A, 2003, ORAL MICROBIOL IMMUN, V18, P339, DOI 10.1046/j.0902-0055.2003.00082.x; Nevot M, 2006, ENVIRON MICROBIOL, V8, P1523, DOI 10.1111/j.1462-2920.2006.01043.x; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Nordstrom T, 2005, J IMMUNOL, V175, P3628, DOI 10.4049/jimmunol.175.6.3628; Olsen I, 2015, J ORAL MICROBIOL, V7, DOI 10.3402/jom.v7.27468; Oscarsson J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-206; Paino A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070509; Paju S, 2000, FEMS MICROBIOL LETT, V182, P231, DOI 10.1016/S0378-1097(99)00595-9; Park AJ, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00464; Park SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017629; Paul-Satyaseela M, 2006, J MED MICROBIOL, V55, P931, DOI 10.1099/jmm.0.46470-0; Perez-Cruz C, 2013, APPL ENVIRON MICROB, V79, P1874, DOI 10.1128/AEM.03657-12; Promega, 2015, TECHNICAL BULLETIN, V373; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rompikuntal PK, 2012, INFECT IMMUN, V80, P31, DOI 10.1128/IAI.06069-11; Rylev M, 2011, J PROTEOMICS, V74, P2972, DOI 10.1016/j.jprot.2011.07.022; SAARELA M, 1992, ORAL MICROBIOL IMMUN, V7, P277, DOI 10.1111/j.1399-302X.1992.tb00588.x; Schreiner HC, 2003, P NATL ACAD SCI USA, V100, P7295, DOI 10.1073/pnas.1237223100; Siljamaki P, 2014, J PROTEOME RES, V13, P3249, DOI 10.1021/pr500075j; SIMPSON DL, 1988, INFECT IMMUN, V56, P1162, DOI 10.1128/IAI.56.5.1162-1166.1988; Smith KP, 2015, MOL ORAL MICROBIOL, V30, P97, DOI 10.1111/omi.12074; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Sun RX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066472; Tan KS, 2002, J PERIODONTAL RES, V37, P268, DOI 10.1034/j.1600-0765.2002.01618.x; Tan TT, 2007, J INFECT DIS, V195, P1661, DOI 10.1086/517611; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Thay B, 2014, INFECT IMMUN, V82, P4034, DOI 10.1128/IAI.01980-14; Thay B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054661; Tsuzukibashi O, 2014, ARCH MICROBIOL, V196, P261, DOI 10.1007/s00203-014-0965-3; Uhlin B.E., 2014, PATHOGENIC ESCHERICH, P161; van Winkelhoff AJ, 1999, PERIODONTOL 2000, V20, P122; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang Y, 2002, J BACTERIOL, V184, P3442, DOI 10.1128/JB.184.13.3442-3449.2002; WILSON ME, 1991, J PERIODONTOL, V62, P211, DOI 10.1902/jop.1991.62.3.211; WILSON ME, 1995, INFECT IMMUN, V63, P1062, DOI 10.1128/IAI.63.3.1062-1069.1995; Wooster DG, 2006, IMMUNOLOGY, V117, P482, DOI 10.1111/j.1365-2567.2006.02323.x; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Yue G, 2007, INFECT IMMUN, V75, P4440, DOI 10.1128/IAI.02020-06; Zijnge V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041662	119	34	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138591	10.1371/journal.pone.0138591	http://dx.doi.org/10.1371/journal.pone.0138591			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26381655	Green Published, Green Submitted, gold			2022-12-27	WOS:000361790200135
J	Hatcher, HC; Tesfay, L; Torti, SV; Torti, FM				Hatcher, Heather C.; Tesfay, Lia; Torti, Suzy V.; Torti, Frank M.			Cytoprotective Effect of Ferritin H in Renal Ischemia Reperfusion Injury	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; ALPHA-INDUCED APOPTOSIS; TUMOR-NECROSIS-FACTOR; OXIDATIVE STRESS; HEAVY-CHAIN; IN-VIVO; ISCHEMIA/REPERFUSION INJURY; CELLULAR-REGULATION; EPITHELIAL-CELLS; HEME OXYGENASE-1	Oxidative stress is a major contributor to kidney injury following ischemia reperfusion. Ferritin, a highly conserved iron-binding protein, is a key protein in the maintenance of cellular iron homeostasis and protection from oxidative stress. Ferritin mitigates oxidant stress by sequestering iron and preventing its participation in reactions that generate reactive oxygen species. Ferritin is composed of two subunit types, ferritin H and ferritin L. Using an in vivo model that enables conditional tissue-specific doxycycline-inducible expression of ferritin H in the mouse kidney, we tested the hypothesis that an increased level of H-rich ferritin is renoprotective in ischemic acute renal failure. Prior to induction of ischemia, doxycycline increased ferritin H in the kidneys of the transgenicmice nearly 6.5-fold. Following reperfusion for 24 hours, induction of neutrophil gelatinous-associated lipocalin (NGAL, a urine marker of renal dysfunction) was reduced in the ferritin H overexpressers compared to controls. Histopathologic examination following ischemia reperfusion revealed that ferritin H overexpression increased intact nuclei in renal tubules, reduced the frequency of tubular profiles with luminal cast materials, and reduced activated caspase-3 in the kidney. In addition, generation of 4-hydroxy 2-nonenal protein adducts, a measurement of oxidant stress, was decreased in ischemia-reperfused kidneys of ferritin H overexpressers. These studies demonstrate that ferritin H can inhibit apoptotic cell death, enhance tubular epithelial viability, and preserve renal function by limiting oxidative stress following ischemia reperfusion injury.	[Hatcher, Heather C.; Tesfay, Lia; Torti, Suzy V.; Torti, Frank M.] Wake Forest Univ, Sch Med, Dept Canc Biol, Winston Salem, NC 27109 USA; [Torti, Suzy V.] Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27109 USA; [Torti, Suzy V.; Torti, Frank M.] Wake Forest Univ, Sch Med, Ctr Comprehens Canc, Winston Salem, NC 27109 USA	Wake Forest University; Wake Forest University; Wake Forest University	Torti, FM (corresponding author), Univ Connecticut, Hlth Sci Ctr, Dept Internal Med, Farmington, CT 06030 USA.	ftorti@uchc.edu			NIH [R37 DK42412, RO1 CA-171101]; NATIONAL CANCER INSTITUTE [R01CA171101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042412] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work described in this study was supported by NIH R37 DK42412 and RO1 CA-171101 (FMT). There was no additional funding received for this study.	Agarwal A, 2000, J AM SOC NEPHROL, V11, P965, DOI 10.1681/ASN.V115965; BALIGA R, 1993, BIOCHEM J, V291, P901, DOI 10.1042/bj2910901; Bennett M, 2008, CLIN J AM SOC NEPHRO, V3, P665, DOI 10.2215/CJN.04010907; Berberat PO, 2003, FASEB J, V17, P1724, DOI 10.1096/fj.03-0229fje; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Bonventre JV, 2003, J AM SOC NEPHROL, V14, P2199, DOI 10.1097/01.ASN.0000079785.13922.F6; Cantley LG, 2005, NAT CLIN PRACT NEPHR, V1, P22, DOI 10.1038/ncpneph0021; CASKEY JH, 1983, P NATL ACAD SCI-BIOL, V80, P482, DOI 10.1073/pnas.80.2.482; Chien CT, 2001, J AM SOC NEPHROL, V12, P973, DOI 10.1681/ASN.V125973; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Coffman LG, 2009, P NATL ACAD SCI USA, V106, P570, DOI 10.1073/pnas.0812010106; Cozzi A, 2003, FEBS LETT, V537, P187, DOI 10.1016/S0014-5793(03)00114-5; De Vries B, 2004, TRANSPLANTATION, V77, P669, DOI 10.1097/01.TP.0000115002.28575.E7; Duan WR, 2003, J PATHOL, V199, P221, DOI 10.1002/path.1289; Duffield JS, 2005, J CLIN INVEST, V115, P1743, DOI 10.1172/JCI22593; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Halliwell B., 2007, FREE RADICALS BIOL M; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Hintze KJ, 2006, CELL MOL LIFE SCI, V63, P591, DOI 10.1007/s00018-005-5285-y; Jennette J, 2006, HEPINSTALLS PATHOLOG; Kanayama M, 2007, J BIOL CHEM, V282, P24166, DOI 10.1074/jbc.M703212200; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; Kell DB, 2010, ARCH TOXICOL, V84, P825, DOI 10.1007/s00204-010-0577-x; Kezic A, 2013, AM J NEPHROL, V37, P291, DOI 10.1159/000348496; LAWSON DM, 1989, FEBS LETT, V254, P207, DOI 10.1016/0014-5793(89)81040-3; Le Dorze M, 2009, CURR OPIN CRIT CARE, V15, P503, DOI 10.1097/MCC.0b013e328332f6cf; LEVI S, 1994, J MOL BIOL, V238, P649, DOI 10.1006/jmbi.1994.1325; Liang HL, 2009, AM J PHYSIOL-RENAL, V296, pF266, DOI 10.1152/ajprenal.90533.2008; LIU QS, 1995, J BIOL CHEM, V270, P22565, DOI 10.1074/jbc.270.38.22565; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mehta RL, 2004, KIDNEY INT, V66, P1613, DOI 10.1111/j.1523-1755.2004.00927.x; MILLER LL, 1991, P NATL ACAD SCI USA, V88, P4946, DOI 10.1073/pnas.88.11.4946; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Nath KA, 2006, KIDNEY INT, V70, P432, DOI 10.1038/sj.ki.5001565; Nath KA, 2000, AM J MED, V109, P665, DOI 10.1016/S0002-9343(00)00612-4; Obolensky A, 2008, FREE RADICAL BIO MED, V44, P1286, DOI 10.1016/j.freeradbiomed.2007.10.060; Orino K, 2001, BIOCHEM J, V357, P241, DOI 10.1042/0264-6021:3570241; PALLER MS, 1988, AM J PHYSIOL, V255, pF539, DOI 10.1152/ajprenal.1988.255.3.F539; Paragas N, 2012, BBA-MOL CELL RES, V1823, P1451, DOI 10.1016/j.bbamcr.2012.06.014; Patel RP, 1999, BBA-BIOENERGETICS, V1411, P385, DOI 10.1016/S0005-2728(99)00028-6; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Picard V, 1998, J BIOL CHEM, V273, P15382, DOI 10.1074/jbc.273.25.15382; Pietsch EC, 2003, BIOCHEM PHARMACOL, V65, P1261, DOI 10.1016/S0006-2952(03)00081-9; Pietsch EC, 2003, J BIOL CHEM, V278, P2361, DOI 10.1074/jbc.M210664200; Rouault TA, 2002, BLOOD CELL MOL DIS, V29, P309, DOI 10.1006/bcmd.2002.0571; Schonig K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf134; Schrier RW, 2004, J CLIN INVEST, V114, P5, DOI 10.1172/JC1200422353; SHAH SV, 1988, AM J PHYSIOL, V255, pF438, DOI 10.1152/ajprenal.1988.255.3.F438; THEIL EC, 1990, ADV ENZYMOL RAMB, V63, P421; Theil EC, 2003, J NUTR, V133, p1549S, DOI 10.1093/jn/133.5.1549S; Thompson K, 2003, J NEUROSCI RES, V71, P46, DOI 10.1002/jnr.10463; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; TORTI SV, 1988, J BIOL CHEM, V263, P12638; Tsuji Y, 2000, MOL CELL BIOL, V20, P5818, DOI 10.1128/MCB.20.16.5818-5827.2000; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Vesey DA, 2004, NEPHROL DIAL TRANSPL, V19, P348, DOI 10.1093/ndt/gfg547; Waikar SS, 2008, CLIN J AM SOC NEPHRO, V3, P844, DOI 10.2215/CJN.05191107; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; WEI Y, 1990, BIOCHEM BIOPH RES CO, V169, P289, DOI 10.1016/0006-291X(90)91466-6; Wilkinson J, 2006, BIOCHEM J, V395, P501, DOI 10.1042/BJ20060063; Yang B, 2006, TRANSPLANTATION, V81, P1442, DOI 10.1097/01.tp.0000209412.77312.69; Yeh CH, 2011, NEUROUROL URODYNAM, V30, P472, DOI 10.1002/nau.20855; ZAGER RA, 1992, J CLIN INVEST, V90, P711, DOI 10.1172/JCI115942; Zarjou A, 2013, J CLIN INVEST, V123, P4423, DOI 10.1172/JCI67867	65	23	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138505	10.1371/journal.pone.0138505	http://dx.doi.org/10.1371/journal.pone.0138505			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379029	gold, Green Published, Green Submitted			2022-12-27	WOS:000361769400107
J	Kerbert, AJC; Verbeke, L; Chiang, FWT; Laleman, W; van der Reijden, JJ; van Duijn, W; Nevens, F; Wolterbeek, R; van Hoek, B; Verspaget, HW; Coenraad, MJ				Kerbert, Annarein J. C.; Verbeke, Len; Chiang, Fang W. T.; Laleman, Wim; van der Reijden, Johan J.; van Duijn, Wim; Nevens, Frederik; Wolterbeek, Ron; van Hoek, Bart; Verspaget, Hein W.; Coenraad, Minneke J.			Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver Cirrhosis	PLOS ONE			English	Article							ANTIDIURETIC-HORMONE; HEPATORENAL-SYNDROME; PIG PITUITARIES; PLASMA COPEPTIN; POSTERIOR LOBE; RENAL-FUNCTION; GLYCOPEPTIDE; MODEL; VASOPRESSIN; DIAGNOSIS	Background Advanced liver cirrhosis is associated with systemic hemodynamic derangement leading to the development of severe complications associated with increased mortality. Copeptin is a stable cleavage product of the precursor of arginine vasopressin, a key-regulator in hemodynamic homeostasis. Copeptin is currently considered a reliable prognostic marker in a wide variety of diseases other than cirrhosis. The present study aimed to assess copeptin, both experimentally and clinically, as a potential biomarker of hemodynamic derangement and to evaluate its prognostic significance in cirrhosis. Materials and Methods Two studies were executed: 1) in 18 thioacetamide-induced cirrhotic rats and 5 control rats, plasma copeptin and hemodynamic measurements were performed, 2) in 61 cirrhotic patients, serum copeptin concentration was measured in samples collected at time of registration at the waiting list for liver transplantation. In 46 patients, also a second copeptin measurement was performed during follow-up while registered at the waiting list for liver transplantation. To determine the association of serum copeptin and clinical data with outcome, Cox proportional hazard regression analysis and Kaplan Meier analysis were performed. Results Plasma copeptin concentration was significantly higher in cirrhotic rats than in controls (1.6 +/- 0.5 vs. 0.9 +/- 0.1 pmol/L, p< 0.01) and was negatively correlated to the mean arterial blood pressure (r = -0.574, p = 0.013). In cirrhotic patients, serum copeptin concentration was high [11.0 (5.2-24.0) pmol/L] and increased significantly during the time of registration at the waiting list for liver transplantation. MELD and MELD-sodium score were significantly correlated to serum copeptin [MELD: (r = 0.33, p = 0.01), MELD-sodium: (r = 0.29, p = 0.02)], also at time of the second copeptin measurement [MELD and MELD-sodium: r = 0.39, p< 0.01]. In cirrhotic humans, serum copeptin concentration was significantly associated with outcome, independently of the MELD and MELD-sodium score. Patients with a low serum copeptin concentration at time of registration at the liver transplant waiting list had significantly better transplant-free survival rates at 3, 6 and 12 months of follow-up as compared to those with a high serum copeptin concentration (Log-rank: p< 0.01, p< 0.01 and p = 0.02 respectively). Conclusions Circulating copeptin levels are elevated in rats and humans with cirrhosis. Copeptin is independently associated with outcome in cirrhotic patients awaiting liver transplantation.	[Kerbert, Annarein J. C.; Chiang, Fang W. T.; van der Reijden, Johan J.; van Duijn, Wim; van Hoek, Bart; Verspaget, Hein W.; Coenraad, Minneke J.] Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, Leiden, Netherlands; [Verbeke, Len; Laleman, Wim; Nevens, Frederik] Univ Hosp Gasthuisberg, Dept Liver & Biliopancreat Dis, Leuven, Belgium; [Wolterbeek, Ron] Leiden Univ, Dept Med Stat & Bioinformat, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; KU Leuven; University Hospital Leuven; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kerbert, AJC (corresponding author), Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, Leiden, Netherlands.	j.c.kerbert@lumc.nl; rn.j.coenraad@lumc.nl	van Hoek, Bart/AAU-8953-2020; Coenraad, Minneke/AAU-1684-2020; Kerbert, J.C./AAN-7747-2020; Laleman, Wim/H-7272-2019	Coenraad, Minneke/0000-0002-3434-4421; Kerbert, J.C./0000-0001-9845-2176; Laleman, Wim/0000-0002-0842-7813; van Hoek, Bart/0000-0001-6527-764X	Leiden University Medical Center [8219-70550]	Leiden University Medical Center	Support was provided by a research grant from the Leiden University Medical Center (number: 8219-70550). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balanescu S, 2011, J CLIN ENDOCR METAB, V96, P1046, DOI 10.1210/jc.2010-2499; BAUMANN G, 1976, J CLIN INVEST, V57, P1109, DOI 10.1172/JCI108377; Bhandari SS, 2009, CLIN SCI, V116, P257, DOI 10.1042/CS20080140; Biggins SW, 2006, GASTROENTEROLOGY, V130, P1652, DOI 10.1053/j.gastro.2006.02.010; BOSCH J, 1980, GASTROENTEROLOGY, V78, P92; Dobsa L, 2013, BIOCHEM MEDICA, V23, P172, DOI 10.11613/BM.2013.021; Fernandez-Esparrach G, 2001, J HEPATOL, V34, P46, DOI 10.1016/S0168-8278(00)00011-8; GINES A, 1993, GASTROENTEROLOGY, V105, P229, DOI 10.1016/0016-5085(93)90031-7; Gines P, 2009, NEW ENGL J MED, V361, P1279, DOI 10.1056/NEJMra0809139; HOLWERDA DA, 1972, EUR J BIOCHEM, V28, P340, DOI 10.1111/j.1432-1033.1972.tb01919.x; HOLWERDA DA, 1972, EUR J BIOCHEM, V28, P334, DOI 10.1111/j.1432-1033.1972.tb01918.x; Kimer N, 2014, EUR J CLIN INVEST, V44, P441, DOI 10.1111/eci.12249; Krag A, 2010, GUT, V59, P105, DOI 10.1136/gut.2009.180570; Laleman W, 2006, EUR J CLIN INVEST, V36, P242, DOI 10.1111/j.1365-2362.2006.01620.x; Lippi G, 2012, CLIN CHEM LAB MED, V50, P243, DOI 10.1515/cclm-2011-0845; LLACH J, 1988, GASTROENTEROLOGY, V94, P482, DOI 10.1016/0016-5085(88)90441-6; Miller WL, 2013, AM J CARDIOL, V111, P880, DOI 10.1016/j.amjcard.2012.11.053; Montgomery A, 2005, CARDIOVASC INTER RAD, V28, P307, DOI 10.1007/s00270-004-0145-y; Moreno JP, 2013, LIVER INT, V33, P843, DOI 10.1111/liv.12175; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Neuhold S, 2008, J AM COLL CARDIOL, V52, P266, DOI 10.1016/j.jacc.2008.03.050; Nigro N, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13270; Przybylowski P, 2010, TRANSPL P, V42, P1808, DOI 10.1016/j.transproceed.2010.03.138; ROBERTSON GL, 1976, J CLIN ENDOCR METAB, V42, P613, DOI 10.1210/jcem-42-4-613; Robertson GL, 2001, ENDOCRIN METAB CLIN, V30, P671, DOI 10.1016/S0889-8529(05)70207-3; Salerno F, 2007, GUT, V56, P1310, DOI 10.1136/gut.2006.107789; SCHRIER RW, 1988, HEPATOLOGY, V8, P1151, DOI 10.1002/hep.1840080532; SMYTH DG, 1979, BIOCHEM BIOPH RES CO, V87, P1006, DOI 10.1016/S0006-291X(79)80007-8; Szinnai G, 2007, J CLIN ENDOCR METAB, V92, P3973, DOI 10.1210/jc.2007-0232; von Haehling S, 2012, INT J CARDIOL, V162, P27, DOI 10.1016/j.ijcard.2011.12.105; Wiese S, 2014, LIVER INT, V34, pE19, DOI 10.1111/liv.12428; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016	32	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138264	10.1371/journal.pone.0138264	http://dx.doi.org/10.1371/journal.pone.0138264			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378453	Green Published, Green Submitted, gold			2022-12-27	WOS:000361769400076
J	Tausch, SH; Renard, BY; Nitsche, A; Dabrowski, PW				Tausch, Simon H.; Renard, Bernhard Y.; Nitsche, Andreas; Dabrowski, Piotr Wojciech			RAMBO-K: Rapid and Sensitive Removal of Background Sequences from Next Generation Sequencing Data	PLOS ONE			English	Article							CLASSIFICATION	Background The assembly of viral or endosymbiont genomes from Next Generation Sequencing (NGS) data is often hampered by the predominant abundance of reads originating from the host organism. These reads increase the memory and CPU time usage of the assembler and can lead to misassemblies. Results We developed RAMBO-K (Read Assignment Method Based On K-mers), a tool which allows rapid and sensitive removal of unwanted host sequences from NGS datasets. Reaching a speed of 10 Megabases/s on 4 CPU cores and a standard hard drive, RAMBOK is faster than any tool we tested, while showing a consistently high sensitivity and specificity across different datasets. Conclusions RAMBO-K rapidly and reliably separates reads from different species without data preprocessing. It is suitable as a straightforward standard solution for workflows dealing with mixed datasets. Binaries and source code (Java and python) are available from http:// sourceforgesietiprojectskambok/.	[Tausch, Simon H.; Nitsche, Andreas; Dabrowski, Piotr Wojciech] Robert Koch Inst, Ctr Biol Threats & Special Pathogens, D-13353 Berlin, Germany; [Renard, Bernhard Y.; Dabrowski, Piotr Wojciech] Robert Koch Inst, Res Grp Bioinformat NG4, D-13353 Berlin, Germany	Robert Koch Institute; Robert Koch Institute	Dabrowski, PW (corresponding author), Robert Koch Inst, Ctr Biol Threats & Special Pathogens, D-13353 Berlin, Germany.	DabrowskiW@rki.de	Tausch, Simon/ABC-5777-2021; Dabrowski, Piotr Wojtek/L-1423-2015	Dabrowski, Piotr Wojtek/0000-0003-4893-805X; Renard, Bernhard/0000-0003-4589-9809; Tausch, Simon/0000-0002-6874-233X; Nitsche, Andreas/0000-0001-8185-3176				Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Metcalf JA, 2014, PEERJ, V2, DOI 10.7717/peerj.529; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Wu YW, 2011, J COMPUT BIOL, V18, P523, DOI 10.1089/cmb.2010.0245	5	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137896	10.1371/journal.pone.0137896	http://dx.doi.org/10.1371/journal.pone.0137896			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379285	Green Published, Green Submitted, gold			2022-12-27	WOS:000361769400033
J	Wang, GF; Liu, GF; Zhang, RH; Ji, RJ; Gao, BQ; Wang, YL; Pan, YS; Li, ZX; Wang, YJ				Wang, Guifen; Liu, Gaifen; Zhang, Runhua; Ji, Ruijun; Gao, Baoqin; Wang, Yilong; Pan, Yuesong; Li, Zixiao; Wang, Yongjun			Evaluation of Off-Hour Emergency Care in Acute Ischemic Stroke: Results from the China National Stroke Registry	PLOS ONE			English	Article							CASE-FATALITY; PERFORMANCE-MEASURES; WEEKDAY ADMISSION; WEEKEND; MORTALITY; QUALITY; ASSOCIATION; COHORT; TIME	Background and Purpose The quality of after-hour emergency care of patients with acute ischemic stroke is debatable. We therefore, sought to analyze the performance measures, quality of care and clinical outcomes in these patients admitted during off-hours. Methods Our study included 4493 patients from a selected cohort of patients admitted to the hospitals with ischemic stroke in the China National Stroke Registry (CNSR) from September 2007 to August 2008. On-hour presentation was defined as arrival at the emergency department from the scene between 8AM and 5PM from Monday through Friday. Off-hours included the remainder of the on-hours and statutory holidays. The association between off-hour presentation and outcome was analyzed using multivariate logistic-regression models. Results Off-hour presentation was identified in 2672 (59.5%) patients with ischemic stroke. Comparison of patients admitted during off-hours with those admitted during on-hours revealed an unadjusted odds ratio of in-hospital mortality of 1.38 (95% confidence interval, 1.04-1.85), which declined to 1.34 (95% confidence interval, 0.93-1.93) after adjusting for patient characteristics (especially, pre-hospital delay). No difference in 30-day mortality, total death or dependence at three, six and 12 months between two groups was observed. No association between off-hour admission and quality of care was found. Conclusions In the CNSR database, compared with on-hour patients, off-hour patients with acute ischemic stroke admitted to the emergency departments from scene manifested a higher incidence of in-hospital mortality. However, the difference in incidence and quality of care between the groups disappeared after adjusting for pre-hospital delay and other variables.	[Wang, Guifen; Gao, Baoqin] Capital Med Univ, Beijing Tiantan Hosp, Dept Pediat, Beijing, Peoples R China; [Liu, Gaifen; Zhang, Runhua; Ji, Ruijun; Wang, Yilong; Pan, Yuesong; Li, Zixiao; Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Wang, Guifen; Liu, Gaifen; Zhang, Runhua; Ji, Ruijun; Gao, Baoqin; Wang, Yilong; Pan, Yuesong; Li, Zixiao; Wang, Yongjun] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Wang, Guifen; Liu, Gaifen; Zhang, Runhua; Ji, Ruijun; Gao, Baoqin; Wang, Yilong; Pan, Yuesong; Li, Zixiao; Wang, Yongjun] Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China; [Wang, Guifen; Liu, Gaifen; Zhang, Runhua; Ji, Ruijun; Gao, Baoqin; Wang, Yilong; Pan, Yuesong; Li, Zixiao; Wang, Yongjun] Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Wang, YJ (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China.	yongjunwang1962@gmail.com	Pan, Yuesong/AAI-6303-2020	Pan, Yuesong/0000-0003-3082-6789	Ministry of Science and Technology; Ministry of Health of the People's Republic of China: National Science and Technology Major Project of China [2008ZX09312-008]; State Key Development Program of Basic Research of China [2009CB521905]; National 11th & 12th Five-year S & T Major Project [2006BAI01A11, 2011BAI08B01, 2011BAI08B02]; Beijing Biobank of Cerebral Vascular Disease [D131100005313003]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health of the People's Republic of China: National Science and Technology Major Project of China; State Key Development Program of Basic Research of China(State Key Development Program for Basic Research of China); National 11th & 12th Five-year S & T Major Project; Beijing Biobank of Cerebral Vascular Disease	This study was funded by the Ministry of Science and Technology and the Ministry of Health of the People's Republic of China: National Science and Technology Major Project of China (2008ZX09312-008) and State Key Development Program of Basic Research of China (2009CB521905). The grant numbers are the National 11th & 12th Five-year S & T Major Project (2006BAI01A11, 2011BAI08B01, 2011BAI08B02) and Beijing Biobank of Cerebral Vascular Disease (D131100005313003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright KC, 2009, CEREBROVASC DIS, V27, P107, DOI 10.1159/000177916; [Anonymous], 1989, STROKE, V20, P1407; Bejot Y, 2013, EUR J NEUROL, V20, P1177, DOI 10.1111/ene.12154; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Cloud G, 2013, CLIN MED, V13, P444, DOI 10.7861/clinmedicine.13-5-444; Concha OP, 2014, BMJ QUAL SAF, V23, P215, DOI 10.1136/bmjqs-2013-002218; Fang JM, 2010, NEUROLOGY, V75, P1589, DOI 10.1212/WNL.0b013e3181fb84bc; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; He Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092763; Hoh BL, 2010, STROKE, V41, P2323, DOI 10.1161/STROKEAHA.110.591081; Janszky I, 2007, STROKE, V38, pE94, DOI 10.1161/STROKEAHA.107.491449; Jauss M, 2009, EUR J NEUROL, V16, P1165, DOI 10.1111/j.1468-1331.2009.02656.x; Kazley AS, 2010, ARCH NEUROL-CHICAGO, V67, P39, DOI 10.1001/archneurol.2009.286; Kim C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105799; Kostis WJ, 2007, NEW ENGL J MED, V356, P1099, DOI 10.1056/NEJMoa063355; Kristiansen NS, 2014, STROKE, V45, P3663, DOI 10.1161/STROKEAHA.114.005535; Manfredini R, 2007, STROKE, V38, pE112, DOI 10.1161/STROKEAHA.107.489898; Martinez-Martinez MM, 2012, EUR J NEUROL, V19, P1140, DOI 10.1111/j.1468-1331.2012.03692.x; McKinney JS, 2011, STROKE, V42, P2403, DOI 10.1161/STROKEAHA.110.612317; Minister of Health, 1989, ACTS HOSP CLASS; Minister of Health, 2010, SINGL DIS QUAL MAN M, P142; Ogbu UC, 2011, J NEUROL NEUROSUR PS, V82, P8, DOI 10.1136/jnnp.2009.202176; Palmer WL, 2012, ARCH NEUROL-CHICAGO, V69, P1296, DOI 10.1001/archneurol.2012.1030; Reeves MJ, 2010, STROKE, V41, P1573, DOI 10.1161/STROKEAHA.109.577171; Reeves MJ, 2009, STROKE, V40, P569, DOI 10.1161/STROKEAHA.108.519355; Saposnik G, 2007, STROKE, V38, P1211, DOI 10.1161/01.STR.0000259622.78616.ea; Sorita A, 2014, EUR J INTERN MED, V25, P394, DOI 10.1016/j.ejim.2014.03.012; Streifler JY, 2012, EUR J NEUROL, V19, P643, DOI 10.1111/j.1468-1331.2011.03603.x; Wang PL, 2012, CHINESE MED J-PEKING, V125, P2449, DOI 10.3760/cma.j.issn.0366-6999.2012.14.010; Wang YL, 2011, STROKE, V42, P1658, DOI 10.1161/STROKEAHA.110.604249; Wang YJ, 2011, INT J STROKE, V6, P355, DOI 10.1111/j.1747-4949.2011.00584.x	31	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138046	10.1371/journal.pone.0138046	http://dx.doi.org/10.1371/journal.pone.0138046			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26379280	Green Submitted, Green Published, gold			2022-12-27	WOS:000361769400047
J	Bagcioglu, M; Zimmermann, B; Kohler, A				Bagcioglu, Murat; Zimmermann, Boris; Kohler, Achim			A Multiscale Vibrational Spectroscopic Approach for Identification and Biochemical Characterization of Pollen	PLOS ONE			English	Article							MULTIPLICATIVE SIGNAL CORRECTION; RAMAN; IR; MICROSPECTROSCOPY; QUANTIFICATION; DISCRIMINATION; CLASSIFICATION; SPECTRA; TOOL	Background Analysis of pollen grains reveals valuable information on biology, ecology, forensics, climate change, insect migration, food sources and aeroallergens. Vibrational (infrared and Raman) spectroscopies offer chemical characterization of pollen via identifiable spectral features without any sample pretreatment. We have compared the level of chemical information that can be obtained by different multiscale vibrational spectroscopic techniques. Methodology Pollen from 15 different species of Pinales (conifers) were measured by seven infrared and Raman methodologies. In order to obtain infrared spectra, both reflectance and transmission measurements were performed on ground and intact pollen grains (bulk measurements), in addition, infrared spectra were obtained by microspectroscopy of multigrain and single pollen grain measurements. For Raman microspectroscopy measurements, spectra were obtained from the same pollen grains by focusing two different substructures of pollen grain. The spectral data from the seven methodologies were integrated into one data model by the Consensus Principal Component Analysis, in order to obtain the relations between the molecular signatures traced by different techniques. Results The vibrational spectroscopy enabled biochemical characterization of pollen and detection of phylogenetic variation. The spectral differences were clearly connected to specific chemical constituents, such as lipids, carbohydrates, carotenoids and sporopollenins. The extensive differences between pollen of Cedrus and the rest of Pinaceae family were unambiguously connected with molecular composition of sporopollenins in pollen grain wall, while pollen of Picea has apparently higher concentration of carotenoids than the rest of the family. It is shown that vibrational methodologies have great potential for systematic collection of data on ecosystems and that the obtained phylogenetic variation can be well explained by the biochemical composition of pollen. Out of the seven tested methodologies, the best taxonomical differentiation of pollen was obtained by infrared measurements on bulk samples, as well as by Raman microspectroscopy measurements of the corpus region of the pollen grain. Raman microspectroscopy measurements indicate that measurement area, as well as the depth of focus, can have crucial influence on the obtained data.	[Bagcioglu, Murat; Zimmermann, Boris; Kohler, Achim] Norwegian Univ Life Sci, Fac Environm Sci & Technol, Dept Math Sci & Technol, As, Norway; [Kohler, Achim] Nofima AS, As, Norway	Norwegian University of Life Sciences; Nofima	Bagcioglu, M (corresponding author), Norwegian Univ Life Sci, Fac Environm Sci & Technol, Dept Math Sci & Technol, As, Norway.	murat.bagcioglu@nmbu.no	Zimmermann, Boris/N-8297-2014; Bağcıoğlu, Murat/N-7791-2019; Zimmermann, Boris/GVS-6235-2022; Bağcıoğlu, Murat/P-5549-2014	Zimmermann, Boris/0000-0001-5046-520X; Bağcıoğlu, Murat/0000-0003-0575-9246; Zimmermann, Boris/0000-0001-5046-520X; Bağcıoğlu, Murat/0000-0003-0575-9246; Kohler, Achim/0000-0001-5759-1989	European Commission [328289]; Ministry of Education, Sciences and Sports of the Republic of Croatia [098-0982904-2927]; Nofima AS	European Commission(European CommissionEuropean Commission Joint Research Centre); Ministry of Education, Sciences and Sports of the Republic of Croatia; Nofima AS(Nofima)	This work was supported by the European Commission through the Seventh Framework Programme (FP7-PEOPLE-2012-IEF project No. 328289) (BZ,AK); The Ministry of Education, Sciences and Sports of the Republic of Croatia (project No. 098-0982904-2927) (BZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Nofima AS provided support in the form of a salary for author AK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "Author Contributions" section.	Afseth NK, 2012, CHEMOMETR INTELL LAB, V117, P92, DOI 10.1016/j.chemolab.2012.03.004; Benton M. J., 2009, INTRO PALEOBIOLOGY F, P608; Blokker P, 2006, PLANT ECOL, V182, P197, DOI 10.1007/s11258-005-9026-y; Bocker U, 2007, APPL SPECTROSC, V61, P1032, DOI 10.1366/000370207782217707; Boyain-Goitia AR, 2003, APPL OPTICS, V42, P6119, DOI 10.1364/AO.42.006119; de Oliveira VE, 2010, J RAMAN SPECTROSC, V41, P642, DOI 10.1002/jrs.2493; Dell'Anna R, 2009, ANAL BIOANAL CHEM, V394, P1443, DOI 10.1007/s00216-009-2794-9; Fraser WT, 2012, NEW PHYTOL, V196, P397, DOI 10.1111/j.1469-8137.2012.04301.x; Garcia-Asua G, 1998, TRENDS PLANT SCI, V3, P445, DOI 10.1016/S1360-1385(98)01329-6; Glauser AL, 2014, REV PALAEOBOT PALYNO, V210, P62, DOI 10.1016/j.revpalbo.2014.07.005; Gottardini E, 2007, AEROBIOLOGIA, V23, P211, DOI 10.1007/s10453-007-9065-z; Hassani S, 2010, CHEMOMETR INTELL LAB, V104, P140, DOI 10.1016/j.chemolab.2010.08.008; Ivleva NP, 2005, ANAL BIOANAL CHEM, V381, P261, DOI 10.1007/s00216-004-2942-1; Kano H, 2006, CHEM LETT, V35, P1124, DOI 10.1246/cl.2006.1124; Karaman I, 2015, METABOLOMICS, V11, P367, DOI 10.1007/s11306-014-0698-y; Kohler A, 2005, APPL SPECTROSC, V59, P707, DOI 10.1366/0003702054280649; Kohler A, 2007, INTERPRETING SEVERAL, P333; Lin CP, 2010, GENOME BIOL EVOL, V2, P504, DOI 10.1093/gbe/evq036; Lomax BH, 2012, EARTH PLANET SC LETT, V353, P22, DOI 10.1016/j.epsl.2012.07.039; Lukacs R, 2015, ANALYST, V140, P3273, DOI [10.1039/c5an00401b, 10.1039/C5AN00401B]; Martens H., 1992, MULTIVARIATE CALIBRA; MERLIN JC, 1985, PURE APPL CHEM, V57, P785, DOI 10.1351/pac198557050785; Mirabella Francis M. Jr., 1993, V15, P17; Mularczyk-Oliwa M, 2012, SPECTROCHIM ACTA A, V97, P246, DOI 10.1016/j.saa.2012.05.063; Newsham KK, 2009, GLOBAL CHANGE BIOL, V15, P2574, DOI 10.1111/j.1365-2486.2009.01944.x; Pappas CS, 2003, APPL SPECTROSC, V57, P23, DOI 10.1366/000370203321165160; Perisic N, 2013, FOOD CHEM, V138, P679, DOI 10.1016/j.foodchem.2012.10.117; Pummer BG, 2013, J RAMAN SPECTROSC, V44, P1654, DOI 10.1002/jrs.4395; Robledo-Arnuncio JJ, 2005, HEREDITY, V94, P13, DOI 10.1038/sj.hdy.6800542; Schulte F, 2008, ANAL CHEM, V80, P9551, DOI 10.1021/ac801791a; Sivaguru M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039129; Terrab A, 2008, AM J BOT, V95, P1262, DOI 10.3732/ajb.0800010; Westerhuis JA, 1998, J CHEMOMETR, V12, P301, DOI 10.1002/(SICI)1099-128X(199809/10)12:5<301::AID-CEM515>3.0.CO;2-S; Willis KJ, 2011, NEW PHYTOL, V192, P553, DOI 10.1111/j.1469-8137.2011.03815.x; Zimmermann B, 2015, PLANTA, V242, P1237, DOI 10.1007/s00425-015-2380-7; Zimmermann B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124240; Zimmermann B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095417; Zimmermann B, 2013, APPL SPECTROSC, V67, P892, DOI 10.1366/12-06723; Zimmermann B, 2010, APPL SPECTROSC, V64, P1364, DOI 10.1366/000370210793561664; Zuk M, 2011, SPECTROCHIM ACTA A, V78, P1080, DOI 10.1016/j.saa.2010.12.054	40	45	46	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137899	10.1371/journal.pone.0137899	http://dx.doi.org/10.1371/journal.pone.0137899			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376486	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000361610200059
J	Lopes-Pires, ME; Naime, ACA; Cardelli, NJA; Anjos, DJ; Antunes, E; Marcondes, S				Elisa Lopes-Pires, M.; Antunes Naime, Ana C.; Almeida Cardelli, Nadia J.; Anjos, Debora J.; Antunes, Edson; Marcondes, Sisi			PKC and AKT Modulate cGMP/PKG Signaling Pathway on Platelet Aggregation in Experimental Sepsis	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; INTACT HUMAN PLATELETS; PROTEIN-KINASE-C; PHOSPHORYLATION; SRC; LIPOPOLYSACCHARIDE; ADHESION; ACTIVATION; ALPHA-IIB-BETA-3; INHIBITION	Sepsis severity has been positively correlated with platelet dysfunction, which may be due to elevations in nitric oxide (NO) and cGMP levels. Protein kinase C, Src kinases, PI3K and AKT modulate platelet activity in physiological conditions, but no studies evaluated the role of these enzymes in platelet aggregation in sepsis. In the present study we tested the hypothesis that in sepsis these enzymes positively modulate upstream the NO-cGMP pathway resulting in platelet inhibition. Rats were injected with lipopolysaccharide (LPS, 1 mg/kg, i.p.) and blood was collected after 6 h. Platelet aggregation was induced by ADP (10 mu M). Western blotting assays were carried out to analyze c-Src and AKT activation in platelets. Intraplatelet cGMP levels were determined by enzyme immunoassay kit. Phosphorylation of c-SRC at Tyr416 was the same magnitude in platelets of control and LPS group. Incubation of the non-selective Src inhibitor PP2 (10 mu M) had no effect on platelet aggregation of LPS-treated rats. LPS increased intraplatelet cGMP levels by 5-fold compared with control group, which was accompanied by 76% of reduction in ADP-induced platelet aggregation. The guanylyl cyclase inhibitor ODQ (25 mu M) and the PKG inhibitor Rp-8-Br-PETcGMPS (25 mu M) fully reversed the inhibitory effect of LPS on platelet aggregation. Likewise, the PKC inhibitor GF109203X (10 mu M) reversed the inhibition by LPS of platelet aggregation and decreased cGMP levels in platelets. AKT phosphorylation at Thr308 was significantly higher in platelets of LPS compared with control group, which was not reduced by PI3K inhibition. The AKT inhibitor API-1 (20 mu M) significantly increased aggregation and reduced cGMP levels in platelets of LPS group. However, the PI3K inhibitor wortmannin and LY29004 had no effect on platelet aggregation of LPS-treated rats. Therefore, inhibition of ADP-induced platelet aggregation after LPS injection is mediated by cGMP/PKG-dependent mechanisms, and PKC and AKT act upstream upregulating this pathway.	[Elisa Lopes-Pires, M.; Antunes Naime, Ana C.; Almeida Cardelli, Nadia J.; Anjos, Debora J.; Antunes, Edson; Marcondes, Sisi] Univ Campinas UNICAMP, Fac Med Sci, Dept Pharmacol, Campinas, SP, Brazil	Universidade Estadual de Campinas	Marcondes, S (corresponding author), Univ Campinas UNICAMP, Fac Med Sci, Dept Pharmacol, Campinas, SP, Brazil.	sisimp@fcm.unicamp.br	ANTUNES, EDSON/F-6731-2012	ANTUNES, EDSON/0000-0003-2201-8247	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/17003-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	S. Marcondes received a grant from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; grant 2010/17003-4). M.E. Lopes Pires received a fellowship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP).	Adamzik M, 2012, CRIT CARE, V16, DOI 10.1186/cc11816; Bauer PM, 2003, J BIOL CHEM, V278, P14841, DOI 10.1074/jbc.M211926200; Bergandi L, 2010, CLIN RES CARDIOL, V99, P557, DOI 10.1007/s00392-010-0157-3; Butt E, 2001, J BIOL CHEM, V276, P7108, DOI 10.1074/jbc.M009234200; Cavallini L, 1996, J BIOL CHEM, V271, P5545, DOI 10.1074/jbc.271.10.5545; Chung SH, 2000, J BIOL CHEM, V275, P25286, DOI 10.1074/jbc.M004204200; Cicala C, 1996, LIFE SCI, V60, pPL31, DOI 10.1016/S0024-3205(96)00607-8; Derbyshire ER, 2012, ANNU REV BIOCHEM, V81, P533, DOI 10.1146/annurev-biochem-050410-100030; Dong HP, 2005, SHOCK, V24, P239, DOI 10.1097/01.shk.0000174019.10311.80; Dudzinski DM, 2007, CARDIOVASC RES, V75, P247, DOI 10.1016/j.cardiores.2007.03.023; Lopes-Pires ME, 2012, PLATELETS, V23, P195, DOI 10.3109/09537104.2011.603065; Flevaris P, 2007, J CELL BIOL, V179, P553, DOI 10.1083/jcb.200703185; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; Galler AB, 2006, HISTOCHEM CELL BIOL, V125, P457, DOI 10.1007/s00418-005-0091-z; Gambaryan S, 2008, J THROMB HAEMOST, V6, P1376, DOI 10.1111/j.1538-7836.2008.03014.x; Gratacap MP, 2011, ADV ENZYME REGUL, V51, P106, DOI 10.1016/j.advenzreg.2010.09.011; Hartwig J H, 1997, Curr Opin Hematol, V4, P351; HORSTRUP K, 1994, EUR J BIOCHEM, V225, P21, DOI 10.1111/j.1432-1033.1994.00021.x; Isenberg JS, 2008, BLOOD, V111, P613, DOI 10.1182/blood-2007-06-098392; Jackson SP, 2004, BIOCHEM SOC T, V32, P387, DOI 10.1042/BST0320387; Kim D, 2010, J BIOL CHEM, V285, P8383, DOI 10.1074/jbc.M109.094060; Kim S, 2011, J BIOL CHEM, V286, P24170, DOI 10.1074/jbc.M110.212274; Kroner C, 2000, J BIOL CHEM, V275, P27790, DOI 10.1074/jbc.M000540200; Leu TH, 2006, MOL IMMUNOL, V43, P308, DOI 10.1016/j.molimm.2005.03.015; Li ZY, 2010, ARTERIOSCL THROM VAS, V30, P2341, DOI 10.1161/ATVBAHA.110.207522; Lin WN, 2008, TOXICOL APPL PHARM, V228, P256, DOI 10.1016/j.taap.2007.11.026; Liu J, 2008, J THROMB HAEMOST, V6, P1035, DOI 10.1111/j.1538-7836.2008.02958.x; Liu YQ, 2013, BIOCHEM PHARMACOL, V86, P914, DOI 10.1016/j.bcp.2013.07.009; Lu WJ, 2014, THROMB RES, V133, P1088, DOI 10.1016/j.thromres.2014.03.042; Lundahl TH, 1998, PLATELETS, V9, P223, DOI 10.1080/09537109876735; Maxwell MJ, 2004, J BIOL CHEM, V279, P32196, DOI 10.1074/jbc.M400746200; Michell BJ, 2001, J BIOL CHEM, V276, P17625, DOI 10.1074/jbc.C100122200; Monti M, 2010, J MOL CELL CARDIOL, V48, P746, DOI 10.1016/j.yjmcc.2009.11.002; Naseem KM, 2008, J THROMB HAEMOST, V6, P1373, DOI 10.1111/j.1538-7836.2008.03035.x; Newman DK, 2009, J THROMB HAEMOST, V7, P195, DOI 10.1111/j.1538-7836.2009.03369.x; Niu HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047356; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; Ognibene DT, 2010, HYPERTENS RES, V33, P899, DOI 10.1038/hr.2010.102; Polgar J, 2003, J BIOL CHEM, V278, P44369, DOI 10.1074/jbc.M307864200; RADOMSKI MW, 1990, P NATL ACAD SCI USA, V87, P5193, DOI 10.1073/pnas.87.13.5193; Riba R, 2006, J THROMB HAEMOST, V4, P2636, DOI 10.1111/j.1538-7836.2006.02195.x; Russwurm S, 2002, SHOCK, V17, P263, DOI 10.1097/00024382-200204000-00004; Shattil SJ, 1999, THROMB HAEMOSTASIS, V82, P318; Signorello MG, 2011, CURR NEUROVASC RES, V8, P200; Smolenski A, 2012, J THROMB HAEMOST, V10, P167, DOI 10.1111/j.1538-7836.2011.04576.x; Smolinska MJ, 2008, MOL IMMUNOL, V45, P990, DOI 10.1016/j.molimm.2007.07.026; Stalker Timothy J, 2012, Handb Exp Pharmacol, P59, DOI 10.1007/978-3-642-29423-5_3; Yaguchi A, 2004, J THROMB HAEMOST, V2, P2096, DOI 10.1111/j.1538-7836.2004.01009.x; Yamakawa K, 2013, J TRAUMA ACUTE CARE, V74, P411, DOI 10.1097/TA.0b013e31827a34cf; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Zhao YD, 2000, BIOCHEMISTRY-US, V39, P10848, DOI 10.1021/bi9929296	52	14	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137901	10.1371/journal.pone.0137901	http://dx.doi.org/10.1371/journal.pone.0137901			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375024	Green Submitted, Green Published, gold			2022-12-27	WOS:000361610200060
J	Fuchs, SC; Pakter, HM; Maestri, MK; Beltrami-Moreira, M; Gus, M; Moreira, LB; Oliveira, MM; Fuchs, FD				Fuchs, Sandra C.; Pakter, Helena M.; Maestri, Marcelo K.; Beltrami-Moreira, Marina; Gus, Miguel; Moreira, Leila B.; Oliveira, Manuel M.; Fuchs, Flavio D.			Are Retinal Vessels Calibers Influenced by Blood Pressure Measured at the Time of Retinography Acquisition?	PLOS ONE			English	Article							VASCULAR CALIBER; MICROVASCULAR ABNORMALITIES; VENULAR DIAMETER; ARTERIOLAR; RISK; HYPERTENSION; ASSOCIATION; POPULATION; RATIO; METAANALYSIS	Background Retinal arterial narrowing is associated with higher office blood pressure (BP) and ambulatory blood pressure monitoring, and increased incidence of cardiovascular disease, but it is still unknown if the vessel caliber is associated with BP measured at the time of retinography acquisition. Methods Retinal arteriolar and venular calibers were measured by the microdensitometric method in 448 patients with hypertension. Participants underwent 24-hours ambulatory blood pressure (24-h ABP) monitoring simultaneously with the retinography acquisition. Association between arteriolar and venular calibers with increase of 10 mmHg in the mean 24-hours, daily, and nightly BP, and with BP measured at the time of retinography, was evaluated by ANOVA and multivariate analyses. Results Mean 24-hours, daytime and nighttime systolic and diastolic BP were inversely associated with the arteriolar caliber, but not with the venular caliber. Arteriolar caliber decreased -0.8 (95% CI -1.4 to -0.2) mu m per 10-mmHg increase in 24-hours mean systolic BP, adjusted for age, gender, fellow vessel, and duration of hypertension (P = 0.01). The corresponding decreasing in arteriolar caliber by 10 mmHg of increasing in mean diastolic BP was -1.1 mu m(-2.0 to -0.2, P = 0.02). The decrease of arteriolar caliber by the same increasing of BP measured at the time of retinography was lower and not statistically significant, particularly for mean diastolic BP and outer arterioles calibers: -1.0 (-1.8 to -0.2) mu m in the daytime BP average versus -0.3 (-0.9 to 0.3) at the moment of retinography acquisition. Conclusions These findings suggest that the caliber of arteriolar retinal vessels in patients with uncontrolled hypertension are not significantly influenced by blood pressure measured at the time of retinography acquisition.	[Fuchs, Sandra C.; Pakter, Helena M.; Moreira, Leila B.] Univ Fed Rio Grande do Sul, Sch Med, Postgrad Studies Program Epidemiol, BR-90035003 Porto Alegre, RS, Brazil; [Fuchs, Sandra C.; Beltrami-Moreira, Marina; Gus, Miguel; Moreira, Leila B.; Fuchs, Flavio D.] Univ Fed Rio Grande do Sul, Sch Med, Postgrad Studies Program Cardiol, BR-90035003 Porto Alegre, RS, Brazil; [Fuchs, Sandra C.; Beltrami-Moreira, Marina; Gus, Miguel; Moreira, Leila B.; Fuchs, Flavio D.] Univ Fed Rio Grande do Sul, HCPA, BR-90035003 Porto Alegre, RS, Brazil; [Maestri, Marcelo K.] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Div Ophthalmol, BR-90035003 Porto Alegre, RS, Brazil; [Oliveira, Manuel M.] Univ Fed Rio Grande do Sul, Inst Informat, BR-91501970 Porto Alegre, RS, Brazil; [Fuchs, Flavio D.] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, CNPq, Natl Inst Sci & Technol Hlth Technol Assessment I, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Fuchs, SC (corresponding author), Univ Fed Rio Grande do Sul, Sch Med, Postgrad Studies Program Epidemiol, R Ramiro Barcelos 2600, BR-90035003 Porto Alegre, RS, Brazil.	scfuchs@terra.com.br	Beltrami Moreira, Marina/AGW-5591-2022; MOREIRA, LEILA LEILA B/AAC-2240-2019; Oliveira, Manuel M/H-1508-2011; Fuchs, Sandra C/T-2670-2019; Fuchs, Flávio D/L-5078-2016; Beltrami Moreira, Marina/ADG-6570-2022	Beltrami Moreira, Marina/0000-0001-7449-9789; MOREIRA, LEILA LEILA B/0000-0002-4730-7988; Oliveira, Manuel M/0000-0003-4957-9984; Messinger Pakter, Helena/0000-0003-4569-116X; fuchs, flavio/0000-0002-1191-0523	National Counsel of Technological and Scientific Development (CNPq) [485831/2007-4]; Brazilian Federal Agency for the Improvement of Higher Education (CAPES); Hospital de Cl~nicas de Porto Alegre-FIPE [GPPG 04-465]; CNPq fellowship [305613/2007-3]	National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Federal Agency for the Improvement of Higher Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Hospital de Cl~nicas de Porto Alegre-FIPE; CNPq fellowship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by National Counsel of Technological and Scientific Development (CNPq, Grant number: 485831/2007-4), the Brazilian Federal Agency for the Improvement of Higher Education (CAPES) and the Hospital de Cl~nicas de Porto Alegre-FIPE (Protocol GPPG 04-465), RS, Brazil. Manuel M. Oliveira acknowledges a CNPq fellowship (305613/2007-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Ding J, 2014, J HYPERTENS, V32, P207, DOI 10.1097/HJH.0b013e32836586f4; Dolan E, 2005, HYPERTENSION, V46, P156, DOI 10.1161/01.HYP.0000170138.56903.7a; Duncan BB, 2002, BRIT J OPHTHALMOL, V86, P1002, DOI 10.1136/bjo.86.9.1002; Fuchs SC, 2012, J HYPERTENS, V30, P75, DOI 10.1097/HJH.0b013e32834e5a4f; Garcia-Ortiz L, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006144; Grosso A, 2006, BLOOD PRESSURE, V15, P308, DOI 10.1080/08037050600996792; Hatanaka Y, 2005, P ANN INT IEEE EMBS, P286, DOI 10.1109/IEMBS.2005.1616400; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Ikram MK, 2006, HYPERTENSION, V47, P189, DOI 10.1161/01.HYP.0000199104.61945.33; Ikram MK, 2004, INVEST OPHTH VIS SCI, V45, P2129, DOI 10.1167/iovs.03-1390; Kawasaki R, 2009, J HYPERTENS, V27, P2386, DOI 10.1097/HJH.0b013e3283310f7e; Keith NM, 1939, AM J MED SCI, V197, P332, DOI 10.1097/00000441-193903000-00006; Knudtson MD, 2003, CURR EYE RES, V27, P143, DOI 10.1076/ceyr.27.3.143.16049; LATIES AM, 1967, ARCH OPHTHALMOL-CHIC, V77, P405, DOI 10.1001/archopht.1967.00980020407021; Li HQ, 2005, IEEE T BIO-MED ENG, V52, P1352, DOI 10.1109/TBME.2005.847402; Liew G, 2007, INVEST OPHTH VIS SCI, V48, P52, DOI 10.1167/iovs.06-0672; Maestri MM, 2007, AM J HYPERTENS, V20, P501, DOI 10.1016/j.amjhyper.2006.10.012; McGeechan K, 2009, ANN INTERN MED, V151, P404, DOI 10.7326/0003-4819-151-6-200909150-00005; Pakter HM, 2011, INVEST OPHTH VIS SCI, V52, P810, DOI 10.1167/iovs.10-5876; Pakter HM, 2005, AM J HYPERTENS, V18, P417, DOI 10.1016/j.amjhyper.2004.10.011; Pickering TG, 2006, NEW ENGL J MED, V354, P2368, DOI 10.1056/NEJMra060433; Pose-Reino A, 2005, J HYPERTENS, V23, P843, DOI 10.1097/01.hjh.0000163154.35577.8e; Relan D, 2014, IEEE ENG MED BIO, P142, DOI 10.1109/EMBC.2014.6943549; Ruggeri A, 2007, P ANN INT IEEE EMBS, P6464; Salvetti M, 2014, HYPERTENSION, V63, P1110, DOI 10.1161/HYPERTENSIONAHA.113.03004; Smith W, 2004, HYPERTENSION, V44, P442, DOI 10.1161/01.HYP.0000140772.40322.ec; Staessen JA, 1999, JAMA-J AM MED ASSOC, V282, P539, DOI 10.1001/jama.282.6.539; Tanabe Y, 2010, MICROCIRCULATION, V17, P94, DOI 10.1111/j.1549-8719.2009.00006.x; Torres FS, 2013, ATHEROSCLEROSIS, V229, P134, DOI 10.1016/j.atherosclerosis.2013.04.019; Tramontan L, 2011, IEEE T BIO-MED ENG, V58, P818, DOI 10.1109/TBME.2010.2085001; Tramontan L, 2008, IEEE ENG MED BIO, P3550, DOI 10.1109/IEMBS.2008.4649972; Triantafyllou A, 2014, AM J HYPERTENS, V27, P1472, DOI 10.1093/ajh/hpu074; Trucco E., 2015, BIOMEDICAL IMAGE UND; Trucco E, 2013, 4 IEEE BIOS BIOR C I; Wang JJ, 2008, AM J EPIDEMIOL, V168, P80, DOI 10.1093/aje/kwn100; Wang JJ, 2003, HYPERTENSION, V42, P534, DOI 10.1161/01.HYP.0000090122.38230.41; Wong TY, 2006, INVEST OPHTH VIS SCI, V47, P2341, DOI 10.1167/iovs.05-1539; Wong TY, 2004, BMJ-BRIT MED J, V329, P79, DOI 10.1136/bmj.38124.682523.55; Wong TY, 2004, AM J OPHTHALMOL, V137, P1050, DOI 10.1016/j.ajo.2004.01.035; Wong TY, 2004, ANN INTERN MED, V140, P248, DOI 10.7326/0003-4819-140-4-200402170-00006; Wong TY, 2003, OPHTHALMOLOGY, V110, P933, DOI 10.1016/S0161-6420(03)00084-8; Wong TY, 2001, SURV OPHTHALMOL, V46, P59, DOI 10.1016/S0039-6257(01)00234-X; Zhu PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106551	44	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136678	10.1371/journal.pone.0136678	http://dx.doi.org/10.1371/journal.pone.0136678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375034	Green Published, gold			2022-12-27	WOS:000361610200021
J	Nigam, N; Grover, A; Goyal, S; Katiyar, SP; Bhargava, P; Wang, PC; Sundar, D; Kaul, SC; Wadhwa, R				Nigam, Nupur; Grover, Abhinav; Goyal, Sukriti; Katiyar, Shashank P.; Bhargava, Priyanshu; Wang, Pi-Chao; Sundar, Durai; Kaul, Sunil C.; Wadhwa, Renu			Targeting Mortalin by Embelin Causes Activation of Tumor Suppressor p53 and Deactivation of Metastatic Signaling in Human Breast Cancer Cells	PLOS ONE			English	Article							BAX CONFORMATIONAL-CHANGE; TRAIL-INDUCED APOPTOSIS; XIAP INHIBITOR EMBELIN; MITOCHONDRIAL PATHWAY; HEPATOCELLULAR-CARCINOMA; HUMAN CARCINOGENESIS; GLUCOSE DEPRIVATION; LINKED INHIBITOR; DIABETIC-RATS; UP-REGULATION	Embelin, a natural quinone found in the fruits of Embelia ribes, is commonly used in Ayurvedic home medicine for a variety of therapeutic potentials including anti-inflammation, antifever, anti-bacteria and anti-cancer. Molecular mechanisms of these activities and cellular targets have not been clarified to-date. We demonstrate that the embelin inhibits mortalin-p53 interactions, and activates p53 protein in tumor cells. We provide bioinformatics, molecular docking and experimental evidence to the binding affinity of embelin with mortalin and p53. Binding of embelin with mortalin/p53 abrogates their complex resulted in nuclear translocation and transcriptional activation function of p53 causing growth arrest in cancer cells. Furthermore, analyses of growth factors and metastatic signaling using antibody membrane array revealed their downregulation in embelin-treated cells. We also found that the embelin causes transcriptional attenuation of mortalin and several other proteins involved in metastatic signaling in cancer cells. Based on these molecular dynamics and experimental data, it is concluded that the anticancer activity of embelin involves targeting of mortalin, activation of p53 and inactivation of metastatic signaling.	[Nigam, Nupur; Bhargava, Priyanshu; Kaul, Sunil C.; Wadhwa, Renu] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, DBT AIST Int Lab Adv Biomed DAILAB, Drug Discovery & Assets Innovat Lab, Tsukuba, Ibaraki, Japan; [Nigam, Nupur; Bhargava, Priyanshu; Wang, Pi-Chao] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Grover, Abhinav; Goyal, Sukriti] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India; [Katiyar, Shashank P.; Sundar, Durai] Indian Inst Technol IIT Delhi, Dept Biochem Engn & Biotechnol, New Delhi, India	National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; Jawaharlal Nehru University, New Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Kaul, SC (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, DBT AIST Int Lab Adv Biomed DAILAB, Drug Discovery & Assets Innovat Lab, Tsukuba, Ibaraki, Japan.	s-kaul@aist.go.jp; renu-wadhwa@aist.go.jp	Bhargava, Priyanshu/AAQ-1548-2020; Kaul, Sunil C/L-8671-2018; Wadhwa, Renu/L-8898-2018	Kaul, Sunil C/0000-0002-0046-3916; Wadhwa, Renu/0000-0001-8248-5192; bhargava, priyanshu/0000-0003-3598-4890; Katiyar, Shashank/0000-0002-8496-5103; Sundar, Durai/0000-0002-6549-6663	National Institute of Advanced Industrial Science & Technology (AIST) Special Research Grant	National Institute of Advanced Industrial Science & Technology (AIST) Special Research Grant	The study was supported by National Institute of Advanced Industrial Science & Technology (AIST) Special Research Grant.	Ahn KS, 2007, MOL PHARMACOL, V71, P209, DOI 10.1124/mol.106.028787; Aird KM, 2008, MOL CANCER THER, V7, P38, DOI 10.1158/1535-7163.MCT-07-0370; Ando K, 2014, GASTRIC CANCER, V17, P255, DOI 10.1007/s10120-013-0279-1; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Bolton EE, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-32; Chen J, 2014, INT J ONCOL, V44, P247, DOI 10.3892/ijo.2013.2161; Chen X, 2011, ANAT REC, V294, P1344, DOI 10.1002/ar.21433; Cheng YJ, 2010, EUR J PHARMACOL, V627, P75, DOI 10.1016/j.ejphar.2009.11.003; CHITRA M, 1994, CHEMOTHERAPY, V40, P109, DOI 10.1159/000239181; Chitra M, 2003, FITOTERAPIA, V74, P401, DOI 10.1016/S0367-326X(03)00066-2; Dai Y, 2009, CANCER RES, V69, P4776, DOI 10.1158/0008-5472.CAN-08-4754; Deocaris CC, 2013, CURR PHARM DESIGN, V19, P418; Deshmukh PT, 2013, J ASIAN NAT PROD RES, V15, P158, DOI 10.1080/10286020.2012.758634; Dhanjal JK, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-775; Dundas SR, 2005, J PATHOL, V205, P74, DOI 10.1002/path.1672; Gandhi GR, 2013, BBA-GEN SUBJECTS, V1830, P2243, DOI 10.1016/j.bbagen.2012.10.016; Hu R, 2015, TUMOR BIOL, V36, P769, DOI 10.1007/s13277-014-2702-6; Joshi R, 2007, CHEM-BIOL INTERACT, V167, P125, DOI 10.1016/j.cbi.2007.02.004; Joy B, 2010, MOL CARCINOGEN, V49, P324, DOI 10.1002/mc.20599; Kaul SC, 2005, J BIOL CHEM, V280, P39373, DOI 10.1074/jbc.M500022200; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Kumar GK, 2011, EUR J PHARMACOL, V662, P63, DOI 10.1016/j.ejphar.2011.04.037; Kutmon M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004085; Li Y, 2013, ONCOL LETT, V5, P1005, DOI 10.3892/ol.2012.1084; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu WJ, 2011, CELL DEATH DIFFER, V18, P1046, DOI 10.1038/cdd.2010.177; Lu WJ, 2011, INT J CANCER, V129, P1806, DOI 10.1002/ijc.25857; Ma Z, 2006, ONCOGENE, V25, P5377, DOI 10.1038/sj.onc.1209543; MAKAWITI DW, 1990, FEBS LETT, V266, P26, DOI 10.1016/0014-5793(90)81497-C; Melson AJ, 2012, ADDICTION, V107, P1883, DOI [10.1111/j.1360-0443.2012.03956.x, 10.1111/j.1360-0443.2012.03988.x]; Modak R, 2013, ACS CHEM BIOL, V8, P1311, DOI 10.1021/cb4000597; Mori T, 2007, J SURG RES, V142, P281, DOI 10.1016/j.jss.2007.03.068; Naik SR, 2013, PHYTOMEDICINE, V20, P797, DOI 10.1016/j.phymed.2013.03.003; Narayanaswamy R, 2014, ADV PHARM BULL, V4, P543, DOI 10.5681/apb.2014.080; Qu MY, 2012, NEUROSCI RES, V72, P94, DOI 10.1016/j.neures.2011.09.009; Rozenberg P, 2013, INT J CANCER, V133, P514, DOI 10.1002/ijc.28029; Ryu J, 2014, J BIOL CHEM, V289, P24832, DOI 10.1074/jbc.M114.565929; Siegelin MD, 2009, NEUROCHEM INT, V55, P423, DOI 10.1016/j.neuint.2009.04.011; Singh D, 2009, BASIC CLIN PHARMACOL, V105, P243, DOI 10.1111/j.1742-7843.2009.00429.x; Sreepriya M, 2005, FITOTERAPIA, V76, P549, DOI 10.1016/j.fitote.2005.04.014; Taghiyev A, 2012, EXP THER MED, V4, P649, DOI 10.3892/etm.2012.637; Thippeswamy BS, 2011, NEUROTOX RES, V20, P379, DOI 10.1007/s12640-011-9258-7; Vaishnavi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044419; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van der Spoel D, 2012, BIOINFORMATICS, V28, P752, DOI 10.1093/bioinformatics/bts020; Wadhwa R, 2003, EMBO REP, V4, P595, DOI 10.1038/sj.embor.embor855; Wadhwa R, 2002, CANCER RES, V62, P4434; Wadhwa R, 2000, CANCER RES, V60, P6818; Wadhwa R, 2006, INT J CANCER, V118, P2973, DOI 10.1002/ijc.21773; Wang AP, 2013, ONCOL REP, V29, P2473, DOI 10.3892/or.2013.2369; Widodo N, 2008, CANCER LETT, V262, P37, DOI 10.1016/j.canlet.2007.11.037; Widodo N, 2007, CLIN CANCER RES, V13, P2298, DOI 10.1158/1078-0432.CCR-06-0948; Xue ZY, 2014, MOL NEUROBIOL, V49, P1087, DOI 10.1007/s12035-013-8583-7; Yang L, 2008, ACTA BIOCH BIOPH SIN, V40, P339, DOI 10.1111/j.1745-7270.2008.00409.x; Yang L, 2011, J MOL BIOL, V414, P654, DOI 10.1016/j.jmb.2011.09.009; Yoo JY, 2010, J GENE MED, V12, P586, DOI 10.1002/jgm.1471; Zhou XL, 2015, INFLAMMATION	58	34	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138192	10.1371/journal.pone.0138192	http://dx.doi.org/10.1371/journal.pone.0138192			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376435	Green Submitted, gold, Green Published			2022-12-27	WOS:000361610200084
J	Sirohi, K; Kumari, A; Radha, V; Swarup, G				Sirohi, Kapil; Kumari, Asha; Radha, Vegesna; Swarup, Ghanshyam			A Glaucoma-Associated Variant of Optineurin, M98K, Activates Tbk1 to Enhance Autophagosome Formation and Retinal Cell Death Dependent on Ser177 Phosphorylation of Optineurin	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; COPY NUMBER VARIATIONS; BINDING KINASE 1; NORMAL-TENSION GLAUCOMA; NF-KAPPA-B; GANGLION-CELLS; RGC-5 CELLS; GENE; RECEPTOR; TANK	Certain missense mutations in optineurin/ OPTN and amplification of TBK1 are associated with normal tension glaucoma. A glaucoma-associated variant of OPTN, M98K, induces autophagic degradation of transferrin receptor (TFRC) and death in retinal cells. Here, we have explored the role of Tbk1 in M98K-OPTN-induced autophagy and cell death, and the effect of Tbk1 overexpression in retinal cells. Cell death induced by M98K-OPTN was dependent on Tbk1 as seen by the effect of Tbk1 knockdown and blocking of Tbk1 activity by a chemical inhibitor. Inhibition of Tbk1 also restores M98K-OPTN-induced transferrin receptor degradation. M98K-OPTN-induced autophagosome formation, autophagy and cell death were dependent on its phosphorylation at S177 by Tbk1. Knockdown of OPTN reduced starvation-induced autophagosome formation. M98K-OPTN expressing cells showed higher levels of Tbk1 activation and enhanced phosphorylation at Ser177 compared to WT-OPTN expressing cells. M98K-OPTN-induced activation of Tbk1 and its ability to be phosphorylated better by Tbk1 was dependent on ubiquitin binding. Phosphorylated M98K-OPTN localized specifically to autophagosomes and endogenous Tbk1 showed increased localization to autophagosomes in M98K-OPTN expressing cells. Overexpression of Tbk1 induced cell death and caspase-3 activation that were dependent on its catalytic activity. Tbk1-induced cell death possibly involves autophagy, as shown by the effect of Atg5 knockdown, and requirement of autophagic function of OPTN. Our results show that phosphorylation of Ser177 plays a crucial role in M98K-OPTN-induced autophagosome formation, autophagy flux and retinal cell death. In addition, we provide evidence for cross talk between two glaucoma associated proteins and their inter-dependence to mediate autophagy- dependent cell death.	[Sirohi, Kapil; Kumari, Asha; Radha, Vegesna; Swarup, Ghanshyam] CSIR, Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Radha, V (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.	vradha@ccmb.res.in; gshyam@ccmb.res.in	Sirohi, Kapil/GVT-2867-2022; Sirohi, Kapil/N-6676-2019	Sirohi, Kapil/0000-0001-5039-2848; Sirohi, Kapil/0000-0001-5039-2848; Swarup, Ghanshyam/0000-0002-8098-0509	Council of Scientific and Industrial Research, Government of India [BSC-0115, BSC-0208]; Department of Science and Technology, Government of India [SR/S2/JCB-41/2010]	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported by grants (BSC-0115 and BSC-0208) to GS from the Council of Scientific and Industrial Research, Government of India. GS gratefully acknowledges the Department of Science and Technology, Government of India for J C Bose National Fellowship grant SR/S2/JCB-41/2010.	Agudo-Barriuso M, 2013, CURR OPIN PHARMACOL, V13, P5, DOI 10.1016/j.coph.2012.09.006; Alward WLM, 2003, AM J OPHTHALMOL, V136, P904, DOI 10.1016/S0002-9394(03)00577-4; Awadalla MS, 2015, AM J OPHTHALMOL, V159, P124, DOI 10.1016/j.ajo.2014.09.044; Ayala-Lugo RM, 2007, MOL VIS, V13, P151; Chalasani ML, 2007, INVEST OPHTH VIS SCI, V48, P1607, DOI 10.1167/iovs.06-0834; Chalasani ML, 2009, OPHTHALMIC RES, V42, P176, DOI 10.1159/000232400; Chalasani MLS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095758; Chau TL, 2008, TRENDS BIOCHEM SCI, V33, P171, DOI 10.1016/j.tibs.2008.01.002; Chi ZL, 2010, HUM MOL GENET, V19, P2606, DOI 10.1093/hmg/ddq146; Choi SS, 2011, BRIT J OPHTHALMOL, V95, P131, DOI 10.1136/bjo.2010.183756; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Davis LK, 2011, INVEST OPHTH VIS SCI, V52, P7122, DOI 10.1167/iovs.10-5606; Delhase M, 2012, P NATL ACAD SCI USA, V109, pE177, DOI 10.1073/pnas.1119296109; Fernaandez-Saanchez L, 2014, INVEST OPHTH VIS SCI, V55, P6059, DOI 10.1167/iovs.14-14421; Fingert JH, 2011, EYE, V25, P587, DOI 10.1038/eye.2011.97; Fingert JH, 2014, OPHTHALMIC GENET, V35, P35, DOI 10.3109/13816810.2013.768674; Fingert JH, 2011, HUM MOL GENET, V20, P2482, DOI 10.1093/hmg/ddr123; Gleason CE, 2011, J BIOL CHEM, V286, P35663, DOI 10.1074/jbc.M111.267567; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Gupta V, 2006, J CELL SCI, V119, P1703, DOI 10.1242/jcs.02885; Harada T, 2007, J CLIN INVEST, V117, P1763, DOI 10.1172/JCI30178; Helgason E, 2013, FEBS LETT, V587, P1230, DOI 10.1016/j.febslet.2013.01.059; Journo C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000521; Kachaner D, 2012, CELL CYCLE, V11, P2808, DOI 10.4161/cc.20946; Kachaner D, 2012, MOL CELL, V45, P553, DOI 10.1016/j.molcel.2011.12.030; Kim JK, 2013, NEOPLASIA, V15, P1064, DOI 10.1593/neo.13402; Korac J, 2013, J CELL SCI, V126, P580, DOI 10.1242/jcs.114926; Krishnamoorthy RR, 2013, INVEST OPHTH VIS SCI, V54, P5712, DOI 10.1167/iovs.13-12085; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Kumar A, 2007, MOL VIS, V13, P667; Marchlik E, 2010, J LEUKOCYTE BIOL, V88, P1171, DOI 10.1189/jlb.0210071; May MJ, 2004, J BIOL CHEM, V279, P45528, DOI 10.1074/jbc.M408579200; Minegishi Y, 2013, HUM MOL GENET, V22, P3559, DOI 10.1093/hmg/ddt210; Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; Morton S, 2008, FEBS LETT, V582, P997, DOI 10.1016/j.febslet.2008.02.047; Muppirala M, 2011, BIOL CELL, V103, P333, DOI 10.1042/BC20110006; Nagabhushana A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017477; Nagabhushana A, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-4; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Park BC, 2006, AM J PATHOL, V169, P1976, DOI 10.2353/ajpath.2006.060400; Park B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011547; Park HYL, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.26; Pasutto F, 2012, HUM MOL GENET, V21, P1336, DOI 10.1093/hmg/ddr572; Pasutto F, 2009, AM J HUM GENET, V85, P447, DOI 10.1016/j.ajhg.2009.08.016; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Pilli M, 2012, IMMUNITY, V37, P223, DOI 10.1016/j.immuni.2012.04.015; Piras A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022514; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; QUIGLEY HA, 1993, NEW ENGL J MED, V328, P1097, DOI 10.1056/NEJM199304153281507; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Sadasivam S, 2005, ONCOGENE, V24, P627, DOI 10.1038/sj.onc.1208201; Shen XA, 2011, J BIOL CHEM, V286, P3618, DOI 10.1074/jbc.M110.175810; Sippl C, 2014, ADV EXP MED BIOL, V801, P145, DOI 10.1007/978-1-4614-3209-8_19; Sippl C, 2011, EXP EYE RES, V93, P669, DOI 10.1016/j.exer.2011.08.011; Sirohi K, 2013, AUTOPHAGY, V9, P510, DOI 10.4161/auto.23458; Sripriya S, 2006, MOL VIS, V12, P816; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Sudhakar C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005114; Swarup G, 2004, J BIOSCIENCES, V29, P129, DOI 10.1007/BF02703408; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Tucker Budd A, 2014, J Stem Cell Res Ther, V3, P161; Tumbarello DA, 2012, NAT CELL BIOL, V14, P1024, DOI 10.1038/ncb2589; Turturro S, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-99; Van Bergen NJ, 2009, INVEST OPHTH VIS SCI, V50, P4267, DOI 10.1167/iovs.09-3484; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Wong YC, 2014, P NATL ACAD SCI USA, V111, pE4439, DOI 10.1073/pnas.1405752111; Wood JPM, 2010, INVEST OPHTH VIS SCI, V51, P3774, DOI 10.1167/iovs.09-4305; Ying HY, 2012, INT REV CEL MOL BIO, V294, P223, DOI 10.1016/B978-0-12-394305-7.00005-7; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Yu T, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/979105; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041	73	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138289	10.1371/journal.pone.0138289	http://dx.doi.org/10.1371/journal.pone.0138289			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376340	Green Published, Green Submitted, gold			2022-12-27	WOS:000361610200096
J	Areces, F; Gonzalez-Millan, C; Salinero, JJ; Abian-Vicen, J; Lara, B; Gallo-Salazar, C; Ruiz-Vicente, D; Del Coso, J				Areces, Francisco; Gonzalez-Millan, Cristina; Jose Salinero, Juan; Abian-Vicen, Javier; Lara, Beatriz; Gallo-Salazar, Cesar; Ruiz-Vicente, Diana; Del Coso, Juan			Changes in Serum Free Amino Acids and Muscle Fatigue Experienced during a Half-Ironman Triathlon	PLOS ONE			English	Article							LACTATE-DEHYDROGENASE; INCREMENTAL EXERCISE; SUSTAINED EXERCISE; SKELETAL-MUSCLE; SUPPLEMENTATION; PERFORMANCE; DAMAGE; TRYPTOPHAN; METABOLISM; INCREASES	The aim of this study was to investigate the relationship between changes in serum free amino acids, muscle fatigue and exercise-induced muscle damage during a half-ironman triathlon. Twenty-six experienced triathletes (age = 37.0 +/- 6.8 yr; experience = 7.4 +/- 3.0 yr) competed in a real half-ironman triathlon in which sector times and total race time were measured by means of chip timing. Before and after the race, a countermovement jump and a maximal isometric force test were performed, and blood samples were withdrawn to measure serum free amino acids concentrations, and serum creatine kinase levels as a blood marker of muscle damage. Total race time was 320 +/- 37 min and jump height (-16.3 +/- 15.2%, P < 0.001) and isometric force (-14.9 +/- 9.8%; P = 0.007) were significantly reduced after the race in all participants. After the race, the serum concentration of creatine kinase increased by 368 +/- 187% (P < 0.001). In contrast, the serum concentrations of essential (-27.1 +/- 13.0%; P < 0.001) and non-essential amino acids (-24.4 +/- 13.1%; P < 0.001) were significantly reduced after the race. The tryptophan/ BCAA ratio increased by 42.7 +/- 12.7% after the race. Pre-to-post changes in serum free amino acids did not correlate with muscle performance variables or post-race creatine kinase concentration. In summary, during a half-ironman triathlon, serum amino acids concentrations were reduced by >20%. However, neither the changes in serum free amino acids nor the tryptophan/ BCAA ratio were related muscle fatigue or muscle damage during the race.	[Areces, Francisco; Gonzalez-Millan, Cristina; Jose Salinero, Juan; Abian-Vicen, Javier; Lara, Beatriz; Gallo-Salazar, Cesar; Ruiz-Vicente, Diana; Del Coso, Juan] Camilo Jose Cela Univ, Sports Sci Inst, Exercise Physiol Lab, Madrid, Spain	Camilo Jose Cela University	Del Coso, J (corresponding author), Camilo Jose Cela Univ, Sports Sci Inst, Exercise Physiol Lab, Madrid, Spain.	jdelcoso@ucjc.edu	Ruiz-Vicente, Diana/AAH-3689-2019; Areces, Francisco/ABH-3023-2020; GALLO, CESAR/O-4823-2019; Abián-Vicén, Javier/I-8509-2012; Salinero, Juan J./GLT-1243-2022; MARTÍN, JUAN JOSÉ JJ SALINERO/I-4212-2012; Del Coso, Juan/AAC-7117-2020; Lara, Beatriz/AAQ-5269-2021	Areces, Francisco/0000-0003-2996-4156; GALLO, CESAR/0000-0001-8676-4658; Abián-Vicén, Javier/0000-0001-9635-3289; Salinero, Juan J./0000-0003-4153-5100; MARTÍN, JUAN JOSÉ JJ SALINERO/0000-0003-4153-5100; Del Coso, Juan/0000-0002-5785-984X; Lara, Beatriz/0000-0001-5516-4852; Gonzalez-Millan, Cristina/0000-0002-3371-9420				Anthony JC, 2000, J NUTR, V130, P2413; Areces F, 2014, AMINO ACIDS, V46, P1169, DOI 10.1007/s00726-014-1677-3; Assenza A, 2004, J ANIM PHYSIOL AN N, V88, P172, DOI 10.1111/j.1439-0396.2004.00493.x; Blomstrand E, 2006, J NUTR, V136, p544S, DOI 10.1093/jn/136.2.544S; BLOMSTRAND E, 1988, ACTA PHYSIOL SCAND, V133, P115, DOI 10.1111/j.1748-1716.1988.tb08388.x; Buerger-Mendonca M, 2008, ANN HEPATOL, V7, P245, DOI 10.1016/S1665-2681(19)31855-1; Chang CK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121866; CHAOULOFF F, 1989, J NEURAL TRANSM-GEN, V78, P121, DOI 10.1007/BF01252498; Cheuvront SN, 2004, J APPL PHYSIOL, V97, P1275, DOI 10.1152/japplphysiol.00357.2004; Coombes JS, 2000, J SPORT MED PHYS FIT, V40, P240; Crowe MJ, 2006, EUR J APPL PHYSIOL, V97, P664, DOI 10.1007/s00421-005-0036-1; Del Coso J, 2014, J SPORT SCI, V32, P1680, DOI 10.1080/02640414.2014.915425; Del Coso J, 2014, EUR J APPL PHYSIOL, V114, P587, DOI 10.1007/s00421-013-2789-2; Del Coso J, 2013, APPL PHYSIOL NUTR ME, V38, P286, DOI 10.1139/apnm-2012-0241; Del Coso J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057602; Del Coso J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043280; DOHM GL, 1987, MED SCI SPORT EXER, V19, pS166; Fernstrom JD, 2006, J NUTR, V136, p553S, DOI 10.1093/jn/136.2.553S; Gleeson M, 2005, J NUTR, V135, p1591S, DOI 10.1093/jn/135.6.1591S; Greer BK, 2007, INT J SPORT NUTR EXE, V17, P595, DOI 10.1123/ijsnem.17.6.595; Greer BK, 2011, J STRENGTH COND RES, V25, P539, DOI 10.1519/JSC.0b013e3181bf443a; Howatson G, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-20; Hsu MC, 2011, CHINESE J PHYSIOL, V54, P71, DOI 10.4077/CJP.2011.AMK075; Jeukendrup AE, 2011, J SPORT SCI, V29, pS91, DOI 10.1080/02640414.2011.610348; Knechtle B, 2011, J INT SOC SPORT NUTR, V8, DOI 10.1186/1550-2783-8-6; Koba T, 2007, J SPORT MED PHYS FIT, V47, P316; Lynch CJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE854, DOI 10.1152/ajpendo.00153.2003; Garcia-Manso JM, 2011, J SPORT SCI, V29, P619, DOI 10.1080/02640414.2010.548822; Margaritis I, 1999, J SPORT MED PHYS FIT, V39, P133; Matsumoto K, 2009, J NUTR SCI VITAMINOL, V55, P52, DOI 10.3177/jnsv.55.52; Maughan RJ, 2012, P NUTR SOC, V71, P112, DOI 10.1017/S0029665111003211; Meeusen R, 2007, INT J SPORT NUTR EXE, V17, pS37, DOI 10.1123/ijsnem.17.s1.s37; Millet GP, 2007, INTJ SPORT PHYSIOL, V2, P315, DOI 10.1123/ijspp.2.3.315; Mueller SM, 2013, EUR J APPL PHYSIOL, V113, P2343, DOI 10.1007/s00421-013-2670-3; Nelson AR, 2012, MED SCI SPORT EXER, V44, P57, DOI 10.1249/MSS.0b013e3182290371; Newsholme EA, 2006, J NUTR, V136, p274S, DOI 10.1093/jn/136.1.274S; Nosaka K, 2006, INT J SPORT NUTR EXE, V16, P620, DOI 10.1123/ijsnem.16.6.620; Roelands B, 2013, SPORTS MED, V43, P301, DOI 10.1007/s40279-013-0030-4; Shimomura Y, 2006, J NUTR, V136, p529S, DOI 10.1093/jn/136.2.529S; Smriga M, 2006, J NUTR, V136, p548S, DOI 10.1093/jn/136.2.548S; Stepanyan V, 2014, APPL PHYSIOL NUTR ME, V39, P1029, DOI 10.1139/apnm-2013-0566; Suzuki K, 2006, EUR J APPL PHYSIOL, V98, P525, DOI 10.1007/s00421-006-0296-4; Tang FC, 2006, J AM COLL NUTR, V25, P188, DOI 10.1080/07315724.2006.10719531; VANHALL G, 1995, J PHYSIOL-LONDON, V486, P789, DOI 10.1113/jphysiol.1995.sp020854; VARNIER M, 1994, EUR J APPL PHYSIOL O, V69, P26, DOI 10.1007/BF00867923; Williams, 2001, AMINO ACID ANAL PROT	46	21	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138376	10.1371/journal.pone.0138376	http://dx.doi.org/10.1371/journal.pone.0138376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372162	Green Published, Green Submitted, gold			2022-12-27	WOS:000361604400069
J	Hapca, S; Baveye, PC; Wilson, C; Lark, RM; Otten, W				Hapca, Simona; Baveye, Philippe C.; Wilson, Clare; Lark, Richard Murray; Otten, Wilfred			Three-Dimensional Mapping of Soil Chemical Characteristics at Micrometric Scale by Combining 2D SEM-EDX Data and 3D X-Ray CT Images	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY IMAGES; ANISOTROPIC SHRINKAGE; QUANTITATIVE-ANALYSIS; NEXAFS SPECTROSCOPY; CARBON DISTRIBUTION; SPATIAL PREDICTION; POROUS-MEDIA; SPECIATION; MICROTOMOGRAPHY; MICROORGANISMS	There is currently a significant need to improve our understanding of the factors that control a number of critical soil processes by integrating physical, chemical and biological measurements on soils at microscopic scales to help produce 3D maps of the related properties. Because of technological limitations, most chemical and biological measurements can be carried out only on exposed soil surfaces or 2-dimensional cuts through soil samples. Methods need to be developed to produce 3D maps of soil properties based on spatial sequences of 2D maps. In this general context, the objective of the research described here was to develop a method to generate 3D maps of soil chemical properties at the microscale by combining 2D SEM-EDX data with 3D X-ray computed tomography images. A statistical approach using the regression tree method and ordinary kriging applied to the residuals was developed and applied to predict the 3D spatial distribution of carbon, silicon, iron, and oxygen at the microscale. The spatial correlation between the X-ray grayscale intensities and the chemical maps made it possible to use a regression-tree model as an initial step to predict the 3D chemical composition. For chemical elements, e.g., iron, that are sparsely distributed in a soil sample, the regression-tree model provides a good prediction, explaining as much as 90% of the variability in some of the data. However, for chemical elements that are more homogenously distributed, such as carbon, silicon, or oxygen, the additional kriging of the regression tree residuals improved significantly the prediction with an increase in the R-2 value from 0.221 to 0.324 for carbon, 0.312 to 0.423 for silicon, and 0.218 to 0.374 for oxygen, respectively. The present research develops for the first time an integrated experimental and theoretical framework, which combines geostatistical methods with imaging techniques to unveil the 3-D chemical structure of soil at very fine scales. The methodology presented in this study can be easily adapted and applied to other types of data such as bacterial or fungal population densities for the 3D characterization of microbial distribution.	[Hapca, Simona; Otten, Wilfred] Abertay Univ, Sch Sci Engn & Technol, Dundee DD1 1HG, Scotland; [Baveye, Philippe C.] Rensselaer Polytech Inst, Dept Civil & Environm Engn, Lab Soil & Water Engn, Troy, NY USA; [Baveye, Philippe C.] Univ Paris Saclay, AgroParisTech, Unite EcoSYS, F-78850 Thiverval Grignon, France; [Wilson, Clare] Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland; [Lark, Richard Murray] British Geol Survey, Nottingham NG12 5GG, England	Rensselaer Polytechnic Institute; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; University of Stirling; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey	Hapca, S (corresponding author), Abertay Univ, Sch Sci Engn & Technol, 40 Bell St, Dundee DD1 1HG, Scotland.	s.hapca@abertay.ac.uk	Otten, Wilfried/H-7168-2019; Lark, Richard/G-6744-2012; Wilson, Clare/J-7060-2012	Otten, Wilfried/0000-0002-3847-9825; Lark, Richard/0000-0003-2571-8521; Wilson, Clare/0000-0002-0287-8576; Baveye, Philippe/0000-0002-8432-6141	Scottish Alliance for Geoscience, Environment and Society (SAGES); NERC at Abertay, and by the Kodak Endowment in Environmental Engineering at RPI [NE/H01263X/1]; Natural Environment Research Council [NE/H01263X/1, bgs05013] Funding Source: researchfish; NERC [bgs05013, NE/H01263X/1] Funding Source: UKRI	Scottish Alliance for Geoscience, Environment and Society (SAGES); NERC at Abertay, and by the Kodak Endowment in Environmental Engineering at RPI; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	PB, WO and CW were supported by the Scottish Alliance for Geoscience, Environment and Society (SAGES). The work was supported by NERC (grant NE/H01263X/1) at Abertay, and by the Kodak Endowment in Environmental Engineering at RPI. The Abertay University is a charity registered in Scotland, No: SC016040.	ALEXANDER M, 1964, ANNU REV MICROBIOL, V18, P217, DOI 10.1146/annurev.mi.18.100164.001245; Baveye PC, 2010, GEODERMA, V157, P51, DOI 10.1016/j.geoderma.2010.03.015; Bleuet P, 2010, TRAC-TREND ANAL CHEM, V29, P518, DOI 10.1016/j.trac.2010.02.011; Cazelles K, 2013, ECOL MODEL, V248, P165, DOI 10.1016/j.ecolmodel.2012.08.008; Clode PL, 2009, PLANT PHYSIOL, V151, P1751, DOI 10.1104/pp.109.141499; DeLeo PC, 1997, J MICROBIOL METH, V30, P193, DOI 10.1016/S0167-7012(97)00065-1; EICKHORST T, 2008, MICROSC MICROANAL, V14, P754, DOI DOI 10.1017/S1431927608083025; Eickhorst T, 2008, SOIL BIOL BIOCHEM, V40, P1284, DOI 10.1016/j.soilbio.2007.06.019; Elliot TR, 2007, GEODERMA, V141, P60, DOI 10.1016/j.geoderma.2007.05.001; Garnier P, 1997, SOIL SCI, V162, P410, DOI 10.1097/00010694-199706000-00003; Gebhardt S, 2012, SOIL TILL RES, V125, P96, DOI 10.1016/j.still.2012.06.017; Hapca SM, 2013, VADOSE ZONE J, V12, DOI 10.2136/vzj2012.0172; Hapca SM, 2011, GEODERMA, V164, P146, DOI 10.1016/j.geoderma.2011.05.018; Hastie T., 2009, ELEMENTS STAT LEARNI; Hengl T, 2004, GEODERMA, V120, P75, DOI 10.1016/j.geoderma.2003.08.018; Houston AN, 2013, GEODERMA, V207, P154, DOI 10.1016/j.geoderma.2013.05.017; Houston AN, 2013, COMPUT GEOSCI-UK, V54, P239, DOI 10.1016/j.cageo.2012.11.016; Iassonov P, 2010, VADOSE ZONE J, V9, P187, DOI 10.2136/vzj2009.0042; Iassonov P, 2009, WATER RESOUR RES, V45, DOI 10.1029/2009WR008087; Jacobson AR, 2007, ENVIRON SCI TECHNOL, V41, P6343, DOI 10.1021/es070707m; Kravchenko A, 2011, ECOL APPL, V21, P1202, DOI 10.1890/10-0525.1; Lark RM, 2006, EUR J SOIL SCI, V57, P787, DOI 10.1111/j.1365-2389.2005.00768.x; Long HL, 2009, SEDIMENT GEOL, V220, P116, DOI 10.1016/j.sedgeo.2009.07.003; Moreau E, 1999, GEODERMA, V92, P55, DOI 10.1016/S0016-7061(99)00025-7; Okabe H, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066135; Otten W, 2004, SOIL BIOL BIOCHEM, V36, P203, DOI 10.1016/j.soilbio.2003.09.006; Pajor R, 2010, BIOGEOSCIENCES, V7, P3731, DOI 10.5194/bg-7-3731-2010; Peng X, 2007, EUR J SOIL SCI, V58, P98, DOI 10.1111/j.1365-2389.2006.00808.x; Prado B, 2009, AGR WATER MANAGE, V96, P1377, DOI 10.1016/j.agwat.2009.04.012; Prietzel J, 2010, J SYNCHROTRON RADIAT, V17, P166, DOI 10.1107/S0909049509049917; Rau C, 2003, NUCL INSTRUM METH B, V200, P444, DOI 10.1016/S0168-583X(02)01737-8; Remeysen K, 2008, MAR PETROL GEOL, V25, P486, DOI 10.1016/j.marpetgeo.2007.07.008; Schluter S, 2014, WATER RESOUR RES, V50, P3615, DOI 10.1002/2014WR015256; Schumacher M, 2005, ENVIRON SCI TECHNOL, V39, P9094, DOI 10.1021/es050099f; Shokri N, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4861755; Sleutel S, 2008, COMPUT GEOSCI-UK, V34, P931, DOI 10.1016/j.cageo.2007.10.006; Solomon D, 2009, SOIL SCI SOC AM J, V73, P1817, DOI 10.2136/sssaj2008.0228; Stein ML, 1999, SPRINGER SERIES STAT, Vxvii, P247; Strawn DG, 2008, ENVIRON SCI TECHNOL, V42, P37, DOI 10.1021/es071605z; Strawn DG, 2009, ENVIRON POLLUT, V157, P2813, DOI 10.1016/j.envpol.2009.04.018; Taina IA, 2008, CAN J SOIL SCI, V88, P1, DOI 10.4141/CJSS06027; Thieme J, 2010, J SYNCHROTRON RADIAT, V17, P149, DOI 10.1107/S0909049509049905; Thullner M, 2008, BIOTECHNOL BIOENG, V99, P1337, DOI 10.1002/bit.21708; Van Geet M, 2000, SEDIMENT GEOL, V132, P25, DOI 10.1016/S0037-0738(99)00127-X; Van Loo D, 2014, GEODERMA, V213, P485, DOI 10.1016/j.geoderma.2013.08.036; Wan J, 2007, GEOCHIM COSMOCHIM AC, V71, P5439, DOI 10.1016/j.gca.2007.07.030; Webster R., 2007, GEOSTATISTICS ENV SC, P315, DOI 10.1002/9780470517277; Willson CS, 2012, GEOTECH TEST J, V35, P911, DOI 10.1520/GTJ20120075; Wilson CA, 2008, J ARCHAEOL SCI, V35, P412, DOI 10.1016/j.jas.2007.04.006; Yao YB, 2009, INT J COAL GEOL, V80, P113, DOI 10.1016/j.coal.2009.08.001	50	35	37	4	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137205	10.1371/journal.pone.0137205	http://dx.doi.org/10.1371/journal.pone.0137205			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372473	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000361604400012
J	Kwok, KO; Davoudi, B; Riley, S; Pourbohloul, B				Kwok, Kin On; Davoudi, Bahman; Riley, Steven; Pourbohloul, Babak			Early real-time estimation of the basic reproduction number of emerging or reemerging infectious diseases in a community with heterogeneous contact pattern: Using data from Hong Kong 2009 H1N1 Pandemic Influenza as an illustrative example	PLOS ONE			English	Article							TRANSMISSION DYNAMICS; AGENT; SARS	Emerging and re-emerging infections such as SARS ( 2003) and pandemic H1N1 ( 2009) have caused concern for public health researchers and policy makers due to the increased burden of these diseases on health care systems. This concern has prompted the use of mathematical models to evaluate strategies to control disease spread, making these models invaluable tools to identify optimal intervention strategies. A particularly important quantity in infectious disease epidemiology is the basic reproduction number, R-0. Estimation of this quantity is crucial for effective control responses in the early phase of an epidemic. In our previous study, an approach for estimating the basic reproduction number in real time was developed. This approach uses case notification data and the structure of potential transmission contacts to accurately estimate R-0 from the limited amount of information available at the early stage of an outbreak. Based on this approach, we extend the existing methodology; the most recent method features intra- and inter-age groups contact heterogeneity. Given the number of newly reported cases at the early stage of the outbreak, with parsimony assumptions on removal distribution and infectivity profile of the diseases, experiments to estimate real time R-0 under different levels of intra- and inter-group contact heterogeneity using two age groups are presented. We show that the new method converges more quickly to the actual value of R-0 than the previous one, in particular when there is high-level intra- group and inter-group contact heterogeneity. With the age specific contact patterns, number of newly reported cases, removal distribution, and information about the	[Kwok, Kin On; Riley, Steven] Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, Hong Kong Special Adm Reg, Hong Kong, Hong Kong, Peoples R China; [Davoudi, Bahman; Pourbohloul, Babak] British Columbia Ctr Dis Control, Div Math Modeling, Vancouver, BC, Canada; [Riley, Steven] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London SW7 2AZ, England; [Pourbohloul, Babak] Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada	University of Hong Kong; Imperial College London; University of British Columbia	Pourbohloul, B (corresponding author), British Columbia Ctr Dis Control, Div Math Modeling, Vancouver, BC, Canada.	babak.p@ubc.ca	Kwok, Kin On/A-5074-2018	Kwok, Kin On/0000-0002-2804-5433; Riley, Steven/0000-0001-7904-4804	Canadian Institutes of Health Research [PTL-97126]; Michael Smith Foundation for Health Research [CI-SSH-00931(06-1)]; British Columbia Ministry of Health (Pandemic Preparedness Modeling Project); Medical Research Council (UK) [MR/J008761/1]; Wellcome Trust [093488/Z/10/Z]; National Institute for Health Research (UK, Health Protection Research Unit); Fogarty International Centre (FluScape) [R01 TW008246-01]; Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SARResearch Grants Council, Hong Kong [110642, PHE 21]; Research Grants Council, Hong Kong [776810]; FOGARTY INTERNATIONAL CENTER [R01TW008246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM110721] Funding Source: NIH RePORTER; MRC [MR/K010174/1, MR/J008761/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1, MR/K010174/1B, MR/J008761/1] Funding Source: researchfish; National Institute for Health Research [HPRU-2012-10080] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); British Columbia Ministry of Health (Pandemic Preparedness Modeling Project); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research (UK, Health Protection Research Unit); Fogarty International Centre (FluScape); Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SARResearch Grants Council, Hong Kong; Research Grants Council, Hong Kong(Hong Kong Research Grants Council); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	BP would like to acknowledge the support of the Canadian Institutes of Health Research (Grant No. PTL-97126), the Michael Smith Foundation for Health Research (Grant No. CI-SSH-00931(06-1)), and the British Columbia Ministry of Health (Pandemic Preparedness Modeling Project). SR thanks the Medical Research Council (UK, Project Grant MR/J008761/1), Wellcome Trust (Project Award 093488/Z/10/Z) and the National Institute for Health Research (UK, Health Protection Research Unit). KOK would like to acknowledge the support by R01 TW008246-01 from Fogarty International Centre (FluScape); the Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SAR (RFCID Number: 110642 and PHE 21) and Research Grants Council, Hong Kong (Grant No. 776810). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Cowling BJ, 2010, EPIDEMIOLOGY, V21, P842, DOI 10.1097/EDE.0b013e3181f20977; Davoudi B, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.031005; Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Glass K, 2012, EPIDEMIOLOGY, V23, P86, DOI 10.1097/EDE.0b013e31823a44a5; Kwok KO, 2014, P ROYAL SOC B; Kwok KO, 2014, TEMPORAL PATTERNS HU; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Meyers LA, 2005, J THEOR BIOL, V232, P71, DOI 10.1016/j.jtbi.2004.07.026; Noel PA, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.026101; Pourbohloul B, 2009, INFLUENZA OTHER RESP, V3, P215, DOI 10.1111/j.1750-2659.2009.00100.x; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Riley S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000442; Teukolsky S.A., 2007, NUMERICAL RECIPES, V3rd; Tuite AR, 2010, CAN MED ASSOC J, V182, P128, DOI 10.1503/cmaj.091807; Wallinga J, 2010, P NATL ACAD SCI; Wang LD, 2009, NEW ENGL J MED, V360, P121, DOI 10.1056/NEJMoa0800135; Wu JT, 2010, EMERG INFECT DIS, V16, P538, DOI 10.3201/eid1603.091216	20	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137959	10.1371/journal.pone.0137959	http://dx.doi.org/10.1371/journal.pone.0137959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372219	Green Published, Green Submitted, gold			2022-12-27	WOS:000361604400040
J	Xiang, Y; Wu, XQ; Zhou, AD				Xiang, Yang; Wu, Xiao-Qin; Zhou, Ai-Dong			Bacterial Diversity and Community Structure in the Pine Wood Nematode Bursaphelenchus xylophilus and B-mucronatus with Different Virulence by High-Throughput Sequencing of the 16S rDNA	PLOS ONE			English	Article							ENDOPHYTIC BACTERIA; PATHOGENICITY	Bursaphelenchus xylophilus is the pathogen of pine wilt disease. Bursaphelenchus mucronatus is similar to B. xylophilus in morphology. Both species share a common niche, but they are quite different in pathogenicity. Presently, the role of bacteria in pine wilt disease development has been widely speculated. The diversity of bacteria associated with B. xylophilus and B. mucronatus with different virulence remains unclear. In this study, virulence of four B. xylophilus and four B. mucronatus strains were evaluated by inoculating Pinus thunbergii. High-throughput sequencing targeted 16S rDNA of different virulence nematode strains was carried out. The associated bacterial community structures of the eight strains were analyzed. The results showed that 634,051 high-quality sequences were obtained from the eight nematode strains. The number of OTUs of bacteria associated with B. mucronatus was generally greater than those of B. xylophilus. The richness of the community of bacteria associated with high virulent B. xylophilus ZL1 and AmA3 was higher than moderately virulent B. xylophilus AA3, HE2, and all B. mucronatus strains. While the diversity of bacteria associated with B. mucronatus was higher than B. xylophilus. Stenotrophomonas, Pseudomonadaceae_Unclassified or Rhizobiaceae_Unclassified were predominant in the nematode strains with different virulence. Oxalobacteraceae and Achromobacter were found more abundant in the low virulent B. xylophilus and non-virulent B. mucronatus strains.	[Xiang, Yang; Wu, Xiao-Qin; Zhou, Ai-Dong] Nanjing Forestry Univ, Coll Forestry, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing, Jiangsu, Peoples R China; [Xiang, Yang; Wu, Xiao-Qin; Zhou, Ai-Dong] Nanjing Forestry Univ, Jiangsu Key Lab Prevent & Management Invas Specie, Nanjing, Jiangsu, Peoples R China	Nanjing Forestry University; Nanjing Forestry University	Wu, XQ (corresponding author), Nanjing Forestry Univ, Coll Forestry, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing, Jiangsu, Peoples R China.	xqwu@njfu.edu.cn			National Natural Science Foundation of China [31270683]; Southern China Collaborative Innovation Center of Sustainable Forestry; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Southern China Collaborative Innovation Center of Sustainable Forestry; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (NO. 31270683), Southern China Collaborative Innovation Center of Sustainable Forestry, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakke A, 1991, SCAND J FOREST RES, V6, P407, DOI 10.1080/02827589109382678; Braasch Helen, 1997, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes (Stuttgart), V49, P209; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cheng H. R. (et al.), 1983, Forest Pest and Disease, P1; Cheng XY, 2013, SCI REP-UK, V3, DOI 10.1038/srep01869; Chi SY, 2003, THESIS NANJING FORES; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Fang ZD, 1998, METHODS RES PLANT DI; FUTAI K, 1980, APPL ENTOMOL ZOOL, V15, P115, DOI 10.1303/aez.15.115; Ju Yunwei, 2008, Journal of Northeast Forestry University, V36, P84; Kanzaki N, 2006, NEMATOLOGY, V8, P485, DOI 10.1163/156854106778613994; Kawazu K, 1997, JAPANESE J NEMATOLOG, V27; Kawazu K, 1999, WHAT FACTORS GOVERN, P42; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; KIYOHARA T, 1990, FOREST SCI, V36, P1061; Li H, 2008, THESIS GHENT U; Liu X.L., 2007, THESIS NANJING FORES; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; MAMIYA Y, 1983, ANNU REV PHYTOPATHOL, V21, P201, DOI 10.1146/annurev.py.21.090183.001221; MAMIYA Y, 1979, NEMATOLOGICA, V25, P353, DOI 10.1163/187529279X00091; MCNAMARA D G, 1988, Bulletin OEPP, V18, P353, DOI 10.1111/j.1365-2338.1988.tb00386.x; Nascimento FX, 2014, ENV MICROBIOLOGY REP, DOI 10:1111/1758-2229.12202.; Paiva G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079705; PPQ New Pest Advisory Group, 2001, NPGA DAT BURS MUCR P; Proenca DN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105190; Proenca DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015191; Proenca DN, 2011, BACTERIA ARCHAEA COM; Shen PY, 1995, FOREST PEST DIS, V4, P1; Shinya R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067377; Tan JJ., 2008, CHINA FORESTRY SCI T, V22, P23; Tian XL, 2010, THESIS NW A F U; Tian XL, 2011, CURR MICROBIOL, V62, P117, DOI 10.1007/s00284-010-9681-7; TOMMINEN J, 1993, EUR J FOREST PATHOL, V23, P236; Vicente CSL, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-299; Vicente CSL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046661; Vicente CSL, 2011, ANTON LEEUW INT J G, V100, P477, DOI 10.1007/s10482-011-9602-1; Wu GuangChao, 2006, Acta Agriculturae Shanghai, V22, P61; Wu XQ, 2013, INT J BIOL SCI, V9, P34, DOI 10.7150/ijbs.5071; Yuan Weimin, 2011, Weishengwu Xuebao, V51, P1071; [岳秀娟 Yue Xiujuan], 2004, [微生物学通报, Microbiology], V31, P108; [张治宇 Zhang Zhiyu], 2002, [南京农业大学学报, Journal of Nanjing Agricultural University], V25, P43; Zhang ZY, 2004, J NANJING AGR U, V27, P46; Zhang ZY, 2001, J SHENYANG AGR U, V32, P28; Zhao BoGuang, 2005, Journal of Nanjing Forestry University (Natural Sciences Edition), V29, P1; Zhao YX, 2003, J SW FORESTRY COLL, V23, P62	45	24	26	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137386	10.1371/journal.pone.0137386	http://dx.doi.org/10.1371/journal.pone.0137386			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372013	Green Published, gold, Green Submitted			2022-12-27	WOS:000361604400018
J	Henao-Tamayo, M; Shanley, CA; Verma, D; Zilavy, A; Stapleton, MC; Furney, SK; Podell, B; Orme, IM				Henao-Tamayo, Marcela; Shanley, Crystal A.; Verma, Deepshikha; Zilavy, Andrew; Stapleton, Margaret C.; Furney, Synthia K.; Podell, Brendan; Orme, Ian M.			The Efficacy of the BCG Vaccine against Newly Emerging Clinical Strains of Mycobacterium tuberculosis	PLOS ONE			English	Article							W-BEIJING STRAINS; GUINEA-PIGS; PROTECTIVE EFFICACY; RHESUS MACAQUES; SOUTH-AFRICA; TB VACCINE; IMMUNITY; MODEL; RATES	To date, most new vaccines against Mycobacterium tuberculosis, including new recombinant versions of the current BCG vaccine, have usually been screened against the laboratory strains H37Rv or Erdman. In this study we took advantage of our recent work in characterizing an increasingly large panel of newly emerging clinical isolates [from the United States or from the Western Cape region of South Africa], to determine to what extent vaccines would protect against these [mostly high virulence] strains. We show here that both BCG Pasteur and recombinant BCG Aeras-422 [used here as a good example of the new generation BCG vaccines] protected well in both mouse and guinea pig low dose aerosol infection models against the majority of clinical isolates tested. However, Aeras-422 was not effective in a long term survival assay compared to BCG Pasteur. Protection was very strongly expressed against all of the Western Cape strains tested, reinforcing our viewpoint that any attempt at boosting BCG would be very difficult to achieve statistically. This observation is discussed in the context of the growing argument made by others that the failure of a recent vaccine trial disqualifies the further use of animal models to predict vaccine efficacy. This viewpoint is in our opinion completely erroneous, and that it is the fitness of prevalent strains in the trial site area that is the centrally important factor, an issue that is not being addressed by the field.	[Henao-Tamayo, Marcela; Shanley, Crystal A.; Verma, Deepshikha; Zilavy, Andrew; Stapleton, Margaret C.; Furney, Synthia K.; Podell, Brendan; Orme, Ian M.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA	Colorado State University	Orme, IM (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA.	ian.orme@colostate.edu	Henao-Tamayo, Marcela/D-8189-2017; Podell, Brendan/D-8396-2017	Henao-Tamayo, Marcela/0000-0002-4249-9650; Podell, Brendan/0000-0003-2548-8826	National Institutes of Health [AI106779]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI106779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI106779 to IMO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a018523; Brennan MJ, 2012, INT J TUBERC LUNG D, V16, P1566, DOI 10.5588/ijtld.12.0569; Falzon Dennis, 2013, Lancet Respir Med, V1, pe9, DOI 10.1016/S2213-2600(12)70056-5; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Jeon BY, 2008, INFECT IMMUN, V76, P5173, DOI 10.1128/IAI.00019-08; Johnson LF, 2015, AIDS, V29, P1401, DOI 10.1097/QAD.0000000000000721; Karim QA, 2011, INT J EPIDEMIOL, V40, P922, DOI 10.1093/ije/dyq176; Kato-Maeda M, 2012, CLIN VACCINE IMMUNOL, V19, P1227, DOI 10.1128/CVI.00250-12; Kupferschmidt K, 2011, SCIENCE, V334, P1488, DOI 10.1126/science.334.6062.1488; Martinez N, 2014, EUR J IMMUNOL, V44, P617, DOI 10.1002/eji.201344301; McShane H, 2014, TUBERCULOSIS, V94, P105, DOI 10.1016/j.tube.2013.11.003; Ordway D, 2007, J IMMUNOL, V179, P522, DOI 10.4049/jimmunol.179.1.522; Ordway DJ, 2011, CLIN VACCINE IMMUNOL, V18, P1527, DOI 10.1128/CVI.05127-11; Orme I, 2014, TUBERCULOSIS, V94, P717, DOI 10.1016/j.tube.2014.08.004; Orme IM, 2013, DRUGS, V73, P1015, DOI 10.1007/s40265-013-0081-8; Orme IM, 2011, FUTURE MICROBIOL, V6, P161, DOI 10.2217/FMB.10.168; Palanisamy GS, 2009, TUBERCULOSIS, V89, P203, DOI 10.1016/j.tube.2009.01.005; Podell BK, 2014, AM J PATHOL, V184, P1104, DOI 10.1016/j.ajpath.2013.12.015; Ramirez-Avila L, 2015, INT J STD AIDS, V26, P704, DOI 10.1177/0956462414551234; Shang SB, 2011, TUBERCULOSIS, V91, P378, DOI 10.1016/j.tube.2011.06.001; Shanley CA, 2013, VACCINE, V31, P5934, DOI 10.1016/j.vaccine.2013.10.044; Sharpe SA, 2010, CLIN VACCINE IMMUNOL, V17, P1170, DOI 10.1128/CVI.00079-10; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Verreck FAW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005264; Walker NF, 2013, FUTURE VIROL, V8, P57, DOI 10.2217/FVL.12.123; Williams A, 2005, INFECT IMMUN, V73, P3814, DOI 10.1128/IAI.73.6.3814-3816.2005; World Health Organization, 2014, GLOB TUB REP	28	27	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136500	10.1371/journal.pone.0136500	http://dx.doi.org/10.1371/journal.pone.0136500			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368806	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100018
J	Liu, M; Lam, MKH; Zhang, QF; Elderfield, R; Barclay, WS; Shaw, PC				Liu, Ming; Lam, Mandy Ka-Han; Zhang, Qinfen; Elderfield, Ruth; Barclay, Wendy S.; Shaw, Pang-Chui			The Functional Study of the N-Terminal Region of Influenza B Virus Nucleoprotein	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; NUCLEAR-LOCALIZATION; RNA-BINDING; REDUCED SENSITIVITY; REPLICATION; PROTEIN; ARCHITECTURE; EXPRESSION	Influenza nucleoprotein (NP) is a major component of the ribonucleoprotein (vRNP) in influenza virus, which functions for the transcription and replication of viral genome. Compared to the nucleoprotein of influenza A (ANP), the N-terminal region of influenza B nucleoprotein (BNP) is much extended. By virus reconstitution, we found that the first 38 residues are essential for viral growth. We further illustrated the function of BNP by mini-genome reconstitution, fluorescence microscopy, electron microscopy, light scattering and gel shift. Results show that the N terminus is involved in the formation of both higher homo-oligomers of BNP and BNP-RNA complex.	[Liu, Ming; Lam, Mandy Ka-Han; Shaw, Pang-Chui] Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Shatin, Hong Kong, Peoples R China; [Zhang, Qinfen] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Elderfield, Ruth; Barclay, Wendy S.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Virol Sect, London, England	Chinese University of Hong Kong; Sun Yat Sen University; Imperial College London	Shaw, PC (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Shatin, Hong Kong, Peoples R China.	pcshaw@cuhk.edu.hk		Barclay, Wendy/0000-0002-3948-0895	General Research Fund grant from the Research Grants Council of Hong Kong (PCS) [CUHK473810]; Area of Excellence Scheme of the University Grants Committee of Hong Kong [AoE/M-12/06]; University Grants Council of Hong Kong [SEG CUHK08]	General Research Fund grant from the Research Grants Council of Hong Kong (PCS); Area of Excellence Scheme of the University Grants Committee of Hong Kong; University Grants Council of Hong Kong	This research was supported by a General Research Fund grant (CUHK473810) from the Research Grants Council of Hong Kong (PCS), http://www.ugc.edu.hk/eng/rgc/index.htm, and an Area of Excellence Scheme of the University Grants Committee of Hong Kong (Grant AoE/M-12/06) (PCS). Equipment used was obtained through a Special Equipment Grant (SEG CUHK08) from the University Grants Council of Hong Kong, http://www.ugc.edu.hk/eng/ugc/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini AAV, 2006, SCIENCE, V313, P360, DOI 10.1126/science.1125280; Ariza A, 2013, NUCLEIC ACIDS RES, V41, P5912, DOI 10.1093/nar/gkt268; Escuret V, 2008, J CLIN VIROL, V41, P25, DOI 10.1016/j.jcv.2007.10.019; Glezen WP, 2013, AM J PUBLIC HEALTH, V103, pE43, DOI 10.2105/AJPH.2012.301137; Green TJ, 2006, SCIENCE, V313, P357, DOI 10.1126/science.1126953; Hatakeyama S, 2007, JAMA-J AM MED ASSOC, V297, P1435, DOI 10.1001/jama.297.13.1435; Hatta M, 2003, J VIROL, V77, P6050, DOI 10.1128/JVI.77.10.6050-6054.2003; Jackson D, 2002, J VIROL, V76, P11744, DOI 10.1128/JVI.76.22.11744-11747.2002; Jackson D, 2011, J GEN VIROL, V92, P1, DOI 10.1099/vir.0.026187-0; Jambrina E, 1997, VIROLOGY, V235, P209, DOI 10.1006/viro.1997.8682; Kawai N, 2006, CLIN INFECT DIS, V43, P439, DOI 10.1086/505868; Macville M, 1999, CANCER RES, V59, P141; MOWSHOWITZ SL, 1980, ARCH VIROL, V63, P159, DOI 10.1007/BF01320774; Ng AKL, 2008, FASEB J, V22, P3638, DOI 10.1096/fj.08-112110; Ng AKL, 2012, J VIROL, V86, P6758, DOI 10.1128/JVI.00073-12; Niu FF, 2013, P NATL ACAD SCI USA, V110, P9054, DOI 10.1073/pnas.1300035110; Ozawa M, 2007, J VIROL, V81, P30, DOI 10.1128/JVI.01434-06; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Rainsford EW, 2010, J VIROL, V84, P1741, DOI 10.1128/JVI.01803-09; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sherry L, 2014, J VIROL, V88, P12326, DOI 10.1128/JVI.01542-14; Stevens MP, 1998, J VIROL, V72, P5307, DOI 10.1128/JVI.72.6.5307-5312.1998; Wanitchang A, 2013, VIROLOGY, V443, P59, DOI 10.1016/j.virol.2013.04.025; Yang Yinhua, 2014, Biodesign, V2, P91; Zhao B, 2015, CLIN MICROBIOL INFEC, V21, P694, DOI 10.1016/j.cmi.2015.03.009	25	9	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137802	10.1371/journal.pone.0137802	http://dx.doi.org/10.1371/journal.pone.0137802			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368391	Green Published, Green Submitted, gold			2022-12-27	WOS:000361601100142
J	Zhang, XZ; Zhang, YW; Meng, QX; Li, N; Ren, LP				Zhang, Xinzhuang; Zhang, Yawei; Meng, Qingxiang; Li, Ning; Ren, Liping			Evaluation of Beef by Electronic Tongue System TS-5000Z: Flavor Assessment, Recognition and Chemical Compositions According to Its Correlation with Flavor	PLOS ONE			English	Article							MEAT QUALITY; GROUND-BEEF; TAURINE; CATTLE	The aim of this study was to assess the ability of electronic tongue system TS-5000Z to evaluate meat quality based on flavor assessment, recognition and correlation with the meat chemical composition. Meat was sampled from eighteen beef cattle including 6 Wagyu breed cattle, 6 Angus breed cattle and 6 Simmental breed cattle. Chemical composition including dry matter, crude protein, fat, ash, cholesterol and taurine and flavor of the meat were measured. The results showed that different breed cattle had different chemical compositions and flavor, which contains sourness, umami, saltiness, bitterness, astringency, aftertaste from astringency, aftertaste from bitterness and aftertaste from umami, respectively. A principal component analysis (PCA) showed an easily visible separation between different breeds of cattle and indicated that TS-5000Z made a rapid identification of different breeds of cattle. In addition, TS-5000Z seemed to be used to predict the chemical composition according to its correlation with the flavor. In conclusion, TS-5000Z would be used as a rapid analytical tool to evaluate the beef quality both qualitatively and quantitatively, based on flavor assessment, recognition and chemical composition according to its correlation with flavor.	[Zhang, Xinzhuang; Zhang, Yawei; Meng, Qingxiang; Ren, Liping] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing 100193, Peoples R China; [Li, Ning] Ying Sheng Hengtai Technol Co LTD, Beijing, Peoples R China	China Agricultural University	Ren, LP (corresponding author), China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing 100193, Peoples R China.	renlp@cau.edu.cn	Meng, Q./GSI-6185-2022	Zhang, Yawei/0000-0002-0571-8383	Beijing municipal government [201202910411136]	Beijing municipal government	This study was supported by a grant from the Beijing municipal government (201202910411136).	Andersen HJ, 2005, MEAT SCI, V70, P543, DOI 10.1016/j.meatsci.2004.07.015; AOAC, 1999, OFFICIAL METHODS ANA; Bartoshuk LM, 2000, CHEM SENSES, V25, P447, DOI 10.1093/chemse/25.4.447; Beullens K, 2008, SENSOR ACTUAT B-CHEM, V131, P10, DOI 10.1016/j.snb.2007.12.024; Calkins CR, 2007, MEAT SCI, V77, P63, DOI 10.1016/j.meatsci.2007.04.016; Chabanet C, 2013, MEAT SCI, V94, P253, DOI 10.1016/j.meatsci.2012.09.023; Chung KY, 2006, MEAT SCI, V73, P432, DOI 10.1016/j.meatsci.2006.01.002; Cram A, 2009, INT J PHARMACEUT, V365, P1, DOI 10.1016/j.ijpharm.2008.09.015; Dang YL, 2015, LWT-FOOD SCI TECHNOL, V60, P1179, DOI 10.1016/j.lwt.2014.09.014; Delwiche J, 2004, FOOD QUAL PREFER, V15, P137, DOI 10.1016/S0950-3293(03)00041-7; Escuder-Gilabert L, 2010, ANAL CHIM ACTA, V665, P15, DOI 10.1016/j.aca.2010.03.017; FISCHER U, 1994, AM J ENOL VITICULT, V45, P6; Guhmann M, 2012, INT J PHARMACEUT, V438, P81, DOI 10.1016/j.ijpharm.2012.08.047; Inoue H, 2003, ANAL BIOCHEM, V319, P138, DOI 10.1016/S0003-2697(03)00277-X; LEFEBVRE N, 1994, MEAT SCI, V36, P371, DOI 10.1016/0309-1740(94)90133-3; Legin A, 2003, ANAL CHIM ACTA, V484, P33, DOI 10.1016/S0003-2670(03)00301-5; Priolo A, 2001, ANIM RES, V50, P185, DOI 10.1051/animres:2001125; Rule DC, 2002, J ANIM SCI, V80, P1202; Silva J, 2012, INT J FOOD SCI TECH, V47, P1630; Stapleton PP, 1997, CLIN NUTR, V16, P103, DOI 10.1016/S0261-5614(97)80234-8; Togersen G, 2003, MEAT SCI, V63, P515, DOI 10.1016/S0309-1740(02)00113-4; Vlasov Y, 2002, ANAL BIOANAL CHEM, V373, P136, DOI 10.1007/s00216-002-1310-2; Woertz K, 2011, J PHARMACEUT BIOMED, V55, P272, DOI 10.1016/j.jpba.2011.02.002; Woertz K, 2010, J PHARMACEUT BIOMED, V51, P497, DOI 10.1016/j.jpba.2009.09.029; Xie XX, 2012, ASIAN AUSTRAL J ANIM, V25, P824, DOI 10.5713/ajas.2011.11462; Yamamoto K, 2013, SEMIN CELL DEV BIOL, V24, P240, DOI 10.1016/j.semcdb.2012.08.005; Zhang M, 2004, AMINO ACIDS, V26, P203, DOI 10.1007/s00726-003-0002-3	27	29	31	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137807	10.1371/journal.pone.0137807	http://dx.doi.org/10.1371/journal.pone.0137807			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368555	Green Published, gold, Green Submitted			2022-12-27	WOS:000361601100143
